PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Ferrer, A; Sebastian, R; Sanchez-Quintana, D; Rodriguez, JF; Godoy, EJ; Martinez, L; Saiz, J				Ferrer, Ana; Sebastian, Rafael; Sanchez-Quintana, Damian; Rodriguez, Jose F.; Godoy, Eduardo J.; Martinez, Laura; Saiz, Javier			Detailed Anatomical and Electrophysiological Models of Human Atria and Torso for the Simulation of Atrial Activation	PLOS ONE			English	Article							BODY-SURFACE; CONDUCTION-VELOCITY; SINUS RHYTHM; VOLUME CONDUCTOR; RATE-DEPENDENCE; CANINE RIGHT; HUMAN HEART; REPOLARIZATION; FIBRILLATION; ARCHITECTURE	Atrial arrhythmias, and specifically atrial fibrillation (AF), induce rapid and irregular activation patterns that appear on the torso surface as abnormal P-waves in electrocardiograms and body surface potential maps (BSPM). In recent years both P-waves and the BSPM have been used to identify the mechanisms underlying AF, such as localizing ectopic foci or high-frequency rotors. However, the relationship between the activation of the different areas of the atria and the characteristics of the BSPM and P-wave signals are still far from being completely understood. In this work we developed a multi-scale framework, which combines a highly-detailed 3D atrial model and a torso model to study the relationship between atrial activation and surface signals in sinus rhythm. Using this multi scale model, it was revealed that the best places for recording P-waves are the frontal upper right and the frontal and rear left quadrants of the torso. Our results also suggest that only nine regions (of the twenty-one structures in which the atrial surface was divided) make a significant contribution to the BSPM and determine the main P-wave characteristics.	[Ferrer, Ana; Godoy, Eduardo J.; Martinez, Laura; Saiz, Javier] Univ Politecn Valencia, Ctr Invest & Innovac Bioingn Ci2B, E-46071 Valencia, Spain; [Sebastian, Rafael] Univ Valencia, Dept Comp Sci, Computat Multiscale Physiol Lab CoMMLab, Valencia, Spain; [Sanchez-Quintana, Damian] Univ Extremadura, Fac Med, Dept Anat & Cell Biol, Badajoz, Spain; [Rodriguez, Jose F.] Univ Zaragoza, Appl Mech & Bioengn Grp AMB, Zaragoza, Spain; [Rodriguez, Jose F.] Politecn Milan, Dipartimento Chim Mat & Ingn Chim Giulio Natta, I-20133 Milan, Italy	Universitat Politecnica de Valencia; University of Valencia; Universidad de Extremadura; University of Zaragoza; Polytechnic University of Milan	Ferrer, A (corresponding author), Univ Politecn Valencia, Ctr Invest & Innovac Bioingn Ci2B, E-46071 Valencia, Spain.	anferal0@upvnet.upv.es	Matas, Jose F Rodriguez/H-4589-2011; Godoy, Eduardo Jorge/AAP-7659-2020; Martinez-Mateu, Laura/AAB-2815-2020; Sebastian, Rafael/E-9386-2011; Saiz, Javier/I-1295-2015	Matas, Jose F Rodriguez/0000-0001-7612-266X; Godoy, Eduardo Jorge/0000-0001-5625-2846; Martinez-Mateu, Laura/0000-0003-0291-7683; Sebastian, Rafael/0000-0001-6746-5740; Sanchez-Quintana, Damian/0000-0002-5374-8317; Saiz, Javier/0000-0002-9850-0825; Sanchez-Quintana, Damian/0000-0002-6714-5322	"VI Plan Nacional de Investigacion Cientifica, Desarrollo e Innovacion Tecnologica" from the Ministerio de Economia y Competitividad of Spain; European Commission (European Regional Development Funds - ERDF - FEDER) [TIN2012-37546-C03-01, TIN2014-59932-JIN]; "Programa Estatal de Investigacion, Desarrollo e Innovacion Orientado a los Retos de la Sociedad" from the Ministerio de Economia y Competitividad; "Programa Prometeo" from the Generalitat Valenciana [2012/030]	"VI Plan Nacional de Investigacion Cientifica, Desarrollo e Innovacion Tecnologica" from the Ministerio de Economia y Competitividad of Spain(Spanish Government); European Commission (European Regional Development Funds - ERDF - FEDER); "Programa Estatal de Investigacion, Desarrollo e Innovacion Orientado a los Retos de la Sociedad" from the Ministerio de Economia y Competitividad; "Programa Prometeo" from the Generalitat Valenciana	This work was partially supported by the "VI Plan Nacional de Investigacion Cientifica, Desarrollo e Innovacion Tecnologica" from the Ministerio de Economia y Competitividad of Spain and the European Commission (European Regional Development Funds - ERDF - FEDER), Award Number: TIN2012-37546-C03-01 (Recipient: Ana Ferrer); the "Programa Estatal de Investigacion, Desarrollo e Innovacion Orientado a los Retos de la Sociedad" from the Ministerio de Economia y Competitividad and the European Commission (European Regional Development Funds - ERDF - FEDER), Award Number: TIN2014-59932-JIN (Recipient: Rafael Sebastion); and the "Programa Prometeo" from the Generalitat Valenciana, Award Number: 2012/030 (Recipient: Laura Martinez).	ABBOUD S, 1991, CIRC RES, V68, P1751, DOI 10.1161/01.RES.68.6.1751; Cabrera JA, 2013, HEART, V99, P417, DOI 10.1136/heartjnl-2011-301154; Aslanidi OV, 2013, IEEE T MED IMAGING, V32, P8, DOI 10.1109/TMI.2012.2209183; Aslanidi OV, 2012, EUR J PHARM SCI, V46, P209, DOI 10.1016/j.ejps.2011.08.014; Aslanidi OV, 2011, IEEE ENG MED BIO, P1693, DOI 10.1109/IEMBS.2011.6090486; Aslanidi OV, 2011, PROG BIOPHYS MOL BIO, V107, P156, DOI 10.1016/j.pbiomolbio.2011.06.011; Boulakia M, 2010, ANN BIOMED ENG, V38, P1071, DOI 10.1007/s10439-009-9873-0; Bradley CP, 2000, ANN BIOMED ENG, V28, P721, DOI 10.1114/1.1289467; Bressler SL, 2006, WILEY ENCY BIOMEDICA, P1; Burdumy M, 2012, BIOMED ENG-BIOMED TE, V57, P79, DOI 10.1515/bmt-2011-0059; Cabrera JA, 2008, EUR HEART J, V29, P356, DOI 10.1093/eurheartj/ehm606; Cha TJ, 2005, CIRCULATION, V111, P728, DOI 10.1161/01.CIR.0000155240.05251.D0; Cibc, 2013, SEG3D VOL IM SEGM VI; Colman M, 2014, CARDIOLOGY, DOI [10.1007/978-3-319-01643-6, DOI 10.1007/978-3-319-01643-6]; Guillem MD, 2009, IEEE T INF TECHNOL B, V13, P330, DOI 10.1109/TITB.2008.2011894; Deng DD, 2012, J ZHEJIANG UNIV-SC B, V13, P676, DOI 10.1631/jzus.B1100339; Dobrev D, 2001, CIRCULATION, V104, P2551, DOI 10.1161/hc4601.099466; Dossel O, 2012, MED BIOL ENG COMPUT, V50, P773, DOI 10.1007/s11517-012-0924-6; Fedorov VV, 2010, J AM COLL CARDIOL, V56, P1386, DOI 10.1016/j.jacc.2010.03.098; Feng JL, 1998, CIRC RES, V83, P541, DOI 10.1161/01.RES.83.5.541; Fereniec M, 2011, MED SCI MONITOR, V17, pMT26, DOI 10.12659/MSM.881436; Gabriel S, 1996, PHYS MED BIOL, V41, P2251, DOI 10.1088/0031-9155/41/11/002; Gozolits S, 2002, J CARDIOVASC ELECTR, V13, P1240, DOI 10.1046/j.1540-8167.2002.01240.x; Hansson A, 1998, EUR HEART J, V19, P293, DOI 10.1053/euhj.1997.0742; Heidenreich EA, 2010, ANN BIOMED ENG, V38, P2331, DOI 10.1007/s10439-010-9997-2; Ho SY, 2009, CLIN ANAT, V22, P52, DOI 10.1002/ca.20634; Ho SY, 2012, CIRC-ARRHYTHMIA ELEC, V5, P220, DOI 10.1161/CIRCEP.111.962720; Ho SY, 2010, PACE, V33, P620, DOI 10.1111/j.1540-8159.2009.02659.x; Huo Y, 2014, J ELECTROCARDIOL, V47, P275, DOI 10.1016/j.jelectrocard.2014.01.011; January CT, 2014, J AM COLL CARDIOL, V64, P2304, DOI 10.1016/j.jacc.2014.04.004; Keller DUJ, 2010, IEEE T BIO-MED ENG, V57, P1568, DOI 10.1109/TBME.2010.2046485; Klepfer RN, 1997, IEEE T BIO-MED ENG, V44, P706, DOI 10.1109/10.605427; Kojodjojo P, 2006, J CARDIOVASC ELECTR, V17, P120, DOI 10.1111/j.1540-8167.2005.00293.x; Kozlikova K, 2007, PHYSIOL RES, V56, pS123, DOI 10.33549/physiolres.931310; Krogh-Madsen T, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002390; Krueger MW, 2013, MED BIOL ENG COMPUT, V51, P1105, DOI 10.1007/s11517-013-1090-1; Krueger MW, 2013, IEEE T MED IMAGING, V32, P73, DOI 10.1109/TMI.2012.2201948; Krueger MW, 2010, BIOMED TECH ENG, V55, P1, DOI [10.1515/bmt.2010.712, DOI 10.1515/BMT.2010.712]; Kruger M., 2012, PERSONALIZED MULTISC; Lamata P, 2013, IEEE T MED IMAGING, V32, P130, DOI 10.1109/TMI.2012.2231094; Lemery R, 2007, J CARDIOVASC ELECTR, V18, P402, DOI 10.1111/j.1540-8167.2007.00762.x; Lenkova J, 2012, J ELECTROCARDIOL, V45, P231, DOI 10.1016/j.jelectrocard.2012.01.006; LEON LJ, 1991, J ELECTROCARDIOL, V24, P1, DOI 10.1016/0022-0736(91)90077-Y; Li DS, 2001, CIRC RES, V88, P1168, DOI 10.1161/hh1101.091266; Lian J, 2002, MED BIOL ENG COMPUT, V40, P650, DOI 10.1007/BF02345304; Lux RL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085689; MACLEOD RS, 1991, PROCEEDINGS OF THE ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING IN MEDICINE AND BIOLOGY SOCIETY, VOL 13, PTS 1-5, P688, DOI 10.1109/IEMBS.1991.684145; Maesen B, 2013, CIRC-ARRHYTHMIA ELEC, V6, P967, DOI 10.1161/CIRCEP.113.000050; Maleckar MM, 2009, AM J PHYSIOL-HEART C, V297, pH1398, DOI 10.1152/ajpheart.00411.2009; Malmivuo P., 1995, BIOELECTROMAGNETISM; Nygren A, 1998, CIRC RES, V82, P63; Poletti E, 2009, IFMBE PROC, V25, P137, DOI 10.1007/978-3-642-03891-4_37; Ramanathan C, 2006, P NATL ACAD SCI USA, V103, P6309, DOI 10.1073/pnas.0601533103; ROBERTS DE, 1979, CIRC RES, V44, P701, DOI 10.1161/01.RES.44.5.701; Rodrigo M, 2014, HEART RHYTHM, V11, P1584, DOI 10.1016/j.hrthm.2014.05.013; RUDY Y, 1980, CIRC RES, V46, P283, DOI 10.1161/01.RES.46.2.283; Safdarian Naser, 2013, J Med Signals Sens, V3, P129; SAFFITZ JE, 1994, CIRC RES, V74, P1065, DOI 10.1161/01.RES.74.6.1065; Sanchez-Quintana D, 2013, J CARDIOVASC TRANSL, V6, P124, DOI 10.1007/s12265-013-9447-2; Sanchez-Quintana D, 2012, CURR CARDIOL REV, V8, P310, DOI 10.2174/157340312803760721; Seemann G, 2006, PHILOS T R SOC A, V364, P1465, DOI 10.1098/rsta.2006.1781; Si H, 2005, PROCEEDINGS OF THE 14TH INTERNATIONAL MESHING ROUNDTABLE, P147, DOI 10.1007/3-540-29090-7_9; SippensGroenewegen A, 1998, CIRCULATION, V97, P369; SPACH MS, 1988, CIRC RES, V62, P811, DOI 10.1161/01.RES.62.4.811; Tobon C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0050883; van Dam Peter M, 2005, Europace, V7 Suppl 2, P30, DOI 10.1016/j.eupc.2005.03.013; van der Graaf AWM, 2014, ANN NONINVAS ELECTRO, V19, P105, DOI 10.1111/anec.12140; WANG Z, 1990, CIRCULATION, V82, P274, DOI 10.1161/01.CIR.82.1.274; WANG ZG, 1993, CIRC RES, V73, P1061, DOI 10.1161/01.RES.73.6.1061; Weber FM, 2011, IEEE T BIO-MED ENG, V58, P265, DOI 10.1109/TBME.2010.2090151; Wilhelms Mathias, 2012, Front Physiol, V3, P487, DOI 10.3389/fphys.2012.00487; Zarychta P, 2007, COMPUT CARDIOL, V34, P181, DOI 10.1109/CIC.2007.4745451; Zhao JC, 2012, CIRC-ARRHYTHMIA ELEC, V5, P361, DOI 10.1161/CIRCEP.111.967950	73	39	40	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2015	10	11							e0141573	10.1371/journal.pone.0141573	http://dx.doi.org/10.1371/journal.pone.0141573			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV1PG	26523732	Green Published, gold, Green Submitted			2022-12-26	WOS:000364029800012
J	Foguet-Boreu, Q; Violan, C; Rodriguez-Blanco, T; Roso-Llorach, A; Pons-Vigues, M; Pujol-Ribera, E; Gil, YC; Valderas, JM				Foguet-Boreu, Quinti; Violan, Concepcion; Rodriguez-Blanco, Teresa; Roso-Llorach, Albert; Pons-Vigues, Mariona; Pujol-Ribera, Enriqueta; Cossio Gil, Yolima; Valderas, Jose M.			Multimorbidity Patterns in Elderly Primary Health Care Patients in a South Mediterranean European Region: A Cluster Analysis	PLOS ONE			English	Article							SOCIOECONOMIC-STATUS; PREVALENCE; POPULATION; DISORDERS; SERVICES; GENDER; LIFE; AGE	Objective The purpose of this study was to identify clusters of diagnoses in elderly patients with multimorbidity, attended in primary care. Design Cross-sectional study. Setting 251 primary care centres in Catalonia, Spain. Participants Individuals older than 64 years registered with participating practices. Main outcome measures Multimorbidity, defined as the coexistence of 2 or more ICD-10 disease categories in the electronic health record. Using hierarchical cluster analysis, multimorbidity clusters were identified by sex and age group (65-79 and >= 80 years). Results 322,328 patients with multimorbidity were included in the analysis (mean age, 75.4 years [Standard deviation, SD: 7.4], 57.4% women; mean of 7.9 diagnoses [SD: 3.9]). For both men and women, the first cluster in both age groups included the same two diagnoses: Hypertensive diseases and Metabolic disorders. The second cluster contained three diagnoses of the musculoskeletal system in the 65- to 79-year-old group, and five diseases coincided in the >= 80 age group: varicose veins of the lower limbs, senile cataract, dorsalgia, functional intestinal disorders and shoulder lesions. The greatest overlap (54.5%) between the three most common diagnoses was observed in women aged 65-79 years. Conclusion This cluster analysis of elderly primary care patients with multimorbidity, revealed a single cluster of circulatory-metabolic diseases that were the most prevalent in both age groups and sex, and a cluster of second-most prevalent diagnoses that included musculoskeletal diseases. Clusters unknown to date have been identified. The clusters identified should be considered when developing clinical guidance for this population.	[Foguet-Boreu, Quinti; Violan, Concepcion; Rodriguez-Blanco, Teresa; Roso-Llorach, Albert; Pons-Vigues, Mariona; Pujol-Ribera, Enriqueta; Cossio Gil, Yolima] Univ Autonoma Barcelona, Inst Univ Invest Atencio Primaria Jordi Gol IDIAP, E-08193 Barcelona, Spain; [Foguet-Boreu, Quinti; Pons-Vigues, Mariona; Pujol-Ribera, Enriqueta] Univ Girona, Girona, Catalonia, Spain; [Valderas, Jose M.] Univ Exeter, Sch Med, Hlth Serv & Policy Res Grp, Exeter, Devon, England	Autonomous University of Barcelona; Universitat de Girona; University of Exeter	Foguet-Boreu, Q (corresponding author), Univ Autonoma Barcelona, Inst Univ Invest Atencio Primaria Jordi Gol IDIAP, Gran Via Corts Catalanes,587 Atic, E-08193 Barcelona, Spain.	42292qfb@comb.cat	Pons-Vigués, Mariona/D-6079-2019; Valderas, Jose M/Y-9814-2019; Violán, Concepcion/HHC-2893-2022; Martín, Teresa Rodríguez/GZL-1938-2022; Valderas, Jose M/G-7967-2014; Violan, Concepcion/I-4493-2019	Pons-Vigués, Mariona/0000-0002-7929-3701; Violán, Concepcion/0000-0003-3309-5360; Valderas, Jose M/0000-0002-9299-1555; Violan, Concepcion/0000-0003-3309-5360; Rodriguez-Blanco, Teresa/0000-0003-1395-9723; Roso-Llorach, Albert/0000-0002-9264-0405; Foguet-Boreu, Quinti/0000-0002-6069-5305; Pujol Ribera, Enriqueta/0000-0002-9475-0755	Ministry of Science and Innovation through the Instituto Carlos III (ISCiii) under the National Plan for Scientific Research, Development and Technological Innovation; European Regional Development Fund, Primary Care Prevention and Health Promotion Research Network (rediAPP) [IP12/00427]; ISCiii-RETICS [RD12/0005]; Institut Universitari d'Investigacio en Atencio Primaria Jordi Gol (IDIAP Jordi Gol); National Institute for Health Research Clinician Scientist Award [NIHR/CS/010/024]; XIX by Agrupacio Mutua Foundation; National Institute for Health Research [NIHR/CS/010/024] Funding Source: researchfish	Ministry of Science and Innovation through the Instituto Carlos III (ISCiii) under the National Plan for Scientific Research, Development and Technological Innovation; European Regional Development Fund, Primary Care Prevention and Health Promotion Research Network (rediAPP); ISCiii-RETICS; Institut Universitari d'Investigacio en Atencio Primaria Jordi Gol (IDIAP Jordi Gol); National Institute for Health Research Clinician Scientist Award; XIX by Agrupacio Mutua Foundation; National Institute for Health Research(National Institute for Health Research (NIHR))	This study was supported by a grant from the Ministry of Science and Innovation through the Instituto Carlos III (ISCiii) in the 2012 call for Strategic Health Action proposals under the National Plan for Scientific Research, Development and Technological Innovation 2008-2011; by the European Union through the European Regional Development Fund (IP12/00427), as part of the Primary Care Prevention and Health Promotion Research Network (rediAPP), by ISCiii-RETICS (RD12/0005), by a 2011-2013 scholarship that aims to promote research in Primary Health Care by health professionals who have completed their specialty training, awarded by Institut Universitari d'Investigacio en Atencio Primaria Jordi Gol (IDIAP Jordi Gol), by a National Institute for Health Research Clinician Scientist Award (Jose M Valderas, NIHR/CS/010/024) and by a grant from the XIX call for research projects in the elderly population by Agrupacio Mutua Foundation (Premio ambito para las personas mayores, 2012). The funders had no role in the study design, collection, analysis and interpretation of data, writing of the manuscript or decision to submit for publication.	Aldenderfer MS, 1984, CLUSTER ANAL QUANTIT; Blozik E, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-352; Cornell JE, 2007, APPL MULTIVARIATE RE, V2007, P163, DOI [10.22329/amr.v12i3.658, DOI 10.22329/AMR.V12I3.658]; Everitt B. S, 2011, CLUSTER ANAL, DOI DOI 10.1002/9780470977811; Foguet-Boreu Q, 2014, BMC FAM PRACT, V15, DOI 10.1186/1471-2296-15-55; Fortin M, 2012, ANN FAM MED, V10, P142, DOI 10.1370/afm.1337; Fortin M, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-111; Freund T, 2012, POPUL HEALTH MANAG, V15, P119, DOI 10.1089/pop.2011.0026; Frost H. M., 2003, Journal of Musculoskeletal & Neuronal Interactions, V3, P201; Garcia-Gil M Del Mar, 2011, Inform Prim Care, V19, P135; Garin N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084794; Gatchel R.J., 2011, PRACT PAIN MANAG, V11, P1; Haregu T, 2012, INTERNET J EPIDEMIOL; Hemingway H, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.e5595; Marengoni A, 2011, AGEING RES REV, V10, P430, DOI 10.1016/j.arr.2011.03.003; Abad-Diez JM, 2014, BMC GERIATR, V14, DOI 10.1186/1471-2318-14-75; McWilliams LA, 2003, PAIN, V106, P127, DOI 10.1016/S0304-3959(03)00301-4; Menche J, 2015, SCIENCE, V347, DOI 10.1126/science.1257601; Prados-Torres A, 2014, J CLIN EPIDEMIOL, V67, P254, DOI 10.1016/j.jclinepi.2013.09.021; Prados-Torres A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032190; Raina P, 2002, HEALTH SERV RES, V37, P751, DOI 10.1111/1475-6773.00047; SAS Institute Inc, 2008, STAT AN SYST SAS STA; Schafer A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014060; Schafer I, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-89; Shimodaira H, 2004, ANN STAT, V32, P2616, DOI 10.1214/009053604000000823; van den Bussche H, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-101; Velasco S, 2006, REV ESP SALUD PUBLIC, V80, P317, DOI 10.1590/S1135-57272006000400003; Violan C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102149; Violan C, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-530; Violan C, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-251; Wallace E, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h176; Weiss CO, 2014, J GEN INTERN MED, V29, P653, DOI 10.1007/s11606-013-2660-5	32	30	32	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2015	10	11							e0141155	10.1371/journal.pone.0141155	http://dx.doi.org/10.1371/journal.pone.0141155			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV1PG	26524599	Green Published, gold, Green Submitted			2022-12-26	WOS:000364029800007
J	Alvarado, SG; Lenkov, K; Williams, B; Fernald, RD				Alvarado, Sebastian G.; Lenkov, Kapa; Williams, Blake; Fernald, Russell D.			Social Crowding during Development Causes Changes in GnRH1 DNA Methylation	PLOS ONE			English	Article							GONADOTROPIN-RELEASING-HORMONE; PROTEIN-RESTRICTED DIET; GENE-EXPRESSION; GLUCOCORTICOID-RECEPTOR; EPIGENETIC REGULATION; IN-VIVO; CPG METHYLATION; GENOME-WIDE; PROMOTER; DEPRESSION	Gestational and developmental cues have important consequences for long-term health, behavior and adaptation to the environment. In addition, social stressors cause plastic molecular changes in the brain that underlie unique behavioral phenotypes that also modulate fitness. In the adult African cichlid, Astatotilapia burtoni, growth and social status of males are both directly regulated by social interactions in a dynamic social environment, which causes a suite of plastic changes in circuits, cells and gene transcription in the brain. We hypothesized that a possible mechanism underlying some molecular changes might be DNA methylation, a reversible modification made to cytosine nucleotides that is known to regulate gene function. Here we asked whether changes in DNA methylation of the GnRH1 gene, the central regulator of the reproductive axis, were altered during development of A. burtoni. We measured changes in methylation state of the GnRH1 gene during normal development and following the gestational and developmental stress of social crowding. We found differential DNA methylation within developing juveniles between 14-, 28- and 42-day-old. Following gestational crowding of mouth brooding mothers, we saw differential methylation and transcription of GnRH1 in their offspring. Taken together, our data provides evidence for social control of GnRH1 developmental responses to gestational cues through DNA methylation.	[Fernald, Russell D.] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; Stanford Univ, Inst Neurosci, Stanford, CA 94305 USA	Stanford University; Stanford University	Fernald, RD (corresponding author), Stanford Univ, Dept Biol, Gilbert Hall,371 Serra Mall, Stanford, CA 94305 USA.	rfernald@stanford.edu	Alvarado, Sebastian/S-7607-2018	Alvarado, Sebastian/0000-0001-5866-4043	Stanford Interdisciplinary Graduate Fellowship; VPUE Fellowship;  [NIH-NS 034950];  [NSF IOS-0923588]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS034950, R01NS034950, R56NS034950] Funding Source: NIH RePORTER	Stanford Interdisciplinary Graduate Fellowship; VPUE Fellowship; ; ; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research was supported by Stanford Interdisciplinary Graduate Fellowship to KL, VPUE Fellowship (BW), and grants NIH-NS 034950 and NSF IOS-0923588 to R.D.F. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarado S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7513; Alvarado S, 2014, INTEGR COMP BIOL, V54, P68, DOI 10.1093/icb/icu034; Batten SV, 2004, J CLIN PSYCHIAT, V65, P249; Bonasio R, 2012, CURR BIOL, V22, P1755, DOI 10.1016/j.cub.2012.07.042; Bradley RG, 2008, ARCH GEN PSYCHIAT, V65, P190, DOI 10.1001/archgenpsychiatry.2007.26; Burmeister SS, 2007, HORM BEHAV, V51, P164, DOI 10.1016/j.yhbeh.2006.09.008; Burmeister SS, 2005, PLOS BIOL, V3, P1996, DOI 10.1371/journal.pbio.0030363; CLARK SJ, 1994, NUCLEIC ACIDS RES, V22, P2990, DOI 10.1093/nar/22.15.2990; DAVIS MR, 1990, J NEUROBIOL, V21, P1180, DOI 10.1002/neu.480210804; Dias BG, 2014, NAT NEUROSCI, V17, P89, DOI 10.1038/nn.3594; Feng SH, 2010, P NATL ACAD SCI USA, V107, P8689, DOI 10.1073/pnas.1002720107; Fernald RD, 1999, FRONT NEUROENDOCRIN, V20, P224, DOI 10.1006/frne.1999.0181; FERNALD RD, 1977, ANIM BEHAV, V25, P964, DOI 10.1016/0003-3472(77)90048-3; FRALEY NB, 1982, Z TIERPSYCHOL, V60, P66; FRANCIS RC, 1993, P NATL ACAD SCI USA, V90, P7794, DOI 10.1073/pnas.90.16.7794; Franklin TB, 2010, BIOL PSYCHIAT, V68, P408, DOI 10.1016/j.biopsych.2010.05.036; Gharizadeh B, 2006, J BIOTECHNOL, V124, P504, DOI 10.1016/j.jbiotec.2006.01.025; Gore AC, 1997, FRONT NEUROENDOCRIN, V18, P209, DOI 10.1006/frne.1996.0149; Gore AC, 2002, PROG BRAIN RES, V141, P193; Gregg C, 2010, SCIENCE, V329, P643, DOI 10.1126/science.1190830; Hellman A, 2007, SCIENCE, V315, P1141, DOI 10.1126/science.1136352; Herman JG, 2003, NEW ENGL J MED, V349, P2042, DOI 10.1056/NEJMra023075; Hofmann HA, 2000, J NEUROSCI, V20, P4740, DOI 10.1523/JNEUROSCI.20-12-04740.2000; Iyer AK, 2011, MOL ENDOCRINOL, V25, P460, DOI 10.1210/me.2010-0403; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Jones PA, 2012, NAT REV GENET, V13, P484, DOI 10.1038/nrg3230; Kalantaridou SN, 2003, ANN NY ACAD SCI, V997, P129, DOI 10.1196/annals.1290.015; Klug M, 2006, EPIGENETICS-US, V1, P127, DOI 10.4161/epi.1.3.3327; Kubosaki A, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-4-r41; Laurent L, 2010, GENOME RES, V20, P320, DOI 10.1101/gr.101907.109; Lillycrop KA, 2008, BRIT J NUTR, V100, P278, DOI 10.1017/S0007114507894438; Lillycrop KA, 2007, BRIT J NUTR, V97, P1064, DOI 10.1017/S000711450769196X; Lyko F, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000506; Maruska KP, 2011, PHYSIOLOGY, V26, P412, DOI 10.1152/physiol.00032.2011; McGowan PO, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002085; McGowan PO, 2009, NAT NEUROSCI, V12, P342, DOI 10.1038/nn.2270; Mueller BR, 2008, J NEUROSCI, V28, P9055, DOI 10.1523/JNEUROSCI.1424-08.2008; Murgatroyd C, 2009, NAT NEUROSCI, V12, P1559, DOI 10.1038/nn.2436; Nelson SB, 1998, MOL CELL ENDOCRINOL, V140, P151, DOI 10.1016/S0303-7207(98)00043-4; Oberlander TF, 2008, EPIGENETICS-US, V3, P97, DOI 10.4161/epi.3.2.6034; OKA Y, 1990, J COMP NEUROL, V300, P511, DOI 10.1002/cne.903000406; Onishchenko N, 2008, J NEUROCHEM, V106, P1378, DOI 10.1111/j.1471-4159.2008.05484.x; Pavlidis M, 2013, ZEBRAFISH, V10, P524, DOI 10.1089/zeb.2012.0819; Razin A, 1998, EMBO J, V17, P4905, DOI 10.1093/emboj/17.17.4905; Roth TL, 2009, BIOL PSYCHIAT, V65, P760, DOI 10.1016/j.biopsych.2008.11.028; Sisk CL, 2001, ENDOCRINOLOGY, V142, P2929, DOI 10.1210/en.142.7.2929; Somoza GM, 2002, CELL MOL NEUROBIOL, V22, P589, DOI 10.1023/A:1021888420271; Szyf M, 2008, ENVIRON MOL MUTAGEN, V49, P46, DOI 10.1002/em.20357; Tajerian M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055259; Tsigos C, 2002, J PSYCHOSOM RES, V53, P865, DOI 10.1016/S0022-3999(02)00429-4; URBANSKI HF, 1985, ENDOCRINOLOGY, V117, P644, DOI 10.1210/endo-117-2-644; WATANABE G, 1989, ENDOCRINOLOGY, V125, P92, DOI 10.1210/endo-125-1-92; Weaver ICG, 2004, NAT NEUROSCI, V7, P847, DOI 10.1038/nn1276; Weiner SA, 2013, NATURWISSENSCHAFTEN, V100, P795, DOI 10.1007/s00114-013-1064-z; White RB, 1998, GEN COMP ENDOCR, V112, P322, DOI 10.1006/gcen.1998.7142; WHITE SA, 1993, J NEUROSCI, V13, P434	56	11	12	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2015	10	10							e0142043	10.1371/journal.pone.0142043	http://dx.doi.org/10.1371/journal.pone.0142043			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0EH	26517121	Green Published, gold			2022-12-26	WOS:000363920800104
J	Tremblay-Franco, M; Cabaton, NJ; Canlet, C; Gautier, R; Schaeberle, CM; Jourdan, F; Sonnenschein, C; Vinson, F; Soto, AM; Zalko, D				Tremblay-Franco, Marie; Cabaton, Nicolas J.; Canlet, Cecile; Gautier, Roselyne; Schaeberle, Cheryl M.; Jourdan, Fabien; Sonnenschein, Carlos; Vinson, Florence; Soto, Ana M.; Zalko, Daniel			Dynamic Metabolic Disruption in Rats Perinatally Exposed to Low Doses of Bisphenol-A	PLOS ONE			English	Article							CD-1 MICE; ASCA; CHEMICALS; NETWORKS; DISORDERS; HORMONES; DESIGN	Along with the well-established effects on fertility and fecundity, perinatal exposure to endocrine disrupting chemicals, and notably to xeno-estrogens, is strongly suspected of modulating general metabolism. The metabolism of a perinatally exposed individual may be durably altered leading to a higher susceptibility of developing metabolic disorders such as obesity and diabetes; however, experimental designs involving the long term study of these dynamic changes in the metabolome raise novel challenges. H-1-NMR-based metabolomics was applied to study the effects of bisphenol-A (BPA, 0; 0.25; 2.5, 25 and 250 mu g/kg BW/day) in rats exposed perinatally. Serum and liver samples of exposed animals were analyzed on days 21, 50, 90, 140 and 200 in order to explore whether maternal exposure to BPA alters metabolism. Partial Least Squares-Discriminant Analysis (PLS-DA) was independently applied to each time point, demonstrating a significant pair-wise discrimination for liver as well as serum samples at all time-points, and highlighting unequivocal metabolic shifts in rats perinatally exposed to BPA, including those exposed to lower doses. In BPA exposed animals, metabolism of glucose, lactate and fatty acids was modified over time. To further explore dynamic variation, ANOVA-Simultaneous Component Analysis (A-SCA) was used to separate data into blocks corresponding to the different sources of variation (Time, Dose and Time*Dose interaction). A-SCA enabled the demonstration of a dynamic, time/age dependent shift of serum metabolome throughout the rats' lifetimes. Variables responsible for the discrimination between groups clearly indicate that BPA modulates energy metabolism, and suggest alterations of neurotransmitter signaling, the latter finding being compatible with the neurodevelopmental effect of this xenoestrogen. In conclusion, long lasting metabolic effects of BPA could be characterized over 200 days, despite physiological (and thus metabolic) changes connected with sexual maturation and aging.	[Tremblay-Franco, Marie; Cabaton, Nicolas J.; Canlet, Cecile; Gautier, Roselyne; Jourdan, Fabien; Vinson, Florence; Zalko, Daniel] Univ Toulouse, INRA, Res Ctr Food Toxicol, TOXALIM,UMR1331, Toulouse, France; [Schaeberle, Cheryl M.; Sonnenschein, Carlos; Soto, Ana M.] Tufts Univ, Sch Med, Dept Integrat Physiol & Pathobiol, Boston, MA 02111 USA	INRAE; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Tufts University	Zalko, D (corresponding author), Univ Toulouse, INRA, Res Ctr Food Toxicol, TOXALIM,UMR1331, Toulouse, France.	daniel.zalko@toulouse.inra.fr	Jourdan, Fabien/AAW-5075-2021	Jourdan, Fabien/0000-0001-9401-2894; Schaeberle, Cheryl/0000-0001-9635-429X	National Institute of Environmental Health Sciences [R01ES08314];  [RC2ES018822]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [RC2ES018822, R01ES008314] Funding Source: NIH RePORTER	National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); ; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by Award Number RC2ES018822 and its supplement, as well as R01ES08314 from the National Institute of Environmental Health Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acevedo N, 2013, ENVIRON HEALTH PERSP, V121, P1040, DOI 10.1289/ehp.1306734; Alonso-Magdalena P, 2010, ENVIRON HEALTH PERSP, V118, P1243, DOI 10.1289/ehp.1001993; Cabaton NJ, 2013, ENVIRON HEALTH PERSP, V121, P586, DOI 10.1289/ehp.1205588; Cabaton NJ, 2011, ENVIRON HEALTH PERSP, V119, P547, DOI 10.1289/ehp.1002559; Calafat AM, 2008, ENVIRON HEALTH PERSP, V116, P39, DOI 10.1289/ehp.10753; Cline MS, 2007, NAT PROTOC, V2, P2366, DOI 10.1038/nprot.2007.324; Cottret L, 2010, NUCLEIC ACIDS RES, V38, pW132, DOI 10.1093/nar/gkq312; Crain DA, 2008, FERTIL STERIL, V90, P911, DOI 10.1016/j.fertnstert.2008.08.067; Diamanti-Kandarakis E, 2009, ENDOCR REV, V30, P293, DOI 10.1210/er.2009-0002; Faust K, 2010, BIOINFORMATICS, V26, P1211, DOI 10.1093/bioinformatics/btq105; Garcia-Arevalo M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100214; Janesick A, 2011, BIRTH DEFECTS RES C, V93, P34, DOI 10.1002/bdrc.20197; Jansen JJ, 2005, J CHEMOMETR, V19, P469, DOI 10.1002/cem.952; Jourdan F, 2010, METABOLOMICS, V6, P312, DOI 10.1007/s11306-009-0196-9; KRUSKAL WH, 1952, J AM STAT ASSOC, V47, P583, DOI 10.1080/01621459.1952.10483441; Li C, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-92; Markey CM, 2005, BIOL REPROD, V72, P1344, DOI 10.1095/biolreprod.104.036301; McCombie G, 2009, METABOLOMICS, V5, P363, DOI 10.1007/s11306-009-0161-7; Rubin BS, 2011, J STEROID BIOCHEM, V127, P27, DOI 10.1016/j.jsbmb.2011.05.002; Rubin BS, 2001, ENVIRON HEALTH PERSP, V109, P675, DOI 10.2307/3454783; Saal FSV, 2012, MOL CELL ENDOCRINOL, V354, P74, DOI 10.1016/j.mce.2012.01.001; Schonfelder G, 2002, ENVIRON HEALTH PERSP, V110, pA703, DOI 10.1289/ehp.021100703; Smilde AK, 2008, J CHEMOMETR, V22, P464, DOI 10.1002/cem.1175; Smilde AK, 2005, BIOINFORMATICS, V21, P3043, DOI 10.1093/bioinformatics/bti476; Somm E, 2009, ENVIRON HEALTH PERSP, V117, P1549, DOI 10.1289/ehp.11342; SOTO AM, 1992, ADV MOD ENV, V21, P295; Stahlhut RW, 2009, ENVIRON HEALTH PERSP, V117, P784, DOI 10.1289/ehp.0800376; Thissen U, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-52; Vandenberg LN, 2014, VITAM HORM, V94, P129, DOI 10.1016/B978-0-12-800095-3.00005-5; Vandenberg LN, 2012, ENDOCR REV, V33, P378, DOI 10.1210/er.2011-1050; Vis DJ, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-322; vom Saal FS, 2008, JAMA-J AM MED ASSOC, V300, P1353, DOI 10.1001/jama.300.11.1353; Wold S, 1998, CHEMOMETR INTELL LAB, V44, P175, DOI 10.1016/S0169-7439(98)00109-9; Zalko D, 2011, CHEMOSPHERE, V82, P424, DOI 10.1016/j.chemosphere.2010.09.058; Zeng J, 2013, ENVIRON SCI TECHNOL, V47, P7457, DOI 10.1021/es400490f	35	28	29	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2015	10	10							e0141698	10.1371/journal.pone.0141698	http://dx.doi.org/10.1371/journal.pone.0141698			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0EH	26517871	Green Published, gold, Green Submitted			2022-12-26	WOS:000363920800070
J	Banda, R; Sandoy, IF; Fylkesnes, K; Janssen, F				Banda, Richard; Sandoy, Ingvild Fossgard; Fylkesnes, Knut; Janssen, Fanny			Impact of Pregnancy-Related Deaths on Female Life Expectancy in Zambia: Application of Life Table Techniques to Census Data	PLOS ONE			English	Article							MATERNAL MORTALITY; SYSTEMATIC ANALYSIS; HIV-INFECTION; COUNTS; HEALTH; PATTERNS	Introduction Since 2000, the world has been coalesced around efforts to reduce maternal mortality. However, few studies have estimated the significance of eliminating maternal deaths on female life expectancy. We estimated, based on census data, the potential gains in female life expectancy assuming complete elimination of pregnancy-related mortality in Zambia. Methods We used data on all-cause and pregnancy-related deaths of females aged 15-49 reported in the Zambia 2010 census, and evaluated, adjusted and smoothed them using existing and verified techniques. We used associated single decrement life tables, assuming complete elimination of pregnancy-related deaths to estimate the potential gains in female life expectancy at birth, at age 15, and over the ages 15-49. We compared these gains with the gains from eliminating deaths from accidents, injury, violence and suicide. Results Complete elimination of pregnancy-related deaths would extend life expectancy at birth among Zambian women by 1.35 years and life expectancy at age 15 by 1.65 years. In rural areas, this would be 1.69 years and 2.19 years, respectively, and in urban areas, 0.78 years and 0.85 years. An additional 0.72 years would be spent in the reproductive age group 15-49; 1.00 years in rural areas and 0.35 years in urban areas. Eliminating deaths from accidents, injury, suicide and violence among women aged 15-49 would cumulatively contribute 0.55 years to female life expectancy at birth. Conclusion Eliminating pregnancy-related mortality would extend female life expectancy in Zambia substantially, with more gains among adolescents and females in rural areas. The application of life table techniques to census data proved very valuable, although rigorous evaluation and adjustment of reported deaths and age was necessary to attain plausible estimates. The collection of detailed high quality cause-specific mortality data in future censuses is indispensable.	[Banda, Richard] Cent Stat Off, Lusaka, Zambia; [Sandoy, Ingvild Fossgard; Fylkesnes, Knut] Univ Bergen, Ctr Int Hlth, Bergen, Norway; [Janssen, Fanny] Univ Groningen, Populat Res Ctr, Groningen, Netherlands	University of Bergen; University of Groningen	Banda, R (corresponding author), Univ Bergen, Ctr Int Hlth, Bergen, Norway.	richardbanda@gmail.com	Sandøy, Ingvild Fossgard/ABD-3557-2020	Janssen, Fanny/0000-0002-3110-238X; Sandoy, Ingvild/0000-0001-5567-4588	Norwegian State Educational Loan Fund as part of a PhD training programme at the University of Bergen	Norwegian State Educational Loan Fund as part of a PhD training programme at the University of Bergen	This study was fully funded by the Norwegian State Educational Loan Fund as part of a PhD training programme at the University of Bergen. The funders had no decision in the design, analysis, preparation of manuscript or decision to publish this manuscript.	ABOUZAHR C, 2000, MATERNAL MORTALITY 2; AbouZahr C, 2007, LANCET, V370, P1791, DOI 10.1016/S0140-6736(07)61310-5; [Anonymous], 2014, MIDWIFERY, V30; [Anonymous], 2010, MICR EXC; [Anonymous], 2012, AN MAN DAT PROT RISK; Beltran-Sanchez H, 2008, DEMOGR RES, V19, P1323, DOI 10.4054/DemRes.2008.19.35; BENNETT NG, 1984, DEMOGRAPHY, V21, P217, DOI 10.2307/2061041; BENNETT NG, 1981, POPUL INDEX, V47, P207, DOI 10.2307/2736447; Blanc AK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059864; Boerma J T, 1988, Ann IFORD, V12, P49; Boerma JT, 2007, LANCET, V369, P779, DOI 10.1016/S0140-6736(07)60364-X; BOERMA JT, 1987, STUD FAMILY PLANN, V18, P213, DOI 10.2307/1966872; Campbell OMR, 2006, LANCET, V368, P1284, DOI 10.1016/S0140-6736(06)69381-1; Canudas-Romo V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086694; Central Statistical Office, 2012, 2010 ZAMB CENS POP H, V11; Central Statistical Office, 2013, MIGR URB AN REP; Central Statistical Office Ministry of Health Tropical Diseases Research Centre Inc University of Zambia Macro International Inc, 2009, ZAMB DEM HLTH SURV 2; Central Statistics Office, 2012, ZAMB 2010 CENS POP H; CSO MOH, 2014, ZAMB DEM HLTH SURV 2; Dzekedzeke K, 2008, TROP MED INT HEALTH, V13, P152, DOI 10.1111/j.1365-3156.2007.01985.x; Fylkesnes K, 1997, AIDS, V11, P339, DOI 10.1097/00002030-199703110-00012; Gabrysch S, 2011, INT J GYNECOL OBSTET, V114, P174, DOI 10.1016/j.ijgo.2011.05.007; Gobopamang L, 2001, SA J DEMOGRAPHY, V8, P29; Graham WJ, 2008, BMC MED, V6, DOI 10.1186/1741-7015-6-12; Hill K, 1987, Asian Pac Popul Forum, V1, P8; Hill K, 1987, ASIAN PACIFIC POPULA, V1, P8; Hill K, 2009, MEASURING MATERNAL M; Hill K, 2007, LANCET, V370, P1726, DOI 10.1016/S0140-6736(07)61309-9; Hill K, 2011, J POPUL RES, V28, P31, DOI 10.1007/s12546-011-9058-1; Hill K, 2009, B WORLD HEALTH ORGAN, V87, P288, DOI 10.2471/BLT.08.052233; Hinde A., 1998, DEMOGRAPHIC METHODS; Institute for Health Metrics and Evaluation, 2010, BUILD MOM GLOB PROGR; Kassebaum NJ, 2014, LANCET, V384, P980, DOI 10.1016/S0140-6736(14)60696-6; Kyei NNA, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-151; Kyei NNA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046475; Levine AC, 2008, INT J EMERG MED, V1, P113, DOI 10.1007/s12245-008-0032-4; Liu PC, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1193; McIntyre J, 2005, REPROD HEALTH MATTER, V13, P129, DOI 10.1016/S0968-8080(05)25184-4; Moran NF, 2012, INT J GYNECOL OBSTET, V119, pS26, DOI 10.1016/j.ijgo.2012.03.011; Ng SK, 2014, BMC PREGNANCY CHILDB, V14, DOI [10.1186/1471-2393-14-314, 10.1186/1471-2393-14-323]; Nsemukila BG, 1998, STUDY FACTORS ASS MA; Patton GC, 2009, LANCET, V374, P881, DOI 10.1016/S0140-6736(09)60741-8; Preston H., 2001, DEMOGRAPHY MEASURING; Ronsmans C, 2006, LANCET, V368, P1189, DOI 10.1016/S0140-6736(06)69380-X; Salomon JA, 2012, LANCET, V380, P2144, DOI 10.1016/S0140-6736(12)61690-0; Setel PW, 2007, LANCET, V370, P1569, DOI 10.1016/S0140-6736(07)61307-5; Siegel, 2004, METHODS MAT DEMOGRAP; Stanton C, 2001, B WORLD HEALTH ORGAN, V79, P657; U.S. Census Bureau, 1994, POP AN MICR; United Nations Statistics Division, 2008, PRINC REC POP HOUS C; van Eijk AM, 2008, TROP MED INT HEALTH, V13, P1314, DOI 10.1111/j.1365-3156.2008.02136.x; WHO UNICEF, 2013, TRENDS MAT MORT 1990; World Health Organization, 2013, WHO GUID MEAS MAT MO; World Health Organization, 2009, INT STAT CLASS DIS R; World Health Organization (WHO), 2012, TRENDS MAT MORT 1990; Zambia Ministry of Health, 2009, HLTH INF SYST STRAT	56	6	6	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2015	10	10							e0141689	10.1371/journal.pone.0141689	http://dx.doi.org/10.1371/journal.pone.0141689			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0ED	26513160	Green Published, gold, Green Submitted			2022-12-26	WOS:000363920300070
J	Jamet, S; Bubnell, J; Pfister, P; Tomoiaga, D; Rogers, ME; Feinstein, P				Jamet, Sophie; Bubnell, Jaclyn; Pfister, Patrick; Tomoiaga, Delia; Rogers, Matthew E.; Feinstein, Paul			In Vitro Mutational Analysis of the beta(2) Adrenergic Receptor, an In Vivo Surrogate Odorant Receptor	PLOS ONE			English	Article							OLFACTORY SENSORY NEURONS; HUMAN BETA-2-ADRENERGIC RECEPTOR; PROTEIN COUPLED RECEPTORS; FUNCTIONAL EXPRESSION; ENDOPLASMIC-RETICULUM; HETEROLOGOUS CELLS; DRUG DISCOVERY; ACTIVATION; GLYCOSYLATION; SPECIFICITY	Many G-protein coupled receptors (GPCRs), such as odorant receptors (ORs), cannot be characterized in heterologous cells because of their difficulty in trafficking to the plasma membrane. In contrast, a surrogate OR, the GPCR mouse beta 2-adrenergic-receptor (m beta 2AR), robustly traffics to the plasma membrane. We set out to characterize m beta 2AR mutants in vitro for their eventual use in olfactory axon guidance studies. We performed an extensive mutational analysis of m beta 2AR using a Green Fluorescent Protein-tagged m beta 2AR (m beta 2AR::GFP) to easily assess the extent of its plasma membrane localization. In order to characterize mutants for their ability to successfully transduce ligand-initiated signal cascades, we determined the half maximal effective concentrations (EC50) and maximal response to isoprenaline, a known m beta 2AR agonist. Our analysis reveals that removal of amino terminal (Nt) N-glycosylation sites and the carboxy terminal (Ct) palmitoylation site of m beta 2AR do not affect its plasma membrane localization. By contrast, when both the Nt and Ct of m beta 2AR are replaced with those of M71 OR, plasma membrane trafficking is impaired. We further analyze three m beta 2AR mutants (RDY, E268A, and C327R) used in olfactory axon guidance studies and are able to decorrelate their plasma membrane trafficking with their capacity to respond to isoprenaline. A deletion of the Ct prevents proper trafficking and abolishes activity, but plasma membrane trafficking can be selectively rescued by a Tyrosine to Alanine mutation in the highly conserved GPCR motif NPxxY. This new loss-of-function mutant argues for a model in which residues located at the end of transmembrane domain 7 can act as a retention signal when unmasked. Additionally, to our surprise, amongst our set of mutations only Ct mutations appear to lower m beta 2AR EC50s revealing their critical role in G-protein coupling. We propose that an interaction between the Nt and Ct is necessary for proper folding and/or transport of GPCRs.	[Jamet, Sophie; Bubnell, Jaclyn; Tomoiaga, Delia; Feinstein, Paul] CUNY Hunter Coll, Dept Biol Sci, New York, NY 10021 USA; [Feinstein, Paul] CUNY, Grad Ctr, Biol Program, New York, NY 10021 USA; [Feinstein, Paul] CUNY, Grad Ctr, Behav & Cognit Neurosci Program, New York, NY 10021 USA; [Pfister, Patrick; Rogers, Matthew E.] Firmenich Inc, Corp Res & Dev, Plainsboro, NJ USA	City University of New York (CUNY) System; Hunter College (CUNY); City University of New York (CUNY) System; City University of New York (CUNY) System; Firmenich	Feinstein, P (corresponding author), CUNY Hunter Coll, Dept Biol Sci, 695 Pk Ave, New York, NY 10021 USA.	Feinstein@genectr.hunter.cuny.edu		Pfister, Patrick/0000-0002-1192-8600	National Institute on Minority Health and Health Disparities of the National Institutes of Health [MD007599]; Firmenich Inc.; National Institute on Minority Health and Health Disparities [G12MD007599] Funding Source: NIH RePORTER	National Institute on Minority Health and Health Disparities of the National Institutes of Health; Firmenich Inc.; National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	SJ, JB, DT and PF used NIH SC1 GM088114 for experiments. This publication was made possible by a Research Centers in Minority Institutions Program grant from the National Institute on Minority Health and Health Disparities (MD007599) of the National Institutes of Health, and its contents are solely the responsibility of the authors and do not necessarily represent the official views of the NIMHD or the NIH. PP and MB are supported by Firmenich Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funder provided support in the form of salaries for authors PP and MER, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Ballesteros JA, 2001, J BIOL CHEM, V276, P29171, DOI 10.1074/jbc.M103747200; Bubnell J, 2015, PLOS ONE IN PRESS; Bubnell J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074941; CHAN SK, 1993, GENE DEV, V7, P796, DOI 10.1101/gad.7.5.796; Clowney EJ, 2011, GENOME RES, V21, P1249, DOI 10.1101/gr.120162.110; Connelly T, 2015, P NATL ACAD SCI USA, V112, P590, DOI 10.1073/pnas.1418515112; Dong CM, 2007, BBA-BIOMEMBRANES, V1768, P853, DOI 10.1016/j.bbamem.2006.09.008; Faix J, 2006, CURR OPIN CELL BIOL, V18, P18, DOI 10.1016/j.ceb.2005.11.002; Feinstein P, 2004, CELL, V117, P817, DOI 10.1016/j.cell.2004.05.011; Feinstein P, 2004, CELL, V117, P833, DOI 10.1016/j.cell.2004.05.013; Ferreira T, 2014, NEURON, V81, P847, DOI 10.1016/j.neuron.2014.01.001; Galandrin S, 2007, TRENDS PHARMACOL SCI, V28, P423, DOI 10.1016/j.tips.2007.06.005; Gimelbrant AA, 1999, J NEUROCHEM, V72, P2301, DOI 10.1046/j.1471-4159.1999.0722301.x; Hofmann KP, 2009, TRENDS BIOCHEM SCI, V34, P540, DOI 10.1016/j.tibs.2009.07.005; Illing N, 2002, MOL CELL NEUROSCI, V20, P225, DOI 10.1006/mcne.2002.1106; Imai T, 2006, SCIENCE, V314, P657, DOI 10.1126/science.1131794; KOBILKA BK, 1988, SCIENCE, V240, P1310, DOI 10.1126/science.2836950; Krautwurst D, 1998, CELL, V95, P917, DOI 10.1016/S0092-8674(00)81716-X; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Lefkowitz RJ, 2013, ANGEW CHEM INT EDIT, V52, P6366, DOI 10.1002/anie.201301924; Lu M, 2003, TRAFFIC, V4, P416, DOI 10.1034/j.1600-0854.2003.00097.x; Lundstrom K, 2009, METHODS MOL BIOL, V552, P51, DOI 10.1007/978-1-60327-317-6_4; Mattila PK, 2008, NAT REV MOL CELL BIO, V9, P446, DOI 10.1038/nrm2406; McClintock TS, 1997, MOL BRAIN RES, V48, P270, DOI 10.1016/S0169-328X(97)00099-5; Minic J, 2005, FEBS J, V272, P524, DOI 10.1111/j.1742-4658.2004.04494.x; Nakashima A, 2013, CELL, V154, P1314, DOI 10.1016/j.cell.2013.08.033; ODOWD BF, 1989, J BIOL CHEM, V264, P7564; ODOWD BF, 1988, J BIOL CHEM, V263, P15985; Omura M, 2014, MOL CELL NEUROSCI, V58, P1, DOI 10.1016/j.mcn.2013.10.010; Pathak N, 2009, J NEUROCHEM, V108, P486, DOI 10.1111/j.1471-4159.2008.05780.x; Peterlin Z, 2014, J GEN PHYSIOL, V143, P527, DOI 10.1085/jgp.201311151; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; RANDS E, 1990, J BIOL CHEM, V265, P10759; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Richard M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080100; Saito H, 2004, CELL, V119, P679, DOI 10.1016/j.cell.2004.11.021; Soto AG, 2010, J BIOL CHEM, V285, P18781, DOI 10.1074/jbc.M110.111088; Zhang JJ, 2012, MOL CELL NEUROSCI, V51, P79, DOI 10.1016/j.mcn.2012.08.006; Zhuang H, 2008, NAT PROTOC, V3, P1402, DOI 10.1038/nprot.2008.120	39	5	5	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2015	10	10							e0141696	10.1371/journal.pone.0141696	http://dx.doi.org/10.1371/journal.pone.0141696			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0ED	26513247	Green Published, gold			2022-12-26	WOS:000363920300071
J	Mulu, A; Maier, M; Liebert, UG				Mulu, Andargachew; Maier, Melanie; Liebert, Uwe Gerd			Low Incidence of HIV-1C Acquired Drug Resistance 10 Years after Roll-Out of Antiretroviral Therapy in Ethiopia: A Prospective Cohort Study	PLOS ONE			English	Article								The emergence of HIV-1 drug resistance mutations has mainly been linked to the duration and composition of antiretroviral treatment (ART), as well as the level of adherence. This study reports the incidence and pattern of acquired antiretroviral drug resistance mutations and long-term outcomes of ART in a prospective cohort from Northwest Ethiopia. Two hundred and twenty HIV-1C infected treatment naive patients were enrolled and 127 were followed-up for up to 38 months on ART. ART initiation and patients' monitoring was based on the WHO clinical and immunological parameters. HIV viral RNA measurement and drug resistance genotyping were done at baseline (N = 160) and after a median time of 30 (IQR, 27-38) months on ART (N = 127). Viral suppression rate (HIV RNA levels <= 400 copies/ml) after a median time of 30 months on ART was found to be 88.2%(112/127), which is in the range for HIV drug resistance prevention suggested by WHO. Of those 15 patients with viral load > 400 copies/ml, six harboured one or more drug resistant associated mutations in the reverse transcriptase (RT) region. Observed NRTIs resistance associated mutations were the lamivudine-induced mutation M184V (n = 4) and tenofovir associated mutation K65R (n = 1). The NNRTIs resistance associated mutations were K103N (n = 2), V106M, Y181S, Y188L, V90I, K101E and G190A (n = 1 each). Thymidine analogue mutations and major drug resistance mutations in the protease (PR) region were not detected. Most of the patients (13/15) with virologic failure and accumulated drug resistance mutations had not met the WHO clinical and/or immunological failure criteria and continued the failing regimen. The incidence and pattern of acquired antiretroviral drug resistance mutations is lower and less complex than previous reports from sub Saharan Africa countries. Nevertheless, the data suggest the need for virological monitoring and resistance testing for early detection of failure. Moreover, adherence reinforcement will contribute to improving overall treatment outcomes.	[Mulu, Andargachew; Maier, Melanie; Liebert, Uwe Gerd] Univ Leipzig, Fac Med, Inst Virol, D-04109 Leipzig, Germany; [Mulu, Andargachew] Univ Gondar, Coll Med & Hlth Sci, Dept Microbiol, Gondar, Ethiopia	Leipzig University; University of Gondar	Mulu, A (corresponding author), Univ Leipzig, Fac Med, Inst Virol, D-04109 Leipzig, Germany.	andargachewmulu@yahoo.com	Mulu, Andargachew/GMW-4823-2022	Mulu, Andargachew/0000-0003-2862-0175	German Academic Exchange Service (DAAD); Association of Sponsors and Friends of Leipzig University; HIV/AIDS Prevention and Control Office of Amhara Regional State, Ethiopia	German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); Association of Sponsors and Friends of Leipzig University; HIV/AIDS Prevention and Control Office of Amhara Regional State, Ethiopia	This work was partly supported by German Academic Exchange Service (DAAD), Association of Sponsors and Friends of Leipzig University, and HIV/AIDS Prevention and Control Office of Amhara Regional State, Ethiopia.	Abdissa A, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-181; Barth RE, 2010, LANCET INFECT DIS, V10, P155, DOI 10.1016/S1473-3099(09)70328-7; Bourgeois A, 2005, ANTIVIR THER, V10, P335; Coetzee D, 2004, AIDS, V18; Doyle T, 2012, CURR OPIN INFECT DIS, V25, P17, DOI 10.1097/QCO.0b013e32834ef5d9; Ferradini L, 2006, LANCET, V367, P1335, DOI 10.1016/S0140-6736(06)68580-2; Geretti AM, 2008, ANTIVIR THER, V13; Gilks CF, 2006, LANCET, V368; Gupta RK, 2009, LANCET INFECT DIS, V9, P409, DOI 10.1016/S1473-3099(09)70136-7; Hamers R, 2013, CURR OPIN HIV AIDS, V8; Hamers RL, 2012, CLIN INFECT DIS, V54; Hamers RL, 2008, ANTIVIR THER, V13; Hazenberg M.D., 2003, AIDS, V17; Hogg RS, 2006, PLOS MED, V3, P1570, DOI 10.1371/journal.pmed.0030356; Hosseinipour MC, 2009, AIDS, V23, P1127, DOI 10.1097/QAD.0b013e32832ac34e; Huruy K, 2015, J MED VIROL, V87, P978, DOI 10.1002/jmv.24110; Ivers LC, 2005, CLIN INFECT DIS, V41; Kantor R, 2004, AIDS, V18, P1503, DOI 10.1097/01.aids.0000131358.29586.6b; Kassu A, 2003, CLIN EXP IMMUNOL, V132, P113, DOI 10.1046/j.1365-2249.2003.02106.x; Kiwelu IE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102258; Kouanfack C, 2009, CLIN INFECT DIS, V48, P1318, DOI 10.1086/597779; Koyalta D, 2009, CLIN INFECT DIS, V49, P155, DOI 10.1086/599611; Kozal MJ, 2007, HIV CLIN TRIALS, V8; Ledergerber B, 2004, LANCET, V364, P51, DOI 10.1016/S0140-6736(04)16589-6; Lederman MM, 2000, AIDS, V14; Marconi VC, 2008, CLIN INFECT DIS, V46, P1589, DOI 10.1086/587109; Messele T, 1999, CLIN EXP IMMUNOL, V115, P443; Mulu A., 2014, BMC INFECT DIS, V14; Mulu A, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-158; Muwonga J, 2011, JAIDS-J ACQ IMM DEF, V57, pS27, DOI 10.1097/QAI.0b013e31821f596c; Nakanjako D, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-43; Rusine J, 2013, PLOS ONE, V8; Sigaloff KC, 2011, J ACQUIR IMMUNE DEFI, V58; Tessema B, 2010, AIDS RES THER, V7, DOI 10.1186/1742-6405-7-2; Wallis CL, 2012, ANTIVIR THER, V17, P313, DOI 10.3851/IMP1985; Wallis CL, 2010, J ACQUIR IMMUNE DEFI, V53; Wensing AM, 2014, TOP ANTIVIR MED, V22; WHO, 2012, WHO HIV DRUG RES REP; World Health Organization, 2010, UN ACC SCAL PRIOR HI	39	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2015	10	10							e0141318	10.1371/journal.pone.0141318	http://dx.doi.org/10.1371/journal.pone.0141318			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0ED	26512902	Green Published, Green Submitted, gold			2022-12-26	WOS:000363920300028
J	Schussler, S; Lohrmann, C				Schuessler, Sandra; Lohrmann, Christa			Change in Care Dependency and Nursing Care Problems in Nursing Home Residents with and without Dementia: A 2-Year Panel Study	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; INCONTINENCE; PREVALENCE; PREDICTORS; URINARY; RISK	Over time, chronic conditions like dementia can lead to care dependency and nursing care problems, often necessitating nursing home admission. This panel study (2012-2014) aims to explore changes in care dependency and nursing care problems (incontinence, malnutrition, decubitus, falls and restraints) in residents with and without dementia over time. In total, nine Austrian nursing homes participated, including 258 residents (178 with, 80 without dementia) who completed all five measurements. Data were collected with the International Prevalence Measurement of Care Problems questionnaire, the Care Dependency Scale and the Mini-Mental State Examination-2. Repeated measures ANOVA and crosstabs were used to analyse changes. The results showed that care dependency in dementia residents increased significantly for all 15 items of the Care Dependency Scale, with the highest increase being residents' day-/night pattern, contact with others, sense of rules/values and communication. In contrast, care dependency in residents without dementia increased for four of the 15 items, with the highest increase being for continence, followed by getting (un) dressed. With respect to the assessed nursing care problems, residents with dementia and those without only differed significantly in terms of an increase in urinary(12.3% vs. 14.2%), fecal-(17.4% vs. 10%), and double incontinence (16.7% vs. 11.9%). The results indicated that residents with dementia experienced increased care dependency in different areas than residents without dementia. Furthermore, residents with dementia experienced a lower increase in urinary incontinence but a higher increase in fecal-and double incontinence. These results help professionals to identify areas for improvement in dementia care.	[Schuessler, Sandra; Lohrmann, Christa] Med Univ Graz, Inst Nursing Sci, Graz, Austria	Medical University of Graz	Schussler, S (corresponding author), Med Univ Graz, Inst Nursing Sci, Graz, Austria.	sandra.schuessler@medunigraz.at	Lohrmann, Christa/AHA-0202-2022	Lohrmann, Christa/0000-0002-0778-5854				ADI (Alzheimer's Disease International), 2013, WORLD ALZH REP JOUM; Aslan E, 2009, J CLIN NURS, V18, P3290, DOI 10.1111/j.1365-2702.2009.02936.x; Banaszak-Holl J, 2011, J AGING HEALTH, V23, P862, DOI 10.1177/0898264311399759; Berger S, 2012, WISSENSCHAFTLICHE HI; BMASK (Bundesministerium fur Arbeit Soziales und Konsumentenschutz), 2014, INF ALT U PFLEG; Boyd M, 2012, AUSTRALAS J AGEING, V31, P233, DOI 10.1111/j.1741-6612.2011.00584.x; Braunseis F, 2012, ARCH GERONTOL GERIAT, V54, pE63, DOI 10.1016/j.archger.2011.06.023; Caljouw MAA, 2014, BMC GERIATR, V14, DOI 10.1186/1471-2318-14-67; Carpenter G Iain, 2006, BMC Geriatr, V6, P7, DOI 10.1186/1471-2318-6-7; DEGAM (Deutsche Gesellschaft fur Allgemeinmedizin und Familienmedizin), 2008, DEM LEITL 12; Dijkstra A, 1998, Aust N Z J Ment Health Nurs, V7, P142; Dijkstra A, 1999, INT J NURS STUD, V36, P487, DOI 10.1016/S0020-7489(99)00044-9; Dijkstra A, 2012, NCG SERIES MEASUREME, V10, P40; DuBeau CE, 2010, NEUROUROL URODYNAM, V29, P165, DOI 10.1002/nau.20842; Folstein MF, 2010, MMSE 2 MANUAL DURCHF; Gustavsson A, 2011, ALZHEIMERS DEMENT, V7, P318, DOI 10.1016/j.jalz.2010.09.001; Helvik AS, 2014, BMC GERIATR, V14, DOI 10.1186/1471-2318-14-45; Hjaltadottir I, 2012, INT J NURS STUD, V49, P1342, DOI 10.1016/j.ijnurstu.2012.06.004; Kow JK, 2013, BCMJ, V55, P96; Lohrmann C, 2003, SCAND J CARING SCI, V17, P51, DOI 10.1046/j.1471-6712.2003.00117.x; Lohrmann C, 2013, PFLEGEQUALITATSERHEB; McConnell ES, 2003, NURS RES, V52, P119, DOI 10.1097/00006199-200303000-00008; Nakrem S, 2009, INT J NURS STUD, V46, P848, DOI 10.1016/j.ijnurstu.2008.11.005; OECD, 2013, GOOD LIFE OLD AGE MO; Offermans MPW, 2009, NEUROUROL URODYNAM, V28, P288, DOI 10.1002/nau.20668; Reid C, 2008, CAN STUD POPUL, V35, P49; Saga S, 2013, BMC GERIATR, V13, DOI 10.1186/1471-2318-13-87; Schussler S, 2015, EUR GERIATR MED, V6, P46, DOI 10.1016/j.eurger.2014.04.015; van Nie-Visser NC, 2013, J ADV NURS, V69, pE18, DOI 10.1111/jan.12190; WHO, 2001, WHO INT CLASS FUNCT	30	11	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2015	10	10							e0141653	10.1371/journal.pone.0141653	http://dx.doi.org/10.1371/journal.pone.0141653			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CV0ED	26513358	gold, Green Submitted, Green Published			2022-12-26	WOS:000363920300062
J	Huss, A; van Eijsden, M; Guxens, M; Beekhuizen, J; van Strien, R; Kromhout, H; Vrijkotte, T; Vermeulen, R				Huss, Anke; van Eijsden, Manon; Guxens, Monica; Beekhuizen, Johan; van Strien, Rob; Kromhout, Hans; Vrijkotte, Tania; Vermeulen, Roel			Environmental Radiofrequency Electromagnetic Fields Exposure at Home, Mobile and Cordless Phone Use, and Sleep Problems in 7-Year-Old Children	PLOS ONE			English	Article							SCHOOL-AGED CHILDREN; BASE STATIONS; BEHAVIOR PROBLEMS; HABITS QUESTIONNAIRE; ADOLESCENTS; SYMPTOMS; CONSEQUENCES; DISTURBANCE; VALIDATION; DURATION	Background We evaluated if exposure to RF-EMF was associated with reported quality of sleep in 2,361 children, aged 7 years. Methods This study was embedded in the Amsterdam Born Children and their Development (ABCD) birth cohort study. When children were about five years old, school and residential exposure to RF-EMF from base stations was assessed with a geospatial model (NISMap) and from indoor sources (cordless phone/WiFi) using parental self-reports. Parents also reported their children's use of mobile or cordless phones. When children were seven years old, we evaluated sleep quality as measured with the Child Sleep Habits Questionnaire (CSHQ) filled in by parents. Of eight CSHQ subscales, we evaluated sleep onset delay, sleep duration, night wakenings, parasomnias and daytime sleepiness with logistic or negative binomial regression models, adjusting for child's age and sex and indicators of socio-economic position of the parents. We evaluated the remaining three subscales (bedtime resistance, sleep anxiety, sleep disordered breathing) as unrelated outcomes (negative control) because these were a priori hypothesised not to be associated with RF-EMF. Results Sleep onset delay, night wakenings, parasomnias and daytime sleepiness were not associated with residential exposure to RF-EMF from base stations. Sleep duration scores were associated with RF-EMF levels from base stations. Higher use mobile phones was associated with less favourable sleep duration, night wakenings and parasomnias, and also with bedtime resistance. Cordless phone use was not related to any of the sleeping scores. Conclusion Given the different results across the evaluated RF-EMF exposure sources and the observed association between mobile phone use and the negative control sleep scale, our study does not support the hypothesis that it is the exposure to RF-EMF that is detrimental to sleep quality in 7-year old children, but potentially other factors that are related to mobile phone usage.	[Huss, Anke; Beekhuizen, Johan; Kromhout, Hans; Vermeulen, Roel] Univ Utrecht, Inst Risk Assessment Sci, Utrecht, Netherlands; [Huss, Anke] Inst Social & Prevent Med, Bern, Switzerland; [van Eijsden, Manon] Publ Hlth Serv Amsterdam GGD, Dept Epidemiol Documentat & Hlth Promot, Amsterdam, Netherlands; [Guxens, Monica] Ctr Res Environm Epidemiol, Barcelona, Spain; [van Strien, Rob] Publ Hlth Serv Amsterdam GGD, Dept Environm Hlth, Amsterdam, Netherlands; [Vrijkotte, Tania] Univ Amsterdam, Acad Med Ctr, Dept Publ Hlth, Amsterdam, Netherlands; [Vermeulen, Roel] Univ Med Ctr, Julius Ctr Publ Hlth Sci & Primary Care, Utrecht, Netherlands	Utrecht University; Public Health Service Amsterdam; Public Health Service Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Utrecht University; Utrecht University Medical Center	Huss, A (corresponding author), Univ Utrecht, Inst Risk Assessment Sci, Utrecht, Netherlands.	a.huss@uu.nl	Guxens, Monica/T-2285-2018; Kromhout, Hans/A-9159-2008; Vermeulen, Roel/F-8037-2011	Guxens, Monica/0000-0002-8624-0333; Kromhout, Hans/0000-0002-4233-1890; Vermeulen, Roel/0000-0003-4082-8163; Huss, Anke/0000-0001-9268-1867; Vrijkotte, Tanja/0000-0003-3641-4048	Netherlands Organization for Health Research (ZonMW) within the programme Electromagnetic Fields and Health Research [85600004, 85800001]; Miguel Servet fellowship - Spanish Institute of Health Carlos III (Ministry of Economy and Competitiveness) [MS13/00054]	Netherlands Organization for Health Research (ZonMW) within the programme Electromagnetic Fields and Health Research; Miguel Servet fellowship - Spanish Institute of Health Carlos III (Ministry of Economy and Competitiveness)	This work was supported by The Netherlands Organization for Health Research (ZonMW) within the programme Electromagnetic Fields and Health Research under grant numbers 85600004 and 85800001. Monica Guxens is funded by a Miguel Servet fellowship (MS13/00054) awarded by the Spanish Institute of Health Carlos III (Ministry of Economy and Competitiveness). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnetz B, 2007, PIERS ONLINE, V3; Aydin D, 2011, PROG BIOPHYS MOL BIO, V107, P356, DOI 10.1016/j.pbiomolbio.2011.08.013; Beebe DW, 2011, PEDIATR CLIN N AM, V58, P649, DOI 10.1016/j.pcl.2011.03.002; Beekhuizen J, 2014, ENVIRON INT, V67, P22, DOI 10.1016/j.envint.2014.02.008; Beekhuizen J, 2013, SCI TOTAL ENVIRON, V445, P202, DOI 10.1016/j.scitotenv.2012.12.020; Berg-Beckhoff G, 2009, OCCUP ENVIRON MED, V66, P124, DOI 10.1136/oem.2008.039834; Bolte JFB, 2012, ENVIRON INT, V48, P133, DOI 10.1016/j.envint.2012.07.006; Cain N, 2010, SLEEP MED, V11, P735, DOI 10.1016/j.sleep.2010.02.006; Cappuccio FP, 2008, SLEEP, V31, P619, DOI 10.1093/sleep/31.5.619; Danker-Hopfe H, 2011, J SLEEP RES, V20, P73, DOI 10.1111/j.1365-2869.2010.00850.x; Dewald JF, 2010, SLEEP MED REV, V14, P179, DOI 10.1016/j.smrv.2009.10.004; Frei P, 2009, SCI TOTAL ENVIRON, V408, P102, DOI 10.1016/j.scitotenv.2009.09.023; Frei P, 2009, ENVIRON RES, V109, P779, DOI 10.1016/j.envres.2009.04.015; Garrison MM, 2011, PEDIATRICS, V128, P29, DOI 10.1542/peds.2010-3304; Guxens M, 2013, J EPIDEMIOL COMMUN H, V67, P432, DOI 10.1136/jech-2012-201792; Hagstrom M, 2013, Pathophysiology, V20, P117, DOI 10.1016/j.pathophys.2013.02.001; Heinrich S, 2011, ENVIRON INT, V37, P26, DOI 10.1016/j.envint.2010.06.008; Hutter HP, 2006, OCCUP ENVIRON MED, V63, P307, DOI 10.1136/oem.2005.020784; Inyang I, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-36; Kato Yasuko, 2012, Pathophysiology, V19, P95, DOI 10.1016/j.pathophys.2012.02.002; Lauer O, 2013, BIOELECTROMAGNETICS, V34, P366, DOI 10.1002/bem.21782; Lowden A, 2011, BIOELECTROMAGNETICS, V32, P4, DOI 10.1002/bem.20609; Mohler E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037455; Mohler E, 2010, RADIAT RES, V174, P347, DOI 10.1667/RR2153.1; Munezawa T, 2011, SLEEP, V34, P1013, DOI 10.5665/SLEEP.1152; Nixon GM, 2008, SLEEP, V31, P71, DOI 10.1093/sleep/31.1.71; Owens J, 1999, PEDIATRICS, V104, DOI 10.1542/peds.104.3.e27; Owens JA, 2000, SLEEP, V23, P1043; Paavonen EJ, 2000, ACTA PAEDIATR, V89, P223, DOI 10.1080/080352500750028870; Redmayne M, 2013, ENVIRON HEALTH-GLOB, V12, DOI 10.1186/1476-069X-12-90; Roosli M, 2004, INT J HYG ENVIR HEAL, V207, P141, DOI 10.1078/1438-4639-00269; Sadeh A, 2002, CHILD DEV, V73, P405, DOI 10.1111/1467-8624.00414; Seitz H, 2005, SCI TOTAL ENVIRON, V349, P45, DOI 10.1016/j.scitotenv.2005.05.009; Stein MA, 2001, PEDIATRICS, V107, DOI 10.1542/peds.107.4.e60; van Eijsden M, 2011, INT J EPIDEMIOL, V40, P1176, DOI 10.1093/ije/dyq128; van Rongen E, 2009, J TOXICOL ENV HEAL B, V12, P572, DOI 10.1080/10937400903458940; Vrijheid M, 2006, OCCUP ENVIRON MED, V63, P237, DOI 10.1136/oem.2004.019281; Waumans RC, 2010, SLEEP, V33, P841, DOI 10.1093/sleep/33.6.841; Williams SM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093117	39	23	25	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2015	10	10							e0139869	10.1371/journal.pone.0139869	http://dx.doi.org/10.1371/journal.pone.0139869			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0DL	26509676	Green Submitted, Green Published, gold			2022-12-26	WOS:000363918100014
J	Laborel-Preneron, E; Bianchi, P; Boralevi, F; Lehours, P; Fraysse, F; Morice-Picard, F; Sugai, M; Sato'o, Y; Badiou, C; Lina, G; Schmitt, AM; Redoules, D; Casas, C; Davrinche, C				Laborel-Preneron, Emeline; Bianchi, Pascale; Boralevi, Franck; Lehours, Philippe; Fraysse, Frederique; Morice-Picard, Fanny; Sugai, Motoyuki; Sato'o, Yusuke; Badiou, Cedric; Lina, Gerard; Schmitt, Anne-Marie; Redoules, Daniel; Casas, Christiane; Davrinche, Christian			Effects of the Staphylococcus aureus and Staphylococcus epidermidis Secretomes Isolated from the Skin Microbiota of Atopic Children on CD4(+) T Cell Activation	PLOS ONE			English	Article							DENDRITIC CELLS; HEALTHY SKIN; DERMATITIS; MONOCYTES; INFLAMMATION; DISEASE; COLONIZATION; INFECTIONS; PROTEINS; IMMUNITY	Interactions between the immune system and skin bacteria are of major importance in the pathophysiology of atopic dermatitis (AD), yet our understanding of them is limited. From a cohort of very young AD children (1 to 3 years old), sensitized to Dermatophagoides pteronyssinus allergens (Der p), we conducted culturomic analysis of skin microbiota, cutaneous transcript profiling and quantification of anti-Der p CD4(+) T cells. This showed that the presence of S. aureus in inflamed skin of AD patients was associated with a high IgE response, increased expression of inflammatory and Th2/Th22 transcripts and the prevalence of a peripheral Th2 anti-Der p response. Monocyte-derived dendritic cells (moDC) exposed to the S. aureus and S. epidermidis secretomes were found to release pro-inflammatory IFN-gamma and anti-inflammatory IL-10, respectively. Allogeneic moDC exposed to the S. aureus secretome also induced the proliferation of CD4(+) T cells and this effect was counteracted by concurrent exposure to the S. epidermidis secretome. In addition, whereas the S. epidermidis secretome promoted the activity of regulatory T cells (Treg) in suppressing the proliferation of conventional CD4(+) T cells, the Treg lost this ability in the presence of the S. aureus secretome. We therefore conclude that S. aureus may cause and promote inflammation in the skin of AD children through concomitant Th2 activation and the silencing of resident Treg cells. Commensals such as S. epidermidis may counteract these effects by inducing the release of IL-10 by skin dendritic cells.	[Laborel-Preneron, Emeline; Fraysse, Frederique; Davrinche, Christian] Univ Toulouse 3, INSERM UMR 1043, CNRS UMR 5282, F-31062 Toulouse, France; [Bianchi, Pascale; Schmitt, Anne-Marie; Redoules, Daniel; Casas, Christiane] Dermocosmet, Toulouse, France; [Boralevi, Franck; Morice-Picard, Fanny] Pellegrin Childrens Hosp, Pediat Dermatol unit, Bordeaux, France; [Lehours, Philippe] CHU Bordeaux, Dept Bacteriol, Bordeaux, France; [Sugai, Motoyuki; Sato'o, Yusuke] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Bacteriol, Minami Ku, Hiroshima, Hiroshima 7348551, Japan; [Badiou, Cedric; Lina, Gerard] Univ Lyon 1, Hosp Civils Lyon, INSERM U1111, F-69622 Villeurbanne, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; CHU Bordeaux; CHU Bordeaux; Hiroshima University; CHU Lyon; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Davrinche, C (corresponding author), Univ Toulouse 3, INSERM UMR 1043, CNRS UMR 5282, F-31062 Toulouse, France.	christian.davrinche@inserm.fr	MORICE-PICARD, Fanny/M-5125-2014	boralevi, franck/0000-0002-0477-5909; Lina, Gerard/0000-0002-9236-7998	INSERM; Pierre Fabre Dermo Cosmetique	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Pierre Fabre Dermo Cosmetique	Pierre Fabre Dermo-Cosmetique, Institutional grants from INSERM. The funder Pierre Fabre Dermo Cosmetique provided support in the form of research material and of salaries for authors (EL-P, PB, A-MS, DR, CC) who had different roles in study design, data collection and analysis, decision to publish and preparation of the manuscript. The specific roles of these authors are articulated in the author contributions.	Alonso MN, 2011, BLOOD, V118, P3311, DOI 10.1182/blood-2011-03-341065; Ardern-Jones MR, 2007, P NATL ACAD SCI USA, V104, P5557, DOI 10.1073/pnas.0700733104; Bianchi P, 2012, J INVEST DERMATOL, V132, P469, DOI 10.1038/jid.2011.306; Bieber T, 2008, NEW ENGL J MED, V358, P1483, DOI 10.1056/NEJMra074081; Cardona ID, 2006, J ALLERGY CLIN IMMUN, V117, P688, DOI 10.1016/j.jaci.2005.11.037; Carlier J, 2011, BLOOD, V118, P6783, DOI 10.1182/blood-2011-02-337956; Chau TA, 2009, NAT MED, V15, P641, DOI 10.1038/nm.1965; Chu CC, 2012, J EXP MED, V209, P935, DOI 10.1084/jem.20112583; Clark RA, 2010, J INVEST DERMATOL, V130, P362, DOI 10.1038/jid.2009.247; Franchi L, 2012, NAT IMMUNOL, V13, P325, DOI 10.1038/ni.2231; Gaide O, 2015, NAT MED, V21, P647, DOI 10.1038/nm.3860; Gittler JK, 2013, J ALLERGY CLIN IMMUN, V131, P300, DOI 10.1016/j.jaci.2012.06.048; Gittler JK, 2012, J ALLERGY CLIN IMMUN, V130, P1344, DOI 10.1016/j.jaci.2012.07.012; Grice EA, 2008, GENOME RES, V18, P1043, DOI 10.1101/gr.075549.107; Hennino A, 2011, J ALLERGY CLIN IMMUN, V127, P1064, DOI 10.1016/j.jaci.2010.11.022; Jarraud S, 2001, J IMMUNOL, V166, P669, DOI 10.4049/jimmunol.166.1.669; Kabashima K, 2013, J DERMATOL SCI, V70, P3, DOI 10.1016/j.jdermsci.2013.02.001; Kim HK, 2012, CURR OPIN MICROBIOL, V15, P92, DOI 10.1016/j.mib.2011.10.012; Kong HDH, 2012, GENOME RES, V22, P850, DOI 10.1101/gr.131029.111; Lai YP, 2010, J INVEST DERMATOL, V130, P2211, DOI 10.1038/jid.2010.123; Lai YP, 2009, NAT MED, V15, P1377, DOI 10.1038/nm.2062; Mandron M, 2008, J INVEST DERMATOL, V128, P882, DOI 10.1038/sj.jid.5701112; Mandron M, 2006, J ALLERGY CLIN IMMUN, V117, P1141, DOI 10.1016/j.jaci.2005.12.1360; Mariotti S, 2002, EUR J IMMUNOL, V32, P3050, DOI 10.1002/1521-4141(200211)32:11<3050::AID-IMMU3050>3.0.CO;2-K; Naik S, 2015, NATURE; Naik S, 2012, SCIENCE, V337, P1115, DOI 10.1126/science.1225152; Nakamura Y, 2013, NATURE, V503, P397, DOI 10.1038/nature12655; Nyirenda MH, 2011, J IMMUNOL, V187, P2278, DOI 10.4049/jimmunol.1003715; Pellerin L, 2013, J ALLERGY CLIN IMMUN, V131, P1094, DOI 10.1016/j.jaci.2012.12.1566; Rodriguez RS, 2014, J CLIN INVEST, V124, P1027, DOI 10.1172/JCI72932; Schroeder Jens-M., 2011, Allergology International, V60, P17, DOI 10.2332/allergolint.10-RAI-0292; Seneschal J, 2012, IMMUNITY, V36, P873, DOI 10.1016/j.immuni.2012.03.018; Simanski M, 2010, J INVEST DERMATOL, V130, P2836, DOI 10.1038/jid.2010.217; Tamoutounour S, 2013, IMMUNITY, V39, P925, DOI 10.1016/j.immuni.2013.10.004; Volz T, 2014, J INVEST DERMATOL, V134, P96, DOI 10.1038/jid.2013.291; Zollner TM, 2000, CLIN EXP ALLERGY, V30, P994	36	57	57	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2015	10	10							e0141067	10.1371/journal.pone.0141067	http://dx.doi.org/10.1371/journal.pone.0141067			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0DL	26510097	Green Published, Green Submitted, gold			2022-12-26	WOS:000363918100048
J	Oczkowski, A; McKinney, R; Ayvazian, S; Hanson, A; Wigand, C; Markham, E				Oczkowski, Autumn; McKinney, Richard; Ayvazian, Suzanne; Hanson, Alana; Wigand, Cathleen; Markham, Erin			Preliminary Evidence for the Amplification of Global Warming in Shallow, Intertidal Estuarine Waters	PLOS ONE			English	Article							NARRAGANSETT BAY; GROWTH-RATES; HEAT-WAVE; TEMPERATURE; OCEAN; NITROGEN; PHYTOPLANKTON; SILVERSIDES; ABUNDANCE; RECORD	Over the past 50 years, mean annual water temperature in northeastern U.S. estuaries has increased by approximately 1.2 degrees C, with most of the warming recorded in the winter and early spring. A recent survey and synthesis of data from four locations in Southern Rhode Island has led us to hypothesize that this warming may be amplified in the shallow (<1 m), nearshore portions of these estuaries. While intertidal areas are not typically selected as locations for long-term monitoring, we compiled data from published literature, theses, and reports that suggest that enhanced warming may be occurring, perhaps at rates three times higher than deeper estuarine waters. Warmer spring waters may be one of the factors influencing biota residing in intertidal regions both in general as well as at our specific sites. We observed greater abundance of fish, and size of Menidia sp., in recent (2010- 2012) seine surveys compared to similar collections in 1962. While any linkages are speculative and data are preliminary, taken together they suggest that shallow intertidal portions of estuaries may be important places to look for the effects of climate change.	[Oczkowski, Autumn; McKinney, Richard; Ayvazian, Suzanne; Hanson, Alana; Wigand, Cathleen] United States Environm Protect Agcy, Atlantic Ecol Div, Narragansett, RI 02882 USA; [Markham, Erin] Univ Rhode Isl, Grad Sch Oceanog, Narragansett, RI 02882 USA	United States Environmental Protection Agency; University of Rhode Island	Oczkowski, A (corresponding author), United States Environm Protect Agcy, Atlantic Ecol Div, Narragansett, RI 02882 USA.	Oczkowski.autumn@epa.gov		Oczkowski, Autumn/0000-0002-2421-0956	U.S. Environmental Protection Agency	U.S. Environmental Protection Agency(United States Environmental Protection Agency)	The research described in this article has been funded by the U.S. Environmental Protection Agency, but has not been subjected to Agency review. Therefore, it does not necessarily reflect the views of the Agency. The funders had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript.	Bengtson D, 1977, LENGTH WEIGHT UNPUB; BENGTSON DA, 1981, PROG FISH CULT, V43, P146, DOI 10.1577/1548-8659(1981)43[146:GOPASI]2.0.CO;2; Bengtson DA, 1982, THESIS U RHODE ISLAN; Bintz JC, 2003, ESTUARIES, V26, P765, DOI 10.1007/BF02711987; Bradley M., 2013, 2012 MAPPING SUBMERG; BRIGGS P T, 1971, New York Fish and Game Journal, V18, P15; Burgess GH, 1971, SPRING SURVEY UNPUB, V466; Chen K, 2014, J GEOPHYS RES-OCEANS, V119, P218, DOI 10.1002/2013JC009393; Chollett I, 2012, MAR POLLUT BULL, V64, P956, DOI 10.1016/j.marpolbul.2012.02.016; Clark E, 1999, HYDROL PROCESS, V13, P423, DOI 10.1002/(SICI)1099-1085(19990228)13:3<423::AID-HYP747>3.0.CO;2-#; Collie JS, 2008, CAN J FISH AQUAT SCI, V65, P1352, DOI 10.1139/F08-048; COOPER R. A., 1964, CHESAPEAKE SCI, V5, P155, DOI 10.2307/1350559; Deegan LA, 2002, AQUAT CONSERV, V12, P193, DOI 10.1002/aqc.490; Domingues CM, 2008, NATURE, V453, P1090, DOI 10.1038/nature07080; DURBIN AG, 1981, ESTUARIES, V4, P24, DOI 10.2307/1351540; Ernst LM, 1999, NARROW RIVER SPECIAL; Field C.B., 2014, CLIM CHANG 2014 IMP, P1, DOI [DOI 10.1038/446727A, 10.1017/CBO9781107415379]; Fulweiler RW, 2015, ESTUAR COAST SHELF S, V157, pA1, DOI 10.1016/j.ecss.2015.01.021; Grassle JP, 1984, CONCEPTS MARINE POLL, P621; Hanisak MD, 1973, THESIS U RHODE ISLAN; Hefferman S, 1982, NUTR INPUTS RHODE IS; HOFF JG, 1977, ESTUAR COAST MAR SCI, V5, P665, DOI 10.1016/0302-3524(77)90091-3; HSIUNG J, 1986, J GEOPHYS RES-OCEANS, V91, P585, DOI 10.1029/JC091iC09p10585; Hurst TP, 2004, ESTUARIES, V27, P659, DOI 10.1007/BF02907651; Kesler D, 1973, SPRING SURVEY UNPUB, V466; LaBrecque E, 1996, BIOL BULL, V191, P319, DOI 10.1086/BBLv191n2p319; Lee V, 1997, TECHNICAL REPORT; LETCHER BH, 1993, J FISH BIOL, V43, P671; Levitus S, 2000, SCIENCE, V287, P2225, DOI 10.1126/science.287.5461.2225; Mackenzie BR, 2007, GLOBAL CHANGE BIOL, V13, P1335, DOI 10.1111/j.1365-2486.2007.01360.x; McNamee J, 2011, F61R18; Meng L, 2000, MAR ECOL PROG SER, V201, P287, DOI 10.3354/meps201287; Mills KE, 2013, OCEANOGRAPHY, V26, P191, DOI 10.5670/oceanog.2013.27; MULKANA MOHAMMED SAEED, 1966, GULF RES REP, V2, P97; Mulkana MS, 1964, THESIS U RHODE ISLAN; Najjar RG, 2010, ESTUAR COAST SHELF S, V86, P1, DOI 10.1016/j.ecss.2009.09.026; Nixon SW, 2008, SPRINGER SER ENV MAN, P101, DOI 10.1007/978-0-387-35299-2_5; Nixon SW, 2007, NITROGEN INPUTS RHOD; Nixon SX, 2004, ESTUARIES, V27, P397, DOI 10.1007/BF02803532; Oviatt C, 2002, ESTUAR COAST SHELF S, V54, P1013, DOI 10.1006/ecss.2001.0872; Oviatt CA, 2004, ESTUARIES, V27, P895, DOI 10.1007/BF02803416; Pearce AF, 2013, J MARINE SYST, V111, P139, DOI 10.1016/j.jmarsys.2012.10.009; Preston BL, 2004, ENVIRON MANAGE, V34, P125, DOI 10.1007/s00267-004-0159-x; RIGIS, 2013, RHOD ISL GROGR INF S; RUDNICK DT, 1985, OECOLOGIA, V67, P157, DOI 10.1007/BF00384279; Seekell DA, 2011, J ENVIRON MONITOR, V13, P2321, DOI 10.1039/c1em10053j; Seiburth JM, 1983, WATER QUALITY NARROW; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Tober Joanna D., 2000, Aquatic Ecology, V34, P299, DOI 10.1023/A:1009982208382; Uncles RJ, 2001, J SEA RES, V46, P143, DOI 10.1016/S1385-1101(01)00078-8; Vaughan CF, 1971, THESIS U RHODE ISLAN; Webb BW, 2008, HYDROL PROCESS, V22, P902, DOI 10.1002/hyp.6994; Wigand C, 2015, NORTHEAST NAT, V22, P1, DOI 10.1656/045.022.0101; Yamahira K, 2002, ECOLOGY, V83, P1252, DOI 10.1890/0012-9658(2002)083[1252:IVILVI]2.0.CO;2	54	19	19	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2015	10	10							e0141529	10.1371/journal.pone.0141529	http://dx.doi.org/10.1371/journal.pone.0141529			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0DL	26510009	gold, Green Published, Green Submitted			2022-12-26	WOS:000363918100098
J	Pereira, MD; Sathler, MF; Valli, TD; Marques, RS; Ventura, ALM; Peccinalli, NR; Fraga, MC; Manhaes, AC; Kubrusly, R				Pereira, Mauricio dos Santos; Sathler, Matheus Figueiredo; Valli, Thais da Rosa; Marques, Richard Souza; Marques Ventura, Ana Lucia; Peccinalli, Ney Ronner; Fraga, Mabel Carneiro; Manhaes, Alex C.; Kubrusly, Regina			Long Withdrawal of Methylphenidate Induces a Differential Response of the Dopaminergic System and Increases Sensitivity to Cocaine in the Prefrontal Cortex of Spontaneously Hypertensive Rats	PLOS ONE			English	Article							ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; DEFICIT HYPERACTIVITY DISORDER; NUCLEUS-ACCUMBENS; ANIMAL-MODEL; EXTRACELLULAR DOPAMINE; ORAL METHYLPHENIDATE; SUBSTANCE-ABUSE; RODENT MODEL; ADULT RATS; FOLLOW-UP	Methylphenidate (MPD) is one of the most prescribed drugs for alleviating the symptoms of Attention Deficit/Hyperactivity Disorder (ADHD). However, changes in the molecular mechanisms related to MPD withdrawal and susceptibility to consumption of other psychostimulants in normal individuals or individuals with ADHD phenotype are not completely understood. The aims of the present study were: (i) to characterize the molecular differences in the prefrontal dopaminergic system of SHR and Wistar strains, (ii) to establish the neurochemical consequences of short- (24 hours) and long-term (10 days) MPD withdrawal after a subchronic treatment (30 days) with Ritalin (R) (Methylphenidate Hydrochloride; 2.5 mg/kg orally), (iii) to investigate the dopaminergic synaptic functionality after a cocaine challenge in adult MPD-withdrawn SHR and Wistar rats. Our results indicate that SHR rats present reduced [H-3]-Dopamine uptake and cAMP accumulation in the prefrontal cortex (PFC) and are not responsive to dopaminergic stimuli in when compared to Wistar rats. After a 24-hour withdrawal of MPD, SHR did not present any alterations in [H-3]-Dopamine Uptake, [H-3]-SCH 23390 binding and cAMP production; nonetheless, after a 10-day MPD withdrawal, the results showed a significant increase of [H-3]-Dopamine uptake, of the quantity of [H-3]-SCH 23390 binding sites and of cAMP levels in these animals. Finally, SHR that underwent a 10-day MPD withdrawal and were challenged with cocaine (10 mg/kg i.p.) presented reduced [H-3]-Dopamine uptake and increased cAMP production. Wistar rats were affected by the 10-day withdrawal of MPD in [H-3]-dopamine uptake but not in cAMP accumulation; in addition, cocaine was unable to induce significant modifications in [H-3]-dopamine uptake and in cAMP levels after the 10-day withdrawal of MPD. These results indicate a mechanism that could explain the high comorbidity between ADHD adolescent patients under methylphenidate treatment and substance abuse in adult life.	[Pereira, Mauricio dos Santos; Sathler, Matheus Figueiredo; Valli, Thais da Rosa; Marques, Richard Souza; Peccinalli, Ney Ronner; Kubrusly, Regina] Univ Fed Fluminense, Inst Biomed, Dept Fisiol & Farmacol, Lab Neurofarmacol, Niteroi, RJ, Brazil; [Marques Ventura, Ana Lucia] Univ Fed Fluminense, Inst Biol, Dept Neurobiol, Lab Neuroquim, Niteroi, RJ, Brazil; [Fraga, Mabel Carneiro; Manhaes, Alex C.] Univ Estado Rio de Janeiro, Ctr Biomed, Inst Biol Roberto Alcantara Gomes, Lab Neurofisiol,Dept Ciencias Fisiol, BR-20550011 Rio De Janeiro, RJ, Brazil	Universidade Federal Fluminense; Universidade Federal Fluminense; Universidade do Estado do Rio de Janeiro	Kubrusly, R (corresponding author), Univ Fed Fluminense, Inst Biomed, Dept Fisiol & Farmacol, Lab Neurofarmacol, Niteroi, RJ, Brazil.	kubrusly@vm.uff.br	ManhÃes, Alex C/F-5499-2011; Kubrusly, Regina C C/E-2626-2018; Sathler, Matheus/G-8128-2017; dos-Santos-Pereira, Mauricio/J-7820-2017	ManhÃes, Alex C/0000-0003-4629-8343; Kubrusly, Regina C C/0000-0002-6016-2197; Sathler, Matheus/0000-0003-3928-0751; Souza-Marques, Richard/0000-0002-8352-8606; dos-Santos-Pereira, Mauricio/0000-0001-9012-7379	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Fundacao Carlos Chaga Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ); Pro-reitoria de Pesquisa e Pos-graduacao - Universidade Federal Fluminense (UFF), Brazil	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao Carlos Chaga Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Pro-reitoria de Pesquisa e Pos-graduacao - Universidade Federal Fluminense (UFF), Brazil	Supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Fundacao Carlos Chaga Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ), Pro-reitoria de Pesquisa e Pos-graduacao - Universidade Federal Fluminense (UFF), Brazil to RCCK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adriani W, 2004, BEHAV PHARMACOL, V15, P341, DOI 10.1097/00008877-200409000-00005; Andersen SL, 2000, SYNAPSE, V37, P167, DOI 10.1002/1098-2396(200008)37:2<167::AID-SYN11>3.0.CO;2-B; Arnsten AFT, 2005, BEHAV BRAIN FUNCT, V1, DOI 10.1186/1744-9081-1-2; Arnsten AFT, 2009, CNS DRUGS, V23, P33, DOI 10.2165/00023210-200923000-00005; Barkley RA, 2003, PEDIATRICS, V111, P97, DOI 10.1542/peds.111.1.97; Baskin BM, 2015, PHARMACOL BIOCHEM BE, V131, P51, DOI 10.1016/j.pbb.2015.01.019; Beaudin SA, 2015, TOXICOL SCI, V144, P318, DOI 10.1093/toxsci/kfv007; Berridge CW, 2006, BIOL PSYCHIAT, V60, P1111, DOI 10.1016/j.biopsych.2006.04.022; BIEDERMAN J, 1994, PSYCHIAT RES, V53, P13, DOI 10.1016/0165-1781(94)90092-2; Biederman J, 2008, AM J PSYCHIAT, V165, P597, DOI 10.1176/appi.ajp.2007.07091486; Browne JD, 2014, PSYCHOPHARMACOLOGY B, P4503; Chadchankar H, 2012, J PHARMACOL EXP THER, V341, P484, DOI 10.1124/jpet.111.189225; Challman TD, 2000, MAYO CLIN PROC, V75, P711; Chong SL, 2012, BRAIN RES BULL, V87, P445, DOI 10.1016/j.brainresbull.2012.01.004; Crawford CA, 2011, PSYCHOPHARMACOLOGY, V213, P43, DOI 10.1007/s00213-010-2011-8; dela Pena I, 2012, PSYCHOPHARMACOLOGY, V221, P217, DOI 10.1007/s00213-011-2564-1; Devilbiss DM, 2008, BIOL PSYCHIAT, V64, P62; Faraone SV, 2005, BIOL PSYCHIAT, V57, P1313, DOI 10.1016/j.biopsych.2004.11.024; Feron FJM, 2005, PEDIATR NEUROL, V33, P179, DOI 10.1016/j.pediatrneurol.2005.04.008; Ferreira R, 2010, NEUROSCI RES, V68, P290, DOI 10.1016/j.neures.2010.08.009; Gatley SJ, 1996, LIFE SCI, V58, P231; GILMAN AG, 1970, P NATL ACAD SCI USA, V67, P305, DOI 10.1073/pnas.67.1.305; Gronier B, 2011, EUR NEUROPSYCHOPHARM, V21, P192, DOI 10.1016/j.euroneuro.2010.11.002; Harvey RC, 2011, NEUROPSYCHOPHARMACOL, V36, P837, DOI 10.1038/npp.2010.223; Kieling C, 2008, CHILD ADOL PSYCH CL, V17, P285, DOI 10.1016/j.chc.2007.11.012; KIROUAC GJ, 1993, NEUROSCIENCE, V52, P135, DOI 10.1016/0306-4522(93)90188-L; Kubrusly RCC, 2005, BRAIN RES, V1038, P141, DOI 10.1016/j.brainres.2005.01.031; Lambert NM, 1998, J LEARN DISABIL-US, V31, P533, DOI 10.1177/002221949803100603; Li Q, 2007, NEUROCHEM INT, V50, P848, DOI 10.1016/j.neuint.2007.02.005; Logue SF, 2014, PHARMACOL BIOCHEM BE, V123, P45, DOI 10.1016/j.pbb.2013.08.007; Mannuzza S, 2008, AM J PSYCHIAT, V165, P604, DOI 10.1176/appi.ajp.2008.07091465; Mill J, 2005, BEHAV BRAIN FUNCT, V1, DOI 10.1186/1744-9081-1-24; MOGHADDAM B, 1989, SYNAPSE, V4, P156, DOI 10.1002/syn.890040209; Napolitano F, 2010, J NEUROSCI, V30, P11043, DOI 10.1523/JNEUROSCI.1682-10.2010; Pehek EA, 1997, PROG NEURO-PSYCHOPH, V21, P671, DOI 10.1016/S0278-5846(97)00040-7; Pliszka SR, 2005, BIOL PSYCHIAT, V57, P1385, DOI 10.1016/j.biopsych.2004.08.026; Polanczyk G, 2007, AM J PSYCHIAT, V164, P942, DOI 10.1176/appi.ajp.164.6.942; RIDLEY RM, 1994, PROG NEUROBIOL, V44, P221, DOI 10.1016/0301-0082(94)90039-6; RUSSELL V, 1995, BRAIN RES, V676, P343, DOI 10.1016/0006-8993(95)00135-D; Russell VA, 2003, METAB BRAIN DIS, V18, P161, DOI 10.1023/A:1023819220840; Russell VA, 2002, BEHAV BRAIN RES, V130, P191, DOI 10.1016/S0166-4328(01)00425-9; Sagvolden T, 2000, NEUROSCI BIOBEHAV R, V24, P31, DOI 10.1016/S0149-7634(99)00058-5; Sagvolden T, 1998, BEHAV BRAIN RES, V94, P1; Sakrikar D, 2012, J NEUROSCI, V32, P5385, DOI 10.1523/JNEUROSCI.6033-11.2012; Simchon Y, 2010, EUR NEUROPSYCHOPHARM, V20, P714, DOI 10.1016/j.euroneuro.2010.04.007; Somkuwar SS, 2013, BIOCHEM PHARMACOL, V86, P309, DOI 10.1016/j.bcp.2013.04.013; SORG BA, 1993, NEUROSCIENCE, V53, P695, DOI 10.1016/0306-4522(93)90617-O; Sorg BA, 1997, J PHARMACOL EXP THER, V281, P54; Steketee JD, 2003, BRAIN RES REV, V41, P203, DOI 10.1016/S0165-0173(02)00233-3; Taylor E, 1998, BEHAV BRAIN RES, V94, P11, DOI 10.1016/S0166-4328(97)00165-4; Taylor E, 2004, EUR CHILD ADOLESC S1, V13, P17, DOI DOI 10.1007/s00787-004-1002-x; Tripp G, 2009, NEUROPHARMACOLOGY, V57, P579, DOI 10.1016/j.neuropharm.2009.07.026; Ueno K, 2002, BEHAV PHARMACOL, V13, P1, DOI 10.1097/00008877-200202000-00001; Viggiano Davide, 2004, Neural Plasticity, V11, P97, DOI 10.1155/NP.2004.97; Volkow ND, 1998, AM J PSYCHIAT, V155, P1325, DOI 10.1176/ajp.155.10.1325; Volkow ND, 2008, AM J PSYCHIAT, V165, P553, DOI 10.1176/appi.ajp.2008.08020237; Yang PB, 2006, BRAIN RES BULL, V71, P301, DOI 10.1016/j.brainresbull.2006.09.019; Zhu JM, 2011, NEUROPHARMACOLOGY, V61, P283, DOI 10.1016/j.neuropharm.2011.04.015	58	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2015	10	10							e0141249	10.1371/journal.pone.0141249	http://dx.doi.org/10.1371/journal.pone.0141249			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0DL	26509840	gold, Green Published, Green Submitted			2022-12-26	WOS:000363918100066
J	Szeto, CC; Kwan, BCH; Chow, KM; Cheng, PMS; Kwong, VWK; Choy, ASM; Law, MC; Leung, CB; Li, PKT				Szeto, Cheuk-Chun; Kwan, Bonnie C. H.; Chow, Kai-Ming; Cheng, Phyllis M. S.; Kwong, Vickie W. K.; Choy, Agnes S. M.; Law, Man-Ching; Leung, Chi-Bon; Li, Philip K. T.			The Effect of Neutral Peritoneal Dialysis Solution with Low Glucose-Degradation Product on the Fluid Status and Body Composition - A Randomized Control Trial	PLOS ONE			English	Article							RESIDUAL RENAL-FUNCTION; ARTERIAL STIFFNESS; IN-VITRO; PH; BIOCOMPATIBILITY; MEMBRANE; BIOIMPEDANCE; INFLAMMATION; KINETICS; BENEFITS	Background Previous studies report conflicting results on the benefit of peritoneal dialysis (PD) patients treated with low glucose degradation product (GDP) solution. The effects of low GDP solution on body fluid status and arterial pulse wave velocity (PWV) have not been studied. Methods We randomly assigned 68 incident PD patients to low GDP (Intervention Group) or conventional solutions (Control Group); 4 dropped off before they received the assigned treatment. Patients were followed for 52 weeks for changes in ultrafiltration, residual renal function, body fluid status and arterial PWV. Result After 52 weeks, Intervention Group had higher overhydration (3.1 +/- 2.6 vs 1.9 +/- 2.2 L, p = 0.045) and extracellular water volume (17.7 +/- 3.9 vs 15.8 +/- 3.1 L, p = 0.034) than Control Group. There was no significant difference in PWV between groups. There was no significant difference in residual renal function between the Groups. Intervention Group had lower ultrafiltration volume than Control Group at 4 weeks (0.45 +/-.0.61 vs 0.90 +/- 0.79 L/day, p = 0.013), but the difference became insignificant at later time points. Intervention Group had lower serum CRP levels than Control Group (4.17 +/- 0.77 vs 4.91 +/- 0.95 mg/dL, p < 0.0001). Conclusion Incident PD patients treated with low GDP solution have less severe systemic inflammation but trends of less ultrafiltration, and more fluid accumulation. However, the effects on ultrafiltration and fluid accumulation disappear with time. The long term effect of low GDP solution requires further study.	[Szeto, Cheuk-Chun; Kwan, Bonnie C. H.; Chow, Kai-Ming; Cheng, Phyllis M. S.; Kwong, Vickie W. K.; Choy, Agnes S. M.; Law, Man-Ching; Leung, Chi-Bon; Li, Philip K. T.] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Med & Therapeut, Carol & Richard Yu Peritoneal Dialysis Res Ctr, Shatin, Hong Kong, Peoples R China	Chinese University of Hong Kong; Prince of Wales Hospital	Szeto, CC (corresponding author), Chinese Univ Hong Kong, Prince Wales Hosp, Dept Med & Therapeut, Carol & Richard Yu Peritoneal Dialysis Res Ctr, Shatin, Hong Kong, Peoples R China.	ccszeto@cuhk.edu.hk	Li, Philip K. T./D-4051-2017; Szeto, Cheuk Chun/N-4954-2015; Ming, Chow Kai/Y-5568-2019; Kwan, Bonnie/N-3463-2015	Szeto, Cheuk Chun/0000-0002-8898-8505; Ming, Chow Kai/0000-0001-5310-5197; Kwan, Bonnie/0000-0001-6742-8480	Fresenius Medical Care; CUHK research account [6901031]; Baxter Healthcare	Fresenius Medical Care; CUHK research account(Chinese University of Hong Kong); Baxter Healthcare	This study was supported in part by the Fresenius Medical Care, CUHK research account 6901031, and a research grant and consultancy from Baxter Healthcare (CCS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alscher DM, 2000, NEPHRON, V86, P62, DOI 10.1159/000045714; Bergstrom J, 1998, PERITON DIALYSIS INT, V18, P467; Breborowicz A, 1996, AM J KIDNEY DIS, V27, P738, DOI 10.1016/S0272-6386(96)90114-6; Cappelli G, 1999, ADV PERIT D, V15, P238; Cho Y, 2013, KIDNEY INT, V84, P969, DOI 10.1038/ki.2013.190; Choi HY, 2008, PERITON DIALYSIS INT, V28, P174; Contreras-Velazquez JC, 2008, KIDNEY INT S, V108, pS34; Davies SJ, 2014, KIDNEY INT, V86, P489, DOI 10.1038/ki.2014.207; Davies SJ, 1996, NEPHROL DIAL TRANSPL, V11, P498; ENIA G, 1993, NEPHROL DIAL TRANSPL, V8, P1094; Fan SLS, 2008, KIDNEY INT, V73, P200, DOI 10.1038/sj.ki.5002574; FORBES GB, 1976, AM J CLIN NUTR, V29, P1359, DOI 10.1093/ajcn/29.12.1359; Haag-Weber M, 2010, NEPHROL DIAL TRANSPL, V25, P2288, DOI 10.1093/ndt/gfq087; Johnson DW, 2012, NEPHROL DIAL TRANSPL, V27, P4445, DOI 10.1093/ndt/gfs314; Johnson DW, 2012, J AM SOC NEPHROL, V23, P1097, DOI 10.1681/ASN.2011121201; Johnson DW, 2004, PERITON DIALYSIS INT, V24, P460; Kalantar-Zadeh K, 2001, AM J KIDNEY DIS, V38, P1251, DOI 10.1053/ajkd.2001.29222; Kim S, 2009, NEPHROL DIAL TRANSPL, V24, P2899, DOI 10.1093/ndt/gfp054; Kocyigit I, 2014, PERITON DIALYSIS INT, V34, P781, DOI 10.3747/pdi.2013.00057; KREDIET R T, 1986, Blood Purification, V4, P194, DOI 10.1159/000169445; Kwan BCH, 2014, PERITON DIALYSIS INT, V34, P409, DOI 10.3747/pdi.2013.00066; Lage C, 2000, PERITON DIALYSIS INT, V20, pS28; Li PKT, 2010, CLIN J AM SOC NEPHRO, V5, P652, DOI 10.2215/CJN.05620809; LIBEREK T, 1993, NEPHRON, V65, P260, DOI 10.1159/000187485; Mak TWL, 1997, NEPHROL DIAL TRANSPL, V12, P184, DOI 10.1093/ndt/12.1.184; Montenegro J, 2006, PERITON DIALYSIS INT, V26, P89; Passlick-Deetjen J, 2001, PERITON DIALYSIS INT, V21, pS96; Schmitt CP, 2002, KIDNEY INT, V61, P1527, DOI 10.1046/j.1523-1755.2002.00255.x; Szeto CC, 2007, NEPHROL DIAL TRANSPL, V22, P552, DOI 10.1093/ndt/gfl559; Szeto CC, 2012, AM J NEPHROL, V35, P127, DOI 10.1159/000335580; TWARDOWSKI ZJ, 1987, PERITON DIALYSIS INT, V7, P138; Van Biesen W., 1999, PERIT DIAL INT, V19, pS43; vanOlden RW, 1996, J AM SOC NEPHROL, V7, P745; *WHO COLL CTR DRUG, 1995, GUID ATC CLASS DDD A, P22; Williams JD, 2004, KIDNEY INT, V66, P408, DOI 10.1111/j.1523-1755.2004.00747.x	35	11	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2015	10	10							e0141425	10.1371/journal.pone.0141425	http://dx.doi.org/10.1371/journal.pone.0141425			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0DL	26510186	Green Published, Green Submitted, gold			2022-12-26	WOS:000363918100079
J	Zhang, CL; Deng, ZY; Pan, XL; Uehara, T; Suzuki, M; Xie, MQ				Zhang, Chunlin; Deng, Zeyi; Pan, Xiaoli; Uehara, Takayuki; Suzuki, Mikio; Xie, Minqiang			Effects of Methylation Status of CpG Sites within the HPV16 Long Control Region on HPV16-Positive Head and Neck Cancer Cells	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS TYPE-16; CERVICAL-CARCINOMA CELLS; DNA METHYLATION; OROPHARYNGEAL CANCER; CELLULAR-DIFFERENTIATION; CAUSAL ASSOCIATION; E2 PROTEINS; VIRAL LOAD; 5-AZA-2'-DEOXYCYTIDINE; REPRESSION	Objective To map comprehensively the methylation status of the CpG sites within the HPV16 long control region (LCR) in HPV-positive cancer cells, and to explore further the effects of methylation status of HPV16 LCR on cell bioactivity and E6 and E7 expression. In addition, to analyze the methylation status of the LCR in HPV-positive oropharyngeal squamous cell carcinoma (OPSCC) patients. Methods and Materials Methylation patterns of HPV16 LCR in UM-SCC47, CaSki, and SiHa cells and HPV16-positiive OPSCC specimens were detected by bisulfite-sequencing PCR and TA cloning. For cells treated with 5-aza-2'-deoxycytidine and E6 and E7 knockdown, MTS and trypan blue staining, annexin-V and 7-AAD staining, and prodidium iodide were used to evaluate cell growth and cell proliferation, cell apoptosis, and cell cycle arrest, respectively. E6 and E7 mRNA and protein expression were analyzed by quantitative real-time PCR and immunocytochemistry, respectively. Results Hypermethylation status of the LCR in UM-SCC47 (79.8%) and CaSki cells (90.0%) and unmethylation status of the LCR in SiHa cells (0%) were observed. Upon demethylation, the cells with different methylation levels responded differently during growth, apoptosis, and cell cycle arrest, as well as in terms of their E6 and E7 expression. In HPV16-positive OPSCC patients, the methylation rates were 9.5% in the entire LCR region, 13.9% in the 5'-LCR, 6.0% in the E6 enhancer, and 9.5% in the p97 promoter, and hypermethylation of p97 promoter was found in a subset of cases (20.0%, 2/10). Conclusions Our study revealed two different methylation levels of the LCR in HPV16-positive cancer cells and OPSCC patients, which may represent different carcinogenesis mechanisms of HPV-positive cancers cells. Demethylating the meCpGs in HPV16 LCR might be a potential target for a subgroup of HPV16-positive patients with head and neck squamous cell carcinoma.	[Zhang, Chunlin; Deng, Zeyi; Pan, Xiaoli; Xie, Minqiang] Southern Med Univ, Zhujiang Hosp, Dept Otorhinolaryngol Head & Neck Surg, Guangzhou, Guangdong, Peoples R China; [Zhang, Chunlin; Deng, Zeyi; Pan, Xiaoli; Uehara, Takayuki; Suzuki, Mikio] Univ Ryukyus, Dept Otorhinolaryngol Head & Neck Surg, Okinawa, Japan; [Zhang, Chunlin] Zunyi Med Univ, Affiliated Hosp, Dept Otorhinolaryngol Head & Neck Surg, Zunyi, Peoples R China; [Pan, Xiaoli] First Peoples Hosp Guangzhou, Dept Otorhinolaryngol Head & Neck Surg, Guangzhou, Guangdong, Peoples R China	Southern Medical University - China; University of the Ryukyus; Zunyi Medical University; South China University of Technology	Suzuki, M (corresponding author), Univ Ryukyus, Dept Otorhinolaryngol Head & Neck Surg, Okinawa, Japan.	suzuki@med.u-ryukyu.ac.jp; min_qiang_x@hotmail.com		Deng, Zeyi/0000-0003-1064-1031	National Natural Science Foundation of China [81372477]; Japan Society for the Promotion of Science [KAKENHI 26462610, KAKENHI 26462611]; Specialized Research Fund for the Doctoral Program of Higher Education, China [20114433110001]; Natural Science Foundation of Guangdong Province, China [2014A030310411]; Science and Technology Development Center, Ministry of Education of China [20134433120021]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Specialized Research Fund for the Doctoral Program of Higher Education, China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Natural Science Foundation of Guangdong Province, China(National Natural Science Foundation of Guangdong Province); Science and Technology Development Center, Ministry of Education of China(Ministry of Education, China)	This work was supported by the National Natural Science Foundation of China, (81372477 to MX); (http://www.nsfc.gov.cn/publish/portal1/), the Japan Society for the Promotion of Science (KAKENHI 26462610 to MS and KAKENHI 26462611 to ZD); (http://www.jsps.go.jp/english/), the Specialized Research Fund for the Doctoral Program of Higher Education, China (20114433110001 to MX); (http://www.cutech.edu.cn/cn/kyjj/gdxxbsdkyjj/A010301index_1.htm), the Natural Science Foundation of Guangdong Province, China (2014A030310411 to ZD);(http://www.gdstc.gov.cn/eng/mission.html), and a grant from the Science and Technology Development Center, Ministry of Education of China (20134433120021 to ZD); (http://www.cutech.edu.cn/cn/kyjj/gdxxbsdkyjj/A010301index_1.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Applebaum KM, 2007, JNCI-J NATL CANCER I, V99, P1801, DOI 10.1093/jnci/djm233; Arias-Pulido H, 2006, J CLIN MICROBIOL, V44, P1755, DOI 10.1128/JCM.44.5.1755-1762.2006; Badal V, 2003, J VIROL, V77, P6227, DOI 10.1128/JVI.77.11.6227-6234.2003; Balderas-Loaeza A, 2007, INT J CANCER, V120, P2165, DOI 10.1002/ijc.22563; Barbieri D, 2014, J CLIN VIROL, V60, P243, DOI 10.1016/j.jcv.2014.04.014; Bastien N, 2000, VIROLOGY, V270, P124, DOI 10.1006/viro.2000.0265; Bhattacharjee B, 2006, VIROLOGY, V354, P280, DOI 10.1016/j.virol.2006.06.018; Brenner JC, 2010, HEAD NECK-J SCI SPEC, V32, P417, DOI 10.1002/hed.21198; Chen Z, 1997, CANCER RES, V57, P1614; CHIANG CM, 1992, P NATL ACAD SCI USA, V89, P5799, DOI 10.1073/pnas.89.13.5799; D'Souza G, 2007, NEW ENGL J MED, V356, P1944, DOI 10.1056/NEJMoa065497; Das Ghosh D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044678; Deng ZY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113702; Deng ZY, 2013, HEAD NECK-J SCI SPEC, V35, P800, DOI 10.1002/hed.23034; Deng ZY, 2012, CANCER SCI, V103, P2127, DOI 10.1111/cas.12009; Deng ZY, 2011, EUR ARCH OTO-RHINO-L, V268, P1625, DOI 10.1007/s00405-011-1515-0; Ding DC, 2009, EUR J OBSTET GYN R B, V147, P215, DOI 10.1016/j.ejogrb.2009.08.023; Fernandez AF, 2009, GENOME RES, V19, P438, DOI 10.1101/gr.083550.108; Frattini MG, 1997, EMBO J, V16, P318, DOI 10.1093/emboj/16.2.318; Gillison ML, 2008, JNCI-J NATL CANCER I, V100, P407, DOI 10.1093/jnci/djn025; Gillison ML, 2000, JNCI-J NATL CANCER I, V92, P709, DOI 10.1093/jnci/92.9.709; Goodwin EC, 2000, P NATL ACAD SCI USA, V97, P12513, DOI 10.1073/pnas.97.23.12513; Hama T, 2014, ONCOLOGY-BASEL, V87, P173, DOI 10.1159/000360991; Horner SM, 2004, J VIROL, V78, P4063, DOI 10.1128/JVI.78.8.4063-4073.2004; JONES PA, 1980, CELL, V20, P85, DOI 10.1016/0092-8674(80)90237-8; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; JUTTERMANN R, 1994, P NATL ACAD SCI USA, V91, P11797, DOI 10.1073/pnas.91.25.11797; Kalantari M, 2008, INT J CANCER, V123, P1832, DOI 10.1002/ijc.23707; Kalantari M, 2008, VIROLOGY, V374, P292, DOI 10.1016/j.virol.2007.12.016; Karahoca M, 2013, CLIN EPIGENETICS, V5, DOI 10.1186/1868-7083-5-3; Kim K, 2003, J VIROL, V77, P12450, DOI 10.1128/JVI.77.23.12450-12459.2003; Klussmann JP, 2001, CANCER-AM CANCER SOC, V92, P2875, DOI 10.1002/1097-0142(20011201)92:11&lt;2875::AID-CNCR10130&gt;3.0.CO;2-7; Lewis H, 1999, J GEN VIROL, V80, P2087, DOI 10.1099/0022-1317-80-8-2087; Lin BM, 2013, CANCER-AM CANCER SOC, V119, P3462, DOI 10.1002/cncr.28250; Liu T, 2014, BIOMATERIALS, V35, P3865, DOI 10.1016/j.biomaterials.2014.01.040; MOMPARLER RL, 1984, CANCER CHEMOTH PHARM, V13, P191, DOI 10.1007/BF00269027; MUNGER K, 1989, J VIROL, V63, P4417; Olthof NC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088718; Parish JL, 2006, J VIROL, V80, P4580, DOI 10.1128/JVI.80.9.4580-4590.2006; Park IS, 2011, CANCER PREV RES, V4, P207, DOI 10.1158/1940-6207.CAPR-10-0147; Psyrri A, 2004, CANCER RES, V64, P3079, DOI 10.1158/0008-5472.CAN-03-3739; Rajeevan MS, 2006, J VIROL METHODS, V138, P170, DOI 10.1016/j.jviromet.2006.08.012; Rampias T, 2009, JNCI-J NATL CANCER I, V101, P412, DOI 10.1093/jnci/djp017; Ritchie JM, 2003, INT J CANCER, V104, P336, DOI 10.1002/ijc.10960; ROSL F, 1993, J GEN VIROL, V74, P791, DOI 10.1099/0022-1317-74-5-791; Snellenberg S, 2012, VIROLOGY, V422, P357, DOI 10.1016/j.virol.2011.11.006; Stunkel W, 1999, J VIROL, V73, P1918; Sun C, 2011, GYNECOL ONCOL, V121, P59, DOI 10.1016/j.ygyno.2011.01.013; Thierry F, 2009, VIROLOGY, V384, P375, DOI 10.1016/j.virol.2008.11.014; Vinokurova S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024451; Wells SI, 2000, EMBO J, V19, P5762, DOI 10.1093/emboj/19.21.5762; Wilson GA, 2013, EPIGENETICS-US, V8, P953, DOI 10.4161/epi.25614	52	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2015	10	10							e0141245	10.1371/journal.pone.0141245	http://dx.doi.org/10.1371/journal.pone.0141245			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0DL	26509736	Green Submitted, Green Published, gold			2022-12-26	WOS:000363918100065
J	Linger, RJ; Belikoff, EJ; Scott, MJ				Linger, Rebecca J.; Belikoff, Esther J.; Scott, Maxwell J.			Dosage Compensation of X-Linked Muller Element F Genes but Not X-Linked Transgenes in the Australian Sheep Blowfly	PLOS ONE			English	Article							POLYTENE TRICHOGEN CELLS; LUCILIA-SERICATA DIPTERA; DROSOPHILA-MELANOGASTER; CUPRINA DIPTERA; SEX-CHROMOSOMES; EXPRESSION; CALLIPHORIDAE; SYSTEM; AUTOSOMES; CHRYSOMYA	In most animals that have X and Y sex chromosomes, chromosome-wide mechanisms are used to balance X-linked gene expression in males and females. In the fly Drosophila melanogaster, the dosage compensation mechanism also generally extends to X-linked transgenes. Over 70 transgenic lines of the Australian sheep blowfly Lucilia cuprina have been made as part of an effort to develop male-only strains for a genetic control program of this major pest of sheep. All lines carry a constitutively expressed fluorescent protein marker gene. In all 12 X-linked lines, female larvae show brighter fluorescence than male larvae, suggesting the marker gene is not dosage compensated. This has been confirmed by quantitative RT-PCR for selected lines. To determine if endogenous X-linked genes are dosage compensated, we isolated 8 genes that are orthologs of genes that are on the fourth chromosome in D. melanogaster. Recent evidence suggests that the D. melanogaster fourth chromosome, or Muller element F, is the ancestral X chromosome in Diptera that has reverted to an autosome in Drosophila species. We show by quantitative PCR of male and female DNA that 6 of the 8 linkage group F genes reside on the X chromosome in L. cuprina. The other two Muller element F genes were found to be autosomal in L. cuprina, whereas two Muller element B genes were found on the same region of the X chromosome as the L. cuprina orthologs of the D. melanogaster Ephrin and gawky genes. We find that the L. cuprina X chromosome genes are equally expressed in males and females (i.e., fully dosage compensated). Thus, unlike in Drosophila, it appears that the Lucilia dosage compensation system is specific for genes endogenous to the X chromosome and cannot be co-opted by recently arrived transgenes.	[Linger, Rebecca J.; Belikoff, Esther J.; Scott, Maxwell J.] N Carolina State Univ, Dept Entomol, Raleigh, NC 27695 USA	University of North Carolina; North Carolina State University	Scott, MJ (corresponding author), N Carolina State Univ, Dept Entomol, Campus Box 7613, Raleigh, NC 27695 USA.	mjscott3@ncsu.edu	Scott, Maxwell J/J-1935-2015	Scott, Maxwell J/0000-0001-6536-4735	NCSU	NCSU	RJL was supported with start-up funds to MJS from NCSU.	Akhtar A, 2003, CURR OPIN GENET DEV, V13, P161, DOI 10.1016/S0959-437X(03)00016-9; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Anstead CA, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8344; Arkhipova I, 1997, GENETICS, V145, P729; Bagnall NH, 2010, MED VET ENTOMOL, V24, P176, DOI 10.1111/j.1365-2915.2010.00866.x; BASHAW GJ, 1995, DEVELOPMENT, V121, P3245; Bassett A, 2014, METHODS, V69, P128, DOI 10.1016/j.ymeth.2014.02.019; BEDO DG, 1980, CHROMOSOMA, V77, P299, DOI 10.1007/BF00286055; BEDO DG, 1982, CHROMOSOMA, V87, P21, DOI 10.1007/BF00333507; BEDO DG, 1992, GENOME, V35, P283, DOI 10.1139/g92-044; Concha C, 2012, INSECT MOL BIOL, V21, P169, DOI 10.1111/j.1365-2583.2011.01123.x; Concha C, 2011, INSECT BIOCHEM MOLEC, V41, P70, DOI 10.1016/j.ibmb.2010.09.006; Concha C, 2009, GENETICS, V182, P785, DOI 10.1534/genetics.109.100982; Conrad T, 2012, SCIENCE, V337, P742, DOI 10.1126/science.1221428; Conrad T, 2012, NAT REV GENET, V13, P123, DOI 10.1038/nrg3124; Edman RM, 2015, INSECT MOL BIOL, V24, P58, DOI 10.1111/imb.12135; Ferrari F, 2014, NAT STRUCT MOL BIOL, V21, P118, DOI 10.1038/nsmb.2763; FIELLER EC, 1954, J ROY STAT SOC B, V16, P175; Fitzsimons HL, 1999, GENETICA, V105, P215, DOI 10.1023/A:1003801402153; FOSTER GG, 1980, CHROMOSOMA, V81, P151, DOI 10.1007/BF00285946; Gelbart ME, 2009, DEVELOPMENT, V136, P1399, DOI 10.1242/dev.029645; Gorchakov AA, 2009, GENE DEV, V23, P2266, DOI 10.1101/gad.1840409; Heinrich JC, 2000, P NATL ACAD SCI USA, V97, P8229, DOI 10.1073/pnas.140142697; Hochman B., 1976, GENET BIOL DROSOPHIL, V1b, P903; Hoskins RA, 2015, GENOME RES, V25, P445, DOI 10.1101/gr.185579.114; Johansson AM, 2007, EMBO J; Johansson AM, 2007, PLOS GENET, V3, P2235, DOI 10.1371/journal.pgen.0030209; KELLEY RL, 1995, CELL, V81, P867, DOI 10.1016/0092-8674(95)90007-1; Landeen EL, 2013, CURR BIOL, V23, pR848, DOI 10.1016/j.cub.2013.08.021; Larschan E, 2011, NATURE, V471, P115, DOI 10.1038/nature09757; Laverty C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020455; Li F, 2014, INSECT BIOCHEM MOLEC, V51, P80, DOI 10.1016/j.ibmb.2014.06.001; Lucchesi JC, 1998, CURR OPIN GENET DEV, V8, P179, DOI 10.1016/S0959-437X(98)80139-1; MADDERN RH, 1984, GENETICA, V63, P203, DOI 10.1007/BF00128414; Poelchau M, 2015, NUCLEIC ACIDS RES, V43, pD714, DOI 10.1093/nar/gku983; Riddle NC, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002954; Riddle NC, 2009, BIOCHEM CELL BIOL, V87, P229, DOI 10.1139/O08-119; Sandeman RM, 2014, INT J PARASITOL, V44, P879, DOI 10.1016/j.ijpara.2014.08.009; SASS H, 1991, P NATL ACAD SCI USA, V88, P6795, DOI 10.1073/pnas.88.15.6795; Scott MJ, 2014, BMC GENET, V15, DOI 10.1186/1471-2156-15-S2-S3; SPRADLING AC, 1983, CELL, V34, P47, DOI 10.1016/0092-8674(83)90135-6; St Pierre SE, 2014, NUCLEIC ACIDS RES, V42, pD780, DOI 10.1093/nar/gkt1092; Sze SH, 2012, INSECT MOL BIOL, V21, P205, DOI 10.1111/j.1365-2583.2011.01127.x; ULLERICH FH, 1963, CHROMOSOMA, V14, P45, DOI 10.1007/BF00332610; Ullerich FH, 2006, GENOME, V49, P584, DOI 10.1139/G06-013; Vicoso B, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002078; Vicoso B, 2013, NATURE, V499, P332, DOI 10.1038/nature12235; WELLER GL, 1993, GENOME, V36, P495, DOI 10.1139/g93-068; Yan Y, 2015, SCI REP IN PRESS	49	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2015	10	10							e0141544	10.1371/journal.pone.0141544	http://dx.doi.org/10.1371/journal.pone.0141544			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU8PC	26506426	Green Submitted, Green Published, gold			2022-12-26	WOS:000363804200082
J	Murashov, AK; Pak, ES; Koury, M; Ajmera, A; Jeyakumar, M; Parker, M; Williams, O; Ding, J; Walters, D; Neufer, PD				Murashov, Alexander K.; Pak, Elena S.; Koury, Michael; Ajmera, Ajay; Jeyakumar, Maneesh; Parker, Matthew; Williams, Oksana; Ding, Jian; Walters, Dianne; Neufer, P. Darrell			Paternal long-term exercise programs offspring for low energy expenditure and increased risk for obesity in mice	FASEB JOURNAL			English	Article						epigenetics; transgenerational; metabolic phenotype; miRNA; spermatozoal	TRANSGENERATIONAL INHERITANCE; OXIDATIVE STRESS; PHYSICAL-EXERCISE; GENE-EXPRESSION; SPERM; METHYLATION; GENERATIONS; SPERMATOZOA; DIET; ADOLESCENTS	Obesity has more than doubled in children and tripled in adolescents in the past 30 yr. The association between metabolic disorders in offspring of obese mothers with diabetes has long been known; however, a growing body of research indicates that fathers play a significant role through presently unknown mechanisms. Recent observations have shown that changes in paternal diet may result in transgenerational inheritance of the insulin-resistant phenotype. Although diet-induced epigenetic reprogramming via paternal lineage has recently received much attention in the literature, the effect of paternal physical activity on offspring metabolism has not been adequately addressed. In the current study, we investigated the effects of long-term voluntary wheel-running in C57BL/6J male mice on their offspring's predisposition to insulin resistance. Our observations revealed that fathers subjected to wheel-running for 12 wk produced offspring that were more susceptible to the adverse effects of a high-fat diet, manifested in increased body weight and adiposity, impaired glucose tolerance, and elevated insulin levels. Long-term paternal exercise also altered expression of several metabolic genes, including Ogt, Oga, Pdk4, H19, Glut4, and Ptpn1, in offspring skeletal muscle. Finally, prolonged exercise affected gene methylation patterns and micro-RNA content in the sperm of fathers, providing a potential mechanism for the transgenerational inheritance. These findings suggest that paternal exercise produces offspring with a thrifty phenotype, potentially via miRNA-induced modification of sperm.	[Murashov, Alexander K.; Pak, Elena S.; Koury, Michael; Ajmera, Ajay; Jeyakumar, Maneesh; Parker, Matthew; Williams, Oksana; Ding, Jian; Walters, Dianne; Neufer, P. Darrell] E Carolina Univ, Dept Physiol, Greenville, NC USA; [Murashov, Alexander K.; Neufer, P. Darrell] E Carolina Univ, East Carolina Diabet & Obes Inst, Greenville, NC USA	University of North Carolina; East Carolina University; University of North Carolina; East Carolina University	Murashov, AK (corresponding author), E Carolina Univ, Sch ofMedicine, Brody Bldg,6N-98,600 Moye Blvd, Greenville, NC 27834 USA.	murashoval@ecu.edu	Murashov, Alexander K/F-2241-2011	Murashov, Alexander K/0000-0002-8912-5891	East Carolina Diabetes and Obesity Institute, East Carolina University; U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases [R01 DK096907]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK096907] Funding Source: NIH RePORTER	East Carolina Diabetes and Obesity Institute, East Carolina University; U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported by a seed grant from the East Carolina Diabetes and Obesity Institute, East Carolina University, and was supported in part by a U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases Grant R01 DK096907 (to P.D.N.). The authors declare no conflicts of interest.	Anway MD, 2006, J ANDROL, V27, P868, DOI 10.2164/jandrol.106.000349; Barres R, 2012, CELL METAB, V15, P405, DOI 10.1016/j.cmet.2012.01.001; Barton M, 2010, PEDIATRICS, V125, P361, DOI 10.1542/peds.2009-2037; Call JA, 2010, MUSCLE NERVE, V42, P871, DOI 10.1002/mus.21764; Carone BR, 2010, CELL, V143, P1084, DOI 10.1016/j.cell.2010.12.008; Chen LQ, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-52; Di Luigi L, 2012, ENDOCRINE, V42, P278, DOI 10.1007/s12020-012-9655-6; Dunn GA, 2009, ENDOCRINOLOGY, V150, P4999, DOI 10.1210/en.2009-0500; Ferland-McCollough D, 2012, CELL DEATH DIFFER, V19, P1003, DOI 10.1038/cdd.2011.183; Friedenreich CM, 2011, RECENT RESULTS CANC, V188, P125, DOI 10.1007/978-3-642-10858-7_11; Fullston T, 2012, HUM REPROD, V27, P1391, DOI 10.1093/humrep/des030; Fullston T, 2013, FASEB J, V27, P4226, DOI 10.1096/fj.12-224048; Gapp K, 2014, NAT NEUROSCI, V17, P667, DOI 10.1038/nn.3695; Gharagozloo P, 2011, HUM REPROD, V26, P1628, DOI 10.1093/humrep/der132; Govindaraju A, 2012, REPROD BIOL ENDOCRIN, V10, DOI 10.1186/1477-7827-10-82; Gower BA, 2013, NUTR METAB, V10, DOI 10.1186/1743-7075-10-3; Gu XL, 2013, NEUROBIOL AGING, V34, P1069, DOI 10.1016/j.neurobiolaging.2012.10.013; Guth LM, 2013, EXP PHYSIOL, V98, P1469, DOI 10.1113/expphysiol.2012.070300; Hackney AC, 2008, J ENDOCRINOL INVEST, V31, P932, DOI 10.1007/BF03346444; Hanover JA, 2012, NAT REV MOL CELL BIO, V13, P312, DOI 10.1038/nrm3334; Ji ZL, 2014, REPRODUCTION, V147, P693, DOI 10.1530/REP-13-0656; Jinno Y, 1996, HUM MOL GENET, V5, P1155, DOI 10.1093/hmg/5.8.1155; Kawano M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044542; Knezovich Jaysen Gregory, 2012, Frontiers in Genetics, V3, P10, DOI 10.3389/fgene.2012.00010; Knight JA, 2012, ANN CLIN LAB SCI, V42, P320; Kouzmenko A, 2010, EPIGENOMICS-UK, V2, P765, DOI 10.2217/EPI.10.58; Krawetz SA, 2011, HUM REPROD, V26, P3401, DOI 10.1093/humrep/der329; Kumarswamy R, 2011, RNA BIOL, V8, P706, DOI 10.4161/rna.8.5.16154; Lambard S, 2004, MOL HUM REPROD, V10, P535, DOI 10.1093/molehr/gah064; Li Y, 2012, B ENVIRON CONTAM TOX, V89, P1111, DOI 10.1007/s00128-012-0827-0; Liu WM, 2012, P NATL ACAD SCI USA, V109, P490, DOI 10.1073/pnas.1110368109; Loomba R, 2008, GASTROENTEROLOGY, V134, P953, DOI 10.1053/j.gastro.2008.01.037; Marczylo EL, 2012, EPIGENETICS-US, V7, P432, DOI 10.4161/epi.19794; Mathias RA, 2009, METABOLISM, V58, P1439, DOI 10.1016/j.metabol.2009.04.041; Meerson A, 2013, DIABETOLOGIA, V56, P1971, DOI 10.1007/s00125-013-2950-9; Ng SF, 2010, NATURE, V467, P963, DOI 10.1038/nature09491; Ogden CL, 2012, JAMA-J AM MED ASSOC, V307, P483, DOI 10.1001/jama.2012.40; Pedersen BK, 2012, NAT REV ENDOCRINOL, V8, P457, DOI 10.1038/nrendo.2012.49; Pemberton VL, 2010, CIRCULATION, V121, P1153, DOI 10.1161/CIRCULATIONAHA.109.921544; Pembrey ME, 2006, EUR J HUM GENET, V14, P159, DOI 10.1038/sj.ejhg.5201538; Perkins E, 2012, J PEDIATR-US, V161, P31, DOI 10.1016/j.jpeds.2012.01.015; Permutt MA, 2005, J CLIN INVEST, V115, P1431, DOI 10.1172/JCI24758; Piao L, 2013, J MOL MED, V91, P333, DOI 10.1007/s00109-012-0982-0; Radak Z, 2013, ANTIOXID REDOX SIGN, V18, P1208, DOI 10.1089/ars.2011.4498; Rassoulzadegan M, 2006, NATURE, V441, P469, DOI 10.1038/nature04674; Rimer J, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004366.pub5; Rodgers AB, 2013, J NEUROSCI, V33, P9003, DOI 10.1523/JNEUROSCI.0914-13.2013; Safarinejad MR, 2009, J ENDOCRINOL, V200, P259, DOI 10.1677/JOE-08-0477; Skinner MK, 2011, EPIGENETICS-US, V6, P838, DOI 10.4161/epi.6.7.16537; Tsou RC, 2012, J OBES, V2012, DOI 10.1155/2012/926857; Walley AJ, 2006, HUM MOL GENET, V15, pR124, DOI 10.1093/hmg/ddl215; Wei YC, 2014, P NATL ACAD SCI USA, V111, P1873, DOI 10.1073/pnas.1321195111; Wu D, 2013, FRONT MOL NEUROSCI, V6, DOI 10.3389/fnmol.2013.00035; Xue C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026027	54	59	65	0	46	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2016	30	2					775	784		10.1096/fj.15-274274	http://dx.doi.org/10.1096/fj.15-274274			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DC7IA	26506979	Green Published			2022-12-26	WOS:000369391900027
J	Kayukawa, T; Nagamine, K; Ito, Y; Nishita, Y; Ishikawa, Y; Shinoda, T				Kayukawa, Takumi; Nagamine, Keisuke; Ito, Yuka; Nishita, Yoshinori; Ishikawa, Yukio; Shinoda, Tetsuro			Kruppel Homolog 1 Inhibits Insect Metamorphosis via Direct Transcriptional Repression of Broad-Complex, a Pupal Specifier Gene	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							JUVENILE-HORMONE; DROSOPHILA-MELANOGASTER; BOMBYX-MORI; METHOPRENE-TOLERANT; TRIBOLIUM-CASTANEUM; TOBACCO HORNWORM; MANDUCA-SEXTA; EXPRESSION; SILKWORM; EPIDERMIS	The Broad-Complex gene (BR-C) encodes transcription factors that dictate larval-pupal metamorphosis in insects. The expression of BR-C is induced by molting hormone (20-hydroxyecdysone (20E)), and this induction is repressed by juvenile hormone (JH), which exists during the premature larval stage. Kriippel homolog 1 gene (Kr-hi) has been known as a JH-early inducible gene responsible for repression of metamorphosis; however, the functional relationship between Kr-hl and repression of BR-C has remained unclear. To elucidate this relationship, we analyzed cis-and trans elements involved in the repression of BR-C using a Bombyx mori cell line. In the cells, as observed in larvae, JH induced the expression of Kr-hl and concurrently suppressed 20E -induced expression of BR-C. Forced expression of Kr-hl repressed the 20E-dependent activation of the BR-C promoter in the absence of JH, and Kr-hl RNAi inhibited the JH-mediated repression, suggesting that Kr-hl controlled the repression of BR-C. A survey of the upstream sequence of BR-C gene revealed a Kr -hl binding site (KBS) in the BR-C promoter. When KBS was deleted from the promoter, the repression of BR-C was abolished, Electrophoresis mobility shift demonstrated that two Kr -hl molecules bound to KBS in the BR-C promoter. Based on these results, we conclude that Kr-hl protein molecules directly bind to the KBS sequence in the BR-C promoter and thereby repress 20E -dependent activation of the pupal specifier, BR-C. This study has revealed a considerable portion of the picture of JH signaling pathways from the reception of JH to the repression of metamorphosis.	[Kayukawa, Takumi; Nagamine, Keisuke; Ito, Yuka; Shinoda, Tetsuro] Natl Inst Agrobiol Sci, Insect Growth Regulat Res Unit, Ohwashi 1-2, Tsukuba, Ibaraki 3058634, Japan; [Nagamine, Keisuke; Ishikawa, Yukio] Univ Tokyo, Grad Sch Agr & Life Sci, Lab Appl Entomol, Bunkyo Ku, Tokyo 1138657, Japan; [Nishita, Yoshinori] Hokkaido Univ, Fac Sci, Dept Biol Sci, Sapporo, Hokkaido 0600810, Japan; [Nishita, Yoshinori] Hokkaido Univ, Fac Sci, Ctr Genome Dynam, Sapporo, Hokkaido 0600810, Japan	National Institute of Agrobiological Sciences - Japan; University of Tokyo; Hokkaido University; Hokkaido University	Kayukawa, T (corresponding author), Natl Inst Agrobiol Sci, Insect Growth Regulat Res Unit, Ohwashi 1-2, Tsukuba, Ibaraki 3058634, Japan.	kayu@affrc.go.jp	Ishikawa, Yukio/J-5676-2019; Nishita, Yoshinori/S-8888-2018	Ishikawa, Yukio/0000-0003-3067-2513; 	JSPS KAKENHI [25850230]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI Grant 25850230 (to T. K.). The authors declare that they have no conflicts of interest with the contents of this article.	Ashok M, 1998, P NATL ACAD SCI USA, V95, P2761, DOI 10.1073/pnas.95.6.2761; Bayer CA, 1996, DEV BIOL, V177, P1, DOI 10.1006/dbio.1996.0140; Cui YJ, 2014, INSECT BIOCHEM MOLEC, V52, P23, DOI 10.1016/j.ibmb.2014.05.009; DIBELLO PR, 1991, GENETICS, V129, P385; Huang JH, 2011, DEVELOPMENT, V138, P2283, DOI 10.1242/dev.057687; Iuchi S, 2001, CELL MOL LIFE SCI, V58, P625, DOI 10.1007/PL00000885; Jindra M, 2013, ANNU REV ENTOMOL, V58, P181, DOI 10.1146/annurev-ento-120811-153700; Kanamori Y, 2010, J BIOL CHEM, V285, P36933, DOI 10.1074/jbc.M110.180398; Kayukawa T, 2015, APPL ENTOMOL ZOOL, V50, P383, DOI 10.1007/s13355-015-0345-8; Kayukawa T, 2014, DEV BIOL, V388, P48, DOI 10.1016/j.ydbio.2014.01.022; Kayukawa T, 2013, SCI REP-UK, V3, DOI 10.1038/srep01570; Kayukawa T, 2012, P NATL ACAD SCI USA, V109, P11729, DOI 10.1073/pnas.1204951109; KISS I, 1988, GENETICS, V118, P247; KISS I, 1976, NATURE, V262, P136, DOI 10.1038/262136a0; Kobayashi I, 2011, ARCH INSECT BIOCHEM, V76, P195, DOI 10.1002/arch.20402; Konopova B, 2008, DEVELOPMENT, V135, P559, DOI 10.1242/dev.016097; Konopova B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028728; Li M, 2014, MOL CELL ENDOCRINOL, V394, P47, DOI 10.1016/j.mce.2014.06.021; Lozano J, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004769; Lozano J, 2011, SCI REP-UK, V1, DOI 10.1038/srep00163; Minakuchi C, 2009, DEV BIOL, V325, P341, DOI 10.1016/j.ydbio.2008.10.016; Minakuchi C, 2008, MECH DEVELOP, V125, P91, DOI 10.1016/j.mod.2007.10.002; Muramatsu D, 2008, MECH DEVELOP, V125, P411, DOI 10.1016/j.mod.2008.02.001; Nagamine K, 2014, SPRINGERPLUS, V3, DOI 10.1186/2193-1801-3-539; Nishita Y, 2004, GENE, V339, P161, DOI 10.1016/j.gene.2004.06.039; Nishita Y, 2014, INSECT MOL BIOL, V23, P341, DOI 10.1111/imb.12085; Nishita Y, 2006, INSECT BIOCHEM MOLEC, V36, P779, DOI 10.1016/j.ibmb.2006.07.005; PANKRATZ MJ, 1989, NATURE, V341, P337, DOI 10.1038/341337a0; Piulachs MD, 2010, INSECT BIOCHEM MOLEC, V40, P468, DOI 10.1016/j.ibmb.2010.04.006; Reza AMS, 2004, COMP BIOCHEM PHYS B, V139, P753, DOI 10.1016/j.cbpc.2004.09.009; RIDDIFORD LM, 1994, ADV INSECT PHYSIOL, V24, P213, DOI 10.1016/S0065-2806(08)60084-3; ROSENBERG UB, 1986, NATURE, V319, P336, DOI 10.1038/319336a0; Sailsbery JK, 2012, MOL BIOL EVOL, V29, P1301, DOI 10.1093/molbev/msr288; Shin SW, 2012, P NATL ACAD SCI USA, V109, P16576, DOI 10.1073/pnas.1214209109; Spokony RF, 2007, DEV GENES EVOL, V217, P499, DOI 10.1007/s00427-007-0159-y; Suzuki Y, 2008, DEVELOPMENT, V135, P569, DOI 10.1242/dev.015263; WILSON TG, 1986, DEV BIOL, V118, P190, DOI 10.1016/0012-1606(86)90087-4; Zhang ZL, 2011, J BIOL CHEM, V286, P8437, DOI 10.1074/jbc.M110.191684; Zhou BH, 1998, DEV BIOL, V203, P233, DOI 10.1006/dbio.1998.9059; Zhou BH, 2001, DEV BIOL, V231, P125, DOI 10.1006/dbio.2000.0143; Zhou XF, 2002, DEVELOPMENT, V129, P2259; Zhou XF, 2004, J EXP BIOL, V207, P1151, DOI 10.1242/jeb.00855	42	85	93	2	45	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 22	2016	291	4					1751	1762		10.1074/jbc.M115.686121	http://dx.doi.org/10.1074/jbc.M115.686121			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DB6JI	26518872	Green Published, hybrid			2022-12-26	WOS:000368620700017
J	Guo, JF; Lv, J; Liu, M; Tang, H				Guo, Junfei; Lv, Jing; Liu, Min; Tang, Hua			miR-346 Up-regulates Argonaute 2 (AGO2) Protein Expression to Augment the Activity of Other MicroRNAs (miRNAs) and Contributes to Cervical Cancer Cell Malignancy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA TRANSLATION; MESENCHYMAL TRANSITION; ACTIVATION; GROWTH; REPRESSION; BIOMARKERS; MIGRATION; INVASION; OOCYTES; DICER	MicroRNAs (miRNAs) are a class of post-transcriptional regulators of gene expression, and AGO2 is essential for miRNA activity. In this study, we focused on the regulation of AGO2 by miR-346 and the consequences in cervical cancer cells. miR-346 enhanced the expression of AGO2, resulting in the increased activity of other miRNAs and contributing to the malignancy of HeLa cells. GRSF1 participated in the regulation of AGO2 by miR-346, and the middle sequence of miR-346 was vital for the synergy effect of miR-346 and GRSF1. We determined that miR-346 promoted the migration and invasion of HeLa cells. In summary, we are the first to report that AGO2 is regulated positively by miRNA and that GRSF1 participates in the miRNA pathway.	[Guo, Junfei; Lv, Jing; Liu, Min; Tang, Hua] Tianjin Med Univ, Sch Basic Med Sci, Tianjin Life Sci Res Ctr, Tianjin 300070, Peoples R China	Tianjin Medical University	Tang, H (corresponding author), 22 Qi Xiang Tai Rd, Tianjin 300070, Peoples R China.	htang2002@yahoo.com			National Natural Science Foundation of China [31270818, 91029714, 31071191]; Natural Science Foundation of Tianjin Grant [12JCZDJC25100]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Tianjin Grant	This work was supported in part by National Natural Science Foundation of China Grants 31270818, 91029714, and 31071191 and Natural Science Foundation of Tianjin Grant 12JCZDJC25100. The authors declare that they have no conflicts of interest with the contents of this article.	Antonicka H, 2013, CELL METAB, V17, P386, DOI 10.1016/j.cmet.2013.02.006; Banno K, 2014, SCI WORLD J, DOI 10.1155/2014/178075; Betel D, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r90; Bian XJ, 2014, TUMOR BIOL, V35, P11571, DOI 10.1007/s13277-014-2462-3; Bumrungthai S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127109; Ciafre SA, 2013, RNA BIOL, V10, P935, DOI 10.4161/rna.24641; Dasari S, 2015, CLIN CHIM ACTA, V445, P7, DOI 10.1016/j.cca.2015.03.005; Eiring AM, 2010, CELL, V140, P652, DOI 10.1016/j.cell.2010.01.007; Goodman A, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h2372; Lopez AJG, 2014, INT J MOL SCI, V15, P15700, DOI 10.3390/ijms150915700; Hauptmann J, 2013, NAT STRUCT MOL BIOL, V20, P814, DOI 10.1038/nsmb.2577; Jourdain AA, 2013, CELL METAB, V17, P399, DOI 10.1016/j.cmet.2013.02.005; Kash JC, 2002, J VIROL, V76, P10417, DOI 10.1128/JVI.76.20.10417-10426.2002; Kruger J, 2006, NUCLEIC ACIDS RES, V34, pW451, DOI 10.1093/nar/gkl243; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li CF, 2013, J VIROL, V87, P2193, DOI 10.1128/JVI.02831-12; Li L, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-38; Lin SB, 2015, NAT REV CANCER, V15, P321, DOI 10.1038/nrc3932; Long MJ, 2012, CANCER LETT, V324, P186, DOI 10.1016/j.canlet.2012.05.022; Martinez NJ, 2013, RNA, V19, P605, DOI 10.1261/rna.036434.112; Mortensen RD, 2011, P NATL ACAD SCI USA, V108, P8281, DOI 10.1073/pnas.1105401108; Orom UA, 2008, MOL CELL, V30, P460, DOI 10.1016/j.molcel.2008.05.001; Poria D. K., 2015, ONCOGENE; Prodromaki E, 2015, CELL ONCOL, V38, P307, DOI 10.1007/s13402-015-0231-y; Rivas FV, 2005, NAT STRUCT MOL BIOL, V12, P340, DOI 10.1038/nsmb918; Smibert P, 2013, NAT STRUCT MOL BIOL, V20, P789, DOI 10.1038/nsmb.2606; Song G, 2015, SCI REP-UK, V5, DOI 10.1038/srep15793; Tian RQ, 2011, J BIOL CHEM, V286, P25556, DOI 10.1074/jbc.M111.221564; Truesdell SS, 2012, SCI REP-UK, V2, DOI 10.1038/srep00842; Tsai NP, 2009, BIOCHEM J, V424, P411, DOI 10.1042/BJ20090915; Ufer C, 2008, GENE DEV, V22, P1838, DOI 10.1101/gad.466308; Vasudevan S, 2007, SCIENCE, V318, P1931, DOI 10.1126/science.1149460; Voller D, 2013, BRIT J CANCER, V109, P3116, DOI 10.1038/bjc.2013.646; Wang M, 2014, INT J ONCOL, V45, P362, DOI 10.3892/ijo.2014.2413; Ye ZL, 2015, J CANCER, V6, P877, DOI 10.7150/jca.11735; Zhang J, 2014, ONCOGENESIS, V3, DOI 10.1038/oncsis.2014.11; Zhang LY, 2013, J BIOL CHEM, V288, P4035, DOI 10.1074/jbc.M112.410506; Zhang XR, 2014, CELL, V158, P607, DOI 10.1016/j.cell.2014.05.047; Zhang YJ, 2014, RNA, V20, P1878, DOI 10.1261/rna.045633.114	39	57	61	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2015	290	51					30342	30350		10.1074/jbc.M115.691857	http://dx.doi.org/10.1074/jbc.M115.691857			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CY9PG	26518874	hybrid, Green Published			2022-12-26	WOS:000366738200013
J	Incalzi, RA; Aucella, F; Leosco, D; Brunori, G; Dalmartello, M; Paolisso, G				Incalzi, Raffaele Antonelli; Aucella, Filippo; Leosco, Dario; Brunori, Giuliano; Dalmartello, Michela; Paolisso, Giuseppe			Assessing Nephrological Competence among Geriatricians: A Proof of Concept Internet Survey	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; CONTRAST-INDUCED NEPHROPATHY; RENAL-INSUFFICIENCY; HEART-FAILURE; MORTALITY; AGE; ADULTS; DEATH; RISK; CARE	Chronic kidney disease (CKD) is highly prevalent in the elderly and negatively impacts survival and health status. Thus, nephrological competence is mandatory for a skilled geriatrician. The present study aimed to assess nephrological competence in a sample of geriatricians recruited through a web survey. To this aim, a 12-items questionnaire was produced by an expert panel of nephrologists and geriatricians and was available online for members of the Italian Society of Gerontology and Geriatrics (SIGG). Two-hundred-eightyseven geriatricians volunteered to fill in the questionnaire. The majority of them indirectly estimated the glomerular filtration rate (GFR) using mainly the Cockroft-Gault (C-G) formula. Selected nephrological exams, such as urinary Na and serum D-vitamin measurements, did not qualify as routine exams although the majority of geriatricians supplemented their patients with fat-soluble secosteroids. Ten percent of geriatricians asked for nephrological consultation only for stage 5 CKD patients and 30,9% only for stage 4 or 5. Erythropoietin supplementation was common practice for the majority of geriatricians, while only one third of them systematically used a procedure intended to prevent the contrast induced nephropathy (CIN). Finally, an alleged 50% adherence to the international guidelines for the management of CKD patients emerged from the questionnaire. Overall, results from this survey strongly recommend promoting nephrological education among geriatricians. Didactic standards for in training geriatricians need to be updated and the cooperation between geriatrics and nephrological societies promoted.	[Incalzi, Raffaele Antonelli] Campus Biomedico Univ, Dept Geriatr, Rome, Italy; [Aucella, Filippo] IRCCS, Casa Sollievo Sofferenza Hosp, Dept Nephrol & Dialysis, Foggia, Italy; [Leosco, Dario] Univ Naples Federico II, Dept Translat Med Sci, Naples, Italy; [Brunori, Giuliano] Santa Chiara Hosp, Dept Nephrol & Dialysis, Trento, Italy; [Dalmartello, Michela] Dept Hlth & Social Serv, Naples, Provincia Auton, Italy; [Paolisso, Giuseppe] Univ Naples 2, Dept Med Surg Neurol Aging & Metab Sci, Naples, Italy	University Campus Bio-Medico - Rome Italy; IRCCS Casa Sollievo Della Sofferenza; University of Naples Federico II; Santa Chiara Hospital; Universita della Campania Vanvitelli	Leosco, D (corresponding author), Univ Naples Federico II, Dept Translat Med Sci, Naples, Italy.	dleosco@unina.it	paolisso, giuseppe/AAP-8516-2020	paolisso, giuseppe/0000-0002-2137-455X; DALMARTELLO, MICHELA/0000-0001-8764-9299; Aucella, Filippo/0000-0003-1027-7049				Anavekar NS, 2004, NEW ENGL J MED, V351, P1285, DOI 10.1056/NEJMoa041365; [Anonymous], 2013, Kidney Int Suppl (2011), V3, P73; [Anonymous], 2013, KIDNEY INT S, V3, P91, DOI DOI 10.1038/kisup.2012.67; Au TH, 2014, ANN PHARMACOTHER, V48, P1332, DOI 10.1177/1060028014541996; Boudville N, 2012, BMC GERIATR, V12, DOI 10.1186/1471-2318-12-43; Chonchol M, 2007, KIDNEY INT, V71, P134, DOI 10.1038/sj.ki.5002002; Conte G, 2014, NEPHROL DIAL TRANSPL, V29, P770, DOI 10.1093/ndt/gft324; Corsonello A, 2005, ARCH INTERN MED, V165, P790, DOI 10.1001/archinte.165.7.790; De Nicola L, 2012, KIDNEY INT, V82, P482, DOI 10.1038/ki.2012.174; Franco G, 2014, J CARDIOVASC MED, V15, P491, DOI 10.2459/JCM.0000000000000038; Giannelli SV, 2007, J AM GERIATR SOC, V55, P816, DOI 10.1111/j.1532-5415.2007.01196.x; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Hallan SI, 2012, JAMA-J AM MED ASSOC, V308, P2349, DOI 10.1001/jama.2012.16817; Incalzi RA, 1997, EUR RESPIR J, V10, P2794, DOI 10.1183/09031936.97.10122794; Istituto Superiore di Sanita, 2012, ID PREV GEST MAL REN; McAlister FA, 2004, CIRCULATION, V109, P1004, DOI 10.1161/01.CIR.0000116764.53225.A9; Mehran R, 2004, J AM COLL CARDIOL, V44, P1393, DOI 10.1016/j.jacc.2004.06.068; Minutolo R, 2014, CLIN J AM SOC NEPHRO, V9, P1586, DOI 10.2215/CJN.10481013; Murray J E Jr, 1996, Endocr Pract, V2, P211; Navaneethan SD, 2010, CLIN NEPHROL, V73, P260; Pedone C, 2008, AGING CLIN EXP RES, V20, P496; Poelzl G, 2014, INT J CARDIOL, V175, P83, DOI 10.1016/j.ijcard.2014.04.255; Rengo F, 2012, J NEPHROL, V25, pS73, DOI 10.5301/jn.5000164; Steinman MA, 2013, MED CARE, V51, P901, DOI 10.1097/MLR.0b013e3182a3e525; Viazzi F, 2010, CLIN J AM SOC NEPHRO, V5, P1099, DOI 10.2215/CJN.07271009	25	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2015	10	11							e0141388	10.1371/journal.pone.0141388	http://dx.doi.org/10.1371/journal.pone.0141388			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV1QH	26528530	Green Published, Green Submitted, gold			2022-12-26	WOS:000364032600025
J	Ellis, RJ; Ng, YS; Zhu, SG; Tan, DM; Anderson, B; Schlaug, G; Wang, Y				Ellis, Robert J.; Ng, Yee Sien; Zhu, Shenggao; Tan, Dawn M.; Anderson, Boyd; Schlaug, Gottfried; Wang, Ye			A Validated Smartphone-Based Assessment of Gait and Gait Variability in Parkinson's Disease	PLOS ONE			English	Article							RHYTHMIC AUDITORY-STIMULATION; OLDER-ADULTS; EFFECT SIZE; SPATIOTEMPORAL PARAMETERS; MOVEMENT-DISORDERS; WEARABLE SENSORS; FALLS; WALKING; PEOPLE; MOTOR	Background A well-established connection exists between increased gait variability and greater fall likelihood in Parkinson's disease (PD); however, a portable, validated means of quantifying gait variability (and testing the efficacy of any intervention) remains lacking. Furthermore, although rhythmic auditory cueing continues to receive attention as a promising gait therapy for PD, its widespread delivery remains bottlenecked. The present paper describes a smart-phone-based mobile application ("SmartMOVE") to address both needs. Methods The accuracy of smartphone-based gait analysis (utilizing the smartphone's built-in tri-axial accelerometer and gyroscope to calculate successive step times and step lengths) was validated against two heel contact-based measurement devices: heel-mounted footswitch sensors (to capture step times) and an instrumented pressure sensor mat (to capture step lengths). 12 PD patients and 12 age-matched healthy controls walked along a 26-m path during self-paced and metronome-cued conditions, with all three devices recording simultaneously. Results Four outcome measures of gait and gait variability were calculated. Mixed-factorial analysis of variance revealed several instances in which between-group differences (e.g., increased gait variability in PD patients relative to healthy controls) yielded medium-to-large effect sizes (eta-squared values), and cueing-mediated changes (e.g., decreased gait variability when PD patients walked with auditory cues) yielded small-to-medium effect sizes-while at the same time, device-related measurement error yielded small-to-negligible effect sizes. Conclusion These findings highlight specific opportunities for smartphone-based gait analysis to serve as an alternative to conventional gait analysis methods (e.g., footswitch systems or sensor-embedded walkways), particularly when those methods are cost-prohibitive, cumbersome, or inconvenient.	[Ellis, Robert J.; Anderson, Boyd; Wang, Ye] Natl Univ Singapore, Sch Comp, Singapore 117417, Singapore; [Zhu, Shenggao; Wang, Ye] NUS Grad Sch Integrat Sci & Engn, Singapore 117456, Singapore; [Ng, Yee Sien; Tan, Dawn M.] Singapore Gen Hosp, Dept Rehabil Med, Singapore 117456, Singapore; [Schlaug, Gottfried] Beth Israel Deaconess Med Ctr, Dept Neurol, Boston, MA 02215 USA; [Schlaug, Gottfried] Harvard Univ, Sch Med, Boston, MA 02215 USA	National University of Singapore; National University of Singapore; Singapore General Hospital; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School	Wang, Y (corresponding author), Natl Univ Singapore, Sch Comp, Comp 1,13 Comp Dr, Singapore 117417, Singapore.	wangye@comp.nus.edu.sg			National Research Foundation (NRF) [R-253-300-001-490]; Agency for Science, Technology and Research (A*STAR) [R-252-000-510-305]; Singapore 544 Ministry of Education (MOE) [R-252-000-516-112]	National Research Foundation (NRF); Agency for Science, Technology and Research (A*STAR)(Agency for Science Technology & Research (A*STAR)); Singapore 544 Ministry of Education (MOE)(Ministry of Education, Singapore)	This project was partially funded by a grant from the National Research Foundation (NRF; http://www.nrf.gov.sg/) under grant R-253-300-001-490 (to Y.W.) and managed through the multi-agency Interactive & Digital Media Programme Office (IDMPO) hosted by the Media Development Authority of Singapore (MDA; http://www.mda.gov.sg/) under the Center of Social Media Innovations for Communities (COSMIC; http://cosmiccentres.org/); and by a grant from the Agency for Science, Technology and Research (A*STAR; http://www.a-star.edu.sg/) under grant R-252-000-510-305 (to Y.W. and G.S.) and by the Singapore 544 Ministry of Education (MOE) under grant R-252-000-516-112. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achey M, 2014, MOVEMENT DISORD, V29, P871, DOI 10.1002/mds.25903; Arias P, 2008, EXP BRAIN RES, V186, P589, DOI 10.1007/s00221-007-1263-y; Bachlin M, 2010, IEEE T INF TECHNOL B, V14, P436, DOI 10.1109/TITB.2009.2036165; Bakeman R, 2005, BEHAV RES METHODS, V37, P379, DOI 10.3758/BF03192707; Baker K, 2008, PARKINSONISM RELAT D, V14, P314, DOI 10.1016/j.parkreldis.2007.09.008; Begg RK, 2005, IEEE T BIO-MED ENG, V52, P828, DOI 10.1109/TBME.2005.845241; Bello O, 2014, J PARKINSON DIS, V4, P33, DOI 10.3233/JPD-130251; Bello O, 2010, GAIT POSTURE, V32, P118, DOI 10.1016/j.gaitpost.2010.04.015; BLIN O, 1990, J NEUROL SCI, V98, P91, DOI 10.1016/0022-510X(90)90184-O; Bloem BR, 2004, MOVEMENT DISORD, V19, P871, DOI 10.1002/mds.20115; Boonstra TA, 2008, CURR OPIN NEUROL, V21, P461, DOI 10.1097/WCO.0b013e328305bdaf; Brach Jennifer S, 2005, J Neuroeng Rehabil, V2, P21, DOI 10.1186/1743-0003-2-21; Bryant MS, 2011, NEUROL RES, V33, P959, DOI 10.1179/1743132811Y.0000000044; Cai Z, 2013, P 14 INT C MUS INF R, P541; Callisaya ML, 2011, AGE AGEING, V40, P481, DOI 10.1093/ageing/afr055; Callisaya ML, 2010, AGE AGEING; Casamassima F, 2014, SENSORS-BASEL, V14, P6229, DOI 10.3390/s140406229; Chan H. K. Y., 2011, 2011 5th International Conference on Pervasive Computing Technologies for Healthcare (PervasiveHealth 2011), P184, DOI 10.4108/icst.pervasivehealth.2011.245995; Cohen J.E., 1988, STAT POWER ANAL BEHA; Damouras S, 2010, GAIT POSTURE, V31, P336, DOI 10.1016/j.gaitpost.2009.12.002; Danoudis M, 2012, PARKINSONISM RELAT D, V18, P543, DOI 10.1016/j.parkreldis.2012.02.005; de Dreu M J, 2012, Parkinsonism Relat Disord, V18 Suppl 1, pS114, DOI 10.1016/S1353-8020(11)70036-0; Dijkstra B, 2010, AGE AGEING, V39, P259, DOI 10.1093/ageing/afp249; Dorsey ER, 2007, NEUROLOGY, V68, P384, DOI 10.1212/01.wnl.0000247740.47667.03; Dorsey ER, 2013, JAMA NEUROL, V70, P565, DOI 10.1001/jamaneurol.2013.123; Ellis RJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110452; Espay AJ, 2010, J REHABIL RES DEV, V47, P573, DOI 10.1682/JRRD.2009.10.0165; Fahn S., 1987, RECENT DEV PARKINSON, P153; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Freedland RL, 2002, NEUROREHABILITATION, V17, P81; Giladi N, 2000, PARKINSONISM RELAT D, V6, P165, DOI 10.1016/S1353-8020(99)00062-0; Giladi N, 2005, SCI BASIS TREATMENT, P321; Goetz CG, 2004, MOVEMENT DISORD, V19, P1020, DOI 10.1002/mds.20213; Hamacher D, 2011, J R SOC INTERFACE, V8, P1682, DOI 10.1098/rsif.2011.0416; Hartmann A, 2009, GAIT POSTURE, V29, P444, DOI 10.1016/j.gaitpost.2008.11.003; Hausdorff JM, 2007, HUM MOVEMENT SCI, V26, P555, DOI 10.1016/j.humov.2007.05.003; Hausdorff JM, 2007, EUR J NEUROSCI, V26, P2369, DOI 10.1111/j.1460-9568.2007.05810.x; Hausdorff JM, 2009, CHAOS, V19, DOI 10.1063/1.3147408; Hausdorff JM, 1996, J APPL PHYSIOL, V80, P1448, DOI 10.1152/jappl.1996.80.5.1448; Hausdorff JM, 2003, J GERIATR PSYCH NEUR, V16, P53, DOI 10.1177/0891988702250580; Hausdorff JM, 2003, EXP BRAIN RES, V149, P187, DOI 10.1007/s00221-002-1354-8; Hausdorff JM, 2001, J APPL PHYSIOL, V90, P2117, DOI 10.1152/jappl.2001.90.6.2117; Hausdorff JM, 1998, MOVEMENT DISORD, V13, P428, DOI 10.1002/mds.870130310; Hausdorff JM, 2005, J NEUROENG REHABIL, V2, P19, DOI [DOI 10.1186/1743-0003-2-19, 10.1186/1743-0003-2-19]; Hollman JH, 2011, GAIT POSTURE, V34, P111, DOI 10.1016/j.gaitpost.2011.03.024; Horak FB, 2013, MOVEMENT DISORD, V28, P1544, DOI 10.1002/mds.25684; Hove MJ, 2013, PSYCHOL RES-PSYCH FO, V77, P388, DOI 10.1007/s00426-012-0441-0; Hove MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032600; How TV, 2013, INT CONF PER COMP, P73, DOI 10.4108/icst.pervasivehealth.2013.252118; Howcroft J, 2013, J NEUROENG REHABIL, V10, DOI 10.1186/1743-0003-10-91; Howell D. C., 2007, SAGE HDB SOCIAL SCI, P208; Kirchner M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085787; Klucken J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056956; Lemoyne R, 2008, J MECH MED BIOL, V8, P137, DOI 10.1142/S0219519408002656; LeMoyne R, 2011, IEEE ENG MED BIO, P7904, DOI 10.1109/IEMBS.2011.6091949; Levine TR, 2002, HUM COMMUN RES, V28, P612, DOI 10.1093/hcr/28.4.612; Lewis GN, 2000, BRAIN, V123, P2077, DOI 10.1093/brain/123.10.2077; Lim I, 2005, CLIN REHABIL, V19, P695, DOI 10.1191/0269215505cr906oa; Lord SR, 2007, FALLS IN OLDER PEOPLE: RISK FACTORS AND STRATEGIES FOR PREVENTION, 2ND EDITION, P1, DOI 10.1017/CBO9780511722233; Lord S, 2008, GAIT POSTURE, V27, P357, DOI 10.1016/j.gaitpost.2007.04.001; Lord S, 2013, J GERONTOL A-BIOL, V68, P820, DOI 10.1093/gerona/gls255; Lord S, 2013, MOVEMENT DISORD, V28, P634, DOI 10.1002/mds.25338; Lord S, 2011, GAIT POSTURE, V34, P443, DOI 10.1016/j.gaitpost.2011.07.010; Lord S, 2011, J NEUROL, V258, P566, DOI 10.1007/s00415-010-5789-8; Maetzler W, 2013, MOVEMENT DISORD, V28, P1628, DOI 10.1002/mds.25628; Mazilu S, 2015, ACM T INTERACT INTEL, V5, DOI 10.1145/2701431; McIntosh GC, 1997, J NEUROL NEUROSUR PS, V62, P22, DOI 10.1136/jnnp.62.1.22; Mellone S, 2012, Z GERONTOL GERIATR, V45, P722, DOI 10.1007/s00391-012-0404-5; Moe-Nilssen R, 2010, GAIT POSTURE, V32, P98, DOI 10.1016/j.gaitpost.2010.03.019; Moore ST, 2007, GAIT POSTURE, V26, P200, DOI 10.1016/j.gaitpost.2006.09.011; Nishiguchi S, 2012, TELEMED E-HEALTH, V18, P292, DOI 10.1089/tmj.2011.0132; Olejnik S, 2000, CONTEMP EDUC PSYCHOL, V25, P241, DOI 10.1006/ceps.2000.1040; Owings TM, 2003, J BIOMECH, V36, P1215, DOI 10.1016/S0021-9290(03)00108-8; Ozinga SJ, 2015, MOVEMENT DISORDERS; Palmerini L, 2013, IEEE T NEUR SYS REH, V21, P664, DOI 10.1109/TNSRE.2012.2236577; Palmerini L, 2011, IEEE ENG MED BIO, P7179, DOI 10.1109/IEMBS.2011.6091814; Patel S, 2012, J NEUROENG REHABIL, V9, DOI 10.1186/1743-0003-9-21; Picelli A, 2010, NEUROL SCI, V31, P423, DOI 10.1007/s10072-010-0228-2; Plotnik M, 2007, EXP BRAIN RES, V181, P561, DOI 10.1007/s00221-007-0955-7; Pogorelc B, 2012, MULTIMED TOOLS APPL, V58, P333, DOI 10.1007/s11042-011-0786-1; Rdio API, 2014, RDI AP; Rochester L, 2011, MOVEMENT DISORD, V26, P430, DOI 10.1002/mds.23450; Rochester L, 2009, MOVEMENT DISORD, V24, P839, DOI 10.1002/mds.22400; Rubenstein LZ, 2006, AGE AGEING, V35, P37, DOI 10.1093/ageing/afl084; Rubinstein TC, 2002, MOVEMENT DISORD, V17, P1148, DOI 10.1002/mds.10259; Salarian A, 2010, IEEE T NEUR SYS REH, V18, P303, DOI 10.1109/TNSRE.2010.2047606; Schaafsma JD, 2003, J NEUROL SCI, V212, P47, DOI 10.1016/S0022-510X(03)00104-7; Schlaug G, 2001, ANN NY ACAD SCI, V930, P281, DOI 10.1111/j.1749-6632.2001.tb05739.x; Shenggao Zhu, 2012, Advances in Multimedia Information Processing - PCM 2012. 13th Pacific-Rim Conference on Multimedia. Proceedings, P93, DOI 10.1007/978-3-642-34778-8_9; Spaulding SJ, 2013, ARCH PHYS MED REHAB, V94, P562, DOI 10.1016/j.apmr.2012.10.026; Sterling DA, 2001, J TRAUMA, V50, P116, DOI 10.1097/00005373-200101000-00021; Tahir N.M., 2012, J APPL SCI, V12, P180, DOI [10.3923/jas.2012.180.185, DOI 10.3923/JAS.2012.180.185, DOI 10.3923/jas.2012.180.185]; Thaut MH, 2003, ANN NY ACAD SCI, V999, P364, DOI 10.1196/annals.1284.044; Thaut MH, 2010, MUSIC PERCEPT, V27, P263, DOI 10.1525/MP.2010.27.4.263; Verghese J, 2009, J GERONTOL A-BIOL, V64, P896, DOI 10.1093/gerona/glp033; Wagner R, 2012, IEEE ENG MED BIO, P280, DOI 10.1109/EMBC.2012.6345924; Weiss A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068885; Weiss A, 2010, MED ENG PHYS, V32, P119, DOI 10.1016/j.medengphy.2009.10.015; Willems AM, 2006, DISABIL REHABIL, V28, P721, DOI 10.1080/09638280500386569; Yamada M, 2012, RHEUMATOL INT, V32, P3869, DOI 10.1007/s00296-011-2283-2; Yang MJ, 2012, HEALTH TECHNOL-GER, V2, P81, DOI 10.1007/s12553-012-0021-8; Yogev G, 2005, EUR J NEUROSCI, V22, P1248, DOI 10.1111/j.1460-9568.2005.04298.x; Zatorre RJ, 2007, NAT REV NEUROSCI, V8, P547, DOI 10.1038/nrn2152; Zhu S, 2015, ERRATUM VALIDATING I; Zhu S, 2015, VALIDATING IOS BASED; Zhu SG, 2014, PROCEEDINGS OF THE 2014 ACM CONFERENCE ON MULTIMEDIA (MM'14), P487, DOI 10.1145/2647868.2654952; Zijlstra W, 2004, EUR J APPL PHYSIOL, V92, P39, DOI 10.1007/s00421-004-1041-5; Zijlstra W, 2003, GAIT POSTURE, V18, P1, DOI 10.1016/S0966-6362(02)00190-X	108	60	61	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2015	10	10							e0141694	10.1371/journal.pone.0141694	http://dx.doi.org/10.1371/journal.pone.0141694			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CV0EH	26517720	gold, Green Published, Green Submitted			2022-12-26	WOS:000363920800068
J	Ramanathan, N; Simakov, O; Merten, CA; Arendt, D				Ramanathan, Nirupama; Simakov, Oleg; Merten, Christoph A.; Arendt, Detlev			Quantifying Preferences and Responsiveness of Marine Zooplankton to Changing Environmental Conditions using Microfluidics	PLOS ONE			English	Article							BEHAVIORAL-RESPONSES; OCEAN ACIDIFICATION; CLIMATE-CHANGE; SALINITY TOLERANCE; CHEMICAL ECOLOGY; COPEPODS; WATER; GRADIENTS; GENERATION; ELEGANS	Global environmental change significantly affects marine species composition. However, analyzing the impact of these changes on marine zooplankton communities was so far mostly limited to assessing lethal doses through mortality assays and hence did not allow a direct assessment of the preferred conditions, or preferendum. Here, we use a microfluidic device to characterize individual behavior of actively swimming zooplankton, and to quantitatively determine their ecological preferendum. For the annelid zooplankton model Platynereis dumerilii we observe a broader pH preferendum than for the copepod Euterpina acutifrons, and reveal previously unrecognized sub-populations with different pH preferenda. For Platynereis, the minimum concentration difference required to elicit a response (responsiveness) is similar to 1 mu M for H+ and similar to 13.7 mM for NaCl. Furthermore, using laser ablations we show that olfactomedin-expressing sensory cells mediate chemical responsiveness in the Platynereis foregut. Taken together, our microfluidic approach allows precise assessment and functional understanding of environmental perception on planktonic behaviour.	[Ramanathan, Nirupama; Simakov, Oleg; Merten, Christoph A.; Arendt, Detlev] European Mol Biol Lab, Heidelberg, Germany; [Simakov, Oleg] Okinawa Inst Sci & Technol, Okinawa, Japan	European Molecular Biology Laboratory (EMBL); Okinawa Institute of Science & Technology Graduate University	Merten, CA (corresponding author), European Mol Biol Lab, Heidelberg, Germany.	christoph.merten@embl.de; arendt@embl.de	Simakov, Oleg/G-4572-2015; /AAL-3738-2021; Simakov, Oleg/AAV-2494-2020	Simakov, Oleg/0000-0002-3585-4511; Simakov, Oleg/0000-0002-3585-4511; Merten, Christoph/0000-0001-8790-4659	European Molecular Biology Laboratory; EMBL International PhD Programme; Boehringer Ingelheim Fonds Graduate Programme; ERC [EA-AdG-2011-294810_BrainEvoDevo]; Association of European Marine Biological Laboratories (ASSEMBLE) in Banyuls-surmer and Roscoff, France.	European Molecular Biology Laboratory; EMBL International PhD Programme; Boehringer Ingelheim Fonds Graduate Programme(Boehringer Ingelheim); ERC(European Research Council (ERC)European Commission); Association of European Marine Biological Laboratories (ASSEMBLE) in Banyuls-surmer and Roscoff, France.	The work was supported by the European Molecular Biology Laboratory (all authors); the EMBL International PhD Programme (N.R.); the Boehringer Ingelheim Fonds Graduate Programme (O.S.), and the ERC grant EA-AdG-2011-294810_BrainEvoDevo (D. A.), and by the Association of European Marine Biological Laboratories (ASSEMBLE) in Banyuls-surmer and Roscoff, France. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aderhold A, 2012, ECOL INFORM, V11, P55, DOI 10.1016/j.ecoinf.2012.05.002; Albrecht DR, 2011, NAT METHODS, V8, P599, DOI [10.1038/NMETH.1630, 10.1038/nmeth.1630]; Anthony KRN, 2008, P NATL ACAD SCI USA, V105, P17442, DOI 10.1073/pnas.0804478105; Barembaum M, 2000, NAT CELL BIOL, V2, P219, DOI 10.1038/35008643; Brittain S, 1998, PHYS WORLD, V11, P31; Calosi P, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0444; Chung KH, 2008, NAT METHODS, V5, P637, DOI 10.1038/nmeth.1227; Cigliano M, 2010, MAR BIOL, V157, P2489, DOI 10.1007/s00227-010-1513-6; Crane MM, 2009, LAB CHIP, V9, P38, DOI 10.1039/b813730g; Dupont S, 2013, NATURE, V498, P429, DOI 10.1038/498429a; Edwards M, 2004, NATURE, V430, P881, DOI 10.1038/nature02808; Evans D. H., 2008, OSMOTIC IONIC REGULA; Fabry VJ, 2008, ICES J MAR SCI, V65, P414, DOI 10.1093/icesjms/fsn048; Fechter A, 2004, MAR ECOL-P S Z N I, V25, P217, DOI 10.1111/j.1439-0485.2004.00026.x; Fischer A, 2004, BIOESSAYS, V26, P314, DOI 10.1002/bies.10409; Fry FEJ, 1947, EFFECTS ENV ANIMAL A; Gutierrez MF, 2011, MAR FRESHW BEHAV PHY, V44, P289, DOI 10.1080/10236244.2011.633770; Hall-Spencer JM, 2008, NATURE, V454, P96, DOI 10.1038/nature07051; Hauenschild C, 1969, GROSSES ZOOLOGISCH B; Hay ME, 2009, ANNU REV MAR SCI, V1, P193, DOI 10.1146/annurev.marine.010908.163708; Hays GC, 2003, HYDROBIOLOGIA, V503, P163, DOI 10.1023/B:HYDR.0000008476.23617.b0; Hays GC, 2005, TRENDS ECOL EVOL, V20, P337, DOI 10.1016/j.tree.2005.03.004; Hesselager M, 2004, J BIOL CHEM, V279, P11006, DOI 10.1074/jbc.M313507200; Heuschele J, 2014, J PLANKTON RES, V36, P895, DOI 10.1093/plankt/fbu025; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Hofmann GE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028983; Isari S, 2015, J PLANKTON RES, V37, P912, DOI 10.1093/plankt/fbv057; Jeon NL, 2000, LANGMUIR, V16, P8311, DOI 10.1021/la000600b; Jha AN, 1996, MUTAT RES-ENVIR MUTA, V359, P141, DOI 10.1016/S0165-1161(96)90260-5; Kendeigh S, 1961, ANIMAL ECOLOGY; Kroeker KJ, 2011, P NATL ACAD SCI USA, V108, P14515, DOI 10.1073/pnas.1107789108; Kroeker KJ, 2010, ECOL LETT, V13, P1419, DOI 10.1111/j.1461-0248.2010.01518.x; LANCE J, 1963, LIMNOL OCEANOGR, V8, P440, DOI 10.4319/lo.1963.8.4.0440; Lard M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013516; LAZZARETTO I, 1992, MAR BIOL, V113, P579, DOI 10.1007/BF00349701; Lee CE, 2002, PHYSIOL BIOCHEM ZOOL, V75, P335, DOI 10.1086/343138; Levitus S., 1994, SALINITY NOAA ATLAS, V3; Lucchetta EM, 2005, NATURE, V434, P1134, DOI 10.1038/nature03509; Marine D, 1913, J EXP MED, V17, P379, DOI 10.1084/jem.17.4.379; McManus MA, 2012, J EXP BIOL, V215, P1008, DOI 10.1242/jeb.059014; Michalec FG, 2010, J PLANKTON RES, V32, P805, DOI 10.1093/plankt/fbq006; OGLESBY LC, 1965, COMP BIOCHEM PHYSIOL, V16, P437, DOI 10.1016/0010-406X(65)90308-7; POULET SA, 1982, J PLANKTON RES, V4, P341, DOI 10.1093/plankt/4.2.341; POULET SA, 1978, SCIENCE, V200, P1403, DOI 10.1126/science.200.4348.1403; Qin D, 1998, TOP CURR CHEM, V194, P1; Reul N, 2014, SURV GEOPHYS, V35, P681, DOI 10.1007/s10712-013-9244-0; Ricevuto E, 2014, MAR BIOL, V161, P2909, DOI 10.1007/s00227-014-2555-y; Richardson AJ, 2008, ICES J MAR SCI, V65, P279, DOI 10.1093/icesjms/fsn028; Seymour JR, 2010, SCIENCE, V329, P342, DOI 10.1126/science.1188418; Simakov O, 2013, BRIEF FUNCT GENOMICS, V12, P430, DOI 10.1093/bfgp/els049; SNELL TW, 1993, HYDROBIOLOGIA, V255, P109, DOI 10.1007/BF00025828; Takayama S, 2001, NATURE, V411, P1016, DOI 10.1038/35082637; Telesh I, 2013, ESTUAR COAST SHELF S, V135, P317, DOI 10.1016/j.ecss.2013.10.013; VALENTINE JW, 2004, ORIGIN PHYLA; Veillette PA, 2007, GEN COMP ENDOCR, V151, P116, DOI 10.1016/j.ygcen.2006.12.019; Weisse T, 2013, FRESHWATER BIOL, V58, P1008, DOI 10.1111/fwb.12104; Wemmie JA, 2013, NAT REV NEUROSCI, V14, P461, DOI 10.1038/nrn3529; Woodson CB, 2007, INTEGR COMP BIOL, V47, P831, DOI 10.1093/icb/icm091; Woodson CB, 2005, LIMNOL OCEANOGR, V50, P1552, DOI 10.4319/lo.2005.50.5.1552; Woodson CB, 2007, CUE HIERARCHY FORAGI; Yamada Yuichiro, 1999, Plankton Biology and Ecology, V46, P62; YOKOE H, 1993, P NATL ACAD SCI USA, V90, P4655, DOI 10.1073/pnas.90.10.4655; Zupo V, 2015, J CHEM ECOL, V41, P766, DOI 10.1007/s10886-015-0610-x	63	8	8	3	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2015	10	10							e0140553	10.1371/journal.pone.0140553	http://dx.doi.org/10.1371/journal.pone.0140553			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0EH	26517120	Green Published, gold, Green Submitted			2022-12-26	WOS:000363920800008
J	Sangphukieo, A; Nawae, W; Laomettachit, T; Supasitthimethee, U; Ruengjitchatchawalya, M				Sangphukieo, Apiwat; Nawae, Wanapinun; Laomettachit, Teeraphan; Supasitthimethee, Umaporn; Ruengjitchatchawalya, Marasri			Computational Design of Hypothetical New Peptides Based on a Cyclotide Scaffold as HIV gp120 Inhibitor	PLOS ONE			English	Article							DRUG DESIGN; KALATA B1; EVOLUTIONARY ALGORITHMS; ENTRY INHIBITORS; HOT-SPOTS; FRAMEWORK; PROTEINS; CD4; OPTIMIZATION; GENERATION	Cyclotides are a family of triple disulfide cyclic peptides with exceptional resistance to thermal/chemical denaturation and enzymatic degradation. Several cyclotides have been shown to possess anti-HIV activity, including kalata B1 (KB1). However, the use of cyclotides as anti-HIV therapies remains limited due to the high toxicity in normal cells. Therefore, grafting anti-HIV epitopes onto a cyclotide might be a promising approach for reducing toxicity and simultaneously improving anti-HIV activity. Viral envelope glycoprotein gp120 is required for entry of HIV into CD4+ T cells. However, due to a high degree of variability and physical shielding, the design of drugs targeting gp120 remains challenging. We created a computational protocol in which molecular modeling techniques were combined with a genetic algorithm (GA) to automate the design of new cyclotides with improved binding to HIV gp120. We found that the group of modified cyclotides has better binding scores (23.1%) compared to the KB1. By using molecular dynamic (MD) simulation as a post filter for the final candidates, we identified two novel cyclotides, GA763 and GA190, which exhibited better interaction energies (36.6% and 22.8%, respectively) when binding to gp120 compared to KB1. This computational design represents an alternative tool for modifying peptides, including cyclotides and other stable peptides, as therapeutic agents before the synthesis process.	[Sangphukieo, Apiwat; Laomettachit, Teeraphan; Ruengjitchatchawalya, Marasri] KMUTT, Bioinformat & Syst Biol Program, Bangkok 10150, Thailand; [Nawae, Wanapinun] KMUTT Bang Khun Thian, Pilot Plant Dev & Training Inst, Bangkok 10150, Thailand; [Ruengjitchatchawalya, Marasri] KMUTT Bang Khun Thian, Sch Bioresources & Technol, Biotechnol Program, Bangkok 10150, Thailand; [Supasitthimethee, Umaporn] KMUTT, Sch Informat Technol, Bangkok 10140, Thailand	King Mongkuts University of Technology Thonburi; King Mongkuts University of Technology Thonburi	Ruengjitchatchawalya, M (corresponding author), KMUTT, Bioinformat & Syst Biol Program, Bangkok 10150, Thailand.	marasri.rue@kmutt.ac.th	Ruengjitchatchawalya, Marasri/N-5694-2014	Laomettachit, Teeraphan/0000-0003-3194-1391	National Research Council of Thailand [NRMJ: 2557A3060229557000139]; National Center for Genetic Engineering and Biotechnology, National Science and Technology Development Agency, Thailand [P-11-01089]	National Research Council of Thailand(National Research Council of Thailand (NRCT)); National Center for Genetic Engineering and Biotechnology, National Science and Technology Development Agency, Thailand	This work was partly supported by a research grant (NRMJ: 2557A30602295#57000139) from the National Research Council of Thailand (http://en.nrct.go.th); and a grant (P-11-01089) from the National Center for Genetic Engineering and Biotechnology, National Science and Technology Development Agency, Thailand (http://www.biotec.or.th). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboye TL, 2012, J MED CHEM, V55, P10729, DOI 10.1021/jm301468k; Austin J, 2009, CHEMBIOCHEM, V10, P2663, DOI 10.1002/cbic.200900534; Azoitei ML, 2011, SCIENCE, V334, P373, DOI 10.1126/science.1209368; Belda I, 2006, SOFT COMPUT, V10, P295, DOI 10.1007/s00500-005-0487-7; Belda I, 2007, MOL DIVERS, V11, P7, DOI 10.1007/s11030-006-9053-1; Bellows ML, 2010, BIOPHYS J, V99, P3445, DOI 10.1016/j.bpj.2010.09.050; Bogan AA, 1998, J MOL BIOL, V280, P1, DOI 10.1006/jmbi.1998.1843; Bokesch HR, 2001, J NAT PROD, V64, P249, DOI 10.1021/np000372l; Briz V, 2006, J ANTIMICROB CHEMOTH, V57, P619, DOI 10.1093/jac/dkl027; Caffrey M, 2011, TRENDS MICROBIOL, V19, P191, DOI 10.1016/j.tim.2011.02.001; Chaudhury S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022477; Colgrave ML, 2008, BIOCHEMISTRY-US, V47, P5581, DOI 10.1021/bi800223y; Colgrave ML, 2004, BIOCHEMISTRY-US, V43, P5965, DOI 10.1021/bi049711q; Cukuroglu E, 2012, NUCLEIC ACIDS RES, V40, pD829, DOI 10.1093/nar/gkr929; Daly NL, 2004, FEBS LETT, V574, P69, DOI 10.1016/j.febslet.2004.08.007; Daly NL, 2009, FUTURE MED CHEM, V1, P1613, DOI 10.4155/FMC.09.129; De Feo CJ, 2012, VIRUSES-BASEL, V4, P3859, DOI 10.3390/v4123859; DeLano WL, 2002, CURR OPIN STRUC BIOL, V12, P14, DOI 10.1016/S0959-440X(02)00283-X; Devi RV, 2015, APPL SOFT COMPUT, V27, P543, DOI 10.1016/j.asoc.2014.09.042; Douguet D, 2000, J COMPUT AID MOL DES, V14, P449, DOI 10.1023/A:1008108423895; Douguet D, 2005, J MED CHEM, V48, P2457, DOI 10.1021/jm0492296; Eliasen R, 2012, J BIOL CHEM, V287, P40493, DOI 10.1074/jbc.M112.395442; Fiser A, 2003, METHOD ENZYMOL, V374, P461, DOI 10.1016/S0076-6879(03)74020-8; Fortin FA, 2012, J MACH LEARN RES, V13, P2171; Gray JJ, 2003, J MOL BIOL, V331, P281, DOI 10.1016/S0022-2836(03)00670-3; Guo WX, 2014, BIOORG MED CHEM LETT, V24, P2546, DOI 10.1016/j.bmcl.2014.03.095; GUSTAFSON KR, 1994, J AM CHEM SOC, V116, P9337, DOI 10.1021/ja00099a064; Haupt R.L., 2004, PRACTICAL GENETIC AL, VSecond, DOI DOI 10.1002/0471671746; Henriques ST, 2010, DRUG DISCOV TODAY, V15, P57, DOI 10.1016/j.drudis.2009.10.007; Holland J. H., 1992, ADAPTATION NATURAL A; Huang CC, 2005, STRUCTURE, V13, P755, DOI 10.1016/j.str.2005.03.006; Kortemme T, 2003, J MOL BIOL, V326, P1239, DOI 10.1016/S0022-2836(03)00021-4; Koziara KB, 2014, J COMPUT AID MOL DES, V28, P221, DOI 10.1007/s10822-014-9713-7; Kubinyi H., 2007, HYDROGEN BONDING LAS, P513; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; Li L, 2006, BIOINFORMATION, V1, P121, DOI 10.6026/97320630001121; Liu YY, 2013, CHEM BIOL DRUG DES, V81, P72, DOI 10.1111/cbdd.12075; Martin L, 2003, NAT BIOTECHNOL, V21, P71, DOI 10.1038/nbt768; Meireles LMC, 2010, NUCLEIC ACIDS RES, V38, pW407, DOI 10.1093/nar/gkq502; Moreira IS, 2007, PROTEINS, V68, P803, DOI 10.1002/prot.21396; Nawae W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114473; Nawae W, 2014, SCI REP-UK, V4, DOI 10.1038/srep03933; Ofran Y, 2007, PLOS COMPUT BIOL, V3, P1169, DOI 10.1371/journal.pcbi.0030119; Oostenbrink C, 2004, J COMPUT CHEM, V25, P1656, DOI 10.1002/jcc.20090; Pantophlet R, 2006, ANNU REV IMMUNOL, V24, P739, DOI 10.1146/annurev.immunol.24.021605.090557; Pierce BG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024657; Poth AG, 2013, BIOPOLYMERS, V100, P480, DOI 10.1002/bip.22284; Pronk S, 2013, BIOINFORMATICS, V29, P845, DOI 10.1093/bioinformatics/btt055; Rosengren KJ, 2003, J BIOL CHEM, V278, P8606, DOI 10.1074/jbc.M211147200; Rubinstein R, 2008, BIOINFORMATICS, V24, P498, DOI 10.1093/bioinformatics/btm637; Thongyoo P, 2008, ORG BIOMOL CHEM, V6, P1462, DOI 10.1039/b801667d; Thongyoo P, 2009, J MED CHEM, V52, P6197, DOI 10.1021/jm901233u; Tlatli R, 2013, FEBS J, V280, P139, DOI 10.1111/febs.12056; Wang CK, 2014, ACS CHEM BIOL, V9, P156, DOI 10.1021/cb400548s; Yagi Y, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-11; Zhou P, 2013, CURR MED CHEM, V20, P1985, DOI 10.2174/0929867311320150005	56	7	10	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2015	10	10							e0139562	10.1371/journal.pone.0139562	http://dx.doi.org/10.1371/journal.pone.0139562			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0EH	26517259	Green Published, Green Submitted, gold			2022-12-26	WOS:000363920800001
J	Smaldini, PL; Delgado, MLO; Fossati, CA; Docena, GH				Smaldini, Paola Lorena; Delgado, MarIa LucIa Orsini; Fossati, Carlos Alberto; Docena, Guillermo Horacio			Orally-Induced Intestinal CD4(+) CD25(+) FoxP3(+) Treg Controlled Undesired Responses towards Oral Antigens and Effectively Dampened Food Allergic Reactions	PLOS ONE			English	Article							COWS MILK ALLERGY; TOLERANCE INDUCTION; DOUBLE-BLIND; MOUSE MODEL; B-CELLS; IMMUNOTHERAPY; CHILDREN; EFFICACY; MECHANISMS; MICE	The induction of peripheral tolerance may constitute a disease-modifying treatment for allergic patients. We studied how oral immunotherapy (OIT) with milk proteins controlled allergy in sensitized mice (cholera toxin plus milk proteins) upon exposure to the allergen. Symptoms were alleviated, skin test was negativized, serum specific IgE and IgG1 were abrogated, a substantial reduction in the secretion of IL-5 and IL-13 by antigen-stimulated spleen cells was observed, while IL-13 gene expression in jejunum was down-regulated, and IL-10 and TGF-beta were increased. In addition, we observed an induction of CD4(+)CD25(+)FoxP3(+) cells and IL-10- and TGF-beta-producing regulatory T cells in the lamina propria. Finally, transfer experiments confirmed the central role of these cells in tolerance induction. We demonstrated that the oral administration of milk proteins pre- or post-sensitization controlled the Th2-immune response through the elicitation of mucosal IL-10- and TGF-beta-producing Tregs that inhibited hypersensitivity symptoms and the allergic response.	[Docena, Guillermo Horacio] Univ Nacl La Plata, Fac Ciencias Exactas, Inst Estudios Inmunol & Fisiopatol IIFP, La Plata, Argentina; Consejo Nacl Invest Cient & Tecn, La Plata, Argentina	National University of La Plata; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Docena, GH (corresponding author), Univ Nacl La Plata, Fac Ciencias Exactas, Inst Estudios Inmunol & Fisiopatol IIFP, La Plata, Argentina.	guidoc@biol.unlp.edu.ar		Smaldini, Paola/0000-0002-2734-516X; Orsini Delgado, Maria Lucia/0000-0003-4655-1695	National Agency for Research [PICT 2012-1772]; University of La Plata [X455]	National Agency for Research(French National Research Agency (ANR)); University of La Plata(National University of La Plata)	This study was supported with grants to G.H.D. from the National Agency for Research (PICT 2012-1772) and to C.A.F. from the University of La Plata (X455). The funders had no role in experimental design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adel-Patient K, 2011, ALLERGY, V66, P1312, DOI 10.1111/j.1398-9995.2011.02653.x; Akdis CA, 2009, J ALLERGY CLIN IMMUN, V123, P735, DOI 10.1016/j.jaci.2009.02.030; Ashour HM, 2007, INT ARCH ALLERGY IMM, V144, P343, DOI 10.1159/000106461; Ashour HM, 2007, J LEUKOCYTE BIOL, V82, P1033, DOI 10.1189/jlb.0507310; Berin MC, 2013, TRENDS IMMUNOL, V34, P390, DOI 10.1016/j.it.2013.04.003; Bhattacharya P, 2014, CLIN IMMUNOL, V153, P187, DOI 10.1016/j.clim.2014.04.014; Brozek JL, 2012, CLIN EXP ALLERGY, V42, P363, DOI 10.1111/j.1365-2222.2011.03948.x; Burks AW, 2012, NEW ENGL J MED, V367, P233, DOI 10.1056/NEJMoa1200435; Curciarello R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0082341; Docena G, 2010, CLIN EXP IMMUNOL, V162, P108, DOI 10.1111/j.1365-2249.2010.04203.x; Enrique E, 2005, J ALLERGY CLIN IMMUN, V116, P1073, DOI 10.1016/j.jaci.2005.08.027; Fiocchi A, 2010, PEDIAT ALLERG IMM-UK, V21, P1, DOI [10.1097/WOX.0b013e3181defeb9, 10.1111/j.1399-3038.2010.01068.x]; Fischer JAA, 2015, ARTHRITIS RHEUMATOL, V67, P51, DOI 10.1002/art.38896; Gonnella PA, 2001, J IMMUNOL, V166, P4456, DOI 10.4049/jimmunol.166.7.4456; Hossain DMS, 2013, IMMUNITY, V39, P1057, DOI 10.1016/j.immuni.2013.11.005; HOST A, 1990, ALLERGY, V45, P587, DOI 10.1111/j.1398-9995.1990.tb00944.x; Ibanez AE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069438; Isolauri E, 1998, J PEDIATR-US, V132, P1004, DOI 10.1016/S0022-3476(98)70399-3; Karlsson MR, 2004, J EXP MED, V199, P1679, DOI 10.1084/jem.20032121; Kobayashi I, 2011, CLIN IMMUNOL, V141, P83, DOI 10.1016/j.clim.2011.05.010; Krogulska A, 2011, J CLIN IMMUNOL, V31, P205, DOI 10.1007/s10875-010-9487-1; Li QC, 2014, INT IMMUNOPHARMACOL, V21, P119, DOI 10.1016/j.intimp.2014.04.018; Moran TP, 2013, CURR OPIN IMMUNOL, V25, P781, DOI 10.1016/j.coi.2013.07.011; Nguyen KD, 2009, J ALLERGY CLIN IMMUN, V123, P933, DOI 10.1016/j.jaci.2008.11.037; Pajno GB, 2010, ANN ALLERG ASTHMA IM, V105, P376, DOI 10.1016/j.anai.2010.03.015; Rolinck-Werninghaus C, 2005, ALLERGY, V60, P1320, DOI 10.1111/j.1398-9995.2005.00882.x; Rupa P, 2012, ALLERGY, V67, P74, DOI 10.1111/j.1398-9995.2011.02724.x; Sanchez-Garcia S, 2012, ISR MED ASSOC J, V14, P43; Sicherer SH, 2014, J ALLERGY CLIN IMMUN, V133, P291, DOI 10.1016/j.jaci.2013.11.020; Sicherer SH, 2011, J ALLERGY CLIN IMMUN, V127, P594, DOI 10.1016/j.jaci.2010.11.044; Skripak JM, 2008, J ALLERGY CLIN IMMUN, V122, P1154, DOI 10.1016/j.jaci.2008.09.030; Smaldini P, 2012, INT ARCH ALLERGY IMM, V158, P335, DOI 10.1159/000333562; Smaldini PL, 2013, INNATE IMMUNITY; Smaldini PL, 2014, HUMAN VACCINES IMMUN, V10, P1; Staden U, 2007, ALLERGY, V62, P1261, DOI 10.1111/j.1398-9995.2007.01501.x; Syed A, 2014, J ALLERGY CLIN IMMUN, V133, P500, DOI 10.1016/j.jaci.2013.12.1037; Varshney P, 2011, J ALLERGY CLIN IMMUN, V127, P654, DOI 10.1016/j.jaci.2010.12.1111; Vickery BP, 2011, J ALLERGY CLIN IMMUN, V127, P576, DOI 10.1016/j.jaci.2010.12.1116; Wang J, 2011, J CLIN INVEST, V121, P827, DOI [10.1172/JCI45434, 10.1186/1710-1492-7-S1-S7]; Xu L, 2010, MUCOSAL IMMUNOL, V3, P230, DOI 10.1038/mi.2010.7; Yamada Takaya, 2012, J Allergy (Cairo), V2012, P490905, DOI 10.1155/2012/490905	42	36	39	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2015	10	10							e0141116	10.1371/journal.pone.0141116	http://dx.doi.org/10.1371/journal.pone.0141116			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0EH	26517875	Green Published, gold			2022-12-26	WOS:000363920800022
J	DaMata, JP; Mendes, BP; Maciel-Lima, K; Menezes, CAS; Dutra, WO; Sousa, LP; Horta, MF				DaMata, Jarina Pena; Mendes, Barbara Pinheiro; Maciel-Lima, Katia; Silva Menezes, Cristiane Alves; Dutra, Walderez Ornelas; Sousa, Lirlandia Pires; Horta, Maria Fatima			Distinct Macrophage Fates after in vitro Infection with Different Species of Leishmania: Induction of Apoptosis by Leishmania (Leishmania) amazonensis, but Not by Leishmania (Viannia) guyanensis	PLOS ONE			English	Article							CD4(+) T-CELLS; CUTANEOUS LEISHMANIASIS; NEUTROPHIL GRANULOCYTES; PARASITE; PATHOGENESIS; PROMASTIGOTES; BRAZILIENSIS; AMASTIGOTES; RESPONSES; VECTOR	Leishmania is an intracellular parasite in vertebrate hosts, including man. During infection, amastigotes replicate inside macrophages and are transmitted to healthy cells, leading to amplification of the infection. Although transfer of amastigotes from infected to healthy cells is a crucial step that may shape the outcome of the infection, it is not fully understood. Here we compare L. amazonensis and L. guyanensis infection in C57BL/6 and BALB/c mice and investigate the fate of macrophages when infected with these species of Leishmania in vitro. As previously shown, infection of mice results in distinct outcomes: L. amazonensis causes a chronic infection in both strains of mice (although milder in C57BL/6), whereas L. guyanensis does not cause them disease. In vitro, infection is persistent in L. amazonensis-infected macrophages whereas L. guyanensis growth is controlled by host cells from both strains of mice. We demonstrate that, in vitro, L. amazonensis induces apoptosis of both C57BL/6 and BALB/c macrophages, characterized by PS exposure, DNA cleavage into nucleosomal size fragments, and consequent hypodiploidy. None of these signs were seen in macrophages infected with L. guyanensis, which seem to die through necrosis, as indicated by increased PI-, but not Annexin V-, positive cells. L. amazonensis-induced macrophage apoptosis was associated to activation of caspases-3, -8 and -9 in both strains of mice. Considering these two species of Leishmania and strains of mice, macrophage apoptosis, induced at the initial moments of infection, correlates with chronic infection, regardless of its severity. We present evidence suggestive that macrophages phagocytize L. amazonensis-infected cells, which has not been verified so far. The ingestion of apoptotic infected macrophages by healthy macrophages could be a way of amastigote spreading, leading to the establishment of infection.	[DaMata, Jarina Pena; Mendes, Barbara Pinheiro; Horta, Maria Fatima] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Bioquim & Imunol, Belo Horizonte, MG, Brazil; [Maciel-Lima, Katia; Silva Menezes, Cristiane Alves; Dutra, Walderez Ornelas] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Morfol, Belo Horizonte, MG, Brazil; [Sousa, Lirlandia Pires] Univ Fed Minas Gerais, Fac Farm, Dept Anal Clin & Toxicol, Belo Horizonte, MG, Brazil	Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais	Horta, MF (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Bioquim & Imunol, Belo Horizonte, MG, Brazil.	phorta@icb.ufmg.br	Dutra, Walderez Ornelas/CAH-1502-2022; Mendes, Barbara/HGB-2866-2022; menezes, cristiane/N-7945-2019	Dutra, Walderez Ornelas/0000-0002-7586-9996; Sousa, Lirlandia/0000-0002-1042-9762; DaMata, Jarina/0000-0002-6117-7630	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); CAPES	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by the following Brazilian financing programs or institutions: Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG), and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES). JPD, BPM, and KML were supported by CAPES. LPS, WOD, and MFH are CNPq research fellows. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu-Silva AL, 2004, VET PARASITOL, V121, P179, DOI 10.1016/j.vetpar.2004.03.002; Afonso L, 2008, J LEUKOCYTE BIOL, V84, P389, DOI 10.1189/jlb.0108018; Aga E, 2002, J IMMUNOL, V169, P898, DOI 10.4049/jimmunol.169.2.898; Almeida-Campos FR, 2002, MICROBES INFECT, V4, P741, DOI 10.1016/S1286-4579(02)01593-9; Vercosa BLA, 2012, VET PARASITOL, V189, P162, DOI 10.1016/j.vetpar.2012.04.035; Assis RR, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001543; Balanco JMD, 2001, CURR BIOL, V11, P1870, DOI 10.1016/S0960-9822(01)00563-2; Banuls AL, 2007, ADV PARASIT, V64, P1, DOI 10.1016/S0065-308X(06)64001-3; BARRALNETTO M, 1992, SCIENCE, V257, P545, DOI 10.1126/science.1636092; Bourreau E, 2009, INFECT IMMUN, V77, P1465, DOI 10.1128/IAI.01398-08; Bourreau E, 2001, SCAND J IMMUNOL, V54, P335, DOI 10.1046/j.1365-3083.2001.00981.x; Bourreau E, 2001, J INFECT DIS, V183, P953, DOI 10.1086/319249; Bourreau E, 2007, MICROBES INFECT, V9, P1034, DOI 10.1016/j.micinf.2007.04.009; Bray R.S., 1987, P211; Catelas I, 2005, BIOMATERIALS, V26, P2441, DOI 10.1016/j.biomaterials.2004.08.004; Chatelain R, 1999, PARASITE IMMUNOL, V21, P211, DOI 10.1046/j.1365-3024.1999.00224.x; Cullen SP, 2009, CELL DEATH DIFFER, V16, P935, DOI 10.1038/cdd.2009.59; DEDET JP, 1990, AM J TROP MED HYG, V43, P25, DOI 10.4269/ajtmh.1990.43.25; Deschacht M, 2012, PARASITOLOGY, V139, P1429, DOI 10.1017/S003118201200073X; Dinarello CA, 2011, EUR J IMMUNOL, V41, P1203, DOI 10.1002/eji.201141550; Dostalova A, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-276; Ferreira KS, 2012, APOPTOSIS, V17, P503, DOI 10.1007/s10495-011-0691-0; Getti GT, 2008, PARASITOLOGY, V135, P1391, DOI 10.1017/S0031182008004915; Gontijo Bernardo, 2003, Rev. Soc. Bras. Med. Trop., V36, P71, DOI 10.1590/S0037-86822003000100011; Gueirard P, 2008, CELL MICROBIOL, V10, P100, DOI 10.1111/j.1462-5822.2007.01018.x; Handman E, 2000, ADV PARASIT, V44, P1; Ibraim IC, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-54; Ives A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096766; Ji JX, 2005, J IMMUNOL, V174, P7147, DOI 10.4049/jimmunol.174.11.7147; Ji JX, 2002, AM J TROP MED HYG, V66, P338, DOI 10.4269/ajtmh.2002.66.338; Kaye P, 2011, NAT REV MICROBIOL, V9, P604, DOI 10.1038/nrmicro2608; Kedzierski L, 2014, PARASITOLOGY, V141, P1544, DOI 10.1017/S003118201400095X; Laskay T, 2003, TRENDS MICROBIOL, V11, P210, DOI 10.1016/S0966-842X(03)00075-1; LIEW FY, 1993, ADV PARASIT, V32, P161, DOI 10.1016/S0065-308X(08)60208-0; Maelfait J, 2008, J EXP MED, V205, P1967, DOI 10.1084/jem.20071632; McMahon-Pratt D, 2004, IMMUNOL REV, V201, P206, DOI 10.1111/j.0105-2896.2004.00190.x; Wanderley JLM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005733; Noronha FSM, 2000, INFECT IMMUN, V68, P4578, DOI 10.1128/IAI.68.8.4578-4584.2000; Probst CM, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-22; Real F, 2014, CELL MICROBIOL, V16, P1549, DOI 10.1111/cmi.12311; Ribeiro-Gomes FL, 2004, J IMMUNOL, V172, P4454, DOI 10.4049/jimmunol.172.7.4454; Riccardi C, 2006, NAT PROTOC, V1, P1458, DOI 10.1038/nprot.2006.238; Rittig MG, 2000, PARASITOL TODAY, V16, P292, DOI 10.1016/S0169-4758(00)01692-6; Romero Gustavo A. S., 2001, Clinical Infectious Diseases, V32, P1304, DOI 10.1086/319990; Santos JL, 2006, J INTERF CYTOK RES, V26, P682, DOI 10.1089/jir.2006.26.682; Shweash M, 2011, MOL IMMUNOL, V48, P1800, DOI 10.1016/j.molimm.2011.05.013; Siegel RM, 2006, NAT REV IMMUNOL, V6, P308, DOI 10.1038/nri1809; Silveira FT, 2009, PARASITE IMMUNOL, V31, P423, DOI 10.1111/j.1365-3024.2009.01116.x; Soong L, 1997, J IMMUNOL, V158, P5374; Soong L, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00058; Sousa LP, 2005, BIOCHEM BIOPH RES CO, V337, P1065, DOI 10.1016/j.bbrc.2005.09.154; Sousa-Franco J, 2006, MICROBES INFECT, V8, P390, DOI 10.1016/j.micinf.2005.07.007; Taylor RC, 2008, NAT REV MOL CELL BIO, V9, P231, DOI 10.1038/nrm2312; van Zandbergen G, 2004, J IMMUNOL, V173, P6521, DOI 10.4049/jimmunol.173.11.6521; van Zandbergen G, 2006, P NATL ACAD SCI USA, V103, P13837, DOI 10.1073/pnas.0600843103; WHO, 2010, CONTR LEISHM; WIDMER G, 1989, P NATL ACAD SCI USA, V86, P5979, DOI 10.1073/pnas.86.15.5979; Wilson M. E., 1990, Modern parasite biology: cellular, immunological, and molecular aspects., P200; World Health Organization, 2014, LEISHM DIS ITS EP; World Health Organization, 2014, GLOB AL RESP	60	13	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2015	10	10							e0141196	10.1371/journal.pone.0141196	http://dx.doi.org/10.1371/journal.pone.0141196			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0ED	26513474	gold, Green Published, Green Submitted			2022-12-26	WOS:000363920300023
J	Huang, Q; Zhou, CH; Chen, X; Dong, B; Chen, SQ; Zhang, N; Liu, YW; Li, AR; Yao, MC; Miao, J; Li, Q; Wang, Z				Huang, Qiang; Zhou, Changhua; Chen, Xiao; Dong, Bing; Chen, Siqi; Zhang, Ning; Liu, Yawei; Li, Anrong; Yao, Meicun; Miao, Ji; Li, Qing; Wang, Zhong			Prodrug AST-003 Improves the Therapeutic Index of the Multi-Targeted Tyrosine Kinase Inhibitor Sunitinib	PLOS ONE			English	Article							SIGNALING PATHWAYS; IN-VIVO; ANGIOGENESIS; APOPTOSIS	Patients have responded well to the multi-targeted tyrosine kinase inhibitor (TKI) Sunitinib in the clinic. But the severe toxic side effects associated with Sunitinib limit its therapeutic index. To improve the therapeutic index of Sunitinib, a prodrug strategy was employed to modify Sunitinib. The inactive prodrug AST-003 can be converted to Sunitinib in vitro and in vivo. Compared with Sunitinib, AST-003 has unique biochemical, cellular and pharmacokinetic properties with improved tolerability in mice and yield higher efficacy in tumor xenograft models. This prodrug strategy may constitute a novel paradigm to improve the therapeutic index of Sunitinib and other TKI or anti-angiogenesis drugs in general.	[Huang, Qiang; Zhou, Changhua; Chen, Xiao; Dong, Bing; Chen, Siqi; Yao, Meicun; Miao, Ji; Li, Qing; Wang, Zhong] Sun Yat Sen Univ, Sch Pharmaceut Sci, Guangzhou 510275, Guangdong, Peoples R China; [Huang, Qiang; Zhou, Changhua; Dong, Bing; Chen, Siqi; Li, Qing; Wang, Zhong] Sun Yat Sen Univ, Ctr Cellular & Struct Biol, Guangzhou 510275, Guangdong, Peoples R China; [Zhang, Ning] Peking Univ, Canc Hosp, Beijing Inst Canc Res, Beijing 100871, Peoples R China; [Liu, Yawei] Gen Staff Dept PLA, Hlth Div, Guard Bur, Beijing, Peoples R China; [Li, Anrong] Ascenta Pharmaceut, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Peking University	Li, Q (corresponding author), Sun Yat Sen Univ, Sch Pharmaceut Sci, Guangzhou 510275, Guangdong, Peoples R China.	liqing66@mail.sysu.edu.cn; wangzh357@mail.sysue.edu.cn			Introduced Innovative R&D Team Leadership of Guangdong Province (P.R. China) [2011Y038]	Introduced Innovative R&D Team Leadership of Guangdong Province (P.R. China)	This work received financial support from the Introduced Innovative R&D Team Leadership of Guangdong Province (P.R. China) (2011Y038) to Qing Li and Zhong Wang. The funder provided support in the form of partial salaries for authors Miao J, Li Q, and Wang Z, and research materials. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams RH, 2007, NAT REV MOL CELL BIO, V8, P464, DOI 10.1038/nrm2183; Campbell MT, 2014, CLIN GENITOURIN CANC; Mena AC, 2010, ANTI-CANCER DRUG, V21, pS3, DOI 10.1097/01.cad.0000361534.44052.c5; Christensen JG, 2007, ANN ONCOL, V18, P3, DOI 10.1093/annonc/mdm408; Escudier B, 2012, ANN ONCOL, V23, P65, DOI 10.1093/annonc/mds227; Faivre S, 2007, NAT REV DRUG DISCOV, V6, P734, DOI 10.1038/nrd2380; Faivre S, 2006, SEMIN ONCOL, V33, P407, DOI 10.1053/j.seminoncol.2006.04.005; Ferrara N, 2005, NATURE, V438, P967, DOI 10.1038/nature04483; Haznedar JO, 2009, CANCER CHEMOTH PHARM, V64, P691, DOI 10.1007/s00280-008-0917-1; Huttunen KM, 2011, PHARMACOL REV, V63, P750, DOI 10.1124/pr.110.003459; Jain RK, 2014, CANCER CELL, V26, P605, DOI 10.1016/j.ccell.2014.10.006; Jain RK, 2006, NAT CLIN PRACT ONCOL, V3, P24, DOI 10.1038/ncponc0403; Jing S, 2012, PLOS ONE, V7, P1; Keith Ian Q, 2014, BMJ CASE REPORTS, V2014, P1; Kutach AK, 2010, CHEM BIOL DRUG DES, V76, P154, DOI 10.1111/j.1747-0285.2010.00993.x; Laird AD, 2002, FASEB J, V16, DOI 10.1096/fj.01-0700com; Lin EY, 2007, CANCER RES, V67, P5064, DOI 10.1158/0008-5472.CAN-07-0912; Massey PR, 2014, SUPPORT CARE CANC; Mendel DB, 2003, CLIN CANCER RES, V9, P327; O'Farrell AM, 2003, BLOOD, V101, P3597, DOI 10.1182/blood-2002-07-2307; Schmid MC, 2007, CANCER LETT, V250, P1, DOI 10.1016/j.canlet.2006.09.002; Valle JW, 2014, CANCER TREAT REV, V40, P1230, DOI 10.1016/j.ctrv.2014.09.001; Whittaker S, 2010, ONCOGENE, V29, P4989, DOI 10.1038/onc.2010.236; Wilhelm SM, 2004, CANCER RES, V64, P7099, DOI 10.1158/0008-5472.CAN-04-1443; Xin H, 2009, CANCER RES, V69, P2506, DOI 10.1158/0008-5472.CAN-08-4323	25	6	6	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2015	10	10							e0141395	10.1371/journal.pone.0141395	http://dx.doi.org/10.1371/journal.pone.0141395			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0ED	26513662	gold, Green Published, Green Submitted			2022-12-26	WOS:000363920300035
J	Sauter, TC; Kreher, J; Ricklin, ME; Haider, DG; Exadaktylos, AK				Sauter, Thomas C.; Kreher, Jannes; Ricklin, Meret E.; Haider, Dominik G.; Exadaktylos, Aristomenis K.			Risk Factors for Intracranial Haemorrhage in Accidents Associated with the Shower or Bathtub	PLOS ONE			English	Article							CT HEAD RULE; COMPUTED-TOMOGRAPHY; BATHROOM INJURIES; CHILDREN; FALLS	Background There has been little research on bathroom accidents. It is unknown whether the shower or bathtub are connected with special dangers in different age groups or whether there are specific risk factors for adverse outcomes. Methods This cross-sectional analysis included all direct admissions to the Emergency Department at the Inselspital Bern, Switzerland from 1 January 2000 to 28 February 2014 after accidents associated with the bathtub or shower. Time, age, location, mechanism and diagnosis were assessed and special risk factors were examined. Patient groups with and without intracranial bleeding were compared with the Mann-Whitney U test. The association of risk factors with intracranial bleeding was investigated using univariate analysis with Fisher's exact test or logistic regression. The effects of different variables on cerebral bleeding were analysed by multivariate logistic regression. Results Two hundred and eighty (280) patients with accidents associated with the bathtub or shower were included in our study. Two hundred and thirty-five (235) patients suffered direct trauma by hitting an object (83.9%) and traumatic brain injury (TBI) was detected in 28 patients (10%). Eight (8) of the 27 patients with mild traumatic brain injuries (GCS 1315), (29.6%) exhibited intracranial haemorrhage. All patients with intracranial haemorrhage were older than 48 years and needed in-hospital treatment. Patients with intracranial haemorrhage were significantly older and had higher haemoglobin levels than the control group with TBI but without intracranial bleeding (p<0.05 for both). In univariate analysis, we found that intracranial haemorrhage in patients with TBI was associated with direct trauma in general and with age (both p<0.05), but not with the mechanism of the fall, its location (shower or bathtub) or the gender of the patient. Multivariate logistic regression analysis identified only age as a risk factor for cerebral bleeding (p<0.05; OR 1.09 (CI 1.01; 1.171)) Conclusion In patients with ED admissions associated with the bathtub or shower direct trauma and age are risk factors for intracranial haemorrhage. Additional effort in prevention should be considered, especially in the elderly.	[Sauter, Thomas C.; Kreher, Jannes; Ricklin, Meret E.; Haider, Dominik G.; Exadaktylos, Aristomenis K.] Univ Hosp Bern, Inselspital, Dept Emergency Med, CH-3010 Bern, Switzerland	University of Bern; University Hospital of Bern	Sauter, TC (corresponding author), Univ Hosp Bern, Inselspital, Dept Emergency Med, CH-3010 Bern, Switzerland.	thomas.sauter@insel.ch	Ricklin, Meret Elisabeth/AAY-7948-2021	Ricklin, Meret Elisabeth/0000-0003-3047-9350; Sauter, Thomas C/0000-0002-6646-5789				Albers CE, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/453978; Hashiguchi N, 2000, J PHYSL ANTHR APPL H, V21, P22; Haydel MJ, 2000, NEW ENGL J MED, V343, P100, DOI 10.1056/NEJM200007133430204; Head EN, 2013, INJURY PREV, V19, P316, DOI 10.1136/injuryprev-2012-040600; Ibanez J, 2004, J NEUROSURG, V100, P825, DOI 10.3171/jns.2004.100.5.0825; Mack LR, 2003, J EMERG MED, V24, P157, DOI 10.1016/S0736-4679(02)00714-X; Mao SJ, 2009, PEDIATRICS, V124, P541, DOI 10.1542/peds.2008-2489; NEVITT MC, 1991, J GERONTOL, V46, pM164, DOI 10.1093/geronj/46.5.M164; Rosen Tony, 2013, J Inj Violence Res, V5, P61, DOI 10.5249/jivr.v5i1.177; Rubenstein LZ, 2002, CLIN GERIATR MED, V18, P141, DOI 10.1016/S0749-0690(02)00002-2; Smits M, 2005, JAMA-J AM MED ASSOC, V294, P1519, DOI 10.1001/jama.294.12.1519; Stevens JA, 2011, J SAFETY RES, V42, P311, DOI 10.1016/j.jsr.2011.07.001; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X	13	2	2	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2015	10	10							e0141812	10.1371/journal.pone.0141812	http://dx.doi.org/10.1371/journal.pone.0141812			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0ED	26513749	Green Published, gold, Green Submitted			2022-12-26	WOS:000363920300086
J	Valenti, G; Bonomi, AG; Westerterp, KR				Valenti, Giulio; Bonomi, Alberto G.; Westerterp, Klaas R.			Body Acceleration as Indicator for Walking Economy in an Ageing Population	PLOS ONE			English	Article							LOCAL DYNAMIC STABILITY; AGE-RELATED DIFFERENCES; OLDER-ADULTS; GAIT VARIABILITY; FALL RISK; ENERGETIC COST; SPEED; COMMUNITY; RELIABILITY; EXPENDITURE	Background In adults, walking economy declines with increasing age and negatively influences walking speed. This study aims at detecting determinants of walking economy from body acceleration during walking in an ageing population. Methods 35 healthy elderly (18 males, age 51 to 83 y, BMI 25.5 +/- 2.4 kg/m(2)) walked on a treadmill. Energy expenditure was measured with indirect calorimetry while body acceleration was sampled at 60Hz with a tri-axial accelerometer (GT3X+, ActiGraph), positioned on the lower back. Walking economy was measured as lowest energy needed to displace one kilogram of body mass for one meter while walking (WCost(min), J/m/kg). Gait features were extracted from the acceleration signal and included in a model to predict WCost(min). Results On average WCost(min) was 2.43 +/- 0.42 J/m/kg and correlated significantly with gait rate (r(2) = 0.21, p < 0.01) and regularity along the frontal (anteroposterior) and lateral (mediolateral) axes (r(2) = 0.16, p < 0.05 and r(2) = 0.12, p < 0.05 respectively). Together, the three variables explained 46% of the inter-subject variance (p < 0.001) with a standard error of estimate of 0.30 J/m/kg. WCost(min) and regularity along the frontal and lateral axes were related to age (WCost(min): r(2) = 0.44, p < 0.001; regularity: r(2) = 0.16, p < 0.05 and r(2) = 0.12, p < 0.05 respectively frontal and lateral). Conclusions The age associated decline in walking economy is induced by the adoption of an increased gait rate and by irregular body acceleration in the horizontal plane.	[Valenti, Giulio; Westerterp, Klaas R.] Maastricht Univ, Dept Human Biol, Maastricht, Netherlands; [Bonomi, Alberto G.] Philips Res Labs, Personal Hlth Solut, Eindhoven, Netherlands	Maastricht University; Philips; Philips Research	Valenti, G (corresponding author), Maastricht Univ, Dept Human Biol, Maastricht, Netherlands.	g.valenti@maastrichtuniversity.nl			Maastricht University; Philips Research Laboratories	Maastricht University; Philips Research Laboratories	Maastricht University provided support in the form of materials and salaries for GV and KRW but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Philips Research Laboratories provided support in the form of salaries for AGB but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of the authors are articulated in the "author contributions" section. The clinical trial was not sponsored by Philips Research Laboratories.	Allor KM, 2000, J APPL PHYSIOL, V89, P512, DOI 10.1152/jappl.2000.89.2.512; Bastien GJ, 2005, EUR J APPL PHYSIOL, V94, P76, DOI 10.1007/s00421-004-1286-z; Bernardi M, 1999, J ELECTROMYOGR KINES, V9, P149, DOI 10.1016/S1050-6411(98)00046-7; Brooks VB, 1986, NEURAL BASIS MOTOR C, pxiv; BROUWER E, 1957, ACTA PHYSIOL PHARM N, V6, P795; Callisaya ML, 2010, AGE AGEING, V39, P191, DOI 10.1093/ageing/afp250; Dadashi F, 2014, SENSORS-BASEL, V14, P443, DOI 10.3390/s140100443; Dingwell JB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124879; Doi T, 2013, J NEUROENG REHABIL, V10, DOI 10.1186/1743-0003-10-7; Ejupi A, 2014, CURR OPIN CLIN NUTR, V17, P407, DOI 10.1097/MCO.0000000000000081; Fritz S, 2009, J GERIATR PHYS THER, V32, P2, DOI 10.1519/00139143-200932020-00002; Garcia-Pinillos F, 2016, PSYCHOGERIATRICS, V16, P165, DOI 10.1111/psyg.12133; Gill T, 2005, GERONTOLOGY, V51, P340, DOI 10.1159/000086372; GURALNIK JM, 1995, NEW ENGL J MED, V332, P556, DOI 10.1056/NEJM199503023320902; Hausdorff JM, 2001, ARCH PHYS MED REHAB, V82, P1050, DOI 10.1053/apmr.2001.24893; Kang HG, 2008, GAIT POSTURE, V27, P572, DOI 10.1016/j.gaitpost.2007.07.009; Kavanagh J, 2006, EXP BRAIN RES, V172, P454, DOI 10.1007/s00221-006-0353-6; Keevil VL, 2015, P NUTR SOC, V74, P337, DOI 10.1017/S0029665115002037; Kobsar D, 2014, GAIT POSTURE, V39, P553, DOI 10.1016/j.gaitpost.2013.09.008; LARISH DD, 1988, ANN NY ACAD SCI, V515, P18, DOI 10.1111/j.1749-6632.1988.tb32960.x; Lee RYW, 2011, AGE AGEING, V40, P690, DOI [10.1093/ageing/afr050, 10.1155/2011/653570]; Malatesta D, 2003, J APPL PHYSIOL, V95, P2248, DOI 10.1152/japplphysiol.01106.2002; MARTIN PE, 1992, J APPL PHYSIOL, V73, P200; Menz HB, 2003, AGE AGEING, V32, P137, DOI 10.1093/ageing/32.2.137; Mian OS, 2006, ACTA PHYSIOL, V186, P127, DOI 10.1111/j.1748-1716.2006.01522.x; Montero-Odasso M, 2011, J GERONTOL A-BIOL, V66, P568, DOI 10.1093/gerona/glr007; Niazmand K, 2010, IEEE ENG MED BIO, P6377, DOI 10.1109/IEMBS.2010.5627298; OLOUGHLIN JL, 1993, AM J EPIDEMIOL, V137, P342, DOI 10.1093/oxfordjournals.aje.a116681; Peterson DS, 2010, GAIT POSTURE, V31, P355, DOI 10.1016/j.gaitpost.2009.12.005; RALSTON H J, 1958, Int Z Angew Physiol, V17, P277; Richardson CA, 2015, J GERONTOL A-BIOL, V70, P487, DOI 10.1093/gerona/glu146; Rispens SM, 2015, NEUROREHAB NEURAL RE, V29, P54, DOI 10.1177/1545968314532031; Riva F, 2013, GAIT POSTURE, V37, P1, DOI 10.1016/j.gaitpost.2012.06.015; ROSE J, 1993, ARCH PHYS MED REHAB, V74, P702, DOI 10.1016/0003-9993(93)90029-A; Schrack JA, 2012, J AM GERIATR SOC, V60, P1811, DOI 10.1111/j.1532-5415.2012.04153.x; Sim SY, 2011, IEEE ENG MED BIO, P4935, DOI 10.1109/IEMBS.2011.6091223; Smith S.W., 1997, SCI ENG GUIDE DIGITA, V14; Studenski S, 2011, JAMA-J AM MED ASSOC, V305, P50, DOI 10.1001/jama.2010.1923; Tang PF, 1998, J GERONTOL A-BIOL, V53, pM471, DOI 10.1093/gerona/53A.6.M471; TINETTI ME, 1988, NEW ENGL J MED, V319, P1701, DOI 10.1056/NEJM198812293192604; Toebes MJP, 2012, GAIT POSTURE, V36, P527, DOI 10.1016/j.gaitpost.2012.05.016; van Schooten KS, 2013, J BIOMECH, V46, P137, DOI 10.1016/j.jbiomech.2012.10.032; VanSwearingen JM, 2014, J GERONTOL A-BIOL, V69, P1429, DOI 10.1093/gerona/glu153; Verghese J, 2009, J GERONTOL A-BIOL, V64, P896, DOI 10.1093/gerona/glp033; WATERS R L, 1983, Journal of Orthopaedic Research, V1, P73, DOI 10.1002/jor.1100010110; Waters RL, 1999, GAIT POSTURE, V9, P207, DOI 10.1016/S0966-6362(99)00009-0	46	5	5	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2015	10	10							e0141431	10.1371/journal.pone.0141431	http://dx.doi.org/10.1371/journal.pone.0141431			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CV0ED	26512982	gold, Green Published, Green Submitted			2022-12-26	WOS:000363920300039
J	Kumar, A; Henrissat, B; Arvas, M; Syed, MF; Thieme, N; Benz, JP; Sorensen, JL; Record, E; Poggeler, S; Kempken, F				Kumar, Abhishek; Henrissat, Bernard; Arvas, Mikko; Syed, Muhammad Fahad; Thieme, Nils; Benz, J. Philipp; Sorensen, Jens Laurids; Record, Eric; Poeggeler, Stefanie; Kempken, Frank			De Novo Assembly and Genome Analyses of the Marine-Derived Scopulariopsis brevicaulis Strain LF580 Unravels Life-Style Traits and Anticancerous Scopularide Biosynthetic Gene Cluster	PLOS ONE			English	Article							SEQUENCE SIMILARITY; NATURAL-PRODUCTS; FAMILY; DATABASE; FUNGUS; IDENTIFICATION; EXPRESSION; EVOLUTION; ANNOTATION; DISCOVERY	The marine-derived Scopulariopsis brevicaulis strain LF580 produces scopularides A and B, which have anticancerous properties. We carried out genome sequencing using three next-generation DNA sequencing methods. De novo hybrid assembly yielded 621 scaffolds with a total size of 32.2 Mb and 16298 putative gene models. We identified a large non-ribosomal peptide synthetase gene (nrps1) and supporting pks2 gene in the same biosynthetic gene cluster. This cluster and the genes within the cluster are functionally active as confirmed by RNA-Seq. Characterization of carbohydrate-active enzymes and major facilitator superfamily (MFS)-type transporters lead to postulate S. brevicaulis originated from a soil fungus, which came into contact with the marine sponge Tethya aurantium. This marine sponge seems to provide shelter to this fungus and micro-environment suitable for its survival in the ocean. This study also builds the platform for further investigations of the role of life-style and secondary metabolites from S. brevicaulis.	[Kumar, Abhishek; Kempken, Frank] Univ Kiel, Inst Bot, Dept Genet & Mol Biol Bot, Kiel, Germany; [Henrissat, Bernard] Aix Marseille Univ, Architecture & Fonct Macromol Biol, F-13288 Marseille, France; [Henrissat, Bernard] CNRS, UMR 7257, F-13288 Marseille, France; [Arvas, Mikko; Syed, Muhammad Fahad] VTT Tech Res Ctr Finland Ltd, FI-02044 Espoo, Finland; [Syed, Muhammad Fahad] Biocomp Platforms Ltd, FI-02150 Espoo, Finland; [Thieme, Nils; Benz, J. Philipp] Tech Univ Munich, TUM Sch Life Sci Weihenstephan, Holzforsch Munchen, Freising Weihenstephan, Germany; [Sorensen, Jens Laurids] Aalborg Univ, Dept Chem & Biosci, DK-6700 Esbjerg, Denmark; [Record, Eric] Aix Marseille Univ, INRA, Biotechnol Champignons Filamenteux UMR1163, Polytech Marseille, F-13288 Marseille 09, France; [Record, Eric] Aix Marseille Univ, INRA, Biotechnol Champignons Filamenteux UMR1163, Fac Sci,Luminy Polytech, F-13288 Marseille 09, France; [Poeggeler, Stefanie] Univ Gottingen, Inst Microbiol & Genet, Dept Genet Eukaryot Microorganisms, D-37073 Gottingen, Germany	University of Kiel; UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; VTT Technical Research Center Finland; Technical University of Munich; Aalborg University; INRAE; UDICE-French Research Universities; Aix-Marseille Universite; INRAE; UDICE-French Research Universities; Aix-Marseille Universite; University of Gottingen	Kempken, F (corresponding author), Univ Kiel, Inst Bot, Dept Genet & Mol Biol Bot, Olshausenstr 40, Kiel, Germany.	fkempken@bot.uni-kiel.de	Benz, J. Philipp/ABG-5009-2020; Henrissat, Bernard/J-2475-2012; Arvas, Mikko/AAA-7438-2021; Sørensen, Jens Laurids/L-8358-2013; Record, Eric/AAL-4275-2020; Kumar, Abhishek/A-8727-2012	Benz, J. Philipp/0000-0001-5361-4514; Henrissat, Bernard/0000-0002-3434-8588; Arvas, Mikko/0000-0002-6902-8488; Sørensen, Jens Laurids/0000-0002-2392-5343; Kempken, Frank/0000-0002-7853-8009; Record, Eric/0000-0002-7545-9997; Thieme, Nils/0000-0003-3405-5563; Kumar, Abhishek/0000-0003-4172-4059	European Union Seventh Framework Program FP7 [265926]	European Union Seventh Framework Program FP7	Funded by European Union Seventh Framework Program FP7/2007-2013 under grant agreement number 265926.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Apeltsin L, 2011, BIOINFORMATICS, V27, P326, DOI 10.1093/bioinformatics/btq655; Arvas M, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-325; Bachmann BO, 2009, COMPLEX ENZYMES IN M; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bayry J, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002700; Bey M, 2013, APPL ENVIRON MICROB, V79, P488, DOI 10.1128/AEM.02942-12; Blin K, 2013, NUCLEIC ACIDS RES, V41, pW204, DOI 10.1093/nar/gkt449; Brakhage AA, 2013, NAT REV MICROBIOL, V11, P21, DOI 10.1038/nrmicro2916; Bugni TS, 2004, NAT PROD REP, V21, P143, DOI 10.1039/b301926h; Chiang YM, 2008, CHEM BIOL, V15, P527, DOI 10.1016/j.chembiol.2008.05.010; Cox R, 1997, P NATL ACAD SCI USA, V94, P5237, DOI 10.1073/pnas.94.10.5237; Cuenca-Estrella M, 2003, ANTIMICROB AGENTS CH, V47, P2339, DOI 10.1128/AAC.47.7.2339-2341.2003; Culligan E, 2013, VIRULENCE, V5, P1; Debuchy R, 2006, MYCOTA, P293, DOI DOI 10.1007/3-540-28135-5_15; Dubey MK, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-18; Duressa Dechassa, 2013, BMC Genomics, V14, P607, DOI 10.1186/1471-2164-14-607; Dyer Paul S., 2007, P123; Ebada SS, 2013, MARINE PHARMACOGNOSY: TRENDS AND APPLICATIONS, P27; Enright AJ, 2002, NUCLEIC ACIDS RES, V30, P1575, DOI 10.1093/nar/30.7.1575; Finn RD, 2011, NUCLEIC ACIDS RES, V39, pW29, DOI 10.1093/nar/gkr367; Fraser JA, 2004, MOL MICROBIOL, V51, P299, DOI 10.1046/j.1365-2958.2003.03874.x; Galagan JE, 2005, NATURE, V438, P1105, DOI 10.1038/nature04341; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Hancock JM, 2002, GENETICA, V115, P93, DOI 10.1023/A:1016028332006; Hansen FT, 2014, FUNGAL GENETICS AND; Harris PV, 2010, BIOCHEMISTRY-US, V49, P3305, DOI 10.1021/bi100009p; Hemsworth GR, 2014, NAT CHEM BIOL, V10, P122, DOI 10.1038/nchembio.1417; Hunter S, 2012, NUCLEIC ACIDS RES, V40, pD306, DOI 10.1093/nar/gkr948; Imhoff JF, 2010, Patent WO, Patent No. [2010/142258, 2010142258]; Jones EBG, 2011, BOT MAR, V54, P343, DOI 10.1515/BOT.2011.043; Kanehisa M, 2010, NUCLEIC ACIDS RES, V38, pD355, DOI 10.1093/nar/gkp896; Keller NP, 2005, NAT REV MICROBIOL, V3, P937, DOI 10.1038/nrmicro1286; Kempken F, 1996, MOL CELL BIOL, V16, P6563; Khaldi N, 2010, FUNGAL GENET BIOL, V47, P736, DOI 10.1016/j.fgb.2010.06.003; King N, 2008, NATURE, V451, P783, DOI 10.1038/nature06617; Kis-Papo T, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4745; Knudsen T, 2013, CLC GENOMICS BENCHWO, V6; Kollath-Leiss K, 2014, EUKARYOT CELL, V13, P1051, DOI 10.1128/EC.00061-14; Konig GM, 2006, CHEMBIOCHEM, V7, P229, DOI 10.1002/cbic.200500087; Kramer A, 2015, PLOS ONE UNDER REVIS; Kramer A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103320; Kuck U, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003950; Kumar A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086012; Levasseur A, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-486; Levasseur A, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-41; Linda P, 2015, FUNGAL TRANSPOSABLE; Lo Leggio L, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6961; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Lukassen MB, 2015, MAR DRUGS, V13, P4331, DOI 10.3390/md13074331; Marchler-Bauer Aron, 2011, Nucleic Acids Res, V39, pD225, DOI 10.1093/nar/gkq1189; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Martin F, 2010, NATURE, V464, P1033, DOI 10.1038/nature08867; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Mora C, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000606; NEWTON GGF, 1955, NATURE, V175, P548, DOI 10.1038/175548a0; Nowrousian M, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000891; Ohm RA, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003037; Pao SS, 1998, MICROBIOL MOL BIOL R, V62, P1; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Phillips CM, 2011, ACS CHEM BIOL, V6, P1399, DOI 10.1021/cb200351y; Plett JM, 2012, FUNGAL GENET BIOL, V49, P199, DOI 10.1016/j.fgb.2012.01.002; Poggeler S, 2004, EUKARYOT CELL, V3, P232, DOI 10.1128/EC.3.1.232-240.2004; Qi J, 2004, J MOL EVOL, V58, P1, DOI 10.1007/s00239-003-2493-7; R Development Core Team RDC, 2013, R A LANGUAGE AND ENV; Rateb ME, 2011, NAT PROD REP, V28, P290, DOI 10.1039/c0np00061b; Rydholm C, 2007, EUKARYOT CELL, V6, P868, DOI 10.1128/EC.00319-06; Saier MH, 2006, NUCLEIC ACIDS RES, V34, pD181, DOI 10.1093/nar/gkj001; Saleem M, 2007, NAT PROD REP, V24, P1142, DOI 10.1039/b607254m; Schippers KJ, 2012, ADV MAR BIOL, V62, P273, DOI 10.1016/B978-0-12-394283-8.00006-0; Sorensen JL, 2014, FUNG BIOL-US, P317, DOI 10.1007/978-1-4939-1191-2_15; Sorensen JL, 2014, J NAT PROD, V77, P2619, DOI 10.1021/np500436r; Tamminen A, 2014, MICROB CELL FACT, V13, DOI 10.1186/1475-2859-13-89; Tobiasen C, 2007, CURR GENET, V51, P43, DOI 10.1007/s00294-006-0103-0; Traeger S, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003820; Veeramachaneni V, 2004, GENOME RES, V14, P1160, DOI 10.1101/gr.2079204; Vidotto M, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-407; Vu VV, 2014, P NATL ACAD SCI USA, V111, P13822, DOI 10.1073/pnas.1408090111; Walmsley AR, 1998, TRENDS BIOCHEM SCI, V23, P476, DOI 10.1016/S0968-0004(98)01326-7; Wang H, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-195; Wickerham LJ, 1951, TAXONOMY OF YEASTS U; Wiese J, 2011, MAR DRUGS, V9, P561, DOI 10.3390/md9040561; Xu Z, 2009, NUCLEIC ACIDS RES, V37, pW174, DOI 10.1093/nar/gkp278; Yu ZG, 2008, J NAT PROD, V71, P1052, DOI 10.1021/np070580e	84	18	19	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2015	10	10							e0140398	10.1371/journal.pone.0140398	http://dx.doi.org/10.1371/journal.pone.0140398			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU8PC	26505484	gold, Green Submitted, Green Published			2022-12-26	WOS:000363804200009
J	Alayev, A; Salamon, RS; Berger, SM; Schwartz, NS; Cuesta, R; Snyder, RB; Holz, MK				Alayev, A.; Salamon, R. S.; Berger, S. M.; Schwartz, N. S.; Cuesta, R.; Snyder, R. B.; Holz, M. K.			mTORC1 directly phosphorylates and activates ER alpha upon estrogen stimulation	ONCOGENE			English	Article							BREAST-CANCER; RECEPTOR-ALPHA; TUBEROUS SCLEROSIS; MAMMALIAN TARGET; PHOSPHATIDYLINOSITOL 3-KINASE; ENDOCRINE-THERAPY; RAPAMYCIN TOR; CELL-GROWTH; EVEROLIMUS; RAPTOR	Breast cancer is the leading cause of cancer-related deaths among women. Approximately 75% of breast cancers are estrogen receptor-alpha (ER alpha) positive, underscoring the dependence of cancer cells on estrogen for growth and survival. Patients treated with endocrine therapy often develop resistance, either de novo or acquired, which in some cases is caused by aberrations within the growth factor signaling pathways. The mechanistic target of rapamycin complex 1 (mTORC1) has emerged as a critical node in estrogenic signaling. We have previously shown that mTORC1 can phosphorylate and activate ER alpha on S167 via its effector-the 40S ribosomal S6 kinase 1 (S6K1). Presently, we have uncovered a direct link between mTORC1 and ER alpha. We found that ERa binds to regulatory-associated protein of mTOR (Raptor) and causes it to translocate to the nucleus upon estrogen stimulation. In addition, we identified mTOR as the kinase that phosphorylates ERa on S104/106 and activates transcription of ER target genes. Our findings show a direct link between mTORC1 and ER alpha, which further implicates mTORC1 signaling in the pathogenesis of ER-positive breast cancer and provides rationale for FDA-approved use of mTORC1 inhibitors in combination with endocrine agents for treatment of this disease.	[Alayev, A.; Salamon, R. S.; Berger, S. M.; Schwartz, N. S.; Cuesta, R.; Snyder, R. B.; Holz, M. K.] Yeshiva Univ, Dept Biol, 245 Lexington Ave Bio 341, New York, NY 10016 USA; [Holz, M. K.] Albert Einstein Coll Med, Dept Mol Pharmacol, Bronx, NY 10467 USA; [Holz, M. K.] Albert Einstein Coll Med, Albert Einstein Canc Ctr, Bronx, NY 10467 USA	Yeshiva University; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Holz, MK (corresponding author), Yeshiva Univ, Dept Biol, 245 Lexington Ave Bio 341, New York, NY 10016 USA.	mholz@yu.edu			NIH [CA151112]; Atol Charitable Trust; LAM Foundation [098P0113]; American Cancer Society [RSG-13-287-01-TBE]; National Cancer Center; NATIONAL CANCER INSTITUTE [R15CA151112] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Atol Charitable Trust; LAM Foundation; American Cancer Society(American Cancer Society); National Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We acknowledge Dr Jonathan M Backer (Albert Einstein College of Medicine) for his help with the kinase assay and Adi Berman for excellent technical assistance. This work was supported by the NIH-CA151112; Atol Charitable Trust; LAM Foundation-098P0113; American Cancer Society-RSG-13-287-01-TBE ( all to MKH) and National Cancer Center-no grant number (to AA).	Alayev A, 2013, J CELL PHYSIOL, V228, P1658, DOI 10.1002/jcp.24351; Bachelot T, 2012, J CLIN ONCOL, V30, P2718, DOI 10.1200/JCO.2011.39.0708; Baselga J, 2012, NEW ENGL J MED, V366, P520, DOI 10.1056/NEJMoa1109653; Baselga J, 2009, J CLIN ONCOL, V27, P2630, DOI 10.1200/JCO.2008.18.8391; Campbell RA, 2001, J BIOL CHEM, V276, P9817, DOI 10.1074/jbc.M010840200; Chambliss KL, 2010, J CLIN INVEST, V120, P2319, DOI 10.1172/JCI38291; Chaveroux C, 2013, CELL METAB, V17, P586, DOI 10.1016/j.cmet.2013.03.003; Couse JF, 1999, ENDOCR REV, V20, P358, DOI 10.1210/er.20.3.358; Cunningham JT, 2007, NATURE, V450, P736, DOI 10.1038/nature06322; Ellis M, 2004, ONCOLOGIST, V9, P20, DOI 10.1634/theoncologist.9-suppl_3-20; Fingar DC, 2004, ONCOGENE, V23, P3151, DOI 10.1038/sj.onc.1207542; Fonseca BD, 2015, J BIOL CHEM, V290, P15996, DOI 10.1074/jbc.M114.621730; Garami A, 2003, MOL CELL, V11, P1457, DOI 10.1016/S1097-2765(03)00220-X; Generali D, 2008, CLIN CANCER RES, V14, P2673, DOI 10.1158/1078-0432.CCR-07-1046; Hara K, 2002, CELL, V110, P177, DOI 10.1016/S0092-8674(02)00833-4; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Holz MK, 2005, J BIOL CHEM, V280, P26089, DOI 10.1074/jbc.M504045200; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; James MJ, 2004, J BIOL CHEM, V279, P8911, DOI 10.1074/jbc.M307735200; Kim DH, 2003, MOL CELL, V11, P895, DOI 10.1016/S1097-2765(03)00114-X; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Land SC, 2007, J BIOL CHEM, V282, P20534, DOI 10.1074/jbc.M611782200; Le Romancer M, 2011, ENDOCR REV, V32, P597, DOI 10.1210/er.2010-0016; Long X, 2005, CURR BIOL, V15, P702, DOI 10.1016/j.cub.2005.02.053; Ma L, 2005, CELL, V121, P179, DOI 10.1016/j.cell.2005.02.031; Madak-Erdogan Z, 2014, MOL CANCER RES, V12, P714, DOI 10.1158/1541-7786.MCR-13-0588; Madak-Erdogan Z, 2011, MOL CELL BIOL, V31, P226, DOI 10.1128/MCB.00821-10; Manning BD, 2002, MOL CELL, V10, P151, DOI 10.1016/S1097-2765(02)00568-3; Martina JA, 2012, AUTOPHAGY, V8, P903, DOI 10.4161/auto.19653; Maruani DM, 2012, ONCOGENE, V31, P5073, DOI 10.1038/onc.2011.657; Miller TW, 2011, J CLIN ONCOL, V29, P4452, DOI 10.1200/JCO.2010.34.4879; Miller TW, 2010, J CLIN INVEST, V120, P2406, DOI 10.1172/JCI41680; Miller WR, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr2931; Oshiro N, 2007, J BIOL CHEM, V282, P20329, DOI 10.1074/jbc.M702636200; Paplomata E, 2014, THER ADV MED ONCOL, V6, P154, DOI 10.1177/1758834014530023; Paplomata E, 2013, BREAST CANCER RES TR, V140, P453, DOI 10.1007/s10549-013-2630-y; Paplomata E, 2013, THER CLIN RISK MANAG, V9, P27, DOI 10.2147/TCRM.S30349; Peterson TR, 2009, CELL, V137, P873, DOI 10.1016/j.cell.2009.03.046; Petz LN, 2002, ENDOCRINOLOGY, V143, P4583, DOI 10.1210/en.2002-220369; Piccart M, 2014, ANN ONCOL, V25, P2357, DOI 10.1093/annonc/mdu456; Potter CJ, 2002, NAT CELL BIOL, V4, P658, DOI 10.1038/ncb840; Roux PP, 2004, P NATL ACAD SCI USA, V101, P13489, DOI 10.1073/pnas.0405659101; Sancak Y, 2007, MOL CELL, V25, P903, DOI 10.1016/j.molcel.2007.03.003; Schaim SS, 2003, CURR BIOL, V13, P797, DOI 10.1016/S0960-9822(03)00329-4; Schalm SS, 2002, CURR BIOL, V12, P632, DOI 10.1016/S0960-9822(02)00762-5; Shou J, 2004, JNCI-J NATL CANCER I, V96, P926, DOI 10.1093/jnci/djh166; Tee AR, 2003, J BIOL CHEM, V278, P37288, DOI 10.1074/jbc.M303257200; Thomas RS, 2008, J MOL ENDOCRINOL, V40, P173, DOI 10.1677/JME-07-0165; Vander Haar E, 2007, NAT CELL BIOL, V9, P316, DOI 10.1038/ncb1547; Yamashita H, 2005, BREAST CANCER RES, V7, pR753, DOI 10.1186/bcr1285; Yamashita H, 2008, ENDOCR-RELAT CANCER, V15, P755, DOI 10.1677/ERC-08-0078; Yamnik RL, 2010, FEBS LETT, V584, P124, DOI 10.1016/j.febslet.2009.11.041; Yamnik RL, 2009, J BIOL CHEM, V284, P6361, DOI 10.1074/jbc.M807532200; Yokogami K, 2000, CURR BIOL, V10, P47, DOI 10.1016/S0960-9822(99)00268-7; Yu J, 2006, CANCER RES, V66, P9461, DOI 10.1158/0008-5472.CAN-06-1895; Zhang Y, 2003, NAT CELL BIOL, V5, P578, DOI 10.1038/ncb999	56	47	47	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 7	2016	35	27					3535	3543		10.1038/onc.2015.414	http://dx.doi.org/10.1038/onc.2015.414			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DR0UD	26522726	Green Accepted			2022-12-26	WOS:000379621500006
J	Thomas, LR; Foshage, AM; Weissmiller, AM; Popay, TM; Grieb, BC; Qualls, SJ; Ng, V; Carboneau, B; Lorey, S; Eischen, CM; Tansey, WP				Thomas, L. R.; Foshage, A. M.; Weissmiller, A. M.; Popay, T. M.; Grieb, B. C.; Qualls, S. J.; Ng, V.; Carboneau, B.; Lorey, S.; Eischen, C. M.; Tansey, W. P.			Interaction of MYC with host cell factor-1 is mediated by the evolutionarily conserved Myc box IV motif	ONCOGENE			English	Article							DNA-BINDING; C-MYC; PROTEIN; VP16; COMPLEX; HCF; ASSOCIATION; RECRUITMENT; FORMS	The MYC family of oncogenes encodes a set of three related transcription factors that are overexpressed in many human tumors and contribute to the cancer-related deaths of more than 70,000 Americans every year. MYC proteins drive tumorigenesis by interacting with co-factors that enable them to regulate the expression of thousands of genes linked to cell growth, proliferation, metabolism and genome stability. One effective way to identify critical co-factors required for MYC function has been to focus on sequence motifs within MYC that are conserved throughout evolution, on the assumption that their conservation is driven by protein-protein interactions that are vital for MYC activity. In addition to their DNA-binding domains, MYC proteins carry five regions of high sequence conservation known as Myc boxes (Mb). To date, four of the Mb motifs (MbI, MbII, MbIIIa and MbIIIb) have had a molecular function assigned to them, but the precise role of the remaining Mb, MbIV, and the reason for its preservation in vertebrate Myc proteins, is unknown. Here, we show that MbIV is required for the association of MYC with the abundant transcriptional coregulator host cell factor-1 (HCF-1). We show that the invariant core of MbIV resembles the tetrapeptide HCF-binding motif (HBM) found in many HCF-interaction partners, and demonstrate that MYC interacts with HCF-1 in a manner indistinguishable from the prototypical HBM-containing protein VP16. Finally, we show that rationalized point mutations in MYC that disrupt interaction with HCF-1 attenuate the ability of MYC to drive tumorigenesis in mice. Together, these data expose a molecular function for MbIV and indicate that HCF-1 is an important co-factor for MYC.	[Thomas, L. R.; Foshage, A. M.; Weissmiller, A. M.; Popay, T. M.; Qualls, S. J.; Ng, V.; Lorey, S.; Tansey, W. P.] Vanderbilt Univ, Sch Med, Dept Cell & Dev Biol, 465 21st Ave S 4140 MRB 3, Nashville, TN 37232 USA; Vanderbilt Univ, Vanderbilt Int Scholar Program, 221 Kirkland Hall, Nashville, TN 37235 USA; Vanderbilt Univ, Dept Pathol Microbiol & Immunol, Sch Med, 221 Kirkland Hall, Nashville, TN 37235 USA; Vanderbilt Univ, Sch Med, Dept Mol Physiol & Biophys, 221 Kirkland Hall, Nashville, TN 37235 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Tansey, WP (corresponding author), Vanderbilt Univ, Sch Med, Dept Cell & Dev Biol, 465 21st Ave S 4140 MRB 3, Nashville, TN 37232 USA.	william.p.tansey@vanderbilt.edu		Popay, Tessa/0000-0002-4694-8804; Ng, Victoria/0000-0003-2344-8468; Grieb, Brian/0000-0003-3980-8050; Weissmiller, April/0000-0003-4505-0530	Edward P. Evans Foundation; Melanoma Research Foundation; Vanderbilt Ingram Cancer Center Support grant [NIH: CA68485]; NCI SPORE in Breast Cancer [P50 CA098131]; Cellular, Biochemical, and Molecular Sciences Training Program [T32 GM008554]; Integrated Biological Systems Training in Oncology Program [T32 CA119925]; National Center for Advancing Translational Sciences [UL1 TR000445]; Vanderbilt International Scholar Program; National Institutes of Health [R01CA148950, F30AG039164]; NATIONAL CANCER INSTITUTE [P30CA068485, T32CA119925, P50CA098131, R01CA148950, R01CA200709] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000445] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008554] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [F30AG039164] Funding Source: NIH RePORTER	Edward P. Evans Foundation; Melanoma Research Foundation; Vanderbilt Ingram Cancer Center Support grant; NCI SPORE in Breast Cancer; Cellular, Biochemical, and Molecular Sciences Training Program; Integrated Biological Systems Training in Oncology Program; National Center for Advancing Translational Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Vanderbilt International Scholar Program; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank S Dey, S Hiebert, H McDonald, L Neitzel and A Wilson for reagents, experimental assistance and advice. This work was supported by the Edward P. Evans Foundation (to WPT), the Melanoma Research Foundation (to WPT), the Vanderbilt Ingram Cancer Center Support grant (NIH: CA68485), the NCI SPORE in Breast Cancer (P50 CA098131), the Cellular, Biochemical, and Molecular Sciences Training Program (T32 GM008554), the Integrated Biological Systems Training in Oncology Program (T32 CA119925), the National Center for Advancing Translational Sciences (UL1 TR000445), the Vanderbilt International Scholar Program and grants R01CA148950 (to CME) and F30AG039164 (to BCG) from the National Institutes of Health.	BLACKWOOD EM, 1991, SCIENCE, V251, P1211, DOI 10.1126/science.2006410; Cai Y, 2010, J BIOL CHEM, V285, P4268, DOI 10.1074/jbc.C109.087981; Cowling VH, 2006, MOL CELL BIOL, V26, P4226, DOI 10.1128/MCB.01959-05; Dingar D, 2015, J PROTEOMICS, V118, P95, DOI 10.1016/j.jprot.2014.09.029; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Freiman RN, 1997, GENE DEV, V11, P3122, DOI 10.1101/gad.11.23.3122; Furrer M, 2010, J BIOL CHEM, V285, P39623, DOI 10.1074/jbc.M110.140467; Goto H, 1997, GENE DEV, V11, P726, DOI 10.1101/gad.11.6.726; Kurland JF, 2008, CANCER RES, V68, P3624, DOI 10.1158/0008-5472.CAN-07-6552; Luciano RL, 2003, J BIOL CHEM, V278, P51116, DOI 10.1074/jbc.M303470200; Mahajan SS, 2000, MOL CELL BIOL, V20, P919, DOI 10.1128/MCB.20.3.919-928.2000; McMahon SB, 1998, CELL, V94, P363, DOI 10.1016/S0092-8674(00)81479-8; Meyer N, 2008, NAT REV CANCER, V8, P976, DOI 10.1038/nrc2231; Misaghi S, 2009, MOL CELL BIOL, V29, P2181, DOI 10.1128/MCB.01517-08; Tansey W.P., 2014, NEW J SCI, V2014, P1; Thomas LR, 2015, MOL CELL, V58, P440, DOI 10.1016/j.molcel.2015.02.028; Thomas LR, 2015, J SCI TECHNOL, V3; Vogel JL, 2013, VIRUSES-BASEL, V5, P1272, DOI 10.3390/v5051272; Wang YL, 2008, J BIOL CHEM, V283, P33808, DOI 10.1074/jbc.M806936200; Welcker M, 2004, P NATL ACAD SCI USA, V101, P9085, DOI 10.1073/pnas.0402770101; WILSON AC, 1993, CELL, V74, P115, DOI 10.1016/0092-8674(93)90299-6; Yokoyama A, 2004, MOL CELL BIOL, V24, P5639, DOI 10.1128/MCB.24.13.5639-5649.2004; Zargar ZU, 2012, TRANSCR-AUSTIN, V3, P187, DOI 10.4161/trns.20711	23	19	19	1	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 7	2016	35	27					3613	3618		10.1038/onc.2015.416	http://dx.doi.org/10.1038/onc.2015.416			6	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DR0UD	26522729	Green Accepted			2022-12-26	WOS:000379621500014
J	Chauss, D; Brennan, LA; Bakina, O; Kantorow, M				Chauss, Daniel; Brennan, Lisa A.; Bakina, Olga; Kantorow, Marc			Integrin alpha V beta 5-mediated Removal of Apoptotic Cell Debris by the Eye Lens and Its Inhibition by UV Light Exposure	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ROD OUTER SEGMENTS; IN-VIVO EXPOSURE; EPITHELIAL-CELLS; ULTRAVIOLET-LIGHT; MITOCHONDRIAL-FUNCTION; OXIDATIVE STRESS; NUCLEAR CATARACT; ALPHA-CRYSTALLIN; VISION LOSS; RAT LENS	Accumulation of apoptotic material is toxic and associated with cataract and other disease states. Identification of mechanisms that prevent accumulation of apoptotic debris is important for establishing the etiology of these diseases. The ocular lens is routinely assaulted by UV light that causes lens cell apoptosis and is associated with cataract formation. To date, no molecular mechanism for removal of toxic apoptotic debris has been identified in the lens. Vesicular debris within lens cells exposed to UV light has been observed raising speculation that lens cells themselves could act as phagocytes to remove toxic apoptotic debris. However, phagocytosis has not been confirmed as a function of the intact eye lens, and no mechanism for lens phagocytosis has been established. Here, we demonstrate that the eye lens is capable of phagocytizing extracellular lens cell debris. Using high throughput RNA sequencing and bioinformatics analysis, we establish that lens epithelial cells express members of the integrin alpha V beta 5-mediated phagocytosis pathway and that internalized cell debris co-localizes with alpha V beta 5 and with RAB7 and Rab-interacting lysosomal protein that are required for phagosome maturation and fusion with lysosomes. We demonstrate that the alpha V beta 5 receptor is required for lens epithelial cell phagocytosis and that UV light treatment of lens epithelial cells results in damage to the alpha V beta 5 receptor with concomitant loss of phagocytosis. These data suggest that loss of alpha V beta 5-mediated phagocytosis by the eye lens could result in accumulation of toxic cell debris that could contribute to UV light-induced cataract formation.	[Chauss, Daniel; Brennan, Lisa A.; Bakina, Olga; Kantorow, Marc] Florida Atlantic Univ, Charles E Schmidt Coll Med, Boca Raton, FL 33431 USA	State University System of Florida; Florida Atlantic University	Kantorow, M (corresponding author), Florida Atlantic Univ, Charles E Schmidt Coll Med, 777 Glades Rd, Boca Raton, FL 33431 USA.	mkantoro@health.fau.edu		Chauss, Daniel/0000-0002-8343-0860	National Institutes of Health from NEI [EY13022]; NATIONAL EYE INSTITUTE [R01EY013022] Funding Source: NIH RePORTER	National Institutes of Health from NEI; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by National Institutes of Health Grant EY13022 from NEI (to M. K.) and a gift from The Rand Eye Institute, Deerfield Beach, FL (to M. K.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abraham Alison G, 2006, Ophthalmol Clin North Am, V19, P415; Abraham AG, 2010, INVEST OPHTH VIS SCI, V51, P3919, DOI 10.1167/iovs.09-4557; Aderem A, 1999, ANNU REV IMMUNOL, V17, P593, DOI 10.1146/annurev.immunol.17.1.593; Akakura S, 2004, EXP CELL RES, V292, P403, DOI 10.1016/j.yexcr.2003.09.011; Albert ML, 2000, NAT CELL BIOL, V2, P899, DOI 10.1038/35046549; Andley UP, 2008, INT J BIOCHEM CELL B, V40, P317, DOI 10.1016/j.biocel.2007.10.034; Balasubramanian D., 2000, J OCUL PHARMACOL TH, V16, P285; Bassnett S, 2011, PHILOS T R SOC B, V366, P1250, DOI 10.1098/rstb.2010.0302; Basu S, 2014, AUTOPHAGY, V10, P1193, DOI 10.4161/auto.28768; Bhat SP, 2001, BIOSCIENCE REP, V21, P537, DOI 10.1023/A:1017952128502; Borchman D, 2010, J LIPID RES, V51, P2473, DOI 10.1194/jlr.R004119; Bourne RRA, 2014, BRIT J OPHTHALMOL, V98, P629, DOI 10.1136/bjophthalmol-2013-304033; Brennan LA, 2009, MOL VIS, V15, P985; Brennan LA, 2009, BBA-GEN SUBJECTS, V1790, P1665, DOI 10.1016/j.bbagen.2009.08.011; Brennan LA, 2009, EXP EYE RES, V88, P195, DOI 10.1016/j.exer.2008.05.018; Brennan LA, 2012, MOL VIS, V18, P1773; Brennan Lisa Ann, 2012, Front Biosci (Elite Ed), V4, P141; Cantalupo G, 2001, EMBO J, V20, P683, DOI 10.1093/emboj/20.4.683; Chandler HL, 2010, INVEST OPHTH VIS SCI, V51, P172, DOI 10.1167/iovs.09-3996; Chauss D, 2014, G3-GENES GENOM GENET, V4, P1515, DOI 10.1534/g3.114.012120; Costello MJ, 2013, EXP EYE RES, V116, P141, DOI 10.1016/j.exer.2013.08.017; CRUICKSHANKS KJ, 1992, AM J PUBLIC HEALTH, V82, P1658, DOI 10.2105/AJPH.82.12.1658; Dawes LJ, 2007, MOL VIS, V13, P1181; Delamere NA, 2009, EXP EYE RES, V88, P140, DOI 10.1016/j.exer.2008.05.005; Erwig LP, 2008, CELL DEATH DIFFER, V15, P243, DOI 10.1038/sj.cdd.4402184; Finneman SC, 2001, J EXP MED, V194, P1289, DOI 10.1084/jem.194.9.1289; Finnemann SC, 1997, P NATL ACAD SCI USA, V94, P12932, DOI 10.1073/pnas.94.24.12932; Finnemann SC, 1999, J EXP MED, V190, P861, DOI 10.1084/jem.190.6.861; Flannagan RS, 2012, ANNU REV PATHOL-MECH, V7, P61, DOI 10.1146/annurev-pathol-011811-132445; Foukas LC, 1998, J BIOL CHEM, V273, P14813, DOI 10.1074/jbc.273.24.14813; Gagen D., 2003, INVEST OPHTH VIS SCI, V54, P5000; Galichanin K, 2010, EXP EYE RES, V91, P369, DOI 10.1016/j.exer.2010.06.009; Giblin FJ, 2000, J OCUL PHARMACOL TH, V16, P121, DOI 10.1089/jop.2000.16.121; Giblin FJ, 2011, INVEST OPHTH VIS SCI, V52, P3667, DOI 10.1167/iovs.10-6885; Grimsley C, 2003, TRENDS CELL BIOL, V13, P648, DOI 10.1016/j.tcb.2003.10.004; Hawse JR, 2005, MOL VIS, V11, P274; HIGHTOWER KR, 1995, CURR EYE RES, V14, P71, DOI 10.3109/02713689508999916; Hochreiter-Hufford A, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a008748; HORWITZ J, 1992, P NATL ACAD SCI USA, V89, P10449, DOI 10.1073/pnas.89.21.10449; Ibaraki N, 1998, EXP EYE RES, V67, P577, DOI 10.1006/exer.1998.0551; Juncadella IJ, 2013, NATURE, V493, P547, DOI 10.1038/nature11714; Kinchen JM, 2008, NAT REV MOL CELL BIO, V9, P781, DOI 10.1038/nrm2515; Kronschlager M, 2013, CURR EYE RES, V38, P880, DOI 10.3109/02713683.2013.783079; Labuzek K, 2010, N-S ARCH PHARMACOL, V381, P171, DOI 10.1007/s00210-009-0477-x; Lekstrom-Himes JA, 2000, NEW ENGL J MED, V343, P1703, DOI 10.1056/NEJM200012073432307; LESKE MC, 1991, ARCH OPHTHALMOL-CHIC, V109, P244, DOI 10.1001/archopht.1991.01080020090051; LI WC, 1995, J CELL BIOL, V130, P169, DOI 10.1083/jcb.130.1.169; Li W, 2013, AGEING RES REV, V12, P1005, DOI 10.1016/j.arr.2013.05.006; Lin H, 1998, INVEST OPHTH VIS SCI, V39, P1703; Liu K, 2015, P NATL ACAD SCI USA, V112, P1071, DOI 10.1073/pnas.1404059112; Lou MF, 2003, PROG RETIN EYE RES, V22, P657, DOI 10.1016/S1350-9462(03)00050-8; Luzio JP, 2000, J CELL SCI, V113, P1515; Mamuya FA, 2014, J CELL MOL MED, V18, P656, DOI 10.1111/jcmm.12213; MATTEONI R, 1987, J CELL BIOL, V105, P1253, DOI 10.1083/jcb.105.3.1253; McGreal RS, 2012, BBA-GEN SUBJECTS, V1820, P921, DOI 10.1016/j.bbagen.2012.04.004; MENKO AS, 1984, DEV BIOL, V103, P129, DOI 10.1016/0012-1606(84)90014-9; Mesa R, 2013, INVEST OPHTH VIS SCI, V54, P6789, DOI 10.1167/iovs.13-12644; Meyer LM, 2014, ACTA OPHTHALMOL, V92, P635, DOI 10.1111/aos.12376; Meyer LM, 2009, EXP EYE RES, V89, P833, DOI 10.1016/j.exer.2009.07.020; Michael R, 1998, INVEST OPHTH VIS SCI, V39, P2681; Michael R, 2011, PHILOS T R SOC B, V366, P1278, DOI 10.1098/rstb.2010.0300; Monks J, 2005, CELL DEATH DIFFER, V12, P107, DOI 10.1038/sj.cdd.4401517; Moreau KL, 2012, TRENDS MOL MED, V18, P273, DOI 10.1016/j.molmed.2012.03.005; Munoz LE, 2010, NAT REV RHEUMATOL, V6, P280, DOI 10.1038/nrrheum.2010.46; Nakaya M, 2006, J BIOL CHEM, V281, P8836, DOI 10.1074/jbc.M510972200; Petersen A, 2007, CURR EYE RES, V32, P871, DOI 10.1080/02713680701642327; Petrovski G, 2011, ACTA OPHTHALMOL, V89, pE30, DOI 10.1111/j.1755-3768.2010.02047.x; Poon IKH, 2010, CELL DEATH DIFFER, V17, P381, DOI 10.1038/cdd.2009.195; Qingxian Lu, 2010, Front Biol (Beijing), V5, P227; RACZ P, 1988, OPHTHALMIC RES, V20, P10, DOI 10.1159/000266248; Reddy VN, 2004, EXP EYE RES, V79, P859, DOI 10.1016/j.exer.2004.04.005; REDDY VN, 1990, EXP EYE RES, V50, P771, DOI 10.1016/0014-4835(90)90127-G; Rogers CS, 2004, EXP EYE RES, V78, P1007, DOI 10.1016/j.exer.2003.12.011; Russell MRG, 2006, CURR OPIN CELL BIOL, V18, P422, DOI 10.1016/j.ceb.2006.06.002; Sasaki H, 1998, INVEST OPHTH VIS SCI, V39, P544; Shang F, 2001, EXP EYE RES, V73, P229, DOI 10.1006/exer.2001.1029; Shiratsuchi A, 1999, J BIOL CHEM, V274, P5901, DOI 10.1074/jbc.274.9.5901; Shui YB, 2000, EXP EYE RES, V71, P609, DOI 10.1006/exer.2000.0917; Singh S, 2007, BIOCHEM BIOPH RES CO, V364, P540, DOI 10.1016/j.bbrc.2007.10.049; Talebizadeh N, 2014, ACTA OPHTHALMOL, V92, P769, DOI 10.1111/aos.12407; Truscott RJW, 2005, EXP EYE RES, V80, P709, DOI 10.1016/j.exer.2004.12.007; TRUSCOTT RJW, 1977, BIOCHIM BIOPHYS ACTA, V492, P43, DOI 10.1016/0005-2795(77)90212-4; WAYNER EA, 1991, J CELL BIOL, V113, P919, DOI 10.1083/jcb.113.4.919; Wignes JA, 2013, EXP EYE RES, V115, P263, DOI 10.1016/j.exer.2013.06.026; Wong TY, 2014, BRIT J OPHTHALMOL, V98, P599, DOI 10.1136/bjophthalmol-2013-304047; Wu H., 2011, FREE RADIC BIOL MED, V51, P2108; Wu HL, 2014, J BIOL CHEM, V289, P36125, DOI 10.1074/jbc.M114.620047; Wu Y, 2005, J CELL SCI, V118, P539, DOI 10.1242/jcs.01632; Xing KY, 2002, EXP EYE RES, V74, P113, DOI 10.1006/exer.2001.1103; Yam JCS, 2014, INT OPHTHALMOL, V34, P383, DOI 10.1007/s10792-013-9791-x; Yeung T, 2009, J CELL BIOL, V185, P917, DOI 10.1083/jcb.200903020; Zigman S., 1995, OPTOMETRY VISION SCI, V72, P899	92	8	9	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2015	290	51					30253	30266		10.1074/jbc.M115.688390	http://dx.doi.org/10.1074/jbc.M115.688390			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CY9PG	26527683	Green Published, hybrid			2022-12-26	WOS:000366738200005
J	Allais, L; Kumar, S; Debusschere, K; Verschuere, S; Maes, T; De Smet, R; Conickx, G; De Vos, M; Laukens, D; Joos, GF; Brusselle, GG; Elewaut, D; Cuvelier, CA; Bracke, KR				Allais, Liesbeth; Kumar, Smitha; Debusschere, Karlijn; Verschuere, Stephanie; Maes, Tania; De Smet, Rebecca; Conickx, Griet; De Vos, Martine; Laukens, Debby; Joos, Guy F.; Brusselle, Guy G.; Elewaut, Dirk; Cuvelier, Claude A.; Bracke, Ken R.			The Effect of Cigarette Smoke Exposure on the Development of Inflammation in Lungs, Gut and Joints of TNF Delta ARE Mice	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; INDUCED PULMONARY INFLAMMATION; CYTOKINE MESSENGER-RNA; BOWEL-DISEASE; FACTOR-ALPHA; RHEUMATOID-ARTHRITIS; EXTRAINTESTINAL MANIFESTATIONS; IMMUNE-RESPONSE; TOBACCO-SMOKE; SPONDYLOARTHRITIS	The inflammatory cytokine TNF-alpha is a central mediator in many immune-mediated diseases, such as Crohn's disease (CD), spondyloarthritis (SpA) and chronic obstructive pulmonary disease (COPD). Epidemiologic studies have shown that cigarette smoking (CS) is a prominent common risk factor in these TNF-dependent diseases. We exposed TNF Delta ARE mice; in which a systemic TNF-alpha overexpression leads to the development of inflammation; to 2 or 4 weeks of air or CS. We investigated the effect of deregulated TNF expression on CS-induced pulmonary inflammation and the effect of CS exposure on the initiation and progression of gut and joint inflammation. Upon 2 weeks of CS exposure, inflammation in lungs of TNF Delta ARE mice was significantly aggravated. However, upon 4 weeks of CS-exposure, this aggravation was no longer observed. TNF Delta ARE mice have no increases in CD4+ and CD8+ T cells and a diminished neutrophil response in the lungs after 4 weeks of CS exposure. In the gut and joints of TNF Delta ARE mice, 2 or 4 weeks of CS exposure did not modulate the development of inflammation. In conclusion, CS exposure does not modulate gut and joint inflammation in TNF Delta ARE mice. The lung responses towards CS in TNF Delta ARE mice however depend on the duration of CS exposure.	[Allais, Liesbeth; De Smet, Rebecca; Cuvelier, Claude A.] Univ Ghent, Dept Med & Forens Pathol, B-9000 Ghent, Belgium; [Kumar, Smitha; Maes, Tania; Conickx, Griet; Joos, Guy F.; Brusselle, Guy G.; Bracke, Ken R.] Ghent Univ Hosp, Dept Resp Med, Lab Translat Res Obstruct Pulm Dis, Ghent, Belgium; [Debusschere, Karlijn; Elewaut, Dirk] Univ Ghent, Dept Rheumatol, Lab Mol Immunol & Inflammat, B-9000 Ghent, Belgium; [Verschuere, Stephanie] Acad Hosp St Jan, Dept Pathol, Brugge, Belgium; [De Vos, Martine; Laukens, Debby] Univ Ghent, Dept Gastroenterol, B-9000 Ghent, Belgium; [Debusschere, Karlijn; Elewaut, Dirk] Univ Ghent, VIB Inflammat Res Ctr, B-9000 Ghent, Belgium	Ghent University; Ghent University; Ghent University Hospital; Ghent University; Ghent University; Flanders Institute for Biotechnology (VIB); Ghent University	Allais, L (corresponding author), Univ Ghent, Dept Med & Forens Pathol, B-9000 Ghent, Belgium.	liesbeth.allais@ugent.be; ken.bracke@ugent.be	Maes, Tania/M-8675-2016; Elewaut, Dirk/K-6831-2014; Bracke, Ken R/GSN-7630-2022	Maes, Tania/0000-0002-3037-6928; Bracke, Ken R/0000-0001-5906-4605; Brusselle, Guy/0000-0001-7021-8505; Conickx, Griet/0000-0002-9475-8749; Elewaut, Dirk/0000-0002-7468-974X; Laukens, Debby/0000-0002-1984-5850; Allais, Liesbeth/0000-0003-2663-8566	Special Research Fund of Ghent University [01D41012]; Concerted Research Action of Ghent University [BOF/GOA 01251504]; Interuniversity Attraction Poles (IUAP) - Belgian Science Policy [P6/35, P7/30]; Fund for Scientific Research Flanders Belgium [G.0329.11N]	Special Research Fund of Ghent University(Ghent University); Concerted Research Action of Ghent University; Interuniversity Attraction Poles (IUAP) - Belgian Science Policy; Fund for Scientific Research Flanders Belgium(FWO)	This study was supported by the Special Research Fund of Ghent University (01D41012), the Concerted Research Action of Ghent University (BOF/GOA 01251504), Interuniversity Attraction Poles (IUAP) - Belgian Science Policy P6/35 and P7/30, and Fund for Scientific Research Flanders Belgium (G.0329.11N). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allais L, 2015, ENV MICROBIOL; Ananthakrishnan AN, 2013, GASTROENTEROL HEPATO, V9, P367; Arcavi L, 2004, ARCH INTERN MED, V164, P2206, DOI 10.1001/archinte.164.20.2206; Arnson Y, 2010, J AUTOIMMUN, V34, pJ258, DOI 10.1016/j.jaut.2009.12.003; Bagaitkar Juhi, 2008, Tob Induc Dis, V4, P12, DOI 10.1186/1617-9625-4-12; Biswas SK, 2009, TRENDS IMMUNOL, V30, P475, DOI 10.1016/j.it.2009.07.009; Bracke KR, 2006, J IMMUNOL, V177, P4350, DOI 10.4049/jimmunol.177.7.4350; Callhoff J, 2014, ANN RHEUM DIS; Chang K, 2014, INT J MOL SCI, V15, P22279, DOI 10.3390/ijms151222279; Chassaing B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044328; Churg A, 2004, AM J RESP CRIT CARE, V170, P492, DOI 10.1164/rccm.200404-511OC; D'hulst AI, 2006, EUR RESPIR J, V28, P102, DOI 10.1183/09031936.06.00059305; D'hulst AI, 2005, EUR RESPIR J, V26, P204, DOI 10.1183/09031936.05.00095204; De Vos M, 2011, BEST PRACT RES CL GA, V25, pS19, DOI 10.1016/S1521-6918(11)70006-3; Dupont LL, 2014, PULM PHARMACOL THER, V28, P60, DOI 10.1016/j.pupt.2013.10.003; George J, 1997, SCAND J IMMUNOL, V45, P1, DOI 10.1046/j.1365-3083.1997.d01-366.x; Hreggvidsdottir HS, 2014, MOL IMMUNOL, V57, P28, DOI 10.1016/j.molimm.2013.07.016; Jacques P, 2014, ANN RHEUM DIS, V73, P437, DOI 10.1136/annrheumdis-2013-203643; Jacques P, 2012, RHEUM DIS CLIN N AM, V38, P569, DOI 10.1016/j.rdc.2012.08.012; Karczewski J, 2014, PRZ GASTROENTEROL, V9, P153, DOI 10.5114/pg.2014.43577; Klareskog L, 2006, ARTHRITIS RHEUM-US, V54, P38, DOI 10.1002/art.21575; Kollias G, 1999, IMMUNOL REV, V169, P175, DOI 10.1111/j.1600-065X.1999.tb01315.x; Kontoyiannis D, 2002, J EXP MED, V196, P1563, DOI 10.1084/jem.20020281; Kontoyiannis D, 1999, IMMUNITY, V10, P387, DOI 10.1016/S1074-7613(00)80038-2; Laukens D, 2006, ANN RHEUM DIS, V65, P1293, DOI 10.1136/ard.2005.047738; Laukens D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013795; Lundblad LKA, 2005, AM J RESP CRIT CARE, V171, P1363, DOI 10.1164/rccm.200410-1349OC; Macdonald G, 2004, RADIOTHER ONCOL, V73, P367, DOI 10.1016/j.radonc.2004.09.002; Matsuda R, 2009, INFLAMM BOWEL DIS, V15, P328, DOI 10.1002/ibd.20759; Montbarbon M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062208; Mukhopadhyay S, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-125; Neurath MF, 1997, EUR J IMMUNOL, V27, P1743, DOI 10.1002/eji.1830270722; Oberholzer A, 2000, CRIT CARE MED, V28, pN3, DOI 10.1097/00003246-200004001-00002; Ott C, 2014, WORLD J GASTROENTERO, V20, P12269, DOI 10.3748/wjg.v20.i34.12269; Papadakis KA, 2000, GASTROENTEROLOGY, V119, P1148, DOI 10.1053/gast.2000.18160; Peng JC, 2014, J DIGEST DIS, V15, P585, DOI 10.1111/1751-2980.12193; Perry E, 2014, RHEUMATOLOGY, V53, P1940, DOI 10.1093/rheumatology/keu195; PERSSON PG, 1990, GUT, V31, P1377, DOI 10.1136/gut.31.12.1377; Peschon JJ, 1998, J IMMUNOL, V160, P943; Poddubnyy D, 2013, ANN RHEUM DIS, V72, P1430, DOI 10.1136/annrheumdis-2012-203148; Poddubnyy D, 2012, ARTHRITIS RHEUM-US, V64, P1388, DOI 10.1002/art.33465; Raddatz D, 2005, EUR J GASTROEN HEPAT, V17, P547, DOI 10.1097/00042737-200505000-00012; Roberts H, 2014, DIGESTION, V90, P122, DOI 10.1159/000363228; Strober W, 2002, ANNU REV IMMUNOL, V20, P495, DOI 10.1146/annurev.immunol.20.100301.064816; Suissa S, 2008, PULM PHARMACOL THER, V21, P234, DOI 10.1016/j.pupt.2007.03.003; Tangedal S, 2014, RESP RES, V15, DOI 10.1186/s12931-014-0138-6; Thomson EM, 2012, AM J PATHOL, V180, P1413, DOI 10.1016/j.ajpath.2011.12.020; VASSALLI P, 1992, ANNU REV IMMUNOL, V10, P411, DOI 10.1146/annurev.iy.10.040192.002211; Vermaelen K, 2004, CYTOM PART A, V61A, P170, DOI 10.1002/cyto.a.20064; Verschuere S, 2012, HISTOCHEM CELL BIOL, V137, P293, DOI 10.1007/s00418-011-0902-3; Verschuere S, 2011, LAB INVEST, V91, P1056, DOI 10.1038/labinvest.2011.74; Vlahos R, 2006, AM J PHYSIOL-LUNG C, V290, pL931, DOI 10.1152/ajplung.00201.2005; Vlahos R, 2014, CLIN SCI, V126, P253, DOI 10.1042/CS20130182; Vuillemenot BR, 2004, AM J RESP CELL MOL, V30, P438, DOI 10.1165/rcmb.2003-0062OC; Wendling D, 2013, EXPERT REV CLIN IMMU, V9, P511, DOI [10.1586/ECI.13.35, 10.1586/eci.13.35]	55	7	8	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2015	10	11							e0141570	10.1371/journal.pone.0141570	http://dx.doi.org/10.1371/journal.pone.0141570			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV1PG	26523550	Green Published, gold, Green Submitted			2022-12-26	WOS:000364029800011
J	Reynaud, Y; Millet, J; Rastogi, N				Reynaud, Yann; Millet, Julie; Rastogi, Nalin			Genetic Structuration, Demography and Evolutionary History of Mycobacterium tuberculosis LAM9 Sublineage in the Americas as Two Distinct Subpopulations Revealed by Bayesian Analyses	PLOS ONE			English	Article							DRUG-RESISTANT TUBERCULOSIS; POPULATION-STRUCTURE; MOLECULAR EPIDEMIOLOGY; 1ST INSIGHT; SPOLIGOTYPING DATA; FRENCH-GUIANA; MUTATION-RATE; MIRU-VNTRS; DIVERSITY; COMPLEX	Tuberculosis (TB) remains broadly present in the Americas despite intense global efforts for its control and elimination. Starting from a large dataset comprising spoligotyping (n = 21183 isolates) and 12-loci MIRU-VNTRs data (n = 4022 isolates) from a total of 31 countries of the Americas (data extracted from the SITVIT2 database), this study aimed to get an overview of lineages circulating in the Americas. A total of 17119 (80.8%) strains belonged to the Euro-American lineage 4, among which the most predominant genotypic family belonged to the Latin American and Mediterranean (LAM) lineage (n = 6386, 30.1% of strains). By combining classical phylogenetic analyses and Bayesian approaches, this study revealed for the first time a clear genetic structuration of LAM9 sublineage into two subpopulations named LAM9C1 and LAM9C2, with distinct genetic characteristics. LAM9C1 was predominant in Chile, Colombia and USA, while LAM9C2 was predominant in Brazil, Dominican Republic, Guadeloupe and French Guiana. Globally, LAM9C2 was characterized by higher allelic richness as compared to LAM9C1 isolates. Moreover, LAM9C2 sublineage appeared to expand close to twenty times more than LAM9C1 and showed older traces of expansion. Interestingly, a significant proportion of LAM9C2 isolates presented typical signature of ancestral LAM-RDRio MIRU-VNTR type (224226153321). Further studies based on Whole Genome Sequencing of LAM strains will provide the needed resolution to decipher the biogeographical structure and evolutionary history of this successful family.	[Reynaud, Yann; Millet, Julie; Rastogi, Nalin] WHO, Supranat TB Reference Lab, TB & Mycobacteria Unit, Inst Pasteur Guadeloupe, Abymes, Guadeloupe, France	World Health Organization	Reynaud, Y (corresponding author), WHO, Supranat TB Reference Lab, TB & Mycobacteria Unit, Inst Pasteur Guadeloupe, Abymes, Guadeloupe, France.	yreynaud@pasteur-guadeloupe.fr; nrastogi@pasteur-guadeloupe.fr	RASTOGI, NALIN/AAP-1958-2020; Reynaud, Yann/ABD-7936-2021	RASTOGI, NALIN/0000-0002-7199-7747; Reynaud, Yann/0000-0002-1966-7249	Institut Pasteur	Institut Pasteur(European Commission)	Yann Reynaud was awarded a Calmette and Yersin postdoctoral fellowship by the Institut Pasteur. No additional external funding was received for this study	[Anonymous], 2014, TRACER V1 6; Aristimuno L, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-90; Baboolal S, 2009, J CLIN MICROBIOL, V47, P1911, DOI 10.1128/JCM.00535-09; Santos ACB, 2013, INT J MYCOBACT, V2, P156, DOI 10.1016/j.ijmyco.2013.06.003; Beaumont MA, 1999, GENETICS, V153, P2013; Brudey K, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-23; Caceres O, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112789; Candia N, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-75; Cerezo I, 2012, INFECT GENET EVOL, V12, P657, DOI 10.1016/j.meegid.2011.07.006; Coll F, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5812; Cowan LS, 2005, J CLIN MICROBIOL, V43, P688, DOI 10.1128/JCM.43.2.688-695.2005; de Miranda SS, 2011, MEM I OSWALDO CRUZ, V106, P267, DOI 10.1590/S0074-02762011000300003; Demay C, 2012, INFECT GENET EVOL, V12, P755, DOI 10.1016/j.meegid.2012.02.004; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Ellegren H, 2004, NAT REV GENET, V5, P435, DOI 10.1038/nrg1348; Balcells ME, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118007; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Ferdinand S, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-364; Ford CB, 2013, NAT GENET, V45, P784, DOI 10.1038/ng.2656; Ford CB, 2011, NAT GENET, V43, P482, DOI 10.1038/ng.811; Gagneux S, 2006, P NATL ACAD SCI USA, V103, P2869, DOI 10.1073/pnas.0511240103; Gagneux S, 2006, SCIENCE, V312, P1944, DOI 10.1126/science.1124410; Gibson AL, 2008, J CLIN MICROBIOL, V46, P1259, DOI 10.1128/JCM.02231-07; Gomes HM, 2012, INFECT GENET EVOL, V12, P649, DOI 10.1016/j.meegid.2011.08.027; Guernier V, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-46; Hill V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041991; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Kalinowski ST, 2005, MOL ECOL NOTES, V5, P187, DOI 10.1111/j.1471-8286.2004.00845.x; Kamerbeek J, 1997, J CLIN MICROBIOL, V35, P907, DOI 10.1128/JCM.35.4.907-914.1997; Lopes JS, 2013, INFECT GENET EVOL, V18, P238, DOI 10.1016/j.meegid.2013.04.028; Nieto LM, 2012, J CLIN MICROBIOL, V50, P4185, DOI 10.1128/JCM.01946-12; Martinez-Guarneros A, 2013, INFECT GENET EVOL, V14, P434, DOI 10.1016/j.meegid.2012.12.024; Martins MC, 2013, INFECT GENET EVOL, V14, P39, DOI 10.1016/j.meegid.2012.10.015; Merker M, 2015, NAT GENET, V47, P242, DOI 10.1038/ng.3195; Millet J, 2011, BMC P, V5, pP81; Millet J, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/718496; Millet J, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/689852; Millet J, 2011, J CLIN MICROBIOL, V49, P2685, DOI 10.1128/JCM.00708-11; Millet J, 2009, INFECT GENET EVOL, V9, P1336, DOI 10.1016/j.meegid.2009.09.006; Mokrousov I, 2014, J BACTERIOL, V196, P1833, DOI 10.1128/JB.01485-13; Molina-Torres CA, 2010, J CLIN MICROBIOL, V48, P448, DOI 10.1128/JCM.01894-09; Ocheretina O, 2012, REV PANAM SALUD PUBL, V31, P221, DOI 10.1590/S1020-49892012000300006; Lazzarini LCO, 2007, J CLIN MICROBIOL, V45, P3891, DOI 10.1128/JCM.01394-07; Pritchard JK, 2000, GENETICS, V155, P945; Realpe T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093848; Rosales S, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-208; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Sheen P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065873; Sola C, 2001, J MOL EVOL, V53, P680, DOI 10.1007/s002390010255; Sola C, 2003, INFECT GENET EVOL, V3, P125, DOI 10.1016/S1567-1348(03)00011-X; Storz JF, 2002, EVOLUTION, V56, P154; Streit E, 2015, INFECT GENET EVOL, V30, P114, DOI 10.1016/j.meegid.2014.12.015; Supply P, 2006, J CLIN MICROBIOL, V44, P4498, DOI 10.1128/JCM.01392-06; Tessema B, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-131; Valcheva V, 2015, INT J MYCOBACT, V4, P191, DOI 10.1016/j.ijmyco.2015.04.003; VANEMBDEN JDA, 1993, J CLIN MICROBIOL, V31, P406, DOI 10.1128/JCM.31.2.406-409.1993; Vasconcellos SEG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107747; Warren RM, 2002, J CLIN MICROBIOL, V40, P4457, DOI 10.1128/JCM.40.12.4457-4465.2002; Wirth T, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000160; World Health Organization, 2014, WHOHTMTB201408	60	11	12	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2015	10	10							e0140911	10.1371/journal.pone.0140911	http://dx.doi.org/10.1371/journal.pone.0140911			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0EH	26517715	Green Published, gold, Green Submitted			2022-12-26	WOS:000363920800012
J	Samuvel, DJ; Saxena, N; Dhindsa, JS; Singh, AK; Gill, GS; Grobelny, DW; Singh, I				Samuvel, Devadoss J.; Saxena, Nishant; Dhindsa, Jasdeep S.; Singh, Avtar K.; Gill, Gurmit S.; Grobelny, Damian W.; Singh, Inderjit			AKP-11-A Novel S1P1 Agonist with Favorable Safety Profile Attenuates Experimental Autoimmune Encephalomyelitis in Rat Model of Multiple Sclerosis	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; SPHINGOSINE 1-PHOSPHATE RECEPTORS; T-CELL SUBSETS; IMMUNOMODULATORY DRUG FTY720; PROTEIN-COUPLED RECEPTORS; ORAL FINGOLIMOD FTY720; DEMYELINATING DISEASES; SIGNAL-TRANSDUCTION; LYMPHOCYTE EGRESS; MODULATOR FTY720	Sphingosine-1-phosphate receptor 1 (S1P1) mediated regulation of lymphocyte egress from lymphoid organs is recognized as the mechanism of FTY720 (Fingolimod, Gilenya) efficacy in relapsing-remitting forms of multiple sclerosis (RRMS). In this study we describe a novel S1P1 agonist AKP-11, next generation of S1P1 agonist, with immunomodulatory activities in cell culture model and for therapeutic efficacy against an animal model of MS, i.e. experimental autoimmune encephalomyelitis (EAE) but without the adverse effects observed with FTY720. Like FTY720, AKP-11 bound to S1P1 is internalized and activates intracellular AKT and ERKs cellular signaling pathways. In contrast to FTY720, AKP-11 mediated S1P1 downregulation is independent of sphingosine kinase activity indicating it to be a direct agonist of S1P1. The S1P1 loss and inhibition of lymphocyte egress by FTY720 leads to lymphopenia. In comparison with FTY720, oral administration of AKP-11 caused milder and reversible lymphopenia while providing a similar degree of therapeutic efficacy in the EAE animal model. Consistent with the observed reversible lymphopenia with AKP-11, the S1P1 recycled back to cell membrane in AKP-11 treated cells following its withdrawal, but not with withdrawal of FTY720. Accordingly, a smaller degree of ubiquitination and proteolysis of S1P1 was observed in AKP-11 treated cells as compared to FTY720. Consistent with previous observations, FTY720 treatment is associated with adverse effects of bradycardia and lung vascular leaks in rodents, whereas AKP-11 treatment had undetectable effects on bradycardia and reduced lung vascular leaks as compared to FTY720. Taken together, the data documents that AKP-11 treatment cause milder and reversible lymphopenia with milder adverse effects while maintaining therapeutic efficacy similar to that observed with FTY720, thus indicating therapeutic potential of AKP-11 for treatment of MS and related autoimmune disorders.	[Saxena, Nishant; Singh, Inderjit] Med Univ S Carolina, Dept Pediat, Charles P Darby Childrens Res Inst, Charleston, SC 29425 USA; [Samuvel, Devadoss J.; Dhindsa, Jasdeep S.; Singh, Avtar K.; Singh, Inderjit] Med Univ S Carolina, Dept Pathol & Lab Med, Charleston, SC 29425 USA; [Gill, Gurmit S.; Grobelny, Damian W.] Akaal Pharma Pty Ltd, Bundoora, Vic, Australia	Medical University of South Carolina; Medical University of South Carolina	Singh, I (corresponding author), Med Univ S Carolina, Dept Pediat, Charles P Darby Childrens Res Inst, Charleston, SC 29425 USA.	singhi@musc.edu	Singh, Ashok/HGF-2506-2022		National Institute of Health [NS-72511, NS-37766, NS-22576]; Veterans Administration [BX2829]; NIH Grant from the Extramural Research Facilities Program of the National Center for Research Resources [C06 RR-018823, C06 RR-015455]; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR015455, C06RR018823] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM103342] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS022576, R01NS037766, R01NS072511, R37NS022576] Funding Source: NIH RePORTER; Veterans Affairs [I01BX002829] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Administration(US Department of Veterans Affairs); NIH Grant from the Extramural Research Facilities Program of the National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported in part by grants from National Institute of Health (NS-72511) to AKS and (NS-37766, and NS-22576) and Veterans Administration (BX2829) to IS. This work was also supported by NIH Grants C06 RR-018823 and C06 RR-015455 from the Extramural Research Facilities Program of the National Center for Research Resources. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. GSG and DWG are employed by Akaal Pharma Pty Ltd. Akaal Pharma Pty Ltd. provided support in the form of salaries for authors GSG and DWG and provided the drug AKP-11, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allende ML, 2004, J BIOL CHEM, V279, P52487, DOI 10.1074/jbc.M406512200; Balatoni B, 2007, BRAIN RES BULL, V74, P307, DOI 10.1016/j.brainresbull.2007.06.023; Bashir K, 2002, ARCH NEUROL-CHICAGO, V59, P726, DOI 10.1001/archneur.59.5.726; Bohler T, 2004, NEPHROL DIAL TRANSPL, V19, P702, DOI 10.1093/ndt/gfg599; Brinkmann V, 2002, J BIOL CHEM, V277, P21453, DOI 10.1074/jbc.C200176200; Brinkmann V, 2007, PHARMACOL THERAPEUT, V115, P84, DOI 10.1016/j.pharmthera.2007.04.006; Brinkmann V, 2010, NAT REV DRUG DISCOV, V9, P883, DOI 10.1038/nrd3248; Camm J, 2014, AM HEART J, V168, P632, DOI 10.1016/j.ahj.2014.06.028; Charmandari E, 2005, MOL ENDOCRINOL, V19, P52, DOI 10.1210/me.2004-0112; Chiba K, 2005, PHARMACOL THERAPEUT, V108, P308, DOI 10.1016/j.pharmthera.2005.05.002; Chiba K, 2012, PHARMACEUTICALS, V5, P514, DOI 10.3390/ph5050514; Choi JW, 2013, BBA-MOL CELL BIOL L, V1831, P20, DOI 10.1016/j.bbalip.2012.07.015; Chun J, 2010, CLIN NEUROPHARMACOL, V33, P91, DOI 10.1097/WNF.0b013e3181cbf825; Cohen BA, 2007, INT J CLIN PRACT, V61, P1922, DOI 10.1111/j.1742-1241.2007.01561..x; Cohen JA, 2011, ANN NEUROL, V69, P759, DOI 10.1002/ana.22426; Comi G, 2010, MULT SCLER, V16, P197, DOI 10.1177/1352458509357065; Compston A, 2002, LANCET, V359, P1221, DOI 10.1016/S0140-6736(02)08220-X; Cox Darcy, 2006, J Neurosci Nurs, V38, P167; Deng HF, 2013, ACS MED CHEM LETT, V4, P942, DOI 10.1021/ml400194r; Dev KK, 2008, PHARMACOL THERAPEUT, V117, P77, DOI 10.1016/j.pharmthera.2007.08.005; Faber H, 2013, MULT SCLER J, V19, P126, DOI 10.1177/1352458512447596; Filippini G, 2003, LANCET, V361, P545, DOI 10.1016/S0140-6736(03)12512-3; Forrest M, 2004, J PHARMACOL EXP THER, V309, P758, DOI 10.1124/jpet.103.062828; Foster CA, 2007, J PHARMACOL EXP THER, V323, P469, DOI 10.1124/jpet.107.127183; Foster CA, 2009, BRAIN PATHOL, V19, P254, DOI 10.1111/j.1750-3639.2008.00182.x; Fragoso YD, 2014, ARQ NEURO-PSIQUIAT, V72, P712, DOI 10.1590/0004-282X20140102; Fryer RM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052985; Gergely P, 2012, BRIT J PHARMACOL, V167, P1035, DOI 10.1111/j.1476-5381.2012.02061.x; Gonzalez-Cabrera PJ, 2012, MOL PHARMACOL, V81, P166, DOI 10.1124/mol.111.076109; Graler MH, 2010, CELL PHYSIOL BIOCHEM, V26, P79, DOI 10.1159/000315108; Graler MH, 2004, FASEB J, V18, P551, DOI 10.1096/fj.03-0910fje; Gran B, 2002, J IMMUNOL, V169, P7104, DOI 10.4049/jimmunol.169.12.7104; HAUSER SL, 1986, ANN NEUROL, V19, P578, DOI 10.1002/ana.410190610; Hiestand Peter C., 2008, V66; Imeri F, 2014, NEUROPHARMACOLOGY, V85, P314, DOI 10.1016/j.neuropharm.2014.05.012; Jin J, 2014, BIOCHEM PHARMACOL, V90, P50, DOI 10.1016/j.bcp.2014.04.010; Johnson TA, 2010, CLIN IMMUNOL, V137, P15, DOI 10.1016/j.clim.2010.06.005; Kataoka H, 2005, CELL MOL IMMUNOL, V2, P439; Langer-Gould A, 2004, NEUROLOGY, V63, pS35, DOI 10.1212/WNL.63.11_suppl_5.S35; Liu CH, 1999, MOL BIOL CELL, V10, P1179, DOI 10.1091/mbc.10.4.1179; Mandala S, 2002, SCIENCE, V296, P346, DOI 10.1126/science.1070238; MARTIN R, 1992, ANNU REV IMMUNOL, V10, P153, DOI 10.1146/annurev.iy.10.040192.001101; Matloubian M, 2004, NATURE, V427, P355, DOI 10.1038/nature02284; McGiffert C, 2002, FEBS LETT, V531, P103, DOI 10.1016/S0014-5793(02)03404-X; Mehling M, 2008, NEUROLOGY, V71, P1261, DOI 10.1212/01.wnl.0000327609.57688.ea; Mehling M, 2010, NEUROLOGY, V75, P403, DOI 10.1212/WNL.0b013e3181ebdd64; Miron VE, 2008, J NEUROL SCI, V274, P13, DOI 10.1016/j.jns.2008.06.031; MOKHTARIAN F, 1984, NATURE, V309, P356, DOI 10.1038/309356a0; Murakami A, 2010, MOL PHARMACOL, V77, P704, DOI 10.1124/mol.109.061481; Myhr KM, 2009, ACTA NEUROL SCAND, V120, P73, DOI 10.1111/j.1600-0404.2009.01213.x; Oo ML, 2007, J BIOL CHEM, V282, P9082, DOI 10.1074/jbc.M610318200; Oo ML, 2011, J CLIN INVEST, V121, P2290, DOI 10.1172/JCI45403; Osinde M, 2007, NEUROPHARMACOLOGY, V52, P1210, DOI 10.1016/j.neuropharm.2006.11.010; Paintlia AS, 2013, AM J PATHOL, V183, P526, DOI 10.1016/j.ajpath.2013.04.030; Papadopoulos D, 2010, J NEUROSCI RES, V88, P346, DOI 10.1002/jnr.22196; Pham THM, 2008, IMMUNITY, V28, P122, DOI 10.1016/j.immuni.2007.11.017; Procaccini C, 2015, EUR J PHARM; Quancard J, 2012, CHEM BIOL, V19, P1142, DOI 10.1016/j.chembiol.2012.07.016; Rao TS, 2003, BRAIN RES, V990, P182, DOI 10.1016/S0006-8993(03)03527-3; Samuel Lena, 2006, J Drugs Dermatol, V5, P366; Sanchez T, 2003, J BIOL CHEM, V278, P47281, DOI 10.1074/jbc.M306896200; Sanna MG, 2004, J BIOL CHEM, V279, P13839, DOI 10.1074/jbc.M311743200; Singer II, 2005, J IMMUNOL, V175, P7151, DOI 10.4049/jimmunol.175.11.7151; SRIRAM S, 1982, J IMMUNOL, V129, P1649; Steinman L, 2008, J CLIN INVEST, V118, P3557, DOI 10.1172/JCI36532; Thone J, 2013, DRUG HEALTHC PATIENT, V5, P37, DOI 10.2147/DHPS.S28822; TRAUGOTT U, 1983, SCIENCE, V219, P308, DOI 10.1126/science.6217550; Vargas WS, 2013, THER ADV DRUG SAF, V4, P119, DOI 10.1177/2042098613481023; Virley David J, 2005, NeuroRx, V2, P638, DOI 10.1602/neurorx.2.4.638; Webb M, 2004, J NEUROIMMUNOL, V153, P108, DOI 10.1016/j.jneuroim.2004.04.015; Wilkerson BA, 2012, J BIOL CHEM, V287, P44645, DOI 10.1074/jbc.M112.423426; Young N, 2006, THESCIENTIFICWORLDJO, V6, P946, DOI 10.1100/tsw.2006.182; Zemann B, 2006, BLOOD, V107, P1454, DOI 10.1182/blood-2005-07-2628; Zhang GX, 2003, J IMMUNOL, V171, P4485, DOI 10.4049/jimmunol.171.9.4485	74	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2015	10	10							e0141781	10.1371/journal.pone.0141781	http://dx.doi.org/10.1371/journal.pone.0141781			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0ED	26513477	Green Submitted, gold, Green Published			2022-12-26	WOS:000363920300083
J	Deisting, W; Raum, T; Kufer, P; Baeuerle, PA; Munz, M				Deisting, Wibke; Raum, Tobias; Kufer, Peter; Baeuerle, Patrick A.; Muenz, Markus			Impact of Diverse Immune Evasion Mechanisms of Cancer Cells on T Cells Engaged by EpCAM/CD3-Bispecific Antibody Construct AMG 110	PLOS ONE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; TUMOR-CELLS; INDOLEAMINE 2,3-DIOXYGENASE; BITE ANTIBODY; MELANOMA; THERAPY; LINES; BLINATUMOMAB; INHIBITION; ACTIVATION	Background Bispecific T cell engager (BiTE (R)) are single-chain bispecific antibody constructs with dual specificity for CD3 on T cells and a surface antigen on target cells. They can elicit a polyclonal cytotoxic T cell response that is not restricted by T cell receptor (TCR) specificity, and surface expression of MHC class I/peptide antigen complexes. Using human EpCAM/CD3-bispecific BiTE (R) antibody construct AMG 110, we here assessed to what extent surface expression of PD-L1, cytoplasmic expression of indoleamine-2,3-deoxygenase type 1, Bcl-2 and serpin PI-9, and the presence of transforming growth factor beta (TGF-beta), interleukin-10 (IL-10) and adenosine in culture medium can impact redirected lysis by AMG 110-engaged T cells. Methods The seven factors, which are all involved in inhibiting T cell functions by cancer cells, were tested with human EpCAM-expressing Chinese hamster ovary (CHO) target cells at levels that in most cases exceeded those observed in a number of human cancer cell lines. Coculture experiments were used to determine the impact of the evasion mechanisms on EC50 values and amplitude of redirected lysis by AMG 110, and on BiTE (R)-induced proliferation of previously resting human peripheral T cells. Findings An inhibitory effect on redirected lysis by AMG 110-engaged T cells was seen upon overexpression of serpin PI-9, Bcl-2, TGF-beta and PD-L1. An inhibitory effect on induction of T cell proliferation was only seen with CHO cells overexpressing IDO. In no case, a single evasion mechanism rendered target cells completely resistant to BiTE (R)-induced lysis, and even various combinations could not. Conclusions Our data suggest that diverse mechanisms employed by cancer cells to fend off T cells cannot inactivate AMG 110-engaged T cells, and that inhibitory effects observed in vitro may be overcome by increased concentrations of the BiTE (R) antibody construct.	[Deisting, Wibke; Raum, Tobias; Kufer, Peter; Muenz, Markus] Amgen Res Munich GmbH, Munich, Germany; [Baeuerle, Patrick A.] MPM Capital, Cambridge, MA USA	Amgen; Amgen Research Munich GmbH	Munz, M (corresponding author), Amgen Res Munich GmbH, Munich, Germany.	mmuenz@amgen.com			AMGEN Inc.; AMGEN; MPM Capital	AMGEN Inc.(Amgen); AMGEN(Amgen); MPM Capital	Funding of this study has been supplied by AMGEN Inc., a publically listed company who provided support in the form of salaries for authors WD, TR, PK and MM, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. AMGEN supported this study, however, because of an interest in the results of this research. MPM Capital provided support in the form of a salary for author PAB, who was formerly employed by AMGEN Research Munich, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author is articulated in the 'author contributions' section.	Amann M, 2009, J IMMUNOTHER, V32, P452, DOI 10.1097/CJI.0b013e3181a1c097; Baeuerle PA, 2009, CURR OPIN MOL THER, V11, P22; Blank C, 2004, CANCER RES, V64, P1140, DOI 10.1158/0008-5472.CAN-03-3259; Brahmer JR, 2012, NEW ENGL J MED, V366, P2455, DOI 10.1056/NEJMoa1200694; Brandl C, 2007, CANCER IMMUNOL IMMUN, V56, P1551, DOI 10.1007/s00262-007-0298-z; Brischwein K, 2006, MOL IMMUNOL, V43, P1129, DOI 10.1016/j.molimm.2005.07.034; Brischwein K, 2007, J IMMUNOTHER, V30, P798, DOI 10.1097/CJI.0b013e318156750c; Burrell RA, 2013, NATURE, V501, P338, DOI 10.1038/nature12625; Carter LL, 2002, EUR J IMMUNOL, V32, P634, DOI 10.1002/1521-4141(200203)32:3<634::AID-IMMU634>3.0.CO;2-9; Dudley ME, 2005, J CLIN ONCOL, V23, P2346, DOI 10.1200/JCO.2005.00.240; Fiedler WM, 2012, ASCO M S, V30, P2504; Fiedler WM, 2010, ASCO M S, V28, P2573; Fogh J, 1975, HUMAN TUMOR CELL VIT; Frankel SR, 2013, CURR OPIN CHEM BIOL, V17, P385, DOI 10.1016/j.cbpa.2013.03.029; GIARD DJ, 1973, J NATL CANCER I, V51, P1417, DOI 10.1093/jnci/51.5.1417; Goping IS, 2003, IMMUNITY, V18, P355, DOI 10.1016/S1074-7613(03)00032-3; Hamid O, 2013, NEW ENGL J MED, V369, P134, DOI 10.1056/NEJMoa1305133; Hoskin DW, 2008, INT J ONCOL, V32, P527; Kischel R, 2009, AACR M 2009 2 ANN M, V2009, P3252; Klinger M, 2012, BLOOD, V119, P6226, DOI 10.1182/blood-2012-01-400515; LEIBOVITZ A, 1976, CANCER RES, V36, P4562; Medema JP, 2001, P NATL ACAD SCI USA, V98, P11515, DOI 10.1073/pnas.201398198; Mosser DM, 2008, IMMUNOL REV, V226, P205, DOI 10.1111/j.1600-065X.2008.00706.x; Muller Ludmila, 2002, J Environ Pathol Toxicol Oncol, V21, P277; Munn DH, 2007, J CLIN INVEST, V117, P1147, DOI 10.1172/JCI31178; Offner S, 2006, MOL IMMUNOL, V43, P763, DOI 10.1016/j.molimm.2005.03.007; Real LM, 2001, CANCER IMMUNOL IMMUN, V49, P621, DOI 10.1007/s002620000154; Schlegel P, 2014, HAEMATOLOGICA, V99, P1212, DOI 10.3324/haematol.2013.100073; SEKIGUCHI M, 1978, JPN J EXP MED, V48, P61; Senzer NN, 2009, J CLIN ONCOL, V27, P5763, DOI 10.1200/JCO.2009.24.3675; TAN MH, 1986, CANCER INVEST, V4, P15, DOI 10.3109/07357908609039823; Terness P, 2002, J EXP MED, V196, P447, DOI 10.1084/jem.20020052; Thomas DA, 2005, CANCER CELL, V8, P369, DOI 10.1016/j.ccr.2005.10.012; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Topfer K, 2011, J BIOMED BIOTECHNOL, V2011, DOI [10.1155/2011/918471, DOI 10.1155/2011/918471]; Topp MS, 2011, J CLIN ONCOL, V29, P2493, DOI 10.1200/JCO.2010.32.7270; Wolchok JD, 2013, ANN NY ACAD SCI, V1291, P1, DOI 10.1111/nyas.12180; YASUI H, 1986, P NATL ACAD SCI USA, V83, P6622, DOI 10.1073/pnas.83.17.6622; Zhang B, 2010, CANCER RES, V70, P6407, DOI 10.1158/0008-5472.CAN-10-1544	39	15	20	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2015	10	10							e0141669	10.1371/journal.pone.0141669	http://dx.doi.org/10.1371/journal.pone.0141669			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0DL	26510188	Green Submitted, gold, Green Published			2022-12-26	WOS:000363918100119
J	Huang, J; Ou, HY; Lin, J; Karnchanasorn, R; Feng, W; Samoa, R; Chuang, LM; Chiu, KC				Huang, Jean; Ou, Horng-Yih; Lin, James; Karnchanasorn, Rudruidee; Feng, Wei; Samoa, Raynald; Chuang, Lee-Ming; Chiu, Ken C.			The Impact of Hepatitis B Vaccination Status on the Risk of Diabetes, Implicating Diabetes Risk Reduction by Successful Vaccination	PLOS ONE			English	Article							LIFE-STYLE INTERVENTION; IMPAIRED GLUCOSE-TOLERANCE; VIRUS-INFECTION; C VIRUS; LIVER-DISEASE; FOLLOW-UP; PREVENTION; TRIAL; PREVALENCE	Background The liver plays a key role in fuel metabolism. It is well established that liver disease is associated with an increased risk for diabetes mellitus. Hepatitis C virus infection has been known to increase the risk of diabetes. However, much less is known about the role of hepatitis B virus (HBV) infection in diabetes. We examined the association of diabetes based on the vaccination status for HBV. Methods In this cross-sectional study, we included adult subjects (>= 20 y/o) with HBV serology available from the National Health and Nutrition Examination Survey 2005-2010. Diabetes was defined as established diabetes or fasting plasma glucose concentration >= 7.0 mmol/L, 2-hour plasma glucose concentration >= 11.1 mmol/L, or HbA1c >= 47.5 mmol/mol (6.5%). Vaccination was based on the reported history and immunization was determined by HBV serology. The odds ratio (OR) with 95% confidence intervals (95% CI) were calculated with consideration of the following covariates: age, gender, BMI, ethnic/racial group, current smoker, current alcohol consumption, family history of diabetes, poverty index, and education. Results This study included 15,316 subjects. Among them, 2,320 subjects was immunized based the HBV serology. Among 4,063 subjects who received HBV vaccination, successful vaccination was only noted in 39% of subjects. The HBV vaccination was not associated with diabetes (OR: 1.08, 95% CI: 0.96-1.23). Serology evidence of HBV immunization was associated with a reduced OR of diabetes (0.75, 95% CI: 0.62-0.90). Successful HBV vaccination was also associated with a reduced OR of diabetes (0.67, 95% CI: 0.52-0.84). Conclusions Although our study shows the association of HBV vaccination with the reduced odds of diabetes by 33%, a prospective study is warranted to confirm and examine the impact of HBV vaccination in prevention of diabetes.	[Huang, Jean; Feng, Wei; Samoa, Raynald; Chiu, Ken C.] City Hope Natl Med Ctr, Dept Clin Diabet Endocrinol & Metab, 1500 E Duarte Rd, Duarte, CA 91010 USA; [Huang, Jean; Feng, Wei; Samoa, Raynald; Chiu, Ken C.] Harbor UCLA Med Ctr, Dept Internal Med, Div Endocrinol Metab & Nutr, Torrance, CA 90509 USA; [Ou, Horng-Yih] Natl Cheng Kung Univ, Med Coll & Hosp, Dept Internal Med, Div Endocrinol & Metab, Tainan 70101, Taiwan; [Lin, James] City Hope Natl Med Ctr, Dept Gastroenterol, Duarte, CA 91010 USA; [Karnchanasorn, Rudruidee] Univ Kansas, Med Ctr, Div Endocrinol, Dept Med, Kansas City, KS 66103 USA; [Chuang, Lee-Ming] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei, Taiwan; [Chuang, Lee-Ming] Natl Taiwan Univ, Sch Publ Hlth, Grad Inst Prevent Med, Taipei 10764, Taiwan	City of Hope; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; National Cheng Kung University; City of Hope; University of Kansas; University of Kansas Medical Center; National Taiwan University; National Taiwan University Hospital; National Taiwan University	Chiu, KC (corresponding author), City Hope Natl Med Ctr, Dept Clin Diabet Endocrinol & Metab, 1500 E Duarte Rd, Duarte, CA 91010 USA.	kchiu@coh.org	Chiu, Ken/M-6473-2013; Chuang, Lee-Ming/AAF-3324-2019	Chiu, Ken/0000-0002-2226-1039; CHUANG, LEE-MING/0000-0003-0978-2662				Amer Diabet Assoc, 2014, DIABETES CARE, V37, pS81, DOI 10.2337/dc14-S081; [Anonymous], 2014, NATIONAL DIABETES ST; Antonelli A, 2009, NAT CLIN PRACT ENDOC, V5, P26, DOI 10.1038/ncpendmet1027; BOUTER KP, 1992, DIABETIC MED, V9, P66, DOI 10.1111/j.1464-5491.1992.tb01717.x; Chang MH, 1997, NEW ENGL J MED, V336, P1855, DOI 10.1056/NEJM199706263362602; Chiasson JL, 2004, DIABETOLOGIA, V47, P969, DOI 10.1007/s00125-004-1409-4; DeFronzo RA, 2011, NEW ENGL J MED, V364, P1104, DOI 10.1056/NEJMoa1010949; DeFronzo RA, 2009, DIABETES, V58, P773, DOI 10.2337/db09-9028; Douvin C, 1997, DIABETES CARE, V20, P148, DOI 10.2337/diacare.20.2.148; Eslam M, 2011, GUT, V60, P1139, DOI 10.1136/gut.2010.228262; Gerstein HC, 2006, LANCET, V368, P1096, DOI 10.1016/S0140-6736(06)69420-8; Herman WH, 2003, DIABETES CARE, V26, P36; Huang ZS, 2010, J GASTROEN HEPATOL, V25, P1420, DOI 10.1111/j.1440-1746.2010.06268.x; Kahn R, 2014, DIABETES CARE, V37, P943, DOI 10.2337/dc13-1954; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Kosaka K, 2005, DIABETES RES CLIN PR, V67, P152, DOI 10.1016/j.diabres.2004.06.010; Lao TT, 2007, J HEPATOL, V47, P46, DOI 10.1016/j.jhep.2007.02.014; Lecube A, 2006, DIABETES CARE, V29, P1096, DOI 10.2337/dc05-2509; Li GW, 2008, LANCET, V371, P1783, DOI 10.1016/S0140-6736(08)60766-7; Li-Ng M, 2007, DIGEST LIVER DIS, V39, P549, DOI 10.1016/j.dld.2007.02.014; Lindstrom J, 2006, LANCET, V368, P1673, DOI 10.1016/S0140-6736(06)69701-8; Malamug LR, 2014, SCIENTIFICA, V2014, DOI 10.1155/2014/870165; Masini M, 2005, DIABETES CARE, V28, P940, DOI 10.2337/diacare.28.4.940; Mast Eric E., 2005, Morbidity and Mortality Weekly Report, V54, P1; Moscatiello S, 2007, NUTR METAB CARDIOVAS, V17, P63, DOI 10.1016/j.numecd.2006.08.004; Negro F, 2009, WORLD J GASTROENTERO, V15, P1537, DOI 10.3748/wjg.15.1537; Picardi A, 2006, DIABETES-METAB RES, V22, P274, DOI 10.1002/dmrr.636; Reilly Meredith L, 2012, J Diabetes Sci Technol, V6, P858; Selvin E, 2014, ANN INTERN MED, V160, P517, DOI 10.7326/M13-2411; Te Helen S, 2010, Clin Liver Dis, V14, P1, DOI 10.1016/j.cld.2009.11.009; White DL, 2008, J HEPATOL, V49, P831, DOI 10.1016/j.jhep.2008.08.006; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047	32	14	14	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2015	10	10							e0139730	10.1371/journal.pone.0139730	http://dx.doi.org/10.1371/journal.pone.0139730			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0DL	26509504	Green Submitted, gold, Green Published			2022-12-26	WOS:000363918100012
J	Navarro-Zaragoza, J; Ros-Simo, C; Milanes, MV; Valverde, O; Laorden, ML				Navarro-Zaragoza, Javier; Ros-Simo, Clara; Milanes, Maria-Victoria; Valverde, Olga; Laorden, Maria-Luisa			Binge Ethanol and MDMA Combination Exacerbates Toxic Cardiac Effects by Inducing Cellular Stress	PLOS ONE			English	Article							HEAT-SHOCK-PROTEIN; PRECIPITATED MORPHINE-WITHDRAWAL; SIMULTANEOUS POLYSUBSTANCE USE; ALPHA-B-CRYSTALLIN; TYROSINE-HYDROXYLASE; ATRIAL-FIBRILLATION; 3,4-METHYLENEDIOXYMETHAMPHETAMINE ECSTASY; CONTRACTILE DYSFUNCTION; ALCOHOL-CONSUMPTION; OXIDATIVE STRESS	Binge drinking is a common pattern of ethanol consumption among young people. Binge drinkers are especially susceptible to brain damage when other substances are co-administered, in particular 3,4 methylendioxymethamphetamine (MDMA). The aim of the present work was to study the mechanisms implicated in the adaptive changes observed after administration of these drugs of abuse. So, we have evaluated the cardiac sympathetic activity and the expression and activation of heat shock protein 27 (HSP27), after voluntary binge ethanol consumption, alone and in combination with MDMA. Both parameters are markers of stressful situations and they could be modified inducing several alterations in different systems. Adolescent mice received MDMA, ethanol or both (ethanol plus MDMA). Drinking in the dark (DID) procedure was used as a model of binge. Noradrenaline (NA) turnover, tyrosine hydroxylase (TH), TH phosphorylated at serine 31 and HSP27 expression and its phosphorylation at serine 82 were evaluated in adolescent mice 48 h, 72 h, and 7 days after treatments in the left ventricle. NA and normetanephrine (NMN) were determined by high-performance liquid chromatography (HPLC); TH and HSP27 expression and phosphorylation were measured by quantitative blot immunollabeling using specific antibodies. Ethanol and MDMA co-administration increased NA turnover and TH expression and phosphorylation versus the consumption of each one of these drugs. In parallel with the described modifications in the cardiac sympathetic activity, our results showed that binge ethanol+MDMA exposure is associated with an increase in HSP27 expression and phosphorylation in the left ventricle, supporting the idea that the combination of both drugs exacerbates the cellular stress induced by ethanol or MDMA alone.	[Navarro-Zaragoza, Javier; Milanes, Maria-Victoria; Laorden, Maria-Luisa] Univ Murcia, Fac Med, Dept Pharmacol, Murcia, Spain; [Ros-Simo, Clara; Valverde, Olga] Univ Pompeu Fabra, GRNC, Barcelona, Spain	University of Murcia; Pompeu Fabra University	Navarro-Zaragoza, J (corresponding author), Univ Murcia, Fac Med, Dept Pharmacol, Murcia, Spain.	jnavarrozaragoza@um.es	Milanés, M. Victoria/AGB-4075-2022; Milanés, M Victoria/K-6591-2017	Milanés, M. Victoria/0000-0002-0984-2218; Milanés, M Victoria/0000-0002-0984-2218; Navarro-Zaragoza, Javier/0000-0003-1653-8131	Ministerio de Economia y Competitividad [SAF2013/49076]; Instituto de Salud Carlos III, Ministerio de Sanidad [RD12/0028/0003]	Ministerio de Economia y Competitividad(Spanish Government); Instituto de Salud Carlos III, Ministerio de Sanidad(Instituto de Salud Carlos IIISpanish Government)	The funders of this research have been Ministerio de Economia y Competitividad (Grant: SAF2013/49076) and Instituto de Salud Carlos III, Ministerio de Sanidad (Grant: RD12/0028/0003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almela P, 2011, J MOL CELL CARDIOL, V51, P129, DOI 10.1016/j.yjmcc.2011.04.002; Ann JJ, 2008, FEBS J, V275, P1296; Barrett SP, 2006, HUM PSYCHOPHARM CLIN, V21, P255, DOI 10.1002/hup.766; Barrett SP, 2005, SUBST USE MISUSE, V40, P1525, DOI 10.1081/JA-200066866; Bitar KN, 2002, AM J PHYSIOL-GASTR L, V282, pG894, DOI 10.1152/ajpgi.00141.2001; Bobrovskaya L, 2007, J NEUROCHEM, V100, P479, DOI 10.1111/j.1471-4159.2006.04213.x; Boundy VA, 1998, J NEUROSCI, V18, P9989; Crabbe JC, 2011, ANN NY ACAD SCI, V1216, P24, DOI 10.1111/j.1749-6632.2010.05895.x; Dettmeyer R, 2009, FORENSIC SCI INT, V187, P42, DOI 10.1016/j.forsciint.2009.02.014; Do Couto BR, 2011, PHYSIOL BEHAV, V103, P585, DOI 10.1016/j.physbeh.2011.02.012; Drastichova Z, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047167; Dumont GJH, 2010, J PSYCHOPHARMACOL, V24, P165, DOI 10.1177/0269881108100020; Dumont GJH, 2006, J PSYCHOPHARMACOL, V20, P176, DOI 10.1177/0269881106063271; Green AR, 2003, PHARMACOL REV, V55, P463, DOI 10.1124/pr.55.3.3; Guo R, 2012, CARDIOVASC RES, V94, P480, DOI 10.1093/cvr/cvs127; Haorah J, 2008, FREE RADICAL BIO MED, V45, P1542, DOI 10.1016/j.freeradbiomed.2008.08.030; Hayase Tamaki, 2003, Leg Med (Tokyo), V5 Suppl 1, pS87, DOI 10.1016/S1344-6223(02)00093-7; Hernandez-Lopez C, 2002, J PHARMACOL EXP THER, V300, P236, DOI 10.1124/jpet.300.1.236; Izco M, 2007, PSYCHOPHARMACOLOGY, V189, P459, DOI 10.1007/s00213-006-0602-1; Kas S, 1987, ANN EMERG MED, V16, P481; KATO K, 1992, J BIOL CHEM, V267, P7718; Kodama S, 2011, J AM COLL CARDIOL, V57, P427, DOI 10.1016/j.jacc.2010.08.641; Kristian T, 1998, STROKE, V29, P705, DOI 10.1161/01.STR.29.3.705; Kumer SC, 1996, J NEUROCHEM, V67, P443; Lieber CS, 2004, ALCOHOL, V34, P9, DOI 10.1016/j.alcohol.2004.07.008; Lu Y, 2008, FREE RADICAL BIO MED, V44, P723, DOI 10.1016/j.freeradbiomed.2007.11.004; Martinez-Laorden E, 2014, BRIT J PHARMACOL, V171, P688, DOI 10.1111/bph.12511; Menezes AR, 2013, MAYO CLIN PROC, V88, P394, DOI 10.1016/j.mayocp.2013.01.022; Mukamal KJ, 2005, CIRCULATION, V112, P3839, DOI 10.1161/CIRCULATIONAHA.105.574749; NESTLER EJ, 1992, J NEUROSCI, V12, P2439; O'Keefe JH, 2007, J AM COLL CARDIOL, V50, P1009, DOI 10.1016/j.jacc.2007.04.089; Parrott AC, 2014, BEHAV PHARMACOL, V25, P458, DOI 10.1097/FBP.0000000000000060; Phillips TJ, 2015, GENES BRAIN BEHAV, V14, P98, DOI 10.1111/gbb.12189; Pontes H, 2008, TOXICOLOGY, V252, P64, DOI 10.1016/j.tox.2008.07.064; Rhodes JS, 2007, GENES BRAIN BEHAV, V6, P1, DOI 10.1111/j.1601-183X.2006.00210.x; Rhodes JS, 2005, PHYSIOL BEHAV, V84, P53, DOI 10.1016/j.physbeh.2004.10.007; Robinson AA, 2010, J MOL CELL CARDIOL, V49, P370, DOI 10.1016/j.yjmcc.2010.06.004; Ros-Simo C, 2012, PSYCHOPHARMACOLOGY, V221, P511, DOI 10.1007/s00213-011-2598-4; Ruiz-Medina J, 2011, J PSYCHOPHARMACOL, V25, P550, DOI 10.1177/0269881110389210; Ryabinin AE, 2003, PSYCHOPHARMACOLOGY, V165, P296, DOI 10.1007/s00213-002-1284-y; Salvatore MF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029867; Samokhvalov AV, 2010, EUR J CARDIOV PREV R, V17, P706, DOI 10.1097/HJR.0b013e32833a1947; Schindler CW, 2014, BRIT J PHARMACOL, V171, P83, DOI 10.1111/bph.12423; Shenouda SK, 2010, CURR PHARM BIOTECHNO, V11, P470, DOI 10.2174/138920110791591526; Shintani-Ishida K, 2014, BBA-MOL BASIS DIS, V1842, P691, DOI 10.1016/j.bbadis.2014.01.013; Song BJ, 2010, CURR PHARM BIOTECHNO, V11, P434, DOI 10.2174/138920110791591436; Stetler RA, 2009, CURR MOL MED, V9, P863, DOI 10.2174/156652409789105561; Stolle M, 2009, DTSCH ARZTEBL INT, V106, P323, DOI 10.3238/arztebl.2009.0323; Strote J, 2002, J ADOLESCENT HEALTH, V30, P64, DOI 10.1016/S1054-139X(01)00315-9; Topp L, 1999, DRUG ALCOHOL DEPEN, V55, P105, DOI 10.1016/S0376-8716(99)00002-2; Toth ME, 2010, CELL STRESS CHAPERON, V15, P807, DOI 10.1007/s12192-010-0188-8; Tourino C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009143; Upreti VV, 2009, TOXICOL LETT, V188, P167, DOI 10.1016/j.toxlet.2009.03.023; Walker RK, 2013, ALCOHOL CLIN EXP RES, V37, P1253, DOI 10.1111/acer.12109; Waszkiewicz N, 2013, ALCOHOL CLIN EXP RES, V37, P1261, DOI 10.1111/acer.12208; Wechsler H, 2001, PSYCHOL ADDICT BEHAV, V15, P287, DOI 10.1037/0893-164X.15.4.287; White MY, 2006, J MOL CELL CARDIOL, V40, P761, DOI 10.1016/j.yjmcc.2006.02.007; Winstock AR, 2001, DRUG ALCOHOL DEPEN, V64, P9, DOI 10.1016/S0376-8716(00)00215-5; Zagrosek A, 2010, JAMA-J AM MED ASSOC, V304, P1328, DOI 10.1001/jama.2010.1343	59	12	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2015	10	10							e0141502	10.1371/journal.pone.0141502	http://dx.doi.org/10.1371/journal.pone.0141502			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0DL	26509576	Green Published, gold, Green Submitted			2022-12-26	WOS:000363918100093
J	Ying, S; Zeng, DN; Chi, L; Tan, Y; Galzote, C; Cardona, C; Lax, S; Gilbert, J; Quan, ZX				Ying, Shi; Zeng, Dan-Ning; Chi, Liang; Tan, Yuan; Galzote, Carlos; Cardona, Cesar; Lax, Simon; Gilbert, Jack; Quan, Zhe-Xue			The Influence of Age and Gender on Skin-Associated Microbial Communities in Urban and Rural Human Populations	PLOS ONE			English	Article							MOLECULAR ANALYSIS; BODY HABITATS; DIVERSITY; BACTERIAL; SEQUENCES; TAXONOMY; SAMPLES; FLORA; TIME; LIFE	Differences in the bacterial community structure associated with 7 skin sites in 71 healthy people over five days showed significant correlations with age, gender, physical skin parameters, and whether participants lived in urban or rural locations in the same city. While body site explained the majority of the variance in bacterial community structure, the composition of the skin-associated bacterial communities were predominantly influenced by whether the participants were living in an urban or rural environment, with a significantly greater relative abundance of Trabulsiella in urban populations. Adults maintained greater overall microbial diversity than adolescents or the elderly, while the intragroup variation among the elderly and rural populations was significantly greater. Skin-associated bacterial community structure and composition could predict whether a sample came from an urban or a rural resident similar to 5x greater than random.	[Ying, Shi; Zeng, Dan-Ning; Chi, Liang; Quan, Zhe-Xue] Fudan Univ, Dept Microbiol & Microbial Engn, Sch Life Sci, Shanghai 200433, Peoples R China; [Tan, Yuan; Galzote, Carlos] Johnson & Johnson China Ltd, Sci Affairs, Shanghai, Peoples R China; [Cardona, Cesar; Gilbert, Jack] Univ Chicago, Grad Program Biophys Sci, Chicago, IL 60637 USA; [Lax, Simon; Gilbert, Jack] Univ Chicago, Dept Ecol & Evolut, Chicago, IL 60637 USA; [Gilbert, Jack] Argonne Natl Lab, Inst Genom & Syst Biol, Argonne, IL 60439 USA; [Gilbert, Jack] Marine Biol Lab, Woods Hole, MA 02543 USA; [Gilbert, Jack] Zhejiang Univ, Coll Environm & Resource Sci, Hangzhou 310003, Zhejiang, Peoples R China	Fudan University; Johnson & Johnson; University of Chicago; University of Chicago; United States Department of Energy (DOE); Argonne National Laboratory; Marine Biological Laboratory - Woods Hole; Zhejiang University	Quan, ZX (corresponding author), Fudan Univ, Dept Microbiol & Microbial Engn, Sch Life Sci, Shanghai 200433, Peoples R China.	quanzx@fudan.edu.cn	Gilbert, Jack/AAF-3270-2019; Quan, Zhexue/B-8046-2013; Zeng, Danning/HII-4228-2022	Quan, Zhexue/0000-0002-7561-8572; 	Johnson & Johnson (China); Johnson & Johnson Consumer Companies, Inc. (Skillman, NJ USA)	Johnson & Johnson (China)(Johnson & Johnson); Johnson & Johnson Consumer Companies, Inc. (Skillman, NJ USA)	This work was supported by a grant from Johnson & Johnson (China). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funder provided support in the form of salaries for investigator/authors [YT, CG], but did not have any additional role in the study design, data collection and analysis, decision to publish. The specific roles of these authors are articulated in the 'author contributions' section. Editorial services were provided by Evidence Scientific Solutions (Philadelphia, PA) and were funded by Johnson & Johnson Consumer Companies, Inc. (Skillman, NJ USA).	Blaser MJ, 2013, ISME J, V7, P85, DOI 10.1038/ismej.2012.81; Capone KA, 2011, J INVEST DERMATOL, V131, P2026, DOI 10.1038/jid.2011.168; Caporaso JG, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-5-r50; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636; Costello EK, 2009, SCIENCE, V326, P1694, DOI 10.1126/science.1177486; David LA, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-7-r89; Dominguez-Bello MG, 2010, P NATL ACAD SCI USA, V107, P11971, DOI 10.1073/pnas.1002601107; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; FAITH DP, 1992, BIOL CONSERV, V61, P1, DOI 10.1016/0006-3207(92)91201-3; Fierer N, 2008, P NATL ACAD SCI USA, V105, P17994, DOI 10.1073/pnas.0807920105; Gao Z, 2007, P NATL ACAD SCI USA, V104, P2927, DOI 10.1073/pnas.0607077104; Giacomoni PU, 2009, J DERMATOL SCI, V55, P144, DOI 10.1016/j.jdermsci.2009.06.001; Grice EA, 2008, GENOME RES, V18, P1043, DOI 10.1101/gr.075549.107; Grice EA, 2011, NAT REV MICROBIOL, V9, P244, DOI 10.1038/nrmicro2537; Grice EA, 2009, SCIENCE, V324, P1190, DOI 10.1126/science.1171700; Group NHW, 2009, GENOME RES, V19, P2317; Hamady M, 2008, NAT METHODS, V5, P235, DOI 10.1038/NMETH.1184; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Kuczynski J, 2010, NAT METHODS, V7, P813, DOI [10.1038/NMETH.1499, 10.1038/nmeth.1499]; Lax S, 2014, SCIENCE, V345, P1048, DOI 10.1126/science.1254529; LEEMING JP, 1984, J GEN MICROBIOL, V130, P803; LEYDEN JJ, 1975, J INVEST DERMATOL, V65, P379, DOI 10.1111/1523-1747.ep12607630; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Luebberding S, 2013, INT J COSMETIC SCI, V35, P477, DOI 10.1111/ics.12068; MARPLES RR, 1982, ARCH DERMATOL RES, V272, P317, DOI 10.1007/BF00509062; Mathieu A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065288; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; Oh J, 2013, GENOME RES, V23, P2103, DOI 10.1101/gr.159467.113; Paulino LC, 2006, J CLIN MICROBIOL, V44, P2933, DOI 10.1128/JCM.00785-06; Price MN, 2009, MOL BIOL EVOL, V26, P1641, DOI 10.1093/molbev/msp077; Rosenthal M, 2011, INFECT GENET EVOL, V11, P839, DOI 10.1016/j.meegid.2011.03.022; Shade A, 2013, ISME J, V7, P1493, DOI 10.1038/ismej.2013.54; SOMERVILLE DA, 1969, BRIT J DERMATOL, V81, P248, DOI 10.1111/j.1365-2133.1969.tb13976.x; Song SJ, 2013, ELIFE, V2, DOI 10.7554/eLife.00458; Tyakht AV, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3469; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07	37	117	123	5	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2015	10	10							e0141842	10.1371/journal.pone.0141842	http://dx.doi.org/10.1371/journal.pone.0141842			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0DL	26510185	Green Submitted, gold, Green Published			2022-12-26	WOS:000363918100139
J	Ahmed, A; Ward, NJ; Moxon, S; Lopez-Gomollon, S; Viaut, C; Tomlinson, ML; Patrushev, I; Gilchrist, MJ; Dalmay, T; Dotlic, D; Munsterberg, AE; Wheeler, GN				Ahmed, Ayisha; Ward, Nicole J.; Moxon, Simon; Lopez-Gomollon, Sara; Viaut, Camille; Tomlinson, Matthew L.; Patrushev, Ilya; Gilchrist, Michael J.; Dalmay, Tamas; Dotlic, Dario; Muensterberg, Andrea E.; Wheeler, Grant N.			A Database of microRNA Expression Patterns in Xenopus laevis	PLOS ONE			English	Article							RNAS; ROBUSTNESS; BIOGENESIS; PRECURSORS; MATURATION; GENOMICS; MIR-206; XENBASE; GENES	MicroRNAs (miRNAs) are short, non-coding RNAs around 22 nucleotides long. They inhibit gene expression either by translational repression or by causing the degradation of the mRNAs they bind to. Many are highly conserved amongst diverse organisms and have restricted spatio-temporal expression patterns during embryonic development where they are thought to be involved in generating accuracy of developmental timing and in supporting cell fate decisions and tissue identity. We determined the expression patterns of 180 miRNAs in Xenopus laevis embryos using LNA oligonucleotides. In addition we carried out small RNA-seq on different stages of early Xenopus development, identified 44 miRNAs belonging to 29 new families and characterized the expression of 5 of these. Our analyses identified miRNA expression in many organs of the developing embryo. In particular a large number were expressed in neural tissue and in the somites. Surprisingly none of the miRNAs we have looked at show expression in the heart. Our results have been made freely available as a resource in both XenMARK and Xenbase.	[Ahmed, Ayisha; Ward, Nicole J.; Lopez-Gomollon, Sara; Viaut, Camille; Tomlinson, Matthew L.; Dalmay, Tamas; Dotlic, Dario; Muensterberg, Andrea E.; Wheeler, Grant N.] Univ E Anglia, Sch Biol Sci, Norwich NR4 7TJ, Norfolk, England; [Moxon, Simon] Genome Anal Ctr TGAC, Norwich NR4 7UH, Norfolk, England; [Patrushev, Ilya; Gilchrist, Michael J.] Mill Hill Lab, Francis Crick Inst, London NW7 1AA, England	University of East Anglia; The Genome Analysis Centre (TGAC); Francis Crick Institute	Wheeler, GN (corresponding author), Univ E Anglia, Sch Biol Sci, Norwich Res Pk, Norwich NR4 7TJ, Norfolk, England.	grant.wheeler@uea.ac.uk	VIAUT, Camille/A-4374-2018; Wheeler, Grant N/D-3023-2009; Munsterberg, Andrea E/E-2205-2011; Lopez-Gomollon, Sara/AAX-4442-2021; Lopez-Gomollon, Sara/C-6610-2013; Dalmay, Tamas/E-1377-2011	Wheeler, Grant N/0000-0002-4335-8577; Munsterberg, Andrea E/0000-0002-4577-4240; Lopez-Gomollon, Sara/0000-0001-8504-0340; Lopez-Gomollon, Sara/0000-0001-8504-0340; Dalmay, Tamas/0000-0003-1492-5429; Moxon, Simon/0000-0003-4644-1816	Francis Crick Institute; Cancer Research UK; UK Medical Research Council; Wellcome Trust; BBSRC DTP studentship; BBSRC Industrial Partnership Award [BB/H003525]; BBSRC [BB/K003437/1, BB/H003525/1, BB/D016444/1, BBS/E/T/000PR5885, BBS/E/T/000PR6193] Funding Source: UKRI; MRC [MC_U117597137] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/K003437/1, BBS/E/T/000PR6193, 1369578, BB/D016444/1, BBS/E/T/000PR5885, BB/H003525/1] Funding Source: researchfish; Medical Research Council [MC_U117597137] Funding Source: researchfish; The Francis Crick Institute [10082] Funding Source: researchfish	Francis Crick Institute; Cancer Research UK(Cancer Research UK); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); BBSRC DTP studentship(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC Industrial Partnership Award(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); The Francis Crick Institute	This project would not have been possible without the support of Exiqon. MJG and IP were supported by the Francis Crick Institute, which receives its core funding from Cancer Research UK, the UK Medical Research Council, and the Wellcome Trust. This project was also funded by BBSRC DTP studentship to NW and CV and a BBSRC Industrial Partnership Award (BB/H003525) to GW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript except for Exiqon who were involved in the design of the LNA probes used in the project.	Agrawal R, 2009, DEVELOPMENT, V136, P3927, DOI 10.1242/dev.037432; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bazzini AA, 2012, SCIENCE, V336, P233, DOI 10.1126/science.1215704; Bonnet E, 2004, BIOINFORMATICS, V20, P2911, DOI 10.1093/bioinformatics/bth374; Bowes JB, 2008, NUCLEIC ACIDS RES, V36, pD761, DOI 10.1093/nar/gkm826; Darnell DK, 2006, DEV DYNAM, V235, P3156, DOI 10.1002/dvdy.20956; Ebert MS, 2012, CELL, V149, P515, DOI 10.1016/j.cell.2012.04.005; Faber J., 1994, NORMAL TABLE XENOPUS, P2; Gilchrist MJ, 2009, DEV DYNAM, V238, P1379, DOI 10.1002/dvdy.21940; Goljanek-Whysall K, 2014, DEVELOPMENT, V141, P3378, DOI 10.1242/dev.108787; Goljanek-Whysall K, 2011, P NATL ACAD SCI USA, V108, P11936, DOI 10.1073/pnas.1105362108; Harrison M, 2004, DEV DYNAM, V231, P214, DOI 10.1002/dvdy.20113; Hawrylycz MJ, 2012, NATURE, V489, P391, DOI 10.1038/nature11405; HEMMATIBRIVANLOU A, 1990, DEVELOPMENT, V110, P325; Hsu SD, 2014, NUCLEIC ACIDS RES, V42, pD78, DOI 10.1093/nar/gkt1266; Hubbard SJ, 2005, GENOME RES, V15, P174, DOI 10.1101/gr.3011405; Hutvagner G, 2001, SCIENCE, V293, P834, DOI 10.1126/science.1062961; Karpinka JB, 2015, NUCLEIC ACIDS RES, V43, pD756, DOI 10.1093/nar/gku956; Kozomara A, 2014, NUCLEIC ACIDS RES, V42, pD68, DOI 10.1093/nar/gkt1181; Krol J, 2004, J BIOL CHEM, V279, P42230, DOI 10.1074/jbc.M404931200; Lee Y, 2004, EMBO J, V23, P4051, DOI 10.1038/sj.emboj.7600385; Lee Y, 2002, EMBO J, V21, P4663, DOI 10.1093/emboj/cdf476; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lopez-Gomollon S, 2011, METHODS MOL BIOL, V732, P25, DOI 10.1007/978-1-61779-083-6_3; Lorenz R, 2011, ALGORITHM MOL BIOL, V6, DOI 10.1186/1748-7188-6-26; Martello G, 2007, NATURE, V449, P183, DOI 10.1038/nature06100; Stocks MB, 2012, BIOINFORMATICS, V28, P2059, DOI 10.1093/bioinformatics/bts311; Sweetman D, 2008, DEV BIOL, V321, P491, DOI 10.1016/j.ydbio.2008.06.019; Sweetman D, 2006, DEV DYNAM, V235, P2185, DOI 10.1002/dvdy.20881; Walker JC, 2008, GENE EXPR PATTERNS, V8, P452, DOI 10.1016/j.gep.2008.03.002; Watanabe T, 2005, FEBS LETT, V579, P318, DOI 10.1016/j.febslet.2004.11.067; Wienholds E, 2005, SCIENCE, V309, P310, DOI 10.1126/science.1114519; Wylie AD, 2014, DEV BIOL, V386, P53, DOI 10.1016/j.ydbio.2013.12.003; Zhao Y, 2007, CELL, V129, P303, DOI 10.1016/j.cell.2007.03.030	34	16	16	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2015	10	10							e0138313	10.1371/journal.pone.0138313	http://dx.doi.org/10.1371/journal.pone.0138313			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU8PC	26506012	Green Published, Green Submitted, Green Accepted, gold			2022-12-26	WOS:000363804200002
J	Jiao, JJ; Zhang, XT; Liu, Y; Kuang, XX				Jiao, Jiu Jimmy; Zhang, Xiaotao; Liu, Yi; Kuang, Xingxing			Increased Water Storage in the Qaidam Basin, the North Tibet Plateau from GRACE Gravity Data	PLOS ONE			English	Article							GROUNDWATER DEPLETION; SOURCE REGION; PERMAFROST; SIMULATION; DISCHARGE; CHINA; LAKES	Groundwater plays a key role in maintaining the ecology and environment in the hyperarid Qaidam Basin (QB). Indirect evidence and data from sparse observation wells suggest that groundwater in the QB is increasing but there has been no regional assessment of the groundwater conditions in the entire basin because of its remoteness and the severity of the arid environment. Here we report changes in the spatial and temporal distribution of terrestrial water storage (TWS) in the northern Tibetan Plateau (NTP) using Gravity Recovery and Climate Experiment (GRACE) data. Our study confirms long-term (2003-2012) TWS increases in the NTP. Between 2003 and 2012 the TWS increased by 88.4 and 20.6 km(3) in the NTP and the QB, respectively, which is 225% and 52% of the capacity of the Three Gorges Reservoir, respectively. Soil and water changes from the Global Land Data Assimilation System (GLDAS) were also used to identify groundwater storage in the TWS and to demonstrate a long-term increase in groundwater storage in the QB. We demonstrate that increases in groundwater, not lake water, are dominant in the QB, as observed by groundwater levels. Our study suggests that the TWS increase was likely caused by a regional increase in precipitation and a decrease in evaporation. Degradation of the permafrost increases the thickness of the active layers providing increased storage for infiltrated precipitation and snow and ice melt water, which may also contribute to the increased TWS. The huge increase of water storage in the NTP will have profound effects, not only on local ecology and environment, but also on global water storage and sea level changes.	[Jiao, Jiu Jimmy; Zhang, Xiaotao; Liu, Yi; Kuang, Xingxing] Univ Hong Kong, Dept Earth Sci, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong	Jiao, JJ (corresponding author), Univ Hong Kong, Dept Earth Sci, Pokfulam Rd, Hong Kong, Hong Kong, Peoples R China.	jjiao@hku.hk	Jiao, Jiu/B-5185-2008; Kuang, Xingxing/F-6080-2019; Liu, Yi/L-7400-2019	Jiao, Jiu/0000-0002-7180-6488; Liu, Yi/0000-0002-4951-8391	General Fund of the Research Grants Council; Hong Kong Special Administrative Region, China [HKU 703109P]; National Natural Science Foundation of China [41372261]; AXA Research Fund Post-Doctoral Fellowship	General Fund of the Research Grants Council; Hong Kong Special Administrative Region, China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); AXA Research Fund Post-Doctoral Fellowship	This study was supported financially by the General Fund of the Research Grants Council, the Hong Kong Special Administrative Region, China (HKU 703109P), National Natural Science Foundation of China (No. 41372261), and an AXA Research Fund Post-Doctoral Fellowship awarded to X.K.	Andermann C, 2012, NAT GEOSCI, V5, P127, DOI [10.1038/ngeo1356, 10.1038/NGEO1356]; [Anonymous], 2015, ENVIRON RES LETT, DOI DOI 10.1088/1748-9326/10/3/034013; Bao Z, 2010, J QINGHAI U NATURE S, V28, P54; [Cao Ge 高歌], 2006, Journal of Geographical Sciences, V16, P3, DOI 10.1007/s11442-006-0101-7; Chen SB, 2006, CLIMATIC CHANGE, V76, P291, DOI 10.1007/s10584-006-9080-z; Cheng GD, 2007, J GEOPHYS RES-EARTH, V112, DOI 10.1029/2006JF000631; Cheng GD, 2013, HYDROGEOL J, V21, P5, DOI 10.1007/s10040-012-0927-2; China Geological Survey, 2008, INV ASS GROUNDW RES; Dong ZB, 2000, J SOIL WATER CONSERV, V55, P439; Fasullo JT, 2013, GEOPHYS RES LETT, V40, P4368, DOI 10.1002/grl.50834; Fu YN, 2012, J GEOPHYS RES-SOL EA, V117, DOI 10.1029/2011JB008925; Gardner AS, 2013, SCIENCE, V340, P852, DOI 10.1126/science.1234532; Guo DL, 2013, J GEOPHYS RES-ATMOS, V118, P5216, DOI 10.1002/jgrd.50457; Guo DL, 2012, J GEOPHYS RES-ATMOS, V117, DOI 10.1029/2011JD016545; Jacob T, 2012, NATURE, V482, P514, DOI 10.1038/nature10847; Jiang CR, 2009, PEOPLES DAILY ONLINE; Jiao JJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep08960; Jin HJ, 2009, ENVIRON RES LETT, V4, DOI 10.1088/1748-9326/4/4/045206; Li R, 2012, CHINESE SCI BULL, V57, P4609, DOI 10.1007/s11434-012-5323-8; Matsuo K, 2010, EARTH PLANET SC LETT, V290, P30, DOI 10.1016/j.epsl.2009.11.053; Moiwo JP, 2011, WATER RESOUR RES, V47, DOI 10.1029/2010WR010157; Muskett RR, 2008, EGU GEN ASSEMBLY, V2008; Pokhrel YN, 2013, J GEOPHYS RES-ATMOS, V118, P3233, DOI 10.1002/jgrd.50335; Qian KZ, 2012, J ARID LAND, V4, P113, DOI 10.3724/SP.J.1227.2012.00113; Qinghai Provincial Climate Monitoring and Assessment Centre, 2009, REP ASS CLIM CHANG Q; Qiu J, 2008, NATURE, V454, P393, DOI 10.1038/454393a; Ran YH, 2012, PERMAFROST PERIGLAC, V23, P322, DOI 10.1002/ppp.1756; Rodell M, 2007, HYDROGEOL J, V15, P159, DOI 10.1007/s10040-006-0103-7; Rodell M, 2009, NATURE, V460, P999, DOI 10.1038/nature08238; Schaner N, 2012, ENVIRON RES LETT, V7, DOI 10.1088/1748-9326/7/3/034029; Song CQ, 2014, WATER RESOUR RES, V50, P3170, DOI 10.1002/2013WR014724; Swenson S, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL025285; Tiwari VM, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL039401; Voss KA, 2013, WATER RESOUR RES, V49, P904, DOI 10.1002/wrcr.20078; Phan VH, 2012, INT J APPL EARTH OBS, V17, P12, DOI 10.1016/j.jag.2011.09.015; Wang XJ, 2014, INT J CLIMATOL, V34, P1524, DOI 10.1002/joc.3781; WILLIAMS JR, 1970, 696 US GEOL SURV; Wu TH, 2005, COLD REG SCI TECHNOL, V41, P211, DOI 10.1016/j.coldregions.2004.10.006; Xu M, 2013, J ARID LAND, V5, P384, DOI 10.1007/s40333-013-0169-8; Xu XD, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL035867; Yuan WH, 2012, GEOMORPHOLOGY, V147, P27, DOI 10.1016/j.geomorph.2011.06.039; Zhang GQ, 2013, GEOPHYS RES LETT, V40, P2125, DOI 10.1002/grl.50462; Zhang GQ, 2011, REMOTE SENS ENVIRON, V115, P1733, DOI 10.1016/j.rse.2011.03.005; Zhang LL, 2013, J GEOPHYS RES-ATMOS, V118, P8500, DOI 10.1002/jgrd.50665; Zhang XD, 2013, NAT CLIM CHANGE, V3, P47, DOI [10.1038/nclimate1631, 10.1038/NCLIMATE1631]; Zhang YQ, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2006JD008161	46	49	50	9	91	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2015	10	10							e0141442	10.1371/journal.pone.0141442	http://dx.doi.org/10.1371/journal.pone.0141442			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU8PC	26506230	Green Published, gold, Green Submitted			2022-12-26	WOS:000363804200070
J	Kide, SO; Mante, C; Dubroca, L; Demarcq, H; Merigot, B				Kide, Saikou Oumar; Mante, Claude; Dubroca, Laurent; Demarcq, Herve; Merigot, Bastien			Spatio-Temporal Dynamics of Exploited Groundfish Species Assemblages Faced to Environmental and Fishing Forcings: Insights from the Mauritanian Exclusive Economic Zone	PLOS ONE			English	Article							CO-INERTIA ANALYSIS; CONTINENTAL-SHELF; DEMERSAL ASSEMBLAGES; COMMUNITY STRUCTURE; UPWELLING AREA; UPPER SLOPE; NORTHWEST AFRICA; INTERANNUAL VARIABILITY; SPATIAL-PATTERNS; WEST-AFRICA	Environmental changes and human activities can have strong impacts on biodiversity and ecosystem functioning. This study investigates how, from a quantitative point of view, simultaneously both environmental and anthropogenic factors affect species composition and abundance of exploited groundfish assemblages (i.e. target and non-target species) at large spatio-temporal scales. We aim to investigate (1) the spatial and annual stability of groundfish assemblages, (2) relationships between these assemblages and structuring factors in order to better explain the dynamic of the assemblages' structure. The Mauritanian Exclusive Economic Zone (MEEZ) is of particular interest as it embeds a productive ecosystem due to upwelling, producing abundant and diverse resources which constitute an attractive socio-economic development. We applied the multi-variate and multi-table STATICO method on a data set consisting of 854 hauls collected during 14-years (1997-2010) from scientific trawl surveys (species abundance), logbooks of industrial fishery (fishing effort), sea surface temperature and chlorophyll a concentration as environmental variables. Our results showed that abiotic factors drove four main persistent fish assemblages. Overall, chlorophyll a concentration and sea surface temperature mainly influenced the structure of assemblages of coastal soft bottoms and those of the offshore near rocky bottoms where upwellings held. While highest levels of fishing effort were located in the northern permanent upwelling zone, effects of this variable on species composition and abundances of assemblages were relatively low, even if not negligible in some years and areas. The temporal trajectories between environmental and fishing conditions and assemblages did not match for all the entire time series analyzed in the MEEZ, but interestingly for some specific years and areas. The quantitative approach used in this work may provide to stakeholders, scientists and fishers a useful assessment for the spatio-temporal dynamics of exploited assemblages under stable or changing conditions in fishing and environment.	[Kide, Saikou Oumar] Inst Mauritanien Rech Oceanog & Peches, Lab Biol & Ecol Organismes Aquat, Nouadhibou, Mauritania; [Kide, Saikou Oumar; Mante, Claude] Aix Marseille Univ, Mediterranean Inst Oceanog, Marseille, France; [Dubroca, Laurent] IFREMER, F-14520 Port En Bessin Huppain, France; [Demarcq, Herve] IRD, UMR MARBEC 9190, Ctr Rech Halieut Mediterraneenne, Sete, France; [Merigot, Bastien] Univ Montpellier, UMR MARBEC 9190, Ctr Rech Halieut Mediterraneenne, Sete, France	UDICE-French Research Universities; Aix-Marseille Universite; Ifremer; Ifremer; Institut de Recherche pour le Developpement (IRD); Ifremer; Universite de Montpellier	Kide, SO (corresponding author), Inst Mauritanien Rech Oceanog & Peches, Lab Biol & Ecol Organismes Aquat, Nouadhibou, Mauritania.	sokidefr@yahoo.fr	Mérigot, Bastien/H-7754-2018; Mérigot, Bastien/M-7052-2019; Dubroca, Laurent/AAS-5187-2021; Demarcq, Herve/AAU-6514-2020	Mérigot, Bastien/0000-0001-5264-4324; Mérigot, Bastien/0000-0001-5264-4324; Dubroca, Laurent/0000-0002-1861-0507; Demarcq, Herve/0000-0003-1995-1183; Mante, Claude/0000-0002-7268-9789	Mauritanian Institute of Oceanographic Researches and Fisheries (IMROP); Department of Cooperation and Cultural Action (SCAC) of the Embassy of France in Mauritania; Aix-Marseille Universite	Mauritanian Institute of Oceanographic Researches and Fisheries (IMROP); Department of Cooperation and Cultural Action (SCAC) of the Embassy of France in Mauritania; Aix-Marseille Universite	This work had financial support in the form of grants (four stays in Aix-Marseille University) by the Mauritanian Institute of Oceanographic Researches and Fisheries (IMROP) and the Department of Cooperation and Cultural Action (SCAC) of the Embassy of France in Mauritania. SOK has received funding during these four stays in Aix-Marseille Universite. The data were collected by the Mauritanian Institute of Oceanographic Researches and Fisheries and allowed their publications.	[Anonymous], 2014, R LANG ENV STAT COMP; ANSARI ZA, 1995, ESTUAR COAST SHELF S, V41, P593, DOI 10.1016/0272-7714(95)90029-2; ARFI R, 1987, OCEANOL ACTA, V10, P151; Baeta F, 2010, FISH RES, V102, P123, DOI 10.1016/j.fishres.2009.10.016; Bast D, 1983, B CTR NAT RECH OCEAN, V11, P157; Bast D, 1984, B CTR NAT RECH OCEAN, V12, P149; Bast D, 1984, B CTR NAT RECH OCEAN, V12, P127; Bergerard P., 1983, B CTR NAT RECH OCEAN, V11, P217; Bianchi G, 2000, ICES J MAR SCI, V57, P558, DOI 10.1006/jmsc.2000.0727; BIANCHI G, 1991, MAR ECOL PROG SER, V73, P121, DOI 10.3354/meps073121; BIANCHI G, 1992, MAR ECOL PROG SER, V81, P101, DOI 10.3354/meps081101; BIANCHI G, 1992, MAR ECOL PROG SER, V85, P9, DOI 10.3354/meps085009; Blanchard F, 2004, MAR ECOL PROG SER, V280, P249, DOI 10.3354/meps280249; Bosman SH, 2011, ESTUAR COAST SHELF S, V92, P232, DOI 10.1016/j.ecss.2010.12.036; Boulangeat I, 2012, ECOL LETT, V15, P584, DOI 10.1111/j.1461-0248.2012.01772.x; Brulhet J, 1973, B CTR NAT RECH OCEAN, V2, P57; Brulhet J, 1974, B LAB PECHES NOUADHI, V3, P77; Cavieres LA, 2014, ECOL LETT, V17, P193, DOI 10.1111/ele.12217; Cheung WWL, 2013, NATURE, V497, P365, DOI 10.1038/nature12156; Cheung WWL, 2010, GLOBAL CHANGE BIOL, V16, P24, DOI 10.1111/j.1365-2486.2009.01995.x; Christensen V., 2011, ECOSYSTEM APPROACHES, DOI 10.1017/CBO9780511920943; Colloca F, 2003, ESTUAR COAST SHELF S, V56, P469, DOI 10.1016/S0272-7714(02)00196-8; Costanza R, 1998, SCIENCE, V281, P198, DOI 10.1126/science.281.5374.198; Cury PM, 2008, TRENDS ECOL EVOL, V23, P338, DOI 10.1016/j.tree.2008.02.005; DOLEDEC S, 1994, FRESHWATER BIOL, V31, P277, DOI 10.1111/j.1365-2427.1994.tb01741.x; Domain F., 1985, RAPP GROUP TRAV CNRO; Domain F, 1980, THESIS U PARIS 6; Dray S, 2003, ECOLOGY, V84, P3078, DOI 10.1890/03-0178; Dubrovin B., 1991, B CTR NAT RECH OCEAN, V23, P6; Ferreira T, 2007, FISHERIES MANAG ECOL, V14, P473, DOI 10.1111/j.1365-2400.2007.00584.x; Filipsson HL, 2011, J QUATERNARY SCI, V26, P448, DOI 10.1002/jqs.1473; Freon P, 2006, LAR MAR ECOSYST, V14, P185; FUJITA T, 1995, MAR ECOL PROG SER, V118, P13, DOI 10.3354/meps118013; Garcia CB, 1998, MAR ECOL PROG SER, V174, P13, DOI 10.3354/meps174013; Garcia S, 1986, CECAF ECAF SERIES, V83, P1; Gascuel D, 2007, AFR J MAR SCI, V29, P331, DOI 10.2989/AJMS.2007.29.3.3.333; Gascuel D, 2006, RAPP 6 GROUP TRAV EV; Gaudechoux JP, 1984, B CTR NAT RECH OCEAN, V12, P114; Genner MJ, 2010, GLOBAL CHANGE BIOL, V16, P517, DOI 10.1111/j.1365-2486.2009.02027.x; GILLBRICHT M, 1977, HELGOLAND WISS MEER, V29, P417, DOI 10.1007/BF01609981; Giller PS, 2004, OIKOS, V104, P423, DOI 10.1111/j.0030-1299.2004.13253.x; Greenstreet SPR, 1999, FISH RES, V40, P107, DOI 10.1016/S0165-7836(98)00207-0; Greenstreet SPR, 1996, J ANIM ECOL, V65, P577, DOI 10.2307/5738; Hagen E, 2001, OCEANOL ACTA, V24, pS113; Harley CDG, 2006, ECOL LETT, V9, P228, DOI 10.1111/j.1461-0248.2005.00871.x; Hollingworth C, 2000, ICES J MAR SCI, V57, P465, DOI 10.1006/jmsc.2000.0745; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; HUGHES P, 1974, DEEP-SEA RES, V21, P611, DOI 10.1016/0011-7471(74)90046-1; Hughes TP, 2005, TRENDS ECOL EVOL, V20, P380, DOI 10.1016/j.tree.2005.03.022; Jannot JE, 2013, ECOL APPL, V23, P1645, DOI 10.1890/12-2225.1; Jaureguizar AJ, 2006, FISH OCEANOGR, V15, P326, DOI 10.1111/j.1365-2419.2006.00405.x; Josse E, 1986, COPACE PACE SERIES; Jouffre D, 2005, ICES J MAR SCI, V62, P380, DOI 10.1016/j.icesjms.2004.11.007; Klaoudatos Dimitris, 2010, International Aquatic Research, V2, P143; Koranteng KA, 2001, MAR ECOL PROG SER, V220, P1, DOI 10.3354/meps220001; Labropoulou M, 2005, BELG J ZOOL, V135, P191; Laurans M, 2004, AQUAT LIVING RESOUR, V17, P163, DOI 10.1051/alr:2004023; LAVIT C, 1994, COMPUT STAT DATA AN, V18, P97, DOI 10.1016/0167-9473(94)90134-1; Levin PS, 2006, CONSERV BIOL, V20, P1181, DOI 10.1111/j.1523-1739.2006.00400.x; Llinas O, 1996, OCEANOGRAFIA RECURSO; Loktionov Y, 1989, B CTR NAT RECH OCEAN, V18, P1; Loreau M, 1999, AM NAT, V154, P427, DOI 10.1086/303252; Lozano Cabo F, 1968, SANTA CRUZ TENERIFE, V38, P1; Lozano Cabo F, 1950, B R SOC ESPA HIST NA, V48, P5; Mazzocchi MG, 2012, PROG OCEANOGR, V97, P135, DOI 10.1016/j.pocean.2011.11.003; Menezes GM, 2006, MAR ECOL PROG SER, V324, P241, DOI 10.3354/meps324241; Merigot B, 2010, ECOLOGY, V91, P1850, DOI 10.1890/09-1387.1; Minas H. J., 1982, RAPPORTS PROCES VERB, V180, P148; MITTELSTAEDT E, 1991, PROG OCEANOGR, V26, P307, DOI 10.1016/0079-6611(91)90011-A; MITTELSTAEDT E, 1983, PROG OCEANOGR, V12, P307, DOI 10.1016/0079-6611(83)90012-5; Moranta J, 1998, MAR ECOL PROG SER, V171, P247, DOI 10.3354/meps171247; Pauly D, 2002, NATURE, V418, P689, DOI 10.1038/nature01017; Pradhan Y, 2006, DEEP-SEA RES PT II, V53, P1548, DOI 10.1016/j.dsr2.2006.05.016; Queirolo D, 2011, FISH RES, V110, P149, DOI 10.1016/j.fishres.2011.04.001; ROY C, 1992, S AFR J MARINE SCI, V12, P135; Schemainda R, 1975, GEODATISCHE GEOPHYS, V4, P4; Simpson SD, 2011, CURR BIOL, V21, P1565, DOI 10.1016/j.cub.2011.08.016; Soberon J, 2007, ECOL LETT, V10, P1115, DOI 10.1111/j.1461-0248.2007.01107.x; THIOULOUSE J, 1987, ACTA OECOL-OEC GEN, V8, P463; Thioulouse J, 2004, ECOLOGY, V85, P272, DOI 10.1890/02-0605; Tian YJ, 2011, FISH RES, V112, P140, DOI 10.1016/j.fishres.2011.01.034; Tibshirani R, 2001, J ROY STAT SOC B, V63, P411, DOI 10.1111/1467-9868.00293; Tixerant G, 1968, CHAL EXP 1963 1965 P; Tolimieri N, 2006, T AM FISH SOC, V135, P317, DOI 10.1577/T05-092.1; Vaz S, 2007, ICES J MAR SCI, V64, P271, DOI 10.1093/icesjms/fsl031; WOOSTER WS, 1976, J MAR RES, V34, P131; Yemane D, 2005, ICES J MAR SCI, V62, P374, DOI 10.1016/j.icesjms.2005.01.009; Zeeberg J, 2006, FISH RES, V78, P186, DOI 10.1016/j.fishres.2006.01.012	88	12	12	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2015	10	10							e0141566	10.1371/journal.pone.0141566	http://dx.doi.org/10.1371/journal.pone.0141566			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU8PC	26505198	Green Published, gold, Green Submitted			2022-12-26	WOS:000363804200085
J	Wagner, GK; Pesnot, T; Palcic, MM; Jorgensen, R				Wagner, Gerd K.; Pesnot, Thomas; Palcic, Monica M.; Jorgensen, Rene			Novel UDP-GaINAc Derivative Structures Provide Insight into the Donor Specificity of Human Blood Group Glycosyltransferase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CLOSTRIDIUM-DIFFICILE TOXIN; GROUP-A GLYCOSYLTRANSFERASE; GROUP-B; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; SUBSTRATE; INHIBITORS; ANALOGS; BINDING; SUGARS	Two closely related glycosyltransferases are responsible for the final step of the biosynthesis of ABO(H) human blood group A and B antigens. The two enzymes differ by only four amino acid residues, which determine whether the enzymes transfer GalNAc from UDP-GalNAc or Gal from UDP-Gal to the H-antigen acceptor. The enzymes belong to the class of GT-A folded enzymes, grouped as GT6 in the CAZy database, and are characterized by a single domain with a metal dependent retaining reaction mechanism. However, the exact role of the four amino acid residues in the specificity of the enzymes is still unresolved. In this study, we report the first structural information of a dual specificity cis-AB blood group glycosyltransferase in complex with a synthetic UDP-GalNAc derivative. Interestingly, the GalNAc moiety adopts an unusual yet catalytically productive conformation in the binding pocket, which is different from the "tucked under" conformation previously observed for the UDPGal donor. In addition, we show that this UDP-GalNAc derivative in complex with the H-antigen acceptor provokes the same unusual binding pocket closure as seen for the corresponding UDP-Gal derivative. Despite this, the two derivatives show vastly different kinetic properties. Our results provide a important structural insight into the donor substrate specificity and utilization in blood group biosynthesis, which can very likely be exploited for the development of new glycosyltransferase inhibitors and probes.	[Wagner, Gerd K.] Kings Coll London, Fac Nat & Math Sci, Dept Chem, London SE1 1DB, England; [Pesnot, Thomas] Univ E Anglia, Sch Pharm, Norwich NR4 7TJ, Norfolk, England; [Palcic, Monica M.; Jorgensen, Rene] Carlsberg Lab, DK-1799 Copenhagen V, Denmark	University of London; King's College London; University of East Anglia	Jorgensen, R (corresponding author), Statens Serum Inst, Dept Microbiol & Infect Control, DK-2300 Copenhagen S, Denmark.	renj@ssi.dk	Wagner, Gerd/D-4759-2013; Jørgensen, René/P-5619-2014	Wagner, Gerd/0000-0003-1086-2301; Jørgensen, René/0000-0003-0672-466X	Engineering and Physical Sciences Research Council [EP/D059186/1]; Medical Research Council [G0901746]; Danish Council for Independent Research/Natural Sciences; DFF-Sapere Aude Starting Grant from the Danish Council for Independent Research Grant [11-104831/FSS]; EPSRC [EP/D059186/1] Funding Source: UKRI; MRC [G0901746] Funding Source: UKRI	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Danish Council for Independent Research/Natural Sciences(Det Frie Forskningsrad (DFF)); DFF-Sapere Aude Starting Grant from the Danish Council for Independent Research Grant; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported in part by Engineering and Physical Sciences Research Council Grant EP/D059186/1 (to G. K. W.), Medical Research Council Grant G0901746 (to G. K. W.), and the Danish Council for Independent Research/Natural Sciences (FNU, to M. M. P.). The authors declare that they have no conflicts of interests of this article.; Supported by the DFF-Sapere Aude Starting Grant from the Danish Council for Independent Research Grant 11-104831/FSS.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Alfaro JA, 2008, J BIOL CHEM, V283, P10097, DOI 10.1074/jbc.M708669200; Breton C, 2012, CURR OPIN STRUC BIOL, V22, P540, DOI 10.1016/j.sbi.2012.06.007; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Collier A, 2008, CHEM COMMUN, P178, DOI 10.1039/b714379f; Descroix K, 2012, J MED CHEM, V55, P2015, DOI 10.1021/jm201154p; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evitt A, 2012, CHEM COMMUN, V48, P11856, DOI 10.1039/c2cc36798j; Gastinel LN, 2001, EMBO J, V20, P638, DOI 10.1093/emboj/20.4.638; Gloster TM, 2011, NAT CHEM BIOL, V7, P174, DOI 10.1038/NCHEMBIO.520; Jorgensen R, 2013, J BIOL CHEM, V288, P26201, DOI 10.1074/jbc.M113.465963; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Laferte S, 2000, EUR J BIOCHEM, V267, P4840, DOI 10.1046/j.1432-1327.2000.01544.x; Lairson LL, 2008, ANNU REV BIOCHEM, V77, P521, DOI 10.1146/annurev.biochem.76.061005.092322; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Negishi M, 2003, BIOCHEM BIOPH RES CO, V303, P393, DOI 10.1016/S0006-291X(03)00356-5; Persson K, 2001, NAT STRUCT BIOL, V8, P166, DOI 10.1038/84168; Pesnot T, 2008, ORG BIOMOL CHEM, V6, P2884, DOI 10.1039/b805216f; Pesnot T, 2010, CHEMBIOCHEM, V11, P1392, DOI 10.1002/cbic.201000013; Pesnot T, 2010, NAT CHEM BIOL, V6, P321, DOI 10.1038/nchembio.343; Pham TTK, 2014, J BIOL CHEM, V289, P8041, DOI 10.1074/jbc.M113.545384; Pruitt RN, 2012, J BIOL CHEM, V287, P8013, DOI 10.1074/jbc.M111.298414; Ramakrishnan B, 2002, J BIOL CHEM, V277, P20833, DOI 10.1074/jbc.M111183200; Ramakrishnan B, 2002, J MOL BIOL, V318, P491, DOI 10.1016/S0022-2836(02)00020-7; Reinert DJ, 2005, J MOL BIOL, V351, P973, DOI 10.1016/j.jmb.2005.06.071; Rillahan CD, 2012, NAT CHEM BIOL, V8, P661, DOI [10.1038/NCHEMBIO.999, 10.1038/nchembio.999]; Seto NOL, 1999, EUR J BIOCHEM, V259, P770, DOI 10.1046/j.1432-1327.1999.00086.x; Seto NOL, 1997, J BIOL CHEM, V272, P14133, DOI 10.1074/jbc.272.22.14133; SETO NOL, 1995, EUR J BIOCHEM, V234, P323, DOI 10.1111/j.1432-1033.1995.323_c.x; Sheng F, 2009, J BIOL CHEM, V284, P17796, DOI 10.1074/jbc.M809804200; Sindhuwinata N, 2010, GLYCOBIOLOGY, V20, P718, DOI 10.1093/glycob/cwq019; Soya N, 2009, GLYCOBIOLOGY, V19, P1224, DOI 10.1093/glycob/cwp114; Tedaldi LM, 2012, CARBOHYD RES, V364, P22, DOI 10.1016/j.carres.2012.10.009; Unligil UM, 2000, EMBO J, V19, P5269, DOI 10.1093/emboj/19.20.5269; Wagstaff BA, 2015, CARBOHYD RES, V404, P17, DOI 10.1016/j.carres.2014.12.005; Weadge J. T., 2008, WILEY ENCY CHEM BIOL, V2, P198; Wittmann V, 1997, J ORG CHEM, V62, P2144, DOI 10.1021/jo9620066; YAMAMOTO F, 1990, J BIOL CHEM, V265, P19257; YAMAMOTO F, 1990, NATURE, V345, P229, DOI 10.1038/345229a0; Yamamoto F, 2012, TRANSFUS MED REV, V26, P103, DOI 10.1016/j.tmrv.2011.08.002; Yamamoto M, 2001, J BIOL CHEM, V276, P13701, DOI 10.1074/jbc.M010805200; Zheng Y, 2011, J BIOL CHEM, V286, P36108, DOI 10.1074/jbc.M111.275974	44	7	7	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 25	2015	290	52					31162	31172		10.1074/jbc.M115.681262	http://dx.doi.org/10.1074/jbc.M115.681262			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CZ6GK	26527682	hybrid, Green Published			2022-12-26	WOS:000367199000043
J	Erbel, C; Korosoglou, G; Ler, P; Akhavanpoor, M; Domschke, G; Linden, F; Doesch, AO; Buss, SJ; Giannitsis, E; Katus, HA; Gleissner, CA				Erbel, Christian; Korosoglou, Grigorios; Ler, Pearlyn; Akhavanpoor, Mohammadreza; Domschke, Gabriele; Linden, Fabian; Doesch, Andreas O.; Buss, Sebastian J.; Giannitsis, Evangelos; Katus, Hugo A.; Gleissner, Christian A.			CXCL4 Plasma Levels Are Not Associated with the Extent of Coronary Artery Disease or with Coronary Plaque Morphology	PLOS ONE			English	Article							PLATELET FACTOR 4; BETA-THROMBOGLOBULIN; INFLAMMATORY MECHANISMS; PLATELET-FACTOR-4; ATHEROSCLEROSIS; ACTIVATION; FACTOR-4; CHEMOKINES; PF4	Background CXCL4 is a platelet chemokine released at micromolar concentrations upon platelet activation. CXCL4 has been shown to promote atherogenesis by various mechanisms. However, data on CXCL4 plasma levels in patients with coronary artery disease are largely inconclusive. Computed coronary artery angiography (CCTA) represents an excellent tool to quantify and characterize coronary atherosclerotic plaques. We hypothesized that increased CXCL4 plasma levels may be associated with features of plaque instability resulting in adverse cardiovascular events. Specifically, we sought to determine whether CXCL4 levels are correlated with specific features of coronary artery disease including (1) plaque volume, (2) calcium score, (3) degree of stenosis, or (4) vascular remodeling. Methods and Results CXCL4 plasma levels were measured by ELISA in 217 patients undergoing CCTA for suspected CAD (mean age 64.2 +/- 9.4 years, 107 (49.3%) male). Mean CXCL4 plasma levels were 12.5 +/- 4.6 ng/mL. There was no significant correlation between CXCL4 levels and any clinical or demographic parameters including cardiovascular risk factors. CXCL4 plasma levels did not differ between patient with or without coronary artery disease (CAD: 12.5 +/- 4.5 ng/ml, no CAD: 12.5 +/- 4.8 ng/ml). Neither univariate nor multivariate analysis showed an association between CXCL4 levels and plaque volume, total calcium score, degree of stenosis, or vascular remodeling. Subgroup analysis of patients with CAD as confirmed by CCTA did not show any association of CXCL4 levels with the extent of CAD. Conclusions While CXCL4 may be present and active within the arterial wall, local increase of CXCL4 may not translate into systemically elevated CXCL4 levels. Further studies will have to test whether CXCL4 may still represent a suitable therapeutic target in human atherosclerosis.	[Erbel, Christian; Korosoglou, Grigorios; Ler, Pearlyn; Akhavanpoor, Mohammadreza; Domschke, Gabriele; Linden, Fabian; Doesch, Andreas O.; Buss, Sebastian J.; Giannitsis, Evangelos; Katus, Hugo A.; Gleissner, Christian A.] Univ Heidelberg Hosp, Dept Cardiol, D-69120 Heidelberg, Germany; [Erbel, Christian; Ler, Pearlyn; Akhavanpoor, Mohammadreza; Domschke, Gabriele; Linden, Fabian; Doesch, Andreas O.; Buss, Sebastian J.; Giannitsis, Evangelos; Katus, Hugo A.; Gleissner, Christian A.] DZHK German Ctr Cardiovasc Res, Heidelberg, Germany	Ruprecht Karls University Heidelberg; German Centre for Cardiovascular Research	Gleissner, CA (corresponding author), Univ Heidelberg Hosp, Dept Cardiol, Im Neuenheimer Feld 410, D-69120 Heidelberg, Germany.	christian.gleissner@med.uni-heidelberg.de			Ernst und Berta Grimmke-Stiftung [10/14]; DZHK (German Centre for Cardiovascular Research); BMBF (German Ministry of Education and Research)	Ernst und Berta Grimmke-Stiftung; DZHK (German Centre for Cardiovascular Research); BMBF (German Ministry of Education and Research)(Federal Ministry of Education & Research (BMBF))	This work was funded by the Ernst und Berta Grimmke-Stiftung (10/14) to F.L. and C.A.G. and by the DZHK (German Centre for Cardiovascular Research) and the BMBF (German Ministry of Education and Research) to H.A.K.	ABE S, 1994, INT J CARDIOL, V47, pS7, DOI 10.1016/0167-5273(94)90320-4; Akhavanpoor M, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00296; Brandt E, 2000, J LEUKOCYTE BIOL, V67, P471, DOI 10.1002/jlb.67.4.471; CELLA G, 1983, THROMB RES, V29, P499, DOI 10.1016/0049-3848(83)90345-6; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; DECATERINA R, 1988, EUR HEART J, V9, P913, DOI 10.1093/oxfordjournals.eurheartj.a062587; Erbel C, 2014, INNATE IMMUN; Erbel C, 2015, INT J CARDI IN PRESS; Erbel C, 2015, INNATE IMMUN-LONDON, V21, P255, DOI 10.1177/1753425914526461; FUSTER V, 1975, THROMB DIATH HAEMOST, V34, P601; Galkina E, 2009, ANNU REV IMMUNOL, V27, P165, DOI 10.1146/annurev.immunol.021908.132620; Gleissner CA, 2012, CURR VASC P IN PRESS; Gleissner CA, 2008, ARTERIOSCL THROM VAS, V28, P1920, DOI 10.1161/ATVBAHA.108.169417; Gleissner CA, 2015, CLIN RES CARDIOL, V104, P13, DOI 10.1007/s00392-014-0750-y; Gleissner CA, 2010, J IMMUNOL, V184, P4810, DOI 10.4049/jimmunol.0901368; Gleissner CA, 2010, CIRC RES, V106, P203, DOI 10.1161/CIRCRESAHA.109.199505; Go AS, 2014, CIRCULATION, V129, pE28, DOI 10.1161/01.cir.0000441139.02102.80; Grundy SM, 2004, CIRCULATION, V110, P227, DOI 10.1161/01.CIR.0000133317.49796.0E; Hansson GK, 2009, J THROMB HAEMOST, V7, P328, DOI 10.1111/j.1538-7836.2009.03416.x; Huo YQ, 2003, NAT MED, V9, P61, DOI 10.1038/nm810; Koenen RR, 2009, NAT MED, V15, P97, DOI 10.1038/nm.1898; Korosoglou G, 2011, HEART, V97, P823, DOI 10.1136/hrt.2010.193201; LaghrissiThode F, 1997, BIOL PSYCHIAT, V42, P290, DOI 10.1016/S0006-3223(96)00345-9; LEVINE SP, 1977, THROMB RES, V11, P673, DOI 10.1016/0049-3848(77)90025-1; LEVINE SP, 1981, CIRCULATION, V64, P626, DOI 10.1161/01.CIR.64.3.626; NICHOLS AB, 1982, BLOOD, V60, P650; Pitsilos S, 2003, THROMB HAEMOSTASIS, V90, P1112, DOI 10.1160/TH03-02-0069; Sachais BS, 2007, THROMB HAEMOSTASIS, V98, P1108, DOI 10.1160/TH07-04-0271; SADAYASU T, 1991, CLIN CARDIOL, V14, P725, DOI 10.1002/clc.4960140906; Scheuerer B, 2000, BLOOD, V95, P1158, DOI 10.1182/blood.V95.4.1158.004k31_1158_1166; STRAUSS WE, 1985, AM HEART J, V110, P293, DOI 10.1016/0002-8703(85)90147-4; von Hundelshausen P, 2005, BLOOD, V105, P924, DOI 10.1182/blood-2004-06-2475; Weber C, 2011, NAT MED, V17, P1410, DOI 10.1038/nm.2538; WHELTON PK, 1994, LANCET, V344, P101, DOI 10.1016/S0140-6736(94)91285-8	34	8	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2015	10	11							e0141693	10.1371/journal.pone.0141693	http://dx.doi.org/10.1371/journal.pone.0141693			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV1PG	26524462	Green Published, gold, Green Submitted			2022-12-26	WOS:000364029800018
J	Neves, MP; Delariva, RL; Guimaraes, ATB; Sanches, PV				Neves, Mayara Pereira; Delariva, Rosilene Luciana; Bittencourt Guimaraes, Ana Tereza; Sanches, Paulo Vanderlei			Carnivory during Ontogeny of the Plagioscion squamosissimus: A Successful Non-Native Fish in a Lentic Environment of the Upper Parana River Basin	PLOS ONE			English	Article							TEMPORAL DISTRIBUTION; FEEDING SELECTIVITY; MATO-GROSSO; LARVAE; CANNIBALISM; ASSEMBLAGES; PATTERNS; ICHTHYOPLANKTON; PERCIFORMES; SCIANIDAE	This study evaluated feeding patterns and ontogenetic variations in a non-native fish species (Plagioscion squamosissimus) in an isolated lake in the Upper Parana River floodplain. Quarterly samplings were performed from April 2005 to February 2006 using plankton nets to capture larvae, seining nets for juveniles, and gill nets and trammel for adults. Stomach contents (n = 378) were examined according to the volumetric method in which the volume of each food item was estimated using graduated test tubes or a glass counting plate. During early development (larval stage), P. squamosissimus consumed mainly Cladocera and Copepoda. Juveniles showed a more diverse diet, including shrimp (Macrobrachium amazonicum), fish, aquatic insects (Trichoptera, Ephemeroptera, Chironomidae and pupae of Diptera) and plants. It was notable the high proportion of cannibalism (23.3%) in this stage. Adults consumed predominantly shrimp and fish. The use of food resources varied significantly between development stages (ANOSIM; r = 0.458; p<0.005), showing changes in food preferences during ontogeny. The Similarity Percentage Analysis (SIMPER) indicated that Cladocera and Copepoda were responsible for the differences observed between the larval stages of pre-flexion, flexion and post-flexion. M. amazonicum and Chironomidae were responsible for the differences between juvenile and larval stages, while M. amazonicum and other fishes caused the differences between adults and other ontogenetic stages. These results are confirmed by the relationship between standard length and developmental periods (ANCOVA; r(2) = 0.94; p<0.0001). In general, there were low values of trophic niche breadth. The essentially carnivorous habit from the early stages of P. squamosissimus and the predominant use of M. amazonicum by adults have important roles in feeding patterns of the species, suggesting a major contribution to its success and establishment, especially in lentic environments.	[Neves, Mayara Pereira; Delariva, Rosilene Luciana; Bittencourt Guimaraes, Ana Tereza] Univ Estadual Oeste Parana, Ctr Ciencias Biol & Saude, Programa Posgrad Conservacao & Manejo Recursos Na, Cascavel, Parana, Brazil; [Sanches, Paulo Vanderlei] Univ Estadual Oeste Parana, Posgrad Recursos Pesqueiros & Engn Pesca, Toledo, Parana, Brazil	Universidade Estadual do Oeste do Parana; Universidade Estadual do Oeste do Parana	Neves, MP (corresponding author), Univ Estadual Oeste Parana, Ctr Ciencias Biol & Saude, Programa Posgrad Conservacao & Manejo Recursos Na, Cascavel, Parana, Brazil.	mayara-nevesbio@hotmail.com	Guimarães, Ana Tereza T B Bittencourt/C-1053-2019; Delariva, Rosilene L/L-2000-2016; Guimarães, Ana Tereza Bittencourt/AAI-5021-2021; Neves, Mayara Pereira/AAD-4449-2019	Guimarães, Ana Tereza T B Bittencourt/0000-0002-3633-6484; Delariva, Rosilene L/0000-0002-6489-2437; Guimarães, Ana Tereza Bittencourt/0000-0002-3633-6484; Neves, Mayara Pereira/0000-0003-2523-3874; Sanches, Paulo Vanderlei/0000-0003-2159-9115				Ahlstrom E. H., 1954, Fishery Bulletin United States, V56, P209; Baras E, 2014, AQUAT LIVING RESOUR, V27, P51, DOI 10.1051/alr/2014006; Baumgartner G, 2010, WETLANDS, V30, P309, DOI 10.1007/s13157-010-0031-0; Baumgartner MST, 2003, BRAZ J BIOL, V63, P381; Bennemann Sirlei T., 2006, Iheringia, Sér. Zool., V96, P115, DOI 10.1590/S0073-47212006000100020; Bialetzki A, 2004, J PLANKTON RES, V26, P1327, DOI 10.1093/plankt/fbh123; BIALETZKI A., 2002, Braz. J. Biol., V62, P211, DOI 10.1590/S1519-69842002000200004; Bialetzki Andrea, 1997, Revista Brasileira de Zoologia, V14, P379; Bicudo CEM., 1970, ALGAS AGUAS CONTINEN; Bozza AN, 2010, BIOTA NEOTROP, V10, P217, DOI 10.1590/S1676-06032010000300025; CAMPOS JB, 2001, PARQUE NACL ILHA GRA; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; COSTA S. A. G. L., 2009, ACTA SCI-BIOL SCI, V31, P285; CRUZ JA, 1990, LEVANTAMENTO ICTIOFA; DABROWSKI K, 1984, REPROD NUTR DEV, V24, P807, DOI 10.1051/rnd:19840701; Daga VS, 2015, HYDROBIOLOGIA, V746, P327, DOI 10.1007/s10750-014-2032-0; Daga VS, 2009, NEOTROP ICHTHYOL, V7, P429, DOI 10.1590/S1679-62252009000300010; deAlmeida VLL, 1997, ECOL FRESHW FISH, V6, P123; Delariva RL, 2009, RAMA, V2, P141; Félix Renata Triane da Silva, 2009, Biota Neotrop., V9, P131, DOI 10.1590/S1676-06032009000300012; Ferreira VP, 2014, IHERINGIA SER ZOOL, V104, P134, DOI 10.1590/1678-476620141042134142; Fessehaye Y, 2006, AQUACULTURE, V255, P314, DOI 10.1016/j.aquaculture.2005.11.033; FOX LR, 1975, ANNU REV ECOL SYST, V6, P87, DOI 10.1146/annurev.es.06.110175.000511; Freire A. G., 2001, ACTA LIMNOL BRAS, V13, P1; Gallagher CP, 2015, HYDROBIOLOGIA, P1; Garutti Valdener, 2000, Iheringia Serie Zoologia, V88, P25; Gerking SD., 2014, FEEDING ECOLOGY FISH; Gogola TM, 2010, NEOTROP ICHTHYOL, V8, P341, DOI 10.1590/S1679-62252010000200013; Goulding M., 1984, Revista Brasileira de Zoologia, V2, P85; Hahn Norma Segatti, 1999, Acta Scientiarum, V21, P309; Hahn Norma Segatti, 2007, Oecologia Brasiliensis, V11, P469; Hammer O, 2006, PALEONTOLOGICAL DATA ANALYSIS, P1; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; HELLAWELL JM, 1971, J FISH BIOL, V3, P29, DOI 10.1111/j.1095-8649.1971.tb05903.x; HURLBERT SH, 1978, ECOLOGY, V59, P67, DOI 10.2307/1936632; HYSLOP EJ, 1980, J FISH BIOL, V17, P411, DOI 10.1111/j.1095-8649.1980.tb02775.x; Kamler E., 1992, EARLY LIFE HIST FISH; Langeani Francisco, 2007, Biota Neotrop., V7, P181, DOI 10.1590/S1676-06032007000300020; Lima A.F., 2013, IHERINGIA S RIE ZOOL, V103, P214; Makrakis MC, 2008, J FISH BIOL, V72, P1690, DOI 10.1111/j.1095-8649.2008.01845.x; Makrakis MC, 2005, ENVIRON BIOL FISH, V72, P99, DOI 10.1007/s10641-004-6596-9; Mugnai R., 2010, MANUAL IDENTIFICACAO; Nakatani K, 2001, OVOS LARVAR PEIXES A; Nunn AD, 2012, REV FISH BIOL FISHER, V22, P377, DOI 10.1007/s11160-011-9240-8; Pavanelli CS., 2007, PEIXES PLANICIE INUN; Pepin P, 2015, ICES J MAR SCI, V72, P359, DOI 10.1093/icesjms/fsu201; Pereira LS, 2015, HYDROBIOLOGIA, V746, P223, DOI 10.1007/s10750-014-2031-1; PYKE GH, 1984, ANNU REV ECOL SYST, V15, P523, DOI 10.1146/annurev.es.15.110184.002515; Reynalte-Tataje DA, 2011, NEOTROP ICHTHYOL, V9, P427, DOI 10.1590/S1679-62252011005000017; Ronnestad I, 2013, REV AQUACULT, V5, pS59, DOI 10.1111/raq.12010; SANTOS N. C. L., 2014, BOL I PESCA, V40, P397; Smith C., 1991, Reviews in Fish Biology and Fisheries, V1, P41, DOI 10.1007/BF00042661; STATSOFT INC, 2004, STAT DAT AN SOFTW SY; Teixeira I, 2007, BIOTA NEOTROP, V7, P68; Thomaz SM, 2015, HYDROBIOLOGIA, V746, P1, DOI 10.1007/s10750-014-2150-8; Torloni CEC, 1994, PRODUCAO PESQUEIRA C; Uieda VS, 2011, COMMUNITY ECOL, V12, P31, DOI 10.1556/ComEc.12.2011.1.5; Wittenrich ML, 2009, AQUACULTURE, V294, P221, DOI 10.1016/j.aquaculture.2009.06.006; WOOTON RJ, 1990, ECOLOGY TELEOST FISH; Yaniv S, 2014, J EXP BIOL, V217, P3748, DOI 10.1242/jeb.104331; Zar JH, 1999, BIOSTATISTICAL ANAL	61	17	18	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2015	10	11							e0141651	10.1371/journal.pone.0141651	http://dx.doi.org/10.1371/journal.pone.0141651			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV1PG	26524336	Green Published, gold, Green Submitted			2022-12-26	WOS:000364029800017
J	Yang, HK; Han, K; Cho, JH; Yoon, KH; Cha, BY; Lee, SH				Yang, Hae Kyung; Han, Kyungdo; Cho, Jae-Hyoung; Yoon, Kun-Ho; Cha, Bong-Yun; Lee, Seung-Hwan			Ambient Temperature and Prevalence of Obesity: A Nationwide Population-Based Study in Korea	PLOS ONE			English	Article							BROWN ADIPOSE-TISSUE; BODY-MASS INDEX; ENERGY-EXPENDITURE; INDUCED THERMOGENESIS; INDOOR TEMPERATURE; ADULT HUMANS; ASSOCIATION; INCREASE; COLD; FAT	Background Recent studies have suggested a possible association between outdoor or indoor temperature and obesity. We aimed to examine whether ambient temperature is associated with the prevalence of obesity or abdominal obesity in the Korean population. Methods Data on anthropometric, socio-demographic, laboratory and lifestyle factors were retrieved from National Health Insurance System data obtained in 2009-2010. Thirty years (1981 to 2010) of meteorological parameters for 71 observation areas were acquired from the Korea Meteorological Administration. Included in this analysis were 124,354 individuals. A body mass index (BMI) >= 25 kg/m(2) and a waist circumference (WC) >= 90 cm (men) or 85 cm (women) were considered to represent obesity and abdominal obesity, respectively. Results The mean annual temperature (MAT) ranged from 6.6 degrees C to 16.6 degrees C, and BMI was positively correlated with MAT (r = 0.0078, P = 0.0065). WC was positively correlated with MAT (r = 0.0165, P < 0.0001) and negatively correlated with the number of days with mean temperature < 0 degrees C (DMT0; r = -0.0129, P = 0.0002). After adjusting for age, sex, smoking status, alcohol consumption, exercise, income, residential area and altitude, the odds ratios (95% CI) for obesity and abdominal obesity in the highest quintile MAT group were 1.045 (1.010, 1.081) and 1.082 (1.042, 1.124), respectively, compared with the lower four quintiles of the MAT group. Similarly, subjects in the area of the lowest quintile of DMT0 had significantly higher odds of abdominal obesity compared with the higher four quintile groups of DMT0. Conclusion This study finds an association between ambient temperature and prevalence of obesity in the Korean population when controlling for several confounding factors. Adaptive thermogenesis might be a possible explanation for this phenomenon.	[Yang, Hae Kyung; Cho, Jae-Hyoung; Yoon, Kun-Ho; Cha, Bong-Yun; Lee, Seung-Hwan] Catholic Univ Korea, Coll Med, Seoul St Marys Hosp, Div Endocrinol & Metab,Dept Internal Med, Seoul, South Korea; [Han, Kyungdo] Catholic Univ Korea, Coll Med, Dept Med Stat, Seoul, South Korea	Catholic University of Korea; Seoul St. Mary's Hospital; Catholic University of Korea	Lee, SH (corresponding author), Catholic Univ Korea, Coll Med, Seoul St Marys Hosp, Div Endocrinol & Metab,Dept Internal Med, Seoul, South Korea.	hwanx2@catholic.ac.kr	Lee, Seung-Hwan/AAG-1361-2019; Lee, Seung-Hwan/C-7568-2018	Lee, Seung-Hwan/0000-0002-3964-3877; Lee, Seung-Hwan/0000-0002-3964-3877	National Research Foundation of Korea (NRF) - Korea government (MSIP) [2013M3C8A2075675]	National Research Foundation of Korea (NRF) - Korea government (MSIP)	This study was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIP, 2013M3C8A2075675). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Au-Yong ITH, 2009, DIABETES, V58, P2583, DOI 10.2337/db09-0833; Bakker LEH, 2014, LANCET DIABETES ENDO, V2, P210, DOI 10.1016/S2213-8587(13)70156-6; Bartelt A, 2014, NAT REV ENDOCRINOL, V10, P24, DOI 10.1038/nrendo.2013.204; Cai ZJ, 1999, WHO TECH REP SER, V887, P1; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Cannon B, 2011, J EXP BIOL, V214, P242, DOI 10.1242/jeb.050989; Carobbio S, 2013, J MOL ENDOCRINOL, V51, pT75, DOI 10.1530/JME-13-0158; Celi FS, 2010, EUR J ENDOCRINOL, V163, P863, DOI 10.1530/EJE-10-0627; Chen KY, 2013, J CLIN ENDOCR METAB, V98, pE1218, DOI 10.1210/jc.2012-4213; Choi NK, 2007, ANN PHARMACOTHER, V41, P667, DOI 10.1345/aph.1H247; Choi NK, 2010, PHARMACOEPIDEM DR S, V19, P238, DOI 10.1002/pds.1902; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; Daly M, 2014, OBESITY, V22, P626, DOI 10.1002/oby.20546; DAUNCEY MJ, 1981, BRIT J NUTR, V45, P257, DOI 10.1079/BJN19810102; Feldmann HM, 2009, CELL METAB, V9, P203, DOI 10.1016/j.cmet.2008.12.014; Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5; Flegal KM, 2005, JAMA-J AM MED ASSOC, V293, P1861, DOI 10.1001/jama.293.15.1861; Foster F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072269; Hansen JC, 2010, MED HYPOTHESES, V75, P250, DOI 10.1016/j.mehy.2010.02.033; Johnson F, 2011, OBES REV, V12, P543, DOI 10.1111/j.1467-789X.2010.00851.x; Keith SW, 2006, INT J OBESITY, V30, P1585, DOI 10.1038/sj.ijo.0803326; Kern PA, 2014, J CLIN ENDOCR METAB, V99, pE2772, DOI 10.1210/jc.2014-2440; Kim CS, 2014, DIABETES METAB J, V38, P35, DOI 10.4093/dmj.2014.38.1.35; Kingma Boris, 2012, Front Biosci (Elite Ed), V4, P1975; Lichtenbelt WDV, 2011, AM J PHYSIOL-REG I, V301, pR285, DOI 10.1152/ajpregu.00652.2010; Lichtenbelt WDV, 2009, NEW ENGL J MED, V360, P1500, DOI 10.1056/NEJMoa0808718; Ouellet V, 2011, J CLIN ENDOCR METAB, V96, P192, DOI 10.1210/jc.2010-0989; Rintamaki Hannu, 2007, Alaska Med, V49, P245; ROBERTS WC, 1988, AM J CARDIOL, V62, P345, DOI 10.1016/0002-9149(88)90248-2; Saito M, 2013, DIABETES METAB J, V37, P22, DOI 10.4093/dmj.2013.37.1.22; Saito M, 2009, DIABETES, V58, P1526, DOI 10.2337/db09-0530; Scheffers FR, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1119; Sherpa LY, 2010, INT J ENV RES PUB HE, V7, P1670, DOI 10.3390/ijerph7041670; Sidossis L, 2015, J CLIN INVEST, V125, P478, DOI 10.1172/JCI78362; Tan CE, 2004, DIABETES CARE, V27, P1182, DOI 10.2337/diacare.27.5.1182; Ulijaszek SJ, 2006, ANNU REV ANTHROPOL, V35, P337, DOI 10.1146/annurev.anthro.35.081705.123301; Valdes S, 2014, OBESITY, V22, P2328, DOI 10.1002/oby.20866; Voss JD, 2013, INT J OBESITY, V37, P1407, DOI 10.1038/ijo.2013.5; Wasse LK, 2013, APPL PHYSIOL NUTR ME, V38, P905, DOI 10.1139/apnm-2013-0008; Whitlock G, 2009, LANCET, V373, P1083, DOI 10.1016/S0140-6736(09)60318-4; Yoon YS, 2014, ENDOCRINOL METAB, V29, P418, DOI 10.3803/EnM.2014.29.4.418; Zheng W, 2011, NEW ENGL J MED, V364, P719, DOI 10.1056/NEJMoa1010679	42	23	24	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2015	10	11							e0141724	10.1371/journal.pone.0141724	http://dx.doi.org/10.1371/journal.pone.0141724			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV1PG	26524686	gold, Green Published, Green Submitted			2022-12-26	WOS:000364029800020
J	Caldeira, J; Bustos, J; Peabody, J; Chackerian, B; Peabody, DS				Caldeira, Jerri; Bustos, Jeremiah; Peabody, Julianne; Chackerian, Bryce; Peabody, David S.			Epitope-Specific Anti-hCG Vaccines on a Virus Like Particle Platform	PLOS ONE			English	Article							HUMAN CHORIONIC-GONADOTROPIN; BETA-SUBUNIT; CONTRACEPTIVE VACCINE; IMMUNOGENIC DISPLAY; PREVENTS PREGNANCY; DIVERSE PEPTIDES; COAT PROTEIN; IDENTIFICATION; IMMUNIZATION; FUSION	The possibility of a contraceptive vaccine targeting human chorionic gonadotropin has long been recognized, but never fully realized. Here we describe an epitope-specific approach based on immunogenic display of hCG-derived peptides on virus-like particles of RNA bacteriophage. A number of recombinant VLPs were constructed, each displaying a different hCG-derived peptide. Some were taken from the disordered C-terminal tail of the hormone, another came from an internal loop, and yet another was an epitope mimic produced by affinity-selection on an hCG-neutralizing antibody target. Immunization of mice with some VLPs yielded antisera that bound the hormone and neutralized hCG biological activity.	[Caldeira, Jerri; Bustos, Jeremiah; Peabody, Julianne; Chackerian, Bryce; Peabody, David S.] Univ New Mexico, Sch Med, Dept Mol Genet & Microbiol, Albuquerque, NM 87131 USA	University of New Mexico	Peabody, DS (corresponding author), Univ New Mexico, Sch Med, Dept Mol Genet & Microbiol, Albuquerque, NM 87131 USA.	dpeabody@salud.unm.edu			NIH [RO1 GM42901, R01 A1083305]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI083305] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM042901] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the NIH to DSP (RO1 GM42901) and BC (R01 A1083305). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Caldeira JD, 2010, VACCINE, V28, P4384, DOI 10.1016/j.vaccine.2010.04.049; Chackerian B, 2001, J CLIN INVEST, V108, P415, DOI 10.1172/JCI11849; Chackerian B, 2007, EXPERT REV VACCINES, V6, P381, DOI 10.1586/14760584.6.3.381; Chackerian B, 2011, J MOL BIOL, V409, P225, DOI 10.1016/j.jmb.2011.03.072; Cole LA, 2010, REPROD BIOL ENDOCRIN, V8, DOI 10.1186/1477-7827-8-102; Dhar R, 2004, AM J REPROD IMMUNOL, V51, P358, DOI 10.1111/j.1600-0897.2004.00169.x; DIRNHOFER S, 1993, FASEB J, V7, P1381, DOI 10.1096/fasebj.7.14.7693535; Gadkari RA, 2005, J MOL ENDOCRINOL, V34, P879, DOI 10.1677/jme.1.01683; He YP, 2011, J BIOTECHNOL, V151, P15, DOI 10.1016/j.jbiotec.2010.11.003; HOBSON BM, 1983, J REPROD FERTIL, V68, P457; Hoshi S, 2000, INT J UROL, V7, P218, DOI 10.1046/j.1442-2042.2000.00181.x; Iles RK, 2007, MOL CELL ENDOCRINOL, V260, P264, DOI 10.1016/j.mce.2006.02.019; Jennings GT, 2008, BIOL CHEM, V389, P521, DOI 10.1515/BC.2008.064; LAPTHORN AJ, 1994, NATURE, V369, P455, DOI 10.1038/369455a0; Naz RK, 2005, HUM REPROD, V20, P3271, DOI 10.1093/humrep/dei256; Peabody DS, 2008, J MOL BIOL, V380, P252, DOI 10.1016/j.jmb.2008.04.049; PEABODY DS, 1990, J BIOL CHEM, V265, P5684; Peabody DS, 1997, ARCH BIOCHEM BIOPHYS, V347, P85, DOI 10.1006/abbi.1997.0312; Rose N, 1988, SAFETY EVALUATION HC, V1, P231; Sabeur K, 1997, J ANDROL, V18, P151; Safaeian M, 2013, CANCER PREV RES, V6, P1242, DOI 10.1158/1940-6207.CAPR-13-0203; SAHAL D, 1982, J REPROD IMMUNOL, V4, P145, DOI 10.1016/0165-0378(82)90032-8; Sehgal S, 1996, AM J REPROD IMMUNOL, V36, P167; STEVENS VC, 1981, FERTIL STERIL, V36, P98; Sturgeon CM, 1998, ANN CLIN BIOCHEM, V35, P460, DOI 10.1177/000456329803500402; TALWAR GP, 1976, P NATL ACAD SCI USA, V73, P218, DOI 10.1073/pnas.73.1.218; TALWAR GP, 1994, P NATL ACAD SCI USA, V91, P8532, DOI 10.1073/pnas.91.18.8532; Talwar GP, 1997, AM J REPROD IMMUNOL, V37, P153; Talwar GP, 2011, AM J REPROD IMMUNOL, V66, P26, DOI 10.1111/j.1600-0897.2011.01002.x; Tumban E, 2013, VACCINE, V31, P4647, DOI 10.1016/j.vaccine.2013.07.052	30	11	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2015	10	10							e0141407	10.1371/journal.pone.0141407	http://dx.doi.org/10.1371/journal.pone.0141407			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0EH	26516771	Green Published, gold, Green Submitted			2022-12-26	WOS:000363920800039
J	O'Leary, RA; Low-Choy, S; Fisher, R; Mengersen, K; Caley, MJ				O'Leary, Rebecca A.; Low-Choy, Samantha; Fisher, Rebecca; Mengersen, Kerrie; Caley, M. Julian			Characterising Uncertainty in Expert Assessments: Encoding Heavily Skewed Judgements	PLOS ONE			English	Article							SPECIES RICHNESS; PROBABILITY-DISTRIBUTIONS; KNOWLEDGE; ELICITATION; HOMELESS; TOOL	When limited or no observed data are available, it is often useful to obtain expert knowledge about parameters of interest, including point estimates and the uncertainty around these values. However, it is vital to elicit this information appropriately in order to obtain valid estimates. This is particularly important when the experts' uncertainty about these estimates is strongly skewed, for instance when their best estimate is the same as the lowest value they consider possible. Also this is important when interest is in the aggregation of elicited values. In this paper, we compare alternative distributions for describing such estimates. The distributions considered include the lognormal, mirror lognormal, Normal and scaled Beta. The case study presented here involves estimation of the number of species in coral reefs, which requires eliciting counts within broader taxonomic groups, with highly skewed uncertainty estimates. This paper shows substantial gain in using the scaled Beta distribution, compared with Normal or lognormal distributions. We demonstrate that, for this case study on counting species, applying the novel encoding methodology developed in this paper can facilitate the acquisition of more rigorous estimates of (hierarchical) count data and credible bounds. The approach can also be applied to the more general case of enumerating a sampling frame via elicitation.	[O'Leary, Rebecca A.; Fisher, Rebecca] Australian Inst Marine Sci, UWA Oceans Inst M096, Crawley, WA 6009, Australia; [Low-Choy, Samantha; Mengersen, Kerrie] Queensland Univ Technol, Fac Sci & Engn, Sch Math Sci, Brisbane, Qld 4001, Australia; [Caley, M. Julian] Australian Inst Marine Sci, Townsville, Qld 4810, Australia	Australian Institute of Marine Science; University of Western Australia; Queensland University of Technology (QUT); Australian Institute of Marine Science	O'Leary, RA (corresponding author), Dept Agr & Food Western Australia, 3 Baron Hay Court, S Perth, WA 6151, Australia.	rebecca.oleary@agric.wa.gov.au	Fisher, Rebecca/C-5459-2011; Mengersen, Kerrie/AHC-4096-2022; Caley, Julian/A-4042-2008	Fisher, Rebecca/0000-0001-5148-6731; Caley, Julian/0000-0001-5739-749X; Low Choy, Samantha/0000-0002-1722-4428; Mengersen, Kerrie/0000-0001-8625-9168	BHP Billiton through CReefs Australia (CReefs, Census of Marine Life)	BHP Billiton through CReefs Australia (CReefs, Census of Marine Life)	BHP Billiton through CReefs Australia (CReefs, Census of Marine Life) supported RAO, RF, and MJC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert I, 2012, BAYESIAN ANAL, V7, P541, DOI 10.1214/12-BA717REJ; Berk RA, 2008, IMS COLLECTIONS PROB, V2, P127, DOI DOI 10.1214/193940307000000428; Berry B, 2007, EVALUATION REV, V31, P166, DOI 10.1177/0193841X06296947; Bowley AL, 1920, ELEMENTS STAT; Boxshall G., 2010, HARPACTICOIDA; Caley MJ, 2014, TRENDS ECOL EVOL, V29, P187, DOI 10.1016/j.tree.2014.02.002; Caley MJ, 2014, ECOL EVOL, V4, P231, DOI 10.1002/ece3.926; Chamberlain C, 2006, AUSTR CENSUS ANAL PR; Chambers JM., 1992, STAT MODELS S; Choy SL, 2009, ECOLOGY, V90, P265, DOI 10.1890/07-1886.1; CHOY SJL, 2008, J APPL PROBABILITY S, V3, P1; Clemen RT, 1999, RISK ANAL, V19, P187, DOI 10.1023/A:1006917509560; Costello MJ, 2013, SCIENCE, V339, P413, DOI 10.1126/science.1230318; Cowen DD, 1991, HOUS POLICY DEBATE, V2, P869; de Carvalho MR, 2007, EVOL BIOL, V34, P140, DOI 10.1007/s11692-007-9011-6; DEGROOT MH, 1974, J AM STAT ASSOC, V69, P118, DOI 10.2307/2285509; Fisher R, 2015, CURR BIOL, V25, P500, DOI 10.1016/j.cub.2014.12.022; Fisher R, 2012, ENVIRON MODELL SOFTW, V30, P1, DOI 10.1016/j.envsoft.2011.11.011; FUNTOWICZ SO, 1994, ENVIRON TOXICOL CHEM, V13, P1881, DOI 10.1002/etc.5620131203; GARTHWAITE PH, 1985, J ECONOMETRICS, V29, P149, DOI 10.1016/0304-4076(85)90036-3; Garthwaite PH, 2000, J ROY STAT SOC D-STA, V49, P455, DOI 10.1111/1467-9884.00246; GAVASAKAR U, 1988, MANAGE SCI, V34, P784, DOI 10.1287/mnsc.34.6.784; Girard M. C., 2006, CANADIAN REV SOCIAL, V58, P101; GROENEVELD RA, 1984, STATISTICIAN, V33, P391, DOI 10.2307/2987742; Hammond TR, 2001, ICES J MAR SCI, V58, P1133, DOI 10.1006/jmsc.2001.1103; Hughes G, 2002, CROP PROT, V21, P203, DOI 10.1016/S0261-2194(01)00087-4; James A, 2010, ENVIRON MODELL SOFTW, V25, P129, DOI 10.1016/j.envsoft.2009.07.003; Kadane JB, 2006, BAYESIAN ANAL, V1, P363, DOI 10.1214/06-BA113; Kynn M, 2008, J ROY STAT SOC A STA, V171, P239; LOW-CHOY S, 2010, OXFORD HDB APPL BAYE, P511; Malcolm C, 1959, OPER RES, V7, P646, DOI [10.1287/opre.7.5.646, DOI 10.1287/0PRE.7.5.646]; Martin TG, 2012, CONSERV BIOL, V26, P29, DOI 10.1111/j.1523-1739.2011.01806.x; McKenzie DJ, 2009, J R STAT SOC A STAT, V172, P339, DOI 10.1111/j.1467-985X.2009.00584.x; Morris DE, 2014, ENVIRON MODELL SOFTW, V52, P1, DOI 10.1016/j.envsoft.2013.10.010; NELDER JA, 1965, COMPUT J, V7, P308, DOI 10.1093/comjnl/7.4.308; O'Hagan A, 1998, J ROY STAT SOC D-STA, V47, P21, DOI 10.1111/1467-9884.00114; O'Hagan A., 2006, UNCERTAIN JUDGMENTS; O'Leary RA, 2011, 19TH INTERNATIONAL CONGRESS ON MODELLING AND SIMULATION (MODSIM2011), P2149; Perera AH, 2012, EXPERT KNOWLEDGE AND ITS APPLICATION IN LANDSCAPE ECOLOGY, P1, DOI 10.1007/978-1-4614-1034-8_1; Phillips LD, 1993, ELICITATION JUDGMENT; Reaka-Kudla Marjorie L., 1997, P83; Reaka-Kudla ML, 2005, CARIBBEAN MARINE BIO, P259; RECKHOW KH, 1990, ECOLOGY, V71, P2053, DOI 10.2307/1938619; SMALL AM, 1998, ATOLL RES B, V458, P1, DOI DOI 10.5479/SI.00775630.458.1; Speirs-Bridge A, 2010, RISK ANAL, V30, P512, DOI 10.1111/j.1539-6924.2009.01337.x; SPETZLER CS, 1975, MANAGE SCI, V22, P340, DOI 10.1287/mnsc.22.3.340; Vose D., 2000, RISK ANAL QUANTITATI; WRIGHT JD, 1992, EVALUATION REV, V16, P355, DOI 10.1177/0193841X9201600401	48	4	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2015	10	10							e0141697	10.1371/journal.pone.0141697	http://dx.doi.org/10.1371/journal.pone.0141697			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CV0EH	26517835	Green Published, Green Submitted, gold			2022-12-26	WOS:000363920800069
J	Franca, L; Simoes, C; Taborda, M; Diogo, C; da Costa, MS				Franca, Luis; Simoes, Catarina; Taborda, Marco; Diogo, Catarina; da Costa, Milton S.			Microbial Contaminants of Cord Blood Units Identified by 16S rRNA Sequencing and by API Test System, and Antibiotic Sensitivity Profiling	PLOS ONE			English	Article							BACTERIA; STEM	Over a period of ten months a total of 5618 cord blood units (CBU) were screened for microbial contamination under routine conditions. The antibiotic resistance profile for all isolates was also examined using ATB strips. The detection rate for culture positive units was 7.5%, corresponding to 422 samples. 16S rRNA sequence analysis and identification with API test system were used to identify the culturable aerobic, microaerophilic and anaerobic bacteria from CBUs. From these samples we recovered 485 isolates (84 operational taxonomic units, OTUs) assigned to the classes Bacteroidia, Actinobacteria, Clostridia, Bacilli, Betaproteobacteria and primarily to the Gammaproteobacteria. Sixty-nine OTUs, corresponding to 447 isolates, showed 16S rRNA sequence similarities above 99.0% with known cultured bacteria. However, 14 OTUs had 16S rRNA sequence similarities between 95 and 99% in support of genus level identification and one OTU with 16S rRNA sequence similarity of 90.3% supporting a family level identification only. The phenotypic identification formed 29 OTUs that could be identified to the species level and 9 OTUs that could be identified to the genus level by API test system. We failed to obtain identification for 14 OTUs, while 32 OTUs comprised organisms producing mixed identifications. Forty-two OTUs covered species not included in the API system databases. The API test system Rapid ID 32 Strep and Rapid ID 32 E showed the highest proportion of identifications to the species level, the lowest ratio of unidentified results and the highest agreement to the results of 16S rRNA assignments. Isolates affiliated to the Bacilli and Bacteroidia showed the highest antibiotic multi-resistance indices and microorganisms of the Clostridia displayed the most antibiotic sensitive phenotypes.	[Franca, Luis] Univ Coimbra, Ctr Neurosci & Cell Biol, Coimbra, Portugal; [Simoes, Catarina; Taborda, Marco; Diogo, Catarina; da Costa, Milton S.] BIOCANT Biotechnol Pk, Microbiol Unit, Cantanhede, Portugal	Universidade de Coimbra	da Costa, MS (corresponding author), BIOCANT Biotechnol Pk, Microbiol Unit, Cantanhede, Portugal.	milton@ci.uc.pt		da Costa, Milton/0000-0003-4027-4412	FEDER funds through the Operational Programme Competitiveness Factors - COMPETE;  [UID/NEU/04539/2013]	FEDER funds through the Operational Programme Competitiveness Factors - COMPETE; 	This work was funded by FEDER funds through the Operational Programme Competitiveness Factors - COMPETE and the strategic project UID/NEU/04539/2013. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ballen KK, 2013, BLOOD, V122, P491, DOI 10.1182/blood-2013-02-453175; Bosshard PP, 2006, J CLIN MICROBIOL, V44, P1359, DOI 10.1128/JCM.44.4.1359-1366.2006; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Carbonnelle E, 2011, CLIN BIOCHEM, V44, P104, DOI 10.1016/j.clinbiochem.2010.06.017; Clark P, 2012, TRANSFUSION, V52, P1770, DOI 10.1111/j.1537-2995.2011.03507.x; Cockerill FR, 2012, PERFORMANCE STANDARD; Cordero-Laurent E, 2012, REV ESP QUIM, V25, P261; Oliveira MGD, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-162; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Honohan A, 2002, VOX SANG, V82, P32, DOI 10.1046/j.1423-0410.2002.00133.x; Janda JM, 2007, J CLIN MICROBIOL, V45, P2761, DOI 10.1128/JCM.01228-07; Jimenez E, 2005, CURR MICROBIOL, V51, P270, DOI 10.1007/s00284-005-0020-3; Koski LB, 2001, J MOL EVOL, V52, P540, DOI 10.1007/s002390010184; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; Magiorakos AP, 2012, CLIN MICROBIOL INFEC, V18, P268, DOI 10.1111/j.1469-0691.2011.03570.x; Maraki S, 2012, SURG INFECT, V13, P326, DOI 10.1089/sur.2011.115; MARMUR J, 1963, METHOD ENZYMOL, V6, P726, DOI 10.1016/0076-6879(63)06240-6; Meyer TPH, 2006, CYTOTHERAPY, V8, P265, DOI 10.1080/14653240600735685; Moore ERB, 2010, RES MICROBIOL, V161, P430, DOI 10.1016/j.resmic.2010.05.007; NetCord Foundation for the Accreditation of Cell Therapy (FACT), 2013, NETCORD FACT INT STA; Pruesse E, 2012, BIOINFORMATICS, V28, P1823, DOI 10.1093/bioinformatics/bts252; Rainey FA, 1996, INT J SYST BACTERIOL, V46, P1088, DOI 10.1099/00207713-46-4-1088; Rerambiah LK, 2014, INT J INFECT DIS, V29, P48, DOI 10.1016/j.ijid.2014.01.015; Riedel S, 2009, J CLIN MICROBIOL, V47, P1645, DOI 10.1128/JCM.00302-09; Rossello-Mora R, 2001, FEMS MICROBIOL REV, V25, P39, DOI 10.1016/S0168-6445(00)00040-1; Stackebrandt E, 2006, MICROBIOLOGY TODAY, V06, P152, DOI DOI 10.1038/MSB.2013.22; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Yarza P, 2008, SYST APPL MICROBIOL, V31, P241, DOI 10.1016/j.syapm.2008.07.001; Yarza P, 2014, NAT REV MICROBIOL, V12, P635, DOI 10.1038/nrmicro3330	29	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2015	10	10							e0141152	10.1371/journal.pone.0141152	http://dx.doi.org/10.1371/journal.pone.0141152			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0ED	26512991	Green Published, Green Submitted, gold			2022-12-26	WOS:000363920300019
J	Hong, RX; Dai, Z; Zhu, WJ; Xu, BH				Hong, Ruoxi; Dai, Zhen; Zhu, Wenjie; Xu, Binghe			Association between Lymph Node Ratio and Disease Specific Survival in Breast Cancer Patients with One or Two Positive Lymph Nodes Stratified by Different Local Treatment Modalities	PLOS ONE			English	Article							INTERNATIONAL EXPERT CONSENSUS; AXILLARY DISSECTION; PROGNOSTIC VALUE; PRIMARY THERAPY; WOMEN; NUMBER; HIGHLIGHTS; CARCINOMA; ACCURACY; BIOPSY	Purpose Results of the American College of Surgeons Oncology Group (ACOSOG) Z0011 trial indicated that complete axillary node dissection (ALND) may not be warranted in some breast cancer patients with low tumor burden who are undergoing breast-conserving surgery following whole-breast irradiation. However, this study did not address patients undergoing mastectomy or those undergoing breast-conserving surgery without whole-breast radiotherapy. Given that lymph node ratio (LNR; ratio of positive lymph nodes to the total number removed) has been shown to be a prognostic factor in breast cancer, we first sought to determine the prognostic value of LNR in a low risk population comparable to that of the Z0011 trial and further to investigate whether the prognostic significance differs with local treatment modality. Method We used the Surveillance Epidemiology and End Results (SEER) database to identify breast cancer patients with T1-T2 tumor and 1-2 positive nodes. Patients were subclassified by the local therapy they underwent for the primary tumor. The prognostic value of LNR in predicting disease-specific survival (DSS) was examined in each treatment group. Results A total of 53,109 patients were included. In the subgroup of 20,602 patients who underwent lumpectomy following radiotherapy, LNR was not found to be significantly associated with DSS in both the univariate and multivariate model. For the 4,664 patients 21,031 with mastectomy without radiotherapy, LNR independently predict DSS in each of these subgroups. Conclusions Our results add evidence to the concept that axillary dissection could be omitted in patients with one or two positive nodes following breast-conserving surgery and whole breast radiation.	[Hong, Ruoxi; Zhu, Wenjie; Xu, Binghe] Chinese Acad Med Sci, Canc Hosp, Dept Med Oncol, Beijing 100730, Peoples R China; [Hong, Ruoxi; Zhu, Wenjie; Xu, Binghe] Peking Union Med Coll, Beijing 100021, Peoples R China; [Dai, Zhen] Chengdu Ctr Dis Control & Prevent, Chengdu, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Xu, BH (corresponding author), Chinese Acad Med Sci, Canc Hosp, Dept Med Oncol, Beijing 100730, Peoples R China.	xubinghe@medmail.com.cn						Abe O, 2005, LANCET, V366, P2087; Aizer AA, 2013, J CLIN ONCOL, V31, P3869, DOI 10.1200/JCO.2013.49.6489; AXELSSON CK, 1992, EUR J CANCER, V28A, P1415, DOI 10.1016/0959-8049(92)90534-9; Blancas I, 2006, ANN ONCOL, V17, P1644, DOI 10.1093/annonc/mdl169; Boyer-Chammard A, 1999, CANCER DETECT PREV, V23, P463, DOI 10.1046/j.1525-1500.1999.99049.x; Dehal A, 2013, BREAST CANCER RES TR, V139, P561, DOI 10.1007/s10549-013-2567-1; Dings PJM, 2013, ANN SURG ONCOL, V20, P2607, DOI 10.1245/s10434-013-2932-7; Edge S, 2010, AJCC CANC STAGING MA, V7th; FISHER B, 1981, SURG GYNECOL OBSTET, V152, P765; Fisher B, 2002, NEW ENGL J MED, V347, P1233, DOI 10.1056/NEJMoa022152; GIULIANO AE, 1995, ANN SURG, V222, P394, DOI 10.1097/00000658-199509000-00016; Giuliano AE, 2010, ANN SURG, V252, P426, DOI 10.1097/SLA.0b013e3181f08f32; Giuliano AE, 2011, JAMA-J AM MED ASSOC, V305, P569, DOI 10.1001/jama.2011.90; Goldhirsch A, 2013, ANN ONCOL, V24, P2206, DOI 10.1093/annonc/mdt303; Goldhirsch A, 2011, ANN ONCOL, V22, P1736, DOI 10.1093/annonc/mdr304; GRAVERSEN HP, 1988, EUR J SURG ONCOL, V14, P407; Halsted WS, 1907, ANN SURG, V46, P1, DOI 10.1097/00000658-190707000-00001; IVENS D, 1992, BRIT J CANCER, V66, P136, DOI 10.1038/bjc.1992.230; Kim SI, 2013, BRIT J CANCER, V109, P1165, DOI 10.1038/bjc.2013.465; Krag DN, 2010, LANCET ONCOL, V11, P927, DOI 10.1016/S1470-2045(10)70207-2; Kuru B, 2006, INT J RADIAT ONCOL, V66, P1328, DOI 10.1016/j.ijrobp.2006.07.015; LOTZE MT, 1981, ANN SURG, V193, P288, DOI 10.1097/00000658-198103000-00007; Lyman GH, 2005, J CLIN ONCOL, V23, P7703, DOI 10.1200/JCO.2005.08.001; Morrow M, 2011, ANN SURG ONCOL, V18, P2413, DOI 10.1245/s10434-011-1857-2; Orr RK, 1999, ANN SURG ONCOL, V6, P109, DOI 10.1007/s10434-999-0109-1; Schaapveld M, 2004, J SURG ONCOL, V87, P4, DOI 10.1002/jso.20061; Surveillance Epidemiology and End Results Program, 2013, SEER STAT DAT INC SE; Tausch C, 2012, ANN SURG ONCOL, V19, P1808, DOI 10.1245/s10434-011-2189-y; Veronesi U, 2010, ANN SURG, V251, P595, DOI 10.1097/SLA.0b013e3181c0e92a; Vinh-Hung V, 2010, ONCOLOGIST, V15, P1050, DOI 10.1634/theoncologist.2010-0044; Vinh-Hung V, 2009, J CLIN ONCOL, V27, P1062, DOI 10.1200/JCO.2008.18.6965; Voordeckers M, 2004, RADIOTHER ONCOL, V70, P225, DOI 10.1016/j.radonc.2003.10.015; Weir L, 2002, J CLIN ONCOL, V20, P1793, DOI 10.1200/JCO.2002.07.112; Wiznia LE, 2014, ANN SURG ONCOL, V21, P389, DOI 10.1245/s10434-013-3308-8; Woodward WA, 2006, J CLIN ONCOL, V24, P2910, DOI 10.1200/JCO.2005.03.1526; YEOH EK, 1986, ACTA ONCOL, V25, P105, DOI 10.3109/02841868609136386	36	6	6	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2015	10	10							e0138908	10.1371/journal.pone.0138908	http://dx.doi.org/10.1371/journal.pone.0138908			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0ED	26513258	Green Published, gold, Green Submitted			2022-12-26	WOS:000363920300001
J	Roperto, S; Russo, V; Esposito, I; Ceccarelli, DM; Paciello, O; Avallone, L; Capparelli, R; Roperto, F				Roperto, Sante; Russo, Valeria; Esposito, Iolanda; Ceccarelli, Dora Maria; Paciello, Orlando; Avallone, Luigi; Capparelli, Rosanna; Roperto, Franco			Mincle, an Innate Immune Receptor, Is Expressed in Urothelial Cancer Cells of Papillomavirus-Associated Urothelial Tumors of Cattle	PLOS ONE			English	Article							C-TYPE LECTIN; URINARY-BLADDER; ACTIVATING RECEPTOR; ENZOOTIC HEMATURIA; INFECTION; TYPE-2	Background Mincle, macrophage-inducible C-type lectin, is a member of C-type lectin receptors. It plays an important role in anti-mycobacterial and anti-fungal immunity. Furthermore it senses dead cells through its primary ligand SAP130. Materials and Findings We examined ten urothelial tumors of the urinary bladder of cattle. Eight of them expressed E5 cDNA of bovine papillomaviruses type 2 (BPV-2) and type 13 (BPV-13) that belong to Deltapapillomavirus genus. Two of them were not examined for detection of E5 cDNA. Mincle expression appeared to occur in urothelial neoplastic cells only. No mincle expression was detected in urothelial cells from healthy cattle. Mincle expression was characterized by a membranous pattern in papillary urothelial cancers; isolated and/or clustered urothelial cells showing a strong cytoplasmic immunoreactivity were primarily seen in invasive urothelial cancers. Conclusion This is the first study about the expression of mincle in veterinary oncology and the first report which describes the expression of functional mincle receptor in neoplastic cells in medical literature. As it has been shown that urothelial cancer cells have the ability to function as antigen-presenting cells (APCs), it is conceivable that mincle expression is involved in the presentation of cancer cell antigens to cells of the immune system. Furthermore, since expression of mincle contributes to the control of Mycobacterium bovis BCG infection, this study has exciting clinical implications in comparative medicine keeping in mind that Bacillus Calmette-Guerin (BCG) immunotherapy is currently the most effective treatment of non-muscle invasive bladder cancer in man. Mincle expression in urothelial tumor cells warrants further study to better understand the role, if any, of this receptor in bladder cancer. Future studies will provide insights in the role of mincle receptor of urothelial cancer cells in antitumor immunotherapy.	[Roperto, Sante] Univ Naples Federico II, Dipartimento Med Vet & Prod Anim, Settore Malattie Infett, Naples, Italy; [Russo, Valeria; Esposito, Iolanda; Ceccarelli, Dora Maria; Paciello, Orlando] Univ Naples Federico II, Dipartimento Med Vet & Prod Anim, Settore Patol Gen, Naples, Italy; [Avallone, Luigi] Univ Naples Federico II, Dipartimento Med Vet & Prod Anim, Settore Fisiol, Naples, Italy; [Capparelli, Rosanna] Univ Naples Federico II, Dipartimento Agr, Naples, Italy; [Roperto, Franco] Univ Naples Federico II, Dipartimento Biol, Naples, Italy	University of Naples Federico II; University of Naples Federico II; University of Naples Federico II; University of Naples Federico II; University of Naples Federico II	Roperto, S (corresponding author), Univ Naples Federico II, Dipartimento Med Vet & Prod Anim, Settore Malattie Infett, Naples, Italy.	sante.roperto@unina.it	Capparelli, Rosanna/Q-3144-2017	Capparelli, Rosanna/0000-0001-8614-6251; roperto, sante/0000-0001-6210-5519				Ayari C, 2011, J UROLOGY, V185, P1915, DOI 10.1016/j.juro.2010.12.097; Behler F, 2015, INFECT IMMUN, V83, P184, DOI 10.1128/IAI.02500-14; Bevers RFM, 2000, AKTUEL UROL, V31, P31; Borzacchiello G, 2008, VET RES, V39, DOI 10.1051/vetres:2008022; Carvalho T, 2006, J COMP PATHOL, V134, P336, DOI 10.1016/j.jcpa.2006.01.001; Sousa MD, 2011, CELL HOST MICROBE, V9, P436, DOI 10.1016/j.chom.2011.04.005; Dambuza IM, 2015, CURR OPIN IMMUNOL, V32, P21, DOI 10.1016/j.coi.2014.12.002; Gandhi NM, 2013, BJU INT, V112, P288, DOI 10.1111/j.1464-410X.2012.11754.x; da Costa RMG, 2014, ARCH VIROL, V159, P191, DOI 10.1007/s00705-013-1801-9; Gosalbez M, 2014, J UROLOGY, V191, P1899, DOI 10.1016/j.juro.2013.11.053; International Agency for Cancer Research (IARC), 2007, IARC MONOGRAPHS EVAL, V90, p[47, 473]; Ishikawa E, 2009, J EXP MED, V206, P2879, DOI 10.1084/jem.20091750; Jacobsen KM, 2015, MEDCHEMCOMM, V6, P647, DOI 10.1039/c4md00512k; Jegouzo SAF, 2014, GLYCOBIOLOGY, V24, P1291, DOI 10.1093/glycob/cwu072; Masumoto M, 1999, J IMMUNOL, V163, P5039; Meuten DJ, 2002, TUMORS DOMESTIC ANIM, P524; Miyake Yasunobu, 2010, Self Nonself, V1, P310, DOI 10.4161/self.1.4.13736; PAMUKCU AM, 1976, VET PATHOL, V13, P110, DOI 10.1177/030098587601300205; Redelman-Sidi G, 2014, NAT REV UROL, V11, P153, DOI 10.1038/nrurol.2014.15; Roperto S, 2016, TRANSBOUND EMERG DIS, V63, P628, DOI 10.1111/tbed.12322; Roperto S, 2010, J COMP PATHOL, V142, P95, DOI 10.1016/j.jcpa.2009.08.156; Roperto S, 2013, J GEN VIROL, V94, P403, DOI 10.1099/vir.0.047662-0; Roperto S, 2012, RES VET SCI, V93, P1361, DOI 10.1016/j.rvsc.2012.06.009; Sancho D, 2012, ANNU REV IMMUNOL, V30, P491, DOI 10.1146/annurev-immunol-031210-101352; Schoenen H, 2010, J IMMUNOL, V184, P2756, DOI 10.4049/jimmunol.0904013; Suzuki Y, 2013, SCI REP-UK, V3, DOI 10.1038/srep03177; Vaccari JCD, 2015, J NEUROTRAUM, V32, P228, DOI 10.1089/neu.2014.3436; Videira PA, 2009, UROLOGY, V74, P944, DOI 10.1016/j.urology.2009.02.053; Wells CA, 2008, J IMMUNOL, V180, P7404, DOI 10.4049/jimmunol.180.11.7404; Wosiacki SR, 2005, J VIROL METHODS, V126, P215, DOI 10.1016/j.jviromet.2005.01.021; Yamasaki S, 2009, P NATL ACAD SCI USA, V106, P1897, DOI 10.1073/pnas.0805177106; Yamasaki S, 2008, NAT IMMUNOL, V9, P1179, DOI 10.1038/ni.1651; Yates TJ, 2013, CANCER-AM CANCER SOC, V119, P61, DOI 10.1002/cncr.27661; Zelensky AN, 2005, FEBS J, V272, P6179, DOI 10.1111/j.1742-4658.2005.05031.x	34	11	11	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2015	10	10							e0141624	10.1371/journal.pone.0141624	http://dx.doi.org/10.1371/journal.pone.0141624			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0ED	26513724	Green Submitted, Green Published, gold			2022-12-26	WOS:000363920300056
J	Swiatkowska, A; Zydowicz, P; Gorska, A; Suchacka, J; Dutkiewicz, M; Ciesiolka, J				Swiatkowska, Agata; Zydowicz, Paulina; Gorska, Agnieszka; Suchacka, Julia; Dutkiewicz, Mariola; Ciesiolka, Jerzy			The Role of Structural Elements of the 5 '-Terminal Region of p53 mRNA in Translation under Stress Conditions Assayed by the Antisense Oligonucleotide Approach	PLOS ONE			English	Article							IRES-MEDIATED TRANSLATION; HUMAN CANCER-CELLS; DNA-DAMAGE; SECONDARY STRUCTURE; ENTRY SITE; ISOFORMS; EXPRESSION; INITIATION; MECHANISMS; INDUCTION	The p53 protein is one of the major factors responsible for cell cycle regulation and stress response. In the 5'-terminal region of p53 mRNA, an IRES element has been found which takes part in the translational regulation of p53 expression. Two characteristic hairpin motifs are present in this mRNA region: G56-C169, with the first AUG codon, and U180-A218, which interacts with the Hdm2 protein (human homolog of mouse double minute 2 protein). 20-OMe modified antisense oligomers hybridizing to the 5'-terminal region of p53 mRNA were applied to assess the role of these structural elements in translation initiation under conditions of cellular stress. Structural changes in the RNA target occurring upon oligomers' binding were monitored by the Pb2+-induced cleavage method. The impact of antisense oligomers on the synthesis of two proteins, the full-length p53 and its isoform Delta 40p53, was analysed in HT-29, MCF-7 and HepG2 cells, under normal conditions and under stress, as well as in vitro conditions. The results revealed that the hairpin U180-A218 and adjacent single-stranded region A219-A228 were predominantly responsible for high efficacy of IRES-mediated translation in the presence of stress factors. These motifs play a role of cis-acting elements which are able to modulate IRES activity, likely via interactions with protein factors.	[Swiatkowska, Agata; Zydowicz, Paulina; Gorska, Agnieszka; Suchacka, Julia; Dutkiewicz, Mariola; Ciesiolka, Jerzy] Polish Acad Sci, Inst Bioorgan Chem, PL-61704 Poznan, Poland	Polish Academy of Sciences; Institute of Bioorganic Chemistry of the Polish Academy of Sciences	Ciesiolka, J (corresponding author), Polish Acad Sci, Inst Bioorgan Chem, Noskowskiego 12-14, PL-61704 Poznan, Poland.	jerzy.ciesiolka@ibch.poznan.pl	Dutkiewicz, Mariola/M-5588-2016; Swiatkowska, Agata/W-4117-2018; Zydowicz-Machtel, Paulina/W-5169-2018; Dutkiewicz, Mariola/AAG-5242-2021	Dutkiewicz, Mariola/0000-0003-1098-0308; Swiatkowska, Agata/0000-0002-3100-2952; Zydowicz-Machtel, Paulina/0000-0001-6866-029X; Dutkiewicz, Mariola/0000-0003-1098-0308	Foundation for Polish Science Homing Plus grant [HP/2012-6/15]; Ministry of Science and Higher Education of the Republic of Poland [2013/09/B/NZ1/01884]; KNOW program	Foundation for Polish Science Homing Plus grant; Ministry of Science and Higher Education of the Republic of Poland(Ministry of Science and Higher Education, Poland); KNOW program	This work was supported by Foundation for Polish Science Homing Plus grant HP/2012-6/15 (to AS) and the Ministry of Science and Higher Education of the Republic of Poland, grant 2013/09/B/NZ1/01884 (to JC) and KNOW program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avery-Kiejda KA, 2014, CARCINOGENESIS, V35, P586, DOI 10.1093/carcin/bgt411; Bellaousov S, 2013, NUCLEIC ACIDS RES, V41, pW471, DOI 10.1093/nar/gkt290; Bernard H, 2013, ONCOGENE, V32, P2150, DOI 10.1038/onc.2012.242; Blaszczyk L, 2011, BIOCHEMISTRY-US, V50, P7080, DOI 10.1021/bi200659b; Bourdon JC, 2005, GENE DEV, V19, P2122, DOI 10.1101/gad.1339905; Bourougaa K, 2010, MOL CELL, V38, P78, DOI 10.1016/j.molcel.2010.01.041; Brooks CL, 2011, FEBS LETT, V585, P2803, DOI 10.1016/j.febslet.2011.05.022; Candeias MM, 2006, ONCOGENE, V25, P6936, DOI 10.1038/sj.onc.1209996; Candeias MM, 2008, NAT CELL BIOL, V10, P1098, DOI 10.1038/ncb1770; Candeias MM, 2011, BIOCHIMIE, V93, P1962, DOI 10.1016/j.biochi.2011.06.010; Chen J, 2010, GENE DEV, V24, P2146, DOI 10.1101/gad.1968910; Courtois S, 2002, ONCOGENE, V21, P6722, DOI 10.1038/sj.onc.1205874; Dias N, 2002, MOL CANCER THER, V1, P347; Diaz-Toledano R, 2009, NUCLEIC ACIDS RES, V37, P5498, DOI 10.1093/nar/gkp553; Fernandez-Miragall O, 2009, VIRUS RES, V139, P172, DOI 10.1016/j.virusres.2008.07.009; Gorska A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078863; Grover R, 2009, ONCOGENE, V28, P2766, DOI 10.1038/onc.2009.138; Grover R, 2008, CELL CYCLE, V7, P2189, DOI 10.4161/cc.7.14.6271; Grover R, 2011, RNA BIOL, V8, P132, DOI 10.4161/rna.8.1.14260; Hafsi H, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-134; Hellen CUT, 2009, BBA-GENE REGUL MECH, V1789, P558, DOI 10.1016/j.bbagrm.2009.06.001; Holcik M, 2005, NAT REV MOL CELL BIO, V6, P318, DOI 10.1038/nrm1618; Ji H, 2004, P NATL ACAD SCI USA, V101, P16990, DOI 10.1073/pnas.0407402101; Khan D, 2013, ONCOGENE, V32, P4148, DOI 10.1038/onc.2012.422; Khoury MP, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000927; Kirsebom LA, 2013, HDB RNA BIOCH, P214; Komar AA, 2011, CELL CYCLE, V10, P229, DOI 10.4161/cc.10.2.14472; Leroy B, 2013, NUCLEIC ACIDS RES, V41, pD962, DOI 10.1093/nar/gks1033; Ma W, 2012, ONCOGENE, V31, P1024, DOI 10.1038/onc.2011.300; Madan E, 2012, BIOCHEM J, V443, P811, DOI 10.1042/BJ20111627; Malbert-Colas L, 2014, MOL CELL, V54, P500, DOI 10.1016/j.molcel.2014.02.035; Marcel V, 2011, CELL DEATH DIFFER, V18, P1815, DOI 10.1038/cdd.2011.120; Menendez D, 2013, NUCLEIC ACIDS RES, V41, P7286, DOI 10.1093/nar/gkt504; Murray-Zmijewski F, 2006, CELL DEATH DIFFER, V13, P962, DOI 10.1038/sj.cdd.4401914; Olivares-Illana V, 2010, ONCOGENE, V29, P5113, DOI 10.1038/onc.2010.266; Powell DJ, 2008, CELL CYCLE, V7, P950, DOI 10.4161/cc.7.7.5626; Ravizza R, 2004, BMC CANCER, V4, DOI 10.1186/1471-2407-4-92; Ray PS, 2006, EMBO REP, V7, P404, DOI 10.1038/sj.embor.7400623; Sharathchandra A, 2014, WIRES RNA, V5, P131, DOI 10.1002/wrna.1202; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Takagi M, 2005, CELL, V123, P49, DOI 10.1016/j.cell.2005.07.034; Wei JX, 2012, P NATL ACAD SCI USA, V109, pE2543, DOI 10.1073/pnas.1205664109; Yang DQ, 2006, ONCOGENE, V25, P4613, DOI 10.1038/sj.onc.1209483	43	11	11	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2015	10	10							e0141676	10.1371/journal.pone.0141676	http://dx.doi.org/10.1371/journal.pone.0141676			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0ED	26513723	Green Submitted, Green Published, gold			2022-12-26	WOS:000363920300066
J	Zhang, MH; Zhang, AD; Shi, ZD; Wang, LG; Qiu, Y				Zhang, Mei-Hua; Zhang, Ai-Dong; Shi, Zhi-Da; Wang, Lei-Guang; Qiu, Yi			Changes in Levels of Seminal Nitric Oxide Synthase, Macrophage Migration Inhibitory Factor, Sperm DNA Integrity and Caspase-3 in Fertile Men after Scrotal Heat Stress	PLOS ONE			English	Article							GERM-CELL APOPTOSIS; HUMAN SPERMATOZOA; NUCLEAR MATURITY; SPERMATOGENESIS; TESTOSTERONE; EXPRESSION; EXPOSURE; MONKEY; FRAGMENTATION; HYPERTHERMIA	Background This study observes changes in levels of seminal nitric oxide (NO), nitric oxide synthase (NOS), macrophage migration inhibitory factor (MIF), sperm DNA integrity, chromatin condensation and Caspase-3in adult healthy men after scrotal heat stress (SHS). Methods Exposure of the scrotum of 25 healthy male volunteers locally at 40-43 degrees C SHS belt warming 40 min each day for successive 2 d per week. The course of SHS was continuously 3 months. Routine semen analysis, hypo-osmotic swelling (HOS) test, Aniline blue (AB) staining, HOS/AB and terminal deoxynucleotidyl transferase-mediated d UDP nick-end labeling (TUNEL) were carried out before, during and after SHS. Seminal NO and NOS contents were determined by nitrate reduction method. The activated Caspase-3 levels of spermatozoa and MIF in seminal plasma were measured by the enzyme-linked immunosorbent assay (ELISA) method. Statistical significance between mean values was determined using statistical ANOVA tests. Results The mean parameters of sperm concentration, motile and progressive motile sperm and normal morphological sperm were significantly decreased in groups during SHS 1, 2 and 3 months compared with those in groups of pre-SHS (P<0.001). Statistically significant differences of sperm DNA fragmentation, normal sperm membrane, and Caspase-3 activity as well as the level of NO, NOS and MIF in semen were observed between the groups before SHS and after SHS 3 months and the groups during SHS 1, 2 and 3 months (P<0.001). After three months of the SHS, various parameters recovered to the level before SHS. WBC in semen showed a positively significant correlation with the levels of NO, NOS, MIF and Caspase-3 activity. The percentage of abnormal sperm by using the test of HOS showed a positively significant correlation with that of HOS/AB. Conclusions The continuously constant SHS can impact the semen quality and sperm DNA and chromatin, which may be contributed to the high level of NO, NOS, MIF and Caspase-3 by SHS.	[Zhang, Mei-Hua; Zhang, Ai-Dong; Shi, Zhi-Da; Wang, Lei-Guang; Qiu, Yi] Shandong Prov Family Planning Inst Sci & Technol, Key Lab Improving Birth Outcome Tech, Key Lab Birth Regulat & Control Technol Natl Hlth, Jinan 250002, Shandong, Peoples R China		Qiu, Y (corresponding author), Shandong Prov Family Planning Inst Sci & Technol, Key Lab Improving Birth Outcome Tech, Key Lab Birth Regulat & Control Technol Natl Hlth, Jinan 250002, Shandong, Peoples R China.	qiuyi987@sina.com			National "China's 12th Five-Year Plan of Science and Technology" [2012BAI31B08]; Key Research and Development Program in Shandong Province [GSF118072]	National "China's 12th Five-Year Plan of Science and Technology"; Key Research and Development Program in Shandong Province	The work was supported by the National "China's 12th Five-Year Plan (2011-2015)" of Science and Technology (No: 2012BAI31B08) and the Key Research and Development Program in Shandong Province (No: GSF118072).	Alkhayal A, 2013, J ASSIST REPROD GEN, V30, P1519, DOI 10.1007/s10815-013-0101-3; Amiri I., 2006, DARU-Journal of Pharmaceutical Sciences, V14, P197; Aquila S, 2011, REPROD BIOL ENDOCRIN, V9, DOI 10.1186/1477-7827-9-133; Banks S, 2005, REPRODUCTION, V129, P505, DOI 10.1530/rep.1.00531; Beyret E, 2011, DEV BIOL, V355, P215, DOI 10.1016/j.ydbio.2011.04.021; Carreira BP, 2012, STEM CELLS INT, V12, P15; Chen M, 2008, ENDOCRINOLOGY, V149, P4871, DOI 10.1210/en.2007-1093; Chen M, 2008, ASIAN J ANDROL, V10, P474, DOI 10.1111/j.1745-7262.2008.00391.x; Chihara M, 2014, AM J PATHOL, V184, P2480, DOI 10.1016/j.ajpath.2014.06.004; Dadoune JP, 1995, MICRON, V26, P323, DOI 10.1016/0968-4328(95)00007-0; du Plessis SS, 2010, ANDROLOGIA, V42, P206, DOI 10.1111/j.1439-0272.2009.00980.x; du Plessis SS, 2010, ANDROLOGIA, V42, P112, DOI 10.1111/j.1439-0272.2009.00964.x; Faleiro L, 2000, J CELL BIOL, V151, P951, DOI 10.1083/jcb.151.5.951; Fariello RM, 2009, J ASSIST REPROD GEN, V26, P151, DOI 10.1007/s10815-008-9288-0; Foghi K, 2011, IRAN J REPROD MED, V9, P277; Frenette G, 1998, ARCH ANDROLOGY, V41, P185, DOI 10.3109/01485019808994890; Frenette G, 2005, MOL HUM REPROD, V11, P575, DOI 10.1093/molehr/gah197; Frenette G, 2003, BIOL REPROD, V69, P1586, DOI 10.1095/biolreprod.103.019216; Garolla A, 2013, HUM REPROD, V28, P877, DOI 10.1093/humrep/det020; Guo J, 2007, ENDOCRINOLOGY, V131, P1137; Hammadeh ME, 1996, HUM REPROD, V11, P2468; Hjollund NHI, 2002, REPROD TOXICOL, V16, P215, DOI 10.1016/S0890-6238(02)00025-4; KANDEEL FR, 1988, FERTIL STERIL, V49, P1; Lewis SE, 1996, MOL HUM REPROD, V2, P873, DOI 10.1093/molehr/2.11.873; Liu MX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045694; Liu Yi-Xun, 2010, Front Biosci (Schol Ed), V2, P730; Lue YH, 1999, ENDOCRINOLOGY, V140, P1709, DOI 10.1210/en.140.4.1709; Lue YH, 2006, J CLIN ENDOCR METAB, V91, P539, DOI 10.1210/jc.2005-1808; Lue YH, 2000, ENDOCRINOLOGY, V141, P1414, DOI 10.1210/en.141.4.1414; MCNITT J I, 1970, International Journal of Biometeorology, V14, P373, DOI 10.1007/BF01462914; Meiser H, 2003, ANAT HISTOL EMBRYOL, V32, P321, DOI 10.1111/j.1439-0264.2003.00459.x; Moran JM, 2008, THERIOGENOLOGY, V70, P91, DOI 10.1016/j.theriogenology.2008.02.010; Morel F, 2001, REPRODUCTION, V121, P783, DOI 10.1530/reprod/121.5.783; Morel F, 1998, FERTIL STERIL, V69, P1122, DOI 10.1016/S0015-0282(98)00058-2; Paasch U, 2003, J ANDROL, V24, P246; Paul C, 2008, REPRODUCTION, V136, P73, DOI 10.1530/REP-08-0036; Paul C, 2009, BIOL REPROD, V80, P913, DOI 10.1095/biolreprod.108.071779; Qiu Y, 2012, J ANDROL, V33, P1036, DOI 10.2164/jandrol.111.014902; Qiu Y, 2012, J ASSIST REPROD GEN, V29, P185, DOI 10.1007/s10815-011-9688-4; Qiu Y, 2011, J ZHEJIANG UNIV-SC B, V12, P448, DOI 10.1631/jzus.B1000347; Rodriguez PC, 2011, REPROD DOMEST ANIM, V46, P74, DOI 10.1111/j.1439-0531.2010.01583.x; Salter M, 1998, METH MOL B, V100, P61; Sellami A, 2013, ADV UROL, V2013, DOI 10.1155/2013/578631; Setchell BP, 1998, J REPROD FERTIL, V114, P179, DOI 10.1530/jrf.0.1140179; Sheikh N, 2010, AFR J BIOTECHNOL, V9, P5739; Shrivastava V, 2010, REPRODUCTION, V139, P999, DOI 10.1530/REP-09-0492; Simon L, 2014, HUM REPROD, V29, P904, DOI 10.1093/humrep/deu040; Wang C, 2007, J CLIN ENDOCR METAB, V92, P3292, DOI 10.1210/jc.2007-0367; Wang DH, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0039920, 10.1371/journal.pone.0040364]; WETTEMANN RP, 1979, J ANIM SCI, V49, P1501, DOI 10.2527/jas1979.4961501x; World Health Organization, 2010, WHO LAB MAN EX PROC, P30; World Health Organization, 1999, WHO LAB MAN EX HUM S; Zhang LH, 2010, FERTIL STERIL, V94, P1027, DOI 10.1016/j.fertnstert.2009.04.034; Zhang XS, 2005, FRONT BIOSCI-LANDMRK, V10, P3110, DOI 10.2741/1767; Zhang ZH, 2004, INT J ANDROL, V27, P234, DOI 10.1111/j.1365-2605.2004.00477.x; Zhu H, 2010, PROTEOMICS, V10, P3480, DOI 10.1002/pmic.201000281	56	17	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2015	10	10							e0141320	10.1371/journal.pone.0141320	http://dx.doi.org/10.1371/journal.pone.0141320			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0ED	26512992	Green Submitted, Green Published, gold			2022-12-26	WOS:000363920300029
J	Bin Cha, S; Kim, WS; Kim, JS; Kim, H; Kwon, KW; Han, SJ; Eum, SY; Cho, SN; Shin, SJ				Bin Cha, Seung; Kim, Woo Sik; Kim, Jong-Seok; Kim, Hongmin; Kwon, Kee Woong; Han, Seung Jung; Eum, Seok-Yong; Cho, Sang-Nae; Shin, Sung Jae			Repeated Aerosolized-Boosting with Gamma-Irradiated Mycobacterium bovis BCG Confers Improved Pulmonary Protection against the Hypervirulent Mycobacterium tuberculosis Strain HN878 in Mice	PLOS ONE			English	Article							SPLIT-PRODUCT VACCINES; T-CELL RESPONSES; SUPERIOR PROTECTION; INFLUENZA VACCINE; RANDOMIZED-TRIAL; BELLS-PALSY; IMMUNITY; INFECTION; EFFICACY; MEMORY	Mycobacterium bovis bacillus Calmette-Guerin (BCG), the only licensed vaccine, shows limited protection efficacy against pulmonary tuberculosis (TB), particularly hypervirulent Mycobacterium tuberculosis (Mtb) strains, suggesting that a logistical and practical vaccination strategy is urgently required. Boosting the BCG-induced immunity may offer a potentially advantageous strategy for advancing TB vaccine development, instead of replacing BCG completely. Despite the improved protection of the airway immunization by using live BCG, the use of live BCG as an airway boosting agent may evoke safety concerns. Here, we analyzed the protective efficacy of.-irradiated BCG as a BCG-prime boosting agent for airway immunization against a hypervirulent clinical strain challenge with Mycobacterium tuberculosis HN878 in a mouse TB model. After the aerosol challenge with the HN878 strain, the mice vaccinated with BCG via the parenteral route exhibited only mild and transient protection, whereas BCG vaccination followed by multiple aerosolized boosting withn gamma-irradiated BCG efficiently maintained long-lasting control of Mtb in terms of bacterial reduction and pathological findings. Further immunological investigation revealed that this approach resulted in a significant increase in the cellular responses in terms of a robust expansion of antigen (PPD and Ag85A)-specific CD4(+)T cells concomitantly producing IFN-gamma, TNF-alpha, and IL-2, as well as a high level of IFN-gamma-producing recall response via both the local and systemic immune systems upon further boosting. Collectively, aerosolized boosting of gamma-irradiated BCG is able to elicit strong Th1-biased immune responses and confer enhanced protection against a hypervirulent Mycobacterium tuberculosis HN878 infection in a boosting number-dependent manner.	[Bin Cha, Seung; Kim, Woo Sik; Kim, Jong-Seok; Kim, Hongmin; Kwon, Kee Woong; Han, Seung Jung; Cho, Sang-Nae; Shin, Sung Jae] Yonsei Univ, Coll Med, Inst Immunol & Immunol Dis, Dept Microbiol, Seoul 120749, South Korea; [Kim, Hongmin; Kwon, Kee Woong; Cho, Sang-Nae; Shin, Sung Jae] Yonsei Univ, Coll Med, Brain Korea PLUS Project Med Sci 21, Seoul 120749, South Korea; [Eum, Seok-Yong] Int TB Res Ctr, Div Immunopathol & Cellular Immunol, Chang Won, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Shin, SJ (corresponding author), Yonsei Univ, Coll Med, Inst Immunol & Immunol Dis, Dept Microbiol, Seoul 120749, South Korea.	sjshin@yuhs.ac		Shin, Sung Jae/0000-0003-0854-4582	Basic Science Research Program through the Ministry of Science, ICT, and Future Planning [NRF-2013R1A2A1A01009932]	Basic Science Research Program through the Ministry of Science, ICT, and Future Planning	This work was supported the Basic Science Research Program through the Ministry of Science, ICT, and Future Planning (NRF-2013R1A2A1A01009932). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilo N, 2014, CLIN VACCINE IMMUNOL, V21, P594, DOI 10.1128/CVI.00700-13; Andersen P, 2005, NAT REV MICROBIOL, V3, P656, DOI 10.1038/nrmicro1211; [Anonymous], 1995, WKLY EPIDEMIOL REC, V70, P229; Barreto ML, 2011, VACCINE, V29, P4875, DOI 10.1016/j.vaccine.2011.05.023; BARRY DW, 1974, INFECT IMMUN, V10, P1329, DOI 10.1128/IAI.10.6.1329-1336.1974; BARRY DW, 1976, AM J EPIDEMIOL, V104, P34, DOI 10.1093/oxfordjournals.aje.a112272; Bernatowska EA, 2007, EMERG INFECT DIS, V13, P799, DOI 10.3201/eid1305.060865; Beverley PCL, 2014, MUCOSAL IMMUNOL, V7, P20, DOI 10.1038/mi.2013.99; Blazevic A, 2014, MICROBES INFECT, V16, P73, DOI 10.1016/j.micinf.2013.09.006; Caccamo N, 2010, EUR J IMMUNOL, V40, P2211, DOI 10.1002/eji.201040455; COLDITZ GA, 1994, JAMA-J AM MED ASSOC, V271, P698, DOI 10.1001/jama.271.9.698; Commandeur S, 2011, EUR J IMMUNOL, V41, P2925, DOI 10.1002/eji.201141602; Connor LM, 2010, EUR J IMMUNOL, V40, P2482, DOI 10.1002/eji.200940279; Datta SK, 2006, IMMUNITY, V25, P143, DOI 10.1016/j.immuni.2006.05.013; Derrick SC, 2014, CLIN VACCINE IMMUNOL, V21, P1443, DOI 10.1128/CVI.00394-14; Fine PEM, 1996, LANCET, V348, P17, DOI 10.1016/S0140-6736(96)02166-6; Furuya Y, 2010, J GEN VIROL, V91, P1450, DOI 10.1099/vir.0.018168-0; Giri PK, 2006, J INFECTION, V53, P350, DOI 10.1016/j.jinf.2005.12.017; Glynn JR, 2002, EMERG INFECT DIS, V8, P843; Goldsack L, 2007, TUBERCULOSIS, V87, P465, DOI 10.1016/j.tube.2007.07.001; Goonetilleke NP, 2003, J IMMUNOL, V171, P1602, DOI 10.4049/jimmunol.171.3.1602; Haile M, 2005, TUBERCULOSIS, V85, P107, DOI 10.1016/j.tube.2004.09.013; Henao-Tamayo MI, 2010, CLIN VACCINE IMMUNOL, V17, P618, DOI 10.1128/CVI.00368-09; Jeon BY, 2008, INFECT IMMUN, V76, P5173, DOI 10.1128/IAI.00019-08; Jeon BY, 2011, MICROBES INFECT, V13, P284, DOI 10.1016/j.micinf.2010.11.002; Jonges M, 2010, J CLIN MICROBIOL, V48, P928, DOI 10.1128/JCM.02045-09; Kita Y, 2011, HUM VACCINES, V7, P108, DOI 10.4161/hv.7.0.14571; Lalvani A, 1998, P NATL ACAD SCI USA, V95, P270; Leung CC, 2001, INT J TUBERC LUNG D, V5, P717; Lewis DJM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006999; Lopez B, 2003, CLIN EXP IMMUNOL, V133, P30, DOI 10.1046/j.1365-2249.2003.02171.x; Manca C, 2001, P NATL ACAD SCI USA, V98, P5752, DOI 10.1073/pnas.091096998; Mangtani P, 2014, CLIN INFECT DIS, V58, P470, DOI 10.1093/cid/cit790; Thomas ZR, 2015, T ROY SOC TROP MED H, V109, P175, DOI 10.1093/trstmh/tru206; McKinstry KK, 2008, IMMUNOL RES, V40, P114, DOI 10.1007/s12026-007-8004-y; Mittrucker HW, 2007, P NATL ACAD SCI USA, V104, P12434, DOI 10.1073/pnas.0703510104; Mutsch M, 2004, NEW ENGL J MED, V350, P896, DOI 10.1056/NEJMoa030595; Nials AT, 2008, DIS MODEL MECH, V1, P213, DOI 10.1242/dmm.000323; Ordway DJ, 2011, CLIN VACCINE IMMUNOL, V18, P1527, DOI 10.1128/CVI.05127-11; Orme IM, 2010, TUBERCULOSIS, V90, P329, DOI 10.1016/j.tube.2010.06.002; Roth AE, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c671; Roy A, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4643; Schoenberger SP, 2009, SEMIN IMMUNOL, V21, P51, DOI 10.1016/j.smim.2009.02.007; Schrager L, 2015, DEV AER VACC MYC TUB, DOI [10.1016/j.vaccine.2015.03.060, DOI 10.1016/J.VACCINE.2015.03.060]; Tameris MD, 2013, LANCET, V381, P1021, DOI 10.1016/S0140-6736(13)60177-4; VANSOOLINGEN D, 1995, J CLIN MICROBIOL, V33, P3234, DOI 10.1128/JCM.33.12.3234-3238.1995; Vashist H, 2012, INT J RECENT ADV PHA, V2, P20; White AD, 2013, CLIN VACCINE IMMUNOL, V20, P663, DOI 10.1128/CVI.00690-12; Woodworth JSM, 2006, CRIT REV IMMUNOL, V26, P317, DOI 10.1615/CritRevImmunol.v26.i4.30; Young JM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011237	50	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2015	10	10							e0141577	10.1371/journal.pone.0141577	http://dx.doi.org/10.1371/journal.pone.0141577			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0DL	26509812	Green Submitted, Green Published, gold			2022-12-26	WOS:000363918100106
J	Chen, HJ; Chiang, BL				Chen, Hsing-Jin; Chiang, Bor-Luen			Effect of Hyperoxia on Retinoid Metabolism and Retinoid Receptor Expression in the Lungs of Newborn Mice	PLOS ONE			English	Article							VITAMIN-A SUPPLEMENTATION; BIRTH-WEIGHT INFANTS; BRONCHOPULMONARY DYSPLASIA; ACID RECEPTORS; MOUSE; RAR; MATURATION; ISOFORMS; DISEASE; ENZYMES	Background Preterm newborns that receive oxygen therapy often develop bronchopulmonary dysplasia (BPD), which is abnormal lung development characterized by impaired alveologenesis. Oxygen-mediated injury is thought to disrupt normal lung growth and development. However, the mechanism of hyperoxia-induced BPD has not been extensively investigated. We established a neonatal mouse model to investigate the effects of normobaric hyperoxia on retinoid metabolism and retinoid receptor expression. Methods Newborn mice were exposed to hyperoxic or normoxic conditions for 15 days. The concentration of retinol and retinyl palmitate in the lung was measured by HPLC to gauge retinoid metabolism. Retinoid receptor mRNA levels were assessed by real-time PCR. Proliferation and retinoid receptor expression in A549 cells were assessed in the presence and absence of exogenous vitamin A. Results Hyperoxia significantly reduced the body and lung weight of neonatal mice. Hyperoxia also downregulated expression of RAR alpha, RAR gamma, and RXR gamma in the lungs of neonatal mice. In vitro, hyperoxia inhibited proliferation and expression of retinoid receptors in A549 cells. Conclusion Hyperoxia disrupted retinoid receptor expression in neonatal mice.	[Chen, Hsing-Jin] Natl Taiwan Univ, Grad Inst Clin Med, Coll Med, Taipei 10764, Taiwan; [Chiang, Bor-Luen] Natl Taiwan Univ, Grad Inst Immunol, Taipei 10764, Taiwan	National Taiwan University; National Taiwan University	Chiang, BL (corresponding author), Natl Taiwan Univ, Grad Inst Immunol, Taipei 10764, Taiwan.	gicmbor@ntu.edu.tw		CHIANG, BOR-LUEN/0000-0002-6705-0286				Ambalavanan N, 2005, PEDIATRICS, V115, pE249, DOI 10.1542/peds.2004-1812; Bastien J, 2004, GENE, V328, P1, DOI 10.1016/j.gene.2003.12.005; Belloni PN, 2000, CHEST, V117, p235S, DOI 10.1378/chest.117.5_suppl_1.235S; Bhandari V, 2010, SEMIN FETAL NEONAT M, V15, P223, DOI 10.1016/j.siny.2010.03.009; BONIKOS DS, 1976, HUM PATHOL, V7, P643, DOI 10.1016/S0046-8177(76)80077-9; Chambon P, 1996, FASEB J, V10, P940, DOI 10.1096/fasebj.10.9.8801176; Couroucli XI, 2006, J PHARMACOL EXP THER, V317, P946, DOI 10.1124/jpet.105.100677; Darlow BA, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000501.pub2; Eber E, 2001, THORAX, V56, P317, DOI 10.1136/thorax.56.4.317; Garcia-Regalado A, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-44; Ghyselinck NB, 1998, DEV BIOL, V198, P303, DOI 10.1006/dbio.1998.8908; Guimaraes H, 2012, CURR PHARM DESIGN, V18, P3101, DOI 10.2174/1381612811209023101; Hind M, 2002, AM J RESP CELL MOL, V26, P67, DOI 10.1165/ajrcmb.26.1.4575; Hind M, 2002, AM J PHYSIOL-LUNG C, V282, pL468, DOI 10.1152/ajplung.00196.2001; James ML, 2013, AM J PHYSIOL-LUNG C, V304, pL803, DOI 10.1152/ajplung.00257.2012; James ML, 2010, PEDIATR RES, V67, P591, DOI 10.1203/PDR.0b013e3181dbac3d; Kastner P, 1997, DEVELOPMENT, V124, P313; Kimura Y, 2002, CLIN SCI, V103, P613, DOI 10.1042/cs1030613; LEID M, 1992, TRENDS BIOCHEM SCI, V17, P427, DOI 10.1016/0968-0004(92)90014-Z; LEID M, 1992, CELL, V68, P377, DOI 10.1016/0092-8674(92)90478-U; LOHNES D, 1993, CELL, V73, P643, DOI 10.1016/0092-8674(93)90246-M; Londhe VA, 2013, AM J RESP CELL MOL, V48, P179, DOI 10.1165/rcmb.2012-0229OC; Londhe VA, 2011, PEDIATR RES, V69, P371, DOI 10.1203/PDR.0b013e318211c917; Malpel S, 2000, DEVELOPMENT, V127, P3057; Mark Manuel, 2009, Nucl Recept Signal, V7, pe002, DOI 10.1621/nrs.07002; Massaro GD, 1996, AM J PHYSIOL-LUNG C, V270, pL305, DOI 10.1152/ajplung.1996.270.2.L305; McGrath-Morrow SA, 2004, AM J RESP CELL MOL, V30, P635, DOI 10.1165/rcmb.2003-0049OC; MENDELSOHN C, 1994, DEVELOPMENT, V120, P2749; Nabeyrat E, 2001, AM J RESP CELL MOL, V25, P507, DOI 10.1165/ajrcmb.25.4.4478; NORTHWAY WH, 1967, NEW ENGL J MED, V276, P357, DOI 10.1056/NEJM196702162760701; Popova AP, 2013, J CELL COMMUN SIGNAL, V7, P119, DOI 10.1007/s12079-013-0190-x; Shenai JP, 1999, PEDIATRICS, V104, P1369, DOI 10.1542/peds.104.6.1369; SHENAI JP, 1985, PEDIATR RES, V19, P892, DOI 10.1203/00006450-198509000-00003; SHENAI JP, 1985, PEDIATR RES, V19, P185, DOI 10.1203/00006450-198502000-00007; Tepper J, 2000, CHEST, V117, p242S, DOI 10.1378/chest.117.5_suppl_1.242S; Tyson JE, 1999, NEW ENGL J MED, V340, P1962, DOI 10.1056/NEJM199906243402505; Van Marter LJ, 2009, SEMIN FETAL NEONAT M, V14, P358, DOI 10.1016/j.siny.2009.08.007; ZACHMAN RD, 1995, J NUTR, V125, pS1634; Zimova-Herknerova M, 2008, PHYSIOL RES, V57, P33, DOI 10.33549/physiolres.930794	39	6	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2015	10	10							e0140343	10.1371/journal.pone.0140343	http://dx.doi.org/10.1371/journal.pone.0140343			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0DL	26509921	Green Published, gold, Green Submitted			2022-12-26	WOS:000363918100027
J	Diaz, RS; Inocencio, LA; Sucupira, MCA; Pereira, AA; Hunter, J; Ferreira, JE; Araujo, LV; Souza, DFC; Sabino, EC				Diaz, Ricardo Sobhie; Inocencio, Lilian A.; Sucupira, Maria Cecilia Araripe; Pereira, Anderson Alvarenga; Hunter, James; Ferreira, Joao Eduardo; Araujo, Luciano V.; Souza, Denise F. C.; Sabino, Ester Cerdeira			The Virological and Immunological Characteristics of the HIV-1-Infected Population in Brazil: From Initial Diagnosis to Impact of Antiretroviral Use	PLOS ONE			English	Article							HIV-INFECTION; SUBTYPE-B; THERAPY; INDIVIDUALS; EXPERIENCE; ADULTS; RISK	Background Immunological and virological status of HIV-infected individuals entering the Brazilian public system over time was analyzed. We evaluated the impact of ART on virological, immunological and antiretroviral resistance over time. Methods CD4+ T cell counts, viral loads and genotypes from patients over 13 years old from 2001-2011 were analyzed according to demographic data. We compared groups using parametric t-tests and linear regression analysis in the R statistical software language. Results Mean baseline CD4+ T cell counts varied from 348 (2003) to 389 (2009) and was higher among women (p = 1.1 x 10(-8)), lower in older patients (p < 1 x 10(-8)) and lower in less developed regions (p = 1.864 x 10(-5)). Percentage of treated patients with undetectable viral loads increased linearly from 46% (2001) to 77% (2011), was lower among women (p = 2.851 x 10(-6)), younger ages (p = 1 x 10(-3)), and in less developed regions (p = 1.782 x 10(-4)). NRTI acquired resistance was 86% in 2001-3 and decreased over time. NNRTI resistance increased from 2001-3(50%) to 2006-9 (60%), PI resistance decreased from 2001-3 (60%) to 2009 (40%), and 3-class resistance was stable over time around 25%. Subtype prevalence comprised B (75.3%), B/F recombinants (12.2%), C (5.7%), F (5.3%) and B/C recombinants (1.5%), with regional variations. Three-class resistance was 26.5% among Bs, 22.4% among Fs and 17.2% among Cs. Conclusions HIV diagnosis occurs late, especially among elderly Brazilians. Younger individuals need special attention due to poor virological response to treatment. Antiretroviral Resistance profile is subtype related.	[Diaz, Ricardo Sobhie; Inocencio, Lilian A.; Sucupira, Maria Cecilia Araripe; Hunter, James] Univ Fed Sao Paulo, Sao Paulo, Brazil; [Inocencio, Lilian A.; Pereira, Anderson Alvarenga; Souza, Denise F. C.] Brazilian STD AIDS, Brasilia, DF, Brazil; [Inocencio, Lilian A.; Pereira, Anderson Alvarenga; Souza, Denise F. C.] Minist Hlth, Viruses Hepatitis Dept, Brasilia, DF, Brazil; [Ferreira, Joao Eduardo; Araujo, Luciano V.; Sabino, Ester Cerdeira] Univ Sao Paulo, Sao Paulo, Brazil	Universidade Federal de Sao Paulo (UNIFESP); Universidade de Sao Paulo	Diaz, RS (corresponding author), Univ Fed Sao Paulo, Sao Paulo, Brazil.	rsdiaz@catg.com.br	Ferreira, João E/L-1287-2016; Sabino, Ester C/F-7750-2010; Ferreira, Joao Eduardo/C-6025-2012; Hunter, James/J-6106-2016; Araripe Sucupira, Maria Cecilia/K-1931-2012	Sabino, Ester C/0000-0003-2623-5126; Ferreira, Joao Eduardo/0000-0001-9607-2014; Hunter, James/0000-0001-9524-0629; Araripe Sucupira, Maria Cecilia/0000-0002-1114-5382	Brazilian Ministry of Health	Brazilian Ministry of Health	Funding was provided by the Brazilian Ministry of Health. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Althoff KN, 2010, AIDS RES THER, V7, DOI 10.1186/1742-6405-7-45; Althoff KN, 2010, CLIN INFECT DIS, V50, P1512, DOI 10.1086/652650; Caseiro MM, 2008, BRAZ J INFECT DIS, V12, P162, DOI 10.1590/S1413-86702008000300001; Chin-Hong PV, 2005, JAIDS-J ACQ IMM DEF, V40, P463, DOI 10.1097/01.qai.0000162238.93988.0c; Daar ES, 2011, ANN INTERN MED, V154, DOI 10.7326/0003-4819-154-7-201104050-00316; Deeks SG, 2001, NEW ENGL J MED, V344, P472, DOI 10.1056/NEJM200102153440702; Dickson NP, 2012, HIV MED, V13, P182, DOI 10.1111/j.1468-1293.2011.00959.x; Granich RM, 2009, LANCET, V373, P48, DOI 10.1016/S0140-6736(08)61697-9; Iwuji CC, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-397; Johnson Victoria A, 2010, Top HIV Med, V18, P156; Leal E, 2008, VIROLOGY, V381, P222, DOI 10.1016/j.virol.2008.08.029; Medeiros Roseane, 2002, Braz J Infect Dis, V6, P298, DOI 10.1590/S1413-86702002000600005; Miranda Ana Claudia, 2014, J Int AIDS Soc, V17, P19688, DOI 10.7448/IAS.17.4.19688; Montlahuc C, 2013, JAIDS-J ACQ IMM DEF, V64, P197, DOI 10.1097/QAI.0b013e31829cfbfa; Munerato P, 2010, AIDS RES HUM RETROV, V26, P265, DOI 10.1089/aid.2009.0288; O'Shea D, 2013, IRISH J MED SCI, V182, P389, DOI 10.1007/s11845-012-0898-2; R Core Team, 2014, R FDN STAT COMP; Riddler SA, 2008, NEW ENGL J MED, V358, P2095, DOI 10.1056/NEJMoa074609; Sabin CA, 2008, AIDS, V22, P1463; SABINO EC, 1994, J VIROL, V68, P6340, DOI 10.1128/JVI.68.10.6340-6346.1994; Soares C, 2011, 18 C RETR OPP INF BO; Souza DCF, 2011, J INT AIDS SOC, V14, DOI 10.1186/1758-2652-14-45; Teixeira PR, 2004, AIDS, V18, pS5, DOI 10.1097/00002030-200406003-00002; Torres AJL, 2009, BRAZ J INFECT DIS, V13, P221, DOI 10.1590/S1413-86702009000300013; Wensing Annemarie M, 2014, Top Antivir Med, V22, P642	25	17	17	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2015	10	10							e0139677	10.1371/journal.pone.0139677	http://dx.doi.org/10.1371/journal.pone.0139677			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0DL	26509441	Green Published, gold, Green Submitted			2022-12-26	WOS:000363918100011
J	Liu, MJ; Zhang, XQ; Geng, L; Xia, MD; Zhai, JY; Zhang, W; Zhang, YC; Sun, YH; Zhang, JT; Zhu, DY; Zhao, H; Chen, ZJ				Liu, Meiju; Zhang, Xiuqing; Geng, Ling; Xia, Mingdi; Zhai, Junyu; Zhang, Wei; Zhang, Yuchao; Sun, Yinhua; Zhang, Jiangtao; Zhu, Dongyi; Zhao, Han; Chen, Zi-Jiang			Risk Factors and Early Predictors for Heterotopic Pregnancy after In Vitro Fertilization	PLOS ONE			English	Article							HUMAN CHORIONIC-GONADOTROPIN; OF-THE-LITERATURE; ECTOPIC PREGNANCY; EMBRYO-TRANSFER; UNITED-STATES; DIAGNOSIS; MANAGEMENT; ABSENCE	This study investigated the risk factors and early predictors for heterotopic pregnancy (HP) after in vitro fertilization and embryo transfer (IVF-ET). From January 2008 to January 2013, 41 cases of HP and 72 cases of intrauterine twin pregnancy after IVF-ET were recruited and retrospectively analyzed. Compared with intrauterine twin pregnancy group, the HP group had a lower basal luteinizing hormone (LH) level (P = 0.005) and more cases had a history of hydrosalpinx (P = 0.008). After 14 days of IVF-ET, the serum beta-HCG (beta-human chorionic gonadotropin), E2 (Estradiol) and P (Progesterone) levels were lower in HP group (P<0.001, respectively). Moreover, vaginal bleeding and abdominal pain were the significant features of HP before diagnosis (P<0.001, respectively). Further by logistic regression, serum beta-hCG, P levels on the 14th day after ET, and vaginal bleeding were identified as the independent factors of HP. These results indicate that when two or more embryos transferred in IVF procedure, beta-hCG, P levels on the 14th day after ET, and vaginal bleeding could be taken as predictors for HP.	[Liu, Meiju; Zhang, Xiuqing; Geng, Ling; Xia, Mingdi; Zhai, Junyu; Zhang, Yuchao; Sun, Yinhua; Zhang, Jiangtao; Zhao, Han; Chen, Zi-Jiang] Shandong Univ, Prov Hosp Affiliated, Ctr Reprod Med, Jinan 250001, Peoples R China; [Liu, Meiju; Zhang, Xiuqing; Geng, Ling; Xia, Mingdi; Zhang, Yuchao; Sun, Yinhua; Zhang, Jiangtao; Zhao, Han; Chen, Zi-Jiang] Natl Res Ctr Assisted Reprod Technol & Reprod Gen, Jinan, Peoples R China; [Liu, Meiju; Zhang, Xiuqing; Geng, Ling; Xia, Mingdi; Zhang, Yuchao; Sun, Yinhua; Zhang, Jiangtao; Zhao, Han; Chen, Zi-Jiang] Minist Educ, Key Lab Reprod Endocrinol, Jinan, Peoples R China; [Liu, Meiju; Zhang, Xiuqing; Geng, Ling; Xia, Mingdi; Zhang, Yuchao; Sun, Yinhua; Zhang, Jiangtao; Zhao, Han; Chen, Zi-Jiang] Shandong Prov Key Lab Reprod Med, Jinan 250021, Peoples R China; [Liu, Meiju; Zhu, Dongyi] Linyi Peoples Hosp, Dept Reprod Med, Linyi 276000, Peoples R China; [Zhang, Wei] Shandong Univ, Prov Hosp Affiliated, Dept Joint & Bone Oncol, Jinan 250001, Peoples R China; [Zhai, Junyu; Chen, Zi-Jiang] Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Ctr Reprod Med, Shanghai 200135, Peoples R China; [Zhai, Junyu; Chen, Zi-Jiang] Shanghai Key Lab Assisted Reprod & Reprod Genet, Shanghai 200135, Peoples R China	Shandong University; Shandong University; Shanghai Jiao Tong University	Geng, L (corresponding author), Shandong Univ, Prov Hosp Affiliated, Ctr Reprod Med, Jinan 250001, Peoples R China.	gengling78@126.com; hanzh80@yahoo.com	Yan, Junhao/AAH-8310-2019; Li, Yuan/GXV-1310-2022; Chen, Zi-Jiang/GOE-6119-2022		National Basic Research Program of China (973 Program) [2012CB944700]; National Natural Science Foundation of China [81201441]; Scientific Research Foundation of Shandong Province of Outstanding Young Scientist [2012BSE27089]; Young Scholars Program of Shandong University [2015WLJH54]; Program for New Century Excellent Talents in University [NCET-13-0355]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Scientific Research Foundation of Shandong Province of Outstanding Young Scientist; Young Scholars Program of Shandong University; Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET))	This research was supported by the National Basic Research Program of China (973 Program) (2012CB944700) (Zi-Jiang Chen), the National Natural Science Foundation of China (81201441) (Wei Zhang), the Scientific Research Foundation of Shandong Province of Outstanding Young Scientist (2012BSE27089) (Han Zhao) and the Young Scholars Program of Shandong University (2015WLJH54) (Han Zhao), the Program for New Century Excellent Talents in University (NCET-13-0355) (Han Zhao).	Anastasakis E, 2007, FETAL DIAGN THER, V22, P285, DOI 10.1159/000100792; Avitabile NC, 2015, J ULTRAS MED, V34, P527, DOI 10.7863/ultra.34.3.527; Barrenetxea G, 2007, FERTIL STERIL, V87, DOI 10.1016/j.fertnstert.2006.05.085; Blazar AS, 1997, FERTIL STERIL, V67, P517, DOI 10.1016/S0015-0282(97)80079-9; Casikar I, 2012, CLIN OBSTET GYNECOL, V55, P402, DOI 10.1097/GRF.0b013e31825109bd; Condous G, 2005, HUM REPROD, V20, P1404, DOI 10.1093/humrep/deh770; Farquharson RG, 2005, HUM REPROD, V20, P3008, DOI 10.1093/humrep/dei167; Gergolet M, 2015, REPROD BIOMED ONLINE, V30, P622, DOI 10.1016/j.rbmo.2015.02.003; Kulkarni AD, 2013, NEW ENGL J MED, V369, P2218, DOI 10.1056/NEJMoa1301467; Li XH, 2013, ULTRASOUND OBST GYN, V41, P563, DOI 10.1002/uog.12341; Migda M, 2011, GINEKOL POL, V82, P866; Mol BWJ, 1999, FERTIL STERIL, V72, P643, DOI 10.1016/S0015-0282(99)00328-3; Perkins KM, 2015, OBSTET GYNECOL, V125, P70, DOI 10.1097/AOG.0000000000000584; Pezzuto A, 2009, J MINIM INVAS GYN, V16, P792, DOI 10.1016/j.jmig.2009.08.007; REECE EA, 1983, AM J OBSTET GYNECOL, V146, P323, DOI 10.1016/0002-9378(83)90755-X; Sparic R, 2012, SRP ARK CELOK LEK, V140, P511, DOI 10.2298/SARH1208511S; Strandell A, 1999, FERTIL STERIL, V71, P282, DOI 10.1016/S0015-0282(98)00441-5; Sugantha SE, 2000, HUM REPROD, V15, P469, DOI 10.1093/humrep/15.2.469; Talbot K, 2011, J OBSTET GYNAECOL, V31, P7, DOI 10.3109/01443615.2010.522749; Varras M, 2003, EUR J OBSTET GYN R B, V106, P79, DOI 10.1016/S0301-2115(02)00154-9; VERHULST G, 1993, HUM REPROD, V8, P1284, DOI 10.1093/oxfordjournals.humrep.a138242; WESTROM L, 1980, AM J OBSTET GYNECOL, V138, P880, DOI 10.1016/0002-9378(80)91077-7; Xiuqing Zhang, 2013, CHIN J MOD NURS, V7, P3511; Yu Y, 2014, EUR J OBSTET GYN R B, V180, P157, DOI 10.1016/j.ejogrb.2014.04.046	24	24	30	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2015	10	10							e0139146	10.1371/journal.pone.0139146	http://dx.doi.org/10.1371/journal.pone.0139146			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0DL	26510008	Green Published, Green Submitted, gold			2022-12-26	WOS:000363918100008
J	Mauprivez, C; Bataille, C; Baroukh, B; Llorens, A; Lesieur, J; Marie, PJ; Saffar, JL; Duplan, MB; Cherruau, M				Mauprivez, Cedric; Bataille, Caroline; Baroukh, Brigitte; Llorens, Annie; Lesieur, Julie; Marie, Pierre J.; Saffar, Jean-Louis; Duplan, Martin Biosse; Cherruau, Marc			Periosteum Metabolism and Nerve Fiber Positioning Depend on Interactions between Osteoblasts and Peripheral Innervation in Rat Mandible	PLOS ONE			English	Article							GROWTH-FACTOR; BONE-RESORPTION; SYMPATHETIC NEURONS; SEMAPHORIN 3A; IN-VIVO; EXPRESSION; SYSTEM; OSTEOCLASTS; RECEPTORS; CELLS	The sympathetic nervous system controls bone remodeling by regulating bone formation and resorption. How nerves and bone cells influence each other remains elusive. Here we modulated the content or activity of the neuropeptide Vasoactive Intestinal Peptide to investigate nerve-bone cell interplays in the mandible periosteum by assessing factors involved in nerve and bone behaviors. Young adult rats were chemically sympathectomized or treated with Vasoactive Intestinal Peptide or Vasoactive Intestinal Peptide(10-28), a receptor antagonist. Sympathectomy depleted the osteogenic layer of the periosteum in neurotrophic proNerve Growth Factor and neurorepulsive semaphorin3a; sensory Calcitonin-Gene Related Peptide-positive fibers invaded this layer physiologically devoid of sensory fibers. In the periosteum non-osteogenic layer, sympathectomy activated mast cells to release mature Nerve Growth Factor while Calcitonin-Gene Related Peptide-positive fibers increased. Vasoactive Intestinal Peptide treatment reversed sympathectomy effects. Treating intact animals with Vasoactive Intestinal Peptide increased proNerve Growth Factor expression and stabilized mast cells. Vasoactive Intestinal Peptide(10-28) treatment mimicked sympathectomy effects. Our data suggest that sympathetic Vasoactive Intestinal Peptide modulate the interactions between nervous fibers and bone cells by tuning expressions by osteogenic cells of factors responsible for mandible periosteum maintenance while osteogenic cells keep nervous fibers at a distance from the bone surface.	[Mauprivez, Cedric; Bataille, Caroline; Baroukh, Brigitte; Llorens, Annie; Lesieur, Julie; Saffar, Jean-Louis; Cherruau, Marc] Univ Paris 05, Sorbonne Paris Cite, EA2496 Lab Pathol Imagerie & Biothrapies Oro Faci, Fac Chirurg Dentaire, F-92120 Montrouge, France; [Mauprivez, Cedric; Bataille, Caroline; Saffar, Jean-Louis; Duplan, Martin Biosse; Cherruau, Marc] AP HP, Paris, France; [Marie, Pierre J.] INSERM, UMR 1132, Paris, France; [Marie, Pierre J.] Univ Paris Diderot, Sorbonne Paris Cite, Hop Lariboisiere, Paris, France; [Duplan, Martin Biosse] Univ Paris 05, INSERM, Sorbonne Paris Cite, Inst Imagine,Hop Necker Enfants Malades,U 1163, Paris, France	UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Saffar, JL (corresponding author), Univ Paris 05, Sorbonne Paris Cite, EA2496 Lab Pathol Imagerie & Biothrapies Oro Faci, Fac Chirurg Dentaire, 1 Rue Maurice Arnoux, F-92120 Montrouge, France.	jean-louis.saffar@parisdescartes.fr	Biosse Duplan, Martin/H-7491-2017	Biosse Duplan, Martin/0000-0001-9417-3970; Lerner, Ulf/0000-0002-3579-1960; Lesieur, Julie/0000-0002-5981-3458; Saffar, Jean-Louis/0000-0001-6288-9325				ABERDEEN J, 1990, NEUROSCIENCE, V35, P175, DOI 10.1016/0306-4522(90)90132-N; Aloe L, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-239; Asaumi K, 2000, BONE, V26, P625, DOI 10.1016/S8756-3282(00)00281-7; Asmus SE, 2000, J NEUROSCI, V20, P1495; Asmus SE, 2001, DEV BIOL, V235, P1, DOI 10.1006/dbio.2001.0282; Baroukh B, 2000, BONE, V27, P627, DOI 10.1016/S8756-3282(00)00372-0; Bataille C, 2012, BONE, V50, P1162, DOI 10.1016/j.bone.2012.01.023; Biosse-Duplan M, 2009, AM J PATHOL, V174, P1426, DOI 10.2353/ajpath.2009.080871; Bruno MA, 2006, P NATL ACAD SCI USA, V103, P6735, DOI 10.1073/pnas.0510645103; Buttigieg H, 2007, EXP NEUROL, V204, P832, DOI 10.1016/j.expneurol.2006.12.011; Cabrera-Vasquez S, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-34; Chen Y, 1997, MOL CELL ENDOCRINOL, V127, P129, DOI 10.1016/S0303-7207(96)04001-4; Cherruau M, 1999, BONE, V25, P545, DOI 10.1016/S8756-3282(99)00211-2; Cherruau M, 2003, J CELL PHYSIOL, V194, P341, DOI 10.1002/jcp.10209; de Wit J, 2003, PROG NEUROBIOL, V71, P249, DOI 10.1016/j.pneurobio.2003.06.001; Delaire S, 2001, J IMMUNOL, V166, P4348, DOI 10.4049/jimmunol.166.7.4348; Elefteriou F, 2005, NATURE, V434, P514, DOI 10.1038/nature03398; Fouilloux I, 2006, BONE, V38, P59, DOI 10.1016/j.bone.2005.07.026; Fukuda T, 2013, NATURE, V497, P490, DOI 10.1038/nature12115; Gavazzi I, 2001, CELL TISSUE RES, V305, P275, DOI 10.1007/s004410100365; Hayashi M, 2012, NATURE, V485, P69, DOI 10.1038/nature11000; JOHNSON EM, 1984, INT REV NEUROBIOL, V25, P1, DOI 10.1016/S0074-7742(08)60676-5; Khosla S, 2001, ENDOCRINOLOGY, V142, P5050, DOI 10.1210/en.142.12.5050; Kimura K, 2010, AUTON NEUROSCI-BASIC, V156, P27, DOI 10.1016/j.autneu.2010.02.005; Lee R, 2001, SCIENCE, V294, P1945, DOI 10.1126/science.1065057; LEON A, 1994, P NATL ACAD SCI USA, V91, P3739, DOI 10.1073/pnas.91.9.3739; Lessmann V, 2003, PROG NEUROBIOL, V69, P341, DOI 10.1016/S0301-0082(03)00019-4; Lundberg P, 2000, BONE, V27, P803, DOI 10.1016/S8756-3282(00)00394-X; Mogi M, 2000, LIFE SCI, V67, P1197, DOI 10.1016/S0024-3205(00)00705-0; Mrak E, 2010, J CELL PHYSIOL, V225, P701, DOI 10.1002/jcp.22266; Narazaki M, 2006, BLOOD, V107, P3892, DOI 10.1182/blood-2005-10-4113; Pascual M, 2005, HIPPOCAMPUS, V15, P184, DOI 10.1002/hipo.20040; Pinski J, 2002, CANCER RES, V62, P986; Schutz B, 2008, NEUROSCIENCE, V156, P310, DOI 10.1016/j.neuroscience.2008.06.074; Takeda S, 2002, CELL, V111, P305, DOI 10.1016/S0092-8674(02)01049-8; Taniguchi M, 1997, NEURON, V19, P519, DOI 10.1016/S0896-6273(00)80368-2; Togari A, 2000, BRAIN RES, V878, P204, DOI 10.1016/S0006-8993(00)02700-1; Tolofari SK, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2898; Wang L, 2006, J ORTHOP RES, V24, P2238, DOI 10.1002/jor.20269; Wang LP, 2010, BONE, V46, P1369, DOI 10.1016/j.bone.2009.11.029; YADA M, 1994, BIOCHEM BIOPH RES CO, V205, P1187, DOI 10.1006/bbrc.1994.2791	41	12	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2015	10	10							e0140848	10.1371/journal.pone.0140848	http://dx.doi.org/10.1371/journal.pone.0140848			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0DL	26509533	Green Published, gold, Green Submitted			2022-12-26	WOS:000363918100042
J	Nichols, DP; Jiang, D; Happoldt, C; Berman, R; Chu, HW				Nichols, David P.; Jiang, Di; Happoldt, Carrie; Berman, Reena; Chu, Hong Wei			Therapeutic Effects of alpha 1-Antitrypsin on Psedumonas aeruginosa Infection in ENaC Transgenic Mice	PLOS ONE			English	Article							MYCOPLASMA-PNEUMONIAE INFECTION; SURFACTANT-PROTEIN-A; CYSTIC-FIBROSIS; LUNG-DISEASE; ALPHA(1)-ANTITRYPSIN; INFLAMMATION; DEFENSE	Cystic fibrosis (CF) is a genetic disease with many airway pathological features, including aberrant epithelial sodium channel (ENaC) function, persistent Pseudomonas aeruginosa (PA) infection and neutrophil-dominant inflammation. PA infection in CF airways is difficult to treat due to antibiotic resistance and other factors. Recently, alpha 1-antitrypsin (A1AT) have been shown to be effective to reduce CF airway PA infection. However, there is a dearth of studies about the mechanisms underlying A1AT's therapeutic effects. The goal of our study is to provide an animal model of A1AT therapy in CF lungs. ENaC transgenic mice with PA infection were used as a CF-like model. Mice were intratracheally treated with PA or saline (control) in a fibrin plug. Two hours after PA infection, aerosolized A1AT were delivered to mouse lungs once daily. At day 1 and day 3 post PA infection, lung inflammation, PA load as well as host defence protein short palate, lung, and nasal epithelium clone 1 (SPLUNC1) were measured. At day 1 post PA infection when A1AT was delivered once to ENaC transgenic mouse lungs, A1AT did not reduce lung inflammation (e.g., neutrophils) and PA load. However, at day 3 post PA infection when ENaC transgenic mice received three repeated A1AT treatments, a significant decrease in airspace inflammation and PA load was observed. Although A1AT prevented the loss of SPLUNC1 in bronchoalveolar lavage fluid of PA-infected wild-type mice, it did not restore SPLUNC1 levels in ENaC transgenic mice. Our current study has provided a valid and quick A1AT therapeutic model in CF-like lungs that may serve as a platform for future mechanistic studies about how A1AT exerts beneficial effects in human CF patients.	[Nichols, David P.; Jiang, Di; Berman, Reena; Chu, Hong Wei] Natl Jewish Hlth, Dept Med, Denver, CO 80206 USA; [Nichols, David P.; Jiang, Di; Happoldt, Carrie; Berman, Reena; Chu, Hong Wei] Univ Colorado, Sch Med, Denver, CO 80202 USA; [Nichols, David P.; Happoldt, Carrie] Natl Jewish Hlth, Dept Pediat, Denver, CO USA	National Jewish Health; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; National Jewish Health	Chu, HW (corresponding author), Natl Jewish Hlth, Dept Med, Denver, CO 80206 USA.	chuhw@njhealth.org		Nichols, David/0000-0001-8611-7960	Grifols Inc.; Flight Attendant Medical Research Institute (FAMRI) [CIA 130041]	Grifols Inc.; Flight Attendant Medical Research Institute (FAMRI)	Part of the study was funded by the Grifols Inc. as an investigator-initiated research project. HWC received the grant from Flight Attendant Medical Research Institute (FAMRI), grant # CIA 130041. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cantin AM, 2015, J CYST FIBROS, V14, P419, DOI 10.1016/j.jcf.2015.03.003; Chandler JD, 2013, BRIT J PHARMACOL, V169, P1166, DOI 10.1111/bph.12206; Chandler JD, 2014, AM J RESP CELL MOL B, DOI [10.1165/rcmb.2014-0208OC, DOI 10.1165/RCMB.2014-02080C]; Chu HW, 2003, INFECT IMMUN, V71, P1520, DOI 10.1128/IAI.71.3.1520-1526.2003; Gally F, 2011, AM J PATHOL, V178, P2159, DOI 10.1016/j.ajpath.2011.01.026; Geraghty P, 2014, AM J RESP CRIT CARE, V190, P1229, DOI 10.1164/rccm.201405-0872OC; Giannoni E, 2006, AM J RESP CELL MOL, V34, P704, DOI 10.1165/rcmb.2005-0461OC; Gibson RL, 2003, AM J RESP CRIT CARE, V168, P918, DOI 10.1164/rccm.200304-505SO; Griese M, 2007, EUR RESPIR J, V29, P240, DOI 10.1183/09031936.00047306; Jiang D, 2013, RESP RES, V14, DOI 10.1186/1465-9921-14-122; Lyczak JB, 2002, CLIN MICROBIOL REV, V15, P194, DOI 10.1128/CMR.15.2.194-222.2002; Rubio F, 2004, THORAX, V59, P318, DOI 10.1136/thx.2003.014902; Seear M, 1997, AM J RESP CRIT CARE, V155, P364, DOI 10.1164/ajrccm.155.1.9001337; Stoller JK, 2012, AM J RESP CRIT CARE, V185, P246, DOI 10.1164/rccm.201108-1428CI; Yang H, 2015, EXPERT OPIN THER PAT, V25, P991, DOI 10.1517/13543776.2015.1045878; Zelvyte I, 2003, EUR J CANCER PREV, V12, P117, DOI 10.1097/00008469-200304000-00005	16	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2015	10	10							e0141232	10.1371/journal.pone.0141232	http://dx.doi.org/10.1371/journal.pone.0141232			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0DL	26509529	Green Submitted, gold, Green Published			2022-12-26	WOS:000363918100062
J	Bin, W				Wen, Bin			Effects of High Temperature and Water Stress on Seed Germination of the Invasive Species Mexican Sunflower	PLOS ONE			English	Article							PIPER-ADUNCUM; TITHONIA-DIVERSIFOLIA; PLANT INVASION; FOREST EDGES; GROWTH; DISTURBANCE; POTENTIALS; EVOLUTION; ECOLOGY; WEAPONS	Mexican sunflower is native to Mexico and Central America and was introduced into China early last century. Now it has widely naturalized and is exhibiting increasing invasiveness in South China. As this species often dominates bare ground, a habitat characterized by extreme fluctuation in temperature and water, it is reasonable to hypothesize that it has special adaptations to high temperature and water stress. Using laboratory experiments to simulate these stresses, this study investigated the response of Mexican sunflower seed germination to temperature and water stress, and compared these responses with those previously reported for another invasive, bamboo piper, which is confined to relatively cool and moist habitats in Xishuangbanna. As expected, Mexican sunflower seeds exhibited higher tolerance to these stresses than bamboo piper. Germination of Mexican sunflower seeds was highest at 15-30 degrees C, but significant numbers of seeds germinated and formed seedlings at 10 degrees C and 35 degrees C, at which no bamboo piper seeds formed seedlings, indicating a wider temperature range for germination than the latter. Roughly half the seeds survived 240 h continuous heat treatment and up to 15 h daily periodical heat treatment at 40 degrees C, while bamboo piper seeds were mostly killed by these treatments. About 20% of Mexican sunflower but no bamboo piper seeds germinated after heat treatment for 30 min at 80 degrees C. Germination was completely inhibited in bamboo piper seeds at -0.6 mPa, while 20-60% of Mexican sunflower seeds germinated depending on PEG or NaCl as osmoticum. This higher tolerance in Mexican sunflower seeds accords with its stronger invasiveness in this area. This comparison between two plant invaders demonstrates that invasiveness is not an all-or-nothing situation, and that adaptation to local habitats is a critical determinant of successful invasiveness for an alien plant.	Chinese Acad Sci, Ctr Integrat Conservat, Xishuangbanna Trop Bot Garden, Mengla 666303, Yunnan, Peoples R China	Chinese Academy of Sciences; Xishuangbanna Tropical Botanical Garden, CAS	Bin, W (corresponding author), Chinese Acad Sci, Ctr Integrat Conservat, Xishuangbanna Trop Bot Garden, Mengla 666303, Yunnan, Peoples R China.	wenb@xtbg.org.cn			National Natural Science Foundation of China [31170626]; Chinese Academy of Sciences (CAS) 135 Program [XTBG-F03]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences (CAS) 135 Program	The National Natural Science Foundation of China (31170626, http://www.nsfc.gov.cn/) and the Chinese Academy of Sciences (CAS) 135 Program (XTBG-F03) is thanked for providing financial support to WB for this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayeni AO, 1997, WEED RES, V37, P443, DOI 10.1046/j.1365-3180.1997.d01-72.x; Blumenthal D, 2009, P NATL ACAD SCI USA, V106, P7899, DOI 10.1073/pnas.0812607106; Burke MJW, 1996, ECOLOGY, V77, P776, DOI 10.2307/2265501; Callaway RM, 2004, FRONT ECOL ENVIRON, V2, P436, DOI 10.1890/1540-9295(2004)002[0436:NWISAT]2.0.CO;2; CAMARGO JLC, 1995, J TROP ECOL, V11, P205, DOI 10.1017/S026646740000866X; Corbin JD, 2004, ECOLOGY, V85, P1273, DOI 10.1890/02-0744; Donohue K, 2010, ANNU REV ECOL EVOL S, V41, P293, DOI 10.1146/annurev-ecolsys-102209-144715; Dousseau Sara, 2011, Braz. J. Bot., V34, P297, DOI 10.1590/S0100-84042011000300005; Gascon C, 2000, SCIENCE, V288, P1356, DOI 10.1126/science.288.5470.1356; Hartemink AE, 2010, J TROP FOR SCI, V22, P202; Hill SJ, 2005, AUSTRAL ECOL, V30, P775, DOI 10.1111/j.1442-9993.2005.01518.x; HOBBS RJ, 1992, CONSERV BIOL, V6, P324, DOI 10.1046/j.1523-1739.1992.06030324.x; International Seed Testing Association, 2006, INT RUL SEED TEST; KAPOS V, 1989, J TROP ECOL, V5, P173, DOI 10.1017/S0266467400003448; Lake JC, 2004, BIOL CONSERV, V117, P215, DOI 10.1016/S0006-3207(03)00294-5; LANG ARG, 1967, AUST J CHEM, V20, P2017, DOI 10.1071/CH9672017; Leps J, 2002, APPL VEG SCI, V5, P255, DOI 10.1111/j.1654-109X.2002.tb00555.x; Li HM, 2009, BIODIVERS CONSERV, V18, P3421, DOI 10.1007/s10531-009-9651-1; Luo J, 2012, WEED RES, V52, P112, DOI 10.1111/j.1365-3180.2011.00898.x; Ma YX, 1998, ACTA PHYTOECOLOGICA, V22, P250; Mack RN, 2000, ECOL APPL, V10, P689, DOI 10.1890/1051-0761(2000)010[0689:BICEGC]2.0.CO;2; Maillet J, 2000, WEED RES, V40, P11, DOI 10.1046/j.1365-3180.2000.00171.x; MICHEL BE, 1983, PLANT PHYSIOL, V72, P66, DOI 10.1104/pp.72.1.66; Muoghalu JI, 2008, WEED RES, V48, P157, DOI 10.1111/j.1365-3180.2007.00613.x; Padmanaba M, 2014, TROP CONSERV SCI, V7, P35, DOI 10.1177/194008291400700108; Pysek Petr, 2007, V193, P97; Qin RM, 2013, NEW PHYTOL, V197, P979, DOI 10.1111/nph.12071; Rashid I, 2007, ANN APPL BIOL, V150, P361, DOI 10.1111/j.1744-7348.2007.00136.x; Rejmanek M, 1996, ECOLOGY, V77, P1655, DOI 10.2307/2265768; Ren MX, 2009, WEED RES, V49, P449, DOI 10.1111/j.1365-3180.2009.00723.x; Rogers HM, 2000, J TROP ECOL, V16, P243, DOI 10.1017/S0266467400001383; Tongma S., 1999, Journal of Weed Science and Technology, V44, P51; Tongma S, 1998, WEED SCI, V46, P432, DOI 10.1017/S0043174500090858; van Kleunen M, 2010, ECOL LETT, V13, P235, DOI 10.1111/j.1461-0248.2009.01418.x; Wainwright CE, 2013, BIOL INVASIONS, V15, P2253, DOI 10.1007/s10530-013-0449-4; Wang SH, 2004, ACTA ECOL SIN, V24, P444; [王四海 WANG SiHai], 2008, [生态学报, Acta Ecologica Sinica], V28, P1307; Wen B, 2015, WEED RES, V55, P155, DOI 10.1111/wre.12134; WILLIAMSLINERA G, 1990, J ECOL, V78, P356, DOI 10.2307/2261117; Xu ChengDong, 2007, Guangxi Zhiwu / Guihaia, V27, P564; Yang J, 2012, WEED SCI, V60, P552, DOI 10.1614/WS-D-11-00175.1	41	16	18	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2015	10	10							e0141567	10.1371/journal.pone.0141567	http://dx.doi.org/10.1371/journal.pone.0141567			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0DL	26509675	Green Submitted, Green Published, gold			2022-12-26	WOS:000363918100104
J	Gill, SJ; Travers, J; Pshenichnaya, I; Kogera, FA; Barthorpe, S; Mironenko, T; Richardson, L; Benes, CH; Stratton, MR; McDermott, U; Jackson, SP; Garnett, MJ				Gill, Sonja J.; Travers, Jon; Pshenichnaya, Irina; Kogera, Fiona A.; Barthorpe, Syd; Mironenko, Tatiana; Richardson, Laura; Benes, Cyril H.; Stratton, Michael R.; McDermott, Ultan; Jackson, Stephen P.; Garnett, Mathew J.			Combinations of PARP Inhibitors with Temozolomide Drive PARP1 Trapping and Apoptosis in Ewing's Sarcoma	PLOS ONE			English	Article							POLY(ADP-RIBOSE) POLYMERASE INHIBITOR; CELL LUNG-CANCER; DNA-DAMAGE; MUTANT-CELLS; REPAIR; SENSITIVITY; TUMORS	Ewing's sarcoma is a malignant pediatric bone tumor with a poor prognosis for patients with metastatic or recurrent disease. Ewing's sarcoma cells are acutely hypersensitive to poly (ADP-ribose) polymerase (PARP) inhibition and this is being evaluated in clinical trials, although the mechanism of hypersensitivity has not been directly addressed. PARP inhibitors have efficacy in tumors with BRCA1/2 mutations, which confer deficiency in DNA double-strand break (DSB) repair by homologous recombination (HR). This drives dependence on PARP1/2 due to their function in DNA single-strand break (SSB) repair. PARP inhibitors are also cytotoxic through inhibiting PARP1/2 auto-PARylation, blocking PARP1/2 release from substrate DNA. Here, we show that PARP inhibitor sensitivity in Ewing's sarcoma cells is not through an apparent defect in DNA repair by HR, but through hypersensitivity to trapped PARP1-DNA complexes. This drives accumulation of DNA damage during replication, ultimately leading to apoptosis. We also show that the activity of PARP inhibitors is potentiated by temozolomide in Ewing's sarcoma cells and is associated with enhanced trapping of PARP1-DNA complexes. Furthermore, through mining of large-scale drug sensitivity datasets, we identify a subset of glioma, neuroblastoma and melanoma cell lines as hypersensitive to the combination of temozolomide and PARP inhibition, potentially identifying new avenues for therapeutic intervention. These data provide insights into the anti-cancer activity of PARP inhibitors with implications for the design of treatment for Ewing's sarcoma patients with PARP inhibitors.	[Gill, Sonja J.; Pshenichnaya, Irina; Kogera, Fiona A.; Barthorpe, Syd; Mironenko, Tatiana; Richardson, Laura; Stratton, Michael R.; McDermott, Ultan; Jackson, Stephen P.; Garnett, Mathew J.] Wellcome Trust Sanger Inst, Hinxton, England; [Travers, Jon; Jackson, Stephen P.] Univ Cambridge, Gurdon Inst, Wellcome Trust Canc Res UK, Cambridge, England; [Travers, Jon; Jackson, Stephen P.] Univ Cambridge, Dept Biochem, Cambridge, England; [Benes, Cyril H.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Ctr Canc, Charlestown, MA USA	Wellcome Trust Sanger Institute; Cancer Research UK; University of Cambridge; University of Cambridge; Harvard University; Massachusetts General Hospital	Jackson, SP (corresponding author), Wellcome Trust Sanger Inst, Hinxton, England.	s.jackson@gurdon.cam.ac.uk; mg12@sanger.ac.uk	Jackson, Stephen Philip/R-4548-2019	Jackson, Stephen Philip/0000-0001-9317-7937; McDermott, Ultan/0000-0001-9032-4700; Gill, Sonja/0000-0002-7273-9053	Wellcome Trust [086357, 102696/Z/13/Z, WT092096]; Cancer Research UK [C6/A11224, C6946/A14492]; European Research Council; European Community Seventh Framework Program [HEALTH-F2-2010-259893]; University of Cambridge; Cancer Research UK [11224, 18796] Funding Source: researchfish	Wellcome Trust(Wellcome Trust); Cancer Research UK(Cancer Research UK); European Research Council(European Research Council (ERC)European Commission); European Community Seventh Framework Program(European Commission); University of Cambridge(University of Cambridge); Cancer Research UK(Cancer Research UK)	Research in the M.J.G. laboratory is supported by grants from the Wellcome Trust (086357 and 102696/Z/13/Z; http://www.wellcome.ac.uk/Funding). Research in the S.P.J. laboratory is funded by Cancer Research UK Program Grant C6/A11224 (http://www.cancerresearchuk.org/fundingfor-researchers/our-funding-schemes), the European Research Council (http://erc.europa.eu/funding-andgrants)and the European Community Seventh Framework Program grant agreement no. HEALTH-F2-2010-259893 (DDResponse). Core infrastructure funding was provided by Cancer Research UK Grant C6946/A14492 and Wellcome Trust Grant WT092096. S.P.J. receives a salary from the University of Cambridge, supplemented by Cancer Research UK. J.T. was funded by the European Community Seventh Framework Program grant agreement no. HEALTH-F2-2010-259893 (DDResponse). U.M. is supported by a Cancer Research UK Clinician Scientist Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Administration USFaD, 2014, OL 2014; Audeh MW, 2010, LANCET, V376, P245, DOI 10.1016/S0140-6736(10)60893-8; Balmana J, 2011, CANCER DISCOV, V1, P29, DOI 10.1158/2159-8274.CD-11-0048; Blasius M, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-8-r78; Brenner JC, 2012, CANCER RES, V72, P1608, DOI 10.1158/0008-5472.CAN-11-3648; Bryant HE, 2005, NATURE, V434, P913, DOI 10.1038/nature03443; Byers LA, 2012, CANCER DISCOV, V2, P798, DOI 10.1158/2159-8290.CD-12-0112; Choy E, 2013, CANCER RES, V73, DOI 10.1158/1538-7445.AM2013-LB-174; ClinicalTrials.gov A service of the U.S. National Institutes of Health, 2014, OL AD REC MET EW SAR; Crompton BD, 2014, CANCER DISCOV, V4, P1326, DOI 10.1158/2159-8290.CD-13-1037; D'Atri S, 1998, MOL PHARMACOL, V54, P334, DOI 10.1124/mol.54.2.334; Donawho CK, 2007, CLIN CANCER RES, V13, P2728, DOI 10.1158/1078-0432.CCR-06-3039; Esiashvili N, 2008, J PEDIAT HEMATOL ONC, V30, P425, DOI 10.1097/MPH.0b013e31816e22f3; Farmer H, 2005, NATURE, V434, P917, DOI 10.1038/nature03445; Fong PC, 2009, NEW ENGL J MED, V361, P123, DOI 10.1056/NEJMoa0900212; Garnett MJ, 2012, NATURE, V483, P570, DOI 10.1038/nature11005; Gibson BA, 2012, NAT REV MOL CELL BIO, V13, P411, DOI 10.1038/nrm3376; Hawkins DS, 2011, PEDIATR BLOOD CANCER, V57, P535, DOI 10.1002/pbc.23126; Helleday T, 2011, MOL ONCOL, V5, P387, DOI 10.1016/j.molonc.2011.07.001; Janknecht R, 2005, GENE, V363, P1, DOI 10.1016/j.gene.2005.08.007; Jones P, 2009, J MED CHEM, V52, P7170, DOI 10.1021/jm901188v; Jones RM, 2012, BIOCHEM J, V443, P13, DOI 10.1042/BJ20112100; Liu XS, 2009, MOL CANCER RES, V7, P1686, DOI 10.1158/1541-7786.MCR-09-0299; Lord CJ, 2012, NATURE, V481, P287, DOI 10.1038/nature10760; Macmillan Cancer Support, 2014, EW SARC BON 2014; McCabe N, 2006, CANCER RES, V66, P8109, DOI 10.1158/0008-5472.CAN-06-0140; McDermott U, 2010, CANCER RES, V70, P1625, DOI 10.1158/0008-5472.CAN-09-3620; Mendes-Pereira AM, 2009, EMBO MOL MED, V1, P315, DOI 10.1002/emmm.200900041; Menear KA, 2008, J MED CHEM, V51, P6581, DOI 10.1021/jm8001263; Mortusewicz O, 2007, NUCLEIC ACIDS RES, V35, P7665, DOI 10.1093/nar/gkm933; Murai J, 2014, J PHARMACOL EXP THER, V349, P408, DOI 10.1124/jpet.113.210146; Murai J, 2014, MOL CANCER THER, V13, P433, DOI 10.1158/1535-7163.MCT-13-0803; Murai J, 2012, CANCER RES, V72, P5588, DOI 10.1158/0008-5472.CAN-12-2753; National Cancer Institute at the National Institutes of Health, 2013, EW SARC TREATM TREAT; National Cancer Institute at the National Institutes of Health, 2013, EW SARC TREATM EW SA; Nik-Zainal S, 2012, CELL, V149, P979, DOI 10.1016/j.cell.2012.04.024; Pettitt SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061520; PRASAD SC, 1990, CANCER RES, V50, P38; Sartori AA, 2007, NATURE, V450, P509, DOI 10.1038/nature06337; SATOH MS, 1992, NATURE, V356, P356, DOI 10.1038/356356a0; Shen YQ, 2013, CLIN CANCER RES, V19, P5003, DOI 10.1158/1078-0432.CCR-13-1391; Smith M, 2013, MOL CANC THERAPEUT S, V12; Soldatenkov VA, 1999, ONCOGENE, V18, P3954, DOI 10.1038/sj.onc.1202778; Stewart E, 2014, CELL REP, V9, P829, DOI 10.1016/j.celrep.2014.09.028; Thomas HD, 2007, MOL CANCER THER, V6, P945, DOI 10.1158/1535-7163.MCT-06-0552; Vilar E, 2011, CANCER RES, V71, P2632, DOI 10.1158/0008-5472.CAN-10-1120; Vormoor B, 2012, EUROPEAN J CANC S, V48; Vormoor B, 2014, CURR OPIN ONCOL, V26, P428, DOI 10.1097/CCO.0000000000000091; Wellcome Trust Sanger Institute GRL, 2014, COSMIC CAT SOM MUT C; Wilcoxen KM, 2013, MOL CANCER THER, V12, DOI 10.1158/1535-7163.TARG-13-A258	50	50	51	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2015	10	10							e0140988	10.1371/journal.pone.0140988	http://dx.doi.org/10.1371/journal.pone.0140988			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU8PC	26505995	Green Published, gold, Green Submitted			2022-12-26	WOS:000363804200024
J	Moharil, J; Lei, P; Tian, J; Gaile, DP; Andreadis, ST				Moharil, Janhavi; Lei, Pedro; Tian, Jun; Gaile, Daniel P.; Andreadis, Stelios T.			Lentivirus Live Cell Array for Quantitative Assessment of Gene and Pathway Activation during Myogenic Differentiation of Mesenchymal Stem Cells	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; GROWTH-FACTOR-BETA; SERUM RESPONSE FACTOR; TGF-BETA; ACTIN EXPRESSION; TRANSCRIPTION FACTORS; MOLECULAR REGULATION; SIGNALING PATHWAYS; ASCORBIC-ACID; ALPHA-ACTIN	Stem cell differentiation involves multiple cascades of transcriptional regulation that govern the cell fate. To study the real-time dynamics of this complex process, quantitative and high throughput live cell assays are required. Herein, we developed a lentiviral library of promoters and transcription factor binding sites to quantitatively capture the gene expression dynamics over a period of several days during myogenic differentiation of human mesenchymal stem cells (MSCs) harvested from two different anatomic locations, bone marrow and hair follicle. Our results enabled us to monitor the sequential activation of signaling pathways and myogenic gene promoters at various stages of differentiation. In conjunction with chemical inhibitors, the lentiviral array (LVA) results also revealed the relative contribution of key signaling pathways that regulate the myogenic differentiation. Our study demonstrates the potential of LVA to monitor the dynamics of gene and pathway activation during MSC differentiation as well as serve as a platform for discovery of novel molecules, genes and pathways that promote or inhibit complex biological processes.	[Moharil, Janhavi; Lei, Pedro; Tian, Jun; Andreadis, Stelios T.] SUNY Buffalo, Dept Chem & Biol Engn, Bioengn Lab, Amherst, NY 14260 USA; [Moharil, Janhavi; Gaile, Daniel P.] SUNY Buffalo, Dept Biostat, Buffalo, NY 14214 USA; [Andreadis, Stelios T.] SUNY Buffalo, Dept Biomed Engn, Amherst, NY 14260 USA; [Andreadis, Stelios T.] Ctr Excellence Bioinformat & Life Sci, Buffalo, NY 14203 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Andreadis, ST (corresponding author), SUNY Buffalo, Dept Chem & Biol Engn, Bioengn Lab, 908 Furnas Hall, Amherst, NY 14260 USA.	sandread@buffalo.edu	Lei, Pedro/U-1027-2019		National Science Foundation [CBET-0853993]; New York State Stem Cell Science (NYSTEM) [C024315]	National Science Foundation(National Science Foundation (NSF)); New York State Stem Cell Science (NYSTEM)	This work was supported by a grant from the National Science Foundation (CBET-0853993) and the New York State Stem Cell Science (NYSTEM Contract #C024315) to S.T. Andreadis.	Adam PJ, 2000, J BIOL CHEM, V275, P37798, DOI 10.1074/jbc.M006323200; Alimperti S, 2012, GENE THER, V19, P1123, DOI 10.1038/gt.2011.208; Alimperti S, 2014, BIOTECHNOL PROGR, V30, P974, DOI 10.1002/btpr.1904; Arakawa E, 2003, J CARDIOVASC PHARM, V42, P745, DOI 10.1097/00005344-200312000-00008; Bajpai VK, 2012, STEM CELL RES, V8, P74, DOI 10.1016/j.scr.2011.07.003; Beamish JA, 2010, TISSUE ENG PART B-RE, V16, P467, DOI [10.1089/ten.teb.2009.0630, 10.1089/ten.TEB.2009.0630]; Bellis AD, 2011, BIOTECHNOL BIOENG, V108, P395, DOI 10.1002/bit.22916; Chen JX, 2007, CELL MOTIL CYTOSKEL, V64, P248, DOI 10.1002/cm.20178; Chen SY, 2004, CIRC RES, V94, P1195, DOI 10.1161/01.RES.0000126897.41658.81; Deaton RA, 2005, J BIOL CHEM, V280, P31172, DOI 10.1074/jbc.M504774200; Han JH, 2012, STEM CELLS, V30, P2746, DOI 10.1002/stem.1223; Han JH, 2010, CARDIOVASC RES, V87, P147, DOI 10.1093/cvr/cvq024; Hautmann MB, 1997, J BIOL CHEM, V272, P10948; Hayashi K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089016; Hill CS, 2009, CELL RES, V19, P36, DOI 10.1038/cr.2008.325; Hinson JS, 2007, AM J PHYSIOL-HEART C, V292, pH1170, DOI 10.1152/ajpheart.00864.2006; Hinz B, 2001, MOL BIOL CELL, V12, P2730, DOI 10.1091/mbc.12.9.2730; Huang NF, 2008, REGEN MED, V3, P877, DOI 10.2217/17460751.3.6.877; Ito T, 2008, CYTOTECHNOLOGY, V56, P1, DOI 10.1007/s10616-007-9092-1; Jeon ES, 2008, CIRC RES, V103, P635, DOI 10.1161/CIRCRESAHA.108.180885; Kim MR, 2009, STEM CELLS, V27, P191, DOI 10.1634/stemcells.2008-0363; Kim MR, 2008, STEM CELLS, DOI [10.1634/stemcells.2008-1019, DOI 10.1634/STEMCELLS.2008-1019]; Kim YM, 2008, INT J BIOCHEM CELL B, V40, P2482, DOI 10.1016/j.biocel.2008.04.016; King KE, 2003, J BIOL CHEM, V278, P11661, DOI 10.1074/jbc.M211337200; King KR, 2007, LAB CHIP, V7, P77, DOI 10.1039/b612516f; Kinner B, 2002, EXP CELL RES, V278, P72, DOI 10.1006/excr.2002.5561; Kratchmarova I, 2005, SCIENCE, V308, P1472, DOI 10.1126/science.1107627; Kurpinski K, 2010, STEM CELLS, V28, P734, DOI 10.1002/stem.319; Liu JW, 2007, J THROMB HAEMOST, V5, P826, DOI 10.1111/j.1538-7836.2007.02381.x; Liu JY, 2010, TISSUE ENG PT A, V16, P2553, DOI [10.1089/ten.tea.2009.0833, 10.1089/ten.TEA.2009.0833]; Liu QH, 2008, PERITON DIALYSIS INT, V28, pS88; Liu SX, 2007, MOL BIOL CELL, V18, P2169, DOI 10.1091/mbc.E06-12-1121; Lockman K, 2004, J BIOL CHEM, V279, P42422, DOI 10.1074/jbc.M405432200; Mack CP, 2011, ARTERIOSCL THROM VAS, V31, P1495, DOI 10.1161/ATVBAHA.110.221135; Matsuda C, 2005, CYTOTECHNOLOGY, V47, P11, DOI 10.1007/s10616-005-3751-x; Miano JM, 2000, J BIOL CHEM, V275, P9814, DOI 10.1074/jbc.275.13.9814; Miano JM, 2007, AM J PHYSIOL-CELL PH, V292, pC70, DOI 10.1152/ajpcell.00386.2006; Mirman D., 2014, GROWTH CURVE ANAL VI; Narita Y, 2008, CELL TISSUE RES, V333, P449, DOI 10.1007/s00441-008-0654-0; NEWCOMB PM, 1993, J CELL PHYSIOL, V155, P385, DOI 10.1002/jcp.1041550220; Ng F, 2008, BLOOD, V112, P295, DOI 10.1182/blood-2007-07-103697; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; Padmashali RM, 2014, MOL THER, V22, P1971, DOI 10.1038/mt.2014.103; Padmashali RM, 2011, BIOMATERIALS, V32, P3330, DOI 10.1016/j.biomaterials.2011.01.035; Pannier AK, 2007, BIOTECHNOL BIOENG, V98, P486, DOI 10.1002/bit.21477; Perrella MA, 1998, MINER ELECTROL METAB, V24, P136, DOI 10.1159/000057361; Potier J N E., 2010, J BIOMECH, P43; Raut SD, 2010, J CONTROL RELEASE, V144, P213, DOI 10.1016/j.jconrel.2010.02.009; REILLY CF, 1986, J CELL PHYSIOL, V129, P11, DOI 10.1002/jcp.1041290103; Ross JJ, 2006, J CLIN INVEST, V116, P3139, DOI 10.1172/JCI28184; Sinha S, 2004, AM J PHYSIOL-CELL PH, V287, pC1560, DOI 10.1152/ajpcell.00221.2004; Smith PC, 2006, J PERIODONTAL RES, V41, P418, DOI 10.1111/j.1600-0765.2006.00886.x; Thompson DM, 2004, ANAL CHEM, V76, P4098, DOI 10.1021/ac0354241; Tian J, 2009, GENE THER, V16, P874, DOI 10.1038/gt.2009.46; Tian J, 2010, LAB CHIP, V10, P1967, DOI 10.1039/c003153d; Wieder KJ, 2005, BIOMED MICRODEVICES, V7, P213, DOI 10.1007/s10544-005-3028-3; Xiao QZ, 2010, THROMB HAEMOSTASIS, V104, P440, DOI 10.1160/TH09-11-0794; Yan XH, 2011, BIOCHEM J, V434, P1, DOI 10.1042/BJ20101827; Yoshida K, 2005, AM J PATHOL, V166, P1029, DOI 10.1016/S0002-9440(10)62324-3; Yoshida T, 2004, CIRC RES, V94, P1075, DOI 10.1161/01.RES.0000125622.46280.95; You H, 2013, TISSUE BARRIERS, V1, DOI 10.4161/tisb.26845	61	7	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2015	10	10							e0141365	10.1371/journal.pone.0141365	http://dx.doi.org/10.1371/journal.pone.0141365			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU8PC	26505747	Green Published, gold			2022-12-26	WOS:000363804200055
J	Palazzo, E; Kellett, M; Cataisson, C; Gormley, A; Bible, PW; Pietroni, V; Radoja, N; Hwang, J; Blumenberg, M; Yuspa, SH; Morasso, MI				Palazzo, E.; Kellett, M.; Cataisson, C.; Gormley, A.; Bible, P. W.; Pietroni, V.; Radoja, N.; Hwang, J.; Blumenberg, M.; Yuspa, S. H.; Morasso, M. I.			The homeoprotein DLX3 and tumor suppressor p53 co-regulate cell cycle progression and squamous tumor growth	ONCOGENE			English	Article							HOMEOBOX GENE; HUMAN KERATINOCYTES; BINDING-SITES; P63; DIFFERENTIATION; SKIN; EXPRESSION; CANCER; TAP63; TUMORIGENESIS	Epidermal homeostasis depends on the coordinated control of keratinocyte cell cycle. Differentiation and the alteration of this balance can result in neoplastic development. Here we report on a novel DLX3-dependent network that constrains epidermal hyperplasia and squamous tumorigenesis. By integrating genetic and transcriptomic approaches, we demonstrate that DLX3 operates through a p53-regulated network. DLX3 and p53 physically interact on the p21 promoter to enhance p21 expression. Elevating DLX3 in keratinocytes produces a G1-S blockade associated with p53 signature transcriptional profiles. In contrast, DLX3 loss promotes a mitogenic phenotype associated with constitutive activation of ERK. DLX3 expression is lost in human skin cancers and is extinguished during progression of experimentally induced mouse squamous cell carcinoma (SCC). Reinstatement of DLX3 function is sufficient to attenuate the migration of SCC cells, leading to decreased wound closure. Our data establish the DLX3-p53 interplay as a major regulatory axis in epidermal differentiation and suggest that DLX3 is a modulator of skin carcinogenesis.	[Palazzo, E.; Kellett, M.; Gormley, A.; Bible, P. W.; Pietroni, V.; Radoja, N.; Hwang, J.; Morasso, M. I.] NIAMS, Skin Biol Lab, NIH, Bldg 50,Room 1523, Bethesda, MD 20892 USA; [Cataisson, C.; Yuspa, S. H.] NCI, Lab Canc Biol & Genet, NIH, Bethesda, MD 20892 USA; [Blumenberg, M.] NYU, Dept Dermatol, New York, NY 10016 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); New York University	Morasso, MI (corresponding author), NIAMS, Skin Biol Lab, NIH, Bldg 50,Room 1523, Bethesda, MD 20892 USA.	morasso@nih.gov	Palazzo, Elisabetta/J-5287-2016	Palazzo, Elisabetta/0000-0002-0812-5524; McCarter, Anna/0000-0003-3828-9797; Blumenberg, Miroslav/0000-0002-8672-7774	Intramural Research Program of the National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health [ZIA AR041124-14]; NATIONAL CANCER INSTITUTE [ZIABC004504] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [ZICAR041186, ZIAAR041124] Funding Source: NIH RePORTER	Intramural Research Program of the National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank current and past members of the Laboratory of Skin Biology and members of the Laboratory of Cancer Biology and Genetics, and Dr Mark Udey for helpful discussions. We also thank Andrew Ryscavage (LCBG), Gustavo Gutierrez-Cruz (NIAMS Genome Analysis Core Facility), Dr Hong-Wei Sun (Biodata Mining and Discovery Section, NIAMS) and Kristina Zaal of the NIAMS Light Imaging Core Facility. This work was supported by the Intramural Research Program of the National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health (M.I.M. ZIA AR041124-14).	Aasen T, 2010, NAT PROTOC, V5, P371, DOI 10.1038/nprot.2009.241; Abate-Shen C, 2002, NAT REV CANCER, V2, P777, DOI 10.1038/nrc907; Botchkarev VA, 2014, CSH PERSPECT MED, V4, DOI 10.1101/cshperspect.a015248; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; BURNS JE, 1993, BRIT J CANCER, V67, P1274, DOI 10.1038/bjc.1993.238; Cai BH, 2012, J BIOCHEM, V152, P99, DOI 10.1093/jb/mvs053; Candi E, 2007, P NATL ACAD SCI USA, V104, P11999, DOI 10.1073/pnas.0703458104; Candi E, 2014, HUM MUTAT, V35, P702, DOI 10.1002/humu.22523; Cataisson C, 2012, J EXP MED, V209, P1689, DOI 10.1084/jem.20101355; Cataisson C, 2009, CANCER RES, V69, P319, DOI 10.1158/0008-5472.CAN-08-2490; Chakravarti D, 2014, P NATL ACAD SCI USA, V111, pE572, DOI 10.1073/pnas.1319743111; Crum CP, 2010, ANNU REV PATHOL-MECH, V5, P349, DOI 10.1146/annurev-pathol-121808-102117; Darwiche N, 2007, ONCOGENE, V26, P6885, DOI 10.1038/sj.onc.1210491; Di Costanzo A, 2009, CELL CYCLE, V8, P1185, DOI 10.4161/cc.8.8.8202; Dotto JE, 2006, J CUTAN PATHOL, V33, P413, DOI 10.1111/j.0303-6987.2006.00477.x; Duverger O, 2008, J CELL PHYSIOL, V216, P337, DOI 10.1002/jcp.21491; Duverger O, 2008, J BIOL CHEM, V283, P20198, DOI 10.1074/jbc.M709562200; Flores ER, 2007, CELL CYCLE, V6, P300, DOI 10.4161/cc.6.3.3793; Gandarillas A, 2012, CELL CYCLE, V11, P4507, DOI 10.4161/cc.22529; Guo XC, 2009, NAT CELL BIOL, V11, P1451, DOI 10.1038/ncb1988; Ha LA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021877; Hodis E, 2012, CELL, V150, P251, DOI 10.1016/j.cell.2012.06.024; Hwang J, 2008, DEVELOPMENT, V135, P3149, DOI 10.1242/dev.022202; Hwang J, 2011, P NATL ACAD SCI USA, V108, P11566, DOI 10.1073/pnas.1019658108; Karia PS, 2013, J AM ACAD DERMATOL, V68, P957, DOI 10.1016/j.jaad.2012.11.037; Kelder T, 2012, NUCLEIC ACIDS RES, V40, pD1301, DOI 10.1093/nar/gkr1074; King KE, 2007, MOL CARCINOGEN, V46, P716, DOI 10.1002/mc.20337; King KE, 2013, J SKIN CANCER, V2013, DOI 10.1155/2013/632028; Koh LF, 2015, EXP DERMATOL, V24, P754, DOI 10.1111/exd.12764; Koster MI, 2004, DIFFERENTIATION, V72, P364, DOI 10.1111/j.1432-0436.2004.07208002.x; Lessard JC, 2015, EXP DERMATOL, V24, P55, DOI 10.1111/exd.12568; Levine AJ, 2006, CELL DEATH DIFFER, V13, P1027, DOI 10.1038/sj.cdd.4401910; Lichti U, 2008, NAT PROTOC, V3, P799, DOI 10.1038/nprot.2008.50; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Masse I, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.62; Missero C, 1996, GENE DEV, V10, P3065, DOI 10.1101/gad.10.23.3065; Morasso Maria I., 2005, Birth Defects Research, V75, P163, DOI 10.1002/bdrc.20047; Morasso MI, 1996, J CELL BIOL, V135, P1879, DOI 10.1083/jcb.135.6.1879; Paik JH, 2007, CELL, V128, P309, DOI 10.1016/j.cell.2006.12.029; Park GT, 1999, J BIOL CHEM, V274, P26599, DOI 10.1074/jbc.274.37.26599; Petitjean A, 2007, ONCOGENE, V26, P2157, DOI 10.1038/sj.onc.1210302; Priolo M, 2001, J MED GENET, V38, P579, DOI 10.1136/jmg.38.9.579; Radoja N, 2006, PHYSIOL GENOMICS, V27, P65, DOI 10.1152/physiolgenomics.00031.2006; Radoja N, 2007, DEVELOPMENT, V134, P13, DOI 10.1242/dev.02703; Ratushny V, 2012, J CLIN INVEST, V122, P464, DOI 10.1172/JCI57415; Rocco JW, 2006, CANCER CELL, V9, P45, DOI 10.1016/j.ccr.2005.12.013; Romano RA, 2012, DEVELOPMENT, V139, P772, DOI 10.1242/dev.071191; ROOP DR, 1986, NATURE, V323, P822, DOI 10.1038/323822a0; Saramaki A, 2006, NUCLEIC ACIDS RES, V34, P543, DOI 10.1093/nar/gkj460; Schavolt KL, 2007, ONCOGENE, V26, P6125, DOI 10.1038/sj.onc.1210441; Senoo M, 2007, CELL, V129, P523, DOI 10.1016/j.cell.2007.02.045; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Su XH, 2013, NAT REV CANCER, V13, P136, DOI 10.1038/nrc3446; Su XH, 2010, NATURE, V467, P986, DOI 10.1038/nature09459; Su XH, 2009, CELL STEM CELL, V5, P64, DOI 10.1016/j.stem.2009.04.003; Taylor WR, 2001, ONCOGENE, V20, P1803, DOI 10.1038/sj.onc.1204252; Topley GI, 1999, P NATL ACAD SCI USA, V96, P9089, DOI 10.1073/pnas.96.16.9089; Tu Zhigang, 2012, Small GTPases, V3, P163, DOI 10.4161/sgtp.19884; Vanbokhoven H, 2011, J INVEST DERMATOL, V131, P1196, DOI 10.1038/jid.2011.84; Wei CL, 2006, CELL, V124, P207, DOI 10.1016/j.cell.2005.10.043	61	19	21	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 16	2016	35	24					3114	3124		10.1038/onc.2015.380	http://dx.doi.org/10.1038/onc.2015.380			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DO9GI	26522723	Bronze, Green Accepted			2022-12-26	WOS:000378092700004
J	Pisani, DF; Beranger, GE; Corinus, A; Giroud, M; Ghandour, RA; Altirriba, J; Chambard, JC; Mazure, NM; Bendahhou, S; Duranton, C; Michiels, JF; Frontini, A; Rohner-Jeanrenaud, F; Cinti, S; Christian, M; Barhanin, J; Amri, EZ				Pisani, Didier F.; Beranger, Guillaume E.; Corinus, Alain; Giroud, Maude; Ghandour, Rayane A.; Altirriba, Jordi; Chambard, Jean-Claude; Mazure, Nathalie M.; Bendahhou, Said; Duranton, Christophe; Michiels, Jean-Francois; Frontini, Andrea; Rohner-Jeanrenaud, Franoise; Cinti, Saverio; Christian, Mark; Barhanin, Jacques; Amri, Ez-Zoubir			The K+ channel TASK1 modulates beta-adrenergic response in brown adipose tissue through the mineralocorticoid receptor pathway	FASEB JOURNAL			English	Article						UCP1; KCNK3; thermogenesis; aldosterone; obesity	ADIPOCYTE DYSFUNCTION; UNCOUPLING PROTEIN; GENE-EXPRESSION; COLD-EXPOSURE; WHITE; FAT; ACTIVATION; CELL; IDENTIFICATION; ALDOSTERONE	Brown adipose tissue (BAT) is essential for adaptive thermogenesis and dissipation of caloric excess through the activity of uncoupling protein (UCP)-1. BAT in humans is of great interest for the treatment of obesity and related diseases. In this study, the expression of Twik-related acid-sensitive K+ channel (TASK)-1 [a pH-sensitive potassium channel encoded by the potassium channel, 2-pore domain, subfamily K, member 3 (Kcnk3) gene] correlated highly with Ucp1 expression in obese and cold-exposed mice. In addition, Task1-nullmice, compared with their controls, became overweight, mainly because of an increase in white adipose tissue mass and BAT whitening. Task1(-/-) -mouse-derived brown adipocytes, compared with wild-typemouse-derived brown adipocytes, displayed an impaired beta 3-adrenergic receptor response that was characterized by a decrease in oxygen consumption, Ucp1 expression, and lipolysis. This phenotype was thought to be caused by an exacerbation of mineralocorticoid receptor (MR) signaling, given that it was mimicked by corticoids and reversed by an MR inhibitor. We concluded that the K+ channel TASK1 controls the thermogenic activity in brown adipocytes through modulation of beta-adrenergic receptor signaling.	[Pisani, Didier F.; Beranger, Guillaume E.; Corinus, Alain; Giroud, Maude; Ghandour, Rayane A.; Chambard, Jean-Claude; Mazure, Nathalie M.; Bendahhou, Said; Duranton, Christophe; Michiels, Jean-Francois; Barhanin, Jacques; Amri, Ez-Zoubir] Univ Nice Sophia Antipolis, F-06189 Nice, France; [Pisani, Didier F.; Beranger, Guillaume E.; Giroud, Maude; Ghandour, Rayane A.; Chambard, Jean-Claude; Amri, Ez-Zoubir] CNRS, IBV, UMR 7277, F-06034 Nice, France; [Pisani, Didier F.; Beranger, Guillaume E.; Giroud, Maude; Ghandour, Rayane A.; Chambard, Jean-Claude; Amri, Ez-Zoubir] Fac Med Nice, INSERM, IBV, U1091, U210, F-06034 Nice, France; [Corinus, Alain; Bendahhou, Said; Duranton, Christophe; Barhanin, Jacques] CNRS, UMR 7370, F-06034 Nice, France; [Corinus, Alain; Bendahhou, Said; Duranton, Christophe; Barhanin, Jacques] CNRS, LP2M, Labs Excellence Ion Channel Sci & Therapeut, F-06034 Nice, France; [Altirriba, Jordi; Rohner-Jeanrenaud, Franoise] Univ Geneva, Fac Med, Dept Internal Med Specialties, Lab Metab, Geneva, Switzerland; [Mazure, Nathalie M.; Michiels, Jean-Francois] CNRS, Inst Res Canc & Aging Nice, INSERM, UMR 7284, F-06034 Nice, France; [Mazure, Nathalie M.; Michiels, Jean-Francois] CNRS, Inst Res Canc & Aging Nice, INSERM, U1081, F-06034 Nice, France; [Michiels, Jean-Francois] CHU Nice, Pasteur Hosp, Serv Anatomopathol, F-06202 Nice, France; [Frontini, Andrea; Cinti, Saverio] Obes Ctr, Dept Expt & Clin Med, Ancona, Italy; [Christian, Mark] Univ Warwick, Warwick Med Sch, Coventry CV4 7AL, W Midlands, England	UDICE-French Research Universities; Universite Cote d'Azur; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Cote d'Azur; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Cote d'Azur; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; University of Geneva; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); CHU Nice; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; Centre National de la Recherche Scientifique (CNRS); CHU Nice; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; CHU Nice; University of Warwick	Amri, EZ (corresponding author), Univ Nice Sophia Antipolis, Inst Biol Valrose, 28 Ave Valombrose, F-06107 Nice 2, France.; Barhanin, J (corresponding author), Lab Physiomed Mol, 28 Ave Valombrose, F-06107 Nice 2, France.	jacques.barhanin@unice.fr; amri@unice.fr	Beranger, Guillaume E/L-7554-2016; Beranger, Guillaume/AAH-2608-2019; Frontini, A/AAB-8767-2021; Pisani, Didier/AAC-2997-2019	Beranger, Guillaume E/0000-0001-8770-864X; Beranger, Guillaume/0000-0001-8770-864X; Pisani, Didier/0000-0001-5879-8527; Mazure, Nathalie/0000-0003-1350-7161; CINTI, Saverio/0000-0003-0362-5017; Christian, Mark/0000-0002-1616-4179; Frontini, Andrea/0000-0002-7381-4107	Centre National de la Recherche Scientifique; EU FP7 project DIABAT [HEALTH-F2-2011-278373]; French Agence Nationale de la Recherche (ANR) [ANR-10-BLAN-1105 miRBAT, ANR-11-BSV1-005 02 BeyondTASK]; LabEx Ion Channel Science and Therapeutics Grant [ANR-11-LABX-0015-01]	Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); EU FP7 project DIABAT; French Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR)); LabEx Ion Channel Science and Therapeutics Grant	The authors thank the Institut de Pharmacologie Moleculaire et Cellulaire, and the Institute for Research in Cancer and Aging in Nice animal core facilities. This work was supported by the Centre National de la Recherche Scientifique, EU FP7 project DIABAT (HEALTH-F2-2011-278373), French Agence Nationale de la Recherche (ANR) Grants ANR-10-BLAN-1105 miRBAT (to E.-Z.A.) and ANR-11-BSV1-005 02 BeyondTASK (to J.B.), and LabEx Ion Channel Science and Therapeutics Grant ANR-11-LABX-0015-01.	Armani A, 2014, FASEB J, V28, P3745, DOI 10.1096/fj.13-245415; Bandulik S., 2014, PFLUGERS ARCH, V467, P1027, DOI DOI 10.1007/S00424-014-1628-6); Barbatelli G, 2010, AM J PHYSIOL-ENDOC M, V298, pE1244, DOI 10.1152/ajpendo.00600.2009; Beranger GE, 2014, ENDOCRINOLOGY, V155, P1340, DOI 10.1210/en.2013-1688; Borga M, 2014, METHOD ENZYMOL, V537, P141, DOI 10.1016/B978-0-12-411619-1.00008-2; Brand MD, 2011, BIOCHEM J, V435, P297, DOI 10.1042/BJ20110162; Briones AM, 2012, HYPERTENSION, V59, P1069, DOI 10.1161/HYPERTENSIONAHA.111.190223; Caprio M, 2011, ENDOCRINOLOGY, V152, P113, DOI 10.1210/en.2010-0674; Cinti S, 1997, ENDOCRINOLOGY, V138, P797, DOI 10.1210/en.138.2.797; Cypess AM, 2015, CELL METAB, V21, P33, DOI 10.1016/j.cmet.2014.12.009; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; Dadi PK, 2014, ENDOCRINOLOGY, V155, P3757, DOI 10.1210/en.2013-2051; Duprat F, 1997, EMBO J, V16, P5464, DOI 10.1093/emboj/16.17.5464; Fallo F, 2008, CURR DIABETES REP, V8, P42, DOI 10.1007/s11892-008-0009-y; Farman N, 2000, KIDNEY INT, V57, P1364, DOI 10.1046/j.1523-1755.2000.00976.x; Fukuhara K, 1996, J NEUROENDOCRINOL, V8, P533, DOI 10.1046/j.1365-2826.1996.04877.x; Funder JW, 2005, HEART FAIL REV, V10, P15, DOI 10.1007/s10741-005-2344-2; Heitzmann D, 2008, EMBO J, V27, P179, DOI 10.1038/sj.emboj.7601934; Hirata A, 2009, CARDIOVASC RES, V84, P164, DOI 10.1093/cvr/cvp191; Kozak LP, 2010, CELL METAB, V11, P263, DOI 10.1016/j.cmet.2010.03.009; Langin D, 2010, BBA-MOL CELL BIOL L, V1801, P372, DOI 10.1016/j.bbalip.2009.09.008; Lesage F, 2011, PHYSIOLOGY, V26, P424, DOI 10.1152/physiol.00029.2011; Lichtenbelt WDV, 2009, NEW ENGL J MED, V360, P1500, DOI 10.1056/NEJMoa0808718; Locke AE, 2015, NATURE, V518, P197, DOI 10.1038/nature14177; Manieri M, 2010, NUTR METAB CARDIOVAS, V20, P567, DOI 10.1016/j.numecd.2009.04.020; Marzolla V, 2014, STEROIDS, V91, P46, DOI 10.1016/j.steroids.2014.05.001; Marzolla V, 2012, MOL CELL ENDOCRINOL, V350, P281, DOI 10.1016/j.mce.2011.09.011; Nedergaard J, 2007, AM J PHYSIOL-ENDOC M, V293, pE444, DOI 10.1152/ajpendo.00691.2006; Nogueira EF, 2010, CLIN ENDOCRINOL, V73, P22, DOI 10.1111/j.1365-2265.2009.03738.x; Petrovic N, 2010, J BIOL CHEM, V285, P7153, DOI 10.1074/jbc.M109.053942; Pisani DF, 2014, MOL METAB, V3, P834, DOI 10.1016/j.molmet.2014.09.003; Pisani Didier F, 2011, Front Endocrinol (Lausanne), V2, P87, DOI 10.3389/fendo.2011.00087; RICQUIER D, 1986, J BIOL CHEM, V261, P13905; Ricquier D, 2000, INT J OBESITY, V24, pS86, DOI 10.1038/sj.ijo.0801286; Rogerson FM, 2014, FASEB J, V28, P4200, DOI 10.1096/fj.13-242479; Rosell M, 2014, AM J PHYSIOL-ENDOC M, V306, pE945, DOI 10.1152/ajpendo.00473.2013; Saito M, 2009, DIABETES, V58, P1526, DOI 10.2337/db09-0530; Shabalina IG, 2013, CELL REP, V5, P1196, DOI 10.1016/j.celrep.2013.10.044; Shibata S, 2013, CELL METAB, V18, P660, DOI 10.1016/j.cmet.2013.10.005; Shinoda K, 2015, NAT MED, V21, P389, DOI 10.1038/nm.3819; Soumano K, 2000, MOL CELL ENDOCRINOL, V165, P7, DOI 10.1016/S0303-7207(00)00276-8; Stow LR, 2009, J BIOL CHEM, V284, P30087, DOI 10.1074/jbc.M109.030718; Svensson PA, 2011, INT J MOL MED, V27, P227, DOI 10.3892/ijmm.2010.566; Thomas SA, 1997, NATURE, V387, P94, DOI 10.1038/387094a0; Viengchareun S, 2001, AM J PHYSIOL-ENDOC M, V280, pE640, DOI 10.1152/ajpendo.2001.280.4.E640; Virtanen KA, 2009, NEW ENGL J MED, V360, P1518, DOI 10.1056/NEJMoa0808949; Wu J, 2012, CELL, V150, P366, DOI 10.1016/j.cell.2012.05.016; Zingaretti MC, 2009, FASEB J, V23, P3113, DOI 10.1096/fj.09-133546	48	27	28	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2016	30	2					909	922		10.1096/fj.15-277475	http://dx.doi.org/10.1096/fj.15-277475			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DC7IA	26527067	Green Published			2022-12-26	WOS:000369391900038
J	Kotzler, MP; Withers, SG				Koetzler, Miriam P.; Withers, Stephen G.			Proteolytic Cleavage Driven by Glycosylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						glutamate; glycobiology; glycosidase; glycosylation; protein processing; protein splicing; proteolysis; glutamyl ester; glycosyl ester; pyroglutamate	O-GLCNAC TRANSFERASE; AGROBACTERIUM BETA-GLUCOSIDASE; ENZYME INTERMEDIATE; KINETIC-ANALYSIS; ACTIVE-SITE; MECHANISM; IDENTIFICATION; HYDROLYSIS; INHIBITORS; PEPTIDES	Proteolytic processing of human host cell factor 1 (HCF-1) to its mature form was recently shown, unexpectedly, to occur in a UDP-GlcNAc-dependent fashion within the transferase active site of O-GlcNAc-transferase (OGT) (Lazarus, M. B., Jiang, J., Kapuria, V., Bhuiyan, T., Janetzko, J., Zandberg, W. F., Vocadlo, D. J., Herr, W., and Walker, S. (2013) Science 342, 1235-1239). An interesting mechanism involving formation and then intramolecular rearrangement of a covalent glycosyl ester adduct of the HCF-1 polypeptide was proposed to account for this unprecedented proteolytic activity. However, the key intermediate remained hypothetical. Here, using a model enzyme system for which the formation of a glycosyl ester within the enzyme active site has been shown unequivocally, we show that ester formation can indeed lead to proteolysis of the adjacent peptide bond, thereby providing substantive support for the mechanism of HCF-1 processing proposed.	[Koetzler, Miriam P.; Withers, Stephen G.] Univ British Columbia, Dept Chem, Vancouver, BC V6T 1Z1, Canada	University of British Columbia	Withers, SG (corresponding author), Univ British Columbia, Dept Chem, 2036 Main Mall, Vancouver, BC V6T 1Z1, Canada.	withers@chem.ubc.ca			Natural Sciences and Engineering Research Council of Canada; Canada Council for the Arts; German Research Foundation (DFG)	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canada Council for the Arts; German Research Foundation (DFG)(German Research Foundation (DFG))	This work was supported by the Natural Sciences and Engineering Research Council of Canada, the Canada Council for the Arts, and the German Research Foundation (DFG). The authors declare that they have no conflicts of interest with the contents of this article.	ADAMSON J, 1970, CARBOHYD RES, V15, P351, DOI 10.1016/S0008-6215(00)80451-6; BATTERSBY AR, 1956, J CHEM SOC, P2076, DOI 10.1039/jr9560002076; Bhuiyan T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136636; Capotosti F, 2011, CELL, V144, P376, DOI 10.1016/j.cell.2010.12.030; Chulin AN, 2005, J PEPT SCI, V11, P175, DOI 10.1002/psc.611; HALL LD, 1971, CAN J CHEMISTRY, V49, P118, DOI 10.1139/v71-017; KHAN SA, 1984, J AM CHEM SOC, V106, P798, DOI 10.1021/ja00315a060; Lazarus MB, 2013, SCIENCE, V342, P1235, DOI 10.1126/science.1243990; Lazarus MB, 2012, NAT CHEM BIOL, V8, P966, DOI [10.1038/nchembio.1109, 10.1038/NCHEMBIO.1109]; McCarter JD, 1996, J AM CHEM SOC, V118, P241, DOI 10.1021/ja952732a; Namchuk MN, 1995, BIOCHEMISTRY-US, V34, P16194, DOI 10.1021/bi00049a035; Quesne L. W. J., 1952, J CHEM SOC, P594; Sanz-Aparicio J, 1998, J MOL BIOL, V275, P491, DOI 10.1006/jmbi.1997.1467; STREET IP, 1992, BIOCHEMISTRY-US, V31, P9970, DOI 10.1021/bi00156a016; STREET IP, 1986, BIOCHEMISTRY-US, V25, P6021, DOI 10.1021/bi00368a028; WAKARCHUK WW, 1988, J BACTERIOL, V170, P301, DOI 10.1128/jb.170.1.301-307.1988; WANG Q, 1995, BIOCHEMISTRY-US, V34, P14554, DOI 10.1021/bi00044a034; Wells L, 2003, FEBS LETT, V546, P154, DOI 10.1016/S0014-5793(03)00641-0; WITHERS SG, 1992, BIOCHEMISTRY-US, V31, P9979, DOI 10.1021/bi00156a017; WITHERS SG, 1988, J AM CHEM SOC, V110, P8551, DOI 10.1021/ja00233a045; WITHERS SG, 1987, J AM CHEM SOC, V109, P7530, DOI 10.1021/ja00258a047	21	7	7	0	41	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 1	2016	291	1					429	434		10.1074/jbc.C115.698696	http://dx.doi.org/10.1074/jbc.C115.698696			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DA1XP	26515062	Green Published, hybrid			2022-12-26	WOS:000367589500038
J	Le Trinh, T; Zhu, GZ; Xiao, XL; Puszyk, W; Sefah, K; Wu, QF; Tan, WH; Liu, C				Le Trinh, Thu; Zhu, Guizhi; Xiao, Xilin; Puszyk, William; Sefah, Kwame; Wu, Qunfeng; Tan, Weihong; Liu, Chen			A Synthetic Aptamer-Drug Adduct for Targeted Liver Cancer Therapy	PLOS ONE			English	Article							DOXORUBICIN-ELUTING BEADS; IN-VITRO; DELIVERY; NUCLEOLIN; NANOPARTICLES; CELLS; RNA; CYTOTOXICITY; LIPOPROTEINS; DISCOVERY	AS1411 (previously known as AGRO100) is a 26 nucleotide guanine-rich DNA aptamer which forms a guanine quadruplex structure. AS1411 has shown promising utility as a treatment for cancers in Phase I and Phase II clinical trials without causing major side-effects. AS1411 inhibits tumor cell growth by binding to nucleolin which is aberrantly expressed on the cell membrane of many tumors. In this study, we utilized a simple technique to conjugate a widely-used chemotherapeutic agent, doxorubicin (Dox), to AS1411 to form a synthetic Drug-DNA Adduct (DDA), termed as AS1411-Dox. We demonstrate the utility of AS1411-Dox in the treatment of hepatocellular carcinoma (HCC) by evaluating the targeted delivery of Dox to Huh7 cells in vitro and in a murine xenograft model of HCC.	[Le Trinh, Thu; Puszyk, William; Wu, Qunfeng; Liu, Chen] Univ Florida, Coll Med, Dept Pathol Immunol & Lab Med, Gainesville, FL USA; [Zhu, Guizhi; Xiao, Xilin; Sefah, Kwame; Tan, Weihong] Univ Florida, Shands Canc Ctr, Ctr Res Bio Nano Interface, UF Genet Inst,Dept Chem, Gainesville, FL 32611 USA; [Zhu, Guizhi; Xiao, Xilin; Sefah, Kwame; Tan, Weihong] Univ Florida, Dept Physiol & Funct Genom, Gainesville, FL USA; [Zhu, Guizhi; Xiao, Xilin; Sefah, Kwame; Tan, Weihong] Univ Florida, McKnight Brain Inst, Gainesville, FL USA; [Tan, Weihong] Hunan Univ, State Key Lab Chemo Biosensing & Chemometr, Mol Sci & Biomed Lab, Coll Biol, Changsha 410082, Hunan, Peoples R China; [Tan, Weihong] Hunan Univ, Coll Chem & Chem Engn, Changsha 410082, Hunan, Peoples R China	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; Hunan University; Hunan University	Tan, WH (corresponding author), Univ Florida, Shands Canc Ctr, Ctr Res Bio Nano Interface, UF Genet Inst,Dept Chem, Gainesville, FL 32611 USA.	tan@chem.ufl.edu; liu@pathology.ufl.edu	Tan, Weihong/AAA-4536-2020; Tan, Weihong/A-5412-2008; Zhu, Guizhi/AAN-2888-2020	Tan, Weihong/0000-0002-8066-1524; Zhu, Guizhi/0000-0002-2945-7982	National Institute of Heath [R01 CA133086]; NATIONAL CANCER INSTITUTE [R01CA133086, K24CA139570] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001427] Funding Source: NIH RePORTER	National Institute of Heath; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	The authors thank the National Institute of Heath for awarding the funding for this project R01 CA133086 to (CL) and (WT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen TM, 2002, NAT REV CANCER, V2, P750, DOI 10.1038/nrc903; Bates PJ, 2009, EXP MOL PATHOL, V86, P151, DOI 10.1016/j.yexmp.2009.01.004; Bates PJ, 1999, J BIOL CHEM, V274, P26369, DOI 10.1074/jbc.274.37.26369; Cao ZH, 2009, ANGEW CHEM INT EDIT, V48, P6494, DOI 10.1002/anie.200901452; Chen H, 2013, J BIOTECHNOL, V168, P362, DOI 10.1016/j.jbiotec.2013.10.024; CHIN J H, 1986, Annals Academy of Medicine Singapore, V15, P162; Christian S, 2003, J CELL BIOL, V163, P871, DOI 10.1083/jcb.200304132; DASHTI N, 1984, BIOCHIM BIOPHYS ACTA, V794, P373, DOI 10.1016/0005-2760(84)90003-1; DiPaola R.S., 2002, CLIN CANCER RES, V8, P3512; ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0; Golfieri R, 2014, BRIT J CANCER, V111, P255, DOI 10.1038/bjc.2014.199; Guo JW, 2011, BIOMATERIALS, V32, P8010, DOI 10.1016/j.biomaterials.2011.07.004; Huang YF, 2009, CHEMBIOCHEM, V10, P862, DOI 10.1002/cbic.200800805; Hughes B, 2010, NAT REV DRUG DISCOV, V9, P665, DOI 10.1038/nrd3270; Injac R, 2009, BIOMATERIALS, V30, P1184, DOI 10.1016/j.biomaterials.2008.10.060; Keefe AD, 2010, NAT REV DRUG DISCOV, V9, P537, DOI 10.1038/nrd3141; Koutsioumpa M, 2013, J BIOL CHEM, V288, P343, DOI 10.1074/jbc.M112.387076; Lahoti TS, 2012, CURR NEUROVASC RES, V9, P282; LEVISCHAFFER F, 1982, CANCER TREAT REP, V66, P107; Li WM, 2014, ANAT REC, V297, P2280, DOI 10.1002/ar.22990; Lilienberg E, 2014, MOL PHARMACEUT, V11, P131, DOI 10.1021/mp4002574; Low PS, 2008, ACCOUNTS CHEM RES, V41, P120, DOI 10.1021/ar7000815; Meng L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014018; Menna P, 2012, EXPERT OPIN DRUG SAF, V11, pS21, DOI 10.1517/14740338.2011.589834; Mongelard F, 2010, CURR OPIN MOL THER, V12, P107; OKUDA S, 1986, KIDNEY INT, V29, P502, DOI 10.1038/ki.1986.28; Oney S, 2009, NAT MED, V15, P1224, DOI 10.1038/nm.1990; Pan X, 2010, TRANSPL P, V42, P1899, DOI 10.1016/j.transproceed.2009.11.043; Park Eun-sung, 2003, J Vet Sci, V4, P129; Rosenberg JE, 2014, INVEST NEW DRUG, V32, P178, DOI 10.1007/s10637-013-0045-6; Rusconi CP, 2004, NAT BIOTECHNOL, V22, P1423, DOI 10.1038/nbt1023; Santra S, 2011, J AM CHEM SOC, V133, P16680, DOI 10.1021/ja207463b; Scharf A, 2013, ACS NANO, V7, P10695, DOI 10.1021/nn403443r; SEMENKOVICH CF, 1990, BIOCHEMISTRY-US, V29, P9708, DOI 10.1021/bi00493a028; Shao RG, 2004, ACTA PHARMACOL SIN, V25, P756; Shieh YA, 2010, ACS NANO, V4, P1433, DOI 10.1021/nn901374b; Soundararajan S, 2008, CANCER RES, V68, P2358, DOI 10.1158/0008-5472.CAN-07-5723; Soundararajan S, 2009, MOL PHARMACOL, V76, P984, DOI 10.1124/mol.109.055947; Tan WH, 2011, TRENDS BIOTECHNOL, V29, P634, DOI 10.1016/j.tibtech.2011.06.009; Tate A, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-197; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; Tyagi AK, 2002, CLIN CANCER RES, V8, P3512; Vogl TJ, 2014, EXPERT OPIN PHARMACO, V15, P115, DOI 10.1517/14656566.2014.855719; Webb S, 2011, NAT BIOTECHNOL, V29, P297, DOI 10.1038/nbt0411-297; Xiong XL, 2013, ANGEW CHEM INT EDIT, V52, P1472, DOI 10.1002/anie.201207063; Yang L, 2011, ADV DRUG DELIVER REV, V63, P1361, DOI 10.1016/j.addr.2011.10.002; Yang M, 1998, BBA-GEN SUBJECTS, V1380, P329, DOI 10.1016/S0304-4165(97)00161-X; Yu DH, 2013, MACROMOL BIOSCI, V13, P1413, DOI 10.1002/mabi.201300165; Zeman SM, 1998, P NATL ACAD SCI USA, V95, P11561, DOI 10.1073/pnas.95.20.11561; Zhang BL, 2014, J CONTROL RELEASE, V192, P192, DOI 10.1016/j.jconrel.2014.06.037; Zhang YW, 2009, ARCH IMMUNOL THER EX, V57, P435, DOI 10.1007/s00005-009-0051-8	51	40	43	2	93	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2015	10	11							e0136673	10.1371/journal.pone.0136673	http://dx.doi.org/10.1371/journal.pone.0136673			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV1PG	26523833	Green Published, Green Submitted, gold			2022-12-26	WOS:000364029800001
J	Babushkina, ES; Bessonov, NM; Ataullakhanov, FI; Panteleev, MA				Babushkina, Evgenia S.; Bessonov, Nikolay M.; Ataullakhanov, Fazoil I.; Panteleev, Mikhail A.			Continuous Modeling of Arterial Platelet Thrombus Formation Using a Spatial Adsorption Equation	PLOS ONE			English	Article							BLOOD-COAGULATION; MULTILAYER ADSORPTION; SYSTEMS BIOLOGY; KINETICS; HEMOSTASIS; DESORPTION; GASES; FLOW; WAVE	In this study, we considered a continuous model of platelet thrombus growth in an arteriole. A special model describing the adhesion of platelets in terms of their concentration was derived. The applications of the derived model are not restricted to only describing arterial platelet thrombus formation; the model can also be applied to other similar adhesion processes. The model reproduces an auto-wave solution in the one-dimensional case; in the two-dimensional case, in which the surrounding flow is taken into account, the typical torchlike thrombus is reproduced. The thrombus shape and the growth velocity are determined by the model parameters. We demonstrate that the model captures the main properties of the thrombus growth behavior and provides us a better understanding of which mechanisms are important in the mechanical nature of the arterial thrombus growth.	[Babushkina, Evgenia S.; Bessonov, Nikolay M.] Russian Acad Sci, Inst Problems Mech Engn, St Petersburg 196140, Russia; [Babushkina, Evgenia S.] Free Univ Berlin, Dept Math & Comp Sci, Berlin, Germany; [Ataullakhanov, Fazoil I.; Panteleev, Mikhail A.] Moscow State Univ Univ, Dept Phys, Moscow, Russia; [Ataullakhanov, Fazoil I.; Panteleev, Mikhail A.] Fed Res & Clin Ctr Pediat Hematol Oncol & Immunol, Moscow, Russia; [Ataullakhanov, Fazoil I.; Panteleev, Mikhail A.] HemaCore LLC, Moscow, Russia; [Ataullakhanov, Fazoil I.; Panteleev, Mikhail A.] Russian Acad Sci, Ctr Theoret Problems Phys Chem Pharmacol, Moscow, Russia; [Ataullakhanov, Fazoil I.; Panteleev, Mikhail A.] Moscow Inst Phys & Technol, Fac Biol & Med Phys, Dept Translat & Regenerat Med, Moscow, Russia	Russian Academy of Sciences; Free University of Berlin; Dmitry Rogachev National Medical Research Center Of Pediatric Hematology, Oncology & Immunology; Center for Theoretical Problems of Physicochemical Pharmacology of the Russian Academy of Sciences; Russian Academy of Sciences; Moscow Institute of Physics & Technology	Panteleev, MA (corresponding author), Moscow State Univ Univ, Dept Phys, Moscow, Russia.	mapanteleev@yandex.ru	Panteleev, Mikhail A/H-5491-2012; Ataullakhanov, Fazoil/J-8076-2012; Ataullakhanov, Fazoil/O-3458-2019	Panteleev, Mikhail A/0000-0002-8128-7757; 	Russian Science Foundation [14-14-00195]	Russian Science Foundation(Russian Science Foundation (RSF))	This study was supported by the Russian Science Foundation grant 14-14-00195. The funder HemaCore LLC provided support in the form of salaries for authors Fazoil I. Ataullakhanov and Mikhail A. Panteleev, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions" section.	Ataullakhanov FI, 2005, PATHOPHYSIOL HAEMO T, V34, P60, DOI 10.1159/000089927; Belyaev AV, 2015, BIOPHYSICAL IN PRESS; Brunauer S, 1938, J AM CHEM SOC, V60, P309, DOI 10.1021/ja01269a023; Celi A, 2003, J THROMB HAEMOST, V1, P60, DOI 10.1046/j.1538-7836.2003.t01-1-00033.x; Chen Y, 2014, ADV EXP MED BIOL, V844, P85, DOI 10.1007/978-1-4939-2095-2_5; CHORIN AJ, 1969, MATH COMPUT, V23, P341, DOI 10.2307/2004428; Dashkevich NM, 2012, BIOPHYS J, V103, P2233, DOI 10.1016/j.bpj.2012.10.011; Jackson SP, 2009, J THROMB HAEMOST, V7, P17, DOI 10.1111/j.1538-7836.2009.03401.x; Juneja HS, 2006, IND ENG CHEM RES, V45, P6585, DOI 10.1021/ie060475k; Leiderman K, 2014, THROMB RES, V133, pS12, DOI 10.1016/j.thromres.2014.03.005; McFadyen JD, 2013, THROMB HAEMOSTASIS, V110, P859, DOI 10.1160/TH13-05-0379; MURRAY JD, 1976, J THEOR BIOL, V56, P329, DOI 10.1016/S0022-5193(76)80078-1; Panteleev MA, 2007, CURR PHARM DESIGN, V13, P1457, DOI 10.2174/138161207780765936; Panteleev MA, 2014, MATH MODEL NAT PHENO, V9, P4, DOI 10.1051/mmnp/20149602; PAYNE SH, 1995, SURF SCI, V338, P261, DOI 10.1016/0039-6028(95)00559-5; Qiu H, 2009, J ZHEJIANG UNIV-SC A, V10, P716, DOI 10.1631/jzus.A0820524; ROSEN JB, 1952, J CHEM PHYS, V20, P387, DOI 10.1063/1.1700431; Shankar V, 2013, APPL NUMER MATH, V63, P58, DOI 10.1016/j.apnum.2012.09.006; Shibeko AM, 2015, BRIEFINGS BIOINFORMA; Stalker TJ, 2013, BLOOD, V121, P1875, DOI 10.1182/blood-2012-09-457739; Storti F, 2014, INT J NUMER METH BIO, V30, P634, DOI 10.1002/cnm.2623; Storti F, 2014, INT J NUMERICAL METH; TALBOT J, 1994, LANGMUIR, V10, P1663, DOI 10.1021/la00018a009; Tokarev A, 2012, RUSS J NUMER ANAL M, V27, P191, DOI 10.1515/rnam-2012-0011; Tosenberger A, 2015, J MATH BIOL; VanTassel PR, 1997, J CHEM PHYS, V106, P761, DOI 10.1063/1.473164; Vinokurov IA, 2002, LANGMUIR, V18, P6789, DOI 10.1021/la025777f; Wang W., 2013, PLOS ONE, V8; Wang Yiming, 2012, Cardiovascular & Hematological Disorders - Drug Targets, V12, P126; Wu ZH, 2014, PHILOS T R SOC A, V372, DOI 10.1098/rsta.2013.0380; Xu ZL, 2012, WIRES SYST BIOL MED, V4, P237, DOI 10.1002/wsbm.1160	31	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2015	10	10							e0141068	10.1371/journal.pone.0141068	http://dx.doi.org/10.1371/journal.pone.0141068			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0EH	26517377	Green Published, gold, Green Submitted			2022-12-26	WOS:000363920800018
J	Halamoda-Kenzaoui, B; Ceridono, M; Colpo, P; Valsesia, A; Urban, P; Ojea-Jimenez, I; Gioria, S; Gilliland, D; Rossi, F; Kinsner-Ovaskainen, A				Halamoda-Kenzaoui, Blanka; Ceridono, Mara; Colpo, Pascal; Valsesia, Andrea; Urban, Patricia; Ojea-Jimenez, Isaac; Gioria, Sabrina; Gilliland, Douglas; Rossi, Francois; Kinsner-Ovaskainen, Agnieszka			Dispersion Behaviour of Silica Nanoparticles in Biological Media and Its Influence on Cellular Uptake	PLOS ONE			English	Article							TITANIUM-DIOXIDE NANOPARTICLES; IRON-OXIDE NANOPARTICLES; IN-VITRO; PROTEIN CORONA; GOLD NANOPARTICLES; INORGANIC NANOPARTICLES; ENDOTHELIAL-CELLS; SIZE; AGGLOMERATION; CYTOTOXICITY	Given the increasing variety of manufactured nanomaterials, suitable, robust, standardized in vitro screening methods are needed to study the mechanisms by which they can interact with biological systems. The in vitro evaluation of interactions of nanoparticles (NPs) with living cells is challenging due to the complex behaviour of NPs, which may involve dissolution, aggregation, sedimentation and formation of a protein corona. These variable parameters have an influence on the surface properties and the stability of NPs in the biological environment and therefore also on the interaction of NPs with cells. We present here a study using 30 nm and 80 nm fluorescently-labelled silicon dioxide NPs (Rubipy-SiO2 NPs) to evaluate the NPs dispersion behaviour up to 48 hours in two different cellular media either supplemented with 10% of serum or in serum-free conditions. Size-dependent differences in dispersion behaviour were observed and the influence of the living cells on NPs stability and deposition was determined. Using flow cytometry and fluorescence microscopy techniques we studied the kinetics of the cellular uptake of Rubipy-SiO2 NPs by A549 and CaCo-2 cells and we found a correlation between the NPs characteristics in cell media and the amount of cellular uptake. Our results emphasize how relevant and important it is to evaluate and to monitor the size and agglomeration state of nanoparticles in the biological medium, in order to interpret correctly the results of the in vitro toxicological assays.	[Halamoda-Kenzaoui, Blanka; Ceridono, Mara; Colpo, Pascal; Valsesia, Andrea; Urban, Patricia; Ojea-Jimenez, Isaac; Gioria, Sabrina; Gilliland, Douglas; Rossi, Francois; Kinsner-Ovaskainen, Agnieszka] Commiss European Communities, Joint Res Ctr, Inst Hlth & Consumer Protect, Nanobiosci Unit, I-21027 Ispra, VA, Italy	European Commission Joint Research Centre; EC JRC ISPRA Site	Kinsner-Ovaskainen, A (corresponding author), Commiss European Communities, Joint Res Ctr, Inst Hlth & Consumer Protect, Nanobiosci Unit, Via E Fermi 2749, I-21027 Ispra, VA, Italy.	agnieszka.kinsner-ovaskainen@ec.europa.eu	Urbán, Patricia/J-9196-2016	Urban, Patricia/0000-0002-2865-778X				Albanese A, 2014, ACS NANO, V8, P5515, DOI 10.1021/nn4061012; Albanese A, 2011, ACS NANO, V5, P5478, DOI 10.1021/nn2007496; Bell NC, 2013, ANAL METHODS-UK, V5, P4591, DOI 10.1039/c3ay40771c; Calzolai L, 2011, J CHROMATOGR A, V1218, P4234, DOI 10.1016/j.chroma.2011.01.017; Cascio C, 2014, ANAL CHEM, V86, P12143, DOI 10.1021/ac503307r; Cedervall T, 2007, ANGEW CHEM INT EDIT, V46, P5754, DOI 10.1002/anie.200700465; Cho EC, 2011, NAT NANOTECHNOL, V6, P385, DOI [10.1038/NNANO.2011.58, 10.1038/nnano.2011.58]; Choi SJ, 2009, J INORG BIOCHEM, V103, P463, DOI 10.1016/j.jinorgbio.2008.12.017; Coradeghini R, 2013, TOXICOL LETT, V217, P205, DOI 10.1016/j.toxlet.2012.11.022; Drescher D, 2011, ANAL BIOANAL CHEM, V400, P1367, DOI 10.1007/s00216-011-4893-7; Dudkiewicz A, 2011, TRAC-TREND ANAL CHEM, V30, P28, DOI 10.1016/j.trac.2010.10.007; Gualtieri M, 2012, NANOTOXICOLOGY, V6, P700, DOI 10.3109/17435390.2011.604441; Guarnieri D, 2011, J NANOPART RES, V13, P4295, DOI 10.1007/s11051-011-0375-2; Hartlen KD, 2008, LANGMUIR, V24, P1714, DOI 10.1021/la7025285; Herd H, 2013, ACS NANO, V7, P1961, DOI 10.1021/nn304439f; Hinderliter PM, 2010, PART FIBRE TOXICOL, V7, DOI 10.1186/1743-8977-7-36; Hirsch V, 2014, NANOSCALE, V6, P7325, DOI 10.1039/c4nr00460d; Hirsch V, 2013, NANOSCALE, V5, P3723, DOI 10.1039/c2nr33134a; Kenzaoui BH, 2012, NANOMEDICINE-UK, V7, P39, DOI [10.2217/NNM.11.85, 10.2217/nnm.11.85]; Krug HF, 2014, ANGEW CHEM INT EDIT, V53, P12304, DOI 10.1002/anie.201403367; Lankoff A, 2012, TOXICOL LETT, V208, P197, DOI 10.1016/j.toxlet.2011.11.006; Lesniak A, 2013, J AM CHEM SOC, V135, P1438, DOI 10.1021/ja309812z; Lesniak A, 2012, ACS NANO, V6, P5845, DOI 10.1021/nn300223w; Liang S, 2013, NANOSCALE, V5, P9365, DOI 10.1039/c3nr02500d; Liong M, 2008, ACS NANO, V2, P889, DOI 10.1021/nn800072t; Lison D, 2008, TOXICOL SCI, V104, P155, DOI 10.1093/toxsci/kfn072; Lundqvist M, 2008, P NATL ACAD SCI USA, V105, P14265, DOI 10.1073/pnas.0805135105; Magdolenova Z, 2012, J ENVIRON MONITOR, V14, P455, DOI 10.1039/c2em10746e; Napierska D, 2009, SMALL, V5, P846, DOI 10.1002/smll.200800461; Oberdorster G, 2010, J INTERN MED, V267, P89, DOI 10.1111/j.1365-2796.2009.02187.x; Okoturo-Evans O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072363; Rong Y, 2013, ENVIRON TOXICOL PHAR, V36, P921, DOI 10.1016/j.etap.2013.08.007; Saaf AM, 2007, MOL BIOL CELL, V18, P4245, DOI 10.1091/mbc.E07-04-0309; Saha K, 2012, CHEM REV, V112, P2739, DOI 10.1021/cr2001178; Sambuy Y, 2005, CELL BIOL TOXICOL, V21, P1, DOI 10.1007/s10565-005-0085-6; Schrade A, 2012, MACROMOL BIOSCI, V12, P1459, DOI 10.1002/mabi.201200166; Schutz CA, 2014, INT J NANOMED, V9, P3481, DOI 10.2147/IJN.S65082; Shannahan JH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074001; Sharma G, 2014, NANOTOXICOLOGY, V8, P663, DOI 10.3109/17435390.2013.822115; Sterling MC, 2005, WATER RES, V39, P1818, DOI 10.1016/j.watres.2005.02.007; Treuel L, 2014, ACS NANO, V8, P503, DOI 10.1021/nn405019v; Walczyk D, 2010, J AM CHEM SOC, V132, P5761, DOI 10.1021/ja910675v; Walkey CD, 2014, ACS NANO, V8, P2439, DOI 10.1021/nn406018q; Wilhelm C, 2002, LANGMUIR, V18, P8148, DOI 10.1021/la0257337; Zhu Y, 2009, CARBON, V47, P1351, DOI 10.1016/j.carbon.2009.01.026	45	46	48	0	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2015	10	10							e0141593	10.1371/journal.pone.0141593	http://dx.doi.org/10.1371/journal.pone.0141593			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0EH	26517371	Green Submitted, gold, Green Published			2022-12-26	WOS:000363920800058
J	Akiba, M; Ota, Y; Tsai, IJ; Hattori, T; Sahashi, N; Kikuchi, T				Akiba, Mitsuteru; Ota, Yuko; Tsai, Isheng J.; Hattori, Tsutomu; Sahashi, Norio; Kikuchi, Taisei			Genetic Differentiation and Spatial Structure of Phellinus noxius, the Causal Agent of Brown Root Rot of Woody Plants in Japan	PLOS ONE			English	Article							POPULATION-STRUCTURE; HOST PLANTS; MICROSATELLITE MARKERS; SPORE DISPERSAL; RYUKYU ISLANDS; NORTH-AMERICAN; F-STATISTICS; DISEASE; TREES; SOFTWARE	Phellinus noxius is a pathogenic fungus that causes brown root rot disease in a variety of tree species. This fungus is distributed in tropical and sub-tropical regions of Southeast and East Asia, Oceania, Australia, Central America and Africa. In Japan, it was first discovered on Ishigaki Island in Okinawa Prefecture in 1988; since then, it has been found on several of the Ryukyu Islands. Recently, this fungus was identified from the Ogasawara (Bonin) Islands, where it has killed trees, including rare endemic tree species. For effective control or quarantine methods, it is important to clarify whether the Japanese populations of P. noxius are indigenous to the area or if they have been introduced from other areas. We developed 20 microsatellite markers from genome assembly of P. noxius and genotyped 128 isolates from 12 of the Ryukyu Islands and 3 of the Ogasawara Islands. All isolates had unique genotypes, indicating that basidiospore infection is a primary dissemination method for the formation of new disease foci. Genetic structure analyses strongly supported genetic differentiation between the Ryukyu populations and the Ogasawara populations of P. noxius. High polymorphism of microsatellite loci suggests that Japanese populations are indigenous or were introduced a very long time ago. We discuss differences in invasion patterns between the Ryukyu Islands and the Ogasawara Islands.	[Akiba, Mitsuteru; Ota, Yuko; Hattori, Tsutomu; Sahashi, Norio] Forestry & Forest Prod Res Inst, Dept Forest Microbiol, Tsukuba, Ibaraki 305, Japan; [Tsai, Isheng J.] Acad Sinica, Biodivers Res Ctr, Taipei 115, Taiwan; [Kikuchi, Taisei] Miyazaki Univ, Fac Med, Div Parasitol, Miyazaki, Japan	Forestry & Forest Products Research Institute - Japan; Academia Sinica - Taiwan; University of Miyazaki	Akiba, M (corresponding author), Forestry & Forest Prod Res Inst, Dept Forest Microbiol, Tsukuba, Ibaraki 305, Japan.	akiban@ffpri.affrc.go.jp	Tsai, Isheng Jason/ABB-8273-2021	Tsai, Isheng Jason/0000-0002-2123-5058; Kikuchi, Taisei/0000-0003-2759-9167	Japan Society for the Promotion of Science KAKENHI Grant [25292096]	Japan Society for the Promotion of Science KAKENHI Grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Japan Society for the Promotion of Science KAKENHI Grant Number 25292096. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe Yasuhisa, 1995, Annals of the Phytopathological Society of Japan, V61, P425, DOI 10.3186/jjphytopath.61.425; Aguayo J, 2013, PHYTOPATHOLOGY, V103, P190, DOI 10.1094/PHYTO-05-12-0116-R; Ann PJ, 1999, PLANT DIS, V83, P746, DOI 10.1094/PDIS.1999.83.8.746; Ann PJ, 2002, PLANT DIS, V86, P820, DOI 10.1094/PDIS.2002.86.8.820; [Anonymous], 1990, SYNOPSIS FUNGORUM, DOI DOI 10.2307/3760175; ARITA I, 1979, MYCOLOGIA, V71, P603, DOI 10.2307/3759069; Baumgartner K, 2009, MOL ECOL RESOUR, V9, P943, DOI 10.1111/j.1755-0998.2008.02494.x; Blacket MJ, 2012, MOL ECOL RESOUR, V12, P456, DOI 10.1111/j.1755-0998.2011.03104.x; Bolland L., 1984, Australian Forestry, V47, P2; Brooks Fred E., 2002, Pacific Science, V56, P377, DOI 10.1353/psc.2002.0031; CABI/EPPO Phellinus noxius, 1997, PHELL NOX DISTR MAPS; Chang TT, 1996, PHYTOPATHOLOGY, V86, P272, DOI 10.1094/Phyto-86-272; CHANG TT, 1995, PLANT DIS, V79, P962, DOI 10.1094/PD-79-0962; Chang TT, 1998, MYCOL RES, V102, P1085, DOI 10.1017/S0953756297005571; Coetzee MPA, 2001, MOL ECOL, V10, P387, DOI 10.1046/j.1365-294x.2001.01187.x; Croucher PJP, 2013, BIOL INVASIONS, V15, P2281, DOI 10.1007/s10530-013-0453-8; Dutech C, 2012, MOL ECOL, V21, P3931, DOI 10.1111/j.1365-294X.2012.05575.x; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Garbelotto M, 2013, MOL ECOL, V22, P4855, DOI 10.1111/mec.12452; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Gross A, 2014, MOL ECOL, V23, P2943, DOI 10.1111/mec.12792; Guillaumin JJ, 2013, INFECTIOUS FOREST DISEASES, P159, DOI 10.1079/9781780640402.0159; Hallenberg N, 2001, NORD J BOT, V21, P431, DOI 10.1111/j.1756-1051.2001.tb00793.x; Hansen EM, 1999, STRUCTURE DYNAMICS F, P251; Hattori T, 1996, EUR J FOREST PATHOL, V26, P69; HODGES CS, 1984, PLANT DIS, V68, P334, DOI 10.1094/PD-69-334; HOLM S, 1979, SCAND J STAT, V6, P65; Ito M, 1998, RES POPUL ECOL, V40, P205, DOI 10.1007/BF02763405; Ivory M. H., 1996, P111; Jarne P, 1996, TRENDS ECOL EVOL, V11, P424, DOI 10.1016/0169-5347(96)10049-5; Kawabe Y, 1993, FOR PESTS, V42, P176; Kobayashi T., 1991, FOREST CHEM, V118, P1; Lacey J, 1996, MYCOL RES, V100, P641, DOI 10.1016/S0953-7562(96)80194-8; Lewis KJ, 2013, INFECTIOUS FOREST DISEASES, P178, DOI 10.1079/9781780640402.0178; MANTEL N, 1967, CANCER RES, V27, P209; Masuda Paul, 1995, Mycoscience, V36, P413, DOI 10.1007/BF02268625; NANDRIS D, 1987, PLANT DIS, V71, P298, DOI 10.1094/PD-71-0298; NANDRIS D, 1987, EUR J FOREST PATHOL, V17, P271; NEIL PE, 1986, EUR J FOREST PATHOL, V16, P274; Oliva J, 2011, FOREST PATHOL, V41, P243, DOI 10.1111/j.1439-0329.2010.00682.x; Ota Y, 2014, MYCOLOGIA, V106, P66, DOI 10.3852/13-045; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Powell W, 1996, TRENDS PLANT SCI, V1, P215, DOI 10.1016/1360-1385(96)86898-1; Pritchard JK, 2000, GENETICS, V155, P945; Prospero S, 2010, EUR J PLANT PATHOL, V127, P165, DOI 10.1007/s10658-010-9594-0; Rousset F, 1997, GENETICS, V145, P1219; Sahashi N, 2007, FOREST PATHOL, V37, P167, DOI 10.1111/j.1439-0329.2007.00491.x; Sahashi N, 2012, FOREST PATHOL, V42, P353, DOI 10.1111/j.1439-0329.2012.00767.x; Sahashi N, 2014, EUR J PLANT PATHOL, V140, P869, DOI 10.1007/s10658-014-0503-9; Sahashi N, 2010, PLANT DIS, V94, P358, DOI 10.1094/PDIS-94-3-0358; Sakai AK, 2001, ANNU REV ECOL SYST, V32, P305, DOI 10.1146/annurev.ecolsys.32.081501.114037; Toyoda T., 2003, FLORA BONIN ISLANDS; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; WOLFENBARGER DO, 1946, AM MIDL NAT, V35, P1, DOI 10.2307/2421351; Worrall JJ, 2004, FOREST ECOL MANAG, V192, P191, DOI 10.1016/j.foreco.2004.01.009; Yasuda A., 1916, BOT MAG TOKYO, V30, P350; Zerillo MM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112847; Zimin AV, 2013, BIOINFORMATICS, V29, P2669, DOI 10.1093/bioinformatics/btt476	60	15	16	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2015	10	10							e0141792	10.1371/journal.pone.0141792	http://dx.doi.org/10.1371/journal.pone.0141792			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0ED	26513585	Green Submitted, gold, Green Published			2022-12-26	WOS:000363920300084
J	Barp, A; Bello, L; Politano, L; Melacini, P; Calore, C; Polo, A; Vianello, S; Soraru, G; Semplicini, C; Pantic, B; Taglia, A; Picillo, E; Magri, F; Gorni, K; Messina, S; Vita, GL; Vita, G; Comi, GP; Ermani, M; Calvo, V; Angelini, C; Hoffman, EP; Pegoraro, E				Barp, Andrea; Bello, Luca; Politano, Luisa; Melacini, Paola; Calore, Chiara; Polo, Angela; Vianello, Sara; Soraru, Gianni; Semplicini, Claudio; Pantic, Boris; Taglia, Antonella; Picillo, Ester; Magri, Francesca; Gorni, Ksenija; Messina, Sonia; Vita, Gian Luca; Vita, Giuseppe; Comi, Giacomo P.; Ermani, Mario; Calvo, Vincenzo; Angelini, Corrado; Hoffman, Eric P.; Pegoraro, Elena			Genetic Modifiers of Duchenne Muscular Dystrophy and Dilated Cardiomyopathy	PLOS ONE			English	Article							LEFT-VENTRICULAR DYSFUNCTION; MUSCLE REGENERATION; MOUSE MODEL; OSTEOPONTIN EXPRESSION; SPP1 GENOTYPE; ONSET; ASSOCIATION; PROMOTER	Objective Dilated cardiomyopathy (DCM) is a major complication and leading cause of death in Duchenne muscular dystrophy (DMD). DCM onset is variable, suggesting modifier effects of genetic or environmental factors. We aimed to determine if polymorphisms previously associated with age at loss of independent ambulation (LoA) in DMD (rs28357094 in the SPP1 promoter, rs10880 and the VTTT/IAAM haplotype in LTBP4) also modify DCM onset. Methods A multicentric cohort of 178 DMD patients was genotyped by TaqMan assays. We performed a time-to-event analysis of DCM onset, with age as time variable, and finding of left ventricular ejection fraction < 50% and/or end diastolic volume > 70 mL/m(2) as event (confirmed by a previous normal exam < 12 months prior); DCM-free patients were censored at the age of last echocardiographic follow-up. Results Patients were followed up to an average age of 15.9 +/- 6.7 years. Seventy-one/178 patients developed DCM, and median age at onset was 20.0 years. Glucocorticoid corticosteroid treatment (n = 88 untreated; n = 75 treated; n = 15 unknown) did not have a significant independent effect on DCM onset. Cardiological medications were not administered before DCM onset in this population. We observed trends towards a protective effect of the dominant G allele at SPP1 rs28357094 and recessive T allele at LTBP4 rs10880, which was statistically significant in steroid-treated patients for LTBP4 rs10880 (< 50% T/T patients developing DCM during follow-up [n = 13]; median DCM onset 17.6 years for C/C-C/T, log-rank p = 0.027). Conclusions We report a putative protective effect of DMD genetic modifiers on the development of cardiac complications, that might aid in risk stratification if confirmed in independent cohorts.	[Barp, Andrea; Bello, Luca; Vianello, Sara; Soraru, Gianni; Semplicini, Claudio; Pantic, Boris; Ermani, Mario; Pegoraro, Elena] Univ Padua, Neuromuscular Ctr, Dept Neurosci, Padua, Italy; [Politano, Luisa; Taglia, Antonella; Picillo, Ester] Univ Naples 2, Dept Expt Med Cardiomyol & Med Genet, Naples, Italy; [Melacini, Paola; Calore, Chiara; Polo, Angela] Univ Padua, Dept Cardiac Thorac & Vasc Sci, Cardiol Sect, Padua, Italy; [Magri, Francesca; Comi, Giacomo P.] Univ Milan, Osped Maggiore Policlin, IRCCS Fdn Ca Granda, Dino Ferrari Ctr,Dept Neurol Sci, Milan, Italy; [Gorni, Ksenija] Osped Niguarda Ca Granda, Fdn Serena Onlus, NEMO, Milan, Italy; [Messina, Sonia; Vita, Gian Luca; Vita, Giuseppe] Univ Messina, Dept Neurosci Psychiat & Anaesthesiol, Messina, Italy; [Calvo, Vincenzo] Univ Padua, Dept Philosophy Sociol Pedag & Appl Psychol FISPP, Padua, Italy; [Angelini, Corrado] Ist Ricovero & Cura Carattere Sci IRCCS San Camil, Venice, Italy; [Hoffman, Eric P.] Childrens Natl Med Ctr, Med Genet Res Ctr, Washington, DC 20010 USA	University of Padua; Universita della Campania Vanvitelli; University of Padua; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan; IRCCS Ca Granda Ospedale Maggiore Policlinico; Ospedale Niguarda Ca' Granda; University of Messina; University of Padua; IRCCS Ospedale San Camillo; Children's National Health System	Pegoraro, E (corresponding author), Univ Padua, Neuromuscular Ctr, Dept Neurosci, Padua, Italy.	elena.pegoraro@unipd.it	POLITANO, LUISA/AAK-6885-2020; Vita, Gianluca/AAR-4587-2020; Calvo, Vincenzo/H-9090-2012; Comi, Giacomo P/K-5702-2016; Gorni, Ksenija/HCH-8475-2022; Sorarù, Gianni/AAB-8891-2019; Magri, Francesca/K-5739-2016; Angelini, Corrado I/J-3655-2019	Vita, Gianluca/0000-0003-4190-8042; Calvo, Vincenzo/0000-0002-9828-0551; Comi, Giacomo P/0000-0002-1383-5248; Magri, Francesca/0000-0001-8974-9453; Angelini, Corrado I/0000-0002-9554-8794; Messina, Sonia/0000-0001-7994-3391; Hoffman, Eric/0000-0001-6470-5139; Semplicini, Claudio/0000-0003-0870-1349; Bello, Luca/0000-0002-3075-6525; Soraru, Gianni/0000-0001-9691-6328	NIH (Wellstone Muscular Dystrophy Center) [1U54HD053177]; Telethon Genetic BioBank [GTB12001D, GTB12001H]; Eurobiobank network; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [U54HD053177] Funding Source: NIH RePORTER	NIH (Wellstone Muscular Dystrophy Center); Telethon Genetic BioBank(Fondazione Telethon); Eurobiobank network; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by grants from NIH 1U54HD053177 (Wellstone Muscular Dystrophy Center, https://www.nichd.nih.gov/research/supported/Pages/mdcrc.aspx). The authors also acknowledge support from Telethon Genetic BioBank (GTB12001D, GTB12001H) and the Eurobiobank network (www.eurobiobank.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashwath ML, 2014, AM J CARDIOL, V114, P284, DOI 10.1016/j.amjcard.2014.04.038; Barber BJ, 2013, J PEDIATR-US, V163, P1080, DOI 10.1016/j.jpeds.2013.05.060; Barfield WL, 2014, HUM MOL GENET, V23, P4043, DOI 10.1093/hmg/ddu118; Bauer R, 2008, CARDIOVASC RES, V79, P652, DOI 10.1093/cvr/cvn131; Bauer R, 2009, EUR J HEART FAIL, V11, P463, DOI 10.1093/eurjhf/hfp028; Bello L, 2015, ANN NEUROL, V77, P684, DOI 10.1002/ana.24370; Bello L, 2012, NEUROLOGY, V79, P159, DOI 10.1212/WNL.0b013e31825f04ea; Ceco E, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3010018; Ceco E, 2013, FEBS J, V280, P4198, DOI 10.1111/febs.12266; Duboc D, 2005, J AM COLL CARDIOL, V45, P855, DOI 10.1016/j.jacc.2004.09.078; Eagle M, 2002, NEUROMUSCULAR DISORD, V12, P926, DOI 10.1016/S0960-8966(02)00140-2; Flanigan KM, 2013, ANN NEUROL, V73, P481, DOI 10.1002/ana.23819; Giacopelli F, 2004, PHYSIOL GENOMICS, V20, P87, DOI 10.1152/physiolgenomics.00138.2004; Heydemann A, 2009, J CLIN INVEST, V119, P3703, DOI 10.1172/JCI39845; HOFFMAN EP, 1987, CELL, V51, P919, DOI 10.1016/0092-8674(87)90579-4; Hoffman EP, 2013, MED SCI SPORT EXER, V45, P1060, DOI 10.1249/MSS.0b013e31828093c1; Hullinger TG, 2001, EXP CELL RES, V262, P69, DOI 10.1006/excr.2000.5074; Jefferies JL, 2005, CIRCULATION, V112, P2799, DOI 10.1161/CIRCULATIONAHA.104.528281; Manzur AY, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003725.pub3; Markham LW, 2008, NEUROMUSCULAR DISORD, V18, P365, DOI 10.1016/j.nmd.2008.03.002; Nagueh SF, 2011, J AM SOC ECHOCARDIOG, V24, P473, DOI 10.1016/j.echo.2011.03.006; NIGRO G, 1990, INT J CARDIOL, V26, P271, DOI 10.1016/0167-5273(90)90082-G; Pane M, 2014, PLOS ONE, V8; Pegoraro E, 2011, NEUROLOGY, V76, P219, DOI 10.1212/WNL.0b013e318207afeb; Piva L, 2012, J PATHOL, V228, P251, DOI 10.1002/path.4026; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Raman SV, 2015, LANCET NEUROL, V14, P153, DOI 10.1016/S1474-4422(14)70318-7; Renault MA, 2010, CIRC-HEART FAIL, V3, P431, DOI 10.1161/CIRCHEARTFAILURE.109.898114; Sali A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034204; Schiller N B, 1989, J Am Soc Echocardiogr, V2, P358; Silversides CK, 2003, AM J CARDIOL, V91, P769, DOI 10.1016/S0002-9149(02)03429-X; Spurney C, 2014, MUSCLE NERVE, V50, P250, DOI 10.1002/mus.24163; Spurney CF, 2011, MUSCLE NERVE, V44, P8, DOI 10.1002/mus.22097; Uaesoontrachoon K, 2008, INT J BIOCHEM CELL B, V40, P2303, DOI 10.1016/j.biocel.2008.03.020; Uaesoontrachoon K, 2013, DIS MODEL MECH, V6, P197, DOI 10.1242/dmm.009993; van den Bergen J C, 2014, J Neuromuscul Dis, V1, P91; van den Bergen JC, 2015, J NEUROL NEUROSUR PS, V86, P1060, DOI 10.1136/jnnp-2014-308409; Vetrone SA, 2009, J CLIN INVEST, V119, P1583, DOI 10.1172/JCI37662; Waller AH, 2010, CARDIOL REV, V18, P125, DOI 10.1097/CRD.0b013e3181cfb646; Wang KX, 2008, CYTOKINE GROWTH F R, V19, P333, DOI 10.1016/j.cytogfr.2008.08.001; Zanotti S, 2011, HISTOPATHOLOGY, V59, P1215, DOI 10.1111/j.1365-2559.2011.04051.x	41	41	42	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2015	10	10							e0141240	10.1371/journal.pone.0141240	http://dx.doi.org/10.1371/journal.pone.0141240			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0ED	26513582	Green Published, Green Submitted, gold			2022-12-26	WOS:000363920300024
J	Fourie, T; Cromarty, D; Duncan, N; Wolter, K; Naidoo, V				Fourie, Tamsyn; Cromarty, Duncan; Duncan, Neil; Wolter, Kerri; Naidoo, Vinny			The Safety and Pharmacokinetics of Carprofen, Flunixin and Phenylbutazone in the Cape Vulture (Gyps coprotheres) following Oral Exposure	PLOS ONE			English	Article							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; DICLOFENAC; TOXICITY; BIRDS; STABILITY; MELOXICAM	The following study evaluates the overt toxic potential of carprofen (CRP), flunixin (FXN) and phenylbutazone (PBZ) in Old world vultures in relation to historic toxicity data for diclofenac and ketoprofen, with the Cape vulture (Gyps coprotheres) being the indicator species. The toxic potential of a single oral dose of CRP (11.5 mg/kg), FXN (1 mg/kg), PBZ (1.7 mg/kg) or water was evaluated by means of a four-way parallel study (n = 2), as means of ascertaining if these drugs were as toxic as diclofenac in the vulture. No unscheduled deaths or pathological lesions were noted following exposure. Clinical signs of lethargy and depression were, however, noted in one CRP, two FXN and one PBZ treated birds. Mild reversible inhibition of UA excretion was evident in all three groups, although UA remained within the population reference interval in contrast to the effects previously described for diclofenac and ketoprofen. All treatment groups had a drug concentration responsive increase in alanine transferase activity. CRP, FXN and PBZ were characterised by a maximum plasma concentration (Cmax) of 1051.8 +/- 620.7 ng/ml, 335.9 +/- 36.3 ng/ml and 11150 +/- 2474.9 ng/ml at 4 +/- 4.3, 0.45 +/- 0.02 and 5.3 +/- 5.2 hours (Tmax) respectively and a half-life of elimination of 13.3 +/- 5, 1.8 +/- 1 and 18.7 +/- 11.4 hours respectively. While we could not demonstrate a lethal effect of the tested substances, the presence of toxic clinical signs, clinical pathological changes and/or long half-lives of elimination suggests that all three drugs have a potential for toxicity in a larger population or on repeat administration. In conclusion while the studied substances were not as overtly toxic as diclofenac, they are of safety concern.	[Fourie, Tamsyn; Duncan, Neil; Naidoo, Vinny] Univ Pretoria, Fac Vet Sci, Dept Paraclin Sci, ZA-0002 Pretoria, South Africa; [Cromarty, Duncan] Univ Pretoria, Fac Hlth Sci, Dept Pharmacol, ZA-0002 Pretoria, South Africa; [Wolter, Kerri] Vulture Programme VulPro, ZA-0048 Rietfontein, South Africa	University of Pretoria; University of Pretoria	Naidoo, V (corresponding author), Univ Pretoria, Fac Vet Sci, Dept Paraclin Sci, ZA-0002 Pretoria, South Africa.	vinny.naidoo@up.ac.za	Naidoo, Vinny/A-1508-2008; Cromarty, A Duncan/N-4438-2015	Naidoo, Vinny/0000-0003-2740-5983; Cromarty, A Duncan/0000-0002-9512-6081; Fourie, Tamsyn/0000-0003-3822-1813; Duncan, Neil/0000-0002-5604-9976	WWF, South Africa [GT 1456]	WWF, South Africa	VN obtained funding from the WWF, South Africa -(http://www.wwf.org.za) (Grant GT 1456). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AARBAKKE J, 1978, CLIN PHARMACOKINET, V3, P369, DOI 10.2165/00003088-197803050-00003; Anderson MD, 1999, OSTRICH, V70, P139, DOI 10.1080/00306525.1999.9634530; Anderson MD, 2000, OSTRICH, V71, P25, DOI 10.1080/00306525.2000.9639859; [Anonymous], 1998, EMEAMRL04295 EUR AG; [Anonymous], 1997, EMEAMRL29797 EUR AG; Awan AF, 2003, PAK J PHARM, V16-20, P25; Baert K, 2003, COMP BIOCHEM PHYS C, V134, P25, DOI 10.1016/S1532-0456(02)00184-9; Bain P. J., 2011, Duncan & Prasse's veterinary laboratory medicine: clinical pathology, P211; BERGER L, 1960, AM J PHYSIOL, V198, P575, DOI 10.1152/ajplegacy.1960.198.3.575; BURNS JJ, 1958, NATURE, V182, P1162, DOI 10.1038/1821162a0; Carpenter JW, 2005, EXOTIC ANIMAL FORMUL, P220; Clyde Victoria L., 1999, P309; Cuthbert R, 2007, ENVIRON TOXICOL PHAR, V23, P254, DOI 10.1016/j.etap.2006.10.001; Cuthbert R, 2007, BIOL LETTERS, V3, P90, DOI 10.1098/rsbl.2006.0554; Danbury TC, 2000, VET REC, V146, P307, DOI 10.1136/vr.146.11.307; EMEA/CVMP/315/98, 1999, EMEACVMP31598; Gislefoss RE, 2008, SCAND J CLIN LAB INV, V68, P402, DOI 10.1080/00365510701809235; Gislefoss RE, 2009, CLIN CHEM LAB MED, V47, P596, DOI 10.1515/CCLM.2009.121; HOUSTON D C, 1975, Journal of Wildlife Diseases, V11, P306; Jones M P, 1999, Vet Clin North Am Exot Anim Pract, V2, P663; Klein P. N., 1994, Proceedings American Association of Zoo Veterinarians and Association of Reptilian and Amphibian Veterinarians Annual Conference Pittsburgh, USA, 22-27, October, 1994., P128; KOMEN J, 1992, J RAPTOR RES, V26, P213; LEDGER JA, 1981, BIOL CONSERV, V20, P15, DOI 10.1016/0006-3207(81)90057-4; LEES P, 1994, EQUINE VET J, V26, P203, DOI 10.1111/j.2042-3306.1994.tb04370.x; Lehman RN, 2007, BIOL CONSERV, V136, P159, DOI 10.1016/j.biocon.2006.09.015; LUMEIJ JT, 1987, VET QUART, V9, P255, DOI 10.1080/01652176.1987.9694110; Mander M, 2007, SURVEY TRADE VULTURE, P54; Mc Geown D, 1999, VET REC, V144, P668, DOI 10.1136/vr.144.24.668; MCKELLAR QA, 1990, J SMALL ANIM PRACT, V31, P443, DOI 10.1111/j.1748-5827.1990.tb00510.x; Musser JMB, 2013, JAVMA-J AM VET MED A, V242, P205, DOI 10.2460/javma.242.2.205; Naidoo V, 2008, J VET PHARMACOL THER, V31, P128, DOI 10.1111/j.1365-2885.2007.00923.x; Naidoo V, 2010, ARCH TOXICOL, V84, P761, DOI 10.1007/s00204-010-0521-0; Naidoo V, 2009, REGUL TOXICOL PHARM, V53, P205, DOI 10.1016/j.yrtph.2009.01.010; Naidoo V, 2010, BIOL LETTERS, V6, P339, DOI 10.1098/rsbl.2009.0818; Nozaki Y, 2007, J PHARMACOL EXP THER, V322, P1162, DOI 10.1124/jpet.107.121491; Oaks JL, 2004, NATURE, V427, P630, DOI 10.1038/nature02317; Paul-Murphy JR, 2009, AM J VET RES, V70, P1201, DOI 10.2460/ajvr.70.10.1201; Piper SE, 1999, BIRD STUDY, V46, P230; Prakash V, 2003, BIOL CONSERV, V109, P381, DOI 10.1016/S0006-3207(02)00164-7; Swan G, 2006, PLOS BIOL, V4, P395, DOI 10.1371/journal.pbio.0040066; Swan GE, 2006, BIOL LETT-UK, V2, P279, DOI 10.1098/rsbl.2005.0425; Swarup D, 2007, ANIM CONSERV, V10, P192, DOI 10.1111/j.1469-1795.2006.00086.x; WILLIAMS RJ, 1990, AM J VET RES, V51, P367; Zorrilla I, 2014, CONSERV BIOL IN PRES; IUCN RED LIST THREAT	45	25	25	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2015	10	10							e0141419	10.1371/journal.pone.0141419	http://dx.doi.org/10.1371/journal.pone.0141419			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0ED	26512724	Green Submitted, Green Published, gold			2022-12-26	WOS:000363920300037
J	Nickel, AE; Henke, K; Hannula, DE				Nickel, Allison E.; Henke, Katharina; Hannula, Deborah E.			Relational Memory Is Evident in Eye Movement Behavior despite the Use of Subliminal Testing Methods	PLOS ONE			English	Article							PREVIOUSLY ATTENDED OBJECTS; SEMANTIC ASSOCIATIONS; VISUAL MEMORY; PERCEPTION; INFORMATION; HIPPOCAMPUS; ACTIVATION; ACCURATE; OPINION; VISION	While it is generally agreed that perception can occur without awareness, there continues to be debate about the type of representational content that is accessible when awareness is minimized or eliminated. Most investigations that have addressed this issue evaluate access to well-learned representations. Far fewer studies have evaluated whether or not associations encountered just once prior to testing might also be accessed and influence behavior. Here, eye movements were used to examine whether or not memory for studied relationships is evident following the presentation of subliminal cues. Participants assigned to experimental or control groups studied scene-face pairs and test trials evaluated implicit and explicit memory for these pairs. Each test trial began with a subliminal scene cue, followed by three visible studied faces. For experimental group participants, one face was the studied associate of the scene (implicit test); for controls none were a match. Subsequently, the display containing a match was presented to both groups, but now it was preceded by a visible scene cue (explicit test). Eye movements were recorded and recognition memory responses were made. Participants in the experimental group looked disproportionately at matching faces on implicit test trials and participants from both groups looked disproportionately at matching faces on explicit test trials, even when that face had not been successfully identified as the associate. Critically, implicit memory-based viewing effects seemed not to depend on residual awareness of subliminal scene cues, as subjective and objective measures indicated that scenes were successfully masked from view. The reported outcomes indicate that memory for studied relationships can be expressed in eye movement behavior without awareness.	[Nickel, Allison E.; Hannula, Deborah E.] Univ Wisconsin, Dept Psychol, Milwaukee, WI 53201 USA; [Henke, Katharina] Univ Bern, Dept Psychol, Bern, Switzerland; [Henke, Katharina] Univ Bern, Ctr Cognit Learning & Memory, Bern, Switzerland	University of Wisconsin System; University of Wisconsin Milwaukee; University of Bern; University of Bern	Hannula, DE (corresponding author), Univ Wisconsin, Dept Psychol, Milwaukee, WI 53201 USA.	hannula@uwm.edu			Swiss National Science Foundation [320000-114012]; UW-Milwaukee Advanced Opportunity Fellowship	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); UW-Milwaukee Advanced Opportunity Fellowship	The experiment reported in this manuscript was supported by the Swiss National Science Foundation (Grant Number 320000-114012 awarded to KH) and by a UW-Milwaukee Advanced Opportunity Fellowship awarded to AEN.	Ansorge U, 2014, CONSCIOUS COGN, V27, P268, DOI 10.1016/j.concog.2014.05.009; Baym CL, 2014, AM J CLIN NUTR, V99, P1026, DOI 10.3945/ajcn.113.079624; BIEDERMAN I, 1974, J EXP PSYCHOL, V103, P597, DOI 10.1037/h0037158; Chong TTJ, 2014, CURR BIOL, V24, pR1033, DOI 10.1016/j.cub.2014.09.035; Chua EF, 2012, MEMORY, V20, P48, DOI 10.1080/09658211.2011.633919; Cohen N. J., 1993, MEMORY AMNESIA HIPPO; Degonda N, 2005, NEURON, V46, P505, DOI 10.1016/j.neuron.2005.02.030; Dehaene S, 1998, NATURE, V395, P597, DOI 10.1038/26967; Duss SB, 2014, BRAIN, P1; Duss SB, 2011, CONSCIOUS COGN, V20, P928, DOI 10.1016/j.concog.2011.03.018; EICHENBAUM H, 1994, BEHAV BRAIN SCI, V17, P449, DOI 10.1017/S0140525X00035391; GREENWALD AG, 1995, J EXP PSYCHOL GEN, V124, P22, DOI 10.1037/0096-3445.124.1.22; Hannula DE, 2005, NAT REV NEUROSCI, V6, P247, DOI 10.1038/nrn1630; Hannula DE, 2007, J COGNITIVE NEUROSCI, V19, P1690, DOI 10.1162/jocn.2007.19.10.1690; Hannula DE, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00080; Hannula DE, 2012, PSYCHOL SCI, V23, P278, DOI 10.1177/0956797611429799; Hannula DE, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00166; Hannula DE, 2009, NEURON, V63, P592, DOI 10.1016/j.neuron.2009.08.025; Hayhoe MM, 1998, VISION RES, V38, P125, DOI 10.1016/S0042-6989(97)00116-8; Henderson JM, 2003, PERCEPT PSYCHOPHYS, V65, P58, DOI 10.3758/BF03194783; Henke K, 2003, NEUROPSYCHOLOGIA, V41, P863, DOI 10.1016/S0028-3932(03)00035-6; Henke K, 2013, FRONT BEHAV NEUROSCI, V7, P1; Henke K, 2010, NAT REV NEUROSCI, V11, P523, DOI 10.1038/nrn2850; HOLENDER D, 1986, BEHAV BRAIN SCI, V9, P1, DOI 10.1017/S0140525X00021269; Hollingworth A, 2001, PSYCHON B REV, V8, P761, DOI 10.3758/BF03196215; Hollingworth A, 2002, J EXP PSYCHOL HUMAN, V28, P113, DOI 10.1037//0096-1523.28.1.113; Hollingworth A, 2008, J EXP PSYCHOL GEN, V137, P163, DOI 10.1037/0096-3445.137.1.163; Kadar I, 2012, J VISION, V12, DOI 10.1167/12.13.16; Kafkas A, 2012, NEUROPSYCHOLOGIA, V50, P3080, DOI 10.1016/j.neuropsychologia.2012.08.001; Klauer KC, 2007, CONSCIOUS COGN, V16, P63, DOI 10.1016/j.concog.2005.12.002; Kouider S, 2007, PHILOS T R SOC B, V362, P857, DOI 10.1098/rstb.2007.2093; Loschky LC, 2010, VIS COGN, V18, P513, DOI 10.1080/13506280902937606; Merikle P. M., 1998, J CONSCIOUSNESS STUD, V5, P5; MERIKLE PM, 1982, PERCEPT PSYCHOPHYS, V31, P298, DOI 10.3758/BF03202538; Mudrik L, 2014, TRENDS COGN SCI, V18, P488, DOI 10.1016/j.tics.2014.04.009; Mudrik L, 2013, J VISION, V13, DOI 10.1167/13.13.24; Naccache L, 2001, CEREB CORTEX, V11, P966, DOI 10.1093/cercor/11.10.966; Pathman T, 2014, CHILD DEV, V85, P792, DOI 10.1111/cdev.12152; Persaud N, 2008, CONSCIOUS COGN, V17, P984, DOI 10.1016/j.concog.2007.06.002; Reber TP, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00009; Reber TP, 2012, J NEUROSCI, V32, P6138, DOI 10.1523/JNEUROSCI.5639-11.2012; Reber TP, 2011, FRONT PSYCHOL, V2, P1; REINGOLD EM, 1988, PERCEPT PSYCHOPHYS, V44, P563, DOI 10.3758/BF03207490; Richmond J, 2009, DEVELOPMENTAL SCI, V12, P549, DOI 10.1111/j.1467-7687.2009.00795.x; Rolls ET, 2013, FRONT SYST NEUROSCI, V7, DOI 10.3389/fnsys.2013.00074; Ryan JD, 2000, PSYCHOL SCI, V11, P454, DOI 10.1111/1467-9280.00288; Ryan JD, 2004, J EXP PSYCHOL HUMAN, V30, P988, DOI 10.1037/0096-1523.30.5.988; Ryan JD, 2007, MEMORY, V15, P508, DOI 10.1080/09658210701391022; Simons DJ, 2007, CAMB HANDB PSYCHOL, P207; Smith CN, 2006, J NEUROSCI, V26, P11304, DOI 10.1523/JNEUROSCI.3071-06.2006; Smith CN, 2008, J NEUROSCI, V28, P12825, DOI 10.1523/JNEUROSCI.4542-08.2008; Squire LR, 2011, ANNU REV NEUROSCI, V34, P259, DOI 10.1146/annurev-neuro-061010-113720; van Gaal S, 2014, PHILOS T R SOC B, V369, P1; Williams LE, 2010, BIOL PSYCHIAT, V68, P617, DOI 10.1016/j.biopsych.2010.05.035	55	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2015	10	10							e0141677	10.1371/journal.pone.0141677	http://dx.doi.org/10.1371/journal.pone.0141677			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CV0ED	26512726	gold, Green Published, Green Submitted			2022-12-26	WOS:000363920300067
J	Althaus, F; Hill, N; Ferrari, R; Edwards, L; Przeslawski, R; Schonberg, CHL; Stuart-Smith, R; Barrett, N; Edgar, G; Colquhoun, J; Tran, M; Jordan, A; Rees, T; Gowlett-Holmes, K				Althaus, Franziska; Hill, Nicole; Ferrari, Renata; Edwards, Luke; Przeslawski, Rachel; Schoenberg, Christine H. L.; Stuart-Smith, Rick; Barrett, Neville; Edgar, Graham; Colquhoun, Jamie; Tran, Maggie; Jordan, Alan; Rees, Tony; Gowlett-Holmes, Karen			A Standardised Vocabulary for Identifying Benthic Biota and Substrata from Underwater Imagery: The CATAMI Classification Scheme	PLOS ONE			English	Article							REEF; BIODIVERSITY; VIDEO; SPONGE; CORAL; AUSTRALIA; COASTAL; SHELF; COMMUNITIES; ABUNDANCE	Imagery collected by still and video cameras is an increasingly important tool for minimal impact, repeatable observations in the marine environment. Data generated from imagery includes identification, annotation and quantification of biological subjects and environmental features within an image. To be long-lived and useful beyond their project-specific initial purpose, and to maximize their utility across studies and disciplines, marine imagery data should use a standardised vocabulary of defined terms. This would enable the compilation of regional, national and/or global data sets from multiple sources, contributing to broad-scale management studies and development of automated annotation algorithms. The classification scheme developed under the Collaborative and Automated Tools for Analysis of Marine Imagery (CATAMI) project provides such a vocabulary. The CATAMI classification scheme introduces Australian-wide acknowledged, standardised terminology for annotating benthic substrates and biota in marine imagery. It combines coarse-level taxonomy and morphology, and is a flexible, hierarchical classification that bridges the gap between habitat/biotope characterisation and taxonomy, acknowledging limitations when describing biological taxa through imagery. It is fully described, documented, and maintained through curated online databases, and can be applied across benthic image collection methods, annotation platforms and scoring methods. Following release in 2013, the CATAMI classification scheme was taken up by a wide variety of users, including government, academia and industry. This rapid acceptance highlights the scheme's utility and the potential to facilitate broad-scale multidisciplinary studies of marine ecosystems when applied globally. Here we present the CATAMI classification scheme, describe its conception and features, and discuss its utility and the opportunities as well as challenges arising from its use.	[Althaus, Franziska; Rees, Tony; Gowlett-Holmes, Karen] CSIRO Oceans & Atmosphere, Hobart, Tas, Australia; [Hill, Nicole; Stuart-Smith, Rick; Barrett, Neville; Edgar, Graham] Univ Tasmania, Inst Marine & Antarctic Studies, Hobart, Tas, Australia; [Ferrari, Renata] Univ Sydney, Sch Biol Sci, Sydney, NSW 2006, Australia; [Ferrari, Renata] Univ Sydney, Australian Ctr Field Robot, Sydney, NSW 2006, Australia; [Ferrari, Renata] Sydney Inst Marine Sci, Sydney, NSW, Australia; [Edwards, Luke] Pawsey Supercomp Ctr WAMSI, Mt Lawley, WA, Australia; [Przeslawski, Rachel; Tran, Maggie] Geosci Australia, Natl Earth & Marine Observat Grp, Canberra, ACT, Australia; [Schoenberg, Christine H. L.] UWA Oceans Inst M096, Crawley, WA, Australia; [Colquhoun, Jamie] UWA Oceans Inst M096, Australian Inst Marine Sci, Crawley, WA 6009, Australia; [Jordan, Alan] NSW Dept Ind, Nelson Bay, NSW, Australia; [Schoenberg, Christine H. L.] Western Australian Museum, Welshpool, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Tasmania; University of Sydney; University of Sydney; Sydney Institute of Marine Science; Geoscience Australia; University of Western Australia; Australian Institute of Marine Science; University of Western Australia; Western Australian Museum	Althaus, F (corresponding author), CSIRO Oceans & Atmosphere, Hobart, Tas, Australia.	Franzis.Althaus@csiro.au	Edgar, Graham/AAY-3797-2020; Stuart-Smith, Rick/I-5214-2019; Schönberg, Christine/B-3925-2009; Hill, Nicole/AAI-7323-2021; Hill, Nicole A/J-7856-2014; Barrett, Neville S/J-7593-2014; Ferrari, Renata/E-3109-2016; Stuart-Smith, Rick D/M-1829-2013; Rees, Tony/K-9837-2015; Althaus, Franziska/E-4660-2017	Edgar, Graham/0000-0003-0833-9001; Stuart-Smith, Rick/0000-0002-8874-0083; Schönberg, Christine/0000-0001-6286-8196; Hill, Nicole/0000-0001-9329-6717; Hill, Nicole A/0000-0001-9329-6717; Barrett, Neville S/0000-0002-6167-1356; Ferrari, Renata/0000-0002-5056-1178; Stuart-Smith, Rick D/0000-0002-8874-0083; Rees, Tony/0000-0003-1887-5211; Althaus, Franziska/0000-0002-5336-4612; Edwards, Luke/0000-0001-8590-3361; Przeslawski, Rachel/0000-0003-0269-3755	NeCTAR project; Australian Government; Education Investment Fund; Australian National Data Service (ANDS); Australia Government's National Environmental Research Program (NERP), Marine Biodiversity Hub; Australian Government's National Environmental Research Program (NERP)	NeCTAR project; Australian Government(Australian GovernmentCGIAR); Education Investment Fund; Australian National Data Service (ANDS); Australia Government's National Environmental Research Program (NERP), Marine Biodiversity Hub; Australian Government's National Environmental Research Program (NERP)(Australian Government)	CATAMI acknowledges funding from the following: the NeCTAR project (http://www.nectar.org.au), an Australian Government project conducted as part of the Super Science initiative and financed by the Education Investment Fund; the Australian National Data Service (ANDS) (http://www.ands.org.au/index.html); and the Australia Government's National Environmental Research Program (NERP), Marine Biodiversity Hub (http://www.nerpmarine.edu.au/). The Marine Biodiversity Hub is supported through funding from the Australian Government's National Environmental Research Program (NERP), administered by the Department of Sustainability, Environment, Water, Population and Communities (DSEWPaC).	ABC Science IMOS, 2015, EXPL SEAFL AUSTR ABC; Abdo D., 2004, SURVEYS BENTHIC REEF; Alcolado Pedro M., 2007, V28, P3; Althaus F, 2009, MAR ECOL PROG SER, V397, P279, DOI 10.3354/meps08248; Althaus F, 2014, CATAMI CLASSIFICATIO; Althaus F, 2012, ELSEV INSIGHT, P665, DOI 10.1016/B978-0-12-385140-6.00048-7; Andrews K, 2013, EXPLORE SEAFLOOR ABC; Barrett NS, 2010, AQUAT CONSERV, V20, P397, DOI 10.1002/aqc.1085; Bax NJ, 2015, MARINE BIODIVERSITY; Beijbom O, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130312; Bird TJ, 2014, BIOL CONSERV, V173, P144, DOI 10.1016/j.biocon.2013.07.037; Bridge TCL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113079; Buhl-Mortensen L, 2012, HYDROBIOLOGIA, V685, P191, DOI 10.1007/s10750-011-0988-6; CATAMI Technical Working Group, 2014, CATAMI CLASS SCHEM S; Chevron, 2013, WS00000HESRPTCVX0000; CMECS Team, 2012, FGDCSTD018 CMECS TEA; CORALNET, 2015, CORALNET ALPH WEB SO; Costello MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051629; Costello MJ, 2009, MAR ECOL PROG SER, V397, P253, DOI 10.3354/meps08317; Davies C. E., 2004, EUNIS HABITAT CLASSI; Devillers R, 2015, AQUAT CONSERV, V25, P480, DOI 10.1002/aqc.2445; Durnden JM, OCEANOGRAPHY MARINE; DUSTAN P, 1987, CORAL REEFS, V6, P91, DOI 10.1007/BF00301378; Edgar GJ, 2009, MAR ECOL PROG SER, V388, P51, DOI 10.3354/meps08149; Ferrari R, 2012, CORAL REEFS, V31, P683, DOI 10.1007/s00338-012-0889-9; Fithian W, 2015, METHODS ECOL EVOL, V6, P424, DOI 10.1111/2041-210X.12242; Foster SD, 2009, ENVIRONMETRICS, V20, P541, DOI 10.1002/env.952; Friedman A., 2013, AUTOMATED INTERPRETA; Friedman A, 2015, SQUIDLE 2015; Galparsoro I, 2012, MAR POLLUT BULL, V64, P2630, DOI 10.1016/j.marpolbul.2012.10.010; Gerovasileiou V, 2015, J MAR BIOL ASSOC UK, P1; Gomes-Pereira JN, PROGR OCEANOGRAPHY; Guinotte JM, 2008, ANN NY ACAD SCI, V1134, P320, DOI 10.1196/annals.1439.013; Hayes K, 2015, BLUEPRINT MONITORING; Heyward Andrew, 2010, Open Marine Biology Journal, V4, P3; Hill MS, 2002, BIOL BULL-US, V202, P86, DOI 10.2307/1543225; Hill NA, 2013, AUSTR MAR SCI ASS C; Hill NA, 2014, ESTUAR COAST SHELF S, V147, P137, DOI 10.1016/j.ecss.2014.05.019; Hill NA, 2010, MAR ECOL PROG SER, V417, P83, DOI 10.3354/meps08815; Howell KL, 2014, ICES J MAR SCI, V71, P899, DOI 10.1093/icesjms/fsu052; Howell KL, 2010, DEEP SEA SPECIES IMA; HURL, 2013, AN ID GUID HAW UND R; Kenchington E, 2009, CONTRACT NO 09 6; Kirk P, 2012, BIOINFORMATICS, V28, P3290, DOI 10.1093/bioinformatics/bts595; Kloser RJ, 2010, CONT SHELF RES, V30, P1772, DOI 10.1016/j.csr.2010.08.004; Kloser RJ, MAPPING SEAFLOOR HAB, P93; Kohler KE, 2006, COMPUT GEOSCI-UK, V32, P1259, DOI 10.1016/j.cageo.2005.11.009; Kramer Philip A., 2003, Atoll Research Bulletin, V496, P1; Lafratta A, BIOL B IN PRESS; Langlois TJ, 2012, ECOL INDIC, V23, P524, DOI 10.1016/j.ecolind.2012.04.030; Last P., 2005, VALIDATION NATL DEME; Last PR, 2010, BIOL CONSERV, V143, P1675, DOI 10.1016/j.biocon.2010.04.008; LITTLER MM, 1980, AM NAT, V116, P25, DOI 10.1086/283610; Loh TL, 2012, HYDROBIOLOGIA, V687, P205, DOI 10.1007/s10750-011-0806-1; Lough JM, 2000, GEOPHYS RES LETT, V27, P3901, DOI 10.1029/2000GL011715; Lucieer V, 2013, ESTUAR COAST SHELF S, V117, P94, DOI 10.1016/j.ecss.2012.11.001; Mallet D, 2014, FISH RES, V154, P44, DOI 10.1016/j.fishres.2014.01.019; Mees J, 2014, WORLD REGISTER MARIN; Meroz-Fine E, 2005, MAR BIOL, V147, P243, DOI 10.1007/s00227-004-1532-2; Molnar JL, 2008, FRONT ECOL ENVIRON, V6, P485, DOI 10.1890/070064; Mount R., 2007, NATL INTERTIDAL SUBT; Neptune Canada, 2012, MAR LIF FIELD GUID; NSW Government, 2015, MAR PARKS 2015; O'Hara TD, 2011, CURR BIOL, V21, P226, DOI 10.1016/j.cub.2011.01.002; OPG, 2012, OFFSH ENV MON OIL GA; Orfanidis S., 2001, MEDITERRANEAN MARINE, V2, P45, DOI [DOI 10.12681/MMS.266, 10.12681/mms.266]; PANGEA, 2015, PANGEA DAT PUBL EART; Parker S, 2009, CCAMLR VME TAXA IDEN; Pizarro O, 2013, IEEE UNDERWATER TECH; Przeslawski R, 2011, 2011040 GEOSC AUSTR; Przeslawski R, 2012, DEEP-SEA RES PT I, V65, P26, DOI 10.1016/j.dsr.2012.03.006; Reef Life Survey, 2014, REEF LIF SURV METH M; Rees AJJ, 1999, CODES AUSTR AQUATIC; Riegl B, 1999, CORAL REEFS, V18, P63, DOI 10.1007/s003380050156; Rooper CN, 2007, CONT SHELF RES, V27, P947, DOI 10.1016/j.csr.2006.12.006; Royle JA, 2012, METHODS ECOL EVOL, V3, P545, DOI 10.1111/j.2041-210X.2011.00182.x; Sandin SA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001548; Schlacher TA, 2010, MAR ECOL-EVOL PERSP, V31, P200, DOI 10.1111/j.1439-0485.2009.00286.x; Schonberg CHL, 2015, BIOL BULL-US, V228, P137, DOI 10.1086/BBLv228n2p137; Schonberg CHL, 2012, HYDROBIOLOGIA, V687, P143, DOI 10.1007/s10750-011-0863-5; Schoening T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038179; Schonberg CHL, 1997, MAR BIOL, V130, P133, DOI 10.1007/s002270050232; Schonberg CHL, 2014, SPONGE FUNCTIONAL GR; Seiler J, 2012, CONT SHELF RES, V45, P87, DOI 10.1016/j.csr.2012.06.003; Siwabessy PJW, 2013, 2013011 GEOSC AUSTR; Sommer B, 2014, ECOLOGY, V95, P1000, DOI 10.1890/13-1445.1; Spalding MD, 2007, BIOSCIENCE, V57, P573, DOI 10.1641/B570707; Spalding MD, 2014, CONSERV LETT, V7, P293, DOI 10.1111/conl.12074; Spencer ML, 2005, ESTUAR COAST SHELF S, V64, P497, DOI 10.1016/j.ecss.2005.03.012; State of the Environment 2011 Committee, 2011, AUSTR STAT ENV 2011; Stuart-Smith RD, 2013, NATURE, V501, P539, DOI 10.1038/nature12529; Thresher R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085872; Tittensor DP, 2009, J BIOGEOGR, V36, P1111, DOI 10.1111/j.1365-2699.2008.02062.x; Tracey D., 2008, SP08SWGDW03 S PAC RE; Tran M, 2014, MAR IM WORKSH SOUTH; Warton DI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079168; Wells E, 2007, MAR POLLUT BULL, V55, P151, DOI 10.1016/j.marpolbul.2006.08.031; Williams A, 2010, MAR ECOL-EVOL PERSP, V31, P183, DOI 10.1111/j.1439-0485.2010.00385.x; Williams SB, 2012, IEEE ROBOT AUTOM MAG, V19, P73, DOI 10.1109/MRA.2011.2181772; Zaun L, 1996, STATE MARINE ENV REP; Zooniverse, 2015, SEAFL EXPL ZOON	101	121	121	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2015	10	10							e0141039	10.1371/journal.pone.0141039	http://dx.doi.org/10.1371/journal.pone.0141039			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0DL	26509918	Green Published, gold			2022-12-26	WOS:000363918100047
J	Beck, G; Shinzawa, K; Hayakawa, H; Baba, K; Yasuda, T; Sumi-Akamaru, H; Tsujimoto, Y; Mochizuki, H				Beck, Goichi; Shinzawa, Koei; Hayakawa, Hideki; Baba, Kousuke; Yasuda, Toru; Sumi-Akamaru, Hisae; Tsujimoto, Yoshihide; Mochizuki, Hideki			Deficiency of Calcium-Independent Phospholipase A2 Beta Induces Brain Iron Accumulation through Upregulation of Divalent Metal Transporter 1	PLOS ONE			English	Article							INFANTILE NEUROAXONAL DYSTROPHY; NEURODEGENERATIVE DISORDERS; MITOCHONDRIAL DYSFUNCTION; DOCOSAHEXAENOIC ACID; PHENOTYPIC SPECTRUM; PLA2G6 MUTATION; NITRIC-OXIDE; MOUSE MODEL; RAT-BRAIN; A(2)	Mutations in PLA2G6 have been proposed to be the cause of neurodegeneration with brain iron accumulation type 2. The present study aimed to clarify the mechanism underlying brain iron accumulation during the deficiency of calcium-independent phospholipase A2 beta (iPLA(2)beta), which is encoded by the PLA2G6 gene. Perl's staining with diaminobenzidine enhancement was used to visualize brain iron accumulation. Western blotting was used to investigate the expression of molecules involved in iron homeostasis, including divalent metal transporter 1 (DMT1) and iron regulatory proteins (IRP1 and 2), in the brains of iPLA(2)beta-knockout (KO) mice as well as in PLA2G6-knockdown (KD) SH-SY5Y human neuroblastoma cells. Furthermore, mitochondrial functions such as ATP production were examined. We have discovered for the first time that marked iron deposition was observed in the brains of iPLA(2)beta-KO mice since the early clinical stages. DMT1 and IRP2 were markedly upregulated in all examined brain regions of aged iPLA(2)beta-KO mice compared to age-matched wild-type control mice. Moreover, peroxidized lipids were increased in the brains of iPLA(2)beta-KO mice. DMT1 and IRPs were significantly upregulated in PLA2G6-KD cells compared with cells treated with negative control siRNA. Degeneration of the mitochondrial inner membrane and decrease of ATP production were observed in PLA2G6-KD cells. These results suggest that the genetic ablation of iPLA(2)beta increased iron uptake in the brain through the activation of IRP2 and upregulation of DMT1, which may be associated with mitochondrial dysfunction.	[Beck, Goichi; Hayakawa, Hideki; Baba, Kousuke; Yasuda, Toru; Sumi-Akamaru, Hisae; Mochizuki, Hideki] Osaka Univ, Grad Sch Med, Dept Neurol, Suita, Osaka, Japan; [Shinzawa, Koei; Tsujimoto, Yoshihide] Osaka Univ, Grad Sch Med, Dept Med Genet, Suita, Osaka, Japan; [Yasuda, Toru] Natl Ctr Child Hlth & Dev, Dept Human Genet, Tokyo, Japan; [Tsujimoto, Yoshihide] Osaka Med Ctr Canc & Cardiovasc Dis, Osaka, Japan	Osaka University; Osaka University; National Center for Child Health & Development - Japan; Osaka Medical Center for Cancer & Cardiovascular Diseases	Mochizuki, H (corresponding author), Osaka Univ, Grad Sch Med, Dept Neurol, Suita, Osaka, Japan.	hmochizuki@neurol.med.osaka-u.ac.jp			Japan Society for the Promotion of Science (JSPS) [24591294, 24591295, 22790314]	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was supported by Grant-in-Aid for Scientific Research (C) from the Japan Society for the Promotion of Science (JSPS) (Grant Number 24591294 to GB and Grant Number 24591295 to HSA), and a Grant-in-Aid for Young Scientists (B) (Grant Number 22790314 to KS) from JSPS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asano T, 2015, NEUROSCI LETT, V588, P29, DOI 10.1016/j.neulet.2014.12.052; Asano T, 2011, MOL CELL BIOL, V31, P2040, DOI 10.1128/MCB.01437-10; Balsinde J, 1997, J BIOL CHEM, V272, P29317, DOI 10.1074/jbc.272.46.29317; Beck G, 2011, J NEUROSCI, V31, P11411, DOI 10.1523/JNEUROSCI.0345-11.2011; Berg D, 2006, MOVEMENT DISORD, V21, P1299, DOI 10.1002/mds.21020; Bouton C, 2002, J BIOL CHEM, V277, P31220, DOI 10.1074/jbc.M203276200; Butt J, 1996, P NATL ACAD SCI USA, V93, P4345, DOI 10.1073/pnas.93.9.4345; Engel LA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012897; Gonzalez RJ, 2001, TOXICOL IN VITRO, V15, P257, DOI 10.1016/S0887-2333(01)00014-5; Green JT, 2008, J LIPID RES, V49, P939, DOI 10.1194/jlr.R700017-JLR200; Gregory A, 2008, NEUROLOGY, V71, P1402, DOI 10.1212/01.wnl.0000327094.67726.28; Hentze MW, 2010, CELL, V142, P24, DOI 10.1016/j.cell.2010.06.028; Hentze MW, 1996, P NATL ACAD SCI USA, V93, P8175, DOI 10.1073/pnas.93.16.8175; HILL JM, 1984, NEUROSCIENCE, V11, P595, DOI 10.1016/0306-4522(84)90046-0; Hooks SB, 2008, BIOCHEM PHARMACOL, V76, P1059, DOI 10.1016/j.bcp.2008.07.044; Horowitz MP, 2010, J ALZHEIMERS DIS, V20, pS551, DOI 10.3233/JAD-2010-100354; Illingworth MA, 2014, MOL GENET METAB, V112, P183, DOI 10.1016/j.ymgme.2014.03.008; JEFFERIES WA, 1984, NATURE, V312, P162, DOI 10.1038/312162a0; Jiang H, 2010, CELL RES, V20, P345, DOI 10.1038/cr.2010.20; Khateeb S, 2006, AM J HUM GENET, V79, P942, DOI 10.1086/508572; Kiebish MA, 2008, J NEUROCHEM, V106, P299, DOI 10.1111/j.1471-4159.2008.05383.x; Kinghorn KJ, 2015, BRAIN, V138, P1801, DOI 10.1093/brain/awv132; Kurian MA, 2008, NEUROLOGY, V70, P1623, DOI 10.1212/01.wnl.0000310986.48286.8e; LaVaute T, 2001, NAT GENET, V27, P209, DOI 10.1038/84859; LEVINE SM, 1991, J NEUROSCI RES, V29, P413, DOI 10.1002/jnr.490290317; Liu W, 2011, FREE RADICAL BIO MED, V50, P166, DOI 10.1016/j.freeradbiomed.2010.10.709; Malik I, 2008, AM J PATHOL, V172, P406, DOI 10.2353/ajpath.2008.070823; Meguro R, 2003, HISTOCHEM CELL BIOL, V120, P73, DOI 10.1007/s00418-003-0539-y; Meyron-Holtz EG, 2004, EMBO J, V23, P386, DOI 10.1038/sj.emboj.7600041; Mills E, 2010, FUTURE MED CHEM, V2, P51, DOI 10.4155/FMC.09.140; Moos T, 2007, J NEUROCHEM, V103, P1730, DOI 10.1111/j.1471-4159.2007.04976.x; Morgan NV, 2006, NAT GENET, V38, P752, DOI 10.1038/ng1826; Murakami M, 2011, PROG LIPID RES, V50, P152, DOI 10.1016/j.plipres.2010.12.001; Paisan-Ruiz C, 2009, ANN NEUROL, V65, P19, DOI 10.1002/ana.21415; Roede JR, 2010, ENVIRON MOL MUTAGEN, V51, P380, DOI 10.1002/em.20553; Salazar J, 2008, P NATL ACAD SCI USA, V105, P18578, DOI 10.1073/pnas.0804373105; Schneider SA, 2012, MOVEMENT DISORD, V27, P42, DOI 10.1002/mds.23971; Seleznev K, 2006, J BIOL CHEM, V281, P22275, DOI 10.1074/jbc.M604330200; Shinzawa K, 2003, J CELL BIOL, V163, P1219, DOI 10.1083/jcb.200306159; Shinzawa K, 2008, J NEUROSCI, V28, P2212, DOI 10.1523/JNEUROSCI.4354-07.2008; Strokin M, 2003, BRIT J PHARMACOL, V139, P1014, DOI 10.1038/sj.bjp.0705326; Todorich B, 2009, GLIA, V57, P467, DOI 10.1002/glia.20784; Wang J, 2013, BBA-MOL BASIS DIS, V1832, P618, DOI 10.1016/j.bbadis.2013.01.021; Yasuda T, 2011, J NEUROPATH EXP NEUR, V70, P686, DOI 10.1097/NEN.0b013e3182269ecd; Yoshino H, 2010, NEUROLOGY, V75, P1356, DOI 10.1212/WNL.0b013e3181f73649; Zachman DK, 2010, J LIPID RES, V51, P525, DOI 10.1194/jlr.M000646; Zecca L, 2004, NAT REV NEUROSCI, V5, P863, DOI 10.1038/nrn1537; Zhang SZ, 2009, NEUROBIOL AGING, V30, P1466, DOI 10.1016/j.neurobiolaging.2007.11.025; Zhao ZS, 2010, ENDOCRINOLOGY, V151, P3038, DOI 10.1210/en.2010-0016; Zhou B, 2001, NAT GENET, V28, P345, DOI 10.1038/ng572	50	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2015	10	10							e0141629	10.1371/journal.pone.0141629	http://dx.doi.org/10.1371/journal.pone.0141629			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU8PC	26506412	Green Published, gold, Green Submitted			2022-12-26	WOS:000363804200093
J	Lu, LL; Liu, Q; Jin, L; Yin, ZH; Xu, L; Xiao, M				Lu, Lili; Liu, Qian; Jin, Lan; Yin, Zhenhao; Xu, Li; Xiao, Min			Enzymatic Synthesis of Rhamnose Containing Chemicals by Reverse Hydrolysis	PLOS ONE			English	Article							GLYCOSIDASE-CATALYZED SYNTHESIS; ALPHA-L-RHAMNOSIDASE; BETA-GALACTOSIDASE; CELL-SURFACE; OLIGOSACCHARIDES; GLYCANS	Rhamnose containing chemicals (RCCs) are widely occurred in plants and bacteria and are known to possess important bioactivities. However, few of them were available using the enzymatic synthesis method because of the scarcity of the alpha-L-rhamnosidases with wide acceptor specificity. In this work, an alpha-L-rhamnosidase from Alternaria sp. L1 was expressed in Pichia pastroris strain GS115. The recombinant enzyme was purified and used to synthesize novel RCCs through reverse hydrolysis in the presence of rhamnose as donor and mannitol, fructose or esculin as acceptors. The effects of initial substrate concentrations, reaction time, and temperature on RCC yields were investigated in detail when using mannitol as the acceptor. The mannitol derivative achieved a maximal yield of 36.1% by incubation of the enzyme with 0.4 M L-rhamnose and 0.2 M mannitol in pH 6.5 buffers at 55 degrees C for 48 h. In identical conditions except for the initial acceptor concentrations, the maximal yields of fructose and esculin derivatives reached 11.9% and 17.9% respectively. The structures of the three derivatives were identified to be alpha-L-rhamnopyranosyl-(1 -> 6')-D-mannitol, alpha-L-rhamnopyranosyl-(1 -> 1')-alpha-D-fructopyranose, and 6,7-dihydroxycoumarin alpha-Lrhamnopyranosyl-( 1 -> 6')-alpha-D-glucopyranoside by ESI-MS and NMR spectroscopy. The high glycosylation efficiency as well as the broad acceptor specificity of this enzyme makes it a powerful tool for the synthesis of novel rhamnosyl glycosides.	[Lu, Lili; Liu, Qian; Jin, Lan; Yin, Zhenhao; Xu, Li; Xiao, Min] Shandong Univ, State Key Lab Microbial Technol, Jinan 250100, Peoples R China; [Lu, Lili; Liu, Qian; Jin, Lan; Yin, Zhenhao; Xu, Li; Xiao, Min] Shandong Univ, Shandong Prov Key Lab Carbohydrate Chem & Glycobi, Natl Glycoengn Res Ctr, Jinan 250100, Peoples R China; [Liu, Qian] Acad State Adm Grain, Beijing 100037, Peoples R China	Shandong University; Shandong University	Xiao, M (corresponding author), Shandong Univ, State Key Lab Microbial Technol, Jinan 250100, Peoples R China.	minxiao@sdu.edu.cn			Major State Basic Research Development Program of China (973 Program) [2012CB822102]; National Major Scientific and Technological Special Project for Significant New Drugs Development [2012ZX09502001-005]; National High Technology Research and Development Program of China (863 Program) [2012AA021504]; Science and Technology Development Project of Shandong Province [2014GSF121006, 2015GSF121004]; Keygrant Project of Chinese Ministry of Education [313033]	Major State Basic Research Development Program of China (973 Program)(National Basic Research Program of China); National Major Scientific and Technological Special Project for Significant New Drugs Development; National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); Science and Technology Development Project of Shandong Province; Keygrant Project of Chinese Ministry of Education(Ministry of Education, China)	This work was supported in parts by the Major State Basic Research Development Program of China (973 Program) (No. 2012CB822102), National Major Scientific and Technological Special Project for Significant New Drugs Development (2012ZX09502001-005), National High Technology Research and Development Program of China (863 Program) (No. 2012AA021504), Science and Technology Development Project of Shandong Province (2014GSF121006, 2015GSF121004), and the Keygrant Project of Chinese Ministry of Education (No. 313033). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashida H, 2010, GLYCOCONJUGATE J, V27, P125, DOI 10.1007/s10719-009-9247-8; Babu P, 2014, ACS CHEM BIOL, V9, P96, DOI 10.1021/cb400784j; Bojarova P, 2009, TRENDS BIOTECHNOL, V27, P199, DOI 10.1016/j.tibtech.2008.12.003; Chang LC, 1998, BIOCHEM BIOPH RES CO, V242, P21, DOI 10.1006/bbrc.1997.7903; Cobucci-Ponzano B, 2011, ADV SYNTH CATAL, V353, P2284, DOI 10.1002/adsc.201100461; Daines AM, 2004, CURR OPIN CHEM BIOL, V8, P106, DOI 10.1016/j.cbpa.2004.02.003; De Winter K, 2013, BIORESOURCE TECHNOL, V147, P640, DOI 10.1016/j.biortech.2013.08.083; Driguez PA, 2014, NAT PROD REP, V31, P980, DOI 10.1039/c4np00012a; Liu Q, 2012, BIORESOURCE TECHNOL, V123, P144, DOI 10.1016/j.biortech.2012.05.083; Lu LL, 2010, BIORESOURCE TECHNOL, V101, P6868, DOI 10.1016/j.biortech.2010.03.106; Majumder AB, 2008, BIOORG MED CHEM LETT, V18, P124, DOI 10.1016/j.bmcl.2007.11.006; Martearena MR, 2008, BIOCATAL BIOTRANSFOR, V26, P177, DOI 10.1080/10242420701568617; McCranie EK, 2014, NAT PROD REP, V31, P1026, DOI 10.1039/c3np70128j; Murata T, 2006, BIOSCI BIOTECH BIOCH, V70, P1049, DOI 10.1271/bbb.70.1049; Muthana S, 2009, CURR OPIN CHEM BIOL, V13, P573, DOI 10.1016/j.cbpa.2009.09.013; Perugino G, 2005, ADV SYNTH CATAL, V347, P941, DOI 10.1002/adsc.200505070; Ravelojaona V, 2006, BIOMED PHARMACOTHER, V60, P359, DOI 10.1016/j.biopha.2006.06.019; Schmaltz RM, 2011, CHEM REV, V111, P4259, DOI 10.1021/cr200113w; Sears P, 2001, SCIENCE, V291, P2344, DOI 10.1126/science.1058899; Seeberger PH, 2007, NATURE, V446, P1046, DOI 10.1038/nature05819; Singh S, 2000, TETRAHEDRON-ASYMMETR, V11, P223, DOI 10.1016/S0957-4166(99)00532-7; Su YS, 2007, ENZYME MICROB TECH, V40, P1496, DOI 10.1016/j.enzmictec.2006.10.029; van Rantwijk F, 1999, J MOL CATAL B-ENZYM, V6, P511, DOI 10.1016/S1381-1177(99)00042-9; Voutquenne L, 1999, PHYTOCHEMISTRY, V50, P63, DOI 10.1016/S0031-9422(98)00483-X; Wang LX, 2012, ACS CHEM BIOL, V7, P110, DOI 10.1021/cb200429n; Yadav V, 2010, PROCESS BIOCHEM, V45, P1226, DOI 10.1016/j.procbio.2010.05.025; Zechel DL, 2000, ACCOUNTS CHEM RES, V33, P11, DOI 10.1021/ar970172+; Zou ZZ, 2012, BIORESOURCE TECHNOL, V118, P425, DOI 10.1016/j.biortech.2012.04.040	28	10	11	4	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2015	10	10							e0140531	10.1371/journal.pone.0140531	http://dx.doi.org/10.1371/journal.pone.0140531			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU8PC	26505759	Green Submitted, Green Published, gold			2022-12-26	WOS:000363804200011
J	Pinto, ID; das Chagas, BD; Rodrigues, AAF; Ferreira, AL; Rezende, HR; Bruno, RV; Falqueto, A; Andrade, JD; Galati, EAB; Shimabukuro, PHF; Brazil, RP; Peixoto, AA				Pinto, Israel de Souza; das Chagas, Bruna Dias; Fuzari Rodrigues, Andressa Alencastre; Ferreira, Adelson Luiz; Rezende, Helder Ricas; Bruno, Rafaela Vieira; Falqueto, Aloisio; Andrade-Filho, Jose Dilermando; Bianchi Galati, Eunice Aparecida; Fernandes Shimabukuro, Paloma Helena; Brazil, Reginaldo Pecanha; Peixoto, Alexandre Afranio			DNA Barcoding of Neotropical Sand Flies (Diptera, Psychodidae, Phlebotominae): Species Identification and Discovery within Brazil	PLOS ONE			English	Article							LUTZOMYIA-LONGIPALPIS DIPTERA; ESPIRITO-SANTO; VISCERAL LEISHMANIASIS; MULTILOCUS ANALYSIS; SANDFLIES DIPTERA; FLY DIPTERA; PERIOD GENE; MATO-GROSSO; STATE; INTROGRESSION	DNA barcoding has been an effective tool for species identification in several animal groups. Here, we used DNA barcoding to discriminate between 47 morphologically distinct species of Brazilian sand flies. DNA barcodes correctly identified approximately 90% of the sampled taxa (42 morphologically distinct species) using clustering based on neighborjoining distance, of which four species showed comparatively higher maximum values of divergence (range 4.23-19.04%), indicating cryptic diversity. The DNA barcodes also corroborated the resurrection of two species within the shannoni complex and provided an efficient tool to differentiate between morphologically indistinguishable females of closely related species. Taken together, our results validate the effectiveness of DNA barcoding for species identification and the discovery of cryptic diversity in sand flies from Brazil.	[Pinto, Israel de Souza; das Chagas, Bruna Dias; Bruno, Rafaela Vieira; Peixoto, Alexandre Afranio] Fiocruz MS, Inst Oswaldo Cruz, Lab Biol Mol Insetos, BR-21040360 Rio De Janeiro, RJ, Brazil; [Pinto, Israel de Souza; Ferreira, Adelson Luiz; Falqueto, Aloisio] Univ Fed Espirito Santo, Unidade Med Trop, BR-29043900 Vitoria, ES, Brazil; [Fuzari Rodrigues, Andressa Alencastre; Brazil, Reginaldo Pecanha] Fiocruz MS, Inst Oswaldo Cruz, Lab Doencas Parasitarias, BR-21040360 Rio De Janeiro, RJ, Brazil; [Bruno, Rafaela Vieira] Inst Nacl Ciencia & Tecnol Entomol Mol INCT EM CN, Rio De Janeiro, Brazil; [Andrade-Filho, Jose Dilermando; Fernandes Shimabukuro, Paloma Helena] Fiocruz MS, Ctr Pesquisas Rene Rachou, Grp Estudos Leishmanioses, BR-30190002 Belo Horizonte, MG, Brazil; [Bianchi Galati, Eunice Aparecida] Univ Sao Paulo, Fac Saude Publ, Dept Epidemiol, BR-01246904 Sao Paulo, SP, Brazil	Fundacao Oswaldo Cruz; Universidade Federal do Espirito Santo; Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; Universidade de Sao Paulo	Pinto, ID (corresponding author), Fiocruz MS, Inst Oswaldo Cruz, Lab Biol Mol Insetos, Brasil Ave 4365, BR-21040360 Rio De Janeiro, RJ, Brazil.	pintoisrael@gmail.com	Galati, Eunice Aparecida Bianchi/D-2720-2016; Shimabukuro, Paloma Helena Fernandes/AAC-8695-2022; Bruno, Rafaela/AAQ-7611-2020; Brazil, Reginaldo Peçanha/AAF-6777-2019; Andrade Filho, José Dilermando/B-7852-2013	Shimabukuro, Paloma Helena Fernandes/0000-0002-5114-953X; Andrade Filho, José Dilermando/0000-0002-9754-8464; Chagas, Bruna/0000-0003-3710-2337	CNPq; FIOCRUZ	CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FIOCRUZ	This work was supported by grants from the CNPq and FIOCRUZ.	Alves GB, 2012, REV SOC BRAS MED TRO, V45, P437, DOI 10.1590/S0037-86822012005000010; Andrade Filho José Dilermando, 2004, Rev. Bras. entomol., V48, P583, DOI 10.1590/S0085-56262004000400024; Andrade JD, 2009, J MED ENTOMOL, V46, P969, DOI 10.1603/033.046.0501; Araki AS, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002495; ARIAS JR, 1985, AM J TROP MED HYG, V34, P1098, DOI 10.4269/ajtmh.1985.34.1098; Avise JC, 2000, PHYLOGEOGRAPHY HIST, DOI 10.2307/j.ctv1nzfgj7; Azpurua J, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000627; Bachtrog D, 2006, EVOLUTION, V60, P292, DOI 10.1111/j.0014-3820.2006.tb01107.x; Barrett RDH, 2005, CAN J ZOOL, V83, P481, DOI 10.1139/Z05-024; Barretto MP, 1940, ARQ FAC HIG SAUD PUB, V6, P34; Beati L, 2004, INT J PARASITOL, V34, P225, DOI 10.1016/j.ijpara.2003.10.012; Bensasson D, 2001, TRENDS ECOL EVOL, V16, P314, DOI 10.1016/S0169-5347(01)02151-6; Bergsten J, 2012, SYST BIOL, V61, P851, DOI 10.1093/sysbio/sys037; Galati EAB, 2010, REV BRAS ENTOMOL, V54, P665, DOI 10.1590/S0085-56262010000400020; Carnaval AC, 2008, J BIOGEOGR, V35, P1187, DOI 10.1111/j.1365-2699.2007.01870.x; Clare EL, 2007, MOL ECOL NOTES, V7, P184, DOI 10.1111/j.1471-8286.2006.01657.x; Gutierrez MAC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085496; Costa LP, 2003, J BIOGEOGR, V30, P71, DOI 10.1046/j.1365-2699.2003.00792.x; Costa LP, 2000, BIOTROPICA, V32, P872; Coutinho JO, 1940, AN FAC MED U SAO PAU, V16, P193; Coyne J.A., 2004, SPECIATION; Crease TJ, 1999, GENE, V233, P89, DOI 10.1016/S0378-1119(99)00151-1; das Virgens TM, 2015, J VECTOR ECOL, V40, P28, DOI 10.1111/jvec.12129; das Virgens TM, 2008, CAD SAUDE PUBLICA, V24, P2969, DOI 10.1590/S0102-311X2008001200029; de Carvalho MR, 2010, ACTA TROP, V116, P108, DOI 10.1016/j.actatropica.2010.03.009; de Pita-Pereira D, 2005, T ROY SOC TROP MED H, V99, P905, DOI 10.1016/j.trstmh.2005.06.019; de Pita-Pereira D, 2008, ACTA TROP, V107, P66, DOI 10.1016/j.actatropica.2008.04.015; Ersts PJ, 2014, GEOGRAPHIC DISTANCE; Falqueto A, 2013, DINAMICA DOENCAS INF, P786; Ferreira AL, 2013, J MED ENTOMOL, V50, P1215, DOI 10.1603/ME13037; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Rodrigues AAF, 2013, MEM I OSWALDO CRUZ, V108, P943, DOI 10.1590/0074-0276130688; Galati E.A.B., 1995, B DIR MALARIOL SAN A, V35, P133; Galati EAB, 2014, PHLEBOTOMINAE DIPTER; Galati EAB, 2003, FLEBOTOMINEOS BRASIL, P53, DOI DOI 10.1590/S0085-56262003000200017; Gil LHS, 2003, MEM I OSWALDO CRUZ, V98, P751, DOI 10.1590/S0074-02762003000600007; Figueira EAG, 2013, MEM I OSWALDO CRUZ, V108, P280, DOI 10.1590/S0074-02762013000300004; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Jowett T, 1998, DROSOPHILA PRACTICAL, P347; Kerr Kevin C R, 2007, Mol Ecol Notes, V7, P535; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kumar NP, 2012, MOL ECOL RESOUR, V12, P414, DOI 10.1111/j.1755-0998.2012.03117.x; Ladeia-Andrade S, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-400; LAINSON R, 1973, T ROY SOC TROP MED H, V67, P184, DOI 10.1016/0035-9203(73)90143-0; LEWIS DJ, 1977, SYST ENTOMOL, V2, P319, DOI 10.1111/j.1365-3113.1977.tb00381.x; Lins RMMA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044323; Marcondes CB, 2007, ENTOMOL NEWS, V118, P351, DOI 10.3157/0013-872X(2007)118[351:APOGAS]2.0.CO;2; Marcondes CB, 1997, T ROY SOC TROP MED H, V91, P725, DOI 10.1016/S0035-9203(97)90540-X; Martins AV, 1975, REV BRAS BIOL, V35, P259; Mazzoni CJ, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-85; Mazzoni CJ, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-141; Missawa Nanci Akemi, 2011, Rev. Soc. Bras. Med. Trop., V44, P76, DOI 10.1590/S0037-86822011000100017; Nei M, 2000, MOL EVOLUTION PHYLOG; Nekola JC, 1999, J BIOGEOGR, V26, P867, DOI 10.1046/j.1365-2699.1999.00305.x; Oliveira AG, 2012, J MED ENTOMOL, V49, P43, DOI 10.1603/ME11082; Pinto ID, 2012, BIOTA NEOTROP, V12, P323, DOI 10.1590/S1676-06032012000100025; Pinto ID, 2010, CAD SAUDE PUBLICA, V26, P365, DOI 10.1590/S0102-311X2010000200015; Pinto IS, 2010, NEOTROP ENTOMOL, V39, P732, DOI 10.1590/S1519-566X2010000500010; Pinto IS, 2010, J MED ENTOMOL, V47, P16, DOI 10.1603/033.047.0102; Pinto IS, 2010, J VECTOR ECOL, V35, P325, DOI 10.1111/j.1948-7134.2010.00090.x; POWELL JR, 1983, P NATL ACAD SCI-BIOL, V80, P492, DOI 10.1073/pnas.80.2.492; Pugedo H, 2005, REV SOC BRAS MED TRO, V38, P70, DOI 10.1590/S0037-86822005000100017; Puillandre N, 2012, MOL ECOL, V21, P1864, DOI 10.1111/j.1365-294X.2011.05239.x; RANGEL E F, 1985, Memorias do Instituto Oswaldo Cruz, V80, P373, DOI 10.1590/S0074-02761985000300017; Rangel EF, 2003, FLEBOTOMINEOS BRASIL; Ready PD, 2013, ANNU REV ENTOMOL, V58, P227, DOI 10.1146/annurev-ento-120811-153557; Ridley M., 2004, EVOLUTION; Rivera J, 2009, MOL ECOL RESOUR, V9, P224, DOI 10.1111/j.1755-0998.2009.02648.x; Rocha LS, 2010, T ROY SOC TROP MED H, V104, P461, DOI 10.1016/j.trstmh.2010.02.005; Ruiz-Lopez F, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-44; RYAN L, 1986, Memorias do Instituto Oswaldo Cruz, V81, P323, DOI 10.1590/S0074-02761986000300009; Sabio PB, 2014, J MED ENTOMOL, V51, P331, DOI 10.1603/ME13153; Sanguinette CD, 2013, J AM MOSQUITO CONTR, V29, P54, DOI 10.2987/12-6290R.1; Santos AMM, 2007, J BIOGEOGR, V34, P437, DOI 10.1111/j.1365-2699.2006.01604.x; Shannon RC, 1927, REV I BACTERIOL DEP, V4, P724; Shimabukuro Paloma Helena Fernandes, 2011, Pap. Avulsos Zool. (São Paulo), V51, P399, DOI 10.1590/S0031-10492011002700001; Sinclair BJ, 2007, ZOOL J LINN SOC-LOND, V150, P711, DOI 10.1111/j.1096-3642.2007.00314.x; StatSoft Inc., 2011, STAT DAT AN SOFTW SY; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Vigoder FM, 2010, INFECT GENET EVOL, V10, P734, DOI 10.1016/j.meegid.2010.05.004; Watts PC, 2005, AM J TROP MED HYG, V73, P734, DOI 10.4269/ajtmh.2005.73.734; Wright S, 1943, GENETICS, V28, P114; Young David G., 1994, Memoirs of the American Entomological Institute (Gainesville), V54, P1	86	8	8	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2015	10	10							e0140636	10.1371/journal.pone.0140636	http://dx.doi.org/10.1371/journal.pone.0140636			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU8PC	26506007	Green Published, Green Submitted, gold			2022-12-26	WOS:000363804200013
J	Statton, MA; Encarnacion, M; Celnik, P; Bastian, AJ				Statton, Matthew A.; Encarnacion, Marysol; Celnik, Pablo; Bastian, Amy J.			A Single Bout of Moderate Aerobic Exercise Improves Motor Skill Acquisition	PLOS ONE			English	Article							PAIRED ASSOCIATIVE STIMULATION; NEUROTROPHIC FACTOR; BRAIN; PERFORMANCE; PLASTICITY; MEMORY; STRESS; TIME	Long-term exercise is associated with improved performance on a variety of cognitive tasks including attention, executive function, and long-term memory. Remarkably, recent studies have shown that even a single bout of aerobic exercise can lead to immediate improvements in declarative learning and memory, but less is known about the effect of exercise on motor learning. Here we sought to determine the effect of a single bout of moderate intensity aerobic exercise on motor skill learning. In experiment 1, we investigated the effect of moderate aerobic exercise on motor acquisition. 24 young, healthy adults performed a motor learning task either immediately after 30 minutes of moderate intensity running, after running followed by a long rest period, or after slow walking. Motor skill was assessed via a speed-accuracy tradeoff function to determine how exercise might differentially affect two distinct components of motor learning performance: movement speed and accuracy. In experiment 2, we investigated both acquisition and retention of motor skill across multiple days of training. 20 additional participants performed either a bout of running or slow walking immediately before motor learning on three consecutive days, and only motor learning (no exercise) on a fourth day. We found that moderate intensity running led to an immediate improvement in motor acquisition for both a single session and on multiple sessions across subsequent days, but had no effect on between-day retention. This effect was driven by improved movement accuracy, as opposed to speed. However, the benefit of exercise was dependent upon motor learning occurring immediately after exercise-resting for a period of one hour after exercise diminished the effect. These results demonstrate that moderate intensity exercise can prime the nervous system for the acquisition of new motor skills, and suggest that similar exercise protocols may be effective in improving the outcomes of movement rehabilitation programs.	[Statton, Matthew A.; Encarnacion, Marysol; Bastian, Amy J.] Kennedy Krieger Inst, Mot Anal Lab, Baltimore, MD 21205 USA; [Celnik, Pablo] Johns Hopkins Sch Med, Dept Phys Med & Rehabil, Baltimore, MD 21205 USA; [Bastian, Amy J.] Johns Hopkins Sch Med, Dept Neurosci, Baltimore, MD 21205 USA	Kennedy Krieger Institute; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine	Statton, MA (corresponding author), Kennedy Krieger Inst, Mot Anal Lab, Baltimore, MD 21205 USA.	mstatto1@jhu.edu	Meijer, Anna/K-5118-2016		National Institutes of Health (NIH) [R01 HD040289]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD040289] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG028747] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Funding for this work was provided by National Institutes of Health (NIH) grant R01 HD040289, received by AJB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth BE, 2000, MED SCI SPORT EXER, V32, pS498, DOI 10.1097/00005768-200009001-00009; Audiffren M, 2008, ACTA PSYCHOL, V129, P410, DOI 10.1016/j.actpsy.2008.09.006; Audiffren M, 2009, ACTA PSYCHOL, V132, P85, DOI 10.1016/j.actpsy.2009.06.008; Balady GJ, 1998, CIRCULATION, V97, P2283, DOI 10.1161/01.CIR.97.22.2283; BORG G, 1970, Scandinavian Journal of Rehabilitation Medicine, V2, P92; Cantarero G, 2015, J NEUROSCI, V35, P3285, DOI 10.1523/JNEUROSCI.2885-14.2015; Cantarero G, 2013, J NEUROSCI, V33, P12862, DOI 10.1523/JNEUROSCI.1399-13.2013; Cantarero G, 2013, J NEUROSCI, V33, P4634, DOI 10.1523/JNEUROSCI.4706-12.2013; Cian C, 2001, INT J PSYCHOPHYSIOL, V42, P243, DOI 10.1016/S0167-8760(01)00142-8; Colcombe SJ, 2004, P NATL ACAD SCI USA, V101, P3316, DOI 10.1073/pnas.0400266101; Colcombe SJ, 2006, J GERONTOL A-BIOL, V61, P1166, DOI 10.1093/gerona/61.11.1166; Etnier J. L., 2012, OXFORD HDB EXERCISE, P76, DOI DOI 10.1093/OXFORDHB/9780195394313.013.0005; FELLOWS IW, 1986, J NEUROL NEUROSUR PS, V49, P396, DOI 10.1136/jnnp.49.4.396; Ferris LT, 2007, MED SCI SPORT EXER, V39, P728, DOI 10.1249/mss.0b013e31802f04c7; HECKLER B, 1992, PERCEPT MOTOR SKILL, V75, P1059, DOI 10.2466/pms.1992.75.3f.1059; Hillman CH, 2008, NAT REV NEUROSCI, V9, P58, DOI 10.1038/nrn2298; Joyce J, 2009, BRAIN COGNITION, V71, P14, DOI 10.1016/j.bandc.2009.03.004; Kashihara K, 2005, PERCEPT MOTOR SKILL, V100, P275; Knaepen K, 2010, SPORTS MED, V40, P765, DOI 10.2165/11534530-000000000-00000; Krakauer JW, 2006, CURR OPIN NEUROL, V19, P84, DOI 10.1097/01.wco.0000200544.29915.cc; KRUSE P, 1986, J APPL PHYSIOL, V61, P417, DOI 10.1152/jappl.1986.61.2.417; Labban JD, 2011, RES Q EXERCISE SPORT, V82, P712, DOI 10.1080/02701367.2011.10599808; Lambourne K, 2010, BRAIN RES, V1341, P12, DOI 10.1016/j.brainres.2010.03.091; Mang CS, 2014, J APPL PHYSIOL, V117, P1325, DOI 10.1152/japplphysiol.00498.2014; MARTENS R, 1970, J PERS SOC PSYCHOL, V16, P29, DOI 10.1037/h0029787; McDonnell MN, 2013, J APPL PHYSIOL, V114, P1174, DOI 10.1152/japplphysiol.01378.2012; McGaugh JL, 2000, SCIENCE, V287, P248, DOI 10.1126/science.287.5451.248; McMorris T., 2009, EXERCISE COGNITIVE F, DOI [10.1002/9780470740668.ch2, DOI 10.1002/9780470740668.CH2]; Pereira AC, 2007, P NATL ACAD SCI USA, V104, P5638, DOI 10.1073/pnas.0611721104; Quaney BM, 2009, NEUROREHAB NEURAL RE, V23, P879, DOI 10.1177/1545968309338193; Rasmussen P, 2009, EXP PHYSIOL, V94, P1062, DOI 10.1113/expphysiol.2009.048512; Reis J, 2015, CEREB CORTEX, V25, P109, DOI 10.1093/cercor/bht208; Reis J, 2009, P NATL ACAD SCI USA, V106, P1590, DOI 10.1073/pnas.0805413106; Roig M, 2013, NEUROSCI BIOBEHAV R, V37, P1645, DOI 10.1016/j.neubiorev.2013.06.012; Roig M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044594; Segal SK, 2012, J ALZHEIMERS DIS, V32, P1011, DOI 10.3233/JAD-2012-121078; Singh AM, 2014, EXP BRAIN RES, V232, P3675, DOI 10.1007/s00221-014-4049-z; Singh AM, 2014, BMC SPORTS SCI MED R, V6, DOI 10.1186/2052-1847-6-23; Skriver K, 2014, NEUROBIOL LEARN MEM, V116, P46, DOI 10.1016/j.nlm.2014.08.004; Smith PJ, 2010, PSYCHOSOM MED, V72, P239, DOI 10.1097/PSY.0b013e3181d14633; Soderstrom NC, 2015, PERSPECT PSYCHOL SCI, V10, P176, DOI 10.1177/1745691615569000; TOMPOROWSKI PD, 1987, ERGONOMICS, V30, P121, DOI 10.1080/00140138708969682; Tomporowski PD, 2003, ACTA PSYCHOL, V112, P297, DOI 10.1016/S0001-6918(02)00134-8; Winter B, 2007, NEUROBIOL LEARN MEM, V87, P597, DOI 10.1016/j.nlm.2006.11.003	44	100	102	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2015	10	10							e0141393	10.1371/journal.pone.0141393	http://dx.doi.org/10.1371/journal.pone.0141393			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CU8PC	26506413	Green Published, Green Submitted, gold			2022-12-26	WOS:000363804200060
J	Fajol, A; Chen, H; Umbach, AT; Quarles, LD; Lang, F; Foller, M				Fajol, Abul; Chen, Hong; Umbach, Anja T.; Quarles, L. Darryl; Lang, Florian; Foeller, Michael			Enhanced FGF23 production in mice expressing PI3K-insensitive GSK3 is normalized by beta-blocker treatment	FASEB JOURNAL			English	Article						protein kinase B; calcitriol; propranolol; sympathetic activity	GROWTH-FACTOR 23; DOMINANT HYPOPHOSPHATEMIC RICKETS; VITAMIN-D-RECEPTOR; PHOSPHATE HOMEOSTASIS; DIETARY PHOSPHATE; FACTOR-23; SERUM; METABOLISM; PHOSPHORYLATION; GLUCOSE	Glycogen synthase kinase (GSK)-3 is a ubiquitously expressed kinase inhibited by insulin-dependent Akt/PKB/SGK. Mice expressing Akt/PKB/SGK-resistant GSK3 alpha/GSK3 beta (gsk3(KI)) exhibit enhanced sympathetic nervous activity and phosphaturia with decreased bone density. Hormones participating in phosphate homeostasis include fibroblast growth factor (FGF)-23, a bone-derived hormone that inhibits 1,25-dihydroxyvitamin D-3 (1,25(OH)(2)D-3; calcitriol) formation and phosphate reabsorption in the kidney and counteracts vascular calcification and aging. FGF23 secretion is stimulated by the sympathetic nervous system. We studied the role of GSK3-controlled sympathetic activity in FGF23 production and phosphate metabolism. Serum FGF23, 1,25(OH)(2)D-3, and urinary vanillylmandelic acid (VMA) were measured by ELISA, and serum and urinary phosphate and calcium were measured by photometry in gsk3(KI) and gsk3(WT) mice, before and after 1 wk of oral treatment with the beta-blocker propranolol. Urinary VMA excretion, serum FGF23, and renal phosphate and calcium excretion were significantly higher, and serum 1,25(OH)(2)D-3 and phosphate concentrations were lower in gsk3(KI) mice than in gsk3(WT) mice. Propranolol treatment decreased serum FGF23 and loss of renal calcium and phosphate and increased serum phosphate concentration in gsk3(KI) mice. We conclude that Akt/PKB/SGK-sensitive GSK3 inhibition participates in the regulation of FGF23 release, 1,25(OH)(2)D-3 formation, and thus mineral metabolism, by controlling the activity of the sympathetic nervous system.	[Fajol, Abul; Chen, Hong; Umbach, Anja T.; Lang, Florian] Univ Tubingen, Dept Physiol, Tubingen, Germany; [Quarles, L. Darryl] Univ Tennessee, Ctr Hlth Sci, Div Nephrol, Memphis, TN 38163 USA; [Foeller, Michael] Univ Halle Wittenberg, Inst Agr & Nutr Sci, D-06120 Halle, Saale, Germany	Eberhard Karls University of Tubingen; University of Tennessee System; University of Tennessee Health Science Center; Martin Luther University Halle Wittenberg	Foller, M (corresponding author), Univ Halle Wittenberg, Inst Agr & Ernahrungswissensch, Von Danckelmann Pl 2, D-06120 Halle, Saale, Germany.	michael.foeller@landw.uni-halle.de	Fajol, Abul/AAD-1605-2019	Fajol, Abul/0000-0002-3202-5697; Quarles, L. Darryl/0000-0002-5082-7896	Deutsche Forschungsgemeinschaft [Fo 695/1-1, Fo 695/1-2, La 315/15-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The authors thank E. Faber for technical assistance and L. Subasic for meticulous preparation of the manuscript. This study was supported by Deutsche Forschungsgemeinschaft Grants Fo 695/1-1 (to M.F.), Fo 695/1-2 (to M.F.), and La 315/15-1 (to F.L.). The authors declare no conflicts of interest.	ALLON M, 1992, J AM SOC NEPHROL, V2, P1593; Andrukhova O, 2014, EMBO MOL MED, V6, P744, DOI 10.1002/emmm.201303716; Bai XY, 2003, J BIOL CHEM, V278, P9843, DOI 10.1074/jbc.M210490200; Bhandaru M, 2011, KIDNEY INT, V80, P61, DOI 10.1038/ki.2011.67; Bhattacharyya N, 2012, J BONE MINER RES, V27, P1132, DOI 10.1002/jbmr.1546; Boini KM, 2009, AM J PHYSIOL-RENAL, V296, pF153, DOI 10.1152/ajprenal.90398.2008; Camm AJ, 2012, EUR HEART J, V33, P2719, DOI 10.1093/eurheartj/ehs253; Clinkenbeard EL, 2014, J BONE MINER RES, V29, P361, DOI 10.1002/jbmr.2049; de Jongh Renate T, 2013, Ned Tijdschr Geneeskd, V157, pA5908; DEFRONZO RA, 1976, J CLIN INVEST, V58, P83, DOI 10.1172/JCI108463; Fakhri H, 2014, PFLUG ARCH EUR J PHY, V466, P467, DOI 10.1007/s00424-013-1340-y; Farrow EG, 2011, P NATL ACAD SCI USA, V108, pE1146, DOI 10.1073/pnas.1110905108; Faul C, 2011, J CLIN INVEST, V121, P4393, DOI 10.1172/JCI46122; Ferrari SL, 2005, J CLIN ENDOCR METAB, V90, P1519, DOI 10.1210/jc.2004-1039; Foller M, 2011, J AM SOC NEPHROL, V22, P873, DOI 10.1681/ASN.2010070757; Fournier C, 2014, ENDOCRINOLOGY, V155, P4305, DOI 10.1210/en.2014-1308; Gattineni J, 2011, AM J PHYSIOL-RENAL, V301, pF371, DOI 10.1152/ajprenal.00740.2010; Gutierrez OM, 2009, CIRCULATION, V119, P2545, DOI 10.1161/CIRCULATIONAHA.108.844506; Hawkins PT, 2006, BIOCHEM SOC T, V34, P647, DOI 10.1042/BST0340647; Hori M, 2011, ENDOCRINOLOGY, V152, P4, DOI 10.1210/en.2010-0800; Hu MC, 2013, ANNU REV PHYSIOL, V75, P503, DOI 10.1146/annurev-physiol-030212-183727; Imel EA, 2011, J CLIN ENDOCR METAB, V96, P3541, DOI 10.1210/jc.2011-1239; Inoue Y, 2005, BIOCHEM J, V390, P325, DOI 10.1042/BJ20041799; Kawai M, 2014, J BIOL CHEM, V289, P1457, DOI 10.1074/jbc.M113.500850; Kempe DS, 2010, ACTA PHYSIOL, V200, P75, DOI 10.1111/j.1748-1716.2010.02109.x; Kuro-o M, 2010, PEDIATR NEPHROL, V25, P583, DOI 10.1007/s00467-009-1260-4; Lang F, 2006, PHYSIOL REV, V86, P1151, DOI 10.1152/physrev.00050.2005; Larsson T, 2004, ENDOCRINOLOGY, V145, P3087, DOI 10.1210/en.2003-1768; Lavi-Moshayoff V, 2010, AM J PHYSIOL-RENAL, V299, pF882, DOI 10.1152/ajprenal.00360.2010; Lu Yongbo, 2011, Curr Osteoporos Rep, V9, P103, DOI 10.1007/s11914-011-0053-4; Mancia G, 2013, J HYPERTENS, V31, P1281, DOI 10.1097/01.hjh.0000431740.32696.cc; Marsell R, 2010, ACTA PHYSIOL, V200, P97, DOI 10.1111/j.1748-1716.2010.02163.x; Martin A, 2011, FASEB J, V25, P2551, DOI 10.1096/fj.10-177816; Masuyama R, 2006, J CLIN INVEST, V116, P3150, DOI 10.1172/JCI29463; Mathew JS, 2014, CIRCULATION, V130, P298, DOI 10.1161/CIRCULATIONAHA.113.005499; McManus EJ, 2005, EMBO J, V24, P1571, DOI 10.1038/sj.emboj.7600633; Parker BD, 2010, ANN INTERN MED, V152, P640, DOI 10.7326/0003-4819-152-10-201005180-00004; Perwad F, 2005, ENDOCRINOLOGY, V146, P5358, DOI 10.1210/en.2005-0777; Quarles LD, 2003, AM J PHYSIOL-ENDOC M, V285, pE1, DOI 10.1152/ajpendo.00016.2003; Rhee Y, 2011, BONE, V49, P636, DOI 10.1016/j.bone.2011.06.025; Rhee Y, 2011, J BONE MINER RES, V26, P1035, DOI 10.1002/jbmr.304; Saini RK, 2013, CALCIFIED TISSUE INT, V92, P339, DOI 10.1007/s00223-012-9683-5; Sakoda H, 2003, J BIOL CHEM, V278, P25802, DOI 10.1074/jbc.M301127200; Segawa H, 2003, PFLUG ARCH EUR J PHY, V446, P585, DOI 10.1007/s00424-003-1084-1; Seifert ME, 2014, AM J NEPHROL, V39, P392, DOI 10.1159/000362251; Shaw M, 1997, FEBS LETT, V416, P307, DOI 10.1016/S0014-5793(97)01235-0; Shimada T, 2004, J CLIN INVEST, V113, P561, DOI 10.1172/JCI200419081; Shimada T, 2001, P NATL ACAD SCI USA, V98, P6500, DOI 10.1073/pnas.101545198; Shimada T, 2004, J BONE MINER RES, V19, P429, DOI 10.1359/JBMR.0301264; Shimada T, 2005, AM J PHYSIOL-RENAL, V289, pF1088, DOI 10.1152/ajprenal.00474.2004; Siraskar B, 2011, PFLUG ARCH EUR J PHY, V462, P811, DOI 10.1007/s00424-011-1006-6; Spichtig D, 2014, KIDNEY INT, V85, P1340, DOI 10.1038/ki.2013.526; Takashi Yuichi, 2015, Clin Calcium, V25, P1037, DOI CliCa150710371042; Tenenhouse HS, 2002, PFLUG ARCH EUR J PHY, V444, P317, DOI 10.1007/s00424-002-0839-4; Voelkl J, 2013, J CLIN INVEST, V123, P812, DOI 10.1172/JCI64093; White KE, 2001, J CLIN ENDOCR METAB, V86, P497, DOI 10.1210/jc.86.2.497; White KE, 2000, NAT GENET, V26, P345, DOI 10.1038/81664; Wolf M, 2013, J BONE MINER RES, V28, P1793, DOI 10.1002/jbmr.1923; Wyatt AW, 2006, CELL PHYSIOL BIOCHEM, V17, P137, DOI 10.1159/000092075; Yamamoto K, 2015, J CARDIOL, V66, P189, DOI 10.1016/j.jjcc.2015.02.004	60	21	21	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2016	30	2					994	1001		10.1096/fj.15-279943	http://dx.doi.org/10.1096/fj.15-279943			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DC7IA	26527066	Green Published			2022-12-26	WOS:000369391900045
J	Sun, J; Xu, M; Ortsater, H; Lundeberg, E; Juntti-Berggren, L; Chen, YQ; Haeggstrom, JZ; Gudmundsson, GH; Diana, J; Agerberth, B				Sun, Jia; Xu, Meng; Ortsater, Henrik; Lundeberg, Erik; Juntti-Berggren, Lisa; Chen, Yong Q.; Haeggstrom, Jesper Z.; Gudmundsson, Gudmundur H.; Diana, Julien; Agerberth, Birgitta			Cathelicidins positively regulate pancreatic beta-cell functions	FASEB JOURNAL			English	Article						antimicrobial peptide; CRAMP; immunomodulation; endocrine cells; type 1 diabetes	ANTIMICROBIAL PEPTIDE LL-37; HOST-DEFENSE; HUMAN LUNG; EXPRESSION; GENE; APOPTOSIS; CYCLOOXYGENASE-2; ACTIVATION; MICROBIOTA; PATHWAYS	Cathelicidins are pleiotropic antimicrobial peptides largely described for innate antimicrobial defenses and, more recently, immunomodulation. They are shown to modulate a variety of immune or nonimmune host cell responses. However, how cathelicidins are expressed by beta cells and modulate beta-cell functions under steady-state or proinflammatory conditions are unknown. We find that cathelicidin-related antimicrobial peptide (CRAMP) is constitutively expressed by rat insulinoma b-cell clone INS-1 832/13. CRAMP expression is inducible by butyrate or phenylbutyric acid and its secretion triggered upon inflammatory challenges by IL-1 beta or LPS. CRAMP promotes b-cell survival in vitro via the epidermal growth factor receptor (EGFR) and by modulating expression of antiapoptotic Bcl-2 family proteins: p-Bad, Bcl-2, and Bcl-xL. Also via EGFR, CRAMP stimulates glucose-stimulated insulin secretion ex vivo by rat islets. A similar effect is observed in diabetes-prone nonobese diabetic (NOD) mice. Additional investigation under inflammatory conditions reveals that CRAMP modulates inflammatory responses and beta-cell apoptosis, asmeasured by prostaglandin E2 production, cyclooxygenases (COXs), and caspase activation. Finally, CRAMP-deficient cnlp(-/-) mice exhibit defective insulin secretion, and administration of CRAMP to prediabetic NOD mice improves blood glucose clearance upon glucose challenge. Our finding suggests that cathelicidins positively regulate beta-cell functions and may be potentially used for intervening b-cell dysfunction-associated diseases.	[Sun, Jia; Chen, Yong Q.] Jiangnan Univ, Ctr Food Safety & Nutr, Sch Food Sci & Technol & Synerget Innovat, State Key Lab Food Sci & Technol, Wuxi 214122, Peoples R China; [Xu, Meng; Haeggstrom, Jesper Z.] Uppsala Univ, Biomed Ctr, Uppsala, Sweden; [Ortsater, Henrik] Karolinska Inst, Dept Clin Sci & Educ, Diabet Res Unit, Stockholm, Sweden; [Lundeberg, Erik] Karolinska Inst, Dept Physiol & Pharmacol, Stockholm, Sweden; [Juntti-Berggren, Lisa] Karolinska Inst, Rolf Luft Res Ctr Diabet & Endocrinol, Stockholm, Sweden; [Gudmundsson, Gudmundur H.] Univ Iceland, Biomed Ctr, Reykjavik, Iceland; [Diana, Julien] CNRS, INSERM, Inst Necker Enfants Malades, Paris, France; [Diana, Julien] Univ Paris 05, Sorbonne Paris Cite, Paris, France; [Agerberth, Birgitta] Karolinska Univ Hosp Huddinge, Div Clin Microbiol, Dept Lab Med, Stockholm, Sweden	Jiangnan University; Uppsala University; Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; University of Iceland; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Karolinska Institutet; Karolinska University Hospital	Sun, J (corresponding author), Jiangnan Univ, Ctr Food Safety & Nutr, Sch Food Sci & Technol & Synerget Innovat, State Key Lab Food Sci & Technol, Wuxi 214122, Peoples R China.	jiasun@jiangnan.edu.cn	Chen, Yong Q/AAI-9864-2021; DIANA, Julien/A-2873-2014; Gudmundsson, Gudmundur H/K-9178-2015	Chen, Yong Q/0000-0003-4747-4708; DIANA, Julien/0000-0001-7542-042X; Gudmundsson, Gudmundur H/0000-0001-5793-0565	Rolf Luft Fellowship; National Natural Science Foundation of China [31400779, 31570915]; National Natural Science Foundation of China (National Youth 1000 Talents Plan); Provincial Natural Science Foundation of Jiangsu [BK20130133]; Jiangsu Provincial Shuang Chuang Innovator Plan; Icelandic Centre for Research; Juvenile Diabetes Research Foundation-Helmsley [47-2013-524, 2-SRA-2015-73]; European Foundation for the Study of Diabetes-Lilly; Swedish Research Council [20854, 10350, K2014-67X-11217-20-3]; Swedish Strategic Foundation [RBd08-0014]	Rolf Luft Fellowship; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of China (National Youth 1000 Talents Plan); Provincial Natural Science Foundation of Jiangsu(Natural Science Foundation of Jiangsu Province); Jiangsu Provincial Shuang Chuang Innovator Plan; Icelandic Centre for Research; Juvenile Diabetes Research Foundation-Helmsley; European Foundation for the Study of Diabetes-Lilly(Eli Lilly); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Strategic Foundation	J.S., M.X., and J.D. performed experiments and analyzed the data, with assistance from H.O., E.L., and L.J.-B., on rat and mouse islet isolation and insulin secretion studies. Y.Q.C., J.Z.H., G.H.G., and B.A. provided intellectual input and contributed to data acquisition. J.S., J.D., and B.A. designed and interpreted the experiments. J.S. and H.O. wrote the paper. The authors thank Dr. Kerstin Brismar (Karolinska Institutet, Karolinska University Hospital) for support with the Rolf Luft Fellowship, Dr. Christopher B. Newgard (Duke University, Durham, NC, USA) for kindly providing the INS-1 832/13 insulinoma clone, Dr. Malin Flodstrom-Tullberg (Karolinska Institutet, Karolinska University Hospital) for critical discussion on the insulin secretion experiment and assistance with obtaining the INS-1 832/13 insulinoma clone, Drs. Lennart Lindbom and Harvest F. Gu (Karolinska Institutet) for critical discussion on the implications of the peptides in diabetes prevention, and Liselotte Fransson (Sodersjukhuset, Stockholm, Sweden) and Chengfei Wu and Kang Chen (Jiangnan University) for assistance with islet preparation and 3-dimensional live-cell imaging experiments. This work was supported by funds from the National Natural Science Foundation of China (31400779, 31570915, and National Youth 1000 Talents Plan) and Provincial Natural Science Foundation of Jiangsu (BK20130133), Jiangsu Provincial Shuang Chuang Innovator Plan (to J.S.); Icelandic Centre for Research (to G.H.G.); Juvenile Diabetes Research Foundation-Helmsley (47-2013-524 and 2-SRA-2015-73) and European Foundation for the Study of Diabetes-Lilly (to J.D.); and Swedish Research Council (20854, Linneus grant CERIC, 10350, K2014-67X-11217-20-3) and Swedish Strategic Foundation (RBd08-0014 to B.A.). The authors declare no conflicts of interest.	Atkinson MA, 2011, DIABETES, V60, P1370, DOI 10.2337/db10-1797; Bals R, 1998, P NATL ACAD SCI USA, V95, P9541, DOI 10.1073/pnas.95.16.9541; Barlow PG, 2006, J LEUKOCYTE BIOL, V80, P509, DOI 10.1189/jlb.1005560; Brauner H., 2014, CLIN EXP IMMUNOL, V177, P478; Carretero M, 2008, J INVEST DERMATOL, V128, P223, DOI 10.1038/sj.jid.5701043; Colli ML, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002267; de Goffau MC, 2013, DIABETES, V62, P1238, DOI 10.2337/db12-0526; Gallo RL, 2012, NAT REV IMMUNOL, V12, P503, DOI 10.1038/nri3228; Gallo RL, 1997, J BIOL CHEM, V272, P13088, DOI 10.1074/jbc.272.20.13088; Hakonen E, 2011, DIABETOLOGIA, V54, P1735, DOI 10.1007/s00125-011-2153-1; Hakonen E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093651; Hober D, 2013, CURR OPIN INFECT DIS, V26, P263, DOI 10.1097/QCO.0b013e3283608300; Kai-Larsen Y, 2008, FRONT BIOSCI, V13, P3760, DOI 10.2741/2964; Kida Y, 2006, MOL IMMUNOL, V43, P1972, DOI 10.1016/j.molimm.2005.11.014; Korkmaz B, 2010, PHARMACOL REV, V62, P726, DOI 10.1124/pr.110.002733; Mansour SC, 2014, TRENDS IMMUNOL, V35, P443, DOI 10.1016/j.it.2014.07.004; Nagaoka I, 2006, J IMMUNOL, V176, P3044, DOI 10.4049/jimmunol.176.5.3044; Parazzoli S, 2012, J BIOL CHEM, V287, P32246, DOI 10.1074/jbc.M112.364612; Persaud SJ, 2004, DIABETES, V53, pS190, DOI 10.2337/diabetes.53.2007.S190; Pestonjamasp VK, 2001, PEPTIDES, V22, P1643, DOI 10.1016/S0196-9781(01)00499-5; Piper K, 2004, J ENDOCRINOL, V181, P11, DOI 10.1677/joe.0.1810011; Rutter Guy A., 2001, Molecular Aspects of Medicine, V22, P247, DOI 10.1016/S0098-2997(01)00013-9; Sarker P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020637; Scarim AL, 2001, AM J PATHOL, V159, P273, DOI 10.1016/S0002-9440(10)61693-8; Schauber J, 2003, GUT, V52, P735, DOI 10.1136/gut.52.5.735; Shaykhiev R, 2005, AM J PHYSIOL-LUNG C, V289, pL842, DOI 10.1152/ajplung.00286.2004; Shimada S, 2002, INT J MOL MED, V10, P599; Steinmann J, 2009, ANTIMICROB AGENTS CH, V53, P5127, DOI 10.1128/AAC.00818-09; Sun J, 2013, ALLERGY, V68, P304, DOI 10.1111/all.12087; Sun J, 2015, IMMUNITY, V43, P304, DOI 10.1016/j.immuni.2015.07.013; Termen S, 2003, CELL MOL LIFE SCI, V60, P536, DOI 10.1007/s000180300045; Termen S, 2008, MOL IMMUNOL, V45, P3947, DOI 10.1016/j.molimm.2008.06.020; Vetere A, 2014, NAT REV DRUG DISCOV, V13, P278, DOI 10.1038/nrd4231; Weir GC, 2004, DIABETES, V53, pS16, DOI 10.2337/diabetes.53.suppl_3.S16; Yang F, 2004, J BIOL CHEM, V279, P35403, DOI 10.1074/jbc.M404055200; Yang YH, 2006, J PHARMACOL EXP THER, V318, P547, DOI 10.1124/jpet.106.102467; Yu M, 2011, CYTOKINE GROWTH F R, V22, P63, DOI 10.1016/j.cytogfr.2011.02.001; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a; Zheng X, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.66	39	16	16	0	18	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2016	30	2					884	894		10.1096/fj.15-275826	http://dx.doi.org/10.1096/fj.15-275826			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DC7IA	26527065				2022-12-26	WOS:000369391900036
J	Muthusamy, S; Hong, KU; Dassanayaka, S; Hamid, T; Jones, SP				Muthusamy, Senthilkumar; Hong, Kyung U.; Dassanayaka, Sujith; Hamid, Tariq; Jones, Steven P.			E2F1 Transcription Factor Regulates O-linked N-acetylglucosamine (O-GlcNAc) Transferase and O-GlcNAcase Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CYCLE CONTROL; NUTRIENT REGULATION; FAILING HEART; BINDING-SITES; GENE; GLCNACYLATION; FAMILY; METABOLISM; PROTEINS; PROMOTER	Protein O-GlcNAcylation, which is controlled by O-GlcNAc transferase (OGT) and O-GlcNAcase (OGA), has emerged as an important posttranslational modification that may factor in multiple diseases. Until recently, it was assumed that OGT/OGAprotein expression was relatively constant. Several groups, including ours, have shown that OGT and/or OGA expression changes in several pathologic contexts, yet the cis and trans elements that regulate the expression of these enzymes remain essentially unexplored. Here, we used a reporter-based assay to analyze minimal promoters and leveraged in silico modeling to nominate several candidate transcription factor binding sites in both Ogt (i.e. the gene for OGT protein) and Mgea5 (i.e. the gene for OGA protein). We noted multiple E2F binding site consensus sequences in both promoters. We performed chromatin immunoprecipitation in both human and mouse cells and found that E2F1 bound to candidate E2F binding sites in both promoters. In HEK293 cells, we overexpressed E2F1, which significantly reduced OGT and MGEA5 expression. Conversely, E2F1-deficient mouse fibroblasts had increased Ogt and Mgea5 expression. Of the known binding partners for E2F1, we queried whether retinoblastoma 1 (Rb1) might be involved. Rb1-deficient mouse embryonic fibroblasts showed increased levels of Ogt and Mgea5 expression, yet overexpression of E2F1 in the Rb1-deficient cells did not alter Ogt and Mgea5 expression, suggesting that Rb1 is required for E2F1-mediated suppression. In conclusion, this work identifies and validates some of the promoter elements for mouse Ogt and Mgea5 genes. Specifically, E2F1 negatively regulates both Ogt and Mgea5 expression in an Rb1 protein-dependent manner.	Univ Louisville, Inst Mol Cardiol, Louisville, KY 40202 USA; Univ Louisville, Diabet & Obes Ctr, Louisville, KY 40202 USA	University of Louisville; University of Louisville	Jones, SP (corresponding author), 580 S Preston St,Delia Baxter Bldg 321F, Louisville, KY 40202 USA.	Steven.P.Jones@Louisville.edu	Muthusamy, Senthilkumar/Y-1353-2018; Hong, Kyung Uk/G-7145-2011; Muthusamy, Senthilkumar/G-7875-2015; Jones, Steven P./D-5092-2009; Regan, Clinton/E-6250-2012	Hong, Kyung Uk/0000-0001-6700-9470; Muthusamy, Senthilkumar/0000-0003-1603-9965; Jones, Steven P./0000-0001-5376-8089; Hamid, Tariq/0000-0002-4588-3754	National Institutes of Health [R01 HL083320, R01 HL094419, P20 GM103492, P01 HL078825]; American Heart Association (Great Rivers Affiliate) Predoctoral Fellowship [14PRE19710015]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL083320, R01HL094419, P01HL078825] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103492] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association (Great Rivers Affiliate) Predoctoral Fellowship(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants R01 HL083320, R01 HL094419, P20 GM103492, and P01 HL078825 (to S. P. J.) and American Heart Association (Great Rivers Affiliate) Predoctoral Fellowship 14PRE19710015 (to S. D.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Attwooll C, 2004, EMBO J, V23, P4709, DOI 10.1038/sj.emboj.7600481; Blanchet E, 2011, NAT CELL BIOL, V13, P1146, DOI 10.1038/ncb2309; Carninci P, 2006, NAT GENET, V38, P626, DOI 10.1038/ng1789; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; Cobrinik D, 2005, ONCOGENE, V24, P2796, DOI 10.1038/sj.onc.1208619; Crowe DL, 2001, NUCLEIC ACIDS RES, V29, P2789, DOI 10.1093/nar/29.13.2789; Croxton R, 2002, ONCOGENE, V21, P1359, DOI 10.1038/sj.onc.1205157; Du W, 2006, ONCOGENE, V25, P5190, DOI 10.1038/sj.onc.1209651; Facundo HT, 2012, AM J PHYSIOL-HEART C, V302, pH2122, DOI 10.1152/ajpheart.00775.2011; Fajas L, 2002, DEV CELL, V3, P39, DOI 10.1016/S1534-5807(02)00190-9; Foerster S, 2014, BBA-MOL BASIS DIS, V1842, P1333, DOI 10.1016/j.bbadis.2014.05.014; Guo RF, 2010, J BIOL CHEM, V285, P19308, DOI 10.1074/jbc.M110.121939; Hardiville S, 2014, CELL METAB, V20, P208, DOI 10.1016/j.cmet.2014.07.014; Hart GW, 2014, J BIOL CHEM, V289, P34422, DOI 10.1074/jbc.R114.609776; Hu P, 2010, FEBS LETT, V584, P2526, DOI 10.1016/j.febslet.2010.04.044; Kong LJ, 2007, ONCOGENE, V26, P321, DOI 10.1038/sj.onc.1209817; Lu Z, 2006, ONCOGENE, V25, P230, DOI 10.1038/sj.onc.1209025; Lukas J, 1996, MOL CELL BIOL, V16, P1047; Ma ZY, 2014, J BIOL CHEM, V289, P34457, DOI 10.1074/jbc.R114.577718; Muthusamy S, 2014, J BIOL CHEM, V289, P29665, DOI 10.1074/jbc.M114.578682; Ouseph MM, 2012, DEV CELL, V22, P849, DOI 10.1016/j.devcel.2012.01.013; Park K, 2010, DIABETES, V59, P1845, DOI 10.2337/db09-1086; Perez-Cervera Y, 2013, FASEB J, V27, P3478, DOI 10.1096/fj.12-217984; Rabinovich A, 2008, GENOME RES, V18, P1763, DOI 10.1101/gr.080622.108; Shafi R, 2000, P NATL ACAD SCI USA, V97, P5735, DOI 10.1073/pnas.100471497; Slawson C, 2010, TRENDS BIOCHEM SCI, V35, P547, DOI 10.1016/j.tibs.2010.04.005; Srikanth B, 2010, J BIOL CHEM, V285, P34062, DOI 10.1074/jbc.M109.098996; Stevaux O, 2002, CURR OPIN CELL BIOL, V14, P684, DOI 10.1016/S0955-0674(02)00388-5; Stevens C, 2003, ARCH BIOCHEM BIOPHYS, V412, P157, DOI 10.1016/S0003-9861(03)00054-7; Taylor RP, 2008, J BIOL CHEM, V283, P6050, DOI 10.1074/jbc.M707328200; Valdez CD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025187; Watson LJ, 2010, P NATL ACAD SCI USA, V107, P17797, DOI 10.1073/pnas.1001907107; Wells L, 2011, AMINO ACIDS, V40, P877, DOI 10.1007/s00726-010-0709-x; Wingender E, 2000, NUCLEIC ACIDS RES, V28, P316, DOI 10.1093/nar/28.1.316; Wu ZL, 2009, INT J BIOCHEM CELL B, V41, P2389, DOI 10.1016/j.biocel.2009.06.004; Yang YR, 2012, AGING CELL, V11, P439, DOI 10.1111/j.1474-9726.2012.00801.x; Yuzwa SA, 2014, CHEM SOC REV, V43, P6839, DOI 10.1039/c4cs00038b; Zachara NE, 2006, BBA-MOL CELL BIOL L, V1761, P599, DOI 10.1016/j.bbalip.2006.04.007; Zafir A, 2013, STEM CELLS, V31, P765, DOI 10.1002/stem.1325; Zhang Z, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00206	40	23	23	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 25	2015	290	52					31013	31024		10.1074/jbc.M115.677534	http://dx.doi.org/10.1074/jbc.M115.677534			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CZ6GK	26527687	hybrid, Green Published			2022-12-26	WOS:000367199000031
J	Nagaoka, A; Yoshida, H; Nakamura, S; Morikawa, T; Kawabata, K; Kobayashi, M; Sakai, S; Takahashi, Y; Okada, Y; Inoue, S				Nagaoka, Aya; Yoshida, Hiroyuki; Nakamura, Sachiko; Morikawa, Tomohiko; Kawabata, Keigo; Kobayashi, Masaki; Sakai, Shingo; Takahashi, Yoshito; Okada, Yasunori; Inoue, Shintaro			Regulation of Hyaluronan (HA) Metabolism Mediated by HYBID (Hyaluronan-binding Protein Involved in HA Depolymerization, KIAA1199) and HA Synthases in Growth Factor-stimulated Fibroblasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN DERMAL FIBROBLASTS; BETA TGF-BETA; RHEUMATOID-ARTHRITIS; CELL-MIGRATION; MOUSE SKIN; EXPRESSION; CD44; ANGIOGENESIS; IL-1-BETA; CYTOKINES	Regulation of hyaluronan (HA) synthesis and degradation is essential to maintenance of extracellular matrix homeostasis. We recently reported that HYBID (HYaluronan-Binding protein Involved in hyaluronan Depolymerization), also called KIAA1199, plays a key role in HA depolymerization in skin and arthritic synovial fibroblasts. However, regulation of HA metabolism mediated by HYBID and HA synthases (HASs) under stimulation with growth factors remains obscure. Here we report that TGF-beta 1, basic FGF, EGF, and PDGF-BB commonly enhance total amount of HA in skin fibroblasts through up-regulation of HAS expression, but molecular size of newly producedHAis dependent on HYBID expression levels. Stimulation of HAS1/2 expression and suppression of HYBID expression by TGF-beta 1 were abrogated by blockade of the MAPK and/or Smad signaling and the PI3K-Akt signaling, respectively. In normal human skin, expression of the TGF-beta 1 receptors correlated positively with HAS2 expression and inversely with HYBID expression. On the other hand, TGF-beta 1 upregulated HAS1/2 expression but exerted only a slight suppressive effect on HYBID expression in synovial fibroblasts from the patients with osteoarthritis or rheumatoid arthritis, resultinginthe production of lower molecular weight HA compared with normal skin and synovial fibroblasts. These data demonstrate that although TGF-beta 1, basic FGF, EGF, and PDGF-BB enhance HA production in skin fibroblasts, TGF-beta 1 most efficiently contributes to production of high molecular weight HA by HAS up-regulation and HYBID down-regulation and suggests that inefficient downregulation of HYBID by TGF-beta 1 in arthritic synovial fibroblasts may be linked to accumulation of depolymerized HA in synovial fluids in arthritis patients.	[Nagaoka, Aya; Yoshida, Hiroyuki; Nakamura, Sachiko; Morikawa, Tomohiko; Kawabata, Keigo; Kobayashi, Masaki; Takahashi, Yoshito] Kao Corp, Biol Sci Res, Odawara, Kanagawa 2500002, Japan; [Sakai, Shingo] Kao Corp, Hlth Beauty Prod Res, Odawara, Kanagawa 2500002, Japan; [Okada, Yasunori] Keio Univ, Sch Med, Dept Pathol, Shinjuku Ku, Tokyo 1600016, Japan; [Inoue, Shintaro] Kanebo Cosmet Inc, Chuo Ku, Tokyo 1038210, Japan	KAO Corporation; KAO Corporation; Keio University; Kanebo Cosmetics Inc.	Yoshida, H (corresponding author), Kao Corp, Biol Sci Res, 3-28,5 Chome,Kotobuki Cho, Odawara, Kanagawa 2500002, Japan.	yoshida.hiroyuki2@kao.co.jp; okada@z6.keio.jp	Inoue, Shintaro/AAR-6767-2021; Okada, Yasunori/B-5550-2014	Inoue, Shintaro/0000-0002-4996-5693; Okada, Yasunori/0000-0001-9208-4755				Barrientos S, 2008, WOUND REPAIR REGEN, V16, P585, DOI 10.1111/j.1524-475X.2008.00410.x; Bourguignon LYW, 2014, AM J PATHOL, V184, P1912, DOI 10.1016/j.ajpath.2014.03.010; Bourguignon LYW, 2013, J DERMATOL SCI, V72, P32, DOI 10.1016/j.jdermsci.2013.05.003; Chen L, 2012, MATRIX BIOL, V31, P373, DOI 10.1016/j.matbio.2012.10.002; Ellis I, 1997, DEVELOPMENT, V124, P1593; Frenkel JS, 2014, INT WOUND J, V11, P159, DOI 10.1111/j.1742-481X.2012.01057.x; GHOSH P, 1994, CLIN EXP RHEUMATOL, V12, P75; Greaves NS, 2013, J DERMATOL SCI, V72, P206, DOI 10.1016/j.jdermsci.2013.07.008; Hattori N, 2009, AM J PATHOL, V175, P533, DOI 10.2353/ajpath.2009.081080; Itano N, 2002, IUBMB LIFE, V54, P195, DOI 10.1080/15216540214929; Karouzakis E, 2009, ARTHRITIS RHEUM-US, V60, P3613, DOI 10.1002/art.25018; Kawakami T, 1998, J INVEST DERMATOL, V110, P47, DOI 10.1046/j.1523-1747.1998.00073.x; Kuscu C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044661; LAURENT TC, 1992, FASEB J, V6, P2397, DOI 10.1096/fasebj.6.7.1563592; Li LL, 2007, BIOCHEM J, V404, P327, DOI 10.1042/BJ20061757; Noble PW, 2002, MATRIX BIOL, V21, P25, DOI 10.1016/S0945-053X(01)00184-6; Oguchi T, 2004, CONNECT TISSUE RES, V45, P197, DOI 10.1080/03008200490523031; Pandey MS, 2008, J BIOL CHEM, V283, P21453, DOI 10.1074/jbc.M800886200; Polytarchou Kali, 2015, Cardiovascular & Hematological Agents in Medicinal Chemistry, V13, P31; Rojas A, 2009, BBA-MOL CELL RES, V1793, P1165, DOI 10.1016/j.bbamcr.2009.02.001; Shen W, 2006, J AM SOC NEPHROL, V17, P2414, DOI 10.1681/ASN.2005111157; Stern R, 2006, EUR J CELL BIOL, V85, P699, DOI 10.1016/j.ejcb.2006.05.009; Stuhlmeier KM, 2004, J BIOL CHEM, V279, P8753, DOI 10.1074/jbc.M303945200; Sugahara KN, 2003, J BIOL CHEM, V278, P32259, DOI 10.1074/jbc.M300347200; Sugiyama Y, 1998, J INVEST DERMATOL, V110, P116, DOI 10.1046/j.1523-1747.1998.00093.x; Tanimoto K, 2004, J DENT RES, V83, P40, DOI 10.1177/154405910408300108; Torronen K, 2014, HISTOCHEM CELL BIOL, V141, P17, DOI 10.1007/s00418-013-1143-4; VARGA J, 1987, BIOCHEM J, V247, P597, DOI 10.1042/bj2470597; VUORIO E, 1982, RHEUMATOL INT, V2, P97, DOI 10.1007/BF00541160; Yamada Y, 2004, J INVEST DERMATOL, V122, P631, DOI 10.1111/j.0022-202X.2004.22332.x; Yoshida H, 2014, FEBS LETT, V588, P111, DOI 10.1016/j.febslet.2013.11.017; Yoshida H, 2013, FEBS OPEN BIO, V3, P352, DOI 10.1016/j.fob.2013.08.003; Yoshida H, 2013, P NATL ACAD SCI USA, V110, P5612, DOI 10.1073/pnas.1215432110; Yoshida M, 2004, ARTHRITIS RES THER, V6, pR514, DOI 10.1186/ar1223	34	60	60	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 25	2015	290	52					30910	30923		10.1074/jbc.M115.673566	http://dx.doi.org/10.1074/jbc.M115.673566			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CZ6GK	26518873	Green Published, hybrid			2022-12-26	WOS:000367199000023
J	Joseph, MA; Fraize, N; Ansoud-Lerouge, J; Sapin, E; Peyron, C; Arthaud, S; Libourel, PA; Parmentier, R; Salin, PA; Malleret, G				Joseph, Mickael Antoine; Fraize, Nicolas; Ansoud-Lerouge, Jennifer; Sapin, Emilie; Peyron, Christelle; Arthaud, Sebastien; Libourel, Paul-Antoine; Parmentier, Regis; Salin, Paul Antoine; Malleret, Gael			Differential Involvement of the Dentate Gyrus in Adaptive Forgetting in the Rat	PLOS ONE			English	Article							SPATIAL WORKING-MEMORY; EARLY GENE ZIF268; LONG-TERM-MEMORY; SYNAPTIC PLASTICITY; PATTERN SEPARATION; HIPPOCAMPAL NEUROGENESIS; EXPRESSION; BRAIN; REORGANIZATION; TRANSCRIPTION	How does the brain discriminate essential information aimed to be stored permanently from information required only temporarily, and that needs to be cleared away for not saturating our precious memory space? Reference Memory (RM) refers to the long-term storage of invariable information whereas Working Memory (WM) depends on the short-term storage of trial-unique information. Previous work has revealed that WM tasks are very sensitive to proactive interference. In order to prevent such interference, irrelevant old memories must be forgotten to give new ones the opportunity to be stabilized. However, unlike memory, physiological processes underlying this adaptive form of forgetting are still poorly understood. Here, we precisely ask what specific brain structure(s) could be responsible for such process to occur. To answer this question, we trained rats in a radial maze using three paradigms, a RM task and two WM tasks involving or not the processing of interference but strictly identical in terms of locomotion or motivation. We showed that an inhibition of the expression of Zif268 and c-Fos, two indirect markers of neuronal activity and synaptic plasticity, was observed in the dentate gyrus of the dorsal hippocampus when processing such interfering previously stored information. Conversely, we showed that inactivating the dentate gyrus impairs both RM and WM, but improves the processing of interference. Altogether, these results strongly suggest for the first time that the dentate gyrus could be a key structure involved in adaptive forgetting.	[Joseph, Mickael Antoine; Fraize, Nicolas; Ansoud-Lerouge, Jennifer; Sapin, Emilie; Peyron, Christelle; Arthaud, Sebastien; Libourel, Paul-Antoine; Parmentier, Regis; Salin, Paul Antoine; Malleret, Gael] Univ Lyon 1, F-69365 Lyon, France; [Sapin, Emilie; Peyron, Christelle; Arthaud, Sebastien; Libourel, Paul-Antoine; Parmentier, Regis; Salin, Paul Antoine; Malleret, Gael] CNRS, Unite Mixte Rech 5292, Lyon, France; [Sapin, Emilie; Peyron, Christelle; Arthaud, Sebastien; Libourel, Paul-Antoine; Parmentier, Regis; Salin, Paul Antoine; Malleret, Gael] INSERM, U1028, F-69008 Lyon, France; [Sapin, Emilie; Peyron, Christelle; Arthaud, Sebastien; Libourel, Paul-Antoine; Parmentier, Regis; Salin, Paul Antoine; Malleret, Gael] Lyon Neurosci Res Ctr CRNL, Lyon, France	UDICE-French Research Universities; Universite Claude Bernard Lyon 1; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Jean Monnet; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm)	Malleret, G (corresponding author), Univ Lyon 1, F-69365 Lyon, France.	gaelmalleret@gmail.com	JOSEPH, M A/GYJ-5320-2022; Peyron, Christelle/H-6223-2017; joseph, Mickael/AAY-2966-2021	JOSEPH, M A/0000-0001-8661-0042; Peyron, Christelle/0000-0002-9317-3546; joseph, Mickael/0000-0002-5008-0542; Salin, Paul/0000-0001-5221-9109; Libourel, Paul-Antoine/0000-0001-6726-5829; Arthaud, Sebastien/0000-0001-7271-5468	CNRS (ATIP program); Fondation pour la recherche sur le cerveau (FRC); Region Rhone-Alpes (CIBLE program); Fondation pour la recherche medicale [FRM-FDT20130928087]; Region Rhone-Alpes (ARC2 doctoral fellowship)	CNRS (ATIP program); Fondation pour la recherche sur le cerveau (FRC); Region Rhone-Alpes (CIBLE program)(Region Auvergne-Rhone-Alpes); Fondation pour la recherche medicale(Fondation pour la Recherche Medicale); Region Rhone-Alpes (ARC2 doctoral fellowship)(Region Auvergne-Rhone-Alpes)	This work was supported by grants from CNRS (ATIP program), Fondation pour la recherche sur le cerveau (FRC), and Region Rhone-Alpes (CIBLE program). M.A.J and N.F. were also supported by Fondation pour la recherche medicale (FRM-FDT20130928087) and Region Rhone-Alpes (ARC2 doctoral fellowship). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aimone JB, 2011, NEURON, V70, P589, DOI 10.1016/j.neuron.2011.05.010; Akers KG, 2014, SCIENCE, V344, P598, DOI 10.1126/science.1248903; BADDELEY A, 1981, COGNITION, V10, P17, DOI 10.1016/0010-0277(81)90020-2; Bohbot V, 1996, P NATL ACAD SCI USA, V93, P4016, DOI 10.1073/pnas.93.9.4016; Bontempi B, 1999, NATURE, V400, P671, DOI 10.1038/23270; Bozon B, 2002, HIPPOCAMPUS, V12, P570, DOI 10.1002/hipo.10100; Cabeza R, 2002, NEUROIMAGE, V16, P317, DOI 10.1006/nimg.2002.1063; Chen C, 1997, ANNU REV NEUROSCI, V20, P157, DOI 10.1146/annurev.neuro.20.1.157; Colgin LL, 2008, TRENDS NEUROSCI, V31, P469, DOI 10.1016/j.tins.2008.06.008; D'Esposito M, 2007, PHILOS T R SOC B, V362, P761, DOI 10.1098/rstb.2007.2086; Davis S, 2003, BEHAV BRAIN RES, V142, P17, DOI 10.1016/S0166-4328(02)00421-7; Della Sala S., 2009, FORGETTING FORGETTIN; Dolan RJ, 1997, NATURE, V388, P582, DOI 10.1038/41561; Dudchenko PA, 2004, NEUROSCI BIOBEHAV R, V28, P699, DOI 10.1016/j.neubiorev.2004.09.002; ELLEN P, 1968, PHYSIOL BEHAV, V3, P857, DOI 10.1016/0031-9384(68)90167-4; Herdegen T, 1998, BRAIN RES REV, V28, P370, DOI 10.1016/S0165-0173(98)00018-6; Izquierdo I., 2015, ART FORGETTING; Jones MW, 2001, NAT NEUROSCI, V4, P289, DOI 10.1038/85138; Kaczmarek L, 1997, BRAIN RES REV, V23, P237, DOI 10.1016/S0165-0173(97)00005-2; Kandel ER, 2001, SCIENCE, V294, P1030, DOI 10.1126/science.1067020; Kraemer PJ, 1997, PSYCHON B REV, V4, P480, DOI 10.3758/BF03214337; Kubik S, 2007, LEARN MEMORY, V14, P758, DOI 10.1101/lm.698107; Levy BJ, 2009, FUNCTIONNAL NEUROIMA, P135; MacLeod CM, 1999, PSYCHON B REV, V6, P123, DOI 10.3758/BF03210819; Malleret G, 2010, J NEUROSCI, V30, P3813, DOI 10.1523/JNEUROSCI.1330-09.2010; Maviel T, 2004, SCIENCE, V305, P96, DOI 10.1126/science.1098180; Nicholls RE, 2008, NEURON, V58, P104, DOI 10.1016/j.neuron.2008.01.039; OLTON DS, 1979, NEUROPSYCHOLOGIA, V17, P669, DOI 10.1016/0028-3932(79)90042-3; Paxinos G., 1996, RAT BRAIN STEREOTAXI; Poirier GL, 2008, J NEUROSCI, V28, P1034, DOI 10.1523/JNEUROSCI.4607-07.2008; Postle BR, 2006, NEUROSCIENCE, V139, P23, DOI 10.1016/j.neuroscience.2005.06.005; Ranganath C, 2005, TRENDS COGN SCI, V9, P374, DOI 10.1016/j.tics.2005.06.009; Rauchs G, 2011, J NEUROSCI, V31, P2563, DOI 10.1523/JNEUROSCI.3972-10.2011; ROBERTS WA, 1981, LEARN MOTIV, V12, P261, DOI 10.1016/0023-9690(81)90009-6; Rosenzweig ES, 2002, NAT NEUROSCI, V5, P6, DOI 10.1038/nn0102-6; Sahay A, 2011, NEURON, V70, P582, DOI 10.1016/j.neuron.2011.05.012; Saxe MD, 2007, P NATL ACAD SCI USA, V104, P4642, DOI 10.1073/pnas.0611718104; Schmidt B, 2012, BEHAV BRAIN RES, V226, P56, DOI 10.1016/j.bbr.2011.08.039; Vago DR, 2008, BEHAV BRAIN RES, V189, P273, DOI 10.1016/j.bbr.2008.01.002; WHISHAW IQ, 1995, PHYSIOL BEHAV, V58, P687, DOI 10.1016/0031-9384(95)00110-5; Wimber M, 2015, NAT NEUROSCI, V18, P582, DOI 10.1038/nn.3973; Yoon T, 2008, LEARN MEMORY, V15, P97, DOI 10.1101/lm.850808; [No title captured]	43	3	3	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2015	10	11							e0142065	10.1371/journal.pone.0142065	http://dx.doi.org/10.1371/journal.pone.0142065			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV1QH	26528714	gold, Green Published, Green Submitted			2022-12-26	WOS:000364032600096
J	Kibira, SPS; Muhumuza, C; Bukenya, JN; Atuyambe, LM				Kibira, Simon P. S.; Muhumuza, Christine; Bukenya, Justine N.; Atuyambe, Lynn M.			"I Spent a Full Month Bleeding, I Thought I Was Going to Die..." A Qualitative Study of Experiences of Women Using Modern Contraception in Wakiso District, Uganda	PLOS ONE			English	Article							HEALTH-SERVICES; PERCEPTIONS; BARRIERS; DISCONTINUATION; PLEASURE; REGION; USERS; MEN	Introduction There is high unmet need for family planning (FP) in Uganda as well as high contraceptive discontinuation rates. These contribute to the high fertility rates that in part are due to unplanned pregnancies. There are gaps in knowledge about experiences that couples go through while using contraceptives in their lives. This study explored women's experiences during the course of their contraceptive use. Methods We conducted a qualitative study involving 30 women who had used modern contraception for at least one year in Wakiso district, central Uganda. We used in-depth interviews to obtain their personal accounts. Index women were approached through health officers at four health centres in the district. All ethical approvals and informed consent were obtained. We used conventional content analysis; identifying codes through open coding, on which basis categories were developed and grouped into overarching themes. Results Women's accounts were summarised in the following themes: negative experiences with modern contraceptive use, motivation to continue using FP in spite of these negative experiences, the role of influential people, and discontinuation of use. Negative accounts dominated the experiences of most women but they expressed strong desire to continue using modern contraception even amidst all challenges. Health workers emerged as the most influential people that played a vital role in women's decisions. Conclusion Varied negative experiences with modern contraception and misperceptions exist amidst a determination to continue use. Partner engagement, health service strengthening to improve side effects management and health worker skills, and engaging older women that have successfully used contraception as community champions, are potential strategies to support women's contraceptive decisions.	[Kibira, Simon P. S.; Bukenya, Justine N.; Atuyambe, Lynn M.] Makerere Univ, Coll Hlth Sci, Sch Publ Hlth, Dept Community Hlth & Behav Sci, Kampala, Uganda; [Kibira, Simon P. S.] Univ Bergen, Fac Med & Dent, Ctr Int Hlth, Dept Global Publ Hlth & Primary Care, Bergen, Norway; [Muhumuza, Christine] Makerere Univ, Coll Hlth Sci, Sch Publ Hlth, Dept Epidemiol & Biostat, Kampala, Uganda	Makerere University; University of Bergen; Makerere University	Kibira, SPS (corresponding author), Makerere Univ, Coll Hlth Sci, Sch Publ Hlth, Dept Community Hlth & Behav Sci, Kampala, Uganda.	pskibira@gmail.com		Kibira, Simon Peter Sebina/0000-0002-7385-423X	Family Health Research and Development Centre at Makerere University School of Public Health; The Bill and Melinda Gates Institute for Population and Reproductive Health at the Johns Hopkins Bloomberg School of Public Health, USA	Family Health Research and Development Centre at Makerere University School of Public Health; The Bill and Melinda Gates Institute for Population and Reproductive Health at the Johns Hopkins Bloomberg School of Public Health, USA	The funds for data collection for this study were provided by the Family Health Research and Development Centre at Makerere University School of Public Health, and The Bill and Melinda Gates Institute for Population and Reproductive Health at the Johns Hopkins Bloomberg School of Public Health, USA. SPSK received the faculty grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayiasi MR, 2015, THE PAN AFRICAN MEDI, V21; Babigumira JB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030735; Barden-O'Fallon J, 2009, HEALTH CARE WOMEN IN, V30, P475, DOI 10.1080/07399330902801187; Campbell M, 2006, STUD FAMILY PLANN, V37, P87, DOI 10.1111/j.1728-4465.2006.00088.x; Cleary S, 2013, SOC SCI MED, V80, P37, DOI 10.1016/j.socscimed.2012.11.035; Davis AR, 2004, ANN REV SEX RES, V15, P297; Eskindir L, 2003, ETHIOP J HEALTH DEV, V18, P8; Guest G, 2006, FIELD METHOD, V18, P59, DOI 10.1177/1525822X05279903; Hardon A, 1997, M WOM MENS PERSP FER; Higgins JA, 2008, SEX HEALTH, V5, P321, DOI 10.1071/SH08021; Higgins JA, 2008, AM J PUBLIC HEALTH, V98, P1803, DOI 10.2105/AJPH.2007.115790; Hsieh HF, 2005, QUAL HEALTH RES, V15, P1277, DOI 10.1177/1049732305276687; Kabagenyi A, 2014, REPROD HEALTH, V11, DOI 10.1186/1742-4755-11-21; Kasedde S., 2000, LONG TERM AND PERMAN; Khan MA, 2003, HEALTH POLICY PLANN, V18, P101, DOI 10.1093/heapol/18.1.101; Lopez LM, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001863.pub2; Machado JC, 2014, REV PANAM SALUD PUBL, V36, P134; Morse JE, 2014, INT J GYNECOL OBSTET, V124, P30, DOI 10.1016/j.ijgo.2013.07.014; Mosha I, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-523; Mota K, 2015, BMC WOMENS HEALTH, V15, DOI 10.1186/s12905-015-0209-y; Mugisha JF, 2008, J FAM PLAN REPROD H, V34, P37, DOI 10.1783/147118908783332230; Nalwadda G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027908; Nalwadda G, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-220; Ochako R, 2015, BMC PUBLIC HEALTH, V15, P1483; Population Reference Bureau, 2013, WORLD POPULATION DAT; Rahnama P, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-779; Reuter S, 2003, EUR J CONTRACEP REPR, V8, P27; Schaffir J, 2006, J SEX MARITAL THER, V32, P305, DOI 10.1080/00926230600666311; Sedgh G, 2007, OCCASIONAL REPORT; Shattuck D, 2011, AM J PUBLIC HEALTH, V101, P1089, DOI 10.2105/AJPH.2010.300091; Smit J, 2002, SOC SCI MED, V55, P1511, DOI 10.1016/S0277-9536(01)00284-2; Tolley E, 2005, INT FAM PLAN PERSPEC, V31, P15, DOI 10.1363/3101505; Uganda Bureau of Statistics, 2007, PROJECTIONS OF DEMOG; Uganda Bureau of Statistics (UBOS) and Macro International Inc, 2007, UGANDA DEMOGRAPHIC A; Uganda Bureau of Statistics (UBOS) & ICF International Inc, 2012, UGANDA DEMOGRAPHIC A; United Nations, 1995, INTERNATIONAL CONFER; United Nations, 2012, WORKING PAPER 2013; Wanyenze RK, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-98; Williamson Lisa M, 2009, Reprod Health, V6, P3, DOI 10.1186/1742-4755-6-3; World Health Organization Department of Reproductive Health and Research (WHO/RHR) and Johns Hopkins Bloomberg School of Public Health/Center for Communication Programs (CCP) Knowledge for Health Project, 2011, FAMILY PLANNING A GL	40	16	16	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2015	10	11							e0141998	10.1371/journal.pone.0141998	http://dx.doi.org/10.1371/journal.pone.0141998			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV1PG	26524603	Green Submitted, Green Published, gold			2022-12-26	WOS:000364029800031
J	Ahmad, M; Asghar, A; Raman, AAA; Daud, WMAW				Ahmad, Mushtaq; Asghar, Anam; Raman, Abdul Aziz Abdul; Daud, Wan Mohd Ashri Wan			Enhancement of Treatment Efficiency of Recalcitrant Wastewater Containing Textile Dyes Using a Newly Developed Iron Zeolite Socony Mobil-5 Heterogeneous Catalyst	PLOS ONE			English	Article							WET PEROXIDE OXIDATION; FENTON OXIDATION; AZO-DYE; PHOTOCATALYTIC DEGRADATION; EXCHANGED ZEOLITE; AQUEOUS-SOLUTION; RHODAMINE 6G; DECOLORIZATION; OPTIMIZATION; EFFLUENT	Fenton oxidation, an advanced oxidation process, is an efficient method for the treatment of recalcitrant wastewaters. Unfortunately, it utilizes H2O2 and iron-based homogeneous catalysts, which lead to the formation of high volumes of sludge and secondary pollutants. To overcome these problems, an alternate option is the usage of heterogeneous catalyst. In this study, a heterogeneous catalyst was developed to provide an alternative solution for homogeneous Fenton oxidation. Iron Zeolite Socony Mobile-5 (Fe-ZSM-5) was synthesized using a new two-step process. Next, the catalyst was characterized by scanning electron microscopy, energy-dispersive X-ray spectroscopy, fourier transform infrared spectroscopy, and Brunauer-Emmett-Teller analysis and tested against a model wastewater containing the azo dye Acid Blue 113. Results showed that the loading of iron particles reduced the surface area of the catalyst from 293.59 to 243.93 m(2)/g; meanwhile, the average particle size of the loaded material was 12.29 nm. Furthermore, efficiency of the developed catalyst was evaluated by performing heterogeneous Fenton oxidation. Taguchi method was coupled with principal component analysis in order to assess and optimize mineralization efficiency. Experimental results showed that under optimized conditions, over 99.7% degradation and 77% mineralization was obtained, with a 90% reduction in the consumption of the developed catalyst. Furthermore, the developed catalyst was stable and reusable, with less than 2% leaching observed under optimized conditions. Thus, the present study proved that newly developed catalyst has enhanced the oxidation process and reduced the chemicals consumption.	[Ahmad, Mushtaq; Asghar, Anam; Raman, Abdul Aziz Abdul; Daud, Wan Mohd Ashri Wan] Univ Malaya, Fac Engn, Dept Chem Engn, Kuala Lumpur 50603, Malaysia	Universiti Malaya	Raman, AAA (corresponding author), Univ Malaya, Fac Engn, Dept Chem Engn, Kuala Lumpur 50603, Malaysia.	azizraman@um.edu.my	DAUD, WAN MOHD ASHRI WAN/C-1022-2010; Asghar, Anam/K-7200-2016; ABDUL RAMAN, ABDUL AZIZ/B-8094-2010	Asghar, Anam/0000-0001-7099-4109; ABDUL RAMAN, ABDUL AZIZ/0000-0001-7586-1903	University of Malaya High Impact Research Grant from the Ministry of Higher Education Malaysia [HIR-MOHE-D000038-16001]; University of Malaya Bright Sparks Unit	University of Malaya High Impact Research Grant from the Ministry of Higher Education Malaysia; University of Malaya Bright Sparks Unit	We are thankful to the University of Malaya High Impact Research Grant (HIR-MOHE-D000038-16001) from the Ministry of Higher Education Malaysia and University of Malaya Bright Sparks Unit which financially supported this work.	Ahmad M, 2014, LOW TEMPERATURE SYNT, P20; Ahmad M, 2015, AUST J BASIC APPL SC, V9, P114; Ahmad M, 2015, POWDER TECHNOL, V280, P42, DOI 10.1016/j.powtec.2015.03.030; Ajeel MA, 2015, ELECTROCHIM ACTA, V153, P379, DOI 10.1016/j.electacta.2014.11.163; Akan J. C., 2009, Australian Journal of Basic and Applied Sciences, V3, P1933; Asghar A, 2014, SCI WORLD J, DOI 10.1155/2014/869120; Banerjee A, 2012, J MATER CHEM, V22, P19694, DOI 10.1039/c2jm33798c; Battiston AA, 2003, J CATAL, V213, P251, DOI 10.1016/S0021-9517(02)00051-9; Bolova E, 2012, INT J CHEM REACT ENG, V10, DOI 10.1515/1542-6580.2852; Chang JH, 2009, SCI TOTAL ENVIRON, V407, P5914, DOI 10.1016/j.scitotenv.2009.07.041; Dantas TLP, 2006, CHEM ENG J, V118, P77, DOI 10.1016/j.cej.2006.01.016; Dong YC, 2010, SCI TOTAL ENVIRON, V408, P2245, DOI 10.1016/j.scitotenv.2010.01.020; Dubey AK, 2008, OPT LASER ENG, V46, P124, DOI 10.1016/j.optlaseng.2007.08.011; Dukkanci M, 2010, J HAZARD MATER, V181, P343, DOI 10.1016/j.jhazmat.2010.05.016; Dukkanci M, 2010, APPL CATAL B-ENVIRON, V95, P270, DOI 10.1016/j.apcatb.2010.01.004; Faryal R, 2005, PAK J BOT, V37, P1003; Gauri SK, 2009, INT J ADV MANUF TECH, V41, P741, DOI 10.1007/s00170-008-1529-y; Gomathi D L, 2009, JOURNAL OF HAZARDOUS, V164, P459, DOI DOI 10.1016/J.JHAZMAT.2008.08.017; Gu F, 2014, MATER DESIGN, V62, P189, DOI 10.1016/j.matdes.2014.05.013; de Souza SMDGU, 2010, J HAZARD MATER, V179, P35, DOI 10.1016/j.jhazmat.2010.02.053; Inoue M, 2006, ULTRASON SONOCHEM, V13, P313, DOI 10.1016/j.ultsonch.2005.05.003; Karthikeyan S, 2012, ENVIRON SCI POLLUT R, V19, P1828, DOI 10.1007/s11356-011-0691-1; Karthikeyan S, 2011, DESALINATION, V281, P438, DOI 10.1016/j.desal.2011.08.019; Kaur J, 2013, PHYSICA B, V416, P33, DOI 10.1016/j.physb.2013.02.005; Kiss E, 2006, REV ROUM CHIM, V51, P931; Korbahti BK, 2008, J HAZARD MATER, V151, P422, DOI 10.1016/j.jhazmat.2007.06.010; Kusic H, 2006, CHEMOSPHERE, V65, P65, DOI 10.1016/j.chemosphere.2006.02.053; Li YM, 2014, CHEMOSPHERE, V105, P24, DOI 10.1016/j.chemosphere.2013.10.043; Liao HC, 2004, COMPUT IND ENG, V46, P817, DOI 10.1016/j.cie.2004.05.012; Lucas MS, 2006, DYES PIGMENTS, V71, P236, DOI 10.1016/j.dyepig.2005.07.007; Matta R, 2007, SCI TOTAL ENVIRON, V385, P242, DOI 10.1016/j.scitotenv.2007.06.030; Meric S, 2003, J ENVIRON SCI HEAL A, V38, P2241, DOI 10.1081/ESE-120023371; Navalon S, 2010, APPL CATAL B-ENVIRON, V99, P1, DOI 10.1016/j.apcatb.2010.07.006; Nazir R, 2012, J THERM ANAL CALORIM, V110, P707, DOI 10.1007/s10973-011-1919-5; Neyens E, 2003, J HAZARD MATER, V98, P33, DOI 10.1016/S0304-3894(02)00282-0; Pirkanniemi K, 2002, CHEMOSPHERE, V48, P1047, DOI 10.1016/S0045-6535(02)00168-6; Prihod'ko R, 2011, APPL CATAL B-ENVIRON, V104, P201, DOI 10.1016/j.apcatb.2011.02.004; Qin X, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113282; Qiu ZM, 2005, CHEM ENG PROCESS, V44, P1013, DOI 10.1016/j.cep.2005.01.004; Queiros S, 2015, SEP PURIF TECHNOL, V141, P235, DOI 10.1016/j.seppur.2014.11.046; Roberts DA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081631; Savin II, 2008, ENVIRON ENG MANAG J, V7, P859, DOI 10.30638/eemj.2008.113; Shu HY, 2010, J HAZARD MATER, V184, P499, DOI 10.1016/j.jhazmat.2010.08.064; Sun JH, 2007, DYES PIGMENTS, V74, P647, DOI 10.1016/j.dyepig.2006.04.006; SZOSTAK R, 1987, J CHEM SOC FARAD T 1, V83, P487, DOI 10.1039/f19878300487; Tantak NP, 2006, J HAZARD MATER, V136, P698, DOI 10.1016/j.jhazmat.2005.12.049; Tekbas M, 2008, MICROPOR MESOPOR MAT, V115, P594, DOI 10.1016/j.micromeso.2008.03.001; Tekin H, 2006, J HAZARD MATER, V136, P258, DOI 10.1016/j.jhazmat.2005.12.012; Turhan K, 2012, DYES PIGMENTS, V92, P897, DOI 10.1016/j.dyepig.2011.07.012; Uslu MO, 2009, SCI TOTAL ENVIRON, V407, P3450, DOI 10.1016/j.scitotenv.2009.01.045; Vinodgopal K, 2003, RES CHEM INTERMEDIAT, V29, P307, DOI 10.1163/156856703764929967; Yaman C, 2015, J ENVIRON HEALTH SCI, V13, DOI 10.1186/s40201-015-0162-6; Yan Y, 2014, SEP PURIF TECHNOL, V133, P365, DOI 10.1016/j.seppur.2014.07.014; Yang SJ, 2011, J HAZARD MATER, V186, P376, DOI 10.1016/j.jhazmat.2010.11.019; Zayani G, 2008, J ENVIRON SCI HEAL A, V43, P202, DOI 10.1080/10934520701781608	55	40	40	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2015	10	10							e0141348	10.1371/journal.pone.0141348	http://dx.doi.org/10.1371/journal.pone.0141348			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0EH	26517827	Green Submitted, Green Published, gold			2022-12-26	WOS:000363920800037
J	Ekins, S; Madrid, PB; Sarker, M; Li, SG; Mittal, N; Kumar, P; Wang, X; Stratton, TP; Zimmerman, M; Talcott, C; Bourbon, P; Travers, M; Yadav, M; Freundlich, JS				Ekins, Sean; Madrid, Peter B.; Sarker, Malabika; Li, Shao-Gang; Mittal, Nisha; Kumar, Pradeep; Wang, Xin; Stratton, Thomas P.; Zimmerman, Matthew; Talcott, Carolyn; Bourbon, Pauline; Travers, Mike; Yadav, Maneesh; Freundlich, Joel S.			Combining Metabolite-Based Pharmacophores with Bayesian Machine Learning Models for Mycobacterium tuberculosis Drug Discovery	PLOS ONE			English	Article							TB MOBILE; GENETIC REQUIREMENTS; DATA SETS; IN-VITRO; INHIBITORS; SURVIVAL; TARGET; MOLECULES; DERIVATIVES; CHEMISTRY	Integrated computational approaches for Mycobacterium tuberculosis (Mtb) are useful to identify new molecules that could lead to future tuberculosis (TB) drugs. Our approach uses information derived from the TBCyc pathway and genome database, the Collaborative Drug Discovery TB database combined with 3D pharmacophores and dual event Bayesian models of whole-cell activity and lack of cytotoxicity. We have prioritized a large number of molecules that may act as mimics of substrates and metabolites in the TB metabolome. We computationally searched over 200,000 commercial molecules using 66 pharmacophores based on substrates and metabolites from Mtb and further filtering with Bayesian models. We ultimately tested 110 compounds in vitro that resulted in two compounds of interest, BAS 04912643 and BAS 00623753 (MIC of 2.5 and 5 mu g/mL, respectively). These molecules were used as a starting point for hit-to-lead optimization. The most promising class proved to be the quinoxaline di-N-oxides, evidenced by transcriptional profiling to induce mRNA level perturbations most closely resembling known protonophores. One of these, SRI58 exhibited an MIC = 1.25 mu g/mL versus Mtb and a CC50 in Vero cells of >40 mu g/mL, while featuring fair Caco-2 A-B permeability (2.3 x 10(-6) cm/s), kinetic solubility (125 mu M at pH 7.4 in PBS) and mouse metabolic stability (63.6% remaining after 1 h incubation with mouse liver microsomes). Despite demonstration of how a combined bioinformatics/cheminformatics approach afforded a small molecule with promising in vitro profiles, we found that SRI58 did not exhibit quantifiable blood levels in mice.	[Ekins, Sean; Travers, Mike] Collaborat Drug Discovery Inc, Burlingame, CA 94010 USA; [Ekins, Sean] Collaborat Chem, Fuquay Varina, NC 27526 USA; [Madrid, Peter B.; Sarker, Malabika; Talcott, Carolyn; Bourbon, Pauline; Yadav, Maneesh] SRI Int, Menlo Pk, CA 94025 USA; [Li, Shao-Gang; Mittal, Nisha; Wang, Xin; Stratton, Thomas P.; Freundlich, Joel S.] Rutgers State Univ, Sch Med, Ctr Emerging & Reemerging Pathogens, Dept Physiol & Pharmacol, Newark, NJ 07103 USA; [Li, Shao-Gang; Mittal, Nisha; Kumar, Pradeep; Wang, Xin; Stratton, Thomas P.; Freundlich, Joel S.] Rutgers State Univ, Sch Med, Ctr Emerging & Reemerging Pathogens, Dept Med, Newark, NJ 07103 USA; [Zimmerman, Matthew] Rutgers State Univ, Sch Med, Publ Hlth Res Inst, Newark, NJ 07103 USA	SRI International; Rutgers State University Newark; Rutgers State University New Brunswick; Rutgers State University Newark; Rutgers State University New Brunswick; Rutgers State University Newark; Rutgers State University New Brunswick	Ekins, S (corresponding author), Collaborat Drug Discovery Inc, 1633 Bayshore Highway,Suite 342, Burlingame, CA 94010 USA.	ekinssean@yahoo.com; peter.madrid@sri.com; freundjs@rutgers.edu	Li, Shao-Gang/O-4223-2019; Kumar, Pradeep/I-7989-2014	Kumar, Pradeep/0000-0003-0042-7525; Madrid, Peter/0000-0002-4895-5610; Wang, Xin/0000-0002-6930-3347	Bill and Melinda Gates Foundation [49852]; National Institutes of Health / National Institute of Allergy and Infectious Diseases [2R42AI088893-02]; Rutgers University-New Jersey Medical School; NIH/NIAID [R21 AI111647-01, CETR 1 U19 AI109713-01]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI111647, R42AI088893, U19AI109713] Funding Source: NIH RePORTER	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); National Institutes of Health / National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Rutgers University-New Jersey Medical School; NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The CDD TB database was made possible with funding from the Bill and Melinda Gates Foundation (Grant #49852 "Collaborative drug discovery for TB through a novel database of SAR data optimized to promote data archiving and sharing"). The project described was supported by Award Number 2R42AI088893-02 from the National Institutes of Health / National Institute of Allergy and Infectious Diseases. J.S.F. acknowledges additional start-up funding from Rutgers University-New Jersey Medical School. P.K was supported by NIH/NIAID R21 AI111647-01 and CETR 1 U19 AI109713-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahams KA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052951; Boshoff HIM, 2004, J BIOL CHEM, V279, P40174, DOI 10.1074/jbc.M406796200; Chen FC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100829; Chopra S, 2012, J MED CHEM, V55, P6047, DOI 10.1021/jm300123s; Clark AM, 2014, J CHEMINFORMATICS, V6, DOI 10.1186/s13321-014-0038-2; Clark AM, 2013, TB MOBILE 2013; Cole ST, 1999, FEBS LETT, V452, P7, DOI 10.1016/S0014-5793(99)00536-0; Collins LA, 1997, ANTIMICROB AGENTS CH, V41, P1004, DOI 10.1128/AAC.41.5.1004; Doman TN, 2002, J MED CHEM, V45, P2213, DOI 10.1021/jm010548w; Dutta NK, 2010, J INFECT DIS, V201, P1743, DOI 10.1086/652497; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Ekins S, 2000, J PHARMACOL TOX MET, V44, P251, DOI 10.1016/S1056-8719(00)00109-X; Ekins S, 2000, J PHARMACOL TOX MET, V44, P313, DOI 10.1016/S1056-8719(00)00110-6; Ekins S, 2013, PHARM RES IN PRESS; Ekins S, 2013, MLSMR DUAL EVENT TB; Ekins S, 2013, KINASE TB DUAL EVENT; Ekins S, 2013, TUBERCULOSI IN PRESS; Ekins S, 2013, CB2 DUAL EVENT TUBER; Ekins S, 2010, MOL BIOSYST, V6, P2316, DOI 10.1039/c0mb00104j; Ekins S, 2014, J CHEM INF MODEL, V54, P2157, DOI 10.1021/ci500264r; Ekins S, 2014, J CHEM INF MODEL, V54, P1070, DOI 10.1021/ci500077v; Ekins S, 2014, TUBERCULOSIS, V94, P162, DOI 10.1016/j.tube.2013.12.001; Ekins S, 2014, PHARM RES-DORDR, V31, P414, DOI 10.1007/s11095-013-1172-7; Ekins S, 2013, J CHEM INF MODEL, V53, P3054, DOI 10.1021/ci400480s; Ekins S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063240; Ekins Sean, 2013, Methods Mol Biol, V993, P245, DOI 10.1007/978-1-62703-342-8_16; Ekins S, 2013, J CHEMINFORMATICS, V5, DOI 10.1186/1758-2946-5-13; Ekins S, 2013, CHEM BIOL, V20, P370, DOI 10.1016/j.chembiol.2013.01.011; Ekins S, 2011, PHARM RES-DORDR, V28, P1859, DOI 10.1007/s11095-011-0413-x; Ekins S, 2011, TRENDS MICROBIOL, V19, P65, DOI 10.1016/j.tim.2010.10.005; Ekins S, 2010, MEDCHEMCOMM, V1, P325, DOI 10.1039/c0md00129e; Ekins S, 2010, DRUG DISCOV TODAY, V15, P812, DOI 10.1016/j.drudis.2010.08.010; Ekins S, 2010, MOL BIOSYST, V6, P840, DOI 10.1039/b917766c; Fontan P, 2008, INFECT IMMUN, V76, P717, DOI 10.1128/IAI.00974-07; Galagan JE, 2010, TUBERCULOSIS, V90, P225, DOI 10.1016/j.tube.2010.03.010; Ganley B, 2001, BIOORGAN MED CHEM, V9, P2395, DOI 10.1016/S0968-0896(01)00163-8; Hohman M, 2009, DRUG DISCOV TODAY, V14, P261, DOI 10.1016/j.drudis.2008.11.015; Jain SK, 2007, J INFECT DIS, V195, P1634, DOI 10.1086/517526; Karp PD, 2001, SCIENCE, V293, P2040, DOI 10.1126/science.1064621; Kinnings SL, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000976; Kushwaha SK, 2010, J THEOR BIOL, V262, P284, DOI 10.1016/j.jtbi.2009.09.029; Lamichhane G, 2005, INFECT IMMUN, V73, P2533, DOI 10.1128/IAI.73.4.2533-2540.2005; Lamichhane G, 2011, MBIO, V2, DOI 10.1128/mBio.00301-10; Li SG, 2015, TETRAHEDRON LETT, V56, P3246, DOI 10.1016/j.tetlet.2015.02.129; Manikandan K, 2011, PROTEINS, V79, P35, DOI 10.1002/prot.22856; Mugumbate G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121492; Munoz-Elias EJ, 2005, NAT MED, V11, P638, DOI 10.1038/nm1252; Munoz-Elias EJ, 2006, MOL MICROBIOL, V60, P1109, DOI 10.1111/j.1365-2958.2006.05155.x; Nandakumar M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5306; North EJ, 2014, CURR PHARM DESIGN, V20, P4357; Palomino JC, 2002, ANTIMICROB AGENTS CH, V46, P2720, DOI 10.1128/AAC.46.8.2720-2722.2002; Pauli I, 2013, J CHEM INF MODEL, V53, P2390, DOI 10.1021/ci400202t; Polgar T, 2005, J MED CHEM, V48, P7946, DOI 10.1021/jm050504d; Rahman SA, 2006, BIOINFORMATICS, V22, P1767, DOI 10.1093/bioinformatics/btl181; Reddy TBK, 2009, NUCLEIC ACIDS RES, V37, pD499, DOI 10.1093/nar/gkn652; Sarker M, 2012, PHARM RES-DORDR, V29, P2115, DOI 10.1007/s11095-012-0741-5; Sassetti CM, 2003, P NATL ACAD SCI USA, V100, P12989, DOI 10.1073/pnas.2134250100; Talcott C, 2003, PACIFIC SYMPOSIUM ON BIOCOMPUTING 2004, P568; Talcott C, 2006, PROCEEDINGS OF THE 2006 WINTER SIMULATION CONFERENCE, VOLS 1-5, P1656, DOI 10.1109/WSC.2006.322940; Tiwari A, 2007, LECT NOTES COMPUT SC, V4545, P155; Vicente E, 2008, ANTIMICROB AGENTS CH, V52, P3321, DOI 10.1128/AAC.00379-08; Vilcheze C, 2011, ANTIMICROB AGENTS CH, V55, P3889, DOI 10.1128/AAC.00266-11; Villar R, 2008, J ANTIMICROB CHEMOTH, V62, P547, DOI 10.1093/jac/dkn214; Walters WP, 1999, CURR OPIN CHEM BIOL, V3, P384, DOI 10.1016/S1367-5931(99)80058-1; Wang D, 2013, J CHEM INF MODEL, V53, P343, DOI 10.1021/ci3004545; Warner DF, 2014, CURR TOP MICROBIOL, V374, P27, DOI 10.1007/82_2013_328; Wei JR, 2008, TUBERCULOSIS, V88, pS19, DOI 10.1016/S1472-9792(08)70033-7; Wilson R, 2013, NAT CHEM BIOL, V9, P499, DOI 10.1038/nchembio.1277; Wilson W, 1999, P NATL ACAD SCI USA, V96, P12833, DOI 10.1073/pnas.96.22.12833; Zheng XW, 2009, MOL PHARMACEUT, V6, P1591, DOI 10.1021/mp900163d	70	12	13	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2015	10	10							e0141076	10.1371/journal.pone.0141076	http://dx.doi.org/10.1371/journal.pone.0141076			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0EH	26517557	Green Published, gold, Green Submitted			2022-12-26	WOS:000363920800019
J	Kowalski, T; Bilanski, P; Holdenrieder, O				Kowalski, Tadeusz; Bilanski, Piotr; Holdenrieder, Ottmar			Virulence of Hymenoscyphus albidus and H. fraxineus on Fraxinus excelsior and F. pennsylvanica	PLOS ONE			English	Article							EUROPEAN ASH DIEBACK; CHALARA-FRAXINEA; CAUSAL AGENT; PSEUDOALBIDUS; PATHOGEN; VIRIDIOL; SUSCEPTIBILITY; MANAGEMENT; CHALLENGE; INVASION	European ash (Fraxinus excelsior) is currently battling an onslaught of ash dieback, a disease emerging in the greater part of its native area, brought about by the introduction of the ascomycete Hymenoscyphus fraxineus (= Hymenoscyphus pseudoalbidus). The closely-related fungus Hymenoscyphus albidus, which is indigenous to Europe, is non-pathogenic when in contact with F. excelsior, but could pose a potential risk to exotic Fraxinus species. The North American green ash (Fraxinus pennsylvanica) is planted widely throughout Europe and regenerates naturally within this environment but little is known about the susceptibility of this species to ash dieback. We performed wound inoculations with both fungi (nine strains of H. fraxineus and three strains of H. albidus) on rachises and stems of F. excelsior and F. pennsylvanica under field conditions in Southern Poland. Necrosis formation was evaluated after two months on the rachises and after 12 months on the stems. After inoculation of H. albidus, only small lesions (of up to 1.3 cm in length) developed on the F. excelsior and F. pennsylvanica rachises, but with no significant distinction from the controls. Hymenoscyphus albidus did not cause necrotic lesions on the stems of either Fraxinus species. In contrast, H. fraxineus induced necroses on all inoculated rachises of both ash species with mean lengths of 8.4 cm (F. excelsior) and 1.9 cm (F. pennsylvanica). Necroses also developed on all of the inoculated F. excelsior stems (mean length 18.0 cm), whereas on F. pennsylvanica such lesions only occurred on about 5% of the stems (mean length 1.9 cm). The differences between strains were negligible. No necroses were observed on the control plants. Reisolations of H. albidus were only successful in around 8-11% of the cases, while H. fraxineus was reisolated from 50-70% of the inoculated organs showing necrotic lesions. None of the Hymenoscyphus species were isolated from the control plants. Our data confirm H. fraxineus' high virulence with regards to F. excelsior and demonstrate a low virulence in relation to F. pennsylvanica under field conditions in Poland. Hymenoscyphus albidus did not express any perceivable pathogenicity on both host species.	[Kowalski, Tadeusz] Univ Agr, Dept Forest Pathol Mycol & Tree Physiol, Krakow, Poland; [Bilanski, Piotr] Univ Agr, Dept Forest Protect Forest Entomol & Climatol, Krakow, Poland; [Holdenrieder, Ottmar] ETH, Inst Integrat Biol, Forest Pathol & Dendrol, Zurich, Switzerland	Agricultural University Krakow; Agricultural University Krakow; Swiss Federal Institutes of Technology Domain; ETH Zurich	Holdenrieder, O (corresponding author), ETH, Inst Integrat Biol, Forest Pathol & Dendrol, Zurich, Switzerland.	ottmar.holdenrieder@usys.ethz.ch	Kowalski, Tadeusz/H-8662-2013	Kowalski, Tadeusz/0000-0001-9897-5604; Bilanski, Piotr/0000-0001-9935-6274; Bilanski, Piotr/0000-0002-2750-6699	Polish National Science Centre [DEC-2011/03/B/NZ9/00078]	Polish National Science Centre	The study was financially supported by the Polish National Science Centre (http://ncn.gov.pl), grant number DEC-2011/03/B/NZ9/00078 (grant recipient: TK).	ANAGNOSTAKIS SL, 1987, MYCOLOGIA, V79, P23, DOI 10.2307/3807741; Andersson PF, 2010, FOREST PATHOL, V40, P43, DOI 10.1111/j.1439-0329.2009.00605.x; Andersson PF, 2013, PHYTOCHEMISTRY, V86, P195, DOI 10.1016/j.phytochem.2012.09.012; Andersson PF, 2012, MOLECULES, V17, P7769, DOI 10.3390/molecules17077769; Bakys R, 2009, PLANT PATHOL, V58, P284, DOI 10.1111/j.1365-3059.2008.01977.x; Baral Hans-Otto, 2014, Mycology, V5, P228, DOI 10.1080/21501203.2014.963720; Baral HO, 2014, IMA FUNGUS, V5, P79, DOI 10.5598/imafungus.2014.05.01.09; Bengtsson SBK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0076429; Bostock RM, 2014, ANNU REV PHYTOPATHOL, V52, P517, DOI 10.1146/annurev-phyto-081211-172902; Breitenbach J, 1984, FUNGI SWITZERLAND AS, V1; Citron CA, 2014, ANGEW CHEM INT EDIT, V53, P4346, DOI 10.1002/anie.201402290; Cleary MR, 2014, PHYTOCHEMISTRY, V102, P115, DOI 10.1016/j.phytochem.2014.03.005; Cleary MR, 2013, PLANT PATHOL, V62, P1294, DOI 10.1111/ppa.12048; Cleary MR, 2013, FOREST PATHOL, V43, P83, DOI 10.1111/efp.12012; Drenkhan R., 2010, New Disease Reports, V22, P16, DOI 10.5197/j.2044-0588.2010.022.016; Ellis M.B., 1985, MICROFUNGI LAND PLAN; Farr D. F., 2018, FUNGAL DATABASES SYS; Geils BW, 2010, FOREST PATHOL, V40, P147, DOI 10.1111/j.1439-0329.2010.00654.x; Gogin VA, 1976, LESN KHOZ, V6, P31; Grad B, 2009, PHYTOPATHOLOGIA, V54, P61; Gross A, 2015, MYCOL PROG, V14, DOI 10.1007/s11557-015-1035-1; Gross A, 2015, FOREST PATHOL, V45, P172, DOI 10.1111/efp.12182; Gross A., 2015, PLANT PATHO IN PRESS; Gross A, 2014, MOL ECOL, V23, P2943, DOI 10.1111/mec.12792; Gross A, 2014, MOL PLANT PATHOL, V15, P5, DOI 10.1111/mpp.12073; Hausman CE, 2014, PLANT GENET RESOUR-C, V12, P286, DOI 10.1017/S1479262114000033; Holdenrieder O, 2014, TRENDS ECOL EVOL, V19, P446; Husson C, 2011, EUR J PLANT PATHOL, V130, P311, DOI 10.1007/s10658-011-9755-9; Junker C, 2014, FOREST PATHOL, V44, P39, DOI 10.1111/efp.12066; Kennedy H. E., 1990, AGR HDB, V654; Kirisits T, 2014, 6 MC MEET WORKSH 15, P8; KLIMO E., 2001, 10 EUR FOR I; Kowalski T, 2009, FOREST PATHOL, V39, P1, DOI 10.1111/j.1439-0329.2008.00565.x; Kowalski T, 2009, FOREST PATHOL, V39, P304, DOI 10.1111/j.1439-0329.2008.00589.x; Kowalski T, 2009, SYLWAN, V153, P668; Krautler K, 2015, FOREST PATHOL, V45, P274, DOI 10.1111/efp.12168; Kraj W, 2014, J PHYTOPATHOL, V162, P218, DOI 10.1111/jph.12173; Krautler K., 2012, J AGR EXTENSION RURA, V4, P261, DOI [DOI 10.5897/JAERD12.065, 10.5897/jaerd12.065]; Kremer D, 2005, J FOREST, V103, P309; Lindenmayer DB, 2010, P NATL ACAD SCI USA, V107, P21957, DOI 10.1073/pnas.1015696107; Littlewood NA, 2015, J INSECT CONSERV, V19, P75, DOI 10.1007/s10841-014-9745-2; Losing H, 2013, ACTA HORTIC, V1014, P201; McKinney LV, 2014, PLANT PATHOL, V63, P485, DOI 10.1111/ppa.12196; Mitchell RJ, 2014, BIOL CONSERV, V175, P95, DOI 10.1016/j.biocon.2014.04.019; Orlova-Bienkowskaja MJ, 2014, BIOL INVASIONS, V16, P1345, DOI 10.1007/s10530-013-0579-8; Pautasso M, 2015, MICROB ECOL, V69, P826, DOI 10.1007/s00248-014-0545-8; Pautasso M, 2013, BIOL CONSERV, V158, P37, DOI 10.1016/j.biocon.2012.08.026; Pysek Petr, 2002, Preslia (Prague), V74, P97; Queloz V, 2011, FOREST PATHOL, V41, P133, DOI 10.1111/j.1439-0329.2010.00645.x; Rehm H, 1896, KRYPTOGAMEN FLORA DE, V3; Santini A, 2015, IFOREST, V8, P126, DOI [10.3832/ifor1231-008, 10.1504/IJPM.2015.066292]; Schmiedel D, 2013, ENVIRON MANAGE, V52, P851, DOI 10.1007/s00267-013-0135-4; Selikhovkin AV, 2013, 4 MC MEET WORKSH FRO, P26; Sturrock RN, 2011, PLANT PATHOL, V60, P133, DOI 10.1111/j.1365-3059.2010.02406.x; Tiborcz V, 2011, 3 INT S ENV WEEDS IN; Valenta V, 2015, FORESTS, V6, P3075, DOI 10.3390/f6093075; Wallander E., 2012, BELGISCHE DENDROLOGI, V2012, P39; Zhao YJ, 2012, MYCOTAXON, V122, P25, DOI 10.5248/122.25	58	26	26	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2015	10	10							e0141592	10.1371/journal.pone.0141592	http://dx.doi.org/10.1371/journal.pone.0141592			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0EH	26517266	gold, Green Submitted, Green Published			2022-12-26	WOS:000363920800057
J	McCormick, DL; Horn, TL; Johnson, WD; Peng, XJ; Lubet, RA; Steele, VE				McCormick, David L.; Horn, Thomas L.; Johnson, William D.; Peng, Xinjian; Lubet, Ronald A.; Steele, Vernon E.			Suppression of Rat Oral Carcinogenesis by Agonists of Peroxisome Proliferator Activated Receptor gamma	PLOS ONE			English	Article							PPAR-GAMMA; NECK-CANCER; INTERNATIONAL HEAD; POOLED ANALYSIS; RISK; EPIDEMIOLOGY; ROSIGLITAZONE; EXPRESSION; ALCOHOL; SMOKING	Peroxisome-proliferator-activated receptor. (PPAR.) is a ligand-activated transcription factor that regulates cell proliferation, differentiation, and apoptosis. In vivo studies were performed to evaluate the activities of two thiazolidinedione PPAR. agonists, rosiglitazone and pioglitazone, as inhibitors of oral carcinogenesis in rats. Oral squamous cell carcinomas (OSCC) were induced in male F344 rats by 4-nitroquinoline-1-oxide (NQO; 20 ppm in the drinking water for 10 weeks). In each study, groups of 30 NQO-treated rats were exposed to a PPAR. agonist beginning at week 10 (one day after completion of NQO administration) or at week 17 (7 weeks post-NQO); chemopreventive agent exposure was continued until study termination at week 22 (rosiglitazone study) or week 24 (pioglitazone study). Administration of rosiglitazone (800 mg/kg diet) beginning at week 10 increased survival, reduced oral cancer incidence, and reduced oral cancer invasion score in comparison to dietary controls; however, chemopreventive activity was largely lost when rosiglitazone administration was delayed until week 17. Administration of pioglitazone (500 mg/kg diet beginning at week 10 or 1000 mg/kg diet beginning at week 17) induced significant reductions in oral cancer incidence without significant effects on OSCC invasion scores. Transcript levels of PPAR. and its three transcriptional variants (PPAR.v1, PPAR.v2, and PPAR.v3) were not significantly different in OSCC versus age-and site-matched phenotypically normal oral tissues from rats treated with NQO. These data suggest that PPAR. provides a useful molecular target for oral cancer chemoprevention, and that overexpression of PPAR. at the transcriptional level in neoplastic lesions is not essential for chemopreventive efficacy.	[McCormick, David L.; Horn, Thomas L.; Johnson, William D.; Peng, Xinjian] IIT Res Inst, Life Sci Grp, Chicago, IL 60616 USA; [Lubet, Ronald A.; Steele, Vernon E.] NCI, Chemoprevent Agent Dev Res Grp, Canc Prevent Div, Bethesda, MD 20852 USA	Illinois Institute of Technology; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	McCormick, DL (corresponding author), IIT Res Inst, Life Sci Grp, Chicago, IL 60616 USA.	dmccormick@iitri.org			U.S. National Cancer Institute [N01-CN-85175, HHSN261200433003C (N01-CN-43303)]; DIVISION OF CANCER PREVENTION AND CONTROL [N01CN085175] Funding Source: NIH RePORTER	U.S. National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); DIVISION OF CANCER PREVENTION AND CONTROL(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Grants N01-CN-85175 and HHSN261200433003C (N01-CN-43303) were awarded to DLM by the U.S. National Cancer Institute (www.nci.nih.gov). National Cancer Institute scientists (RAL and VES) participated in study design and preparation of the manuscript.	Ahmadian M, 2013, NAT MED, V19, P557, DOI 10.1038/nm.3159; Aljada A, 2008, ANGIOGENESIS, V11, P361, DOI 10.1007/s10456-008-9118-0; American Cancer Society, 2015, WHAT AR KEY STAT OR; Astarci E, 2009, ATL GENET CYTOGENET, V13, P417; Bhalla K, 2011, J BIOL CHEM, V286, P41626, DOI 10.1074/jbc.M111.257915; BLOT WJ, 1988, CANCER RES, V48, P3282; Burotto M, 2014, ORAL ONCOL, V50, P924, DOI 10.1016/j.oraloncology.2013.12.020; Chen YC, 2009, 2009 INTERNATIONAL CONFERENCE ON ENGINEERING COMPUTATION, P25, DOI 10.1109/ICEC.2009.46; Danaei G, 2005, LANCET, V366, P1784, DOI 10.1016/S0140-6736(05)67725-2; Food and Drug Administration, 1999, DRUG APPR PACK AV RO; Frohlich E, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/845340; Gupta B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113385; Hashibe M, 2009, CANCER EPIDEM BIOMAR, V18, P541, DOI 10.1158/1055-9965.EPI-08-0347; International Agency for Research on Cancer, 2015, IARC MONOGRAPHS EVAL, V108; Jayalekshmi PA, 2011, CANCER SCI, V102, P460, DOI 10.1111/j.1349-7006.2010.01785.x; Liu HJ, 2015, J PHARMACOL EXP THER, V353, P573, DOI 10.1124/jpet.115.223107; Lubet RA, 2008, INT J CANCER, V123, P2254, DOI 10.1002/ijc.23765; Mattson M E, 1989, NCI Monogr, P13; McCormick DL, 2010, CANCER PREV RES, V3, P73, DOI 10.1158/1940-6207.CAPR-09-0151; Muwonge R, 2008, ORAL ONCOL, V44, P446, DOI 10.1016/j.oraloncology.2007.06.002; National Cancer Institute Surveillance Epidemiology and End Results Program, 2015, SEER STAT FACT SHEET; Peng XJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116285; Peters JM, 2012, NAT REV CANCER, V12, P181, DOI 10.1038/nrc3214; Pytynia KB, 2014, ORAL ONCOL, V50, P380, DOI 10.1016/j.oraloncology.2013.12.019; Robbins GT, 2012, FRONT BIOSCI-LANDMRK, V17, P1816, DOI 10.2741/4021; Rosenson RS, 2012, AM HEART J, V164, P672, DOI 10.1016/j.ahj.2012.06.023; ROTHMAN K, 1972, J CHRON DIS, V25, P711, DOI 10.1016/0021-9681(72)90006-9; Rubenstrunk A, 2007, BBA-MOL CELL BIOL L, V1771, P1065, DOI 10.1016/j.bbalip.2007.02.003; Sabichi AL, 2004, CANCER EPIDEM BIOMAR, V13, P1704; Schwartz SM, 1998, JNCI-J NATL CANCER I, V90, P1626, DOI 10.1093/jnci/90.21.1626; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Singh S, 2007, JAMA-J AM MED ASSOC, V298, P1189, DOI 10.1001/jama.298.10.1189; Smolarek AK, 2013, MOL CARCINOGEN, V52, P514, DOI 10.1002/mc.21886; Tanaka Takuji, 2011, Patholog Res Int, V2011, P431246, DOI 10.4061/2011/431246; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; Tsimplaki E, 2014, ANTICANCER RES, V34, P1021; VidalPuig AJ, 1997, J CLIN INVEST, V99, P2416, DOI 10.1172/JCI119424; Wang LM, 2014, BIOCHEM PHARMACOL, V92, P73, DOI 10.1016/j.bcp.2014.07.018; Westra WH, 2009, HEAD NECK PATHOL, V3, P78, DOI 10.1007/s12105-009-0100-y; Wyss A, 2013, AM J EPIDEMIOL, V178, P679, DOI 10.1093/aje/kwt029	40	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2015	10	10							e0141849	10.1371/journal.pone.0141849	http://dx.doi.org/10.1371/journal.pone.0141849			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0EH	26516762	Green Submitted, Green Published, gold			2022-12-26	WOS:000363920800087
J	Moura, MC; Novaes, MRCG; Eduardo, EJ; Zago, YSSP; Freitas, RDB; Casulari, LA				Moura, Mirian Conceicao; Carvalho Garbi Novaes, Maria Rita; Eduardo, Emanoel Junio; Zago, Yuri S. S. P.; Barroso Freitas, Ricardo Del Negro; Casulari, Luiz Augusto			Prognostic Factors in Amyotrophic Lateral Sclerosis: A Population-Based Study	PLOS ONE			English	Article							BODY-MASS INDEX; MOTOR-NEURON DISEASE; REVISED EL ESCORIAL; ONSET ALS; SURVIVAL; EPIDEMIOLOGY; DIAGNOSIS; CRITERIA; RILUZOLE; TIME	Objective To determine the prognostic factors associated with survival in amyotrophic lateral sclerosis at diagnosis. Methods This retrospective population-based study evaluated 218 patients treated with riluzole between 2005 and 2014 and described their clinical and demographic profiles after the analysis of clinical data and records from the mortality information system in the Federal District, Brazil. Cox multivariate regression analysis was conducted for the parameters found. Results The study sample consisted of 132 men and 86 women with a mean age at disease onset of 57.2 +/- 12.3 years; 77.6% of them were Caucasian. The mean periods between disease onset and diagnosis were 22.7 months among men and 23.5 months among women, and the mean survival periods were 45.7 +/- 47.0 months among men and 39.3 +/- 29.8 months among women. In addition, 80.3% patients presented non-bulbar-onset amyotrophic lateral sclerosis, and 19.7% presented bulbar-onset. Cox regression analysis indicated worse prognosis for body mass index (BMI) <25 kg/m(2) (relative risk [RR]: 3.56, 95% confidence interval [CI]: 1.44-8.86), age >75 years (RR: 12.47, 95% CI: 3.51-44.26), and bulbar-onset (RR: 4.56, 95% CI: 2.06-10.12). Electromyography did not confirm the diagnosis in 55.6% of the suspected cases and in 27.9% of the bulbar-onset cases. Conclusions The factors associated with lower survival in amyotrophic lateral sclerosis were age >75 years, BMI <25 kg/m(2), and bulbar-onset.	[Moura, Mirian Conceicao] Hosp Reg Asa Norte, State Secretariat Hlth Fed Dist, Brasilia, DF, Brazil; [Carvalho Garbi Novaes, Maria Rita] Sch Hlth Sci, Brasilia, DF, Brazil; [Carvalho Garbi Novaes, Maria Rita] Univ Brasilia, Brasilia, DF, Brazil; [Eduardo, Emanoel Junio; Zago, Yuri S. S. P.; Barroso Freitas, Ricardo Del Negro] Sch Hlth Sci, Brasilia, DF, Brazil; [Casulari, Luiz Augusto] Univ Hosp Brasilia, Brasilia, DF, Brazil	Universidade de Brasilia; Universidade de Brasilia	Moura, MC (corresponding author), Hosp Reg Asa Norte, State Secretariat Hlth Fed Dist, Brasilia, DF, Brazil.	mcmoura0812@yahoo.com.br	Novaes, Maria Rita/S-7077-2019	CARVALHO GARBI NOVAES, MARIA RITA/0000-0002-9366-6017				Al-Chalabi A, 2013, NAT REV NEUROL, V9, P617, DOI 10.1038/nrneurol.2013.203; Beghi E, 2011, AMYOTROPH LATERAL SC, V12, P1, DOI 10.3109/17482968.2010.502940; Brasil. Ministerio da Saude, 2010, PROTOCOLOS CLINICOS; Bresch S, 2014, REV NEUROL-FRANCE, V170, P134, DOI 10.1016/j.neurol.2013.10.004; Caller TA, 2015, NEURODEGENER DIS; Chediek J., 2014, ATLAS DESENVOLVIMENT; Chio A, 2013, NEUROEPIDEMIOLOGY, V41, P118, DOI 10.1159/000351153; Chio A, 2009, NEUROLOGY, V72, P725, DOI 10.1212/01.wnl.0000343008.26874.d1; Chio A, 2009, AMYOTROPH LATERAL SC, V10, P310, DOI 10.3109/17482960802566824; Collett, 2003, MODELLING SURVIVAL D; Coon EA, 2011, NEUROLOGY, V76, P1886, DOI 10.1212/WNL.0b013e31821d767b; Costa J, 2012, ARCH NEUROL-CHICAGO, V69, P1410, DOI 10.1001/archneurol.2012.254; D'Amico E, 2013, FREE RADICAL BIO MED, V65, P509, DOI 10.1016/j.freeradbiomed.2013.06.029; de Jong SW, 2012, AM J EPIDEMIOL, V176, P233, DOI 10.1093/aje/kws015; Dietrich-Neto F, 2000, ARQ NEURO-PSIQUIAT, V58, P607, DOI 10.1590/S0004-282X2000000400002; Finsterer Josef, 2013, Open Neurol J, V7, P4, DOI 10.2174/1874205X01307010004; Flegal KM, 2013, JAMA-J AM MED ASSOC, V309, P71, DOI 10.1001/jama.2012.113905; Forbes RB, 2004, J NEUROL NEUROSUR PS, V75, P1753, DOI 10.1136/jnnp.2003.024364; Fujimura-Kiyono C, 2011, J NEUROL NEUROSUR PS, V82, P1244, DOI 10.1136/jnnp-2011-300141; Ganesalingam J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007107; Garcia-Redondo A, 2013, HUM MUTAT, V34, P79, DOI 10.1002/humu.22211; Georgoulopoulou E, 2013, AMYOTROPH LAT SCL FR, V14, P338, DOI 10.3109/21678421.2013.763281; Goh KJ, 2011, AMYOTROPH LATERAL SC, V12, P124, DOI 10.3109/17482968.2010.527986; Harms MB, 2013, NEUROL CLIN, V31, P929, DOI 10.1016/j.ncl.2013.05.003; Hu WT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057584; Instituto Brasileiro de Geografia e Estatistica (IBGE), 2014, CENSO DEMOGRAFICO; Jordan H, 2015, NEUROEPIDEMIOLOGY, V44, P114, DOI 10.1159/000380855; Katz JS, 1999, NEUROLOGY, V53, P1071, DOI 10.1212/WNL.53.5.1071; Lee CTC, 2013, J EPIDEMIOL, V23, P35, DOI 10.2188/jea.JE20120119; Limousin N, 2010, J NEUROL SCI, V297, P36, DOI 10.1016/j.jns.2010.06.028; Lund and Manchester Groups, 1994, J NEUROL NEUROSURG P, V57; Marin B, 2011, J NEUROL NEUROSUR PS, V82, P628, DOI 10.1136/jnnp.2010.211474; Nakamura R, 2013, J NEUROL NEUROSUR PS, V84, P1365, DOI 10.1136/jnnp-2013-306020; Ngo ST, 2014, J NEUROL SCI, V340, P5, DOI 10.1016/j.jns.2014.02.035; Okita T, 2011, J NEUROL SCI, V302, P29, DOI 10.1016/j.jns.2010.12.007; Paganoni S, 2011, MUSCLE NERVE, V44, P20, DOI 10.1002/mus.22114; Rooney J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074733; Turner MR, 2010, AMYOTROPH LATERAL SC, V11, P369, DOI 10.3109/17482960903420140; Valenzuela D, 2015, AMYOTROPH LATERAL SC, P1; Wingo TS, 2011, PLOS ONE, V6, P6; Zaldivar T, 2009, NEUROLOGY, V72, P1640, DOI 10.1212/WNL.0b013e3181a55f7b; Zinman L, 2011, LANCET NEUROL, V10, P481, DOI 10.1016/S1474-4422(11)70024-2	42	19	21	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2015	10	10							e0141500	10.1371/journal.pone.0141500	http://dx.doi.org/10.1371/journal.pone.0141500			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0EH	26517122	Green Published, gold, Green Submitted			2022-12-26	WOS:000363920800048
J	Sonnemann, I; Pfestorf, H; Jeltsch, F; Wurst, S				Sonnemann, Ilja; Pfestorf, Hans; Jeltsch, Florian; Wurst, Susanne			Community-Weighted Mean Plant Traits Predict Small Scale Distribution of Insect Root Herbivore Abundance	PLOS ONE			English	Article							DIABROTICA-VIRGIFERA-VIRGIFERA; LAND-USE INTENSITY; WIREWORMS COLEOPTERA; SPATIAL-DISTRIBUTION; AGRIOTES-USTULATUS; FUNCTIONAL TRAITS; ARABLE LAND; ELATERIDAE; GRASSLAND; LEAF	Small scale distribution of insect root herbivores may promote plant species diversity by creating patches of different herbivore pressure. However, determinants of small scale distribution of insect root herbivores, and impact of land use intensity on their small scale distribution are largely unknown. We sampled insect root herbivores and measured vegetation parameters and soil water content along transects in grasslands of different management intensity in three regions in Germany. We calculated community-weighted mean plant traits to test whether the functional plant community composition determines the small scale distribution of insect root herbivores. To analyze spatial patterns in plant species and trait composition and insect root herbivore abundance we computed Mantel correlograms. Insect root herbivores mainly comprised click beetle (Coleoptera, Elateridae) larvae (43%) in the investigated grasslands. Total insect root herbivore numbers were positively related to community-weighted mean traits indicating high plant growth rates and biomass (specific leaf area, reproductive-and vegetative plant height), and negatively related to plant traits indicating poor tissue quality (leaf C/N ratio). Generalist Elaterid larvae, when analyzed independently, were also positively related to high plant growth rates and furthermore to root dry mass, but were not related to tissue quality. Insect root herbivore numbers were not related to plant cover, plant species richness and soil water content. Plant species composition and to a lesser extent plant trait composition displayed spatial autocorrelation, which was not influenced by land use intensity. Insect root herbivore abundance was not spatially autocorrelated. We conclude that in semi-natural grasslands with a high share of generalist insect root herbivores, insect root herbivores affiliate with large, fast growing plants, presumably because of availability of high quantities of food. Affiliation of insect root herbivores with large, fast growing plants may counteract dominance of those species, thus promoting plant diversity.	[Sonnemann, Ilja; Wurst, Susanne] Free Univ Berlin, Dahlem Ctr Plant Sci, Berlin, Germany; [Pfestorf, Hans; Jeltsch, Florian] Univ Potsdam, Inst Biochem & Biol, Plant Ecol & Nat Conservat, Potsdam, Germany; [Jeltsch, Florian] ZALF, Leibniz Ctr Agr Landscape Res, Muncheberg, Germany; [Sonnemann, Ilja; Jeltsch, Florian; Wurst, Susanne] Berlin Brandenburg Inst Adv Biodivers Res BBIB, Berlin, Germany	Free University of Berlin; University of Potsdam; Leibniz Zentrum fur Agrarlandschaftsforschung (ZALF)	Sonnemann, I (corresponding author), Free Univ Berlin, Dahlem Ctr Plant Sci, Berlin, Germany.	i.sonnemann@fu-berlin.de		Jeltsch, Florian/0000-0002-4670-6469	Deutsche Forschungsgemeinnschaft [JE 207/7-2, WU 603/3-2]	Deutsche Forschungsgemeinnschaft	Funding was provided by Deutsche Forschungsgemeinnschaft (www.dfg.de): FJ received grant number JE 207/7-2; SW received grant number WU 603/3-2. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, R LANG ENV STAT COMP; Barnett K, 2013, ADV INSECT PHYSIOL, V45, P1, DOI 10.1016/B978-0-12-417165-7.00001-5; Benefer C, 2010, APPL SOIL ECOL, V45, P269, DOI 10.1016/j.apsoil.2010.05.002; Berner D, 2011, PEDOBIOLOGIA, V54, P341, DOI 10.1016/j.pedobi.2011.08.001; Bluthgen N, 2012, BASIC APPL ECOL, V13, P207, DOI 10.1016/j.baae.2012.04.001; Borcard D, 2011, USE R, P1, DOI 10.1007/978-1-4419-7976-6; Brown V.K., 1990, Advances in Ecological Research, V20, P1, DOI 10.1016/S0065-2504(08)60052-5; Cherry R, 2008, FLA ENTOMOL, V91, P383, DOI 10.1653/0015-4040(2008)91[383:AASDOW]2.0.CO;2; Chesson P, 2000, ANNU REV ECOL SYST, V31, P343, DOI 10.1146/annurev.ecolsys.31.1.343; COLEY PD, 1985, SCIENCE, V230, P895, DOI 10.1126/science.230.4728.895; Cornelissen JHC, 2003, AUST J BOT, V51, P335, DOI 10.1071/BT02124; Craine JM, 2001, OIKOS, V93, P274, DOI 10.1034/j.1600-0706.2001.930210.x; Craine JM, 2002, FUNCT ECOL, V16, P563, DOI 10.1046/j.1365-2435.2002.00660.x; de Bello F, 2010, BIOL CONSERV, V143, P9, DOI 10.1016/j.biocon.2009.04.022; DEKROON H, 1995, J ECOL, V83, P143, DOI 10.2307/2261158; Diniz JAF, 2013, GENET MOL BIOL, V36, P475, DOI 10.1590/S1415-47572013000400002; Dormann CF, 2007, ECOGRAPHY, V30, P609, DOI 10.1111/j.2007.0906-7590.05171.x; Ettema CH, 2002, TRENDS ECOL EVOL, V17, P177, DOI 10.1016/S0169-5347(02)02496-5; Fischer M, 2010, BASIC APPL ECOL, V11, P473, DOI 10.1016/j.baae.2010.07.009; Furlan L, 1996, J APPL ENTOMOL, V120, P269, DOI 10.1111/j.1439-0418.1996.tb01605.x; Furlan L, 1998, J APPL ENTOMOL, V122, P71, DOI 10.1111/j.1439-0418.1998.tb01464.x; GARNIER E, 1994, NEW PHYTOL, V128, P725, DOI 10.1111/j.1469-8137.1994.tb04036.x; Garnier E, 2007, ANN BOT-LONDON, V99, P967, DOI 10.1093/aob/mcl215; GROSS KL, 1995, J ECOL, V83, P357, DOI 10.2307/2261590; Halekoh U, 2014, J STAT SOFTW, V59, P1; Hemerik L, 2003, J INSECT BEHAV, V16, P647, DOI 10.1023/B:JOIR.0000007701.04296.45; Hodgson JG, 2005, BIOL CONSERV, V122, P263, DOI 10.1016/j.biocon.2004.07.016; Hunter MD, 2001, AGR FOREST ENTOMOL, V3, P153, DOI 10.1046/j.1461-9555.2001.00108.x; IUSS Working Group WRB, 2006, WORLD REF BAS SOIL R, V103; Jedlicka P, 2007, BIOLOGIA, V62, P103, DOI 10.2478/s11756-007-0017-4; Johnson SN, 2006, ECOL ENTOMOL, V31, P395, DOI 10.1111/j.1365-2311.2006.00776.x; Kempson D., 1963, Pedobiologia, V3, P1; Kleyer M, 2008, J ECOL, V96, P1266, DOI 10.1111/j.1365-2745.2008.01430.x; Kleyer M, 2015, BASIC APPL ECOL, V16, P1, DOI 10.1016/j.baae.2014.11.002; Klimesova J, 2009, J VEG SCI, V20, P511, DOI 10.1111/j.1654-1103.2009.01050.x; Korner K, 2014, ECOL MODEL, V273, P79, DOI 10.1016/j.ecolmodel.2013.10.025; Kumar S, 2006, ECOLOGY, V87, P3186, DOI 10.1890/0012-9658(2006)87[3186:SHINAN]2.0.CO;2; Kutschera L., 1992, WURZELATLAS MITTELEU; Kutschera L., 1982, WURZELATLAS MITTELEU; Meinke LJ, 2009, AGR FOREST ENTOMOL, V11, P29, DOI 10.1111/j.1461-9563.2008.00419.x; Mortimer SR, 1999, HERBIVORES: BETWEEN PLANTS AND PREDATORS, P205; Nakagawa S, 2013, METHODS ECOL EVOL, V4, P133, DOI 10.1111/j.2041-210x.2012.00261.x; O'Neill RV, 1999, ECOSYST HEALTH, V5, P225, DOI 10.1046/j.1526-0992.1999.09942.x; Pakeman RJ, 2007, APPL VEG SCI, V10, P91, DOI 10.1111/j.1654-109X.2007.tb00507.x; Parker WE, 1997, ANN APPL BIOL, V130, P409, DOI 10.1111/j.1744-7348.1997.tb07671.x; Paula S, 2011, OECOLOGIA, V165, P321, DOI 10.1007/s00442-010-1806-y; Petersen MJ, 2013, ECOL ENTOMOL, V38, P585, DOI 10.1111/een.12058; Pfestorf H, 2013, PERSPECT PLANT ECOL, V15, P1, DOI 10.1016/j.ppees.2012.10.003; Poschlod P, 2005, BASIC APPL ECOL, V6, P93, DOI 10.1016/j.baae.2004.12.001; Roumet C, 2006, NEW PHYTOL, V170, P357, DOI 10.1111/j.1469-8137.2006.01667.x; SALT G, 1946, J EXP BIOL, V23, P1; Schallhart N, 2012, ECOLOGY, V93, P2650, DOI 10.1890/11-2067.1; Scheipl F., 2020, LINEAR MIXED EFFECTS, DOI 10.18637/jss.v067.i01; SEAL DR, 1992, J ECON ENTOMOL, V85, P1802, DOI 10.1093/jee/85.5.1802; Socher SA, 2012, J ECOL, V100, P1391, DOI 10.1111/j.1365-2745.2012.02020.x; Sonnemann I, 2014, ENTOMOL EXP APPL, V150, P174, DOI 10.1111/eea.12150; Sonnemann I, 2012, BASIC APPL ECOL, V13, P579, DOI 10.1016/j.baae.2012.09.010; Stehr F. W., 1991, IMMATURE INSECTS, V2; STEHR F. W., 2005, IMMATURE INSECTS, VI; Stevens GN, 2006, NEW PHYTOL, V171, P127, DOI 10.1111/j.1469-8137.2006.01731.x; Tjoelker MG, 2005, NEW PHYTOL, V167, P493, DOI 10.1111/j.1469-8137.2005.01428.x; Toepfer S, 2007, ENTOMOL EXP APPL, V124, P61, DOI 10.1111/j.1570-7458.2007.00549.x; Traugott M, 2008, SOIL BIOL BIOCHEM, V40, P342, DOI 10.1016/j.soilbio.2007.08.013; Traugott M, 2015, ANNU REV ENTOMOL, V60, P313, DOI 10.1146/annurev-ento-010814-021035; Wang YQ, 2009, GEODERMA, V150, P141, DOI 10.1016/j.geoderma.2009.01.021; Weiss L, 2014, OIKOS, V123, P599, DOI 10.1111/j.1600-0706.2013.00957.x; Westoby M, 2002, ANNU REV ECOL SYST, V33, P125, DOI 10.1146/annurev.ecolsys.33.010802.150452; Westoby M, 2006, TRENDS ECOL EVOL, V21, P261, DOI 10.1016/j.tree.2006.02.004; Zhou ZY, 2008, PLANT SOIL, V310, P103, DOI 10.1007/s11104-008-9633-1; Zuur A.F, 2012, ZERO INFLATED MODELS	70	5	5	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2015	10	10							e0141148	10.1371/journal.pone.0141148	http://dx.doi.org/10.1371/journal.pone.0141148			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0EH	26517119	Green Published, gold, Green Submitted			2022-12-26	WOS:000363920800024
J	Cinti, A; De Giorgi, M; Chisci, E; Arena, C; Galimberti, G; Farina, L; Bugarin, C; Rivolta, I; Gaipa, G; Smolenski, RT; Cerrito, MG; Lavitrano, M; Giovannoni, R				Cinti, Alessandro; De Giorgi, Marco; Chisci, Elisa; Arena, Claudia; Galimberti, Gloria; Farina, Laura; Bugarin, Cristina; Rivolta, Ilaria; Gaipa, Giuseppe; Smolenski, Ryszard Tom; Cerrito, Maria Grazia; Lavitrano, Marialuisa; Giovannoni, Roberto			Simultaneous Overexpression of Functional Human HO-1, E5NT and ENTPD1 Protects Murine Fibroblasts against TNF-alpha-Induced Injury In Vitro	PLOS ONE			English	Article							HEME OXYGENASE 1; NUCLEOSIDE TRIPHOSPHATE DIPHOSPHOHYDROLASE-1; NECROSIS-FACTOR RECEPTORS; ADENOSINE A2 RECEPTORS; HUMAN CD39; HEPATIC ISCHEMIA/REPERFUSION; ISCHEMIA-REPERFUSION; TARGETED DISRUPTION; SIGNAL-TRANSDUCTION; MEDIATED APOPTOSIS	Several biomedical applications, such as xenotransplantation, require multiple genes simultaneously expressed in eukaryotic cells. Advances in genetic engineering technologies have led to the development of efficient polycistronic vectors based on the use of the 2A self-processing oligopeptide. The aim of this work was to evaluate the protective effects of the simultaneous expression of a novel combination of anti-inflammatory human genes, ENTPD1, E5NT and HO-1, in eukaryotic cells. We produced an F2A system-based multicistronic construct to express three human proteins in NIH3T3 cells exposed to an inflammatory stimulus represented by tumor necrosis factor alpha (TNF-alpha), a pro-inflammatory cytokine which plays an important role during inflammation, cell proliferation, differentiation and apoptosis and in the inflammatory response during ischemia/reperfusion injury in several organ transplantation settings. The protective effects against TNF-alpha-induced cytotoxicity and cell death, mediated by HO-1, ENTPD1 and E5NT genes were better observed in cells expressing the combination of genes as compared to cells expressing each single gene and the effect was further improved by administrating enzymatic substrates of the human genes to the cells. Moreover, a gene expression analyses demonstrated that the expression of the three genes has a role in modulating key regulators of TNF-alpha signalling pathway, namely Nemo and Tnfaip3, that promoted pro-survival phenotype in TNF-alpha injured cells. These results could provide new insights in the research of protective mechanisms in transplantation settings.	[Cinti, Alessandro; De Giorgi, Marco; Chisci, Elisa; Arena, Claudia; Galimberti, Gloria; Farina, Laura; Smolenski, Ryszard Tom; Cerrito, Maria Grazia; Lavitrano, Marialuisa; Giovannoni, Roberto] Univ Milano Bicocca, Dept Surg & Translat Med, Monza, Italy; [De Giorgi, Marco; Smolenski, Ryszard Tom] Med Univ Gdansk, Gdansk, Poland; [Bugarin, Cristina; Gaipa, Giuseppe] Univ Milano Bicocca, Pediat Clin, M Tettamanti Res Ctr, Monza, Italy; [Rivolta, Ilaria] Univ Milano Bicocca, Dept Hlth Sci, Monza, Italy	University of Milano-Bicocca; Fahrenheit Universities; Medical University Gdansk; University of Milano-Bicocca; University of Milano-Bicocca	Giovannoni, R (corresponding author), Univ Milano Bicocca, Dept Surg & Translat Med, Monza, Italy.	roberto.giovannoni@unimib.it	Giovannoni, Roberto/A-1413-2009; Farina, Laura/ACM-9711-2022; Cerrito, Maria Grazia/AAA-1190-2019	Giovannoni, Roberto/0000-0002-7706-0672; Cerrito, Maria Grazia/0000-0002-3347-5817; Lavitrano, Marialuisa/0000-0003-4852-1318; De Giorgi, Marco/0000-0002-9823-1397; Gaipa, Giuseppe/0000-0002-1006-5946; Smolenski, Ryszard/0000-0002-0190-9414	Ministero della Ricerca e dell'Universita [FIRB-RBAP06LAHL]; University of Milano-Bicocca	Ministero della Ricerca e dell'Universita(Ministry of Education, Universities and Research (MIUR)); University of Milano-Bicocca	This work was supported by grants from the Ministero della Ricerca e dell'Universita [FIRB-RBAP06LAHL to ML] and the University of Milano-Bicocca [F.A.R. 2009 and 2010 to ML and RG]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn J, 2012, CURR HYPERTENS REP, V14, P510, DOI 10.1007/s11906-012-0309-0; Akamatsu Y, 2004, FASEB J, V18, P771, DOI 10.1096/fj.03-0921fje; Antonioli L, 2013, TRENDS MOL MED, V19, P355, DOI 10.1016/j.molmed.2013.03.005; Ngo BTT, 2013, XENOTRANSPLANTATION, V20, P177, DOI 10.1111/xen.12035; Bach FH, 1997, NAT MED, V3, P196, DOI 10.1038/nm0297-196; Bradley JR, 2008, J PATHOL, V214, P149, DOI 10.1002/path.2287; Brouard S, 2000, J EXP MED, V192, P1015, DOI 10.1084/jem.192.7.1015; Cabal-Hierro L, 2012, CELL SIGNAL, V24, P1297, DOI 10.1016/j.cellsig.2012.02.006; Cai M, 2011, J MOL CELL CARDIOL, V51, P927, DOI 10.1016/j.yjmcc.2011.09.003; Chan HY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028885; Charniot JC, 2007, FREE RADICAL RES, V41, P911, DOI 10.1080/10715760701429775; Cooper DKC, 2012, XENOTRANSPLANTATION, V19, P144, DOI 10.1111/j.1399-3089.2012.00708.x; Crikis S, 2010, AM J TRANSPLANT, V10, P2586, DOI 10.1111/j.1600-6143.2010.03257.x; CRONSTEIN BN, 1983, J EXP MED, V158, P1160, DOI 10.1084/jem.158.4.1160; de Felipe P, 2006, TRENDS BIOTECHNOL, V24, P68, DOI 10.1016/j.tibtech.2005.12.006; De Giorgi M, 2014, NUCLEOS NUCLEOT NUCL, V33, P313, DOI 10.1080/15257770.2014.896466; De Giorgi M, 2015, PLASMID, V79, P22, DOI 10.1016/j.plasmid.2015.03.004; Delikouras A, 2003, EUR J IMMUNOL, V33, P3127, DOI 10.1002/eji.200323566; Dwyer KM, 2006, TRANSPLANTATION, V82, P428, DOI 10.1097/01.tp.0000229023.38873.c0; Dwyer KM, 2004, J CLIN INVEST, V113, P1440, DOI 10.1172/JCI200419560; Eltzschig HK, 2013, TRENDS MOL MED, V19, P345, DOI 10.1016/j.molmed.2013.02.005; Enjyoji K, 1999, NAT MED, V5, P1010, DOI 10.1038/12447; Fang JM, 2005, NAT BIOTECHNOL, V23, P584, DOI 10.1038/nbt1087; Fang J, 2011, J PHARMACOL EXP THER, V339, P779, DOI 10.1124/jpet.111.185348; Fei DS, 2012, TRANSL RES, V159, P99, DOI 10.1016/j.trsl.2011.10.009; Fisicaro N, 2011, XENOTRANSPLANTATION, V18, P121, DOI 10.1111/j.1399-3089.2011.00631.x; Fondevila C, 2004, HEPATOLOGY, V40, P1333, DOI 10.1002/hep.20480; Gock H, 2011, TRANSPLANT REV-ORLAN, V25, P9, DOI 10.1016/j.trre.2010.10.001; Gozzelino R, 2010, ANNU REV PHARMACOL, V50, P323, DOI 10.1146/annurev.pharmtox.010909.105600; Griesemer A, 2014, IMMUNOL REV, V258, P241, DOI 10.1111/imr.12152; Grunewald JKG, 2010, J INFLAMM-LOND, V7, DOI 10.1186/1476-9255-7-10; Israel A, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000158; Iwase H, 2014, XENOTRANSPLANTATION, V21, P201, DOI 10.1111/xen.12085; Kim SJ, 2013, SHOCK, V39, P380, DOI 10.1097/SHK.0b013e31828aab7f; Klemz R, 2009, FREE RADICAL BIO MED, V46, P305, DOI 10.1016/j.freeradbiomed.2008.10.044; Koszalka P, 2004, CIRC RES, V95, P814, DOI 10.1161/01.RES.0000144796.82787.6f; Kriz A, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1120; LAPPIN D, 1984, CLIN EXP IMMUNOL, V57, P454; Lavitrano M, 2004, FASEB J, V18, P1093, DOI 10.1096/fj.03-0996fje; Li JX, 2013, ADV IMMUNOL, V119, P135, DOI 10.1016/B978-0-12-407707-2.00005-9; Luke GA, 2013, FUTURE VIROL, V8, P983, DOI 10.2217/fvl.13.82; Micheau O, 2003, CELL, V114, P181, DOI 10.1016/S0092-8674(03)00521-X; Mori DN, 2014, IMMUNOL REV, V258, P132, DOI 10.1111/imr.12146; Ollinger R, 2007, ANTIOXID REDOX SIGN, V9, P2175, DOI 10.1089/ars.2007.1807; Ollinger R, 2010, TRANSPL INT, V23, P1071, DOI 10.1111/j.1432-2277.2010.01158.x; Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X; OPIPARI AW, 1992, J BIOL CHEM, V267, P12424; Osborne FN, 2005, AM J TRANSPLANT, V5, P1248, DOI 10.1111/j.1600-6143.2005.00868.x; Paine A, 2010, BIOCHEM PHARMACOL, V80, P1895, DOI 10.1016/j.bcp.2010.07.014; PARMELY MJ, 1993, J IMMUNOL, V151, P389; Pujari R, 2013, IMMUNOL RES, V57, P166, DOI 10.1007/s12026-013-8463-2; Rath PC, 1999, J CLIN IMMUNOL, V19, P350, DOI 10.1023/A:1020546615229; Robson SC, 1999, ANN NY ACAD SCI, V875, P261, DOI 10.1111/j.1749-6632.1999.tb08509.x; Rothwell DG, 2010, HUM GENE THER, V21, P1631, DOI 10.1089/hum.2009.197; RYAN MD, 1994, EMBO J, V13, P928, DOI 10.1002/j.1460-2075.1994.tb06337.x; Sato K, 2001, J IMMUNOL, V166, P4185, DOI 10.4049/jimmunol.166.6.4185; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shuh M, 2013, OCHSNER J, V13, P119; SMOLENSKI RT, 1990, J CHROMATOGR-BIOMED, V527, P414, DOI 10.1016/S0378-4347(00)82125-8; Smolenski Ryszard T, 2006, Pharmacol Rep, V58 Suppl, P118; Soares MP, 1998, NAT MED, V4, P1073, DOI 10.1038/2063; Speeckaert MM, 2012, AM J NEPHROL, V36, P261, DOI 10.1159/000342333; Tabata T, 2003, TRANSPLANTATION, V75, P607, DOI 10.1097/01.TP.0000053353.03389.1C; Wang HJ, 2006, ENDOCRINOLOGY, V147, P762, DOI 10.1210/en.2005-0632; Wegiel B, 2014, ANTIOXID REDOX SIGN, V20, P1709, DOI 10.1089/ars.2013.5667; Wheeler DG, 2012, J MOL CELL CARDIOL, V52, P958, DOI 10.1016/j.yjmcc.2012.01.002; Xia ZW, 2007, PEDIATR TRANSPLANT, V11, P850, DOI 10.1111/j.1399-3046.2007.00701; Yang S, 2008, GENE THER, V15, P1411, DOI 10.1038/gt.2008.90; Yin WX, 2005, ANAL BIOCHEM, V346, P289, DOI 10.1016/j.ab.2005.08.029; Zelova H, 2013, INFLAMM RES, V62, P641, DOI 10.1007/s00011-013-0633-0	70	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2015	10	10							e0141933	10.1371/journal.pone.0141933	http://dx.doi.org/10.1371/journal.pone.0141933			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0ED	26513260	Green Published, gold, Green Submitted			2022-12-26	WOS:000363920300091
J	Ojo, OO; Srinivasan, DK; Owolabi, BO; Vasu, S; Conlon, JM; Flatt, PR; Abdel-Wahab, YHA				Ojo, Opeolu O.; Srinivasan, Dinesh K.; Owolabi, Bosede O.; Vasu, Srividya; Conlon, J. Michael; Flatt, Peter R.; Abdel-Wahab, Yasser H. A.			Esculentin-2CHa-Related Peptides Modulate Islet Cell Function and Improve Glucose Tolerance in Mice with Diet-Induced Obesity and Insulin Resistance	PLOS ONE			English	Article							HOST-DEFENSE PEPTIDES; FROG-SKIN PEPTIDE; TIGERININ-1R; SECRETION; HOMEOSTASIS; MOUSE	The frog skin host-defense peptide esculentin-2CHa (GFSSIFRGVA(10)KFASKGLGK D(20)LAKLGVDLVA(30)CKISKQC) displays antimicrobial, antitumor, and immunomodulatory properties. This study investigated the antidiabetic actions of the peptide and selected analogues. Esculentin-2CHa stimulated insulin secretion from rat BRIN-BD11 clonal pancreatic beta-cells at concentrations greater than 0.3 nM without cytotoxicity by a mechanism involving membrane depolarization and increase of intracellular Ca2+. Insulinotropic activity was attenuated by activation of KATP channels, inhibition of voltage-dependent Ca2+ channels and chelation of extracellular Ca2+. The [L21K], [L24K], [D20K, D27K] and [C31S, C37S] analogues were more potent but less effective than esculentin-2CHa whereas the [L28K] and [C31K] analogues were both more potent and produced a significantly (P < 0.001) greater maximum response. Acute administration of [L28K] esculentin-2CHa (75 nmol/kg body weight) to high fat fed mice with obesity and insulin resistance enhanced glucose tolerance and insulin secretion. Twice-daily administration of this dose of [L28K] esculentin-2CHa for 28 days had no significant effect on body weight, food intake, indirect calorimetry or body composition. However, mice exhibited decreased non-fasting plasma glucose (P < 0.05), increased non-fasting plasma insulin (P < 0.05) as well as improved glucose tolerance and insulin secretion (P < 0.01) following both oral and intraperitoneal glucose loads. Impaired responses of isolated islets from high fat fed mice to established insulin secretagogues were restored by [L28K] esculentin-2CHa treatment. Peptide treatment was accompanied by significantly lower plasma and pancreatic glucagon levels and normalization of a-cell mass. Circulating triglyceride concentrations were decreased but plasma cholesterol and LDL concentrations were not significantly affected. The data encourage further investigation of the potential of esculentin-2CHa related peptides for treatment of patients with type 2 diabetes.	[Ojo, Opeolu O.; Srinivasan, Dinesh K.; Owolabi, Bosede O.; Vasu, Srividya; Conlon, J. Michael; Flatt, Peter R.; Abdel-Wahab, Yasser H. A.] Univ Ulster, Sch Biomed Sci, SAAD Ctr Pharm & Diabet, Coleraine BT52 1SA, Londonderry, North Ireland; [Ojo, Opeolu O.] Univ E London, Sch Sport Hlth & Biosci, Stratford E15 4LZ, England	Ulster University; University of East London	Abdel-Wahab, YHA (corresponding author), Univ Ulster, Sch Biomed Sci, SAAD Ctr Pharm & Diabet, Coleraine BT52 1SA, Londonderry, North Ireland.	y.abdel-wahab@ulster.ac.uk		Ojo, Opeolu/0000-0003-2758-0474; Flatt, Peter/0000-0001-8548-7943	Diabetes UK [12/0004457]; University Vice Chancellor Research Studentship	Diabetes UK(Diabetes UK); University Vice Chancellor Research Studentship	Funding for this study was provided by a project grant from Diabetes UK (https://www.diabetes.org.uk, Grant Number 12/0004457) and an award of a University Vice Chancellor Research Studentship to DKS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Wahab YHA, 2010, HORM METAB RES, V42, P652, DOI 10.1055/s-0030-1254126; Abdel-Wahab YHA, 2008, BIOL CHEM, V389, P143, DOI 10.1515/BC.2008.018; Albanese CV, 2003, J CLIN DENSITOM, V6, P75, DOI 10.1385/JCD:6:2:75; Attoub S, 2013, PEPTIDES, V39, P95, DOI 10.1016/j.peptides.2012.11.004; Blonde Lawrence, 2005, Clin Cornerstone, V7 Suppl 3, pS6, DOI 10.1016/S1098-3597(05)80084-5; Bowie JH, 2012, PEPTIDES, V37, P174, DOI 10.1016/j.peptides.2012.06.017; Conlon JM, 2014, PEPTIDES, V57, P67, DOI 10.1016/j.peptides.2014.04.019; Conlon JM, 2014, PHARMACEUTICALS, V7, P58, DOI 10.3390/ph7010058; Conlon JM, 2011, CELL MOL LIFE SCI, V68, P2303, DOI 10.1007/s00018-011-0720-8; Conlon JM, 2011, PEPTIDES, V32, P664, DOI 10.1016/j.peptides.2011.01.018; D'Alessio D, 2011, DIABETES OBES METAB, V13, P126, DOI 10.1111/j.1463-1326.2011.01449.x; FLATT PR, 1981, DIABETOLOGIA, V20, P573; FRIDOLF T, 1991, DIABETES RES CLIN EX, V16, P185; Gault VA, 2011, J ENDOCRINOL, V208, P265, DOI 10.1530/JOE-10-0419; GOTOH M, 1985, TRANSPLANTATION, V40, P437, DOI 10.1097/00007890-198510000-00018; Heppner KM, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00092; Johnson R, 1997, CLIN CHEM, V43, P2183; Koster JC, 2005, DIABETES, V54, P3065, DOI 10.2337/diabetes.54.11.3065; LACY PE, 1967, DIABETES, V16, P35, DOI 10.2337/diab.16.1.35; Mechkarska M, 2011, PEPTIDES, V32, P203, DOI 10.1016/j.peptides.2010.11.002; Nicolas P, 2009, BBA-BIOMEMBRANES, V1788, P1537, DOI 10.1016/j.bbamem.2008.09.006; Ojo OO, 2015, BBA-GEN SUBJECTS, V1850, P80, DOI 10.1016/j.bbagen.2014.10.011; Ojo OO, 2011, DIABETES OBES METAB, V13, P1114, DOI 10.1111/j.1463-1326.2011.01470.x; Ojo OO, HDB BIOL ACTIVE PEPT, P364; Ojo OO, 2015, BIOCHIMIE, V109, P18, DOI 10.1016/j.biochi.2014.11.018; Ojo OO, 2013, CHEM BIOL DRUG DES, V82, P196, DOI 10.1111/cbdd.12151; Pukala TL, 2006, NAT PROD REP, V23, P368, DOI 10.1039/b512118n; Srinivasan D, 2015, EUR J PHARMACOL, V764, P38, DOI 10.1016/j.ejphar.2015.06.042; Srinivasan D, 2014, PEPTIDES, V55, P23, DOI 10.1016/j.peptides.2014.02.002; Srinivasan DK, ACTA DIABET IN PRESS; Winzell MS, 2004, DIABETES, V53, pS215, DOI 10.2337/diabetes.53.suppl_3.S215	31	16	16	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2015	10	10							e0141549	10.1371/journal.pone.0141549	http://dx.doi.org/10.1371/journal.pone.0141549			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0ED	26512980	gold, Green Published, Green Accepted			2022-12-26	WOS:000363920300049
J	Singarapu, KK; Otte, MM; Tonelli, M; Westler, WM; Escalante-Semerena, JC; Markley, JL				Singarapu, Kiran K.; Otte, Michele M.; Tonelli, Marco; Westler, William M.; Escalante-Semerena, Jorge C.; Markley, John L.			Solution Structural Studies of GTP: Adenosylcobinamide-Phosphateguanylyl Transferase (CobY) from Methanocaldococcus jannaschii	PLOS ONE			English	Article							SALMONELLA-TYPHIMURIUM LT2; GUANYLYLTRANSFERASE COBY; 3-DIMENSIONAL STRUCTURE; 3D STRUCTURE; ENZYME; SERVER; IDENTIFICATION; SYNTHETASE; PROTEINS; PACKAGE	GTP:adenosylcobinamide-phosphate (AdoCbi-P) guanylyl transferase (CobY) is an enzyme that transfers the GMP moiety of GTP to AdoCbi yielding AdoCbi-GDP in the late steps of the assembly of Ado-cobamides in archaea. The failure of repeated attempts to crystallize ligand-free (apo) CobY prompted us to explore its 3D structure by solution NMR spectroscopy. As reported here, the solution structure has a mixed alpha/beta fold consisting of seven beta-strands and five alpha-helices, which is very similar to a Rossmann fold. Titration of apo-CobY with GTP resulted in large changes in amide proton chemical shifts that indicated major structural perturbations upon complex formation. However, the CobY:GTP complex as followed by H-1-N-15 HSQC spectra was found to be unstable over time:GTP hydrolyzed and the protein converted slowly to a species with an NMR spectrum similar to that of apo-CobY. The variant CobY(G153D), whose GTP complex was studied by X-ray crystallography, yielded NMR spectra similar to those of wild-type CobY in both its apo-state and in complex with GTP. The CobY(G153D):GTP complex was also found to be unstable over time.	[Singarapu, Kiran K.; Tonelli, Marco; Westler, William M.; Markley, John L.] Univ Wisconsin, Natl Magnet Resonance Facil Madison, Madison, WI 53706 USA; [Singarapu, Kiran K.; Tonelli, Marco; Westler, William M.; Markley, John L.] Univ Wisconsin, Dept Biochem, Madison, WI 53705 USA; [Singarapu, Kiran K.] Indian Inst Chem Technol, CSIR, Ctr NMR & Struct Chem, Hyderabad 500007, Telangana, India; [Otte, Michele M.; Escalante-Semerena, Jorge C.] Univ Georgia, Dept Microbiol, Athens, GA 30602 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Technology (IICT); University System of Georgia; University of Georgia	Singarapu, KK (corresponding author), Univ Wisconsin, Natl Magnet Resonance Facil Madison, Madison, WI 53706 USA.	singarapu@iict.res.in; jmarkley@wisc.edu	Singarapu, Kiran/AAU-3435-2020		National Institutes of Health (NIH) [R37 GM040313, P41 GM103399]; Ramanujan Fellowship from the Department of Science and Technology (DST-India); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103399, R37GM040313, P41GM066326] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ramanujan Fellowship from the Department of Science and Technology (DST-India); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health (NIH) Grants R37 GM040313 to JCE-S and P41 GM103399 to JLM, which supports the National Magnetic Resonance Facility at Madison. KKS received support from a Ramanujan Fellowship from the Department of Science and Technology (DST-India).	Bahrami A, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000307; Battersby AR, 2000, NAT PROD REP, V17, P507, DOI 10.1039/b002635m; Baur S, 2009, J BACTERIOL, V191, P1200, DOI 10.1128/JB.01120-08; Bhattacharya A, 2007, PROTEINS, V66, P778, DOI 10.1002/prot.21165; Billeter M, 1995, J BIOMOL NMR, V5, P1; Chan CH, 2011, MOL MICROBIOL, V81, P952, DOI 10.1111/j.1365-2958.2011.07741.x; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DeLano WL, 2005, ABSTR PAP AM CHEM S, V230, pU1371; Guntert Peter, 2004, Methods Mol Biol, V278, P353; HOLM L, 1995, TRENDS BIOCHEM SCI, V20, P478, DOI 10.1016/S0968-0004(00)89105-7; Jelakovic S, 2001, J MOL BIOL, V312, P143, DOI 10.1006/jmbi.2001.4948; Kanelis V, 1998, BIOCHEM CELL BIOL, V76, P341, DOI 10.1139/bcb-76-2-3-341; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Koropatkin NM, 2005, J BIOL CHEM, V280, P10774, DOI 10.1074/jbc.M414111200; Laskowski RA, 2005, NUCLEIC ACIDS RES, V33, pW89, DOI 10.1093/nar/gki414; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lee W, 2015, BIOINFORMATICS, V31, P1325, DOI 10.1093/bioinformatics/btu830; Lee W, 2014, J BIOMOL NMR, V60, P73, DOI 10.1007/s10858-014-9855-x; Mosimann SC, 2001, J BIOL CHEM, V276, P8190, DOI 10.1074/jbc.M007235200; Newmister SA, 2011, BIOCHEMISTRY-US, V50, P5301, DOI 10.1021/bi200329t; Nguyen MN, 2011, NUCLEIC ACIDS RES, V39, pW24, DOI 10.1093/nar/gkr393; OTOOLE GA, 1995, J BIOL CHEM, V270, P23560, DOI 10.1074/jbc.270.40.23560; Otte MM, 2009, BIOCHEMISTRY-US, V48, P5882, DOI 10.1021/bi8023114; Pei JM, 2008, NUCLEIC ACIDS RES, V36, pW30, DOI 10.1093/nar/gkn322; RAO ST, 1973, J MOL BIOL, V76, P241, DOI 10.1016/0022-2836(73)90388-4; Sattler M, 1999, PROG NUCL MAG RES SP, V34, P93, DOI 10.1016/S0079-6565(98)00025-9; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Thomas MG, 2000, J BIOL CHEM, V275, P27576; Thomas MG, 2000, J BACTERIOL, V182, P4227, DOI 10.1128/JB.182.15.4227-4233.2000; Thompson TB, 1999, BIOCHEMISTRY-US, V38, P12995, DOI 10.1021/bi990910x; Thompson TB, 1998, BIOCHEMISTRY-US, V37, P7686, DOI 10.1021/bi973178f; Zhao Qin, 2004, Journal of Structural and Functional Genomics, V5, P87, DOI 10.1023/B:JSFG.0000029205.65813.42	34	1	1	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2015	10	10							e0141297	10.1371/journal.pone.0141297	http://dx.doi.org/10.1371/journal.pone.0141297			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0ED	26513744	Green Published, Green Submitted, gold			2022-12-26	WOS:000363920300026
J	Aringstrom-Brannstrom, C; Engvall, G; Mullaney, T; Nilsson, K; Wickart-Johansson, G; Svard, AM; Nyholm, T; Lindh, J; Lindh, V				Angstrom-Brannstrom, Charlotte; Engvall, Gunn; Mullaney, Tara; Nilsson, Kristina; Wickart-Johansson, Gun; Svard, Anna-Maja; Nyholm, Tufve; Lindh, Jack; Lindh, Viveca			Children Undergoing Radiotherapy: Swedish Parents' Experiences and Suggestions for Improvement	PLOS ONE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; PEDIATRIC RADIOTHERAPY; GENERAL-ANESTHESIA; CANCER; PERCEPTIONS; INTERVENTION; SYMPTOMS; TOOL	Approximately 300 children, from 0 to 18 years old, are diagnosed with cancer in Sweden every year. Of these children, 80-90 of them undergo radiotherapy treatment for their cancer. Although radiotherapy is an encounter with advanced technology, few studies have investigated the child's and the parent's view of the procedure. As part of an ongoing multi-center study aimed to improve patient preparation and the care environment in pediatric radiotherapy, this article reports the findings from interviews with parents at baseline. The aim of the present study was twofold: to describe parents' experience when their child undergoes radiotherapy treatment, and to report parents' suggestions for improvements during radiotherapy for their children. Sixteen mothers and sixteen fathers of children between 2-16 years old with various cancer diagnoses were interviewed. Data were analyzed using content analysis. The findings showed that cancer and treatment turns people's lives upside down, affecting the entire family. Further, the parents experience the child's suffering and must cope with intense feelings. Radiotherapy treatment includes preparation by skilled and empathetic staff. The parents gradually find that they can deal with the process; and lastly, parents have suggestions for improvements during the radiotherapy treatment. An overarching theme emerged: that despair gradually turns to a sense of security, with a sustained focus on and close interaction with the child. In conclusion, an extreme burden was experienced around the start of radiotherapy, though parents gradually coped with the process.	[Angstrom-Brannstrom, Charlotte; Lindh, Viveca] Umea Univ, Dept Nursing, Umea, Sweden; [Engvall, Gunn] Uppsala Univ, Dept Women s & Childrens Hlth, Uppsala, Sweden; [Engvall, Gunn] Uppsala Univ, Dept Publ Hlth & Caring Sci, Uppsala, Sweden; [Mullaney, Tara] Umea Univ, Umea Inst Design, Umea, Sweden; [Nilsson, Kristina] Univ Uppsala Hosp, Dept Oncol Radiol & Clin Immunol, Sect Oncol, Uppsala, Sweden; [Wickart-Johansson, Gun] Karolinska Univ Hosp, Dept Oncol Radiumhemmet, Stockholm, Sweden; [Svard, Anna-Maja; Nyholm, Tufve; Lindh, Jack] Umea Univ, Dept Radiat Sci, Umea, Sweden	Umea University; Uppsala University; Uppsala University; Umea University; Uppsala University; Uppsala University Hospital; Karolinska Institutet; Karolinska University Hospital; Umea University	Aringstrom-Brannstrom, C (corresponding author), Umea Univ, Dept Nursing, Umea, Sweden.	charlotte.angstrom@umu.se	Nyholm, Tufve/I-1402-2019; Mullaney, Tara/N-5628-2015	Nyholm, Tufve/0000-0002-8971-9788; Engvall, Gunn/0000-0002-5225-9650; Mullaney, Tara/0000-0002-7097-7736	Swedish Childhood Cancer Foundation (Barncancerfonden) [PR 2013-0025]	Swedish Childhood Cancer Foundation (Barncancerfonden)	Funding provided by grant number PR 2013-0025, The Swedish Childhood Cancer Foundation (Barncancerfonden), URL: http://www.barncancerfonden.se. TN received the funding.	Angstrom-Brannstrom C, 2010, J PEDIATR ONCOL NURS, V27, P266, DOI 10.1177/1043454210364623; Bertoni F, 1999, RADIOTHER ONCOL, V52, P185, DOI 10.1016/S0167-8140(99)00082-1; Bjork Maria, 2009, J Pediatr Nurs, V24, P423, DOI 10.1016/j.pedn.2008.01.082; Bowlby J., 1973, ATTACHMENT LOSS, P1; Bucholtz J D, 1994, Oncol Nurs Forum, V21, P987; Delany C, 2012, PEDIATR RADIOL, V42, P139, DOI 10.1007/s00247-011-2271-4; Benedetti GMD, 2014, REV LAT-AM ENFERM, V22, P425, DOI 10.1590/0104-1169.3264.2433; Filin A, 2009, J PEDIATR ONCOL NURS, V26, P81, DOI 10.1177/1043454208328766; Flury M, 2011, J PEDIATR ONCOL NURS, V28, P143, DOI 10.1177/1043454210378015; Gibbins J, 2012, J PEDIATR ONCOL NURS, V29, P253, DOI 10.1177/1043454212452791; Graneheim UH, 2004, NURS EDUC TODAY, V24, P105, DOI 10.1016/j.nedt.2003.10.001; Griffiths M, 2011, J PEDIATR ONCOL NURS, V28, P83, DOI 10.1177/1043454210377902; Gustafsson G, CHILDHOOD CANC INCID; Haeberli S, 2008, RADIAT ONCOL, V3, DOI 10.1186/1748-717X-3-17; Harrison TM, 2010, J PEDIATR NURS, V25, P335, DOI 10.1016/j.pedn.2009.01.006; Heden L, 2013, J PAIN SYMPTOM MANAG, V46, P366, DOI 10.1016/j.jpainsymman.2012.09.012; Hildenbrand AK, 2011, J PEDIATR ONCOL NURS, V28, P344, DOI 10.1177/1043454211430823; Jackson AC, 2007, J PEDIATR ONCOL NURS, V24, P95, DOI 10.1177/1043454206296030; Kazak AE, 2004, J PEDIATR PSYCHOL, V29, P211, DOI 10.1093/jpepsy/jsh022; Klosky JL, 2007, CHILD HEALTH CARE, V36, P323, DOI 10.1080/02739610701601312; Kristensen I, 2009, ACTA ONCOL, V48, P146, DOI 10.1080/02841860802409520; Mealer Meredith, 2014, Nurse Res, V21, P32, DOI 10.7748/nr2014.03.21.4.32.e1229; Mullaney T, 2012, INT J DES, V6, P27; Olsen PR, 2009, CANCER NURS, V32, P493, DOI 10.1097/NCC.0b013e3181b3857e; Patton M. Q., 2002, QUALITATIVE RES EVAL, V3rd; Poder U, 2008, PSYCHO-ONCOLOGY, V17, P430, DOI 10.1002/pon.1263; Poder U, 2010, J PAIN SYMPTOM MANAG, V40, P661, DOI 10.1016/j.jpainsymman.2010.02.012; Scott Linda, 2002, Eur J Oncol Nurs, V6, P15, DOI 10.1054/ejon.2001.0162; Shrimpton BJM, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-001666; Soanes L, 2009, EUR J ONCOL NURS, V13, P255, DOI 10.1016/j.ejon.2009.03.009; Tornqvist E, 2015, J CHILD HEALTH CARE, V19, P359, DOI 10.1177/1367493513518374; Trier-Bieniek A, 2012, QUAL RES, V12, P630, DOI 10.1177/1468794112439005; Willis D, 2010, J MED IMAG RADIAT ON, V54, P249, DOI 10.1111/j.1754-9485.2010.02165.x	33	14	14	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2015	10	10							e0141086	10.1371/journal.pone.0141086	http://dx.doi.org/10.1371/journal.pone.0141086			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CV0DL	26509449	Green Published, Green Submitted, gold			2022-12-26	WOS:000363918100051
J	Cai, M; Kappelman, MD; Girman, CJ; Jain, N; Sturmer, T; Brookhart, MA				Cai, Mona; Kappelman, Michael D.; Girman, Cynthia J.; Jain, Nina; Stuermer, Til; Brookhart, Maurice Alan			Trends and Determinants of Oral Anti-Diabetic Initiation in Youth with Suspected Type 2 Diabetes	PLOS ONE			English	Article							INSULIN-RESISTANCE; OBESE YOUTH; GLUCOSE-TOLERANCE; PEDIATRIC OBESITY; MEDICATION USE; UNITED-STATES; ADOLESCENTS; CHILDREN; PREVALENCE; MANAGEMENT	Objective To evaluate trends and identify predictors of treatment initiation of oral anti-diabetic drugs (OAD) in youth. Patients and Methods We identified a select population of children, ages 8-18 years, with at least 13 months of continuous health plan coverage within the years 2001-2012 in a large US commercial insurance claims database. New use of an OAD was defined as the first claim for an outpatient dispensing following a 12-month wash out period. Treatment incidence was estimated monthly over the study period, and stratified by age, gender, geographic region, and provider specialty. Results The median size of the source population during the study period was 2.2 million children. A total of 13,824 initiators (mean monthly incidence of 4.6 (95% CI = 3.6, 5.5) per 100,000 youths) were identified. Initiators were more likely to be females, age 15-18, from the southern region, and have visited a family practitioner (versus a general pediatrician) prior to initiation. Time trends demonstrate a 43% increase in initiation from 2002-2012, with a gradual decrease starting from early 2008. Conclusion Incidence of filled OAD medications in youth increased over time, especially for patients treated by family practitioners. Additional research is needed into factors influencing prescribing by family practitioners and pediatricians.	[Cai, Mona; Stuermer, Til; Brookhart, Maurice Alan] UNC Gillings Sch Global Publ Hlth, Dept Epidemiol, Chapel Hill, NC 27515 USA; [Kappelman, Michael D.] UNC Gillings Sch Global Publ Hlth, Dept Pediat, Div Pediat Gastroenterol, Chapel Hill, NC USA; [Girman, Cynthia J.] LLC, CERobs Consulting, Chapel Hill, NC USA; [Jain, Nina] UNC Sch Med, Dept Pediat, Div Pediat Endocrinol, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Cai, M (corresponding author), UNC Gillings Sch Global Publ Hlth, Dept Epidemiol, Chapel Hill, NC 27515 USA.	caim@email.unc.edu	Stürmer, Til/AAB-5459-2022		CERobs Consulting; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R21HD080214] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG023178, R01AG042845] Funding Source: NIH RePORTER	CERobs Consulting; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	One of the co-authors, Cynthia Girman, is the President of CERobs Consulting. However, the company did not play any financial role in this study. The authors did not receive funding for this work. CERobs Consulting provided support in the form of salary for author CJG, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	[Anonymous], 2008, EPIDEMIOLOGY PEDIAT; [Anonymous], 2011, PRODUCTS HLTH E STAT; Brown JB, 2002, FAM PRACT, V19, P344, DOI 10.1093/fampra/19.4.344; Centers for Disease Control, 2020, NATL DIABETES STAT R; Choudhry NK, 2010, NEW ENGL J MED, V363, P1885, DOI 10.1056/NEJMp1006189; Cleveland W.S., 1992, LOCAL REGRESSION MOD, P309; Copeland KC, 2013, PEDIATRICS, V131, P364, DOI 10.1542/peds.2012-3494; Copeland KC, 2011, J CLIN ENDOCR METAB, V96, P159, DOI 10.1210/jc.2010-1642; Cowie CC, 2009, DIABETES CARE, V32, P287, DOI DOI 10.2337/DC08-1296; Cox ER, 2008, PEDIATRICS, V122, pE1053, DOI 10.1542/peds.2008-0214; Dabelea D, 2007, JAMA-J AM MED ASSOC, V297, P2716; Hamman RF, 2014, DIABETES CARE, V37, P3336, DOI 10.2337/dc14-0574; Hannon TS, 2005, PEDIATRICS, V116, P473, DOI 10.1542/peds.2004-2536; Imperatore G, 2012, DIABETES CARE, V35, P2515, DOI 10.2337/dc12-0669; Jelalian E, 2003, CLIN PEDIATR, V42, P235, DOI 10.1177/000992280304200307; Kim G, 2011, PEDIATR CLIN N AM, V58, P1355, DOI 10.1016/j.pcl.2011.09.002; Lauffenburger JC, 2013, PHARMACOEPIDEM DR S, V22, P899, DOI 10.1002/pds.3458; Lee JM, 2006, DIABETES CARE, V29, P2427, DOI 10.2337/dc06-0709; Liberman JN, 2009, ARCH PEDIAT ADOL MED, V163, P357, DOI 10.1001/archpediatrics.2009.5; Lidfeldt J, 2007, AM J EPIDEMIOL, V165, P882, DOI 10.1093/aje/kwk078; Liese AD, 2006, PEDIATRICS, V118, P1510, DOI DOI 10.1542/PEDS.2006-0690; Mayer-Davis EJ, 2009, DIABETES CARE, V32, pS99, DOI 10.2337/dc09-S201; Meltzer S, 1998, CAN MED ASSOC J, V159, pS1; Nadeau K, 2008, ENDOCR RES, V33, P35, DOI 10.1080/07435800802080138; Nader N, 2014, J PRIM CARE COMMUNIT, V5, P44, DOI 10.1177/2150131913495739; Rodriguez BL, 2006, DIABETES CARE, V29, P1891, DOI 10.2337/dc06-0310; Rosenbloom A, 2000, DIABETES CARE, V23, P381; Selvin E, 2014, ANN INTERN MED, V160, P517, DOI 10.7326/M13-2411; Tfayli H, 2009, DIABETES, V58, P738, DOI 10.2337/db08-1372; Thomson Reuters, 2007, MARKETSCAN USER GUID; Weiss R, 2005, DIABETES CARE, V28, P902, DOI 10.2337/diacare.28.4.902; Weiss R, 2003, LANCET, V362, P951, DOI 10.1016/S0140-6736(03)14364-4; Wong K, 2010, DIABETES CARE, V33, P512, DOI 10.2337/dc09-1333	33	0	0	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2015	10	10							e0140611	10.1371/journal.pone.0140611	http://dx.doi.org/10.1371/journal.pone.0140611			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0DL	26509706	gold, Green Published, Green Submitted			2022-12-26	WOS:000363918100035
J	Gonzalez-Gonzalez, C; Lopez-Vazquez, P; Vazquez-Lago, JM; Pineiro-Lamas, M; Herdeiro, MT; Arzamendi, PC; Figueiras, A				Gonzalez-Gonzalez, Cristian; Lopez-Vazquez, Paula; Vazquez-Lago, Juan Manuel; Pineiro-Lamas, Marai; Herdeiro, Maria Teresa; Chavarri Arzamendi, Pilar; Figueiras, Adolfo		GREPHEPI Grp	Effect of Physicians' Attitudes and Knowledge on the Quality of Antibiotic Prescription: A Cohort Study	PLOS ONE			English	Article							ANTIMICROBIAL CONSUMPTION ESAC; PRIMARY-CARE; UNDERSTANDING PHYSICIAN; EUROPEAN SURVEILLANCE; RESISTANCE; COMMUNITY; PATIENT; SCALES	Resistance increases with the use and abuse of antibiotics. Since physicians are primarily responsible for the decision to use antibiotics, ascertaining the attitudes and knowledge that underlie their prescribing habits is thus a prerequisite for improving prescription. Three-year follow-up cohort study (2008-2010) targeting primary-care physicians (n = 2100) in Galicia, a region in NW Spain. We used data obtained from a postal survey to assess knowledge and attitudes. A physician was deemed to have demonstrated Appropriate Quality Prescription of Antibiotics (dependent variable) in any case where half or more of the indicators proposed by the European Surveillance of Antimicrobial Consumption had values that were better than the reference values for Spain. The mail-questionnaire response rate was 68.0% (1428/2100). The adjusted increase in the interquartile OR of displaying good prescribing of antibiotics for each attitude was: 205% for fear ("When in doubt, it is better to ensure that a patient is cured of an infection by using a broad-spectrum antibiotic"; 95% CI: 125% to 321%); 119% for better knowledge ("Amoxicillin is useful for resolving most respiratory infections in primary care"; 95% CI: 67% to 193%); and 21% for complacency with patients' demands ("Antibiotics are often prescribed due to patients' demands"; 95% CI: 0% to 45%). Due to the fact that physicians' knowledge and attitudes are potentially modifiable, the implementation of purpose-designed educational interventions based on the attitudes identified may well serve to improve antibiotic prescription.	[Gonzalez-Gonzalez, Cristian; Lopez-Vazquez, Paula; Vazquez-Lago, Juan Manuel; Figueiras, Adolfo] Univ Santiago de Compostela, Dept Prevent Med & Publ Hlth, Santiago De Compostela, Spain; [Pineiro-Lamas, Marai; Figueiras, Adolfo] CIBER Epidemiol & Salud Publ CIBERESP, Consortium Biomed Res Epidemiol & Publ Hlth, Santiago De Compostela, Spain; [Pineiro-Lamas, Marai] CESPU, Gandra PRD, Polytech & Univ Teaching Inst, Gandra, Portugal; [Pineiro-Lamas, Marai] Gandra PRD, Inst Adv Res & Training Hlth Sci & Technol, Gandra, Portugal; [Pineiro-Lamas, Marai] Univ Porto, Fac Med, Northern Pharmacovigilance Unit, P-4100 Oporto, Portugal; [Chavarri Arzamendi, Pilar] Serv Gallego Salud SERGAS, Subdirectorate Gen Pharm, Galician Hlth Serv, Santiago De Compostela, Spain	Universidade de Santiago de Compostela; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Universidade do Porto	Figueiras, A (corresponding author), Univ Santiago de Compostela, Dept Prevent Med & Publ Hlth, Santiago De Compostela, Spain.	adolfo.figueiras@usc.es	Herdeiro, Maria/H-8195-2013; Figueiras, Adolfo/K-8563-2015; Vazquez-Lago, Juan/N-4174-2019; /AAD-1740-2020; Vazquez, Juan/M-2632-2016	Herdeiro, Maria/0000-0002-0500-4049; Figueiras, Adolfo/0000-0002-5766-8672; Vazquez-Lago, Juan/0000-0003-3457-9957; Vazquez, Juan/0000-0003-3457-9957; Lopez-Vazquez, Paula M/0000-0002-6836-2863; Pineiro-Lamas, Maria/0000-0003-3655-100X; Zapata Cachafeiro, Maruxa/0000-0002-0648-7716	Health Research Fund (Fondo de Investigacion Sanitaria) grant from the Spanish Ministry of Health; Health Research Fund (Fondo de Investigacion Sanitaria) grant from the Mutua Madrilena insurance company	Health Research Fund (Fondo de Investigacion Sanitaria) grant from the Spanish Ministry of Health; Health Research Fund (Fondo de Investigacion Sanitaria) grant from the Mutua Madrilena insurance company	This work was supported by the Health Research Fund (Fondo de Investigacion Sanitaria) grants from the Spanish Ministry of Health to AF and the Mutua Madrilena insurance company to AF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adriaenssens N, 2010, EUROPEAN SURVEILLANC; Adriaenssens N, 2011, J ANTIMICROB CHEMOTH, V66, P71, DOI 10.1093/jac/dkr459; Cadieux G, 2007, CAN MED ASSOC J, V177, P877, DOI 10.1503/cmaj.070151; Campos J, 2012, ENFERM INFEC MICR CL, V30, P589, DOI 10.1016/j.eimc.2012.07.003; Coenen S, 2007, QUAL SAF HEALTH CARE, V16, P440, DOI 10.1136/qshc.2006.021121; Costelloe C, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2096; Du Toit R, 2002, OPTOMETRY VISION SCI, V79, P313, DOI 10.1097/00006324-200205000-00011; European Centre for Disease Prevention and Control, 2011, SURV REP SURV ANT CO; European Centre for Disease Prevention and Control, QUAL IND ANT CONS CO; European Commission, 2010, ANT RES EUR 338 WAV; Figueiras A, 1999, MED CARE, V37, P809, DOI 10.1097/00005650-199908000-00010; Finch RG, 2004, LANCET INFECT DIS, V4, P44, DOI 10.1016/S1473-3099(03)00860-0; Goossens H, 2005, LANCET, V365, P579, DOI 10.1016/S0140-6736(05)17907-0; Grant S, 1999, CHEST, V116, P1208, DOI 10.1378/chest.116.5.1208; Hoye S, 2011, BMC FAM PRACT, V12, DOI 10.1186/1471-2296-12-34; Johnson TP, 2012, JAMA-J AM MED ASSOC, V307, P1805, DOI 10.1001/jama.2012.3532; Johnson TP, 2004, 2003 P SECT SURV RES, P127; Laxminarayan R, 2013, LANCET INFECT DIS, V13, P1057, DOI 10.1016/S1473-3099(13)70318-9; Livermore DM, 2005, LANCET INFECT DIS, V5, P450, DOI 10.1016/S1473-3099(05)70166-3; Lopez-Vazquez P, 2012, J EVAL CLIN PRACT, V18, P473, DOI 10.1111/j.1365-2753.2010.01610.x; Lorenzetti RC, 2013, AM FAM PHYSICIAN, V87, P419; Mcdowell I., 2006, MEASURING HLTH GUIDE, V3, P37, DOI [DOI 10.1093/ACPROF:OSO/9780195165678.001.0001, 10.1093/acprof:oso/9780195165678.001.0001]; Rodrigues AT, 2013, INT J ANTIMICROB AG, V41, P203, DOI 10.1016/j.ijantimicag.2012.09.003; Scheipl F., 2020, LINEAR MIXED EFFECTS, DOI 10.18637/jss.v067.i01; SIMPSON M, 1991, BRIT MED J, V303, P1385, DOI 10.1136/bmj.303.6814.1385; Spurling GKP, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004417.pub4; Srinivasan A, 2004, ARCH INTERN MED, V164, P1451, DOI 10.1001/archinte.164.13.1451; Vazquez-Lago JM, 2012, FAM PRACT, V29, P352, DOI 10.1093/fampra/cmr084; WARTMAN SA, 1983, PUBLIC HEALTH REP, V98, P141; World Health Organization, ESS MED HLTH PROD IN; Zapata-Cachafeiro M, 2014, J ANTIMICROB CHEMOTH, V69, P3156, DOI 10.1093/jac/dku229	31	44	44	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2015	10	10							e0141820	10.1371/journal.pone.0141820	http://dx.doi.org/10.1371/journal.pone.0141820			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0DL	26509966	Green Published, Green Submitted, gold			2022-12-26	WOS:000363918100137
J	Li, CG; Luo, XF; Lin, YY; Tang, XQ; Ling, LM; Wang, L; Jiang, YF				Li, Chenguang; Luo, Xiaofan; Lin, Yuyang; Tang, Xiuqi; Ling, Limian; Wang, Lei; Jiang, Yanfang			A Higher Frequency of CD14(+)CD169(+) Monocytes/Macrophages in Patients with Colorectal Cancer	PLOS ONE			English	Article							TUMOR-ASSOCIATED MACROPHAGES; ALTERNATIVELY ACTIVATED MACROPHAGES; INTESTINAL MACROPHAGES; MONOCYTES; INFLAMMATION; EXPRESSION; DISEASE; TISSUE; CELLS; DIFFERENTIATION	Objective Monocytes and macrophages can infiltrate into tumor microenvironment and regulate the progression of tumors. This study aimed at determining the frequency of different subsets of circulating monocytes and tumor infiltrating macrophages (TIMs) in patients with colorectal cancer (CRC). Methods The frequency of different subsets of circulating monocytes was characterized in 46 CRC patients and 22 healthy controls (HC) by flow cytometry. The frequency of different subsets of macrophages was analyzed in TIMs from 30 tumor tissues and in lamina propria mononuclear cells (LPMCs) from 12 non-tumor tissues. The concentrations of plasma cytokines and carcinoembryonic antigen (CEA) were determined. The potential association of these measures with the values of clinical parameters was analyzed. Results In comparison with that in the HC, the percentages of circulating CD14(+)CD169(+), CD14(+)CD169(+) CD163(+) and CD14(+)CD169(+)CD206(+) monocytes and TIMs CD14(+)CD169(+) as well as IL-10(+)CD14(+)CD169(+), but not IL-12(+)CD14(+)CD169(+) macrophages were significantly increased, accompanied by higher levels of plasma IL-10 in the CRC patients. The percentages of CD14(+)CD169(+) circulating monocytes and TIM macrophages were associated with the stage of disease and correlated positively with the levels of plasma IL-10 and CEA in CRC patients. Conclusion Our data suggest that an increase in the frequency of CD14(+)CD169(+) cells may be associated with the development and progression of CRC and is concomitant rise of both, pro-tumor (M2-like, IL-10 producing) and anti-tumor (M1-like, IL-12 producing) monocytes and infiltrating macrophages. The frequency of CD14(+)CD169(+) circulating monocytes and infiltrating macrophages may serve as a biomarker for evaluating the pathogenic degrees of CRC.	[Li, Chenguang; Luo, Xiaofan; Lin, Yuyang; Tang, Xiuqi; Ling, Limian; Wang, Lei] Jilin Univ, Dept Colorectal & Anal Surg, Hosp 1, Changchun 130023, Peoples R China; [Jiang, Yanfang] Jilin Univ, Hosp 1, Genet Diag Ctr, Changchun 130023, Peoples R China; [Jiang, Yanfang] Jilin Univ, Hosp 1, Minist Educ, Key Lab Zoonosis Res, Changchun 130023, Peoples R China	Jilin University; Jilin University; Jilin University	Wang, L (corresponding author), Jilin Univ, Dept Colorectal & Anal Surg, Hosp 1, Changchun 130023, Peoples R China.	wanglei309@163.com; yanfangjiang@hotmail.com						Allavena P, 2008, CRIT REV ONCOL HEMAT, V66, P1, DOI 10.1016/j.critrevonc.2007.07.004; Atsumi T, 2014, CANCER RES, V74, P8, DOI 10.1158/0008-5472.CAN-13-2322; Bain CC, 2013, MUCOSAL IMMUNOL, V6, P498, DOI 10.1038/mi.2012.89; Biesen R, 2008, ARTHRITIS RHEUM-US, V58, P1136, DOI 10.1002/art.23404; Buckner CM, 2011, CELL IMMUNOL, V267, P109, DOI 10.1016/j.cellimm.2010.12.004; Coffelt SB, 2014, NATURE, V507, P48, DOI 10.1038/nature13062; Cook J, 2013, CURR OPIN PHARMACOL, V13, P595, DOI 10.1016/j.coph.2013.05.017; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; De Palma M, 2013, CANCER CELL, V23, P277, DOI 10.1016/j.ccr.2013.02.013; Edge SB, 2010, AJCC CANC STAGING HD, P63; Erreni M, 2011, CANCER MICROENVIRON, V4, P141, DOI 10.1007/s12307-010-0052-5; Gentek R, 2014, IMMUNOL REV, V262, P56, DOI 10.1111/imr.12224; Gundra UM, 2014, BLOOD, V123, pE110, DOI 10.1182/blood-2013-08-520619; Hagemann T, 2006, J IMMUNOL, V176, P5023, DOI 10.4049/jimmunol.176.8.5023; Hartnell A, 2001, BLOOD, V97, P288, DOI 10.1182/blood.V97.1.288; Herszenyi L, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-194; Hiemstra IH, 2014, IMMUNOLOGY, V142, P269, DOI 10.1111/imm.12251; Ikezumi Y, 2005, NEPHROL DIAL TRANSPL, V20, P2704, DOI 10.1093/ndt/gfi105; Kamada N, 2008, J CLIN INVEST, V118, P2269, DOI [10.1172/JCI34610, 10.1172/JC134610]; Kurahara H, 2011, J SURG RES, V167, pE211, DOI 10.1016/j.jss.2009.05.026; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Mantovani A, 2010, CURR OPIN IMMUNOL, V22, P231, DOI 10.1016/j.coi.2010.01.009; Mariani F, 2014, WORLD J GASTROENTERO, V20, P9716, DOI 10.3748/wjg.v20.i29.9716; Marmey B., 2006, HUM PATHOL, V37, P68; Martinez FO, 2006, J IMMUNOL, V177, P7303, DOI 10.4049/jimmunol.177.10.7303; Meng FY, 1997, J EXP MED, V185, P1661, DOI 10.1084/jem.185.9.1661; Mills CD, 2000, J IMMUNOL, V164, P6166, DOI 10.4049/jimmunol.164.12.6166; Mills CD, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00620; Mills CD, 2012, CRIT REV IMMUNOL, V32, P463, DOI 10.1615/CritRevImmunol.v32.i6.10; Miranda DO, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/739650; Miteva LD, 2014, TUMOR BIOL, V35, P12655, DOI 10.1007/s13277-014-2589-2; Nordenvall C, 2006, GUT, V55, P703, DOI 10.1136/gut.2005.070201; Ohnishi K, 2013, CANCER SCI, V104, P1236, DOI 10.1111/cas.12212; Pages F, 2010, ONCOGENE, V29, P1093, DOI 10.1038/onc.2009.416; Prasse A, 2007, J ALLERGY CLIN IMMUN, V119, P464, DOI 10.1016/j.jaci.2006.09.030; Schenk M, 2005, J IMMUNOL, V174, P517, DOI 10.4049/jimmunol.174.1.517; Sica A, 2000, J IMMUNOL, V164, P762, DOI 10.4049/jimmunol.164.2.762; Sica A, 2007, J CLIN INVEST, V117, P1155, DOI 10.1172/JCI31422; Siegel R, 2014, CA-CANCER J CLIN, V64, P104, DOI 10.3322/caac.21220; Smith PD, 2011, MUCOSAL IMMUNOL, V4, P31, DOI 10.1038/mi.2010.66; Tang Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088343; Weigmann B, 2007, NAT PROTOC, V2, P2307, DOI 10.1038/nprot.2007.315; Xiong YS, 2014, RHEUMATOLOGY, V53, P250, DOI 10.1093/rheumatology/ket342; York MR, 2007, ARTHRITIS RHEUM-US, V56, P1010, DOI 10.1002/art.22382; Zigmond E, 2012, IMMUNITY, V37, P1076, DOI 10.1016/j.immuni.2012.08.026	45	22	25	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2015	10	10							e0141817	10.1371/journal.pone.0141817	http://dx.doi.org/10.1371/journal.pone.0141817			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0DL	26509874	Green Published, Green Submitted, gold			2022-12-26	WOS:000363918100136
J	Sandner, P; Tinel, H; Affaitati, G; Costantini, R; Giamberardino, MA				Sandner, Peter; Tinel, Hanna; Affaitati, Giannapia; Costantini, Raffaele; Giamberardino, Maria Adele			Effects of PDE5 Inhibitors and sGC Stimulators in a Rat Model of Artificial Ureteral Calculosis	PLOS ONE			English	Article							LOWER URINARY-TRACT; VISCERO-VISCERAL HYPERALGESIA; SHOCK-WAVE LITHOTRIPSY; IN-VITRO; MUSCLE HYPERALGESIA; FUNCTIONAL-ROLE; PAIN; VARDENAFIL; MANAGEMENT; SYMPTOMS	Urinary colics from calculosis are frequent and intense forms of pain whose current pharmacological treatment remains unsatisfactory. New and more effective drugs are needed to control symptoms and improve stone expulsion. Recent evidence suggested that the Nitric Oxide (NO) / cyclic guanosine monophosphate (cGMP) / phosphodiesterase type 5 (PDE5) system may contribute to ureteral motility influencing stone expulsion. We investigated if PDE5 inhibitors and sGC stimulators influence ureteral contractility, pain behaviour and stone expulsion in a rat model of ureteral calculosis. We investigated: a) the sex-specific PDE5 distribution in the rat ureter; b) the functional in vitro effects of vardenafil and sildenafil (PDE5 inhibitors) and BAY41-2272 (sGC stimulator) on induced ureteral contractility in rats and c) the in vivo effectiveness of vardenafil and BAY41-2272, alone and combined with ketoprofen, vs hyoscine-N-butylbromide alone or combined with ketoprofen, on behavioural pain indicators and stone expulsion in rats with artificial calculosis in one ureter. PDE5 was abundantly expressed in male and female rats' ureter. In vitro, both vardenafil and BAY41-2272 significantly relaxed pre-contracted ureteral strips. In vivo, all compounds significantly reduced number and global duration of "ureteral crises" and post-stone lumbar muscle hyperalgesia in calculosis rats. The highest level of reduction of the pain behaviour was observed with BAY41-2272 among all spasmolytics administered alone, and with the combination of ketoprofen with BAY41-2272. The percentage of stone expulsion was maximal in the ketoprofen+BAY41-2272 group. The NO/cGMP/PDE5 pathway is involved in the regulation of ureteral contractility and pain behaviour in urinary calculosis. PDE5 inhibitors and sGC stimulators could become a potent new option for treatment of urinary colic pain.	[Sandner, Peter; Tinel, Hanna] Bayer HealthCare, Global Drug Discovery, Dept Cardiol, Pharma Res Ctr, Wuppertal, Germany; [Sandner, Peter] Hannover Med Sch, Inst Pharmacol, Hannover, Germany; [Affaitati, Giannapia; Giamberardino, Maria Adele] Univ G dAnnunzio, Pathophysiol Pain Lab, CeSI, Chieti, Italy; [Affaitati, Giannapia; Giamberardino, Maria Adele] Univ G dAnnunzio, Dept Med & Sci Aging, Chieti, Italy; [Costantini, Raffaele] Univ G dAnnunzio, Inst Surg Pathol, Chieti, Italy	Bayer AG; Bayer Healthcare Pharmaceuticals; Hannover Medical School; G d'Annunzio University of Chieti-Pescara; G d'Annunzio University of Chieti-Pescara; G d'Annunzio University of Chieti-Pescara	Giamberardino, MA (corresponding author), Univ G dAnnunzio, Pathophysiol Pain Lab, CeSI, Chieti, Italy.	mag@unich.it			Bayer Health Care AG	Bayer Health Care AG(Bayer AGBayer Healthcare Pharmaceuticals)	The research was supported by a limited research grant from Bayer Health Care AG to MAG for conducting the in vivo experiments. Peter Sandner and Hanna Tinel are employees of Bayer HealthCare AG, therefore the funder provided support in the form of salaries for authors [PS and HT]. The in vitro and ex vivo organ bath parts of the study were performed in the laboratories of the authors P. Sandner and H. Tinel at the funders' research site. The detailed contributions by each author are articulated in the "author contributions" section.	Affaitati G, 2002, FUND CLIN PHARMACOL, V16, P23, DOI 10.1046/j.1472-8206.2002.00068.x; Affaitati G, 2011, HORM BEHAV, V59, P9, DOI 10.1016/j.yhbeh.2010.09.008; ALBEFESSARD D, 1990, ADV PAIN RES THER, V13, P11; Albersen M, 2013, J SEX MED, V10, P1268, DOI 10.1111/jsm.12095; ALM P, 1993, ACTA PHYSIOL SCAND, V148, P421, DOI 10.1111/j.1748-1716.1993.tb09578.x; Aloisi AM, 2010, EUR J PAIN, V14, P602, DOI 10.1016/j.ejpain.2009.10.016; Bultitude M, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5499; Canda AE, 2007, UROL INT, V78, P289, DOI 10.1159/000100830; EHREN I, 1994, UROLOGY, V44, P683, DOI 10.1016/S0090-4295(94)80206-8; Filippi S, 2007, ENDOCRINOLOGY, V148, P1019, DOI 10.1210/en.2006-1079; GIAMBERARDINO MA, 1995, EUR J PHARMACOL, V278, P97, DOI 10.1016/0014-2999(95)00104-S; Giamberardino MA, 2000, BRAIN RES, V878, P148, DOI 10.1016/S0006-8993(00)02728-1; GIAMBERARDINO MA, 1995, PAIN, V61, P459, DOI 10.1016/0304-3959(94)00208-V; GIAMBERARDINO MA, 1994, PAIN, V56, P77, DOI 10.1016/0304-3959(94)90152-X; Giamberardino MA, 2014, CURR OPIN OBSTET GYN, V26, P253, DOI 10.1097/GCO.0000000000000083; Giamberardino MA, 2010, PAIN, V151, P307, DOI 10.1016/j.pain.2010.06.023; Giamberardino MA, 2006, HAND CLINIC, V81, P343, DOI 10.1016/S0072-9752(06)80028-X; Gratzke C, 2007, UROL RES, V35, P49, DOI 10.1007/s00240-006-0073-1; Iuvone T, 2015, PAIN; Kedia GT, 2013, UROLOGY, V82, DOI 10.1016/j.urology.2013.08.023; Kilkenny C, 2010, BRIT J PHARMACOL, V160, P1577, DOI [10.1113/expphysiol.2010.053793, 10.1111/j.1476-5381.2010.00872.x, 10.1113/jphysiol.2010.192278]; Laird JMA, 1997, AM J PHYSIOL-REG I, V272, pR1409, DOI 10.1152/ajpregu.1997.272.5.R1409; Laird JMA, 1998, INFLAMM RES, V47, P389, DOI 10.1007/s000110050349; Liatsikos E, 2013, J ENDOUROL, V27, P1400, DOI 10.1089/end.2012.0612; Lin CS, 2013, UROLOGY, V81, P480, DOI 10.1016/j.urology.2012.11.028; Lopopolo M, 2014, FUND CLIN PHARMACOL, V28, P331, DOI 10.1111/fcp.12038; Macneil F, 2011, AUST FAM PHYSICIAN, V40, P772; Martinez-Salamanca JI, 2011, EUR UROL, V60, P527, DOI 10.1016/j.eururo.2011.05.054; Miller MS, 2013, ANN PHARMACOTHER, V47, P278, DOI 10.1345/aph.1R528; Miyaoka R, 2014, UROLOGY, V83, DOI 10.1016/j.urology.2013.09.005; MULVANY MJ, 1977, CIRC RES, V41, P19, DOI 10.1161/01.RES.41.1.19; Singh A, 2007, ANN EMERG MED, V50, P552, DOI 10.1016/j.annemergmed.2007.05.015; Stasch JP, 2011, CIRCULATION, V123, P2263, DOI 10.1161/CIRCULATIONAHA.110.981738; TAHER A, 1994, WORLD J UROL, V12, P286; Tinel H, 2006, BJU INT, V98, P1259, DOI 10.1111/j.1464-410X.2006.06501.x; Trinchieri A, 2008, CLIN CASES MINER BON, V5, P101; Tseng TY, 2011, MED CLIN N AM, V95, P169, DOI 10.1016/j.mcna.2010.08.034; VECCHIET L, 1989, PAIN, V36, P289, DOI 10.1016/0304-3959(89)90087-0; VECCHIET L, 1992, ADV PAIN RES THER, V20, P101; Zhu YF, 2010, BJU INT, V106, P256, DOI 10.1111/j.1464-410X.2009.09014.x	40	6	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2015	10	10							e0141477	10.1371/journal.pone.0141477	http://dx.doi.org/10.1371/journal.pone.0141477			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0DL	26509272	Green Published, gold, Green Submitted			2022-12-26	WOS:000363918100090
J	Zwerts, JA; Prins, HHT; Bomhoff, D; Verhagen, I; Swart, JM; de Boer, WF				Zwerts, J. A.; Prins, H. H. T.; Bomhoff, D.; Verhagen, I.; Swart, J. M.; de Boer, W. F.			Competition between a Lawn-Forming Cynodon dactylon and a Tufted Grass Species Hyparrhenia hirta on a South-African Dystrophic Savanna	PLOS ONE			English	Article							GRAZING LAWNS; ASYMMETRIC COMPETITION; PLANT; COMMUNITY; DYNAMICS; PASTURES; CATTLE; FIRE; HERBIVORES; MANAGEMENT	South African savanna grasslands are often characterised by indigestible tufted grass species whereas lawn grasses are far more desirable in terms of herbivore sustenance. We aimed to investigate the role of nutrients and/or the disturbance (grazing, trampling) by herbivores on the formation of grazing lawns. We conducted a series of common garden experiments to test the effect of nutrients on interspecific competition between a typical lawn-forming grass species (Cynodon dactylon) and a species that is frequently found outside grazing lawns (Hyparrhenia hirta), and tested for the effect of herbivore disturbance in the form of trampling and clipping. We also performed a vegetation and herbivore survey to apply experimentally derived insights to field observations. Our results showed that interspecific competition was not affected by soil nutrient concentrations. C. dactylon did show much more resilience to disturbance than H. hirta, presumably due to the regenerative capacity of its rhizomes. Results from the field survey were in line with these findings, describing a correlation between herbivore pressure and C. dactylon abundance. We conclude that herbivore disturbance, and not soil nutrients, provide C. dactylon with a competitive advantage over H. hirta, due to vegetative regeneration from its rhizomes. This provides evidence for the importance of concentrated, high herbivore densities for the creation and maintenance of grazing lawns.	[Zwerts, J. A.; Prins, H. H. T.; Bomhoff, D.; Verhagen, I.; de Boer, W. F.] Wageningen Univ, Resource Ecol Grp, NL-6708 PB Wageningen, Netherlands; [Prins, H. H. T.] Univ Kwazulu Natal, Sch Life Sci, ZA-4000 Durban, South Africa; [Swart, J. M.] Welgevonden Game Reserve, ZA-0530 Vaalwater, South Africa	Wageningen University & Research; University of Kwazulu Natal	de Boer, WF (corresponding author), Wageningen Univ, Resource Ecol Grp, Droevendaalsesteeg 3A, NL-6708 PB Wageningen, Netherlands.	fred.deboer@wur.nl	Verhagen, Irene/AAF-5815-2019	Verhagen, Irene/0000-0001-5588-1333; Zwerts, Joeri/0000-0003-3841-6389; Prins, Herbert/0000-0003-1131-5107				Amiaud B, 2008, PLANT ECOL, V197, P107, DOI 10.1007/s11258-007-9364-z; Archibald S, 2008, J WILDLIFE MANAGE, V72, P492, DOI 10.2193/2007-045; Archibald S, 2005, ECOL APPL, V15, P96, DOI 10.1890/03-5210; Augustine DJ, 1998, J WILDLIFE MANAGE, V62, P1165, DOI 10.2307/3801981; Ball JP, 2000, J APPL ECOL, V37, P247, DOI 10.1046/j.1365-2664.2000.00487.x; BINKLEY D, 1983, SOIL SCI SOC AM J, V47, P1050, DOI 10.2136/sssaj1983.03615995004700050045x; CLUZEAU D, 1992, SOIL BIOL BIOCHEM, V24, P1661, DOI 10.1016/0038-0717(92)90166-U; Connolly J, 1996, OECOLOGIA, V108, P311, DOI 10.1007/BF00334656; Cromsigt JPGM, 2008, OIKOS, V117, P1444, DOI 10.1111/j.0030-1299.2008.16651.x; DEKROON H, 1991, J ECOL, V79, P519, DOI 10.2307/2260730; DONG M, 1994, OIKOS, V70, P99, DOI 10.2307/3545704; Drescher M, 2006, APPL ANIM BEHAV SCI, V101, P10, DOI 10.1016/j.applanim.2006.01.011; Fernandez ON, 2003, WEED RES, V43, P130, DOI 10.1046/j.1365-3180.2003.00324.x; FIELD A., 2009, DESCOBRINDO ESTATIST, V2; FLOYD DA, 1987, J ECOL, V75, P221, DOI 10.2307/2260547; Freckleton RP, 2001, FUNCT ECOL, V15, P615, DOI 10.1046/j.0269-8463.2001.00558.x; Fynn RWS, 2005, J ECOL, V93, P384, DOI 10.1111/j.0022-0477.2005.00993.x; GEORGIADIS NJ, 1990, J APPL ECOL, V27, P623, DOI 10.2307/2404307; GEORGIADIS NJ, 1988, OIKOS, V51, P343, DOI 10.2307/3565316; GOODALL DW, 1952, AUST J SCI RES SER B, V5, P1, DOI 10.1071/BI9520001; Grant CC, 2006, BIOL CONSERV, V130, P426, DOI 10.1016/j.biocon.2006.01.004; Holm L., 1979, GEOGRAPHICAL ATLAW; Knapp AK, 1999, BIOSCIENCE, V49, P39, DOI 10.2307/1313492; Kohler F, 2004, J VEG SCI, V15, P143, DOI 10.1111/j.1654-1103.2004.tb02249.x; Kraaij T, 2010, AFR J RANGE FOR SCI, V27, P21, DOI 10.2989/10220111003703450; Laundre John W., 2010, OPEN ECOL J, V3, P1, DOI [10.2174/1874213001003030001, DOI 10.2174/1874213001003030001]; McIvor JG, 2005, AUSTRAL ECOL, V30, P445, DOI 10.1111/j.1442-9993.2005.01488.x; MCNAUGHTON SJ, 1983, ECOL MONOGR, V53, P291, DOI 10.2307/1942533; MCNAUGHTON SJ, 1984, AM NAT, V124, P863, DOI 10.1086/284321; OCONNOR TG, 1994, J APPL ECOL, V31, P155, DOI 10.2307/2404608; Person BT, 2003, OECOLOGIA, V135, P583, DOI 10.1007/s00442-003-1197-4; STOBBS TH, 1973, AUST J AGR RES, V24, P821, DOI 10.1071/AR9730821; SUTHERLAND WJ, 1988, OIKOS, V52, P239, DOI 10.2307/3565196; Suzuki Jun-ichirou, 1999, Plant Species Biology, V14, P11, DOI 10.1046/j.1442-1984.1999.00002.x; Tessema ZK, 2011, J ARID ENVIRON, V75, P662, DOI 10.1016/j.jaridenv.2011.02.004; van der Waal C, 2009, J ECOL, V97, P430, DOI 10.1111/j.1365-2745.2009.01498.x; Verweij RJT, 2006, OIKOS, V114, P108, DOI 10.1111/j.2006.0030-1299.14209.x; Ward D., 2005, African Journal of Range & Forage Science, V22, P101, DOI 10.2989/10220110509485867; WEDIN D, 1993, ECOL MONOGR, V63, P199, DOI 10.2307/2937180; WHICKER AD, 1988, BIOSCIENCE, V38, P778, DOI 10.2307/1310787	40	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2015	10	10							e0140789	10.1371/journal.pone.0140789	http://dx.doi.org/10.1371/journal.pone.0140789			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0DL	26510157	Green Submitted, Green Published, gold			2022-12-26	WOS:000363918100039
J	Cai, FQ; Gao, L; Gong, HH; Jiang, F; Pei, CG; Zhang, X; Zeng, XJ; Huang, RW				Cai, Fengqin; Gao, Lei; Gong, Honghan; Jiang, Fei; Pei, Chonggang; Zhang, Xu; Zeng, Xianjun; Huang, Ruiwang			Network Centrality of Resting-State fMRI in Primary Angle-Closure Glaucoma Before and After Surgery	PLOS ONE			English	Article							DIFFUSION TENSOR TRACTOGRAPHY; VOXEL-BASED MORPHOMETRY; FUNCTIONAL CONNECTIVITY; VISUAL-CORTEX; HUMAN BRAIN; CHAMBER DEPTH; BLINDNESS; DISEASE; CONNECTOMICS; REGISTRATION	Purpose Using voxel-wise degree centrality (DC), as measured by resting-state fMRI, we aimed to study alterations in the brain functional networks in patients with primary angle-closure glaucoma (PACG) and to reveal the plastic trajectories of surgery. Methods A total of 23 preoperative PACG patients (49.48 +/- 14.37 years old) were recruited to undergo a resting-state fMRI scan, and 9 of them were rescanned 3 months after surgery. All PACG patients underwent a complete ophthalmologic examination, including intraocular pressure (IOP), retinal nerve fiber layer (RNFL) thickness, vertical cup to disc ratio (V C/D), and average cup to disc ratio (A C/D). Another 23 gender-and age-matched healthy controls (48.18 +/- 9.40 years old) underwent scanning once for comparison. The group difference in DC was calculated in each voxel, and the correlations between the DC value and each of the clinical variables were analyzed in the PACG patients. Results Preoperative PACG (pre-PACG) patients showed significantly decreased DC in the bilateral visual cortices but increased DC in the left anterior cingulate cortex (ACC) and caudate (p < 0.05, corrected) compared with the controls. Statistical analysis showed a significantly negative correlation between DC in the bilateral visual cortices and the IOP score and between DC in the anterior cingulate cortex (ACC) and both the A C/D and V C/D scores in the pre-PACG patients. Three months after surgery, these postoperative PACG (post-PACG) patients showed a significantly increased DC in both the bilateral visual cortices and the left precentral gyrus compared with the pre-PACG patients. Conclusions Our results suggest that PACG may contribute to decreased functional centrality in the visual system and to increased degree centrality in cognition-emotional processing regions. Alterations in visual areas seem to parallel the cup to disc ratio, but not the duration of angle closure. The changes of functional centrality in PACG patients after operation may reveal the plasticity or degeneration of the visual-associated brain areas. Our findings may provide further understanding of the pathophysiology of PACG.	[Cai, Fengqin; Gao, Lei; Gong, Honghan; Jiang, Fei; Zeng, Xianjun] Nanchang Univ, Affiliated Hosp 1, Dept Radiol, Nanchang 330006, Jiangxi, Peoples R China; [Huang, Ruiwang] S China Normal Univ, Sch Psychol, Key Lab Mental Hlth & Cognit Sci Guangdong Prov, Ctr Study Appl Psychol, Guangzhou 510631, Guangdong, Peoples R China; [Pei, Chonggang] Nanchang Univ, Affiliated Hosp 1, Dept Ophthalmol, Nanchang 330006, Jiangxi, Peoples R China; [Zhang, Xu] Nanchang Univ, Affiliated Eye Hosp, Jiangxi Res Inst Ophthalmol & Visual Sci, Nanchang 330006, Jiangxi, Peoples R China	Nanchang University; South China Normal University; Nanchang University; Nanchang University	Zeng, XJ (corresponding author), Nanchang Univ, Affiliated Hosp 1, Dept Radiol, Nanchang 330006, Jiangxi, Peoples R China.	xianjun-zeng@126.com; ruiwang.huang@gmail.com		Gao, Lei/0000-0002-0081-0172	National Natural Science Foundation of China [81360219, 81371535, 81428013, 81271548]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China (Grant No. 81360219, 81371535, 81428013, 81371535, and 81271548).	Agorastos A, 2013, J NEUROPSYCH CLIN N, V25, P205, DOI 10.1176/appi.neuropsych.12020030; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Biswal BB, 2010, P NATL ACAD SCI USA, V107, P4734, DOI 10.1073/pnas.0911855107; Black AA, 2008, OPTOMETRY VISION SCI, V85, P489, DOI 10.1097/OPX.0b013e31817882db; Bogorodzki P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093682; Boucard CC, 2009, BRAIN, V132, P1898, DOI 10.1093/brain/awp119; Buckner RL, 2009, J NEUROSCI, V29, P1860, DOI 10.1523/JNEUROSCI.5062-08.2009; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Chan KC, 2009, EXP EYE RES, V88, P61, DOI 10.1016/j.exer.2008.10.002; Chen WW, 2013, INVEST OPHTH VIS SCI, V54, P545, DOI 10.1167/iovs.12-9893; Dai H, 2013, HUM BRAIN MAPP, V34, P2455, DOI 10.1002/hbm.22079; Day AC, 2012, BRIT J OPHTHALMOL, V96, P1162, DOI 10.1136/bjophthalmol-2011-301189; Devereux JG, 2000, ARCH OPHTHALMOL-CHIC, V118, P257; Di Martino A, 2013, BIOL PSYCHIAT, V74, P623, DOI 10.1016/j.biopsych.2013.02.011; Duncan RO, 2012, VISION RES, V60, P51, DOI 10.1016/j.visres.2012.03.012; Etkin A, 2011, TRENDS COGN SCI, V15, P85, DOI 10.1016/j.tics.2010.11.004; Foster PJ, 2000, BRIT J OPHTHALMOL, V84, P186, DOI 10.1136/bjo.84.2.186; Frezzotti P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105931; Friston KJ, 1996, MAGNET RESON MED, V35, P346, DOI 10.1002/mrm.1910350312; Gupta N, 2007, CURR OPIN OPHTHALMOL, V18, P110, DOI 10.1097/ICU.0b013e3280895aea; Hernowo AT, 2011, INVEST OPHTH VIS SCI, V52, P2758, DOI 10.1167/iovs.10-5682; HUANG D, 1991, SCIENCE, V254, P1178, DOI 10.1126/science.1957169; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Kong XM, 2015, J GLAUCOMA, V24, pe57, DOI 10.1097/IJG.0000000000000025; Kotecha A, 2012, INVEST OPHTH VIS SCI, V53, P7795, DOI 10.1167/iovs.12-10866; Kullmann S, 2014, NEUROIMAGE-CLIN, V4, P615, DOI 10.1016/j.nicl.2014.04.002; Li CY, 2012, CURR EYE RES, V37, P794, DOI 10.3109/02713683.2012.683506; Li JJ, 2013, CEREB CORTEX, V23, P542, DOI [10.1093/cercor/bhs034, 10.1093/cercor/bhs410]; Li K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097445; Li T, 2015, INVEST OPHTH VIS SCI, V56, P322, DOI 10.1167/iovs.14-14974; Liu Y, 2007, BRAIN, V130, P2085, DOI 10.1093/brain/awm121; Merabet LB, 2010, NAT REV NEUROSCI, V11, P44, DOI 10.1038/nrn2758; Morgan JE, 2012, CLIN EXP OPHTHALMOL, V40, P364, DOI 10.1111/j.1442-9071.2012.02789.x; Mueller S, 2013, NEURON, V77, P586, DOI 10.1016/j.neuron.2012.12.028; Quigley HA, 2001, BRIT J OPHTHALMOL, V85, P1271, DOI 10.1136/bjo.85.11.1271; Ramulu P, 2009, CURR OPIN OPHTHALMOL, V20, P92, DOI 10.1097/ICU.0b013e32832401a9; Sato JR, 2015, NEUROIMAGE, V104, P44, DOI 10.1016/j.neuroimage.2014.09.063; Satterthwaite TD, 2013, NEUROIMAGE, V64, P240, DOI 10.1016/j.neuroimage.2012.08.052; Shu N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007228; Song YW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089493; Villablanca JR, 2010, ACTA NEUROBIOL EXP, V70, P95; Vithana EN, 2012, NAT GENET, V44, P1142, DOI 10.1038/ng.2390; Wang BS, 2011, BRIT J OPHTHALMOL, V95, P46, DOI 10.1136/bjo.2009.178129; Wei X, 2014, INVEST OPHTH VIS SCI, V55, P1143, DOI 10.1167/iovs.13-13552; Weinreb RN, 2014, JAMA-J AM MED ASSOC, V311, P1901, DOI 10.1001/jama.2014.3192; Williams AL, 2013, INVEST OPHTH VIS SCI, V54, P5880, DOI 10.1167/iovs.13-11776; Yan CG, 2013, NEUROIMAGE, V80, P246, DOI 10.1016/j.neuroimage.2013.04.081; Yan CG, 2013, NEUROIMAGE, V76, P183, DOI 10.1016/j.neuroimage.2013.03.004; Yu LH, 2014, BRAIN RES, V1588, P135, DOI 10.1016/j.brainres.2014.09.005; Yu LH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073208; Yucel YH, 2003, PROG RETIN EYE RES, V22, P465, DOI 10.1016/S1350-9462(03)00026-0; Zhang Y., 2013, MATH PROB ENG, V2013, DOI DOI 10.4018/JIIT.2013010101; Zhou Y, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00200; Zikou AK, 2012, AM J NEURORADIOL, V33, P128, DOI 10.3174/ajnr.A2714; Zuo XN, 2014, NEUROSCI BIOBEHAV R, V45, P100, DOI 10.1016/j.neubiorev.2014.05.009; Zuo XN, 2012, CEREB CORTEX, V22, P1862, DOI 10.1093/cercor/bhr269	57	37	41	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2015	10	10							e0141389	10.1371/journal.pone.0141389	http://dx.doi.org/10.1371/journal.pone.0141389			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU8PC	26506229	gold, Green Published, Green Submitted			2022-12-26	WOS:000363804200059
J	Sanchez-Bretano, A; Blanco, AM; Unniappan, S; Kah, O; Gueguen, MM; Bertucci, JI; Alonso-Gomez, AL; Valenciano, AI; Isorna, E; Delgado, MJ				Sanchez-Bretano, Aida; Blanco, Ayelen M.; Unniappan, Suraj; Kah, Olivier; Gueguen, Marie M.; Bertucci, Juan I.; Alonso-Gomez, Angel L.; Valenciano, Ana I.; Isorna, Esther; Delgado, Maria J.			In Situ Localization and Rhythmic Expression of Ghrelin and ghs-r1 Ghrelin Receptor in the Brain and Gastrointestinal Tract of Goldfish (Carassius auratus)	PLOS ONE			English	Article							HORMONE SECRETAGOGUE RECEPTOR; COMPLEMENTARY DEOXYRIBONUCLEIC-ACID; MESSENGER-RNA EXPRESSION; FOOD-INTAKE; TISSUE DISTRIBUTION; ACYLATED PEPTIDE; GENE-EXPRESSION; RAINBOW-TROUT; CLOCK; CELLS	Ghrelin is a gut-brain peptide hormone, which binds to the growth hormone secretagogue receptor (GHS-R) to regulate a wide variety of biological processes in fish. Despite these prominent physiological roles, no studies have reported the anatomical distribution of preproghrelin transcripts using in situ hybridization in a non-mammalian vertebrate, and its mapping within the different encephalic areas remains unknown. Similarly, no information is available on the possible 24-h variations in the expression of preproghrelin and its receptor in any vertebrate species. The first aim of this study was to investigate the anatomical distribution of ghrelin and GHS-R1a ghrelin receptor subtype in brain and gastrointestinal tract of goldfish (Carassius auratus) using immunohistochemistry and in situ hybridization. Our second aim was to characterize possible daily variations of preproghrelin and ghs-r1 mRNA expression in central and peripheral tissues using real-time reverse transcription-quantitative PCR. Results show ghrelin expression and immunoreactivity in the gastrointestinal tract, with the most abundant signal observed in the mucosal epithelium. These are in agreement with previous findings on mucosal cells as the primary synthesizing site of ghrelin in goldfish. Ghrelin receptor was observed mainly in the hypothalamus with low expression in telencephalon, pineal and cerebellum, and in the same gastrointestinal areas as ghrelin. Daily rhythms in mRNA expression were found for preproghrelin and ghs-r1 in hypothalamus and pituitary with the acrophase occurring at nighttime. Preproghrelin, but not ghs-r1a, displayed a similar daily expression rhythm in the gastrointestinal tract with an amplitude 3-fold higher than the rest of tissues. Together, these results described for the first time in fish the mapping of preproghrelin and ghrelin receptor ghs-r1a in brain and gastrointestinal tract of goldfish, and provide the first evidence for a daily regulation of both genes expression in such locations, suggesting a possible connection between the ghrelinergic and circadian systems in teleosts.	[Sanchez-Bretano, Aida; Blanco, Ayelen M.; Alonso-Gomez, Angel L.; Valenciano, Ana I.; Isorna, Esther; Delgado, Maria J.] Univ Complutense, Fac Biol, Dept Fisiol Fisiol Anim 2, E-28040 Madrid, Spain; [Unniappan, Suraj] Univ Saskatchewan, Western Coll Vet Med, Dept Vet Biomed Sci, Lab Integrat Neuroendocrinol, Saskatoon, SK S7N 0W0, Canada; [Kah, Olivier; Gueguen, Marie M.] SFR Biosit Univ Rennes 1, INSERM, IRSET, Res Inst Hlth Environm & Occupat, Rennes, France; [Bertucci, Juan I.] Inst Tecnol Chascomus, Inst Invest Biotecnol, Buenos Aires, DF, Argentina	Complutense University of Madrid; University of Saskatchewan; Institut National de la Sante et de la Recherche Medicale (Inserm)	Delgado, MJ (corresponding author), Univ Complutense, Fac Biol, Dept Fisiol Fisiol Anim 2, E-28040 Madrid, Spain.	mjdelgad@bio.ucm.es	kah, olivier/K-7624-2012; Delgado, María J/I-3856-2017; Delgado, María J./I-3535-2017; Alonso-Gómez, Ángel L/F-4033-2016; Valenciano, Ana Isabel/F-4119-2016	Delgado, María J/0000-0002-1185-9377; Delgado, María J./0000-0002-1185-9377; Alonso-Gómez, Ángel L/0000-0003-3219-2265; Isorna, Esther/0000-0002-2387-0119; Blanco, Ayelen Melisa/0000-0002-7683-4154; Sanchez-Bretano Sanchez, Aida/0000-0002-0156-6781; Valenciano, Ana Isabel/0000-0002-0416-2192	Spanish Ministerio de Economia y Competitividad [AGL2013-46448-C3-2-R]; Natural Sciences and Engineering Research Council of Canada; Saskatchewan Health Research Foundation; Canada Foundation for Innovation; Canadian Institutes of Health Research New Investigator Award; Emerging Leaders of the Americas Program; Government of Canada	Spanish Ministerio de Economia y Competitividad(Spanish Government); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Saskatchewan Health Research Foundation; Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Canadian Institutes of Health Research New Investigator Award(Canadian Institutes of Health Research (CIHR)); Emerging Leaders of the Americas Program; Government of Canada(CGIAR)	This collaborative research was supported by the Spanish Ministerio de Economia y Competitividad (AGL2013-46448-C3-2-R) to MJD, and partly by a Discovery Grant and Discovery Accelerator Supplement award from the Natural Sciences and Engineering Research Council of Canada, an Establishment grant from Saskatchewan Health Research Foundation and John R. Evans Leaders Fund from the Canada Foundation for Innovation to SU. SU is a recipient of the Canadian Institutes of Health Research New Investigator Award. ASB and AMB are predoctoral fellows from the Spanish Ministerio de Economia y Competitividad and Ministerio de Educacion y Ciencia, respectively. JIB is a predoctoral fellow from the Argentinian Agencia Nacional de Promocion Cientifica y Tecnologica, and a recipient of the Emerging Leaders of the Americas Program funded by the Government of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abizaid Alfonso, 2012, Indian J Endocrinol Metab, V16, pS617, DOI 10.4103/2230-8210.105580; Arcamone N, 2009, MICROSC RES TECHNIQ, V72, P525, DOI 10.1002/jemt.20709; Cerda-Reverter JM, 2000, J CHEM NEUROANAT, V19, P197, DOI 10.1016/S0891-0618(00)00063-6; Cowley MA, 2003, NEURON, V37, P649, DOI 10.1016/S0896-6273(03)00063-1; Date Y, 2000, ENDOCRINOLOGY, V141, P4255, DOI 10.1210/en.141.11.4255; DELGADO MJ, 1993, GEN COMP ENDOCR, V92, P143, DOI 10.1006/gcen.1993.1151; Delporte C, 2013, SCIENTIFICA, V2013, DOI 10.1155/2013/518909; Depoortere I, 2009, REGUL PEPTIDES, V156, P13, DOI 10.1016/j.regpep.2009.04.002; Dibner C, 2010, ANNU REV PHYSIOL, V72, P517, DOI 10.1146/annurev-physiol-021909-135821; Diotel N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028375; Escobar S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070177; Falcon J, 2010, GEN COMP ENDOCR, V165, P469, DOI 10.1016/j.ygcen.2009.04.026; Feliciano A, 2011, J BIOL RHYTHM, V26, P24, DOI 10.1177/0748730410388600; Feng K, 2013, J EXP ZOOL PART A, V319A, P202, DOI 10.1002/jez.1784; Ghelardoni S, 2006, J ENDOCRINOL INVEST, V29, P115, DOI 10.1007/BF03344083; Gnanapavan S, 2002, J CLIN ENDOCR METAB, V87, P2988, DOI 10.1210/jc.87.6.2988; Guan JL, 2003, PEPTIDES, V24, P1921, DOI 10.1016/j.peptides.2003.10.017; Gutierrez JA, 2008, P NATL ACAD SCI USA, V105, P6320, DOI 10.1073/pnas.0800708105; Hayashida T, 2001, DOMEST ANIM ENDOCRIN, V21, P17, DOI 10.1016/S0739-7240(01)00104-7; Hoskins LJ, 2012, COMP BIOCHEM PHYS A, V163, P127, DOI 10.1016/j.cbpa.2012.05.197; KAH O, 1989, FISH PHYSIOL BIOCHEM, V7, P69, DOI 10.1007/BF00004691; Kaiya H, 2003, ENDOCRINOLOGY, V144, P5215, DOI 10.1210/en.2003-1085; Kaiya H, 2013, FRONT ENDOCRINOL, V4, P1, DOI DOI 10.3389/FEND0.2013.00117; Kaiya H, 2008, COMP BIOCHEM PHYS A, V149, P109, DOI 10.1016/j.cbpa.2007.12.004; Kaiya H, 2010, MOL CELL ENDOCRINOL, V327, P25, DOI 10.1016/j.mce.2010.06.004; Kaslin J, 2004, J NEUROSCI, V24, P2678, DOI 10.1523/JNEUROSCI.4908-03.2004; Kerbel B, 2012, J NEUROENDOCRINOL, V24, P366, DOI 10.1111/j.1365-2826.2011.02246.x; Kitazawa T, 2012, GEN COMP ENDOCR, V178, P539, DOI 10.1016/j.ygcen.2012.06.025; Kojima M, 1999, NATURE, V402, P656, DOI 10.1038/45230; Kojima M, 2005, PHYSIOL REV, V85, P495, DOI 10.1152/physrev.00012.2004; Koukkari WL, 2006, CHRONOBIOMETRY ANAL, P577; LeSauter J, 2009, P NATL ACAD SCI USA, V106, P13582, DOI 10.1073/pnas.0906426106; Lin XW, 2000, COMP BIOCHEM PHYS A, V126, P415, DOI 10.1016/S1095-6433(00)00230-0; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Patino MAL, 2011, CHRONOBIOL INT, V28, P381, DOI 10.3109/07420528.2011.566398; Martin-Robles AJ, 2012, J COMP PHYSIOL B, V182, P673, DOI 10.1007/s00360-012-0653-z; Matsuda K, 2006, PEPTIDES, V27, P1335, DOI 10.1016/j.peptides.2005.10.011; Matsuda K, 2006, PEPTIDES, V27, P2321, DOI 10.1016/j.peptides.2006.03.028; Miura T, 2007, PEPTIDES, V28, P1207, DOI 10.1016/j.peptides.2007.03.023; Miura T, 2006, NEUROSCI LETT, V407, P279, DOI 10.1016/j.neulet.2006.08.071; Neglia S, 2005, ACTA HISTOCHEM, V107, P3, DOI 10.1016/j.acthis.2004.12.001; Nisembaum LG, 2014, GEN COMP ENDOCR, V205, P287, DOI 10.1016/j.ygcen.2014.03.016; Nisembaum LG, 2012, CHRONOBIOL INT, V29, P665, DOI 10.3109/07420528.2012.686947; Olsson C, 2008, GEN COMP ENDOCR, V155, P217, DOI 10.1016/j.ygcen.2007.05.016; Panula P, 2010, ACTA PHYSIOL, V198, P381, DOI 10.1111/j.1748-1716.2009.02038.x; PETER RE, 1975, J COMP NEUROL, V159, P69, DOI 10.1002/cne.901590106; Rindi G, 2002, HISTOCHEM CELL BIOL, V117, P511, DOI 10.1007/s00418-002-0415-1; Sakata I, 2004, ZOOL SCI, V21, P757, DOI 10.2108/zsj.21.757; Sanchez-Bretano A, 2015, CHRONOBIOL INT, V32, P889, DOI 10.3109/07420528.2015.1049615; Sato T, 2012, J BIOCHEM, V151, P119, DOI 10.1093/jb/mvr134; Tannenbaum GS, 1998, ENDOCRINOLOGY, V139, P4420, DOI 10.1210/en.139.10.4420; Tinoco AB, 2014, GEN COMP ENDOCR, V204, P239, DOI 10.1016/j.ygcen.2014.06.006; Tsang AH, 2014, J MOL ENDOCRINOL, V52, pR1, DOI 10.1530/JME-13-0118; Unniappan S, 2004, AM J PHYSIOL-REG I, V286, pR1093, DOI 10.1152/ajpregu.00669.2003; Unniappan S, 2002, ENDOCRINOLOGY, V143, P4143, DOI 10.1210/en.2002-220644; Velarde E, 2009, J BIOL RHYTHM, V24, P104, DOI 10.1177/0748730408329901; Volkoff H, 2005, GEN COMP ENDOCR, V142, P3, DOI 10.1016/j.ygcen.2004.11.001; Willesen MG, 1999, NEUROENDOCRINOLOGY, V70, P306, DOI 10.1159/000054491; Yabuki A, 2004, J ANAT, V205, P239, DOI 10.1111/j.0021-8782.2004.00331.x; Yang J, 2008, CELL, V132, P387, DOI 10.1016/j.cell.2008.01.017; Yildiz BO, 2004, P NATL ACAD SCI USA, V101, P10434, DOI 10.1073/pnas.0403465101; Yin Y, 2014, INT J MOL SCI, V15, P4837, DOI 10.3390/ijms15034837; Zigman JM, 2006, J COMP NEUROL, V494, P528, DOI 10.1002/cne.20823	63	26	27	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2015	10	10							e0141043	10.1371/journal.pone.0141043	http://dx.doi.org/10.1371/journal.pone.0141043			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU8PC	26506093	gold, Green Submitted, Green Published			2022-12-26	WOS:000363804200025
J	Palinkas, LA; Chavarin, CV; Rafful, CM; Um, MY; Mendoza, DV; Staines, H; Aarons, GA; Patterson, TL				Palinkas, Lawrence A.; Chavarin, Claudia V.; Rafful, Claudia M.; Um, Mee Young; Mendoza, Doroteo V.; Staines, Hugo; Aarons, Gregory A.; Patterson, Thomas L.			Sustainability of Evidence-Based Practices for HIV Prevention among Female Sex Workers in Mexico	PLOS ONE			English	Article							HEALTH-SERVICES; PROGRAM; IMPLEMENTATION; ORGANIZATIONS; PROPHYLAXIS; ADOLESCENT; INFECTION; SCIENCE; WOMEN; RISK	Objective This study examined service provider perceptions of requirements for successful sustainment of an efficacious intervention for preventing HIV/AIDS and STIs in female sex workers (FSWs) in Mexico. Methods Semi-structured interviews were conducted with 77 leaders and counselors from 12 community-based reproductive health clinics located throughout Mexico participating in a large hybrid effectiveness-implementation randomized controlled trial to scale-up the use of Mujer Segura, a psychoeducational intervention designed to promote condom use and enhance safer sex negotiation skills among FSWs. Results Five sets of requirements for sustainment were identified: 1) characteristics of the provider, including competence in delivering the intervention, need for continued technical support and assistance from outside experts, and satisfaction with addressing the needs of this population; 2) characteristics of the clients (i.e., FSWs), including client need and demand for services and incentives for participation; 3) characteristics of the organization, including its mission, benefits, and operations; 4) characteristics of the outer setting, including financial support and relationship with the community-based organization's central offices, and transportation and security in areas where FSWs live and work; and 5) outcomes associated with the intervention itself, including a reduction of risk through education and increased out-reach through referrals from FSWs who received the intervention. Conclusions Although the requirements for successful sustainment of interventions like Mujer Segura are consistent with the factors identified in many models of implementation, the results illustrate the importance of local context in assigning priority to these model elements and suggest that the five categories are not discrete entities but interconnected.	[Palinkas, Lawrence A.; Um, Mee Young] Univ So Calif, Sch Social Work, Los Angeles, CA 90089 USA; [Chavarin, Claudia V.; Aarons, Gregory A.; Patterson, Thomas L.] Univ Calif San Diego, Sch Med, Dept Psychiat, La Jolla, CA 92093 USA; [Rafful, Claudia M.] Univ Calif San Diego, Sch Med, Div Global Publ Hlth, La Jolla, CA 92093 USA; [Rafful, Claudia M.] San Diego State Univ, Sch Publ Hlth, San Diego, CA 92182 USA; [Mendoza, Doroteo V.] Mexican Fdn Family Planning Mexfam, Res & Evaluat Unit, Mexico City, DF, Mexico; [Staines, Hugo] Autonomous Univ Ciudad Juarez, Fac Biomed Sci, Ciudad Juarez, Chihuahua, Mexico	University of Southern California; University of California System; University of California San Diego; University of California System; University of California San Diego; California State University System; San Diego State University; Universidad Autonoma de Ciudad Juarez	Palinkas, LA (corresponding author), Univ So Calif, Sch Social Work, Los Angeles, CA 90089 USA.	palinkas@usc.edu	Um, Mee Young/AAV-6838-2021; Rafful, Claudia/E-6764-2018	Rafful, Claudia/0000-0003-0083-7276	NIH [R01 MH087054]; Fogarty International Center [D43TW008633]; CONACyT scholarship [209407/313533]; FOGARTY INTERNATIONAL CENTER [D43TW008633] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH087054] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); CONACyT scholarship(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Funding for this study was provided by NIH grant R01 MH087054. C Rafful was supported by a training grant from the Fogarty International Center, Grant number D43TW008633 and a CONACyT scholarship 209407/313533. The funders had no role in study design, data collection and analysis, decision to publich, or preparation of the manuscript.	Aarons GA, 2014, ANNU REV PUBL HEALTH, V35, P255, DOI 10.1146/annurev-publhealth-032013-182447; Aarons GA, 2011, ADM POLICY MENT HLTH, V38, P4, DOI 10.1007/s10488-010-0327-7; Abdool Karim Quarraisha, 2010, Science, V329, P1168, DOI 10.1126/science.1193748; [Anonymous], 1991, MOTIVATIONAL INTERVI; Bandura A., 1986, SOCIAL FOUNDATIONS O; Bekker LG, 2015, LANCET, V385, P72, DOI 10.1016/S0140-6736(14)60974-0; Bennett S, 2011, GLOBAL HEALTH ACTION, V4, DOI 10.3402/gha.v4i0.7360; Boyatzis R. E., 1998, TRANSFORMING QUALITA, DOI 10.1191/1478088706qp063oa; Brimmer DJ, 2008, BMC MED EDUC, V8, DOI 10.1186/1472-6920-8-49; Burgos JL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011413; Chambers DA, 2013, IMPLEMENT SCI, V8, DOI 10.1186/1748-5908-8-117; Choopanya K, 2013, LANCET, V381, P2083, DOI 10.1016/S0140-6736(13)61127-7; Damschroder LJ, 2009, IMPLEMENT SCI, V4, DOI 10.1186/1748-5908-4-50; Dedoose, DEDOOSE GREAT RESEAR; Fixsen D. L., 2005, IMPLEMENTATION RES S; Glaser BG, 1967, THE DISCOVERY OF GRO; Godwin J, 2012, SEX WORK AND THE LAW; Goldenberg SM, 2015, VIOLENCE AGAINST WOM, V21, P478, DOI 10.1177/1077801215569079; Greenhalgh T, 2004, MILBANK Q, V82, P581, DOI 10.1111/j.0887-378X.2004.00325.x; Gruen RL, 2008, LANCET, V372, P1579, DOI 10.1016/S0140-6736(08)61659-1; Kalichman SC, 2007, JAIDS-J ACQ IMM DEF, V44, P594, DOI 10.1097/QAI.0b013e3180415e07; Kerrigan D, 2015, LANCET, V385, P172, DOI 10.1016/S0140-6736(14)60973-9; Kongelf A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121014; McMillan KE, 2015, HEALTH PROMOT INT; O'Brien L, 2015, J CONTIN EDUC HEALTH, V35, P46, DOI 10.1002/chp.21262; Palinkas LA., 2015, IMPLEMENT SCI, DOI [DOI 10.1186/1748-5908-10-S1-A41, 10.1186/1748-5908-10-S1-A41]; Palinkas LA, 2011, ADM POLICY MENT HLTH, V38, P44, DOI 10.1007/s10488-010-0314-z; Patterson TL, 2012, IMPLEMENT SCI, V7, DOI 10.1186/1748-5908-7-105; Patterson TL, 2008, AMERICAN JOURNAL OF, V9, P2051; Pearce J, 2012, J CONTIN EDUC HEALTH, V32, P215, DOI 10.1002/chp.21148; Pluye P, 2004, EVAL PROGRAM PLANN, V27, P121, DOI 10.1016/j.evalprogplan.2004.01.001; Proctor EK, 2009, ADM POLICY MENT HLTH, V36, P24, DOI 10.1007/s10488-008-0197-4; Scheirer MA, 2005, AM J EVAL, V26, P320, DOI 10.1177/1098214005278752; Shediac-Rizkallah MC, 1998, HEALTH EDUC RES, V13, P87, DOI 10.1093/her/13.1.87; Silverman JG, 2015, JAMA-J AM MED ASSOC, V314, P516, DOI 10.1001/jama.2015.7376; Stirman SW, 2012, IMPLEMENT SCI, V7, DOI 10.1186/1748-5908-7-17; Stover J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111956; Strathdee SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065812; Strathdee SA, 2013, ANNU REV PUBL HEALTH, V34, P301, DOI 10.1146/annurev-publhealth-031912-114411; Strauss A., 1990, BASICS OF QUALITATIV; Thigpen MC, 2012, NEW ENGL J MED, V367, P423, DOI 10.1056/NEJMoa1110711; UNAIDS, 2015, HOW AIDS CHANGED EVE; Weiss SM, 2015, INT J BEHAV MED, V22, P415, DOI 10.1007/s12529-014-9399-1; WHO, 2010, ANT THER HIV INF AD; WILLMS DG, 1990, MED ANTHROPOL Q, V4, P391, DOI 10.1525/maq.1990.4.4.02a00020; Wilson D, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001808	46	6	6	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2015	10	10							e0141508	10.1371/journal.pone.0141508	http://dx.doi.org/10.1371/journal.pone.0141508			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CV0EH	26517265	Green Submitted, gold, Green Published			2022-12-26	WOS:000363920800049
J	Yuan, FW; Cheng, Q; Li, GD; Tong, TJ				Yuan, Fuwen; Cheng, Qian; Li, Guodong; Tong, Tanjun			Nucleostemin Knockdown Sensitizes Hepatocellular Carcinoma Cells to Ultraviolet and Serum Starvation-Induced Apoptosis	PLOS ONE			English	Article							CYCLE ARREST; STEM-CELLS; CELLULAR SENESCENCE; PROLIFERATION; EXPRESSION; CANCER; PROTEIN; P53; IDENTIFICATION; ACTIVATION	Nucleostemin (NS) is a GTP-binding protein that is predominantly expressed in embryonic and adult stem cells but not in terminally differentiated cells. NS plays an essential role in maintaining the continuous proliferation of stem cells and some types of cancer cells. However, the role of NS in hepatocellular carcinoma (HCC) remains unclear. Therefore, this study aimed to clarify the role of NS in HCC. First, we demonstrated high expression of NS in most HCC cell lines and liver cancer tissues. NS knockdown induced a severe decline in cell viability of MHCC97H cells as detected by MTT and cell proliferation assays. Next, we used ultraviolet (UV) and serum starvation-induced apoptosis models to investigate whether NS suppression or up-regulation affects HCC cell apoptosis. After UV treatment or serum starvation, apoptosis was strongly enhanced in MHCC97H and Bel7402 cells transfected with small interfering RNA against NS, whereas NS overexpression inhibited UV and serum-induced apoptosis of HCC cells. Furthermore, after UV irradiation, inhibition of NS increased the expression of pro-apoptosis protein caspase 3 and decreased the expression of anti-apoptosis protein Bcl-2. A caspase 3 inhibitor could obviously prevent NS knockdown-induced apoptosis. In conclusion, our study demonstrated overexpression of NS in most HCC tissues compared with their matched surrounding tissues, and silencing NS promoted UV- and serum starvation-induced apoptosis of MHCC97H and Bel7402 cells. Therefore, the NS gene might be a potential therapeutic target of HCC.	[Yuan, Fuwen; Cheng, Qian; Li, Guodong; Tong, Tanjun] Peking Univ, Sch Basic Med Sci, Res Ctr Aging, Dept Biochem & Mol Biol, Beijing 100871, Peoples R China; [Yuan, Fuwen; Cheng, Qian; Li, Guodong; Tong, Tanjun] Beijing Key Lab Prot Posttranslat Modificat & Cel, Beijing, Peoples R China	Peking University	Tong, TJ (corresponding author), Peking Univ, Sch Basic Med Sci, Res Ctr Aging, Dept Biochem & Mol Biol, Beijing 100871, Peoples R China.	ttj@bjmu.edu.cn	Yuan, Fuwen/M-4704-2019	Yuan, Fuwen/0000-0001-5764-2504	National Natural Science Foundation of China [81372164]; National Basic Research Program of China [2013CB530801, 2012CB911203]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China)	This work was supported by grants from the National Natural Science Foundation of China (No. 81372164) and National Basic Research Program of China (No. 2013CB530801 and 2012CB911203).	Baddoo M, 2003, J CELL BIOCHEM, V89, P1235, DOI 10.1002/jcb.10594; Bai LC, 2014, ANNU REV MED, V65, P139, DOI 10.1146/annurev-med-010713-141310; Beekman C, 2006, MOL CELL BIOL, V26, P9291, DOI 10.1128/MCB.01183-06; Chen ZY, 2013, INT J MOL SCI, V14, P1763, DOI 10.3390/ijms14011763; Cheng Q, 2015, ONCOTARGET, V6, P4733, DOI 10.18632/oncotarget.2900; Cheng Q, 2014, BIOCHEM BIOPH RES CO, V448, P248, DOI 10.1016/j.bbrc.2014.04.117; Cui CP, 2008, HEPATOLOGY, V47, P986, DOI 10.1002/hep.22126; Dai MS, 2008, MOL CELL BIOL, V28, P4365, DOI 10.1128/MCB.01662-07; FERNANDESALNEMRI T, 1994, J BIOL CHEM, V269, P30761; Hsu JK, 2012, J CELL BIOL, V197, P613, DOI 10.1083/jcb.201109038; Jia YL, 2011, HEPATOLOGY, V54, P1808, DOI 10.1002/hep.24562; Li Q, 2013, EMBO J, V32, P858, DOI 10.1038/emboj.2013.35; Li XJ, 2014, J HEPATOL, V60, P975, DOI 10.1016/j.jhep.2013.12.014; Lin S, 2011, INT J GYNECOL CANCER, V21, P1166, DOI 10.1097/IGC.0b013e31822c76e1; Liu RL, 2009, CHIN MED J, V121, P299; Liu RL, 2009, ZHONGHUA ZHONG LIU Z, V8, P561; Liu SJ, 2004, WORLD J GASTROENTERO, V10, P1246; Lo D, 2010, CELL CYCLE, V9, P3227, DOI 10.4161/cc.9.16.12605; Ma HH, 2007, MOL BIOL CELL, V18, P2630, DOI 10.1091/mbc.E07-03-0244; Ma HH, 2008, TRENDS CELL BIOL, V18, P575, DOI 10.1016/j.tcb.2008.09.003; Ma L, 2013, ONCOL LETT, V6, P1313, DOI 10.3892/ol.2013.1562; Maki N, 2007, DEV DYNAM, V236, P941, DOI 10.1002/dvdy.21027; Meng LJ, 2006, J CELL SCI, V119, P5124, DOI 10.1242/jcs.03292; Meng LJ, 2013, P NATL ACAD SCI USA, V110, P11415, DOI 10.1073/pnas.1301672110; Meng LJ, 2011, J CELL SCI, V124, P3706, DOI 10.1242/jcs.089672; Nikpour P, 2009, CELL PROLIFERAT, V42, P762, DOI 10.1111/j.1365-2184.2009.00635.x; Ohmura M, 2008, STEM CELLS, V26, P3237, DOI 10.1634/stemcells.2008-0506; Pederson T, 2009, J CELL BIOL, V184, P771, DOI 10.1083/jcb.200812014; Rahmati M, 2014, HEMATOLOGY, V19, P455, DOI 10.1179/1607845414Y.0000000153; Romanova L, 2009, J BIOL CHEM, V284, P4968, DOI 10.1074/jbc.M804594200; Sijin L, 2004, J EXP CLIN CANC RES, V23, P529; Tsai RYL, 2009, INT J BIOCHEM CELL B, V41, P2122, DOI 10.1016/j.biocel.2009.05.020; Tsai RYL, 2002, GENE DEV, V16, P2991, DOI 10.1101/gad.55671; Wang SS, 2012, J HEPATOL, V57, P322, DOI 10.1016/j.jhep.2012.03.029; Yamashita M, 2013, BIOCHEM BIOPH RES CO, V441, P196, DOI 10.1016/j.bbrc.2013.10.032; Yan NL, 2013, MINI-REV MED CHEM, V13, P2047; Yang HX, 2005, WORLD J GASTROENTERO, V11, P4812, DOI 10.3748/wjg.v11.i31.4812; Yue Bao-Hong, 2009, Zhongguo Shi Yan Xue Ye Xue Za Zhi, V17, P319; Zhu QB, 2006, MOL CELL BIOL, V26, P9279, DOI 10.1128/MCB.00724-06; Zwolinska AK, 2012, ONCOGENE, V31, P3311, DOI 10.1038/onc.2011.507	40	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2015	10	10							e0141678	10.1371/journal.pone.0141678	http://dx.doi.org/10.1371/journal.pone.0141678			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0EH	26517370	Green Published, Green Submitted, gold			2022-12-26	WOS:000363920800066
J	Kang, W; Cannon, JL				Kang, Wei; Cannon, Jennifer L.			A Membrane-Based Electro-Separation Method (MBES) for Sample Clean-Up and Norovirus Concentration	PLOS ONE			English	Article							CAPILLARY-ELECTROPHORESIS; UNITED-STATES; FOODBORNE ILLNESS; MURINE NOROVIRUS; VIRUSES; EXTRACTION; SURFACE; FOOD; ELECTRODIALYSIS; EPIDEMIOLOGY	Noroviruses are the leading cause of acute gastroenteritis and foodborne illnesses in the United States. Enhanced methods for detecting noroviruses in food matrices are needed as current methods are complex, labor intensive and insensitive, often resulting in inhibition of downstream molecular detection and inefficient recovery. Membrane-based electro-separation (MBES) is a technique to exchange charged particles through a size-specific dialysis membrane from one solution to another using electric current as the driving force. Norovirus has a net negative surface charge in a neutrally buffered environment, so when placed in an electric field, it moves towards the anode. It can then be separated from the cathodic compartment where the sample is placed and then collected in the anodic compartment for downstream detection. In this study, a MBES-based system was designed, developed and evaluated for concentrating and recovering murine norovirus (MNV-1) from phosphate buffer. As high as 30.8% MNV-1 migrated from the 3.5 ml sample chamber to the 1.5 ml collection chamber across a 1 mu m separation membrane when 20 V was applied for 30 min using 20 mM sodium phosphate with 0.01% SDS (pH 7.5) as the electrolyte. In optimization of the method, weak applied voltage (20 V), moderate duration (30 min), and low ionic strength electrolytes with SDS addition were needed to increase virus movement efficacy. The electric field strength of the system was the key factor to enhance virus movement, which could only be improved by shortening the electrodes distance, instead of increasing system applied voltage because of virus stability. This study successfully demonstrated the norovirus mobility in an electric field and migration across a size-specific membrane barrier in sodium phosphate electrolyte. With further modification and validation in food matrixes, a novel, quick, and cost-effective sample clean-up technique might be developed to separate norovirus particles from food matrices by electric force.	[Kang, Wei; Cannon, Jennifer L.] Univ Georgia, Ctr Food Safety, Griffin, GA 30223 USA	University System of Georgia; University of Georgia	Cannon, JL (corresponding author), Univ Georgia, Ctr Food Safety, Griffin, GA 30223 USA.	jcannon@uga.edu			National Institute of Food and Agriculture, U.S. Department of Agriculture [2011-68003-30395]	National Institute of Food and Agriculture, U.S. Department of Agriculture(United States Department of Agriculture (USDA))	This material is based upon work that is supported by the National Institute of Food and Agriculture, U.S. Department of Agriculture, under award number 2011-68003-30395.	Baert L, 2008, INT J FOOD MICROBIOL, V123, P101, DOI 10.1016/j.ijfoodmicro.2007.12.020; Balchen M, 2009, J CHROMATOGR A, V1216, P6900, DOI 10.1016/j.chroma.2009.08.037; Bazinet Laurent, 2009, Recent Pat Biotechnol, V3, P61, DOI 10.2174/187220809787172623; BOOM R, 1990, J CLIN MICROBIOL, V28, P495, DOI 10.1128/JCM.28.3.495-503.1990; Buscher BAP, 1997, J CHROMATOGR A, V788, P165, DOI 10.1016/S0021-9673(97)00707-3; Cannon JL, 2008, VIRUSES ENV, P45; Cheong S, 2009, J FOOD PROTECT, V72, P2001, DOI 10.4315/0362-028X-72.9.2001; DEBETS AJJ, 1992, J CHROMATOGR, V600, P163, DOI 10.1016/0021-9673(92)85544-4; DiCaprio E, 2013, INFECT DIS CLIN N AM, V27, P651, DOI 10.1016/j.idc.2013.05.009; Girard B, 2000, CRIT REV BIOTECHNOL, V20, P109, DOI 10.1080/07388550008984168; Goodridge L, 2004, ANAL CHEM, V76, P48, DOI 10.1021/ac034848s; Hall AJ, 2014, MMWR-MORBID MORTAL W, P491; Hall AJ, 2012, EMERG INFECT DIS, V18, P1566, DOI 10.3201/eid1810.120833; Hida K, 2013, INT J FOOD MICROBIOL, V161, P143, DOI 10.1016/j.ijfoodmicro.2012.12.007; Hill VR, 2005, APPL ENV MICROBIOLOG, V71, P6878; ISSAQ HJ, 1991, CHROMATOGRAPHIA, V32, P155, DOI 10.1007/BF02325019; Jeong J, 2007, CHEMOSPHERE, V67, P652, DOI 10.1016/j.chemosphere.2006.11.035; Kamphorst JJ, 2009, ELECTROPHORESIS, V30, P2284, DOI 10.1002/elps.200800500; KAYES JB, 1976, J COLLOID INTERF SCI, V56, P426, DOI 10.1016/0021-9797(76)90109-0; KEESOM WH, 1988, J COLLOID INTERF SCI, V125, P575, DOI 10.1016/0021-9797(88)90024-0; Kremser L, 2004, ELECTROPHORESIS, V25, P2282, DOI 10.1002/elps.200305868; Kuban P, 2010, ELECTROPHORESIS, V31, P768, DOI 10.1002/elps.200900561; Matthieu G, 1994, ANALYST, V119, P1753; Mironov GG, 2011, ANAL CHEM, V83, P5431, DOI 10.1021/ac201006u; Morales-Cid G, 2010, TRAC-TREND ANAL CHEM, V29, P158, DOI 10.1016/j.trac.2009.11.006; Ogle D., 2005, ELECTROPHORESIS DIAL; Park GW, 2010, J FOOD PROTECT, V73, P2232, DOI 10.4315/0362-028X-73.12.2232; Patel MM, 2009, J CLIN VIROL, V44, P1, DOI 10.1016/j.jcv.2008.10.009; Pedersen-Bjergaard S, 2006, J CHROMATOGR A, V1109, P183, DOI 10.1016/j.chroma.2006.01.025; REYNOLDS JA, 1970, P NATL ACAD SCI USA, V66, P1002, DOI 10.1073/pnas.66.3.1002; Rodriguez-Lazaro D, 2013, WOODHEAD PUBL FOOD S, V249, P49, DOI 10.1533/9780857098870.2.49; Rylatt D, 2012, POLYM POLYACRYLAMIDE; Scallan E, 2011, EMERG INFECT DIS, V17, P16, DOI [10.3201/eid1701.P21101, 10.3201/eid1701.091101p2]; Scharff RL, 2012, J FOOD PROTECT, V75, P123, DOI 10.4315/0362-028X.JFP-11-058; Seo K, 2012, J FOOD PROTECT, V75, P533, DOI 10.4315/0362-028X.JFP-11-199; SHARMA MM, 1985, COLLOID SURFACE, V16, P193, DOI 10.1016/0166-6622(85)80252-3; Stals A, 2013, J AOAC INT, V96, P998, DOI 10.5740/jaoacint.13-020; Stals A, 2012, INT J FOOD MICROBIOL, V153, P1, DOI 10.1016/j.ijfoodmicro.2011.10.014; Stals A, 2011, FOOD MICROBIOL, V28, P52, DOI 10.1016/j.fm.2010.08.004; VER BA, 1968, J VIROL, V2, P21, DOI 10.1128/JVI.2.1.21-25.1968	40	6	6	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2015	10	10							e0141484	10.1371/journal.pone.0141484	http://dx.doi.org/10.1371/journal.pone.0141484			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0ED	26513464	Green Submitted, Green Published, gold			2022-12-26	WOS:000363920300043
J	Kramer, CEM; Singh, A; Helfrich, S; Grunberger, A; Wiechert, W; Noh, K; Kohlheyer, D				Kraemer, Christina E. M.; Singh, Abhijeet; Helfrich, Stefan; Gruenberger, Alexander; Wiechert, Wolfgang; Noeh, Katharina; Kohlheyer, Dietrich			Non-Invasive Microbial Metabolic Activity Sensing at Single Cell Level by Perfusion of Calcein Acetoxymethyl Ester	PLOS ONE			English	Article							CORYNEBACTERIUM-GLUTAMICUM; MYCOBACTERIUM-TUBERCULOSIS; BACTERIAL-POPULATIONS; GROWTH; RESUSCITATION; HETEROGENEITY; REGULATORS; INHIBITION; CULTURES; PROBES	Phase contrastmicroscopy cannot give sufficient information on bacterial metabolic activity, or if a cell is dead, it has the fate to die or it is in a viable but non-growing state. Thus, a reliable sensing of themetabolic activity helps to distinguish different categories of viability. We present a non-invasive instantaneous sensing method using a fluorogenic substrate for online monitoring of esterase activity and calcein efflux changes in growing wild type bacteria. The fluorescent conversion product of calcein acetoxymethyl ester (CAM) and its efflux indicates the metabolic activity of cells grown under different conditions at real-time. The dynamic conversion of CAM and the active efflux of fluorescent calcein were analyzed by combining microfluidic single cell cultivation technology and fluorescence time lapse microscopy. Thus, an instantaneous and non-invasive sensing method for apparent esterase activity was created without the requirement of genetic modification or harmful procedures. The metabolic activity sensing method consisting of esterase activity and calcein secretion was demonstrated in two applications. Firstly, growing colonies of our model organism Corynebacterium glutamicum were confronted with intermittent nutrient starvation by interrupting the supply of iron and carbon, respectively. Secondly, bacteria were exposed for one hour to fatal concentrations of antibiotics. Bacteria could be distinguished in growing and non-growing cells with metabolic activity as well as non-growing and non-fluorescent cells with no detectable esterase activity. Microfluidic single cell cultivation combined with high temporal resolution time-lapse microscopy facilitated monitoring metabolic activity of stressed cells and analyzing their descendants in the subsequent recovery phase. Results clearly show that the combination of CAM with a sampling free microfluidic approach is a powerful tool to gain insights in the metabolic activity of growing and non-growing bacteria.	[Kraemer, Christina E. M.; Singh, Abhijeet; Helfrich, Stefan; Gruenberger, Alexander; Wiechert, Wolfgang; Noeh, Katharina; Kohlheyer, Dietrich] Forschungszentrum Julich, IBG Biotechnol 1, D-52425 Julich, Germany	Helmholtz Association; Research Center Julich	Kohlheyer, D (corresponding author), Forschungszentrum Julich, IBG Biotechnol 1, D-52425 Julich, Germany.	d.kohlheyer@fz-juelich.de	Kohlheyer, Dietrich/A-9645-2012; Singh, Abhijeet/AAH-7890-2020	Kohlheyer, Dietrich/0000-0001-6215-1857; Singh, Abhijeet/0000-0002-0807-6080; Helfrich, Stefan/0000-0003-3549-8649; Grunberger, Alexander/0000-0002-7564-4957; Wiechert, Wolfgang/0000-0001-8501-0694; Noh, Katharina/0000-0002-5407-2275	Deutsche Forschungsgemeinschaft (DFG) [KO 4537/1-2]; Helmholtz Gemeinschaft [NWG VH-NG-1029]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Helmholtz Gemeinschaft(Helmholtz Association)	Deutsche Forschungsgemeinschaft (DFG), (http://www.dfg.de/) Grant KO 4537/1-2, DK, Helmholtz Gemeinschaft (http://www.helmholtz.de/) Grant NWG VH-NG-1029, DK.	Besant JD, 2015, LAB CHIP, V15, P2799, DOI 10.1039/c5lc00375j; Bhargava P, 2015, CELL METAB, V21, P154, DOI 10.1016/j.cmet.2015.01.012; Braissant O, 2015, METHODS, V76, P27, DOI 10.1016/j.ymeth.2014.10.009; Brune I, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-21; Burke HM, 2015, CHEM COMMUN, V51, P10576, DOI 10.1039/c5cc02793d; Byrd TF, 2014, SCI REPORT, V4, P10; Comas J, 1998, J MICROBIOL METH, V32, P45, DOI 10.1016/S0167-7012(98)00003-7; Dertz EA, 2006, J BIOL INORG CHEM, V11, P1087, DOI 10.1007/s00775-006-0151-4; Dhar N, 2015, ANTIMICROB AGENTS CH, V59, P1308, DOI 10.1128/AAC.03461-14; Di Carlo D, 2006, ANAL CHEM, V78, P4925, DOI 10.1021/ac060541s; DIAPER JP, 1994, J APPL BACTERIOL, V77, P221, DOI 10.1111/j.1365-2672.1994.tb03067.x; Essodai M, 1998, KINETIC ANAL CALCEIN, V2960, P2243; Evangelopoulos D, 2015, INT J INFECT DIS, V32, P76, DOI 10.1016/j.ijid.2014.11.028; FELLER N, 1995, FEBS LETT, V368, P385, DOI 10.1016/0014-5793(95)00677-2; Follmann M, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-621; Foudeh AM, 2015, ANAL BIOANAL CHEM, V407, P5541, DOI 10.1007/s00216-015-8726-y; Gengenbacher M, 2012, FEMS MICROBIOL REV, V36, P514, DOI 10.1111/j.1574-6976.2012.00331.x; Gomez-Sjoberg R, 2007, ANAL CHEM, V79, P8557, DOI 10.1021/ac071311w; Grunberger A, 2015, CYTOM PART A, V87A, P1101, DOI 10.1002/cyto.a.22779; Gruenberger A, 2013, JOVE-J VIS EXP, DOI 10.3791/50560; Halldorsson S, 2015, BIOSENS BIOELECTRON, V63, P218, DOI 10.1016/j.bios.2014.07.029; Hammes F, 2011, ADV BIOCHEM ENG BIOT, V124, P123, DOI 10.1007/10_2010_95; Hammes F, 2010, ANAL BIOANAL CHEM, V397, P1083, DOI 10.1007/s00216-010-3646-3; Hartmann M, 2004, ARCH MICROBIOL, V182, P299, DOI 10.1007/s00203-004-0713-1; Haugland R. P., 1994, US Patent, Patent No. [5,314,805, 5314805]; Helfrich S, 2015, VIZARDOUS INTERACTIV, P10; Joux F, 2000, MICROBES INFECT, V2, P1523, DOI 10.1016/S1286-4579(00)01307-1; Jungwirth B, 2008, FEMS MICROBIOL LETT, V281, P190, DOI 10.1111/j.1574-6968.2008.01098.x; Keep NH, 2006, TRENDS MICROBIOL, V14, P271, DOI 10.1016/j.tim.2006.04.003; KEILHAUER C, 1993, J BACTERIOL, V175, P5595, DOI 10.1128/JB.175.17.5595-5603.1993; LICHTENFELS R, 1994, J IMMUNOL METHODS, V172, P227, DOI 10.1016/0022-1759(94)90110-4; LIEBL W, 1989, APPL MICROBIOL BIOT, V32, P205, DOI 10.1007/BF00165889; Liu D, 2015, METAB ENG, V31, P35, DOI 10.1016/j.ymben.2015.06.008; Maglica Z, 2015, MBIO, V6, DOI 10.1128/mBio.02236-14; Manina G, 2015, CELL HOST MICROBE, V17, P32, DOI 10.1016/j.chom.2014.11.016; Marienfeld S, 1997, ANTON LEEUW INT J G, V72, P291, DOI 10.1023/A:1000578811089; Nebe-von-Caron G, 2000, J MICROBIOL METH, V42, P97, DOI 10.1016/S0167-7012(00)00181-0; Orenga S, 2009, J MICROBIOL METH, V79, P139, DOI 10.1016/j.mimet.2009.08.001; Peng B, 2015, CELL METAB, V21, P249, DOI 10.1016/j.cmet.2015.01.008; Poulsen CR, 2005, ANAL CHEM, V77, P667, DOI 10.1021/ac049279i; Rotman B, 1965, BIOCHEMISTRY-US, V55, P134; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schluesener D, 2005, PROTEOMICS, V5, P1317, DOI 10.1002/pmic.200400993; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schroder J, 2010, FEMS MICROBIOL REV, V34, P685, DOI 10.1111/j.1574-6976.2010.00228.x; Seletzky JM, 2006, APPL MICROBIOL BIOT, V72, P1297, DOI 10.1007/s00253-006-0436-0; Shapiro HH, 2000, J MICROBIOL METH, V42, P3, DOI 10.1016/S0167-7012(00)00167-6; Sim S, 2014, ANAL CEPA ENCODING E, V52, P278; Timmins GS, 2015, TRENDS MICROBIOL, V23, P321, DOI 10.1016/j.tim.2015.02.013; Tuson HH, 2012, MOL MICROBIOL, V84, P874, DOI 10.1111/j.1365-2958.2012.08063.x; Ullrich S, 1996, APPL ENVIRON MICROB, V62, P4587, DOI 10.1128/AEM.62.12.4587-4593.1996; Unge A, 1999, APPL ENVIRON MICROB, V65, P813; Unthan S, 2014, BIOTECHNOL BIOENG, V111, P359, DOI 10.1002/bit.25103; VOTYAKOVA TV, 1994, APPL ENVIRON MICROB, V60, P3284, DOI 10.1128/AEM.60.9.3284-3291.1994; Waidmann Mark S, 2011, Bioeng Bugs, V2, P8, DOI 10.4161/bbug.2.1.13566; Wang C, 2015, ADV APPL BIOTECHNOLO, P375; Wennerhold J, 2005, J BIOL CHEM, V280, P40500, DOI 10.1074/jbc.M508693200; Westerwalbesloh C, 2015, LAB CHIP, V15, P4177, DOI 10.1039/c5lc00646e; Young JW, 2013, P NATL ACAD SCI USA, V110, P4140, DOI 10.1073/pnas.1213060110; Ziegelhoffer EC, 2009, NAT REV MICROBIOL, V7, P856, DOI 10.1038/nrmicro2237	60	12	12	3	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2015	10	10							e0141768	10.1371/journal.pone.0141768	http://dx.doi.org/10.1371/journal.pone.0141768			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0ED	26513257	Green Published, gold, Green Submitted			2022-12-26	WOS:000363920300081
J	Yadav, A; Kumar, B; Yu, JG; Old, M; Teknos, TN; Kumar, P				Yadav, Arti; Kumar, Bhavna; Yu, Jun-Ge; Old, Matthew; Teknos, Theodoros N.; Kumar, Pawan			Tumor-Associated Endothelial Cells Promote Tumor Metastasis by Chaperoning Circulating Tumor Cells and Protecting Them from Anoikis	PLOS ONE			English	Article							FOCAL ADHESION KINASE; SIALYL-LEWIS-X; E-SELECTIN; CANCER-CELLS; BLOOD; CARCINOMA; BCL-2; SRC; ACTIVATION; EXPRESSION	Tumor metastasis is a highly inefficient biological process as millions of tumor cells are released in circulation each day and only a few of them are able to successfully form distal metastatic nodules. This could be due to the fact that most of the epithelial origin cancer cells are anchorage-dependent and undergo rapid anoikis in harsh circulating conditions. A number of studies have shown that in addition to tumor cells, activated endothelial cells are also released into the blood circulation from the primary tumors. However, the precise role of these activated circulating endothelial cells (CECs) in tumor metastasis process is not known. Therefore, we performed a series of experiments to examine if CECs promoted tumor metastasis by chaperoning the tumor cells to distal sites. Our results demonstrate that blood samples from head and neck cancer patients contain significantly higher Bcl-2positive CECs as compared to healthy volunteers. Technically, it is challenging to know the origin of CECs in patient blood samples, therefore we used an orthotopic SCID mouse model and co-implanted GFP-labeled endothelial cells along with tumor cells. Our results suggest that activated CECs (Bcl-2-positive) were released from primary tumors and they co-migrated with tumor cells to distal sites. Bcl-2 overexpression in endothelial cells (EC-Bcl- 2) significantly enhanced adhesion molecule expression and tumor cell binding that was predominantly mediated by E-selectin. In addition, tumor cells bound to EC-Bcl-2 showed a significantly higher anoikis resistance via the activation of Src-FAK pathway. In our in vivo experiments, we observed significantly higher lung metastasis when tumor cells were co-injected with EC-Bcl-2 as compared to EC-VC. E-selectin knockdown in EC-Bcl-2 cells or FAK/FUT3 knockdown in tumor cells significantly reversed EC-Bcl-2-mediated tumor metastasis. Taken together, our results suggest a novel role for CECs in protecting the tumor cells in circulation and chaperoning them to distal sites.	[Yadav, Arti; Kumar, Bhavna; Yu, Jun-Ge; Old, Matthew; Teknos, Theodoros N.; Kumar, Pawan] Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA; [Kumar, Bhavna; Old, Matthew; Teknos, Theodoros N.; Kumar, Pawan] Ohio State Univ, Dept Otolaryngol Head & Neck Surg, Columbus, OH 43210 USA	James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Kumar, P (corresponding author), Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA.	Pawan.Kumar@osumc.edu	Old, Matthew/E-3783-2011; Old, Matthew/J-2315-2017	Old, Matthew/0000-0003-1795-5877	University of Michigan Head and Neck SPORE developmental project grant; Ohio State Comprehensive Cancer Center;  [NIH/NCI-CA178649]; NATIONAL CANCER INSTITUTE [R21CA178649] Funding Source: NIH RePORTER	University of Michigan Head and Neck SPORE developmental project grant; Ohio State Comprehensive Cancer Center; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by NIH/NCI-CA178649 (PK), University of Michigan Head and Neck SPORE developmental project grant (PK), and The Ohio State Comprehensive Cancer Center (PK and TNT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attwell S, 2000, ONCOGENE, V19, P3811, DOI 10.1038/sj.onc.1203711; Beerepoot LV, 2004, CANCER LETT, V213, P241, DOI 10.1016/j.canlet.2004.04.019; Beerepoot LV, 2004, ANN ONCOL, V15, P139, DOI 10.1093/annonc/mdh017; Bogenrieder T, 2003, ONCOGENE, V22, P6524, DOI 10.1038/sj.onc.1206757; Bouchard V, 2007, J CELL PHYSIOL, V212, P717, DOI 10.1002/jcp.21096; Braun S, 2005, J CLIN ONCOL, V23, P1623, DOI 10.1200/JCO.2005.10.073; Brenner JC, 2010, HEAD NECK-J SCI SPEC, V32, P417, DOI 10.1002/hed.21198; Brunton VG, 2005, CANCER RES, V65, P1335, DOI 10.1158/0008-5472.CAN-04-1949; Burdick MM, 2012, FRONT ONCOL, V2, DOI 10.3389/fonc.2012.00103; BUTLER TP, 1975, CANCER RES, V35, P512; Chaffer CL, 2011, SCIENCE, V331, P1559, DOI 10.1126/science.1203543; Chen HC, 1996, J BIOL CHEM, V271, P26329, DOI 10.1074/jbc.271.42.26329; Duxbury MS, 2004, SURGERY, V135, P555, DOI 10.1016/j.surg.2003.10.017; Enis DR, 2005, P NATL ACAD SCI USA, V102, P425, DOI 10.1073/pnas.0408357102; Farmer RW, 1998, HEAD NECK-J SCI SPEC, V20, P726, DOI 10.1002/(SICI)1097-0347(199812)20:8<726::AID-HED11>3.0.CO;2-C; FIDLER IJ, 1970, JNCI-J NATL CANCER I, V45, P773; Frisch SM, 1996, J CELL BIOL, V134, P793, DOI 10.1083/jcb.134.3.793; FRISCH SM, 1994, J CELL BIOL, V124, P619, DOI 10.1083/jcb.124.4.619; GEORGE F, 1992, THROMB HAEMOSTASIS, V67, P147; Glinskii AB, 2003, CANCER RES, V63, P4239; Gorelik E, 2001, CANCER METAST REV, V20, P245, DOI 10.1023/A:1015535427597; Joyce JA, 2009, NAT REV CANCER, V9, P239, DOI 10.1038/nrc2618; Kalavrezos N, 2010, ORAL ONCOL, V46, P429, DOI 10.1016/j.oraloncology.2010.03.007; Khatib AM, 2002, CANCER RES, V62, P5393; Kim JW, 2004, CANCER LETT, V213, P203, DOI 10.1016/j.canlet.2004.03.042; Kumar P, 2004, J BIOL CHEM, V279, P43352, DOI 10.1074/jbc.M405777200; Kumar P, 2003, BLOOD, V101, P3960, DOI 10.1182/blood-2002-04-1237; Kumar P, 2001, J BIOL CHEM, V276, P21039, DOI 10.1074/jbc.M009099200; Kumar P, 2008, LAB INVEST, V88, P740, DOI 10.1038/labinvest.2008.46; Kumar P, 2007, CANCER RES, V67, P1193, DOI 10.1158/0008-5472.CAN-06-2265; Lee JW, 2004, MOL CELLS, V17, P188; Lowe JB, 2002, IMMUNOL REV, V186, P19, DOI 10.1034/j.1600-065X.2002.18603.x; Mancuso P, 2003, ADV EXP MED BIOL, V522, P83; Mancuso P, 2001, BLOOD, V97, P3658, DOI 10.1182/blood.V97.11.3658; Millan MT, 1997, TRANSPLANTATION, V63, P421, DOI 10.1097/00007890-199702150-00016; Nor JE, 2001, LAB INVEST, V81, P453, DOI 10.1038/labinvest.3780253; Nor JE, 2001, CANCER RES, V61, P2183; Padua D, 2008, CELL, V133, P66, DOI 10.1016/j.cell.2008.01.046; Paoli P, 2013, BBA-MOL CELL RES, V1833, P3481, DOI 10.1016/j.bbamcr.2013.06.026; Porquet N, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-285; PROCTOR JW, 1976, INT J CANCER, V18, P255, DOI 10.1002/ijc.2910180217; Qi XJ, 2006, J BIOL CHEM, V281, P813, DOI 10.1074/jbc.M505546200; Ragin CCR, 2007, J DENT RES, V86, P104, DOI 10.1177/154405910708600202; Reddig PJ, 2005, CANCER METAST REV, V24, P425, DOI 10.1007/s10555-005-5134-3; ROOS E, 1979, BIOCHIM BIOPHYS ACTA, V560, P135, DOI 10.1016/0304-419X(79)90005-2; Shattil SJ, 2010, NAT REV MOL CELL BIO, V11, P288, DOI 10.1038/nrm2871; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; TAKADA A, 1993, CANCER RES, V53, P354; Wang HG, 1996, P NATL ACAD SCI USA, V93, P7063, DOI 10.1073/pnas.93.14.7063; Wiest I, 2010, ANTICANCER RES, V30, P1849; Windham TC, 2002, ONCOGENE, V21, P7797, DOI 10.1038/sj.onc.1205989; Wong CW, 2001, CANCER RES, V61, P333; Yin XY, 2010, CARBOHYD RES, V345, P2334, DOI 10.1016/j.carres.2010.07.028	54	38	42	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2015	10	10							e0141602	10.1371/journal.pone.0141602	http://dx.doi.org/10.1371/journal.pone.0141602			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0DL	26509633	Green Submitted, Green Published, gold			2022-12-26	WOS:000363918100113
J	Wu, Y; Yang, LY; Cao, AQ; Wang, JB				Wu, Ya; Yang, Liyu; Cao, Aqin; Wang, Jianbo			Gene Expression Profiles in Rice Developing Ovules Provided Evidence for the Role of Sporophytic Tissue in Female Gametophyte Development	PLOS ONE			English	Article							CELL-CELL COMMUNICATION; ARABIDOPSIS-THALIANA; DNA METHYLATION; FLORAL ORGANS; EMBRYO SACS; WILD-TYPE; CYTOKININ; PROTEIN; IDENTIFICATION; DYNAMICS	The development of ovule in rice (Oryza sativa) is vital during its life cycle. To gain more understanding of the molecular events associated with the ovule development, we used RNA sequencing approach to perform transcriptome-profiling analysis of the leaf and ovules at four developmental stages. In total, 25,401, 23,343, 23,647 and 23,806 genes were identified from the four developmental stages of the ovule, respectively. We identified a number of differently expressed genes (DEGs) from three adjacent stage comparisons, which may play crucial roles in ovule development. The DEGs were then conducted functional annotations and Kyoto encyclopedia of genes and genomes (KEGG) pathway analyses. Genes related to cellular component biogenesis, membrane-bounded organelles and reproductive regulation were identified to be highly expressed during the ovule development. Different expression levels of auxin-related and cytokinin-related genes were also identified at various stages, providing evidence for the role of sporophytic ovule tissue in female gametophyte development from the aspect of gene expression. Generally, an overall transcriptome analysis for rice ovule development has been conducted. These results increased our knowledge of the complex molecular and cellular events that occur during the development of rice ovule and provided foundation for further studies on rice ovule development.	[Wu, Ya; Yang, Liyu; Cao, Aqin; Wang, Jianbo] Wuhan Univ, Coll Life Sci, State Key Lab Hybrid Rice, Wuhan 430072, Peoples R China	Wuhan University	Wang, JB (corresponding author), Wuhan Univ, Coll Life Sci, State Key Lab Hybrid Rice, Wuhan 430072, Peoples R China.	jbwang@whu.edu.cn			State Key Basic Research and Development Plan of China [2013CB126900]	State Key Basic Research and Development Plan of China(National Basic Research Program of China)	This work was supported by the State Key Basic Research and Development Plan of China (2013CB126900).	Abiko M, 2013, J EXP BOT, V64, P1927, DOI 10.1093/jxb/ert054; Anderson SN, 2013, PLANT J, V76, P729, DOI 10.1111/tpj.12336; Bartrina I, 2011, PLANT CELL, V23, P69, DOI 10.1105/tpc.110.079079; Bencivenga S, 2012, PLANT CELL, V24, P2886, DOI 10.1105/tpc.112.100164; Bencivenga S, 2011, SEX PLANT REPROD, V24, P113, DOI 10.1007/s00497-011-0162-3; Benkova E, 2003, CELL, V115, P591, DOI 10.1016/S0092-8674(03)00924-3; Cheng YF, 2006, GENE DEV, V20, P1790, DOI 10.1101/gad.1415106; Chettoor AM, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00187; Chevalier E, 2013, PLANT J, V73, P1019, DOI 10.1111/tpj.12096; Chevalier E, 2011, NEW PHYTOL, V192, P13, DOI 10.1111/j.1469-8137.2011.03836.x; Christensen CA, 1997, SEX PLANT REPROD, V10, P49, DOI 10.1007/s004970050067; Deng YT, 2014, PLANT PHYSIOL, V166, P853, DOI 10.1104/pp.114.242560; Deng ZY, 2007, PLANT MOL BIOL, V65, P31, DOI 10.1007/s11103-007-9195-2; Drews GN, 1998, PLANT CELL, V10, P5, DOI 10.1105/tpc.10.1.5; Evans MMS, 2007, PLANT CELL, V19, P46, DOI 10.1105/tpc.106.047506; Gao Y, 2013, PLANT MOL BIOL, V81, P363, DOI 10.1007/s11103-013-0009-4; Haecker A, 2004, DEVELOPMENT, V131, P657, DOI 10.1242/dev.00963; Ito Y, 2006, GENE, V382, P57, DOI 10.1016/j.gene.2006.06.020; Jeong SH, 2011, J EXP BOT, V62, P1687, DOI 10.1093/jxb/erq398; Johnston AJ, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r204; Ju CL, 2012, P NATL ACAD SCI USA, V109, P19486, DOI 10.1073/pnas.1214848109; Jullien PE, 2008, PLOS BIOL, V6, P1693, DOI 10.1371/journal.pbio.0060194; Jullien PE, 2012, CURR BIOL, V22, P1825, DOI 10.1016/j.cub.2012.07.061; Kakimoto T, 2003, ANNU REV PLANT BIOL, V54, P605, DOI 10.1146/annurev.arplant.54.031902.134802; Kanehisa M, 2006, NUCLEIC ACIDS RES, V34, pD354, DOI 10.1093/nar/gkj102; Kankel MW, 2003, GENETICS, V163, P1109; KIEBER JJ, 1993, CELL, V72, P427, DOI 10.1016/0092-8674(93)90119-B; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Kubo T, 2013, PLANT CELL PHYSIOL, V54, P750, DOI 10.1093/pcp/pct029; Lee DS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058748; Lee S, 2004, PLANT MOL BIOL, V54, P755, DOI 10.1023/B:PLAN.0000040904.15329.29; Leibfried A, 2005, NATURE, V438, P1172, DOI 10.1038/nature04270; Li N, 2006, PLANT CELL, V18, P2999, DOI 10.1105/tpc.106.044107; Li XW, 2011, PLANT CELL, V23, P1416, DOI 10.1105/tpc.110.082636; Lopez-Dee ZP, 1999, DEV GENET, V25, P237, DOI 10.1002/(SICI)1520-6408(1999)25:3&lt;237::AID-DVG6&gt;3.0.CO;2-L; MANSFIELD SG, 1991, CAN J BOT, V69, P461, DOI 10.1139/b91-063; Muller B, 2007, SCIENCE, V318, P68, DOI 10.1126/science.1145461; Nadeau JA, 1996, PLANT CELL, V8, P213, DOI 10.1105/tpc.8.2.213; Nonomura KI, 2007, PLANT CELL, V19, P2583, DOI 10.1105/tpc.107.053199; Ohnishi T, 2011, PLANT PHYSIOL, V155, P881, DOI 10.1104/pp.110.167502; Pagnussat GC, 2009, SCIENCE, V324, P1684, DOI 10.1126/science.1167324; Pagnussat GC, 2007, PLANT CELL, V19, P3578, DOI 10.1105/tpc.107.054890; Panoli A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126164; Park SO, 2005, DEVELOPMENT, V132, P841, DOI 10.1242/dev.01654; Qi ZY, 2013, J INTEGR PLANT BIOL, V55, P1119, DOI 10.1111/jipb.12101; ROBINSONBEERS K, 1992, PLANT CELL, V4, P1237, DOI 10.1105/tpc.4.10.1237; RUSSELL SD, 1992, INT REV CYTOL, V140, P357, DOI 10.1016/S0074-7696(08)61102-X; Sakamoto T, 2006, PLANT PHYSIOL, V142, P54, DOI 10.1104/pp.106.085811; Sieber P, 2004, DEV BIOL, V273, P321, DOI 10.1016/j.ydbio.2004.05.037; Skinner DJ, 2004, PLANT CELL, V16, pS32, DOI 10.1105/tpc.015933; Solomon M, 1999, PLANT CELL, V11, P431, DOI 10.1105/tpc.11.3.431; Susaki D, 2015, PLANT CELL PHYSIOL, V56, P1031, DOI 10.1093/pcp/pcv031; To JPC, 2004, PLANT CELL, V16, P658, DOI 10.1105/tpc.018978; Wang LK, 2010, BIOINFORMATICS, V26, P136, DOI 10.1093/bioinformatics/btp612; WEBB MC, 1990, SEX PLANT REPROD, V3, P244, DOI 10.1007/BF00202882; Xiao WY, 2006, PLANT CELL, V18, P805, DOI 10.1105/tpc.105.038836; Xu H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030646; Zhang JR, 2015, J EXP BOT, V66, P99, DOI 10.1093/jxb/eru396; Zhao PF, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0492-7; Zhao Y, 2009, PLANT CELL, V21, P736, DOI 10.1105/tpc.108.061655; ZHOU C, 1985, PLANTA, V165, P225, DOI 10.1007/BF00395045	61	15	15	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2015	10	10							e0141613	10.1371/journal.pone.0141613	http://dx.doi.org/10.1371/journal.pone.0141613			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU8PC	26506227	Green Published, gold, Green Submitted			2022-12-26	WOS:000363804200092
J	Wang, Z; Kim, J; Teng, Y; Ding, HF; Zhang, J; Hai, T; Cowell, JK; Yan, C				Wang, Z.; Kim, J.; Teng, Y.; Ding, H-F; Zhang, J.; Hai, T.; Cowell, J. K.; Yan, C.			Loss of ATF3 promotes hormone-induced prostate carcinogenesis and the emergence of CK5(+)CK8(+) epithelial cells	ONCOGENE			English	Article							ACTIVATING TRANSCRIPTION FACTOR-3; TO-LUMINAL DIFFERENTIATION; ADAPTIVE-RESPONSE; CANCER; ESTROGEN; BASAL; PTEN; GROWTH; BETA; INFLAMMATION	Steroid sex hormones can induce prostate carcinogenesis, and are thought to contribute to the development of prostate cancer during aging. However, the mechanism for hormone-induced prostate carcinogenesis remains elusive. Here, we report that activating transcription factor 3 (ATF3)-a broad stress sensor-suppressed hormone-induced prostate carcinogenesis in mice. Although implantation of testosterone and estradiol (T+E-2) pellets for 2 months in wild-type mice rarely induced prostatic intraepithelial neoplasia (PIN) in dorsal prostates (one out of eight mice), the loss of ATF3 led to the appearance of not only PIN but also invasive lesions in almost all examined animals. The enhanced carcinogenic effects of hormones on ATF3-deficient prostates did not appear to be caused by a change in estrogen signaling, but were more likely a consequence of elevated androgen signaling that stimulated differentiation of prostatic basal cells into transformation-preferable luminal cells. Indeed, we found that hormone-induced lesions in ATF3-knockout mice often contained cells with both basal and luminal characteristics, such as p63(+) cells (a basal-cell marker) showing luminal-like morphology, or cells double-stained with basal (CK5(+)) and luminal (CK8(+)) markers. Consistent with these findings, low ATF3 expression was found to be a poor prognostic marker for prostate cancer in a cohort of 245 patients. Our results thus support that ATF3 is a tumor suppressor in prostate cancer.	[Wang, Z.; Teng, Y.; Ding, H-F; Cowell, J. K.; Yan, C.] Georgia Regents Univ, GRU Canc Ctr, 1410 Laney Walker Blvd,CN2134, Augusta, GA 30912 USA; [Wang, Z.; Yan, C.] Albany Med Coll, Ctr Cell Biol & Canc Res, Albany, NY 12208 USA; [Kim, J.] Sungkyunkwan Univ, Dept Stat, Seoul, South Korea; [Ding, H-F] Georgia Regents Univ, Med Coll Georgia, Dept Pathol, Augusta, GA USA; [Zhang, J.] Case Western Reserve Univ, Sch Med, Dept Radiat Oncol, Cleveland, OH 44106 USA; [Hai, T.] Ohio State Univ, Dept Biol Chem & Pharmacol, Columbus, OH 43210 USA; [Yan, C.] Georgia Regents Univ, Med Coll Georgia, Dept Biochem & Mol Biol, Augusta, GA USA	University System of Georgia; Augusta University; Albany Medical College; Sungkyunkwan University (SKKU); University System of Georgia; Augusta University; Case Western Reserve University; University System of Ohio; Ohio State University; University System of Georgia; Augusta University	Yan, C (corresponding author), Georgia Regents Univ, GRU Canc Ctr, 1410 Laney Walker Blvd,CN2134, Augusta, GA 30912 USA.	cyan@gru.edu	Hai, Tsonwin/E-3185-2011; Teng, Yong/AAK-4160-2020	Hai, Tsonwin/0000-0003-4510-0315; Teng, Yong/0000-0002-1856-7289; Ding, Han-Fei/0000-0001-5702-3439; Yan, Chunhong/0000-0002-3974-7991	NIH [R01CA139107, R01CA164006]; Department of Defense award [W81XWH-15-1-0049]; NATIONAL CANCER INSTITUTE [R01CA139107, R01CA164006, P30CA016058] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense award(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by NIH grants R01CA139107 and R01CA164006, and a Department of Defense award W81XWH-15-1-0049 to CY. We thank Dr Ahmed Chadli for providing the PR antibody.	Bennett NC, 2010, INT J BIOCHEM CELL B, V42, P813, DOI 10.1016/j.biocel.2009.11.013; Berger R, 2004, CANCER RES, V64, P8867, DOI 10.1158/0008-5472.CAN-04-2938; Bonkhoff H, 1996, PROSTATE, V28, P98; Bosland Maarten C, 2005, Rev Urol, V7 Suppl 3, pS4; Carver BS, 2011, CANCER CELL, V19, P575, DOI 10.1016/j.ccr.2011.04.008; Choi N, 2012, CANCER CELL, V21, P253, DOI 10.1016/j.ccr.2012.01.005; Culig ZR, 2003, J UROLOGY, V170, P1363, DOI 10.1097/01.ju.0000075099.20662.7f; Ding ZH, 2011, NATURE, V470, P269, DOI 10.1038/nature09677; Gilchrist M, 2006, NATURE, V441, P173, DOI 10.1038/nature04768; Gnanapragasam VJ, 2000, BJU INT, V86, P1001, DOI 10.1046/j.1464-410x.2000.00943.x; Goldstein AS, 2013, GENE DEV, V27, P1539, DOI 10.1101/gad.222380.113; Hai T, 1999, GENE EXPRESSION, V7, P321; Hai T, 2010, GENE EXPRESSION, V15, P1, DOI 10.3727/105221610X12819686555015; Hartman MG, 2004, MOL CELL BIOL, V24, P5721, DOI 10.1128/MCB.24.13.5721-5732.2004; Heemers HW, 2005, ENDOCR REV, V28, P778; Hoetzenecker W, 2012, NAT MED, V18, P128, DOI 10.1038/nm.2557; Huang XW, 2008, J BIOL CHEM, V283, P29795, DOI 10.1074/jbc.M802515200; Kang YB, 2003, MOL CELL, V11, P915, DOI 10.1016/S1097-2765(03)00109-6; Kwon OJ, 2014, P NATL ACAD SCI USA, V111, pE592, DOI 10.1073/pnas.1318157111; Lapointe J, 2004, P NATL ACAD SCI USA, V101, P811, DOI 10.1073/pnas.0304146101; Lau KM, 2000, CANCER RES, V60, P3175; Liu YQ, 2013, CANCER LETT, V337, P66, DOI 10.1016/j.canlet.2013.05.022; Lu TL, 2013, AM J PATHOL, V182, P975, DOI 10.1016/j.ajpath.2012.11.025; Mulholland DJ, 2011, CANCER CELL, V19, P792, DOI 10.1016/j.ccr.2011.05.006; NOBLE RL, 1977, CANCER RES, V37, P1929; Okamoto A, 2006, MOL CELL BIOL, V26, P1087, DOI 10.1128/MCB.26.3.1087-1097.2006; Prins GS, 2008, STEROIDS, V73, P233, DOI 10.1016/j.steroids.2007.10.013; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Ricke WA, 2008, FASEB J, V22, P1512, DOI 10.1096/fj.07-9526com; Ricke WA, 2007, DIFFERENTIATION, V75, P871, DOI 10.1111/j.1432-0436.2007.00224.x; Risbridger G, 2001, DEV BIOL, V229, P432, DOI 10.1006/dbio.2000.9994; Risbridger GP, 2001, ENDOCRINOLOGY, V142, P2443, DOI 10.1210/en.142.6.2443; Thompson MR, 2009, J MOL MED, V87, P1053, DOI 10.1007/s00109-009-0520-x; Tomlins SA, 2007, NAT GENET, V39, P41, DOI 10.1038/ng1935; Wang HB, 2012, MOL CELL BIOL, V32, P3190, DOI 10.1128/MCB.00159-12; Wang JJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4415; Wang L, 2005, PROSTATE, V63, P117, DOI 10.1002/pros.20170; Wang Z, 2015, ONCOGENE, V34, P4975, DOI 10.1038/onc.2014.426; Wang Z, MOL CELL ON IN PRESS; Wang ZA, 2014, CELL REP, V8, P1339, DOI 10.1016/j.celrep.2014.08.002; Wolford CC, 2013, J CLIN INVEST, V123, P2893, DOI 10.1172/JCI64410; Yan CH, 2005, EMBO J, V24, P2425, DOI 10.1038/sj.emboj.7600712; Yan CH, 2006, CELL CYCLE, V5, P926, DOI 10.4161/cc.5.9.2714	43	14	14	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 7	2016	35	27					3555	3564		10.1038/onc.2015.417	http://dx.doi.org/10.1038/onc.2015.417			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DR0UD	26522727	Green Accepted			2022-12-26	WOS:000379621500008
J	Hunter, JE; Butterworth, JA; Zhao, B; Sellier, H; Campbell, KJ; Thomas, HD; Bacon, CM; Cockell, SJ; Gewurz, BE; Perkins, ND				Hunter, J. E.; Butterworth, J. A.; Zhao, B.; Sellier, H.; Campbell, K. J.; Thomas, H. D.; Bacon, C. M.; Cockell, S. J.; Gewurz, B. E.; Perkins, N. D.			The NF-kappa B subunit c-Rel regulates Bach2 tumour suppressor expression in B-cell lymphoma	ONCOGENE			English	Article							CLASSICAL HODGKIN LYMPHOMA; MYC-INDUCED LYMPHOMAGENESIS; REPRESSOR BACH2; SURVIVAL; GENE; ACTIVATION; MUTATIONS; ROLES; ONCOPROTEIN; ASSOCIATION	The REL gene, encoding the NF-kappa B subunit c-Rel, is frequently amplified in B-cell lymphoma and functions as a tumour-promoting transcription factor. Here we report the surprising result that c-rel-/- mice display significantly earlier lymphomagenesis in the c-Myc driven, E mu-Myc model of B-cell lymphoma. c-Rel loss also led to earlier onset of disease in a separate TCL1-Tg-driven lymphoma model. Tumour reimplantation experiments indicated that this is an effect intrinsic to the E mu-Myc lymphoma cells but, counterintuitively, c-rel-/- E mu-Myc lymphoma cells were more sensitive to apoptotic stimuli. To learn more about why loss of c-Rel led to earlier onset of disease, microarray gene expression analysis was performed on B cells from 4-week-old, wild-type and c-rel-/E mu- Myc mice. Extensive changes in gene expression were not seen at this age, but among those transcripts significantly downregulated by the loss of c-Rel was the B-cell tumour suppressor BTB and CNC homology 2 ( Bach2). Quantitative PCR and western blot analysis confirmed loss of Bach2 in c-Rel mutant E mu-Myc tumours at both 4 weeks and the terminal stages of disease. Moreover, Bach2 expression was also downregulated in c-rel-/- TCL1-Tg mice and RelA Thr505Ala mutant E mu-Myc mice. Analysis of wild-type E mu-Myc mice demonstrated that the population expressing low levels of Bach2 exhibited the earlier onset of lymphoma seen in c-rel-/- mice. Confirming the relevance of these findings to human disease, analysis of chromatin immunoprecipitation sequencing data revealed that Bach2 is a c-Rel and NF-kappa B target gene in transformed human B cells, whereas treatment of Burkitt's lymphoma cells with inhibitors of the NF-kappa B/I kappa B kinase pathway or deletion of c-Rel or RelA resulted in loss of Bach2 expression. These data reveal a surprising tumour suppressor role for c-Rel in lymphoma development explained by regulation of Bach2 expression, underlining the context-dependent complexity of NF-kappa B signalling in cancer.	[Hunter, J. E.; Butterworth, J. A.; Sellier, H.; Perkins, N. D.] Newcastle Univ, Sch Med, Inst Cell & Mol Biosci ICaMB, Catherine Cookson Bldg,Framlington Pl, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [Zhao, B.; Gewurz, B. E.] Brigham & Womens Hosp, Boston, MA 02115 USA; [Campbell, K. J.] Beatson Inst Canc Res, Glasgow, Lanark, Scotland; [Thomas, H. D.; Bacon, C. M.] Northern Inst Canc Res, Newcastle Upon Tyne, Tyne & Wear, England; [Cockell, S. J.] Newcastle Univ, Fac Med Sci, Bioinformat Support Unit, Newcastle Upon Tyne, Tyne & Wear, England	Newcastle University - UK; Harvard University; Brigham & Women's Hospital; Beatson Institute; Newcastle University - UK; Newcastle University - UK	Perkins, ND (corresponding author), Newcastle Univ, Sch Med, Inst Cell & Mol Biosci ICaMB, Catherine Cookson Bldg,Framlington Pl, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.	neil.perkins@ncl.ac.uk		Cockell, Simon/0000-0002-6831-9806; Bacon, Chris/0000-0002-8268-2812	Leukemia Lymphoma Research [11022]; Wellcome Trust [094409]; NDP lab from Cancer Research UK [C1443/A12750]; Welcome Trust Equipment grant [087961]; US National Institutes of Health [K08 CA140780, RO1 CA12850]; Burroughs Wellcome Medical Scientist career award; NATIONAL CANCER INSTITUTE [K08CA140780, R01CA085180] Funding Source: NIH RePORTER; Cancer Research UK [22095, 22311, 12750] Funding Source: researchfish	Leukemia Lymphoma Research; Wellcome Trust(Wellcome TrustEuropean Commission); NDP lab from Cancer Research UK; Welcome Trust Equipment grant; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Medical Scientist career award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Cancer Research UK(Cancer Research UK)	We thank Fiona Oakley, Sonia Rocha, Derek Mann, Claire Richardson, Saimir Luli, Elaine Willmore and all members of the NDP laboratory for their helpful advice and assistance. We are very grateful to Michael J. Walsh for assistance with generation of CRISPR/Cas9 knock-out cell lines. JEH is funded by Leukemia Lymphoma Research grant 11022, JAB and HS are funded by the Wellcome Trust grant 094409, further funding from the NDP lab was obtained from Cancer Research UK grant C1443/A12750. The IVIS Spectrum was funded by Welcome Trust Equipment grant 087961. BZ and BEG are funded by US National Institutes of Health (grants K08 CA140780 and RO1 CA12850) and by a Burroughs Wellcome Medical Scientist career award.	Barth TFE, 2003, BLOOD, V101, P3681, DOI 10.1182/blood-2002-08-2577; Cariappa A, 2000, J EXP MED, V192, P1175, DOI 10.1084/jem.192.8.1175; Carlsen H, 2002, J IMMUNOL, V168, P1441, DOI 10.4049/jimmunol.168.3.1441; Casolari DA, 2013, LEUKEMIA, V27, P409, DOI 10.1038/leu.2012.220; Chien YC, 2011, GENE DEV, V25, P2125, DOI 10.1101/gad.17276711; Chin M, 2009, ONCOGENE, V28, P2100, DOI 10.1038/onc.2009.74; Courtois G, 2006, ONCOGENE, V25, P6831, DOI 10.1038/sj.onc.1209939; Curry Choladda V, 2009, J Hematop, V2, P20, DOI 10.1007/s12308-009-0021-4; Davis RE, 2001, J EXP MED, V194, P1861, DOI 10.1084/jem.194.12.1861; Doench JG, 2014, NAT BIOTECHNOL, V32, P1262, DOI 10.1038/nbt.3026; Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224; Eischen CM, 1999, GENE DEV, V13, P2658, DOI 10.1101/gad.13.20.2658; Enciso-Mora V, 2010, NAT GENET, V42, P1126, DOI 10.1038/ng.696; Fan YJ, 2004, ONCOGENE, V23, P1030, DOI 10.1038/sj.onc.1207221; Fan YJ, 2008, ADV EXP MED BIOL, V615, P223, DOI 10.1007/978-1-4020-6554-5_11; Feuerhake F, 2005, BLOOD, V106, P1392, DOI 10.1182/blood-2004-12-4901; Fullard N, 2012, INT J BIOCHEM CELL B, V44, P851, DOI 10.1016/j.biocel.2012.02.017; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gilmore TD, 1999, ONCOGENE, V18, P6925, DOI 10.1038/sj.onc.1203222; Greenfeld H, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004890; Grossmann M, 1999, P NATL ACAD SCI USA, V96, P11848, DOI 10.1073/pnas.96.21.11848; GRUMONT RJ, 1994, CELL GROWTH DIFFER, V5, P1321; HARRIS AW, 1988, J EXP MED, V167, P353, DOI 10.1084/jem.167.2.353; Hoshino H, 2000, J BIOL CHEM, V275, P15370, DOI 10.1074/jbc.275.20.15370; Hoyer KK, 2002, P NATL ACAD SCI USA, V99, P14392, DOI 10.1073/pnas.212410199; Ichikawa S, 2014, CANCER SCI, V105, P437, DOI 10.1111/cas.12361; Jing H, 2011, GENE DEV, V25, P2137, DOI 10.1101/gad.17620611; Joos S, 2002, BLOOD, V99, P1381, DOI 10.1182/blood.V99.4.1381; Keller U, 2005, ONCOGENE, V24, P6231, DOI 10.1038/sj.onc.1208779; Keller U, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-348; KONTGEN F, 1995, GENE DEV, V9, P1965, DOI 10.1101/gad.9.16.1965; Kuppers R, 2009, NAT REV CANCER, V9, P15, DOI 10.1038/nrc2542; Lenz G, 2008, SCIENCE, V319, P1676, DOI 10.1126/science.1153629; LIOU HC, 1994, MOL CELL BIOL, V14, P5349, DOI 10.1128/MCB.14.8.5349; Martin-Subero JI, 2002, BLOOD, V99, P1474, DOI 10.1182/blood.V99.4.1474; Msaki A, 2011, MOL BIOL CELL, V22, P3032, DOI 10.1091/mbc.E11-04-0280; Muto A, 2002, J BIOL CHEM, V277, P20724, DOI 10.1074/jbc.M112003200; Naito Y, 2015, BIOINFORMATICS, V31, P1120, DOI 10.1093/bioinformatics/btu743; Perkins ND, 2012, NAT REV CANCER, V12, P121, DOI 10.1038/nrc3204; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pham LV, 2005, BLOOD, V106, P3940, DOI 10.1182/blood-2005-03-1167; Rosenwald A, 2003, J EXP MED, V198, P851, DOI 10.1084/jem.20031074; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Sasaki S, 2000, ONCOGENE, V19, P3739, DOI 10.1038/sj.onc.1203716; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Starczynowski DT, 2003, ONCOGENE, V22, P6928, DOI 10.1038/sj.onc.1206801; Staudt LM, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000109; Swaminathan S, 2013, NAT MED, V19, P1014, DOI 10.1038/nm.3247; Tumang JR, 1998, EUR J IMMUNOL, V28, P4299, DOI 10.1002/(SICI)1521-4141(199812)28:12<4299::AID-IMMU4299>3.0.CO;2-Y; Tumang JR, 2002, CELL IMMUNOL, V217, P47, DOI 10.1016/S0008-8749(02)00513-0; WEIH F, 1994, ONCOGENE, V9, P3289; Zhao B, 2014, CELL REP, V8, P1595, DOI 10.1016/j.celrep.2014.07.037	52	25	25	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 30	2016	35	26					3476	3484		10.1038/onc.2015.399	http://dx.doi.org/10.1038/onc.2015.399			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DQ5UI	26522720	Green Published, Green Accepted, hybrid			2022-12-26	WOS:000379270100012
J	Eiseler, T; Wille, C; Koehler, C; Illing, A; Seufferlein, T				Eiseler, Tim; Wille, Christoph; Koehler, Conny; Illing, Anett; Seufferlein, Thomas			Protein Kinase D2 Assembles a Multiprotein Complex at the Trans-Golgi Network to Regulate Matrix Metalloproteinase Secretion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ADP ribosylation factor (ARF); metalloprotease; protein kinase D (PKD); secretion; vesicles	ADP-RIBOSYLATION FACTOR; MANNOSE 6-PHOSPHATE RECEPTORS; BAR-DOMAIN; ACTIN POLYMERIZATION; MEMBRANE-BINDING; ADAPTER COMPLEX; CELL-SURFACE; ARF FAMILY; ARFAPTIN 1; RECRUITMENT	Vesicle formation and fission are tightly regulated at the trans-Golgi network (TGN) during constitutive secretion. Two major protein families regulate these processes: members of the adenosyl-ribosylation factor family of small G-proteins (ARFs) and the protein kinase D (PKD) family of serine/threonine kinases. The functional relationship between these two key regulators of protein transport from the TGN so far is elusive. We here demonstrate the assembly of a novel functional protein complex at the TGN and its key members: cytosolic PKD2 binds ARF-like GTPase (ARL1) and shuttles ARL1 to the TGN. ARL1, in turn, localizes Arfaptin2 to the TGN. At the TGN, where PKD2 interacts with active ARF1, PKD2, and ARL1 are required for the assembly of a complex comprising of ARF1 and Arfaptin2 leading to secretion of matrix metalloproteinase-2 and -7. In conclusion, our data indicate that PKD2 is a core factor in the formation of this multiprotein complex at the TGN that controls constitutive secretion of matrix metalloproteinase cargo.	[Eiseler, Tim; Wille, Christoph; Illing, Anett; Seufferlein, Thomas] Univ Ulm, Dept Internal Med 1, D-89081 Ulm, Germany; [Koehler, Conny] Univ Halle Wittenberg, Dept Internal Med 1, D-06120 Halle, Saale, Germany	Ulm University; Martin Luther University Halle Wittenberg	Eiseler, T (corresponding author), Univ Ulm, Dept Internal Med 1, Albert Einstein Allee 23, D-89081 Ulm, Germany.	tim.eiseler@uniklinik-ulm.de; thomas.seufferlein@uniklinik-ulm.de	Seufferlein, Thomas TW/P-7147-2018		Deutsche Forschungsgemeinschaft [EI792/3-1, SE676/10-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grants EI792/3-1 (to T. E.) and SE676/10-1 (to T. S.). The authors declare no conflict of interest.	Ambroggio EE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062963; Anel AMD, 2005, J CELL BIOL, V169, P83, DOI 10.1083/jcb.200412089; Atik N, 2014, CELL STRUCT FUNCT, V39, P61, DOI 10.1247/csf.13020; Baron CL, 2002, SCIENCE, V295, P325, DOI 10.1126/science.1066759; Campelo F, 2012, ANNU REV BIOCHEM, V81, P407, DOI 10.1146/annurev-biochem-051710-094912; Chang L, 2013, MOL BIOL CELL, V24, P1749, DOI 10.1091/mbc.E12-09-0697; Christis C, 2012, J CELL BIOL, V196, P327, DOI 10.1083/jcb.201107115; Cruz-Garcia D, 2013, EMBO J, V32, P1717, DOI 10.1038/emboj.2013.116; Dell'Angelica EC, 2000, J CELL BIOL, V149, P81, DOI 10.1083/jcb.149.1.81; Donaldson JG, 2005, BIOCHEM SOC T, V33, P639, DOI 10.1042/BST0330639; DONALDSON JG, 1992, P NATL ACAD SCI USA, V89, P6408, DOI 10.1073/pnas.89.14.6408; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Eiseler T, 2012, J BIOL CHEM, V287, P32367, DOI 10.1074/jbc.M112.370999; Eiseler T, 2010, J BIOL CHEM, V285, P18672, DOI 10.1074/jbc.M109.093880; English JL, 2006, J BIOL CHEM, V281, P10337, DOI 10.1074/jbc.M512009200; Fugmann T, 2007, J CELL BIOL, V178, P15, DOI 10.1083/jcb.200612017; Gehart H, 2012, DEV CELL, V23, P756, DOI 10.1016/j.devcel.2012.07.019; Gillingham AK, 2007, ANNU REV CELL DEV BI, V23, P579, DOI 10.1146/annurev.cellbio.23.090506.123209; Gu Y, 2004, J MICROSC-OXFORD, V215, P162, DOI 10.1111/j.0022-2720.2004.01365.x; Habermann B, 2004, EMBO REP, V5, P250, DOI 10.1038/sj.embor.7400105; Hausser A, 2005, NAT CELL BIOL, V7, P880, DOI 10.1038/ncb1289; Hausser A, 2002, J CELL BIOL, V156, P65, DOI 10.1083/jcb.200110047; Itoh Y, 2006, J CELL PHYSIOL, V206, P1, DOI 10.1002/jcp.20431; Kahn Richard A, 2011, Cell Logist, V1, P49; Kanoh H, 1997, J BIOL CHEM, V272, P5421, DOI 10.1074/jbc.272.9.5421; Kunkel Maya T, 2009, Curr Protoc Chem Biol, V1, P17; Liljedahl M, 2001, CELL, V104, P409, DOI 10.1016/S0092-8674(01)00228-8; Maeda Y, 2001, EMBO J, V20, P5982, DOI 10.1093/emboj/20.21.5982; Man ZQ, 2011, J BIOL CHEM, V286, P11569, DOI 10.1074/jbc.M110.201442; Marsh BJ, 2002, NAT REV MOL CELL BIO, V3, P789, DOI 10.1038/nrm933; Matthews SA, 2010, BIOCHEM J, V432, P153, DOI 10.1042/BJ20101188; Moss J, 1998, J BIOL CHEM, V273, P21431, DOI 10.1074/jbc.273.34.21431; Munro S, 2005, BIOCHEM SOC T, V33, P601, DOI 10.1042/BST0330601; Nakamura K, 2012, J BIOL CHEM, V287, P25478, DOI 10.1074/jbc.M112.365783; Navarro MN, 2012, BIOCHEM J, V442, P649, DOI 10.1042/BJ20111700; Ooi CE, 1998, J CELL BIOL, V142, P391, DOI 10.1083/jcb.142.2.391; Oser M, 2010, J CELL SCI, V123, P3662, DOI 10.1242/jcs.068163; Page-McCaw A, 2007, NAT REV MOL CELL BIO, V8, P221, DOI 10.1038/nrm2125; Peter BJ, 2004, SCIENCE, V303, P495, DOI 10.1126/science.1092586; Puertollano R, 2001, SCIENCE, V292, P1712, DOI 10.1126/science.1060750; Pusapati GV, 2010, MOL BIOL CELL, V21, P1011, DOI 10.1091/mbc.E09-09-0814; Rykx A, 2003, FEBS LETT, V546, P81, DOI 10.1016/S0014-5793(03)00487-3; Shin OH, 2001, BIOCHEM BIOPH RES CO, V285, P1267, DOI 10.1006/bbrc.2001.5330; Stockmann M, 2013, STEM CELL REV REP, V9, P475, DOI 10.1007/s12015-011-9329-4; Takatsu H, 2002, BIOCHEM J, V365, P369, DOI 10.1042/BJ20020428; Valente C, 2012, NAT CELL BIOL, V14, P343, DOI 10.1038/ncb2445; Wille C, 2014, MOL BIOL CELL, V25, P324, DOI 10.1091/mbc.E13-06-0334; Williger BT, 1999, FEBS LETT, V454, P85, DOI 10.1016/S0014-5793(99)00771-1; Wouters FS, 1998, EMBO J, V17, P7179, DOI 10.1093/emboj/17.24.7179; Yeaman C, 2004, NAT CELL BIOL, V6, P106, DOI 10.1038/ncb1090; Zeug A, 2012, BIOPHYS J, V103, P1821, DOI 10.1016/j.bpj.2012.09.031; Zhu YX, 1999, MOL BIOL CELL, V10, P537, DOI 10.1091/mbc.10.3.537; Ziegler S, 2011, MOL BIOL CELL, V22, P570, DOI 10.1091/mbc.E10-05-0427	53	31	31	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 1	2016	291	1					462	477		10.1074/jbc.M115.673582	http://dx.doi.org/10.1074/jbc.M115.673582			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DA1XP	26507660	Green Published, hybrid			2022-12-26	WOS:000367589500041
J	Guo, LL; Shestov, AA; Worth, AJ; Nath, K; Nelson, DS; Leeper, DB; Glickson, JD; Blair, IA				Guo, Lili; Shestov, Alexander A.; Worth, Andrew J.; Nath, Kavindra; Nelson, David S.; Leeper, Dennis B.; Glickson, Jerry D.; Blair, Ian A.			Inhibition of Mitochondrial Complex II by the Anticancer Agent Lonidamine	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						anticancer drug; cancer therapy; chromatography; drug action; glucose metabolism; glutamate; glutamine; glycolysis; high-performance liquid chromatography (HPLC); mass spectrometry (MS)	ALPHA-TOCOPHERYL SUCCINATE; TARGETING MITOCHONDRIA; AEROBIC GLYCOLYSIS; DRUG LONIDAMINE; OVARIAN-CANCER; TUMOR; METABOLISM; APOPTOSIS; GROWTH; CELLS	The antitumor agent lonidamine (LND; 1-(2,4-dichlorobenzyl)-1H-indazole-3-carboxylic acid) is known to interfere with energy-yielding processes in cancer cells. However, the effect of LND on central energy metabolism has never been fully characterized. In this study, we report that a significant amount of succinate is accumulated in LND-treated cells. LND inhibits the formation of fumarate and malate and suppresses succinate-induced respiration of isolated mitochondria. Utilizing biochemical assays, we determined that LND inhibits the succinate-ubiquinone reductase activity of respiratory complex II without fully blocking succinate dehydrogenase activity. LND also induces cellular reactive oxygen species through complex II, which reduced the viability of the DB-1 melanoma cell line. The ability of LND to promote cell death was potentiated by its suppression of the pentose phosphate pathway, which resulted in inhibition of NADPH and glutathione generation. Using stable isotope tracers in combination with isotopologue analysis, we showed that LND increased glutaminolysis but decreased reductive carboxylation of glutamine-derived -ketoglutarate. Our findings on the previously uncharacterized effects of LND may provide potential combinational therapeutic approaches for targeting cancer metabolism.	[Guo, Lili; Worth, Andrew J.; Blair, Ian A.] Univ Penn, Ctr Excellence Environm Toxicol, Penn Superfund Res & Training Program Ctr, Philadelphia, PA 19104 USA; [Guo, Lili; Worth, Andrew J.; Blair, Ian A.] Univ Penn, Dept Syst Pharmacol & Translat Therapeut, Philadelphia, PA 19104 USA; [Shestov, Alexander A.; Nath, Kavindra; Nelson, David S.; Glickson, Jerry D.] Univ Penn, Dept Radiol, Lab Mol Imaging, Philadelphia, PA 19104 USA; [Leeper, Dennis B.] Thomas Jefferson Univ, Dept Radiat Oncol, Philadelphia, PA 19107 USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Jefferson University	Glickson, JD (corresponding author), Univ Penn, Perelman Sch Med, Dept Radiol, Blockley Hall Basement B-6,423 Guardian Dr, Philadelphia, PA 19104 USA.	glickson@mail.med.upenn.edu; ianblair@mail.med.upenn.edu	Glickson, Jerry/AAR-7116-2021		National Institutes of Health [P30ES013508, P30CA016520, T32ES019851, R01CA172820, R01CA129544]; NATIONAL CANCER INSTITUTE [R01CA129544, R01CA172820, P30CA016520] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES019851, P30ES013508] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by the National Institutes of Health Grants P30ES013508 (to I. A. B.), P30CA016520 (to I. A. B.), T32ES019851 (to I. A. B.), R01CA172820 (to J. D. G.), and R01CA129544 (to J. D. G.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Albayrak T, 2003, MOL BIOL CELL, V14, P3082, DOI 10.1091/mbc.e02-10-0631; Amadori D, 1998, BREAST CANCER RES TR, V49, P209, DOI 10.1023/A:1006063412726; Aspuria PJP, 2014, CANCER METAB, V2, DOI 10.1186/2049-3002-2-21; Ben-Yoseph O, 1998, J NEURO-ONCOL, V36, P149, DOI 10.1023/A:1005819604858; BENHORIN H, 1995, CANCER RES, V55, P2814; Blair IA, 2006, CURR DRUG METAB, V7, P853, DOI 10.2174/138920006779010601; Daye D, 2012, SEMIN CELL DEV BIOL, V23, P362, DOI 10.1016/j.semcdb.2012.02.002; De Lena M, 2001, EUR J CANCER, V37, P364, DOI 10.1016/S0959-8049(00)00400-7; Di Cosimo S, 2003, DRUGS TODAY, V39, P157, DOI 10.1358/dot.2003.39.3.799451; Dong LF, 2008, ONCOGENE, V27, P4324, DOI 10.1038/onc.2008.69; Dong LF, 2011, J BIOL CHEM, V286, P3717, DOI 10.1074/jbc.M110.186643; Dong LF, 2009, CLIN CANCER RES, V15, P1593, DOI 10.1158/1078-0432.CCR-08-2439; Drose S, 2013, BBA-BIOENERGETICS, V1827, P578, DOI 10.1016/j.bbabio.2013.01.004; Emadi A, 2014, EXP HEMATOL, V42, P247, DOI 10.1016/j.exphem.2013.12.001; Evans JMM, 2005, BMJ-BRIT MED J, V330, P1304, DOI 10.1136/bmj.38415.708634.F7; Fang J, 2006, MOL PHARMACOL, V70, P2108, DOI 10.1124/mol.106.026245; Fernandez CA, 1996, J MASS SPECTROM, V31, P255, DOI 10.1002/(SICI)1096-9888(199603)31:3<255::AID-JMS290>3.0.CO;2-3; FLORIDI A, 1983, ARCH BIOCHEM BIOPHYS, V226, P73, DOI 10.1016/0003-9861(83)90272-2; FLORIDI A, 1981, J NATL CANCER I, V66, P497; Floridi A, 1998, BIOCHEM PHARMACOL, V56, P841, DOI 10.1016/S0006-2952(98)00054-9; FLORIDI A, 1981, CANCER RES, V41, P4661; Franciosi M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071583; Frezza C, 2007, NAT PROTOC, V2, P287, DOI 10.1038/nprot.2006.478; Frezza C, 2011, NATURE, V477, P225, DOI 10.1038/nature10363; Fulda S, 2010, NAT REV DRUG DISCOV, V9, P447, DOI 10.1038/nrd3137; Galluzzi L, 2013, NAT REV DRUG DISCOV, V12, P829, DOI 10.1038/nrd4145; Granchi C, 2014, BIOORG MED CHEM LETT, V24, P4915, DOI 10.1016/j.bmcl.2014.09.041; Guzy RD, 2008, MOL CELL BIOL, V28, P718, DOI 10.1128/MCB.01338-07; HILL LL, 1991, CANCER RES, V51, P4937; Ivanova D, 2013, ADV CLIN EXP MED, V22, P899; Kalia VK, 2009, J CANCER RES THER, V5, P57, DOI 10.4103/0973-1482.55145; Kluckova K, 2013, BBA-BIOENERGETICS, V1827, P552, DOI 10.1016/j.bbabio.2012.10.015; Lemarie A, 2011, CELL DEATH DIFFER, V18, P338, DOI 10.1038/cdd.2010.93; Li N, 2013, BIOMATERIALS, V34, P3366, DOI 10.1016/j.biomaterials.2013.01.055; Madiraju AK, 2014, NATURE, V510, P542, DOI 10.1038/nature13270; Marrache S, 2012, P NATL ACAD SCI USA, V109, P16288, DOI 10.1073/pnas.1210096109; Mehrmohamadi M, 2014, CELL REP, V9, P1507, DOI 10.1016/j.celrep.2014.10.026; Metallo CM, 2012, NATURE, V481, P380, DOI 10.1038/nature10602; Milane L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024075; Milane L, 2011, NANOMED-NANOTECHNOL, V7, P435, DOI 10.1016/j.nano.2010.12.009; Miyadera H, 2003, P NATL ACAD SCI USA, V100, P473, DOI 10.1073/pnas.0237315100; MUZYKANTOV VS, 1986, REACT KINET CATAL L, V32, P307, DOI 10.1007/BF02068328; NATALI PG, 1984, ONCOLOGY, V41, P7, DOI 10.1159/000225879; Nath K, 2015, NMR BIOMED, V28, P281, DOI 10.1002/nbm.3240; Nath K, 2013, NMR BIOMED, V26, P98, DOI 10.1002/nbm.2824; Neuzil J, 2001, FASEB J, V15, P403, DOI 10.1096/fj.00-0251com; Patra KC, 2014, TRENDS BIOCHEM SCI, V39, P347, DOI 10.1016/j.tibs.2014.06.005; Prabhakara S, 2008, INDIAN J MED RES, V128, P140; Quinlan CL, 2012, J BIOL CHEM, V287, P27255, DOI 10.1074/jbc.M112.374629; Rasola A, 2014, TRENDS CELL BIOL, V24, P455, DOI 10.1016/j.tcb.2014.03.005; Selak MA, 2005, CANCER CELL, V7, P77, DOI 10.1016/j.ccr.2004.11.022; Shestov AA, 2007, J NEUROSCI RES, V85, P3294, DOI 10.1002/jnr.21269; Shestov AA, 2012, NEUROCHEM RES, V37, P2388, DOI 10.1007/s11064-012-0782-5; Singh G, 2000, ANAL CHEM, V72, P3007, DOI 10.1021/ac000374a; Sotgia F, 2013, ONCOTARGET, V4, P1309, DOI 10.18632/oncotarget.1182; Vander Heiden MG, 2011, NAT REV DRUG DISCOV, V10, P671, DOI 10.1038/nrd3504; Wang J, 2008, CANCER BIOL THER, V7, P1875, DOI 10.4161/cbt.7.12.7067; Warburg O, 1924, BIOCHEM Z, V152, P319; Weinberg SE, 2015, NAT CHEM BIOL, V11, P9, DOI 10.1038/nchembio.1712; Wheaton WW, 2014, ELIFE, V3, DOI 10.7554/eLife.02242; Worth AJ, 2014, J BIOL CHEM, V289, P26895, DOI 10.1074/jbc.M114.591354; Yankovskaya V, 2003, SCIENCE, V299, P700, DOI 10.1126/science.1079605; Zhu PJ, 2008, RAPID COMMUN MASS SP, V22, P432, DOI 10.1002/rcm.3380	63	98	101	2	62	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 1	2016	291	1					42	57		10.1074/jbc.M115.697516	http://dx.doi.org/10.1074/jbc.M115.697516			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DA1XP	26521302	hybrid, Green Published			2022-12-26	WOS:000367589500004
J	Chen, RP; Zhang, KX; Chen, H; Zhao, XY; Wang, JQ; Li, L; Cong, YS; Ju, ZY; Xu, DK; Williams, BRG; Jia, JH; Liu, JP				Chen, Ruping; Zhang, Kexiong; Chen, Hao; Zhao, Xiaoyin; Wang, Jianqiu; Li, Li; Cong, Yusheng; Ju, Zhenyu; Xu, Dakang; Williams, Bryan R. G.; Jia, Jihui; Liu, Jun-Ping			Telomerase Deficiency Causes Alveolar Stem Cell Senescence-associated Low-grade Inflammation in Lungs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; BONE-MARROW FAILURE; PULMONARY-FIBROSIS; TGF-BETA; REVERSE-TRANSCRIPTASE; SHORTENED TELOMERES; GENE-EXPRESSION; POTENTIAL ROLE; I CELLS; MUTATIONS	Mutations of human telomerase RNA component (TERC) and telomerase reverse transcriptase (TERT) are associated with a subset of lung aging diseases, but the mechanisms by which TERC and TERT participate in lung diseases remain unclear. In this report, we show that knock-out (KO) of the mouse gene Terc or Tert causes pulmonary alveolar stem cell replicative senescence, epithelial impairment, formation of alveolar sacs, and characteristic inflammatory phenotype. Deficiency in TERC or TERT causes a remarkable elevation in various proinflammatory cytokines, including IL-1, IL-6, CXCL15 (human IL-8 homolog), IL-10, TNF-alpha, and monocyte chemotactic protein 1 (chemokine ligand 2 (CCL2)); decrease in TGF-beta 1 and TGF beta RI receptor in the lungs; and spillover of IL-6 and CXCL15 into the bronchoalveolar lavage fluids. In addition to increased gene expressions of alpha-smooth muscle actin and collagen 1 alpha 1, suggesting myofibroblast differentiation, TERC deficiency also leads to marked cellular infiltrations of a mononuclear cell population positive for the leukocyte common antigen CD45, low-affinity Fc receptor CD16/CD32, and pattern recognition receptor CD11b in the lungs. Our data demonstrate for the first time that telomerase deficiency triggers alveolar stem cell replicative senescence-associated low-grade inflammation, thereby driving pulmonary premature aging, alveolar sac formation, and fibrotic lesion.	[Chen, Ruping; Jia, Jihui; Liu, Jun-Ping] Shandong Univ, Sch Med, Chinese Minist Educ, Dept Microbiol,Key Lab Expt Teratol, Jinan 250012, Shandong, Peoples R China; [Chen, Ruping; Zhang, Kexiong; Chen, Hao; Zhao, Xiaoyin; Wang, Jianqiu; Li, Li; Cong, Yusheng; Ju, Zhenyu; Xu, Dakang; Liu, Jun-Ping] Hangzhou Normal Univ, Inst Aging Res, Sch Med, Hangzhou 311121, Zhejiang, Peoples R China; [Xu, Dakang; Williams, Bryan R. G.; Liu, Jun-Ping] Hudson Inst Med Res, Clayton, Vic 3168, Australia; [Xu, Dakang; Williams, Bryan R. G.; Liu, Jun-Ping] Monash Univ, Fac Med, Dept Mol & Translat Sci, Clayton, Vic 3168, Australia; [Liu, Jun-Ping] Monash Univ, Cent Clin Sch, Fac Med, Dept Immunol, Prahran, Vic 3018, Australia	Shandong University; Hangzhou Normal University; Hudson Institute of Medical Research; Monash University; Monash University	Liu, JP (corresponding author), Shandong Univ, Sch Med, Chinese Minist Educ, Dept Microbiol,Key Lab Expt Teratol, Jinan 250012, Shandong, Peoples R China.	jun-ping.liu@monash.edu	Williams, Bryan R. G./A-5021-2009; Liu, Jun-Ping/AAA-5521-2020	Williams, Bryan R. G./0000-0002-4969-1151; Liu, Jun-Ping/0000-0001-7442-2116; Zhang, Kexiong/0000-0001-9517-8386	National Basic Research Program of China [2012CB911204]; National Natural Science Foundation of China [81170313, 81272889]; National Health and Medical Research Council of Australia [1051882]; Victorian Government's Operational Infrastructure Support Program	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Victorian Government's Operational Infrastructure Support Program	This work was supported by National Basic Research Program of China Grant 2012CB911204, National Natural Science Foundation of China Grants 81170313 and 81272889, National Health and Medical Research Council of Australia Grant 1051882, and the Victorian Government's Operational Infrastructure Support Program. The authors declare that they have no conflicts of interest with the contents of this article.	Alder JK, 2015, P NATL ACAD SCI USA, V112, P5099, DOI 10.1073/pnas.1504780112; Alder JK, 2011, AM J RESP CRIT CARE, V184, P904, DOI 10.1164/rccm.201103-0520OC; Alipio ZA, 2011, DIFFERENTIATION, V82, P89, DOI 10.1016/j.diff.2011.05.001; Amsellem V, 2011, AM J RESP CRIT CARE, V184, P1358, DOI 10.1164/rccm.201105-0802OC; Armanios M, 2013, J CLIN INVEST, V123, P996, DOI 10.1172/JCI66370; Armanios MY, 2007, NEW ENGL J MED, V356, P1317, DOI 10.1056/NEJMoa066157; Arnoult N, 2012, NAT STRUCT MOL BIOL, V19, P948, DOI 10.1038/nsmb.2364; Barkauskas CE, 2013, J CLIN INVEST, V123, P3025, DOI 10.1172/JCI68782; Bhaskaran M, 2007, J BIOL CHEM, V282, P3968, DOI 10.1074/jbc.M609060200; Blackburn EH, 2005, FEBS LETT, V579, P859, DOI 10.1016/j.febslet.2004.11.036; Blasco MA, 1997, CELL, V91, P25, DOI 10.1016/S0092-8674(01)80006-4; Calado RT, 2011, HEPATOLOGY, V53, P1600, DOI 10.1002/hep.24173; Cassar L, 2010, MOL CELL ENDOCRINOL, V320, P97, DOI 10.1016/j.mce.2010.02.002; Chang S, 2005, MUTAT RES-FUND MOL M, V576, P39, DOI 10.1016/j.mrfmmm.2004.08.020; Chilosi M, 2012, RESP RES, V13, DOI 10.1186/1465-9921-13-3; Cronkhite JT, 2008, AM J RESP CRIT CARE, V178, P729, DOI 10.1164/rccm.200804-550OC; Damjanovic AK, 2007, J IMMUNOL, V179, P4249, DOI 10.4049/jimmunol.179.6.4249; Degryse AL, 2012, EXP LUNG RES, V38, P124, DOI 10.3109/01902148.2012.658148; Desai TJ, 2014, NATURE, V507, P190, DOI 10.1038/nature12930; Driscoll B, 2000, AM J PHYSIOL-LUNG C, V279, pL1191, DOI 10.1152/ajplung.2000.279.6.L1191; Erdmann N, 2004, P NATL ACAD SCI USA, V101, P6080, DOI 10.1073/pnas.0401580101; Fridlender ZG, 2007, EUR RESPIR J, V30, P205, DOI 10.1183/09031936.00009407; Fujitani Y, 2002, J IMMUNOL, V168, P443, DOI 10.4049/jimmunol.168.1.443; Gansner JM, 2012, NEW ENGL J MED, V366, P1551, DOI 10.1056/NEJMc1200999; Hartmann D, 2011, HEPATOLOGY, V53, P1608, DOI 10.1002/hep.24217; He H, 2009, MOL CELL BIOL, V29, P229, DOI 10.1128/MCB.01400-08; Huaux F, 2015, J PATHOL, V235, P698, DOI 10.1002/path.4487; Iannello A, 2014, ONCOIMMUNOLOGY, V3, DOI 10.4161/onci.27616; Jackson SR, 2011, AM J PHYSIOL-LUNG C, V300, pL898, DOI 10.1152/ajplung.00409.2010; Ju ZY, 2007, NAT MED, V13, P742, DOI 10.1038/nm1578; Jurk D, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5172; Kaczorowski DJ, 2012, MOL MED, V18, P851, DOI 10.2119/molmed.2012.00011; Kasai H, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-56; Kim JK, 2000, TOXICOL LETT, V111, P263, DOI 10.1016/S0378-4274(99)00195-2; Kojima H, 2012, CELL CYCLE, V11, P730, DOI 10.4161/cc.11.4.19172; Kong CM, 2013, FEBS J, V280, P3180, DOI 10.1111/febs.12326; Kropski JA, 2012, AM J PHYSIOL-LUNG C, V302, pL441, DOI 10.1152/ajplung.00335.2011; Kurz DJ, 2000, J CELL SCI, V113, P3613; Lee J, 2006, AM J PHYSIOL-LUNG C, V290, pL685, DOI 10.1152/ajplung.00020.2005; Lee J, 2009, AM J PHYSIOL-LUNG C, V296, pL57, DOI 10.1152/ajplung.90411.2008; Li H, 2006, J BIOL CHEM, V281, P25588, DOI 10.1074/jbc.M602381200; Li M, 2011, J CLIN INVEST, V121, P277, DOI 10.1172/JCI42090; Liu TJ, 2007, J CLIN INVEST, V117, P3800, DOI 10.1172/JCI32369; Liu TJ, 2013, AM J RESP CELL MOL, V49, P260, DOI 10.1165/rcmb.2012-0514OC; Maida Y, 2002, ONCOGENE, V21, P4071, DOI 10.1038/sj.onc.1205509; Marrone A, 2007, HAEMATOLOGICA, V92, P1013, DOI 10.3324/haematol.11407; Mitchell JR, 1999, NATURE, V402, P551, DOI 10.1038/990141; Nandakumar J, 2013, NAT REV MOL CELL BIO, V14, P71, DOI 10.1038/nrm3505; Nozaki Y, 2000, AM J RESP CELL MOL, V23, P460, DOI 10.1165/ajrcmb.23.4.3958; Nunes H, 2014, AM J RESP CRIT CARE, V189, P753, DOI 10.1164/rccm.201309-1724LE; Parry EM, 2011, BLOOD, V117, P5607, DOI 10.1182/blood-2010-11-322149; Rahaman SO, 2014, J CLIN INVEST, V124, P5225, DOI 10.1172/JCI75331; Reddy R, 2004, AM J PHYSIOL-LUNG C, V286, pL658, DOI 10.1152/ajplung.00159.2003; Robin JD, 2014, GENE DEV, V28, P2464, DOI 10.1101/gad.251041.114; Rodier F, 2009, NAT CELL BIOL, V11, P973, DOI 10.1038/ncb1909; Rudolph KL, 1999, CELL, V96, P701, DOI 10.1016/S0092-8674(00)80580-2; Savale L, 2009, AM J RESP CRIT CARE, V179, P566, DOI 10.1164/rccm.200809-1398OC; Schneider DJ, 2012, FASEB J, V26, P503, DOI 10.1096/fj.11-186098; Song XD, 2013, LAB INVEST, V93, P1219, DOI 10.1038/labinvest.2013.108; Stanley SE, 2015, J CLIN INVEST, V125, P563, DOI 10.1172/JCI78554; Strong MA, 2011, MOL CELL BIOL, V31, P2369, DOI 10.1128/MCB.05312-11; Tsakiri KD, 2007, P NATL ACAD SCI USA, V104, P7552, DOI 10.1073/pnas.0701009104; Tsang AR, 2012, AGING CELL, V11, P482, DOI 10.1111/j.1474-9726.2012.00810.x; Vulliamy T, 2001, NATURE, V413, P432, DOI 10.1038/35096585; Vulliamy T, 2002, LANCET, V359, P2168, DOI 10.1016/S0140-6736(02)09087-6; Waisberg DR, 2010, HUM PATHOL, V41, P385, DOI 10.1016/j.humpath.2009.08.019; Warburton D, 2013, AM J PHYSIOL-LUNG C, V304, pL83, DOI 10.1152/ajplung.00258.2012; Watanabe-Takano H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127888; Willis BC, 2005, AM J PATHOL, V166, P1321, DOI 10.1016/S0002-9440(10)62351-6; Wong KK, 2003, NATURE, V421, P643, DOI 10.1038/nature01385; Xu DK, 2008, J BIOL CHEM, V283, P23567, DOI 10.1074/jbc.M800790200; Yamaguchi H, 2005, NEW ENGL J MED, V352, P1413, DOI 10.1056/NEJMoa042980; Yang H, 2001, CELL GROWTH DIFFER, V12, P119; Zhang FJ, 2004, AM J RESP CELL MOL, V31, P679, DOI 10.1165/rcmb.2004-0182OC; Zhang Q, 2010, NATURE, V464, P104, DOI 10.1038/nature08780; Zhao L, 2013, AM J PHYSIOL-LUNG C, V305, pL409, DOI 10.1152/ajplung.00032.2013; Zhou BY, 2012, J BIOL CHEM, V287, P7026, DOI 10.1074/jbc.M111.276311; Zhou BH, 2005, NAT IMMUNOL, V6, P1047, DOI 10.1038/ni1247; Zhou H, 2013, J IMMUNOL, V190, P115, DOI 10.4049/jimmunol.1202136	79	53	55	1	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 25	2015	290	52					30813	30829		10.1074/jbc.M115.681619	http://dx.doi.org/10.1074/jbc.M115.681619			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CZ6GK	26518879	Green Published, hybrid			2022-12-26	WOS:000367199000015
J	Yoon, HJ; Kim, HN; Yun, Y; Kim, Y; Ha, AN; Kim, HL; Kim, BS				Yoon, Hai-Jeon; Kim, Han-Na; Yun, Yeojun; Kim, Yemi; Ha, Ae-Na; Kim, Hyung-Lae; Kim, Bom Sahn			Background Intestinal F-18-FDG Uptake Is Related to Serum Lipid Profile and Obesity in Breast Cancer Patients	PLOS ONE			English	Article							GUT MICROBIOTA; GLUCOSE; METABOLISM; METFORMIN	Background This study investigated the relationships between background intestinal uptake on F-18-FDG PET and cardio-metabolic risk (CMR) factors. Methods A total of 326 female patients that underwent F-18-FDG PET to determine the initial stage of breast cancer were enrolled. None of the patients had history of diabetes or hypertension. The background intestinal uptake on PET was visually graded (low vs. high uptake group) and quantitatively measured using the maximal standardized uptake value (SUVmax). SUVmax of 7 bowel segments (duodenum, jejunum, ileum, cecum, hepatic flexure, splenic flexure, and descending colon-sigmoid junction) were averaged for the total bowel (TB SUVmax). Age, body mass index (BMI), fasting blood glucose level (BST), triglyceride (TG), cholesterol, high density lipoprotein (HDL), and low density lipoprotein (LDL) were the considered CMR factors. The relationships between background intestinal F-18-FDG uptake on PET and diverse CMR factors were analyzed. Results The visual grades based on background intestinal F-18-FDG uptake classified 100 (30.7%) patients into the low uptake group, while 226 (69.3%) were classified into the high uptake group. Among CMR factors, age (p = 0.004), BMI (p<0.001), and TG (p<0.001) were significantly different according to visual grade of background intestinal F-18-FDG uptake. Quantitative TB SUVmax showed significant positive correlation with age (r = 0.203, p<0.001), BMI (r = 0.373, p<0.001), TG (r = 0.338, p<0.001), cholesterol (r = 0.148, p = 0.008), and LDL (r = 0.143, p = 0.024) and significant negative correlation with HDL (r = -0.147, p = 0.022). Multivariate analysis indicated that BMI and TG were independent factors in both visually graded background intestinal F-18-FDG uptake (p = 0.027 and p = 0.023, respectively) and quantitatively measured TB SUVmax (p = 0.006 and p = 0.004, respectively). Conclusion Increased background intestinal 18F-FDG uptake on PET may suggest alteration of lipid metabolism and risk of cardio-metabolic disease in non-diabetic and non-hypertensive breast cancer patients.	[Yoon, Hai-Jeon; Kim, Bom Sahn] Ewha Womans Univ, Sch Med, Dept Nucl Med, Seoul, South Korea; [Kim, Han-Na; Yun, Yeojun; Kim, Hyung-Lae] Ewha Womans Univ, Dept Biochem, Sch Med, Seoul, South Korea; [Kim, Yemi; Ha, Ae-Na; Kim, Bom Sahn] Ewha Womans Univ, Med Res Inst, Sch Med, Seoul, South Korea	Ewha Womans University; Ewha Womans University; Ewha Womans University	Kim, HL (corresponding author), Ewha Womans Univ, Dept Biochem, Sch Med, Seoul, South Korea.	hyung@ewha.ac.kr; kbomsahn@ewha.ac.kr			Ewha Womans University [1-2015-1057-001-1, 1-2014-1676-001-1]; National Research Foundation [2015R1C1A1A02037051, 2012M3A9B6055379, NRF-2014R1A2A2A04006291]	Ewha Womans University; National Research Foundation	This research was supported by grants from Ewha Womans University (1-2015-1057-001-1 and 1-2014-1676-001-1) and the National Research Foundation (2015R1C1A1A02037051, 2012M3A9B6055379, and NRF-2014R1A2A2A04006291). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Backhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101; Backhed F, 2007, P NATL ACAD SCI USA, V104, P979, DOI 10.1073/pnas.0605374104; BAILEY CJ, 1994, BRIT J PHARMACOL, V112, P671, DOI 10.1111/j.1476-5381.1994.tb13128.x; Chatterjee A, 2012, CAN FAM PHYSICIAN, V58, P389; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Cook GJR, 2004, SEMIN NUCL MED, V34, P122, DOI 10.1053/j.semnuclmed.2003.12.003; Fava F, 2006, CURR MED CHEM, V13, P3005, DOI 10.2174/092986706778521814; FEINGOLD KR, 1992, J LIPID RES, V33, P1765; Franquet E, 2014, NUCL MED COMMUN, V35, P1026, DOI 10.1097/MNM.0000000000000170; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; Gontier E, 2008, EUR J NUCL MED MOL I, V35, P95, DOI 10.1007/s00259-007-0563-6; GORBACH SL, 1984, REV INFECT DIS, V6, pS85; Greiner T, 2011, TRENDS ENDOCRIN MET, V22, P117, DOI 10.1016/j.tem.2011.01.002; Harris K, 2012, J OBES, V2012, DOI 10.1155/2012/879151; Kim Seok ki, 1999, Clin Positron Imaging, V2, P273, DOI 10.1016/S1095-0397(99)00030-8; Ley RE, 2008, SCIENCE, V320, P1647, DOI 10.1126/science.1155725; Maitra U, 2011, J IMMUNOL, V186, P4467, DOI 10.4049/jimmunol.1003300; Oh JR, 2010, AM J ROENTGENOL, V195, P1404, DOI 10.2214/AJR.10.4663; PENICAUD L, 1989, BIOCHEM J, V262, P881, DOI 10.1042/bj2620881; Stephenson GD, 2003, NUTR CANCER, V45, P1, DOI 10.1207/S15327914NC4501_1; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Walker J, 2005, BIOCHEM J, V385, P485, DOI 10.1042/BJ20040694; Xu DB, 2014, GASTROENTEROLOGY, V146, P484, DOI 10.1053/j.gastro.2013.10.026; Yasuda Seiei, 1998, Tokai Journal of Experimental and Clinical Medicine, V23, P241	24	5	5	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2015	10	11							e0141473	10.1371/journal.pone.0141473	http://dx.doi.org/10.1371/journal.pone.0141473			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV1PG	26523374	Green Published, gold			2022-12-26	WOS:000364029800010
J	Prasad, SG; Patil, GS; Mishra, RK				Prasad, Seema Gorur; Patil, Gouri Shanker; Mishra, Ramesh Kumar			Effect of Exogenous Cues on Covert Spatial Orienting in Deaf and Normal Hearing Individuals	PLOS ONE			English	Article							CONGENITALLY DEAF; VISUAL-ATTENTION; TIME-COURSE; INHIBITION; RETURN; FIELD	Deaf individuals have been known to process visual stimuli better at the periphery compared to the normal hearing population. However, very few studies have examined attention orienting in the oculomotor domain in the deaf, particularly when targets appear at variable eccentricity. In this study, we examined if the visual perceptual processing advantage reported in the deaf people also modulates spatial attentional orienting with eye movement responses. We used a spatial cueing task with cued and uncued targets that appeared at two different eccentricities and explored attentional facilitation and inhibition. We elicited both a saccadic and a manual response. The deaf showed a higher cueing effect for the ocular responses than the normal hearing participants. However, there was no group difference for the manual responses. There was also higher facilitation at the periphery for both saccadic and manual responses, irrespective of groups. These results suggest that, owing to their superior visual processing ability, the deaf may orient attention faster to targets. We discuss the results in terms of previous studies on cueing and attentional orienting in deaf.	[Prasad, Seema Gorur; Mishra, Ramesh Kumar] Univ Hyderabad, Ctr Neural & Cognit Sci, Hyderabad 500134, Andhra Pradesh, India; [Patil, Gouri Shanker] AliYavar Jung Natl Inst Hearing Handicapped, Secunderabad, India	University of Hyderabad	Prasad, SG (corresponding author), Univ Hyderabad, Ctr Neural & Cognit Sci, Hyderabad 500134, Andhra Pradesh, India.	gp.seema@gmail.com	Prasad, Seema/ABG-7659-2021					Bao Y, 2013, EXP PSYCHOL, V60, P425, DOI 10.1027/1618-3169/a000215; Bao Y, 2013, NEUROSCI LETT, V534, P7, DOI 10.1016/j.neulet.2012.11.046; Bao Y, 2012, COGN PROCESS, V13, pS93, DOI 10.1007/s10339-012-0469-5; Bao Y, 2011, NEUROSCI LETT, V500, P47, DOI 10.1016/j.neulet.2011.06.003; Bao Yan, 2007, Cogn Process, V8, P37, DOI 10.1007/s10339-006-0151-x; Bavelier D, 2000, J NEUROSCI, V20, DOI 10.1523/JNEUROSCI.20-17-j0001.2000; Bavelier D, 2006, TRENDS COGN SCI, V10, P512, DOI 10.1016/j.tics.2006.09.006; Belanger NN, 2012, PSYCHOL SCI, V23, P816, DOI 10.1177/0956797611435130; Bompas A, 2008, J VISION, V8, DOI 10.1167/8.8.10; Bottari D, 2012, COGN NEUROSCI-UK, V3, P8, DOI 10.1080/17588928.2011.578209; Briand KA, 2000, PERCEPT PSYCHOPHYS, V62, P1512, DOI 10.3758/BF03212152; Burnstine T. H., 1984, EARLY BRAIN DAMAGE, P3; Castel AD, 2005, ACTA PSYCHOL, V119, P217, DOI 10.1016/j.actpsy.2005.02.004; Chen Q, 2006, BRAIN RES, V1109, P117, DOI 10.1016/j.brainres.2006.06.043; Colmenero JM, 2004, EUR J COGN PSYCHOL, V16, P791, DOI 10.1080/09541440340000312; Dye MWG, 2013, SPRINGER HANDB AUDIT, V47, P237, DOI 10.1007/2506_2013_9; Hilchey M. D., 2014, RETURNING INHIBITION; HOFFMAN JE, 1995, PERCEPT PSYCHOPHYS, V57, P787, DOI 10.3758/BF03206794; Klein R. M., 2000, TRENDS COGNITIVE S4, V4; Lei Q, 2012, COGN PROCESS, V13, pS223, DOI 10.1007/s10339-012-0487-3; [Liu Xingjuan 刘幸娟], 2011, [心理科学, Psychological Science], V34, P558; LOKE WH, 1991, B PSYCHONOMIC SOC, V29, P437; Mishra RK, 2012, Q J EXP PSYCHOL, V65, P1502, DOI 10.1080/17470218.2012.657656; Mushquash AR, 2012, SCHIZOPHR RES, V135, P55, DOI 10.1016/j.schres.2011.11.034; Nava E, 2008, EXP BRAIN RES, V190, P179, DOI 10.1007/s00221-008-1459-9; Neville H. J., 1988, DEV SPATIAL COGNITIO, P327; NEVILLE HJ, 1987, BRAIN RES, V405, P268, DOI 10.1016/0006-8993(87)90296-4; PARASNIS I, 1985, BRAIN COGNITION, V4, P313, DOI 10.1016/0278-2626(85)90024-7; Pavani F., 2012, NEURAL BASEMULTISE; POSNER MI, 1980, Q J EXP PSYCHOL, V32, P3, DOI 10.1080/00335558008248231; Proksch J, 2002, J COGNITIVE NEUROSCI, V14, P687, DOI 10.1162/08989290260138591; RIZZOLATTI G, 1987, NEUROPSYCHOLOGIA, V25, P31, DOI 10.1016/0028-3932(87)90041-8; Taylor TL, 2000, J EXP PSYCHOL HUMAN, V26, P1639, DOI 10.1037//0096-1523.26.5.1639	33	8	8	3	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2015	10	10							e0141324	10.1371/journal.pone.0141324	http://dx.doi.org/10.1371/journal.pone.0141324			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CV0EH	26517363	Green Published, Green Submitted, gold			2022-12-26	WOS:000363920800034
J	Sun, MX; Qi, XH; Hou, LP; Xu, XY; Zhu, ZJ; Li, ML				Sun, Mengxia; Qi, Xianhui; Hou, Leiping; Xu, Xiaoyong; Zhu, Zhujun; Li, Meilan			Gene Expression Analysis of Pak Choi in Response to Vernalization	PLOS ONE			English	Article							SALICYLIC-ACID; ARABIDOPSIS; REPRESSOR; PROTEIN; WHEAT	Pak choi is a seed vernalization-type plant whose vernalization mechanism is currently unclear. Therefore, it is critical to discover genes related to vernalization and research its functions during vernalization in pak choi. Here, the gene expression profiles in the shoot apex were analyzed after low temperature treatment using high-throughput RNA sequencing technology. The results showed that there are 1,664 and 1,192 differentially expressed genes (DEGs) in pak choi in cold treatment ending and before flower bud differentiation, respectively, including 42 genes that exhibited similar expression trend at both stages. Detailed annotation revealed that the proteins encoded by the DEGs are located in the extracellular region, cell junction and extracellular matrix. These proteins exhibit activity such as antioxidant activity and binding protein/transcription factor activity, and they are involved in signal transduction and the immune system/biological processes. Among the DEGs, Bra014527 was up-regulated in low temperature treatment ending, Bra024097 was up-regulated before flower bud differentiation and Bra035940 was down-regulated at both stages in low temperature-treated shoot apices. Homologues of these genes in A. thaliana, AT3G59790, AT4G30200 and AT5G61150, are involved in flowering and vernalization, suggesting that they take part in the vernalization process in pak choi. Further pathway enrichment analysis revealed that most genes were enriched in the tryptophan metabolism and glucosinolate biosynthesis pathways. However, the functions of tryptophan and glucosinolate in vernalization are not yet clear and require further analysis.	[Sun, Mengxia; Qi, Xianhui; Hou, Leiping; Xu, Xiaoyong; Li, Meilan] Shanxi Agr Univ, Coll Hort, Taigu, Shanxi, Peoples R China; [Zhu, Zhujun] Zhejiang A&F Univ, Coll Agr & Food Sci, Key Lab Qual Improvement Agr Prod Zhejiang Prov, Hangzhou 311300, Zhejiang, Peoples R China	Shanxi Agricultural University; Zhejiang A&F University	Li, ML (corresponding author), Shanxi Agr Univ, Coll Hort, Taigu, Shanxi, Peoples R China.	15935485975@163.com		Zhu, Zhujun/0000-0001-8551-7751	Agricultural Science and Technology Research Plan Project of Shanxi Province, Shanxi Science and Technology Department [201403110093]; Shanxi Scholarship Council of China, Shanxi Scholarship Council of China [2013-062]; College and University Specific Scientific Research Fund, Ministry of Education of the People's Republic of China [20131403110006]; National Natural Science Foundation of China, National Natural Science Foundation of China [31401885]; Agricultural Science and Technology Research Plan Project of Shanxi Province [20140311011-4]	Agricultural Science and Technology Research Plan Project of Shanxi Province, Shanxi Science and Technology Department; Shanxi Scholarship Council of China, Shanxi Scholarship Council of China; College and University Specific Scientific Research Fund, Ministry of Education of the People's Republic of China; National Natural Science Foundation of China, National Natural Science Foundation of China; Agricultural Science and Technology Research Plan Project of Shanxi Province	This work was supported by: 1) the Agricultural Science and Technology Research Plan Project of Shanxi Province (grant no. 201403110093), Shanxi Science and Technology Department, http://www.sxinfo.gov.cn/ (LML); 2) the Research Project Supported by Shanxi Scholarship Council of China (grant no. 2013-062), Shanxi Scholarship Council of China, http://www.sxscc.com.cn/sxlxInternet/C_index.asp (LML); 3) the College and University Specific Scientific Research Fund (grant no. 20131403110006), Ministry of Education of the People's Republic of China, http://www.moe.edu.cn/ (LML); 4) the National Natural Science Foundation of China (grant no. 31401885), National Natural Science Foundation of China, http://www.nsfc.gov.cn/ (XXY); and 5) the Agricultural Science and Technology Research Plan Project of Shanxi Province, grant no. 20140311011-4. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansorge WJ, 2009, NEW BIOTECHNOL, V25, P195, DOI 10.1016/j.nbt.2008.12.009; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Bastow R, 2004, NATURE, V427, P164, DOI 10.1038/nature02269; Boss PK, 2004, PLANT CELL, V16, pS18, DOI 10.1105/tpc.015958; Brown PD, 2003, PHYTOCHEMISTRY, V62, P471, DOI 10.1016/S0031-9422(02)00549-6; CHAILAKH.MK, 1968, ANN REV PLANT PHYSIO, V19, P1, DOI 10.1146/annurev.pp.19.060168.000245; [陈欢 Chen Huan], 2012, [中国油料作物学报, Chinese Journal of Oil Crop Sciences], V34, P129; Cheng F, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-136; Erwin JE, 2002, PHYSIOL PLANTARUM, V115, P298, DOI 10.1034/j.1399-3054.2002.1150217.x; Fan LX, 2013, EFFECTS EXOGENOUS SA; Ge ShuJuan, 2014, Acta Agronomica Sinica, V40, P1164; Gendall AR, 2001, CELL, V107, P525, DOI 10.1016/S0092-8674(01)00573-6; Geraldo N, 2009, PLANT PHYSIOL, V150, P1611, DOI 10.1104/pp.109.137448; He YH, 2005, TRENDS PLANT SCI, V10, P30, DOI 10.1016/j.tplants.2004.11.003; HOU LP, 2009, CHINESE AGR SCI B, V25, P171; Jin FenFen, 2012, Journal of Henan Agricultural Sciences, V41, P1; Leng N, 2013, BIOINFORMATICS, V29, P1035, DOI 10.1093/bioinformatics/btt087; Levy YY, 2002, SCIENCE, V297, P243, DOI 10.1126/science.1072147; Li N, 2007, EFFECTS METABOLISM C; Li PeiPei, 2014, Genomics and Applied Biology, V33, P365; Li SX, 1990, CHINESE AGR ENCY; Li YuLiang, 2013, Acta Agronomica Sinica, V39, P269, DOI 10.3724/SP.J.1006.2013.00269; Lin M, 2015, PLANT BIOLOGY, V15, P1; Loake G, 2007, CURR OPIN PLANT BIOL, V10, P466, DOI 10.1016/j.pbi.2007.08.008; MENG XJ, 2010, CHINESE AGR SCI B, V26, P207; Michaels SD, 1999, PLANT CELL, V11, P949, DOI 10.1105/tpc.11.5.949; Mithen R, 2001, PLANT GROWTH REGUL, V34, P91, DOI 10.1023/A:1013330819778; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Reichelt M, 2002, PHYTOCHEMISTRY, V59, P663, DOI 10.1016/S0031-9422(02)00014-6; Rohit S, 2008, P NATL ACAD SCI USA, V105, P6296; Sheldon CC, 1999, PLANT CELL, V11, P445, DOI 10.1105/tpc.11.3.445; Singh B, 2003, PLANT GROWTH REGUL, V39, P137, DOI 10.1023/A:1022556103536; Srikanth A, 2011, CELL MOL LIFE SCI, V68, P2013, DOI 10.1007/s00018-011-0673-y; Stanko V, 2014, MOL PLANT, V7, P1637, DOI 10.1093/mp/ssu080; Sung SB, 2004, NATURE, V427, P159, DOI 10.1038/nature02195; Suter L, 2014, PLANT PHYSIOL, V166, P1928, DOI 10.1104/pp.114.247346; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Trevaskis B, 2007, TRENDS PLANT SCI, V12, P352, DOI 10.1016/j.tplants.2007.06.010; Wang BL, 2004, VERNALIZATION ITS RE; Wang JQ, 2011, COMP GENE EXPRESSION; Xin HP, 2013, PLOS ONE, V8, P1; Yan L, 2006, P NATL ACAD SCI USA, V103, P19581, DOI 10.1073/pnas.0607142103; [尹钧 Yin Jun], 2002, [麦类作物学报, Journal of triticeae crops], V22, P33; Yuan XiuYun, 2008, Acta Botanica Boreali-Occidentalia Sinica, V28, P1486; Zhao Q, 2015, FISH SHELLFISH IMMUN, V42, P400, DOI 10.1016/j.fsi.2014.11.020; Zhou F, 2013, GENE EXPRESSION ANAL	47	18	18	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2015	10	10							e0141446	10.1371/journal.pone.0141446	http://dx.doi.org/10.1371/journal.pone.0141446			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0EH	26517271	gold, Green Submitted, Green Published			2022-12-26	WOS:000363920800041
J	Musha, A; Shimada, H; Shirai, K; Saitoh, JI; Yokoo, S; Chikamatsu, K; Ohno, T; Nakano, T				Musha, Atsushi; Shimada, Hirofumi; Shirai, Katsuyuki; Saitoh, Jun-ichi; Yokoo, Satoshi; Chikamatsu, Kazuaki; Ohno, Tatsuya; Nakano, Takashi			Prediction of Acute Radiation Mucositis using an Oral Mucosal Dose Surface Model in Carbon Ion Radiotherapy for Head and Neck Tumors	PLOS ONE			English	Article							RISK; CHEMOTHERAPY; CARCINOMA; OUTCOMES	Purpose To evaluate the dose-response relationship for development of acute radiation mucositis (ARM) using an oral mucosal dose surface model (OMDS-model) in carbon ion radiotherapy (C-ion RT) for head and neck tumors. Methods Thirty-nine patients receiving C-ion RT for head and neck cancer were evaluated for ARM (once per week for 6 weeks) according to the Common Terminology Criteria for Adverse Events (CTCAE), version 4.0, and the Radiation Therapy Oncology Group (RTOG) scoring systems. The irradiation schedule typically used was 64 Gy [relative biological effectiveness (RBE)] in 16 fractions for 4 weeks. Maximum point doses in the palate and tongue were compared with ARM in each patient. Results The location of the ARM coincided with the high-dose area in the OMDS-model. There was a clear dose-response relationship between maximum point dose and ARM grade assessed using the RTOG criteria but not the CTCAE. The threshold doses for grade 2-3 ARM in the palate and tongue were 43.0 Gy(RBE) and 54.3 Gy(RBE), respectively. Conclusions The OMDS-model was useful for predicting the location and severity of ARM. Maximum point doses in the model correlated well with grade 2-3 ARM.	[Musha, Atsushi; Shimada, Hirofumi; Shirai, Katsuyuki; Saitoh, Jun-ichi; Ohno, Tatsuya; Nakano, Takashi] Gunma Univ, Heavy Ion Med Ctr, Maebashi, Gunma 371, Japan; [Musha, Atsushi; Yokoo, Satoshi] Gunma Univ, Dept Stomatol & Maxillofacial Surg, Maebashi, Gunma 371, Japan; [Chikamatsu, Kazuaki] Gunma Univ, Grad Sch Med, Dept Otolaryngol Head & Neck Surg, Maebashi, Gunma 371, Japan	Gunma University; Gunma University; Gunma University	Musha, A (corresponding author), Gunma Univ, Heavy Ion Med Ctr, Maebashi, Gunma 371, Japan.	musha@gunma-u.ac.jp	Musha, Atsushi/AAI-9662-2021		Japan Society for the Promotion of Science (JSPS) [15K19769]; Grants-in-Aid for Scientific Research [24390288] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Japan Society for the Promotion of Science (JSPS) Grants-in-Aid for Scientific Research (KAKENHI) Grant Number 15K19769 (https://www.jsps.go.jp/index.html). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bentzen SM, 2007, J CLIN ONCOL, V25, P4096, DOI 10.1200/JCO.2007.13.3983; Denham JW, 1999, RADIOTHER ONCOL, V52, P157, DOI 10.1016/S0167-8140(99)00107-3; Dorr W, 2001, RADIOTHER ONCOL, V61, P223, DOI 10.1016/S0167-8140(01)00429-7; Elting LS, 2007, INT J RADIAT ONCOL, V68, P1110, DOI 10.1016/j.ijrobp.2007.01.053; Jingu K, 2011, RADIOTHER ONCOL, V98, P68, DOI 10.1016/j.radonc.2010.09.017; Jingu K, 2010, RADIAT ONCOL, V5, DOI 10.1186/1748-717X-5-89; Koto M, 2014, RADIOTHER ONCOL, V113, P60, DOI 10.1016/j.radonc.2014.09.009; Mizoguchi N, 2015, RADIOTHER ONCOL, V114, P373, DOI 10.1016/j.radonc.2015.01.009; Narayan S, 2008, INT J RADIAT ONCOL, V72, P756, DOI 10.1016/j.ijrobp.2008.01.060; National Cancer Institute, 2010, NAT CANC I COMM TERM; Sanguineti G, 2012, INT J RADIAT ONCOL, V83, P235, DOI 10.1016/j.ijrobp.2011.06.2000; Silverman Sol Jr, 2007, J Support Oncol, V5, P13; Trotti A, 2003, RADIOTHER ONCOL, V66, P253, DOI 10.1016/S0167-8140(02)00404-8; Vera-Llonch M, 2006, CANCER-AM CANCER SOC, V106, P329, DOI 10.1002/cncr.21622	14	26	30	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2015	10	10							e0141734	10.1371/journal.pone.0141734	http://dx.doi.org/10.1371/journal.pone.0141734			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0ED	26512725	Green Published, gold, Green Submitted			2022-12-26	WOS:000363920300077
J	Narendra, SC; Chalise, JP; Magnusson, M; Uppugunduri, S				Narendra, Sudeep Chenna; Chalise, Jaya Prakash; Magnusson, Mattias; Uppugunduri, Srinivas			Local but Not Systemic Administration of Uridine Prevents Development of Antigen-Induced Arthritis	PLOS ONE			English	Article							RHEUMATOID-ARTHRITIS; IN-VIVO; AIRWAY INFLAMMATION; LUNG INFLAMMATION; MODEL; ADHESION; ACTIVATION; SAFETY	Objective Uridine has earlier been show to down modulate inflammation in models of lung inflammation. The aim of this study was to evaluate the anti-inflammatory effect of uridine in arthritis. Methods Arthritis was induced by intra-articular injection of mBSA in the knee of NMRI mice preimmunized with mBSA. Uridine was either administered locally by direct injection into the knee joint or systemically. Systemic treatment included repeated injections or implantation of a pellet continuously releasing uridine during the entire experimental procedure. Anti-mBSA specific immune responses were determined by ELISA and cell proliferation and serum cytokine levels were determined by Luminex. Immunohistochemistry was used to identify cells, study expression of cytokines and adhesion molecules in the joint. Results Local administration of 25-100 mg/kg uridine at the time of arthritis onset clearly prevented development of joint inflammation. In contrast, systemic administration of uridine (max 1.5 mg uridine per day) did not prevent development of arthritis. Protection against arthritis by local administration of uridine did not affect the anti-mBSA specific immune response and did not prevent the rise in serum levels of pro-inflammatory cytokines associated with the triggering of arthritis. In contrast, local uridine treatment efficiently inhibited synovial expression of ICAM-1 and CD18, local cytokine production and recruitment of leukocytes to the synovium. Conclusion Local, but not systemic administration of uridine efficiently prevented development of antigen- induced arthritis. The protective effect did not involve alteration of systemic immunity to mBSA but clearly involved inhibition of synovial expression of adhesion molecules, decreased TNF and IL-6 production and prevention of leukocyte extravasation. Further, uridine is a small, inexpensive molecule and may thus be a new therapeutic option to treat joint inflammation in RA.	[Narendra, Sudeep Chenna; Chalise, Jaya Prakash; Magnusson, Mattias] Linkoping Univ, Dept Clin & Expt Med, AIR, Linkoping, Sweden; [Uppugunduri, Srinivas] Linkoping Univ, Dept Clin Chem, Linkoping, Sweden; [Uppugunduri, Srinivas] Linkoping Univ, Dept Clin & Expt Med, Linkoping, Sweden	Linkoping University; Linkoping University; Linkoping University	Narendra, SC (corresponding author), Linkoping Univ, Dept Clin & Expt Med, AIR, Linkoping, Sweden.	sudeep.chenna.narendra@liu.se	Chalise, Jaya Prakash/Z-1141-2019; magnusson, mattias/G-2079-2011	magnusson, mattias/0000-0002-6565-4027	Vetenskapsradet-Grant [521-2011-3095]; Reumatikerforbundet Grant [155261]; County Council of Ostergotland, Sweden; Linkoping University	Vetenskapsradet-Grant; Reumatikerforbundet Grant; County Council of Ostergotland, Sweden; Linkoping University	The work was supported by the following: 1) Vetenskapsradet-Grant number 521-2011-3095 (http://www.vr.se/); 2) Reumatikerforbundet Grant no 155261 (https://reumatikerforbundet.org/); 3) County Council of Ostergotland, Sweden; and 4) Linkoping University (www.liu.se). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Burmester GR, 2014, NAT REV RHEUMATOL, V10, P77, DOI 10.1038/nrrheum.2013.168; Burnstock G, 2007, CELL MOL LIFE SCI, V64, P1471, DOI 10.1007/s00018-007-6497-0; Chalise JP, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4326; Choy E, 2012, RHEUMATOLOGY, V51, pV3, DOI 10.1093/rheumatology/kes113; DARNOWSKI JW, 1986, CANCER RES, V46, P3490; Evaldsson C, 2007, INT IMMUNOPHARMACOL, V7, P1025, DOI 10.1016/j.intimp.2007.03.008; Feldmann M, 1996, ANNU REV IMMUNOL, V14, P397, DOI 10.1146/annurev.immunol.14.1.397; GASSER T, 1981, SCIENCE, V213, P777, DOI 10.1126/science.7256279; Giannattasio G, 2011, J IMMUNOL, V187, P1486, DOI 10.4049/jimmunol.1003669; Grespan R, 2008, ARTHRITIS RHEUM, V58, P2030, DOI 10.1002/art.23597; Guma M, 2011, ARTHRITIS RHEUM-US, V63, P1603, DOI 10.1002/art.30271; LaBranche TP, 2010, AM J PATHOL, V177, P1388, DOI 10.2353/ajpath.2010.100195; Lee SW, 2009, ANN RHEUM DIS, V68, P1761, DOI 10.1136/ard.2008.097709; Meyer P.W., 2010, MEDIAT INFLAMM, V2010, DOI DOI 10.1155/2010/158514; Mojcik CF, 1997, ARTHRITIS RHEUM-US, V40, P991, DOI 10.1002/art.1780400602; Muller T, 2010, CLIN EXP ALLERGY, V40, P1552, DOI 10.1111/j.1365-2222.2010.03518.x; Oh JY, 2007, INVEST OPHTH VIS SCI, V48, P1102, DOI 10.1167/iovs.06-0809; Rubbert-Roth A, 2012, RHEUMATOLOGY, V51, pV38, DOI 10.1093/rheumatology/kes114; Simon J, 2001, J AUTOIMMUN, V17, P127, DOI 10.1006/jaut.2001.0534; Taylor PC, 2010, MEDICINE, V38, P163, DOI DOI 10.1016/J.MPMED.2009.12.005; Uppugunduri S, 2004, INT IMMUNOPHARMACOL, V4, P1241, DOI 10.1016/j.intimp.2004.04.016; van den Berg Wim B., 2007, V136, P243; Vieira RP, 2011, AM J RESP CRIT CARE, V184, P215, DOI 10.1164/rccm.201011-1762OC; Woodrick RS, 2011, NAT REV RHEUMATOL, V7, P639, DOI 10.1038/nrrheum.2011.145; Ying F, 2011, EUR J IMMUNOL, V41, P1687, DOI 10.1002/eji.201040956; Yoshino S, 1996, COMP IMMUNOL MICROB, V19, P133, DOI 10.1016/0147-9571(95)00026-7; Zhang XW, 2000, INFLAMM RES, V49, P529, DOI 10.1007/s000110050627	27	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2015	10	10							e0141863	10.1371/journal.pone.0141863	http://dx.doi.org/10.1371/journal.pone.0141863			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0ED	26512984	Green Submitted, Green Published, gold			2022-12-26	WOS:000363920300089
J	Sammer, U; Walter, M; Knupfer, SC; Mehnert, U; Bode-Lesniewska, B; Kessler, TM				Sammer, Ulla; Walter, Matthias; Knuepfer, Stephanie C.; Mehnert, Ulrich; Bode-Lesniewska, Beata; Kessler, Thomas M.			Do We Need Surveillance Urethro-Cystoscopy in Patients with Neurogenic Lower Urinary Tract Dysfunction?	PLOS ONE			English	Article							SPINAL-CORD INJURY; SCREENING CYSTOSCOPY; SQUAMOUS METAPLASIA; BLADDER-CANCER; CYTOLOGY	Purpose To examine the value of surveillance urethro-cystoscopy in patients with neurogenic lower urinary tract dysfunction (NLUTD) in regard to the conflicting literature as it is generally agreed that patients with NLUTD are at increased risk for bladder cancer. Materials and Methods In a cross-sectional study, a consecutive series of 129 patients (50 females, 79 males, mean age 51, range 18-88) suffering from NLUTD for at least 5 years was prospectively investigated using urethro-cystoscopy and bladder washing cytology at a single university spinal cord injury (SCI) center. Results Due to suspicious urethro-cystoscopy and/or bladder washing cytology findings, 13 (10%) of 129 patients underwent transurethral resection of the bladder lesion and/or random bladder biopsies. Overall, 9 relevant histological findings were found in 5% (7/129) of our patients: bladder melanosis (n = 1), nephrogenic adenoma (n = 3), keratinizing squamous metaplasia (n = 1), intestinal metaplasia (n = 3), and muscle-invasive adenocarcinoma of the bladder (n = 1). Conclusions Using surveillance urethro-cystoscopy, we found relevant histological findings in 5% of our patients suffering from NLUTD for at least 5 years. Thus, surveillance urethro-cystoscopy might be warranted, although the ideal starting point and frequency remain to be determined in further prospective studies.	[Sammer, Ulla; Walter, Matthias; Knuepfer, Stephanie C.; Mehnert, Ulrich; Kessler, Thomas M.] Univ Zurich, Balgrist Univ Hosp, Spinal Cord Injury Ctr & Res, Neurourol, Zurich, Switzerland; [Bode-Lesniewska, Beata] Univ Zurich, Univ Zurich Hosp, Inst Surg Pathol, Zurich, Switzerland	University of Zurich; University of Zurich; University Zurich Hospital	Kessler, TM (corresponding author), Univ Zurich, Balgrist Univ Hosp, Spinal Cord Injury Ctr & Res, Neurourol, Zurich, Switzerland.	tkessler@gmx.ch	Walter, M/ABB-9592-2020	Walter, M/0000-0001-5347-1584; Bode-Lesniewska, Beata/0000-0002-3329-4186				Ahmad I, 2008, UROL INT, V81, P247, DOI 10.1159/000151398; [Anonymous], 2006, J SPINAL CORD MED, V29, P527; Averbeck MA, 2015, BJU INT, V115, P39, DOI 10.1111/bju.13084; BROECKER BH, 1981, J UROLOGY, V125, P196, DOI 10.1016/S0022-5347(17)54963-0; Bryan RT, 2003, J UROLOGY, V170, P1892, DOI 10.1097/01.ju.0000092740.51330.39; Chen Chuan-Shu, 2006, J Chin Med Assoc, V69, P166; Clouston D, 2013, BJU INT, V112, P27, DOI 10.1111/bju.12378; Donsky H, 2013, UROL ONCOL; El Masri WS, 2014, SPINAL CORD, V52, P49, DOI 10.1038/sc.2013.119; Ferlay J, 2013, EUR J CANCER, V49, P1374, DOI 10.1016/j.ejca.2012.12.027; Groah SL, 2002, ARCH PHYS MED REHAB, V83, P346, DOI 10.1053/apmr.2002.29653; Hamid R, 2003, J UROLOGY, V170, P425, DOI 10.1097/01.ju.0000076700.00853.ad; Harikrishnan J A, 2012, Ann R Coll Surg Engl, V94, pe152, DOI 10.1308/003588412X13171221589135; Hollingsworth JM, 2013, ANN INTERN MED, V159, P401, DOI 10.7326/0003-4819-159-6-201309170-00006; Hungerhuber Edwin, 2008, J Med Case Rep, V2, P164, DOI 10.1186/1752-1947-2-164; Kalisvaart JF, 2010, SPINAL CORD, V48, P257, DOI 10.1038/sc.2009.118; KERLEY SW, 1991, ARCH PATHOL LAB MED, V115, P950; Khan MS, 2002, EUR UROL, V42, P469, DOI 10.1016/S0302-2838(02)00358-5; Navon JD, 1997, J UROLOGY, V157, P2109, DOI 10.1016/S0022-5347(01)64687-1; Pannek J., 2014, EAU GUIDELINES NEURO; Planz B, 2005, EJSO-EUR J SURG ONC, V31, P304, DOI 10.1016/j.ejso.2004.12.008; RIVAS DA, 1994, PARAPLEGIA, V32, P454, DOI 10.1038/sc.1994.72; Samaratunga H, 2013, PATHOLOGY, V45, P243, DOI 10.1097/PAT.0b013e32835f6169; Sanborn SL, 2009, UROLOGY, V73, DOI 10.1016/j.urology.2008.05.039; Stamatiou K, 2009, ANN SAUDI MED, V29, P134, DOI 10.4103/0256-4947.51802; Stonehill WH, 1997, J UROLOGY, V157, P2112, DOI 10.1016/S0022-5347(01)64688-3; Welk B, 2013, SPINAL CORD; WHO, 2012, EST CANC INC MORT PR; WHO, 2019, INT STAT CLASS DIS R, V10th; Witjes JA, 2014, EAU GUIDELINES MUSCL; Zougkas Konstantinos, 2004, International Urology and Nephrology, V36, P513, DOI 10.1007/s11255-004-0848-7	31	21	21	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2015	10	10							e0140970	10.1371/journal.pone.0140970	http://dx.doi.org/10.1371/journal.pone.0140970			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0ED	26513149	Green Published, Green Accepted, Green Submitted, gold			2022-12-26	WOS:000363920300010
J	Xystrakis, E; Yuksel, M; Lin, F; Huang, XH; Pop, OT; Quaglia, A; Heaton, N; Prachalias, A; Rela, M; Fuggle, S; Ma, Y; Jassem, W				Xystrakis, Emmanuel; Yuksel, Muhammed; Lin, Fang; Huang, Xiaohong; Pop, Oltin Tiberiu; Quaglia, Alberto; Heaton, Nigel; Prachalias, Andreas; Rela, Mohamed; Fuggle, Susan; Ma, Yun; Jassem, Wayel			Impact of Donation Mode on the Proportion and Function of T Lymphocytes in the Liver	PLOS ONE			English	Article							LIVING-DONOR LIVERS; BRAIN-DEATH; CELLS; TRANSPLANTATION; INJURY; MEMORY; EXPRESSION; REPERFUSION; ISCHEMIA; EFFECTOR	Background Liver T-cells respond to the inflammatory insult generated during organ procurement and contribute to the injury following reperfusion. The mode of liver donation alters various metabolic and inflammatory pathways but the way it affects intrahepatic T-cells is still unclear. Methods We investigated the modifications occurring in the proportion and function of T-cells during liver procurement for transplantation. We isolated hepatic mononuclear cells (HMC) from liver perfusate of living donors (LD) and donors after brain death (DBD) or cardiac death (DCD) and assessed the frequency of T-cell subsets, their cytokine secretion profile and CD8 T-cell cytotoxicity function, responsiveness to a danger associated molecular pattern (High Mobility Group Box1, HMGB1) and association with donor and recipient clinical parameters and immediate graft outcome. Results We found that T-cells in healthy human livers were enriched in memory CD8 T-cells exhibiting a phenotype of non-circulating tissue-associated lymphocytes, functionally dominated by more cytotoxicity and IFN-gamma-production in DBD donors, including upon activation by HMGB1 and correlating with peak of post-transplant AST. This liver-specific pattern of CD8 T-cell was prominent in DBD livers compared to DCD and LD livers suggesting that it was influenced by events surrounding brain death, prior to retrieval. Conclusion Mode of liver donation can affect liver T-cells with increased liver damage in DBD donors. These findings may be relevant in designing therapeutic strategies aimed at organ optimization prior to transplantation.	[Xystrakis, Emmanuel; Yuksel, Muhammed; Lin, Fang; Huang, Xiaohong; Pop, Oltin Tiberiu; Quaglia, Alberto; Heaton, Nigel; Prachalias, Andreas; Rela, Mohamed; Ma, Yun; Jassem, Wayel] Kings Coll London, Kings Coll Hosp, Fac Life Sci & Med, Inst Liver Studies, London, England; [Fuggle, Susan] Univ Oxford, John Radcliffe Hosp, Nuffield Dept Surg Sci, Oxford OX3 9DU, England	King's College Hospital NHS Foundation Trust; King's College Hospital; University of London; King's College London; University of Oxford	Jassem, W (corresponding author), Kings Coll London, Kings Coll Hosp, Fac Life Sci & Med, Inst Liver Studies, London, England.	wayel.jassem@kcl.ac.uk	Heaton, Nigel/AAK-8363-2020; yuksel, muhammed/F-1706-2019; yuksel, muhammed/C-7861-2017; yuksel, muhammed/AAT-4783-2021	yuksel, muhammed/0000-0002-3390-6007; Jassem, Wayel/0000-0003-2918-5232; Xystrakis, Emmanuel (Emmanouil)/0000-0003-0658-1451	NHS Blood and Transplant, UK; King's Health Partners; Beijing 302 Hospital, Beijing, China	NHS Blood and Transplant, UK; King's Health Partners; Beijing 302 Hospital, Beijing, China	Dr. Emmanuel Xystrakis was supported by a grant from NHS Blood and Transplant, UK, and Mr. Muhammed Yuksel is supported by a grant from King's Health Partners; Dr Fang Lin was supported by a scholarship from Beijing 302 Hospital, Beijing, China.	Amatschek S, 2012, J HEPATOL, V56, P1305, DOI 10.1016/j.jhep.2012.01.020; [Anonymous], 2009, ANN REPORT; Champagne P, 2001, NATURE, V410, P106, DOI 10.1038/35065118; Crispe IN, 2009, ANNU REV IMMUNOL, V27, P147, DOI 10.1146/annurev.immunol.021908.132629; Crispe IN, 2003, NAT REV IMMUNOL, V3, P51, DOI 10.1038/nri981; de Vries DK, 2011, AM J TRANSPLANT, V11, P1064, DOI 10.1111/j.1600-6143.2011.03466.x; Dikopoulos N, 2004, HEPATOLOGY, V39, P1256, DOI 10.1002/hep.20173; Dikopoulos N, 2003, J HEPATOL, V39, P910, DOI 10.1016/S0168-8278(03)00469-0; Dooms H, 2007, J EXP MED, V204, P547, DOI 10.1084/jem.20062381; Floerchinger B, 2012, TRANSPL IMMUNOL, V27, P25, DOI 10.1016/j.trim.2012.04.002; Floerchinger B, 2012, TRANSPLANT REV-ORLAN, V26, P54, DOI 10.1016/j.trre.2011.10.001; Ilmakunnas M, 2008, LIVER TRANSPLANT, V14, P1517, DOI 10.1002/lt.21573; Jassem W, 2003, TRANSPLANTATION, V75, P2001, DOI 10.1097/01.TP.0000061605.30685.03; Jassem W, 2003, TRANSPLANTATION, V75, P1386, DOI 10.1097/01.TP.0000062863.06782.89; Jonsson JR, 1997, HEPATOLOGY, V26, P1111; Kaech SM, 2003, NAT IMMUNOL, V4, P1191, DOI 10.1038/ni1009; Kaech SM, 2012, NAT REV IMMUNOL, V12, P749, DOI 10.1038/nri3307; Kruger B, 2009, P NATL ACAD SCI USA, V106, P3390, DOI 10.1073/pnas.0810169106; Mackay LK, 2015, J IMMUNOL, V194, P2059, DOI 10.4049/jimmunol.1402256; Masopust D, 2013, NAT REV IMMUNOL, V13, P309, DOI 10.1038/nri3442; Mitry RR, 2003, CELL TRANSPLANT, V12, P69, DOI 10.3727/000000003783985197; Paiardini M, 2005, J IMMUNOL, V174, P2900, DOI 10.4049/jimmunol.174.5.2900; Peralta C, 2013, J HEPATOL, V59, P1094, DOI 10.1016/j.jhep.2013.06.017; Pratschke J, 2000, ANN SURG, V232, P263, DOI 10.1097/00000658-200008000-00017; Sathaliyawala T, 2013, IMMUNITY, V38, P187, DOI 10.1016/j.immuni.2012.09.020; Scaffidi P, 2002, NATURE, V418, P191, DOI 10.1038/nature00858; Schlegel A, 2013, J HEPATOL, V59, P984, DOI 10.1016/j.jhep.2013.06.022; Seddiki N, 2006, J EXP MED, V203, P1693, DOI 10.1084/jem.20060468; Segel LD, 2002, J HEART LUNG TRANSPL, V21, P804, DOI 10.1016/S1053-2498(02)00382-0; Steinert EM, 2015, CELL, V161, P737, DOI 10.1016/j.cell.2015.03.031; Tsung A, 2005, J EXP MED, V201, P1135, DOI 10.1084/jem.20042614; Tu Z, 2007, CLIN EXP IMMUNOL, V149, P186, DOI 10.1111/j.1365-2249.2007.03415.x; van der Hoeven JAB, 2003, TRANSPLANTATION, V76, P1150, DOI 10.1097/01.TP.0000080983.14161.95; van der Hoeven JAB, 2003, KIDNEY INT, V64, P1874, DOI 10.1046/j.1523-1755.2003.00272.x; Ward SM, 2004, EUR J IMMUNOL, V34, P1526, DOI 10.1002/eji.200324275; Weiss S, 2007, AM J TRANSPLANT, V7, P1584, DOI 10.1111/j.1600-6143.2007.01799.x; Wertheim JA, 2011, AM J TRANSPLANT, V11, P1773, DOI 10.1111/j.1600-6143.2011.03587.x; Zaritskaya L, 2010, EXPERT REV VACCINES, V9, P601, DOI [10.1586/erv.10.49, 10.1586/ERV.10.49]	38	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2015	10	10							e0139791	10.1371/journal.pone.0139791	http://dx.doi.org/10.1371/journal.pone.0139791			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0ED	26513368	Green Submitted, Green Published, gold			2022-12-26	WOS:000363920300002
J	Chen, O; Wu, MM; Jiang, LF				Chen, Ou; Wu, Miaomiao; Jiang, Liangfu			The Effect of Hypoxic Preconditioning on Induced Schwann Cells under Hypoxic Conditions	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; IN-VITRO; INDUCED APOPTOSIS; CYTOCHROME-C; DIFFERENTIATION; MITOCHONDRIA; HEART; BCL-2; REPERFUSION; EXPRESSION	Object Our objective was to explore the protective effects of hypoxic preconditioning on induced Schwann cells exposed to an environment with low concentrations of oxygen. It has been observed that hypoxic preconditioning of induced Schwann cells can promote axonal regeneration under low oxygen conditions. Method Rat bone marrow mesenchymal stem cells (MSCs) were differentiated into Schwann cells and divided into a normal oxygen control group, a hypoxia-preconditioning group and a hypoxia group. The ultrastructure of each of these groups of cells was observed by electron microscopy. In addition, flow cytometry was used to measure changes in mitochondrial membrane potential. Annexin V-FITC/PI staining was used to detect apoptosis, and Western blots were used to detect the expression of Bcl-2/Bax. Fluorescence microscopic observations of axonal growth in NG-108 cells under hypoxic conditions were also performed. Results The hypoxia-preconditioning group maintained mitochondrial cell membrane and crista integrity, and these cells exhibited less edema than the hypoxia group. In addition, the cells in the hypoxia-preconditioning group were found to be in early stages of apoptosis, whereas cells from the hypoxia group were in the later stages of apoptosis. The hypoxia-preconditioning group also had higher levels of Bcl-2/Bax expression and longer NG-108 cell axons than were observed in the hypoxia group. Conclusion Hypoxic preconditioning can improve the physiological state of Schwann cells in a severe hypoxia environment and improve the ability to promote neurite outgrowth.	[Chen, Ou] Wenzhou Hosp Integrated Tradit Chinese & Western, Dept Orthoped Surg, Wenzhou, Zhejiang, Peoples R China; [Wu, Miaomiao] Wenzhou Med Univ, Affiliated Hosp 2, Dept Orthoped Surg, Wenzhou, Zhejiang, Peoples R China; [Wu, Miaomiao; Jiang, Liangfu] Wenzhou Med Univ, Yuying Childrens Hosp, Wenzhou, Zhejiang, Peoples R China; [Jiang, Liangfu] Wenzhou Med Univ, Affiliated Hosp 2, Dept Hand & Plast Surg, Wenzhou, Zhejiang, Peoples R China	Wenzhou Medical University; Wenzhou Medical University; Wenzhou Medical University	Wu, MM (corresponding author), Wenzhou Med Univ, Affiliated Hosp 2, Dept Orthoped Surg, Wenzhou, Zhejiang, Peoples R China.	teresa0577@sina.com			Natural Sciences Foundation of Zhejiang Province [Y2100253]; Traditional Chinese Medicine Science and Technology Plan Project of Zhe Jiang Province [2014ZB113]	Natural Sciences Foundation of Zhejiang Province(Natural Science Foundation of Zhejiang Province); Traditional Chinese Medicine Science and Technology Plan Project of Zhe Jiang Province	This work was supported by: 1. The Natural Sciences Foundation of Zhejiang Province (Y2100253), and 2. The Traditional Chinese Medicine Science and Technology Plan Project of Zhe Jiang Province (2014ZB113).	DiezRoux G, 1997, DEVELOPMENT, V124, P3633; Follmar KE, 2006, TISSUE ENG, V12, P3525, DOI 10.1089/ten.2006.12.3525; Francis KR, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2009.22; Geng YJ, 2003, ANN NY ACAD SCI, V1010, P687, DOI 10.1196/annals.1299.126; Geske FJ, 2001, HUM PATHOL, V32, P1029, DOI 10.1053/hupa.2001.28250; Greijer AE, 2004, J CLIN PATHOL, V57, P1009, DOI 10.1136/jcp.2003.015032; Hu XY, 2011, AM J PHYSIOL-CELL PH, V301, pC362, DOI 10.1152/ajpcell.00013.2010; Jiang L, 2008, NEUROREPORT, V19, P1015, DOI 10.1097/WNR.0b013e3283040efc; Kienle K, 2005, TRANSPL P, V37, P439, DOI 10.1016/j.transproceed.2004.12.268; Kingham PJ, 2007, EXP NEUROL, V207, P267, DOI 10.1016/j.expneurol.2007.06.029; Kluck RM, 1997, SCIENCE, V275, P1132, DOI 10.1126/science.275.5303.1132; Lennon DP, 2001, J CELL PHYSIOL, V187, P345, DOI 10.1002/jcp.1081; Liu M, 2005, J CEREBR BLOOD F MET, V25, P939, DOI 10.1038/sj.jcbfm.9600085; Nakamura M, 2000, CARDIOVASC RES, V45, P661, DOI 10.1016/S0008-6363(99)00393-4; Pacary E, 2006, J CELL SCI, V119, P2667, DOI 10.1242/jcs.03004; Petit PX, 1996, FEBS LETT, V396, P7, DOI 10.1016/0014-5793(96)00988-X; Phinney DG, 2005, CURR PHARM DESIGN, V11, P1255, DOI 10.2174/1381612053507495; Qian T, 1999, TOXICOL APPL PHARM, V154, P117, DOI 10.1006/taap.1998.8580; Reddien PW, 2001, NATURE, V412, P198, DOI 10.1038/35084096; Riva C, 2001, MOL CELL BIOCHEM, V226, P9, DOI 10.1023/A:1012772931313; Saini U, 2013, J CELL BIOCHEM, V114, P2612, DOI 10.1002/jcb.24609; Santore MT, 2002, AM J PHYSIOL-LUNG C, V282, pL727, DOI 10.1152/ajplung.00281.2001; Schlosshauer B, 2003, BRAIN RES, V963, P321, DOI 10.1016/S0006-8993(02)03930-6; Selzner M, 2002, J HEPATOL, V36, P218, DOI 10.1016/S0168-8278(01)00259-8; SHEN JG, 1995, BIOCHEM MOL BIOL INT, V35, P125; Sun XJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090667; Terenghi G, 1999, J ANAT, V194, P1, DOI 10.1046/j.1469-7580.1999.19410001.x; Theus MH, 2008, EXP NEUROL, V210, P656, DOI 10.1016/j.expneurol.2007.12.020; Toma C, 2002, CIRCULATION, V105, P93, DOI 10.1161/hc0102.101442; Xie XJ, 2006, ACTA PHARMACOL SIN, V27, P1153, DOI 10.1111/j.1745-7254.2006.00436.x; Yang J, 1997, SCIENCE, V275, P1129, DOI 10.1126/science.275.5303.1129	31	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2015	10	10							e0141201	10.1371/journal.pone.0141201	http://dx.doi.org/10.1371/journal.pone.0141201			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0DL	26509259	Green Submitted, gold, Green Published			2022-12-26	WOS:000363918100060
J	Fortini, LB; Vorsino, AE; Amidon, FA; Paxton, EH; Jacobi, JD				Fortini, Lucas B.; Vorsino, Adam E.; Amidon, Fred A.; Paxton, Eben H.; Jacobi, James D.			Large-Scale Range Collapse of Hawaiian Forest Birds under Climate Change and the Need 21st Century Conservation Options	PLOS ONE			English	Article							SPECIES DISTRIBUTION MODELS; AVIAN MALARIA; POPULATION-GENETICS; MOSQUITO VECTORS; PRESENCE-ABSENCE; RAIN-FOREST; HABITAT; TRENDS; CHRONOSEQUENCE; PREDICTION	Hawaiian forest birds serve as an ideal group to explore the extent of climate change impacts on at-risk species. Avian malaria constrains many remaining Hawaiian forest bird species to high elevations where temperatures are too cool for malaria's life cycle and its principal mosquito vector. The impact of climate change on Hawaiian forest birds has been a recent focus of Hawaiian conservation biology, and has centered on the links between climate and avian malaria. To elucidate the differential impacts of projected climate shifts on species with known varying niches, disease resistance and tolerance, we use a comprehensive database of species sightings, regional climate projections and ensemble distribution models to project distribution shifts for all Hawaiian forest bird species. We illustrate that, under a likely scenario of continued disease-driven distribution limitation, all 10 species with highly reliable models (mostly narrow-ranged, single-island endemics) are expected to lose > 50% of their range by 2100. Of those, three are expected to lose all range and three others are expected to lose > 90% of their range. Projected range loss was smaller for several of the more widespread species; however improved data and models are necessary to refine future projections. Like other at-risk species, Hawaiian forest birds have specific habitat requirements that limit the possibility of range expansion for most species, as projected expansion is frequently in areas where forest habitat is presently not available (such as recent lava flows). Given the large projected range losses for all species, protecting high elevation forest alone is not an adequate long-term strategy for many species under climate change. We describe the types of additional conservation actions practitioners will likely need to consider, while providing results to help with such considerations.	[Fortini, Lucas B.; Paxton, Eben H.; Jacobi, James D.] US Geol Survey, Pacific Isl Ecosyst Res Ctr, Honolulu, HI 96818 USA; [Fortini, Lucas B.] Pacific Isl Climate Change Cooperat, Honolulu, HI USA; [Vorsino, Adam E.; Amidon, Fred A.] US Fish & Wildlife Serv, Strateg Habitat Conservat Div, Pacific Isl Off, Honolulu, HI USA	United States Department of the Interior; United States Geological Survey; United States Department of the Interior; US Fish & Wildlife Service	Fortini, LB (corresponding author), US Geol Survey, Pacific Isl Ecosyst Res Ctr, Honolulu, HI 96818 USA.	lfortini@usgs.gov		Paxton, Eben/0000-0001-5578-7689; Fortini, Lucas/0000-0002-5781-7295	U.S. Geological Survey Pacific Island Ecosystems Research Center; Pacific Islands Climate Change Cooperative; U.S. FWS Ecological Services	U.S. Geological Survey Pacific Island Ecosystems Research Center; Pacific Islands Climate Change Cooperative; U.S. FWS Ecological Services	We are grateful for the support of the U.S. Geological Survey Pacific Island Ecosystems Research Center, the Pacific Islands Climate Change Cooperative, and the U.S. FWS Ecological Services that volunteered significant effort and resources to make this project possible. The expert-derived maps of current distribution for all Hawaiian forest birds were compiled by Marcos Gorresen. Information on bird surveys was provided by Rick Camp, manager of the Hawaii Forest Bird Interagency Database. We thank Eric VanderWerf for additional recently collected forest bird survey data. We thank Ian Caldwell for his help in organizing and documenting the R scripts. We thank the comments and suggestions by Rick Camp, Jeff Burgett, Loyal Mehrhoff, Steve Miller and our anonymous journal reviewers. The findings and conclusions of this article are those of the authors and do not necessarily represent the views of the U.S. Fish and Wildlife Service. Any use of trade, firm, or product names is for descriptive purposes only and does not imply endorsement by the U.S. Government.	Abbitt RJF, 2001, CONSERV BIOL, V15, P1274, DOI 10.1046/j.1523-1739.2001.00430.x; Ahumada JA, 2004, J MED ENTOMOL, V41, P1157, DOI 10.1603/0022-2585-41.6.1157; Ahumada JA, 2009, CONSERVATION BIOL HA; Alphey L, 2014, ANNU REV ENTOMOL, V59, P205, DOI 10.1146/annurev-ento-011613-162002; Amante-Helweg VL, 2009, CONSERVATION BIOL HA; [Anonymous], 2014, R LANG ENV STAT COMP; Aruch S, 2007, J WILDLIFE DIS, V43, P567, DOI 10.7589/0090-3558-43.4.567; Atkinson CT, 2014, GLOBAL CHANGE BIOL, V20, P2426, DOI 10.1111/gcb.12535; Atkinson CT, 2010, J AVIAN BIOL, V41, P357, DOI 10.1111/j.1600-048X.2009.04915.x; ATKINSON IA, 1970, PAC SCI, V24, P387; Bartholomeus RP, 2011, J GEOPHYS RES-BIOGEO, V116, DOI 10.1029/2011JG001693; Benedict MQ, 2007, VECTOR-BORNE ZOONOT, V7, P76, DOI 10.1089/vbz.2006.0562; Beniston M, 1997, CLIMATIC CHANGE, V36, P233, DOI 10.1023/A:1005380714349; Benning TL, 2002, P NATL ACAD SCI USA, V99, P14246, DOI 10.1073/pnas.162372399; Brotons L, 2004, ECOGRAPHY, V27, P437, DOI 10.1111/j.0906-7590.2004.03764.x; Camp RJ, 2010, CONDOR, V112, P196, DOI 10.1525/cond.2010.080113; Camp RJ., 2006, HAWAII FOREST BIRD I, P343; Camp RJ, 2009, 012 HAW COOP STUD UN, P120; CAO G, 2007, THESIS U HAWAII MANO; Caruana Rich, 2006, P 23 INT C MACH LEAR, P161, DOI DOI 10.1145/1143844.1143865.[38]X; Cord A, 2011, ECOL APPL, V21, P3285, DOI 10.1890/11-0114.1; Diaz HF, 2011, GLOBAL PLANET CHANGE, V77, P21, DOI 10.1016/j.gloplacha.2011.02.007; Diaz HF, 1997, CLIMATIC CHANGE, V36, P253, DOI 10.1023/A:1005335731187; Diuk-Wasser MA, 2006, VECTOR-BORNE ZOONOT, V6, P283, DOI 10.1089/vbz.2006.6.283; DRAKE DR, 1993, ECOLOGY, V74, P1012, DOI 10.2307/1940471; Elith J, 2008, J ANIM ECOL, V77, P802, DOI 10.1111/j.1365-2656.2008.01390.x; Elith J, 2005, ECOL MODEL, V186, P280, DOI 10.1016/j.ecolmodel.2004.12.007; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; Fonseca DM, 2000, MOL ECOL, V9, P1803, DOI 10.1046/j.1365-294x.2000.01070.x; Franklin, 2010, MAPPING SPECIES DIST; Gaston KJ, 2003, STRUCTURE DYNAMICS G; Giambelluca T. W., 2014, EVAPOTRANSPIRA UNPUB; Giambelluca TW, 2013, B AM METEOROL SOC, V94, P313, DOI 10.1175/BAMS-D-11-00228.1; Giambelluca TW, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL034377; Hastie TJ, 2011, ELEMENTS STAT LEARNI; Hawkins E, 2011, CLIM DYNAM, V37, P407, DOI 10.1007/s00382-010-0810-6; Hedrick PW, 2011, HEREDITY, V107, P283, DOI 10.1038/hdy.2011.16; Heller NE, 2009, BIOL CONSERV, V142, P14, DOI 10.1016/j.biocon.2008.10.006; Hess SC, 2006, 004 HAW COOP STUD UN, P60; Hijmans R. J., 2012, DISMO SPECIES DISTRI; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hughen KA, 2004, SCIENCE, V304, P1955, DOI 10.1126/science.1092995; IUCN, 2016, NARDOSTACHYS JATAMAN, DOI DOI 10.2305/IUCN.UK.20213.RLTS.T50126627A88304158.EN; Izsvak Z, 2000, J MOL BIOL, V302, P93, DOI 10.1006/jmbi.2000.4047; Jacobi JD, 1996, LONG TERM POPULATION; Jimenez-Valverde A, 2007, ACTA OECOL, V31, P361, DOI 10.1016/j.actao.2007.02.001; KITAYAMA K, 1995, J VEG SCI, V6, P211, DOI 10.2307/3236216; Knutti R, 2013, NAT CLIM CHANGE, V3, P369, DOI [10.1038/nclimate1716, 10.1038/NCLIMATE1716]; Krend KL, 2011, THESIS U HAWAII MANO; Kwiatkowski DP, 2005, AM J HUM GENET, V77, P171, DOI 10.1086/432519; LaPointe DA, 2009, CONSERVATION BIOL HA; LaPointe DA, 2012, ANN NY ACAD SCI, V1249, P211, DOI 10.1111/j.1749-6632.2011.06431.x; Le Quere C, 2009, NAT GEOSCI, V2, P831, DOI 10.1038/ngeo689; Leonard DL, 2008, BIOL CONSERV, V141, P2054, DOI 10.1016/j.biocon.2008.06.001; Lindsey GD, 2009, CONSERVATION BIOL HA; Liu CR, 2011, ECOGRAPHY, V34, P232, DOI 10.1111/j.1600-0587.2010.06354.x; Mawdsley JR, 2009, CONSERV BIOL, V23, P1080, DOI 10.1111/j.1523-1739.2009.01264.x; Moreira LA, 2009, CELL, V139, P1268, DOI 10.1016/j.cell.2009.11.042; Murdock CC, 2014, SCI REP-UK, V4, DOI 10.1038/srep03932; Nakicenovic N., 2000, SPECIAL REPORT EMISS; Ohlemuller R, 2008, BIOL LETTERS, V4, P568, DOI 10.1098/rsbl.2008.0097; Ortega-Huerta MA, 2008, REV MEX BIODIVERS, V79, P205; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Pejchar L, 2005, ECOL APPL, V15, P1053, DOI 10.1890/04-0577; Platts PJ, 2014, DIVERS DISTRIB; Pratt HD, 1994, STUD AVIAN BIOL, V15, P103; Pratt LW, 2009, CONSERVATION BIOL HA; Pratt T.K., 2009, CONSERVATION BIOL HA; Raupach MR, 2007, P NATL ACAD SCI USA, V104, P10288, DOI 10.1073/pnas.0700609104; Rollins MG, 2009, INT J WILDLAND FIRE, V18, P235, DOI 10.1071/WF08088; ROMMENS CMT, 1995, PLANT CELL, V7, P1537, DOI 10.1105/tpc.7.10.1537; Samuel MD, 2011, ECOL APPL, V21, P2960, DOI 10.1890/10-1311.1; Scott JM, 1989, J WILDL MANAGE, V53, P1; Scott JM, 2001, EVOLUTION ECOLOGY CO; Sperling FN, 2004, CLIMATIC CHANGE, V65, P103, DOI 10.1023/B:CLIM.0000037488.33377.bf; Thuiller W., 2014, **DATA OBJECT**; U.S. Fish and Wildlife Service, 2006, REV REC PLAN HAW FOR, P622; Vanderwerf EA, 2001, WILSON BULL, V113, P10, DOI 10.1676/0043-5643(2001)113[0010:CDAAOT]2.0.CO;2; Vanderwerf EA, 2013, WILSON J ORNITHOL, V125, P600, DOI 10.1676/13-018.1; Veloz SD, 2012, GLOBAL CHANGE BIOL, V18, P1698, DOI 10.1111/j.1365-2486.2011.02635.x; Vorsino AE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095427; Warren DL, 2008, EVOLUTION, V62, P2868, DOI 10.1111/j.1558-5646.2008.00482.x; Woodworth BL, 2005, P NATL ACAD SCI USA, V102, P1531, DOI 10.1073/pnas.0409454102; Zele F, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2837; Zhang C, 2012, MON WEATHER REV	87	40	40	1	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2015	10	10							e0140389	10.1371/journal.pone.0140389	http://dx.doi.org/10.1371/journal.pone.0140389			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0DL	26509270	Green Submitted, gold, Green Published			2022-12-26	WOS:000363918100030
J	Hattori, Y; Kim, HS; Tsuboi, N; Yamamoto, A; Akiyama, S; Shi, YQ; Katsuno, T; Kosugi, T; Ueda, M; Matsuo, S; Maruyama, S				Hattori, Yuka; Kim, Hangsoo; Tsuboi, Naotake; Yamamoto, Akihito; Akiyama, Shinichi; Shi, Yiqin; Katsuno, Takayuki; Kosugi, Tomoki; Ueda, Minoru; Matsuo, Seiichi; Maruyama, Shoichi			Therapeutic Potential of Stem Cells from Human Exfoliated Deciduous Teeth in Models of Acute Kidney Injury	PLOS ONE			English	Article							ISCHEMIA-REPERFUSION INJURY; ACUTE-RENAL-FAILURE; TUBULAR EPITHELIAL-CELLS; MONOCYTE CHEMOATTRACTANT PROTEIN-1; HEPATOCYTE GROWTH-FACTOR; STROMAL CELLS; DENTAL-PULP; BONE-MARROW; ADIPOSE-TISSUE; EXTRACELLULAR VESICLES	Background Acute kidney injury (AKI) is a critical condition associated with high mortality. However, the available treatments for AKI are limited. Stem cells from human exfoliated deciduous teeth (SHED) have recently gained attention as a novel source of stem cells. The purpose of this study was to clarify whether SHED have a therapeutic effect on AKI induced by ischemia-reperfusion injury. Methods The left renal artery and vein of the mice were clamped for 20 min to induce ischemia. SHED, bone marrow derived mesenchymal stem cells (BMMSC) or phosphate-buffered saline (control) were administered into the subrenal capsule. To confirm the potency of SHED in vitro, H2O2 stimulation assays and scratch assays were performed. Results The serum creatinine and blood urea nitrogen levels of the SHED group were significantly lower than those of the control group, while BMMSC showed no therapeutic effect. Infiltration of macrophages and neutrophils in the kidney was significantly attenuated in mice treated with SHED. Cytokine levels (MIP-2, IL-1 beta, and MCP-1) in mice kidneys were significantly reduced in the SHED group. In in vitro experiments, SHED significantly decreased MCP-1 secretion in tubular epithelial cells (TEC) stimulated with H2O2. In addition, SHED promoted wound healing in the scratch assays, which was blunted by anti-HGF antibodies. Discussion SHED attenuated the levels of inflammatory cytokines and improved kidney function in AKI induced by IRI. SHED secreted factors reduced MCP-1 and increased HGF expression, which promoted wound healing. These results suggest that SHED might provide a novel stem cell resource, which can be applied for the treatment of ischemic kidney injury.	[Hattori, Yuka; Yamamoto, Akihito; Ueda, Minoru] Nagoya Univ, Grad Sch Med, Dept Oral & Maxillofacial Surg, Showa Ku, Nagoya, Aichi 466, Japan; [Kim, Hangsoo; Tsuboi, Naotake; Akiyama, Shinichi; Shi, Yiqin; Katsuno, Takayuki; Kosugi, Tomoki; Matsuo, Seiichi; Maruyama, Shoichi] Nagoya Univ, Grad Sch Med, Dept Nephrol, Showa Ku,Internal Med, Nagoya, Aichi 466, Japan	Nagoya University; Nagoya University	Maruyama, S (corresponding author), Nagoya Univ, Grad Sch Med, Dept Nephrol, Showa Ku,Internal Med, 65 Tsurumai Cho, Nagoya, Aichi 466, Japan.	marus@med.nagoya-u.ac.jp		Tsuboi, Naotake/0000-0003-0760-845X	Kyowa Hakko Kirin Co., Ltd; Otsuka Pharmaceutical Co., Ltd; Dainippon Sumitomo Pharma Co., Ltd; MOCHIDA PHARMACEUTICAL CO. LTD	Kyowa Hakko Kirin Co., Ltd(Kyowa Kirin Ltd); Otsuka Pharmaceutical Co., Ltd(Otsuka Pharmaceutical); Dainippon Sumitomo Pharma Co., Ltd(Dainippon Sumitomo Pharma Co., Ltd.); MOCHIDA PHARMACEUTICAL CO. LTD	Funding was received for other and/or previous research from Kyowa Hakko Kirin Co., Ltd; Otsuka Pharmaceutical Co., Ltd; Dainippon Sumitomo Pharma Co., Ltd; and MOCHIDA PHARMACEUTICAL CO. LTD.	Adachi E, 2014, PHARMACOLOGY, V94, P190, DOI 10.1159/000363412; Bi B, 2007, J AM SOC NEPHROL, V18, P2486, DOI 10.1681/ASN.2007020140; Bonventre JV, 2004, KIDNEY INT, V66, P480, DOI 10.1111/j.1523-1755.2004.761_2.x; Broekema M, 2005, KIDNEY INT, V68, P2572, DOI 10.1111/j.1523-1755.2005.00728.x; Bruno S, 2013, PEDIATR NEPHROL, V28, P2249, DOI 10.1007/s00467-013-2413-z; Bruno S, 2009, J AM SOC NEPHROL, V20, P1053, DOI 10.1681/ASN.2008070798; Chen YT, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-51; d'Aquino R, 2008, STEM CELL REV, V4, P21, DOI 10.1007/s12015-008-9013-5; Fang TC, 2005, J AM SOC NEPHROL, V16, P1723, DOI 10.1681/ASN.2004121089; Furuhashi K, 2013, J AM SOC NEPHROL, V24, P587, DOI 10.1681/ASN.2012030264; Furuichi K, 2003, J AM SOC NEPHROL, V14, P2503, DOI 10.1097/01.ASN.0000089563.63641.A8; Furuichi K, 2006, AM J PATHOL, V169, P372, DOI 10.2353/ajpath.2006.060043; Furuichi K, 2009, CLIN EXP NEPHROL, V13, P9, DOI 10.1007/s10157-008-0119-5; Gatti S, 2011, NEPHROL DIAL TRANSPL, V26, P1474, DOI 10.1093/ndt/gfr015; Gnecchi M, 2005, NAT MED, V11, P367, DOI 10.1038/nm0405-367; Goodell MA, 2003, CURR OPIN HEMATOL, V10, P208, DOI 10.1097/00062752-200305000-00003; Gronthos S, 2002, J DENT RES, V81, P531, DOI 10.1177/154405910208100806; Gronthos S, 2000, P NATL ACAD SCI USA, V97, P13625, DOI 10.1073/pnas.240309797; Gyorgy B, 2011, CELL MOL LIFE SCI, V68, P2667, DOI 10.1007/s00018-011-0689-3; Humphreys BD, 2008, ANNU REV MED, V59, P311, DOI 10.1146/annurev.med.59.061506.154239; Hwang Y, 2014, SCI REP-UK, V4, DOI 10.1038/srep05916; Iwashima S, 2009, STEM CELLS DEV, V18, P533, DOI 10.1089/scd.2008.0358; Kale S, 2003, J CLIN INVEST, V112, P42, DOI 10.1172/JCI200317856; Kanemura H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085336; Katsuno T, 2013, CELL TRANSPLANT, V22, P287, DOI 10.3727/096368912X655019; Kern S, 2006, STEM CELLS, V24, P1294, DOI 10.1634/stemcells.2005-0342; Kim H, 2014, CYTOTHERAPY, V16, P357, DOI 10.1016/j.jcyt.2013.10.011; Kim HR, 2011, NEPHROLOGY, V16, P545, DOI 10.1111/j.1440-1797.2011.01473.x; Kinnaird T, 2004, CIRC RES, V94, P678, DOI 10.1161/01.RES.0000118601.37875.AC; Kinnaird T, 2004, CIRCULATION, V109, P1543, DOI 10.1161/01.CIR.0000124062.31102.57; Lee H, 2000, AM J PHYSIOL-CELL PH, V278, pC612, DOI 10.1152/ajpcell.2000.278.3.C612; Li L, 2008, KIDNEY INT, V74, P1526, DOI 10.1038/ki.2008.500; da Silva UBL, 2007, INT IMMUNOPHARMACOL, V7, P1609, DOI 10.1016/j.intimp.2007.08.014; Melnikov VY, 2002, J CLIN INVEST, V110, P1083, DOI 10.1172/JCI200215623; Miura M, 2003, P NATL ACAD SCI USA, V100, P5807, DOI 10.1073/pnas.0937635100; Nakamura S, 2009, J ENDODONT, V35, P1536, DOI 10.1016/j.joen.2009.07.024; Nishino Y, 2011, CYTOTHERAPY, V13, P598, DOI 10.3109/14653249.2010.542462; Oh DJ, 2008, AM J PHYSIOL-RENAL, V294, pF264, DOI 10.1152/ajprenal.00204.2007; Perin L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009357; Roy S, 2013, P NATL ACAD SCI USA, V110, P4598, DOI 10.1073/pnas.1218682110; Rozkalne A, 2014, HUM GENE THER, V25, P73, DOI 10.1089/hum.2013.126; Sakai K, 2012, J CLIN INVEST, V122, P80, DOI 10.1172/JCI59251; Sanchez MBH, 2014, STEM CELL RES THER, V5, DOI 10.1186/scrt514; Sato W, 2001, J IMMUNOL, V167, P3463, DOI 10.4049/jimmunol.167.6.3463; Seo BM, 2008, ORAL DIS, V14, P428, DOI 10.1111/j.1601-0825.2007.01396.x; Shi S, 2003, J BONE MINER RES, V18, P696, DOI 10.1359/jbmr.2003.18.4.696; Shimizu H, 2003, J AM SOC NEPHROL, V14, P1496, DOI 10.1097/01.ASN.0000069223.98703.8E; Thurman JM, 2007, J IMMUNOL, V178, P1819, DOI 10.4049/jimmunol.178.3.1819; Togel F, 2005, AM J PHYSIOL-RENAL, V289, pF31, DOI 10.1152/ajprenal.00007.2005; Togel F, 2007, AM J PHYSIOL-RENAL, V292, pF1626, DOI 10.1152/ajprenal.00339.2006; Tsuboi N, 2002, J IMMUNOL, V169, P2026, DOI 10.4049/jimmunol.169.4.2026; Wada T, 2004, J AM SOC NEPHROL, V15, P940, DOI 10.1097/01.ASN.0000120371.09769.80; Wagers AJ, 2002, SCIENCE, V297, P2256, DOI 10.1126/science.1074807; White LR, 2007, AM J PHYSIOL-RENAL, V292, pF567, DOI 10.1152/ajprenal.00212.2006; WUTHRICH RP, 1990, KIDNEY INT, V37, P783, DOI 10.1038/ki.1990.46; Yamagata M, 2013, STROKE, V44, P551, DOI 10.1161/STROKEAHA.112.676759; Yap SC, 2012, ANESTHESIOLOGY, V116, P1139, DOI 10.1097/ALN.0b013e31824f951b; Yoshida M, 2014, J PHARMACOL SCI, V124, P117, DOI 10.1254/jphs.13R12CP; Zhou D, 2013, KIDNEY INT, V84, P509, DOI 10.1038/ki.2013.102	59	21	24	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2015	10	10							e0140121	10.1371/journal.pone.0140121	http://dx.doi.org/10.1371/journal.pone.0140121			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0DL	26509261	Green Published, gold, Green Submitted			2022-12-26	WOS:000363918100020
J	Hernandez, CL; Soares, P; Dugoujon, JM; Novelletto, A; Rodriguez, JN; Rito, T; Oliveira, M; Melhaoui, M; Baali, A; Pereira, L; Calderon, R				Hernandez, Candela L.; Soares, Pedro; Dugoujon, Jean M.; Novelletto, Andrea; Rodriguez, Juan N.; Rito, Teresa; Oliveira, Marisa; Melhaoui, Mohammed; Baali, Abdellatif; Pereira, Luisa; Calderon, Rosario			Early Holocenic and Historic mtDNA African Signatures in the Iberian Peninsula: The Andalusian Region as a Paradigm	PLOS ONE			English	Article							NORTH-AFRICA; GENETIC IMPACT; NEAR-EASTERN; MITOCHONDRIAL; HAPLOGROUP; POPULATION; DIVERSITY; U6; EXPANSION; LINEAGES	Determining the timing, identity and direction of migrations in the Mediterranean Basin, the role of "migratory routes" in and among regions of Africa, Europe and Asia, and the effects of sex-specific behaviors of population movements have important implications for our understanding of the present human genetic diversity. A crucial component of the Mediterranean world is its westernmost region. Clear features of transcontinental ancient contacts between North African and Iberian populations surrounding the maritime region of Gibraltar Strait have been identified from archeological data. The attempt to discern origin and dates of migration between close geographically related regions has been a challenge in the field of uniparental-based population genetics. Mitochondrial DNA (mtDNA) studies have been focused on surveying the H1, H3 and V lineages when trying to ascertain north-south migrations, and U6 and L in the opposite direction, assuming that those lineages are good proxies for the ancestry of each side of the Mediterranean. To this end, in the present work we have screened entire mtDNA sequences belonging to U6, M1 and L haplogroups in Andalusians -from Huelva and Granada provinces-and Moroccan Berbers. We present here pioneer data and interpretations on the role of NW Africa and the Iberian Peninsula regarding the time of origin, number of founders and expansion directions of these specific markers. The estimated entrance of the North African U6 lineages into Iberia at 10 ky correlates well with other L African clades, indicating that U6 and some L lineages moved together from Africa to Iberia in the Early Holocene. Still, founder analysis highlights that the high sharing of lineages between North Africa and Iberia results from a complex process continued through time, impairing simplistic interpretations. In particular, our work supports the existence of an ancient, frequently denied, bridge connecting the Maghreb and Andalusia.	[Hernandez, Candela L.; Calderon, Rosario] Univ Complutense, Fac Biol, Dept Zool & Antropol Fis, E-28040 Madrid, Spain; [Soares, Pedro; Rito, Teresa; Oliveira, Marisa; Pereira, Luisa] Univ Porto IPATIMUP, Inst Patol & Imunol Mol, Porto, Portugal; [Soares, Pedro] Univ Minho, CBMA Ctr Mol & Environm Biol, Dept Biol, Braga, Portugal; [Dugoujon, Jean M.] Univ Toulouse 3, CNRS, UMR 5288, Lab Anthropol Mol & Imagerie Synth AMIS, F-31073 Toulouse, France; [Novelletto, Andrea] Univ Roma Tor Vergata, Dept Biol, I-00173 Rome, Italy; [Rodriguez, Juan N.] Hosp Juan Ramon Jimenez, Serv Hematol, Huelva, Spain; [Melhaoui, Mohammed] Univ Mohammed Premier, Fac Sci, Oujda, Morocco; [Baali, Abdellatif] Univ Cadi Ayyad, FSSM, Marrakech, Morocco; [Pereira, Luisa] Univ Porto, Inst Invest & Inovacao Saude, P-4100 Porto, Portugal; [Pereira, Luisa] Univ Porto, Fac Med, P-4100 Porto, Portugal	Complutense University of Madrid; Universidade do Porto; Universidade do Minho; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; University of Rome Tor Vergata; Hospital Juan Ramon Jimenez; Mohammed First University of Oujda; Cadi Ayyad University of Marrakech; Universidade do Porto; i3S - Instituto de Investigacao e Inovacao em Saude, Universidade do Porto; Universidade do Porto	Calderon, R (corresponding author), Univ Complutense, Fac Biol, Dept Zool & Antropol Fis, E-28040 Madrid, Spain.	rcalfer@bio.ucm.es	Calderon, Rosario/K-2514-2014; Rito, Teresa/O-7726-2014; Soares, Pedro A/G-9422-2011; Rito, Teresa/AAC-9041-2019; Hernández, Candela L/K-3713-2014; Pereira, Luisa/H-3050-2011	Calderon, Rosario/0000-0001-9196-5323; Rito, Teresa/0000-0002-8374-6347; Soares, Pedro A/0000-0002-2807-690X; Rito, Teresa/0000-0002-8374-6347; Hernández, Candela L/0000-0002-0816-7169; Pereira, Luisa/0000-0002-4271-1527; Novelletto, Andrea/0000-0002-1146-7680	Spanish Ministry of Competitiveness [CGL2010-15191/BOS]; International Mobility Program Acciones Integradas Hispano-Portuguesas [PRI-AIBPT-2011-1004]; E.C. Sixth Framework Programme [ERAS-CT-2003-980409]; Complutense University; FCT Investigator Programme [IF/01641/2013]; FCT; Portuguese Foundation for Science and Technology; FEDER funds through the Operational Programme for Competitiveness Factors COMPETE; National Funds through the FCT [PEst-C/SAU/LA0003/2013]	Spanish Ministry of Competitiveness; International Mobility Program Acciones Integradas Hispano-Portuguesas; E.C. Sixth Framework Programme(European CommissionEuropean Commission Joint Research Centre); Complutense University; FCT Investigator Programme(Portuguese Foundation for Science and Technology); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); Portuguese Foundation for Science and Technology(Portuguese Foundation for Science and Technology); FEDER funds through the Operational Programme for Competitiveness Factors COMPETE; National Funds through the FCT(Portuguese Foundation for Science and Technology)	Financial support was provided by the Spanish Ministry of Competitiveness through Research Project CGL2010-15191/BOS granted to RC and International Mobility Program Acciones Integradas Hispano-Portuguesas (PRI-AIBPT-2011-1004) granted to RC (Spain) and LP (Portugal) (http://www.mineco.gob.es/portal/site/mineco/idi). The E.C. Sixth Framework Programme under Contract no ERAS-CT-2003-980409 (EUROCORES project of the European Science Foundation) also provided financial support to JMD for North African population research. CLH has a predoctoral fellowship granted by Complutense University. PS is supported by FCT Investigator Programme (IF/01641/2013). IPATIMUP (https://www.ipatimup.pt/) integrates the Instituto the Investigacao em Saude (i3S) Research Unit, which is partially supported by FCT, the Portuguese Foundation for Science and Technology. IPATIMUP is funded by FEDER funds through the Operational Programme for Competitiveness Factors COMPETE and National Funds through the FCT under the project PEst-C/SAU/LA0003/2013. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Abri A, 2012, AM J PHYS ANTHROPOL, V149, P291, DOI 10.1002/ajpa.22131; Alves M, 2012, ADV INTEL SOFT COMPU, V154, P129; Ambrosio B, 2010, ANN HUM BIOL, V37, P86, DOI 10.3109/03014460903229155; Ambrosio B, 2010, COLLEGIUM ANTROPOL, V34, P1215; Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Barton RNE, 2013, J HUM EVOL, V65, P266, DOI 10.1016/j.jhevol.2013.06.003; Bekada A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056775; Bocquet-Appel JP, 2005, J ARCHAEOL SCI, V32, P1656, DOI 10.1016/j.jas.2005.05.006; Brakez Z, 2001, ANN HUM BIOL, V28, P295, DOI 10.1080/030144601300119106; Brandt G, 2015, J HUM EVOL, V79, P73, DOI 10.1016/j.jhevol.2014.06.017; Camps G, 1974, LES CIVILISATIONS PR; Casas MJ, 2006, AM J PHYS ANTHROPOL, V131, P539, DOI 10.1002/ajpa.20463; Castaneda IS, 2009, P NATL ACAD SCI USA, V106, P20159, DOI 10.1073/pnas.0905771106; Cerezo M, 2012, GENOME RES, V22, P821, DOI 10.1101/gr.134452.111; Cherni L, 2005, HUM BIOL, V77, P61, DOI 10.1353/hub.2005.0028; Cherni L, 2009, AM J PHYS ANTHROPOL, V139, P253, DOI 10.1002/ajpa.20979; Coudray C, 2009, ANN HUM GENET, V73, P196, DOI 10.1111/j.1469-1809.2008.00493.x; Coulthard TJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074834; Currat M, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-237; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Ennafaa H, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-8; Fadhlaoui-Zid K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080293; Fadhlaoui-Zid K, 2011, AM J PHYS ANTHROPOL, V145, P107, DOI 10.1002/ajpa.21472; Falchi A, 2006, J HUM GENET, V51, P9, DOI 10.1007/s10038-005-0324-y; Fernandes V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118625; Fortes-Lima C, 2014, CR BIOL, V337, P646, DOI 10.1016/j.crvi.2014.08.004; Gamble C, 2004, PHILOS T R SOC B, V359, P243, DOI 10.1098/rstb.2003.1396; Gonzalez AM, 2003, AM J PHYS ANTHROPOL, V120, P391, DOI 10.1002/ajpa.10168; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Harich N, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-138; Hellenthal G, 2014, SCIENCE, V343, P747, DOI 10.1126/science.1243518; Henn BM, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002397; Hernandez CL, 2014, BMC GENET, V15, DOI 10.1186/1471-2156-15-11; Irish JD, 2000, J HUM EVOL, V39, P393, DOI 10.1006/jhev.2000.0430; Kivisild T, 2006, GENETICS, V172, P373, DOI 10.1534/genetics.105.043901; Linard C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031743; Linstadter J, 2012, QUATERN INT, V274, P219, DOI 10.1016/j.quaint.2012.01.013; Lubell D., 2001, ENCY PREHISTORY, V1, P129; Maca-Meyer N, 2003, BMC GENET, V4, DOI 10.1186/1471-2156-4-15; Maca-Meyer N, 2001, BMC GENET, V2, DOI 10.1186/1471-2156-2-13; Malyarchuk BA, 2008, EUR J HUM GENET, V16, P1091, DOI 10.1038/ejhg.2008.70; Manen C, 2007, 26 C PREH FRANC C CE, P133; Moorjani P, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001373; Olivieri A, 2006, SCIENCE, V314, P1767, DOI 10.1126/science.1135566; Onrubia-Pintado J, 1991, ENCYCLOPEDIE BERBERE, P1731; Ottoni C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013378; Ottoni C, 2009, ANN HUM BIOL, V36, P785, DOI 10.3109/03014460903198509; Pardinas AF, 2014, AM J HUM BIOL, V26, P777, DOI 10.1002/ajhb.22601; Pennarun E, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-234; Pereira L, 2005, HUM BIOL, V77, P213, DOI 10.1353/hub.2005.0041; Pereira L, 2004, INT J LEGAL MED, V118, P132, DOI 10.1007/s00414-003-0424-1; Pereira L, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-390; Pereira L, 2009, AM J HUM GENET, V84, P628, DOI 10.1016/j.ajhg.2009.04.013; Podgorna E, 2013, ANN HUM GENET, V77, P513, DOI 10.1111/ahg.12040; Rando JC, 1998, ANN HUM GENET, V62, P531, DOI 10.1046/j.1469-1809.1998.6260531.x; Rhouda T, 2009, MITOCHONDRION, V9, P402, DOI 10.1016/j.mito.2009.07.003; Richards M, 2000, AM J HUM GENET, V67, P1251, DOI 10.1016/S0002-9297(07)62954-1; Rito T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080031; Saillard J, 2000, AM J HUM GENET, V67, P718, DOI 10.1086/303038; Salas A, 2002, AM J HUM GENET, V71, P1082, DOI 10.1086/344348; Secher B, 2014, BMC EVOL BIOL, V14, DOI 10.1186/1471-2148-14-109; Soares P, 2012, MOL BIOL EVOL, V29, P915, DOI 10.1093/molbev/msr245; Soares P, 2010, CURR BIOL, V20, pR174, DOI 10.1016/j.cub.2009.11.054; Soares P, 2009, AM J HUM GENET, V84, P740, DOI 10.1016/j.ajhg.2009.05.001; Souville G, 1998, COMPTESRENDUS DES SE, V142, P163; Straus LG, 2001, QUATERN INT, V75, P91, DOI 10.1016/S1040-6182(00)00081-1; Turchi C, 2009, FORENSIC SCI INT-GEN, V3, P166, DOI 10.1016/j.fsigen.2009.01.014; van Oven M, 2009, HUM MUTAT, V30, pE386, DOI 10.1002/humu.20921; Villaverde V., 2012, QUATERN INT, V272-273, P17, DOI DOI 10.1016/J.QUAINT.2012.04.025; Walker M, 2009, J QUATERNARY SCI, V24, P3, DOI 10.1002/jqs.1227; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Zilhao J, 1999, J WORLD PREHIST, V13, P1, DOI 10.1023/A:1022348410845	73	13	13	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2015	10	10							e0139784	10.1371/journal.pone.0139784	http://dx.doi.org/10.1371/journal.pone.0139784			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CV0DL	26509580	Green Submitted, Green Accepted, Green Published, gold			2022-12-26	WOS:000363918100013
J	Honjo, M; Omodaka, K; Ishizaki, T; Ohkubo, S; Araie, M; Nakazawa, T				Honjo, Megumi; Omodaka, Kazuko; Ishizaki, Tatsuro; Ohkubo, Shinji; Araie, Makoto; Nakazawa, Toru			Retinal Thickness and the Structure/Function Relationship in the Eyes of Older Adults with Glaucoma	PLOS ONE			English	Article							OPTICAL COHERENCE TOMOGRAPHY; NERVE-FIBER LAYER; INNER PLEXIFORM LAYER; STANDARD AUTOMATED PERIMETRY; VISUAL-FIELD SENSITIVITY; OPEN-ANGLE GLAUCOMA; NORMAL-TENSION GLAUCOMA; CELL COMPLEX THICKNESS; SPECTRAL-DOMAIN OCT; TIME-DOMAIN	Glaucoma is common and shows high prevalence in older adults. However, there are few studies on the structure/function relationship in older adults with glaucoma. This prospective, cross-sectional study (conducted between February and August 2014), enrolled 102 eyes of 102 subjects aged over 75 years, including 57 eyes with primary open angle glaucoma (POAG), 15 eyes with pseudoexfoliation glaucoma (PXG), and 30 healthy eyes. Multiple regression analysis was used to determine the correlation of circumpapillary retinal nerve fiber layer thickness (cpRNFLT) and macular parameters to mean deviation (MD) to and standard automated perimetry (SAP)-measured sensitivity, assessed with the 30-2 and 10-2 programs. In each 10-2 SAP test point, Spearman's rank correlation coefficient was used to compare macular retinal nerve fiber layer thickness (mRNFLT), macular ganglion cell-inner plexiform layer thickness (GCIPLT), and mRNFL+GCIPL thickness (GCCT) with sensitivity after adjusting for retinal ganglion cell (RGC) displacement. In eyes with POAG and PXG, cpRNFLT was significantly correlated with 30-2 MD and 30-2 sensitivity. Multiple regression analysis revealed that the POAG had significantly lower cpRNFLT, mRNFLT, GCIPLT, and GCCT according to the severity of disease than control eyes after adjusting for sensitivity, age, sex, and axial length. The PXG eyes had significantly lower cpRNFLT, mRNFLT, and GCCT when compared with the early to moderate POAG eyes. GCCT was significantly correlated with 10-2 sensitivity, except in one juxtafoveal point, (r = 0.338-0.778) in the POAG eyes. The periphery of the central 10 degrees area showed a good correlation between sensitivity and mRNFLT, while the central 5.8 degrees showed a good correlation between sensitivity and GCIPLT. The correlation between structure and function was significant, and objective and quantitative method with OCT assessing glaucoma that does not require patient ability could be a possible parameter to assess diagnosis and progression in older patients with glaucoma.	[Honjo, Megumi] Univ Tokyo, Grad Sch Med, Dept Ophthalmol, Tokyo, Japan; [Honjo, Megumi] Tokyo Metropolitan Geriatr Hosp, Dept Ophthalmol, Tokyo 173, Japan; [Omodaka, Kazuko; Nakazawa, Toru] Tohoku Univ, Grad Sch Med, Dept Ophthalmol, Sendai, Miyagi 980, Japan; [Ishizaki, Tatsuro] Tokyo Metropolitan Inst Gerontol, Longitudinal Interdisciplinary Study Aging, Tokyo, Japan; [Ohkubo, Shinji] Kanazawa Univ, Grad Sch Med Sci, Dept Ophthalmol & Visual Sci, Kanazawa, Ishikawa, Japan; [Araie, Makoto] Kanto Cent Hosp, Tokyo, Japan	University of Tokyo; Tokyo Metropolitan Institute of Gerontology; Tohoku University; Tokyo Metropolitan Institute of Gerontology; Kanazawa University	Honjo, M (corresponding author), Univ Tokyo, Grad Sch Med, Dept Ophthalmol, Tokyo, Japan.	m_honjo@kuhp.kyoto-u.ac.jp						Anderson DR, 1999, AUTOMATED STATIC PER, P152; Araie M, 2014, INVEST OPHTH VIS SCI, V55, P7199, DOI 10.1167/iovs.14-14964; Barkana Y, 2009, J GLAUCOMA, V18, P601, DOI 10.1097/IJG.0b013e3181996ef4; Birt CM, 1997, OPHTHALMOLOGY, V104, P1126, DOI 10.1016/S0161-6420(97)30173-0; Cheng CSM, 2011, CLIN EXP OPHTHALMOL, V39, P215, DOI 10.1111/j.1442-9071.2010.02460.x; Cho JW, 2010, INVEST OPHTH VIS SCI, V51, P6401, DOI 10.1167/iovs.09-5035; Ferreras A, 2008, INVEST OPHTH VIS SCI, V49, P3018, DOI 10.1167/iovs.08-1775; Girkin CA, 2011, OPHTHALMOLOGY, V118, P2403, DOI 10.1016/j.ophtha.2011.06.013; Hantzschel J, 2013, ACTA OPHTHALMOL, V91, pE386, DOI 10.1111/aos.12061; HEIJL A, 1987, ARCH OPHTHALMOL-CHIC, V105, P1544; Heijl A, 2009, OPHTHALMOLOGY, V116, P2271, DOI 10.1016/j.ophtha.2009.06.042; Hood DC, 2007, PROG RETIN EYE RES, V26, P688, DOI 10.1016/j.preteyeres.2007.08.001; Hood DC, 2013, PROG RETIN EYE RES, V32, P1, DOI 10.1016/j.preteyeres.2012.08.003; Iwase A, 2004, OPHTHALMOLOGY, V111, P1641, DOI 10.1016/j.ophtha.2004.03.029; Iwase A, 2006, OPHTHALMOLOGY, V113, P1354, DOI 10.1016/j.ophtha.2006.04.022; Jampel H, 2009, J GLAUCOMA, V18, P37, DOI 10.1097/IJG.0b013e31816f75e9; Johnson C A, 2000, Semin Ophthalmol, V15, P221, DOI 10.3109/08820530009037873; Kang Eun Min, 2015, Korean J Ophthalmol, V29, P263, DOI 10.3341/kjo.2015.29.4.263; KATZ J, 1986, ARCH OPHTHALMOL-CHIC, V104, P65; Khawaja AP, 2013, INVEST OPHTH VIS SCI, V54, P5028, DOI 10.1167/iovs.13-11971; Kim Gyu Ah, 2014, Korean J Ophthalmol, V28, P138, DOI 10.3341/kjo.2014.28.2.138; Kim JH, 2011, CURR EYE RES, V36, P937, DOI 10.3109/02713683.2011.597535; Kim NR, 2012, J GLAUCOMA, V21, P116, DOI 10.1097/IJG.0b013e31820277da; Kim NR, 2010, INVEST OPHTH VIS SCI, V51, P4646, DOI 10.1167/iovs.09-5053; Kim S, 2013, OPHTHALMOLOGY, V120, P1798, DOI 10.1016/j.ophtha.2013.02.015; Koh VT, 2012, INVEST OPHTH VIS SCI, V53, P5853, DOI 10.1167/iovs.12-10414; LACHENMAYR BJ, 1994, INVEST OPHTH VIS SCI, V35, P2741; Leite MT, 2012, J GLAUCOMA, V21, P49, DOI 10.1097/IJG.0b013e31822af27a; Leung CKS, 2013, OPHTHALMOLOGY, V120, P2485, DOI 10.1016/j.ophtha.2013.07.021; Leung CKS, 2011, OPHTHALMOLOGY, V118, P1551, DOI 10.1016/j.ophtha.2010.12.035; Leung CKS, 2010, INVEST OPHTH VIS SCI, V51, P217, DOI 10.1167/iovs.09-3468; Mwanza JC, 2011, INVEST OPHTH VIS SCI, V52, P7872, DOI 10.1167/iovs.11-7896; Mwanza JC, 2011, INVEST OPHTH VIS SCI, V52, P8323, DOI 10.1167/iovs.11-7962; Na JH, 2012, INVEST OPHTH VIS SCI, V53, P5044, DOI 10.1167/iovs.11-9401; Nilforushan N, 2012, INVEST OPHTH VIS SCI, V53, P2740, DOI 10.1167/iovs.11-8320; Ohkubo S, 2014, INVEST OPHTH VIS SCI, V55, P5269, DOI 10.1167/iovs.14-14153; Ooto S, 2011, INVEST OPHTH VIS SCI, V52, P8769, DOI 10.1167/iovs.11-8388; Parikh RS, 2007, OPHTHALMOLOGY, V114, P921, DOI 10.1016/j.ophtha.2007.01.023; Park HYL, 2012, OPHTHALMOLOGY, V119, P10, DOI 10.1016/j.ophtha.2011.07.033; Patel NB, 2014, INVEST OPHTH VIS SCI, V55, P5134, DOI 10.1167/iovs.14-14303; Pinto LM, 2014, INVEST OPHTH VIS SCI, V55, P3074, DOI 10.1167/iovs.13-13664; Quigley HA, 2006, BRIT J OPHTHALMOL, V90, P262, DOI 10.1136/bjo.2005.081224; QUIGLEY HA, 1989, AM J OPHTHALMOL, V107, P453, DOI 10.1016/0002-9394(89)90488-1; Raza AS, 2011, ARCH OPHTHALMOL-CHIC, V129, P1529, DOI 10.1001/archophthalmol.2011.352; Ritch R, 2003, PROG RETIN EYE RES, V22, P253, DOI 10.1016/S1350-9462(02)00014-9; Seong M, 2010, INVEST OPHTH VIS SCI, V51, P1446, DOI 10.1167/iovs.09-4258; Shin HY, 2013, INVEST OPHTH VIS SCI, V54, P7344, DOI 10.1167/iovs.13-12667; Sjostrand J, 1999, GRAEF ARCH CLIN EXP, V237, P1014, DOI 10.1007/s004170050338; Sung KR, 2009, OPHTHALMOLOGY, V116, P1119, DOI 10.1016/j.ophtha.2009.01.004; Takahashi M, 2013, CURR EYE RES, V38, P1133, DOI 10.3109/02713683.2013.807932; Tan O, 2008, OPHTHALMOLOGY, V115, P949, DOI 10.1016/j.ophtha.2007.08.011; Tan O, 2009, OPHTHALMOLOGY, V116, P2305, DOI 10.1016/j.ophtha.2009.05.025; Traynis I, 2014, JAMA OPHTHALMOL, V132, P291, DOI 10.1001/jamaophthalmol.2013.7656; Vergados A, 2015, SEMIN OPHTHALMOL, V30, P44, DOI 10.3109/08820538.2013.821509; Wang M, 2009, ARCH OPHTHALMOL-CHIC, V127, P875, DOI 10.1001/archophthalmol.2009.145; Weinreb RN, 2004, LANCET, V363, P1711, DOI 10.1016/S0140-6736(04)16257-0; Zhao L, 2014, ACTA OPHTHALMOL, V92, pE35, DOI 10.1111/aos.12240	57	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2015	10	10							e0141293	10.1371/journal.pone.0141293	http://dx.doi.org/10.1371/journal.pone.0141293			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU8PC	26505757	Green Published, gold, Green Submitted			2022-12-26	WOS:000363804200044
J	Hykin, SM; Bi, K; McGuire, JA				Hykin, Sarah M.; Bi, Ke; McGuire, Jimmy A.			Fixing Formalin: A Method to Recover Genomic-Scale DNA Sequence Data from Formalin-Fixed Museum Specimens Using High-Throughput Sequencing	PLOS ONE			English	Article							NUCLEAR-DNA; EXTRACTION; ALIGNMENT; ANCIENT; TISSUES; IDENTIFICATION; DAMAGE; FRESH; COST; AVES	For 150 years or more, specimens were routinely collected and deposited in natural history collections without preserving fresh tissue samples for genetic analysis. In the case of most herpetological specimens (i.e. amphibians and reptiles), attempts to extract and sequence DNA from formalin-fixed, ethanol-preserved specimens-particularly for use in phylogenetic analyses-has been laborious and largely ineffective due to the highly fragmented nature of the DNA. As a result, tens of thousands of specimens in herpetological collections have not been available for sequence-based phylogenetic studies. Massively parallel High-Throughput Sequencing methods and the associated bioinformatics, however, are particularly suited to recovering meaningful genetic markers from severely degraded/fragmented DNA sequences such as DNA damaged by formalin-fixation. In this study, we compared previously published DNA extraction methods on three tissue types subsampled from formalin-fixed specimens of Anolis carolinensis, followed by sequencing. Sufficient quality DNA was recovered from liver tissue, making this technique minimally destructive to museum specimens. Sequencing was only successful for the more recently collected specimen (collected similar to 30 ybp). We suspect this could be due either to the conditions of preservation and/or the amount of tissue used for extraction purposes. For the successfully sequenced sample, we found a high rate of base misincorporation. After rigorous trimming, we successfully mapped 27.93% of the cleaned reads to the reference genome, were able to reconstruct the complete mitochondrial genome, and recovered an accurate phylogenetic placement for our specimen. We conclude that the amount of DNA available, which can vary depending on specimen age and preservation conditions, will determine if sequencing will be successful. The technique described here will greatly improve the value of museum collections by making many formalin-fixed specimens available for genetic analysis.	[Hykin, Sarah M.; McGuire, Jimmy A.] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; [Bi, Ke] Univ Calif Berkeley, Calif Inst Quantitat Biosci QB3, CGRL, Berkeley, CA 94720 USA; [Hykin, Sarah M.; Bi, Ke; McGuire, Jimmy A.] Univ Calif Berkeley, Museum Vertebrate Zool, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Hykin, SM (corresponding author), Univ Calif Berkeley, Dept Integrat Biol, 3101 Valley Life Sci Bldg, Berkeley, CA 94720 USA.	smhykin@berkeley.edu; kebi@berkeley.edu	McGuire, Jimmy/N-7357-2019	Hykin, Sarah/0000-0002-5666-7440	Gordon and Betty Moore Foundation [2983]; Berkeley Initiative for Global Change Biology; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027303, S10RR029668] Funding Source: NIH RePORTER	Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Berkeley Initiative for Global Change Biology; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This research is funded by the Gordon and Betty Moore Foundation, grant number 2983 awarded to Dr. Charles Marshall and the Berkeley Initiative for Global Change Biology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abi-Rached L, 2011, SCIENCE, V334, P89, DOI 10.1126/science.1209202; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bazinet AL, 2014, SYST BIOL, V63, P812, DOI 10.1093/sysbio/syu031; Bennett EA, 2014, BIOTECHNIQUES, V56, P289, DOI 10.2144/000114176; Bi K, 2013, MOL ECOL, V22, P6018, DOI 10.1111/mec.12516; Bi K, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-403; Briggs AW, 2007, P NATL ACAD SCI USA, V104, P14616, DOI 10.1073/pnas.0704665104; Burrell AS, 2015, J HUM EVOL, V79, P35, DOI 10.1016/j.jhevol.2014.10.015; Campos PF, 2012, METHODS MOL BIOL, V840, P81, DOI 10.1007/978-1-61779-516-9_11; Do HD, 2012, ONCOTARGET, V3, P546; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; Fu LM, 2012, BIOINFORMATICS, V28, P3150, DOI 10.1093/bioinformatics/bts565; Fulton TL, 2012, ANN ANAT, V194, P52, DOI 10.1016/j.aanat.2011.02.017; Gansauge MT, 2013, NAT PROTOC, V8, P737, DOI 10.1038/nprot.2013.038; Grinnell Joseph, 1910, Popular Science Monthly, V77, P163; HIGUCHI R, 1984, NATURE, V312, P282, DOI 10.1038/312282a0; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Jonsson H, 2013, BIOINFORMATICS, V29, P1682, DOI 10.1093/bioinformatics/btt193; Jonsson KA, 2008, MOL PHYLOGENET EVOL, V47, P221, DOI 10.1016/j.ympev.2008.01.017; Jonsson KA, 2011, P NATL ACAD SCI USA, V108, P2328, DOI 10.1073/pnas.1018956108; Kearney M, 2004, P ROY SOC B-BIOL SCI, V271, P1677, DOI 10.1098/rspb.2004.2771; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Kerick M, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-68; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Loudig O, 2011, HUM PATHOL, V42, P1911, DOI 10.1016/j.humpath.2011.02.011; Miller MR, 2007, GENOME RES, V17, P240, DOI 10.1101/gr.5681207; Moyle RG, 2013, MOL PHYLOGENET EVOL, V66, P1060, DOI 10.1016/j.ympev.2012.11.024; O'Keefe K, 2009, MOL ECOL, V18, P4775, DOI 10.1111/j.1365-294X.2009.04382.x; Paireder S, 2013, ANAL BIOCHEM, V439, P152, DOI 10.1016/j.ab.2013.04.006; Quach Nancy, 2004, BMC Clin Pathol, V4, P1, DOI 10.1186/1472-6890-4-1; Quail MA, 2012, NAT METHODS, V9, P10, DOI 10.1038/nmeth.1814; Rasmussen M, 2010, NATURE, V463, P757, DOI 10.1038/nature08835; Ristaino JB, 2001, NATURE, V411, P695, DOI 10.1038/35079606; Rowe KC, 2011, MOL ECOL RESOUR, V11, P1082, DOI 10.1111/j.1755-0998.2011.03052.x; Sawyer S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034131; Scheinin I, 2014, GENOME RES, V24, P2022, DOI 10.1101/gr.175141.114; Simpson JT, 2009, GENOME RES, V19, P1117, DOI 10.1101/gr.089532.108; Singhal S, 2013, MOL ECOL RESOUR, V13, P403, DOI 10.1111/1755-0998.12077; Steinau M, 2011, J MOL DIAGN, V13, P377, DOI 10.1016/j.jmoldx.2011.03.007; Stiller M, 2009, GENOME RES, V19, P1843, DOI 10.1101/gr.095760.109; Stuart BL, 2006, SYST BIODIVERS, V4, P133, DOI 10.1017/S1477200005001891; Wilgenbusch James C, 2003, Curr Protoc Bioinformatics, VChapter 6, DOI 10.1002/0471250953.bi0604s00; Wong SQ, 2014, BMC MED GENOMICS, V7, DOI 10.1186/1755-8794-7-23	45	81	86	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2015	10	10							e0141579	10.1371/journal.pone.0141579	http://dx.doi.org/10.1371/journal.pone.0141579			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU8PC	26505622	Green Published, gold, Green Submitted			2022-12-26	WOS:000363804200087
J	Wang, LY; Ge, L; Wang, L; Morano, JP; Guo, W; Khoshnood, K; Qin, QQ; Ding, ZW; Sun, DY; Liu, XY; Luo, HB; Tillman, J; Cui, Y				Wang, Liyan; Ge, Lin; Wang, Lu; Morano, Jamie P.; Guo, Wei; Khoshnood, Kaveh; Qin, Qianqian; Ding, Zhengwei; Sun, Dingyong; Liu, Xiaoyan; Luo, Hongbing; Tillman, Jonas; Cui, Yan			Causes of Death among AIDS Patients after Introduction of Free Combination Antiretroviral Therapy (cART) in Three Chinese Provinces, 2010-2011	PLOS ONE			English	Article							MORTALITY; HISTORY	Introduction Although AIDS-related deaths have had significant economic and social impact following an increased disease burden internationally, few studies have evaluated the cause of AIDS-related deaths among patients with AIDS on combination anti-retroviral therapy (cART) in China. This study examines the causes of death among AIDS-patients in China and uses a methodology to increase data accuracy compared to the previous studies on AIDS-related mortality in China, that have taken the reported cause of death in the National HIV Registry at face-value. Methods Death certificates/medical records were examined and a cross-sectional survey was conducted in three provinces to verify the causes of death among AIDS patients who died between January 1, 2010 and June 30, 2011. Chi-square analysis was conducted to examine the categorical variables by causes of death and by ART status. Univariate and multivariate logistic regression were used to evaluate factors associated with AIDS-related death versus non-AIDS related death. Results This study used a sample of 1,109 subjects. The average age at death was 44.5 years. AIDS-related deaths were significantly higher than non-AIDS and injury-related deaths. In the sample, 41.9%(465/1109) were deceased within a year of HIV diagnosis and 52.7% (584/1109) of the deceased AIDS patients were not on cART. For AIDS-related deaths (n = 798), statistically significant factors included CD4 count <200 cells/mm(3) at the time of cART initiation (AOR 1.94, 95% CI 1.24-3.05), ART naive (AOR 1.69, 95% CI 1.09-2.61; p = 0.019) and age <39 years (AOR 2.96, 95% CI 1.77-4.96). Conclusion For the AIDS patients that were deceased, only those who initiated cART while at a CD4 count >= 200 cells/mm(3) were less likely to die from AIDS-related causes compared to those who didn't initiate ART at all.	[Wang, Liyan; Ge, Lin; Wang, Lu; Guo, Wei; Qin, Qianqian; Ding, Zhengwei; Cui, Yan] Chinese Ctr Dis Control & Prevent, Div Epidemiol, Natl Ctr AIDS STD Control & Prevent, Beijing, Peoples R China; [Morano, Jamie P.] Univ S Florida, Morsani Coll Med, Div Infect Dis & Int Med, USF Med Int, Tampa, FL USA; [Khoshnood, Kaveh] Yale Univ, Sch Publ Hlth, New Haven, CT USA; [Sun, Dingyong] Henan Ctr Dis Control & Prevent, Henan Ctr AIDS STD Control & Prevent, Shangcai, Henan, Peoples R China; [Liu, Xiaoyan] Jiangsu Ctr Dis Control & Prevent, Jiangsu Ctr AIDS STD Control & Prevent, Nanjing, Jiangsu, Peoples R China; [Luo, Hongbing] Yunnan Ctr Dis Control & Prevent, Yunnan Ctr AIDS STD Control & Prevent, Kunming, Yunnan, Peoples R China; [Tillman, Jonas] Chinese Ctr Dis Control & Prevent, Div Intervent, Natl Ctr AIDS STD Control & Prevent, Beijing, Peoples R China	Chinese Center for Disease Control & Prevention; National Center for AIDS/STD Control & Prevention, Chinese Center for Disease Control & Prevention; State University System of Florida; University of South Florida; Yale University; Jiangsu Provincial Center for Disease Control & Prevention; Chinese Center for Disease Control & Prevention; National Center for AIDS/STD Control & Prevention, Chinese Center for Disease Control & Prevention	Cui, Y (corresponding author), Chinese Ctr Dis Control & Prevent, Div Epidemiol, Natl Ctr AIDS STD Control & Prevent, Beijing, Peoples R China.	ycui@chinaaids.cn	qin, qin x/GXG-6164-2022; Khoshnood, Kaveh/AAX-1402-2020; Qin, Qin/GVT-5910-2022	Khoshnood, Kaveh/0000-0003-2795-0447; 	China National AIDS Programme; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH062294] Funding Source: NIH RePORTER	China National AIDS Programme; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This survey was supported by the China National AIDS Programme. The funding organizations had no role in the development of study design, collection, analysis and interpretation of data, or the final decision to submit the manuscript for publication.	[Anonymous], 2002, VERSION 3 1 DENMARK; [Anonymous], 2010, SPSS COMPUTER PROGRA; Brinkhof MWG, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000066; Brook MG, 2005, HIV MED, V4, P42; Chene G, 2003, LANCET, V362, P679, DOI 10.1016/S0140-6736(03)14229-8; Chihana M, 2012, TROP MED INT HEALTH, V17, pe74, DOI 10.1111/j.1365-3156.2012.02929.x; Cui Y, 2009, CHINESE MED J-PEKING, V122, P2251, DOI 10.3760/cma.j.issn.0366-6999.2009.19.013; Egger M, 2002, LANCET, V360, P119, DOI 10.1016/S0140-6736(02)09411-4; Feng Rui-fang, 2013, Zhonghua Liu Xing Bing Xue Za Zhi, V34, P1237; Gabillard D, 2013, JAIDS-J ACQ IMM DEF, V62, P555, DOI 10.1097/QAI.0b013e3182821821; Guest JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062273; He N, 2005, CELL RES, V15, P825, DOI 10.1038/sj.cr.7290354; Hogg R, 2008, LANCET, V372, P293, DOI 10.1016/S0140-6736(08)61113-7; Huang L, 2014, SOFT SCIENCE OF HEAL, V28, P533; Ledergerber B, 1999, LANCET, V353, P863, DOI 10.1016/S0140-6736(99)01122-8; Ministry of Health People's Republic of China Joint United Nations Programme on HIV/AIDS World Health Organization, 2006, JOINT ASS HIV AIDS E; Ministry of Public Health of China, 2008, CHIN DIAGN CRIT PULM; National writing group, 2012, NATIONAL ANTI VIRAL; Porter K, 2003, LANCET, V362, P1267, DOI 10.1016/S0140-6736(03)14570-9; Qin S, 2014, GUIDE OF CHINA MEDIC, V7, P72; Ruan YH, 2005, CHINESE JOURNAL OF S, V5, P1; Schneider Eileen, 2008, Morbidity and Mortality Weekly Report, V57, P1; Tang HL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096098; UNAIDS, 2013, AIDS EPIDEMIC UPDATE; Verucchi G, 2004, INFECTION, V32, P33, DOI 10.1007/s15010-004-3063-7; Yang H, 2000, CHINESE J AIDS STD P, V6, P254; Zhang FJ, 2011, LANCET INFECT DIS, V11, P516, DOI 10.1016/S1473-3099(11)70097-4; Zhang H, 2014, CHINA HEALTH CARE NU, V5, P2902; Zhang Lei, 2012, Open AIDS J, V6, P163, DOI 10.2174/1874613601206010163	29	3	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2015	10	10							e0139998	10.1371/journal.pone.0139998	http://dx.doi.org/10.1371/journal.pone.0139998			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU8PC	26506621	gold, Green Submitted, Green Published			2022-12-26	WOS:000363804200007
J	Mizutani, R; Imamachi, N; Suzuki, Y; Yoshida, H; Tochigi, N; Oonishi, T; Suzuki, Y; Akimitsu, N				Mizutani, R.; Imamachi, N.; Suzuki, Y.; Yoshida, H.; Tochigi, N.; Oonishi, T.; Suzuki, Y.; Akimitsu, N.			Oncofetal protein IGF2BP3 facilitates the activity of proto-oncogene protein eIF4E through the destabilization of EIF4E-BP2 mRNA	ONCOGENE			English	Article							BINDING PROTEINS; TRANSLATIONAL CONTROL; CANCER; GROWTH; EXPRESSION; PHOSPHORYLATION; PROLIFERATION; ACTIVATION; STABILITY; REGULONS	RNA-binding proteins (RBPs) have important roles in tumorigenesis. Although IGF2BP3, an evolutionally conserved RBP, has been reported as a useful diagnostic marker for various cancers and has been considered a regulator of tumorigenesis, little is known of the function of IGF2BP3 because of lack of information regarding IGF2BP3 target mRNAs. Here, we report the identification of IGF2BP3 target mRNAs and IGF2BP3 function in cancer proliferation. We identified mRNAs with altered expression in IGF2BP3-depleted cells by massive sequencing analysis and IGF2BP3-binding RNAs by immunoprecipitation of IGF2BP3 followed by massive sequencing analysis, resulting in the identification of 110 candidates that are negatively regulated by IGF2BP3. We found that IGF2BP3 destabilized EIF4E-BP2 and MEIS3 mRNAs. Co-immunoprecipitation analysis revealed the interaction between IGF2BP3 and ribonucleases such as XRN2 and exosome component. The retarded proliferation of IGF2BP3-depleted cells was partially rescued by the depletion of EIF4E-BP2, which negatively regulates eukaryotic translation initiation factor 4E (eIF4E), an activator of translation and a well-known proto-oncogene. Consistent with this observation, IGF2BP3 depletion reduced phosphorylated eIF4E, the active form, and translational efficiency of eIF4E target transcripts. Reduction of phosphorylated eIF4E by IGF2BP3 depletion was rescued by EIF4E-BP2 depletion. At last, we found an inverse correlation between the expression level of IGF2BP3 and EIF4E-BP2 in human lung adenocarcinoma tissues. Together, these results suggest that IGF2BP3 promotes eIF4E-mediated translational activation through the reduction of EIF4E-BP2 via mRNA degradation, leading to enhanced cell proliferation. This is the first report demonstrating that IGF2BP3 is an RNA-destabilizing factor. Notably, here we provide the first evidence for the functional linkage between two previously well-known cancer biomarkers, IGF2BP3 and eIF4E.	[Mizutani, R.; Imamachi, N.; Akimitsu, N.] Univ Tokyo, Isotope Sci Ctr, Tokyo, Japan; [Suzuki, Y.; Yoshida, H.; Tochigi, N.] Asahi Gen Hosp, Dept Pathol, Chiba, Japan; [Oonishi, T.] Med Consultat Off Inc, Yokohama, Kanagawa, Japan; [Suzuki, Y.] Univ Tokyo, Grad Sch Frontier Sci, Dept Computat Biol, Kashiwa, Chiba, Japan	University of Tokyo; University of Tokyo	Akimitsu, N (corresponding author), Univ Tokyo, Radioisotope Ctr, Bunkyo Ku, 2-11-16 Yayoi, Tokyo 1130032, Japan.	akimitsu@ric.u-tokyo.ac.jp		Imamachi, Naoto/0000-0002-3503-7589	Research Fellowship of the Japan Society for the Promotion of Science; Ministry of Education, Culture, Sports, Science and Technology of Japan; Funding Program for World-Leading Innovative R&D on Science and Technology of the Japan Society for the Promotion of Science	Research Fellowship of the Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Funding Program for World-Leading Innovative R&D on Science and Technology of the Japan Society for the Promotion of Science	We thank Dr Hiroki Kurihara, Dr Yukiko Kurihara, Dr Hiro-oki Iwakawa and Dr Yukihide Tomari (The University of Tokyo) for helpful supports and fruitful discussions. This work was financially supported by the Research Fellowship of the Japan Society for the Promotion of Science, Grant-in-Aid for Scientific Research, Grant-in-Aid for Scientific Research on Innovative Areas 'Functional machinery for noncoding RNAs' and 'Genome science' from the Ministry of Education, Culture, Sports, Science and Technology of Japan, and The Funding Program for World-Leading Innovative R&D on Science and Technology of the Japan Society for the Promotion of Science.	Avdulov S, 2004, CANCER CELL, V5, P553, DOI 10.1016/j.ccr.2004.05.024; Bell JL, 2013, CELL MOL LIFE SCI, V70, P2657, DOI 10.1007/s00018-012-1186-z; Bhardwaj A, 2013, NUCLEIC ACIDS RES, V41, P5062, DOI 10.1093/nar/gkt189; Bitterman PB, 2014, BIOCHIM BIOPHYS ACTA, V1849, P774; Blackinton JG, 2014, SEMIN CELL DEV BIOL, V34, P44, DOI 10.1016/j.semcdb.2014.05.014; Coleman LJ, 2009, BRIT J CANCER, V100, P1393, DOI 10.1038/sj.bjc.6605044; Cook KB, 2011, NUCLEIC ACIDS RES, V39, pD301, DOI 10.1093/nar/gkq1069; Dowling RJO, 2010, SCIENCE, V328, P1172, DOI 10.1126/science.1187532; Farina KL, 2003, J CELL BIOL, V160, P77, DOI 10.1083/jcb.200206003; Fedele M, 2010, MOL CELL ENDOCRINOL, V326, P19, DOI 10.1016/j.mce.2010.03.019; Findeis-Hosey JJ, 2010, HUM PATHOL, V41, P477, DOI 10.1016/j.humpath.2009.10.004; Furic L, 2010, P NATL ACAD SCI USA, V107, P14134, DOI 10.1073/pnas.1005320107; Graff JR, 1997, BIOCHEM BIOPH RES CO, V240, P15, DOI 10.1006/bbrc.1997.7592; Hammerle M, 2013, HEPATOLOGY, V58, P1703, DOI 10.1002/hep.26537; Hsieh AC, 2010, CANCER CELL, V17, P249, DOI 10.1016/j.ccr.2010.01.021; Huttelmaier S, 2005, NATURE, V438, P512, DOI 10.1038/nature04115; Hwang YS, 2012, CARCINOGENESIS, V33, P2135, DOI 10.1093/carcin/bgs258; Imamachi N, 2014, METHODS, V67, P55, DOI 10.1016/j.ymeth.2013.07.014; Jeng YM, 2008, HEPATOLOGY, V48, P1118, DOI 10.1002/hep.22459; Jonson L, 2014, CELL REP, V7, P539, DOI 10.1016/j.celrep.2014.03.015; Kanematsu S, 2014, GENE, V533, P520, DOI 10.1016/j.gene.2013.08.005; Keene JD, 2007, NAT REV GENET, V8, P533, DOI 10.1038/nrg2111; Kevil CG, 1996, INT J CANCER, V65, P785, DOI 10.1002/(SICI)1097-0215(19960315)65:6<785::AID-IJC14>3.0.CO;2-3; Kim YY, 2009, CANCER RES, V69, P8455, DOI 10.1158/0008-5472.CAN-09-1923; Liao BS, 2005, J BIOL CHEM, V280, P18517, DOI 10.1074/jbc.M500270200; Lukong KE, 2008, TRENDS GENET, V24, P416, DOI 10.1016/j.tig.2008.05.004; Martineau Y, 2013, ONCOGENE, V32, P671, DOI 10.1038/onc.2012.116; Moore MJ, 2005, SCIENCE, V309, P1514, DOI 10.1126/science.1111443; Muller D, 2013, TRANSLATION, V1, DOI 10.4161/trla.25819; MuellerPillasch F, 1997, ONCOGENE, V14, P2729, DOI 10.1038/sj.onc.1201110; Mukherjee N, 2011, MOL CELL, V43, P327, DOI 10.1016/j.molcel.2011.06.007; Musunuru K, 2003, TRENDS CARDIOVAS MED, V13, P188, DOI 10.1016/S1050-1738(03)00075-6; Nathan CA, 1997, ONCOGENE, V15, P1087, DOI 10.1038/sj.onc.1201272; Nielsen J, 1999, MOL CELL BIOL, V19, P1262; Richter JD, 2005, NATURE, V433, P477, DOI 10.1038/nature03205; She QB, 2010, CANCER CELL, V18, P39, DOI 10.1016/j.ccr.2010.05.023; Sonenberg N, 2007, MOL CELL, V28, P721, DOI 10.1016/j.molcel.2007.11.018; Stohr N, 2006, J CELL BIOL, V175, P527, DOI 10.1083/jcb.200608071; Sutandy FX, 2015, CRIT REV BIOTECHNOL, V20, P1; Suvasini R, 2011, J BIOL CHEM, V286, P25882, DOI 10.1074/jbc.M110.178012; Tani H, 2012, GENOME RES, V22, P947, DOI 10.1101/gr.130559.111; Topisirovic I, 2011, COLD SH Q B, V76, P355, DOI 10.1101/sqb.2011.76.010785; Vargas TR, 2014, ONCOGENE, V33, P2866, DOI 10.1038/onc.2013.252; Vikesaa J, 2006, EMBO J, V25, P1456, DOI 10.1038/sj.emboj.7601039; Wagner M, 2003, GASTROENTEROLOGY, V124, P1901, DOI 10.1016/S0016-5085(03)00402-5; Wei QZ, 2014, HUM PATHOL, V45, P2218, DOI 10.1016/j.humpath.2014.07.006; Weidensdorfer D, 2009, RNA, V15, P104, DOI 10.1261/rna.1175909; Yuan RH, 2009, ANN SURG ONCOL, V16, P1711, DOI 10.1245/s10434-009-0446-0; Zhao J, 2010, MOL CELL, V40, P939, DOI 10.1016/j.molcel.2010.12.011	49	36	36	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 7	2016	35	27					3495	3502		10.1038/onc.2015.410	http://dx.doi.org/10.1038/onc.2015.410			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DR0UD	26522719				2022-12-26	WOS:000379621500002
J	Metzig, MO; Fuchs, D; Tagscherer, KE; Grone, HJ; Schirmacher, P; Roth, W				Metzig, M. Oliver; Fuchs, D.; Tagscherer, K. E.; Groene, H-J; Schirmacher, P.; Roth, W.			Inhibition of caspases primes colon cancer cells for 5-fluorouracil-induced TNF-alpha-dependent necroptosis driven by RIP1 kinase and NF-kappa B	ONCOGENE			English	Article							APOPTOSIS RESISTANCE; DRUG-RESISTANCE; DEATH; ACTIVATION; INDUCTION; CLEAVAGE; NECROSIS; IDENTIFICATION; RIPOPTOSOME; IAPS	Resistance towards the drug 5-fluorouracil (5-FU) is a key challenge in the adjuvant chemotherapy of colorectal cancer (CRC), and novel targeted approaches are required to improve the therapeutic outcome. Necroptosis is a recently discovered form of programmed cell death, which depends on receptor interacting protein 1 (RIP1) and particularly occurs under caspase-deficient conditions. The targeted induction of necroptosis represents a promising strategy to overcome apoptosis resistance in cancer. The aim of this study was to systematically explore the usage of pan-caspase inhibitors to sensitize resistant CRC cells for 5-FU. We found that pan-caspase inhibitors facilitated 5-FU-induced necroptosis, which was mediated by autocrine secretion of tumor necrosis factor alpha (TNF-alpha). TNF-alpha production was driven by nuclear factor kappa B (NF-kappa B) and required RIP1 kinase. In vivo xenograft experiments showed that the novel pan-caspase inhibitor IDN-7314 in combination with 5-FU synergistically blocked tumor growth. Ex vivo experiments with fresh human CRC tissue specimens further indicated that a subgroup of patients could benefit from combinatory treatment. Thereby, elevated levels of secreted TNF-alpha and expression of components of the necroptotic pathway might help to predict the sensitivity to pro-necroptotic therapies. Together, our results shed new light on the molecular regulation of necroptosis by NF-kappa B and RIP1. Moreover, we identify necroptotic cell death as an important effector mechanism of 5-FU-mediated anti-tumoral activity. On the basis of this study, we propose pan-caspase inhibitors as a novel approach in the adjuvant chemotherapy of CRC.	[Metzig, M. Oliver; Fuchs, D.; Schirmacher, P.; Roth, W.] Heidelberg Univ, Inst Pathol, Heidelberg, Germany; [Metzig, M. Oliver; Fuchs, D.; Tagscherer, K. E.; Roth, W.] German Canc Res Ctr, Mol Tumor Pathol, Heidelberg, Germany; [Groene, H-J] German Canc Res Ctr, Cellular & Mol Pathol, Heidelberg, Germany; [Roth, W.] Univ Med Ctr Mainz, Inst Pathol, Langenbeckstr 1, D-55131 Mainz, Germany	Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Johannes Gutenberg University of Mainz	Roth, W (corresponding author), Univ Med Ctr Mainz, Inst Pathol, Langenbeckstr 1, D-55131 Mainz, Germany.	Wilfried.Roth@unimedizin-mainz.de	Tagscherer, Katrin/AAS-3809-2021	Tagscherer, Katrin/0000-0002-0657-6399	Manfred-Stolte-Foundation; Rahel Goitein-Straus Program of the Medical Faculty of Heidelberg	Manfred-Stolte-Foundation; Rahel Goitein-Straus Program of the Medical Faculty of Heidelberg	We are grateful to Marina Gernold, Martina Keith, Katarina Duglova and Scott Oliver for excellent technical assistance. We thank Sylvia Kaden for technical assistance during electron microscopy. We thank the tissue bank of the Center for National Tumor Disease (NCT, Heidelberg, Germany) for providing CRC tissues, and Sarah MeBnard and David Jansen for technical assistance during immunohistochemistry. This study was supported by a grant from the Manfred-Stolte-Foundation to WR, and by the Rahel Goitein-Straus Program of the Medical Faculty of Heidelberg (fellowship to MOM).	Biton S, 2011, CELL, V145, P92, DOI 10.1016/j.cell.2011.02.023; Chaudhary PM, 2000, ONCOGENE, V19, P4451, DOI 10.1038/sj.onc.1203812; Christofferson DE, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.64; Christofferson DE, 2014, ANNU REV PHYSIOL, V76, P129, DOI 10.1146/annurev-physiol-021113-170259; Cooks T, 2013, CANCER CELL, V23, P634, DOI 10.1016/j.ccr.2013.03.022; Darding M, 2012, CELL DEATH DIFFER, V19, P58, DOI 10.1038/cdd.2011.163; Degterev A, 2008, NAT CHEM BIOL, V4, P313, DOI 10.1038/nchembio.83; Douillard JY, 2003, ANN ONCOL, V14, P7, DOI 10.1093/annonc/mdg723; Dunai ZA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041945; Fassl A, 2012, ONCOGENE, V31, P4698, DOI 10.1038/onc.2011.615; Feoktistova M, 2011, MOL CELL, V43, P449, DOI 10.1016/j.molcel.2011.06.011; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Festjens N, 2007, CELL DEATH DIFFER, V14, P400, DOI 10.1038/sj.cdd.4402085; Fuchs D, 2015, ONCOGENE, V34, P2753, DOI 10.1038/onc.2014.213; Fulda S, 2014, SEMIN CELL DEV BIOL, V35, P51, DOI 10.1016/j.semcdb.2014.07.002; Grassilli E, 2013, CLIN CANCER RES, V19, P3820, DOI 10.1158/1078-0432.CCR-12-3289; Hagan Suzanne, 2013, EPMA J, V4, P3, DOI 10.1186/1878-5085-4-3; Han WD, 2007, MOL CANCER THER, V6, P1641, DOI 10.1158/1535-7163.MCT-06-0511; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; He SD, 2009, CELL, V137, P1100, DOI 10.1016/j.cell.2009.05.021; Hitomi JI, 2008, CELL, V135, P1311, DOI 10.1016/j.cell.2008.10.044; Jouan-Lanhouet S, 2014, SEMIN CELL DEV BIOL, V35, P2, DOI 10.1016/j.semcdb.2014.08.010; Kaiser WJ, 2013, J BIOL CHEM, V288, P31268, DOI 10.1074/jbc.M113.462341; Kreuzaler P, 2012, NAT REV CANCER, V12, P411, DOI 10.1038/nrc3264; Kroemer G, 2009, CELL DEATH DIFFER, V16, P3, DOI 10.1038/cdd.2008.150; Lamkanfi M, 2006, J CELL BIOL, V173, P165, DOI 10.1083/jcb.200509092; Laukens B, 2011, NEOPLASIA, V13, P971, DOI 10.1593/neo.11610; Lin Y, 1999, GENE DEV, V13, P2514, DOI 10.1101/gad.13.19.2514; Linton SD, 2005, J MED CHEM, V48, P6779, DOI 10.1021/jm050307e; Marshall John L, 2007, Gastrointest Cancer Res, V1, P146; McComb S, 2014, J IMMUNOL, V192, P5671, DOI 10.4049/jimmunol.1303380; Micheau O, 2003, CELL, V114, P181, DOI 10.1016/S0092-8674(03)00521-X; Moretti L, 2009, MOL CANCER THER, V8, P1270, DOI 10.1158/1535-7163.MCT-08-0893; Probst BL, 2010, CELL DEATH DIFFER, V17, P1645, DOI 10.1038/cdd.2010.44; Shiffman ML, 2010, ALIMENT PHARM THER, V31, P969, DOI 10.1111/j.1365-2036.2010.04264.x; Shikama Y, 2003, EUR J IMMUNOL, V33, P1998, DOI 10.1002/eji.200324013; Staal J, 2011, CELL RES, V21, P40, DOI 10.1038/cr.2010.168; Steinhart L, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.320; Sun LM, 2012, CELL, V148, P213, DOI 10.1016/j.cell.2011.11.031; Tenev T, 2011, MOL CELL, V43, P432, DOI 10.1016/j.molcel.2011.06.006; Tournigand C, 2004, J CLIN ONCOL, V22, P229, DOI 10.1200/JCO.2004.05.113; Vanden Berghe T, 2013, METHODS, V61, P117, DOI 10.1016/j.ymeth.2013.02.011; Varfolomeev E, 2007, CELL, V131, P669, DOI 10.1016/j.cell.2007.10.030; Wang WG, 2004, CANCER RES, V64, P8167, DOI 10.1158/0008-5472.CAN-04-0970; Wilson P. M., 2007, CANCER RES, V1, P237; Zhang LQ, 2015, MOL CELL BIOL, V35, P3324, DOI 10.1128/MCB.00692-15; Zhou W, 2014, SEMIN CELL DEV BIOL, V35, P14, DOI 10.1016/j.semcdb.2014.07.013	47	66	66	1	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 30	2016	35	26					3399	3409		10.1038/onc.2015.398	http://dx.doi.org/10.1038/onc.2015.398			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DQ5UI	26522725				2022-12-26	WOS:000379270100005
J	Yue, JC; Ben Messaoud, N; Lopez, JM				Yue, Jicheng; Ben Messaoud, Nabil; Lopez, Jose M.			Hyperosmotic Shock Engages Two Positive Feedback Loops through Caspase-3-dependent Proteolysis of JNK1-2 and Bid	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED APOPTOSIS; SIGNAL-TRANSDUCTION; DEPENDENT APOPTOSIS; POTASSIUM CHANNELS; CALPAIN INHIBITOR; CYTOCHROME-C; CLEAVAGE; PATHWAY; CASPASE; PROTEIN	Hyperosmotic shock induces early calpain activation, Smac/DIABLO release from the mitochondria, and p38/JNK activation in Xenopus oocytes. These pathways regulate late cytochrome c release and caspase-3 activation. Here, we show that JNK1-1 and JNK1-2 are activated early by osmostress, and sustained activation of both isoforms accelerates the apoptotic program. When caspase-3 is activated, JNK1-2 is proteolyzed at Asp-385 increasing the release of cytochrome c and caspase-3 activity, thereby creating a positive feedback loop. Expression of Bcl-x(L) markedly reduces hyperosmotic shock-induced apoptosis. In contrast, expression of Bid induces rapid caspase-3 activation, even in the absence of osmostress, which is blocked by Bcl-xL co-expression. In these conditions a significant amount of Bid in the cytosol is mono-and bi-ubiquitinated. Caspase-3 activation by hyperosmotic shock induces proteolysis of Bid and mono-ubiquitinated Bid at Asp-52 increasing the release of cytochrome c and caspase-3 activation, and thus creating a second positive feedback loop. Revealing the JNK isoforms and the loops activated by osmostress could help to design better treatments for human diseases caused by perturbations in fluid osmolarity.	[Yue, Jicheng; Ben Messaoud, Nabil; Lopez, Jose M.] Univ Autonoma Barcelona, Inst Neurociencies, Dept Bioquim & Biol Mol, Unitat Bioquim,Fac Med, E-08193 Barcelona, Spain	Autonomous University of Barcelona; University of Barcelona	Lopez, JM (corresponding author), Univ Autonoma Barcelona, Inst Neurociencies, Edifici M,Campus Bellaterra, E-08193 Barcelona, Spain.	josemanuel.lopez@uab.cat	Lopez, Jose M/D-1654-2011	Lopez, Jose M/0000-0002-4104-6262	Spanish Ministerio de Economia y Competitividad [BFU2010-15978]	Spanish Ministerio de Economia y Competitividad(Spanish Government)	This work was supported by Spanish Ministerio de Economia y Competitividad Grant BFU2010-15978. The authors declare that they have no conflicts of interest with the contents of this article.	Bagowski CP, 2001, J BIOL CHEM, V276, P1459, DOI 10.1074/jbc.M008050200; Ben Messaoud N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135249; Ben Messaoud N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124482; Bhuyan AK, 2001, CELL DEATH DIFFER, V8, P63, DOI 10.1038/sj.cdd.4400773; Billen LP, 2008, ONCOGENE, V27, pS93, DOI 10.1038/onc.2009.47; Breitschopf K, 2000, J BIOL CHEM, V275, P21648, DOI 10.1074/jbc.M001083200; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; Deng YB, 2003, CELL, V115, P61, DOI 10.1016/S0092-8674(03)00757-8; Desagher S., MOL CELL, V8, P601; Dhanasekaran DN, 2008, ONCOGENE, V27, P6245, DOI 10.1038/onc.2008.301; Enomoto A, 2003, BIOCHEM BIOPH RES CO, V306, P837, DOI 10.1016/S0006-291X(03)01050-7; Esposti MD, 2003, J BIOL CHEM, V278, P15749, DOI 10.1074/jbc.M209208200; Fan Y, 2010, CELL DEATH DIFFER, V17, P534, DOI 10.1038/cdd.2009.185; Kerscher O, 2006, ANNU REV CELL DEV BI, V22, P159, DOI 10.1146/annurev.cellbio.22.010605.093503; Kominami K, 2006, GENES CELLS, V11, P701, DOI 10.1111/j.1365-2443.2006.00983.x; Konig HG, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-7; Lei K, 2003, P NATL ACAD SCI USA, V100, P2432, DOI 10.1073/pnas.0438011100; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; Mandic A, 2002, MOL CELL BIOL, V22, P3003, DOI 10.1128/MCB.22.9.3003-3013.2002; Martianez T, 2009, J BIOL CHEM, V284, P23902, DOI 10.1074/jbc.M109.026054; McDonnell JM, 1999, CELL, V96, P625, DOI 10.1016/S0092-8674(00)80573-5; MCGREW LL, 1989, GENE DEV, V3, P803, DOI 10.1101/gad.3.6.803; Porn-Ares MI, 1998, CELL DEATH DIFFER, V5, P1028, DOI 10.1038/sj.cdd.4400424; Saitoh T., BIOCH BIOPHYS RES CO, V384, P491; Schroeter H, 2003, BIOCHEM J, V372, P359, DOI 10.1042/BJ20030201; Slee EA, 2000, CELL DEATH DIFFER, V7, P556, DOI 10.1038/sj.cdd.4400689; Song JN, 2010, BIOINFORMATICS, V26, P752, DOI 10.1093/bioinformatics/btq043; Srivastava RK, 1999, P NATL ACAD SCI USA, V96, P3775, DOI 10.1073/pnas.96.7.3775; Tait SWG, 2007, J CELL BIOL, V179, P1453, DOI 10.1083/jcb.200707063; Tan KO, 1999, J BIOL CHEM, V274, P23687, DOI 10.1074/jbc.274.34.23687; Thomas D, 2004, CARDIOVASC RES, V64, P467, DOI 10.1016/j.cardiores.2004.07.023; Thomas D, 2001, J PHARMACOL EXP THER, V297, P753; Tsuruta F, 2004, EMBO J, V23, P1889, DOI 10.1038/sj.emboj.7600194; Valentijn AJ, 2004, J BIOL CHEM, V279, P32848, DOI 10.1074/jbc.M313375200; Ventura JJ, 2006, MOL CELL, V21, P701, DOI 10.1016/j.molcel.2006.01.018; Wang K, 1996, GENE DEV, V10, P2859, DOI 10.1101/gad.10.22.2859; Wang KKW, 1998, ARCH BIOCHEM BIOPHYS, V356, P187, DOI 10.1006/abbi.1998.0748; Weston CR, 2007, CURR OPIN CELL BIOL, V19, P142, DOI 10.1016/j.ceb.2007.02.001; Yamamoto K, 1999, MOL CELL BIOL, V19, P8469; Yamanaka H, 2002, EMBO REP, V3, P69, DOI 10.1093/embo-reports/kvf008	40	10	10	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2015	290	51					30375	30389		10.1074/jbc.M115.660506	http://dx.doi.org/10.1074/jbc.M115.660506			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CY9PG	26511318	Green Published, hybrid			2022-12-26	WOS:000366738200016
J	Buck, JR; McKinley, ET; Fu, A; Abel, TW; Thompson, RC; Chambless, L; Watchmaker, JM; Harty, JP; Cooper, MK; Manning, HC				Buck, Jason R.; McKinley, Eliot T.; Fu, Allie; Abel, Ty W.; Thompson, Reid C.; Chambless, Lola; Watchmaker, Jennifer M.; Harty, James P.; Cooper, Michael K.; Manning, H. Charles			Preclinical TSPO Ligand PET to Visualize Human Glioma Xenotransplants: A Preliminary Study	PLOS ONE			English	Article							PROTEIN 18 KDA; BENZODIAZEPINE-RECEPTOR; TRANSLOCATOR PROTEIN; BRAIN-TUMORS; HUMAN ASTROCYTOMAS; HEDGEHOG PATHWAY; EXPRESSION; BINDING; PROLIFERATION; F-18-FDG	Current positron emission tomography (PET) imaging biomarkers for detection of infiltrating gliomas are limited. Translocator protein (TSPO) is a novel and promising biomarker for glioma PET imaging. To validate TSPO as a potential target for molecular imaging of glioma, TSPO expression was assayed in a tumor microarray containing 37 high-grade (III, IV) gliomas. TSPO staining was detected in all tumor specimens. Subsequently, PET imaging was performed with an aryloxyanilide-based TSPO ligand, [F-18]PBR06, in primary orthotopic xenograft models of WHO grade III and IV gliomas. Selective uptake of [F-18]PBR06 in engrafted tumor was measured. Furthermore, PET imaging with [F-18] PBR06 demonstrated infiltrative glioma growth that was undetectable by traditional magnetic resonance imaging (MRI). Preliminary PET with [F-18] PBR06 demonstrated a preferential tumor-to-normal background ratio in comparison to 2-deoxy-2-[F-18] fluoro-D-glucose ([F-18] FDG). These results suggest that TSPO PET imaging with such high-affinity radiotracers may represent a novel strategy to characterize distinct molecular features of glioma growth, as well as better define the extent of glioma infiltration for therapeutic purposes.	[Buck, Jason R.; Fu, Allie; Watchmaker, Jennifer M.; Manning, H. Charles] Vanderbilt Univ, Med Ctr, VUIIS, Nashville, TN 37235 USA; [McKinley, Eliot T.] Vanderbilt Univ, Med Ctr, Dept Med, Nashville, TN 37235 USA; [Abel, Ty W.] Vanderbilt Univ, Med Ctr, Dept Pathol, Nashville, TN 37235 USA; [Thompson, Reid C.; Cooper, Michael K.; Manning, H. Charles] Vanderbilt Univ, Med Ctr, VICC, Nashville, TN 37235 USA; [Thompson, Reid C.; Chambless, Lola; Manning, H. Charles] Vanderbilt Univ, Med Ctr, Dept Neurol Surg, Nashville, TN 37235 USA; [Watchmaker, Jennifer M.; Manning, H. Charles] Vanderbilt Univ, Med Ctr, Program Chem & Phys Biol, Nashville, TN 37235 USA; [Harty, James P.; Manning, H. Charles] Vanderbilt Univ, Med Ctr, Dept Radiol & Radiol Sci, Nashville, TN 37235 USA; [Cooper, Michael K.] Vet Affairs Tennessee Valley Healthcare Syst, Neurol Serv, Nashville, TN USA; [Cooper, Michael K.] Vanderbilt Univ, Med Ctr, Dept Neurol, Nashville, TN 37235 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System; Vanderbilt University	Manning, HC (corresponding author), Vanderbilt Univ, Med Ctr, VUIIS, 221 Kirkland Hall, Nashville, TN 37235 USA.	henry.c.manning@vanderbilt.edu			National Cancer Institute (NCI) [K25 CA127349, R01 CA163806, R25 CA092043, P50 CA128323]; NIGMS [T32 GM07347]; Department of Veterans Affairs, Biomedical Laboratory Research and Development grant [1 I01 BX000744-01]; Kleberg Foundation; NATIONAL CANCER INSTITUTE [P50CA128323, F30CA196087, R01CA163806, R25CA092043, K25CA127349] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [T32EB014841] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007347] Funding Source: NIH RePORTER	National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Department of Veterans Affairs, Biomedical Laboratory Research and Development grant; Kleberg Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work received funding from the National Cancer Institute (NCI): K25 CA127349 (JB, EM, AF, JW, JH, HM), R01 CA163806 (JB, EM, AF, HM), R25 CA092043, and P50 CA128323 (EM); NIGMS T32 GM07347 (JW), Department of Veterans Affairs, Biomedical Laboratory Research and Development grant 1 I01 BX000744-01 (MC), and the Kleberg Foundation, www.klebergfoundation.org (HM). The contents do not represent the views of the Department of Veterans Affairs or the United States Government.	Batarseh A, 2010, MOL CELL ENDOCRINOL, V327, P1, DOI 10.1016/j.mce.2010.06.013; Batarseh A, 2010, BIOCHEMISTRY-US, V49, P4766, DOI 10.1021/bi100020e; BLACK KL, 1989, J NEUROSURG, V71, P113, DOI 10.3171/jns.1989.71.1.0113; Buck JR, 2011, J NUCL MED, V52, P107, DOI 10.2967/jnumed.110.081703; Chen MK, 2008, PHARMACOL THERAPEUT, V118, P1, DOI 10.1016/j.pharmthera.2007.12.004; Chen W, 2005, J NUCL MED, V46, P945; Cheung YY, 2014, BIOORG MED CHEM LETT, V24, P4466, DOI 10.1016/j.bmcl.2014.07.091; CORNU P, 1992, ACTA NEUROCHIR, V119, P146, DOI 10.1007/BF01541799; Dandekar M, 2007, J NUCL MED, V48, P602, DOI 10.2967/jnumed.106.036608; Dhermain FG, 2010, LANCET NEUROL, V9, P906, DOI 10.1016/S1474-4422(10)70181-2; Fueger BJ, 2006, J NUCL MED, V47, P999; Goldman S, 2011, METHODS MOL BIOL, V727, P291, DOI 10.1007/978-1-61779-062-1_16; Hardwick M, 1999, CANCER RES, V59, P831; JUNCK L, 1989, ANN NEUROL, V26, P752, DOI 10.1002/ana.410260611; la Fougere C, 2011, NEURO-ONCOLOGY, V13, P806, DOI 10.1093/neuonc/nor054; MIETTINEN H, 1995, CANCER RES, V55, P2691; Nihashi T, 2013, AM J ROENTGENOL, V200, pW654, DOI 10.2214/AJR.12.9168; OLSON JMM, 1988, CANCER RES, V48, P5837; Ouwerkerk R, 2007, BREAST CANCER RES TR, V106, P151, DOI 10.1007/s10549-006-9485-4; Papadopoulos V, 2006, TRENDS PHARMACOL SCI, V27, P402, DOI 10.1016/j.tips.2006.06.005; PAPPATA S, 1991, J NUCL MED, V32, P1608; Pirotte B, 2004, J NUCL MED, V45, P1293; Powell AE, 2014, AM J PHYSIOL-GASTR L, V307, pG16, DOI 10.1152/ajpgi.00358.2013; Santra A, 2011, NEURORADIOLOGY, V53, P1017, DOI 10.1007/s00234-011-0898-3; Sarangi A, 2009, ONCOGENE, V28, P3468, DOI 10.1038/onc.2009.208; Shu Q, 2008, STEM CELLS, V26, P1414, DOI 10.1634/stemcells.2007-1009; STAROSTARUBINSTEIN S, 1987, P NATL ACAD SCI USA, V84, P891, DOI 10.1073/pnas.84.3.891; Su ZJ, 2015, J NUCL MED, V56, P512, DOI 10.2967/jnumed.114.151621; Tang DW, 2014, MOL IMAGING BIOL, V16, P813, DOI 10.1007/s11307-014-0743-2; Tang DW, 2013, J MED CHEM, V56, P3429, DOI 10.1021/jm4001874; Tang DW, 2012, J NUCL MED, V53, P287, DOI 10.2967/jnumed.111.095653; Valadez JG, 2013, CANCER LETT, V328, P297, DOI 10.1016/j.canlet.2012.10.002; Vlodavsky E, 2007, J NEURO-ONCOL, V81, P1, DOI 10.1007/s11060-006-9199-9; Weissleder R, 2008, NATURE, V452, P580, DOI 10.1038/nature06917; Zhang H, 2014, EUR J RADIOL, V83, P2181, DOI 10.1016/j.ejrad.2014.09.018	35	18	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2015	10	10							e0141659	10.1371/journal.pone.0141659	http://dx.doi.org/10.1371/journal.pone.0141659			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0EH	26517124	Green Published, gold, Green Submitted			2022-12-26	WOS:000363920800064
J	Oduor, AMO; Stift, M; van Kleunen, M				Oduor, Ayub M. O.; Stift, Marc; van Kleunen, Mark			The Interaction between Root Herbivory and Competitive Ability of Native and Invasive-Range Populations of Brassica nigra	PLOS ONE			English	Article							ENEMY RELEASE; NORTH-AMERICAN; PLANT; EVOLUTION; DEFENSE; SUCCESS; GROWTH; METAANALYSIS; SPECIALIST; HYPOTHESIS	The evolution of increased competitive ability (EICA) hypothesis predicts that escape from intense herbivore damage may enable invasive plants to evolve higher competitive ability in the invasive range. Below-ground root herbivory can have a strong impact on plant performance, and invasive plants often compete with multiple species simultaneously, but experimental approaches in which EICA predictions are tested with root herbivores and in a community setting are rare. Here, we used Brassica nigra plants from eight invasive- and seven native-range populations to test whether the invasive-range plants have evolved increased competitive ability when competing with Achillea millefolium and with a community (both with and without A. millefolium). Further, we tested whether competitive interactions depend on root herbivory on B. nigra by the specialist Delia radicum. Without the community, competition with A. millefolium reduced biomass of invasive-but not of nativerange B. nigra. With the community, invasive-range B. nigra suffered less than native-range B. nigra. Although the overall effect of root herbivory was not significant, it reduced the negative effect of the presence of the community. The community produced significantly less biomass when competing with B. nigra, irrespective of the range of origin, and independent of the presence of A. millefolium. Taken together, these results offer no clear support for the EICA hypothesis. While native-range B. nigra plants appear to be better in dealing with a single competitor, the invasive-range plants appear to be better in dealing with a more realistic multi-species community. Possibly, this ability of tolerating multiple competitors simultaneously has contributed to the invasion success of B. nigra in North America.	[Oduor, Ayub M. O.; Stift, Marc; van Kleunen, Mark] Univ Konstanz, Dept Biol, Ecol, D-78457 Constance, Germany	University of Konstanz	Oduor, AMO (corresponding author), Univ Konstanz, Dept Biol, Ecol, Univ Str 10, D-78457 Constance, Germany.	aoduor02@gmail.com	van Kleunen, Mark/B-3769-2009; Stift, Marc/H-4371-2019	van Kleunen, Mark/0000-0002-2861-3701; Stift, Marc/0000-0001-7801-9498	Georg Forster Research Fellowship programme of the Alexander von Humboldt Foundation [3.4-KEN/1148979]	Georg Forster Research Fellowship programme of the Alexander von Humboldt Foundation(Alexander von Humboldt Foundation)	The authors acknowledge financial support from the Georg Forster Research Fellowship programme of the Alexander von Humboldt Foundation (grant number 3.4-KEN/1148979 STP) to A.M.O. Oduor.	BAZZAZ FA, 1987, BIOSCIENCE, V37, P58, DOI 10.2307/1310178; BELL DT, 1973, AM MIDL NAT, V90, P277, DOI 10.2307/2424453; Bezemer TM, 2005, TRENDS ECOL EVOL, V20, P617, DOI 10.1016/j.tree.2005.08.006; Biron DG, 2003, ANN ENTOMOL SOC AM, V96, P245, DOI 10.1603/0013-8746(2003)096[0245:IAIVOT]2.0.CO;2; Blair AC, 2004, ECOLOGY, V85, P3035, DOI 10.1890/04-0341; BLOSSEY B, 1995, J ECOL, V83, P887, DOI 10.2307/2261425; Bossdorf O, 2004, ECOL LETT, V7, P346, DOI 10.1111/j.1461-0248.2004.00583.x; Bossdorf O, 2005, OECOLOGIA, V144, P1, DOI 10.1007/s00442-005-0070-z; BOURDOT GW, 1984, NEW PHYTOL, V97, P653, DOI 10.1111/j.1469-8137.1984.tb03629.x; Buschmann H, 2005, J ECOL, V93, P322, DOI 10.1111/j.1365-2745.2005.00991.x; Cahill JF, 2005, J ECOL, V93, P958, DOI 10.1111/j.1365-2745.2005.01013.x; Callaway RM, 1997, ECOLOGY, V78, P1958, DOI 10.1890/0012-9658(1997)078[1958:CAFASA]2.0.CO;2; Callaway RM, 2000, SCIENCE, V290, P521, DOI 10.1126/science.290.5491.521; Catford JA, 2009, DIVERS DISTRIB, V15, P22, DOI 10.1111/j.1472-4642.2008.00521.x; Colautti RI, 2004, ECOL LETT, V7, P721, DOI 10.1111/j.1461-0248.2004.00616.x; Deck A, 2013, ECOL EVOL, V3, P3663, DOI 10.1002/ece3.716; Dixon PL, 2004, CAN ENTOMOL, V136, P427; Dlugosch KM, 2008, MOL ECOL, V17, P431, DOI 10.1111/j.1365-294X.2007.03538.x; Doorduin LJ, 2011, PHYTOCHEM REV, V10, P99, DOI 10.1007/s11101-010-9195-8; FEENY P, 1982, BIOCHEM SYST ECOL, V10, P23, DOI 10.1016/0305-1978(82)90047-3; Felker-Quinn E, 2013, ECOL EVOL, V3, P739, DOI 10.1002/ece3.488; GOLDBERG DE, 1991, J ECOL, V79, P1013, DOI 10.2307/2261095; GOLDBERG DE, 1987, J ECOL, V75, P1131, DOI 10.2307/2260318; Gruntman M, 2014, BIOL INVASIONS, V16, P141, DOI 10.1007/s10530-013-0509-9; He WM, 2009, OECOLOGIA, V159, P803, DOI 10.1007/s00442-008-1234-4; Heard MJ, 2013, ECOL LETT, V16, P206, DOI 10.1111/ele.12030; HERMS DA, 1992, Q REV BIOL, V67, P283, DOI 10.1086/417659; Jones T, 2006, PLANT ECOL, V184, P245, DOI 10.1007/s11258-005-9070-7; Joshi J, 2005, ECOL LETT, V8, P704, DOI 10.1111/j.1461-0248.2005.00769.x; Joshi S, 2014, ANN BOT-LONDON, V114, P1761, DOI 10.1093/aob/mcu199; KEDDY PA, 1994, J ECOL, V82, P635, DOI 10.2307/2261270; Keser LH, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00273; Lankau RA, 2008, AM NAT, V171, P150, DOI 10.1086/524959; Leger EA, 2003, ECOL LETT, V6, P257, DOI 10.1046/j.1461-0248.2003.00423.x; Liu H, 2006, BIOL INVASIONS, V8, P1535, DOI 10.1007/s10530-005-5845-y; McKenney JL, 2007, PLANT ECOL, V193, P293, DOI 10.1007/s11258-007-9268-y; Metlen KL, 2015, BIOL INVASIONS, V17, P1227, DOI 10.1007/s10530-014-0790-2; Muller-Scharer H, 2004, TRENDS ECOL EVOL, V19, P417, DOI 10.1016/j.tree.2004.05.010; Oduor AMO, 2015, BIOL INVASIONS, V17, P2447, DOI 10.1007/s10530-015-0888-1; Oduor AMO, 2013, NEW PHYTOL, V200, P986, DOI 10.1111/nph.12429; Oduor AMO, 2013, ECOLOGY, V94, P2288, DOI 10.1890/12-2021.1; Oduor AMO, 2011, NEW PHYTOL, V191, P536, DOI 10.1111/j.1469-8137.2011.03685.x; OUBORG NJ, 1995, J ECOL, V83, P369, DOI 10.2307/2261591; Pickering C, 2007, MT RES DEV, V27, P359, DOI 10.1659/mrd.0805; Pinheiro J, 2007, RC TEAM NLME LINEAR; R Core Team, 2021, R LANGUAGE ENV STAT; Ridenour WM, 2008, ECOL MONOGR, V78, P369, DOI 10.1890/06-1926.1; Rius M, 2014, TRENDS ECOL EVOL, V29, P233, DOI 10.1016/j.tree.2014.02.003; SHIPLEY B, 1992, AM NAT, V139, P467, DOI 10.1086/285339; Siemens DH, 2003, EVOL ECOL, V17, P247, DOI 10.1023/A:1025517229934; Stastny M, 2005, J ECOL, V93, P27, DOI 10.1111/j.1365-2745.2004.00962.x; van Dam NM, 2012, AOB PLANTS, DOI 10.1093/aobpla/pls021; van Kleunen M, 2008, BASIC APPL ECOL, V9, P213, DOI 10.1016/j.baae.2007.03.006; van Kleunen M, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.1487; van Kleunen M, 2014, BASIC APPL ECOL, V15, P1, DOI 10.1016/j.baae.2013.10.006; van Kleunen M, 2010, ECOL LETT, V13, P235, DOI 10.1111/j.1461-0248.2009.01418.x; Westman AL, 1999, EUPHYTICA, V109, P85, DOI 10.1023/A:1003637814963; Willis AJ, 1999, OECOLOGIA, V120, P632, DOI 10.1007/s004420050899; Zheng YL, 2015, NEW PHYTOL, V205, P1350, DOI 10.1111/nph.13135; Zou JW, 2008, BIOL INVASIONS, V10, P291, DOI 10.1007/s10530-007-9130-0; Zuur Alain F., 2009, P1; Zvereva EL, 2012, OECOLOGIA, V169, P441, DOI 10.1007/s00442-011-2210-y	62	7	7	0	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2015	10	10							e0141857	10.1371/journal.pone.0141857	http://dx.doi.org/10.1371/journal.pone.0141857			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0EH	26517125	Green Published, Green Submitted, gold			2022-12-26	WOS:000363920800088
J	Peterson, SM; Pack, TF; Caron, MG				Peterson, Sean M.; Pack, Thomas F.; Caron, Marc G.			Receptor, Ligand and Transducer Contributions to Dopamine D2 Receptor Functional Selectivity	PLOS ONE			English	Article							MU-OPIOID RECEPTOR; BETA-ARRESTIN; G-PROTEIN; BIASED AGONISM; CRYSTAL-STRUCTURE; DYNAMIC PROCESS; COMPLEX; INTERNALIZATION; MODULATION; ANTAGONISM	Functional selectivity (or biased agonism) is a property exhibited by some G protein-coupled receptor (GPCR) ligands, which results in the modulation of a subset of a receptor's signaling capabilities and more precise control over complex biological processes. The dopamine D2 receptor (D2R) exhibits pleiotropic responses to the biogenic amine dopamine (DA) to mediate complex central nervous system functions through activation of G proteins and beta-arrestins. D2R is a prominent therapeutic target for psychological and neurological disorders in which DA biology is dysregulated and targeting D2R with functionally selective drugs could provide a means by which pharmacotherapies could be developed. However, factors that determine GPCR functional selectivity in vivo may be multiple with receptors, ligands and transducers contributing to the process. We have recently described a mutagenesis approach to engineer biased D2R mutants in which G protein-dependent ((D2R)-D-[Gprot]) and beta-arrestin-dependent signaling ((D2R)-D-[beta arr]) were successfully separated (Peterson, et al. PNAS, 2015). Here, permutations of these mutants were used to identify critical determinants of the D2R signaling complex that impart signaling bias in response to the natural or synthetic ligands. Critical residues identified in generating (D2R)-D-[Gprot] and (D2R)-D-[beta arr] conferred control of partial agonism at G protein and/or beta-arrestin activity. Another set of mutations that result in G protein bias was identified that demonstrated that full agonists can impart unique activation patterns, and provided further credence to the concept of ligand texture. Finally, the contributions and interplay between different transducers indicated that G proteins are not aberrantly activated, and that receptor kinase and beta-arrestin activities are inextricably linked. These data provide a thorough elucidation of the feasibility and malleability of D2R functional selectivity and point to means by which novel in vivo therapies could be modeled.	[Peterson, Sean M.; Pack, Thomas F.; Caron, Marc G.] Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA; [Caron, Marc G.] Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA; [Caron, Marc G.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA	Duke University; Duke University; Duke University	Caron, MG (corresponding author), Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA.	marc.caron@dm.duke.edu		Peterson, Sean/0000-0003-4873-0283; Pack, Thomas/0000-0002-1240-8324	National Institutes of Health [5R37MH073853]; Ruth K. Broad Biomedical Research Foundation; Pall Family Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH073853] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ruth K. Broad Biomedical Research Foundation; Pall Family Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The authors wish to thank Drs. Bernard Masri, Nikhil Urs, Angela Dawn Wilkins, Olivier Lichtarge, and Lawrence Barak for helpful discussions during the course of this work. This work was supported in part by grants from the National Institutes of Health grant 5R37MH073853 to MGC. TFP is supported by an award from the Ruth K. Broad Biomedical Research Foundation. The continued support of the Pall Family Foundation is greatly appreciated. The expert technical assistance of Yushi Bai and Caroline Ray is also greatly appreciated.	Allen JA, 2011, P NATL ACAD SCI USA, V108, P18488, DOI 10.1073/pnas.1104807108; Barak LS, 2012, BIOCHEMISTRY-US, V51, P1114, DOI 10.1021/bi201308s; Beaulieu JM, 2011, PHARMACOL REV, V63, P182, DOI 10.1124/pr.110.002642; Beaulieu JM, 2005, CELL, V122, P261, DOI 10.1016/j.cell.2005.05.012; Bohn LM, 1999, SCIENCE, V286, P2495, DOI 10.1126/science.286.5449.2495; Chien EYT, 2010, SCIENCE, V330, P1091, DOI 10.1126/science.1197410; Clayton CC, 2014, J BIOL CHEM, V289, P33663, DOI 10.1074/jbc.M114.605378; Conroy JL, 2015, ACS CHEM NEUROSCI, V6, P681, DOI 10.1021/acschemneuro.5b00020; Evron T, 2014, J BIOL CHEM, V289, P33442, DOI 10.1074/jbc.M114.581397; Felker GM, 2015, JACC-HEART FAIL, V3, P193, DOI 10.1016/j.jchf.2014.09.008; Free RB, 2014, MOL PHARMACOL, V86, P96, DOI 10.1124/mol.113.090563; Gesty-Palmer D, 2013, MOL ENDOCRINOL, V27, P296, DOI 10.1210/me.2012-1091; Kang YY, 2015, NATURE, V523, P561, DOI 10.1038/nature14656; Katritch V, 2014, TRENDS BIOCHEM SCI, V39, P233, DOI 10.1016/j.tibs.2014.03.002; Kenakin T, 2013, NAT REV DRUG DISCOV, V12, P205, DOI 10.1038/nrd3954; Kenakin T, 2013, BRIT J PHARMACOL, V168, P554, DOI 10.1111/j.1476-5381.2012.02223.x; Kenakin TP, 2012, BRIT J PHARMACOL, V165, P1659, DOI 10.1111/j.1476-5381.2011.01749.x; Kenakin TP, 2009, NAT REV DRUG DISCOV, V8, P617, DOI 10.1038/nrd2838; Kommaddi RP, 2013, PROG MOL BIOL TRANSL, V118, P175, DOI 10.1016/B978-0-12-394440-5.00007-3; Kruse AC, 2013, NATURE, V504, P101, DOI 10.1038/nature12735; Lan HX, 2009, MOL PHARMACOL, V75, P113, DOI 10.1124/mol.108.050534; Lane JR, 2013, TRENDS PHARMACOL SCI, V34, P59, DOI 10.1016/j.tips.2012.10.003; Laporte SA, 1999, P NATL ACAD SCI USA, V96, P3712, DOI 10.1073/pnas.96.7.3712; Leftowitz RJ, 2005, SCIENCE, V308, P512, DOI 10.1126/science.1109237; Li LY, 2015, J BIOL CHEM, V290, P10775, DOI 10.1074/jbc.M115.644773; Luttrell LM, 1999, SCIENCE, V283, P655, DOI 10.1126/science.283.5402.655; Lymperopoulos A, 2009, P NATL ACAD SCI USA, V106, P5825, DOI 10.1073/pnas.0811706106; Manglik A, 2015, CELL, V161, P1101, DOI 10.1016/j.cell.2015.04.043; Masri B, 2008, P NATL ACAD SCI USA, V105, P13656, DOI 10.1073/pnas.0803522105; Massink A, 2015, MOL PHARMACOL, V87, P305, DOI 10.1124/mol.114.095737; Maudsley S, 2015, MOL PHARMACOL, V87, P706, DOI 10.1124/mol.114.095224; Moller D, 2014, J MED CHEM, V57, P4861, DOI 10.1021/jm5004039; NEVE KA, 1991, MOL PHARMACOL, V39, P733; Nobles KN, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001707; Nygaard R, 2013, CELL, V152, P532, DOI 10.1016/j.cell.2013.01.008; Peterson SM, 2015, P NATL ACAD SCI USA, V112, P7097, DOI 10.1073/pnas.1502742112; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Scholten DJ, 2012, BRIT J PHARMACOL, V165, P1617, DOI 10.1111/j.1476-5381.2011.01551.x; Shonberg J, 2013, J MED CHEM, V56, P9199, DOI 10.1021/jm401318w; Shukla AK, 2008, P NATL ACAD SCI USA, V105, P9988, DOI 10.1073/pnas.0804246105; Soergel DG, 2014, PAIN, V155, P1829, DOI 10.1016/j.pain.2014.06.011; Stallaert W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029420; Strange PG, 2008, TRENDS PHARMACOL SCI, V29, P314, DOI 10.1016/j.tips.2008.03.009; Thompson GL, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00262; Tschammer N, 2011, MOL PHARMACOL, V79, P575, DOI 10.1124/mol.110.068106; Urban JD, 2007, J PHARMACOL EXP THER, V320, P1, DOI 10.1124/jpet.106.104463; Urs NM, 2012, P NATL ACAD SCI USA, V109, P20732, DOI 10.1073/pnas.1215489109; Walters RW, 2009, J CLIN INVEST, V119, P1312, DOI 10.1172/JCI36806; Weichert D, 2015, J MED CHEM, V58, P2703, DOI 10.1021/jm501889t; Whalen EJ, 2011, TRENDS MOL MED, V17, P126, DOI 10.1016/j.molmed.2010.11.004; Wootten D, 2013, NAT REV DRUG DISCOV, V12, P630, DOI 10.1038/nrd4052; Zhang J, 1998, P NATL ACAD SCI USA, V95, P7157, DOI 10.1073/pnas.95.12.7157	52	13	13	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2015	10	10							e0141637	10.1371/journal.pone.0141637	http://dx.doi.org/10.1371/journal.pone.0141637			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0EH	26516769	gold, Green Published, Green Submitted			2022-12-26	WOS:000363920800063
J	Ramanaik, S; McClarty, LM; Khan, S; Ramesh, BM; Doshi, M; Becker, ML; Lorway, RR				Ramanaik, Satyanarayana; McClarty, Leigh M.; Khan, Shamshad; Ramesh, B. M.; Doshi, Monika; Becker, Marissa L.; Lorway, Robert R.			Frontline Health Service Providers' Perspectives on HIV Vaccine Trials among Female Sex Workers and Men Who Have Sex with Men in Karnataka, South India	PLOS ONE			English	Article							CLINICAL-RESEARCH; HPV VACCINATION; WILLINGNESS; PARTICIPATE; POPULATIONS	Background Little qualitative research is available on the role of frontline health service providers (FHSPs) in the implementation of clinical trials, particularly in developing countries. This paper presents findings from a qualitative study about the perspectives of FHSPs on future HIV vaccine trials involving female sex workers (FSWs) and men who have sex with men (MSM) in three districts of Karnataka, India. In particular, we explore FHSPs' knowledge of and views on clinical trials in general, and examine their potential willingness to play a role if such trials were introduced or implemented in the region. Methods A field team of four researchers from Karnataka-two of whom self-identified with FSW or MSM communities ("community researchers") and two with backgrounds in social work-conducted in-depth interviews with FHSPs. Including community researchers in the study helped to build rapport with FSWand MSM participants and facilitate in-depth discussions. A coding scheme for transcribed and translated data was developed using a framework analysis approach. Data was then analysed thematically using a combination of a priori and emergent codes. Results Over half of FHSPs demonstrated limited knowledge or understanding of clinical trials. Despite reported skepticism around the testing of HIV vaccines in developing countries and concerns around potential side effects, most FHSPs strongly advocated for the implementation of HIV vaccine clinical trials in Karnataka. Further, most FHSPs expressed their willingness to be involved in future HIV vaccine clinical trials in varying capacities. Conclusion Given that FHSPs are often directly involved in the promotion of health and well-being of FSWs and MSM, they are well-positioned to play leadership, ethical, and communicative roles in future HIV vaccine trials. However, our findings reveal a lack of awareness of clinical trials among FHSP participants, suggesting an important area for capacity building and staff development before viable and ethical clinical trials can be set up in the region.	[Ramanaik, Satyanarayana] Ctr Multi Disciplinary Dev Res, Dharwad, Karnataka, India; [Ramanaik, Satyanarayana; Ramesh, B. M.] Karnataka Hlth Promot Trust, Bangalore, Karnataka, India; [McClarty, Leigh M.; Ramesh, B. M.; Doshi, Monika; Becker, Marissa L.; Lorway, Robert R.] Univ Manitoba, Dept Community Hlth Sci, Ctr Global Publ Hlth, Winnipeg, MB R3T 2N2, Canada; [Khan, Shamshad] Univ Texas San Antonio, Dept Commun, San Antonio, TX USA; [Becker, Marissa L.] Univ Manitoba, Dept Med Microbiol, Winnipeg, MB, Canada	University of Manitoba; University of Texas System; University of Texas at San Antonio (UTSA); University of Manitoba	Ramanaik, S (corresponding author), Ctr Multi Disciplinary Dev Res, Dharwad, Karnataka, India.	satya@khpt.org		McClarty, Leigh/0000-0003-0183-2768; Ramanaik, Satyanarayana/0000-0002-0157-7253; Becker, Marissa/0000-0002-9235-0547	International Infectious Disease and Global Health Training Program through the University of Manitoba, Canada; Canadian Institutes of Health Research (CIHR), Research Manitoba; David G. Fish Memorial Scholarship through the Department of Community Health Sciences, University of Manitoba; CIHR New Investigator Award; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH062294] Funding Source: NIH RePORTER	International Infectious Disease and Global Health Training Program through the University of Manitoba, Canada; Canadian Institutes of Health Research (CIHR), Research Manitoba(Canadian Institutes of Health Research (CIHR)); David G. Fish Memorial Scholarship through the Department of Community Health Sciences, University of Manitoba; CIHR New Investigator Award(Canadian Institutes of Health Research (CIHR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	SR was supported in part by the International Infectious Disease and Global Health Training Program through the University of Manitoba, Canada. LMM received funding from the Canadian Institutes of Health Research (CIHR), Research Manitoba, and the David G. Fish Memorial Scholarship through the Department of Community Health Sciences, University of Manitoba. MB is supported by a CIHR New Investigator Award.	Allman D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100058; [Anonymous], 2001, THE HINDU; AVAC-Global Advocacy for HIV Prevention, 2014, AIDS VACC THER IS MO; Avahan, 2008, IND AIDS IN BUS HIV; Bagla P, 2001, SCIENCE, V293, P1024, DOI 10.1126/science.293.5532.1024; Chakrapani V, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-731; Chakrapani V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051080; Dhar A, 2010, THE HINDU; Emanuel EJ, 2004, J INFECT DIS, V189, P930, DOI 10.1086/381709; Excler JL, 2008, INDIAN J MED RES, V127, P531; Guest G., 2012, APPL THEMATIC ANAL V, DOI 10.4135/9781483384436; International AIDS Vaccine Initiative (IAVI), 2014, VULN POP VACC COULD; International AIDS Vaccine Initiative (IAVI), 2014, VACC IS ESS END AIDS; International AIDS Vaccine Initiative (IAVI), 2012, AIDS VACC EXPL POT C; International Council of AIDS Service Organizations (ICASO), 2006, COMM INV HIV ACC RES; Mattheij I, 2012, J ROY SOC MED, V105, P250, DOI 10.1258/jrsm.2012.110343; McClarty LM, 2015, VACCINE, V33, P656, DOI 10.1016/j.vaccine.2014.12.009; McClarty LM, 2013, POTENTIAL BARRIERS F; McNeilly PJ, 2002, COMMUNICATION; Mehendale Sanjay, 2013, Perspect Clin Res, V4, P84, DOI 10.4103/2229-3485.106401; National AIDS Control Organisation, 2012, HIV SENT SURV 2010 1; National AIDS Control Organization (NACO), 2014, NACO ANN REP 2013 14; National Institute of Medical Stastistics, 2014, CLIN TRIALS REG IND; Newman PA, 2014, VACCINE, V32, P5854, DOI 10.1016/j.vaccine.2014.08.043; PANDEY A, 2013, PHARM MED, V27, P83, DOI DOI 10.1007/s40290-013-0009-3; Pandey V, 2010, CANC VACCINE PROGRAM; QSR, 2011, NVIVO QUAL DAT AN SO; Ritchie JSL., 1994, QUALITATIVE DATA ANA, DOI DOI 10.4324/9780203413081_CHAPTER_9; Sahay S, 2005, VACCINE, V23, P1351, DOI 10.1016/j.vaccine.2004.09.032; Sarojini N, 2010, PRELIMINARY FINDINGS; Saxena Pikee, 2014, Indian J Community Med, V39, P197, DOI 10.4103/0970-0218.143018; Sharma DC, 2001, LANCET, V358, P992, DOI 10.1016/S0140-6736(01)06160-8; Sirohi B, 2014, INDIAN J MED PAEDIAT, V35, P133, DOI 10.4103/0971-5851.138947; Srinivasan S, 2006, LANCET, V367, P1962, DOI 10.1016/S0140-6736(06)68861-2; Srinivasan S, 2009, ETHICAL CLIN TRIALS; Suba EJ, 2010, LANCET, V375, P639, DOI 10.1016/S0140-6736(10)60270-X; Suhadev M, 2009, AIDS RES HUM RETROV, V25, P217, DOI 10.1089/aid.2007.0312; UNAIDS WHO, 2007, ETH CONS BIOM HIV PR; Van Damme L, 2008, NEW ENGL J MED, V359, P463, DOI 10.1056/NEJMoa0707957	39	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2015	10	10							e0141822	10.1371/journal.pone.0141822	http://dx.doi.org/10.1371/journal.pone.0141822			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0EH	26517272	Green Submitted, gold, Green Published			2022-12-26	WOS:000363920800081
J	Wang, J; Zhang, KC; Zhang, XM; Yan, GH; Zhou, Y; Feng, LB; Ni, Y; Duan, XW				Wang, Jing; Zhang, Kaichun; Zhang, Xiaoming; Yan, Guohua; Zhou, Yu; Feng, Laibao; Ni, Yang; Duan, Xuwei			Construction of Commercial Sweet Cherry Linkage Maps and QTL Analysis for Trunk Diameter	PLOS ONE			English	Article							SNP DISCOVERY; GIGANTEA; MARKERS; GROWTH; ARCHITECTURE; CROSS; PLANT; GENE; SET	A cross between the sweet cherry (Prunus avium) cultivars 'Wanhongzhu' and 'Lapins' was performed to create a mapping population suitable for the construction of a linkage map. The specific-locus amplified fragment (SLAF) sequencing technique used as a single nucleotide polymorphism (SNP) discovery platform and generated 701 informative genotypic assays; these, along with 16 microsatellites (SSRs) and the incompatibility (S) gene, were used to build a map which comprised 8 linkage groups (LGs) and covered a genetic distance of 849.0 cM. The mean inter-marker distance was 1.18 cM and there were few gaps > 5 cM in length. Marker collinearity was maintained with the established peach genomic sequence. The map was used to show that trunk diameter (TD) is under the control of 4 loci, mapping to 3 different LGs. Different locus influenced TD at a varying stage of the tree's development. The high density 'WxL' genetic linkage map has the potential to enable high-resolution identification of QTLs of agronomically relevant traits, and accelerate sweet cherry breeding.	[Wang, Jing; Zhang, Kaichun; Zhang, Xiaoming; Yan, Guohua; Zhou, Yu; Ni, Yang; Duan, Xuwei] Beijing Acad Agr & Forestry Sci, Inst Forestry & Pomol, Beijing 100093, Peoples R China; [Wang, Jing; Zhang, Kaichun; Zhang, Xiaoming; Yan, Guohua; Zhou, Yu; Ni, Yang; Duan, Xuwei] Beijing Engn Res Ctr Deciduous Fruit Trees, Beijing 100093, Peoples R China; [Wang, Jing; Zhang, Kaichun; Zhang, Xiaoming; Yan, Guohua; Zhou, Yu; Ni, Yang; Duan, Xuwei] Minist Agr, Key Lab Biol & Genet Improvement Hort Crops North, Beijing, Peoples R China; [Feng, Laibao] Chinese Acad Sci, Inst Bot, Lab Photosynthesis & Environm Mol Physiol, Beijing 100093, Peoples R China	Beijing Academy of Agriculture & Forestry; Ministry of Agriculture & Rural Affairs; Chinese Academy of Sciences; Institute of Botany, CAS	Zhang, KC (corresponding author), Beijing Acad Agr & Forestry Sci, Inst Forestry & Pomol, Beijing 100093, Peoples R China.	kaichunzhang@126.com			National Natural Science Foundation of China [31401827, 31272123]; Special Fund for the Construction of Scientific and Technological Innovation Capability [KJCX201101009, KJCX201004003, KJCX20140110]; National Plan for Science, Technology and Innovation [2013BAD02B03-1-04]; Key Project of Beijing Municipal Science and Technology Commission [D131100000113001]; National Crop Germplasm Resources Platform Project [2012-068]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special Fund for the Construction of Scientific and Technological Innovation Capability; National Plan for Science, Technology and Innovation; Key Project of Beijing Municipal Science and Technology Commission; National Crop Germplasm Resources Platform Project	This work was supported by the National Natural Science Foundation of China (31401827); URL: (http://www.nsfc.gov.cn/). JW received the funding. The funder had a role in study design, data collection and analysis, and decision to publish. This work was supported by the National Natural Science Foundation of China (31272123); URL: (http://www.nsfc.gov.cn/). KCZ received the funding. The funder had a role in the decision to publish. This work was supported by the Special Fund for the Construction of Scientific and Technological Innovation Capability (KJCX201101009, KJCX201004003, KJCX20140110); URL: (http://www.baafs.net.cn/). KCZ received these funding. The funder had a role in the decision to publish. This work was supported by the National Plan for Science, Technology and Innovation (2013BAD02B03-1-04); URL: (http://program.most.gov.cn/). KCZ received these funding. The funder had role in decision to publish. This work was supported by the Key Project of Beijing Municipal Science and Technology Commission (D131100000113001); URL: (http://www.bjkw.gov.cn). KCZ received these funding. The funder had a role in the decision to publish. This work was supported by the National Crop Germplasm Resources Platform Project (2012-068); URL: (http://www.most.gov.cn/). GHY received these funding. The funder had a role in data collection and analysis.	Salazar JA, 2014, PLANT MOL BIOL REP, V32, P1, DOI 10.1007/s11105-013-0643-7; Aranzana MJ, 2003, THEOR APPL GENET, V106, P819, DOI 10.1007/s00122-002-1094-y; Arumuganathan K, 1991, PLANT MOL BIOL REP, V9, P208, DOI DOI 10.1007/BF02672069; Arus P, 2012, TREE GENET GENOMES, V8, P531, DOI 10.1007/s11295-012-0493-8; Baird NA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003376; Baxter SW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019315; Brock MT, 2007, MOL ECOL, V16, P3050, DOI 10.1111/j.1365-294X.2007.03298.x; Cabrera A, 2012, TREE GENET GENOMES, V8, P237, DOI 10.1007/s11295-011-0436-9; Cao SQ, 2005, PLANT CELL REP, V24, P683, DOI 10.1007/s00299-005-0061-x; Chen SQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065122; CHURCHILL GA, 1994, GENETICS, V138, P963; Chutimanitsakun Y, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-4; Clarke JB, 2009, TREE GENET GENOMES, V5, P41, DOI 10.1007/s11295-008-0166-9; Dirlewanger E, 2004, P NATL ACAD SCI USA, V101, P9891, DOI 10.1073/pnas.0307937101; Edwards J, 2010, PLANT J, V63, P651, DOI 10.1111/j.1365-313X.2010.04269.x; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; Emebiri LC, 2004, FIELD CROP RES, V87, P195, DOI 10.1016/j.fcr.2003.11.002; Gore MA, 2009, SCIENCE, V326, P1115, DOI 10.1126/science.1177837; Guajardo V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127750; Gupta PK, 1999, PLANT BREEDING, V118, P369, DOI 10.1046/j.1439-0523.1999.00401.x; Han YY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073541; Hyten DL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-38; Klagges C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054743; Kosambi DD, 1943, ANN EUGENIC, V12, P172, DOI 10.1111/j.1469-1809.1943.tb02321.x; LaFlamme B, 2015, NAT GENET, V47, P311, DOI DOI 10.1038/ng.3264; Lambert P, 2004, THEOR APPL GENET, V108, P1120, DOI 10.1007/s00122-003-1526-3; Laurens F, 2000, FRUITS, V54, P441; Lewis ZA, 2007, GENETICS, V177, P1163, DOI 10.1534/genetics.107.078147; Mammadov JA, 2010, THEOR APPL GENET, V121, P577, DOI 10.1007/s00122-010-1331-8; Miller SS, 2010, J AM POMOL SOC, V64, P199; Olmstead JW, 2008, TREE GENET GENOMES, V4, P897, DOI 10.1007/s11295-008-0161-1; Ooijen JWv, 2006, JOINMAP 4 SOFTWARE C; Pfender WF, 2011, THEOR APPL GENET, V122, P1467, DOI 10.1007/s00122-011-1546-3; Socquet-Juglard D, 2013, PLANT MOL BIOL REP, V31, P387, DOI 10.1007/s11105-012-0511-x; Sooriyapathirana SS, 2010, TREE GENET GENOMES, V6, P821, DOI 10.1007/s11295-010-0294-x; Sosinski B, 2010, 5 INT ROS GEN C STEL; Suh Y, 2005, MUTAT RES-FUND MOL M, V573, P41, DOI 10.1016/j.mrfmmm.2005.01.005; Sun LD, 2014, BMC GENET, V15, DOI 10.1186/1471-2156-15-S1-S1; Sun XW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058700; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; Wittenberg AHJ, 2005, MOL GENET GENOMICS, V274, P30, DOI 10.1007/s00438-005-1145-6; Wu R, 1996, TREES-STRUCT FUNCT, V11, P99; WU R, 1994, THEOR APPL GENET, V89, P1046, DOI 10.1007/BF00224537; Xia C, 2015, EUPHYTICA, V202, P35, DOI 10.1007/s10681-014-1202-5; Zhang YX, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-141	45	12	12	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2015	10	10							e0141261	10.1371/journal.pone.0141261	http://dx.doi.org/10.1371/journal.pone.0141261			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0EH	26516760	gold, Green Published, Green Submitted			2022-12-26	WOS:000363920800031
J	Wilks, SA; Fader, MJ; Keevil, CW				Wilks, Sandra A.; Fader, Mandy J.; Keevil, C. William			Novel Insights into the Proteus mirabilis Crystalline Biofilm Using Real-Time Imaging	PLOS ONE			English	Article							SCANNING-ELECTRON-MICROSCOPY; INDWELLING URINARY CATHETERS; URETHRAL CATHETERS; BACTERIAL BIOFILMS; TERM CATHETERIZATION; ARTIFICIAL URINE; FOLEY CATHETERS; ENCRUSTATION; PATHOGENS; INFECTION	The long-term use of indwelling catheters results in a high risk from urinary tract infections (UTI) and blockage. Blockages often occur from crystalline deposits, formed as the pH rises due to the action of urease-producing bacteria; the most commonly found species being Proteus mirabilis. These crystalline biofilms have been found to develop on all catheter materials with P. mirabilis attaching to all surfaces and forming encrustations. Previous studies have mainly relied on electron microscopy to describe this process but there remains a lack of understanding into the stages of biofilm formation. Using an advanced light microscopy technique, episcopic differential interference contrast (EDIC) microscopy combined with epifluorescence (EF), we describe a non-destructive, non-contact, real-time imaging method used to track all stages of biofilm development from initial single cell attachment to complex crystalline biofilm formation. Using a simple six-well plate system, attachment of P. mirabilis (in artificial urine) to sections of silicone and hydrogel latex catheters was tracked over time (up to 24 days). Using EDIC and EF we show how initial attachment occurred in less than 1 h following exposure to P. mirabilis. This was rapidly followed by an accumulation of an additional material (indicated to be carbohydrate based using lectin staining) and the presence of highly elongated, motile cells. After 24 h exposure, a layer developed above this conditioning film and within 4 days the entire surface (of both catheter materials) was covered with diffuse crystalline deposits with defined crystals embedded. Using three-dimensional image reconstruction software, cells of P. mirabilis were seen covering the crystal surfaces. EDIC microscopy could resolve these four components of the complex crystalline biofilm and the close relationship between P. mirabilis and the crystals. This real-time imaging technique permits study of this complex biofilm development with no risk of artefacts due to sample manipulation. A full understanding of the stages and components involved in crystalline encrustation formation will aid in the development of new protocols to manage and ultimately prevent catheter blockage.	[Wilks, Sandra A.; Keevil, C. William] Univ Southampton, Fac Nat & Environm Sci, Ctr Biol Sci, Southampton, Hants, England; [Wilks, Sandra A.; Fader, Mandy J.] Univ Southampton, Fac Hlth Sci, Southampton, Hants, England	University of Southampton; University of Southampton	Wilks, SA (corresponding author), Univ Southampton, Fac Nat & Environm Sci, Ctr Biol Sci, Southampton, Hants, England.	S.A.Wilks@soton.ac.uk		Wilks, Sandra/0000-0002-4134-9415; Fader, Mandy/0000-0002-0801-543X; Keevil, Charles/0000-0003-1917-7706	University of Southampton Institute for Life Sciences Knowledge Mobilisation Fellowship in Healthcare Technologies; National Institute for Health Research [RP-PG-0610-10078] Funding Source: researchfish	University of Southampton Institute for Life Sciences Knowledge Mobilisation Fellowship in Healthcare Technologies; National Institute for Health Research(National Institute for Health Research (NIHR))	Funding was provided through a University of Southampton Institute for Life Sciences Knowledge Mobilisation Fellowship in Healthcare Technologies awarded to Sandra A. Wilks (SAW) (http://www.southampton.ac.uk/ifls/index.page). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brooks T, 1997, LETT APPL MICROBIOL, V24, P203, DOI 10.1046/j.1472-765X.1997.00378.x; Broomfield RJ, 2009, J MED MICROBIOL, V58, P1367, DOI 10.1099/jmm.0.012419-0; COX AJ, 1989, J UROLOGY, V142, P1347, DOI 10.1016/S0022-5347(17)39095-X; COX AJ, 1987, BIOMATERIALS, V8, P500, DOI 10.1016/0142-9612(87)90089-5; Davenport K, 2005, J HOSP INFECT, V60, P298, DOI 10.1016/j.jhin.2005.01.026; Djeribi R, 2012, AM J INFECT CONTROL, V40, P854, DOI 10.1016/j.ajic.2011.10.009; Gabi M, 2011, UROL RES, V39, P81, DOI 10.1007/s00240-010-0284-3; Health Protection Agency, 2009, TREND RAT HEALTHC IN; HEDELIN H, 1991, BRIT J UROL, V67, P527, DOI 10.1111/j.1464-410X.1991.tb15200.x; HEDELIN H, 1984, BRIT J UROL, V56, P250, DOI 10.1111/j.1464-410X.1984.tb05382.x; Holling N, 2014, FEMS MICROBIOL LETT, V355, P20, DOI 10.1111/1574-6968.12451; Jacobsen SM, 2008, CLIN MICROBIOL REV, V21, P26, DOI 10.1128/CMR.00019-07; Jones SM, 2007, FEMS MICROBIOL LETT, V268, P16, DOI 10.1111/j.1574-6968.2006.00587.x; Keevil CW, 2003, WATER SCI TECHNOL, V47, P105, DOI 10.2166/wst.2003.0293; KohlerOckmore J, 1996, BRIT J UROL, V77, P347, DOI 10.1046/j.1464-410X.1996.09074.x; KUNIN CM, 1989, J CLIN EPIDEMIOL, V42, P835, DOI 10.1016/0895-4356(89)90096-6; Macleod SM, 2007, J MED MICROBIOL, V56, P1549, DOI 10.1099/jmm.0.47395-0; Maki DG, 2001, EMERG INFECT DIS, V7, P342, DOI 10.3201/eid0702.010240; MOBLEY HLT, 1987, J CLIN MICROBIOL, V25, P2216, DOI 10.1128/JCM.25.11.2216-2217.1987; Morgan SD, 2009, UROL RES, V37, P89, DOI 10.1007/s00240-009-0176-6; Morris NS, 1997, BRIT J UROL, V80, P58, DOI 10.1046/j.1464-410X.1997.00185.x; Pickard R, 2012, LANCET, V380, P1927, DOI 10.1016/S0140-6736(12)61380-4; Schlapp G, 2011, J MICROBIOL METH, V87, P234, DOI 10.1016/j.mimet.2011.07.021; STICKLER D, 1993, UROL RES, V21, P407, DOI 10.1007/BF00300077; Stickler DJ, 2008, J HOSP INFECT, V69, P350, DOI 10.1016/j.jhin.2008.04.031; Stickler DJ, 2008, NAT CLIN PRACT UROL, V5, P598, DOI 10.1038/ncpuro1231; Stickler DJ, 2006, J MED MICROBIOL, V55, P489, DOI 10.1099/jmm.0.46404-0; Stickler DJ, 1996, BIOFOULING, V9, P293, DOI 10.1080/08927019609378311; Suller MTE, 2005, UROL RES, V33, P254, DOI 10.1007/s00240-004-0458-y; Winters C, 1995, CELL MATER, V5, P245	30	31	31	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2015	10	10							e0141711	10.1371/journal.pone.0141711	http://dx.doi.org/10.1371/journal.pone.0141711			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0EH	26516766	Green Accepted, Green Published, Green Submitted, gold			2022-12-26	WOS:000363920800071
J	Ham, DJ; Gleeson, BG; Chee, A; Baum, DM; Caldow, MK; Lynch, GS; Koopman, R				Ham, Daniel J.; Gleeson, Benjamin G.; Chee, Annabel; Baum, Dale M.; Caldow, Marissa K.; Lynch, Gordon S.; Koopman, Rene			L-Citrulline Protects Skeletal Muscle Cells from Cachectic Stimuli through an iNOS-Dependent Mechanism	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; MASSIVE INTESTINAL RESECTION; ORAL L-CITRULLINE; OXIDATIVE STRESS; MITOCHONDRIAL DYSFUNCTION; HEALTHY-SUBJECTS; MESSENGER-RNA; SEPTIC MICE; AMINO-ACIDS; FIBER-TYPE	Dietary L-citrulline is thought to modulate muscle protein turnover by increasing L-arginine availability. To date, the direct effects of increased L-citrulline concentrations in muscle have been completely neglected. Therefore, we determined the role of L-citrulline in regulating cell size during catabolic conditions by depriving mature C2C12 myotubes of growth factors (serum free; SF) or growth factors and nutrients (HEPES buffered saline; HBS). Cells were treated with L-citrulline or equimolar concentrations of L-arginine (positive control) or L-alanine (negative control) and changes in cell size and protein turnover were assessed. In myotubes incubated in HBS or SF media, L-citrulline improved rates of protein synthesis (HBS: +63%, SF: +37%) and myotube diameter (HBS: +18%, SF: +29%). L-citrulline treatment substantially increased iNOS mRNA expression (SF: 350%, HBS: 750%). The general NOS inhibitor L-NAME and the iNOS specific inhibitor aminoguanidine prevented these effects in both models. Depriving myotubes in SF media of L-arginine or L-leucine, exacerbated wasting which was not attenuated by L-citrulline. The increased iNOS mRNA expression was temporally associated with increases in mRNA of the endogenous antioxidants SOD1, SOD3 and catalase. Furthermore, L-citrulline prevented inflammation (LPS) and oxidative stress (H2O2) induced muscle cell wasting. In conclusion, we demonstrate a novel direct protective effect of L-citrulline on skeletal muscle cell size independent of L-arginine that is mediated through induction of the inducible NOS (iNOS) isoform. This discovery of a nutritional modulator of iNOS mRNA expression in skeletal muscle cells could have substantial implications for the treatment of muscle wasting conditions.	[Ham, Daniel J.; Gleeson, Benjamin G.; Chee, Annabel; Baum, Dale M.; Caldow, Marissa K.; Lynch, Gordon S.; Koopman, Rene] Univ Melbourne, Dept Physiol, Basic & Clin Myol Lab, Parkville, Vic 3052, Australia	University of Melbourne	Koopman, R (corresponding author), Univ Melbourne, Dept Physiol, Basic & Clin Myol Lab, Parkville, Vic 3052, Australia.	rkoopman@unimelb.edu.au	Caldow, Marissa/G-5260-2011	Caldow, Marissa/0000-0002-4447-9020; Ham, Daniel/0000-0002-4552-8373	Ajinomoto Amino Acid Research Program [3ARP: 09/07]; ESPEN postdoctoral fellowship	Ajinomoto Amino Acid Research Program; ESPEN postdoctoral fellowship	This work was funded by a grant from the Ajinomoto Amino Acid Research Program (3ARP: 09/07). D.J. Ham & M.K. Caldow were funded by an ESPEN postdoctoral fellowship.	Akashi K, 2001, FEBS LETT, V508, P438, DOI 10.1016/S0014-5793(01)03123-4; Anderson JE, 2000, MOL BIOL CELL, V11, P1859, DOI 10.1091/mbc.11.5.1859; Bae SK, 2012, J APPL PHYSIOL, V113, P114, DOI 10.1152/japplphysiol.00431.2011; Biolo G, 2004, J PHYSIOL-LONDON, V558, P381, DOI 10.1113/jphysiol.2004.066365; Biolo G, 2007, AM J CLIN NUTR, V86, P366, DOI 10.1093/ajcn/86.2.366; CASTILLO L, 1993, P NATL ACAD SCI USA, V90, P7749, DOI 10.1073/pnas.90.16.7749; Churchward-Venne TA, 2014, AM J PHYSIOL-ENDOC M, V307, pE71, DOI 10.1152/ajpendo.00096.2014; Escames G, 2006, J PINEAL RES, V40, P71, DOI 10.1111/j.1600-079X.2005.00281.x; Escames G, 2007, FEBS J, V274, P2135, DOI 10.1111/j.1742-4658.2007.05755.x; Evans RW, 2004, J NUTR BIOCHEM, V15, P534, DOI 10.1016/j.jnutbio.2004.03.005; Glover EI, 2008, J PHYSIOL-LONDON, V586, P6049, DOI 10.1113/jphysiol.2008.160333; Goodman CA, 2011, FASEB J, V25, P1028, DOI 10.1096/fj.10-168799; GRIFFITHS MJD, 1993, BRIT J PHARMACOL, V110, P963, DOI 10.1111/j.1476-5381.1993.tb13907.x; Hall DT, 2011, AGING-US, V3, P702, DOI 10.18632/aging.100358; Ham DJ, 2015, J NUTR, V145, P900, DOI 10.3945/jn.114.203737; Ham DJ, 2014, CLIN NUTR, V33, P937, DOI 10.1016/j.clnu.2014.09.016; Ham DJ, 2014, AMINO ACIDS, V46, P2643, DOI 10.1007/s00726-014-1815-y; Herningtyas EH, 2008, BBA-GEN SUBJECTS, V1780, P1115, DOI 10.1016/j.bbagen.2008.06.004; Hirai DM, 2013, MICROVASC RES, V85, P104, DOI 10.1016/j.mvr.2012.11.006; Kim SJ, 2002, AM J PHYSIOL-HEART C, V282, pH423, DOI 10.1152/ajpheart.00609.2001; Koopman R, 2009, J APPL PHYSIOL, V106, P2040, DOI 10.1152/japplphysiol.91551.2008; Krolick KA, 2006, CLIN IMMUNOL, V121, P286, DOI 10.1016/j.clim.2006.07.005; Lameu C, 2012, J BIOL CHEM, V287, P29690, DOI 10.1074/jbc.M111.338095; Long JHD, 2006, J MUSCLE RES CELL M, V27, P577, DOI 10.1007/s10974-006-9078-1; Louboutin JP, 2001, MOL MED, V7, P355, DOI 10.1007/BF03402218; Lynch GS, 2007, PHARMACOL THERAPEUT, V113, P461, DOI 10.1016/j.pharmthera.2006.11.004; Magne H, 2013, NUTR RES REV, V26, P149, DOI 10.1017/S0954422413000115; McClung JM, 2010, AM J PHYSIOL-CELL PH, V298, pC542, DOI 10.1152/ajpcell.00192.2009; Moinard C, 2008, BRIT J NUTR, V99, P855, DOI 10.1017/S0007114507841110; Moinard C, 2007, J NUTR, V137, p1621S, DOI 10.1093/jn/137.6.1621S; Moinard C, 2015, J NUTR, V145, P1429, DOI 10.3945/jn.114.200626; Morita Masahiko, 2013, Immunology Endocrine & Metabolic Agents in Medicinal Chemistry, V13, P214; Muller FL, 2006, FREE RADICAL BIO MED, V40, P1993, DOI 10.1016/j.freeradbiomed.2006.01.036; Obasanjo-Blackshire K, 2006, CARDIOVASC RES, V71, P672, DOI 10.1016/j.cardiores.2006.05.026; Osowska S, 2004, GUT, V53, P1781, DOI 10.1136/gut.2004.042317; Osowska S, 2006, AM J PHYSIOL-ENDOC M, V291, pE582, DOI 10.1152/ajpendo.00398.2005; Osowska S, 2008, CLIN SCI, V115, P159, DOI 10.1042/CS20070451; Raghavan SAV, 2001, EUR J PHARMACOL, V431, P61, DOI 10.1016/S0014-2999(01)01407-8; Rigamonti E, 2013, J IMMUNOL, V190, P1767, DOI 10.4049/jimmunol.1202903; Salloum F, 2003, CIRC RES, V92, P595, DOI 10.1161/01.RES.0000066853.09821.98; Schwedhelm E, 2008, BRIT J CLIN PHARMACO, V65, P51, DOI 10.1111/j.1365-2125.2007.02990.x; Sellman JE, 2006, J APPL PHYSIOL, V100, P258, DOI 10.1152/japplphysiol.00936.2005; Smith LW, 2002, J APPL PHYSIOL, V92, P2005, DOI 10.1152/japplphysiol.00950.2001; Vasilaki A, 2007, PROTEOM CLIN APPL, V1, P362, DOI 10.1002/prca.200600702; Vasilaki A, 2013, FREE RADICAL BIO MED, V65, P317, DOI 10.1016/j.freeradbiomed.2013.07.008; Ventura G, 2013, AMINO ACIDS, V45, P1123, DOI 10.1007/s00726-013-1564-3; WINDMUELLER HG, 1981, AM J PHYSIOL, V241, pE473, DOI 10.1152/ajpendo.1981.241.6.E473; Wu GY, 1998, BIOCHEM J, V336, P1, DOI 10.1042/bj3360001; Yu Z, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002086	49	34	35	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2015	10	10							e0141572	10.1371/journal.pone.0141572	http://dx.doi.org/10.1371/journal.pone.0141572			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0ED	26513461	Green Published, gold			2022-12-26	WOS:000363920300053
J	Osler, M; Prescott, E; Wium-Andersen, IK; Ibfelt, EH; Jorgensen, MB; Andersen, PK; Jorgensen, TSH; Wium-Andersen, MK; Martensson, S				Osler, Merete; Prescott, Eva; Wium-Andersen, Ida Kim; Ibfelt, Else Helene; Jorgensen, Martin Balslev; Andersen, Per Kragh; Jorgensen, Terese Sara Hoj; Wium-Andersen, Marie Kim; Martensson, Solvej			The Impact of Comorbid Depression on Educational Inequality in Survival after Acute Coronary Syndrome in a Cohort of 83 062 Patients and a Matched Reference Population	PLOS ONE			English	Article							ACUTE MYOCARDIAL-INFARCTION; SOCIOECONOMIC POSITION; CASE-FATALITY; REVASCULARIZATION PROCEDURES; MORTALITY; INCOME; RISK; DISPARITIES; HEALTH; ASSOCIATION	Background Patients with low socioeconomic position have higher rates of mortality after diagnosis of acute coronary syndrome (ACS), but little is known about the mechanisms behind this social inequality. The aim of the present study was to examine whether any educational inequality in survival after ACS was influenced by comorbid conditions including depression. Methods From 2001 to 2009 all first-time ACS patients were identified in the Danish National Patient Registry. This cohort of 83 062 ACS patients and a matched reference population were followed for incident depression and mortality until December 2012 by linkage to person, patients and prescription registries. Educational status was defined at study entry and the impact of potential confounders and mediators (age, gender, cohabitation status, somatic comorbidity and depression) on the relation between education and mortality were identified by drawing a directed acyclic graph and analysed using multiple Cox regression analyses. Findings During follow-up, 29 583(35.6%) of ACS patients and 19 105(22.9%) of the reference population died. Cox regression analyses showed an increased mortality in the lowest educated compared to those with high education in both ACS patients and the reference population. Adjustment for previous and incident depression or other covariables only attenuated the relations slightly. This pattern of associations was seen for mortality after 30 days, 1 year and during total follow-up. Conclusion In this study the relative excess mortality rate in lower educated ACS patients was comparable with the excess risk associated with low education in the background population. This educational inequality in survival remained after adjustment for somatic comorbidity and depression.	[Osler, Merete; Ibfelt, Else Helene; Jorgensen, Terese Sara Hoj; Martensson, Solvej] Univ Copenhagen, Rigshosp Glostrup, Res Ctr Prevent & Hlth, Glostrup, Denmark; [Prescott, Eva] Bispebjerg Hosp, Dept Cardiol Y, DK-2400 Copenhagen, Denmark; [Wium-Andersen, Ida Kim; Jorgensen, Martin Balslev] Rigshosp, Dept Psychiat O, DK-2100 Copenhagen, Denmark; [Andersen, Per Kragh] Univ Copenhagen, Dept Biostat, Copenhagen, Denmark; [Wium-Andersen, Marie Kim] Frederiksberg Univ Hosp, Dept Psychiat, Frederiksberg, Denmark	University of Copenhagen; University of Copenhagen; Bispebjerg Hospital; Rigshospitalet; University of Copenhagen; University of Copenhagen	Osler, M (corresponding author), Univ Copenhagen, Rigshosp Glostrup, Res Ctr Prevent & Hlth, Glostrup, Denmark.	merete.osler@regionh.dk	Osler, Merete/AAF-7885-2019; Prescott, Eva/AAJ-7441-2020; Jorgensen, Martin Balslev MBJ/K-5758-2012	Jorgensen, Martin Balslev MBJ/0000-0002-1321-8901; Osler, Merete/0000-0002-6921-220X; Prescott, Eva/0000-0002-4134-0349; Wium-Andersen, Marie Kim/0000-0002-3277-4356; Jorgensen, Terese Sara Hoj/0000-0003-1450-4472; Ibfelt, Else Helene/0000-0002-5253-8465	Danish Trygfoundation [Idn106450]; Danish Heart Association [14-R97-A5003-22834]	Danish Trygfoundation; Danish Heart Association	The work was supported by the Danish Trygfoundation [Idn106450] and the Danish Heart Association (Bnr: 14-R97-A5003-22834). The funding body has not influenced the analysis of data or its interpretation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler NE, 2010, ANN NY ACAD SCI, V1186, P5, DOI 10.1111/j.1749-6632.2009.05337.x; Alter DA, 2006, ANN INTERN MED, V144, P82, DOI 10.7326/0003-4819-144-2-200601170-00005; Alter DA, 1999, NEW ENGL J MED, V341, P1359, DOI 10.1056/NEJM199910283411806; Bernheim SM, 2007, AM HEART J, V153, P313, DOI 10.1016/j.ahj.2006.10.037; Cesana G, 2001, INT J EPIDEMIOL, V30, pS53, DOI 10.1093/ije/30.suppl_1.S53; Coady SA, BMC PUBLIC HLTH, V14, P705; Foraker RE, 2013, AM HEART J, V165, P102, DOI 10.1016/j.ahj.2012.10.022; Gardarsdottir H, 2009, PHARMACOEPIDEM DR S, V18, P7, DOI 10.1002/pds.1677; Gerber Y, 2008, MAYO CLIN PROC, V83, P663, DOI 10.4065/83.6.663; Gerber Y, 2010, CIRCULATION, V121, P375, DOI 10.1161/CIRCULATIONAHA.109.882555; Gnavi R, 2014, INT J CARDIOL, V176, P724, DOI 10.1016/j.ijcard.2014.07.107; Hanley GE, 2011, J GEN INTERN MED, V26, P1329, DOI 10.1007/s11606-011-1799-1; Hernan MA, 2015, CAUSAL INFERENCE; Igland J, 2014, INT J CARDIOL, V177, P874, DOI 10.1016/j.ijcard.2014.10.045; Kirchberger I, 2014, INT J EQUITY HEALTH, V13, DOI 10.1186/1475-9276-13-19; Lammintausta A, 2012, ANN EPIDEMIOL, V22, P87, DOI 10.1016/j.annepidem.2011.10.012; Lichtman JH, 2014, CIRCULATION, V129, P1350, DOI 10.1161/CIR.0000000000000019; Lorant V, 2003, AM J EPIDEMIOL, V157, P98, DOI 10.1093/aje/kwf182; Martensson S, 2016, EUROINTERVENTION, V11, P1495, DOI 10.4244/EIJY15M09_06; Matthews KA, 2010, ANN NY ACAD SCI, V1186, P146, DOI 10.1111/j.1749-6632.2009.05332.x; Mehta RH, 2011, J AM COLL CARDIOL, V57, P138, DOI 10.1016/j.jacc.2010.09.021; Molshatzki N, 2011, MED CARE, V49, P673, DOI 10.1097/MLR.0b013e318222a508; Oeffelen AAM, 2012, EUR J EPIDEMIOL, V27, P605, DOI [10.1007/s10654-012-9700-z, DOI 10.1007/S10654-012-9700-Z]; Pasco JA, 2010, PSYCHOTHER PSYCHOSOM, V79, P323, DOI 10.1159/000319530; Pell JP, 2000, BRIT MED J, V320, P15, DOI 10.1136/bmj.320.7226.15; Rasmussen JN, 2007, CARDIOVASC DRUG THER, V21, P449, DOI 10.1007/s10557-007-6058-7; Rasmussen JN, 2007, J EPIDEMIOL COMMUN H, V61, P1091, DOI 10.1136/jech.2006.055525; Rasmussen JN, 2006, J EPIDEMIOL COMMUN H, V60, P351, DOI 10.1136/jech.200X.040972; Rosvall M, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-44; Rosvall M, 2008, EUR J PUBLIC HEALTH, V18, P533, DOI 10.1093/eurpub/ckn059; Salomaa V, 2001, J EPIDEMIOL COMMUN H, V55, P475, DOI 10.1136/jech.55.7.475; Stirbu I, 2012, J EPIDEMIOL COMMUN H, V66, P1159, DOI 10.1136/jech-2011-200924; Thygesen LC, 2011, SCAND J PUBLIC HEALT, V39, P12, DOI 10.1177/1403494811399956; Yang D, 2012, EUR J PREV CARDIOL, V19, P1304, DOI 10.1177/1741826711425340	34	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2015	10	10							e0141598	10.1371/journal.pone.0141598	http://dx.doi.org/10.1371/journal.pone.0141598			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CV0ED	26513652	Green Published, Green Submitted, gold			2022-12-26	WOS:000363920300055
J	van Liere, GAFS; van Rooijen, MS; Hoebe, CJPA; Heijman, T; de Vries, HJC; Dukers-Muijrers, NHTM				van Liere, Genevieve A. F. S.; van Rooijen, Martijn S.; Hoebe, Christian J. P. A.; Heijman, Titia; de Vries, Henry J. C.; Dukers-Muijrers, Nicole H. T. M.			Prevalence of and Factors Associated with Rectal-Only Chlamydia and Gonorrhoea in Women and in Men Who Have Sex with Men	PLOS ONE			English	Article							SEXUALLY-TRANSMITTED-DISEASES; NEISSERIA-GONORRHOEAE; INFECTION; TRACHOMATIS; CLINICS; PHARYNGEAL	Background Both anorectal Chlamydia trachomatis (CT) and Neisseria gonorrhoea (NG) can occur as a rectal-only infection or concurrently with simultaneous urogenital infection with the same pathogen. Characterising the target groups in which rectal-only infections occur may improve the efficacy of screening practices. Methods We analysed data from two Dutch outpatient sexually transmitted infection (STI) clinics between 2011 and 2012. We included all men who have sex with men (MSM) (n = 9549) and women (n = 11113), >= 18 years, who had been tested for anorectal and urogenital CT and/or NG (either as a result of reporting anal sex/symptoms or via routine universal testing). Factors associated with rectal-only CT and NG infections were assessed using univariable and multivariable logistic regression. Results In MSM, anorectal CT prevalence was 9.8% (693/7094), anorectal NG prevalence was 4.2% (397/9534). In women this was 9.5% overall (439/4597) and 0.9% (96/10972) respectively. Anorectal CT prevalence among women who were routinely universally tested was 10.4% (20/192), for selective testing this was 9.5% (419/4405) (p = 0.68). Anorectal NG infections were not detected among women who were routinely universally tested (p = 0.19). Among CT or NG positive MSM, rectal-only CT infections were found in 85.9%(595/693), for NG this was 85.6% (340/397) respectively. In positive women these figures were 22.1% (97/439) for CT and 20.8% (20/96) for NG, respectively. In MSM, independent factors associated with rectal-only CT were: being a sex worker (OR0.4, CI0.2-1.0), exclusively having sex with men (OR3.4, CI1.7-6.8), and absence of urogenital symptoms (OR0.2, CI0.2-0.4). In women, these factors were: older age (OR2.3, CI1.3-4.0) and non-Western nationality (OR1.8, CI1.0-3.5). Factors associated with rectal-only NG in MSM were: having been warned for STIs by an (ex) partner (OR2.9, CI1.1-7.5), oropharyngeal NG infection (OR2.4, CI1.0-5.3), and absence of urogenital symptoms (OR0.02, CI0.01-0.04), while in women no significant factors were identified. Conclusions The prevalence of anorectal CT and NG was substantial in MSM and prevalence of anorectal CT was also substantial in women. Anorectal infections occurred mostly as rectal-only infections in MSM and mostly concurrent with other infections in women. Given the lack of useful indicators for rectal-only infections, selective screening based on a priori patient characteristics will have low discriminatory power both in relation to MSM and women.	[van Liere, Genevieve A. F. S.; Hoebe, Christian J. P. A.; Dukers-Muijrers, Nicole H. T. M.] South Limburg Publ Hlth Serv, Dept Sexual Hlth Infect Dis & Environm Hlth, Geleen, Netherlands; [van Liere, Genevieve A. F. S.; Hoebe, Christian J. P. A.; Dukers-Muijrers, Nicole H. T. M.] MUMC, Sch Publ Hlth & Primary Care CAPHRI, Dept Med Microbiol, Maastricht, Netherlands; [van Rooijen, Martijn S.] Publ Hlth Serv Amsterdam GGD Amsterdam, Publ Hlth Lab, Amsterdam, Netherlands; [van Rooijen, Martijn S.; Heijman, Titia] Publ Hlth Serv Amsterdam GGD Amsterdam, Dept Res, Amsterdam, Netherlands; [van Rooijen, Martijn S.; Heijman, Titia; de Vries, Henry J. C.] Publ Hlth Serv Amsterdam GGD Amsterdam, STI Outpatient Clin, Amsterdam, Netherlands; [de Vries, Henry J. C.] Univ Amsterdam, Acad Med Ctr, Dept Dermatol, NL-1105 AZ Amsterdam, Netherlands; [de Vries, Henry J. C.] Univ Amsterdam, Acad Med Ctr, Ctr Infect & Immunol Amsterdam CINIMA, NL-1105 AZ Amsterdam, Netherlands	Maastricht University; Public Health Service Amsterdam; Public Health Service Amsterdam; Public Health Service Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	van Liere, GAFS (corresponding author), South Limburg Publ Hlth Serv, Dept Sexual Hlth Infect Dis & Environm Hlth, Geleen, Netherlands.	genevieve.vanliere@ggdzl.nl	Dukers-Muijrers, Nicole/M-7178-2014; de Vries, Henry/K-5963-2012	de Vries, Henry/0000-0001-9784-547X; van Liere, Genevieve/0000-0002-9286-4548; Heijman, Titia/0000-0002-1944-2007; Dukers-Muijrers, Nicole/0000-0003-4896-758X; Hoebe, Christian/0000-0003-1815-0974				Annan NT, 2009, SEX TRANSM INFECT, V85, P176, DOI 10.1136/sti.2008.031773; Barry PM, 2010, OBSTET GYNECOL, V115, P753, DOI 10.1097/AOG.0b013e3181d444f6; Bax CJ, 2011, SEX TRANSM INFECT, V87, P503, DOI 10.1136/sti.2010.048173; Bazan JA, J WOMENS HLTH LARCHM, V24, P182; Bernstein KT, 2010, JAIDS-J ACQ IMM DEF, V53, P537, DOI 10.1097/QAI.0b013e3181c3ef29; de Coul ELMO, 2014, INT J STD AIDS, V25, P40, DOI 10.1177/0956462413491736; de Vries HJC, MULTIDISCIPLINAIRE R; Dudareva-Vizule S, 2014, SEX TRANSM INFECT, V90, P46, DOI 10.1136/sextrans-2012-050929; Fleming DT, 1999, SEX TRANSM INFECT, V75, P3, DOI 10.1136/sti.75.1.3; Geisler WM, 2008, SEX TRANSM DIS, V35, P856, DOI 10.1097/OLQ.0b013e3181788313; Gratrix J, 2013, SEX TRANSM INFECT, V89, pA152, DOI 10.1136/sextrans-2013-051184.0476; Gratrix J, 2015, CLIN INFECT DIS, V60, P398, DOI 10.1093/cid/ciu831; Hathorn E, 2012, SEX TRANSM INFECT, V88, P352, DOI 10.1136/sextrans-2011-050466; Hunte T, 2010, INT J STD AIDS, V21, P819, DOI 10.1258/ijsa.2010.009279; Javanbakht M, 2012, SEX TRANSM DIS, V39, P917, DOI 10.1097/OLQ.0b013e31826ae9a2; Kent CK, 2005, CLIN INFECT DIS, V41, P67, DOI 10.1086/430704; Khosropour CM, 2014, SEX TRANSM DIS, V41, P79, DOI 10.1097/OLQ.0000000000000088; Koedijk FDH, 2012, INT J STD AIDS, V23, P626, DOI 10.1258/ijsa.2012.011378; Ladd J, 2014, SEX TRANSM INFECT, V90, P485, DOI 10.1136/sextrans-2013-051167; Li JH, 2011, JPN J INFECT DIS, V64, P143; Manavi K, 2004, INT J STD AIDS, V15, P162, DOI 10.1258/095646204322916588; Nwokolo NC, 2014, 2014 DRAFT UK NATL G; Papp JR, 2014, RECOMMENDATONS LAB B; Patton ME, 2014, CLIN INFECT DIS, V58, P1564, DOI 10.1093/cid/ciu184; Peters RPH, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-203; Peters RPH, 2011, SEX TRANSM DIS, V38, P783, DOI 10.1097/OLQ.0b013e31821890e9; Schachter J, 2011, SEX TRANSM DIS, V38, P925, DOI 10.1097/OLQ.0b013e318230f3d6; Sethupathi M, 2010, INT J STD AIDS, V21, P93, DOI 10.1258/ijsa.2008.008406; Shaw SG, 2013, SEX TRANSM INFECT, V89, P397, DOI 10.1136/sextrans-2013-051159; Trebach JD, 2015, SEX TRANSM DIS, V42, P233, DOI 10.1097/OLQ.0000000000000248; Turner AN, 2013, SEX TRANSM DIS, V40, P433, DOI 10.1097/OLQ.0b013e31828fd163; van Liere GAFS, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-274; van Liere GAFS, 2014, SEX TRANSM INFECT, V90, P58, DOI 10.1136/sextrans-2013-051248; van Liere GAFS, 2013, SEX TRANSM DIS, V40, P285, DOI 10.1097/OLQ.0b013e31828098f8; Versteeg B, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-464; Workowski Kimberly A, 2010, MMWR Recomm Rep, V59, P1	36	20	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2015	10	10							e0140297	10.1371/journal.pone.0140297	http://dx.doi.org/10.1371/journal.pone.0140297			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0ED	26513479	Green Published, gold, Green Submitted			2022-12-26	WOS:000363920300003
J	Cheng, XK; Liu, XM; Wang, HY; Ji, XX; Wang, KY; Wei, M; Qiao, K				Cheng, Xingkai; Liu, Xiumei; Wang, Hongyan; Ji, Xiaoxue; Wang, Kaiyun; Wei, Min; Qiao, Kang			Effect of Emamectin Benzoate on Root-Knot Nematodes and Tomato Yield	PLOS ONE			English	Article							MELOIDOGYNE-INCOGNITA; NEMATOCIDAL ACTIVITY; METHYL-BROMIDE; BOTANICAL NEMATICIDES; BIOLOGICAL-CONTROL; SOIL; EFFICACY; JAVANICA	Southern root-knot nematode (Meloidogyne incognita) is an obligate, sedentary endoparasite of more than 3000 plant species, that causes heavy economic losses and limit the development of protected agriculture of China. As a biological pesticide, emamectin benzoate has effectively prevented lepidopteran pests; however, its efficacy to control M. incognita remains unknown. The purpose of the present study was to test soil application of emamectin benzoate for management of M. incognita in laboratory, greenhouse and field trials. Laboratory results showed that emamectin benzoate exhibited high toxicity to M. incognita, with LC50 and LC90 values 3.59 and 18.20 mg L-1, respectively. In greenhouse tests, emamectin benzoate soil application offered good efficacy against M. incognita while maintaining excellent plant growth. In field trials, emamectin benzoate provided control efficacy against M. incognita and resulted in increased tomato yields. Compared with the untreated control, there was a 36.5% to 81.3% yield increase obtained from all treatments and the highest yield was received from the highest rate of emamectin benzoate. The results confirmed that emamectin benzoate has enormous potential for the control of M. incognita in tomato production in China.	[Cheng, Xingkai; Liu, Xiumei; Wang, Kaiyun; Qiao, Kang] Shandong Agr Univ, Coll Plant Protect, Tai An, Shandong, Peoples R China; [Wang, Hongyan] Shandong Acad Agr Sci, Cotton Res Ctr, Jinan, Shandong, Peoples R China; [Ji, Xiaoxue] Plant Protect & Inspect Stn Feicheng, Feicheng, Shandong, Peoples R China; [Wei, Min] Shandong Agr Univ, Coll Hort Sci & Engn, Tai An, Shandong, Peoples R China	Shandong Agricultural University; Chinese Academy of Agricultural Sciences; Institute of Cotton Research, CAAS; Shandong Academy of Agricultural Sciences; Shandong Agricultural University	Wei, M (corresponding author), Shandong Agr Univ, Coll Hort Sci & Engn, Tai An, Shandong, Peoples R China.	minwei@sdau.edu.cn; qiaokang11-11@163.com	乔, 康/F-9851-2013; Wei, Min/GSI-8510-2022	乔, 康/0000-0001-7389-7662; 	Postdoctor Innovation Research Program of Shandong Province [201402018]; Project of Shandong Province Higher Educational Science and Technology Program [J15LF05]; National Key Technology R&D Program of China [2014BAD05B03]	Postdoctor Innovation Research Program of Shandong Province; Project of Shandong Province Higher Educational Science and Technology Program; National Key Technology R&D Program of China(National Key Technology R&D Program)	This work was supported by the Special Fund from the Postdoctor Innovation Research Program of Shandong Province (201402018), A Project of Shandong Province Higher Educational Science and Technology Program (J15LF05) and the National Key Technology R&D Program of China (2014BAD05B03). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdeldaym EA, 2014, SCI HORTIC-AMSTERDAM, V180, P156, DOI 10.1016/j.scienta.2014.10.032; Barker K.R., 1986, METHODS EVALUATING P, P283; Burkhard R, 2015, ENVIRON TOXICOL CHEM, V34, P297, DOI 10.1002/etc.2795; Caboni P, 2016, PEST MANAG SCI, V72, P125, DOI 10.1002/ps.3978; Caboni P, 2013, J AGR FOOD CHEM, V61, P9784, DOI 10.1021/jf403684h; Caboni P, 2012, J AGR FOOD CHEM, V60, P1146, DOI 10.1021/jf2044586; Cheng Yong, 2011, Acta Phytophylacica Sinica, V38, P461; [丁晓帆 DING Xiao-fan], 2009, [南京农业大学学报, Journal of Nanjing Agricultural University], V32, P85; Echeverrigaray S, 2010, PHYTOPATHOLOGY, V100, P199, DOI 10.1094/PHYTO-100-2-0199; Giannakou IO, 2002, PEST MANAG SCI, V58, P290, DOI 10.1002/ps.453; Hanson BD, 2010, PEST MANAG SCI, V66, P892, DOI 10.1002/ps.1959; Hashem M, 2011, CROP PROT, V30, P285, DOI 10.1016/j.cropro.2010.12.009; Huang WK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089717; HUSSEY RS, 1973, PLANT DIS REP, V57, P1025; (IRAC) Insecticide Resistance Action Committee, 2012, IRAC MOD ACT CLASS; Ishaaya I, 2002, PEST MANAG SCI, V58, P1091, DOI 10.1002/ps.535; JENKINS W. R., 1964, PLANT DIS REP, V48, P692; Jones JT, 2013, MOL PLANT PATHOL, V14, P946, DOI 10.1111/mpp.12057; KASS IS, 1980, P NATL ACAD SCI-BIOL, V77, P6211, DOI 10.1073/pnas.77.10.6211; Kunwar S, 2015, PLANT DIS, V99, P119, DOI 10.1094/PDIS-09-13-0936-RE; Luambano ND, 2015, BIOL CONTROL, V80, P23, DOI 10.1016/j.biocontrol.2014.09.003; Meher HC, 2010, J AGR FOOD CHEM, V58, P1815, DOI 10.1021/jf903609d; Ministry of Agriculture P. R. China, 2015, MAIN POINTS PLANT IN; Ntalli NG, 2012, PHYTOCHEM REV, V11, P351, DOI 10.1007/s11101-012-9254-4; Ntalli NG, 2012, J AGR FOOD CHEM, V60, P9929, DOI 10.1021/jf303107j; Ntalli NG, 2011, J AGR FOOD CHEM, V59, P7098, DOI 10.1021/jf2013474; Nyczepir AP, 2012, PLANT DIS, V96, P1309, DOI 10.1094/PDIS-05-11-0373-RE; Qiao K, 2012, PEST MANAG SCI, V68, P853, DOI 10.1002/ps.2338; Sahebani N, 2008, SOIL BIOL BIOCHEM, V40, P2016, DOI 10.1016/j.soilbio.2008.03.011; Schneider-Orelli O., 1947, ENTOMOLOGISCHES PRAK; Zasada IA, 2010, ANNU REV PHYTOPATHOL, V48, P311, DOI 10.1146/annurev-phyto-073009-114425; Zhu J, 2011, CROP PROT, V30, P1356, DOI 10.1016/j.cropro.2011.06.006	32	26	26	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2015	10	10							e0141235	10.1371/journal.pone.0141235	http://dx.doi.org/10.1371/journal.pone.0141235			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0DL	26509680	Green Published, gold, Green Submitted			2022-12-26	WOS:000363918100064
J	Muller, DC; Johansson, M; Zaridze, D; Moukeria, A; Janout, V; Holcatova, I; Navratilova, M; Mates, D; Midttun, O; Ueland, PM; Brennan, P; Scelo, G				Muller, David C.; Johansson, Mattias; Zaridze, David; Moukeria, Anush; Janout, Vladimir; Holcatova, Ivana; Navratilova, Marie; Mates, Dana; Midttun, Oivind; Ueland, Per Magne; Brennan, Paul; Scelo, Ghislaine			Circulating Concentrations of Vitamin B6 and Kidney Cancer Prognosis: A Prospective Case-Cohort Study	PLOS ONE			English	Article							BODY-MASS INDEX; RENAL-CELL CARCINOMA; SERUM-ALBUMIN; SURVIVAL; PLASMA; INFLAMMATION; POPULATION; MARKERS	Prospective cohort studies have found that prediagnostic circulating vitamin B6 is inversely associated with both risk of kidney cancer and kidney cancer prognosis. We investigated whether circulating concentrations of vitamin B6 at kidney cancer diagnosis are associated with risk of death using a case-cohort study of 630 renal cell carcinoma (RCC) patients. Blood was collected at the time of diagnosis, and vitamin B6 concentrations were quantified using LC-MS/MS. Hazard ratios (HR) and 95% confidence intervals (CI) were calculated using Cox regression models. After adjusting for stage, age, and sex, the hazard was 3 times lower among those in the highest compared to the lowest fourth of B6 concentration (HR4vs1 0.33, 95% CI [0.18, 0.60]). This inverse association was solely driven by death from RCC (HR4vs1 0.22, 95% CI [0.11, 0.46]), and not death from other causes (HR4vs1 0.89, 95% CI [0.35, 2.28], p-interaction = 0.008). These results suggest that circulating vitamin B6 could provide additional prognostic information for kidney cancer patients beyond that afforded by tumour stage.	[Muller, David C.; Johansson, Mattias; Brennan, Paul; Scelo, Ghislaine] Int Agcy Res Canc, F-69372 Lyon 08, France; [Zaridze, David; Moukeria, Anush] Russian NN Blokhin Canc Res Ctr, Moscow 115478, Russia; [Janout, Vladimir] Palacky Univ, Fac Med, Dept Prevent Med, CZ-77515 Olomouc, Czech Republic; [Holcatova, Ivana] Charles Univ Prague, Fac Med 1, Inst Hyg & Epidemiol, CZ-12800 Prague 2, Czech Republic; [Navratilova, Marie] Masaryk Mem Canc Inst, Dept Canc Epidemiol & Genet, CZ-65653 Brno, Czech Republic; [Mates, Dana] Natl Inst Publ Hlth, Bucharest 050463, Romania; [Midttun, Oivind] Helse Bergen, Bevital AS, NO-5021 Bergen, Norway; [Ueland, Per Magne] Univ Bergen, Dept Clin Sci, NO-5021 Bergen, Norway; [Ueland, Per Magne] Haukeland Hosp, Lab Clin Biochem, N-5021 Bergen, Norway	World Health Organization; International Agency for Research on Cancer (IARC); N.N. Blokhin Russian Cancer Research Center; Palacky University Olomouc; Charles University Prague; Masaryk Memorial Cancer Institute; University of Bergen; University of Bergen; Haukeland University Hospital	Muller, DC (corresponding author), Int Agcy Res Canc, 150 Cours Albert Thomas, F-69372 Lyon 08, France.	mullerd@fellows.iarc.fr; brennanp@iarc.fr	Ueland, Per M/C-7340-2013; Scelo, Ghislaine/CAF-8077-2022; Janout, Vladimir/M-5133-2014; Johansson, Mattias/ABF-3365-2020; Holcatova, Ivana/C-8327-2017; Muller, David C/V-8207-2017	Holcatova, Ivana/0000-0002-1366-0337; Muller, David C/0000-0002-2350-0417; Ueland, Per Magne/0000-0002-1903-0571; Johansson, Mattias/0000-0002-3116-5081	World Cancer Research Fund (UK) [2010/254]; NCI [U01-CA155309]; Ministry of Health Czech Republic - DRO (MMCI) [00209805]; IARC-Australia Postdoctoral Fellowship; Cancer Council Australia; NATIONAL CANCER INSTITUTE [U01CA155309] Funding Source: NIH RePORTER	World Cancer Research Fund (UK); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Ministry of Health Czech Republic - DRO (MMCI); IARC-Australia Postdoctoral Fellowship; Cancer Council Australia(Cancer Council Australia); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	A grant from the World Cancer Research Fund (UK, http://www.wcrf.org/) no 2010/254 funded the biochemical analyses for this study. This work was also supported by a grant from the NCI (U01-CA155309, http://www.cancer.gov/), and the Ministry of Health Czech Republic - DRO (MMCI, 00209805, http://www.mzcr.cz/En/). The work carried out by DCM was undertaken during the tenure of an IARC-Australia Postdoctoral Fellowship funded by Cancer Council Australia (http://training.iarc.fr/en/fellowships/iarcaustralia_postdoc.php). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, STAT OUTLOOK KIDNEY; Choi Y, 2013, INT J CANCER, V132, P625, DOI 10.1002/ijc.27639; Ferlay J, 2013, EUR J CANCER, V49, P1374, DOI 10.1016/j.ejca.2012.12.027; Fox P, 2013, BRIT J CANCER, V109, P147, DOI 10.1038/bjc.2013.300; Hakimi AA, 2013, JNCI-J NATL CANCER I, V105, P1862, DOI 10.1093/jnci/djt310; Huang SC, 2012, ANN NUTR METAB, V60, P83, DOI 10.1159/000336175; Johansson M, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju327; Kluth LA, 2014, BJU INT, V113, P911, DOI 10.1111/bju.12369; Ko K, 2013, BJU INT, V112, P775, DOI 10.1111/bju.12275; LEKLEM JE, 1990, J NUTR, V120, P1503, DOI 10.1093/jn/120.suppl_11.1503; LUI A, 1985, J LAB CLIN MED, V106, P491; LUNN M, 1995, BIOMETRICS, V51, P524, DOI 10.2307/2532940; Midttun O, 2007, AM J CLIN NUTR, V86, P131, DOI 10.1093/ajcn/86.1.131; Midttun O, 2011, J NUTR, V141, P611, DOI 10.3945/jn.110.133082; Midttun O, 2009, RAPID COMMUN MASS SP, V23, P1371, DOI 10.1002/rcm.4013; Morgan TM, 2011, EUR UROL, V59, P923, DOI 10.1016/j.eururo.2011.01.034; Ohno Y, 2013, BRIT J CANCER, V109, P1899, DOI 10.1038/bjc.2013.512; Platten M, 2012, CANCER RES, V72, P5435, DOI 10.1158/0008-5472.CAN-12-0569; PRENTICE RL, 1986, BIOMETRIKA, V73, P1; R Core Team, 2021, R LANGUAGE ENV STAT; Renehan AG, 2008, LANCET, V371, P569, DOI 10.1016/S0140-6736(08)60269-X; Royston P, 2002, STAT MED, V21, P2175, DOI 10.1002/sim.1203; Sakakeeny L, 2012, J NUTR, V142, P1280, DOI 10.3945/jn.111.153056; Scelo G, 2007, NAT CLIN PRACT UROL, V4, P205, DOI 10.1038/ncpuro0760; Stenman M, 2014, MED ONCOL, V31, DOI 10.1007/s12032-014-0841-7; Sunela KL, 2013, CLIN GENITOURIN CANC, V11, P458, DOI 10.1016/j.clgc.2013.04.017	26	7	8	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2015	10	10							e0140677	10.1371/journal.pone.0140677	http://dx.doi.org/10.1371/journal.pone.0140677			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU8PC	26506437	Green Published, Green Submitted, gold			2022-12-26	WOS:000363804200016
J	Price, KE; Orazi, G; Ruoff, KL; Hebert, WP; O'Toole, GA; Mastoridis, P				Price, Katherine E.; Orazi, Giulia; Ruoff, Kathryn L.; Hebert, Wesley P.; O'Toole, George A.; Mastoridis, Paul			Mannitol Does Not Enhance Tobramycin Killing of Pseudomonas aeruginosa in a Cystic Fibrosis Model System of Biofilm Formation	PLOS ONE			English	Article							AIRWAY EPITHELIAL-CELLS; SECRETION; SURVIVAL	Cystic Fibrosis (CF) is a human genetic disease that results in the accumulation of thick, sticky mucus in the airways, which results in chronic, life-long bacterial biofilm infections that are difficult to clear with antibiotics. Pseudomonas aeruginosa lung infection is correlated with worsening lung disease and P. aeruginosa transitions to an antibiotic tolerant state during chronic infections. Tobramycin is an aminoglycoside currently used to combat lung infections in individuals with CF. While tobramycin is effective at eradicating P. aeruginosa in the airways of young patients, it is unable to completely clear the chronic P. aeruginosa infections in older patients. A recent report showed that co-addition of tobramycin and mannitol enhanced killing of P. aeruginosa grown in vitro as a biofilm on an abiotic surface. Here we employed a model system of bacterial biofilms formed on the surface of CF-derived airway cells to determine if mannitol would enhance the antibacterial activity of tobramycin against P. aeruginosa grown on a more clinically relevant surface. Using this model system, which allows the growth of robust biofilms with high-level antibiotic tolerance analogous to in vivo biofilms, we were unable to find evidence for enhanced antibacterial activity of tobramycin with the addition of mannitol, supporting the observation that this type of co-treatment failed to reduce the P. aeruginosa bacterial load in a clinical setting.	[Price, Katherine E.; Orazi, Giulia; Ruoff, Kathryn L.; Hebert, Wesley P.; O'Toole, George A.] Geisel Sch Med Dartmouth, Hanover, NH 03756 USA; [Mastoridis, Paul] Novartis Pharmaceut, E Hanover, NJ USA	Dartmouth College; Novartis	O'Toole, GA (corresponding author), Geisel Sch Med Dartmouth, Hanover, NH 03756 USA.	georgeo@dartmouth.edu; paul.mastoridis@novartis.com		Orazi, Giulia/0000-0001-5228-2992; Price, Katherine/0000-0001-9736-1491	Novartis Pharmaceuticals [TMB100C_S2241686]; Cystic Fibrosis Foundation [PRICE13F0]	Novartis Pharmaceuticals(Novartis); Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation)	This work was supported by Novartis Pharmaceuticals (Joint collaboration between Novartis and Geisel School of Medicine at Dartmouth, Hanover, NH, US. S-code: TMB100C_S2241686 MA PLA 2014; https://www.novartis.com/) and by Cystic Fibrosis Foundation (Grant no. PRICE13F0; www.cff.org/). PM of Novartis had a role in study design, the decision to publish and preparation of manuscript but no role in data collection or analysis. Cystic Fibrosis Foundation had no role in study design, data collection and analysis, decision to publish, or preparation of manuscript.	Allison KR, 2011, NATURE, V473, P216, DOI 10.1038/nature10069; Anderson GG, 2008, INFECT IMMUN, V76, P1423, DOI 10.1128/IAI.01373-07; ANWAR H, 1992, ANTIMICROB AGENTS CH, V36, P1208, DOI 10.1128/AAC.36.6.1208; Barraud N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084220; Bilton D, 2011, EUR RESPIR J, V38, P1071, DOI 10.1183/09031936.00187510; Bilton D, 2013, J CYST FIBROS, V12, P367, DOI 10.1016/j.jcf.2012.11.002; Bruscia E, 2002, GENE THER, V9, P683, DOI 10.1038/sj.gt.3301741; Costerton JW, 2001, TRENDS MICROBIOL, V9, P50, DOI 10.1016/S0966-842X(00)01918-1; COZENS AL, 1994, AM J RESP CELL MOL, V10, P38, DOI 10.1165/ajrcmb.10.1.7507342; Donlan RM, 2002, CLIN MICROBIOL REV, V15, P167, DOI 10.1128/CMR.15.2.167-193.2002; Garrett ES, 1999, J BACTERIOL, V181, P7401, DOI 10.1128/JB.181.23.7401-7404.1999; Heijerman Harry, 2005, J Cyst Fibros, V4 Suppl 2, P3, DOI 10.1016/j.jcf.2005.05.005; Hentchel-Franks K, 2004, AM J RESP CELL MOL, V31, P140, DOI 10.1165/rcmb.2004-0012OC; HOLLOWAY BW, 1955, J GEN MICROBIOL, V13, P572, DOI 10.1099/00221287-13-3-572; Lewis K, 2005, BIOCHEMISTRY-MOSCOW+, V70, P267, DOI 10.1007/s10541-005-0111-6; Lyczak JB, 2002, CLIN MICROBIOL REV, V15, P194, DOI 10.1128/CMR.15.2.194-222.2002; Moreau-Marquis S, 2008, AM J PHYSIOL-LUNG C, V295, pL25, DOI 10.1152/ajplung.00391.2007; Moreau-Marquis S, 2008, PULM PHARMACOL THER, V21, P595, DOI 10.1016/j.pupt.2007.12.001; RAHME LG, 1995, SCIENCE, V268, P1899, DOI 10.1126/science.7604262; SUCI PA, 1994, ANTIMICROB AGENTS CH, V38, P2125, DOI 10.1128/AAC.38.9.2125; Tran CS, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004479; Yu QR, 2012, J ANTIMICROB CHEMOTH, V67, P2673, DOI 10.1093/jac/dks296	23	14	14	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2015	10	10							e0141192	10.1371/journal.pone.0141192	http://dx.doi.org/10.1371/journal.pone.0141192			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU8PC	26506004	Green Published, gold, Green Submitted			2022-12-26	WOS:000363804200035
J	Taguchi, S; Fukuhara, H; Shiraishi, K; Nakagawa, K; Morikawa, T; Kakutani, S; Takeshima, Y; Miyazaki, H; Fujimura, T; Nakagawa, T; Kume, H; Homma, Y				Taguchi, Satoru; Fukuhara, Hiroshi; Shiraishi, Kenshiro; Nakagawa, Keiichi; Morikawa, Teppei; Kakutani, Shigenori; Takeshima, Yuta; Miyazaki, Hideyo; Fujimura, Tetsuya; Nakagawa, Tohru; Kume, Haruki; Homma, Yukio			Radical Prostatectomy versus External Beam Radiotherapy for cT1-4N0M0 Prostate Cancer: Comparison of Patient Outcomes Including Mortality	PLOS ONE			English	Article							RADIATION-THERAPY; RANDOMIZED-TRIAL; V RADIATION; PROVIDE; ANSWER	Background Although radical prostatectomy (RP) and external beam radiotherapy (EBRT) have been considered as comparable treatments for localized prostate cancer (PC), it is controversial which treatment is better. The present study aimed to compare outcomes, including mortality, of RP and EBRT for localized PC. Methods We retrospectively analyzed 891 patients with cT1-4N0M0 PC who underwent either RP (n = 569) or EBRT (n = 322) with curative intent at our single institution between 2005 and 2012. Of the EBRT patients, 302 (93.8%) underwent intensity-modulated radiotherapy. Primary endpoints were overall survival (OS) and cancer-specific survival (CSS). Related to these, other-cause mortality (OCM) was also calculated. Biochemical recurrence-free survival was assessed as a secondary endpoint. Cox proportional hazards model was used for multivariate analysis. Results edian follow-up durations were 53 and 45 months, and median ages were 66 and 70 years (P < 0.0001), in the RP and EBRT groups, respectively. As a whole, significantly better prognoses of the RP group than the EBRT group were observed for both OS and CSS, although OCM was significantly higher in the EBRT group. There was no death from PC in men with low and intermediate D'Amico risks, except one with intermediate-risk in the EBRT group. In high-risk patients, significantly more patients died from PC in the EBRT group than the RP group. Multivariate analysis demonstrated the RP group to be an independent prognostic factor for better CSS. On the other hand, the EBRT group had a significantly longer biochemical recurrence-free survival than the RP group. Conclusions Mortality outcomes of both RP and EBRT were generally favorable in low and intermediate risk patients. Improvement of CSS in high risk patients was seen in patients receiving RP over those receiving EBRT.	[Taguchi, Satoru; Fukuhara, Hiroshi; Kakutani, Shigenori; Takeshima, Yuta; Miyazaki, Hideyo; Fujimura, Tetsuya; Nakagawa, Tohru; Kume, Haruki; Homma, Yukio] Univ Tokyo, Grad Sch Med, Dept Urol, Tokyo, Japan; [Shiraishi, Kenshiro; Nakagawa, Keiichi] Tokyo Univ Hosp, Dept Radiol, Tokyo 113, Japan; [Morikawa, Teppei] Univ Tokyo, Grad Sch Med, Dept Pathol, Tokyo, Japan	University of Tokyo; University of Tokyo; University of Tokyo	Fukuhara, H (corresponding author), Univ Tokyo, Grad Sch Med, Dept Urol, Tokyo, Japan.	hfukuhara-jua@umin.ac.jp						Abdollah F, 2012, INT J UROL, V19, P836, DOI 10.1111/j.1442-2042.2012.03052.x; Aizer AA, 2009, RADIOTHER ONCOL, V93, P185, DOI 10.1016/j.radonc.2009.09.001; Arcangeli G, 2009, INT J RADIAT ONCOL, V75, P975, DOI 10.1016/j.ijrobp.2008.12.045; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; D'Amico AV, 1998, JAMA-J AM MED ASSOC, V280, P969, DOI 10.1001/jama.280.11.969; Dolezel M, 2015, STRAHLENTHER ONKOL, V191, P338, DOI 10.1007/s00066-014-0806-y; Ferlay J, 2013, IARC CANCERBASE; Hirao Y, 2012, CLIN PRACTICE GUIDEL; Hoffman RM, 2013, JNCI-J NATL CANCER I, V105, P711, DOI 10.1093/jnci/djt059; Kim YJ, 2015, STRAHLENTHER ONKOL, V191, P321, DOI 10.1007/s00066-014-0765-3; Kupelian PA, 2004, INT J RADIAT ONCOL, V58, P25, DOI 10.1016/S0360-3016(03)00784-3; Lieffers JR, 2012, BRIT J CANCER, V107, P931, DOI 10.1038/bjc.2012.350; Matsuda A, 2014, JPN J CLIN ONCOL, V44, P388, DOI 10.1093/jjco/hyu003; Merino T, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-530; Nakagawa K, 2007, IEEE T BIO-MED ENG, V54, P943, DOI 10.1109/TBME.2007.893490; Roach M, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2266; Roach M, 2006, INT J RADIAT ONCOL, V65, P965, DOI 10.1016/j.ijrobp.2006.04.029; Shiraishi K, 2015, P 74 ANN M JAP RAD S, pS247; Shiraishi Kenshiro, 2006, Radiat Med, V24, P17, DOI 10.1007/BF02489984; Sooriakumaran P, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2271; Sooriakumaran P, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g1502; Stephenson AJ, 2006, J CLIN ONCOL, V24, P3973, DOI 10.1200/JCO.2005.04.0756; Sun M, 2014, BJU INT, V113, P200, DOI 10.1111/bju.12321	23	13	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2015	10	10							e0141123	10.1371/journal.pone.0141123	http://dx.doi.org/10.1371/journal.pone.0141123			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU8PC	26506569	Green Submitted, gold, Green Published			2022-12-26	WOS:000363804200028
J	Yong, CSM; Westwood, JA; Schroder, J; Papenfuss, AT; von Scheidt, B; Moeller, M; Devaud, C; Darcy, PK; Kershaw, MH				Yong, Carmen S. M.; Westwood, Jennifer A.; Schroeder, Jan; Papenfuss, Anthony T.; von Scheidt, Bianca; Moeller, Maria; Devaud, Christel; Darcy, Phillip K.; Kershaw, Michael H.			Expression of a Chimeric Antigen Receptor in Multiple Leukocyte Lineages in Transgenic Mice	PLOS ONE			English	Article							T-CELL DEVELOPMENT; HIGH-COPY NUMBERS; IN-VIVO; VAV PROTOONCOGENE; HEMATOPOIETIC COMPARTMENT; ADOPTIVE IMMUNOTHERAPY; CHROMOSOMAL INTEGRATION; THYMOCYTE DEVELOPMENT; ESTABLISHED TUMORS; POSITIVE SELECTION	Genetically modified CD8(+) T lymphocytes have shown significant anti-tumor effects in the adoptive immunotherapy of cancer, with recent studies highlighting a potential role for a combination of other immune subsets to enhance these results. However, limitations in present genetic modification techniques impose difficulties in our ability to fully explore the potential of various T cell subsets and assess the potential of other leukocytes armed with chimeric antigen receptors (CARs). To address this issue, we generated a transgenic mouse model using a pan-hematopoietic promoter (vav) to drive the expression of a CAR specific for a tumor antigen. Here we present a characterization of the immune cell compartment in two unique vav-CAR transgenic mice models, Founder 9 (F9) and Founder 38 (F38). We demonstrate the vav promoter is indeed capable of driving the expression of a CAR in cells from both myeloid and lymphoid lineage, however the highest level of expression was observed in T lymphocytes from F38 mice. Lymphoid organs in vav-CAR mice were smaller and had reduced cell numbers compared to the wild type (WT) controls. Furthermore, the immune composition of F9 mice differed greatly with a significant reduction in lymphocytes found in the thymus, lymph node and spleen of these mice. To gain insight into the altered immune phenotype of F9 mice, we determined the chromosomal integration site of the transgene in both mouse strains using whole genome sequencing (WGS). We demonstrated that compared to the 7 copies found in F38 mice, F9 mice harbored almost 270 copies. These novel vav-CAR models provide a ready source of CAR expressing myeloid and lymphoid cells and will aid in facilitating future experiments to delineate the role for other leukocytes for adoptive immunotherapy against cancer.	[Yong, Carmen S. M.; Westwood, Jennifer A.; Papenfuss, Anthony T.; von Scheidt, Bianca; Moeller, Maria; Devaud, Christel; Darcy, Phillip K.; Kershaw, Michael H.] Univ Melbourne, Sir Peter MacCallum Dept Oncol, Parkville, Vic 3010, Australia; [Schroeder, Jan; Papenfuss, Anthony T.] Walter & Eliza Hall Inst Med Res, Bioinformat Div, Parkville, Vic 3052, Australia; [Schroeder, Jan; Papenfuss, Anthony T.] Peter MacCallum Canc Ctr, Bioinformat & Canc Genom, East Melbourne, Vic 3002, Australia; [Schroeder, Jan; Papenfuss, Anthony T.] Univ Melbourne, Dept Comp & Informat Syst, Parkville, Vic 3010, Australia; [Papenfuss, Anthony T.] Univ Melbourne, Dept Med Biol, Parkville, Vic 3010, Australia; [Devaud, Christel] Fac Med Toulouse, INSERM, U1043, CPTP, F-31073 Toulouse, France; [Darcy, Phillip K.; Kershaw, Michael H.] Monash Univ, Dept Immunol, Prahran, Vic 3181, Australia	Peter Maccallum Cancer Center; University of Melbourne; Walter & Eliza Hall Institute; Peter Maccallum Cancer Center; University of Melbourne; University of Melbourne; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Monash University	Devaud, C (corresponding author), Univ Melbourne, Sir Peter MacCallum Dept Oncol, Parkville, Vic 3010, Australia.	christel.devaud@inserm.fr; phil.darcy@petermac.org; Michael.kershaw@petermac.org	Papenfuss, Anthony T/C-6297-2008; Devaud, Christel'/W-8141-2019	Papenfuss, Anthony T/0000-0002-1102-8506; Devaud, Christel'/0000-0003-3511-3219; Kershaw, Michael/0000-0002-2697-487X; SCHROEDER, JAN/0000-0001-5270-0605; Darcy, Phillip/0000-0002-5303-9561	Cancer Council of Victoria, Australia [1066554]; National Health and Medical Research Council (NHMRC) of Australia [1003667]; Senior Research Fellowships from the NHMRC; National Health and Medical Research Council (NHMRC) Career Development Fellowship [1003856]; NHMRC Program Grant [1054618]; Victorian State Government Operational Infrastructure Support; Australian Government NHMRC Independent Research Institute Infrastructure Support Scheme	Cancer Council of Victoria, Australia(Canadian Institutes of Health Research (CIHR)Cancer Council Victoria); National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); Senior Research Fellowships from the NHMRC(National Health and Medical Research Council (NHMRC) of Australia); National Health and Medical Research Council (NHMRC) Career Development Fellowship(National Health and Medical Research Council (NHMRC) of Australia); NHMRC Program Grant(National Health and Medical Research Council (NHMRC) of Australia); Victorian State Government Operational Infrastructure Support; Australian Government NHMRC Independent Research Institute Infrastructure Support Scheme(Australian GovernmentNational Health and Medical Research Council (NHMRC) of Australia)	This work was supported by grants from the Cancer Council of Victoria, Australia (1066554) and the National Health and Medical Research Council (NHMRC) of Australia (1003667). MHK and PKD were supported by Senior Research Fellowships from the NHMRC. ATP was supported by a National Health and Medical Research Council (NHMRC) Career Development Fellowship (1003856), an NHMRC Program Grant (1054618), and benefitted from support by the Victorian State Government Operational Infrastructure Support and Australian Government NHMRC Independent Research Institute Infrastructure Support Scheme.	Bhatnagar S, 2014, J BIOL CHEM, V289, P25276, DOI 10.1074/jbc.M114.575985; Bhatnagar S, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002323; Bhavsar PJ, 2009, EXP CELL RES, V315, P3345, DOI 10.1016/j.yexcr.2009.08.010; BISHOP JO, 1989, MOL BIOL MED, V6, P283; Boeva V, 2012, BIOINFORMATICS, V28, P423, DOI 10.1093/bioinformatics/btr670; BRINSTER RL, 1981, CELL, V27, P223, DOI 10.1016/0092-8674(81)90376-7; Bustelo XR, 2000, MOL CELL BIOL, V20, P1461, DOI 10.1128/MCB.20.5.1461-1477.2000; BUSTELO XR, 1992, NATURE, V356, P68, DOI 10.1038/356068a0; Chan GD, 2001, EUR J IMMUNOL, V31, P2403, DOI 10.1002/1521-4141(200108)31:8<2403::AID-IMMU2403>3.0.CO;2-O; Chen ZY, 2001, MOL THER, V3, P403, DOI 10.1006/mthe.2001.0278; Chu DH, 1998, IMMUNOL REV, V165, P167, DOI 10.1111/j.1600-065X.1998.tb01238.x; Colucci F, 2001, J EXP MED, V193, P1413, DOI 10.1084/jem.193.12.1413; Corre I, 2001, J EXP MED, V194, P903, DOI 10.1084/jem.194.7.903; Darcy PK, 2000, J IMMUNOL, V164, P3705, DOI 10.4049/jimmunol.164.7.3705; Davila ML, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008226; DeFranco AL, 2001, NAT IMMUNOL, V2, P482, DOI 10.1038/88669; Fischer KD, 1998, CURR BIOL, V8, P554, DOI 10.1016/S0960-9822(98)70224-6; FISCHER KD, 1995, NATURE, V374, P474, DOI 10.1038/374474a0; FOLGER KR, 1982, MOL CELL BIOL, V2, P1372, DOI 10.1128/MCB.2.11.1372; Frankel TL, 2010, J IMMUNOL, V184, P5988, DOI 10.4049/jimmunol.1000189; Fujikawa K, 2003, J EXP MED, V198, P1595, DOI 10.1084/jem.20030874; Gakidis MAM, 2004, J CELL BIOL, V166, P273, DOI 10.1083/jcb.200404166; Geerts CJ, 2014, BRAIN STRUCTURE FUNC; GILFILLAN S, 1990, P NATL ACAD SCI USA, V87, P7319, DOI 10.1073/pnas.87.18.7319; Godfrey DI, 2000, IMMUNOL TODAY, V21, P573, DOI 10.1016/S0167-5699(00)01735-7; Hall AB, 2006, IMMUNITY, V24, P305, DOI 10.1016/j.immuni.2006.02.005; HAMADA T, 1993, GENE, V128, P197, DOI 10.1016/0378-1119(93)90563-I; Haynes NM, 2001, J IMMUNOL, V166, P182, DOI 10.4049/jimmunol.166.1.182; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; John LB, 2013, CLIN CANCER RES, V19, P5636, DOI 10.1158/1078-0432.CCR-13-0458; Klebanoff CA, 2011, CLIN CANCER RES, V17, P5343, DOI 10.1158/1078-0432.CCR-11-0503; Klug F, 2013, CANCER CELL, V24, P589, DOI 10.1016/j.ccr.2013.09.014; Kochenderfer JN, 2014, J CLIN ONCOLOGY OFFI; Lacorazza HD, 2001, J IMMUNOL, V167, P5689, DOI 10.4049/jimmunol.167.10.5689; Lahl K, 2011, METHODS MOL BIOL, V707, P157, DOI 10.1007/978-1-61737-979-6_10; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Le Bourhis L, 2011, TRENDS IMMUNOL, V32, P212, DOI 10.1016/j.it.2011.02.005; Lu Y, 2014, P NATL ACAD SCI USA, V111, P2265, DOI 10.1073/pnas.1317431111; MARGOLIS B, 1992, NATURE, V356, P71, DOI 10.1038/356071a0; Maude SL, 2014, NEW ENGL J MED, V371, P1507, DOI 10.1056/NEJMoa1407222; Moeller M, 2005, BLOOD, V106, P2995, DOI 10.1182/blood-2004-12-4906; Morgan DJ, 1996, J IMMUNOL, V157, P978; Ogilvy S, 1998, BLOOD, V91, P419, DOI 10.1182/blood.V91.2.419.419_419_430; Ogilvy S, 1999, BLOOD, V94, P1855; Ogilvy S, 1999, P NATL ACAD SCI USA, V96, P14943, DOI 10.1073/pnas.96.26.14943; Overwijk WW, 2003, J EXP MED, V198, P569, DOI 10.1084/jem.20030590; Piechocki MP, 2003, J IMMUNOL, V171, P5787, DOI 10.4049/jimmunol.171.11.5787; Pivniouk V, 1998, CELL, V94, P229, DOI 10.1016/S0092-8674(00)81422-1; Raberger J, 2008, EUR J IMMUNOL, V38, P3530, DOI 10.1002/eji.200838388; Restifo NP, 2012, NAT REV IMMUNOL, V12, P269, DOI 10.1038/nri3191; Saveliev A, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000420; Schietinger A, 2010, J EXP MED, V207, P2469, DOI 10.1084/jem.20092450; Schroder J, 2014, BIOINFORMATICS; Singer SM, 1996, P NATL ACAD SCI USA, V93, P2947, DOI 10.1073/pnas.93.7.2947; Singer T, 2003, METH MOL B, V236, P241; Slater GS, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-31; TARAKHOVSKY A, 1995, NATURE, V374, P467, DOI 10.1038/374467a0; Turner M, 2002, NAT REV IMMUNOL, V2, P476, DOI 10.1038/nri840; Turner M, 1997, IMMUNITY, V7, P451, DOI 10.1016/S1074-7613(00)80367-2; Walker JA, 2013, NAT REV IMMUNOL, V13, P75, DOI 10.1038/nri3349; WANG BP, 1994, P NATL ACAD SCI USA, V91, P9402, DOI 10.1073/pnas.91.20.9402; Wells CM, 2005, EXP CELL RES, V310, P303, DOI 10.1016/j.yexcr.2005.07.015; Williams AL, 2011, J BIOL CHEM, V286, P14542, DOI 10.1074/jbc.M110.215624; Yan BW, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-58; ZHANG R, 1995, NATURE, V374, P470, DOI 10.1038/374470a0; Zhang WG, 1999, IMMUNITY, V10, P323, DOI 10.1016/S1074-7613(00)80032-1; ZMUIDZINAS A, 1995, EMBO J, V14, P1	67	9	9	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2015	10	10							e0140543	10.1371/journal.pone.0140543	http://dx.doi.org/10.1371/journal.pone.0140543			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU8PC	26505904	Green Published, Green Submitted, gold			2022-12-26	WOS:000363804200012
J	Haigney, A; Ricketts, MD; Marmorstein, R				Haigney, Allison; Ricketts, M. Daniel; Marmorstein, Ronen			Dissecting the Molecular Roles of Histone Chaperones in Histone Acetylation by Type B Histone Acetyltransferases (HAT-B)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRUCTURAL BASIS; CHROMATIN REPLICATION; HAT1P/HAT2P COMPLEX; H4; YEAST; H3; DNA; ASF1; H-4; HETERODIMER	The HAT-B enzyme complex is responsible for acetylating newly synthesized histone H4 on lysines K5 and K12. HAT-B is a multisubunit complex composed of the histone acetyltransferase 1 (Hat1) catalytic subunit and the Hat2 (rbap46) histone chaperone. Hat1 is predominantly localized in the nucleus as a member of a trimeric NuB4 complex containing Hat1, Hat2, and a histone H3-H4 specific histone chaperone called Hif1 (NASP). In addition to Hif1 and Hat2, Hat1 interacts with Asf1 (anti-silencing function 1), a histone chaperone that has been reported to be involved in both replication-dependent and-independent chromatin assembly. To elucidate the molecular roles of the Hif1 and Asf1 histone chaperones inHAT-Bhistone binding and acetyltransferase activity, we have characterized the stoichiometry and binding mode of Hif1 and Asf1 to HAT-B and the effect of this binding on the enzymatic activity of HAT-B. We find that Hif1 and Asf1 bind through different modes and independently to HAT-B, whereby Hif1 binds directly to Hat2, and Asf1 is only capable of interactions with HAT-B through contacts with histones H3-H4. We also demonstrate that HAT-B is significantly more active against an intact H3-H4 heterodimer over a histone H4 peptide, independent of either Hif1 or Asf1 binding. Mutational studies further demonstrate that HAT-B binding to the histone tail regions is not sufficient for this enhanced activity. Based on these data, we propose a model for HAT-B/histone chaperone assembly and acetylation of H3-H4 complexes.	[Haigney, Allison; Ricketts, M. Daniel; Marmorstein, Ronen] Univ Penn, Perelman Sch Med, Abramson Family Canc Res Inst, Dept Biochem & Biophys, Philadelphia, PA 19104 USA; [Ricketts, M. Daniel] Univ Penn, Perelman Sch Med, Grad Grp Biochem & Mol Biophys, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania	Marmorstein, R (corresponding author), Univ Penn, Perelman Sch Med, Abramson Family Canc Res Inst, Dept Biochem & Biophys, 421 Curie Blvd, Philadelphia, PA 19104 USA.	marmor@mail.med.upenn.edu	Regan, Clinton/E-6250-2012		National Institutes of Health [R01 GM060293, P01 AG031862, F32CA180504, P30 CA010815, P30 CA016520]; NATIONAL CANCER INSTITUTE [P30CA016520, P30CA010815, F32CA180504] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060293] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG031862] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health Grants R01 GM060293 and P01 AG031862 (to R. M.), Training Grant F32CA180504 (to A. H.), Grant P30 CA010815 (to the proteomics core facility at the Wistar Institute), and Grant P30 CA016520 (to the University of Pennsylvania DNA Sequencing Facility at the Perelman School of Medicine). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ai X, 2004, MOL CELL, V14, P195, DOI 10.1016/S1097-2765(04)00184-4; ANNUNZIATO AT, 1983, J BIOL CHEM, V258, P2675; Benson LJ, 2006, J BIOL CHEM, V281, P9287, DOI 10.1074/jbc.M512956200; Brownell JE, 1996, CURR OPIN GENET DEV, V6, P176, DOI 10.1016/S0959-437X(96)80048-7; Campos EI, 2010, NAT STRUCT MOL BIOL, V17, P1343, DOI 10.1038/nsmb.1911; CHICOINE LG, 1986, J BIOL CHEM, V261, P1071; COUSENS LS, 1982, J BIOL CHEM, V257, P3945; English CM, 2006, CELL, V127, P495, DOI 10.1016/j.cell.2006.08.047; English CM, 2005, BIOCHEMISTRY-US, V44, P13673, DOI 10.1021/bi051333h; Ge ZQ, 2011, J BIOL CHEM, V286, P16790, DOI 10.1074/jbc.M110.216846; Groth A, 2007, SCIENCE, V318, P1928, DOI 10.1126/science.1148992; Han JH, 2007, J BIOL CHEM, V282, P28587, DOI 10.1074/jbc.M702496200; Harding S. E., 1992, ANAL ULTRACENTRIFUGA; Jasencakova Z, 2010, MOL CELL, V37, P736, DOI 10.1016/j.molcel.2010.01.033; KLEFF S, 1995, J BIOL CHEM, V270, P24674, DOI 10.1074/jbc.270.42.24674; Lebowitz J, 2002, PROTEIN SCI, V11, P2067, DOI 10.1110/ps.0207702; Lee KK, 2007, NAT REV MOL CELL BIO, V8, P284, DOI 10.1038/nrm2145; Li Y, 2014, GENE DEV, V28, P1217, DOI 10.1101/gad.240531.114; Ma XJ, 1998, P NATL ACAD SCI USA, V95, P6693, DOI 10.1073/pnas.95.12.6693; MINGARRO I, 1993, J BIOL CHEM, V268, P13248; Murzina NV, 2008, STRUCTURE, V16, P1077, DOI 10.1016/j.str.2008.05.006; Nagarajan P, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003518; Natsume R, 2007, NATURE, V446, P338, DOI 10.1038/nature05613; Parthun MR, 2012, BBA-GENE REGUL MECH, V1819, P256, DOI 10.1016/j.bbagrm.2011.07.006; Parthun MR, 1996, CELL, V87, P85, DOI 10.1016/S0092-8674(00)81325-2; Poveda A, 2004, J BIOL CHEM, V279, P16033, DOI 10.1074/jbc.M314228200; Qin S, 2002, MOL CELL BIOL, V22, P8353, DOI 10.1128/MCB.22.23.8353-8365.2002; RICHMAN R, 1988, J CELL BIOL, V106, P1017, DOI 10.1083/jcb.106.4.1017; Ricketts MD, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8711; Ruiz-Garcia AB, 1998, J BIOL CHEM, V273, P12599, DOI 10.1074/jbc.273.20.12599; SOBEL RE, 1994, J BIOL CHEM, V269, P18576; WIEGAND RC, 1981, J BIOL CHEM, V256, P4578; Winkler DD, 2012, NUCLEIC ACIDS RES, V40, P10139, DOI 10.1093/nar/gks812; Wu H, 2012, P NATL ACAD SCI USA, V109, P8925, DOI 10.1073/pnas.1114117109; Yan Y, 2002, NAT STRUCT BIOL, V9, P862, DOI 10.1038/nsb849	35	18	19	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2015	290	51					30648	30657		10.1074/jbc.M115.688523	http://dx.doi.org/10.1074/jbc.M115.688523			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CY9PG	26522166	Green Published, hybrid			2022-12-26	WOS:000366738200039
J	Shanmugam, NKN; Chen, KJ; Cherayil, BJ				Shanmugam, Nanda Kumar N.; Chen, Kejie; Cherayil, Bobby J.			Commensal Bacteria-induced Interleukin 1 beta (IL-1 beta) Secreted by Macrophages Up-regulates Hepcidin Expression in Hepatocytes by Activating the Bone Morphogenetic Protein Signaling Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTESTINAL INFLAMMATION; IRON; FERROPORTIN; ANEMIA; STAT3; BMP6; SMAD1/5/8; AUTOPHAGY; DISEASE; AXIS	The liver hormone hepcidin is the central regulator of systemic iron metabolism. Its increased expression in inflammatory states leads to hypoferremia and anemia. Elucidation of the mechanisms that up-regulate hepcidin during inflammation is essential for developing rational therapies for this anemia. Using mouse models of inflammatory bowel disease, we have shown previously that colitis-associated hepcidin induction is influenced by intestinal microbiota composition. Here we investigate how two commensal bacteria, Bifidobacterium longum and Bacteroides fragilis, representative members of the gut microbiota, affect hepcidin expression. We found that supernatants of a human macrophage cell line infected with either of the bacteria up-regulated hepcidin when added to a human hepatocyte cell line. This activity was abrogated by neutralization of IL-1 beta. Moreover, purified IL-1 beta increased hepcidin expression when added to the hepatocyte line or primary human hepatocytes and when injected into mice. IL-1 beta activated the bone morphogenetic protein (BMP) signaling pathway in hepatocytes and in mouse liver, as indicated by increased phosphorylation of small mothers against decapentaplegic proteins. Activation of BMP signaling correlated with IL-1 beta -induced expression of BMP2in human hepatocytes and activinBin mouse liver. Treatment of hepatocytes with two different chemical inhibitors of BMP signaling or with a neutralizing antibody to BMP2 prevented IL-1 beta-induced up-regulation of hepcidin. Our results clarify how commensal bacteria affect hepcidin expression and reveal a novel connection between IL-1 beta and activation of BMP signaling. They also suggest that there may be differences between mice and humans with respect to the mechanism by which IL-1 beta up-regulates hepcidin.	[Shanmugam, Nanda Kumar N.; Chen, Kejie; Cherayil, Bobby J.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Mucosal Immunol & Biol Res Ctr,Dept Pediat, Boston, MA 02129 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital	Cherayil, BJ (corresponding author), Massachusetts Gen Hosp, Mucosal Immunol & Biol Res Ctr, Bldg 114,16th St, Charlestown, MA 02129 USA.	cherayil@helix.mgh.harvard.edu	Regan, Clinton/E-6250-2012		National Institutes of Health [R01 AI089700]; China Scholarship Council; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI089700] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK040561] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); China Scholarship Council(China Scholarship Council); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grant R01 AI089700 (to B. J. C.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by funding from the China Scholarship Council.	Andriopoulos B, 2009, NAT GENET, V41, P482, DOI 10.1038/ng.335; Babitt JL, 2007, J CLIN INVEST, V117, P1933, DOI 10.1172/JCI31342; Besson-Fournier C, 2012, BLOOD, V120, P431, DOI 10.1182/blood-2012-02-411470; Bode JG, 2012, EUR J CELL BIOL, V91, P496, DOI 10.1016/j.ejcb.2011.09.008; Cohen P, 2014, J CELL SCI, V127, P2383, DOI 10.1242/jcs.149831; Core AB, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00104; Cuny GD, 2008, BIOORG MED CHEM LETT, V18, P4388, DOI 10.1016/j.bmcl.2008.06.052; de Luca A, 2014, P NATL ACAD SCI USA, V111, P3526, DOI 10.1073/pnas.1322831111; DeBleser PJ, 1997, HEPATOLOGY, V26, P905; Drakesmith H, 2012, SCIENCE, V338, P768, DOI 10.1126/science.1224577; DUNN JCY, 1991, BIOTECHNOL PROGR, V7, P237, DOI 10.1021/bp00009a007; Erichsen K, 2005, SCAND J GASTROENTERO, V40, P1058, DOI 10.1080/00365520510023198; Falzacappa MVV, 2007, BLOOD, V109, P353, DOI 10.1182/blood-2006-07-033969; Ganz T, 2013, PHYSIOL REV, V93, P1721, DOI 10.1152/physrev.00008.2013; Kautz L, 2008, BLOOD, V112, P1503, DOI 10.1182/blood-2008-03-143354; Koening CL, 2009, J INFLAMM-LOND, V6, DOI 10.1186/1476-9255-6-33; Kramer F, 2008, MOL IMMUNOL, V45, P2678, DOI 10.1016/j.molimm.2007.12.017; Kulnigg S, 2006, ALIMENT PHARM THER, V24, P1507, DOI 10.1111/j.1365-2036.2006.03146.x; Lee P, 2005, P NATL ACAD SCI USA, V102, P1906, DOI 10.1073/pnas.0409808102; Lozupone CA, 2012, NATURE, V489, P220, DOI 10.1038/nature11550; MAHIDA YR, 1989, GUT, V30, P835, DOI 10.1136/gut.30.6.835; Matak P, 2009, HAEMATOL-HEMATOL J, V94, P773, DOI 10.3324/haematol.2008.003400; Meynard D, 2009, NAT GENET, V41, P478, DOI 10.1038/ng.320; Nemeth E, 2004, SCIENCE, V306, P2090, DOI 10.1126/science.1104742; Nemeth E, 2004, J CLIN INVEST, V113, P1271, DOI 10.1172/JCI200420945; Nemeth E, 2014, HEMATOL ONCOL CLIN N, V28, P671, DOI 10.1016/j.hoc.2014.04.005; Parrow NL, 2014, ANNU REV NUTR, V34, P77, DOI 10.1146/annurev-nutr-071813-105646; Pietrangelo A, 2007, GASTROENTEROLOGY, V132, P294, DOI 10.1053/j.gastro.2006.10.018; Plantinga TS, 2011, GUT, V60, P1229, DOI 10.1136/gut.2010.228908; Saitoh T, 2008, NATURE, V456, P264, DOI 10.1038/nature07383; Seo SU, 2015, IMMUNITY, V42, P744, DOI 10.1016/j.immuni.2015.03.004; Shanmugam NKN, 2014, J IMMUNOL, V193, P1398, DOI 10.4049/jimmunol.1400278; Shanmugam NKN, 2013, BIOCHEM BIOPH RES CO, V441, P383, DOI 10.1016/j.bbrc.2013.10.065; Shanmugam NKN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038136; Sun CC, 2012, AM J HEMATOL, V87, P392, DOI 10.1002/ajh.23110; Truksa J, 2009, BLOOD, V113, P688, DOI 10.1182/blood-2008-05-160184; Vanaja SK, 2015, TRENDS CELL BIOL, V25, P308, DOI 10.1016/j.tcb.2014.12.009; Wang LJ, 2012, INFLAMM BOWEL DIS, V18, P112, DOI 10.1002/ibd.21675; Wang LJ, 2009, J CLIN INVEST, V119, P3322, DOI 10.1172/JCI39939; Ward DM, 2012, BBA-MOL CELL RES, V1823, P1426, DOI 10.1016/j.bbamcr.2012.03.004; Werner T, 2011, GUT, V60, P325, DOI 10.1136/gut.2010.216929; Worthen CA, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00034; Wrighting DM, 2006, BLOOD, V108, P3204, DOI 10.1182/blood-2006-06-027631; Yui PB, 2008, NAT CHEM BIOL, V4, P33, DOI 10.1038/nchembio.2007.54; Zhang AS, 2011, BLOOD, V117, P1687, DOI 10.1182/blood-2010-06-287292; Zimmermann MB, 2010, AM J CLIN NUTR, V92, P1406, DOI 10.3945/ajcn.110.004564	46	30	31	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2015	290	51					30637	30647		10.1074/jbc.M115.689190	http://dx.doi.org/10.1074/jbc.M115.689190			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CY9PG	26515063	Green Published, hybrid			2022-12-26	WOS:000366738200038
J	Textoris-Taube, K; Keller, C; Liepe, J; Henklein, P; Sidney, J; Sette, A; Kloetzel, PM; Mishto, M				Textoris-Taube, Kathrin; Keller, Christin; Liepe, Juliane; Henklein, Petra; Sidney, John; Sette, Alessandro; Kloetzel, Peter M.; Mishto, Michele			The T210M Substitution in the HLA-a*02:01 gp100 Epitope Strongly Affects Overall Proteasomal Cleavage Site Usage and Antigen Processing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CTL EPITOPE; PEPTIDE HYDROLYSIS; IMMUNOPROTEASOMES; RECOGNITION; SEQUENCE; BINDING; INDUCTION; STANDARD; LENGTH	MHC class I-restricted epitopes, which carry a tumor-specific mutation resulting in improved MHC binding affinity, are preferred T cell receptor targets in innovative adoptive T cell therapies. However, T cell therapy requires efficient generation of the selected epitope. How such mutations may affect proteasome-mediated antigen processing has so far not been studied. Therefore, we analyzed by in vitro experiments the effect on antigen processing and recognition of a T210M exchange, which previously had been introduced into the melanoma gp100(209-217) tumor epitope to improve the HLA-A*02: 01 binding and its immunogenicity. A quantitative analysis of the main steps of antigen processing shows that the T210M exchange affects proteasomal cleavage site usage within the (mut)gp100(201-230) polypeptide, leading to the generation of an unique set of cleavage products. The T210M substitution qualitatively affects the proteasome-catalyzed generation of spliced and non-spliced peptides predicted to bind HLA-A or -B complexes. The T210M substitution also induces an enhanced production of the (mut)gp100(209-217) epitope and its N-terminally extended peptides. The T210M exchange revealed no effect on ERAP1-mediated N-terminal trimming of the precursor peptides. However, mutant N-terminally extended peptides exhibited significantly increased HLA-A*02:01 binding affinity and elicited CD8(+) T cell stimulation in vitro similar to the (wt)gp100(209-217) epitope. Thus, our experiments demonstrate that amino acid exchanges within an epitope can result in the generation of an altered peptide pool with new antigenic peptides and in a wider CD8(+) T cell response also towards N-terminally extended versions of the minimal epitope.	[Textoris-Taube, Kathrin; Keller, Christin; Henklein, Petra; Kloetzel, Peter M.; Mishto, Michele] Charite, Inst Biochem, D-10117 Berlin, Germany; [Liepe, Juliane] Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, Ctr Integrat Syst Biol & Bioinformat, London SW7 2AZ, England; [Sidney, John; Sette, Alessandro] La Jolla Inst Allergy & Immunol, Div Vaccine Discovery, La Jolla, CA 92037 USA	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Imperial College London; La Jolla Institute for Immunology	Kloetzel, PM (corresponding author), Charite, Inst Biochem, Charitepl 1,Virchowweg 6, D-10117 Berlin, Germany.	p-m.kloetzel@charite.de; michele.mishto@charite.de	mishto, michele/A-5592-2010; Sette, Alessandro/AFO-8916-2022	mishto, michele/0000-0003-3042-2792; Henklein, Petra/0000-0001-7468-8926; Liepe, Juliane/0000-0003-2515-9707	Berlin Institute of Health [CRG1-TP1]; Einstein Stiftung Berlin [A2013-174]; NC3Rs (National Center for the Replacement, Refinement, and Reduction of Animal in Research) through a David Sainsbury Fellowship [NC/K001949/1]; National Centre for the Replacement [NC/K001949/1] Funding Source: researchfish	Berlin Institute of Health; Einstein Stiftung Berlin; NC3Rs (National Center for the Replacement, Refinement, and Reduction of Animal in Research) through a David Sainsbury Fellowship(UK Research & Innovation (UKRI)National Centre for the Replacement, Refinement & Reduction of Animals in Research (NC3Rs)); National Centre for the Replacement	This work was supported by a grant of the Berlin Institute of Health (CRG1-TP1) and the Einstein Stiftung Berlin (A2013-174) (to P. M. K.) and by NC3Rs (National Center for the Replacement, Refinement, and Reduction of Animal in Research) through a David Sainsbury Fellowship (to J. L.) (NC/K001949/1). The authors declare that they have no conflict of interest.	Beekman NJ, 2000, J IMMUNOL, V164, P1898, DOI 10.4049/jimmunol.164.4.1898; Blankenstein T, 2015, CURR OPIN IMMUNOL, V33, P112, DOI 10.1016/j.coi.2015.02.005; Chapiro J, 2006, J IMMUNOL, V176, P1053, DOI 10.4049/jimmunol.176.2.1053; Dalet A, 2011, EUR J IMMUNOL, V41, P39, DOI 10.1002/eji.201040750; Dalet A, 2010, J IMMUNOL, V184, P3016, DOI 10.4049/jimmunol.0901277; DELVAL M, 1991, CELL, V66, P1145, DOI 10.1016/0092-8674(91)90037-Y; Deol P, 2007, J IMMUNOL, V178, P7557, DOI 10.4049/jimmunol.178.12.7557; EGGERS M, 1995, J EXP MED, V182, P1865, DOI 10.1084/jem.182.6.1865; Gulukota K, 1997, J MOL BIOL, V267, P1258, DOI 10.1006/jmbi.1997.0937; Hanada K, 2004, NATURE, V427, P252, DOI 10.1038/nature02240; Hassan C, 2015, J BIOL CHEM, V290, P2593, DOI 10.1074/jbc.M114.607028; Kincaid EZ, 2012, NAT IMMUNOL, V13, P129, DOI 10.1038/ni.2203; Kisselev AF, 2002, J BIOL CHEM, V277, P22260, DOI 10.1074/jbc.M112360200; Liepe J, 2015, ELIFE, V4, DOI 10.7554/eLife.07545; Liepe J, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000830; Liu YC, 2013, J BIOL CHEM, V288, P15442, DOI 10.1074/jbc.M112.447185; Lundegaard C, 2008, NUCLEIC ACIDS RES, V36, pW509, DOI 10.1093/nar/gkn202; Melief CJM, 2008, NAT REV CANCER, V8, P351, DOI 10.1038/nrc2373; Mishto M, 2008, J MOL BIOL, V377, P1607, DOI 10.1016/j.jmb.2008.01.086; Mishto M, 2014, EUR J IMMUNOL, V44, P3508, DOI 10.1002/eji.201444902; Mishto M, 2012, MOL CELL PROTEOMICS, V11, P1008, DOI 10.1074/mcp.M112.020164; Mommen GPM, 2014, P NATL ACAD SCI USA, V111, P4507, DOI 10.1073/pnas.1321458111; Ossendorp F, 1996, IMMUNITY, V5, P115, DOI 10.1016/S1074-7613(00)80488-4; Parkhurst MR, 1996, J IMMUNOL, V157, P2539; Saric T, 2002, NAT IMMUNOL, V3, P1169, DOI 10.1038/ni859; Schmidtke G, 2000, J BIOL CHEM, V275, P22056, DOI 10.1074/jbc.M002513200; Seifert U, 2004, J CLIN INVEST, V114, P250, DOI 10.1172/JCI200420985; Sidney J., 2013, CURR PROTOC IMMUNOL, V100, p18.3.1, DOI [DOI 10.1002/0471142735.IM1803S100, 10.1002/0471142735.im1803s100]; Sijts AJAM, 2000, J IMMUNOL, V164, P4500, DOI 10.4049/jimmunol.164.9.4500; Strehl B, 2006, J IMMUNOL, V177, P6238, DOI 10.4049/jimmunol.177.9.6238; Tenzer S, 2009, NAT IMMUNOL, V10, P636, DOI 10.1038/ni.1728; Theobald M, 1998, J EXP MED, V188, P1017, DOI 10.1084/jem.188.6.1017; Tynan FE, 2005, NAT IMMUNOL, V6, P1114, DOI 10.1038/ni1257; Velders MP, 2001, J IMMUNOL, V166, P5366, DOI 10.4049/jimmunol.166.9.5366; Vigneron N, 2004, SCIENCE, V304, P587, DOI 10.1126/science.1095522; Vigneron N, 2012, CURR OPIN IMMUNOL, V24, P84, DOI 10.1016/j.coi.2011.12.002; Zanker D, 2014, EUR J IMMUNOL, V44, P3500, DOI 10.1002/eji.201445272; Zanker D, 2013, J IMMUNOL, V191, P52, DOI 10.4049/jimmunol.1300802	38	19	20	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2015	290	51					30417	30428		10.1074/jbc.M115.695189	http://dx.doi.org/10.1074/jbc.M115.695189			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CY9PG	26507656	Green Published, hybrid			2022-12-26	WOS:000366738200019
J	Nilsson, M; Szczepankiewicz, F; van Westen, D; Hansson, O				Nilsson, Markus; Szczepankiewicz, Filip; van Westen, Danielle; Hansson, Oskar			Extrapolation-Based References Improve Motion and Eddy-Current Correction of High B-Value DWI Data: Application in Parkinson's Disease Dementia	PLOS ONE			English	Article							DIFFUSIONAL KURTOSIS; WATER DIFFUSION; ORIENTATION DISPERSION; IMAGE REGISTRATION; IN-VIVO; BRAIN; MICROSTRUCTURE; DISTORTION; QUANTIFICATION; ELIMINATION	Purpose Conventional motion and eddy-current correction, where each diffusion-weighted volume is registered to a non diffusion-weighted reference, suffers from poor accuracy for high b-value data. An alternative approach is to extrapolate reference volumes from low b-value data. We aim to compare the performance of conventional and extrapolation-based correction of diffusional kurtosis imaging (DKI) data, and to demonstrate the impact of the correction approach on group comparison studies. Methods DKI was performed in patients with Parkinson's disease dementia (PDD), and healthy age-matched controls, using b-values of up to 2750 s/mm(2). The accuracy of conventional and extrapolation-based correction methods was investigated. Parameters from DTI and DKI were compared between patients and controls in the cingulum and the anterior thalamic projection tract. Results Conventional correction resulted in systematic registration errors for high b-value data. The extrapolation-based methods did not exhibit such errors, yielding more accurate tractography and up to 50% lower standard deviation in DKI metrics. Statistically significant differences were found between patients and controls when using the extrapolation-based motion correction that were not detected when using the conventional method. Conclusion We recommend that conventional motion and eddy-current correction should be abandoned for high b-value data in favour of more accurate methods using extrapolation-based references.	[Nilsson, Markus] Lund Univ, Bioimaging Ctr, Lund, Sweden; [Szczepankiewicz, Filip] Lund Univ, Dept Med Radiat Phys, Lund, Sweden; [van Westen, Danielle] Lund Univ, Dept Radiol, Lund, Sweden; [van Westen, Danielle] Skane Univ Hosp, Imaging & Physiol, Lund, Sweden; [Hansson, Oskar] Lund Univ, Dept Clin Sci, Clin Memory Res Unit, Lund, Sweden; [Hansson, Oskar] Skane Univ Hosp, Memory Clin, Malmo, Sweden	Lund University; Lund University; Lund University; Lund University; Skane University Hospital; Lund University; Lund University; Skane University Hospital	Nilsson, M (corresponding author), Lund Univ, Bioimaging Ctr, Lund, Sweden.	markus.nilsson@med.lu.se	Szczepankiewicz, Filip/AAV-9958-2021; Hansson, Oskar/A-7134-2013; Nilsson, Markus/C-6920-2012	Szczepankiewicz, Filip/0000-0002-5251-587X; Hansson, Oskar/0000-0001-8467-7286; Nilsson, Markus/0000-0002-3140-8223; van Westen, Danielle/0000-0001-8649-9874	European Research Council; Swedish Research Council; Parkinson Foundation of Sweden; Swedish Brain Foundation; Swedish Cancer Society [CAN 2009/1076]; Swedish Foundation for Strategic Research [AM13-0090]; Swedish Federal Government under the ALF Agreement	European Research Council(European Research Council (ERC)European Commission); Swedish Research Council(Swedish Research CouncilEuropean Commission); Parkinson Foundation of Sweden; Swedish Brain Foundation; Swedish Cancer Society(Swedish Cancer Society); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Swedish Federal Government under the ALF Agreement	The study was supported by the European Research Council, the Swedish Research Council, The Parkinson Foundation of Sweden, the Swedish Brain Foundation, the Swedish Cancer Society (grant no. CAN 2009/1076), the Swedish Foundation for Strategic Research (AM13-0090), and the Swedish Federal Government under the ALF Agreement. The funding sources had no role in the design and conduct of the study; in the collection, analysis, interpretation of the data; or in the preparation, review, or approval of the manuscript.	Andersson J.L.R, 2007, TR07JA2 FMRIB; Andersson JLR, 2002, NEUROIMAGE, V16, P177, DOI 10.1006/nimg.2001.1039; Assaf Y, 2005, NEUROIMAGE, V27, P48, DOI 10.1016/j.neuroimage.2005.03.042; Assaf Y, 2004, MAGN RESON MED, V52, P965, DOI 10.1002/mrm.20274; Assaf Y, 2008, J MOL NEUROSCI, V34, P51, DOI 10.1007/s12031-007-0029-0; Bai Y, 2008, BIOMEDICAL IMAGING N, DOI [10.1109/ISBI.2008.4541154, DOI 10.1109/ISBI.2008.4541154]; Bastin ME, 2001, MAGN RESON IMAGING, V19, P937, DOI 10.1016/S0730-725X(01)00427-1; Ben-Amitay S, 2012, MAGN RESON MED, V67, P1694, DOI 10.1002/mrm.23186; Bennett KM, 2003, MAGNET RESON MED, V50, P727, DOI 10.1002/mrm.10581; Bracht T, 2015, J AFFECT DISORDERS, V170, P143, DOI 10.1016/j.jad.2014.08.031; Burton EJ, 2004, BRAIN, V127, P791, DOI 10.1093/brain/awh088; Chan LL, 2007, J NEUROL NEUROSUR PS, V78, P1383, DOI 10.1136/jnnp.2007.121525; Child ND, 2013, NEUROLOGY, V81, P1869, DOI 10.1212/01.wnl.0000436078.95856.56; Compta Y, 2011, BRAIN, V134, P1493, DOI 10.1093/brain/awr031; Crum WR, 2003, NEUROIMAGE, V20, P1425, DOI 10.1016/j.neuroimage.2003.07.014; Douaud G, 2011, NEUROIMAGE, V55, P880, DOI 10.1016/j.neuroimage.2010.12.008; Emre M, 2007, MOVEMENT DISORD, V22, P1689, DOI 10.1002/mds.21507; Gattellaro G, 2009, AM J NEURORADIOL, V30, P1222, DOI 10.3174/ajnr.A1556; Hansen MS, 2013, MAGN RESON MED, V69, P1768, DOI [10.1002/mrm.24743, 10.1002/mrm.24389]; Haselgrove JC, 1996, MAGNET RESON MED, V36, P960, DOI 10.1002/mrm.1910360620; Irfanoglu MO, 2015, NEUROIMAGE, V106, P284, DOI 10.1016/j.neuroimage.2014.11.042; Jensen JH, 2011, NMR BIOMED, V24, P452, DOI 10.1002/nbm.1610; Jensen JH, 2005, MAGNET RESON MED, V53, P1432, DOI 10.1002/mrm.20508; Jones DK, 2013, NEUROPSYCHOLOGIA, V51, P67, DOI 10.1016/j.neuropsychologia.2012.11.018; Kamagata K, 2013, MAGN RESON IMAGING, V31, P1501, DOI 10.1016/j.mri.2013.06.009; Klein S, 2010, IEEE T MED IMAGING, V29, P196, DOI 10.1109/TMI.2009.2035616; Lasic S, 2014, FRONT PHYS-LAUSANNE, V2, DOI 10.3389/fphy.2014.00011; Latt J, 2010, P INT SOC MAG RESON, P3972; Latt J, 2013, J MAGN RESON IMAGING, V37, P610, DOI 10.1002/jmri.23857; Lebel C, 2012, NEUROIMAGE, V60, P340, DOI 10.1016/j.neuroimage.2011.11.094; Leemans A, 2009, MAGN RESON MED, V61, P1336, DOI 10.1002/mrm.21890; Liptrot MG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096247; Maes F, 1997, IEEE T MED IMAGING, V16, P187, DOI 10.1109/42.563664; Metzler-Baddeley C, 2012, NEUROIMAGE, V59, P1394, DOI 10.1016/j.neuroimage.2011.08.043; Mohammadi S, 2015, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00427; Mohammadi S, 2010, MAGN RESON MED, V64, P1047, DOI 10.1002/mrm.22501; Nam H, 2011, NEUROIMAGE, V57, P968, DOI 10.1016/j.neuroimage.2011.05.018; Nielsen JF, 2004, MAGN RESON IMAGING, V22, P1319, DOI 10.1016/j.mri.2004.08.024; Nilsson M, 2013, MAGN RESON MATER PHY, V26, P345, DOI 10.1007/s10334-013-0371-x; Nilsson M, 2013, MAGN RESON MED, V69, P1572, DOI 10.1002/mrm.24395; Nilsson M, 2009, MAGN RESON IMAGING, V27, P176, DOI 10.1016/j.mri.2008.06.003; Pasternak O, 2009, MAGN RESON MED, V62, P717, DOI 10.1002/mrm.22055; Poot DHJ, 2010, IEEE T MED IMAGING, V29, P819, DOI 10.1109/TMI.2009.2037915; Rohde GK, 2004, MAGN RESON MED, V51, P103, DOI 10.1002/mrm.10677; Sotiropoulos SN, 2013, NEUROIMAGE, V80, P125, DOI 10.1016/j.neuroimage.2013.05.057; Sundgren PC, 2004, NEURORADIOLOGY, V46, P339, DOI 10.1007/s00234-003-1114-x; Szczepankiewicz F, 2015, NEUROIMAGE, V104, P241, DOI 10.1016/j.neuroimage.2014.09.057; Szczepankiewicz F, 2013, NEUROIMAGE, V76, P145, DOI 10.1016/j.neuroimage.2013.02.078; Theilmann RJ, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00037; Tournier JD, 2008, NEUROIMAGE, V42, P617, DOI 10.1016/j.neuroimage.2008.05.002; Tournier JD, 2013, NMR BIOMED, V26, P1775, DOI 10.1002/nbm.3017; Tournier JD, 2012, INT J IMAG SYST TECH, V22, P53, DOI 10.1002/ima.22005; Tournier JD, 2004, NEUROIMAGE, V23, P1176, DOI 10.1016/j.neuroimage.2004.07.037; Van Cauter S, 2012, RADIOLOGY, V263, P492, DOI 10.1148/radiol.12110927; Westin CF, 2014, LECT NOTES COMPUT SC, V8675, P209, DOI 10.1007/978-3-319-10443-0_27; Yendiki A, 2014, NEUROIMAGE, V88, P79, DOI 10.1016/j.neuroimage.2013.11.027; Yoshikawa K, 2004, J NEUROL NEUROSUR PS, V75, P481, DOI 10.1136/jnnp.2003.021873; Zhan W, 2012, MOVEMENT DISORD, V27, P90, DOI 10.1002/mds.23917; Zhang H, 2012, NEUROIMAGE, V61, P1000, DOI 10.1016/j.neuroimage.2012.03.072	59	47	47	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2015	10	11							e0141825	10.1371/journal.pone.0141825	http://dx.doi.org/10.1371/journal.pone.0141825			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV1QH	26528541	gold, Green Published, Green Submitted			2022-12-26	WOS:000364032600065
J	Sbragaglia, V; Lamanna, F; Mat, AM; Rotllant, G; Joly, S; Ketmaier, V; de la Iglesia, HO; Aguzzi, J				Sbragaglia, Valerio; Lamanna, Francesco; Mat, Audrey M.; Rotllant, Guiomar; Joly, Silvia; Ketmaier, Valerio; de la Iglesia, Horacio O.; Aguzzi, Jacopo			Identification, Characterization, and Diel Pattern of Expression of Canonical Clock Genes in Nephrops norvegicus (Crustacea: Decapoda) Eyestalk	PLOS ONE			English	Article							LONG-TERM-MEMORY; RNA-SEQ DATA; NORWAY LOBSTER; RHYTHMS; GENERATION; SMART; TOOL	The Norway lobster, Nephrops norvegicus, is a burrowing decapod with a rhythmic burrow emergence (24 h) governed by the circadian system. It is an important resource for European fisheries and its behavior deeply affects its availability. The current knowledge of Nephrops circadian biology is phenomenological as it is currently the case for almost all crustaceans. In attempt to elucidate the putative molecular mechanisms underlying circadian gene regulation in Nephrops, we used a transcriptomics approach on cDNA extracted from the eyestalk, a structure playing a crucial role in controlling behavior of decapods. We studied 14 male lobsters under 12-12 light-darkness blue light cycle. We used the Hiseq 2000 Illumina platform to sequence two eyestalk libraries (under light and darkness conditions) obtaining about 90 millions 100-bp paired-end reads. Trinity was used for the de novo reconstruction of transcriptomes; the size at which half of all assembled bases reside in contigs (N50) was equal to 1796 (light) and 2055 (darkness). We found a list of candidate clock genes and focused our attention on canonical ones: timeless, period, clock and bmal1. The cloning of assembled fragments validated Trinity outputs. The putative Nephrops clock genes showed high levels of identity (blastx on NCBI) with known crustacean clock gene homologs such as Eurydice pulchra (period: 47%, timeless: 59%, bmal1: 79%) and Macrobrachium rosenbergii (clock: 100%). We also found a vertebrate-like cryptochrome 2. RT-qPCR showed that only timeless had a robust diel pattern of expression. Our data are in accordance with the current knowledge of the crustacean circadian clock, reinforcing the idea that the molecular clockwork of this group shows some differences with the established model in Drosophila melanogaster.	[Sbragaglia, Valerio; Rotllant, Guiomar; Joly, Silvia; Aguzzi, Jacopo] ICM CSIC, Inst Marine Sci, Barcelona, Spain; [Lamanna, Francesco] Univ Potsdam, Inst Biochem & Biol, Unit Evolutionary Biol Systemat Zool, Potsdam, Germany; [Mat, Audrey M.; de la Iglesia, Horacio O.] Univ Washington, Dept Biol, Seattle, WA 98195 USA; [Ketmaier, Valerio] Univ Roma La Sapienza, Dept Biol & Biotechnol Charles Darwin, I-00185 Rome, Italy	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Mediterraneo de Investigaciones Marinas y Ambientales (CMIMA); CSIC - Instituto de Ciencias del Mar (ICM); University of Potsdam; University of Washington; University of Washington Seattle; Sapienza University Rome	Sbragaglia, V (corresponding author), ICM CSIC, Inst Marine Sci, Barcelona, Spain.	Sbragaglia@icm.csic.es	sbragaglia, valerio/AAB-1507-2019; Joly, Silvia/ABG-9801-2020; Mat, Audrey M/GVS-6454-2022; sbragaglia, valerio/ABA-7409-2020; Rotllant, Guiomar/I-1838-2013; Aguzzi, Jacopo/D-6574-2012	Joly, Silvia/0000-0003-0106-1895; sbragaglia, valerio/0000-0002-4775-7049; Rotllant, Guiomar/0000-0002-6692-9678; Aguzzi, Jacopo/0000-0002-1484-8219; Lamanna, Francesco/0000-0002-0447-759X; , Audrey/0000-0003-2930-6268	FPI grant by the Spanish Ministry of Research Science and Technology [CTM2010-16274]; Belgian American Educational Foundation; Deutsche Forschungsgemeinschaft; Open Access Publishing Fund of University of Potsdam	FPI grant by the Spanish Ministry of Research Science and Technology; Belgian American Educational Foundation; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Open Access Publishing Fund of University of Potsdam	VS was supported by a FPI grant by the Spanish Ministry of Research Science and Technology in the frame of the project RITFIM (CTM2010-16274); AM was supported by a Fellowship of the Belgian American Educational Foundation. We acknowledge the support of the Deutsche Forschungsgemeinschaft and Open Access Publishing Fund of University of Potsdam.	Aguzzi J, 2003, MAR ECOL PROG SER, V258, P201, DOI 10.3354/meps258201; Aguzzi J, 2008, J NEUROSCI METH, V173, P215, DOI 10.1016/j.jneumeth.2008.06.009; Aguzzi J, 2008, REV FISH BIOL FISHER, V18, P235, DOI 10.1007/s11160-007-9071-9; Aguzzi J, 2010, ADV MAR BIOL, V58, P155, DOI 10.1016/S0065.2881(10)58003.9; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Arechiga H, 2002, CRUSTACEAN NERVOUS SYSTEM, P113; Arechiga H., 1985, P361; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bell Mike C., 2006, P412, DOI 10.1002/9780470995969.ch13; Bell-Pedersen D, 2005, NAT REV GENET, V6, P544, DOI 10.1038/nrg1633; Bocking D, 2002, CRUSTACEAN NERVOUS SYSTEM, P84; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Ceriani MF, 2002, J NEUROSCI, V22, P9305, DOI 10.1523/jneurosci.22-21-09305.2002; Crawford JE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014202; De Pitta C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068652; Escamilla-Chimal EG, 2010, J EXP BIOL, V213, P3723, DOI 10.1242/jeb.047548; Escamllla-Chimal EG, 2001, J EXP BIOL, V204, P1073; Farmer A. S. D., 1975, FAO FISHERIES SYNOPS, V112, P1; Gallego M, 2007, NAT REV MOL CELL BIO, V8, P139, DOI 10.1038/nrm2106; GARFIAS A, 1995, J EXP BIOL, V198, P1447; GATEN E, 1990, J MAR BIOL ASSOC UK, V70, P343, DOI 10.1017/S0025315400035451; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; Hardeland R, 2003, J PINEAL RES, V34, P233, DOI 10.1034/j.1600-079X.2003.00040.x; Hennig S, 2009, PLOS BIOL, V7, P836, DOI 10.1371/journal.pbio.1000094; Johnson M. L., 2013, ADVANCES IN MARINE B, V64, P325; Chiesa JJ, 2010, J BIOL RHYTHM, V25, P277, DOI 10.1177/0748730410376159; Kula-Eversole E, 2010, P NATL ACAD SCI USA, V107, P13497, DOI 10.1073/pnas.1002081107; Le Trionnaire G, 2013, PHYSIOL ENTOMOL, V38, P117, DOI 10.1111/phen.12021; Leng N, 2013, BIOINFORMATICS, V29, P1035, DOI 10.1093/bioinformatics/btt087; Letunic I, 2009, NUCLEIC ACIDS RES, V37, pD229, DOI 10.1093/nar/gkn808; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Lin C. M., 2012, J BIOMEDICAL SCI, V19, P1; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Main J., 1985, DEP AGR FISHERIES SC, V34, P1; Martin JA, 2011, NAT REV GENET, V12, P671, DOI 10.1038/nrg3068; Mazzotta GM, 2010, CHRONOBIOL INT, V27, P425, DOI 10.3109/07420521003697494; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Morozova O, 2009, ANNU REV GENOM HUM G, V10, P135, DOI 10.1146/annurev-genom-082908-145957; Nagoshi E, 2010, NAT NEUROSCI, V13, P60, DOI 10.1038/nn.2451; NEWLAND PL, 1989, FISH RES, V8, P63, DOI 10.1016/0165-7836(89)90041-6; Peschel N, 2011, FEBS LETT, V585, P1435, DOI 10.1016/j.febslet.2011.02.028; Rao KR, 2001, AM ZOOL, V41, P364, DOI 10.1668/0003-1569(2001)041[0364:CPEHCA]2.0.CO;2; Refinetti R, 2006, CIRCADIAN PHYSIOLOGY, P688; Rodrigue S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011840; Sakai T, 2004, P NATL ACAD SCI USA, V101, P16058, DOI 10.1073/pnas.0401472101; Sarda F., 1995, ICES Marine Science Symposia, V199, P78; Sarda F, 2012, REV FISH BIOL FISHER, V22, P409, DOI 10.1007/s11160-011-9242-6; Sbragaglia V, 2013, J EXP MAR BIOL ECOL, V446, P177, DOI 10.1016/j.jembe.2013.05.018; Sbragaglia V, 2013, SCI MAR, V77, P641, DOI 10.3989/scimar.03902.28C; Scheuermann TH, 2007, METHOD ENZYMOL, V435, P3, DOI 10.1016/S0076-6879(07)35001-5; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; Seear P, 2009, J EXP MAR BIOL ECOL, V381, P57, DOI 10.1016/j.jembe.2009.09.010; SOKOLOVE PG, 1978, J THEOR BIOL, V72, P131, DOI 10.1016/0022-5193(78)90022-X; Strauss J, 2010, FRONT BIOSCI-LANDMRK, V15, P1040, DOI 10.2741/3661; Taylor BL, 1999, MICROBIOL MOL BIOL R, V63, P479, DOI 10.1128/MMBR.63.2.479-506.1999; Teschke M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026090; Winbush A, 2012, G3-GENES GENOM GENET, V2, P1437, DOI 10.1534/g3.112.004119; Yang JS, 2006, BRAIN RES, V1067, P13, DOI 10.1016/j.brainres.2005.10.003; Zhang L, 2013, CURR BIOL, V23, P1863, DOI 10.1016/j.cub.2013.08.038; Zhu HS, 2005, CURR BIOL, V15, pR953, DOI 10.1016/j.cub.2005.11.030	61	22	22	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2015	10	11							e0141893	10.1371/journal.pone.0141893	http://dx.doi.org/10.1371/journal.pone.0141893			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV1PG	26524198	gold, Green Published, Green Submitted			2022-12-26	WOS:000364029800028
J	Zurawska-Plaksej, E; Lugowska, A; Hetmanczyk, K; Knapik-Kordecka, M; Piwowar, A				Zurawska-Plaksej, Ewa; Lugowska, Agnieszka; Hetmanczyk, Katarzyna; Knapik-Kordecka, Maria; Piwowar, Agnieszka			Neutrophils as a Source of Chitinases and Chitinase-Like Proteins in Type 2 Diabetes	PLOS ONE			English	Article							ACIDIC MAMMALIAN CHITINASE; PLASMA CHITOTRIOSIDASE ACTIVITY; LEUKOCYTE ACTIVATION; INFLAMMATION; YKL-40; FAMILY; EXPRESSION; BIOMARKER; LINK; MACROPHAGES	Purpose The pathophysiological role of human chitinases and chitinase-like proteins (CLPs) is not fully understood. We aimed to determine the levels of neutrophil-derived chitotriosidase (CHIT1), acidic mammalian chitinase (AMCase) and chitinase 3-like protein 1 (YKL-40) in patients with type 2 diabetes (T2D) and verify their association with metabolic and clinical conditions of these patients. Methods Neutrophils were obtained from the whole blood by gradient density centrifugation from 94 T2D patients and 40 control subjects. The activities of CHIT1 and AMCase as well as leukocyte elastase (LE) were measured fluorometrically and concentration of YKL-40 immunoenzymatically. Also, routine laboratory parameters in serum/plasma were determined by standard methods. Results The levels of all three examined proteins were about 2-times higher in diabetic patients in comparison to control subjects. They were significantly correlated with the activity of LE and increased progressively across tertiles of LE activity. Moreover, the activities of CHIT1 and AMCase were significantly correlated with each other. Metabolic compensation of diabetes did not influence the levels of these proteins. In the subgroup of patients with inflammatory evidence only YKL-40 concentration was significantly higher compared to those without inflammation. The highest levels of all three proteins were observed in patients with macroangiopathies. Insulin therapy was associated with lower levels of examined proteins. Conclusions We revealed that neutrophils may be an important source of the increased levels of chitinases and CLPs in T2D, and these proteins may participate in inflammatory mechanisms in the course of the disease and consequent development of diabetic angiopathies.	[Zurawska-Plaksej, Ewa] Wroclaw Med Univ, Dept Pharmaceut Biochem, Wroclaw, Poland; [Lugowska, Agnieszka; Hetmanczyk, Katarzyna] Inst Psychiat & Neurol Warsaw, Dept Genet, Warsaw, Poland; [Knapik-Kordecka, Maria] Wroclaw Med Univ, Dept Angiol Hypertens & Diabetol, Wroclaw, Poland; [Piwowar, Agnieszka] Wroclaw Med Univ, Dept Toxicol, Wroclaw, Poland	Wroclaw Medical University; Institute of Psychiatry & Neurology; Wroclaw Medical University; Wroclaw Medical University	Zurawska-Plaksej, E (corresponding author), Wroclaw Med Univ, Dept Pharmaceut Biochem, Wroclaw, Poland.	ewa.zurawska-plaksej@umed.wroc.pl	Zurawska-Plaksej, Ewa/AAF-4748-2019	Zurawska-Plaksej, Ewa/0000-0001-8566-3943; Piwowar, Agnieszka/0000-0001-6971-3883; Lugowska, Agnieszka/0000-0002-2848-6407	Wroclaw Medical University	Wroclaw Medical University	This work was granted from Wroclaw Medical University. All funds were spent for reagent and the funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alba-Loureiro TC, 2007, BRAZ J MED BIOL RES, V40, P1037, DOI 10.1590/S0100-879X2006005000143; [Anonymous], 2014, DIABETOL KLIN SA, V3, pA1; Aydogdu A, 2012, EXP CLIN ENDOCR DIAB, V120, P261, DOI 10.1055/s-0032-1309010; BARRETT AJ, 1981, METHOD ENZYMOL, V80, P581; Boot RG, 2001, J BIOL CHEM, V276, P6770, DOI 10.1074/jbc.M009886200; Boot RG, 1999, ARTERIOSCL THROM VAS, V19, P687, DOI 10.1161/01.ATV.19.3.687; Boot RG, 1998, J BIOL CHEM, V273, P25680, DOI 10.1074/jbc.273.40.25680; Bouzas L, 2003, J CLIN LAB ANAL, V17, P271, DOI 10.1002/jcla.10108; Cho SJ, 2015, ALLERGY ASTHMA IMMUN, V7, P14, DOI 10.4168/aair.2015.7.1.14; Contreras JAV, 1999, CLIN CHEM LAB MED, V37, P607; de Vries MA, 2015, METABOLISM, V64, P213, DOI 10.1016/j.metabol.2014.10.011; Di Rosa M, 2013, MOL CELL BIOCHEM, V374, P73, DOI 10.1007/s11010-012-1506-5; Elias JA, 2005, J ALLERGY CLIN IMMUN, V116, P497, DOI 10.1016/j.jaci.2005.06.028; Espinoza-Jimenez A, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/815953; Esser N, 2014, DIABETES RES CLIN PR, V105, P141, DOI 10.1016/j.diabres.2014.04.006; Flehmig G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099785; Gu ZW, 2011, J OTOLARYNGOL-HEAD N, V40, P64, DOI 10.2310/7070.2010.100059; Guo YF, 1995, J INHERIT METAB DIS, V18, P717, DOI 10.1007/BF02436762; Hartl D, 2009, J IMMUNOL, V182, P5098, DOI 10.4049/jimmunol.0803446; HOLLAK CEM, 1994, J CLIN INVEST, V93, P1288, DOI 10.1172/JCI117084; Johansen JS, 2006, DAN MED BULL, V53, P172; Kabaroglu C, 2012, CLIN BIOCHEM, V45, P281, DOI 10.1016/j.clinbiochem.2011.12.007; Kawada Mayumi, 2007, Keio Journal of Medicine, V56, P21, DOI 10.2302/kjm.56.21; Larsen T, 2014, FEBS LETT, V588, P746, DOI 10.1016/j.febslet.2013.12.035; Lee CG, 2012, J IMMUNOL, V189, P2635, DOI 10.4049/jimmunol.1201115; Lee CG, 2011, ANNU REV PHYSIOL, V73, P479, DOI 10.1146/annurev-physiol-012110-142250; Mocsai A, 2013, J EXP MED, V210, P1283, DOI 10.1084/jem.20122220; Park SJ, 2013, AM J RHINOL ALLERGY, V27, P372, DOI 10.2500/ajra.2013.27.3941; Piwowar A, 2000, CLIN CHEM LAB MED, V38, P1257, DOI 10.1515/CCLM.2000.198; Prakash M, 2013, CELL SIGNAL, V25, P1567, DOI 10.1016/j.cellsig.2013.03.016; Rathcke CN, 2006, INFLAMM RES, V55, P53, DOI 10.1007/s00011-005-0010-8; Renkema GH, 1998, EUR J BIOCHEM, V251, P504, DOI 10.1046/j.1432-1327.1998.2510504.x; Riabov V, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00075; Schalkwijk CG, 2005, CLIN SCI, V109, P143, DOI 10.1042/CS20050025; Sonmez A, 2010, ENDOCRINE, V37, P455, DOI 10.1007/s12020-010-9334-4; Talukdar S, 2012, NAT MED, V18, P1407, DOI 10.1038/nm.2885; Volck B, 1998, P ASSOC AM PHYSICIAN, V110, P351; Zheng XY, 2015, DIABETES, V64, P1898, DOI 10.2337/db15-0184; Zhu Z, 2004, SCIENCE, V304, P1678, DOI 10.1126/science.1095336; Zurawska-Plaksej E, 2016, ARCH MED SI IN PRESS, P3; Zurawska-Plaksej E, 2015, BIOMARKERS, V20, P52, DOI 10.3109/1354750X.2014.992475; Zurawska-Plaksej E, 2014, ARCH MED RES, V45, P36, DOI 10.1016/j.arcmed.2013.10.003	42	15	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2015	10	10							e0141730	10.1371/journal.pone.0141730	http://dx.doi.org/10.1371/journal.pone.0141730			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0EH	26517273	Green Submitted, Green Published, gold			2022-12-26	WOS:000363920800073
J	Gomersall, AC; Phan, HA; Iacuone, S; Li, SF; Parish, RW				Gomersall, Amber Cathie; Huy Anh Phan; Iacuone, Sylvana; Li, Song Feng; Parish, Roger W.			The Mycoplasma hyorhinis p37 Protein Rapidly Induces Genes in Fibroblasts Associated with Inflammation and Cancer	PLOS ONE			English	Article							LEUKEMIA INHIBITORY FACTOR; ANGIOPOIETIN-LIKE 4; RHEUMATOID-ARTHRITIS; CELL INVASIVENESS; INTERFERON-GAMMA; LIPOCALIN 2; BREAST; STAT3; INTERLEUKIN-6; INFECTIONS	The p37 protein at the surface of Mycoplasma hyorhinis cells forms part of a high-affinity transport system and has been found associated with animal and human cancers. Here we show in NIH3T3 fibroblasts, p37 rapidly induces the expression of genes implicated in inflammation and cancer progression. This gene activation was principally via the Tlr4 receptor. Activity was lost from p37 when the C-terminal 20 amino acids were removed or the four amino acids specific for the hydrogen bonding of thiamine pyrophosphate had been replaced by valine. Blocking the IL6 receptor or inhibiting STAT3 signalling resulted in increased p37-induced gene expression. Since cancer associated fibroblasts support growth, invasion and metastasis via their ability to regulate tumour-related inflammation, the rapid induction in fibroblasts of pro-inflammatory genes by p37 might be expected to influence cancer development.	[Gomersall, Amber Cathie; Huy Anh Phan; Iacuone, Sylvana; Li, Song Feng; Parish, Roger W.] La Trobe Univ, AgriBio, Dept Anim Plant & Soil Sci, Melbourne, Vic, Australia	La Trobe University	Gomersall, AC (corresponding author), La Trobe Univ, AgriBio, Dept Anim Plant & Soil Sci, Melbourne, Vic, Australia.	A.Gomersall@latrobe.edu.au; R.Parish@latrobe.edu.au	Xia, Bo/P-9380-2016		Australian Postgraduate Award	Australian Postgraduate Award(Australian Government)	A.C.G. was a recipient of an Australian Postgraduate Award. Megan Drew purified the p37 protein used in the initial microarray. Darren Lowen completed site-directed mutagenesis of the seven TGA codons of p37 to TGG.	Adhikary T, 2013, ONCOGENE, V32, P5241, DOI 10.1038/onc.2012.549; BARTHOLOMEW LE, 1965, ARTHRITIS RHEUM-US, V8, P376, DOI 10.1002/art.1780080306; Bernert B, 2011, J BIOL CHEM, V286, P42349, DOI 10.1074/jbc.M111.278598; Chang Q, 2013, NEOPLASIA, V15, P848, DOI 10.1593/neo.13706; Choi HS, 2014, BIOCHEM BIOPH RES CO, V446, P620, DOI 10.1016/j.bbrc.2014.03.024; Costa-Pereira AP, 2002, P NATL ACAD SCI USA, V99, P8043, DOI 10.1073/pnas.122236099; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Deguchi A, 2013, J IMMUNOL, V191, P1856, DOI 10.4049/jimmunol.1201996; Duan H, 2014, CANCER RES, V74, P1; Duan HY, 2014, CANCER LETT, V354, P447, DOI 10.1016/j.canlet.2014.08.018; DUDLER R, 1988, EMBO J, V7, P3963, DOI 10.1002/j.1460-2075.1988.tb03283.x; El Behi M, 2013, EMBO MOL MED, V5, P1835, DOI 10.1002/emmm.201302655; El Kasmi KC, 2014, J IMMUNOL, V193, P597, DOI 10.4049/jimmunol.1303048; Erez N, 2013, BIOCHEM BIOPH RES CO, V437, P397, DOI 10.1016/j.bbrc.2013.06.089; FAREED GC, 1988, J BIOL RESP MODIF, V7, P11; Feng SH, 1999, MOL CELL BIOL, V19, P7995; Geurts J, 2011, RHEUMATOLOGY, V50, P1216, DOI 10.1093/rheumatology/ker021; GILSON E, 1988, EMBO J, V7, P3971, DOI 10.1002/j.1460-2075.1988.tb03284.x; Goh YY, 2010, AM J PATHOL, V177, P2791, DOI 10.2353/ajpath.2010.100129; Gong MM, 2008, MOL CANCER THER, V7, P530, DOI 10.1158/1535-7163.MCT-07-2191; Goodison S, 2007, CYTOGENET GENOME RES, V118, P204, DOI 10.1159/000108302; Grabner B, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7285; Guo L, 2014, INFLAMM RES, V63, P13, DOI 10.1007/s00011-013-0678-0; Gyotoku E, 2001, ARCH DERMATOL RES, V293, P508, DOI 10.1007/PL00007465; Haier J, 1999, RHEUMATOLOGY, V38, P504, DOI 10.1093/rheumatology/38.6.504; Hansen MT, 2015, ONCOGENE, V34, P424, DOI 10.1038/onc.2013.568; Hiratsuka S, 2008, NAT CELL BIOL, V10, P1349, DOI 10.1038/ncb1794; Huang S, 2001, WORLD J GASTROENTERO, V7, P266; Huang XF, 2012, ONCOL REP, V27, P1541, DOI 10.3892/or.2012.1672; ILANTZIS C, 1993, MICROBIOL IMMUNOL, V37, P119, DOI 10.1111/j.1348-0421.1993.tb03188.x; Jiang YW, 2014, ORTHOPEDICS, V37, pE460, DOI 10.3928/01477447-20140430-57; Johnson S, 2000, J CLIN MICROBIOL, V38, P90; Kano A, 2003, J EXP MED, V198, P1517, DOI 10.1084/jem.20030077; Ketcham CM, 2005, MOL CANCER THER, V4, P1031, DOI 10.1158/1535-7163.MCT-05-0040; Kim B, 2010, J VET MED SCI, V72, P1225, DOI 10.1292/jvms.10-0062; Lee JM, 2014, EUR J IMMUNOL, V44, P1672, DOI 10.1002/eji.201343867; Li H, 2011, HEPATOLOGY, V54, P910, DOI 10.1002/hep.24479; Lim ST, 2012, J CELL BIOL, V197, P907, DOI 10.1083/jcb.201109067; Lippi G, 2014, ADV CLIN CHEM, V64, P179, DOI 10.1016/B978-0-12-800263-6.00004-5; Litvak V, 2009, NAT IMMUNOL, V10, P437, DOI 10.1038/ni.1721; Lu B, 2010, BIOCHEM BIOPH RES CO, V391, P1737, DOI 10.1016/j.bbrc.2009.12.145; Lysakova-Devine T, 2010, J IMMUNOL, V185, P4261, DOI 10.4049/jimmunol.1002013; Ning JY, 2003, CHINESE SCI BULL, V48, P658, DOI 10.1360/03tb9141; Nishimoto N, 2010, CLIN PHARMACOL THER, V87, P483, DOI 10.1038/clpt.2009.313; Nishimoto N, 2008, BLOOD, V112, P3959, DOI 10.1182/blood-2008-05-155846; Okuda H, 2012, CANCER RES, V72, P537, DOI 10.1158/0008-5472.CAN-11-1678; Padua D, 2008, CELL, V133, P66, DOI 10.1016/j.cell.2008.01.046; Polanska UM, 2013, J CELL PHYSIOL, V228, P1651, DOI 10.1002/jcp.24347; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Ramana CV, 2005, BIOCHEM BIOPH RES CO, V327, P727, DOI 10.1016/j.bbrc.2004.12.074; Raptis L, 2009, BIOCHEM CELL BIOL, V87, P835, DOI [10.1139/o09-061, 10.1139/O09-061]; Rivera A, 2002, BMC MUSCULOSKELET DI, V3, DOI 10.1186/1471-2474-3-15; Rodvold JJ, 2012, CANCER LETT, V316, P132, DOI 10.1016/j.canlet.2011.11.002; SCHMIDHAUSER C, 1990, J CELL SCI, V95, P499; Servais C, 2013, J PATHOL, V229, P198, DOI 10.1002/path.4103; Shimoda M, 2010, SEMIN CELL DEV BIOL, V21, P19, DOI 10.1016/j.semcdb.2009.10.002; Siddiquee K, 2007, P NATL ACAD SCI USA, V104, P7391, DOI 10.1073/pnas.0609757104; Sippel KH, 2008, ACTA CRYSTALLOGR D, V64, P1172, DOI 10.1107/S0907444908030175; STEINEMANN C, 1984, INT J CANCER, V34, P407, DOI 10.1002/ijc.2910340319; STEINEMANN C, 1984, P NATL ACAD SCI-BIOL, V81, P3747, DOI 10.1073/pnas.81.12.3747; Tan MJ, 2012, MOL CANCER RES, V10, P677, DOI 10.1158/1541-7786.MCR-11-0519; Tsumoto K, 2010, CURR PHARM BIOTECHNO, V11, P309, DOI 10.2174/138920110791111924; Uphoff CC, 2002, IN VITRO CELL DEV-AN, V38, P79; Urbanek C, 2011, BMC CANCER, V11, P1; Vallon R, 2001, J IMMUNOL, V166, P2801, DOI 10.4049/jimmunol.166.4.2801; Wang PC, 2014, INT J MOL SCI, V15, P3560, DOI 10.3390/ijms15033560; Wang Y, 2012, CYTOKINE, V59, P228, DOI 10.1016/j.cyto.2012.04.020; Yang CJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036138; Yang H, 2010, BMC GASTROENTEROL, V10, DOI 10.1186/1471-230X-10-132; Yang J, 2009, P NATL ACAD SCI USA, V106, P3913, DOI 10.1073/pnas.0810617106; Zheng L, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh110	71	12	15	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2015	10	10							e0140753	10.1371/journal.pone.0140753	http://dx.doi.org/10.1371/journal.pone.0140753			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0ED	26512722	Green Published, Green Submitted, gold			2022-12-26	WOS:000363920300007
J	Melotek, JM; Liao, CH; Liauw, SL				Melotek, James M.; Liao, Chuanhong; Liauw, Stanley L.			Quality of Life after Post-Prostatectomy Intensity Modulated Radiation Therapy: Pelvic Nodal Irradiation Is Not Associated with Worse Bladder, Bowel, or Sexual Outcomes	PLOS ONE			English	Article							PROSTATE-CANCER; RADICAL PROSTATECTOMY; ADJUVANT RADIOTHERAPY; URINARY CONTINENCE; SALVAGE RADIATION; RISK; SURVIVAL; OBESITY; IMPACT; MEN	Background Limited data exist regarding toxicity and quality of life (QOL) after post-prostatectomy intensity modulated radiation therapy (IMRT) and whether pelvic nodal RT influences these outcomes. Methods 118 men were treated with curative-intent RT after radical prostatectomy. 69 men (58%) received pelvic nodal RT. QOL data and physician-assigned toxicity were prospectively collected. Changes in QOL from baseline were assessed with Wilcoxon signed-rank tests and risk factors associated with each domain were identified with generalized estimating equation (GEE) models. Late freedom from (FF) toxicity was estimated by the Kaplan-Meier method and comparisons were tested using the log-rank test. Results Urinary irritation/obstruction, bowel, and sexual domain scores declined at 2 months (all P <= 0.01) but were no different than baseline at subsequent visits through 4 years of followup. At 4 years, FF grade 2+ GI toxicity was 90% and FF grade 2+ GU toxicity was 89%. On GEE analysis, pelvic nodal RT was associated with decreased bowel function (P = 0.09) and sexual function (P = 0.01). On multivariate analysis, however, there was no significant association with either decreased bowel (P = 0.31) or sexual (P = 0.84) function. There was also no association with either FF grade 2+ GI toxicity (P = 0.24) or grade 2+ GU toxicity (P = 0.51). Conclusions Receipt of pelvic nodal RT was not associated with inferior QOL or toxicity compared to prostate bed alone RT. For the entire cohort, RT was associated with only temporary declines in patient-reported urinary, bowel, or sexual QOL.	[Melotek, James M.; Liauw, Stanley L.] Univ Chicago, Dept Radiat & Cellular Oncol, Chicago, IL 60637 USA; [Liao, Chuanhong] Univ Chicago, Dept Publ Hlth Sci, Chicago, IL 60637 USA	University of Chicago; University of Chicago	Liauw, SL (corresponding author), Univ Chicago, Dept Radiat & Cellular Oncol, Chicago, IL 60637 USA.	sliauw@radonc.uchicago.edu		Liauw, Stanley/0000-0002-4701-2469	NCATS NIH HHS [UL1 TR000430] Funding Source: Medline; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000430] Funding Source: NIH RePORTER	NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))		Ahlering TE, 2005, UROLOGY, V65, P740, DOI 10.1016/j.urology.2004.10.061; Alongi F, 2009, RADIOTHER ONCOL, V93, P207, DOI 10.1016/j.radonc.2009.08.042; Bolla M, 2012, LANCET, V380, P2018, DOI 10.1016/S0140-6736(12)61253-7; Cooperberg MR, 2010, J CLIN ONCOL, V28, P1117, DOI 10.1200/JCO.2009.26.0133; Corbin KS, 2013, PRACT RADIAT ONCOL, V3, P138, DOI 10.1016/j.prro.2012.05.005; Cotter SE, 2011, CANCER-AM CANCER SOC, V117, P3925, DOI 10.1002/cncr.25993; Eton DT, 2001, CANCER, V92, P1451, DOI 10.1002/1097-0142(20010915)92:6<1451::AID-CNCR1469>3.0.CO;2-R; Goenka A, 2011, EUR UROL, V60, P1142, DOI 10.1016/j.eururo.2011.08.006; Jain P, 2011, OBSTET GYNAECOL, V13, P133, DOI 10.1576/toag.13.3.133.27664; Michalski JM, 2010, INT J RADIAT ONCOL, V76, P361, DOI 10.1016/j.ijrobp.2009.02.006; Moghanaki D, 2013, CANCER-AM CANCER SOC, V119, P52, DOI 10.1002/cncr.27712; Moinpour CM, 2008, J CLIN ONCOL, V26, P112, DOI 10.1200/JCO.2006.10.4505; Montgomery JS, 2006, J UROLOGY, V176, P257, DOI 10.1016/S0022-5347(06)00504-0; Roach M, 2006, INT J RADIAT ONCOL, V66, P647, DOI 10.1016/j.ijrobp.2006.05.074; Sanda MG, 2008, NEW ENGL J MED, V358, P1250, DOI 10.1056/NEJMoa074311; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Song SS, 2012, RADIOTHER ONCOL, V103, P270, DOI 10.1016/j.radonc.2011.07.024; Spiotto MT, 2007, INT J RADIAT ONCOL, V69, P54, DOI 10.1016/j.ijrobp.2007.02.035; Suardi N, 2014, EUR UROL, V65, P546, DOI 10.1016/j.eururo.2013.01.027; Thompson IM, 2009, J UROLOGY, V181, P956, DOI 10.1016/j.juro.2008.11.032; Trock BJ, 2008, JAMA-J AM MED ASSOC, V299, P2760, DOI 10.1001/jama.299.23.2760; VanCangh PJ, 1998, J UROLOGY, V159, P164, DOI 10.1016/S0022-5347(01)64044-8; Wiegel T, 2009, J CLIN ONCOL, V27, P2924, DOI 10.1200/JCO.2008.18.9563; Wolin KY, 2010, J UROLOGY, V183, P629, DOI 10.1016/j.juro.2009.09.082	24	10	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2015	10	10							e0141639	10.1371/journal.pone.0141639	http://dx.doi.org/10.1371/journal.pone.0141639			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0ED	26512986	Green Published, Green Submitted, gold			2022-12-26	WOS:000363920300059
J	Yoon, A; Yi, KS; Chang, SY; Kim, SH; Song, M; Choi, JA; Bourgeois, M; Hossain, MJ; Chen, LM; Donis, RO; Kim, H; Lee, Y; Hwang, DB; Min, JY; Chang, SJ; Chung, J				Yoon, Aerin; Yi, Kye Sook; Chang, So Young; Kim, Sung Hwan; Song, Manki; Choi, Jung Ah; Bourgeois, Melissa; Hossain, M. Jaber; Chen, Li-Mei; Donis, Ruben O.; Kim, Hyori; Lee, Yujean; Hwang, Do Been; Min, Ji-Young; Chang, Shin Jae; Chung, Junho			An Anti-Influenza Virus Antibody Inhibits Viral Infection by Reducing Nucleus Entry of Influenza Nucleoprotein	PLOS ONE			English	Article							NEUTRALIZING ANTIBODY; RECEPTOR-BINDING; A VIRUSES; HEMAGGLUTININ; EPITOPE; CELLS; NEURAMINIDASE; TRANSCRIPTION; PROTECTION; CHALLENGE	To date, four main mechanisms mediating inhibition of influenza infection by anti-hemagglutinin antibodies have been reported. Anti-globular-head-domain antibodies block either influenza virus receptor binding to the host cell or progeny virion release from the host cell. Anti-stem region antibodies hinder the membrane fusion process or induce antibody-dependent cytotoxicity to infected cells. In this study we identified a human monoclonal IgG1 antibody (CT302), which does not inhibit both the receptor binding and the membrane fusion process but efficiently reduced the nucleus entry of viral nucleoprotein suggesting a novel inhibition mechanism of viral infection by antibody. This antibody binds to the subtype-H3 hemagglutinin globular head domain of group-2 influenza viruses circulating throughout the population between 1997 and 2007.	[Yoon, Aerin; Kim, Hyori; Lee, Yujean; Hwang, Do Been; Chung, Junho] Seoul Natl Univ, Coll Med, Dept Biochem & Mol Biol, Seoul, South Korea; [Yoon, Aerin; Kim, Hyori; Lee, Yujean; Hwang, Do Been; Chung, Junho] Seoul Natl Univ, Coll Med, Canc Res Inst, Seoul, South Korea; [Yi, Kye Sook; Kim, Sung Hwan; Chang, Shin Jae] Celltrion Inc, Biotechnol Res Inst, Inchon, South Korea; [Chang, So Young; Min, Ji-Young] Inst Pasteur Korea, Songnam, Gyeonggi Do, South Korea; [Song, Manki; Choi, Jung Ah] Int Vaccine Inst, Seoul, South Korea; [Bourgeois, Melissa; Hossain, M. Jaber; Chen, Li-Mei; Donis, Ruben O.] Ctr Dis Control & Prevent, Influenza Div, Atlanta, GA USA	Seoul National University (SNU); Seoul National University (SNU); Celltrion; Institut Pasteur Korea; International Vaccine Institute; Centers for Disease Control & Prevention - USA	Chung, J (corresponding author), Seoul Natl Univ, Coll Med, Dept Biochem & Mol Biol, Seoul, South Korea.	jiyoung.min@ip-korea.org; ShinJae.Chang@celltrion.com; jjhchung@snu.ac.kr		Hwang, Dobeen/0000-0003-1897-0470; Chang, So Young/0000-0002-6390-6462	Korea Healthcare Technology R&D Project, Ministry of Health & Welfare, Republic of Korea [A103001]; National Research Foundation of Korea (NRF) - Korea government (MSIP) [2012R1A5A2A44671346]	Korea Healthcare Technology R&D Project, Ministry of Health & Welfare, Republic of Korea; National Research Foundation of Korea (NRF) - Korea government (MSIP)	This study was supported in part by a grant from the Korea Healthcare Technology R&D Project, Ministry of Health & Welfare, Republic of Korea (Grant No.: A103001). Additional funding was provided by a National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIP) (No. 2012R1A5A2A44671346).	ANDERSON LJ, 1985, J CLIN MICROBIOL, V22, P1050, DOI 10.1128/JCM.22.6.1050-1052.1985; Banerjee I, 2014, SCIENCE, V346, P473, DOI 10.1126/science.1257037; Banerjee I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068450; Baras B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001401; Barbas C. F., 2001, PHAGE DISPLAY LAB MA; Barbey-Martin C, 2002, VIROLOGY, V294, P70, DOI 10.1006/viro.2001.1320; Brandenburg B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080034; Corti D, 2011, SCIENCE, V333, P850, DOI 10.1126/science.1205669; DiLillo DJ, 2014, NAT MED, V20, P143, DOI 10.1038/nm.3443; DOWDLE WR, 1974, J VIROL, V13, P269, DOI 10.1128/JVI.13.2.269-275.1974; Dreyfus C, 2012, SCIENCE, V337, P1343, DOI 10.1126/science.1222908; Ekiert DC, 2012, CURR OPIN VIROL, V2, P134, DOI 10.1016/j.coviro.2012.02.005; Ekiert DC, 2011, SCIENCE, V333, P843, DOI 10.1126/science.1204839; Ekiert DC, 2009, SCIENCE, V324, P246, DOI 10.1126/science.1171491; Fletcher AJ, 2013, CURR TOP MICROBIOL, V371, P29, DOI 10.1007/978-3-642-37765-5_2; Fleury D, 1999, NAT STRUCT BIOL, V6, P530, DOI 10.1038/9299; Gamblin SJ, 2010, J BIOL CHEM, V285, P28403, DOI 10.1074/jbc.R110.129809; Gulati U, 2002, J VIROL, V76, P12274, DOI 10.1128/JVI.76.23.12274-12280.2002; Hai R, 2012, J VIROL, V86, P5774, DOI 10.1128/JVI.00137-12; Jin H, 1996, ARCH VIROL, V141, P923, DOI 10.1007/BF01718166; JOHNSSON B, 1991, ANAL BIOCHEM, V198, P268, DOI 10.1016/0003-2697(91)90424-R; Kim HY, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0024749, 10.1371/journal.pone.0019867]; Medina RA, 2011, NAT REV MICROBIOL, V9, P590, DOI 10.1038/nrmicro2613; Oh HLJ, 2010, J VIROL, V84, P8275, DOI 10.1128/JVI.02593-09; Okada J, 2011, J GEN VIROL, V92, P326, DOI 10.1099/vir.0.026419-0; Palese P, 2004, NAT MED, V10, pS82, DOI 10.1038/nm1141; Prabakaran M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004566; Shao HX, 2011, VIROLOGY, V417, P379, DOI 10.1016/j.virol.2011.06.021; Shen S, 2008, J MED VIROL, V80, P1972, DOI 10.1002/jmv.21298; Shibuya T, 2008, MICROBIOL IMMUNOL, V52, P162, DOI 10.1111/j.1348-0421.2008.00025.x; Skehel JJ, 2000, ANNU REV BIOCHEM, V69, P531, DOI 10.1146/annurev.biochem.69.1.531; Steel J, 2010, MBIO, V1, DOI 10.1128/mBio.00018-10; Stray SJ, 2000, GLYCOBIOLOGY, V10, P649, DOI 10.1093/glycob/10.7.649; Sun J, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00038; Tsibane T, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003067; Van Der Geld YM, 1999, CLIN EXP IMMUNOL, V118, P487; Wang TT, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000796; Wu XL, 2006, P NATL ACAD SCI USA, V103, P7465, DOI 10.1073/pnas.0510483103; Yamashita A, 2010, BIOCHEM BIOPH RES CO, V393, P614, DOI 10.1016/j.bbrc.2010.02.031; Zielinska E, 2005, VIROL J, V2, DOI 10.1186/1743-422X-2-84	40	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2015	10	10							e0141312	10.1371/journal.pone.0141312	http://dx.doi.org/10.1371/journal.pone.0141312			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0ED	26512723	Green Published, gold			2022-12-26	WOS:000363920300027
J	Quattrin, AM; Nizinski, MS; Chaytor, JD; Demopoulos, AWJ; Roark, EB; France, SC; Moore, JA; Heyl, T; Auster, PJ; Kinlan, B; Ruppel, C; Elliott, KP; Kennedy, BRC; Lobecker, E; Skarke, A; Shank, TM				Quattrin, Andrea M.; Nizinski, Martha S.; Chaytor, Jason D.; Demopoulos, Amanda W. J.; Roark, E. Brendan; France, Scott C.; Moore, Jon A.; Heyl, Taylor; Auster, Peter J.; Kinlan, Brian; Ruppel, Carolyn; Elliott, Kelley P.; Kennedy, Brian R. C.; Lobecker, Elizabeth; Skarke, Adam; Shank, Timothy M.			Exploration of the Canyon-Incised Continental Margin of the Northeastern United States Reveals Dynamic Habitats and Diverse Communities	PLOS ONE			English	Article							GULF-OF-MEXICO; CORAL LOPHELIA-PERTUSA; DEEP-WATER CORALS; HUDSON SUBMARINE-CANYON; FOOD-SUPPLY MECHANISMS; SEA HYDROTHERMAL VENTS; NEW-ENGLAND; NORTH-ATLANTIC; COLD SEEPS; BOTTOM CURRENTS	The continental margin off the northeastern United States (NEUS) contains numerous, topographically complex features that increase habitat heterogeneity across the region. However, the majority of these rugged features have never been surveyed, particularly using direct observations. During summer 2013, 31 Remotely-Operated Vehicle (ROV) dives were conducted from 494 to 3271 m depth across a variety of seafloor features to document communities and to infer geological processes that produced such features. The ROV surveyed six broad-scale habitat features, consisting of shelf-breaching canyons, slope-sourced canyons, inter-canyon areas, open-slope/landslide-scar areas, hydrocarbon seeps, and Mytilus Seamount. Four previously unknown chemosynthetic communities dominated by Bathymodiolus mussels were documented. Seafloor methane hydrate was observed at two seep sites. Multivariate analyses indicated that depth and broad-scale habitat significantly influenced megafaunal coral (58 taxa), demersal fish (69 taxa), and decapod crustacean (34 taxa) assemblages. Species richness of fishes and crustaceans significantly declined with depth, while there was no relationship between coral richness and depth. Turnover in assemblage structure occurred on the middle to lower slope at the approximate boundaries of water masses found previously in the region. Coral species richness was also an important variable explaining variation in fish and crustacean assemblages. Coral diversity may serve as an indicator of habitat suitability and variation in available niche diversity for these taxonomic groups. Our surveys added 24 putative coral species and three fishes to the known regional fauna, including the black coral Telopathes magna, the octocoral Metallogorgia melanotrichos and the fishes Gaidropsarus argentatus, Guttigadus latifrons, and Lepidion guentheri. Marine litter was observed on 81% of the dives, with at least 12 coral colonies entangled in debris. While initial exploration revealed the NEUS region to be both geologically dynamic and biologically diverse, further research into the abiotic conditions and the biotic interactions that influence species abundance and distribution is needed.	[Quattrin, Andrea M.] US Geol Survey, Contracted Wetland & Aquat Res Ctr, Cherokee Nations Technol Solut, Gainesville, FL 32653 USA; [Nizinski, Martha S.] Natl Museum Nat Hist, Natl Syst Lab, NMFS, NOAA, Washington, DC 20560 USA; [Chaytor, Jason D.; Ruppel, Carolyn] USGS Woods Hole Coastal & Marine Sci Ctr, Woods Hole, MA USA; [Demopoulos, Amanda W. J.] US Geol Survey, Wetland & Aquat Res Ctr, Gainesville, FL USA; [Roark, E. Brendan] Texas A&M Univ, Dept Geog, College Stn, TX USA; [France, Scott C.] Univ Louisiana Lafayette, Dept Biol, Lafayette, LA 70504 USA; [Moore, Jon A.] Florida Atlantic Univ, Wilkes Honors Coll, Jupiter, FL USA; [Moore, Jon A.] FAU, Harbor Branch Oceanog Inst, Ft Pierce, FL USA; [Heyl, Taylor; Shank, Timothy M.] Woods Hole Oceanog Inst, Dept Biol, Woods Hole, MA 02543 USA; [Auster, Peter J.] Univ Connecticut, Dept Marine Sci, Groton, CT 06340 USA; [Auster, Peter J.] Univ Connecticut, Northest Undersea Res Technol & Educ Ctr, Groton, CT 06340 USA; [Auster, Peter J.] Myst Aquarium, Sea Res Fdn, Mystic, CT USA; [Kinlan, Brian] NOAA Natl Ocean Serv, Silver Spring, MD USA; [Elliott, Kelley P.] NOAA Off Ocean Explorat & Res, Silver Spring, MD USA; [Kennedy, Brian R. C.] NOAA Off Ocean Explorat & Res, Narragansett, RI USA; [Lobecker, Elizabeth] Contracted NOAA Off Ocean Explorat & Res, Earth Resources Technol Corp, Durham, NH USA; [Skarke, Adam] Mississippi State Univ, Dept Geosci, Mississippi State, MS 39762 USA	United States Department of the Interior; United States Geological Survey; National Oceanic Atmospheric Admin (NOAA) - USA; Smithsonian Institution; Smithsonian National Museum of Natural History; United States Department of the Interior; United States Geological Survey; United States Department of the Interior; United States Geological Survey; Texas A&M University System; Texas A&M University College Station; University of Louisiana Lafayette; State University System of Florida; Florida Atlantic University; Harbor Branch Oceanographic Institute Foundation; Woods Hole Oceanographic Institution; University of Connecticut; University of Connecticut; National Oceanic Atmospheric Admin (NOAA) - USA; Mississippi State University	Quattrin, AM (corresponding author), US Geol Survey, Contracted Wetland & Aquat Res Ctr, Cherokee Nations Technol Solut, Gainesville, FL 32653 USA.	aquattrini@usgs.gov	Skarke, Adam/S-2488-2017; Moore, Jon A./A-5959-2008; Auster, Peter/ABI-3568-2020	Skarke, Adam/0000-0002-3843-5152; Moore, Jon A./0000-0002-0053-3347; France, Scott/0000-0002-2114-5968; Chaytor, Jason/0000-0001-8135-8677; Ruppel, Carolyn/0000-0003-2284-6632; Quattrini, Andrea/0000-0002-4247-3055	NOAA's Office of Ocean Exploration and Research; NOAA's Deep Sea Coral Research and Technology Program, Northeast Initiative; USGS Terrestrial, Marine, and Freshwater Environments-Outer Continental Shelf Ecosystem Program	NOAA's Office of Ocean Exploration and Research; NOAA's Deep Sea Coral Research and Technology Program, Northeast Initiative; USGS Terrestrial, Marine, and Freshwater Environments-Outer Continental Shelf Ecosystem Program	Funding for the ship and ROV time was provided by NOAA's Office of Ocean Exploration and Research with support from NOAA's Deep Sea Coral Research and Technology Program, Northeast Initiative. NOAA's Office of Ocean Exploration guided the general operating area and data collection for the expedition, but specific dive sites and transects were proposed by the science community. The funders had no role in study design, data analysis, manuscript preparation, or the decision to publish. Funding was provided to AWJD by the USGS Terrestrial, Marine, and Freshwater Environments-Outer Continental Shelf Ecosystem Program.	ABLE KW, 1982, ENVIRON BIOL FISH, V7, P199, DOI 10.1007/BF00002496; Akaike H., 1973, P 2 INT S INF THEOR, VI, P610, DOI DOI 10.1007/978-1-4612-1694-0_15; Allen P., 2005, BASIN ANAL PRINCIPLE; Andersen AC, 2004, CAN J ZOOL, V82, P980, DOI 10.1139/Z04-049; Anderson M.J., 2008, PERMANOVA PRIMER GUI; AUSTER PJ, 1995, MAR ECOL PROG SER, V127, P77, DOI 10.3354/meps127077; Auster PJ, 2005, ERLANGEN EARTH C SER, P747, DOI 10.1007/3-540-27673-4_39; Auster PJ, 2005, ERLANGEN EARTH C SER, P761, DOI 10.1007/3-540-27673-4_40; Baker KD, 2012, DEEP-SEA RES PT I, V65, P171, DOI 10.1016/j.dsr.2012.03.012; Baker KD, 2012, MAR ECOL PROG SER, V445, P235, DOI 10.3354/meps09448; Buhl-Mortensen L, 2005, ERLANGEN EARTH C SER, P849, DOI 10.1007/3-540-27673-4_44; Buhl-Mortensen L, 2004, SYMBIOSIS, V37, P33; Buhl-Mortensen L, 2010, MAR ECOL-EVOL PERSP, V31, P21, DOI 10.1111/j.1439-0485.2010.00359.x; Cairns SD, 2011, P 1 INT S DEEP SEA C, P30; Canals M, 2006, NATURE, V444, P354, DOI 10.1038/nature05271; Carney RS, 2005, OCEANOGR MAR BIOL, V43, P211; CARNEY RS, 1994, GEO-MAR LETT, V14, P149, DOI 10.1007/BF01203726; CARUSO JH, 1989, COPEIA, P153, DOI 10.2307/1445616; Cho W, 2010, MAR ECOL-EVOL PERSP, V31, P121, DOI 10.1111/j.1439-0485.2010.00395.x; Clarke KR., 2001, CHANGE MARINE COMMUN, V2; Cohen DM, 1979, CHECKLIST FISHES NE, V1, P322; Colwell RK, 2004, ECOLOGY, V85, P2717, DOI 10.1890/03-0557; Colwell RK, 2005, ESTIMATES STAT ESTIM, V7, P5; COOPER RA, 1987, SUBMARINE CANYONS, P52; Cordes EE, 2005, MAR ECOL PROG SER, V305, P17, DOI 10.3354/meps305017; Cordes EE, 2008, DEEP-SEA RES PT I, V55, P777, DOI 10.1016/j.dsr.2008.03.005; Cordes EE, 2009, ANNU REV MAR SCI, V1, P143, DOI 10.1146/annurev.marine.010908.163912; Davies AJ, 2008, DEEP-SEA RES PT I, V55, P1048, DOI 10.1016/j.dsr.2008.04.010; Davies AJ, 2009, LIMNOL OCEANOGR, V54, P620, DOI 10.4319/lo.2009.54.2.0620; De Leo FC, 2010, P ROY SOC B-BIOL SCI, V277, P2783, DOI 10.1098/rspb.2010.0462; Demopoulos AWJ, 2014, DEEP-SEA RES PT I, V93, P91, DOI 10.1016/j.dsr.2014.07.014; Etnoyer P, 2007, B MAR SCI, V81, P553; Fisher CR, 2014, P NATL ACAD SCI USA, V111, P11744, DOI 10.1073/pnas.1403492111; FREDERIKSEN R, 1992, SARSIA, V77, P157, DOI 10.1080/00364827.1992.10413502; GAGE JD, 1995, INT REV GES HYDROBIO, V80, P235, DOI 10.1002/iroh.19950800211; GARDNER WD, 1989, DEEP-SEA RES, V36, P323, DOI 10.1016/0198-0149(89)90041-1; GENIN A, 1986, NATURE, V322, P59, DOI 10.1038/322059a0; GOODAY AJ, 1990, PHILOS T R SOC A, V331, P119, DOI 10.1098/rsta.1990.0060; Gorley R.N., 2006, USER MANUAL TUTORIAL; Gotelli NJ, 2001, ECOL LETT, V4, P379, DOI 10.1046/j.1461-0248.2001.00230.x; Govenar B, 2010, TOP GEOBIOL, V33, P403, DOI 10.1007/978-90-481-9572-5_13; HAEDRICH RL, 1975, J MAR RES, V33, P191; HAEDRICH RL, 1980, MAR BIOL, V57, P165, DOI 10.1007/BF00390735; Hartel KE, 2008, NORTHEAST NAT, V15, P317, DOI 10.1656/1092-6194-15.3.317; Hastie LC, 1995, OCEANOGR MAR BIOL, V33, P561; Hecker B, 1983, CANYON SLOPE PROCESS; Hecker B., 1980, BLMAA551CT849 US DEP; Heirtzler JR, 1977, WHOI778; Herrera S, 2012, MOL ECOL, V21, P6053, DOI 10.1111/mec.12074; Hilario A, 2011, DEEP-SEA RES PT I, V58, P200, DOI 10.1016/j.dsr.2010.11.009; HOUGHTON RL, 1977, NATURWISSENSCHAFTEN, V64, P348, DOI 10.1007/BF00368733; Huvenne VAI, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028755; Johnson MP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079917; KELLER GH, 1973, SCIENCE, V180, P181, DOI 10.1126/science.180.4082.181; Kelly NE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013832; Lessard-Pilon S, 2010, DEEP-SEA RES PT II, V57, P1891, DOI 10.1016/j.dsr2.2010.05.012; Levin LA, 2001, ANNU REV ECOL SYST, V32, P51, DOI 10.1146/annurev.ecolsys.32.081501.114002; Levin LA, 2012, ANNU REV MAR SCI, V4, P79, DOI 10.1146/annurev-marine-120709-142714; Long DJ, 2014, DEEP-SEA RES PT II, V99, P158, DOI 10.1016/j.dsr2.2013.05.032; Lorance P, 2006, J EXP MAR BIOL ECOL, V332, P106, DOI 10.1016/j.jembe.2005.11.007; Lunden JJ, 2013, LIMNOL OCEANOGR, V58, P354, DOI 10.4319/lo.2013.58.1.0354; LUX F E, 1982, Journal of Shellfish Research, V2, P71; MacAvoy SE, 2002, MAR ECOL PROG SER, V225, P65, DOI 10.3354/meps225065; Macisaac KG, 2013, ZOOTAXA, V3700, P237, DOI 10.11646/zootaxa.3700.2.3; Mah Christopher L., 2015, Marine Biodiversity Records, V8, pe5, DOI 10.1017/S1755267214001407; MARKLE DF, 1988, CAN J ZOOL, V66, P1952, DOI 10.1139/z88-286; Marsh AG, 2001, NATURE, V411, P77, DOI 10.1038/35075063; MCHUGH CM, 1993, AAPG BULL, V77, P145; Melendez R, 1997, B MAR SCI, V61, P593; Menot Lanaick, 2010, P79, DOI 10.1002/9781444325508.ch5; MERRETT N R, 1985, Biological Oceanography, V3, P349; Moore JA, 2003, NORTHEAST NAT, V10, P159, DOI 10.1656/1092-6194(2003)010[0159:AALODF]2.0.CO;2; Moore Jon A., 2008, Bulletin of the Peabody Museum of Natural History, V49, P31, DOI 10.3374/0079-032X(2008)49[31:FBNHIT]2.0.CO;2; Moranta J, 1998, MAR ECOL PROG SER, V171, P247, DOI 10.3354/meps171247; Morgan NB, 2015, DEEP-SEA RES PT I, V104, P92, DOI 10.1016/j.dsr.2015.07.003; Mosher CV, 2009, MAR ECOL PROG SER, V397, P81, DOI 10.3354/meps08113; O'Leary DW, 1996, GEOLOGY US SEAFLOOR, P47; Obelcz J, 2014, DEEP-SEA RES PT II, V104, P106, DOI 10.1016/j.dsr2.2013.09.013; Oliveira A, 2007, MAR GEOL, V246, P105, DOI 10.1016/j.margeo.2007.04.017; Packer D. B, 2007, STATE DEEP CORAL ECO, P195; Pante E, 2012, J MAR BIOL ASSOC UK, V92, P911, DOI 10.1017/S0025315411001354; Pante E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038357; PEARCY W G, 1982, Biological Oceanography, V1, P375; PEQUEGNAT WE, 1990, AM ZOOL, V30, P45; PICKART RS, 1992, DEEP-SEA RES, V39, P1553, DOI 10.1016/0198-0149(92)90047-W; POAG CW, 1987, INITIAL REP DEEP SEA, V95, P31; Powell Shawna M., 2003, Journal of Northwest Atlantic Fishery Science, V31, P19; Prouty NG, 2014, DEEP SEA RE IN PRESS, VII, DOI [10.1016/j.dsr2.2014.10.021, DOI 10.1016/J.DSR2.2014.10.021]; Puig P, 2003, MAR GEOL, V193, P129, DOI 10.1016/S0025-3227(02)00641-2; Quattrini AM, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.0008; Quattrini AM, 2014, DEEP-SEA RES PT II, V99, P92, DOI 10.1016/j.dsr2.2013.05.027; Ramirez-Llodra E, 2010, BIOGEOSCIENCES, V7, P2851, DOI 10.5194/bg-7-2851-2010; Ramirez-Llodra E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022588; Roark EB, 2006, MAR ECOL PROG SER, V327, P1, DOI 10.3354/meps327001; Robinson LF, 2014, DEEP-SEA RES PT II, V99, P184, DOI 10.1016/j.dsr2.2013.06.005; Ross SW, 2007, DEEP-SEA RES PT I, V54, P975, DOI 10.1016/j.dsr.2007.03.010; Ross SW, 2015, DEEP-SEA RES PT I, V103, P137, DOI 10.1016/j.dsr.2015.06.004; Ross SW, 2009, MAR ECOL-EVOL PERSP, V30, P74, DOI 10.1111/j.1439-0485.2008.00260.x; ROWE GT, 1974, J SEDIMENT PETROL, V44, P549; ROWE GT, 1982, DEEP-SEA RES, V29, P257, DOI 10.1016/0198-0149(82)90113-3; RYAN WBF, 1978, OCEANOL ACTA, V1, P233; RYAN WBF, 1981, MAR GEOL, V44, P213, DOI 10.1016/0025-3227(81)90119-5; SARDA F, 1994, MAR BIOL, V120, P211, DOI 10.1007/BF00349681; Sarda F, 1997, MAR ECOL PROG SER, V159, P133, DOI 10.3354/meps159133; Sarda F, 2009, PROG OCEANOGR, V82, P227, DOI 10.1016/j.pocean.2009.07.001; Scott W.B., 1988, CAN B FISH AQ SCI, V219, P1; Shank TM, 2010, OCEANOGRAPHY, V23, P108, DOI 10.5670/oceanog.2010.65; Shank TM, 1998, DEEP-SEA RES PT II, V45, P465, DOI 10.1016/S0967-0645(97)00089-1; Shepard FP, 1979, AM ASS PETROLEUM GEO, V8; Skarke A, 2014, NAT GEOSCI, V7, P657, DOI [10.1038/ngeo2232, 10.1038/NGEO2232]; STEFANESCU C, 1994, J MAR BIOL ASSOC UK, V74, P499, DOI 10.1017/S0025315400047627; Stoner AW, 2008, CAN J FISH AQUAT SCI, V65, P1230, DOI 10.1139/F08-032; Thiem O, 2006, J MARINE SYST, V60, P207, DOI 10.1016/j.jmarsys.2005.12.004; Thoma JN, 2009, MAR ECOL PROG SER, V397, P25, DOI 10.3354/meps08318; Tyler P. A., 2002, OCEAN MARGIN SYSTEMS, P339; Tyron MD, 2001, GEOPHYS RES LETT, V28, P2863; VALENTINE PC, 1980, MAR GEOL, V38, P283, DOI 10.1016/0025-3227(80)90004-3; Valentine PC, 1987, US GEOLOGICAL SURVEY, V1782; Van Dover CL, 2003, DEEP-SEA RES PT I, V50, P281, DOI 10.1016/S0967-0637(02)00162-0; VETTER EW, 1994, NATURE, V372, P47, DOI 10.1038/372047a0; Vetter EW, 1999, MAR ECOL PROG SER, V186, P137, DOI 10.3354/meps186137; Vetter EW, 1998, DEEP-SEA RES PT II, V45, P25, DOI 10.1016/S0967-0645(97)00048-9; Wareham VE, 2007, CONSERVATION AND ADAPTIVE MANAGEMENT OF SEAMOUNT AND DEEP-SEA CORAL ECOSYSTEMS, P289; Watanabe S, 2009, DEEP-SEA RES PT I, V56, P2235, DOI 10.1016/j.dsr.2009.09.003; Wating L, 2011, ADV MAR BIOL, V60, P41, DOI 10.1016/B978-0-12-385529-9.00002-0; Watling L, 2005, ERLANGEN EARTH C SER, P279, DOI 10.1007/3-540-27673-4_13; Watling L, 2011, B PEABODY MUS NAT HI, V51, P209; Weed EGA, 1974, US GEOLOGICAL SURVEY, VI-861; Wicksten MK, 2005, DEEP-SEA RES PT I, V52, P1745, DOI 10.1016/j.dsr.2005.04.006; Yoklavich MM, 2000, FISH B-NOAA, V98, P625; Zeigler JM, 1975, SEAMOUNTS NEAR E COA	131	42	43	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2015	10	10							e0139904	10.1371/journal.pone.0139904	http://dx.doi.org/10.1371/journal.pone.0139904			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0DL	26509818	gold, Green Published, Green Submitted			2022-12-26	WOS:000363918100016
J	Ren, CP; Wang, LJ; Zheng, BH; Holbach, A				Ren, Chunping; Wang, Lijing; Zheng, Binghui; Holbach, Andreas			Total Nitrogen Sources of the Three Gorges Reservoir - A Spatio-Temporal Approach	PLOS ONE			English	Article							GROUND-WATER RECHARGE; XIANGXI BAY; NUTRIENT LIMITATION; PHOSPHORUS BUDGET; SPATIAL-ANALYSIS; FRESH-WATER; LAND-USE; RIVER; PHYTOPLANKTON; POLLUTION	Understanding the spatial and temporal variation of nutrient concentrations, loads, and their distribution from upstream tributaries is important for the management of large lakes and reservoirs. The Three Gorges Dam was built on the Yangtze River in China, the world's third longest river, and impounded the famous Three Gorges Reservoir (TGR). In this study, we analyzed total nitrogen (TN) concentrations and inflow data from 2003 till 2010 for the main upstream tributaries of the TGR that contribute about 82% of the TGR's total inflow. We used time series analysis for seasonal decomposition of TN concentrations and used non-parametric statistical tests (Kruskal-Walli H, Mann-Whitney U) as well as base flow segmentation to analyze significant spatial and temporal patterns of TN pollution input into the TGR. Our results show that TN concentrations had significant spatial heterogeneity across the study area (Tuo River> Yangtze River> Wu River> Min River> Jialing River> Jinsha River). Furthermore, we derived apparent seasonal changes in three out of five upstream tributaries of the TGR rivers (Kruskal-Walli H rho = 0.009, 0.030 and 0.029 for Tuo River, Jinsha River and Min River in sequence). TN pollution from non-point sources in the upstream tributaries accounted for 68.9% of the total TN input into the TGR. Non-point source pollution of TN revealed increasing trends for 4 out of five upstream tributaries of the TGR. Land use/cover and soil type were identified as the dominant driving factors for the spatial distribution of TN. Intensifying agriculture and increasing urbanization in the upstream catchments of the TGR were the main driving factors for non-point source pollution of TN increase from 2003 till 2010. Land use and land cover management as well as chemical fertilizer use restriction were needed to overcome the threats of increasing TN pollution.	[Ren, Chunping; Zheng, Binghui] Beijing Normal Univ, Coll Water Sci, Beijing 100875, Peoples R China; [Ren, Chunping; Wang, Lijing; Zheng, Binghui] Chinese Res Inst Environm Sci, State Environm Protect Key Lab Drinking Water Sou, Beijing, Peoples R China; [Ren, Chunping] Sichuan Res Acad Environm Sci, Environm Planning Inst, Chengdu, Peoples R China; [Holbach, Andreas] Karlsruhe Inst Technol, Inst Mineral & Geochem, D-76021 Karlsruhe, Germany	Beijing Normal University; Chinese Research Academy of Environmental Sciences; Helmholtz Association; Karlsruhe Institute of Technology	Zheng, BH (corresponding author), Beijing Normal Univ, Coll Water Sci, Beijing 100875, Peoples R China.	r2226723@163.com		Holbach, Andreas/0000-0002-7665-9341	Chinese National Special Science and Technology Program of Water Pollution Control and Treatment [2012ZX07503-002]	Chinese National Special Science and Technology Program of Water Pollution Control and Treatment	This research design, data collection was supported by the Chinese National Special Science and Technology Program of Water Pollution Control and Treatment (No. 2012ZX07503-002).	Albiac J, 2012, MANAGEMENT WATER QUA; Altizer S, 2004, J ANIM ECOL, V73, P309, DOI 10.1111/j.0021-8790.2004.00807.x; Arnold JG, 1999, J AM WATER RESOUR AS, V35, P411, DOI 10.1111/j.1752-1688.1999.tb03599.x; BAXTER RM, 1977, ANNU REV ECOL SYST, V8, P255, DOI 10.1146/annurev.es.08.110177.001351; Binghui Z, 2009, RES ENV SCI, V22, P125; Boggess CF, 1995, ECOL ENG, V5, P143, DOI 10.1016/0925-8574(95)00022-4; Box GE, 1976, TIME SERIES ANAL FOR, V2nd; Cai M., 2006, YELLOW RIVER, V28, P24; Cai Qing-Hua, 2006, Acta Hydrobiologica Sinica, V30, P7; Carpenter SR, 1998, ECOL APPL, V8, P559, DOI 10.1890/1051-0761(1998)008[0559:NPOSWW]2.0.CO;2; Chang H, 2008, WATER RES, V42, P3285, DOI 10.1016/j.watres.2008.04.006; CHEN S, 2008, ADV WATER SCI, V4, P004; [陈友媛 Chen Youyuan], 2003, [环境科学研究, Research of Environmental Sciences], V16, P10; Cherkauer DS, 2005, GROUND WATER, V43, P102, DOI 10.1111/j.1745-6584.2005.tb02289.x; Chongqing municipality Bureau of Statistics, 2010, CHONGQ STAT YB; Chongqing municipality Bureau of Statistics, 2000, CHONGQ STAT YB; Dudgeon D, 2000, ANNU REV ECOL SYST, V31, P239, DOI 10.1146/annurev.ecolsys.31.1.239; DYNESIUS M, 1994, SCIENCE, V266, P753, DOI 10.1126/science.266.5186.753; [于涛 YU Tao], 2008, [环境科学学报, Acta Scientiae Circumstantiae], V28, P401; HECKY RE, 1988, LIMNOL OCEANOGR, V33, P796, DOI 10.4319/lo.1988.33.4_part_2.0796; Hiscock JG, 2003, ECOL ENG, V21, P63, DOI 10.1016/j.ecoleng.2003.09.005; Holbach A, 2013, ENVIRON SCI POLLUT R, V20, P7027, DOI 10.1007/s11356-012-1373-3; Holloway JM, 1998, NATURE, V395, P785, DOI 10.1038/27410; HOWARTH RW, 1988, ANNU REV ECOL SYST, V19, P89, DOI 10.1146/annurev.es.19.110188.000513; Huaien LI, 2000, ACTA SCI CIRCUMSTANT, P4; Jiang CL, 2011, EUTROPHICATION: CAUSES, CONSEQUENCES AND CONTROL, P325, DOI 10.1007/978-90-481-9625-8_16; Keeney DR, 1971, NATURE, V217, P42; Kuang Q. J., 2005, ACTA HYDROBIOL, V29, P358; Kummu M, 2007, GEOMORPHOLOGY, V85, P275, DOI 10.1016/j.geomorph.2006.03.024; Liu L, 2012, WATER RES, V46, P2121, DOI 10.1016/j.watres.2012.01.029; Lyne V.D., 1979, P HYDROLOGY WATER RE, P89; Ma L, 2014, LAND USE POLICY, V37, P52, DOI 10.1016/j.landusepol.2013.01.008; McGee SMSW, 1983, FORECASTING METHODS; Ministry of Environmental Protection of the People's Republic of China (MEPPRC), 2012, GAZ EC MON 3 GORG PR, P1997; NATHAN RJ, 1990, WATER RESOUR RES, V26, P1465, DOI 10.1029/WR026i007p01465; Novotny V, 1999, WATER SCI TECHNOL, V39, P1, DOI 10.1016/S0273-1223(99)00027-X; Novotny V, 1994, TECHNOL ENG, DOI DOI 10.2134/JEQ1995.00472425002400020024; Ongley ED, 2010, ENVIRON POLLUT, V158, P1159, DOI 10.1016/j.envpol.2009.10.047; Plateau T., 2006, SCIENCE, V25, P1034; REDSHAW CJ, 1988, WATER RES, V22, P413, DOI 10.1016/0043-1354(88)90035-8; Shen ZY, 2013, SCI TOTAL ENVIRON, V454, P383, DOI 10.1016/j.scitotenv.2013.03.036; Shen ZL, 2009, ENVIRON MONIT ASSESS, V153, P27, DOI 10.1007/s10661-008-0334-2; Sichuan Province Bureau of Statistics, 2010, SICH STAT YB; Sichuan Province Bureau of Statistics, 2000, SICH STAT YB; SiChuan Provincial Agricultural Department Soil Survey Office of Sichuan Province, 1997, SICHUAN SOIL; Sloto R.A., 1996, HYSEP COMPUTER PROGR; Smith V. H., 1998, CULTURAL EUTROPHICAT, P7; Smith VH, 1999, ENVIRON POLLUT, V100, P179, DOI 10.1016/S0269-7491(99)00091-3; Staged Assessment Group of Chinese Academy of Engineering (CAESAGTGP), 2010, STAG ASS REP 3 GORG, P490; State Environmental Protection Bureau Editorial Committee, 2002, WAT WAST MON AN METH, V4th; Le TPQ, 2014, AGR WATER MANAGE, V142, P152, DOI 10.1016/j.agwat.2014.04.014; Tiemeyer B, 2009, AGR WATER MANAGE, V96, P677, DOI 10.1016/j.agwat.2008.10.004; Tiffan KF, 2002, N AM J FISH MANAGE, V22, P713, DOI 10.1577/1548-8675(2002)022<0713:QFDCIS>2.0.CO;2; Wang XW, 2013, QUATERN INT, V304, P115, DOI 10.1016/j.quaint.2013.03.041; Wu JG, 2004, FRONT ECOL ENVIRON, V2, P241, DOI 10.1890/1540-9295(2004)002[0241:TTGDAE]2.0.CO;2; [肖玖金 Xiao Jiujin], 2010, [中国给水排水, China Water & Wastewater], V26, P119; Xikang H, 2013, ACTA SCI CIRCUMSTANT, V34, P1585; Xu XB, 2013, EARTH-SCI REV, V124, P115, DOI 10.1016/j.earscirev.2013.05.007; Yang GS, 2009, YANGTZE RIVER CONSER, P293; Yang ZJ, 2010, SCI CHINA TECHNOL SC, V53, P1114, DOI 10.1007/s11431-009-0387-7; Ye L, 2007, ENVIRON MONIT ASSESS, V127, P135, DOI 10.1007/s10661-006-9267-9; Yunnan Province Bureau of Statistics, 2000, YUNN STAT YB; Zeng H, 2006, SCI TOTAL ENVIRON, V367, P999, DOI 10.1016/j.scitotenv.2006.03.001; Zhiliang S, 2003, CHINESE J OCEANOLOGY, V21, P368	64	9	9	2	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2015	10	10							e0141458	10.1371/journal.pone.0141458	http://dx.doi.org/10.1371/journal.pone.0141458			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0DL	26510158	gold, Green Published			2022-12-26	WOS:000363918100089
J	Tian, A; Ma, H; Zhang, RW; Tan, WF; Wang, XL; Wu, BY; Wang, J; Wan, CF				Tian, Ayong; Ma, Hong; Zhang, Rongwei; Tan, Wenfei; Wang, Xiaolong; Wu, Binyang; Wang, Jun; Wan, Chengfu			Interleukin17A Promotes Postoperative Cognitive Dysfunction by Triggering beta-Amyloid Accumulation via the Transforming Growth Factor-beta (TGF beta)/Smad Signaling Pathway	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; ALZHEIMERS-DISEASE; TH17 CELLS; INFLAMMATORY DISEASES; PARKINSONS-DISEASE; MULTIPLE-SCLEROSIS; GENERAL-ANESTHESIA; GLIAL ACTIVATION; ELDERLY-PATIENTS; TRANSGENIC MICE	Although postoperative cognitive dysfunction (POCD) is relatively common in elderly patients who have undergone major surgery, the mechanisms underlying this postoperative complication are unclear. Previously, we have investigated the role of cytokine-mediated hippocampal inflammation in the development of POCD in a rat model. Here, we sought to determine in mice the role of cytokine interleukin17A (IL17A) in POCD and to characterize the associated signaling pathways. Old mice underwent hepatectomy surgery in the presence or absence of IL17A monoclonal antibody, and cognitive function, hippocampal neuroinflammation, and pathologic markers of Alzheimer's disease (AD) were assessed. We found that the level of IL17A in the hippocampus was increased in hepatectomy mice and that cognitive impairment after surgery was associated with the appearance of certain pathological hallmarks of AD: activation of astrocytes, beta-amyloid(1-42) (A beta(1-42)) production, upregulation of transforming growth factor-beta (TGF beta), and increased phosphorylation of signaling mother against decapentaplegic peptide 3 (Smad3) protein in the hippocampus. Surgery-induced changes in cognitive dysfunction and changes in A beta(1-42) and TGF beta/Smad signaling were prevented by the administration of IL17A monoclonal antibody. In addition, IL17A-stimulated TGF beta/Smad activation and A beta(1-42) expression were reversed by IL17A receptor small interfering RNA and a TGF beta receptor inhibitor in cultured astrocytes. Our findings suggest that surgery can provoke IL17A-related hippocampal damage, as characterized by activation of astrocytes and TGF beta/Smad pathway dependent A beta(1-42) accumulation in old subjects. These changes likely contribute to the cognitive decline seen in POCD.	[Tian, Ayong; Ma, Hong; Tan, Wenfei; Wang, Xiaolong; Wu, Binyang] China Med Univ, Affiliated Hosp 1, Dept Anesthesiol, Shenyang, Liaoning, Peoples R China; [Zhang, Rongwei] China Med Univ, Dept Gerontol & Geriatr, Affiliated Hosp 1, Shenyang, Liaoning, Peoples R China; [Wang, Jun] China Med Univ, Dept Neurol, Affiliated Hosp 1, Shenyang, Liaoning, Peoples R China; [Wan, Chengfu] China Med Univ, Dept Pain Med, Affiliated Hosp 1, Shenyang, Liaoning, Peoples R China	China Medical University; China Medical University; China Medical University; China Medical University	Ma, H (corresponding author), China Med Univ, Affiliated Hosp 1, Dept Anesthesiol, Nanjing North St 155, Shenyang, Liaoning, Peoples R China.	mahong626@126.com		tian, ayong/0000-0002-0183-8556	Department of science and technology of Liaoning province [2012408002, 2012225021-73]	Department of science and technology of Liaoning province	This work was supported by: 1) No. 2012408002, to Dr. Ma; http://www.lninfo.gov.cn/ (Department of science and technology of Liaoning province); and 2) No. 2012225021-73, to Dr. Tian; http://www.lninfo.gov.cn/ (Department of science and technology of Liaoning province). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham J, 2008, NEUROBIOL AGING, V29, P614, DOI 10.1016/j.neurobiolaging.2006.11.002; Akama KT, 2000, J BIOL CHEM, V275, P7918, DOI 10.1074/jbc.275.11.7918; Akiyama H, 2000, NEUROBIOL AGING, V21, P383, DOI 10.1016/S0197-4580(00)00124-X; Baig S, 2009, NEUROSCIENCE, V163, P561, DOI 10.1016/j.neuroscience.2009.06.045; Bettelli E, 2008, NATURE, V453, P1051, DOI 10.1038/nature07036; Blasko I, 2000, NEUROBIOL DIS, V7, P682, DOI 10.1006/nbdi.2000.0321; Cao XZ, 2010, PROG NEURO-PSYCHOPH, V34, P1426, DOI 10.1016/j.pnpbp.2010.07.027; Chen XG, 2001, ANESTH ANALG, V93, P1489, DOI 10.1097/00000539-200112000-00029; Christensen JR, 2013, PLOS ONE, V8; Cibelli M, 2010, ANN NEUROL, V68, P360, DOI 10.1002/ana.22082; Craft JM, 2004, NEUROBIOL AGING, V25, P1283, DOI 10.1016/j.neurobiolaging.2004.01.006; Das Sarma Jayasri, 2009, J Neuroinflammation, V6, P14, DOI 10.1186/1742-2094-6-14; Deacon RMJ, 2006, NAT PROTOC, V1, P7, DOI 10.1038/nprot.2006.2; Docagne F, 2004, BIOCHEM J, V383, P393, DOI 10.1042/BJ20040682; Dong C, 2008, NAT REV IMMUNOL, V8, P337, DOI 10.1038/nri2295; FLANDERS KC, 1995, NEUROLOGY, V45, P1561, DOI 10.1212/WNL.45.8.1561; FORLONI G, 1993, NEUROREPORT, V4, P523, DOI 10.1097/00001756-199305000-00015; Gaffen SL, 2009, NAT REV IMMUNOL, V9, P556, DOI 10.1038/nri2586; Graber JJ, 2008, J NEUROIMMUNOL, V196, P124, DOI 10.1016/j.jneuroim.2008.02.008; Griffin WST, 1998, BRAIN PATHOL, V8, P65; Hu JG, 1998, BRAIN RES, V785, P195, DOI 10.1016/S0006-8993(97)01318-8; Inoue D, 2006, BIOCHEM BIOPH RES CO, V347, P852, DOI 10.1016/j.bbrc.2006.06.137; Kamer AR, 2012, EUR J ANAESTH, V29, P332, DOI 10.1097/EJA.0b013e3283534f56; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Lee HG, 2006, J NEUROSCI RES, V84, P1856, DOI 10.1002/jnr.21072; Lesne S, 2003, J BIOL CHEM, V278, P18408, DOI 10.1074/jbc.M300819200; LOO DT, 1993, P NATL ACAD SCI USA, V90, P7951, DOI 10.1073/pnas.90.17.7951; MANDYBUR TI, 1990, NEUROLOGY, V40, P635, DOI 10.1212/WNL.40.4.635; Martinez GJ, 2008, ANN NY ACAD SCI, V1143, P188, DOI 10.1196/annals.1443.021; Massague J, 2000, EMBO J, V19, P1745, DOI 10.1093/emboj/19.8.1745; MASSAGUE J, 1990, ANNU REV CELL BIOL, V6, P597, DOI 10.1146/annurev.cb.06.110190.003121; Masters CL, 2006, J NEUROCHEM, V97, P1700, DOI 10.1111/j.1471-4159.2006.03989.x; Mattson MP, 1998, BRAIN RES, V807, P167, DOI 10.1016/S0006-8993(98)00763-X; McGeer PL, 1995, BRAIN RES REV, V21, P195, DOI 10.1016/0165-0173(95)00011-9; Miossec P, 2009, MICROBES INFECT, V11, P625, DOI 10.1016/j.micinf.2009.04.003; Moller JT, 1998, LANCET, V351, P857, DOI 10.1016/S0140-6736(97)07382-0; Newman MF, 2001, NEW ENGL J MED, V344, P395, DOI 10.1056/NEJM200102083440601; Onishi RM, 2010, IMMUNOLOGY, V129, P311, DOI 10.1111/j.1365-2567.2009.03240.x; Qian YC, 2010, CELL MOL IMMUNOL, V7, P328, DOI 10.1038/cmi.2010.27; Qin HW, 2008, J IMMUNOL, V181, P3167, DOI 10.4049/jimmunol.181.5.3167; Rasmussen LS, 1998, EUR J ANAESTH, V15, P761, DOI 10.1097/00003643-199811000-00026; Rasmussen LS, 2003, ACTA ANAESTH SCAND, V47, P260, DOI 10.1034/j.1399-6576.2003.00057.x; Reynolds AD, 2010, J IMMUNOL, V184, P2261, DOI 10.4049/jimmunol.0901852; Rosczyk HA, 2008, EXP GERONTOL, V43, P840, DOI 10.1016/j.exger.2008.06.004; Samad TA, 2001, NATURE, V410, P471, DOI 10.1038/35068566; Schultz J, 2004, AM J PATHOL, V165, P671, DOI 10.1016/S0002-9440(10)63331-7; Servi B, 2002, EXP GERONTOL, V37, P813; Steinmetz J, 2009, ANESTHESIOLOGY, V110, P548, DOI 10.1097/ALN.0b013e318195b569; Tesseur I, 2006, J CLIN INVEST, V116, P3060, DOI 10.1172/JCI27341; Toy D, 2006, J IMMUNOL, V177, P36, DOI 10.4049/jimmunol.177.1.36; van Horssen J, 2006, NEUROBIOL DIS, V24, P484, DOI 10.1016/j.nbd.2006.08.005; Vawter MP, 1996, EXP NEUROL, V142, P313, DOI 10.1006/exnr.1996.0200; Viviani B, 2003, J NEUROSCI, V23, P8692; Vorhees CV, 2006, NAT PROTOC, V1, P848, DOI 10.1038/nprot.2006.116; White JA, 2005, NEUROBIOL DIS, V18, P459, DOI 10.1016/j.nbd.2004.12.013; Wyss-Coray T, 2000, AM J PATHOL, V156, P139, DOI 10.1016/S0002-9440(10)64713-X; Zhang J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075786; Zhao J, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-150	58	27	30	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2015	10	10							e0141596	10.1371/journal.pone.0141596	http://dx.doi.org/10.1371/journal.pone.0141596			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0DL	26509545	Green Published, Green Submitted, gold			2022-12-26	WOS:000363918100112
J	Mohr, F; Krejci, E; Zimmermann, M; Klein, J				Mohr, Franziska; Krejci, Eric; Zimmermann, Martina; Klein, Jochen			Dysfunctional Presynaptic M-2 Receptors in the Presence of Chronically High Acetylcholine Levels: Data from the PRiMA Knockout Mouse	PLOS ONE			English	Article							IN-VIVO MICRODIALYSIS; DEFICIENT MICE; RELEASE; FACILITATION; HIPPOCAMPUS; INHIBITION; ANTAGONIST; NEURONS; OUTPUT	The muscarinic M-2 receptor (M2R) acts as a negative feedback regulator in central cholinergic systems. Activation of the M-2 receptor limits acetylcholine (ACh) release, especially when ACh levels are increased because acetylcholinesterase (AChE) activity is acutely inhibited. Chronically high ACh levels in the extracellular space, however, were reported to down-regulate M2R to various degrees. In the present study, we used the PRiMA knockout mouse which develops severely reduced AChE activity postnatally to investigate ACh release, and we used microdialysis to investigate whether the function of M2R to reduce ACh release in vivo was impaired in adult PRiMA knockout mice. We first show that striatal and hippocampal ACh levels, while strongly increased, still respond to AChE inhibitors. Infusion or injection of oxotremorine, a muscarinic M-2 agonist, reduced ACh levels in wild-type mice but did not significantly affect ACh levels in PRiMA knockout mice or in wild-type mice in which ACh levels were artificially increased by infusion of neostigmine. Scopolamine, a muscarinic antagonist, increased ACh levels in wild-type mice receiving neostigmine, but not in wild-type mice or in PRiMA knockout mice. These results demonstrate that M2R are dysfunctional and do not affect ACh levels in PRiMA knockout mice, likely because of down-regulation and/ or loss of receptor-effector coupling. Remarkably, this loss of function does not affect cognitive functions in PRiMA knockout mice. Our results are discussed in the context of AChE inhibitor therapy as used in dementia.	[Mohr, Franziska; Zimmermann, Martina; Klein, Jochen] Goethe Univ Frankfurt, Sch Pharm, Dept Pharmacol, D-60054 Frankfurt, Germany; [Krejci, Eric] Univ Paris 05, CNRS UMR 8194, Ctr Etud Sensorimotr, Paris, France; [Zimmermann, Martina] Kings Coll London, Dept English, Ctr Human & Hlth, London WC2R 2LS, England	Goethe University Frankfurt; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; University of London; King's College London	Klein, J (corresponding author), Goethe Univ Frankfurt, Sch Pharm, Dept Pharmacol, D-60054 Frankfurt, Germany.	klein@em.uni-frankfurt.de	Klein, Jochen/B-9730-2008	Klein, Jochen/0000-0001-6971-3381; Krejci, Eric/0000-0001-8564-0290; Zimmermann, Martina/0000-0003-4274-6145	Landes-Offensive zur Entwicklung Wissenschaftlichokonomischer Exzellenz (LOEWE) from the State of Hesse; Goethe University, Frankfurt	Landes-Offensive zur Entwicklung Wissenschaftlichokonomischer Exzellenz (LOEWE) from the State of Hesse; Goethe University, Frankfurt	This work was supported by the Landes-Offensive zur Entwicklung Wissenschaftlichokonomischer Exzellenz (LOEWE) from the State of Hesse and by internal funds of Goethe University, Frankfurt.	Bernard V, 2003, MOL CELL NEUROSCI, V23, P121, DOI 10.1016/S1044-7431(03)00034-4; Bernard W, 2006, TRENDS NEUROSCI, V29, P140, DOI 10.1016/j.tins.2006.01.006; Bohnen NI, 2005, J NEUROL NEUROSUR PS, V76, P315, DOI 10.1136/jnnp.2004.038729; Crawley J., 2007, WHATS WRONG WITH MY; Day JC, 2001, METHODS, V23, P21, DOI 10.1006/meth.2000.1103; Dobbertin A, 2009, J NEUROSCI, V29, P4519, DOI 10.1523/JNEUROSCI.3863-08.2009; Farar V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068265; Farar V, 2012, J NEUROCHEM, V122, P1065, DOI 10.1111/j.1471-4159.2012.07856.x; Francis PT, 2010, NEUROPHARMACOLOGY, V59, P221, DOI 10.1016/j.neuropharm.2010.02.010; Hartmann J, 2007, J NEUROCHEM, V100, P1421, DOI 10.1111/j.1471-4159.2006.04347.x; Hrabovska A, 2014, J MOL NEUROSCI, V53, P352, DOI 10.1007/s12031-013-0164-8; Koppen A, 1997, J PHARMACOL EXP THER, V282, P1139; Kruse AC, 2014, NAT REV DRUG DISCOV, V13, P549, DOI 10.1038/nrd4295; Lachowicz JE, 2001, LIFE SCI, V68, P2585, DOI 10.1016/S0024-3205(01)01056-6; Li G, 2013, NEUROSCIENCE, V240, P349, DOI 10.1016/j.neuroscience.2013.02.040; LIU JK, 1994, NEUROCHEM INT, V24, P589, DOI 10.1016/0197-0186(94)90012-4; Michal P, 2007, J PHARMACOL EXP THER, V320, P607, DOI 10.1124/jpet.106.114314; Minic J, 2002, EUR J NEUROSCI, V15, P439, DOI 10.1046/j.0953-816x.2001.01875.x; Mohr F, 2013, NEUROPHARMACOLOGY, V67, P37, DOI 10.1016/j.neuropharm.2012.11.001; Moor E, 1998, NEUROSCIENCE, V82, P819; Nathanson NM, 2008, PHARMACOL THERAPEUT, V119, P33, DOI 10.1016/j.pharmthera.2008.04.006; Pepeu G, CURR ALZHEIMER RES, V6, P86; QUIRION R, 1995, J NEUROSCI, V15, P1455; RINGDAHL B, 1983, LIFE SCI, V32, P2401, DOI 10.1016/0024-3205(83)90365-X; Volpicelli-Daley LA, 2003, MOL PHARMACOL, V64, P1309, DOI 10.1124/mol.64.6.1309; Xie WH, 2000, J PHARMACOL EXP THER, V293, P896; Zhang WL, 2002, J NEUROSCI, V22, P1709, DOI 10.1523/JNEUROSCI.22-05-01709.2002	27	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2015	10	10							e0141136	10.1371/journal.pone.0141136	http://dx.doi.org/10.1371/journal.pone.0141136			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU8PC	26506622	Green Published, gold, Green Submitted			2022-12-26	WOS:000363804200029
J	Nguyen, TPL; Krabbe, PFM; Nguyen, TBY; Schuiling-Veninga, CCM; Wright, EP; Postma, MJ				Nguyen, Thi-Phuong-Lan; Krabbe, Paul F. M.; Nguyen, Thi-Bach-Yen; Schuiling-Veninga, Catharina C. M.; Wright, E. Pamela; Postma, Maarten J.			Utilities of Patients with Hypertension in Northern Vietnam	PLOS ONE			English	Article							QUALITY-OF-LIFE; SURVEY VERSION 2; HEALTH STATES; OLDER-PEOPLE; POPULATION; SF-36; RELIABILITY; LANGUAGE; VALIDITY; CLINICS	Objectives The study aims to inform potential cost-effectiveness analysis of hypertension management in Vietnam by providing utilities and predictors of utilities in patients with hypertension. Methods Hypertensive patients up to 80 years old visiting the hospital were invited to participate in a survey using Quality Metric's Short-form 36v2 (TM) translated into Vietnamese. Health-state utilities were estimated by applying a previously published algorithm. Results The mean utility of the 691 patients interviewed was 0.73. Controlling for age, sex, blood pressure (BP) stage, and history of stroke, the utilities in older patients were lower than those in younger ones, and statistically significantly different between the extremes of youngest and oldest groups (p = 0.03). Utility in males was higher than in females (p = 0.002). As expected, patients with a history of stroke appeared to exhibit lower utilities than patients without such history, but the difference was not statistically significant (p = 0.73). Patients with more than three comorbidities did have lower utilities than patients without comorbidity (p = 0.01). Conclusions Health-state utilities found among hypertensive patients in Vietnam were similar to those found in other international studies. It is suggested that lower of health-state utilities exist among those patients who were older, female or had more than three comorbidities in comparison with respective reference groups. However, further research for confirmation is required. The data from this study provide a potential reference on health-state utilities of hypertensive patients in Vietnam as an input for future cost-effectiveness analysis of interventions. Also, it may serve as a reference for other similar populations, especially in the context of similar environments in low income countries.	[Nguyen, Thi-Phuong-Lan; Schuiling-Veninga, Catharina C. M.; Postma, Maarten J.] Univ Groningen, Dept Pharm, Unit PharmacoEpidemiol & PharmacoEcon PE2, Antonius Deusinglaan 1, NL-9713 AV Groningen, Netherlands; [Krabbe, Paul F. M.] Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, NL-9713 AV Groningen, Netherlands; [Nguyen, Thi-Bach-Yen] Hanoi Med Univ, Dept Hlth Econ, Hanoi 100803, Vietnam; [Wright, E. Pamela] Med Comm Netherlands Vietnam, Amsterdam, Netherlands; [Postma, Maarten J.] Univ Groningen, Univ Med Ctr Groningen, Inst Sci Hlth Aging & healthcaRE SHARE, NL-9713 AV Groningen, Netherlands	University of Groningen; University of Groningen; Hanoi Medical University; University of Groningen	Nguyen, TPL (corresponding author), Univ Groningen, Dept Pharm, Unit PharmacoEpidemiol & PharmacoEcon PE2, Antonius Deusinglaan 1, NL-9713 AV Groningen, Netherlands.	ntplan75@gmail.com	Krabbe, Paul/B-2563-2013; Krabbe, Paul/AAO-6590-2020	Krabbe, Paul/0000-0001-6042-1243; Krabbe, Paul/0000-0001-6042-1243; Postma, Maarten/0000-0002-6306-3653	NUFFIC (Netherlands Organization for International Cooperation in Higher Education) Vietnam Netherlands project on Preventive Medicine; Centers of Excellence for Human Resources for Health: University-based Centers to Act as Resource and Transfer Point for Development Across the Health Sector in Vietnam	NUFFIC (Netherlands Organization for International Cooperation in Higher Education) Vietnam Netherlands project on Preventive Medicine; Centers of Excellence for Human Resources for Health: University-based Centers to Act as Resource and Transfer Point for Development Across the Health Sector in Vietnam	The research was funded by the NUFFIC (Netherlands Organization for International Cooperation in Higher Education) Vietnam Netherlands project on Preventive Medicine and a project called "Centers of Excellence for Human Resources for Health: University-based Centers to Act as Resource and Transfer Point for Development Across the Health Sector in Vietnam." These funds support PhD research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aydemir O, 2005, ARCH MED RES, V36, P136, DOI 10.1016/j.arcmed.2004.12.009; Banegas JR, 2006, AM J HYPERTENS, V19, P686, DOI 10.1016/j.amjhyper.2006.01.015; Bardage C, 2003, BLOOD PRESSURE, V12, P203, DOI 10.1080/08037050310002083; Bardage C, 2001, J CLIN EPIDEMIOL, V54, P172, DOI 10.1016/S0895-4356(00)00293-6; Brazier J, 2002, J HEALTH ECON, V21, P271, DOI 10.1016/S0167-6296(01)00130-8; Castillo-Carandang NT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083794; Chong CAKY, 2009, HEALTH QUAL LIFE OUT, V7, DOI 10.1186/1477-7525-7-78; de Carvalho MV, 2013, ARQ BRAS CARDIOL, V100, P164, DOI 10.5935/abc.20130030; de Gusmao JL, 2009, CLINICS, V64, P619, DOI 10.1590/S1807-59322009000700003; Ekwunife Obinna I, 2011, BMC Res Notes, V4, P528, DOI 10.1186/1756-0500-4-528; FRYBACK DG, 1993, MED DECIS MAKING, V13, P89, DOI 10.1177/0272989X9301300202; Havranek EP, 2005, MED CARE, V43, P201, DOI 10.1097/01.mlr.0000157214.08791.6a; Hoi LV, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-549; John E., 2013, SF 36 HLTH SURVEY UP; Johnson JA, 2005, MED CARE, V43, P221, DOI 10.1097/00005650-200503000-00004; Kaplan RM, 2005, MED CARE, V43, P79; Kim SH, 2013, ASIAN NURS RES, V7, P61, DOI 10.1016/j.anr.2013.03.001; Konerman M, 2011, J CLIN HYPERTENS, V13, P385, DOI 10.1111/j.1751-7176.2010.00402.x; Lawrence WF, 1996, J CLIN EPIDEMIOL, V49, P1239, DOI 10.1016/S0895-4356(96)00220-X; Leger D, 2012, SLEEP MED, V13, P43, DOI 10.1016/j.sleep.2011.03.020; Li W, 2005, J HYPERTENS, V23, P1667, DOI 10.1097/01.hjh.0000174971.64589.39; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Mena-Martin FJ, 2003, J HYPERTENS, V21, P1283, DOI 10.1097/00004872-200307000-00015; Qian Y, 2009, CLIN EXP HYPERTENS, V31, P71, DOI 10.1080/10641960802409804; Sazlina SG, 2012, J NUTR HEALTH AGING, V16, P498, DOI 10.1007/s12603-012-0038-8; Nguyen PL, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/s12913-014-0514-4; Thumboo J, 2013, QUAL LIFE RES, V22, P2501, DOI 10.1007/s11136-013-0381-1; Wee HL, 2004, CLIN THER, V26, P1137, DOI 10.1016/S0149-2918(04)90186-5; WHO, 2013, WHODCOWHD20132; Zhou KN, 2013, J VIRAL HEPATITIS, V20, pe47, DOI 10.1111/jvh.12030	30	4	4	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2015	10	10							e0139560	10.1371/journal.pone.0139560	http://dx.doi.org/10.1371/journal.pone.0139560			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU8PC	26506444	Green Published, gold, Green Submitted			2022-12-26	WOS:000363804200005
J	Rodriguez-Marin, E; Ortiz, M; de Urbina, JMO; Quelle, P; Walter, J; Abid, N; Addis, P; Alot, E; Andrushchenko, I; Deguara, S; Di Natale, A; Gatt, M; Golet, W; Karakulak, S; Kimoto, A; Macias, D; Saber, S; Santos, MN; Zarrad, R				Rodriguez-Marin, Enrique; Ortiz, Mauricio; Ortiz de Urbina, Jose Maria; Quelle, Pablo; Walter, John; Abid, Noureddine; Addis, Piero; Alot, Enrique; Andrushchenko, Irene; Deguara, Simeon; Di Natale, Antonio; Gatt, Mark; Golet, Walter; Karakulak, Saadet; Kimoto, Ai; Macias, David; Saber, Samar; Neves Santos, Miguel; Zarrad, Rafik			Atlantic Bluefin Tuna (Thunnus thynnus) Biometrics and Condition	PLOS ONE			English	Article							LENGTH-LENGTH RELATIONSHIPS; POPULATION-STRUCTURE; REPRODUCTIVE STATUS; WEIGHT; AGE; L.; METAANALYSIS; MIGRATION; GROWTH; SIZE	The compiled data for this study represents the first Atlantic and Mediterranean-wide effort to pool all available biometric data for Atlantic bluefin tuna (Thunnus thynnus) with the collaboration of many countries and scientific groups. Biometric relationships were based on an extensive sampling (over 140,000 fish sampled), covering most of the fishing areas for this species in the North Atlantic Ocean and Mediterranean Sea. Sensitivity analyses were carried out to evaluate the representativeness of sampling and explore the most adequate procedure to fit the weight-length relationship (WLR). The selected model for the WLRs by stock included standardized data series (common measurement types) weighted by the inverse variability. There was little difference between annual stock-specific round weight-straight fork length relationships, with an overall difference of 6% in weight. The predicted weight by month was estimated as an additional component in the exponent of the weight-length function. The analyses of monthly variations of fish condition by stock, maturity state and geographic area reflect annual cycles of spawning and feeding behavior. We update and improve upon the biometric relationships for bluefin currently used by the International Commission for the Conservation of Atlantic Tunas, by incorporating substantially larger datasets than ever previously compiled, providing complete documentation of sources and employing robust statistical fitting. WLRs and other conversion factors estimated in this study differ from the ones used in previous bluefin stock assessments.	[Rodriguez-Marin, Enrique; Quelle, Pablo] Inst Espanol Oceanog, CO Santander, Santander, Spain; [Ortiz, Mauricio; Neves Santos, Miguel] Int Commiss Conservat Atlantic Tunas, Madrid, Spain; [Ortiz de Urbina, Jose Maria; Alot, Enrique; Macias, David] Inst Espanol Oceanog, CO Malaga, Malaga, Spain; [Walter, John] Natl Marine Fisheries Serv, Southeast Fisheries Ctr, Sustainable Fisheries Div, Miami, FL USA; [Abid, Noureddine] INRH, Reg Ctr Tangier, Tangier, Morocco; [Addis, Piero] Univ Cagliari, Dept Life Sci & Environm, Cagliari, Italy; [Andrushchenko, Irene] Fisheries & Oceans Canada, St Andrews Biol Stn, St Andrews, NB, Canada; [Deguara, Simeon] Federat Maltese Aquaculture Producers, Valletta, Malta; [Di Natale, Antonio] Int Commiss Conservat Atlantic Tunas, GBYP Program, Madrid, Spain; [Gatt, Mark] Dept Fisheries & Aquaculture, Fisheries Resource Unit, Marsa, Malta; [Golet, Walter] Gulf Maine Res Inst, Portland, ME USA; [Karakulak, Saadet] Istanbul Univ, Fac Fisheries, Istanbul, Turkey; [Kimoto, Ai] Fisheries Res Agcy, Natl Res Inst Far Seas Fisheries, Shizuoka, Japan; [Saber, Samar] Univ Malaga, Dept Biol Anim, E-29071 Malaga, Spain; [Zarrad, Rafik] Inst Natl Sci & Technol Mer, Mahdia, Tunisia	Spanish Institute of Oceanography; Spanish Institute of Oceanography; National Oceanic Atmospheric Admin (NOAA) - USA; University of Cagliari; Fisheries & Oceans Canada; Gulf of Maine Research Institute; Istanbul University; Japan Fisheries Research & Education Agency (FRA); Universidad de Malaga; Institut National des Sciences et Technologies de la Mer	Rodriguez-Marin, E (corresponding author), Inst Espanol Oceanog, CO Santander, Santander, Spain.	rodriguez.marin@st.ieo.es	Rodriguez-Marin, Enrique/AAB-8082-2020; Saber, Samar/AAA-4540-2020; Addis, Piero/C-5855-2016; Karakulak, F. Saadet/B-7602-2018	Addis, Piero/0000-0002-0464-0270; Karakulak, F. Saadet/0000-0002-6053-5256; Macias, David/0000-0003-3054-2858; Saber, Samar/0000-0002-3863-2949	national research projects; EU; International Commission for the Conservation of Atlantic Tunas	national research projects; EU(European Commission); International Commission for the Conservation of Atlantic Tunas	This study was funded by national research projects and partially supported by the European data collection programme within the EU Fisheries Data Collection Regulation Framework and by the Atlantic Wide Research Programme for Bluefin tuna from the International Commission for the Conservation of Atlantic Tunas.	Aguado-Gimenez F, 2005, AQUACULTURE, V249, P303, DOI 10.1016/j.aquaculture.2005.04.064; Andersen R, 2008, U PAPER SERIES QUANT, V152; Anon, 1993, COLLECT VOL SCI PAP, V40, P11; [Anonymous], 2014, INT COMM CONS ATL CO; Arena P., 1980, Memorie di Biologia Marina e di Oceanografia, V10, P119; BAGLIN RE, 1980, FISH B-NOAA, V77, P995; BAGLIN RE, 1982, FISH B-NOAA, V80, P121; Baty F., 2015, J STAT SOFT IN PRESS; Block BA, 2005, NATURE, V434, P1121, DOI 10.1038/nature03463; Boustany AM, 2008, MAR BIOL, V156, P13, DOI 10.1007/s00227-008-1058-0; Canty A, 2014, BOOT BOOTSTRAP R S P; Chapman EW, 2011, CAN J FISH AQUAT SCI, V68, P1934, DOI 10.1139/F2011-109; Corriero A, 2005, J APPL ICHTHYOL, V21, P483, DOI 10.1111/j.1439-0426.2005.00700.x; Cort JL, 2013, REV FISH SCI, V21, P181, DOI 10.1080/10641262.2013.793284; Davison AC, 1997, BOOTSTRAP METHODS TH; Deguara S., 2010, COL VOL SCI PAP ICCA, V65, P776; El Tawil M., 2004, International Commission for the Conservation of Atlantic Tunas Collective Volume of Scientific Papers, V56, P1192; ERZINI K, 1994, J APPL ICHTHYOL, V10, P17, DOI 10.1111/j.1439-0426.1994.tb00140.x; Froese R, 2006, J APPL ICHTHYOL, V22, P241, DOI 10.1111/j.1439-0426.2006.00805.x; Fromentin JM, 2005, FISH FISH, V6, P281, DOI 10.1111/j.1467-2979.2005.00197.x; Galuardi B, 2010, CAN J FISH AQUAT SCI, V67, P966, DOI 10.1139/F10-033; Goldstein J, 2007, MAR BIOL, V151, P2063, DOI 10.1007/s00227-007-0638-8; ICCAT, 1997, COLLECT VOL SCI PAP, V46, P159; ICCAT, 1984, COLLECT VOL SCI PAP, V19, P1; ICCAT, 2013, INT COMM CONS ATL CO, V69, P1; ICCAT, 2014, 2014 ICCAT BLUEF DAT; Jennings S, 2005, ICES J MAR SCI, V62, P397, DOI 10.1016/j.icesjms.2004.07.030; Karakulak S, 2001, RAPP COMM INT MER ME, V36, P284; Knapp JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098233; Koenker R., 2010, ECONOMETRIC SOC MONO, V2005, P295; KOENKER R., 2013, QUANTREG QUANTILE RE; Little RC, 2006, SAS MIXED MODELS; Mather FJ, 1995, NMFSSEFSC370 NOAA; Medina A, 2002, J FISH BIOL, V60, P203, DOI [10.1111/j.1095-8649.2002.tb02398.x, 10.1006/jfbi.2001.1835]; Newman MEJ, 2005, CONTEMP PHYS, V46, P323, DOI 10.1080/00107510500052444; Ortiz M, 2014, SCRS2014040 ICCAT, V71; Parrack M., 1979, COL VOL SCI PAP ICCA, V8, P391; Percin F, 2009, J APPL ICHTHYOL, V25, P782, DOI 10.1111/j.1439-0426.2009.01288.x; Riccioni G, 2010, P NATL ACAD SCI USA, V107, P2102, DOI 10.1073/pnas.0908281107; RODRIGUEZ-RODA JULIO, 1964, INVEST PESQUERA, V25, P33; Rooker JR, 2007, REV FISH SCI, V15, P265, DOI 10.1080/10641260701484135; Rooker JR, 2014, MAR ECOL PROG SER, V504, P265, DOI 10.3354/meps10781; Santamaria N, 2009, J APPL ICHTHYOL, V25, P38, DOI 10.1111/j.1439-0426.2009.01191.x; Santos MN, 2002, FISH RES, V59, P289, DOI 10.1016/S0165-7836(01)00401-5; Sinovcic G, 2004, J APPL ICHTHYOL, V20, P156, DOI 10.1046/j.1439-0426.2003.00519.x; Tiews K, 1963, FAO FISH REP, V6, P422; [No title captured]	47	19	19	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2015	10	10							e0141478	10.1371/journal.pone.0141478	http://dx.doi.org/10.1371/journal.pone.0141478			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU8PC	26505476	Green Published, Green Submitted, gold			2022-12-26	WOS:000363804200075
J	Schmidt, R; Muniz, RR; Cola, E; Stauffert, D; Silveira, MF; Miranda, AE				Schmidt, Renylena; Muniz, Renan Rosetti; Cola, Elizandra; Stauffert, Dulce; Silveira, Mariangela Freitas; Miranda, Angelica E.			Maternal Chlamydia trachomatis Infections and Preterm Births in a University Hospital in Vitoria, Brazil	PLOS ONE			English	Article							PREGNANCY; DELIVERY; PREVALENCE; MORBIDITY; MORTALITY; OUTCOMES; COHORT	Background Preterm birth (PTB) is a major determinant of neonatal morbimortality with adverse consequences for health. The causes are multifactorial, with intrauterine infection probably explaining most of these outcomes. It is believed that infection with Chlamydia trachomatis (CT) is also involved in PTB and premature rupture of membranes. Objetives To evaluate the prevalence of and associated factors for CT among cases of PTB attended at a University Hospital in Vitoria, Brazil. Methods A cross-sectional study performed among parturient who had preterm birth from June 2012 to August 2013 in Vitoria, Brazil. Participants answered a questionnaire including demographic, behavioral, and clinical data. A sample of urine was collected and screened for CT using polymerase chain reaction. Chi-square tests were used for proportion differences and Student's-t tests and variance analysis were used for testing differences between mean values. Odds ratio was used as a measure of association with a 95% confidence interval. Results The prevalence of PTB during the period of the study was 26% and the prevalence of CT among them was 13.9%. A total of 31.6% pregnant women were younger than 25 years old and women infected by CT were even younger than women not infected by CT (p = 0.022). Most of them (76.2%) were married or had a living partner, and CT infection was more frequent among the single ones (p = 0.018); 16.7% of women reported their first sexual intercourse under 14 years old. The causes of prematurity were maternal-fetal in 40.9%; rupture of the membranes in 29.7% and premature labor in 29.4%. In multivariate analysis, being married was a protective factor for infection [OR = 0.48 (95% CI: 0.24-0.97)]. None of the other characteristics were associated with CT infection. Conclusions This study shows a high prevalence of CT infection among parturient who have preterm birth. This high prevalence highlight the need for defining screening strategies focused on young pregnant women in Brazil.	[Schmidt, Renylena; Muniz, Renan Rosetti; Cola, Elizandra; Miranda, Angelica E.] Univ Fed Espirito Santo, Programa Posgrad Doencas Infecciosas, Vitoria, Brazil; [Stauffert, Dulce] Univ Fed Pelotas, Fac Med, Dept Materno Infantil, Pelotas, Brazil; [Silveira, Mariangela Freitas] Univ Fed Pelotas, Programa Posgrad Epidemiol, Pelotas, Brazil	Universidade Federal do Espirito Santo; Universidade Federal de Pelotas; Universidade Federal de Pelotas	Miranda, AE (corresponding author), Univ Fed Espirito Santo, Programa Posgrad Doencas Infecciosas, Vitoria, Brazil.	espinosa@ndi.ufes.br	Silveira, Mariangela F/L-6868-2013; Miranda, Angelica/AAE-5571-2021	Silveira, Mariangela F/0000-0002-3551-9713; Miranda, Angelica/0000-0002-5556-8379				Andrews WW, 2000, AM J OBSTET GYNECOL, V183, P662, DOI 10.1067/mob.2000.106556; Baud D, 2008, CURR OPIN INFECT DIS, V21, P70, DOI 10.1097/QCO.0b013e3282f3e6a5; Baud D, 2011, EMERG INFECT DIS, V17, P1630, DOI 10.3201/eid1709.100865; Beck S, 2010, B WORLD HEALTH ORGAN, V88, P31, DOI 10.2471/BLT.08.062554; Bias MM, 2007, SEX TRANSM INFECT, V83, DOI 10.1136/sti.2006.022665; Brasil. Ministerio da Saude Departamento de Informatica do Sistema Unico de Saude (BR), INF SAUD NASC VIV NO; de Borborema-Alfaia APB, 2013, BRAZ J INFECT DIS, V17, P545, DOI 10.1016/j.bjid.2013.01.014; Folger AT, 2014, MATERN CHILD HLTH J, V18, P1795, DOI 10.1007/s10995-013-1423-6; Gencay M, 2001, APMIS, V109, P636, DOI 10.1034/j.1600-0463.2001.d01-186.x; Gencay M, 2000, APMIS, V108, P584, DOI 10.1034/j.1600-0463.2000.d01-101.x; Goldenberg RL, 2008, LANCET, V371, P75, DOI 10.1016/S0140-6736(08)60074-4; Jalil EM, 2008, REV BRAS GINECOL OBS, V30, P614, DOI 10.1590/S0100-72032008001200005; Kishore Janak, 2003, Indian J Pathol Microbiol, V46, P684; Lawn JE, 2006, INT J EPIDEMIOL, V35, P706, DOI 10.1093/ije/dyl043; Liu B, 2013, SEX TRANSM INFECT, V89, P672, DOI 10.1136/sextrans-2013-051118; Mathews T J, 2010, Natl Vital Stat Rep, V58, P1; MCCORMICK MC, 1985, NEW ENGL J MED, V312, P82, DOI 10.1056/NEJM198501103120204; Miranda AE, 2012, REV PANAM SALUD PUBL, V32, P330, DOI 10.1590/S1020-49892012001100002; Ng BE, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001220.pub3; Passini R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109069; Pinto VM, 2011, SEX TRANSM DIS, V38, P957, DOI 10.1097/OLQ.0b013e31822037fc; Rours GIJG, 2011, EUR J EPIDEMIOL, V26, P493, DOI 10.1007/s10654-011-9586-1; Rours GIJG, 2011, EUR J EPIDEMIOL, V26, P421, DOI 10.1007/s10654-011-9569-2; Silveira Mariângela F, 2008, Rev. Saúde Pública, V42, P957, DOI 10.1590/S0034-89102008000500023; Victora CG, 2011, LANCET, V377, P1863, DOI 10.1016/S0140-6736(11)60138-4	25	10	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2015	10	10							e0141367	10.1371/journal.pone.0141367	http://dx.doi.org/10.1371/journal.pone.0141367			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU8PC	26505892	Green Submitted, Green Published, gold			2022-12-26	WOS:000363804200056
J	Gogl, G; Alexa, A; Kiss, B; Katona, G; Kovacs, M; Bodor, A; Remenyi, A; Nyitray, L				Gogl, Gergo; Alexa, Anita; Kiss, Bence; Katona, Gergely; Kovacs, Mihaly; Bodor, Andrea; Remenyi, Attila; Nyitray, Laszlo			Structural Basis of Ribosomal S6 Kinase 1 (RSK1) Inhibition by S100B Protein: MODULATION OF THE EXTRACELLULAR SIGNAL-REGULATED KINASE (ERK) SIGNALING CASCADE IN A CALCIUM-DEPENDENT WAY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						calcium; crystal structure; extracellular-signal-regulated kinase (ERK); kinetics; melanoma; mitogen-activated protein kinase (MAPK); nuclear magnetic resonance (NMR); RSK; S100 proteins; small-angle X-ray scattering (SAXS)	ACTIVATION; DOMAIN; COMPLEX; PHOSPHORYLATION; EVOLUTION; FAMILY; TARGET	Mitogen-activated protein kinases (MAPK) promote MAPK-activated protein kinase activation. In the MAPK pathway responsible for cell growth, ERK2 initiates the first phosphorylation event on RSK1, which is inhibited by Ca2+-binding S100 proteins in malignant melanomas. Here, we present a detailed in vitro biochemical and structural characterization of the S100B-RSK1 interaction. The Ca2+-dependent binding of S100B to the calcium/calmodulin-dependent protein kinase (CaMK)-type domain of RSK1 is reminiscent of the better known binding of calmodulin to CaMKII. Although S100B-RSK1 and the calmodulin-CAMKII system are clearly distinct functionally, they demonstrate how unrelated intracellular Ca2+-binding proteins could influence the activity of the CaMK domain-containing protein kinases. Our crystallographic, small angle x-ray scattering, and NMR analysis revealed that S100B forms a fuzzy complex with RSK1 peptide ligands. Based on fast-kinetics experiments, we conclude that the binding involves both conformation selection and induced fit steps. Knowledge of the structural basis of this interaction could facilitate therapeutic targeting of melanomas.	[Gogl, Gergo; Kiss, Bence; Nyitray, Laszlo] Eotvos Lorand Univ, Dept Biochem, H-1117 Budapest, Hungary; [Kovacs, Mihaly] Eotvos Lorand Univ, Dept Biochem, ELTE MTA Momentum Motor Enzymol Res Grp, H-1117 Budapest, Hungary; [Bodor, Andrea] Eotvos Lorand Univ, Inst Chem, H-1117 Budapest, Hungary; [Alexa, Anita; Remenyi, Attila] Hungarian Acad Sci, Res Ctr Nat Sci, Inst Enzymol, Momentum Prot Interact Grp, H-1117 Budapest, Hungary; [Katona, Gergely] Univ Gothenburg, Dept Chem & Mol Biol, S-40530 Gothenburg, Sweden	Eotvos Lorand University; Eotvos Lorand University; Eotvos Lorand University; Hungarian Academy of Sciences; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Research Centre for Natural Sciences; University of Gothenburg	Remenyi, A (corresponding author), Hungarian Acad Sci, Res Ctr Nat Sci, Inst Enzymol, Magyar Tudosok Korutja 2, H-1117 Budapest, Hungary.	remenyi.attila@ttk.mta.hu; nyitray@elte.hu	Bodor, Andrea/AAL-7854-2020; Nyitray, László/AAE-5910-2020; Kiss, Bence/AAF-1808-2020; Remenyi, Attila/N-1345-2016; Katona, Gergely/B-3491-2008; Gogl, Gergo/ABH-4309-2020; Kovacs, Mihaly/A-6841-2011; Bodor, Andrea/G-1797-2018	Bodor, Andrea/0000-0002-7422-298X; Nyitray, László/0000-0003-4717-5994; Katona, Gergely/0000-0002-2031-8716; Gogl, Gergo/0000-0002-8597-3711; Bodor, Andrea/0000-0002-7422-298X; Remenyi, Attila/0000-0002-8345-1311; Kovacs, Mihaly/0000-0002-1200-4741; Alexa, Anita/0000-0002-5740-7835; Kiss, Bence/0000-0001-5810-5858	Hungarian National Research Fund (OTKA) [K108437, NK101072]; Momentum Program of the Hungarian Academy of Sciences [LP2013-57, LP-006/2011]; Swedish Research Council; MedInProt Program of the Hungarian Academy of Sciences; European Union; European Social Fund Grant [TAMOP4.2.1./B-09/KMR-2010-0003]	Hungarian National Research Fund (OTKA)(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Momentum Program of the Hungarian Academy of Sciences; Swedish Research Council(Swedish Research CouncilEuropean Commission); MedInProt Program of the Hungarian Academy of Sciences; European Union(European Commission); European Social Fund Grant	This work was supported in part by Hungarian National Research Fund (OTKA) Grants K108437 (to L. N.) and NK101072 (to A. B.), the Momentum Program of the Hungarian Academy of Sciences Grants LP2013-57 (to A. R.) and LP-006/2011 (to M. K.), the Swedish Research Council (to G. K.), the MedInProt Program of the Hungarian Academy of Sciences, the European Union, and the European Social Fund Grant (TAMOP4.2.1./B-09/KMR-2010-0003). The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Alexa A, 2015, P NATL ACAD SCI USA, V112, P2711, DOI 10.1073/pnas.1417571112; Anjum R, 2005, CURR BIOL, V15, P1762, DOI 10.1016/j.cub.2005.08.050; Bresnick AR, 2015, NAT REV CANCER, V15, P96, DOI 10.1038/nrc3893; Cargnello M, 2011, MICROBIOL MOL BIOL R, V75, P50, DOI 10.1128/MMBR.00031-10; Cavalier MC, 2014, BIOCHEMISTRY-US, V53, P6628, DOI 10.1021/bi5005552; Chrestensen CA, 2002, J BIOL CHEM, V277, P27733, DOI 10.1074/jbc.M202663200; Donato R, 2001, INT J BIOCHEM CELL B, V33, P637, DOI 10.1016/S1357-2725(01)00046-2; Dunker AK, 2001, J MOL GRAPH MODEL, V19, P26, DOI 10.1016/S1093-3263(00)00138-8; Elliott PR, 2012, STRUCTURE, V20, P654, DOI 10.1016/j.str.2012.02.002; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Frodin M, 2002, EMBO J, V21, P5396, DOI 10.1093/emboj/cdf551; Gaertner TR, 2004, J BIOL CHEM, V279, P12484, DOI 10.1074/jbc.M313597200; Gao XL, 2012, MOL BIOL CELL, V23, P503, DOI 10.1091/mbc.E11-07-0658; Garai A, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003004; Gavin AC, 1999, CURR BIOL, V9, P281, DOI 10.1016/S0960-9822(99)80120-1; Gogas H, 2009, ANN ONCOL, V20, P8, DOI 10.1093/annonc/mdp251; Hartman KG, 2014, J BIOL CHEM, V289, P12886, DOI 10.1074/jbc.M114.561613; Hartman KG, 2013, FUTURE MED CHEM, V5, P97, DOI 10.4155/fmc.12.191; Ikuta M, 2007, PROTEIN SCI, V16, P2626, DOI 10.1110/ps.073123707; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Keller R., 2004, COMPUTER AIDED RESON, V1; Kiss B, 2012, P NATL ACAD SCI USA, V109, P6048, DOI 10.1073/pnas.1114732109; Li D, 2012, ACTA CRYSTALLOGR D, V68, P680, DOI 10.1107/S0907444912007457; Malakhova M, 2008, NAT STRUCT MOL BIOL, V15, P112, DOI 10.1038/nsmb1347; Marenholz I, 2004, BIOCHEM BIOPH RES CO, V322, P1111, DOI 10.1016/j.bbrc.2004.07.096; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Micsonai A, 2015, P NATL ACAD SCI USA, V112, pE3095, DOI 10.1073/pnas.1500851112; Ostendorp T, 2011, BBA-MOL CELL RES, V1813, P1083, DOI 10.1016/j.bbamcr.2010.10.006; Pearce LR, 2010, NAT REV MOL CELL BIO, V11, P9, DOI 10.1038/nrm2822; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; Rellos P, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000426; Riuzzi F, 2006, J CELL PHYSIOL, V207, P461, DOI 10.1002/jcp.20580; Romeo Y, 2013, ONCOGENE, V32, P2917, DOI 10.1038/onc.2012.312; Romeo Y, 2012, BIOCHEM J, V441, P553, DOI 10.1042/BJ20110289; Tompa P, 2008, TRENDS BIOCHEM SCI, V33, P2, DOI 10.1016/j.tibs.2007.10.003; Tria G, 2015, IUCRJ, V2, P207, DOI 10.1107/S205225251500202X; Underwood KW, 2003, STRUCTURE, V11, P627, DOI 10.1016/S0969-2126(03)00092-3; van Dieck J, 2009, J MOL BIOL, V394, P922, DOI 10.1016/j.jmb.2009.10.002; Weichenberger CX, 2014, ACTA CRYSTALLOGR D, V70, P1579, DOI 10.1107/S1399004714005550; Zaru R, 2007, NAT IMMUNOL, V8, P1227, DOI 10.1038/ni1517	41	37	37	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 1	2016	291	1					11	27		10.1074/jbc.M115.684928	http://dx.doi.org/10.1074/jbc.M115.684928			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DA1XP	26527685	hybrid, Green Published, Green Accepted			2022-12-26	WOS:000367589500002
J	Lu, JF; Li, JE; Liu, YL; Ren, S; Cao, ZH; Jin, Y; Ma, LN; Shen, CL; Chen, XY				Lu, Junfeng; Li, Jin'e; Liu, Yali; Ren, Shan; Cao, Zhenhuan; Jin, Yi; Ma, Lina; Shen, Chengli; Chen, Xinyue			Study on Post-Treatment Relapse in HBeAg Positive CHB Patients	PLOS ONE			English	Article							CHRONIC HEPATITIS-B; E-ANTIGEN SEROCONVERSION; PEGINTERFERON ALPHA-2A; OFF-TREATMENT; VIRUS DNA; LAMIVUDINE; DURABILITY; THERAPY; COMBINATION	Background Many factors are associated with post-treatment relapse in CHB patients, and there are no effective factors to predict relapse. In this study, we investigate the influence factors associated with post-treatment relapse and their predictive value in HBeAg positive CHB (eP-CHB). Methods The factors associated with post-treatment relapse were analyzed firstly by a retrospective study in eP-CHB. Variables included age, sex, regimen, baseline HBeAg and HBV DNA level, total course of treatment as well as duration of consolidation therapy after HBeAg seroconversion. The predictive effects of the influence factors were evaluated in an eP-CHB prospective cohort. Results 89 patients were enrolled in the retrospective study, 42(47.2%) relapsed after discontinuation of treatment. Factors related to post-treatment relapse were total course of treatment, duration of consolidation therapy and baseline HBV DNA level. Relapse rates in patients with total course >36 months, consolidation duration >12 months and baseline HBV DNA level < 1.0E+5IU/ml were lower than those of total course <24 months (P = 0.002), consolidation duration <= 1 = 0.01) respectively. Patients with HBV DNA >= 1.0E+ 7IU/ml plus HBeAg<200COI at baseline had the highest relapse rate and cumulative relapse rate than the other three arms (P = 0.048 and 0.008 respectively). Logistic regression analysis demonstrated that baseline HBV DNA level, duration of consolidation therapy and combination of baseline HBV DNA and HBeAg (Ig(DNA)/Ig(HBeAg)) were independent factors to predict post-treatment relapse. The model based on baseline Ig(DNA)/Ig(HBeAg) and consolidation duration worked well in predicting post-treatment relapse in the prospective study and the accuracy, specificity, sensitivity, PPV and NPV for prediction were 80.3%, 81.1%, 79.2%, 73.1% and 85.7% respectively. Conclusions Virological factors including baseline HBV DNA, HBeAg and treatment course were major influence factors associated with post-treatment relapse in eP-CHB. Patients with higher HBV DNA and lower HBeAg levels at baseline, shorter total course as well as consolidation therapy were more likely to develop relapse after discontinuation of therapy. The antiviral therapy in eP-CHB patients should be individually managed at different levels. It is better to treat those with higher viral load and lower HBeAg levels at baseline for a longer course, especially longer consolidation duration so as to decrease the relapse rate.	[Lu, Junfeng; Li, Jin'e; Liu, Yali; Ren, Shan; Cao, Zhenhuan; Jin, Yi; Ma, Lina; Chen, Xinyue] Capital Med Univ, Beijing Youan Hosp, Beijing, Peoples R China; [Shen, Chengli] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Infect Dis & Microbiol, Pittsburgh, PA 15261 USA	Capital Medical University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Chen, XY (corresponding author), Capital Med Univ, Beijing Youan Hosp, Beijing, Peoples R China.	chenxydoc@163.com	chen, xinyue/HHR-9308-2022		Beijing Youan Hospital hepatic Disease HIV Fund [20150205];  [PXM2015 014226 000058];  [2013ZX1000 2002-006];  [Z151100004015181]	Beijing Youan Hospital hepatic Disease HIV Fund; ; ; 	This work was supported by The capital characteristic clinical application research and extension of achievements, Z151100004015181(XC), Beijing Youan Hospital hepatic Disease & HIV Fund 20150205 (XC), Collaborative innovation project, PXM2015 014226 000058 (XC), and The twelfth Five-Year major science and technology projects, 2013ZX1000 2002-006 (XC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cao ZH, 2013, J DIGEST DIS, V14, P446, DOI 10.1111/1751-2980.12065; Chaung KT, 2012, J CLIN GASTROENTEROL, V46, P865, DOI 10.1097/MCG.0b013e31825ceed9; Chien RN, 2003, HEPATOLOGY, V38, P1267, DOI 10.1053/jhep.2003.50458; Chinese Society of Hepatology and Chinese Society of Infectious Diseases Chinese Medical Association, 2011, Zhonghua Gan Zang Bing Za Zhi, V19, P13, DOI 10.3760/cma.j.issn.1007-3418.2011.01.007; Flink HJ, 2007, GUT, V56, P1485, DOI 10.1136/gut.2007.125633; Fried MW, 2008, HEPATOLOGY, V47, P428, DOI 10.1002/hep.22065; Lee HW, 2010, HEPATOLOGY, V51, P415, DOI 10.1002/hep.23323; Liaw YF, 2012, HEPATOL INT, V6, P531, DOI 10.1007/s12072-012-9365-4; Lok ASF, 2009, HEPATOLOGY, V50, P661, DOI 10.1002/hep.23190; Pan XF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068568; Papatheodoridis G, 2012, J HEPATOL, V57, P167, DOI 10.1016/j.jhep.2012.02.010; Sohn HR, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-439; Song BC, 2000, HEPATOLOGY, V32, P803, DOI 10.1053/jhep.2000.16665; Song MJ, 2012, WORLD J GASTROENTERO, V18, P6277, DOI 10.3748/wjg.v18.i43.6277; van Nunen AB, 2003, GUT, V52, P420, DOI 10.1136/gut.52.3.420; Wang L, 2010, J VIRAL HEPATITIS, V17, P298, DOI 10.1111/j.1365-2893.2009.01178.x; Xie Dong-ying, 2008, Zhonghua Gan Zang Bing Za Zhi, V16, P341; Yeh CT, 2009, J CLIN VIROL, V45, P114, DOI 10.1016/j.jcv.2009.04.006	18	0	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2015	10	11							e0141072	10.1371/journal.pone.0141072	http://dx.doi.org/10.1371/journal.pone.0141072			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV1PG	26524467	Green Published, Green Submitted, gold, Green Accepted			2022-12-26	WOS:000364029800006
J	Arundell, L; Hinkley, T; Veitch, J; Salmon, J				Arundell, Lauren; Hinkley, Trina; Veitch, Jenny; Salmon, Jo			Contribution of the After-School Period to Children's Daily Participation in Physical Activity and Sedentary Behaviours	PLOS ONE			English	Article							5-YEAR CHANGES; AGED CHILDREN; ASSOCIATIONS; VALIDITY; MODERATE; GENDER; YOUTH; PLAY	Objectives Children's after-school physical activity (PA) and sedentary behaviours (SB) are not well understood, despite the potential this period holds for intervention. This study aimed to describe children's after-school physical activity and sedentary behaviours; establish the contribution this makes to daily participation and to achieving physical activity and sedentary behaviours guidelines; and to determine the association between after-school moderate-to vigorous-intensity physical activity (MVPA), screen-based sedentary behaviours and achieving the physical activity and sedentary behaviour guidelines. Methods Children (n = 406, mean age 8.1 years, 58% girls) wore an ActiGraph GT3X accelerometer. The percentage of time and minutes spent sedentary (SED), in light-physical activity (LPA) and MVPA between the end-of-school and 6pm (weekdays) was calculated. Parents (n = 318, 40 years, 89% female) proxy-reported their child's after-school participation in screen-based sedentary behaviours. The contribution that after-school SED, LPA, MVPA, and screen-based sedentary behaviours made to daily levels, and that after-school MVPA and screen-based sedentary behaviours made to achieving the physical activity/sedentary behaviour guidelines was calculated. Regression analysis determined the association between after-school MVPA and screen-based sedentary behaviours and achieving the physical activity/sedentary behaviours guidelines. Results Children spent 54% of the after-school period SED, and this accounted for 21% of children's daily SED levels. Boys spent a greater percentage of time in MVPA than girls (14.9% vs. 13.6%; p<0.05), but this made a smaller contribution to their daily levels (27.6% vs 29.8%; p<0.05). After school, boys and girls respectively performed 18.8 minutes and 16.7 minutes of MVPA, which is 31.4% and 27.8% of the MVPA (p<0.05) required to achieve the physical activity guidelines. Children spent 96 minutes in screen-based sedentary behaviours, contributing to 84% of their daily screen-based sedentary behaviours and 80% of the sedentary behaviour guidelines. After-school MVPA was positively associated with achieving the physical activity guidelines (OR: 1.31, 95% CI 1.18, 1.44, p<0.05), and after-school screen-based sedentary behaviours were negatively associated with achieving the sedentary behaviours guidelines (OR: 0.97, 95% CI: 0.96, 0.97, p<0.05). Conclusions The after-school period plays a critical role in the accumulation of children's physical activity and sedentary behaviours. Small changes to after-school behaviours can have large impacts on children's daily behaviours levels and likelihood of meeting the recommended levels of physical activity and sedentary behaviour. Therefore interventions should target reducing after-school sedentary behaviours and increasing physical activity.	[Arundell, Lauren; Hinkley, Trina; Veitch, Jenny; Salmon, Jo] Deakin Univ, Fac Hlth, Sch Exercise & Nutr Sci, Ctr Phys Activ & Nutr Res, Burwood, Australia	Deakin University	Arundell, L (corresponding author), Deakin Univ, Fac Hlth, Sch Exercise & Nutr Sci, Ctr Phys Activ & Nutr Res, Burwood, Australia.	lauren.arundell@deakin.edu.au	Arundell, Lauren/K-2577-2019; Salmon, Jo/C-1226-2009; Salmon, Jo/X-2630-2019	Arundell, Lauren/0000-0002-8178-4104; Salmon, Jo/0000-0002-4734-6354; Salmon, Jo/0000-0002-4734-6354; Veitch, Jenny/0000-0001-8962-0887; Hinkley, Trina/0000-0003-2742-8579	National Health and Medical Research Council (NHMRC) [533815, APP1074484, APP1053426, APP1070571, APP1026216]	National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia)	Transform-Us! was funded by the National Health and Medical Research Council (NHMRC) (533815), www.nhmrc.gov.au. Lauren Arundell is supported by a National Health and Medical Research Council (NHMRC) Postgraduate Research Scholarship (APP1074484), www.nhmrc.gov.au. Jenny Veitch is supported by a National Health and Medical Research Council (NHMRC) Early Career Research Fellowship (APP1053426), www.nhmrc.gov.au. Trina Hinkley is supported by a National Health and Medical Research Council (NHMRC) Early Career Fellowship (APP1070571), www.nhmrc.gov.au. Jo Salmon is supported by a National Health and Medical Research Council (NHMRC) Principal Research Fellowship (APP1026216), www.nhmrc.gov.au. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Active Healthy Kids Canada, 2010, HLTH HAB START EARL; Active Healthy Kids England, 2014, 2014 ACT HLTH KIDS E; Active Healthy Kids Scotland, 2013, CHILDS PLAY 2013 ACT; [Anonymous], 2014, AUSTR PHYS ACT SED B; Arundell L, 2013, AM J PREV MED, V44, P605, DOI 10.1016/j.amepre.2013.01.029; Arundell L, 2013, HEALTH PROMOT J AUST, V24, P65, DOI 10.1071/HE12910; Australian Bureau of Statistics, 2013, AUSTR HLTH SURV PHYS; BAILEY RC, 1995, MED SCI SPORT EXER, V27, P1033, DOI 10.1249/00005768-199507000-00012; Barnes J, 2012, APPL PHYSIOL NUTR ME, V37, P540, DOI [10.1139/H2012-024, 10.1139/h2012-024]; Brockman R, 2010, PREV MED, V51, P144, DOI 10.1016/j.ypmed.2010.05.012; Cain K, 2012, J PHYS ACTI IN PRESS; Canada AHK, 2012, 2012 ACT HLTH KIDS C; Canada AHK, 2014, 2014 ACT HLTH KIDS C; Cooper AR, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-31; Department of Health, 2011, PHYS ACT GUID CHILDR; Dzewaltowski DA, 2008, PSYCHOL SPORT EXERC, V9, P848, DOI 10.1016/j.psychsport.2007.10.004; Flohr JA, 2006, RES Q EXERCISE SPORT, V77, P309; Hager RL, 2006, J ADOLESCENT HEALTH, V39, P656, DOI 10.1016/j.jadohealth.2006.04.020; Healthy Active Kids New Zealand, 2014, NZ PHYS ACT REP CARD; Hesketh K, 2008, PEDIATR EXERC SCI, V20, P84, DOI 10.1123/pes.20.1.84; Jago R, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-59; Janssen I, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-40; Janssen X, 2014, SCI SPORTS, V29, pS44; Kalman M, 2015, EUR J PUBLIC HEALTH, V25, P37, DOI 10.1093/eurpub/ckv024; Lau J, 2013, PEDIATR EXERC SCI, V25, P124, DOI 10.1123/pes.25.1.124; Olds T, 2009, J ADOLESCENT HEALTH, V44, P64, DOI 10.1016/j.jadohealth.2008.05.003; Ridgers ND, 2012, BRIT J SPORT MED, V46, P741, DOI 10.1136/bjsm.2011.084921; Ridgers ND, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-15; Ridley K, 2008, INT J BEHAV NUTR PHY, V5, DOI 10.1186/1479-5868-5-45; Robinson Thomas N, 2003, Ethn Dis, V13, pS65; Sallis JF, 2000, MED SCI SPORT EXER, V32, P963, DOI 10.1097/00005768-200009000-00012; Salmon J, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-759; Sim J, 2000, RES HLTH CARE CONCEP; Stone MR, 2014, PREV MED, V65, P122, DOI 10.1016/j.ypmed.2014.05.008; Telford A, 2004, PEDIATR EXERC SCI, V16, P64, DOI 10.1123/pes.16.1.64; The NHS Information Centre, 2008, HLTH SURV ENGL 2008; Tremblay MS, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-98; Tremblay MS, 2011, APPL PHYSIOL NUTR ME, V36, P65, DOI 10.1139/H11-013; Tremblay MS, 2011, APPL PHYSIOL NUTR ME, V36, P36, DOI [10.1139/H11-009, 10.1139/H11-010]; Troiano RP, 2008, MED SCI SPORT EXER, V40, P181, DOI 10.1249/mss.0b013e31815a51b3; Trost SG, 2000, MED SCI SPORT EXER, V32, P426, DOI 10.1097/00005768-200002000-00025; Trost SG, 1998, MED SCI SPORT EXER, V30, P629, DOI 10.1097/00005768-199804000-00023; Trost SG, 2002, MED SCI SPORT EXER, V34, P350, DOI 10.1097/00005768-200202000-00025; Trost SG, 2008, MED SCI SPORT EXER, V40, P622, DOI 10.1249/MSS.0b013e318161eaa5; Trost SG, 2011, MED SCI SPORT EXER, V43, P1360, DOI 10.1249/MSS.0b013e318206476e	45	32	32	3	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2015	10	10							e0140132	10.1371/journal.pone.0140132	http://dx.doi.org/10.1371/journal.pone.0140132			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CV0EH	26517362	gold, Green Submitted, Green Published			2022-12-26	WOS:000363920800002
J	Brobey, RK; Dheghani, M; Foster, PP; Kuro-o, M; Rosenblatt, KP				Brobey, Reynolds K.; Dheghani, Mehdi; Foster, Philip P.; Kuro-o, Makoto; Rosenblatt, Kevin P.			Klotho Regulates 14-3-3 zeta Monomerization and Binding to the ASK1 Signaling Complex in Response to Oxidative Stress	PLOS ONE			English	Article							HORMONE KLOTHO; CELL-DEATH; PROTEIN; APOPTOSIS; PATHWAYS; GROWTH; THIOREDOXIN; PHOSPHORYLATION; IDENTIFICATION; SUPPRESSION	The reactive oxygen species (ROS)-sensitive apoptosis signal-regulating kinase 1 (ASK1) signaling complex is a key regulator of p38 MAPK activity, a major modulator of stress-associated with aging disorders. We recently reported that the ratio of free ASK1 to the complex-bound ASK1 is significantly decreased in Klotho-responsive manner and that Klotho-deficient tissues have elevated levels of free ASK1 which coincides with increased oxidative stress. Here, we tested the hypothesis that: 1) covalent interactions exist among three identified proteins constituting the ASK1 signaling complex; 2) in normal unstressed cells the ASK1, 14-3-3 zeta and thioredoxin (Trx) proteins simultaneously engage in a tripartite complex formation; 3) Klotho's stabilizing effect on the complex relied solely on 14-3-3 zeta expression and its apparent phosphorylation and dimerization changes. To verify the hypothesis, we performed 14-3-3 zeta siRNA knock-down experiments in conjunction with cell-based assays to measure ASK1-client protein interactions in the presence and absence of Klotho, and with or without an oxidant such as rotenone. Our results show that Klotho activity induces post-translational modifications in the complex targeting 14-3-3 zeta monomer/dimer changes to effectively protect against ASK1 oxidation and dissociation. This is the first observation implicating all three proteins constituting the ASK1 signaling complex in close proximity.	[Brobey, Reynolds K.; Dheghani, Mehdi; Foster, Philip P.; Rosenblatt, Kevin P.] Univ Texas Hlth Sci Ctr Houston UTHlth, Brown Fdn Inst Mol Med, Sch Med, Ctr Prote, Houston, TX 77030 USA; [Brobey, Reynolds K.; Dheghani, Mehdi; Foster, Philip P.; Rosenblatt, Kevin P.] Univ Texas Hlth Sci Ctr Houston UTHlth, Brown Fdn Inst Mol Med, Sch Med, Ctr Syst Biol, Houston, TX 77030 USA; [Brobey, Reynolds K.] Univ Texas Hlth Sci Ctr Houston UTHlth, Sch Med, Dept Internal Med, Div Oncol, Houston, TX 77030 USA; [Dheghani, Mehdi; Rosenblatt, Kevin P.] Compan Dx Reference Lab LLC, Houston, TX 77025 USA; [Foster, Philip P.] Univ Texas Hlth Sci Ctr Houston UTHlth, MD Anderson Canc Ctr, Dept NanoMed & Biomed Engn, Houston, TX 77030 USA; [Foster, Philip P.] Univ Texas Hlth Sci Ctr Houston UTHlth, Sch Med, Dept Internal Med, Div Pulm Med, Houston, TX 77030 USA; [Kuro-o, Makoto] Jichi Med Univ, Ctr Mol Med, Shimotsuke, Tochigi 3290498, Japan; [Kuro-o, Makoto] Univ Texas SW Med Ctr Dallas, Ctr Mineral Metab, Dept Pathol, Dallas, TX 75390 USA	University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; UTMD Anderson Cancer Center; University of Texas System; University of Texas Health Science Center Houston; Jichi Medical University; University of Texas System; University of Texas Southwestern Medical Center Dallas	Rosenblatt, KP (corresponding author), Univ Texas Hlth Sci Ctr Houston UTHlth, Brown Fdn Inst Mol Med, Sch Med, Ctr Prote, 1825 Pressler St, Houston, TX 77030 USA.	Kevin.Rosenblatt@uth.tmc.edu			National Heart, Lung and Blood Institute [HHSN268201000037C]; Levit Chair Foundation [70P-1-4116]; Welch Foundation [L-AU-0002]; Clinical and Translational Sciences Award [5UL1TR000371-07]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000371] Funding Source: NIH RePORTER	National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Levit Chair Foundation; Welch Foundation(The Welch Foundation); Clinical and Translational Sciences Award; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was funded by National Heart, Lung and Blood Institute grant no. HHSN268201000037C for KPR; Levit Chair Foundation grant no. 70P-1-4116 for KPR; Welch Foundation grant no. L-AU-0002 for KPR RKB; Clinical and Translational Sciences Award grant no. 5UL1TR000371-07 for KPR.	Aitken A, 2002, BIOCHEM SOC T, V30, P351, DOI 10.1042/bst0300351; AITKEN A, 1995, BIOCHEM SOC T, V23, P605, DOI 10.1042/bst0230605; Aitken A, 1996, TRENDS CELL BIOL, V6, P341, DOI 10.1016/0962-8924(96)10029-5; ASHFORD JW, 1985, NEW ENGL J MED, V313, P388; Chen CD, 2013, J NEUROSCI, V33, P1927, DOI 10.1523/JNEUROSCI.2080-12.2013; Choi JE, 2011, CANCER LETT, V303, P99, DOI 10.1016/j.canlet.2011.01.015; Deary IJ, 2005, NEUROSCI LETT, V378, P22, DOI 10.1016/j.neulet.2004.12.005; Dubal DB, 2014, CELL REP, V7, P1065, DOI 10.1016/j.celrep.2014.03.076; Duce JA, 2008, GLIA, V56, P106, DOI 10.1002/glia.20593; Geleziunas R, 2001, NATURE, V410, P834, DOI 10.1038/35071111; Hansen RE, 2009, ANAL BIOCHEM, V394, P147, DOI 10.1016/j.ab.2009.07.051; HOLMGREN A, 1989, J BIOL CHEM, V264, P13963; Hsieh CC, 2010, AGING-US, V2, P582, DOI 10.18632/aging.100194; Hsieh CC, 2004, MECH AGEING DEV, V125, P785, DOI 10.1016/j.mad.2004.07.008; Hsieh CC, 2006, FASEB J, V20, P259, DOI 10.1096/fj.05-4376com; Komurov K, 2010, J BIOL CHEM, V285, P21134, DOI 10.1074/jbc.M110.137828; Kuro-o M, 2006, CURR OPIN NEPHROL HY, V15, P437, DOI 10.1097/01.mnh.0000232885.81142.83; Kuroo M, 1997, NATURE, V390, P45, DOI 10.1038/36285; Kurosu H, 2006, J BIOL CHEM, V281, P6120, DOI 10.1074/jbc.C500457200; Kurosu H, 2005, SCIENCE, V309, P1829, DOI 10.1126/science.1112766; Lakowski B, 1998, P NATL ACAD SCI USA, V95, P13091, DOI 10.1073/pnas.95.22.13091; Liu QH, 2006, MOL CELL BIOL, V26, P3785, DOI 10.1128/MCB.26.10.3785-3797.2006; Liu YM, 2002, CIRC RES, V90, P1259, DOI 10.1161/01.RES.0000022160.64355.62; Liu YM, 2001, J CLIN INVEST, V107, P917, DOI 10.1172/JCI11947; Mengel-From J, 2016, J GERONTOL A-BIOL, V71, P1151, DOI 10.1093/gerona/glv163; Nadeau PJ, 2007, MOL BIOL CELL, V18, P3903, DOI 10.1091/mbc.E07-05-0491; PAPACONSTANTINOU J, 1994, ANN NY ACAD SCI, V719, P195, DOI 10.1111/j.1749-6632.1994.tb56829.x; Porter GW, 2006, SEMIN CANCER BIOL, V16, P193, DOI 10.1016/j.semcancer.2006.03.003; Powell DW, 2003, MOL CELL BIOL, V23, P5376, DOI 10.1128/MCB.23.15.5376-5387.2003; Powell DW, 2002, J BIOL CHEM, V277, P21639, DOI 10.1074/jbc.M203167200; Saitoh M, 1998, EMBO J, V17, P2596, DOI 10.1093/emboj/17.9.2596; Shardell M, 2016, J GERONTOL A-BIOL, V71, P677, DOI 10.1093/gerona/glv140; Shin EJ, 2015, INT J NEUROPSYCHOPH, V18, DOI 10.1093/ijnp/pyu105; SOHAL RS, 1995, MECH AGEING DEV, V81, P15, DOI 10.1016/0047-6374(94)01578-A; Sturm N, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000383; Tobiume K, 2001, EMBO REP, V2, P222, DOI 10.1093/embo-reports/kve046; Tzivion G, 1998, NATURE, V394, P88, DOI 10.1038/27938; Wang XQ, 2010, PHYSIOL GENOMICS, V41, P120, DOI 10.1152/physiolgenomics.00192.2009; Wolf I, 2008, ONCOGENE, V27, P7094, DOI 10.1038/onc.2008.292; Woodcock JM, 2003, J BIOL CHEM, V278, P36323, DOI 10.1074/jbc.M304689200; Xiao Bing, 1995, Nature (London), V376, P188, DOI 10.1038/376188a0; Yamamoto M, 2005, J BIOL CHEM, V280, P38029, DOI 10.1074/jbc.M509039200; Yokoyama JS, 2015, ANN CLIN TRANSL NEUR, V2, P215, DOI 10.1002/acn3.161; Zeldich E, 2014, J BIOL CHEM, V289, P24700, DOI 10.1074/jbc.M114.567321; Zhang LX, 1999, P NATL ACAD SCI USA, V96, P8511, DOI 10.1073/pnas.96.15.8511; Zhou JB, 2009, MOL CELL BIOL, V29, P4167, DOI 10.1128/MCB.01067-08	47	11	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2015	10	10							e0141968	10.1371/journal.pone.0141968	http://dx.doi.org/10.1371/journal.pone.0141968			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0EH	26517365	Green Submitted, Green Published, gold			2022-12-26	WOS:000363920800098
J	Nakata, PA				Nakata, Paul A.			An Assessment of Engineered Calcium Oxalate Crystal Formation on Plant Growth and Development as a Step toward Evaluating Its Use to Enhance Plant Defense	PLOS ONE			English	Article							OXALYL-COA SYNTHETASE; BROWN PLANTHOPPER; FINE-STRUCTURE; ARABIDOPSIS; RICE; ACID; DELPHACIDAE; HOMOPTERA; RAPHIDES; INSECTS	The establishment of new approaches to control chewing insects has been sought not only for direct use in reducing crop loss but also in managing resistance to the pesticides already in use. Engineered formation of calcium oxalate crystals is a potential strategy that could be developed to fulfill both these needs. As a step toward this development, this study investigates the effects of transforming a non-calcium oxalate crystal accumulating plant, Arabidopsis thaliana, into a crystal accumulating plant. Calcium oxalate crystal accumulating A. thaliana lines were generated by ectopic expression of a single bacterial gene encoding an oxalic acid biosynthetic enzyme. Biochemical and cellular studies suggested that the engineered A. thaliana lines formed crystals of calcium oxalate in a manner similar to naturally occurring crystal accumulating plants. The amount of calcium oxalate accumulated in leaves also reached levels similar to those measured in the leaves of Medicago truncatula in which the crystals are known to play a defensive role. Visual inspection of the different engineered lines, however, suggested a phenotypic consequence on plant growth and development with higher calcium oxalate concentrations. The restoration of a near wildtype plant phenotype through an enzymatic reduction of tissue oxalate supported this observation. Overall, this study is a first to provide initial insight into the potential consequences of engineering calcium oxalate crystal formation in non-crystal accumulating plants.	Baylor Univ, USDA ARS, Childrens Nutr Res Ctr, Baylor Coll Med,Dept Pediat, Houston, TX 77030 USA	Baylor College of Medicine; Baylor University; United States Department of Agriculture (USDA)	Nakata, PA (corresponding author), Baylor Univ, USDA ARS, Childrens Nutr Res Ctr, Baylor Coll Med,Dept Pediat, Houston, TX 77030 USA.	paul.nakata@ars.usda.gov		Nakata, Paul/0000-0002-6331-9700	U.S. Department of Agriculture, Agricultural Research Service [58-3092-5-001]	U.S. Department of Agriculture, Agricultural Research Service(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	U.S. Department of Agriculture, Agricultural Research Service, 58-3092-5-001. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bradbury JH, 1998, J SCI FOOD AGR, V76, P608, DOI [10.1002/(SICI)1097-0010(199804)76:4&lt;608::AID-JSFA996&gt;3.0.CO;2-2, 10.1002/(SICI)1097-0010(199804)76:4<608::AID-JSFA996>3.3.CO;2-U]; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Duffey SS, 1996, ARCH INSECT BIOCHEM, V32, P3, DOI 10.1002/(SICI)1520-6327(1996)32:1&lt;3::AID-ARCH2&gt;3.0.CO;2-1; Foster J, 2014, FEBS LETT, V588, P160, DOI 10.1016/j.febslet.2013.11.026; Foster J, 2012, PLANT CELL, V24, P1217, DOI 10.1105/tpc.112.096032; Franceschi VR, 2005, ANNU REV PLANT BIOL, V56, P41, DOI 10.1146/annurev.arplant.56.032604.144106; FRANCESCHI VR, 1980, BOT REV, V46, P361, DOI 10.1007/BF02860532; Howe GA, 2015, CURR OPIN INSECT SCI; James LF, 1999, J NAT TOXINS, V8, P395; Julian CG, 1997, CONTACT DERMATITIS, V37, P259, DOI 10.1111/j.1600-0536.1997.tb02461.x; Konno K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091341; Korth KL, 2006, PLANT PHYSIOL, V141, P188, DOI 10.1104/pp.106.076737; Koul O, 2008, CRIT REV PLANT SCI, V27, P1, DOI 10.1080/07352680802053908; MASSONIE G, 1980, ANN NUTR ALIMENT, V34, P139; Mithofer A, 2012, ANNU REV PLANT BIOL, V63, P431, DOI 10.1146/annurev-arplant-042110-103854; Nakata P. A., 2012, FRONT BIOL, V7, P254, DOI DOI 10.1007/S11515-012-1224-0; Nakata PA, 2000, PLANT PHYSIOL, V124, P1097, DOI 10.1104/pp.124.3.1097; Nakata PA, 2003, PLANT SCI, V164, P901, DOI 10.1016/S0168-9452(03)00120-1; Nakata PA, 2012, PLANT CELL PHYSIOL, V53, P1275, DOI 10.1093/pcp/pcs071; Nakata PA, 2011, MICROBIOL RES, V166, P531, DOI 10.1016/j.micres.2010.11.002; Nakata PA, 2010, FEMS MICROBIOL LETT, V304, P177, DOI 10.1111/j.1574-6968.2010.01895.x; Park SH, 2009, ENTOMOL EXP APPL, V131, P208, DOI 10.1111/j.1570-7458.2009.00846.x; Salinas ML, 2001, CONTACT DERMATITIS, V44, P94, DOI 10.1034/j.1600-0536.2001.440208.x; THURSTON EL, 1976, AM J BOT, V63, P710, DOI 10.2307/2442029; Wang YC, 2008, ENTOMOL EXP APPL, V129, P295, DOI 10.1111/j.1570-7458.2008.00785.x; YOSHIHARA T, 1979, ENTOMOL EXP APPL, V26, P314, DOI 10.1111/j.1570-7458.1979.tb02932.x; YOSHIHARA T, 1980, ENTOMOL EXP APPL, V27, P149, DOI 10.1007/BF00573889	27	17	18	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2015	10	10							e0141982	10.1371/journal.pone.0141982	http://dx.doi.org/10.1371/journal.pone.0141982			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0EH	26517544	gold, Green Submitted, Green Published			2022-12-26	WOS:000363920800099
J	Tateishi, R; Akiyama, N; Miyauchi, M; Yoshinaga, R; Sasanuma, H; Kudo, T; Shimbo, M; Shinohara, M; Obata, K; Inoue, J; Shirakawa, M; Shiba, D; Asahara, H; Yoshida, N; Takahashi, S; Morita, H; Akiyama, T				Tateishi, Ryosuke; Akiyama, Nobuko; Miyauchi, Maki; Yoshinaga, Riko; Sasanuma, Hiroki; Kudo, Takashi; Shimbo, Miki; Shinohara, Masahiro; Obata, Koji; Inoue, Jun-ichiro; Shirakawa, Masaki; Shiba, Dai; Asahara, Hiroshi; Yoshida, Nobuaki; Takahashi, Satoru; Morita, Hironobu; Akiyama, Taishin			Hypergravity Provokes a Temporary Reduction in CD4+CD8+Thymocyte Number and a Persistent Decrease in Medullary Thymic Epithelial Cell Frequency in Mice	PLOS ONE			English	Article							IMMUNE-SYSTEM; SPACE-FLIGHT; ADULT THYMUS; STRESS; RATS; MICROGRAVITY; REGENERATION; SPACEFLIGHT; TOLERANCE; AIRE	Gravity change affects many immunological systems. We investigated the effects of hypergravity (2G) on murine thymic cells. Exposure of mice to 2G for three days reduced the frequency of CD4(+)CD8(+) thymocytes (DP) and mature medullary thymic epithelial cells (mTECs), accompanied by an increment of keratin-5 and keratin-8 double-positive (K5(+)K8(+)) TECs that reportedly contain TEC progenitors. Whereas the reduction of DP was recovered by a 14-day exposure to 2G, the reduction of mature mTECs and the increment of K5(+)K8(+) TEC persisted. Interestingly, a surgical lesion of the inner ear's vestibular apparatus inhibited these hypergravity effects. Quantitative PCR analysis revealed that the gene expression of Aire and RANK that are critical for mTEC function and development were upregulated by the 3-day exposure and subsequently down-regulated by the 14-day exposure to 2G. Unexpectedly, this dynamic change in mTEC gene expression was independent of the vestibular apparatus. Overall, data suggest that 2G causes a temporary reduction of DP and a persistent reduction of mature mTECs in a vestibular system-dependent manner, and also dysregulates mTEC gene expression without involving the vestibular system. These data might provide insight on the impact of gravity change on thymic functions during space-flight and living.	[Tateishi, Ryosuke; Akiyama, Nobuko; Miyauchi, Maki; Yoshinaga, Riko; Inoue, Jun-ichiro; Akiyama, Taishin] Univ Tokyo, Inst Med Sci, Div Cellular & Mol Biol, Tokyo, Japan; [Tateishi, Ryosuke; Akiyama, Nobuko; Miyauchi, Maki; Yoshinaga, Riko; Sasanuma, Hiroki; Kudo, Takashi; Shimbo, Miki; Shinohara, Masahiro; Obata, Koji; Shirakawa, Masaki; Shiba, Dai; Asahara, Hiroshi; Yoshida, Nobuaki; Takahashi, Satoru; Morita, Hironobu; Akiyama, Taishin] Japan Aerosp Explorat Agcy, Mouse Epigenet Project, ISS Kibo Expt, JAXA, Tsukuba, Ibaraki, Japan; [Sasanuma, Hiroki; Yoshida, Nobuaki] Univ Tokyo, Ctr Expt Med & Syst Biol, Lab Dev Genet, Tokyo, Japan; [Kudo, Takashi; Shimbo, Miki; Takahashi, Satoru] Univ Tsukuba, Lab Anim Resource Ctr, Tsukuba, Ibaraki, Japan; [Kudo, Takashi; Shimbo, Miki; Takahashi, Satoru] Univ Tsukuba, Dept Anat & Embryol, Fac Med, Tsukuba, Ibaraki, Japan; [Shinohara, Masahiro; Asahara, Hiroshi] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Syst BioMed, Tokyo, Japan; [Shinohara, Masahiro] PRESTO, JST, Kawaguchi, Saitama, Japan; [Obata, Koji; Morita, Hironobu] Gifu Univ, Grad Sch Med, Dept Physiol, Gifu, Japan; [Shirakawa, Masaki; Shiba, Dai] JAXA, JEM Utilizat Ctr, Human Spaceflight Technol Directorate, Tsukuba, Ibaraki, Japan	University of Tokyo; Japan Aerospace Exploration Agency (JAXA); University of Tokyo; University of Tsukuba; University of Tsukuba; Tokyo Medical & Dental University (TMDU); Japan Science & Technology Agency (JST); Gifu University; Japan Aerospace Exploration Agency (JAXA)	Morita, H (corresponding author), Japan Aerosp Explorat Agcy, Mouse Epigenet Project, ISS Kibo Expt, JAXA, Tsukuba, Ibaraki, Japan.	zunzunmorita@gmail.com; taishin@ims.u-tokyo.ac.jp		Shinohara, Masahiro/0000-0002-5532-1042; Kudo, Takashi/0000-0001-5477-7235	JAXA [13YPTK-013584, 4YPTK-000980, 15YPTK-002009, 14YPTK-005512]; Specially Promoted Project of the Toyota Physical and Chemical Research Institute; Princess Takamatsu Cancer Research Fund;  [26670234];  [15H01150]; Grants-in-Aid for Scientific Research [26670234, 26290036, 15K21745] Funding Source: KAKEN	JAXA; Specially Promoted Project of the Toyota Physical and Chemical Research Institute; Princess Takamatsu Cancer Research Fund; ; ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Short arm centrifuge project commissioned from JAXA (13YPTK-013584, 4YPTK-000980, and 15YPTK-002009) (H.M.), Prioritized research selected for life science from JAXA (14YPTK-005512)(T.S., H.A., N.Y., and H.M.), a grant from Specially Promoted Project of the Toyota Physical and Chemical Research Institute (T.A.), a grant from Princess Takamatsu Cancer Research Fund (T.A.), Grant-in-Aid for Challenging Exploratory Research (26670234) (T.A.). and Grant-in-Aid for Scientific Research on Innovative Areas (15H01150) (T.A.).	Abe C, 2013, J APPL PHYSIOL, V115, P1082, DOI 10.1152/japplphysiol.00285.2013; Abe C, 2010, J APPL PHYSIOL, V109, P1635, DOI 10.1152/japplphysiol.00515.2010; Akiyama N, 2014, J EXP MED, V211, P2425, DOI 10.1084/jem.20141207; Akiyama T, 2008, IMMUNITY, V29, P423, DOI 10.1016/j.immuni.2008.06.015; Akiyama T, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00278; Anderson G, 2012, TRENDS IMMUNOL, V33, P256, DOI 10.1016/j.it.2012.03.005; Baqai FP, 2009, J APPL PHYSIOL, V106, P1935, DOI 10.1152/japplphysiol.91361.2008; Bennett AR, 2002, IMMUNITY, V16, P803, DOI 10.1016/S1074-7613(02)00321-7; Blaber E, 2010, ASTROBIOLOGY, V10, P463, DOI 10.1089/ast.2009.0415; CHAPES SK, 1993, J LEUKOCYTE BIOL, V54, P227, DOI 10.1002/jlb.54.3.227; Chrousos GP, 2009, NAT REV ENDOCRINOL, V5, P374, DOI 10.1038/nrendo.2009.106; Congdon CC, 1996, J APPL PHYSIOL, V81, P172, DOI 10.1152/jappl.1996.81.1.172; Crucian B, 2014, BRAIN BEHAV IMMUN, V39, P23, DOI 10.1016/j.bbi.2014.01.011; Danzl NM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086129; Diedrich A, 2007, AM J MED SCI, V334, P80, DOI 10.1097/MAJ.0b013e318065b89b; Dooley J, 2012, EUR J IMMUNOL, V42, P1073, DOI 10.1002/eji.201142305; Dudakov JA, 2012, SCIENCE, V336, P91, DOI 10.1126/science.1218004; DURNOVA GN, 1976, AVIAT SPACE ENVIR MD, V47, P588; Fletcher AL, 2009, J IMMUNOL, V183, P823, DOI 10.4049/jimmunol.0900225; Gill J, 2002, NAT IMMUNOL, V3, P635, DOI 10.1038/ni812; Gill J, 2003, IMMUNOL REV, V195, P28, DOI 10.1034/j.1600-065X.2003.00077.x; Gotoh TM, 2004, AM J PHYSIOL-REG I, V286, pR25, DOI 10.1152/ajpregu.00458.2003; Gridley DS, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0075097, 10.1371/annotation/e66bdc4e-2409-4582-b163-7bc182db275e]; Gridley Daila S, 2002, J Gravit Physiol, V9, P15; Gruver AL, 2008, J LEUKOCYTE BIOL, V84, P915, DOI 10.1189/jlb.0108025; Gueguinou N, 2012, PSYCHONEUROENDOCRINO, V37, P137, DOI 10.1016/j.psyneuen.2011.05.015; Gueguinou N, 2009, J LEUKOCYTE BIOL, V86, P1027, DOI 10.1189/jlb.0309167; Heng TSP, 2010, CURR OPIN PHARMACOL, V10, P425, DOI 10.1016/j.coph.2010.04.006; Hikosaka Y, 2008, IMMUNITY, V29, P438, DOI 10.1016/j.immuni.2008.06.018; Howard JK, 1999, J CLIN INVEST, V104, P1051, DOI 10.1172/JCI6762; Klein L, 2014, NAT REV IMMUNOL, V14, P377, DOI 10.1038/nri3667; Klug DB, 1998, P NATL ACAD SCI USA, V95, P11822, DOI 10.1073/pnas.95.20.11822; Klug DB, 2002, J IMMUNOL, V169, P2842, DOI 10.4049/jimmunol.169.6.2842; Kostenuik PJ, 2005, CURR OPIN PHARMACOL, V5, P618, DOI 10.1016/j.coph.2005.06.005; Kyewski B, 2006, ANNU REV IMMUNOL, V24, P571, DOI 10.1146/annurev.immunol.23.021704.115601; Malchow S, 2013, SCIENCE, V339, P1219, DOI 10.1126/science.1233913; Mathis D, 2009, ANNU REV IMMUNOL, V27, P287, DOI 10.1146/annurev.immunol.25.022106.141532; Morey-Holton E, 2005, ADV SPACE B, V10, P7, DOI 10.1016/S1569-2574(05)10002-1; Morey-Holton ER, 2002, J APPL PHYSIOL, V92, P1367, DOI 10.1152/japplphysiol.00969.2001; Mouri Y, 2011, J IMMUNOL, V186, P5047, DOI 10.4049/jimmunol.1003533; Popa I, 2007, INT IMMUNOL, V19, P1249, DOI 10.1093/intimm/dxm092; Rossi SW, 2007, J EXP MED, V204, P1267, DOI 10.1084/jem.20062497; SCIBETTA SM, 1984, AVIAT SPACE ENVIR MD, V55, P1004; Sonnenfeld G, 2003, ADV SPACE RES-SERIES, V32, P1473, DOI 10.1016/S0273-1177(03)90383-8; Sonnenfeld G, 1999, ADV SPACE RES, V23, P1945, DOI 10.1016/S0273-1177(99)00455-X; Wade CE, 2005, ADV SPACE B, V10, P225, DOI 10.1016/S1569-2574(05)10009-4; Wong K, 2014, CELL REP, V8, P1198, DOI 10.1016/j.celrep.2014.07.029; Zayzafoon M, 2005, IMMUNOL REV, V208, P267, DOI 10.1111/j.0105-2896.2005.00330.x; Zhu ML, 2013, CANCER RES, V73, P2104, DOI 10.1158/0008-5472.CAN-12-3781	49	7	7	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2015	10	10							e0141650	10.1371/journal.pone.0141650	http://dx.doi.org/10.1371/journal.pone.0141650			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0ED	26513242	Green Published, gold, Green Submitted			2022-12-26	WOS:000363920300061
J	Zhang, YB; Guo, ZD; Li, MY; Fong, P; Zhang, JG; Zhang, CW; Gong, KR; Yang, MF; Niu, JZ; Ji, XM; Lv, GW				Zhang, Yan-bo; Guo, Zheng-dong; Li, Mei-yi; Fong, Peter; Zhang, Ji-guo; Zhang, Can-wen; Gong, Ke-rui; Yang, Ming-feng; Niu, Jing-zhong; Ji, Xun-ming; Lv, Guo-wei			Gabapentin Effects on PKC-ERK1/2 Signaling in the Spinal Cord of Rats with Formalin-Induced Visceral Inflammatory Pain	PLOS ONE			English	Article							PROTEIN-KINASE-C; NEUROPATHIC PAIN; CENTRAL SENSITIZATION; NMDA RECEPTOR; NEURONS; HYPERSENSITIVITY; PHOSPHORYLATION; ACTIVATION; MORPHINE; PATHWAY	Currently, the clinical management of visceral pain remains unsatisfactory for many patients suffering from this disease. While preliminary animal studies have suggested the effectiveness of gabapentin in successfully treating visceral pain, the mechanism underlying its analgesic effect remains unclear. Evidence from other studies has demonstrated the involvement of protein kinase C (PKC) and extracellular signal-regulated kinase1/2 (ERK1/2) in the pathogenesis of visceral inflammatory pain. In this study, we tested the hypothesis that gabapentin produces analgesia for visceral inflammatory pain through its inhibitory effect on the PKC-ERK1/2 signaling pathway. Intracolonic injections of formalin were performed in rats to produce colitis pain. Our results showed that visceral pain behaviors in these rats decreased after intraperitoneal injection of gabapentin. These behaviors were also reduced by intrathecal injections of the PKC inhibitor, H-7, and the ERK1/2 inhibitor, PD98059. Neuronal firing of wide dynamic range neurons in L6-S1 of the rat spinal cord dorsal horn were significantly increased after intracolonic injection of formalin. This increased firing rate was inhibited by intraperitoneal injection of gabapentin and both the individual and combined intrathecal application of H-7 and PD98059. Western blot analysis also revealed that PKC membrane translocation and ERK1/2 phosphorylation increased significantly following formalin injection, confirming the recruitment of PKC and ERK1/2 during visceral inflammatory pain. These effects were also significantly reduced by intraperitoneal injection of gabapentin. Therefore, we concluded that the analgesic effect of gabapentin on visceral inflammatory pain is mediated through suppression of PKC and ERK1/2 signaling pathways. Furthermore, we found that the PKC inhibitor, H-7, significantly diminished ERK1/2 phosphorylation levels, implicating the involvement of PKC and ERK1/2 in the same signaling pathway. Thus, our results suggest a novel mechanism of gabapentin-mediated analgesia for visceral inflammatory pain through a PKC-ERK1/2 signaling pathway that may be a future therapeutic target for the treatment of visceral inflammatory pain.	[Zhang, Yan-bo; Zhang, Can-wen; Yang, Ming-feng; Niu, Jing-zhong] Affiliated Hosp Taishan Med Univ, Dept Neurol, Tai An, Shandong, Peoples R China; [Guo, Zheng-dong] Affiliated Hosp Taishan Med Univ, Dept Endocrinol, Tai An, Shandong, Peoples R China; [Li, Mei-yi] Shandong Taishan Chron Dis Hosp, Dept Neurol, Tai An, Shandong, Peoples R China; [Fong, Peter] Univ Calif San Francisco, Dept Neurol, San Francisco, CA USA; [Zhang, Ji-guo] Taishan Med Univ, Coll Pharm, Dept Pharmacol, Tai An, Shandong, Peoples R China; [Gong, Ke-rui] Univ Calif San Francisco, Dept Oral & Maxillofacial Surg, San Francisco, CA USA; [Ji, Xun-ming; Lv, Guo-wei] Capital Med Univ, Xuanwu Hosp, Hypoxia Med Inst, Beijing, Peoples R China	Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong First Medical University & Shandong Academy of Medical Sciences; University of California System; University of California San Francisco; Shandong First Medical University & Shandong Academy of Medical Sciences; University of California System; University of California San Francisco; Capital Medical University	Zhang, YB (corresponding author), Affiliated Hosp Taishan Med Univ, Dept Neurol, Tai An, Shandong, Peoples R China.	bbnnbn@163.com	Ji, Xunming/AAN-3370-2021		National Science and Technology Support Program in China [2013BAI07B01]; Natural Science Foundation of Shandong Province in China [ZR2012HQ014, ZR2011HM044]; Shandong Province Medical and Health Plan [2014WSB32015]	National Science and Technology Support Program in China; Natural Science Foundation of Shandong Province in China(Natural Science Foundation of Shandong Province); Shandong Province Medical and Health Plan	This study was supported by the National Science and Technology Support Program in China (2013BAI07B01), the Natural Science Foundation of Shandong Province in China (ZR2012HQ014, ZR2011HM044), and Shandong Province Medical and Health Plan (2014WSB32015). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baillie JK, 2005, NEW ENGL J MED, V352, P2650; Bogoyevitch MA, 2007, DRUG DISCOV TODAY, V12, P622, DOI 10.1016/j.drudis.2007.06.008; Camara CC, 2013, NEUROSCI LETT, V556, P93, DOI 10.1016/j.neulet.2013.10.010; Davis MP, 2012, PAIN RES TREAT, V2012, DOI 10.1155/2012/265605; Doolen S, 2012, MOL PAIN, V8, DOI 10.1186/1744-8069-8-56; El-Zein O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083360; Galan A, 2003, MOL BRAIN RES, V116, P126, DOI 10.1016/S0169-328X(03)00284-5; Gong KR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095491; Greenwood-Van Meerveld B, 2014, J PHARMACOL EXP THER, V351, P146, DOI 10.1124/jpet.114.216028; Hauer JM, 2007, PEDIATRICS, V119, pE519, DOI 10.1542/peds.2006-1609; Horing B, 2014, SCHMERZ, V28, P252, DOI 10.1007/s00482-014-1403-9; Ji RR, 1999, NAT NEUROSCI, V2, P1114, DOI 10.1038/16040; Ji RR, 2003, TRENDS NEUROSCI, V26, P696, DOI 10.1016/j.tins.2003.09.017; Jia KQ, 2014, MOL MED REP, V10, P839, DOI 10.3892/mmr.2014.2301; [江新泉 Jiang Xinquan], 2014, [中华行为医学与脑科学杂志, Chinese Journal of Behavioral Medicine and Brain Science], V23, P781; Kang TW, 2014, ANN REHABIL MED-ARM, V38, P682, DOI 10.5535/arm.2014.38.5.682; Kantito Supattra, 2014, Journal of the Medical Association of Thailand, V97, P767; KAWAMOTO S, 1984, BIOCHEM BIOPH RES CO, V125, P258, DOI 10.1016/S0006-291X(84)80362-9; Kawasaki Y, 2004, J NEUROSCI, V24, P8310, DOI 10.1523/JNEUROSCI.2396-04.2004; Kayssi A, 2007, J PHYSIOL-LONDON, V580, P977, DOI 10.1113/jphysiol.2006.126599; Lee KJ, 2005, ALIMENT PHARM THERAP, V22, P981, DOI 10.1111/j.1365-2036.2005.02685.x; Lin YM, 2015, AM J PHYSIOL-GASTR L, V308, pG434, DOI 10.1152/ajpgi.00328.2014; Liu K, 2014, AUTON NEUROSCI-BASIC, V186, P91, DOI 10.1016/j.autneu.2014.08.004; Luo XQ, 2014, BRAIN RES, V1542, P167, DOI 10.1016/j.brainres.2013.10.008; Meymandi MS, 2008, EUR J ANAESTH, V25, P129, DOI 10.1017/S0265021507001226; Meymandi MS, 2013, CAN J ANESTH, V60, P44, DOI 10.1007/s12630-012-9813-6; MIAMPAMBA M, 1994, PAIN, V57, P327, DOI 10.1016/0304-3959(94)90008-6; Miranda A, 2014, EUR J PHARMACOL, V744, P28, DOI 10.1016/j.ejphar.2014.09.034; Muscella A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112186; NEWTON AC, 1995, J BIOL CHEM, V270, P28495, DOI 10.1074/jbc.270.48.28495; O'Mahony SM, 2011, EUR J PHARMACOL, V667, P169, DOI 10.1016/j.ejphar.2011.05.055; Padi SSV, 2004, EUR J PHARMACOL, V491, P69, DOI 10.1016/j.ejphar.2004.03.013; Poylin V, 2014, INT J COLORECTAL DIS, V29, P1565, DOI 10.1007/s00384-014-2018-4; Rosenberg JM, 1997, CLIN J PAIN, V13, P251, DOI 10.1097/00002508-199709000-00011; Rosner H, 1996, CLIN J PAIN, V12, P56, DOI 10.1097/00002508-199603000-00010; Sakurai J, 2008, GASTROENTEROLOGY, V134, P1094, DOI 10.1053/j.gastro.2008.01.031; Sun SR, 2014, AM J NEPHROL, V39, P436, DOI 10.1159/000362249; To TP, 2002, SPINAL CORD, V40, P282, DOI 10.1038/sj.sc.3101300; Tsubaki M, 2015, INT J CANCER, V137, P243, DOI 10.1002/ijc.29367; Zhang YB, 2013, NEURAL REGEN RES, V8, P3003, DOI 10.3969/j.issn.1673-5374.2013.32.003; Zhang YB, 2011, NEUROSIGNALS, V19, P142, DOI 10.1159/000328311; Zhou JR, 2013, J NEUROIMMUNOL, V260, P55, DOI 10.1016/j.jneuroim.2013.04.005; Zhou L, 2014, CELL IMMUNOL, V287, P86, DOI 10.1016/j.cellimm.2013.12.001	43	9	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2015	10	10							e0141142	10.1371/journal.pone.0141142	http://dx.doi.org/10.1371/journal.pone.0141142			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0ED	26512901	Green Published, Green Submitted, gold			2022-12-26	WOS:000363920300018
J	Lee, E; Ha, S; Logan, SK				Lee, Eugine; Ha, Susan; Logan, Susan K.			Divergent Androgen Receptor and Beta-Catenin Signaling in Prostate Cancer Cells	PLOS ONE			English	Article							TRANSCRIPTIONAL ACTIVITY; INCREASED SURVIVAL; STEM-CELLS; RESISTANCE; INHIBITION; ANTIANDROGEN; ACTIVATION; CASTRATION; CARCINOMA; GROWTH	Despite decades of effort to develop effective therapy and to identify promising new drugs, prostate cancer is lethal once it progresses to castration-resistant disease. Studies show mis-regulation of multiple pathways in castration-resistant prostate cancer (CRPC), reflecting the heterogeneity of the tumors and also hinting that targeting androgen receptor (AR) pathway alone might not be sufficient to treat CRPC. In this study, we present evidence that the Wnt/beta-catenin pathway might be activated in prostate cancer cells after androgen-deprivation to promote androgen-independent growth, partly through enhanced interaction of beta-catenin with TCF4. Androgen-independent prostate cancer cells were more prone to activate a Wnt-reporter, and inhibition of the Wnt/beta-catenin pathway increased sensitivity of these cells to the second-generation antiandrogen, enzalutamide. Combined treatment of enzalutamide and Wnt/beta-catenin inhibitor showed increased growth repression in both androgen-dependent and -independent prostate cancer cells, suggesting therapeutic potential for this approach.	[Lee, Eugine; Logan, Susan K.] NYU, Sch Med, Dept Biochem & Mol Pharmacol, New York, NY 10010 USA; [Ha, Susan; Logan, Susan K.] NYU, Sch Med, Dept Urol, New York, NY 10003 USA; [Lee, Eugine; Logan, Susan K.] NYU, Sch Med, Stem Cell Biol Program, New York, NY USA	New York University; New York University; New York University	Logan, SK (corresponding author), NYU, Sch Med, Dept Biochem & Mol Pharmacol, New York, NY 10010 USA.	susan.logan@nyumc.org		Lee, Eugine/0000-0002-7090-852X; Logan, Susan/0000-0002-7904-5927	National Institutes of Health [R01CA112226]; American Cancer Society [RSG-11-108-01-CDD]; NATIONAL CANCER INSTITUTE [R01CA112226] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by National Institutes of Health R01CA112226 (SL) and American Cancer Society RSG-11-108-01-CDD (SL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anastas JN, 2013, NAT REV CANCER, V13, P11, DOI 10.1038/nrc3419; Arora VK, 2013, CELL, V155, P1309, DOI 10.1016/j.cell.2013.11.012; Attard G, 2009, CANCER RES, V69, P4937, DOI 10.1158/0008-5472.CAN-08-4531; Barbieri CE, 2012, NAT GENET, V44, P685, DOI 10.1038/ng.2279; Baselga J, 2012, NEW ENGL J MED, V366, P520, DOI 10.1056/NEJMoa1109653; Bruxvoort KJ, 2007, CANCER RES, V67, P2490, DOI 10.1158/0008-5472.CAN-06-3028; Carver BS, 2011, CANCER CELL, V19, P575, DOI 10.1016/j.ccr.2011.04.008; Chen CD, 2004, NAT MED, V10, P33, DOI 10.1038/nm972; Chen GP, 2004, CANCER-AM CANCER SOC, V101, P1345, DOI 10.1002/cncr.20518; Chesire DR, 2002, ONCOGENE, V21, P8453, DOI 10.1038/sj.onc.1206049; Chong CR, 2013, NAT MED, V19, P1389, DOI 10.1038/nm.3388; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Culig Z, 1999, BRIT J CANCER, V81, P242, DOI 10.1038/sj.bjc.6690684; De Bono JS, 2011, NEW ENGL J MED, V364, P1995, DOI 10.1056/NEJMoa1014618; de la Taille A, 2003, CLIN CANCER RES, V9, P1801; Feldman BJ, 2001, NAT REV CANCER, V1, P34, DOI 10.1038/35094009; Fuerer C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009370; Glickman MS, 2012, CELL, V148, P1089, DOI 10.1016/j.cell.2012.02.015; Gonsalves FC, 2011, P NATL ACAD SCI USA, V108, P5954, DOI 10.1073/pnas.1017496108; Grasso CS, 2012, NATURE, V487, P239, DOI 10.1038/nature11125; Haber DA, 2011, CELL, V145, P19, DOI 10.1016/j.cell.2011.03.026; Hieronymus H, 2012, NAT GENET, V44, P613, DOI 10.1038/ng.2301; Hobisch A, 2000, UROL INT, V65, P73, DOI 10.1159/000064843; Kypta RM, 2012, NAT REV UROL, V9, P418, DOI 10.1038/nrurol.2012.116; Lee E, 2013, P NATL ACAD SCI USA, V110, P15710, DOI 10.1073/pnas.1218168110; Lian XJ, 2012, P NATL ACAD SCI USA, V109, pE1848, DOI 10.1073/pnas.1200250109; Lorente D, 2014, EUR J CANCER, V50, P753, DOI 10.1016/j.ejca.2013.12.004; Mita P, 2011, MOL CELL BIOL, V31, P3639, DOI 10.1128/MCB.05429-11; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; Mulholland DJ, 2003, ONCOGENE, V22, P5602, DOI 10.1038/sj.onc.1206802; Mulholland DJ, 2002, J BIOL CHEM, V277, P17933, DOI 10.1074/jbc.M200135200; Pawlowski JE, 2002, J BIOL CHEM, V277, P20702, DOI 10.1074/jbc.M200545200; Placencio VR, 2008, CANCER RES, V68, P4709, DOI 10.1158/0008-5472.CAN-07-6289; Robinson D, 2015, CELL, V161, P1215, DOI 10.1016/j.cell.2015.05.001; Saraon P, 2011, CLIN CHEM, V57, P1366, DOI 10.1373/clinchem.2011.165977; Scher HI, 2012, NEW ENGL J MED, V367, P1187, DOI 10.1056/NEJMoa1207506; Sineva GS, 2010, BIOL CELL, V102, P549, DOI 10.1042/BC20100016; Song LN, 2005, J BIOL CHEM, V280, P37853, DOI 10.1074/jbc.M503850200; Sramkoski RM, 1999, IN VITRO CELL DEV-AN, V35, P403; Sun Y, 2012, NAT MED, V18, P1359, DOI 10.1038/nm.2890; Terry S, 2006, J CELL BIOCHEM, V99, P402, DOI 10.1002/jcb.20983; Tran C, 2009, SCIENCE, V324, P787, DOI 10.1126/science.1168175; Truica CI, 2000, CANCER RES, V60, P4709; van Noort M, 2002, J BIOL CHEM, V277, P17901, DOI 10.1074/jbc.M111635200; Wang G, 2008, CANCER RES, V68, P9918, DOI 10.1158/0008-5472.CAN-08-1718; Wang QB, 2009, CELL, V138, P245, DOI 10.1016/j.cell.2009.04.056; Wilson TR, 2012, NATURE, V487, P505, DOI 10.1038/nature11249; Wong KK, 2010, CURR OPIN GENET DEV, V20, P87, DOI 10.1016/j.gde.2009.11.002; Yang X, 2006, ONCOGENE, V25, P3436, DOI 10.1038/sj.onc.1209366; Yap TA, 2013, J CLIN ONCOL, V31, P1592, DOI 10.1200/JCO.2011.37.6418; Yu XP, 2009, PROSTATE, V69, P249, DOI 10.1002/pros.20877; Yumoto F, 2012, P NATL ACAD SCI USA, V109, P143, DOI 10.1073/pnas.1117036108; Zong Y, 2012, P NATL ACAD SCI USA, V109, pE3395, DOI 10.1073/pnas.1217982109	53	30	32	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2015	10	10							e0141589	10.1371/journal.pone.0141589	http://dx.doi.org/10.1371/journal.pone.0141589			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0DL	26509262	Green Published, gold, Green Submitted			2022-12-26	WOS:000363918100110
J	Talavera, S; Munoz-Munoz, F; Duran, M; Verdun, M; Soler-Membrives, A; Oleaga, A; Arenas, A; Ruiz-Fons, F; Estrada, R; Pages, N				Talavera, Sandra; Munoz-Munoz, Francesc; Duran, Mauricio; Verdun, Marta; Soler-Membrives, Anna; Oleaga, Alvaro; Arenas, Antonio; Ruiz-Fons, Francisco; Estrada, Rosa; Pages, Nitu			Culicoides Species Communities Associated with Wild Ruminant Ecosystems in Spain: Tracking the Way to Determine Potential Bridge Vectors for Arboviruses	PLOS ONE			English	Article							BITING MIDGES DIPTERA; BLUETONGUE VIRUS; SCHMALLENBERG VIRUS; OBSOLETUS GROUP; SOUTHERN SPAIN; NATIONAL-PARK; CERATOPOGONIDAE; EUROPE; IDENTIFICATION; LATREILLE	The genus Culicoides Latreille 1809 is a well-known vector for protozoa, filarial worms and, above all, numerous viruses. The Bluetongue virus (BTV) and the recently emerged Schmallenberg virus (SBV) are responsible for important infectious, non-contagious, insect-borne viral diseases found in domestic ruminants and transmitted by Culicoides spp. Both of these diseases have been detected in wild ruminants, but their role as reservoirs during the vector-free season still remains relatively unknown. In fact, we tend to ignore the possibility of wild ruminants acting as a source of disease (BTV, SBV) and permitting its reintroduction to domestic ruminants during the following vector season. In this context, a knowledge of the composition of the Culicoides species communities that inhabit areas where there are wild ruminants is of major importance as the presence of a vector species is a prerequisite for disease transmission. In this study, samplings were conducted in areas inhabited by different wild ruminant species; samples were taken in both 2009 and 2010, on a monthly basis, during the peak season for midge activity (in summer and autumn). A total of 102,693 specimens of 40 different species of the genus Culicoides were trapped; these included major BTV and SBV vector species. The most abundant vector species were C. imicola and species of the Obsoletus group, which represented 15% and 11% of total numbers of specimens, respectively. At the local scale, the presence of major BTV and SBV vector species in areas with wild ruminants coincided with that of the nearest sentinel farms included in the Spanish Bluetongue Entomological Surveillance Programme, although their relative abundance varied. The data suggest that such species do not exhibit strong host specificity towards either domestic or wild ruminants and that they could consequently play a prominent role as bridge vectors for different pathogens between both types of ruminants. This finding would support the hypothesis that wild ruminants could act as reservoirs for such pathogens, and subsequently be involved in the reintroduction of disease to livestock on neighbouring farms.	[Talavera, Sandra; Verdun, Marta; Pages, Nitu] Univ Autonoma Barcelona, Ctr Recerca Sanitat Anim CReSA IRTA UAB, IRTA, Bellaterra, Catalonia, Spain; [Munoz-Munoz, Francesc; Soler-Membrives, Anna] Univ Autonoma Barcelona, Dept Biol Anim Biol Vegetal & Ecol, Bellaterra, Catalonia, Spain; [Duran, Mauricio; Oleaga, Alvaro; Ruiz-Fons, Francisco] Inst Invest Recursos Cineget IREC, Hlth & Biotechnol SaBio Grp, Ciudad Real, Castilla La Man, Spain; [Oleaga, Alvaro] Sociedad Serv Principado Asturias SA, SERPA, Gijon, Asturias, Spain; [Arenas, Antonio] Univ Cordoba, Fac Vet, Dept Sanidad Anim, Cordoba, Andalucia, Spain; [Estrada, Rosa] Univ Zaragoza, Fac Vet, Dept Anim Pathol, Zaragoza, Spain	Autonomous University of Barcelona; IRTA; Autonomous University of Barcelona; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigacion en Recursos Cinegeticos (IREC); Universidad de Castilla-La Mancha; Universidad de Cordoba; University of Zaragoza	Talavera, S (corresponding author), Univ Autonoma Barcelona, Ctr Recerca Sanitat Anim CReSA IRTA UAB, IRTA, Bellaterra, Catalonia, Spain.	sandra.talavera@cresa.uab.cat	Pages, Nonito/Q-1274-2016; Oleaga, Alvaro/Q-8070-2019; Oleaga, Alvaro/S-3966-2018; Soler-Membrives, Anna/L-3169-2014; Ruiz-Fons, Francisco/K-3161-2014; ARENAS, Antonio J/I-3997-2017; Muñoz Muñoz, Francesc/L-1997-2014; Talavera, Sandra/ABG-8759-2020	Pages, Nonito/0000-0001-6020-7175; Oleaga, Alvaro/0000-0002-4080-3057; Oleaga, Alvaro/0000-0002-4080-3057; Soler-Membrives, Anna/0000-0002-6543-8367; Ruiz-Fons, Francisco/0000-0002-0820-5292; ARENAS, Antonio J/0000-0001-5334-2440; Muñoz Muñoz, Francesc/0000-0003-2084-0368; 	Instituto Nacional de Investigaciones Agrarias [FAU 2008-0019]; EU grant [GOCE-2003-010284 EDENext]; Spanish Ministry for the Economy and Competitiveness through a Juan de la Cierva postdoctoral contract	Instituto Nacional de Investigaciones Agrarias; EU grant(European Commission); Spanish Ministry for the Economy and Competitiveness through a Juan de la Cierva postdoctoral contract	This study was supported by the project FAU 2008-0019 from Instituto Nacional de Investigaciones Agrarias, and was partially funded by EU grant GOCE-2003-010284 EDENext and is cataloged by the EDENext Steering Committee as EDENext429 (http://www.edenext.eu). F. Ruiz-Fons is supported by the Spanish Ministry for the Economy and Competitiveness through a Juan de la Cierva postdoctoral contract. The funder provided support in the form of salaries for an author [FRF], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the "author contributions" section.	Acevedo P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014236; Alarcon-Elbal P. M., 2012, Graellsia, V68, P353, DOI 10.3989/graellsia.2012.v68.064; Balenghien T, 2014, PREVET IN PRESS; Bartsch S, 2009, PARASITOL RES, V105, P373, DOI 10.1007/s00436-009-1408-y; Blackwell A, 2004, J VECTOR ECOL, V29, P51; Borkent A, 2012, CATALOG CERATOPOGONI; Borkent A, 2012, SUBGENERIC CLASSIFIC; BURYLOVA A M, 1975, Parazitologiya (St. Petersburg), V9, P197; BUTENKO O M, 1967, Byulleten' Moskovskogo Obshchestva Ispytatelei Prirody Otdel Biologicheskii, V72, P132; Calvete C, 2008, MED VET ENTOMOL, V22, P124, DOI 10.1111/j.1365-2915.2008.00728.x; Calvo JH, 2012, B ENTOMOL RES, V102, P692, DOI 10.1017/S0007485312000284; Campbell J. A., 1960, Proceedings of the Royal Society of Edinburgh (Sect B), V67, P181; Caracappa S, 2003, VET REC, V153, P71, DOI 10.1136/vr.153.3.71; Carpenter S, 2008, VET REC, V163, P589, DOI 10.1136/vr.163.20.589; Carpenter S, 2006, J MED ENTOMOL, V43, P73, DOI 10.1603/0022-2585(2006)043[0073:OSTBVO]2.0.CO;2; Cerny O, 2011, MED VET ENTOMOL, V25, P104, DOI 10.1111/j.1365-2915.2010.00875.x; Chiari M, 2014, TRANSBOUND EMERG DIS, V61, P1, DOI 10.1111/tbed.12158; Clarke KR, 2006, J EXP MAR BIOL ECOL, V338, P179, DOI 10.1016/j.jembe.2006.06.019; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Clarke KR, 2015, PRIMER V7 USER MANUA; De Liberato C, 2005, VET REC, V156, P301, DOI 10.1136/vr.156.10.301; De Regge N, 2012, TRANSBOUND EMERG DIS, V59, P471, DOI 10.1111/tbed.12000; Del?colle J.C., 1985, THESIS U LOUIS PASTE; Dijkstra E, 2008, VET REC, V162, P422, DOI 10.1136/vr.162.13.422-a; Dipeolu O. O., 1976, Veterinary Parasitology, V1, P257, DOI 10.1016/0304-4017(76)90098-4; Ducheyne E, 2007, GEOSPATIAL HEALTH, V1, P177, DOI 10.4081/gh.2007.266; Duran Martinez M, 2013, THESIS U CASTILLA LA; DYCE A L, 1969, Journal of the Australian Entomological Society, V8, P11; Elbers ARW, 2013, EMERG INFECT DIS, V19, P106, DOI 10.3201/eid1901.121054; European Commission, 2003, GLOB LAND COV 2000 D; Falconi C, 2011, VET MICROBIOL, V151, P209, DOI 10.1016/j.vetmic.2011.02.011; Fernandez Aguilar X, 2014, EMERG INFECT DIS, DOI [10.3201/eid2006.130961, DOI 10.3201/EID2006.130961]; Garcia I, 2009, EUR J WILDLIFE RES, V55, P173, DOI 10.1007/s10344-008-0231-6; Garcia-Bocanegra I, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-88; Glukhova VM, 1989, FAUNA USSR, V139, P408; Goffredo M, 2013, PREV VET MED, V111, P230, DOI 10.1016/j.prevetmed.2013.05.014; Hoffmann B, 2012, EMERG INFECT DIS, V18, P469, DOI 10.3201/eid1803.111905; KREMER M, 1973, Polskie Pismo Entomologiczne, V43, P61; Kremer M, 1965, CONTRIBUTION ETUDE G; Laloy E, 2014, EMERG INFECT DIS, V20, P131, DOI 10.3201/eid2001.130411; Larska M, 2013, VET J, V198, P279, DOI 10.1016/j.tvjl.2013.08.013; Larska M, 2013, VET MICROBIOL, V166, P467, DOI 10.1016/j.vetmic.2013.07.015; Lassen SB, 2011, PARASITOL RES, V108, P823, DOI 10.1007/s00436-010-2123-4; LILLIE TH, 1981, CAN ENTOMOL, V113, P419, DOI 10.4039/Ent113419-5; Linden A, 2012, EMERG INFECT DIS, V18, DOI [10.3201/eid1812.121067, DOI 10.3201/EID1812.121067.D0I:10.3201/EID1812.121067]; Lucientes J, 2008, VECTORES LENGUA AZUL; Martinez-de la Puente J, 2009, PARASITOLOGY, V136, P1033, DOI 10.1017/S0031182009006374; Meiswinkel R, 2008, PREV VET MED, V87, P182, DOI 10.1016/j.prevetmed.2008.06.008; Meiswinkel R, 2007, VET REC, V161, P564, DOI 10.1136/vr.161.16.564; Mellor PS, 2000, ANNU REV ENTOMOL, V45, P307, DOI 10.1146/annurev.ento.45.1.307; Mellor PS, 2002, VET J, V164, P20, DOI 10.1053/tvjl.2002.0713; Munoz-Munoz F, 2014, MED VET ENTOMOL, V28, P319, DOI 10.1111/mve.12042; Ninio C, 2011, PARASITOL RES, V108, P657, DOI 10.1007/s00436-010-2110-9; Ninyerola M, 2005, ATLAS CLIMATICO DIGI; Nolan DV, 2008, MED VET ENTOMOL, V22, P340, DOI 10.1111/j.1365-2915.2008.00744.x; Nolan DV, 2007, VET MICROBIOL, V124, P82, DOI 10.1016/j.vetmic.2007.03.019; Ortega MD, 1998, ARCH VIROL, P85; Ortega MD, 1999, J AM MOSQUITO CONTR, V15, P391; Pages N, 2005, J MED ENTOMOL, V42, P1026, DOI 10.1603/0022-2585(2005)042[1026:DOCOAC]2.0.CO;2; Pages N, 2009, VET PARASITOL, V165, P298, DOI 10.1016/j.vetpar.2009.07.020; Palomo LJ., 2007, ATLAS LIBRO ROJO MAM; Purse BV, 2004, MED VET ENTOMOL, V18, P90, DOI 10.1111/j.0269-283X.2004.00492.x; Purse BV, 2005, NAT REV MICROBIOL, V3, P171, DOI 10.1038/nrmicro1090; Rodriguez-Prieto V, 2012, 1 CASE SCHMALLENBERG; Rodriguez-Sanchez B, 2010, EMERG INFECT DIS, V16, P518, DOI 10.3201/eid1603.090626; Ruiz-Fons F, 2008, EMERG INFECT DIS, V14, P951, DOI 10.3201/eid1406.071586; Ruiz-Fons F, 2014, VIRUS RES, V182, P50, DOI 10.1016/j.virusres.2013.12.031; Santiago-Alarcon D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031098; Savini G, 2005, VET REC, V157, P133, DOI 10.1136/vr.157.5.133; Talavera S, 2011, ANN SOC ENTOMOL FR, V47, P214, DOI 10.1080/00379271.2011.10697714; Zientara S, 2009, B ACAD VET FRANCE, V162, P73	71	19	19	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2015	10	10							e0141667	10.1371/journal.pone.0141667	http://dx.doi.org/10.1371/journal.pone.0141667			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0DL	26510136	Green Published, gold, Green Submitted			2022-12-26	WOS:000363918100118
J	Han, JH; Yu, HS; Lee, JY; Kim, J; Kang, DH; Kwon, JK; Choi, YD; Cho, KS				Han, Jang Hee; Yu, Ho Song; Lee, Joo Yong; Kim, Joohan; Kang, Dong Hyuk; Kwon, Jong Kyu; Choi, Young Deuk; Cho, Kang Su			Simple Modification of the Bladder Outlet Obstruction Index for Better Prediction of Endoscopically-Proven Prostatic Obstruction: A Preliminary Study	PLOS ONE			English	Article							URINARY-TRACT FUNCTION; URETHRAL RESISTANCE; PRESSURE-FLOW; TRANSURETHRAL RESECTION; HYPERPLASIA; CONTRACTILITY; MEN; STANDARDIZATION; TERMINOLOGY	Purpose The bladder outlet obstruction index (BOOI), also known as the Abrams-Griffiths (AG) number, is the most widely used index for predicting BOO. However, the obstructed prostatic urethra determined by the BOOI is often inconsistent with endoscopically-proven obstruction. We assessed abdominal straining pattern as a novel parameter for improving the prediction of BOO. Materials and Methods We retrospectively reviewed the pressure-flow studies (PFS) and cystourethroscopy in 176 BPH/LUTS patients who were unresponsive to medical therapy. During PFS, some groups of patients tried to urinate with abdominal straining, which can increases intravesical pressure and underestimate BOOI theoretically. Accordingly, the modified BOOI was defined as (P(det)Q(max)+Delta P-abd)-2Q(max). Results Ultimately, 130 patients were eligible for the analysis. In PFS,Delta P-abd (P(abd)Q(max)-initial P-abd) was 11.81 +/- 13.04 cmH(2)O, and it was 0-9 cmH(2)O in 75 (57.7%), 10-19 cmH(2)O in 23 (17.7%) and >= 20 cmH(2)O in 32 (24.6%) patients. An endoscopically obstructed prostatic urethra in 92 patients was correctly determined in 47 patients (51.1%) by the original BOOI versus 72 patients (78.3%) based on the modified BOOI. Meanwhile, an "unobstructed" urethra according to the original BOOI was present in 11 patients (12.0%), whereas according to the modified BOOI, only 2 (2.1%) would be labeled as "unobstructed". In receiver operating characteristic curves, the area under the curve was 0.906 using the modified BOOI number versus 0.849 in the original BOOI (p < 0.05). Conclusions The change in abdominal pressure was correlated with endoscopically-proven obstruction. Our simple modification of the BOOI on the basis of this finding better predicted bladder outlet obstruction and, therefore, should be considered when evaluating BOO in patients with LUTS/BPH.	[Han, Jang Hee; Cho, Kang Su] Yonsei Univ, Coll Med, Gangnam Severance Hosp, Dept Urol,Urol Sci Inst, Seoul, South Korea; [Yu, Ho Song] Chonnam Natl Univ, Sch Med, Dept Urol, Gwangju, South Korea; [Lee, Joo Yong; Kwon, Jong Kyu; Choi, Young Deuk] Yonsei Univ, Coll Med, Urol Sci Inst, Dept Urol,Severance Hosp, Seoul, South Korea; [Kim, Joohan] Seoul Natl Univ Sci & Technol, Dept Mech Engn, Seoul, South Korea; [Kang, Dong Hyuk] Yangpyeong Hlth Ctr, Dept Urol, Yangpyeong, South Korea	Yonsei University; Yonsei University Health System; Chonnam National University; Yonsei University; Yonsei University Health System; Seoul National University of Science & Technology	Cho, KS (corresponding author), Yonsei Univ, Coll Med, Gangnam Severance Hosp, Dept Urol,Urol Sci Inst, Seoul, South Korea.	kscho99@yuhs.ac	Lee, Joo Yong/C-3851-2013	Lee, Joo Yong/0000-0002-3470-1767; Choi, Young Deuk/0000-0002-8545-5797; Cho, Kang Su/0000-0002-3500-8833				Abrams P, 2003, UROLOGY, V61, P37, DOI 10.1016/S0090-4295(02)02243-4; Abrams P, 1995, P 3 INT CONS BEN PRO, V6, P26; ABRAMS PH, 1979, BRIT J UROL, V51, P129, DOI 10.1111/j.1464-410X.1979.tb02846.x; Blake C, 2004, J UROLOGY, V171, P12, DOI 10.1097/01.ju.0000102685.44036.b9; Bushman W, 2009, UROL CLIN N AM, V36, P403, DOI 10.1016/j.ucl.2009.07.003; CHANCELLOR MB, 1991, J UROLOGY, V145, P810, DOI 10.1016/S0022-5347(17)38458-6; Cucchi A, 1997, J UROLOGY, V157, P866, DOI 10.1016/S0022-5347(01)65067-5; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; DUBEAU CE, 1995, J UROLOGY, V154, P498, DOI 10.1016/S0022-5347(01)67085-X; Eckhardt MD, 2001, NEUROUROL URODYNAM, V20, P175; ElDin KE, 1996, J UROLOGY, V155, P1018, DOI 10.1016/S0022-5347(01)66373-0; Ezz ell Din K, 1996, UROLOGY, V48, P393; Griffiths D, 1997, NEUROUROL URODYNAM, V16, P1, DOI 10.1002/(SICI)1520-6777(1997)16:1<1::AID-NAU1>3.0.CO;2-I; GRIFFITHS D, 1989, NEUROUROL URODYNAM, V8, P17, DOI 10.1002/nau.1930080104; Han DH, 2008, UROLOGY, V71, P657, DOI 10.1016/j.urology.2007.11.109; Harding C, 2009, INDIAN J UROL, V25, P116, DOI 10.4103/0970-1591.45549; JENSEN KME, 1988, SCAND J UROL NEPHROL, P72; LIM CS, 1995, WORLD J UROL, V13, P34; Michel M, 2009, EUR UROL SUPPL, V8, P496, DOI 10.1016/j.eursup.2009.02.001; Nitti Victor W, 2005, Rev Urol, V7 Suppl 6, pS14; ROLLEMA HJ, 1992, J UROLOGY, V148, P111, DOI 10.1016/S0022-5347(17)36527-8; Rossi C, 2001, J UROLOGY, V165, P38, DOI 10.1097/00005392-200101000-00010; SCHAFER W, 1990, UROL CLIN N AM, V17, P553; Sekido N, 2012, INT J UROL, V19, P216, DOI 10.1111/j.1442-2042.2011.02947.x; van Venrooij GEPM, 2003, UROLOGY, V62, P672, DOI 10.1016/S0090-4295(03)00511-9; Yamanishi T, 2010, NEUROUROL URODYNAM, V29, P558, DOI 10.1002/nau.20802; Zhao JM, 2011, UROL INT, V86, P90, DOI 10.1159/000319968	27	3	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2015	10	10							e0141745	10.1371/journal.pone.0141745	http://dx.doi.org/10.1371/journal.pone.0141745			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU8PC	26505196	Green Published, gold, Green Submitted			2022-12-26	WOS:000363804200096
J	Hiratsuka, T; Takei, Y; Ohmori, R; Imai, Y; Ozeki, M; Tamaki, K; Haga, H; Nakamura, T; Tsuruyama, T				Hiratsuka, T.; Takei, Y.; Ohmori, R.; Imai, Y.; Ozeki, M.; Tamaki, K.; Haga, H.; Nakamura, T.; Tsuruyama, T.			ZFP521 contributes to pre-B-cell lymphomagenesis through modulation of the pre-B-cell receptor signaling pathway	ONCOGENE			English	Article							ZINC-FINGER PROTEIN; ACUTE LYMPHOBLASTIC-LEUKEMIA; NF-KAPPA-B; RETROVIRUS INTEGRATION; BONE-MARROW; BCR CHECKPOINT; HEAVY-CHAINS; GENE; BTK; LOCUS	ZFP521 was previously identified as a putative gene involved in induction of B-cell lymphomagenesis. However, the contribution of ZFP521 to lymphomagenesis has not been confirmed. In this study, we sought to elucidate the role of ZFP521 in B-cell lymphomagenesis. To this end, we used a retroviral insertion method to show that ZFP521 was a target of mutagenesis in pre-B-lymphoblastic lymphoma cells. The pre-B-cell receptor (pre-BCR) signaling molecules BLNK, BTK and BANK1 were positively regulated by the ZFP521 gene, leading to enhancement of the pre-BCR signaling pathway. In addition, c-myc and c-jun were upregulated following activation of ZFP521. Stimulation of pre-BCR signaling using anti-Vpreb antibodies caused aberrant upregulation of c-myc and c-jun and of Ccnd3, which encodes cyclin D3, thereby inducing the growth of pre-B cells. Stimulation with Vpreb affected the growth of pre-B cells, and addition of interleukin (IL)-7 receptor exerted competitive effects on pre-B-cell growth. Knockdown of BTK and BANK1, targets of ZFP521, suppressed the effects of Vpreb stimulation on cell growth. Furthermore, in human lymphoblastic lymphoma, analogous to pre-B-cell lymphoma in mice, the expression of ZNF521, the homolog of ZFP521 in humans, was upregulated. In conclusion, our data showed that the ZFP521 gene comprehensively induced pre-B-cell lymphomagenesis by modulating the pre-B-cell receptor signaling pathway.	[Hiratsuka, T.] Kyoto Univ, Grad Sch Med, Dept Pathol & Biol Dis, Kyoto, Japan; [Takei, Y.; Haga, H.; Tsuruyama, T.] Kyoto Univ Hosp, Dept Diagnost Pathol, Kyoto 606, Japan; [Ohmori, R.; Tsuruyama, T.] Kyoto Univ, Grad Sch Med, Ctr Anat Pathol & Forens Med Res, Kyoto, Japan; [Imai, Y.; Ozeki, M.; Tamaki, K.] Kyoto Univ, Grad Sch Med, Dept Forens Med, Kyoto, Japan; [Nakamura, T.] Carcinogenesis Lab, Inst Canc, Tokyo, Japan	Kyoto University; Kyoto University; Kyoto University; Kyoto University	Tsuruyama, T (corresponding author), Kyoto Univ Hosp, Dept Diagnost Pathol, Sakyo Ku, 54 Shogoin Kawaharacho, Kyoto 6068506, Japan.	tsuruyam@kuhp.kyoto-u.ac.jp		Haga, Hironori/0000-0003-4322-9561				Addison WN, 2014, MOL CELL BIOL, V34, P3076, DOI 10.1128/MCB.00185-14; Akinleye A, 2013, J HEMATOL ONCOL, V6, DOI 10.1186/1756-8722-6-59; Bernal-Quiros M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059842; Bond HM, 2008, INT J BIOCHEM CELL B, V40, P848, DOI 10.1016/j.biocel.2007.04.006; Bond HM, 2004, BLOOD, V103, P2062, DOI 10.1182/blood-2003-07-2388; Clark MR, 2014, NAT REV IMMUNOL, V14, P69, DOI 10.1038/nri3570; Corcoran AE, 1998, NATURE, V391, P904, DOI 10.1038/36122; Dai XZ, 2007, J IMMUNOL, V179, P1068, DOI 10.4049/jimmunol.179.2.1068; DAVIDSON WF, 1984, J IMMUNOL, V133, P744; Fernandez-Vega I, 2015, VIRCHOWS ARCH, V466, P229, DOI 10.1007/s00428-014-1698-z; Flemming A, 2003, NAT IMMUNOL, V4, P38, DOI 10.1038/ni862; Geier JK, 2006, SEMIN IMMUNOL, V18, P31, DOI 10.1016/j.smim.2005.11.001; HARDY RR, 1991, J EXP MED, V173, P1213, DOI 10.1084/jem.173.5.1213; Hendriks RW, 2004, TRENDS IMMUNOL, V25, P249, DOI 10.1016/j.it.2004.02.011; Hiai H, 2003, CANCER SCI, V94, P847, DOI 10.1111/j.1349-7006.2003.tb01365.x; Hiratsuka T, 2008, LEUKEMIA RES, V32, P309, DOI 10.1016/j.leukres.2007.05.013; Imai C, 2004, LEUKEMIA, V18, P922, DOI 10.1038/sj.leu.2403349; Imamura Y, 2009, J BIOL CHEM, V284, P9804, DOI 10.1074/jbc.M809051200; Jin G, 2003, CANCER SCI, V94, P791, DOI 10.1111/j.1349-7006.2003.tb01520.x; Kamiya D, 2011, NATURE, V470, P503, DOI 10.1038/nature09726; Kaszynski RH, 2010, CANCER SCI, V101, P800, DOI 10.1111/j.1349-7006.2009.01437.x; Kiviranta R, 2013, J EXP MED, V210, P969, DOI 10.1084/jem.20121187; Li LX, 2010, J IMMUNOL, V184, P1728, DOI 10.4049/jimmunol.0903023; Lu LM, 1999, CANCER RES, V59, P2593; Malin S, 2010, NAT IMMUNOL, V11, P171, DOI 10.1038/ni.1827; Mandal M, 2009, NAT IMMUNOL, V10, P1110, DOI 10.1038/ni.1785; Mega T, 2011, CELL CYCLE, V10, P2129, DOI 10.4161/cc.10.13.16045; Melchers F, 2005, NAT REV IMMUNOL, V5, P578, DOI 10.1038/nri1649; Minegishi Y, 2001, IMMUNITY, V14, P631, DOI 10.1016/S1074-7613(01)00131-5; Muschen M, 2015, BLOOD, V125, P3688, DOI 10.1182/blood-2015-01-567842; Mullighan CG, 2007, NATURE, V446, P758, DOI 10.1038/nature05690; Murray MY, 2015, CELL CYCLE, V14, P2367, DOI 10.1080/15384101.2014.998067; Nakayama J, 2009, BLOOD, V113, P1483, DOI 10.1182/blood-2008-07-166355; Nutt SL, 1997, GENE DEV, V11, P476, DOI 10.1101/gad.11.4.476; Rickert RC, 2013, NAT REV IMMUNOL, V13, P578, DOI 10.1038/nri3487; Rushworth SA, 2013, CELL SIGNAL, V25, P106, DOI 10.1016/j.cellsig.2012.09.008; Stadhouders R, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001791; Tsuruyama T, 2002, P NATL ACAD SCI USA, V99, P8253, DOI 10.1073/pnas.112202899; Tsuruyama T, 2011, AM J PATHOL, V178, P1374, DOI 10.1016/j.ajpath.2010.12.012; Tsuruyama T, 2010, J LEUKOCYTE BIOL, V88, P107, DOI 10.1189/jlb.1109748; Warming S, 2003, BLOOD, V101, P1934, DOI 10.1182/blood-2002-08-2652; Wei CJ, 2000, J IMMUNOL, V164, P1961, DOI 10.4049/jimmunol.164.4.1961; Wollscheid B, 1999, CURR TOP MICROBIOL, V246, P283; Yamasaki N, 2010, ONCOGENE, V29, P1963, DOI 10.1038/onc.2009.475; Yasuda T, 2002, J EXP MED, V196, P51, DOI 10.1084/jem.20020068; Yokoyama K, 2002, EMBO J, V21, P83, DOI 10.1093/emboj/21.1.83	46	17	18	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 23	2016	35	25					3227	3238		10.1038/onc.2015.385	http://dx.doi.org/10.1038/onc.2015.385			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DP2GN	26522721				2022-12-26	WOS:000378306400002
J	Ishii, Y; Saeki, K; Liu, M; Sasaki, F; Koga, T; Kitajima, K; Meno, C; Okuno, T; Yokomizo, T				Ishii, Yumiko; Saeki, Kazuko; Liu, Min; Sasaki, Fumiyuki; Koga, Tomoaki; Kitajima, Keiko; Meno, Chikara; Okuno, Toshiaki; Yokomizo, Takehiko			Leukotriene B-4 receptor type 2 (BLT2) enhances skin barrier function by regulating tight junction proteins	FASEB JOURNAL			English	Article						GPCR; G protein; p38 MAPK; claudin-4	UP-REGULATION; 12-HYDROXYHEPTADECATRIENOIC ACID; EXPRESSION; AFADIN; MODULATION; ACTIVATION; ADHESION; BINDING; GENE; INVOLVEMENT	GPCRs are involved in numerous physiologic functions and are important drug targets. Although the epithelial barrier is important for protection from invading pathogens, the correlation between GPCRs and epithelial barrier function remains unknown. Leukotriene B-4 (LTB4) receptor type 2 (BLT2), mainly expressed in epithelial cells, is a GPCR for 12(S)-hydroxyheptadeca-5Z, 8E, 10E-trienoic acid (12-HHT) and LTB4. In our study, BLT2 localized at the lateral membrane in BLT2-overexpressing Madin-Darby canine kidney (MDCK) II cells and in the small intestine of BLT2-transgenic mice. BLT2-deficient mice exhibited higher transepidermal water loss and were more sensitive to epicutaneous sensitization. MDCK-BLT2 cells recovered transepithelial electrical resistance (TER) after a calcium switch faster than did MDCK-Mock cells, and 12-HHT stimulation accelerated TER recovery only in MDCK-BLT2 cells. Quantitative PCR and immunoblot analyses revealed that the 12-HHT/BLT2 axis up-regulated claudin-4 (CLDN4) expression in MDCK-BLT2 cells and human primary keratinocytes, and CLDN4 knockdown abolished 12-HHT-dependent TER recovery. Acceleration of TER recovery and induction of CLDN4 expression by 12-HHT stimulation were abolished by inhibition of G alpha(i) protein or p38 MAPK. These results show that 12-HHT/BLT2 enhances epithelial barrier function by increasing CLDN4 expression via the Gai protein-p38 MAPK pathway.	[Ishii, Yumiko; Saeki, Kazuko; Liu, Min; Sasaki, Fumiyuki; Koga, Tomoaki; Okuno, Toshiaki; Yokomizo, Takehiko] Kyushu Univ, Grad Sch Med Sci, Dept Med Biochem, Fukuoka 812, Japan; [Ishii, Yumiko] Kyushu Univ, Grad Sch Med Sci, Chest Dis Res Inst, Fukuoka 812, Japan; [Kitajima, Keiko; Meno, Chikara] Kyushu Univ, Grad Sch Med Sci, Dept Dev Biol, Fukuoka 812, Japan; [Saeki, Kazuko; Liu, Min; Sasaki, Fumiyuki; Koga, Tomoaki; Okuno, Toshiaki; Yokomizo, Takehiko] Juntendo Univ, Sch Med, Dept Biochem, Tokyo 113, Japan; [Liu, Min] Shanghai Jiao Tong Univ, Sch Med, Shanghai Peoples Hosp 9, Dept Endocrinol, Shanghai 200030, Peoples R China	Kyushu University; Kyushu University; Kyushu University; Juntendo University; Shanghai Jiao Tong University	Saeki, K; Yokomizo, T (corresponding author), Juntendo Univ, Sch Med, Dept Biochem, Bunkyo Ku, Hongo 2-1-1, Tokyo 1138421, Japan.	ksaeki@juntendo.ac.jp; yokomizo-tky@umin.ac.jp	Yokomizo, Takehiko/P-5673-2016	Yokomizo, Takehiko/0000-0002-5219-1553; Ishii, Yumiko/0000-0002-7438-3695	Ministry of Education, Culture, Sports, Science and Technology (MEXT) [22116001, 22116002, 15H05901, 15H05904, 15H04708, 24590386, 15K08316, 24102522, 25460374]; Naito Foundation; Ono Medical Research Foundation; Uehara Memorial Foundation; Mitsubishi Foundation; Takeda Science Foundation; Foundation of Strategic Research Projects in Private Universities from the MEXT [S1311011]; institutional grant for Environmental and Gender-Specific Medicine; Grants-in-Aid for Scientific Research [15H05897] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Naito Foundation(Naito Memorial Foundation); Ono Medical Research Foundation; Uehara Memorial Foundation(Uehara Memorial Foundation); Mitsubishi Foundation; Takeda Science Foundation(Takeda Science Foundation (TSF)); Foundation of Strategic Research Projects in Private Universities from the MEXT; institutional grant for Environmental and Gender-Specific Medicine; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The authors thank Y. Taketomi and M. Murakami (Tokyo Metropolitan Institute of Medical Science), H. Katoh (Kyoto University), S. Nakajima (Kyoto University), M. Koike (Juntendo University), and T. Ito (Kyushu University) for technical support; J. Hayase (Kyushu University) and the members of our laboratories for advice and helpful discussions; the Support Center for Education and Research (Kyushu University) for technical support; and J. Miyazaki (Osaka University) for supplying the pCXN2 expression vector. This work was supported by Grants-in-Aid for Scientific Research 22116001, 22116002, 15H05901, 15H05904, and 15H04708 (to T. Y.) and 24590386 and 15K08316 (to K.S.) and Grants-in Aid 24102522 and 25460374 (to T.O.) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT); the Naito Foundation; the Ono Medical Research Foundation; the Uehara Memorial Foundation; the Mitsubishi Foundation; the Takeda Science Foundation; and in part by Grant-in-Aid S1311011 from the Foundation of Strategic Research Projects in Private Universities from the MEXT and an institutional grant for Environmental and Gender-Specific Medicine. The authors declare no conflicts of interest.	Carrozzino F, 2009, AM J PHYSIOL-CELL PH, V297, pC775, DOI 10.1152/ajpcell.00084.2009; Cho KJ, 2010, AM J RESP CELL MOL, V42, P294, DOI 10.1165/rcmb.2008-0445OC; Dalmasso AP, 2014, J BIOL CHEM, V289, P838, DOI 10.1074/jbc.M113.455766; Das P, 2012, VIRCHOWS ARCH, V460, P261, DOI 10.1007/s00428-012-1195-1; DEALMEIDA JB, 1994, J CELL SCI, V107, P507; Denker BM, 1996, J BIOL CHEM, V271, P25750, DOI 10.1074/jbc.271.42.25750; Dufresne J, 2007, BIOL REPROD, V76, P825, DOI 10.1095/biolreprod.106.057430; Fujita-Yoshigaki J, 2008, AM J PHYSIOL-CELL PH, V294, pC774, DOI 10.1152/ajpcell.00472.2007; Furuse M, 1998, J CELL BIOL, V141, P1539, DOI 10.1083/jcb.141.7.1539; Furuse M, 2002, J CELL BIOL, V156, P1099, DOI 10.1083/jcb.200110122; GONZALEZMARISCAL L, 1990, AM J PHYSIOL, V259, pC978, DOI 10.1152/ajpcell.1990.259.6.C978; Gunzel D, 2013, PHYSIOL REV, V93, P525, DOI 10.1152/physrev.00019.2012; Hayase J, 2013, J CELL BIOL, V200, P635, DOI 10.1083/jcb.201208150; Hayashi D, 2012, GASTROENTEROLOGY, V142, P292, DOI 10.1053/j.gastro.2011.10.040; Hennig R, 2008, BRIT J CANCER, V99, P1064, DOI 10.1038/sj.bjc.6604655; Honda H, 2007, CANCER BIOL THER, V6, P1733, DOI 10.4161/cbt.6.11.4832; Hopkins AM, 2000, ADV DRUG DELIVER REV, V41, P329, DOI 10.1016/S0169-409X(00)00050-8; Iizuka Y, 2005, J BIOL CHEM, V280, P24816, DOI 10.1074/jbc.M413257200; Iizuka Y, 2010, FASEB J, V24, P4678, DOI 10.1096/fj.10-165050; Ikari A, 2013, BBA-MOL CELL RES, V1833, P2617, DOI 10.1016/j.bbamcr.2013.06.016; Ishii K, 2005, J INVEST DERMATOL, V124, P939, DOI 10.1111/j.0022-202X.2005.23714.x; Izumi Y, 1998, J CELL BIOL, V143, P95, DOI 10.1083/jcb.143.1.95; Kamohara M, 2000, J BIOL CHEM, V275, P27000; Khan N, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/219843; Kim GY, 2010, J IMMUNOL, V184, P3946, DOI 10.4049/jimmunol.0901735; Leung DYM, 2013, ALLERGOL INT, V62, P151, DOI 10.2332/allergolint.13-RAI-0564; Lin S, 2010, MOL BIOL CELL, V21, P3902, DOI 10.1091/mbc.E10-03-0242; Liu M, 2014, J EXP MED, V211, P1063, DOI 10.1084/jem.20132063; Luk JM, 2004, FEBS LETT, V578, P251, DOI 10.1016/j.febslet.2004.11.010; Madison BB, 2002, J BIOL CHEM, V277, P33275, DOI 10.1074/jbc.M204935200; Mandai K, 1997, J CELL BIOL, V139, P517, DOI 10.1083/jcb.139.2.517; Martin-Belmonte F, 2007, CELL, V128, P383, DOI 10.1016/j.cell.2006.11.051; Matsunaga Y, 2013, FASEB J, V27, P3306, DOI 10.1096/fj.12-217000; Matsunobu T, 2013, J LIPID RES, V54, P2979, DOI 10.1194/jlr.M037754; Merritt AJ, 2002, MOL CELL BIOL, V22, P5846, DOI 10.1128/MCB.22.16.5846-5858.2002; Monteiro AC, 2013, MOL BIOL CELL, V24, P2849, DOI 10.1091/mbc.E13-06-0298; Morita K, 1999, P NATL ACAD SCI USA, V96, P511, DOI 10.1073/pnas.96.2.511; Nakajima S, 2012, J ALLERGY CLIN IMMUN, V129, P1048, DOI 10.1016/j.jaci.2012.01.063; Nitta T, 2003, J CELL BIOL, V161, P653, DOI 10.1083/jcb.200302070; Okuno T, 2008, J EXP MED, V205, P759, DOI 10.1084/jem.20072329; Oyoshi MK, 2009, J ALLERGY CLIN IMMUN, V124, P485, DOI 10.1016/j.jaci.2009.05.042; Peltonen S, 2007, BRIT J DERMATOL, V156, P466, DOI 10.1111/j.1365-2133.2006.07642.x; POWELL DW, 1981, AM J PHYSIOL, V241, pG275, DOI 10.1152/ajpgi.1981.241.4.G275; Raiko L, 2012, EXP DERMATOL, V21, P586, DOI 10.1111/j.1600-0625.2012.01520.x; Ryu HC, 2010, J INVEST DERMATOL, V130, P1095, DOI 10.1038/jid.2009.436; Saha C, 1998, J BIOL CHEM, V273, P21629, DOI 10.1074/jbc.273.34.21629; Sakisaka T, 1999, ONCOGENE, V18, P1609, DOI 10.1038/sj.onc.1202451; Sasaki F, 2012, ANAL BIOCHEM, V425, P157, DOI 10.1016/j.ab.2012.03.014; Severson EA, 2009, MOL BIOL CELL, V20, P1916, DOI 10.1091/mbc.E08-10-1014; Shao WH, 2006, J IMMUNOL, V176, P6254, DOI 10.4049/jimmunol.176.10.6254; Sheth P, 2007, AM J PHYSIOL-GASTR L, V293, pG308, DOI 10.1152/ajpgi.00582.2006; Stahley SN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087809; Tsukita S, 2001, NAT REV MOL CELL BIO, V2, P285, DOI 10.1038/35067088; Van Itallie C, 2001, J CLIN INVEST, V107, P1319, DOI 10.1172/JCI12464; Van Itallie CM, 2003, AM J PHYSIOL-RENAL, V285, pF1078, DOI 10.1152/ajprenal.00116.2003; Vasioukhin V, 2001, CURR OPIN CELL BIOL, V13, P76, DOI 10.1016/S0955-0674(00)00177-0; Yamamoto K., 2015, J EXP MED; Yokomizo T, 2000, J EXP MED, V192, P421, DOI 10.1084/jem.192.3.421; Yokomizo T, 1997, NATURE, V387, P620, DOI 10.1038/42506; Yokomizo T, 2001, J BIOL CHEM, V276, P12454, DOI 10.1074/jbc.M011361200; Yokomizo T, 2015, J BIOCHEM, V157, P65, DOI 10.1093/jb/mvu078; Yokomizo T, 2011, ADV ENZYME REGUL, V51, P59, DOI 10.1016/j.advenzreg.2010.08.002; Yoo MH, 2004, ONCOGENE, V23, P9259, DOI 10.1038/sj.onc.1208151; Zeissig S, 2007, GUT, V56, P61, DOI 10.1136/gut.2006.094375	64	32	32	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2016	30	2					933	947		10.1096/fj.15-279653	http://dx.doi.org/10.1096/fj.15-279653			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DC7IA	26527063	Green Accepted			2022-12-26	WOS:000369391900040
J	Meng, XF; Pijning, T; Dobruchowska, JM; Gerwig, GJ; Dijkhuizen, L				Meng, Xiangfeng; Pijning, Tjaard; Dobruchowska, Justyna M.; Gerwig, Gerrit J.; Dijkhuizen, Lubbert			Characterization of the Functional Roles of Amino Acid Residues in Acceptor-binding Subsite+1 in the Active Site of the Glucansucrase GTF180 from Lactobacillus reuteri 180	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-D-GLUCANS; STRUCTURAL-CHARACTERIZATION; MOLECULAR CHARACTERIZATION; 121 REUTERANSUCRASE; DSR-E; EXOPOLYSACCHARIDES; DEXTRANSUCRASE; SPECIFICITY; ENZYMES; BACTERIA	alpha-Glucans produced by glucansucrase enzymes hold strong potential for industrial applications. The exact determinants of the linkage specificity of glucansucrase enzymes have remained largely unknown, even with the recent elucidation of glucansucrase crystal structures. Guided by the crystal structure of glucansucrase GTF180-Delta N from Lactobacillus reuteri 180 in complex with the acceptor substrate maltose, we identified several residues (Asp-1028 and Asn-1029 from domain A, as well as Leu-938, Ala-978, and Leu-981 from domain B) near subsite + 1 that may be critical for linkage specificity determination, and we investigated these by random site-directed mutagenesis. First, mutants of Ala-978 (to Leu, Pro, Phe, or Tyr) and Asp-1028 (to Tyr or Trp) with larger side chains showed reduced degrees of branching, likely due to the steric hindrance by these bulky residues. Second, Leu-938 mutants (except L938F) and Asp-1028 mutants showed altered linkage specificity, mostly with increased (alpha 1 -> 6) linkage synthesis. Third, mutation of Leu-981 and Asn-1029 significantly affected the transglycosylation reaction, indicating their essential roles in acceptor substrate binding. In conclusion, glucansucrase product specificity is determined by an interplay of domain A and B residues surrounding the acceptor substrate binding groove. Residues surrounding the +1 subsite thus are critical for activity and specificity of the GTF180 enzyme and play different roles in the enzyme functions. This study provides novel insights into the structure-function relationships of glucansucrase enzymes and clearly shows the potential of enzyme engineering to produce tailor-made alpha-glucans.	[Meng, Xiangfeng; Dobruchowska, Justyna M.; Gerwig, Gerrit J.; Dijkhuizen, Lubbert] Univ Groningen, Groningen Biomol Sci & Biotechnol Inst, Dept Microbial Physiol, NL-9747 AG Groningen, Netherlands; [Pijning, Tjaard] Univ Groningen, Groningen Biomol Sci & Biotechnol Inst, Dept Biophys Chem, NL-9747 AG Groningen, Netherlands	University of Groningen; University of Groningen	Dijkhuizen, L (corresponding author), Univ Groningen, Groningen Biomol Sci & Biotechnol Inst, Microbial Physiol, Nijenborgh 7, NL-9747 AG Groningen, Netherlands.	l.dijkhuizen@rug.nl	DOBRUCHOWSKA, JUSTYNA/AAY-1409-2021; Pijning, Tjaard/ABA-2929-2021; Dijkhuizen, Lubbert/E-9454-2014; Dijkhuizen, Lubbert/K-3539-2019; Pijning, Tjaard/HDO-3704-2022	Pijning, Tjaard/0000-0003-4107-3663; Dijkhuizen, Lubbert/0000-0003-2312-7162; 	China Scholarship Council; European Union [NOVOSIDES FP7-KBBE-2010-4-265854]	China Scholarship Council(China Scholarship Council); European Union(European Commission)	This work was supported by the China Scholarship Council (to X. M.) and by European Union Project NOVOSIDES FP7-KBBE-2010-4-265854 (to L. D.). The authors declare that they have no conflicts of interest with the contents of this article.	Badel S, 2011, BIOTECHNOL ADV, V29, P54, DOI 10.1016/j.biotechadv.2010.08.011; Bozonnet S, 2002, J BACTERIOL, V184, P5753, DOI 10.1128/JB.184.20.5753-5761.2002; Brison Y, 2013, CARBOHYD POLYM, V94, P567, DOI 10.1016/j.carbpol.2013.01.064; Brison Y, 2012, J BIOL CHEM, V287, P7915, DOI 10.1074/jbc.M111.305078; Brison Y, 2010, APPL MICROBIOL BIOT, V86, P545, DOI 10.1007/s00253-009-2241-z; CIUCANU I, 1984, CARBOHYD RES, V131, P209, DOI 10.1016/0008-6215(84)85242-8; Cote GL, 2006, CARBOHYD RES, V341, P2066, DOI 10.1016/j.carres.2006.04.044; Cote GL, 2014, APPL MICROBIOL BIOT, V98, P6651, DOI 10.1007/s00253-014-5622-x; Cote GL, 2009, CARBOHYD RES, V344, P187, DOI 10.1016/j.carres.2008.10.017; Davies GJ, 1997, BIOCHEM J, V321, P557, DOI 10.1042/bj3210557; Desmet T, 2012, CHEM-EUR J, V18, P10786, DOI 10.1002/chem.201103069; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Hellmuth H, 2008, BIOCHEMISTRY-US, V47, P6678, DOI 10.1021/bi800563r; Irague R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077837; Irague R, 2012, BIOMACROMOLECULES, V13, P187, DOI 10.1021/bm201453r; Irague R, 2011, ANAL CHEM, V83, P1202, DOI 10.1021/ac1032148; Ito K, 2011, J MOL BIOL, V408, P177, DOI 10.1016/j.jmb.2011.02.028; Jolly L, 2002, ANTON LEEUW INT J G, V82, P367, DOI 10.1023/A:1020668523541; Kralj S, 2005, BIOCHEMISTRY-US, V44, P9206, DOI 10.1021/bi050447q; Kralj S, 2004, MICROBIOL-SGM, V150, P2099, DOI 10.1099/mic.0.27105-0; Kralj S, 2006, FEBS J, V273, P3735, DOI 10.1111/j.1742-4658.2006.05376.x; Leemhuis H, 2013, J BIOTECHNOL, V163, P250, DOI 10.1016/j.jbiotec.2012.06.037; Leemhuis H, 2012, BIOCATAL BIOTRANSFOR, V30, P366, DOI 10.3109/10242422.2012.676301; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; MacGregor EA, 1996, FEBS LETT, V378, P263, DOI 10.1016/0014-5793(95)01428-4; Meng XF, 2014, J BIOL CHEM, V289, DOI 10.1074/jbc.M114.602524; MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030; Monchois V, 2000, APPL ENVIRON MICROB, V66, P1923, DOI 10.1128/AEM.66.5.1923-1927.2000; Monchois V, 1999, FEMS MICROBIOL REV, V23, P131, DOI 10.1016/S0168-6445(98)00041-2; Monsan P, 2001, INT DAIRY J, V11, P675, DOI 10.1016/S0958-6946(01)00113-3; Moulis C, 2006, J BIOL CHEM, V281, P31254, DOI 10.1074/jbc.M604850200; Naessens M, 2005, J CHEM TECHNOL BIOT, V80, P845, DOI 10.1002/jctb.1322; Seo ES, 2005, J BIOTECHNOL, V117, P31, DOI 10.1016/j.jbiotec.2004.10.013; Tsumori H, 1997, J BACTERIOL, V179, P3391, DOI 10.1128/jb.179.11.3391-3396.1997; Van Geel-Schutten GH, 1999, APPL ENVIRON MICROB, V65, P3008; van Hijum SAFT, 2006, MICROBIOL MOL BIOL R, V70, P157, DOI 10.1128/MMBR.70.1.157-176.2006; van Leeuwen SS, 2008, BIOMACROMOLECULES, V9, P2251, DOI 10.1021/bm800410w; van Leeuwen SS, 2008, CARBOHYD RES, V343, P1237, DOI 10.1016/j.carres.2008.01.042; van Leeuwen SS, 2008, CARBOHYD RES, V343, P1114, DOI 10.1016/j.carres.2008.01.043; van Leeuwen SS, 2009, BIOMACROMOLECULES, V10, P580, DOI 10.1021/bm801240r; Vujicic-Zagar A, 2010, P NATL ACAD SCI USA, V107, P21406, DOI 10.1073/pnas.1007531107; Welman AD, 2003, TRENDS BIOTECHNOL, V21, P269, DOI 10.1016/S0167-7799(03)00107-0	42	24	28	2	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 11	2015	290	50					30131	30141		10.1074/jbc.M115.687558	http://dx.doi.org/10.1074/jbc.M115.687558			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CY7UL	26507662	Green Published, hybrid			2022-12-26	WOS:000366614700043
J	Willemsen, I; Oome, S; Verhulst, C; Pettersson, A; Verduin, K; Kluytmans, J				Willemsen, Ina; Oome, Stijn; Verhulst, Carlo; Pettersson, Annika; Verduin, Kees; Kluytmans, Jan			Trends in Extended Spectrum Beta-Lactamase (ESBL) Producing Enterobacteriaceae and ESBL Genes in a Dutch Teaching Hospital, Measured in 5 Yearly Point Prevalence Surveys (2010-2014)	PLOS ONE			English	Article							ESCHERICHIA-COLI; CHICKEN MEAT; CTX-M; CARRIAGE; STRAINS; SPREAD; HUMANS	This paper describes the trends in prevalence of ESBL producing Enterobacteriaceae (ESBL-E) and ESBL genes, measured in five consecutive yearly Point Prevalence Surveys (PPS). All patients present in the hospital and in a day-care clinic (including patients on dialysis) on the day of the survey, were screened for perianal ESBL-E carriage. Perianal swabs were taken and cultured using an enrichment broth and a selective agar plate. Both phenotypic and genotypic methods were used to detect the production of ESBL, presence of ESBL-genes and clonal relatedness. Out of 2,695 patients, 135 (5.0%) were tested ESBL-E positive. The overall ESBL-E prevalence was stable over the years. Overall 5.2% of all ESBL-E were acquired by nosocomial transmission. A relative decrease of CTX-M-1-1-like ESBL genes (from 44 to 25%, p = 0.026) was observed, possibly related to the strong (>60%) decrease in antibiotic use in livestock in our country during the same period.	[Willemsen, Ina; Oome, Stijn; Verhulst, Carlo; Verduin, Kees; Kluytmans, Jan] Amphia Hosp, Lab Microbiol & Infect Control, Breda, Netherlands; [Pettersson, Annika; Kluytmans, Jan] Vrije Univ Amsterdam Med Ctr, Dept Med Microbiol & Infect Control, Amsterdam, Netherlands; [Kluytmans, Jan] UMC Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands	Amphia Hospital; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Utrecht University; Utrecht University Medical Center	Willemsen, I (corresponding author), Amphia Hosp, Lab Microbiol & Infect Control, Breda, Netherlands.	iwillemsen@amphia.nl	van den Bergh, Marjolein Kluytmans -/A-7267-2016	van den Bergh, Marjolein Kluytmans -/0000-0002-6576-6408				[Anonymous], 2014, MORT CANC HLTH GLANC, DOI 10.1787/health_glance_eur-2014-en; Bernards AT, 2012, NVMM GUIDELINE LAB D; Cuzon G, 2012, J ANTIMICROB CHEMOTH, V67, P1865, DOI 10.1093/jac/dks156; Falagas ME, 2009, J HOSP INFECT, V73, P345, DOI 10.1016/j.jhin.2009.02.021; Kaier K, 2009, J ANTIMICROB CHEMOTH, V63, P609, DOI 10.1093/jac/dkn534; Kluytmans JAJW, 2013, CLIN INFECT DIS, V56, P478, DOI 10.1093/cid/cis929; Livermore DM, 2007, J ANTIMICROB CHEMOTH, V59, P165, DOI 10.1093/jac/dkl483; MARAN, 2014, MON ANT RES ANT US A; Mohammadi T, 2005, BRIT J HAEMATOL, V131, P403, DOI 10.1111/j.1365-2141.2005.05771.x; Overdevest I, 2011, EMERG INFECT DIS, V17, P1216, DOI 10.3201/eid1707.110209; Reuland EA, 2013, CLIN MICROBIOL INFEC, V19, P542, DOI 10.1111/j.1469-0691.2012.03947.x; Shitrit P, 2013, J HOSP INFECT, V85, P230, DOI 10.1016/j.jhin.2013.07.014; van Mansfeld R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158106; Willemsen I, 2008, INFECT CONT HOSP EP, V29, P1110, DOI 10.1086/592408; Willemsen I, 2014, ANTIMICROB RESIST IN, V3, DOI 10.1186/2047-2994-3-26	15	22	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2015	10	11							e0141765	10.1371/journal.pone.0141765	http://dx.doi.org/10.1371/journal.pone.0141765			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV1QH	26528549	Green Published, gold			2022-12-26	WOS:000364032600055
J	Yu, D; Makkar, G; Dong, T; Strickland, DK; Sarkar, R; Monahan, TS				Yu, Dan; Makkar, George; Dong, Tuo; Strickland, Dudley K.; Sarkar, Rajabrata; Monahan, Thomas Stacey			MARCKS Signaling Differentially Regulates Vascular Smooth Muscle and Endothelial Cell Proliferation through a KIS-, p27(kip1)-Dependent Mechanism	PLOS ONE			English	Article							UBIQUITIN-MEDIATED DEGRADATION; NEOINTIMAL HYPERPLASIA; INDIVIDUAL PROPENSITY; GENE-EXPRESSION; CDK INHIBITORS; SAPHENOUS-VEIN; CANCER CELLS; P27(KIP1); KINASE; GROWTH	Background Overexpression of the myristolated alanine-rich C kinase substrate (MARCKS) occurs in vascular proliferative diseases such as restenosis after bypass surgery. MARCKS knockdown results in arrest of vascular smooth muscle cell (VSMC) proliferation with little effect on endothelial cell (EC) proliferation. We sought to identify the mechanism of differential regulation by MARCKS of VSMC and EC proliferation in vitro and in vivo. Methods and Results siRNA-mediated MARCKS knockdown in VSMCs inhibited proliferation and prevented progression from phase G(0)/G(1) to S. Protein expression of the cyclin-dependent kinase inhibitor p27(kip1), but not p21(cip1) was increased by MARCKS knockdown. MARCKS knockdown did not affect proliferation in VSMCs derived from p27(kip1)-/- mice indicating that the effect of MARCKS is p27(kip1)-dependent. MARCKS knockdown resulted in decreased phosphorylation of p27(kip1) at threonine 187 and serine 10 as well as, kinase interacting with stathmin (KIS), cyclin D1, and Skp2 expression. Phosphorylation of p27(kip1) at serine 10 by KIS is required for nuclear export and degradation of p27(kip1). MARCKS knockdown caused nuclear trapping of p27(kip1). Both p27(kip1) nuclear trapping and cell cycle arrest were released by overexpression of KIS, but not catalytically inactive KIS. In ECs, MARCKS knockdown paradoxically increased KIS expression and cell proliferation. MARCKS knockdown in a murine aortic injury model resulted in decreased VSMC proliferation determined by bromodeoxyuridine (BrdU) integration assay, and inhibition of vascular wall thickening. MARCKS knockdown increased the rate of re-endothelialization. Conclusions MARCKS knockdown arrested VSMC cell cycle by decreasing KIS expression. Decreased KIS expression resulted in nuclear trapping of p27(kip1) in VSMCs. MARCKS knockdown paradoxically increased KIS expression in ECs resulting in increased EC proliferation. MARCKS knockdown significantly attenuated the VSMC proliferative response to vascular injury, but accelerated reestablishment of an intact endothelium. MARCKS is a novel translational target with beneficial cell type-specific effects on both ECs and VSMCs.	[Yu, Dan; Dong, Tuo; Strickland, Dudley K.; Sarkar, Rajabrata; Monahan, Thomas Stacey] Baltimore Vet Affairs Med Ctr, Dept Surg, Baltimore, MD 21201 USA; [Makkar, George; Strickland, Dudley K.; Sarkar, Rajabrata; Monahan, Thomas Stacey] Univ Maryland, Sch Med, Dept Surg, Baltimore, MD 21201 USA; [Strickland, Dudley K.; Sarkar, Rajabrata] Univ Maryland, Sch Med, Dept Physiol, Baltimore, MD 21201 USA; [Yu, Dan; Strickland, Dudley K.; Sarkar, Rajabrata; Monahan, Thomas Stacey] Univ Maryland, Sch Med, Ctr Vasc & Inflammatory Dis, Baltimore, MD 21201 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Baltimore VA Medical Center; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Monahan, TS (corresponding author), Baltimore Vet Affairs Med Ctr, Dept Surg, Baltimore, MD 21201 USA.	tmonahan@smail.umaryland.edu			Veterans Administration Career Development Award (CDA-2), Mechanisms for cell specific modulation of proliferation and migration [1IK2BX001553-01]; Vascular Cures, E.J. Wylie Scholarship, Mechanisms for differential proliferation of vascular smooth muscle and endothelial cells; Veterans Affairs [IK2BX001553] Funding Source: NIH RePORTER	Veterans Administration Career Development Award (CDA-2), Mechanisms for cell specific modulation of proliferation and migration; Vascular Cures, E.J. Wylie Scholarship, Mechanisms for differential proliferation of vascular smooth muscle and endothelial cells; Veterans Affairs(US Department of Veterans Affairs)	Funding was provided by Veterans Administration Career Development Award (CDA-2), Mechanisms for cell specific modulation of proliferation and migration, (1IK2BX001553-01) TSM; Vascular Cures, E.J. Wylie Scholarship, Mechanisms for differential proliferation of vascular smooth muscle and endothelial cells, TSM.	Alessandrini A, 1997, LEUKEMIA, V11, P342, DOI 10.1038/sj.leu.2400581; Aoki T, 2002, STROKE, V33, P2711, DOI 10.1161/01.STR.0000033932.34467.97; Bentzon JF, 2006, ARTERIOSCL THROM VAS, V26, P2696, DOI 10.1161/01.ATV.0000247243.48542.9d; Bickeboller M, 2015, ONCOGENE, V34, P1150, DOI 10.1038/onc.2014.40; Boehm M, 2002, EMBO J, V21, P3390, DOI 10.1093/emboj/cdf343; Brooks G, 1996, CARCINOGENESIS, V17, P683, DOI 10.1093/carcin/17.4.683; Browne BC, 2013, FEBS J, V280, P5237, DOI 10.1111/febs.12441; Carrano AC, 1999, NAT CELL BIOL, V1, P193, DOI 10.1038/12013; Castronuovo JJ, 2002, J VASC SURG, V35, P146, DOI 10.1067/mva.2002.119230; Cheng MG, 1999, EMBO J, V18, P1571, DOI 10.1093/emboj/18.6.1571; Conte MS, 2013, J VASC SURG, V57, P1179, DOI 10.1016/j.jvs.2012.11.040; Disatnik MH, 2002, J CELL SCI, V115, P2151; Finn AV, 2007, CIRCULATION, V115, P2435, DOI 10.1161/CIRCULATIONAHA.107.693739; Gardner-Thorpe J, 2002, BIOCHEM BIOPH RES CO, V293, P391, DOI 10.1016/S0006-291X(02)00237-1; Hakanpaa L, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6962; Hayashi S, 2009, AM J PATHOL, V175, P2226, DOI 10.2353/ajpath.2009.090152; Hirai A, 1997, J BIOL CHEM, V272, P13; Jarboe JS, 2012, CLIN CANCER RES, V18, P3030, DOI 10.1158/1078-0432.CCR-11-3091; Kalish JA, 2004, J VASC SURG, V39, P645, DOI 10.1016/j.jvs.2003.10.049; Langenickel TH, 2008, J CLIN INVEST, V118, P3848, DOI 10.1172/JCI33206; Lee JG, 2011, INVEST OPHTH VIS SCI, V52, P8216, DOI 10.1167/iovs.11-8213; Li T, 2009, BIOCHEM BIOPH RES CO, V383, P280, DOI 10.1016/j.bbrc.2009.03.077; Lim Y, 2010, ATHEROSCLEROSIS, V210, P372, DOI 10.1016/j.atherosclerosis.2009.11.037; Manceau V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043946; Masaki T, 2005, INT J ONCOL, V26, P661; Monahan TS, 2007, J VASC SURG, V45, P581, DOI 10.1016/j.jvs.2006.12.016; Monahan TS, 2009, FASEB J, V23, P557, DOI 10.1096/fj.08-114173; Ohmitsu M, 1999, J BIOL CHEM, V274, P408, DOI 10.1074/jbc.274.1.408; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; PANETTA TF, 1992, J VASC SURG, V16, P867; Ray Jenna Lynn, 2001, Methods in Cell Science, V23, P185; REYNISDOTTIR I, 1995, GENE DEV, V9, P1831, DOI 10.1101/gad.9.15.1831; Schonwasser DC, 1996, FEBS LETT, V395, P1; Shirane M, 1999, J BIOL CHEM, V274, P13886, DOI 10.1074/jbc.274.20.13886; Shuchman M, 2006, NEW ENGL J MED, V355, P1949, DOI 10.1056/NEJMp068234; Techasen A, 2010, CANCER SCI, V101, P658, DOI 10.1111/j.1349-7006.2009.01427.x; Tsui LV, 2001, CIRC RES, V89, P323, DOI 10.1161/hh1601.094482; Vlach J, 1997, EMBO J, V16, P5334, DOI 10.1093/emboj/16.17.5334; Voytik-Harbin SL, 1998, IN VITRO CELL DEV-AN, V34, P239; Wang XW, 2006, MED SCI MONITOR, V12, pRA177; Willis DJ, 2004, J SURG RES, V120, P27, DOI 10.1016/j.jss.2003.12.014; Wysokinski W, 2008, THROMB RES, V122, P390, DOI 10.1016/j.thromres.2007.10.010; Wysokinski WE, 1999, ARTERIOSCL THROM VAS, V19, P883, DOI 10.1161/01.ATV.19.4.883; Ye WZ, 2007, HISTOCHEM CELL BIOL, V127, P195, DOI 10.1007/s00418-006-0238-6; Yu D, 2012, ONCOGENE, V31, P3561, DOI 10.1038/onc.2011.509	45	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2015	10	11							e0141397	10.1371/journal.pone.0141397	http://dx.doi.org/10.1371/journal.pone.0141397			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV1QH	26528715	Green Published, gold, Green Submitted			2022-12-26	WOS:000364032600026
J	den Heijer, AE; Groen, Y; Fuermaier, ABM; van Heuvelen, MJG; van der Zee, EA; Tucha, L; Tucha, O				den Heijer, Anne E.; Groen, Yvonne; Fuermaier, Anselm B. M.; van Heuvelen, Marieke J. G.; van der Zee, Eddy A.; Tucha, Lara; Tucha, Oliver			Acute Effects of Whole Body Vibration on Inhibition in Healthy Children	PLOS ONE			English	Article							ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; DOPAMINE; EXERCISE; ADHD; THERAPY; SLEEP	Objectives Whole Body Vibration (WBV) is a passive exercise method known to have beneficial effects on various physical measures. Studies on adults furthermore demonstrated beneficial effects of WBV treatment on cognition (e.g. inhibition). The present study replicated these findings in healthy children and examined acute effects of WBV treatment on inhibition. Methods Fifty-five healthy children (aged 8-13) participated in this within-subject design study. WBV treatment was applied by having the children sit on a chair mounted to a vibrating platform. After each condition (vibration vs. non-vibration), inhibition was measured by using the Stroop Color-Word Interference Test. Repeated measures analyses were applied in order to explore the effects of WBV treatment on inhibition, and correlations were computed between the treatment effect and participant characteristics in order to explore individual differences in treatment sensitivity. Results Three-minute WBV treatments had significant beneficial effects on inhibition in this sample of healthy children. Especially the repeated application (three times) of WBV treatment appeared beneficial for cognition. Stronger WBV treatment effects were correlated with higher intelligence and younger age, but not with symptoms of Attention Deficit Hyperactivity Disorder (ADHD). Conclusions This study demonstrates that especially repeated WBV treatment improves inhibition in healthy children. As this cognitive function is often impaired in children with developmental disorders (e.g. ADHD), future studies should further explore the effects, working mechanism and potential applicability of WBV treatment for this target group.	[den Heijer, Anne E.; Groen, Yvonne; Fuermaier, Anselm B. M.; Tucha, Lara; Tucha, Oliver] Univ Groningen, Clin & Dev Neuropsychol, Groningen, Netherlands; [van Heuvelen, Marieke J. G.] Univ Groningen, Univ Med Ctr Groningen, Ctr Human Movement Sci, Groningen, Netherlands; [van der Zee, Eddy A.] Univ Groningen, Dept Mol Neurobiol, Ctr Behav & Neurosci, Groningen, Netherlands	University of Groningen; University of Groningen; University of Groningen	den Heijer, AE (corresponding author), Univ Groningen, Clin & Dev Neuropsychol, Groningen, Netherlands.	a.e.den.heijer@rug.nl	Tucha, Oliver/AAD-1403-2019; van der Zee, Eddy/AAZ-2120-2020	Groen, Yvonne/0000-0002-7242-0317; Fuermaier, Anselm/0000-0002-2331-0840				Achenbach T. M, 2001, MANUAL ASEBA SCH AGE; American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; APA, 1994, DIAGN STAT MAN MENT; Arias-Carrion O, 2007, ACTA NEUROBIOL EXP, V67, P481; Arnsten AFT, 2012, NEURON, V76, P223, DOI 10.1016/j.neuron.2012.08.038; Banaschewski T, 2006, EUR CHILD ADOLES PSY, V15, P476, DOI 10.1007/s00787-006-0549-0; Barkley RA, 1997, PSYCHOL BULL, V121, P65, DOI 10.1037/0033-2909.121.1.65; Best JR, 2010, DEV REV, V30, P331, DOI 10.1016/j.dr.2010.08.001; BIEDERMAN J, 1991, AM J PSYCHIAT, V148, P564; Bishop DVM, 2007, J PAEDIATR CHILD H, V43, P653, DOI 10.1111/j.1440-1754.2007.01225.x; Bogaerts A, 2007, GAIT POSTURE, V26, P309, DOI 10.1016/j.gaitpost.2006.09.078; Bolduc V, 2013, AM J PHYSIOL-HEART C, V305, pH620, DOI 10.1152/ajpheart.00624.2012; Boonstra AM, 2005, PSYCHOL MED, V35, P1097, DOI 10.1017/S003329170500499X; Buitelaar J, 2010, EUR CHILD ADOLES PSY, V19, P325, DOI 10.1007/s00787-009-0056-1; Cardinale M, 2003, EXERC SPORT SCI REV, V31, P3, DOI 10.1097/00003677-200301000-00002; Chang YK, 2012, ARCH CLIN NEUROPSYCH, V27, P225, DOI 10.1093/arclin/acr094; Cochrane DI, 2008, ARCH PHYS MED REHAB, V89, P815, DOI 10.1016/j.apmr.2007.09.055; Cohen J., 1988, AM EDUC; Da Cunha Sa-Caputo D., 2014, PUBLIC HLTH RES, V4, P136; dela Pena I, 2013, ARCH PHARM RES, V36, P400, DOI 10.1007/s12272-013-0037-2; Duan X., 2010, PSYCHOL TEST ASSESSM, V52, P419, DOI DOI 10.1044/2F2016_JSLHR-L-15-0310; Dunn W., 1999, SENSORY PROFILES USE; Fuermaier A.B.M., 2014, WHOLE BODY VIBRATION; Fuermaier ABM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090747; Geissler J, 2011, EXPERT REV NEUROTHER, V11, P1467, DOI [10.1586/ERN.11.136, 10.1586/ern.11.136]; Groen Y., UNPUB; Halperin JM, 2012, NEUROTHERAPEUTICS, V9, P531, DOI 10.1007/s13311-012-0123-z; HATTORI S, 1994, BRAIN RES BULL, V35, P41, DOI 10.1016/0361-9230(94)90214-3; Huang CLC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095014; Ishihara S., 1917, TESTS COLOR BLINDNES; Keijser N., 2011, 9 DUTCH END ENP M, P125; Kim H, 2011, NEUROSCI LETT, V504, P35, DOI 10.1016/j.neulet.2011.08.052; Lahr M. M. H., 2009, 8 DUTCH END M; Lam FMH, 2012, MATURITAS, V72, P206, DOI 10.1016/j.maturitas.2012.04.009; Matute-Llorente A, 2014, J ADOLESCENT HEALTH, V54, P385, DOI 10.1016/j.jadohealth.2013.11.001; Muller SV, 2002, ARCH PHYS MED REHAB, V83, P115, DOI 10.1053/apmr.2002.27472; Myers KA, 2014, PEDIATR NEUROL, V51, P126, DOI 10.1016/j.pediatrneurol.2014.03.005; Owens JA, 2000, ARCH PEDIAT ADOL MED, V154, P549, DOI 10.1001/archpedi.154.6.549; Pesce C, 2009, EXERCISE COGNITIVE F, P211, DOI [DOI 10.1002/9780470740668.CH11, 10.1002/9780470740668.ch11]; Pinto N, 2010, J MED MED SCI, V2; Regterschot GRH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100506; Santos Filho S. D., 2014, British Journal of Medicine and Medical Research, V4, P1539; Scholte E. M., 1998, HANDLEIDING VRAGENLI; Schultz W, 2007, ANNU REV NEUROSCI, V30, P259, DOI 10.1146/annurev.neuro.28.061604.135722; Soderpalm AC, 2013, J MUSCULOSKEL NEURON, V13, P13; Sonuga-Barke EJS, 2009, J CHILD ADOL PSYCHOP, V19, P683, DOI 10.1089/cap.2009.0024; Stein MA, 2003, PEDIATRICS, V112, pE404, DOI 10.1542/peds.112.5.e404; Stern Y, 2009, NEUROPSYCHOLOGIA, V47, P2015, DOI 10.1016/j.neuropsychologia.2009.03.004; Stewart JM, 2005, AM J PHYSIOL-REG I, V288, pR623, DOI 10.1152/ajpregu.00513.2004; Taylor E, 2004, EUR CHILD ADOLES PSY, V13, P7, DOI 10.1007/s00787-004-1002-x; Timmer M, 2006, FEDERATION EUROPEAN; Van der Heijden KB, 2006, J SLEEP RES, V15, P55; Van der Zee E. A., 2010, FEDERATION EUROPEAN; Wechsler D., 1991, WISC 3 WECHSLER INTE; Wilens TE, 2008, J AM ACAD CHILD PSY, V47, P21, DOI 10.1097/chi.0b013e31815a56f1; Willcutt EG, 2005, BIOL PSYCHIAT, V57, P1336, DOI 10.1016/j.biopsych.2005.02.006; Willcutt E, 2012, NEUROTHERAPEUTICS, V9, P490, DOI 10.1007/s13311-012-0135-8	57	8	8	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2015	10	11							e0140665	10.1371/journal.pone.0140665	http://dx.doi.org/10.1371/journal.pone.0140665			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV1PG	26524188	Green Published, gold, Green Submitted			2022-12-26	WOS:000364029800004
J	Canfran-Duque, A; Pastor, O; Reina, M; Lerma, M; Cruz-Jentoft, AJ; Lasuncion, MA; Busto, R				Canfran-Duque, Alberto; Pastor, Oscar; Reina, Manuel; Lerma, Milagros; Cruz-Jentoft, Alfonso J.; Lasuncion, Miguel A.; Busto, Rebeca			Curcumin Mitigates the Intracellular Lipid Deposit Induced by Antipsychotics In Vitro	PLOS ONE			English	Article							LIPOGENIC GENE-EXPRESSION; INDUCED ACTIVATION; LDL RECEPTOR; CHOLESTEROL; MECHANISM; HALOPERIDOL; TRAFFICKING; DRUGS; INHIBITION; SECRETION	Scope First-and second-generation antipsychotics (FGAs and SGAs, respectively), both inhibit cholesterol biosynthesis and impair the intracellular cholesterol trafficking, leading to lipid accumulation in the late endosome/lysosome compartment. In this study we examined if curcumin, a plant polyphenol that stimulates exosome release, can alleviate antipsychoticinduced intracellular lipid accumulation. Methods HepG2 hepatocarcinoma cells were treated with antipsychotics or placebo and DiI-labelled LDL for 18 h and then exposed to curcumin for the last 2 h. Cells and media were collected separately and used for biochemical analyses, electron microscopy and immunocytochemistry. Exosomes were isolated from the incubation medium by ultracentrifugation. Results Curcumin treatment reduced the number of heterolysosomes and shifted their subcellular localization to the periphery, as revealed by electron microscopy, and stimulated the release of lysosomal beta-hexosaminidase and exosome markers flotillin-2 and CD63 into the media. The presence of DiI in exosomes released by cells preloaded with DiI-LDL demonstrated the endolysosomal origin of the microvesicles. Furthermore, curcumin increased the secretion of cholesterol as well as LDL-derived DiI and [H-3]-cholesterol, in association with a decrease of intracellular lipids. Thus, the disruption of lipid trafficking induced by FGAs or SGAs can be relieved by curcumin treatment. This polyphenol, however, did not mitigate the reduction of cholesterol esterification induced by antipsychotics. Conclusion Curcumin stimulates exosome release to remove cholesterol (and presumably other lipids) accumulated within the endolysosomal compartment, thereby normalizing intracellular lipid homeostasis. This action may help minimize the adverse metabolic effects of antipsychotic treatment, which should now be evaluated in clinical trials.	[Canfran-Duque, Alberto; Lerma, Milagros; Lasuncion, Miguel A.; Busto, Rebeca] Hosp Univ Ramon & Cajal, IRyCIS, Serv Bioquim Invest, Madrid, Spain; [Pastor, Oscar] Hosp Univ Ramon & Cajal, IRyCIS, Serv Bioquim Clin, Madrid, Spain; [Reina, Manuel] Univ Barcelona, Dept Cell Biol, Celltec UB, Barcelona, Spain; [Cruz-Jentoft, Alfonso J.] Hosp Univ Ramon & Cajal, IRyCIS, Unidad Geriatria, Madrid, Spain; [Lasuncion, Miguel A.; Busto, Rebeca] Inst Salud Carlos III ISCIII, CIBER Fisiopatol Obesidad & Nutr CIBEROBN, Madrid, Spain	Hospital Universitario Ramon y Cajal; Hospital Universitario Ramon y Cajal; University of Barcelona; Hospital Universitario Ramon y Cajal; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN	Lasuncion, MA (corresponding author), Hosp Univ Ramon & Cajal, IRyCIS, Serv Bioquim Invest, Madrid, Spain.	miguel.a.lasuncion@hrc.es; rebeca.busto@hrc.es	PASTOR, OSCAR/ABD-6831-2020; Lasunción, Miguel A./K-6167-2014; Cruz-Jentoft, Alfonso J/G-2675-2015; Reina, Manuel/D-4655-2014	PASTOR, OSCAR/0000-0002-4368-433X; Lasunción, Miguel A./0000-0003-0299-9391; Cruz-Jentoft, Alfonso J/0000-0001-7628-4861; Reina, Manuel/0000-0002-0701-200X; Busto, Rebeca/0000-0001-9869-4087	Ministerio de Ciencia e Innovacion, Spain [SAF2011-29951]; Comunidad de Madrid, Madrid, Spain [ALIBIRD S2013/ABI-2728]; Fundacion Espanola de Arteriosclerosis y Sociedad Espanola de Arteriosclerosis (BECA FEA/SEA Investigacion Basica), Spain; Instituto de Salud Carlos III (CIBERobn), Spain	Ministerio de Ciencia e Innovacion, Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Comunidad de Madrid, Madrid, Spain(Comunidad de Madrid); Fundacion Espanola de Arteriosclerosis y Sociedad Espanola de Arteriosclerosis (BECA FEA/SEA Investigacion Basica), Spain; Instituto de Salud Carlos III (CIBERobn), Spain	This work was funded by Ministerio de Ciencia e Innovacion (SAF2011-29951), (http://www.mineco.gob.es/portal/site/mineco/), Spain, to MAL; Comunidad de Madrid (Program ALIBIRD S2013/ABI-2728), (http://www.madrid.org/; http://www.alibird.org/), Madrid, Spain, to MAL; Fundacion Espanola de Arteriosclerosis y Sociedad Espanola de Arteriosclerosis (BECA FEA/SEA 2014 Investigacion Basica), (http://www.searteriosclerosis.org/), Spain, to RB; Instituto de Salud Carlos III (CIBERobn, http://www.ciberobn.es/), (http://www.isciii.es/), Spain, to MAL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal BB, 2009, TRENDS PHARMACOL SCI, V30, P85, DOI 10.1016/j.tips.2008.11.002; Baum L, 2007, PHARMACOL RES, V56, P509, DOI 10.1016/j.phrs.2007.09.013; Bilmen JG, 2001, EUR J BIOCHEM, V268, P6318, DOI 10.1046/j.0014-2956.2001.02589.x; Bishnoi M, 2008, PHARMACOL BIOCHEM BE, V88, P511, DOI 10.1016/j.pbb.2007.10.009; Brini Marisa, 2013, Met Ions Life Sci, V13, P81, DOI 10.1007/978-94-007-7500-8_4; Calvo D, 1998, J LIPID RES, V39, P777; Canfran-Duque A, 2014, MOL NUTR FOOD RES, V58, P687, DOI 10.1002/mnfr.201300350; Canfran-Duque A, 2013, J LIPID RES, V54, P310, DOI 10.1194/jlr.M026948; Chamorro L, 2013, CLIN CHIM ACTA, V421, P132, DOI 10.1016/j.cca.2013.02.007; Chen FW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015054; Dong SZ, 2011, MOL CELL BIOCHEM, V358, P281, DOI 10.1007/s11010-011-0978-z; Fan CL, 2006, PHARMACOL REP, V58, P577; Ferno J, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-69; Ferno J, 2011, FRONT BIOSCI-LANDMRK, V16, P49, DOI 10.2741/3675; Ghislat G, 2013, CURR PROTEIN PEPT SC, V14, P97, DOI 10.2174/13892037112139990033; Goldstein JL, 2006, CELL, V124, P35, DOI 10.1016/j.cell.2005.12.022; Guenette MD, 2014, DRUG AGING, V31, P159, DOI 10.1007/s40266-014-0152-x; Ikonen E, 2008, NAT REV MOL CELL BIO, V9, P125, DOI 10.1038/nrm2336; Kang QH, 2009, BRIT J PHARMACOL, V157, P1354, DOI 10.1111/j.1476-5381.2009.00261.x; Kristiana I, 2010, PHARMACOGENOMICS J, V10, P396, DOI 10.1038/tpj.2009.62; Lloyd-Evans E, 2008, NAT MED, V14, P1247, DOI 10.1038/nm.1876; Ludwig AK, 2012, INT J BIOCHEM CELL B, V44, P11, DOI 10.1016/j.biocel.2011.10.005; Martinez-Botas J, 2001, BBA-MOL CELL BIOL L, V1532, P185, DOI 10.1016/S1388-1981(01)00125-1; Mathivanan S, 2012, NUCLEIC ACIDS RES, V40, pD1241, DOI 10.1093/nar/gkr828; Maxfield FR, 2010, CURR OPIN CELL BIOL, V22, P422, DOI 10.1016/j.ceb.2010.05.004; Miyamoto S, 2005, MOL PSYCHIATR, V10, P79, DOI 10.1038/sj.mp.4001556; Peschel D, 2007, J NUTR BIOCHEM, V18, P113, DOI 10.1016/j.jnutbio.2006.03.007; Record M, 2014, BBA-MOL CELL BIOL L, V1841, P108, DOI 10.1016/j.bbalip.2013.10.004; Record M, 2011, BIOCHEM PHARMACOL, V81, P1171, DOI 10.1016/j.bcp.2011.02.011; Reverter M, 2014, CELL REP, V7, P883, DOI 10.1016/j.celrep.2014.03.043; Rummel-Kluge C, 2010, SCHIZOPHR RES, V123, P225, DOI 10.1016/j.schres.2010.07.012; Sacchetti E, 2010, DRUG SAFETY, V33, P273, DOI 10.2165/11319120-000000000-00000; Sanchez-Wandelmer J, 2010, NEUROSCIENCE, V167, P143, DOI 10.1016/j.neuroscience.2010.01.051; Sanchez-Wandelmer J, 2009, J NEUROCHEM, V110, P631, DOI 10.1111/j.1471-4159.2009.06159.x; Savina A, 2003, J BIOL CHEM, V278, P20083, DOI 10.1074/jbc.M301642200; Shakor ABA, 2014, BBA-MOL CELL BIOL L, V1841, P1672, DOI 10.1016/j.bbalip.2014.09.006; Shin SK, 2011, MOL NUTR FOOD RES, V55, P1829, DOI 10.1002/mnfr.201100440; Singla N, 2012, NEUROTOX RES, V22, P115, DOI 10.1007/s12640-011-9307-2; Skrede S, 2013, J LIPID RES, V54, P307, DOI 10.1194/jlr.E034736; Sookram C, 2011, SYNAPSE, V65, P788, DOI 10.1002/syn.20905; Strauss K, 2010, J BIOL CHEM, V285, P26279, DOI 10.1074/jbc.M110.134775; Suarez Y, 2004, CARDIOVASC RES, V64, P346, DOI 10.1016/j.cardiores.2004.06.024; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; Trajkovic K, 2008, SCIENCE, V319, P1244, DOI 10.1126/science.1153124; Um MY, 2013, BASIC CLIN PHARMACOL, V113, P152, DOI 10.1111/bcpt.12076; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; XU QB, 1992, BIOCHEM J, V285, P105, DOI 10.1042/bj2850105; Zhao JF, 2012, MOL NUTR FOOD RES, V56, P691, DOI 10.1002/mnfr.201100735; Zingg JM, 2013, BIOFACTORS, V39, P101, DOI 10.1002/biof.1072	49	17	20	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2015	10	10							e0141829	10.1371/journal.pone.0141829	http://dx.doi.org/10.1371/journal.pone.0141829			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0EH	26517556	Green Published, gold, Green Submitted			2022-12-26	WOS:000363920800083
J	Ren, HW; Yang, BX; Molina, PA; Sands, JM; Klein, JD				Ren, Huiwen; Yang, Baoxue; Molina, Patrick A.; Sands, Jeff M.; Klein, Janet D.			NSAIDs Alter Phosphorylated Forms of AQP2 in the Inner Medullary Tip	PLOS ONE			English	Article							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; BILATERAL URETERAL OBSTRUCTION; PREVENTS DOWN-REGULATION; COLLECTING DUCT; UREA TRANSPORTERS; AQUAPORIN-2 TRAFFICKING; ANGIOTENSIN-II; RENAL-FAILURE; VASOPRESSIN; KIDNEY	Vasopressin increases urine concentration through activation of aquaporin-2 (AQP2) in the collecting duct. Nonsteroidal anti-inflammatory drugs (NSAIDs) block prostaglandin E2 synthesis, and may suppress AQP2 producing a urine concentrating defect. There are four serines in AQP2 that are phosphorylated by vasopressin. To determine if chronic use of NSAIDs changes AQP2's phosphorylation at any of these residues, the effects of a nonselective NSAID, ibuprofen, and a COX-2-selective NSAID, meloxicam, were investigated. Daily ibuprofen or meloxicam increased the urine output and decreased the urine osmolality significantly by days 7 through 14. Concomitantly, meloxicam significantly reduced total AQP2 protein abundance in inner medulla (IM) tip to 64% of control and base to 63%, respectively. Ibuprofen significantly decreased total AQP2 in IM tip to 70% of control, with no change in base. Meloxicam significantly increased the ratios of p(256)-AQP2 and p(261)-AQP2 to total AQP2 in IM tip (to 44% and 40%, respectively). Ibuprofen increased the ratio of p(256)-AQP2 to total AQP2 in IM tip but did not affect p(261)-AQP2/total AQP2 in tip or base. Both ibuprofen and meloxicam increased p(264)-AQP2 and p(269)-AQP2 ratios in both tip and base. Ibuprofen increased UT-A1 levels in IM tip, but not in base. We conclude that NSAIDs reduce AQP2 abundance, contributing to decreased urine concentrating ability. They also increase some phosphorylated forms of AQP2. These changes may partially compensate for the decrease in AQP2 abundance, thereby lessening the decrease in urine osmolality.	[Ren, Huiwen; Molina, Patrick A.; Sands, Jeff M.; Klein, Janet D.] Emory Univ, Sch Med, Div Renal, Dept Med, Atlanta, GA 30322 USA; [Sands, Jeff M.; Klein, Janet D.] Emory Univ, Dept Physiol, Atlanta, GA 30322 USA; [Ren, Huiwen; Yang, Baoxue] Peking Univ, Sch Basic Med Sci, Dept Pharmacol, Beijing 100871, Peoples R China	Emory University; Emory University; Peking University	Klein, JD (corresponding author), Emory Univ, Sch Med, Div Renal, Dept Med, Atlanta, GA 30322 USA.	janet.klein@emory.edu		Molina, Patrick/0000-0001-8855-0880	National Institutes of Health (NIH) [R01-DK89828, R01-DK89828-S1, R01-DK41707]; research plan for CSC Scholarship Program; National Natural Science Foundation of China [81330074]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK089828, R01DK041707] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); research plan for CSC Scholarship Program; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health (NIH) Grants R01-DK89828, R01-DK89828-S1, R01-DK41707 and research plan for CSC Scholarship Program and National Natural Science Foundation of China grant 81330074.	Adegboyega PA, 2004, APPL IMMUNOHISTO M M, V12, P71; Baggaley E, 2010, AM J PHYSIOL-RENAL, V298, pF1051, DOI 10.1152/ajprenal.90202.2008; Baldari CT, 2014, BLOOD, V124, P1543, DOI 10.1182/blood-2014-07-590471; Bleumink GS, 2003, DRUGS, V63, P525, DOI 10.2165/00003495-200363060-00001; Blount MA, 2007, AM J PHYSIOL-RENAL, V293, pF1308, DOI 10.1152/ajprenal.00197.2007; Borer JS, 2005, ARTHRITIS RES THER, V7, pS14, DOI 10.1186/ar1794; Cheng X, 2004, J UROLOGY, V172, P2387, DOI 10.1097/01.ju.0000143882.52960.ee; Fenton RA, 2004, P NATL ACAD SCI USA, V101, P7469, DOI 10.1073/pnas.0401704101; Fenton RA, 2008, CURR OPIN NEPHROL HY, V17, P513, DOI 10.1097/MNH.0b013e3283050969; Fushimi K, 1997, J BIOL CHEM, V272, P14800, DOI 10.1074/jbc.272.23.14800; Gambaro G, 2003, J INTERN MED, V253, P643, DOI 10.1046/j.1365-2796.2003.01146.x; Harirforoosh S, 2009, EXPERT OPIN DRUG SAF, V8, P669, DOI 10.1517/14740330903311023; Hoffert JD, 2007, AM J PHYSIOL-RENAL, V292, pF691, DOI 10.1152/ajprenal.00284.2006; Hoffert JD, 2008, J BIOL CHEM, V283, P24617, DOI 10.1074/jbc.M803074200; Jensen AM, 2010, AM J PHYSIOL-RENAL, V298, pF941, DOI 10.1152/ajprenal.00605.2009; Kamsteeg EJ, 2000, J CELL BIOL, V151, P919, DOI 10.1083/jcb.151.4.919; Kim SW, 2004, J AM SOC NEPHROL, V15, P2998, DOI 10.1097/01.ASN.0000145877.28811.82; Klein JD, 2006, AM J PHYSIOL-RENAL, V291, pF952, DOI 10.1152/ajprenal.00173.2006; KLEINKNECHT D, 1995, SEMIN NEPHROL, V15, P228; Laine L, 2003, J PAIN SYMPTOM MANAG, V25, pS32; Lauridsen TG, 2010, BMC NEPHROL, V11, DOI 10.1186/1471-2369-11-28; Lu HJ, 2008, AM J PHYSIOL-RENAL, V295, pF290, DOI 10.1152/ajprenal.00072.2008; Moeller HB, 2010, P NATL ACAD SCI USA, V107, P424, DOI 10.1073/pnas.0910683107; Moeller HB, 2009, AM J PHYSIOL-RENAL, V296, pF649, DOI 10.1152/ajprenal.90682.2008; Moeller HB, 2009, KIDNEY INT, V75, P295, DOI 10.1038/ki.2008.505; Nejsum LN, 2005, AM J PHYSIOL-RENAL, V288, pF930, DOI 10.1152/ajprenal.00291.2004; Nilsson L, 2012, AM J PHYSIOL-RENAL, V302, pF1430, DOI 10.1152/ajprenal.00682.2011; Noda Y, 2006, BBA-BIOMEMBRANES, V1758, P1117, DOI 10.1016/j.bbamem.2006.03.004; Norregaard R, 2005, AM J PHYSIOL-RENAL, V289, pF322, DOI 10.1152/ajprenal.00061.2005; Norregaard R, 2007, AM J PHYSIOL-RENAL, V292, pF1322, DOI 10.1152/ajprenal.00394.2006; Norregaard R, 2010, AM J PHYSIOL-REG I, V298, pR1017, DOI 10.1152/ajpregu.00336.2009; Pedersen RS, 2001, SCAND J CLIN LAB INV, V61, P631, DOI 10.1080/003655101753267991; Ren H, 2014, AM J PHYSIOL-RENAL, V307, pF1363, DOI 10.1152/ajprenal.00421.2014; Shibata M, 2005, ORAL ONCOL, V41, P304, DOI 10.1016/j.oraloncology.2004.09.009; Sostres C, 2010, BEST PRACT RES CL GA, V24, P121, DOI 10.1016/j.bpg.2009.11.005; STAR RA, 1988, J CLIN INVEST, V81, P1879, DOI 10.1172/JCI113534; Takata K, 2006, CELL MOL BIOL, V52, P34, DOI 10.1170/T747; Tamma G, 2011, AM J PHYSIOL-CELL PH, V300, pC636, DOI 10.1152/ajpcell.00433.2009; Ulinski T, 2004, EUR J PEDIATR, V163, P148, DOI 10.1007/s00431-003-1392-7; Valenti G, 2005, ENDOCRINOLOGY, V146, P5063, DOI 10.1210/en.2005-0868; Wang WD, 2010, AM J PHYSIOL-RENAL, V299, pF577, DOI 10.1152/ajprenal.00168.2010; WHELTON A, 1991, J CLIN PHARMACOL, V31, P588, DOI 10.1002/j.1552-4604.1991.tb03743.x; Yang BX, 2005, AM J PHYSIOL-RENAL, V288, pF881, DOI 10.1152/ajprenal.00367.2004; Zelenina M, 2000, AM J PHYSIOL-RENAL, V278, pF388, DOI 10.1152/ajprenal.2000.278.3.F388	44	8	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2015	10	10							e0141714	10.1371/journal.pone.0141714	http://dx.doi.org/10.1371/journal.pone.0141714			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0EH	26517129	Green Submitted, Green Published, gold			2022-12-26	WOS:000363920800072
J	Bubnell, J; Jamet, S; Tomoiaga, D; D'Hulst, C; Krampis, K; Feinstein, P				Bubnell, Jaclyn; Jamet, Sophie; Tomoiaga, Delia; D'Hulst, Charlotte; Krampis, Konstantinos; Feinstein, Paul			In Vitro Mutational and Bioinformatics Analysis of the M71 Odorant Receptor and Its Superfamily	PLOS ONE			English	Article							OLFACTORY RECEPTOR; MOUSE; EXPRESSION; PROTEIN; TRAFFICKING; GENOMICS; NEURONS; FAMILY	We performed an extensive mutational analysis of the canonical mouse odorant receptor (OR) M71 to determine the properties of ORs that inhibit plasma membrane trafficking in heterologous expression systems. We employed the use of the M71::GFP fusion protein to directly assess plasma membrane localization and functionality of M71 in heterologous cells in vitro or in olfactory sensory neurons (OSNs) in vivo. OSN expression of M71:: GFP show only small differences in activity compared to untagged M71. However, M71::GFP could not traffic to the plasma membrane even in the presence of proposed accessory proteins RTP1S or m beta 2AR. To ask if ORs contain an internal "kill sequence", we mutated similar to 15 of the most highly conserved OR specific amino acids not found amongst the trafficking non-OR GPCR superfamily; none of these mutants rescued trafficking. Addition of various amino terminal signal sequences or different glycosylation motifs all failed to produce trafficking. The addition of the amino and carboxy terminal domains of m beta 2AR or the mutation Y289A in the highly conserved GPCR motif NPxxY does not rescue plasma membrane trafficking. The failure of targeted mutagenesis on rescuing plasma membrane localization in heterologous cells suggests that OR trafficking deficits may not be attributable to conserved collinear motifs, but rather the overall amino acid composition of the OR family. Thus, we performed an in silico analysis comparing the OR and other amine receptor superfamilies. We find that ORs contain fewer charged residues and more hydrophobic residues distributed throughout the protein and a conserved overall amino acid composition. From our analysis, we surmise that it may be difficult to traffic ORs at high levels to the cell surface in vitro, without making significant amino acid modifications. Finally, we observed specific increases in methionine and histidine residues as well as a marked decrease in tryptophan residues, suggesting that these changes provide ORs with special characteristics needed for them to function in olfactory neurons.	[Bubnell, Jaclyn; Jamet, Sophie; Tomoiaga, Delia; D'Hulst, Charlotte; Krampis, Konstantinos; Feinstein, Paul] CUNY Hunter Coll, Dept Biol Sci, New York, NY 10021 USA; [Feinstein, Paul] CUNY, Grad Ctr, Biol Program, New York, NY 10021 USA; [Feinstein, Paul] CUNY, Grad Ctr, Behav & Cognit Neurosci Program, New York, NY 10021 USA; [Krampis, Konstantinos] CUNY, Ctr Translat & Basic Res, New York, NY 10021 USA	City University of New York (CUNY) System; Hunter College (CUNY); City University of New York (CUNY) System; City University of New York (CUNY) System; City University of New York (CUNY) System	Feinstein, P (corresponding author), CUNY Hunter Coll, Dept Biol Sci, 695 Pk Ave, New York, NY 10021 USA.	Feinstein@genectr.hunter.cuny.edu			NIH [SC1 GM088114]; National Institute on Minority Health, and Health Disparities of the National Institutes of Health [MD007599]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [SC1GM088114] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute on Minority Health, and Health Disparities of the National Institutes of Health; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH SC1 GM088114 to SJ, JB, DT, CD and PF for experiments. This publication was made possible by a Research Centers in Minority Institutions Program grant from the National Institute on Minority Health, and Health Disparities (MD007599) of the National Institutes of Health. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the NIMHD or the NIH.	Bohme I, 2009, CELL COMMUN SIGNAL, V7, DOI 10.1186/1478-811X-7-16; Bubnell J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074941; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; Cao LX, 2012, SCI REP-UK, V2, DOI 10.1038/srep00231; Dong CM, 2007, BBA-BIOMEMBRANES, V1768, P853, DOI 10.1016/j.bbamem.2006.09.008; Duan XF, 2012, P NATL ACAD SCI USA, V109, P3492, DOI 10.1073/pnas.1111297109; Feinstein P, 2004, CELL, V117, P833, DOI 10.1016/j.cell.2004.05.013; Glusman G, 2001, GENOME RES, V11, P685, DOI 10.1101/gr.171001; Hague C, 2004, P NATL ACAD SCI USA, V101, P13672, DOI 10.1073/pnas.0403854101; Illing N, 2002, MOL CELL NEUROSCI, V20, P225, DOI 10.1006/mcne.2002.1106; Ivic L, 2002, J NEUROBIOL, V50, P56, DOI 10.1002/neu.10016; Jamet S, 2015, PLOS ONE IN PRESS; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Lu M, 2003, TRAFFIC, V4, P416, DOI 10.1034/j.1600-0854.2003.00097.x; Peterlin Z, 2014, J GEN PHYSIOL, V143, P527, DOI 10.1085/jgp.201311151; Saito H, 2004, CELL, V119, P679, DOI 10.1016/j.cell.2004.11.021; Saito H, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000016; Wallrabenstein I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054950; Xie SY, 2000, MAMM GENOME, V11, P1070, DOI 10.1007/s003350010217; Yasuoka A, 2000, BIOSCI BIOTECH BIOCH, V64, P1688, DOI 10.1271/bbb.64.1688; Young JM, 2002, HUM MOL GENET, V11, P1153, DOI 10.1093/hmg/11.10.1153; Zhang JJ, 2012, MOL CELL NEUROSCI, V51, P79, DOI 10.1016/j.mcn.2012.08.006; Zhang XH, 2009, RESULTS PROBL CELL D, V47, P25, DOI 10.1007/400_2008_28; Zhang XM, 2002, NAT NEUROSCI, V5, P124, DOI 10.1038/nn800	24	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2015	10	10							e0141712	10.1371/journal.pone.0141712	http://dx.doi.org/10.1371/journal.pone.0141712			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0ED	26513476	Green Published, gold			2022-12-26	WOS:000363920300073
J	Tadi, M; Allaman, I; Lengacher, S; Grenningloh, G; Magistretti, PJ				Tadi, Monika; Allaman, Igor; Lengacher, Sylvain; Grenningloh, Gabriele; Magistretti, Pierre J.			Learning-Induced Gene Expression in the Hippocampus Reveals a Role of Neuron-Astrocyte Metabolic Coupling in Long Term Memory	PLOS ONE			English	Article							MONOCARBOXYLATE TRANSPORTER MCT2; PROTEIN-SYNTHESIS; GLUCOSE-UPTAKE; TRANSLATIONAL ACTIVATION; INHIBITORY AVOIDANCE; BRAIN; GLYCOGEN; AMYGDALA; PERSISTENCE; MECHANISM	We examined the expression of genes related to brain energy metabolism and particularly those encoding glia (astrocyte)-specific functions in the dorsal hippocampus subsequent to learning. Context-dependent avoidance behavior was tested in mice using the step-through Inhibitory Avoidance (IA) paradigm. Animals were sacrificed 3, 9, 24, or 72 hours after training or 3 hours after retention testing. The quantitative determination of mRNA levels revealed learning-induced changes in the expression of genes thought to be involved in astrocyte-neuron metabolic coupling in a time dependent manner. Twenty four hours following IA training, an enhanced gene expression was seen, particularly for genes encoding monocarboxylate transporters 1 and 4 (MCT1, MCT4), alpha2 subunit of the Na/K-ATPase and glucose transporter type 1. To assess the functional role for one of these genes in learning, we studied MCT1 deficient mice and found that they exhibit impaired memory in the inhibitory avoidance task. Together, these observations indicate that neuron-glia metabolic coupling undergoes metabolic adaptations following learning as indicated by the change in expression of key metabolic genes.	[Tadi, Monika; Allaman, Igor; Lengacher, Sylvain; Grenningloh, Gabriele; Magistretti, Pierre J.] Ecole Polytech Fed Lausanne, Brain Mind Inst, CH-1015 Lausanne, Switzerland; [Magistretti, Pierre J.] KAUST, Div Biol & Environm Sci & Engn, Thuwal, Saudi Arabia	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; King Abdullah University of Science & Technology	Magistretti, PJ (corresponding author), Ecole Polytech Fed Lausanne, Brain Mind Inst, CH-1015 Lausanne, Switzerland.	pierre.magistretti@kaust.edu.sa	Lengacher, Sylvain/C-2591-2009; Allaman, Igor/R-8092-2016	Lengacher, Sylvain/0000-0003-2190-9654; Allaman, Igor/0000-0002-7525-0536; Magistretti, Pierre Julius/0000-0002-6678-320X	FNRS [31003A-130821/1, 310030B-148169/1]; National Center of Competence in Research (NCCR) "SYNAPSY" [51AU40-125759]; Panacee and Biaggi Foundations	FNRS(Fonds de la Recherche Scientifique - FNRS); National Center of Competence in Research (NCCR) "SYNAPSY"(Swiss National Science Foundation (SNSF)); Panacee and Biaggi Foundations	This work was supported by FNRS grant 31003A-130821/1 and 310030B-148169/1, by the National Center of Competence in Research (NCCR) "SYNAPSY" (no 51AU40-125759) and by the Panacee and Biaggi Foundations. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel T, 2001, CURR OPIN NEUROBIOL, V11, P180, DOI 10.1016/S0959-4388(00)00194-X; Alberini CM, 2009, PHYSIOL REV, V89, P121, DOI 10.1152/physrev.00017.2008; Allaman I, 2000, GLIA, V30, P382, DOI 10.1002/(SICI)1098-1136(200006)30:4<382::AID-GLIA70>3.3.CO;2-S; Allaman I., 2009, ENCY NEUROSCIENCE, P811; Allaman I, 2013, FUNDAMENTAL NEUROSCI, P261, DOI 10.1016/B978-0-12-385870-2.00012-3; Barkus C, 2010, EUR J PHARMACOL, V626, P49, DOI 10.1016/j.ejphar.2009.10.014; Bekinschtein P, 2008, P NATL ACAD SCI USA, V105, P2711, DOI 10.1073/pnas.0711863105; Brown AM, 2004, NEUROCHEM INT, V45, P529, DOI 10.1016/j.neuint.2003.11.005; Chenal J, 2008, EUR J NEUROSCI, V27, P53, DOI 10.1111/j.1460-9568.2007.05981.x; Chenal J, 2007, J NEUROCHEM, V102, P389, DOI 10.1111/j.1471-4159.2007.04495.x; Cholet N, 2001, J CEREBR BLOOD F MET, V21, P404, DOI 10.1097/00004647-200104000-00009; Chuquet J, 2010, J NEUROSCI, V30, P15298, DOI 10.1523/JNEUROSCI.0762-10.2010; Cybulska-Klosowicz A, 2009, BEHAV BRAIN RES, V204, P102, DOI 10.1016/j.bbr.2009.05.024; D'Agata V, 2003, EUR J NEUROSCI, V18, P2835, DOI 10.1111/j.1460-9568.2003.03025.x; Davachi L, 2001, J NEUROPHYSIOL, V85, P2590, DOI 10.1152/jn.2001.85.6.2590; Dienel GA, 2012, J CEREBR BLOOD F MET, V32, P1107, DOI 10.1038/jcbfm.2011.175; DiNuzzo M, 2010, J CEREBR BLOOD F MET, V30, P586, DOI 10.1038/jcbfm.2009.232; Dudai Y, 2004, NEURON, V44, P93, DOI 10.1016/j.neuron.2004.09.003; Duran J, 2013, J CEREBR BLOOD F MET, V33, P550, DOI 10.1038/jcbfm.2012.200; Fanselow MS, 2010, NEURON, V65, P7, DOI 10.1016/j.neuron.2009.11.031; Gibbs ME, 2007, J NEUROSCI RES, V85, P3326, DOI 10.1002/jnr.21307; Greenberg CC, 2003, J BIOL CHEM, V278, P30835, DOI 10.1074/jbc.M303846200; Herrero-Mendez A, 2009, NAT CELL BIOL, V11, P747, DOI 10.1038/ncb1881; Hof PR., 2000, COMP CYTOARCHITECTON; Holloway CM, 2011, NEUROBIOL LEARN MEM, V95, P425, DOI 10.1016/j.nlm.2011.02.002; Holt W, 1999, J NEUROSCI, V19, P9054, DOI 10.1523/JNEUROSCI.19-20-09054.1999; Igaz LM, 2004, MOL BRAIN RES, V132, P1, DOI 10.1016/j.molbrainres.2004.08.016; Izquierdo I, 1997, NEUROBIOL LEARN MEM, V68, P285, DOI 10.1006/nlme.1997.3799; Izquierdo I, 1997, EUR J NEUROSCI, V9, P786, DOI 10.1111/j.1460-9568.1997.tb01427.x; Jakoby P, 2014, CEREB CORTEX, V24, P222, DOI 10.1093/cercor/bhs309; Jones D, 2001, J NEUROPHYSIOL, V86, P809, DOI 10.1152/jn.2001.86.2.809; Kandel ER, 2001, SCIENCE, V294, P1030, DOI 10.1126/science.1067020; Kandel ER, 2014, CELL, V157, P163, DOI 10.1016/j.cell.2014.03.001; Kapogiannis D, 2011, LANCET NEUROL, V10, P187, DOI 10.1016/S1474-4422(10)70277-5; Katche C, 2010, P NATL ACAD SCI USA, V107, P349, DOI 10.1073/pnas.0912931107; KIM JJ, 1993, BEHAV NEUROSCI, V107, P1093, DOI 10.1037/0735-7044.107.6.1093; KIM JJ, 1992, SCIENCE, V256, P675, DOI 10.1126/science.1585183; Klann E, 2008, NEUROBIOL LEARN MEM, V89, P247, DOI 10.1016/j.nlm.2007.08.009; Kovar JL, 2009, ANAL BIOCHEM, V384, P254, DOI 10.1016/j.ab.2008.09.050; Lee YJ, 2012, NATURE, V487, P443, DOI 10.1038/nature11314; Lengacher S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082505; Lingrel JB, 2007, J BIOENERG BIOMEMBR, V39, P385, DOI 10.1007/s10863-007-9107-9; Lundgaard I, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7807; Magistretti PJ, 2015, NEURON, V86, P883, DOI 10.1016/j.neuron.2015.03.035; Magistretti PJ, 2005, J NEURAL TRANSM, V112, P77, DOI 10.1007/s00702-004-0171-6; MAGISTRETTI PJ, 1981, P NATL ACAD SCI-BIOL, V78, P6535, DOI 10.1073/pnas.78.10.6535; Mangia S, 2009, J CEREBR BLOOD F MET, V29, P441, DOI 10.1038/jcbfm.2008.134; McGaugh JL, 2000, SCIENCE, V287, P248, DOI 10.1126/science.287.5451.248; Miniaci MC, 2008, NEURON, V59, P1024, DOI 10.1016/j.neuron.2008.07.036; Miyashita T, 2008, NEUROBIOL LEARN MEM, V89, P269, DOI 10.1016/j.nlm.2007.08.012; Moseley AE, 2007, J NEUROSCI, V27, P616, DOI 10.1523/JNEUROSCI.4464-06.2007; Nader K, 2000, NATURE, V406, P722, DOI 10.1038/35021052; Nehlig A, 2004, PROSTAG LEUKOTR ESS, V70, P265, DOI 10.1016/j.plefa.2003.07.006; Newman LA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028427; Patel AB, 2014, P NATL ACAD SCI USA, V111, P5385, DOI 10.1073/pnas.1403576111; PELLERIN L, 1994, P NATL ACAD SCI USA, V91, P10625, DOI 10.1073/pnas.91.22.10625; Pellerin L, 2012, J CEREBR BLOOD F MET, V32, P1152, DOI 10.1038/jcbfm.2011.149; Pierre K, 2005, J NEUROCHEM, V94, P1, DOI 10.1111/j.1471-4159.2005.03168.x; Pierre K, 2009, EUR J NEUROSCI, V29, P1951, DOI 10.1111/j.1460-9568.2009.06756.x; Riedel G, 1999, NAT NEUROSCI, V2, P898, DOI 10.1038/13202; Rodriguez-Rodriguez P, 2013, J CEREBR BLOOD F MET, V33, P1843, DOI 10.1038/jcbfm.2013.168; Sandusky LA, 2013, BEHAV BRAIN RES, V245, P83, DOI 10.1016/j.bbr.2013.02.006; Schmidt S, 2008, AM J PHYSIOL-ENDOC M, V295, pE1084, DOI 10.1152/ajpendo.90491.2008; Simpson JE, 2010, NEUROBIOL AGING, V31, P578, DOI 10.1016/j.neurobiolaging.2008.05.015; SOKOLOFF L, 1977, J NEUROCHEM, V28, P897, DOI 10.1111/j.1471-4159.1977.tb10649.x; Squire LR, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a021766; Stranahan AM, 2012, J ALZHEIMERS DIS, V30, pS5, DOI 10.3233/JAD-2011-110899; Stuart CA, 2011, BRAIN RES, V1384, P15, DOI 10.1016/j.brainres.2011.02.014; Suzuki A, 2011, CELL, V144, P810, DOI 10.1016/j.cell.2011.02.018; Sybirska E, 2000, J NEUROSCI, V20, P5827, DOI 10.1523/JNEUROSCI.20-15-05827.2000; Tang JR, 2005, MOL PAIN, V1, DOI 10.1186/1744-8069-1-6; Taubenfeld SM, 1999, NAT NEUROSCI, V2, P309, DOI 10.1038/7217; Taubenfeld SM, 2001, J NEUROSCI, V21, P84, DOI 10.1523/JNEUROSCI.21-01-00084.2001; Toledo-Rodriguez M, 2012, NEUROBIOL LEARN MEM, V98, P93, DOI 10.1016/j.nlm.2012.05.006; Vianna MRM, 2000, LEARN MEMORY, V7, P333, DOI 10.1101/lm.34600; Vilchez D, 2007, NAT NEUROSCI, V10, P1407, DOI 10.1038/nn1998; Voutsinos-Porche B, 2003, NEURON, V37, P275, DOI 10.1016/S0896-6273(02)01170-4; Wang D, 2006, HUM MOL GENET, V15, P1169, DOI 10.1093/hmg/ddl032; Yang JY, 2014, P NATL ACAD SCI USA, V111, P12228, DOI 10.1073/pnas.1322912111; Zhang XH, 2008, MOL BRAIN, V1, DOI 10.1186/1756-6606-1-9; Zhang YW, 2011, MOL BRAIN, V4, DOI 10.1186/1756-6606-4-3	81	59	59	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2015	10	10							e0141568	10.1371/journal.pone.0141568	http://dx.doi.org/10.1371/journal.pone.0141568			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0ED	26513352	gold, Green Published, Green Submitted			2022-12-26	WOS:000363920300052
J	Stern, JA; Hsue, WH; Song, KH; Ontiveros, ES; Fuentes, VL; Stepien, RL				Stern, Joshua A.; Hsue, Weihow; Song, Kun-Ho; Ontiveros, Eric S.; Fuentes, Virginia Luis; Stepien, Rebecca L.			Severity of Mitral Valve Degeneration Is Associated with Chromosome 15 Loci in Whippet Dogs	PLOS ONE			English	Article							CAVALIER-KING-CHARLES; VALVULAR DISEASE; NATURAL-HISTORY; PROLAPSE; ENDOCARDIOSIS; SPANIELS	Mitral valve degeneration (MVD) is the most common form of heart disease in dogs, frequently leading to left-sided congestive heart failure and cardiac mortality. Although breed-specific disease characteristics and overrepresentation point towards a genetic origin for MVD, a causative mutation and complete molecular pathogenesis are unknown. Whippet dogs are overrepresented in incidence of MVD, suggesting an inherited component in this breed. Expressivity of this condition is variable with some dogs showing evidence of more severe disease at earlier ages than other dogs. This phenomenon makes a traditional case versus control genetic study prone to phenotyping error. This study sought to avoid these common pitfalls by identifying genetic loci associated with severity of MVD in Whippets through a genome-wide association study (GWAS). 138 Whippet dogs were characterized for MVD by echocardiographic examination and a novel disease severity score was developed and adjusted for age in each subject. Single nucleotide polymorphism (SNP) genotype data (170k Illumina CanineHD SnpChip) was obtained for DNA isolated from blood of each study subject. Continuous variable genome wide association was performed after correction for population stratification by efficient mixed model association expedited (EMMAX) in 130 dogs. A genome wide significant association was identified on chromosome 15 (peak locus 57,770,326; P-adj = 0.049) and secondary loci of suggestive association were identified on chromosome 2 (peak locus 37,628,875; P-adj = 0.079). Positional candidate genes were identified within the primary and secondary loci including follistatin-related protein 5 precursor (FSTL5) and Rho GTPase-activating protein 26 (ARHGAP26). These results support the hypothesis that severity of MVD in whippets has a genetic basis and warrants further study by either candidate gene sequencing or next-generation techniques.	[Stern, Joshua A.; Hsue, Weihow; Song, Kun-Ho; Ontiveros, Eric S.] Univ Calif Davis, Dept Med & Epidemiol, Davis, CA 95616 USA; [Fuentes, Virginia Luis] Royal Vet Coll, Clin Sci & Serv, N Mymms AL9 7TA, Herts, England; [Stepien, Rebecca L.] Univ Wisconsin, Sch Vet Med, Dept Med Sci Cardiol, Madison, WI 53706 USA	University of California System; University of California Davis; University of London; University of London Royal Veterinary College; University of Wisconsin System; University of Wisconsin Madison	Stern, JA (corresponding author), Univ Calif Davis, Dept Med & Epidemiol, One Shields Ave, Davis, CA 95616 USA.	jstern@ucdavis.edu		Hsue, Weihow/0000-0002-2972-0760; Stern, Joshua/0000-0001-5611-5745	Center for Companion Animal Health, School of Veterinary Medicine, University of California, Davis [2014-26-F]	Center for Companion Animal Health, School of Veterinary Medicine, University of California, Davis(University of California System)	This study was supported by the Center for Companion Animal Health, School of Veterinary Medicine, University of California, Davis (Grant # 2014-26-F).	ABBOTT J. A., 2008, MANUAL CANINE FELINE, Vfourth, P110; Aupperle H, 2009, J COMP PATHOL, V140, P271, DOI 10.1016/j.jcpa.2009.01.001; Beardow A, 1991, J AM VET MED ASSOC, V203, P1023; Boon J, 2011, VET ECHOCARDIOGRAPHY, P351; Boon J.A., 2011, VET ECHOCARDIOGRAPHY, P206; Borgarelli M, 2008, J VET INTERN MED, V22, P120, DOI 10.1111/j.1939-1676.2007.0008.x; Borgarelli M, 2012, J VET CARDIOL, V14, P93, DOI 10.1016/j.jvc.2012.01.011; Borgarelli M, 2010, VET CLIN N AM-SMALL, V40, P651, DOI 10.1016/j.cvsm.2010.03.008; Buchanan J W, 1977, Adv Vet Sci Comp Med, V21, P75; Chetboul V, 2004, CAN VET J, V45, P1012; Chetboul V, 2012, J VET CARDIOL, V14, P127, DOI 10.1016/j.jvc.2011.11.005; DETWEILER D. K., 1965, ANN NY ACAD SCI, V127, P481, DOI 10.1111/j.1749-6632.1965.tb49421.x; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Freed LA, 2003, AM J HUM GENET, V72, P1551, DOI 10.1086/375452; French AT, 2012, VET J, V193, P283, DOI 10.1016/j.tvjl.2011.09.011; Kang HM, 2010, NAT GENET, V42, P348, DOI 10.1038/ng.548; KOGURE K, 1980, JPN J VET SCI, V42, P323; LEVY D, 1987, AM HEART J, V113, P1281, DOI 10.1016/0002-8703(87)90956-2; Madsen MB, 2011, J HERED, V102, P562; Parker Heidi G, 2006, J Vet Cardiol, V8, P115, DOI 10.1016/j.jvc.2006.04.002; Parker HG, 2012, J VET CARDIOL, V14, P19, DOI 10.1016/j.jvc.2012.01.006; PEDERSEN HD, 1995, CAN J VET RES, V59, P294; Pedersen HD, 1996, J VET MED A, V43, P103, DOI 10.1111/j.1439-0442.1996.tb00433.x; Philipp U, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036691; Remke M, 2011, J CLIN ONCOL, V29, P3852, DOI 10.1200/JCO.2011.36.2798; THOMAS WP, 1993, J VET INTERN MED, V7, P247, DOI 10.1111/j.1939-1676.1993.tb01015.x; THRUSFIELD MV, 1985, J SMALL ANIM PRACT, V26, P709, DOI 10.1111/j.1748-5827.1985.tb02199.x	27	12	12	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2015	10	10							e0141234	10.1371/journal.pone.0141234	http://dx.doi.org/10.1371/journal.pone.0141234			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0DL	26509595	Green Submitted, Green Published, gold			2022-12-26	WOS:000363918100063
J	Lhermie, G; El Garch, F; Toutain, PL; Ferran, AA; Bousquet-Melou, A				Lhermie, Guillaume; El Garch, Farid; Toutain, Pierre-Louis; Ferran, Aude A.; Bousquet-Melou, Alain			Bacterial Species-Specific Activity of a Fluoroquinolone against Two Closely Related Pasteurellaceae with Similar MICs: Differential In Vitro Inoculum Effects and In Vivo Efficacies	PLOS ONE			English	Article							ANTIBIOTIC-RESISTANCE; KLEBSIELLA-PNEUMONIAE; ESCHERICHIA-COLI; LUNG INFECTION; MODEL; SIZE; PHARMACODYNAMICS; EMERGENCE; SELECTION; DESIGN	We investigated the antimicrobial activity of a fluoroquinolone against two genetically close bacterial species belonging to the Pasteurellaceae family. Time-kill experiments were used to measure the in vitro activity of marbofloxacin against two strains of Mannheimia haemolytica and Pasteurella multocida with similar MICs. We observed that marbofloxacin was equally potent against 105 CFU/mL inocula M. haemolytica and P. multocida. However, an inoculum effect was observed with P. multocida, meaning that marbofloxacin activity was decreased against a 108 CFU/mL inoculum, whereas no inoculum effect was observed with M. haemolytica. Marbofloxacin activity was also tested in a lung infection model with immuno-compromised mice intratracheally infected with 109 CFU of each bacteria. At the same dose, the clinical and bacteriological outcomes were much better for mice infected with M. haemolytica than for those infected with P. multocida. Moreover, bacteriological eradication was obtained with a lower marbofloxacin dose for mice infected with M. haemolytica. Our results suggest that the differential in vivo marbofloxacin efficacy observed with the two bacterial species of similar MIC could be explained by a differential inoculum effect. Consequently, MICs determined on 105 CFU inocula were not predictive of the differences in antibiotic efficacies against high bacterial inocula of closely related bacterial strains. These results could stimulate further investigations on bacterial species-specific antibiotic doses in a clinical setting.	[Lhermie, Guillaume; El Garch, Farid] LURE, Vetoquinol, Toulouse, France; [Toutain, Pierre-Louis; Ferran, Aude A.; Bousquet-Melou, Alain] INRA, TOXALIM UMR1331, F-31931 Toulouse, France; [Toutain, Pierre-Louis; Ferran, Aude A.; Bousquet-Melou, Alain] Univ Toulouse, INPT, ENVT, EIP,UPS, Toulouse, France	INRAE; Universite de Toulouse; Ecole Nationale Veterinaire de Toulouse; Universite Toulouse III - Paul Sabatier; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National Polytechnique de Toulouse	Bousquet-Melou, A (corresponding author), INRA, TOXALIM UMR1331, F-31931 Toulouse, France.	a.bousquet-melou@envt.fr	Toutain, Pierre Louis/G-4540-2011; Ferran, Aude/J-6344-2013; BOUSQUET-MELOU, Alain/AAS-5425-2020; BOUSQUET-MELOU, Alain/O-5357-2017; Lhermie, Guillaume/F-6396-2019	Toutain, Pierre Louis/0000-0002-8846-8892; Ferran, Aude/0000-0002-6629-1088; BOUSQUET-MELOU, Alain/0000-0002-7661-4311; Lhermie, Guillaume/0000-0003-2538-1586	Vetoquinol (Lure, France)	Vetoquinol (Lure, France)	The experimental assays were supported by Vetoquinol (Lure, France). The funders (Vetoquinol) had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andes D, 2002, ANTIMICROB AGENTS CH, V46, P1665, DOI 10.1128/AAC.46.6.1665-1670.2002; Canton R, 2011, FEMS MICROBIOL REV, V35, P977, DOI 10.1111/j.1574-6976.2011.00295.x; Drusano GL, 2004, J INFECT DIS, V189, P1590, DOI 10.1086/383320; Ferran A, 2007, ANTIMICROB AGENTS CH, V51, P4163, DOI 10.1128/AAC.00156-07; Ferran AA, 2013, INT J ANTIMICROB AG, V42, P429, DOI 10.1016/j.ijantimicag.2013.07.008; Ferran AA, 2011, VET MICROBIOL, V148, P292, DOI 10.1016/j.vetmic.2010.09.005; Ferran AA, 2009, ANTIMICROB AGENTS CH, V53, P3384, DOI 10.1128/AAC.01347-08; FORREST A, 1993, ANTIMICROB AGENTS CH, V37, P1073, DOI 10.1128/AAC.37.5.1073; Gehring R, 2013, VET J, V198, P15, DOI 10.1016/j.tvjl.2013.07.034; Jumbe N, 2003, J CLIN INVEST, V112, P275, DOI 10.1172/JCI200316814; Kesteman AS, 2010, ANTIMICROB AGENTS CH, V54, P2960, DOI 10.1128/AAC.01612-09; Kesteman AS, 2009, ANTIMICROB AGENTS CH, V53, P4740, DOI 10.1128/AAC.00608-09; Mizunaga S, 2005, J ANTIMICROB CHEMOTH, V56, P91, DOI 10.1093/jac/dki163; Morrissey I, 1999, J ANTIMICROB CHEMOTH, V43, P423; Regoes RR, 2004, ANTIMICROB AGENTS CH, V48, P3670, DOI 10.1128/AAC.48.10.3670-3676.2004; Udekwu KI, 2009, J ANTIMICROB CHEMOTH, V63, P745, DOI 10.1093/jac/dkn554; Vasseur MV, 2014, ANTIMICROB AGENTS CH, V58, P1744, DOI 10.1128/AAC.02135-13	17	8	8	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2015	10	10							e0141441	10.1371/journal.pone.0141441	http://dx.doi.org/10.1371/journal.pone.0141441			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU8PC	26506096	Green Published, Green Submitted, gold			2022-12-26	WOS:000363804200069
J	Li, XL; Wu, ZN; Liu, ZY; Hou, XY; Badgery, W; Guo, HQ; Zhao, QS; Hu, NN; Duan, JJ; Ren, WB				Li, Xiliang; Wu, Zinian; Liu, Zhiying; Hou, Xiangyang; Badgery, Warwick; Guo, Huiqin; Zhao, Qingshan; Hu, Ningning; Duan, Junjie; Ren, Weibo			Contrasting Effects of Long-Term Grazing and Clipping on Plant Morphological Plasticity: Evidence from a Rhizomatous Grass	PLOS ONE			English	Article							LEYMUS-CHINENSIS; INNER-MONGOLIA; FUNCTIONAL TRAITS; LAND-USE; RESOURCE AVAILABILITY; ROOT RESPIRATION; CLIMATE-CHANGE; LEAF TRAITS; RESPONSES; BIOMASS	Understanding the mechanism of plant morphological plasticity in response to grazing and clipping of semiarid grassland can provide insight into the process of disturbance-induced decline in grassland productivity. In recent studies there has been controversy regarding two hypotheses: 1) grazing avoidance; and 2) growth limiting mechanisms of morphological plasticity in response to defoliation. However, the experimental evidence presented for the memory response to grazing and clipping of plants has been poorly reported. This paper reports on two experiments that tested these hypotheses in field and in a controlled environment, respectively. We examined the effects of long-term clipping and grazing on the functional traits and their plasticity for Leymus chinensis (Trin.) Tzvelev (the dominate species) in the typical-steppe grassland of Inner Mongolia, China. There were four main findings from these experiments. (i) The majority of phenotypic traits of L. chinensis tended to significantly miniaturize in response to long-term field clipping and grazing. (ii) The significant response of morphological plasticity with and without grazing was maintained in a hydroponic experiment designed to remove environmental variability, but there was no significant difference in L. chinensis individual size traits for the clipping comparison. (iii) Plasticity indexes of L. chinensis traits in a controlled environment were significantly lower than under field conditions indicating that plants had partial and slight memory effect to long-term grazing. (iv) The allometry of various phenotypic traits, indicated significant trade-offs between leaf and stem allocation with variations in plant size induced by defoliation, which were maintained only under grazing in the hydroponic controlled environment experiment. Taken together, our findings suggest that the morphological plasticity of L. chinensis induced by artificial clipping was different with that by livestock grazing. The miniaturization of plant size in long-term grazed grassland may reflect retained characteristics of dwarf memory for adaptation to long-term grazing by large herbivores.	[Li, Xiliang; Wu, Zinian; Liu, Zhiying; Hou, Xiangyang; Zhao, Qingshan; Hu, Ningning; Duan, Junjie; Ren, Weibo] Chinese Acad Agr Sci, Natl Forage Improvement Ctr, Key Lab Grassland Resources & Utilizat, Minist Agr,Inst Grassland Res, Hohhot 010010, Inner Mongolia, Peoples R China; [Badgery, Warwick] Orange Agr Inst, New South Wales Dept Primary Ind, Orange, NSW 2800, Australia; [Guo, Huiqin] Inner Mongolia Agr Univ, Coll Life Sci, Hohhot 010010, Inner Mongolia, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Grassland Research, CAAS; Ministry of Agriculture & Rural Affairs; NSW Department of Primary Industries; Inner Mongolia Agricultural University	Ren, WB (corresponding author), Chinese Acad Agr Sci, Natl Forage Improvement Ctr, Key Lab Grassland Resources & Utilizat, Minist Agr,Inst Grassland Res, Hohhot 010010, Inner Mongolia, Peoples R China.	rppcaucau@163.com	Badgery, Warwick/D-3922-2017	Badgery, Warwick/0000-0001-8299-8713	National Key Basic Research Development Program of China [2014CB138804]; National Natural Sciences Foundation of China [31201846]; National Project of Scientific and Technical Supporting Programs - Ministry of Science & Technology of China [2012BAD13B07]; International Science and Technology Cooperation Project of China [2013DFR30760]; Basic Research Funding Project for National Common Wealth Research Institute [1610332015002]	National Key Basic Research Development Program of China(National Basic Research Program of China); National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); National Project of Scientific and Technical Supporting Programs - Ministry of Science & Technology of China(Ministry of Science and Technology, China); International Science and Technology Cooperation Project of China; Basic Research Funding Project for National Common Wealth Research Institute	This study was financially supported by the National Key Basic Research Development Program of China (2014CB138804), the National Natural Sciences Foundation of China (31201846), the National Project of Scientific and Technical Supporting Programs Funded by Ministry of Science & Technology of China (No. 2012BAD13B07), the International Science and Technology Cooperation Project of China (2013DFR30760), and the Basic Research Funding Project for National Common Wealth Research Institute (1610332015002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Gallo B, 2011, PLANT BIOSYST, V145, P584, DOI 10.1080/11263504.2011.578836; Angassa A, 2014, LAND DEGRAD DEV, V25, P438, DOI 10.1002/ldr.2160; Badger MR, 2013, APPLYING PHOTOSYNTHE, V20; Bahn M, 2006, GLOBAL CHANGE BIOL, V12, P995, DOI 10.1111/j.1365-2486.2006.01144.x; Baoyin T, 2014, RANGELAND J, V36, P593, DOI 10.1071/RJ13088; Bardgett RD, 2002, APPL SOIL ECOL, V19, P121, DOI 10.1016/S0929-1393(01)00188-3; Benot ML, 2013, BOTANY, V91, P62, DOI 10.1139/cjb-2012-0100; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Blois JL, 2013, P NATL ACAD SCI USA, V110, P9374, DOI 10.1073/pnas.1220228110; Butterfield BJ, 2013, J ECOL, V101, P9, DOI 10.1111/1365-2745.12013; Chen SY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089495; Cingolani AM, 2005, J APPL ECOL, V42, P50, DOI 10.1111/j.1365-2664.2004.00978.x; Cruz P, 2010, RANGELAND ECOL MANAG, V63, P350, DOI 10.2111/08-016.1; Damhoureyeh SA, 2002, AM J BOT, V89, P1634, DOI 10.3732/ajb.89.10.1634; De Deyn GB, 2008, ECOL LETT, V11, P516, DOI 10.1111/j.1461-0248.2008.01164.x; Diaz S, 2001, J APPL ECOL, V38, P497, DOI 10.1046/j.1365-2664.2001.00635.x; Diaz S, 2007, GLOBAL CHANGE BIOL, V13, P313, DOI 10.1111/j.1365-2486.2006.01288.x; FAO, 2006, WORLD REF BAS SOIL R, P132, DOI DOI 10.1017/S0014479706394902; Flothe CR, 2014, EUR J PHYCOL, V49, P356, DOI 10.1080/09670262.2014.946452; Fort F, 2015, ENVIRON EXP BOT, V110, P62, DOI 10.1016/j.envexpbot.2014.09.007; Fu YB, 2005, RANGELAND ECOL MANAG, V58, P637, DOI 10.2111/05-032R2.1; Fujita N, 2015, ECOL RES, V30, P517, DOI 10.1007/s11284-015-1249-3; Gao H, 2014, J ARID LAND, V6, P97, DOI 10.1007/s40333-013-0196-5; Gao Y, 2008, ENVIRON EXP BOT, V63, P113, DOI 10.1016/j.envexpbot.2007.10.030; Garcia CAM, 2014, APPL VEG SCI, V17, P470, DOI 10.1111/avsc.12092; Guo YJ, 2012, J ARID ENVIRON, V78, P128, DOI 10.1016/j.jaridenv.2011.11.003; Guo Y, 2012, THEOR APPL GENET, V124, P851, DOI 10.1007/s00122-011-1749-7; Harrison MT, 2012, FIELD CROP RES, V136, P127, DOI 10.1016/j.fcr.2012.06.014; He NP, 2008, SOIL BIOL BIOCHEM, V40, P2952, DOI 10.1016/j.soilbio.2008.08.018; Herrero-Jauregui C, 2014, PUBLICE, P1; Hoagland D.R., 1950, CALIF AES C, V347, P1, DOI DOI 10.1016/S0140-6736(00)73482-9; Kemp DR, 2013, P NATL ACAD SCI USA, V110, P8369, DOI 10.1073/pnas.1208063110; Kleijn D, 2002, J ECOL, V90, P360, DOI 10.1046/j.1365-2745.2001.00676.x; Laliberte E, 2012, J ECOL, V100, P662, DOI 10.1111/j.1365-2745.2011.01947.x; Le Bagousse-Pinguet Y, 2014, J ECOL, V102, P466, DOI 10.1111/1365-2745.12201; Lee JM, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-8; Li SY, 2012, REG ENVIRON CHANGE, V12, P461, DOI 10.1007/s10113-011-0264-3; Li XL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124443; Li YH, 2008, RESTOR ECOL, V16, P572, DOI 10.1111/j.1526-100X.2007.00332.x; Li ZL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103633; Liu JS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029259; Lu X, 2014, IEEE EMERGING TECHNO, P1, DOI DOI 10.1109/IGBSG.2014.6835217; Ludvikova V, 2014, AGR ECOSYST ENVIRON, V197, P204, DOI 10.1016/j.agee.2014.07.017; Malo Juan E., 1996, Biodiversity Letters, V3, P54, DOI 10.2307/2999769; Matlaga D, 2004, J RANGE MANAGE, V57, P275, DOI 10.2307/4003796; Mcintire EJB, 2002, J ECOL, V90, P348, DOI 10.1046/j.1365-2745.2001.00672.x; MCKINNEY KK, 1991, OECOLOGIA, V88, P238, DOI 10.1007/BF00320817; Milchunas DG, 2013, J ARID ENVIRON, V92, P81, DOI 10.1016/j.jaridenv.2013.01.012; N'Guessan M, 2011, PLANT ECOL, V212, P1275, DOI 10.1007/s11258-011-9904-4; Niu KC, 2009, FUNCT ECOL, V23, P274, DOI 10.1111/j.1365-2435.2008.01502.x; Olmo M, 2014, PLANT SOIL, V384, P113, DOI 10.1007/s11104-014-2178-6; Osem Y, 2004, J ECOL, V92, P297, DOI 10.1111/j.0022-0477.2004.00859.x; Paz-Ferreiro J, 2012, ENVIRON RES LETT, V7, DOI 10.1088/1748-9326/7/1/014027; Perez-Harguindeguy N, 2013, AUST J BOT, V61, P167, DOI 10.1071/BT12225; Qiu L, 2013, J NANOMATER, V2013, DOI 10.1155/2013/252417; Roscher C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036760; Schrama MJJ, 2013, PLANT SOIL, V366, P401, DOI 10.1007/s11104-012-1435-9; Szpak P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033741; Thorne MA, 2009, PLANT ECOL, V200, P205, DOI 10.1007/s11258-008-9445-7; Tilman D, 1996, NATURE, V379, P718, DOI 10.1038/379718a0; Tomas MA, 2000, PLANT ECOL, V147, P227, DOI 10.1023/A:1009856732262; Tong C, 2004, J ARID ENVIRON, V59, P133, DOI 10.1016/j.jaridenv.2004.01.004; Veron SR, 2011, OECOLOGIA, V165, P501, DOI 10.1007/s00442-010-1780-4; Walker LR, 2010, J ECOL, V98, P725, DOI 10.1111/j.1365-2745.2010.01664.x; Wang L, 2010, J APPL ECOL, V47, P868, DOI 10.1111/j.1365-2664.2010.01837.x; Wang RZ, 2004, GRASS FORAGE SCI, V59, P191, DOI 10.1111/j.1365-2494.2004.00417.x; Warton DI, 2012, METHODS ECOL EVOL, V3, P257, DOI 10.1111/j.2041-210X.2011.00153.x; Wen L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058432; Wesuls D, 2012, J VEG SCI, V23, P98, DOI 10.1111/j.1654-1103.2011.01342.x; Zhao W, 2009, ECOL RES, V24, P99, DOI 10.1007/s11284-008-0486-0; Zheng SX, 2010, BIOGEOSCIENCES, V7, P1117, DOI 10.5194/bg-7-1117-2010; Zheng SX, 2011, PLANT SOIL, V340, P141, DOI 10.1007/s11104-010-0369-3; Zhou Z, 2006, FUNCT ECOL, V20, P753, DOI 10.1111/j.1365-2435.2006.01175.x	73	29	31	3	88	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2015	10	10							e0141055	10.1371/journal.pone.0141055	http://dx.doi.org/10.1371/journal.pone.0141055			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU8PC	26506228	Green Submitted, gold, Green Published			2022-12-26	WOS:000363804200026
J	Liu, JL; Chen, FF; Chang, SF; Chen, CN; Lung, J; Lo, CH; Lee, FH; Lu, YC; Hung, CH				Liu, Jing-Lan; Chen, Fen-Fen; Chang, Shun-Fu; Chen, Cheng-Nan; Lung, Jrhau; Lo, Cheng-Hsing; Lee, Fang-Hui; Lu, Ying-Chou; Hung, Chien-Hui			Expression of Beclin Family Proteins Is Associated with Tumor Progression in Oral Cancer	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; POOR-PROGNOSIS; COLORECTAL-CANCER; COUPLED RECEPTORS; AUTOPHAGY GENE; BREAST-CANCER; ADENOCARCINOMA; TUMORIGENESIS; BCL-2; HIF-1-ALPHA	Background Beclin 1 and Beclin 2 are autophagy-related proteins that show similar amino acid sequences and domain structures. Beclin 1 established the first connection between autophagy and cancer. However, the role of Beclin 2 in cancer is unclear. The aims of this study were to analyze Beclin 1 and Beclin 2 expressions in oral cancer tissues and in cell lines, and to evaluate their possible roles in cancer progression. Methods We investigated Beclin 1 and Beclin 2 expressions by immunohistochemistry in 195 cases of oral cancer. The prognostic roles of Beclin 1 and Beclin 2 were analyzed statistically. In vitro, overexpression and knockdown of Beclin proteins were performed on an oral cancer cell line, SAS. The immunofluorescence and autophagy flux assays confirmed that Beclin proteins were involved in autophagy. The impacts of Beclin 1 and Beclin 2 on autophagy and tumor growth were evaluated by conversion of LC3-I to LC3-II and by clonogenic assays, respectively. Results Oral cancer tissues exhibited aberrant expressions of Beclin 1 and Beclin 2. The cytoplasmic Beclin 1 and Beclin 2 expressions were unrelated in oral cancer tissues. In survival analyses, high cytoplasmic Beclin 1 expression was associated with low disease specific survival, and negative nuclear Beclin 1 expression was associated with high recurrent free survival. Patients with either high or low cytoplasmic Beclin 2 expression had significantly lower overall survival and disease specific survival rates than those with moderate expression. In oral cancer cells, overexpression of either Beclin 1 or Beclin 2 led to autophagy activation and increased clonogenic survival; knockdown of Beclin 2 impaired autophagy and increased clonogenic survival. Conclusions Our results indicated that distinct patterns of Beclin 1 and Beclin 2 were associated with aggressive clinical outcomes. Beclin 1 overexpression, as well as Beclin 2 overexpression and depletion, contributed to tumor growth. These findings suggest Beclin proteins are associated with tumorigenesis.	[Liu, Jing-Lan; Chen, Fen-Fen] Chang Gung Mem Hosp, Chiayi Branch, Dept Pathol, Chiayi, Taiwan; [Liu, Jing-Lan; Hung, Chien-Hui] Chang Gung Univ, Coll Med, Grad Inst Clin Med Sci, Taoyuan, Taiwan; [Chang, Shun-Fu] Chang Gung Mem Hosp, Chiayi Branch, Dept Med Res & Dev, Chiayi, Taiwan; [Chen, Cheng-Nan] Natl Chiayi Univ, Dept Biochem Sci & Technol, Chiayi 60004, Taiwan; [Lung, Jrhau] Chang Gung Mem Hosp, Chiayi Branch, Dept Med, Div Pulm & Crit Care Med, Chiayi, Taiwan; [Lo, Cheng-Hsing; Lee, Fang-Hui] St Martin De Porres Hosp, Dept Oral & Maxillofacial Surg, Chiayi, Taiwan; [Lu, Ying-Chou] St Martin De Porres Hosp, Dept Otolaryngol, Chiayi, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; National Chiayi University; Chang Gung Memorial Hospital	Hung, CH (corresponding author), Chang Gung Univ, Coll Med, Grad Inst Clin Med Sci, Taoyuan, Taiwan.	hungc01@mail.cgu.edu.tw			Ministry of Science and Technology of Taiwan [MOST 103-2320-B-182A-018-, NMRPG6D0071, MOST 104-2320-B-182A-012-, NMRPG6E0041]; Chang Gung Memorial Hospital Chiayi Branch [CMRPG6E0071]; Chang Gung Medical Research Center [CMRPD6C0013]	Ministry of Science and Technology of Taiwan(Ministry of Science and Technology, Taiwan); Chang Gung Memorial Hospital Chiayi Branch; Chang Gung Medical Research Center	This work was supported by grants from the Ministry of Science and Technology of Taiwan (MOST 103-2320-B-182A-018-, NMRPG6D0071) (MOST 104-2320-B-182A-012-, NMRPG6E0041), Chang Gung Memorial Hospital Chiayi Branch (CMRPG6E0071), and Chang Gung Medical Research Center (CMRPD6C0013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Buraschi S, 2013, P NATL ACAD SCI USA, V110, pE2582, DOI 10.1073/pnas.1305732110; Camp RL, 2004, CLIN CANCER RES, V10, P7252, DOI 10.1158/1078-0432.CCR-04-0713; Charafe-Jaufrret E, 2004, J PATHOL, V202, P265, DOI 10.1002/path.1515; Chaturvedi AK, 2013, J CLIN ONCOL, V31, P4550, DOI 10.1200/JCO.2013.50.3870; Chen YS, 2009, PATHOL ONCOL RES, V15, P487, DOI 10.1007/s12253-008-9143-8; Ding ZB, 2008, CANCER RES, V68, P9167, DOI 10.1158/0008-5472.CAN-08-1573; Dong LW, 2011, AUTOPHAGY, V7, P1222, DOI 10.4161/auto.7.10.16610; Dong M, 2013, MED ONCOL, V30, DOI 10.1007/s12032-012-0355-0; Dorsam RT, 2007, NAT REV CANCER, V7, P79, DOI 10.1038/nrc2069; Edge SB, 2010, ANN SURG ONCOL, V17, P1471, DOI 10.1245/s10434-010-0985-4; Fan W, 2011, P NATL ACAD SCI USA, V108, P7769, DOI 10.1073/pnas.1016472108; Galluzzi L, 2015, EMBO J, V34, P856, DOI 10.15252/embj.201490784; Giatromanolaki A, 2011, GYNECOL ONCOL, V123, P147, DOI 10.1016/j.ygyno.2011.06.023; Guo JY, 2013, CELL, V155, P1216, DOI 10.1016/j.cell.2013.11.019; Han J, 2013, J BIOL CHEM, V288, P20315, DOI 10.1074/jbc.M113.461350; Han Y, 2014, ASIAN PAC J CANCER P, V15, P4583, DOI 10.7314/APJCP.2014.15.11.4583; He CC, 2013, CELL, V154, P1085, DOI 10.1016/j.cell.2013.07.035; Huang JJ, 2011, HUM PATHOL, V42, P1459, DOI 10.1016/j.humpath.2010.12.014; Huang JJ, 2010, AUTOPHAGY, V6, P777, DOI 10.4161/auto.6.6.12784; Huang L, 2013, PATHOL ONCOL RES, V19, P771, DOI 10.1007/s12253-013-9642-0; Kenific CM, 2015, TRENDS CELL BIOL, V25, P37, DOI 10.1016/j.tcb.2014.09.001; Kihara A, 2001, EMBO REP, V2, P330, DOI 10.1093/embo-reports/kve061; Kim HS, 2011, PATHOL RES PRACT, V207, P247, DOI 10.1016/j.prp.2011.02.007; Kononen J, 1998, NAT MED, V4, P844, DOI 10.1038/nm0798-844; Koukourakis MI, 2010, BRIT J CANCER, V103, P1209, DOI 10.1038/sj.bjc.6605904; Liang XH, 1999, NATURE, V402, P672, DOI 10.1038/45257; Liang XH, 2001, CANCER RES, V61, P3443; LIN H, 2013, MATH PROBL ENG, V2013, P1, DOI DOI 10.1371/J0URNAL.P0NE.0060516; Liu J, 2014, BIOFUELS FROM ALGAE, P111; Liu JL, 2013, BMC VET RES, V9, DOI 10.1186/1746-6148-9-75; Liu JL, 2011, CELL, V147, P223, DOI 10.1016/j.cell.2011.08.037; Maejima Y, 2013, NAT MED, V19, P1478, DOI 10.1038/nm.3322; Nicotra G, 2010, MODERN PATHOL, V23, P937, DOI 10.1038/modpathol.2010.80; Parkhitko A, 2011, P NATL ACAD SCI USA, V108, P12455, DOI 10.1073/pnas.1104361108; Pattingre S, 2005, CELL, V122, P927, DOI 10.1016/j.cell.2005.07.002; Perez E, 2015, ONCOGENE, V34, P3369, DOI 10.1038/onc.2014.285; Qu XP, 2003, J CLIN INVEST, V112, P1809, DOI 10.1172/JCI200320039; Ram H, 2011, J MAXILLOFAC ORAL SU, V10, P132, DOI 10.1007/s12663-011-0195-z; Rosenfeldt MT, 2013, NATURE, V504, P296, DOI 10.1038/nature12865; Rothenberg SM, 2012, J CLIN INVEST, V122, P1951, DOI 10.1172/JCI59889; Sakakura K, 2015, CANCER SCI, V106, P1, DOI [10.1111/cas.12559, 10.1111/cas.12579]; Subramani S, 2013, EMBO REP, V14, P143, DOI 10.1038/embor.2012.220; Tang JY, 2013, ANTICANCER RES, V33, P5611; Valentin-Vega YA, 2012, BLOOD, V119, P1490, DOI 10.1182/blood-2011-08-373639; Wan XB, 2010, AUTOPHAGY, V6, P395, DOI 10.4161/auto.6.3.11303; Wang JR, 2013, J INEQUAL APPL, P1, DOI 10.1186/1029-242X-2013-308; Warnakulasuriya S, 2009, ORAL ONCOL, V45, P309, DOI 10.1016/j.oraloncology.2008.06.002; Wei YJ, 2013, CELL, V154, P1269, DOI 10.1016/j.cell.2013.08.015; Won KY, 2012, HUM PATHOL, V43, P62, DOI 10.1016/j.humpath.2011.04.007; Wu XY, 2013, TUMOR BIOL, V34, P713, DOI 10.1007/s13277-012-0599-5; Yao Q, 2011, TUMOR BIOL, V32, P1163, DOI 10.1007/s13277-011-0219-9; Yu M, 2013, TUMOR BIOL, V34, P1071, DOI 10.1007/s13277-013-0648-8; Yue ZY, 2003, P NATL ACAD SCI USA, V100, P15077, DOI 10.1073/pnas.2436255100	53	5	7	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2015	10	10							0141308	10.1371/journal.pone.0141308	http://dx.doi.org/10.1371/journal.pone.0141308			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU8PC	26506105	gold, Green Published, Green Submitted			2022-12-26	WOS:000363804200047
J	Matsuzaki, H; Mikami, Y; Makita, K; Takeshima, H; Horie, M; Noguchi, S; Jo, T; Narumoto, O; Kohyama, T; Takizawa, H; Nagase, T; Yamauchi, Y				Matsuzaki, Hirotaka; Mikami, Yu; Makita, Kousuke; Takeshima, Hideyuki; Horie, Masafumi; Noguchi, Satoshi; Jo, Taisuke; Narumoto, Osamu; Kohyama, Tadashi; Takizawa, Hajime; Nagase, Takahide; Yamauchi, Yasuhiro			Interleukin-17A and Toll-Like Receptor 3 Ligand Poly(I:C) Synergistically Induced Neutrophil Chemoattractant Production by Bronchial Epithelial Cells	PLOS ONE			English	Article							DOUBLE-STRANDED-RNA; COLONY-STIMULATING FACTOR; MESSENGER-RNA; AIRWAY INFLAMMATION; GENE-EXPRESSION; RIG-I; ASTHMA; SPUTUM; EXACERBATIONS; CYTOKINES	Chronic inflammatory airway diseases, such as bronchial asthma and chronic obstructive pulmonary disease, are common respiratory disorders worldwide. Exacerbations of these diseases are frequent and worsen patients' respiratory condition and overall health. However, the mechanisms of exacerbation have not been fully elucidated. Recently, it was reported that interleukin (IL)-17A might play an important role in neutrophilic inflammation, which is characteristic of such exacerbations, through increased production of neutrophil chemoattractants. Therefore, we hypothesized that IL-17A was involved in the pathogenesis of acute exacerbation, due to viral infection in chronic inflammatory airway diseases. In this study, we assessed chemokine production by bronchial epithelial cells and investigated the underlying mechanisms. Comprehensive chemokine analysis showed that, compared with poly(I:C) alone, co-stimulation of BEAS-2B cells with IL-17A and poly(I:C) strongly induced production of such neutrophil chemoattractants as CXC chemokine ligand (CXCL) 8, growth-related oncogene (GRO), and CXCL1. Co-stimulation synergistically induced CXCL8 and CXCL1 mRNA and protein production by BEAS-2B cells and normal human bronchial epithelial cells. Poly(I: C) induced chemokine expression by BEAS-2B cells mainly via Toll-like receptor 3/TIR-domain-containing adapter-inducing interferon-beta-mediated signals. The co-stimulation with IL-17A and poly(I:C) markedly activated the p38 and extracellular-signal-regulated kinase 1/2 pathway, compared with poly(I: C), although there was little change in nuclear factor-kappa B translocation into the nucleus or the transcriptional activities of nuclear factor-kappa B and activator protein 1. IL-17A promoted stabilization of CXCL8 mRNA in BEAS-2B cells treated with poly(I:C). In conclusion, IL-17A appears to be involved in the pathogenesis of chronic inflammatory airway disease exacerbation, due to viral infection by promoting release of neutrophil chemoattractants from bronchial epithelial cells.	[Matsuzaki, Hirotaka; Mikami, Yu; Makita, Kousuke; Takeshima, Hideyuki; Horie, Masafumi; Noguchi, Satoshi; Jo, Taisuke; Narumoto, Osamu; Nagase, Takahide; Yamauchi, Yasuhiro] Univ Tokyo, Grad Sch Med, Dept Resp Med, Tokyo, Japan; [Mikami, Yu] Tokyo Univ Hosp, Dept Clin Lab, Tokyo 113, Japan; [Horie, Masafumi; Jo, Taisuke] Univ Tokyo, Div Hlth Serv Promot, Tokyo, Japan; [Kohyama, Tadashi] Teikyo Univ, Sch Med, Mizonokuchi Hosp, Dept Internal Med 4, Kamakura, Kanagawa, Japan; [Takizawa, Hajime] Kyorin Univ, Sch Med, Dept Resp Med, Tokyo, Japan	University of Tokyo; University of Tokyo; University of Tokyo; Teikyo University; Kyorin University	Yamauchi, Y (corresponding author), Univ Tokyo, Grad Sch Med, Dept Resp Med, Tokyo, Japan.	YAMAUCHIY-INT@h.u-tokyo.ac.jp	Nagase, Takeshi/M-1189-2015	Nagase, Takeshi/0000-0003-4868-0773; MIKAMI, YU/0000-0003-3262-2958; Makita, Kosuke/0000-0002-8260-5761				Aaron SD, 2001, AM J RESP CRIT CARE, V163, P349, DOI 10.1164/ajrccm.163.2.2003122; Bafadhel M, 2012, RESPIRATION, V83, P36, DOI 10.1159/000330667; Braman SS, 2006, CHEST, V130, p4S, DOI 10.1378/chest.130.1_suppl.4S; Bullens DMA, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-135; Bullens DMA, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/840315; Caramori G, 2014, INT J CHRONIC OBSTR, V9, P397, DOI 10.2147/COPD.S42544; Diaz-Guzman E, 2014, CLIN CHEST MED, V35, P7, DOI 10.1016/j.ccm.2013.10.002; Doe C, 2010, CHEST, V138, P1140, DOI 10.1378/chest.09-3058; Dougherty RH, 2009, CLIN EXP ALLERGY, V39, P193, DOI 10.1111/j.1365-2222.2008.03157.x; Fujimoto K, 2005, EUR RESPIR J, V25, P640, DOI 10.1183/09031936.05.00047504; Gernez Y, 2010, EUR RESPIR J, V35, P467, DOI 10.1183/09031936.00186109; Gitlin L, 2006, P NATL ACAD SCI USA, V103, P8459, DOI 10.1073/pnas.0603082103; Guillot L, 2005, J BIOL CHEM, V280, P5571, DOI 10.1074/jbc.M410592200; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Hartupee J, 2007, J IMMUNOL, V179, P4135, DOI 10.4049/jimmunol.179.6.4135; Henness S, 2006, AM J PHYSIOL-LUNG C, V290, pL1283, DOI 10.1152/ajplung.00367.2005; Iwakura Y, 2011, IMMUNITY, V34, P149, DOI 10.1016/j.immuni.2011.02.012; Jin W, 2013, EMERG MICROBES INFEC, V2, DOI 10.1038/emi.2013.58; Jones CE, 2002, AM J RESP CELL MOL, V26, P748, DOI 10.1165/ajrcmb.26.6.4757; Kersul AL, 2011, ARCH BRONCONEUMOL, V47, P176, DOI 10.1016/j.arbres.2010.12.003; Koarai A, 2010, AM J RESP CELL MOL, V42, P651, DOI 10.1165/rcmb.2008-0345OC; Laan M, 2001, BRIT J PHARMACOL, V133, P200, DOI 10.1038/sj.bjp.0704063; Larsson K, 2007, J INTERN MED, V262, P311, DOI 10.1111/j.1365-2796.2007.01837.x; Lemanske RF, 2010, J ALLERGY CLIN IMMUN, V125, pS95, DOI 10.1016/j.jaci.2009.10.047; MacIntyre Neil, 2008, Proc Am Thorac Soc, V5, P530, DOI 10.1513/pats.200707-088ET; Maneechotesuwan K, 2007, CHEST, V132, P98, DOI 10.1378/chest.06-2982; Matsukura S, 2007, INT ARCH ALLERGY IMM, V143, P80, DOI 10.1159/000101411; McAllister F, 2005, J IMMUNOL, V175, P404, DOI 10.4049/jimmunol.175.1.404; O'Neill LAJ, 2013, NAT REV IMMUNOL, V13, P453, DOI 10.1038/nri3446; Ordonez CL, 2000, AM J RESP CRIT CARE, V161, P1185, DOI 10.1164/ajrccm.161.4.9812061; Prause O, 2003, EUR J PHARMACOL, V462, P193, DOI 10.1016/S0014-2999(03)01341-4; Qiu YS, 2003, AM J RESP CRIT CARE, V168, P968, DOI 10.1164/rccm.200208-794OC; Roos AB, 2015, AM J RESP CRIT CARE, V191, P1232, DOI 10.1164/rccm.201410-1861OC; Ruddy MJ, 2004, J LEUKOCYTE BIOL, V76, P135, DOI 10.1189/jlb.0204065; Stowell NC, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-43; Tillie-Leblond I, 2005, ALLERGY, V60, P23, DOI 10.1111/j.1398-9995.2005.00632.x; Xagorari Angeliki, 2008, Open Microbiol J, V2, P49, DOI 10.2174/1874285800802010049; Xiao W, 2005, CHEST, V128, P2316, DOI 10.1378/chest.128.4.2316; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087	40	14	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2015	10	10							e0141746	10.1371/journal.pone.0141746	http://dx.doi.org/10.1371/journal.pone.0141746			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU8PC	26505478	Green Published, gold, Green Submitted			2022-12-26	WOS:000363804200097
J	Hifumi, E; Matsumoto, S; Nakashima, H; Itonaga, S; Arakawa, M; Katayama, Y; Kato, R; Uda, T				Hifumi, Emi; Matsumoto, Shingo; Nakashima, Hiroki; Itonaga, Shogo; Arakawa, Mitsue; Katayama, Yoshiki; Kato, Ryuichi; Uda, Taizo			A novel method of preparing the monoform structure of catalytic antibody light chain	FASEB JOURNAL			English	Article						charge heterogeneity; 2D electrophoresis; pI; copper ion	MONOCLONAL-ANTIBODY; GEL-ELECTROPHORESIS; FACTOR-VIII; HETEROGENEITY; SITES; TRASTUZUMAB; HEMOPHILIA; HYDROLYSIS; CLEAVAGE; FEATURES	Along with the development of antibody drugs and catalytic antibodies, the structural diversity (heterogeneity) of antibodies has been given attention. For > 20 yr, detailed studies on the subject have not been conducted, because the phenomenon presents many difficult and complex problems. Structural diversity provides some (or many) isoforms of an antibody distinguished by different charges, different molecular sizes, and modifications of amino acid residues. For practicaluse, the antibody and the subunits must have a defined structure. In recent work, we have found that the copper (Cu) ion plays a substantial role in solving the diversity problem. In the current study, we used several catalytic antibody light chains to examine the effect of the Cu ion. In all cases, the different electrical charges of the molecule converged to a single charge, giving 1 peak in cation-exchange chromatography, as well as a single spot in 2-dimensional gel electrophoresis. The Cu-binding site was investigated by using mutagenesis, ultraviolet-visible spectroscopy, atomic force microscope analysis, and molecular modeling, which suggested that histidine and cysteine residues close to the C-terminus are involved with the binding site. The constant region domain of the antibody light chain played an important role in the heterogeneity of the light chain. Our findings may be a significant tool for preparing a single defined, not multiple, isoform structure.	[Hifumi, Emi] Oita Univ, Res Promot Inst, 700 Dan Noharu, Oita, Oita 8701192, Japan; [Matsumoto, Shingo; Nakashima, Hiroki; Itonaga, Shogo; Uda, Taizo] Oita Univ, Dept Appl Chem, Fac Engn, Oita 87011, Japan; [Hifumi, Emi; Uda, Taizo] Inst Syst Informat Technol & Nanotechnol ISIT, Nanotechnol Lab, Fukuoka, Japan; [Matsumoto, Shingo; Katayama, Yoshiki] Kyushu Univ, Grad Sch Syst Life Sci, Fukuoka 812, Japan; [Arakawa, Mitsue] Tottori Coll Nursing, Tottori, Japan; [Kato, Ryuichi] High Energy Accelerator Res Org, Tsukuba, Ibaraki, Japan	Oita University; Oita University; Kyushu University; High Energy Accelerator Research Organization (KEK)	Hifumi, E (corresponding author), Oita Univ, Res Promot Inst, 700 Dan Noharu, Oita, Oita 8701192, Japan.	e-hifumi@oita-u.ac.jp		Uda, Taizo/0000-0001-8146-7902; Kato, Ryuichi/0000-0003-2087-2896	Japan Science and Technology Agency; Ministry of Education, Culture, Sports, Science, and Technology of Japan [24350085]	Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	The authors thank Dr. H. Sugasawa (Oxford Instruments KK, Tokyo, Japan), Ms. E. Saito, Ms. S. Takemoto, and Ms. Y. Akiyoshi (Oita University) for assistance. This study was supported by the Japan Science and Technology Agency (CREST/Establishment of Innovative Manufacturing Technology Based on Nanoscience; Super Highway: accelerated research to bridge university intellectual properties and practical use), and Grant-in-Aid 24350085 for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (to E. H. and T.U.). The authors declare no conflicts of interest.	Bezuglova AM, 2011, J MOL RECOGNIT, V24, P960, DOI 10.1002/jmr.1143; Buneva VN, 1998, APPL BIOCHEM BIOTECH, V75, P63, DOI 10.1007/BF02787709; Dick LW, 2008, BIOTECHNOL BIOENG, V100, P1132, DOI 10.1002/bit.21855; Durova OM, 2009, MOL IMMUNOL, V47, P87, DOI 10.1016/j.molimm.2008.12.020; Harris RJ, 2001, J CHROMATOGR B, V752, P233, DOI 10.1016/S0378-4347(00)00548-X; Hifumi E, 2002, J IMMUNOL METHODS, V269, P283, DOI 10.1016/S0022-1759(02)00242-9; Hifumi E, 2000, BIOMETALS, V13, P289, DOI 10.1023/A:1009252200231; Hifumi E, 2008, J BIOL CHEM, V283, P899, DOI 10.1074/jbc.M705674200; Hifumi E, 2013, J BIOL CHEM, V288, P19558, DOI 10.1074/jbc.M113.454579; Hifumi E, 2012, FASEB J, V26, P1607, DOI 10.1096/fj.11-195339; Hifumi E, 2010, FEBS J, V277, P3823, DOI 10.1111/j.1742-4658.2010.07785.x; Holm RH, 1996, CHEM REV, V96, P2239, DOI 10.1021/cr9500390; Hunt G, 1996, J CHROMATOGR A, V744, P295, DOI 10.1016/0021-9673(96)00437-2; Kotia RB, 2010, ANAL BIOCHEM, V399, P190, DOI 10.1016/j.ab.2010.01.008; Kou JH, 2015, MOL NEUROBIOL, V51, P43, DOI 10.1007/s12035-014-8691-z; Lacroix-Desmazes S, 1999, NAT MED, V5, P1044, DOI 10.1038/12483; Matsuura K, 1998, BIOCHEM BIOPH RES CO, V243, P719, DOI 10.1006/bbrc.1998.8164; Nebija D, 2014, INT J MOL SCI, V15, P6399, DOI 10.3390/ijms15046399; Nebija D, 2011, J PHARMACEUT BIOMED, V56, P684, DOI 10.1016/j.jpba.2011.07.006; Nishiyama Y, 2014, J BIOTECHNOL, V180, P17, DOI 10.1016/j.jbiotec.2014.03.026; Odintsova ES, 2011, J MOL RECOGNIT, V24, P45, DOI 10.1002/jmr.1022; Ouerghi O, 2002, SENSOR ACTUAT B-CHEM, V84, P167, DOI 10.1016/S0925-4005(02)00020-5; Parkhomenko TA, 2010, BIOCHIMIE, V92, P545, DOI 10.1016/j.biochi.2010.01.022; Paul S, 2004, J BIOL CHEM, V279, P39611, DOI 10.1074/jbc.M406719200; Planque S, 2008, AUTOIMMUN REV, V7, P473, DOI 10.1016/j.autrev.2008.04.002; Ponomarenko N., ACTA CRYSTALLOGR D, V70, P708; Ponomarenko NA, 2006, BIOCHEMISTRY-US, V45, P324, DOI 10.1021/bi050675k; Ramsland PA, 2006, BIOCHEM J, V395, P473, DOI 10.1042/BJ20051739; Saveliev AN, 2003, IMMUNOL LETT, V86, P291, DOI 10.1016/S0165-2478(03)00042-7; Sharma V, 2009, J BIOL CHEM, V284, P33079, DOI 10.1074/jbc.M109.036087; Smirnov I, 2011, P NATL ACAD SCI USA, V108, P15954, DOI 10.1073/pnas.1108460108; Solomon EI, 2006, INORG CHEM, V45, P8012, DOI 10.1021/ic060450d; STEVENS FJ, 1988, P NATL ACAD SCI USA, V85, P6895, DOI 10.1073/pnas.85.18.6895; Wootla B, 2009, FEBS LETT, V583, P2565, DOI 10.1016/j.febslet.2009.07.009	34	6	9	1	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2016	30	2					895	908		10.1096/fj.15-276394	http://dx.doi.org/10.1096/fj.15-276394			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DC7IA	26527062				2022-12-26	WOS:000369391900037
J	Theurl, M; Song, DL; Clark, E; Sterling, J; Grieco, S; Altamura, S; Galy, B; Hentze, M; Muckenthaler, MU; Dunaief, JL				Theurl, Milan; Song, Delu; Clark, Esther; Sterling, Jacob; Grieco, Steve; Altamura, Sandro; Galy, Bruno; Hentze, Matthias; Muckenthaler, Martina U.; Dunaief, Joshua L.			Mice with hepcidin-resistant ferroportin accumulate iron in the retina	FASEB JOURNAL			English	Article						retinal pigment epithelium; vascular endothelium; iron transport; blood-brain barrier	MACULAR DEGENERATION; HEREDITARY HEMOCHROMATOSIS; TARGETED DISRUPTION; PIGMENT EPITHELIUM; KNOCKOUT MICE; OVERLOAD; HOMEOSTASIS; MUTATION; FEATURES; BINDING	Because ferroportin (Fpn) is theonlyknown mammalian cellular iron exporter, understanding its localization and regulation within the retina would shed light on the direction of retinal iron flux. The hormone hepcidin may regulate retinal Fpn, as it triggers Fpn degradation in the gut. Immunofluorescence was used to label Fpn in retinas of mice with 4 different genotypes (wild type; Fpn C326S, a hepcidin-resistant Fpn; hepcidin knockout; and ceruloplasmin/hephaestin double knockout). No significant difference in Fpn levels was observed in these retinas. Fpn localized to the abluminal side of the outer plexiform vascular endothelial cells, Muller glia cells, and the basolateral side of the retinal pigment epithelium. Adeno-associated virus (AAV)-hepcidin was injected into the eyes of hepcidin knockout mice, while AAV-lacZ was injected into the contralateral eyes as a control. AAV-hepcidin injected eyes had increased ferritin immunolabeling in retinal vascular endothelial cells. Fpn C326S mice had systemic iron overload compared to wild type and had the fastest retinal iron accumulation of any hereditary model studied to date. The results suggest that physiologic hepcidin levels are insufficient to alter Fpn levels within the retinal pigment epithelium and Muller cells, but may limit iron transport into the retina from vascular endothelial cells.	[Theurl, Milan; Song, Delu; Clark, Esther; Sterling, Jacob; Dunaief, Joshua L.] Univ Penn, Scheie Eye Inst, FM Kirby Ctr Mol Ophthalmol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Theurl, Milan] Med Univ Innsbruck, Dept Ophthalmol & Optometry, A-6020 Innsbruck, Austria; [Grieco, Steve] Univ Florida, Dept Psychiat & Behav Sci, Gainesville, FL USA; [Grieco, Steve] Univ Florida, Dept Biochem & Mol Biol, Gainesville, FL USA; [Altamura, Sandro; Muckenthaler, Martina U.] Heidelberg Univ, Dept Pediat Hematol Oncol & Immunol, Heidelberg, Germany; [Altamura, Sandro; Hentze, Matthias; Muckenthaler, Martina U.] Mol Med Partnership Unit, Heidelberg, Germany; [Galy, Bruno; Hentze, Matthias] European Mol Biol Lab, Heidelberg, Germany	University of Pennsylvania; Pennsylvania Medicine; Medical University of Innsbruck; State University System of Florida; University of Florida; State University System of Florida; University of Florida; Ruprecht Karls University Heidelberg; European Molecular Biology Laboratory (EMBL)	Dunaief, JL (corresponding author), Univ Penn, Perelman Sch Med, FM Kirby Ctr Mol Ophthalmol, Scheie Eye Inst,Stellar Chance Lab 305, 422 Curie Blvd, Philadelphia, PA 19104 USA.	jdunaief@upenn.edu	Hentze, Matthias W/V-3980-2017; Altamura, Sandro/R-1195-2016	Hentze, Matthias W/0000-0002-4023-7876; Altamura, Sandro/0000-0002-6781-1073; Galy, Bruno/0000-0002-0501-6357; Muckenthaler, Martina/0000-0002-3778-510X; Sterling, Jacob/0000-0001-7535-1073	U.S. National Institutes of Health, National Eye Institute Grant [NEI EY015240]; Research to Prevent Blindness; F. M. Kirby Foundation; Paul and Evanina Bell Mackall Foundation Trust; Deutsche Forschungsgemeinschaft [SFB1118]; Max Kade Foundation; NATIONAL EYE INSTITUTE [P30EY001583, R01EY015240] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Eye Institute Grant; Research to Prevent Blindness(Research to Prevent Blindness (RPB)); F. M. Kirby Foundation; Paul and Evanina Bell Mackall Foundation Trust; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Max Kade Foundation; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by U.S. National Institutes of Health, National Eye Institute Grant NEI EY015240; Research to Prevent Blindness; the F. M. Kirby Foundation, a gift in memory of L. F. Mauger; and the Paul and Evanina Bell Mackall Foundation Trust. M.U.M. acknowledges funding from the Deutsche Forschungsgemeinschaft and Grant SFB1118 (to S.A.); and M.T. acknowledges funding from the Max Kade Foundation.	Altamura S, 2014, CELL METAB, V20, P359, DOI 10.1016/j.cmet.2014.07.007; BRESSLER NM, 1988, SURV OPHTHALMOL, V32, P375, DOI 10.1016/0039-6257(88)90052-5; Donovan A, 2005, CELL METAB, V1, P191, DOI 10.1016/j.cmet.2005.01.003; Dunaief JL, 2005, OPHTHALMOLOGY, V112, P1062, DOI 10.1016/j.ophtha.2004.12.029; Dunaief JL, 2002, ARCH OPHTHALMOL-CHIC, V120, P1435, DOI 10.1001/archopht.120.11.1435; Finkenstedt A, 2010, J HEPATOL, V53, P1101, DOI 10.1016/j.jhep.2010.04.039; Galy B, 2013, CELL REP, V3, P844, DOI 10.1016/j.celrep.2013.02.026; Gnana-Prakasam JP, 2008, BIOCHEM J, V411, P79, DOI 10.1042/BJ20071377; Hadziahmetovic M, 2008, INVEST OPHTH VIS SCI, V49, P2728, DOI 10.1167/iovs.07-1472; Hadziahmetovic M, 2011, AM J PATHOL, V179, P335, DOI 10.1016/j.ajpath.2011.03.033; Hadziahmetovic M, 2011, INVEST OPHTH VIS SCI, V52, P959, DOI 10.1167/iovs.10-6207; Hadziahmetovic M, 2011, INVEST OPHTH VIS SCI, V52, P109, DOI 10.1167/iovs.10-6113; Hahn P, 2004, P NATL ACAD SCI USA, V101, P13850, DOI 10.1073/pnas.0405146101; Hahn P, 2003, ARCH OPHTHALMOL-CHIC, V121, P1099, DOI 10.1001/archopht.121.8.1099; He XN, 2007, PROG RETIN EYE RES, V26, P649, DOI 10.1016/j.preteyeres.2007.07.004; Itkonen O, 2012, CLIN CHEM, V58, P1158, DOI 10.1373/clinchem.2012.186916; Lesbordes-Brion JC, 2006, BLOOD, V108, P1402, DOI 10.1182/blood-2006-02-003376; Marro S, 2010, HAEMATOL-HEMATOL J, V95, P1261, DOI 10.3324/haematol.2009.020123; McKie AT, 2000, MOL CELL, V5, P299, DOI 10.1016/S1097-2765(00)80425-6; Nemeth E, 2004, SCIENCE, V306, P2090, DOI 10.1126/science.1104742; Peslova G, 2009, BLOOD, V113, P6225, DOI 10.1182/blood-2009-01-201590; Qiao B, 2012, CELL METAB, V15, P918, DOI 10.1016/j.cmet.2012.03.018; SARKS JP, 1988, EYE, V2, P552, DOI 10.1038/eye.1988.106; Sham RL, 2005, BLOOD CELL MOL DIS, V34, P157, DOI 10.1016/j.bcmd.2004.12.002; Sham RL, 2009, BLOOD, V114, P493, DOI 10.1182/blood-2009-04-216226; Syrbu SI, 2011, METHODS MOL BIOL, V717, P101, DOI 10.1007/978-1-61779-024-9_6; Theurl M, 2014, HAEMATOLOGICA, V99, P1516, DOI 10.3324/haematol.2013.099481; Wong RW, 2007, RETINA-J RET VIT DIS, V27, P997, DOI 10.1097/IAE.0b013e318074c290; Zhang DL, 2009, CELL METAB, V9, P461, DOI 10.1016/j.cmet.2009.03.006; Zhao LL, 2014, AM J PATHOL, V184, P2862, DOI 10.1016/j.ajpath.2014.07.008; Zoller H, 2002, BLOOD CELL MOL DIS, V29, P488, DOI 10.1006/bcmd.2002.0587; Zumerle S, 2014, BLOOD, V123, P3646, DOI 10.1182/blood-2014-01-550467	32	28	28	0	16	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2016	30	2					813	823		10.1096/fj.15-276758	http://dx.doi.org/10.1096/fj.15-276758			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DC7IA	26506980	Green Published			2022-12-26	WOS:000369391900030
J	Wang, W; Degroote, J; Van Ginneken, C; Van Poucke, M; Vergauwen, H; Dam, TMT; Vanrompay, D; Peelman, LJ; De Smet, S; Michiels, J				Wang, Wei; Degroote, Jeroen; Van Ginneken, Chris; Van Poucke, Mario; Vergauwen, Hans; Thi Minh Tho Dam; Vanrompay, Daisy; Peelman, Luc J.; De Smet, Stefaan; Michiels, Joris			Intrauterine growth restriction in neonatal piglets affects small intestinal mucosal permeability and mRNA expression of redox-sensitive genes	FASEB JOURNAL			English	Article						intestinal tight junction; IUGR; occludin; antioxidant capacity	BIRTH-WEIGHT PIGLETS; OXIDATIVE STRESS; HEME OXYGENASE; NEWBORN PIGS; GLUTATHIONE; TRANSPORT; PERFORMANCE; PLASMA; RATS; MALONDIALDEHYDE	Neonates with intrauterine growth restriction (IUGR) show lower efficiency of nutrient utilization compared to normal birth weight (NBW) newborns. This study was conducted using neonatal piglets as a model to test the hypothesis that IUGR affects the intestinal barrier function, intestinal structure, and antioxidant system development during the suckling period. The small intestinal mucosae were obtained from IUGR and NBW littermates in the suckling period (d 0, 3, 8, and 19 postnatal). The epithelial barrier function was assessed by FITC-dextran 4 (FD4) and horseradish peroxidase (HRP) fluxes across the epithelium, histomorphologic measurements, and expression of tight-junction proteins. Redox status represented by the glutathione disulfide/glutathione ratio and malondialdehyde concentrations was determined, whereas mRNA expressions of some redox-sensitive proteins were quantified. Results showed that IUGR piglets exhibited a 2-fold higher intestinal permeability in the proximal small intestine on d 0 (P < 0.05), and this difference between IUGR and NBW piglets was widened to 3 and 4 times for FD4 and HRP, respectively (P < 0.05), on d 3. In accordance, expression of occludin was down-regulated at the transcriptional level in IUGR pigletsat d 0 and 19 (P < 0.01). Furthermore, the transcription of heme oxygenase 1, catalase, and thioredoxin reductase genes was down-regulated in IUGR piglets, mainly on postnatal d 0 and 19 (P < 0.01). It appears that IUGR subjects have a lower capacity to mount an antioxidant response in the early postnatal period. Collectively, these results add to our understanding of the mechanisms responsible for intestinal dysfunction in IUGR neonates.	[Wang, Wei; De Smet, Stefaan] Univ Ghent, Fac Biosci Engn, Dept Anim Prod, Lab Anim Nutr & Anim Prod Qual, Melle, Belgium; [Wang, Wei; Degroote, Jeroen; Michiels, Joris] Univ Ghent, Fac Biosci Engn, Dept Appl Biosci, Valentin Vaerwyckweg 1, B-9000 Ghent, Belgium; [Thi Minh Tho Dam; Vanrompay, Daisy] Univ Ghent, Lab Immunol & Anim Biotechnol, Dept Anim Prod, Fac Biosci Engn, B-9000 Ghent, Belgium; [Van Ginneken, Chris; Vergauwen, Hans] Univ Antwerp, Dept Vet Sci, Lab Appl Vet Morphol, Antwerp, Belgium; [Van Poucke, Mario; Peelman, Luc J.] Univ Ghent, Fac Vet Med, Dept Nutr Genet & Ethol, Merelbeke, Belgium	Ghent University; Ghent University; Ghent University; University of Antwerp; Ghent University	Michiels, J (corresponding author), Univ Ghent, Fac Biosci Engn, Dept Appl Biosci, Valentin Vaerwyckweg 1, B-9000 Ghent, Belgium.	joris.michiels@ugent.be	DeSmet, Stefaan/N-7576-2017; Van Ginneken, Chris/AAK-2559-2020	DeSmet, Stefaan/0000-0003-1422-805X; Van Ginneken, Chris/0000-0002-1622-9120; Van Poucke, Mario/0000-0002-4316-8984	Agency for Innovation by Science and Technology [IWT-LO100856]; Ghent University Special Research Funding [BOF-01SC1034]	Agency for Innovation by Science and Technology; Ghent University Special Research Funding	The authors thank Sabine Coolsaet, Erik Claeys, Anneke Ovyn, Tessa Van Der Eecken (Laboratory of Animal Nutrition and Animal Product Quality, Ghent University), Katty Huybrechts, Gunther Vrolix, and Karen Jennes (Laboratory of Applied Veterinary Morphology, University of Antwerp) for their excellent technical support. This work was supported by the Agency for Innovation by Science and Technology (IWT-LO100856) and Ghent University Special Research Funding (BOF-01SC1034).	Aw TY, 2005, TOXICOL APPL PHARM, V204, P320, DOI 10.1016/j.taap.2004.11.016; Berruyer C, 2004, MOL CELL BIOL, V24, P7214, DOI 10.1128/MCB.24.16.7214-7224.2004; Berruyer C, 2006, J EXP MED, V203, P2817, DOI 10.1084/jem.20061640; Blanquicett C, 2010, FREE RADICAL BIO MED, V48, P1618, DOI 10.1016/j.freeradbiomed.2010.03.007; Blasig IE, 2011, ANTIOXID REDOX SIGN, V15, P1195, DOI 10.1089/ars.2010.3542; Boudry G, 2005, ANIM RES, V54, P219, DOI 10.1051/animres:2005014; Circu ML, 2012, SEMIN CELL DEV BIOL, V23, P729, DOI 10.1016/j.semcdb.2012.03.014; D'Inca R, 2010, LIVEST SCI, V133, P20, DOI 10.1016/j.livsci.2010.06.015; D'Inca R, 2011, NEONATOLOGY, V99, P208, DOI 10.1159/000314919; DARMON N, 1993, J NUTR, V123, P1068; De Vos M, 2014, LIVEST SCI, V159, P165, DOI 10.1016/j.livsci.2013.11.012; Degroote J, 2012, J ANIM SCI, V90, P359, DOI 10.2527/jas.53809; Dixit P, 2012, EUR J DRUG METAB PH, V37, P203, DOI 10.1007/s13318-012-0099-4; Drozdowski LA, 2010, WORLD J GASTROENTERO, V16, P787, DOI 10.3748/wjg.v16.i7.787; Erkens T, 2006, BMC BIOTECHNOL, V6, DOI 10.1186/1472-6750-6-41; Fanca-Berthon P, 2009, PEDIATR RES, V66, P47, DOI 10.1203/PDR.0b013e3181a2047e; Ferenc K, 2014, REPROD BIOL, V14, P51, DOI 10.1016/j.repbio.2014.01.005; Friel JK, 2004, PEDIATR RES, V56, P878, DOI 10.1203/01.PDR.0000146032.98120.43; Grotto D, 2007, J PHARMACEUT BIOMED, V43, P619, DOI 10.1016/j.jpba.2006.07.030; He QH, 2011, MOL BIOSYST, V7, P2147, DOI 10.1039/c1mb05024a; Huygelen V, 2014, J ANIM SCI, V92, P3398, DOI 10.2527/jas.2014-7742; JOLMA VM, 1980, AM J ANAT, V158, P211, DOI 10.1002/aja.1001580209; Juarez JC, 2008, P NATL ACAD SCI USA, V105, P7147, DOI 10.1073/pnas.0709451105; Maeda T, 2010, CANCER CHEMOTH PHARM, V65, P1117, DOI 10.1007/s00280-009-1119-1; Martin F, 2004, J CLIN INVEST, V113, P591, DOI 10.1172/JCI200419557; MARTIN MG, 1993, J CLIN INVEST, V91, P2844, DOI 10.1172/JCI116528; Martin MG, 1997, DIGEST DIS SCI, V42, P1062, DOI 10.1023/A:1018853506830; McKie AT, 1999, GUT, V45, P879, DOI 10.1136/gut.45.6.879; Michiels J, 2013, BRIT J NUTR, V109, P65, DOI 10.1017/S0007114512000670; Mickiewicz M, 2012, J PHYSIOL PHARMACOL, V63, P225; Nielsen F, 1997, CLIN CHEM, V43, P1209; Oates PS, 2006, WORLD J GASTROENTERO, V12, P4281, DOI 10.3748/wjg.v12.i27.4281; Otterbein LE, 2000, AM J PHYSIOL-LUNG C, V279, pL1029, DOI 10.1152/ajplung.2000.279.6.L1029; Pacha J, 2000, PHYSIOL REV, V80, P1633, DOI 10.1152/physrev.2000.80.4.1633; Quesnel H, 2012, LIVEST SCI, V146, P105, DOI 10.1016/j.livsci.2012.03.010; Rao RK, 2002, BIOCHEM J, V368, P471, DOI 10.1042/BJ20011804; REED DJ, 1980, ANAL BIOCHEM, V106, P55, DOI 10.1016/0003-2697(80)90118-9; Robles R, 2001, EARLY HUM DEV, V65, pS75, DOI 10.1016/S0378-3782(01)00209-2; SHAN XQ, 1990, PHARMACOL THERAPEUT, V47, P61, DOI 10.1016/0163-7258(90)90045-4; Sheth P, 2003, J BIOL CHEM, V278, P49239, DOI 10.1074/jbc.M305654200; Surh YJ, 2005, J NUTR, V135, p2993S, DOI 10.1093/jn/135.12.2993S; TELEMO E, 1987, BIOL NEONATE, V52, P141, DOI 10.1159/000242703; TENHUNEN R, 1968, P NATL ACAD SCI USA, V61, P748, DOI 10.1073/pnas.61.2.748; Tsang CK, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4446; Untergasser A, 2007, NUCLEIC ACIDS RES, V35, pW71, DOI 10.1093/nar/gkm306; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vergauwen H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120485; VILE GF, 1994, P NATL ACAD SCI USA, V91, P2607, DOI 10.1073/pnas.91.7.2607; Walter JK, 2009, ANN NY ACAD SCI, V1165, P19, DOI 10.1111/j.1749-6632.2009.04058.x; Wang JJ, 2008, J NUTR, V138, P60, DOI 10.1093/jn/138.1.60; Wang XQ, 2010, J PROTEOME RES, V9, P924, DOI 10.1021/pr900747d; WESTROM BR, 1984, BIOL NEONATE, V46, P20; Wu G, 2006, J ANIM SCI, V84, P2316, DOI 10.2527/jas.2006-156; Yin J, 2013, FREE RADICAL RES, V47, P1027, DOI 10.3109/10715762.2013.848277; Yuan TL, 2015, J ZHEJIANG UNIV-SC B, V16, P417, DOI 10.1631/jzus.B1500010; Zabielski R, 2008, J PHYSIOL PHARMACOL, V59, P35; Zhang B, 2011, BLOOD, V117, P4569, DOI 10.1182/blood-2010-09-304931; Zhang H, 2014, BRIT J NUTR, V112, P876, DOI 10.1017/S000711451400155X; Zhang HH, 2014, ANTIOXID REDOX SIGN, V21, P669, DOI 10.1089/ars.2013.5499; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	60	51	59	0	34	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2016	30	2					863	873		10.1096/fj.15-274779	http://dx.doi.org/10.1096/fj.15-274779			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DC7IA	26514167				2022-12-26	WOS:000369391900034
J	Zhou, Y; Chang, RX; Ji, WW; Wang, N; Qi, MY; Xu, Y; Guo, JY; Zhan, LX				Zhou, Yi; Chang, Renxu; Ji, Weiwei; Wang, Na; Qi, Meiyan; Xu, Yi; Guo, Jingyu; Zhan, Lixing			Loss of Scribble Promotes Snail Translation through Translocation of HuR and Enhances Cancer Drug Resistance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						apoptosis; cancer biology; cancer therapy; cell polarity; drug resistance; cisplatin; HuR; Scribble; Snail	MESSENGER-RNA CONTROLS; CELL POLARITY; MESENCHYMAL TRANSITION; TRANSCRIPTION FACTORS; COMPETITIVE-BINDING; PARP CLEAVAGE; EMT; PROTEIN; SLUG; ACTIVATION	Drug resistance of cancer cells to various therapeutic agents and molecular targets is a major problem facing current cancer research. The tumor suppressor gene Scribble encodes a polarity protein that is conserved between Drosophila and mammals; loss of the locus disrupts cell polarity, inhibits apoptosis, and mediates cancer process. However, the role of Scribble in drug resistance remains unknown. We show here that knockdown of Scribble enhances drug resistance by permitting accumulation of Snail, which functions as a transcription factor during the epithelial-mesenchymal transition. Then, loss of Scribble activates the mRNA-binding protein human antigen R (HuR) by facilitating translocation of HuR from the nucleus to the cytoplasm. Furthermore, we demonstrate HuR can recognize AU-rich elements of the Snail-encoding mRNA, thereby regulating Snail translation. Moreover, loss of Scribble-induced HuR translocation mediates the accumulation of Snail via activation of the p38 MAPK pathway. Thus, this work clarifies the role of polarity protein Scribble, which is directly implicated in the regulation of developmental transcription factor Snail, and suggesting a mechanism for Scribble mediating cancer drug resistance.	[Zhou, Yi; Chang, Renxu; Ji, Weiwei; Wang, Na; Qi, Meiyan; Xu, Yi; Guo, Jingyu; Zhan, Lixing] Chinese Acad Sci, Univ Chinese Acad Sci, Shanghai Inst Biol Sci,Inst Nutr Sci, Key Lab Nutr & Metab,Key Lab Food Safety Res, Shanghai 200031, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; University of Chinese Academy of Sciences, CAS	Zhan, LX (corresponding author), 320 Yue Yang Rd, Shanghai 200031, Peoples R China.	lxzhan@sibs.ac.cn	Guo, Jingyu/H-7760-2019	Zhan, Lixing/0000-0003-4949-4358; Guo, Jingyu/0000-0001-7700-6468	National Program on Key Basic Research Project of China 973 Program [2011CB510100, 2012CB945004]; Major Program of the National Natural Sciences Foundation of China [31090362]; National Natural Science Foundation of China [81071684, 81301855]; Hundred Talents Program [2010OHTP11]; Science and Technology Service Network Initiative [KFJ-EW-STS-099]	National Program on Key Basic Research Project of China 973 Program(National Basic Research Program of China); Major Program of the National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hundred Talents Program(Chinese Academy of Sciences); Science and Technology Service Network Initiative	This work was supported by National Program on Key Basic Research Project of China 973 Program Grants 2011CB510100 and 2012CB945004, Major Program of the National Natural Sciences Foundation of China Grant 31090362, National Natural Science Foundation of China Grants 81071684 and 81301855, Hundred Talents Program Grant 2010OHTP11, and Science and Technology Service Network Initiative Grant KFJ-EW-STS-099. The authors declare that they have no conflicts of interest with the contents of this article.	Arumugam T, 2009, CANCER RES, V69, P5820, DOI 10.1158/0008-5472.CAN-08-2819; Bilder D, 2000, NATURE, V403, P676, DOI 10.1038/35001108; Bilder D, 2000, SCIENCE, V289, P113, DOI 10.1126/science.289.5476.113; Boulares AH, 1999, J BIOL CHEM, V274, P22932, DOI 10.1074/jbc.274.33.22932; Chen DH, 2012, NAT MED, V18, P1511, DOI 10.1038/nm.2940; Cordenonsi M, 2011, CELL, V147, P759, DOI 10.1016/j.cell.2011.09.048; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Dong R, 2007, BIOCHEM BIOPH RES CO, V356, P318, DOI 10.1016/j.bbrc.2007.02.145; Elsum IA, 2013, J CELL SCI, V126, P3990, DOI 10.1242/jcs.129387; Fan XHC, 1998, P NATL ACAD SCI USA, V95, P15293, DOI 10.1073/pnas.95.26.15293; Gardiol D, 2006, INT J CANCER, V119, P1285, DOI 10.1002/ijc.21982; Haslehurst AM, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-91; Heinonen M, 2005, CANCER RES, V65, P2157, DOI 10.1158/0008-5472.CAN-04-3765; Hoey T, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001056; Holohan C, 2013, NAT REV CANCER, V13, P714, DOI 10.1038/nrc3599; Kurrey NK, 2009, STEM CELLS, V27, P2059, DOI 10.1002/stem.154; Latorre E, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-13; Le Chevalier T, 2004, NEW ENGL J MED, V350, P351, DOI 10.1056/nejmoa031644; Li X, 2011, EMBO REP, V12, P818, DOI 10.1038/embor.2011.106; Liao BS, 2007, NAT STRUCT MOL BIOL, V14, P511, DOI 10.1038/nsmb1249; Lim S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066558; Lowe SW, 2004, NATURE, V432, P307, DOI 10.1038/nature03098; Moreno-Bueno G, 2008, ONCOGENE, V27, P6958, DOI 10.1038/onc.2008.346; Nagasaka K, 2010, ONCOGENE, V29, P5311, DOI 10.1038/onc.2010.265; Navarro C, 2005, ONCOGENE, V24, P4330, DOI 10.1038/sj.onc.1208632; Norman M, 2012, J CELL SCI, V125, P59, DOI 10.1242/jcs.085803; Qiao M, 2010, MOL CELL, V38, P512, DOI 10.1016/j.molcel.2010.03.017; Saxena M, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.61; Sequist LV, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002003; Shih JY, 2011, CARCINOGENESIS, V32, P1299, DOI 10.1093/carcin/bgr110; Tarquini F, 2014, CELL BIOCHEM FUNCT, V32, P87, DOI 10.1002/cbf.2975; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Uramoto H, 2011, LUNG CANCER, V73, P361, DOI 10.1016/j.lungcan.2011.01.008; Wu YD, 2010, CELL ADHES MIGR, V4, P199, DOI 10.4161/cam.4.2.10943; Yamben IF, 2013, DEV BIOL, V384, P41, DOI 10.1016/j.ydbio.2013.09.027; Yanagiya A, 2012, MOL CELL, V46, P847, DOI 10.1016/j.molcel.2012.04.004; Yoon JH, 2014, NUCLEIC ACIDS RES, V42, P1196, DOI 10.1093/nar/gkt903; Yu TX, 2013, MOL BIOL CELL, V24, P85, DOI 10.1091/mbc.E12-07-0531; Zhan LX, 2008, CELL, V135, P865, DOI 10.1016/j.cell.2008.09.045; Zhang K, 2012, EMBO J, V31, P29, DOI 10.1038/emboj.2011.357	40	24	24	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 1	2016	291	1					291	302		10.1074/jbc.M115.693853	http://dx.doi.org/10.1074/jbc.M115.693853			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DA1XP	26527679	hybrid, Green Published			2022-12-26	WOS:000367589500023
J	Dey, S; North, JA; Sriram, J; Evans, BS; Tabita, FR				Dey, Swati; North, Justin A.; Sriram, Jaya; Evans, Bradley S.; Tabita, F. Robert			In Vivo Studies in Rhodospirillum rubrum Indicate That Ribulose-1,5-bisphosphate Carboxylase/Oxygenase (Rubisco) Catalyzes Two Obligatorily Required and Physiologically Significant Reactions for Distinct Carbon and Sulfur Metabolic Pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MECHANISTIC DIVERSITY; PHOTOSYNTHETIC RUBISCO; CHLOROBIUM-TEPIDUM; PROTEIN; SUPERFAMILY; FIXATION; STRAIN; EXPRESSION; BACTERIA; BACILLUS	All organisms possess fundamental metabolic pathways to ensure that needed carbon and sulfur compounds are provided to the cell in the proper chemical form and oxidation state. For most organisms capable of using CO2 as sole source of carbon, ribulose-1,5-bisphosphate (RuBP) carboxylase/oxygenase (Rubisco) catalyzes primary carbon dioxide assimilation. In addition, sulfur salvage pathways are necessary to ensure that key sulfur-containing compounds are both available and, where necessary, detoxified in the cell. Using knock-out mutations and metabolomics in the bacterium Rhodospirillum rubrum, we show here that Rubisco concurrently catalyzes key and essential reactions for seemingly unrelated but physiologically essential central carbon and sulfur salvage metabolic pathways of the cell. In this study, complementation and mutagenesis studies indicated that representatives of all known extant functional Rubisco forms found in nature are capable of simultaneously catalyzing reactions required for both CO2-dependent growth as well as growth using 5-methylthioadenosine as sole sulfur source under anaerobic photosynthetic conditions. Moreover, specific inactivation of the CO2 fixation reaction did not affect the ability of Rubisco to support anaerobic 5-methylthioadenosine metabolism, suggesting that the active site of Rubisco has evolved to ensure that this enzyme maintains both key functions. Thus, despite the coevolution of both functions, the active site of this protein may be differentially modified to affect only one of its key functions.	[Dey, Swati; North, Justin A.; Sriram, Jaya; Tabita, F. Robert] Ohio State Univ, Dept Microbiol, Columbus, OH 43210 USA; [Evans, Bradley S.] Donald Danforth Plant Sci Ctr, St Louis, MO 63132 USA	University System of Ohio; Ohio State University; Donald Danforth Plant Science Center	Tabita, FR (corresponding author), Ohio State Univ, Dept Microbiol, 484 W 12th Ave, Columbus, OH 43210 USA.	tabita.1@osu.edu	Evans, Bradley S/M-2842-2013	Evans, Bradley S/0000-0002-1207-9006	National Science Foundation [DBI-0922879]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM109547, R01GM095742] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Dr. Kevin Sowers of the University of Maryland, Center of Marine Biotechnology for providing M. burtonii genomic DNA and Dr. Brian Witte for constructing plasmid pRPS-MBR We thank Dr. Sriram Satagopan and Dr Vanessa Varaljay for many useful conversations, This work was also supported by the National Science Foundation under Grant DBI-0922879 for acquisition of the LTQ-Velos Pro Orbitrap LC-MS/MS (to B. S. E.).	Alonso H, 2009, J BIOL CHEM, V284, P33876, DOI 10.1074/jbc.M109.050989; Ashida H, 2003, SCIENCE, V302, P286, DOI 10.1126/science.1086997; Carre-Mlouka A, 2006, J BIOL CHEM, V281, P24462, DOI 10.1074/jbc.M602973200; Chan CM, 2014, ENVIRON MICROBIOL, V16, P101, DOI 10.1111/1462-2920.12210; Cipollone R, 2007, IUBMB LIFE, V59, P51, DOI 10.1080/15216540701206859; Cleland WW, 1998, CHEM REV, V98, P549, DOI 10.1021/cr970010r; Erb TJ, 2012, NAT CHEM BIOL, V8, P926, DOI [10.1038/NCHEMBIO.1087, 10.1038/nchembio.1087]; FALCONE DL, 1993, J BACTERIOL, V175, P5066, DOI 10.1128/JB.175.16.5066-5077.1993; GIBSON JL, 1986, GENE, V44, P271, DOI 10.1016/0378-1119(86)90191-5; Hanson TE, 2003, PHOTOSYNTH RES, V78, P231, DOI 10.1023/B:PRES.0000006829.41444.3d; Hanson TE, 2001, P NATL ACAD SCI USA, V98, P4397, DOI 10.1073/pnas.081610398; Hauser T, 2015, NAT PLANTS, V1, P1, DOI [10.1038/NPLANTS.2015.65, 10.1038/nplants.2015.65]; Imker HJ, 2008, BIOCHEMISTRY-US, V47, P11171, DOI 10.1021/bi801685f; Imker HJ, 2007, BIOCHEMISTRY-US, V46, P4077, DOI 10.1021/bi7000483; Joshi HM, 1996, P NATL ACAD SCI USA, V93, P14515, DOI 10.1073/pnas.93.25.14515; Kim K, 2004, FEBS LETT, V571, P124, DOI 10.1016/j.febslet.2004.06.064; Li HY, 2005, STRUCTURE, V13, P779, DOI 10.1016/j.str.2005.02.017; McKinlay JB, 2010, P NATL ACAD SCI USA, V107, P11669, DOI 10.1073/pnas.1006175107; Munk AC, 2011, STAND GENOMIC SCI, V4, P293, DOI 10.4056/sigs.1804360; ORMEROD JG, 1961, ARCH BIOCHEM BIOPHYS, V94, P449, DOI 10.1016/0003-9861(61)90073-X; Peleg M, 2011, CRIT REV FOOD SCI, V51, P917, DOI 10.1080/10408398.2011.570463; Rebeille F, 2006, P NATL ACAD SCI USA, V103, P15687, DOI 10.1073/pnas.0606195103; Satagopan S, 2014, J BIOL CHEM, V289, P21433, DOI 10.1074/jbc.M114.578625; Satagopan S, 2009, BIOCHEMISTRY-US, V48, P9076, DOI 10.1021/bi9006385; SCHLENK F, 1964, ARCH BIOCHEM BIOPHYS, V106, P95, DOI 10.1016/0003-9861(64)90161-4; Singh J, 2010, J BACTERIOL, V192, P1324, DOI 10.1128/JB.01442-09; Smith SA, 2004, J BIOL CHEM, V279, P25632, DOI 10.1074/jbc.M401360200; Smith SA, 2003, J MOL BIOL, V331, P557, DOI 10.1016/S0022-2836(03)00786-1; Spreitzer RJ, 2002, ANNU REV PLANT BIOL, V53, P449, DOI 10.1146/annurev.arplant.53.100301.135233; Tabita FR, 2008, PHILOS T R SOC B, V363, P2629, DOI 10.1098/rstb.2008.0023; Tabita FR, 2007, MICROBIOL MOL BIOL R, V71, P576, DOI 10.1128/MMBR.00015-07; Tabita FR, 1999, PHOTOSYNTH RES, V60, P1, DOI 10.1023/A:1006211417981; Wang D, 2011, J BACTERIOL, V193, P3293, DOI 10.1128/JB.00265-11; Wang D, 2010, INT J HYDROGEN ENERG, V35, P7377, DOI 10.1016/j.ijhydene.2010.04.183; Warlick BPE, 2012, BIOCHEMISTRY-US, V51, P9470, DOI 10.1021/bi301311t; Witte B. H., 2012, THESIS	36	19	19	0	32	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 25	2015	290	52					30658	30668		10.1074/jbc.M115.691295	http://dx.doi.org/10.1074/jbc.M115.691295			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CZ6GK	26511314	Green Published, hybrid			2022-12-26	WOS:000367199000001
J	Nishino, K; Obara, K; Kihara, A				Nishino, Kanako; Obara, Keisuke; Kihara, Akio			The C-terminal Cytosolic Region of Rim21 Senses Alterations in Plasma Membrane Lipid Composition INSIGHTS INTO SENSING MECHANISMS FOR PLASMA MEMBRANE LIPID ASYMMETRY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P-TYPE ATPASE; SACCHAROMYCES-CEREVISIAE; PHOSPHOLIPID TRANSLOCATION; AMBIENT PH; RIM101 PATHWAY; YEAST; PROTEIN; GENE; EXPRESSION; EXPOSURE	Yeast responds to alterations in plasma membrane lipid asymmetry and external alkalization via the sensor protein Rim21 in the Rim101 pathway. However, the sensing mechanism used by Rim21 remains unclear. Here, we found that the C-terminal cytosolic domain of Rim21 (Rim21C) fused with GFP was associated with the plasma membrane under normal conditions but dissociated upon alterations in lipid asymmetry or external alkalization. This indicates that Rim21C contains a sensor motif. Rim21C contains multiple clusters of charged residues. Among them, three consecutive Glu residues (EEE motif) were essential for Rim21 function and dissociation of Rim21C from the plasma membrane in response to changes in lipid asymmetry. In contrast, positively charged residues adjacent to the EEE motif were required for Rim21C to associate with the membrane. We therefore propose an "antenna hypothesis," in which Rim21C moves to or from the plasma membrane and functions as the sensing mechanism of Rim21.	[Nishino, Kanako; Obara, Keisuke; Kihara, Akio] Hokkaido Univ, Fac Pharmaceut Sci, Sapporo, Hokkaido 0600812, Japan	Hokkaido University	Kihara, A (corresponding author), Hokkaido Univ, Fac Pharmaceut Sci, Kita Ku, Kita 12 Jo Nishi 6 Chome, Sapporo, Hokkaido 0600812, Japan.	kihara@pharm.hokudai.ac.jp	Obara, Keisuke/A-3824-2012; KIHARA, AKIO/A-3802-2012	KIHARA, AKIO/0000-0001-5889-0788	Japan Society for the Promotion of Science [25440038, 23770135, 25650059]; Dr. Yoshifumi Jigami Memorial Fund from the Society of Yeast Scientists; Sumitomo Foundation; Institute for Fermentation (Osaka, Japan)	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Dr. Yoshifumi Jigami Memorial Fund from the Society of Yeast Scientists; Sumitomo Foundation; Institute for Fermentation (Osaka, Japan)(Institute for Fermentation (IFO))	This work was supported by Grant-in-Aid for Scientific Research C 25440038 and Grant-in-Aid for Young Scientists B 23770135 (to K.O.) and Grant-in-Aid for Challenging Exploratory Research 25650059 (to A. K.) from the Japan Society for the Promotion of Science. This work was also supported by Dr. Yoshifumi Jigami Memorial Fund from the Society of Yeast Scientists, by a Grant for Basic Science Research Projects from the Sumitomo Foundation, and by a grant from the Institute for Fermentation (Osaka, Japan; to K. O.). The authors declare that they have no conflicts of interest with the contents of this article.	Albuquerque CP, 2008, MOL CELL PROTEOMICS, V7, P1389, DOI 10.1074/mcp.M700468-MCP200; Allikmets R, 1997, NAT GENET, V15, P236, DOI 10.1038/ng0397-236; Axelsen KB, 1998, J MOL EVOL, V46, P84, DOI 10.1007/PL00006286; Bodenmiller B, 2008, NAT BIOTECHNOL, V26, P1339, DOI 10.1038/nbt1208-1339; Bull LN, 1998, NAT GENET, V18, P219, DOI 10.1038/ng0398-219; Chen CY, 1999, J CELL BIOL, V147, P1223, DOI 10.1083/jcb.147.6.1223; DEVAUX PF, 1991, BIOCHEMISTRY-US, V30, P1163, DOI 10.1021/bi00219a001; Emoto K, 2000, J CELL BIOL, V149, P1215, DOI 10.1083/jcb.149.6.1215; FADOK VA, 1992, J IMMUNOL, V148, P2207; Furuta N, 2007, MOL BIOL CELL, V18, P295, DOI 10.1091/mbc.E06-05-0461; Galindo A, 2012, J CELL SCI, V125, P1784, DOI 10.1242/jcs.098897; Gomez-Raja J, 2012, EUKARYOT CELL, V11, P683, DOI 10.1128/EC.05211-11; Gurtovenko AA, 2008, J PHYS CHEM B, V112, P4629, DOI 10.1021/jp8001993; Herrador A, 2015, MOL BIOL CELL, V26, P2128, DOI 10.1091/mbc.E14-11-1552; Hua ZL, 2002, MOL BIOL CELL, V13, P3162, DOI 10.1091/mbc.E02-03-0172; Ikeda M, 2008, MOL BIOL CELL, V19, P1922, DOI 10.1091/mbc.E07-08-0806; Ikeda M, 2006, BIOL PHARM BULL, V29, P1542, DOI 10.1248/bpb.29.1542; Iwamoto K, 2004, GENES CELLS, V9, P891, DOI 10.1111/j.1365-2443.2004.00782.x; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; Kato U, 2002, J BIOL CHEM, V277, P37855, DOI 10.1074/jbc.M205564200; Kihara A, 2004, MOL BIOL CELL, V15, P4949, DOI 10.1091/mbc.E04-06-0458; Kihara A, 2002, J BIOL CHEM, V277, P30048, DOI 10.1074/jbc.M203385200; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; MUMBERG D, 1995, GENE, V156, P119, DOI 10.1016/0378-1119(95)00037-7; Nishimura K, 2009, NAT METHODS, V6, P917, DOI 10.1038/nmeth.1401; Obara K, 2014, MOL CELL BIOL, V34, P3525, DOI 10.1128/MCB.00408-14; Obara K, 2013, J LIPID RES, V54, P831, DOI 10.1194/jlr.M034678; Obara K, 2012, J BIOL CHEM, V287, P38473, DOI 10.1074/jbc.M112.394205; Penalva MA, 2004, ANNU REV MICROBIOL, V58, P425, DOI 10.1146/annurev.micro.58.030603.123715; Pomorski T, 2003, MOL BIOL CELL, V14, P1240, DOI 10.1091/mbc.E02-08-0501; ROBINSON JS, 1988, MOL CELL BIOL, V8, P4936, DOI 10.1128/MCB.8.11.4936; Saito K, 2004, MOL BIOL CELL, V15, P3418, DOI 10.1091/mbc.E03-11-0829; Saito K, 2007, DEV CELL, V13, P743, DOI 10.1016/j.devcel.2007.09.014; SEIGNEURET M, 1984, P NATL ACAD SCI-BIOL, V81, P3751, DOI 10.1073/pnas.81.12.3751; SIKORSKI RS, 1989, GENETICS, V122, P19; Stevens HC, 2007, J BIOL CHEM, V282, P17563, DOI 10.1074/jbc.M700454200; Suzuki J, 2010, NATURE, V468, P834, DOI 10.1038/nature09583; Toti F, 1996, BLOOD, V87, P1409, DOI 10.1182/blood.V87.4.1409.bloodjournal8741409; Verkleij AJ, 2000, J MEMBRANE BIOL, V178, P1, DOI 10.1007/s002320010009; Xu WJ, 2001, J BACTERIOL, V183, P6917, DOI 10.1128/JB.183.23.6917-6923.2001; Xu WJ, 2004, MOL BIOL CELL, V15, P5528, DOI 10.1091/mbc.E04-08-0666; Yamauchi S, 2015, J CELL SCI, V128, P61, DOI 10.1242/jcs.153890	42	19	19	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 25	2015	290	52					30797	30805		10.1074/jbc.M115.674382	http://dx.doi.org/10.1074/jbc.M115.674382			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CZ6GK	26527678	hybrid, Green Submitted, Green Published			2022-12-26	WOS:000367199000013
J	Jalin, AMAA; Rajasekaran, M; Prather, PL; Kwon, JS; Gajulapati, V; Choi, Y; Kim, C; Pahk, K; Ju, C; Kim, WK				Jalin, Angela M. A. Anthony; Rajasekaran, Maheswari; Prather, Paul L.; Kwon, Jin Sun; Gajulapati, Veeraswamy; Choi, Yongseok; Kim, Chunsook; Pahk, Kisoo; Ju, Chung; Kim, Won-Ki			Non-Selective Cannabinoid Receptor Antagonists, Hinokiresinols Reduce Infiltration of Microglia/Macrophages into Ischemic Brain Lesions in Rat via Modulating 2-Arachidonolyglycerol-Induced Migration and Mitochondrial Activity	PLOS ONE			English	Article							FOCAL CEREBRAL-ISCHEMIA; ENERGY-METABOLISM; OXIDATIVE STRESS; CELL-MIGRATION; INJURY; AGONIST; ENDOCANNABINOIDS; NEUROPROTECTION; ANTIOXIDANT; CHEMOTAXIS	Growing evidence suggests that therapeutic strategies to modulate the post-ischemic inflammatory responses are promising approaches to improve stroke outcome. Although the endocannabinoid system has been emerged as an endogenous therapeutic target to regulate inflammation after stroke insult, the downstream mechanisms and their potentials for therapeutic intervention remain controversial. Here we identified trans-and cis-hinokiresinols as novel non-selective antagonists for two G-protein-coupled cannabinoid receptors, cannabinoid receptor type 1 and type 2. The Electric Cell-substrate Impedance Sensing and Boyden chamber migration assays using primary microglial cultures revealed that both hinokiresinols significantly inhibited an endocannabinoid, 2-arachidonoylglycerol-induced migration. Hinokiresinols modulated 2-arachidonoylglycerol-induced mitochondrial bioenergetics in microglia as evidenced by inhibition of ATP turnover and reduction in respiratory capacity, thereby resulting in impaired migration activity. In rats subjected to transient middle cerebral artery occlusion (1.5-h) followed by 24-h reperfusion, post-ischemic treatment with hinokiresinols (2 and 7-h after the onset of ischemia, 10 mg/kg) significantly reduced cerebral infarct and infiltration of ED1-positive microglial/macrophage cells into cerebral ischemic lesions in vivo. Co-administration of exogenous 2-AG (1 mg/kg, i.v., single dose at 2 h after starting MCAO) abolished the protective effect of trans-hinokiresionol. These results suggest that hinokiresinols may serve as stroke treatment by targeting the endocannabinoid system. Alteration of mitochondrial bioenergetics and consequent inhibition of inflammatory cells migration may be a novel mechanism underlying anti-ischemic effects conferred by cannabinoid receptor antagonists.	[Jalin, Angela M. A. Anthony; Pahk, Kisoo; Ju, Chung; Kim, Won-Ki] Korea Univ, Coll Med, Dept Neurosci, Seoul 136705, South Korea; [Rajasekaran, Maheswari; Prather, Paul L.] Univ Arkansas Med Sci, Dept Pharmacol & Toxicol, Little Rock, AR 72205 USA; [Kwon, Jin Sun; Gajulapati, Veeraswamy; Choi, Yongseok] Korea Univ, Sch Life Sci & Biotechnol, Dept Biotechnol, Seoul, South Korea; [Kim, Chunsook] Kyungdong Univ, Dept Nursing, Wonju, Kangwon Do, South Korea	Korea University; Korea University Medicine (KU Medicine); University of Arkansas System; University of Arkansas Medical Sciences; Korea University; Kyungdong University	Ju, C (corresponding author), Korea Univ, Coll Med, Dept Neurosci, Seoul 136705, South Korea.	cj2013@korea.ac.kr; wonki@korea.ac.kr	Choi, Yongseok/F-8375-2012; Pahk, Kisoo/AAD-5965-2020	Choi, Yongseok/0000-0002-3622-3439; Anthony Jalin, Angela Melinda/0000-0002-2831-7996; Pahk, Kisoo/0000-0003-2971-4202	National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning, Korea [2015R1A2A2A01004202, 2014R1A1A1037088]	National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning, Korea	This study was supported by grants from Basic Science Research Program (#NRF-2015R1A2A2A01004202 to W-KK) and Basic Science Research Program (#NRF-2014R1A1A1037088 to CJ) through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT & Future Planning, Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso de Lecinana Maria, 2006, Cerebrovasc Dis, V21 Suppl 2, P48; Benard G, 2012, NAT NEUROSCI, V15, P558, DOI 10.1038/nn.3053; Brents LK, 2012, XENOBIOTICA, V42, P139, DOI 10.3109/00498254.2011.609570; Calandra B, 1999, EUR J PHARMACOL, V374, P445, DOI 10.1016/S0014-2999(99)00349-0; Campello S, 2006, J EXP MED, V203, P2879, DOI 10.1084/jem.20061877; Capettini LSA, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/824093; Chiurchiu V, 2015, J NEUROIMMUNE PHARM, V10, P268, DOI 10.1007/s11481-015-9584-2; Chiurchiu V, 2015, IMMUNOLOGY, V144, P352, DOI 10.1111/imm.12441; Choi IY, 2013, AM J PATHOL, V182, P928, DOI 10.1016/j.ajpath.2012.11.024; Choi IY, 2011, AM J PATHOL, V179, P2042, DOI 10.1016/j.ajpath.2011.07.006; Fisar Z, 2014, TOXICOL LETT, V231, P62, DOI 10.1016/j.toxlet.2014.09.002; Gertsch J, 2010, BRIT J PHARMACOL, V160, P523, DOI 10.1111/j.1476-5381.2010.00745.x; Hadjout N, 2007, J IMMUNOL METHODS, V320, P70, DOI 10.1016/j.jim.2006.12.005; Hillard CJ, 2008, CURR PHARM DESIGN, V14, P2347, DOI 10.2174/138161208785740054; Ju C, 2013, NEUROPHARMACOLOGY, V67, P465, DOI 10.1016/j.neuropharm.2012.12.006; Lassen PR, 2005, J NAT PROD, V68, P1603, DOI 10.1021/np0502995; Liang HW, 2008, NEUROSCI LETT, V438, P116, DOI 10.1016/j.neulet.2008.04.058; Ma YL, 2010, AM J PHYSIOL-REG I, V299, pR871, DOI 10.1152/ajpregu.00031.2010; Mounsey RB, 2015, EXP NEUROL, V273, P36, DOI 10.1016/j.expneurol.2015.07.024; Murikinati S, 2010, FASEB J, V24, P788, DOI 10.1096/fj.09-141275; Pacher P, 2008, BRIT J PHARMACOL, V153, P252, DOI 10.1038/sj.bjp.0707582; Panikashvili D, 2001, NATURE, V413, P527, DOI 10.1038/35097089; Schmidt W, 2012, NEUROSCIENCE, V227, P313, DOI 10.1016/j.neuroscience.2012.09.080; Shoemaker JL, 2005, J PHARMACOL EXP THER, V314, P868, DOI 10.1124/jpet.105.085282; Stella N, 2009, NEUROPHARMACOLOGY, V56, P244, DOI 10.1016/j.neuropharm.2008.07.037; Tedesco L, 2010, DIABETES, V59, P2826, DOI 10.2337/db09-1881; Walter L, 2003, J NEUROSCI, V23, P1398, DOI 10.1523/JNEUROSCI.23-04-01398.2003; Zhang J, 2012, NAT PROTOC, V7, P1068, DOI 10.1038/nprot.2012.048; Zhang M, 2007, J CEREBR BLOOD F MET, V27, P1387, DOI 10.1038/sj.jcbfm.9600447; Zhang YH, 2007, EXP NEUROL, V204, P819, DOI 10.1016/j.expneurol.2007.01.015	30	10	10	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2015	10	10							e0141600	10.1371/journal.pone.0141600	http://dx.doi.org/10.1371/journal.pone.0141600			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0EH	26517721	gold, Green Published, Green Submitted			2022-12-26	WOS:000363920800060
J	Lima, SIVC; Diniz, RS; Egito, EST; Azevedo, PRM; Oliveira, AG; Araujo, IB				Lima, Sara I. V. C.; Diniz, Rodrigo S.; Egito, Eryvaldo S. T.; Azevedo, Paulo R. M.; Oliveira, Antonio G.; Araujo, Ivonete B.			Rationality of Antimicrobial Prescriptions in Community Pharmacy Users	PLOS ONE			English	Article							ANTIBIOTICS; COMPLETENESS; HANDWRITTEN; LEGIBILITY; QUALITY; MISUSE; CITY	Background Although there is a conflict between the treatment benefits for a single individual and society, restrictions on antibiotic use are needed to reduce the prevalence of resistance to these drugs, which is the main result of irrational use. Brazil, cataloged as a pharmemerging market, has implemented restrictive measures for the consumption of antibiotics. The objective of this study was to investigate the quality of antimicrobial prescriptions and user knowledge of their treatment with these drugs. Methods and Findings A two-stage cross-sectional, combined and stratified survey of pharmacy users holding an antimicrobial prescription was conducted in the community between May and November 2014. A pharmacist analyzed each prescription for legibility and completeness, and applied a structured questionnaire to the users or their caregivers on their knowledge regarding treatment and user sociodemographic data. An estimated 29.3% of prescriptions had one or more illegible items, 91.3% had one or more missing items, and 29.0% had both illegible and missing items. Dosing schedule and patient identification were the most commonly unreadable items in prescriptions, 18.81% and 12.14%, respectively. The lack of complete patient identification occurred in 90.53% of the prescriptions. It is estimated that 40.3% of users have used antimicrobials without prescription and that 46.49% did not receive any guidance on the administration of the drug. Conclusions Despite the measures taken by health authorities to restrict the misuse of antimicrobials, it was observed that prescribers still do not follow the criteria of current legislation, particularly relating to items needed for completion of the prescription. Moreover, users receive little information about their antimicrobial treatment.	[Lima, Sara I. V. C.; Diniz, Rodrigo S.; Egito, Eryvaldo S. T.; Oliveira, Antonio G.; Araujo, Ivonete B.] Univ Fed Rio Grande do Norte, Ctr Ciencias Saude, Programa Posgrad Ciencias Saude, BR-59072970 Natal, RN, Brazil; [Diniz, Rodrigo S.] Univ Fed Campina Grande, Ctr Educ Saude, Dept Farmacia, Cuite, PB, Brazil; [Egito, Eryvaldo S. T.; Araujo, Ivonete B.] Univ Fed Rio Grande do Norte, Ctr Ciencias Saude, Dept Farmacia, BR-59072970 Natal, RN, Brazil; [Azevedo, Paulo R. M.] Univ Fed Rio Grande do Norte, Ctr Ciencias Exatas Terra, Dept Estat, BR-59072970 Natal, RN, Brazil	Universidade Federal do Rio Grande do Norte; Universidade Federal de Campina Grande; Universidade Federal do Rio Grande do Norte; Universidade Federal do Rio Grande do Norte	Lima, SIVC (corresponding author), Univ Fed Rio Grande do Norte, Ctr Ciencias Saude, Programa Posgrad Ciencias Saude, BR-59072970 Natal, RN, Brazil.	sivclima@gmail.com	ST Egito, Socrates/O-1813-2014	ST Egito, Socrates/0000-0002-2180-3991				Abrantes PD, 2008, CIENC SAUDE COLETIVA, V13, P711, DOI 10.1590/S1413-81232008000700021; Agencia Nacional de Vigilancia Sanitiria-ANVISA, 2010, RDC 44 OCTOBER 26 20; Agencia Nacional de Vigilancia Sanitiria-ANVISA, 2011, RDC 20 MAY 5 2011; Albarrak AI, 2014, SAUDI PHARM J, V22, P522, DOI 10.1016/j.jsps.2014.02.013; Barker KN, 2002, ARCH INTERN MED, V162, P1897, DOI 10.1001/archinte.162.16.1897; BRASIL, 2013, DEFINIDA NOVA DATA P; BRENNAN TA, 1991, NEW ENGL J MED, V324, P370, DOI 10.1056/NEJM199102073240604; Butler CC, 1998, BMJ-BRIT MED J, V317, P637, DOI 10.1136/bmj.317.7159.637; Calligaris Laura, 2009, BMC Clin Pharmacol, V9, P9, DOI 10.1186/1472-6904-9-9; Cisneros Jose Miguel, 2010, Enferm Infecc Microbiol Clin, V28 Suppl 4, P28, DOI 10.1016/S0213-005X(10)70039-2; de Vries TPGM, 1994, GUIDE GOOD PRESCRIBI; French GL, 2010, INT J ANTIMICROB AG, V36, pS3, DOI 10.1016/S0924-8579(10)70003-0; IBGE, 2010, DIRETORIA PESQISAS C; IMS Health, PHARMERGING MARKETS; Nicolini P, 2008, CIENC SAUDE COLETIVA, V13, P689, DOI 10.1590/S1413-81232008000700018; Porco TC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046505; Rosa Mário Borges, 2009, Rev. Saúde Pública, V43, P490, DOI 10.1590/S0034-89102009005000028; Santa-Ana-Tellez Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075550; Shehadeh M, 2012, SAUDI PHARM J, V20, P125, DOI 10.1016/j.jsps.2011.11.005; Silverio MS, 2010, REV ASSOC MED BRAS, V56, P675, DOI 10.1590/S0104-42302010000600016; Tripathi N, 2012, CLIN PERINATOL, V39, P61, DOI 10.1016/j.clp.2011.12.003; Waltham MA, 2015, CIPROFLOXACIN SYSTEM; WHO, 2001, WHO GLOB STRAT CONT; Wilf-Miron R, 2012, J MANAGE CARE PHARM, V18, P324, DOI 10.18553/jmcp.2012.18.4.324; Winslow EH, 1997, HEART LUNG, V26, P158, DOI 10.1016/S0147-9563(97)90076-5	25	6	6	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2015	10	10							e0141615	10.1371/journal.pone.0141615	http://dx.doi.org/10.1371/journal.pone.0141615			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0EH	26517874	Green Published, gold, Green Submitted			2022-12-26	WOS:000363920800062
J	Le, MT; van Veldhuizen, M; Porcelli, I; Bongaerts, RJ; Gaskin, DJH; Pearson, BM; van Vliet, AHM				My Thanh Le; van Veldhuizen, Mart; Porcelli, Ida; Bongaerts, Roy J.; Gaskin, Duncan J. H.; Pearson, Bruce M.; van Vliet, Arnoud H. M.			Conservation of sigma(28)-Dependent Non-Coding RNA Paralogs and Predicted sigma(54)-Dependent Targets in Thermophilic Campylobacter Species	PLOS ONE			English	Article							BIOFILM FORMATION; GENE-EXPRESSION; JEJUNI; MOTILITY; IDENTIFICATION; INFECTION; FLAGELLA; TRANSCRIPTION; CHEMOTAXIS; VIRULENCE	Assembly of flagella requires strict hierarchical and temporal control via flagellar sigma and anti-sigma factors, regulatory proteins and the assembly complex itself, but to date non-coding RNAs (ncRNAs) have not been described to regulate genes directly involved in flagellar assembly. In this study we have investigated the possible role of two ncRNA paralogs (CjNC1, CjNC4) in flagellar assembly and gene regulation of the diarrhoeal pathogen Campylobacter jejuni. CjNC1 and CjNC4 are 37/44 nt identical and predicted to target the 5' untranslated region (5' UTR) of genes transcribed from the flagellar sigma factor sigma(54). Orthologs of the sigma(54)-dependent 5' UTRs and ncRNAs are present in the genomes of other thermophilic Campylobacter species, and transcription of CjNC1 and CNC4 is dependent on the flagellar sigma factor sigma 28. Surprisingly, inactivation and overexpression of CjNC1 and CjNC4 did not affect growth, motility or flagella-associated phenotypes such as autoagglutination. However, CjNC1 and CjNC4 were able tomediate sequence-dependent, but Hfq-independent, partial repression of fluorescence of predicted target 5' UTRs in an Escherichia colibased GFP reporter gene system. This hints towards a subtle role for the CjNC1 and CjNC4 ncRNAs in post-transcriptional gene regulation in thermophilic Campylobacter species, and suggests that the currently used phenotypic methodologies are insufficiently sensitive to detect such subtle phenotypes. The lack of a role of Hfq in the E. coli GFP-based system indicates that the CjNC1 and CjNC4 ncRNAs may mediate post-transcriptional gene regulation in ways that do not conform to the paradigms obtained from the Enterobacteriaceae.	[My Thanh Le; van Veldhuizen, Mart; Porcelli, Ida; Bongaerts, Roy J.; Gaskin, Duncan J. H.; Pearson, Bruce M.; van Vliet, Arnoud H. M.] Inst Food Res, Norwich Res Pk, Gut Hlth & Food Safety Programme, Norwich NR4 7UA, Norfolk, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Quadram Institute; University of East Anglia	van Vliet, AHM (corresponding author), Inst Food Res, Norwich Res Pk, Gut Hlth & Food Safety Programme, Norwich NR4 7UA, Norfolk, England.	arnoud.vanvliet@ifr.ac.uk		van Vliet, Arnoud/0000-0003-0203-1305; Pearson, Bruce/0000-0002-9223-7712	Biotechnology and Biological Sciences Research Council (BBSRC) via the BBSRC Institute Strategic Programme [BB/J004529/1, BB/F016816/1]; BBSRC [BBS/E/F/00044403] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/F/00044403] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council (BBSRC) via the BBSRC Institute Strategic Programme(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The authors gratefully acknowledge the support of the Biotechnology and Biological Sciences Research Council (BBSRC) via the BBSRC Institute Strategic Programme Grant BB/J004529/1 (Gut Health and Food Safety) and the Doctoral Training Grant to the IFR (BB/F016816/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JK, 2010, TRENDS MICROBIOL, V18, P30, DOI 10.1016/j.tim.2009.11.001; [Anonymous], 2010, EFSA J, V8, P1437, DOI DOI 10.2903/J.EFSA.2010.1437; Asakura H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070418; Baba Tomoya, 2006, Mol Syst Biol, V2; Baldvinsson SB, 2014, APPL ENVIRON MICROB, V80, P7096, DOI 10.1128/AEM.02057-14; Barrero-Tobon AM, 2012, MOL MICROBIOL, V84, P352, DOI 10.1111/j.1365-2958.2012.08027.x; Bell JA, 2013, MICROB PATHOGENESIS, V54, P1, DOI 10.1016/j.micpath.2012.08.001; Bens M, 1996, AM J PHYSIOL-CELL PH, V270, pC1666, DOI 10.1152/ajpcell.1996.270.6.C1666; Brown HL, 2014, APPL ENVIRON MICROB, V80, P7053, DOI 10.1128/AEM.02614-14; Buelow DR, 2011, MOL MICROBIOL, V80, P1296, DOI 10.1111/j.1365-2958.2011.07645.x; Butcher J, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1661-7; Butcher J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079475; Butcher J, 2012, P NATL ACAD SCI USA, V109, P10047, DOI 10.1073/pnas.1118321109; Carrillo CD, 2004, J BIOL CHEM, V279, P20327, DOI 10.1074/jbc.M401134200; Chao YJ, 2010, CURR OPIN MICROBIOL, V13, P24, DOI 10.1016/j.mib.2010.01.001; Chaudhuri RR, 2011, MICROBIOL-SGM, V157, P2922, DOI 10.1099/mic.0.050278-0; Chevance FFV, 2008, NAT REV MICROBIOL, V6, P455, DOI 10.1038/nrmicro1887; De Lay N, 2013, J BIOL CHEM, V288, P7996, DOI 10.1074/jbc.R112.441386; De Lay N, 2012, MOL MICROBIOL, V86, P524, DOI 10.1111/j.1365-2958.2012.08209.x; Dugar G, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003495; Evans LDB, 2014, TRENDS MICROBIOL, V22, P566, DOI 10.1016/j.tim.2014.05.009; Fitzgerald DM, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004649; Friis LM, 2005, J MICROBIOL METH, V61, P145, DOI 10.1016/j.mimet.2004.12.003; Gao BL, 2014, MBIO, V5, DOI 10.1128/mBio.01349-14; Gilbreath JJ, 2011, MICROBIOL MOL BIOL R, V75, P84, DOI 10.1128/MMBR.00035-10; Golden NJ, 2002, INFECT IMMUN, V70, P1761, DOI 10.1128/IAI.70.4.1761-1771.2002; Goon S, 2006, INFECT IMMUN, V74, P769, DOI 10.1128/IAI.74.1.769-772.2006; Guerry P, 2006, MOL MICROBIOL, V60, P299, DOI 10.1111/j.1365-2958.2006.05100.x; Guerry P, 2007, TRENDS MICROBIOL, V15, P456, DOI 10.1016/j.tim.2007.09.006; Handley RA, 2015, MICROBIOL-SGM, V161, P1524, DOI 10.1099/mic.0.000109; HEIMBROOK ME, 1989, J CLIN MICROBIOL, V27, P2612, DOI 10.1128/JCM.27.11.2612-2615.1989; Hendrixson DR, 2003, MOL MICROBIOL, V50, P687, DOI 10.1046/j.1365-2958.2003.03731.x; Holmes K, 2005, MICROBIOL-SGM, V151, P243, DOI 10.1099/mic.0.27412-0; Hooton SPT, 2015, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00744; Jackson RJ, 2007, J BACTERIOL, V189, P1604, DOI 10.1128/JB.00897-06; Janssen R, 2008, CLIN MICROBIOL REV, V21, P505, DOI 10.1128/CMR.00055-07; Joslin SN, 2009, J BACTERIOL, V191, P2656, DOI 10.1128/JB.01689-08; KODAKA H, 1982, J CLIN MICROBIOL, V16, P948, DOI 10.1128/JCM.16.5.948-952.1982; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Le MT, 2012, EUR J MICROBIOL IMMU, V2, P12, DOI 10.1556/EuJMI.2.2012.1.3; Lertsethtakarn P, 2011, ANNU REV MICROBIOL, V65, P389, DOI 10.1146/annurev-micro-090110-102908; Logan SM, 2009, FEBS J, V276, P1014, DOI 10.1111/j.1742-4658.2008.06840.x; Lucchetti-Miganeh C, 2008, MICROBIOL-SGM, V154, P16, DOI 10.1099/mic.0.2007/012286-0; Miller WG, 2014, GENOME BIOL EVOL, V6, P3252, DOI 10.1093/gbe/evu249; Parkhill J, 2000, NATURE, V403, P665, DOI 10.1038/35001088; Pearson BM, 2015, GENOME BIOL EVOL, V7, P2663, DOI 10.1093/gbe/evv174; Pernitzsch SR, 2014, P NATL ACAD SCI USA, V111, pE501, DOI 10.1073/pnas.1315152111; Pernitzsch SR, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00014; Porcelli I, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-616; Poropatich KO, 2010, J HEALTH POPUL NUTR, V28, P545, DOI 10.3329/jhpn.v28i6.6602; Reuter M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054390; Reuter M, 2010, APPL ENVIRON MICROB, V76, P2122, DOI 10.1128/AEM.01878-09; Rieder R, 2012, RNA BIOL, V9, P520, DOI 10.4161/rna.20331; Shaw FL, 2012, J BACTERIOL, V194, P3814, DOI 10.1128/JB.06586-11; Sobrero P, 2012, CRIT REV MICROBIOL, V38, P276, DOI 10.3109/1040841X.2012.664540; Sommerlad SM, 2007, J BACTERIOL, V189, P179, DOI 10.1128/JB.01199-06; Storz G, 2011, MOL CELL, V43, P880, DOI 10.1016/j.molcel.2011.08.022; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Taveirne ME, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073586; Tjaden B, 2008, NUCLEIC ACIDS RES, V36, pW109, DOI 10.1093/nar/gkn264; Tsang J, 2014, SCIENTIFICA, V2014, DOI 10.1155/2014/681754; Urban JH, 2007, NUCLEIC ACIDS RES, V35, P1018, DOI 10.1093/nar/gkl1040; van Vliet AHM, 2001, FEMS MICROBIOL LETT, V196, P189, DOI 10.1016/S0378-1097(01)00067-2; Wen Y, 2013, J BACTERIOL, V195, P444, DOI 10.1128/JB.01022-12; Wosten MMSM, 2010, MOL MICROBIOL, V75, P1577, DOI 10.1111/j.1365-2958.2010.07079.x; Wosten MMSM, 2004, J BIOL CHEM, V279, P16214, DOI 10.1074/jbc.M400357200	66	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2015	10	10							e0141627	10.1371/journal.pone.0141627	http://dx.doi.org/10.1371/journal.pone.0141627			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0ED	26512728	gold, Green Published, Green Submitted			2022-12-26	WOS:000363920300057
J	Urmi, AZ; Leung, DT; Wilkinson, V; Miah, MAA; Rahman, M; Azim, T				Urmi, Arunthia Zaidi; Leung, Daniel T.; Wilkinson, Vanessa; Miah, Mohammad Abdul Awal; Rahman, Mahfuza; Azim, Tasnim			Profile of an HIV Testing and Counseling Unit in Bangladesh: Majority of New Diagnoses among Returning Migrant Workers and Spouses	PLOS ONE			English	Article							INDIA	Introduction Analysis of data from HIV testing and counseling (HTC) services provides an opportunity to identify important populations for targeting of HIV prevention efforts. Our primary aim was to describe the demographics of clients presenting to HTC in Bangladesh, a low HIV prevalence country. Our secondary aim was to determine the risk factors for HIV positivity among returning migrant workers who were tested. Methods We performed a cross-sectional study of data collected between 2002 and 2010 from the first HTC service established in Bangladesh, located in three large cities. Results 8973 individuals attended HTC services, with 558 (6.2%) of clients testing positive for HIV, including 33 children. The majority of those who tested positive were aged 25-44 (71%), male (70%), and married (68%). Key populations considered at increased risk of HIV, such as female sex workers, people who inject drugs, and males who have sex with males accounted for only 11% of adults who tested positive. Notably, 75% of adults testing positive had a history of migrant work or was the spouse of a migrant worker. In multivariable logistic regression of those with a migrant work history presenting for HTC, we found rural residence, working in the Middle East, and longer duration of migrant work to be independently associated with testing positive, and female gender and higher level of education to be negatively associated. Conclusions These data suggest that in Bangladesh, in addition to targeting traditional key populations, HIV prevention efforts should also focus on migrant workers and their spouses.	[Urmi, Arunthia Zaidi; Leung, Daniel T.; Miah, Mohammad Abdul Awal; Rahman, Mahfuza; Azim, Tasnim] Int Ctr Diarrheal Dis Res Bangladesh, Ctr HIV AIDS, Dhaka, Bangladesh; [Urmi, Arunthia Zaidi; Miah, Mohammad Abdul Awal; Rahman, Mahfuza] Int Ctr Diarrheal Dis Res Bangladesh, Hosp, Dhaka, Bangladesh; [Leung, Daniel T.] Int Ctr Diarrheal Dis Res Bangladesh, Ctr Vaccine Sci, Dhaka, Bangladesh; [Wilkinson, Vanessa] Austin Hlth, Inst Breathing & Sleep, Heidelberg, Vic, Australia	International Centre for Diarrhoeal Disease Research (ICDDR); International Centre for Diarrhoeal Disease Research (ICDDR); International Centre for Diarrhoeal Disease Research (ICDDR); Austin Research Institute; Florey Institute of Neuroscience & Mental Health; Institute for Breathing & Sleep (IBAS)	Leung, DT (corresponding author), Univ Utah, Sch Med, Div Infect Dis, Salt Lake City, UT 84112 USA.	Daniel.Leung@utah.edu		Leung, Daniel/0000-0001-8401-0801	United Nations Programme on HIV and AIDS (UNAIDS); Family Health International; International Centre for Diarrheal Disease Research (icddr,b); Australian Aid; Government of the People's Republic of Bangladesh; Department of Foreign Affairs; Trade and Development Canada; Swedish International Development Cooperation Agency (Sida); UK Department for International Development (UKAID); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI100923] Funding Source: NIH RePORTER	United Nations Programme on HIV and AIDS (UNAIDS); Family Health International; International Centre for Diarrheal Disease Research (icddr,b); Australian Aid(CGIAR); Government of the People's Republic of Bangladesh; Department of Foreign Affairs; Trade and Development Canada; Swedish International Development Cooperation Agency (Sida); UK Department for International Development (UKAID)(CGIAR); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The HIV Testing and Counseling Unit was supported by Joint United Nations Programme on HIV and AIDS (UNAIDS), Family Health International and the International Centre for Diarrheal Disease Research (icddr,b). icddr,b gratefully acknowledges the following donors which provide unrestricted support: Australian Aid, Government of the People's Republic of Bangladesh, Department of Foreign Affairs, Trade and Development Canada, Swedish International Development Cooperation Agency (Sida) and the UK Department for International Development (UKAID). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-del Arco D, 2013, EUR J PUBLIC HEALTH, V23, P1039, DOI 10.1093/eurpub/cks130; [Anonymous], 2012, GLOB REP UNAIDS REP; Azim T, 2008, INT J STD AIDS, V19, P327, DOI 10.1258/ijsa.2007.007269; Azim T, 2008, J HEALTH POPUL NUTR, V26, P311; Bontell I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079193; Dandona L, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-327; Government of Bangladesh, 2011, NAT HIV SER SURV 201; Guy RJ, 2009, INT J STD AIDS, V20, P378, DOI 10.1258/ijsa.2009.009005; International Organization for Migration (IOM), 2013, SIT AN MIGR HIV BANG; Kennedy CE, 2013, AIDS BEHAV, V17, P1571, DOI 10.1007/s10461-012-0241-y; Mazroa Mohammed A A I, 2012, PLoS One, V7, pe45919, DOI 10.1371/journal.pone.0045919; Mercer A, 2007, SEX TRANSM DIS, V34, P265, DOI 10.1097/01.olq.0000240384.61924.65; Saggurti N, 2008, AIDS, V22, pS127, DOI 10.1097/01.aids.0000343771.75023.cc; Saggurti N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043222; Shahrin L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113095; Shahrin L, 2014, PAEDIATR INT CHILD H, V34, P133, DOI 10.1179/2046905513Y.0000000100; UNDP, 2009, HIV VULN FAC WOM MIG; Vajpayee M, 2009, AIDS CARE, V21, P826, DOI 10.1080/09540120701857835; Wilson KD, 2014, AIDS CARE, V26, pS83, DOI 10.1080/09540121.2014.906554; World Bank, MIGR REM REC DEV OUT; World Health Organization ROfS-EA, 2004, VOL HIV COUNS TEST 2	21	15	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2015	10	10							e0141483	10.1371/journal.pone.0141483	http://dx.doi.org/10.1371/journal.pone.0141483			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CV0ED	26513357	Green Submitted, Green Published, gold			2022-12-26	WOS:000363920300042
J	Wang, PH; Sun, H; Shang, L; Zhang, QL; He, YX; Chen, ZG; Zhou, YL; Zhang, JJ; Wang, QQ; Zhao, JK; Shen, HB				Wang, Peihua; Sun, Hong; Shang, Li; Zhang, Qinglan; He, Yingxia; Chen, Zhigao; Zhou, Yonglin; Zhang, Jingjing; Wang, Qingqing; Zhao, Jinkou; Shen, Hongbing			Low Goiter Rate Associated with Small Average Thyroid Volume in Schoolchildren after the Elimination of Iodine Deficiency Disorders	PLOS ONE			English	Article							URINARY IODINE; ENDEMIC GOITER; EXCESSIVE IODINE; DRINKING-WATER; CHILDREN; CHINA; SALT; POPULATION; PREVALENCE; ULTRASOUND	Background After the implementation of the universal salt iodization (USI) program in 1996, seven cross-sectional school-based surveys have been conducted to monitor iodine deficiency disorders (IDD) among children in eastern China. Objectives This study aimed to examine the correlation of total goiter rate (TGR) with average thyroid volume (Tvol) and urinary iodine concentration (UIC) in Jiangsu province after IDD elimination. Design Probability-proportional-to-size sampling was applied to select 1,200 children aged 8-10 years old in 30 clusters for each survey in 1995, 1997, 1999, 2001, 2002, 2005, 2009 and 2011. We measured Tvol using ultrasonography in 8,314 children and measured UIC (4,767 subjects) and salt iodine (10,184 samples) using methods recommended by the World Health Organization. Tvol was used to calculate TGR based on the reference criteria specified for sex and body surface area (BSA). Results TGR decreased from 55.2% in 1997 to 1.0% in 2009, and geometric means of Tvol decreased from 3.63 mL to 1.33 mL, along with the UIC increasing from 83 mu g/L in 1995 to 407 mu g/L in 1999, then decreasing to 243 mu g/L in 2005, and then increasing to 345 mu g/L in 2011. In the low goiter population (TGR < 3.9%), TGR was positively associated with average Tvol (r = 0.99); UIC showed a non-linear association with average Tvol, and UIC > 300 mu g/L was associated with a smaller average Tvol in children. Conclusions After IDD elimination in Jiangsu province in 2001, lower TGR was associated with smaller average Tvol. Average Tvol was more sensitive than TGR in detecting the fluctuation of UIC. A UIC of 300 mu g/L may be defined as a critical value for population level iodine status monitoring.	[Wang, Peihua; Shen, Hongbing] Nanjing Med Univ, Sch Publ Hlth, Dept Epidemiol & Stat, Nanjing, Jiangsu, Peoples R China; [Wang, Peihua; Sun, Hong; Shang, Li; Zhang, Qinglan; He, Yingxia; Chen, Zhigao; Zhou, Yonglin; Zhang, Jingjing; Wang, Qingqing; Zhao, Jinkou] Jiangsu Prov Ctr Dis Control & Prevent, Dept Environm & Endem Dis Control & Prevent, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Jiangsu Provincial Center for Disease Control & Prevention	Shen, HB (corresponding author), Nanjing Med Univ, Sch Publ Hlth, Dept Epidemiol & Stat, Nanjing, Jiangsu, Peoples R China.	hbshen@njmu.edu.cn			State Program of National Natural Science Fund of China [30901222]; Endemic Disease Control and Prevention Research Fund from Jiangsu Provincial Health Bureau [X201420]; Research fund from Jiangsu Provincial Health Bureau [LJ 201129]; Research Fund for Fostering Talents of Jiangsu Provincial Center for Disease Control and Prevention in China [JKRC2011016, JKRC2011015]	State Program of National Natural Science Fund of China; Endemic Disease Control and Prevention Research Fund from Jiangsu Provincial Health Bureau; Research fund from Jiangsu Provincial Health Bureau; Research Fund for Fostering Talents of Jiangsu Provincial Center for Disease Control and Prevention in China	This work was supported by State Program of National Natural Science Fund of China (H.S., Grant No. 30901222); the Endemic Disease Control and Prevention Research Fund from Jiangsu Provincial Health Bureau (PW, Grant No. X201420); Research fund from Jiangsu Provincial Health Bureau (H.S., No. LJ 201129) and Research Fund for Fostering Talents of Jiangsu Provincial Center for Disease Control and Prevention in China (P.W., Grant No. JKRC2011016; H.S., No. JKRC2011015). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bourdoux P, 1988, IDD NEWSLETTER, V4, P8; Brahmbhatt S, 2000, EUR J ENDOCRINOL, V143, P37, DOI 10.1530/eje.0.1430037; DUNN JT, 1993, THYROID, V3, P119, DOI 10.1089/thy.1993.3.119; Fuse Y, 2007, THYROID, V17, P145, DOI 10.1089/thy.2006.0209; Henjum S, 2010, PUBLIC HEALTH NUTR, V13, P1472, DOI 10.1017/S1368980010000650; Huang W, 2013, FOOD NUTR BULL, V34, P331, DOI 10.1177/156482651303400305; Konig F, 2011, J NUTR, V141, P2049, DOI 10.3945/jn.111.144071; LI M, 1987, LANCET, V2, P257; Li SM, 2011, ASIA PAC J CLIN NUTR, V20, P501; Nystrom HF, 2010, EUR J CLIN NUTR, V64, P1289, DOI 10.1038/ejcn.2010.162; Pino S, 1998, EXP CLIN ENDOCR DIAB, V106, pS22, DOI 10.1055/s-0029-1212041; Prakash R, 2005, AM J CLIN NUTR, V82, P708, DOI 10.1093/ajcn/82.3.708; Rossi A, 2002, J CLIN ULTRASOUND, V30, P226, DOI 10.1002/jcu.10060; SUZUKI H, 1965, ACTA ENDOCRINOL-COP, V50, P161, DOI 10.1530/acta.0.0500161; Tong Y, 1999, 1302571999 GBT; Wright PRD, 2010, ENVIRON GEOCHEM HLTH, V32, P567, DOI 10.1007/s10653-010-9318-6; Yan YQ, 2006, 1072006 WST; Zhao Jinkou, 1998, Food and Nutrition Bulletin, V19, P347; Zhao JK, 2000, AM J PUBLIC HEALTH, V90, P1633, DOI 10.2105/AJPH.90.10.1633; Zhao JK, 1998, LANCET, V352, P2024, DOI 10.1016/S0140-6736(05)61375-X; Zimmermann MB, 2005, AM J CLIN NUTR, V81, P840, DOI 10.1093/ajcn/81.4.840; Zimmermann MB, 2004, AM J CLIN NUTR, V79, P231; Zimmermann MB, 2003, AM J CLIN NUTR, V77, P663, DOI 10.1093/ajcn/77.3.663; Zimmermann MB, 2012, NUTR REV, V70, P553, DOI 10.1111/j.1753-4887.2012.00528.x; Zou SR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040718; Zou Y, 2013, EUR J CLIN NUTR, V67, P1138, DOI 10.1038/ejcn.2013.173	26	15	15	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2015	10	10							e0141552	10.1371/journal.pone.0141552	http://dx.doi.org/10.1371/journal.pone.0141552			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0ED	26513146	Green Published, gold, Green Submitted			2022-12-26	WOS:000363920300050
J	Hassett, MO; Fischer, MWF; Money, NP				Hassett, Maribeth O.; Fischer, Mark W. F.; Money, Nicholas P.			Mushrooms as Rainmakers: How Spores Act as Nuclei for Raindrops	PLOS ONE			English	Article							SCANNING-ELECTRON-MICROSCOPY; AEROSOL-PARTICLES; BULLERS DROP; BALLISTOSPORE; NUCLEATION; DISCHARGE	Millions of tons of fungal spores are dispersed in the atmosphere every year. These living cells, along with plant spores and pollen grains, may act as nuclei for condensation of water in clouds. Basidiospores released by mushrooms form a significant proportion of these aerosols, particularly above tropical forests. Mushroom spores are discharged from gills by the rapid displacement of a droplet of fluid on the cell surface. This droplet is formed by the condensation of water on the spore surface stimulated by the secretion of mannitol and other hygroscopic sugars. This fluid is carried with the spore during discharge, but evaporates once the spore is airborne. Using environmental electron microscopy, we have demonstrated that droplets reform on spores in humid air. The kinetics of this process suggest that basidiospores are especially effective as nuclei for the formation of large water drops in clouds. Through this mechanism, mushroom spores may promote rainfall in ecosystems that support large populations of ectomycorrhizal and saprotrophic basidiomycetes. Our research heightens interest in the global significance of the fungi and raises additional concerns about the sustainability of forests that depend on heavy precipitation.	[Hassett, Maribeth O.; Money, Nicholas P.] Miami Univ, Dept Biol, Oxford, OH 45056 USA; [Fischer, Mark W. F.] Mt St Joseph Univ, Dept Chem & Phys Sci, Cincinnati, OH 45233 USA; [Money, Nicholas P.] Miami Univ, Western Program, Oxford, OH 45056 USA	University System of Ohio; Miami University; Mount St. Joseph University; University System of Ohio; Miami University	Money, NP (corresponding author), Miami Univ, Dept Biol, Oxford, OH 45056 USA.	moneynp@miamioh.edu						Ariya PA, 2009, INT REV PHYS CHEM, V28, P1, DOI 10.1080/01442350802597438; Cotton William R., 2009, P13, DOI 10.1007/978-1-4020-8690-8_2; Ebert M, 2002, ATMOS ENVIRON, V36, P5909, DOI 10.1016/S1352-2310(02)00774-4; Elbert W, 2007, ATMOS CHEM PHYS, V7, P4569, DOI 10.5194/acp-7-4569-2007; Fischer MWF, 2010, FUNGAL BIOL-UK, V114, P669, DOI 10.1016/j.funbio.2010.06.002; Griffiths PT, 2012, ATMOS SCI LETT, V13, P289, DOI 10.1002/asl.397; Haga DI, 2014, ATMOS CHEM PHYS, V14, P8611, DOI 10.5194/acp-14-8611-2014; Hiranuma N, 2008, ATMOS ENVIRON, V42, P1983, DOI 10.1016/j.atmosenv.2007.12.003; Lamb D., 2011, PHYS CHEM CLOUDS; Mohler O, 2007, BIOGEOSCIENCES, V4, P1059; Money NP, 2011, MUSHROOM; Poschl U, 2010, SCIENCE, V329, P1513, DOI 10.1126/science.1191056; Pope FD, 2010, ENV RES LETT, V5; Posfai M, 2010, ANNU REV EARTH PL SC, V38, P17, DOI 10.1146/annurev.earth.031208.100032; Pringle A, 2005, MYCOLOGIA, V97, P866, DOI 10.3852/mycologia.97.4.866; Seinfeld J.H., 2012, ATMOSPHERIC CHEM PHY; Stolze-Rybczynski JL, 2009, PLOS ONE, V4; Tedersoo L, SCIENCE, V346; WEBSTER J, 1984, T BRIT MYCOL SOC, V82, P13, DOI 10.1016/S0007-1536(84)80207-7; WEBSTER J, 1989, MYCOL RES, V93, P297, DOI 10.1016/S0953-7562(89)80156-X; WEBSTER J, 1995, MYCOL RES, V99, P833, DOI 10.1016/S0953-7562(09)80737-5	21	26	28	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2015	10	10							e0140407	10.1371/journal.pone.0140407	http://dx.doi.org/10.1371/journal.pone.0140407			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0DL	26509436	Green Published, gold, Green Submitted			2022-12-26	WOS:000363918100031
J	Martin-Silverstone, E; Vincze, O; McCann, R; Jonsson, CHW; Palmer, C; Kaiser, G; Dyke, G				Martin-Silverstone, Elizabeth; Vincze, Orsolya; McCann, Ria; Jonsson, Carl H. W.; Palmer, Colin; Kaiser, Gary; Dyke, Gareth			Exploring the Relationship between Skeletal Mass and Total Body Mass in Birds	PLOS ONE			English	Article							SIZE; MAMMALS; BONE; TEMPERATURE; DIMENSIONS; DINOSAURS; TIME	Total body mass (TBM) is known to be related to a number of different osteological features in vertebrates, including limb element measurements and total skeletal mass. The relationship between skeletal mass and TBM in birds has been suggested as a way of estimating the latter in cases where only the skeleton is known (e.g., fossils). This relationship has thus also been applied to other extinct vertebrates, including the non-avian pterosaurs, while other studies have used additional skeletal correlates found in modern birds to estimate TBM. However, most previous studies have used TBM compiled from the literature rather than from direct measurements, producing values from population averages rather than from individuals. Here, we report a new dataset of 487 extant birds encompassing 79 species that have skeletal mass and TBM recorded at the time of collection or preparation. We combine both historical and new data for analyses with phylogenetic control and find a similar and well-correlated relationship between skeletal mass and TBM. Thus, we confirm that TBM and skeletal mass are accurate proxies for estimating one another. We also look at other factors that may have an effect on avian body mass, including sex, ontogenetic stage, and flight mode. While data are well-correlated in all cases, phylogeny is a major control on TBM in birds strongly suggesting that this relationship is not appropriate for estimating the total mass of taxa outside of crown birds, Neornithes (e.g., non-avian dinosaurs, pterosaurs). Data also reveal large variability in both bird skeletal and TBM within single species; caution should thus be applied when using published mass to test direct correlations with skeletal mass and bone lengths.	[Martin-Silverstone, Elizabeth; McCann, Ria; Dyke, Gareth] Univ Southampton, Ocean & Earth Sci, Southampton, Hants, England; [Martin-Silverstone, Elizabeth; Palmer, Colin] Univ Bristol, Sch Earth Sci, Bristol, Avon, England; [Vincze, Orsolya; Dyke, Gareth] Debrecen Univ Med, MTA DE Lendulet Behav Ecol Res Grp, Dept Evolutionary Zool, H-4012 Debrecen, Hungary; [Vincze, Orsolya] Univ Babes Bolyai, Fac Biol & Geol, R-3400 Cluj Napoca, Romania; [Jonsson, Carl H. W.; Kaiser, Gary] Royal British Columbia Museum, Victoria, BC, Canada	University of Southampton; University of Bristol; University of Debrecen; Babes Bolyai University from Cluj	Martin-Silverstone, E (corresponding author), Univ Southampton, Ocean & Earth Sci, Southampton, Hants, England.	e.g.martin@soton.ac.uk	Vincze, Orsolya/AEQ-1159-2022; Dyke, Gareth/AAJ-9320-2020	Vincze, Orsolya/0000-0001-5789-2124; Dyke, Gareth/0000-0002-8390-7817	Natural Sciences and Engineering Council of Canada; University of Southampton; Ginko Investments	Natural Sciences and Engineering Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); University of Southampton; Ginko Investments	As part of her PhD project, EMS receives funding from the Natural Sciences and Engineering Council of Canada in the form of a Postgraduate Doctoral Scholarship [http://www.nserc-crsng.gc.ca], the University of Southampton, and Ginko Investments. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON JF, 1985, J ZOOL, V207, P53, DOI 10.1111/j.1469-7998.1985.tb04915.x; [Anonymous], 2007, CRC HDB AVIAN BODY M, DOI [DOI 10.1201/9781420064452, DOI 10.1080/10888705.2011.527604]; Bates KT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004532; Bell A, 2016, J SYST PALAEONTOL, V14, P239, DOI 10.1080/14772019.2015.1036141; Bennett SC, 1996, ZOOL J LINN SOC-LOND, V118, P261, DOI 10.1111/j.1096-3642.1996.tb01267.x; BENTON MJ, 1990, PHILOS T ROY SOC B, V328, P213, DOI 10.1098/rstb.1990.0114; BIEWENER AA, 1989, BIOSCIENCE, V39, P776, DOI 10.2307/1311183; Biknevicius AR, 1999, J ZOOL, V248, P179, DOI 10.1111/j.1469-7998.1999.tb01194.x; BirdLife International, 2015, SPEC FACTSH PORPH AL; Blomberg SP, 2003, EVOLUTION, V57, P717, DOI 10.1111/j.0014-3820.2003.tb00285.x; BRAMWELL CD, 1974, PHILOS T R SOC B, V267, P503, DOI 10.1098/rstb.1974.0007; BROWN JH, 1993, AM NAT, V142, P573, DOI 10.1086/285558; Bruderer B, 2010, IBIS, V152, P272, DOI 10.1111/j.1474-919X.2010.01014.x; Campione NE, 2014, METHODS ECOL EVOL, V5, P913, DOI 10.1111/2041-210X.12226; Campione NE, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-60; Chiappe Luis M., 2002, P240; Close RA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036664; DACKE CG, 1993, J EXP BIOL, V184, P63; Dunning J. B., 1992, HDB AVIAN BODY MASSE; Dyke GJ, 2009, LETHAIA, V42, P248, DOI 10.1111/j.1502-3931.2008.00135.x; Farlow JO, 2005, J VERTEBR PALEONTOL, V25, P354, DOI 10.1671/0272-4634(2005)025[0354:FDABSO]2.0.CO;2; Field DJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082000; Gillooly JF, 2001, SCIENCE, V293, P2248, DOI 10.1126/science.1061967; Gillooly JF, 2002, NATURE, V417, P70, DOI 10.1038/417070a; Hackett SJ, 2008, SCIENCE, V320, P1763, DOI 10.1126/science.1157704; Hansen TF, 2012, SYST BIOL, V61, P413, DOI 10.1093/sysbio/syr122; Henderson DM, 2010, J VERTEBR PALEONTOL, V30, P768, DOI 10.1080/02724631003758334; Hone DWE, 2007, J SYST PALAEONTOL, V5, P465, DOI 10.1017/S1477201907002064; HURLBURT GR, 2003, N M MUS NAT HIST SCI, V24, P105; Jetz W, 2012, NATURE, V491, P444, DOI 10.1038/nature11631; Kubo T, 2011, PALAEOGEOGR PALAEOCL, V299, P197, DOI 10.1016/j.palaeo.2010.11.001; Longrich NR, 2011, P NATL ACAD SCI USA, V108, P15253, DOI 10.1073/pnas.1110395108; Martin EG, 2014, J VERTEBR PALEONTOL, V34, P1466, DOI 10.1080/02724634.2014.859621; Martin EG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097159; Metzger RN, 2006, J HERPETOL, V40, P381; MURPHY ME, 1992, CAN J ZOOL, V70, P1109, DOI 10.1139/z92-155; Olmos M, 1996, ANN SCI NAT ZOOL, V17, P39; Orme D., 2018, R PACKAGE VERSION, V5, P1; Pennycuick CJ, 2008, THEOR ECOL SER, P1; PRANGE HD, 1979, AM NAT, V113, P103, DOI 10.1086/283367; PRANGE HD, 1976, COPEIA, P542; Sachs G, 2013, J EXP BIOL, V216, P4222, DOI 10.1242/jeb.085209; Schmidt-Nielson K., 1984, SCALING WHY IS ANIMA; Sellers WI, 2012, BIOL LETTERS, V8, P842, DOI 10.1098/rsbl.2012.0263; Sereno P.C., 1991, Journal of Vertebrate Paleontology, V11, P1; Serrano FJ, 2015, ZOOL J LINN SOC-LOND, V173, P929, DOI 10.1111/zoj.12215; Sukumaran J, 2010, BIOINFORMATICS, V26, P1569, DOI 10.1093/bioinformatics/btq228; Van Perlo, 1998, RAILS GUIDE RAILS CR; WALKER CA, 1981, NATURE, V292, P51, DOI 10.1038/292051a0; Walker Cyril A., 2009, Irish Journal of Earth Sciences, V27, P15; White CR, 2009, EVOLUTION, V63, P2658, DOI 10.1111/j.1558-5646.2009.00747.x; Witton M.P., 2013, PTEROSAURS NATURAL H, DOI DOI 10.1515/9781400847655; Witton MP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013982; Witton Mark P., 2008, Zitteliana Reihe B, V28, P143	54	9	9	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2015	10	10							e0141794	10.1371/journal.pone.0141794	http://dx.doi.org/10.1371/journal.pone.0141794			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0DL	26509531	Green Published, Green Accepted, Green Submitted, gold			2022-12-26	WOS:000363918100132
J	Nikolaidou, T; Cai, XJ; Stephenson, RS; Yanni, J; Lowe, T; Atkinson, AJ; Jones, CB; Sardar, R; Corno, AF; Dobrzynski, H; Withers, PJ; Jarvis, JC; Hart, G; Boyett, MR				Nikolaidou, Theodora; Cai, Xue J.; Stephenson, Robert S.; Yanni, Joseph; Lowe, Tristan; Atkinson, Andrew J.; Jones, Caroline B.; Sardar, Rida; Corno, Antonio F.; Dobrzynski, Halina; Withers, Philip J.; Jarvis, Jonathan C.; Hart, George; Boyett, Mark R.			Congestive Heart Failure Leads to Prolongation of the PR Interval and Atrioventricular Junction Enlargement and Ion Channel Remodelling in the Rabbit	PLOS ONE			English	Article							COMPUTER 3-DIMENSIONAL RECONSTRUCTION; CARDIAC RESYNCHRONIZATION THERAPY; SINOATRIAL NODE; GENE-EXPRESSION; MYOCYTES; SYSTEM; MOUSE; CELLS; MODEL; ELECTROCARDIOGRAM	Heart failure is a major killer worldwide. Atrioventricular conduction block is common in heart failure; it is associated with worse outcomes and can lead to syncope and bradycardic death. We examine the effect of heart failure on anatomical and ion channel remodelling in the rabbit atrioventricular junction (AVJ). Heart failure was induced in New Zealand rabbits by disruption of the aortic valve and banding of the abdominal aorta resulting in volume and pressure overload. Laser micro-dissection and real-time polymerase chain reaction (RT-PCR) were employed to investigate the effects of heart failure on ion channel remodelling in four regions of the rabbit AVJ and in septal tissues. Investigation of the AVJ anatomy was performed using micro-computed tomography (micro-CT). Heart failure animals developed first degree heart block. Heart failure caused ventricular myocardial volume increase with a 35% elongation of the AVJ. There was downregulation of HCN1 and Cx43 mRNA transcripts across all regions and downregulation of Ca(v)1.3 in the transitional tissue. Cx40 mRNA was significantly downregulated in the atrial septum and AVJ tissues but not in the ventricular septum. mRNA abundance for ANP, CLCN2 and Na-v beta 1 was increased with heart failure; Na(v)1.1 was increased in the inferior nodal extension/compact node area. Heart failure in the rabbit leads to prolongation of the PR interval and this is accompanied by downregulation of HCN1, Ca(v)1.3, Cx40 and Cx43 mRNAs and anatomical enlargement of the entire heart and AVJ.	[Nikolaidou, Theodora; Cai, Xue J.; Yanni, Joseph; Atkinson, Andrew J.; Jones, Caroline B.; Sardar, Rida; Dobrzynski, Halina; Hart, George; Boyett, Mark R.] Univ Manchester, Inst Cardiovasc Sci, Manchester, Lancs, England; [Stephenson, Robert S.; Jarvis, Jonathan C.] Liverpool John Moores Univ, Sch Sport & Exercise Sci, Liverpool L3 5UX, Merseyside, England; [Lowe, Tristan; Withers, Philip J.] Univ Manchester, Manchester Henry Moseley Xray Imaging Facil, Manchester, Lancs, England; [Corno, Antonio F.] Univ Sains Malaysia, Sch Med Sci, Kubang Kerian, Malaysia	University of Manchester; Liverpool John Moores University; University of Manchester; Universiti Sains Malaysia	Nikolaidou, T (corresponding author), Univ Hull, Dept Acad Cardiol, Kingston Upon Hull HU6 7RX, N Humberside, England.	t.nikolaidou@hull.ac.uk	Withers, Phil/A-6760-2009; Stephenson, Robert/AAO-4019-2021	Withers, Phil/0000-0002-1946-5647; Stephenson, Robert/0000-0002-4153-6026; Nikolaidou, Theodora/0000-0002-8810-0414; Dobrzynski, Halina/0000-0003-4754-5975; Atkinson, Andrew/0000-0003-2017-0747	British Heart Foundation [RG/06/005]; EPSRC [EP/F007906/1, EP/F001452/1, EP/I02249X/1]; Biotechnology and Biological Sciences Research Council; Wellcome Trust; University of Manchester Strategic Fund; Manchester Biomedical Research Centre; Alder Hey Children's NHS Foundation Trust; Engineering and Physical Sciences Research Council [EP/F001452/1, EP/F007906/1, EP/I02249X/1, EP/M010619/1] Funding Source: researchfish; National Institute for Health Research [CL-2013-03-001] Funding Source: researchfish; EPSRC [EP/M010619/1] Funding Source: UKRI	British Heart Foundation(British Heart Foundation); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); University of Manchester Strategic Fund; Manchester Biomedical Research Centre(National Institute for Health Research (NIHR)); Alder Hey Children's NHS Foundation Trust; Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); National Institute for Health Research(National Institute for Health Research (NIHR)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was funded by a programme grant from the British Heart Foundation RG/06/005. The Manchester X-ray Imaging Facility was funded in part by the EPSRC (grants EP/F007906/1, EP/F001452/1 and EP/I02249X/1). The Bioimaging Facility microscopes used in this study were purchased with grants from the Biotechnology and Biological Sciences Research Council, Wellcome Trust and the University of Manchester Strategic Fund. TN was funded by the Manchester Biomedical Research Centre. RSS was funded by the Alder Hey Children's NHS Foundation Trust. GH held the David A. Price Evans Chair of Medicine at the University of Liverpool during the course of this work.	Aslanidi OV, 2013, IEEE T MED IMAGING, V32, P8, DOI 10.1109/TMI.2012.2209183; Atkinson AJ, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000246; Baruscotti M, 2011, P NATL ACAD SCI USA, V108, P1705, DOI 10.1073/pnas.1010122108; Borlak J, 2003, FASEB J, V17, P1592, DOI 10.1096/fj.02-0889com; Cheng S, 2009, JAMA-J AM MED ASSOC, V301, P2571, DOI 10.1001/jama.2009.888; Corno AF, 2013, FRONT PEDIATR, V1, DOI 10.3389/fped.2013.00001; Dobrzynski H, 2005, CIRCULATION, V111, P846, DOI 10.1161/01.CIR.0000152100.04087.DB; Dobrzynski H, 2003, CIRC RES, V93, P1102, DOI 10.1161/01.RES.0000101913.95604.B9; Dupont E, 2001, J MOL CELL CARDIOL, V33, P359, DOI 10.1006/jmcc.2000.1308; Foeger NC, 2013, J PHYSIOL-LONDON, V591, P4149, DOI 10.1113/jphysiol.2013.255836; Gervais R, 2009, EUR J HEART FAIL, V11, P699, DOI 10.1093/eurjhf/hfp074; Greener ID, 2011, J MOL CELL CARDIOL, V50, P642, DOI 10.1016/j.yjmcc.2010.12.017; Greener ID, 2009, CIRC-ARRHYTHMIA ELEC, V2, P305, DOI 10.1161/CIRCEP.108.803569; Han W, 2001, CIRCULATION, V104, P2095, DOI 10.1161/hc4201.097134; HANCOX JC, 1994, AM J PHYSIOL-HEART C, V267, pH1670, DOI 10.1152/ajpheart.1994.267.5.H1670; Hucker WJ, 2008, ANAT REC, V291, P204, DOI 10.1002/ar.20631; Jarvis JC, 2013, FRONT PEDIATR, V1, DOI 10.3389/fped.2013.00026; Jeanmougin M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012336; Kupershmidt S, 1999, CIRC RES, V84, P146, DOI 10.1161/01.RES.84.2.146; Li DS, 2000, CIRCULATION, V101, P2631, DOI 10.1161/01.CIR.101.22.2631; Li GR, 2004, HEART RHYTHM, V1, P460, DOI 10.1016/j.hrthm.2004.06.003; Li J, 2008, CIRC RES, V102, P975, DOI 10.1161/CIRCRESAHA.108.172403; LUU M, 1989, CIRCULATION, V80, P1675, DOI 10.1161/01.CIR.80.6.1675; Mangoni ME, 2003, P NATL ACAD SCI USA, V100, P5543, DOI 10.1073/pnas.0935295100; Marger L, 2011, CHANNELS, V5, P251, DOI 10.4161/chan.5.3.15266; Mitcheson JS, 1999, PFLUG ARCH EUR J PHY, V438, P68, DOI 10.1007/s004240050881; MOE GK, 1956, CIRC RES, V4, P357, DOI 10.1161/01.RES.4.4.357; Mueller O, 2000, ELECTROPHORESIS, V21, P128, DOI 10.1002/(SICI)1522-2683(20000101)21:1<128::AID-ELPS128>3.0.CO;2-M; National Institute Health and Clinical Excellence, 2010, CHRON HEART FAIL MAN; Noujaim SF, 2004, CIRCULATION, V110, P2802, DOI 10.1161/01.CIR.0000146785.15995.67; Olshansky B, 2012, HEART RHYTHM, V9, P34, DOI 10.1016/j.hrthm.2011.07.038; Ruijter JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp045; Sanders P, 2004, CIRCULATION, V110, P897, DOI 10.1161/01.CIR.0000139336.69955.AB; Sanders P, 2003, CIRCULATION, V108, P1461, DOI 10.1161/01.CIR.0000090688.49283.67; Shannon TR, 2003, CIRC RES, V93, P592, DOI 10.1161/01.RES.0000093399.11734.B3; Stephenson RS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035299; Valdivia CR, 2005, J MOL CELL CARDIOL, V38, P475, DOI 10.1016/j.yjmcc.2004.12.012; Verkerk AO, 2003, CIRCULATION, V108, P760, DOI 10.1161/01.CIR.0000083719.51661.B9; Yanni J, 2014, HISTOL HISTOPATHOL, V29, P891, DOI 10.14670/HH-29.891; Yanni J, 2011, CIRC-HEART FAIL, V4, P496, DOI 10.1161/CIRCHEARTFAILURE.110.957647; Zhang QA, 2011, J MOL CELL CARDIOL, V50, P194, DOI 10.1016/j.yjmcc.2010.10.002; Zicha S, 2005, CARDIOVASC RES, V66, P472, DOI 10.1016/j.cardiores.2005.02.011	42	17	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2015	10	10							e0141452	10.1371/journal.pone.0141452	http://dx.doi.org/10.1371/journal.pone.0141452			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0DL	26509807	Green Accepted, gold, Green Published, Green Submitted			2022-12-26	WOS:000363918100086
J	Heuch, I; Heuch, I; Hagen, K; Zwart, JA				Heuch, Ingrid; Heuch, Ivar; Hagen, Knut; Zwart, John-Anker			A Comparison of Anthropometric Measures for Assessing the Association between Body Size and Risk of Chronic Low Back Pain: The HUNT Study	PLOS ONE			English	Article							NORD-TRONDELAG-HEALTH; QUALITY-OF-LIFE; MASS INDEX; WAIST CIRCUMFERENCE; DISC DEGENERATION; FOLLOW-UP; FAT DISTRIBUTION; LUMBAR SPINE; ABDOMINAL ADIPOSITY; PHYSICAL-ACTIVITY	Background Previous work indicates that overweight and obese individuals carry an increased risk of experiencing chronic low back pain (LBP). It is not known, however, how the association with body size depends on the choice of anthropometric measure used. Objective This work compares relationships with LBP for several measures of body size. Different results may indicate underlying mechanisms for the association between body size and risk of LBP. Methods In a cohort study, baseline information was collected in the community-based HUNT2 (1995-1997) and HUNT3 (2006-2008) surveys in Norway. Participants were 10,059 women and 8725 men aged 30-69 years without LBP, and 3883 women and 2662 men with LBP at baseline. Associations with LBP at end of follow-up were assessed by generalized linear modeling, with adjustment for potential confounders. Results Relationships between waist-hip-ratio and occurrence of LBP at end of follow-up were weak and non-significant after adjustment for age, education, work status, physical activity, smoking, lipid levels and blood pressure. Positive associations with LBP at end of follow-up were all significant for body weight, BMI, waist circumference and hip circumference after similar adjustment, both in women without and with LBP at baseline, and in men without LBP at baseline. After additional mutual adjustment for anthropometric measures, the magnitude of the association with body weight increased in women without LBP at baseline (RR: 1.130 per standard deviation, 95% CI: 0.995-1.284) and in men (RR: 1.124, 95% CI 0.976-1.294), with other measures showing weak associations only. Conclusion Central adiposity is unlikely to play a major role in the etiology of LBP. Total fat mass may be one common factor underlying the associations observed. The association with body weight remaining after mutual adjustment may reflect mechanical or structural components behind the relationship between overweight or obesity and LBP.	[Heuch, Ingrid; Zwart, John-Anker] Oslo Univ Hosp, Dept Neurol, Oslo, Norway; [Heuch, Ingrid; Zwart, John-Anker] Oslo Univ Hosp, FORMI, Oslo, Norway; [Heuch, Ivar] Univ Bergen, Dept Math, N-5007 Bergen, Norway; [Hagen, Knut] Norwegian Univ Sci & Technol, Dept Neurosci, N-7034 Trondheim, Norway; [Hagen, Knut] St Olavs Hosp, Dept Neurol, Norwegian Natl Headache Ctr, Trondheim, Norway; [Zwart, John-Anker] Univ Oslo, Fac Med, Oslo, Norway	University of Oslo; University of Oslo; University of Bergen; Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); University of Oslo	Heuch, I (corresponding author), Oslo Univ Hosp, Dept Neurol, Oslo, Norway.	ingrid.heuch@ous-hf.no	Heuch, Ivar/A-4510-2008	Heuch, Ivar/0000-0003-3386-9688	Legacy of Trygve Gythfeldt and Wife	Legacy of Trygve Gythfeldt and Wife	This study was supported by grants from the Legacy of Trygve Gythfeldt and Wife. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Ingrid Heuch received the funding.	ARO S, 1985, INT J OBESITY, V9, P267; Barreira TV, 2012, MAYO CLIN PROC, V87, P452, DOI 10.1016/j.mayocp.2011.12.017; Berentzen TL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032213; Bigaard J, 2003, OBES RES, V11, P895, DOI 10.1038/oby.2003.123; Brooks C, 2013, SPINE, V38, P2190, DOI 10.1097/BRS.0000000000000002; Canoy D, 2007, CIRCULATION, V116, P2933, DOI 10.1161/CIRCULATIONAHA.106.673756; Chou D, 2011, SPINE, V36, pS43, DOI 10.1097/BRS.0b013e31822ef700; Coenen P, 2014, OCCUP ENVIRON MED, V71, P332, DOI 10.1136/oemed-2013-101862; CROFT PR, 1994, J EPIDEMIOL COMMUN H, V48, P166, DOI 10.1136/jech.48.2.166; Croft PR, 1999, SPINE, V24, P1556, DOI 10.1097/00007632-199908010-00009; Deyo RA, 2001, NEW ENGL J MED, V344, P363, DOI 10.1056/NEJM200102013440508; GARZILLO MJD, 1994, J MANIP PHYSIOL THER, V17, P601; Guh DP, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-88; Han TS, 1997, INT J OBESITY, V21, P600, DOI 10.1038/sj.ijo.0800448; Hemingway H, 1999, J EPIDEMIOL COMMUN H, V53, P197, DOI 10.1136/jech.53.4.197; Heneweer H, 2011, EUR SPINE J, V20, P826, DOI 10.1007/s00586-010-1680-7; Heuch I, 2015, BMJ OPEN, V5, DOI [10.1136/bmiopen-2014-006983, DOI 10.1136/BMIOPEN-2014-006983]; Heuch I, 2013, SPINE, V38, P133, DOI 10.1097/BRS.0b013e3182647af2; Heuch I, 2010, EPIDEMIOLOGY, V21, P837, DOI 10.1097/EDE.0b013e3181f20808; Heymsfield SB, 2009, INT J OBESITY, V33, P1363, DOI 10.1038/ijo.2009.184; Holmen J, 2003, NORSK EPIDEMIOLOGI, V13, P19, DOI DOI 10.1093/eurheartj/eht019; Hong JH, 2013, SPINE, V38, P75, DOI 10.1097/BRS.0b013e318276450f; Hoy D, 2014, ANN RHEUM DIS, V73, P968, DOI 10.1136/annrheumdis-2013-204428; Janke EA, 2007, J REHABIL RES DEV, V44, P245, DOI 10.1682/JRRD.2006.06.0060; Kauppila LI, 1997, SPINE, V22, P1642, DOI 10.1097/00007632-199707150-00023; Keith SW, 2013, MOL METAB, V2, P65, DOI 10.1016/j.molmet.2013.03.005; Koskimaki J, 2009, AM J MED, V122, pE7, DOI 10.1016/j.amjmed.2009.02.001; Krokstad S, 2013, INT J EPIDEMIOL, V42, P968, DOI 10.1093/ije/dys095; Kuisma M, 2008, BMC MUSCULOSKEL DIS, V9, DOI 10.1186/1471-2474-9-51; Kurtze N, 2008, SCAND J PUBLIC HEALT, V36, P52, DOI 10.1177/1403494807085373; Langhammer A, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-143; Lean MEJ, 1998, LANCET, V351, P853, DOI 10.1016/S0140-6736(97)10004-6; Leboeuf-Yde C, 2000, SPINE, V25, P226, DOI 10.1097/00007632-200001150-00015; Lidar Z, 2012, SPINE, V37, P1947, DOI 10.1097/BRS.0b013e31825fab16; Liuke M, 2005, INT J OBESITY, V29, P903, DOI 10.1038/sj.ijo.0802974; MELLIN G, 1987, SPINE, V12, P464, DOI 10.1097/00007632-198706000-00008; Merskey HB, 1994, CLASSIFICATION CHRON, P39; Mirtz Timothy A, 2005, Chiropr Osteopat, V13, P2, DOI 10.1186/1746-1340-13-2; Nilsen TIL, 2011, AM J EPIDEMIOL, V174, P267, DOI 10.1093/aje/kwr087; Price GM, 2006, AM J CLIN NUTR, V84, P449; Samartzis D, 2012, ARTHRITIS RHEUM-US, V64, P1488, DOI 10.1002/art.33462; Shiri R, 2008, AM J EPIDEMIOL, V167, P1110, DOI 10.1093/aje/kwn007; Shiri R, 2013, SEMIN ARTHRITIS RHEU, V42, P640, DOI 10.1016/j.semarthrit.2012.09.002; Shiri R, 2010, AM J EPIDEMIOL, V171, P135, DOI 10.1093/aje/kwp356; Snijder MB, 2003, OBES RES, V11, P104, DOI 10.1038/oby.2003.18; Srikanthan P, 2009, ANN EPIDEMIOL, V19, P724, DOI 10.1016/j.annepidem.2009.05.003; Staiano AE, 2012, INT J OBESITY, V36, P1450, DOI 10.1038/ijo.2011.268; Taanila HP, 2012, SPINE J, V12, P737, DOI 10.1016/j.spinee.2012.01.006; Tilg H, 2006, NAT REV IMMUNOL, V6, P772, DOI 10.1038/nri1937; Toda Y, 2000, ARCH INTERN MED, V160, P3265, DOI 10.1001/archinte.160.21.3265; Urquhart DM, 2014, SPINE, V39, pE962, DOI 10.1097/BRS.0000000000000411; Urquhart DM, 2011, SPINE, V36, P1320, DOI 10.1097/BRS.0b013e3181f9fb66; Vazquez G, 2007, EPIDEMIOL REV, V29, P115, DOI 10.1093/epirev/mxm008; Vinknes KJ, 2013, AM J EPIDEMIOL, V177, P586, DOI 10.1093/aje/kws271; Wormser D, 2011, LANCET, V377, P1085, DOI 10.1016/S0140-6736(11)60105-0; Yip YB, 2001, INT J OBESITY, V25, P887, DOI 10.1038/sj.ijo.0801557; Zhang C, 2008, CIRCULATION, V117, P1658, DOI 10.1161/CIRCULATIONAHA.107.739714	57	32	32	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2015	10	10							e0141268	10.1371/journal.pone.0141268	http://dx.doi.org/10.1371/journal.pone.0141268			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU8PC	26506618	gold, Green Published, Green Accepted, Green Submitted			2022-12-26	WOS:000363804200040
J	Metzger, J; Wohlke, A; Mischke, R; Hoffmann, A; Hewicker-Trautwein, M; Kuch, EM; Naim, HY; Distl, O				Metzger, Julia; Woehlke, Anne; Mischke, Reinhard; Hoffmann, Annalena; Hewicker-Trautwein, Marion; Kuech, Eva-Maria; Naim, Hassan Y.; Distl, Ottmar			A Novel SLC27A4 Splice Acceptor Site Mutation in Great Danes with Ichthyosis	PLOS ONE			English	Article							ACID TRANSPORT PROTEIN-4; ACYL-COA SYNTHETASE; CONGENITAL ICHTHYOSIS; WRINKLE-FREE; SKIN; FAMILY; REVEALS; MUTANT; GENE	Ichthyoses are a group of various different types of hereditary disorders affecting skin cornification. They are characterized by hyperkeratoses of different severity levels and are associated with a dry and scaling skin. Genome-wide association analysis of nine affected and 13 unaffected Great Danes revealed a genome-wide significant peak on chromosome 9 at 57-58 Mb in the region of SLC27A4. Sequence analysis of genomic DNA of SLC27A4 revealed the non-synonymous SNV SLC27A4: g.8684G>A in perfect association with ichthyosis-affection in Great Danes. The mutant transcript of SLC27A4 showed an in-frame loss of 54 base pairs in exon 8 probably induced by a new splice acceptor site motif created by the mutated A-allele of the SNV. Genotyping 413 controls from 35 different breeds of dogs and seven wolves revealed that this mutation could not be found in other populations except in Great Danes. Affected dogs revealed high amounts of mutant transcript but only low levels of the wild type transcript. Targeted analyses of SLC27A4 protein from skin tissues of three affected and two unaffected Great Danes indicated a markedly reduced or not detectable wild type and truncated protein levels in affected dogs but a high expression of wild type SLC27A4 protein in unaffected controls. Our data provide evidence of a new splice acceptor site creating SNV that results in a reduction or loss of intact SLC27A4 protein and probably explains the severe skin phenotype in Great Danes. Genetic testing will allow selective breeding to prevent ichthyosis-affected puppies in the future.	[Metzger, Julia; Woehlke, Anne; Distl, Ottmar] Univ Vet Med Hannover, Inst Anim Breeding & Genet, Hannover, Germany; [Mischke, Reinhard] Univ Vet Med Hannover, Clin Small Anim, Hannover, Germany; [Hoffmann, Annalena; Hewicker-Trautwein, Marion] Univ Vet Med Hannover, Dept Pathol, Hannover, Germany; [Kuech, Eva-Maria; Naim, Hassan Y.] Univ Vet Med Hannover, Dept Physiol Chem, Hannover, Germany	University of Veterinary Medicine Hannover, Foundation; University of Veterinary Medicine Hannover, Foundation; University of Veterinary Medicine Hannover, Foundation; University of Veterinary Medicine Hannover, Foundation	Distl, O (corresponding author), Univ Vet Med Hannover, Inst Anim Breeding & Genet, Hannover, Germany.	ottmar.distl@tiho-hannover.de		Metzger, Julia/0000-0002-2089-8933				Akiyama M, 2003, J INVEST DERMATOL, V121, P1029, DOI 10.1046/j.1523-1747.2003.12520.x; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; CARTER TC, 1950, J HERED, V41, P297, DOI 10.1093/oxfordjournals.jhered.a106065; Credille KM, 2009, BRIT J DERMATOL, V161, P265, DOI 10.1111/j.1365-2133.2009.09161.x; Credille KM, 2005, BRIT J DERMATOL, V153, P51, DOI 10.1111/j.1365-2133.2005.06735.x; Dahlqvist J, 2007, J MED GENET, V44, P615, DOI 10.1136/jmg.2007.050542; Dardano S, 2008, J HERED, V99, P81, DOI 10.1093/jhered/esm101; Desmet FO, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp215; Fachal L, 2014, BRIT J DERMATOL, V170, P980, DOI 10.1111/bjd.12757; Forman OP, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002462; Goldberg AL, 2003, NATURE, V426, P895, DOI 10.1038/nature02263; Grall A, 2012, NAT GENET, V44, P140, DOI 10.1038/ng.1056; Guan B, 2012, NEOPLASIA, V14, P986, DOI 10.1593/neo.121218; Hoffmann A, 2016, VET PATHOL, V53, P614, DOI 10.1177/0300985815595516; Hunter S, 2012, NUCLEIC ACIDS RES, V40, pD306, DOI 10.1093/nar/gkr948; Jia ZZ, 2007, J BIOL CHEM, V282, P20573, DOI 10.1074/jbc.M700568200; Jones P, 2014, BIOINFORMATICS, V30, P1236, DOI 10.1093/bioinformatics/btu031; Klar J, 2009, AM J HUM GENET, V85, P248, DOI 10.1016/j.ajhg.2009.06.021; KNOX WE, 1978, J HERED, V69, P391, DOI 10.1093/oxfordjournals.jhered.a108979; Mauldin EA, 2015, VET PATHOL, V52, P654, DOI 10.1177/0300985814551425; Mecklenburg L, 2000, J COMP PATHOL, V122, P307, DOI 10.1053/jcpa.1999.0371; Metzger J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056497; Milger K, 2006, J CELL SCI, V119, P4678, DOI 10.1242/jcs.03280; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Molteni L, 2006, VET REC, V158, P412, DOI 10.1136/vr.158.12.412; Moulson CL, 2007, J BIOL CHEM, V282, P15912, DOI 10.1074/jbc.M701779200; Moulson CL, 2003, P NATL ACAD SCI USA, V100, P5274, DOI 10.1073/pnas.0431186100; O'Goshi KI, 2000, SKIN PHARMACOL APPL, V13, P120, DOI 10.1159/000029916; Oji V, 2010, J AM ACAD DERMATOL, V63, P607, DOI 10.1016/j.jaad.2009.11.020; RUSSELL LJ, 1995, NAT GENET, V9, P279, DOI 10.1038/ng0395-279; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Sobol Maria, 2011, BMC Res Notes, V4, P90, DOI 10.1186/1756-0500-4-90; Thomas PD, 2004, P NATL ACAD SCI USA, V101, P15398, DOI 10.1073/pnas.0404380101; Thomas PD, 2003, GENOME RES, V13, P2129, DOI 10.1101/gr.772403	35	16	16	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2015	10	10							e0141514	10.1371/journal.pone.0141514	http://dx.doi.org/10.1371/journal.pone.0141514			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU8PC	26506231	gold, Green Published, Green Submitted			2022-12-26	WOS:000363804200081
J	Semprucci, E; Tocci, P; Cianfrocca, R; Sestito, R; Caprara, V; Veglione, M; Di Castro, V; Spadaro, F; Ferrandina, G; Bagnato, A; Rosano, L				Semprucci, E.; Tocci, P.; Cianfrocca, R.; Sestito, R.; Caprara, V.; Veglione, M.; Di Castro, V.; Spadaro, F.; Ferrandina, G.; Bagnato, A.; Rosano, L.			Endothelin A receptor drives invadopodia function and cell motility through the beta-arrestin/PDZ-RhoGEF pathway in ovarian carcinoma	ONCOGENE			English	Article							TO-MESENCHYMAL TRANSITION; CANCER CELLS; EPITHELIAL CARCINOMA; ACTIN REORGANIZATION; PDZ-RHOGEF; N-WASP; MIGRATION; ACTIVATION; RHOC; INVASION	The endothelin-1 (ET-1)/ET A receptor (ETAR) signalling pathway is a well-established driver of epithelial ovarian cancer (EOC) progression. One key process promoted by ET-1 is tumor cell invasion, which requires the scaffolding functions of beta-arrestin-1 (beta-arr1) downstream of the receptor; however, the potential role of ET-1 in inducing invadopodia, which are crucial for cellular invasion and tumor metastasis, is completely unknown. We describe here that ET-1/ETAR, through beta-arr1, activates RhoA and RhoC GTPase and downstream ROCK (Rho-associated coiled coil-forming kinase) kinase activity, promoting actin-based dynamic remodelling and enhanced cell invasion. This is accomplished by the direct interaction of beta-arr1 with PDZ-RhoGEF (postsynaptic density protein 95/disc-large/zonula occludens-RhoGEF). Interestingly, ETAR-mediated invasive properties are related to the regulation of invadopodia, as evaluated by colocalization of actin with cortactin, as well as with TKS5 and MT1-MMP (membrane type 1-matrix metalloproteinase) with areas of matrix degradation, and activation of cofilin pathway, which is crucial for regulating invadopodia activity. Depletion of PDZ-RhoGEF, or beta-arr1, or RhoC, as well as the treatment with the dual ET-1 receptor antagonist macitentan, significantly impairs invadopodia function, MMP activity and invasion, demonstrating that beta-arr1/PDZ-RhoGEF interaction mediates ETAR-driven ROCK-LIMK-cofilin pathway through the control of RhoC activity. In vivo, macitentan is able to inhibit metastatic dissemination and cofilin phosphorylation. Collectively, our data unveil a noncanonical activation of the RhoC/ROCK pathway through the beta-arr1/PDZ-RhoGEF complex as a regulator of ETAR-induced motility and metastasis, establishing ET-1 axis as a novel regulator of invadopodia protrusions through the RhoC/ROCK/LIMK/cofilin pathway during the initial steps of EOC invasion.	[Semprucci, E.; Tocci, P.; Cianfrocca, R.; Sestito, R.; Caprara, V.; Veglione, M.; Di Castro, V.; Bagnato, A.; Rosano, L.] Regina Elena Natl Canc Inst Rome, Via Elio Chianesi 53, I-00144 Rome, Italy; [Spadaro, F.] Ist Super Sanita, Dept Haematol Oncol & Mol Med, Sect Expt Immunotherapy, Rome, Italy; [Ferrandina, G.] Univ Cattolica Sacro Cuore, Gynecol Oncol Unit, Rome, Italy	Istituto Superiore di Sanita (ISS); Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli	Bagnato, A; Rosano, L (corresponding author), Regina Elena Natl Canc Inst Rome, Via Elio Chianesi 53, I-00144 Rome, Italy.	bagnato@ifo.it; rosano@ifo.it	Rosanò, Laura/B-2863-2018; Spadaro, Francesca/M-7512-2017; ROSANO', Laura/AAK-1424-2020; Ferrandina, Gabriella/AAA-9083-2019; Sestito, Rosanna/K-2361-2018; Di Castro, Valeriana/H-8873-2017; Tocci, Piera/AAX-9815-2021; Bagnato, Anna/G-9747-2016; Tocci, Piera/ABH-7630-2020; Rosanò, Laura/AAB-7821-2019	Rosanò, Laura/0000-0002-9962-6411; Spadaro, Francesca/0000-0002-6610-350X; ROSANO', Laura/0000-0002-9962-6411; Sestito, Rosanna/0000-0001-5460-2777; Di Castro, Valeriana/0000-0002-1899-3683; Tocci, Piera/0000-0003-3771-013X; Bagnato, Anna/0000-0002-7269-9522; Rosanò, Laura/0000-0002-3981-8593; FERRANDINA, Maria Gabriella/0000-0003-4672-4197	Associazione Italiana Ricerca sul Cancro (AIRC) [AIRC 14199, AIRC 12852]; Fondazione Italiana Ricerca sul Cancro (FIRC) fellowship	Associazione Italiana Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); Fondazione Italiana Ricerca sul Cancro (FIRC) fellowship(Fondazione AIRC per la ricerca sul cancro)	We gratefully acknowledge Aldo Lupo for excellent technical assistance, Maria Vincenza Sarcone for secretarial assistance. This work was supported by Associazione Italiana Ricerca sul Cancro (AIRC) to AB (AIRC 14199) and LR (AIRC 12852). PT is recipient of Fondazione Italiana Ricerca sul Cancro (FIRC) fellowship.	Aittaleb M, 2009, CELL SIGNAL, V21, P1569, DOI 10.1016/j.cellsig.2009.06.003; Anthony DF, 2011, MOL CELL BIOL, V31, P1066, DOI 10.1128/MCB.00883-10; Bhattacharya M, 2002, NAT CELL BIOL, V4, P547, DOI 10.1038/ncb821; Bravo-Cordero JJ, 2013, NAT REV MOL CELL BIO, V14, P405, DOI 10.1038/nrm3609; Bravo-Cordero JJ, 2011, CURR BIOL, V21, P635, DOI 10.1016/j.cub.2011.03.039; Chen S, 2013, INT J MOL SCI, V14, P24187, DOI 10.3390/ijms141224187; Chikumi H, 2004, ONCOGENE, V23, P233, DOI 10.1038/sj.onc.1207012; Cleghorn WM, 2015, MOL BIOL CELL, V26, P622, DOI 10.1091/mbc.E14-02-0740; Coffman L, 2013, CANCER BIOL THER, V14, P184, DOI 10.4161/cbt.22959; Cook DR, 2014, ONCOGENE, V33, P4021, DOI 10.1038/onc.2013.362; DeFea KA, 2013, PROG MOL BIOL TRANSL, V118, P205, DOI 10.1016/B978-0-12-394440-5.00008-5; Dunn HA, 2015, MOL PHARMACOL, V88, P624, DOI 10.1124/mol.115.098509; Eckert MA, 2011, CANCER CELL, V19, P372, DOI 10.1016/j.ccr.2011.01.036; Gligorijevic B, 2012, J CELL SCI, V125, P724, DOI 10.1242/jcs.092726; Gou WF, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-477; Hall A, 2009, CANCER METAST REV, V28, P5, DOI 10.1007/s10555-008-9166-3; Horiuchi A, 2003, LAB INVEST, V83, P861, DOI 10.1097/01.LAB.0000073128.16098.31; Jaiswal M, 2011, J BIOL CHEM, V286, P18202, DOI 10.1074/jbc.M111.226431; Kim SJ, 2015, CLIN CANCER RES, V21, P4630, DOI 10.1158/1078-0432.CCR-14-3195; Kim SJ, 2012, TRANSL ONCOL, V5, P39, DOI 10.1593/tlo.11286; Kim SJ, 2011, NEOPLASIA, V13, P167, DOI 10.1593/neo.10806; Korkina O, 2013, J BIOL CHEM, V288, P5364, DOI 10.1074/jbc.M112.414060; Ma XJ, 2014, J BIOL CHEM, V289, P13638, DOI 10.1074/jbc.M113.511360; Ma XJ, 2012, J BIOL CHEM, V287, P18925, DOI 10.1074/jbc.M112.352260; Martin-Villar E, 2015, ONCOGENE, V34, P4531, DOI 10.1038/onc.2014.388; Mikelis CM, 2013, J BIOL CHEM, V288, P12232, DOI 10.1074/jbc.M112.428599; Min JA, 2011, MOL PHARMACOL, V80, P760, DOI 10.1124/mol.111.072470; Mittal N, 2013, CELL REP, V5, P1010, DOI 10.1016/j.celrep.2013.10.015; Moshfegh Y, 2014, NAT CELL BIOL, V16, P571, DOI 10.1038/ncb2972; Murphy DA, 2011, NAT REV MOL CELL BIO, V12, P413, DOI 10.1038/nrm3141; Mythreye K, 2009, P NATL ACAD SCI USA, V106, P8221, DOI 10.1073/pnas.0812879106; Ogata S, 2009, INT J GYNECOL CANCER, V19, P1473, DOI 10.1111/IGC.0b013e3181c03909; Patel M, 2014, MOL PHARMACOL, V86, P252, DOI 10.1124/mol.114.093914; Pichot CS, 2010, CANCER RES, V70, P8347, DOI 10.1158/0008-5472.CAN-09-4149; Ridley AJ, 2013, J MICROSC-OXFORD, V251, P242, DOI 10.1111/jmi.12025; Roh-Johnson M, 2014, ONCOGENE, V33, P4203, DOI 10.1038/onc.2013.377; Rosano L, 2005, CANCER RES, V65, P11649, DOI 10.1158/0008-5472.CAN-05-2123; Rosano L, 2013, ONCOGENE, V32, P5066, DOI 10.1038/onc.2012.527; Rosano L, 2001, CANCER RES, V61, P8340; Rosano L, 2014, CANCER RES, V74, P7453, DOI 10.1158/0008-5472.CAN-13-3133; Rosano L, 2013, NAT REV CANCER, V13, P637, DOI 10.1038/nrc3546; Rosano L, 2011, CLIN CANCER RES, V17, P2350, DOI 10.1158/1078-0432.CCR-10-2325; Rosano L, 2009, P NATL ACAD SCI USA, V106, P2806, DOI 10.1073/pnas.0807158106; Sahai E, 2002, NAT REV CANCER, V2, P133, DOI 10.1038/nrc725; Saykali BA, 2014, CELL COMMUN ADHES, V21, P207, DOI 10.3109/15419061.2014.923845; Shankar H, 2010, J BIOL CHEM, V285, P8316, DOI 10.1074/jbc.M109.062521; Shukla AK, 2011, TRENDS BIOCHEM SCI, V36, P457, DOI 10.1016/j.tibs.2011.06.003; Siehler S, 2009, BRIT J PHARMACOL, V158, P41, DOI 10.1111/j.1476-5381.2009.00121.x; Spiering D, 2011, CELL ADHES MIGR, V5, P170, DOI 10.4161/cam.5.2.14403; Spinella F, 2013, J MOL MED, V91, P395, DOI 10.1007/s00109-012-0956-2; Struckhoff AP, 2013, J CELL SCI, V126, P4514, DOI 10.1242/jcs.132381; Ward JD, 2015, CANCER LETT, V356, P382, DOI 10.1016/j.canlet.2014.09.030; Xiao K, 2007, P NATL ACAD SCI USA, V104, P12011, DOI 10.1073/pnas.0704849104; Zhao Y, 2013, GYNECOL ONCOL, V130, P570, DOI 10.1016/j.ygyno.2013.06.004; Zhao Y, 2010, GYNECOL ONCOL, V116, P563, DOI 10.1016/j.ygyno.2009.11.015; Zheng R, 2006, ONCOGENE, V25, P5942, DOI 10.1038/sj.onc.1209586; Zoudilova M, 2010, J BIOL CHEM, V285, P14318, DOI 10.1074/jbc.M109.055806	57	40	40	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 30	2016	35	26					3432	3442		10.1038/onc.2015.403	http://dx.doi.org/10.1038/onc.2015.403			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DQ5UI	26522724				2022-12-26	WOS:000379270100008
J	Booth, ES; Basran, J; Lee, M; Handa, S; Raven, EL				Booth, Elizabeth S.; Basran, Jaswir; Lee, Michael; Handa, Sandeep; Raven, Emma L.			Substrate Oxidation by Indoleamine 2,3-Dioxygenase EVIDENCE FOR A COMMON REACTION MECHANISM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEME CHEMISTRY; MISSING PIECE; TRYPTOPHAN; INHIBITORS; REDOX; SITE	The kynurenine pathway is the major route of L-tryptophan (L-Trp) catabolism in biology, leading ultimately to the formation of NAD(+). The initial and rate-limiting step of the kynurenine pathway involves oxidation of L-Trp to N-formylkynurenine. This is an O-2-dependent process and catalyzed by indoleamine 2,3-dioxygenase and tryptophan 2,3-dioxygenase. More than 60 years after these dioxygenase enzymes were first isolated (Kotake, Y., and Masayama, I. (1936) Z. Physiol. Chem. 243, 237244), the mechanism of the reaction is not established. We examined the mechanism of substrate oxidation for a series of substituted tryptophan analogues by indoleamine 2,3-dioxygenase. We observed formation of a transient intermediate, assigned as a Compound II (ferryl) species, during oxidation of L-Trp, 1-methyl-L-Trp, and a number of other substrate analogues. The data are consistent with a common reaction mechanism for indoleamine 2,3-dioxygenase-catalyzed oxidation of tryptophan and other tryptophan analogues.	[Booth, Elizabeth S.; Lee, Michael; Handa, Sandeep; Raven, Emma L.] Univ Leicester, Dept Chem, Leicester LE1 7RH, Leics, England; [Basran, Jaswir] Univ Leicester, Dept Mol & Cellular Biol, Leicester LE1 9HN, Leics, England; [Basran, Jaswir] Univ Leicester, Henry Wellcome Labs Struct Biol, Leicester LE1 9HN, Leics, England	University of Leicester; University of Leicester; University of Leicester	Raven, EL (corresponding author), Univ Leicester, Dept Chem, Univ Rd, Leicester LE1 7RH, Leics, England.	emma.raven@le.ac.uk	Handa, Sandeep/AAV-2646-2021	Raven, Emma/0000-0002-1643-8694; Handa, Sandeep/0000-0002-7109-1523	Engineering and Physical Sciences Research Council; Biotechnology and Biological Sciences Research Council [BB/L004585/1]; BBSRC [BB/L004585/1] Funding Source: UKRI	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by an Engineering and Physical Sciences Research Council studentship grant (to E. S. B.) and Biotechnology and Biological Sciences Research Council Fellowship Grant BB/L004585/1 (to E. L. R.). The authors declare that they have no conflicts of interest with the contents of this article.	Basran J, 2008, BIOCHEMISTRY-US, V47, P4752, DOI 10.1021/bi702393b; Basran J, 2011, J AM CHEM SOC, V133, P16251, DOI 10.1021/ja207066z; CADY SG, 1991, ARCH BIOCHEM BIOPHYS, V291, P326, DOI 10.1016/0003-9861(91)90142-6; Chauhan N, 2008, BIOCHEMISTRY-US, V47, P4761, DOI 10.1021/bi702405a; Chauhan N, 2009, J AM CHEM SOC, V131, P4186, DOI 10.1021/ja808326g; Chung LW, 2008, J AM CHEM SOC, V130, P12299, DOI 10.1021/ja803107w; Chung LW, 2010, J AM CHEM SOC, V132, P11993, DOI 10.1021/ja103530v; Davydov RM, 2010, J AM CHEM SOC, V132, P5494, DOI 10.1021/ja100518z; Dolusic E, 2013, EXPERT OPIN THER PAT, V23, P1367, DOI 10.1517/13543776.2013.827662; Efimov I, 2012, J AM CHEM SOC, V134, P3034, DOI 10.1021/ja208694g; Efimov I, 2011, BIOCHEMISTRY-US, V50, P2717, DOI 10.1021/bi101732n; Forouhar F, 2007, P NATL ACAD SCI USA, V104, P473, DOI 10.1073/pnas.0610007104; Gen JF, 2012, J AM CHEM SOC, V134, P12209, DOI 10.1021/ja304164b; HAMILTON GA, 1969, ADV ENZYMOL RAMB, V32, P55; HO PS, 1983, J BIOL CHEM, V258, P4356; Joule J.A., 2000, HETEROCYCLIC CHEM; Kotake Y., 1936, H-S Z PHYSIOL CHEM, V243, P237; Lewis-Ballester A, 2009, P NATL ACAD SCI USA, V106, P17371, DOI 10.1073/pnas.0906655106; Lob S, 2009, NAT REV CANCER, V9, P445, DOI 10.1038/nrc2639; Lu CY, 2009, J AM CHEM SOC, V131, P12866, DOI 10.1021/ja9029768; Makino R, 2015, BIOCHEMISTRY-US, V54, P3604, DOI 10.1021/acs.biochem.5b00048; Meng B, 2014, PROTEINS, V82, P3210, DOI 10.1002/prot.24653; Millett ES, 2012, CURR OPIN CHEM BIOL, V16, P60, DOI 10.1016/j.cbpa.2012.01.014; Pantouris G, 2014, AMINO ACIDS, V46, P2155, DOI 10.1007/s00726-014-1766-3; Papadopoulou ND, 2005, BIOCHEMISTRY-US, V44, P14318, DOI 10.1021/bi0513958; Rohrig UF, 2010, J MED CHEM, V53, P1172, DOI 10.1021/jm9014718; Rosell FI, 2011, J BIOL CHEM, V286, P29273, DOI 10.1074/jbc.M111.262139; Yanagisawa S, 2010, CHEM LETT, V39, P36, DOI 10.1246/cl.2010.36	28	30	30	1	34	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 25	2015	290	52					30924	30930		10.1074/jbc.M115.695684	http://dx.doi.org/10.1074/jbc.M115.695684			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CZ6GK	26511316	Green Published, hybrid			2022-12-26	WOS:000367199000024
J	Ando, K; Carr, KM; Colle, M; Mansfeld, BN; Grumet, R				Ando, Kaori; Carr, Kevin M.; Colle, Marivi; Mansfeld, Ben N.; Grumet, Rebecca			Exocarp Properties and Transcriptomic Analysis of Cucumber (Cucumis sativus) Fruit Expressing Age-Related Resistance to Phytophthora capsici	PLOS ONE			English	Article							BINDING CASSETTE TRANSPORTER; GLUTATHIONE S-TRANSFERASES; SALICYLIC-ACID; CELL-DEATH; ONTOGENIC RESISTANCE; DEFENSE RESPONSES; POWDERY MILDEW; ARABIDOPSIS; PLANTS; ACCUMULATION	Very young cucumber (Cucumis sativus) fruit are highly susceptible to infection by the oomycete pathogen, Phytophthora capsici. As the fruit complete exponential growth, at approximately 10-12 days post pollination (dpp), they transition to resistance. The development of age-related resistance (ARR) is increasingly recognized as an important defense against pathogens, however, underlying mechanisms are largely unknown. Peel sections from cucumber fruit harvested at 8 dpp (susceptible) and 16 dpp (resistant) showed equivalent responses to inoculation as did whole fruit, indicating that the fruit surface plays an important role in defense against P. capsici. Exocarp from 16 dpp fruit had thicker cuticles, and methanolic extracts of peel tissue inhibited growth of P. capsici in vitro, suggesting physical or chemical components to the ARR. Transcripts specifically expressed in the peel vs. pericarp showed functional differentiation. Transcripts predominantly expressed in the peel were consistent with fruit surface associated functions including photosynthesis, cuticle production, response to the environment, and defense. Peel-specific transcripts that exhibited increased expression in 16 dpp fruit relative to 8 dpp fruit, were highly enriched (P<0.0001) for response to stress, signal transduction, and extracellular and transport functions. Specific transcripts included genes associated with potential physical barriers (i.e., cuticle), chemical defenses (flavonoid biosynthesis), oxidative stress, penetration defense, and molecular pattern (MAMP)-triggered or effector-triggered (R-gene mediated) pathways. The developmentally regulated changes in gene expression between peels from susceptible-and resistant-age fruits suggest programming for increased defense as the organ reaches full size.	[Ando, Kaori; Colle, Marivi; Mansfeld, Ben N.; Grumet, Rebecca] Michigan State Univ, Program Plant Breeding Genet & Biotechnol, E Lansing, MI 48824 USA; [Carr, Kevin M.] Michigan State Univ, Res Technol Support Facil, E Lansing, MI 48824 USA	Michigan State University; Michigan State University	Grumet, R (corresponding author), Michigan State Univ, Program Plant Breeding Genet & Biotechnol, E Lansing, MI 48824 USA.	grumet@msu.edu			USDA-NIFA-SCRI (United States Department of Agriculture-National Institute for Food and Agriculture-Specialty Crops Research Initiative) [2011-51181-30661]; Pickle Packers International - Agriculture Research Fund	USDA-NIFA-SCRI (United States Department of Agriculture-National Institute for Food and Agriculture-Specialty Crops Research Initiative); Pickle Packers International - Agriculture Research Fund	This work was supported by USDA-NIFA-SCRI (United States Department of Agriculture-National Institute for Food and Agriculture-Specialty Crops Research Initiative) 2011-51181-30661, http://nifa.usda.gov/funding-opportunity/specialty-crop-research-initiative-scri, to RG and Pickle Packers International - Agriculture Research Fund, https://www.ilovepickles.org/, to RG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abedon BG, 1996, J HERED, V87, P219, DOI 10.1093/oxfordjournals.jhered.a022988; Agati G, 2012, PLANT SCI, V196, P67, DOI 10.1016/j.plantsci.2012.07.014; Alcazar R, 2011, CURR OPIN PLANT BIOL, V14, P378, DOI 10.1016/j.pbi.2011.04.001; Ando K., 2009, THESIS MICHIGAN STAT; Ando K, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-518; Ando K, 2010, J AM SOC HORTIC SCI, V135, P291, DOI 10.21273/JASHS.135.4.291; Ando K, 2009, J AM SOC HORTIC SCI, V134, P176, DOI 10.21273/JASHS.134.2.176; Asalf B, 2014, PHYTOPATHOLOGY, V104, P954, DOI 10.1094/PHYTO-12-13-0345-R; Badri DV, 2008, PLANT PHYSIOL, V146, P762, DOI 10.1104/pp.107.109587; Banasiak J, 2013, J EXP BOT, V64, P1005, DOI 10.1093/jxb/ers380; Bigeard J, 2015, MOL PLANT, V8, P521, DOI 10.1016/j.molp.2014.12.022; Colle M, 2012, CUCURBITACEAE 2012: PROCEEDINGS OF THE XTH EUCARPIA MEETING ON GENETICS AND BREEDING OF CUCURBITACEAE, P585; Develey-Riviere MP, 2007, NEW PHYTOL, V175, P405, DOI 10.1111/j.1469-8137.2007.02130.x; Dominguez E, 2015, TRENDS PLANT SCI, V20, P551, DOI 10.1016/j.tplants.2015.05.009; Dubos C, 2010, TRENDS PLANT SCI, V15, P573, DOI 10.1016/j.tplants.2010.06.005; Dunn AR, 2013, AUSTRALAS PLANT PATH, V42, P583, DOI 10.1007/s13313-013-0222-2; Fofana B, 2005, PHYTOPATHOLOGY, V95, P114, DOI 10.1094/PHYTO-95-0114; Fu FQ, 2008, J EXP BOT, V59, P2299, DOI 10.1093/jxb/ern093; Fu ZQ, 2012, NATURE, V486, P228, DOI 10.1038/nature11162; Ge YH, 2014, J PHYTOPATHOL, V162, P48, DOI 10.1111/jph.12158; Gee CT, 2008, PLANT DIS, V92, P1067, DOI 10.1094/PDIS-92-7-1067; Gevens AJ, 2006, PLANT DIS, V90, P1276, DOI 10.1094/PD-90-1276; GILLASPY G, 1993, PLANT CELL, V5, P1439, DOI 10.1105/tpc.5.10.1439; Gusberti M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078457; Haas BJ, 2003, NUCLEIC ACIDS RES, V31, P5654, DOI 10.1093/nar/gkg770; Hausbeck MK, 2004, PLANT DIS, V88, P1292, DOI 10.1094/PDIS.2004.88.12.1292; Huang SW, 2009, NAT GENET, V41, P1275, DOI 10.1038/ng.475; Hugot K, 2004, PLANT PHYSIOL, V134, P858, DOI 10.1104/pp.103.034173; Humphry M, 2010, P NATL ACAD SCI USA, V107, P21896, DOI 10.1073/pnas.1003619107; Jasinski M, 2001, PLANT CELL, V13, P1095, DOI 10.1105/tpc.13.5.1095; Jayaprakasam B, 2003, CANCER LETT, V189, P11, DOI 10.1016/S0304-3835(02)00497-4; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Koch M, 2006, PLANT J, V47, P629, DOI 10.1111/j.1365-313X.2006.02813.x; Kuzniak E, 2015, J PLANT PHYSIOL, V181, P9, DOI 10.1016/j.jplph.2015.03.017; Lin TC, 2009, J PHYTOPATHOL, V157, P40, DOI 10.1111/j.1439-0434.2008.01448.x; MARCELIS LFM, 1993, J HORTIC SCI, V68, P665, DOI 10.1080/00221589.1993.11516398; McNally DJ, 2003, PHYSIOL MOL PLANT P, V63, P293, DOI 10.1016/j.pmpp.2004.03.005; Meyer MD, 2013, PLANT DIS, V97, P446, DOI 10.1094/PDIS-01-12-0082-RE; Noutoshi Y, 2006, PLANT MOL BIOL, V62, P29, DOI 10.1007/s11103-006-9001-6; O'Brien JA, 2012, PLANTA, V236, P765, DOI 10.1007/s00425-012-1696-9; Ongena M, 2000, PLANT PATHOL, V49, P523, DOI 10.1046/j.1365-3059.2000.00468.x; Oztetik E, 2008, BOT REV, V74, P419, DOI 10.1007/s12229-008-9013-9; Panter SN, 2002, ADV BOT RES, V38, P251, DOI 10.1016/S0065-2296(02)38032-7; Pel MJC, 2013, J EXP BOT, V64, P1237, DOI 10.1093/jxb/ers262; Provart NJ., 2003, CURRENT COMPUTER MOL, V2003, P271; Raffaele S, 2008, PLANT CELL, V20, P752, DOI 10.1105/tpc.107.054858; Rojo E, 2004, CURR BIOL, V14, P1897, DOI 10.1016/j.cub.2004.09.056; Rusterucci C, 2005, PHYSIOL MOL PLANT P, V66, P222, DOI 10.1016/j.pmpp.2005.08.004; Sanogo S, 2012, CAN J PLANT PATHOL, V34, P479, DOI 10.1080/07060661.2012.732117; Sappl PG, 2004, PLANT MOL BIOL, V54, P205, DOI 10.1023/B:PLAN.0000028786.57439.b3; Schilmiller AL, 2009, P NATL ACAD SCI USA, V106; Straus MR, 2010, PLANT J, V62, P628, DOI 10.1111/j.1365-313X.2010.04178.x; Stukkens Y, 2005, PLANT PHYSIOL, V139, P341, DOI 10.1104/pp.105.062372; Underwood W, 2008, J EXP BOT, V59, P3501, DOI 10.1093/jxb/ern205; Verrier PJ, 2008, TRENDS PLANT SCI, V13, P151, DOI 10.1016/j.tplants.2008.02.001; Whalen MC, 2005, MOL PLANT PATHOL, V6, P347, DOI [10.1111/j.1364-3703.2005.00286.x, 10.1111/J.1364-3703.2005.00286.X]; Wilson DC, 2013, PLANT MOL BIOL, V83, P235, DOI 10.1007/s11103-013-0083-7; Wisser RJ, 2011, P NATL ACAD SCI USA, V108, P7339, DOI 10.1073/pnas.1011739108; Yang XY, 2013, J EXP BOT, V64, P4541, DOI 10.1093/jxb/ert269; Yeats TH, 2013, PLANT PHYSIOL, V163, P5, DOI 10.1104/pp.113.222737; Zhang YX, 2010, P NATL ACAD SCI USA, V107, P18220, DOI 10.1073/pnas.1005225107; Zhao J, 2010, TRENDS PLANT SCI, V15, P72, DOI 10.1016/j.tplants.2009.11.006	62	14	14	3	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2015	10	11							e0142133	10.1371/journal.pone.0142133	http://dx.doi.org/10.1371/journal.pone.0142133			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV1QH	26528543	gold, Green Published, Green Submitted			2022-12-26	WOS:000364032600105
J	Liu, Y; Lv, HB; Jiang, XD; Hu, XD; Zhang, MZ; Li, XM				Liu, Yan; Lv, Huibin; Jiang, Xiaodan; Hu, Xiaodan; Zhang, Mingzhou; Li, Xuemin			Intraocular Pressure Changes during Accommodation in Progressing Myopes, Stable Myopes and Emmetropes	PLOS ONE			English	Article							GOLDMANN APPLANATION TONOMETER; AXIAL LENGTH; REBOUND TONOMETRY; REFRACTIVE ERROR; ICARE TONOMETER; GLAUCOMA; BIOMECHANICS; BIOMETRICS; THICKNESS; SUBGROUP	Purpose To investigate the changes of intraocular pressure (IOP) induced by 3-diopter (3 D) accommodation in progressing myopes, stable myopes and emmetropes. Design Cross-sectional study. Participants 318 subjects including 270 myopes and 48 emmetropes. Methods 195 progressing myopes, 75 stable myopes and 48 emmetropes participated in this study. All subjects had their IOP measured using iCare rebound tonometer while accommodative stimuli of 0 D and 3 D were presented. Main Outcome Measures IOP values without accommodation and with 3 D accommodation were measured in all subjects. Baseline IOPs and IOP changes were compared within and between groups. Results There was no significant difference in IOPs between progressing myopes, stable myopes and emmetropes when no accommodation was induced (17.47 +/- 3.46, 16.62 +/- 2.98 and 16.80 +/- 3.62 respectively, p > 0.05). IOP experienced an insignificantly slight decrease after 3 D accommodation in three groups (mean change -0.19 +/- 2.16, -0.03 +/- 1.68 and -0.39 +/- 2.65 respectively, p > 0.05). Subgroup analysis showed in progressing myopic group, IOP of children (<18 years old) declined with accommodation while IOP of adults (>= 18 years) increased, and the difference was statistically significant (p = 0.008). However, after excluding the age factor, accommodation induced IOP changes of high progressing myopes (<=- 6 D), low, moderate and non- myopes (>-6 D) was not significantly different after Bonferroni correction (p = 0.838). Conclusions Although no difference was detected between the baseline IOPs and accommodation induced IOP changes in progressing myopes, stable myopes and emmetropes, this study found accommodation could cause transient IOP elevation in adult progressing myopes.	[Liu, Yan; Lv, Huibin; Jiang, Xiaodan; Hu, Xiaodan; Zhang, Mingzhou; Li, Xuemin] Peking Univ, Hosp 3, Dept Ophthalmol, Beijing 100871, Peoples R China	Peking University	Li, XM (corresponding author), Peking Univ, Hosp 3, Dept Ophthalmol, Beijing 100871, Peoples R China.	lxmlxm66@sina.com.cn		Li, Xuemin/0000-0002-4018-9974; Li, Xuemin/0000-0001-7822-4694				ARMALY MF, 1962, INVEST OPHTH VISUAL, V1, P480; Au Eong K G, 1993, Singapore Med J, V34, P29; Brookes ST, 2004, J CLIN EPIDEMIOL, V57, P229, DOI 10.1016/j.jclinepi.2003.08.009; Brusini P, 2006, J GLAUCOMA, V15, P213, DOI 10.1097/01.ijg.0000212208.87523.66; Chakraborty R, 2011, INVEST OPHTH VIS SCI, V52, P5121, DOI 10.1167/iovs.11-7364; Coudrillier B, 2012, INVEST OPHTH VIS SCI, V53, P1714, DOI 10.1167/iovs.11-8009; Drexler W, 1998, INVEST OPHTH VIS SCI, V39, P2140; Faria-Ribeiro M, 2013, OPTOMETRY VISION SCI, V90, P9, DOI 10.1097/OPX.0b013e318278153c; Glickman ME, 2014, J CLIN EPIDEMIOL, V67, P850, DOI 10.1016/j.jclinepi.2014.03.012; GOSS DA, 1985, AM J OPTOM PHYS OPT, V62, P470; GREENE PR, 1980, AM J OPTOM PHYS OPT, V57, P902; Hartwig A, 2011, VISION RES, V51, P1712, DOI 10.1016/j.visres.2011.05.014; JENSEN H, 1992, DOC OPHTHALMOL, V82, P249, DOI 10.1007/BF00160772; Lee AJ, 2004, BRIT J OPHTHALMOL, V88, P5, DOI 10.1136/bjo.88.1.5; Leydolt C, 2008, EYE, V22, P657, DOI 10.1038/sj.eye.6702709; Loh KL, 2015, AM J OPHTHALMOL, V159, P945, DOI 10.1016/j.ajo.2015.01.029; Mallen EAH, 2006, INVEST OPHTH VIS SCI, V47, P1251, DOI 10.1167/iovs.05-1086; Manny RE, 2008, OPTOMETRY VISION SCI, V85, P97, DOI 10.1097/OPX.0b013e3181622633; McBrien NA, 2009, OPTOMETRY VISION SCI, V86, P23, DOI 10.1097/OPX.0b013e3181940669; Moghimi Sasan, 2014, J Ophthalmic Vis Res, V9, P439, DOI 10.4103/2008-322X.150812; Muttuvelu DV, 2012, ACTA OPHTHALMOL, V90, P322, DOI 10.1111/j.1755-3768.2010.01987.x; Nomura H, 2004, OPHTHAL PHYSL OPT, V24, P41, DOI 10.1046/j.1475-1313.2003.00158.x; Pruett R C, 1988, Acta Ophthalmol Suppl, V185, P117; Read SA, 2008, INVEST OPHTH VIS SCI, V49, P2911, DOI 10.1167/iovs.08-1833; Read SA, 2010, OPTOMETRY VISION SCI, V87, P656, DOI 10.1097/OPX.0b013e3181e87dd3; Read SA, 2010, BRIT J OPHTHALMOL, V94, P332, DOI 10.1136/bjo.2009.166355; Schreiber W, 2007, OPHTHALMOLOGE, V104, P299, DOI 10.1007/s00347-007-1487-z; TOMLINSON A, 1970, BRIT J OPHTHALMOL, V54, P548, DOI 10.1136/bjo.54.8.548; Vandewalle E, 2009, EUR J OPHTHALMOL, V19, P783, DOI 10.1177/112067210901900516; Vera-Diaz FA, 2002, CURR EYE RES, V24, P289, DOI 10.1076/ceyr.24.4.289.8418; Yan L, 2014, EYE, V28, P1334, DOI 10.1038/eye.2014.208; Yeo ACH, 2006, ANN ACAD MED SINGAP, V35, P868	32	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2015	10	10							e0141839	10.1371/journal.pone.0141839	http://dx.doi.org/10.1371/journal.pone.0141839			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0EH	26517725	Green Published, gold, Green Submitted			2022-12-26	WOS:000363920800084
J	Riviere, J; Le Strat, Y; Dufour, B; Hendrikx, P				Riviere, Julie; Le Strat, Yann; Dufour, Barbara; Hendrikx, Pascal			Sensitivity of Bovine Tuberculosis Surveillance in Wildlife in France: A Scenario Tree Approach	PLOS ONE			English	Article							MYCOBACTERIUM-BOVIS; MEMBER STATES; RED DEER; FREEDOM; BOAR; INFECTION; SYSTEMS; LESIONS	Bovine tuberculosis (bTB) is a common disease in cattle and wildlife, with an impact on animal and human health, and economic implications. Infected wild animals have been detected in some European countries, and bTB reservoirs in wildlife have been identified, potentially hindering the eradication of bTB from cattle populations. However, the surveillance of bTB in wildlife involves several practical difficulties and is not currently covered by EU legislation. We report here the first assessment of the sensitivity of the bTB surveillance system for free-ranging wildlife launched in France in 2011 (the Sylvatub system), based on scenario tree modelling. Three surveillance system components were identified: (i) passive scanning surveillance for hunted wild boar, red deer and roe deer, based on carcass examination, (ii) passive surveillance on animals found dead, moribund or with abnormal behaviour, for wild boar, red deer, roe deer and badger and (iii) active surveillance for wild boar and badger. The application of these three surveillance system components depends on the geographic risk of bTB infection in wildlife, which in turn depends on the prevalence of bTB in cattle. We estimated the effectiveness of the three components of the Sylvatub surveillance system quantitatively, for each species separately. Active surveillance and passive scanning surveillance by carcass examination were the approaches most likely to detect at least one infected animal in a population with a given design prevalence, regardless of the local risk level and species considered. The awareness of hunters, which depends on their training and the geographic risk, was found to affect surveillance sensitivity. The results obtained are relevant for hunters and veterinary authorities wishing to determine the actual efficacy of wildlife bTB surveillance as a function of geographic area and species, and could provide support for decision-making processes concerning the enhancement of surveillance strategies.	[Riviere, Julie; Dufour, Barbara] Alfort Natl Vet Sch, Res Unit EpiMAI USC Anses Epidemiol Anim Infect D, Maisons Alfort, France; [Le Strat, Yann] French Inst Publ Hlth Surveillance, Dept Infect Dis, St Maurice, France; [Hendrikx, Pascal] French Agcy Food Environm & Occupat Hlth & Safety, Unit UCAS, Maisons Alfort, France	Ecole Nationale Veterinaire d'Alfort (ENVA); Institute of Public Health Surveillance; Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement du Travail (ANSES); Ecole Nationale Veterinaire d'Alfort (ENVA)	Riviere, J (corresponding author), Alfort Natl Vet Sch, Res Unit EpiMAI USC Anses Epidemiol Anim Infect D, Maisons Alfort, France.	julie.riviere@vet-alfort.fr	; Le Strat, Yann/C-9848-2013	RIVIERE, Julie/0000-0002-5857-6665; Le Strat, Yann/0000-0002-6180-4200				Ahnlund H., 1980, THESIS STOCKHOLM; Alba A, 2010, PREV VET MED, V97, P107, DOI 10.1016/j.prevetmed.2010.09.002; [Anonymous], 2013, DGALSDSPAN20138129, V2013; Baubet E., 1998, THESIS U C BERNARD L; Boadella M, 2011, J VET DIAGN INVEST, V23, P77, DOI 10.1177/104063871102300111; Cameron AR, 1998, PREV VET MED, V34, P1, DOI 10.1016/S0167-5877(97)00081-0; Cannon R.M., 1982, LIVESTOCK DIS SURVEY; Corner LAL, 2006, VET MICROBIOL, V112, P303, DOI 10.1016/j.vetmic.2005.11.015; Courcoul A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090334; DZIECIOLOWSKI R, 1979, ACTA THERIOL, V24, P3; EFSA, 2013, EN450 EFSA, VEN-450; Fitzgerald SD, 2013, VET PATHOL, V50, P488, DOI 10.1177/0300985812467472; Gavier-Widen D, 2009, NEW ZEAL VET J, V57, P122, DOI 10.1080/00480169.2009.36891; Gortazar C, 2012, MAMMAL REV, V42, P193, DOI 10.1111/j.1365-2907.2011.00191.x; Hadorn DC, 2008, VET RES, V39, DOI 10.1051/vetres:2008033; Hardstaff JL, 2014, RES VET SCI, V97, pS86, DOI 10.1016/j.rvsc.2013.12.002; Lamarque F., 2000, Epidemiologie et Sante Animale, P21; Martin PAJ, 2007, PREV VET MED, V79, P98, DOI 10.1016/j.prevetmed.2006.09.007; Martin RAJ, 2007, PREV VET MED, V79, P71, DOI 10.1016/j.prevetmed.2006.09.008; Martin-Hernando MP, 2010, J COMP PATHOL, V142, P43, DOI 10.1016/j.jcpa.2009.07.003; Martin-Hernando MP, 2007, TUBERCULOSIS, V87, P360, DOI 10.1016/j.tube.2007.02.003; More SJ, 2009, PREV VET MED, V90, P254, DOI 10.1016/j.prevetmed.2009.03.013; Muller B, 2013, EMERG INFECT DIS, V19, P899, DOI 10.3201/eid1906.120543; Naranjo V, 2008, VET MICROBIOL, V127, P1, DOI 10.1016/j.vetmic.2007.10.002; O'Brien DJ, 2004, J WILDLIFE DIS, V40, P42, DOI 10.7589/0090-3558-40.1.42; Rich KM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082019; Richomme C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077842; Riviere J, 2014, VET MICROBIOL, V173, P323, DOI 10.1016/j.vetmic.2014.08.013; Rogers LM, 1997, J ZOOL, V242, P705, DOI 10.1111/j.1469-7998.1997.tb05821.x; Rohonczy EB, 1996, CAN J VET RES, V60, P108; Rolland JC, 2003, THESIS ENVT; Santos N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012663; Schoning JM, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0054253, 10.1371/journal.pone.0060336]; Servanty S., 2007, THESIS U C BERNARD L; Vicente J, 2006, VET RES, V37, P107, DOI 10.1051/vetres:2005044; Wahlstrom H, 2010, PREV VET MED, V94, P108, DOI 10.1016/j.prevetmed.2009.11.017; Zanella G, 2008, VET REC, V163, P43, DOI 10.1136/vr.163.2.43	37	15	15	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2015	10	10							e0141884	10.1371/journal.pone.0141884	http://dx.doi.org/10.1371/journal.pone.0141884			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0EH	26517372	Green Published, Green Submitted, gold			2022-12-26	WOS:000363920800090
J	Lu, XY; Hu, B; Zheng, J; Ji, C; Fan, XH; Gao, Y				Lu, Xiaoyan; Hu, Bin; Zheng, Jie; Ji, Cai; Fan, Xiaohui; Gao, Yue			Predose and Postdose Blood Gene Expression Profiles Identify the Individuals Susceptible to Acetaminophen-Induced Liver Injury in Rats	PLOS ONE			English	Article							MATRIX METALLOPROTEINASES; INDUCED HEPATOTOXICITY; OXIDATIVE STRESS; IDENTIFICATION; MODEL; PHARMACOGENETICS; METABONOMICS; DISEASE; KINASE; REPAIR	The extent of drug-induced liver injury (DILI) can vary greatly between different individuals. Thus, it is crucial to identify susceptible population to DILI. The aim of this study was to determine whether transcriptomics analysis of predose and postdose rat blood would allow prediction of susceptible individuals to DILI using the widely applied analgesic acetaminophen (APAP) as a model drug. Based on ranking in alanine aminotransferase levels, five most susceptible and five most resistant rats were identified as two sub-groups after APAP treatment. Predose and postdose gene expression profiles of blood samples from these rats were determined by microarray analysis. The expression of 158 genes innately differed in the susceptible rats from the resistant rats in predose data. In order to identify more reliable biomarkers related to drug responses for detecting individuals susceptibility to APAP-induced liver injury (AILI), the changes of these genes' expression posterior to APAP treatment were detected. Through the further screening method based on the trends of gene expression between the two sub-groups before and after drug treatment, 10 genes were identified as potential predose biomarkers to distinguish between the susceptible and resistant rats. Among them, four genes, Incenp, Rpgrip1, Sbf1, and Mmp12, were found to be reproducibly in real-time PCR with an independent set of animals. They were all innately higher expressed in resistant rats to AILI, which are closely related to cell proliferation and tissue repair functions. It indicated that rats with higher ability of cell proliferation and tissue repair prior to drug treatment might be more resistant to AILI. In this study, we demonstrated that combination of predose and postdose gene expression profiles in blood might identify the drug related inter-individual variation in DILI, which is a novel and important methodology for identifying susceptible population to DILI.	[Lu, Xiaoyan; Hu, Bin; Zheng, Jie; Ji, Cai; Fan, Xiaohui] Zhejiang Univ, Coll Pharmaceut Sci, Pharmaceut Informat Inst, Hangzhou 310003, Zhejiang, Peoples R China; [Gao, Yue] Beijing Inst Radiat Med, Dept Pharmacol & Toxicol, Beijing, Peoples R China	Zhejiang University; Academy of Military Medical Sciences - China	Fan, XH (corresponding author), Zhejiang Univ, Coll Pharmaceut Sci, Pharmaceut Informat Inst, Hangzhou 310003, Zhejiang, Peoples R China.	fanxh@zju.edu.cn; gaoyue@bmi.ac.cn	FAN, Xiaohui/F-6458-2010	FAN, Xiaohui/0000-0002-6336-3007	National ST Major Project [2012ZX09505001-001]; National Natural Science Foundation of China [81403275]; Specialized Research Fund for the Doctoral Program of Higher Education [20120101120137]; Fundamental Research Funds for the Central Universities [2015QNA7038]	National ST Major Project; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by National S&T Major Project (No. 2012ZX09505001-001), the National Natural Science Foundation of China (No. 81403275), the Specialized Research Fund for the Doctoral Program of Higher Education (No. 20120101120137) and the Fundamental Research Funds for the Central Universities (No. 2015QNA7038).	Asadollahi Akram, 2014, Int J Prev Med, V5, P1281; Baken KA, 2008, TOXICOL APPL PHARM, V226, P46, DOI 10.1016/j.taap.2007.08.026; Clayton TA, 2009, P NATL ACAD SCI USA, V106, P14728, DOI 10.1073/pnas.0904489106; Clayton TA, 2006, NATURE, V440, P1073, DOI 10.1038/nature04648; Evans WE, 2004, NATURE, V429, P464, DOI 10.1038/nature02626; Fannin RD, 2010, HEPATOLOGY, V51, P227, DOI 10.1002/hep.23330; Firestein R, 2001, J CELL SCI, V114, P2921; Gardner LD, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-530; Harrill AH, 2009, GENOME RES, V19, P1507, DOI 10.1101/gr.090241.108; Harrill AH, 2009, TOXICOL SCI, V110, P235, DOI 10.1093/toxsci/kfp096; Hinson Jack A, 2010, Handb Exp Pharmacol, P369, DOI 10.1007/978-3-642-00663-0_12; Ito Y, 2005, TOXICOL SCI, V83, P190, DOI 10.1093/toxsci/kfh291; Jaeschke H, 2011, LIFE SCI, V88, P737, DOI 10.1016/j.lfs.2011.01.025; Kheradpezhouh E, 2014, P NATL ACAD SCI USA, V111, P3176, DOI 10.1073/pnas.1322657111; Knittel T, 2000, HISTOCHEM CELL BIOL, V113, P443; Korytina GF, 2013, J HUM GENET, V58, P467, DOI 10.1038/jhg.2013.24; Liss G, 2010, EXPERT OPIN DRUG MET, V6, P1047, DOI 10.1517/17425255.2010.503706; Liu HH, 2010, GENOME RES, V20, P28, DOI 10.1101/gr.097212.109; Lu XY, 2013, FOOD CHEM TOXICOL, V55, P444, DOI 10.1016/j.fct.2013.01.020; Lu XY, 2013, NANOTECHNOLOGY, V24, DOI 10.1088/0957-4484/24/1/015106; Malarstig A, 2008, HEART, V94, P724, DOI 10.1136/hrt.2007.119271; McGill MR, 2012, TOXICOL APPL PHARM, V264, P387, DOI 10.1016/j.taap.2012.08.015; MITCHELL JR, 1973, J PHARMACOL EXP THER, V187, P185; Moore DF, 2007, P NATL ACAD SCI USA, V104, P8065, DOI 10.1073/pnas.0701991104; Nebert DW, 2008, DRUG METAB REV, V40, P187, DOI [10.1080/03602530801952864, 10.1080/03602530801952864 ]; Nebert Daniel W, 2003, Am J Pharmacogenomics, V3, P361, DOI 10.2165/00129785-200303060-00002; Padua BD, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/196598; Park HK, 2015, J VET SCI; Rao PS, 1997, TOXICOLOGY, V118, P181, DOI 10.1016/S0300-483X(97)03617-2; Roepman R, 2000, HUM MOL GENET, V9, P2095, DOI 10.1093/hmg/9.14.2095; Russmann S, 2010, HEPATOLOGY, V52, P748, DOI 10.1002/hep.23720; Sistayanarain A, 2006, ANTICANCER RES, V26, P3585; Sumida K, 2015, RAPID COMMUN MASS SP, V29, P695, DOI 10.1002/rcm.7155; Syed I, 2012, MOL CELL BIOCHEM, V365, P351, DOI 10.1007/s11010-012-1277-z; Wang T, 2012, EURASIP J WIREL COMM, P1, DOI 10.1186/1687-1499-2012-111; Welch KD, 2006, CHEM RES TOXICOL, V19, P223, DOI 10.1021/tx050285z; Welch KD, 2005, CHEM RES TOXICOL, V18, P924, DOI 10.1021/tx050011b; Winnike JH, 2010, CLIN PHARMACOL THER, V88, P45, DOI 10.1038/clpt.2009.240; Yafune A, 2013, ARCH TOXICOL, V87, P1141, DOI 10.1007/s00204-013-1011-y; Yun JW, 2014, TOXICOL LETT, V229, P59, DOI 10.1016/j.toxlet.2014.06.010; Yun JW, 2010, TOXICOL SCI, V115, P12, DOI 10.1093/toxsci/kfq037; Yun JW, 2010, TOXICOL APPL PHARM, V242, P91, DOI 10.1016/j.taap.2009.09.017; Yun JW, 2009, TOXICOL APPL PHARM, V239, P55, DOI 10.1016/j.taap.2009.05.018	43	2	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2015	10	10							e0141750	10.1371/journal.pone.0141750	http://dx.doi.org/10.1371/journal.pone.0141750			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0ED	26512990	Green Published, Green Submitted, gold			2022-12-26	WOS:000363920300079
J	Qi, J; Nie, ZN; Jiao, T; Zhang, DG				Qi, Juan; Nie, Zhongnan; Jiao, Ting; Zhang, Degang			Phosphorus and Defoliation Interact and Improve the Growth and Composition of the Plant Community and Soil Properties in an Alpine Pasture of Qinghai-Tibet Plateau	PLOS ONE			English	Article							PHOSPHATE REQUIREMENTS; NITROGEN-FERTILIZER; EFFICIENCY; PRODUCTIVITY; MANAGEMENT; NUTRITION; DENSITY; IMPACT; CLOVER; GRASS	Pasture degradation caused by overgrazing and inappropriate fertiliser management is a major production and environmental threat in Qinghai-Tibet Plateau. Previous research has focused on the effects of mixed nitrogen (N) and phosphorus (P) fertiliser and reduced grazing pressure on the plant community of the grassland; however, the role of P and how it interacts with various defoliation (the process of the complete or partial removal of the above-ground parts of plants by grazing or cutting) intensities on the plant and soil of the grassland ecosystem have not been quantified. A field experiment was conducted to quantify how P application in combination of defoliation pressure could impact the dynamic change of the plant and soil in a native alpine grassland ecosystem of the Qinghai-Tibet Plateau, China, from May 2012 to September 2014. A split-plot design with 4 replicates and repeated measures was used to determine the growth and composition of plant community and soil physical and chemical properties under various levels of P fertiliser and defoliation intensity. The results showed that applying 20 kg P/ha increased the herbage yield of Melissitus ruthenica by 68% and total pasture yield by 25%. Close defoliation favoured the growth and plant frequency of the shorter species, whereas lax defoliation favoured that of the taller plant species. Medium P rate and cutting to 3 cm above ground gave an overall best outcome in pasture yield, quality and frequency and soil moisture and nutrient concentration. Application of P fertiliser with a moderate defoliation pressure to promote legume growth and N fixation has the potential to achieve multiple benefits in increasing pasture and livestock production and improving environmental sustainability in the alpine pasture of Qinghai-Tibet Plateau, a fragile and P-deficient ecosystem zone in China and its western neighbouring countries.	[Qi, Juan; Nie, Zhongnan; Jiao, Ting; Zhang, Degang] Gansu Agr Univ, Coll Grassland Sci, Lanzhou, Gansu, Peoples R China; [Nie, Zhongnan] Dept Econ Dev Jobs Transport & Resources, Hamilton, Vic, Australia	Gansu Agricultural University	Nie, ZN (corresponding author), Gansu Agr Univ, Coll Grassland Sci, Lanzhou, Gansu, Peoples R China.	zhongnannie@gmail.com			Gansu provincial government through the senior expert program with Gansu Agricultural University	Gansu provincial government through the senior expert program with Gansu Agricultural University	The study was funded by Gansu provincial government through the senior expert program with Gansu Agricultural University.	Akiyama Tsuyoshi, 2007, Grassland Science, V53, P1, DOI 10.1111/j.1744-697X.2007.00073.x; Andrews M, 2007, ANN APPL BIOL, V151, P11, DOI 10.1111/j.1744-7348.2007.00137.x; [Anonymous], 2011, GENSTAT REL 14 1; CARADUS JR, 1980, NEW ZEAL J AGR RES, V23, P75; CARSON WP, 1988, ECOLOGY, V69, P984, DOI 10.2307/1941253; Cayley J.W.D., 1996, TECHNIQUES MEASURING; Cheng JM, 1991, GRASSLAND HERBAGE, V6, P29; Cordell D, 2011, SUSTAINABILITY-BASEL, V3, P2027, DOI 10.3390/su3102027; Cui QingHu, 2007, Pratacultural Science, V24, P20; Du Guo-Zhen, 1995, Acta Botanica Sinica, V37, P306; GOLDBERG DE, 1990, ECOLOGY, V71, P213, DOI 10.2307/1940261; Gough L, 2000, OIKOS, V89, P428, DOI 10.1034/j.1600-0706.2000.890302.x; Gu MH, 2009, NEW ZEAL J AGR RES, V52, P171, DOI 10.1080/00288230909510501; Hill JO, 2005, AUST J AGR RES, V56, P1027, DOI 10.1071/AR04279; HODGSON J, 1979, GRASS FORAGE SCI, V34, P11, DOI 10.1111/j.1365-2494.1979.tb01442.x; Hua LM, 2001, PRATACULTURAL SCI, V18, P53; JACKMAN RH, 1972, NEW ZEAL J AGR RES, V15, P667, DOI 10.1080/00288233.1972.10421623; Korn MDA, 2005, TALANTA, V65, P710, DOI 10.1016/j.talanta.2004.07.047; Lambers H, 2011, PLANT PHYSIOL, V156, P1058, DOI 10.1104/pp.111.174318; Li H, 2011, PLANT SOIL, V349, P157, DOI 10.1007/s11104-011-0909-5; Li Y, 1999, GRASSL CHINA, V3, P11; [刘兴元 LIU Xingyuan], 2006, [草业科学, Pratacultural Science], V23, P39; [洛桑·灵智多杰 Luo Sanglingzhiduojie], 2005, [资源科学, Resources science], V27, P23; Martin DW, 2001, WETLANDS, V21, P422, DOI 10.1672/0277-5212(2001)021[0422:EOWTCA]2.0.CO;2; Nie ZN, 2012, GRASS FORAGE SCI, V67, P231, DOI 10.1111/j.1365-2494.2011.00838.x; Nie ZN, 1997, PLANT SOIL, V197, P201, DOI 10.1023/A:1004249613045; Nie ZN, 2014, GRASS FORAGE SCI; Nie ZN, 2013, AGR RES UPDATES, V6, P181; Nuruzzaman M, 2005, PLANT SOIL, V271, P175, DOI 10.1007/s11104-004-2386-6; Nuttall JG, 2003, AUST J SOIL RES, V41, P277, DOI 10.1071/SR02022; OESTERHELD M, 1990, J VEG SCI, V1, P353, DOI 10.2307/3235711; OZANNE PG, 1969, AUST J AGR RES, V20, P809, DOI 10.1071/AR9690809; OZANNE PG, 1976, AUST J AGR RES, V27, P479, DOI 10.1071/AR9760479; PRATT CR, 1984, B TORREY BOT CLUB, V111, P469, DOI 10.2307/2995897; Rochester IJ, 2010, CROP PASTURE SCI, V61, P825, DOI 10.1071/CP10043; Shen JingLin, 2000, Grassland of China, P49; Simpson RJ, 2014, CROP PASTURE SCI, V65, P556, DOI 10.1071/CP13395; Unkovich M, 2012, CROP PASTURE SCI, V63, P787, DOI 10.1071/CP12180; Venterink HO, 2011, PLANT SOIL, V345, P1, DOI 10.1007/s11104-011-0796-9; Wang F, 2010, J LANZHOU U NATURAL, V46, P7; Wu GL, 2009, PLANT SOIL, V319, P115, DOI 10.1007/s11104-008-9854-3; Yang BJ, 2011, NUTR CYCL AGROECOSYS, V91, P91, DOI 10.1007/s10705-011-9448-y; Yang Zhong-ling, 2012, Shengtaixue Zazhi, V31, P2276; Zhang JH, 2006, EUR J SOIL SCI, V57, P365, DOI 10.1111/j.1365-2389.2005.00747.x; Zhang Lu-Lu, 2011, Chinese Journal of Plant Ecology, V35, P641, DOI 10.3724/SP.J.1258.2011.00641; [张镱锂 Zhang Yili], 2002, [地理研究, Geographical Research], V21, P1; Zhang ZH, 2000, PRATACULTURAL SCI, V17, P10; Zhu Z.H., 1996, CHINESE B BOT, V38, P895	48	5	7	6	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2015	10	10							e0141701	10.1371/journal.pone.0141701	http://dx.doi.org/10.1371/journal.pone.0141701			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0ED	26513363	Green Published, gold, Green Submitted			2022-12-26	WOS:000363920300072
J	Davids, M; Dheda, K; Pai, NP; Cogill, D; Pai, M; Engel, N				Davids, Malika; Dheda, Keertan; Pai, Nitika Pant; Cogill, Dolphina; Pai, Madhukar; Engel, Nora			A Survey on Use of Rapid Tests and Tuberculosis Diagnostic Practices by Primary Health Care Providers in South Africa: Implications for the Development of New Point-of-Care Tests	PLOS ONE			English	Article							XPERT MTB/RIF; IMPLEMENTATION; RESISTANCE; FEASIBILITY; SPECIMENS; ACCURACY; DELAYS; COST	Background Effective infectious disease control requires early diagnosis and treatment initiation. Point-of-care testing offers rapid turn-around-times, facilitating same day clinical management decisions. To maximize the benefits of such POC testing programs, we need to understand how rapid tests are used in everyday clinical practice. Methods In this cross-sectional survey study, 400 primary healthcare providers in two cities in South Africa were interviewed on their use of rapid tests in general, and tuberculosis diagnostic practices, between September 2012 and June 2013. Public healthcare facilities were selected using probability-sampling techniques and private healthcare providers were randomly selected from the Health Professional Council of South Africa list. To ascertain differences between the two healthcare sectors 2-sample z-tests were used to compare sample proportions. Results The numbers of providers interviewed were equally distributed between the public (n = 200) and private sector (n = 200). The most frequently reported tests in the private sector include blood pressure (99.5%), glucose finger prick (89.5%) and urine dipstick (38.5%); and in the public sector were pregnancy (100%), urine dipstick (100%), blood pressure (100%), glucose finger prick (99%) and HIV rapid test (98%). The majority of TB testing occurs in the public sector, where significantly more providers prefer Xpert MTB/RIF assay, the designated clinical TB diagnostic tool by the national TB program, as compared to the private sector (87% versus 71%, p-value >0.0001). Challenges with regard to TB diagnosis included the long laboratory turn-around-time, difficulty in obtaining sputum samples and lost results. All providers indicated that a new POC test for TB should be rapid and cheap, have good sensitivity and specificity, ease of sample acquisition, detect drug-resistance and work in HIV-infected persons. Conclusion/significance The existing centralized laboratory services, poor quality assurance, and lack of staff capacity deter the use of more rapid tests at POC. Further research into the practices and choices of these providers is necessary to aid the development of new POC tests.	[Davids, Malika; Dheda, Keertan; Cogill, Dolphina] Univ Cape Town, Lung Infect & Immun Unit, Div Pulmonol, ZA-7925 Cape Town, South Africa; [Davids, Malika; Dheda, Keertan; Cogill, Dolphina] Univ Cape Town, UCT Lung Inst, Dept Med, ZA-7925 Cape Town, South Africa; [Pai, Nitika Pant] McGill Univ, Div Clin Epidemiol, Dept Med, Montreal, PQ H3A 1A1, Canada; [Pai, Nitika Pant] McGill Univ, Ctr Hlth, Royal Victoria Hosp, Montreal, PQ H3A 1A1, Canada; [Pai, Madhukar] McGill Univ, McGill Int TB Ctr, Dept Epidemiol & Biostat, Montreal, PQ H3A 1A2, Canada; [Engel, Nora] Maastricht Univ, Dept Hlth Eth & Soc, Res Sch Publ Hlth & Primary Care, NL-6200 MD Maastricht, Netherlands	University of Cape Town; University of Cape Town; McGill University; McGill University; Royal Victoria Hospital; McGill University; Maastricht University	Davids, M (corresponding author), Univ Cape Town, Lung Infect & Immun Unit, Div Pulmonol, Anzio Rd, ZA-7925 Cape Town, South Africa.	Malika.davids@uct.ac.za	PAL, MRINAL/ABG-9676-2020; Pai, Madhukar/AAX-9901-2021	PAL, MRINAL/0000-0002-1032-272X; Pai, Madhukar/0000-0003-3667-4536; Engel, Nora/0000-0002-1823-3908	Bill and Melinda Gates Foundation [OPP OPP1061487]	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	This study was funded by the Bill and Melinda Gates Foundation (OPP OPP1061487). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, NAT TUB MAN GUID 200; Bassett IV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085197; Clouse K, 2012, SAMJ S AFR MED J, V102, P805, DOI [10.7196/SAMJ.5851, 10.7196/samj.5851]; Dheda K, 2013, RESPIROLOGY, V18, P217, DOI 10.1111/resp.12022; Drobniewski F, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-190; Engel N, 2015, TROP MED INT HEALTH, V20, P493, DOI 10.1111/tmi.12450; Hislop J, 2010, HEALTH TECHNOL ASSES, V14, P1, DOI 10.3310/hta14290; Jaroslawski S, 2012, J EPIDEMIOL GLOB HEA, V2, P39, DOI 10.1016/j.jegh.2011.12.001; Jones CHD, 2013, BMC FAM PRACT, V14, DOI 10.1186/1471-2296-14-117; Kenyon C, 2008, SAMJ S AFR MED J, V98, P350; Lawn SD, 2011, FUTURE MICROBIOL, V6, P1067, DOI [10.2217/FMB.11.84, 10.2217/fmb.11.84]; Lonnroth K, 2009, SOC SCI MED, V68, P2240, DOI 10.1016/j.socscimed.2009.03.041; Maisel AS, 2001, AM HEART J, V141, P367, DOI 10.1067/mhj.2001.113215; Marner ES, 2011, DIAGN MICR INFEC DIS, V69, P382, DOI 10.1016/j.diagmicrobio.2010.11.005; Millen SJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001933; Negin J, 2009, TROP MED INT HEALTH, V14, P849, DOI 10.1111/j.1365-3156.2009.02304.x; Pai NP, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001306; Pronyk PM, 2001, INT J TUBERC LUNG D, V5, P619; Shisana O, 2012, S AFRICAN NATL HIV P; Stein J, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-240; Theron G, 2014, LANCET, V383, P424, DOI 10.1016/S0140-6736(13)62073-5; UNITAID, 2013, UNITAID ANN REP TRAN; Wallach JB, 2007, INTERPRETATION DIAGN; *WHO, 2008, MON ACH HLTH REL MIL; Wilson D, 2011, J INFECT DIS, V204, pS1102, DOI 10.1093/infdis/jir453; Zar HJ, 2012, CLIN INFECT DIS, V55, P1088, DOI 10.1093/cid/cis598	26	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2015	10	10							e0141453	10.1371/journal.pone.0141453	http://dx.doi.org/10.1371/journal.pone.0141453			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0DL	26509894	Green Published, Green Submitted, gold			2022-12-26	WOS:000363918100087
J	Ding, JQ; Zhang, LY; Chen, JF; Li, XT; Li, YM; Cheng, HL; Huang, RR; Zhou, B; Li, ZM; Wang, JK; Wu, JY				Ding, Junqiang; Zhang, Luyan; Chen, Jiafa; Li, Xiantang; Li, Yongming; Cheng, Hongliang; Huang, Rongrong; Zhou, Bo; Li, Zhimin; Wang, Jiankang; Wu, Jianyu			Genomic Dissection of Leaf Angle in Maize (Zea mays L.) Using a Four-Way Cross Mapping Population	PLOS ONE			English	Article							GENERATION INTER-CROSS; GENETIC-ANALYSIS; ORIENTATION; TRAITS; YIELD; CONSTRUCTION; ARCHITECTURE; HYBRIDS; QTL; MAP	Increasing grain yield by the selection for optimal plant architecture has been the key focus in modern maize breeding. As a result, leaf angle, an important determinant of plant architecture, has been significantly improved to adapt to the ever-increasing plant density in maize production over the past several decades. To extend our understanding on the genetic mechanisms of leaf angle in maize, we developed the first four-way cross mapping population, consisting of 277 lines derived from four maize inbred lines with varied leaf angles. The four-way cross mapping population together with the four parental lines were evaluated for leaf angle in two environments. In this study, we reported linkage maps built in the population and quantitative trait loci (QTL) on leaf angle detected by inclusive composite interval mapping (ICIM). ICIM applies a two-step strategy to effectively separate the cofactor selection from the interval mapping, which controls the background additive and dominant effects at the same time. A total of 14 leaf angle QTL were identified, four of which were further validated in near-isogenic lines (NILs). Seven of the 14 leaf angle QTL were found to overlap with the published leaf angle QTL or genes, and the remaining QTL were unique to the four-way population. This study represents the first example of QTL mapping using a four-way cross population in maize, and demonstrates that the use of specially designed four-way cross is effective in uncovering the basis of complex and polygenetic trait like leaf angle in maize.	[Ding, Junqiang; Chen, Jiafa; Li, Xiantang; Li, Yongming; Cheng, Hongliang; Huang, Rongrong; Zhou, Bo; Li, Zhimin; Wu, Jianyu] Henan Agr Univ, Coll Agron, Synerget Innovat Ctr Henan Grain Crops, Zhengzhou, Peoples R China; [Ding, Junqiang; Chen, Jiafa; Li, Xiantang; Li, Yongming; Cheng, Hongliang; Huang, Rongrong; Zhou, Bo; Li, Zhimin; Wu, Jianyu] Henan Agr Univ, Natl Key Lab Wheat & Maize Crop Sci, Zhengzhou, Peoples R China; [Zhang, Luyan; Wang, Jiankang] Chinese Acad Agr Sci, Natl Key Facil Crop Gene Resources & Genet Improv, Inst Crop Sci, Beijing 100193, Peoples R China; [Zhang, Luyan; Wang, Jiankang] Chinese Acad Agr Sci, CIMMYT China Off, Beijing 100193, Peoples R China	Henan Agricultural University; Henan Agricultural University; Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS; Chinese Academy of Agricultural Sciences	Wang, JK (corresponding author), Chinese Acad Agr Sci, Natl Key Facil Crop Gene Resources & Genet Improv, Inst Crop Sci, Beijing 100193, Peoples R China.	wangjiankang@caas.cn; wujianyu40@126.com	li, yong/HDN-3885-2022	chen, jiafa/0000-0002-5684-6692; Wu, Jianyu/0000-0002-9090-2512				Bandillo N, 2013, RICE, V6, DOI 10.1186/1939-8433-6-11; Cavanagh C, 2008, CURR OPIN PLANT BIOL, V11, P215, DOI 10.1016/j.pbi.2008.01.002; Chen XN, 2015, EUPHYTICA, V204, P395, DOI 10.1007/s10681-015-1351-1; Churchill G, 2004, NAT GENET, V36, P1133, DOI 10.1038/ng1104-1133; DUNCAN WG, 1971, CROP SCI, V11, P482, DOI 10.2135/cropsci1971.0011183X001100040006x; Duvick DN, 2005, MAYDICA, V50, P193; Gnan S, 2014, GENETICS, V198, P1751, DOI 10.1534/genetics.114.170746; Huang BE, 2012, PLANT BIOTECHNOL J, V10, P826, DOI 10.1111/j.1467-7652.2012.00702.x; Huang XQ, 2011, P NATL ACAD SCI USA, V108, P4488, DOI 10.1073/pnas.1100465108; KNAPP SJ, 1985, CROP SCI, V25, P192, DOI 10.2135/cropsci1985.0011183X002500010046x; Kover PX, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000551; Ku LX, 2012, J EXP BOT, V63, P261, DOI 10.1093/jxb/err277; Ku LX, 2010, THEOR APPL GENET, V121, P951, DOI 10.1007/s00122-010-1364-z; LAMBERT RJ, 1978, CROP SCI, V18, P499, DOI 10.2135/cropsci1978.0011183X001800030037x; Lauer S, 2012, CROP SCI, V52, P1033, DOI [10.2135/cropsci2011.05.0274, 10.2135/cropsci2011.12.0668]; Li CH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121624; LIN S, 1973, OPER RES, V21, P498, DOI 10.1287/opre.21.2.498; Lu Ming, 2007, Yichuan, V29, P1131, DOI 10.1360/yc-007-1131; Mickelson SM, 2002, CROP SCI, V42, P1902, DOI 10.2135/cropsci2002.1902; Moreno MA, 1997, GENE DEV, V11, P616, DOI 10.1101/gad.11.5.616; Pascual L, 2015, PLANT BIOTECHNOL J, V13, P565, DOI 10.1111/pbi.12282; PENDLETON JW, 1968, AGRON J, V60, P422, DOI 10.2134/agronj1968.00021962006000040027x; PEPPER GE, 1977, CROP SCI, V17, P883, DOI 10.2135/cropsci1977.0011183X001700060017x; Ram R, 2014, GENETICS, V198, P75, DOI 10.1534/genetics.114.163014; Rebetzke GJ, 2014, PLANT BIOTECHNOL J, V12, P219, DOI 10.1111/pbi.12130; Sannemann W, 2015, MOL BREEDING, V35, DOI 10.1007/s11032-015-0284-7; SAS Institute, 2011, SAS WIND VERS 9 2; Stewart DW, 2003, AGRON J, V95, P1465, DOI 10.2134/agronj2003.1465; Sun ZiQi, 2013, Acta Agronomica Sinica, V39, P1, DOI 10.3724/SP.J.1006.2013.00001; Svenson KL, 2012, GENETICS, V190, P437, DOI 10.1534/genetics.111.132597; Tian F, 2011, NAT GENET, V43, P159, DOI 10.1038/ng.746; Tokatlidis IS, 2004, FIELD CROP RES, V88, P103, DOI 10.1016/j.fcr.2003.11.013; Verbyla AP, 2014, THEOR APPL GENET, V127, P1753, DOI 10.1007/s00122-014-2337-4; Xu SZ, 1996, GENET RES, V68, P175, DOI 10.1017/S0016672300034066; Yu YongTao, 2006, Journal of Maize Sciences, V14, P88; Zhang L, 2015, J INTEGR PLANT BIOL; Zhang LY, 2015, G3-GENES GENOM GENET, V5, P427, DOI 10.1534/g3.114.016022	37	41	47	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2015	10	10							e0141619	10.1371/journal.pone.0141619	http://dx.doi.org/10.1371/journal.pone.0141619			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0DL	26509792	gold, Green Published, Green Submitted			2022-12-26	WOS:000363918100115
J	Klinger, M; Pepin, F; Wilkins, J; Asbury, T; Wittkop, T; Zheng, JB; Moorhead, M; Faham, M				Klinger, Mark; Pepin, Francois; Wilkins, Jen; Asbury, Thomas; Wittkop, Tobias; Zheng, Jianbiao; Moorhead, Martin; Faham, Malek			Multiplex Identification of Antigen-Specific T Cell Receptors Using a Combination of Immune Assays and Immune Receptor Sequencing	PLOS ONE			English	Article							PEPTIDE; CLONES; REPERTOIRE; VIRUS; INFECTION; SELECTION; CANCER; LYMPHOCYTES; GENERATION; RESPONSES	Monitoring antigen-specific T cells is critical for the study of immune responses and development of biomarkers and immunotherapeutics. We developed a novel multiplex assay that combines conventional immune monitoring techniques and immune receptor repertoire sequencing to enable identification of T cells specific to large numbers of antigens simultaneously. We multiplexed 30 different antigens and identified 427 antigen-specific clonotypes from 5 individuals with frequencies as low as 1 per million T cells. The clonotypes identified were validated several ways including repeatability, concordance with published clonotypes, and high correlation with ELISPOT. Applying this technology we have shown that the vast majority of shared antigen-specific clonotypes identified in different individuals display the same specificity. We also showed that shared antigen-specific clonotypes are simpler sequences and are present at higher frequencies compared to non-shared clonotypes specific to the same antigen. In conclusion this technology enables sensitive and quantitative monitoring of T cells specific for hundreds or thousands of antigens simultaneously allowing the study of T cell responses with an unprecedented resolution and scale.	[Klinger, Mark; Pepin, Francois; Wilkins, Jen; Asbury, Thomas; Wittkop, Tobias; Zheng, Jianbiao; Moorhead, Martin; Faham, Malek] Adapt Biotechnol, South San Francisco, CA 94080 USA		Faham, M (corresponding author), Adapt Biotechnol, South San Francisco, CA 94080 USA.	mfaham@adaptivebiotech.com			Adaptive Biotechnologies	Adaptive Biotechnologies	The authors received no specific funding for this work. Authors are employees and stockholders of Adaptive Biotechnologies Corporation. Adaptive Biotechnologies provided support in the form of salaries for all authors, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Altman John D, 2003, Curr Protoc Immunol, VChapter 17, DOI 10.1002/0471142735.im1703s53; ARGAET VP, 1994, J EXP MED, V180, P2335, DOI 10.1084/jem.180.6.2335; Babel N, 2009, J AM SOC NEPHROL, V20, P344, DOI 10.1681/ASN.2007111225; Bacher P, 2013, CYTOM PART A, V83A, P692, DOI [10.1002/cyto.22317, 10.1002/cyto.a.22317]; Becattini S, 2015, SCIENCE, V347, P400, DOI 10.1126/science.1260668; Calarota SA, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/637649; Cameron TO, 2002, IMMUNOGENETICS, V54, P611, DOI 10.1007/s00251-002-0508-y; Cha E, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008211; Chapuis AG, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3004916; Chattopadhyay PK, 2008, CYTOM PART A, V73A, P1001, DOI 10.1002/cyto.a.20642; Hadrup SR, 2010, CANCER IMMUNOL IMMUN, V59, P1425, DOI 10.1007/s00262-010-0824-2; Hennecke J, 2000, EMBO J, V19, P5611, DOI 10.1093/emboj/19.21.5611; JONES CM, 1994, EUR J IMMUNOL, V24, P1137, DOI 10.1002/eji.1830240519; Klinger M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074231; Lim A, 2000, J IMMUNOL, V165, P2001, DOI 10.4049/jimmunol.165.4.2001; Moodie Z, 2010, CANCER IMMUNOL IMMUN, V59, P1489, DOI 10.1007/s00262-010-0875-4; MOSS PAH, 1991, P NATL ACAD SCI USA, V88, P8987, DOI 10.1073/pnas.88.20.8987; Murugan A, 2012, P NATL ACAD SCI USA, V109, P16161, DOI 10.1073/pnas.1212755109; PREVOSTBLONDEL A, 1995, J VIROL, V69, P8046; Retiere C, 2000, J VIROL, V74, P3948, DOI 10.1128/JVI.74.9.3948-3952.2000; Rizvi NA, 2015, SCIENCE, V348, P124, DOI 10.1126/science.aaa1348; Robins H, 2013, CURR OPIN IMMUNOL, V25, P646, DOI 10.1016/j.coi.2013.09.017; Robins HS, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001442; Schwanninger Angelika, 2008, Immun Ageing, V5, P14, DOI 10.1186/1742-4933-5-14; Sharma P, 2011, NAT REV CANCER, V11, P805, DOI 10.1038/nrc3153; Siota M, 2011, EXPERT REV VACCINES, V10, P299, DOI [10.1586/ERV.10.169, 10.1586/erv.10.169]; Snyder A, 2014, NEW ENGL J MED, V371, P2189, DOI 10.1056/NEJMoa1406498; Suessmuth Y, 2015, BLOOD, V125, P3835, DOI 10.1182/blood-2015-03-631853; Tran E, 2014, SCIENCE, V344, P641, DOI 10.1126/science.1251102; Trautmann L, 2005, J IMMUNOL, V175, P6123, DOI 10.4049/jimmunol.175.9.6123; van Heijst JWJ, 2013, NAT MED, V19, P372, DOI 10.1038/nm.3100; van Leeuwen EMM, 2006, BLOOD, V108, P3121, DOI 10.1182/blood-2006-03-006809; Weekes MP, 1999, J VIROL, V73, P2099, DOI 10.1128/JVI.73.3.2099-2108.1999	33	57	62	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2015	10	10							e0141561	10.1371/journal.pone.0141561	http://dx.doi.org/10.1371/journal.pone.0141561			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0DL	26509579	Green Published, Green Submitted, gold			2022-12-26	WOS:000363918100103
J	Pan, A; Teng, GG; Yuan, JM; Koh, WP				Pan, An; Teng, Gim Gee; Yuan, Jian-Min; Koh, Woon-Puay			Bidirectional Association between Self-Reported Hypertension and Gout: The Singapore Chinese Health Study	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; OF-THE-LITERATURE; SERUM URIC-ACID; BLOOD-PRESSURE; RISK-FACTORS; INCIDENT GOUT; CARDIOVASCULAR MORTALITY; INDEPENDENT MECHANISM; CELL-PROLIFERATION; FOLLOW-UP	It has been hypothesized that the association between hypertension and gout is bidirectional, however, few studies have examined this in a prospective cohort. We analyzed data from the Singapore Chinese Health Study (SCHS) follow-up I (1999-2004) and II (2006-2010) interviews, when both physician-diagnosed hypertension and gout were self-reported. We included participants with data for both follow-up interviews and who were free of heart disease, stroke and cancer at follow-up I. The analysis of hypertension and risk of gout included 31,137 participants when prevalent gout cases were excluded, while the analysis of gout and risk of hypertension included 20,369 participants when prevalent hypertension cases were excluded. Cox proportional hazards models were used to estimate multivariable-adjusted hazard ratios (HRs) and 95% confidence intervals (CIs). The mean age at follow-up I was 60.1 (SD 7.3) years, and the average follow-up was 6.8 (SD 1.4) years. In the analysis of hypertension and risk of gout, 682 incident cases were identified. Compared to normotensive participants, hypertensive patients had an88% increased risk of developing gout (HR 1.88; 95% CI 1.61-2.21). In the parallel analysis, 5,450 participants reported to have newly diagnosed hypertension during follow-up. Compared to participants without gout, those with gout had an18% increased risk of developing hypertension (HR 1.18; 95% CI 1.02-1.37). The bidirectional association was stronger in normal weight adults compared to overweight/obese individuals (P-interaction = 0.06 and 0.04, respectively). The hypertension to gout association was stronger in women compared to men (P-interaction = 0.04), while the gout to hypertension association was evident in women but not in men (P-interaction = 0.02). In conclusion, our results suggest that the hypertension-gout association is bidirectional in this cohort of Singapore Chinese adults. The potential interactions of the bidirectional association with obesity and sex deserve further investigations.	[Pan, An] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth,Minist Educ, Dept Epidemiol & Biostat,Key Lab Environm & Hlth, Wuhan 430074, Hubei, Peoples R China; [Teng, Gim Gee] Natl Univ Singapore, Yong Loo Lin Sch Med, Singapore 117595, Singapore; [Teng, Gim Gee; Koh, Woon-Puay] Natl Univ Hlth Syst, Singapore, Singapore; [Teng, Gim Gee] Natl Univ Singapore Hosp, Div Rheumatol, Univ Med Cluster, Singapore, Singapore; [Yuan, Jian-Min] Univ Pittsburgh, Div Canc Control & Populat Sci, Inst Canc, Pittsburgh, PA USA; [Yuan, Jian-Min] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Epidemiol, Pittsburgh, PA USA; [Koh, Woon-Puay] Duke NUS Grad Med Sch Singapore, Singapore, Singapore; [Koh, Woon-Puay] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore 117548, Singapore	Huazhong University of Science & Technology; National University of Singapore; National University of Singapore; National University of Singapore; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; National University of Singapore; National University of Singapore	Pan, A (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth,Minist Educ, Dept Epidemiol & Biostat,Key Lab Environm & Hlth, Wuhan 430074, Hubei, Peoples R China.	panan@hust.edu.cn	Pan, An/C-5572-2011	Pan, An/0000-0002-1089-7945; Teng, Gim Gee/0000-0002-1128-5780; Yuan, Jian-Min/0000-0002-4620-3108	National Institutes of Health, USA [NCI R01 CA144034, UM1 CA182876]; National Institutes of Health, USA [NCI R01 CA144034, UM1 CA182876]; NATIONAL CANCER INSTITUTE [UM1CA182876, R01CA144034] Funding Source: NIH RePORTER	National Institutes of Health, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by the National Institutes of Health, USA (NCI R01 CA144034 and UM1 CA182876). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alper AB, 2005, HYPERTENSION, V45, P34, DOI 10.1161/01.HYP.0000150783.79172.bb; Anzai Naohiko, 2005, Curr Rheumatol Rep, V7, P227, DOI 10.1007/s11926-996-0044-0; Bauer UE, 2014, LANCET, V384, P45, DOI 10.1016/S0140-6736(14)60648-6; Bhole V, 2010, ARTHRITIS RHEUM-US, V62, P1069, DOI 10.1002/art.27338; Campion E W, 1987, Am J Med, V82, P421, DOI 10.1016/0002-9343(87)90441-4; Chen JH, 2012, CLIN RHEUMATOL, V31, P239, DOI 10.1007/s10067-011-1802-6; Chien KL, 2011, J HUM HYPERTENS, V25, P294, DOI 10.1038/jhh.2010.63; Chobanian AV., 2003, HYPERTENSION, V42, P1206, DOI [10.1161/01.HYP.0000107251, DOI 10.1161/01.HYP.9.2_PT_2.II36, DOI 10.1161/01.HYP.0000107251.49515.C2]; Choi HK, 2005, ARCH INTERN MED, V165, P742, DOI 10.1001/archinte.165.7.742; Choi HK, 2012, BRIT MED J, V344, DOI 10.1136/bmj.d8190; Choi YJ, 2014, FASEB J, V28, P3197, DOI 10.1096/fj.13-247148; Chuang SY, 2011, ASIA PAC J CLIN NUTR, V20, P301; Clarson LE, 2015, EUR J PREV CARDIOL, V22, P335, DOI 10.1177/2047487313514895; Clarson LE, 2015, ANN RHEUM DIS, V74, P642, DOI 10.1136/annrheumdis-2014-205252; Feig DI, 2008, JAMA-J AM MED ASSOC, V300, P924, DOI 10.1001/jama.300.8.924; Feig DI, 2003, HYPERTENSION, V42, P247, DOI 10.1161/01.HYP.0000085858.66548.59; Gelber AC, 1997, ARCH INTERN MED, V157, P1436, DOI 10.1001/archinte.157.13.1436; Gibson TJ, 2013, CURR OPIN RHEUMATOL, V25, P217, DOI 10.1097/BOR.0b013e32835cedd4; Grayson PC, 2011, ARTHRIT CARE RES, V63, P102, DOI 10.1002/acr.20344; Hankin JH, 2001, NUTR CANCER, V39, P187, DOI 10.1207/S15327914nc392_5; HOCHBERG MC, 1995, ARTHRITIS RHEUM-US, V38, P628, DOI 10.1002/art.1780380508; Johnson RJ, 2003, HYPERTENSION, V41, P1183, DOI 10.1161/01.HYP.0000069700.62727.C5; Kanbay M, 2007, INT UROL NEPHROL, V39, P1227, DOI 10.1007/s11255-007-9253-3; Kanbay M, 2013, HEART, V99, P759, DOI 10.1136/heartjnl-2012-302535; Kanbay M, 2011, CLIN J AM SOC NEPHRO, V6, P1887, DOI 10.2215/CJN.11451210; Kang DH, 2005, J AM SOC NEPHROL, V16, P3553, DOI 10.1681/ASN.2005050572; Karis E, 2014, SOUTH MED J, V107, P235, DOI 10.1097/SMJ.0000000000000082; Kim SY, 2010, ARTHRIT CARE RES, V62, P170, DOI 10.1002/acr.20065; Krishnan E, 2008, ARCH INTERN MED, V168, P1104, DOI 10.1001/archinte.168.10.1104; Lawrence RC, 2008, ARTHRITIS RHEUM, V58, P26, DOI 10.1002/art.23176; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Luk AJ, 2005, AM J MANAG CARE, V11, pS435; Mazzali M, 2001, HYPERTENSION, V38, P1101, DOI 10.1161/hy1101.092839; Mazzali M, 2002, AM J PHYSIOL-RENAL, V282, pF991, DOI 10.1152/ajprenal.00283.2001; Mazzali Marilda, 2010, Curr Rheumatol Rep, V12, P108, DOI 10.1007/s11926-010-0094-1; McAdams MA, 2011, J RHEUMATOL, V38, P135, DOI 10.3899/jrheum.100418; McAdams-DeMarco MA, 2012, J CLIN HYPERTENS, V14, P675, DOI 10.1111/j.1751-7176.2012.00674.x; MESSERLI FH, 1980, ANN INTERN MED, V93, P817, DOI 10.7326/0003-4819-93-6-817; Nakanishi N, 2003, EUR J EPIDEMIOL, V18, P523, DOI 10.1023/A:1024600905574; Perlstein TS, 2004, KIDNEY INT, V66, P1465, DOI 10.1111/j.1523-1755.2004.00909.x; RAO GN, 1991, J BIOL CHEM, V266, P8604; Rothenbacher D, 2011, RHEUMATOLOGY, V50, P973, DOI 10.1093/rheumatology/keq363; ROUBENOFF R, 1991, JAMA-J AM MED ASSOC, V266, P3004, DOI 10.1001/jama.266.21.3004; Saag KG, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1907; Sanchez-Lozada LG, 2005, KIDNEY INT, V67, P237, DOI 10.1111/j.1523-1755.2005.00074.x; Singh JA, 2011, CURR OPIN RHEUMATOL, V23, P192, DOI 10.1097/BOR.0b013e3283438e13; Smith EUR, 2010, BEST PRACT RES CL RH, V24, P811, DOI 10.1016/j.berh.2010.10.004; Teng GG, 2012, ANN RHEUM DIS, V71, P924, DOI 10.1136/ard.2011.200523; Terkeltaub RA, 2003, NEW ENGL J MED, V349, P1647, DOI 10.1056/NEJMcp030733; van Durme C, 2014, J RHEUMATOL, V41, P9, DOI 10.3899/jrheum.140457; Wang JW, 2014, AM J HYPERTENS, V27, P1355, DOI 10.1093/ajh/hpu053; Wang SF, 2014, BLOOD PRESSURE, V6, P1; Wu Y, 2009, J HYPERTENS, V27, P190, DOI 10.1097/HJH.0b013e328317c8c3; Wun YT, 1998, FAM PRACT, V15, P266, DOI 10.1093/fampra/15.3.266; Yang T, 2012, METABOLISM, V61, P1747, DOI 10.1016/j.metabol.2012.05.006; Zhang Q, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-419; Zhang WL, 2009, CLIN CHEM, V55, P2026, DOI 10.1373/clinchem.2009.124891; Zhu YY, 2012, AM J MED, V125, P679, DOI 10.1016/j.amjmed.2011.09.033	58	20	25	3	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2015	10	10							e0141749	10.1371/journal.pone.0141749	http://dx.doi.org/10.1371/journal.pone.0141749			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0DL	26510154	gold, Green Submitted, Green Accepted, Green Published			2022-12-26	WOS:000363918100128
J	Theis, C; Zirbel, CL; Siederdissen, CHZ; Anthon, C; Hofacker, IL; Nielsen, H; Gorodkin, J				Theis, Corinna; Zirbel, Craig L.; Siederdissen, Christian Honer Zu; Anthon, Christian; Hofacker, Ivo L.; Nielsen, Henrik; Gorodkin, Jan			RNA 3D Modules in Genome-Wide Predictions of RNA 2D Structure	PLOS ONE			English	Article							SECONDARY STRUCTURE; NONCODING RNAS; FUNCTIONAL RNAS; SEQUENCE; MOTIF; ALIGNMENTS; PROTEIN; IDENTIFICATION; TRANSCRIPTOME; REVEALS	Recent experimental and computational progress has revealed a large potential for RNA structure in the genome. This has been driven by computational strategies that exploit multiple genomes of related organisms to identify common sequences and secondary structures. However, these computational approaches have two main challenges: they are computationally expensive and they have a relatively high false discovery rate (FDR). Simultaneously, RNA 3D structure analysis has revealed modules composed of non-canonical base pairs which occur in non-homologous positions, apparently by independent evolution. These modules can, for example, occur inside structural elements which in RNA 2D predictions appear as internal loops. Hence one question is if the use of such RNA 3D information can improve the prediction accuracy of RNA secondary structure at a genome-wide level. Here, we use RNAz in combination with 3D module prediction tools and apply them on a 13-way vertebrate sequence-based alignment. We find that RNA 3D modules predicted by metaRNAmodules and JAR3D are significantly enriched in the screened windows compared to their shuffled counterparts. The initially estimated FDR of 47.0% is lowered to below 25% when certain 3D module predictions are present in the window of the 2D prediction. We discuss the implications and prospects for further development of computational strategies for detection of RNA 2D structure in genomic sequence.	[Theis, Corinna; Anthon, Christian; Hofacker, Ivo L.; Nielsen, Henrik; Gorodkin, Jan] Univ Copenhagen, Ctr Non Coding RNA Technol & Hlth, Frederiksberg, Denmark; [Theis, Corinna; Gorodkin, Jan] Univ Copenhagen, Fac Hlth & Med Sci, Dept Vet Clin & Anim Sci, Frederiksberg, Denmark; [Zirbel, Craig L.] Bowling Green State Univ, Dept Math & Stat, Bowling Green, OH 43403 USA; [Siederdissen, Christian Honer Zu; Hofacker, Ivo L.] Univ Vienna, Inst Theoret Chem, Vienna, Austria; [Hofacker, Ivo L.] Univ Vienna, Res Grp Bioinformat & Computat Biol, Vienna, Austria; [Nielsen, Henrik] Univ Copenhagen, Panum Inst, Dept Cellular & Mol Med, Copenhagen, Denmark; [Siederdissen, Christian Honer Zu] Univ Leipzig, Dept Comp Sci, Bioinformat Grp, D-04109 Leipzig, Germany; [Siederdissen, Christian Honer Zu] Univ Leipzig, Interdisciplinary Ctr Bioinformat, D-04109 Leipzig, Germany	University of Copenhagen; University of Copenhagen; Bowling Green State University; University of Vienna; University of Vienna; University of Copenhagen; Leipzig University; Leipzig University	Gorodkin, J (corresponding author), Univ Copenhagen, Ctr Non Coding RNA Technol & Hlth, Frederiksberg, Denmark.	gorodkin@rth.dk	Hofacker, Ivo L/A-2378-2013	Hofacker, Ivo L/0000-0001-7132-0800; Anthon, Christian/0000-0002-4336-1688; Gorodkin, Jan/0000-0001-5823-4000; Honer zu Siederdissen, Christian/0000-0001-9517-5839	Danish Center for Scientific Computing (DCSC, DeiC); Innovation Fund Denmark (Programme Commission on Strategic Growth Technologies) [09-067036]; Lundbeck Foundation [R19-A2306]; Austrian Fonds zur Forderung der wissenschaftlichen Forschung [SFB F43]; Department of Health and Human Services, National Institutes of Health, NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [2R01GM085328-05]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085328] Funding Source: NIH RePORTER	Danish Center for Scientific Computing (DCSC, DeiC); Innovation Fund Denmark (Programme Commission on Strategic Growth Technologies); Lundbeck Foundation(Lundbeckfonden); Austrian Fonds zur Forderung der wissenschaftlichen Forschung(Austrian Science Fund (FWF)); Department of Health and Human Services, National Institutes of Health, NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was funded by the Danish Center for Scientific Computing (DCSC, DeiC) (JG) http://www.dcsc.dk/http://www.deic.dk; Innovation Fund Denmark (Programme Commission on Strategic Growth Technologies) (09-067036 to JG) http://innovationsfonden.dk/en; Lundbeck Foundation (R19-A2306 to JG, HN) lundbeckfonden.dk; Austrian Fonds zur Forderung der wissenschaftlichen Forschung, project "SFB F43 RNA regulation of the transcriptome" (CHzS, IH) www.fwf.ac.at; Department of Health and Human Services, National Institutes of Health, NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES (2R01GM085328-05 to CZ) http://nih.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bernhart SH, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-474; Blanchette M, 2004, GENOME RES, V14, P708, DOI 10.1101/gr.1933104; Blouin S, 2007, RNA, V13, P1256, DOI 10.1261/rna.560307; Costa FF, 2007, GENE, V386, P1, DOI 10.1016/j.gene.2006.09.028; Cruz JA, 2011, NAT METHODS, V8, P513, DOI [10.1038/NMETH.1603, 10.1038/nmeth.1603]; Ding YL, 2014, NATURE, V505, P696, DOI 10.1038/nature12756; Dinger Marcel E., 2009, Briefings in Functional Genomics & Proteomics, V8, P407, DOI 10.1093/bfgp/elp038; Edvardsson S, 2003, BIOINFORMATICS, V19, P865, DOI 10.1093/bioinformatics/btg080; Ferre-d'Amare AR, 1999, ANNU REV BIOPH BIOM, V28, P57, DOI 10.1146/annurev.biophys.28.1.57; Gesell T, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-248; Gorodkin J, 2010, TRENDS BIOTECHNOL, V28, P9, DOI 10.1016/j.tibtech.2009.09.006; Gruber A.R., 2010, PAC S BIOCOMPUT, V2010, P69; Havgaard JH, 2007, PLOS COMPUT BIOL, V3, P1896, DOI 10.1371/journal.pcbi.0030193; Hendrix DK, 2005, Q REV BIOPHYS, V38, P221, DOI 10.1017/S0033583506004215; Heppell B, 2008, BIOCHEMISTRY-US, V47, P1490, DOI 10.1021/bi701164y; Hertel J, 2014, METHODS MOL BIOL, V1097, P437, DOI 10.1007/978-1-62703-709-9_20; Huang Y, 2013, BIOCHEMISTRY-MOSCOW+, V78, P221, DOI 10.1134/S0006297913030024; Jossinet F, 2010, BIOINFORMATICS, V26, P2057, DOI 10.1093/bioinformatics/btq321; Kapranov P, 2007, SCIENCE, V316, P1484, DOI 10.1126/science.1138341; Kertesz M, 2010, NATURE, V467, P103, DOI 10.1038/nature09322; Klein DJ, 2001, EMBO J, V20, P4214, DOI 10.1093/emboj/20.15.4214; Kuhn JF, 2002, NUCLEIC ACIDS RES, V30, P931, DOI 10.1093/nar/30.4.931; Laing C, 2010, J PHYS-CONDENS MAT, V22, DOI 10.1088/0953-8984/22/28/283101; Leontis NB, 1998, J MOL BIOL, V283, P571, DOI 10.1006/jmbi.1998.2106; Leontis NB, 2002, NUCLEIC ACIDS RES, V30, P3497, DOI 10.1093/nar/gkf481; Lin YT, 2010, RNA, V16, P1540, DOI 10.1261/rna.1967910; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Martinez HM, 2008, J BIOMOL STRUCT DYN, V25, P669, DOI 10.1080/07391102.2008.10531240; Mattick JS, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000459; Mdl Pena, 2009, RNA, V15, P1949, DOI [10.1261/rna.1889509, DOI 10.1261/RNA.1889509]; Moore PB, 1999, ANNU REV BIOCHEM, V68, P287, DOI 10.1146/annurev.biochem.68.1.287; Nawrocki EP, 2014, METHODS MOL BIOL, V1097, P163, DOI 10.1007/978-1-62703-709-9_9; Nawrocki EP, 2013, BIOINFORMATICS, V29, P2933, DOI 10.1093/bioinformatics/btt509; Nissen P, 2001, P NATL ACAD SCI USA, V98, P4899, DOI 10.1073/pnas.081082398; Parisien M, 2008, NATURE, V452, P51, DOI 10.1038/nature06684; Pedersen JS, 2006, PLOS COMPUT BIOL, V2, P251, DOI 10.1371/journal.pcbi.0020033; Preker P, 2011, NUCLEIC ACIDS RES, V39, P7179, DOI 10.1093/nar/gkr370; Pyle AM, 2002, J BIOL INORG CHEM, V7, P679, DOI 10.1007/s00775-002-0387-6; Reinharz V, 2012, BIOINFORMATICS, V28, pI207, DOI 10.1093/bioinformatics/bts226; Rozhdestvensky TS, 2003, NUCLEIC ACIDS RES, V31, P869, DOI 10.1093/nar/gkg175; Serganov A, 2013, CELL, V152, P17, DOI 10.1016/j.cell.2012.12.024; Smith MA, 2013, NUCLEIC ACIDS RES, V41, P8220, DOI 10.1093/nar/gkt596; Stadler PF, 2014, METHODS MOL BIOL, V1097, P199, DOI 10.1007/978-1-62703-709-9_10; Szewczak LBW, 2005, RNA, V11, P1407, DOI 10.1261/rna.2830905; Theis C, 2013, NUCLEIC ACIDS RES, V41, P9999, DOI 10.1093/nar/gkt795; Torarinsson E, 2008, GENOME RES, V18, P242, DOI 10.1101/gr.6887408; Torarinsson E, 2006, GENOME RES, V16, P885, DOI 10.1101/gr.5226606; Underwood JG, 2010, NAT METHODS, V7, P995, DOI 10.1038/NMETH.1529; Vidovic I, 2000, MOL CELL, V6, P1331, DOI 10.1016/S1097-2765(00)00131-3; Wan Y, 2014, NATURE, V505, P706, DOI 10.1038/nature12946; Washietl S, 2004, J MOL BIOL, V342, P19, DOI 10.1016/j.jmb.2004.07.018; Washietl S, 2005, P NATL ACAD SCI USA, V102, P2454, DOI 10.1073/pnas.0409169102; Weinberg Z, 2009, NATURE, V462, P656, DOI 10.1038/nature08586; Yao ZZ, 2006, BIOINFORMATICS, V22, P445, DOI 10.1093/bioinformatics/btk008; Youssef OA, 2007, NUCLEIC ACIDS RES, V35, P6196, DOI 10.1093/nar/gkm673; Zirbel CL, 2015, NUCLEIC ACIDS RES, V43, P7504, DOI 10.1093/nar/gkv651	58	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2015	10	10							e0139900	10.1371/journal.pone.0139900	http://dx.doi.org/10.1371/journal.pone.0139900			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0DL	26509713	Green Published, Green Submitted, gold			2022-12-26	WOS:000363918100015
J	Hou, YN; Cheng, KK; Li, ZH; Ma, XH; Wei, YH; Zhang, L; Wang, Y				Hou, Yunnan; Cheng, Keke; Li, Zehua; Ma, Xiaohui; Wei, Yahong; Zhang, Lei; Wang, Yao			Biosorption of Cadmium and Manganese Using Free Cells of Klebsiella sp Isolated from Waste Water	PLOS ONE			English	Article							AQUEOUS-SOLUTIONS; HEAVY-METALS; TOXIC METALS; LEAD; COPPER; REMOVAL; BIOMASS; ZINC; BACTERIA; AMPLIFICATION	In the present study, we evaluated a bacterium that was isolated from waste water for its ability to take up cadmium and manganese. The strain, identified both biochemically and by its 16S rRNA gene sequence as Klebsiella, was named Yangling I2 and was found to be highly resistant to heavy metals. Surface characterization of the bacterium via SEM revealed gross morphological changes, with cells appearing as biconcave discs after metal exposure rather than their typical rod shape. The effects of pH, temperature, heavy metal concentration, agitation and biomass concentration on the uptake of Cd(II) and Mn(II) was measured using atomic absorption spectrophotometry. The results showed that the biosorption was most affected by pH and incubation temperature, being maximized at pH 5.0 and 30 degrees C, with absorption capacities of 170.4 and 114.1 mg/g for Cd(II) and Mn(II), respectively. Two models were investigated to compare the cells' capacity for the biosorption of Cd and Mn, and the Langmuir model based on fuzzy linear regression was found to be close to the observed absorption curves and yield binding constants of 0.98 and 0.86 for Cd and Mn, respectively. This strain of Klebsiella has approximately ten times the absorption capacity reported for other strains and is promising for the removal of heavy metals from waste water.	[Hou, Yunnan; Cheng, Keke; Li, Zehua; Ma, Xiaohui; Wei, Yahong; Zhang, Lei; Wang, Yao] Northwest A&F Univ, Coll Life Sci, Yangling, Shaanxi, Peoples R China; [Wei, Yahong; Zhang, Lei; Wang, Yao] Northwest A&F Univ, State Key Lab Crop Stress Biol Arid Areas, Yangling, Shaanxi, Peoples R China; [Wei, Yahong] Northwest A&F Univ, Biomass Energy Ctr Arid & Semiarid Lands, Yangling, Shaanxi, Peoples R China	Northwest A&F University - China; Northwest A&F University - China; Northwest A&F University - China	Wei, YH (corresponding author), Northwest A&F Univ, Coll Life Sci, Yangling, Shaanxi, Peoples R China.	yahongwei@nwsuaf.edu.cn	MA, XIAO/HHN-5611-2022		National Natural Science Foundation of China [31070453]; International Scientific and Technological Cooperation Project of Shaanxi Province [2013KW-29]; Science and Technology Innovation Project of Northwest AF University [QN2011113]; International Scientific and Technological Cooperation Project of Northwest AF University [A213021311]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); International Scientific and Technological Cooperation Project of Shaanxi Province; Science and Technology Innovation Project of Northwest AF University; International Scientific and Technological Cooperation Project of Northwest AF University	This work was supported by the National Natural Science Foundation of China (No. 31070453), by the International Scientific and Technological Cooperation Project of Shaanxi Province (No. 2013KW-29), and by the Science and Technology Innovation Project of Northwest A&F University (No. QN2011113) and the International Scientific and Technological Cooperation Project of Northwest A&F University (No. A213021311).	Abu Hasan H, 2012, J ENVIRON MANAGE, V111, P34, DOI 10.1016/j.jenvman.2012.06.027; Ahluwalia SS, 2007, BIORESOURCE TECHNOL, V98, P2243, DOI 10.1016/j.biortech.2005.12.006; Aksu Z, 2005, PROCESS BIOCHEM, V40, P997, DOI 10.1016/j.procbio.2004.04.008; [Anonymous], 2001, MERCURY CADMIUM LEAD; Benguella B, 2002, WATER RES, V36, P2463, DOI 10.1016/S0043-1354(01)00459-6; Buxbaum G, 2008, IND INORGANIC PIGMEN; Chand Shri, 1994, Indian Journal of Environmental Health, V36, P151; Chang JS, 1997, WATER RES, V31, P1651, DOI 10.1016/S0043-1354(97)00008-0; Corporation HP, 2013, J WASTE MANAGEMENT, V2013; Deng SB, 2003, LANGMUIR, V19, P5058, DOI 10.1021/la034061x; Elsner RJF, 2005, MED HYPOTHESES, V65, P607, DOI 10.1016/j.mehy.2005.01.043; Emsley J., 2011, NATURES BUILDING BLO; Finley JW, 1999, BIOFACTORS, V10, P15, DOI 10.1002/biof.5520100102; FISHER NS, 1985, MAR BIOL, V87, P137, DOI 10.1007/BF00539421; Frank JA, 2008, APPL ENVIRON MICROB, V74, P2461, DOI 10.1128/AEM.02272-07; Freundlich H, 1906, Z PHYS; GADD GM, 1990, EXPERIENTIA, V46, P834, DOI 10.1007/BF01935534; GADD GM, 1994, FEMS SYMP, P361; Galkiewicz JP, 2008, APPL ENVIRON MICROB, V74, P7828, DOI 10.1128/AEM.01303-08; Goyal N, 2003, ADV ENVIRON RES, V7, P311, DOI 10.1016/S1093-0191(02)00004-7; GUIBAL E, 1993, WATER SA, V19, P119; Guo J, 2012, CURR MICROBIOL, V65, P350, DOI 10.1007/s00284-012-0164-x; Han RP, 2005, J HAZARD MATER, V125, P266, DOI 10.1016/j.jhazmat.2005.05.031; Henriques CA, 2011, ELECTRON J BIOTECHN, V14, DOI 10.2225/vol14-issue5-fulltext-8; Langmuir I, 1918, J AM CHEM SOC, V40, P1361, DOI 10.1021/ja02242a004; Li HF, 2010, J HAZARD MATER, V179, P151, DOI 10.1016/j.jhazmat.2010.02.072; Liu Y, 2008, SEP PURIF TECHNOL, V61, P229, DOI 10.1016/j.seppur.2007.10.002; Lu WB, 2006, J HAZARD MATER, V134, P80, DOI 10.1016/j.jhazmat.2005.10.036; Luna AS, 2010, BIORESOURCE TECHNOL, V101, P5104, DOI 10.1016/j.biortech.2010.01.138; Manasi, 2014, CHEM ENG J, V235, P176, DOI 10.1016/j.cej.2013.09.016; Matheickal JT, 1999, BIORESOURCE TECHNOL, V69, P223, DOI 10.1016/S0960-8524(98)00196-5; Mishra V, 2010, CLEAN-SOIL AIR WATER, V38, P1062, DOI 10.1002/clen.201000030; Mishra V, 2010, WATER AIR SOIL POLL, V211, P489, DOI 10.1007/s11270-009-0317-0; NOURBAKHSH M, 1994, PROCESS BIOCHEM, V29, P1, DOI 10.1016/0032-9592(94)80052-9; Pardo R, 2003, ANAL BIOANAL CHEM, V376, P26, DOI 10.1007/s00216-003-1843-z; Park D, 2006, IND ENG CHEM RES, V45, P5059, DOI 10.1021/ie060002d; Parvathi K, 2007, WORLD J MICROB BIOT, V23, P671, DOI 10.1007/s11274-006-9281-7; Silva RMP, 2009, BIORESOURCE TECHNOL, V100, P1533, DOI 10.1016/j.biortech.2008.06.057; Puranik PR, 1999, BIOTECHNOL PROGR, V15, P228, DOI 10.1021/bp990002r; Shapiro A.F., 2005, FUZZY REGRESSION MOD; SHARMA YC, 1995, J COLLOID INTERF SCI, V173, P66, DOI 10.1006/jcis.1995.1297; Sheng PX, 2004, J COLLOID INTERF SCI, V275, P131, DOI 10.1016/j.jcis.2004.01.036; Song KB, 2005, IEEE T POWER SYST, V20, P96, DOI 10.1109/TPWRS.2004.835632; TANAKA H, 1988, FUZZY SET SYST, V27, P275, DOI 10.1016/0165-0114(88)90054-1; Veglio F, 1997, PROCESS BIOCHEM, V32, P99, DOI 10.1016/S0032-9592(96)00047-7; Vieira Regine H. S. F., 2000, International Microbiology, V3, P17; Vijayaraghavan K, 2011, DESALINATION, V266, P195, DOI 10.1016/j.desal.2010.08.026; Volesky B, 2001, HYDROMETALLURGY, V59, P203, DOI 10.1016/S0304-386X(00)00160-2; Wang JL, 2006, BIOTECHNOL ADV, V24, P427, DOI 10.1016/j.biotechadv.2006.03.001; Wang JL, 2009, BIOTECHNOL ADV, V27, P195, DOI 10.1016/j.biotechadv.2008.11.002; WEBER TW, 1974, AICHE J, V20, P228, DOI 10.1002/aic.690200204; Yilmaz EI, 2005, WORLD J MICROB BIOT, V21, P777, DOI 10.1007/s11274-004-7258-y; YIN J, 1989, BIOTECHNOL BIOENG, V34, P180, DOI 10.1002/bit.260340206; Zouboulis AI, 2004, PROCESS BIOCHEM, V39, P909, DOI 10.1016/S0032-9592(03)00200-0	54	27	28	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2015	10	10							e0140962	10.1371/journal.pone.0140962	http://dx.doi.org/10.1371/journal.pone.0140962			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU8PC	26505890	Green Published, Green Submitted, gold			2022-12-26	WOS:000363804200023
J	Shen, B; Jiang, WH; Fan, J; Dai, W; Ding, XX; Jiang, YP				Shen, Bin; Jiang, Wenhong; Fan, Jie; Dai, Wei; Ding, Xinxin; Jiang, Yongping			Residues 39-56 of Stem Cell Factor Protein Sequence Are Capable of Stimulating the Expansion of Cord Blood CD34(+) Cells	PLOS ONE			English	Article							HEMATOPOIETIC GROWTH-FACTOR; EX-VIVO EXPANSION; STRUCTURAL BASIS; KIT RECEPTOR; SI-LOCUS; LIGAND; MOUSE; GENE; TRANSPLANTATION; ACTIVATION	Background Stem cell factor (SCF) can stimulate hematopoietic stem cell (HSC) expansion; however, the specific structural region(s) of SCF protein that are critical for this function are still unknown. A novel monoclonal antibody (named 23C8) against recombinant human SCF (rhSCF) was previously found to inhibit the ability of rhSCF to enhance HSC expansion, making it possible to identify the relevant active region to HSC. Methods Eleven polypeptides were synthesized, which were designed to cover the full-length of rhSCF, with overlaps that are at least 3 amino acids long. ELISA was used to identify the polypeptide(s) that specifically react with the anti-SCF. The effects of the synthetic polypeptides on human HSC expansion, or on the ability of the full-length rhSCF to stimulate cell proliferation, were evaluated ex vivo. Total cell number was monitored using hemocytometer whereas CD34(+) cell number was calculated based on the proportion determined via flow cytometry on day 6 of culture. Results Of all polypeptides analyzed, only one, named P0, corresponding to the SCF protein sequence at residues 39-56, was recognized by 23C8 mAb during ELISA. P0 stimulated the expansion of CD34(+) cells derived from human umbilical cord blood (UCB). Addition of P0 increased the numbers of total mononucleated cells and CD34(+) cells, by similar to 2 fold on day 6. P0 also showed partial competition against full-length rhSCF in the ex vivo cell expansion assay. Conclusion Residues 39-56 of rhSCF comprise a critical functional region for its ability to enhance expansion of human UCB CD34(+) cells. The peptide P0 is a potential candidate for further development as a synthetic substitute for rhSCF in laboratory and clinical applications.	[Shen, Bin; Fan, Jie; Dai, Wei; Ding, Xinxin; Jiang, Yongping] Chinese Acad Med Sci, Biopharmaceut R&D Ctr, Suzhou, Peoples R China; [Shen, Bin; Fan, Jie; Dai, Wei; Ding, Xinxin; Jiang, Yongping] Peking Union Med Coll, Suzhou, Peoples R China; [Jiang, Wenhong] Biopharmagen Corp, Suzhou, Peoples R China; [Dai, Wei] NYU, Langone Med Ctr, Dept Environm Med, Tuxedo Pk, NY USA; [Ding, Xinxin] SUNY Polytech Inst, Coll Nanoscale Sci, Albany, NY USA	Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; New York University; NYU Langone Medical Center; SUNY Polytechnic Institute	Ding, XX (corresponding author), Chinese Acad Med Sci, Biopharmaceut R&D Ctr, Suzhou, Peoples R China.	xding@sunypoly.edu; yjiang@biopharmagen.com			 [2011ZX09102-010-04];  [2011ZX09401-027];  [2013DFA30830]; NATIONAL CANCER INSTITUTE [P30CA016087] Funding Source: NIH RePORTER	; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was funded by 2011ZX09102-010-04 YJ and 2011ZX09401-027 YJ 2013DFA30830 YJ. YJ conceived and designed the experiments, analyzed the data and contributed to the writing of the manuscript. Wenhong Jiang is currently employed by Biopharmagen Corp. The funder provided support in the form of salaries for author WJ, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions" section.	ANDERSON DM, 1991, CELL GROWTH DIFFER, V2, P373; Ashman LK, 1999, INT J BIOCHEM CELL B, V31, P1037, DOI 10.1016/S1357-2725(99)00076-X; Barker JN, 2005, BLOOD, V105, P1343, DOI 10.1182/blood-2004-07-2717; Broudy VC, 1997, BLOOD, V90, P1345, DOI 10.1182/blood.V90.4.1345.1345_1345_1364; Brunstein CG, 2010, BLOOD, V116, P4693, DOI 10.1182/blood-2010-05-285304; Cohen Y, 2004, BLOOD REV, V18, P167, DOI 10.1016/S0268-960X(03)00064-X; Cohen Yossi, 2003, Cell and Tissue Banking, V4, P29, DOI 10.1023/A:1026379514314; COPELAND NG, 1990, CELL, V63, P175, DOI 10.1016/0092-8674(90)90298-S; Dahlberg A, 2011, BLOOD, V117, P6083, DOI 10.1182/blood-2011-01-283606; Fan J, 2012, J HEMATOL ONCOL, V5, DOI 10.1186/1756-8722-5-73; GALLI SJ, 1994, ADV IMMUNOL, V55, P1; GEISSLER EN, 1991, SOMAT CELL MOLEC GEN, V17, P207, DOI 10.1007/BF01232978; HUANG E, 1990, CELL, V63, P225, DOI 10.1016/0092-8674(90)90303-V; HUANG EJ, 1992, MOL BIOL CELL, V3, P349, DOI 10.1091/mbc.3.3.349; Jiang YP, 2011, J HEMATOL ONCOL, V4, DOI 10.1186/1756-8722-4-28; Kelly SS, 2009, BONE MARROW TRANSPL, V44, P673, DOI 10.1038/bmt.2009.284; Kent D, 2008, CLIN CANCER RES, V14, P1926, DOI 10.1158/1078-0432.CCR-07-5134; Liao WB, 2013, J HEMATOL ONCOL, V6, DOI 10.1186/1756-8722-6-84; Liu HL, 2007, EMBO J, V26, P891, DOI 10.1038/sj.emboj.7601545; Liu Xiao-xiao, 2010, Chinese Medical Sciences Journal, V25, P13; Montrone C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070348; Noulin F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112496; Ren ZH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107823; Scholbach J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046772; Weng YP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103251; WYPYCH J, 1995, BLOOD, V85, P66, DOI 10.1182/blood.V85.1.66.bloodjournal85166; Xu D, 2011, J HEMATOL ONCOL, V4, DOI 10.1186/1756-8722-4-54; Yang JC, 2011, J HEMATOL ONCOL, V4, DOI 10.1186/1756-8722-4-38; Yuzawa S, 2007, CELL, V130, P323, DOI 10.1016/j.cell.2007.05.055; ZSEBO KM, 1990, CELL, V63, P195, DOI 10.1016/0092-8674(90)90300-4; ZSEBO KM, 1990, CELL, V63, P213, DOI 10.1016/0092-8674(90)90302-U	31	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2015	10	10							e0141485	10.1371/journal.pone.0141485	http://dx.doi.org/10.1371/journal.pone.0141485			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU8PC	26505626	Green Published, gold, Green Submitted			2022-12-26	WOS:000363804200076
J	Wang, Y; Wang, JH; Chai, GQ; Li, CL; Hu, YG; Chen, XH; Wang, ZH				Wang, Yong; Wang, Jiahuan; Chai, Guaiqiang; Li, Chunlian; Hu, Yingang; Chen, Xinhong; Wang, Zhonghua			Developmental Changes in Composition and Morphology of Cuticular Waxes on Leaves and Spikes of Glossy and Glaucous Wheat (Triticum aestivum L.)	PLOS ONE			English	Article							EPICUTICULAR-WAXES; PLANT-SURFACES; BIOSYNTHESIS; MAIZE; INHIBITOR; MUTATION; LIPIDS; CUTIN; LIGHT; PARTS	The glossy varieties (A14 and Jing 2001) and glaucous varieties (Fanmai 5 and Shanken 99) of wheat (Triticum aestivum L.) were selected for evaluation of developmental changes in the composition and morphology of cuticular waxes on leaves and spikes. The results provide us with two different wax development patterns between leaf and spike. The general accumulation trend of the total wax load on leaf and spike surfaces is first to increase and then decrease during the development growth period, but these changes were caused by different compound classes between leaf and spike. Developmental changes of leaf waxes were mainly the result of variations in composition of alcohols and alkanes. In addition, diketones were the third important contributor to the leaf wax changes in the glaucous varieties. Alkanes and diketones were the two major compound classes that caused the developmental changes of spike waxes. For leaf waxes, beta- and OH-beta-diketones were first detected in flag leaves from 200-day-old plants, and the amounts of beta- and OH-beta-diketones were significantly higher in glaucous varieties compared with glossy varieties. In spike waxes, beta-diketone existed in all varieties, but OH-beta-diketone was detectable only in the glaucous varieties. Unexpectedly, the glaucous variety Fanmai 5 yielded large amounts of OH-beta-diketone. There was a significant shift in the chain length distribution of alkanes between early stage leaf and flag leaf. Unlike C-28 alcohol being the dominant chain length in leaf waxes, the dominant alcohol chain length of spikes was C-24 or C-26 depending on varieties. Epicuticular wax crystals on wheat leaf and glume were comprised of platelets and tubules, and the crystal morphology changed constantly throughout plant growth, especially the abaxial leaf crystals. Moreover, our results suggested that platelets and tubules on glume surfaces could be formed rapidly within a few days.	[Wang, Yong; Wang, Jiahuan; Chai, Guaiqiang; Li, Chunlian; Hu, Yingang; Chen, Xinhong; Wang, Zhonghua] Northwest A&F Univ, Coll Agron, State Key Lab Crop Stress Biol Arid Areas, Yangling, Shaanxi, Peoples R China	Northwest A&F University - China	Wang, ZH (corresponding author), Northwest A&F Univ, Coll Agron, State Key Lab Crop Stress Biol Arid Areas, Yangling, Shaanxi, Peoples R China.	zhwangnew@126.com		Wang, Zhonghua/0000-0001-5470-3092	National Natural Science Foundation of China [31271794, 31471568]; Science and Technology Innovation Team Project of Shaanxi Province, China [2014KCT-25]; Natural Science Foundation of Shaanxi Province, China [2014JQ3089]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Innovation Team Project of Shaanxi Province, China; Natural Science Foundation of Shaanxi Province, China(Natural Science Foundation of Shaanxi Province)	This work was supported by the National Natural Science Foundation of China (grant numbers: 31271794, 31471568), Science and Technology Innovation Team Project of Shaanxi Province, China (grant number: 2014KCT-25), and the Natural Science Foundation of Shaanxi Province, China (grant number: 2014JQ3089). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamski NM, 2013, PLANT J, V74, P989, DOI 10.1111/tpj.12185; ARAUS JL, 1991, PLANT CELL ENVIRON, V14, P545, DOI 10.1111/j.1365-3040.1991.tb01525.x; AVATO P, 1990, PHYTOCHEMISTRY, V29, P1571, DOI 10.1016/0031-9422(90)80124-Y; Baker E. A., 1982, The plant cuticle, P139; Barthlott W, 1996, FLORA, V191, P169; Barthlott W, 1997, PLANTA, V202, P1, DOI 10.1007/s004250050096; Barthlott W, 1998, BOT J LINN SOC, V126, P237, DOI 10.1111/j.1095-8339.1998.tb02529.x; BIANCHI A, 1985, MAYDICA, V30, P179; BIANCHI G, 1989, PHYTOCHEMISTRY, V28, P165, DOI 10.1016/0031-9422(89)85031-9; BIANCHI G, 1980, PLANTA, V148, P328, DOI 10.1007/BF00388119; BIANCHI G, 1986, J AGR FOOD CHEM, V34, P429, DOI 10.1021/jf00069a012; Buschhaus C, 2007, NEW PHYTOL, V176, P311, DOI 10.1111/j.1469-8137.2007.02190.x; Eigenbrode SD, 2000, ENTOMOL EXP APPL, V97, P161, DOI 10.1023/A:1004051823556; Javelle M, 2011, NEW PHYTOL, V189, P17, DOI 10.1111/j.1469-8137.2010.03514.x; Jeffree C. E, 1996, PLANT CUTICLES INTEG, P33; Jenks M. A., 1999, Horticultural Reviews, V23, P1, DOI 10.1002/9780470650752.ch1; JENKS MA, 1995, PLANT PHYSIOL, V108, P369, DOI 10.1104/pp.108.1.369; Jetter R, 2006, ANNU PLANT REV, V23, P145; Kerstiens G, 1996, TRENDS PLANT SCI, V1, P125, DOI 10.1016/S1360-1385(96)90007-2; Koch K, 2006, PLANTA, V223, P258, DOI 10.1007/s00425-005-0081-3; Koch K, 2008, MICRON, V39, P759, DOI 10.1016/j.micron.2007.11.010; Kolattukudy PE, 2001, ADV BIOCHEM ENG BIOT, P4; Kosma DK., 2007, ADV MOL BREEDING DRO, P91, DOI DOI 10.1007/978-1-4020-5578-2_5; Kosma DK, 2009, PLANT PHYSIOL, V151, P1918, DOI 10.1104/pp.109.141911; Li YH, 2009, BIOCHIMIE, V91, P685, DOI 10.1016/j.biochi.2009.03.016; LOWE HJB, 1985, ANN APPL BIOL, V106, P555, DOI 10.1111/j.1744-7348.1985.tb03146.x; Meusel I, 2000, PLANT BIOLOGY, V2, P462, DOI 10.1055/s-2000-5961; Pollard M, 2008, TRENDS PLANT SCI, V13, P236, DOI 10.1016/j.tplants.2008.03.003; PostBeittenmiller D, 1996, ANNU REV PLANT PHYS, V47, P405, DOI 10.1146/annurev.arplant.47.1.405; PREUSS D, 1993, GENE DEV, V7, P974, DOI 10.1101/gad.7.6.974; Reina-Pinto JJ, 2009, PLANT PHYSIOL BIOCH, V47, P540, DOI 10.1016/j.plaphy.2009.01.004; Samuels L, 2008, ANNU REV PLANT BIOL, V59, P683, DOI 10.1146/annurev.arplant.59.103006.093219; Shepherd T, 2006, NEW PHYTOL, V171, P469, DOI 10.1111/j.1469-8137.2006.01826.x; TULLOCH AP, 1974, PHYTOCHEMISTRY, V13, P2535, DOI 10.1016/S0031-9422(00)86932-0; TULLOCH AP, 1973, PHYTOCHEMISTRY, V12, P2225, DOI 10.1016/0031-9422(73)85124-6; VONWETTSTEINKNOWLES P, 1974, J ULTRA MOL STRUCT R, V46, P483, DOI 10.1016/S0022-5320(74)90069-0; Wang J, 2014, THEOR APPL GENET, V127, P831, DOI 10.1007/s00122-014-2260-8; Wang Y, 2015, J EXP BOT, V66, P1165, DOI 10.1093/jxb/eru457; Yeats TH, 2013, PLANT PHYSIOL, V163, P5, DOI 10.1104/pp.113.222737; Zhang ZG, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0054129, 10.1371/journal.pone.0056344, 10.1371/journal.pone.0054577, 10.1371/journal.pone.0065268]; ZIEGLERJONS A, 1989, PLANTA, V178, P164, DOI 10.1007/BF00392530	41	42	49	2	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2015	10	10							e0141239	10.1371/journal.pone.0141239	http://dx.doi.org/10.1371/journal.pone.0141239			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU8PC	26506246	Green Published, gold, Green Submitted			2022-12-26	WOS:000363804200037
J	Luo, FY; Le, NB; Mills, T; Chen, NY; Karmouty-Quintana, H; Molina, JG; Davies, J; Philip, K; Volcik, KA; Liu, H; Xia, Y; Eltzschig, HK; Blackburn, MR				Luo, Fayong; Le, Ngoc-Bao; Mills, Tingting; Chen, Ning-Yuan; Karmouty-Quintana, Harry; Molina, Jose G.; Davies, Jonathan; Philip, Kemly; Volcik, Kelly A.; Liu, Hong; Xia, Yang; Eltzschig, Holger K.; Blackburn, Michael R.			Extracellular adenosine levels are associated with the progression and exacerbation of pulmonary fibrosis	FASEB JOURNAL			English	Article						bleomycin; dipyridamole; IPF; IL-17; IL-6	CEREBRAL-BLOOD-FLOW; S-ADENOSYLMETHIONINE; RECEPTOR; INFLAMMATION; PROMOTES; MICE; DIPYRIDAMOLE; CONTRIBUTES; REPRESSION; RESOLUTION	Idiopathic pulmonary fibrosis is a devastating lung disease with limited treatment options. The signaling molecule adenosine is produced in response to injury and serves a protective role in early stages of injury and is detrimental during chronic stages of disease such as seen in lung conditions such as pulmonary fibrosis. Understanding the association of extracellular adenosine levels and the progression of pulmonary fibrosis is critical for designing adenosine based approaches to treat pulmonary fibrosis. The goal of this study was to use various models of experimental lung fibrosis to understand when adenosine levels are elevated during pulmonary fibrosis and whether these elevations were associated with disease progression and severity. To accomplish this, extracellular adenosine levels, defined as adenosine levels found in bronchioalveolar lavage fluid, were determined in mouse models of resolvable and progressive pulmonary fibrosis. We found that relative bronchioalveolar lavage fluid adenosine levels are progressively elevated in association with pulmonary fibrosis and that adenosine levels diminish in association with the resolution of lung fibrosis. In addition, treatment of these models with dipyridamole, an inhibitor of nucleoside transporters that potentiates extracellular adenosine levels, demonstrated that the resolution of lung fibrosis is blocked by the failure of adenosine levels to subside. Furthermore, exacerbating adenosine levels led to worse fibrosis in a progressive fibrosis model. Increased adenosine levels were associated with elevation of IL-6 and IL-17, which are important inflammatory cytokines in pulmonary fibrosis. These results demonstrate that extracellular adenosine levels are closely associated with the progression of experimental pulmonary fibrosis and that this signaling pathway maymediate fibrosis by regulating IL-6 and IL-17 production.	[Luo, Fayong; Le, Ngoc-Bao; Mills, Tingting; Chen, Ning-Yuan; Karmouty-Quintana, Harry; Molina, Jose G.; Philip, Kemly; Volcik, Kelly A.; Liu, Hong; Xia, Yang; Blackburn, Michael R.] Univ Texas Med Sch Houston, Dept Biochem & Mol Biol, 6431 Fannin, Houston, TX 77030 USA; [Davies, Jonathan] Baylor Coll Med, Dept Pediat, Div Neonatal Perinatal Med, Houston, TX 77030 USA; [Eltzschig, Holger K.] Univ Colorado Denver, Dept Anesthesiol, Aurora, CO USA	University of Texas System; University of Texas Health Science Center Houston; Baylor College of Medicine; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Blackburn, MR (corresponding author), Univ Texas Med Sch Houston, Dept Biochem & Mol Biol, 6431 Fannin, Houston, TX 77030 USA.	michael.r.blackburn@uth.tmc.edu	Karmouty-Quintana, Harry/ABC-9144-2020	Karmouty-Quintana, Harry/0000-0003-4753-9823; liu, hong/0000-0001-9976-2985; Blackburn, Michael/0000-0002-1394-9966; Philip, Kemly/0000-0002-7749-9781	U.S. National Institutes of Health, National Heart, Lung, and Blood Institute [R01-HL070952, P01-HL114457]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000371] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL113574, R01HL070952, P01HL114457, R01HL119837] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK097075] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by U.S. National Institutes of Health, National Heart, Lung, and Blood Institute Grants R01-HL070952 and P01-HL114457 (to M.R.B.).	Blackburn Michael R, 2009, Handb Exp Pharmacol, P215, DOI 10.1007/978-3-540-89615-9_8; Blackburn MR, 2000, J EXP MED, V192, P159, DOI 10.1084/jem.192.2.159; Blackburn MR, 2003, J CLIN INVEST, V112, P332, DOI 10.1172/JCI200316815; Blackburn MR, 2003, TRENDS PHARMACOL SCI, V24, P66, DOI 10.1016/S0165-6147(02)00045-7; Bouma MG, 1996, AM J PHYSIOL-CELL PH, V270, pC522, DOI 10.1152/ajpcell.1996.270.2.C522; CHAN TCK, 1988, CANCER RES, V48, P215; Chen CJ, 2013, NEW ENGL J MED, V368, P1260, DOI 10.1056/NEJMc1300259; Chiang PK, 1996, FASEB J, V10, P471, DOI 10.1096/fasebj.10.4.8647346; Chunn JL, 2006, AM J PHYSIOL-LUNG C, V290, pL579, DOI 10.1152/ajplung.00258.2005; Chunn JL, 2005, J IMMUNOL, V175, P1937, DOI 10.4049/jimmunol.175.3.1937; Colgan Sean P, 2006, Purinergic Signal, V2, P351, DOI 10.1007/s11302-005-5302-5; Davies J, 2014, PHYSIOL REP, V2, DOI 10.14814/phy2.12155; Eckle T, 2008, J CLIN INVEST, V118, P3301, DOI 10.1172/JCI34203; Eckle T, 2008, BLOOD, V111, P2024, DOI 10.1182/blood-2007-10-117044; Eckle T, 2013, FASEB J, V27, P3078, DOI 10.1096/fj.13-228551; Eckle T, 2009, PHYSIOLOGY, V24, P298, DOI 10.1152/physiol.00022.2009; Fernandez P, 2008, AM J PATHOL, V172, P1675, DOI 10.2353/ajpath.2008.070952; Fernandez P, 2013, AM J PATHOL, V183, P1740, DOI 10.1016/j.ajpath.2013.08.024; Hart ML, 2010, J IMMUNOL, V184, P4017, DOI 10.4049/jimmunol.0901851; Idzko M, 2014, NATURE, V509, P310, DOI 10.1038/nature13085; Izbicki G, 2002, INT J EXP PATHOL, V83, P111, DOI 10.1046/j.1365-2613.2002.00220.x; Karmouty-Quintana H, 2015, FASEB J, V29, P50, DOI 10.1096/fj.14-260182; Karmouty-Quintana H, 2013, J MOL MED, V91, P173, DOI 10.1007/s00109-013-0997-1; Karmouty-Quintana H, 2012, FASEB J, V26, P2546, DOI 10.1096/fj.11-200907; Kim HH, 2008, J CEREBR BLOOD F MET, V28, P1285, DOI 10.1038/jcbfm.2008.24; King TE, 2014, NEW ENGL J MED, V370, P2083, DOI 10.1056/NEJMoa1402582; King TE, 2011, LANCET, V378, P1949, DOI 10.1016/S0140-6736(11)60052-4; KO KR, 1990, AM J PHYSIOL, V259, pH1703, DOI 10.1152/ajpheart.1990.259.6.H1703; Kuroki M, 2003, J IMMUNOL, V170, P567, DOI 10.4049/jimmunol.170.1.567; Le TTT, 2014, J IMMUNOL, V193, P3755, DOI 10.4049/jimmunol.1302470; Luo FY, 2014, RESP RES, V15, DOI 10.1186/1465-9921-15-51; Mi S, 2011, J IMMUNOL, V187, P3003, DOI 10.4049/jimmunol.1004081; Mi T, 2008, J CLIN INVEST, V118, P1491, DOI 10.1172/JCI33467; MILLS DCB, 1971, BIOCHEM J, V121, P185, DOI 10.1042/bj1210185; Moore BB, 2008, AM J PHYSIOL-LUNG C, V294, pL152, DOI 10.1152/ajplung.00313.2007; Morote-Garcia JC, 2013, AM J RESP CELL MOL, V49, P296, DOI 10.1165/rcmb.2012-0457OC; Nalysnyk L, 2012, EUR RESPIR REV, V21, P355, DOI 10.1183/09059180.00002512; Ohta A, 2001, NATURE, V414, P916, DOI 10.1038/414916a; Pedroza M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022667; Peng ZS, 2008, NUCLEOS NUCLEOT NUCL, V27, P821, DOI 10.1080/15257770802146403; Pfalzer AC, 2014, PHYSIOL GENOMICS, V46, P617, DOI 10.1152/physiolgenomics.00056.2014; PHAN SH, 1983, CHEST, V83, pS44; Raghu G, 2011, AM J RESP CRIT CARE, V183, P788, DOI 10.1164/rccm.2009-040GL; Redente EF, 2014, AM J RESP CELL MOL, V50, P825, DOI 10.1165/rcmb.2013-0386OC; Song ZY, 2005, BBA-MOL CELL RES, V1743, P205, DOI 10.1016/j.bbamcr.2004.12.001; Sun CX, 2006, J CLIN INVEST, V116, P2173, DOI 10.1172/JCI27303; Synnestvedt K, 2002, J CLIN INVEST, V110, P993, DOI 10.1172/JCI200215337; Volmer JB, 2006, J IMMUNOL, V176, P4449, DOI 10.4049/jimmunol.176.7.4449; WAKAMIYA M, 1995, P NATL ACAD SCI USA, V92, P3673, DOI 10.1073/pnas.92.9.3673; Wen JM, 2010, FASEB J, V24, P740, DOI 10.1096/fj.09-144147; Wilson JM, 2011, J IMMUNOL, V186, P6746, DOI 10.4049/jimmunol.1100117; Wynn TA, 2011, J EXP MED, V208, P1339, DOI 10.1084/jem.20110551; Zhou Y, 2011, J IMMUNOL, V186, P1097, DOI 10.4049/jimmunol.1002907; Zhou Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009224; Zhou Y, 2009, PHARMACOL THERAPEUT, V123, P105, DOI 10.1016/j.pharmthera.2009.04.003; Zimmerman MA, 2013, HEPATOLOGY, V58, P1766, DOI 10.1002/hep.26505	56	31	31	0	13	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2016	30	2					874	883		10.1096/fj.15-274845	http://dx.doi.org/10.1096/fj.15-274845			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DC7IA	26527068	Green Published			2022-12-26	WOS:000369391900035
J	Yu, M; Liu, K; Mao, ZB; Luo, JY; Gu, W; Zhao, WH				Yu, Miao; Liu, Kun; Mao, Zebin; Luo, Jianyuan; Gu, Wei; Zhao, Wenhui			USP11 Is a Negative Regulator to gamma H2AX Ubiquitylation by RNF8/RNF168	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-DAMAGE RESPONSE; GENOME INTEGRITY; HISTONE H2B; UBIQUITIN; RNF168; REPAIR; RNF8; INHIBITION; BRCA1; COUNTERACTS	Ubiquitin modification at double strand breaks (DSB) sites is an essential regulator of signaling and repair. gamma H2AX extends from DSB sites and provides a platform for subsequent recruitment and amplification of DNA repair proteins and signaling factors. Here, we found that RNF8/RNF168 ubiquitylates gamma H2AX. We identified that USP11 is a unique deubiquitylation enzyme for gamma H2AX. USP11 deubiquitylates gamma H2AX both in vivo and in vitro but not the canonical (ub)-K119-H2A and (ub)-K120-H2B in vitro, and USP11 ablation enhances the levels of gamma H2AX ubiquitylation. We also found that USP11 interacts with gamma H2AX both in vivo and in vitro. We found that 53BP1 and ubiquitin-conjugated proteins are misregulated to be retained longer and stronger at DSB sites after knockdown of USP11. We further found that cells are hypersensitive to gamma-irradiation after ablation of USP11. Together, our findings elucidate deeply and extensively the mechanism of RNF8/RNF168 and USP11 to maintain the proper status of ubiquitylation gamma H2AX to repair DSB.	[Yu, Miao; Liu, Kun; Mao, Zebin; Zhao, Wenhui] Peking Univ, Hlth Sci Ctr, Beijing Key Lab Prot Posttranslat Modificat & Cel, Dept Biochem & Mol Biol, Beijing 100191, Peoples R China; [Luo, Jianyuan] Peking Univ, Hlth Sci Ctr, Dept Genet, Beijing 100191, Peoples R China; [Gu, Wei] Columbia Univ, Coll Physicians & Surg, Inst Canc Genet, New York, NY 10032 USA; [Gu, Wei] Columbia Univ, Coll Physicians & Surg, Dept Pathol & Cell Biol, New York, NY 10032 USA	Peking University; Peking University; Columbia University; Columbia University	Zhao, WH (corresponding author), Peking Univ, Hlth Sci Ctr, Beijing Key Lab Prot Posttranslat Modificat & Cel, Dept Biochem & Mol Biol, 38 Xueyuan Rd, Beijing 100191, Peoples R China.	zhao6025729@bjmu.edu.cn	Luo, Jianyuan/ABI-7585-2020	Luo, Jianyuan/0000-0001-6057-2914; ZHAO, WENHUI/0000-0002-7703-7106	Peking University Health Science Center Initial Aid Grant [BMU20140379]	Peking University Health Science Center Initial Aid Grant	Supported by Peking University Health Science Center Initial Aid Grant BMU20140379.	Bekker-Jensen S, 2010, NAT CELL BIOL, V12, P80, DOI 10.1038/ncb2008; Bin W, 2007, P NATL ACAD SCI USA, V104, P20759, DOI 10.1073/pnas.0710061104; Butler LR, 2012, EMBO J, V31, P3918, DOI 10.1038/emboj.2012.232; Cooper EM, 2009, EMBO J, V28, P621, DOI 10.1038/emboj.2009.27; Doil C, 2009, CELL, V136, P435, DOI 10.1016/j.cell.2008.12.041; Dong YS, 2003, MOL CELL, V12, P1087, DOI 10.1016/S1097-2765(03)00424-6; Gatti M, 2012, CELL CYCLE, V11, P2538, DOI 10.4161/cc.20919; Huen MSY, 2007, CELL, V131, P901, DOI 10.1016/j.cell.2007.09.041; Jackson SP, 2013, MOL CELL, V49, P795, DOI 10.1016/j.molcel.2013.01.017; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Juang YC, 2012, MOL CELL, V45, P384, DOI 10.1016/j.molcel.2012.01.011; Kolas NK, 2007, SCIENCE, V318, P1637, DOI 10.1126/science.1150034; Li ML, 2012, TRENDS BIOCHEM SCI, V37, P418, DOI 10.1016/j.tibs.2012.06.007; Li MY, 2003, SCIENCE, V302, P1972, DOI 10.1126/science.1091362; Lukas J, 2011, NAT CELL BIOL, V13, P1161, DOI 10.1038/ncb2344; Mailand N, 2007, CELL, V131, P887, DOI 10.1016/j.cell.2007.09.040; Mattiroli F, 2012, CELL, V150, P1182, DOI 10.1016/j.cell.2012.08.005; Mosbech A, 2013, J BIOL CHEM, V288, P16579, DOI 10.1074/jbc.M113.459917; Moyal L, 2011, MOL CELL, V41, P529, DOI 10.1016/j.molcel.2011.02.015; Nakada S, 2010, NATURE, V466, P941, DOI 10.1038/nature09297; Nakamura K, 2011, MOL CELL, V41, P515, DOI 10.1016/j.molcel.2011.02.002; Nicassio F, 2007, CURR BIOL, V17, P1972, DOI 10.1016/j.cub.2007.10.034; Noon AT, 2011, DNA REPAIR, V10, P1071, DOI 10.1016/j.dnarep.2011.07.012; Shan J, 2009, MOL CELL, V36, P469, DOI 10.1016/j.molcel.2009.10.018; Shanbhag NM, 2010, CELL, V141, P970, DOI 10.1016/j.cell.2010.04.038; Shao G, 2009, P NATL ACAD SCI USA, V106, P3166, DOI 10.1073/pnas.0807485106; Sharma N, 2014, CELL CYCLE, V13, P106, DOI 10.4161/cc.26814; Sobhian B, 2007, SCIENCE, V316, P1198, DOI 10.1126/science.1139516; Stucki M, 2005, CELL, V123, P1213, DOI 10.1016/j.cell.2005.09.038; Wiener R, 2012, NATURE, V483, P618, DOI 10.1038/nature10911; Wiltshire TD, 2010, J BIOL CHEM, V285, P14565, DOI 10.1074/jbc.M110.104745; Yang W, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4818; Zhang Z, 2014, J BIOL CHEM, V289, DOI 10.1074/jbc.M114.599605; Zhu B, 2005, MOL CELL, V20, P601, DOI 10.1016/j.molcel.2005.09.025	34	41	42	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 8	2016	291	2					959	967		10.1074/jbc.M114.624478	http://dx.doi.org/10.1074/jbc.M114.624478			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DA5GF	26507658	Green Published, hybrid			2022-12-26	WOS:000367830500041
J	Sergeev, E; Hansen, AH; Pandey, SK; MacKenzie, AE; Hudson, BD; Ulven, T; Milligan, G				Sergeev, Eugenia; Hansen, Anders Hojgaard; Pandey, Sunil K.; MacKenzie, Amanda E.; Hudson, Brian D.; Ulven, Trond; Milligan, Graeme			Non-equivalence of Key Positively Charged Residues of the Free Fatty Acid 2 Receptor in the Recognition and Function of Agonist Versus Antagonist Ligands	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						fatty acid; G protein-coupled receptor (GPCR); homology modeling; intestinal metabolism; medicinal chemistry; 7 transmembrane domain receptor; free fatty acid	PROTEIN-COUPLED RECEPTORS; CRYSTAL-STRUCTURE; MOLECULAR-BASIS; BINDING; FFA2; DISSOCIATION; PHARMACOLOGY; ALLOSTERISM; METABOLITES; GPR43	Short chain fatty acids (SCFAs) are produced in the gut by bacterial fermentation of poorly digested carbohydrates. A key mediator of their actions is the G protein-coupled free fatty acid 2 (FFA2) receptor, and this has been suggested as a therapeutic target for the treatment of both metabolic and inflammatory diseases. However, a lack of understanding of the molecular determinants dictating how ligands bind to this receptor has hindered development. We have developed a novel radiolabeled FFA2 antagonist to probe ligand binding to FFA2, and in combination with mutagenesis and molecular modeling studies, we define how agonist and antagonist ligands interact with the receptor. Although both agonist and antagonist ligands contain negatively charged carboxylates that interact with two key positively charged arginine residues in transmembrane domains V and VII of FFA2, there are clear differences in how these interactions occur. Specifically, although agonists require interaction with both arginine residues to bind the receptor, antagonists require an interaction with only one of the two. Moreover, different chemical series of antagonist interact preferentially with different arginine residues. A homology model capable of rationalizing these observations was developed and provides a tool that will be invaluable for identifying improved FFA2 agonists and antagonists to further define function and therapeutic opportunities of this receptor.	[Sergeev, Eugenia; MacKenzie, Amanda E.; Hudson, Brian D.; Milligan, Graeme] Univ Glasgow, Coll Med Vet & Life Sci, Inst Mol Cell & Syst Biol, Mol Pharmacol Grp, Glasgow G12 8QQ, Lanark, Scotland; [Hansen, Anders Hojgaard; Pandey, Sunil K.; Ulven, Trond] Univ Southern Denmark, Dept Phys Chem & Pharm, DK-5230 Odense M, Denmark	University of Glasgow; University of Southern Denmark	Ulven, T (corresponding author), Univ Southern Denmark, Dept Phys Chem & Pharm, Campusvej 55, DK-5230 Odense M, Denmark.	ulven@sdu.dk; Graeme.Milligan@glasgow.ac.uk	Pandey, Sunil Kumar/AAP-2234-2021; Ulven, Trond/H-5500-2015; Hudson, Brian/H-4845-2013	Ulven, Trond/0000-0002-8135-1755; Milligan, Graeme/0000-0002-6946-3519; Hudson, Brian/0000-0001-7059-0091; Sergeev, Eugenia/0000-0001-8271-3693	Biotechnology and Biological Sciences Research Council [BB/L027887/1]; BBSRC [BB/L027887/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	[<SUP>3</SUP>H]GLPG0974 was provided by Astra-Zeneca within the terms of Biotechnology and Biological Sciences Research Council Grant BB/L027887/1.	Alvarez-Curto E, 2010, J BIOL CHEM, V285, P23316, DOI 10.1074/jbc.M110.122184; [Anonymous], SCHR SUIT 2013 2 PRO; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; Banks JL, 2005, J COMPUT CHEM, V26, P1752, DOI 10.1002/jcc.20292; Bindels LB, 2013, TRENDS PHARMACOL SCI, V34, P226, DOI 10.1016/j.tips.2013.02.002; Blad CC, 2012, NAT REV DRUG DISCOV, V11, P603, DOI 10.1038/nrd3777; Brown AJ, 2003, J BIOL CHEM, V278, P11312, DOI 10.1074/jbc.M211609200; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Cooper T, 2009, METHODS MOL BIOL, V552, P143, DOI 10.1007/978-1-60327-317-6_10; Dowling MR, 2006, BRIT J PHARMACOL, V148, P927, DOI 10.1038/sj.bjp.0706819; Garland SL, 2011, CURR TOP MED CHEM, V11, P1872; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Hansen SVF, 2015, ORG LETT, V17, P2832, DOI 10.1021/acs.orglett.5b01252; Hara T, 2011, J PHARM SCI-US, V100, P3594, DOI 10.1002/jps.22639; Hoffmann C, 2015, MOL PHARMACOL, V88, P552, DOI 10.1124/mol.115.099671; Hudson BD, 2011, ADV PHARMACOL, V62, P175, DOI 10.1016/B978-0-12-385952-5.00006-3; Hudson BD, 2014, J BIOL CHEM, V289, P20345, DOI 10.1074/jbc.M114.561449; Hudson BD, 2013, J BIOL CHEM, V288, P17296, DOI 10.1074/jbc.M113.455337; Hudson BD, 2013, CURR TOP MED CHEM, V13, P14; Hudson BD, 2012, J BIOL CHEM, V287, P41195, DOI 10.1074/jbc.M112.396259; Hulme E. C., 1992, RECEPTOR LIGAND INTE, P63; Hulme EC, 2013, TRENDS PHARMACOL SCI, V34, P67, DOI 10.1016/j.tips.2012.11.002; Jaakola VP, 2008, SCIENCE, V322, P1211, DOI 10.1126/science.1164772; Kim MH, 2013, GASTROENTEROLOGY, V145, P396, DOI 10.1053/j.gastro.2013.04.056; Kooistra AJ, 2014, ADV EXP MED BIOL, V796, P129, DOI 10.1007/978-94-007-7423-0_7; Layden BT, 2013, TRANSL RES, V161, P131, DOI 10.1016/j.trsl.2012.10.007; Le Poul E, 2003, J BIOL CHEM, V278, P25481, DOI 10.1074/jbc.M301403200; Lee T, 2008, MOL PHARMACOL, V74, P1599, DOI 10.1124/mol.108.049536; MacKenzie AE, 2014, MOL PHARMACOL, V85, P91, DOI 10.1124/mol.113.089482; McKeage K, 2015, DRUGS, V75, P809, DOI 10.1007/s40265-015-0393-y; Milligan G, 2003, TRENDS PHARMACOL SCI, V24, P87, DOI 10.1016/S0165-6147(02)00027-5; Milligan G, 2014, BRIT J NUTR, V111, pS3, DOI 10.1017/S0007114513002249; Milligan G, 2009, BRIT J PHARMACOL, V158, P146, DOI 10.1111/j.1476-5381.2009.00421.x; Natarajan N, 2014, AM J PHYSIOL-CELL PH, V307, pC979, DOI 10.1152/ajpcell.00228.2014; Olsson MHM, 2011, J CHEM THEORY COMPUT, V7, P525, DOI 10.1021/ct100578z; Pan AC, 2013, DRUG DISCOV TODAY, V18, P667, DOI 10.1016/j.drudis.2013.02.007; Pizzonero M, 2014, J MED CHEM, V57, P10044, DOI 10.1021/jm5012885; Schmidt J, 2011, J BIOL CHEM, V286, P10628, DOI 10.1074/jbc.M110.210872; Shonberg J, 2015, BIOORGAN MED CHEM, V23, P3880, DOI 10.1016/j.bmc.2014.12.034; Smith NJ, 2011, MOL PHARMACOL, V80, P163, DOI 10.1124/mol.110.070789; Srivastava A, 2014, NATURE, V513, P124, DOI 10.1038/nature13494; Stoddart LA, 2008, J BIOL CHEM, V283, P32913, DOI 10.1074/jbc.M805601200; Stoddart LA, 2008, PHARMACOL REV, V60, P405, DOI 10.1124/pr.108.00802; Sykes DA, 2012, BRIT J PHARMACOL, V165, P2672, DOI 10.1111/j.1476-5381.2011.01639.x; Tan J, 2014, ADV IMMUNOL, V121, P91, DOI 10.1016/B978-0-12-800100-4.00003-9; Tolhurst G, 2012, DIABETES, V61, P364, DOI 10.2337/db11-1019; Trompette A, 2014, NAT MED, V20, P159, DOI 10.1038/nm.3444; Ulven Trond, 2012, Front Endocrinol (Lausanne), V3, P111, DOI 10.3389/fendo.2012.00111; Vinolo MAR, 2011, NUTRIENTS, V3, P858, DOI 10.3390/nu3100858; Wang YC, 2010, BIOORG MED CHEM LETT, V20, P493, DOI 10.1016/j.bmcl.2009.11.112; Ward RJ, 2011, J BIOL CHEM, V286, P37414, DOI 10.1074/jbc.M111.287649; Ward RJ, 2011, METHODS MOL BIOL, V746, P21, DOI 10.1007/978-1-61779-126-0_2; Watterson KR, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00137	53	35	35	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 1	2016	291	1					303	317		10.1074/jbc.M115.687939	http://dx.doi.org/10.1074/jbc.M115.687939			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DA1XP	26518871	Green Published, hybrid, Green Accepted			2022-12-26	WOS:000367589500024
J	Stojanovski, BM; Ferreira, GC				Stojanovski, Bosko M.; Ferreira, Gloria C.			Asn-150 of Murine Erythroid 5-Aminolevulinate Synthase Modulates the Catalytic Balance between the Rates of the Reversible Reaction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINOLEVULINIC-ACID SYNTHASE; SERINE PALMITOYLTRANSFERASE; REACTION-MECHANISM; ESCHERICHIA-COLI; HEME-BIOSYNTHESIS; AUTOINDUCER CAI-1; SUBSTRATE-BINDING; CRYSTAL-STRUCTURE; ACTIVE-SITE; ENZYME CQSA	5-Aminolevulinate synthase (ALAS) catalyzes the first step in mammalian heme biosynthesis, the pyridoxal 5'-phosphate (PLP)-dependent and reversible reaction between glycine and succinyl-CoA to generate CoA, CO2, and 5-aminolevulinate (ALA). Apart from coordinating the positioning of succinylCoA, Rhodobacter capsulatus ALAS Asn-85 has a proposed role in regulating the opening of an active site channel. Here, we constructed a library of murine erythroid ALAS variants with substitutions at the position occupied by the analogous bacterial asparagine, screened for ALAS function, and characterized the catalytic properties of the N150H and N150F variants. Quinonoid intermediate formation occurred with a significantly reduced rate for either the N150H-or N150F-catalyzed condensation of glycine with succinyl-CoA during a single turnover. The introduced mutations caused modifications in the ALAS active site such that the resulting variants tipped the balance between the forward-and reverse-catalyzed reactions. Although wild-type ALAS catalyzes the conversion of ALA into the quinonoid intermediate at a rate 6.3-fold slower than the formation of the same quinonoid intermediate from glycine and succinyl-CoA, the N150F variant catalyzes the forward reaction at a mere 1.2-fold faster rate than that of the reverse reaction, and the N150H variant reverses the rate values with a 1.7-fold faster rate for the reverse reaction than that for the forward reaction. We conclude that the evolutionary selection of Asn-150 was significant for optimizing the forward enzymatic reaction at the expense of the reverse, thus ensuring that ALA is predominantly available for heme biosynthesis.	[Stojanovski, Bosko M.; Ferreira, Gloria C.] Univ S Florida, Dept Mol Med, Morsani Coll Med, Tampa, FL 33612 USA; [Ferreira, Gloria C.] Univ S Florida, Dept Chem, Tampa, FL 33612 USA	State University System of Florida; University of South Florida; State University System of Florida; University of South Florida	Stojanovski, BM (corresponding author), Univ S Florida, Dept Mol Med, Morsani Coll Med, MDC 7, Tampa, FL 33612 USA.	gferreir@health.usf.edu	Ferreira, Gloria C/A-4709-2012; Regan, Clinton/E-6250-2012	Ferreira, Gloria C/0000-0001-9279-2217; 	National Institutes of Health [GM080270]; American Heart Association, Greater Southeast Affiliate [10GRNT4300073, 13GRNT16970019]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080270] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association, Greater Southeast Affiliate(American Heart Association); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant GM080270 and American Heart Association, Greater Southeast Affiliate, Grants 10GRNT4300073 and 13GRNT16970019 (to G. C. F.).	Astner I, 2005, EMBO J, V24, P3166, DOI 10.1038/sj.emboj.7600792; Balwani Manisha, 2013, Mol Med, V19, P26, DOI 10.2119/molmed.2012.00340; Bottomley S. S., 2013, HDB PORPHYRIN SCI, P44; Eliot AC, 2004, ANNU REV BIOCHEM, V73, P383, DOI 10.1146/annurev.biochem.73.011303.074021; FERREIRA GC, 1993, J BIOL CHEM, V268, P584; Fratz E. J., 2013, HDB PORPHYRIN SCI, P1; GONG J, 1995, BIOCHEMISTRY-US, V34, P1678, DOI 10.1021/bi00005a024; Gong J, 1998, BIOCHEMISTRY-US, V37, P3509, DOI 10.1021/bi9719298; Han G, 2009, P NATL ACAD SCI USA, V106, P8186, DOI 10.1073/pnas.0811269106; HUNTER GA, 1995, ANAL BIOCHEM, V226, P221, DOI 10.1006/abio.1995.1217; Hunter GA, 1999, BIOCHEMISTRY-US, V38, P3711, DOI 10.1021/bi982390w; Hunter GA, 1999, J BIOL CHEM, V274, P12222, DOI 10.1074/jbc.274.18.12222; Hunter GA, 2007, J BIOL CHEM, V282, P23025, DOI 10.1074/jbc.M609330200; Hunter GA, 2011, BBA-PROTEINS PROTEOM, V1814, P1467, DOI 10.1016/j.bbapap.2010.12.015; Ikushiro H, 2011, BBA-PROTEINS PROTEOM, V1814, P1474, DOI 10.1016/j.bbapap.2011.02.005; Ikushiro H, 2009, J BIOCHEM, V146, P549, DOI 10.1093/jb/mvp100; Jahan N, 2009, J MOL BIOL, V392, P763, DOI 10.1016/j.jmb.2009.07.042; Johnson K. A., 1992, ENZYMES, P1; Kaufholz AL, 2013, BIOCHEM J, V451, P205, DOI 10.1042/BJ20121041; Kelly RC, 2009, NAT CHEM BIOL, V5, P891, DOI 10.1038/nchembio.237; Lendrihas T, 2010, J BIOL CHEM, V285, P13704, DOI 10.1074/jbc.M109.074237; Lendrihas T, 2010, J BIOL CHEM, V285, P3351, DOI 10.1074/jbc.M109.066548; Mann S, 2011, BBA-PROTEINS PROTEOM, V1814, P1459, DOI 10.1016/j.bbapap.2010.12.004; NANDI DL, 1978, J BIOL CHEM, V253, P8872; Reetz MT, 2006, CHEM-EUR J, V12, P6031, DOI 10.1002/chem.200600459; Schmidt A, 2001, BIOCHEMISTRY-US, V40, P5151, DOI 10.1021/bi002204y; Shoolingin-Jordan PM, 2003, BBA-PROTEINS PROTEOM, V1647, P361, DOI 10.1016/S1570-9639(03)00095-5; Spirig T, 2008, J BIOL CHEM, V283, P18113, DOI 10.1074/jbc.M801929200; Stojanovski BM, 2015, FEBS OPEN BIO, V5, P824, DOI 10.1016/j.fob.2015.09.009; Stojanovski BM, 2014, BBA-PROTEINS PROTEOM, V1844, P2145, DOI 10.1016/j.bbapap.2014.09.013; Stojanovski BM, 2014, J BIOL CHEM, V289, P22915, DOI 10.1074/jbc.M114.574731; Tan DW, 1996, BIOCHEMISTRY-US, V35, P8934, DOI 10.1021/bi952918m; Tan DW, 1998, BIOCHEMISTRY-US, V37, P1478, DOI 10.1021/bi971928f; UMANOFF H, 1988, J BACTERIOL, V170, P4969, DOI 10.1128/jb.170.10.4969-4971.1988; Webster SP, 2000, BIOCHEMISTRY-US, V39, P516, DOI 10.1021/bi991620j; Whatley SD, 2008, AM J HUM GENET, V83, P408, DOI 10.1016/j.ajhg.2008.08.003; Yard BA, 2007, J MOL BIOL, V370, P870, DOI 10.1016/j.jmb.2007.04.086; Zhang JS, 2002, J BIOL CHEM, V277, P44660, DOI 10.1074/jbc.M203584200	38	5	5	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 25	2015	290	52					30750	30761		10.1074/jbc.M115.655399	http://dx.doi.org/10.1074/jbc.M115.655399			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CZ6GK	26511319	hybrid, Green Published			2022-12-26	WOS:000367199000009
J	Lee, D; Goldberg, AL				Lee, Donghoon; Goldberg, Alfred L.			Muscle Wasting in Fasting Requires Activation of NF-kappa B and Inhibition of AKT/Mechanistic Target of Rapamycin (mTOR) by the Protein Acetylase, GCN5	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UBIQUITIN-PROTEASOME PATHWAY; SKELETAL-MUSCLE; TRANSCRIPTION FACTORS; ATROPHY; AUTOPHAGY; FOXO3; PHOSPHORYLATION; DEGRADATION; PGC-1-ALPHA; REPRESSION	NF-kappa B is best known for its pro-inflammatory and anti-apoptotic actions, but in skeletal muscle, NF-kappa B activation is important for atrophy upon denervation or cancer. Here, we show that also upon fasting, NF-kappa B becomes activated in muscle and is critical for the subsequent atrophy. Following food deprivation, the expression and acetylation of the p65 of NF-kappa B on lysine 310 increase markedly in muscles. NF-kappa B inhibition in mouse muscles by overexpression of the I kappa B alpha superrepressor (I kappa B alpha-SR) or of p65 mutated at Lys-310 prevented atrophy. Knockdown of GCN5 with shRNA or a dominant-negative GCN5 or over-expression of SIRT1 decreased p65K310 acetylation and muscle wasting upon starvation. In addition to reducing atrogene expression, surprisingly inhibiting NF-kappa B with I kappa B alpha-SR or by GCN5 knockdown in these muscles also enhanced AKT and mechanistic target of rapamycin (mTOR) activities, which also contributed to the reduction in atrophy. These new roles of NF-kappa B and GCN5 in regulating muscle proteolysis and AKT/mTOR signaling suggest novel approaches to combat muscle wasting.	[Lee, Donghoon; Goldberg, Alfred L.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Goldberg, AL (corresponding author), 240 Longwood Ave, Boston, MA 02115 USA.	alfred_goldberg@hms.harvard.edu			National Institutes of Health from NIA [2 R01 AR055255-06A1]; Muscular Dystrophy Association; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR055255] Funding Source: NIH RePORTER	National Institutes of Health from NIA; Muscular Dystrophy Association(Muscular Dystrophy Association); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grant 2 R01 AR055255-06A1 from the NIA and the Muscular Dystrophy Association. The authors declare no conflict of interest.	Acharyya S, 2005, CANCER CELL, V8, P421, DOI 10.1016/j.ccr.2005.10.004; Baker RG, 2011, CELL METAB, V13, P11, DOI 10.1016/j.cmet.2010.12.008; Brault JJ, 2010, J BIOL CHEM, V285, P19460, DOI 10.1074/jbc.M110.113092; Cai DS, 2004, CELL, V119, P285, DOI 10.1016/j.cell.2004.09.027; Chamberlain W, 2012, BIOCHEM CELL BIOL, V90, P200, DOI [10.1139/O11-082, 10.1139/o11-082]; Chen LF, 2001, SCIENCE, V293, P1653, DOI 10.1126/science.1062374; Chen LF, 2005, MOL CELL BIOL, V25, P7966, DOI 10.1128/MCB.25.18.7966-7975.2005; Comb WC, 2012, MOL CELL, V45, P719, DOI 10.1016/j.molcel.2012.01.010; Cornwell EW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087776; Downey M, 2013, CURR BIOL, V23, P1638, DOI 10.1016/j.cub.2013.06.050; Egerman MA, 2014, CRIT REV BIOCHEM MOL, V49, P59, DOI 10.3109/10409238.2013.857291; Gerhart-Hines Z, 2007, EMBO J, V26, P1913, DOI 10.1038/sj.emboj.7601633; Holmlund T, 2013, LEUKEMIA, V27, P578, DOI 10.1038/leu.2012.265; Hunter RB, 2004, J CLIN INVEST, V114, P1504, DOI 10.1172/JCI200421696; Lee D, 2013, J BIOL CHEM, V288, P30515, DOI 10.1074/jbc.M113.489716; Lee JH, 2009, DIABETES, V58, P344, DOI 10.2337/db07-1795; Lerin C, 2006, CELL METAB, V3, P429, DOI 10.1016/j.cmet.2006.04.013; Levy D, 2011, NAT IMMUNOL, V12, P29, DOI 10.1038/ni.1968; Liu Y, 2010, GENETICS, V184, P91, DOI 10.1534/genetics.109.110957; Mammucari C, 2007, CELL METAB, V6, P458, DOI 10.1016/j.cmet.2007.11.001; Mao XC, 2009, GENE DEV, V23, P849, DOI 10.1101/gad.1748409; Milan G, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7670; Mitch WE, 1996, NEW ENGL J MED, V335, P1897, DOI 10.1056/NEJM199612193352507; Mourkioti F, 2008, J MOL MED, V86, P747, DOI 10.1007/s00109-008-0308-4; Mourkioti F, 2006, J CLIN INVEST, V116, P2945, DOI 10.1172/JCI28721; Nagy Z, 2007, ONCOGENE, V26, P5341, DOI 10.1038/sj.onc.1210604; PALOMBELLA VJ, 1994, CELL, V78, P773, DOI 10.1016/S0092-8674(94)90482-0; Sandri M, 2004, CELL, V117, P399, DOI 10.1016/S0092-8674(04)00400-3; Sandri M, 2008, PHYSIOLOGY, V23, P160, DOI 10.1152/physiol.00041.2007; Sandri M, 2006, P NATL ACAD SCI USA, V103, P16260, DOI 10.1073/pnas.0607795103; Sandri M, 2013, INT J BIOCHEM CELL B, V45, P2121, DOI 10.1016/j.biocel.2013.04.023; Schiaffino S, 2013, FEBS J, V280, P4294, DOI 10.1111/febs.12253; Senf SM, 2011, AM J PHYSIOL-CELL PH, V300, pC1490, DOI 10.1152/ajpcell.00255.2010; Takahashi H, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.411165; Tang XL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072503; Yeung F, 2004, EMBO J, V23, P2369, DOI 10.1038/sj.emboj.7600244; Zhao J, 2007, CELL METAB, V6, P472, DOI 10.1016/j.cmet.2007.11.004	37	31	33	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2015	290	51					30269	30279		10.1074/jbc.M115.685164	http://dx.doi.org/10.1074/jbc.M115.685164			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CY9PG	26515065	Green Published, hybrid			2022-12-26	WOS:000366738200008
J	Zhou, MH; Bavencoffe, A; Pan, HL				Zhou, Meng-Hua; Bavencoffe, Alexis; Pan, Hui-Lin			Molecular Basis of Regulating High Voltage-Activated Calcium Channels by S-Nitrosylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE; N-TYPE; SENSORY NEURONS; MICE LACKING; SUBUNIT; RELEASE; TRAFFICKING; RECEPTORS; CURRENTS; TRANSMISSION	Nitric oxide (NO) is involved in a variety of physiological processes, such as vasoregulation and neurotransmission, and has a complex role in the regulation of pain transduction and synaptic transmission. We have shown previously that NO inhibits high voltage-activated Ca2+ channels in primary sensory neurons and excitatory synaptic transmission in the spinal dorsal horn. However, the molecular mechanism involved in this inhibitory action remains unclear. In this study, we investigated the role of S-nitrosylation in the NO regulation of high voltage-activated Ca2+ channels. The NO donor S-nitroso-N-acetyl-DL-penicillamine (SNAP) rapidly reduced N-type currents when Cav2.2 was coexpressed with the Cav beta 1 or Cav beta 3 subunits in HEK293 cells. In contrast, SNAP only slightly inhibited P/Q-type and L-type currents reconstituted with various Cav beta subunits. SNAP caused a depolarizing shift in voltage-dependent N-type channel activation, but it had no effect on Cav2.2 protein levels on the membrane surface. The inhibitory effect of SNAP on N-type currents was blocked by the sulfhydryl-specific modifying reagent methanethiosulfonate ethylammonium. Furthermore, the consensus motifs of S-nitrosylation were much more abundant in Cav2.2 than in Cav1.2 and Cav2.1. Site-directed mutagenesis studies showed that Cys-805, Cys-930, and Cys-1045 in the II-III intracellular loop, Cys-1835 and Cys-2145 in the C terminus of Cav2.2, and Cys-346 in the Cav beta 3 subunit were nitrosylation sites mediating NO sensitivity of N-type channels. Our findings demonstrate that the consensus motifs of S-nitrosylation in cytoplasmically accessible sites are critically involved in post-translational regulation of N-type Ca2+ channels by NO. S-Nitrosylation mediates the feedback regulation of N-type channels by NO.	[Zhou, Meng-Hua; Bavencoffe, Alexis; Pan, Hui-Lin] Univ Texas MD Anderson Canc Ctr, Ctr Neurosci & Pain Res, Dept Anesthesiol & Perioperat Med, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center	Pan, HL (corresponding author), Unit 110,1515 Holcombe Blvd, Houston, TX 77030 USA.	huilinpan@mdanderson.org	Regan, Clinton/E-6250-2012	Bavencoffe, Alexis Guillaume/0000-0001-5659-5988; Pan, Hui-Lin/0000-0001-8444-3770	National Institutes of Health [HL077400, NS073935]; N. G. and Helen T. Hawkins endowment; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL077400] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS073935] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); N. G. and Helen T. Hawkins endowment; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants HL077400 and NS073935 and the N. G. and Helen T. Hawkins endowment (to H.-L. P.). The authors declare no conflict of interest.	Altier C, 2002, J BIOL CHEM, V277, P33598, DOI 10.1074/jbc.M202476200; Bao JP, 1998, J NEUROSCI, V18, P8740; Bavencoffe A, 2014, VITAM HORM, V96, P1, DOI 10.1016/B978-0-12-800254-4.00001-5; Buraei Z., 2010, PHYSIOL REV, V90, P1461; Cao XH, 2011, J NEUROCHEM, V119, P594, DOI 10.1111/j.1471-4159.2011.07456.x; Catterall WA, 2000, ANNU REV CELL DEV BI, V16, P521, DOI 10.1146/annurev.cellbio.16.1.521; Catterall WA, 2008, NEURON, V59, P882, DOI 10.1016/j.neuron.2008.09.005; Chen XJ, 1999, J NEUROPHYSIOL, V81, P963, DOI 10.1152/jn.1999.81.3.963; Chen YH, 2004, NATURE, V429, P675, DOI 10.1038/nature02641; Choi YB, 2000, NAT NEUROSCI, V3, P15, DOI 10.1038/71090; FILLOUX F, 1994, NEUROSCI LETT, V178, P263, DOI 10.1016/0304-3940(94)90774-9; Gilbert M, 2008, J BIOL CHEM, V283, P24334, DOI 10.1074/jbc.M802097200; Gonzalez DR, 2009, J CARDIOVASC PHARM, V54, P188, DOI 10.1097/FJC.0b013e3181b72c9f; Guan Y, 2007, MOL PAIN, V3, DOI 10.1186/1744-8069-3-29; HALL KE, 1995, J PHYSIOL-LONDON, V486, P313, DOI 10.1113/jphysiol.1995.sp020814; Hendrich J, 2008, P NATL ACAD SCI USA, V105, P3628, DOI 10.1073/pnas.0708930105; Hess DT, 2005, NAT REV MOL CELL BIO, V6, P150, DOI 10.1038/nrm1569; Hoheisel U, 2000, PAIN, V88, P249, DOI 10.1016/S0304-3959(00)00336-5; Holmgren M, 1996, NEUROPHARMACOLOGY, V35, P797, DOI 10.1016/0028-3908(96)00129-3; Hopper R, 2004, EUR J NEUROSCI, V19, P1675, DOI 10.1111/j.1460-9568.2004.03306.x; Hu H, 1997, CIRC RES, V81, P742; Jaffrey SR, 2001, NAT CELL BIOL, V3, P193, DOI 10.1038/35055104; Jin XG, 2011, J BIOL CHEM, V286, P33190, DOI 10.1074/jbc.M111.270967; Kakizawa S, 2012, EMBO J, V31, P417, DOI 10.1038/emboj.2011.386; Li L, 2014, MOL PHARMACOL, V86, P760, DOI 10.1124/mol.114.095505; Li L, 2012, J BIOL CHEM, V287, P6002, DOI 10.1074/jbc.M111.310110; Luvisetto S, 2006, NEUROSCIENCE, V142, P823, DOI 10.1016/j.neuroscience.2006.06.049; Muller CS, 2010, P NATL ACAD SCI USA, V107, P14950, DOI 10.1073/pnas.1005940107; Murali SS, 2012, J PHYSIOL-LONDON, V590, P1655, DOI 10.1113/jphysiol.2012.228429; Nimmervoll B, 2013, NEUROSCIENCE, V253, P330, DOI 10.1016/j.neuroscience.2013.08.052; O'Reilly JP, 2012, BBA-BIOMEMBRANES, V1818, P443, DOI 10.1016/j.bbamem.2011.11.031; Robbe D, 2002, J NEUROSCI, V22, P4346, DOI 10.1523/JNEUROSCI.22-11-04346.2002; Saegusa H, 2001, EMBO J, V20, P2349, DOI 10.1093/emboj/20.10.2349; Simms BA, 2012, CELL MOL LIFE SCI, V69, P843, DOI 10.1007/s00018-011-0843-y; Stamler JS, 1997, NEURON, V18, P691, DOI 10.1016/S0896-6273(00)80310-4; Urbano FJ, 2001, PFLUG ARCH EUR J PHY, V441, P824, DOI 10.1007/s004240000489; Wu Z. Z., 2009, J BIOL CHEM, V284, P36453; Wu ZZ, 2004, J PHARMACOL EXP THER, V311, P939, DOI 10.1124/jpet.104.073429; Wu ZZ, 2004, NEUROSCI LETT, V368, P96, DOI 10.1016/j.neulet.2004.06.067; Xu L, 1998, SCIENCE, V279, P234, DOI 10.1126/science.279.5348.234; ZHUO M, 1993, PAIN, V54, P71, DOI 10.1016/0304-3959(93)90101-T	41	12	12	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2015	290	51					30616	30623		10.1074/jbc.M115.685206	http://dx.doi.org/10.1074/jbc.M115.685206			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CY9PG	26507659	Green Published, hybrid			2022-12-26	WOS:000366738200036
J	Davenport, ER; Cusanovich, DA; Michelini, K; Barreiro, LB; Ober, C; Gilad, Y				Davenport, Emily R.; Cusanovich, Darren A.; Michelini, Katelyn; Barreiro, Luis B.; Ober, Carole; Gilad, Yoav			Genome-Wide Association Studies of the Human Gut Microbiota	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; 3,000 SHARED CONTROLS; ULCERATIVE-COLITIS; CROHNS-DISEASE; GASTROINTESTINAL-TRACT; FECAL MICROBIOTA; PHOSPHOLIPASE-D; HOST GENETICS; FAECALIBACTERIUM-PRAUSNITZII; COMMON DISEASES	The bacterial composition of the human fecal microbiome is influenced by many lifestyle factors, notably diet. It is less clear, however, what role host genetics plays in dictating the composition of bacteria living in the gut. In this study, we examined the association of similar to 200K host genotypes with the relative abundance of fecal bacterial taxa in a founder population, the Hutterites, during two seasons (n = 91 summer, n = 93 winter, n = 57 individuals collected in both). These individuals live and eat communally, minimizing variation due to environmental exposures, including diet, which could potentially mask small genetic effects. Using a GWAS approach that takes into account the relatedness between subjects, we identified at least 8 bacterial taxa whose abundances were associated with single nucleotide polymorphisms in the host genome in each season (at genome-wide FDR of 20%). For example, we identified an association between a taxon known to affect obesity )genus Akkermansia) and a variant near PLD1, a gene previously associated with body mass index. Moreover, we replicate a previously reported association from a quantitative trait locus (QTL) mapping study of fecal microbiome abundance in mice (genus Lactococcus, rs3747113, P = 3.13 x 10(-7)). Finally, based on the significance distribution of the associated microbiome QTLs in our study with respect to chromatin accessibility profiles, we identified tissues in which host genetic variation may be acting to influence bacterial abundance in the gut.	[Davenport, Emily R.; Cusanovich, Darren A.; Michelini, Katelyn; Ober, Carole; Gilad, Yoav] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; [Barreiro, Luis B.] St Justine Hosp Res Ctr, Dept Pediat, Montreal, PQ, Canada	University of Chicago; Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine	Ober, C (corresponding author), Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA.	c-ober@genetics.uchicago.edu; gilad@uchicago.edu	Barreiro, Luis/I-7772-2015	Davenport, Emily R./0000-0002-6938-4933; Cusanovich, Darren/0000-0001-6889-0095; Barreiro, Luis/0000-0001-9456-367X; Ober, Carole/0000-0003-4626-9809	National Institutes of Health (NIH) [HG006123, HL085197, U19 AI095230]; University of Chicago Digestive Disease Research Core Center [P30-DK42086]; NIH [T32 GM007197]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000430] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL085197] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG006123] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI095230] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK042086] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007197] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Chicago Digestive Disease Research Core Center(University of Chicago); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by the National Institutes of Health (NIH, http://www.nih.gov/) grants HG006123 to YG, HL085197 to CO, U19 AI095230 to CO, and the University of Chicago Digestive Disease Research Core Center (http://www.uchicagoddrcc. org/) grant P30-DK42086 (through a P&F grant to YG). DAC was partially supported by NIH grant T32 GM007197. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2007, NATURE, V447, P661, DOI DOI 10.1038/NATURE05911; Backhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101; Barman M, 2008, INFECT IMMUN, V76, P907, DOI 10.1128/IAI.01432-07; Benson AK, 2010, P NATL ACAD SCI USA, V107, P18933, DOI 10.1073/pnas.1007028107; BERGMAN EN, 1990, PHYSIOL REV, V70, P567, DOI 10.1152/physrev.1990.70.2.567; Bibiloni R, 2006, J MED MICROBIOL, V55, P1141, DOI 10.1099/jmm.0.46498-0; Chen YG, 1997, J CELL BIOL, V138, P495, DOI 10.1083/jcb.138.3.495; Cho YS, 2009, NAT GENET, V41, P527, DOI 10.1038/ng.357; Collins SM, 2009, DIGEST LIVER DIS, V41, P850, DOI 10.1016/j.dld.2009.07.023; Craddock N, 2010, NATURE, V464, P713, DOI 10.1038/nature08979; Cusanovich DA, 2012, HUM MOL GENET, V21, P2111, DOI 10.1093/hmg/dds021; Davenport ER, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090731; De Filippo C, 2010, P NATL ACAD SCI USA, V107, P14691, DOI 10.1073/pnas.1005963107; De Palma G, 2010, CURR ISSUES MOL BIOL, V12, P1; De Palma G, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-63; Dicksved J, 2008, ISME J, V2, P716, DOI 10.1038/ismej.2008.37; DiStasi MR, 2009, TRENDS IMMUNOL, V30, P539, DOI 10.1016/j.it.2009.07.012; Dominguez-Pumar M., 2010, P SPIE C DSS 2010 OR, V7679, P1; Duncan SH, 2007, APPL ENVIRON MICROB, V73, P1073, DOI 10.1128/AEM.02340-06; Emoto M, 2000, J BIOL CHEM, V275, P7144, DOI 10.1074/jbc.275.10.7144; Everard A, 2013, P NATL ACAD SCI USA, V110, P9066, DOI 10.1073/pnas.1219451110; Galili O, 2007, AM J PHYSIOL-HEART C, V292, pH904, DOI 10.1152/ajpheart.00628.2006; Gomez-Cambronero J, 1998, CELL SIGNAL, V10, P387, DOI 10.1016/S0898-6568(97)00197-6; Goodrich JK, 2014, CELL, V159, P789, DOI 10.1016/j.cell.2014.09.053; Gregor MF, 2011, ANNU REV IMMUNOL, V29, P415, DOI 10.1146/annurev-immunol-031210-101322; Han LD, 2013, EUR J HUM GENET, V21, P205, DOI 10.1038/ejhg.2012.148; Hansen R, 2012, AM J GASTROENTEROL, V107, P1913, DOI 10.1038/ajg.2012.335; Harmsen HJM, 2000, J PEDIATR GASTR NUTR, V30, P61, DOI 10.1097/00005176-200001000-00019; Hehemann JH, 2010, NATURE, V464, P908, DOI 10.1038/nature08937; Hiersche M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071775; Hopkins MJ, 2002, J MED MICROBIOL, V51, P448, DOI 10.1099/0022-1317-51-5-448; Hostetler J, 1974, HUTTERITE SOC; Kassinen A, 2007, GASTROENTEROLOGY, V133, P24, DOI 10.1053/j.gastro.2007.04.005; Khachatryan ZA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003064; Knights D, 2014, GENOME MED, V6, DOI 10.1186/s13073-014-0107-1; Korn JM, 2008, NAT GENET, V40, P1253, DOI 10.1038/ng.237; Levy D, 2009, NAT GENET, V41, P677, DOI 10.1038/ng.384; Macfarlane S, 2005, BRIT J NUTR, V93, pS67, DOI 10.1079/BJN20041347; Manichanh C, 2006, GUT, V55, P205, DOI 10.1136/gut.2005.073817; MANTOVANI A, 1992, FASEB J, V6, P2591, DOI 10.1096/fasebj.6.8.1592209; Markiewski MM, 2007, AM J PATHOL, V171, P715, DOI 10.2353/ajpath.2007.070166; Marti A, 2001, Obes Rev, V2, P131, DOI 10.1046/j.1467-789x.2001.00025.x; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; Miquel S, 2013, CURR OPIN MICROBIOL, V16, P255, DOI 10.1016/j.mib.2013.06.003; Mondot S, 2011, INFLAMM BOWEL DIS, V17, P185, DOI 10.1002/ibd.21436; Nadal I, 2007, J MED MICROBIOL, V56, P1669, DOI 10.1099/jmm.0.47410-0; Natarajan A, 2012, GENOME RES, V22, P1711, DOI 10.1101/gr.135129.111; Ng MCY, 2012, OBESITY, V20, P622, DOI 10.1038/oby.2011.154; Ober C, 2008, NEW ENGL J MED, V358, P1682, DOI 10.1056/NEJMoa0708801; Ober C, 2009, J LIPID RES, V50, P798, DOI 10.1194/jlr.M800515-JLR200; Oksanen J., 2019, VEGAN COMMUNITY ECOL; Ouwehand AC, 1999, FEMS MICROBIOL LETT, V172, P61, DOI [10.1016/S0378-1097(99)00013-0, 10.1111/j.1574-6968.1999.tb13450.x]; Ouwerkerk JP, 2013, BEST PRACT RES CL GA, V27, P25, DOI 10.1016/j.bpg.2013.03.001; Petnicki-Ocwieja T, 2009, P NATL ACAD SCI USA, V106, P15813, DOI 10.1073/pnas.0907722106; Pluznick JL, 2013, P NATL ACAD SCI USA, V110, P4410, DOI 10.1073/pnas.1215927110; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; RDCT, 2011, R LANG ENV STAT COMP; Russell SL, 2012, EMBO REP, V13, P440, DOI 10.1038/embor.2012.32; Samartin S, 2001, NUTR RES, V21, P243, DOI 10.1016/S0271-5317(00)00255-4; SAVAGE DC, 1977, ANNU REV MICROBIOL, V31, P107, DOI 10.1146/annurev.mi.31.100177.000543; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schnorr SL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4654; Shin NR, 2014, GUT, V63, P727, DOI 10.1136/gutjnl-2012-303839; Sokol H, 2006, J CLIN MICROBIOL, V44, P3172, DOI 10.1128/JCM.02600-05; Sokol H, 2006, INFLAMM BOWEL DIS, V12, P106, DOI 10.1097/01.MIB.0000200323.38139.c6; Sokol H, 2008, P NATL ACAD SCI USA, V105, P16731, DOI 10.1073/pnas.0804812105; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Sudo N, 2004, J PHYSIOL-LONDON, V558, P263, DOI 10.1113/jphysiol.2004.063388; Suzuki K, 2004, P NATL ACAD SCI USA, V101, P1981, DOI 10.1073/pnas.0307317101; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; van Beek JHDA, 2015, EUR J HUM GENET, V23, P1223, DOI 10.1038/ejhg.2014.259; Vogler C, 2014, TRANSL PSYCHIAT, V4, DOI 10.1038/tp.2014.81; Wang M, 2007, DIGEST DIS SCI, V52, P620, DOI 10.1007/s10620-006-9461-1; Wrzosek L, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-61; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608; Yao TC, 2014, J ALLERGY CLIN IMMUN, V133, P248, DOI 10.1016/j.jaci.2013.06.018; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053; Zhang CH, 2010, ISME J, V4, P232, DOI 10.1038/ismej.2009.112; Zhou X, 2012, NAT GENET, V44, P821, DOI 10.1038/ng.2310; Zoetendal E.G., 2001, MICROBIAL ECOLOGY HL, V13	81	149	157	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2015	10	11							e0140301	10.1371/journal.pone.0140301	http://dx.doi.org/10.1371/journal.pone.0140301			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV1QH	26528553	Green Submitted, gold, Green Published			2022-12-26	WOS:000364032600005
J	Dold, S; Richter, S; Kollmar, O; von Heesen, M; Scheuer, C; Laschke, MW; Vollmar, B; Schilling, MK; Menger, MD				Dold, Stefan; Richter, Sven; Kollmar, Otto; von Heesen, Maximilian; Scheuer, Claudia; Laschke, Matthias W.; Vollmar, Brigitte; Schilling, Martin K.; Menger, Michael D.			Portal Hyperperfusion after Extended Hepatectomy Does Not Induce a Hepatic Arterial Buffer Response (HABR) but Impairs Mitochondrial Redox State and Hepatocellular Oxygenation	PLOS ONE			English	Article							BLOOD-FLOW; NITRIC-OXIDE; LIVER-TRANSPLANTATION; TISSUE OXYGENATION; SHEAR-STRESS; RAT; REGENERATION; HYPOXIA; VEIN; FLUORESCENCE	Background & Aims Portal hyperperfusion after extended hepatectomy or small-for-size liver transplantation may induce organ dysfunction and failure. The underlying mechanisms, however, are still not completely understood. Herein, we analysed whether hepatectomy-associated portal hyperperfusion induces a hepatic arterial buffer response, i.e., an adaptive hepatic arterial constriction, which may cause hepatocellular hypoxia and organ dysfunction. Methods Sprague-Dawley rats underwent 30%, 70% and 90% hepatectomy. Baseline measurements before hepatectomy served as controls. Hepatic arterial and portal venous flows were analysed by ultrasonic flow measurement. Microvascular blood flow and mitochondrial redox state were determined by intravital fluorescence microscopy. Hepatic tissue pO2 was analysed by polarographic techniques. Hepatic function and integrity were studied by bromosulfophthalein bile excretion and liver histology. Results Portal blood flow was 2- to 4-fold increased after 70% and 90% hepatectomy. This, however, did not provoke a hepatic arterial buffer response. Nonetheless, portal hyperperfusion and constant hepatic arterial blood flow were associated with a reduced mitochondrial redox state and a decreased hepatic tissue pO2 after 70% and 90% hepatectomy. Microvascular blood flow increased significantly after hepatectomy and functional sinusoidal density was found only slightly reduced. Major hepatectomy further induced a 2- to 3-fold increase of bile flow. This was associated with a 2-fold increase of bromosulfophthalein excretion. Conclusions Portal hyperperfusion after extended hepatectomy does not induce a hepatic arterial buffer response but reduces mitochondrial redox state and hepatocellular oxygenation. This is not due to a deterioration of microvascular perfusion, but rather due to a relative hypermetabolism of the remnant liver after major resection.	[Dold, Stefan; Richter, Sven; Kollmar, Otto; von Heesen, Maximilian; Schilling, Martin K.] Univ Saarland, Dept Gen Visceral Vasc & Pediat Surg, Homburg, Germany; [Scheuer, Claudia; Laschke, Matthias W.; Menger, Michael D.] Univ Saarland, Inst Clin & Expt Surg, Homburg, Germany; [Vollmar, Brigitte] Univ Rostock, Inst Expt Surg, D-18055 Rostock, Germany	Saarland University; Saarland University; University of Rostock	von Heesen, M (corresponding author), Univ Saarland, Dept Gen Visceral Vasc & Pediat Surg, Homburg, Germany.	maximilian.von.heesen@uniklinik-saarland.de			HOMFOR grant of the University of Saarland	HOMFOR grant of the University of Saarland	This study was supported by a HOMFOR grant of the University of Saarland.	Boermeester MA, 1999, J HEPATOL, V31, P905, DOI 10.1016/S0168-8278(99)80293-1; Cantre D, 2008, BRIT J SURG, V95, P785, DOI 10.1002/bjs.6139; Carnovale CE, 2012, ANN HEPATOL, V11, P636, DOI 10.1016/S1665-2681(19)31436-X; Castello PR, 2006, CELL METAB, V3, P277, DOI 10.1016/j.cmet.2006.02.011; Chouker A, 2008, MOL MED, V14, P116, DOI 10.2119/2007-00075.Chouker; Cray SH, 2001, BRIT J ANAESTH, V86, P425, DOI 10.1093/bja/86.3.425; Dahm F, 2005, AM J TRANSPLANT, V5, P2605, DOI 10.1111/j.1600-6143.2005.01081.x; Decking UKM, 1997, CIRC RES, V81, P154, DOI 10.1161/01.RES.81.2.154; Dutkowski P, 2015, GASTROENTEROLOGY, V148, P307, DOI 10.1053/j.gastro.2014.08.045; Eipel C, 2005, ANN SURG, V241, P477, DOI 10.1097/01.sla.0000154264.41201.51; Eipel C, 2010, TRANSPL INT, V23, P998, DOI 10.1111/j.1432-2277.2010.01079.x; EZZAT WR, 1987, AM J PHYSIOL, V252, pH836, DOI 10.1152/ajpheart.1987.252.4.H836; Gaucher C, 2007, CLIN HEMORHEOL MICRO, V37, P99; Guo X, 2009, ACTA PHYSIOL, V197, P99, DOI 10.1111/j.1748-1716.2009.01999.x; Hayashi H, 2009, HEPATOL RES, V39, P78, DOI 10.1111/j.1872-034X.2008.00404.x; HICKMAN R, 1995, DIGEST DIS SCI, V40, P1246, DOI 10.1007/BF02065532; HOSHINO M, 1995, BIOCHEM J, V305, P367, DOI 10.1042/bj3050367; Knopp J, 1997, ANN NY ACAD SCI, V827, P489, DOI 10.1111/j.1749-6632.1997.tb51859.x; Kostopanagiotou G, 2007, J SURG RES, V141, P257, DOI 10.1016/j.jss.2006.11.005; Lautt WW, 2007, HEPATOL RES, V37, P891, DOI 10.1111/j.1872-034X.2007.00148.x; LAUTT WW, 1990, GASTROENTEROLOGY, V98, P1024, DOI 10.1016/0016-5085(90)90029-Z; LAUTT WW, 1985, AM J PHYSIOL, V249, pG549, DOI 10.1152/ajpgi.1985.249.5.G549; Macedo MP, 1998, AM J PHYSIOL-GASTR L, V274, pG253, DOI 10.1152/ajpgi.1998.274.2.G253; Madrahimov N, 2006, ANN SURG, V244, P89, DOI 10.1097/01.sla.0000218093.12408.0f; Asencio JM, 2014, J HEPATO-BIL-PAN SCI, V21, P399, DOI 10.1002/jhbp.97; Marcos A, 2000, TRANSPLANTATION, V70, P1697, DOI 10.1097/00007890-200012270-00006; Martin-Sanz P, 2002, METAB BRAIN DIS, V17, P325, DOI 10.1023/A:1021909902310; MENGER MD, 1991, EUR SURG RES, V23, P158, DOI 10.1159/000129148; Mucke I, 2000, INT J COLORECTAL DIS, V15, P335, DOI 10.1007/s003840000247; Palmes D, 2004, TRANSPL INT, V17, P862, DOI 10.1111/j.1432-2277.2004.tb00522.x; Richter S, 2001, J PHYSIOL-LONDON, V531, P193, DOI 10.1111/j.1469-7793.2001.0193j.x; Schafer T, 2003, FASEB J, V17, P660, DOI 10.1096/fj.02-0774com; Schild L, 2003, FASEB J, V17, P2194, DOI 10.1096/fj.02-1170com; Serenari M, 2013, WORLD J GASTROENTERO, V19, P7922, DOI 10.3748/wjg.v19.i44.7922; Smyrniotis V, 2002, TRANSPL INT, V15, P355, DOI 10.1111/j.1432-2277.2002.tb00178.x; Tazuma S, 2001, DIGEST DIS SCI, V46, P1285, DOI 10.1023/A:1010623631456; Vollmar B, 1997, MICROVASC RES, V54, P164, DOI 10.1006/mvre.1997.2028; VOLLMAR B, 1994, AM J PATHOL, V145, P1421	38	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2015	10	11							e0141877	10.1371/journal.pone.0141877	http://dx.doi.org/10.1371/journal.pone.0141877			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV1PG	26523932	gold, Green Submitted, Green Published			2022-12-26	WOS:000364029800026
J	Li, LB; Leung, DYM; Goleva, E				Li, Ling-bo; Leung, Donald Y. M.; Goleva, Elena			Activated p38 MAPK in Peripheral Blood Monocytes of Steroid Resistant Asthmatics	PLOS ONE			English	Article							NF-KAPPA-B; PROTEIN-KINASE; CORTICOSTEROID INSENSITIVITY; ALVEOLAR MACROPHAGES; INHIBITION; PATHWAYS; CELLS; INFLAMMATION; MECHANISMS; DISEASE	Steroid resistance is a significant problem in management of chronic inflammatory diseases, including asthma. Accessible biomarkers are needed to identify steroid resistant patients to optimize their treatment. This study examined corticosteroid resistance in severe asthma. 24 asthmatics with forced expiratory volume in one second of less then 80% predicted were classified as steroid resistant or steroid sensitive based on changes in their lung function following a week of treatment with oral prednisone. Heparinised blood was collected from patients prior to oral prednisone administration. Phosphorylated mitogen activated kinases (MAPK) (extracellular regulated kinase (ERK), p38 and jun kinase (JNK)) were analyzed in whole blood samples using flow cytometry. Activation of phospho-p38 MAPK and phospho-mitogen-and stress-activated protein kinase 1 (MSK1) in asthmatics' peripheral blood mononuclear cells (PBMC) were confirmed by Western blot. Dexamethasone suppression of the LPS-induced IL-8 mRNA production by steroid resistant asthmatics PBMC in the presence of p38 and ERK inhibitors was evaluated by real time PCR. Flow cytometry analysis identified significantly stronger p38 phosphorylation in CD14(+) monocytes from steroid resistant than steroid sensitive asthmatics (p = 0.014), whereas no difference was found in phosphorylation of ERK or JNK in CD14(+) cells from these two groups of asthmatics. No difference in phosphorylated p38, ERK, JNK was detected in CD4(+), CD8(+) T cells, B cells and NK cells from steroid resistant vs. steroid sensitive asthmatics. P38 MAPK pathway activation was confirmed by Western blot, as significantly higher phospho-p38 and phospho-MSK1 levels were detected in the PBMC lysates from steroid resistant asthmatics. P38 inhibitor significantly enhanced DEX suppression of LPS-induced IL-8 mRNA by PBMC of steroid resistant asthmatics. This is the first report demonstrating selective p38 MAPK pathway activation in blood monocytes of steroid resistant asthmatics, suggesting that p38 and MSK1 phosphorylation can serve as blood biomarkers of steroid resistance.	[Li, Ling-bo; Leung, Donald Y. M.; Goleva, Elena] Natl Jewish Hlth, Dept Pediat, Denver, CO 80206 USA; [Leung, Donald Y. M.] Univ Colorado Denver, Dept Pediat, Aurora, CO USA	National Jewish Health; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Goleva, E (corresponding author), Natl Jewish Hlth, Dept Pediat, Denver, CO 80206 USA.	GolevaE@njhealth.org			National Institutes of Health [AI070140, HL036577]; National Institutes of Health/National Center for Advancing Translational Sciences Colorado Clinical and Translational Institute [UL1 TR001082]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001082] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL036577] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI070140, R01AI070140] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health/National Center for Advancing Translational Sciences Colorado Clinical and Translational Institute; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health grants AI070140 (DL), HL036577 (DL) and National Institutes of Health/National Center for Advancing Translational Sciences Colorado Clinical and Translational Institute grant UL1 TR001082. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Althuis MD, 1999, J ASTHMA, V36, P257, DOI 10.3109/02770909909075409; Barnes PJ, 2013, J ALLERGY CLIN IMMUN, V131, P636, DOI 10.1016/j.jaci.2012.12.1564; Beck IME, 2009, BIOCHEM PHARMACOL, V77, P1194, DOI 10.1016/j.bcp.2008.12.008; Beck IM, 2008, EMBO J, V27, P1682, DOI 10.1038/emboj.2008.95; Bhavsar P, 2008, THORAX, V63, P784, DOI 10.1136/thx.2007.090027; Bhavsar P, 2010, EUR RESPIR J, V35, P750, DOI 10.1183/09031936.00071309; Carter AB, 1999, AM J RESP CELL MOL, V20, P751, DOI 10.1165/ajrcmb.20.4.3420; Chung KF, 2011, CHEST, V139, P1470, DOI 10.1378/chest.10-1914; Cohen P, 1997, TRENDS CELL BIOL, V7, P353, DOI 10.1016/S0962-8924(97)01105-7; Enslen H, 2000, EMBO J, V19, P1301, DOI 10.1093/emboj/19.6.1301; Gallelli L, 2010, INT J IMMUNOPATH PH, V23, P471, DOI 10.1177/039463201002300209; Galliher-Beckley AJ, 2009, IUBMB LIFE, V61, P979, DOI 10.1002/iub.245; Goleva E, 2008, J ALLERGY CLIN IMMUN, V122, P550, DOI 10.1016/j.jaci.2008.07.007; Goleva E, 2013, AM J RESP CRIT CARE, V188, P1193, DOI 10.1164/rccm.201304-0775OC; Ismaili N, 2004, ANN NY ACAD SCI, V1024, P86, DOI 10.1196/annals.1321.007; Khorasani N, 2015, INT J CHRONIC OBSTR, V10, P283, DOI 10.2147/COPD.S72403; Kumar S, 1999, BIOCHEM BIOPH RES CO, V263, P825, DOI 10.1006/bbrc.1999.1454; Lasa M, 2002, MOL CELL BIOL, V22, P7802, DOI 10.1128/MCB.22.22.7802-7811.2002; Lea S, 2015, BRIT J CLIN PHARMACO, V79, P756, DOI 10.1111/bcp.12536; Lee JC, 1999, PHARMACOL THERAPEUT, V82, P389, DOI 10.1016/S0163-7258(99)00008-X; Leung DYM, 2003, J ALLERGY CLIN IMMUN, V111, P3, DOI 10.1067/mai.2003.97; Lim W, 2005, J IMMUNOL, V175, P5690, DOI 10.4049/jimmunol.175.9.5690; Liu WM, 2008, J ALLERGY CLIN IMMUN, V121, P893, DOI 10.1016/j.jaci.2008.02.004; Liu WM, 2010, MOL CELL BIOL, V30, P1783, DOI 10.1128/MCB.01003-09; Liu YS, 2007, NAT REV IMMUNOL, V7, P202, DOI 10.1038/nri2035; McManus R, 2003, J ENDOCRINOL, V178, P1, DOI 10.1677/joe.0.1780001; Mercado N, 2011, MOL PHARMACOL, V80, P1128, DOI 10.1124/mol.111.071993; Mercado N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041582; Oeckinghaus A, 2011, NAT IMMUNOL, V12, P695, DOI 10.1038/ni.2065; Ramamoorthy S, 2013, ENDOCR DEV, V24, P41, DOI 10.1159/000342502; Rawadi G, 1999, J IMMUNOL, V162, P2193; Shan LY, 2010, J IMMUNOL, V184, P7134, DOI 10.4049/jimmunol.0902515; Singh D, 2010, J CLIN PHARMACOL, V50, P94, DOI 10.1177/0091270009347873; Sutherland ER, 2010, AM J RESP CRIT CARE, V181, P699, DOI 10.1164/rccm.200911-1710OC; Vermeulen L, 2003, EMBO J, V22, P1313, DOI 10.1093/emboj/cdg139; Yang M, 2009, J IMMUNOL, V182, P5107, DOI 10.4049/jimmunol.0803468	36	21	24	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2015	10	10							e0141909	10.1371/journal.pone.0141909	http://dx.doi.org/10.1371/journal.pone.0141909			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0EH	26517722	gold, Green Published, Green Submitted			2022-12-26	WOS:000363920800092
J	Schutte, KH; Maas, EA; Exadaktylos, V; Berckmans, D; Venter, RE; Vanwanseele, B				Schutte, Kurt H.; Maas, Ellen A.; Exadaktylos, Vasileios; Berckmans, Daniel; Venter, Rachel E.; Vanwanseele, Benedicte			Wireless Tri-Axial Trunk Accelerometry Detects Deviations in Dynamic Center of Mass Motion Due to Running-Induced	PLOS ONE			English	Article							VERTICAL DISPLACEMENT; MOUNTED ACCELEROMETER; APPROXIMATE ENTROPY; GAIT SYMMETRY; FATIGUE; VARIABILITY; WALKING; REGULARITY; ACCELERATIONS; KINEMATICS	Small wireless trunk accelerometers have become a popular approach to unobtrusively quantify human locomotion and provide insights into both gait rehabilitation and sports performance. However, limited evidence exists as to which trunk accelerometry measures are suitable for the purpose of detecting movement compensations while running, and specifically in response to fatigue. The aim of this study was therefore to detect deviations in the dynamic center of mass (CoM) motion due to running-induced fatigue using tri-axial trunk accelerometry. Twenty runners aged 18-25 years completed an indoor treadmill running protocol to volitional exhaustion at speeds equivalent to their 3.2 km time trial performance. The following dependent measures were extracted from tri-axial trunk accelerations of 20 running steps before and after the treadmill fatigue protocol: the tri-axial ratio of acceleration root mean square (RMS) to the resultant vector RMS, step and stride regularity (auto-correlation procedure), and sample entropy. Running-induced fatigue increased mediolateral and anteroposterior ratios of acceleration RMS (p < .05), decreased the anteroposterior step regularity (p < .05), and increased the anteroposterior sample entropy (p < .05) of trunk accelerometry patterns. Our findings indicate that treadmill running-induced fatigue might reveal itself in a greater contribution of variability in horizontal plane trunk accelerations, with anteroposterior trunk accelerations that are less regular from step-to-step and are less predictable. It appears that trunk accelerometry parameters can be used to detect deviations in dynamic CoM motion induced by treadmill running fatigue, yet it is unknown how robust or generalizable these parameters are to outdoor running environments.	[Schutte, Kurt H.; Maas, Ellen A.; Vanwanseele, Benedicte] Katholieke Univ Leuven, Dept Kinesiol, Human Movement Biomech Res Grp, Leuven, Belgium; [Schutte, Kurt H.; Exadaktylos, Vasileios; Berckmans, Daniel] Katholieke Univ Leuven, Dept Biosyst, Measure Model & Manage Bioresponses M3 BIORES, Leuven, Belgium; [Schutte, Kurt H.; Venter, Rachel E.] Univ Stellenbosch, Dept Sport Sci, Movement Lab, ZA-7600 Stellenbosch, South Africa	KU Leuven; KU Leuven; Stellenbosch University	Schutte, KH (corresponding author), Katholieke Univ Leuven, Dept Kinesiol, Human Movement Biomech Res Grp, Leuven, Belgium.	kurtschutte.sa@gmail.com	Vanwanseele, Benedicte/AAQ-1706-2021; Venter, Ranel/B-2123-2018	Vanwanseele, Benedicte/0000-0002-6158-9483; Berckmans, Daniel/0000-0002-2974-6055; Venter, Ranel/0000-0002-6620-7915	National Research Foundation [SFH13071922430]; Erasmus Mundus scholarship of the European Union	National Research Foundation; Erasmus Mundus scholarship of the European Union	KS received doctoral scholarships from the National Research Foundation (ZA) (# SFH13071922430, http://www.nrf.ac.za/) and the Erasmus Mundus scholarship of the European Union (http://www.ema2sa.eu/).	Arellano CJ, 2011, J BIOMECH, V44, P1291, DOI 10.1016/j.jbiomech.2011.01.002; BORG GAV, 1982, MED SCI SPORT EXER, V14, P377, DOI 10.1249/00005768-198205000-00012; Derrick TR, 2002, MED SCI SPORT EXER, V34, P998, DOI 10.1097/00005768-200206000-00015; ELLIOTT B, 1981, RES Q EXERCISE SPORT, V52, P160, DOI 10.1080/02701367.1981.10607853; Gerlach KE, 2005, MED SCI SPORT EXER, V37, P657, DOI 10.1249/01.MSS.0000158994.29358.71; Gullstrand L, 2009, GAIT POSTURE, V30, P71, DOI 10.1016/j.gaitpost.2009.03.001; HINRICHS RN, 1987, INT J SPORT BIOMECH, V3, P222, DOI 10.1123/ijsb.3.3.222; Kavanagh J, 2005, EUR J APPL PHYSIOL, V94, P468, DOI 10.1007/s00421-005-1328-1; Kavanagh JJ, 2008, GAIT POSTURE, V28, P1, DOI 10.1016/j.gaitpost.2007.10.010; Kobayashi H, 2014, J NEUROENG REHABIL, V11, DOI 10.1186/1743-0003-11-109; Koblbauer IF, 2014, J SCI MED SPORT, V17, P419, DOI 10.1016/j.jsams.2013.05.013; Kobsar D, 2014, J BIOMECH, V47, P2508, DOI 10.1016/j.jbiomech.2014.04.017; Kobsar D, 2014, GAIT POSTURE, V39, P553, DOI 10.1016/j.gaitpost.2013.09.008; Komi PV, 2000, J BIOMECH, V33, P1197, DOI 10.1016/S0021-9290(00)00064-6; Lamoth CC, 2010, MED ENG PHYS, V32, P1009, DOI 10.1016/j.medengphy.2010.07.001; Lamoth CJC, 2009, GAIT POSTURE, V29, P546, DOI 10.1016/j.gaitpost.2008.12.006; Le Bris R, 2006, J SPORT MED PHYS FIT, V46, P227; Lee JB, 2010, J SCI MED SPORT, V13, P559, DOI 10.1016/j.jsams.2009.08.004; LIPSITZ LA, 1992, JAMA-J AM MED ASSOC, V267, P1806, DOI 10.1001/jama.267.13.1806; MCCLAY IS, 1994, CLIN BIOMECH, V9, P117, DOI 10.1016/0268-0033(94)90034-5; McGregor SJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007355; Meardon SA, 2011, GAIT POSTURE, V33, P36, DOI 10.1016/j.gaitpost.2010.09.020; Mizrahi J, 2000, HUM MOVEMENT SCI, V19, P139, DOI 10.1016/S0167-9457(00)00013-0; Moe-Nilssen R, 2004, J BIOMECH, V37, P121, DOI 10.1016/S0021-9290(03)00233-1; Morin JB, 2011, MED SCI SPORT EXER, V43, P829, DOI 10.1249/MSS.0b013e3181fec518; Novacheck TF, 1998, GAIT POSTURE, V7, P77, DOI 10.1016/S0966-6362(97)00038-6; Orendurff MS, 2004, J REHABIL RES DEV, V41, P829, DOI 10.1682/JRRD.2003.10.0150; Preatoni E, 2010, J SPORT SCI, V28, P1327, DOI 10.1080/02640414.2010.507250; Richman JS, 2000, AM J PHYSIOL-HEART C, V278, pH2039; Riley PO, 2008, MED SCI SPORT EXER, V40, P1093, DOI 10.1249/MSS.0b013e3181677530; Sekine M, 2013, J NEUROENG REHABIL, V10, DOI 10.1186/1743-0003-10-118; SILER WL, 1991, INT J SPORT BIOMECH, V7, P12, DOI 10.1123/ijsb.7.1.12; Slawinski JS, 2004, MED SCI SPORT EXER, V36, P1440, DOI 10.1249/01.MSS.0000135785.68760.96; Terada M, 2015, HUM MOVEMENT SCI, V40, P154, DOI 10.1016/j.humov.2014.12.004; Thirunarayan M.A., 1996, GAIT POSTURE, P306, DOI 10.1016/0966-6362(95)01058-0; Tochigi Y, 2012, J ORTHOP RES, V30, P897, DOI 10.1002/jor.22022; Tura A, 2010, J NEUROENG REHABIL, V7, DOI 10.1186/1743-0003-7-4; Verbitsky O, 1998, J APPL BIOMECH, V14, P300, DOI 10.1123/jab.14.3.300; VOLOSHIN A, 1982, J BIOMECH, V15, P21, DOI 10.1016/0021-9290(82)90031-8; Wundersitz DWT, 2015, EUR J SPORT SCI, V15, P382, DOI 10.1080/17461391.2014.955131; Wundersitz DWT, 2013, SPORT BIOMECH, V12, P403, DOI 10.1080/14763141.2013.811284; Yentes JM, 2013, ANN BIOMED ENG, V41, P349, DOI 10.1007/s10439-012-0668-3	42	60	60	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2015	10	10							e0141957	10.1371/journal.pone.0141957	http://dx.doi.org/10.1371/journal.pone.0141957			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0EH	26517261	Green Published, gold, Green Submitted			2022-12-26	WOS:000363920800097
J	Ghirardi, L; Bisoffi, G; Mirandola, R; Ricci, G; Baccini, M				Ghirardi, Laura; Bisoffi, Giulia; Mirandola, Rina; Ricci, Giorgio; Baccini, Michela			The Impact of Heat on an Emergency Department in Italy: Attributable Visits among Children, Adults, and the Elderly during the Warm Season	PLOS ONE			English	Article							TIME-SERIES ANALYSIS; AMBIENT-TEMPERATURE; HOSPITAL ADMISSIONS; HUMAN HEALTH; EXTREME TEMPERATURES; EUROPEAN CITIES; CLIMATE-CHANGE; ROOM VISITS; MORTALITY; WAVES	Introduction Recent studies suggest that heat is associated with an increase in the number of ambulance calls and emergency department visits. We investigated the association between heat and daily number of emergency department visits at the University Hospital of Verona during the warm seasons 2011-2012 and we assessed the magnitude of the impact in terms of attributable events, focusing on the role of age and triage codification. Materials and methods We used a Poisson model to analyse the association between daily number of visits and daily mean apparent temperature, accounting for air pollution level and seasonality. The analyses were stratified by age group and were performed both on the total number of emergency department visits and on the subsample of high-priority visits. Impact estimates were obtained only for this subsample, using a Monte Carlo approach to account for sampling variability. Number of attributable events and attributable community rate were calculated. Results We found a positive and immediate association between event occurrence and mean apparent temperatures exceeding a threshold located around 28-29 degrees C. The estimated percent change in the total number of visits per 1 degrees C increase of exposure above the threshold was equal to 3.75 (90% CI: 3.01; 4.49). Focusing only on high-priority visits, the estimated percent change was larger and the greatest effect was among children. We estimated that apparent temperatures above the threshold were responsible for 1177 high-priority visits during the study period. Due to the record high temperatures observed in 2012 in Italy and in Europe, the impact in 2012 was much larger than in 2011, and consisted in 34 high-priority visits every 10000 children, 30 every 10000 people aged 15-64, and 38 every 10000 people aged 65 and over. Discussion Our results indicate that heat affects not only the elderly, but also children and non-elderly adults, stressing the need for developing public health preparedness plans for the entire community.	[Ghirardi, Laura; Baccini, Michela] Univ Florence, Dept Stat Informat & Applicat G Parenti, Florence, Italy; [Baccini, Michela] ISPO Canc Prevent & Res Inst, Biostat Unit, Florence, Italy; [Bisoffi, Giulia; Mirandola, Rina] Univ Hosp Verona, Res Support & Biostat Unit, Verona, Italy; [Ricci, Giorgio] Univ Hosp Verona, Dept Accid & Emergency, Verona, Italy	University of Florence; ISPRO Istituto per lo studio, la prevenzione e la rete oncologica; University of Verona; Azienda Ospedaliera Universitaria Integrata Verona; University of Verona; Azienda Ospedaliera Universitaria Integrata Verona	Baccini, M (corresponding author), Univ Florence, Dept Stat Informat & Applicat G Parenti, Florence, Italy.	baccini@disia.unifi.it						Alessandrini E, 2011, ENVIRON RES, V111, P1192, DOI 10.1016/j.envres.2011.07.005; Almeida S, 2013, J TOXICOL ENV HEAL A, V76, P422, DOI 10.1080/15287394.2013.771550; Analitis A, 2014, EPIDEMIOLOGY, V25, P15, DOI 10.1097/EDE.0b013e31828ac01b; Anderson GB, 2013, AM J RESP CRIT CARE, V187, P1098, DOI 10.1164/rccm.201211-1969OC; Armstrong BG, 2011, J EPIDEMIOL COMMUN H, V65, P340, DOI 10.1136/jech.2009.093161; Astrom DO, 2013, EPIDEMIOLOGY, V24, P820, DOI 10.1097/01.ede.0000434530.62353.0b; Baccini M, 2011, J EPIDEMIOL COMMUN H, V65, P64, DOI 10.1136/jech.2008.085639; Baccini M, 2008, EPIDEMIOLOGY, V19, P711, DOI 10.1097/EDE.0b013e318176bfcd; Baccini M, 2011, AM J EPIDEMIOL, V174, P1396, DOI 10.1093/aje/kwr256; Bai L, 2014, SCI TOTAL ENVIRON, V490, P838, DOI 10.1016/j.scitotenv.2014.05.024; Bassil KL, 2011, J EPIDEMIOL COMMUN H, V65, P829, DOI 10.1136/jech.2009.101485; Basu R, 2012, EPIDEMIOLOGY, V23, P813, DOI 10.1097/EDE.0b013e31826b7f97; Bouchama A, 2007, ARCH INTERN MED, V167, P2170, DOI 10.1001/archinte.167.20.ira70009; BURMASTER DE, 1994, RISK ANAL, V14, P477, DOI 10.1111/j.1539-6924.1994.tb00265.x; Hajat S, 2006, EPIDEMIOLOGY, V17, P632, DOI 10.1097/01.ede.0000239688.70829.63; Hajat S, 2014, J EPIDEMIOL COMMUN H, V68, P641, DOI 10.1136/jech-2013-202449; Iniguez C, 2010, INT J ENV RES PUB HE, V7, P3196, DOI 10.3390/ijerph7083196; ISTAT, 2009, ATL GEOGR STAT AMM; Josseran L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011984; Josseran L, 2009, BMC MED INFORM DECIS, V9, DOI 10.1186/1472-6947-9-14; KALKSTEIN LS, 1986, B AM METEOROL SOC, V67, P842, DOI 10.1175/1520-0477(1986)067<0842:AEOSDI>2.0.CO;2; Knowlton K, 2009, ENVIRON HEALTH PERSP, V117, P61, DOI 10.1289/ehp.11594; Kovats RS, 2006, EUR J PUBLIC HEALTH, V16, P592, DOI 10.1093/eurpub/ckl049; Kovats RS, 2005, RISK ANAL, V25, P1409, DOI 10.1111/j.1539-6924.2005.00688.x; Kovats RS, 2004, OCCUP ENVIRON MED, V61, P893, DOI 10.1136/oem.2003.012047; Leone M, 2013, ENVIRON HEALTH-GLOB, V12, DOI 10.1186/1476-069X-12-55; Lippmann SJ, 2013, ENVIRON RES, V124, P35, DOI 10.1016/j.envres.2013.03.009; Louis TA, 2009, BIOSTATISTICS, V10, P1, DOI 10.1093/biostatistics/kxn014; Mastrangelo G, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-200; McMichael AJ, 2008, INT J EPIDEMIOL, V37, P1121, DOI 10.1093/ije/dyn086; Michelozzi P, 2009, AM J RESP CRIT CARE, V179, P383, DOI 10.1164/rccm.200802-217OC; Muggeo VMR, 2003, STAT MED, V22, P3055, DOI 10.1002/sim.1545; Schaffer A, 2012, ENVIRON HEALTH-GLOB, V11, DOI 10.1186/1476-069X-11-3; Schwartz J, 2004, EPIDEMIOLOGY, V15, P755, DOI 10.1097/01.ede.0000134875.15919.0f; Sterne JAC, 2001, BMJ-BRIT MED J, V322, P226, DOI 10.1136/bmj.322.7280.226; Toloo GS, 2014, CRIT CARE, V18, DOI 10.1186/cc13826; TsuzukiHayakawa K, 1995, EUR J APPL PHYSIOL O, V72, P12, DOI 10.1007/BF00964108; Turner LR, 2013, PREHOSP DISASTER MED, V28, P482, DOI 10.1017/S1049023X13008789; Turner LR, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001074; Vaneckova P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055459; Wacholder S, 2005, EPIDEMIOLOGY, V16, P1, DOI 10.1097/01.ede.0000147633.09891.16; Xu ZW, 2014, INT J BIOMETEOROL, V58, P239, DOI 10.1007/s00484-013-0655-x; Xu ZW, 2014, J EPIDEMIOL COMMUN H, V68, P304, DOI 10.1136/jech-2013-202725; Zhang Y, 2014, ENVIRON HEALTH-GLOB, V13, DOI 10.1186/1476-069X-13-100	44	6	6	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2015	10	10							e0141054	10.1371/journal.pone.0141054	http://dx.doi.org/10.1371/journal.pone.0141054			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0ED	26513471	gold, Green Submitted, Green Published			2022-12-26	WOS:000363920300013
J	Halleran, A; Clamons, S; Saha, M				Halleran, Andrew; Clamons, Samuel; Saha, Margaret			Transcriptomic Characterization of an Infection of Mycobacterium smegmatis by the Cluster A4 Mycobacteriophage Kampy	PLOS ONE			English	Article							GENE-EXPRESSION; BACTERIOPHAGE; TUBERCULOSIS; ASSAY; ACQUISITION; DIAGNOSIS; GENOMICS; TUC2009; GILES; TOOL	The mycobacteriophages, phages that infect the genus Mycobacterium, display profound genetic diversity and widespread geographical distribution, and possess significant medical and ecological importance. However, most of the majority of functions of mycobacteriophage proteins and the identity of most genetic regulatory elements remain unknown. We characterized the gene expression profile of Kampy, a cluster A4 mycobacteriophage, during infection of its host, Mycobacterium smegmatis, using RNA-Seq and mass spectrometry. We show that mycobacteriophage Kampy transcription occurs in roughly two phases, an early phase consisting of genes for metabolism, DNA synthesis, and gene regulation, and a late phase consisting of structural genes and lysis genes. Additionally, we identify the earliest genes transcribed during infection, along with several other possible regulatory units not obvious from inspection of Kampy's genomic structure. The transcriptional profile of Kampy appears similar to that of mycobacteriophage TM4 but unlike that of mycobacteriophage Giles, a result which further expands our understanding of the diversity of mycobacteriophage gene expression programs during infection.	[Halleran, Andrew; Clamons, Samuel; Saha, Margaret] Coll William & Mary, Dept Biol, Williamsburg, VA 23185 USA	William & Mary	Saha, M (corresponding author), Coll William & Mary, Dept Biol, Williamsburg, VA 23185 USA.	mssaha@wm.edu		Halleran, Andrew/0000-0001-8720-1451	Howard Hughes Medical Institute [52006919]; National Science Foundation [IOS- 1257895]; National Institutes of Health [1R15HD077624-01]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R15HD077624] Funding Source: NIH RePORTER; Direct For Biological Sciences [1257895] Funding Source: National Science Foundation	Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	The work was supported by the following: MSS - Howard Hughes Medical Institute - 52006919; MSS - National Science Foundation - IOS- 1257895; and MSS - National Institutes of Health - 1R15HD077624-01.	Ainsworth S, 2013, APPL ENVIRON MICROB, V79, P4786, DOI 10.1128/AEM.01197-13; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Cresawn SG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118725; Cresawn SG, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-395; Dedrick RM, 2013, MOL MICROBIOL, V88, P577, DOI 10.1111/mmi.12210; Dotsch A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031092; Ford M. E., 1998, Tubercle and Lung Disease, V79, P63, DOI 10.1054/tuld.1998.0007; GARDNER GM, 1947, P SOC EXP BIOL MED, V66, P205; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Hatfull GF, 2006, PLOS GENET, V2, P835, DOI 10.1371/journal.pgen.0020092; Hatfull GF, 2013, GENOME ANNOUNCEMENTS, V1, DOI 10.1128/genomeA.00847-13; Hatfull GF, 2010, J MOL BIOL, V397, P119, DOI 10.1016/j.jmb.2010.01.011; Jordan TC, 2014, MBIO, V5, DOI 10.1128/mBio.01051-13; Lavigne R, 2013, MBIO, V4, DOI 10.1128/mBio.00061-13; Lawrence JG, 2002, J BACTERIOL, V184, P4891, DOI 10.1128/JB.184.17.4891-4905.2002; LEE MH, 1991, P NATL ACAD SCI USA, V88, P3111, DOI 10.1073/pnas.88.8.3111; Luke K, 2002, VIROLOGY, V299, P182, DOI 10.1006/viro.2002.1409; Marei AM, 2003, J MED MICROBIOL, V52, P331, DOI 10.1099/jmm.0.05091-0; McNerney R, 2004, J CLIN MICROBIOL, V42, P2115, DOI 10.1128/JCM.42.5.2115-2120.2004; Mehla J, 2015, J BACTERIOL, pJB; Morris P, 2008, J BACTERIOL, V190, P2172, DOI 10.1128/JB.01657-07; Muzaffar R, 2002, INT J TUBERC LUNG D, V6, P635; NESBIT CE, 1995, MOL MICROBIOL, V17, P1045, DOI 10.1111/j.1365-2958.1995.mmi_17061045.x; Osterhout RE, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-82; Pearson RE, 1996, GENE, V183, P129, DOI 10.1016/S0378-1119(96)00530-6; Pedulla ML, 2003, CELL, V113, P171, DOI 10.1016/S0092-8674(03)00233-2; Pelleg D, 2000, ICML; Pope WH, 2015, ELIFE, V4, DOI 10.7554/eLife.06416; Pope WH, 2014, MBIO, V5, DOI 10.1128/mBio.02145-14; Pope WH, 2014, J VIROL, V88, P2461, DOI 10.1128/JVI.03363-13; Poranen MM, 2006, J VIROL, V80, P8081, DOI 10.1128/JVI.00065-06; SARKIS GJ, 1995, MOL MICROBIOL, V15, P1055, DOI 10.1111/j.1365-2958.1995.tb02281.x; Seegers JFML, 2004, VIROLOGY, V329, P40, DOI 10.1016/j.virol.2004.07.003; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Stella EJ, 2009, REV ARGENT MICROBIOL, V41, P45; STOVER CK, 1991, NATURE, V351, P456, DOI 10.1038/351456a0; Wang C, 2014, NAT BIOTECHNOL, V32, P926, DOI 10.1038/nbt.3001; Wang R, 2005, GENOME RES, V15, P1118, DOI 10.1101/gr.3994105; Xu J, 2004, MOL CELL, V16, P11, DOI 10.1016/j.molcel.2004.09.006	40	11	11	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2015	10	10							e0141100	10.1371/journal.pone.0141100	http://dx.doi.org/10.1371/journal.pone.0141100			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0ED	26513661	Green Published, Green Submitted, gold			2022-12-26	WOS:000363920300015
J	He, JY; Chen, SH; Tsai, TM				He, Ji-Yin; Chen, Shih-Heng; Tsai, Tsu-Min			The Risk Factors for Failure of an Upper Extremity Replantation: Is the Use of Cigarettes/Tobacco a Significant Factor?	PLOS ONE			English	Article							FLAP BREAST RECONSTRUCTION; TOBACCO SMOKING; SKIN FLAPS; NICOTINE; RATS; COMPLICATIONS; EXPERIENCE; SMOKERS; DIGIT	Background The purpose of this study was to explore the potential risk factors associated with the failure of an upper extremity replantation with a focus on cigarette or tobacco use. Patients and Methods A cohort of 102 patients with 149 replants (6 extremities, 143 digits) and a mean age of 41 years (range 5 to 72 years) was enrolled in this study. The data collected included age, gender, tobacco/cigarettes use, trauma mechanism, underlying disease (e.g., hypertension (HTN), diabetes mellitus (DM), etc.), and vein graft use. An analysis with a multivariable regression was conducted to identify the risk factors of replant failure and their respective odds ratios (ORs). Results Multilevel generalized linear mixed models (GLMMs) with a binomial distribution and logit link showed that smoking did not increase the risk of replant failure (p = 0.234). In addition, the survival of replants was not affected by DM or HTN (p = 0.285 and 0.938, respectively). However, the replantation results were significantly affected by the age of the patients and the mechanism of injury. Patients older than 50 years and those with avulsion or crush injuries tended to have a higher risk of replant failure (OR = 2.29, 6.45, and 5.42, respectively; p = 0.047, 0.028, and 0.032, respectively). Conclusions This study showed that the use of cigarettes/tobacco did not affect the replantation outcome. The main risks for replant failure included being older than 50 years and the trauma mechanism (avulsion or crush injuries).	[He, Ji-Yin] Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Dept Plast Surg, Shanghai 200030, Peoples R China; [Chen, Shih-Heng] Chang Gung Univ, Chang Gung Mem Hosp, Dept Plast & Reconstruct Surg, Coll Med, Taipei, Taiwan; [Tsai, Tsu-Min] Christine M Kleinert Inst Hand & Microsurg, Louisville, KY 40202 USA	Shanghai Jiao Tong University; Chang Gung Memorial Hospital; Chang Gung University	Tsai, TM (corresponding author), Christine M Kleinert Inst Hand & Microsurg, Louisville, KY 40202 USA.	tmt@kkahand.com						Beris AE, 2010, ARCH ORTHOP TRAUM SU, V130, P1141, DOI 10.1007/s00402-009-1021-7; Black CE, 2001, AM J PHYSIOL-REG I, V281, pR1097, DOI 10.1152/ajpregu.2001.281.4.R1097; Campos JHO, 2008, EXP TOXICOL PATHOL, V60, P449, DOI 10.1016/j.etp.2008.02.004; Chang DW, 2000, PLAST RECONSTR SURG, V105, P2374, DOI 10.1097/00006534-200006000-00010; Dec Wojciech, 2006, Tech Hand Up Extrem Surg, V10, P124; Dixon AJ, 2009, BRIT J DERMATOL, V160, P365, DOI 10.1111/j.1365-2133.2008.08846.x; Eckardt A, 2003, J CRANIO MAXILL SURG, V31, P197, DOI 10.1016/S1010-5182(03)00039-8; Ellis CN, 2007, DIS COLON RECTUM, V50, P459, DOI 10.1007/s10350-006-0829-2; Freitas FAS, 2010, J SURG RES, V164, P139, DOI 10.1016/j.jss.2010.05.028; Fufa D, 2013, J BONE JOINT SURG AM, V95A, P2127, DOI 10.2106/JBJS.L.01219; Midttun M, 2006, INT ANGIOL, V25, P293; Nahabedian MY, 2004, PLAST RECONSTR SURG, V114, P74, DOI 10.1097/01.PRS.0000127798.69644.65; REUS WF, 1984, BRIT J PLAST SURG, V37, P213, DOI 10.1016/0007-1226(84)90011-0; Sears ED, 2011, J HAND SURG-AM, V36A, P686, DOI 10.1016/j.jhsa.2010.12.023; Selber JC, 2006, ANN PLAS SURG, V56, P492, DOI 10.1097/01.sap.0000210180.72721.4a; Shah A, 2014, MICROSURG, V34, P390, DOI 10.1002/micr.22237; Yin W, 2008, THROMB RES, V122, P221, DOI 10.1016/j.thromres.2007.11.005	17	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2015	10	10							e0141451	10.1371/journal.pone.0141451	http://dx.doi.org/10.1371/journal.pone.0141451			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0ED	26513147	Green Published, gold, Green Submitted			2022-12-26	WOS:000363920300040
J	Kumar, JD; Holmberg, C; Balabanova, S; Borysova, L; Burdyga, T; Beynon, R; Dockray, GJ; Varro, A				Kumar, J. Dinesh; Holmberg, Chris; Balabanova, Silvia; Borysova, Lyudmyla; Burdyga, Ted; Beynon, Robert; Dockray, Graham J.; Varro, Andrea			Mesenchymal Stem Cells Exhibit Regulated Exocytosis in Response to Chemerin and IGF	PLOS ONE			English	Article							SECRETORY GRANULE BIOGENESIS; GASTRIC EPITHELIAL-CELLS; MATRIX METALLOPROTEINASE-7; CHEMOKINE RECEPTORS; HELICOBACTER-PYLORI; CANCER PROGRESSION; PATHWAYS; MYOFIBROBLASTS; FIBROBLASTS; MIGRATION	Mesenchymal stem cells (MSCs) play important roles in tissue repair and cancer progression. Our recent work suggests that some mesenchymal cells, notably myofibroblasts exhibit regulated exocytosis resembling that seen in neuroendocrine cells. We now report that MSCs also exhibit regulated exocytosis. Both a G-protein coupled receptor agonist, chemerin, and a receptor tyrosine kinase stimulant, IGF-II, evoked rapid increases in secretion of a marker protein, TGF beta ig-h3. The calcium ionophore, ionomycin, also rapidly increased secretion of TGF beta ig-h3 while inhibitors of translation (cycloheximide) or secretory protein transport (brefeldin A) had no effect, indicating secretion from preformed secretory vesicles. Inhibitors of the chemerin and IGF receptors specifically reduced the secretory response. Confocal microscopy of MSCs loaded with Fluo-4 revealed chemerin and IGF-II triggered intracellular Ca2+ oscillations requiring extracellular calcium. Immunocytochemistry showed co-localisation of TGF beta ig-h3 and MMP-2 to secretory vesicles, and transmission electron-microscopy showed dense-core secretory vesicles in proximity to the Golgi apparatus. Proteomic studies on the MSC secretome identified 64 proteins including TGF beta ig-h3 and MMP-2 that exhibited increased secretion in response to IGF-II treatment for 30min and western blot of selected proteins confirmed these data. Gene ontology analysis of proteins exhibiting regulated secretion indicated functions primarily associated with cell adhesion and in bioassays chemerin increased adhesion of MSCs and adhesion, proliferation and migration of myofibroblasts. Thus, MSCs exhibit regulated exocytosis that is compatible with an early role in tissue remodelling.	[Kumar, J. Dinesh; Holmberg, Chris; Balabanova, Silvia; Borysova, Lyudmyla; Burdyga, Ted; Dockray, Graham J.; Varro, Andrea] Univ Liverpool, Inst Translat Med, Dept Cell & Mol Physiol, Liverpool L69 3BX, Merseyside, England; [Beynon, Robert] Univ Liverpool, Inst Integrat Biol, Dept Biochem, Liverpool L69 3BX, Merseyside, England	University of Liverpool; University of Liverpool	Varro, A (corresponding author), Univ Liverpool, Inst Translat Med, Dept Cell & Mol Physiol, Crown St, Liverpool L69 3BX, Merseyside, England.	avarro@liverpool.ac.uk	Varro, Andras/M-2647-2016; Kumar, Jothi Dinesh/I-6168-2019; Beynon, Robert/K-1408-2014	Kumar, Jothi Dinesh/0000-0003-1086-0509; Burdyga, Theodor/0000-0002-6312-1550; Borysova, Lyudmyla/0000-0003-0458-9871; Beynon, Robert/0000-0003-0857-495X	North West Cancer Research Fund (United Kingdom); Wellcome Trust; MRC	North West Cancer Research Fund (United Kingdom); Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Funding provided by North West Cancer Research Fund (United Kingdom) to AV, Wellcome Trust Studentship to CH and MRC studentship to SB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amable PR, 2014, STEM CELL RES THER, V5, DOI 10.1186/scrt442; Arvan P, 1998, BIOCHEM J, V332, P593, DOI 10.1042/bj3320593; Balabanova S, 2014, CARCINOGENESIS, V35, P1798, DOI 10.1093/carcin/bgu086; Borgonovo B, 2002, NAT CELL BIOL, V4, P955, DOI 10.1038/ncb888; Campbell JJ, 2008, J APPL BIOMATER BIOM, V6, P9; Chavez RA, 1996, J CELL BIOL, V133, P1177, DOI 10.1083/jcb.133.6.1177; Cho RJ, 2000, TRENDS GENET, V16, P409, DOI 10.1016/S0168-9525(00)02065-5; Coorssen JR, 1996, EMBO J, V15, P3787, DOI 10.1002/j.1460-2075.1996.tb00752.x; De Boeck A, 2013, PROTEOMICS, V13, P379, DOI 10.1002/pmic.201200179; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Gao ZB, 2013, NANOMED-NANOTECHNOL, V9, P174, DOI 10.1016/j.nano.2012.06.003; Greco SJ, 2012, THER DELIV, V3, P997, DOI 10.4155/TDE.12.69; Hemers E, 2005, CANCER RES, V65, P7363, DOI 10.1158/0008-5472.CAN-05-0157; Honczarenko M, 2006, STEM CELLS, V24, P1030, DOI 10.1634/stemcells.2005-0319; Jorgensen C, 2003, GENE THER, V10, P928, DOI 10.1038/sj.gt.3302019; Kawano S, 2002, CELL CALCIUM, V32, P165, DOI 10.1016/S0143416002001240; KELLY RB, 1985, SCIENCE, V230, P25, DOI 10.1126/science.2994224; Kim T, 2006, PHYSIOLOGY, V21, P124, DOI 10.1152/physiol.00043.2005; Kim TJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109378; Kumar JD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104877; Lavoie JR, 2013, BIOCHIMIE, V95, P2212, DOI 10.1016/j.biochi.2013.06.017; McCaig C, 2006, GASTROENTEROLOGY, V130, P1754, DOI 10.1053/j.gastro.2006.02.031; McLean L, 2007, J CHEM ECOL, V33, P1997, DOI 10.1007/s10886-007-9354-6; Meder W, 2003, FEBS LETT, V555, P495, DOI 10.1016/S0014-5793(03)01312-7; Mi HY, 2013, NAT PROTOC, V8, P1551, DOI 10.1038/nprot.2013.092; Muruganandan S, 2013, STEM CELLS, V31, P2172, DOI 10.1002/stem.1450; Muruganandan S, 2011, J BIOL CHEM, V286, P23982, DOI 10.1074/jbc.M111.220491; Ninomiya Y, 1996, J BIOL CHEM, V271, P17751, DOI 10.1074/jbc.271.30.17751; Nombela-Arrieta C, 2011, NAT REV MOL CELL BIO, V12, P126, DOI 10.1038/nrm3049; Norsett KG, 2011, AM J PHYSIOL-GASTR L, V301, pG446, DOI 10.1152/ajpgi.00527.2010; Quante M, 2011, CANCER CELL, V19, P257, DOI 10.1016/j.ccr.2011.01.020; Singer NG, 2011, ANNU REV PATHOL-MECH, V6, P457, DOI 10.1146/annurev-pathol-011110-130230; Skalnikova HK, 2013, BIOCHIMIE, V95, P2196, DOI 10.1016/j.biochi.2013.07.015; Sordi V, 2005, BLOOD, V106, P419, DOI 10.1182/blood-2004-09-3507; Taylor AM, 2010, RHEUMATOLOGY, V49, P1412, DOI 10.1093/rheumatology/keq027; Wittamer V, 2003, J EXP MED, V198, P977, DOI 10.1084/jem.20030382; Wroblewski LE, 2003, J CELL SCI, V116, P3017, DOI 10.1242/jcs.00518	37	8	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2015	10	10							e0141331	10.1371/journal.pone.0141331	http://dx.doi.org/10.1371/journal.pone.0141331			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0ED	26513261	Green Published, Green Submitted, gold			2022-12-26	WOS:000363920300031
J	Liccardo, A; Fierro, A				Liccardo, Antonella; Fierro, Annalisa			Multiple Lattice Model for Influenza Spreading	PLOS ONE			English	Article							SOCIAL CONTACTS; COMPLEX NETWORKS; MIXING PATTERNS; TRANSMISSION; DISEASE; PERCOLATION; INFECTIONS; EPIDEMICS; DYNAMICS; OUTBREAK	Behavioral differences among age classes, together with the natural tendency of individuals to prefer contacts with individuals of similar age, naturally point to the existence of a community structure in the population network, in which each community can be identified with a different age class. Data on age-dependent contact patterns also reveal how relevant is the role of the population age structure in shaping the spreading of an infectious disease. In the present paper we propose a simple model for epidemic spreading, in which a contact network with an intrinsic community structure is coupled with a simple stochastic SIR model for the epidemic spreading. The population is divided in 4 different age-communities and hosted on a multiple lattice, each community occupying a specific age-lattice. Individuals are allowed to move freely to nearest neighbor empty sites on the age-lattice. Different communities are connected with each other by means of inter-lattices edges, with a different number of external links connecting different age class populations. The parameters of the contact network model are fixed by requiring the simulated data to fully reproduce the contact patterns matrices of the Polymod survey. The paper shows that adopting a topology which better implements the age-class community structure of the population, one gets a better agreement between experimental contact patterns and simulated data, and this also improves the accordance between simulated and experimental data on the epidemic spreading.	[Liccardo, Antonella; Fierro, Annalisa] Univ Naples Federico II, Dept Phys, Naples, Italy; [Liccardo, Antonella] Ist Nazl Fis Nucl, Sez Napoli, I-80125 Naples, Italy; [Fierro, Annalisa] CNR, Inst Superconductors Oxides & Other Innovat Mat &, I-80125 Naples, Italy	University of Naples Federico II; Istituto Nazionale di Fisica Nucleare (INFN); Consiglio Nazionale delle Ricerche (CNR)	Fierro, A (corresponding author), Univ Naples Federico II, Dept Phys, Naples, Italy.	annalisa.fierro@spin.cnr.it	Fierro, Annalisa/G-8479-2013	Fierro, Annalisa/0000-0001-8431-942X				Ajelli M, 2014, SCI REP-UK, V4, DOI 10.1038/srep07218; Bansal S, 2007, J R SOC INTERFACE, V4, P879, DOI 10.1098/rsif.2007.1100; Beutels P, 2006, EPIDEMIOL INFECT, V134, P1158, DOI 10.1017/S0950268806006418; Boguna M, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.047104; Cattuto C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011596; Cauchemez S, 2011, P NATL ACAD SCI USA, V108, P2825, DOI 10.1073/pnas.1008895108; Danon L, 2012, J R SOC INTERFACE, V9, P2826, DOI 10.1098/rsif.2012.0357; Eames KTD, 2002, P NATL ACAD SCI USA, V99, P13330, DOI 10.1073/pnas.202244299; Edmunds WJ, 1997, P ROY SOC B-BIOL SCI, V264, P949, DOI 10.1098/rspb.1997.0131; Fierro A, 2011, EUR PHYS J E, V34, DOI 10.1140/epje/i2011-11011-2; Fierro A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083641; Foster DV, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.066117; Fournet J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107878; INFLUNET, 2010, RISULTATI DELLA SORV; Isella L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017144; Keeling MJ, 2005, J R SOC INTERFACE, V2, P295, DOI 10.1098/rsif.2005.0051; Keeling MJ, 1999, P ROY SOC B-BIOL SCI, V266, P859, DOI 10.1098/rspb.1999.0716; Kucharski AJ, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004206; Kwok KO, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0709; Lessler J, 2009, NEW ENGL J MED, V361, P2628, DOI 10.1056/NEJMoa0906089; Liccardo A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063935; Liu ZH, 2005, EUROPHYS LETT, V72, P315, DOI 10.1209/epl/i2004-10550-5; Mccaw JM, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-166; Melegaro A, 2011, EPIDEMICS-NETH, V3, P143, DOI 10.1016/j.epidem.2011.04.001; Merler S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074785; Meyers LA, 2006, J THEOR BIOL, V240, P400, DOI 10.1016/j.jtbi.2005.10.004; Mikolajczyk RT, 2008, EPIDEMIOL INFECT, V136, P813, DOI 10.1017/S0950268807009181; Moore C, 2000, PHYS REV E, V61, P5678, DOI 10.1103/PhysRevE.61.5678; Moreno Y, 2002, EUR PHYS J B, V26, P521, DOI 10.1140/epjb/e20020122; Mossong J, 2008, PLOS MED, V5, P381, DOI 10.1371/journal.pmed.0050074; Newman M., 2010, NETWORKS INTRO, DOI [10.1162/artl_r_00062, 10.1093/acprof:oso/9780199206650.001.0001, DOI 10.1093/ACPROF:OSO/9780199206650.001.0001]; Newman MEJ, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.026121; Newman MEJ, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.036122; Newman MEJ, 1999, PHYS REV E, V60, P7332, DOI 10.1103/PhysRevE.60.7332; Newman MEJ, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.016128; Pan W, 2015, J THEOR BIOL, V382, P309, DOI 10.1016/j.jtbi.2015.07.009; Pastor-Satorras R, 2001, PHYS REV E, V63, DOI 10.1103/PhysRevE.63.066117; Potter GE, 2012, ANN APPL STAT, V6, P1, DOI 10.1214/11-AOAS505; Read JM, 2012, EPIDEMIOL INFECT, V140, P2117, DOI 10.1017/S0950268812000842; Read JM, 2008, J R SOC INTERFACE, V5, P1001, DOI 10.1098/rsif.2008.0013; Reinheimer C, 2011, INFECTION, V39, P101, DOI 10.1007/s15010-011-0105-9; Salathe M, 2010, P NATL ACAD SCI USA, V107, P22020, DOI 10.1073/pnas.1009094108; Smieszek T, 2012, EPIDEMIOL INFECT, V140, P744, DOI 10.1017/S0950268811001130; Sun GQ, 2012, NONLINEAR DYNAM, V69, P1097, DOI 10.1007/s11071-012-0330-5; Sun GQ, 2010, J THEOR BIOL, V264, P95, DOI 10.1016/j.jtbi.2010.01.006; Volz E, 2008, J MATH BIOL, V56, P293, DOI 10.1007/s00285-007-0116-4; Wallinga J, 2006, AM J EPIDEMIOL, V164, P936, DOI 10.1093/aje/kwj317; Wang Y, 2015, PHYSICA A, V437, P75, DOI 10.1016/j.physa.2015.05.103; Wang Y, 2012, NONLINEAR ANAL-REAL, V13, P543, DOI 10.1016/j.nonrwa.2011.07.033; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; White LF, 2009, INFLUENZA OTHER RESP, V3, P267, DOI 10.1111/j.1750-2659.2009.00106.x; Zhang JP, 2012, APPL MATH COMPUT, V219, P2829, DOI 10.1016/j.amc.2012.06.057	52	7	7	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2015	10	10							e0141065	10.1371/journal.pone.0141065	http://dx.doi.org/10.1371/journal.pone.0141065			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0ED	26513580	Green Published, Green Submitted, gold			2022-12-26	WOS:000363920300014
J	Vijayvergiya, V; Acharya, S; Wilson, SP; Schmidt, JJ				Vijayvergiya, Viksita; Acharya, Shiv; Wilson, Sidney P.; Schmidt, Jacob J.			Measurement of Ensemble TRPV1 Ion Channel Currents Using Droplet Bilayers	PLOS ONE			English	Article							LIPID-BILAYER; IN-VITRO; RECEPTOR; RECONSTITUTION; ANTAGONIST; MONOLAYERS	Electrophysiological characterization of ion channels is useful for elucidation of channel function as well as quantitative assessment of pharmaceutical effects on ion channel conductance. We used droplet bilayers to measure ensemble ion channel currents from membrane preparations made from TRPV1-expressing HEK cells. Conductance measurements showed rectification, activation by acid and capsaicin, and inhibition by capsazepine, SB 452533, and JNJ 17293212. We also quantitatively measured concentration-dependent inhibition of channel conductance through determination of capsazepine IC50 in agreement with previously published studies using patch clamp. These results, combined with the reduced apparatus and material requirements of droplet bilayers, indicate that this platform could be used for study of other physiologically relevant ion channels.	[Vijayvergiya, Viksita; Acharya, Shiv; Wilson, Sidney P.; Schmidt, Jacob J.] Univ Calif Los Angeles, Dept Bioengn, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles	Schmidt, JJ (corresponding author), Univ Calif Los Angeles, Dept Bioengn, Los Angeles, CA 90095 USA.	schmidt@seas.ucla.edu			National Institute of General Medical Sciences [R44GM097763]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R44GM097763] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding to J.J.S.: National Institute of General Medical Sciences, R44GM097763.	Bhattacharya A, 2007, J PHARMACOL EXP THER, V323, P665, DOI 10.1124/jpet.107.127258; Cao E, 2013, NEURON, V77, P667, DOI 10.1016/j.neuron.2012.12.016; DICKENSON AH, 1991, BRIT J PHARMACOL, V104, P1045, DOI 10.1111/j.1476-5381.1991.tb12547.x; El-Arabi AM, 2012, LAB CHIP, V12, P2409, DOI [10.1039/c2lc40087a, 10.1039/c21c40087a]; Funakoshi K, 2006, ANAL CHEM, V78, P8169, DOI 10.1021/ac0613479; Holden MA, 2007, J AM CHEM SOC, V129, P8650, DOI 10.1021/ja072292a; Julius D, 2013, ANNU REV CELL DEV BI, V29, P355, DOI 10.1146/annurev-cellbio-101011-155833; Kawano R, 2013, SCI REP-UK, V3, DOI 10.1038/srep01995; Korepanova A, 2009, PROTEIN EXPRES PURIF, V65, P38, DOI 10.1016/j.pep.2008.12.006; Leptihn S, 2011, J AM CHEM SOC, V133, P9370, DOI 10.1021/ja200128n; Lu B, 2015, NANOSCALE, V7, P7858, DOI 10.1039/c4nr06892k; Lu B, 2014, BIOTECHNOL J, V9, P446, DOI 10.1002/biot.201300271; Miller C., 1986, ION CHANNEL RECONSTI; MONTAL M, 1972, P NATL ACAD SCI USA, V69, P3561, DOI 10.1073/pnas.69.12.3561; MUELLER P, 1962, NATURE, V194, P979, DOI 10.1038/194979a0; Portonovo SA, 2013, BIOMED MICRODEVICES, V15, P255, DOI 10.1007/s10544-012-9725-9; Poulos JL, 2010, J PHYS-CONDENS MAT, V22, DOI 10.1088/0953-8984/22/45/454105; Poulos JL, 2009, BIOSENS BIOELECTRON, V24, P1806, DOI 10.1016/j.bios.2008.08.041; Sakmann B., 2005, SINGLE CHANNEL RECOR; SCHINDLER H, 1980, P NATL ACAD SCI-BIOL, V77, P3052, DOI 10.1073/pnas.77.5.3052; Seabrook GR, 2002, J PHARMACOL EXP THER, V303, P1052, DOI 10.1124/jpet.102.040394; Sun XH, 2015, J BIOL CHEM, V290, P4741, DOI 10.1074/jbc.M114.611459; Thapliyal T, 2011, BIOSENS BIOELECTRON, V26, P2651, DOI 10.1016/j.bios.2010.01.017; Valente P, 2008, FASEB J, V22, P3298, DOI 10.1096/fj.08-107425; Vijayvergiya V, 2015, BIOMED MICRODEVICES, V17, DOI 10.1007/s10544-014-9919-4; Weil A, 2005, MOL PHARMACOL, V68, P518, DOI 10.1124/mol.105.012146	26	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2015	10	10							e0141366	10.1371/journal.pone.0141366	http://dx.doi.org/10.1371/journal.pone.0141366			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0ED	26513481	Green Published, Green Submitted, gold			2022-12-26	WOS:000363920300033
J	Abadia-Cardoso, A; Garza, JC; Mayden, RL; de Leon, FJG				Abadia-Cardoso, Alicia; Garza, John Carlos; Mayden, Richard L.; Javier Garica de leon, Francisco			Genetic Structure of Pacific Trout at the Extreme Southern End of Their Native Range	PLOS ONE			English	Article							WESTSLOPE CUTTHROAT TROUT; SINGLE-NUCLEOTIDE POLYMORPHISMS; STEELHEAD ONCORHYNCHUS-MYKISS; CROSS-SPECIES AMPLIFICATION; INTRODUCED RAINBOW-TROUT; SALMON SALMO-SALAR; POPULATION-STRUCTURE; MICROSATELLITE LOCI; ATLANTIC SALMON; PHYLOGENETIC ANALYSIS	Salmonid fishes are cold water piscivores with a native distribution spanning nearly the entire temperate and subarctic northern hemisphere. Trout in the genus Oncorhynchus are the most widespread salmonid fishes and are among the most important fish species in the world, due to their extensive use in aquaculture and valuable fisheries. Trout that inhabit northwestern Mexico are the southernmost native salmonid populations in the world, and the least studied in North America. They are unfortunately also facing threats to their continued existence. Previous work has described one endemic species, the Mexican golden trout (O. chrysogaster), and one endemic subspecies, Nelson's trout (O. mykiss nelsoni), in Mexico, but previous work indicated that there is vastly more biodiversity in this group than formally described. Here we conducted a comprehensive genetic analysis of this important group of fishes using novel genetic markers and techniques to elucidate the biodiversity of trout inhabiting northwestern Mexico, examine genetic population structure of Mexican trout and their relationships to other species of Pacific trout, and measure introgression from non-native hatchery rainbow trout. We confirmed substantial genetic diversity and extremely strong genetic differentiation present in the Mexican trout complex, not only between basins but also between some locations within basins, with at least four specieslevel taxa present. We also revealed significant divergence between Mexican trout and other trout species and found that introgression from non-native rainbow trout is present but limited, and that the genetic integrity of native trout is still maintained in most locations. This information will help to guide effective conservation strategies for this important group of fishes.	[Abadia-Cardoso, Alicia; Garza, John Carlos] Natl Marine Fisheries Serv, Southwest Fisheries Sci Ctr, Fisheries Ecol Div, Santa Cruz, CA 95060 USA; [Abadia-Cardoso, Alicia; Garza, John Carlos] Univ Calif Santa Cruz, Inst Marine Sci, Santa Cruz, CA 95064 USA; [Mayden, Richard L.] St Louis Univ, Dept Biol, St Louis, MO 63103 USA; [Javier Garica de leon, Francisco] Ctr Invest Biol Noroeste SC, Lab Genet Conservac, La Paz, Baja California, Mexico	National Oceanic Atmospheric Admin (NOAA) - USA; University of California System; University of California Santa Cruz; Saint Louis University; CIBNOR - Centro de Investigaciones Biologicas del Noroeste	Garza, JC (corresponding author), Natl Marine Fisheries Serv, Southwest Fisheries Sci Ctr, Fisheries Ecol Div, Santa Cruz, CA 95060 USA.	carlos.garza@noaa.gov; fgarciadl@cibnor.mx	Abadía-Cardoso, Alicia/AAU-2069-2020; León, Francisco García-De/AAH-9391-2019	Abadía-Cardoso, Alicia/0000-0003-0691-0358; León, Francisco García-De/0000-0003-2323-2560	Consejo Nacional de Ciencia y Tecnologia; University of California Institute for Mexico and the US	Consejo Nacional de Ciencia y Tecnologia(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); University of California Institute for Mexico and the US	Support was provided by the National Science Foundation (http://www.nsf.gov/; award # DEB-0240184, DEB-0817027) for samples collection. Additional support for Alicia Abadia-Cardoso was provided by the Consejo Nacional de Ciencia y Tecnologia (www.conacyt.mx) and the University of California Institute for Mexico and the US (www.ucmexus.ucr.edu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abadia-Cardoso A, 2011, MOL ECOL RESOUR, V11, P31, DOI 10.1111/j.1755-0998.2010.02971.x; Aguilar A, 2006, MOL ECOL, V15, P923, DOI 10.1111/j.1365-294X.2006.02843.x; Aguilar A, 2008, MOL ECOL RESOUR, V8, P659, DOI 10.1111/j.1471-8286.2007.02038.x; Allendorf FW, 2004, CONSERV BIOL, V18, P1203, DOI 10.1111/j.1523-1739.2004.00305.x; [Anonymous], 1999, J HERED; [Anonymous], CULTURED AQUATIC SPE; [Anonymous], 2010, MEX GOB DUR IMP PROD; Arredondo-Figueroa JL, 1983, BIOTICA, V9, P23; Barriga-Sosa I de los A, PRIMERAS EXPERIENCIA; Behnke R.J., 1992, AM FISHERIES SOC MON, V6, pi; Behnke RJ, 2002, TROUT SALMON N AM; Belkhir K, 2004, GENETIX 4 05 LOGICIE; Bjorkstedt E. P., 2005, NOAATMNMFSSWFSC382 U; Busby PJ, 1996, NOAATMNMFSNWFSC27 US; Cailliez F, 1976, INTRO ANAL DONNEES; Calix M., 2018, EUROPEAN RED LIST SA; Camarena-Rosales F, 2007, REV FISH BIOL FISHER, V18, P33; Campbell NR, 2012, MOL ECOL RESOUR, V12, P942, DOI 10.1111/j.1755-0998.2012.03161.x; Campbell NR, 2009, MOL ECOL RESOUR, V9, P318, DOI 10.1111/j.1755-0998.2008.02376.x; CAVALLISFORZA LL, 1967, EVOLUTION, V21, P550, DOI 10.1111/j.1558-5646.1967.tb03411.x; CAVENDER T M, 1982, Contributions from the Museum of Paleontology University of Michigan, V26, P1; Clemento AJ, 2009, CONSERV GENET, V10, P1321, DOI 10.1007/s10592-008-9712-0; Condrey MJ, 1998, MOL ECOL, V7, P787; Cope E. D., 1886, AM NAT, V20, P735; De Los Santos-Camarillo A. B., 2008, THESIS CTR INVESTIGA; Diaz L, 2010, COMPRA CHIHUAHUA 70; Dominguez-Dominguez O, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-153; DOWLING TE, 1992, CONSERV BIOL, V6, P355, DOI 10.1046/j.1523-1739.1992.06030355.x; Escalante MA, 2014, CONSERV GENET, V15, P1063, DOI 10.1007/s10592-014-0599-7; Evermann Barton Warren, 1908, Proceedings of the Biological Society of Washington, V21; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Felsenstein J., 2004, PHYLIP PHYLOGENY INF; Garza J. C., 2008, POPULATION GENETIC S; Garza JC, 2014, T AM FISH SOC, V143, P134, DOI 10.1080/00028487.2013.822420; Goudet J, 2005, MOL ECOL NOTES, V5, P184, DOI 10.1111/j.1471-8286.2004.00828.x; Hedrick PW, 1999, EVOLUTION, V53, P313, DOI 10.1111/j.1558-5646.1999.tb03767.x; Hendrickson D.A., 1980, Journal of the Arizona-Nevada Academy of Science, V15, P65; Hendrickson DA, 2002, REV FISH BIOL FISHER, V12, P273, DOI 10.1023/A:1025062415188; Hendrickson DA, 2006, CONSERVATION MEXICAM, P162; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; LEARY RF, 1985, EVOLUTION, V39, P1318, DOI 10.1111/j.1558-5646.1985.tb05697.x; LOUDENSLAGER EJ, 1986, SOUTHWEST NAT, V31, P221, DOI 10.2307/3670563; Mayden RL, 1995, AM FISH S S, V17, P58; Mayden RL, 2010, CONSERVING WILD TROU, P134; McConnell S, 1995, AQUACULTURE, V137, P19, DOI 10.1016/0044-8486(95)01111-0; MCCONNELL SK, 1995, CAN J FISH AQUAT SCI, V52, P1863, DOI 10.1139/f95-779; Morris DB, 1996, CAN J FISH AQUAT SCI, V53, P120, DOI 10.1139/cjfas-53-1-120; Needham P. R., 1964, Copeia, V1964, P169, DOI 10.2307/1440847; Needham P. R., 1938, T AM FISH SOC, V67, P139; NEI M, 1978, GENETICS, V89, P583; Nielsen JL, 1998, ENVIRON BIOL FISH, V51, P7, DOI 10.1023/A:1007456529627; Nielsen JL, 2001, GENETICA, V111, P269, DOI 10.1023/A:1013777701213; Nielsen JL, 2002, T AM FISH SOC, V131, P376, DOI 10.1577/1548-8659(2002)131&lt;0376:PGSILC&gt;2.0.CO;2; NORRIS S. M., 2005, FRESHWATER FISHES ME; OReilly PT, 1996, CAN J FISH AQUAT SCI, V53, P2292, DOI 10.1139/cjfas-53-10-2292; Pearse DE, 2007, ENVIRON BIOL FISH, V80, P377, DOI 10.1007/s10641-006-9135-z; Phillips R, 2001, BIOL REV, V76, P1, DOI 10.1017/S1464793100005613; Pritchard JK, 2000, GENETICS, V155, P945; R Development Core Team, 2011, LANG ENV STAT COMP, DOI 10.1007/978-3-540-74686-7; Rhymer JM, 1996, ANNU REV ECOL SYST, V27, P83, DOI 10.1146/annurev.ecolsys.27.1.83; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Rubidge E, 2001, J FISH BIOL, V59, P42, DOI [10.1006/jfbi.2001.1761, 10.1111/j.1095-8649.2001.tb01377.x]; Ruiz-Campos G, 2003, REV FISH BIOL FISHER, V13, P91, DOI 10.1023/A:1026367113735; Ruiz-Campos Gorgonio, 1995, Bulletin Southern California Academy of Sciences, V94, P131; Schonhuth S, 2014, MOL PHYLOGENET EVOL, V70, P210, DOI 10.1016/j.ympev.2013.09.021; Schonhuth S, 2011, J BIOGEOGR, V38, P1406, DOI 10.1111/j.1365-2699.2011.02481.x; Scribner KT, 1996, CAN J FISH AQUAT SCI, V53, P833, DOI 10.1139/cjfas-53-4-833; SEMARNAT, 2000, NORM OF MEX NOM 059; Shepard BB, 2005, N AM J FISH MANAGE, V25, P1426, DOI 10.1577/M05-004.1; Small MP, 1998, MOL ECOL, V7, P141, DOI 10.1046/j.1365-294x.1998.00324.x; Smith CT, 1998, MOL ECOL, V7, P1614; SNYDER JOHN OTTERBEIN, 1926, UNIV CALIFORNIA PUBL ZOOL, V21, P419; USFWS, 2003, GILA TROUT REC PLAN; Weigel DE, 2003, ECOL APPL, V13, P38, DOI 10.1890/1051-0761(2003)013[0038:IHBNCT]2.0.CO;2; Wenburg JK, 1998, MOL ECOL, V7, P733, DOI 10.1046/j.1365-294x.1998.00386.x; Williamson KS, 2002, MOL ECOL NOTES, V2, P17, DOI 10.1046/j.1471-8286.2002.00129.x; Wilson WD, 2009, MOL PHYLOGENET EVOL, V52, P406, DOI 10.1016/j.ympev.2009.03.018	79	17	17	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2015	10	10							e0141775	10.1371/journal.pone.0141775	http://dx.doi.org/10.1371/journal.pone.0141775			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0DL	26509445	Green Published, gold, Green Submitted			2022-12-26	WOS:000363918100131
J	Geremia, C; Miller, MW; Hoeting, JA; Antolin, MF; Hobbs, NT				Geremia, Chris; Miller, Michael W.; Hoeting, Jennifer A.; Antolin, Michael F.; Hobbs, N. Thompson			Bayesian Modeling of Prion Disease Dynamics in Mule Deer Using Population Monitoring and Capture-Recapture Data	PLOS ONE			English	Article							CHRONIC WASTING DISEASE; WHITE-TAILED DEER; ODOCOILEUS-HEMIONUS; INFECTIOUS PRIONS; TRANSMISSION; ECOLOGY; EPIDEMIOLOGY; PREVALENCE; WILDLIFE; COLORADO	Epidemics of chronic wasting disease (CWD) of North American Cervidae have potential to harm ecosystems and economies. We studied a migratory population of mule deer (Odocoileus hemionus) affected by CWD for at least three decades using a Bayesian framework to integrate matrix population and disease models with long-term monitoring data and detailed process-level studies. We hypothesized CWD prevalence would be stable or increase between two observation periods during the late 1990s and after 2010, with higher CWD prevalence making deer population decline more likely. The weight of evidence suggested a reduction in the CWD outbreak over time, perhaps in response to intervening harvest-mediated population reductions. Disease effects on deer population growth under current conditions were subtle with a 72% chance that CWD depressed population growth. With CWD, we forecasted a growth rate near one and largely stable deer population. Disease effects appear to be moderated by timing of infection, prolonged disease course, and locally variable infection. Long-term outcomes will depend heavily on whether current conditions hold and high prevalence remains a localized phenomenon.	[Geremia, Chris; Hobbs, N. Thompson] Colorado State Univ, Nat Resource Ecol Lab, Dept Ecosyst Sci & Sustainabil, Ft Collins, CO 80523 USA; [Geremia, Chris; Hobbs, N. Thompson] Colorado State Univ, Grad Degree Program Ecol, Ft Collins, CO 80523 USA; [Miller, Michael W.] Colorado Div Parks & Wildlife, Wildlife Hlth Program, Ft Collins, CO USA; [Hoeting, Jennifer A.] Colorado State Univ, Dept Stat, Ft Collins, CO 80523 USA; [Antolin, Michael F.] Colorado State Univ, Dept Biol, Ft Collins, CO 80523 USA	Colorado State University; Colorado State University; Colorado Parks & Wildlife; Colorado State University; Colorado State University	Geremia, C (corresponding author), Colorado State Univ, Nat Resource Ecol Lab, Dept Ecosyst Sci & Sustainabil, Ft Collins, CO 80523 USA.	Chris_Geremia@nps.gov	Hobbs, Tom/C-5263-2016; Antolin, Michael Franc/AAT-5971-2021		National Science Foundation [EF-00914489]; Colorado Division of (Parks and) Wildlife	National Science Foundation(National Science Foundation (NSF)); Colorado Division of (Parks and) Wildlife	This research was funded by the National Science Foundation (EF-00914489) and the Colorado Division of (Parks and) Wildlife.	Almberg ES, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019896; Bruno JF, 2003, ECOL LETT, V6, P1056, DOI 10.1046/j.1461-0248.2003.00544.x; Caswell, 2000, MATRIX POPULATION MO; Conner MM, 2007, ECOL APPL, V17, P140, DOI 10.1890/1051-0761(2007)017[0140:AMAFEM]2.0.CO;2; Conner MM, 2000, J WILDLIFE DIS, V36, P691, DOI 10.7589/0090-3558-36.4.691; Conner MM, 2004, ECOL APPL, V14, P1870, DOI 10.1890/03-5309; Daszak P, 2000, SCIENCE, V287, P443, DOI 10.1126/science.287.5452.443; Daszak P, 2003, DIVERS DISTRIB, V9, P141, DOI 10.1046/j.1472-4642.2003.00016.x; DeCesare NJ, 2010, ANIM CONSERV, V13, P353, DOI 10.1111/j.1469-1795.2009.00328.x; Dulberger J, 2010, J WILDLIFE DIS, V46, P1086, DOI 10.7589/0090-3558-46.4.1086; Edmunds DR, 2013, THESIS U WYOMING; Farnsworth ML, 2006, ECOL APPL, V16, P1026, DOI 10.1890/1051-0761(2006)016[1026:LCWDTM]2.0.CO;2; Geremia C, 2014, THESIS COLORADO STAT; Geremia C, 2015, J WILDLIFE DIS, V51, P801, DOI 10.7589/2014-12-284; Gross JE, 2001, J WILDLIFE MANAGE, V65, P205, DOI 10.2307/3802899; Haley NJ, 2011, J VIROL, V85, P6309, DOI 10.1128/JVI.00425-11; Harvell CD, 1999, SCIENCE, V285, P1505, DOI 10.1126/science.285.5433.1505; Harvell CD, 2002, SCIENCE, V296, P2158, DOI 10.1126/science.1063699; Heisey DM, 2010, ECOL MONOGR, V80, P221, DOI 10.1890/09-0052.1; Hobbs N.T., 2015, BAYESIAN MODELS, DOI [DOI 10.1515/9781400866557, 10.1515/9781400866557]; Jewell JE, 2005, J GEN VIROL, V86, P2127, DOI 10.1099/vir.0.81077-0; Krumm CE, 2010, BIOL LETTERS, V6, P209, DOI 10.1098/rsbl.2009.0742; Krumm CE, 2005, J WILDLIFE DIS, V41, P503, DOI 10.7589/0090-3558-41.3.503; Mathiason CK, 2006, SCIENCE, V314, P133, DOI 10.1126/science.1132661; Mathiason CK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005916; MCCALLUM H, 1995, TRENDS ECOL EVOL, V10, P190, DOI 10.1016/S0169-5347(00)89050-3; Miller MW, 2006, ECOL APPL, V16, P2208, DOI 10.1890/1051-0761(2006)016[2208:DOPDTI]2.0.CO;2; Miller MW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004019; Miller MW, 2005, J WILDLIFE DIS, V41, P275, DOI 10.7589/0090-3558-41.2.275; Miller MW, 2000, J WILDLIFE DIS, V36, P676, DOI 10.7589/0090-3558-36.4.676; Miller MW, 2003, NATURE, V425, P35, DOI 10.1038/425035a; Miller MW, 2004, EMERG INFECT DIS, V10, P1003, DOI 10.3201/eid1006.040010; Ostfeld RS, 2004, FRONT ECOL ENVIRON, V2, P13, DOI 10.1890/1540-9295(2004)002[0013:APGFYH]2.0.CO;2; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; R Core Team, 2013, R LANG ENV STAT COMP; ROBINETTE W. LESLIE, 1957, JOUR WILDLIFE MANAGEMENT, V21, P134, DOI 10.2307/3797579; ROBINSON GR, 1992, SCIENCE, V257, P524, DOI 10.1126/science.257.5069.524; Sharp A, 2011, ECOL APPL, V21, P1024, DOI 10.1890/10-1449.1; SINCLAIR ARE, 1995, SERENGETI, V2; Spraker TR, 1997, J WILDLIFE DIS, V33, P1, DOI 10.7589/0090-3558-33.1.1; Tamguney G, 2009, NATURE, V461, P529, DOI 10.1038/nature08289; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Unsworth JW, 1999, J WILDLIFE MANAGE, V63, P315, DOI 10.2307/3802515; Vieira M, 2006, TECHNICAL REPORT; Wasserberg G, 2009, J APPL ECOL, V46, P457, DOI 10.1111/j.1365-2664.2008.01576.x; Wild MA, 2011, J WILDLIFE DIS, V47, P78, DOI 10.7589/0090-3558-47.1.78; Williams E.S., 1992, Revue Scientifique et Technique Office International des Epizooties, V11, P551; Williams ES, 2005, VET PATHOL, V42, P530, DOI 10.1354/vp.42-5-530; Wolfe LL, 2007, J GEN VIROL, V88, P2078, DOI 10.1099/vir.0.82342-0	49	11	11	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2015	10	10							e0140687	10.1371/journal.pone.0140687	http://dx.doi.org/10.1371/journal.pone.0140687			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0DL	26509806	Green Submitted, gold, Green Published			2022-12-26	WOS:000363918100036
J	Moura, MVH; da Silva, GP; Machado, ACD; Torres, FAG; Freire, DMG; Almeida, RV				Holanda Moura, Marcelo Victor; da Silva, Giulia Pontes; de Oliveira Machado, Antonio Carlos; Goncalves Torres, Fernando Araripe; Guimaraes Freire, Denise Maria; Almeida, Rodrigo Volcan			Displaying Lipase B from Candida antarctica in Pichia pastoris Using the Yeast Surface Display Approach: Prospection of a New Anchor and Characterization of the Whole Cell Biocatalyst	PLOS ONE			English	Article							BIODIESEL PRODUCTION; INDUSTRIAL APPLICATIONS; HETEROLOGOUS PROTEINS; BURKHOLDERIA-CEPACIA; IONIC LIQUIDS; SYSTEM; CLASSIFICATION; CONSTRUCTION; OPTIMIZATION; CONFORMATION	Yeast Surface Display (YSD) is a strategy to anchor proteins on the yeast cell wall which has been employed to increase enzyme stability thus decreasing production costs. Lipase B from Candida antarctica (LipB) is one of the most studied enzymes in the context of industrial biotechnology. This study aimed to assess the biochemical features of this important biocatalyst when immobilized on the cell surface of the methylotrophic yeast Pichia pastoris using the YSD approach. For that purpose, two anchors were tested. The first (Flo9) was identified after a prospection of the P. pastoris genome being related to the family of flocculins similar to Flo1 but significantly smaller. The second is the Protein with Internal Repeats (Pir1) from P. pastoris. An immunolocalization assay showed that both anchor proteins were able to display the reporter protein EGFP in the yeast outer cell wall. LipB was expressed in P. pastoris fused either to Flo9 (FLOLIPB) or Pir1 (PIRLIPB). Both constructions showed hydrolytic activity towards tributyrin (>100 U/mg(dcw) and >80 U/mg(dcw), respectively), optimal hydrolytic activity around 45 degrees C and pH 7.0, higher thermostability at 45 degrees C and stability in organic solvents when compared to a free lipase.	[Holanda Moura, Marcelo Victor; da Silva, Giulia Pontes; de Oliveira Machado, Antonio Carlos; Guimaraes Freire, Denise Maria; Almeida, Rodrigo Volcan] Univ Fed Rio de Janeiro, Inst Quim, Rio De Janeiro, RJ, Brazil; [Goncalves Torres, Fernando Araripe] Univ Brasilia, Dept Biol Celular, Brasilia, DF, Brazil	Universidade Federal do Rio de Janeiro; Universidade de Brasilia	Moura, MVH (corresponding author), Univ Fed Rio de Janeiro, Inst Quim, Rio De Janeiro, RJ, Brazil.	marcelovhm21@gmail.com; volcan@iq.ufrj.br	Almeida, Rodrigo/GZH-0682-2022; Almeida, Rodrigo V/I-4362-2013; FREIRE, Denise Maria/D-8699-2014; Torres, Fernando A.G./D-5651-2012; Almeida, Rodrigo/AAE-3019-2019	Almeida, Rodrigo V/0000-0002-0164-6044; FREIRE, Denise Maria/0000-0002-8298-5936; Torres, Fernando A.G./0000-0002-3650-7271; Almeida, Rodrigo/0000-0002-0164-6044	CNPq; FAPERJ; CAPES; PETROBRAS	CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPERJ(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); PETROBRAS(Fundacao de Amparo a Pesquisa do Amapa (FAPEAP)Petrobras)	The authors would like to thank CNPq, FAPERJ, CAPES and PETROBRAS for the financial and structural support given to the present work. Marcelo Victor Holanda Moura and Giulia Pontes da Silva were supported by CNPq. Antonio Carlos de Oliveira Machado was supported by Petrobras. The laboratories of Prof Fernando Araripe, Denise Freire and Rodrigo Almeida are supported by CNPq, CAPES, FAPERJ and Petrobras.	Aguieiras ECG, 2014, FUEL, V135, P315, DOI 10.1016/j.fuel.2014.06.069; Anobom CD, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/684506; [Anonymous], 2014, BCC RES ENZYMES; Arpigny JL, 1999, BIOCHEM J, V343, P177, DOI 10.1042/0264-6021:3430177; Bornscheuer UT, 2002, FEMS MICROBIOL REV, V26, P73, DOI 10.1016/S0168-6445(01)00075-4; Daiha KG, PLOSONE IN PRESS; de Groot PWJ, 2003, YEAST, V20, P781, DOI 10.1002/yea.1007; Eom GT, 2013, J BIOSCI BIOENG, V116, P165, DOI 10.1016/j.jbiosc.2013.02.016; Freedonia Group,, 2014, WORLD ENZ; Fukuda H, 2008, TRENDS BIOTECHNOL, V26, P668, DOI 10.1016/j.tibtech.2008.08.001; Hasan F, 2006, ENZYME MICROB TECH, V39, P235, DOI 10.1016/j.enzmictec.2005.10.016; He XP, 2008, ENZYME MICROB TECH, V43, P13, DOI 10.1016/j.enzmictec.2008.03.011; Houde A, 2004, APPL BIOCHEM BIOTECH, V118, P155, DOI 10.1385/ABAB:118:1-3:155; Jin Z, 2013, BIORESOURCE TECHNOL, V130, P102, DOI 10.1016/j.biortech.2012.12.020; Kato M, 2007, APPL MICROBIOL BIOT, V75, P549, DOI 10.1007/s00253-006-0835-2; Khasa YP, 2011, YEAST, V28, P213, DOI 10.1002/yea.1832; Kondo A, 2004, APPL MICROBIOL BIOT, V64, P28, DOI 10.1007/s00253-003-1492-3; Laszlo JA, 2007, J MOL CATAL B-ENZYM, V69, P60; Levisson M, 2009, EXTREMOPHILES, V13, P567, DOI 10.1007/s00792-009-0260-4; Liang XX, 2013, BIOTECHNOL LETT, V35, P367, DOI 10.1007/s10529-012-1085-2; Liu Y, 2014, J MOL CATAL B-ENZYM, V106, P17, DOI 10.1016/j.molcatb.2014.04.011; Liu Y, 2011, BIORESOURCE TECHNOL, V102, P10414, DOI 10.1016/j.biortech.2011.08.056; Manoel EA, 2012, ORG PROCESS RES DEV, V16, P1378, DOI 10.1021/op300063f; Matsumoto T, 2002, APPL ENVIRON MICROB, V68, P4517, DOI 10.1128/AEM.68.9.4517-4522.2002; Maurer M, 2006, MICROB CELL FACT, V5, DOI 10.1186/1475-2859-5-37; Ni Y, 2004, BIOTECHNOL BIOENG, V87, P804, DOI 10.1002/bit.20202; Nielsen PM, 2008, EUR J LIPID SCI TECH, V110, P692, DOI 10.1002/ejlt.200800064; Pan ST, 2010, BIORESOURCE TECHNOL, V101, P9822, DOI 10.1016/j.biortech.2010.07.107; Prim N, 2003, J MOL CATAL B-ENZYM, V22, P339, DOI 10.1016/S1381-1177(03)00048-1; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Sato N, 2002, APPL MICROBIOL BIOT, V60, P469, DOI 10.1007/s00253-002-1121-6; Schuurmann J, 2014, APPL MICROBIOL BIOT, V98, P8031, DOI 10.1007/s00253-014-5897-y; Su GD, 2010, BIOTECHNOL LETT, V32, P1131, DOI 10.1007/s10529-010-0270-4; Sun YF, 2012, APPL MICROBIOL BIOT, V96, P1539, DOI 10.1007/s00253-012-4264-0; Tanino T, 2006, BIOTECHNOL PROGR, V22, P989, DOI 10.1021/bp060133+; Wang QJ, 2007, BIOTECHNOL LETT, V29, P1561, DOI 10.1007/s10529-007-9430-6; Yan JY, 2014, BIORESOURCE TECHNOL, V151, P43, DOI 10.1016/j.biortech.2013.10.037; Zhang L, 2013, APPL ENVIRON MICROB, V79, P5519, DOI 10.1128/AEM.00824-13	38	33	35	2	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2015	10	10							e0141454	10.1371/journal.pone.0141454	http://dx.doi.org/10.1371/journal.pone.0141454			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0DL	26510006	Green Submitted, gold, Green Published			2022-12-26	WOS:000363918100088
J	Kottke, R; Hefti, JP; Rummel, C; Hauf, M; Hefti, U; Merz, TM				Kottke, Raimund; Hefti, Jacqueline Pichler; Rummel, Christian; Hauf, Martinus; Hefti, Urs; Merz, Tobias Michael			Morphological Brain Changes after Climbing to Extreme Altitudes-A Prospective Cohort Study	PLOS ONE			English	Article							OBSTRUCTIVE SLEEP-APNEA; ACUTE MOUNTAIN-SICKNESS; RESONANCE-IMAGING MRI; CEREBRAL EDEMA; ANOREXIA-NERVOSA; EXPOSURE; HYPOXIA; ATROPHY; ASCENT; OXYGEN	Background Findings of cerebral cortical atrophy, white matter lesions and microhemorrhages have been reported in high-altitude climbers. The aim of this study was to evaluate structural cerebral changes in a large cohort of climbers after an ascent to extreme altitudes and to correlate these findings with the severity of hypoxia and neurological signs during the climb. Methods Magnetic resonance imaging (MRI) studies were performed in 38 mountaineers before and after participating in a high altitude (7126m) climbing expedition. The imaging studies were assessed for occurrence of new WM hyperintensities and microhemorrhages. Changes of partial volume estimates of cerebrospinal fluid, grey matter, and white matter were evaluated by voxel-based morphometry. Arterial oxygen saturation and acute mountain sickness scores were recorded daily during the climb. Results On post-expedition imaging no new white matter hyperintensities were observed. Compared to baseline testing, we observed a significant cerebrospinal fluid fraction increase (0.34% [95% CI 0.10-0.58], p = 0.006) and a white matter fraction reduction (-0.18% [95% CI -0.32--0.04], p = 0.012), whereas the grey matter fraction remained stable (0.16% [95% CI -0.46-0.13], p = 0.278). Post-expedition imaging revealed new microhemorrhages in 3 of 15 climbers reaching an altitude of over 7000m. Affected climbers had significantly lower oxygen saturation values but not higher acute mountain sickness scores than climbers without microhemorrhages. Conclusions A single sojourn to extreme altitudes is not associated with development of focal white matter hyperintensities and grey matter atrophy but leads to a decrease in brain white matter fraction. Microhemorrhages indicative of substantial blood-brain barrier disruption occur in a significant number of climbers attaining extreme altitudes.	[Kottke, Raimund; Hauf, Martinus] Univ Hosp Bern, Inst Diagnost & Intervent Neuroradiol, CH-3010 Bern, Switzerland; [Kottke, Raimund; Hefti, Jacqueline Pichler; Rummel, Christian; Hauf, Martinus; Merz, Tobias Michael] Univ Bern, CH-3010 Bern, Switzerland; [Hefti, Jacqueline Pichler; Merz, Tobias Michael] Univ Hosp Bern, Dept Intens Care Med, CH-3010 Bern, Switzerland; [Rummel, Christian] Univ Hosp Bern, SCAN, Inst Diagnost & Intervent Neuroradiol, CH-3010 Bern, Switzerland; [Hefti, Urs] Swiss Sport Clin, CH-3014 Bern, Switzerland	University of Bern; University Hospital of Bern; University of Bern; University of Bern; University Hospital of Bern; University of Bern; University Hospital of Bern	Merz, TM (corresponding author), Univ Hosp Bern, Dept Intens Care Med, CH-3010 Bern, Switzerland.	tobias.merz@insel.ch	Merz, Tobias/AAE-8323-2020	Kottke, Raimund/0000-0003-0166-2770; Rummel, Christian/0000-0003-2345-7938	Swiss Society of Mountain Medicine; Swiss Alpine Club; Lotteriefonds Kanton Aargau	Swiss Society of Mountain Medicine; Swiss Alpine Club; Lotteriefonds Kanton Aargau	This study was supported by unrestricted research funds from the Swiss Society of Mountain Medicine, the Swiss Alpine Club and Lotteriefonds Kanton Aargau. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anooshiravani M, 1999, MED SCI SPORT EXER, V31, P969, DOI 10.1097/00005768-199907000-00008; Bartsch P, 2004, HIGH ALT MED BIOL, V5, P110, DOI 10.1089/1527029041352108; Boghi A, 2011, PSYCHIAT RES-NEUROIM, V192, P154, DOI 10.1016/j.pscychresns.2010.12.008; Fayed N., 2006, AM J MED, V119, p168., DOI [10.1016/j.amjmed.2005.07.062, DOI 10.1016/J.AMJMED.2005.07.062]; Freund W, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-170; Gallagher SA, 2004, EMERG MED CLIN N AM, V22, P329, DOI 10.1016/j.emc.2004.02.001; Garrido E, 1996, CLIN SCI, V90, P81, DOI 10.1042/cs0900081; GARRIDO E, 1993, INT J SPORTS MED, V14, P232, DOI 10.1055/s-2007-1021169; GARRIDO E, 1995, EUR J APPL PHYSIOL O, V70, P477, DOI 10.1007/BF00634375; Good CD, 2001, NEUROIMAGE, V14, P21, DOI 10.1006/nimg.2001.0786; GREENE R, 1957, BRIT MED J, V1, P1028, DOI 10.1136/bmj.1.5026.1028; Hackett PH, 1998, JAMA-J AM MED ASSOC, V280, P1920, DOI 10.1001/jama.280.22.1920; Hefti JP, 2013, HIGH ALT MED BIOL, V14, P273, DOI 10.1089/ham.2012.1110; Hornbein TF, 2001, J EXP BIOL, V204, P3129; Kallenberg K, 2008, J CEREBR BLOOD F MET, V28, P1635, DOI 10.1038/jcbfm.2008.55; Kumar R, 2014, SLEEP, V37, P723, DOI 10.5665/sleep.3578; Lavie L, 2015, SLEEP MED REV, V20, P27, DOI 10.1016/j.smrv.2014.07.003; Macey PM, 2008, SLEEP, V31, P967; McGuire SA, 2014, ANN NEUROL, V76, P719, DOI 10.1002/ana.24264; MCLAURIN J, 1995, INT J DEV NEUROSCI, V13, P369, DOI 10.1016/0736-5748(95)00012-6; McNicholas WT, 2009, PROG CARDIOVASC DIS, V51, P392, DOI 10.1016/j.pcad.2008.10.005; Paola MD, 2008, EUR J NEUROL, V15, P1050, DOI [10.1111/j.1468-1331.2008.02243.x, 10.1111/j.1468-1331.2008.02137.x]; ROACH RC, 1993, HYPOXIA AND MOLECULAR MEDICINE, P272; Roach R, 2007, HIGH ALT MED BIOL, V8, P171, DOI 10.1089/ham.2007.8301; Rostrup E, 2005, NEUROIMAGE, V28, P947, DOI 10.1016/j.neuroimage.2005.06.032; Schommer K, 2013, NEUROLOGY, V81, P1776, DOI 10.1212/01.wnl.0000435563.84986.78; Smith CD, 2007, NEUROBIOL AGING, V28, P1075, DOI 10.1016/j.neurobiolaging.2006.05.018; Swayze VW, 2003, INT J EAT DISORDER, V33, P33, DOI 10.1002/eat.10111; Wagner DR, 2012, HIGH ALT MED BIOL, V13, P245, DOI 10.1089/ham.2012.1030; WEST JB, 1986, LANCET, V2, P387; Westerterp-Plantenga MS, 1999, J APPL PHYSIOL, V87, P391, DOI 10.1152/jappl.1999.87.1.391; Wilson MH, 2009, LANCET NEUROL, V8, P175, DOI 10.1016/S1474-4422(09)70014-6	32	17	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2015	10	10							e0141097	10.1371/journal.pone.0141097	http://dx.doi.org/10.1371/journal.pone.0141097			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0DL	26509635	Green Published, Green Submitted, gold			2022-12-26	WOS:000363918100053
J	Liu, XH; Xie, N; Li, W; Zhou, ZY; Zhong, ZJ; Shen, LH; Cao, SH; Yu, XM; Hu, YC; Chen, WG; Peng, GN				Liu, Xuehan; Xie, Na; Li, Wei; Zhou, Ziyao; Zhong, Zhijun; Shen, Liuhong; Cao, Suizhong; Yu, Xingming; Hu, Yanchuan; Chen, Weigang; Peng, Gangneng			Emergence of Cryptosporidium hominis Monkey Genotype II and Novel Subtype Family Ik in the Squirrel Monkey (Saimiri sciureus) in China	PLOS ONE			English	Article							PATHOGENIC ENTEROCYTOZOON-BIENEUSI; MOLECULAR CHARACTERIZATION; PHYLOGENETIC ANALYSIS; GIARDIA-DUODENALIS; MUSTELA-VISON; PARASITES; PARVUM; GENE; HUMANS; LOCUS	A single Cryptosporidium isolate from a squirrel monkey with no clinical symptoms was obtained from a zoo in Ya'an city, China, and was genotyped by PCR amplification and DNA sequencing of the small-subunit ribosomal RNA (SSU rRNA), 70-kDa heat shock protein (HSP70), Cryptosporidium oocyst wall protein, and actin genes. This multilocus genetic characterization determined that the isolate was Cryptosporidium hominis, but carried 2, 10, and 6 nucleotide differences in the SSU rRNA, HSP70, and actin loci, respectively, which is comparable to the variations at these loci between C. hominis and the previously reported monkey genotype (2, 3, and 3 nucleotide differences). Phylogenetic studies, based on neighbor-joining and maximum likelihood methods, showed that the isolate identified in the current study had a distinctly discordant taxonomic status, distinct from known C. hominis and also from the monkey genotype, with respect to the three loci. Restriction fragment length polymorphisms of the SSU rRNA gene obtained from this study were similar to those of known C. hominis but clearly differentiated from the monkey genotype. Further subtyping was performed by sequence analysis of the gene encoding the 60-kDa glycoprotein (gp60). Maximum homology of only 88.3% to C. hominis subtype IdA10G4 was observed for the current isolate, and phylogenetic analysis demonstrated that this particular isolate belonged to a novel C. hominis subtype family, IkA7G4. This study is the first to report C. hominis infection in the squirrel monkey and, based on the observed genetic characteristics, confirms a new C. hominis genotype, monkey genotype II. Thus, these results provide novel insights into genotypic variation in C. hominis.	[Liu, Xuehan; Xie, Na; Li, Wei; Zhou, Ziyao; Zhong, Zhijun; Shen, Liuhong; Cao, Suizhong; Hu, Yanchuan; Peng, Gangneng] Sichuan Agr Univ, Coll Vet Med, Key Lab Anim Dis & Human Hlth Sichuan Prov, Chengdu 625014, Sichuan Provinc, Peoples R China; [Yu, Xingming; Chen, Weigang] Inst Wild Animals, Chengdu Zoo, Chengdu 625001, Sichuan Provinc, Peoples R China	Key Laboratory of Animal Disease & Human Health of Sichuan Province; Sichuan Agricultural University	Peng, GN (corresponding author), Sichuan Agr Univ, Coll Vet Med, Key Lab Anim Dis & Human Hlth Sichuan Prov, Chengdu 625014, Sichuan Provinc, Peoples R China.	pgn.sicau@163.com			funds for the Chengdu Giant Panda Breeding Research Foundation [CPF2012-01, CPF2014-19]; National Natural Science Foundation of China [31272620]	funds for the Chengdu Giant Panda Breeding Research Foundation; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported in part by funds for the Chengdu Giant Panda Breeding Research Foundation (nos. CPF2012-01 and CPF2014-19) and the National Natural Science Foundation of China (no. 31272620). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bouzid M, 2013, CLIN MICROBIOL REV, V26, P115, DOI 10.1128/CMR.00076-12; Caccio SM., 2014, EPIDEMIOLOGY HUMAN C, P43, DOI [DOI 10.1007/978-3-7091-1562-6_2, 10.1007/978-3-7091-1562-6_2]; Chalmers RM, 2010, EXP PARASITOL, V124, P138, DOI 10.1016/j.exppara.2009.02.003; Elwin K, 2012, EPIDEMIOL INFECT, V140, P673, DOI 10.1017/S0950268811000860; Fayer R, 2010, EXP PARASITOL, V124, P90, DOI 10.1016/j.exppara.2009.03.005; Feng YY, 2011, EXP PARASITOL, V127, P238, DOI 10.1016/j.exppara.2010.08.002; Feng YY, 2009, J CLIN MICROBIOL, V47, P153, DOI 10.1128/JCM.01777-08; Gomez-Couso H, 2007, PARASITOL RES, V100, P877, DOI 10.1007/s00436-006-0338-1; Hunter PR, 2007, EMERG INFECT DIS, V13, P82, DOI 10.3201/eid1301.060481; Karim MR, 2014, INT J PARASITOL, V44, P1039, DOI 10.1016/j.ijpara.2014.07.006; Kvac M, 2014, J CLIN MICROBIOL, V52, P347, DOI 10.1128/JCM.02456-13; Li W, 2011, J CLIN MICROBIOL, V49, P4326, DOI 10.1128/JCM.05051-11; Liu XH, 2015, VET PARASITOL, V207, P144, DOI 10.1016/j.vetpar.2014.11.009; Liu XH, 2013, PARASITOL INT, V62, P454, DOI 10.1016/j.parint.2013.06.004; Ng-Hublin JSY, 2013, J CLIN MICROBIOL, V51, P2463, DOI 10.1128/JCM.00424-13; Plutzer J, 2009, VET PARASITOL, V165, P187, DOI 10.1016/j.vetpar.2009.07.003; Retief J D, 2000, Methods Mol Biol, V132, P243; Ryan U, 2015, EXP PARASITOL, V150, P31, DOI 10.1016/j.exppara.2015.01.009; Ryan U, 2014, PARASITOLOGY, V141, P1667, DOI 10.1017/S0031182014001085; Sulaiman IM, 2000, APPL ENVIRON MICROB, V66, P2385, DOI 10.1128/AEM.66.6.2385-2391.2000; Sulaiman IM, 2002, J PARASITOL, V88, P388, DOI 10.1645/0022-3395(2002)088[0388:MPAERO]2.0.CO;2; Wang RJ, 2008, VET PARASITOL, V154, P162, DOI 10.1016/j.vetpar.2007.12.038; Xiao LH, 2000, J PARASITOL, V86, P1166, DOI 10.1645/0022-3395(2000)086[1166:MCOACI]2.0.CO;2; Xiao LH, 1999, APPL ENVIRON MICROB, V65, P3386; Xiao LH, 1999, APPL ENVIRON MICROB, V65, P1578; Xiao LH, 2000, APPL ENVIRON MICROB, V66, P5499, DOI 10.1128/AEM.66.12.5499-5502.2000; Xiao LH, 2004, CLIN MICROBIOL REV, V17, P72, DOI 10.1128/CMR.17.1.72-97.2004; Xiao LH, 2010, EXP PARASITOL, V124, P80, DOI 10.1016/j.exppara.2009.03.018; Ye JB, 2014, PARASITOL INT, V63, P132, DOI 10.1016/j.parint.2013.10.007; Ye JB, 2012, EMERG INFECT DIS, V18, P1640, DOI 10.3201/eid1810.120653	30	10	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2015	10	10							e0141450	10.1371/journal.pone.0141450	http://dx.doi.org/10.1371/journal.pone.0141450			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0DL	26509708	Green Submitted, gold, Green Published			2022-12-26	WOS:000363918100085
J	Tschinkel, WR; Rink, WJ; Kwapich, CL				Tschinkel, Walter R.; Rink, William J.; Kwapich, Christina L.			Sequential Subterranean Transport of Excavated Sand and Foraged Seeds in Nests of the Harvester Ant, Pogonomyrmex badius	PLOS ONE			English	Article							DIVISION-OF-LABOR; INSECT SOCIETIES; ATTA; HYMENOPTERA; FORMICIDAE; SITE; BIOTURBATION; ORGANIZATION; ARCHITECTURE; EFFICIENCY	During their approximately annual nest relocations, Florida harvester ants (Pogonomyrmex badius) excavate large and architecturally-distinct subterranean nests. Aspects of this process were studied by planting a harvester ant colony in the field in a soil column composed of layers of 12 different colors of sand. Quantifying the colors of excavated sand dumped on the surface by the ants revealed the progress of nest deepening to 2 m and enlargement to 8 L in volume. Most of the excavation was completed within about 2 weeks, but the nest was doubled in volume after a winter lull. After 7 months, we excavated the nest and mapped its structure, revealing colored sand deposited in non-host colored layers, especially in the upper 30 to 40 cm of the nest. In all, about 2.5% of the excavated sediment was deposited below ground, a fact of importance to sediment dating by optically-stimulated luminescence (OSL). Upward transport of excavated sand is carried out in stages, probably by different groups of ants, through deposition, re-transport, incorporation into the nest walls and floors and remobilization from these. This results in considerable mixing of sand from different depths, as indicated in the multiple sand colors even within single sand pellets brought to the surface. Just as sand is transported upward by stages, incoming seeds are transported downward to seed chambers. Foragers collect seeds and deposit them only in the topmost nest chambers from which a separate group of workers rapidly transports them downward in increments detectable as a "wave" of seeds that eventually ends in the seed chambers, 20 to 80 cm below the surface. The upward and downward transport is an example of task-partitioning in a series-parallel organization of work carried out by a highly redundant work force in which each worker usually completes only part of a multi-step process.	[Tschinkel, Walter R.; Kwapich, Christina L.] Florida State Univ, Dept Biol Sci, Tallahassee, FL 32306 USA; [Rink, William J.] McMaster Univ, Sch Geog & Earth Sci, Hamilton, ON, Canada	State University System of Florida; Florida State University; McMaster University	Tschinkel, WR (corresponding author), Florida State Univ, Dept Biol Sci, B-157, Tallahassee, FL 32306 USA.	tschinkel@bio.fsu.edu		Kwapich, Christina/0000-0001-5141-7605	National Science Foundation (United States) [IOS-1021632]	National Science Foundation (United States)(National Science Foundation (NSF))	Funding provided by National Science Foundation (United States) IOS-1021632. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson C, 1999, AM NAT, V154, P521, DOI 10.1086/303255; Anderson C, 2002, INSECT SOC, V49, P171, DOI 10.1007/s00040-002-8298-7; Anderson C, 2001, ANIM BEHAV, V62, P643, DOI 10.1006/anbe.2001.1795; Arnan X, 2011, BEHAV ECOL SOCIOBIOL, V65, P1881, DOI 10.1007/s00265-011-1197-z; Bateman MD, 2007, SEDIMENT GEOL, V195, P5, DOI 10.1016/j.sedgeo.2006.07.003; Bateman MD, 2007, QUAT GEOCHRONOL, V2, P57, DOI 10.1016/j.quageo.2006.05.004; Bateman MD, 2003, QUATERNARY SCI REV, V22, P1169, DOI 10.1016/S0277-3791(03)00019-2; Buhl J, 2006, J THEOR BIOL, V243, P287, DOI 10.1016/j.jtbi.2006.06.018; Burd M, 2008, BIOL LETTERS, V4, P627, DOI 10.1098/rsbl.2008.0398; Cerquera LM, 2010, J INSECT SCI, V10, DOI 10.1673/031.010.6401; Darwin C, 1881, FORMATION VEGETABLE, DOI DOI 10.1017/CBO9780511703850; Detrain C, 2000, NATURWISSENSCHAFTEN, V87, P373, DOI 10.1007/s001140050744; Forrest B, 2003, QUATERNARY SCI REV, V22, P1279, DOI 10.1016/S0277-3791(03)00028-3; Galbraith RF, 1999, ARCHAEOMETRY, V41, P339, DOI 10.1111/j.1475-4754.1999.tb00987.x; Gruter C, 2013, J THEOR BIOL, V327, P23, DOI 10.1016/j.jtbi.2013.02.013; Halfen AF, 2010, 19 WORLD C SOIL SCI; Halley JD, 2005, INSECT SOC, V52, P350, DOI 10.1007/s00040-005-0818-9; Hart AG, 2001, ANIM BEHAV, V62, P227, DOI 10.1006/anbe.2001.1743; Hart AG, 2002, BEHAV ECOL, V13, P224, DOI 10.1093/beheco/13.2.224; Hart AG, 2001, BEHAV ECOL SOCIOBIOL, V49, P387, DOI 10.1007/s002650000312; HOWARD DF, 1976, BEHAVIOUR, V56, P157, DOI 10.1163/156853976X00334; HUNTLEY DJ, 1985, NATURE, V313, P105, DOI 10.1038/313105a0; Johnson DL, 2010, 19 WORLD C SOIL SCI; Jonkman JCM, 1980, Z FUER ANGEW ENTOMOL, V89, P158; Kwapich CL, 2013, BEHAV ECOL SOCIOBIOL, V67, P2011, DOI 10.1007/s00265-013-1611-9; LEUTHOLD RH, 1976, BEHAV ECOL SOCIOBIOL, V1, P127, DOI 10.1007/BF00299194; Lincoln F. C., 1930, Circular United States Department of Agriculture, Vno. 118, P1; Mallon EB, 2001, BEHAV ECOL SOCIOBIOL, V50, P352, DOI 10.1007/s002650100377; McGlynn TP, 2012, ANNU REV ENTOMOL, V57, P291, DOI 10.1146/annurev-ento-120710-100708; Mikheyev AS, 2004, INSECT SOC, V51, P30, DOI 10.1007/s00040-003-0703-3; Moser JC, 2006, ANN ENTOMOL SOC AM, V99, P891, DOI 10.1603/0013-8746(2006)99[891:CEAMOA]2.0.CO;2; Naug D, 2002, J THEOR BIOL, V215, P427, DOI 10.1006/jtbi.2001.2524; Oster G.F., 1978, Monographs in Population Biology, pi; Persson T, 2007, R06123 SWED NUCL FUE; Pielstrom S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057040; Pielstrom S, 2012, ANIM BEHAV, V84, P743, DOI 10.1016/j.anbehav.2012.07.008; PORTER SD, 1981, BEHAV ECOL SOCIOBIOL, V9, P247, DOI 10.1007/BF00299879; PORTER SD, 1990, J KANSAS ENTOMOL SOC, V63, P138; Pratt SC, 2005, INSECT SOC, V52, P383, DOI 10.1007/s00040-005-0823-z; Pratt SC, 2008, BEHAV ECOL SOCIOBIOL, V62, P1369, DOI 10.1007/s00265-008-0565-9; Reyes JL, 1999, INSECT SOC, V46, P119, DOI 10.1007/s000400050121; Rink WJ, 2013, J ARCHAEOL SCI, V40, P2217, DOI 10.1016/j.jas.2012.11.006; Roschard J, 2003, INSECT SOC, V50, P237, DOI 10.1007/s00040-003-0663-7; Seal JN, 2006, ANN ENTOMOL SOC AM, V99, P673, DOI 10.1603/0013-8746(2006)99[673:CPOTFA]2.0.CO;2; SMALLWOOD J, 1982, INSECT SOC, V29, P138, DOI 10.1007/BF02228747; Tschinkel W. R., 2010, J INSECT SCI, V10, P26; Tschinkel WR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120407; Tschinkel WR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112981; Tschinkel WR, 2004, J INSECT SCI, V4, DOI 10.1093/jis/4.1.21; Tschinkel WR, 2003, PALAEOGEOGR PALAEOCL, V192, P321, DOI 10.1016/S0031-0182(02)00690-9; Tschinkel WR, 2011, J INSECT SCI; Wilder M., 2007, FLORIDA ANTHR, V60, P97; Wilkinson MT, 2009, EARTH-SCI REV, V97, P257, DOI 10.1016/j.earscirev.2009.09.005; WILSON EO, 1980, BEHAV ECOL SOCIOBIOL, V7, P143, DOI 10.1007/BF00299520	54	9	9	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2015	10	10							e0139922	10.1371/journal.pone.0139922	http://dx.doi.org/10.1371/journal.pone.0139922			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0DL	26509900	Green Published, gold, Green Submitted			2022-12-26	WOS:000363918100017
J	Bunn, C; Laderach, P; Jimenez, JGP; Montagnon, C; Schilling, T				Bunn, Christian; Laederach, Peter; Perez Jimenez, Juan Guillermo; Montagnon, Christophe; Schilling, Timothy			Multiclass Classification of Agro-Ecological Zones for Arabica Coffee: An Improved Understanding of the Impacts of Climate Change	PLOS ONE			English	Article							WINE REGIONS	Cultivation of Coffea arabica is highly sensitive to and has been shown to be negatively impacted by progressive climatic changes. Previous research contributed little to support forward-looking adaptation. Agro-ecological zoning is a common tool to identify homologous environments and prioritize research. We demonstrate here a pragmatic approach to describe spatial changes in agro-climatic zones suitable for coffee under current and future climates. We defined agro-ecological zones suitable to produce arabica coffee by clustering geo-referenced coffee occurrence locations based on bio-climatic variables. We used random forest classification of climate data layers to model the spatial distribution of these agro-ecological zones. We used these zones to identify spatially explicit impact scenarios and to choose locations for the long-term evaluation of adaptation measures as climate changes. We found that in zones currently classified as hot and dry, climate change will impact arabica more than those that are better suited to it. Research in these zones should therefore focus on expanding arabica's environmental limits. Zones that currently have climates better suited for arabica will migrate upwards by about 500m in elevation. In these zones the up-slope migration will be gradual, but will likely have negative ecosystem impacts. Additionally, we identified locations that with high probability will not change their climatic characteristics and are suitable to evaluate C. arabica germplasm in the face of climate change. These locations should be used to investigate long term adaptation strategies to production systems.	[Bunn, Christian; Perez Jimenez, Juan Guillermo] Ctr Int Agr Trop, Cali, Colombia; [Laederach, Peter] Ctr Int Agr Trop, Hotel Seminole, Managua, Nicaragua; [Montagnon, Christophe; Schilling, Timothy] World Coffee Res, College Stn, TX 77843 USA	Alliance; International Center for Tropical Agriculture - CIAT	Bunn, C (corresponding author), Ctr Int Agr Trop, Km 17,Apartado Aereo,6713, Cali, Colombia.	Christian.bunn@gmail.com	montagnon, christophe/AAQ-9291-2021; Bunn, Christian/AAE-9504-2019	montagnon, christophe/0000-0002-6967-9256; Bunn, Christian/0000-0003-2175-8745; Laderach, Peter/0000-0001-8708-6318	Norman Borlaug Institute, part of Texas AM University; World Coffee Research	Norman Borlaug Institute, part of Texas AM University; World Coffee Research	World Coffee Research funded this research through the project "Identifying Long Term Variety Trial Locations, Provide Climate Information to Support World Coffee Research Variety Trials and Support on Trial Data Analysis." http://worldcoffeeresearch.org/who-we-are/contact-us. World Coffee Research was represented by CM and TS and continuously interacted with CB and PL to design, implement and evaluate the research. CM and TS from World Coffee Research supported the manuscript preparation with comments. World Coffee Research is a 501 (c)(5) non-profit, collaborative research and development program of the global coffee industry to grow, protect, and enhance supplies of quality coffee while improving the livelihoods of the families who produce it. The program is funded and driven by the global coffee industry, guided by producers, executed by coffee scientists around the world and supported by the Norman Borlaug Institute, part of Texas A&M University.	Assad ED, 2004, PESQUI AGROPECU BRAS, V39, P1057, DOI 10.1590/S0100-204X2004001100001; Barbet-Massin M, 2012, METHODS ECOL EVOL, V3, P327, DOI 10.1111/j.2041-210X.2011.00172.x; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Bretz F., 2010, MULTIPLE COMP USING; Bunn C, 2014, P 25 INT C COFF SCI; Bunn C, 2015, CLIMATIC CHANGE, V129, P89, DOI 10.1007/s10584-014-1306-x; Calinski R.B., 1974, COMMUNICATIONS STAT, V3, P1, DOI [10.1080/03610927408827101, DOI 10.1080/03610927408827101]; DaMatta Fábio M., 2006, Braz. J. Plant Physiol., V18, P55, DOI 10.1590/S1677-04202006000100006; DaMatta Fábio Murilo, 2004, Braz. J. Plant Physiol., V16, P1, DOI 10.1590/S1677-04202004000100001; DaMatta FM, 2004, FIELD CROP RES, V86, P99, DOI 10.1016/j.fcr.2003.09.001; Davis AS, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0047149, 10.1371/journal.pone.0047981]; Edenhofer O., 2014, CONTRIBUTION WORKING; Eriyagama N, 2014, J WATER CLIM CHANGE, V5, P128, DOI 10.2166/wcc.2013.035; Fujino J, 2006, ENERG J, P343, DOI 10.5547/issn0195-6574-ej-volsi2006-nosi3-17; Gaal M, 2012, APPL ECOL ENV RES, V10, P121, DOI 10.15666/aeer/1002_121140; Garcia JC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113510; Gay C, 2006, CLIMATIC CHANGE, V79, P259, DOI 10.1007/s10584-006-9066-x; Hand DJ, 2001, MACH LEARN, V45, P171, DOI 10.1023/A:1010920819831; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Jaramillo J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006487; Laderach P, 2011, CLIM CHANG MANAG, P703, DOI 10.1007/978-3-642-14776-0_42; Moriondo M, 2013, CLIMATIC CHANGE, V119, P825, DOI 10.1007/s10584-013-0739-y; Ovalle-Rivera O, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124155; Pendergrast Mark., 2010, UNCOMMON GROUNDS HIS; R Core Team, 2021, R LANGUAGE ENV STAT; Ramirez J., 2010, DISAGGREGATION GLOBA; Ratkowsky D. A., 1978, Australian Computer Journal, V10, P115; Schroth G, 2014, REG ENV CHANGE; Schroth G, 2009, MITIG ADAPT STRAT GL, V14, P605, DOI 10.1007/s11027-009-9186-5; USDA, 2012, PROD SUPPL DISTR ONL; van der Vossen H, 2015, EUPHYTICA, V204, P243, DOI 10.1007/s10681-015-1398-z; Van Oijen M, 2010, AGROFOREST SYST, P1; van Oijen M, 2010, AGROFOREST SYST, V80, P341, DOI 10.1007/s10457-010-9294-y; Vermeulen SJ, 2013, P NATL ACAD SCI USA, V110, P8357, DOI 10.1073/pnas.1219441110; White JW, 2011, FIELD CROP RES, V124, P357, DOI 10.1016/j.fcr.2011.07.001; Wintgens JN, 2009, COFFEE GROWING PROCE; Zullo J, 2011, POTENTIAL GROWING AR	37	47	48	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2015	10	10							e0140490	10.1371/journal.pone.0140490	http://dx.doi.org/10.1371/journal.pone.0140490			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU8PC	26505637	Green Published, Green Submitted, gold			2022-12-26	WOS:000363804200010
J	Mondal, TK; Ganie, SA; Debnath, AB				Mondal, Tapan Kumar; Ganie, Showkat Ahmad; Debnath, Ananda Bhusan			Identification of Novel and Conserved miRNAs from Extreme Halophyte, Oryza coarctata, a Wild Relative of Rice	PLOS ONE			English	Article								Oryza coarctata, a halophyte and wild relative of rice, is grown normally in saline water. MicroRNAs (miRNAs) are non-coding RNAs that play pivotal roles in every domain of life including stress response. There are very few reports on the discovery of salt-responsive miRNAs from halophytes. In this study, two small RNA libraries, one each from the control and salt-treated (450 mM NaCl for 24 h) leaves of O. coarctata were sequenced, which yielded 338 known and 95 novel miRNAs. Additionally, we used publicly available transcriptomics data of O. coarctata which led to the discovery of additional 48 conserved miRNAs along with their pre-miRNA sequences through in silico analysis. In total, 36 known and 7 novel miRNAs were up-regulated whereas, 12 known and 7 novel miRNAs were down-regulated under salinity stress. Further, 233 and 154 target genes were predicted for 48 known and 14 novel differentially regulated miRNAs respectively. These targets with the help of gene ontology analysis were found to be involved in several important biological processes that could be involved in salinity tolerance. Relative expression trends of majority of the miRNAs as detected by real time-PCR as well as predicted by Illumina sequencing were found to be coherent. Additionally, expression of most of the target genes was negatively correlated with their corresponding miRNAs. Thus, the present study provides an account of miRNA-target networking that is involved in salinity adaption of O. coarctata.	[Mondal, Tapan Kumar; Ganie, Showkat Ahmad; Debnath, Ananda Bhusan] Natl Bur Plant Genet Resources, Div Genom Resources, New Delhi 110012 4, India	Indian Council of Agricultural Research (ICAR); ICAR - National Bureau of Plant Genetics Resources	Mondal, TK (corresponding author), Natl Bur Plant Genet Resources, Div Genom Resources, IARI Campus, New Delhi 110012 4, India.	mondaltk@rediffmail.com	Ganie, Showkat/M-1659-2019	Ganie, Showkat/0000-0002-8654-9840	Indian Council of Agricultural Research-National Bureau of Plant Genetic Resources [IXX10476]	Indian Council of Agricultural Research-National Bureau of Plant Genetic Resources	The work was funded by Indian Council of Agricultural Research-National Bureau of Plant Genetic Resources through an in-house grant (Project code: IXX10476).		0	25	26	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2015	10	10							e0140675	10.1371/journal.pone.0140675	http://dx.doi.org/10.1371/journal.pone.0140675			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU8PC	26506249	Green Published, Green Submitted, gold			2022-12-26	WOS:000363804200015
J	Sun, GY; Chen, ZH; Jasmer, KJ; Chuang, DY; Gu, ZZ; Hannink, M; Simonyi, A				Sun, Grace Y.; Chen, Zihong; Jasmer, Kimberly J.; Chuang, Dennis Y.; Gu, Zezong; Hannink, Mark; Simonyi, Agnes			Quercetin Attenuates Inflammatory Responses in BV-2 Microglial Cells: Role of MAPKs on the Nrf2 Pathway and Induction of Heme Oxygenase-1	PLOS ONE			English	Article							NF-KAPPA-B; INDUCED NITRIC-OXIDE; GENE-EXPRESSION; CYTOKINE PRODUCTION; UP-REGULATION; LIPOPOLYSACCHARIDE; LPS; ACTIVATION; KEAP1; HO-1	A large group of flavonoids found in fruits and vegetables have been suggested to elicit health benefits due mainly to their anti-oxidative and anti-inflammatory properties. Recent studies with immune cells have demonstrated inhibition of these inflammatory responses through down-regulation of the pro-inflammatory pathway involving NF-kappa B and up-regulation of the anti-oxidative pathway involving Nrf2. In the present study, the murine BV-2 microglial cells were used to compare anti-inflammatory activity of quercetin and cyanidin, two flavonoids differing by their alpha, beta keto carbonyl group. Quercetin was 10 folds more potent than cyanidin in inhibition of lipopolysaccharide (LPS)-induced NO production as well as stimulation of Nrf2-induced heme-oxygenase-1 (HO-1) protein expression. In addition, quercetin demonstrated enhanced ability to stimulate HO-1 protein expression when cells were treated with LPS. In an attempt to unveil mechanism(s) for quercetin to enhance Nrf2/HO-1 activity under endotoxic stress, results pointed to an increase in phospho-p38MAPK expression upon addition of quercetin to LPS. In addition, pharmacological inhibitors for phospho-p38MAPK and MEK1/2 for ERK1/2 further showed that these MAPKs target different sites of the Nrf2 pathway that regulates HO-1 expression. However, inhibition of LPS-induced NO by quercetin was not fully reversed by TinPPIX, a specific inhibitor for HO-1 activity. Taken together, results suggest an important role of quercetin to regulate inflammatory responses in microglial cells and its ability to upregulate HO-1 against endotoxic stress through involvement of MAPKs.	[Sun, Grace Y.; Chen, Zihong; Hannink, Mark; Simonyi, Agnes] Univ Missouri, Dept Biochem, Columbia, MO 65211 USA; [Jasmer, Kimberly J.] Univ Missouri, Div Biol Sci, Columbia, MO 65211 USA; [Sun, Grace Y.; Chuang, Dennis Y.; Gu, Zezong] Univ Missouri, Interdisciplinary Neurosci Program, Columbia, MO USA; [Sun, Grace Y.; Gu, Zezong] Univ Missouri, Dept Pathol & Anat Sci, Columbia, MO USA; [Sun, Grace Y.; Chen, Zihong; Chuang, Dennis Y.; Gu, Zezong; Hannink, Mark; Simonyi, Agnes] Univ Missouri, Ctr Bot Interact Studies, Columbia, MO USA	University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia	Sun, GY (corresponding author), Univ Missouri, Dept Biochem, Columbia, MO 65211 USA.	sung@missouri.edu	Jasmer, Kimberly/V-2522-2019	Jasmer, Kimberly/0000-0002-8669-428X	NIH grant from NCCAM [1P50 AT006273]; NIH grant from ODS [1P50 AT006273]; NIH grant from NCI [1P50 AT006273]; NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE [P50AT006273] Funding Source: NIH RePORTER	NIH grant from NCCAM; NIH grant from ODS; NIH grant from NCI; NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine)	This work is supported by NIH grant from NCCAM, ODS and NCI [1P50 AT006273].	Abraham NG, 2008, PHARMACOL REV, V60, P79, DOI 10.1124/pr.107.07104; Adami C, 2001, GLIA, V33, P131, DOI 10.1002/1098-1136(200102)33:2<131::AID-GLIA1012>3.0.CO;2-D; Annapurna A, 2013, EUR REV MED PHARMACO, V17, P491; Bachstetter AD, 2014, J NEUROINFLAMM, V11, DOI 10.1186/s12974-014-0175-6; Bachstetter AD, 2010, AGING DIS, V1, P199; Bachstetter AD, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-79; BLASI E, 1990, J NEUROIMMUNOL, V27, P229, DOI 10.1016/0165-5728(90)90073-V; Block ML, 2005, PROG NEUROBIOL, V76, P77, DOI 10.1016/j.pneurobio.2005.06.004; Boots AW, 2008, EUR J PHARMACOL, V585, P325, DOI 10.1016/j.ejphar.2008.03.008; Calabrese V, 2010, ANTIOXID REDOX SIGN, V13, P1763, DOI 10.1089/ars.2009.3074; Chen JC, 2005, EUR J PHARMACOL, V521, P9, DOI 10.1016/j.ejphar.2005.08.005; Chow JM, 2005, BIOCHEM PHARMACOL, V69, P1839, DOI 10.1016/j.bcp.2005.03.017; Chuang DY, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-15; Dajas Federico, 2013, Central Nervous System Agents in Medicinal Chemistry, V13, P30; Dilshara MG, 2015, INT IMMUNOPHARMACOL, V24, P14, DOI 10.1016/j.intimp.2014.10.030; Dilshara MG, 2014, INT IMMUNOPHARMACOL, V18, P203, DOI 10.1016/j.intimp.2013.11.020; Ernst IMA, 2012, BRIT J NUTR, V107, P360, DOI 10.1017/S0007114511002984; Gan L, 2014, BBA-MOL BASIS DIS, V1842, P1208, DOI 10.1016/j.bbadis.2013.12.011; Gao B, 2014, CLIN PHARMACOL-ADV A, V6, P19, DOI 10.2147/CPAA.S35078; Henagan TM, 2015, GENES NUTR, V10, DOI 10.1007/s12263-014-0451-1; Hwang IK, 2009, J MED FOOD, V12, P990, DOI 10.1089/jmf.2008.1400; Jiang JH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089748; Kang CH, 2013, INT IMMUNOPHARMACOL, V17, P808, DOI 10.1016/j.intimp.2013.09.009; Kang CH, 2013, TOXICOL IN VITRO, V27, P782, DOI 10.1016/j.tiv.2012.12.012; Kao TK, 2010, LIFE SCI, V86, P315, DOI 10.1016/j.lfs.2009.12.014; Kobayashi A, 2004, MOL CELL BIOL, V24, P7130, DOI 10.1128/MCB.24.16.7130-7139.2004; Larson AJ, 2012, ADV NUTR, V3, P39, DOI 10.3945/an.111.001271; Lee DS, 2014, PHYTOTHER RES, V28, P1216, DOI 10.1002/ptr.5119; Lee J, 2014, PHARMACOL REV, V66, P815, DOI 10.1124/pr.113.007757; Lee SE, 2011, J CELL BIOCHEM, V112, P2352, DOI 10.1002/jcb.23158; Lee S, 2007, BIOCHEM PHARMACOL, V74, P723, DOI 10.1016/j.bcp.2007.06.016; Li LR, 2014, CHEM-BIOL INTERACT, V209, P56, DOI 10.1016/j.cbi.2013.12.005; Nair S, 2008, BRIT J CANCER, V99, P2070, DOI 10.1038/sj.bjc.6604703; Paine A, 2010, BIOCHEM PHARMACOL, V80, P1895, DOI 10.1016/j.bcp.2010.07.014; Panchal SK, 2012, J NUTR, V142, P1026, DOI 10.3945/jn.111.157263; Park EJ, 2014, INT IMMUNOPHARMACOL, V22, P332, DOI 10.1016/j.intimp.2014.07.012; Park EJ, 2013, FOOD CHEM TOXICOL, V55, P386, DOI 10.1016/j.fct.2012.12.027; Park HH, 2013, INT IMMUNOPHARMACOL, V15, P296, DOI 10.1016/j.intimp.2012.12.005; Qu Z, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-17; Saw CLL, 2014, FOOD CHEM TOXICOL, V72, P303, DOI 10.1016/j.fct.2014.07.038; Scapagnini G, 2011, MOL NEUROBIOL, V44, P192, DOI 10.1007/s12035-011-8181-5; Shen SM, 2005, NEUROCHEM INT, V47, P298, DOI 10.1016/j.neuint.2005.03.007; Sheng WW, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-121; Silva-Gomes S, 2013, INFECT IMMUN, V81, P2536, DOI 10.1128/IAI.00251-13; Simonyi A, 2015, LIFE SCI; Soares MP, 2009, CURR OPIN PHARMACOL, V9, P482, DOI 10.1016/j.coph.2009.05.008; Son TG, 2008, NEUROMOL MED, V10, P236, DOI 10.1007/s12017-008-8037-y; Sorrenti V, 2007, MOL NUTR FOOD RES, V51, P580, DOI 10.1002/mnfr.200600204; Sun AY, 2008, NEUROMOL MED, V10, P259, DOI 10.1007/s12017-008-8052-z; Tanigawa S, 2007, FREE RADICAL BIO MED, V42, P1690, DOI 10.1016/j.freeradbiomed.2007.02.017; Terazawa R, 2013, PHARMACOL RES, V71, P34, DOI 10.1016/j.phrs.2013.02.002; Wu W, 2015, MOL NUTR FOOD RES; Xia SF, 2015, PHYSIOL BEHAV, V138, P325, DOI 10.1016/j.physbeh.2014.09.008; Xu GL, 2013, TOXICOL APPL PHARM, V272, P221, DOI 10.1016/j.taap.2013.05.025; Zhang DD, 2003, MOL CELL BIOL, V23, P8137, DOI 10.1128/MCB.23.22.8137-8151.2003; Zhang DD, 2004, MOL CELL BIOL, V24, P10941, DOI 10.1128/MCB.24.24.10941-10953.2004; Zhou LT, 2015, EUR J PHARMACOL, V761, P211, DOI 10.1016/j.ejphar.2015.06.003	57	117	122	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2015	10	10							e0141509	10.1371/journal.pone.0141509	http://dx.doi.org/10.1371/journal.pone.0141509			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU8PC	26505893	Green Published, Green Submitted, gold			2022-12-26	WOS:000363804200078
J	Saha, B; Momen-Heravi, F; Kodys, K; Szabo, G				Saha, Banishree; Momen-Heravi, Fatemeh; Kodys, Karen; Szabo, Gyongyi			MicroRNA Cargo of Extracellular Vesicles from Alcohol-exposed Monocytes Signals Naive Monocytes to Differentiate into M2 Macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell signaling; exosome (vesicle); extracellular vesicles; liver injury; phagocytosis; alcoholic hepatitis	LIVER-DISEASE; CIRCULATING MICRORNAS; INTERFERON-ALPHA; DENDRITIC CELLS; INNATE IMMUNITY; THP-1 CELLS; PHAGOCYTOSIS; MICROVESICLES; ACTIVATION; EXOSOMES	Membrane-coated extracellular vesicles (EVs) released by cells can serve as vehicles for delivery of biological materials and signals. Recently, we demonstrated that alcohol-treated hepatocytes cross-talk with immune cells via exosomes containing microRNA (miRNAs). Here, we hypothesized that alcohol-exposed monocytes can communicate with naive monocytes via EVs. We observed increased numbers of EVs, mostly exosomes, secreted by primary human monocytes and THP-1 monocytic cells in the presence of alcohol in a concentration- and time-dependent manner. EVs derived from alcohol-treated monocytes stimulated naive monocytes to polarize into M2 macrophages as indicated by increased surface expression of CD68 (macrophage marker), M2 markers (CD206 (mannose receptor) and CD163 (scavenger receptor)), secretion of IL-10, and TGF and increased phagocytic activity. miRNA profiling of the EVs derived from alcohol-treated THP-1 monocytes revealed high expression of the M2-polarizing miRNA, miR-27a. Treatment of naive monocytes with control EVs overexpressing miR-27a reproduced the effect of EVs from alcohol-treated monocytes on naive monocytes and induced M2 polarization, suggesting that the effect of alcohol EVs was mediated by miR-27a. We found that miR-27a modulated the process of phagocytosis by targeting CD206 expression on monocytes. Importantly, analysis of circulating EVs from plasma of alcoholic hepatitis patients revealed increased numbers of EVs that contained high levels of miR-27a as compared with healthy controls. Our results demonstrate the following: first, alcohol increases EV production in monocytes; second, alcohol-exposed monocytes communicate with naive monocytes via EVs; and third, miR-27a cargo in monocyte-derived EVs can program naive monocytes to polarize into M2 macrophages.	[Saha, Banishree; Momen-Heravi, Fatemeh; Kodys, Karen; Szabo, Gyongyi] Univ Massachusetts, Sch Med, Dept Med, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester	Szabo, G (corresponding author), Univ Massachusetts, Sch Med, Dept Med, LRB208,364 Plantat St, Worcester, MA 01605 USA.	Gyongyi.Szabo@umassmed.edu	Momen-Heravi, Fatemeh/G-7955-2012	Momen-Heravi, Fatemeh/0000-0003-4534-1450	National Institutes of Health [R01AA011576 UO1, AA021907 UO1, AA021893]; Defeat Alcoholic SteatoHepatitis (DASH) consortium; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA011576, U01AA021893, R21AA023628, U01AA021907] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Defeat Alcoholic SteatoHepatitis (DASH) consortium; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by National Institutes of Health Grants R01AA011576 UO1, AA021907 UO1, and AA021893 (to G. S.) and the Defeat Alcoholic SteatoHepatitis (DASH) consortium. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The authors declare that they have no conflicts of interest with the contents of this article.	Ampel NM, 2005, INFECT IMMUN, V73, P2554, DOI 10.1128/IAI.73.4.2554-2555.2005; Arroyo JD, 2011, P NATL ACAD SCI USA, V108, P5003, DOI 10.1073/pnas.1019055108; Bala S, 2015, SCI REP-UK, V5, DOI 10.1038/srep10721; Bala S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096864; Bala S, 2012, HEPATOLOGY, V56, P1946, DOI 10.1002/hep.25873; Bazzoni F, 2009, P NATL ACAD SCI USA, V106, P5282, DOI 10.1073/pnas.0810909106; Beier JI, 2010, BIOL CHEM, V391, P1249, DOI 10.1515/BC.2010.137; Campos JH, 2015, J IMMUNOL RES, V2015, DOI 10.1155/2015/832057; Daigneault M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008668; Das A, 2014, J IMMUNOL, V192, P1120, DOI 10.4049/jimmunol.1300613; de Vrij J, 2015, INT J CANCER, V137, P1630, DOI 10.1002/ijc.29521; den Brouw MLO, 2009, VIROLOGY, V393, P84, DOI 10.1016/j.virol.2009.07.015; El Gazzar M, 2012, IMMUNOL CELL BIOL, V90, P587, DOI 10.1038/icb.2011.74; Etzrodt M, 2012, CELL REPORTS, V1, P317, DOI 10.1016/j.celrep.2012.02.009; Gao B, 2011, GASTROENTEROLOGY, V141, P1572, DOI 10.1053/j.gastro.2011.09.002; Graff JW, 2012, J BIOL CHEM, V287, P21816, DOI 10.1074/jbc.M111.327031; Guay C, 2015, CELL COMMUN SIGNAL, V13, DOI 10.1186/s12964-015-0097-7; Gyorgy B, 2011, CELL MOL LIFE SCI, V68, P2667, DOI 10.1007/s00018-011-0689-3; Ismail N, 2013, BLOOD, V121, P984, DOI 10.1182/blood-2011-08-374793; Julich H, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00413; Kalra H, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001450; Karavitis J, 2012, CELL IMMUNOL, V274, P61, DOI 10.1016/j.cellimm.2012.02.002; Karavitis J, 2011, J LEUKOCYTE BIOL, V90, P1065, DOI 10.1189/jlb.0311114; LANDMANN R, 1991, J CELL BIOCHEM, V47, P317, DOI 10.1002/jcb.240470406; Lee J, 2014, EXP MOL PATHOL, V96, P118, DOI 10.1016/j.yexmp.2013.09.004; Louvet A, 2015, NAT REV GASTRO HEPAT, V12, P231, DOI 10.1038/nrgastro.2015.35; Malathi K, 2007, NATURE, V448, P816, DOI 10.1038/nature06042; Mandrekar P., 2012, TRENDS ALCOHOLIC LIV, DOI [10.5772/27412, DOI 10.5772/27412]; Martinez F.O., 2014, F1000PRIME REP, V6, DOI DOI 10.12703/P6-13; McClain CJ, 2002, ALCOHOL, V27, P53, DOI 10.1016/S0741-8329(02)00212-4; Momen-Heravi F, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0623-9; Momen-Heravi F, 2015, SCI REP-UK, V5, DOI 10.1038/srep09991; Momen-Heravi F, 2014, NANOMED-NANOTECHNOL, V10, P1517, DOI 10.1016/j.nano.2014.03.014; Momen-Heravi F, 2013, BIOL CHEM, V394, P1253, DOI 10.1515/hsz-2013-0141; Moon HG, 2014, J IMMUNOL, V193, P4558, DOI 10.4049/jimmunol.1401372; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Naqvi AR, 2015, J IMMUNOL, V194, P1916, DOI 10.4049/jimmunol.1401893; O'Connell RM, 2010, NAT REV IMMUNOL, V10, P111, DOI 10.1038/nri2708; O'Shea RS, 2010, HEPATOLOGY, V51, P307, DOI 10.1002/hep.23258; Pap E, 2011, ADV EXP MED BIOL, V714, P183, DOI 10.1007/978-94-007-0782-5_10; Piemonti L, 1999, INT IMMUNOL, V11, P1519, DOI 10.1093/intimm/11.9.1519; Qin ZY, 2012, ATHEROSCLEROSIS, V221, P2, DOI 10.1016/j.atherosclerosis.2011.09.003; Raposo G, 2013, J CELL BIOL, V200, P373, DOI 10.1083/jcb.201211138; Ratajczak J, 2006, LEUKEMIA, V20, P1487, DOI 10.1038/sj.leu.2404296; Saha B, 2015, J IMMUNOL, V194, P3079, DOI 10.4049/jimmunol.1402190; Sharbati S, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-23; Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643; Silva MT, 2010, J LEUKOCYTE BIOL, V87, P93, DOI 10.1189/jlb.0809549; Stuart LM, 2005, IMMUNITY, V22, P539, DOI 10.1016/j.immuni.2005.05.002; Szabo G, 1997, ALCOHOL HEALTH RES W, V21, P30; Szabo G, 2001, ALCOHOL CLIN EXP RES, V25, P1188; Szabo G, 2015, GASTROENTEROLOGY, V148, P30, DOI 10.1053/j.gastro.2014.10.042; Szabo G, 2012, DIGEST DIS, V30, P55, DOI 10.1159/000341126; Taylor Douglas D., 2013, Frontiers in Genetics, V4, P142, DOI 10.3389/fgene.2013.00142; Undi Ram Babu, 2013, Adv Hematol, V2013, P695754, DOI 10.1155/2013/695754; Wang ZJ, 2012, P NATL ACAD SCI USA, V109, P15413, DOI 10.1073/pnas.1204525109; Zhang SY, 2013, GASTROENTEROLOGY, V144, P414, DOI 10.1053/j.gastro.2012.10.034; Zhang YY, 2013, INT J MOL MED, V31, P797, DOI 10.3892/ijmm.2013.1260	58	133	139	3	33	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 1	2016	291	1					149	159		10.1074/jbc.M115.694133	http://dx.doi.org/10.1074/jbc.M115.694133			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DA1XP	26527689	hybrid, Green Published			2022-12-26	WOS:000367589500012
J	Matsuo, S; Ogawa, M; Muckenthaler, MU; Mizui, Y; Sasaki, S; Fujimura, T; Takizawa, M; Ariga, N; Ozaki, H; Sakaguchi, M; Gonzalez, FJ; Inoue, Y				Matsuo, Shunsuke; Ogawa, Masayuki; Muckenthaler, Martina U.; Mizui, Yumiko; Sasaki, Shota; Fujimura, Takafumi; Takizawa, Masayuki; Ariga, Nagayuki; Ozaki, Hiroaki; Sakaguchi, Masakiyo; Gonzalez, Frank J.; Inoue, Yusuke			Hepatocyte Nuclear Factor 4 alpha Controls Iron Metabolism and Regulates Transferrin Receptor 2 in Mouse Liver	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENRICHED TRANSCRIPTION FACTORS; GENE-EXPRESSION; HEPCIDIN; PROTEIN; DISRUPTION; HYPOTRANSFERRINEMIA; HOMEOSTASIS; PROMOTER; BINDING; BMP	Iron is an essential element in biological systems, but excess iron promotes the formation of reactive oxygen species, resulting in cellular toxicity. Several iron-related genes are highly expressed in the liver, a tissue in which hepatocyte nuclear factor 4 alpha (HNF4 alpha) plays a critical role in controlling gene expression. Therefore, the role of hepatic HNF4 alpha in iron homeostasis was examined using liver-specific HNF4 alpha-null mice (Hnf4a(Delta H) mice). Hnf4a(Delta H) mice exhibit hypoferremia and a significant change in hepatic gene expression. Notably, the expression of transferrin receptor 2 (Tfr2) mRNA was markedly decreased in Hnf4a(Delta H) mice. Promoter analysis of the Tfr2 gene showed that the basal promoter was located at a GC-rich region upstream of the transcription start site, a region that can be transactivated in an HNF4 alpha-independent manner. HNF4 alpha-dependent expression of Tfr2 was mediated by a proximal promoter containing two HNF4 alpha-binding sites located between the transcription start site and the translation start site. Both the GC-rich region of the basal promoter and the HNF4 alpha-binding sites were required for maximal transactivation. Moreover, siRNA knockdown of HNF4 alpha suppressed TFR2 expression in human HCC cells. These results suggest that Tfr2 is a novel target gene for HNF4 alpha, and hepatic HNF4 alpha plays a critical role in iron homeostasis.	[Matsuo, Shunsuke; Ogawa, Masayuki; Mizui, Yumiko; Sasaki, Shota; Fujimura, Takafumi; Takizawa, Masayuki; Ariga, Nagayuki; Ozaki, Hiroaki; Inoue, Yusuke] Gunma Univ, Grad Sch Sci & Technol, Div Mol Sci, Kiryu, Gunma 3768515, Japan; [Muckenthaler, Martina U.] Heidelberg Univ, Dept Pediat Oncol Hematol & Immunol, D-69120 Heidelberg, Germany; [Sakaguchi, Masakiyo] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Cell Biol, Okayama 7008558, Japan; [Gonzalez, Frank J.] NCI, Lab Metab, Ctr Canc Res, NIH, Bethesda, MD 20852 USA	Gunma University; Ruprecht Karls University Heidelberg; Okayama University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Inoue, Y (corresponding author), Gunma Univ, Grad Sch Sci & Technol, Div Mol Sci, 1-5-1 Tenjin Cho, Kiryu, Gunma 3768515, Japan.	yinoue@gunma-u.ac.jp	Inoue, Yusuke/O-6207-2018; Sakaguchi, Masakiyo/B-2280-2011	Inoue, Yusuke/0000-0002-9710-7482; Muckenthaler, Martina/0000-0002-3778-510X	Ministry of Education, Culture, Sports, Science, and Technology of Japan [25460490]; Kato Memorial Bioscience Foundation; NATIONAL CANCER INSTITUTE [ZIABC005562] Funding Source: NIH RePORTER	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Kato Memorial Bioscience Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by grants from the Ministry of Education, Culture, Sports, Science, and Technology of Japan Grant-in-aid for Scientific Research 25460490 (to Y. I.) and Kato Memorial Bioscience Foundation (to Y. I.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aisen P, 2004, INT J BIOCHEM CELL B, V36, P2137, DOI 10.1016/j.biocel.2004.02.007; [Anonymous], 2001, NUCL RECEPTORS GENET; Bartnikas TB, 2012, BIOMETALS, V25, P677, DOI 10.1007/s10534-012-9520-3; BERNSTEIN SE, 1987, J LAB CLIN MED, V110, P690; Camaschella C, 2000, NAT GENET, V25, P14, DOI 10.1038/75534; Core AB, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00104; Courselaud B, 2002, J BIOL CHEM, V277, P41163, DOI 10.1074/jbc.M202653200; Ganz T, 2013, PHYSIOL REV, V93, P1721, DOI 10.1152/physrev.00008.2013; Gao JW, 2009, CELL METAB, V9, P217, DOI 10.1016/j.cmet.2009.01.010; Handy DE, 2012, ANTIOXID REDOX SIGN, V16, P1323, DOI 10.1089/ars.2011.4123; HAYASHI A, 1993, AM J HUM GENET, V53, P201; Hayhurst GP, 2001, MOL CELL BIOL, V21, P1393, DOI 10.1128/MCB.21.4.1393-1403.2001; Inoue Y, 2006, J LIPID RES, V47, P215, DOI 10.1194/jlr.M500430-JLR200; Inoue Y, 2004, J BIOL CHEM, V279, P44740, DOI 10.1074/jbc.M405177200; Inoue Y, 2004, J BIOL CHEM, V279, P2480, DOI 10.1074/jbc.M311015200; Inoue Y, 2002, J BIOL CHEM, V277, P25257, DOI 10.1074/jbc.M203126200; Kardassis D, 2002, BIOCHEMISTRY-US, V41, P1217, DOI 10.1021/bi015618f; Kawabata H, 1999, J BIOL CHEM, V274, P20826, DOI 10.1074/jbc.274.30.20826; Kawabata H, 2001, BLOOD, V98, P1949, DOI 10.1182/blood.V98.6.1949; Muckenthaler M, 2003, NAT GENET, V34, P102, DOI 10.1038/ng1152; Muckenthaler M, 2003, BLOOD, V101, P3690, DOI 10.1182/blood-2002-07-2140; Munoz M, 2011, J CLIN PATHOL, V64, P281, DOI 10.1136/jcp.2010.079046; Nemeth E, 2004, SCIENCE, V306, P2090, DOI 10.1126/science.1104742; PEVNY L, 1991, NATURE, V349, P257, DOI 10.1038/349257a0; Richter A, 2002, BIOTECHNIQUES, V33, P620, DOI 10.2144/02333rr05_11834a; Rolo AP, 2012, FREE RADICAL BIO MED, V52, P59, DOI 10.1016/j.freeradbiomed.2011.10.003; SCHAEFFER E, 1993, J BIOL CHEM, V268, P23399; Schrem H, 2004, PHARMACOL REV, V56, P291, DOI 10.1124/pr.56.2.5; Schrem H, 2002, PHARMACOL REV, V54, P129, DOI 10.1124/pr.54.1.129; Truksa J, 2009, BLOOD, V113, P688, DOI 10.1182/blood-2008-05-160184; Wallace DF, 2007, GASTROENTEROLOGY, V132, P301, DOI 10.1053/j.gastro.2006.11.028; Wallace DF, 2005, GUT, V54, P980, DOI 10.1136/gut.2004.062018; Wallander ML, 2006, BBA-MOL CELL RES, V1763, P668, DOI 10.1016/j.bbamcr.2006.05.004; Wang JA, 2011, BIOCHEM J, V434, P365, DOI 10.1042/BJ20101825; Welch JJ, 2004, BLOOD, V104, P3136, DOI 10.1182/blood-2004-04-1603; West AP, 2000, J BIOL CHEM, V275, P38135, DOI 10.1074/jbc.C000664200; Wiwi CA, 2004, MOL ENDOCRINOL, V18, P1975, DOI 10.1210/me.2004-0129; Worthen CA, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00034; Yun S, 2015, CRIT REV ONCOL HEMAT, V95, P12, DOI 10.1016/j.critrevonc.2015.02.006	39	19	20	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 25	2015	290	52					30855	30865		10.1074/jbc.M115.694414	http://dx.doi.org/10.1074/jbc.M115.694414			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CZ6GK	26527688	hybrid, Green Published			2022-12-26	WOS:000367199000018
J	Huang, FF; Li, X; Wang, C; Xu, Q; Wang, W; Luo, YX; Tao, LX; Gao, Q; Guo, J; Chen, SP; Cao, K; Liu, L; Gao, N; Liu, XT; Yang, K; Yan, AS; Guo, XH				Huang, Fangfang; Li, Xia; Wang, Chao; Xu, Qin; Wang, Wei; Luo, Yanxia; Tao, Lixin; Gao, Qi; Guo, Jin; Chen, Sipeng; Cao, Kai; Liu, Long; Gao, Ni; Liu, Xiangtong; Yang, Kun; Yan, Aoshuang; Guo, Xiuhua			PM2.5 Spatiotemporal Variations and the Relationship with Meteorological Factors during 2013-2014 in Beijing, China	PLOS ONE			English	Article							FINE PARTICULATE MATTER; PARTICLE NUMBER CONCENTRATIONS; EMERGENCY-ROOM VISITS; YANGTZE-RIVER DELTA; AIR-POLLUTION; AMBIENT AIR; TEMPORAL VARIATIONS; GASEOUS-POLLUTANTS; PM10; TEMPERATURE	Objective Limited information is available regarding spatiotemporal variations of particles with median aerodynamic diameter < 2.5 mu m (PM2.5) at high resolutions, and their relationships with meteorological factors in Beijing, China. This study aimed to detect spatiotemporal change patterns of PM2.5 from August 2013 to July 2014 in Beijing, and to assess the relationship between PM2.5 and meteorological factors. Methods Daily and hourly PM2.5 data from the Beijing Environmental Protection Bureau (BJEPB) were analyzed separately. Ordinary kriging (OK) interpolation, time-series graphs, Spearman correlation coefficient and coefficient of divergence (COD) were used to describe the spatiotemporal variations of PM2.5. The Kruskal-Wallis H test, Bonferroni correction, and Mann-Whitney U test were used to assess differences in PM2.5 levels associated with spatial and temporal factors including season, region, daytime and day of week. Relationships between daily PM2.5 and meteorological variables were analyzed using the generalized additive mixed model (GAMM). Results Annual mean and median of PM2.5 concentrations were 88.07 mu g/m(3) and 71.00 mu g/m(3), respectively, from August 2013 to July 2014. PM2.5 concentration was significantly higher in winter (P < 0.0083) and in the southern part of the city (P < 0.0167). Day to day variation of PM2.5 showed a long-term trend of fluctuations, with 2-6 peaks each month. PM2.5 concentration was significantly higher in the night than day (P < 0.0167). Meteorological factors were associated with daily PM2.5 concentration using the GAMM model (R-2 = 0.59, AIC = 7373.84). Conclusion PM2.5 pollution in Beijing shows strong spatiotemporal variations. Meteorological factors influence the PM2.5 concentration with certain patterns. Generally, prior day wind speed, sunlight hours and precipitation are negatively correlated with PM2.5, whereas relative humidity and air pressure three days earlier are positively correlated with PM2.5.	[Huang, Fangfang; Wang, Chao; Xu, Qin; Wang, Wei; Luo, Yanxia; Tao, Lixin; Gao, Qi; Guo, Jin; Chen, Sipeng; Cao, Kai; Liu, Long; Gao, Ni; Liu, Xiangtong; Yang, Kun; Yan, Aoshuang; Guo, Xiuhua] Capital Med Univ, Sch Publ Hlth, Dept Epidemiol & Hlth Stat, Beijing, Peoples R China; [Huang, Fangfang; Wang, Chao; Xu, Qin; Wang, Wei; Luo, Yanxia; Tao, Lixin; Gao, Qi; Guo, Jin; Chen, Sipeng; Cao, Kai; Liu, Long; Gao, Ni; Liu, Xiangtong; Yang, Kun; Guo, Xiuhua] Beijing Municipal Key Lab Clin Epidemiol, Beijing, Peoples R China; [Li, Xia] Univ Limerick, Grad Entry Med Sch, Limerick, Ireland; [Wang, Wei] Edith Cowan Univ, Sch Med Sci, Perth, WA, Australia; [Yan, Aoshuang] Beijing Municipal Sci & Technol Commiss, Beijing, Peoples R China	Capital Medical University; University of Limerick; Edith Cowan University; Beijing Municipal Science & Technology Commission	Yan, AS (corresponding author), Capital Med Univ, Sch Publ Hlth, Dept Epidemiol & Hlth Stat, Beijing, Peoples R China.	hnlg0771@hotmail.com; guoxiuh@ccmu.edu.cn	TAO, Li/HIR-4254-2022; Gao, Qi/N-8721-2019	Gao, Qi/0000-0002-5370-5536	Natural Science Fund of China [81302516]; National S&T Major Project Grant [2014ZX10004005-001]; National "12th Five-Year" Plan for Science and Technology Support, China [2012BAI37B03]; Edith Cowan University Strategic Funding (SRF); Edith Cowan University Industry Collaboration Scheme [G1001368]; Importation and Development of High-Calibre Talents Project of Beijing Municipal Institutions	Natural Science Fund of China(National Natural Science Foundation of China (NSFC)); National S&T Major Project Grant; National "12th Five-Year" Plan for Science and Technology Support, China; Edith Cowan University Strategic Funding (SRF); Edith Cowan University Industry Collaboration Scheme; Importation and Development of High-Calibre Talents Project of Beijing Municipal Institutions	This work was supported by grants from the Natural Science Fund of China Grant (81302516), National S&T Major Project Grant (2014ZX10004005-001), National "12th Five-Year" Plan for Science and Technology Support, China (2012BAI37B03), Edith Cowan University Strategic Funding (SRF 2015-2016), and Edith Cowan University Industry Collaboration Scheme-2013 (G1001368). WW is supported by the Importation and Development of High-Calibre Talents Project of Beijing Municipal Institutions. The funders had no role in study design,	Ailshire JA, 2014, AM J EPIDEMIOL, V180, P359, DOI 10.1093/aje/kwu155; Akyuz M, 2009, J HAZARD MATER, V170, P13, DOI 10.1016/j.jhazmat.2009.05.029; Beijing Municipal Bureau of Statistics, 2014, BEIJ STAT YB; Blanchard CL, 2006, J AIR WASTE MANAGE, V56, P271, DOI 10.1080/10473289.2006.10464455; Bravo MA, 2011, J AIR WASTE MANAGE, V61, P69, DOI 10.3155/1047-3289.61.1.69; Chai FH, 2014, J ENVIRON SCI, V26, P75, DOI 10.1016/S1001-0742(13)60383-6; Clifford S, 2011, ATMOS ENVIRON, V45, P5934, DOI 10.1016/j.atmosenv.2011.05.004; Coull B A, 2001, Biostatistics, V2, P337, DOI 10.1093/biostatistics/2.3.337; Cyrys J, 2008, SCI TOTAL ENVIRON, V401, P168, DOI 10.1016/j.scitotenv.2008.03.043; DOCKERY DW, 1994, ANNU REV PUBL HEALTH, V15, P107, DOI 10.1146/annurev.pu.15.050194.000543; Giakoumi A, 2009, ENVIRON MONIT ASSESS, V152, P83, DOI 10.1007/s10661-008-0298-2; Guinot B, 2006, ATMOS ENVIRON, V40, P5167, DOI 10.1016/j.atmosenv.2006.03.051; Guo YM, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f7139; Guo YM, 2009, SCI TOTAL ENVIRON, V407, P4826, DOI 10.1016/j.scitotenv.2009.05.022; Hu JL, 2014, ATMOS ENVIRON, V95, P598, DOI 10.1016/j.atmosenv.2014.07.019; Huang P, 2015, INT J ENV RES PUB HE, V12, P6608, DOI 10.3390/ijerph120606608; Ito K, 2007, J EXPO SCI ENV EPID, V17, pS45, DOI 10.1038/sj.jes.7500627; Ji DS, 2012, ATMOS ENVIRON, V50, P338, DOI 10.1016/j.atmosenv.2011.11.053; Lee BJ, 2014, TOXICOL RES-GER, V30, P71, DOI [10.5487/TR.2014.30.2.71, 10.5487/TR.2014.30.2.071]; Leitte AM, 2011, ENVIRON HEALTH PERSP, V119, P508, DOI 10.1289/ehp.1002203; Li F, 2013, ZHONG GUO HUAN JING, V29, P22; Li L, 2014, ENVIRON POLLUT, V190, P75, DOI 10.1016/j.envpol.2014.03.020; Li MN, 2014, ENVIRON POLLUT, V189, P85, DOI 10.1016/j.envpol.2014.02.024; Liang RJ, 2014, J HYPERTENS, V32, P2130, DOI 10.1097/HJH.0000000000000342; Liu J., 2015, ENVIRON SCI POLLUT R, DOI DOI 10.1007/S11356-015-5252-6; Liu Y, 2009, ENVIRON HEALTH PERSP, V117, P886, DOI 10.1289/ehp.0800123; Liu ZH, 2015, ENVIRON SCI POLLUT R, V22, P4753, DOI [10.1007/s11356-014-3347-0, 10.1007/s11356-014-3981-6]; Matheron G., 1963, ECON GEOL, V58, P1246, DOI DOI 10.2113/GSECONGEO.58.8.1246; Miao SG, 2009, J APPL METEOROL CLIM, V48, P484, DOI 10.1175/2008JAMC1909.1; Motallebi N, 2003, J AIR WASTE MANAGE, V53, P876, DOI 10.1080/10473289.2003.10466229; Olivares G, 2007, ATMOS ENVIRON, V41, P2145, DOI 10.1016/j.atmosenv.2006.10.068; Pal S, 2014, SCI TOTAL ENVIRON, V496, P424, DOI 10.1016/j.scitotenv.2014.07.067; Pelucchi C, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-453; Peters A, 2006, PART FIBRE TOXICOL, V3, DOI 10.1186/1743-8977-3-13; Pinto JP, 2004, J AIR WASTE MANAGE, V54, P440, DOI 10.1080/10473289.2004.10470919; Shen GF, 2014, J ENVIRON SCI HEAL A, V49, P171, DOI 10.1080/10934529.2013.838851; Shin HH, 2014, EPIDEMIOLOGY, V25, P835, DOI 10.1097/EDE.0000000000000162; Song C, 2015, INT J ENV RES PUB HE, V12, P1099, DOI 10.3390/ijerph120201099; State Forestry Administration of the People's Republic of China, 2013, CHIN FOR DEV REP; Trivedi DK, 2014, SCI TOTAL ENVIRON, V478, P175, DOI 10.1016/j.scitotenv.2014.01.101; Turner MC, 2011, AM J RESP CRIT CARE, V184, P1374, DOI 10.1164/rccm.201106-1011OC; Vassilakos C, 2005, SCI TOTAL ENVIRON, V349, P223, DOI 10.1016/j.scitotenv.2005.01.012; Wallace J, 2009, SCI TOTAL ENVIRON, V407, P5085, DOI 10.1016/j.scitotenv.2009.05.050; Wang G, 2015, ENVIRON MONIT ASSESS, V187, DOI 10.1007/s10661-015-4288-x; Wang JF, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0053400, 10.1371/journal.pone.0070519]; Wang YG, 2014, ENVIRON INT, V73, P413, DOI 10.1016/j.envint.2014.08.016; Wilson JG, 2006, SCI TOTAL ENVIRON, V367, P559, DOI 10.1016/j.scitotenv.2005.08.045; Wood S.N., 2017, GEN ADDITIVE MODELS, V2nd ed., DOI [10.1201/9781315370279, DOI 10.1201/9781315370279]; Wu SW, 2014, CHEMOSPHERE, V108, P168, DOI 10.1016/j.chemosphere.2014.01.032; Xiao QY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117311; Xu MM, 2014, ENVIRON HEALTH-GLOB, V13, DOI 10.1186/1476-069X-13-109; Yanosky JD, 2014, ENVIRON HEALTH-GLOB, V13, DOI 10.1186/1476-069X-13-63; Yu Y, 2011, J ENVIRON MONITOR, V13, P334, DOI 10.1039/c0em00467g; Zhang A, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0080969, 10.1371/journal.pone.0063486, 10.1371/journal.pone.0059428, 10.1371/journal.pone.0059254, 10.1371/journal.pone.0064689]; Zhang HL, 2015, ENVIRON RES, V140, P242, DOI 10.1016/j.envres.2015.04.004; Zhang Q, 2015, SCI TOTAL ENVIRON, V502, P578, DOI 10.1016/j.scitotenv.2014.09.079; Zhang YQ, 2014, WATER AIR SOIL POLL, V225, DOI 10.1007/s11270-014-2187-3	57	111	119	8	127	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2015	10	11							e0141642	10.1371/journal.pone.0141642	http://dx.doi.org/10.1371/journal.pone.0141642			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV1QH	26528542	Green Published, gold, Green Submitted			2022-12-26	WOS:000364032600045
J	Ghosh, B; Mitra, J; Chakraborty, S; Bhattacharyya, J; Chakraborty, A; Sen, SK; Neerathilingam, M				Ghosh, Bidisha; Mitra, Joy; Chakraborty, Saikat; Bhattacharyya, Jagannath; Chakraborty, Anirban; Sen, Soumitra Kumar; Neerathilingam, Muniasamy			Simple Detection Methods for Antinutritive Factor beta-ODAP Present in Lathyrus sativus L. by High Pressure Liquid Chromatography and Thin Layer Chromatography	PLOS ONE			English	Article							NONPROTEIN AMINO-ACIDS; BETA-N-OXALYL-L-ALPHA,BETA-DIAMINOPROPIONIC ACID; GRASS-PEA; PRECOLUMN DERIVATIZATION; ALPHA-ISOMER; NEUROTOXIN; REACTOR; ASSAY	Lathyrus sativus L. (Grass pea) is the source for cheap and nutritious food choice in drought and famine susceptible zones in greater part of North India and Africa. The non-protein amino acid beta-N-oxalyl-L-alpha, beta-diaminopropionic acid (beta-ODAP) has been known for decades for its potent neurotoxic effect, causing irreversible neurodegenerative disease "neurolathyrism", present in both seed and leaf of Lathyrus sativus L. and other species in varying proportions. It is crucial to establish a rapid as well as reliable detection methodology for beta-ODAP content in various Lathyrus plants. Currently available HPLC based methods involve multi-step derivatization of the sample. To overcome this, we have developed beta-ODAP analysis method by HPLC without any prior derivatization. This method is statistically significant in the range of 2 to 100 mu g/ml and exhibited linear response with r(2) > 0.99. Limit of detection and quantitation of the later method was determined to be 5.56 mu g/ml and 16.86 mu g/ml, respectively. In addition to this, a TLC based method has also been developed. The limit of detection of beta-ODAP is 0.6 mu g and for its substrate, L-1,2-diaminopropionic acid is 5 mu g. Both HPLC and TLC methods were validated by conducting in-vitro bioconversion test to detect the presence of biocatalyst in plant extract. This method is economical, rapid and simple.	[Ghosh, Bidisha; Neerathilingam, Muniasamy] NCBS TIFR, Ctr Cellular & Mol Platforms, Prot Technol Core, Bangalore, Karnataka, India; [Mitra, Joy; Chakraborty, Saikat; Bhattacharyya, Jagannath; Chakraborty, Anirban; Sen, Soumitra Kumar] Indian Inst Technol, Adv Lab Plant Genet Engn, Kharagpur 721302, W Bengal, India	Tata Institute of Fundamental Research (TIFR); National Centre for Biological Sciences (NCBS); Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Kharagpur	Neerathilingam, M (corresponding author), NCBS TIFR, Ctr Cellular & Mol Platforms, Prot Technol Core, Bangalore, Karnataka, India.	munish@ccamp.res.in	Mitra, Joy/AAH-5977-2020; CHAKRABORTY, ANIRBAN/ABC-6552-2020; /AAO-4852-2020	Mitra, Joy/0000-0002-5985-0582; 	Department of Biotechnology, India; Centre for Cellular and Molecular Platforms	Department of Biotechnology, India(Department of Biotechnology (DBT) India); Centre for Cellular and Molecular Platforms	This work was supported by the Department of Biotechnology, India and Centre for Cellular and Molecular Platforms.	ADDIS G, 1994, ANN BOT-LONDON, V74, P209, DOI 10.1006/anbo.1994.1111; Alizadeh K., 2013, DEV FEED LEGUMES SUI; Astha AN, 1996, INT PLANT GENETIC RE, P144; Bhowmick M.K., 2015, LIV DEV SUST AGR 9 A; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chen X, 2000, J AGR FOOD CHEM, V48, P3383, DOI 10.1021/jf000033y; Fikre A, 2008, FOOD CHEM, V110, P422, DOI 10.1016/j.foodchem.2008.02.019; Fuchs B, 2011, J CHROMATOGR A, V1218, P2754, DOI 10.1016/j.chroma.2010.11.066; Getahun H, 2003, LANCET, V362, P1808, DOI 10.1016/S0140-6736(03)14902-1; Gulla V, 2008, CHROMATOGRAPHIA, V68, P663, DOI 10.1365/s10337-008-0783-3; Hanbury CD, 2000, ANIM FEED SCI TECH, V87, P1, DOI 10.1016/S0377-8401(00)00186-3; Jiao CJ, 2011, FOOD CHEM TOXICOL, V49, P543, DOI 10.1016/j.fct.2010.04.050; KHAN JK, 1993, ANAL BIOCHEM, V208, P237, DOI 10.1006/abio.1993.1038; Kumar S, 2011, FOOD CHEM TOXICOL, V49, P589, DOI 10.1016/j.fct.2010.06.051; Long YC, 2000, INT J PEPT PROT RES, V47, P42; MALATHI K, 1970, PHYTOCHEMISTRY, V9, P1603, DOI 10.1016/S0031-9422(00)85283-8; MOGES G, 1994, ANAL CHEM, V66, P3834, DOI 10.1021/ac00093a046; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Paleacu D, 1999, PARKINSONISM RELAT D, V5, P55, DOI 10.1016/S1353-8020(99)00016-4; Paradkar MM, 2003, J SCI FOOD AGR, V83, P727, DOI 10.1002/jsfa.1361; Pati S, 2007, ANAL CHIM ACTA, V594, P234, DOI 10.1016/j.aca.2007.05.026; Rosenthal G.A., 1982, PLANT NONPROTEIN AMI; Salazar C, 2012, METABOLITES, V2, P398, DOI 10.3390/metabo2030398; Santiago M, 2013, METHOD ENZYMOL, V533, P303, DOI 10.1016/B978-0-12-420067-8.00024-6; SHAH AJ, 1992, PHYTOCHEM ANALYSIS, V3, P20, DOI 10.1002/pca.2800030104; Tarade KM, 2007, FOOD CHEM, V104, P643, DOI 10.1016/j.foodchem.2006.12.018; Thippeswamy R, 2007, FOOD CHEM, V101, P1290, DOI 10.1016/j.foodchem.2005.12.024; Truei YH, 1992, ADV BIOCHEM ENG BIOT, V47, P1; Wang F, 2000, J CHROMATOGR A, V883, P113, DOI 10.1016/S0021-9673(00)00264-8; Williams P. C., 2001, NEAR INFRARED TECHNO, V2, P145; Woldeamanuel YW, 2012, J NEUROL, V259, P1263, DOI 10.1007/s00415-011-6306-4; Yan ZY, 2006, PHYTOCHEMISTRY, V67, P107, DOI 10.1016/j.phytochem.2005.10.022; Yan ZY, 2005, CHINESE CHEM LETT, V16, P627; Zhao L, 1999, J CHROMATOGR A, V857, P295, DOI 10.1016/S0021-9673(99)00788-8	34	7	7	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2015	10	11							e0140649	10.1371/journal.pone.0140649	http://dx.doi.org/10.1371/journal.pone.0140649			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV1PG	26524073	gold, Green Published, Green Submitted			2022-12-26	WOS:000364029800003
J	Yu, JB; Shi, J; Zhang, Y; Gong, LR; Dong, SA; Cao, XS; Wu, LL; Wu, LN				Yu, Jian-bo; Shi, Jia; Zhang, Yuan; Gong, Li-rong; Dong, Shu-an; Cao, Xin-shun; Wu, Li-li; Wu, Li-na			Electroacupuncture Ameliorates Acute Renal Injury in Lipopolysaccharide-Stimulated Rabbits via Induction of HO-1 through the PI3K/Akt/Nrf2 Pathways	PLOS ONE			English	Article							ACUTE KIDNEY INJURY; ACUTE LUNG INJURY; HEME OXYGENASE-1; ISCHEMIA-REPERFUSION; OXIDATIVE STRESS; LIVER-INJURY; FAILURE; SEPSIS; RATS; CELLS	Electroacupuncture at select acupoints have been verified to protect against organ dysfunctions during endotoxic shock. And, heme oxygenase (HO)-1 as a phase II enzyme and antioxidant contributed to the protection of kidney in septic shock rats. The phosphatidylinositol 3-kinase (PI3K)-Akt pathway mediated the activation of NF-E2 related factor-2 (Nrf2), which was involved in HO-1 induction. To understand the efficacy of electroacupuncture stimulation in ameliorating acute kidney injury (AKI) through the PI3K/Akt/Nrf2 pathway and subsequent HO-1 upregulation, a dose of LPS 5mg/kg was administered intravenously to replicate the rabbit model of AKI induced by endotoxic shock. Electroacupuncture pretreatment was handled bilaterally at Zusanli and Neiguan acupoints for five consecutive days while sham electroacupuncture at non-acupoints as control. Results displayed that electroacupuncture stimulation significantly alleviated the morphologic renal damage, attenuated renal tubular apoptosis, suppressed the elevated biochemical indicators of AKI caused by LPS, enhanced the expressions of phospho-Akt, HO-1protein, Nrf2 total and nucleoprotein, and highlighted the proportions of Nrf2 nucleoprotein as a parallel. Furthermore, partial protective effects of elecroacupuncture were counteracted by preconditioning with wortmannin ( the selective PI3K inhibitor), indicating a direct involvement of PI3K/Akt pathway. Inconsistently, wortmannin pretreatment made little difference to the expressions of HO-1, Nrf2 nucleoprotein and total protein, which indicated that PI3K/Akt may be not the only pathway responsible for electroacupuncture-afforded protection against LPS-induced AKI. These findings provide new insights into the potential future clinical applications of electroacupuncture for AKI induced by endotoxic shock instead of traditional remedies.	[Yu, Jian-bo; Shi, Jia; Zhang, Yuan; Gong, Li-rong; Dong, Shu-an; Cao, Xin-shun; Wu, Li-li; Wu, Li-na] Tianjin Med Univ, Tianjin Nankai Hosp, Dept Anesthesiol, Tianjin, Peoples R China	Tianjin Medical University	Yu, JB (corresponding author), Tianjin Med Univ, Tianjin Nankai Hosp, Dept Anesthesiol, Tianjin, Peoples R China.	yujianbo11@126.com			National Natural Science Foundation of China, Beijing, China [81372096]; Key Projects in the Tianjin Science & Technology Pillar Program, Tianjin, China [12ZCZDSY013300]	National Natural Science Foundation of China, Beijing, China(National Natural Science Foundation of China (NSFC)); Key Projects in the Tianjin Science & Technology Pillar Program, Tianjin, China	Financial support for this research was provided by grant No. 81372096 from the National Natural Science Foundation of China, Beijing, China, and grant No. 12ZCZDSY013300 from the Key Projects in the Tianjin Science & Technology Pillar Program, Tianjin, China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Borovikova LV, 2000, NATURE, V405, P458, DOI 10.1038/35013070; Chen HH, 2012, FREE RADICAL BIO MED, V52, P1054, DOI 10.1016/j.freeradbiomed.2011.12.012; Chen XJ, 2013, RESP PHYSIOL NEUROBI, V188, P214, DOI 10.1016/j.resp.2013.04.014; Chiari PC, 2005, ANESTHESIOLOGY, V102, P102, DOI 10.1097/00000542-200501000-00018; Dear JW, 2006, KIDNEY INT, V69, P832, DOI 10.1038/sj.ki.5000165; Fenhammar J, 2011, ANESTHESIOLOGY, V114, P1130, DOI 10.1097/ALN.0b013e31820b8b44; Ferenbach DA, 2010, MOL THER, V18, P1706, DOI 10.1038/mt.2010.100; Gomez H, 2014, SHOCK, V41, P3, DOI 10.1097/SHK.0000000000000052; HaimovitzFriedman A, 1997, J EXP MED, V186, P1831, DOI 10.1084/jem.186.11.1831; Huang CL, 2007, ANESTH ANALG, V104, P646, DOI 10.1213/01.ane.0000255288.68199.eb; Kang KW, 2002, MOL PHARMACOL, V62, P1001, DOI 10.1124/mol.62.5.1001; Knotek M, 2001, KIDNEY INT, V59, P2243, DOI 10.1046/j.1523-1755.2001.00740.x; Kong XN, 2011, AM J RESP CRIT CARE, V184, P928, DOI 10.1164/rccm.201102-0271OC; Kuwana H, 2008, KIDNEY INT, V73, P430, DOI 10.1038/sj.ki.5002702; Langenberg C, 2014, CRIT CARE MED, V42, pE58, DOI 10.1097/CCM.0b013e3182a639da; Liu HW, 2011, ACUPUNCT MED, V29, P284, DOI 10.1136/aim.2010.003525; LOEWENBERG J. R., 1967, ANAL BIOCHEM, V19, P95, DOI 10.1016/0003-2697(67)90138-8; Lu CY, 2014, BIOCHEM PHARMACOL, V91, P40, DOI 10.1016/j.bcp.2014.06.024; MISRA HP, 1971, J BIOL CHEM, V246, P6886; Nakaso K, 2003, FEBS LETT, V546, P181, DOI 10.1016/S0014-5793(03)00517-9; NATH KA, 1992, J CLIN INVEST, V90, P267, DOI 10.1172/JCI115847; Nath KA, 2014, CURR OPIN NEPHROL HY, V23, P17, DOI 10.1097/01.mnh.0000437613.88158.d3; Nemzek JA, 2004, SHOCK, V21, P17, DOI 10.1097/01.shk.0000101667.49265.fd; OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3; Ozyurt H, 2004, J APPL TOXICOL, V24, P269, DOI 10.1002/jat.983; Ryter SW, 2006, PHYSIOL REV, V86, P583, DOI 10.1152/physrev.00011.2005; Schiffl H, 2012, MOL DIAGN THER, V16, P199, DOI 10.2165/11634310-000000000-00000; Schrier RW, 2004, NEW ENGL J MED, V351, P159, DOI 10.1056/NEJMra032401; Siu FKW, 2004, NEUROSCI LETT, V354, P158, DOI 10.1016/j.neulet.2003.10.009; Song JG, 2012, ANESTHESIOLOGY, V116, P406, DOI 10.1097/ALN.0b013e3182426ebd; Thimmulappa RK, 2006, J CLIN INVEST, V116, P984, DOI 10.1172/JCI25790; Tsai PS, 2006, ANESTHESIOLOGY, V105, P1201, DOI 10.1097/00000542-200612000-00020; Tsao CM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108455; Uchino S, 2005, JAMA-J AM MED ASSOC, V294, P813, DOI 10.1001/jama.294.7.813; Wang K, 2009, ANESTH ANALG, V109, P1666, DOI 10.1213/ANE.0b013e3181b5a234; Wang W, 2007, AM J PHYSIOL-RENAL, V293, pF1131, DOI 10.1152/ajprenal.00212.2007; WELLWOOD JM, 1975, BRIT MED J, V3, P408, DOI 10.1136/bmj.3.5980.408; Williams DL, 2004, J IMMUNOL, V172, P449, DOI 10.4049/jimmunol.172.1.449; Wulfert FM, 2012, ANESTHESIOLOGY, V117, P126, DOI 10.1097/ALN.0b013e31825b57c9; Yap SC, 2012, ANESTHESIOLOGY, V116, P1139, DOI 10.1097/ALN.0b013e31824f951b; Yu JB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104924; Yu JB, 2009, TRANSL RES, V153, P283, DOI 10.1016/j.trsl.2009.01.002; Yu JB, 2013, EXP BIOL MED, V238, P705, DOI 10.1177/1535370213489487; Yu JB, 2013, ANESTH ANALG, V116, P239, DOI 10.1213/ANE.0b013e31826f0a4a; Zhang HX, 2009, CAN J CARDIOL, V25, P359, DOI 10.1016/S0828-282X(09)70095-9; Zhang RX, 2014, ANESTHESIOLOGY, V120, P482, DOI 10.1097/ALN.0000000000000101; Zhao HD, 2010, WORLD J GASTROENTERO, V16, P3002, DOI 10.3748/wjg.v16.i24.3002	47	22	30	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2015	10	11							e0141622	10.1371/journal.pone.0141622	http://dx.doi.org/10.1371/journal.pone.0141622			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV1PG	26524181	Green Submitted, Green Published, gold			2022-12-26	WOS:000364029800016
J	Mohamed, R; Degac, J; Helms, V				Mohamed, Ruzianisra; Degac, Jennifer; Helms, Volkhard			Composition of Overlapping Protein-Protein and Protein-Ligand Interfaces	PLOS ONE			English	Article							STATISTICAL-ANALYSIS; BINDING MOAD; CD-HIT; SITES; DATABASE	Protein-protein interactions (PPIs) play a major role in many biological processes and they represent an important class of targets for therapeutic intervention. However, targeting PPIs is challenging because often no convenient natural substrates are available as starting point for small-molecule design. Here, we explored the characteristics of protein interfaces in five non-redundant datasets of 174 protein-protein (PP) complexes, and 161 protein-ligand (PL) complexes from the ABC database, 436 PP complexes, and 196 PL complexes from the PIBASE database and a dataset of 89 PL complexes from the Timbal database. In all cases, the small molecule ligands must bind at the respective PP interface. We observed similar amino acid frequencies in all three datasets. Remarkably, also the characteristics of PP contacts and overlapping PL contacts are highly similar.	[Mohamed, Ruzianisra; Degac, Jennifer; Helms, Volkhard] Univ Saarland, Ctr Bioinformat, D-66041 Saarbrucken, Germany; [Mohamed, Ruzianisra] Univ Teknol MARA UiTM, Fac Pharm, Dept Pharmaceut Life Sci, Puncak Alam 42300, Selangor, Malaysia	Saarland University; Universiti Teknologi MARA	Helms, V (corresponding author), Univ Saarland, Ctr Bioinformat, Bldg E2 1,POB 151150, D-66041 Saarbrucken, Germany.	volkhard.helms@bioinformatik.uni-saarland.de		Helms, Volkhard/0000-0002-2180-9154	Universiti Teknologi MARA	Universiti Teknologi MARA	RM thanks Universiti Teknologi MARA for a predoctoral scholarship.	Basse MJ, 2013, NUCLEIC ACIDS RES, V41, pD824, DOI 10.1093/nar/gks1002; Benson ML, 2008, NUCLEIC ACIDS RES, V36, pD674, DOI 10.1093/nar/gkm911; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bickerton GR, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-313; Bogan AA, 1998, J MOL BIOL, V280, P1, DOI 10.1006/jmbi.1998.1843; BONDI A, 1964, J PHYS CHEM-US, V68, P441, DOI 10.1021/j100785a001; Chen K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004473; Davis FP, 2005, BIOINFORMATICS, V21, P1901, DOI 10.1093/bioinformatics/bti277; Davis FP, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000668; EISENBERG D, 1982, FARADAY SYMP CHEM S, P109, DOI 10.1039/fs9821700109; Eyrisch S, 2007, J MED CHEM, V50, P3457, DOI 10.1021/jm070095g; Glaser F, 2001, PROTEINS, V43, P89, DOI 10.1002/1097-0134(20010501)43:2<89::AID-PROT1021>3.3.CO;2-8; Hakulinen R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049216; Higueruelo AP, 2013, DATABASE-OXFORD, DOI 10.1093/database/bat039; Higueruelo AP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051742; Holland RCG, 2008, BIOINFORMATICS, V24, P2096, DOI 10.1093/bioinformatics/btn397; Hu LG, 2005, PROTEINS, V60, P333, DOI 10.1002/prot.20512; Huang Y, 2010, BIOINFORMATICS, V26, P680, DOI 10.1093/bioinformatics/btq003; Hubbard S, 1996, V2 1 1; Janin J, 2008, Q REV BIOPHYS, V41, P133, DOI 10.1017/S0033583508004708; Jin LY, 2014, ANNU REV PHARMACOL, V54, P435, DOI 10.1146/annurev-pharmtox-011613-140028; Jones S, 1997, J MOL BIOL, V272, P121, DOI 10.1006/jmbi.1997.1234; Jones S, 1996, P NATL ACAD SCI USA, V93, P13, DOI 10.1073/pnas.93.1.13; Jones S, 2001, NUCLEIC ACIDS RES, V29, P943, DOI 10.1093/nar/29.4.943; Jones S, 2000, PROTEIN ENG, V13, P77, DOI 10.1093/protein/13.2.77; Keskin O, 2007, STRUCTURE, V15, P341, DOI 10.1016/j.str.2007.01.007; Koes DR, 2012, BIOINFORMATICS, V28, P784, DOI 10.1093/bioinformatics/btr717; Lejeune D, 2005, PROTEINS, V61, P258, DOI 10.1002/prot.20607; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; McCoy AJ, 1997, J MOL BIOL, V268, P570, DOI 10.1006/jmbi.1997.0987; Nooren IMA, 2003, J MOL BIOL, V325, P991, DOI 10.1016/S0022-2836(02)01281-0; Ofran Y, 2003, J MOL BIOL, V325, P377, DOI 10.1016/S0022-2836(02)01223-8; Petrescu AJ, 2004, GLYCOBIOLOGY, V14, P103, DOI 10.1093/glycob/cwh008; Sheinerman FB, 2000, CURR OPIN STRUC BIOL, V10, P153, DOI 10.1016/S0959-440X(00)00065-8; Talavera D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021053; Walter P, 2007, J INTEGR BIOINFORMAT, V4; Walter P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058583; Yan C, 2008, PROTEIN J, V27, P59, DOI 10.1007/s10930-007-9108-x	38	9	9	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2015	10	10							e0140965	10.1371/journal.pone.0140965	http://dx.doi.org/10.1371/journal.pone.0140965			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0EH	26517868	gold, Green Published, Green Submitted			2022-12-26	WOS:000363920800014
J	Olivieri, A; Gandini, F; Achilli, A; Fichera, A; Rizzi, E; Bonfiglio, S; Battaglia, V; Brandini, S; De Gaetano, A; El-Beltagi, A; Lancioni, H; Agha, S; Semino, O; Ferretti, L; Torroni, A				Olivieri, Anna; Gandini, Francesca; Achilli, Alessandro; Fichera, Alessandro; Rizzi, Ermanno; Bonfiglio, Silvia; Battaglia, Vincenza; Brandini, Stefania; De Gaetano, Anna; El-Beltagi, Ahmed; Lancioni, Hovirag; Agha, Saif; Semino, Ornella; Ferretti, Luca; Torroni, Antonio			Mitogenomes from Egyptian Cattle Breeds: New Clues on the Origin of Haplogroup Q and the Early Spread of Bos taurus from the Near East	PLOS ONE			English	Article							COMPLETE MITOCHONDRIAL GENOME; ANCIENT DNA; DOMESTIC CATTLE; EUROPEAN CATTLE; GENETIC-EVIDENCE; MTDNA VARIATION; CHINESE CATTLE; AUROCHS; EXPANSION; SEQUENCE	Background Genetic studies support the scenario that Bos taurus domestication occurred in the Near East during the Neolithic transition about 10 thousand years (ky) ago, with the likely exception of a minor secondary event in Italy. However, despite the proven effectiveness of whole mitochondrial genome data in providing valuable information concerning the origin of taurine cattle, until now no population surveys have been carried out at the level of mitogenomes in local breeds from the Near East or surrounding areas. Egypt is in close geographic and cultural proximity to the Near East, in particular the Nile Delta region, and was one of the first neighboring areas to adopt the Neolithic package. Thus, a survey of mitogenome variation of autochthonous taurine breeds from the Nile Delta region might provide new insights on the early spread of cattle rearing outside the Near East. Methodology Using Illumina high-throughput sequencing we characterized the mitogenomes from two cattle breeds, Menofi (N = 17) and Domiaty (N = 14), from the Nile Delta region. Phylogenetic and Bayesian analyses were subsequently performed. Conclusions Phylogenetic analyses of the 31 mitogenomes confirmed the prevalence of haplogroup T1, similar to most African cattle breeds, but showed also high frequencies for haplogroups T2, T3 and Q1, and an extremely high haplotype diversity, while Bayesian skyline plots pointed to a main episode of population growth similar to 12.5 ky ago. Comparisons of Nile Delta mitogenomes with those from other geographic areas revealed that (i) most Egyptian mtDNAs are probably direct local derivatives from the founder domestic herds which first arrived from the Near East and the extent of gene flow from and towards the Nile Delta region was limited after the initial founding event(s); (ii) haplogroup Q1 was among these founders, thus proving that it underwent domestication in the Near East together with the founders of the T clades.	[Olivieri, Anna; Gandini, Francesca; Achilli, Alessandro; Fichera, Alessandro; Bonfiglio, Silvia; Battaglia, Vincenza; Brandini, Stefania; De Gaetano, Anna; Semino, Ornella; Ferretti, Luca; Torroni, Antonio] Univ Pavia, Dipartimento Biol & Biotecnol L Spallanzani, I-27100 Pavia, Italy; [Gandini, Francesca] Univ Huddersfield, Sch Appl Sci, Huddersfield HD1 3DH, W Yorkshire, England; [Achilli, Alessandro; Lancioni, Hovirag] Univ Perugia, Dipartimento Chim Biol & Biotecnol, I-06100 Perugia, Italy; [Rizzi, Ermanno] CNR, Ist Tecnol Biomed, Segrate, Milano, Italy; [Rizzi, Ermanno] Fdn Telethon, Milan, Italy; [El-Beltagi, Ahmed] Minist Agr, APRI, Cairo, Egypt; [Agha, Saif] Ain Shams Univ, Fac Agr, Dept Anim Prod, Cairo, Egypt	University of Pavia; University of Huddersfield; University of Perugia; Consiglio Nazionale delle Ricerche (CNR); Istituto di Tecnologie Biomediche (ITB-CNR); Fondazione Telethon; Ministry of Agriculture & Land Reclamation - Egypt; Egyptian Knowledge Bank (EKB); Ain Shams University	Olivieri, A (corresponding author), Univ Pavia, Dipartimento Biol & Biotecnol L Spallanzani, Via Palestro 3, I-27100 Pavia, Italy.	anna.olivieri@unipv.it	Torroni, Antonio/E-1557-2011; Battaglia, Vincenza/F-6950-2017; Achilli, Alessandro/I-9236-2012; rizzi, ermanno/Q-3399-2016; Gandini, Francesca/H-8936-2015; OLIVIERI, ANNA/I-9235-2012; De Gaetano, Anna/GWC-1521-2022; Bonfiglio, Silvia/AAC-1988-2019; Lancioni, Hovirag/F-9067-2014	Torroni, Antonio/0000-0002-4163-4478; Achilli, Alessandro/0000-0001-6871-3451; rizzi, ermanno/0000-0002-9898-2326; Gandini, Francesca/0000-0001-8930-8295; OLIVIERI, ANNA/0000-0002-3941-8098; Brandini, Stefania/0000-0001-6357-1554; Agha, Saif/0000-0003-3373-146X; Elbeltagy, Ahmed/0000-0001-6000-5290; Lancioni, Hovirag/0000-0001-5514-1853; Ferretti, Luca/0000-0001-5044-8442; Bonfiglio, Silvia/0000-0002-4422-1580	Italian Ministry of Education, University and Research: Progetti Futuro in Ricerca [RBFR126B8I]; Progetti Ricerca Interesse Nazionale [2012JA4BTY]; University of Pavia strategic theme "Towards a governance model for international migration: an interdisciplinary and diachronic perspective"(MIGRAT-IN-G); University of Huddersfield's University Research Fund	Italian Ministry of Education, University and Research: Progetti Futuro in Ricerca(Ministry of Education, Universities and Research (MIUR)); Progetti Ricerca Interesse Nazionale(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); University of Pavia strategic theme "Towards a governance model for international migration: an interdisciplinary and diachronic perspective"(MIGRAT-IN-G); University of Huddersfield's University Research Fund	This work was supported by the Italian Ministry of Education, University and Research: Progetti Futuro in Ricerca 2012 (RBFR126B8I) (to AA, AO, and ER) and Progetti Ricerca Interesse Nazionale 2012 (2012JA4BTY) (to AA, AT, and OS); by the University of Pavia strategic theme "Towards a governance model for international migration: an interdisciplinary and diachronic perspective"(MIGRAT-IN-G). FG was supported by the University of Huddersfield's University Research Fund.	Achilli A, 2008, CURR BIOL, V18, pR157, DOI 10.1016/j.cub.2008.01.019; Achilli A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005753; Ajmone-Marsan P, 2010, EVOL ANTHROPOL, V19, P148, DOI 10.1002/evan.20267; ANDERSON S, 1982, J MOL BIOL, V156, P683, DOI 10.1016/0022-2836(82)90137-1; Anderung C, 2005, P NATL ACAD SCI USA, V102, P8431, DOI 10.1073/pnas.0503396102; Bailey JF, 1996, P ROY SOC B-BIOL SCI, V263, P1467, DOI 10.1098/rspb.1996.0214; Beja-Pereira A, 2006, P NATL ACAD SCI USA, V103, P8113, DOI 10.1073/pnas.0509210103; Bollongino R, 2006, BIOL LETTERS, V2, P155, DOI 10.1098/rsbl.2005.0404; Bollongino R, 2012, MOL BIOL EVOL, V29, P2101, DOI 10.1093/molbev/mss092; Bonfiglio S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038601; Bonfiglio S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015760; Cai DW, 2014, J ARCHAEOL SCI, V41, P423, DOI 10.1016/j.jas.2013.09.003; Chen SY, 2010, MOL BIOL EVOL, V27, P1, DOI 10.1093/molbev/msp213; Colominas L, 2015, J ARCHAEOL SCI, V59, P110, DOI 10.1016/j.jas.2015.04.014; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Edwards CJ, 2007, P ROY SOC B-BIOL SCI, V274, P1377, DOI 10.1098/rspb.2007.0020; Edwards CJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009255; Forster P, 1996, AM J HUM GENET, V59, P935; Gibbs RA, 2009, SCIENCE, V324, P528, DOI 10.1126/science.1167936; Hanotte O, 2002, SCIENCE, V296, P336, DOI 10.1126/science.1069878; Helmer D, 2005, 1 STEPS ANIMAL DOMES; Horsburgh KA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071956; Lai SJ, 2006, MOL PHYLOGENET EVOL, V38, P146, DOI 10.1016/j.ympev.2005.06.013; Lari M, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-32; Lei CZ, 2006, ANIM GENET, V37, P579, DOI 10.1111/j.1365-2052.2006.01524.x; Lenstra J. A., 2014, Diversity, V6, P178, DOI 10.3390/d6010178; Mannen H, 2004, MOL PHYLOGENET EVOL, V32, P539, DOI 10.1016/j.ympev.2004.01.010; Maule JP, REPORT TECHNICAL C D; McTavish EJ, 2013, P NATL ACAD SCI USA, V110, pE1398, DOI 10.1073/pnas.1303367110; Mona S, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-83; Niemi M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123821; Pellecchia M, 2007, P R SOC B, V274, P1175, DOI 10.1098/rspb.2006.0258; Robb JE, 2005, BLACKW STUD GLOB ARC, V6, P24, DOI 10.1002/9780470773536.ch2; Saillard J, 2000, AM J HUM GENET, V67, P718, DOI 10.1086/303038; Salim B, 2014, ANIM GENET, V45, P782, DOI 10.1111/age.12225; Scheu A, 2015, BMC GENET, V16, DOI 10.1186/s12863-015-0203-2; Schibler J, 2014, SCI REP-UK, V4, DOI 10.1038/srep05798; Soares P, 2012, MOL BIOL EVOL, V29, P915, DOI 10.1093/molbev/msr245; Soares P, 2009, AM J HUM GENET, V84, P740, DOI 10.1016/j.ajhg.2009.05.001; Stock F, 2009, ANIM GENET, V40, P694, DOI 10.1111/j.1365-2052.2009.01905.x; Troy CS, 2001, NATURE, V410, P1088, DOI 10.1038/35074088; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Zeder MA, 2008, P NATL ACAD SCI USA, V105, P11597, DOI 10.1073/pnas.0801317105; Zeder MA, 2009, J ARCHAEOL RES, V17, P1, DOI 10.1007/s10814-008-9025-3; Zeyland J, 2013, POL J VET SCI, V16, P265, DOI 10.2478/pjvs-2013-0037; Zhang HC, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3755	47	31	34	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2015	10	10							e0141170	10.1371/journal.pone.0141170	http://dx.doi.org/10.1371/journal.pone.0141170			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0ED	26513361	Green Published, Green Accepted, Green Submitted, gold			2022-12-26	WOS:000363920300022
J	Fiorucci, S; Lin, XC; Sadoul, K; Fournet, G; Bouvard, D; Vinogradova, O; Joseph, B; Block, MR				Fiorucci, Sandrine; Lin, Xiaochen; Sadoul, Karin; Fournet, Guy; Bouvard, Daniel; Vinogradova, Olga; Joseph, Benoit; Block, Marc R.			Targeting Integrin-Dependent Adhesion and Signaling with 3-Arylquinoline and 3-Aryl-2-Quinolone Derivatives: A new Class of Integrin Antagonists	PLOS ONE			English	Article							TYROSINE PHOSPHORYLATION; PLATELET ACTIVATION; THERAPEUTIC TARGETS; STRUCTURAL BASIS; IN-VITRO; BINDING; KINDLIN-2; TALIN; PROTEIN; MECHANISM	We previously reported the anti-migratory function of 3-aryl-2-quinolone derivatives, chemically close to flavonoids (Joseph et al., 2002). Herein we show that 3-arylquinoline or 3-aryl-2-quinolone derivatives disrupt cell adhesion in a dose dependent and reversible manner yet antagonized by artificial integrin activation such as manganese. Relying on this anti-adhesive activity, a Structure-Activity Relationship (SAR) study was established on 20 different compounds to throw the bases of future optimization strategies. Active drugs efficiently inhibit platelet spreading, aggregation, and clot retraction, processes that rely on alpha(llb)beta(3) integrin activation and clustering. In vitro these derivatives interfere with beta(3) cytoplasmic tail interaction with kindlin-2 in pulldown assays albeit little effect was observed with pure proteins suggesting that the drugs may block an alternative integrin activation process that may not be directly related to kindlin recruitment. Ex vivo, these drugs blunt integrin signaling assayed using focal adhesion kinase auto-phosphorylation as a read-out. Hence, 3-arylquinoline and 3-aryl-2-quinolone series are a novel class of integrin activation and signaling antagonists.	[Fiorucci, Sandrine; Sadoul, Karin; Bouvard, Daniel; Block, Marc R.] Univ Grenoble Alpes, Grenoble, France; [Fiorucci, Sandrine; Sadoul, Karin; Bouvard, Daniel; Block, Marc R.] INSERM, U823, Ctr Rech, Grenoble, France; [Lin, Xiaochen; Vinogradova, Olga] Univ Connecticut, Storrs, CT USA; [Fournet, Guy; Joseph, Benoit] Univ Lyon 1, F-69365 Lyon, France	Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Institut National de la Sante et de la Recherche Medicale (Inserm); University of Connecticut; UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Block, MR (corresponding author), Univ Grenoble Alpes, Grenoble, France.	marc.block@ujf-grenoble.fr	Bouvard, Daniel/B-1260-2017; Vinogradova, Olga/ABE-8367-2020; Block, Marc R/M-2740-2013; Joseph, Benoit/AAO-2480-2020; Sadoul, Karin/N-2649-2013	Bouvard, Daniel/0000-0002-0845-6681; Vinogradova, Olga/0000-0001-5101-7361; Block, Marc R/0000-0003-2214-9706; Sadoul, Karin/0000-0001-7174-5016; joseph, benoit/0000-0002-3932-8041	Fondation ARC; INSERM; CNRS; Universite Grenoble Alpes	Fondation ARC; INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); CNRS(Centre National de la Recherche Scientifique (CNRS)); Universite Grenoble Alpes	This work was supported by Fondation ARC, INSERM, CNRS, and Universite Grenoble Alpes. CNRS and Fondation ARC gave a fellowship to SF. INSERM gave bench fees.	Armstrong PC, 2012, THROMB HAEMOSTASIS, V107, P808, DOI 10.1160/TH11-10-0727; Bledzka K, 2012, J BIOL CHEM, V287, P24585, DOI 10.1074/jbc.M111.336743; Bouvard D, 2013, NAT REV MOL CELL BIO, V14, P430, DOI 10.1038/nrm3599; Brunner M, 2011, J CELL BIOL, V194, P307, DOI 10.1083/jcb.201007108; Calderwood DA, 2002, J BIOL CHEM, V277, P21749, DOI 10.1074/jbc.M111996200; Calderwood DA, 2013, NAT REV MOL CELL BIO, V14, P503, DOI 10.1038/nrm3624; Cox D, 2010, NAT REV DRUG DISCOV, V9, P804, DOI 10.1038/nrd3266; Critchley DR, 2008, J CELL SCI, V121, P1345, DOI 10.1242/jcs.018085; Desgrosellier JS, 2010, NAT REV CANCER, V10, P9, DOI 10.1038/nrc2748; Deshmukh L, 2011, J BIOL CHEM, V286, P40943, DOI 10.1074/jbc.M111.231951; ENGVALL E, 1977, INT J CANCER, V20, P1, DOI 10.1002/ijc.2910200102; Evans R, 2009, J CELL SCI, V122, P215, DOI 10.1242/jcs.019117; Fukuda K, 2014, J BIOL CHEM, V289, P28363, DOI 10.1074/jbc.M114.596692; Goodman SL, 2012, TRENDS PHARMACOL SCI, V33, P405, DOI 10.1016/j.tips.2012.04.002; Huet-Calderwood C, 2014, J CELL SCI, V127, P4308, DOI 10.1242/jcs.155879; Joseph B, 2002, J MED CHEM, V45, P2543, DOI 10.1021/jm010978m; Juliano RL, 2001, METHOD ENZYMOL, V333, P151; Kanda R, 2013, CANCER RES, V73, P6243, DOI 10.1158/0008-5472.CAN-12-4502; Karakose E, 2010, J CELL SCI, V123, P2353, DOI 10.1242/jcs.064600; Kasirer-Friede A, 2014, BLOOD, V123, P3156, DOI 10.1182/blood-2013-08-520627; KORNBERG LJ, 1991, P NATL ACAD SCI USA, V88, P8392, DOI 10.1073/pnas.88.19.8392; Kovacs M, 2004, J BIOL CHEM, V279, P35557, DOI 10.1074/jbc.M405319200; Kumar MS, 2009, GENE DEV, V23, P2700, DOI 10.1101/gad.1848209; Kummer C, 2010, J BIOL CHEM, V285, P9462, DOI 10.1074/jbc.M109.066993; Legler DF, 2001, J CELL SCI, V114, P1545; Liu JM, 2011, J BIOL CHEM, V286, P43334, DOI 10.1074/jbc.M111.295352; Ma YQ, 2008, J CELL BIOL, V181, P439, DOI 10.1083/jcb.200710196; Major EO, 2010, ANNU REV MED, V61, P35, DOI 10.1146/annurev.med.080708.082655; Montanez E, 2008, GENE DEV, V22, P1325, DOI 10.1101/gad.469408; Mousa SA, 2002, CURR OPIN CHEM BIOL, V6, P534, DOI 10.1016/S1367-5931(02)00350-2; Nieswandt B, 2009, J THROMB HAEMOST, V7, P206, DOI 10.1111/j.1538-7836.2009.03370.x; Nieswandt B, 2001, EMBO J, V20, P2120, DOI 10.1093/emboj/20.9.2120; Niu G, 2011, THERANOSTICS, V1, P30, DOI 10.7150/thno/v01p0030; Rantala JK, 2011, NAT CELL BIOL, V13, P1315, DOI 10.1038/ncb2340; Reynolds AR, 2009, NAT MED, V15, P392, DOI 10.1038/nm.1941; Ridley AJ, 2011, CELL, V145, P1012, DOI 10.1016/j.cell.2011.06.010; Sadoul K, 2012, BLOOD, V120, P4215, DOI 10.1182/blood-2012-05-428011; Seguin L, 2014, NAT CELL BIOL, V16, P457, DOI 10.1038/ncb2953; Sheldrake HM, 2014, J MED CHEM, V57, P6301, DOI 10.1021/jm5000547; Shen B, 2013, NATURE, V503, P131, DOI 10.1038/nature12613; Shi XH, 2007, J BIOL CHEM, V282, P20455, DOI 10.1074/jbc.M611680200; Silva R, 2008, ARTERIOSCL THROM VAS, V28, P1703, DOI 10.1161/ATVBAHA.108.172015; Vinogradova O, 2002, CELL, V110, P587, DOI 10.1016/S0092-8674(02)00906-6; Wegener KL, 2007, CELL, V128, P171, DOI 10.1016/j.cell.2006.10.048; Ye F, 2013, CURR BIOL, V23, P2288, DOI 10.1016/j.cub.2013.09.050	45	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2015	10	10							e0141205	10.1371/journal.pone.0141205	http://dx.doi.org/10.1371/journal.pone.0141205			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0DL	26509443	Green Published, Green Submitted, gold			2022-12-26	WOS:000363918100061
J	Zhang, T; Chaturvedi, V; Chaturvedi, S				Zhang, Tao; Chaturvedi, Vishnu; Chaturvedi, Sudha			Novel Trichoderma polysporum Strain for the Biocontrol of Pseudogymnoascus destructans, the Fungal Etiologic Agent of Bat White Nose Syndrome	PLOS ONE			English	Article							EX PERS RIFAI; BIOLOGICAL-CONTROL; GEOMYCES-DESTRUCTANS; STRUCTURAL ELUCIDATION; EMERGING DISEASE; PLANT-DISEASES; MECHANISMS; SEQUENCE; DNA; PEPTAIBOLS	White-nose syndrome (WNS), an emerging disease of hibernating bats, has rapidly spread across eastern North America killing millions of bats. Pseudogymnoascus destructans (Pd), the sole etiologic agent of WNS, is widespread and persistent in bat hibernacula. Control of Pd in the affected sites is urgently needed to break the transmission cycle while minimizing any adverse impact on the native organisms. We isolated a novel strain of Trichoderma polysporum (Tp) from one of the caves at the epicenter of WNS zoonotic. Detailed experimental studies revealed: (1) Tp WPM 39143 was highly adapted to grow at temperatures simulating the cave environment (6 degrees C-15 degrees C), (2) Tp WPM 39143 restricted Pd colony growth in dual culture challenges, (3) Tp WPM 39143 caused four logs reduction of Pd colony forming units and genome copies in autoclaved soil samples from one of the WNS affected caves, (4) Tp WPM 39143 extract showed specific fungicidal activity against Pd in disk diffusion assay, but not against closely related fungus P. pannorum (Pp), (5) Tp WPM 39143 extract retained inhibitory activity after exposure to high temperatures, light and proteinase K, and (6) Inhibitory metabolites in Tp WPM 39143 extract comprised of water-soluble, high polarity compounds. These results suggest that Tp WPM 39143 is a promising candidate for further evaluation as a biocontrol agent of Pd in WNS affected sites.	[Zhang, Tao; Chaturvedi, Vishnu; Chaturvedi, Sudha] New York State Dept Hlth, Wadsworth Ctr, Mycol Lab, Albany, NY 12237 USA; [Chaturvedi, Vishnu; Chaturvedi, Sudha] Univ Albany, Sch Publ Hlth, Dept Biomed Sci, Albany, NY USA	State University of New York (SUNY) System; Wadsworth Center; State University of New York (SUNY) System; State University of New York (SUNY) Albany	Chaturvedi, S (corresponding author), New York State Dept Hlth, Wadsworth Ctr, Mycol Lab, Albany, NY 12237 USA.	sudha.chaturvedi@health.ny.gov		Chaturvedi, Vishnu/0000-0002-3922-9676	Fish and Wildlife Service [F12AP01167]; National Science Foundation [000600793]; Wadsworth Center State Purpose Activities	Fish and Wildlife Service(US Fish & Wildlife Service); National Science Foundation(National Science Foundation (NSF)); Wadsworth Center State Purpose Activities	This study was partly supported with funds from Fish and Wildlife Service (F12AP01167), the National Science Foundation (000600793) to V.C. and S.C., and Wadsworth Center State Purpose Activities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alabouvette C, 2006, EUR J PLANT PATHOL, V114, P329, DOI 10.1007/s10658-005-0233-0; Antal Z, 2000, MYCOL RES, V104, P545, DOI 10.1017/S0953756299001653; Bandouchova H, 2015, TRANSBOUND EMERG DIS, V62, P1, DOI 10.1111/tbed.12282; Benitez T, 2004, INT MICROBIOL, V7, P249; Blehert DS, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002779; Blehert DS, 2009, SCIENCE, V323, P227, DOI 10.1126/science.1163874; Buck JC, 2011, BIODIVERS CONSERV, V20, P3549, DOI 10.1007/s10531-011-0147-4; Chaturvedi S, 2011, MYCOPATHOLOGIA, V172, P247, DOI 10.1007/s11046-011-9435-5; Chaturvedi V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010783; Chibucos MC, 2013, GENOME ANNOUNCEMENTS, V1, DOI 10.1128/genomeA.01045-13; Cloyd RA, 2007, J ECON ENTOMOL, V100, P1353, DOI 10.1603/0022-0493(2007)100[1353:EODEAT]2.0.CO;2; Cornelison CT, 2014, BMC MICROBIOL, V14, DOI 10.1186/s12866-014-0246-y; Cornelison CT, 2014, MYCOPATHOLOGIA, V177, P1, DOI 10.1007/s11046-013-9716-2; Cryan PM, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-135; DONNELLY DMX, 1986, PHYTOCHEMISTRY, V25, P2303, DOI 10.1016/S0031-9422(00)81684-2; Driscoll AJ, 2012, CLIN INFECT DIS, V54, pS159, DOI 10.1093/cid/cir1061; DUMAS MT, 1992, EUR J FOREST PATHOL, V22, P379; Eziashi EI, 2010, AFR J AGR RES, V5, P1733; Fravel DR, 2005, ANNU REV PHYTOPATHOL, V43, P337, DOI 10.1146/annurev.phyto.43.032904.092924; Frick WF, 2010, SCIENCE, V329, P679, DOI 10.1126/science.1188594; FUJITA T, 1988, J ANTIBIOT, V41, P814, DOI 10.7164/antibiotics.41.814; FUJITA T, 1984, CHEM PHARM BULL, V32, P4419; Ganley ARD, 2007, GENOME RES, V17, P184, DOI 10.1101/gr.5457707; Gupta V., 2013, OCTA J BIOSCI, V1, P151; Harman GE, 2004, NAT REV MICROBIOL, V2, P43, DOI 10.1038/nrmicro797; Hermosa MR, 2000, APPL ENVIRON MICROB, V66, P1890, DOI 10.1128/AEM.66.5.1890-1898.2000; Howell CR, 2006, PHYTOPATHOLOGY, V96, P178, DOI 10.1094/PHYTO-96-0178; Howell CR, 2003, PLANT DIS, V87, P4, DOI 10.1094/PDIS.2003.87.1.4; Hoyt JR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121329; Hudec K., 2000, Acta Fytotechnica et Zootechnica, V3, P98; Jones T, 2004, P NATL ACAD SCI USA, V101, P7329, DOI 10.1073/pnas.0401648101; Katoh K, 2009, METHODS MOL BIOL, V537, P39, DOI 10.1007/978-1-59745-251-9_3; Kirk P., 2008, Ainsworth and Bisby�s Dictionary of the Fungi, DOI 10.1079/9780851998268.0000; Kredics L, 2003, FOOD TECHNOL BIOTECH, V41, P37; Leopardi S, 2015, CURR BIOL, V25, pR217, DOI 10.1016/j.cub.2015.01.047; Lindner DL, 2011, MYCOLOGIA, V103, P241, DOI 10.3852/10-262; Longa CMO, 2009, J APPL MICROBIOL, V106, P1549, DOI 10.1111/j.1365-2672.2008.04117.x; Lorch JM, 2013, APPL ENVIRON MICROB, V79, P1293, DOI 10.1128/AEM.02939-12; MOLLER EM, 1992, NUCLEIC ACIDS RES, V20, P6115, DOI 10.1093/nar/20.22.6115; Mukherjee PK, 1997, MYCOPATHOLOGIA, V139, P151, DOI 10.1023/A:1006868009184; Muller LK, 2013, MYCOLOGIA, V105, P253, DOI 10.3852/12-242; New AP, 1996, TETRAHEDRON LETT, V37, P3039, DOI 10.1016/0040-4039(96)00463-7; O'Regan SM, 2015, ECOL APPL, V25, P621, DOI 10.1890/14-0417.1; PAPAVIZAS GC, 1985, ANNU REV PHYTOPATHOL, V23, P23, DOI 10.1146/annurev.py.23.090185.000323; Perry RW, 2013, ENVIRON REV, V21, P28, DOI 10.1139/er-2012-0042; Puechmaille SJ, 2011, TRENDS ECOL EVOL, V26, P570, DOI 10.1016/j.tree.2011.06.013; Puechmaille SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019167; Punja ZK, 2003, TRENDS BIOTECHNOL, V21, P400, DOI 10.1016/S0167-7799(03)00193-8; Rajkumar SS, 2011, EMERG INFECT DIS, V17, P1273, DOI 10.3201/eid1707.102056; Reeder DM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038920; Ren P, 2012, EMERG INFECT DIS, V18, P883, DOI 10.3201/eid1805.111711; RUEGGER A, 1976, HELV CHIM ACTA, V59, P1075, DOI 10.1002/hlca.19760590412; Searle CL, 2013, ECOL EVOL, V3, P4129, DOI 10.1002/ece3.777; Shuey MM, 2014, APPL ENVIRON MICROB, V80, P1726, DOI 10.1128/AEM.02897-13; Szekeres A., 2005, Acta Microbiologica et Immunologica Hungarica, V52, P137, DOI 10.1556/AMicr.52.2005.2.2; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tojo M, 2012, FUNGAL ECOL, V5, P395, DOI 10.1016/j.funeco.2012.01.003; Toniolo C, 2001, CELL MOL LIFE SCI, V58, P1179, DOI 10.1007/PL00000932; TRABER R, 1977, HELV CHIM ACTA, V60, P1568, DOI 10.1002/hlca.19770600513; Turner Gregory G., 2009, Bat Research News, V50, P47; Veilleux Jacques Pierre, 2008, Bat Research News, V49, P15; Wang QX, 2011, FITOTERAPIA, V82, P777, DOI 10.1016/j.fitote.2011.04.002; Warnecke L, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2013.0177; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315; Yamazaki Y, 2011, FUNGAL ECOL, V4, P15, DOI 10.1016/j.funeco.2010.06.002; Yedidia I, 1999, APPL ENVIRON MICROB, V65, P1061; Zhang T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108714	68	16	17	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2015	10	10							e0141316	10.1371/journal.pone.0141316	http://dx.doi.org/10.1371/journal.pone.0141316			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0DL	26509269	Green Submitted, Green Published, gold			2022-12-26	WOS:000363918100070
J	Becares, L; Priest, N				Becares, Laia; Priest, Naomi			Understanding the Influence of Race/Ethnicity, Gender, and Class on Inequalities in Academic and Non-Academic Outcomes among Eighth-Grade Students: Findings from an Intersectionality Approach	PLOS ONE			English	Article							RACIAL-ETHNIC DIFFERENCES; RACIAL/ETHNIC DIFFERENCES; STEREOTYPE THREAT; EDUCATIONAL ASPIRATIONS; ECONOMIC DEPRIVATION; SOCIOECONOMIC-STATUS; BEHAVIOR PROBLEMS; REPORTED RACISM; UNITED-STATES; RISK-FACTORS	Socioeconomic, racial/ethnic, and gender inequalities in academic achievement have been widely reported in the US, but how these three axes of inequality intersect to determine academic and non-academic outcomes among school-aged children is not well understood. Using data from the US Early Childhood Longitudinal Study-Kindergarten (ECLS-K; N = 10,115), we apply an intersectionality approach to examine inequalities across eighth-grade outcomes at the intersection of six racial/ethnic and gender groups (Latino girls and boys, Black girls and boys, and White girls and boys) and four classes of socioeconomic advantage/disadvantage. Results of mixture models show large inequalities in socioemotional outcomes (internalizing behavior, locus of control, and self-concept) across classes of advantage/disadvantage. Within classes of advantage/disadvantage, racial/ethnic and gender inequalities are predominantly found in the most advantaged class, where Black boys and girls, and Latina girls, underperform White boys in academic assessments, but not in socioemotional outcomes. In these latter outcomes, Black boys and girls perform better than White boys. Latino boys show small differences as compared to White boys, mainly in science assessments. The contrasting outcomes between racial/ethnic and gender minorities in self-assessment and socioemotional outcomes, as compared to standardized assessments, highlight the detrimental effect that intersecting racial/ethnic and gender discrimination have in patterning academic outcomes that predict success in adult life. Interventions to eliminate achievement gaps cannot fully succeed as long as social stratification caused by gender and racial discrimination is not addressed.	[Becares, Laia] Univ Manchester, Dept Social Stat, Ctr Dynam Ethn, Manchester, Lancs, England; [Priest, Naomi] Australian Natl Univ, Acton, Australia	University of Manchester; Australian National University	Becares, L (corresponding author), Univ Manchester, Dept Social Stat, Ctr Dynam Ethn, Manchester, Lancs, England.	laia.becares@manchester.ac.uk	Becares, Laia/J-6027-2015	Becares, Laia/0000-0002-4207-074X	ESRC [ES/K001582/1]; Hallsworth Research Fellowship; ESRC [ES/K002198/1] Funding Source: UKRI; Economic and Social Research Council [ES/K002198/1, ES/K001582/1] Funding Source: researchfish	ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Hallsworth Research Fellowship; ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	This work was funded by an ESRC grant (ES/K001582/1) and a Hallsworth Research Fellowship to LB.	Ainsworth JW, 2002, SOC FORCES, V81, P117, DOI 10.1353/sof.2002.0038; Ainsworth-Darnell JW, 1998, AM SOCIOL REV, V63, P536, DOI 10.2307/2657266; Asparouhov T., 2021, AUXILIARY VARIABLES, DOI [10.1080/10705511.2014.915181, DOI 10.1080/10705511.2014.919210]; Bauer GR, 2014, SOC SCI MED, V110, P10, DOI 10.1016/j.socscimed.2014.03.022; BLAU FD, 1994, AM ECON REV, V84, P23; Braveman PA, 2010, AM J PUBLIC HEALTH, V100, pS186, DOI 10.2105/AJPH.2009.166082; BrooksGunn J, 1996, CHILD DEV, V67, P396; BROOKSGUNN J, 1993, AM J SOCIOL, V99, P353, DOI 10.1086/230268; Browne I, 2003, ANNU REV SOCIOL, V29, P487, DOI 10.1146/annurev.soc.29.010202.100016; CATSAMBIS S, 1995, J RES SCI TEACH, V32, P243, DOI 10.1002/tea.3660320305; CATSAMBIS S, 1994, SOCIOL EDUC, V67, P199, DOI 10.2307/2112791; Celeux G, 1996, J CLASSIF, V13, P195, DOI 10.1007/BF01246098; Cheng S, 2002, SOCIOL EDUC, V75, P306, DOI 10.2307/3090281; CICCHETTI D, 1993, DEV REV, V13, P471, DOI 10.1006/drev.1993.1021; Coley R, 2001, DIFFERENCES GENDER G; Cormier, 2009, INTERSECTIONALITY MO; Cotter DA, 1999, SOC FORCES, V78, P433, DOI 10.2307/3005563; Crenshaw K., 1989, UNIV CHICAGO LEG FOR, V1989, P139; Cvencek D, 2011, CHILD DEV, V82, P766, DOI 10.1111/j.1467-8624.2010.01529.x; Dayton C. M., 1998, LATENT CLASS SCALING; Dhamoon RK, 2011, HEALTH INEQUITIES IN CANADA: INTERSECTIONAL FRAMEWORKS AND PRACTICES, P16; Duncan GJ, 2005, FUTURE CHILD, V15, P35, DOI 10.1353/foc.2005.0004; DUNCAN GJ, 1994, CHILD DEV, V65, P296, DOI 10.1111/j.1467-8624.1994.tb00752.x; ECCLES JS, 1987, PSYCHOL WOMEN QUART, V11, P135, DOI 10.1111/j.1471-6402.1987.tb00781.x; Ennis S. R., 2011, HISPANIC POPULATION; Entwisle DR, 2007, SOCIOL EDUC, V80, P114, DOI 10.1177/003804070708000202; Fagg J, SOCIAL SCI MED, V63, P636; Fiske ST, 2012, ANN AM ACAD POLIT SS, V639, P33, DOI 10.1177/0002716211418444; Gillborn D, 2012, RACE ETHNIC EDUC-UK, V15, P121, DOI 10.1080/13613324.2012.638869; Gray-Little B, 2000, PSYCHOL BULL, V126, P26, DOI 10.1037/0033-2909.126.1.26; Gutman LM, 2003, DEV PSYCHOL, V39, P777, DOI 10.1037/0012-1649.39.4.777; Hallinan MT, 2001, SOCIOL EDUC, P50; Hankin BL, 1998, J ABNORM PSYCHOL, V107, P128, DOI 10.1037/0021-843X.107.1.128; Hankivsky O, 2012, SOC SCI MED, V74, P1712, DOI 10.1016/j.socscimed.2011.11.029; HINSHAW SP, 1992, PSYCHOL BULL, V111, P127, DOI 10.1037/0033-2909.111.1.127; Hudley C., 2001, SOC PSYCHOL ED INT J, V5, P201, DOI [10.1023/A:1014438702266, DOI 10.1023/A:1014438702266]; Hughes D, 2006, DEV PSYCHOL, V42, P747, DOI 10.1037/0012-1649.42.5.747; Jackson PB., 2006, GENDER RACE CLASS HL, P131; Jencks C., 1998, BLACK WHITE TEST SCO; Johnson KL, 2012, J PERS SOC PSYCHOL, V102, P116, DOI 10.1037/a0025335; Kao G, 1998, AM J EDUC, V106, P349, DOI 10.1086/444188; KAO G, 1996, RES SOCIOL EDUC, V11, P263; Keller J, 2003, PERS SOC PSYCHOL B, V29, P371, DOI 10.1177/0146167202250218; Kelly Y, 2013, J EPIDEMIOL COMMUN H, V67, P35, DOI 10.1136/jech-2011-200814; Kistner JA, 2003, J CLIN CHILD ADOLESC, V32, P341, DOI 10.1207/S15374424JCCP3203_03; Lanza ST, 2010, DEV PSYCHOPATHOL, V22, P313, DOI 10.1017/S0954579410000088; Lo YT, 2001, BIOMETRIKA, V88, P767, DOI 10.1093/biomet/88.3.767; Marsh H.W, 1992, SELF DESCRIPTION QUE; Maynard MJ, 2010, CHILD CARE HLTH DEV, V36, P630, DOI 10.1111/j.1365-2214.2010.01115.x; Maynard MJ, 2007, SOC PSYCH PSYCH EPID, V42, P759, DOI 10.1007/s00127-007-0227-7; McGraw R, 2006, J RES MATH EDUC, V37, P129, DOI 10.2307/30034845; McLaughlin KA, 2007, J ABNORM CHILD PSYCH, V35, P801, DOI 10.1007/s10802-007-9128-1; Mendelson T, 2008, SOC SCI MED, V66, P1284, DOI 10.1016/j.socscimed.2007.11.033; Muller PA, 2001, AM EDUC RES J, V38, P981, DOI 10.3102/00028312038004981; Mulvey KL, 2015, CHILD DEV, V86, P681, DOI 10.1111/cdev.12317; Muthen B.O., 2012, MPLUS USERS GUIDE, V7th; (NCES) NCfES, 2013, NAT REP CARD 1 LOOK; (NCES) NCfES, 2012, NAT REP CARD SCI 201; Noble KG, 2005, FUTURE CHILD, V15, P71, DOI 10.1353/foc.2005.0006; Nowell A, 1998, SEX ROLES, V39, P21, DOI 10.1023/A:1018873615316; Ogbu John U., 1991, MINORITY STATUS SCH; Paradies Y, 2006, INT J EPIDEMIOL, V35, P888, DOI 10.1093/ije/dyl056; Penner AM, 2013, GENDER SOC, V27, P319, DOI 10.1177/0891243213480262; PORTES A, 1987, ANNU REV SOCIOL, V13, P359; Priest N, 2011, AUSTR NZ J PUBLIC HL, DOI [10.1111/j.1753-6405.2011.00803.x8857, DOI 10.1111/J.1753-6405.2011.00803.X8857]; Priest N, 2014, INT J INTERCULT REL, V43, P139, DOI 10.1016/j.ijintrel.2014.08.003; Priest N, 2013, SOC SCI MED, V95, P115, DOI 10.1016/j.socscimed.2012.11.031; Qian ZC, 1999, SOCIOL PERSPECT, V42, P605, DOI 10.2307/1389576; Quinn DM, 2015, SOCIOL EDUC, V88, P120, DOI 10.1177/0038040715573027; Riegle-Crumb C, 2012, CENDER SOC, V26; Roscigno VJ, 2000, SOC PROBL, V47, P266, DOI 10.1525/sp.2000.47.2.03x0291e; Rouse C, 2005, SCH READINESS CLOSIN; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; SIGNORELLA ML, 1986, PSYCHOL BULL, V100, P207, DOI 10.1037/0033-2909.100.2.207; Sinclair S, 2006, J PERS SOC PSYCHOL, V90, P529, DOI 10.1037/0022-3514.90.4.529; Spencer SJ, 1999, J EXP SOC PSYCHOL, V35, P4, DOI 10.1006/jesp.1998.1373; Steele CM, 1997, AM PSYCHOL, V52, P613, DOI 10.1037/0003-066X.52.6.613; STEELE CM, 1995, J PERS SOC PSYCHOL, V69, P797, DOI 10.1037/0022-3514.69.5.797; Tourangeau K., 2009, 2009004 NCES US DEP; Twenge JM, 2002, PSYCHOL BULL, V128, P371, DOI 10.1037//0033-2909.128.3.371; Varner F, 2013, CHILD DEV, V84, P875, DOI 10.1111/cdev.12021; Vermunt JK, 2010, POLIT ANAL, V18, P450, DOI 10.1093/pan/mpq025; Warner DF, 2011, SOC SCI MED, V72, P1236, DOI 10.1016/j.socscimed.2011.02.034; Warren JR, 1996, SOCIOL EDUC, V69, P142, DOI 10.2307/2112803; Washbrook E, 2012, CHILD DEV, V83, P1591, DOI 10.1111/j.1467-8624.2012.01796.x; Williams DR, 2010, ANN NY ACAD SCI, V1186, P69, DOI 10.1111/j.1749-6632.2009.05339.x; Wingfield AH, 2009, GENDER SOC, V23, P5, DOI 10.1177/0891243208323054; Zilanawala A, 2015, SOC SCI MED, V134, P95, DOI 10.1016/j.socscimed.2015.04.012	88	36	36	1	73	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2015	10	10							e0141363	10.1371/journal.pone.0141363	http://dx.doi.org/10.1371/journal.pone.0141363			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CU8PC	26505623	Green Published, Green Submitted, Green Accepted, gold			2022-12-26	WOS:000363804200054
J	Zhao, X; Xiao, JP; Liao, XP; Cai, LY; Xu, F; Chen, DZ; Xiang, JY; Fang, R				Zhao, Xin; Xiao, Jianping; Liao, Xiangpeng; Cai, Liyi; Xu, Fei; Chen, Daozhen; Xiang, Jingying; Fang, Rui			Vitamin D Status among Young Children Aged 1-3 Years: A Cross-Sectional Study in Wuxi, China	PLOS ONE			English	Article							D DEFICIENCY; 25-HYDROXYVITAMIN-D LEVELS; GENETIC-DETERMINANTS; LIFE-STYLE; ASSOCIATION; ADIPOSITY; DIETARY; CANCER; SKIN	Background The increasingly recognized importance of vitamin D has been discussed and vitamin D status among young children has attracted widespread attention in recent years. However, study on vitamin D status in young children aged 1-3 y is limited in China. Objective To evaluate the nutritional vitamin D status of young children aged 1-3 y in Wuxi, southeastern China. Methods A large cohort of 5,571 young children aged 1-3 y were recruited in this study who visited the child health clinics at the Wuxi Maternity and Child Health Hospital (latitude 31.57 degrees N) during January 2014 to January 2015. Wuxi was located in southeastern China at a latitude of 31.57 degrees N. Finger-stick blood sampling was conducted in all the subjects and serum 25-Hydroxyvitamin D (25(OH) D) levels were measured to evaluate their vitamin D status. Results In this study, serum 25(OH) D levels of young children at the age of 1-3 years ranged from 20.6-132.9 nmol/L (Median: 71.5 nmol/L). 16.1% of the population had vitamin D deficiency (<50 nmol/L), while 38.8% of the subjects had a sufficient (50-74.9 nmol/L) vitamin D level. An optimal vitamin D status (>= 75 nmol/L) was found in 45.1% of the young children. The prevalence of vitamin D deficiency was higher in autumn (19.5%) than in summer (12.1%). There was no significant difference in vitamin D status between genders. The binary logistic regression analysis revealed that child age was strongly associated with vitamin D deficiency (adjusted OR: 1.173; 95% CI: 1.053-1.308; P = 0.004). Conclusions The prevalence of vitamin D deficiency was 16.1% among young children aged 1-3 y in Wuxi. Season and child age were associated with their vitamin D status. It is implied that young children should receive adequate amounts of vitamin D supplementation and spend more time outdoors to prolong the sunlight exposure when they grow older.	[Zhao, Xin; Xiao, Jianping; Xiang, Jingying] Nanjing Med Univ, Wuxi Matern & Child Hlth Hosp, Dept Obstet, Wuxi, Jiangsu, Peoples R China; [Zhao, Xin; Cai, Liyi; Fang, Rui] Nanjing Med Univ, Wuxi Matern & Child Hlth Hosp, Ctr Reprod Med, Wuxi, Jiangsu, Peoples R China; [Liao, Xiangpeng] Nanjing Med Univ, Wuxi Matern & Child Hlth Hosp, Dept Child Healthcare & Newborn, Wuxi, Jiangsu, Peoples R China; [Xu, Fei; Chen, Daozhen] Nanjing Med Univ, Wuxi Matern & Child Hlth Hosp, Cent Lab, Wuxi, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University; Nanjing Medical University; Nanjing Medical University	Fang, R (corresponding author), Nanjing Med Univ, Wuxi Matern & Child Hlth Hosp, Ctr Reprod Med, Wuxi, Jiangsu, Peoples R China.	wfangruix@163.com	Xiao, Jian/GYU-4351-2022; Liao, Xiangpeng/GNP-2312-2022; saz, eylem ulas/A-4622-2016		Science and Technology Department of Jiangsu Province [BL2014025]; Wuxi Municipal Hospital Management Center [YGZXM1407]; Jiangsu Province Department of Health [F201305]	Science and Technology Department of Jiangsu Province; Wuxi Municipal Hospital Management Center; Jiangsu Province Department of Health	This research was funded by the Science and Technology Department of Jiangsu Province (http://www.jskjjh.gov.cn/) grant BL2014025, Wuxi Municipal Hospital Management Center (http://yg.chinawuxi.gov.cn/) grant YGZXM1407 and Jiangsu Province Department of Health (http://www.jswst.gov.cn/index.html) grant F201305. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida OP, 2015, MATURITAS, V81, P36, DOI 10.1016/j.maturitas.2015.01.016; Arguelles LM, 2009, J CLIN ENDOCR METAB, V94, P3273, DOI 10.1210/jc.2008-1532; Avagyan D., 2015, PUBLIC HEALTH NUTR, P1; Buyukinan M, 2012, J PEDIATR ENDOCR MET, V25, P83, DOI 10.1515/jpem-2011-0426; Calvo MS, 2005, J NUTR, V135, P310, DOI 10.1093/jn/135.2.310; Gessner BD, 2003, J PEDIATR-US, V143, P434, DOI 10.1067/S0022-3476(03)00410-4; Gilbert-Diamond D, 2010, AM J CLIN NUTR, V92, P1446, DOI 10.3945/ajcn.2010.29746; Gracious BL, 2012, BMC PSYCHIATRY, V12, DOI 10.1186/1471-244X-12-38; Greer FR, 2003, J PEDIATR-US, V143, P422, DOI 10.1067/S0022-3476(03)00465-7; Hatun S, 2005, J NUTR, V135, P279, DOI 10.1093/jn/135.2.279; HOLICK MF, 1980, SCIENCE, V210, P203, DOI 10.1126/science.6251551; Holick MF, 2008, ADV EXP MED BIOL, V624, P1, DOI 10.1007/978-0-387-77574-6_1; Holick MF, 2011, J CLIN ENDOCR METAB, V96, P1911, DOI 10.1210/jc.2011-0385; Hollis BW, 2005, J NUTR, V135, P317, DOI 10.1093/jn/135.2.317; Holmlund-Suila E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060856; Kuhn T, 2014, EUR J NUTR, V53, P731, DOI 10.1007/s00394-013-0577-8; Lips P, 2007, J BONE MINER RES, V22, P1668, DOI 10.1359/JBMR.070716; Litonjua AA, 2012, CURR OPIN ALLERGY CL, V12, P179, DOI 10.1097/ACI.0b013e3283507927; Liu Xiaomin, 2014, INT J LAB MED, V35, P1226; Mellati AA, 2015, J PEDIATR ENDOCR MET, V28, P641, DOI 10.1515/jpem-2013-0495; Monangi N, 2014, ARCH DIS CHILD-FETAL, V99, pF166, DOI 10.1136/archdischild-2013-303999; Neyestani TR, 2012, PUBLIC HEALTH NUTR, V15, P324, DOI 10.1017/S1368980011000188; Nichols EK, 2015, EUR J CLIN NUTR, V69, P90, DOI 10.1038/ejcn.2014.142; Palacios C, 2014, J STEROID BIOCHEM, V144, P138, DOI 10.1016/j.jsbmb.2013.11.003; Ponsonby AL, 2010, NUTRIENTS, V2, P389, DOI 10.3390/nu2030389; Song SJ, 2013, PUBLIC HEALTH NUTR, V16, P687, DOI 10.1017/S1368980012003084; Suaini NHA, 2014, J STEROID BIOCHEM, V144, P445, DOI 10.1016/j.jsbmb.2014.08.018; Thornton KA, 2013, PEDIATR INFECT DIS J, V32, P585, DOI 10.1097/INF.0b013e3182868989; Voortman T, 2015, J NUTR, V145, P791, DOI 10.3945/jn.114.208280; Wilne S, 2007, LANCET ONCOL, V8, P685, DOI 10.1016/S1470-2045(07)70207-3; Xiao JP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117748; Zerofsky M, 2015, MATERN CHILD NUTR; Zhang HQ, 2014, NUTRITION, V30, P1040, DOI 10.1016/j.nut.2014.02.024; Zhu ZW, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-126	34	11	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2015	10	10							e0141595	10.1371/journal.pone.0141595	http://dx.doi.org/10.1371/journal.pone.0141595			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU8PC	26505743	Green Published, gold, Green Submitted			2022-12-26	WOS:000363804200088
J	Berry, GE; Asokan, A				Berry, Garrett E.; Asokan, Aravind			Chemical Modulation of Endocytic Sorting Augments Adeno-associated Viral Transduction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CANCER-CELL DEATH; VIRUS TYPE-2; AUTOPHAGY PATHWAY; CAPSID PROTEINS; TRAFFICKING; INFECTION; COMPARTMENT; VECTORS; IDENTIFICATION; ACCUMULATION	Intracellular trafficking of viruses can be influenced by a variety of inter-connected cellular sorting and degradation pathways involving endo-lysosomal vesicles, the ubiquitin-proteasome system, and autophagy-based or endoplasmic reticulum-associated machinery. In the case of recombinant adeno-associated viruses (AAV), proteasome inhibitors are known to prevent degradation of ubiquitinated AAV capsids, thereby leading to increased nuclear accumulation and transduction. However, the impact of other cellular degradation pathways on AAV trafficking is not well understood. In the current study, we screened a panel of small molecules focused on modulating different cellular degradation pathways and identified eeyarestatin I (EerI) as a novel reagent that enhances AAV transduction. EerI improved AAV transduction by an order of magnitude regardless of vector dose, genome architecture, cell type, or serotype. This effect was preceded by sequestration of AAV within enlarged vesicles that were dispersed throughout the cytoplasm. Specifically, EerI treatment redirected AAV particles toward large vesicles positive for late endosomal (Rab7) and lysosomal (LAMP1) markers. Notably, MG132 and EerI (proteasomal and endoplasmic reticulum-associated degradation inhibitors, respectively) appear to enhance AAV transduction by increasing the intracellular accumulation of viral particles in a mutually exclusive fashion. Taken together, our results expand on potential strategies to redirect recombinant AAV vectors toward more productive trafficking pathways by deregulating cellular degradation mechanisms.	[Berry, Garrett E.; Asokan, Aravind] Univ N Carolina, Gene Therapy Ctr, Chapel Hill, NC 27599 USA; [Berry, Garrett E.; Asokan, Aravind] Univ N Carolina, Dept Genet, Chapel Hill, NC 27599 USA; [Berry, Garrett E.] Univ N Carolina, Curriculum Genet & Mol Biol, Chapel Hill, NC 27599 USA; [Asokan, Aravind] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Asokan, A (corresponding author), Univ N Carolina, Gene Therapy Ctr, CB 7352,5123 Thurston Bldg, Chapel Hill, NC 27599 USA.	aravind@med.unc.edu			National Institutes of Health through the NHLBI [R01HL089221, P01HL112761]; National Institutes of Health through the NIGMS [5T32 GM007092]; NATIONAL CANCER INSTITUTE [F31CA165891] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL089221, P01HL112761] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007092] Funding Source: NIH RePORTER	National Institutes of Health through the NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institutes of Health through the NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by National Institutes of Health Grants R01HL089221 and P01HL112761) (to A. A.) through the NHLBI. This work was also supported by National Institutes of Health Training Grant 5T32 GM007092 (to G. E. B.) through the NIGMS. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the author and does not necessarily represent the official views of the National Institutes of Health.	Aletrari MO, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022713; Bar S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003605; Bantel-Schaal U, 2002, J VIROL, V76, P2340, DOI 10.1128/JVI.76.5.2340-2349.2002; Bennett SM, 2013, J VIROL, V87, P8843, DOI 10.1128/JVI.00664-13; Bowles D.E., 2006, PARVOVIRUSES, P15; Boya P, 2013, NAT CELL BIOL, V15, P713, DOI 10.1038/ncb2788; Byun H, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00330; Castle MJ, 2014, MOL THER, V22, P554, DOI 10.1038/mt.2013.237; Christianson JC, 2014, NAT STRUCT MOL BIOL, V21, P325, DOI 10.1038/nsmb.2793; Cross BCS, 2009, J CELL SCI, V122, P4393, DOI 10.1242/jcs.054494; Douar AM, 2001, J VIROL, V75, P1824, DOI 10.1128/JVI.75.4.1824-1833.2001; Duan DS, 2000, J CLIN INVEST, V105, P1573, DOI 10.1172/JCI8317; Girod A, 2002, J GEN VIROL, V83, P973, DOI 10.1099/0022-1317-83-5-973; Grieger JC, 2006, J VIROL, V80, P5199, DOI 10.1128/JVI.02723-05; Hanson PI, 2005, NAT REV MOL CELL BIO, V6, P519, DOI 10.1038/nrm1684; Huang LY, 2014, CURR OPIN VIROL, V7, P108, DOI 10.1016/j.coviro.2014.05.007; Jackson WT, 2015, VIROLOGY, V479, P450, DOI 10.1016/j.virol.2015.03.042; Johnson JS, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002053; Johnson JS, 2010, J VIROL, V84, P8888, DOI 10.1128/JVI.00687-10; Johnson JS, 2009, J VIROL, V83, P2632, DOI 10.1128/JVI.02309-08; Kirkegaard K, 2009, CURR TOP MICROBIOL, V335, P323, DOI 10.1007/978-3-642-00302-8_16; Lennemann NJ, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004685; Magnaghi P, 2013, NAT CHEM BIOL, V9, P548, DOI [10.1038/nchembio.1313, 10.1038/NCHEMBIO.1313]; Mateo R, 2013, J VIROL, V87, P1312, DOI 10.1128/JVI.02177-12; McKibbin C, 2012, BIOCHEM J, V442, P639, DOI 10.1042/BJ20111220; Mitchell AM, 2013, J VIROL, V87, P13035, DOI 10.1128/JVI.01826-13; Nathwani AC, 2009, GENE THER, V16, P60, DOI 10.1038/gt.2008.137; Nicolson SC, 2014, J VIROL, V88, P4132, DOI 10.1128/JVI.02660-13; Noack J, 2014, J VIROL, V88, P10272, DOI 10.1128/JVI.00801-14; Nonnenmacher M, 2011, CELL HOST MICROBE, V10, P563, DOI 10.1016/j.chom.2011.10.014; Nonnenmacher ME, 2015, J VIROL, V89, P1673, DOI 10.1128/JVI.02520-14; Raaben M, 2010, J VIROL, V84, P7869, DOI 10.1128/JVI.00485-10; Ramadan K, 2007, NATURE, V450, P1258, DOI 10.1038/nature06388; Ramanathan HN, 2012, CELL RES, V22, P346, DOI 10.1038/cr.2011.80; Shen S, 2013, J VIROL, V87, P13206, DOI 10.1128/JVI.02109-13; Shen S, 2013, J BIOL CHEM, V288, P28814, DOI 10.1074/jbc.M113.482380; Venkatakrishnan B, 2013, J VIROL, V87, P4974, DOI 10.1128/JVI.02524-12; Wang QY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015479; Weinberg MS, 2014, J VIROL, V88, P12472, DOI 10.1128/JVI.01971-14; WISTUBA A, 1995, J VIROL, V69, P5311, DOI 10.1128/JVI.69.9.5311-5319.1995; Wobus CE, 2000, J VIROL, V74, P9281, DOI 10.1128/JVI.74.19.9281-9293.2000; Xiao PJ, 2012, J VIROL, V86, P10462, DOI 10.1128/JVI.00935-12; Yan ZY, 2002, J VIROL, V76, P2043, DOI 10.1128/JVI.76.5.2043-2053.2002; Yi P, 2012, MOL CANCER THER, V11, P2610, DOI 10.1158/1535-7163.MCT-12-0516	44	16	17	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 8	2016	291	2					939	947		10.1074/jbc.M115.687657	http://dx.doi.org/10.1074/jbc.M115.687657			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DA5GF	26527686	Green Published, hybrid			2022-12-26	WOS:000367830500039
J	Nitzsche, R; Zagoriy, V; Lucius, R; Gupta, N				Nitzsche, Richard; Zagoriy, Vyacheslav; Lucius, Richard; Gupta, Nishith			Metabolic Cooperation of Glucose and Glutamine Is Essential for the Lytic Cycle of Obligate Intracellular Parasite Toxoplasma gondii	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						bioenergetics; energy metabolism; gluconeogenesis; glucose metabolism; glutamine; glycolysis; lipid synthesis; metabolic regulation; parasite metabolism; tricarboxylic acid cycle (TCA cycle) (Krebs cycle)	FUNCTIONAL-ANALYSIS; GAS-CHROMATOGRAPHY; AEROBIC GLYCOLYSIS; MASS-SPECTROMETRY; ACETATE; TACHYZOITES; APICOPLAST; INVASION; BRAIN; GENE	Toxoplasma gondii is a widespread protozoan parasite infecting nearly all warm-blooded organisms. Asexual reproduction of the parasite within its host cells is achieved by consecutive lytic cycles, which necessitates biogenesis of significant energy and biomass. Here we show that glucose and glutamine are the two major physiologically important nutrients used for the synthesis of macromolecules (ATP, nucleic acid, proteins, and lipids) in T. gondii, and either of them is sufficient to ensure the parasite survival. The parasite can counteract genetic ablation of its glucose transporter by increasing the flux of glutamine-derived carbon through the tricarboxylic acid cycle and by concurrently activating gluconeogenesis, which guarantee a continued biogenesis of ATP and biomass for host-cell invasion and parasite replication, respectively. In accord, a pharmacological inhibition of glutaminolysis or oxidative phosphorylation arrests the lytic cycle of the glycolysis-deficient mutant, which is primarily a consequence of impaired invasion due to depletion of ATP. Unexpectedly, however, intracellular parasites continue to proliferate, albeit slower, notwithstanding a simultaneous deprivation of glucose and glutamine. A growth defect in the glycolysis-impaired mutant is caused by a compromised synthesis of lipids, which cannot be counterbalanced by glutamine but can be restored by acetate. Consistently, supplementation of parasite cultures with exogenous acetate can amend the lytic cycle of the glucose transport mutant. Such plasticity in the parasite's carbon flux enables a growth-and-survival trade-off in assorted nutrient milieus, which may underlie the promiscuous survival of T. gondii tachyzoites in diverse host cells. Our results also indicate a convergence of parasite metabolism with cancer cells.	[Nitzsche, Richard; Lucius, Richard; Gupta, Nishith] Humboldt Univ, Dept Mol Parasitol, D-10115 Berlin, Germany; [Zagoriy, Vyacheslav] MetaSysX GmbH, D-14476 Potsdam, Germany; [Gupta, Nishith] Max Planck Inst Infect Biol, Parasitol Unit, D-10117 Berlin, Germany	Humboldt University of Berlin; Max Planck Society	Gupta, N (corresponding author), Humboldt Univ, Dept Mol Parasitol, Philippstr 13,House 14, D-10099 Berlin, Germany.	Gupta.Nishith@staff.hu-berlin.de		Gupta, Nishith/0000-0003-1452-5126	German Research Foundation (Deutsche Forschungsgemeinschaft) [GRK1121/A7, GU1100/3-1]; German Research Foundation [GRK1121/A7, GU1100/3-1]	German Research Foundation (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG)); German Research Foundation(German Research Foundation (DFG))	The work was supported by German Research Foundation (Deutsche Forschungsgemeinschaft) Grants GRK1121/A7 and GU1100/3-1 (to N. G.). The authors declare that there are no conflicts of interest pertaining to this work.; Supported by German Research Foundation Grants GRK1121/A7 and GU1100/3-1.	BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Blume M, 2015, CELL HOST MICROBE, V18, P210, DOI 10.1016/j.chom.2015.07.008; Blume M, 2009, P NATL ACAD SCI USA, V106, P12998, DOI 10.1073/pnas.0903831106; Brand A, 1997, CELL MOL BIOL, V43, P645; CERDAN S, 1990, J BIOL CHEM, V265, P12916; Comerford SA, 2014, CELL, V159, P1591, DOI 10.1016/j.cell.2014.11.020; Dienel GA, 2006, NEUROCHEM INT, V48, P586, DOI 10.1016/j.neuint.2006.01.004; Donald RGK, 1996, J BIOL CHEM, V271, P14010, DOI 10.1074/jbc.271.24.14010; DONALD RGK, 1993, P NATL ACAD SCI USA, V90, P11703, DOI 10.1073/pnas.90.24.11703; Dubey JP, 1998, CLIN MICROBIOL REV, V11, P267, DOI 10.1128/CMR.11.2.267; DUBREMETZ JF, 1985, EXP PARASITOL, V59, P24, DOI 10.1016/0014-4894(85)90053-0; Echeverria PC, 2010, MOL BIOCHEM PARASIT, V172, P129, DOI 10.1016/j.molbiopara.2010.04.004; Fleige T, 2008, INT J PARASITOL, V38, P1121, DOI 10.1016/j.ijpara.2008.01.007; Fleige T, 2007, EUKARYOT CELL, V6, P984, DOI 10.1128/EC.00061-07; Fox BA, 2009, EUKARYOT CELL, V8, P520, DOI 10.1128/EC.00357-08; Gupta N, 2005, J BIOL CHEM, V280, P16345, DOI 10.1074/jbc.M501523200; Hartmann A, 2014, J BIOL CHEM, V289, P6809, DOI 10.1074/jbc.M113.509406; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hummel J, 2011, FRONT PLANT SCI, V2, DOI 10.3389/fpls.2011.00054; Huynh MH, 2009, EUKARYOT CELL, V8, P530, DOI 10.1128/EC.00358-08; Jung JY, 2015, J CHROMATOGR B, V974, P101, DOI 10.1016/j.jchromb.2014.10.033; Kafsack BFC, 2004, MOL BIOCHEM PARASIT, V136, P309, DOI 10.1016/j.molbiopara.2004.04.004; KIM K, 1993, SCIENCE, V262, P911, DOI 10.1126/science.8235614; Kissinger JC, 2003, NUCLEIC ACIDS RES, V31, P234, DOI 10.1093/nar/gkg072; Lin SS, 2011, INT J PARASITOL, V41, P835, DOI 10.1016/j.ijpara.2011.03.005; Lisec J, 2006, NAT PROTOC, V1, P387, DOI 10.1038/nprot.2006.59; Lunt SY, 2011, ANNU REV CELL DEV BI, V27, P441, DOI 10.1146/annurev-cellbio-092910-154237; Luo QL, 2011, MICROBES INFECT, V13, P1199, DOI 10.1016/j.micinf.2011.08.013; MacRae JI, 2012, CELL HOST MICROBE, V12, P682, DOI 10.1016/j.chom.2012.09.013; Mashimo T, 2014, CELL, V159, P1603, DOI 10.1016/j.cell.2014.11.025; Mazumdar J, 2006, P NATL ACAD SCI USA, V103, P13192, DOI 10.1073/pnas.0603391103; Meissner M, 2002, SCIENCE, V298, P837, DOI 10.1126/science.1074553; OHSAKA A, 1982, PHYSIOL CHEM PHYS M, V14, P381; Oppenheim RD, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004263; Plattner F, 2008, CELL HOST MICROBE, V3, P77, DOI 10.1016/j.chom.2008.01.001; Ramakrishnan S, 2015, MOL MICROBIOL, V97, P64, DOI 10.1111/mmi.13010; Ramakrishnan S, 2012, J BIOL CHEM, V287, P4957, DOI 10.1074/jbc.M111.310144; ROUSER G, 1970, LIPIDS, V5, P494, DOI 10.1007/BF02531316; Sheiner L, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002392; SKUTCHES CL, 1979, J CLIN INVEST, V64, P708, DOI 10.1172/JCI109513; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Thangavelu K, 2014, SCI REP-UK, V4, DOI 10.1038/srep03827; TOLLINGER CD, 1979, CLIN CHEM, V25, P1787; Tymoshenko S, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004261; Vercesi AE, 1998, J BIOL CHEM, V273, P31040, DOI 10.1074/jbc.273.47.31040; WANG T, 1976, NATURE, V261, P702, DOI 10.1038/261702a0; Waniewski RA, 1998, J NEUROSCI, V18, P5225, DOI 10.1523/JNEUROSCI.18-14-05225.1998	47	37	37	2	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 1	2016	291	1					126	141		10.1074/jbc.M114.624619	http://dx.doi.org/10.1074/jbc.M114.624619			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DA1XP	26518878	Green Published, hybrid			2022-12-26	WOS:000367589500010
J	Eckl, JM; Scherr, MJ; Freiburger, L; Daake, MA; Sattler, M; Richter, K				Eckl, Julia M.; Scherr, Matthias J.; Freiburger, Lee; Daake, Marina A.; Sattler, Michael; Richter, Klaus			Hsp90 center dot Cdc37 Complexes with Protein Kinases Form Cooperatively with Multiple Distinct Interaction Sites	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAT-SHOCK-PROTEIN; CO-CHAPERONE; HSP90; BINDING; CLIENT; CYCLE; CDC37; RAF; IDENTIFICATION; GELDANAMYCIN	Protein kinases are the most prominent group of heat shock protein 90 (Hsp90) clients and are recruited to the molecular chaperone by the kinase-specific cochaperone cell division cycle 37 (Cdc37). The interaction between Hsp90 and nematode Cdc37 is mediated by binding of the Hsp90 middle domain to an N-terminal region of Caenorhabditis elegans Cdc37 (CeCdc37). Here we map the binding site by NMR spectroscopy and define amino acids relevant for the interaction between CeCdc37 and the middle domain of Hsp90. Apart from these distinct Cdc37/Hsp90 interfaces, binding of the B-Raf protein kinase to the cochaperone is conserved between mammals and nematodes. In both cases, the C-terminal part of Cdc37 is relevant for kinase binding, whereas the N-terminal domain displaces the nucleotide from the kinase. This interaction leads to a cooperative formation of the ternary complex of Cdc37 and kinase with Hsp90. For the mitogen-activated protein kinase extracellular signal-regulated kinase 2 (Erk2), we observe that certain features of the interaction with Cdc37 center dot Hsp90 are conserved, but the contribution of Cdc37 domains varies slightly, implying that different kinases may utilize distinct variations of this binding mode to interact with the Hsp90 chaperone machinery.	[Eckl, Julia M.; Scherr, Matthias J.; Freiburger, Lee; Daake, Marina A.; Sattler, Michael; Richter, Klaus] Tech Univ Munich, Ctr Integrated Prot Sci Munchen, Dept Chem, D-85748 Garching, Germany; [Freiburger, Lee; Sattler, Michael] Helmholtz Zentrum Munchen, Inst Biol Struct, D-85764 Neuherberg, Germany	Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Richter, K (corresponding author), Tech Univ Munich, Ctr Integrated Prot Sci Munchen, Lichtenbergstr 4, D-85748 Garching, Germany.	klaus.richter@richterlab.de	Sattler, Michael/A-2407-2012; Richter, Klaus/A-2673-2010	Sattler, Michael/0000-0002-1594-0527; Richter, Klaus/0000-0002-8952-9642; Scherr, Matthias Josef/0000-0003-0110-3709	Deutsche Forschungsgemeinschaft [RI1873/1-3, SFB1035]; Fonds der chemischen Industrie; TUM Graduate School's Faculty Graduate Center of Chemistry at the Technische Universitat Munchen; Center for Integrated Protein Science; European Molecular Biology Organization Long Term Fellowship ALTF [1255-2011]; Marie Curie International Incoming Fellowship within the Seventh European Community Framework Programme	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Fonds der chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission); TUM Graduate School's Faculty Graduate Center of Chemistry at the Technische Universitat Munchen; Center for Integrated Protein Science; European Molecular Biology Organization Long Term Fellowship ALTF; Marie Curie International Incoming Fellowship within the Seventh European Community Framework Programme(European Commission)	This work was supported in part by Deutsche Forschungsgemeinschaft Grants RI1873/1-3 (to K. R.) and SFB1035 (to M. J. S.), the Fonds der chemischen Industrie, the TUM Graduate School's Faculty Graduate Center of Chemistry at the Technische Universitat Munchen, and the Center for Integrated Protein Science. The authors declare that they have no conflicts of interest with the contents of this article.; Supported by European Molecular Biology Organization Long Term Fellowship ALTF 1255-2011 and a Marie Curie International Incoming Fellowship within the Seventh European Community Framework Programme.	Bepperling A, 2012, P NATL ACAD SCI USA, V109, P20407, DOI 10.1073/pnas.1209565109; Caplan AJ, 2007, TRENDS CELL BIOL, V17, P87, DOI 10.1016/j.tcb.2006.12.002; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dias SD, 2005, CANCER RES, V65, P10686, DOI 10.1158/0008-5472.CAN-05-2632; Echeverria PC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026044; Eckl JM, 2014, BIOCHEMISTRY-US, V53, P2505, DOI 10.1021/bi5000542; Eckl JM, 2013, J BIOL CHEM, V288, P16032, DOI 10.1074/jbc.M112.439257; Felts S.J., 2007, SCI STKE, V2007, pe22, DOI [DOI 10.1126/STKE.3852007PE22, DOI 10.1126/stke.3852007pe22]; Gaiser AM, 2009, J MOL BIOL, V391, P621, DOI 10.1016/j.jmb.2009.06.051; Genest O, 2013, MOL CELL, V49, P464, DOI 10.1016/j.molcel.2012.11.017; Grenert JP, 1997, J BIOL CHEM, V272, P23843, DOI 10.1074/jbc.272.38.23843; HANKS SK, 1988, SCIENCE, V241, P42, DOI 10.1126/science.3291115; Hayes DB, 2010, MACROMOL BIOSCI, V10, P731, DOI 10.1002/mabi.201000075; Hessling M, 2009, NAT STRUCT MOL BIOL, V16, P287, DOI 10.1038/nsmb.1565; Hubbard SR, 2000, ANNU REV BIOCHEM, V69, P373, DOI 10.1146/annurev.biochem.69.1.373; Lorenz OR, 2014, MOL CELL, V53, P941, DOI 10.1016/j.molcel.2014.02.003; Panaretou B, 1998, EMBO J, V17, P4829, DOI 10.1093/emboj/17.16.4829; Pearl LH, 2006, ANNU REV BIOCHEM, V75, P271, DOI 10.1146/annurev.biochem.75.103004.142738; Perdew GH, 1997, BIOCHEMISTRY-US, V36, P3600, DOI 10.1021/bi9612529; Phillips JJ, 2007, J MOL BIOL, V372, P1189, DOI 10.1016/j.jmb.2007.04.059; Picard D, 2002, CELL MOL LIFE SCI, V59, P1640, DOI 10.1007/PL00012491; Polier S, 2013, NAT CHEM BIOL, V9, P307, DOI [10.1038/NCHEMBIO.1212, 10.1038/nchembio.1212]; Pratt WB, 1997, ENDOCR REV, V18, P306, DOI 10.1210/er.18.3.306; Prince T, 2005, BIOCHEMISTRY-US, V44, P15287, DOI 10.1021/bi051423m; Prince T, 2004, J BIOL CHEM, V279, P39975, DOI 10.1074/jbc.M406882200; Prodromou C, 1997, CELL, V90, P65, DOI 10.1016/S0092-8674(00)80314-1; Roe SM, 2004, CELL, V116, P87, DOI 10.1016/S0092-8674(03)01027-4; Rubin GM, 2000, SCIENCE, V287, P2204, DOI 10.1126/science.287.5461.2204; Sattler M, 1999, PROG NUCL MAG RES SP, V34, P93, DOI 10.1016/S0079-6565(98)00025-9; Siligardi G, 2004, J BIOL CHEM, V279, P51989, DOI 10.1074/jbc.M410562200; STAFFORD WF, 1992, ANAL BIOCHEM, V203, P295, DOI 10.1016/0003-2697(92)90316-Y; Stancato LF, 1997, J BIOL CHEM, V272, P4013, DOI 10.1074/jbc.272.7.4013; STANCATO LF, 1993, J BIOL CHEM, V268, P21711; Stebbins CE, 1997, CELL, V89, P239, DOI 10.1016/S0092-8674(00)80203-2; Taipale M, 2013, NAT BIOTECHNOL, V31, P630, DOI 10.1038/nbt.2620; Taipale M, 2012, CELL, V150, P987, DOI 10.1016/j.cell.2012.06.047; Terasawa K, 2006, MOL CELL BIOL, V26, P3378, DOI 10.1128/MCB.26.9.3378-3389.2006; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tsai J, 2008, P NATL ACAD SCI USA, V105, P3041, DOI 10.1073/pnas.0711741105; Vaughan CK, 2008, MOL CELL, V31, P886, DOI 10.1016/j.molcel.2008.07.021; Vaughan CK, 2006, MOL CELL, V23, P697, DOI 10.1016/j.molcel.2006.07.016; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Wandinger SK, 2008, J BIOL CHEM, V283, P18473, DOI 10.1074/jbc.R800007200; Whitesell L, 2005, NAT REV CANCER, V5, P761, DOI 10.1038/nrc1716; Xu WP, 2012, FUTURE ONCOL, V8, P939, DOI [10.2217/FON.12.80, 10.2217/fon.12.80]; Zhang W, 2004, J MOL BIOL, V340, P891, DOI 10.1016/j.jmb.2004.05.007; Zhao Q, 2004, J BIOL CHEM, V279, P12560, DOI 10.1074/jbc.M308242200	49	34	34	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 25	2015	290	52					30843	30854		10.1074/jbc.M115.693150	http://dx.doi.org/10.1074/jbc.M115.693150			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CZ6GK	26511315	Green Submitted, hybrid, Green Published			2022-12-26	WOS:000367199000017
J	Tan, JS; Davies, BA; Payne, JA; Benson, LM; Katzmann, DJ				Tan, Jason; Davies, Brian A.; Payne, Johanna A.; Benson, Linda M.; Katzmann, David J.			Conformational Changes in the Endosomal Sorting Complex Required for the Transport III Subunit Ist1 Lead to Distinct Modes of ATPase Vps4 Regulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MULTIVESICULAR BODY BIOGENESIS; ESCRT-III; AAA-ATPASE; STRUCTURAL BASIS; MEMBRANE ASSOCIATION; STIMULATORY ELEMENT; PROTEIN CHMP1B; CYTOKINESIS; AUTOINHIBITION; SPASTIN	Intralumenal vesicle formation of the multivesicular body is a critical step in the delivery of endocytic cargoes to the lysosome for degradation. Endosomal sorting complex required for transport III (ESCRT-III) subunits polymerize on endosomal membranes to facilitate membrane budding away from the cytoplasm to generate these intralumenal vesicles. The ATPase Vps4 remodels and disassembles ESCRT-III, but the manner in which Vps4 activity is coordinated with ESCRT-III function remains unclear. Ist1 is structurally homologous to ESCRT-III subunits and has been reported to inhibit Vps4 function despite the presence of a microtubule-interacting and trafficking domain-interacting motif (MIM) capable of stimulating Vps4 in the context of other ESCRT-III subunits. Here we report that Ist1 inhibition of Vps4 ATPase activity involves two elements in Ist1: the MIM itself and a surface containing a conserved ELYC sequence. In contrast, the MIM interaction, in concert with a more open conformation of the Ist1 core, resulted in stimulation of Vps4. Addition of the ESCRT-III subunit binding partner of Ist1, Did2, also converted Ist1 from an inhibitor to a stimulator of Vps4 ATPase activity. Finally, distinct regulation of Vps4 by Ist1 corresponded with altered ESCRT-III disassembly in vitro. Together, these data support a model in which Ist1-Did2 interactions during ESCRT-III polymerization coordinate Vps4 activity with the timing of ESCRT-III disassembly.	[Tan, Jason; Davies, Brian A.; Payne, Johanna A.; Katzmann, David J.] Mayo Clin, Dept Biochem & Mol Biol, Rochester, MN 55905 USA; [Tan, Jason] Mayo Clin, Mayo Grad Sch, Rochester, MN 55905 USA; [Benson, Linda M.] Mayo Clin, Mayo Med Genome Facil Prote Core, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic; Mayo Clinic	Katzmann, DJ (corresponding author), Mayo Clin, Dept Biochem & Mol Biol, 200 First St SW, Rochester, MN 55906 USA.	katzmann.david@mayo.edu	Regan, Clinton/E-6250-2012		National Institutes of Health [R01 GM73024]; National Institutes of Health F31 Predoctoral Fellowship [F31GM106693]; Fraternal Order of the Eagles postdoctoral fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F31GM106693, R01GM073024] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health F31 Predoctoral Fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fraternal Order of the Eagles postdoctoral fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM73024 (to D. J. K.) and National Institutes of Health F31 Predoctoral Fellowship F31GM106693 (to J. A. T.). This work was also supported by a Fraternal Order of the Eagles postdoctoral fellowship (to B. A. D.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adell MAY, 2011, FEBS LETT, V585, P3191, DOI 10.1016/j.febslet.2011.09.001; Agromayor M, 2009, MOL BIOL CELL, V20, P1374, DOI 10.1091/mbc.E08-05-0474; Allison R, 2013, J CELL BIOL, V202, P527, DOI 10.1083/jcb.201211045; Azmi I, 2006, J CELL BIOL, V172, P705, DOI 10.1083/jcb.200508166; Babst M, 1998, EMBO J, V17, P2982, DOI 10.1093/emboj/17.11.2982; Babst M, 2002, DEV CELL, V3, P283, DOI 10.1016/S1534-5807(02)00219-8; Babst M, 2002, DEV CELL, V3, P271, DOI 10.1016/S1534-5807(02)00220-4; Babst M, 1997, EMBO J, V16, P1820, DOI 10.1093/emboj/16.8.1820; Bajorek M, 2009, NAT STRUCT MOL BIOL, V16, P754, DOI 10.1038/nsmb.1621; Bajorek M, 2009, MOL BIOL CELL, V20, P1360, DOI 10.1091/mbc.E08-05-0475; Baker TA, 2012, BBA-MOL CELL RES, V1823, P15, DOI 10.1016/j.bbamcr.2011.06.007; Carlton JG, 2008, P NATL ACAD SCI USA, V105, P10541, DOI 10.1073/pnas.0802008105; Carlton JG, 2007, SCIENCE, V316, P1908, DOI 10.1126/science.1143422; Cashikar AG, 2014, ELIFE, V3, DOI 10.7554/eLife.02184; Cordova JC, 2014, CELL, V158, P647, DOI 10.1016/j.cell.2014.05.043; Davies BA, 2014, J BIOL CHEM, V289, P28707, DOI 10.1074/jbc.M114.580696; Davies BA, 2010, MOL BIOL CELL, V21, P3396, DOI 10.1091/mbc.E10-06-0512; Dimaano C, 2008, MOL BIOL CELL, V19, P465, DOI 10.1091/mbc.E07-08-0747; Fabrikant G, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000575; Gerhardt B, 1998, J BIOL CHEM, V273, P15818, DOI 10.1074/jbc.273.25.15818; Guizetti J, 2011, SCIENCE, V331, P1616, DOI 10.1126/science.1201847; Guo EZ, 2015, J BIOL CHEM, V290, P8396, DOI 10.1074/jbc.M114.607903; Hanson PI, 2008, J CELL BIOL, V180, P389, DOI 10.1083/jcb.200707031; Hurley JH, 2008, DEV CELL, V14, P6, DOI 10.1016/j.devcel.2007.12.013; Im YJ, 2009, DEV CELL, V17, P234, DOI 10.1016/j.devcel.2009.07.008; Jones CB, 2012, TRAFFIC, V13, P468, DOI 10.1111/j.1600-0854.2011.01314.x; Katzmann DJ, 2001, CELL, V106, P145, DOI 10.1016/S0092-8674(01)00434-2; Kieffer C, 2008, DEV CELL, V15, P62, DOI 10.1016/j.devcel.2008.05.014; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Landsberg MJ, 2009, STRUCTURE, V17, P427, DOI 10.1016/j.str.2008.12.020; Lata S, 2008, J MOL BIOL, V378, P818, DOI 10.1016/j.jmb.2008.03.030; Lottridge JM, 2006, P NATL ACAD SCI USA, V103, P6202, DOI 10.1073/pnas.0601712103; Lumb JH, 2012, BBA-MOL CELL RES, V1823, P192, DOI 10.1016/j.bbamcr.2011.08.010; Martin A, 2008, NAT STRUCT MOL BIOL, V15, P1147, DOI 10.1038/nsmb.1503; McCullough J, 2013, ANNU REV BIOCHEM, V82, P663, DOI 10.1146/annurev-biochem-072909-101058; Merrill SA, 2010, J BIOL CHEM, V285, P35428, DOI 10.1074/jbc.M110.126318; Monroe N, 2014, J MOL BIOL, V426, P510, DOI 10.1016/j.jmb.2013.09.043; Morita E, 2007, EMBO J, V26, P4215, DOI 10.1038/sj.emboj.7601850; Morita E, 2011, CELL HOST MICROBE, V9, P235, DOI 10.1016/j.chom.2011.02.004; Muziol T, 2006, DEV CELL, V10, P821, DOI 10.1016/j.devcel.2006.03.013; Norgan AP, 2013, J BIOL CHEM, V288, P26147, DOI 10.1074/jbc.M113.494112; Obita T, 2007, NATURE, V449, P735, DOI 10.1038/nature06171; Piper RC, 2007, ANNU REV CELL DEV BI, V23, P519, DOI 10.1146/annurev.cellbio.23.090506.123319; Reid E, 2005, HUM MOL GENET, V14, P19, DOI 10.1093/hmg/ddi003; Renvoise B, 2010, MOL BIOL CELL, V21, P3293, DOI 10.1091/mbc.E09-10-0879; ROBINSON JS, 1988, MOL CELL BIOL, V8, P4936, DOI 10.1128/MCB.8.11.4936; Rue SM, 2008, MOL BIOL CELL, V19, P475, DOI 10.1091/mbc.E07-07-0694; Saksena S, 2009, CELL, V136, P97, DOI 10.1016/j.cell.2008.11.013; Scott A, 2005, P NATL ACAD SCI USA, V102, P13813, DOI 10.1073/pnas.0502165102; Scott A, 2005, EMBO J, V24, P3658, DOI 10.1038/sj.emboj.7600818; Shestakova A, 2013, J BIOL CHEM, V288, P26810, DOI 10.1074/jbc.M113.497032; Shestakova A, 2010, MOL BIOL CELL, V21, P1059, DOI 10.1091/mbc.E09-07-0572; Shim S, 2007, TRAFFIC, V8, P1068, DOI 10.1111/j.1600-0854.2007.00584.x; SIMONS RW, 1987, GENE, V53, P85, DOI 10.1016/0378-1119(87)90095-3; Stringer DK, 2011, J CELL BIOL, V192, P229, DOI 10.1083/jcb.201008121; Stuchell MD, 2004, J BIOL CHEM, V279, P36059, DOI 10.1074/jbc.M405226200; Stuchell-Brereton MD, 2007, NATURE, V449, P740, DOI 10.1038/nature06172; Teis D, 2008, DEV CELL, V15, P578, DOI 10.1016/j.devcel.2008.08.013; Vietri M, 2015, NATURE, V522, P231, DOI 10.1038/nature14408; Weber-Ban EU, 1999, NATURE, V401, P90, DOI 10.1038/43481; Wollert T, 2010, NATURE, V464, P864, DOI 10.1038/nature08849; Xiao JY, 2007, J MOL BIOL, V374, P655, DOI 10.1016/j.jmb.2007.09.067; Xiao JY, 2009, MOL BIOL CELL, V20, P3514, DOI 10.1091/mbc.E09-05-0403; Yang B, 2015, NAT STRUCT MOL BIOL, V22, P492, DOI 10.1038/nsmb.3015; Yang D, 2008, NAT STRUCT MOL BIOL, V15, P1278, DOI 10.1038/nsmb.1512; Zamborlini A, 2006, P NATL ACAD SCI USA, V103, P19140, DOI 10.1073/pnas.0603788103	66	10	11	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 11	2015	290	50					30053	30065		10.1074/jbc.M115.665604	http://dx.doi.org/10.1074/jbc.M115.665604			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CY7UL	26515066	hybrid, Green Published			2022-12-26	WOS:000366614700036
J	Choe, AS; Jones, CK; Joel, SE; Muschelli, J; Belegu, V; Caffo, BS; Lindquist, MA; van Zijl, PCM; Pekar, JJ				Choe, Ann S.; Jones, Craig K.; Joel, Suresh E.; Muschelli, John; Belegu, Visar; Caffo, Brian S.; Lindquist, Martin A.; van Zijl, Peter C. M.; Pekar, James J.			Reproducibility and Temporal Structure in Weekly Resting-State fMRI over a Period of 3.5 Years	PLOS ONE			English	Article							INTRINSIC CONNECTIVITY NETWORKS; INDEPENDENT COMPONENT ANALYSIS; DEFAULT-MODE NETWORK; SPINAL-CORD-INJURY; RESONANCE-IMAGING DATA; FUNCTIONAL MRI DATA; ALZHEIMERS-DISEASE; HUMAN BRAIN; PARKINSONS-DISEASE; RETEST RELIABILITY	Resting-state functional MRI (rs-fMRI) permits study of the brain's functional networks without requiring participants to perform tasks. Robust changes in such resting state networks (RSNs) have been observed in neurologic disorders, and rs-fMRI outcome measures are candidate biomarkers for monitoring clinical trials, including trials of extended therapeutic interventions for rehabilitation of patients with chronic conditions. In this study, we aim to present a unique longitudinal dataset reporting on a healthy adult subject scanned weekly over 3.5 years and identify rs-fMRI outcome measures appropriate for clinical trials. Accordingly, we assessed the reproducibility, and characterized the temporal structure of, rs-fMRI outcome measures derived using independent component analysis (ICA). Data was compared to a 21-person dataset acquired on the same scanner in order to confirm that the values of the single-subject RSN measures were within the expected range as assessed from the multi-participant dataset. Fourteen RSNs were identified, and the inter-session reproducibility of outcome measures-network spatial map, temporal signal fluctuation magnitude, and between-network connectivity (BNC)-was high, with executive RSNs showing the highest reproducibility. Analysis of the weekly outcome measures also showed that many rs-fMRI outcome measures had a significant linear trend, annual periodicity, and persistence. Such temporal structure was most prominent in spatial map similarity, and least prominent in BNC. High reproducibility supports the candidacy of rs-fMRI outcome measures as biomarkers, but the presence of significant temporal structure needs to be taken into account when such outcome measures are considered as biomarkers for rehabilitation-style therapeutic interventions in chronic conditions.	[Choe, Ann S.; Jones, Craig K.; Joel, Suresh E.; van Zijl, Peter C. M.; Pekar, James J.] Johns Hopkins Univ Sch Med, Russell H Morgan Dept Radiol & Radiol Sci, Baltimore, MD 21218 USA; [Choe, Ann S.; Jones, Craig K.; Joel, Suresh E.; van Zijl, Peter C. M.; Pekar, James J.] Kennedy Krieger Inst, FM Kirby Res Ctr Funct Brain Imaging, Baltimore, MD USA; [Choe, Ann S.; Belegu, Visar] Kennedy Krieger Inst, Int Ctr Spinal Cord Injury, Baltimore, MD USA; [Caffo, Brian S.; Lindquist, Martin A.] Johns Hopkins Univ, Dept Biostat, Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA; [Belegu, Visar] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA	Johns Hopkins University; Kennedy Krieger Institute; Kennedy Krieger Institute; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University	Choe, AS (corresponding author), Johns Hopkins Univ Sch Med, Russell H Morgan Dept Radiol & Radiol Sci, Baltimore, MD 21218 USA.	annschoe@gmail.com	Van Zijl, Peter C/ABF-3732-2020; AS, Choe/I-2637-2019	AS, Choe/0000-0001-7352-1489; Belegu, Visar/0000-0002-1361-4517; Jones, Craig/0000-0002-0629-3006; Pekar, James/0000-0002-9830-0655	National Institute of Health [P41 EB015909, RO1 EB012547]; U.S. Department of Defense [W81XWH-08-1-0192]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001079] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB016061, R01EB012547, P41EB015909] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG005146, T32AG000247] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Department of Defense(United States Department of Defense); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This publication was made possible by grant support from the National Institute of Health (www.nih.gov; P41 EB015909 (PvZ), RO1 EB012547 (BC)) and U.S. Department of Defense (www.defense.gov; W81XWH-08-1-0192 (VB)). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agosta F, 2012, NEUROBIOL AGING, V33, P1564, DOI 10.1016/j.neurobiolaging.2011.06.007; Ahdesmaki M, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-117; Ahdesmaki M, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-233; Allen EA, 2012, NEUROIMAGE, V59, P4141, DOI 10.1016/j.neuroimage.2011.10.010; Allen EA, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00002; Amann M, 2009, MAGN RESON IMAGING, V27, P1347, DOI 10.1016/j.mri.2009.05.016; Anderson JS, 2011, AM J NEURORADIOL, V32, P548, DOI 10.3174/ajnr.A2330; Anderson JAE, 2014, PSYCHOL AGING, V29, P648, DOI 10.1037/a0037243; Andrews-Hanna JR, 2007, NEURON, V56, P924, DOI 10.1016/j.neuron.2007.10.038; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Beckmann CF, 2005, PHILOS T R SOC B, V360, P1001, DOI 10.1098/rstb.2005.1634; Belegu V, 2007, NEUROSURG CLIN N AM, V18, P143, DOI 10.1016/j.nec.2006.10.012; BELL AJ, 1995, NEURAL COMPUT, V7, P1129, DOI 10.1162/neco.1995.7.6.1129; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Blautzik J, 2014, CHRONOBIOL INT, P1; Blautzik J, 2013, NEUROIMAGE, V71, P298, DOI 10.1016/j.neuroimage.2012.08.010; Broersen PMT, 2006, DIGIT SIGNAL PROCESS, V16, P754, DOI 10.1016/j.dsp.2006.01.001; Broersen PMT, 2004, AUTOMATICA, V40, P1495, DOI 10.1016/j.automatica.2004.04.011; Calhoun VD, 2001, HUM BRAIN MAPP, V14, P140, DOI 10.1002/hbm.1048; Chen S, 2008, BRAIN RES, V1239, P141, DOI 10.1016/j.brainres.2008.08.028; Choe AS, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00290; Chou YH, 2012, AM J NEURORADIOL, V33, P833, DOI 10.3174/ajnr.A2894; Cohen AL, 2008, NEUROIMAGE, V41, P45, DOI 10.1016/j.neuroimage.2008.01.066; Courchesne E, 2000, RADIOLOGY, V216, P672, DOI 10.1148/radiology.216.3.r00au37672; Damiano DL, 2006, PHYS THER, V86, P1534, DOI 10.2522/ptj.20050397; Damoiseaux JS, 2008, CEREB CORTEX, V18, P1856, DOI 10.1093/cercor/bhm207; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; Egolf AE., 2004, NEUROIMAGE, V22, P14; Fair DA, 2008, P NATL ACAD SCI USA, V105, P4028, DOI 10.1073/pnas.0800376105; Filippi M, 2013, J NEUROL, V260, P1709, DOI 10.1007/s00415-012-6695-z; Friedman L, 2006, J MAGN RESON IMAGING, V23, P827, DOI 10.1002/jmri.20583; Friston KJ, 1994, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; Ge YL, 2002, AM J NEURORADIOL, V23, P1327; Geerligs L, 2014, CEREB CORTEX; Guo CC, 2012, NEUROIMAGE, V61, P1471, DOI 10.1016/j.neuroimage.2012.03.027; Hacker CD, 2012, BRAIN, V135, P3699, DOI 10.1093/brain/aws281; Helmich RC, 2010, CEREB CORTEX, V20, P1175, DOI 10.1093/cercor/bhp178; Himberg J, 2004, NEUROIMAGE, V22, P1214, DOI 10.1016/j.neuroimage.2004.03.027; Hjelmervik H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103492; Hodkinson DJ, 2014, J CEREBR BLOOD F MET, V34, P1493, DOI 10.1038/jcbfm.2014.109; Inman CS, 2012, NEUROIMAGE, V59, P227, DOI 10.1016/j.neuroimage.2011.07.083; Jafri MJ, 2008, NEUROIMAGE, V39, P1666, DOI 10.1016/j.neuroimage.2007.11.001; Joel SE, 2011, MAGN RESON MED, V66, P644, DOI 10.1002/mrm.22818; Jones CK, 2014, 22 SCI M EXH INT SOC, P1775; Karunanayaka PR, 2007, NEUROIMAGE, V34, P349, DOI 10.1016/j.neuroimage.2006.08.028; Kelly C, 2010, EUR J NEUROSCI, V32, P383, DOI 10.1111/j.1460-9568.2010.07279.x; Kent BA, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00234; Kim JH, 2010, NEUROIMAGE, V49, P2375, DOI 10.1016/j.neuroimage.2009.10.016; Koch W, 2010, NEUROIMAGE, V51, P280, DOI 10.1016/j.neuroimage.2009.12.008; Kosslyn SM, 2005, COGN NEUROPSYCHOL, V22, P333, DOI 10.1080/02643290442000130; Kramer AF, 2004, J GERONTOL A-BIOL, V59, P940; Krmpotich TD, 2013, DRUG ALCOHOL DEPEN, V129, P1, DOI 10.1016/j.drugalcdep.2013.01.021; Landman BA, 2011, NEUROIMAGE, V54, P2854, DOI 10.1016/j.neuroimage.2010.11.047; Li ZJ, 2012, J MAGN RESON IMAGING, V36, P344, DOI 10.1002/jmri.23670; Lorenz DJ, 2012, ARCH PHYS MED REHAB, V93, P1541, DOI 10.1016/j.apmr.2012.01.027; Martin JH, 2011, DEV MED CHILD NEUROL, V53, P9, DOI 10.1111/j.1469-8749.2011.04055.x; Mazoyer B, 2001, BRAIN RES BULL, V54, P287, DOI 10.1016/S0361-9230(00)00437-8; McKeown MJ, 1998, P NATL ACAD SCI USA, V95, P803, DOI 10.1073/pnas.95.3.803; Meindl T, 2010, HUM BRAIN MAPP, V31, P237, DOI 10.1002/hbm.20860; Merrow M, 2005, EMBO REP, V6, P930, DOI 10.1038/sj.embor.7400541; Miller MI, 2005, P NATL ACAD SCI USA, V102, P9685, DOI 10.1073/pnas.0503892102; Oishi K, 2009, NEUROIMAGE, V46, P486, DOI 10.1016/j.neuroimage.2009.01.002; Paredes SD, 2009, J GERONTOL A-BIOL, V64, P340, DOI 10.1093/gerona/gln054; Pesonen AK, 2013, NEUROBIOL AGING, V34, P1674, DOI 10.1016/j.neurobiolaging.2012.12.012; PFEFFERBAUM A, 1994, ARCH NEUROL-CHICAGO, V51, P874, DOI 10.1001/archneur.1994.00540210046012; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; Pruessmann KP, 1999, MAGNET RESON MED, V42, P952, DOI 10.1002/(SICI)1522-2594(199911)42:5<952::AID-MRM16>3.0.CO;2-S; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Richiardi J, 2012, NEUROIMAGE, V62, P2021, DOI 10.1016/j.neuroimage.2012.05.078; Samann PG, 2011, CEREB CORTEX, V21, P2082, DOI 10.1093/cercor/bhq295; Sandler RA, 2014, J COMPUT NEUROSCI; Sato JR, 2014, J PSYCHIATR RES, V58, P89, DOI 10.1016/j.jpsychires.2014.07.004; Schmidt C, 2007, COGN NEUROPSYCHOL, V24, P755, DOI 10.1080/02643290701754158; Schmithorst VJ, 2004, J MAGN RESON IMAGING, V19, P365, DOI 10.1002/jmri.20009; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; Segall JM, 2012, FRONT NEUROINFORM, V6, DOI 10.3389/fninf.2012.00010; Seibert TM, 2012, NEUROIMAGE, V59, P2452, DOI 10.1016/j.neuroimage.2011.08.105; Shehzad Z, 2009, CEREB CORTEX, V19, P2209, DOI 10.1093/cercor/bhn256; Stanculescu I, 2014, IEEE J BIOMED HEALTH, V18, P1560, DOI 10.1109/JBHI.2013.2294692; STEHLING MK, 1991, SCIENCE, V254, P43, DOI 10.1126/science.1925560; Szaflarski JP, 2006, HUM BRAIN MAPP, V27, P202, DOI 10.1002/hbm.20177; Vogel AC, 2010, NEUROPSYCHOL REV, V20, P362, DOI 10.1007/s11065-010-9145-7; Webb SJ, 2001, DEV NEUROPSYCHOL, V19, P147, DOI 10.1207/S15326942DN1902_2; Weiland B. J., 2014, HUM BRAIN MAPP; Wisner KM, 2013, NEUROIMAGE, V76, P236, DOI 10.1016/j.neuroimage.2013.02.066; Yamada H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027493; Yang Z, 2012, NEUROIMAGE, V63, P403, DOI 10.1016/j.neuroimage.2012.06.060; Zuo XN, 2010, NEUROIMAGE, V49, P2163, DOI 10.1016/j.neuroimage.2009.10.080	89	71	72	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2015	10	10							e0140134	10.1371/journal.pone.0140134	http://dx.doi.org/10.1371/journal.pone.0140134			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0EH	26517540	Green Published, Green Submitted, gold			2022-12-26	WOS:000363920800003
J	Iqbal, S; Hoque, MT				Iqbal, Sumaiya; Hoque, Md Tamjidul			DisPredict: A Predictor of Disordered Protein Using Optimized RBF Kernel	PLOS ONE			English	Article							NATIVELY UNFOLDED PROTEINS; SEQUENCE-BASED PREDICTION; BACKBONE TORSION ANGLES; ACCESSIBLE SURFACE-AREA; INTRINSIC DISORDER; UNSTRUCTURED REGIONS; ACCURATE PREDICTION; SERVER; RECOGNITION; DATABASE	Intrinsically disordered proteins or, regions perform important biological functions through their dynamic conformations during binding. Thus accurate identification of these disordered regions have significant implications in proper annotation of function, induced fold prediction and drug design to combat critical diseases. We introduce DisPredict, a disorder predictor that employs a single support vector machine with RBF kernel and novel features for reliable characterization of protein structure. DisPredict yields effective performance. In addition to 10-fold cross validation, training and testing of DisPredict was conducted with independent test datasets. The results were consistent with both the training and test error minimal. The use of multiple data sources, makes the predictor generic. The datasets used in developing the model include disordered regions of various length which are categorized as short and long having different compositions, different types of disorder, ranging from fully to partially disordered regions as well as completely ordered regions. Through comparison with other state of the art approaches and case studies, DisPredict is found to be a useful tool with competitive performance.	[Iqbal, Sumaiya; Hoque, Md Tamjidul] Univ New Orleans, Dept Comp Sci, New Orleans, LA 70148 USA	University of Louisiana System; University of New Orleans	Hoque, MT (corresponding author), Univ New Orleans, Dept Comp Sci, New Orleans, LA 70148 USA.	thoque@uno.edu		Iqbal, Sumaiya/0000-0001-7700-4374	Louisiana Board of Regents through the Board of Regents Support Fund, LEQSF [(2013-16)-RD-A-19]	Louisiana Board of Regents through the Board of Regents Support Fund, LEQSF	SI and MTH gratefully acknowledge the Louisiana Board of Regents through the Board of Regents Support Fund, LEQSF (2013-16)-RD-A-19.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Babu MM, 2011, CURR OPIN STRUC BIOL, V21, P432, DOI 10.1016/j.sbi.2011.03.011; Baens M, 1996, GENOME RES, V6, P404, DOI 10.1101/gr.6.5.404; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Cheng JL, 2005, DATA MIN KNOWL DISC, V11, P213, DOI 10.1007/s10618-005-0001-y; Cheng Y, 2006, TRENDS BIOTECHNOL, V24, P435, DOI 10.1016/j.tibtech.2006.07.005; Colicelli John, 2004, Sci STKE, V2004, pRE13, DOI 10.1126/stke.2502004re13; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Deng X, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-436; Di Domenico T, 2012, BIOINFORMATICS, V28, P2080, DOI 10.1093/bioinformatics/bts327; Dosztanyi Z, 2005, BIOINFORMATICS, V21, P3433, DOI 10.1093/bioinformatics/bti541; Dunker AK, 2001, NAT BIOTECHNOL, V19, P805, DOI 10.1038/nbt0901-805; Dunker AK, 2002, ADV PROTEIN CHEM, V62, P25; Dunker AK, 2002, BIOCHEMISTRY-US, V41, P6573, DOI 10.1021/bi012159+; Dyson HJ, 2002, CURR OPIN STRUC BIOL, V12, P54, DOI 10.1016/S0959-440X(02)00289-0; Faraggi E, 2012, J COMPUT CHEM, V33, P259, DOI 10.1002/jcc.21968; Faraggi E, 2009, PROTEINS, V74, P847, DOI 10.1002/prot.22193; Fukuchi S, 2014, NUCLEIC ACIDS RES, V42, pD320, DOI 10.1093/nar/gkt1010; Fukuchi S, 2012, NUCLEIC ACIDS RES, V40, pD507, DOI 10.1093/nar/gkr884; Hirose S, 2007, BIOINFORMATICS, V23, P2046, DOI 10.1093/bioinformatics/btm302; Iqbal S, 2014, TECH REPORT, P1; Iqbal S, 2015, J THEOR BIOL, V380, P380, DOI 10.1016/j.jtbi.2015.06.012; Ishida T, 2008, BIOINFORMATICS, V24, P1344, DOI 10.1093/bioinformatics/btn195; Ishida T, 2007, NUCLEIC ACIDS RES, V35, pW460, DOI 10.1093/nar/gkm363; Jones DT, 2003, PROTEINS, V53, P573, DOI 10.1002/prot.10528; Kulkarni P, 2011, J CELL BIOCHEM, V112, P1949, DOI 10.1002/jcb.23115; Linding R, 2003, NUCLEIC ACIDS RES, V31, P3701, DOI 10.1093/nar/gkg519; Linding R, 2003, STRUCTURE, V11, P1453, DOI 10.1016/j.str.2003.10.002; Lobanov MY, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000958; McCoy M, 1997, EMBO J, V16, P6230, DOI 10.1093/emboj/16.20.6230; McGuffin LJ, 2008, BIOINFORMATICS, V24, P1798, DOI 10.1093/bioinformatics/btn326; Meiler J, 2001, J MOL MODEL, V7, P360, DOI 10.1007/s008940100038; Mizianty Marcin J, 2013, Intrinsically Disord Proteins, V1, pe24428, DOI 10.4161/idp.24428; Mizianty MJ, 2010, BIOINFORMATICS, V26, pi489, DOI 10.1093/bioinformatics/btq373; Monastyrskyy B, 2014, PROTEINS, V82, P127, DOI 10.1002/prot.24391; Monastyrskyy B, 2011, PROTEINS, V79, P107, DOI 10.1002/prot.23161; Noivirt-Brik O, 2009, PROTEINS, V77, P210, DOI 10.1002/prot.22586; Obradovic Z, 2003, PROTEINS, V53, P566, DOI 10.1002/prot.10532; Peng K, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-208; Peng Kang, 2005, Journal of Bioinformatics and Computational Biology, V3, P35, DOI 10.1142/S0219720005000886; Piskacek S, 2007, GENOMICS, V89, P756, DOI 10.1016/j.ygeno.2007.02.003; Potenza E, 2015, NUCLEIC ACIDS RES, V43, pD315, DOI 10.1093/nar/gku982; Prilusky J, 2005, BIOINFORMATICS, V21, P3435, DOI 10.1093/bioinformatics/bti537; Pruitt KD, 2005, NUCLEIC ACIDS RES, V33, pD501, DOI 10.1093/nar/gki025; Pruitt KD, 2009, NUCLEIC ACIDS RES, V37, pD32, DOI 10.1093/nar/gkn721; Radivojac P, 2004, PROTEIN SCI, V13, P71, DOI 10.1110/ps.03128904; Radivojac P, 2007, BIOPHYS J, V92, P1439, DOI 10.1529/biophysj.106.094045; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; Schlessinger A, 2006, BIOINFORMATICS, V22, P891, DOI 10.1093/bioinformatics/btl032; Schlessinger A, 2007, BIOINFORMATICS, V23, P2376, DOI 10.1093/bioinformatics/btm349; Schlessinger A, 2007, PLOS COMPUT BIOL, V3, P1335, DOI 10.1371/journal.pcbi.0030140; Schlessinger A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004433; Sharma A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089890; Sharma A, 2013, J THEOR BIOL, V320, P41, DOI 10.1016/j.jtbi.2012.12.008; Shimizu K, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-78; Sickmeier M, 2007, NUCLEIC ACIDS RES, V35, pD786, DOI 10.1093/nar/gkl893; Sirota FL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-S1-S15; Slupsky CM, 1998, P NATL ACAD SCI USA, V95, P12129, DOI 10.1073/pnas.95.21.12129; Su CT, 2007, NUCLEIC ACIDS RES, V35, pW465, DOI 10.1093/nar/gkm353; Su CT, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-319; Sun Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097982; Tompa P, 2002, TRENDS BIOCHEM SCI, V27, P527, DOI 10.1016/S0968-0004(02)02169-2; Uversky VN, 2010, BBA-PROTEINS PROTEOM, V1804, P1231, DOI 10.1016/j.bbapap.2010.01.017; Uversky VN, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-S1-S7; Uversky VN, 2000, PROTEINS, V41, P415, DOI 10.1002/1097-0134(20001115)41:3<415::AID-PROT130>3.3.CO;2-Z; Uversky VN, 2002, PROTEIN SCI, V11, P739, DOI 10.1110/ps.4210102; Uversky VN, 2005, J MOL RECOGNIT, V18, P343, DOI 10.1002/jmr.747; Vendruscolo M, 2000, LETTERS TO NATURE, V409, P641, DOI [10.1038/35054591, DOI 10.1038/35054591]; Vucetic S, 2003, PROTEINS, V52, P573, DOI 10.1002/prot.10437; Vullo A, 2006, NUCLEIC ACIDS RES, V34, pW164, DOI 10.1093/nar/gkl166; Walsh I, 2012, BIOINFORMATICS, V28, P503, DOI 10.1093/bioinformatics/btr682; Wang LX, 2008, BIOINFORMATICS, V24, P1401, DOI 10.1093/bioinformatics/btn132; Ward JJ, 2004, BIOINFORMATICS, V20, P2138, DOI 10.1093/bioinformatics/bth195; Whitford PC, 2013, P NATL ACAD SCI USA, V110, P7114, DOI 10.1073/pnas.1305236110; Wright PE, 1999, J MOL BIOL, V293, P321, DOI 10.1006/jmbi.1999.3110; Xue B, 2012, J BIOMOL STRUCT DYN, V29, P843, DOI 10.1080/073911012010525024; Xue B, 2010, BBA-PROTEINS PROTEOM, V1804, P996, DOI 10.1016/j.bbapap.2010.01.011; Yang JY, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-S2-S8; Yang ZR, 2005, BIOINFORMATICS, V21, P3369, DOI 10.1093/bioinformatics/bti534; Zhang T, 2012, J BIOMOL STRUCT DYN, V29, P799, DOI 10.1080/073911012010525022; Zhang T, 2010, PROTEINS, V78, P3353, DOI 10.1002/prot.22842	82	15	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2015	10	10							e0141551	10.1371/journal.pone.0141551	http://dx.doi.org/10.1371/journal.pone.0141551			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0EH	26517719	Green Submitted, Green Published, gold			2022-12-26	WOS:000363920800052
J	Sang, LQ; Zhang, JQ; Wang, L; Zhang, JN; Zhang, Y; Li, PY; Wang, J; Qiu, MG				Sang, Linqiong; Zhang, Jiuquan; Wang, Li; Zhang, Jingna; Zhang, Ye; Li, Pengyue; Wang, Jian; Qiu, Mingguo			Alteration of Brain Functional Networks in Early-Stage Parkinson's Disease: A Resting-State fMRI Study	PLOS ONE			English	Article							STRUCTURAL CORTICAL NETWORKS; GRAPH-THEORETICAL ANALYSIS; SMALL-WORLD; DRUG-NAIVE; CONNECTIVITY; ORGANIZATION; SCHIZOPHRENIA; DEPRESSION; FREQUENCY; NUCLEUS	Although alterations of topological organization have previously been reported in the brain functional network of Parkinson's disease (PD) patients, the topological properties of the brain network in early-stage PD patients who received antiparkinson treatment are largely unknown. This study sought to determine the topological characteristics of the large-scale functional network in early-stage PD patients. First, 26early-stage PD patients (Hoehn and Yahr stage: 1-2) and 30 age-matched normal controls were scanned using resting-state functional MRI. Subsequently, graph theoretical analysis was employed to investigate the abnormal topological configuration of the brain network in early-stage PD patients. We found that both the PD patient and control groups showed small-world properties in their functional brain networks. However, compared with the controls, the early-stage PD patients exhibited abnormal global properties, characterized by lower global efficiency. Moreover, the modular structure and the hub distribution were markedly altered in early-stage PD patients. Furthermore, PD patients exhibited increased nodal centrality, primarily in the bilateral pallidum, the inferior parietal lobule, and the medial superior frontal gyrus, and decreased nodal centrality in the caudate nucleus, the supplementary motor areas, the precentral gyrus, and the middle frontal gyrus. There were significant negative correlations between the Unified Parkinson Disease Rating Scale motor scores and nodal centralities of superior parietal gyrus. These results suggest that the topological organization of the brain functional network was altered in early-stage PD patients who received antiparkinson treatment, and we speculated that the antiparkinson treatment may affect the efficiency of the brain network to effectively relieve clinical symptoms of PD.	[Sang, Linqiong; Wang, Li; Zhang, Jingna; Zhang, Ye; Li, Pengyue; Qiu, Mingguo] Third Mil Med Univ, Coll Biomed Engn, Dept Med Imaging, Chongqing, Peoples R China; [Zhang, Jiuquan; Wang, Jian] Third Mil Med Univ, Southwest Hosp, Dept Radiol, Chongqing, Peoples R China	Army Medical University; Army Medical University	Wang, J (corresponding author), Third Mil Med Univ, Southwest Hosp, Dept Radiol, Chongqing, Peoples R China.	cqwang_2015@163.com; slq724@163.com	ZHANG, JIUQUAN/X-8389-2019	Zhang, Jiuquan/0000-0003-0239-6988	National Natural Science Foundation of China [81171866]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	MGQ has received support from National Natural Science Foundation of China (81171866). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarsland D, 2001, NEUROLOGY, V56, P730, DOI 10.1212/WNL.56.6.730; Achard S, 2006, J NEUROSCI, V26, P63, DOI 10.1523/JNEUROSCI.3874-05.2006; Achard S, 2007, PLOS COMPUT BIOL, V3, P174, DOI 10.1371/journal.pcbi.0030017; ALEXANDER GE, 1990, PROG BRAIN RES, V85, P119; Aron AR, 2009, ENCY NEUROSCIENCE; Baggio HC, 2014, HUM BRAIN MAPP, V35, P4620, DOI 10.1002/hbm.22499; Bassett DS, 2008, J NEUROSCI, V28, P9239, DOI 10.1523/JNEUROSCI.1929-08.2008; Baudrexel S, 2011, NEUROIMAGE, V55, P1728, DOI 10.1016/j.neuroimage.2011.01.017; Blandini F, 2000, PROG NEUROBIOL, V62, P63, DOI 10.1016/S0301-0082(99)00067-2; Braak H, 2003, NEUROBIOL AGING, V24, P197, DOI 10.1016/S0197-4580(02)00065-9; Brooks DJ, 2011, PROG NEUROBIOL, V95, P614, DOI 10.1016/j.pneurobio.2011.08.009; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Cameron IGM, 2012, NEUROIMAGE, V60, P1156, DOI 10.1016/j.neuroimage.2012.01.057; Carbon M, 2004, NEUROIMAGE, V21, P1497, DOI 10.1016/j.neuroimage.2003.12.014; Delaveau P, 2010, EUR NEUROPSYCHOPHARM, V20, P784, DOI 10.1016/j.euroneuro.2010.07.001; Desmurget M, 2012, CURR OPIN NEUROBIOL, V22, P1004, DOI 10.1016/j.conb.2012.06.006; Dickson DW, 2009, PARKINSONISM RELAT D, V15, pS1, DOI 10.1016/S1353-8020(09)70769-2; Dubbelink KTEO, 2014, BRAIN, V137, P197, DOI 10.1093/brain/awt316; Ferrer I, 2011, PARKINSONS DIS, p1e; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; FREEMAN LC, 1977, SOCIOMETRY, V40, P35, DOI 10.2307/3033543; Gallagher DA, 2012, NEUROBIOL DIS, V46, P581, DOI 10.1016/j.nbd.2011.12.041; Galvan A, 2008, CLIN NEUROPHYSIOL, V119, P1459, DOI 10.1016/j.clinph.2008.03.017; Glerean E, 2012, BRAIN CONNECT, V2, P91, DOI 10.1089/brain.2011.0068; Hacker CD, 2012, BRAIN, V135, P3699, DOI 10.1093/brain/aws281; He Y, 2009, BRAIN, V132, P3366, DOI 10.1093/brain/awp089; He Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005226; HOEHN MM, 1967, NEUROLOGY, V17, P427, DOI 10.1212/WNL.17.5.427; HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; Langenecker SA, 2007, BRAIN RES, V1135, P58, DOI 10.1016/j.brainres.2006.11.068; Latora V, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.198701; Lehericy S, 2002, EPILEPTIC DISORD, V4, pS23; Liu Y, 2008, BRAIN, V131, P945, DOI 10.1093/brain/awn018; Lo CY, 2010, J NEUROSCI, V30, P16876, DOI 10.1523/JNEUROSCI.4136-10.2010; Luo CY, 2015, J NEUROL, V262, P1557, DOI 10.1007/s00415-015-7750-3; Maslov S, 2002, SCIENCE, V296, P910, DOI 10.1126/science.1065103; Nachev P, 2008, NAT REV NEUROSCI, V9, P856, DOI 10.1038/nrn2478; Newman MEJ, 2006, P NATL ACAD SCI USA, V103, P8577, DOI 10.1073/pnas.0601602103; Nilsson FM, 2001, ACTA PSYCHIAT SCAND, V104, P380, DOI 10.1034/j.1600-0447.2001.00372.x; Obeso JA, 2000, TRENDS NEUROSCI, V23, pS8, DOI 10.1016/S1471-1931(00)00028-8; Palmer SJ, 2009, NEUROSCIENCE, V158, P693, DOI 10.1016/j.neuroscience.2008.06.053; Polito C, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2010.09.004; Ponsen MM, 2004, ANN NEUROL, V56, P173, DOI 10.1002/ana.20160; Salvador R, 2005, PHILOS T R SOC B, V360, P937, DOI 10.1098/rstb.2005.1645; Schwarz J, 2011, J NEUROL, V258, pS336, DOI 10.1007/s00415-011-6048-3; Shen H, 2010, NEUROIMAGE, V49, P3110, DOI 10.1016/j.neuroimage.2009.11.011; Skidmore F, 2011, NEUROSCI LETT, V499, P47, DOI 10.1016/j.neulet.2011.05.030; Sporns O, 2004, NEUROINFORMATICS, V2, P145, DOI 10.1385/NI:2:2:145; Stam CJ, 2009, BRAIN, V132, P213, DOI 10.1093/brain/awn262; Stocco A, 2010, PSYCHOL REV, V117, P541, DOI 10.1037/a0019077; Tian LX, 2011, NEUROIMAGE, V54, P191, DOI 10.1016/j.neuroimage.2010.07.066; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; van Beilen M, 2008, PARKINSONISM RELAT D, V14, P224, DOI 10.1016/j.parkreldis.2007.08.011; van den Heuvel MP, 2010, J NEUROSCI, V30, P15915, DOI 10.1523/JNEUROSCI.2874-10.2010; Wang JH, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00016; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Wu T, 2009, NEUROSCI LETT, V460, P6, DOI 10.1016/j.neulet.2009.05.046; Zeng LL, 2012, BRAIN, V135, P1498, DOI 10.1093/brain/aws059; Zhang DY, 2010, NAT REV NEUROL, V6, P15, DOI 10.1038/nrneurol.2009.198; Zhang JR, 2011, BIOL PSYCHIAT, V70, P334, DOI 10.1016/j.biopsych.2011.05.018; Zhang YC, 2014, MOVEMENT DISORD, V29, P122, DOI 10.1002/mds.25680	61	38	38	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2015	10	10							e0141815	10.1371/journal.pone.0141815	http://dx.doi.org/10.1371/journal.pone.0141815			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0EH	26517128	gold, Green Submitted, Green Published			2022-12-26	WOS:000363920800080
J	Wu, PY; Yang, SH; Wong, TC; Chen, TW; Chen, HH; Chen, TH; Chen, YT				Wu, Pei-Yu; Yang, Shwu-Huey; Wong, Te-Chih; Chen, Tzen-Wen; Chen, His-Hsien; Chen, Tso-Hsiao; Chen, Yu-Tong			Association of Processed Meat Intake with Hypertension Risk in Hemodialysis Patients: A Cross-Sectional Study	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; C-REACTIVE PROTEIN; BLOOD-PRESSURE; CARDIOVASCULAR-DISEASE; ARTERY CALCIFICATION; DIETARY ASSESSMENT; SODIUM-INTAKE; ENERGY-INTAKE; ALL-CAUSE; MORTALITY	In this cross-sectional study, we hypothesized that hemodialysis patients consuming greater processed meat is associated with hypertension risk, which can be partly explained by the high sodium content in processed meat. From September 2013 to May 2014, one hundred and four patients requiring chronic hemodialysis treatment were recruited from hemodialysis centers. Data on systolic blood pressure and diastolic blood pressure before receiving dialysis, and 3-day dietary records of the recruited patients were collected. HD patients with systolic and diastolic blood pressures greater than 140 mmHg and higher than 90 mmHg, respectively, were considered hypertension risk. Protein foods were divided into 4 categories: red meat, white meat, soybeans, and processed meat (e.g., sausage and ham). In a model adjusted for energy intake and hypertension history, additional servings of processed meats was positively associated to systolic blood pressure >140 mmHg (odds ratio [95% confidence interval]: 2.1 [1.0-4.3]), and diastolic blood pressure > 90 mmHg (odds ratio: 2.5 [1.2-5.5]). After adjustment for dietary sodium contents or body mass index (BMI), most associations were substantially attenuated and were no longer significant. In systolic blood pressure greater than140 mmHg, one serving per day of red meats (beta = -1.22, P < .05) and white meats (beta = -0. 75, P = .05) was associated with a reduced risk compared with one serving per day of processed meats. Similarly, compared with one serving per day of processed meat, a reduced risk of diastolic blood pressure higher than 90 mmHg was associated with one serving per day of red meat (beta = -1. 59, P < .05), white meat (beta = -0. 62, P < .05). Thus, in these hemodialysis patients, intake of processed meat is significantly positively associated with higher blood pressure risk, and both sodium contents in processed meat and BMI significantly contributes to this association.	[Wu, Pei-Yu; Yang, Shwu-Huey; Wong, Te-Chih; Chen, Yu-Tong] Taipei Med Univ, Sch Nutr & Hlth Sci, Taipei, Taiwan; [Chen, Tzen-Wen; Chen, His-Hsien] Taipei Med Univ Hosp, Dept Nephrol, Taipei, Taiwan; [Chen, Tso-Hsiao] Wan Fang Med Ctr, Dept Nephrol, Taipei, Taiwan	Taipei Medical University; Taipei Medical University; Taipei Medical University Hospital; Taipei Municipal WanFang Hospital	Yang, SH (corresponding author), Taipei Med Univ, Sch Nutr & Hlth Sci, Taipei, Taiwan.	sherry@tmu.edu.tw	Wong, Te-Chih/AAH-7667-2020	Wong, Te-Chih/0000-0002-5798-1060	Ministry of Science and Technology (Taiwan);  [NSC-102-2320-B-038-026]	Ministry of Science and Technology (Taiwan)(Ministry of Science and Technology, Taiwan); 	This study was funded by Ministry of Science and Technology (Taiwan), and the website is http://www.most.gov.tw/mp.aspx. The grant number is: NSC-102-2320-B-038-026. PYW, SHY, TCW, and YTC have received the funding.	Agarwal R, 2003, AM J MED, V115, P291, DOI 10.1016/S0002-9343(03)00366-8; [Anonymous], 2014, USRDS 2014 ANN DAT R; Appel LJ, 2006, HYPERTENSION, V47, P296, DOI 10.1161/01.HYP.0000202568.01167.B6; Bernstein AM, 2010, CIRCULATION, V122, P876, DOI 10.1161/CIRCULATIONAHA.109.915165; Blacher J, 2001, HYPERTENSION, V38, P938, DOI 10.1161/hy1001.096358; Bolton K, 2005, AM J KIDNEY DIS, V45, pS7, DOI 10.1053/j.ajkd.2005.01.016; Bross R, 2010, SEMIN DIALYSIS, V23, P359, DOI 10.1111/j.1525-139X.2010.00743.x; Brown IJ, 2009, INT J EPIDEMIOL, V38, P791, DOI 10.1093/ije/dyp139; Caro P, 2010, DIALYSIS TRANSPLANT, V39, P27, DOI 10.1002/dat.20399; Chang TY, 2007, CURR MED RES OPIN, V23, P1879, DOI 10.1185/030079907X218077; Chazot C, 2007, NEPHROL THER, V3, pS137, DOI 10.1016/S1769-7255(07)80022-8; Chen HS, 2014, HEMODIAL INT, V18, P799, DOI 10.1111/hdi.12165; Chen KH, 2008, KIDNEY BLOOD PRESS R, V31, P143, DOI 10.1159/000127388; Chiu YF, 2014, J RENAL NUTR, V24, P163, DOI 10.1053/j.jrn.2013.12.006; Chobanian AV, 2000, HYPERTENSION, V35, P858, DOI 10.1161/01.HYP.35.4.858; Collins Allan J, 2014, Am J Kidney Dis, V63, pA7, DOI 10.1053/j.ajkd.2013.11.001; Fogarty AW, 2009, AM J CLIN NUTR, V89, P1901, DOI 10.3945/ajcn.2008.27006; Gallardo JM, 2007, ARCH MED RES, V38, P34, DOI 10.1016/j.arcmed.2006.08.010; Grossman C, 2013, AM J HYPERTENS, V26, P13, DOI 10.1093/ajh/hps028; He FJ, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1325; Hecking M, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001750; Hecking M, 2014, AM J HYPERTENS, V27, P1160, DOI 10.1093/ajh/hpu040; Heidari B, 2013, CASP J INTERN MED, V4, P611; Huang JC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126668; Hunink MGM, 1997, JAMA-J AM MED ASSOC, V277, P535, DOI 10.1001/jama.277.7.535; Ikizler TA, 1996, KIDNEY INT, V50, P343, DOI 10.1038/ki.1996.323; Kalantar-Zadeh K, 2010, CLIN J AM SOC NEPHRO, V5, P519, DOI 10.2215/CJN.06080809; Kaluza J, 2014, CIRC-HEART FAIL, V7, P552, DOI 10.1161/CIRCHEARTFAILURE.113.000921; Kidney Disease: Improving Global Outcomes (KDIGO) Blood Pressure Work Group, 2012, KIDNEY INT SUPPL, V2, P347; Kobayashi S, 2012, J EPIDEMIOL, V22, P151, DOI 10.2188/jea.JE20110075; Kopple JD, 2001, AM J KIDNEY DIS, V37, pS66, DOI 10.1053/ajkd.2001.20748; Lajous M, 2014, AM J CLIN NUTR, V100, P948, DOI 10.3945/ajcn.113.080598; Larsson SC, 2011, STROKE, V42, P324, DOI 10.1161/STROKEAHA.110.596510; Levin NW, 2010, KIDNEY INT, V77, P273, DOI 10.1038/ki.2009.469; Ley SH, 2014, AM J CLIN NUTR, V99, P352, DOI 10.3945/ajcn.113.075663; Lin HS, 2014, KAOHSIUNG J MED SCI, V30, P206, DOI 10.1016/j.kjms.2013.12.002; Luhrmann PM, 1999, EUR J NUTR, V38, P235, DOI 10.1007/s003940050066; Mafra D, 2012, J RENAL NUTR, V22, P578, DOI 10.1053/j.jrn.2011.10.037; Malluche HH, 2015, J AM SOC NEPHROL; Martinez-Maldonado M, 1998, KIDNEY INT, V54, pS67, DOI 10.1046/j.1523-1755.1998.06816.x; McCullough ML, 2002, AM J CLIN NUTR, V76, P1261, DOI 10.1093/ajcn/76.6.1261; Micha R, 2010, CIRCULATION, V121, P2271, DOI 10.1161/CIRCULATIONAHA.109.924977; Miller GE, 2002, HEALTH PSYCHOL, V21, P531, DOI 10.1037//0278-6133.21.6.531; Moriya H, 2008, CLIN J AM SOC NEPHRO, V3, P416, DOI 10.2215/CJN.03490807; National Kidney Foundation, 2004, AM J KIDNEY DIS S, V43, pS1, DOI [DOI 10.1053/J.AJKD.2004.03.003, 10.1053/j.ajkd.2004.03.003]; Noori N, 2011, AM J NEPHROL, V33, P157, DOI 10.1159/000323972; Ortega RM, 2015, NUTR HOSP, V31, P38, DOI 10.3305/nh.2015.31.sup3.8749; Potter SM, 1998, NUTR REV, V56, P231, DOI 10.1111/j.1753-4887.1998.tb01754.x; Ravel VA, 2013, J NUTR, V143, P1084, DOI 10.3945/jn.112.169722; Renal Data System U.S, 2014, AM J KIDNEY DIS, V63, pe215; Ribeiro S, 1998, NEPHROL DIAL TRANSPL, V13, P2037, DOI 10.1093/ndt/13.8.2037; RIMM EB, 1992, AM J EPIDEMIOL, V135, P1114, DOI 10.1093/oxfordjournals.aje.a116211; Rouhani MH, 2014, OBES REV, V15, P740, DOI 10.1111/obr.12172; Ruusunen M, 2005, MEAT SCI, V70, P531, DOI 10.1016/j.meatsci.2004.07.016; Santarelli RL, 2008, NUTR CANCER, V60, P131, DOI 10.1080/01635580701684872; Shapiro BB, 2015, J RENAL NUTR, V25, P357, DOI 10.1053/j.jrn.2014.12.004; Shinaberger CS, 2006, AM J KIDNEY DIS, V48, P37, DOI 10.1053/j.ajkd.2006.03.049; Sullivan C, 2009, JAMA-J AM MED ASSOC, V301, P629, DOI 10.1001/jama.2009.96; Takeda A, 2005, AM J KIDNEY DIS, V45, P112, DOI 10.1053/j.ajkd.2004.08.045; TERMAN DS, 1971, AM J MED, V50, P744, DOI 10.1016/0002-9343(71)90182-3; Therrien M, 2014, J RENAL NUTR, V24, P72, DOI 10.1053/j.jrn.2013.09.005; THOMPSON GR, 1994, LANCET, V343, P670, DOI 10.1016/S0140-6736(94)92664-6; Uribarri J, 2009, CLIN J AM SOC NEPHRO, V4, P1290, DOI 10.2215/CJN.03950609; Wang Y, 2009, INT J OBESITY, V33, P621, DOI 10.1038/ijo.2009.45; Wanner C, 2002, NEPHROL DIAL TRANSPL, V17, P29, DOI 10.1093/ndt/17.suppl_8.29; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837; Wu M-S, 2012, ACTA NEPHROLOGICA, V26, P104; Wu PY, 2014, NEPHROLOGY, V19, P98; Wu SJ, 2011, ASIA PAC J CLIN NUTR, V20, P251; Zheng ZJ, 1999, AM J EPIDEMIOL, V150, P492, DOI 10.1093/oxfordjournals.aje.a010038	70	12	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2015	10	10							e0141917	10.1371/journal.pone.0141917	http://dx.doi.org/10.1371/journal.pone.0141917			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0EH	26517837	Green Published, gold, Green Submitted			2022-12-26	WOS:000363920800093
J	Farahani, M; Rubbi, C; Liu, L; Slupsky, JR; Kalakonda, N				Farahani, Mosavar; Rubbi, Carlos; Liu, Luning; Slupsky, Joseph R.; Kalakonda, Nagesh			CLL Exosomes Modulate the Transcriptome and Behaviour of Recipient Stromal Cells and Are Selectively Enriched in miR-202-3p	PLOS ONE			English	Article							CHRONIC LYMPHOCYTIC-LEUKEMIA; MICRORNA; MICROENVIRONMENT; CANCER; DIFFERENTIATION; MICROVESICLES; INDUCTION; PROTEINS; DISEASE; PROLIFERATION	Bi-directional communication with the microenvironment is essential for homing and survival of cancer cells with implications for disease biology and behaviour. In chronic lymphocytic leukemia (CLL), the role of the microenvironment on malignant cell behaviour is well described. However, how CLL cells engage and recruit nurturing cells is poorly characterised. Here we demonstrate that CLL cells secrete exosomes that are nanovesicles originating from the fusion of multivesicular bodies with the plasma membrane, to shuttle proteins, lipids, microRNAs (miR) and mRNAs to recipient cells. We characterise and confirm the size (50-100 nm) and identity of the CLL-derived exosomes by Electron microscopy (EM), Atomic force microscopy (AFM), flow cytometry and western blotting using both exosome- and CLL-specific markers. Incubation of CLL-exosomes, derived either from cell culture supernatants or from patient plasma, with human stromal cells shows that they are readily taken up into endosomes, and induce expression of genes such as c-fos and ATM as well as enhance proliferation of recipient HS-5 cells. Furthermore, we show that CLL exosomes encapsulate abundant small RNAs and are enriched in certain miRs and specifically hsa-miR-202-3p. We suggest that such specific packaging of miR-202-3p into exosomes results in enhanced expression of 'suppressor of fused' (Sufu), a Hedgehog (Hh) signalling intermediate, in the parental CLL cells. Thus, our data show that CLL cells secrete exosomes that alter the transcriptome and behaviour of recipient cells. Such communication with microenvironment is likely to have an important role in CLL disease biology.	[Farahani, Mosavar; Rubbi, Carlos; Slupsky, Joseph R.; Kalakonda, Nagesh] Univ Liverpool, Inst Translat Med, Dept Mol & Clin Canc Med, Liverpool L69 3BX, Merseyside, England; [Liu, Luning] Univ Liverpool, Inst Integrat Biol, Dept Funct & Comparat Gen, Liverpool L69 3BX, Merseyside, England; [Farahani, Mosavar; Kalakonda, Nagesh] Royal Liverpool Univ Hosp, Dept Haematol, Liverpool, Merseyside, England	University of Liverpool; University of Liverpool; Royal Liverpool & Broadgreen University Hospitals NHS Trust; Royal Liverpool University Hospital; University of Liverpool	Kalakonda, N (corresponding author), Univ Liverpool, Inst Translat Med, Dept Mol & Clin Canc Med, Liverpool L69 3BX, Merseyside, England.	nageshk@liv.ac.uk	Liu, Lu-Ning/B-1460-2009	Liu, Lu-Ning/0000-0002-8884-4819; Slupsky, Joseph/0000-0002-7410-9004	Royal Liverpool University Hospital Leukemia Fund; Leukemia & Lymphoma Research (UK); The Isle of Man Anticancer Fund; Royal Society University Research Fellowship [UF120411]; Royal Society Research grant [RG130442]; Biotechnology and Biological Sciences Research Council [BB/M024202/1] Funding Source: researchfish; BBSRC [BB/M024202/1] Funding Source: UKRI	Royal Liverpool University Hospital Leukemia Fund; Leukemia & Lymphoma Research (UK); The Isle of Man Anticancer Fund; Royal Society University Research Fellowship(Royal Society of London); Royal Society Research grant(Royal Society of London); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The authors thank the Royal Liverpool University Hospital Leukemia Fund (NK), Leukemia & Lymphoma Research (UK) (JRS, NK), The Isle of Man Anticancer Fund (NK), Royal Society University Research Fellowship (UF120411) (LL) and Royal Society Research grant (RG130442) (LL) for financial support.	Bobrie A, 2011, TRAFFIC, V12, P1659, DOI 10.1111/j.1600-0854.2011.01225.x; Braicu C, 2015, CELL DEATH DIFFER, V22, P34, DOI 10.1038/cdd.2014.130; Burger JA, 2014, SEMIN CANCER BIOL, V24, P71, DOI 10.1016/j.semcancer.2013.08.011; Buschow SI, 2010, IMMUNOL CELL BIOL, V88, P851, DOI 10.1038/icb.2010.64; Caby MP, 2005, INT IMMUNOL, V17, P879, DOI 10.1093/intimm/dxh267; Caligaris-Cappio F, 2014, SEMIN CANCER BIOL, V24, P43, DOI 10.1016/j.semcancer.2013.06.010; Calin GA, 2005, NEW ENGL J MED, V353, P1793, DOI 10.1056/NEJMoa050995; Chaput N, 2011, SEMIN IMMUNOPATHOL, V33, P419, DOI 10.1007/s00281-010-0233-9; Chiorazzi N., 2005, NEW ENGL J MED, V352, P804, DOI [10.1056/NEJMra041720, DOI 10.1056/NEJMRA041720, 10.1002/9781444300857.ch36]; Chowdhury R, 2014, ONCOTARGET; Clayton A, 2005, J CELL SCI, V118, P3631, DOI 10.1242/jcs.02494; Clayton A, 2004, FASEB J, V18, P977, DOI 10.1096/fj.03-1094fje; Clayton A, 2001, J IMMUNOL METHODS, V247, P163, DOI 10.1016/S0022-1759(00)00321-5; Colombo M, 2014, ANNU REV CELL DEV BI, V30, P255, DOI 10.1146/annurev-cellbio-101512-122326; Denzer K, 2000, J CELL SCI, V113, P3365; Duckworth A, 2014, BLOOD, V123, P3277, DOI 10.1182/blood-2013-11-539049; Dweep H, 2014, METHODS MOL BIOL, V1182, P289, DOI 10.1007/978-1-4939-1062-5_25; Eferl R, 2003, NAT REV CANCER, V3, P859, DOI 10.1038/nrc1209; Fabbri M, 2012, P NATL ACAD SCI USA, V109, pE2110, DOI 10.1073/pnas.1209414109; Fabbri M, 2011, JAMA-J AM MED ASSOC, V305, P59, DOI 10.1001/jama.2010.1919; Feng D, 2010, TRAFFIC, V11, P675, DOI 10.1111/j.1600-0854.2010.01041.x; Ferrajoli A, 2013, BLOOD, V122, P1891, DOI 10.1182/blood-2013-01-478222; Fitzner D, 2011, J CELL SCI, V124, P447, DOI 10.1242/jcs.074088; Fulci V, 2007, BLOOD, V109, P4944, DOI 10.1182/blood-2006-12-062398; Ghosh AK, 2010, BLOOD, V115, P1755, DOI 10.1182/blood-2009-09-242719; Gutzeit C, 2014, J IMMUNOL, V192, P5852, DOI 10.4049/jimmunol.1302068; Hegde GV, 2008, MOL CANCER RES, V6, P1928, DOI 10.1158/1541-7786.MCR-08-0142; Hoffman AE, 2013, CANCER EPIDEM BIOMAR, V22, P327, DOI 10.1158/1055-9965.EPI-12-1131-T; Huan J, 2013, CANCER RES, V73, P918, DOI 10.1158/0008-5472.CAN-12-2184; Kahlert C, 2013, J MOL MED, V91, P431, DOI 10.1007/s00109-013-1020-6; Kosaka Nobuyoshi, 2013, Frontiers in Genetics, V4, P173, DOI 10.3389/fgene.2013.00173; McLellan AD, 2009, CRIT REV IMMUNOL, V29, P203, DOI 10.1615/CritRevImmunol.v29.i3.20; Melo SA, 2014, CANCER CELL, V26, P707, DOI 10.1016/j.ccell.2014.09.005; Mittelbrunn M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1285; Montecalvo A, 2012, BLOOD, V119, P756, DOI 10.1182/blood-2011-02-338004; Moussay E, 2011, P NATL ACAD SCI USA, V108, P6573, DOI 10.1073/pnas.1019557108; Negrini M, 2007, J CELL SCI, V120, P1833, DOI 10.1242/jcs.03450; Pegtel DM, 2010, P NATL ACAD SCI USA, V107, P6328, DOI 10.1073/pnas.0914843107; Pizzimenti S, 2009, FREE RADICAL BIO MED, V46, P282, DOI 10.1016/j.freeradbiomed.2008.10.035; Raposo G, 2013, J CELL BIOL, V200, P373, DOI 10.1083/jcb.201211138; Roccaro AM, 2013, J CLIN INVEST, V123, P1542, DOI 10.1172/JCI66517; ROECKLEIN BA, 1995, BLOOD, V85, P997, DOI 10.1182/blood.V85.4.997.bloodjournal854997; Rossi S, 2010, BLOOD, V116, P945, DOI 10.1182/blood-2010-01-263889; Saunderson SC, 2008, J IMMUNOL, V180, P8146, DOI 10.4049/jimmunol.180.12.8146; Skog J, 2008, NAT CELL BIOL, V10, P1470, DOI 10.1038/ncb1800; Squadrito ML, 2014, CELL REP, V8, P1432, DOI 10.1016/j.celrep.2014.07.035; Stacchini A, 1999, LEUKEMIA RES, V23, P127, DOI 10.1016/S0145-2126(98)00154-4; Stoorvogel W, 2012, BLOOD, V119, P646, DOI 10.1182/blood-2011-11-389478; Thery Clotilde, 2011, F1000 Biol Rep, V3, P15, DOI 10.3410/B3-15; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; Tlsty TD, 2006, ANNU REV PATHOL-MECH, V1, P119, DOI 10.1146/annurev.pathol.1.110304.100224; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Wang WX, 2012, HAEMATOL-HEMATOL J, V97, P586, DOI 10.3324/haematol.2011.048132; Zhang SP, 2014, ANNU REV PATHOL-MECH, V9, P103, DOI 10.1146/annurev-pathol-020712-163955	54	58	62	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2015	10	10							e0141429	10.1371/journal.pone.0141429	http://dx.doi.org/10.1371/journal.pone.0141429			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0DL	26509439	Green Published, gold, Green Submitted			2022-12-26	WOS:000363918100081
J	Langhi, LGP; Andrade, LR; Shimabukuro, MK; van Ewijk, W; Taub, DD; Borojevic, R; Coelho, VD				Langhi, Larissa G. P.; Andrade, Leonardo R.; Shimabukuro, Marilia Kimie; van Ewijk, Willem; Taub, Dennis D.; Borojevic, Radovan; Coelho, Valeria de Mello			Lipid-Laden Multilocular Cells in the Aging Thymus Are Phenotypically Heterogeneous	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; MAST-CELLS; IN-VITRO; DIFFERENTIATION; MACROPHAGE; EXPRESSION; TELOCYTES; AUTOPHAGY; RECEPTOR; ORIGIN	Intrathymic lipid-laden multilocular cells (LLMC) are known to express pro-inflammatory factors that might regulate functional activity of the thymus. However, the phenotype of age-associated intrathymic LLMC is still controversial. In this study, we evaluated LLMC density in the aging thymus and better characterized their distribution, ultrastructure and phenotype. Our results show an increased density of LLMC in the thymus from 03 to 24 months of age. Morphologically, intrathymic LLMC exhibit fibroblastoid fusiform, globular or stellate shapes and can be found in the subcapsular region as well as deeper in the parenchyma, including the perivascular area. Some parenchymal LLMC were like telocytes accumulating lipids. We identified lipid droplets with different electrondensities, lipofuscin granules and autolipophagosome-like structures, indicating heterogeneous lipid content in these cells. Autophagosome formation in intrathymic LLMC was confirmed by positive staining for beclin-1 and perilipin (PLIN), marker for lipid droplet-associated proteins. We also found LLMC in close apposition to thymic stromal cells, endothelial cells, mast cells and lymphocytes. Phenotypically, we identified intrathymic LLMC as preadipocytes (PLIN(+)PPAR gamma 2(+)), brown adipocytes (PLIN(+)UCP1(+)), macrophages (PLIN(+)Iba-1(+)) or pericytes (PLIN(+)NG2(+)) but not epithelial cells (PLIN-panCK(+)). These data indicate that intrathymic LLMC are already present in the young thymus and their density significantly increases with age. We also suggest that LLMC, which are morphologically distinct, establish direct contact with lymphocytes and interact with stromal cells. Finally, we evidence that intrathymic LLMC correspond to not only one but to distinct cell types accumulating lipids.	[Langhi, Larissa G. P.; Andrade, Leonardo R.; Shimabukuro, Marilia Kimie; Borojevic, Radovan; Coelho, Valeria de Mello] Univ Fed Rio de Janeiro, Hlth Sci Ctr, Inst Biomed Sci, Rio De Janeiro, Brazil; [van Ewijk, Willem] Erasmus Univ, Dept Immunol, NL-3000 DR Rotterdam, Netherlands; [Taub, Dennis D.] Vet Affairs Med Ctr, Med Serv, Dept Vet Affairs, Washington, DC 20422 USA	Universidade Federal do Rio de Janeiro; Erasmus University Rotterdam; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Coelho, VD (corresponding author), Univ Fed Rio de Janeiro, Hlth Sci Ctr, Inst Biomed Sci, Rio De Janeiro, Brazil.	coelhova@histo.ufrj.br	de Mello Coelho, Valeria/ABA-1201-2021; Borojevic, Radovan/V-8500-2019; de Mello-Coelho, Valeria/N-2242-2014	Borojevic, Radovan/0000-0002-2393-7280; Langhi Prata, Larissa/0000-0001-9617-8089; de Mello-Coelho, Valeria/0000-0002-9367-8181	Rio de Janeiro State Funding Agency/FAPERJ [110.953/2013]; National Council of Technological and Scientific Development/CNPq [475360/2010-9]	Rio de Janeiro State Funding Agency/FAPERJ; National Council of Technological and Scientific Development/CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by the Rio de Janeiro State Funding Agency/FAPERJ http://www.faperj.br/ Grant # 110.953/2013 to VMC, and National Council of Technological and Scientific Development/CNPq http://www.cnpq.br/ Grant# 475360/2010-9 to VMC.	Allan GJ, 2008, J ENDOCRINOL, V199, P155, DOI 10.1677/JOE-08-0269; Armulik A, 2005, CIRC RES, V97, P512, DOI 10.1161/01.RES.0000182903.16652.d7; Aw D, 2008, AGING CELL, V7, P158, DOI 10.1111/j.1474-9726.2007.00365.x; BASCH RS, 1974, P NATL ACAD SCI USA, V71, P1474, DOI 10.1073/pnas.71.4.1474; BOYD RL, 1993, IMMUNOL TODAY, V14, P445, DOI 10.1016/0167-5699(93)90248-J; Charriere G, 2003, J BIOL CHEM, V278, P9850, DOI 10.1074/jbc.M210811200; Cheng JL, 2009, HISTOCHEM CELL BIOL, V132, P281, DOI 10.1007/s00418-009-0615-z; Chung CY, 2013, CLIN DEV IMMUNOL; CLINE MJ, 1972, BLOOD-J HEMATOL, V39, P842, DOI 10.1182/blood.V39.6.842.842; Coelho VD, 2010, INT J MED SCI, V7, P1; de Mello-Coelho V, 2004, 12 INT C IMM 4 ANN C, V14, P279; Franceschi C, 2000, ANN NY ACAD SCI, V908, P244; Frid MG, 2002, CIRC RES, V90, P1189, DOI 10.1161/01.RES.0000021432.70309.28; Gordon J, 2004, NAT IMMUNOL, V5, P546, DOI 10.1038/ni1064; GUNTERN R, 1989, EXPERIENTIA, V45, P159, DOI 10.1007/BF01954858; Jung T, 2010, METHODS MOL BIOL, V594, P173, DOI 10.1007/978-1-60761-411-1_13; Kirkland JL, 2002, EXP GERONTOL, V37, P757, DOI 10.1016/S0531-5565(02)00014-1; Kuper CF, 1992, PATHOBIOLOGY AGING R, V1, P25; Kvell K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010701; Li YK, 2005, J BIOL CHEM, V280, P21763, DOI 10.1074/jbc.M501759200; LOEWENTHAL LA, 1952, ANAT RECORD, V112, P1, DOI 10.1002/ar.1091120102; Meirelles LD, 2008, STEM CELLS, V26, P2287, DOI 10.1634/stemcells.2007-1122; Mello-Coelho V, 2013, J IMMUNOL, V186, P104; Ortman CL, 2002, INT IMMUNOL, V14, P813, DOI 10.1093/intimm/dxf042; Pattingre S, 2008, BIOCHIMIE, V90, P313, DOI 10.1016/j.biochi.2007.08.014; Pearse G, 2006, TOXICOL PATHOL, V34, P504, DOI 10.1080/01926230600865549; Petrie HT, 2003, NAT REV IMMUNOL, V3, P859, DOI 10.1038/nri1223; Platt N, 1996, P NATL ACAD SCI USA, V93, P12456, DOI 10.1073/pnas.93.22.12456; Popescu LM, 2010, J CELL MOL MED, V14, P729, DOI 10.1111/j.1582-4934.2010.01059.x; Raica M, 2010, INT J EXP PATHOL, V91, P17, DOI 10.1111/j.1365-2613.2009.00689.x; Randolph GJ, 2010, CIRC RES, V106, P227, DOI 10.1161/CIRCRESAHA.109.212191; Rosen ED, 2006, NAT REV MOL CELL BIO, V7, P885, DOI 10.1038/nrm2066; Salminen A, 2012, AGING-US, V4, P166, DOI 10.18632/aging.100444; Sears IB, 1996, MOL CELL BIOL, V16, P3410; Sempowski GD, 2000, J IMMUNOL, V164, P2180, DOI 10.4049/jimmunol.164.4.2180; Shapiro H, 2013, J CLIN ENDOCR METAB, V98, P1173, DOI 10.1210/jc.2012-2745; SHIVATSCHEVA T, 1993, FOLIA BIOL-KRAKOW, V41, P37; Singh R, 2009, NATURE, V458, P1131, DOI 10.1038/nature07976; SPICER SS, 1960, AM J PATHOL, V37, P457; SUGIHARA H, 1986, DIFFERENTIATION, V31, P42, DOI 10.1111/j.1432-0436.1986.tb00381.x; Suniara RK, 2000, J EXP MED, V191, P1051, DOI 10.1084/jem.191.6.1051; Taub DD, 2005, IMMUNOL REV, V205, P72, DOI 10.1111/j.0105-2896.2005.00275.x; Theoharides TC, 2012, BBA-MOL BASIS DIS, V1822, P21, DOI 10.1016/j.bbadis.2010.12.014; VANEWIJK W, 1994, IMMUNOL TODAY, V15, P214, DOI 10.1016/0167-5699(94)90246-1; YLAHERTTUALA S, 1991, P NATL ACAD SCI USA, V88, P10143, DOI 10.1073/pnas.88.22.10143; Youm YH, 2009, J BIOL CHEM, V284, P7068, DOI 10.1074/jbc.M808302200; Zheng YH, 2013, J CELL MOL MED, V17, P567, DOI 10.1111/jcmm.12052	47	5	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2015	10	10							e0141516	10.1371/journal.pone.0141516	http://dx.doi.org/10.1371/journal.pone.0141516			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0DL	26509710	gold, Green Published, Green Submitted			2022-12-26	WOS:000363918100095
J	Gundh, J; Singh, A; Singh, RKB				Gundh, Jasleen; Singh, Awaneesh; Singh, R. K. Brojen			Ordering Dynamics in Neuron Activity Pattern Model: An Insight to Brain Functionality	PLOS ONE			English	Article							PHASE-SEPARATION DYNAMICS; ISING-MODEL; RANGE; SYSTEMS; NETWORKS; MOTION	We study the domain ordering kinetics in d = 2 ferromagnets which corresponds to populated neuron activities with both long-ranged interactions, V(r) similar to r(-n) and short-ranged interactions. We present the results from comprehensive Monte Carlo (MC) simulations for the nonconserved Ising model with n >= 2, interaction range considering near and far neighbors. Our model results could represent the long-ranged neuron kinetics (n <= 4) in consistent with the same dynamical behaviour of short-ranged case (n >= 4) at far below and near criticality. We found that emergence of fast and slow kinetics of long and short ranged case could imitate the formation of connections among near and distant neurons. The calculated characteristic length scale in long-ranged interaction is found to be n independent (L(t) similar to t(1/(n) -(2))), whereas short-ranged interaction follows L(t) similar to t(1/2) law and approximately preserve universality in domain kinetics. Further, we did the comparative study of phase ordering near the critical temperature which follows different behaviours of domain ordering near and far critical temperature but follows universal scaling law.	[Gundh, Jasleen; Singh, R. K. Brojen] Jawaharlal Nehru Univ, Sch Computat & Integrat Sci, New Delhi 110067, India; [Singh, Awaneesh] Jawaharlal Nehru Univ, Sch Phys Sci, New Delhi 110067, India	Jawaharlal Nehru University, New Delhi; Jawaharlal Nehru University, New Delhi	Singh, RKB (corresponding author), Jawaharlal Nehru Univ, Sch Computat & Integrat Sci, New Delhi 110067, India.	brojen@mail.jnu.ac.in	Gund, Jasleen/CAE-9327-2022; Singh, Awaneesh/P-3126-2014	Gund, Jasleen/0000-0003-3724-3295; Singh, Awaneesh/0000-0002-8249-4520	CSIR [25(0221)/13/EMR-II]	CSIR(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by CSIR, Grant no. 25(0221)/13/EMR-II.	ALLEN SM, 1979, ACTA METALL MATER, V27, P1085, DOI 10.1016/0001-6160(79)90196-2; Bassettt DS, 2006, P NATL ACAD SCI USA, V103, P19518, DOI 10.1073/pnas.0606005103; Beggs JM, 2003, J NEUROSCI, V23, P11167; Beggs JM, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00163; Bieberich E, 2002, BIOSYSTEMS, V66, P145, DOI 10.1016/S0303-2647(02)00040-0; Binder K., 1988, MONTE CARLO SIMULATI; Blanchard T, 2013, EPL-EUROPHYS LETT, V101, DOI 10.1209/0295-5075/101/56003; BRAY AJ, 1993, PHYS REV E, V47, P3191, DOI 10.1103/PhysRevE.47.3191; BRAY AJ, 1989, PHYS REV LETT, V62, P2841, DOI 10.1103/PhysRevLett.62.2841; BRAY AJ, 1990, PHYS REV B, V41, P6724, DOI 10.1103/PhysRevB.41.6724; BRAY AJ, 1994, ADV PHYS, V43, P357, DOI 10.1080/00018739400101505; BRAY AJ, 1991, PHYS REV LETT, V67, P2670, DOI 10.1103/PhysRevLett.67.2670; Bressler SL, 2010, TRENDS COGN SCI, V14, P277, DOI 10.1016/j.tics.2010.04.004; Bruijn N. G. D., 1981, ASYMPTOTIC METHODS A; Cannas SA, 1996, PHYS REV B, V54, P12661, DOI 10.1103/PhysRevB.54.R12661; Chialvo DR, 2004, PHYSICA A, V340, P756, DOI 10.1016/j.physa.2004.05.064; Deco G, 2012, FRONT COMPUT NEUROSC, V6, DOI 10.3389/fncom.2012.00068; Eguiluz VM, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.018102; FISHER ME, 1972, PHYS REV LETT, V29, P917, DOI 10.1103/PhysRevLett.29.917; Fraiman D, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.061922; Fu M, 2012, NATURE, V483, P92, DOI 10.1038/nature10844; GLAUBER RJ, 1963, J MATH PHYS, V4, P294, DOI 10.1063/1.1703954; Gruneberg D, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.036104; Haldeman C, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.058101; HILEY BJ, 1965, P PHYS SOC LOND, V85, P493, DOI 10.1088/0370-1328/85/3/310; KAWASAKI K, 1966, PHYS REV, V145, P224, DOI 10.1103/PhysRev.145.224; Kinouchi O, 2006, NAT PHYS, V2, P348, DOI 10.1038/nphys289; Lamoreaux SK, 1999, AM J PHYS, V67, P850, DOI 10.1119/1.19138; LIFSHITZ LM, 1962, SOV PHYS JETP-USSR, V15, P939; Liu Y, 2009, PHYS REV E, V79, P2; Lo CC, 2013, EPL-EUROPHYS LETT, V102, DOI 10.1209/0295-5075/102/10008; Marinazzo D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093616; Marinazzo D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045026; Meisel C, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002312; Monceau P, 1998, PHYS REV B, V58, P6386, DOI 10.1103/PhysRevB.58.6386; Newman M., 1999, MONTE CARLO METHODS; Noback CR., 2005, HUMAN NERVOUS SYSTEM; OHTA T, 1982, PHYS REV LETT, V49, P1223, DOI 10.1103/PhysRevLett.49.1223; Onuki A, 2002, PHASE TRANSITION DYN; OONO Y, 1988, PHYS REV A, V38, P434, DOI 10.1103/PhysRevA.38.434; Oono Y., 1988, Modern Physics Letters B, V2, P861, DOI 10.1142/S0217984988000606; OONO Y, 1987, PHYS REV LETT, V58, P836, DOI 10.1103/PhysRevLett.58.836; Picco M, 2012, CRITICAL BEHAV ISING; Porod G., 1982, SMALL ANGLE XRAY SCA; PURI S, 1988, PHYS REV A, V38, P1542, DOI 10.1103/PhysRevA.38.1542; Puri S, 2009, KINETICS PHASE TRANS; Rubinov M, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002038; Schneidman E, 2006, NATURE, V440, P1007, DOI 10.1038/nature04701; Schnitzler A, 2005, NAT REV NEUROSCI, V6, P285, DOI 10.1038/nrn1650; Singh A, 2014, EUR PHYS J E, V37, DOI 10.1140/epje/i2014-14002-9; Socolar JES, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.068702; Stramaglia S, 2014, COMM COM INF SC, V438, P301; Tkacik G, 2008, ARXIVQBIO0611072V1; TOULOUSE G, 1986, P NATL ACAD SCI USA, V83, P1695, DOI 10.1073/pnas.83.6.1695	54	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2015	10	10							e0141463	10.1371/journal.pone.0141463	http://dx.doi.org/10.1371/journal.pone.0141463			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU8PC	26506525	gold, Green Submitted, Green Published			2022-12-26	WOS:000363804200072
J	Novodvorsky, P; Watson, O; Gray, C; Wilkinson, RN; Reeve, S; Smythe, C; Beniston, R; Plant, K; Maguire, R; Rothman, AMK; Elworthy, S; van Eeden, FJM; Chico, TJA				Novodvorsky, Peter; Watson, Oliver; Gray, Caroline; Wilkinson, Robert N.; Reeve, Scott; Smythe, Carl; Beniston, Richard; Plant, Karen; Maguire, Richard; Rothman, Alexander M. K.; Elworthy, Stone; van Eeden, Fredericus J. M.; Chico, Timothy J. A.			klf2a(sh317) Mutant Zebrafish Do Not Recapitulate Morpholino-Induced Vascular and Haematopoietic Phenotypes	PLOS ONE			English	Article							KRUPPEL-LIKE FACTOR-2; KLF2 TRANSCRIPTION FACTOR; CARDIOVASCULAR-SYSTEM; HEMODYNAMIC FORCES; ENDOTHELIAL-CELLS; GENE-EXPRESSION; DANIO-RERIO; IN-VIVO; BLOOD; MUTATIONS	Introduction and Objectives The zinc-finger transcription factor Kruppel-like factor 2 (KLF2) transduces blood flow into molecular signals responsible for a wide range of responses within the vasculature. KLF2 maintains a healthy, quiescent endothelial phenotype. Previous studies report a range of phenotypes following morpholino antisense oligonucleotide-induced klf2a knockdown in zebrafish. Targeted genome editing is an increasingly applied method for functional assessment of candidate genes. We therefore generated a stable klf2a mutant zebrafish and characterised its cardiovascular and haematopoietic development. Methods and Results Using Transcription Activator-Like Effector Nucleases (TALEN) we generated a klf2a mutant (klf2a(sh317)) with a 14bp deletion leading to a premature stop codon in exon 2. Western blotting confirmed loss of wild type Klf2a protein and the presence of a truncated protein in klf2a(sh317) mutants. Homozygous klf2a(sh317) mutants exhibit no defects in vascular patterning, survive to adulthood and are fertile, without displaying previously described morphant phenotypes such as high-output cardiac failure, reduced haematopoetic stem cell (HSC) development or impaired formation of the 5th accessory aortic arch. Homozygous klf2a(sh317) mutation did not reduce angiogenesis in zebrafish with homozygous mutations in von Hippel Lindau (vhl), a form of angiogenesis that is dependent on blood flow. We examined expression of three klf family members in wildtype and klf2a(sh317) zebrafish. We detected vascular expression of klf2b (but not klf4a or biklf/klf4b/klf17) in wildtypes but found no differences in expression that might account for the lack of phenotype in klf2a(sh317) mutants. klf2b morpholino knockdown did not affect heart rate or impair formation of the 5th accessory aortic arch in either wildtypes or klf2ash317 mutants. Conclusions The klf2(ash317) mutation produces a truncated Klf2a protein but, unlike morpholino induced klf2a knockdown, does not affect cardiovascular development.	[Novodvorsky, Peter; Watson, Oliver; Gray, Caroline; Wilkinson, Robert N.; Elworthy, Stone; van Eeden, Fredericus J. M.; Chico, Timothy J. A.] Univ Sheffield, Bateson Ctr, Sheffield, S Yorkshire, England; [Novodvorsky, Peter; Watson, Oliver; Gray, Caroline; Wilkinson, Robert N.; Reeve, Scott; Plant, Karen; Maguire, Richard; Rothman, Alexander M. K.; Chico, Timothy J. A.] Univ Sheffield, Dept Cardiovasc Sci, Sheffield, S Yorkshire, England; [Smythe, Carl; Beniston, Richard; Elworthy, Stone; van Eeden, Fredericus J. M.] Univ Sheffield, Dept Biomed Sci, Sheffield S10 2TN, S Yorkshire, England	University of Sheffield; University of Sheffield; University of Sheffield	Chico, TJA (corresponding author), Univ Sheffield, Bateson Ctr, Sheffield, S Yorkshire, England.	t.j.chico@sheffield.ac.uk	Novodvorsky, Peter/AAW-9679-2020	Novodvorsky, Peter/0000-0002-3292-7586; Wilkinson, Robert/0000-0003-2706-316X; Elworthy, Stone/0000-0002-9739-1540; Chico, Timothy/0000-0002-7458-5481; Rothman, Alexander/0000-0002-7847-4500; Maguire, Richard/0000-0001-7457-6852	Medical Research Council Centre Grant [G0700091]; British Heart Foundation [09/287/28051, 12/12/29433]; European Commission (EC) [HEALTH-F4-2010-242048]; MRC [MR/K002406/1] Funding Source: UKRI; British Heart Foundation [PG/15/17/31332, PG/13/2/29902] Funding Source: researchfish; Medical Research Council [MR/K002406/1] Funding Source: researchfish	Medical Research Council Centre Grant(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); European Commission (EC)(European CommissionEuropean Commission Joint Research Centre); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Medical Research Council (www.mrc.ac.uk) Centre Grant (G0700091) provided a clinical training fellowship to PN. This work was supported by British Heart Foundation (www.bhf.org.uk) project grants 09/287/28051 and 12/12/29433 awarded to TJAC. FvE was supported by European Commission (http://cordis.europa.eu/result/rcn/140792_en.html) as part of its Seventh Framework Programme (EC Grant Agreement HEALTH-F4-2010-242048). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON KP, 1995, MOL CELL BIOL, V15, P5957; [Anonymous], 2001, EXPR ZEBR GEN EMBR I; Barrionuevo WR, 1999, AM J PHYSIOL-REG I, V276, pR505, DOI 10.1152/ajpregu.1999.276.2.R505; Cermak T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr218; Chang YF, 2007, ANNU REV BIOCHEM, V76, P51, DOI 10.1146/annurev.biochem.76.050106.093909; Chen JN, 1996, DEVELOPMENT, V123, P293; Dekker RJ, 2002, BLOOD, V100, P1689, DOI 10.1182/blood-2002-01-0046; Dekker RJ, 2005, AM J PATHOL, V167, P609, DOI 10.1016/S0002-9440(10)63002-7; Driever W, 1996, DEVELOPMENT, V123, P37; Eisen JS, 2008, DEVELOPMENT, V135, P1735, DOI 10.1242/dev.001115; Fledderus JO, 2008, ARTERIOSCL THROM VAS, V28, P1339, DOI 10.1161/ATVBAHA.108.165811; Haffter P, 1996, DEVELOPMENT, V123, P1; Hamik A, 2007, J BIOL CHEM, V282, P13769, DOI 10.1074/jbc.M700078200; Hogan BM, 2009, NAT GENET, V41, P396, DOI 10.1038/ng.321; Huddleson JP, 2004, BIOL CHEM, V385, P723, DOI 10.1515/BC.2004.088; Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501; Kalev-Zylinska ML, 2002, DEVELOPMENT, V129, P2015; Kettleborough RNW, 2013, NATURE, V496, P494, DOI 10.1038/nature11992; Kok FO, 2015, DEV CELL, V32, P97, DOI 10.1016/j.devcel.2014.11.018; Kuo CT, 1997, GENE DEV, V11, P2996, DOI 10.1101/gad.11.22.2996; Lawson ND, 2002, DEV BIOL, V248, P307, DOI 10.1006/dbio.2002.0711; Lee JS, 2006, DEV CELL, V11, P845, DOI 10.1016/j.devcel.2006.09.006; Leslie JD, 2007, DEVELOPMENT, V134, P839, DOI 10.1242/dev.003244; Li IC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020974; Lin ZY, 2010, ARTERIOSCL THROM VAS, V30, P1952, DOI 10.1161/ATVBAHA.110.211474; Lin ZY, 2005, CIRC RES, V96, pE48, DOI 10.1161/01.RES.0000159707.05637.a1; McCormick SM, 2001, P NATL ACAD SCI USA, V98, P8955, DOI 10.1073/pnas.171259298; Nicoli S, 2010, NATURE, V464, P1196, DOI 10.1038/nature08889; Oates AC, 2001, BLOOD, V98, P1792, DOI 10.1182/blood.V98.6.1792; Parmar KM, 2006, J CLIN INVEST, V116, P49, DOI 10.1172/JCI24787; Parmar KM, 2005, J BIOL CHEM, V280, P26714, DOI 10.1074/jbc.C500144200; Quaife NM, 2012, CURR OPIN PHARMACOL, V12, P608, DOI 10.1016/j.coph.2012.06.009; Rossi A, 2015, NATURE, V524, P230, DOI 10.1038/nature14580; Sander JD, 2011, NAT METHODS, V8, P67, DOI 10.1038/NMETH.1542; Schulte-Merker S, 2014, DEVELOPMENT, V141, P3103, DOI 10.1242/dev.112003; Sehnert AJ, 2002, NAT GENET, V31, P106, DOI 10.1038/ng875; SenBanerjee S, 2004, J EXP MED, V199, P1305, DOI 10.1084/jem.20031132; Serluca FC, 2002, CURR BIOL, V12, P492, DOI 10.1016/S0960-9822(02)00694-2; Stainier DYR, 1996, DEVELOPMENT, V123, P285; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; Thompson MA, 1998, DEV BIOL, V197, P248, DOI 10.1006/dbio.1998.8887; van Rooijen E, 2009, BLOOD, V113, P6449, DOI 10.1182/blood-2008-07-167890; Wang L, 2011, BLOOD, V118, P4102, DOI 10.1182/blood-2011-05-353235; Wani MA, 1998, TRANSGENIC RES, V7, P229, DOI 10.1023/A:1008809809843; Wani MA, 1999, GENOMICS, V60, P78, DOI 10.1006/geno.1999.5888; Watson O, 2013, CARDIOVASC RES, V100, P252, DOI 10.1093/cvr/cvt170; WEINSTEIN BM, 1995, NAT MED, V1, P1143, DOI 10.1038/nm1195-1143; Wilkinson RN, 2008, HEDGEHOG TGF BETA FA; Wu JH, 2008, J BIOL CHEM, V283, P3942, DOI 10.1074/jbc.M707882200	49	32	32	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2015	10	10							e0141611	10.1371/journal.pone.0141611	http://dx.doi.org/10.1371/journal.pone.0141611			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU8PC	26506092	Green Published, Green Accepted, Green Submitted, gold			2022-12-26	WOS:000363804200091
J	Stas, JI; Bocksteins, E; Labro, AJ; Snyders, DJ				Stas, Jeroen I.; Bocksteins, Elke; Labro, Alain J.; Snyders, Dirk J.			Modulation of Closed-State Inactivation in Kv2.1/Kv6.4 Heterotetramers as Mechanism for 4-AP Induced Potentiation	PLOS ONE			English	Article							GATED K+ CHANNELS; PULMONARY-ARTERY MYOCYTES; U-TYPE INACTIVATION; POTASSIUM CHANNELS; DELAYED-RECTIFIER; MOLECULAR-BASIS; SMOOTH-MUSCLE; V CHANNEL; S6 GATE; INTERNATIONAL-UNION	The voltage-gated K+ (Kv) channel subunits Kv2.1 and Kv2.2 are expressed in almost every tissue. The diversity of Kv2 current is increased by interacting with the electrically silent Kv (KvS) subunits Kv5-Kv6 and Kv8-Kv9, into functional heterotetrameric Kv2/KvS channels. These Kv2/KvS channels possess unique biophysical properties and display a more tissue-specific expression pattern, making them more desirable pharmacological and therapeutic targets. However, little is known about the pharmacological properties of these heterotetrameric complexes. We demonstrate that Kv5.1, Kv8.1 and Kv9.3 currents were inhibited differently by the channel blocker 4 -aminopyridine (4-AP) compared to Kv2.1 homotetramers. In contrast, Kv6.4 currents were potentiated by 4-AP while displayingmoderately increased affinities for the channel pore blockers quinidine and flecainide. We found that the 4-AP induced potentiation of Kv6.4 currents was caused bymodulation of the Kv6.4-mediated closed-state inactivation: suppression by 4-AP of the Kv2.1/Kv6.4 closed-state inactivation recovered a population of Kv2.1/Kv6.4 channels that was inactivated at resting conditions, i.e. at a holding potential of -80 mV. This modulation also resulted in a slower initiation and faster recovery from closed-state inactivation. Using chimeric substitutions between Kv6.4 and Kv9.3 subunits, we demonstrated that the lower half of the S6 domain (S6c) plays a crucial role in the 4-AP induced potentiation. These results demonstrate that KvS subunits modify the pharmacological response of Kv2 subunits when assembled in heterotetramers and illustrate the potential of KvS subunits to provide unique pharmacological properties to the heterotetramers, as is the case for 4-AP on Kv2.1/Kv6.4 channels.	[Stas, Jeroen I.; Bocksteins, Elke; Labro, Alain J.; Snyders, Dirk J.] Univ Antwerp, Dept Biomed Sci, Lab Mol Biophys Physiol & Pharmacol, CDE, B-2020 Antwerp, Belgium	University of Antwerp	Snyders, DJ (corresponding author), Univ Antwerp, Dept Biomed Sci, Lab Mol Biophys Physiol & Pharmacol, CDE, Univ Pl 1, B-2020 Antwerp, Belgium.	dirk.snyders@uantwerpen.be		Labro, Alain J/0000-0002-0871-7511	Research Foundation - Flanders (FWO) [FWO-G.0449.11, FWO-G.0433.12];  [FWO-11M0514N];  [FWO-1291913N]	Research Foundation - Flanders (FWO)(FWO); ; 	This work was supported by the Ph.D. fellowship FWO-11M0514N to JIS, the postdoctoral fellowship FWO-1291913N to EB and the grants FWO-G.0449.11 and FWO-G.0433.12 to DJS from the Research Foundation - Flanders (FWO).	Ader C, 2009, EMBO J, V28, P2825, DOI 10.1038/emboj.2009.218; Archer SL, 1998, J CLIN INVEST, V101, P2319, DOI 10.1172/JCI333; Bahring R, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00100; Bahring R, 2011, J PHYSIOL-LONDON, V589, P461, DOI 10.1113/jphysiol.2010.191965; Baranauskas G, 1999, J NEUROSCI, V19, P6394; Barghaan J, 2009, J GEN PHYSIOL, V133, P205, DOI 10.1085/jgp.200810073; Baukrowitz T, 1996, P NATL ACAD SCI USA, V93, P13357, DOI 10.1073/pnas.93.23.13357; Bocksteins E, 2011, EUR BIOPHYS J BIOPHY, V40, P783, DOI 10.1007/s00249-011-0694-3; Bocksteins E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037143; Bocksteins E, 2012, PHYSIOLOGY, V27, P73, DOI 10.1152/physiol.00023.2011; Caballero NA, 2007, J MOL MODEL, V13, P579, DOI 10.1007/s00894-007-0184-9; Cheng YM, 2011, BIOPHYS J, V101, P651, DOI 10.1016/j.bpj.2011.06.025; Claydon TW, 2007, J PHARMACOL EXP THER, V320, P162, DOI 10.1124/jpet.106.110411; Coppock EA, 2001, AM J PHYSIOL-LUNG C, V281, pL1, DOI 10.1152/ajplung.2001.281.1.L1; Cuello LG, 2010, NATURE, V466, P272, DOI 10.1038/nature09136; Cuello LG, 2010, NATURE, V466, P203, DOI 10.1038/nature09153; Czirjak G, 2007, J NEUROPHYSIOL, V98, P1213, DOI 10.1152/jn.00493.2007; Decher N, 2004, J BIOL CHEM, V279, P13859, DOI 10.1074/jbc.M313704200; Decher N, 2006, MOL PHARMACOL, V70, P1204, DOI 10.1124/mol.106.026203; Dougherty K, 2008, J GEN PHYSIOL, V131, P257, DOI 10.1085/jgp.200709938; Gutman GA, 2005, PHARMACOL REV, V57, P473, DOI 10.1124/pr.57.4.10; Gutman GA, 2003, PHARMACOL REV, V55, P583, DOI 10.1124/pr.55.4.9; Hackos DH, 2002, J GEN PHYSIOL, V119, P521, DOI 10.1085/jgp.20028569; Hille B, 2001, ION CHANNELS OF EXCI; Hristov KL, 2012, AM J PHYSIOL-CELL PH, V302, pC360, DOI 10.1152/ajpcell.00303.2010; Imbrici P, 2009, CHANNELS, V3, P39, DOI 10.4161/chan.3.1.7548; Jackson AC, 2007, J NEUROSCI, V27, P10785, DOI 10.1523/JNEUROSCI.0935-07.2007; Jorge BS, 2011, P NATL ACAD SCI USA, V108, P5443, DOI 10.1073/pnas.1017539108; Kerschensteiner D, 1999, BIOPHYS J, V77, P248, DOI 10.1016/S0006-3495(99)76886-4; KIRSCH GE, 1993, NEURON, V11, P503, DOI 10.1016/0896-6273(93)90154-J; KIRSCH GE, 1993, J GEN PHYSIOL, V102, P797, DOI 10.1085/jgp.102.5.797; Kitaguchi T, J GEN PHYSL, V124, P319; Klemic KG, 1998, BIOPHYS J, V74, P1779, DOI 10.1016/S0006-3495(98)77888-9; Koh SD, 1999, J PHYSIOL-LONDON, V515, P475, DOI 10.1111/j.1469-7793.1999.475ac.x; Kurata HT, 2005, J PHYSIOL-LONDON, V568, P31, DOI 10.1113/jphysiol.2005.087148; Labro AJ, 2003, J BIOL CHEM, V278, P50724, DOI 10.1074/jbc.M306097200; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Madeja M, 2010, J BIOL CHEM, V285, P33898, DOI 10.1074/jbc.M110.159897; Martinez-Morales E, 2014, BIOPHYS J, V106, P134, DOI 10.1016/j.bpj.2013.11.025; Muller D, 2014, SCIENCE, V343, P1264, DOI 10.1126/science.1246448; Ottschytsch N, 2005, J PHYSIOL-LONDON, V568, P737, DOI 10.1113/jphysiol.2005.090142; Ottschytsch N, 2002, P NATL ACAD SCI USA, V99, P7986, DOI 10.1073/pnas.122617999; Pan AC, 2011, J GEN PHYSIOL, V138, P571, DOI 10.1085/jgp.201110670; Patel AJ, 1999, ANN NY ACAD SCI, V868, P438, DOI 10.1111/j.1749-6632.1999.tb11309.x; Pless SA, 2013, ELIFE, V2, DOI 10.7554/eLife.01289; Rich TC, 1998, BIOPHYS J, V75, P183, DOI 10.1016/S0006-3495(98)77505-8; Robbins J, 2001, PHARMACOL THERAPEUT, V90, P1, DOI 10.1016/S0163-7258(01)00116-4; SHIEH CC, 1994, BIOPHYS J, V67, P2316, DOI 10.1016/S0006-3495(94)80718-0; Shieh CC, 1997, J GEN PHYSIOL, V109, P767, DOI 10.1085/jgp.109.6.767; Shin KS, 2004, NEURON, V41, P737, DOI 10.1016/S0896-6273(04)00083-2; SNYDERS DJ, 1993, J GEN PHYSIOL, V101, P513, DOI 10.1085/jgp.101.4.513; Swartz KJ, 2005, J GEN PHYSIOL, V126, P413, DOI 10.1085/jgp.200509430; Thorneloe KS, 2003, J PHYSIOL-LONDON, V549, P65, DOI 10.1113/jphysiol.2003.039859; Tieleman DP, 2001, PROTEINS, V44, P63, DOI 10.1002/prot.1073; Wu HM, 2006, AM J HUM GENET, V79, P574, DOI 10.1086/507568; Yang YS, 1997, J GEN PHYSIOL, V109, P779, DOI 10.1085/jgp.109.6.779; Yeola SW, 1996, CIRC RES, V78, P1105, DOI 10.1161/01.RES.78.6.1105; Yuan XJ, 1998, AM J PHYSIOL-LUNG C, V274, pL621, DOI 10.1152/ajplung.1998.274.4.L621; Zhang HL, 1998, J PHARMACOL EXP THER, V287, P332; Zhu XR, 1999, RECEPTOR CHANNEL, V6, P337	60	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2015	10	10							e0141349	10.1371/journal.pone.0141349	http://dx.doi.org/10.1371/journal.pone.0141349			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU8PC	26505474	Green Published, Green Submitted, gold			2022-12-26	WOS:000363804200053
J	Wei, NN; Lv, HN; Wu, Y; Yang, SL; Sun, XY; Lai, R; Jiang, Y; Wang, KW				Wei, Ning-Ning; Lv, Hai-Ning; Wu, Yang; Yang, Shi-Long; Sun, Xiao-Ying; Lai, Ren; Jiang, Yong; Wang, KeWei			Selective Activation of Nociceptor TRPV1 Channel and Reversal of Inflammatory Pain in Mice by a Novel Coumarin Derivative Muralatin L from Murraya alata	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VANILLOID RECEPTOR TRPV1; ROOT GANGLION NEURONS; CAPSAICIN RECEPTOR; BLACK PEPPER; MECHANISMS; DESENSITIZATION; HYPERALGESIA; PIPERINE; RAT	Coumarin and its derivatives are fragrant natural compounds isolated from the genus Murraya that are flowering plants widely distributed in East Asia, Australia, and the Pacific Islands. Murraya plants have been widely used as medicinal herbs for relief of pain, such as headache, rheumatic pain, toothache, and snake bites. However, little is known about their analgesic components and the molecular mechanism underlying pain relief. Here, we report the bioassay-guided fractionation and identification of a novel coumarin derivative, named muralatin L, that can specifically activate the nociceptor transient receptor potential vanilloid 1 (TRPV1) channel and reverse the inflammatory pain in mice through channel desensitization. Muralatin L was identified from the active extract of Murraya alata against TRPV1 transiently expressed in HEK-293T cells in fluorescent calcium FlexStation assay. Activation of TRPV1 current by muralatin L and its selectivity were further confirmed by whole-cell patch clamp recordings of TRPV1-expressing HEK-293T cells and dorsal root ganglion neurons isolated from mice. Furthermore, muralatin L could reverse inflammatory pain induced by formalin and acetic acid in mice but not in TRPV1 knock-out mice. Taken together, our findings show that muralatin L specifically activates TRPV1 and reverses inflammatory pain, thus highlighting the potential of coumarin derivatives from Murraya plants for pharmaceutical and medicinal applications such as pain therapy.	[Wei, Ning-Ning; Wang, KeWei] Peking Univ, Hlth Sci Ctr, Dept Neurobiol, Beijing 100191, Peoples R China; [Wei, Ning-Ning; Wang, KeWei] Peking Univ, Neurosci Res Inst, Sch Basic Med Sci, Hlth Sci Ctr, Beijing 100191, Peoples R China; [Lv, Hai-Ning; Jiang, Yong] Peking Univ, State Key Lab Nat & Biomimet Drugs, Beijing 100191, Peoples R China; [Wu, Yang; Wang, KeWei] Peking Univ, Sch Pharmaceut Sci, Dept Mol & Cellular Pharmacol, IDG,McGovern Inst Brain Res, Beijing 100191, Peoples R China; [Yang, Shi-Long; Lai, Ren] Chinese Acad Sci, Kunming Inst Zool, Key Lab Anim Models & Human Dis Mech, Kunming 650223, Yunnan, Peoples R China; [Sun, Xiao-Ying; Wang, KeWei] Qingdao Univ, Sch Pharm, Dept Pharmacol, Qingdao 266021, Peoples R China	Peking University; Peking University; Peking University; Peking University; Chinese Academy of Sciences; Kunming Institute of Zoology; Qingdao University	Jiang, Y (corresponding author), Peking Univ, Xueyuan Rd, Beijing 100191, Peoples R China.	yongjiang@bjmu.edu.cn; wangkw@bjmu.edu.cn	Jiang, Yong/C-4026-2016	Jiang, Yong/0000-0002-8450-7786	Ministry of Science and Technology of China [2013CB531302, 2013ZX09103001-015, 2014 ZX09507003-006-004]; National Natural Sciences Foundation of China [81222051, 81473106]; National Key Technology R&D Program "New Drug Innovation" of China [2012ZX09301002-002-002, 2012ZX09304-005]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Technology R&D Program "New Drug Innovation" of China(National Key Technology R&D Program)	This work was supported by Ministry of Science and Technology of China Research Grants 2013CB531302, 2013ZX09103001-015, and 2014 ZX09507003-006-004 (to K. W. W.), National Natural Sciences Foundation of China Grants 81222051 and 81473106, and National Key Technology R&D Program "New Drug Innovation" of China Grants 2012ZX09301002-002-002 and 2012ZX09304-005 (to Y. J.). The authors declare that they have no conflicts of interest with the contents of this article.	Almasi R, 2003, BRIT J PHARMACOL, V139, P49, DOI 10.1038/sj.bjp.0705234; Armero P, 2012, MED CLIN-BARCELONA, V139, P1, DOI 10.1016/j.medcli.2011.10.028; Arora RK, 2014, ACTA PHARM SIN B, V4, P368, DOI 10.1016/j.apsb.2014.07.001; Basbaum AI, 2009, CELL, V139, P267, DOI 10.1016/j.cell.2009.09.028; Bhardwaj RK, 2002, J PHARMACOL EXP THER, V302, P645, DOI 10.1124/jpet.102.034728; Bolcskei K, 2005, PAIN, V117, P368, DOI 10.1016/j.pain.2005.06.024; Cao EH, 2013, NATURE, V504, P113, DOI 10.1038/nature12823; Cao X, 2012, J BIOL CHEM, V287, P25905, DOI 10.1074/jbc.M112.364869; Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Chen XJ, 2014, J BIOL CHEM, V289, P9600, DOI 10.1074/jbc.M113.536862; Davis JB, 2000, NATURE, V405, P183, DOI 10.1038/35012076; de la Roche J, 2013, J BIOL CHEM, V288, P20280, DOI 10.1074/jbc.M113.479337; Docherty RJ, 1996, PFLUG ARCH EUR J PHY, V431, P828, DOI 10.1007/BF02332166; Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430; Gao Y., 2009, ZHONGGUO YAOSHI, P691; Jones Virginia M, 2011, J Pain Palliat Care Pharmacother, V25, P32, DOI 10.3109/15360288.2010.547561; Koplas PA, 1997, J NEUROSCI, V17, P3525; Lei L, 2013, J BIOL CHEM, V288, P10427, DOI 10.1074/jbc.M113.457291; McNamara FN, 2005, BRIT J PHARMACOL, V144, P781, DOI 10.1038/sj.bjp.0706040; Nahin Richard L, 2009, Natl Health Stat Report, P1; Niiyama Y, 2007, NEUROSCIENCE, V148, P560, DOI 10.1016/j.neuroscience.2007.05.049; Nilius B, 2014, PHARMACOL REV, V66, P676, DOI 10.1124/pr.113.008268; Owsianik G, 2006, ANNU REV PHYSIOL, V68, P685, DOI 10.1146/annurev.physiol.68.040204.101406; Pearce LV, 2004, ORG BIOMOL CHEM, V2, P2281, DOI 10.1039/b404506h; SAFIEHGARABEDIAN B, 1995, BRIT J PHARMACOL, V115, P1265, DOI 10.1111/j.1476-5381.1995.tb15035.x; Salazar H, 2008, NAT NEUROSCI, V11, P255, DOI 10.1038/nn2056; Siemens J, 2006, NATURE, V444, P208, DOI 10.1038/nature05285; Song L. R., 1999, CHINESE MAT MED, V4, P961; Szallasi A, 2000, TRENDS NEUROSCI, V23, P491, DOI 10.1016/S0166-2236(00)01630-1; Szallasi A, 1999, PHARMACOL REV, V51, P159; Szallasi A, 2007, NAT REV DRUG DISCOV, V6, P357, DOI 10.1038/nrd2280; Szallasi A, 2012, EXPERT OPIN INV DRUG, V21, P1351, DOI 10.1517/13543784.2012.704021; TJOLSEN A, 1992, PAIN, V51, P5, DOI 10.1016/0304-3959(92)90003-T; Tominaga M, 2005, PFLUG ARCH EUR J PHY, V451, P143, DOI 10.1007/s00424-005-1457-8; Wong W, 2004, NAT REV MOL CELL BIO, V5, P959, DOI 10.1038/nrm1527; Wu LH, 2010, PHARM BIOL, V48, P1344, DOI 10.3109/13880201003793723; WU TS, 1981, PHYTOCHEMISTRY, V20, P178, DOI 10.1016/0031-9422(81)85247-8; Xu HX, 2006, NAT NEUROSCI, V9, P628, DOI 10.1038/nn1692; Xu HX, 2005, J NEUROSCI, V25, P8924, DOI 10.1523/JNEUROSCI.2574-05.2005; Yang BH, 2003, J DENT RES, V82, P781, DOI 10.1177/154405910308201004; Yang SL, 2013, P NATL ACAD SCI USA, V110, P17534, DOI 10.1073/pnas.1306285110; Zhang F, 2011, J BIOL CHEM, V286, P15308, DOI 10.1074/jbc.M111.223941; Zou L., 2000, ZHONGGUO YIYAO XUEBA, V15, P298	44	20	21	1	36	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 8	2016	291	2					640	651		10.1074/jbc.M115.654392	http://dx.doi.org/10.1074/jbc.M115.654392			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DA5GF	26515068	Green Published, hybrid			2022-12-26	WOS:000367830500012
J	Nakano, R; Edamura, K; Nakayama, T; Narita, T; Okabayashi, K; Sugiya, H				Nakano, Rei; Edamura, Kazuya; Nakayama, Tomohiro; Narita, Takanori; Okabayashi, Ken; Sugiya, Hiroshi			Fibroblast Growth Factor Receptor-2 Contributes to the Basic Fibroblast Growth Factor-Induced Neuronal Differentiation in Canine Bone Marrow Stromal Cells via Phosphoinositide 3-Kinase/Akt Signaling Pathway	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; IN-VITRO DIFFERENTIATION; NEURITE OUTGROWTH; SPINAL-CORD; NEURAL DIFFERENTIATION; EXPRESSION; SURVIVAL; ACTIVATION; RAT; AKT	Bone marrow stromal cells (BMSCs) are considered as candidates for regenerative therapy and a useful model for studying neuronal differentiation. The role of basic fibroblast growth factor (bFGF) in neuronal differentiation has been previously studied; however, the signaling pathway involved in this process remains poorly understood. In this study, we investigated the signaling pathway in the bFGF-induced neuronal differentiation of canine BMSCs. bFGF induced the mRNA expression of the neuron marker, microtubule associated protein-2 (MAP2) and the neuron-like morphological change in canine BMSCs. In the presence of inhibitors of fibroblast growth factor receptors (FGFR), phosphatidylinositol 3-kinase (PI3K) and Akt, i.e., SU5402, LY294002, and MK2206, respectively, bFGF failed to induce the MAP2 mRNA expression and the neuron-like morphological change. bFGF induced Akt phosphorylation, but it was attenuated by the FGFR inhibitor SU5402 and the PI3K inhibitor LY294002. In canine BMSCs, expression of FGFR-1 and FGFR-2 was confirmed, but only FGFR-2 activation was detected by cross-linking and immunoprecipitation analysis. Small interfering RNA-mediated knockdown of FGFR-2 in canine BMSCs resulted in the attenuation of bFGF-induced Akt phosphorylation. These results suggest that the FGFR-2/PI3K/Akt signaling pathway is involved in the bFGF-induced neuronal differentiation of canine BMSCs.	[Nakano, Rei; Edamura, Kazuya] Nihon Univ, Coll Bioresource Sci, Dept Vet Med, Lab Vet Surg, Fujisawa, Kanagawa, Japan; [Nakano, Rei; Narita, Takanori; Okabayashi, Ken; Sugiya, Hiroshi] Nihon Univ, Coll Bioresource Sci, Dept Vet Med, Vet Biochem Lab, Fujisawa, Kanagawa, Japan; [Nakayama, Tomohiro] Nihon Univ, Coll Bioresource Sci, Dept Vet Med, Lab Vet Radiol, Fujisawa, Kanagawa, Japan	Nihon University; Nihon University; Nihon University	Sugiya, H (corresponding author), Nihon Univ, Coll Bioresource Sci, Dept Vet Med, Vet Biochem Lab, Fujisawa, Kanagawa, Japan.	sugiya.hiroshi@nihon-u.ac.jp	Nakayama, Tomohiro/GYU-0303-2022; Narita, Takanori/F-1092-2011	Okabayashi, Ken/0000-0003-2525-9265; Nakano, Rei/0000-0003-0255-6347; Narita, Takanori/0000-0003-0295-5014	Ministry of Education, Science, Sports and Culture of Japan [24580465, 24580433]	Ministry of Education, Science, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a Grant-in-Aid for Scientific Research [#24580465 (KE) and #24580433 (HS)] from the Ministry of Education, Science, Sports and Culture of Japan (https://www.jsps.go.jp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; Anderson KE, 1998, CURR BIOL, V8, P684, DOI 10.1016/S0960-9822(98)70274-X; Bahat-Stroomza M, 2009, J MOL NEUROSCI, V39, P199, DOI 10.1007/s12031-008-9166-3; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brunet A, 2001, CURR OPIN NEUROBIOL, V11, P297, DOI 10.1016/S0959-4388(00)00211-7; Castelo-Branco G, 2004, J CELL SCI, V117, P5731, DOI 10.1242/jcs.01505; Chen XH, 2004, CELL BIOL INT, V28, P791, DOI 10.1016/j.cellbi.2004.07.009; Chu MS, 2006, CELL SIGNAL, V18, P519, DOI 10.1016/j.cellsig.2005.05.018; Cosker KE, 2007, BIOCHEM SOC T, V35, P207, DOI 10.1042/BST0350207; Dastjerdi FV, 2012, CELL BIOL INT, V36, P967, DOI 10.1042/CBI20110541; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; Dezawa M, 2004, J CLIN INVEST, V113, P1701, DOI 10.1172/JCI200420935; Edamura K, 2012, J VET MED SCI, V74, P923, DOI 10.1292/jvms.11-0388; Edamura K, 2012, J VET MED SCI, V74, P817, DOI 10.1292/jvms.11-0367; Egusa H, 2005, J BIOL CHEM, V280, P23691, DOI 10.1074/jbc.M413796200; Ford-Perriss M, 2001, CLIN EXP PHARMACOL P, V28, P493, DOI 10.1046/j.1440-1681.2001.03477.x; Frebel K, 2006, BIOCHEM SOC T, V34, P1287, DOI 10.1042/BST0341287; Gong Y, 2015, MOL MED REP, V11, P367, DOI 10.3892/mmr.2014.2727; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; Han J, 2008, MOL CELL NEUROSCI, V39, P118, DOI 10.1016/j.mcn.2008.06.003; He JCJ, 2005, J BIOL CHEM, V280, P33426, DOI 10.1074/jbc.M502812200; Hughes SE, 1997, J HISTOCHEM CYTOCHEM, V45, P1005, DOI 10.1177/002215549704500710; Itoh N, 2004, TRENDS GENET, V20, P563, DOI 10.1016/j.tig.2004.08.007; Kaka GR, 2012, INT J NEUROSCI, V122, P237, DOI 10.3109/00207454.2011.642037; Khonsari RH, 2012, AM J MED GENET A, V158A, P2797, DOI 10.1002/ajmg.a.35598; Li L, 2015, CELL MOL BIOL LETT, V20, P385, DOI 10.1515/cmble-2015-0023; Lobo MVT, 2003, J HISTOCHEM CYTOCHEM, V51, P89, DOI 10.1177/002215540305100111; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Ma'ayan A, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.254cm1; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Mao YW, 2005, J CELL BIOL, V170, P305, DOI 10.1083/jcb.200505061; Mareschi K, 2006, EXP HEMATOL, V34, P1563, DOI 10.1016/j.exphem.2006.06.020; McIntosh I, 2000, CELL STRUCT FUNCT, V25, P85, DOI 10.1247/csf.25.85; Middlemas DS, 1999, J BIOL CHEM, V274, P16451, DOI 10.1074/jbc.274.23.16451; Mruthyunjaya S, 2011, FEBS LETT, V585, P1915, DOI 10.1016/j.febslet.2011.04.072; Mullenbrock S, 2011, J BIOL CHEM, V286, P45131, DOI 10.1074/jbc.M111.274076; Nakano R, 2015, J VET MED SCI, V77, P27, DOI 10.1292/jvms.14-0284; Nakano R, 2013, AM J VET RES, V74, P1311, DOI 10.2460/ajvr.74.10.1311; Nandy SB, 2014, J BIOMED SCI, V21, DOI 10.1186/s12929-014-0083-1; Neuhuber B, 2004, J NEUROSCI RES, V77, P192, DOI 10.1002/jnr.20147; Niidome T, 2009, BIOCHEM BIOPH RES CO, V390, P1018, DOI 10.1016/j.bbrc.2009.10.100; Ojeda L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023414; Park JH, 2012, BMB REP, V45, P521, DOI 10.5483/BMBRep.2012.45.9.114; Park SS, 2011, J CELL PHYSIOL, V226, P3251, DOI 10.1002/jcp.22686; Poulsom R, 2002, J PATHOL, V197, P441, DOI 10.1002/path.1176; Prockop DJ, 1997, SCIENCE, V276, P71, DOI 10.1126/science.276.5309.71; Qiao JB, 2012, BIOCHEM BIOPH RES CO, V424, P421, DOI 10.1016/j.bbrc.2012.06.125; Read DE, 2009, CELL MOL LIFE SCI, V66, P2975, DOI 10.1007/s00018-009-0057-8; RYDEL RE, 1987, J NEUROSCI, V7, P3639; Shi SH, 2003, CELL, V112, P63, DOI 10.1016/S0092-8674(02)01249-7; Sun D, 2009, EXP NEUROL, V216, P56, DOI 10.1016/j.expneurol.2008.11.011; Terada K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093223; Tondreau T, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-166; Tropel P, 2006, STEM CELLS, V24, P2868, DOI 10.1634/stemcells.2005-0636; Trzaska KA, 2007, STEM CELLS, V25, P2797, DOI 10.1634/stemcells.2007-0212; Trzaska KA, 2009, J NEUROCHEM, V110, P1058, DOI 10.1111/j.1471-4159.2009.06201.x; Tsai HL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104937; Vats A, 2005, LANCET, V366, P592, DOI 10.1016/S0140-6736(05)66879-1; WANG JK, 1994, MOL CELL BIOL, V14, P181, DOI 10.1128/MCB.14.1.181; Wang ZG, 2012, TOXICOL LETT, V212, P137, DOI 10.1016/j.toxlet.2012.05.006; Weiss S, 1996, J NEUROSCI, V16, P7599; Woodbury D, 2000, J NEUROSCI RES, V61, P364, DOI 10.1002/1097-4547(20000815)61:4<364::AID-JNR2>3.0.CO;2-C; Yang HJ, 2008, J BIOL CHEM, V283, P5287, DOI 10.1074/jbc.M706917200; Yu Q, 2013, BIOCHEM BIOPH RES CO, V439, P297, DOI 10.1016/j.bbrc.2013.08.030; Zaragosi LE, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-11; Zeng X, 2015, BIOMATERIALS, V53, P184, DOI 10.1016/j.biomaterials.2015.02.073; Zhang F, 2002, NEUROSCIENCE, V114, P837, DOI 10.1016/S0306-4522(02)00321-4; Zhang HY, 2013, CNS NEUROSCI THER, V19, P20, DOI 10.1111/cns.12013; Zhang ZY, 2012, J CELL MOL MED, V16, P2708, DOI 10.1111/j.1582-4934.2012.01591.x; Zurashvili T, 2013, MOL CELL BIOL, V33, P1027, DOI 10.1128/MCB.01052-12	70	17	18	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2015	10	11							e0141581	10.1371/journal.pone.0141581	http://dx.doi.org/10.1371/journal.pone.0141581			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV1PG	26523832	Green Published, Green Submitted, gold			2022-12-26	WOS:000364029800013
J	Jankovic, J; Eric, M; Stojisavljevic, D; Marinkovic, J; Jankovic, S				Jankovic, Janko; Eric, Milos; Stojisavljevic, Dragana; Marinkovic, Jelena; Jankovic, Slavenka			Socio-Economic Differences in Cardiovascular Health: Findings from a Cross-Sectional Study in a Middle-Income Country	PLOS ONE			English	Article							RISK-FACTORS; EUROPEAN COUNTRY; EARLY RETIREMENT; DISEASE; ASSOCIATIONS; POPULATION; ADULTS; PREVALENCE; EDUCATION; MORTALITY	Background A relatively consistent body of literature, mainly from high-income countries, supports an inverse association between socio-economic status (SES) and risk of cardiovascular disease (CVD). Data from low- and middle-income countries are scarce. This study explores SES differences in cardiovascular health (CVH) in the Republic of Srpska (RS), Bosnia and Herzegovina, a middle-income country. Methods We collected information on SES (education, employment status and household's relative economic status, i.e. household wealth) and the 7 ideal CVH components (smoking status, body mass index, physical activity, diet, blood pressure, total cholesterol, and fasting blood glucose) among 3601 participants 25 years of age and older, from the 2010 National Health Survey in the RS. Based on the sum of all 7 CVH components an overall CVH score (CVHS) was calculated ranging from 0 (all CVH components at poor levels) to 14 (all CVH components at ideal levels). To assess the differences between groups the chi-square test, t-test and ANOVA were used where appropriate. The association between SES and CVHS was analysed with multivariate linear regression analyses. The dependent variable was CVHS, while independent variables were educational level, employment status and wealth index. Results According to multiple linear regression analysis CVHS was independently associated with education attainment and employment status. Participants with higher educational attainment and those economically active had higher CVHS (b = 0.57; CI = 0.29-0.85 and b = 0.27; CI = 0.10-0.44 respectively) after adjustment for sex, age group, type of settlement, and marital status. We failed to find any statistically significant difference between the wealth index and CVHS. Conclusion This study presents the novel information, since CVHS generated from the individual CVH components was not compared by socio-economic status till now. Our finding that the higher overall CVHS was independently associated with a higher education attainment and those economically active supports the importance of reducing socio-economic inequalities in CVH in RS.	[Jankovic, Janko] Univ Belgrade, Fac Med, Inst Social Med, Belgrade, Serbia; [Eric, Milos] Singidunum Univ, Fac Econ Finance & Adm, Ctr European Integrat & Publ Management, Belgrade, Serbia; [Stojisavljevic, Dragana] Inst Publ Hlth, Banja Luka, Republic Of Srp, Bosnia & Herceg; [Marinkovic, Jelena] Univ Belgrade, Fac Med, Inst Med Stat & Informat, Belgrade, Serbia; [Jankovic, Slavenka] Univ Belgrade, Fac Med, Inst Epidemiol, Belgrade, Serbia	University of Belgrade; University of Belgrade; University of Belgrade	Jankovic, J (corresponding author), Univ Belgrade, Fac Med, Inst Social Med, Belgrade, Serbia.	drjankojankovic@yahoo.com	Eric, Milos/B-9602-2018	Eric, Milos/0000-0002-5557-9393; Jankovic, Janko/0000-0002-2387-6596; Marinkovic, Jelena/0000-0001-8852-384X; Jankovic, Slavenka/0000-0001-6791-3056	World Bank; Ministry of Health and Social Welfare of the Republic of Srpska; Ministry of Education, Science and Technological Development of the Republic of Serbia [175025]	World Bank(The World Bank India); Ministry of Health and Social Welfare of the Republic of Srpska; Ministry of Education, Science and Technological Development of the Republic of Serbia	The 2010 National Health Survey was supported by the World Bank and Ministry of Health and Social Welfare of the Republic of Srpska. Funding for this work was obtained from the Ministry of Education, Science and Technological Development of the Republic of Serbia (project No. 175025). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agency for Statistics of BH, 2010, LAB FORC SURV 2010; Alavinia SM, 2008, INT ARCH OCC ENV HEA, V82, P39, DOI 10.1007/s00420-008-0304-6; Albert MA, 2006, CIRCULATION, V114, P2619, DOI 10.1161/CIRCULATIONAHA.106.660043; Annandale E, 1999, GENDER INEQUALITIES IN HEALTH, P1; Artazcoz L, 2004, SOC SCI MED, V59, P263, DOI 10.1016/j.socscimed.2003.10.029; Bahonar A, 2011, INT J PUBLIC HEALTH, V56, P37, DOI 10.1007/s00038-010-0125-8; Ball K, 2005, SOC SCI MED, V60, P1987, DOI 10.1016/j.socscimed.2004.08.056; Beauchamp A, 2010, J EPIDEMIOL COMMUN H, V64, P542, DOI 10.1136/jech.2009.094516; Bostean G, 2013, ANN EPIDEMIOL, V23, P388, DOI 10.1016/j.annepidem.2013.04.012; Braveman P, 2011, ANNU REV PUBL HEALTH, V32, P381, DOI 10.1146/annurev-publhealth-031210-101218; Caleyachetty R, 2015, INT J CARDIOL, V191, P296, DOI 10.1016/j.ijcard.2015.05.007; Clark AM, 2009, NAT REV CARDIOL, V6, P712, DOI 10.1038/nrcardio.2009.163; Eggen AE, 2014, J EPIDEMIOL COMMUN H, V68, P712, DOI 10.1136/jech-2013-203428; Fang J, 2012, J AM HEART ASSOC, V1, DOI 10.1161/JAHA.112.005371; Folsom AR, 2015, AM J HEMATOL, V90, pE92, DOI 10.1002/ajh.23950; Folsom AR, 2011, J AM COLL CARDIOL, V57, P1690, DOI 10.1016/j.jacc.2010.11.041; Ford ES, 2012, CIRCULATION, V125, P987, DOI 10.1161/CIRCULATIONAHA.111.049122; Franks P, 2011, BMC CARDIOVASC DISOR, V11, DOI 10.1186/1471-2261-11-28; Gao BX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066780; Goyal A, 2010, CIRCULATION, V122, P1167, DOI 10.1161/CIRCULATIONAHA.109.919274; Graciani A, 2013, CIRC-CARDIOVASC QUAL, V6, P90, DOI 10.1161/CIRCOUTCOMES.112.967893; Husemoen LLN, 2004, EUR J PUBLIC HEALTH, V14, P86, DOI 10.1093/eurpub/14.1.86; Hussmanns R., 1990, SURVEYS EC ACTIVE PO; Jankovic J, 2011, SCAND J PUBLIC HEALT, V39, P230, DOI 10.1177/1403494811401477; Jankovic S, 2014, INT J PUBLIC HEALTH, V59, P769, DOI 10.1007/s00038-014-0579-1; Jankovic S, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005222; Kang MY, 2015, J OCCUP HEALTH, V57, P28, DOI 10.1539/joh.14-0117-OA; Kim JI, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000058; Kinge JM, 2015, J EPIDEMIOL COMMUN H, V69, P1141, DOI 10.1136/jech-2014-205353; Kulshreshtha A, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.113.000282; Liu Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089161; Lloyd-Jones DM, 2010, CIRCULATION, V121, P586, DOI 10.1161/CIRCULATIONAHA.109.192703; Matovic Miljanovic S, 2011, POP HLTH SURVEY REPU; Olsen GS, 2014, EUR J PREV CARDIOL, V21, P1145, DOI 10.1177/2047487313485513; Reddy KS, 2004, NEW ENGL J MED, V350, P2438, DOI 10.1056/NEJMp048024; Rosengren A, 2009, HEART, V95, P2014, DOI 10.1136/hrt.2009.182436; Rutstein SO, 2004, DHS COMP REPORTS, V6; Stelmach W, 2005, PUBLIC HEALTH, V119, P498, DOI 10.1016/j.puhe.2004.09.006; Stringhini S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102858; Subramanian SV, 2013, INT J EPIDEMIOL, V42, P1410, DOI 10.1093/ije/dyt017; The World Bank, 2015, COUNTR CLASS; The World Bank, 2015, BOSN HERZ; UNDP, HUM DEV REP 2014 SUS; Vukovic D, 2008, CROAT MED J, V49, P832, DOI 10.3325/cmj.2008.49.832; WALDRON I, 1988, J OCCUP ENVIRON MED, V30, P977, DOI 10.1097/00043764-198812000-00019; Wamala SP, 2001, INT J EPIDEMIOL, V30, P275, DOI 10.1093/ije/30.2.275; Wu SL, 2012, CIRC-CARDIOVASC QUAL, V5, P487, DOI 10.1161/CIRCOUTCOMES.111.963694; Yang QH, 2012, JAMA-J AM MED ASSOC, V307, P1273, DOI 10.1001/jama.2012.339; Zhang Q, 2013, STROKE, V44, P2451, DOI 10.1161/STROKEAHA.113.678839	49	18	18	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2015	10	10							e0141731	10.1371/journal.pone.0141731	http://dx.doi.org/10.1371/journal.pone.0141731			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CV0ED	26513729	gold, Green Published, Green Submitted			2022-12-26	WOS:000363920300076
J	Amlie-Wolf, A; Ryvkin, P; Tong, R; Dragomir, I; Suh, E; Xu, Y; Van Deerlin, VM; Gregory, BD; Kwong, LK; Trojanowski, JQ; Lee, VMY; Wang, LS; Lee, EB				Amlie-Wolf, Alexandre; Ryvkin, Paul; Tong, Rui; Dragomir, Isabelle; Suh, EunRan; Xu, Yan; Van Deerlin, Vivianna M.; Gregory, Brian D.; Kwong, Linda K.; Trojanowski, John Q.; Lee, Virginia M. -Y.; Wang, Li-San; Lee, Edward B.			Transcriptomic Changes Due to Cytoplasmic TDP-43 Expression Reveal Dysregulation of Histone Transcripts and Nuclear Chromatin	PLOS ONE			English	Article							FRONTOTEMPORAL LOBAR DEGENERATION; GENE-EXPRESSION; RNA; BINDING; ROLES; ENRICHMENT; FUS/TLS; ALS	TAR DNA-binding protein 43 (TDP-43) is normally a nuclear RNA-binding protein that exhibits a range of functions including regulation of alternative splicing, RNA trafficking, and RNA stability. However, in amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration with TDP-43 inclusions (FTLD-TDP), TDP-43 is abnormally phosphorylated, ubiquitinated, and cleaved, and is mislocalized to the cytoplasm where it forms distinctive aggregates. We previously developed a mouse model expressing human TDP-43 with a mutation in its nuclear localization signal (Delta NLS-hTDP-43) so that the protein preferentially localizes to the cytoplasm. These mice did not exhibit a significant number of cytoplasmic aggregates, but did display dramatic changes in gene expression as measured by microarray, suggesting that cytoplasmic TDP-43 may be associated with a toxic gain-of-function. Here, we analyze new RNA-sequencing data from the Delta NLS-hTDP-43 mouse model, together with published RNA-sequencing data obtained previously from TDP-43 antisense oligonucleotide (ASO) knockdown mice to investigate further the dysregulation of gene expression in the Delta NLS model. This analysis reveals that the transcriptomic effects of the overexpression of the Delta NLS-hTDP-43 transgene are likely due to a gain of cytoplasmic function. Moreover, cytoplasmic TDP-43 expression alters transcripts that regulate chromatin assembly, the nucleolus, lysosomal function, and histone 3' untranslated region (UTR) processing. These transcriptomic alterations correlate with observed histologic abnormalities in heterochromatin structure and nuclear size in transgenic mouse and human brains.	[Amlie-Wolf, Alexandre; Ryvkin, Paul; Tong, Rui; Suh, EunRan; Xu, Yan; Van Deerlin, Vivianna M.; Kwong, Linda K.; Trojanowski, John Q.; Lee, Virginia M. -Y.; Wang, Li-San; Lee, Edward B.] Univ Penn, Dept Pathol & Lab Med, Perelman Sch Med, Philadelphia, PA 19104 USA; [Dragomir, Isabelle; Gregory, Brian D.] Univ Penn, Dept Biol, Sch Arts & Sci, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania	Lee, EB (corresponding author), Univ Penn, Dept Pathol & Lab Med, Perelman Sch Med, Philadelphia, PA 19104 USA.	edward.lee@uphs.upenn.edu	Lee, Edward/AAU-8436-2021; Gregory, Brian D/G-2890-2010	Amlie-Wolf, Alexandre/0000-0002-2073-1519	National Institutes of Health [R01-GM099962, U24-AG041689, K08-AG039510, P01-AG017586]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM099962] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [U24AG041689, K08AG039510, P01AG017586] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health grants R01-GM099962 and U24-AG041689 to LSW, K08-AG039510 to EBL, and P01-AG017586 to VML. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders S, 2012, GENOME RES, V22, P2008, DOI 10.1101/gr.133744.111; [Anonymous], 2014, R LANG ENV STAT COMP; Ayala YM, 2008, J CELL SCI, V121, P3778, DOI 10.1242/jcs.038950; Benjamini Y, 1995, J R STAT SOC B; Bose JK, 2008, J BIOL CHEM, V283, P28852, DOI 10.1074/jbc.M805376200; Buratti E, 2001, J BIOL CHEM, V276, P36337, DOI 10.1074/jbc.M104236200; Buratti E, 2008, FRONT BIOSCI-LANDMRK, V13, P867, DOI 10.2741/2727; Cairns NJ, 2007, AM J PATHOL, V171, P227, DOI 10.2353/ajpath.2007.070182; Chen-Plotkin AS, 2010, NAT REV NEUROL, V6, P211, DOI 10.1038/nrneurol.2010.18; Cunningham F, 2015, NUCLEIC ACIDS RES, V43, pD662, DOI 10.1093/nar/gku1010; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Elliott R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075346; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Igaz LM, 2008, AM J PATHOL, V173, P182, DOI 10.2353/ajpath.2008.080003; Igaz LM, 2011, J CLIN INVEST, V121, P726, DOI 10.1172/JCI44867; Kari V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063745; Kwong LK, 2007, ACTA NEUROPATHOL, V114, P63, DOI 10.1007/s00401-007-0226-5; Lagier-Tourenne C, 2012, NAT NEUROSCI, V15, P1488, DOI 10.1038/nn.3230; Lagier-Tourenne C, 2010, HUM MOL GENET, V19, pR46, DOI 10.1093/hmg/ddq137; Lane RP, 1996, GENOMICS, V35, P456, DOI 10.1006/geno.1996.0385; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lariviere L, 2006, NAT STRUCT MOL BIOL, V13, P895, DOI 10.1038/nsmb1143; Lee EB, 2005, J CELL BIOL, V168, P291, DOI 10.1083/jcb.200407070; Lee EB, 2012, NAT REV NEUROSCI, V13, P38, DOI 10.1038/nrn3121; Ling SC, 2013, NEURON, V79, P416, DOI 10.1016/j.neuron.2013.07.033; Liu R, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/s12859-014-0364-4; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Manley JL, 2010, GENE DEV, V24, P1073, DOI 10.1101/gad.1934910; Martin M, 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, 10.10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Marui T, 2009, INT J NEUROPSYCHOPH, V12, P1, DOI 10.1017/S1461145708009127; Marzluff WF, 2002, GENOMICS, V80, P487, DOI 10.1006/geno.2002.6850; Marzluff WF, 2008, NAT REV GENET, V9, P843, DOI 10.1038/nrg2438; Narita T, 2007, MOL CELL, V26, P349, DOI 10.1016/j.molcel.2007.04.011; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Ou S, 1995, J VIROL; Polymenidou M, 2011, NAT NEUROSCI, V14, P459, DOI 10.1038/nn.2779; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Riudavets MA, 2007, NEUROBIOL AGING, V28, P1484, DOI 10.1016/j.neurobiolaging.2007.05.005; Sullivan KD, 2009, RNA, V15, P459, DOI 10.1261/rna.1205409; Tisdale S, 2013, CELL REP, V5, P1187, DOI 10.1016/j.celrep.2013.11.012; Wang IF, 2002, P NATL ACAD SCI USA, V99, P13583, DOI 10.1073/pnas.212483099; Winton MJ, 2008, J BIOL CHEM, V283, P13302, DOI 10.1074/jbc.M800342200; Zhang Z, 2013, GENE DEV, V27, P1581, DOI 10.1101/gad.211037.112	44	28	29	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2015	10	10							e0141836	10.1371/journal.pone.0141836	http://dx.doi.org/10.1371/journal.pone.0141836			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0DL	26510133	gold, Green Published, Green Submitted			2022-12-26	WOS:000363918100138
J	Kajikawa, A; Zhang, L; LaVoy, A; Bumgardner, S; Klaenhammer, TR; Dean, GA				Kajikawa, Akinobu; Zhang, Lin; LaVoy, Alora; Bumgardner, Sara; Klaenhammer, Todd R.; Dean, Gregg A.			Mucosal Immunogenicity of Genetically Modified Lactobacillus acidophilus Expressing an HIV-1 Epitope within the Surface Layer Protein	PLOS ONE			English	Article							LACTIC-ACID BACTERIA; VIRUS-LIKE PARTICLES; S-LAYER; IMMUNE-RESPONSES; NONNEUTRALIZING ANTIBODIES; PROTECTIVE IMMUNITY; LACTOCOCCUS-LACTIS; VACCINE DELIVERY; DENDRITIC CELLS; IN-VIVO	Surface layer proteins of probiotic lactobacilli are theoretically efficient epitope-displaying scaffolds for oral vaccine delivery due to their high expression levels and surface localization. In this study, we constructed genetically modified Lactobacillus acidophilus strains expressing the membrane proximal external region (MPER) from human immunodeficiency virus type 1 (HIV-1) within the context of the major S-layer protein, SlpA. Intragastric immunization of mice with the recombinants induced MPER-specific and S-layer protein-specific antibodies in serum and mucosal secretions. Moreover, analysis of systemic SlpA-specific cytokines revealed that the responses appeared to be Th1 and Th17 dominant. These findings demonstrated the potential use of the Lactobacillus S-layer protein for development of oral vaccines targeting specific peptides.	[Kajikawa, Akinobu] Tokyo Univ Agr, Dept Appl Biol & Chem, Tokyo, Japan; [Zhang, Lin; LaVoy, Alora; Dean, Gregg A.] Colorado State Univ, Coll Vet Med & Biomed Sci, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA; [Bumgardner, Sara] N Carolina State Univ, Coll Vet Med, Ctr Comparat Med & Translat Res, Raleigh, NC 27695 USA; [Klaenhammer, Todd R.] N Carolina State Univ, Dept Food Bioproc & Nutr Sci, Raleigh, NC 27695 USA	Tokyo University of Agriculture; Colorado State University; University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University	Dean, GA (corresponding author), Colorado State Univ, Coll Vet Med & Biomed Sci, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA.	Gregg.Dean@colostate.edu	Dean, Gregg A/A-5623-2012	Dean, Gregg A/0000-0001-7025-9550; LaVoy, Alora/0000-0003-3376-0842	National Institute of Health grant [R01DE019069]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE019069] Funding Source: NIH RePORTER	National Institute of Health grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by National Institute of Health grant R01DE019069.	Ackerman ME, 2013, CURR HIV RES, V11, P365, DOI 10.2174/1570162X113116660058; Avall-Jaaskelainen S, 2002, APPL ENVIRON MICROB, V68, P5943, DOI 10.1128/AEM.68.12.5943-5951.2002; Bomsel M, 1998, IMMUNITY, V9, P277, DOI 10.1016/S1074-7613(00)80610-X; Brandtzaeg P, 1999, IMMUNOL REV, V171, P45, DOI 10.1111/j.1600-065X.1999.tb01342.x; Brandtzaeg P, 2001, NAT IMMUNOL, V2, P1093, DOI 10.1038/ni1201-1093; BUCHACHER A, 1994, AIDS RES HUM RETROV, V10, P359, DOI 10.1089/aid.1994.10.359; Cattozzo EM, 1997, J BIOTECHNOL, V56, P191, DOI 10.1016/S0168-1656(97)00117-X; Chorny A, 2010, ADV IMMUNOL, V107, P31, DOI [10.1016/S0065-2776(10)07006-9, 10.1016/B978-0-12-381300-8.00002-2]; Corthesy B, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00185; Duong T, 2011, MICROB BIOTECHNOL, V4, P357, DOI 10.1111/j.1751-7915.2010.00200.x; Fauci AS, 2014, SCIENCE, V344, P49, DOI 10.1126/science.1250672; Forthal D, 2013, CURR OPIN HIV AIDS, V8, P393, DOI 10.1097/COH.0b013e328363d486; Girardin SE, 2003, J BIOL CHEM, V278, P8869, DOI 10.1074/jbc.C200651200; Goh YJ, 2009, APPL ENVIRON MICROB, V75, P3093, DOI 10.1128/AEM.02502-08; LeBlanc JG, 2013, FEMS MICROBIOL LETT, V344, P1, DOI 10.1111/1574-6968.12159; Holmgren J, 2005, NAT MED, V11, pS45, DOI 10.1038/nm1213; Jain S, 2010, VACCINE, V28, P7070, DOI 10.1016/j.vaccine.2010.08.009; Kajikawa A, 2007, VACCINE, V25, P3599, DOI 10.1016/j.vaccine.2007.01.055; Kajikawa A, 2012, CLIN VACCINE IMMUNOL, V19, P1374, DOI 10.1128/CVI.00049-12; Kajikawa A, 2011, APPL ENVIRON MICROB, V77, P6587, DOI 10.1128/AEM.05153-11; Kajikawa A, 2010, VACCINE, V28, P3409, DOI 10.1016/j.vaccine.2010.02.077; Kajikawa A, 2010, CLIN VACCINE IMMUNOL, V17, P43, DOI 10.1128/CVI.00337-09; Kayamuro H, 2010, J VIROL, V84, P12703, DOI 10.1128/JVI.01182-10; Konstantinov SR, 2008, P NATL ACAD SCI USA, V105, P19474, DOI 10.1073/pnas.0810305105; Lebeer S, 2010, NAT REV MICROBIOL, V8, P171, DOI 10.1038/nrmicro2297; Lewis GK, 2013, CURR HIV RES, V11, P354, DOI 10.2174/1570162X113116660060; Lopalco L, 2011, EXPERT REV VACCINES, V10, P1253, DOI [10.1586/ERV.11.98, 10.1586/erv.11.98]; Matsuguchi T, 2003, CLIN DIAGN LAB IMMUN, V10, P259, DOI 10.1128/CDLI.10.2.259-266.2003; Mclntyre BTM, 1993, J EXP MED, V177, P1031; Mohamadzadeh M, 2008, EXPERT REV VACCINES, V7, P163, DOI 10.1586/14760584.7.2.163; Moody MA, 2012, J VIROL, V86, P7496, DOI 10.1128/JVI.00426-12; Neutra MR, 2006, NAT REV IMMUNOL, V6, P148, DOI 10.1038/nri1777; Pasquier B, 2005, IMMUNITY, V22, P31, DOI 10.1016/j.immuni.2004.11.017; Ramasamy R, 2006, VACCINE, V24, P3900, DOI 10.1016/j.vaccine.2006.02.040; Reveneau N, 2002, VACCINE, V20, P1769, DOI 10.1016/S0264-410X(02)00027-0; Scheppler L, 2002, VACCINE, V20, P2913, DOI 10.1016/S0264-410X(02)00229-3; Schmaljohn AL, 2013, CURR HIV RES, V11, P345, DOI 10.2174/1570162X113116660057; Smit E, 2002, J MOL BIOL, V324, P953, DOI 10.1016/S0022-2836(02)01135-X; Staats HF, 1999, J IMMUNOL, V162, P6141; Stoeker L, 2011, CLIN VACCINE IMMUNOL, V18, P1834, DOI 10.1128/CVI.05277-11; Szomolanyi-Tsuda E, 1998, J VIROL, V72, P6665, DOI 10.1128/JVI.72.8.6665-6670.1998; Walker LM, 2010, CURR OPIN IMMUNOL, V22, P358, DOI 10.1016/j.coi.2010.02.012; Wells J, 2011, ANNU REV FOOD SCI T, V2, P423, DOI 10.1146/annurev-food-022510-133640; Wells JM, 2008, NAT REV MICROBIOL, V6, P349, DOI 10.1038/nrmicro1840; Xin KQ, 2003, BLOOD, V102, P223, DOI 10.1182/blood-2003-01-0110; Zeuthen LH, 2008, IMMUNOLOGY, V124, P489, DOI 10.1111/j.1365-2567.2007.02800.x	46	23	24	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2015	10	10							e0141713	10.1371/journal.pone.0141713	http://dx.doi.org/10.1371/journal.pone.0141713			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0DL	26509697	gold, Green Published, Green Submitted			2022-12-26	WOS:000363918100124
J	Martin, E; Ray, PD; Smeester, L; Grace, MR; Boggess, K; Fry, RC				Martin, Elizabeth; Ray, Paul D.; Smeester, Lisa; Grace, Matthew R.; Boggess, Kim; Fry, Rebecca C.			Epigenetics and Preeclampsia: Defining Functional Epimutations in the Preeclamptic Placenta Related to the TGF-beta Pathway	PLOS ONE			English	Article							PRENATAL ARSENIC EXPOSURE; ENDOTHELIAL GROWTH-FACTOR; DNA METHYLATION; GENE-EXPRESSION; EPITHELIAL-CELLS; FOLIC-ACID; HYPOMETHYLATION; WOMEN	Preeclampsia is a potentially fatal pregnancy disorder affecting millions of women around the globe. Dysregulation in gene and protein expression within key biological pathways controlling angiogenesis has been implicated in the development of preeclampsia. Altered CpG methylation, a type of epimutation, may underlie this pathway dysregulation. In the present study, placental tissue from preeclamptic cases and normotensive controls was analyzed for genome-wide differential CpG methylation and concomitant changes in gene expression. A set of 123 genes, representing 19.9% of all genes with altered CpG methylation, was associated with functional changes in transcript levels. Underscoring the complex relationships between CpG methylation and gene expression, here hypermethylation was never associated with gene silencing, nor was hypomethylation always associated with gene activation. Moreover, the genomic region of the CpG mark was important in predicting the relationship between CpG methylation and gene expression. The 123 genes were enriched for their involvement in the transforming growth factor beta (TGF-beta) signaling pathway, a known regulator of placental trophoblast invasion and migration. This is the first study to identify CpG hypomethylation as an activator of TGF-beta-associated gene expression in the preeclamptic placenta. The results suggest functional epimutations are associated with preeclampsia disease status and the identified genes may represent novel biomarkers of disease.	[Martin, Elizabeth; Ray, Paul D.; Smeester, Lisa] Univ N Carolina, Dept Environm Sci & Engn, Gillings Sch Global Publ Hlth, Chapel Hill, NC 27515 USA; [Ray, Paul D.; Fry, Rebecca C.] Univ N Carolina, Sch Med, Curriculum Toxicol, Chapel Hill, NC USA; [Grace, Matthew R.; Boggess, Kim] Univ N Carolina, Sch Med, Dept Obstet & Gynecol, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Fry, RC (corresponding author), Univ N Carolina, Dept Environm Sci & Engn, Gillings Sch Global Publ Hlth, 135 Dauer Dr,CB 7431, Chapel Hill, NC 27515 USA.	rfry@unc.edu	Grace, Matthew/GYD-4980-2022	Smeester, Lisa/0000-0001-5283-0485; Grace, Matthew/0000-0003-3654-0677; Fry, Rebecca/0000-0003-0899-9018	National Institutes of Health [R01 ES019315, P42 ES005948, T32 ES007126, T32 ES007018]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007018, P42ES005948, T32ES007126, R01ES019315] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This research was supported by grants from the National Institutes of Health (http://www.nih.gov): R01 ES019315, P42 ES005948, T32 ES007126 and T32 ES007018. The funders of this study had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berg CJ, 2010, OBSTET GYNECOL, V116, P1302, DOI 10.1097/AOG.0b013e3181fdfb11; Blair JD, 2013, MOL HUM REPROD, V19, P697, DOI 10.1093/molehr/gat044; Boellmann F, 2010, TOXICOL SCI, V117, P404, DOI 10.1093/toxsci/kfq225; Caniggia I, 1999, J CLIN INVEST, V103, P1641, DOI 10.1172/JCI6380; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; Chaiworapongsa T, 2014, NAT REV NEPHROL, V10, P531, DOI 10.1038/nrneph.2014.103; Chaiworapongsa T, 2014, NAT REV NEPHROL, V10, P466, DOI 10.1038/nrneph.2014.102; Chen YA, 2013, EPIGENETICS-US, V8, P203, DOI 10.4161/epi.23470; Chu TJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107318; Ferrari G, 2009, J CELL PHYSIOL, V219, P449, DOI 10.1002/jcp.21706; Franceschini A, 2013, NUCLEIC ACIDS RES, V41, pD808, DOI 10.1093/nar/gks1094; Goumans MJ, 2009, CELL RES, V19, P116, DOI 10.1038/cr.2008.326; Hogg K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062969; HOLLIDAY R, 1993, MUTAT RES, V285, P61, DOI 10.1016/0027-5107(93)90052-H; Jirtle RL, 2007, NAT REV GENET, V8, P253, DOI 10.1038/nrg2045; Jjingo D, 2012, ONCOTARGET, V3, P462, DOI 10.18632/oncotarget.497; Leeda M, 1998, AM J OBSTET GYNECOL, V179, P135, DOI 10.1016/S0002-9378(98)70263-7; Loset M, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2010.08.043; Mehta D, 2013, P NATL ACAD SCI USA, V110, P8302, DOI 10.1073/pnas.1217750110; Morris TJ, 2014, BIOINFORMATICS, V30, P428, DOI 10.1093/bioinformatics/btt684; Mutter WP, 2008, MICROVASC RES, V75, P1, DOI 10.1016/j.mvr.2007.04.009; Nagineni CN, 2003, J CELL PHYSIOL, V197, P453, DOI 10.1002/jcp.10378; Nakagawa T, 2004, KIDNEY INT, V66, P605, DOI 10.1111/j.1523-1755.2004.00780.x; Prosdocimo DA, 2014, J BIOL CHEM, V289, P5914, DOI 10.1074/jbc.M113.531384; Rager JE, 2014, ENVIRON MOL MUTAGEN, V55, P196, DOI 10.1002/em.21842; Rager JE, 2013, AM J PHYSIOL-LUNG C, V305, pL432, DOI 10.1152/ajplung.00116.2013; Ray JG, 1999, PLACENTA, V20, P519, DOI 10.1053/plac.1999.0417; Rojas D, 2015, TOXICOL SCI, V143, P97, DOI 10.1093/toxsci/kfu210; Saito S, 2014, J REPROD IMMUNOL, V101, P80, DOI 10.1016/j.jri.2013.06.002; Sanders AP, 2014, EPIGENETICS-US, V9, P212, DOI 10.4161/epi.26798; Schubeler D, 2015, NATURE, V517, P321, DOI 10.1038/nature14192; Peracoli MTS, 2008, J REPROD IMMUNOL, V79, P79, DOI 10.1016/j.jri.2008.08.001; Shaarawy M, 2001, J SOC GYNECOL INVEST, V8, P27, DOI 10.1016/S1071-5576(00)00091-5; Sunderji S, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2009.07.025; Sundrani DP, 2013, CLIN EPIGENETICS, V5, DOI 10.1186/1868-7083-5-6; Vaiman D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065498; Verlohren S, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2009.09.016; Wen SW, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2007.06.067; Winn VD, 2007, ENDOCRINOLOGY, V148, P1059, DOI 10.1210/en.2006-0683; Yu Y, 2015, CARDIOLOGY, V130, P143, DOI 10.1159/000369382; Yuen RKC, 2010, EUR J HUM GENET, V18, P1006, DOI 10.1038/ejhg.2010.63; Zhuang XW, 2014, CURR PHARM DESIGN, V20, P1796, DOI 10.2174/13816128113199990541	42	44	46	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2015	10	10							e0141294	10.1371/journal.pone.0141294	http://dx.doi.org/10.1371/journal.pone.0141294			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0DL	26510177	gold, Green Published, Green Submitted			2022-12-26	WOS:000363918100069
J	Fakhrejahani, E; Toii, M; Kitai, T; Kanao, S; Asao, Y; Hashizume, Y; Mikami, Y; Yamaga, I; Kataoka, M; Sugie, T; Takada, M; Haga, H; Togashi, K; Shiina, T; Toi, M				Fakhrejahani, Elham; Toii, Masae; Kitai, Toshiyuki; Kanao, Shotaro; Asao, Yasufumi; Hashizume, Yohei; Mikami, Yoshiki; Yamaga, Iku; Kataoka, Masako; Sugie, Tomoharu; Takada, Masahiro; Haga, Hironori; Togashi, Kaori; Shiina, Tsuyoshi; Toi, Masakazu			Clinical Report on the First Prototype of a Photoacoustic Tomography System with Dual Illumination for Breast Cancer Imaging	PLOS ONE			English	Article							CARBONIC-ANHYDRASE-IX; VASCULAR MAPS; TUMOR; ANGIOGENESIS; CHEMOTHERAPY; HYPOXIA; THERAPY; MARKER; IMPACT	Photoacoustic tomography is a recently developed imaging modality that can provide high spatial-resolution images of hemoglobin distribution in tissues such as the breast. Because breast cancer is an angiogenesis-dependent type of malignancy, we evaluated the clinical acceptability of breast tissue images produced using our first prototype photoacoustic mammography (PAM) systemin patients with known cancer. Post-excisionally, histological sections of the tumors were stained immunohistochemically (IHC) for CD31 (an endothelial marker) and carbonic anhydrase IX (CAIX) (a marker of hypoxia). Whole-slide scanning and image analyses were used to evaluate the tumor microvessel distribution pattern and to calculate the total vascular perimeter (TVP)/area for each lesion. In this clinical study, 42 lesions were primarily scanned using PAM preoperatively, three of which were reported to be benign and were excluded from statistical analysis. Images were produced for 29 out of 39 cancers (visibility rate = 74.4%) at the median depth of 26.5 (3.25-51.2) mm. Age, menopausal status, body mass index, history of neoadjuvant treatment, clinical stage and histological tumor angiogenesis markers did not seem to affect the visibility. The oxygen saturation level in all of the measured lesions was lower than in the subcutaneous counterpart vessels (Wilcoxon test, p value<0.001), as well as in the counterpart contralateral normal breast region of interest (ROI) (Wilcoxon test, p value = 0.001). Although the oxygen saturation level was not statistically significant between CAIX-positive vs. -negative cases, lesional TVP/area showed a positive correlation with the oxygen saturation level only in the group that had received therapy before PAM. In conclusion, the vascular and oxygenation data obtained by PAM have great potential for identifying functional features of breast tumors.	[Fakhrejahani, Elham; Toii, Masae; Asao, Yasufumi; Yamaga, Iku; Takada, Masahiro; Toi, Masakazu] Kyoto Univ, Grad Sch Med, Dept Breast Surg, Kyoto, Japan; [Kitai, Toshiyuki] Kishiwada City Hosp, Dept Surg, Osaka, Japan; [Kanao, Shotaro; Kataoka, Masako; Togashi, Kaori] Kyoto Univ, Grad Sch Med, Dept Diagnost Imaging & Nucl Med, Kyoto, Japan; [Asao, Yasufumi; Hashizume, Yohei] Canon Inc, Tokyo, Japan; [Mikami, Yoshiki] Kumamoto Univ Hosp, Dept Diagnost Pathol, Kumamoto, Japan; [Sugie, Tomoharu] Kansai Med Univ, Dept Surg, Osaka, Japan; [Haga, Hironori] Kyoto Univ, Grad Sch Med, Dept Diagnost Pathol, Kyoto, Japan; [Shiina, Tsuyoshi] Kyoto Univ, Grad Sch Med, Dept Human Hlth Sci, Kyoto, Japan	Kyoto University; Kyoto University; Canon Incorporated; Kumamoto University; Kansai Medical University; Kyoto University; Kyoto University	Toi, M (corresponding author), Kyoto Univ, Grad Sch Med, Dept Breast Surg, Kyoto, Japan.	toi@kuhp.kyoto-u.ac.jp	Kataoka, Masako/AAA-3475-2019; Takada, Masahiro/AAJ-2942-2020	Kataoka, Masako/0000-0002-6212-3351; Takada, Masahiro/0000-0002-5954-1296; Haga, Hironori/0000-0003-4322-9561	Innovative Techno-Hub for Integrated Medical Bioimaging of the Project for Developing Innovation Systems from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan; Canon Inc.	Innovative Techno-Hub for Integrated Medical Bioimaging of the Project for Developing Innovation Systems from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan; Canon Inc.	This study is partly supported by the Innovative Techno-Hub for Integrated Medical Bioimaging of the Project for Developing Innovation Systems from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan. Yasufumi Asao and Yohei Hashizume are employees of Canon Inc., Japan. All other authors contributed to this study as Kyoto University members at the time of study and do not have any other external funding to disclose. Canon Inc. provided support in the form of salaries for authors YA and YH, and played a role in the decision to publish, but did not have any additional role in the study design, data collection and analysis, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Carpenter PM, 2011, INT J SURG PATHOL, V19, P335, DOI 10.1177/1066896909333511; Chia SK, 2001, J CLIN ONCOL, V19, P3660, DOI 10.1200/JCO.2001.19.16.3660; Corben AD, 2014, ROSELLS BREAST PATHO, V4th, P611; Fakhrejahani E, 2014, INT J BIOL MARKER, V29, pE204, DOI 10.5301/jbm.5000098; Fakhrejahani E, 2014, JPN J CLIN ONCOL, V44, P197, DOI 10.1093/jjco/hyt201; Flexman ML, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.9.096012; Frangioni JV, 2008, J CLIN ONCOL, V26, P4012, DOI 10.1200/JCO.2007.14.3065; Fukutani K, 2011, PROC SPIE, V7899, DOI 10.1117/12.873690; Germer U, 2002, ULTRASOUND OBST GYN, V19, P380, DOI 10.1046/j.1469-0705.2002.00675.x; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Heijblom M, 2011, TECHNOL CANCER RES T, V10, P607, DOI 10.7785/tcrt.2012.500227; Ho JM, 2014, AM J ROENTGENOL, V203, P449, DOI 10.2214/AJR.13.11969; Howlader N NA, 2011, SEER CANC STAT REV; Jain RK, 2013, J CLIN ONCOL, V31, P2205, DOI 10.1200/JCO.2012.46.3653; Kitai T, 2014, BREAST CANCER-TOKYO, V21, P146, DOI 10.1007/s12282-012-0363-0; Knuttel FM, 2014, J SURG ONCOL, V110, P26, DOI 10.1002/jso.23655; Kruger RA, 2013, MED PHYS, V40, DOI 10.1118/1.4824317; Lee CI, 2014, DIS BREAST, P90; Makris A, 1999, CANCER-AM CANCER SOC, V85, P1996; Manohar S, 2005, PHYS MED BIOL, V50, P2543, DOI 10.1088/0031-9155/50/11/007; Manohar S, 2007, OPT EXPRESS, V15, P12277, DOI 10.1364/OE.15.012277; Martincich L, 2011, AM J ROENTGENOL, V196, P1214, DOI 10.2214/AJR.10.5239; Mehrmohammadi Mohammad, 2013, Curr Mol Imaging, V2, P89; Nakamiya N, 2014, CANCER SCI, V105, P833, DOI 10.1111/cas.12432; Oraevsky AA, 2009, OPT SCI ENG-CRC, V144, P411; OTTINETTI A, 1988, BREAST CANCER RES TR, V11, P241, DOI 10.1007/BF01807282; Rajan R, 2004, CANCER-AM CANCER SOC, V100, P1365, DOI 10.1002/cncr.20134; Raza A, 2010, AM J HEMATOL, V85, P593, DOI 10.1002/ajh.21745; Sardanelli F, 2005, RADIOLOGY, V235, P791, DOI 10.1148/radiol.2353040733; Taroni Paola, 2012, Photochem Photobiol Sci, V11, P241, DOI 10.1039/c1pp05230f; Tromberg BJ, 2005, BREAST CANCER RES, V7, P279, DOI 10.1186/bcr1358; Tynninen O, 2002, BRIT J CANCER, V86, P1905, DOI 10.1038/sj.bjc.6600325; Ueda S, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-514; Ueda S, 2012, CANCER RES, V72, P4318, DOI 10.1158/0008-5472.CAN-12-0056; Vordermark D, 2005, INT J RADIAT ONCOL, V61, P1197, DOI 10.1016/j.ijrobp.2004.11.031; Wang LHV, 2012, SCIENCE, V335, P1458, DOI 10.1126/science.1216210; Yuan BH, 2013, AM J PATHOL, V182, P305, DOI 10.1016/j.ajpath.2012.07.036	37	46	49	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2015	10	10							e0139113	10.1371/journal.pone.0139113	http://dx.doi.org/10.1371/journal.pone.0139113			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU8PC	26506106	Green Published, gold, Green Submitted			2022-12-26	WOS:000363804200003
J	Garcia-Ramos, C; Lin, JJ; Prabhakaran, V; Hermann, BP				Garcia-Ramos, Camille; Lin, Jack J.; Prabhakaran, Vivek; Hermann, Bruce P.			Developmental Reorganization of the Cognitive Network in Pediatric Epilepsy	PLOS ONE			English	Article							GRAPH-THEORETICAL ANALYSIS; STRUCTURAL CONNECTIVITY; NEUROPSYCHOLOGICAL STATUS; CHILDREN; ONSET; ORGANIZATION; BEHAVIOR; MATTER	Traditional approaches to understanding cognition in children with epilepsy (CWE) involve cross-sectional or prospective examination of diverse test measures, an approach that does not inform the interrelationship between different abilities or how interrelationships evolve prospectively. Here we utilize graph theory techniques to interrogate the development of cognitive landmarks in CWE and healthy controls (HC) using the two-year percentage change across 20 tests. Additionally, we characterize the development of cognition using traditional analyses, showing that CWE perform worse at baseline, develop in parallel with HC, statically maintaining cognitive differences two years later. Graph analyses, however, showed CWE to exhibit both lower integration and segregation in development of their cognitive networks compared to HC. In conclusion, graph analyses of neuropsychological data capture a dynamic and changing complexity in the interrelationships among diverse cognitive skills, maturation of the cognitive network over time, and the nature of differences between normally developing children and CWE.	[Garcia-Ramos, Camille; Prabhakaran, Vivek] Univ Wisconsin, Dept Med Phys, Madison, WI 53706 USA; [Lin, Jack J.] Univ Calif Irvine, Dept Neurol, Irvine, CA 92717 USA; [Prabhakaran, Vivek] Univ Wisconsin, Dept Radiol, Madison, WI 53706 USA; [Hermann, Bruce P.] Univ Wisconsin, Dept Neurol, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of California System; University of California Irvine; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Garcia-Ramos, C (corresponding author), Univ Wisconsin, Dept Med Phys, 1530 Med Sci Ctr, Madison, WI 53706 USA.	garciaramos@wisc.edu	Hermann, Bruce/ACM-4355-2022	prabhakaran, vivek/0000-0002-1974-3125	National Institutes of Health (NIH) National Institute of Neurological Disorders and Stroke (NINDS) [3RO1-44351, K23 NS060993, 3R01NS044351-09S1]; NIH Clinical and Translational Science Award (CTSA) program [UL1TR000427]; Foundation of the American Society of Neuroadiology; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000427] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K23NS060993, R01NS044351] Funding Source: NIH RePORTER	National Institutes of Health (NIH) National Institute of Neurological Disorders and Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIH Clinical and Translational Science Award (CTSA) program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Foundation of the American Society of Neuroadiology; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported by the National Institutes of Health (NIH) National Institute of Neurological Disorders and Stroke (NINDS) 3RO1-44351 (BH), K23 NS060993 (JJL), 3R01NS044351-09S1 (CGR), the NIH Clinical and Translational Science Award (CTSA) program, grant UL1TR000427, and by the Foundation of the American Society of Neuroadiology (VP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bassett DS, 2009, CURR OPIN NEUROL, V22, P340, DOI 10.1097/WCO.0b013e32832d93dd; Bernhardt BC, 2011, CEREB CORTEX, V21, P2147, DOI 10.1093/cercor/bhq291; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Boccaletti S, 2006, PHYS REP, V424, P175, DOI 10.1016/j.physrep.2005.10.009; Boersma M, 2013, BRAIN CONNECT, V3, P50, DOI 10.1089/brain.2012.0106; Bonilha L, 2012, J NEUROL NEUROSUR PS, V83, P903, DOI 10.1136/jnnp-2012-302476; Bullmore ET, 2012, NAT REV NEUROSCI, V13, P336, DOI 10.1038/nrn3214; Craik FIM, 2006, TRENDS COGN SCI, V10, P131, DOI 10.1016/j.tics.2006.01.007; Delis D.C., 2001, DELIS KAPLAN EXECUTI, DOI DOI 10.1037/T15082-000; Diamond A, 2013, ANNU REV PSYCHOL, V64, P135, DOI 10.1146/annurev-psych-113011-143750; Fair DA, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000381; Fastenau PS, 2009, NEUROLOGY, V73, P526, DOI 10.1212/WNL.0b013e3181b23551; Fastenau PS., 2011, NEUROPSYCHOLOGY CARE, P69; Hagmann P, 2010, P NATL ACAD SCI USA, V107, P19067, DOI 10.1073/pnas.1009073107; Hermann B, 2006, BRAIN, V129, P2609, DOI 10.1093/brain/awl196; Humphries MD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002051; Ibrahim GM, 2014, HUM BRAIN MAPP, V35, P5686, DOI 10.1002/hbm.22580; Jackson DC, 2014, EPILEPSIA, V55, P901, DOI 10.1111/epi.12622; Jackson DC, 2013, J PEDIATR-US, V162, P1047, DOI 10.1016/j.jpeds.2012.10.046; Jaeggi SM, 2011, P NATL ACAD SCI USA, V108, P10081, DOI 10.1073/pnas.1103228108; Kellermann TS, 2015, CORTEX, V66, P1, DOI 10.1016/j.cortex.2015.02.001; Lim S, 2015, CEREB CORTEX, V25, P1477, DOI 10.1093/cercor/bht333; Lin JJ, 2014, ANN NEUROL, V76, P660, DOI 10.1002/ana.24240; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Oostrom KJ, 2005, BRAIN, V128, P1546, DOI 10.1093/brain/awh494; Oostrom KJ, 2003, PEDIATRICS, V112, P1338, DOI 10.1542/peds.112.6.1338; Goldin AP, 2014, P NATL ACAD SCI USA, V111, P6443, DOI 10.1073/pnas.1320217111; Rathouz PJ, 2014, DEV MED CHILD NEUROL, V56, P635, DOI 10.1111/dmcn.12432; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Song J, 2015, BRAIN CONNECT, V5, P276, DOI 10.1089/brain.2014.0308; Sporns O, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001049; Vaessen MJ, 2013, CEREB CORTEX, V23, P1997, DOI 10.1093/cercor/bhs186; Walker NM, 2013, DEV MED CHILD NEUROL, V55, P278, DOI 10.1111/dmcn.12040; Wang JH, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00016; Wechsler D., 2011, WASI 2 WECHSLER ABBR; Wechsler D., 1991, WISC 3 WECHSLER INTE; Williams K.T., 2007, EXPRESSIVE VOCABULAR, V2nd; Wilson RS, 2012, NEUROLOGY, V78, P1116, DOI 10.1212/WNL.0b013e31824f7ff2; Zhao QQ, 2015, DEV MED CHILD NEUROL, V57, P37, DOI 10.1111/dmcn.12549	39	22	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2015	10	10							e0141186	10.1371/journal.pone.0141186	http://dx.doi.org/10.1371/journal.pone.0141186			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU8PC	26505900	Green Published, gold			2022-12-26	WOS:000363804200034
J	Tseng, PH; Yang, WS; Liou, JM; Lee, YC; Wang, HP; Lin, JT; Wu, MS				Tseng, Ping-Huei; Yang, Wei-Shiung; Liou, Jyh-Ming; Lee, Yi-Chia; Wang, Hsiu-Po; Lin, Jaw-Town; Wu, Ming-Shiang			Associations of Circulating Gut Hormone and Adipocytokine Levels with the Spectrum of Gastroesophageal Reflux Disease	PLOS ONE			English	Article							BARRETTS-ESOPHAGUS; METABOLIC SYNDROME; GASTROINTESTINAL-DISEASES; GHRELIN LEVELS; INFLAMMATORY CYTOKINES; PLASMA ADIPONECTIN; DIABETES-MELLITUS; RISK-FACTORS; LEPTIN; OBESITY	Objective The pathogenesis of gastroesophageal reflux disease (GERD) is complex and poorly understood. We aim to investigate the association of various circulating peptide hormones with heterogenous manifestations of GERD. Methods One hundred and four patients that had experienced typical GERD symptoms (heartburn and/or acid regurgitation) for at least 3 episodes per week in the past 3 months were enrolled. All patients received a baseline assessment of symptom severity and frequency with the Reflux Disease Questionnaire and an upper endoscopy to classify GERD into erosive esophagitis (EE, n = 67), non-erosive esophagitis (NE, n = 37), and Barrett's esophagus (BE, n = 8). Fifty asymptomatic subjects with an endoscopically normal esophagus were recruited as the control group. Complete anthropometric measures and blood biochemistry were obtained and fasting serum levels of adipocytokines (adiponectin and leptin) and gut hormones (ghrelin and peptide YY (PYY)) were determined by enzyme-linked immunosorbent assay in all subjects. Results All circulating peptide hormone levels were not statistically different between the GERD and control groups. However, GERD patients appeared to have lower PYY levels [median (25th-75th percentile), 80.1 (49.8-108.3) vs. 99.4 (65.8-131.9) pg/ml, p = 0.057] compared with control subjects. Among the GERD patients, ghrelin levels were inversely associated with the frequency and severity of acid regurgitation. In male GERD patients, EE was associated with significantly higher PYY levels [107.0 (55.0-120.8) vs. 32.8 (28.7-84.5) pg/ml, p = 0.026] but lower adiponectin levels [6.7 (5.6-9.3) vs. 9.9 (9.6-10.6) mu g/ml, p = 0.034] than NE. Patients with BE had significantly lower adiponectin levels [6.0 (5.1-9.2) vs. 9.2 (7.1-11.2) mu g/ml, p = 0.026] than those without BE. Conclusions Humoral derangement of circulating peptide hormones might participate in inflammation and symptom perception in patients suffering from GERD. Further studies to clarify the exact role of these hormones in the pathogenesis of GERD are warranted.	[Tseng, Ping-Huei; Yang, Wei-Shiung; Liou, Jyh-Ming; Lee, Yi-Chia; Wang, Hsiu-Po; Lin, Jaw-Town; Wu, Ming-Shiang] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan; [Tseng, Ping-Huei; Yang, Wei-Shiung] Natl Taiwan Univ, Coll Med, Grad Inst Clin Med, Taipei 10764, Taiwan; [Yang, Wei-Shiung] Natl Taiwan Univ, Res Ctr Dev Biol & Regenerat Med, Taipei 10764, Taiwan; [Lin, Jaw-Town] Fu Jen Catholic Univ, Sch Med, New Taipei, Taiwan; [Lin, Jaw-Town] E Da Hosp, Dept Internal Med, Kaohsiung, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; Fu Jen Catholic University; E-Da Hospital	Wu, MS (corresponding author), Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan.	mingshiang@ntu.edu.tw	Tseng, Ping-Huei/GZA-8772-2022	TSENG, PING-HUEI/0000-0002-7483-7538; YANG, WEI-SHIUNG/0000-0001-5087-373X; Wu, Ming-Shiang/0000-0002-1940-6428; LEE, YI-CHIA/0000-0002-8160-1216; LIOU, JYH-MING/0000-0002-7945-5408	National Taiwan University Hospital [NTUH. 99-M1434, NTUH. 104-002854]	National Taiwan University Hospital(National Taiwan University)	PHT received research grants from the National Taiwan University Hospital (NTUH. 99-M1434 and NTUH. 104-002854) for the present study.	Binn M, 2006, PEPTIDES, V27, P1603, DOI 10.1016/j.peptides.2005.12.008; Chandran M, 2003, DIABETES CARE, V26, P2442, DOI 10.2337/diacare.26.8.2442; Chung SJ, 2008, GUT, V57, P1360, DOI 10.1136/gut.2007.147090; de Martel C, 2007, AM J GASTROENTEROL, V102, P1166, DOI 10.1111/j.1572-0241.2007.01116.x; El-Salhy M, 2013, INT J MOL MED, V31, P275, DOI 10.3892/ijmm.2012.1222; El-Serag HB, 2008, GUT, V57, DOI 10.1136/gut.2007.127878; El-Serag HB, 2005, AM J GASTROENTEROL, V100, P1243, DOI 10.1111/j.1572-0241.2005.41703.x; Fock KM, 2008, J GASTROEN HEPATOL, V23, P8, DOI 10.1111/j.1440-1746.2007.05249.x; Francois F, 2008, GUT, V57, P16, DOI 10.1136/gut.2007.131672; Friedenberg FK, 2008, AM J GASTROENTEROL, V103, P2111, DOI 10.1111/j.1572-0241.2008.01946.x; Garcia JM, 2014, CLIN GASTROENTEROL H, V12, P229, DOI 10.1016/j.cgh.2013.07.038; Hirata A, 2012, NUTR METAB, V9, DOI 10.1186/1743-7075-9-4; Hwang JH, 2011, CLIN ENDOCRINOL, V75, P614, DOI 10.1111/j.1365-2265.2011.04090.x; Isomoto H, 2005, DIGEST DIS SCI, V50, P833, DOI 10.1007/s10620-005-2648-z; Iwasaki E, 2008, J GASTROEN HEPATOL, V23, pS216, DOI 10.1111/j.1440-1746.2008.05441.x; Iwase M, 2009, DIABETES-METAB RES, V25, P344, DOI 10.1002/dmrr.954; Karmiris K, 2006, INFLAMM BOWEL DIS, V12, P100, DOI 10.1097/01.MIB.0000200345.38837.46; Kato M, 2011, J GASTROENTEROL, V46, P1361, DOI 10.1007/s00535-011-0453-3; Kendall BJ, 2008, GUT, V57, P448, DOI 10.1136/gut.2007.131243; Lee YC, 2009, GUT, V58, P174, DOI 10.1136/gut.2008.162305; Lee YC, 2007, J GASTROEN HEPATOL, V22, P1286, DOI 10.1111/j.1440-1746.2007.04942.x; Lu JY, 2008, J BIOMED SCI, V15, P565, DOI 10.1007/s11373-008-9261-z; Lundell LR, 1999, GUT, V45, P172, DOI 10.1136/gut.45.2.172; Masaka T, 2013, GUT, V62, P6, DOI 10.1136/gutjnl-2011-301389; Menon S, 2013, EUR J GASTROEN HEPAT, V25, P772, DOI 10.1097/MEG.0b013e32835fbaab; Moki F, 2007, ALIMENT PHARM THER, V26, P1069, DOI 10.1111/j.1365-2036.2007.03454.x; Monti V, 2006, J AM DIET ASSOC, V106, P822, DOI 10.1016/j.jada.2006.03.015; Murray CDR, 2005, GUT, V54, P1693, DOI 10.1136/gut.2005.069088; Nam SY, 2015, J NEUROGASTROENTEROL, V21, P247, DOI 10.5056/jnm14114; Ogden CL, 2007, GASTROENTEROLOGY, V132, P2087, DOI 10.1053/j.gastro.2007.03.052; PERDIKIS G, 1994, AM J SURG, V167, P186, DOI 10.1016/0002-9610(94)90072-8; Prolo P, 1998, INT J BIOCHEM CELL B, V30, P1285, DOI 10.1016/S1357-2725(98)00094-6; Rubenstein JH, 2008, AM J GASTROENTEROL, V103, P1358, DOI 10.1111/j.1572-0241.2008.01823.x; Rubenstein JH, 2013, GASTROENTEROLOGY, V145, P1237, DOI 10.1053/j.gastro.2013.08.052; Schaffler A, 2009, GUT, V58, P317, DOI 10.1136/gut.2008.159210; Shaw M, 2004, GUT, V53, P25, DOI 10.1136/gut.2003.034280; Shindo T, 2009, DIGESTION, V79, P65, DOI 10.1159/000205740; Somasundar P, 2003, AM J SURG, V186, P575, DOI 10.1016/j.amjsurg.2003.07.017; Thompson OM, 2010, OBESITY, V18, P2204, DOI 10.1038/oby.2009.508; Tseng PH, 2008, J CLIN GASTROENTEROL, V42, P1074, DOI 10.1097/MCG.0b013e31809e7126; Wu YW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092001	41	15	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2015	10	10							e0141410	10.1371/journal.pone.0141410	http://dx.doi.org/10.1371/journal.pone.0141410			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU8PC	26506614	Green Published, Green Submitted, gold			2022-12-26	WOS:000363804200062
J	Zhao, XY; Zhang, JY; Cao, J; Zhao, ZJ				Zhao, Xiao-Ya; Zhang, Ji-Ying; Cao, Jing; Zhao, Zhi-Jun			Oxidative Damage Does Not Occur in Striped Hamsters Raising Natural and Experimentally Increased Litter Size	PLOS ONE			English	Article							RESTING METABOLIC-RATE; HISTORY TRADE-OFFS; ENERGY BUDGET; COLD-EXPOSURE; PHYSIOLOGICAL ADAPTATIONS; REPRODUCTIVE EFFORT; BODY-COMPOSITION; SKELETAL-MUSCLE; GENE-EXPRESSION; LIFE-SPAN	Life-history theory assumes that animals can balance the allocation of limited energy or resources to the competing demands of growth, reproduction and somatic maintenance, while consequently maximizing their fitness. However, somatic damage caused by oxidative stress in reproductive female animals is species-specific or is tissue dependent. In the present study, several markers of oxidative stress (hydrogen peroxide, H2O2 and malona-dialdehyde, MDA) and antioxidant (catalase, CAT and total antioxidant capacity, T-AOC) were examined in striped hamsters during different stages of reproduction with experimentally manipulated litter size. Energy intake, resting metabolic rate (RMR), and mRNA expression of uncoupling protein 1 (UCP1) in brown adipose tissue (BAT) and UCP3 in skeletal muscle were also examined. H2O2 and MDA levels did not change in BAT and liver, although they significantly decreased in skeletal muscle in the lactating hamsters compared to the non-reproductive group. However, H2O2 levels in the brain were significantly higher in lactating hamsters than non-reproductive controls. Experimentally increasing litter size did not cause oxidative stress in BAT, liver and skeletal muscle, but significantly elevated H2O2 levels in the brain. CAT activity of liver decreased, but CAT and T-AOC activity of BAT, skeletal muscle and the brain did not change in lactating hamsters compared to non-reproductive controls. Both antioxidants did not change with the experimentally increasing litter size. RMR significantly increased, but BAT UCP1 mRNA expression decreased with the experimentally increased litter size, suggesting that it was against simple positive links between metabolic rate, UCP1 expression and free radicals levels. It may suggest that the cost of reproduction has negligible effect on oxidative stress or even attenuates oxidative stress in some active tissues in an extensive range of animal species. But the increasing reproductive effort may cause oxidative stress in the brain, indicating that oxidative stress in response to reproduction is tissue dependent. These findings provide partial support for the life-history theory.	[Zhao, Xiao-Ya; Zhang, Ji-Ying; Cao, Jing; Zhao, Zhi-Jun] Wenzhou Univ, Coll Life & Environm Sci, Wenzhou 325035, Peoples R China	Wenzhou University	Zhao, ZJ (corresponding author), Wenzhou Univ, Coll Life & Environm Sci, Wenzhou 325035, Peoples R China.	zhao73@foxmail.com			Education Department of Zhejiang Province [pd2013374]; Zhejiang province college students science and technology innovation activities plan [2015R426031, 2015R426032]; National Natural Science Foundation of China [31270458]	Education Department of Zhejiang Province; Zhejiang province college students science and technology innovation activities plan; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	1. No. pd2013374, Education Department of Zhejiang Province, http://www.zjedu.gov.cn/default.html, to ZJZ, 2. 2015R426031, Zhejiang province college students science and technology innovation activities plan, http://shxy.wzu.edu.cn/ to XYZ, 3. 2015R426032, Zhejiang province college students science and technology innovation activities plan, http://shxy.wzu.edu.cn/, to JYZ, 4. 31270458, National Natural Science Foundation of China, http://www.nsfc.gov.cn/, to ZJZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso-Alvarez C, 2004, ECOL LETT, V7, P363, DOI 10.1111/j.1461-0248.2004.00594.x; Bao Wei-Dong, 2001, Chinese Journal of Zoology, V36, P15; Beckman KB, 1998, PHYSIOL REV, V78, P547, DOI 10.1152/physrev.1998.78.2.547; Bergeron P, 2011, FUNCT ECOL, V25, P1063, DOI 10.1111/j.1365-2435.2011.01868.x; Brand MD, 2000, EXP GERONTOL, V35, P811, DOI 10.1016/S0531-5565(00)00135-2; Brzek P, 2014, J EXP BIOL, V217, P1504, DOI 10.1242/jeb.100073; Buege J A, 1978, Methods Enzymol, V52, P302; Chen KX, 2014, J THERM BIOL, V44, P35, DOI 10.1016/j.jtherbio.2014.06.005; Costantini D, 2014, J EXP BIOL, V217, P4237, DOI 10.1242/jeb.114116; da Silva CCC, 2008, AGING CELL, V7, P552, DOI 10.1111/j.1474-9726.2008.00407.x; Dietrich MO, 2010, PFLUG ARCH EUR J PHY, V459, P269, DOI 10.1007/s00424-009-0729-0; Dowling DK, 2009, P ROY SOC B-BIOL SCI, V276, P1737, DOI 10.1098/rspb.2008.1791; Duarte LC, 2014, AGE, V36, DOI 10.1007/s11357-014-9731-3; Echtay KS, 2002, NATURE, V415, P96, DOI 10.1038/415096a; FIOROTTO ML, 1991, AM J PHYSIOL, V260, pR1104, DOI 10.1152/ajpregu.1991.260.6.R1104; Fletcher QE, 2013, EVOLUTION, V67, P1527, DOI 10.1111/evo.12014; Garratt M, 2013, J EXP BIOL, V216, P2879, DOI 10.1242/jeb.082669; Garratt M, 2011, P ROY SOC B-BIOL SCI, V278, P1098, DOI 10.1098/rspb.2010.1818; Gautam A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043860; Hammond KA, 1996, J EXP BIOL, V199, P337; Hou Xixian, 1993, Zoological Research, V14, P143; Jezek P, 2002, INT J BIOCHEM CELL B, V34, P1190, DOI 10.1016/S1357-2725(02)00061-4; Ji LL, 1997, AGE, V20, P91, DOI 10.1007/s11357-997-0009-x; Johnson MS, 2001, J EXP BIOL, V204, P1925; Keipert S, 2011, AGING CELL, V10, P122, DOI 10.1111/j.1474-9726.2010.00648.x; King EDA, 2013, ECOL EVOL, V3, P4161, DOI 10.1002/ece3.786; Krol E, 2003, J EXP BIOL, V206, P4283, DOI 10.1242/jeb.00676; Krol E, 2011, J EXP BIOL, V214, P4160, DOI 10.1242/jeb.061382; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Manivannan J, 2013, MUTAT RES-GEN TOX EN, V751, P59, DOI 10.1016/j.mrgentox.2012.11.006; Monaghan P, 2009, ECOL LETT, V12, P75, DOI 10.1111/j.1461-0248.2008.01258.x; Mookerjee SA, 2010, MECH AGEING DEV, V131, P463, DOI 10.1016/j.mad.2010.03.010; NIZIELSKI SE, 1993, AM J PHYSIOL, V264, pR16, DOI 10.1152/ajpregu.1993.264.1.R16; Oelkrug R, 2010, J BIOL CHEM, V285, P21961, DOI 10.1074/jbc.M110.122861; Oldakowski L, 2012, J EXP BIOL, V215, P1799, DOI 10.1242/jeb.068452; Parker N, 2009, J BIOENERG BIOMEMBR, V41, P335, DOI 10.1007/s10863-009-9232-8; PERRIGO G, 1987, ANIM BEHAV, V35, P1298, DOI 10.1016/S0003-3472(87)80002-7; Pichaud N, 2013, J EXP BIOL, V216, P2889, DOI 10.1242/jeb.082685; RUSSELL JA, 1980, J PHYSIOL-LONDON, V303, P403, DOI 10.1113/jphysiol.1980.sp013295; Schmidt CM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103286; Selman C, 2000, FREE RADICAL BIO MED, V28, P1279, DOI 10.1016/S0891-5849(00)00263-X; Selman C, 2008, P ROY SOC B-BIOL SCI, V275, P1907, DOI 10.1098/rspb.2008.0355; Selman C, 2012, TRENDS ECOL EVOL, V27, P570, DOI 10.1016/j.tree.2012.06.006; Sharick JT, 2015, FUNCT ECOL, V29, P367, DOI 10.1111/1365-2435.12330; Speakman John R., 2007, Acta Theriologica Sinica, V27, P1; Speakman JR, 2008, PHILOS T R SOC B, V363, P375, DOI 10.1098/rstb.2007.2145; Speakman JR, 2014, BIOESSAYS, V36, P93, DOI 10.1002/bies.201300108; Speakman JR, 2011, J EXP BIOL, V214, P230, DOI 10.1242/jeb.048603; Speakman JR, 2005, J COMP PHYSIOL B, V175, P375, DOI 10.1007/s00360-005-0013-3; Speakman JR, 2004, AGING CELL, V3, P87, DOI 10.1111/j.1474-9728.2004.00097.x; Speakman JR, 2002, J NUTR, V132, p1583S, DOI 10.1093/jn/132.6.1583S; Toime LJ, 2010, FREE RADICAL BIO MED, V49, P606, DOI 10.1016/j.freeradbiomed.2010.05.010; Vaanholt LM, 2009, PHYSIOL BIOCHEM ZOOL, V82, P314, DOI 10.1086/589727; Xiao XQ, 2004, ENDOCRINOLOGY, V145, P5344, DOI 10.1210/en.2004-0721; Xu YC, 2014, FUNCT ECOL, V28, P402, DOI 10.1111/1365-2435.12168; Yang DB, 2013, J EXP BIOL, V216, P4242, DOI 10.1242/jeb.092049; Zhang Z., 1998, ECOLOGY MANAGEMENT R; Zhao ZJ, 2014, HORM BEHAV, V65, P355, DOI 10.1016/j.yhbeh.2014.03.001; Zhao ZJ, 2012, BIOL OPEN, V1, P397, DOI 10.1242/bio.2012661; Zhao ZJ, 2011, COMP BIOCHEM PHYS A, V160, P229, DOI 10.1016/j.cbpa.2011.06.010; Zhao ZJ, 2010, ZOOLOGY, V113, P235, DOI 10.1016/j.zool.2010.01.001; Zhao Zhijun, 2012, Acta Theriologica Sinica, V32, P33; Zhao Zhijun, 2011, Acta Theriologica Sinica, V31, P69	63	4	4	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2015	10	10							e0141604	10.1371/journal.pone.0141604	http://dx.doi.org/10.1371/journal.pone.0141604			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU8PC	26505889	Green Submitted, Green Published, gold			2022-12-26	WOS:000363804200089
J	Liu, H; Yue, JP; Huang, H; Gou, XW; Chen, SY; Zhao, YM; Wu, XY				Liu, Han; Yue, Jiping; Huang, He; Gou, Xuewen; Chen, Shao-Yu; Zhao, Yingming; Wu, Xiaoyang			Regulation of Focal Adhesion Dynamics and Cell Motility by the EB2 and Hax1 Protein Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STEM-CELLS; PLUS-END; MIGRATION; MICROTUBULES; SUBSTRATE; ACTIN; SKIN; DISSOCIATION; PROMOTES; KINASE	Cell migration is a fundamental cellular process requiring integrated activities of the cytoskeleton, membrane, and cell/ extracellular matrix adhesions. Many cytoskeletal activities rely on microtubule filaments. It has been speculated that microtubules can serve as tracks to deliver proteins essential for focal adhesion turnover. Three microtubule end-binding proteins (EB1, EB2, and EB3) in mammalian cells can track the plus ends of growing microtubules. EB1 and EB3 together can regulate microtubule dynamics by promoting microtubule growth and suppressing catastrophe, whereas, in contrast, EB2 does not play a direct role in microtubule dynamic instability, and little is known about the cellular function of EB2. By quantitative proteomics, we identified mammalian HCLS1-associated protein X-1 (HAX1) as an EB2-specific interacting protein. Knockdown of HAX1 and EB2 in skin epidermal cells stabilizes focal adhesions and impairs epidermal migration in vitro and in vivo. Our results further demonstrate that cell motility and focal adhesion turnover require interaction between Hax1 and EB2. Together, our findings provide new insights for this critical cellular process, suggesting that EB2 association with Hax1 plays a significant role in focal adhesion turnover and epidermal migration.	[Liu, Han; Yue, Jiping; Huang, He; Gou, Xuewen; Zhao, Yingming; Wu, Xiaoyang] Univ Chicago, Ben May Dept Canc Res, Chicago, IL 60637 USA; [Chen, Shao-Yu] Univ Louisville, Hlth Sci Ctr, Dept Pharmacol & Toxicol, Louisville, KY 40292 USA	University of Chicago; University of Louisville	Wu, XY (corresponding author), Univ Chicago, GCIS W408B,929 E 57th St, Chicago, IL 60637 USA.	xiaoyangwu@uchicago.edu	Regan, Clinton/E-6250-2012	, Jiping/0000-0003-0717-8613	National Institutes of Health [R01-AR063630]; American Cancer Society Research Scholar Grant [RSG-13-198-01]; V Scholar Award from the V Foundation; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000430] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR063630] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society Research Scholar Grant(American Cancer Society); V Scholar Award from the V Foundation; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by National Institutes of Health Grant R01-AR063630, American Cancer Society Research Scholar Grant RSG-13-198-01, and the V Scholar Award from the V Foundation (to X. W.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alexandrova AY, 1998, CELL MOTIL CYTOSKEL, V39, P147, DOI 10.1002/(SICI)1097-0169(1998)39:2<147::AID-CM5>3.0.CO;2-3; Berrier AL, 2007, J CELL PHYSIOL, V213, P565, DOI 10.1002/jcp.21237; Bershadsky A, 1996, CURR BIOL, V6, P1279, DOI 10.1016/S0960-9822(02)70714-8; Blanpain C, 2006, ANNU REV CELL DEV BI, V22, P339, DOI 10.1146/annurev.cellbio.22.010305.104357; Burridge K, 1996, ANNU REV CELL DEV BI, V12, P463, DOI 10.1146/annurev.cellbio.12.1.463; Cavnar PJ, 2011, J CELL BIOL, V193, P465, DOI 10.1083/jcb.201010143; Delon I, 2007, CURR OPIN CELL BIOL, V19, P43, DOI 10.1016/j.ceb.2006.12.013; Dixit R, 2010, METHOD CELL BIOL, V95, P543, DOI 10.1016/S0091-679X(10)95027-9; Ezratty EJ, 2005, NAT CELL BIOL, V7, P581, DOI 10.1038/ncb1262; Guasch G, 2007, CANCER CELL, V12, P313, DOI 10.1016/j.ccr.2007.08.020; Howard J, 2003, NATURE, V422, P753, DOI 10.1038/nature01600; Howard J, 2009, NAT REV MOL CELL BIO, V10, P569, DOI 10.1038/nrm2713; Kaverina I, 1999, J CELL BIOL, V146, P1033, DOI 10.1083/jcb.146.5.1033; Kaverina I, 2002, J CELL SCI, V115, P2283; Klein C, 2007, NAT GENET, V39, P86, DOI 10.1038/ng1940; Kodama A, 2003, CELL, V115, P343, DOI 10.1016/S0092-8674(03)00813-4; Komarova Y, 2005, MOL BIOL CELL, V16, P5334, DOI 10.1091/mbc.E05-07-0614; Komarova Y, 2009, J CELL BIOL, V184, P691, DOI 10.1083/jcb.200807179; Krylyshkina O, 2003, J CELL BIOL, V161, P853, DOI 10.1083/jcb.200301102; Krylyshkina O, 2002, J CELL BIOL, V156, P349, DOI 10.1083/jcb.200105051; Kuo JC, 2011, NAT CELL BIOL, V13, P383, DOI 10.1038/ncb2216; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; Mazzalupo S, 2002, J INVEST DERMATOL, V118, P866, DOI 10.1046/j.1523-1747.2002.01736.x; Ong SE, 2003, METHODS, V29, P124, DOI 10.1016/S1046-2023(02)00303-1; Radhika V, 2004, J BIOL CHEM, V279, P49406, DOI 10.1074/jbc.M408836200; Ramsay AG, 2007, CANCER RES, V67, P5275, DOI 10.1158/0008-5472.CAN-07-0318; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Rodriguez OC, 2003, NAT CELL BIOL, V5, P599, DOI 10.1038/ncb0703-599; Schober M, 2007, J CELL BIOL, V176, P667, DOI 10.1083/jcb.200608010; Suzuki Y, 1997, J IMMUNOL, V158, P2736; Wu XY, 2008, CELL, V135, P137, DOI 10.1016/j.cell.2008.07.045; Wu XY, 2011, CELL, V144, P341, DOI 10.1016/j.cell.2010.12.033; Yue JP, 2014, DEV CELL, V31, P572, DOI 10.1016/j.devcel.2014.10.025	33	20	21	2	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 25	2015	290	52					30771	30782		10.1074/jbc.M115.671743	http://dx.doi.org/10.1074/jbc.M115.671743			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CZ6GK	26527684	Green Published, hybrid			2022-12-26	WOS:000367199000011
J	Lange, A; Jost, S; Heider, D; Bock, C; Budeus, B; Schilling, E; Strittmatter, A; Boenigk, J; Hoffmann, D				Lange, Anja; Jost, Steffen; Heider, Dominik; Bock, Christina; Budeus, Bettina; Schilling, Elmar; Strittmatter, Axel; Boenigk, Jens; Hoffmann, Daniel			AmpliconDuo: A Split-Sample Filtering Protocol for High-Throughput Amplicon Sequencing of Microbial Communities	PLOS ONE			English	Article							RARE BIOSPHERE; DIVERSITY; DNA; WRINKLES	High throughput sequencing (HTSeq) of small ribosomal subunit amplicons has the potential for a comprehensive characterization of microbial community compositions, down to rare species. However, the error-prone nature of the multi-step experimental process requires that the resulting raw sequences are subjected to quality control procedures. These procedures often involve an abundance cutoff for rare sequences or clustering of sequences, both of which limit genetic resolution. Here we propose a simple experimental protocol that retains the high genetic resolution granted by HTSeq methods while effectively removing many low abundance sequences that are likely due to PCR and sequencing errors. According to this protocol, we split samples and submit both halves to independent PCR and sequencing runs. The resulting sequence data is graphically and quantitatively characterized by the discordance between the two experimental branches, allowing for a quick identification of problematic samples. Further, we discard sequences that are not found in both branches ("AmpliconDuo filter"). We show that the majority of sequences removed in this way, mostly low abundance but also some higher abundance sequences, show features expected from random modifications of true sequences as introduced by PCR and sequencing errors. On the other hand, the filter retains many low abundance sequences observed in both branches and thus provides a more reliable census of the rare biosphere. We find that the AmpliconDuo filter increases biological resolution as it increases apparent community similarity between biologically similar communities, while it does not affect apparent community similarities between biologically dissimilar communities. The filter does not distort overall apparent community compositions. Finally, we quantitatively explain the effect of the AmpliconDuo filter by a simple mathematical model.	[Lange, Anja; Heider, Dominik; Budeus, Bettina; Hoffmann, Daniel] Univ Duisburg Essen, Fac Biol, Res Grp Bioinformat, Essen, Germany; [Jost, Steffen; Bock, Christina; Boenigk, Jens] Univ Duisburg Essen, Fac Biol, Dept Biodivers, Essen, Germany; [Schilling, Elmar; Strittmatter, Axel] Eurofins Genom, Ebersberg, Germany	University of Duisburg Essen; University of Duisburg Essen	Boenigk, J (corresponding author), Univ Duisburg Essen, Fac Biol, Dept Biodivers, Essen, Germany.	Jens.Boenigk@uni-due.de; Daniel.Hoffmann@uni-due.de	Hoffmann, Daniel/P-5624-2019; Hoffmann, Daniel/B-1314-2018; Bock, Christina/S-5649-2017; Heider, Dominik/F-8545-2010	Hoffmann, Daniel/0000-0003-2973-7869; Hoffmann, Daniel/0000-0003-2973-7869; Bock, Christina/0000-0002-6509-3768; Budeus, Bettina/0000-0002-9313-8636; Heider, Dominik/0000-0002-3108-8311	Deutsche Forschungsgemeinschaft (DFG) [TRR60/B1]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	D. Hoffmann gratefully acknowledges funding by Deutsche Forschungsgemeinschaft (DFG), project TRR60/B1 (http://www.dfg.de). DFG had no role in study design, collection, analysis, and interpretation of data, writing of the paper, or decision to submit for publication.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Ashelford KE, 2005, APPL ENVIRON MICROB, V71, P7724, DOI 10.1128/AEM.71.12.7724-7736.2005; Bass D., 2010, BIOGEOGRAPHY MICROOR, P88; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Boenigk J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095340; Bokulich NA, 2013, NAT METHODS, V10, P57, DOI [10.1038/nmeth.2276, 10.1038/NMETH.2276]; Bowen JL, 2012, ISME J, V6, P2014, DOI 10.1038/ismej.2012.47; Bowler C, 2009, NATURE, V459, P180, DOI 10.1038/nature08056; Bruls T, 2011, HUM MOL GENET, V20, pR142, DOI 10.1093/hmg/ddr353; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Cline J, 1996, NUCLEIC ACIDS RES, V24, P3546, DOI 10.1093/nar/24.18.3546; Degnan PH, 2012, ISME J, V6, P183, DOI 10.1038/ismej.2011.74; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Esling P, 2015, NUCLEIC ACIDS RES, V43, P2513, DOI 10.1093/nar/gkv107; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Fierer N, 2008, P NATL ACAD SCI USA, V105, P17994, DOI 10.1073/pnas.0807920105; Fonseca VG, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks002; Gilbert JA, 2010, STAND GENOMIC SCI, V3, P249, DOI [10.4056/aigs.1443528, 10.4056/sigs.1433550]; Haas BJ, 2011, GENOME RES, V21, P494, DOI 10.1101/gr.112730.110; Huse SM, 2010, ENVIRON MICROBIOL, V12, P1889, DOI 10.1111/j.1462-2920.2010.02193.x; Huse SM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000255; Karnati SKR, 2003, J ANIM SCI, V81, P812; Kunin V, 2010, ENVIRON MICROBIOL, V12, P118, DOI 10.1111/j.1462-2920.2009.02051.x; Lee CK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044224; LEVANDOWSKY M, 1971, NATURE, V234, P34, DOI 10.1038/234034a0; Masella AP, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-31; Nolte V, 2010, MOL ECOL, V19, P2908, DOI 10.1111/j.1365-294X.2010.04669.x; Oksanen J., **DATA OBJECT**; Pawlowski J, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001419; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Quince C, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-38; R Core Team, 2021, R LANGUAGE ENV STAT; Schloss PD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027310; Schloss PD, 2011, APPL ENVIRON MICROB, V77, P3219, DOI 10.1128/AEM.02810-10; Schmidt PA, 2013, SOIL BIOL BIOCHEM, V65, P128, DOI 10.1016/j.soilbio.2013.05.014; Tedersoo L, 2010, NEW PHYTOL, V188, P291, DOI 10.1111/j.1469-8137.2010.03373.x; Torchiano M., 2015, **DATA OBJECT**; WINNEPENNINCKX B, 1993, TRENDS GENET, V9, P407	40	29	31	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2015	10	11							e0141590	10.1371/journal.pone.0141590	http://dx.doi.org/10.1371/journal.pone.0141590			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV1PG	26523925	Green Submitted, Green Published, gold			2022-12-26	WOS:000364029800014
J	Gong, XH; Lu, J; Liu, J; Deng, YY; Liu, WZ; Huang, X; Yang, YH; Xu, Q; Yu, ZY				Gong, Xue-Hao; Lu, Jun; Liu, Jin; Deng, Ying-Yuan; Liu, Wei-Zong; Huang, Xian; Yang, Yong-Heng; Xu, Qin; Yu, Zhi-Ying			Segmentation of Uterus Using Laparoscopic Ultrasound by an Image-Based Active Contour Approach for Guiding Gynecological Diagnosis and Surgery	PLOS ONE			English	Article							INTRAOPERATIVE ULTRASONOGRAPHY; CERVICAL-CARCINOMA; LIVER-TUMORS; RECURRENCE; MYOMECTOMY	In laparoscopic gynecologic surgery, ultrasound has been typically implemented to diagnose urological and gynecological conditions. We applied laparoscopic ultrasonography (using Esaote 7.5 similar to 10MHz laparoscopic transducer) on the retrospective analyses of 42 women subjects during laparoscopic extirpation and excision of gynecological tumors in our hospital from August 2011 to August 2013. The objective of our research is to develop robust segmentation technique for isolation and identification of the uterus from the ultrasound images, so as to assess, locate and guide in removing the lesions during laparoscopic operations. Our method enables segmentation of the uterus by the active contour algorithm. We evaluated 42 in-vivo laparoscopic images acquired from the 42 patients (age 39.1 +/- 7.2 years old) and selected images pertaining to 4 cases of congenital uterine malformations and 2 cases of pelvic adhesions masses. These cases (n = 6) were used for our uterus segmentation experiments. Based on them, the active contour method was compared with the manual segmentation method by a medical expert using linear regression and the Bland-Altman analysis (used to measure the correlation and the agreement). Then, the Dice and Jaccard indices are computed for measuring the similarity of uterus segmented between computational and manual methods. Good correlation was achieved whereby 84%-92% results fall within the 95% confidence interval in the Student t-test) and we demonstrate that the proposed segmentation method of uterus using laparoscopic images is effective.	[Gong, Xue-Hao; Deng, Ying-Yuan; Liu, Wei-Zong; Huang, Xian; Yang, Yong-Heng; Xu, Qin] Shenzhen Univ, Affiliated Hosp 1, Peoples Hosp Shenzhen 2, Dept Ultrasound, Shenzhen, Peoples R China; [Lu, Jun] Jinan Univ, Peoples Hosp Shenzhen, Clin Coll 2, Dept Ultrasound, Shenzhen, Peoples R China; [Liu, Jin; Yu, Zhi-Ying] Shenzhen Univ, Affiliated Hosp 1, Dept Obstet & Gynecol, Shenzhen, Peoples R China	Shenzhen University; Jinan University; Shenzhen University	Yu, ZY (corresponding author), Shenzhen Univ, Affiliated Hosp 1, Dept Obstet & Gynecol, Shenzhen, Peoples R China.	11519449@qq.com			Shenzhen science and technology Bureau [201102054]; Shenzhen science and technology innovation Committee [JCYJ20140414170821285, CXZZ20140909004122087]	Shenzhen science and technology Bureau; Shenzhen science and technology innovation Committee	This work was supported part by Grant No. 201102054 from Shenzhen science and technology Bureau, and part by Grant JCYJ20140414170821285, CXZZ20140909004122087 from Shenzhen science and technology innovation Committee. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMAN DG, 1983, J ROY STAT SOC D-STA, V32, P307, DOI 10.2307/2987937; Araki K, 2014, J AM COLL SURGEONS, V218, pE37, DOI 10.1016/j.jamcollsurg.2013.10.022; Barbot DJ, 1997, J SURG ONCOL, V64, P63; Bibicu D, 2015, J MED IMAG HEALTH IN, V5, P241, DOI 10.1166/jmihi.2015.1379; Chahed J, 2010, PEDIATR SURG INT, V26, P413, DOI 10.1007/s00383-010-2555-z; Cheung TH, 2011, J LAPAROENDOSC ADV S, V21, P61, DOI 10.1089/lap.2010.0336; Cheung TH, 2004, GYNECOL ONCOL, V92, P784, DOI 10.1016/j.ygyno.2003.11.015; Cheung TH, 1998, GYNECOL ONCOL, V71, P87, DOI 10.1006/gyno.1998.5166; Chhatkuli A, 2014, 11 INT S BIOM IM ISB; DICE LR, 1945, ECOLOGY, V26, P297, DOI 10.2307/1932409; Duda R.O., 2000, PATTERN CLASSIFICATI; Fauconnier A, 2000, HUM REPROD UPDATE, V6, P595, DOI 10.1093/humupd/6.6.595; Ferrero A, 2014, ULTRASOUND GUIDED LA, P1; Fukuda M, 1983, SCANDINAVIAN J GAS S, V102, P24; Hay SA, 2008, J LAPAROENDOSC ADV S, V18, P783, DOI 10.1089/lap.2008.0008; IGAWA S, 1985, RADIOLOGY, V156, P473, DOI 10.1148/radiology.156.2.2989974; Jerby BL, 1998, ONCOLOGY-NY, V12, P1353; JOHN TG, 1994, ANN SURG, V220, P711, DOI 10.1097/00000658-199412000-00002; Letterie GS, 2000, ULTRASOUND OBST GYN, V16, P63, DOI 10.1046/j.1469-0705.2000.00172.x; Li Si-jing, 2013, Zhonghua Yi Xue Za Zhi, V93, P2986; Machi J, 2009, SURG ENDOSC, V23, P384, DOI 10.1007/s00464-008-9985-x; Majbar MA, 2014, SURG ENDOSC, V28, P1048, DOI 10.1007/s00464-013-3200-4; Rane A, 2010, J ENDOUROL, V24, pP14; Rossetti A, 2001, HUM REPROD, V16, P770, DOI 10.1093/humrep/16.4.770; Seror J, 2014, J MINIM INVAS GYN, V21, P120, DOI 10.1016/j.jmig.2013.07.015; Tan P.-N., 2019, INTRO DATA MINING, V2nd ed.; van Vledder MG, 2010, ANN SURG ONCOL, V17, P2756, DOI 10.1245/s10434-010-1108-y; Vapenstad C, 2010, SURG ENDOSC, V24, P2944, DOI 10.1007/s00464-010-1135-6; Wubuli A, 2014, J MED IMAG HEALTH IN, V4, P814, DOI 10.1166/jmihi.2014.1326; Yang CC, 2002, J AM ASSOC GYN LAP, V9, P327, DOI 10.1016/S1074-3804(05)60412-4; Zhou ZG, 2014, HEPATO-GASTROENTEROL, V61, P285, DOI 10.5754/hge11339; Zhu WB, 2014, J MED IMAG HEALTH IN, V4, P832, DOI 10.1166/jmihi.2014.1332	32	6	6	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2015	10	10							e0141046	10.1371/journal.pone.0141046	http://dx.doi.org/10.1371/journal.pone.0141046			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0EH	26516767	Green Published, Green Submitted, gold			2022-12-26	WOS:000363920800015
J	Li, QF; Wang, JH; Pulkkinen, P; Kong, LS				Li, Q. F.; Wang, J. H.; Pulkkinen, P.; Kong, L. S.			Changes in the Metabolome of Picea balfouriana Embryogenic Tissues That Were Linked to Different Levels of 6-BAP by Gas Chromatography-Mass Spectrometry Approach	PLOS ONE			English	Article							SOMATIC EMBRYOGENESIS; LOBLOLLY-PINE; POTATO-TUBER; INITIATION; REVEALS; ACID; IDENTIFICATION; SYLVESTRIS; PINASTER; CULTURES	Embryogenic cultures of Picea balfouriana, which is an important commercial species for reforestation in Southern China, easily lose their embryogenic ability during long-term culture. Embryogenic tissue that proliferated at lower concentrations (3.6 mu M and 2.5 mu M) of 6-benzylaminopurine (6-BAP) were more productive, and generated 113 +/- 6 and 89 +/- 3 mature embryos per 100 mg embryogenic tissue, respectively. A metabolomic approach was used to study the changes in metabolites linked to embryogenic competence related to three different 6-BAP concentrations (2.5 mu M, 3.6 mu M, and 5 mu M). A total of 309 compounds were obtained, among which 123 metabolites mapped to Kyoto Encyclopedia of Genes and genomes (KEGG) pathways. The levels of 35 metabolites were significantly differentially regulated among the three 6-BAP treatments, and 32 metabolites differed between the 2.5 mu M and 5 mu M treatments. A total of 17 metabolites appeared only once among the three comparisons. The combination of a score plot and a loading plot showed that in the samples with higher embryogenic ability (3.6 mu M and 2.5 mu M), up-regulated metabolites were mostly amino acids and down-regulated metabolites were mostly primary carbohydrates (especially sugars). These results suggested that 6-BAP may influence embryogenic competence by nitrogen metabolism, which could cause an increase in amino acid levels and higher amounts of aspartate, isoleucine, and leucine in tissues with higher embryogenic ability. Furthermore, we speculated that 6-BAP may affect the amount of tryptophan in tissues, which would change the indole-3-acetic acid levels and influence the embryogenic ability.	[Li, Q. F.; Wang, J. H.] Chinese Acad Forestry, Res Inst Forestry, State Key Lab Forest Genet & Tree Breeding, Beijing, Peoples R China; [Li, Q. F.] GuangXi Zhuang Autonomous Reg Forestry Res Ins, Guangxi Key Lab Special Non Wood Forest Cultivat, Nanning, Peoples R China; [Pulkkinen, P.] Finnish Forest Res Inst, Haapastensyrja, Finland; [Kong, L. S.] Univ Victoria, Dept Biol, Unit Ctr Forest Biol, Victoria, BC, Canada	Chinese Academy of Forestry; Research Institute of Forestry, CAF; Natural Resources Institute Finland (Luke); University of Victoria	Wang, JH (corresponding author), Chinese Acad Forestry, Res Inst Forestry, State Key Lab Forest Genet & Tree Breeding, Beijing, Peoples R China.	wangjh@caf.ac.cn			Advanced Generation Breeding Technological Research and Demonstration of Northern Conifer Species [2012BAD01B01]	Advanced Generation Breeding Technological Research and Demonstration of Northern Conifer Species	This research was funded by the Advanced Generation Breeding Technological Research and Demonstration of Northern Conifer Species (2012BAD01B01).	A J, 2005, ANAL CHEM, V77, P8086, DOI 10.1021/ac051211v; Alexandra L, 2005, J BIOL CHEM, V280, P24723, DOI [10.1074/jbc.M502285200, DOI 10.1074/JBC.M502285200]; Alvarez S, 2008, PLANT CELL ENVIRON, V31, P325, DOI 10.1111/j.1365-3040.2007.01770.x; Argueso CT, 2010, CURR OPIN PLANT BIOL, V13, P533, DOI 10.1016/j.pbi.2010.08.006; Azevedo RA, 2006, AMINO ACIDS, V30, P143, DOI 10.1007/s00726-005-0245-2; Broeckling CD, 2005, J EXP BOT, V56, P323, DOI 10.1093/jxb/eri058; Businge E, 2012, TREE PHYSIOL, V32, P232, DOI 10.1093/treephys/tpr142; Bylesjo M, 2006, J CHEMOMETR, V20, P341, DOI 10.1002/cem.1006; Canovas FM, 2007, J EXP BOT, V58, P2307, DOI 10.1093/jxb/erm051; Chen YZ, 2012, MOL PLANT, V5, P1138, DOI 10.1093/mp/sss034; Fiehn O, 2000, NAT BIOTECHNOL, V18, P1157, DOI 10.1038/81137; Fiehn O, 2002, PLANT MOL BIOL, V48, P155, DOI 10.1023/A:1013713905833; GLEDDIE S, 1983, CAN J BOT, V61, P656, DOI 10.1139/b83-074; Gupta Pramod K., 2005, V77, P573; Gupta S, 2012, PLANT CELL REP, V31, P801, DOI 10.1007/s00299-012-1233-0; Hochberg U, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-184; Hosp J, 2007, PLANT MOL BIOL, V63, P137, DOI 10.1007/s11103-006-9078-y; Ikram-ul-Haq, 2004, African Journal of Biotechnology, V3, P319; Joy RW, 1996, PHYSIOL PLANTARUM, V97, P149, DOI 10.1111/j.1399-3054.1996.tb00491.x; Kim S, 2006, J PLANT BIOTECHNOL, V4, P83; Klimaszewska K, 2001, IN VITRO CELL DEV-PL, V37, P392, DOI 10.1007/s11627-001-0069-z; Lelu-Walter MA, 2008, PLANT CELL TISS ORG, V92, P31, DOI 10.1007/s11240-007-9300-x; Lelu-Walter MA, 2006, PLANT CELL REP, V25, P767, DOI 10.1007/s00299-006-0115-8; Li QF, 2015, PHYSIOL PLANTARUM, V154, P95, DOI 10.1111/ppl.12276; Li QF, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-553; Lipavska H, 2004, IN VITRO CELL DEV-PL, V40, P23, DOI 10.1079/IVP2003482; Lisec J, 2006, NAT PROTOC, V1, P387, DOI 10.1038/nprot.2006.59; Litvay JD, 114 IPC; Luedemann A, 2008, BIOINFORMATICS, V24, P732, DOI 10.1093/bioinformatics/btn023; Luedemann Alexander, 2012, Methods Mol Biol, V860, P255, DOI 10.1007/978-1-61779-594-7_16; Lynch JP, 2011, PLANT PHYSIOL, V156, P1041, DOI 10.1104/pp.111.175414; MacKay JJ, 2006, TREE GENET GENOMES, V2, P1, DOI 10.1007/s11295-005-0020-2; Madsen A, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/5/055001; Menke-Milczarek I, 2001, ACTA PHYSIOL PLANT, V23, P37, DOI 10.1007/s11738-001-0020-2; Meyer RC, 2007, P NATL ACAD SCI USA, V104, P4759, DOI 10.1073/pnas.0609709104; Moubayidin L, 2010, CURR BIOL, V20, P1138, DOI 10.1016/j.cub.2010.05.035; Muraro D, 2013, J THEOR BIOL, V317, P71, DOI 10.1016/j.jtbi.2012.08.032; Nicholson JK, 2002, NAT REV DRUG DISCOV, V1, P153, DOI 10.1038/nrd728; Park YS, 2006, PLANT CELL TISS ORG, V86, P87, DOI 10.1007/s11240-006-9101-7; Pullman GS, 2009, TREE PHYSIOL, V29, P147, DOI 10.1093/treephys/tpn013; Pullman GS, 2003, PLANT CELL REP, V22, P85, DOI 10.1007/s00299-003-0673-y; Robinson AR, 2009, PLANT BIOTECHNOL J, V7, P952, DOI 10.1111/j.1467-7652.2009.00456.x; Roessner U, 2001, PLANT CELL, V13, P11, DOI 10.1105/tpc.13.1.11; Roessner U, 2001, PLANT PHYSIOL, V127, P749, DOI [10.1104/pp.010316, 10.1104/pp.127.3.749]; Roessner U, 2000, PLANT J, V23, P131, DOI 10.1046/j.1365-313x.2000.00774.x; Shulaev V, 2008, PHYSIOL PLANTARUM, V132, P199, DOI 10.1111/j.1399-3054.2007.01025.x; Sitbon F, 2000, PLANTA, V211, P715, DOI 10.1007/s004250000338; Srivastava V., 2009, THESIS SWEDISH U AGR; Stasolla C, 2003, PLANT CELL TISS ORG, V74, P15, DOI 10.1023/A:1023345803336; Sumner LW, 2003, PHYTOCHEMISTRY, V62, P817, DOI 10.1016/S0031-9422(02)00708-2; Trygg J, 2002, J CHEMOMETR, V16, P119, DOI 10.1002/cem.695; Vales T, 2007, PLANT CELL REP, V26, P133, DOI 10.1007/s00299-006-0221-7; Wang JH, 2012, Patent No. [ZL 201210274334.9, 201210274334]; Wang JunHui, 2005, Journal of Zhejiang Forestry College, V22, P350; Weckwerth W, 2003, ANNU REV PLANT BIOL, V54, P669, DOI 10.1146/annurev.arplant.54.031902.135014; Weigelt K, 2008, PLANT J, V55, P909, DOI 10.1111/j.1365-313X.2008.03560.x; Widodo, 2009, J EXP BOT, V60, P4089, DOI 10.1093/jxb/erp243; Wiklund S, 2008, ANAL CHEM, V80, P115, DOI 10.1021/ac0713510; WOLD S, 1987, CHEMOMETR INTELL LAB, V2, P37, DOI 10.1016/0169-7439(87)80084-9; Wu DZ, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0056624, 10.1371/journal.pone.0053932, 10.1371/journal.pone.0055431]	60	6	6	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2015	10	10							e0141841	10.1371/journal.pone.0141841	http://dx.doi.org/10.1371/journal.pone.0141841			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0EH	26517840	Green Published, gold			2022-12-26	WOS:000363920800085
J	Prince, TL; Kijima, T; Tatokoro, M; Lee, S; Tsutsumi, S; Yim, K; Rivas, C; Alarcon, S; Schwartz, H; Khamit-Kush, K; Scroggins, BT; Beebe, K; Trepel, JB; Neckers, L				Prince, Thomas L.; Kijima, Toshiki; Tatokoro, Manabu; Lee, Sunmin; Tsutsumi, Shinji; Yim, Kendrick; Rivas, Candy; Alarcon, Sylvia; Schwartz, Harvey; Khamit-Kush, Kofi; Scroggins, Bradley T.; Beebe, Kristin; Trepel, Jane B.; Neckers, Len			Client Proteins and Small Molecule Inhibitors Display Distinct Binding Preferences for Constitutive and Stress-Induced HSP90 Isoforms and Their Conformationally Restricted Mutants	PLOS ONE			English	Article							HEAT-SHOCK; ATP BINDING; CHAPERONE; ACTIVATION; MECHANISM; REVEALS; COMPLEX; KINASE; HSF1; GELDANAMYCIN	The two cytosolic/nuclear isoforms of the molecular chaperone HSP90, stress-inducible HSP90 alpha and constitutively expressed HSP90 beta, fold, assemble and maintain the three-dimensional structure of numerous client proteins. Because many HSP90 clients are important in cancer, several HSP90 inhibitors have been evaluated in the clinic. However, little is known concerning possible unique isoform or conformational preferences of either individual HSP90 clients or inhibitors. In this report, we compare the relative interaction strength of both HSP90 alpha and HSP90 beta with the transcription factors HSF1 and HIF1 alpha, the kinases ERBB2 and MET, the E3-ubiquitin ligases KEAP1 and RHOBTB2, and the HSP90 inhibitors geldanamycin and ganetespib. We observed unexpected differences in relative client and drug preferences for the two HSP90 isoforms, with HSP90 alpha binding each client protein with greater apparent affinity compared to HSP90 beta, while HSP90 beta bound each inhibitor with greater relative interaction strength compared to HSP90 alpha. Stable HSP90 interaction was associated with reduced client activity. Using a defined set of HSP90 conformational mutants, we found that some clients interact strongly with a single, ATP-stabilized HSP90 conformation, only transiently populated during the dynamic HSP90 chaperone cycle, while other clients interact equally with multiple HSP90 conformations. These data suggest different functional requirements among HSP90 clientele that, for some clients, are likely to be ATP-independent. Lastly, the two inhibitors examined, although sharing the same binding site, were differentially able to access distinct HSP90 conformational states.	[Prince, Thomas L.; Kijima, Toshiki; Tatokoro, Manabu; Tsutsumi, Shinji; Yim, Kendrick; Rivas, Candy; Schwartz, Harvey; Khamit-Kush, Kofi; Beebe, Kristin; Neckers, Len] NCI, Urol Oncol Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Lee, Sunmin; Alarcon, Sylvia; Trepel, Jane B.] NCI, Dev Therapeut Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Scroggins, Bradley T.] NCI, Radiat Oncol Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Prince, TL (corresponding author), NCI, Urol Oncol Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA.	thomas.prince@nih.gov; neckers@nih.gov	Kijima, Toshiki/AAF-8264-2020	Kijima, Toshiki/0000-0002-4380-9294	Intramural Research Program, NCI [Z01 BC011032-01, Z01 SC010074-12]; JSPS Research Fellowship for Japanese Biomedical and Behavioral Researchers at NIH; NATIONAL CANCER INSTITUTE [Z01BC011032, ZIABC011032, ZIASC010074, Z01SC010074] Funding Source: NIH RePORTER	Intramural Research Program, NCI; JSPS Research Fellowship for Japanese Biomedical and Behavioral Researchers at NIH; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by funds to L.N. from the Intramural Research Program, NCI (project #s Z01 BC011032-01 and Z01 SC010074-12). Biotinylated ganetespib (STA-7346) was provided by Weiwen Ying (Synta Pharmaceuticals, Lexington, MA). T.K. is supported by a JSPS Research Fellowship for Japanese Biomedical and Behavioral Researchers at NIH.	Barrios-Rodiles M, 2005, SCIENCE, V307, P1621, DOI 10.1126/science.1105776; Blagosklonny MV, 2001, LEUKEMIA, V15, P1537, DOI 10.1038/sj.leu.2402257; Cha JY, 2013, PLANT PHYSIOL BIOCH, V70, P368, DOI 10.1016/j.plaphy.2013.05.039; Chen B, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-156; Citri A, 2004, EMBO REP, V5, P1165, DOI 10.1038/sj.embor.7400300; Citri A, 2004, CELL CYCLE, V3, P51; Conde R, 2005, J BIOL CHEM, V280, P28989, DOI 10.1074/jbc.M503594200; Conde R, 2009, BIOCHEM CELL BIOL, V87, P845, DOI [10.1139/O09-049, 10.1139/o09-049]; Cunningham CN, 2012, PROTEIN SCI, V21, P1162, DOI 10.1002/pro.2103; Donze O, 2001, EMBO J, V20, P3771, DOI 10.1093/emboj/20.14.3771; Eiseman JL, 2005, CANCER CHEMOTH PHARM, V55, P21, DOI 10.1007/s00280-004-0865-3; Gano JJ, 2010, MOL CELL PROTEOMICS, V9, P255, DOI 10.1074/mcp.M900261-MCP200; Gong YC, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.26; Gradin K, 1996, MOL CELL BIOL, V16, P5221; Guo YL, 2001, J BIOL CHEM, V276, P45791, DOI 10.1074/jbc.M105931200; Hartson SD, 2012, BBA-MOL CELL RES, V1823, P656, DOI 10.1016/j.bbamcr.2011.08.013; HEISEY RM, 1986, J NAT PROD, V49, P859, DOI 10.1021/np50047a016; Isaacs JS, 2002, J BIOL CHEM, V277, P29936, DOI 10.1074/jbc.M204733200; JAKOB U, 1995, J BIOL CHEM, V270, P7288, DOI 10.1074/jbc.270.13.7288; Kamal A, 2003, NATURE, V425, P407, DOI 10.1038/nature01913; Leinonen HM, 2014, ADV CANCER RES, V122, P281, DOI 10.1016/B978-0-12-420117-0.00008-6; Li J, 2012, BBA-MOL CELL RES, V1823, P624, DOI 10.1016/j.bbamcr.2011.09.003; Manjarrez JR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090054; McKinnon CM, 2008, ONCOGENE, V27, P6856, DOI 10.1038/onc.2008.317; McLaughlin SH, 2004, J MOL BIOL, V344, P813, DOI 10.1016/j.jmb.2004.09.055; Mendillo ML, 2012, CELL, V150, P549, DOI 10.1016/j.cell.2012.06.031; Meyer P, 2003, MOL CELL, V11, P647, DOI 10.1016/S1097-2765(03)00065-0; Millson SH, 2005, EUKARYOT CELL, V4, P849, DOI 10.1128/EC.4.5.849-860.2005; Millson SH, 2007, FEBS J, V274, P4453, DOI 10.1111/j.1742-4658.2007.05974.x; Mishra P, 2014, MOL CELL, V53, P344, DOI 10.1016/j.molcel.2013.12.024; Neckers L, 2012, CLIN CANCER RES, V18, P64, DOI 10.1158/1078-0432.CCR-11-1000; Niture SK, 2010, J BIOL CHEM, V285, P36865, DOI 10.1074/jbc.M110.175802; Obermann WMJ, 1998, J CELL BIOL, V143, P901, DOI 10.1083/jcb.143.4.901; Panaretou B, 1998, EMBO J, V17, P4829, DOI 10.1093/emboj/17.16.4829; Patel PD, 2013, NAT CHEM BIOL, V9, P677, DOI [10.1038/NCHEMBIO.1335, 10.1038/nchembio.1335]; Pearl LH, 2006, ANNU REV BIOCHEM, V75, P271, DOI 10.1146/annurev.biochem.75.103004.142738; Prince T, 2004, J BIOL CHEM, V279, P39975, DOI 10.1074/jbc.M406882200; Pursell NW, 2012, EUKARYOT CELL, V11, P1033, DOI 10.1128/EC.00099-12; Roe SM, 1999, J MED CHEM, V42, P260, DOI 10.1021/jm980403y; Shimamura T, 2012, CLIN CANCER RES, V18, P4973, DOI 10.1158/1078-0432.CCR-11-2967; Southworth DR, 2008, MOL CELL, V32, P631, DOI 10.1016/j.molcel.2008.10.024; Taherian A, 2008, BIOCHEM CELL BIOL, V86, P37, DOI [10.1139/O07-154, 10.1139/o07-154]; Taipale M, 2014, CELL, V158, P434, DOI 10.1016/j.cell.2014.05.039; Taipale M, 2012, CELL, V150, P987, DOI 10.1016/j.cell.2012.06.047; Tsutsumi S, 2009, NAT STRUCT MOL BIOL, V16, P1141, DOI 10.1038/nsmb.1682; ULLRICH SJ, 1989, J BIOL CHEM, V264, P6810; Vaughan CK, 2006, MOL CELL, V23, P697, DOI 10.1016/j.molcel.2006.07.016; Wang YS, 2010, CURR OPIN INVEST DR, V11, P1466; WHITESELL L, 1994, P NATL ACAD SCI USA, V91, P8324, DOI 10.1073/pnas.91.18.8324; Xu WP, 2007, MOL CELL BIOL, V27, P220, DOI 10.1128/MCB.00899-06; Yano A, 2008, P NATL ACAD SCI USA, V105, P15541, DOI 10.1073/pnas.0805354105; Yoshihara T, 2007, BIOCHEM BIOPH RES CO, V358, P1076, DOI 10.1016/j.bbrc.2007.05.037; Zhao C, 2002, EXP CELL RES, V275, P200, DOI 10.1006/excr.2002.5501; Zou JY, 1998, CELL, V94, P471, DOI 10.1016/S0092-8674(00)81588-3; Zuehlke AD, 2015, GENE	55	37	43	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2015	10	10							e0141786	10.1371/journal.pone.0141786	http://dx.doi.org/10.1371/journal.pone.0141786			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0EH	26517842	Green Published, gold, Green Submitted			2022-12-26	WOS:000363920800077
J	Zheng, MH; Long, H; Zhao, Y; Li, L; Xu, DL; Zhang, HL; Liu, F; Deng, GB; Pan, ZF; Yu, MQ				Zheng, Minghui; Long, Hai; Zhao, Yun; Li, Lin; Xu, Delin; Zhang, Haili; Liu, Feng; Deng, Guangbing; Pan, Zhifen; Yu, Maoqun			RNA-Seq Based Identification of Candidate Parasitism Genes of Cereal Cyst Nematode (Heterodera avenae) during Incompatible Infection to Aegilops variabilis	PLOS ONE			English	Article							UBIQUITIN-MEDIATED PROTEOLYSIS; FUNCTIONAL GENOMICS; GLOBODERA-PALLIDA; ESOPHAGEAL GLAND; BINDING PROTEIN; RESISTANCE; EXPRESSION; WHEAT; TOOL; TRANSCRIPTOMES	One of the reasons for the progressive yield decline observed in cereals production is the rapid build-up of populations of the cereal cyst nematode (CCN, Heterodera avenae). These nematodes secrete so-call effectors into their host plant to suppress the plant defense responses, alter plant signaling pathways and then induce the formation of syncytium after infection. However, little is known about its molecular mechanism and parasitism during incompatible infection. To gain insight into its repertoire of parasitism genes, we investigated the transcriptome of the early parasitic second-stage (30 hours, 3 days and 9 days post infection) juveniles of the CCN as well as the CCN infected tissue of the host Aegilops variabilis by Illumina sequencing. Among all assembled unigenes, 681 putative genes of parasitic nematode were found, in which 56 putative effectors were identified, including novel pioneer genes and genes corresponding to previously reported effectors. All the 681 CCN unigenes were mapped to 229 GO terms and 200 KEGG pathways, including growth, development and several stimulus-related signaling pathways. Sixteen clusters were involved in the CCN unigene expression atlas at the early stages during infection process, and three of which were significantly gene-enriched. Besides, the protein-protein interaction network analysis revealed 35 node unigenes which may play an important role in the plantCCN interaction. Moreover, in a comparison of differentially expressed genes between the pre-parasitic juveniles and the early parasitic juveniles, we found that hydrolase activity was up-regulated in pre J2s whereas binding activity was upregulated in infective J2s. RT-qPCR analysis on some selected genes showed detectable expression, indicating possible secretion of the proteins and putative role in infection. This study provided better insights into the incompatible interaction between H. avenae and the host plant Ae. varabilis. Moreover, RNAi targets with potential lethality were screened out and primarily validated, which provide candidates for engineering-based control of cereal cyst nematode in crops breeding.	[Zheng, Minghui; Long, Hai; Li, Lin; Zhang, Haili; Deng, Guangbing; Pan, Zhifen; Yu, Maoqun] Chinese Acad Sci, Chengdu Inst Biol, Chengdu, Peoples R China; [Zheng, Minghui; Li, Lin] Univ Chinese Acad Sci, Beijing, Peoples R China; [Zheng, Minghui; Zhao, Yun] Sichuan Univ, Coll Life Sci, Chengdu 610064, Peoples R China; [Xu, Delin] Zunyi Med Univ, Zunyi, Peoples R China; [Liu, Feng] Shandong Agr Univ, Plant Protect Coll, Tai An, Shandong, Peoples R China	Chinese Academy of Sciences; Chengdu Institute of Biology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Sichuan University; Zunyi Medical University; Shandong Agricultural University	Yu, MQ (corresponding author), Chinese Acad Sci, Chengdu Inst Biol, Chengdu, Peoples R China.	yumaoqun@cib.ac.cn	zhao, yun/AAJ-4105-2020	Zhang, Haili/0000-0002-7839-4420	Ministry of Science and Technology of the People's Republic of China [2013CB127502]; National Natural Science Foundation of China [31470097]	Ministry of Science and Technology of the People's Republic of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by: No. 2013CB127502, Ministry of Science and Technology of the People's Republic of China (www.most.gov.cn), HL; and 31470097, National Natural Science Foundation of China (www.nsfc.gov.cn), MQY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abad P, 2008, NAT BIOTECHNOL, V26, P909, DOI 10.1038/nbt.1482; Abad P, 2011, GENOMICS AND MOLECULAR GENETICS OF PLANT-NEMATODE INTERACTIONS, P103, DOI 10.1007/978-94-007-0434-3_6; Aditya J, 2015, NEW PHYTOL; Alkharouf NW, 2007, EXP PARASITOL, V115, P247, DOI 10.1016/j.exppara.2006.09.009; Andres MF, 2001, NEW PHYTOL, V152, P343, DOI 10.1111/j.0028-646X.2001.00258.x; ASIEDU R, 1990, THEOR APPL GENET, V79, P331, DOI 10.1007/BF01186075; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Bakhetia M, 2007, MOL PLANT MICROBE IN, V20, P306, DOI 10.1094/MPMI-20-3-0306; Barloy D, 2007, MOL BREEDING, V20, P31, DOI 10.1007/s11032-006-9070-x; Bendtsen JD, 2004, PROTEIN ENG DES SEL, V17, P349, DOI 10.1093/protein/gzh037; Benjamini Y, 2001, ANN STAT, V29, P1165; Bird DM, 2009, ANNU REV PHYTOPATHOL, V47, P333, DOI 10.1146/annurev-phyto-080508-081839; Blaxter M, 2012, PARASITE IMMUNOL, V34, P108, DOI 10.1111/j.1365-3024.2011.01342.x; Chen P, 1989, SCI AGR SINICA, V24, P89; Chitwood DJ, 2003, PEST MANAG SCI, V59, P748, DOI 10.1002/ps.684; Ciechanover A, 2000, BIOESSAYS, V22, P442, DOI 10.1002/(SICI)1521-1878(200005)22:5<442::AID-BIES6>3.0.CO;2-Q; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Coriton O, 2009, GENOME, V52, P338, DOI [10.1139/G09-011, 10.1139/g09-011]; Cotton JA, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-3-r43; Das S, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-480; Deliang P, 2009, CURRENT KNOWLEDGE CE, P29; Dubreuil G, 2007, NEW PHYTOL, V176, P426, DOI 10.1111/j.1469-8137.2007.02181.x; Elling AA, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-58; Ernst J, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-191; Gao BL, 2003, MOL PLANT MICROBE IN, V16, P720, DOI 10.1094/MPMI.2003.16.8.720; Gheysen G, 2007, TRENDS BIOTECHNOL, V25, P89, DOI 10.1016/j.tibtech.2007.01.007; Gheysen G, 2011, CURR OPIN PLANT BIOL, V14, P415, DOI 10.1016/j.pbi.2011.03.012; Haegeman A, 2011, MOL PLANT MICROBE IN, V24, P879, DOI 10.1094/MPMI-03-11-0055; Hamamouch N, 2011, MOL PLANT PATHOL, V12, P355, DOI 10.1111/j.1364-3703.2010.00675.x; Hewezi T, 2008, PLANT CELL, V20, P3080, DOI 10.1105/tpc.108.063065; Huang GZ, 2003, MOL PLANT MICROBE IN, V16, P376, DOI 10.1094/MPMI.2003.16.5.376; Huang W-K, 2011, J HUAZHONG AGR U, V30; Iberkleid I, 2014, PHYTOPATHOLOGY, V104, P484, DOI 10.1094/PHYTO-07-13-0181-R; Jahier J, 2001, PLANT BREEDING, V120, P125, DOI 10.1046/j.1439-0523.2001.00585.x; Jaubert S, 2005, MOL PLANT MICROBE IN, V18, P1277, DOI 10.1094/MPMI-18-1277; Jones D, 2004, CUTIS, V74, P17; Jones JT, 2004, GENE, V324, P47, DOI 10.1016/j.gene.2003.09.051; Jones M, 1972, J CELL SCI, V10, P1; Kikuchi T, 2006, MOL PLANT MICROBE IN, V19, P280, DOI 10.1094/MPMI-19-0280; Kondorosi E, 2005, PLANT PHYSIOL, V137, P1197, DOI 10.1104/pp.105.060004; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kumar M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096311; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Lilley CJ, 2012, PARASITOLOGY, V139, P630, DOI 10.1017/S0031182011002071; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maizels RM, 2000, INT J PARASITOL, V30, P495, DOI 10.1016/S0020-7519(00)00022-9; Mazarei M, 2011, THEOR APPL GENET, V123, P1193, DOI 10.1007/s00122-011-1659-8; Mitreva M, 2004, GENOME RES, V14, P209, DOI 10.1101/gr.1524804; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nicol JM, 2011, GENOMICS AND MOLECULAR GENETICS OF PLANT-NEMATODE INTERACTIONS, P21, DOI 10.1007/978-94-007-0434-3_2; Park BH, 2010, GLYCOBIOLOGY, V20, P1574, DOI 10.1093/glycob/cwq106; Peng D, 2013, PLANT DIS, V97, P1288; Peng D L, 2012, NEMATOLOGY RES CHINA, V4, P162; Peng H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069579; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Prior A, 2001, BIOCHEM J, V356, P387, DOI 10.1042/0264-6021:3560387; Rieu I, 2009, PLANT CELL, V21, P1031, DOI 10.1105/tpc.109.066001; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Rosso MN, 2009, ANNU REV PHYTOPATHOL, V47, P207, DOI 10.1146/annurev.phyto.112408.132605; Rosso M-N., 2012, EFFECTORS PLANT MICR; Seah S, 2000, NEW PHYTOL, V146, P527, DOI 10.1046/j.1469-8137.2000.00654.x; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Simonetti E, 2010, PLANT CELL REP, V29, P1169, DOI 10.1007/s00299-010-0903-z; SLOOTMAKER LA, 1974, EUPHYTICA, V23, P497, DOI 10.1007/BF00022470; Smant G, 1998, P NATL ACAD SCI USA, V95, P4906, DOI 10.1073/pnas.95.9.4906; Sonnhammer E L, 1998, Proc Int Conf Intell Syst Mol Biol, V6, P175; Wang F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091591; Wang JB, 2011, GENOME RES, V21, P1462, DOI 10.1101/gr.121426.111; Williamson VM, 1996, PLANT CELL, V8, P1735, DOI 10.1105/tpc.8.10.1735; Xu DL, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-133; Zambon AC, 2012, BIOINFORMATICS, V28, P2209, DOI 10.1093/bioinformatics/bts366; Zenoni S, 2010, PLANT PHYSIOL, V152, P1787, DOI 10.1104/pp.109.149716	72	14	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2015	10	10							e0141095	10.1371/journal.pone.0141095	http://dx.doi.org/10.1371/journal.pone.0141095			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0EH	26517841	Green Published, Green Submitted, gold			2022-12-26	WOS:000363920800021
J	Linder, JU				Linder, Juergen Ulrich			The YHS-Domain of an Adenylyl Cyclase from Mycobacterium phlei Is a Probable Copper-Sensor Module	PLOS ONE			English	Article							GAF-DOMAIN; CATALYSIS; MECHANISMS; COMPLEX	YHS-domains are small protein modules which have been proposed to bind transition-metal ions like the related TRASH-domains. They are found in a variety of enzymes including copper-transporting ATPases and adenylyl cyclases. Here we investigate a class IIIc adenylyl cyclase from Mycobacterium phlei which contains a C-terminal YHS-domain linked to the catalytic domain by a peptide of 8 amino acids. We expressed the isolated catalytic domain and the full-length enzyme in E. coli. The catalytic domain requires millimolar Mn2+ as a cofactor for efficient production of cAMP, is unaffected by low micromolar concentrations of Cu2+ and inhibited by concentrations higher than 10 mu M. The full-length enzyme also requires Mn2+ in the absence of an activator. However, 1-10 mu M Cu2+ stimulate the M. phlei adenylyl cyclase sixfold when assayed with Mn2+. With Mg2+ as the probable physiological cofactor of the adenylyl cyclase Cu2+ specifically switches the enzyme from an inactive to an active state. Other transition-metal ions do not elicit activity with Mg2+. We favor the view that the YHS-domain of M. phlei adenylyl cyclase acts as a sensor for copper ions and signals elevated levels of the transition-metal via cAMP. By analogy to TRASH-domains binding of Cu2+ probably occurs via one conserved aspartate and three conserved cysteine-residues in the YHS-domain.	Univ Bayreuth, Dept Biochem, Bayreuth, Germany	University of Bayreuth	Linder, JU (corresponding author), Univ Bayreuth, Dept Biochem, Bayreuth, Germany.	Juergen.Linder@uni-bayreuth.de			University of Bayreuth	University of Bayreuth	The author thanks Julian Pfahler and Elena Muller for performing initial experiments. The research project was funded by the University of Bayreuth.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Apweiler R, 2001, NUCLEIC ACIDS RES, V29, P37, DOI 10.1093/nar/29.1.37; Bailey LJ, 2008, P NATL ACAD SCI USA, V105, P19194, DOI 10.1073/pnas.0807948105; BARZU O, 1994, PROG NUCLEIC ACID RE, V49, P241; Bruder S, 2006, J BIOL CHEM, V281, P19969, DOI 10.1074/jbc.M603374200; Cotta MA, 1998, FEMS MICROBIOL LETT, V164, P257, DOI 10.1111/j.1574-6968.1998.tb13095.x; Ettema TJG, 2003, TRENDS BIOCHEM SCI, V28, P170, DOI 10.1016/S0968-0004(03)00037-9; Iseki M, 2002, NATURE, V415, P1047, DOI 10.1038/4151047a; JOHNSON HW, 1949, AM J VET RES, V10, P138; Kanacher T, 2002, EMBO J, V21, P3672, DOI 10.1093/emboj/cdf375; Kanchan K, 2010, J BIOL CHEM, V285, P2090, DOI 10.1074/jbc.M109.051698; Klein DJ, 2001, EMBO J, V20, P4214, DOI 10.1093/emboj/20.15.4214; Kleinboelting S, 2014, P NATL ACAD SCI USA, V111, P3727, DOI 10.1073/pnas.1322778111; Linder JU, 2006, CELL MOL LIFE SCI, V63, P1736, DOI 10.1007/s00018-006-6072-0; Linder JU, 2003, CELL SIGNAL, V15, P1081, DOI 10.1016/S0898-6568(03)00130-X; Linder JU, 2008, BIOCHEM J, V415, P449, DOI 10.1042/BJ20080350; LOWRY OH, 1951, J BIOL CHEM, V193, P265; PRATT D, 1953, J BACTERIOL, V65, P157, DOI 10.1128/JB.65.2.157-159.1953; Sismeiro O, 1998, J BACTERIOL, V180, P3339, DOI 10.1128/JB.180.13.3339-3344.1998; TAKAGI T, 1964, J BIOCHEM-TOKYO, V56, P344, DOI 10.1093/oxfordjournals.jbchem.a127999; Tellez-Sosa J, 2002, J BACTERIOL, V184, P3560, DOI 10.1128/JB.184.13.3560-3568.2002; Tesmer JJG, 1997, SCIENCE, V278, P1907, DOI 10.1126/science.278.5345.1907; Tews I, 2005, SCIENCE, V308, P1020, DOI 10.1126/science.1107642	23	2	2	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2015	10	10							e0141843	10.1371/journal.pone.0141843	http://dx.doi.org/10.1371/journal.pone.0141843			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0ED	26512893	Green Submitted, gold, Green Published			2022-12-26	WOS:000363920300088
J	Marquez, M; Boscan, P; Weir, H; Vogel, P; Twedt, DC				Marquez, Megan; Boscan, Pedro; Weir, Heather; Vogel, Pamela; Twedt, David C.			Comparison of NK-1 Receptor Antagonist (Maropitant) to Morphine as a Pre-Anaesthetic Agent for Canine Ovariohysterectomy	PLOS ONE			English	Article							MINIMUM ALVEOLAR CONCENTRATION; SUBSTANCE-P; DORSAL-HORN; OVARIAN LIGAMENT; EFFICACY; DOGS; NEUROPEPTIDES; LOCALIZATION; STIMULATION; SEVOFLURANE	Objective To compare the NK-1 receptor antagonist maropitant to morphine during and after surgery in dogs undergoing ovariohysterectomy (OHE). Methods 30 healthy female dogs were randomly divided to receive either a pre-anaesthetic dose of morphine (0.5 mg/kg SQ) or maropitant (1 mg/kg, SQ) prior to OHE. Anaesthesia was induced with propofol and maintained with isoflurane. Expired isoflurane concentration, heart rate (HR), systolic arterial pressure (SAP) and respiratory rate were measured. Postoperative pain scores and appetite were evaluated during the recovery period. Rescue analgesia (morphine 0.1 mg/kg IV) was administered as needed post-operatively based on blinded pain score assessments. Results Although clinically comparable; during surgical stimulation, the maropitant group had lower HR (108 +/- 18 vs 115 +/- 24 bpm; p = 0.04), lower SAP (114 +/- 23 vs 125 +/- 23 mmHg; p = 0.003) and required slightly lower percent of isoflurane anaesthetic (1.35 +/- 0.2 vs 1.51 +/- 0.4%; p = 0.005), when compared to the morphine group. In the recovery period, the maropitant group had lower pain scores at extubation (1.7 +/- 0.7 vs 3.4 +/- 2.3; p = 0.0001) and were more likely to eat within 3 hours after extubation (64.7 vs 15.3%). However, post-operative rescue analgesia requirements were similar between groups. All other measured parameters were similar between groups. The overall difference observed between groups was small and all monitored and measured parameters were within the expected range for anesthetized dogs. Clinical Significance No major differences in cardiorespiratory parameters or anaesthetic requirements were observed between maropitant and morphine when used as a pre-anesthetic agent for OHE. Further studies are necessary to fully elucidate the benefits of maropitant as a pre-anaesthetic agent for canine OHE.	[Marquez, Megan; Boscan, Pedro; Weir, Heather; Vogel, Pamela; Twedt, David C.] Colorado State Univ, Vet Teaching Hosp, Dept Clin Sci, Ft Collins, CO 80523 USA	Colorado State University	Boscan, P (corresponding author), Colorado State Univ, Vet Teaching Hosp, Dept Clin Sci, Ft Collins, CO 80523 USA.	pboscan@colostate.edu			Colorado State University	Colorado State University	The pharmaceutical company Zoetis provided a small fund as an incentive to include dogs in the study (veterinary clinical trial). Each dog-client received $100 for participating in the study. Colorado State University provided financial support to publish the study in an online journal. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvillar BM, 2012, VET ANAESTH ANALG, V39, P201, DOI 10.1111/j.1467-2995.2011.00670.x; Becker WM, 2013, VET SURG, V42, P302, DOI 10.1111/j.1532-950X.2012.01080.x; Boscan P, 2011, AM J VET RES, V72, P1576, DOI 10.2460/ajvr.72.12.1576; Boscan P, 2011, VET ANAESTH ANALG, V38, P260, DOI 10.1111/j.1467-2995.2011.00611.x; Brain SD, 1997, IMMUNOPHARMACOLOGY, V37, P133, DOI 10.1016/S0162-3109(97)00055-6; Conder GA, 2008, J VET PHARMACOL THER, V31, P528, DOI 10.1111/j.1365-2885.2008.00990.x; De la Puente-Redondo VA, 2007, J SMALL ANIM PRACT, V48, P93, DOI 10.1111/j.1748-5827.2006.00321.x; DUGGAN AW, 1988, BRAIN RES, V451, P261, DOI 10.1016/0006-8993(88)90771-8; Fox SM, 2000, RES VET SCI, V68, P265, DOI 10.1053/rvsc.2000.0375; Greenwood-Van Meerveld B, 2003, PHARMACOL BIOCHEM BE, V74, P1005, DOI 10.1016/S0091-3057(03)00032-7; Hill R, 2000, TRENDS PHARMACOL SCI, V21, P244, DOI 10.1016/S0165-6147(00)01502-9; Inoue M, 1998, P NATL ACAD SCI USA, V95, P10949, DOI 10.1073/pnas.95.18.10949; Ko JCH, 2009, J AM ANIM HOSP ASSOC, V45, P19, DOI 10.5326/0450019; Kraus BLH, 2013, VET ANAESTH ANALG, V40, P28, DOI 10.1111/j.1467-2995.2012.00788.x; Laird J, 2001, TRENDS PHARMACOL SCI, V22, P169, DOI 10.1016/S0165-6147(00)01703-X; Laird JMA, 2000, NEUROSCIENCE, V98, P345, DOI 10.1016/S0306-4522(00)00148-2; Lawson SN, 1997, J PHYSIOL-LONDON, V505, P177, DOI 10.1111/j.1469-7793.1997.00177.x; MANTYH PW, 1989, J NEUROSCI, V9, P258; McKune CM, 2014, PEERJ, V2, DOI 10.7717/peerj.341; Morris R, 2004, BRAIN RES REV, V46, P173, DOI 10.1016/j.brainresrev.2004.07.002; Niyom S, 2013, VET ANAESTH ANALG, V40, P425, DOI 10.1111/vaa.12017; Okano S, 2002, J PHARMACOL EXP THER, V300, P925, DOI 10.1124/jpet.300.3.925; Perry MJ, 1998, NEUROSCIENCE, V85, P293, DOI 10.1016/S0306-4522(97)00629-5; Ramsey DS, 2008, J VET PHARMACOL THER, V31, P538, DOI 10.1111/j.1365-2885.2008.00992.x; Rost Kristin, 2006, Med Monatsschr Pharm, V29, P200; Ruggieri MR, 2000, J UROLOGY, V164, P197, DOI 10.1016/S0022-5347(05)67494-0; SAKURADA T, 1995, PAIN, V60, P175, DOI 10.1016/0304-3959(94)00107-P; Sedlacek HS, 2008, J VET PHARMACOL THER, V31, P533, DOI 10.1111/j.1365-2885.2008.00991.x; STEFFEY EP, 1993, ANESTH ANALG, V77, P346, DOI 10.1213/00000539-199377020-00023; Teixeira RCR, 2013, VET ANAESTH ANALG, V40, P641, DOI 10.1111/vaa.12080; Vaisanen M, 2004, VET REC, V155, P729; Vera-Portocarrero LP, 2004, PHARMACOL BIOCHEM BE, V77, P631, DOI 10.1016/j.pbb.2004.01.004; Yip J, 2000, CLIN EXP PHARMACOL P, V27, P943, DOI 10.1046/j.1440-1681.2000.03366.x; Zachariou V, 1997, BRAIN RES, V752, P143, DOI 10.1016/S0006-8993(96)01466-7	34	17	17	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2015	10	10							e0140734	10.1371/journal.pone.0140734	http://dx.doi.org/10.1371/journal.pone.0140734			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0ED	26513745	gold, Green Published, Green Submitted			2022-12-26	WOS:000363920300006
J	Fernandez-Carrobles, MM; Bueno, G; Deniz, O; Salido, J; Garcia-Rojo, M; Gonzalez-Lopez, L				Milagro Fernandez-Carrobles, M.; Bueno, Gloria; Deniz, Oscar; Salido, Jesus; Garcia-Rojo, Marcial; Gonzalez-Lopez, Lucia			Influence of Texture and Colour in Breast TMA Classification	PLOS ONE			English	Article							PROSTATE-CANCER; TISSUE MICROARRAY; IMAGES; SELECTION; FEATURES	Breast cancer diagnosis is still done by observation of biopsies under the microscope. The development of automated methods for breast TMA classification would reduce diagnostic time. This paper is a step towards the solution for this problem and shows a complete study of breast TMA classification based on colour models and texture descriptors. The TMA images were divided into four classes: i) benign stromal tissue with cellularity, ii) adipose tissue, iii) benign and benign anomalous structures, and iv) ductal and lobular carcinomas. A relevant set of features was obtained on eight different colour models from first and second order Haralick statistical descriptors obtained from the intensity image, Fourier, Wavelets, Multiresolution Gabor, M-LBP and textons descriptors. Furthermore, four types of classification experiments were performed using six different classifiers: (1) classification per colour model individually, (2) classification by combination of colour models, (3) classification by combination of colour models and descriptors, and (4) classification by combination of colour models and descriptors with a previous feature set reduction. The best result shows an average of 99.05% accuracy and 98.34% positive predictive value. These results have been obtained by means of a bagging tree classifier with combination of six colour models and the use of 1719 non-correlated (correlation threshold of 97%) textural features based on Statistical, M-LBP, Gabor and Spatial textons descriptors.	[Milagro Fernandez-Carrobles, M.; Bueno, Gloria; Deniz, Oscar; Salido, Jesus] Univ Castilla La Mancha, VISILAB, E-13071 Ciudad Real, Spain; [Garcia-Rojo, Marcial] Hosp Jerez de la Frontera, Dept Pathol, Cadiz, Spain; [Gonzalez-Lopez, Lucia] Univ Ciudad Real, Gen Hosp, Dept Pathol, Ciudad Real, Spain	Universidad de Castilla-La Mancha; Universidad de Castilla-La Mancha	Fernandez-Carrobles, MM (corresponding author), Univ Castilla La Mancha, VISILAB, E-13071 Ciudad Real, Spain.	MMilagro.fernandez@uclm.es; Gloria.Bueno@uclm.es	Tercero, Jesus Salido/K-9308-2014; García-Rojo, Marcial/H-4688-2018; Bueno, Gloria/K-6286-2014	Tercero, Jesus Salido/0000-0002-9216-3522; García-Rojo, Marcial/0000-0001-6272-9401; Bueno, Gloria/0000-0002-7345-4869; Fernandez-Carrobles/0000-0003-0213-6473; Deniz, Oscar/0000-0002-0841-4131	Spanish Research Ministry Project [TIN2011-24367]; EC Marie Curie Actions, AIDPATH project [612471]	Spanish Research Ministry Project; EC Marie Curie Actions, AIDPATH project	The authors acknowledge partial financial support from the Spanish Research Ministry Project TIN2011-24367 and from the EC Marie Curie Actions, AIDPATH project (num. 612471).	Amaral T, 2008, MED IMAGE UNDERSTAND, P999; [Anonymous], 2001, RIPPLES MATH DISCRET; Bahlmann C, 2012, PROC SPIE, V8315, DOI 10.1117/12.912484; Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Bueno G, 2013, LECT NOTES COMPUTATI, V6, P165; Chekkoury A, 2012, P SOC PHOTO-OPT INS, P8315; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; DAUBECHIES I, 1990, IEEE T INFORM THEORY, V36, P961, DOI 10.1109/18.57199; Dell'Anna R, 2005, COMPUT METH PROG BIO, V79, P197, DOI 10.1016/j.cmpb.2005.04.004; DETRE S, 1995, J CLIN PATHOL, V48, P876, DOI 10.1136/jcp.48.9.876; DiFranco MD, 2011, COMPUT MED IMAG GRAP, V35, P629, DOI 10.1016/j.compmedimag.2010.12.005; Doyle S, 2007, I S BIOMED IMAGING, P1284, DOI 10.1109/ISBI.2007.357094; Doyle S, 2006, LECT NOTES COMPUT SC, V4191, P504; Doyle S, 2012, IEEE T BIO-MED ENG, V59, P1205, DOI 10.1109/TBME.2010.2053540; Duda R.O., 2000, PATTERN CLASSIFICATI; Farjam R, 2005, P SOC PHOTO-OPT INS, V5747, P840, DOI 10.1117/12.596068; Fernandez-Carrobles MM, 2014, P 18 INT MICR C SEPT; Fernandez-Carrobles MM, 2013, ICES J MAR SCI, P1; Fernandez-Carrobles MM, 2014, COMPUTERIZED MED IMA, DOI DOI 10.1016/J.COMPMEDIMAG.2014.11.009:13; Ferraz CT, 2014, INT J PATTERN RECOGN, V28, DOI 10.1142/S0218001414550106; Freund Y, 1995, DECISION THEORETIC G, V904; Fuchs TJ, 2008, LECT NOTES COMPUT SC, V5242, P1, DOI 10.1007/978-3-540-85990-1_1; Gonzalez R.C., 2008, DIGITAL IMAGE PROCES; Gurcan Metin N, 2009, IEEE Rev Biomed Eng, V2, P147, DOI 10.1109/RBME.2009.2034865; Guyon I., 2003, J MACH LEARN RES, V3, P1157, DOI DOI 10.1162/153244303322753616; Hammes LS, 2007, APPL IMMUNOHISTO M M, V15, P456, DOI 10.1097/01.pai.0000213151.64310.70; Har-peled S, 2003, C ADV NEUR INF PROC, P785; HARALICK RM, 1973, IEEE T SYST MAN CYB, VSMC3, P610, DOI 10.1109/TSMC.1973.4309314; Hongliang Jin, 2004, Proceedings. Third International Conference on Image and Graphics, P306; Huang PW, 2009, IEEE T MED IMAGING, V28, P1037, DOI 10.1109/TMI.2009.2012704; Kamarainen JK, 2006, IEEE T IMAGE PROCESS, V15, P1088, DOI 10.1109/TIP.2005.864174; Khurd P, 2010, I S BIOMED IMAGING, P636, DOI 10.1109/ISBI.2010.5490096; Kong J, 2009, PATTERN RECOGN, V42, P1080, DOI 10.1016/j.patcog.2008.10.035; Korzynska A, 2010, ADV INTEL SOFT COMPU, V84; KORZYNSKA A, 2010, ADV INTELLIGENT SOFT, P84; Kuncheva LI, 2004, COMBINING PATTERN CL; Lessmann B, 2007, J BIOMED INFORM, V40, P631, DOI 10.1016/j.jbi.2007.06.007; Linder N, 2012, DIAGN PATHOL, V7, DOI 10.1186/1746-1596-7-22; Maenpaa T, 2004, PATTERN RECOGN, V37, P1629, DOI 10.1016/j.patcog.2003.11.011; Meas-Yedid V, 2004, INT C PATT RECOG, P514, DOI 10.1109/ICPR.2004.1334579; METE M, 2009, P IEEE S COMP INT BI, P284; Mete M, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S7-S17; Mitra P, 2002, IEEE T PATTERN ANAL, V24, P301, DOI 10.1109/34.990133; Monaco JP, 2010, MED IMAGE ANAL, V14, P617, DOI 10.1016/j.media.2010.04.007; Nateghi R, 2014, COMPUTATIONAL BIOL J, V2014; Niwas S. I., 2011, 2011 IEEE INT C IM S, P219, DOI DOI 10.1109/IST.2011.5962184; O'Brien CM, 2013, INT STAT REV, V81, P471, DOI [10.1111/insr.12042_12, DOI 10.1111/INSR.12042_12]; Ojala T, 1996, PATTERN RECOGN, V29, P51, DOI 10.1016/0031-3203(95)00067-4; Pham NA, 2007, DIAGN PATHOL, V2, DOI 10.1186/1746-1596-2-8; Qi X, 2010, P SOC PHOTO-OPT INS, P7557; Rimm DL, 2001, CANCER J, V7, P24; Stephane M, 2008, WAVELET TOUR SIGNAL; Tabesh A, 2006, CONF REC ASILOMAR C, P841; Tashk Ashkan, 2014, J Med Signals Sens, V4, P139; Trang Kim Le, 2012, 2012 15th International Conference on Information Fusion (FUSION 2012), P1868; Umbaugh SE., 2005, COMPUTER IMAGING DIG; Vallez N, 2014, COMPUT METH PROG BIO, V113, P569, DOI 10.1016/j.cmpb.2013.10.004; Vallez N, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/219407; Xing F, 2012, P SPIE MED IMAGING, V8314, P1; Xu J, 2010, LECT NOTES COMPUT SC, V6367, P77; Yang L, 2009, IEEE T INF TECHNOL B, V13, P636, DOI 10.1109/TITB.2009.2020159; Zhang YG, 2013, MACH VISION APPL, V24, P1405, DOI 10.1007/s00138-012-0459-8	63	15	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2015	10	10							e0141556	10.1371/journal.pone.0141556	http://dx.doi.org/10.1371/journal.pone.0141556			37	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0ED	26513238	gold, Green Published, Green Submitted			2022-12-26	WOS:000363920300051
J	Vlijm, R; van der Torre, J; Dekker, C				Vlijm, Rifka; v. d. Torre, Jaco; Dekker, Cees			Counterintuitive DNA Sequence Dependence in Supercoiling-Induced DNA Melting	PLOS ONE			English	Article							MAGNETIC TWEEZERS; REPLICATION; TRANSITION; INITIATION; PROMOTERS; STABILITY; ORIGIN	The metabolism of DNA in cells relies on the balance between hybridized double-stranded DNA (dsDNA) and local de-hybridized regions of ssDNA that provide access to binding proteins. Traditional melting experiments, in which short pieces of dsDNA are heated up until the point of melting into ssDNA, have determined that AT-rich sequences have a lower binding energy than GC-rich sequences. In cells, however, the double-stranded backbone of DNA is destabilized by negative supercoiling, and not by temperature. To investigate what the effect of GC content is on DNA melting induced by negative supercoiling, we studied DNA molecules with a GC content ranging from 38% to 77%, using single-molecule magnetic tweezer measurements in which the length of a single DNA molecule is measured as a function of applied stretching force and supercoiling density. At low force (<0.5pN), supercoiling results into twisting of the dsDNA backbone and loop formation (plectonemes), without inducing any DNA melting. This process was not influenced by the DNA sequence. When negative supercoiling is introduced at increasing force, local melting of DNA is introduced. We measured for the different DNA molecules a characteristic force Fchar, at which negative supercoiling induces local melting of the dsDNA. Surprisingly, GC-rich sequences melt at lower forces than AT-rich sequences: F-char = 0.56pN for 77% GC but 0.73pN for 38% GC. An explanation for this counterintuitive effect is provided by the realization that supercoiling densities of a few percent only induce melting of a few percent of the base pairs. As a consequence, denaturation bubbles occur in local AT-rich regions and the sequence-dependent effect arises from an increased DNA bending/torsional energy associated with the plectonemes. This new insight indicates that an increased GC-content adjacent to AT-rich DNA regions will enhance local opening of the double-stranded DNA helix.	[Vlijm, Rifka; v. d. Torre, Jaco; Dekker, Cees] Delft Univ Technol, Kavli Inst Nanosci Delft, Dept Bionanosci, Delft, Netherlands	Delft University of Technology	Dekker, C (corresponding author), Delft Univ Technol, Kavli Inst Nanosci Delft, Dept Bionanosci, Delft, Netherlands.	C.Dekker@tudelft.nl	Vlijm, Rifka/ABB-9663-2020	Vlijm, Rifka/0000-0001-8909-9518	Netherlands Organisation for Scientific Research (NWO/OCW), as part of the Frontiers of Nanoscience program; European Research Council [247072, 669598]; Foundation for Fundamental Research on Matter (FOM), as part of the Physics of the Genome Program	Netherlands Organisation for Scientific Research (NWO/OCW), as part of the Frontiers of Nanoscience program; European Research Council(European Research Council (ERC)European Commission); Foundation for Fundamental Research on Matter (FOM), as part of the Physics of the Genome Program	This work was supported by the Netherlands Organisation for Scientific Research (NWO/OCW), as part of the Frontiers of Nanoscience program, and the European Research Council for ERC Advanced Grant NanoForBio (no. 247072) and SynDiv (no. 669598), the Foundation for Fundamental Research on Matter (FOM), as part of the Physics of the Genome Program, all to CD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAKER TA, 1986, CELL, V45, P53, DOI 10.1016/0092-8674(86)90537-4; BAUER WR, 1980, SCI AM, V243, P118; BENHAM CJ, 1992, J MOL BIOL, V225, P835, DOI 10.1016/0022-2836(92)90404-8; BENHAM CJ, 1993, P NATL ACAD SCI USA, V90, P2999, DOI 10.1073/pnas.90.7.2999; De Vlaminck I, 2010, NUCLEIC ACIDS RES, V38, P4133, DOI 10.1093/nar/gkq067; DREW HR, 1985, EMBO J, V4, P1025, DOI 10.1002/j.1460-2075.1985.tb03734.x; FULLER FB, 1971, P NATL ACAD SCI USA, V68, P815, DOI 10.1073/pnas.68.4.815; Galburt EA, 2014, BIOPHYS CHEM, V187, P23, DOI 10.1016/j.bpc.2014.01.001; Geggier S, 2010, P NATL ACAD SCI USA, V107, P15421, DOI 10.1073/pnas.1004809107; GIARDINA C, 1993, SCIENCE, V261, P759, DOI 10.1126/science.8342041; HOGAN M, 1983, NATURE, V304, P752, DOI 10.1038/304752a0; ISBERG RR, 1982, CELL, V30, P9, DOI 10.1016/0092-8674(82)90006-X; KOWALSKI D, 1989, EMBO J, V8, P4335, DOI 10.1002/j.1460-2075.1989.tb08620.x; LANDO DY, 1994, J BIOMOL STRUCT DYN, V12, P355, DOI 10.1080/07391102.1994.10508745; Lankas F, 2000, J MOL BIOL, V299, P695, DOI 10.1006/jmbi.2000.3781; LILLEY DMJ, 1984, BIOCHEM SOC T, V12, P127, DOI 10.1042/bst0120127; Mandel M, 1968, METHODS ENZYMOLOGY B, V12B, P195, DOI [10.1016/0076-6879(67)12133-2, DOI 10.1016/0076-6879(67)12133-2]; Meng H, 2014, BIOPHYS J, V106, P1174, DOI 10.1016/j.bpj.2014.01.017; Mielke SP, 2005, J CHEM PHYS, V123, DOI 10.1063/1.2038767; MILLER JH, 1991, INT J RADIAT BIOL, V59, P941, DOI 10.1080/09553009114550831; Munteanu MG, 1998, TRENDS BIOCHEM SCI, V23, P341, DOI 10.1016/S0968-0004(98)01265-1; RICHET E, 1991, J MOL BIOL, V218, P529; Salerno D, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.118303; SantaLucia J, 1998, P NATL ACAD SCI USA, V95, P1460, DOI 10.1073/pnas.95.4.1460; Sheinin MY, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.108102; Strick TR, 2003, REP PROG PHYS, V66, P1, DOI 10.1088/0034-4885/66/1/201; Strick TR, 1998, BIOPHYS J, V74, P2016, DOI 10.1016/S0006-3495(98)77908-1; Tempestini A, 2013, NUCLEIC ACIDS RES, V41, P2009, DOI 10.1093/nar/gks1206; Vlijm R, 2015, NANOSCALE, V7, P3205, DOI 10.1039/c4nr04332d; Vologodskii AV., 1992, TOPOLOGY PHYS CIRCUL	30	17	17	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2015	10	10							e0141576	10.1371/journal.pone.0141576	http://dx.doi.org/10.1371/journal.pone.0141576			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0ED	26513573	Green Published, Green Submitted, gold			2022-12-26	WOS:000363920300054
J	Fornari, F; Ferracin, M; Trere, D; Milazzo, M; Marinelli, S; Galassi, M; Venerandi, L; Pollutri, D; Patrizi, C; Borghi, A; Foschi, FG; Stefanini, GF; Negrini, M; Bolondi, L; Gramantieri, L				Fornari, Francesca; Ferracin, Manuela; Trere, Davide; Milazzo, Maddalena; Marinelli, Sara; Galassi, Marzia; Venerandi, Laura; Pollutri, Daniela; Patrizi, Clarissa; Borghi, Alberto; Foschi, Francesco G.; Stefanini, Giuseppe F.; Negrini, Massimo; Bolondi, Luigi; Gramantieri, Laura			Circulating microRNAs, miR-939, miR-595, miR-519d and miR-494, Identify Cirrhotic Patients with HCC	PLOS ONE			English	Article							HUMAN HEPATOCELLULAR-CARCINOMA; POTENTIAL BIOMARKER; CANCER; PLASMA; PTEN; EXPRESSION; DIAGNOSIS; HEPATITIS; CELLS; SERUM	The performance of circulating biomarkers for the diagnosis of hepatocellular carcinoma (HCC) is sub-optimal. In this study we tested circulating microRNAs as biomarkers for HCC in cirrhotic patients by performing a two stage study: a discovery phase conducted by microarray and a validation phase performed by qRT-PCR in an independent series of 118 patients. Beside miRNAs emerged from the discovery phase, miR-21, miR-221, miR-519d were also tested in the validation setting on the basis of literary and tissue findings. Deregulated microRNAs were assayed in HCC-derived cells in the intracellular compartment, cell culture supernatant and exosomal fraction. Serum and tissue microRNA levels were compared in 14 patients surgically treated for HCC. From the discovery study, it emerged that seven circulating microRNAs were differentially expressed in cirrhotic patients with and without HCC. In the validation set, miR-939, miR-595 and miR-519d were shown to differentiate cirrhotic patients with and without HCC. MiR-939 and miR-595 are independent factors for HCC. ROC curves of miR-939, miR-595 and miR-519d displayed that AUC was higher than AFP. An exosomal secretion of miR-519d, miR-21, miR-221 and miR-1228 and a correlation between circulating and tissue levels of miR-519d, miR-494 and miR-21 were found in HCC patients. Therefore, we show that circulating microRNAs deserve attention as non-invasive biomarkers in the diagnostic setting of HCC and that exosomal secretion contributes to discharging a subset of microRNAs into the extracellular compartment.	[Fornari, Francesca; Milazzo, Maddalena; Marinelli, Sara; Galassi, Marzia; Venerandi, Laura; Pollutri, Daniela; Patrizi, Clarissa; Borghi, Alberto; Bolondi, Luigi; Gramantieri, Laura] Azienda Osped Univ Policlin S Orsola Malpig, CRBA, Bologna, Italy; [Fornari, Francesca; Milazzo, Maddalena; Marinelli, Sara; Galassi, Marzia; Venerandi, Laura; Pollutri, Daniela; Patrizi, Clarissa; Borghi, Alberto; Bolondi, Luigi; Gramantieri, Laura] Univ Bologna, Bologna, Italy; [Ferracin, Manuela; Negrini, Massimo] Univ Ferrara, Dipartimento Med Sperimentale & Diag, I-44100 Ferrara, Italy; [Ferracin, Manuela; Negrini, Massimo] Univ Ferrara, Ctr Interdipartimentale Ric Cancro, I-44100 Ferrara, Italy; [Trere, Davide] Diagnost & Sperimentale Univ Bologna, Dipartimento Med Specialist, Bologna, Italy; [Foschi, Francesco G.; Stefanini, Giuseppe F.] Osped Infermi, Dipartimento Med Interna, Faenza, Italy	IRCCS Azienda Ospedaliero-Universitaria di Bologna; University of Bologna; University of Ferrara; University of Ferrara; University of Bologna; Hospital of Rimini	Gramantieri, L (corresponding author), Azienda Osped Univ Policlin S Orsola Malpig, CRBA, Bologna, Italy.	laura.gramantieri@aosp.bo.it	Trere', Davide/AAC-4725-2021; Gramantieri, Laura/K-8603-2016; Gramantieri, Laura/J-3862-2019; Fornari, Francesca/K-6748-2016; Milazzo, Maddalena/K-7708-2016; Ferracin, Manuela/K-2097-2016; Negrini, Massimo/J-2377-2016; Pollutri, Daniela/GMW-9654-2022	Trere', Davide/0000-0003-1127-1052; Gramantieri, Laura/0000-0002-5187-9559; Milazzo, Maddalena/0000-0002-7060-7858; Ferracin, Manuela/0000-0002-1595-6887; Negrini, Massimo/0000-0002-0007-1920; Foschi, Francesco Giuseppe/0000-0002-8216-0918; Fornari, Francesca/0000-0002-4302-4411; Pollutri, Daniela/0000-0003-4531-7258; POLLUTRI, DANIELA/0000-0002-7895-5128	Fondazione del Monte di Bologna e Ravenna; Italian Ministry of University and Research - PRIN; Italian Association for Cancer Research (AIRC); Programma di Ricerca Regione-Universita , Regione Emilia-Romagna, Bando "Alessandro Liberati"; Programma di Ricerca Regione-Universita , Regione Emilia-Romagna, Bando "Ricerca Innovativa"	Fondazione del Monte di Bologna e Ravenna(Fondazione del Monte di Bologna e Ravenna); Italian Ministry of University and Research - PRIN(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); Italian Association for Cancer Research (AIRC)(Fondazione AIRC per la ricerca sul cancro); Programma di Ricerca Regione-Universita , Regione Emilia-Romagna, Bando "Alessandro Liberati"; Programma di Ricerca Regione-Universita , Regione Emilia-Romagna, Bando "Ricerca Innovativa"(Regione Emilia Romagna)	This study was supported by Programma di Ricerca Regione-Universita 2010-2012, Regione Emilia-Romagna, Bando "Ricerca Innovativa", to LB and LG, "Innovative approaches to the diagnosis and pharmacogenetic-based therapies of primary hepatic tumors, peripheral B and T-cell lymphomas and lymphoblastic leukaemias"; Fondazione del Monte di Bologna e Ravenna, to LB, GFS and LG; Italian Ministry of University and Research - PRIN 2010-2011 to LB; Italian Association for Cancer Research (AIRC) to MN and MF; Programma di Ricerca Regione-Universita 2010-2012, Regione Emilia-Romagna, Bando "Alessandro Liberati", to FF, "Identification of innovative microRNAs-based biomarkers and anti-cancer strategies for the treatment of Hepatocellular carcinoma".	Arroyo JD, 2011, P NATL ACAD SCI USA, V108, P5003, DOI 10.1073/pnas.1019055108; Bruix J, 2010, HEPATOLOGY, V53, P1020, DOI DOI 10.1002/HEP.24199; Chen X, 2008, CELL RES, V18, P997, DOI 10.1038/cr.2008.282; Collier J, 1998, HEPATOLOGY, V27, P273, DOI 10.1002/hep.510270140; El-Hefnawy T, 2004, CLIN CHEM, V50, P564, DOI 10.1373/clinchem.2003.028506; Fabbri M, 2012, P NATL ACAD SCI USA, V109, pE2110, DOI 10.1073/pnas.1209414109; Fornari F, 2012, J PATHOL, V227, P275, DOI 10.1002/path.3995; Forner A, 2012, LANCET, V379, P1245, DOI 10.1016/S0140-6736(11)61347-0; Gramantieri L, 2007, CANCER RES, V67, P6092, DOI 10.1158/0008-5472.CAN-06-4607; Gui JH, 2011, CLIN SCI, V120, P183, DOI 10.1042/CS20100297; Kosaka N, 2010, CANCER SCI, V101, P2087, DOI 10.1111/j.1349-7006.2010.01650.x; Li JP, 2011, BIOCHEM BIOPH RES CO, V406, P70, DOI 10.1016/j.bbrc.2011.01.111; Liu Y, 2012, J IMMUNOL, V188, P5500, DOI 10.4049/jimmunol.1103505; Llovet JM, 2012, J HEPATOL, V56, P908, DOI 10.1016/j.jhep.2011.12.001; Lucherini OM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073443; Meng FY, 2007, GASTROENTEROLOGY, V133, P647, DOI 10.1053/j.gastro.2007.05.022; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Nilsson RJA, 2011, BLOOD, V118, P3680, DOI 10.1182/blood-2011-03-344408; Peinado H, 2012, NAT MED, V18, P883, DOI 10.1038/nm.2753; Qi P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028486; Schwarzenbach H, 2014, NAT REV CLIN ONCOL, V11, P145, DOI 10.1038/nrclinonc.2014.5; Shen J, 2013, CANCER EPIDEM BIOMAR, V22, P2364, DOI 10.1158/1055-9965.EPI-13-0237; Tomimaru Y, 2012, J HEPATOL, V56, P167, DOI 10.1016/j.jhep.2011.04.026; Vlassov AV, 2012, BBA-GEN SUBJECTS, V1820, P940, DOI 10.1016/j.bbagen.2012.03.017; Xu JA, 2011, MOL CARCINOGEN, V50, P136, DOI 10.1002/mc.20712; Yamamoto Y, 2009, BIOMARKERS, V14, P529, DOI 10.3109/13547500903150771; Zhou J, 2011, J CLIN ONCOL, V29, P4781, DOI 10.1200/JCO.2011.38.2697	27	97	107	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2015	10	10							e0141448	10.1371/journal.pone.0141448	http://dx.doi.org/10.1371/journal.pone.0141448			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0DL	26509672	Green Published, gold, Green Submitted			2022-12-26	WOS:000363918100084
J	Harris, KG; Coyne, CB				Harris, Katharine G.; Coyne, Carolyn B.			Unc93b Induces Apoptotic Cell Death and Is Cleaved by Host and Enteroviral Proteases	PLOS ONE			English	Article							TOLL-LIKE RECEPTOR-3; KAPPA-B ACTIVATION; LARGE GENE LISTS; PROTEIN UNC93B; RNA; EXPRESSION; CASPASE-8; TLR3; TRIF; ENCEPHALITIS	Unc93b is an endoplasmic reticulum (ER)-resident transmembrane protein that serves to bind and traffic toll-like receptors (TLRs) from the ER to their appropriate subcellular locations for ligand sensing. Because of its role in TLR trafficking, Unc93b is necessary for an effective innate immune response to coxsackievirus B3 (CVB), a positive-sense single stranded RNA virus belonging to the enterovirus family. Here, we show that Unc93b is cleaved by a CVB-encoded cysteine protease (3C(pro)) during viral replication. Further, we define a role for Unc93b in the induction of apoptotic cell death and show that expression of wild-type Unc93b, but not a mutant incapable of binding TLRs or exiting the ER (H412R), induces apoptosis. Furthermore, we show that cellular caspases activated during apoptosis directly cleave Unc93b. Interestingly, we show that the 3C(pro) - and caspase-mediated cleavage of Unc93b both occur within ten amino acids in the distal N-terminus of Unc93b. Mechanistically, neither caspase-mediated nor 3C(pro)-mediated cleavage of Unc93b altered its trafficking function, inhibited its role in facilitating TLR3 or TLR8 signaling, or altered its apoptosis-inducing effects. Taken together, our studies show that Unc93b is targeted by both viral-and host cell-specific proteases and identify a function of Unc93b in the induction of apoptotic cell death.	[Harris, Katharine G.; Coyne, Carolyn B.] Univ Pittsburgh, Dept Microbiol & Mol Genet, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Coyne, CB (corresponding author), Univ Pittsburgh, Dept Microbiol & Mol Genet, Pittsburgh, PA 15260 USA.	coynec2@pitt.edu			NIH [R01-AI081759, T32-AI049820, T32-AI060525]; Burroughs Wellcome Investigators in the Pathogenesis of Infectious Disease Award; ARCS Foundation Scholar Award; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI060525, T32AI049820, R01AI081759] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Investigators in the Pathogenesis of Infectious Disease Award(Burroughs Wellcome Fund); ARCS Foundation Scholar Award; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This project was supported by the NIH R01-AI081759 (C.B.C.) and NIH T32-AI049820 and T32-AI060525 (K.G.H.). In addition, C.B.C. is a recipient of the Burroughs Wellcome Investigators in the Pathogenesis of Infectious Disease Award and K.G.H. is a recipient of the ARCS Foundation Scholar Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreoletti L, 2009, ARCH CARDIOVASC DIS, V102, P559, DOI 10.1016/j.acvd.2009.04.010; Ashida H, 2011, J CELL BIOL, V195, P931, DOI 10.1083/jcb.201108081; Blom N, 1996, PROTEIN SCI, V5, P2203, DOI 10.1002/pro.5560051107; Bozym RA, 2012, CELL HOST MICROBE, V11, P153, DOI 10.1016/j.chom.2012.01.008; Brinkmann MM, 2007, J CELL BIOL, V177, P265, DOI 10.1083/jcb.200612056; Carthy CM, 1998, J VIROL, V72, P7669, DOI 10.1128/JVI.72.9.7669-7675.1998; Casrouge A, 2006, SCIENCE, V314, P308, DOI 10.1126/science.1128346; Centers for Disease Control, 2011, NONP ENT INF; Chau DHW, 2007, APOPTOSIS, V12, P513, DOI 10.1007/s10495-006-0013-0; Colston JT, 1998, CARDIOVASC RES, V38, P158, DOI 10.1016/S0008-6363(97)00323-4; Coyne CB, 2006, CELL, V124, P119, DOI 10.1016/j.cell.2005.10.035; Eigenbrod T, 2012, J IMMUNOL, V189, P328, DOI 10.4049/jimmunol.1103258; Estornes Y, 2012, CELL DEATH DIFFER, V19, P1482, DOI 10.1038/cdd.2012.22; Golks A, 2006, J EXP MED, V203, P1295, DOI 10.1084/jem.20051556; Gorbea C, 2010, J BIOL CHEM, V285, P23206, DOI 10.1074/jbc.M109.047464; Han KJ, 2004, J BIOL CHEM, V279, P15652, DOI 10.1074/jbc.M311629200; Harris KG, 2013, CYTOKINE, V63, P230, DOI 10.1016/j.cyto.2013.05.007; Henke A, 2000, J VIROL, V74, P4284, DOI 10.1128/JVI.74.9.4284-4290.2000; Hornung V, 2002, J IMMUNOL, V168, P4531, DOI 10.4049/jimmunol.168.9.4531; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Huh JW, 2014, P NATL ACAD SCI US; International Committee on Taxonomy of Viruses, 2012, VIR TAX 2012 REL CUR; Itoh H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028500; JANEWAY CA, 1989, COLD SPRING HARB SYM, V54, P1; Kaiser WJ, 2005, J IMMUNOL, V174, P4942, DOI 10.4049/jimmunol.174.8.4942; Kang DC, 2004, ONCOGENE, V23, P1789, DOI 10.1038/sj.onc.1207300; Kim W, 2011, MOL CELL, V44, P325, DOI 10.1016/j.molcel.2011.08.025; Kim YM, 2008, NATURE, V452, P234, DOI 10.1038/nature06726; Lafferty EI, 2015, J INNATE IMMUN; Lawrence JK, CASVM SERVER SVM BAS; Lee BL, 2013, ELIFE, V2, DOI [10.7554/eLife.00291, 10.1155/2013/961957]; Lemmers B, 2007, J BIOL CHEM, V282, P7416, DOI 10.1074/jbc.M606721200; Mukherjee A, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001311; Nakano S, 2010, RHEUMATOLOGY, V49, P876, DOI 10.1093/rheumatology/keq001; Negishi H, 2008, P NATL ACAD SCI USA, V105, P20446, DOI 10.1073/pnas.0810372105; Pifer R, 2011, J BIOL CHEM, V286, P3307, DOI 10.1074/jbc.M110.171025; Presley JF, 1997, NATURE, V389, P81, DOI 10.1038/38001; Rajput A, 2011, IMMUNITY, V34, P340, DOI 10.1016/j.immuni.2010.12.018; Rintahaka J, 2008, J IMMUNOL, V180, P1749, DOI 10.4049/jimmunol.180.3.1749; Simbulan-Rosenthal CM, 1998, J BIOL CHEM, V273, P13703, DOI 10.1074/jbc.273.22.13703; Su H, 2005, SCIENCE, V307, P1465, DOI 10.1126/science.1104765; Tabeta K, 2006, NAT IMMUNOL, V7, P156, DOI 10.1038/ni1297; Warrens AN, 1997, GENE, V186, P29, DOI 10.1016/S0378-1119(96)00674-9; Wee LJK, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S5-S14; Zhang SY, 2007, SCIENCE, V317, P1522, DOI 10.1126/science.1139522	46	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2015	10	10							e0141383	10.1371/journal.pone.0141383	http://dx.doi.org/10.1371/journal.pone.0141383			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0DL	26509685	Green Submitted, Green Accepted, Green Published, gold			2022-12-26	WOS:000363918100074
J	Li, PJ; Jin, T; Luo, DH; Shen, T; Mai, DM; Hu, WH; Mo, HY				Li, Pei-Jing; Jin, Ting; Luo, Dong-Hua; Shen, Ting; Mai, Dong-Mei; Hu, Wei-Han; Mo, Hao-Yuan			Effect of Prolonged Radiotherapy Treatment Time on Survival Outcomes after Intensity-Modulated Radiation Therapy in Nasopharyngeal Carcinoma	PLOS ONE			English	Article							CONVENTIONAL 2-DIMENSIONAL RADIOTHERAPY; LOCAL-CONTROL; PHASE-III; CONCURRENT CHEMORADIOTHERAPY; GLOTTIC CARCINOMA; FRACTION SIZE; CHEMOTHERAPY; CANCER; METAANALYSIS; IMPACT	Purpose To estimate the influence of prolonged radiation treatment time (RTT) on survival outcomes in nasopharyngeal carcinoma after continuous intensity-modulated radiation therapy. Methods and Materials Retrospectively review 321 patients with NPC treated between October 2009 and December 2010 and all of them underwent simultaneous accelerated intensity-modulated radiation therapy. The fractionated dose was 2-2.47 Gy/F (median 2.27 Gy), and the total dose for nasopharyngeal region was 64-74 Gy/28-33 fractions. The association of prolonged RTT and treatment interruption with PFS, LRFS and DFFS were assessed by univariate analysis and multivariate analysis. Survival analyses were carried out using Kaplan-Meier methodology and the log-rank test was used to assess the difference. The Cox regression proportional hazard model was used for multivariate analyses and evaluating the prognostic parameters for PFS, LRFS and DFFS. Results Univariate analysis revealed no significant associations between prolonged RTT and PFS, LRFS, DFFS when dichotomized using various cut-off values (all P>0.05). In multivariate analysis, RTT (range, 36-63 days) as a continuous variable, had no influence on any survival outcome as well (P>0.05). T and N classification were independent prognostic factors for PFS, LRFS and DFFS (all P<0.05, except T classification for LRFS, P = 0.057). Age was an independent prognostic factor for PFS (hazard ratio [HR], 1.033; P = 0.008) and DFFS (HR, 1.032; P = 0.043). Conclusion We conclude that no such association between survival outcomes and radiation treatment duration (range: 36-63 days) can be found in the present retrospective study, however, we have to remind that prolongation in treatment should be limited in clinical application and interruptions caused by any reason should be minimized as much as possible.	[Li, Pei-Jing; Luo, Dong-Hua; Mai, Dong-Mei; Hu, Wei-Han; Mo, Hao-Yuan] Sun Yat Sen Univ, Collaborat Innovat Ctr Canc Med, State Key Lab Oncol South China, Dept Nasopharyngeal Carcinoma,Canc Ctr, Guangzhou 510275, Guangdong, Peoples R China; [Jin, Ting] Zhejiang Canc Hosp, Dept Radiat Oncol, Hangzhou, Zhejiang, Peoples R China; [Jin, Ting] Zhejiang Key Lab Radiat Oncol, Hangzhou, Zhejiang, Peoples R China; [Shen, Ting] Peoples Hosp Nanhai Dist, Dept Hematol & Oncol, Foshan, Peoples R China	State Key Lab Oncology South China; Sun Yat Sen University; Zhejiang Cancer Hospital	Hu, WH (corresponding author), Sun Yat Sen Univ, Collaborat Innovat Ctr Canc Med, State Key Lab Oncol South China, Dept Nasopharyngeal Carcinoma,Canc Ctr, Guangzhou 510275, Guangdong, Peoples R China.	huwh@sysucc.org.cn; mohy@sysucc.org.cn	Li, Peijing/AAU-9696-2021		National Natural Science Foundation of China [81372437]; China International Medical Foundation [CIMF-F-H001-043]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China International Medical Foundation	This work was supported by the National Natural Science Foundation of China (grant no. 81372437), the China International Medical Foundation (grant no. CIMF-F-H001-043).	Al-Sarraf M, 1998, J CLIN ONCOL, V16, P1310, DOI 10.1200/JCO.1998.16.4.1310; BARTON MB, 1992, RADIOTHER ONCOL, V23, P137, DOI 10.1016/0167-8140(92)90323-M; Cannon DM, 2014, HEAD NECK-J SCI SPEC, V36, P1120, DOI 10.1002/hed.23419; Chan ATC, 2002, J CLIN ONCOL, V20, P2038, DOI 10.1200/JCO.2002.08.149; Chang JT, 1998, JPN J CLIN ONCOL, V28, P207, DOI 10.1093/jjco/28.3.207; Chatani Masashi, 1993, Strahlentherapie und Onkologie, V169, P102; Chen QY, 2011, JNCI-J NATL CANCER I, V103, P1761, DOI 10.1093/jnci/djr432; Du XH, 2003, CANC RES CLIN, V15, P166; Fang FM, 2008, INT J RADIAT ONCOL, V72, P356, DOI 10.1016/j.ijrobp.2007.12.054; Fein DA, 1996, INT J RADIAT ONCOL, V34, P823, DOI 10.1016/0360-3016(95)02205-8; FOWLER JF, 1992, INT J RADIAT ONCOL, V23, P457, DOI 10.1016/0360-3016(92)90768-D; Gasinska A, 2004, ACTA ONCOL, V43, P657, DOI 10.1080/02841860410018511; [何霞云 He Xiayun], 2002, [复旦学报. 医学版, Journal of fudan university], V29, P145; Huncharek M, 2006, INT J RADIAT ONCOL, V65, P958, DOI 10.1016/j.ijrobp.2006.02.057; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kam MKM, 2004, INT J RADIAT ONCOL, V60, P1440, DOI 10.1016/j.ijrobp.2004.05.022; Kwong DLW, 1997, INT J RADIAT ONCOL, V39, P703, DOI 10.1016/S0360-3016(97)00339-8; Lai SZ, 2011, INT J RADIAT ONCOL, V80, P661, DOI 10.1016/j.ijrobp.2010.03.024; Le QTX, 1997, INT J RADIAT ONCOL, V39, P115, DOI 10.1016/S0360-3016(97)00284-8; Lee AWM, 2014, RADIOTHER ONCOL, V110, P377, DOI 10.1016/j.radonc.2014.02.003; Lee AWM, 2005, J CLIN ONCOL, V23, P6966, DOI 10.1200/JCO.2004.00.7542; LEE AWM, 1995, RADIOTHER ONCOL, V36, P24, DOI 10.1016/0167-8140(95)01579-6; Lee N, 2002, INT J RADIAT ONCOL, V53, P12, DOI 10.1016/S0360-3016(02)02724-4; Liang ZG, 2013, ASIAN PAC J CANCER P, V14, P515, DOI 10.7314/APJCP.2013.14.1.515; Lin JC, 2003, J CLIN ONCOL, V21, P631, DOI 10.1200/JCO.2003.06.158; Lin SJ, 2009, INT J RADIAT ONCOL, V75, P1071, DOI 10.1016/j.ijrobp.2008.12.015; Ma J, 2001, J CLIN ONCOL, V19, P1350, DOI 10.1200/JCO.2001.19.5.1350; Machtay M, 2005, INT J RADIAT ONCOL, V63, P667, DOI 10.1016/j.ijrobp.2005.03.037; Nishimura Y, 1996, RADIOTHER ONCOL, V40, P225, DOI 10.1016/0167-8140(96)01796-3; Overgaard J, 2003, LANCET, V362, P933, DOI 10.1016/S0140-6736(03)14361-9; Overgaard J, 2010, LANCET ONCOL, V11, P553, DOI 10.1016/S1470-2045(10)70072-3; Peng G, 2012, RADIOTHER ONCOL, V104, P286, DOI 10.1016/j.radonc.2012.08.013; Perez CA, 2004, CANCER J, V10, P349, DOI 10.1097/00130404-200411000-00004; Sher DJ, 2011, INT J RADIAT ONCOL, V81, pE813, DOI 10.1016/j.ijrobp.2010.12.005; Su Sheng-fa, 2011, Zhonghua Yi Xue Za Zhi, V91, P469; Tan BX, 1998, CHIN J RAD ONCOL, V7, P41; VANDENBOGAERT W, 1995, RADIOTHER ONCOL, V36, P177, DOI 10.1016/0167-8140(95)01597-A; Vokes EE, 1997, LANCET, V350, P1087, DOI 10.1016/S0140-6736(97)07269-3; WITHERS HR, 1995, INT J RADIAT ONCOL, V33, P549, DOI 10.1016/0360-3016(95)00228-Q; WITHERS HR, 1988, ACTA ONCOL, V27, P131, DOI 10.3109/02841868809090333; Wong FCS, 2010, INT J RADIAT ONCOL, V76, P138, DOI 10.1016/j.ijrobp.2009.01.084; Wu S., 2000, CHIN J CANCER, V19, P923; Yamazaki H, 2006, INT J RADIAT ONCOL, V64, P77, DOI 10.1016/j.ijrobp.2005.06.014	43	29	30	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2015	10	10							e0141332	10.1371/journal.pone.0141332	http://dx.doi.org/10.1371/journal.pone.0141332			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU8PC	26506559	gold, Green Published, Green Submitted			2022-12-26	WOS:000363804200050
J	Mo, L; Ma, ZY; Xu, YS; Sun, FB; Lun, XX; Liu, XH; Chen, JG; Yu, XX				Mo, Li; Ma, Zeyu; Xu, Yansen; Sun, Fengbin; Lun, Xiaoxiu; Liu, Xuhui; Chen, Jungang; Yu, Xinxiao			Assessing the Capacity of Plant Species to Accumulate Particulate Matter in Beijing, China	PLOS ONE			English	Article							AIR-POLLUTION; DEPOSITION; PARTICLES; LEAVES; FINE; RESUSPENSION; CAPABILITY; POLLUTANTS; METALS	Air pollution causes serious problems in spring in northern China; therefore, studying the ability of different plants to accumulate particulate matter (PM) at the beginning of the growing season may benefit urban planners in their attempts to control air pollution. This study evaluated deposits of PM on the leaves and in the wax layer of 35 species (11 shrubs, 24 trees) in Beijing, China. Differences in the accumulation of PM were observed between species. Cephalotaxus sinensis, Euonymus japonicus, Broussonetia papyriferar, Koelreuteria paniculata and Quercus variabilis were all efficient in capturing small particles. The plants exhibiting high amounts of total PM accumulation (on leaf surfaces and/or in the wax layer), also showed comparatively high levels of PM accumulation across all particle sizes. A comparison of shrubs and trees did not reveal obvious differences in their ability to accumulate particles based on growth form; a combination of plantings with different growth forms can efficiently reduce airborne PM concentrations near the ground. To test the relationships between leaf traits and PM accumulation, leaf samples of selected species were observed using a scanning electron microscope. Growth forms with greater amounts of pubescence and increased roughness supported PM accumulation; the adaxial leaf surfaces collected more particles than the abaxial surfaces. The results of this study may inform the selection of species for urban green areas where the goal is to capture air pollutants and mitigate the adverse effects of air pollution on human health.	[Mo, Li; Xu, Yansen; Sun, Fengbin; Liu, Xuhui; Chen, Jungang; Yu, Xinxiao] Beijing Forest Univ, Coll Soil & Water Conservat, Beijing, Peoples R China; [Ma, Zeyu] Beijing Forestry Univ, Coll Forestry, Beijing, Peoples R China; [Lun, Xiaoxiu] Beijing Forestry Univ, Coll Environm Engn, Beijing, Peoples R China	Beijing Forestry University; Beijing Forestry University; Beijing Forestry University	Yu, XX (corresponding author), Beijing Forest Univ, Coll Soil & Water Conservat, Beijing, Peoples R China.	yuxinxiao@bjfu.edu.cn	Mo, Liwen/GRS-6594-2022	xu, yan sen/0000-0002-2509-0992	Forestry Public Welfare Project of China [201304301]	Forestry Public Welfare Project of China	This work was supported by the Forestry Public Welfare Project of China (No. 201304301). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beckett K. Paul, 2000, Journal of Arboriculture, V26, P12; Beckett KP, 1998, ENVIRON POLLUT, V99, P347, DOI 10.1016/S0269-7491(98)00016-5; Bell ML, 2011, ENVIRON SCI POLICY, V14, P357, DOI 10.1016/j.envsci.2011.02.006; Bosco ML, 2005, ENVIRON RES, V99, P18, DOI 10.1016/j.envres.2004.09.011; Burkhardt J, 2010, ECOL MONOGR, V80, P369, DOI 10.1890/09-1988.1; Caricchia AM, 1999, ATMOS ENVIRON, V33, P3731, DOI 10.1016/S1352-2310(99)00199-5; Chai Yixin, 2002, Yingyong Shengtai Xuebao, V13, P1121; Chen F, 2006, CHINESE J ECOL, V25, P34, DOI DOI 10.13292/j.1000-4890.2006.0007; Chen Xiao-ping, 2014, Shengtaixue Zazhi, V33, P2558; Dzierzanowski K, 2011, INT J PHYTOREMEDIAT, V13, P1037, DOI 10.1080/15226514.2011.552929; Escobedo FJ, 2011, ENVIRON POLLUT, V159, P2078, DOI 10.1016/j.envpol.2011.01.010; Faini F, 1999, BIOCHEM SYST ECOL, V27, P673, DOI 10.1016/S0305-1978(98)00131-8; Farmer A., 2002, EFFECTS PARTICULATES, P187; FOWLER D, 1989, PHILOS T ROY SOC B, V324, P247, DOI 10.1098/rstb.1989.0047; Freer-Smith PH, 2005, ENVIRON POLLUT, V133, P157, DOI 10.1016/j.envpol.2004.03.031; FreerSmith PH, 1997, ENVIRON POLLUT, V95, P27, DOI 10.1016/S0269-7491(96)00119-4; Gao JinHui, 2007, Journal of Beijing Forestry University, V29, P94; Grantz DA, 2003, ENVIRON INT, V29, P213, DOI 10.1016/S0160-4120(02)00181-2; Hwang HJ, 2011, ATMOS ENVIRON, V45, P6987, DOI 10.1016/j.atmosenv.2011.09.019; Janssen NAH, 1997, ATMOS ENVIRON, V31, P1185, DOI 10.1016/S1352-2310(96)00291-9; Jouraeva VA, 2002, ENVIRON POLLUT, V120, P331, DOI 10.1016/S0269-7491(02)00121-5; Li HM, 2008, CHINESE J ECOL, V10, P5; Lu SG, 2008, ATMOS ENVIRON, V42, P6431, DOI 10.1016/j.atmosenv.2008.04.039; McDonald AG, 2007, ATMOS ENVIRON, V41, P8455, DOI 10.1016/j.atmosenv.2007.07.025; McPherson EG, 1998, ATMOS ENVIRON, V32, P75, DOI 10.1016/S1352-2310(97)00180-5; Nowak D.J., 1994, ENVIRONMENT, V2, P63; Nowak David J., 2006, Urban Forestry & Urban Greening, V5, P93, DOI [10.1016/j.ufug.2006.04.002, 10.1016/j.ufug.2006.01.007]; Ottele M, 2010, ECOL ENG, V36, P154, DOI 10.1016/j.ecoleng.2009.02.007; Ould-Dada Z, 2001, ATMOS ENVIRON, V35, P3799, DOI 10.1016/S1352-2310(01)00161-3; Pope CA, 2002, JAMA-J AM MED ASSOC, V287, P1132, DOI 10.1001/jama.287.9.1132; Rasanen JV, 2013, ENVIRON POLLUT, V183, P64, DOI 10.1016/j.envpol.2013.05.015; Sabin LD, 2006, ATMOS ENVIRON, V40, P7528, DOI 10.1016/j.atmosenv.2006.07.004; Saebo A, 2012, SCI TOTAL ENVIRON, V427, P347, DOI 10.1016/j.scitotenv.2012.03.084; Salvi S, 2007, PAEDIATR RESPIR REV, V8, P275, DOI 10.1016/j.prrv.2007.08.008; [石辉 Shi Hui], 2011, [生态学报, Acta Ecologica Sinica], V31, P1471; Wang H., 2012, WAP C SERIES ED SOCI, V2012, P1, DOI DOI 10.1093/IJICT/CTS043; Wang Hui-xia, 2010, Yingyong Shengtai Xuebao, V21, P3077; Wang HX, 2013, FRONT ENV SCI ENG, V7, P579, DOI 10.1007/s11783-013-0524-1; Wang Lei, 2006, Yingyong Shengtai Xuebao, V17, P597; [王赞红 Wang Zanhong], 2006, [生态环境, Ecology and Environment], V15, P327; [杨佳 Yang Jia], 2015, [环境科学研究, Research of Environmental Sciences], V28, P384; Yang Jun, 2005, Urban Forestry & Urban Greening, V3, P65, DOI 10.1016/j.ufug.2004.09.001; Zhou Z, 2010, ACTA ECOL SINICA, V22, P2036	43	90	101	6	80	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2015	10	10							e0140664	10.1371/journal.pone.0140664	http://dx.doi.org/10.1371/journal.pone.0140664			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU8PC	26506104	Green Published, gold, Green Submitted			2022-12-26	WOS:000363804200014
J	Zhang, XF; Li, JC; Wen, XD; Ren, CG; Cai, M; Chen, CC				Zhang, Xiao-fen; Li, Jian-ce; Wen, Xin-dong; Ren, Chuan-gen; Cai, Ming; Chen, Cheng-chun			Susceptibility-Weighted Imaging of the Anatomic Variation of Thalamostriate Vein and Its Tributaries	PLOS ONE			English	Article							MAGNETIC-FIELD STRENGTHS; CEREBRAL VEINS; VENOUS VARIATIONS; MICROSURGICAL ANATOMY; MR VENOGRAPHY; 3RD VENTRICLE; 3RD-VENTRICLE; REGION; BRAIN; PHASE	Background and Purpose Thalamostriate vein (TSV) is an important tributary of the internal cerebral vein, which mainly drains the basal ganglia and deep medulla. The purpose of this study was to explore the anatomic variation and quality of TSV and its smaller tributaries using susceptibilityweighted imaging (SWI). Methods We acquired SWI images in 40 volunteers on a 3.0T MR system using an 8-channel high-resolution phased array coil. The frequencies of the TSV and its tributaries were evaluated. We classified TSV into types I (forming a venous angle) and II (forming a false venous angle). We classified anterior caudate vein (ACV) into types 1 (1 trunk) and 2 (2 trunks) as well as into types A (joiningTSV), B (joining anterior septal vein), and C (joining the angle of both veins). Results The TSV drains the areas of caudate nucleus, internal capsule, lentiform nucleus, external capsule, claustrum, extreme capsule and the white matter of the frontoparietal lobes, except thalamus. The frequencies of the TSV, ACV and transverse caudate vein (ACV) were 92.5%, 87.5% and 63.8%, respectively. We found TSV types I and II in 79.7%, and 20.3% with significantly different constitution ratios (P<0.05). The most common types of ACV were type 1 (90.0%) and type A (64.3%). Conclusion The complex three-dimensional (3D) venous architecture of TSV and its small tributaries manifests great variation, with significant and practical implications for neurosurgery.	[Zhang, Xiao-fen; Chen, Cheng-chun] Wenzhou Med Univ, Dept Human Anat, Wenzhou, Zhejiang, Peoples R China; [Li, Jian-ce; Wen, Xin-dong; Ren, Chuan-gen] Wenzhou Med Univ, Affiliated Hosp 1, Dept Radiol, Wenzhou, Zhejiang, Peoples R China; [Cai, Ming] Wenzhou Med Univ, Affiliated Hosp 2, Dept Neurosurg, Wenzhou, Zhejiang, Peoples R China	Wenzhou Medical University; Wenzhou Medical University; Wenzhou Medical University	Chen, CC (corresponding author), Wenzhou Med Univ, Dept Human Anat, Wenzhou, Zhejiang, Peoples R China.	ccczxfwz@163.com			Natural Science Foundation of Zhejiang Province, China [LY15C110001]	Natural Science Foundation of Zhejiang Province, China(Natural Science Foundation of Zhejiang Province)	This work was supported by the Natural Science Foundation of Zhejiang Province, China (NO. LY15C110001).	Boeckh-Behrens T, 2012, EUR J RADIOL, V81, P1238, DOI 10.1016/j.ejrad.2011.02.057; Budde J, 2011, MAGN RESON MED, V65, P544, DOI 10.1002/mrm.22632; Cai M, 2015, NEURORADIOLOGY, V57, P163, DOI 10.1007/s00234-014-1450-z; Cimsit NC, 2003, NEURORADIOLOGY, V45, P900, DOI 10.1007/s00234-003-1103-0; COSSU M, 1984, SURG NEUROL, V21, P325, DOI 10.1016/0090-3019(84)90109-5; Deistung A, 2008, MAGN RESON MED, V60, P1155, DOI 10.1002/mrm.21754; Di Ieva A, 2011, NEUROIMAGE, V54, P74, DOI 10.1016/j.neuroimage.2010.07.045; Elhammady MS, 2015, WORLD NEUROSURG, V83, P320, DOI 10.1016/j.wneu.2013.06.003; Fujii S, 2010, AM J NEURORADIOL, V31, P55, DOI 10.3174/ajnr.A1752; Fujima N, 2011, NEUROIMAGE, V54, P344, DOI 10.1016/j.neuroimage.2010.08.020; Haacke EM, 2009, AM J NEURORADIOL, V30, P19, DOI 10.3174/ajnr.A1400; HASSLER O, 1966, NEUROLOGY, V16, P505, DOI 10.1212/WNL.16.5.505; HIRSCH JF, 1979, ACTA NEUROCHIR, V47, P135, DOI 10.1007/BF01406399; Ishizaka K, 2010, J MAGN RESON IMAGING, V31, P32, DOI 10.1002/jmri.21989; LANG J, 1985, ACTA NEUROCHIR, V75, P5, DOI 10.1007/BF01406320; Leonardo J, 2009, J NEUROSURG-PEDIATR, V3, P507, DOI 10.3171/2009.2.PEDS0969; Lupo Janine M, 2006, Conf Proc IEEE Eng Med Biol Soc, V2006, P747; ONO M, 1984, NEUROSURGERY, V15, P621, DOI 10.1227/00006123-198411000-00002; Rauscher A, 2005, MAGNET RESON MED, V54, P87, DOI 10.1002/mrm.20520; Rauscher A, 2008, MAGN RESON IMAGING, V26, P1145, DOI 10.1016/j.mri.2008.01.029; Reichenbach JR, 1997, RADIOLOGY, V204, P272, DOI 10.1148/radiology.204.1.9205259; Sun J, 2011, AJNR Am J Neuroradiol, V32, pE191, DOI 10.3174/ajnr.A2308; Timurkaynak E, 2006, SURG NEUROL, V66, P544, DOI 10.1016/j.surneu.2006.03.033; Ture U, 1997, J NEUROSURG, V87, P706, DOI 10.3171/jns.1997.87.5.0706; WAUGH JR, 1992, RADIOLOGY, V182, P243, DOI 10.1148/radiology.182.1.1727290; WOLF BS, 1964, AMER J ROENTGENOL RA, V91, P406; Xia XB, 2013, J NEURORADIOLOGY, V40, P355, DOI 10.1016/j.neurad.2013.03.005	27	6	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2015	10	10							e0141513	10.1371/journal.pone.0141513	http://dx.doi.org/10.1371/journal.pone.0141513			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU8PC	26506095	Green Published, gold, Green Submitted			2022-12-26	WOS:000363804200080
J	Mizutani, A; Koinuma, D; Seimiya, H; Miyazono, K				Mizutani, A.; Koinuma, D.; Seimiya, H.; Miyazono, K.			The Arkadia-ESRP2 axis suppresses tumor progression: analyses in clear-cell renal cell carcinoma	ONCOGENE			English	Article							TARGETED UBIQUITIN LIGASE; TGF-BETA; MESENCHYMAL TRANSITION; MESSENGER-RNA; EXPRESSION; COMPLEX; DEGRADATION; METASTASIS; PROTEINS; ESRP1	Tumor-specific alternative splicing is implicated in the progression of cancer, including clear-cell renal cell carcinoma (ccRCC). Using ccRCC RNA sequencing data from The Cancer Genome Atlas, we found that epithelial splicing regulatory protein 2 (ESRP2), one of the key regulators of alternative splicing in epithelial cells, is expressed in ccRCC. ESRP2 mRNA expression did not correlate with the overall survival rate of ccRCC patients, but the expression of some ESRP-target exons correlated with the good prognosis and with the expression of Arkadia ( also known as RNF111) in ccRCC. Arkadia physically interacted with ESRP2, induced polyubiquitination and modulated its splicing function. Arkadia and ESRP2 suppressed ccRCC tumor growth in a coordinated manner. Lower expression of Arkadia correlated with advanced tumor stages and poor outcomes in ccRCC patients. This study thus reveals a novel tumor-suppressive role of the Arkadia-ESRP2 axis in ccRCC.	[Mizutani, A.; Koinuma, D.; Miyazono, K.] Univ Tokyo, Grad Sch Med, Dept Mol Pathol, Tokyo 1130033, Japan; [Mizutani, A.; Seimiya, H.] Japanese Fdn Canc Res, Div Mol Biotherapy, Ctr Canc Chemotherapy, Koto Ku, Tokyo, Japan	University of Tokyo; Japanese Foundation for Cancer Research	Miyazono, K (corresponding author), Univ Tokyo, Dept Mol Pathol, Grad Sch Med, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	miyazono@m.u-tokyo.ac.jp	Koinuma, Daizo/Y-8716-2018	Koinuma, Daizo/0000-0001-5611-2122; Seimiya, Hiroyuki/0000-0003-3314-9736	KAKENHI from the Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT) [22112002, 24700968, 26830066, 24501311]; Grants-in-Aid for Scientific Research [26830066, 22112002] Funding Source: KAKEN	KAKENHI from the Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We are grateful to Dr Hiroshi I Suzuki (The University of Tokyo) for discussion and advice. We also thank Keiko Yuki for technical assistance, as well as the members of the Miyazono laboratory for discussion and advice. This research was supported by KAKENHI grants-in-aid for scientific research on Innovative Area (Integrative Research on Cancer Microenvironment Network; 22112002, to KM), Young Scientists (B) (24700968 and 26830066, to AM) and Scientific Research (C) (24501311, to DK), from the Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT). This study was performed, in part, as a research program for the Project for Development of Innovative Research on Cancer Therapeutics (P-Direct), MEXT.	Barzik M, 2005, J BIOL CHEM, V280, P28653, DOI 10.1074/jbc.M503957200; Biamonti G, 2014, SEMIN CELL DEV BIOL, V32, P30, DOI 10.1016/j.semcdb.2014.03.016; Bierie B, 2006, NAT REV CANCER, V6, P506, DOI 10.1038/nrc1926; Briones-Orta MA, 2013, CANCER RES, V73, P1800, DOI 10.1158/0008-5472.CAN-12-1916; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chen J, 2015, ONCOGENE, V34, P1, DOI 10.1038/onc.2013.570; Cybulsky AV, 2009, AM J PHYSIOL-RENAL, V297, pF971, DOI 10.1152/ajprenal.00294.2009; Di Modugno F, 2007, CANCER RES, V67, P2657, DOI 10.1158/0008-5472.CAN-06-1997; Erker Y, 2013, MOL CELL BIOL, V33, P2163, DOI 10.1128/MCB.01019-12; Gamazon ER, 2014, HUM GENET, V133, P679, DOI 10.1007/s00439-013-1411-3; Geisler S, 2010, NAT CELL BIOL, V12, P119, DOI 10.1038/ncb2012; Harris IS, 2015, CANCER CELL, V27, P211, DOI 10.1016/j.ccell.2014.11.019; Horiguchi K, 2012, ONCOGENE, V31, P3190, DOI 10.1038/onc.2011.493; Horvath A, 2013, SCI REP-UK, V3, DOI 10.1038/srep02256; Hsu RJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047649; Ikushima H, 2010, NAT REV CANCER, V10, P415, DOI 10.1038/nrc2853; Ishii H, 2014, J BIOL CHEM, V289, P27386, DOI 10.1074/jbc.M114.589432; Isogaya K, 2014, CELL RES, V24, P994, DOI 10.1038/cr.2014.97; Kalsotra A, 2011, NAT REV GENET, V12, P715, DOI 10.1038/nrg3052; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Koinuma D, 2003, EMBO J, V22, P6458, DOI 10.1093/emboj/cdg632; Kulathu Y, 2012, NAT REV MOL CELL BIO, V13, P508, DOI 10.1038/nrm3394; Le Scolan E, 2008, CANCER RES, V68, P3277, DOI 10.1158/0008-5472.CAN-07-6793; Levy L, 2007, MOL CELL BIOL, V27, P6068, DOI 10.1128/MCB.00664-07; Miyazono K, 2011, J BIOCHEM, V149, P1, DOI 10.1093/jb/mvq133; Mizutani A, 2011, J BIOL CHEM, V286, P29848, DOI 10.1074/jbc.M110.217745; Mizutani A, 2010, J BIOCHEM, V148, P733, DOI 10.1093/jb/mvq127; Nagano Y, 2007, J BIOL CHEM, V282, P20492, DOI 10.1074/jbc.M701294200; Park JH, 2011, J BIOL CHEM, V286, P10911, DOI 10.1074/jbc.C110.210211; Peng DJ, 2011, J IMMUNOL, V186, P5638, DOI 10.4049/jimmunol.1003801; Poulsen SL, 2013, J CELL BIOL, V201, P797, DOI 10.1083/jcb.201212075; Ray KC, 2014, ONCOGENE, V33, P823, DOI 10.1038/onc.2013.3; Rini BI, 2009, LANCET, V373, P1119, DOI 10.1016/S0140-6736(09)60229-4; Shapiro IM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002218; Sharma V, 2011, CANCER RES, V71, P6438, DOI 10.1158/0008-5472.CAN-11-1645; Shirakihara T, 2011, EMBO J, V30, P783, DOI 10.1038/emboj.2010.351; Turner N, 2010, NAT REV CANCER, V10, P116, DOI 10.1038/nrc2780; Ueda J, 2014, ONCOGENE, V33, P4485, DOI 10.1038/onc.2013.392; Warzecha CC, 2012, SEMIN CANCER BIOL, V22, P417, DOI 10.1016/j.semcancer.2012.04.003; Warzecha CC, 2010, EMBO J, V29, P3286, DOI 10.1038/emboj.2010.195; Warzecha CC, 2009, MOL CELL, V33, P591, DOI 10.1016/j.molcel.2009.01.025; Wild JRL, 2012, INT J EXP PATHOL, V93, P81, DOI 10.1111/j.1365-2613.2012.00810.x; Yae T, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1892; Yuzawa H, 2009, BONE, V44, P53, DOI 10.1016/j.bone.2008.09.013; Zhao Q, 2013, CLIN CANCER RES, V19, P2460, DOI 10.1158/1078-0432.CCR-12-3708; Zhou ZN, 2014, ONCOGENE, V33, P3784, DOI 10.1038/onc.2013.363	46	33	33	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 7	2016	35	27					3514	3523		10.1038/onc.2015.412	http://dx.doi.org/10.1038/onc.2015.412			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DR0UD	26522722	hybrid, Green Published			2022-12-26	WOS:000379621500004
J	Zheng, LS; Khemlani, A; Lorenz, N; Loh, JMS; Langley, RJ; Proft, T				Zheng, Lisa; Khemlani, Adrina; Lorenz, Natalie; Loh, Jacelyn M. S.; Langley, Ries J.; Proft, Thomas			Streptococcal 5 '-Nucleotidase A (S5nA), a Novel Streptococcus pyogenes Virulence Factor That Facilitates Immune Evasion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEUTROPHIL EXTRACELLULAR TRAPS; ACUTE RHEUMATIC-FEVER; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; HUMAN CD73; ADENOSINE; MACROPHAGES; INVOLVEMENT; GENERATION; NUCLEASE	Streptococcus pyogenes is an important human pathogen that causes a wide range of diseases. Using bioinformatics analysis of the complete S. pyogenes strain SF370 genome, we have identified a novel S. pyogenes virulence factor, which we termed streptococcal 5'-nucleotidaseA(S5nA). A recombinant form of S5nA hydrolyzed AMP and ADP, but not ATP, to generate the immunomodulatory molecule adenosine. Michaelis-Menten kinetics revealed a K-m of 169 mu M and a V-max of 7550 nmol/mg/min for the substrate AMP. Furthermore, recombinant S5nA acted synergistically with S. pyogenes nuclease A to generate macrophagetoxic deoxyadenosine from DNA. The enzyme showed optimal activity between pH5 and pH6.5 and between 37 and 47 degrees C. Like other 5'-nucleotidases, S5nA requires divalent cations and was active in the presence of Mg2+, Ca2+, or Mn2+. However, Zn2+ inhibited the enzymatic activity. Structural modeling combined with mutational analysis revealed a highly conserved catalytic dyad as well as conserved substrate and cation-binding sites. Recombinant S5nA significantly increased the survival of the non-pathogenic bacterium Lactococcus lactis during a human whole blood killing assay in a dose-dependent manner, suggesting a role as an S. pyogenes virulence factor. In conclusion, we have identified a novel S. pyogenes enzyme with 5'-nucleotidase activity and immune evasion properties.	[Zheng, Lisa; Khemlani, Adrina; Lorenz, Natalie; Loh, Jacelyn M. S.; Langley, Ries J.; Proft, Thomas] Univ Auckland, Sch Med Sci, Dept Mol Med & Pathol, Auckland 1, New Zealand; [Lorenz, Natalie; Loh, Jacelyn M. S.; Langley, Ries J.; Proft, Thomas] Univ Auckland, Maurice Wilkins Ctr, Auckland 1, New Zealand	University of Auckland; University of Auckland	Proft, T (corresponding author), Univ Auckland, Sch Med Sci, Dept Mol Med & Pathol, Auckland Mail Ctr, Private Bag 92019, Auckland 1, New Zealand.	t.proft@auckland.ac.nz	Lorenz, Natalie/J-9241-2019; Proft, Thomas/H-4686-2019	Lorenz, Natalie/0000-0002-5480-1714; Proft, Thomas/0000-0002-9275-5042; Langley, Ries/0000-0001-8606-2197; Jethanand-Khemlani, Adrina Hema/0000-0003-3015-090X	Faculty Research Development Fund from the Faculty of Medical and Health Sciences, University of Auckland; Health Research Council New Zealand	Faculty Research Development Fund from the Faculty of Medical and Health Sciences, University of Auckland; Health Research Council New Zealand(Health Research Council of New Zealand)	This work was supported by a research grant from the Faculty Research Development Fund from the Faculty of Medical and Health Sciences, University of Auckland. The authors declare that they have no conflicts of interest with the contents of this article.; Supported by the Health Research Council New Zealand.	Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Bouma MG, 1997, J IMMUNOL, V158, P5400; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Carapetis JR, 2005, LANCET INFECT DIS, V5, P685, DOI 10.1016/S1473-3099(05)70267-X; Chang A, 2011, MOL MICROBIOL, V79, P1629, DOI 10.1111/j.1365-2958.2011.07550.x; CRONSTEIN BN, 1983, J EXP MED, V158, P1160, DOI 10.1084/jem.158.4.1160; Cunningham MW, 2008, ADV EXP MED BIOL, V609, P29, DOI 10.1007/978-0-387-73960-1_3; Deaglio S, 2007, J EXP MED, V204, P1257, DOI 10.1084/jem.20062512; Derre-Bobillot A, 2013, MOL MICROBIOL, V89, P518, DOI 10.1111/mmi.12295; Di Virgilio F, 2007, PURINERG SIGNAL, V3, P1, DOI 10.1007/s11302-006-9048-5; Edmond KM, 2012, LANCET, V379, P547, DOI 10.1016/S0140-6736(11)61651-6; EDWARDS CK, 1994, J LEUKOCYTE BIOL, V56, P133, DOI 10.1002/jlb.56.2.133; Fan JY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038059; Ferretti JJ, 2001, P NATL ACAD SCI USA, V98, P4658, DOI 10.1073/pnas.071559398; Firon A, 2014, J BIOL CHEM, V289, P5479, DOI 10.1074/jbc.M113.545632; Garavaglia S, 2012, BIOCHEM J, V441, P131, DOI 10.1042/BJ20111263; Gorini S, 2013, AM J BLOOD RES, V3, P14; Hasko G, 2004, TRENDS IMMUNOL, V25, P33, DOI 10.1016/j.it.2003.11.003; Hasko G, 1996, J IMMUNOL, V157, P4634; Heuts DPHM, 2012, CHEMBIOCHEM, V13, P2384, DOI 10.1002/cbic.201200426; Idzko M, 2014, NATURE, V509, P310, DOI 10.1038/nature13085; Jaine R, 2008, J PAEDIATR CHILD H, V44, P564, DOI 10.1111/j.1440-1754.2008.01384.x; Jaine R, 2011, PEDIATR INFECT DIS J, V30, P315, DOI 10.1097/INF.0b013e3181fbd85b; Junger WG, 2011, NAT REV IMMUNOL, V11, P201, DOI 10.1038/nri2938; Knofel T, 1999, NAT STRUCT BIOL, V6, P448; Liu P, 2014, J INFECT DIS, V210, P35, DOI 10.1093/infdis/jiu050; Lorenz N, 2013, IMMUNOL CELL BIOL, V91, P469, DOI 10.1038/icb.2013.28; Lun ZR, 2007, LANCET INFECT DIS, V7, P201, DOI 10.1016/S1473-3099(07)70001-4; Morita C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103125; NEU HC, 1967, J BIOL CHEM, V242, P3905; Ralph AP, 2013, CURR TOP MICROBIOL, V368, P1, DOI 10.1007/82_2012_280; Robson Simon C, 2006, Purinergic Signal, V2, P409, DOI 10.1007/s11302-006-9003-5; Taylor AR, 2013, PRIMARY CARE, V40, P637, DOI 10.1016/j.pop.2013.06.002; Thammavongsa V, 2013, SCIENCE, V342, P863, DOI 10.1126/science.1242255; Thammavongsa V, 2011, BMC BIOCHEM, V12, DOI 10.1186/1471-2091-12-56; Thammavongsa V, 2009, J EXP MED, V206, P2417, DOI 10.1084/jem.20090097; Trautmann A, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.256pe6; Vitiello L, 2012, BLOOD, V120, P511, DOI 10.1182/blood-2012-01-406496; Wertheim HFL, 2009, CLIN INFECT DIS, V48, P617, DOI 10.1086/596763; Xaus J, 1999, J IMMUNOL, V162, P3607; XU B, 1994, BIOL TRACE ELEM RES, V40, P49, DOI 10.1007/BF02916820; Yang L, 2005, J CLIN MICROBIOL, V43, P3570, DOI 10.1128/JCM.43.7.3570-3573.2005	42	21	21	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 25	2015	290	52					31126	31137		10.1074/jbc.M115.677443	http://dx.doi.org/10.1074/jbc.M115.677443			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CZ6GK	26527680	Green Published, hybrid			2022-12-26	WOS:000367199000040
J	Jansen, RS; Mahakena, S; de Haas, M; Borst, P; van de Wetering, K				Jansen, Robert S.; Mahakena, Sunny; de Haas, Marcel; Borst, Piet; van de Wetering, Koen			ATP-binding Cassette Subfamily C Member 5 (ABCC5) Functions as an Efflux Transporter of Glutamate Conjugates and Analogs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MULTIDRUG-RESISTANCE PROTEIN; CITRYL-L-GLUTAMATE; CENTRAL-NERVOUS-SYSTEM; LENS EPITHELIAL-CELLS; BLOOD-BRAIN-BARRIER; N-ACETYLASPARTYLGLUTAMATE; CARBOXYPEPTIDASE II; RAT-BRAIN; MOLECULAR-IDENTIFICATION; PEPTIDE NEUROTRANSMITTER	The ubiquitous efflux transporter ABCC5 (ATP-binding cassette subfamily C member 5) is present at high levels in the blood-brain barrier, neurons, and glia, but its in vivo substrates and function are not known. Using untargeted metabolomic screens, we show that Abcc5(-/-) mice accumulate endogenous glutamate conjugates in several tissues, but brain in particular. The abundant neurotransmitter N-acetylaspartylglutamate was 2.4-fold higher in Abcc5(-/-) brain. The metabolites that accumulated in Abcc5(-/-) tissues were depleted in cultured cells that overexpressed human ABCC5. In a vesicular membrane transport assay, ABCC5 also transported exogenous glutamate analogs, like the classic excitotoxic neurotoxins kainic acid, domoic acid, and NMDA; the therapeutic glutamate analog ZJ43; and, as previously shown, the anti-cancer drug methotrexate. Glutamate conjugates and analogs are of physiological relevance because they can affect the function of glutamate, the principal excitatory neurotransmitter in the brain. After CO2 asphyxiation, several immediate early genes were expressed at lower levels in Abcc5(-/-) brains than in wild type brains, suggesting altered glutamate signaling. Our results show that ABCC5 is a general glutamate conjugate and analog transporter that affects the disposition of endogenous metabolites, toxins, and drugs.	[Jansen, Robert S.; Mahakena, Sunny; de Haas, Marcel; Borst, Piet; van de Wetering, Koen] Netherlands Canc Inst, Div Mol Oncol, NL-1066 CX Amsterdam, Netherlands	Netherlands Cancer Institute	van de Wetering, K (corresponding author), Div Mol Oncol, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands.	k.vd.wetering@nki.nl	Jansen, Robert/AAR-1318-2021	Jansen, Robert/0000-0001-9612-2798				Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Ashraf Tamima, 2014, Adv Pharmacol, V71, P45, DOI 10.1016/bs.apha.2014.06.010; Belinsky MG, 1998, J NATL CANCER I, V90, P1735, DOI 10.1093/jnci/90.22.1735; Berger M L, 1986, Adv Exp Med Biol, V203, P199; Bergeron R, 2012, CURR MED CHEM, V19, P1360, DOI 10.2174/092986712799462685; Bocker S, 2009, BIOINFORMATICS, V25, P218, DOI 10.1093/bioinformatics/btn603; Borst P, 2007, PFLUG ARCH EUR J PHY, V453, P661, DOI 10.1007/s00424-006-0054-9; Collard F, 2011, J BIOL CHEM, V286, P38220, DOI 10.1074/jbc.M111.287318; Collard F, 2010, J BIOL CHEM, V285, P29826, DOI 10.1074/jbc.M110.152629; Coyle JT, 1997, NEUROBIOL DIS, V4, P231, DOI 10.1006/nbdi.1997.0153; CULLINAN WE, 1995, NEUROSCIENCE, V64, P477, DOI 10.1016/0306-4522(94)00355-9; Dallas S, 2006, PHARMACOL REV, V58, P140, DOI 10.1124/pr.58.2.3; Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8; de Wolf CJF, 2007, FEBS J, V274, P439, DOI 10.1111/j.1742-4658.2006.05591.x; Dean M, 2001, J BIOENERG BIOMEMBR, V33, P475, DOI 10.1023/A:1012823120935; El-Sheikh AAK, 2007, J PHARMACOL EXP THER, V320, P229, DOI 10.1124/jpet.106.110379; Gao Y, 2015, J NEUROCHEM, V134, P340, DOI 10.1111/jnc.13123; Garcia-Cairasco N, 2013, ANGEW CHEM INT EDIT, V52, P13067, DOI 10.1002/anie.201305382; Giacomini KM, 2010, NAT REV DRUG DISCOV, V9, P215, DOI 10.1038/nrd3028; Hamada-Kanazawa M, 2013, BIOL PHARM BULL, V36, P1068, DOI 10.1248/bpb.b12-00991; Hamada-Kanazawa M, 2010, BIOL PHARM BULL, V33, P729, DOI 10.1248/bpb.33.729; Han LQ, 2009, SYNAPSE, V63, P625, DOI 10.1002/syn.20649; Haug K, 2013, NUCLEIC ACIDS RES, V41, pD781, DOI 10.1093/nar/gks1004; Horai H, 2010, J MASS SPECTROM, V45, P703, DOI 10.1002/jms.1777; Jansen RS, 2015, P NATL ACAD SCI USA, V112, P6601, DOI 10.1073/pnas.1424638112; Jansen RS, 2013, P NATL ACAD SCI USA, V110, P20206, DOI 10.1073/pnas.1319582110; Jedlitschky G, 2000, J BIOL CHEM, V275, P30069, DOI 10.1074/jbc.M005463200; Kool M, 1997, CANCER RES, V57, P3537; Korolnek T, 2014, CELL METAB, V19, P1008, DOI 10.1016/j.cmet.2014.03.030; KROGSGAARDLARSEN P, 1992, TOXICOL LETT, V64-5, P409, DOI 10.1016/0378-4274(92)90214-5; Krumpochova P, 2012, FASEB J, V26, P738, DOI 10.1096/fj.11-195743; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Lerea LS, 1997, CELL SIGNAL, V9, P219, DOI 10.1016/S0898-6568(96)00134-9; Lodder-Gadaczek J, 2013, BIOCHEM J, V454, P31, DOI 10.1042/BJ20130300; Lodder-Gadaczek J, 2011, J BIOL CHEM, V286, P16693, DOI 10.1074/jbc.M111.230136; Loos M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108563; McAleer MA, 1999, J BIOL CHEM, V274, P23541, DOI 10.1074/jbc.274.33.23541; MIYAKE M, 1982, BIOCHIM BIOPHYS ACTA, V719, P495, DOI 10.1016/0304-4165(82)90238-0; MIYAKE M, 1992, J NEUROCHEM, V59, P1654, DOI 10.1111/j.1471-4159.1992.tb10995.x; MIYAKE M, 1978, BIOCHIM BIOPHYS ACTA, V544, P656, DOI 10.1016/0304-4165(78)90340-9; MIYAKE M, 1981, J NEUROCHEM, V37, P1064, DOI 10.1111/j.1471-4159.1981.tb04500.x; Mourskaia AA, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3361; Narahara M, 2000, BIOL PHARM BULL, V23, P704; Narahara M, 2010, BIOL PHARM BULL, V33, P1938, DOI 10.1248/bpb.33.1938; Neale JH, 2000, J NEUROCHEM, V75, P443, DOI 10.1046/j.1471-4159.2000.0750443.x; Neale JH, 2011, J NEUROCHEM, V118, P490, DOI 10.1111/j.1471-4159.2011.07338.x; Nies AT, 2004, NEUROSCIENCE, V129, P349, DOI 10.1016/j.neuroscience.2004.07.051; Nongpiur ME, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004089; Okuno H, 2011, NEUROSCI RES, V69, P175, DOI 10.1016/j.neures.2010.12.007; OLNEY JW, 1994, NEUROTOXICOLOGY, V15, P535; Patti GJ, 2012, NAT PROTOC, V7, P508, DOI 10.1038/nprot.2011.454; Plechanovova A, 2011, J MED CHEM, V54, P7535, DOI 10.1021/jm200807m; PRESTON E, 1991, CAN J NEUROL SCI, V18, P39, DOI 10.1017/S0317167100031279; Rasche F, 2011, ANAL CHEM, V83, P1243, DOI 10.1021/ac101825k; Reid G, 2003, MOL PHARMACOL, V63, P1094, DOI 10.1124/mol.63.5.1094; Rowland LM, 2013, SCHIZOPHRENIA BULL, V39, P1096, DOI 10.1093/schbul/sbs092; Sacha P, 2007, NEUROSCIENCE, V144, P1361, DOI 10.1016/j.neuroscience.2006.10.022; Slusher BS, 1999, NAT MED, V5, P1396, DOI 10.1038/70971; Smith CA, 2006, ANAL CHEM, V78, P779, DOI 10.1021/ac051437y; Smith CA, 2005, THER DRUG MONIT, V27, P747, DOI 10.1097/01.ftd.0000179845.53213.39; Soontornmalai A, 2006, NEUROSCIENCE, V138, P159, DOI 10.1016/j.neuroscience.2005.11.011; Soriano MA, 2000, J CEREBR BLOOD F MET, V20, P1045, DOI 10.1097/00004647-200007000-00004; Stone TW, 1998, ADV EXP MED BIOL, V431, P185; Tautenhahn R, 2011, ANAL CHEM, V83, P696, DOI 10.1021/ac102980g; TSUMORI M, 1995, EXP EYE RES, V61, P403, DOI 10.1016/S0014-4835(05)80135-6; van de Wetering K, 2007, MOL PHARMACOL, V72, P387, DOI 10.1124/mol.107.035592; van de Wetering K, 2012, FASEB J, V26, P4014, DOI 10.1096/fj.12-210039; Van De Wetering K, 2009, GASTROENTEROLOGY, V137, P1725, DOI 10.1053/j.gastro.2009.06.052; VandenBerghe G, 1997, J INHERIT METAB DIS, V20, P193, DOI 10.1023/A:1005304722259; Wielinga P, 2005, CANCER RES, V65, P4425, DOI 10.1158/0008-5472.CAN-04-2810; Wijnholds J, 2000, P NATL ACAD SCI USA, V97, P7476, DOI 10.1073/pnas.120159197; WILLIAMSON LC, 1988, BRAIN RES, V475, P151, DOI 10.1016/0006-8993(88)90209-0; Wishart DS, 2009, NUCLEIC ACIDS RES, V37, pD603, DOI 10.1093/nar/gkn810; Zhang Y, 2004, J PHARMACOL EXP THER, V311, P449, DOI 10.1124/jpet.104.068528; Zhou J, 2005, NAT REV DRUG DISCOV, V4, P1015, DOI 10.1038/nrd1903; Zikanova M, 2005, J INHERIT METAB DIS, V28, P493, DOI 10.1007/s10545-005-0493-z; Zuo DY, 2012, J BIOL CHEM, V287, P21773, DOI 10.1074/jbc.M112.363226	77	31	31	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2015	290	51					30429	30440		10.1074/jbc.M115.692103	http://dx.doi.org/10.1074/jbc.M115.692103			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CY9PG	26515061	Green Published, hybrid			2022-12-26	WOS:000366738200020
J	Massenet, D; Yvon, JF; Couteaux, C; Goarant, C				Massenet, Denis; Yvon, Jean-Francois; Couteaux, Clement; Goarant, Cyrille			An Unprecedented High Incidence of Leptospirosis in Futuna, South Pacific, 2004-2014, Evidenced by Retrospective Analysis of Surveillance Data	PLOS ONE			English	Article							RISK-FACTORS	Futuna is a small Polynesian island in the South Pacific with a population of 3,612 in 2013. The first human leptospirosis case was confirmed in 1997. Active surveillance started in 2004. Cases were confirmed by PCR or real time PCR, or by serology using MAT or a combination of IgM-ELISA and MAT. A retrospective analysis of surveillance data shows that the disease was endemic with a mean annual incidence of 844 cases per 100,000 over an 11-year period from 2004 to 2014. An epidemic peak as high as 1,945 cases per 100,000 occurred in 2008. Serogroup Australis was predominant until 2007, Icterohaemorrhagiae was dominant afterwards. Cluster analysis revealed different hot spots over time. Lifestyle habits, such as walking barefoot in irrigated taro fields or pig pens probably contributed to contamination from the swine and rodent reservoirs to humans. Severe forms were rare, and the case fatality rate was 0.5%. The medical community and general population were aware of leptospirosis and rapid treatment with amoxycillin was the main treatment, probably contributing to this low fatality rate.	[Massenet, Denis; Yvon, Jean-Francois; Couteaux, Clement] Agence Sante Iles Wallis & Futuna, Hop SIA, Med Biol Lab, Matautu 98600, Wallis & Futuna, France; [Yvon, Jean-Francois] Lab Ducos, Noumea 98846, New Caledonia; [Goarant, Cyrille] Inst Pasteur New Caledonia, Inst Pasteur Int Network, Leptospirosis Res & Expertise Unit, Noumea 98845, New Caledonia		Goarant, C (corresponding author), Inst Pasteur New Caledonia, Inst Pasteur Int Network, Leptospirosis Res & Expertise Unit, 9-11 Ave Paul Doumer,BP 61, Noumea 98845, New Caledonia.	cgoarant@pasteur.nc	Goarant, Cyrille/D-4267-2018	Goarant, Cyrille/0000-0002-0690-9464	French Fonds de Cooperation economique, sociale et culturelle pour le Pacifique [1134, 1161, 1277]; French Ministry for Research	French Fonds de Cooperation economique, sociale et culturelle pour le Pacifique; French Ministry for Research(Ministry of Research, France)	This study was funded by grant numbers 1134, 1161 and 1277 from the French Fonds de Cooperation economique, sociale et culturelle pour le Pacifique and the French Ministry for Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1999, Wkly Epidemiol Rec, V74, P237; [Anonymous], 2003, HUM LEPT GUID DIAGN; Berlioz-Arthaud A, 2007, T ROY SOC TROP MED H, V101, P714, DOI 10.1016/j.trstmh.2007.02.022; Bovet P, 1999, INT J EPIDEMIOL, V28, P583, DOI 10.1093/ije/28.3.583; Coudert C, 2007, Med Trop (Mars), V67, P137; Desvars A, 2013, VET RES, V44, DOI 10.1186/1297-9716-44-80; Desvars A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020377; Felzemburgh RDM, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002927; Goarant C, 2009, TROP MED INT HEALTH, V14, P926, DOI 10.1111/j.1365-3156.2009.02310.x; Guimaraes RM, 2014, CIENC SAUDE COLETIVA, V19, P3683, DOI 10.1590/1413-81232014199.06432014; Hirschauer C., 2009, Bulletin Epidemiologique Hebdomadaire, P508; Katz AR, 2011, EMERG INFECT DIS, V17, P221, DOI 10.3201/eid1702.101109; KULLDORFF M, 1995, STAT MED, V14, P799, DOI 10.1002/sim.4780140809; Lau CL, 2012, AM J TROP MED HYG, V86, P309, DOI 10.4269/ajtmh.2012.11-0398; Levett PN, 2001, CLIN MICROBIOL REV, V14, P296, DOI 10.1128/CMR.14.2.296-326.2001; Lhomme V, 1996, MED MALADIES INFECT, V26, P94, DOI 10.1016/S0399-077X(96)80161-2; Merien F, 2005, FEMS MICROBIOL LETT, V249, P139, DOI 10.1016/j.femsle.2005.06.011; MERIEN F, 1992, J CLIN MICROBIOL, V30, P2219; Pappas G, 2008, INT J INFECT DIS, V12, P351, DOI 10.1016/j.ijid.2007.09.011; Perez J, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-325; SASAKI DM, 1993, AM J TROP MED HYG, V48, P35, DOI 10.4269/ajtmh.1993.48.35; Stoddard RA, 2009, DIAGN MICR INFEC DIS, V64, P247, DOI 10.1016/j.diagmicrobio.2009.03.014; Theuerkauf J, 2013, NATURWISSENSCHAFTEN, V100, P385, DOI 10.1007/s00114-013-1033-6; Tubiana S, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0001991; Victoriano AFB, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-147; Weinberger D, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002798	26	13	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2015	10	11							e0142063	10.1371/journal.pone.0142063	http://dx.doi.org/10.1371/journal.pone.0142063			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV1QH	26528546	gold, Green Published, Green Submitted			2022-12-26	WOS:000364032600095
J	Passos, CLA; Ferreira, C; Soares, DC; Saraiva, EM				Alves Passos, Carlos Luan; Ferreira, Christian; Soares, Deivid Costa; Saraiva, Elvira Maria			Leishmanicidal Effect of Synthetic trans-Resveratrol Analogs	PLOS ONE			English	Article							IN-VITRO; PICEATANNOL; OXYRESVERATROL; PTEROSTILBENE; MILTEFOSINE; DERIVATIVES; APOPTOSIS; ASSAY	Background Stilbene-based compounds show antitumoral, antioxidant, antihistaminic, anti-inflammatory and antimicrobial activities. Here, we evaluated the effect of the trans-resveratrol analogs, pterostilbene, piceatannol, polydatin and oxyresveratrol, against Leishmania amazonensis. Methodology/Principal Findings Our results demonstrated a low murine macrophage cytotoxicity of all four analogs. Moreover, pterostilbene, piceatannol, polydatin and oxyresveratrol showed an anti-L. amazonensis activity with IC50 values of 18 mu M, 65 mu M, 95 mu M and 65 mu M for promastigotes, respectively. For intracellular amastigotes, the IC50 values of the analogs were 33.2 mu M, 45 mu M, 29 mu M and 30.5 mu M, respectively. Among the analogs assayed only piceatannol altered the cell cycle of the parasite, increasing 5-fold the cells in the Sub-G0 phase and decreasing 1.7-fold the cells in the G0-G1 phase. Piceatannol also changed the parasite mitochondrial membrane potential (Delta psi m) and increased the number of annexin-V positive promastigotes, which suggests incidental death. Conclusion/Significance Among the analogs tested, piceatannol, which is a metabolite of resveratrol, was the more promising candidate for future studies regarding treatment of leishmaniasis.	[Alves Passos, Carlos Luan; Ferreira, Christian; Soares, Deivid Costa; Saraiva, Elvira Maria] Univ Fed Rio de Janeiro, Inst Microbiol Paulo Goes, BR-21941 Rio De Janeiro, RJ, Brazil	Universidade Federal do Rio de Janeiro	Saraiva, EM (corresponding author), Univ Fed Rio de Janeiro, Inst Microbiol Paulo Goes, BR-21941 Rio De Janeiro, RJ, Brazil.	esaraiva@micro.ufrj.br	Saraiva, Elvira M/L-2864-2017; Ferreira, Christian/P-7358-2015	Saraiva, Elvira M/0000-0002-6388-5286; Ferreira, Christian/0000-0003-0504-0354	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [404245/2012-9, 308236]; Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro [E26/203638/2014, E26/102271/2010]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	This work was supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, http://www.cnpq.br, 404245/2012-9, 308236 to EMS; and Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro, http://www.faperj.br, E26/203638/2014 to EMS and E26/102271/2010 to DCS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alosi JA, 2010, J SURG RES, V161, P195, DOI 10.1016/j.jss.2009.07.027; Alvar J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035671; Ambit A, 2008, CELL DEATH DIFFER, V15, P113, DOI 10.1038/sj.cdd.4402232; Andrews KT, 2014, INT J PARASITOL-DRUG, V4, P95, DOI 10.1016/j.ijpddr.2014.02.002; BARRAL A, 1991, AM J TROP MED HYG, V44, P536, DOI 10.4269/ajtmh.1991.44.536; Chung KO, 2003, J PHARM PHARMACOL, V55, P1695, DOI 10.1211/0022357022313; Croft SL, 2006, INDIAN J MED RES, V123, P399; Delorenzi JC, 2002, ANTIMICROB AGENTS CH, V46, P2111, DOI 10.1128/AAC.46.7.2111-2115.2002; Duarte N, 2008, PHYTOTHER RES, V22, P455, DOI 10.1002/ptr.2334; Fabris S, 2008, BIOPHYS CHEM, V135, P76, DOI 10.1016/j.bpc.2008.03.005; Ferreira C, 2011, PHYTOCHEMISTRY, V72, P2155, DOI 10.1016/j.phytochem.2011.08.006; Ferreira C, 2014, ANTIMICROB AGENTS CH, V58, P6197, DOI 10.1128/AAC.00093-14; GEAHLEN RL, 1989, BIOCHEM BIOPH RES CO, V165, P241, DOI 10.1016/0006-291X(89)91060-7; Hsu CL, 2013, J AGR FOOD CHEM, V61, P602, DOI 10.1021/jf304487v; Jang DS, 1999, BIOCHEM PHARMACOL, V57, P705, DOI 10.1016/S0006-2952(98)00350-5; Kadam R. U., 2007, Indian Journal of Pharmaceutical Sciences, V69, P609; Kim HJ, 2008, J NUTR BIOCHEM, V19, P459, DOI 10.1016/j.jnutbio.2007.06.001; Kita Y, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/672416; Lanzilli G, 2012, INFLAMMATION, V35, P240, DOI 10.1007/s10753-011-9310-z; Lipinski CA, 2001, ADV DRUG DELIVER REV, V46, P3, DOI 10.1016/S0169-409X(00)00129-0; Liu LT, 2012, CHIN J INTEGR MED, V18, P714, DOI 10.1007/s11655-012-1060-8; Lorenz P, 2003, NITRIC OXIDE-BIOL CH, V9, P64, DOI 10.1016/j.niox.2003.09.005; Marchal J, 2013, ANN NY ACAD SCI, V1290, P67, DOI 10.1111/nyas.12214; McCormack D, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/575482; Ouellette M, 2004, DRUG RESIST UPDATE, V7, P257, DOI 10.1016/j.drup.2004.07.002; Perecko T, 2008, NEUROENDOCRINOL LETT, V29, P802; Pinheiro LCS, 2012, J MICROBIOL ANTIMICR, V41, P32; Piotrowska H, 2012, MUTAT RES-REV MUTAT, V750, P60, DOI 10.1016/j.mrrev.2011.11.001; Piver B, 2004, BIOCHEM PHARMACOL, V68, P773, DOI 10.1016/j.bcp.2004.05.008; Potter GA, 2002, BRIT J CANCER, V86, P774, DOI 10.1038/sj.bjc.6600197; Poulsen MM, 2013, ANN NY ACAD SCI, V1290, P74, DOI 10.1111/nyas.12141; Qureshi AA, 2012, LIPIDS HEALTH DIS, V11, DOI 10.1186/1476-511X-11-76; Ravagnan G, 2013, INFLAMMATION, V36, P26, DOI 10.1007/s10753-012-9516-8; ROEHM NW, 1991, J IMMUNOL METHODS, V142, P257, DOI 10.1016/0022-1759(91)90114-U; Sanchez-Canete MP, 2009, ANTIMICROB AGENTS CH, V53, P1305, DOI 10.1128/AAC.01694-08; SCUDIERO DA, 1988, CANCER RES, V48, P4827; Sindermann H, 2006, T ROY SOC TROP MED H, V100, pS17, DOI 10.1016/j.trstmh.2006.02.010; Soares DC, 2010, PARASITOL INT, V59, P173, DOI 10.1016/j.parint.2010.01.002; Tolomeo M, 2013, EXP PARASITOL, V133, P37, DOI 10.1016/j.exppara.2012.10.006	39	21	21	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2015	10	10							e0141778	10.1371/journal.pone.0141778	http://dx.doi.org/10.1371/journal.pone.0141778			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0EH	26517558	Green Published, Green Submitted, gold			2022-12-26	WOS:000363920800075
J	Rashid, MU; Muzaffar, M; Khan, FA; Kabisch, M; Muhammad, N; Faiz, S; Loya, A; Hamann, U				Rashid, Muhammad Usman; Muzaffar, Merium; Khan, Faiz Ali; Kabisch, Maria; Muhammad, Noor; Faiz, Sabeen; Loya, Asif; Hamann, Ute			Association between the BsmI Polymorphism in the Vitamin D Receptor Gene and Breast Cancer Risk: Results from a Pakistani Case-Control Study	PLOS ONE			English	Article							UK CAUCASIAN POPULATION; AFRICAN-AMERICAN WOMEN; BONE-MINERAL DENSITY; D PATHWAY; COMPREHENSIVE METAANALYSIS; TRANSCRIPTIONAL ACTIVATION; CONSANGUINEOUS MARRIAGE; POSTMENOPAUSAL WOMEN; OVARIAN-CANCER; MUTATIONS	Background Vitamin D is postulated to decrease the risk of breast cancer by inhibiting cell proliferation via the vitamin D receptor (VDR). Two common single nucleotide polymorphisms (SNPs) in the VDR gene, rs1544410 (BsmI) and rs2228570 (FokI), are inconsistently associated with breast cancer risk in Caucasian populations, while data for Asians are scarce. Here, we investigated the possible contribution of these SNPs to breast cancer risk in Pakistani breast cancer patients and in controls participating in a hospital-based breast cancer case-control study (PAK-BCCC). Methods Genotyping of the BsmI and FokI SNPs was performed by PCR-based restriction fragment length polymorphism (RFLP) analysis of 463 genetically enriched female breast cancer cases with known BRCA1/2 status and in 1,012 controls from Pakistan. The association between SNP genotypes and breast cancer risk was investigated by logistic regression adjusted for potential breast cancer risk factors and stratified by BRCA1/2 status and family history. Odds ratios (ORs) and 95% confidence intervals (CIs) were reported. Results The b allele of the BsmI was associated with an increased breast cancer risk (per b allele OR 1.28, 95% CI 1.09-1.49, P = 0.003). Subgroup analysis revealed that this effect was restricted to BRCA1/2 non-carriers (per b allele OR 1.33, 95% CI 1.11-1.59, P = 0.002) and was stronger in those who reported a positive family history of breast and/or ovarian cancer (per b allele OR 1.64, 95% CI 1.20-2.22, P = 0.002). No association with breast cancer risk was detected for the FokI SNP. Conclusions The BsmI polymorphism in the VDR gene may be associated with an increased breast cancer risk in Pakistani women negative for BRCA1/2 germline mutations.	[Rashid, Muhammad Usman; Muzaffar, Merium; Khan, Faiz Ali; Muhammad, Noor; Faiz, Sabeen] SKMCH & RC, Dept Basic Sci Res, Lahore, Pakistan; [Rashid, Muhammad Usman] Univ Hlth Sci, Dept Human Genet & Mol Biol, Lahore, Pakistan; [Rashid, Muhammad Usman; Kabisch, Maria; Hamann, Ute] German Canc Res Ctr, Mol Genet Breast Canc, Heidelberg, Germany; [Muzaffar, Merium] Univ Hlth Sci, Dept Physiol, Lahore, Pakistan; [Loya, Asif] SKMCH & RC, Dept Pathol, Lahore, Pakistan	Shaukat Khanum Memorial Cancer Hospital & Research Centre; University of Health Science - Pakistan; Helmholtz Association; German Cancer Research Center (DKFZ); University of Health Science - Pakistan; Shaukat Khanum Memorial Cancer Hospital & Research Centre	Hamann, U (corresponding author), German Canc Res Ctr, Mol Genet Breast Canc, Heidelberg, Germany.	hamann@dkfz-heidelberg.de	Muhammad, Noor/GYD-7914-2022; Muhammad, Noor/B-3611-2017	Muhammad, Noor/0000-0001-6811-5064; Rashid, Muhammad Usman/0000-0002-7684-3122	Shaukat Khanum Memorial Cancer Hospital and Research Centre, Lahore, Pakistan; German Cancer Research Center, Heidelberg, Germany	Shaukat Khanum Memorial Cancer Hospital and Research Centre, Lahore, Pakistan; German Cancer Research Center, Heidelberg, Germany	The study was supported by the Shaukat Khanum Memorial Cancer Hospital and Research Centre, Lahore, Pakistan and the German Cancer Research Center, Heidelberg, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas S, 2008, CARCINOGENESIS, V29, P93, DOI 10.1093/carcin/bgm240; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Antoniou AC, 2003, GENET EPIDEMIOL, V25, P190, DOI 10.1002/gepi.10261; Arai H, 1997, J BONE MINER RES, V12, P915, DOI 10.1359/jbmr.1997.12.6.915; Bhopal RS, 2014, EUR J PUBLIC HEALTH, V24, P862, DOI 10.1093/eurpub/ckt166; Bretherton-Watt D, 2001, BRIT J CANCER, V85, P171, DOI 10.1054/bjoc.2001.1864; Chen HK, 2013, BIOCHEM BIOPH RES CO, V430, P370, DOI 10.1016/j.bbrc.2012.11.003; Colston KW, 2008, BEST PRACT RES CL EN, V22, P587, DOI 10.1016/j.beem.2008.08.002; Crew KD, 2009, CANCER PREV RES, V2, P598, DOI 10.1158/1940-6207.CAPR-08-0138; Curran JE, 1999, INT J CANCER, V83, P723, DOI 10.1002/(SICI)1097-0215(19991210)83:6&lt;723::AID-IJC4&gt;3.0.CO;2-3; Deeb KK, 2007, NAT REV CANCER, V7, P684, DOI 10.1038/nrc2196; Dorjgochoo T, 2011, CANCER EPIDEM BIOMAR, V20, P2313, DOI 10.1158/1055-9965.EPI-11-0704; Feldman D, 2014, NAT REV CANCER, V14, P342, DOI 10.1038/nrc3691; Fuhrman BJ, 2013, ANTICANCER RES, V33, P543; Gnagnarella P, 2014, CARCINOGENESIS, V35, P1913, DOI 10.1093/carcin/bgu150; Gross C, 1996, J BONE MINER RES, V11, P1850; Guy M, 2004, CLIN CANCER RES, V10, P5472, DOI 10.1158/1078-0432.CCR-04-0206; Holvik K, 2005, EUR J CLIN NUTR, V59, P57, DOI 10.1038/sj.ejcn.1602033; Huang Y, 2012, J MED RES, V41, P89; Imtiaz Saba, 2012, Indian J Endocrinol Metab, V16, P409, DOI 10.4103/2230-8210.95684; Ingles SA, 2000, CANCER CAUSE CONTROL, V11, P25, DOI 10.1023/A:1008979417618; Ingles SA, 1997, CANCER EPIDEM BIOMAR, V6, P93; Iqbal R, 2013, JCPSP-J COLL PHYSICI, V23, P604, DOI 08.2013/JCPSP.604606; Jones G, 1998, PHYSIOL REV, V78, P1193, DOI 10.1152/physrev.1998.78.4.1193; Khan AA, 2009, AN INTERNATIONAL JOU, V24, P296; Kommagani R, 2007, J BIOL CHEM, V282, P29847, DOI 10.1074/jbc.M703641200; Lauridsen AL, 2005, CALCIFIED TISSUE INT, V77, P15, DOI 10.1007/s00223-004-0227-5; Lin R, 2004, BIOESSAYS, V26, P21, DOI 10.1002/bies.10368; Liu M, 1996, GENE DEV, V10, P142, DOI 10.1101/gad.10.2.142; Lopes N, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-483; Lowe LC, 2005, EUR J CANCER, V41, P1164, DOI 10.1016/j.ejca.2005.01.017; Lowe NM, 2010, BRIT J NUTR, V103, P1706, DOI 10.1017/S0007114509993850; Maruyama R, 2006, CANCER RES, V66, P4574, DOI 10.1158/0008-5472.CAN-05-2562; Mauss D, 2015, INT J MED SCI, V12, P362, DOI 10.7150/ijms.10540; McCullough ML, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1642; Mckay JD, 2009, CANCER EPIDEM BIOMAR, V18, P297, DOI 10.1158/1055-9965.EPI-08-0539; Mishra DK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057967; MORRISON NA, 1992, P NATL ACAD SCI USA, V89, P6665, DOI 10.1073/pnas.89.15.6665; National Institute of Population Studies (NIPS) [Pakistan] and ICF International, 2013, PAKISTAN DEMOGRAPHIC; Nezbedova P, 2004, Endocr Regul, V38, P29; Pfeifer M, 2001, J CLIN ENDOCR METAB, V86, P1633, DOI 10.1210/jc.86.4.1633; Raby BA, 2004, AM J RESP CRIT CARE, V170, P1057, DOI 10.1164/rccm.200404-447OC; Raimondi S, 2014, MUTAT RES-FUND MOL M, V769, P17, DOI 10.1016/j.mrfmmm.2014.06.001; Rashid MU, 2006, INT J CANCER, V119, P2832, DOI 10.1002/ijc.22269; Rashid MU, 2014, BREAST CANCER RES TR, V145, P775, DOI 10.1007/s10549-014-2972-0; Rashid MU, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-312; Rashid MU, 2012, FAM CANCER, V11, P307, DOI 10.1007/s10689-012-9509-7; Shahbazi S, 2013, MED ONCOL, V30, DOI 10.1007/s12032-012-0393-7; Sinotte M, 2008, ENDOCR-RELAT CANCER, V15, P975, DOI 10.1677/ERC-08-0056; Sthanadar AA, 2014, J BIOSOC SCI, V46, P698, DOI 10.1017/S0021932013000552; Tang CB, 2009, BREAST CANCER RES TR, V117, P391, DOI 10.1007/s10549-008-0262-4; Trabert B, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1833; Wang J, 2013, TUMOR BIOL, V34, P3823, DOI 10.1007/s13277-013-0967-9; Yao S, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3162; Ziegler A, 2011, BREAST CANCER RES TR, V128, P197, DOI 10.1007/s10549-010-1295-z	55	28	29	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2015	10	10							e0141562	10.1371/journal.pone.0141562	http://dx.doi.org/10.1371/journal.pone.0141562			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0EH	26517870	Green Published, gold, Green Submitted			2022-12-26	WOS:000363920800054
J	Pallisgaard, JL; Lindhardt, TB; Hansen, ML; Schjerning, AM; Olesen, JB; Staerk, L; Torp-Pedersen, C; Gislason, GH				Pallisgaard, Jannik Langtved; Lindhardt, Tommi Bo; Hansen, Morten Lock; Schjerning, Anne-Marie; Olesen, Jonas Bjerring; Staerk, Laila; Torp-Pedersen, Christian; Gislason, Gunnar Hilmar			Cardioversion and Risk of Adverse Events with Dabigatran versus Warfarin-A Nationwide Cohort Study	PLOS ONE			English	Article							ATRIAL-FIBRILLATION; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; EFFICACY; ANTICOAGULATION; SAFETY; THERAPY	Aim Cardioversion can rapidly and effectively restore sinus rhythm in patients with persistent atrial fibrillation. Since 2011 dabigatran has been available as an alternative to warfarin to prevent thromboembolic events in patients with non-valvular atrial fibrillation undergoing cardioversion. We studied time to cardioversion, risk of adverse events, and risk of readmission with atrial fibrillation after cardioversion according to anticoagulation therapy. Methods and Results Through the nationwide Danish registries we included 1,230 oral anticoagulation naive patients with first time non-valvular atrial fibrillation and first time cardioversion from 2011 to 2012; 37% in the dabigatran group (n = 456), and 63% in the warfarin group (n = 774). Median time to cardioversion was 4.0 (interquartile range [IQR] 2.9 to 6.5) and 6.9 (IQR 3.9 to 12.1) weeks in the dabigatran and warfarin groups respectively, and the adjusted odds ratio of cardioversion within the first 4 weeks was 2.3 (95% confidence interval [CI] 1.7 to 3.1) in favor of dabigatran. The cumulative incidence of composite endpoint of stroke, bleeding or death were 2.0% and 1.0% at 30 weeks in the warfarin and dabigatran groups respectively, with an adjusted hazard ratio of 1.33 (95% CI 0.33 to 5.42). Cumulative incidence of readmission with atrial fibrillation after 30 weeks were 9% and 11% in the warfarin and dabigatran groups, respectively, and an adjusted hazard ratio of 0.66 (95% CI 0.41 to 1.08). Conclusion Anticoagulation treatment with dabigatran allows shorter time to cardioversion for atrial fibrillation than warfarin, and appears to be an effective and safe alternative treatment strategy to warfarin.	[Pallisgaard, Jannik Langtved; Lindhardt, Tommi Bo; Hansen, Morten Lock; Schjerning, Anne-Marie; Olesen, Jonas Bjerring; Staerk, Laila; Gislason, Gunnar Hilmar] Univ Copenhagen, Gentofte Hosp, Dept Cardiol, Hellerup, Denmark; [Pallisgaard, Jannik Langtved; Lindhardt, Tommi Bo; Staerk, Laila; Gislason, Gunnar Hilmar] Univ Copenhagen, Fac Hlth & Med Sci, Copenhagen, Denmark; [Hansen, Morten Lock] Copenhagen Univ Hosp, Rigshosp, Ctr Heart, Copenhagen, Denmark; [Torp-Pedersen, Christian] Aalborg Univ, Inst Hlth Sci & Technol, Aalborg, Denmark; [Gislason, Gunnar Hilmar] Univ Southern Denmark, Natl Inst Publ Hlth, Copenhagen, Denmark; [Gislason, Gunnar Hilmar] Danish Heart Fdn, Copenhagen, Denmark	University of Copenhagen; Herlev & Gentofte Hospital; University of Copenhagen; Rigshospitalet; University of Copenhagen; Aalborg University; University of Southern Denmark	Pallisgaard, JL (corresponding author), Univ Copenhagen, Gentofte Hosp, Dept Cardiol, Hellerup, Denmark.	jannikjannik@gmail.com	Gislason, Gunnar/B-7561-2009; Pallisgaard, Jannik Langtved/S-9546-2019	Gislason, Gunnar/0000-0002-0548-402X; Pallisgaard, Jannik Langtved/0000-0002-8072-3318	Boehringer-Ingelheim; Novo Nordisk Foundation; Novo Nordisk Fonden [NNF12OC1015957] Funding Source: researchfish	Boehringer-Ingelheim(Boehringer Ingelheim); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Novo Nordisk Fonden(Novo Nordisk Foundation)	The study was supported by an unrestricted research grant from Boehringer-Ingelheim. The sponsor had no influence on the study design, interpretation of results or the decision to submit the paper for publication. Dr. Gislason is supported by an unrestricted clinical research scholarship from the Novo Nordisk Foundation.	Andersen TF, 1999, DAN MED BULL, V46, P263; ARNOLD AZ, 1992, J AM COLL CARDIOL, V19, P851, DOI 10.1016/0735-1097(92)90530-Z; Asher CR, 2002, CLEV CLIN J MED, V69, P713, DOI 10.3949/ccjm.69.9.713; BJERKELUND CJ, 1969, AM J CARDIOL, V23, P208, DOI 10.1016/0002-9149(69)90068-X; Camm AJ, 2012, EUR HEART J, V33; Cappato R, 2014, EUR HEART J, V35, P3346, DOI 10.1093/eurheartj/ehu367; Flaker G, 2014, J AM COLL CARDIOL, V63, P1082, DOI 10.1016/j.jacc.2013.09.062; Hijazi Z, 2014, CIRCULATION, V129, P961, DOI 10.1161/CIRCULATIONAHA.113.003628; January CT, 2014, J AM COLL CARDIOL, V64, pE1, DOI [10.1161/CIR.0000000000000041, 10.1016/j.jacc.2014.03.022, 10.1161/CIR.0000000000000142, 10.1016/j.jacc.2014.03.021]; Kildemoes HW, 2011, SCAND J PUBLIC HEALT, V39, P38, DOI 10.1177/1403494810394717; Klein AL, 2006, AM HEART J, V151, P380, DOI 10.1016/j.ahj.2005.07.011; Nagarakanti R, 2011, CIRCULATION, V123, P131, DOI 10.1161/CIRCULATIONAHA.110.977546; Olesen JB, 2011, BMJ, V342; Stellbrink C, 2004, CIRCULATION, V109, P997, DOI 10.1161/01.CIR.0000120509.64740.DC; WIJFFELS MCEF, 1995, CIRCULATION, V92, P1954, DOI 10.1161/01.CIR.92.7.1954	15	26	26	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2015	10	10							e0141377	10.1371/journal.pone.0141377	http://dx.doi.org/10.1371/journal.pone.0141377			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0ED	26513589	gold, Green Published, Green Submitted			2022-12-26	WOS:000363920300034
J	Hadzic, E; Catillon, M; Halavatyi, A; Medves, S; Van Troys, M; Moes, M; Baird, MA; Davidson, MW; Schaffner-Reckinger, E; Ampe, C; Friederich, E				Hadzic, Ermin; Catillon, Marie; Halavatyi, Aliaksandr; Medves, Sandrine; Van Troys, Marleen; Moes, Michele; Baird, Michelle A.; Davidson, Michael W.; Schaffner-Reckinger, Elisabeth; Ampe, Christophe; Friederich, Evelyne			Delineating the Tes Interaction Site in Zyxin and Studying Cellular Effects of Its Disruption	PLOS ONE			English	Article							FOCAL ADHESION PROTEIN; ACTIVATION; DOMAIN; CELLS; LOCALIZATION; RECRUITMENT; INHIBITION; COMPLEXITY; MECHANISM; PAXILLIN	Focal adhesions are integrin-based structures that link the actin cytoskeleton and the extracellular matrix. They play an important role in various cellular functions such as cell signaling, cell motility and cell shape. To ensure and fine tune these different cellular functions, adhesions are regulated by a large number of proteins. The LIM domain protein zyxin localizes to focal adhesions where it participates in the regulation of the actin cytoskeleton. Because of its interactions with a variety of binding partners, zyxin has been proposed to act as a molecular scaffold. Here, we studied the interaction of zyxin with such a partner: Tes. Similar to zyxin, Tes harbors three highly conserved LIM domains of which the LIM1 domain directly interacts with zyxin. Using different zyxin variants in pull-down assays and ectopic recruitment experiments, we identified the Tes binding site in zyxin and showed that four highly conserved amino acids are crucial for its interaction with Tes. Based upon these findings, we used a zyxin mutant defective in Tes-binding to assess the functional consequences of abrogating the zyxin-Tes interaction in focal adhesions. Performing fluorescence recovery after photobleaching, we showed that zyxin recruits Tes to focal adhesions and modulates its turnover in these structures. However, we also provide evidence for zyxin-independent localization of Tes to focal adhesions. Zyxin increases focal adhesion numbers and reduces focal adhesion lifetimes, but does so independent of Tes. Quantitative analysis showed that the loss of interaction between zyxin and Tes affects the process of cell spreading. We conclude that zyxin influences focal adhesion dynamics, that it recruits Tes and that this interaction is functional in regulating cell spreading.	[Hadzic, Ermin; Catillon, Marie; Halavatyi, Aliaksandr; Medves, Sandrine; Moes, Michele; Schaffner-Reckinger, Elisabeth; Friederich, Evelyne] Univ Luxembourg, Life Sci Res Unit, Lab Cytoskeleton & Cell Plast, Luxembourg, Luxembourg; [Van Troys, Marleen; Ampe, Christophe] Univ Ghent, Dept Biochem, B-9000 Ghent, Belgium; [Baird, Michelle A.; Davidson, Michael W.] Florida State Univ, Natl High Magnet Field Lab, Tallahassee, FL 32306 USA; [Baird, Michelle A.; Davidson, Michael W.] Florida State Univ, Dept Biol Sci, Tallahassee, FL 32306 USA	University of Luxembourg; Ghent University; State University System of Florida; Florida State University; State University System of Florida; Florida State University	Ampe, C (corresponding author), Univ Ghent, Dept Biochem, B-9000 Ghent, Belgium.	Christophe.Ampe@UGent.Be		Van Troys, Marleen/0000-0003-4283-8103; Christophe, Ampe/0000-0002-8554-3594	Fonds Wetenschappelijk Onderzoek-Flanders [3G035311]; Fonds National de la Recherche Luxembourg [INTER/FWO/10/01]; National Research Fund Luxembourg	Fonds Wetenschappelijk Onderzoek-Flanders(FWO); Fonds National de la Recherche Luxembourg(Luxembourg National Research Fund); National Research Fund Luxembourg(Luxembourg National Research Fund)	This project was supported by a bilateral grant from the Fonds Wetenschappelijk Onderzoek-Flanders (www.fwo.be) to CA (3G035311) and from the Fonds National de la Recherche Luxembourg (www.fnr.lu) to EF (INTER/FWO/10/01). EH and AH were supported by the PhD fellowships from the National Research Fund Luxembourg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babu SS, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003173; Bear JE, 2002, CELL, V109, P509, DOI 10.1016/S0092-8674(02)00731-6; Beckerle MC, 1997, BIOESSAYS, V19, P949, DOI 10.1002/bies.950191104; Berginski ME, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022025; Boeda B, 2007, MOL CELL, V28, P1071, DOI 10.1016/j.molcel.2007.10.033; Call SG, 2011, BIOCHEM BIOPH RES CO, V415, P485, DOI 10.1016/j.bbrc.2011.10.099; CHEN CA, 1988, BIOTECHNIQUES, V6, P632; Coutts AS, 2003, J CELL SCI, V116, P897, DOI 10.1242/jcs.00278; Drees B, 2000, J BIOL CHEM, V275, P22503, DOI 10.1074/jbc.M001698200; Drees BE, 1999, J CELL BIOL, V147, P1549, DOI 10.1083/jcb.147.7.1549; Fradelizi J, 2001, NAT CELL BIOL, V3, P699, DOI 10.1038/35087009; Garvalov BK, 2003, J CELL BIOL, V161, P33, DOI 10.1083/jcb.200211015; Geiger B, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005033; GOLDMAN R, 2005, LIVE CELL IMAGING LA; Griffith E, 2005, CELL MOTIL CYTOSKEL, V60, P140, DOI 10.1002/cm.20052; Griffith E, 2004, CELL MOTIL CYTOSKEL, V57, P133, DOI 10.1002/cm.10162; HIRAI KI, 1991, CLIN EXP METASTAS, V9, P517, DOI 10.1007/BF01768580; Hirata Hiroaki, 2008, Commun Integr Biol, V1, P192; Hoffman LM, 2012, MOL BIOL CELL, V23, P1846, DOI 10.1091/mbc.E11-12-1057; Hoffman LM, 2006, J CELL BIOL, V172, P771, DOI 10.1083/jcb.200512115; Lele TP, 2008, BIOCHEM BIOPH RES CO, V369, P929, DOI 10.1016/j.bbrc.2008.02.137; Li B, 2001, J BIOL CHEM, V276, P33328, DOI 10.1074/jbc.M100789200; Maritzen T, 2012, P NATL ACAD SCI USA, V109, P10382, DOI 10.1073/pnas.1206468109; Nguyen TN, 2010, J BIOL CHEM, V285, P35439, DOI 10.1074/jbc.M110.119487; Niebuhr K, 1997, EMBO J, V16, P5433, DOI 10.1093/emboj/16.17.5433; Nishiya N, 2001, MOL CELL BIOL, V21, P5332, DOI 10.1128/MCB.21.16.5332-5345.2001; Nix DA, 2001, J BIOL CHEM, V276, P34759, DOI 10.1074/jbc.M102820200; Phair RD, 2004, METHOD ENZYMOL, V375, P393; Reinhard M, 1999, J BIOL CHEM, V274, P13410, DOI 10.1074/jbc.274.19.13410; Smith MA, 2010, DEV CELL, V19, P365, DOI 10.1016/j.devcel.2010.08.008; Sun Z, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00472; Uemura A, 2011, BIOPHYS J, V101, P1069, DOI 10.1016/j.bpj.2011.08.001; van der Gaag EJ, 2002, J INVEST DERMATOL, V118, P246, DOI 10.1046/j.0022-202x.2001.01657.x; Webb DJ, 2004, NAT CELL BIOL, V6, P154, DOI 10.1038/ncb1094; Wojtowicz A, 2010, CIRC RES, V107, P898, DOI 10.1161/CIRCRESAHA.110.227850; Wolfenson H, 2011, J CELL SCI, V124, P1425, DOI 10.1242/jcs.077388; Xu F, 2010, NAGOYA J MED SCI, V72, P139; Yeh YC, 2009, J CELL PHYSIOL, V218, P146, DOI 10.1002/jcp.21578; Zaidel-Bar R, 2004, BIOCHEM SOC T, V32, P416, DOI 10.1042/BST0320416; Zaidel-Bar R, 2007, NAT CELL BIOL, V9, P858, DOI 10.1038/ncb0807-858; Zamir E, 2001, J CELL SCI, V114, P3583; Zamir E, 1999, J CELL SCI, V112, P1655	42	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2015	10	10							e0140511	10.1371/journal.pone.0140511	http://dx.doi.org/10.1371/journal.pone.0140511			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0DL	26509500	Green Published, gold			2022-12-26	WOS:000363918100032
J	Li, XY; Cheng, JY; Zhang, J; da Silva, JAT; Wang, CX; Sun, HM				Li, XueYan; Cheng, JinYun; Zhang, Jing; da Silva, Jaime A. Teixeira; Wang, ChunXia; Sun, HongMei			Validation of Reference Genes for Accurate Normalization of Gene Expression in Lilium davidii var. unicolor for Real Time Quantitative PCR	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; RT-PCR; TRANSCRIPTION FACTOR; HOUSEKEEPING GENES; SELECTION; IDENTIFICATION; OVEREXPRESSION; LONGIFLORUM; TISSUE; BULBS	Lilium is an important commercial market flower bulb. qRT-PCR is an extremely important technique to track gene expression levels. The requirement of suitable reference genes for normalization has become increasingly significant and exigent. The expression of internal control genes in living organisms varies considerably under different experimental conditions. For economically important Lilium, only a limited number of reference genes applied in qRT-PCR have been reported to date. In this study, the expression stability of 12 candidate genes including alpha-TUB, beta-TUB, ACT, eIF, GAPDH, UBQ, UBC, 18S, 60S, AP4, FP, and RH2, in a diverse set of 29 samples representing different developmental processes, three stress treatments ( cold, heat, and salt) and different organs, has been evaluated. For different organs, the combination of ACT, GAPDH, and UBQ is appropriate whereas ACT together with AP4, or ACT along with GAPDH is suitable for normalization of leaves and scales at different developmental stages, respectively. In leaves, scales and roots under stress treatments, FP, ACT and AP4, respectively showed the most stable expression. This study provides a guide for the selection of a reference gene under different experimental conditions, and will benefit future research on more accurate gene expression studies in a wide variety of Lilium genotypes.	[Li, XueYan; Cheng, JinYun; Zhang, Jing; Wang, ChunXia; Sun, HongMei] Shenyang Agr Univ, Coll Hort, Educ Minist, Key Lab Protected Hort, Shenyang 110161, Liaoning Provin, Peoples R China	Shenyang Agricultural University	Sun, HM (corresponding author), Shenyang Agr Univ, Coll Hort, Educ Minist, Key Lab Protected Hort, Shenyang 110161, Liaoning Provin, Peoples R China.	hmbh@sina.com	Sun, Hongmei/CAF-0999-2022	Teixeira da Silva, Jaime A./0000-0003-3299-2772	China National Natural Science Foundation [30972023, 31171981]; Program for Excellent Talents in University of Liaoning province, China [LR2013029]	China National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Program for Excellent Talents in University of Liaoning province, China	China National Natural Science Foundation, Grant No. 30972023, 31171981, the Program for Excellent Talents in University of Liaoning province, China Grant No. LR2013029.	Amil-Ruiz F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070603; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Artico S, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-49; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Butte AJ, 2001, PHYSIOL GENOMICS, V7, P95, DOI 10.1152/physiolgenomics.2001.7.2.95; Carvalho K, 2010, ANAL BIOCHEM, V402, P197, DOI 10.1016/j.ab.2010.03.038; Chandna R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036918; Czechowski T, 2005, PLANT PHYSIOL, V139, P5, DOI 10.1104/pp.105.063743; de Almeida MR, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-73; Egawa C, 2006, GENES GENET SYST, V81, P77, DOI 10.1266/ggs.81.77; Fan CJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056573; Fu JX, 2013, MOL BREEDING, V31, P205, DOI 10.1007/s11032-012-9784-x; Galli V, 2015, GENE, V554, P205, DOI 10.1016/j.gene.2014.10.049; Gong BH, 2014, PLANT CELL REP, V33, P1519, DOI 10.1007/s00299-014-1635-2; Gupta K, 2014, MAR BIOTECHNOL, V16, P657, DOI 10.1007/s10126-014-9582-z; Gutierrez L, 2008, PLANT BIOTECHNOL J, V6, P609, DOI 10.1111/j.1467-7652.2008.00346.x; Hamo MLB, 2015, J PLANT PHYSIOL, V173, P72, DOI 10.1016/j.jplph.2014.09.015; Han H, 2009, J TIANJIN NORMAL U N, V29, P62; Han XJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043084; He H, 2014, GENES GENOM, V36, P497, DOI 10.1007/s13258-014-0185-x; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Hu RB, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-93; Imai T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086492; Jadhao KR, 2014, HEREDITARY GENET, V3, P3; Jain M, 2006, BIOCHEM BIOPH RES CO, V345, P646, DOI 10.1016/j.bbrc.2006.04.140; Kidokoro S, 2015, PLANT J, V81, P505, DOI 10.1111/tpj.12746; Kong FN, 2015, J APPL PHYCOL, V27, P1003, DOI 10.1007/s10811-014-0359-6; Lang V, 2015, PLANT MOL BIOL, V87, P69, DOI 10.1007/s11103-014-0261-2; Lee CS, 2011, J PLANT BIOL, V54, P159, DOI 10.1007/s12374-011-9152-0; Lee JM, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-8; Li HP, 2011, PLANT SCI, V181, P132, DOI 10.1016/j.plantsci.2011.04.014; Li HL, 2014, SCI HORTIC-AMSTERDAM, V168, P9, DOI 10.1016/j.scienta.2013.12.034; Li XY, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0358-4; Li XY, 2011, AFR J BIOTECHNOL, V10, P17907, DOI 10.5897/AJB10.2523; Lin YL, 2010, PLANT SCI, V178, P359, DOI 10.1016/j.plantsci.2010.02.005; LingFei X, 2009, SCI HORTIC-AMSTERDAM, V119, P458, DOI 10.1016/j.scienta.2008.08.026; Liu DS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046451; Lovdal T, 2009, ANAL BIOCHEM, V387, P238, DOI 10.1016/j.ab.2009.01.024; Luo HL, 2010, ANAL BIOCHEM, V404, P100, DOI 10.1016/j.ab.2010.05.002; Mallona I, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-4; Maroufi A, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-15; Matsukura S, 2010, MOL GENET GENOMICS, V283, P185, DOI 10.1007/s00438-009-0506-y; Migocka M, 2011, MOL BREEDING, V28, P343, DOI 10.1007/s11032-010-9487-0; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Pacifici S, 2015, J PLANT PHYSIOL, V173, P116, DOI 10.1016/j.jplph.2014.08.014; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Ray Debashree L, 2014, BMC Res Notes, V7, P304, DOI 10.1186/1756-0500-7-304; Reddy DS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078555; Remans T, 2008, PLANTA, V227, P1343, DOI 10.1007/s00425-008-0706-4; Saha P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106308; Schmidt GW, 2010, MOL GENET GENOMICS, V283, P233, DOI 10.1007/s00438-010-0511-1; Schmittgen TD, 2000, J BIOCHEM BIOPH METH, V46, P69, DOI 10.1016/S0165-022X(00)00129-9; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; [尚爱芹 Shang Aiqin], 2014, [园艺学报, Acta Horticulturae Sinica], V41, P149; Shi SG, 2012, IN VITRO CELL DEV-PL, V48, P1, DOI 10.1007/s11627-011-9383-2; Sun SK, 2014, BIOMED RES INT, V2015, P2; Tong ZG, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-71; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; VanGuilder HD, 2008, BIOTECHNIQUES, V44, P619, DOI 10.2144/000112776; Wan HJ, 2010, ANAL BIOCHEM, V399, P257, DOI 10.1016/j.ab.2009.12.008; Wang HB, 2015, SCI REP-UK, V5, DOI 10.1038/srep08094; Wei LB, 2013, PLANTA, V237, P873, DOI 10.1007/s00425-012-1805-9; Wong ML, 2005, BIOTECHNIQUES, V39, P75, DOI 10.2144/05391RV01; Xi ML, 2012, PLANT CELL REP, V31, P1043, DOI 10.1007/s00299-011-1222-8; Xu M, 2011, ANAL BIOCHEM, V408, P337, DOI 10.1016/j.ab.2010.08.044; Xu RY, 2006, SCI HORTIC-AMSTERDAM, V111, P68, DOI 10.1016/j.scienta.2006.08.004; Xu Y, 2015, ACTA PHYSIOL PLANT, V37, P1; Yamagishi M, 2012, MOL BREEDING, V30, P913, DOI 10.1007/s11032-011-9675-6; Ye X, 2015, SCI HORTIC-AMSTERDAM, V181, P182, DOI 10.1016/j.scienta.2014.10.027; Yeap WC, 2014, PLANT CELL TISS ORG, V116, P55, DOI 10.1007/s11240-013-0382-3; Zhang N, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/370530; Zhou XH, 2014, SCI HORTIC-AMSTERDAM, V176, P200, DOI 10.1016/j.scienta.2014.07.010; Zhou Y, 2012, THESIS HUAZHONG AGR	73	24	26	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2015	10	10							e0141323	10.1371/journal.pone.0141323	http://dx.doi.org/10.1371/journal.pone.0141323			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0DL	26509446	Green Submitted, Green Published, gold			2022-12-26	WOS:000363918100071
J	Magnusson, M; Lu, EX; Larsson, P; Ulfhammer, E; Bergh, N; Caren, H; Jern, S				Magnusson, Mia; Lu, Emma Xuchun; Larsson, Pia; Ulfhammer, Erik; Bergh, Niklas; Caren, Helena; Jern, Sverker			Dynamic Enhancer Methylation - A Previously Unrecognized Switch for Tissue-Type Plasminogen Activator Expression	PLOS ONE			English	Article							HUMAN ENDOTHELIAL-CELLS; DNA METHYLATION; GENE-EXPRESSION; IN-VIVO; 5-HYDROXYMETHYLCYTOSINE; IDENTIFICATION; PATTERNS; EPIGENETICS; MECHANISMS; BUTYRATE	Tissue-type plasminogen activator (t-PA), which is synthesized in the endothelial cells lining the blood vessel walls, is a key player in the fibrinolytic system protecting the circulation against occluding thrombus formation. Although classical gene regulation has been quite extensively studied in order to understand the mechanisms behind t-PA regulation, epigenetics, including DNA methylation, still is a largely unexplored field. The aim of this study was to establish the methylation pattern in the t-PA promoter and enhancer in non-cultured compared to cultured human umbilical vein endothelial cells (HUVECs), and to simultaneously examine the level of t-PA gene expression. Bisulphite sequencing was used to evaluate the methylation status, and real-time RT-PCR to determine the gene expression level. While the t-PA promoter was stably unmethylated, we surprisingly observed a rapid reduction in the amount of methylation in the enhancer during cell culturing. This demethylation was in strong negative correlation with a pronounced (by a factor of approximately 25) increase in t-PA gene expression levels. In this study, we show that the methylation level in the t-PA enhancer appears to act as a previously unrecognized switch controlling t-PA expression. Our findings, which suggest that DNA methylation is quite dynamic, have implications also for the interpretation of cell culture experiments in general, as well as in a wider biological context.	[Magnusson, Mia; Lu, Emma Xuchun; Larsson, Pia; Ulfhammer, Erik; Bergh, Niklas; Jern, Sverker] Univ Gothenburg, Sahlgrenska Acad, Inst Med, Dept Mol & Clin Med,Wallenberg Lab, Gothenburg, Sweden; [Caren, Helena] Univ Gothenburg, Sahlgrenska Acad, Inst Biomed, Dept Pathol,Sahlgrenska Canc Ctr, Gothenburg, Sweden	University of Gothenburg; University of Gothenburg	Caren, H (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Inst Biomed, Dept Pathol,Sahlgrenska Canc Ctr, Gothenburg, Sweden.	helena.caren@gu.se; sverker.jern@gu.se		Ulfhammer, Erik/0000-0002-6326-5175; Larsson, Pia/0000-0001-9115-4213; Caren, Helena/0000-0002-8584-555X	Swedish research council [521-2012-2392]; Swedish heart lung foundation [HLR 20110321]; ALF/LUA support at Sahlgrenska University Hospital; Emelle foundation	Swedish research council(Swedish Research CouncilEuropean Commission); Swedish heart lung foundation(Swedish Heart-Lung Foundation); ALF/LUA support at Sahlgrenska University Hospital; Emelle foundation	Funding provided by Swedish research council: 521-2012-2392 (http://www.vr.se/), SJ; Swedish heart lung foundation: HLR 20110321 (http://www.hjart-lungfonden.se/), SJ; ALF/LUA support at Sahlgrenska University Hospital, SJ; Emelle foundation, MM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aran D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-3-r21; ARTS J, 1995, BIOCHEM J, V310, P171, DOI 10.1042/bj3100171; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Branco MR, 2012, NAT REV GENET, V13, P7, DOI 10.1038/nrg3080; BULENS F, 1995, J BIOL CHEM, V270, P7167, DOI 10.1074/jbc.270.13.7167; Bulens F, 1997, J BIOL CHEM, V272, P663; Cedar H, 2009, NAT REV GENET, V10, P295, DOI 10.1038/nrg2540; Dunoyer-Geindre S, 2011, CARDIOVASC RES, V90, P457, DOI 10.1093/cvr/cvr028; Feil R, 2012, NAT REV GENET, V13, P97, DOI 10.1038/nrg3142; Feinberg AP, 2007, NATURE, V447, P433, DOI 10.1038/nature05919; FROMMER M, 1992, P NATL ACAD SCI USA, V89, P1827, DOI 10.1073/pnas.89.5.1827; Hill PS, 2014, GENOMICS, V104, P324, DOI 10.1016/j.ygeno.2014.08.012; Hrafnkelsdottir T, 2004, J THROMB HAEMOST, V2, P1960, DOI 10.1111/j.1538-7836.2004.00948.x; JAFFE EA, 1973, J CLIN INVEST, V52, P2745, DOI 10.1172/JCI107470; Jiang MH, 2010, LAB INVEST, V90, P282, DOI 10.1038/labinvest.2009.132; Kathiresan S, 2006, ARTERIOSCL THROM VAS, V26, P1405, DOI 10.1161/01.ATV.0000222011.13026.25; Klose RJ, 2006, TRENDS BIOCHEM SCI, V31, P89, DOI 10.1016/j.tibs.2005.12.008; KOOISTRA T, 1987, BIOCHEM J, V247, P605, DOI 10.1042/bj2470605; Kriaucionis S, 2009, SCIENCE, V324, P929, DOI 10.1126/science.1169786; Ladenvall P, 2002, THROMB HAEMOSTASIS, V87, P105; Ladenvall P, 2000, THROMB HAEMOSTASIS, V84, P150, DOI 10.1055/s-0037-1613990; Larsson P, 2013, J THROMB THROMBOLYS, V35, P185, DOI 10.1007/s11239-012-0831-6; Larsson P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031573; Leitch HG, 2013, NAT STRUCT MOL BIOL, V20, P311, DOI 10.1038/nsmb.2510; Patterson K, 2011, JOVE-J VIS EXP, DOI 10.3791/3170; Tjarnlund-Wolf A, 2006, J THROMB HAEMOST, V4, P1414, DOI 10.1111/j.1538-7836.2006.01936.x; VANDENEIJNDENSCHRAUWEN Y, 1995, BLOOD, V85, P3510, DOI 10.1182/blood.V85.12.3510.bloodjournal85123510; Varley KE, 2013, GENOME RES, V23, P555, DOI 10.1101/gr.147942.112; Wiench M, 2011, EMBO J, V30, P3028, DOI 10.1038/emboj.2011.210; Wilson GA, 2013, EPIGENETICS-US, V8, P953, DOI 10.4161/epi.25614; Wu H, 2014, CELL, V156, P45, DOI 10.1016/j.cell.2013.12.019; Wu H, 2011, GENE DEV, V25, P2436, DOI 10.1101/gad.179184.111; You JS, 2011, P NATL ACAD SCI USA, V108, P14497, DOI 10.1073/pnas.1111309108; Yu H, 2001, EUR J NEUROSCI, V14, P799, DOI 10.1046/j.0953-816x.2001.01700.x; Zhang XL, 2014, J NEUROCHEM, V128, P344, DOI 10.1111/jnc.12465; Ziller MJ, 2013, NATURE, V500, P477, DOI 10.1038/nature12433	36	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2015	10	10							e0141805	10.1371/journal.pone.0141805	http://dx.doi.org/10.1371/journal.pone.0141805			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0DL	26509603	gold, Green Published, Green Submitted			2022-12-26	WOS:000363918100133
J	Schultz, MT; Lance, RF				Schultz, Martin T.; Lance, Richard F.			Modeling the Sensitivity of Field Surveys for Detection of Environmental DNA (eDNA)	PLOS ONE			English	Article							OCCUPANCY; PARTICLE; CAPTURE; RARE; TOOL; CARP	The environmental DNA (eDNA) method is the practice of collecting environmental samples and analyzing them for the presence of a genetic marker specific to a target species. Little is known about the sensitivity of the eDNA method. Sensitivity is the probability that the target marker will be detected if it is present in the water body. Methods and tools are needed to assess the sensitivity of sampling protocols, design eDNA surveys, and interpret survey results. In this study, the sensitivity of the eDNA method is modeled as a function of ambient target marker concentration. The model accounts for five steps of sample collection and analysis, including: 1) collection of a filtered water sample from the source; 2) extraction of DNA from the filter and isolation in a purified elution; 3) removal of aliquots from the elution for use in the polymerase chain reaction (PCR) assay; 4) PCR; and 5) genetic sequencing. The model is applicable to any target species. For demonstration purposes, the model is parameterized for bighead carp (Hypophthalmichthys nobilis) and silver carp (H. molitrix) assuming sampling protocols used in the Chicago Area Waterway System (CAWS). Simulation results show that eDNA surveys have a high false negative rate at low concentrations of the genetic marker. This is attributed to processing of water samples and division of the extraction elution in preparation for the PCR assay. Increases in field survey sensitivity can be achieved by increasing sample volume, sample number, and PCR replicates. Increasing sample volume yields the greatest increase in sensitivity. It is recommended that investigators estimate and communicate the sensitivity of eDNA surveys to help facilitate interpretation of eDNA survey results. In the absence of such information, it is difficult to evaluate the results of surveys in which no water samples test positive for the target marker. It is also recommended that invasive species managers articulate concentration-based sensitivity objectives for eDNA surveys. In the absence of such information, it is difficult to design appropriate sampling protocols. The model provides insights into how sampling protocols can be designed or modified to achieve these sensitivity objectives.	[Schultz, Martin T.; Lance, Richard F.] US Army Corps Engn, Engn Res & Dev Ctr, Environm Lab, Vicksburg, MS 39180 USA	United States Department of Defense; United States Army; U.S. Army Corps of Engineers; U.S. Army Engineer Research & Development Center (ERDC)	Schultz, MT (corresponding author), US Army Corps Engn, Engn Res & Dev Ctr, Environm Lab, Vicksburg, MS 39180 USA.	Martin.T.Schultz@usace.army.mil			U.S. Environmental Protection Agency Great Lakes Restoration Initiative through the Asian Carp Regional Coordinating Committee; U.S. Army Corps of Engineers	U.S. Environmental Protection Agency Great Lakes Restoration Initiative through the Asian Carp Regional Coordinating Committee; U.S. Army Corps of Engineers(United States Department of DefenseUnited States Army)	This study was part of the Environmental DNA Calibration Study funded by the U.S. Environmental Protection Agency Great Lakes Restoration Initiative (http://greatlakesrestoration.us) through the Asian Carp Regional Coordinating Committee (http://www.asiancarp.us) and the U.S. Army Corps of Engineers. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen Bing-Yuan, 2002, Methods Mol Biol, V192, P19; Chick JH, 2001, SCIENCE, V292, P2250, DOI 10.1126/science.292.5525.2250; Darling JA, 2011, ENVIRON RES, V111, P978, DOI 10.1016/j.envres.2011.02.001; Deiner K, 2015, BIOL CONSERV, V183, P53, DOI 10.1016/j.biocon.2014.11.018; Dejean T, 2012, J APPL ECOL, V49, P953, DOI 10.1111/j.1365-2664.2012.02171.x; Diaz-Ferguson EE, 2014, REV BIOL TROP, V62, P1273, DOI 10.15517/rbt.v62i4.13231; DIEFFENBACH CW, 1993, PCR METH APPL, V3, pS30; Eichmiller JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112611; ELSHAARAWI AH, 1981, APPL ENVIRON MICROB, V41, P107, DOI 10.1128/AEM.41.1.107-116.1981; Emelko MB, 2010, ENVIRON SCI TECHNOL, V44, P1720, DOI 10.1021/es902382a; Farrington HL, 2014, ECOSYST MANAG REST, V12; Ficetola GF, 2015, MOL ECOL RESOUR, V15, P543, DOI 10.1111/1755-0998.12338; Ficetola GF, 2008, BIOL LETTERS, V4, P423, DOI 10.1098/rsbl.2008.0118; Goldberg CS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022746; HAAS CN, 1986, WATER RES, V20, P525, DOI 10.1016/0043-1354(86)90203-4; Hayward MW, 2015, J APPL ECOL, V52, P286, DOI 10.1111/1365-2664.12408; Jerde CL, 2011, CONSERV LETT, V4, P150, DOI 10.1111/j.1755-263X.2010.00158.x; Klymus KE, 2015, BIOL CONSERV, V183, P77, DOI 10.1016/j.biocon.2014.11.020; Kolar C.S., 2007, AM FISHERIES SOC SPE; Laramie MB, 2015, BIOL CONSERV, V183, P29, DOI 10.1016/j.biocon.2014.11.025; Machler E, 2014, FRESHW SCI, V33, P1174, DOI 10.1086/678128; Moyer GR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103767; Mumy KL, 2004, J MICROBIOL METH, V57, P259, DOI 10.1016/j.mimet.2004.01.013; Pilliod DS, 2013, CAN J FISH AQUAT SCI, V70, P1123, DOI 10.1139/cjfas-2013-0047; Rees HC, 2014, J APPL ECOL, V51, P1450, DOI 10.1111/1365-2664.12306; SANGER F, 1975, J MOL BIOL, V94, P441, DOI 10.1016/0022-2836(75)90213-2; Schmidt BR, 2013, METHODS ECOL EVOL, V4, P646, DOI 10.1111/2041-210X.12052; Spear SF, 2015, BIOL CONSERV, V183, P38, DOI 10.1016/j.biocon.2014.11.016; Thomsen PF, 2015, BIOL CONSERV, V183, P4, DOI 10.1016/j.biocon.2014.11.019; Thomsen PF, 2012, MOL ECOL, V21, P2565, DOI 10.1111/j.1365-294X.2011.05418.x; Turner CR, 2014, METHODS ECOL EVOL, V5, P676, DOI 10.1111/2041-210X.12206; Untergasser A, 2007, NUCLEIC ACIDS RES, V35, pW71, DOI 10.1093/nar/gkm306; Wilcox TM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059520; Yoccoz NG, 2012, MOL ECOL, V21, P2031, DOI 10.1111/j.1365-294X.2012.05505.x	34	32	32	0	81	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2015	10	10							e0141503	10.1371/journal.pone.0141503	http://dx.doi.org/10.1371/journal.pone.0141503			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0DL	26509674	Green Published, Green Submitted, gold			2022-12-26	WOS:000363918100094
J	Sturm, I; Dahne, S; Blankertz, B; Curio, G				Sturm, Irene; Daehne, Sven; Blankertz, Benjamin; Curio, Gabriel			Multi-Variate EEG Analysis as a Novel Tool to Examine Brain Responses to Naturalistic Music Stimuli	PLOS ONE			English	Article							SPEECH; ENVELOPE; TENSION; TIMBRE; SOUND; COMPONENTS; NETWORKS; MOVEMENT; FEATURES; RHYTHM	Note onsets in music are acoustic landmarks providing auditory cues that underlie the perception of more complex phenomena such as beat, rhythm, and meter. For naturalistic ongoing sounds a detailed view on the neural representation of onset structure is hard to obtain, since, typically, stimulus-related EEG signatures are derived by averaging a high number of identical stimulus presentations. Here, we propose a novel multivariate regression-based method extracting onset-related brain responses from the ongoing EEG. We analyse EEG recordings of nine subjects who passively listened to stimuli from various sound categories encompassing simple tone sequences, full-length romantic piano pieces and natural (non-music) soundscapes. The regression approach reduces the 61-channel EEG to one time course optimally reflecting note onsets. The neural signatures derived by this procedure indeed resemble canonical onset-related ERPs, such as the N1-P2 complex. This EEG projection was then utilized to determine the Cortico-Acoustic Correlation (CACor), a measure of synchronization between EEG signal and stimulus. We demonstrate that a significant CACor (i) can be detected in an individual listener's EEG of a single presentation of a full-length complex naturalistic music stimulus, and (ii) it co-varies with the stimuli's average magnitudes of sharpness, spectral centroid, and rhythmic complexity. In particular, the subset of stimuli eliciting a strong CACor also produces strongly coordinated tension ratings obtained from an independent listener group in a separate behavioral experiment. Thus musical features that lead to a marked physiological reflection of tone onsets also contribute to perceived tension in music.	[Sturm, Irene; Curio, Gabriel] Humboldt Univ, Berlin Sch Mind & Brain, D-10099 Berlin, Germany; [Sturm, Irene; Daehne, Sven; Blankertz, Benjamin] Tech Univ Berlin, Neurotechnol Grp, Berlin, Germany; [Sturm, Irene; Curio, Gabriel] Charite, Dept Neurol, Neurophys Grp, D-13353 Berlin, Germany; [Blankertz, Benjamin; Curio, Gabriel] Bernstein Focus Neurotechnol, Berlin, Germany; [Curio, Gabriel] Bernstein Ctr Computat Neurosci, Berlin, Germany	Humboldt University of Berlin; Technical University of Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Sturm, I (corresponding author), Humboldt Univ, Berlin Sch Mind & Brain, D-10099 Berlin, Germany.	irene.sturm@charite.de		Blankertz, Benjamin/0000-0002-2437-4846; Curio, Gabriel/0000-0002-3377-7735	Berlin School of Mind and Brain; Christiane-Nusslein-Volhard Foundation; German Federal Ministry of Education and Research (BMBF) [01GQ0850]	Berlin School of Mind and Brain; Christiane-Nusslein-Volhard Foundation; German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	Irene Sturm's work is supported by the Berlin School of Mind and Brain and by the Christiane-Nusslein-Volhard Foundation. The work of author Benjamin Blankertz was supported by a grant from the German Federal Ministry of Education and Research (BMBF) under contract # 01GQ0850.	Aiken SJ, 2008, EAR HEARING, V29, P139, DOI 10.1097/AUD.0b013e31816453dc; Aiken SJ, 2006, AUDIOL NEURO-OTOL, V11, P213, DOI 10.1159/000092589; Alluri V, 2012, NEUROIMAGE, V59, P3677, DOI 10.1016/j.neuroimage.2011.11.019; Askenfelt A., 1993, STL QPSR, V34, P15; Biessmann F, 2010, MACH LEARN, V79, P5, DOI 10.1007/s10994-009-5153-3; Blankertz B, 2011, NEUROIMAGE, V56, P814, DOI 10.1016/j.neuroimage.2010.06.048; Burger B, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00183; Cong FY, 2012, EUR SIGNAL PR CONF, P494; Ding N, 2014, FRONT HUM NEUROSCI, P8; Doelling KB, 2014, NEUROIMAGE, V85, P761, DOI 10.1016/j.neuroimage.2013.06.035; Eerola T., 2009, P 10 INT SOC MUS INF, P621; Farbood M, 2013, FRONT PSYCHOL, P4; Farbood MM, 2012, MUSIC PERCEPT, V29, P387, DOI 10.1525/MP.2012.29.4.387; Farbood MM, 2009, COMM COM INF SC, V38, P115; Farbood Morwaread M., 2006, QUANTITATIVE PARAMET; Fujioka T, 2006, BRAIN, V129, P2593, DOI 10.1093/brain/awl247; Gaebler M, 2014, NEUROIMAGE, V100, P427, DOI 10.1016/j.neuroimage.2014.06.008; Granot RY, 2011, MUSIC PERCEPT, V28, P219, DOI 10.1525/MP.2011.28.3.219; Haufe S, 2014, NEUROIMAGE, V87, P96, DOI 10.1016/j.neuroimage.2013.10.067; Hertrich I, 2012, PSYCHOPHYSIOLOGY, V49, P322, DOI 10.1111/j.1469-8986.2011.01314.x; HILLYARD SA, 1973, SCIENCE, V182, P177, DOI 10.1126/science.182.4108.177; HOERL AE, 1970, TECHNOMETRICS, V12, P55, DOI 10.1080/00401706.1970.10488634; Ilie G, 2006, MUSIC PERCEPT, V23, P319, DOI 10.1525/mp.2006.23.4.319; Jancke L, 2015, FRONTIERS HUMAN NEUR, V9; Kaneshiro B, 2008, JODI, V4, P24; Kendall MG, 1973, INFERENCE RELATIONSH; Kerlin JR, 2010, J NEUROSCI, V30, P620, DOI 10.1523/JNEUROSCI.3631-09.2010; Higuchi MKK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024437; Krumhansl CL, 1996, MUSIC PERCEPT, V13, P401; KUWADA S, 1986, HEARING RES, V21, P179, DOI 10.1016/0378-5955(86)90038-9; Lalor EC, 2010, EUR J NEUROSCI, V31, P189, DOI 10.1111/j.1460-9568.2009.07055.x; Lalor EC, 2009, J NEUROPHYSIOL, V102, P349, DOI 10.1152/jn.90896.2008; Lartillot O, 2008, ISMIR 2008 9 INT C M, P521; Lartillot O, 2008, ST CLASS DAT ANAL, P261, DOI 10.1007/978-3-540-78246-9_31; Lehne M, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00079; Lehne M, 2013, MUSIC PERCEPT, V31, P171, DOI 10.1525/MP.2013.31.2.171; LERDAHL F, 1983, MUSIC PERCEPT, V1, P229; Low YF, 2007, 2007 3RD INTERNATIONAL IEEE/EMBS CONFERENCE ON NEURAL ENGINEERING, VOLS 1 AND 2, P469, DOI 10.1109/CNE.2007.369711; Madison G, 2011, J EXP PSYCHOL HUMAN, V37, P1578, DOI 10.1037/a0024323; McMenamin BW, 2011, NEUROIMAGE, V54, P4, DOI 10.1016/j.neuroimage.2010.07.057; McMenamin BW, 2010, NEUROIMAGE, V49, P2416, DOI 10.1016/j.neuroimage.2009.10.010; Meyer M, 2006, NEUROIMAGE, V32, P1510, DOI 10.1016/j.neuroimage.2006.04.193; Mosher JC, 1998, IEEE T BIO-MED ENG, V45, P1342, DOI 10.1109/10.725331; Mulert C, 2005, NEUROIMAGE, V28, P49, DOI 10.1016/j.neuroimage.2005.05.041; NAATANEN R, 1987, PSYCHOPHYSIOLOGY, V24, P375, DOI 10.1111/j.1469-8986.1987.tb00311.x; Nielsen F. V, 1983, OPLEVELSE MUSIKALSK; Parra LC, 2005, NEUROIMAGE, V28, P326, DOI 10.1016/j.neuroimage.2005.05.032; Pereira DR, 2014, INT J PSYCHOPHYSIOL, V94, P311, DOI 10.1016/j.ijpsycho.2014.09.012; Purcell DW, 2004, J ACOUST SOC AM, V116, P3581, DOI 10.1121/1.1798354; Pyper BJ, 1998, CAN J FISH AQUAT SCI, V55, P2127; Rohrmeier MA, 2012, INT J PSYCHOPHYSIOL, V83, P164, DOI 10.1016/j.ijpsycho.2011.12.010; RUSSELL JA, 1980, J PERS SOC PSYCHOL, V39, P1161, DOI 10.1037/h0077714; Schadow J, 2007, INT J PSYCHOPHYSIOL, V65, P152, DOI 10.1016/j.ijpsycho.2007.04.006; Schaefer RS, 2011, NEUROIMAGE, V56, P843, DOI 10.1016/j.neuroimage.2010.05.084; Schaefer RS, 2009, BIOL PSYCHOL, V82, P253, DOI 10.1016/j.biopsycho.2009.08.004; Schafer J, 2005, STAT APPL GENET MO B, V4, DOI 10.2202/1544-6115.1175; Schubert E., 2010, HDB MUSIC EMOTION TH, V2nd, P223; Shahin A, 2003, J NEUROSCI, V23, P5545; Shahin A, 2005, NEUROREPORT, V16, P1781, DOI 10.1097/01.wnr.0000185017.29316.63; Shahin AJ, 2010, J NEUROPHYSIOL, V103, P218, DOI 10.1152/jn.00402.2009; Sturm I, 2015, POLYPHONIC IN PRESS; Sturm I, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00798; THEILER J, 1992, PHYSICA D, V58, P77, DOI 10.1016/0167-2789(92)90102-S; Thompson J, 2013, THESIS DARTMOUTH COL; Tremblay K. L., 2014, FRONT SYST NEUROSCI, P8; Upham F, 2012, P 12 INT C MUS PERC, P1037; VarThse Edgard., 1966, PERSPECT NEW MUSIC, V5, P11, DOI DOI 10.2307/832385; Zentner M, 2010, MUSIC ANAL, V29, P102, DOI 10.1111/j.1468-2249.2011.00322.x; Ziehe A, 2004, J MACH LEARN RES, V5, P777	69	26	26	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2015	10	10							e0141281	10.1371/journal.pone.0141281	http://dx.doi.org/10.1371/journal.pone.0141281			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0DL	26510120	Green Published, gold, Green Submitted			2022-12-26	WOS:000363918100068
J	Veneman, JB; Muetzel, S; Hart, KJ; Faulkner, CL; Moorby, JM; Perdok, HB; Newbold, CJ				Veneman, Jolien B.; Muetzel, Stefan; Hart, Kenton J.; Faulkner, Catherine L.; Moorby, Jon M.; Perdok, Hink B.; Newbold, Charles J.			Does Dietary Mitigation of Enteric Methane Production Affect Rumen Function and Animal Productivity in Dairy Cows?	PLOS ONE			English	Article							BEEF-CATTLE; NITRATE SUPPLEMENTATION; PREVOTELLA-RUMINICOLA; FERMENTATION; BACTERIAL; METAANALYSIS; DIVERSITY; EMISSIONS; COMMUNITY; NITRITE	It has been suggested that the rumen microbiome and rumen function might be disrupted if methane production in the rumen is decreased. Furthermore concerns have been voiced that geography and management might influence the underlying microbial population and hence the response of the rumen to mitigation strategies. Here we report the effect of the dietary additives: linseed oil and nitrate on methane emissions, rumen fermentation, and the rumen microbiome in two experiments from New Zealand (Dairy 1) and the UK (Dairy 2). Dairy 1 was a randomized block design with 18 multiparous lactating cows. Dairy 2 was a complete replicated 3 x 3 Latin Square using 6 rumen cannulated, lactating dairy cows. Treatments consisted of a control total mixed ration (TMR), supplementation with linseed oil (4% of feed DM) and supplementation with nitrate (2% of feed DM) in both experiments. Methane emissions were measured in open circuit respiration chambers and rumen samples were analyzed for rumen fermentation parameters and microbial population structure using qPCR and next generation sequencing (NGS). Supplementation with nitrate, but not linseed oil, decreased methane yield (g/kg DMI; P < 0.02) and increased hydrogen (P < 0.03) emissions in both experiments. Furthermore, the effect of nitrate on gaseous emissions was accompanied by an increased rumen acetate to propionate ratio and consistent changes in the rumen microbial populations including a decreased abundance of the main genus Prevotella and a decrease in archaeal mcrA (log(10) copies/g rumen DM content). These results demonstrate that methane emissions can be significantly decreased with nitrate supplementation with only minor, but consistent, effects on the rumen microbial population and its function, with no evidence that the response to dietary additives differed due to geography and different underlying microbial populations.	[Veneman, Jolien B.; Perdok, Hink B.] Cargill Innovat Ctr, Velddriel, Netherlands; [Veneman, Jolien B.; Hart, Kenton J.; Faulkner, Catherine L.; Moorby, Jon M.; Newbold, Charles J.] Aberystwyth Univ, Inst Biol Environm & Rural Sci, Aberystwyth, Dyfed, Wales; [Hart, Kenton J.] AgResearch Ltd, Grasslands Res Ctr, Palmerston North, New Zealand	Aberystwyth University; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Institute of Biological, Environmental, Rural & Sciences (IBERS); AgResearch - New Zealand	Newbold, CJ (corresponding author), Aberystwyth Univ, Inst Biol Environm & Rural Sci, Aberystwyth, Dyfed, Wales.	cjn@aber.ac.uk	Moorby, Jon/L-4586-2018	Moorby, Jon/0000-0002-4449-8432; Hart, Kenton/0000-0003-3447-045X; Muetzel, Stefan/0000-0003-4856-3497	European Community [266018]; Cargill Innovation Center; Biotechnology and Biological Sciences Research Council [BBS/E/W/10964A01B] Funding Source: researchfish; BBSRC [BBS/E/W/10964A01B] Funding Source: UKRI	European Community(European Commission); Cargill Innovation Center; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The research leading to these results has been conducted as part of the AnimalChange project which received funding from the European Community's Seventh Framework Program (FP7/2007-2013) under the grant agreement no 266018. Cargill Innovation Center provided support in the form of salaries for authors J.B. Veneman and H.B. Perdok, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	ALLISON MJ, 1981, J ANIM SCI S1, V53, P391; Appuhamy JADRN, 2013, J DAIRY SCI, V96, P5161, DOI 10.3168/jds.2012-5923; Avgustin G, 1997, INT J SYST BACTERIOL, V47, P284, DOI 10.1099/00207713-47-2-284; Bauman DE, 2003, ANNU REV NUTR, V23, P203, DOI 10.1146/annurev.nutr.23.011702.073408; Belanche A, 2015, FEMS MICROBIOL ECOL, V91, DOI 10.1093/femsec/fiu026; BRUNINGFANN CS, 1993, VET HUM TOXICOL, V35, P521; de la Fuente G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101435; Dhanasekaran S, 2010, J IMMUNOL METHODS, V354, P34, DOI 10.1016/j.jim.2010.01.004; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Eugene M, 2008, CAN J ANIM SCI, V88, P331, DOI 10.4141/CJAS07112; FARRA PA, 1971, J DAIRY SCI, V54, P1018, DOI 10.3168/jds.S0022-0302(71)85965-9; Gerber P.J., 2013, TACKLING CLIMATE CHA, P139; Glasser F, 2008, J DAIRY SCI, V91, P4687, DOI 10.3168/jds.2008-0987; Grainger C, 2011, ANIM FEED SCI TECH, V166-67, P308, DOI 10.1016/j.anifeedsci.2011.04.021; Hart KJ, 2012, TECHNICAL MANUAL RES, P77; Henderson G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074787; Hook SE, 2010, ARCHAEA, V2010, DOI 10.1155/2010/945785; Hristov A.N., 2013, 177 FAO, DOI [DOI 10.18356/3E9D869F-EN, 10.18356/3e9d869f-en]; Hulshof RBA, 2012, J ANIM SCI, V90, P2317, DOI 10.2527/jas.2011-4209; ISO, 1999, AN FEED STUFFS DET F; ISO (International Organization for Standardization), 2000, AN FEED STUFFS DET S; Iwamoto M, 2002, ANAEROBE, V8, P209, DOI 10.1006/anae.2002.0428; Janssen PH, 2008, APPL ENVIRON MICROB, V74, P3619, DOI 10.1128/AEM.02812-07; Kim M, 2012, J ANIM SCI BIOTECHNO, V3, DOI 10.1186/2049-1891-3-28; Kim M, 2011, FEMS MICROBIOL ECOL, V76, P49, DOI 10.1111/j.1574-6941.2010.01029.x; Kittelmann S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0047879; Lin M, 2013, APPL MICROBIOL BIOT, V97, P8719, DOI 10.1007/s00253-013-5143-z; Martin B, 2010, ANIMAL, V4, P351, DOI [10.1017/S1751731109990620, DOI 10.1017/S1751731109990620]; Miranda KM, 2001, NITRIC OXIDE-BIOL CH, V5, P62, DOI 10.1006/niox.2000.0319; Mitsumori M, 2012, BRIT J NUTR, V108, P482, DOI 10.1017/S0007114511005794; Morgavi DP, 2010, ANIMAL, V4, P1024, DOI 10.1017/S1751731110000546; NASEM (National Academies of Science Engineering and Medicine), 2001, NUTR REQ DAIR CATTL, V7th, DOI 10.17226/9825; Nayak D, 2015, AGR ECOSYST ENVIRON, V209, P108, DOI 10.1016/j.agee.2015.04.035; Nolan JV, 2010, ANIM PROD SCI, V50, P801, DOI 10.1071/AN09211; Patra AK, 2013, LIVEST SCI, V155, P244, DOI [10.1016/j.livsci.2013.05.023, DOI 10.1016/J.LIVSCI.2013.05.023]; Patra AK, 2013, BIORESOURCE TECHNOL, V148, P352, DOI 10.1016/j.biortech.2013.08.140; Petri RM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083424; Pinares-Patino C., 2014, TECHNICAL MANUAL RES, P9; Purushe J, 2010, MICROB ECOL, V60, P721, DOI 10.1007/s00248-010-9692-8; Seedorf H, 2014, PEERJ, V2, DOI 10.7717/peerj.494; Skrivanova E, 2010, VET MICROBIOL, V144, P334, DOI 10.1016/j.vetmic.2010.01.013; St-Pierre B, 2013, ANIMAL, V7, P49, DOI 10.1017/S1751731112000912; STROBEL HJ, 1992, APPL ENVIRON MICROB, V58, P2331, DOI 10.1128/AEM.58.7.2331-2333.1992; Ungerfeld E. M., 2006, P55; van Zijderveld SM, 2011, J DAIRY SCI, V94, P4028, DOI 10.3168/jds.2011-4236; van Zijderveld SM, 2010, J DAIRY SCI, V93, P5856, DOI 10.3168/jds.2010-3281; Wallace RJ, 2014, SCI REP-UK, V4, DOI 10.1038/srep05892; Wang M, 2014, ANIM FEED SCI TECH, V194, P1, DOI 10.1016/j.anifeedsci.2014.04.012; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wolin M.J., 1997, MICROBE MICROBE INTE	50	62	63	1	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2015	10	10							e0140282	10.1371/journal.pone.0140282	http://dx.doi.org/10.1371/journal.pone.0140282			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0DL	26509835	Green Published, gold, Green Submitted			2022-12-26	WOS:000363918100026
J	Bertalan, Z; Budrikis, Z; La Porta, CAM; Zapperi, S				Bertalan, Zsolt; Budrikis, Zoe; La Porta, Caterina A. M.; Zapperi, Stefano			Role of the Number of Microtubules in Chromosome Segregation during Cell Division	PLOS ONE			English	Article							MITOTIC-SPINDLE; EJECTION FORCES; CENP-E; KINETOCHORE MICROTUBULES; KINESIN OVEREXPRESSION; DYNAMIC INSTABILITY; DROSOPHILA EMBRYOS; COLORECTAL-CANCER; METAPHASE PLATE; AURORA KINASES	Faithful segregation of genetic material during cell division requires alignment of chromosomes between two spindle poles and attachment of their kinetochores to each of the poles. Failure of these complex dynamical processes leads to chromosomal instability (CIN), a characteristic feature of several diseases including cancer. While a multitude of biological factors regulating chromosome congression and bi-orientation have been identified, it is still unclear how they are integrated so that coherent chromosome motion emerges from a large collection of random and deterministic processes. Here we address this issue by a three dimensional computational model of motor-driven chromosome congression and bi-orientation during mitosis. Our model reveals that successful cell division requires control of the total number of microtubules: if this number is too small bi-orientation fails, while if it is too large not all the chromosomes are able to congress. The optimal number of microtubules predicted by our model compares well with early observations in mammalian cell spindles. Our results shed new light on the origin of several pathological conditions related to chromosomal instability.	[Bertalan, Zsolt; Budrikis, Zoe; Zapperi, Stefano] Inst Sci Interchange Fdn, I-10126 Turin, Italy; [La Porta, Caterina A. M.] Univ Milan, Dept Biosci, Ctr Complex & Biosyst, I-20133 Milan, Italy; [Zapperi, Stefano] Univ Milan, Dept Phys, Ctr Complex & Biosyst, I-20133 Milan, Italy; [Zapperi, Stefano] CNR, Ist Energet & Interfasi, I-20125 Milan, Italy; [Zapperi, Stefano] Aalto Univ, Dept Appl Phys, FIN-00076 Espoo, Finland	University of Milan; University of Milan; Consiglio Nazionale delle Ricerche (CNR); Aalto University	La Porta, CAM (corresponding author), Univ Milan, Dept Biosci, Ctr Complex & Biosyst, Via Celoria 26, I-20133 Milan, Italy.	caterina.laporta@unimi.it; stefano.zapperi@unimi.it	Zapperi, Stefano/C-9473-2009; la porta, caterina/K-7345-2013	Zapperi, Stefano/0000-0001-5692-5465; la porta, caterina/0000-0002-3010-8966	European Research Council [291002 SIZEFFECTS]; Academy of Finland FiDiPro program [13282993]	European Research Council(European Research Council (ERC)European Commission); Academy of Finland FiDiPro program	Z. Bertalan, Z. Budrikis, and SZ are supported by the European Research Council Advanced Grant 291002 SIZEFFECTS. CAMLP thanks the visiting professor program of Aalto University where part of this work was completed. SZ acknowledges support from the Academy of Finland FiDiPro program, project 13282993. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyoshi B, 2010, NATURE, V468, P576, DOI 10.1038/nature09594; Antonio C, 2000, CELL, V102, P425, DOI 10.1016/S0092-8674(00)00048-9; Bakhoum SF, 2012, J CLIN INVEST, V122, P1138, DOI 10.1172/JCI59954; Bakhoum SF, 2009, CURR BIOL, V19, P1937, DOI 10.1016/j.cub.2009.09.055; Barisic M, 2015, SCIENCE, V348, P799, DOI 10.1126/science.aaa5175; Barisic M, 2014, NAT CELL BIOL, V16, P1249, DOI 10.1038/ncb3060; Bertalan Z, 2014, BIOPHYS J, V107, P289, DOI 10.1016/j.bpj.2014.06.004; Bond J, 2005, NAT GENET, V37, P353, DOI 10.1038/ng1539; Boveri T., 1903, UBERMEHRPOLIGE MITOS; Brouhard GJ, 2005, P NATL ACAD SCI USA, V102, P13903, DOI 10.1073/pnas.0506017102; Burrell RA, 2013, NATURE, V501, P338, DOI 10.1038/nature12625; Cai S, 2009, NAT CELL BIOL, V11, P832, DOI 10.1038/ncb1890; Cane S, 2013, J CELL BIOL, V200, P203, DOI 10.1083/jcb.201211119; Chacon JM, 2013, CELL MOL BIOENG, V6, P406, DOI 10.1007/s12195-013-0306-7; Cimini D, 2006, CURR BIOL, V16, P1711, DOI 10.1016/j.cub.2006.07.022; Civelekoglu-Scholey G, 2006, BIOPHYS J, V90, P3966, DOI 10.1529/biophysj.105.078691; Domnitz SB, 2012, J CELL BIOL, V197, P231, DOI 10.1083/jcb.201108147; Ertych N, 2014, NAT CELL BIOL, V16, P779, DOI 10.1038/ncb2994; Ganguly A, 2011, MOL CANCER THER, V10, P929, DOI 10.1158/1535-7163.MCT-10-1109; Gardner MK, 2005, MOL BIOL CELL, V16, P3764, DOI 10.1091/mbc.E05-04-0275; Gluncic M, 2015, PHYS REV LETT, V114, DOI 10.1103/PhysRevLett.114.078103; Gnjatic S, 2010, INT J CANCER, V127, P381, DOI 10.1002/ijc.25058; HILL TL, 1985, P NATL ACAD SCI USA, V82, P4404, DOI 10.1073/pnas.82.13.4404; HOLY TE, 1994, P NATL ACAD SCI USA, V91, P5682, DOI 10.1073/pnas.91.12.5682; Hung LY, 2004, MOL BIOL CELL, V15, P2697, DOI 10.1091/mbc.E04-02-0121; Hunter AW, 2003, MOL CELL, V11, P445, DOI 10.1016/S1097-2765(03)00049-2; Joglekar AP, 2002, BIOPHYS J, V83, P42, DOI 10.1016/S0006-3495(02)75148-5; Kapoor TM, 2006, SCIENCE, V311, P388, DOI 10.1126/science.1122142; Kim Y, 2008, J CELL BIOL, V181, P411, DOI 10.1083/jcb.200802189; Kim Y, 2010, CELL, V142, P444, DOI 10.1016/j.cell.2010.06.039; KIRSCHNER M, 1986, CELL, V45, P329, DOI 10.1016/0092-8674(86)90318-1; Kohlmaier G, 2009, CURR BIOL, V19, P1012, DOI 10.1016/j.cub.2009.05.018; Lampson MA, 2011, TRENDS CELL BIOL, V21, P133, DOI 10.1016/j.tcb.2010.10.007; Lee AJX, 2011, CANCER RES, V71, P1858, DOI 10.1158/0008-5472.CAN-10-3604; Li Y, 2007, CELL RES, V17, P701, DOI 10.1038/cr.2007.65; Magidson V, 2011, CELL, V146, P555, DOI 10.1016/j.cell.2011.07.012; Mallik R, 2004, NATURE, V427, P649, DOI 10.1038/nature02293; Maresca TJ, 2010, J CELL SCI, V123, P825, DOI 10.1242/jcs.064790; Marko JF, 2003, BIOCHEM CELL BIOL, V81, P209, DOI 10.1139/o03-047; Marshall WF, 2001, CURR BIOL, V11, P569, DOI 10.1016/S0960-9822(01)00180-4; Matos I, 2009, J CELL BIOL, V186, P11, DOI 10.1083/jcb.200904153; MCDONALD KL, 1992, J CELL BIOL, V118, P369, DOI 10.1083/jcb.118.2.369; Mclntosh JR, 1975, SOC GEN PHYSL SER, V30, P31; MITCHISON T, 1984, NATURE, V312, P237, DOI 10.1038/312237a0; Nakamura Y, 2007, BRIT J CANCER, V97, P543, DOI 10.1038/sj.bjc.6603905; NICKLAS RB, 1983, J CELL BIOL, V97, P542, DOI 10.1083/jcb.97.2.542; O'Connell CB, 2007, J CELL SCI, V120, P1717, DOI 10.1242/jcs.03442; Paul R, 2009, P NATL ACAD SCI USA, V106, P15708, DOI 10.1073/pnas.0908261106; Putkey FR, 2002, DEV CELL, V3, P351, DOI 10.1016/S1534-5807(02)00255-1; RIEDER CL, 1990, J CELL BIOL, V110, P81, DOI 10.1083/jcb.110.1.81; RIEDER CL, 1986, J CELL BIOL, V103, P581, DOI 10.1083/jcb.103.2.581; Rusan NM, 2001, MOL BIOL CELL, V12, P971, DOI 10.1091/mbc.12.4.971; SALMON ED, 1984, J CELL BIOL, V99, P2157, DOI 10.1083/jcb.99.6.2157; Schmidt TI, 2009, CURR BIOL, V19, P1005, DOI 10.1016/j.cub.2009.05.016; Sharp DJ, 2000, NATURE, V407, P41, DOI 10.1038/35024000; Shimo A, 2008, CANCER SCI, V99, P62, DOI 10.1111/j.1349-7006.2007.00635.x; Silk AD, 2013, P NATL ACAD SCI USA, V110, pE4134, DOI 10.1073/pnas.1317042110; Stout JR, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-26; Stumpff J, 2008, DEV CELL, V14, P252, DOI 10.1016/j.devcel.2007.11.014; Stumpff J, 2012, DEV CELL, V22, P1017, DOI 10.1016/j.devcel.2012.02.013; Stumpff J, 2011, MOL CELL, V43, P764, DOI 10.1016/j.molcel.2011.07.022; Tanenbaum ME, 2011, CURR BIOL, V21, P1356, DOI 10.1016/j.cub.2011.07.017; Thornton GK, 2009, TRENDS GENET, V25, P501, DOI 10.1016/j.tig.2009.09.011; Vorozhko VV, 2008, CHROMOSOMA, V117, P169, DOI 10.1007/s00412-007-0135-3; Walczak CE, 2010, NAT REV MOL CELL BIO, V11, P91, DOI 10.1038/nrm2832; Wandke C, 2012, J CELL BIOL, V198, P847, DOI 10.1083/jcb.201110060; Wollman R, 2005, CURR BIOL, V15, P828, DOI 10.1016/j.cub.2005.03.019; Yang ZY, 2007, CURR BIOL, V17, P973, DOI 10.1016/j.cub.2007.04.056; Zhu CJ, 2005, MOL BIOL CELL, V16, P3187, DOI 10.1091/mbc.E05-02-0167	69	8	8	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2015	10	10							e0141305	10.1371/journal.pone.0141305	http://dx.doi.org/10.1371/journal.pone.0141305			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU8PC	26506005	Green Published, Green Submitted, gold			2022-12-26	WOS:000363804200046
J	Kamada, M; Hase, S; Fujii, K; Miyake, M; Sato, K; Kimura, K; Sakakibara, Y				Kamada, Mayumi; Hase, Sumitaka; Fujii, Kazushi; Miyake, Masato; Sato, Kengo; Kimura, Keitarou; Sakakibara, Yasubumi			Whole-Genome Sequencing and Comparative Genome Analysis of Bacillus subtilis Strains Isolated from Non-Salted Fermented Soybean Foods	PLOS ONE			English	Article							POLY-GAMMA-GLUTAMATE; ACID PRODUCTION; OPEN SOFTWARE; NATTO; ANNOTATION; COMPETENCE; ALGORITHM; MECHANISM; PROGRAM; PRODUCT	Bacillus subtilis is the main component in the fermentation of soybeans. To investigate the genetics of the soybean-fermenting B. subtilis strains and its relationship with the productivity of extracellular poly-gamma-glutamic acid (gamma PGA), we sequenced the whole genome of eight B. subtilis stains isolated from non-salted fermented soybean foods in Southeast Asia. Assembled nucleotide sequences were compared with those of a natto (fermented soybean food) starter strain B. subtilis BEST195 and the laboratory standard strain B. subtilis 168 that is incapable of gamma PGA production. Detected variants were investigated in terms of insertion sequences, biotin synthesis, production of subtilisin NAT, and regulatory genes for gamma PGA synthesis, which were related to fermentation process. Comparing genome sequences, we found that the strains that produce gamma PGA have a deletion in a protein that constitutes the flagellar basal body, and this deletion was not found in the non-producing strains. We further identified diversity in variants of the bio operon, which is responsible for the biotin auxotrophism of the natto starter strains. Phylogenetic analysis using multilocus sequencing typing revealed that the B. subtilis strains isolated from the non-salted fermented soybeans were not clustered together, while the natto-fermenting strains were tightly clustered; this analysis also suggested that the strain isolated from "Tua Nao" of Thailand traces a different evolutionary process from other strains.	[Kamada, Mayumi; Hase, Sumitaka; Miyake, Masato; Sato, Kengo; Sakakibara, Yasubumi] Keio Univ, Dept Biosci & Informat, Kohoku Ku, Yokohama, Kanagawa 2238522, Japan; [Fujii, Kazushi] Univ Tokyo, Dept Biol Sci, Bunkyo Ku, Tokyo 1130032, Japan; [Kimura, Keitarou] Natl Food Res Inst, Div Appl Microbiol, Tsukuba, Ibaraki 3058642, Japan	Keio University; University of Tokyo; National Agriculture & Food Research Organization - Japan; National Food Research Institute - Japan	Sakakibara, Y (corresponding author), Keio Univ, Dept Biosci & Informat, Kohoku Ku, 3-14-1 Hiyoshi, Yokohama, Kanagawa 2238522, Japan.	yasu@bio.keio.ac.jp	Sato, Kengo/D-6043-2012	Sato, Kengo/0000-0001-6744-7390; Kimura, Keitarou/0000-0003-4641-4041	Ministry of Education, Culture, Sports, Science and Technology of Japan [221S0002, 23241066]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a Grant-in-Aid for KAKENHI (Grant-in-Aid for Scientific Research) on Innovative Areas No. 221S0002 and Scientific Research (A) No. 23241066 from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Assefa S, 2009, BIOINFORMATICS, V25, P1968, DOI 10.1093/bioinformatics/btp347; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Barbe V, 2009, MICROBIOL-SGM, V155, P1758, DOI 10.1099/mic.0.027839-0; Boetzer M, 2011, BIOINFORMATICS, V27, P578, DOI 10.1093/bioinformatics/btq683; Buescher JM, 2007, CRIT REV BIOTECHNOL, V27, P1, DOI 10.1080/07388550601166458; Cairns LS, 2013, MOL MICROBIOL, V90, P6, DOI 10.1111/mmi.12342; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Carver T, 2009, BIOINFORMATICS, V25, P119, DOI 10.1093/bioinformatics/btn578; Chan JM, 2014, J BACTERIOL, V196, P740, DOI 10.1128/JB.01217-13; Chevance FFV, 2008, NAT REV MICROBIOL, V6, P455, DOI 10.1038/nrmicro1887; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Delcher AL, 2007, BIOINFORMATICS, V23, P673, DOI 10.1093/bioinformatics/btm009; Fukutake M, 1996, FOOD CHEM TOXICOL, V34, P457, DOI 10.1016/0278-6915(96)87355-8; Geng WT, 2011, J BACTERIOL, V193, P3393, DOI 10.1128/JB.05058-11; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Government of Japan, HIGHL JAPAN NIPP POL; Gurevich A, 2013, BIOINFORMATICS, V29, P1072, DOI 10.1093/bioinformatics/btt086; Inatsu Y, 2006, LETT APPL MICROBIOL, V43, P237, DOI 10.1111/j.1472-765X.2006.01966.x; Inatsu Y, 2002, JARQ-JPN AGR RES Q, V36, P169, DOI 10.6090/jarq.36.169; Jolley KA, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-595; Kamada M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109999; Kimura E, 2002, J BIOSCI BIOENG, V94, P545, DOI 10.1016/S1389-1723(02)80193-1; Kimura K, 2004, MICROBIOL-SGM, V150, P4115, DOI 10.1099/mic.0.27467-0; Kimura K, 2004, MICROBIOL-SGM, V150, P2911, DOI 10.1099/mic.0.27045-0; Kimura K, 2003, APPL ENVIRON MICROB, V69, P2491, DOI 10.1128/AEM.69.5.2491-2497.2003; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kisand V, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-211; Kubo Y, 2011, APPL ENVIRON MICROB, V77, P6463, DOI 10.1128/AEM.00448-11; Kunst F, 1997, NATURE, V390, P249, DOI 10.1038/36786; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Lagesen K, 2007, NUCLEIC ACIDS RES, V35, P3100, DOI 10.1093/nar/gkm160; Lee TY, 2014, J INVEST DERMATOL, V134, P704, DOI 10.1038/jid.2013.389; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Lim EC, 2014, BIOINFORMATICS, V30, P3264, DOI 10.1093/bioinformatics/btu513; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Meerak J, 2008, J GEN APPL MICROBIOL, V54, P159, DOI 10.2323/jgam.54.159; MESSINA MJ, 1994, NUTR CANCER, V21, P113, DOI 10.1080/01635589409514310; Nagai T, 2000, J BACTERIOL, V182, P2387, DOI 10.1128/JB.182.9.2387-2392.2000; NAKAMURA T, 1992, BIOSCI BIOTECH BIOCH, V56, P1869, DOI 10.1271/bbb.56.1869; Nishito Y, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-243; Ogunleye A, 2015, MICROBIOL-SGM, V161, P1, DOI 10.1099/mic.0.081448-0; Pop M, 2004, BRIEF BIOINFORM, V5, P237, DOI 10.1093/bib/5.3.237; Popendorf K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012651; Qiu DR, 2004, APPL ENVIRON MICROB, V70, P6247, DOI 10.1128/AEM.70.10.6247-6256.2004; SAITO H, 1963, BIOCHIM BIOPHYS ACTA, V72, P619, DOI 10.1016/0926-6550(63)90386-4; Sasaki M, 2004, BIOSCI BIOTECH BIOCH, V68, P739, DOI 10.1271/bbb.68.739; Sims D, 2014, NAT REV GENET, V15, P121, DOI 10.1038/nrg3642; SOLOMON JM, 1995, GENE DEV, V9, P547, DOI 10.1101/gad.9.5.547; Steinkraus K H Ph.D, 2002, Compr Rev Food Sci Food Saf, V1, P23, DOI 10.1111/j.1541-4337.2002.tb00004.x; SUMI H, 1987, EXPERIENTIA, V43, P1110, DOI 10.1007/BF01956052; Takahashi K, 2007, MICROBIOL-SGM, V153, P2553, DOI 10.1099/mic.0.2007/007104-0; Tamang JP, 2010, FOOD SCI TECHNOLOGY; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tran LSP, 2000, MOL MICROBIOL, V37, P1159, DOI 10.1046/j.1365-2958.2000.02069.x; WEINRAUCH Y, 1990, GENE DEV, V4, P860, DOI 10.1101/gad.4.5.860; Zeigler DR, 2011, MICROBIOL-SGM, V157, P2033, DOI 10.1099/mic.0.048520-0	58	22	23	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2015	10	10							e0141369	10.1371/journal.pone.0141369	http://dx.doi.org/10.1371/journal.pone.0141369			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU8PC	26505996	Green Published, gold, Green Submitted			2022-12-26	WOS:000363804200057
J	Rodrigues, RR; Pineda, RP; Barney, JN; Nilsen, ET; Barrett, JE; Williams, MA				Rodrigues, Richard R.; Pineda, Rosana P.; Barney, Jacob N.; Nilsen, Erik T.; Barrett, John E.; Williams, Mark A.			Plant Invasions Associated with Change in Root-Zone Microbial Community Structure and Diversity	PLOS ONE			English	Article							AILANTHUS-ALTISSIMA; SOIL; NITROGEN; TREE; IDENTIFICATION; HYPOTHESES; GREENGENES; CHEMISTRY; EVOLUTION; DATABASE	The importance of plant-microbe associations for the invasion of plant species have not been often tested under field conditions. The research sought to determine patterns of change in microbial communities associated with the establishment of invasive plants with different taxonomic and phenetic traits. Three independent locations in Virginia, USA were selected. One site was invaded by a grass (Microstegium vimineum), another by a shrub (Rhamnus davurica), and the third by a tree (Ailanthus altissima). The native vegetation from these sites was used as reference. 16S rRNA and ITS regions were sequenced to study root-zone bacterial and fungal communities, respectively, in invaded and non-invaded samples and analyzed using Quantitative Insights Into Microbial Ecology (QIIME). Though root-zone microbial community structure initially differed across locations, plant invasion shifted communities in similar ways. Indicator species analysis revealed that Operational Taxonomic Units (OTUs) closely related to Proteobacteria, Acidobacteria, Actinobacteria, and Ascomycota increased in abundance due to plant invasions. The Hyphomonadaceae family in the Rhodobacterales order and ammonia-oxidizing Nitrospirae phylum showed greater relative abundance in the invaded root-zone soils. Hyphomicrobiaceae, another bacterial family within the phyla Proteobacteria increased as a result of plant invasion, but the effect associated most strongly with root-zones of M. vimineum and R. davurica. Functional analysis using Phylogenetic Investigation of Communities by Reconstruction of Unobserved States (PICRUSt) showed bacteria responsible for nitrogen cycling in soil increased in relative abundance in association with plant invasion. In agreement with phylogenetic and functional analyses, greater turnover of ammonium and nitrate was associated with plant invasion. Overall, bacterial and fungal communities changed congruently across plant invaders, and support the hypothesis that nitrogen cycling bacteria and functions are important factors in plant invasions. Whether the changes in microbial communities are driven by direct plant microbial interactions or a result of plant-driven changes in soil properties remains to be determined.	[Rodrigues, Richard R.; Williams, Mark A.] Virginia Tech, Interdisciplinary PhD Program Genet Bioinformat &, Blacksburg, VA USA; [Pineda, Rosana P.; Williams, Mark A.] Virginia Tech, Dept Hort, Blacksburg, VA USA; [Barney, Jacob N.] Virginia Tech, Dept Plant Pathol Physiol & Weed Sci, Blacksburg, VA USA; [Nilsen, Erik T.; Barrett, John E.] Virginia Tech, Dept Biol Sci, Blacksburg, VA USA	Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University	Williams, MA (corresponding author), Virginia Tech, Interdisciplinary PhD Program Genet Bioinformat &, Blacksburg, VA USA.	markwill@vt.edu	Barrett, John/D-5851-2016; Barney, Jacob/C-2412-2008	Barrett, John/0000-0002-7610-0505; Williams, Mark A./0000-0002-4766-9399; Barney, Jacob/0000-0003-2949-5003	Organismal Biology and Ecology program of the Fralin Institute of Virginia Tech; Genetics, bioinformatics, and computational biology program at Virginia Tech; College of agriculture and life sciences at Virginia Tech; National Science Foundation [1216074]	Organismal Biology and Ecology program of the Fralin Institute of Virginia Tech; Genetics, bioinformatics, and computational biology program at Virginia Tech; College of agriculture and life sciences at Virginia Tech; National Science Foundation(National Science Foundation (NSF))	Funding provided by the Organismal Biology and Ecology program of the Fralin Institute of Virginia Tech to ETN, MAW, JNB, JEB; Genetics, bioinformatics, and computational biology program at Virginia Tech in support of RRR, MAW; College of agriculture and life sciences at Virginia Tech in support of MAW, RPP, RRR; and National Science Foundation award 1216074 to MAW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abarenkov K, 2010, NEW PHYTOL, V186, P281, DOI 10.1111/j.1469-8137.2009.03160.x; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Barney JN, 2009, PLANT ECOL, V203, P195, DOI 10.1007/s11258-008-9529-4; BEALS EW, 1984, ADV ECOL RES, V14, P1, DOI 10.1016/S0065-2504(08)60168-3; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Brown RL, 2003, ECOLOGY, V84, P32, DOI 10.1890/0012-9658(2003)084[0032:DAIOSA]2.0.CO;2; Callaway RM, 2000, SCIENCE, V290, P521, DOI 10.1126/science.290.5491.521; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Castro-Diez P, 2014, ECOL LETT, V17, P1, DOI 10.1111/ele.12197; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Coelho MRR, 2009, APPL SOIL ECOL, V42, P48, DOI 10.1016/j.apsoil.2009.01.010; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Dufrene M, 1997, ECOL MONOGR, V67, P345, DOI 10.1890/0012-9615(1997)067[0345:SAAIST]2.0.CO;2; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Ehrenfeld JG, 2003, ECOSYSTEMS, V6, P503, DOI 10.1007/s10021-002-0151-3; Elgersma KJ, 2011, OECOLOGIA, V167, P733, DOI 10.1007/s00442-011-2022-0; Eppinga MB, 2006, OIKOS, V114, P168, DOI 10.1111/j.2006.0030-1299.14625.x; Flory SL, 2010, OECOLOGIA, V164, P1029, DOI 10.1007/s00442-010-1697-y; Gomez-Aparicio L, 2008, J ECOL, V96, P447, DOI 10.1111/j.1365-2745.2007.01352.x; Gower JC, 2005, PRINCIPAL COORDINATE; Gundale MJ, 2014, NEW PHYTOL, V202, P415, DOI 10.1111/nph.12699; Haselkorn R, 2010, GENOMES GENOMICS NIT, V3, P71; Hawkes CV, 2005, ECOL LETT, V8, P976, DOI 10.1111/j.1461-0248.2005.00802.x; Heisey RM, 1996, AM J BOT, V83, P192, DOI 10.2307/2445938; Hill TCJ, 2003, FEMS MICROBIOL ECOL, V43, P1, DOI 10.1111/j.1574-6941.2003.tb01040.x; Hobbie SE, 2015, TRENDS ECOL EVOL, V30, P357, DOI 10.1016/j.tree.2015.03.015; Horton JL, 2009, CASTANEA, V74, P340, DOI 10.2179/08-016R3.1; James TY, 2006, NATURE, V443, P818, DOI 10.1038/nature05110; Jangid K, 2011, SOIL BIOL BIOCHEM, V43, P2184, DOI 10.1016/j.soilbio.2011.06.022; Jeschke J. M., 2012, NeoBiota, P1; Jeschke JM, 2014, DIVERS DISTRIB, V20, P1229, DOI 10.1111/ddi.12258; Klironomos JN, 2002, NATURE, V417, P67, DOI 10.1038/417067a; Klironomos JN, 2003, ECOLOGY, V84, P2292, DOI 10.1890/02-0413; Kourtev PS, 2002, ECOLOGY, V83, P3152, DOI 10.1890/0012-9658(2002)083[3152:EPSATM]2.0.CO;2; Kourtev PS, 1998, WATER AIR SOIL POLL, V105, P493, DOI 10.1023/A:1005037105499; Kowarik I, 2007, PERSPECT PLANT ECOL, V8, P207, DOI 10.1016/j.ppees.2007.03.002; Langille MGI, 2013, NAT BIOTECHNOL, V31, P814, DOI 10.1038/nbt.2676; Liao CZ, 2008, NEW PHYTOL, V177, P706, DOI 10.1111/j.1469-8137.2007.02290.x; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Lum G, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar001; Masella AP, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-31; McCune B., 2011, MULTIVARIATE ANAL EC; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; McGrath DA, 2009, SOUTHEAST NAT, V8, P141, DOI 10.1656/058.008.0113; Nilsen ET, 2001, AM MIDL NAT, V145, P325, DOI 10.1674/0003-0031(2001)145[0325:DRMLER]2.0.CO;2; PANG PC, 1975, CAN J SOIL SCI, V55, P15, DOI 10.4141/cjss75-003; Parker SS, 2010, INVAS PLANT SCI MANA, V3, P40, DOI 10.1614/IPSM-09-046.1; Parks DH, 2014, BIOINFORMATICS, V30, P3123, DOI 10.1093/bioinformatics/btu494; Placella SA, 2013, APPL ENVIRON MICROB, V79, P3294, DOI 10.1128/AEM.00404-13; Rout ME, 2013, AM J BOT, V100, P1726, DOI 10.3732/ajb.1200577; Schmidt PA, 2013, SOIL BIOL BIOCHEM, V65, P128, DOI 10.1016/j.soilbio.2013.05.014; Schoch CL, 2009, SYST BIOL, V58, P224, DOI 10.1093/sysbio/syp020; Simonin M, 2015, MICROB ECOL, V70, P809, DOI 10.1007/s00248-015-0604-9; Smith MS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104189; Stinson KA, 2006, PLOS BIOL, V4, P727, DOI 10.1371/journal.pbio.0040140; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Tamura M, 2014, NEW PHYTOL, V203, P110, DOI 10.1111/nph.12795; Thorpe AS, 2005, CONCEPTUAL ECOLOGY I, P333; van der Heijden MGA, 2008, ECOL LETT, V11, P296, DOI 10.1111/j.1461-0248.2007.01139.x; Vazquez-Baeza Y, 2013, GIGASCIENCE, V2, DOI 10.1186/2047-217X-2-16; Vila M, 2011, ECOL LETT, V14, P702, DOI 10.1111/j.1461-0248.2011.01628.x; Walker J, 2002, INOCULUM, V53, P58; Wang CongYan, 2015, American Journal of Plant Sciences, V6, P34; Wang GY, 2009, ISME J, V3, P374, DOI 10.1038/ismej.2008.107; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; WeiHua L, 2008, J TROPICAL SUBTROPIC, V16, P7; WELCH BL, 1947, BIOMETRIKA, V34, P28, DOI 10.2307/2332510; White T.J., 1990, PCR PROTOCOLS GUIDE, P315; Wolfe BE, 2005, BIOSCIENCE, V55, P477, DOI 10.1641/0006-3568(2005)055[0477:BNGSCA]2.0.CO;2; Wurzburger N, 2007, PEDOBIOLOGIA, V50, P563, DOI 10.1016/j.pedobi.2006.10.001; Xu CW, 2012, APPL SOIL ECOL, V54, P32, DOI 10.1016/j.apsoil.2011.10.021; Yang Q, 2013, SOIL BIOL BIOCHEM, V65, P78, DOI 10.1016/j.soilbio.2013.05.004	73	52	53	2	110	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2015	10	10							e0141424	10.1371/journal.pone.0141424	http://dx.doi.org/10.1371/journal.pone.0141424			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU8PC	26505627	Green Published, gold			2022-12-26	WOS:000363804200065
J	Vlijm, R; Lee, M; Ordu, O; Boltengagen, A; Lusser, A; Dekker, NH; Dekker, C				Vlijm, Rifka; Lee, Mina; Ordu, Orkide; Boltengagen, Anastasiya; Lusser, Alexandra; Dekker, Nynke H.; Dekker, Cees			Comparing the Assembly and Handedness Dynamics of (H3.3-H4)(2) Tetrasomes to Canonical Tetrasomes	PLOS ONE			English	Article							HISTONE (H3-H4)(2) TETRAMER; DROSOPHILA-MELANOGASTER; VARIANT H3.3; NUCLEOSOME; CHROMATIN; DNA; TRANSCRIPTION; TWEEZERS; PROTEIN; DEPOSITION	Eukaryotic nucleosomes consists of an (H3-H4)(2) tetramer and two H2A-H2B dimers, around which 147 bp of DNA are wrapped in 1.7 left-handed helical turns. During chromatin assembly, the (H3-H4)(2) tetramer binds first, forming a tetrasome that likely constitutes an important intermediate during ongoing transcription. We recently showed that (H3-H4)(2) tetrasomes spontaneously switch between a left-and right-handed wrapped state of the DNA, a phenomenon that may serve to buffer changes in DNA torque induced by RNA polymerase in transcription. Within nucleosomes of actively transcribed genes, however, canonical H3 is progressively replaced by its variant H3.3. Consequently, one may ask if and how the DNA chirality dynamics of tetrasomes is altered by H3.3. Recent findings that H3.3-containing nucleosomes result in less stable and less condensed chromatin further underline the need to study the microscopic underpinnings of H3.3-containing tetrasomes and nucleosomes. Here we report real-time single-molecule studies of (H3.3-H4)(2) tetrasome dynamics using Freely Orbiting Magnetic Tweezers and Electromagnetic Torque Tweezers. We find that the assembly of H3.3-containing tetrasomes and nucleosomes by the histone chaperone Nucleosome Assembly Protein 1 (NAP1) occurs in an identical manner to that of H3-containing tetrasomes and nucleosomes. Likewise, the flipping behavior of DNA handedness in tetrasomes is not impacted by the presence of H3.3. We also examine the effect of free NAP1, H3.3, and H4 in solution on flipping behavior and conclude that the probability for a tetrasome to occupy the left-handed state is only slightly enhanced by the presence of free protein. These data demonstrate that the incorporation of H3.3 does not alter the structural dynamics of tetrasomes, and hence that the preferred incorporation of this histone variant in transcriptionally active regions does not result from its enhanced ability to accommodate torsional stress, but rather may be linked to specific chaperone or remodeler requirements or communication with the nuclear environment.	[Vlijm, Rifka; Lee, Mina; Ordu, Orkide; Dekker, Nynke H.; Dekker, Cees] Delft Univ Technol, Kavli Inst Nanosci, Dept Bionanosci, Delft, Netherlands; [Boltengagen, Anastasiya; Lusser, Alexandra] Med Univ Innsbruck, Div Mol Biol, Bioctr, A-6020 Innsbruck, Austria	Delft University of Technology; Medical University of Innsbruck	Dekker, NH (corresponding author), Delft Univ Technol, Kavli Inst Nanosci, Dept Bionanosci, Delft, Netherlands.	N.H.Dekker@tudelft.nl; C.Dekker@tudelft.nl	Vlijm, Rifka/ABB-9663-2020	Vlijm, Rifka/0000-0001-8909-9518; Lusser, Alexandra/0000-0002-2226-9081; Dekker, Nynke/0000-0003-4029-0973; Dekker, Cees/0000-0001-6273-071X	Netherlands Organisation for Scientific Research (NWO/OCW), as part of the Frontiers of Nanoscience program; European Research Council for ERC Advanced grants NanoforBio [247072]; SynDiv [669598]; Foundation for Fundamental Research on Matter (FOM), as part of the Physics of the Genome Program; Austrian Science Fund (FWF) [START Y275-B12]; European Community's Seventh Framework Programme FP7 [241548]; European Research Council (ERC) via a Starting Grant (DynGenome)	Netherlands Organisation for Scientific Research (NWO/OCW), as part of the Frontiers of Nanoscience program; European Research Council for ERC Advanced grants NanoforBio; SynDiv; Foundation for Fundamental Research on Matter (FOM), as part of the Physics of the Genome Program; Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); European Community's Seventh Framework Programme FP7; European Research Council (ERC) via a Starting Grant (DynGenome)	This work was supported by the Netherlands Organisation for Scientific Research (NWO/OCW), as part of the Frontiers of Nanoscience program (to C.D.), and the European Research Council for ERC Advanced grants NanoforBio (no. 247072) and SynDiv (no. 669598) to C.D.), the Foundation for Fundamental Research on Matter (FOM), as part of the Physics of the Genome Program (to C.D.), the Austrian Science Fund (FWF): START Y275-B12 (to A.L.), the European Community's Seventh Framework Programme FP7/2007-2013 under grant agreement no. 241548 (MitoSys, to N.H.D.) and by the European Research Council (ERC) via a Starting Grant (DynGenome, to N.H.D.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad K, 2002, MOL CELL, V9, P1191, DOI 10.1016/S1097-2765(02)00542-7; AKHMANOVA AS, 1995, GENOME, V38, P586, DOI 10.1139/g95-075; Andrews AJ, 2010, MOL CELL, V37, P834, DOI 10.1016/j.molcel.2010.01.037; Ausio J, 2002, BIOCHEMISTRY-US, V41, P5945, DOI 10.1021/bi020059d; Bancaud A, 2007, MOL CELL, V27, P135, DOI 10.1016/j.molcel.2007.05.037; Chen P, 2013, GENE DEV, V27, P2109, DOI 10.1101/gad.222174.113; Chien FT, 2009, CURR PHARM BIOTECHNO, V10, P474, DOI 10.2174/138920109788922128; Chong SS, 2014, CELL, V158, P314, DOI 10.1016/j.cell.2014.05.038; Clapier CR, 2009, ANNU REV BIOCHEM, V78, P273, DOI 10.1146/annurev.biochem.77.062706.153223; DABAN JR, 1982, J MOL BIOL, V156, P749, DOI 10.1016/0022-2836(82)90140-1; FRETZIN S, 1991, GENE, V107, P341, DOI 10.1016/0378-1119(91)90337-B; FUJIINAKATA T, 1992, J BIOL CHEM, V267, P20980; Gilbert N, 2014, CURR OPIN GENET DEV, V25, P15, DOI 10.1016/j.gde.2013.10.013; Hamiche A, 1998, J BIOL CHEM, V273, P9261, DOI 10.1074/jbc.273.15.9261; Hamiche A, 1996, P NATL ACAD SCI USA, V93, P7588, DOI 10.1073/pnas.93.15.7588; Henikoff S, 2000, P NATL ACAD SCI USA, V97, P716, DOI 10.1073/pnas.97.2.716; Janssen XJA, 2012, NANO LETT, V12, P3634, DOI 10.1021/nl301330h; Jin CY, 2007, GENE DEV, V21, P1519, DOI 10.1101/gad.1547707; Kamakaka RT, 2005, GENE DEV, V19, P295, DOI 10.1101/gad.1272805; Katan AJ, 2015, SMALL, V11, P976, DOI 10.1002/smll.201401318; Konev AY, 2007, SCIENCE, V317, P1087, DOI 10.1126/science.1145339; Kouzine F, 2013, NAT STRUCT MOL BIOL, V20, P396, DOI 10.1038/nsmb.2517; Kurumizaka H, 2013, CURR OPIN STRUC BIOL, V23, P109, DOI 10.1016/j.sbi.2012.10.009; Levchenko V, 2005, BIOCHEMISTRY-US, V44, P5357, DOI 10.1021/bi047786o; Levenstein ME, 2002, J BIOL CHEM, V277, P8749, DOI 10.1074/jbc.M111212200; Lipfert J, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1450; Lipfert J, 2010, NAT METHODS, V7, P977, DOI [10.1038/nmeth.1520, 10.1038/NMETH.1520]; Luger K, 2003, CURR OPIN GENET DEV, V13, P127, DOI 10.1016/S0959-437X(03)00026-1; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Lusser A, 2005, NAT STRUCT MOL BIOL, V12, P160, DOI 10.1038/nsmb884; Ma J, 2013, SCIENCE, V340, P1580, DOI 10.1126/science.1235441; Mazurkiewicz J, 2006, J BIOL CHEM, V281, P16462, DOI 10.1074/jbc.M511619200; Meyer S, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003785; Moreland JL, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-21; Nakagawa T, 2001, J BIOL CHEM, V276, P27384, DOI 10.1074/jbc.M101331200; Sakai A, 2009, CURR BIOL, V19, P1816, DOI 10.1016/j.cub.2009.09.021; Szenker E, 2011, CELL RES, V21, P421, DOI 10.1038/cr.2011.14; Tachiwana H, 2011, ACTA CRYSTALLOGR D, V67, P578, DOI 10.1107/S0907444911014818; Talbert PB, 2010, NAT REV MOL CELL BIO, V11, P264, DOI 10.1038/nrm2861; Thakar A, 2009, BIOCHEMISTRY-US, V48, P10852, DOI 10.1021/bi901129e; Vlijm R, 2015, CELL REP, V10, P216, DOI 10.1016/j.celrep.2014.12.022; Vlijm R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046306; Zentner GE, 2013, NAT STRUCT MOL BIOL, V20, P259, DOI 10.1038/nsmb.2470	43	9	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2015	10	10							e0141267	10.1371/journal.pone.0141267	http://dx.doi.org/10.1371/journal.pone.0141267			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU8PC	26506534	Green Published, gold			2022-12-26	WOS:000363804200039
J	Brewer, PD; Habtemichael, EN; Romenskaia, I; Mastick, CC; Coster, ACF				Brewer, Paul Duffield; Habtemichael, Estifanos N.; Romenskaia, Irina; Mastick, Cynthia Corley; Coster, Adelle C. F.			Glut4 Is Sorted from a Rab10 GTPase-independent Constitutive Recycling Pathway into a Highly Insulinresponsive Rab10 GTPase-dependent Sequestration Pathway after Adipocyte Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHOTYROSINE-BINDING DOMAIN; PLASMA-MEMBRANE; ACTIVATING-PROTEIN; GLUCOSE-TRANSPORT; EXOCYST COMPLEX; MUSCLE-CELLS; VESICLE TRANSLOCATION; 3T3-L1 ADIPOCYTES; INSULIN ACTION; RATE-CONSTANT	The RabGAP AS160/TBC1D4 controls exocytosis of the insulin-sensitive glucose transporter Glut4 in adipocytes. Glut4 is internalized and recycled through a highly regulated secretory pathway in these cells. Glut4 also cycles through a slow constitutive endosomal pathway distinct from the fast transferrin (Tf) receptor recycling pathway. This slow constitutive pathway is the only Glut4 cycling pathway in undifferentiated fibroblasts. The alpha(2)-macroglobulin receptor LRP1 cycles with Glut4 and the Tf receptor through all three exocytic pathways. To further characterize these pathways, the effects of knockdown of AS160 substrates on the trafficking kinetics of Glut4, LRP1, and the Tf receptor were measured in adipocytes and fibroblasts. Rab10 knockdown decreased cell surface Glut4 in insulin-stimulated adipocytes by 65%, but not in basal adipocytes or in fibroblasts. This decrease was due primarily to a 62% decrease in the rate constant of Glut4 exocytosis (k(ex)), although Rab10 knockdown also caused a 1.4-fold increase in the rate constant of Glut4 endocytosis (k(en)). Rab10 knockdown in adipocytes also decreased cell surface LRP1 by 30% by decreasing kex 30-40%. There was no effect on LRP1 trafficking in fibroblasts or on Tf receptor trafficking in either cell type. These data confirm that Rab10 is an AS160 substrate that limits exocytosis through the highly insulin-responsive specialized secretory pathway in adipocytes. They further show that the slow constitutive endosomal (fibroblast) recycling pathway is Rab10-independent. Thus, Rab10 is a marker for the specialized pathway in adipocytes. Interestingly, mathematical modeling shows that Glut4 traffics predominantly through the specialized Rab10-dependent pathway both before and after insulin stimulation.	[Brewer, Paul Duffield; Romenskaia, Irina; Mastick, Cynthia Corley] Univ Nevada, Dept Biochem & Mol Biol, Reno, NV 89557 USA; [Habtemichael, Estifanos N.] Yale Univ, Sch Med, Dept Internal Med, Sect Endocrinol & Metab, New Haven, CT 06520 USA; [Coster, Adelle C. F.] Univ New S Wales, Sch Math & Stat, Dept Appl Math, Sydney, NSW 2052, Australia	Nevada System of Higher Education (NSHE); University of Nevada Reno; Yale University; University of New South Wales Sydney	Mastick, CC (corresponding author), Univ Nevada, Dept Biochem & Mol Biol, Mailstop 330, Reno, NV 89557 USA.	cmastick@unr.edu	Coster, Adelle CF/A-7234-2013; Mastick, Cynthia/G-9841-2017; Coster, Adelle/AAX-4829-2020	Coster, Adelle CF/0000-0002-5572-6832; Mastick, Cynthia/0000-0003-4769-5412; Coster, Adelle/0000-0002-5572-6832	American Diabetes Association	American Diabetes Association(American Diabetes Association)	This work was supported by grants from the American Diabetes Association. The authors declare that they have no conflicts of interest with the contents of this article.	Babbey CM, 2010, AM J PHYSIOL-RENAL, V299, pF495, DOI 10.1152/ajprenal.00198.2010; Brewer PD, 2014, J BIOL CHEM, V289, P17280, DOI 10.1074/jbc.M114.555714; Brewer PD, 2011, J BIOL CHEM, V286, P26287, DOI 10.1074/jbc.M111.253880; Chen XW, 2007, DEV CELL, V13, P391, DOI 10.1016/j.devcel.2007.07.007; Chen XW, 2011, CELL CYCLE, V10, P2299, DOI 10.4161/cc.10.14.16524; Chen XW, 2011, MOL BIOL CELL, V22, P141, DOI 10.1091/mbc.E10-08-0665; Chen Y, 2012, J CELL BIOL, V198, P545, DOI 10.1083/jcb.201111091; CORMONT M, 1993, J BIOL CHEM, V268, P19491; Coster ACF, 2004, TRAFFIC, V5, P763, DOI 10.1111/j.1600-0854.2004.00218.x; Davey JR, 2012, TRAFFIC, V13, P1429, DOI 10.1111/j.1600-0854.2012.01397.x; Eguez L, 2005, CELL METAB, V2, P263, DOI 10.1016/j.cmet.2005.09.005; Ewing RM, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100134; Govers R, 2004, MOL CELL BIOL, V24, P6456, DOI 10.1128/MCB.24.14.6456-6466.2004; Guilherme A, 2004, J BIOL CHEM, V279, P40062, DOI 10.1074/jbc.M401918200; Habtemichael EN, 2011, J BIOL CHEM, V286, P10115, DOI 10.1074/jbc.M111.217935; Inoue M, 2003, NATURE, V422, P629, DOI 10.1038/nature01533; Ishikura S, 2008, AM J PHYSIOL-CELL PH, V295, pC1016, DOI 10.1152/ajpcell.00277.2008; Ishikura S, 2007, BIOCHEM BIOPH RES CO, V353, P1074, DOI 10.1016/j.bbrc.2006.12.140; JAMES DE, 1988, NATURE, V333, P183, DOI 10.1038/333183a0; Jedrychowski MP, 2010, J BIOL CHEM, V285, P104, DOI 10.1074/jbc.M109.040428; Jewell JL, 2011, J CELL BIOL, V193, P185, DOI 10.1083/jcb.201007176; Jiang L, 2008, J BIOL CHEM, V283, P8508, DOI 10.1074/jbc.M708688200; Jin Y, 2011, DEV CELL, V21, P1156, DOI 10.1016/j.devcel.2011.10.009; Karunanithi S, 2014, MOL BIOL CELL, V25, P3059, DOI 10.1091/mbc.E14-06-1060; Klip A, 2014, AM J PHYSIOL-CELL PH, V306, pC879, DOI 10.1152/ajpcell.00069.2014; Kobayashi H, 2012, J CELL SCI, V125, P2235, DOI 10.1242/jcs.098657; Koumanov F, 2011, J BIOL CHEM, V286, P16574, DOI 10.1074/jbc.M111.226092; Larance M, 2005, J BIOL CHEM, V280, P37803, DOI 10.1074/jbc.M503897200; Li J, 2007, J CELL BIOL, V178, P453, DOI 10.1083/jcb.200608033; Malide D, 2000, J CELL SCI, V113, P4203; Martin OJ, 2006, J BIOL CHEM, V281, P484, DOI 10.1074/jbc.M505944200; Miinea CP, 2005, BIOCHEM J, V391, P87, DOI 10.1042/BJ20050887; Muretta JM, 2008, J BIOL CHEM, V283, P311, DOI 10.1074/jbc.M705756200; Muretta JM, 2009, VITAM HORM, V80, P245, DOI 10.1016/S0083-6729(08)00610-9; Reed SE, 2013, J CELL SCI, V126, P1931, DOI 10.1242/jcs.104307; Roland JT, 2009, J BIOL CHEM, V284, P1213, DOI 10.1074/jbc.M805957200; Sadacca LA, 2013, MOL BIOL CELL, V24, P2544, DOI 10.1091/mbc.E13-02-0103; Sakamoto K, 2008, AM J PHYSIOL-ENDOC M, V295, pE29, DOI 10.1152/ajpendo.90331.2008; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Sano H, 2008, BIOCHEM J, V411, P89, DOI 10.1042/BJ20071318; Sano H, 2007, CELL METAB, V5, P293, DOI 10.1016/j.cmet.2007.03.001; Sano H, 2015, BIOCHEM BIOPH RES CO, V465, P601, DOI 10.1016/j.bbrc.2015.08.069; Shi AB, 2010, MOL BIOL CELL, V21, P2930, DOI 10.1091/mbc.E10-02-0149; SLOT JW, 1991, J CELL BIOL, V113, P123, DOI 10.1083/jcb.113.1.123; Stockli J, 2011, J CELL SCI, V124, P4147, DOI 10.1242/jcs.097063; Sun Y, 2010, P NATL ACAD SCI USA, V107, P19909, DOI 10.1073/pnas.1009523107; Tan SX, 2012, MOL CELL BIOL, V32, P4946, DOI 10.1128/MCB.00761-12; WILEY HS, 1982, J BIOL CHEM, V257, P4222; Xu YK, 2011, J CELL BIOL, V193, P643, DOI 10.1083/jcb.201008135; Yoshizaki T, 2007, MOL CELL BIOL, V27, P5172, DOI 10.1128/MCB.02298-06	50	14	14	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 8	2016	291	2					773	789		10.1074/jbc.M115.694919	http://dx.doi.org/10.1074/jbc.M115.694919			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DA5GF	26527681	Green Published, hybrid			2022-12-26	WOS:000367830500025
J	Bohr, S; Patel, SJ; Vasko, R; Shen, KY; Golberg, A; Berthiaume, F; Yarmush, ML				Bohr, Stefan; Patel, Suraj J.; Vasko, Radovan; Shen, Keyue; Golberg, Alexander; Berthiaume, Francois; Yarmush, Martin L.			The Role of CHI3L1 (Chitinase-3-Like-1) in the Pathogenesis of Infections in Burns in a Mouse Model	PLOS ONE			English	Article							COLONIC EPITHELIAL-CELLS; CHITIN-BINDING PROTEINS; INFLAMMATORY-BOWEL-DISEASE; NECROSIS-FACTOR-ALPHA; PSEUDOMONAS-AERUGINOSA; GENE-EXPRESSION; SERUM YKL-40; INTESTINAL INFLAMMATION; RHEUMATOID-ARTHRITIS; BACTERIAL ADHESION	In severe burn injury the unique setting of a depleted, dysfunctional immune system along with a loss of barrier function commonly results in opportunistic infections that eventually proof fatal. Unfortunately, the dynamic sequence of bacterial contamination, colonization and eventually septic invasion with bacteria such as Pseudomonas species is still poorly understood although a limiting factor in clinical decision making. Increasing evidence supports the notion that inhibition of bacterial translocation into the wound site may be an effective alternative to prevent infection. In this context we investigated the role of the mammalian Chitinase-3-Like-1 (CHI3L1) non-enyzmatic protein predominately expressed on epithelial as well as innate immune cells as a potential bacterial-translocation-mediating factor. We show a strong trend that a modulation of chitinase expression is likely to be effective in reducing mortality rates in a mouse model of burn injury with superinfection with the opportunistic PA14 Pseudomonas strain, thus demonstrating possible clinical leverage.	[Bohr, Stefan; Patel, Suraj J.; Shen, Keyue; Golberg, Alexander; Yarmush, Martin L.] Harvard Univ, Sch Med, Shriners Hosp Children, Ctr Engn Med, Boston, MA 02138 USA; [Bohr, Stefan; Patel, Suraj J.; Shen, Keyue; Golberg, Alexander; Yarmush, Martin L.] Harvard Univ, Sch Med, Dept Surg, Massachusetts Gen Hosp, Boston, MA 02115 USA; [Vasko, Radovan] New York Med Coll, Dept Med, Valhalla, NY 10595 USA; [Berthiaume, Francois; Yarmush, Martin L.] Rutgers State Univ, Dept Biomed Engn, New Brunswick, NJ USA; [Bohr, Stefan] Rhein Westfal TH Aachen, UKA Univ Clin, Dept Plast & Hand Surg, Burn Ctr, D-52062 Aachen, Germany; [Vasko, Radovan] UMG Univ Clin, Dept Nephrol & Rheumatol, Gottingen, Germany; [Golberg, Alexander] Tel Aviv Univ, Porter Sch Environm Studies, IL-69978 Tel Aviv, Israel	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Massachusetts General Hospital; New York Medical College; Rutgers State University New Brunswick; RWTH Aachen University; RWTH Aachen University Hospital; Tel Aviv University	Bohr, S (corresponding author), Harvard Univ, Sch Med, Shriners Hosp Children, Ctr Engn Med, Boston, MA 02138 USA.	sbohr@ukaachen.de	Golberg, Alexander/M-9563-2017; Berthiaume, Francois/ABD-2139-2020	Golberg, Alexander/0000-0001-8782-8879; Yarmush, Martin/0000-0003-4986-8444	Shriners Hospitals for Children; Deutsche Forschungs Gemeinschaft (DFG, Germany) postdoctoral fellowship award [GZ:BO3468/2-1]	Shriners Hospitals for Children; Deutsche Forschungs Gemeinschaft (DFG, Germany) postdoctoral fellowship award	This work was funded by the Shriners Hospitals for Children, https://www.shrinershospitalsforchildren.org/locations/boston. SB is a receipt of a Deutsche Forschungs Gemeinschaft (DFG, Germany) postdoctoral fellowship award (GZ:BO3468/2-1), http://www.dfg.de/en/.	Adrangi S, 2013, BIOTECHNOL ADV, V31, P1786, DOI 10.1016/j.biotechadv.2013.09.012; Atiyeh BS, 2005, WORLD J SURG, V29, P131, DOI 10.1007/s00268-004-1082-2; Aziz M, 2013, J LEUKOCYTE BIOL, V93, P329, DOI 10.1189/jlb.0912437; Azzopardi EA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095042; Baeten D, 2000, ANN RHEUM DIS, V59, P945, DOI 10.1136/ard.59.12.945; Barret JP, 2003, PLAST RECONSTR SURG, V111, P744, DOI 10.1097/01.PRS.0000041445.76730.23; Bohr S, 2013, P NATL ACAD SCI USA, V110, P3513, DOI 10.1073/pnas.1214099110; Bohr S, 2013, WOUND REPAIR REGEN, V21, P35, DOI 10.1111/j.1524-475X.2012.00853.x; Boot RG, 1999, ARTERIOSCL THROM VAS, V19, P687, DOI 10.1161/01.ATV.19.3.687; Brusselaers N, 2010, CRIT CARE, V14, DOI 10.1186/cc9300; CARTER PB, 1974, J EXP MED, V139, P1189, DOI 10.1084/jem.139.5.1189; Church D, 2006, CLIN MICROBIOL REV, V19, P403, DOI 10.1128/CMR.19.2.403-434.2006; Cintin C, 1999, BRIT J CANCER, V79, P1494, DOI 10.1038/sj.bjc.6690238; Da Silva CA, 2008, J IMMUNOL, V181, P4279, DOI 10.4049/jimmunol.181.6.4279; DiGiandomenico A, 2007, P NATL ACAD SCI USA, V104, P4624, DOI 10.1073/pnas.0608657104; Duan XB, 2008, J LEUKOCYTE BIOL, V83, P305, DOI 10.1189/jlb.0407228; Duru S, 2013, TUBERK TORAK, V61, P71, DOI 10.5578/tt.3773; Elias JA, 2003, J CLIN INVEST, V111, P291, DOI 10.1172/JCI200317748; Erol S, 2004, BURNS, V30, P357, DOI 10.1016/j.burns.2003.12.013; Folders J, 2000, J BACTERIOL, V182, P1257, DOI 10.1128/JB.182.5.1257-1263.2000; Frederiksen RF, 2013, MICROBIOL-SGM, V159, P833, DOI 10.1099/mic.0.051839-0; Friedman L, 2004, J BACTERIOL, V186, P4457, DOI 10.1128/JB.186.14.4457-4465.2004; FUCHS RL, 1986, APPL ENVIRON MICROB, V51, P504, DOI 10.1128/AEM.51.3.504-509.1986; Holder IA, 2001, J BURN CARE REHABIL, V22, P311, DOI 10.1097/00004630-200109000-00004; Holmes CJ, 2015, ADV WOUND CARE, V4, P24, DOI 10.1089/wound.2014.0546; Jeon SJ, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0092723, 10.1109/CICC.2014.6946008]; Johansen JS, 1997, SCAND J GASTROENTERO, V32, P582, DOI 10.3109/00365529709025104; Johansen JS, 2015, CANCER EPIDEM BIOMAR, V24, P621, DOI 10.1158/1055-9965.EPI-13-1281; Kamba A, 2013, CURR MOL MED, V13, P1110; Karavolos MH, 2014, ADV EXP MED BIOL, V817, P241, DOI 10.1007/978-1-4939-0897-4_11; Kawada M, 2008, LAB INVEST, V88, P883, DOI 10.1038/labinvest.2008.47; Kawada Mayumi, 2007, Keio Journal of Medicine, V56, P21, DOI 10.2302/kjm.56.21; Kurihara T, 2013, FASEB J, V27, P2270, DOI 10.1096/fj.12-219519; Lee CG, 2011, ANNU REV PHYSIOL, V73, P479, DOI 10.1146/annurev-physiol-012110-142250; Lee CG, 2009, YONSEI MED J, V50, P22, DOI 10.3349/ymj.2009.50.1.22; Lee CG, 2008, CURR OPIN IMMUNOL, V20, P684, DOI 10.1016/j.coi.2008.10.002; Lewis K, 2010, INFLAMM BOWEL DIS, V16, P1138, DOI 10.1002/ibd.21177; Libreros S, 2012, INT J CANCER, V131, P377, DOI 10.1002/ijc.26379; Ling H, 2004, BIOCHEM J, V380, P651, DOI 10.1042/BJ20040099; Liu XM, 2014, MED ONCOL, V31, DOI 10.1007/s12032-014-0085-6; Liu Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090494; Lord JM, 2014, LANCET, V384, P1455, DOI 10.1016/S0140-6736(14)60687-5; Malaguarnera L, 2005, J CLIN LAB ANAL, V19, P128, DOI 10.1002/jcla.20063; Manafi A, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-23; Manjeet K, 2013, MICROBIOL RES, V168, P461, DOI 10.1016/j.micres.2013.01.006; Manos J, 2009, FEMS MICROBIOL LETT, V292, P107, DOI 10.1111/j.1574-6968.2008.01472.x; MANSON WL, 1992, J HOSP INFECT, V22, P55, DOI 10.1016/0195-6701(92)90130-E; MANSON WL, 1992, BURNS, V18, P98, DOI 10.1016/0305-4179(92)90002-C; Mizoguchi E, 2006, GASTROENTEROLOGY, V130, P398, DOI 10.1053/j.gastro.2005.12.007; Mulcahy LR, 2014, MICROB ECOL, V68, P1, DOI 10.1007/s00248-013-0297-x; Nemzek JA, 2008, COMPARATIVE MED, V58, P120; Recklies AD, 2002, BIOCHEM J, V365, P119, DOI 10.1042/BJ20020075; Rehli M, 2003, J BIOL CHEM, V278, P44058, DOI 10.1074/jbc.M306792200; Ridker PM, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.000897; Rojas Y, 2012, EXPERT OPIN PHARMACO, V13, P2485, DOI 10.1517/14656566.2012.738195; Shen HT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050238; Shimizu Kentaro, 2015, Burns, V41, pe28, DOI 10.1016/j.burns.2014.10.019; Smyth D, 2012, CELL MICROBIOL, V14, P1257, DOI 10.1111/j.1462-5822.2012.01796.x; Swartjes JJ, 2014, CURR MED CHEM; Thompson CM, 2014, CRIT CARE MED, V42, P1397, DOI 10.1097/CCM.0000000000000218; Tran A, 2000, EUR J GASTROEN HEPAT, V12, P989, DOI 10.1097/00042737-200012090-00004; Tran HT, 2011, HISTOL HISTOPATHOL, V26, P1453, DOI 10.14670/HH-26.1453; Unal S, 2005, ANN PLAS SURG, V55, P102, DOI 10.1097/01.sap.0000164531.23770.60; Vind I, 2003, SCAND J GASTROENTERO, V38, P599, DOI 10.1080/00365520310000537; Volck B, 1998, P ASSOC AM PHYSICIAN, V110, P351; Volck B, 2001, OSTEOARTHR CARTILAGE, V9, P203, DOI 10.1053/joca.2000.0377; Wong VW, 2013, PLAST RECONSTR SURG, V132, p854E, DOI 10.1097/PRS.0b013e3182a3c11e	67	9	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2015	10	11							e0140440	10.1371/journal.pone.0140440	http://dx.doi.org/10.1371/journal.pone.0140440			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV1QH	26528713	Green Published, gold, Green Submitted			2022-12-26	WOS:000364032600006
J	Tiira, K; Lohi, H				Tiira, Katriina; Lohi, Hannes			Early Life Experiences and Exercise Associate with Canine Anxieties	PLOS ONE			English	Article							SEPARATION ANXIETY; MATERNAL-BEHAVIOR; GENETIC-ANALYSIS; GUIDE-DOGS; STRESS; PERSONALITY; FEAR; TEMPERAMENT; SUITABILITY; PREVALENCE	Personality and anxiety disorders across species are affected by genetic and environmental factors. Shyness-boldness personality continuum exists across species, including the domestic dog, with a large within-and across-breed variation. Domestic dogs are also diagnosed for several anxiety-related behavioral conditions, such as generalized anxiety disorders, phobias, and separation anxiety. Genetic and environmental factors contributing to personality and anxiety are largely unknown. We collected questionnaire data from a Finnish family dog population (N = 3264) in order to study the associating environmental factors for canine fearfulness, noise sensitivity, and separation anxiety. Early life experiences and exercise were found to associate with anxiety prevalence. We found that fearful dogs had less socialization experiences (p = 0.002) and lower quality of maternal care (p < 0.0001) during puppyhood. Surprisingly, the largest environmental factor associating with noise sensitivity (p < 0.0001) and separation anxiety (p = 0.007) was the amount of daily exercise; dogs with noise sensitivity and separation anxiety had less daily exercise. Our findings suggest that dogs share many of the same environmental factors that contribute to anxiety in other species as well, such as humans and rodents. Our study highlights the importance of early life experiences, especially the quality of maternal care and daily exercise for the welfare and management of the dogs, and reveals important confounding factors to be considered in the genetic characterization of canine anxiety.	[Tiira, Katriina; Lohi, Hannes] Univ Helsinki, Dept Vet Biosci, FIN-00014 Helsinki, Finland; [Tiira, Katriina; Lohi, Hannes] Univ Helsinki, Res Programs Unit, Mol Neurol, FIN-00014 Helsinki, Finland; [Tiira, Katriina; Lohi, Hannes] Folkhalsan Res Ctr, Helsinki, Finland	University of Helsinki; University of Helsinki; Folkhalsan Research Center	Lohi, H (corresponding author), Univ Helsinki, Dept Vet Biosci, POB 63, FIN-00014 Helsinki, Finland.	hannes.lohi@helsinki.fi	Lohi, Hannes/F-4596-2011; Tiira, Katriina/U-4035-2018	Lohi, Hannes/0000-0003-1087-5532; Tiira, Katriina/0000-0002-2253-8755	ERC [260997]; Jane and Aatos Erkko Foundation; Academy of Finland; Finnish Cultural Foundation; Finnish Kennel Club	ERC(European Research Council (ERC)European Commission); Jane and Aatos Erkko Foundation; Academy of Finland(Academy of Finland); Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); Finnish Kennel Club	This work was supported by ERC Starting Grant 260997 (http://erc.europa.eu/starting-grants) to HL, Jane and Aatos Erkko Foundation (http://www.jaes.fi/en/) to HL, the Academy of Finland (http://www.aka.fi/en) to HL, Finnish Cultural Foundation (https://skr.fi/en) to KT and The Finnish Kennel Club (http://www.kennelliitto.fi/en) to KT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appleby DL, 2002, VET REC, V150, P434, DOI 10.1136/vr.150.14.434; Arvelius P, 2014, J ANIM SCI, V92, P4843, DOI 10.2527/jas.2014-8169; Bamberger M, 2006, JAVMA-J AM VET MED A, V229, P1591, DOI 10.2460/javma.229.10.1591; Blackwell EJ, 2013, APPL ANIM BEHAV SCI, V145, P15, DOI 10.1016/j.applanim.2012.12.004; Bouchard TJ, 2001, BEHAV GENET, V31, P243; Carere C., 2013, ANIMAL PERSONALITIES; Champagne FA, 2010, DEV PSYCHOBIOL, V52, P299, DOI 10.1002/dev.20436; COHEN S, 1985, PSYCHOL BULL, V98, P310, DOI 10.1037/0033-2909.98.2.310; Conn VS, 2010, ANN BEHAV MED, V39, P128, DOI 10.1007/s12160-010-9172-x; Dale AR, 2010, NEW ZEAL VET J, V58, P286, DOI 10.1080/00480169.2010.69403; Dias BG, 2014, NAT NEUROSCI, V17, P89, DOI 10.1038/nn.3594; Dias BG, 2013, CURR OPIN NEUROBIOL, V23, P346, DOI 10.1016/j.conb.2013.01.013; Dodman NH, 2010, MOL PSYCHIATR, V15, P8, DOI 10.1038/mp.2009.111; Dreschel NA, 2005, APPL ANIM BEHAV SCI, V95, P153, DOI 10.1016/j.applanim.2005.04.009; Dwyer CM, 2004, HORM BEHAV, V46, P529, DOI 10.1016/j.yhbeh.2004.05.011; Epstein S., 1972, ANXIETY CURR TRENDS, V2, P291, DOI 10.1016/B978-0-12-657402-9.50007-7; Feng XL, 2011, P NATL ACAD SCI USA, V108, P14312, DOI 10.1073/pnas.1010943108; Foyer P, 2013, APPL ANIM BEHAV SCI, V146, P79, DOI 10.1016/j.applanim.2013.03.013; Foyer P, 2014, APPL ANIM BEHAV SCI, V155, P93, DOI 10.1016/j.applanim.2014.03.006; Fratkin JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054907; GODDARD ME, 1982, THEOR APPL GENET, V62, P97, DOI 10.1007/BF00293339; GODDARD ME, 1983, APPL ANIM ETHOL, V9, P299, DOI 10.1016/0304-3762(83)90010-X; Grippo AJ, 2007, PSYCHONEUROENDOCRINO, V32, P966, DOI 10.1016/j.psyneuen.2007.07.004; Jagoe A, 1996, APPL ANIM BEHAV SCI, V47, P31, DOI 10.1016/0168-1591(95)01008-4; Jones AC, 2005, APPL ANIM BEHAV SCI, V95, P1, DOI 10.1016/j.applanim.2005.04.008; Kubinyi E, 2009, BEHAV PROCESS, V81, P392, DOI 10.1016/j.beproc.2009.04.004; Leckman JF, 2002, BIOL PSYCHIAT, V51, P27, DOI 10.1016/S0006-3223(01)01277-X; Levine ED, 2009, BSAVA MANUAL CANINE, V2nd, P159, DOI [10.22233/9781905319879.15, DOI 10.22233/9781905319879.15]; Lord K, 2013, BEHAV PROCESS, V92, P131, DOI 10.1016/j.beproc.2012.10.009; McGreevy PD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080529; Mendl M, 2010, P ROY SOC B-BIOL SCI, V277, P2895, DOI 10.1098/rspb.2010.0303; Mills D, 2005, IN PRACTICE, V27, P248; Nettle D, 2006, AM PSYCHOL, V61, P622, DOI 10.1037/0003-066X.61.6.622; Ohman A, 2008, HDB EMOTIONS, P709; Overall KL, 2001, J AM VET MED ASSOC, V219, P467, DOI 10.2460/javma.2001.219.467; Overall KL, 2000, PROG NEURO-PSYCHOPH, V24, P727, DOI 10.1016/S0278-5846(00)00104-4; Overall KL, 2013, MANUAL CLIN BEHAV ME, V1st; Parker KJ, 2004, ARCH GEN PSYCHIAT, V61, P933, DOI 10.1001/archpsyc.61.9.933; Pluijmakers JJTM, 2010, APPL ANIM BEHAV SCI, V126, P51, DOI 10.1016/j.applanim.2010.05.006; Rilling JK, 2014, SCIENCE, V345, P771, DOI 10.1126/science.1252723; Riva J, 2008, APPL ANIM BEHAV SCI, V114, P168, DOI 10.1016/j.applanim.2008.01.020; Roth TL, 2012, DEV PSYCHOBIOL, V54, P590, DOI 10.1002/dev.20550; Ruscio MG, 2007, HORM BEHAV, V51, P54, DOI 10.1016/j.yhbeh.2006.08.004; Saeki Y., 1979, Japanese Poultry Science, V16, P121; Salim S, 2010, BEHAV BRAIN RES, V208, P545, DOI 10.1016/j.bbr.2009.12.039; Salmon P, 2001, CLIN PSYCHOL REV, V21, P33, DOI 10.1016/S0272-7358(99)00032-X; SCOTT JP, 1950, J GENET PSYCHOL, V77, P25; Scott JP, 1997, GENETICS SOCIAL BEHA; Sherman BL, 2008, VET CLIN N AM-SMALL, V38, P1081, DOI 10.1016/j.cvsm.2008.04.012; Sih A, 2004, Q REV BIOL, V79, P241, DOI 10.1086/422893; Spain CV, 2004, JAVMA-J AM VET MED A, V224, P380, DOI 10.2460/javma.2004.224.380; Stamatakis A, 2008, STRESS, V11, P148, DOI 10.1080/10253890701653039; Stamps J, 2010, BIOL REV, V85, P301, DOI 10.1111/j.1469-185X.2009.00103.x; Starling MJ, 2013, BEHAV PROCESS, V97, P53, DOI 10.1016/j.beproc.2013.04.008; Svartberg K, 2002, APPL ANIM BEHAV SCI, V79, P157, DOI 10.1016/S0168-1591(02)00120-X; Svartberg K, 2007, BEHAVIOURAL BIOLOGY OF DOGS, P182, DOI 10.1079/9781845931872.0182; Tami G, 2008, J VET BEHAV, V3, P59, DOI 10.1016/j.jveb.2007.09.002; Tami G, 2009, APPL ANIM BEHAV SCI, V120, P159, DOI 10.1016/j.applanim.2009.06.009; Tiira K, 2014, APPL ANIM BEHAV SCI, V155, P82, DOI 10.1016/j.applanim.2014.03.007; Tiira K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041684; van der Waaij EH, 2008, J ANIM SCI, V86, P2853, DOI 10.2527/jas.2007-0616; Weaver ICG, 2004, NAT NEUROSCI, V7, P847, DOI 10.1038/nn1276; Wipfli B, 2011, SCAND J MED SCI SPOR, V21, P474, DOI 10.1111/j.1600-0838.2009.01049.x; YOUNG PT, 1959, PSYCHOL REV, V66, P104, DOI 10.1037/h0045997	64	64	64	4	132	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2015	10	11							e0141907	10.1371/journal.pone.0141907	http://dx.doi.org/10.1371/journal.pone.0141907			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV1QH	26528555	Green Published, Green Submitted, gold			2022-12-26	WOS:000364032600075
J	Calado, GP; Lopes, AJO; Costa, LM; Lima, FDA; Silva, LA; Pereira, WS; do Amaral, FMM; Garcia, JBS; Cartagenes, MDD; Nascimento, FRF				Calado, Gustavo P.; Lopes, Alberto Jorge O.; Costa Junior, Livio M.; Lima, Francisco das Chagas A.; Silva, Lucilene A.; Pereira, Wanderson S.; do Amaral, Flavia M. M.; Garcia, Joao Batista S.; Cartagenes, Maria do Socorro de S.; Nascimento, Flavia R. F.			Chenopodium ambrosioides L. Reduces Synovial Inflammation and Pain in Experimental Osteoarthritis	PLOS ONE			English	Article							RAT MODEL; DOCKING	The chronicity of osteoarthritis (OA), characterized by pain and inflammation in the joints, is linked to a glutamate receptor, N-methyl-D-aspartate (NMDA). The use of plant species such as Chenopodium ambrosioides L. (Amaranthaceae) as NMDA antagonists offers a promising perspective. This work aims to analyze the antinociceptive and anti-inflammatory responses of the crude hydroalcoholic extract (HCE) of C. ambrosioides leaves in an experimental OA model. Wistar rats were separated into six groups (n = 24): clean (C), negative control (CTL-), positive control (CTL+), HCE0.5, HCE5 and HCE50. The first group received no intervention. The other groups received an intra-articular injection of sodium monoiodoacetate (MIA) (8 mg/kg) on day 0. After six hours, they were orally treated with saline, Maxicam plus (meloxicam + chondroitin sulfate) and HCE at doses of 0.5 mg/kg, 5 mg/kg and 50 mg/kg, respectively. After three, seven and ten days, clinical evaluations were performed (knee diameter, mechanical allodynia, mechanical hyperalgesia and motor activity). On the tenth day, after euthanasia, synovial fluid and draining lymph node were collected for cellular quantification, and cartilage was collected for histopathological analysis. Finally, molecular docking was performed to evaluate the compatibility of ascaridole, a monoterpene found in HCE, with the NMDA receptor. After the third day, HCE reduced knee edema. HCE5 showed less cellular infiltrate in the cartilage and synovium and lower intensities of allodynia from the third day and of hyperalgesia from the seventh day up to the last treatment day. The HCE5 and HCE50 groups improved in forced walking. In relation to molecular docking, ascaridole showed NMDA receptor binding affinity. C. ambrosioides HCE was effective in the treatment of OA because it reduced synovial inflammation and behavioral changes due to pain. This effect may be related to the antagonistic effect of ascaridole on the NMDA receptor.	[Calado, Gustavo P.; Lopes, Alberto Jorge O.; Costa Junior, Livio M.; Silva, Lucilene A.; Pereira, Wanderson S.; do Amaral, Flavia M. M.; Garcia, Joao Batista S.; Cartagenes, Maria do Socorro de S.; Nascimento, Flavia R. F.] Univ Fed Maranhao, Biol & Hlth Sci Ctr, Hlth Sci Grad Program, BR-6508580 Sao Luis, MA, Brazil; [Lima, Francisco das Chagas A.] Univ Estadual Piaui, Dept Chem, Quantum Chem Computat Grp, Chem Grad Program, BR-64002150 Teresina, PI, Brazil	Universidade Federal do Maranhao; Universidade Estadual do Piaui (UESPI)	Nascimento, FRF (corresponding author), Univ Fed Maranhao, Biol & Hlth Sci Ctr, Hlth Sci Grad Program, Av Portugueses 1966, BR-6508580 Sao Luis, MA, Brazil.	nascimentofrf@yahoo.com.br	Lima, Francisco das Chagas das Chagas Alves/D-8730-2017; LOPES, ALBERTO JORGE OLIVEIRA/AAS-9995-2020; Costa-Junior, Livio M/H-7530-2012; Nascimento, Flavia/F-8173-2016	Lima, Francisco das Chagas das Chagas Alves/0000-0002-0447-4911; LOPES, ALBERTO JORGE OLIVEIRA/0000-0001-5267-9500; Costa-Junior, Livio M/0000-0002-1475-049X; Nascimento, Flavia/0000-0001-9328-1806	Fundacao de Amparo a Pesquisa e ao Desenvolvimento Cientifico e Tecnologico do Maranhao (FAPEMA); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Conselho Nacional de Desenvolvimento em Pesquisa (CNPq)	Fundacao de Amparo a Pesquisa e ao Desenvolvimento Cientifico e Tecnologico do Maranhao (FAPEMA)(Fundacao de Amparo a Pesquisa e Desenvolvimento Cientifico do Maranhao (FAPEMA)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento em Pesquisa (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by grants from Fundacao de Amparo a Pesquisa e ao Desenvolvimento Cientifico e Tecnologico do Maranhao (FAPEMA), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) and Conselho Nacional de Desenvolvimento em Pesquisa (CNPq).	Castro RR, 2008, OSTEOARTHRIITIS CART, V14, P769; Dembitsky V, 2008, BIOMED PAP, V152, P209, DOI 10.5507/bp.2008.032; Fernihough J, 2004, PAIN, V112, P83, DOI 10.1016/j.pain.2004.08.004; Goh JZ, 2015, INT J NANOMED, V10, P297, DOI 10.2147/IJN.S75545; Goodsell DS, 1996, J MOL RECOGNIT, V9, P1, DOI 10.1002/(SICI)1099-1352(199601)9:1<1::AID-JMR241>3.0.CO;2-6; Ibironke G. F., 2007, IJP - International Journal of Pharmacology, V3, P111; Ishizuka Pedro, 2007, Rev. Bras. Anestesiol., V57, P19, DOI 10.1590/S0034-70942007000100003; Kiselycznyk C, 2015, BEHAV BRAIN RES, V287, P89, DOI 10.1016/j.bbr.2015.03.023; Kitchen DB, 2004, NAT REV DRUG DISCOV, V3, P935, DOI 10.1038/nrd1549; Kumar R, 2007, INT J FOOD MICROBIOL, V115, P159, DOI 10.1016/j.ijfoodmicro.2006.10.017; Laskowski RA, 2011, J CHEM INF MODEL, V51, P2778, DOI 10.1021/ci200227u; Lee CH, 2009, OSTEOARTHR CARTILAGE, V17, P1485, DOI 10.1016/j.joca.2009.05.006; Liu GW, 2011, IMMUNOL CELL BIOL, V89, P130, DOI 10.1038/icb.2010.70; Lorenzi H., 2002, PLANTAS MED BRASIL N; Mannelli LD, 2013, BMC MUSCULOSKEL DIS, V14, DOI 10.1186/1471-2474-14-228; Martinez FO, 2013, BLOOD, V121, pE57, DOI 10.1182/blood-2012-06-436212; Matos F.J.A., 1997, INTRO FITOQUIMICA EX, V2a; Moller KA, 1998, J NEUROSCI METH, V84, P41, DOI 10.1016/S0165-0270(98)00083-1; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Nascimento FRF, 2006, LIFE SCI, V78, P2650, DOI 10.1016/j.lfs.2005.10.006; Neiva VS, 2011, REV CIENCIAS SAUDE, V13, P155; Olajide O. A., 1997, Fitoterapia, V68, P529; Pastor J, 2015, ACTA TROP, V145, P31, DOI 10.1016/j.actatropica.2015.02.002; Patricio FJ, 2008, J ETHNOPHARMACOL, V115, P313, DOI 10.1016/j.jep.2007.10.009; Pereira WS, 2010, J ETHNOPHARMACOL, V127, P602, DOI 10.1016/j.jep.2009.12.018; PINHEIRO VF, 2005, J BRASILEIRO FITOMED, V3, P62; Rahman W, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/s13075-014-0509-x; Ramos RM, 2012, J MOL MODEL, V18, P4013, DOI 10.1007/s00894-012-1383-6; RANDALL LO, 1957, ARCH INT PHARMACOD T, V111, P409; Rocha FAC, 2003, REV BRAS REUMATOL, V43, P206; Sousa LHA, 2012, REV CIENC SAUDE, V14; Stierand K, 2010, ACS MED CHEM LETT, V1, P540, DOI 10.1021/ml100164p; TrivellatoGrassi L, 2013, J ETHNOPHARMACOL, V145, P127, DOI 10.1016/j.jep.2012.10.040; Yassin NZ, 2015, DRUG DES DEV THER, V9, P1491, DOI 10.2147/DDDT.S79957; Ye H, 2015, WORLD J GASTROENTERO, V21, P4178, DOI 10.3748/wjg.v21.i14.4178	35	25	26	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2015	10	11							e0141886	10.1371/journal.pone.0141886	http://dx.doi.org/10.1371/journal.pone.0141886			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV1PG	26524084	Green Submitted, gold, Green Published			2022-12-26	WOS:000364029800027
J	Schoeman, DS; Schlacher, TA; Jones, AR; Murray, A; Huijbers, CM; Olds, AD; Connolly, RM				Schoeman, David S.; Schlacher, Thomas A.; Jones, Alan R.; Murray, Anna; Huijbers, Chantal M.; Olds, Andrew D.; Connolly, Rod M.			Edging along a Warming Coast: A Range Extension for a Common Sandy Beach Crab	PLOS ONE			English	Article							CLIMATE-CHANGE IMPACTS; GHOST CRABS; DECAPODA BRACHYURA; MARINE LIFE; OCYPODE; CONSERVATION; SHIFTS; BIODIVERSITY; SYSTEMS; LIMITS	Determining the position of range edges is the first step in developing an understanding of the ecological and evolutionary dynamics in play as species' ranges shift in response to climate change. Here, we study the leading (poleward) range edge of Ocypode cordimanus, a ghost crab that is common along the central to northern east coast of Australia. Our study establishes the poleward range edge of adults of this species to be at Merimbula (36.90 degrees S, 149.93 degrees E), 270 km (along the coast) south of the previous southernmost museum record. We also establish that dispersal of pelagic larvae results in recruitment to beaches 248 km (along the coast; 0.9 degrees of latitude) beyond the adult range edge we have documented here. Although we cannot conclusively demonstrate that the leading range edge for this species has moved polewards in response to climate change, this range edge does fall within a "hotspot" of ocean warming, where surface isotherms are moving southwards along the coast at 20-50 km. decade(-1); coastal air temperatures in the region are also warming. If these patterns persist, future range extensions could be anticipated. On the basis of their ecology, allied with their occupancy of ocean beaches, which are home to taxa that are particularly amenable to climate-change studies, we propose that ghost crabs like O. cordimanus represent ideal model organisms with which to study ecological and evolutionary processes associated with climate change. The fact that "hotspots" of ocean warming on four other continents correspond with poleward range edges of ghost crab species suggests that results of hypothesis tests could be generalized, yielding excellent opportunities to rapidly progress knowledge in this field.	[Schoeman, David S.; Schlacher, Thomas A.; Huijbers, Chantal M.; Olds, Andrew D.] Univ Sunshine Coast, Sch Sci & Engn, Maroochydore DC, Sippy Downs, Qld 4558, Australia; [Jones, Alan R.; Murray, Anna] Australian Museum Res Inst, Sydney, NSW 2010, Australia; [Huijbers, Chantal M.; Connolly, Rod M.] Griffith Univ, Australian Rivers Inst Coast & Estuaries, Gold Coast, Qld 4222, Australia; [Huijbers, Chantal M.; Connolly, Rod M.] Griffith Univ, Sch Environm, Gold Coast, Qld 4222, Australia	University of the Sunshine Coast; Australian Museum; Griffith University; Griffith University	Schoeman, DS (corresponding author), Univ Sunshine Coast, Sch Sci & Engn, Maroochydore DC, Sippy Downs, Qld 4558, Australia.	dschoema@usc.edu.au	Huijbers, Chantal/J-5176-2014; Schlacher, Thomas/J-4614-2016; Connolly, Rod M/C-4094-2008	Huijbers, Chantal/0000-0001-5206-3415; Schlacher, Thomas/0000-0003-2184-9217; Connolly, Rod M/0000-0001-6223-1291; Murray, Anna/0000-0002-1765-1286; Schoeman, David/0000-0003-1258-0885; Olds, Andrew/0000-0002-8027-3599	Australian Commonwealth Government's Collaborative Research Network (CRN) Program; University of the Sunshine [USC/CRN2012/01]	Australian Commonwealth Government's Collaborative Research Network (CRN) Program; University of the Sunshine	This work was funded through the Australian Commonwealth Government's Collaborative Research Network (CRN) Program and the University of the Sunshine Coast Collaborative Research Networks Seed Funding Grant USC/CRN2012/01 to Assoc Prof Schoeman, Prof Thomas Schlacher, and Prof Rod Connolly. The funders had no role in the design, analysis or interpretation of this work.	Bates AE, 2015, DIVERS DISTRIB, V21, P13, DOI 10.1111/ddi.12263; Bates AE, 2014, GLOBAL ENVIRON CHANG, V26, P27, DOI 10.1016/j.gloenvcha.2014.03.009; Bates AE, 2014, NAT CLIM CHANGE, V4, P62, DOI 10.1038/NCLIMATE2062; Brown CJ, 2011, GLOBAL CHANGE BIOL, V17, P3697, DOI 10.1111/j.1365-2486.2011.02531.x; Burrows MT, 2014, NATURE, V507, P492, DOI 10.1038/nature12976; Burrows MT, 2011, SCIENCE, V334, P652, DOI 10.1126/science.1210288; Cheung WWL, 2013, NATURE, V497, P365, DOI 10.1038/nature12156; Cheung WWL, 2009, FISH FISH, V10, P235, DOI 10.1111/j.1467-2979.2008.00315.x; Davey K, 1998, PHOTOGRAPHIC GUIDE S, P1; Dawson TP, 2011, SCIENCE, V332, P53, DOI 10.1126/science.1200303; Elith J, 2010, METHODS ECOL EVOL, V1, P330, DOI 10.1111/j.2041-210X.2010.00036.x; Elton CS, 1930, ANIMAL ECOLOGY AND E; Fuentes M. M. P. B., 2009, Endangered Species Research, V9, P33, DOI 10.3354/esr00224; Gaston KJ, 2009, P R SOC B, V276, P1395, DOI 10.1098/rspb.2008.1480; Gaston KJ, 2000, NATURE, V405, P220, DOI 10.1038/35012228; Geber MA, 2011, AM NAT, V178, pS1, DOI 10.1086/661899; Grinnell J, 1917, AM NAT, V51, P115, DOI 10.1086/279591; Hannah L, 2013, P NATL ACAD SCI USA, V110, P6907, DOI 10.1073/pnas.1210127110; Harris I, 2014, INT J CLIMATOL, V34, P623, DOI 10.1002/joc.3711; Harris L, 2014, DIVERS DISTRIB, V20, P1120, DOI 10.1111/ddi.12226; Hobday AJ, 2014, REV FISH BIOL FISHER, V24, P415, DOI 10.1007/s11160-013-9326-6; Hollowed AB, 2013, ICES J MAR SCI, V70, P1023, DOI 10.1093/icesjms/fst081; Huang JF, 1998, CRUSTACEANA, V71, P942, DOI 10.1163/156854098X00941; Jones DS, 2012, INTEGR COMP BIOL, V52, P366, DOI 10.1093/icb/ics100; Last PR, 2011, GLOBAL ECOL BIOGEOGR, V20, P58, DOI 10.1111/j.1466-8238.2010.00575.x; Ling SD, 2012, ECOL APPL, V22, P1232, DOI 10.1890/11-1587.1; Ling SD, 2009, GLOBAL CHANGE BIOL, V15, P719, DOI 10.1111/j.1365-2486.2008.01734.x; Lough JM, 2011, MAR FRESHWATER RES, V62, P984, DOI 10.1071/MF10272; Lucrezi S, 2014, OCEANOGR MAR BIOL, V52, P201; Lucrezi S, 2009, ECOL INDIC, V9, P913, DOI 10.1016/j.ecolind.2008.10.013; Lucrezi S, 2009, ENVIRON MONIT ASSESS, V152, P413, DOI 10.1007/s10661-008-0326-2; McDermott JJ, 2013, NORTHEAST NAT, V20, P578, DOI 10.1656/045.020.0407; MCLACHLAN A, 1980, S AFR J ZOOL, V15, P57; Molinos JG, 2016, NAT CLIM CHANGE, V6, P83, DOI [10.1038/NCLIMATE2769, 10.1038/nclimate2769]; Moss D, 2006, COAST MANAGE, V34, P133, DOI 10.1080/08920750500379383; O'Connor MI, 2015, GLOBAL ECOL BIOGEOGR, V24, P64, DOI 10.1111/geb.12218; PALMER JD, 1971, AM MIDL NAT, V85, P97, DOI 10.2307/2423915; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Parmesan C, 2013, ECOL LETT, V16, P58, DOI 10.1111/ele.12098; Pitt NR, 2010, MAR FRESHWATER RES, V61, P963, DOI 10.1071/MF09225; Poloczanska ES, 2013, NAT CLIM CHANGE, V3, P919, DOI [10.1038/nclimate1958, 10.1038/NCLIMATE1958]; Rayner NA, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002670; Reisinger A, 2014, CLIMATE CHANGE 2014: IMPACTS, ADAPTATION, AND VULNERABILITY, PT B: REGIONAL ASPECTS, P1371; Richardson AJ, 2012, BIOL LETTERS, V8, P907, DOI 10.1098/rsbl.2012.0530; Robinson LM, 2011, GLOBAL ECOL BIOGEOGR, V20, P789, DOI 10.1111/j.1466-8238.2010.00636.x; Sakai Katsushi, 2013, Memoirs of the Queensland Museum, V56, P665; Schlacher TA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068221; Schlacher TA, 2011, ECOL INDIC, V11, P284, DOI 10.1016/j.ecolind.2010.05.006; Schoeman DS, 2014, GLOBAL CHANGE BIOL, V20, P2383, DOI 10.1111/gcb.12505; Short AD, 2006, J COASTAL RES, V22, P11, DOI 10.2112/05A-0002.1; Short AD, 2010, J COASTAL RES, V26, P395, DOI 10.2112/08-1120.1; Soberon J, 2009, P NATL ACAD SCI USA, V106, P19644, DOI 10.1073/pnas.0901637106; Sorte CJB, 2010, ECOLOGY, V91, P2198, DOI 10.1890/10-0238.1; Sorte CJB, 2010, GLOBAL ECOL BIOGEOGR, V19, P303, DOI 10.1111/j.1466-8238.2009.00519.x; Sunday JM, 2015, ECOL LETT, V18, P944, DOI 10.1111/ele.12474; Sunday JM, 2012, NAT CLIM CHANGE, V2, P686, DOI 10.1038/NCLIMATE1539; Thomas CD, 2010, DIVERS DISTRIB, V16, P488, DOI 10.1111/j.1472-4642.2010.00642.x; Tingley MW, 2009, TRENDS ECOL EVOL, V24, P625, DOI 10.1016/j.tree.2009.05.009; Waters JM, 2010, AUSTRAL ECOL, V35, P988, DOI 10.1111/j.1442-9993.2010.02114.x; Wernberg T, 2011, J EXP MAR BIOL ECOL, V400, P7, DOI 10.1016/j.jembe.2011.02.021	61	18	18	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2015	10	11							e0141976	10.1371/journal.pone.0141976	http://dx.doi.org/10.1371/journal.pone.0141976			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV1PG	26524471	Green Published, Green Submitted, gold			2022-12-26	WOS:000364029800030
J	Tsai, CC; Shih, HC; Wang, HV; Lin, YS; Chang, CH; Chiang, YC; Chou, CH				Tsai, Chi-Chu; Shih, Huei-Chuan; Wang, Hao-Ven; Lin, Yu-Shium; Chang, Chia-Hung; Chiang, Yu-Chung; Chou, Chang-Hung			RNA-Seq SSRs of Moth Orchid and Screening for Molecular Markers across Genus Phalaenopsis (Orchidaceae)	PLOS ONE			English	Article							SIMPLE SEQUENCE REPEATS; POLYMORPHIC MICROSATELLITE MARKERS; CROSS-SPECIES AMPLIFICATION; EXPLOITING EST DATABASES; TRANSCRIPTOME CHARACTERIZATION; PCR AMPLIFICATION; GENETIC DIVERSITY; DNA-POLYMERASE; GENOME; GENERATION	Background The moth orchid (Phalaenopsis species) is an ornamental crop that is highly commercialized worldwide. Over 30,000 cultivars of moth orchids have been registered at the Royal Horticultural Society (RHS). These cultivars were obtained by artificial pollination of interspecific hybridization. Therefore, the identification of different cultivars is highly important in the worldwide market. Methods/Results We used Illumina sequencing technology to analyze an important species for breeding, Phalaenopsis aphrodite subsp. formosana and develop the expressed sequence tag (EST)simple sequence repeat (SSR) markers. After de novo assembly, the obtained sequence covered 29.1 Mb, approximately 2.2% of the P. aphrodite subsp. formosana genome (1,300 Mb), and a total of 1,439 EST-SSR loci were detected. SSR occurs in the exon region, including the 5' untranslated region (UTR), coding region (CDS), and 3'UTR, on average every 20.22 kb. The di- and tri-nucleotide motifs (51.49% and 35.23%, respectively) were the two most frequent motifs in the P. aphrodite subsp. formosana. To validate the developed EST-SSR loci and to evaluate the transferability to the genus Phalaenopsis, thirty trinucleotide motifs of the EST-SSR loci were randomly selected to design EST-SSR primers and to evaluate the polymorphism and transferability across 22 native Phalaenopsis species that are usually used as parents for moth orchid breeding. Of the 30 EST-SSR loci, ten polymorphic and transferable SSR loci across the 22 native taxa can be obtained. The validated EST-SSR markers were further proven to discriminate 12 closely related Phalaenopsis cultivars. The results show that it is not difficult to obtain universal SSR markers by transcriptome deep sequencing in Phalaenopsis species. Conclusions This study supported that transcriptome analysis based on deep sequencing is a powerful tool to develop SSR loci in non-model species. A large number of EST-SSR loci can be isolated, and about 33.33% EST-SSR loci are universal markers across the Phalaenopsis breeding germplasm after preliminary validation. The potential universal EST-SSR markers are highly valuable for identifying all of Phalaenopsis cultivars.	[Tsai, Chi-Chu; Lin, Yu-Shium; Chang, Chia-Hung] Kaohsiung Dist Agr Res & Extens Stn, Pingtung 900, Taiwan; [Tsai, Chi-Chu] Natl Pingtung Univ Sci & Technol, Pingtung 912, Taiwan; [Shih, Huei-Chuan] Meiho Univ, Dept Nursing, Pingtung 912, Taiwan; [Wang, Hao-Ven] Natl Cheng Kung Univ, Dept Life Sci, Tainan 701, Taiwan; [Chiang, Yu-Chung] Natl Sun Yat Sen Univ, Dept Biol Sci, Kaohsiung 804, Taiwan; [Chiang, Yu-Chung] Kaohsiung Med Univ, Dept Biomed Sci & Environm Biol, Kaohsiung 807, Taiwan; [Chou, Chang-Hung] China Med Univ, Res Ctr Biodivers, Taichung 404, Taiwan	National Pingtung University Science & Technology; National Cheng Kung University; National Sun Yat Sen University; Kaohsiung Medical University; China Medical University Taiwan	Tsai, CC (corresponding author), Kaohsiung Dist Agr Res & Extens Stn, Pingtung 900, Taiwan.	tsaicc@mail.kdais.gov.tw; yuchung@mail.nsysu.edu.tw; choumasa@mail.cmu.edu.tw	Chiang, Yu-Chung/E-9143-2011	Wang, Hao-Ven/0000-0001-7523-087X	Ministry of Science and Technology, Taiwan [MOST 103-2321-B-067E-001, MOST 103-2621-B-110 -001]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan)	This research was supported by funding from the Ministry of Science and Technology, Taiwan, MOST 103-2321-B-067E-001 to CCT and partial from MOST 103-2621-B-110 -001 to YCC.	Abdelkrim J, 2009, BIOTECHNIQUES, V46, P185, DOI 10.2144/000113084; Amit M, 2012, CELL REP, V1, P543, DOI 10.1016/j.celrep.2012.03.013; Berube Y, 2007, TREE GENET GENOMES, V3, P251, DOI 10.1007/s11295-006-0061-1; Blanca J, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-104; Cai J, 2015, NAT GENET, V47, P65, DOI 10.1038/ng.3149; Cardle L, 2000, GENETICS, V156, P847; Cavagnaro PF, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-569; Chang CC, 2006, MOL BIOL EVOL, V23, P279, DOI 10.1093/molbev/msj029; Chen WH, 2013, SCI HORTIC-AMSTERDAM, V161, P70, DOI 10.1016/j.scienta.2013.06.045; Chiou CY, 2012, AM J BOT, V99, pE199, DOI 10.3732/ajb.1100500; Christenson EA, 2001, PHALAENOPSIS; Chuang HT, 2002, THESIS NATL CHIAYI U; Clarke LA, 2001, J CLIN PATHOL-MOL PA, V54, P351, DOI 10.1136/mp.54.5.351; Cregan PB, 1994, PLANT GENOME ANAL, P43; Csencsics D, 2010, J HERED, V101, P789, DOI 10.1093/jhered/esq069; Diwan N, 2000, THEOR APPL GENET, V101, P165, DOI 10.1007/s001220051465; Doyle JJ, 1987, PHYTOCHEM B, V19, P11, DOI 10.1016/j.bse.2009.07.003; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; EDWARDS A, 1991, AM J HUM GENET, V49, P746; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Falush D, 2007, MOL ECOL NOTES, V7, P574, DOI 10.1111/j.1471-8286.2007.01758.x; Fu Y. M., 1997, Report of the Taiwan Sugar Research Institute, P27; Gao LF, 2003, MOL BREEDING, V12, P245, DOI 10.1023/A:1026346121217; Garcia RAV, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-41; Garneau NL, 2007, NAT REV MOL CELL BIO, V8, P113, DOI 10.1038/nrm2104; Ge XJ, 2015, PLANT MOL BIOL REP, V33, P264, DOI 10.1007/s11105-014-0742-0; Ge XJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043717; Goh MWK, 2005, EUPHYTICA, V141, P11, DOI 10.1007/s10681-005-4814-y; GOODALL GJ, 1989, CELL, V58, P473, DOI 10.1016/0092-8674(89)90428-5; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; GRIESBACH RJ, 1985, J HERED, V76, P74, DOI 10.1093/oxfordjournals.jhered.a110029; Gupta PK, 2003, MOL GENET GENOMICS, V270, P315, DOI 10.1007/s00438-003-0921-4; Han SY, 2005, THESIS NATL C KUNG U; HENTSCHEL CC, 1982, NATURE, V295, P714, DOI 10.1038/295714a0; Hite JM, 1996, NUCLEIC ACIDS RES, V24, P2429, DOI 10.1093/nar/24.12.2429; Ho Chin-Shang, 2014, BMC Res Notes, V7, P255, DOI 10.1186/1756-0500-7-255; Hsiao YY, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-360; Hsu CC, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-3; Hsu TW, 2013, INT J MOL SCI, V14, P20414, DOI 10.3390/ijms141020414; Huang CL, 2014, PLANT J, V80, P834, DOI 10.1111/tpj.12676; Hulzink RJM, 2002, PLANT PHYSIOL, V129, P342, DOI 10.1104/pp.001701; Jia XP, 2009, THEOR APPL GENET, V118, P821, DOI 10.1007/s00122-008-0942-9; Jiao Y, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-201; Kofler R, 2007, BIOINFORMATICS, V23, P1683, DOI 10.1093/bioinformatics/btm157; KUNKEL TA, 1994, P NATL ACAD SCI USA, V91, P6830, DOI 10.1073/pnas.91.15.6830; LEVINSON G, 1987, MOL BIOL EVOL, V4, P203; Li DJ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-192; Liao PC, 2012, INT J MOL SCI, V13, P6469, DOI 10.3390/ijms13056469; Liu KJ, 2005, BIOINFORMATICS, V21, P2128, DOI 10.1093/bioinformatics/bti282; Luro FL, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-287; Martienssen RA, 2001, SCIENCE, V293, P1070, DOI 10.1126/science.293.5532.1070; Metzgar D, 2000, GENOME RES, V10, P72; Morgante M, 2002, NAT GENET, V30, P194, DOI 10.1038/ng822; Neysa M, 1984, AM J BOT, V71, P309; Niu SH, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-263; Parchman TL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-180; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Pfeiffer T, 2011, J HERED, V102, P479, DOI 10.1093/jhered/esr024; Qiu LJ, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-278; Rowland LJ, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-46; Santana QC, 2009, BIOTECHNIQUES, V46, P217, DOI 10.2144/000113085; SCHLOTTERER C, 1992, NUCLEIC ACIDS RES, V20, P211, DOI 10.1093/nar/20.2.211; Schuelke M, 2000, NAT BIOTECHNOL, V18, P233, DOI 10.1038/72708; Shinde D, 2003, NUCLEIC ACIDS RES, V31, P974, DOI 10.1093/nar/gkg178; Sweet HR, 1980, THE GENUS PHALAENOPS; Tanaka R, 1984, ORCHID BIOL REV PERS; Temnykh S, 2001, GENOME RES, V11, P1441, DOI 10.1101/gr.184001; Temnykh S, 2000, THEOR APPL GENET, V100, P697, DOI 10.1007/s001220051342; Thiel T, 2003, THEOR APPL GENET, V106, P411, DOI 10.1007/s00122-002-1031-0; Toth G, 2000, GENOME RES, V10, P967, DOI 10.1101/gr.10.7.967; Tsai CC, 2006, J HORTIC SCI BIOTECH, V81, P691, DOI 10.1080/14620316.2006.11512125; Tsai CC, 2010, PLANT SYST EVOL, V288, P77, DOI 10.1007/s00606-010-0314-1; Tsai CC, 2005, PLANT SYST EVOL, V256, P1, DOI 10.1007/s00606-005-0356-y; Tsai CC, 2010, J PLANT BIOL, V53, P453, DOI 10.1007/s12374-010-9136-5; Tsai CC, 2014, BOT STUD, V55, DOI 10.1186/s40529-014-0072-4; Tsai CC, 2013, SCI HORTIC-AMSTERDAM, V164, P196, DOI 10.1016/j.scienta.2013.09.037; Tsai CC, 2009, BIOCHEM SYST ECOL, V37, P633, DOI 10.1016/j.bse.2009.09.004; Varshney RK, 2005, TRENDS BIOTECHNOL, V23, P48, DOI 10.1016/j.tibtech.2004.11.005; Vigouroux Y, 2005, GENETICS, V169, P1617, DOI 10.1534/genetics.104.032086; Wang ZY, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-726; You FM, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-253; Young L G, 2004, THESIS CENTRAL POLIC; Zhang LD, 2004, BIOINFORMATICS, V20, P1081, DOI 10.1093/bioinformatics/bth043; [张水明 Zhang Shuiming], 2013, [植物遗传资源学报, Journal of Plant Genetic Resources], V14, P560; Zhang S, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-78; Zhang ZH, 2007, DNA RES, V14, P37, DOI 10.1093/dnares/dsm005; Zhu H, 2012, THEOR APPL GENET, V124, P87, DOI 10.1007/s00122-011-1689-2	87	10	14	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2015	10	11							e0141761	10.1371/journal.pone.0141761	http://dx.doi.org/10.1371/journal.pone.0141761			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV1PG	26523377	Green Published, Green Submitted, gold			2022-12-26	WOS:000364029800022
J	Mendonca, AD; Guimaraes, ALS; da Silva, NMA; Caetano, AR; Dode, MAN; Franco, MM				Mendonca, Anelise dos Santos; Silva Guimaraes, Ana Luiza; Augusto da Silva, Naiara Milagres; Caetano, Alexandre Rodrigues; Nunes Dode, Margot Alves; Franco, Mauricio Machaim			Characterization of the IGF2 Imprinted Gene Methylation Status in Bovine Oocytes during Folliculogenesis	PLOS ONE			English	Article							DNA METHYLATION; PREIMPLANTATION EMBRYO; X-CHROMOSOME; EXPRESSION; GROWTH; EPIGENETICS; COMPETENCE; MATURATION; REGIONS; QUALITY	DNA methylation reprogramming occurs during mammalian gametogenesis and embryogenesis. Sex-specific DNA methylation patterns at specific CpG islands controlling imprinted genes are acquired during this window of development. Characterization of the DNA methylation dynamics of imprinted genes acquired by oocytes during folliculogenesis is essential for understanding the physiological and genetic aspects of female gametogenesis and to determine the parameters for oocyte competence. This knowledge can be used to improve in vitro embryo production (IVP), specifically because oocyte competence is one of the most important aspects determining the success of IVP. Imprinted genes, such as IGF2, play important roles in embryo development, placentation and fetal growth. The aim of this study was to characterize the DNA methylation profile of the CpG island located in IGF2 exon 10 in oocytes during bovine folliculogenesis. The methylation percentages in oocytes from primordial follicles, final secondary follicles, small antral follicles, large antral follicles, MII oocytes and spermatozoa were 73.74 +/- 2.88%, 58.70 +/- 7.46%, 56.00 +/- 5.58%, 65.77 +/- 5.10%, 56.35 +/- 7.45% and 96.04 +/- 0.78%, respectively. Oocytes from primordial follicles showed fewer hypomethylated alleles (15.5%) than MII oocytes (34.6%) (p = 0.039); spermatozoa showed only hypermethylated alleles. Moreover, MII oocytes were less methylated than spermatozoa (p<0.001). Our results showed that the methylation pattern of this region behaves differently between mature oocytes and spermatozoa. However, while this region has a classical imprinted pattern in spermatozoa that is fully methylated, it was variable in mature oocytes, showing hypermethylated and hypomethylated alleles. Furthermore, our results suggest that this CpG island may have received precocious reprogramming, considering that the hypermethylated pattern was already found in growing oocytes from primordial follicles. These results may contribute to our understanding of the reprogramming of imprinted genes during bovine oogenesis.	[Mendonca, Anelise dos Santos; Silva Guimaraes, Ana Luiza; Nunes Dode, Margot Alves; Franco, Mauricio Machaim] Embrapa Genet Resources & Biotechnol, Lab Anim Reprod, Brasilia, DF, Brazil; [Mendonca, Anelise dos Santos; Franco, Mauricio Machaim] Univ Fed Uberlandia, Inst Genet & Biochem, BR-38400 Uberlandia, MG, Brazil; [Silva Guimaraes, Ana Luiza; Nunes Dode, Margot Alves] Univ Brasilia, Sch Agr & Vet Med, Brasilia, DF, Brazil; [Augusto da Silva, Naiara Milagres; Caetano, Alexandre Rodrigues] Embrapa Genet Resources & Biotechnol, Brasilia, DF, Brazil; [Franco, Mauricio Machaim] Univ Fed Uberlandia, Sch Vet Med, BR-38400 Uberlandia, MG, Brazil	Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Universidade Federal de Uberlandia; Universidade de Brasilia; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Universidade Federal de Uberlandia	Franco, MM (corresponding author), Embrapa Genet Resources & Biotechnol, Lab Anim Reprod, Brasilia, DF, Brazil.	mauricio.franco@embrapa.br	Franco, Maurício M/B-6204-2013; Dode, Margot/O-2486-2014; dode, margot alves nunes/S-6524-2019; Guimarães, Ana Luiza/ABG-2608-2020; Caetano, Alexandre Rodrigues/B-5227-2017	Franco, Maurício M/0000-0003-4105-9079; Dode, Margot/0000-0002-1096-0457; dode, margot alves nunes/0000-0002-1096-0457; Guimarães, Ana Luiza/0000-0002-6533-2490; Caetano, Alexandre Rodrigues/0000-0002-3419-7337	Brazilian Agriculture Research Corporation	Brazilian Agriculture Research Corporation	This work was supported by Brazilian Agriculture Research Corporation. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Augui S, 2011, NAT REV GENET, V12, P429, DOI 10.1038/nrg2987; Bessa IR, 2013, REPROD DOMEST ANIM, V48, P781, DOI 10.1111/rda.12162; Bock C, 2005, BIOINFORMATICS, V21, P4067, DOI 10.1093/bioinformatics/bti652; Caixeta ES, 2009, REPROD FERT DEVELOP, V21, P655, DOI 10.1071/RD08201; Carvalho JO, 2012, MOL REPROD DEV, V79, P77, DOI 10.1002/mrd.21410; Colosimo A, 2009, ANIM GENET, V40, P900, DOI 10.1111/j.1365-2052.2009.01939.x; de Montera B, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-406; Dieleman SJ, 2002, THERIOGENOLOGY, V57, P5, DOI 10.1016/S0093-691X(01)00655-0; Dindot SV, 2004, BIOL REPROD, V71, P470, DOI 10.1095/biolreprod.103.025775; Fagundes NS, 2011, MOL HUM REPROD, V17, P85, DOI 10.1093/molehr/gaq075; Faulk C, 2011, EPIGENETICS-US, V6, P791, DOI 10.4161/epi.6.7.16209; Franco MM, 2014, BIOL REPROD, V91, DOI 10.1095/biolreprod.114.122945; Franco MM, 2014, J ASSIST REPROD GEN, V31, P115, DOI 10.1007/s10815-013-0106-y; Frost JM, 2010, PLOS GENET, V6, DOI [10.1371/journal.pgen.1001015, DOI 10.1371/J0URNAL.PGEN.1001015]; Gebert C, 2006, GENOMICS, V88, P222, DOI 10.1016/j.ygeno.2006.03.011; Gehring M, 2009, TRENDS GENET, V25, P82, DOI 10.1016/j.tig.2008.12.001; Guseva N, 2012, DEV BIOL, V361, P403, DOI 10.1016/j.ydbio.2011.11.005; Hackett JA, 2012, TRENDS GENET, V28, P164, DOI 10.1016/j.tig.2012.01.005; Hall John W., 1991, CAMBRIDGE HIST JAPAN, VVI, P1; Hiura H, 2006, GENES CELLS, V11, P353, DOI 10.1111/j.1365-2443.2006.00943.x; Ideraabdullah FY, 2008, MUTAT RES-FUND MOL M, V647, P77, DOI 10.1016/j.mrfmmm.2008.08.008; Imamura T, 2005, J BIOL CHEM, V280, P20171, DOI 10.1074/jbc.M501749200; Liu JH, 2008, J GENET GENOMICS, V35, P559, DOI 10.1016/S1673-8527(08)60076-4; LYON MF, 1961, NATURE, V190, P372, DOI 10.1038/190372a0; Manipalviratn S, 2009, FERTIL STERIL, V91, P305, DOI 10.1016/j.fertnstert.2009.01.002; O'Doherty AM, 2015, BMC DEV BIOL, V15, DOI 10.1186/s12861-015-0060-2; O'Doherty AM, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.094946; Ohlsson R, 2001, TRENDS GENET, V17, P520, DOI 10.1016/S0168-9525(01)02366-6; Paradowska, 2009, INT J ONCOL, V35, DOI [10.3892/ijo_00000316, DOI 10.3892/IJ0_]; Picton HM, 2008, REPRODUCTION, V136, P703, DOI 10.1530/REP-08-0290; Reik W, 2001, SCIENCE, V293, P1089, DOI 10.1126/science.1063443; Reik W, 2001, ELECTROPHORESIS, V22, P2838, DOI 10.1002/1522-2683(200108)22:14&lt;2838::AID-ELPS2838&gt;3.0.CO;2-M; Simon I, 1999, NATURE, V401, P929, DOI 10.1038/44866; Teklenburg G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032701; Wijchers PJ, 2011, TRENDS GENET, V27, P132, DOI 10.1016/j.tig.2011.01.004; Wutz A, 1997, NATURE, V389, P745, DOI 10.1038/39631; Yuen RKC, 2011, EPIGENET CHROMATIN, V4, DOI 10.1186/1756-8935-4-10; Zaidi SK, 2010, MOL CELL BIOL, V30, P4758, DOI 10.1128/MCB.00646-10	38	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2015	10	10							e0142072	10.1371/journal.pone.0142072	http://dx.doi.org/10.1371/journal.pone.0142072			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0EH	26517264	Green Published, Green Submitted, gold			2022-12-26	WOS:000363920800105
J	Guy, AJ; Irani, V; MacRaild, CA; Anders, RF; Norton, RS; Beeson, JG; Richards, JS; Ramsland, PA				Guy, Andrew J.; Irani, Vashti; MacRaild, Christopher A.; Anders, Robin F.; Norton, Raymond S.; Beeson, James G.; Richards, Jack S.; Ramsland, Paul A.			Insights into the Immunological Properties of Intrinsically Disordered Malaria Proteins Using Proteome Scale Predictions	PLOS ONE			English	Article							CD8+ T-CELLS; MHC CLASS-I; PLASMODIUM-FALCIPARUM; CIRCUMSPOROZOITE PROTEIN; UNSTRUCTURED PROTEINS; SURFACE-ANTIGEN; TANDEM REPEATS; IMMUNE EVASION; BINDING; ANTIBODIES	Malaria remains a significant global health burden. The development of an effective malaria vaccine remains as a major challenge with the potential to significantly reduce morbidity and mortality. While Plasmodium spp. have been shown to contain a large number of intrinsically disordered proteins (IDPs) or disordered protein regions, the relationship of protein structure to subcellular localisation and adaptive immune responses remains unclear. In this study, we employed several computational prediction algorithms to identify IDPs at the proteome level of six Plasmodium spp. and to investigate the potential impact of protein disorder on adaptive immunity against P. falciparum parasites. IDPs were shown to be particularly enriched within nuclear proteins, apical proteins, exported proteins and proteins localised to the parasitophorous vacuole. Furthermore, several leading vaccine candidates, and proteins with known roles in host-cell invasion, have extensive regions of disorder. Presentation of peptides by MHC molecules plays an important role in adaptive immune responses, and we show that IDP regions are predicted to contain relatively few MHC class I and II binding peptides owing to inherent differences in amino acid composition compared to structured domains. In contrast, linear B-cell epitopes were predicted to be enriched in IDPs. Tandem repeat regions and non-synonymous single nucleotide polymorphisms were found to be strongly associated with regions of disorder. In summary, immune responses against IDPs appear to have characteristics distinct from those against structured protein domains, with increased antibody recognition of linear epitopes but some constraints for MHC presentation and issues of polymorphisms. These findings have major implications for vaccine design, and understanding immunity to malaria.	[Guy, Andrew J.; Irani, Vashti; Beeson, James G.; Richards, Jack S.; Ramsland, Paul A.] Burnet Inst, Ctr Biomed Res, Melbourne, Vic, Australia; [Guy, Andrew J.; Ramsland, Paul A.] Monash Univ, Dept Immunol, Melbourne, Vic 3004, Australia; [Irani, Vashti; Beeson, James G.; Richards, Jack S.] Univ Melbourne, Dept Med, Melbourne, Vic, Australia; [MacRaild, Christopher A.; Norton, Raymond S.] Monash Univ, Monash Inst Pharmaceut Sci, Med Chem, Parkville, Vic, Australia; [Anders, Robin F.] La Trobe Univ, La Trobe Inst Mol Sci, Dept Biochem & Genet, Melbourne, Vic, Australia; [Beeson, James G.; Richards, Jack S.] Monash Univ, Dept Microbiol, Melbourne, Vic, Australia; [Richards, Jack S.] Royal Melbourne Hosp, Victorian Infect Dis Serv, Melbourne, Vic 3050, Australia; [Ramsland, Paul A.] Univ Melbourne, Dept Surg Austin Hlth, Heidelberg, Vic, Australia; [Ramsland, Paul A.] Curtin Univ, Fac Hlth Sci, CHIRI Biosci, Sch Biomed Sci, Perth, WA 6845, Australia	Burnet Institute; Monash University; University of Melbourne; Monash University; La Trobe University; Monash University; Royal Melbourne Hospital; Austin Research Institute; University of Melbourne; Curtin University	Richards, JS (corresponding author), Burnet Inst, Ctr Biomed Res, Melbourne, Vic, Australia.	richards@burnet.edu.au; pramsland@burnet.edu.au		Richards, Jack/0000-0001-5786-6989; Norton, Raymond/0000-0001-8893-0584; MacRaild, Christopher/0000-0002-3694-3989; Guy, Andrew/0000-0003-0376-2329; Anders, Robin/0000-0002-0693-4547; Ramsland, Paul/0000-0002-2107-2738	National Health and Medical Research Council of Australia [APP637406, APP1042520, APP1059060, APP1077636, APP1037722]; Victoria State Government Operational Infrastructure Support grant; Monash University (Australian Postgraduate Award); University of Melbourne	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Victoria State Government Operational Infrastructure Support grant; Monash University (Australian Postgraduate Award); University of Melbourne(University of Melbourne)	Funding was provided by the National Health and Medical Research Council of Australia (grants APP637406 and APP1042520; fellowships to RSN, JGB and JSR: APP1059060, APP1077636 and APP1037722), Victoria State Government Operational Infrastructure Support grant, Monash University (Australian Postgraduate Award to AJG) and the University of Melbourne (Melbourne International Fee Remission Scholarship and Melbourne International Research Scholarship to VI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adda CG, 2012, INFECT IMMUN, V80, P4177, DOI 10.1128/IAI.00665-12; Adda CG, 2009, MOL BIOCHEM PARASIT, V166, P159, DOI 10.1016/j.molbiopara.2009.03.012; Asano N, 2014, BIOCHEM BIOPH RES CO, V443, P1251, DOI 10.1016/j.bbrc.2013.12.143; Aurrecoechea C, 2009, NUCLEIC ACIDS RES, V37, pD539, DOI 10.1093/nar/gkn814; Bai T, 2005, P NATL ACAD SCI USA, V102, P12736, DOI 10.1073/pnas.0501808102; Blanc M, 2014, BBA-PROTEINS PROTEOM, V1844, P2306, DOI 10.1016/j.bbapap.2014.09.023; Boyle MJ, 2015, IMMUNITY, V42, P580, DOI 10.1016/j.immuni.2015.02.012; Burgess BR, 2005, J BIOL CHEM, V280, P37236, DOI 10.1074/jbc.M506753200; Buus S, 2003, TISSUE ANTIGENS, V62, P378, DOI 10.1034/j.1399-0039.2003.00112.x; Carlton JM, 2008, NATURE, V455, P757, DOI 10.1038/nature07327; Chu HM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4139; DAME JB, 1984, SCIENCE, V225, P593, DOI 10.1126/science.6204383; De Genst EJ, 2010, J MOL BIOL, V402, P326, DOI 10.1016/j.jmb.2010.07.001; Dunker AK, 2002, BIOCHEMISTRY-US, V41, P6573, DOI 10.1021/bi012159+; Dunker AK, 2001, J MOL GRAPH MODEL, V19, P26, DOI 10.1016/S1093-3263(00)00138-8; El-Manzalawy Y, 2010, IMMUNOME RES, V6; ENEA V, 1984, SCIENCE, V225, P628, DOI 10.1126/science.6204384; Fassolari M, 2013, J BIOL CHEM, V288, P13110, DOI 10.1074/jbc.M112.444554; Feng ZP, 2006, MOL BIOCHEM PARASIT, V150, P256, DOI 10.1016/j.molbiopara.2006.08.011; Foquet L, 2014, J CLIN INVEST, V124, P140, DOI 10.1172/JCI70349; Goto Y, 2008, INFECT IMMUN, V76, P3967, DOI 10.1128/IAI.00604-08; Goto Y, 2007, INFECT IMMUN, V75, P846, DOI 10.1128/IAI.01205-06; Goto Y, 2006, INFECT IMMUN, V74, P3939, DOI 10.1128/IAI.00101-06; Goto Y, 2010, INFECT IMMUN, V78, P2138, DOI 10.1128/IAI.01102-09; Haerty W, 2011, GENOME BIOL EVOL, V3, P539, DOI 10.1093/gbe/evr045; Healer J, 2004, MOL MICROBIOL, V52, P159, DOI 10.1111/j.1365-2958.2003.03974.x; Healer J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072504; Hisaeda H, 2005, INT J BIOCHEM CELL B, V37, P700, DOI 10.1016/j.biocel.2004.10.009; Hisaoka M, 2014, NUCLEIC ACIDS RES, V42, P1180, DOI 10.1093/nar/gkt897; HOLLINGDALE MR, 1984, J IMMUNOL, V132, P909; Jones DT, 2015, BIOINFORMATICS, V31, P857, DOI 10.1093/bioinformatics/btu744; Jorda J, 2010, FEBS J, V277, P2673, DOI [10.1111/j.1742-4658.2010.07684.x, 10.1111/j.1742-464X.2010.07684.x]; Jorda J, 2009, BIOINFORMATICS, V25, P2632, DOI 10.1093/bioinformatics/btp482; KEMP DJ, 1987, ANNU REV MICROBIOL, V41, P181, DOI 10.1146/annurev.mi.41.100187.001145; Khan T, 2015, GENOME BIOL EVOL, V7, P1815, DOI 10.1093/gbe/evv105; Kringelum JV, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002829; Kulangara C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046112; Kumar N, 1998, IMMUNOLOGY, V94, P28, DOI 10.1046/j.1365-2567.1998.00486.x; Larsen Jens Erik Pontoppidan, 2006, Immunome Res, V2, P2, DOI 10.1186/1745-7580-2-2; Lopaticki S, 2011, INFECT IMMUN, V79, P1107, DOI 10.1128/IAI.01021-10; Luo T, 2009, CLIN VACCINE IMMUNOL, V16, P982, DOI 10.1128/CVI.00048-09; MacRaild CA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119899; Magidovich E, 2006, BIOINFORMATICS, V22, P1546, DOI 10.1093/bioinformatics/btl137; Maier AG, 2009, INFECT IMMUN, V77, P1689, DOI 10.1128/IAI.01331-08; MATSUMURA M, 1992, SCIENCE, V257, P927, DOI 10.1126/science.1323878; McCarthy JS, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0024413, 10.1371/journal.pone.0021914]; Mitic NS, 2014, J IMMUNOL METHODS, V406, P83, DOI 10.1016/j.jim.2014.02.012; Mobegi VA, 2014, MOL BIOL EVOL, V31, P1490, DOI 10.1093/molbev/msu106; Monastyrskyy B, 2014, PROTEINS, V82, P127, DOI 10.1002/prot.24391; Natarajan K, 1999, Rev Immunogenet, V1, P32; Nelson C A, 1999, Rev Immunogenet, V1, P47; Nielsen M, 2003, PROTEIN SCI, V12, P1007, DOI 10.1110/ps.0239403; Nielsen M, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-238; Nielsen M, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-296; Nilsson J, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-7-r65; Ochola LI, 2010, MOL BIOL EVOL, V27, P2344, DOI 10.1093/molbev/msq119; OEUVRAY C, 1994, MEM I OSWALDO CRUZ, V89, P77, DOI 10.1590/S0074-02761994000600018; Olugbile S, 2009, INFECT IMMUN, V77, P5701, DOI 10.1128/IAI.00652-09; Otto TD, 2014, BMC BIOL, V12, DOI 10.1186/s12915-014-0086-0; Pain A, 2008, NATURE, V455, P799, DOI 10.1038/nature07306; Plassmeyer ML, 2009, J BIOL CHEM, V284, P26951, DOI 10.1074/jbc.M109.013706; Radivojac P, 2007, BIOPHYS J, V92, P1439, DOI 10.1529/biophysj.106.094045; RAMMENSEE HG, 1995, CURR OPIN IMMUNOL, V7, P85, DOI 10.1016/0952-7915(95)80033-6; Ramos I, 2014, NUCLEIC ACIDS RES, V42, P1311, DOI 10.1093/nar/gkt899; Receveur-Brechot V, 2006, PROTEINS, V62, P24, DOI 10.1002/prot.20750; SAAD B, 1988, EUR J BIOCHEM, V178, P219, DOI 10.1111/j.1432-1033.1988.tb14446.x; SCHOFIELD L, 1990, B WORLD HEALTH ORGAN, V68, P66; SCHOFIELD L, 1987, NATURE, V330, P664, DOI 10.1038/330664a0; Serriere J, 2011, J MOL BIOL, V405, P33, DOI 10.1016/j.jmb.2010.10.033; SIM BKL, 1994, SCIENCE, V264, P1941, DOI 10.1126/science.8009226; Singh S, 2004, J INFECT DIS, V190, P1010, DOI 10.1086/423208; Tham WH, 2009, INFECT IMMUN, V77, P2427, DOI 10.1128/IAI.00048-09; Tolia NH, 2005, CELL, V122, P183, DOI 10.1016/j.cell.2005.05.033; Tompa P, 2003, BIOESSAYS, V25, P847, DOI 10.1002/bies.10324; Tsai CW, 2009, MOL BIOCHEM PARASIT, V164, P45, DOI 10.1016/j.molbiopara.2008.11.006; van der Lee R, 2014, CHEM REV, V114, P6589, DOI 10.1021/cr400525m; vanLeeuwen HC, 1997, EMBO J, V16, P2043, DOI 10.1093/emboj/16.8.2043; Ward JJ, 2004, J MOL BIOL, V337, P635, DOI 10.1016/j.jmb.2004.02.002; WEISS WR, 1988, P NATL ACAD SCI USA, V85, P573, DOI 10.1073/pnas.85.2.573; WHO, 2013, WORLD MALARIA REPORT 2013, P1; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Xue B, 2012, J BIOMOL STRUCT DYN, V30, P137, DOI 10.1080/07391102.2012.675145; Yagi M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098460; Zandany N, 2015, FEBS LETT, V589, P2441, DOI 10.1016/j.febslet.2015.06.010; Zandany N, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7488; ZAVALA F, 1983, J EXP MED, V157, P1947, DOI 10.1084/jem.157.6.1947; Zhang XC, 2008, J MOL BIOL, V379, P105, DOI 10.1016/j.jmb.2008.03.039	87	28	28	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2015	10	10							e0141729	10.1371/journal.pone.0141729	http://dx.doi.org/10.1371/journal.pone.0141729			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0ED	26513658	Green Published, Green Submitted, gold			2022-12-26	WOS:000363920300075
J	Goliomytis, M; Kartsonas, N; Charismiadou, MA; Symeon, GK; Simitzis, PE; Deligeorgis, SG				Goliomytis, Michael; Kartsonas, Nikos; Charismiadou, Maria A.; Symeon, George K.; Simitzis, Panagiotis E.; Deligeorgis, Stelios G.			The Influence of Naringin or Hesperidin Dietary Supplementation on Broiler Meat Quality and Oxidative Stability	PLOS ONE			English	Article							OREGANO ESSENTIAL OIL; INDUCED LIPID OXIDATION; ALPHA-TOCOPHEROL; CHICKEN MEAT; BREAST MEAT; GROWTH-PERFORMANCE; ASCORBIC-ACID; REFRIGERATED STORAGE; PLANT-EXTRACTS; BETA-CAROTENE	An experiment was conducted to examine the effects of supplementing broiler feed with hesperidin or naringin, on growth performance, carcass characteristics, breast meat quality and the oxidative stability of breast and thighmeat. Two hundred and forty 1-day-old Ross 308 broiler chickens were randomly assigned to 6 groups. One of the groups served as a control (C) and was given commercial basal diets, whereas the other five groups were given the same diets further supplemented with naringin at 0.75 g/kg (N1), naringin at 1.5 g/kg (N2), hesperidin at 0.75 g/kg (E1), hesperidin at 1.5 g/kg (E2) and a-tocopheryl acetate at 0.2 g/kg (E). At 42 days of age, 10 chickens per treatment group were slaughtered for meat quality and oxidative stability assessment. No significant differences were observed among groups in final body weight, carcass weight and internal organs weights (P> 0.05) apart from liver that decreased linearly with increased levels of naringin (P-linear< 0.05). Regarding the breast meat quality parameters, only redness (a*) value was higher in E1 and N1 group compared to VE group (P<0.05), while all the others i.e. shear values (N/mm(2)), pH(24), cooking loss (%) and L* and b* color parameters were not significantly different among groups (P> 0.05). Measurement of lipid oxidation values showed that after hesperidin and naringin dietary supplementation, malondialdehyde values decreased in tissue samples in a dose depended manner (P-linear<0.05). In conclusion, hesperidin and naringin, positively influence meat antioxidative properties without negative implications on growth performance and meat quality characteristics in poultry, thus appearing as important additives for both the consumer and the industry.	[Goliomytis, Michael; Kartsonas, Nikos; Charismiadou, Maria A.; Symeon, George K.; Simitzis, Panagiotis E.; Deligeorgis, Stelios G.] Agr Univ Athens, Dept Anim Sci & Aquaculture, GR-11855 Athens, Greece	Agricultural University of Athens	Goliomytis, M (corresponding author), Agr Univ Athens, Dept Anim Sci & Aquaculture, GR-11855 Athens, Greece.	mgolio@aua.gr	Simitzis, Panayiotis/AAE-6133-2019; Symeon, George/I-8567-2019; Goliomytis, Michael/J-9625-2019	Symeon, George/0000-0002-3782-7031; Goliomytis, Michael/0000-0001-9606-9894	European Union; Hellenic State	European Union(European Commission); Hellenic State	This research project was implemented within the framework of the Project "Thalis-The effects of antioxidant's dietary supplementation on animal product quality," MIS 380231, Funding Body: Hellenic State and European Union.	Botsoglou NA, 2002, MEAT SCI, V62, P259, DOI 10.1016/S0309-1740(01)00256-X; Botsoglou NA, 2004, ARCH ANIM NUTR, V58, P209, DOI 10.1080/00039420410001701404; BOTSOGLOU NA, 1994, J AGR FOOD CHEM, V42, P1931, DOI 10.1021/jf00045a019; Botsoglou NA, 2002, BRIT POULTRY SCI, V43, P223, DOI 10.1080/00071660120121436; Cason JA, 1997, POULTRY SCI, V76, P785, DOI 10.1093/ps/76.5.785; Engberg RM, 1996, POULTRY SCI, V75, P1003, DOI 10.3382/ps.0751003; Erlund I, 2004, NUTR RES, V24, P851, DOI 10.1016/j.nutres.2004.07.005; Fellenberg MA, 2006, WORLD POULTRY SCI J, V62, P53, DOI 10.1079/WPS200584; Florou-Paneri P., 2005, International Journal of Poultry Science, V4, P866; Goliomytis M, 2014, POULTRY SCI, V93, P1957, DOI 10.3382/ps.2013-03585; Govaris A, 2004, INT J FOOD SCI NUTR, V55, P115, DOI 10.1080/09637480410001666487; Hernandez F, 2004, POULTRY SCI, V83, P169, DOI 10.1093/ps/83.2.169; Hong JC, 2012, LIVEST SCI, V144, P253, DOI 10.1016/j.livsci.2011.12.008; Jang A, 2008, POULTRY SCI, V87, P2382, DOI 10.3382/ps.2007-00506; Jeon SM, 2001, LIFE SCI, V69, P2855, DOI 10.1016/S0024-3205(01)01363-7; Jung S, 2010, MEAT SCI, V86, P520, DOI 10.1016/j.meatsci.2010.06.007; Kamboh AA, 2013, POULTRY SCI, V92, P454, DOI 10.3382/ps.2012-02584; Kamboh AA, 2013, J SCI FOOD AGR, V93, P3362, DOI 10.1002/jsfa.6185; KANNER J, 1994, MEAT SCI, V36, P169, DOI 10.1016/0309-1740(94)90040-X; Kim HJ, 2004, LIFE SCI, V74, P1621, DOI 10.1016/j.lfs.2003.08.026; KING AJ, 1995, J FOOD SCI, V60, P1009, DOI 10.1111/j.1365-2621.1995.tb06281.x; Lauridsen C, 1997, MEAT SCI, V46, P9, DOI 10.1016/S0309-1740(97)00010-7; Leunisk G, 2010, POULTRY SCI, V89, P1514, DOI 10.3382/ps.2009-00364; Lien TF, 2008, ARCH ANIM NUTR, V62, P33, DOI 10.1080/17450390701780318; Lopez-Bote CJ, 1998, BRIT POULTRY SCI, V39, P235, DOI 10.1080/00071669889187; Luna A, 2010, POULTRY SCI, V89, P366, DOI 10.3382/ps.2009-00130; Maraschiello C, 1998, LIPIDS, V33, P705, DOI 10.1007/s11745-998-0260-4; Mourao JL, 2008, POULTRY SCI, V87, P733, DOI 10.3382/ps.2007-00411; Park JH, 2014, LIVEST SCI, V165, P87, DOI 10.1016/j.livsci.2014.04.014; Pena JEM, 2008, BRAZ J POULTRY SCI, V10, P125, DOI 10.1590/S1516-635X2008000200008; Rababah TM, 2006, POULTRY SCI, V85, P148, DOI 10.1093/ps/85.1.148; Robbins RJ, 2003, J AGR FOOD CHEM, V51, P1866; Sarraga C, 1999, MEAT SCI, V52, P213, DOI 10.1016/S0309-1740(98)00170-3; SAS Institute Inc, 2005, STAT AN SYST US GUID; Seo HJ, 2003, LIFE SCI, V73, P933, DOI 10.1016/S0024-3205(03)00358-8; Simitzis PE, 2011, CAN J ANIM SCI, V91, P275, DOI [10.4141/CJAS10094, 10.4141/cjas10094]; Simopoulos AP, 2000, POULTRY SCI, V79, P961, DOI 10.1093/ps/79.7.961; Surai PF, 2014, J ANIM PHYSIOL AN N, V98, P19, DOI 10.1111/jpn.12070; Tang SZ, 2000, MEAT SCI, V56, P285, DOI 10.1016/S0309-1740(00)00055-3; Tang SZ, 2001, MEAT SCI, V57, P331, DOI 10.1016/S0309-1740(00)00112-1; van Acker FAA, 2000, FEBS LETT, V473, P145, DOI 10.1016/S0014-5793(00)01517-9; Wenk C, 2003, ASIAN AUSTRAL J ANIM, V16, P282, DOI 10.5713/ajas.2003.282; Yanishlieva-Maslarova N. V., 2001, Antioxidants in food: practical applications, P22, DOI 10.1533/9781855736160.1.22; Young JF, 2003, POULTRY SCI, V82, P1343, DOI 10.1093/ps/82.8.1343	44	41	42	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2015	10	10							e0141652	10.1371/journal.pone.0141652	http://dx.doi.org/10.1371/journal.pone.0141652			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0DL	26509968	Green Submitted, Green Published, gold			2022-12-26	WOS:000363918100117
J	Gustafsson, P; Rylander, L; Lindh, CH; Jonsson, BAG; Ode, A; Olofsson, P; Ivarsson, SA; Rignell-Hydbom, A; Haglund, N; Kallen, K				Gustafsson, Peik; Rylander, Lars; Lindh, Christian H.; Jonsson, Bo A. G.; Ode, Amanda; Olofsson, Per; Ivarsson, Sten A.; Rignell-Hydbom, Anna; Haglund, Nils; Kallen, Karin			Vitamin D Status at Birth and Future Risk of Attention Deficit/Hyperactivity Disorder (ADHD)	PLOS ONE			English	Article							D DEFICIENCY; MATERNAL SERUM; PREVALENCE; PREGNANCY; CHILDREN	Objective To investigate whether children with Attention Deficit/Hyperactivity Disorder have lower levels of Vitamin D-3 at birth than matched controls. Material Umbilical cord blood samples collected at birth from 202 children later diagnosed with Attention Deficit/Hyperactivity Disorder were analysed for vitamin D content and compared with 202 matched controls. 25-OH vitamin D-3 was analysed by liquid chromatography tandem mass spectrometry. Results No differences in cord blood vitamin D concentration were found between children with Attention Deficit/Hyperactivity Disorder (median 13.0 ng/ml) and controls (median 13.5 ng/ml) (p = 0.43). In a logistic regression analysis, Attention Deficit/Hyperactivity Disorder showed a significant association with maternal age (odds ratio: 0.96, 95% confidence interval: 0.92-0.99) but not with vitamin D levels (odds ratio: 0.99, 95% confidence interval: 0.97-1.02). Conclusion We found no difference in intrauterine vitamin D levels between children later developing Attention Deficit/Hyperactivity Disorder and matched control children. However, the statistical power of the study was too weak to detect an eventual small to medium size association between vitamin D levels and Attention Deficit/Hyperactivity Disorder.	[Gustafsson, Peik; Haglund, Nils] Lund Univ, Dept Clin Sci, Child & Adolescent Psychiat, Lund, Sweden; [Rylander, Lars; Lindh, Christian H.; Jonsson, Bo A. G.; Ode, Amanda; Rignell-Hydbom, Anna; Kallen, Karin] Lund Univ, Div Occupat & Environm Med, Lund, Sweden; [Olofsson, Per] Lund Univ, Dept Clin Sci, Malmo, Sweden; [Olofsson, Per] Lund Univ, Skane Univ Hosp, Dept Obstet & Gynaecol, Malmo, Sweden; [Ivarsson, Sten A.] Lund Univ, Unit Pediat Endocrinol, Dept Clin Sci, CRC, Malmo, Sweden; [Kallen, Karin] Lund Univ, Dept Clin Sci, Lund, Sweden; [Kallen, Karin] Lund Univ, Dept Obstet & Gynaecol, Reprod Epidemiol, Lund, Sweden	Lund University; Lund University; Lund University; Lund University; Skane University Hospital; Lund University; Lund University; Lund University	Gustafsson, P (corresponding author), Lund Univ, Dept Clin Sci, Child & Adolescent Psychiat, Lund, Sweden.	Peik.Gustafsson@med.lu.se	Gustafsson, Peik/AAE-3172-2020	Gustafsson, Peik/0000-0002-6767-7169; Rylander, Lars/0000-0001-8288-8207; Kallen, Karin/0000-0001-5765-2630; Lindh, Christian/0000-0001-7435-9890	Lund University; Lindhagastiftelsen; Magnus Bergvalls stiftelse grant; Stifteslen Soderstrom-Konigska sjukhemmet	Lund University; Lindhagastiftelsen; Magnus Bergvalls stiftelse grant; Stifteslen Soderstrom-Konigska sjukhemmet	ALF (post doc grant from Lund University), grant to PG 2009-2011. Lindhagastiftelsen 2010, grant to PG. Magnus Bergvalls stiftelse 2010 grant to PG. Stifteslen Soderstrom-Konigska sjukhemmet 2010, grant to PG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeras L, 2007, PROTEOMICS, V7, P769, DOI 10.1002/pmic.200600392; Bener A, 2009, INT J FOOD SCI NUTR, V60, P60, DOI 10.1080/09637480802400487; CNATTINGIUS S, 1990, SCAND J SOC MED, V18, P143, DOI 10.1177/140349489001800209; Eyles DW, 2013, FRONT NEUROENDOCRIN, V34, P47, DOI 10.1016/j.yfrne.2012.07.001; Fernandes de Abreu D A, 2009, Psychoneuroendocrinology, V34 Suppl 1, pS265, DOI 10.1016/j.psyneuen.2009.05.023; Gale CR, 2008, EUR J CLIN NUTR, V62, P68, DOI 10.1038/sj.ejcn.1602680; Goksugur SB, 2014, PEDIATR INT, V56, P515, DOI 10.1111/ped.12286; Grant WB, 2009, DERM-ENDOCRINOL, V1, P223, DOI 10.4161/derm.1.4.9500; Kamal M, 2014, ADHD-ATTEND DEFICIT, V6, P73, DOI 10.1007/s12402-014-0130-5; Lindh CH, 2012, CHEMOSPHERE, V88, P1269, DOI 10.1016/j.chemosphere.2012.03.049; Major JM, 2013, J CLIN ENDOCR METAB, V98, P97, DOI 10.1210/jc.2012-2643; McCann JC, 2008, FASEB J, V22, P982, DOI 10.1096/fj.07-9326rev; McGrath JJ, 2010, SCHIZOPHRENIA BULL, V36, P1073, DOI 10.1093/schbul/sbq101; Ode A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095891; Skounti M, 2007, EUR J PEDIATR, V166, P117, DOI 10.1007/s00431-006-0299-5; Spencer TJ, 2007, AMBUL PEDIATR, V7, P73, DOI 10.1016/j.ambp.2006.07.006; Strom M, 2014, ANN NUTR METAB, V64, P254, DOI 10.1159/000365030; Swanson JM, 2007, NEUROPSYCHOL REV, V17, P39, DOI 10.1007/s11065-007-9019-9; Tolppanen AM, 2012, PLOS ONE, V7, P1; Whitehouse AJO, 2012, PEDIATRICS, V129, P485, DOI 10.1542/peds.2011-2644; Whiting SJ, 2007, J STEROID BIOCHEM, V103, P626, DOI 10.1016/j.jsbmb.2006.12.067	21	24	24	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2015	10	10							e0140164	10.1371/journal.pone.0140164	http://dx.doi.org/10.1371/journal.pone.0140164			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CV0DL	26509435	Green Published, Green Submitted, gold			2022-12-26	WOS:000363918100021
J	Kremers, RMW; Mohamed, ABO; Pelkmans, L; Hindawi, S; Hemker, HC; de Laat, HB; Huskens, D; Al Dieri, R				Kremers, Romy M. W.; Mohamed, Abdulrahman B. O.; Pelkmans, Leonie; Hindawi, Salwa; Hemker, H. Coenraad; de Laat, H. Bas; Huskens, Dana; Al Dieri, Raed			Thrombin Generating Capacity and Phenotypic Association in ABO Blood Groups	PLOS ONE			English	Article							VON-WILLEBRAND-FACTOR; RECURRENT VENOUS THROMBOEMBOLISM; FACTOR-VIII; MYOCARDIAL-INFARCTION; VONWILLEBRAND-FACTOR; PLASMA-CONCENTRATION; HEMOSTATIC FACTORS; NORMAL POPULATION; ANGINA-PECTORIS; HEART-DISEASE	Individuals with blood group O have a higher bleeding risk than non-O blood groups. This could be explained by the lower levels of FVIII and von Willebrand Factor (VWF) levels in O individuals. We investigated the relationship between blood groups, thrombin generation (TG), prothrombin activation and thrombin inactivation. Plasma levels of VWF, FVIII, antithrombin, fibrinogen, prothrombin and alpha(2)Macroglobulin (alpha M-2) levels were determined. TG was measured in platelet rich (PRP) and platelet poor plasma (PPP) of 217 healthy donors and prothrombin conversion and thrombin inactivation were calculated. VWF and FVIII levels were lower (75% and 78%) and alpha M-2 levels were higher (125%) in the O group. TG is 10% lower in the O group in PPP and PRP. Less prothrombin was converted in the O group (86%) and the thrombin decay capacity was lower as well. In the O group, alpha M-2 plays a significantly larger role in the inhibition of thrombin (126%). In conclusion, TG is lower in the O group due to lower prothrombin conversion, and a larger contribution of alpha M-2 to thrombin inactivation. The former is unrelated to platelet function because it is similar in PRP and PPP, but can be explained by the lower levels of FVIII.	[Kremers, Romy M. W.; Mohamed, Abdulrahman B. O.; Pelkmans, Leonie; Hemker, H. Coenraad; de Laat, H. Bas; Huskens, Dana; Al Dieri, Raed] Maastricht Univ, Cardiovasc Res Inst Maastricht, Synapse, Maastricht, Netherlands; [Mohamed, Abdulrahman B. O.] King Abdulaziz Univ, Dept Pharmacol, Jeddah 21413, Saudi Arabia; [Hindawi, Salwa] King Abdulaziz Univ, Dept Haematol, Jeddah 21413, Saudi Arabia; [Pelkmans, Leonie; de Laat, H. Bas] Maastricht Univ, Cardiovasc Res Inst Maastricht, Dept Biochem, Maastricht, Netherlands	Maastricht University; King Abdulaziz University; King Abdulaziz University; Maastricht University	Kremers, RMW (corresponding author), Maastricht Univ, Cardiovasc Res Inst Maastricht, Synapse, Maastricht, Netherlands.	r.kremers@thrombin.com	de Laat-Kremers, Romy MW/E-1253-2016	de Laat-Kremers, Romy MW/0000-0001-6526-0338; Al Dieri, Raed/0000-0002-2044-7489; HINDAWI, SALWA/0000-0003-3804-5434; Hemker, Coen/0000-0003-1669-2358				Adams M, 2009, SEMIN THROMB HEMOST, V35, P104, DOI 10.1055/s-0029-1214153; Al Dieri R, 2012, BLOOD REV, V26, P197, DOI 10.1016/j.blre.2012.06.001; Alexander KS, 2014, NEUROLOGY, V83, P1271, DOI 10.1212/WNL.0000000000000844; Baglin T, 2005, BRIT J HAEMATOL, V130, P653, DOI 10.1111/j.1365-2141.2005.05612.x; Baglin T, 2010, J THROMB HAEMOST, V8, P228, DOI 10.1111/j.1538-7836.2009.03702.x; Beguin S, 1999, BLOOD, V93, P564, DOI 10.1182/blood.V93.2.564; Berntorp E, 2008, SEMIN THROMB HEMOST, V34, P670, DOI 10.1055/s-0028-1104546; Casari C, 2013, J THROMB HAEMOST, V11, P202, DOI 10.1111/jth.12226; Choi Q, 2015, CLIN CHEM LAB MED, V53, P1425, DOI 10.1515/cclm-2014-0909; CLAUSS A., 1957, ACTA HAEMATOL, V17, P237; Davies JA, 2008, J THROMB HAEMOST, V6, P97; Dentali F, 2013, THROMB HAEMOSTASIS, V110, P1110, DOI 10.1160/TH13-09-0780; Dentali F, 2013, SEMIN THROMB HEMOST, V39, P72, DOI 10.1055/s-0032-1329550; Dielis AWJH, 2008, J THROMB HAEMOST, V6, P125; El-Zawahri MM, 2008, INT J HEMATOL, V87, P303, DOI 10.1007/s12185-008-0036-0; EVANS DAP, 1968, GUT, V9, P319, DOI 10.1136/gut.9.3.319; Flanders MM, 2002, CLIN CHEM, V48, P1622; Folsom AR, 1997, CIRCULATION, V96, P1102, DOI 10.1161/01.CIR.96.4.1102; Franchini M, 2014, THROMB HAEMOSTASIS, V112, P1103, DOI 10.1160/TH14-05-0457; Franchini M, 2012, CRIT REV CL LAB SCI, V49, P137, DOI 10.3109/10408363.2012.708647; Gandara E, 2013, THROMB HAEMOSTASIS, V110, P1172, DOI 10.1160/TH13-06-0488; GILL JC, 1987, BLOOD, V69, P1691; HALL R, 1971, ATHEROSCLEROSIS, V14, P241, DOI 10.1016/0021-9150(71)90053-0; Hemker HC, 2012, J THROMB HAEMOST, V10, P1470, DOI 10.1111/j.1538-7836.2012.04802.x; Hemker HC, 2006, THROMB HAEMOSTASIS, V96, P553, DOI 10.1160/TH06-07-0408; Hemker HC, 2013, THROMB RES, V131, P3, DOI 10.1016/j.thromres.2012.10.011; Hemker HC, 2000, THROMB HAEMOSTASIS, V84, P747; Hemker HC, 2002, PATHOPHYSIOL HAEMO T, V32, P249, DOI 10.1159/000073575; Hemker HC, 2003, PATHOPHYSIOL HAEMO T, V33, P4, DOI 10.1159/000071636; HEMKER HC, 1993, THROMB HAEMOSTASIS, V70, P617; HIRONAKA T, 1992, J BIOL CHEM, V267, P8012; Hoffman M, 2007, HEMATOL ONCOL CLIN N, V21, P1, DOI 10.1016/j.hoc.2006.11.004; HORWICH L, 1966, GUT, V7, P680, DOI 10.1136/gut.7.6.680; JANSSON JH, 1991, BRIT HEART J, V66, P351; Jenkins PV, 2006, TRANSFUSION, V46, P1836, DOI 10.1111/j.1537-2995.2006.00975.x; KINGSBURY KJ, 1971, LANCET, V1, P199; KOSTER T, 1995, LANCET, V345, P152, DOI 10.1016/S0140-6736(95)90166-3; Kremers RMW, 2015, J THROMB HAEMOST, V13, P437, DOI 10.1111/jth.12798; MATSUI T, 1992, J BIOL CHEM, V267, P8723; MATSUI T, 1993, BLOOD, V82, P663; MEADE TW, 1994, BRIT J HAEMATOL, V88, P601, DOI 10.1111/j.1365-2141.1994.tb05079.x; MEDALIE JH, 1971, NEW ENGL J MED, V285, P1348, DOI 10.1056/NEJM197112092852404; O'Donnell J, 2002, THROMB HAEMOSTASIS, V88, P167; PRESTON AE, 1964, BRIT J HAEMATOL, V10, P238, DOI 10.1111/j.1365-2141.1964.tb00698.x; Preston RJS, 2013, BLOOD, V121, P3801, DOI 10.1182/blood-2012-10-415000; SODETZ JM, 1979, J BIOL CHEM, V254, P754; ten Cate H, 2012, THROMB RES, V129, P367, DOI 10.1016/j.thromres.2011.10.017; THOMPSON SG, 1995, NEW ENGL J MED, V332, P635, DOI 10.1056/NEJM199503093321003; van Veen JJ, 2008, BRIT J HAEMATOL, V142, P889, DOI 10.1111/j.1365-2141.2008.07267.x; Vlot AJ, 1998, THROMB HAEMOSTASIS, V79, P456; WAHLBERG TB, 1980, ACTA MED SCAND, V207, P385; Wolberg AS, 2003, BLOOD, V101, P3008, DOI 10.1182/blood-2002-08-2527	52	14	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2015	10	10							e0141491	10.1371/journal.pone.0141491	http://dx.doi.org/10.1371/journal.pone.0141491			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0DL	26509437	Green Submitted, Green Published, gold			2022-12-26	WOS:000363918100091
J	Knihtila, R; Holzapfel, G; Weiss, K; Meilleur, F; Mattos, C				Knihtila, Ryan; Holzapfel, Genevieve; Weiss, Kevin; Meilleur, Flora; Mattos, Carla			Neutron Crystal Structure of RAS GTPase Puts in Question the Protonation State of the GTP gamma-Phosphate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GUANOSINE TRIPHOSPHATE HYDROLYSIS; FREE-ENERGY RELATIONSHIPS; X-RAY; ACTIVATING PROTEIN; EVOLUTIONARY TREE; ATOM POSITIONS; MECHANISM; P21(RAS); COMPLEX; LAUE	RAS GTPase is a prototype for nucleotide-binding proteins that function by cycling between GTP and GDP, with hydrogen atoms playing an important role in the GTP hydrolysis mechanism. It is one of the most well studied proteins in the superfamily of small GTPases, which has representatives in a wide range of cellular functions. These proteins share a GTP-binding pocket with highly conserved motifs that promote hydrolysis to GDP. The neutron crystal structure of RAS presented here strongly supports a protonated gamma-phosphate at physiological pH. This counters the notion that the phosphate groups of GTP are fully deprotonated at the start of the hydrolysis reaction, which has colored the interpretation of experimental and computational data in studies of the hydrolysis mechanism. The neutron crystal structure presented here puts in question our understanding of the pre-catalytic state associated with the hydrolysis reaction central to the function of RAS and other GTPases.	[Knihtila, Ryan; Mattos, Carla] Northeastern Univ, Dept Chem & Chem Biol, 102 Hurtig Hall,360 Huntington Ave, Boston, MA 02115 USA; [Holzapfel, Genevieve; Meilleur, Flora; Mattos, Carla] N Carolina State Univ, Dept Mol & Struct Biochem, Raleigh, NC 27695 USA; [Weiss, Kevin; Meilleur, Flora] Oak Ridge Natl Lab, Biol & Soft Matter Div, Neutron Sci Directorate, Oak Ridge, TN 37831 USA	Northeastern University; University of North Carolina; North Carolina State University; United States Department of Energy (DOE); Oak Ridge National Laboratory	Mattos, C (corresponding author), Northeastern Univ, Dept Chem & Chem Biol, 102 Hurtig Hall,360 Huntington Ave, Boston, MA 02115 USA.	c.mattos@neu.edu	Weiss, Kevin/I-4669-2013	Weiss, Kevin/0000-0002-6486-8007; Meilleur, Flora/0000-0001-9313-8989	National Science Foundation [CHE-0922719]; Scientific User Facilities Division, Office of Basic Energy Sciences, United States Department of Energy; Div Of Molecular and Cellular Bioscience [1244203] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Scientific User Facilities Division, Office of Basic Energy Sciences, United States Department of Energy(United States Department of Energy (DOE)); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We thank Matthew Civic for assistance with x-ray data collection. Neutron data were collected at the High Flux Isotope Reactor; Oak Ridge National Laboratory; the IMAGINE beamline was supported by National Science Foundation Grant CHE-0922719, Research conducted at High Flux Isotope Reactor, Oak Ridge National Laboratory, was supported by the Scientific User Facilities Division, Office of Basic Energy Sciences, United States Department of Energy, Large scale protein expression for crystal optimization was conducted at the Center for Structural Molecular Biology, Oak Ridge National Laboratory, which is supported by the United States Department of Energy, Office of Biological and Environmental Research.	Adams PD, 2009, ACTA CRYSTALLOGR D, V65, P567, DOI 10.1107/S0907444909011548; Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Allin C, 2001, BIOCHEMISTRY-US, V40, P3037, DOI 10.1021/bi0017024; Ankner John F, 2013, Curr Protoc Protein Sci, VChapter 17, DOI 10.1002/0471140864.ps1716s72; [Anonymous], CURR OPIN STRUCT BIO, V16, P630; Arzt S, 1999, J APPL CRYSTALLOGR, V32, P554, DOI 10.1107/S0021889898015350; Bennett BC, 2008, ACTA CRYSTALLOGR D, V64, P764, DOI 10.1107/S0907444908012845; Blum MM, 2009, P NATL ACAD SCI USA, V106, P713, DOI 10.1073/pnas.0807842106; BOURNE HR, 1991, NATURE, V349, P117, DOI 10.1038/349117a0; BOURNE HR, 1990, NATURE, V348, P125, DOI 10.1038/348125a0; Buhrman G, 2011, J MOL BIOL, V413, P773, DOI 10.1016/j.jmb.2011.09.011; Buhrman G, 2011, J BIOL CHEM, V286, P3323, DOI 10.1074/jbc.M110.193854; Buhrman G, 2010, P NATL ACAD SCI USA, V107, P4931, DOI 10.1073/pnas.0912226107; Campbell JW, 1998, J APPL CRYSTALLOGR, V31, P496, DOI 10.1107/S0021889897016683; Cheng H, 2001, J BIOL CHEM, V276, P9931, DOI 10.1074/jbc.M009295200; Cox Adrienne D, 2010, Small GTPases, V1, P2; Du XL, 2009, BIOCHEMISTRY-US, V48, P4538, DOI 10.1021/bi802359b; Du XL, 2004, P NATL ACAD SCI USA, V101, P8858, DOI 10.1073/pnas.0401675101; ECCLESTON JF, 1993, J BIOL CHEM, V268, P27012; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FRANKEN SM, 1993, BIOCHEMISTRY-US, V32, P8411, DOI 10.1021/bi00084a005; Gardberg AS, 2010, ACTA CRYSTALLOGR D, V66, P558, DOI 10.1107/S0907444910005494; GIBBS JB, 1988, P NATL ACAD SCI USA, V85, P5026, DOI 10.1073/pnas.85.14.5026; GLASOE PK, 1960, J PHYS CHEM-US, V64, P188, DOI 10.1021/j100830a521; Grigorenko BL, 2007, PROTEINS, V66, P456, DOI 10.1002/prot.21228; HELLIWELL M, 1989, ACTA CRYSTALLOGR B, V45, P591, DOI 10.1107/S0108768189009328; HERRMANN C, 1995, J BIOL CHEM, V270, P2901, DOI 10.1074/jbc.270.7.2901; JOHN J, 1990, BIOCHEMISTRY-US, V29, P6058, DOI 10.1021/bi00477a025; JOHN J, 1988, J BIOL CHEM, V263, P11792; Kearney BN, 2014, J MOL BIOL, V426, P611, DOI 10.1016/j.jmb.2013.10.036; Klahn M, 2005, BIOPHYS J, V88, P3829, DOI 10.1529/biophysj.104.058644; Krezel A, 2004, J INORG BIOCHEM, V98, P161, DOI 10.1016/j.jinorgbio.2003.10.001; LANGEN R, 1992, BIOCHEMISTRY-US, V31, P8691, DOI 10.1021/bi00152a002; Li GP, 2004, J MOL BIOL, V340, P921, DOI 10.1016/j.jmb.2004.06.007; LUMRY R, 1951, J AM CHEM SOC, V73, P4330, DOI 10.1021/ja01153a090; Maegley KA, 1996, P NATL ACAD SCI USA, V93, P8160, DOI 10.1073/pnas.93.16.8160; Rojas AM, 2012, J CELL BIOL, V196, P189, DOI 10.1083/jcb.201103008; Martin-Garcia F, 2012, BIOPHYS J, V102, P152, DOI 10.1016/j.bpj.2011.11.4005; Meilleur F, 2006, EUR BIOPHYS J BIOPHY, V35, P611, DOI 10.1007/s00249-006-0074-6; Meilleur F, 2013, ACTA CRYSTALLOGR D, V69, P2157, DOI 10.1107/S0907444913019604; Meilleur F, 2009, METHODS MOL BIOL, V544, P281, DOI 10.1007/978-1-59745-483-4_18; MIKKELSEN K, 1960, J PHYS CHEM-US, V64, P632, DOI 10.1021/j100834a026; MILBURN MV, 1990, SCIENCE, V247, P939, DOI 10.1126/science.2406906; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; Myles DAA, 2012, J APPL CRYSTALLOGR, V45, P686, DOI 10.1107/S0021889812019784; PAI EF, 1990, EMBO J, V9, P2351, DOI 10.1002/j.1460-2075.1990.tb07409.x; Prasad BR, 2013, P NATL ACAD SCI USA, V110, P20509, DOI 10.1073/pnas.1319854110; Prior IA, 2012, CANCER RES, V72, P2457, DOI 10.1158/0008-5472.CAN-11-2612; Rudack T, 2012, P NATL ACAD SCI USA, V109, P15295, DOI 10.1073/pnas.1204333109; Scheffzek K, 1997, SCIENCE, V277, P333, DOI 10.1126/science.277.5324.333; Scheidig AJ, 1999, STRUCTURE, V7, P1311, DOI 10.1016/S0969-2126(00)80021-0; Schweins T, 1996, BIOCHEMISTRY-US, V35, P14232, DOI 10.1021/bi961119g; Schweins T, 1996, BIOCHEMISTRY-US, V35, P14225, DOI 10.1021/bi961118o; SCHWEINS T, 1995, NAT STRUCT BIOL, V2, P36, DOI 10.1038/nsb0195-36; Spoerner M, 2005, BIOCHEMISTRY-US, V44, P2225, DOI 10.1021/bi0488000; VALENCIA A, 1991, BIOCHEMISTRY-US, V30, P4637, DOI 10.1021/bi00233a001; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wittinghofer A, 2011, ANNU REV BIOCHEM, V80, P943, DOI 10.1146/annurev-biochem-062708-134043	58	34	35	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 25	2015	290	52					31025	31036		10.1074/jbc.M115.679860	http://dx.doi.org/10.1074/jbc.M115.679860			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CZ6GK	26515069	Green Published, hybrid, Green Submitted			2022-12-26	WOS:000367199000032
J	de la Pena, AH; Suarez, A; Duong-ly, KC; Schoeffield, AJ; Pizarro-Dupuy, MA; Zarr, M; Pineiro, SA; Amzel, LM; Gabelli, SB				de la Pena, Andres H.; Suarez, Allison; Duong-ly, Krisna C.; Schoeffield, Andrew J.; Pizarro-Dupuy, Mario A.; Zarr, Melissa; Pineiro, Silvia A.; Amzel, L. Mario; Gabelli, Sandra B.			Structural and Enzymatic Characterization of a Nucleoside Diphosphate Sugar Hydrolase from Bdellovibrio bacteriovorus	PLOS ONE			English	Article							ADP-RIBOSE PYROPHOSPHATASE; NUDIX HYDROLASE; DEINOCOCCUS-RADIODURANS; CRYSTAL-STRUCTURES; MECHANISM; PROTEIN; IDENTIFICATION; ARABIDOPSIS; REGULATOR; REVEALS	Given the broad range of substrates hydrolyzed by Nudix (nucleoside diphosphate linked to X) enzymes, identification of sequence and structural elements that correctly predict a Nudix substrate or characterize a family is key to correctly annotate the myriad of Nudix enzymes. Here, we present the structure determination and characterization of Bd3179 - a Nudix hydrolase from Bdellovibrio bacteriovorus-that we show localized in the periplasmic space of this obligate Gram-negative predator. We demonstrate that the enzyme is a nucleoside diphosphate sugar hydrolase (NDPSase) and has a high degree of sequence and structural similarity to a canonical ADP-ribose hydrolase and to a nucleoside diphosphate sugar hydrolase (1.4 and 1.3 angstrom C alpha RMSD respectively). Examination of the structural elements conserved in both types of enzymes confirms that an aspartate-X-lysine motif on the C-terminal helix of the alpha-beta-alpha NDPSase fold differentiates NDPSases from ADPRases.	[de la Pena, Andres H.] Johns Hopkins Univ, Sch Med, Dept Biomed Engn, Baltimore, MD 21205 USA; [de la Pena, Andres H.; Suarez, Allison; Duong-ly, Krisna C.; Pizarro-Dupuy, Mario A.; Amzel, L. Mario; Gabelli, Sandra B.] Johns Hopkins Univ, Sch Med, Dept Biophys & Biophys Chem, Struct Enzymol & Thermodynam Grp, Baltimore, MD 21205 USA; [Schoeffield, Andrew J.] Loyola Univ Maryland, Dept Biol, Baltimore, MD USA; [Zarr, Melissa] Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA; [Pineiro, Silvia A.] Univ Maryland, Sch Med, Dept Med & Res Technol, Baltimore, MD 21201 USA; [Gabelli, Sandra B.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Gabelli, Sandra B.] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Loyola University Maryland; Johns Hopkins University; University System of Maryland; University of Maryland Baltimore; Johns Hopkins University; Johns Hopkins University	Amzel, LM (corresponding author), Johns Hopkins Univ, Sch Med, Dept Biophys & Biophys Chem, Struct Enzymol & Thermodynam Grp, Baltimore, MD 21205 USA.	mamzel@jhmi.edu; gabelli@jhmi.edu	Gabelli, Sandra B/A-3705-2008	Gabelli, Sandra B/0000-0003-1205-5204; Duong-Ly, Krisna/0000-0002-4593-8145; Amzel, L. Mario/0000-0002-0129-9572; de la Pena, Andres H./0000-0002-2368-6944	Stewart Trust Fellowship; NIGMS grant [GM066895]; National Science Foundation [DGE-0707427, P50 CA062924]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK089502] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066895] Funding Source: NIH RePORTER	Stewart Trust Fellowship; NIGMS grant; National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	S.B.G. is funded by a Stewart Trust Fellowship. This work was partially supported by NIGMS grant GM066895 to L.M.A; National Science Foundation Graduate Research Fellowships to A.H.P under grant No. DGE-0707427 and P50 CA062924 to S.B.G. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMES BN, 1960, J BIOL CHEM, V235, P769; Bailey S, 2002, STRUCTURE, V10, P589, DOI 10.1016/S0969-2126(02)00746-3; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bessman MJ, 1996, J BIOL CHEM, V271, P25059, DOI 10.1074/jbc.271.41.25059; Bessman MJ, 2001, J BIOL CHEM, V276, P37834; Boto AN, 2011, PROTEINS, V79, P2455, DOI 10.1002/prot.23069; BULLIONS LC, 1994, J BIOL CHEM, V269, P12339; Cowtan K., 1994, JOINT CCP4 ESF EACBM, V31, P34; DeLano W. L., 2002, PYMOL MOL GRAPHICS S, DOI DOI 10.1007/S10822-016-9944-X; Dunn CA, 1999, J BIOL CHEM, V274, P32318, DOI 10.1074/jbc.274.45.32318; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Ferrieres L, 2003, MOL MICROBIOL, V50, P1665, DOI 10.1046/j.1365-2958.2003.03815.x; Fisher DI, 2006, ARCH MICROBIOL, V186, P415, DOI 10.1007/s00203-006-0155-z; Gabelli SB, 2002, BIOCHEMISTRY-US, V41, P9279, DOI 10.1021/bi0259296; Gabelli SB, 2001, NAT STRUCT BIOL, V8, P467, DOI 10.1038/87647; Gabelli SB, 2004, STRUCTURE, V12, P927, DOI 10.1016/j.str.2004.03.028; Ge XC, 2007, PLANT PHYSIOL, V145, P204, DOI 10.1104/pp.107.103374; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Hong MK, 2014, ACTA CRYSTALLOGR D, V70, P1297, DOI 10.1107/S1399004714002570; Huang N, 2009, STRUCTURE, V17, P939, DOI 10.1016/j.str.2009.05.012; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Jones TA, 1997, METHOD ENZYMOL, V277, P173, DOI 10.1016/S0076-6879(97)77012-5; Kang LW, 2003, STRUCTURE, V11, P1015, DOI 10.1016/S0969-2126(03)00154-0; Kang LW, 2003, J BACTERIOL, V185, P4110, DOI 10.1128/JB.185.14.4110-4118.2003; Karunker I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061850; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kuhn FJP, 2004, J BIOL CHEM, V279, P46431, DOI 10.1074/jbc.M407263200; Lambert C, 2010, CURR MICROBIOL, V60, P419, DOI 10.1007/s00284-009-9559-8; Lambert C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008599; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LARSSON A, 1988, SCAND J IMMUNOL, V27, P305, DOI 10.1111/j.1365-3083.1988.tb02351.x; Laskowski RA, 2011, J CHEM INF MODEL, V51, P2778, DOI 10.1021/ci200227u; Leslie NR, 2002, BMC BIOCHEM, V3, DOI 10.1186/1472-2091-3-20; Lundin A, 2003, J BIOL CHEM, V278, P12574, DOI 10.1074/jbc.M212542200; MATHEW N, 1995, BIOCHEM J, V311, P717, DOI 10.1042/bj3110717; Messing SAJ, 2009, STRUCTURE, V17, P472, DOI 10.1016/j.str.2008.12.022; Mildvan AS, 2005, ARCH BIOCHEM BIOPHYS, V433, P129, DOI 10.1016/j.abb.2004.08.017; Nakamura T, 2012, NATURE, V487, P196, DOI 10.1038/nature11181; Okuda K, 2004, BBA-PROTEINS PROTEOM, V1699, P245, DOI 10.1016/j.bbapap.2004.03.004; Ooga T, 2005, BIOCHEMISTRY-US, V44, P9320, DOI 10.1021/bi050078y; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Rendulic S, 2004, SCIENCE, V303, P689, DOI 10.1126/science.1093027; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Rodionov DA, 2008, NUCLEIC ACIDS RES, V36, P2047, DOI 10.1093/nar/gkn047; Scarsdale JN, 2006, STRUCTURE, V14, P331, DOI 10.1016/j.str.2005.11.010; She MP, 2006, NAT STRUCT MOL BIOL, V13, P63, DOI 10.1038/nsmb1033; Steyert SR, 2007, APPL ENVIRON MICROB, V73, P4717, DOI 10.1128/AEM.00640-07; Steyert SR, 2008, J BACTERIOL, V190, P8215, DOI 10.1128/JB.01009-08; Szurmak B, 2008, ACTA BIOCHIM POL, V55, P151, DOI 10.18388/abp.2008_3173; Terwilliger TC, 2003, ACTA CRYSTALLOGR D, V59, P45, DOI 10.1107/S0907444902018048; Terwilliger TC, 2003, ACTA CRYSTALLOGR D, V59, P38, DOI 10.1107/S0907444902018036; TERWILLIGER TC, 1987, ACTA CRYSTALLOGR A, V43, P6, DOI 10.1107/S0108767387099987; TERWILLIGER TC, 1987, ACTA CRYSTALLOGR A, V43, P1, DOI 10.1107/S0108767387099999; TOKUYASU KT, 1973, J CELL BIOL, V57, P551, DOI 10.1083/jcb.57.2.551; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Wolff KA, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004839; Xu WL, 2004, J BIOL CHEM, V279, P24861, DOI 10.1074/jbc.M403272200; Yoshiba S, 2004, J BIOL CHEM, V279, P37163, DOI 10.1074/jbc.M403817200	59	4	4	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2015	10	11							e0141716	10.1371/journal.pone.0141716	http://dx.doi.org/10.1371/journal.pone.0141716			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV1PG	26524597	Green Submitted, Green Published, gold			2022-12-26	WOS:000364029800019
J	Nie, XH; Tu, JL; Wang, B; Zhou, XF; Lin, ZX				Nie, Xinhui; Tu, Jianli; Wang, Bin; Zhou, Xiaofeng; Lin, Zhongxu			A BIL Population Derived from G-hirsutum and G-barbadense Provides a Resource for Cotton Genetics and Breeding	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; INBRED LINE POPULATION; TRANSCRIPTION FACTOR; INTROGRESSION LINES; FIBER QUALITY; LINKAGE MAP; YIELD; RESISTANCE; QTLS; L.	To provide a resource for cotton genetics and breeding, an interspecific hybridization between Gossypium hirsutum cv. Emian22 and G. barbadense acc. 3-79 was made. A population of 54 BILs (backcross inbred lines, BC1F8) was developed with the aim of transferring G. barbadense genes into G. hirsutum in order to genetically analyze these genes' function in a G. hirsutum background and create new germplasms for breeding. Preliminary investigation of the morphological traits showed that the BILs had diverse variations in plant architecture, seed size, and fuzz color; the related traits of yield and fiber quality evaluated in 4 environments also showed abundant phenotypic variation. In order to explore the molecular diversity of the BIL population, 446 SSR markers selected at an average genetic distance of 10 cM from our interspecific linkage map were used to genotype the BIL population. A total of 393 polymorphic loci accounting for 84.4% MAF (major allele frequency) > 0.05 and 922 allele loci were detected, and the Shannon diversity index (I) was 0.417 per locus. The average introgression segment length was 16.24 cM, and an average of 29.53 segments were introgressed in each BIL line with an average background recovery of 79.8%. QTL mapping revealed 58 QTL associated with fiber quality and yield traits, and 47 favored alleles derived from the donor parent were discovered. This study demonstrated that the interspecific BIL population was enriched with much phenotypic and molecular variation which could be a resource for cotton genetics and breeding.	[Nie, Xinhui; Tu, Jianli; Wang, Bin; Lin, Zhongxu] Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Wuhan 430070, Hubei, Peoples R China; [Zhou, Xiaofeng] Xinjiang Acad Agr & Reclamat Sci, Cotton Inst, Shihezi 832000, Xinjiang, Peoples R China	Huazhong Agricultural University	Zhou, XF (corresponding author), Xinjiang Acad Agr & Reclamat Sci, Cotton Inst, Shihezi 832000, Xinjiang, Peoples R China.	xjzhxf@sohu.com; linzhongxu@mail.hzau.edu.cn			Genetically Modified Organisms Breeding Major Project of China [2014ZX08009-001]	Genetically Modified Organisms Breeding Major Project of China	This work was financially supported by the Genetically Modified Organisms Breeding Major Project of China (No. 2014ZX08009-001).	Adams DC, 2000, P NATL ACAD SCI USA, V97, P4106, DOI 10.1073/pnas.97.8.4106; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Cao ZB, 2014, THEOR APPL GENET, V127, P587, DOI 10.1007/s00122-013-2241-3; Chee P, 2005, THEOR APPL GENET, V111, P757, DOI 10.1007/s00122-005-2063-z; Chen Li, 2008, Acta Agronomica Sinica, V34, P1199, DOI 10.3724/SP.J.1006.2008.01199; Chen ZJ, 2007, PLANT PHYSIOL, V145, P1303, DOI 10.1104/pp.107.107672; Cockram J, 2010, P NATL ACAD SCI USA, V107, P21611, DOI 10.1073/pnas.1010179107; Fang H, 2013, EUPHYTICA, V194, P79, DOI 10.1007/s10681-013-0965-4; Gutierrez AG, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-6; Hao J, 2012, J EXP BOT, V63, P6267, DOI 10.1093/jxb/ers278; He DH, 2006, THESIS HUAZHONG AGR; Lee JJ, 2007, ANN BOT-LONDON, V100, P1391, DOI 10.1093/aob/mcm232; Li XM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054444; Li YL, 2012, MOL BREEDING, V29, P627, DOI 10.1007/s11032-011-9578-6; Mei HW, 2003, THESIS HUAZHONG AGR; Paillard S, 2003, THEOR APPL GENET, V107, P1235, DOI 10.1007/s00122-003-1361-6; Pang MX, 2012, MOL BREEDING, V30, P975, DOI 10.1007/s11032-011-9682-7; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Pillen K, 2003, THEOR APPL GENET, V107, P340, DOI 10.1007/s00122-003-1253-9; Pu L, 2008, GENETICS, V180, P811, DOI 10.1534/genetics.108.093070; Saha S, 2010, THEOR APPL GENET, V120, P1193, DOI 10.1007/s00122-009-1247-3; Shi YZ, 2015, J INTEGR PLANT BIOL, V57, P450, DOI 10.1111/jipb.12288; Sun F, 2012, MOL BREEDING, V30, P93, DOI 10.1007/s11032-011-9601-y; Thomson MJ, 2003, THEOR APPL GENET, V107, P479, DOI 10.1007/s00122-003-1270-8; Tiwari RS, 2013, EUPHYTICA, V194, P1, DOI 10.1007/s10681-013-0927-x; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; Wang BH, 2006, EUPHYTICA, V152, P367, DOI 10.1007/s10681-006-9224-2; Wang B, 2012, THEOR APPL GENET, V125, P1263, DOI 10.1007/s00122-012-1911-x; Wang HM, 2008, J INTEGR PLANT BIOL, V50, P174, DOI 10.1111/j.1744-7909.2007.00612.x; Wang XQ, 2011, GENET MOL RES, V10, P3620, DOI 10.4238/2011.December.8.5; Wen ZiXiang, 2008, Acta Agronomica Sinica, V34, P1339, DOI 10.3724/SP.J.1006.2008.01339; [吴翠翠 Wu Cuicui], 2010, [分子植物育种, Molecular Plant Breeding], V8, P680; Xu YH, 2004, PLANT PHYSIOL, V135, P507, DOI 10.1104/pp.104.038612; Yu FF, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-144; Yu JW, 2013, THEOR APPL GENET, V126, P275, DOI 10.1007/s00122-012-1980-x; Yu Y, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-15; Zhang TZ, 2015, NAT BIOTECHNOL, V33, P531, DOI 10.1038/nbt.3207; Zhang TZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057220	38	18	20	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2015	10	10							e0141064	10.1371/journal.pone.0141064	http://dx.doi.org/10.1371/journal.pone.0141064			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0EH	26517274	gold, Green Submitted, Green Published			2022-12-26	WOS:000363920800017
J	Hametner, B; Parragh, S; Mayer, C; Weber, T; Bortel, LV; De Buyzere, M; Segers, P; Rietzschel, E; Wassertheurer, S				Hametner, Bernhard; Parragh, Stephanie; Mayer, Christopher; Weber, Thomas; Luc Van Bortel; De Buyzere, Marc; Segers, Patrick; Rietzschel, Ernst; Wassertheurer, Siegfried			Assessment of Model Based (Input) Impedance, Pulse Wave Velocity, and Wave Reflection in the Asklepios Cohort	PLOS ONE			English	Article							EXPERT CONSENSUS DOCUMENT; NONINVASIVE EVALUATION; ARTERIAL STIFFNESS; AORTIC STIFFNESS; PRESSURE; AGE; HEALTHY; QUANTIFICATION; WOMEN; FLOW	Objectives Arterial stiffness and wave reflection parameters assessed from both invasive and non-invasive pressure and flow readings are used as surrogates for ventricular and vascular load. They have been reported to predict adverse cardiovascular events, but clinical assessment is laborious and may limit widespread use. This study aims to investigate measures of arterial stiffness and central hemodynamics provided by arterial tonometry alone and in combination with aortic root flows derived by echocardiography against surrogates derived by a mathematical pressure and flow model in a healthy middle-aged cohort. Methods Measurements of carotid artery tonometry and echocardiography were performed on 2226 ASKLEPIOS study participants and parameters of systemic hemodynamics, arterial stiffness and wave reflection based on pressure and flow were measured. In a second step, the analysis was repeated but echocardiography derived flows were substituted by flows provided by a novel mathematical model. This was followed by a quantitative method comparison. Results All investigated parameters showed a significant association between the methods. Overall agreement was acceptable for all parameters (mean differences: -0.0102 (0.033 SD) mmHg*s/ml for characteristic impedance, 0.36 (4.21 SD) mmHg for forward pressure amplitude, 2.26 (3.51 SD) mmHg for backward pressure amplitude and 0.717 (1.25 SD) m/s for pulse wave velocity). Conclusion The results indicate that the use of model-based surrogates in a healthy middle aged cohort is feasible and deserves further attention.	[Hametner, Bernhard; Parragh, Stephanie; Mayer, Christopher; Wassertheurer, Siegfried] AIT, Hlth & Environm Dept, Vienna, Austria; [Parragh, Stephanie; Wassertheurer, Siegfried] Vienna Univ Technol, Dept Anal & Sci Comp, A-1040 Vienna, Austria; [Weber, Thomas] Klinikum Wels Grieskirchen, Dept Cardiol, Wels, Austria; [Luc Van Bortel; De Buyzere, Marc] Univ Ghent, Dept Pharmacol, B-9000 Ghent, Belgium; [Segers, Patrick] Univ Ghent, iMinds Med IT, Inst Biomed Technol, B-9000 Ghent, Belgium; [Rietzschel, Ernst] Univ Ghent, Dept Internal Med, B-9000 Ghent, Belgium	Austrian Institute of Technology (AIT); Technische Universitat Wien; Ghent University; Ghent University; IMEC; Ghent University	Wassertheurer, S (corresponding author), AIT, Hlth & Environm Dept, Vienna, Austria.	Siegfried.Wassertheurer@ait.ac.at	Segers, Patrick/AAA-7844-2020; Mayer, Christopher C./J-5425-2019	Segers, Patrick/0000-0003-3870-3409; Mayer, Christopher C./0000-0002-5612-5481; Hametner, Bernhard/0000-0003-2048-1019	government of Lower Austria; EC (EFRD) [WST3-T-81/015-2008]; AIT Austrian Institute of Technology	government of Lower Austria; EC (EFRD); AIT Austrian Institute of Technology	This work and its publication were partly supported by a grant from the government of Lower Austria and the EC (EFRD), contract number WST3-T-81/015-2008. All other costs were covered by internal funding from the AIT Austrian Institute of Technology.	Baumann M, 2014, J HYPERTENS, V32, P899, DOI 10.1097/HJH.0000000000000113; Ben-Shlomo Y, 2014, J AM COLL CARDIOL, V63, P636, DOI 10.1016/j.jacc.2013.09.063; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Butlin M, 2015, J HYPERTENS, V33, P63, DOI 10.1097/HJH.0000000000000389; Chirinos JA, 2012, J AM COLL CARDIOL, V60, P2170, DOI 10.1016/j.jacc.2012.07.054; Chirinos JA, 2010, HYPERTENSION, V56, P563, DOI 10.1161/HYPERTENSIONAHA.110.157339; Chirinos JA, 2010, HYPERTENSION, V56, P555, DOI 10.1161/HYPERTENSIONAHA.110.157321; Devos DGH, 2015, J MAGN RESON IMAGING, V41, P765, DOI 10.1002/jmri.24592; Feistritzer HJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116862; Hametner B, 2013, MATH COMP MODEL DYN, V19, P319, DOI 10.1080/13873954.2013.763831; Hametner B, 2013, BLOOD PRESS MONIT, V18, P173, DOI 10.1097/MBP.0b013e3283614168; Hametner B, 2013, COMPUT METH PROG BIO, V109, P250, DOI 10.1016/j.cmpb.2012.10.005; Kips JG, 2009, HYPERTENSION, V53, P142, DOI 10.1161/HYPERTENSIONAHA.108.123109; Laurent S, 2006, EUR HEART J, V27, P2588, DOI 10.1093/eurheartj/ehl254; Luzardo L, 2012, HYPERTENS RES, V35, P980, DOI 10.1038/hr.2012.78; Mancia G, 2013, EUR HEART J, V34, P2159, DOI 10.1093/eurheartj/eht151; McEniery CM, 2005, J AM COLL CARDIOL, V46, P1753, DOI 10.1016/j.jacc.2005.07.037; Mitchell GF, 2010, CIRCULATION, V122, P1379, DOI 10.1161/CIRCULATIONAHA.109.914507; Mitchell GF, 2004, HYPERTENSION, V43, P1239, DOI 10.1161/01.HYP.0000128420.01881.aa; MURGO JP, 1980, CIRCULATION, V62, P105, DOI 10.1161/01.CIR.62.1.105; Nichols WW, 2011, MCDONALD'S BLOOD FLOW IN ARTERIES: THEORETICAL, EXPERIMENTAL AND CLINICAL PRINCIPLES, 6TH EDITION, P1; Parragh S, 2015, PHYSIOL MEAS, V36, P179, DOI 10.1088/0967-3334/36/2/179; Pucci G, 2015, J HYPERTENS, V33, P153, DOI 10.1097/HJH.0000000000000354; Rietzschel ER, 2007, EUR J CARDIOV PREV R, V14, P179, DOI 10.1097/HJR.0b013e328012c380; Segers P, 2006, AM J PHYSIOL-HEART C, V290, pH2385, DOI 10.1152/ajpheart.01207.2005; Segers P, 2007, HYPERTENSION, V49, P1248, DOI 10.1161/HYPERTENSIONAHA.106.085480; Smulyan H, 2001, J AM COLL CARDIOL, V37, P1374, DOI 10.1016/S0735-1097(01)01166-4; Tomiyama H, 2003, ATHEROSCLEROSIS, V166, P303, DOI 10.1016/S0021-9150(02)00332-5; Van Bortel LM, 2012, J HYPERTENS, V30, P445, DOI 10.1097/HJH.0b013e32834fa8b0; Verbeke F, 2005, HYPERTENSION, V46, P244, DOI 10.1161/01.HYP.0000166723.07809.7e; Vermeersch SJ, 2008, J HYPERTENS, V26, P1411, DOI 10.1097/HJH.0b013e3282ffac00; Waddell TK, 2001, J HYPERTENS, V19, P2205, DOI 10.1097/00004872-200112000-00014; Wang KL, 2010, HYPERTENSION, V55, P799, DOI 10.1161/HYPERTENSIONAHA.109.139964; Wassertheurer S, 2008, SIMUL MODEL PRACT TH, V16, P988, DOI 10.1016/j.simpat.2008.04.016; Weber T, 2015, J HYPERTENS, V33, P1023, DOI 10.1097/HJH.0000000000000518; Weber T, 2012, HYPERTENSION, V60, P534, DOI 10.1161/HYPERTENSIONAHA.112.194571; Westerhof BE, 2006, HYPERTENSION, V48, P595, DOI 10.1161/01.HYP.0000238330.08894.17; WESTERHOF N, 1972, CARDIOVASC RES, V6, P648, DOI 10.1093/cvr/6.6.648; Wilkinson IB, 2010, ARTERY RES, V4, P34, DOI 10.1016/j.artres.2010.03.001	39	20	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2015	10	10							e0141656	10.1371/journal.pone.0141656	http://dx.doi.org/10.1371/journal.pone.0141656			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0ED	26513463	Green Published, Green Submitted, gold			2022-12-26	WOS:000363920300063
J	Klein, DA; Adelman, WP; Thompson, AM; Shoemaker, RG; Shen-Gunther, J				Klein, David A.; Adelman, William P.; Thompson, Amy M.; Shoemaker, Richard G.; Shen-Gunther, Jane			All Military Adolescents Are Not the Same: Sexuality and Substance Use among Adolescents in the US Military Healthcare System	PLOS ONE			English	Article							CHLAMYDIA-TRACHOMATIS INFECTIONS; YOUTH; RISK; PREVALENCE; PREGNANCY	Data examining sexuality and substance use among active duty and military-dependent youth is limited; however, these psychosocial factors have military implications. Adolescents and young adults aged 12-23 were recruited from an active-duty trainee clinic (n = 225) and a military pediatric clinic (n = 223). Active duty participants were more likely to be older, male, White, previous tobacco users, and report a history of sexual activity and less contraception use at their most recent intercourse, compared to the dependent group. Over 10% of all participants indicated attraction to members of the same gender or both genders. In logistic regression analysis, non-White participants were less likely to use contraception compared to White participants. Adolescents and young adults seen in military clinics frequently engage in high-risk behavior. Clinicians who care for military youth should assess their patient's psychosocial history. Further study of this population is warranted to identify factors that may influence risk and resilience.	[Klein, David A.] Ft Belvoir Community Hosp, Dept Family Med, Ft Belvoir, VA 22060 USA; [Klein, David A.; Adelman, William P.] Uniformed Serv Univ Hlth Sci, Dept Pediat, Bethesda, MD 20814 USA; [Thompson, Amy M.] San Antonio Mil Med Ctr, Dept Pediat, San Antonio, TX USA; [Shoemaker, Richard G.] Ft Belvoir Community Hosp, Clin Invest, Ft Belvoir, VA USA; [Shen-Gunther, Jane] San Antonio Mil Med Ctr, Dept Clin Invest, San Antonio, TX USA; [Shen-Gunther, Jane] San Antonio Mil Med Ctr, Dept Obstet & Gynecol, San Antonio, TX USA	Uniformed Services University of the Health Sciences - USA; San Antonio Military Medical Center; San Antonio Military Medical Center; San Antonio Military Medical Center	Klein, DA (corresponding author), Ft Belvoir Community Hosp, Dept Family Med, Ft Belvoir, VA 22060 USA.	david.a.klein26.mil@mail.mil			Clinical Investigations, Lackland Air Force Base; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [TL1TR001119, UL1TR001120, KL2TR001118] Funding Source: NIH RePORTER	Clinical Investigations, Lackland Air Force Base; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was supported by Clinical Investigations, Lackland Air Force Base (intramural research funding). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Astor RA, 2013, CLIN CHILD FAM PSYCH, V16, P233, DOI 10.1007/s10567-013-0139-x; Blankson KL, 2014, PEDIATRICS, V133, P627, DOI 10.1542/peds.2013-1630; Burr JE, 2013, MIL MED, V178, P412, DOI 10.7205/MILMED-D-12-00461; Card NA, 2011, J FAM PSYCHOL, V25, P508, DOI 10.1037/a0024395; Daniels Kimberly, 2014, NCHS Data Brief, P1; Defense Manpower Data Center, 2013, DEM PROF MIL COMM; Department of Defense, 2013, 2011 DEP DEF HLTH RE; Esposito-Smythers C, 2011, J FAM PSYCHOL, V25, P497, DOI 10.1037/a0024534; Gates G, 2011, MANY PEOPLE ARE LESB; Gates GJ., 2010, LESBIAN GAY BISEXUAL; Gaydos CA, 2003, SEX TRANSM DIS, V30, P539, DOI 10.1097/00007435-200307000-00002; Gaydos CA, 1998, NEW ENGL J MED, V339, P739, DOI 10.1056/NEJM199809103391105; Gibbs DA, 2007, JAMA-J AM MED ASSOC, V298, P528, DOI 10.1001/jama.298.5.528; Ho GYF, 1998, NEW ENGL J MED, V338, P423, DOI 10.1056/NEJM199802123380703; Institute of Medicine, 2013, RET HOM IR AFGH ASS; Kann L, 2014, MMWR SURVEILL SUMM, V63, P1; Klein DA, 2008, MIL MED, V173, P658, DOI 10.7205/MILMED.173.7.658; Klein DA, 2010, MIL MED, V175, P890; Kleykamp MA, 2006, SOC SCI QUART, V87, P272, DOI 10.1111/j.1540-6237.2006.00380.x; Lechner BL, 2002, MIL MED, V167, P600; Levine DA, 2013, PEDIATRICS, V132, pE297, DOI 10.1542/peds.2013-1283; Martinez Gladys, 2011, Vital Health Stat 23, P1; Reed SC, 2014, MATERN CHILD HLTH J, V18, P1863, DOI 10.1007/s10995-014-1430-2; Reed SC, 2011, AM J PUBLIC HEALTH, V101, P1676, DOI 10.2105/AJPH.2011.300165; Schlecht NF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037419; Stahlman S, 2014, SEX TRANSM DIS, V41, P359, DOI 10.1097/OLQ.0000000000000133; Tyler Crystal Pirtle, 2012, Morbidity and Mortality Weekly Report, V61, P297; Workowski KA, 2015, MMWR RECOMM REP, V64, P1, DOI 10.15585/mmwr.rr7004a1; Zenilman JM, 2002, SEX TRANSM INFECT, V78, P40, DOI 10.1136/sti.78.1.40	29	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2015	10	10							e0141430	10.1371/journal.pone.0141430	http://dx.doi.org/10.1371/journal.pone.0141430			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CV0ED	26512892	Green Published, Green Submitted, gold			2022-12-26	WOS:000363920300038
J	Marchini, C; Airi, V; Fontana, R; Tortorelli, G; Rocchi, M; Falini, G; Levy, O; Dubinsky, Z; Goffredo, S				Marchini, Chiara; Airi, Valentina; Fontana, Roberto; Tortorelli, Giada; Rocchi, Marta; Falini, Giuseppe; Levy, Oren; Dubinsky, Zvy; Goffredo, Stefano			Annual Reproductive Cycle and Unusual Embryogenesis of a Temperate Coral in the Mediterranean Sea	PLOS ONE			English	Article							BALANOPHYLLIA-EUROPAEA SCLERACTINIA; LEPTOPSAMMIA-PRUVOTI SCLERACTINIA; ANEMONE ACTINIA-EQUINA; GREAT-BARRIER-REEF; SEXUAL REPRODUCTION; POCILLOPORA-DAMICORNIS; ASEXUAL REPRODUCTION; ASTROIDES-CALYCULARIS; RED-SEA; GENETIC DIFFERENTIATION	The variety of reproductive processes and modes among coral species reflects their extraordinary regeneration ability. Scleractinians are an established example of clonal animals that can exhibit a mixed strategy of sexual and asexual reproduction to maintain their populations. This study provides the first description of the annual reproductive cycle and embryogenesis of the temperate species Caryophyllia inornata. Cytometric analyses were used to define the annual development of germ cells and embryogenesis. The species was gonochoric with three times more male polyps than female. Polyps were sexually mature from 6 to 8 mm length. Not only females, but also sexually inactive individuals (without germ cells) and males were found to brood their embryos. Spermaries required 12 months to reach maturity, while oogenesis seemed to occur more rapidly (5-6 months). Female polyps were found only during spring and summer. Furthermore, the rate of gamete development in both females and males increased significantly from March to May and fertilization was estimated to occur from April to July, when mature germ cells disappeared. Gametogenesis showed a strong seasonal influence, while embryos were found throughout the year in males and in sexually inactive individuals without a defined trend. This unusual embryogenesis suggests the possibility of agamic reproduction, which combined with sexual reproduction results in high fertility. This mechanism is uncommon and only four other scleractinians (Pocillopora damicornis, Tubastraea diaphana, T. coccinea and Oulastrea crispata) have been shown to generate their broods asexually. The precise nature of this process is still unknown.	[Marchini, Chiara; Airi, Valentina; Fontana, Roberto; Tortorelli, Giada; Rocchi, Marta; Goffredo, Stefano] Univ Bologna, Dept Biol Geol & Environm Sci, Marine Sci Grp, I-40126 Bologna, Italy; [Falini, Giuseppe] Univ Bologna, Dept Chem G Ciamician, I-40126 Bologna, Italy; [Levy, Oren; Dubinsky, Zvy] Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, IL-52900 Ramat Gan, Israel	University of Bologna; University of Bologna; Bar Ilan University	Goffredo, S (corresponding author), Univ Bologna, Dept Biol Geol & Environm Sci, Marine Sci Grp, I-40126 Bologna, Italy.	s.goffredo@unibo.it	Rocchi, Marta/F-8953-2017	goffredo, stefano/0000-0002-5022-9503; Airi, Valentina/0000-0002-6118-7441	European Research Council under the European Union's Seventh Framework Programme/ERC [249930]	European Research Council under the European Union's Seventh Framework Programme/ERC(European Research Council (ERC))	The research leading to these results has received funding from the European Research Council under the European Union's Seventh Framework Programme (FP7/2007-2013)/ERC grant agreement no. 249930 - CoralWarm: Corals and global warming: the Mediterranean versus the Red Sea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta A, 1997, MAR BIOL, V128, P141, DOI 10.1007/s002270050077; Adjeroud M, 1999, MAR BIOL, V134, P753, DOI 10.1007/s002270050592; Airi V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091792; Ayre DJ, 2004, MAR ECOL PROG SER, V277, P95, DOI 10.3354/meps277095; Ayre DJ, 1997, MAR ECOL PROG SER, V159, P175, DOI 10.3354/meps159175; AYRE DJ, 1986, MAR BIOL, V90, P187, DOI 10.1007/BF00569126; AYRE DJ, 1983, OECOLOGIA, V57, P158, DOI 10.1007/BF00379575; BABCOCK RC, 1986, MAR BIOL, V90, P379, DOI 10.1007/BF00428562; BABCOCK RC, 1994, CORAL REEFS, V13, P161, DOI 10.1007/BF00301193; Baillon S, 2011, DEEP-SEA RES PT I, V58, P260, DOI 10.1016/j.dsr.2010.12.010; Baird AH, 2009, ANNU REV ECOL EVOL S, V40, P551, DOI 10.1146/annurev.ecolsys.110308.120220; BEAUCHAMP KA, 1993, INVERTEBR REPROD DEV, V23, P171, DOI 10.1080/07924259.1993.9672312; BENAYAHU Y, 1984, J EXP MAR BIOL ECOL, V83, P249, DOI 10.1016/S0022-0981(84)80004-0; Bosch TCG, 2009, BIOESSAYS, V31, P478, DOI 10.1002/bies.200800183; BRAZEAU DA, 1990, MAR BIOL, V104, P465, DOI 10.1007/BF01314351; Brooke S, 2013, MAR BIOL, V160, P139, DOI 10.1007/s00227-012-2071-x; CAIRNS S D, 1979, Uitgaven Natuurwetenschappelijke Studiekring voor Suriname en de Nederlandse Antillen, P1; Cairns SD, 1995, NZ OCEANOGRAPHIC I M, P103; Cairns Stephen D., 1999, Atoll Research Bulletin, V459, P1; Caroselli E, 2015, LIMNOL OCEANOGR, V60, P1356, DOI 10.1002/lno.10100; CARTER MA, 1981, J MAR BIOL ASSOC UK, V61, P79, DOI 10.1017/S0025315400045926; CARTER MA, 1989, BIOL J LINN SOC, V36, P129, DOI 10.1111/j.1095-8312.1989.tb00487.x; CARTER MA, 1979, J MAR BIOL ASSOC UK, V59, P989, DOI 10.1017/S0025315400036985; Carter MA, 1980, REPROD BROODING ACTI; Casado-Amezua P, 2013, ZOOLOGY, V116, P159, DOI 10.1016/j.zool.2012.10.005; CLAYTON PD, 1992, HYDROBIOLOGIA, V237, P31, DOI 10.1007/BF00008425; Colley SB, 2000, P 9 INT COR REEF S, V1, P373; Combosch DJ, 2013, ECOL EVOL, V3, P3379, DOI 10.1002/ece3.721; Fadlallah Y.H., 1983, Coral Reefs, V2, P129, DOI 10.1007/BF00336720; FADLALLAH YH, 1982, MAR BIOL, V71, P223, DOI 10.1007/BF00397039; FAN TY, 1995, MAR BIOL, V123, P565, DOI 10.1007/BF00349235; FARRANT PA, 1986, MAR BIOL, V92, P381, DOI 10.1007/BF00392679; Fiorillo I, 2013, MAR BIOL, V160, P719, DOI 10.1007/s00227-012-2126-z; Fujiwara M, 2001, NATURE, V414, P537, DOI 10.1038/35107054; Gilmour JP, 2002, MAR ECOL PROG SER, V235, P81, DOI 10.3354/meps235081; Glynn PW, 2008, MAR BIOL, V153, P529, DOI 10.1007/s00227-007-0827-5; Glynn PW, 2000, MAR BIOL, V136, P785, DOI 10.1007/s002270000286; Goffredo S, 2006, MAR BIOL, V148, P923, DOI 10.1007/s00227-005-0137-8; Goffredo S, 2005, MAR BIOL, V147, P485, DOI 10.1007/s00227-005-1567-z; Goffredo S, 2004, B MAR SCI, V74, P449; Goffredo S, 2002, MAR ECOL PROG SER, V229, P83, DOI 10.3354/meps229083; Goffredo S, 1998, ITAL J ZOOL, V65, P159, DOI 10.1080/11250009809386740; Goffredo S, 2000, ZOOMORPHOLOGY, V119, P231, DOI 10.1007/PL00008495; Goffredo S, 2012, J MORPHOL, V273, P943, DOI 10.1002/jmor.20039; Goffredo S, 2011, B MAR SCI, V87, P589, DOI 10.5343/bms.2010.1068; Goffredo S, 2010, MAR BIOL RES, V6, P421, DOI 10.1080/17451000903428488; Guest JR, 2012, CORAL REEFS, V31, P705, DOI 10.1007/s00338-012-0881-4; Harrison PL, 2011, CORAL REEFS: AN ECOSYSTEM IN TRANSITION, P59, DOI 10.1007/978-94-007-0114-4_6; Harrison PL, 1990, CORAL REEFS ECOSYSTE; Kersting DK, 2013, MAR ECOL PROG SER, V486, P165, DOI 10.3354/meps10356; Kramarsky-Winter E, 1998, MAR ECOL PROG SER, V174, P175, DOI 10.3354/meps174175; KramarskyWinter E, 1997, NATURE, V387, P137, DOI 10.1038/387137a0; Kruger A, 1998, MAR BIOL, V132, P703, DOI 10.1007/s002270050434; Kruzic P, 2008, CORAL REEFS, V27, P337, DOI 10.1007/s00338-007-0334-7; Lam KKY, 2000, MAR ECOL PROG SER, V205, P101, DOI 10.3354/meps205101; Levy O, 2007, SCIENCE, V318, P467, DOI 10.1126/science.1145432; Loya Y, 2008, P ROY SOC B-BIOL SCI, V275, P2335, DOI 10.1098/rspb.2008.0675; Maynard Smith J., 1978, EVOLUTION SEX, DOI DOI 10.1093/bioinformatics/btg412; Miller KJ, 2004, HEREDITY, V92, P557, DOI 10.1038/sj.hdy.6800459; Monteiro FA, 1998, B MAR SCI, V63, P257; Monteiro FA, 1997, MAR BIOL, V129, P425, DOI 10.1007/s002270050183; Nakano Y., 1992, Zoological Science (Tokyo), V9, P1292; Okubo N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084115; ORR J, 1982, MAR ECOL PROG SER, V7, P227, DOI 10.3354/meps007227; OTTAWAY JR, 1979, AUST J ZOOL, V27, P273, DOI 10.1071/ZO9790273; Pechenik JA, 1999, MAR ECOL PROG SER, V177, P269, DOI 10.3354/meps177269; Penland L, 2004, CORAL REEFS, V23, P133, DOI 10.1007/s00338-003-0362-x; Perrin MC, 1999, OCEANOGR MAR BIOL, V37, P129; Pinzon JH, 2012, CORAL REEFS, V31, P765, DOI 10.1007/s00338-012-0887-y; RICHMOND RH, 1990, MAR ECOL PROG SER, V60, P185, DOI 10.3354/meps060185; RINKEVICH B, 1979, MAR ECOL PROG SER, V1, P145, DOI 10.3354/meps001145; RINKEVICH B, 1986, EXPERIENTIA, V42, P320, DOI 10.1007/BF01942521; Roberts J.M., 2009, COLD WATER CORALS BI; Sammarco PW, 2004, MAR ECOL PROG SER, V280, P129, DOI 10.3354/meps280129; Sherman CDH, 2006, CORAL REEFS, V25, P7, DOI 10.1007/s00338-005-0053-x; Sherman CDH, 2007, J EXP MAR BIOL ECOL, V340, P259, DOI 10.1016/j.jembe.2006.09.016; SHILLING FM, 1994, BIOL BULL, V187, P398, DOI 10.2307/1542296; Shlesinger Y, 1998, MAR BIOL, V132, P691, DOI 10.1007/s002270050433; SOONG K, 1991, B MAR SCI, V49, P832; STEINER SCC, 1995, B MAR SCI, V56, P899; STODDART JA, 1984, CORAL REEFS, V3, P149, DOI 10.1007/BF00301959; STODDART JA, 1983, MAR BIOL, V76, P279, DOI 10.1007/BF00393029; SZMANT AM, 1986, CORAL REEFS, V5, P43, DOI 10.1007/BF00302170; SZMANTFROELICH A, 1980, BIOL BULL, V158, P257, DOI 10.2307/1540935; TRANTER PRG, 1982, J MAR BIOL ASSOC UK, V62, P845, DOI 10.1017/S0025315400070387; Waller RG, 2005, CORAL REEFS, V24, P594, DOI 10.1007/s00338-005-0031-3; Ward S., 2002, P1123; Whitaker K, 2006, MAR ECOL PROG SER, V306, P115, DOI 10.3354/meps306115; Williams G.C., 1975, Journal Cell Biol, VNo. 8, pi; Yeoh SR, 2010, MAR BIOL, V157, P351, DOI 10.1007/s00227-009-1322-y; ZIBROWIUS H, 1980, Memoires de l'Institut Oceanographique (Monaco), P1; ZIBROWIUS H, 1978, PUBBLICAZIONI STAZIO, V40, P516	92	7	7	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2015	10	10							e0141162	10.1371/journal.pone.0141162	http://dx.doi.org/10.1371/journal.pone.0141162			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0ED	26513159	gold, Green Published, Green Submitted			2022-12-26	WOS:000363920300020
J	Zhang, LW; Li, YR; Tao, AF; Fang, PP; Qi, JM				Zhang, Liwu; Li, Yanru; Tao, Aifen; Fang, Pingping; Qi, Jianmin			Development and Characterization of 1,906 EST-SSR Markers from Unigenes in Jute (Corchorus spp.)	PLOS ONE			English	Article							MICROSATELLITE MARKERS; BIOSYNTHESIS; BARLEY; GENES	Jute, comprising white and dark jute, is the second important natural fiber crop after cotton worldwide. However, the lack of expressed sequence tag-derived simple sequence repeat (EST-SSR) markers has resulted in a large gap in the improvement of jute. Previously, de novo 48,914 unigenes from white jute were assembled. In this study, 1,906 EST-SSRs were identified from these assembled uingenes. Among these markers, di-, tri- and tetra-nucleotide repeat types were the abundant types (12.0%, 56.9% and 21.6% respectively). The AG-rich or GA-rich nucleotide repeats were the predominant. Subsequently, a sample of 116 SSRs, located in genes encoding transcription factors and cellulose synthases, were selected to survey polymorphisms among12 diverse jute accessions. Of these, 83.6% successfully amplified at least one fragment and detected polymorphism among the 12diverse genotypes, indicating that the newly developed SSRs are of good quality. Furthermore, the genetic similarity coefficients of all the 12 accessions were evaluated using 97 polymorphic SSRs. The cluster analysis divided the jute accessions into two main groups with genetic similarity coefficient of 0.61. These EST-SSR markers not only enrich molecular markers of jute genome, but also facilitate genetic and genomic researches in jute.	[Zhang, Liwu; Li, Yanru; Tao, Aifen; Fang, Pingping; Qi, Jianmin] Fujian Agr & Forestry Univ, Coll Crop Sci, Key Lab, Minist Educ Genet Breeding & Multiple Utilizat Cr, Fuzhou, Peoples R China	Fujian Agriculture & Forestry University	Zhang, LW (corresponding author), Fujian Agr & Forestry Univ, Coll Crop Sci, Key Lab, Minist Educ Genet Breeding & Multiple Utilizat Cr, Fuzhou, Peoples R China.	zhang_liwu@hotmail.com; qijm863@163.com		Zhang, Liwu/0000-0001-8465-2476	Doctoral Program of Higher Education of China [20133515120002]; Introduction Breeding and Varieties Demonstration of Featured Crops between China and Benin [2015I0001]; National Agri-Industry Technology Research System for Crops of Bast and Leaf Fiber, China [nycytx-19-E06]; Construction of Germplasm Resources Platform of Bast Fiber Crops in Fujian, China	Doctoral Program of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Introduction Breeding and Varieties Demonstration of Featured Crops between China and Benin; National Agri-Industry Technology Research System for Crops of Bast and Leaf Fiber, China; Construction of Germplasm Resources Platform of Bast Fiber Crops in Fujian, China	This work was supported by The Doctoral Program of Higher Education of China (20133515120002), [http://www.cutech.edu.cn/]; Introduction Breeding and Varieties Demonstration of Featured Crops between China and Benin (2015I0001), [http://xmgl.fjkjt.gov.cn/]; National Agri-Industry Technology Research System for Crops of Bast and Leaf Fiber, China (nycytx-19-E06), [http://119.253.58.231/]; Construction of Germplasm Resources Platform of Bast Fiber Crops in Fujian, China, [http://xmgl.fjkjt.gov.cn/]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal RK, 2007, THEOR APPL GENET, V114, P359, DOI 10.1007/s00122-006-0440-x; Andersen JR, 2003, TRENDS PLANT SCI, V8, P554, DOI 10.1016/j.tplants.2003.09.010; Biswas C, 2015, MOL BREEDING, V35, DOI 10.1007/s11032-015-0311-8; Chakraborty A, 2015, MOL GENET GENOMICS, V290, P1523, DOI 10.1007/s00438-015-1013-y; Cheng XM, 2009, THEOR APPL GENET, V118, P1121, DOI 10.1007/s00122-009-0967-8; Cloutier S, 2009, THEOR APPL GENET, V119, P53, DOI 10.1007/s00122-009-1016-3; Das M, 2012, EUPHYTICA, V187, P175, DOI 10.1007/s10681-011-0603-y; Das M, 2012, J GENET, V91, P21, DOI 10.1007/s12041-012-0151-9; Doblin MS, 2002, PLANT CELL PHYSIOL, V43, P1407, DOI 10.1093/pcp/pcf164; Gao CS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110638; Kundu A, 2013, J PLANT BIOCHEM BIOT, V22, P372, DOI 10.1007/s13562-012-0165-7; Liu KJ, 2005, BIOINFORMATICS, V21, P2128, DOI 10.1093/bioinformatics/bti282; Liu TM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060346; Mir RR, 2008, EUPHYTICA, V161, P413, DOI 10.1007/s10681-007-9597-x; Mir RR, 2009, CROP SCI, V49, P1687, DOI 10.2135/cropsci2008.10.0599; Peng J. H., 2005, Functional & Integrative Genomics, V5, P80, DOI 10.1007/s10142-004-0128-8; Riechmann JL, 2000, SCIENCE, V290, P2105, DOI 10.1126/science.290.5499.2105; Rohlf F.J., 2002, NTSYS PC NUMERICAL T; Rozen S, 2000, Methods Mol Biol, V132, P365; SAGHAIMAROOF MA, 1984, P NATL ACAD SCI-BIOL, V81, P8014, DOI 10.1073/pnas.81.24.8014; Varshney RK, 2006, THEOR APPL GENET, V113, P239, DOI 10.1007/s00122-006-0289-z; Xiong H., 2008, BREEDING SCI BAST LE; Zhang LiWu, 2014, Acta Agronomica Sinica, V40, P1213; Zhang TZ, 2003, THEOR APPL GENET, V106, P262, DOI 10.1007/s00122-002-1101-3	24	8	11	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2015	10	10							e0140861	10.1371/journal.pone.0140861	http://dx.doi.org/10.1371/journal.pone.0140861			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0ED	26512891	gold, Green Submitted, Green Published			2022-12-26	WOS:000363920300008
J	Niitepold, K; Boggs, CL				Niitepold, Kristjan; Boggs, Carol L.			Effects of Increased Flight on the Energetics and Life History of the Butterfly Speyeria mormonia	PLOS ONE			English	Article							METABOLIC-RATE; DROSOPHILA-MELANOGASTER; WING WEAR; EGG SIZE; BOMBUS-IMPATIENS; BUMBLE BEES; RESOURCE-ALLOCATION; OXIDATIVE DAMAGE; LONG-LIFE; IN-FLIGHT	Movement uses resources that may otherwise be allocated to somatic maintenance or reproduction. How does increased energy expenditure affect resource allocation? Using the butterfly Speyeria mormonia, we tested whether experimentally increased flight affects fecundity, lifespan or flight capacity. We measured body mass (storage), resting metabolic rate and lifespan (repair and maintenance), flight metabolic rate (flight capacity), egg number and composition (reproduction), and food intake across the adult lifespan. The flight treatment did not affect body mass or lifespan. Food intake increased sufficiently to offset the increased energy expenditure. Total egg number did not change, but flown females had higher early-life fecundity and higher egg dry mass than control females. Egg dry mass decreased with age in both treatments. Egg protein, triglyceride or glycogen content did not change with flight or age, but some components tracked egg dry mass. Flight elevated resting metabolic rate, indicating increased maintenance costs. Flight metabolism decreased with age, with a steeper slope for flown females. This may reflect accelerated metabolic senescence from detrimental effects of flight. These effects of a drawdown of nutrients via flight contrast with studies restricting adult nutrient input. There, fecundity was reduced, but flight capacity and lifespan were unchanged. The current study showed that when food resources were abundant, wing-monomorphic butterflies living in a continuous meadow landscape resisted flight-induced stress, exhibiting no evidence of a flight-fecundity or flight-longevity trade-off. Instead, flight changed the dynamics of energy use and reproduction as butterflies adopted a faster lifestyle in early life. High investment in early reproduction may have positive fitness effects in the wild, as long as food is available. Our results help to predict the effect of stressful conditions on the life history of insects living in a changing world.	[Niitepold, Kristjan; Boggs, Carol L.] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Niitepold, Kristjan; Boggs, Carol L.] Rocky Mt Biol Labs, Crested Butte, CO USA; [Niitepold, Kristjan; Boggs, Carol L.] Univ S Carolina, Dept Biol Sci, Columbia, SC 29208 USA	Stanford University; University of South Carolina; University of South Carolina System; University of South Carolina Columbia	Niitepold, K (corresponding author), Univ Helsinki, Dept Biosci, FL-00014 Helsinki, Finland.	kristjan@niitepold.net	Niitepold, Kristjan/I-2210-2019		National Science Foundation [IOS 0923411, IOS 134367]	National Science Foundation(National Science Foundation (NSF))	Funding was provided by the National Science Foundation http://www.nsf.gov to CLB (grant numbers IOS 0923411 and IOS 134367). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGARWAL S, 1994, P NATL ACAD SCI USA, V91, P12332, DOI 10.1073/pnas.91.25.12332; Ahman M, 2009, ECOL ENTOMOL, V34, P783, DOI 10.1111/j.1365-2311.2009.01126.x; BARTHOLOMEW GA, 1978, J EXP BIOL, V76, P11; Boggs CL, 2014, INTEGR COMP BIOL, V54, P880, DOI 10.1093/icb/icu074; Boggs CL, 2012, ECOL LETT, V15, P502, DOI 10.1111/j.1461-0248.2012.01766.x; Boggs CL, 2009, FUNCT ECOL, V23, P27, DOI 10.1111/j.1365-2435.2009.01527.x; BOGGS CL, 1993, ECOLOGY, V74, P433, DOI 10.2307/1939305; CARTAR RV, 1992, J ANIM ECOL, V61, P225, DOI 10.2307/5525; Costantini D, 2008, J EXP BIOL, V211, P377, DOI 10.1242/jeb.012856; Dudley R, 2008, FUNCT ECOL, V22, P264, DOI 10.1111/j.1365-2435.2007.01364.x; Edrey YH, 2014, FREE RADICAL BIO MED, V71, P368, DOI 10.1016/j.freeradbiomed.2014.03.038; Fischer K, 2003, ECOLOGY, V84, P3138, DOI 10.1890/02-0733; Foster DJ, 2011, BEHAV ECOL, V22, P52, DOI 10.1093/beheco/arq160; Fox CW, 2000, ANNU REV ENTOMOL, V45, P341, DOI 10.1146/annurev.ento.45.1.341; Gibbs M, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-345; Gibbs M, 2010, J INSECT PHYSIOL, V56, P1275, DOI 10.1016/j.jinsphys.2010.04.009; Gibbs M, 2010, OECOLOGIA, V163, P341, DOI 10.1007/s00442-010-1613-5; Gibbs M, 2010, PHYSIOL ENTOMOL, V35, P29, DOI 10.1111/j.1365-3032.2009.00706.x; Giron D, 2003, ECOL LETT, V6, P273, DOI 10.1046/j.1461-0248.2003.00429.x; Giron D, 2002, FUNCT ECOL, V16, P750, DOI 10.1046/j.1365-2435.2002.00679.x; Grotewiel MS, 2005, AGEING RES REV, V4, P372, DOI 10.1016/j.arr.2005.04.001; Guerra PA, 2011, BIOL REV, V86, P813, DOI 10.1111/j.1469-185X.2010.00172.x; Haag CR, 2005, P ROY SOC B-BIOL SCI, V272, P2449, DOI 10.1098/rspb.2005.3235; Hedenstrom A, 2001, FUNCT ECOL, V15, P417, DOI 10.1046/j.0269-8463.2001.00531.x; HOLLOSZY JO, 1993, J GERONTOL, V48, pB97, DOI 10.1093/geronj/48.3.B97; Johnson SA, 2014, CAN J ZOOL, V92, P179, DOI 10.1139/cjz-2013-0229; Khazaeli AA, 2005, GENETICS, V169, P231, DOI 10.1534/genetics.104.030403; Kingsolver JG, 1999, EVOLUTION, V53, P1479, DOI [10.2307/2640894, 10.1111/j.1558-5646.1999.tb05412.x]; Lane SJ, 2014, J EXP BIOL, V217, P1437, DOI 10.1242/jeb.095646; Lee IM, 2000, AM J EPIDEMIOL, V151, P293, DOI 10.1093/oxfordjournals.aje.a010205; Magwere T, 2006, J GERONTOL A-BIOL, V61, P136, DOI 10.1093/gerona/61.2.136; Marden JH, 2013, EVOLUTION, V67, P1105, DOI 10.1111/evo.12004; Marden JH, 2003, P NATL ACAD SCI USA, V100, P3369, DOI 10.1073/pnas.0634985100; McIntyre GS, 2000, CAN J ZOOL, V78, P1544, DOI 10.1139/cjz-78-9-1544; Melvin RG, 2007, J INSECT PHYSIOL, V53, P1300, DOI 10.1016/j.jinsphys.2007.07.006; Miller MS, 2008, BIOPHYS J, V95, P2391, DOI [10.1529/biophysj.108.130005, 10.1529/hiophysj.108.130005]; MOUSSEAU TA, 1991, ANNU REV ENTOMOL, V36, P511, DOI 10.1146/annurev.en.36.010191.002455; Niitepold K, 2014, PHYSIOL BIOCHEM ZOOL, V87, P684, DOI 10.1086/677570; Niitepold K, 2013, J EXP BIOL, V216, P1388, DOI 10.1242/jeb.080739; Nudds RL, 2000, J EXP BIOL, V203, P1561; O'Brien DM, 2004, OIKOS, V105, P279, DOI 10.1111/j.0030-1299.2004.13012.x; O'Brien DM, 1999, J EXP BIOL, V202, P441; O'Brien DM, 2002, P NATL ACAD SCI USA, V99, P4413, DOI 10.1073/pnas.072346699; Piazza N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005886; ROFF DA, 1991, AM ZOOL, V31, P243; Saastamoinen M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081289; Saastamoinen M, 2010, AM NAT, V176, P686, DOI 10.1086/657038; Schippers MP, 2010, J COMP PHYSIOL B, V180, P45, DOI 10.1007/s00360-009-0386-9; Skandalis DA, 2012, PHYSIOL BIOCHEM ZOOL, V85, P657, DOI 10.1086/665568; Skandalis DA, 2011, J INSECT PHYSIOL, V57, P704, DOI 10.1016/j.jinsphys.2011.02.001; Speakman JR, 2011, MOL ASPECTS MED, V32, P159, DOI 10.1016/j.mam.2011.07.001; Speakman JR, 2011, BIOESSAYS, V33, P255, DOI 10.1002/bies.201000132; Steigenga MJ, 2007, ENTOMOL EXP APPL, V125, P195, DOI 10.1111/j.1570-7458.2007.00610.x; VAN NOORDWIJK AJ, 1986, AM NAT, V128, P137, DOI 10.1086/284547; Velde LV, 2013, OIKOS, V122, P555, DOI 10.1111/j.1600-0706.2012.20747.x; WIKLUND C, 1984, OIKOS, V43, P391, DOI 10.2307/3544158; Woods WA, 2010, PHYSIOL BIOCHEM ZOOL, V83, P858, DOI 10.1086/656216; Yan LJ, 2000, FREE RADICAL BIO MED, V29, P1143, DOI 10.1016/S0891-5849(00)00423-8; ZEBE E, 1954, Z VERGL PHYSIOL, V36, P290, DOI 10.1007/BF00298218	59	12	12	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2015	10	10							e0140104	10.1371/journal.pone.0140104	http://dx.doi.org/10.1371/journal.pone.0140104			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0DL	26510164	gold, Green Published, Green Submitted			2022-12-26	WOS:000363918100019
J	Packer, RMA; Hendricks, A; Tivers, MS; Burn, CC				Packer, Rowena M. A.; Hendricks, Anke; Tivers, Michael S.; Burn, Charlotte C.			Impact of Facial Conformation on Canine Health: Brachycephalic Obstructive Airway Syndrome	PLOS ONE			English	Article							SLEEP-APNEA SYNDROME; DOG BREEDS; OBESITY; PREVALENCE; DISORDERS; WELFARE	The domestic dog may be the most morphologically diverse terrestrial mammalian species known to man; pedigree dogs are artificially selected for extreme aesthetics dictated by formal Breed Standards, and breed-related disorders linked to conformation are ubiquitous and diverse. Brachycephaly-foreshortening of the facial skeleton-is a discrete mutation that has been selected for in many popular dog breeds e.g. the Bulldog, Pug, and French Bulldog. A chronic, debilitating respiratory syndrome, whereby soft tissue blocks the airways, predominantly affects dogs with this conformation, and thus is labelled Brachycephalic Obstructive Airway Syndrome (BOAS). Despite the name of the syndrome, scientific evidence quantitatively linking brachycephaly with BOAS is lacking, but it could aid efforts to select for healthier conformations. Here we show, in (1) an exploratory study of 700 dogs of diverse breeds and conformations, and (2) a confirmatory study of 154 brachycephalic dogs, that BOAS risk increases sharply in a non-linear manner as relative muzzle length shortens. BOAS only occurred in dogs whose muzzles comprised less than half their cranial lengths. Thicker neck girths also increased BOAS risk in both populations: a risk factor for human sleep apnoea and not previously realised in dogs; and obesity was found to further increase BOAS risk. This study provides evidence that breeding for brachycephaly leads to an increased risk of BOAS in dogs, with risk increasing as the morphology becomes more exaggerated. As such, dog breeders and buyers should be aware of this risk when selecting dogs, and breeding organisations should actively discourage exaggeration of this high-risk conformation in breed standards and the show ring.	[Packer, Rowena M. A.; Hendricks, Anke] Univ London Royal Vet Coll, Dept Clin Sci & Serv, Hatfield, Herts, England; [Tivers, Michael S.] Univ Bristol, Sch Vet Sci, Bristol BS40 5DU, Avon, England; [Burn, Charlotte C.] Univ London Royal Vet Coll, Dept Prod & Populat Hlth, Hatfield, Herts, England	University of London; University of London Royal Veterinary College; University of Bristol; University of London; University of London Royal Veterinary College	Packer, RMA (corresponding author), Univ London Royal Vet Coll, Dept Clin Sci & Serv, Hatfield, Herts, England.	rpacker@rvc.ac.uk		Burn, Charlotte/0000-0002-8734-8610; Tivers, Michael/0000-0001-7047-9334; Packer, Rowena/0000-0002-9988-9828	UFAW; Dogs Trust; BBSRC/RVC	UFAW; Dogs Trust; BBSRC/RVC	This study was funded by UFAW (www.ufaw.org.uk) and Dogs Trust (www.dogstrust.org.uk) while the primary author was supported by a joint BBSRC/RVC doctoral studentship (www.bbsrc.ac.uk; www.rvc.ac.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Kennel Club, 2014, BOST TERR BREED STAN; American Kennel Club, 2014, PEK BREED STAND; American Kennel Club, 2014, JAP CHIN BREED STAND; American Kennel Club, 2014, FRENCH BULLD BREED S; American Kennel Club, 2014, SHIH TZU BREED STAND; American Kennel Club, 2014, BRUSS GRIFF BREED ST; American Kennel Club, 2014, PUG BREED STAND; American Kennel Club, 2014, BULLD BREED STAND; ARON DN, 1985, VET CLIN N AM-SMALL, V15, P891, DOI 10.1016/S0195-5616(85)50101-1; Asher L, 2011, BMC VET RES, V7, DOI 10.1186/1746-6148-7-74; Asher L, 2009, VET J, V182, P402, DOI 10.1016/j.tvjl.2009.08.033; Bannasch D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009632; Bateson P., 2010, INDEPENDENT INQUIRY; Brown D, 2005, BRACHYCEPHALIC AIRWA; Caccamo R, 2014, BMC VET RES, V10, DOI 10.1186/1746-6148-10-12; Carrera I, 2009, AM J VET RES, V70, P340, DOI 10.2460/ajvr.70.3.340; Council of Europe, 1995, MULT CONS PART EUR C; Davies R, 1990, EUR RESPIR J, V5, P509; DAVIES RJO, 1992, THORAX, V47, P101, DOI 10.1136/thx.47.2.101; Drake AG, 2010, AM NAT, V175, P289, DOI 10.1086/650372; Dupre GP, 2008, 33 WORLD SMALL AN VE; Evans H.E., 1993, MILLERS ANATOMY DOG; Farquharson J., 1942, J AM VET MED ASSOC, V100, P427; Farrow T, 2014, NZ VET J, P1; Ginn JA, 2008, J AM ANIM HOSP ASSOC, V44, P243, DOI 10.5326/0440243; Gossellin J, 2007, J VET PHARMACOL THER, V30, P1, DOI 10.1111/j.1365-2885.2007.00863.x; HARVEY CE, 1989, J SMALL ANIM PRACT, V30, P184, DOI 10.1111/j.1748-5827.1989.tb01531.x; Haworth KE, 2001, MAMM GENOME, V12, P622, DOI 10.1007/s00335-001-3011-0; HENDRICKS JC, 1987, J APPL PHYSIOL, V63, P1344, DOI 10.1152/jappl.1987.63.4.1344; HENDRICKS JC, 1992, VET CLIN N AM-SMALL, V22, P1145, DOI 10.1016/S0195-5616(92)50306-0; Hendricks JC, 1995, RECOGNITION TREATMEN; HOFFSTEIN V, 1992, EUR RESPIR J, V5, P377; Hunemeier T, 2009, ANIM GENET, V40, P357, DOI 10.1111/j.1365-2052.2008.01838.x; KATZ I, 1990, AM REV RESPIR DIS, V141, P1228, DOI 10.1164/ajrccm/141.5_Pt_1.1228; Knecht CD., 1979, COMPENDIUM, V1, P25; Knowles TG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001545; LEONARD H C, 1956, J Am Vet Med Assoc, V128, P530; Lund E. M., 2006, International Journal of Applied Research in Veterinary Medicine, V4, P177; Magalang UJ, 2000, AM J RESP CRIT CARE, V161, pA87; Manens J, 2012, VET J, V193, P217, DOI 10.1016/j.tvjl.2011.10.013; Monnet E, 2003, BRACHYCEPHALIC AIRWA; Njikam IN, 2009, INT J APPL RES VET M, V7, P138; Noller C, 2008, NEW ASPECTS BRACHYCE; Oechtering GU, 2010, VET FOCUS, P2; Oechtering TH, 2007, TIERAERZTL PRAX K H, V35, P177, DOI 10.1055/s-0038-1622615; Oltenacu PA, 2010, ANIM WELFARE, V19, P39; Orsher RJ, 1993, BRACHYCEPHALIC AIRWA; Packer R, 2014, C REPORT BUILDING BE, P1; Packer RMA, 2012, ANIM WELFARE, V21, P81, DOI 10.7120/096272812X13345905673809; Packer RMA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123827; Packer RMA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069650; Parker HG, 2007, GENOME RES, V17, P1562, DOI 10.1101/gr.6772807; Parker HG, 2004, SCIENCE, V304, P1160, DOI 10.1126/science.1097406; Pollinger JP, 2005, GENOME RES, V15, P1809, DOI 10.1101/gr.4374505; Poncet CM, 2005, J SMALL ANIM PRACT, V46, P273, DOI 10.1111/j.1748-5827.2005.tb00320.x; Purina, 2012, ASSESSING YOUR DOGS; REGODON S, 1993, ANN ANAT, V175, P361, DOI 10.1016/S0940-9602(11)80043-9; Reiter AM, 2012, VET SURG SMALL ANIMA, P1707; Roberts T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011946; Robertson ID, 2003, PREV VET MED, V58, P75, DOI 10.1016/S0167-5877(03)00009-6; Roedler FS, 2013, VET J, V198, P606, DOI 10.1016/j.tvjl.2013.09.009; Schlotthauer C.F., 1929, J AM VET MED ASS, V75, P370; Schmidt M, 2011, VET RADIOL ULTRASOUN, V4, P436; SMITH PL, 1985, ANN INTERN MED, V103, P850, DOI 10.7326/0003-4819-103-6-850; Steiropoulos P, 2010, MEDIATORS INFLAMMATI, V2010; Stockard CR., 1941, AM ANAT MEM; Summers JF, 2010, VET J, V183, P39, DOI 10.1016/j.tvjl.2009.11.002; Sutter NB, 2008, MAMM GENOME, V19, P713, DOI 10.1007/s00335-008-9153-6; The Kennel Club, 2009, JAP CHIN BREED STAND; The Kennel Club, 2010, BULLD BREED STAND; The Kennel Club, 2013, BREED REGISTRATION S; The Kennel Club, 2009, BOST TERR BREED STAN; The Kennel Club, 2008, PEK BREED STAND; The Kennel Club, 2009, FRENCH BULLD BREED S; The Kennel Club, 2009, SHIH TZU BREED STAND; The Kennel Club, 2012, PUG BREED STAND; The Kennel Club, 2009, GRIFF BRUX BREED STA; The Kennel Club, 2014, BREED REG STAT; Wayne RK, 2001, CONSEQUENCES DOMESTI; White RN, 2012, J SMALL ANIM PRACT, V53, P44, DOI 10.1111/j.1748-5827.2011.01156.x; Wiestner TS, 2007, AM J VET RES, V68, P178, DOI 10.2460/ajvr.68.2.178; Wykes P M, 1991, Probl Vet Med, V3, P188; Yucel A, 2005, AM J NEURORADIOL, V26, P2624	83	85	85	5	150	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2015	10	10							e0137496	10.1371/journal.pone.0137496	http://dx.doi.org/10.1371/journal.pone.0137496			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0DL	26509577	gold, Green Published, Green Submitted			2022-12-26	WOS:000363918100003
J	Havranek, O; Kleiblova, P; Hojny, J; Lhota, F; Soucek, P; Trneny, M; Kleibl, Z				Havranek, Ondrej; Kleiblova, Petra; Hojny, Jan; Lhota, Filip; Soucek, Pavel; Trneny, Marek; Kleibl, Zdenek			Association of Germline CHEK2 Gene Variants with Risk and Prognosis of Non-Hodgkin Lymphoma	PLOS ONE			English	Article							DNA-DAMAGE CHECKPOINT; CANCER SUSCEPTIBILITY; MISSENSE SUBSTITUTIONS; FAMILY-HISTORY; RARE; MUTATIONS; KINASE; ATM; MALIGNANCIES; ACTIVATION	The checkpoint kinase 2 gene (CHEK2) codes for the CHK2 protein, an important mediator of the DNA damage response pathway. The CHEK2 gene has been recognized as a multi-cancer susceptibility gene; however, its role in non-Hodgkin lymphoma (NHL) remains unclear. We performed mutation analysis of the entire CHEK2 coding sequence in 340 NHL patients using denaturing high-performance liquid chromatography (DHPLC) and multiplex ligation-dependent probe amplification (MLPA). Identified hereditary variants were genotyped in 445 non-cancer controls. The influence of CHEK2 variants on disease risk was statistically evaluated. Identified CHEK2 germline variants included four truncating mutations (found in five patients and no control; P = 0.02) and nine missense variants (found in 21 patients and 12 controls; P = 0.02). Carriers of non-synonymous variants had an increased risk of NHL development [odds ratio (OR) 2.86; 95% confidence interval (CI) 1.42-5.79] and an unfavorable prognosis [hazard ratio (HR) of progression-free survival (PFS) 2.1; 95% CI 1.12-4.05]. In contrast, the most frequent intronic variant c.319+43dupA (identified in 22% of patients and 31% of controls) was associated with a decreased NHL risk (OR = 0.62; 95% CI 0.45-0.86), but its positive prognostic effect was limited to NHL patients with diffuse large B-cell lymphoma (DLBCL) treated by conventional chemotherapy without rituximab (HR-PFS 0.4; 94% CI 0.17-0.74). Our results show that germ-line CHEK2 mutations affecting protein coding sequence confer a moderately-increased risk of NHL, they are associated with an unfavorable NHL prognosis, and they may represent a valuable predictive biomarker for patients with DLBCL.	[Havranek, Ondrej; Trneny, Marek] Charles Univ Prague, Fac Med 1, Dept Hematol, Dept Med 1, Prague, Czech Republic; [Havranek, Ondrej; Trneny, Marek] Gen Univ Hosp Prague, Prague, Czech Republic; [Kleiblova, Petra; Hojny, Jan; Lhota, Filip; Kleibl, Zdenek] Charles Univ Prague, Fac Med 1, Inst Biochem & Expt Oncol, Prague, Czech Republic; [Soucek, Pavel] Natl Inst Publ Hlth, Toxicogen Unit, Prague, Czech Republic	Charles University Prague; General University Hospital Prague; Charles University Prague; National Institute of Public Health (SZU) - Czech Republic	Havranek, O (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Lymphoma & Myeloma, Houston, TX 77030 USA.	ohavranek@mdanderson.org; zdekleje@lf1.cuni.cz	Hojný, Jan/H-2842-2017; Soucek, Pavel/H-8018-2019; Havranek, Ondrej/G-9272-2018; Kleibl, Zdenek/A-2009-2008; Kleiblova, Petra/K-9899-2017	Hojný, Jan/0000-0002-3563-2484; Soucek, Pavel/0000-0002-4294-6799; Havranek, Ondrej/0000-0001-5826-3557; Kleibl, Zdenek/0000-0003-2050-9667; Kleiblova, Petra/0000-0002-4806-9854; Trneny, Marek/0000-0002-6952-6073	Charles University in Prague [PRVOUK-P27/LF1/1]; project SVV UK [260148/2015]; Internal Grant Agency, Ministry of Health, Czech Republic [NT12193]	Charles University in Prague; project SVV UK; Internal Grant Agency, Ministry of Health, Czech Republic	This study was supported by the Charles University in Prague, project PRVOUK-P27/LF1/1, (http://www.cuni.cz/UKEN-1.html) to ZK and MT; project SVV UK 260148/2015, (http://www.cuni.cz/UKEN-1.html) to JH, FL, ZK, and PK; and Internal Grant Agency, Ministry of Health, Czech Republic, NT12193, (http://www.mzcr.cz) to MT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Antoni L, 2007, NAT REV CANCER, V7, P925, DOI 10.1038/nrc2251; Bartek J, 2007, ONCOGENE, V26, P7773, DOI 10.1038/sj.onc.1210881; Bartkova J, 2005, NATURE, V434, P864, DOI 10.1038/nature03482; Bendall LJ, 2011, BLOOD, V118, P5983, DOI 10.1182/blood-2011-09-381111; Cai Z, 2009, MOL CELL, V35, P818, DOI 10.1016/j.molcel.2009.09.007; Chrisanthar R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003062; Cybulski C, 2006, J MED GENET, V43, P863, DOI 10.1136/jmg.2006.044974; Cybulski C, 2004, AM J HUM GENET, V75, P1131, DOI 10.1086/426403; Cybulski C, 2007, BREAST CANCER RES TR, V102, P119, DOI 10.1007/s10549-006-9320-y; de Miranda NFCC, 2013, J EXP MED, V210, P1729, DOI 10.1084/jem.20122842; Dusek L, 2010, Klin Onkol, V23, P311; Frei E, 2013, J CLIN PATHOL, V66, P956, DOI 10.1136/jclinpath-2013-201619; Gorgoulis VG, 2005, NATURE, V434, P907, DOI 10.1038/nature03485; Gumy-Pause F, 2006, CANCER GENET CYTOGEN, V166, P101, DOI 10.1016/j.cancergencyto.2005.09.005; Ham MF, 2006, CANCER SCI, V97, P226, DOI 10.1111/j.1349-7006.2006.00165.x; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hangaishi A, 2002, BLOOD, V99, P3075, DOI 10.1182/blood.V99.8.3075; Havranek O, 2011, NEOPLASMA, V58, P392, DOI 10.4149/neo_2011_05_392; Houdayer C, 2011, METHODS MOL BIOL, V760, P269, DOI 10.1007/978-1-61779-176-5_17; Janiszewska H, 2016, BRIT J HAEMATOL, V173, P150, DOI 10.1111/bjh.13559; Janiszewska H, 2012, HAEMATOL-HEMATOL J, V97, P366, DOI 10.3324/haematol.2011.049494; Kadan-Lottick NS, 2006, PEDIATR BLOOD CANCER, V46, P476, DOI 10.1002/pbc.20465; Kiel MJ, 2014, BLOOD, V124, P1460, DOI 10.1182/blood-2014-03-559542; Kleibl Z, 2008, BREAST CANCER RES TR, V112, P159, DOI 10.1007/s10549-007-9838-7; Kleibl Z, 2009, EUR J CANCER, V45, P618, DOI 10.1016/j.ejca.2008.09.022; Kleiblova P, 2010, MOL CELL ENDOCRINOL, V314, P150, DOI 10.1016/j.mce.2009.08.002; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Le Calvez-Kelm F, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2810; Narod SA, 2010, CLIN GENET, V78, P1, DOI 10.1111/j.1399-0004.2010.01402.x; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Prokopcova J, 2007, BREAST CANCER RES TR, V104, P121, DOI 10.1007/s10549-006-9406-6; Rudd MF, 2006, BLOOD, V108, P638, DOI 10.1182/blood-2005-12-5022; Schwarz JM, 2010, NAT METHODS, V7, P575, DOI 10.1038/nmeth0810-575; Skibola CF, 2007, HAEMATOLOGICA, V92, P960, DOI 10.3324/haematol.11011; Sodha N, 2002, HUM MUTAT, V19, P173, DOI 10.1002/humu.10031; Sodha N, 2000, Science, V289, P359; Tavor S, 2001, LEUKEMIA LYMPHOMA, V42, P517, DOI 10.3109/10428190109064610; Tavtigian SV, 2008, HUM MUTAT, V29, P1342, DOI 10.1002/humu.20896; Taylor AMR, 1996, BLOOD, V87, P423, DOI 10.1182/blood.V87.2.423.bloodjournal872423; Tedaldi G, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-478; Tort F, 2002, BLOOD, V100, P4602, DOI 10.1182/blood-2002-04-1078; Walsh T, 2006, JAMA-J AM MED ASSOC, V295, P1379, DOI 10.1001/jama.295.12.1379; Wang SS, 2007, BLOOD, V109, P3479, DOI 10.1182/blood-2006-06-031948; Yang YB, 2014, CANCER DISCOV, V4, P480, DOI 10.1158/2159-8290.CD-13-0915; Zhang YW, 2007, CANCER CAUSE CONTROL, V18, P351, DOI 10.1007/s10552-006-0088-5	46	26	26	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2015	10	10							e0140819	10.1371/journal.pone.0140819	http://dx.doi.org/10.1371/journal.pone.0140819			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU8PC	26506619	gold, Green Published, Green Submitted			2022-12-26	WOS:000363804200018
J	Wang, ZX; Li, QG; Chamba, Y; Zhang, B; Shang, P; Zhang, H; Wu, CX				Wang, Zhixiu; Li, Qinggang; Chamba, Yangzom; Zhang, Bo; Shang, Peng; Zhang, Hao; Wu, Changxin			Identification of Genes Related to Growth and Lipid Deposition from Transcriptome Profiles of Pig Muscle Tissue	PLOS ONE			English	Article							ACID-BINDING-PROTEIN; LONGISSIMUS-DORSI MUSCLE; PORCINE ADIPOSE-TISSUE; JEJU NATIVE PIG; FULL-SIB PAIR; SKELETAL-MUSCLE; RNA-SEQ; INTRAMUSCULAR FAT; FAMILIAL HYPERCHOLESTEROLEMIA; MICRORNA TRANSCRIPTOME	Transcriptome profiles established using high-throughput sequencing can be effectively used for screening genome-wide differentially expressed genes (DEGs). RNA sequences (from RNA-seq) and microRNA sequences (from miRNA-seq) from the tissues of longissimus dorsi muscle of two indigenous Chinese pig breeds (Diannan Small-ear pig [DSP] and Tibetan pig [TP]) and two introduced pig breeds (Landrace [LL] and Yorkshire [YY]) were examined using HiSeq 2000 to identify and compare the differential expression of functional genes related to muscle growth and lipid deposition. We obtained 27.18 G clean data through the RNA-seq and detected that 18,208 genes were positively expressed and 14,633 of them were co-expressed in the muscle tissues of the four samples. In all, 315 DEGs were found between the Chinese pig group and the introduced pig group, 240 of which were enriched with functional annotations from the David database and significantly enriched in 27 Gene Ontology (GO) terms that were mainly associated with muscle fiber contraction, cadmium ion binding, response to organic substance and contractile fiber part. Based on functional annotation, we identified 85 DEGs related to growth traits that were mainly involved in muscle tissue development, muscle system process, regulation of cell development, and growth factor binding, and 27 DEGs related to lipid deposition that were mainly involved in lipid metabolic process and fatty acid biosynthetic process. With miRNA-seq, we obtained 23.78 M reads and 320 positively expressed miRNAs from muscle tissues, including 271 known pig miRNAs and 49 novel miRNAs. In those 271 known miRNAs, 20 were higher and 10 lower expressed in DSP-TP than in LL-YY. The target genes of the 30 miRNAs were mainly participated in MAPK, GnRH, insulin and Calcium signaling pathway and others involved cell development, growth and proliferation, etc. Combining the DEGs and the differentially expressed (DE) miRNAs, we drafted a network of 46 genes and 18 miRNAs for regulating muscle growth and a network of 15 genes and 16 miRNAs for regulating lipid deposition. We identified that CAV2, MYOZ2, FRZB, miR-29b, miR-122, miR-145- 5p and miR-let-7c, etc, were key genes or miRNAs regulating muscle growth, and FASN, SCD, ADORA1, miR-4332, miR-182, miR-92b-3p, miR-let-7a and miR-let-7e, etc, were key genes or miRNAs regulating lipid deposition. The quantitative expressions of eight DEGs and seven DE miRNAs measured with real-time PCR certified that the results of differential expression genes or miRNAs were reliable. Thus, 18,208 genes and 320 miRNAs were positively expressed in porcine longissimus dorsi muscle. We obtained 85 genes and 18 miRNAs related to muscle growth and 27 genes and 16 miRNAs related to lipid deposition, which provided new insights into molecular mechanism of the economical traits in pig.	[Wang, Zhixiu; Zhang, Bo; Shang, Peng; Zhang, Hao; Wu, Changxin] China Agr Univ, Natl Engn Lab Anim Breeding, Beijing 100094, Peoples R China; [Li, Qinggang] Anhui Acad Agr Sci, Inst Anim Sci & Vet Med, Hefei, Peoples R China; [Chamba, Yangzom] Tibet Agr & Anim Husb Univ, Coll Anim Sci, Linzhi, Peoples R China	China Agricultural University; Anhui Academy of Agricultural Sciences; Tibet Agriculture & Animal Husbandry University	Zhang, H (corresponding author), China Agr Univ, Natl Engn Lab Anim Breeding, Beijing 100094, Peoples R China.	zhanghao827@163.com		Zhang, Hao/0000-0001-9576-3059	National Major Special Project on New Varieties Cultivation for Transgenic Organisms [2014ZX08009-003-006]; National Key Technology Research and Development Program [2012BAD03B03]; Chinese Universities Scientific Fund [2015TC026]	National Major Special Project on New Varieties Cultivation for Transgenic Organisms; National Key Technology Research and Development Program(National Key Technology R&D Program); Chinese Universities Scientific Fund	This work was supported by the National Major Special Project on New Varieties Cultivation for Transgenic Organisms (No. 2014ZX08009-003-006), the National Key Technology Research and Development Program (2012BAD03B03) and the Chinese Universities Scientific Fund (2015TC026), to HZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angers S, 2009, NAT REV MOL CELL BIO, V10, P468, DOI 10.1038/nrm2717; Bai Y, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-47; Bessa RJB, 2013, J ANIM SCI, V91, P4540, DOI 10.2527/jas.2012-5963; BROWN MS, 1986, SCIENCE, V232, P34, DOI 10.1126/science.3513311; BROWN MS, 1984, SCI AM, V251, P58, DOI 10.1038/scientificamerican1184-58; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chen CY, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-448; Corominas J, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-843; Esteve-Codina A, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-552; Frey N, 2004, NAT MED, V10, P1336, DOI 10.1038/nm1132; Frey N, 2000, P NATL ACAD SCI USA, V97, P14632, DOI 10.1073/pnas.260501097; Gazi U, 2009, IMMUNOBIOLOGY, V214, P554, DOI 10.1016/j.imbio.2008.11.004; Gerbens F, 2001, J ANIM SCI, V79, P347; Ghosh M, 2015, ANIM GENET, V46, P255, DOI 10.1111/age.12281; GOLDSTEIN JL, 1974, J BIOL CHEM, V249, P5153; Gunawan A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063259; Hausman GJ, 2009, J ANIM SCI, V87, P1218, DOI 10.2527/jas.2008-1427; HESELTINE L, 1995, MOL CELL BIOCHEM, V144, P147, DOI 10.1007/BF00944394; Huang TH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003225; Jing L, 2015, SCI REP-UK, V5, DOI 10.1038/srep11953; Krutzfeldt J, 2006, CELL METAB, V4, P9, DOI 10.1016/j.cmet.2006.05.009; KURODA M, 1987, J BIOL CHEM, V262, P245; Lee S, 2011, INT J ONCOL, V38, P1395, DOI 10.3892/ijo.2011.958; Lee SJ, 2002, SCIENCE, V295, P1898, DOI 10.1126/science.1069540; Li HX, 2008, MOL CELL ENDOCRINOL, V291, P116, DOI 10.1016/j.mce.2008.05.005; Li MZ, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0015168, 10.1371/journal.pone.0011541]; Li WJ, 2008, ANIM BIOTECHNOL, V19, P189, DOI 10.1080/10495390802058319; Li WZ, 2012, RES VET SCI, V93, P1190, DOI 10.1016/j.rvsc.2012.06.006; Li XJ, 2012, ANIM GENET, V43, P144, DOI 10.1111/j.1365-2052.2011.02240.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; McDaneld TG, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-77; Nielsen M, 2010, ANIM GENET, V41, P159, DOI 10.1111/j.1365-2052.2009.01981.x; NTAMBI JM, 1995, PROG LIPID RES, V34, P139, DOI 10.1016/0163-7827(94)00010-J; Pilcher CM, 2015, J ANIM SCI, V93, P2134, DOI 10.2527/jas.2014-8593; Plastow GS, 2005, MEAT SCI, V70, P409, DOI 10.1016/j.meatsci.2004.06.025; Podolska A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014494; Puig-Oliveras A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099720; Rajan S, 2012, PHYSIOL GENOMICS, V44, P183, DOI 10.1152/physiolgenomics.00093.2011; Ramayo-Caldas Y, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-547; Ropka-Molik K, 2014, ANIM GENET, V45, P674, DOI 10.1111/age.12184; Samborski A, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.113.107870; Schaap FG, 1999, CIRC RES, V85, P329, DOI 10.1161/01.RES.85.4.329; Schiaffino S, 2002, TRENDS PHARMACOL SCI, V23, P569, DOI 10.1016/S0165-6147(02)02111-9; Schoelch C, 2004, DIABETES, V53, P1920, DOI 10.2337/diabetes.53.7.1920; Schook L, 2005, ANIM BIOTECHNOL, V16, P183, DOI 10.1080/10495390500265034; Schwarzmann N, 2002, J BIOL CHEM, V277, P50636, DOI 10.1074/jbc.M209061200; Sharbati S, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-275; Sodhi SS, 2014, GENE, V546, P233, DOI 10.1016/j.gene.2014.06.005; Soutar AK, 2007, NAT CLIN PRACT CARD, V4, P214, DOI 10.1038/ncpcardio0836; Tang ZL, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r115; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Tyra M, 2012, ANN ANIM SCI, V12, P169, DOI 10.2478/v10220-012-0014-6; Wan L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082550; Wang M, 2009, AM J PHYSIOL-ENDOC M, V297, pE1378, DOI 10.1152/ajpendo.00252.2009; Wang ZX, 2014, GENE, V543, P198, DOI 10.1016/j.gene.2014.04.023; Xie SS, 2010, ANIM GENET, V41, P179, DOI 10.1111/j.1365-2052.2009.01991.x; Zhao X, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0019774, 10.1371/journal.pone.0021739]; Zhao YQ, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1580-7	58	46	50	4	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2015	10	10							e0141138	10.1371/journal.pone.0141138	http://dx.doi.org/10.1371/journal.pone.0141138			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU8PC	26505482	Green Submitted, Green Published, gold			2022-12-26	WOS:000363804200031
J	McGregor, N; Morar, M; Fenger, TH; Stogios, P; Lenfant, N; Yin, V; Xu, XH; Evdokimova, E; Cui, H; Henrissat, B; Savchenko, A; Brumer, H				McGregor, Nicholas; Morar, Mariya; Fenger, Thomas Hauch; Stogios, Peter; Lenfant, Nicolas; Yin, Victor; Xu, Xiaohui; Evdokimova, Elena; Cui, Hong; Henrissat, Bernard; Savchenko, Alexei; Brumer, Harry			Structure-Function Analysis of a Mixed-linkage beta-Glucanase/Xyloglucanase from the Key Ruminal Bacteroidetes Prevotella bryantii B(1)4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVE-SITE NUCLEOPHILE; SUBSTRATE-SPECIFICITY; ENZYMATIC-HYDROLYSIS; XYLOGLUCAN; ENDOGLUCANASE; GENE; RUMINICOLA; CLONING; FAMILY; PLANT	The recent classification of glycoside hydrolase family 5 (GH5) members into subfamilies enhances the prediction of substrate specificity by phylogenetic analysis. However, the small number of well characterized members is a current limitation to understanding the molecular basis of the diverse specificity observed across individual GH5 subfamilies. GH5 subfamily 4 (GH5_4) is one of the largest, with known activities comprising (carboxymethyl) cellulases, mixedlinkage endo-glucanases, and endo-xyloglucanases. Through detailed structure-function analysis, we have revisited the characterization of a classic GH5_4 carboxymethylcellulase, PbGH5A (also known as Orf4, carboxymethylcellulase, and Cel5A), from the symbiotic rumen Bacteroidetes Prevotella bryantii B(1)4. We demonstrate that carboxymethylcellulose and phosphoric acid-swollen cellulose are in fact relatively poor substrates for PbGH5A, which instead exhibits clear primary specificity for the plant storage and cell wall polysaccharide, mixedlinkage beta-glucan. Significant activity toward the plant cell wall polysaccharide xyloglucan was also observed. Determination of PbGH5A crystal structures in the apo-form and in complex with (xylo) glucan oligosaccharides and an active-site affinity label, together with detailed kinetic analysis using a variety of well defined oligosaccharide substrates, revealed the structural determinants of polysaccharide substrate specificity. In particular, this analysis highlighted the PbGH5A active-site motifs that engender predominant mixed-linkage endo-glucanase activity vis a vis predominant endo-xyloglucanases in GH5_4. However the detailed phylogenetic analysis of GH5_4 members did not delineate particular clades of enzymes sharing these sequence motifs; the phylogeny was instead dominated by bacterial taxonomy. Nonetheless, our results provide key enzyme functional and structural reference data for future bioinformatics analyses of (meta) genomes to elucidate the biology of complex gut ecosystems.	[McGregor, Nicholas; Fenger, Thomas Hauch; Yin, Victor; Brumer, Harry] Univ British Columbia, Michael Smith Labs, Vancouver, BC V6T 1Z4, Canada; [McGregor, Nicholas; Fenger, Thomas Hauch; Yin, Victor; Brumer, Harry] Univ British Columbia, Dept Chem, Vancouver, BC V6T 1Z4, Canada; [Morar, Mariya; Stogios, Peter; Xu, Xiaohui; Evdokimova, Elena; Cui, Hong; Savchenko, Alexei] Univ Toronto, Dept Chem Engn & Appl Chem, Toronto, ON M5G 1L6, Canada; [Lenfant, Nicolas; Henrissat, Bernard] Aix Marseille Univ, CNRS, Architecture & Fonct Macromol Biol, F-13288 Marseille, France; [Henrissat, Bernard] King Abdulaziz Univ, Dept Biol Sci, Jeddah 21589, Saudi Arabia; [Henrissat, Bernard] INRA, AFMB, USC 1408, F-13288 Marseille, France	University of British Columbia; University of British Columbia; University of Toronto; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; King Abdulaziz University; INRAE; UDICE-French Research Universities; Aix-Marseille Universite	Savchenko, A (corresponding author), Univ Toronto, Dept Chem Engn & Appl Chem, Toronto, ON M5G 1L6, Canada.	alexei.savchenko@utoronto.ca; brumer@msl.ubc.ca	Henrissat, Bernard/J-2475-2012	Henrissat, Bernard/0000-0002-3434-8588; Stogios, Peter/0000-0001-8663-1425; McGregor, Nicholas/0000-0003-1075-7368; Lenfant, Nicolas/0000-0002-0519-1120	Natural Sciences and Engineering Research Council of Canada; Canada Foundation for Innovation; British Columbia Knowledge Development Fund; National Institutes of Health [U54-GM074942, U54-GM094585]; Natural Sciences and Engineering Research Council via the Industrial Bio-catalysis Network; Alexander Graham Bell Canada Graduate Doctoral Scholarship from the Natural Sciences and Engineering Research Council of Canada; Carlsberg Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM094585, U54GM074942] Funding Source: NIH RePORTER	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); British Columbia Knowledge Development Fund; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Natural Sciences and Engineering Research Council via the Industrial Bio-catalysis Network; Alexander Graham Bell Canada Graduate Doctoral Scholarship from the Natural Sciences and Engineering Research Council of Canada; Carlsberg Foundation(Carlsberg Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by the Natural Sciences and Engineering Research Council of Canada (Discovery Grant), the Canada Foundation for Innovation, and the British Columbia Knowledge Development Fund (to H.B.) and by National Institutes of Health Grants U54-GM074942 and U54-GM094585 (to A.S. through the Midwest Center for Structural Genomics). H.B. and A.S. also acknowledge joint funding to their laboratories from the Natural Sciences and Engineering Research Council via the Industrial Bio-catalysis Network. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.r Recipient of an Alexander Graham Bell Canada Graduate Doctoral Scholarship from the Natural Sciences and Engineering Research Council of Canada.r Supported by the Carlsberg Foundation.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; ALBERSHEIM P, 2011, PLANT CELL WALLS, P1; Ariza A, 2011, J BIOL CHEM, V286, P33890, DOI 10.1074/jbc.M111.262345; Aspeborg H, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-186; Avgustin G, 1997, INT J SYST BACTERIOL, V47, P284, DOI 10.1099/00207713-47-2-284; BARRAS F, 1992, FEBS LETT, V300, P145, DOI 10.1016/0014-5793(92)80183-H; BERGER E, 1989, MOL GEN GENET, V219, P193, DOI 10.1007/BF00261176; BLACK TS, 1993, CARBOHYD RES, V250, P195, DOI 10.1016/0008-6215(93)84166-4; Burton RA, 2009, MOL PLANT, V2, P873, DOI 10.1093/mp/ssp063; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Davies G.J., 2008, BIOCHEM J, DOI [10.1042/BJ20080382, DOI 10.1042/BJ20080382]; Davies GJ, 2005, CURR OPIN STRUC BIOL, V15, P637, DOI 10.1016/j.sbi.2005.10.008; Davies GJ, 1997, BIOCHEM J, V321, P557, DOI 10.1042/bj3210557; Desmet T, 2007, FEBS J, V274, P356, DOI 10.1111/j.1742-4658.2006.05582.x; DONER LW, 1992, ANAL BIOCHEM, V202, P50, DOI 10.1016/0003-2697(92)90204-K; dos Santos CR, 2015, BIOCHEMISTRY-US, V54, P1930, DOI 10.1021/acs.biochem.5b00011; DUCROS V, 1995, STRUCTURE, V3, P939, DOI 10.1016/S0969-2126(01)00228-3; Dundas J, 2006, NUCLEIC ACIDS RES, V34, pW116, DOI 10.1093/nar/gkl282; Eklof JM, 2013, J BIOL CHEM, V288, P15786, DOI 10.1074/jbc.M113.462887; Eklof JM, 2012, METHOD ENZYMOL, V510, P97, DOI 10.1016/B978-0-12-415931-0.00006-9; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Eschenfeldt William H., 2009, V498, P105, DOI 10.1007/978-1-59745-196-3_7; FAURE E, 1989, GENE, V84, P39, DOI 10.1016/0378-1119(89)90137-6; Fenger TH, 2015, CHEMBIOCHEM, V16, P575, DOI 10.1002/cbic.201402663; Flint HJ, 2008, NAT REV MICROBIOL, V6, P121, DOI 10.1038/nrmicro1817; FOONG F, 1991, J GEN MICROBIOL, V137, P1729, DOI 10.1099/00221287-137-7-1729; FRY SC, 1989, J EXP BOT, V40, P1, DOI 10.1093/jxb/40.1.1; Fry SC, 2008, NEW PHYTOL, V179, P104, DOI 10.1111/j.1469-8137.2008.02435.x; Gardner RG, 1997, CURR MICROBIOL, V35, P274, DOI 10.1007/s002849900253; Garron ML, 2010, GLYCOBIOLOGY, V20, P1547, DOI 10.1093/glycob/cwq122; Gilbert HJ, 2008, CURR OPIN PLANT BIOL, V11, P338, DOI 10.1016/j.pbi.2008.03.004; Gloster TM, 2007, J BIOL CHEM, V282, P19177, DOI 10.1074/jbc.M700224200; HAMAMOTO T, 1992, MOL GEN GENET, V231, P472, DOI 10.1007/BF00292718; HAYASHI T, 1989, ANNU REV PLANT PHYS, V40, P139, DOI 10.1146/annurev.pp.40.060189.001035; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Huson DH, 2012, SYST BIOL, V61, P1061, DOI 10.1093/sysbio/sys062; Ibatullin FM, 2008, BIOCHEMISTRY-US, V47, P7762, DOI 10.1021/bi8009168; Johnson KA, 2011, BIOCHEMISTRY-US, V50, P8264, DOI 10.1021/bi201284u; Katoh K, 2014, METHODS MOL BIOL, V1079, P131, DOI 10.1007/978-1-62703-646-7_8; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; KEMPTON JB, 1992, BIOCHEMISTRY-US, V31, P9961, DOI 10.1021/bi00156a015; KITZ R, 1962, J BIOL CHEM, V237, P3245; Larsbrink J, 2014, MOL MICROBIOL, V94, P418, DOI 10.1111/mmi.12776; Larsbrink J, 2014, NATURE, V506, P498, DOI 10.1038/nature12907; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Lombard V, 2010, BIOCHEM J, V432, P437, DOI 10.1042/BJ20101185; Martens EC, 2014, J MOL BIOL, V426, P3851, DOI 10.1016/j.jmb.2014.06.022; MATSUSHITA O, 1990, J BACTERIOL, V172, P3620, DOI 10.1128/jb.172.7.3620-3630.1990; MIAO SC, 1994, J BIOL CHEM, V269, P10975; Michaelis L, 1913, BIOCHEM Z, V49, P333; MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; Palackal N, 2007, APPL MICROBIOL BIOT, V74, P113, DOI 10.1007/s00253-006-0645-6; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Purushe J, 2010, MICROB ECOL, V60, P721, DOI 10.1007/s00248-010-9692-8; Ravachol J, 2014, J BIOL CHEM, V289, P7335, DOI 10.1074/jbc.M113.545046; Sato S, 2001, PLANT CELL PHYSIOL, V42, P251, DOI 10.1093/pcp/pce045; Schagerlof H, 2009, ANAL BIOANAL CHEM, V394, P1977, DOI 10.1007/s00216-009-2891-9; Stam MR, 2006, PROTEIN ENG DES SEL, V19, P555, DOI 10.1093/protein/gzl044; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Sundqvist G, 2007, J CHROMATOGR B, V852, P188, DOI 10.1016/j.jchromb.2007.01.011; Tseng CW, 2011, ACTA CRYSTALLOGR F, V67, P1189, DOI 10.1107/S1744309111032428; Tull D, 1996, ANAL BIOCHEM, V234, P119, DOI 10.1006/abio.1996.0063; Tuomivaara ST, 2015, CARBOHYD RES, V402, P56, DOI 10.1016/j.carres.2014.06.031; Venditto I, 2015, J BIOL CHEM, V290, P10572, DOI 10.1074/jbc.M115.637827; WALSETH CS, 1952, TAPPI, V35, P233; Waugh DS, 2011, PROTEIN EXPRES PURIF, V80, P283, DOI 10.1016/j.pep.2011.08.005; WITHERS SG, 1992, BIOCHEMISTRY-US, V31, P9979, DOI 10.1021/bi00156a017; Xue XX, 2012, ANN BOT-LONDON, V109, P873, DOI 10.1093/aob/mcs018; YORK WS, 1990, CARBOHYD RES, V200, P9, DOI 10.1016/0008-6215(90)84179-X; YUAN JM, 1994, BIOCHEM J, V299, P527, DOI 10.1042/bj2990527; Zhang YHP, 2006, BIOMACROMOLECULES, V7, P644, DOI 10.1021/bm050799c; Zhou Q, 2007, CELLULOSE, V14, P625, DOI 10.1007/s10570-007-9109-0	73	31	33	2	34	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 15	2016	291	3					1175	1197		10.1074/jbc.M115.691659	http://dx.doi.org/10.1074/jbc.M115.691659			23	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DA8PR	26507654	Green Published, hybrid			2022-12-26	WOS:000368068300013
J	Zhu, GY; Koszelak-Rosenblum, M; Connelly, SM; Dumont, ME; Malkowski, MG				Zhu, Guangyu; Koszelak-Rosenblum, Mary; Connelly, Sara M.; Dumont, Mark E.; Malkowski, Michael G.			The Crystal Structure of an Integral Membrane Fatty Acid alpha-Hydroxylase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; PROTEIN-SEQUENCE; HIGH-THROUGHPUT; USER-INTERFACE; FUSION PROTEIN; GENE; COA; IDENTIFICATION; 2-HYDROXYLASE; DESATURASE	Neuronal electrical impulse propagation is facilitated by the myelin sheath, a compact membrane surrounding the axon. The myelin sheath is highly enriched in galactosylceramide (GalCer) and its sulfated derivative sulfatide. Over 50% of GalCer and sulfatide in myelin is hydroxylated by the integral membrane enzyme fatty acid 2-hydroxylase (FA2H). GalCer hydroxylation contributes to the compact nature of the myelin membrane, and mutations in FA2H result in debilitating leukodystrophies and spastic paraparesis. Wereport here the 2.6 angstrom crystal structure of sphingolipid alpha-hydroxylase (Scs7p), a yeast homolog of FA2H. The Scs7p core is composed of a helical catalytic cap domain that sits atop four transmembrane helices that anchor the enzyme in the endoplasmic reticulum. The structure contains two zinc atoms coordinated by the side chains of 10 highly conserved histidines within a dimetal center located near the plane of the cytosolic membrane. We used a yeast genetic approach to confirm the important role of the dimetal-binding histidines in catalysis and identified Tyr-322 and Asp-323 as critical determinants involved in the hydroxylase reaction. Examination of the Scs7p structure, coupled with molecular dynamics simulations, allowed for the generation of a model of ceramide binding to Scs7p. Comparison of the Scs7p structure and substratebinding model to the structure of steroyl-CoA desaturase revealed significant differences in the architecture of the catalytic cap domain and location of the dimetal centers with respect to the membrane. These observations provide insight into the different mechanisms of substrate binding and recognition of substrates by the hydroxylase and desaturase enzymes.	[Zhu, Guangyu; Koszelak-Rosenblum, Mary; Malkowski, Michael G.] Hauptman Woodward Med Res Inst, Buffalo, NY 14203 USA; [Connelly, Sara M.; Dumont, Mark E.] Univ Rochester, Sch Med & Dent, Dept Biochem & Biophys, Rochester, NY 14642 USA; [Dumont, Mark E.] Univ Rochester, Sch Med & Dent, Dept Pediat, Rochester, NY 14642 USA; [Malkowski, Michael G.] SUNY Buffalo, Dept Biol Struct, Buffalo, NY 14203 USA	Hauptman Woodward Medical Research Institute; University of Rochester; University of Rochester; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Malkowski, MG (corresponding author), SUNY Buffalo, Hauptman Woodward Inst, Dept Biol Struct, 700 Ellicott St, Buffalo, NY 14203 USA.	mgm22@buffalo.edu	Zhu, Guangyu/F-6279-2011	Zhu, Guangyu/0000-0003-4228-135X; Malkowski, Michael/0000-0002-1203-7463	National Institutes of Health from NCI [Y1-CO-1020]; National Institutes of Health from NIGMS [Y1-GM-1104]; United States Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-06CH11357]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM094611] Funding Source: NIH RePORTER	National Institutes of Health from NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health from NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); United States Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	X-ray diffraction experiments and fluorescence scans were conducted at the Advanced Photon Source. Use of IMCACAT beamline 17-ID at the Advanced Photon Source was supported by companies of the Industrial Macromolecular Crystallography Association through a contract with the Hauptman-Woodward Medical Research Institute. GM/CA CAT has been funded in whole or in part with federal funds from the National Institutes of Health Grants Y1-CO-1020 from NCI and Y1-GM-1104 from NIGMS. Use of the Advanced Photon Source was supported by the United States Department of Energy, Office of Science, Office of Basic Energy Sciences, under Contract No. DE-AC02-06CH11357.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Aggarwal S, 2011, TRENDS CELL BIOL, V21, P585, DOI 10.1016/j.tcb.2011.06.004; AKANUMA H, 1979, J BIOL CHEM, V254, P1050; Alderson NL, 2004, J BIOL CHEM, V279, P48562, DOI 10.1074/jbc.M406649200; Alexandrov A, 2001, BIOTECHNIQUES, V30, P1194, DOI 10.2144/01306bm01; ARTHINGTON BA, 1991, GENE, V102, P39, DOI 10.1016/0378-1119(91)90535-J; Bai YH, 2015, NATURE, V524, P252, DOI 10.1038/nature14549; Best RB, 2012, J CHEM THEORY COMPUT, V8, P3257, DOI 10.1021/ct300400x; Blackstone C, 2012, ANNU REV NEUROSCI, V35, P25, DOI 10.1146/annurev-neuro-062111-150400; Bond CS, 2009, ACTA CRYSTALLOGR D, V65, P510, DOI 10.1107/S0907444909007835; Clark KM, 2010, PROTEIN EXPRES PURIF, V71, P207, DOI 10.1016/j.pep.2009.12.012; DAILEY HA, 1979, J BIOL CHEM, V254, P5388; Dick KJ, 2010, HUM MUTAT, V31, pE1251, DOI 10.1002/humu.21205; Eckhardt M, 2005, BIOCHEM J, V388, P245, DOI 10.1042/BJ20041451; Edvardson S, 2008, AM J HUM GENET, V83, P643, DOI 10.1016/j.ajhg.2008.10.010; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Guo L, 2012, J LIPID RES, V53, P1327, DOI 10.1194/jlr.M025742; Haak D, 1997, J BIOL CHEM, V272, P29704, DOI 10.1074/jbc.272.47.29704; Hama H, 2000, FEBS LETT, V478, P26, DOI 10.1016/S0014-5793(00)01821-4; Hama H, 2010, BBA-MOL CELL BIOL L, V1801, P405, DOI 10.1016/j.bbalip.2009.12.004; Hanson MA, 2012, SCIENCE, V335, P851, DOI [10.1126/science.1244693, 10.1126/science.1215904]; Hino T, 2010, SCIENCE, V330, P1666, DOI 10.1126/science.1195591; Hoffman GA, 2000, J BIOL CHEM, V275, P37533, DOI 10.1074/jbc.M005751200; Jo S, 2008, J COMPUT CHEM, V29, P1859, DOI 10.1002/jcc.20945; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.121823, 10.1126/science.1218231]; Koszelak-Rosenblum M, 2009, PROTEIN SCI, V18, P1828, DOI 10.1002/pro.193; Kushnirov VV, 2000, YEAST, V16, P857, DOI 10.1002/1097-0061(20000630)16:9<857::AID-YEA561>3.0.CO;2-B; Li LT, 1996, J BIOL CHEM, V271, P16927, DOI 10.1074/jbc.271.28.16927; Lomize MA, 2012, NUCLEIC ACIDS RES, V40, pD370, DOI 10.1093/nar/gkr703; Luft JR, 2011, EXPERT OPIN DRUG DIS, V6, P465, DOI 10.1517/17460441.2011.566857; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mitchell AG, 1997, J BIOL CHEM, V272, P28281, DOI 10.1074/jbc.272.45.28281; MITCHELL AG, 1995, J BIOL CHEM, V270, P29766; Napier JA, 1997, BIOCHEM J, V328, P717; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pei JM, 2008, NUCLEIC ACIDS RES, V36, P2295, DOI 10.1093/nar/gkn072; Pierson TM, 2012, EUR J HUM GENET, V20, P476, DOI 10.1038/ejhg.2011.222; Potterton E, 2003, ACTA CRYSTALLOGR D, V59, P1131, DOI 10.1107/S0907444903008126; Potterton L, 2004, ACTA CRYSTALLOGR D, V60, P2288, DOI 10.1107/S0907444904023716; Pronk S, 2013, BIOINFORMATICS, V29, P845, DOI 10.1093/bioinformatics/btt055; Pruett ST, 2008, J LIPID RES, V49, P1621, DOI 10.1194/jlr.R800012-JLR200; Shakoury-Elizeh M, 2010, J BIOL CHEM, V285, P14823, DOI 10.1074/jbc.M109.091710; Shanklin J, 1998, ANNU REV PLANT PHYS, V49, P611, DOI 10.1146/annurev.arplant.49.1.611; SHANKLIN J, 1994, BIOCHEMISTRY-US, V33, P12787, DOI 10.1021/bi00209a009; Sperling P, 2003, PROSTAG LEUKOTR ESS, V68, P73, DOI 10.1016/S0952-3278(02)00258-2; Wang H, 2015, NAT STRUCT MOL BIOL, V22, P581, DOI 10.1038/nsmb.3049; Zoete V, 2011, J COMPUT CHEM, V32, P2359, DOI 10.1002/jcc.21816	47	32	32	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 11	2015	290	50					29820	29833		10.1074/jbc.M115.680124	http://dx.doi.org/10.1074/jbc.M115.680124			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CY7UL	26515067	Green Published, Green Submitted, hybrid			2022-12-26	WOS:000366614700017
J	Meng, ZG; Meng, ZH; Zhang, R; Liang, CZ; Wan, JM; Wang, YL; Zhai, HH; Guo, SD				Meng, Zhigang; Meng, Zhaohong; Zhang, Rui; Liang, Chengzhen; Wan, Jianmin; Wang, Yanling; Zhai, Honghong; Guo, Sandui			Expression of the Rice Arginase Gene OsARG in Cotton Influences the Morphology and Nitrogen Transition of Seedlings	PLOS ONE			English	Article							ROOT DEVELOPMENT; ARGININE METABOLISM; LEAF SENESCENCE; USE EFFICIENCY; ARABIDOPSIS; PLANT; SEEDS; REMOBILIZATION; L.; FERTILIZATION	Arginase is the only enzyme capable of producing urea in plants. This enzyme also contributes to many important biological functions during plant growth and development, such as seed development, root development and plant nitrogen using. The unique rice arginase gene OsARG is known to affect nitrogen use efficiency and is also associated with higher yields in rice. In this study, we transformed OsARG into upland cotton R18 by Agrobacterium- mediated genetic transformation and analyzed the function of OsARG in transgenic cotton. Two independent OsARG expression transgenic cotton lines, ARG-26 and ARG-38, were obtained via transformation. Southern blot analysis indicated that two copies and one copy of the OsARG gene were integrated into the ARG-26 and ARG-38 genomes, respectively. Enzyme activity and RNA transcription analysis revealed that the OsARG gene is highly expressed in cotton. The nitric oxide content and the morphology of ARG-26 and ARG-38 seedlings were both affected by expression of the OsARG gene. Field experiments indicated that the polyamine and nitrogen content increased by more than two-fold in the T3 generation plants of the transgenic cotton lines ARG-26-2, ARG-26-7, ARG-38-8, and ARG-38-11, as compared with the control plants. After harvesting cotton fibers grown in field conditions, we analyzed the quality of fiber and found that the fiber length was increased in the transgenic lines. The average cotton fiber length for all of the transgenic cotton lines was two millimeters longer than the fibers of the control plants; the average cotton fiber lengths were 31.94 mm, 32.00 mm, 32.68 mm and 32.84 mm in the ARG-26ARG-26- 2, ARG-26-7, ARG-38-8 and ARG-38-11 lines, respectively, but the average fiber length of the control plants was 29.36mm. Our results indicate that the OsARG gene could potentially be used to improve cotton fiber length traits.	[Meng, Zhigang; Meng, Zhaohong; Zhang, Rui; Liang, Chengzhen; Wang, Yanling; Zhai, Honghong; Guo, Sandui] Chinese Acad Agr Sci, Biotechnol Res Inst, Beijing 100193, Peoples R China; [Wan, Jianmin] Chinese Acad Agr Sci, Inst Crop Sci, Beijing 100193, Peoples R China; [Wang, Yanling] Anhui Agr Univ, Sch Life Sci, Hefei, Anhui, Peoples R China	Chinese Academy of Agricultural Sciences; Biotechnology Research Institute, CAAS; Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS; Anhui Agricultural University	Guo, SD (corresponding author), Chinese Acad Agr Sci, Biotechnol Res Inst, Beijing 100193, Peoples R China.	guosandui@caas.cn	Wang, Yanbo/HFZ-8018-2022; wang, yi/GVT-8516-2022; wang, yan/GSE-6489-2022	Meng, ZhiGang/0000-0001-8959-5685	National Natural Science Foundation of China [31301373]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (grant no. 31301373).	Ando T, 1997, DEV PLANT SOIL SCI, V78, P51; CAGAMPANG GB, 1971, CEREAL CHEM, V48, P533; Canton FR, 2005, PHOTOSYNTH RES, V83, P265, DOI 10.1007/s11120-004-9366-9; Chen YG, 2008, J CHEM ECOL, V34, P1553, DOI 10.1007/s10886-008-9560-x; Cheng L, 2004, TREE PHYSIOL, V24, P91, DOI 10.1093/treephys/24.1.91; Correa-Aragunde N, 2004, PLANTA, V218, P900, DOI 10.1007/s00425-003-1172-7; Lombardo MC, 2006, PLANT SIGNAL BEHAV, V1, P28, DOI 10.4161/psb.1.1.2398; Diaz C, 2005, PLANT PHYSIOL, V138, P898, DOI 10.1104/pp.105.060764; Diaz C, 2008, PLANT PHYSIOL, V147, P1437, DOI 10.1104/pp.108.119040; Draper J, 1988, ISOLATION PLANT NUCL, P212; Fan XR, 2007, J EXP BOT, V58, P1729, DOI 10.1093/jxb/erm033; Flores T, 2008, PLANT PHYSIOL, V147, P1936, DOI 10.1104/pp.108.121459; Haigler CH, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00104; Hao YJ, 2005, J EXP BOT, V56, P1105, DOI 10.1093/jxb/eri102; HAYASHI H, 1990, PLANT CELL PHYSIOL, V31, P247; Hirel B, 2007, J EXP BOT, V58, P2369, DOI 10.1093/jxb/erm097; Hu XY, 2005, PLANT PHYSIOL, V137, P663, DOI 10.1104/pp.104.054494; Jenkinson CP, 1996, COMP BIOCHEM PHYS B, V114, P107, DOI 10.1016/0305-0491(95)02138-8; Jubault M, 2008, PLANT PHYSIOL, V146, P2008, DOI 10.1104/pp.108.117432; King JE, 1997, PLANT PHYSIOL, V113, P1125, DOI 10.1104/pp.113.4.1125; Lattanzi FA, 2005, PLANT PHYSIOL, V137, P383, DOI 10.1104/pp.104.051375; Ma XF, 2013, PLANT J, V73, P190, DOI 10.1111/j.1365-313x.2012.05122.x; Masclaux-Daubresse C, 2010, ANN BOT-LONDON, V105, P1141, DOI 10.1093/aob/mcq028; Meng ZH, 2007, IN VITRO CELL DEV-PL, V43, P111, DOI 10.1007/s11627-007-9031-z; MICALLEF BJ, 1989, PLANT PHYSIOL, V90, P631, DOI 10.1104/pp.90.2.631; Morris SM, 2002, ANNU REV NUTR, V22, P87, DOI 10.1146/annurev.nutr.22.110801.140547; Pagnussat GC, 2004, PLANT PHYSIOL, V135, P279, DOI 10.1104/pp.103.038554; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Sainju UM, 2002, SOIL TILL RES, V63, P167, DOI 10.1016/S0167-1987(01)00244-6; Tabuchi M, 2007, J EXP BOT, V58, P2319, DOI 10.1093/jxb/erm016; Takahashi H, 2006, ANN BOT-LONDON, V98, P819, DOI 10.1093/aob/mcl162; Thu TT, 2007, PLANT CELL TISS ORG, V91, P135, DOI 10.1007/s11240-007-9227-2; VANETTEN CH, 1963, J AGR FOOD CHEM, V11, P399, DOI 10.1021/jf60129a016; WALTER HJP, 1987, PLANT PHYSIOL, V83, P232, DOI 10.1104/pp.83.2.232; ZONIA LE, 1995, PLANT PHYSIOL, V107, P1097, DOI 10.1104/pp.107.4.1097	35	21	23	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2015	10	11							e0141530	10.1371/journal.pone.0141530	http://dx.doi.org/10.1371/journal.pone.0141530			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV1QH	26528551	Green Submitted, gold, Green Published			2022-12-26	WOS:000364032600035
J	El Andari, J; Altegoer, F; Bange, G; Graumann, PL				El Andari, Jihad; Altegoer, Florian; Bange, Gert; Graumann, Peter L.			Bacillus subtilis Bactofilins Are Essential for Flagellar Hook- and Filament Assembly and Dynamically Localize into Structures of Less than 100 nm Diameter underneath the Cell Membrane	PLOS ONE			English	Article							III SECRETION; BACTERIAL; CHAPERONE; EXPORT; MOTILITY; POLYMERIZATION; IDENTIFICATION; LOCATION; ATPASE; SWITCH	Bactofilins are a widely conserved protein family implicated in cell shape maintenance and in bacterial motility. We show that the bactofilins BacE and BacF from Bacillus subtilis are essential for motility. The proteins are required for the establishment of flagellar hook- and filament structures, but apparently not for the formation of basal bodies. Functional YFP fusions to BacE and to BacF localize as discrete assemblies at the B. subtilis cell membrane, and have a diameter of 60 to 70 nm. BacF assemblies are relatively static, and partially colocalize with flagellar basal bodies, while BacE assemblies are fewer per cell than those of BacF and are highly mobile. Tracking of BacE foci showed that the assemblies arrest at a single point for a few hundred milliseconds, showing that a putative interaction with flagellar structures would be transient and fast. When overexpressed or expressed in a heterologous cell system, bactofilins can form filamentous structures, and also form multimers as purified proteins. Our data reveal a propensity for bactofilins to form filaments, however, in B. subtilis cells, bactofilins assemble into defined size assemblies that show a dynamic localization pattern and play a role in flagellar assembly.	[El Andari, Jihad; Altegoer, Florian; Bange, Gert; Graumann, Peter L.] Univ Marburg, LOEWE Ctr Synthet Microbiol, SYNMIKRO, Marburg, Germany; [El Andari, Jihad] Univ Marburg, Dept Chem, SYNMIKRO, Marburg, Germany	Philipps University Marburg; Philipps University Marburg	Graumann, PL (corresponding author), Univ Marburg, LOEWE Ctr Synthet Microbiol, SYNMIKRO, Marburg, Germany.	gert.bange@synmikro.uni-marburg.de; peter.graumann@synmikro.uni-marburg.de	Altegoer, Florian/AAM-1354-2020; Bange, Gert/AAB-3734-2021	EL Andari, Jihad (Josef)/0000-0001-5502-6214; Altegoer, Florian/0000-0002-6012-9047; Bange, Gert/0000-0002-7826-0932; Graumann, Peter/0000-0002-8033-5171	Deutsche Akademischer Austauschdienst (DAAD); Deutsche Forschungsgemeinschaft (DFG); LOEWE program of the state of Hessen, LOEWE Centre for Synthetic Microbiology (SYNMIKRO); BMBF	Deutsche Akademischer Austauschdienst (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); LOEWE program of the state of Hessen, LOEWE Centre for Synthetic Microbiology (SYNMIKRO); BMBF(Federal Ministry of Education & Research (BMBF))	The work was supported by the Deutsche Akademischer Austauschdienst (DAAD), the Deutsche Forschungsgemeinschaft (DFG), and by the LOEWE program of the state of Hessen, LOEWE Centre for Synthetic Microbiology (SYNMIKRO), as well as by the BMBF funded graduate program NANOKAT.	Altegoer F, 2014, BIOTECHNOL GENET ENG, V30, P49, DOI 10.1080/02648725.2014.921500; Auvray F, 2001, J MOL BIOL, V308, P221, DOI 10.1006/jmbi.2001.4597; Bange G, 2010, P NATL ACAD SCI USA, V107, P11295, DOI 10.1073/pnas.1001383107; BISCHOFF DS, 1992, MOL MICROBIOL, V6, P2715, DOI 10.1111/j.1365-2958.1992.tb01448.x; Blair KM, 2008, SCIENCE, V320, P1636, DOI 10.1126/science.1157877; Bulyha I, 2013, DEV CELL, V25, P119, DOI 10.1016/j.devcel.2013.02.017; Calvo RA, 2015, J BACTERIOL, V197, P81, DOI 10.1128/JB.02324-14; Chevance FFV, 2008, NAT REV MICROBIOL, V6, P455, DOI 10.1038/nrmicro1887; CLARK WA, 1976, J CLIN MICROBIOL, V3, P632; Courtney CR, 2012, J BACTERIOL, V194, P4619, DOI 10.1128/JB.00444-12; Dempwolff F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027035; Erhardt M, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000299; Guttenplan SB, 2013, MOL MICROBIOL, V87, P211, DOI 10.1111/mmi.12103; HUGHES KT, 1993, SCIENCE, V262, P1277, DOI 10.1126/science.8235660; JAACKS KJ, 1989, J BACTERIOL, V171, P4121, DOI 10.1128/JB.171.8.4121-4129.1989; Kearns DB, 2005, GENE DEV, V19, P3083, DOI 10.1101/gad.1373905; Kearns DB, 2004, MOL MICROBIOL, V52, P357, DOI 10.1111/j.1365-2958.2004.03996.x; Kinoshita M, 2013, MOL MICROBIOL, V90, P1249, DOI 10.1111/mmi.12430; Koch MK, 2011, MOL MICROBIOL, V80, P1031, DOI 10.1111/j.1365-2958.2011.07629.x; Kuhn J, 2010, EMBO J, V29, P327, DOI 10.1038/emboj.2009.358; Lai EM, 2003, J BACTERIOL, V185, P1443, DOI 10.1128/JB.185.4.1443-1454.2003; Lin L, 2013, CYTOSKELETON, V70, P409, DOI 10.1002/cm.21126; McCarter LL, 2004, J MOL MICROB BIOTECH, V7, P18, DOI 10.1159/000077866; Melnikov S, 2012, NAT STRUCT MOL BIOL, V19, P560, DOI 10.1038/nsmb.2313; Minamino T, 2008, NATURE, V451, P485, DOI 10.1038/nature06449; Muskotal A, 2006, FEBS LETT, V580, P3916, DOI 10.1016/j.febslet.2006.06.024; Ozin AJ, 2003, FEMS MICROBIOL LETT, V219, P219, DOI 10.1016/S0378-1097(02)01208-9; Paul K, 2008, NATURE, V451, P489, DOI 10.1038/nature06497; Pena A, 2013, J MOL MICROB BIOTECH, V23, P357, DOI 10.1159/000351360; Rajagopala SV, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100166; Reimold C, 2013, MOL BIOL CELL, V24, P2340, DOI 10.1091/mbc.E12-10-0728; Schuhmacher JS, 2015, P NATL ACAD SCI USA, V112, P3092, DOI 10.1073/pnas.1419388112; Sircar R, 2013, J BIOL CHEM, V288, P13493, DOI 10.1074/jbc.M112.445171; Sycuro LK, 2010, CELL, V141, P822, DOI 10.1016/j.cell.2010.03.046; Szurmant H, 2003, J BIOL CHEM, V278, P48611, DOI 10.1074/jbc.M306180200; Vasa S, 2015, P NATL ACAD SCI USA, V112, pE127, DOI 10.1073/pnas.1418450112; YOUNGMAN PJ, 1983, P NATL ACAD SCI-BIOL, V80, P2305, DOI 10.1073/pnas.80.8.2305	37	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2015	10	10							e0141546	10.1371/journal.pone.0141546	http://dx.doi.org/10.1371/journal.pone.0141546			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0EH	26517549	gold, Green Submitted, Green Published			2022-12-26	WOS:000363920800051
J	Fourrier, M; Lester, K; Markussen, T; Falk, K; Secombes, CJ; McBeath, A; Collet, B				Fourrier, Mickael; Lester, Katherine; Markussen, Turhan; Falk, Knut; Secombes, Christopher J.; McBeath, Alastair; Collet, Bertrand			Dual Mutation Events in the Haemagglutinin-Esterase and Fusion Protein from an Infectious Salmon Anaemia Virus HPR0 Genotype Promote Viral Fusion and Activation by an Ubiquitous Host Protease	PLOS ONE			English	Article							NEWCASTLE-DISEASE VIRUS; AVIAN INFLUENZA-VIRUS; POLYMORPHIC REGION HPR; HEMATOPOIETIC NECROSIS VIRUS; CLEAVAGE-SITE SEQUENCE; SINGLE AMINO-ACID; ATLANTIC SALMON; PROPROTEIN CONVERTASES; VIRULENCE MECHANISMS; ENDOTHELIAL-CELLS	In Infectious salmon anaemia virus (ISAV), deletions in the highly polymorphic region (HPR) in the near membrane domain of the haemagglutinin-esterase (HE) stalk, influence viral fusion. It is suspected that selected mutations in the associated Fusion (F) protein may also be important in regulating fusion activity. To better understand the underlying mechanisms involved in ISAV fusion, several mutated F proteins were generated from the Scottish Nevis and Norwegian SK779/06 HPR0. Co-transfection with constructs encoding HE and F were performed, fusion activity assessed by content mixing assay and the degree of proteolytic cleavage by western blot. Substitutions in Nevis F demonstrated that K276 was the most likely cleavage site in the protein. Furthermore, amino acid substitutions at three sites and two insertions, all slightly upstream of K276, increased fusion activity. Co-expression with HE harbouring a full-length HPR produced high fusion activities when trypsin and low pH were applied. In comparison, under normal culture conditions, groups containing a mutated HE with an HPR deletion were able to generate moderate fusion levels, while those with a full length HPR HE could not induce fusion. This suggested that HPR length may influence how the HE primes the F protein and promotes fusion activation by an ubiquitous host protease and/or facilitate subsequent post-cleavage refolding steps. Variations in fusion activity through accumulated mutations on surface glycoproteins have also been reported in other orthomyxoviruses and paramyxoviruses. This may in part contribute to the different virulence and tissue tropism reported for HPR0 and HPR deleted ISAV genotypes.	[Fourrier, Mickael; Lester, Katherine; McBeath, Alastair; Collet, Bertrand] Marine Scotland Sci, Aquaculture & Fish Hlth, Aberdeen, Scotland; [Markussen, Turhan; Falk, Knut] Norwegian Vet Inst, Epidemiol, Oslo, Norway; [Secombes, Christopher J.] Univ Aberdeen, Sch Biol Sci, Aberdeen, Scotland	Marine Scotland Science (MSS); Norwegian Veterinary Institute; University of Aberdeen	Fourrier, M (corresponding author), Marine Scotland Sci, Aquaculture & Fish Hlth, Aberdeen, Scotland.	Mickael.Fourrier@gov.scot	Falk, Knut/D-2952-2012; Collet, Bertrand/C-1113-2012	Falk, Knut/0000-0002-9830-3493; Collet, Bertrand/0000-0003-2795-2653	Scottish Government	Scottish Government	The Scottish Government funded this work, as part of their global budget on aquaculture research. The funder had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aamelfot M, 2012, J VIROL, V86, P10571, DOI 10.1128/JVI.00047-12; Ader N, 2012, J BIOL CHEM, V287, P16324, DOI 10.1074/jbc.M112.342493; Aspehaug V, 2005, J VIROL, V79, P12544, DOI 10.1128/JVI.79.19.12544-12553.2005; Baigent SJ, 2001, VIRUS RES, V79, P177, DOI 10.1016/S0168-1702(01)00272-6; Banks J, 2001, ARCH VIROL, V146, P963, DOI 10.1007/s007050170128; Basak A, 2001, BIOCHEM J, V353, P537, DOI 10.1042/0264-6021:3530537; Betts M.J., 2003, BIOINFORMATIC GENETI; Bottcher-Friebertshauser E, 2010, J VIROL, V84, P5605, DOI 10.1128/JVI.00140-10; Bolt G, 1998, VIROLOGY, V252, P387, DOI 10.1006/viro.1998.9464; BOSCH FX, 1979, VIROLOGY, V95, P197, DOI 10.1016/0042-6822(79)90414-8; Bouchard D, 1999, DIS AQUAT ORGAN, V35, P131, DOI 10.3354/dao035131; Bouchard DA, 2001, BULL EUR ASSN FISH P, V21, P86; Brindley MA, 2012, P NATL ACAD SCI USA, V109, pE3018, DOI 10.1073/pnas.1210925109; Burkard C, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004502; Cardenas C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087832; Chen J, 1998, CELL, V95, P409, DOI 10.1016/S0092-8674(00)81771-7; Chen L, 2001, STRUCTURE, V9, P255, DOI 10.1016/S0969-2126(01)00581-0; Chernomordik LV, 2003, ANNU REV BIOCHEM, V72, P175, DOI 10.1146/annurev.biochem.72.121801.161504; Christiansen DH, 2011, J GEN VIROL, V92, P909, DOI 10.1099/vir.0.027094-0; COLLINS MS, 1993, ARCH VIROL, V128, P363, DOI 10.1007/BF01309446; Colman PM, 2003, NAT REV MOL CELL BIO, V4, P309, DOI 10.1038/nrm1076; Cook JR, 2015, J BIOL CHEM, V290, P13972, DOI 10.1074/jbc.M115.638197; Cook-Versloot M, 2004, B EUR ASSOC FISH PAT, V24, P203; Cottet L, 2010, J VIROL, V84, P11916, DOI 10.1128/JVI.01202-10; Craft WW, 2005, VIROLOGY, V341, P130, DOI 10.1016/j.virol.2005.07.004; Cross KJ, 2009, PROTEIN PEPTIDE LETT, V16, P766, DOI 10.2174/092986609788681715; Cunningham CO, 2002, BULL EUR ASSN FISH P, V22, P366; de Wit E, 2010, J VIROL, V84, P1597, DOI 10.1128/JVI.01783-09; DESHPANDE KL, 1985, VIROLOGY, V147, P49, DOI 10.1016/0042-6822(85)90226-0; Devold M, 2006, J GEN VIROL, V87, P2031, DOI 10.1099/vir.0.81687-0; Devold M, 2001, DIS AQUAT ORGAN, V47, P119, DOI 10.3354/dao047119; Falk K, 1997, J VIROL, V71, P9016, DOI 10.1128/JVI.71.12.9016-9023.1997; Fan SF, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6021; Feldmann A, 2000, J VIROL, V74, P8018, DOI 10.1128/JVI.74.17.8018-8027.2000; Fourrier M, 2014, J GEN VIROL, V95, P1015, DOI 10.1099/vir.0.061648-0; Fuller JA, 2009, INVEST OPHTH VIS SCI, V50, P5759, DOI 10.1167/iovs.08-2616; Galloway SE, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003151; Garcia-Rosado E, 2008, VIRUS RES, V133, P228, DOI 10.1016/j.virusres.2008.01.008; Garten W, 1999, TRENDS MICROBIOL, V7, P99, DOI 10.1016/S0966-842X(99)01460-2; GARTEN W, 1980, J GEN VIROL, V50, P135, DOI 10.1099/0022-1317-50-1-135; GLICKMAN RL, 1988, J VIROL, V62, P354, DOI 10.1128/JVI.62.1.354-356.1988; Godoy MG, 2008, BMC VET RES, V4, DOI 10.1186/1746-6148-4-28; Hastings T, 1999, BULL EUR ASSN FISH P, V19, P286; Hellebo A, 2004, J VIROL, V78, P3055, DOI 10.1128/JVI.78.6.3055-3062.2004; Herfst S, 2012, SCIENCE, V336, P1534, DOI 10.1126/science.1213362; HORIMOTO T, 1994, J VIROL, V68, P3120, DOI 10.1128/JVI.68.5.3120-3128.1994; KAWAOKA Y, 1984, VIROLOGY, V139, P303, DOI 10.1016/0042-6822(84)90376-3; KAWAOKA Y, 1988, P NATL ACAD SCI USA, V85, P324, DOI 10.1073/pnas.85.2.324; KHATCHIKIAN D, 1989, NATURE, V340, P156, DOI 10.1038/340156a0; Kibenge FSB, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-34; Kibenge FSB, 2007, J GEN VIROL, V88, P3100, DOI 10.1099/vir.0.83097-0; Kibenge FSB, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-88; Klenk Hans-Dieter, 1994, Trends in Microbiology, V2, P39, DOI 10.1016/0966-842X(94)90123-6; KLENK HD, 1984, EMBO J, V3, P2911, DOI 10.1002/j.1460-2075.1984.tb02231.x; Kobasa D, 2004, NATURE, V431, P703, DOI 10.1038/nature02951; Lamb RA, 2007, CURR OPIN STRUC BIOL, V17, P427, DOI 10.1016/j.sbi.2007.08.016; Li ZJ, 1998, J VIROL, V72, P3789, DOI 10.1128/JVI.72.5.3789-3795.1998; Lu XS, 2012, J VIROL, V86, P12861, DOI 10.1128/JVI.01606-12; Lyngstad TM, 2011, EPIDEMICS-NETH, V3, P1, DOI 10.1016/j.epidem.2010.11.001; Markussen T, 2008, VIROLOGY, V374, P515, DOI 10.1016/j.virol.2008.01.019; Markussen T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081571; Matsuoka Y, 2009, J VIROL, V83, P4704, DOI 10.1128/JVI.01987-08; Maurer-Stroh S, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-139; McBeath AJA, 2006, VIRUS RES, V115, P176, DOI 10.1016/j.virusres.2005.08.005; McBeath A, 2011, ARCH VIROL, V156, P2285, DOI 10.1007/s00705-011-1106-9; McBeath AJA, 2014, VET RES, V45, DOI 10.1186/s13567-014-0083-x; McBeath AJA, 2009, DIS AQUAT ORGAN, V87, P161, DOI 10.3354/dao02128; MCGRATH ME, 1989, BIOCHEMISTRY-US, V28, P9264, DOI 10.1021/bi00450a005; Mikalsen AB, 2005, ARCH VIROL, V150, P1621, DOI 10.1007/s00705-005-0502-4; Mjaaland S, 2002, VIROLOGY, V304, P379, DOI 10.1006/viro.2002.1658; Munier S, 2010, J VIROL, V84, P940, DOI 10.1128/JVI.01581-09; NAGAI Y, 1976, VIROLOGY, V72, P494, DOI 10.1016/0042-6822(76)90178-1; NAGAI Y, 1977, VIROLOGY, V77, P125, DOI 10.1016/0042-6822(77)90412-3; Navaratnarajah CK, 2011, NAT STRUCT MOL BIOL, V18, P128, DOI 10.1038/nsmb.1967; Nylund A, 2003, DIS AQUAT ORGAN, V56, P11, DOI 10.3354/dao056011; Nylund A, 2007, ARCH VIROL, V152, P151, DOI 10.1007/s00705-006-0825-9; Paal T, 2009, J VIROL, V83, P10480, DOI 10.1128/JVI.01195-09; Pager CT, 2004, J VIROL, V78, P9154, DOI 10.1128/JVI.78.17.9154-9163.2004; Panda A, 2004, MICROB PATHOGENESIS, V36, P1, DOI 10.1016/j.micpath.2003.07.003; Pasick J, 2005, J GEN VIROL, V86, P727, DOI 10.1099/vir.0.80478-0; PATERSON RG, 1989, J VIROL, V63, P1293, DOI 10.1128/JVI.63.3.1293-1301.1989; Penaranda MMD, 2009, J GEN VIROL, V90, P2172, DOI 10.1099/vir.0.012286-0; Plumet S, 2005, J VIROL METHODS, V128, P79, DOI 10.1016/j.jviromet.2005.03.020; Porotto M, 2003, J VIROL, V77, P3647, DOI 10.1128/JVI.77.6.3647-3654.2003; Pratt C.W., 2008, FUNDAMENTALS BIOCH L; Purcell MK, 2009, J FISH DIS, V32, P619, DOI 10.1111/j.1365-2761.2009.01045.x; Ramly RB, 2013, VIRUS RES, V177, P1, DOI 10.1016/j.virusres.2013.07.001; Rimstad E, 1999, DIS AQUAT ORGAN, V36, P107, DOI 10.3354/dao036107; Rimstad E, 2001, J VIROL, V75, P5352, DOI 10.1128/JVI.75.11.5352-5356.2001; Rumschlag-Booms E, 2013, ADV VIROL, V2013, DOI 10.1155/2013/121924; Samal S, 2011, J GEN VIROL, V92, P2333, DOI 10.1099/vir.0.033399-0; Senne DA, 1996, AVIAN DIS, V40, P425, DOI 10.2307/1592241; SPRANG S, 1987, SCIENCE, V237, P905, DOI 10.1126/science.3112942; Steinhauer DA, 1999, VIROLOGY, V258, P1, DOI 10.1006/viro.1999.9716; STIENEKEGROBER A, 1992, EMBO J, V11, P2407, DOI 10.1002/j.1460-2075.1992.tb05305.x; Suarez DL, 2004, EMERG INFECT DIS, V10, P693, DOI 10.3201/eid1004.030396; Tan LK, 2014, J VIROL, V88, P14116, DOI 10.1128/JVI.01736-14; Thorud K., 1988, Bulletin of the European Association of Fish Pathologists, V8, P109; TOYODA T, 1987, VIROLOGY, V158, P242, DOI 10.1016/0042-6822(87)90261-3; Tumpey TM, 2007, SCIENCE, V315, P655, DOI 10.1126/science.1136212; Wargo AR, 2011, J VIROL, V85, P3959, DOI 10.1128/JVI.01891-10; Weli SC, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-5; White JM, 2008, CRIT REV BIOCHEM MOL, V43, P189, DOI [10.1080/10409230802058320, 10.1080/10409230802058320 ]; Wright PF, 2007, FIELDS VIROLOGY, V2, P1691; Yin HS, 2005, P NATL ACAD SCI USA, V102, P9288, DOI 10.1073/pnas.0503989102; Zhang Y, 2012, J VIROL, V86, P6924, DOI 10.1128/JVI.07142-11; Zimmer G, 2001, J BIOL CHEM, V276, P31642, DOI 10.1074/jbc.M102633200	107	18	18	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2015	10	10							e0142020	10.1371/journal.pone.0142020	http://dx.doi.org/10.1371/journal.pone.0142020			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0EH	26517828	Green Published, gold, Green Submitted			2022-12-26	WOS:000363920800101
J	Reissig, P; Puri, R; Garry, MI; Summers, JJ; Hinder, MR				Reissig, Paola; Puri, Rohan; Garry, Michael I.; Summers, Jeffery J.; Hinder, Mark R.			The Influence of Mirror-Visual Feedback on Training-Induced Motor Performance Gains in the Untrained Hand	PLOS ONE			English	Article							CROSS-LIMB TRANSFER; OLDER-ADULTS; CORTICAL EXCITABILITY; M1 EXCITABILITY; IPSILATERAL M1; THERAPY; CORTEX; MOVEMENT; MECHANISMS; RETENTION	The well-documented observation of bilateral performance gains following unilateral motor training, a phenomenon known as cross-limb transfer, has important implications for rehabilitation. It has recently been shown that provision of a mirror image of the active hand during unilateral motor training has the capacity to enhance the efficacy of this phenomenon when compared to training without augmented visual feedback (i.e., watching the passive hand), possibly via action observation effects [1]. The current experiment was designed to confirm whether mirror-visual feedback (MVF) during motor training can indeed elicit greater performance gains in the untrained hand compared to more standard visual feedback (i.e., watching the active hand). Furthermore, discussing the mechanisms underlying any such MVF-induced behavioural effects, we suggest that action observation and the cross-activation hypothesis may both play important roles in eliciting cross-limb transfer. Eighty participants practiced a fast-as-possible two-ball rotation task with their dominant hand. During training, three different groups were provided with concurrent visual feedback of the active hand, inactive hand or a mirror image of the active hand with a fourth control group receiving no training. Pre- and post-training performance was measured in both hands. MVF did not increase the extent of training-induced performance changes in the untrained hand following unilateral training above and beyond those observed for other types of feedback. The data are consistent with the notion that cross-limb transfer, when combined with MVF, is mediated by cross-activation with action observation playing a less unique role than previously suggested. Further research is needed to replicate the current and previous studies to determine the clinical relevance and potential benefits of MVF for cases that, due to the severity of impairment, rely on unilateral training programmes of the unaffected limb to drive changes in the contralateral affected limb.	[Reissig, Paola; Puri, Rohan; Garry, Michael I.; Summers, Jeffery J.; Hinder, Mark R.] Univ Tasmania, Fac Hlth, Sch Med, Human Motor Control Lab, Hobart, Tas, Australia; [Reissig, Paola] Univ Tasmania, Fac Hlth, Grad Res Program, Hobart, Tas, Australia; [Summers, Jeffery J.] Liverpool John Moores Univ, Res Inst Sport & Exercise Sci, Liverpool L3 5UX, Merseyside, England	University of Tasmania; University of Tasmania; Liverpool John Moores University	Reissig, P (corresponding author), Univ Tasmania, Fac Hlth, Sch Med, Human Motor Control Lab, Hobart, Tas, Australia.	Paola.Reissig@utas.edu.au	Puri, Rohan/S-1988-2019; Puri, Rohan/N-5421-2017	Puri, Rohan/0000-0002-0231-1369; Puri, Rohan/0000-0002-0231-1369; Garry, Michael/0000-0002-5113-0986; Hinder, Mark/0000-0002-5240-4790	Discovery 631 Early Career Research Award 632 [DE120100729]	Discovery 631 Early Career Research Award 632	This work was supported by a Discovery 631 Early Career Research Award 632 (DE120100729) awarded to MRH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschuler EL, 1999, LANCET, V353, P2035, DOI 10.1016/S0140-6736(99)00920-4; Aziz-Zadeh L, 2002, EXP BRAIN RES, V144, P127, DOI 10.1007/s00221-002-1037-5; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Carroll TJ, 2008, J APPL PHYSIOL, V104, P1656, DOI 10.1152/japplphysiol.01351.2007; Carroll TJ, 2006, J APPL PHYSIOL, V101, P1514, DOI 10.1152/japplphysiol.00531.2006; Carson RG, 2012, J NEUROSCI, V32, P646, DOI 10.1523/JNEUROSCI.4435-11.2012; Deconinck FJA, 2015, NEUROREHAB NEURAL RE, V29, P349, DOI 10.1177/1545968314546134; Diers M, 2010, PAIN, V149, P296, DOI 10.1016/j.pain.2010.02.020; Farthing JP, 2009, EXERC SPORT SCI REV, V37, P179, DOI 10.1097/JES.0b013e3181b7e882; Fritzsch C, 2014, RESTOR NEUROL NEUROS, V32, P269, DOI 10.3233/RNN-130343; Garry MI, 2005, EXP BRAIN RES, V163, P118, DOI 10.1007/s00221-005-2226-9; Gates A. I., 1917, ARCH PSYCHOL, V6; Hinder MR, 2013, EXP BRAIN RES, V227, P19, DOI 10.1007/s00221-013-3481-9; Hinder MR, 2011, J APPL PHYSIOL, V110, P166, DOI 10.1152/japplphysiol.00958.2010; Hoff M, 2015, EUR J NEUROSCI, V41, P1475, DOI 10.1111/ejn.12899; Lappchen CH, 2012, J NEUROPHYSIOL, V108, P2857, DOI 10.1152/jn.00321.2012; Lee M, 2010, J PHYSIOL-LONDON, V588, P201, DOI 10.1113/jphysiol.2009.183855; McCabe CS, 2003, RHEUMATOLOGY, V42, P97, DOI 10.1093/rheumatology/keg041; MORRIS CD, 1977, J VERB LEARN VERB BE, V16, P519, DOI 10.1016/S0022-5371(77)80016-9; Nojima I, 2015, EUR J NEUROSCI; Nojima I, 2013, EXP BRAIN RES, V227, P79, DOI 10.1007/s00221-013-3486-4; Nojima I, 2012, J NEUROSCI, V32, P1293, DOI 10.1523/JNEUROSCI.5364-11.2012; Perez MA, 2008, J NEUROSCI, V28, P5631, DOI 10.1523/JNEUROSCI.0093-08.2008; Ramachandran VS, 2009, BRAIN, V132, P1693, DOI 10.1093/brain/awp135; Ramachandran VS, 1996, P ROY SOC B-BIOL SCI, V263, P377, DOI 10.1098/rspb.1996.0058; Reissig P, 2014, NEUROPSYCHOL REHABIL, V24, P936, DOI 10.1080/09602011.2014.922889; Roediger HL, 2006, PSYCHOL SCI, V17, P249, DOI 10.1111/j.1467-9280.2006.01693.x; ROEDIGER HL, 1990, AM PSYCHOL, V45, P1043, DOI 10.1037/0003-066X.45.9.1043; Shinoura N, 2008, NEUROREHABILITATION, V23, P245; Strafella AP, 2000, NEUROREPORT, V11, P2289, DOI 10.1097/00001756-200007140-00044; Thieme H, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008449.pub2; Touzalin-Chretien P, 2008, J NEUROPHYSIOL, V100, P19, DOI 10.1152/jn.90260.2008; von Rein E, 2015, J NEUROPHYSIOL; Yavuzer G, 2008, ARCH PHYS MED REHAB, V89, P393, DOI 10.1016/j.apmr.2007.08.162	34	11	11	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2015	10	10							e0141828	10.1371/journal.pone.0141828	http://dx.doi.org/10.1371/journal.pone.0141828			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0EH	26517375	Green Published, gold, Green Accepted, Green Submitted			2022-12-26	WOS:000363920800082
J	Kang, JI; Huppe-Gourgues, F; Vaucher, E				Kang, Jun-Il; Huppe-Gourgues, Frederic; Vaucher, Elvire			Pharmacological Mechanisms of Cortical Enhancement Induced by the Repetitive Pairing of Visual/Cholinergic Stimulation	PLOS ONE			English	Article							PRIMARY VISUAL-CORTEX; NICOTINIC ACETYLCHOLINE-RECEPTORS; LONG-TERM POTENTIATION; CHOLINERGIC MODULATION; PREFRONTAL CORTEX; SYNAPTIC PLASTICITY; GAMMA OSCILLATIONS; GLUTAMATE RELEASE; PYRAMIDAL NEURONS; AUDITORY-CORTEX	Repetitive visual training paired with electrical activation of cholinergic projections to the primary visual cortex (V1) induces long-term enhancement of cortical processing in response to the visual training stimulus. To better determine the receptor subtypes mediating this effect the selective pharmacological blockade of V1 nicotinic (nAChR), M1 and M2 muscarinic (mAChR) or GABAergic A (GABAAR) receptors was performed during the training session and visual evoked potentials (VEPs) were recorded before and after training. The training session consisted of the exposure of awake, adult rats to an orientation-specific 0.12 CPD grating paired with an electrical stimulation of the basal forebrain for a duration of 1 week for 10 minutes per day. Pharmacological agents were infused intracortically during this period. The post-training VEP amplitude was significantly increased compared to the pre-training values for the trained spatial frequency and to adjacent spatial frequencies up to 0.3 CPD, suggesting a long-term increase of V1 sensitivity. This increase was totally blocked by the nAChR antagonist as well as by an M2 mAChR subtype and GABAAR antagonist. Moreover, administration of the M2 mAChR antagonist also significantly decreased the amplitude of the control VEPs, suggesting a suppressive effect on cortical responsiveness. However, the M1 mAChR antagonist blocked the increase of the VEP amplitude only for the high spatial frequency (0.3 CPD), suggesting that M1 role was limited to the spread of the enhancement effect to a higher spatial frequency. More generally, all the drugs used did block the VEP increase at 0.3 CPD. Further, use of each of the aforementioned receptor antagonists blocked training-induced changes in gamma and beta band oscillations. These findings demonstrate that visual training coupled with cholinergic stimulation improved perceptual sensitivity by enhancing cortical responsiveness in V1. This enhancement is mainly mediated by nAChRs, M2 mAChRs and GABA(A)Rs. The M1 mAChR subtype appears to be involved in spreading the enhancement of V1 cortical responsiveness to adjacent neurons.	[Kang, Jun-Il; Huppe-Gourgues, Frederic; Vaucher, Elvire] Univ Montreal, Ecole Optometrie, Montreal, PQ H3C 3J7, Canada; [Kang, Jun-Il] Univ Montreal, Dept Neurosci, Montreal, PQ H3C 3J7, Canada	Universite de Montreal; Universite de Montreal	Vaucher, E (corresponding author), Univ Montreal, Ecole Optometrie, CP 6128 Succursale Ctr Ville, Montreal, PQ H3C 3J7, Canada.	elvire.vaucher@umontreal.ca		Huppe-Gourgues, Frederic/0000-0001-7904-2198; Vaucher, Elvire/0000-0001-7075-5263	Canadian Institute for Health Research [MOP-111003]; Natural Sciences and Engineering Research Council of Canada [238835-2011]; Fonds de recherche du quebec - Sante; Vision network; Centre for Interdisciplinary Research in Rehabilitation	Canadian Institute for Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Fonds de recherche du quebec - Sante(Fonds de la Recherche en Sante du Quebec); Vision network; Centre for Interdisciplinary Research in Rehabilitation	This work was supported by the Canadian Institute for Health Research (http://www.cihr-irsc.gc.ca) : Grant# MOP-111003 (EV), the Natural Sciences and Engineering Research Council of Canada (http://www.nserc-crsng.gc.ca) : Grant# 238835-2011 (EV), the Fonds de recherche du quebec - Sante; Vision network (http://www.frqs.gouv.qc.ca): JIK, and the Centre for Interdisciplinary Research in Rehabilitation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alitto HJ, 2013, FRONT SYST NEUROSCI, V6, DOI 10.3389/fnsys.2012.00079; Amar M, 2010, NEUROSCIENCE, V169, P1610, DOI 10.1016/j.neuroscience.2010.06.019; Ayzenshtat I, 2012, J NEUROSCI, V32, P13971, DOI 10.1523/JNEUROSCI.1596-12.2012; Bentley P, 2004, NEURON, V41, P969, DOI 10.1016/S0896-6273(04)00145-X; Bhattacharyya A, 2013, BMC NEUROSCI, V14, DOI 10.1186/1471-2202-14-55; Bosman CA, 2012, NEURON, V75, P875, DOI 10.1016/j.neuron.2012.06.037; Brovelli A, 2004, P NATL ACAD SCI USA, V101, P9849, DOI 10.1073/pnas.0308538101; Buia CI, 2008, J NEUROPHYSIOL, V99, P2158, DOI 10.1152/jn.01004.2007; Buschman TJ, 2007, SCIENCE, V315, P1860, DOI 10.1126/science.1138071; Bymaster FP, 2003, NEUROCHEM RES, V28, P437, DOI 10.1023/A:1022844517200; Cardin JA, 2009, NATURE, V459, P663, DOI 10.1038/nature08002; Chattopadhyaya Bidisha, 2012, Front Psychiatry, V3, P51, DOI 10.3389/fpsyt.2012.00051; Coleman JE, 2010, J NEUROSCI, V30, P9670, DOI 10.1523/JNEUROSCI.1248-10.2010; Cooke SF, 2015, NAT NEUROSCI, V18, P262, DOI 10.1038/nn.3920; Cooke SF, 2010, J NEUROSCI, V30, P16304, DOI 10.1523/JNEUROSCI.4333-10.2010; Disney AA, 2007, NEURON, V56, P701, DOI 10.1016/j.neuron.2007.09.034; Disney AA, 2006, J COMP NEUROL, V499, P49, DOI 10.1002/cne.21096; Donoghue JP, 1998, J NEUROPHYSIOL, V79, P159, DOI 10.1152/jn.1998.79.1.159; Dotigny F, 2008, NEUROSCIENCE, V154, P1607, DOI 10.1016/j.neuroscience.2008.04.030; Douglas CL, 2002, J NEUROPHYSIOL, V88, P3003, DOI 10.1152/jn.00318.2002; Douglas CL, 2001, J PHARMACOL EXP THER, V299, P960; Engel AK, 2010, CURR OPIN NEUROBIOL, V20, P156, DOI 10.1016/j.conb.2010.02.015; Fell J, 2011, NAT REV NEUROSCI, V12, P105, DOI 10.1038/nrn2979; Frenkel MY, 2006, NEURON, V51, P339, DOI 10.1016/j.neuron.2006.06.026; Fries P, 2009, ANNU REV NEUROSCI, V32, P209, DOI 10.1146/annurev.neuro.051508.135603; Froemke RC, 2015, ANNU REV NEUROSCI, V38, P195, DOI 10.1146/annurev-neuro-071714-034002; Froemke RC, 2013, NAT NEUROSCI, V16, P79, DOI 10.1038/nn.3274; Furey ML, 2000, SCIENCE, V290, P2315, DOI 10.1126/science.290.5500.2315; Gil Z, 1997, NEURON, V19, P679, DOI 10.1016/S0896-6273(00)80380-3; Girman SV, 1999, J NEUROPHYSIOL, V82, P301, DOI 10.1152/jn.1999.82.1.301; Goard M, 2009, NAT NEUROSCI, V12, P1444, DOI 10.1038/nn.2402; Groleau Marianne, 2015, Front Synaptic Neurosci, V7, P10, DOI 10.3389/fnsyn.2015.00010; Groleau M, 2014, NEUROIMAGE, V98, P233, DOI 10.1016/j.neuroimage.2014.05.016; Gu Q, 2003, NEUROBIOL LEARN MEM, V80, P291, DOI 10.1016/S1074-7427(03)00073-X; Gulledge AT, 2009, J NEUROSCI, V29, P9888, DOI 10.1523/JNEUROSCI.1366-09.2009; Hasselmo ME, 2002, NEURAL COMPUT, V14, P793, DOI 10.1162/089976602317318965; Hua TM, 2010, CURR BIOL, V20, P887, DOI 10.1016/j.cub.2010.03.066; Ji D, 2001, NEURON, V31, P131, DOI 10.1016/S0896-6273(01)00332-4; Kang JI, 2014, FRONT SYST NEUROSCI, V8, DOI 10.3389/fnsys.2014.00172; Kang JI, 2014, BRAIN STRUCT FUNCT, V219, P1493, DOI 10.1007/s00429-013-0582-y; Kang JI, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005995; Kaur S, 2004, J NEUROPHYSIOL, V91, P2551, DOI 10.1152/jn.01121.2003; Kimura F, 1999, EUR J NEUROSCI, V11, P3597, DOI 10.1046/j.1460-9568.1999.00779.x; Kocharyan A, 2008, J CEREBR BLOOD F MET, V28, P221, DOI 10.1038/sj.jcbfm.9600558; Konradsson-Geuken A, 2009, SYNAPSE, V63, P1069, DOI 10.1002/syn.20693; Kruglikov I, 2008, NEURON, V58, P911, DOI 10.1016/j.neuron.2008.04.024; Lambe EK, 2003, NEUROPSYCHOPHARMACOL, V28, P216, DOI 10.1038/sj.npp.1300032; Laplante F, 2005, NEUROSCIENCE, V132, P501, DOI 10.1016/j.neuroscience.2004.11.059; Lowet E, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004072; Lucas-Meunier E, 2009, CEREB CORTEX, V19, P2411, DOI 10.1093/cercor/bhn258; Metherate R, 2003, NEUROBIOL LEARN MEM, V80, P285, DOI 10.1016/S1074-7427(03)00062-5; Morishita H, 2010, SCIENCE, V330, P1238, DOI 10.1126/science.1195320; MRZLJAK L, 1993, P NATL ACAD SCI USA, V90, P5194, DOI 10.1073/pnas.90.11.5194; Niedermeyer E, 2005, ELECTROENCEPHALOGRAP, pxiii; Nunez A, 2012, J NEUROPHYSIOL, V108, P1656, DOI 10.1152/jn.00156.2012; Nunez PL, 2006, ELECT FIELDS BRAIN N, pxvi; Pafundo DE, 2013, J PHYSIOL-LONDON, V591, P4725, DOI 10.1113/jphysiol.2013.253823; PAVLIDES C, 1988, BRAIN RES, V439, P383, DOI 10.1016/0006-8993(88)91499-0; Paxinos G., 1995, RAT BRAIN STEREOTAXI; Paxinos G, 1995, RAT NERVOUS SYSTEM, V2nd; Rada EM, 2003, ANESTH ANALG, V96, P108, DOI 10.1097/00000539-200301000-00023; Rodriguez R, 2004, J NEUROSCI, V24, P10369, DOI 10.1523/JNEUROSCI.1839-04.2004; Rokem A, 2010, CURR BIOL, V20, P1723, DOI 10.1016/j.cub.2010.08.027; Roopun AK, 2010, FRONT NEURAL CIRCUIT, V4, DOI 10.3389/fncir.2010.00008; Rouse ST, 2000, NEUROSCI LETT, V284, P182, DOI 10.1016/S0304-3940(00)01011-9; Runyan CA, 2010, NEURON, V67, P847, DOI 10.1016/j.neuron.2010.08.006; Salgado H, 2007, J NEUROPHYSIOL, V98, P952, DOI 10.1152/jn.00060.2007; Santos HR, 2006, J PHARMACOL EXP THER, V319, P376, DOI 10.1124/jpet.106.106385; Sanz B, 1997, NEUROCHEM RES, V22, P281, DOI 10.1023/A:1022486721267; Soma S, 2013, SCI REP-UK, V3, DOI 10.1038/srep01138; Vaucher E, 1997, J CEREBR BLOOD F MET, V17, P686; WESNES K, 1983, NEUROPSYCHOBIOLOGY, V9, P41, DOI 10.1159/000117935; Wilson NR, 2012, NATURE, V488, P343, DOI 10.1038/nature11347; Zinke W, 2006, EUR J NEUROSCI, V24, P314, DOI 10.1111/j.1460-9568.2006.04882.x	74	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2015	10	10							e0141663	10.1371/journal.pone.0141663	http://dx.doi.org/10.1371/journal.pone.0141663			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0ED	26513575	gold, Green Published, Green Submitted			2022-12-26	WOS:000363920300064
J	Li, D; Lu, Y; Sun, P; Feng, LX; Liu, M; Hu, LH; Wu, WY; Jiang, BH; Yang, M; Qu, XB; Guo, DA; Liu, X				Li, Dong; Lu, Yu; Sun, Peng; Feng, Li-Xing; Liu, Miao; Hu, Li-Hong; Wu, Wan-Ying; Jiang, Bao-Hong; Yang, Min; Qu, Xiao-Bo; Guo, De-An; Liu, Xuan			Inhibition on Proteasome beta 1 Subunit Might Contribute to the Anti-Cancer Effects of Fangchinoline in Human Prostate Cancer Cells	PLOS ONE			English	Article							KAPPA-B-ALPHA; RADIX-STEPHANIAE-TETRANDRAE; CYCLE ARREST; CARCINOMA-CELLS; MOLECULAR TARGETS; LEUKEMIA-CELLS; G(1) ARREST; IN-VIVO; APOPTOSIS; EXPRESSION	Fangchinoline is a bisbenzylisoquinoline alkaloid isolated from Radix Stephaniae tetrandrae S. Moore. Fangchinoline and its structure analogue, tetrandrine, exhibited direct binding affinity with recombinant human proteasome beta 1 subunit and also inhibited its activity in vitro. In cultured prostate PC-3 cells and LnCap cells, fangchinoline could dose-dependently inhibit cell proliferation and caspase-like activity of cellular proteasome which was mediated by proteasome beta 1 subunit. The inhibitive effect of fangchinoline on caspase-like activity of proteasome was also observed in purified human erythrocyte 20S proteasome. In PC-3 cells, fangchinoline induced cell cycle arrest at G0/G1 phase and apoptosis. Treatment of PC-3 tumor-bearing nudemice with fangchinoline inhibited tumor growth, induced apoptosis and also caused decrease in proteasome activities in tumor xenografts. Dose-dependent and time-dependent accumulation of ubiquitinated proteins and important proteasome substrates such as p27, Bax and I kappa B-a were observed in fangchinoline-treated cells. Over-expression of proteasome beta 1 subunit by plasmid transfection increased sensitivity of cells to the cytotoxicity of fangchinoline while knockdown of proteasome beta 1 subunit ameliorated cytotoxicity of fangchinoline in PC-3 cells. Results of the present study suggested that proteasome inhibition was involved in the anti-cancer effects of fangchinoline. Fangchinoline and its structure analogues might be new natural proteasome inhibitors targeting beta 1 subunit.	[Li, Dong; Sun, Peng; Feng, Li-Xing; Liu, Miao; Hu, Li-Hong; Wu, Wan-Ying; Jiang, Bao-Hong; Yang, Min; Guo, De-An; Liu, Xuan] Chinese Acad Sci, Shanghai Inst Mat Med, Shanghai 201203, Peoples R China; [Li, Dong; Qu, Xiao-Bo] Changchun Univ Chinese Med, Changchun 130117, Peoples R China; [Lu, Yu] Nanjing Tianyi Biosci Co Ltd, Nanjing 210061, Jiangsu, Peoples R China	Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Changchun University of Chinese Medicine	Guo, DA (corresponding author), Chinese Acad Sci, Shanghai Inst Mat Med, Shanghai 201203, Peoples R China.	daguo@simm.ac.cn; xuanliu@simm.ac.cn	Liu, Xuan/AAR-5093-2020; zhou, ju/M-3255-2017	Liu, Xuan/0000-0002-7356-7898; 	Shanghai Science & Technology Support Program [13431900401]; National Nature Science Foundation of China [81373964]; Shanghai Science & Technology Innovation Action program [15140904800]; National Science & Technology Major Project of China [2014ZX09301-306-03]; Twelfth Five-Year National Science & Technology Support Program [2012BAI29B06]; Nanjing Tianyi Bioscience Co. Ltd	Shanghai Science & Technology Support Program; National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Science & Technology Innovation Action program; National Science & Technology Major Project of China; Twelfth Five-Year National Science & Technology Support Program; Nanjing Tianyi Bioscience Co. Ltd	This work was supported in part by Shanghai Science & Technology Support Program (13431900401), the National Nature Science Foundation of China (81373964), Shanghai Science & Technology Innovation Action program (15140904800), the National Science & Technology Major Project of China (2014ZX09301-306-03), and the Twelfth Five-Year National Science & Technology Support Program (2012BAI29B06). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Nanjing Tianyi Bioscience Co. Ltd, provided support in the form of salaries for authors YL, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Azuma M, 1999, EXP CELL RES, V250, P213, DOI 10.1006/excr.1999.4503; Bedford L, 2011, NAT REV DRUG DISCOV, V10, P29, DOI 10.1038/nrd3321; Chen T, 2014, J NAT MED-TOKYO, V68, P46, DOI 10.1007/s11418-013-0765-0; Chen XL, 2008, CANCER BIOL THER, V7, P1073; Chen Y, 2010, ANTI-CANCER AGENT ME, V10, P534, DOI 10.2174/187152010793498609; Feng L, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.222; Frankland-Searby S, 2012, BBA-REV CANCER, V1825, P64, DOI 10.1016/j.bbcan.2011.10.003; Haas M, 1998, J LEUKOCYTE BIOL, V63, P395, DOI 10.1002/jlb.63.3.395; Huang AC, 2013, INT J ONCOL, V43, P485, DOI 10.3892/ijo.2013.1952; Kuo PL, 2003, LIFE SCI, V73, P243, DOI 10.1016/S0024-3205(03)00266-2; Kwan CY, 2002, ACTA PHARMACOL SIN, V23; Landis-Piwowar Kristin R, 2012, Clin Lab Sci, V25, P38; Lang-Rollin I, 2005, APOPTOSIS, V10, P809, DOI 10.1007/s10495-005-0378-5; Lee JH, 2002, INT J ONCOL, V21, P1239; Li BY, 2000, P NATL ACAD SCI USA, V97, P3850, DOI 10.1073/pnas.070047997; Li XD, 2011, J SURG RES, V166, pE45, DOI 10.1016/j.jss.2010.10.034; Liu BR, 2008, CANCER LETT, V268, P166, DOI 10.1016/j.canlet.2008.03.059; Liu T, 2015, ONCOTARGET, V6, P7992, DOI 10.18632/oncotarget.3505; Liu W, 2015, ASIAN J ANDROL, V17, P850, DOI 10.4103/1008-682X.142134; Liu Wenchao, 2012, Int J Biomed Sci, V8, P28; McCubrey JA, 2008, CANCER BIOL THER, V7, P1079, DOI 10.4161/cbt.7.7.6519; Meng LH, 2004, CANCER RES, V64, P9086, DOI 10.1158/0008-5472.CAN-04-0313; Miao RM, 2013, ZHONGHUA LAO DONG WE, V31, P857; Mozzato-Chamay N, 2001, GENES IMMUN, V2, P153, DOI 10.1038/sj.gene.6363753; Murugan RS, 2010, FOOD CHEM TOXICOL, V48, P3281, DOI 10.1016/j.fct.2010.09.002; Picot J, 2011, HEALTH TECHNOL ASSES, V15, P1, DOI 10.3310/hta15410; Pigneux A, 2007, CANCER BIOL THER, V6, P603, DOI 10.4161/cbt.6.4.4226; Rastogi N, 2012, CELL DIV, V7, DOI 10.1186/1747-1028-7-26; Shen YC, 2001, MOL PHARMACOL, V60, P1083, DOI 10.1124/mol.60.5.1083; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Siegel DS, 2013, THER ADV HEMATOL, V4, P354, DOI 10.1177/2040620713511176; Sun YF, 2014, PHYTOMEDICINE, V21, P1110, DOI 10.1016/j.phymed.2014.04.029; Tambyrajah WS, 2007, ARCH BIOCHEM BIOPHYS, V466, P186, DOI 10.1016/j.abb.2007.07.019; Tan W, 2014, ANAL METHODS-UK, V6, P8476, DOI 10.1039/c4ay01881h; Wang CD, 2014, ASIAN PAC J CANCER P, V15, P769, DOI 10.7314/APJCP.2014.15.2.769; Wang CD, 2010, BIOSCI BIOTECH BIOCH, V74, P488, DOI 10.1271/bbb.90490; Wang HQ, 2015, CELL BIOSCI, V5, DOI 10.1186/2045-3701-5-4; Wang N, 2011, BRIT J PHARMACOL, V164, P731, DOI 10.1111/j.1476-5381.2011.01349.x; Wang YP, 2013, EXP THER MED, V5, P1105, DOI 10.3892/etm.2013.924; Wang ZB, 2002, J SURG RES, V102, P198, DOI 10.1006/jsre.2001.6320; Weathington NM, 2014, J CLIN INVEST, V124, P6, DOI 10.1172/JCI71602; Wojcik S, 2013, FOLIA HISTOCHEM CYTO, V51, P249, DOI 10.5603/FHC.2013.0036; Wong TM, 2000, ACTA PHARMACOL SIN, V21, P1083; Wu JM, 2010, CANCER LETT, V287, P187, DOI 10.1016/j.canlet.2009.06.009; Wu K, 2015, INT J ONCOL, V46, P1205, DOI 10.3892/ijo.2014.2800; Wu S, 2001, LIFE SCI, V68, P2853, DOI 10.1016/S0024-3205(01)01068-2; Xiao WK, 2015, INT J ONCOL, V46, P360, DOI 10.3892/ijo.2014.2735; Xing ZB, 2011, CHEM PHARM BULL, V59, P1476, DOI 10.1248/cpb.59.1476; Xing ZB, 2013, PHYTOTHER RES, V27, P1790, DOI 10.1002/ptr.4936; Yerlikaya A, 2012, RECENT PATENTS ANTIC; Yu J, 2003, CANCER BIOL THER, V2, P694; Yuan FQ, 2013, BIOSCIENCE REP, V33, P555, DOI 10.1042/BSR20130013; Yue QX, 2008, CANCER SCI, V99, P1461, DOI 10.1111/j.1349-7006.2008.00824.x; Yue QX, 2008, MOL CELL PROTEOMICS, V7, P949, DOI 10.1074/mcp.M700259-MCP200; Zhang HG, 2004, ONCOGENE, V23, P2009, DOI 10.1038/sj.onc.1207373; Zhang YX, 2015, CANCER BIOL THER, V16, P965, DOI 10.1080/15384047.2015.1040950	56	9	9	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2015	10	10							e0141681	10.1371/journal.pone.0141681	http://dx.doi.org/10.1371/journal.pone.0141681			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0ED	26512898	Green Published, gold, Green Submitted			2022-12-26	WOS:000363920300068
J	Nanvubya, A; Ssempiira, J; Mpendo, J; Ssetaala, A; Nalutaaya, A; Wambuzi, M; Kitandwe, P; Bagaya, BS; Welsh, S; Asiimwe, S; Nielsen, L; Makumbi, F; Kiwanuka, N				Nanvubya, Annet; Ssempiira, Julius; Mpendo, Juliet; Ssetaala, Ali; Nalutaaya, Annet; Wambuzi, Mathias; Kitandwe, Paul; Bagaya, Bernard S.; Welsh, Sabrina; Asiimwe, Stephen; Nielsen, Leslie; Makumbi, Fredrick; Kiwanuka, Noah			Use of Modern Family Planning Methods in Fishing Communities of Lake Victoria, Uganda	PLOS ONE			English	Article							UNMET NEED; HIV; RISK; PATTERNS	Introduction Fishing communities (FCs) in Uganda have high HIV infection rates but poor access to health services including family planning (FP). Although FP is a cost-effective public health intervention, there is a paucity of data on knowledge and use of modern FP in FCs. This study determined knowledge and use of modern FP methods in FCs of Uganda. Methods Data were accrued from a 12-month follow up of 1,688 HIV-uninfected individuals, 18-49 years from 8 FCs along Lake Victoria, between September 2011 and March 2013. Data on knowledge and use of modern FP were collected through a semi-structured questionnaire. Prevalence Risk Ratios with corresponding 95% CIs were used to determine factors associated with Modern FP knowledge and use. Results The mean age was 31.4 years, with nearly half (48.8%) being females while more than half (58.6%) had attained up to primary education level. Knowledge of modern FP was high, 87.5% (1477/1688); significantly higher among females [adj. PRR = 4.84 (95% CI; 3.08, 7.61)], among older respondents (25-29 years) [adj. PRR = 1.83 (95% CI; 1.12, 2.99)] compared to younger ones (18-24 years) and among those conducting business [adj. PRR = 2.42(95% CI; 1.02, 5.74)] relative to those primarily in fishing. Just over a third (35.2%, 595/ 1688) reported use of at least one modern FP method. Use of modern FP methods was significantly higher among females [adj. PRR = 2.04 (95% CI; 1.56, 2.65, and among those reporting multiple sexual partnerships [adj. PRR = 2.12, 95% CI; 1.63, 2.76)]. Nonuse of modern methods was mostly due to desire for more children (30.6%), fear of side effects (12.2%) and partner refusal (5.2%). Conclusion Despite their high knowledge of FP, FCs have low use of modern FP methods. Key barriers to use of modern FP methods were high fertility desires, fear of perceived side effects and partner refusal of methods.	[Nanvubya, Annet; Ssempiira, Julius; Mpendo, Juliet; Ssetaala, Ali; Nalutaaya, Annet; Wambuzi, Mathias; Kitandwe, Paul; Bagaya, Bernard S.; Kiwanuka, Noah] UVRI IAVI HIV Vaccine Program, Entebbe, Uganda; [Asiimwe, Stephen] KCRC, Kabwohe, Uganda; [Welsh, Sabrina; Nielsen, Leslie] Int AIDS Vaccine Initiat, New York, NY USA; [Makumbi, Fredrick; Kiwanuka, Noah] Makerere Univ, Coll Hlth Sci, Sch Publ Hlth, Kampala, Uganda	International AIDS Vaccine Initiative; International AIDS Vaccine Initiative; Makerere University	Nanvubya, A (corresponding author), UVRI IAVI HIV Vaccine Program, Entebbe, Uganda.	ananvubya@iavi.or.ug	Ssetaala, Ali/AAB-3832-2020	Ssetaala, Ali/0000-0003-2156-3024; Ssentalo Bagaya, Bernard/0000-0002-3847-2615	Training Health Researchers into Vocational Excellence in East Africa Project [087540]; Canada-Africa Prevention Trials Network [1063357-001]; International AIDS Vaccine Initiative, USA	Training Health Researchers into Vocational Excellence in East Africa Project; Canada-Africa Prevention Trials Network; International AIDS Vaccine Initiative, USA	This study was supported by the Training Health Researchers into Vocational Excellence in East Africa Project, (http://thrive.or.ug) Grant Number 087540, NK received funding; Canada-Africa Prevention Trials Network, (www.captnetwork.org), Grant number 1063357-001, NK received funding; This work was made possible in part by the generous support of the International AIDS Vaccine Initiative, USA. The funders had no role in study design and data collection.	Asiki G., 2011, SEX TRANSM DIS, V256, P1; Asiki G, 2013, VACCINE, V31, P5055, DOI 10.1016/j.vaccine.2013.08.080; Bakibinga P, 2016, J RELIG HEALTH, V55, P192, DOI 10.1007/s10943-015-0030-9; Beekle AT, 2006, INT NURS REV, V53, P269, DOI 10.1111/j.1466-7657.2006.00492.x; Bhujel R. C., 2008, Development (London), V51, P259, DOI 10.1057/dev.2008.11; Darroch JE, CONTRACEPTIVE TECHNO; FAO, 2005, NEW DIR FISH SER POL, P2; Gebrekidan Mesfin, 2002, Ethiopian Journal of Health Development, V16, P247; Giusti C, 2006, STAT METHODS APPT, V15, P89, DOI DOI 10.1007/S10260-006-0010-Z; Haque N., 2010, INT J CURR RES, V9, P29; Khan S, 2005, STRENGTHENING FAMILY; Khan SM., 2008, UNMET NEED DEMAND FA; Kissling E, 2005, AIDS, V19, P1939, DOI 10.1097/01.aids.0000191925.54679.94; Kiwanuka N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094932; Kiwanuka N, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.1.18621; Lutalo T, 1995, TRENDS DETERMINANTS, V31, P217; Lutalo T, 2013, AIDS, V27, pS27, DOI 10.1097/QAD.0000000000000045; Odimegwu CO, 1999, INT FAM PLAN PERSPEC, V25, P86, DOI 10.2307/2991946; Omo-Aghoja L O, 2009, Ghana Med J, V43, P115; Opio A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070770; Pickering H, 1997, Health Transit Rev, V7, P13; SCHENKER JG, 1993, HUM REPROD, V8, P969, DOI 10.1093/oxfordjournals.humrep.a138176; Seeley J, 2012, SEX TRANSM DIS, V39, P433, DOI 10.1097/OLQ.0b013e318251555d; Seeley J, 2009, ANTHROPOL WORK REV, V30, P66, DOI 10.1111/j.1548-1417.2009.01022.x; SERWADDA D, 1985, LANCET, V2, P849, DOI 10.1016/S0140-6736(85)90122-9; Tilahun T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061335; Tumwesigye NM, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-1069; UBOS, 2011, UG HLTH DEM SURV; United Nations Department of Economic and Social Affairs PD, 2014, WORLD CONTR US; Wanyenze RK, 2015, BMC WOMENS HEALTH, V15, DOI 10.1186/s12905-014-0158-x; Wolff B, 2000, STUD FAMILY PLANN, V31, P124, DOI 10.1111/j.1728-4465.2000.00124.x; World Bank, 2014, UNM NEED CONTR MARR	32	8	8	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2015	10	10							e0141531	10.1371/journal.pone.0141531	http://dx.doi.org/10.1371/journal.pone.0141531			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0ED	26512727	gold, Green Submitted, Green Published			2022-12-26	WOS:000363920300047
J	Raman, G; Park, S				Raman, Gurusamy; Park, SeonJoo			Analysis of the Complete Chloroplast Genome of a Medicinal Plant, Dianthus superbus var. longicalyncinus, from a Comparative Genomics Perspective	PLOS ONE			English	Article							COMPLETE NUCLEOTIDE-SEQUENCE; PROTEIN-CODING GENES; RNA EDITING SITES; PLASTID GENOME; MESSENGER-RNAS; EVOLUTION; DNA; MULTIPLE; CONSERVATION; LOSSES	Dianthus superbus var. longicalycinus is an economically important traditional Chinese medicinal plant that is also used for ornamental purposes. In this study, D. superbus was compared to its closely related family of Caryophyllaceae chloroplast (cp) genomes such as Lychnis chalcedonica and Spinacia oleracea. D. superbus had the longest large single copy (LSC) region (82,805 bp), with some variations in the inverted repeat region A (IRA)/LSC regions. The IRs underwent both expansion and constriction during evolution of the Caryophyllaceae family; however, intense variations were not identified. The pseudogene ribosomal protein subunit S19 (rps19) was identified at the IRA/LSC junction, but was not present in the cp genome of other Caryophyllaceae family members. The translation initiation factor IF-1 (infA) and ribosomal protein subunit L23 (rpl23) genes were absent from the Dianthus cp genome. When the cp genome of Dianthus was compared with 31 other angiosperm lineages, the infA gene was found to have been lost in most members of rosids, solanales of asterids and Lychnis of Caryophyllales, whereas rpl23 gene loss or pseudogization had occurred exclusively in Caryophyllales. Nevertheless, the cp genome of Dianthus and Spinacia has two introns in the proteolytic subunit of ATP-dependent protease (clpP) gene, but Lychnis has lost introns from the clpP gene. Furthermore, phylogenetic analysis of individual protein-coding genes infA and rpl23 revealed that gene loss or pseudogenization occurred independently in the cp genome of Dianthus. Molecular phylogenetic analysis also demonstrated a sister relationship between Dianthus and Lychnis based on 78 protein-coding sequences. The results presented herein will contribute to studies of the evolution, molecular biology and genetic engineering of the medicinal and ornamental plant, D. superbus var. longicalycinus.	[Raman, Gurusamy; Park, SeonJoo] Yeungnam Univ, Dept Life Sci, Gyongsan, Gyeongsan Buk, South Korea	Yeungnam University	Park, S (corresponding author), Yeungnam Univ, Dept Life Sci, Gyongsan, Gyeongsan Buk, South Korea.	sjpark01@ynu.ac.kr	G, Raman/E-8452-2011	G, Raman/0000-0003-3956-4244	National Research Foundation of Korea (KRF) - Korean Government (KRF), South Korea [2012R1A1A2004996]; Research Center for the Policy Suggestion of the Ministry of Educational Science	National Research Foundation of Korea (KRF) - Korean Government (KRF), South Korea; Research Center for the Policy Suggestion of the Ministry of Educational Science	This work was supported by a National Research Foundation of Korea (KRF) grant funded by the Korean Government (KRF, No. 2012R1A1A2004996), South Korea and the Research Center for the Policy Suggestion of the Ministry of Educational Science (2014).	Adams KL, 2000, NATURE, V408, P354, DOI 10.1038/35042567; Bock R, 2004, TRENDS BIOTECHNOL, V22, P311, DOI 10.1016/j.tibtech.2004.03.005; BUBUNENKO MG, 1994, J MOL BIOL, V240, P28, DOI 10.1006/jmbi.1994.1415; BURKE DH, 1993, P NATL ACAD SCI USA, V90, P7134, DOI 10.1073/pnas.90.15.7134; Callaway E, 2013, NATURE NEWS; Chen HY, 2011, J INTEGR PLANT BIOL, V53, P961, DOI 10.1111/j.1744-7909.2011.01082.x; CLEMENT JP, 1994, COLL CRIBLES, P247; Corneille S, 2000, MOL GEN GENET, V264, P419, DOI 10.1007/s004380000295; Cuenoud P, 2002, AM J BOT, V89, P132, DOI 10.3732/ajb.89.1.132; Darling ACE, 2004, GENOME RES, V14, P1394, DOI 10.1101/gr.2289704; Day Anil, 2007, V19, P65, DOI 10.1007/4735_2007_0231; Downie S, 1992, MOL SYSTEMATICS PLAN, P14, DOI DOI 10.1007/978-1-4615-3276-7_2; DOWNIE SR, 1994, CURR GENET, V25, P367, DOI 10.1007/BF00351492; DOWNIE SR, 1991, EVOLUTION, V45, P1245, DOI [10.2307/2409731, 10.1111/j.1558-5646.1991.tb04390.x]; Erixon P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001386; Frazer KA, 2004, NUCLEIC ACIDS RES, V32, pW273, DOI 10.1093/nar/gkh458; Funk HT, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-45; GANTT JS, 1991, EMBO J, V10, P3073, DOI 10.1002/j.1460-2075.1991.tb07859.x; Goulding SE, 1996, MOL GEN GENET, V252, P195, DOI 10.1007/BF02173220; GRAY MW, 1993, FASEB J, V7, P64, DOI 10.1096/fasebj.7.1.8422976; Haston E, 2009, BOT J LINN SOC, V161, P128, DOI 10.1111/j.1095-8339.2009.00996.x; HIRATSUKA J, 1989, MOL GEN GENET, V217, P185, DOI 10.1007/BF02464880; Hirose T, 1999, MOL GEN GENET, V262, P462, DOI 10.1007/s004380051106; Hollingsworth PM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019254; Hupfer H, 2000, MOL GEN GENET, V263, P581, DOI 10.1007/s004380051204; Jansen RK, 2008, MOL PHYLOGENET EVOL, V48, P1204, DOI 10.1016/j.ympev.2008.06.013; Jansen RK, 2007, P NATL ACAD SCI USA, V104, P19369, DOI 10.1073/pnas.0709121104; Katoh Kazutaka, 2013, Mol Biol Evol, V30, P772, DOI 10.1093/molbev/mst010; Kimura M., 1983, NEUTRAL THEORY MOL E; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee HL, 2007, MOL BIOL EVOL, V24, P1161, DOI 10.1093/molbev/msm036; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Logacheva MD, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-59; Lopez Exposito I, 2011, CHIN MED, V6, P35, DOI [10.1186/1749-8546-6-35, DOI 10.1186/1749-8546-6-35]; Lutz KA, 2001, CURR GENET, V40, P214, DOI 10.1007/s002940100242; MAIER RM, 1995, J MOL BIOL, V251, P614, DOI 10.1006/jmbi.1995.0460; Makalowski W, 1998, P NATL ACAD SCI USA, V95, P9407, DOI 10.1073/pnas.95.16.9407; Martin W, 1998, NATURE, V393, P162, DOI 10.1038/30234; Mayer C, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-277; Millen RS, 2001, PLANT CELL, V13, P645, DOI 10.1105/tpc.13.3.645; Mower JP, 2009, NUCLEIC ACIDS RES, V37, pW253, DOI 10.1093/nar/gkp337; NAGANO Y, 1991, CURR GENET, V20, P431, DOI 10.1007/BF00317074; NECKERMANN K, 1994, GENE, V146, P177, DOI 10.1016/0378-1119(94)90290-9; Neuhaus HE, 2000, ANNU REV PLANT PHYS, V51, P111, DOI 10.1146/annurev.arplant.51.1.111; Neyland R, 1996, AM J BOT, V83, P1195, DOI 10.2307/2446204; OSHIMA Y, 1984, PLANTA MED, V50, P254, DOI 10.1055/s-2007-969692; Palmer JD, 2000, P NATL ACAD SCI USA, V97, P6960, DOI 10.1073/pnas.97.13.6960; PALMER JD, 1982, CELL, V29, P537, DOI 10.1016/0092-8674(82)90170-2; Perry AS, 2002, J MOL EVOL, V55, P501, DOI 10.1007/s00239-002-2333-y; POWELL W, 1995, P NATL ACAD SCI USA, V92, P7759, DOI 10.1073/pnas.92.17.7759; Raman G, 2014, MITOCHONDR DNA, V29, P1; Raubeson L. A., 2005, Plant diversity and evolution: genotypic and phenotypic variation in higher plants, P45, DOI 10.1079/9780851999043.0045; Sato S, 1999, DNA Res, V6, P283, DOI 10.1093/dnares/6.5.283; Schmitz-Linneweber C, 2001, PLANT MOL BIOL, V45, P307, DOI 10.1023/A:1006478403810; Shin IS, 2012, J INFLAMM-LOND, V9, DOI 10.1186/1476-9255-9-41; SHINOZAKI K, 1986, EMBO J, V5, P2043, DOI 10.1002/j.1460-2075.1986.tb04464.x; Sloan DB, 2014, MOL PHYLOGENET EVOL, V72, P82, DOI 10.1016/j.ympev.2013.12.004; Smith JF, 2000, AM J BOT, V87, P883, DOI 10.2307/2656896; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; THOMAS F, 1988, NUCLEIC ACIDS RES, V16, P2461, DOI 10.1093/nar/16.6.2461; Tillich M, 2006, MOL BIOL EVOL, V23, P1912, DOI 10.1093/molbev/msl054; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Vasil IK, 1991, CELL CULTURE SOMAT A, V7a, P5, DOI DOI 10.1016/B978-0-12-715007-9.50009-8; Wakasugi T, 1996, P NATL ACAD SCI USA, V93, P8766, DOI 10.1073/pnas.93.16.8766; Wang YC, 1998, PHYTOCHEMISTRY, V49, P1453, DOI 10.1016/S0031-9422(97)00857-1; Wicke S, 2011, PLANT MOL BIOL, V76, P273, DOI 10.1007/s11103-011-9762-4; WOLFE KH, 1992, P NATL ACAD SCI USA, V89, P10648, DOI 10.1073/pnas.89.22.10648; WOLFE KH, 1992, J MOL EVOL, V35, P304, DOI 10.1007/BF00161168; Wu C.Y., 1996, FLORA REIPUBLICAE PO, V26, P47; Wu CS, 2007, MOL BIOL EVOL, V24, P1366, DOI 10.1093/molbev/msm059; Wu ZY, 1995, FLORA YUNNANICA, P125; Zandueta-Criado A, 2004, NUCLEIC ACIDS RES, V32, P542, DOI 10.1093/nar/gkh217; ZURAWSKI G, 1987, ANNU REV PLANT PHYS, V38, P391, DOI 10.1146/annurev.pp.38.060187.002135	74	46	48	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2015	10	10							e0141329	10.1371/journal.pone.0141329	http://dx.doi.org/10.1371/journal.pone.0141329			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0ED	26513163	Green Submitted, gold, Green Published			2022-12-26	WOS:000363920300030
J	Celen, I; Ross, KE; Arighi, CN; Wu, CH				Celen, Irem; Ross, Karen E.; Arighi, Cecilia N.; Wu, Cathy H.			Bioinformatics Knowledge Map for Analysis of Beta-Catenin Function in Cancer	PLOS ONE			English	Article							CYCLIN-DEPENDENT KINASE-5; POSTTRANSLATIONAL MODIFICATIONS; ANDROGEN RECEPTOR; PROTEIN ONTOLOGY; ACTIVATION; CELLS; CDK5; PHOSPHORYLATION; RESOURCE; NETWORK	Given the wealth of bioinformatics resources and the growing complexity of biological information, it is valuable to integrate data from disparate sources to gain insight into the role of genes/proteins in health and disease. We have developed a bioinformatics framework that combines literature mining with information from biomedical ontologies and curated databases to create knowledge "maps" of genes/proteins of interest. We applied this approach to the study of beta-catenin, a cell adhesion molecule and transcriptional regulator implicated in cancer. The knowledge map includes post-translational modifications (PTMs), protein-protein interactions, disease-associated mutations, and transcription factors co-activated by beta-catenin and their targets and captures the major processes in which beta-catenin is known to participate. Using the map, we generated testable hypotheses about beta-catenin biology in normal and cancer cells. By focusing on proteins participating in multiple relation types, we identified proteins that may participate in feedback loops regulating beta-catenin transcriptional activity. By combining multiple network relations with PTM proteoform-specific functional information, we proposed a mechanism to explain the observation that the cyclin dependent kinase CDK5 positively regulates beta-catenin co-activator activity. Finally, by overlaying cancer-associated mutation data with sequence features, we observed mutation patterns in several beta-catenin PTM sites and PTM enzyme binding sites that varied by tissue type, suggesting multiple mechanisms by which beta-catenin mutations can contribute to cancer. The approach described, which captures rich information for molecular species from genes and proteins to PTM proteoforms, is extensible to other proteins and their involvement in disease.	[Celen, Irem; Ross, Karen E.; Arighi, Cecilia N.; Wu, Cathy H.] Univ Delaware, Ctr Bioinformat & Computat Biol, Newark, DE 19716 USA; [Ross, Karen E.] Georgetown Univ, Med Ctr, Dept Biochem & Mol & Cellular Biol, Washington, DC 20007 USA	University of Delaware; Georgetown University	Ross, KE (corresponding author), Univ Delaware, Ctr Bioinformat & Computat Biol, Newark, DE 19716 USA.	ross@dbi.udel.edu	Celen, Irem/K-5329-2019; Arighi, Cecilia N/J-2381-2015	Arighi, Cecilia N/0000-0002-0803-4817; Wu, Cathy/0000-0001-6379-8601	Republic of Turkey Ministry of National Education; National Science Foundation [ABI-1062520]; National Institutes of Health [5R01GM080646, P20GM103446]; Div Of Biological Infrastructure [1062520] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080646, P20GM103446, R13GM109648] Funding Source: NIH RePORTER	Republic of Turkey Ministry of National Education(Ministry of National Education - Turkey); National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	IC acknowledges Republic of Turkey Ministry of National Education for funding her during Master's studies. This work has been supported by the National Science Foundation (grant number: ABI-1062520 to CHW) and the National Institutes of Health (grant number: 5R01GM080646 and P20GM103446 to CHW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arend RC, 2013, GYNECOL ONCOL, V131, P772, DOI 10.1016/j.ygyno.2013.09.034; Bateman A, 2015, NUCLEIC ACIDS RES, V43, pD204, DOI 10.1093/nar/gku989; Blake JA, 2015, NUCLEIC ACIDS RES, V43, pD1049, DOI 10.1093/nar/gku1179; Cervenka I, 2011, MOL CELL BIOL, V31, P179, DOI 10.1128/MCB.00550-10; Cheung ZH, 2012, TRENDS CELL BIOL, V22, P169, DOI 10.1016/j.tcb.2011.11.003; Contreras-Vallejos E, 2012, CELL SIGNAL, V24, P44, DOI 10.1016/j.cellsig.2011.08.022; Dinkel H, 2011, NUCLEIC ACIDS RES, V39, pD261, DOI 10.1093/nar/gkq1104; Evrard-Todeschi N, 2008, J CHEM INF MODEL, V48, P2350, DOI 10.1021/ci800248u; Feldmann G, 2010, CANCER RES, V70, P4460, DOI 10.1158/0008-5472.CAN-09-1107; Forbes SA, 2015, NUCLEIC ACIDS RES, V43, pD805, DOI 10.1093/nar/gku1075; Herbst A, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-74; Hornbeck PV, 2012, NUCLEIC ACIDS RES, V40, pD261, DOI 10.1093/nar/gkr1122; Hovanes K, 2001, NAT GENET, V28, P53, DOI 10.1038/88264; Hsu FN, 2011, J BIOL CHEM, V286, P33141, DOI 10.1074/jbc.M111.252080; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jensen LJ, 2009, NUCLEIC ACIDS RES, V37, pD412, DOI 10.1093/nar/gkn760; Lang D, 2005, NATURE, V433, P884, DOI 10.1038/nature03292; Li BS, 2003, J BIOL CHEM, V278, P35702, DOI 10.1074/jbc.M302004200; Li QJ, 2004, J BIOL CHEM, V279, P45669, DOI 10.1074/jbc.M405025200; Li Y, 2003, CANCER BIOL THER, V2, P187, DOI 10.4161/cbt.2.2.282; Lin H, 2007, J BIOL CHEM, V282, P2776, DOI 10.1074/jbc.M607234200; Liu L, 2012, AM J PHYSIOL-CELL PH, V302, pC277, DOI 10.1152/ajpcell.00341.2011; Lu CT, 2013, NUCLEIC ACIDS RES, V41, pD295, DOI 10.1093/nar/gks1229; Maher MT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010184; Monga SPS, 2002, CANCER RES, V62, P2064; Natale DA, 2014, NUCLEIC ACIDS RES, V42, pD415, DOI 10.1093/nar/gkt1173; Ni M, 2011, CANCER CELL, V20, P119, DOI 10.1016/j.ccr.2011.05.026; Orchard S, 2014, NUCLEIC ACIDS RES, V42, pD358, DOI 10.1093/nar/gkt1115; Pan Q, 2011, CELL MOL LIFE SCI, V68, P3425, DOI 10.1007/s00018-011-0638-1; Polakis P, 2007, CURR OPIN GENET DEV, V17, P45, DOI 10.1016/j.gde.2006.12.007; Prasad TSK, 2009, NUCLEIC ACIDS RES, V37, pD767, DOI 10.1093/nar/gkn892; PUISIEUX A, 1991, CANCER RES, V51, P6185; Rashid T, 2001, J BIOL CHEM, V276, P49043, DOI 10.1074/jbc.M105599200; Ross K, 2014, P 5 INT C BIOM ONT I, P43; Ross KE, 2013, DATABASE-OXFORD, DOI 10.1093/database/bat038; Ross Karen E., 2013, Frontiers in Genetics, V4, P62, DOI 10.3389/fgene.2013.00062; Safran M, 2010, DATABASE-OXFORD, DOI 10.1093/database/baq020; Schaefer U, 2011, NUCLEIC ACIDS RES, V39, pD106, DOI 10.1093/nar/gkq945; Schuman EM, 2003, PHILOS T ROY SOC B, V358, P749, DOI 10.1098/rstb.2002.1256; Smith LM, 2013, NAT METHODS, V10, P186, DOI 10.1038/nmeth.2369; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Torii M, 2014, DATABASE-OXFORD, DOI 10.1093/database/bau081; Tudor CO, 2015, DATABASE-OXFORD, DOI 10.1093/database/bav020; Valenta T, 2012, EMBO J, V31, P2714, DOI 10.1038/emboj.2012.150; van der Horst PH, 2012, MOL CELL ENDOCRINOL, V358, P176, DOI 10.1016/j.mce.2011.06.010	45	6	6	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2015	10	10							e0141773	10.1371/journal.pone.0141773	http://dx.doi.org/10.1371/journal.pone.0141773			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0DL	26509276	Green Submitted, Green Published, gold			2022-12-26	WOS:000363918100130
J	Altara, R; Gu, YM; Struijker-Boudier, HAJ; Thijs, L; Staessen, JA; Blankesteijn, WM				Altara, Raffaele; Gu, Yu-Mei; Struijker-Boudier, Harry A. J.; Thijs, Lutgarde; Staessen, Jan A.; Blankesteijn, W. Matthijs			Left Ventricular Dysfunction and CXCR3 Ligands in Hypertension: From Animal Experiments to a Population-Based Pilot Study	PLOS ONE			English	Article							HIGH SERUM-LEVELS; HEART-FAILURE; TASK-FORCE; BIOMARKERS; CHEMOKINES; INFLAMMATION; PREVALENCE; PREDICTION; GUIDELINES; COMMITTEE	Detecting left ventricular (LV) dysfunction at an early stage is key in addressing the heart failure epidemic. In proteome profiling experiments in mice subjected either to aortic banding or sham, the circulating CXCR3 ligands monokine induced by interferon-gamma (MIG) and interferon-gamma inducible protein 10 (IP10) were 5 to 40 fold up-regulated at eight weeks. We assessed the diagnostic value of circulating NT-pro BNP and CXCR3 ligands (MIG, IP10, Interferon-inducible T-cell alpha chemo-attractant [I-TAC]) in patients with hypertension (>= 140/90 mm Hg) associated with subclinical (n = 19) or symptomatic (n = 16) diastolic LV dysfunction on echocardiography and healthy controls. NT-pro BNP, MIG, IP10, I-TAC all increased (p <= 0.014) across the categories of worsening left ventricular dysfunction. In patients with symptomatic disease, MIG, IP10, and I-TAC increased 210% (p = 0.015), 140% (p = 0.007) and 120% (p = 0.035) more than NT-pro BNP. The optimal discrimination limits, obtained by maximizing Youden's index were 246 pmol/L, 65 pg/mL, 93 pg/mL, and 24 pg/mL, respectively. The odds ratios associated with the four biomarkers were significant (p <= 0.010), ranging from 4.00 for IP10 to 9.69 for MIG. With adjustment for NT-pro BNP, the CXCR3 ligands retained significance (p <= 0.028). Adding optimized thresholds for the CXCR3 ligands to NT-pro BNP enhanced (p <= 0.014) the integrated discrimination improvement and the net reclassification improvement. In conclusion, congruent with the concept that inflammation plays a key role in the pathogenesis of LV dysfunction, MIG, IP10 and I-TAC add diagnostic accuracy over and beyond NT-pro BNP.	[Altara, Raffaele; Struijker-Boudier, Harry A. J.; Blankesteijn, W. Matthijs] Maastricht Univ, Cardiovasc Res Inst Maastricht, Dept Pharmacol & Toxicol, NL-6200 MD Maastricht, Netherlands; [Gu, Yu-Mei; Thijs, Lutgarde; Staessen, Jan A.] Univ Leuven, Res Unit Hypertens & Cardiovasc Epidemiol, Studies Coordinating Ctr, KU Leuven,Dept Cardiovasc Sci, Leuven, Belgium; [Staessen, Jan A.] Maastricht Univ, VitaK Res & Dev, NL-6200 MD Maastricht, Netherlands	Maastricht University; KU Leuven; Maastricht University	Blankesteijn, WM (corresponding author), Maastricht Univ, Cardiovasc Res Inst Maastricht, Dept Pharmacol & Toxicol, NL-6200 MD Maastricht, Netherlands.	wm.blankesteijn@maastrichtuniversity.nl	Altara, Raffaele/ABE-1603-2020; Staessen, Jan A/A-1065-2011; Altara, Raffaele/P-8515-2017	Staessen, Jan A/0000-0002-3026-1637; Altara, Raffaele/0000-0001-5590-6529; Thijs, Lutgarde/0000-0002-8108-2356	Center for Translational Molecular Medicine [01C-103]; Dutch Heart Foundation; European Union [HEALTH-2011.2.4.2-2-EU-MASCARA, HEALTH-F7-305507 HOMAGE]; European Research Council Advanced Researcher [Grant-2011-294713-EPLORE]; Fonds voor Wetenschappelijk Onderzoek Vlaanderen, Ministry of the Flemish Community, Brussels, Belgium [G.0881.13, G.088013]; International Zinc and Lead Research Organization	Center for Translational Molecular Medicine; Dutch Heart Foundation(Netherlands Heart Foundation); European Union(European Commission); European Research Council Advanced Researcher; Fonds voor Wetenschappelijk Onderzoek Vlaanderen, Ministry of the Flemish Community, Brussels, Belgium(FWO); International Zinc and Lead Research Organization	The experimental work was partly supported by the Center for Translational Molecular Medicine (http://www.ctmm.nl; TRIUMPH grant 01C-103) and the Dutch Heart Foundation. The European Union (HEALTH-2011.2.4.2-2-EU-MASCARA, HEALTH-F7-305507 HOMAGE and the European Research Council Advanced Researcher Grant-2011-294713-EPLORE), the Fonds voor Wetenschappelijk Onderzoek Vlaanderen, Ministry of the Flemish Community, Brussels, Belgium (G.0881.13 and G.088013), and the International Zinc and Lead Research Organization currently support the Studies Coordinating Centre in Leuven.	Altara R, 2014, BMC BIOTECHNOL, V14, DOI 10.1186/1472-6750-14-63; Antonelli A, 2008, J HUM HYPERTENS, V22, P579, DOI 10.1038/jhh.2008.15; Antonelli A, 2012, INT J IMMUNOPATH PH, V25, P387, DOI 10.1177/039463201202500208; Bozkurt B, 2010, HEART FAIL REV, V15, P331, DOI 10.1007/s10741-009-9140-3; Braunwald E, 2008, NEW ENGL J MED, V358, P2148, DOI 10.1056/NEJMra0800239; Bujak M, 2009, CIRC RES, V105, P973, DOI 10.1161/CIRCRESAHA.109.199471; Coggins M, 2012, CIRC RES, V110, P116, DOI 10.1161/CIRCRESAHA.111.243196; De Celle T, 2004, EXP PHYSIOL, V89, P605, DOI 10.1113/expphysiol.2004.027649; Dunlay Shannon M, 2014, Curr Heart Fail Rep, V11, P404, DOI 10.1007/s11897-014-0220-x; El Assaad MA, 2003, BLOOD PRESS MONIT, V8, P127, DOI 10.1097/00126097-200306000-00006; Expert Committee on the Diagnosis and Classification of Diabetes Mellitus, 2006, DIABETES CARE S1, V26, pS5; Farber JM, 1997, J LEUKOCYTE BIOL, V61, P246, DOI 10.1002/jlb.61.3.246; Frangogiannis NG, 2012, CIRC RES, V110, P159, DOI 10.1161/CIRCRESAHA.111.243162; Gerszten RE, 2008, NATURE, V451, P949, DOI 10.1038/nature06802; Gottdiener JS, 2004, J AM SOC ECHOCARDIOG, V17, P1086, DOI 10.1016/j.echo.2004.07.013; Groom JR, 2011, IMMUNOL CELL BIOL, V89, P207, DOI 10.1038/icb.2010.158; Hedayat M, 2010, HEART FAIL REV, V15, P543, DOI 10.1007/s10741-010-9168-4; Heijnen BFJ, 2014, J RENIN-ANGIO-ALDO S, V15, P69, DOI 10.1177/1470320313480537; Jarr KU, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/576482; Kaur K, 2009, HEART FAIL REV, V14, P113, DOI 10.1007/s10741-008-9104-z; Kuznetsova T, 2012, EUR HEART J, V33, P2342, DOI 10.1093/eurheartj/ehs185; Kuznetsova T, 2009, CIRC-HEART FAIL, V2, P105, DOI 10.1161/CIRCHEARTFAILURE.108.822627; Lacotte S, 2009, ANN NY ACAD SCI, V1173, P310, DOI 10.1111/j.1749-6632.2009.04813.x; LEVINE B, 1990, NEW ENGL J MED, V323, P236, DOI 10.1056/NEJM199007263230405; Li Y, 2007, HYPERTENSION, V49, P1291, DOI 10.1161/HYPERTENSIONAHA.106.085498; Lopez B, 2010, CIRCULATION, V121, P1645, DOI 10.1161/CIRCULATIONAHA.109.912774; LUSTER AD, 1987, J EXP MED, V166, P1084, DOI 10.1084/jem.166.4.1084; Marchant DJ, 2012, CIRC RES, V110, P126, DOI 10.1161/CIRCRESAHA.111.243170; McMurray JJV, 2012, EUR HEART J, V33, P1787, DOI 10.1093/eurheartj/ehs104; Mueller T, 2003, CLIN CHEM, V49, P976, DOI 10.1373/49.6.976; Palmieri B, 2007, EUR REV MED PHARMACO, V11, P309; Parissis JT, 2013, INT J CARDIOL, V168, P3609, DOI 10.1016/j.ijcard.2013.05.056; Pencina MJ, 2011, STAT MED, V30, P11, DOI 10.1002/sim.4085; Rosamond W, 2008, CIRCULATION, V117, pE25, DOI 10.1161/CIRCULATIONAHA.107.187998; Rose G A, 1968, Monogr Ser World Health Organ, V56, P1; Schisterman EF, 2005, EPIDEMIOLOGY, V16, P73, DOI 10.1097/01.ede.0000147512.81966.ba; Scholten DJ, 2012, BRIT J PHARMACOL, V166, P898, DOI 10.1111/j.1476-5381.2011.01648.x; Staessen JA, 2001, J HYPERTENS, V19, P1349, DOI 10.1097/00004872-200108000-00002; Stumpf C, 2011, HYPERTENS RES, V34, P484, DOI 10.1038/hr.2010.258; van de Schans VAM, 2007, HYPERTENSION, V49, P473, DOI 10.1161/01.HYP.0000255946.55091.24; van Kimmenade RRJ, 2012, CLIN CHEM, V58, P127, DOI 10.1373/clinchem.2011.165720; Wang TJ, 2006, NEW ENGL J MED, V355, P2631, DOI 10.1056/NEJMoa055373; Youn JC, 2013, HYPERTENSION, V62, P126, DOI 10.1161/HYPERTENSIONAHA.113.00689; Zandbergen HR, 2009, J CARDIOVASC PHARM T, V14, P68, DOI 10.1177/1074248408329860	44	25	26	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2015	10	10							e0141394	10.1371/journal.pone.0141394	http://dx.doi.org/10.1371/journal.pone.0141394			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU8PC	26506526	Green Submitted, Green Published, gold			2022-12-26	WOS:000363804200061
J	Cha, K; Sen, P; Raghunayakula, S; Zhang, XD				Cha, Keith; Sen, Progga; Raghunayakula, Sarita; Zhang, Xiang-Dong			The Cellular Distribution of RanGAP1 Is Regulated by CRM1-Mediated Nuclear Export in Mammalian Cells	PLOS ONE			English	Article							GTPASE-ACTIVATING PROTEIN; E3 LIGASE ACTIVITY; PORE COMPLEX; RAN-GTPASE; NUCLEOCYTOPLASMIC TRANSPORT; SEGREGATION DISTORTION; SUMO-1 MODIFICATION; DRUG-RESISTANCE; IMPORTIN-BETA; CRM1	The Ran GTPase activating protein RanGAP1 plays an essential role in nuclear transport by stimulating RanGTP hydrolysis in the cytoplasmic compartment. In mammalian cells, unmodified RanGAP1 is predominantly cytoplasmic, whereas modification by small ubiquitin-related modifier protein (SUMO) targets RanGAP1 to the cytoplasmic filaments of nuclear pore complex (NPC). Although RanGAP1 contains nine putative nuclear export signals and a nuclear localization signal, little is known if RanGAP1 shuttles between the nuclear and cytoplasmic compartments and how its primary localization in the cytoplasm and at the NPC is regulated. Here we show that inhibition of CRM1-mediated nuclear export using RNAi-knockdown of CRM1 and inactivation of CRM1 by leptomycin B (LMB) results in nuclear accumulation of RanGAP1. LMB treatment induced a more robust redistribution of RanGAP1 from the cytoplasm to the nucleoplasm compared to CRM1 RNAi and also uniquely triggered a decrease or loss of RanGAP1 localization at the NPC, suggesting that LMB treatment is more effective in inhibiting CRM1-mediated nuclear export of RanGAP1. Our time-course analysis of LMB treatment reveals that the NPC-associated RanGAP1 is much more slowly redistributed to the nucleoplasm than the cytoplasmic RanGAP1. Furthermore, LMB-induced nuclear accumulation of RanGAP1 is positively correlated with an increase in levels of SUMO-modified RanGAP1, suggesting that SUMOylation of RanGAP1 may mainly take place in the nucleoplasm. Lastly, we demonstrate that the nuclear localization signal at the C-terminus of RanGAP1 is required for its nuclear accumulation in cells treated with LMB. Taken together, our results elucidate that RanGAP1 is actively transported between the nuclear and cytoplasmic compartments, and that the cytoplasmic and NPC localization of RanGAP1 is dependent on CRM1-mediated nuclear export.	[Cha, Keith; Sen, Progga; Raghunayakula, Sarita; Zhang, Xiang-Dong] Wayne State Univ, Dept Biol Sci, Detroit, MI 48202 USA	Wayne State University	Zhang, XD (corresponding author), Wayne State Univ, Dept Biol Sci, Detroit, MI 48202 USA.	xzhang@wayne.edu		Zhang, Xiang-Dong/0000-0001-5097-3191	Wayne State University Research Program [142146]; American Cancer Society Institutional Research Grant [11-053-01-IRG]	Wayne State University Research Program; American Cancer Society Institutional Research Grant(American Cancer Society)	This work was supported by Wayne State University Research Program Grant 142146 (XDZ) and American Cancer Society Institutional Research Grant 11-053-01-IRG (XDZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayaydin F, 2004, MOL BIOL CELL, V15, P5208, DOI 10.1091/mbc.E04-07-0589; Azuma Y, 2001, FASEB J, V15, P1825, DOI 10.1096/fj.00-0818fje; BISCHOFF FR, 1991, NATURE, V354, P80, DOI 10.1038/354080a0; BISCHOFF FR, 1994, P NATL ACAD SCI USA, V91, P2587, DOI 10.1073/pnas.91.7.2587; BISCHOFF FR, 1995, P NATL ACAD SCI USA, V92, P1749, DOI 10.1073/pnas.92.5.1749; Brodie KM, 2012, J BIOL CHEM, V287, P7701, DOI 10.1074/jbc.M111.327296; Chang KC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079863; Crampton N, 2009, MOL BIOL CELL, V20, P5106, DOI 10.1091/mbc.E09-05-0397; Dasso M, 2001, CELL, V104, P321, DOI 10.1016/S0092-8674(01)00218-5; Dasso M, 2008, CELL DIV, V3, DOI 10.1186/1747-1028-3-5; Etchin J, 2013, LEUKEMIA, V27, P66, DOI 10.1038/leu.2012.219; Feng WQ, 1999, J CELL SCI, V112, P339; Fornerod M, 1997, CELL, V90, P1051, DOI 10.1016/S0092-8674(00)80371-2; Fukuda M, 1997, NATURE, V390, P308, DOI 10.1038/36894; Fung HYJ, 2014, SEMIN CANCER BIOL, V27, P52, DOI 10.1016/j.semcancer.2014.03.002; Gareau JR, 2010, NAT REV MOL CELL BIO, V11, P861, DOI 10.1038/nrm3011; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Guttinger S, 2009, NAT REV MOL CELL BIO, V10, P178, DOI 10.1038/nrm2641; Hamada M, 2011, J CELL BIOL, V194, P597, DOI 10.1083/jcb.201102018; Hay RT, 2005, MOL CELL, V18, P1, DOI 10.1016/j.molcel.2005.03.012; He XY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123882; Hillig RC, 1999, MOL CELL, V3, P781, DOI 10.1016/S1097-2765(01)80010-1; Huang WY, 2009, CLIN INVEST MED, V32, pE315; Hutten S, 2008, MOL BIOL CELL, V19, P2300, DOI 10.1091/mbc.E07-12-1279; Jordan M, 1996, NUCLEIC ACIDS RES, V24, P596, DOI 10.1093/nar/24.4.596; Kalab P, 2002, SCIENCE, V295, P2452, DOI 10.1126/science.1068798; Kanai M, 2007, NAT CELL BIOL, V9, P1175, DOI 10.1038/ncb1638; Kau TR, 2004, NAT REV CANCER, V4, P106, DOI 10.1038/nrc1274; KLEBE C, 1995, BIOCHEMISTRY-US, V34, P639, DOI 10.1021/bi00002a031; Kudo N, 1999, P NATL ACAD SCI USA, V96, P9112, DOI 10.1073/pnas.96.16.9112; Kudo N, 1997, J BIOL CHEM, V272, P29742, DOI 10.1074/jbc.272.47.29742; Kusano A, 2002, P NATL ACAD SCI USA, V99, P6866, DOI 10.1073/pnas.102165099; Kusano A, 2001, DEV CELL, V1, P351, DOI 10.1016/S1534-5807(01)00042-9; Lund E, 2004, SCIENCE, V303, P95, DOI 10.1126/science.1090599; Mahajan R, 1997, CELL, V88, P97, DOI 10.1016/S0092-8674(00)81862-0; Mahajan R, 1998, J CELL BIOL, V140, P259, DOI 10.1083/jcb.140.2.259; Matunis MJ, 1996, J CELL BIOL, V135, P1457, DOI 10.1083/jcb.135.6.1457; Matunis MJ, 1998, J CELL BIOL, V140, P499, DOI 10.1083/jcb.140.3.499; Merrill C, 1999, SCIENCE, V283, P1742, DOI 10.1126/science.283.5408.1742; Moore JD, 2001, BIOESSAYS, V23, P77, DOI 10.1002/1521-1878(200101)23:1<77::AID-BIES1010>3.3.CO;2-5; Neville M, 1997, CURR BIOL, V7, P767, DOI 10.1016/S0960-9822(06)00335-6; Nishijima H, 2006, MOL BIOL CELL, V17, P2524, DOI 10.1091/mbc.E05-09-0893; Noske A, 2008, CANCER-AM CANCER SOC, V112, P1733, DOI 10.1002/cncr.23354; OssarehNazari B, 1997, SCIENCE, V278, P141, DOI 10.1126/science.278.5335.141; Pathria G, 2012, J INVEST DERMATOL, V132, P2780, DOI 10.1038/jid.2012.233; Pemberton LF, 2005, TRAFFIC, V6, P187, DOI 10.1111/j.1600-0854.2005.00270.x; Pichler A, 2002, CELL, V108, P109, DOI 10.1016/S0092-8674(01)00633-X; Ranganathan P, 2012, BLOOD, V120, P1765, DOI 10.1182/blood-2012-04-423160; Reverter D, 2005, NATURE, V435, P687, DOI 10.1038/nature03588; Ribet D, 2010, NATURE, V464, P1192, DOI 10.1038/nature08963; Rodriguez MS, 2001, J BIOL CHEM, V276, P12654, DOI 10.1074/jbc.M009476200; Saitoh H, 2002, J BIOL CHEM, V277, P4755, DOI 10.1074/jbc.M104453200; Saitoh H, 1997, P NATL ACAD SCI USA, V94, P3736, DOI 10.1073/pnas.94.8.3736; Sampson DA, 2001, J BIOL CHEM, V276, P21664, DOI 10.1074/jbc.M100006200; Santiago A, 2013, MOL BIOL CELL, V24, P2739, DOI 10.1091/mbc.E12-10-0771; Sekhri P, 2015, BIOCHEM BIOPH RES CO, V458, P128, DOI 10.1016/j.bbrc.2015.01.081; Shao CX, 2011, CANCER CHEMOTH PHARM, V67, P1369, DOI 10.1007/s00280-010-1434-6; Shen AG, 2009, NEUROSURGERY, V65, P153, DOI 10.1227/01.NEU.0000348550.47441.4B; Stade K, 1997, CELL, V90, P1041, DOI 10.1016/S0092-8674(00)80370-0; Taagepera S, 1998, P NATL ACAD SCI USA, V95, P7457, DOI 10.1073/pnas.95.13.7457; Turner JG, 2012, BIOCHEM PHARMACOL, V83, P1021, DOI 10.1016/j.bcp.2011.12.016; Turner JG, 2008, CURR MED CHEM, V15, P2648, DOI 10.2174/092986708786242859; Van der Watt PJ, 2009, INT J CANCER, V124, P1829, DOI 10.1002/ijc.24146; Walker CJ, 2013, BLOOD, V122, P3034, DOI 10.1182/blood-2013-04-495374; Wang YG, 2009, J CELL SCI, V122, P4249, DOI 10.1242/jcs.050542; Weis K, 2003, CELL, V112, P441, DOI 10.1016/S0092-8674(03)00082-5; Werner A, 2012, MOL CELL, V46, P287, DOI 10.1016/j.molcel.2012.02.017; Xu DR, 2012, MOL BIOL CELL, V23, P3673, DOI 10.1091/mbc.E12-01-0045; Yeh ETH, 2009, J BIOL CHEM, V284, P8223, DOI 10.1074/jbc.R800050200; Zemp I, 2009, J CELL BIOL, V185, P1167, DOI 10.1083/jcb.200904048; Zhang H, 2002, MOL CELL BIOL, V22, P6498, DOI 10.1128/MCB.22.18.6498-6508.2002; Zhang XD, 2008, MOL CELL, V29, P729, DOI 10.1016/j.molcel.2008.01.013; Zhu SS, 2009, MOL CELL, V33, P570, DOI 10.1016/j.molcel.2009.02.008	73	3	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2015	10	10							e0141309	10.1371/journal.pone.0141309	http://dx.doi.org/10.1371/journal.pone.0141309			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU8PC	26506250	Green Published, gold, Green Submitted			2022-12-26	WOS:000363804200048
J	Dudek, M; Knutelska, J; Bednarski, M; Nowinski, L; Zygmunt, M; Mordyl, B; Gluch-Lutwin, M; Kazek, G; Sapa, J; Pytka, K				Dudek, Magdalena; Knutelska, Joanna; Bednarski, Marek; Nowinski, Leszek; Zygmunt, Malgorzata; Mordyl, Barbara; Gluch-Lutwin, Monika; Kazek, Grzegorz; Sapa, Jacek; Pytka, Karolina			A Comparison of the Anorectic Effect and Safety of the Alpha(2)-Adrenoceptor Ligands Guanfacine and Yohimbine in Rats with Diet-Induced Obesity	PLOS ONE			English	Article							EXTENDED-RELEASE; ADIPOSE-TISSUE; ALPHA-2-ADRENOCEPTOR; LIPOLYSIS; ADRENOCEPTORS; THERMOGENESIS; HYPERTENSION; AUGMENTS; AGONISTS; MICE	The search for drugs with anorectic activity, acting within the adrenergic system has attracted the interest of researchers. Partial alpha(2)-adrenoceptor agonists might offer the potential for effective and safe treatment of obesity. We compared the effectiveness and safety of alpha(2)-adrenoceptor ligands in reducing body mass. We also analyzed if antagonist and partial agonists of alpha(2)-adrenoceptor-yohimbine and guanfacine-act similarly, and determined which course of action is connected with anorectic activity. We tested intrinsic activity and effect on the lipolysis of these compounds in cell cultures, evaluated their effect on meal size, body weight in Wistar rats with high-fat diet-induced obesity, and determined their effect on blood pressure, heart rate, lipid profile, spontaneous locomotor activity, core temperature and glucose, as well as glycerol and cortisol levels. Both guanfacine and yohimbine showed anorectic activity. Guanfacine was much more effective than yohimbine. Both significantly reduced the amount of intraperitoneal adipose tissue and had a beneficial effect on lipid profiles. Decreased response of alpha(2)A-adrenoceptors and partial stimulation of alpha B-2-receptors seem to be responsible for the anorectic action of guanfacine. The stimulation of alpha(1)-adrenoceptors by guanfacine is responsible for cardiovascular side effects but may also be linked with improved anorexic effect. alpha(1)-adrenoceptor blockade is connected with the side effects of yohimbine, but it is also associated with the improvement of lipid profiles. Guanfacine has been approved by the Food and Drug Administration (FDA) to treat hypertension and conduct disorder, but as it reduces body weight, it is worth examining its effectiveness and safety in models of obesity.	[Dudek, Magdalena; Nowinski, Leszek; Pytka, Karolina] Jagiellonian Univ, Coll Med, Dept Pharmacodynam, PL-30688 Krakow, Poland; [Knutelska, Joanna; Bednarski, Marek; Zygmunt, Malgorzata; Kazek, Grzegorz; Sapa, Jacek] Jagiellonian Univ, Coll Med, Dept Pharmacol Screening, PL-30688 Krakow, Poland; [Mordyl, Barbara; Gluch-Lutwin, Monika] Jagiellonian Univ, Coll Med, Dept Pharmacobiol, PL-30688 Krakow, Poland	Jagiellonian University; Collegium Medicum Jagiellonian University; Jagiellonian University; Collegium Medicum Jagiellonian University; Jagiellonian University; Collegium Medicum Jagiellonian University	Dudek, M (corresponding author), Jagiellonian Univ, Coll Med, Dept Pharmacodynam, 9 Med St, PL-30688 Krakow, Poland.	magda.dudek@uj.edu.pl	Kotańska, Magdalena/AAX-5140-2021; Głuch-Lutwin, Monika/AAE-2702-2019; Mordyl, Barbara/AAD-8247-2019; Pytka, Karolina/Z-5491-2019	Kotańska, Magdalena/0000-0002-3946-1192; Głuch-Lutwin, Monika/0000-0003-1632-6569; Mordyl, Barbara/0000-0001-7906-0353; Pytka, Karolina/0000-0001-7134-9515; Nowinski, Leszek/0000-0003-2958-8453; Bednarski, Marek/0000-0002-4639-9913; Knutelska, Joanna/0000-0002-2480-1617; SAPA, JACEK/0000-0003-4670-1665	National Science Centre in Poland [DEC-2011/03/B/NZ7/00635]	National Science Centre in Poland(National Science Centre, Poland)	The studies described in the above paper were financially supported by the National Science Centre in Poland within the grant entitled "Partial agonists of alpha-2 adrenoceptors as a new perspective of the effective and safe in reducing body weight and obesity" (decision no. DEC-2011/03/B/NZ7/00635), http://www.ncn.gov.pl, MD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adeniyi AA, 2007, ASIAN J ANDROL, V9, P403, DOI 10.1111/j.1745-7262.2007.00276.x; Arner P, 2005, BEST PRACT RES CL EN, V19, P471, DOI 10.1016/j.beem.2005.07.004; ARNSTEN AFT, 1988, J NEUROSCI, V8, P4287; BALAZOVJECH I, 1987, Cor et Vasa, V29, P46; BILL DJ, 1989, BRIT J PHARMACOL, V96, P133, DOI 10.1111/j.1476-5381.1989.tb11793.x; CARPENE C, 1990, J LIPID RES, V31, P811; GALITZKY J, 1991, BRIT J PHARMACOL, V104, P514, DOI 10.1111/j.1476-5381.1991.tb12460.x; Gogga P, 2011, POSTEP HIG MED DOSW, V65, P255, DOI 10.5604/17322693.940259; Gribble FM, 2010, NEW ENGL J MED, V362, P361, DOI 10.1056/NEJMcibr0911499; HAHN P, 1989, BIOL NEONATE, V55, P180; HAUGERKLEVENE JH, 1985, EUR J CLIN PHARMACOL, V29, P391, DOI 10.1007/BF00613450; Hoeren M, 2008, N-S ARCH PHARMACOL, V378, P17, DOI 10.1007/s00210-008-0295-6; Hu XR, 2005, J MOL ENDOCRINOL, V35, P73, DOI 10.1677/jme.1.01764; Janhunen SK, 2013, OBESITY, V21, pE700, DOI 10.1002/oby.20581; Janhunen SK, 2011, OBESITY, V19, P1979, DOI 10.1038/oby.2011.51; Khan MA, 2012, J CHILD ADOL PSYCHOP, V22, P256, DOI 10.1089/cap.2011.0125; Kojima Y, 2011, J UROLOGY, V186, P1530, DOI 10.1016/j.juro.2011.05.048; Kovacs P, 2006, NEUROSCI LETT, V402, P253, DOI 10.1016/j.neulet.2006.04.011; LAFONTAN M, 1992, AM J CLIN NUTR, V55, P219; Langin D, 2006, PHARMACOL RES, V53, P482, DOI 10.1016/j.phrs.2006.03.009; Llado I, 2002, OBES RES, V10, P296, DOI 10.1038/oby.2002.41; MAURON C, 1980, LIFE SCI, V27, P781, DOI 10.1016/0024-3205(80)90332-X; Minns AB, 2010, CLIN TOXICOL, V48, P146, DOI 10.3109/15563650903505174; Patel D., 2015, METABOLISM; Pessina AC, 2006, NUTR METAB CARDIOVAS, V16, P137, DOI 10.1016/j.numecd.2005.04.005; Philipp M, 2002, AM J PHYSIOL-REG I, V283, pR287, DOI 10.1152/ajpregu.00123.2002; Posey DJ, 2007, CNS DRUG REV, V13, P465, DOI 10.1111/j.1527-3458.2007.00026.x; Rodriguez-Cuenca S, 2002, J BIOL CHEM, V277, P42958, DOI 10.1074/jbc.M207229200; Scholtysik G, 1998, J VET PHARMACOL THER, V21, P477, DOI 10.1046/j.1365-2885.1998.00166.x; SILLENCE MN, 1992, J ANIM SCI, V70, P3429, DOI 10.2527/1992.70113429x; Sinclair MD, 2003, CAN VET J, V44, P885; TAKEUCHI K, 1987, JPN J PHARMACOL, V43, P267, DOI 10.1254/jjp.43.267; Tank J, 2007, HYPERTENSION, V50, P899, DOI 10.1161/HYPERTENSIONAHA.107.095984; Thomsson O, 2014, ACTA VET SCAND, V56, DOI 10.1186/s13028-014-0055-1; World Health Organization,, 2015, OB OV	35	24	24	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2015	10	10							e0141327	10.1371/journal.pone.0141327	http://dx.doi.org/10.1371/journal.pone.0141327			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU8PC	26506439	Green Published, gold, Green Submitted			2022-12-26	WOS:000363804200049
J	Freedman, DS; Kit, BK; Ford, ES				Freedman, David S.; Kit, Brian K.; Ford, Earl S.			Are the Recent Secular Increases in Waist Circumference among Children and Adolescents Independent of Changes in BMI?	PLOS ONE			English	Article							BODY-MASS INDEX; TO-HEIGHT RATIO; X-RAY ABSORPTIOMETRY; ABDOMINAL OBESITY; CARDIOVASCULAR-DISEASE; CARDIOMETABOLIC RISK; US CHILDREN; VISCERAL FAT; TRENDS; ADIPOSITY	Background Several studies have shown that the waist circumference of children and adolescents has increased over the last 25 years. However, given the strong correlation between waist circumference and BMI, it is uncertain if the secular trends in waist circumference are independent of those in BMI. Methods We analyzed data from 6- to 19-year-olds who participated in the 1988-1994 through 2011-2012 cycles of the National Health and Nutrition Examination Survey to assess whether the trends in waist circumference were independent of changes in BMI, race-ethnicity and age. Results Mean, unadjusted levels of waist circumference increased by 3.7 cm (boys) and 6.0 cm (girls) from 1988-94 through 2011-12, while mean BMI levels increased by 1.1 kg/m(2) (boys) and 1.6 kg/m(2) (girls). Overall, the proportional changes in mean levels of both waist circumference and BMI were fairly similar among boys (5.3%, waist vs. 5.6%, BMI) and girls (8.7%, waist vs. 7.7%, BMI). As assessed by the area under the curve, adjustment for BMI reduced the secular increases in waist circumference by about 75% (boys) and 50% (girls) beyond that attributable to age and race-ethnicity. There was also a race-ethnicity interaction (p < 0.001). Adjustment for BMI reduced the secular trend in waist circumference among non-Hispanic (NH) black children (boys and girls) to a greater extent (about 90%) than among other children. Conclusions Our results indicate that among children in the U.S., about 75% (boys) and 50% (girls) of the secular increases in waist circumference since 1988-94 can be accounted for by changes in BMI. The reasons for the larger independent effects among girls and among NH blacks are uncertain.	[Freedman, David S.] Ctr Dis Control & Prevent, Div Nutr Phys Act & Obes, Atlanta, GA USA; [Kit, Brian K.] Ctr Dis Control & Prevent, Div Hlth & Nutr Examinat Surveys, Natl Ctr Hlth Stat, Hyattsville, MD USA; [Ford, Earl S.] Ctr Dis Control & Prevent, Div Populat Hlth, Atlanta, GA USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; CDC National Center for Health Statistics (NCHS); Centers for Disease Control & Prevention - USA	Freedman, DS (corresponding author), Ctr Dis Control & Prevent, Div Nutr Phys Act & Obes, Atlanta, GA USA.	dxf1@cdc.gov		Freedman, David/0000-0001-8014-0289				Ashwell M, 2012, OBES REV, V13, P275, DOI 10.1111/j.1467-789X.2011.00952.x; Aydin N, 2004, TOHOKU J EXP MED, V202, P173, DOI 10.1620/tjem.202.173; Bjorntorp P, 2001, Obes Rev, V2, P73, DOI 10.1046/j.1467-789x.2001.00027.x; Carmienke S, 2013, EUR J CLIN NUTR, V67, P573, DOI 10.1038/ejcn.2013.61; Carroll JF, 2008, OBESITY, V16, P600, DOI 10.1038/oby.2007.92; Centers for Disease Control and Prevention, 2012, NAST CTR HLTH STAT N; Cortese S, 2013, PEDIATRICS, V131, pE1731, DOI 10.1542/peds.2012-0540; de Hollander EL, 2012, INT J EPIDEMIOL, V41, P805, DOI 10.1093/ije/dys008; Despres JP, 2008, ARTERIOSCL THROM VAS, V28, P1039, DOI 10.1161/ATVBAHA.107.159228; Elobeid MA, 2007, OBESITY, V15, P2380, DOI 10.1038/oby.2007.282; Flegal KM, 2009, AM J CLIN NUTR, V90, P1314, DOI 10.3945/ajcn.2009.28335; Ford ES, 2014, JAMA-J AM MED ASSOC, V312, P1151, DOI 10.1001/jama.2014.8362; Ford ES, 2003, OBES RES, V11, P1223, DOI 10.1038/oby.2003.168; Freedman DS, 2007, AM J CLIN NUTR, V86, P33, DOI 10.1093/ajcn/86.1.33; Freedman DS, 2015, AM J CLIN NUTR, V101, P425, DOI 10.3945/ajcn.114.094672; Fryar C.D., 2014, PREVALENCE OVERWEIGH; Grundy SM, 2013, J OBES, V2013, DOI 10.1155/2013/454285; Hariri AA, 2013, DIS MARKERS, V2013, P753, DOI 10.1155/2013/763907; Harrell FE, 2001, REGRESSION MODELING; Janssen I, 2011, OBES REV, V12, P397, DOI 10.1111/j.1467-789X.2010.00815.x; Katzmarzyk PT, 2014, INT J OBESITY, V38, P753, DOI 10.1038/ijo.2013.170; Klein S, 2007, OBESITY, V15, P1061, DOI 10.1038/oby.2007.632; Kodama S, 2012, AM J EPIDEMIOL, V176, P959, DOI 10.1093/aje/kws172; Kolle E, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-389; Korn E, 1998, SURV METHODOL, V24, P193; Kuczmarski RJ, 2000, ADV DATA, V2000, P1; Kuczmarski RJ, 2000, VITAL HLTH STAT, V11, P1; Li CY, 2006, PEDIATRICS, V118, pE1390, DOI 10.1542/peds.2006-1062; Lumley T., 2010, ANAL COMPLEX SURVEY; Ma YS, 2013, AM J PUBLIC HEALTH, V103, pE34, DOI 10.2105/AJPH.2013.301394; McCarthy HD, 2005, INT J OBESITY, V29, P157, DOI 10.1038/sj.ijo.0802849; McCarthy HD, 2003, BRIT MED J, V326, P624, DOI 10.1136/bmj.326.7390.624; Moreno LA, 2005, ARCH DIS CHILD, V90, P818, DOI 10.1136/adc.2004.067066; Moreno LA, 2001, INT J OBESITY, V25, P1656, DOI 10.1038/sj.ijo.0801803; National Center for Health Statistics (NCHS), 2011, ANTHR PROC MAN; Nyamdorj R, 2008, OBESITY, V16, P1622, DOI 10.1038/oby.2008.73; Ogden CL, 2002, JAMA-J AM MED ASSOC, V288, P1728, DOI 10.1001/jama.288.14.1728; Ogden CL, 2014, JAMA-J AM MED ASSOC, V311, P806, DOI 10.1001/jama.2014.732; Ogden Cynthia L, 2010, Natl Health Stat Report, P1; Okosun IS, 2004, PREV MED, V39, P197, DOI 10.1016/j.ypmed.2004.01.023; Peeters A, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-003667; R Core Team, 2013, R LANG ENV STAT COMP; Reilly JJ, 2010, OBES REV, V11, P645, DOI 10.1111/j.1467-789X.2009.00709.x; Savva SC, 2013, DIABET METAB SYND OB, V6, P403, DOI 10.2147/DMSO.S34220; Schwartz BS, 2014, PEDIATRICS, V133, P668, DOI 10.1542/peds.2013-3427; Steinberger J, 2005, INT J OBESITY, V29, P1346, DOI 10.1038/sj.ijo.0803026; Sun Q, 2010, AM J EPIDEMIOL, V172, P1442, DOI 10.1093/aje/kwq306; Visscher TLS, 2015, INT J OBESITY, V39, P189, DOI 10.1038/ijo.2014.98; Visser SN, 2014, J AM ACAD CHILD PSY, V53, P34, DOI 10.1016/j.jaac.2013.09.001; Walls HL, 2011, OBESITY, V19, P216, DOI 10.1038/oby.2010.149; Wang J, 2003, AM J CLIN NUTR, V77, P379, DOI 10.1093/ajcn/77.2.379; Wormser D, 2011, LANCET, V377, P1085, DOI 10.1016/S0140-6736(11)60105-0; Xi B, 2014, PEDIATRICS, V134, pE334, DOI 10.1542/peds.2014-0970	53	8	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2015	10	10							e0141056	10.1371/journal.pone.0141056	http://dx.doi.org/10.1371/journal.pone.0141056			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU8PC	26506450	Green Published, Green Submitted, gold			2022-12-26	WOS:000363804200027
J	Waldron-Roby, E; Hoerauf, J; Arbez, N; Zhu, SS; Kulcsar, K; Ross, CA				Waldron-Roby, Elaine; Hoerauf, Janine; Arbez, Nicolas; Zhu, Shanshan; Kulcsar, Kirsten; Ross, Christopher A.			Sox11 Reduces Caspase-6 Cleavage and Activity	PLOS ONE			English	Article							AMYLOID PRECURSOR PROTEIN; TRANSCRIPTION FACTORS; HUMAN NEURONS; DNA-BINDING; CELL-DEATH; DEGENERATION; ACTIVATION; APOPTOSIS; IDENTIFICATION; EXPRESSION	The apoptotic cascade is an orchestrated event, whose final stages are mediated by effector caspases. Regulatory binding proteins have been identified for caspases such as caspase- 3, -7, -8, and -9. Many of these proteins belong to the inhibitor of apoptosis (IAP) family. By contrast, caspase-6 is not believed to be influenced by IAPs, and little is known about its regulation. We therefore performed a yeast-two-hybrid screen using a constitutively inactive form of caspase-6 for bait in order to identify novel regulators of caspase-6 activity. Sox11 was identified as a potential caspase-6 interacting protein. Sox11 was capable of dramatically reducing caspase-6 activity, as well as preventing caspase-6 self-cleavage. Several regions, including amino acids 117-214 and 362-395 within sox11 as well as a nuclear localization signal (NLS) all contributed to the reduction in caspase-6 activity. Furthermore, sox11 was also capable of decreasing other effector caspase activity but not initiator caspases -8 and -9. The ability of sox11 to reduce effector caspase activity was also reflected in its capacity to reduce cell death following toxic insult. Interestingly, other sox proteins also had the ability to reduce caspase-6 activity but to a lesser extent than sox11.	[Waldron-Roby, Elaine; Hoerauf, Janine; Arbez, Nicolas; Zhu, Shanshan; Kulcsar, Kirsten; Ross, Christopher A.] Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Div Neurobiol, Baltimore, MD 21287 USA; [Ross, Christopher A.] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21287 USA; [Ross, Christopher A.] Johns Hopkins Univ, Sch Med, Dept Pharmacol, Baltimore, MD 21287 USA; [Ross, Christopher A.] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21287 USA; [Ross, Christopher A.] Johns Hopkins Univ, Sch Med, Program Cellular & Mol Med, Baltimore, MD 21287 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Ross, CA (corresponding author), Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Div Neurobiol, CMSC 8-121,600 North Wolfe St, Baltimore, MD 21287 USA.	caross@jhu.edu		Kulcsar, Kirsten/0000-0001-9385-8775				Ahmad M, 1997, CANCER RES, V57, P615; Akpan N, 2011, J NEUROSCI, V31, P8894, DOI 10.1523/JNEUROSCI.0698-11.2011; Albrecht S, 2009, J NEUROPATH EXP NEUR, V68, P1282, DOI 10.1097/NEN.0b013e3181c1da10; Araya R, 2002, CELL DEATH DIFFER, V9, P322, DOI 10.1038/sj.cdd.4400949; Baumgartner R, 2009, BIOCHEM J, V423, P429, DOI 10.1042/BJ20090540; Bhattaram P, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1008; Bulat N, 2009, BRAIN RES BULL, V80, P251, DOI 10.1016/j.brainresbull.2009.07.007; Cribbs DH, 2004, AM J PATHOL, V165, P353, DOI 10.1016/S0002-9440(10)63302-0; Cusack CL, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2910; Deveraux QL, 1997, NATURE, V388, P300, DOI 10.1038/40901; Dictor M, 2009, HAEMATOL-HEMATOL J, V94, P1563, DOI 10.3324/haematol.2009.008474; Dy P, 2008, NUCLEIC ACIDS RES, V36, P3101, DOI 10.1093/nar/gkn162; Gadi J, 2013, J BIOL CHEM; Galvan V, 2006, P NATL ACAD SCI USA, V103, P7130, DOI 10.1073/pnas.0509695103; Graham RK, 2006, CELL, V125, P1179, DOI 10.1016/j.cell.2006.04.026; Graham RK, 2010, J NEUROSCI, V30, P15019, DOI 10.1523/JNEUROSCI.2071-10.2010; Gray DC, 2010, CELL, V142, P637, DOI 10.1016/j.cell.2010.07.014; Guo H, 2006, CELL DEATH DIFFER, V13, P285, DOI 10.1038/sj.cdd.4401753; Halawani D, 2010, J NEUROSCI, V30, P6132, DOI 10.1523/JNEUROSCI.5874-09.2010; Hegde R, 2002, J BIOL CHEM, V277, P432, DOI 10.1074/jbc.M109721200; Hirata H, 1998, J EXP MED, V187, P587, DOI 10.1084/jem.187.4.587; Horowitz PM, 2004, J NEUROSCI, V24, P7895, DOI 10.1523/JNEUROSCI.1988-04.2004; Inoue S, 2009, CELL DEATH DIFFER, V16, P1053, DOI 10.1038/cdd.2009.29; Jing XT, 2012, EXP NEUROL, V233, P221, DOI 10.1016/j.expneurol.2011.10.005; Jung JY, 2014, J MICROBIOL BIOTECHN, V24, P714, DOI 10.4014/jmb.1312.12068; Kamachi Y, 2013, DEVELOPMENT, V140, P4129, DOI 10.1242/dev.091793; Klaiman G, 2008, MOL CELL PROTEOMICS, V7, P1541, DOI 10.1074/mcp.M800007-MCP200; Klaiman G, 2009, BBA-MOL CELL RES, V1793, P592, DOI 10.1016/j.bbamcr.2008.12.004; LeBlanc A, 1999, J BIOL CHEM, V274, P23426, DOI 10.1074/jbc.274.33.23426; Mu LF, 2012, J NEUROSCI, V32, P3067, DOI 10.1523/JNEUROSCI.4679-11.2012; Nhan TQ, 2006, AM J PATHOL, V169, P729, DOI 10.2353/ajpath.2006.060105; Nikolaev A, 2009, NATURE, V457, P981, DOI 10.1038/nature07767; Nucifora LG, 2012, J BIOL CHEM, V287, P16017, DOI 10.1074/jbc.M111.252577; Orth K, 1996, J BIOL CHEM, V271, P16443, DOI 10.1074/jbc.271.28.16443; Penzo-Mendez AI, 2010, INT J BIOCHEM CELL B, V42, P425, DOI 10.1016/j.biocel.2009.07.018; Poncy A, 2015, DEV BIOL; Riedl SJ, 2004, NAT REV MOL CELL BIO, V5, P897, DOI 10.1038/nrm1496; Roy N, 1997, EMBO J, V16, P6914, DOI 10.1093/emboj/16.23.6914; Ruchaud S, 2002, EMBO J, V21, P1967, DOI 10.1093/emboj/21.8.1967; Schindler T, 2000, SCIENCE, V289, P1938, DOI 10.1126/science.289.5486.1938; Simon DJ, 2012, J NEUROSCI, V32, P17540, DOI 10.1523/JNEUROSCI.3012-12.2012; Sivananthan SN, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.74; Srinivasula SM, 2001, NATURE, V410, P112, DOI 10.1038/35065125; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; Uribe V, 2012, HUM MOL GENET, V21, P1954, DOI 10.1093/hmg/dds005; Vaidya S, 2011, J MOL BIOL, V406, P75, DOI 10.1016/j.jmb.2010.11.031; Vito P, 1997, J BIOL CHEM, V272, P28315, DOI 10.1074/jbc.272.45.28315; Wang X, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014085; Wang XJ, 2010, EMBO REP, V11, P841, DOI 10.1038/embor.2010.141; Warby SC, 2008, HUM MOL GENET, V17, P2390, DOI 10.1093/hmg/ddn139; Wiebe MS, 2003, J BIOL CHEM, V278, P17901, DOI 10.1074/jbc.M212211200; Wissmuller S, 2006, NUCLEIC ACIDS RES, V34, P1735, DOI 10.1093/nar/gkl105; Xu W, 2010, LEUKEMIA LYMPHOMA, V51, P1962, DOI 10.3109/10428194.2010.514968; Zheng TS, 2000, NAT MED, V6, P1241, DOI 10.1038/81343; Zhou Q, 1998, BIOCHEMISTRY-US, V37, P10757, DOI 10.1021/bi980893w	55	3	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2015	10	10							e0141439	10.1371/journal.pone.0141439	http://dx.doi.org/10.1371/journal.pone.0141439			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU8PC	26505998	Green Submitted, Green Published, gold			2022-12-26	WOS:000363804200068
J	Kobayashi, K; Tanaka, T; Okada, S; Morimoto, Y; Matsumura, S; Manio, MCC; Inoue, K; Kimura, K; Yagi, T; Saito, Y; Fushiki, T; Inoue, H; Matsumoto, M; Nabeshima, Y				Kobayashi, Kanako; Tanaka, Tomohiro; Okada, Sadanori; Morimoto, Yuki; Matsumura, Shigenobu; Manio, Mark Christian C.; Inoue, Kazuo; Kimura, Kumi; Yagi, Takashi; Saito, Yoshihiko; Fushiki, Tohru; Inoue, Hiroshi; Matsumoto, Michihiro; Nabeshima, Yo-ichi			Hepatocyte beta-Klotho regulates lipid homeostasis but not body weight in mice	FASEB JOURNAL			English	Article						bile acid; cholesterol; fibroblast growth factor; metabolomics; triglyceride	BILE-ACID SYNTHESIS; GROWTH-FACTOR 21; SIMULTANEOUS QUANTIFICATION; ENERGY-EXPENDITURE; LIPOPROTEIN-LIPASE; INSULIN-RESISTANCE; HEPATIC STEATOSIS; EXPRESSION; TRIGLYCERIDE; METABOLISM	beta-Klotho (beta-Kl), a transmembrane protein expressed in the liver, pancreas, adipose tissues, and brain, is essential for feedback suppression of hepatic bile acid synthesis. Because bile acid is a key regulator of lipid and energy metabolism, we hypothesized potential and tissue-specific roles of beta-Kl in regulating plasma lipid levels and body weight. By crossing beta-kl(-/-) mice with newly developed hepatocyte-specific beta-kl transgenic (Tg) mice, we generated mice expressing beta-kl solely in hepatocytes (beta-kl2/2/Tg). Gene expression, metabolomic, and in vivo flux analyses consistently revealed that plasma level of cholesterol, which is over-excreted into feces as bile acids in beta-kl2/2, ismaintained in beta-kl2/2 mice by enhanced de novo cholesterogenesis. No compensatory increase in lipogenesis was observed, despite markedly decreased plasma triglyceride. Along with enhanced bile acid synthesis, these lipid dysregulations in beta-kl2/2 were completely reversed in beta-kl2/2/Tgmice. In contrast, reduced body weight and resistance to diet-induced obesity in beta-kl2/2 mice were not reversed by hepatocyte-specific restoration of beta-Kl expression. We conclude that beta-Kl in hepatocytes is necessary and sufficient for lipid homeostasis, whereas nonhepatic beta-Kl regulates energy metabolism. We further demonstrate that in a condition with excessive cholesterol disposal, a robust compensatory mechanism maintains cholesterol levels but not triglyceride levels in mice.	[Kobayashi, Kanako; Tanaka, Tomohiro; Nabeshima, Yo-ichi] Fdn Biomed Res & Innovat, Lab Mol Life Sci, Kobe, Hyogo, Japan; [Tanaka, Tomohiro] Kyoto Univ, Med Innovat Ctr, Sakyo Ku, Kyoto, Japan; [Morimoto, Yuki] Kyoto Univ, Dept Pathol & Tumor Biol, Grad Sch Med, Sakyo Ku, Kyoto, Japan; [Matsumura, Shigenobu; Manio, Mark Christian C.; Inoue, Kazuo; Fushiki, Tohru] Kyoto Univ, Nutr Chem Lab, Grad Sch Agr, Sakyo Ku, Kyoto, Japan; [Okada, Sadanori; Saito, Yoshihiko] Nara Med Univ, Dept Internal Med 1, Kashihara, Nara 634, Japan; [Kimura, Kumi; Inoue, Hiroshi] Kanazawa Univ, Coll Med Pharmaceut & Hlth Sci, Brain Liver Interface Med Res Ctr, Dept Physiol & Metab, Kanazawa, Ishikawa, Japan; [Yagi, Takashi; Matsumoto, Michihiro] Natl Ctr Global Hlth & Med, Diabet Res Ctr, Res Inst, Dept Mol Metab Regulat,Shinjuku Ku, Tokyo, Japan	Institute for Biomedical Research & Innovation (IBRI); Kyoto University; Kyoto University; Kyoto University; Nara Medical University; Kanazawa University; National Center for Global Health & Medicine - Japan	Nabeshima, Y (corresponding author), Fdn Biomed Res & Innovat, Lab Mol Life Sci, Chuo Ku, Kobe Hybrid Business Ctr Bldg,2F,6-7-6 Minatojima, Kobe, Hyogo 6500047, Japan.	nabemr@lmls-kobe.org	Matsumura, Shigenobu/Z-2088-2019	Inoue, Hiroshi/0000-0002-7724-6637; Kobayashi, Kanako/0000-0003-4565-6604	Japan Society for the Promotion of Science [20-3988]; Ministry of Education, Culture, Sports, Science and Technology [22790859, 24591355]; Health and Labor Sciences Research grant from the Ministry of Health, Labor and Welfare; Fujiwara Memorial Foundation; Suzuken Memorial Foundation; Foundation for Research into Metabolic Disorders; Japan Diabetes Foundation; Takeda Science Foundation; Okinaka Memorial Institute; Kanae Foundation for the Promotion of Medical Science; Banyu Foundation;  [22229003]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Health and Labor Sciences Research grant from the Ministry of Health, Labor and Welfare(Ministry of Health, Labour and Welfare, Japan); Fujiwara Memorial Foundation; Suzuken Memorial Foundation; Foundation for Research into Metabolic Disorders; Japan Diabetes Foundation; Takeda Science Foundation(Takeda Science Foundation (TSF)); Okinaka Memorial Institute; Kanae Foundation for the Promotion of Medical Science; Banyu Foundation; 	The authors are grateful to all staff of the animal facility center at Kyoto University and RIKEN Center for Developmental Biology for their help and to Dr. R. D. Palmiter (University of Washington, Seattle, WA, USA) for providing mouse albumin promoter construct; Dr. J. Y. L. Chiang (Northeast Ohio Medical University, Rootstown, OH, USA) for technical advice on in vivo flux analysis; M. Washida (Foundation for Biomedical Research and Innovation), M. Nakagawa, and S. Maki for technical assistance; and A. Imura, Y.-K. Nabeshima, R. Maeda, Y. Hashimoto, N. Nakamura (Foundation for Biomedical Research and Innovation), K. Tomiyama, and S. Ito (Kyoto University) for critical suggestions and discussions. This work was supported by a Grant-in-Aid for Scientific Research (S) 22229003 (to Y. N.); and funding from the Japan Society for the Promotion of Science fellows (Grant 20-3988 to T.T.), for Young Scientists (B) (Grant 22790859 to T.T.), and for Scientific Research (C) (Grant 24591355 to T.T.) from the Ministry of Education, Culture, Sports, Science and Technology, as well as a Health and Labor Sciences Research grant (to T.T.) from the Ministry of Health, Labor and Welfare and research grants (to T.T.) from Fujiwara Memorial Foundation, Suzuken Memorial Foundation, Foundation for Research into Metabolic Disorders, Japan Diabetes Foundation, Takeda Science Foundation, Okinaka Memorial Institute, Kanae Foundation for the Promotion of Medical Science, and Banyu Foundation. The authors declare no conflicts of interest.	Adams AC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049977; ANGELIN B, 1978, J LIPID RES, V19, P1017; Bookout AL, 2013, NAT MED, V19, P1147, DOI 10.1038/nm.3249; Chatterjee C, 2011, AM J PATHOL, V178, P1429, DOI 10.1016/j.ajpath.2010.12.050; Chiang JYL, 2009, J LIPID RES, V50, P1955, DOI 10.1194/jlr.R900010-JLR200; Ding XS, 2012, CELL METAB, V16, P387, DOI 10.1016/j.cmet.2012.08.002; EINARSSON K, 1974, J CLIN INVEST, V54, P1301, DOI 10.1172/JCI107876; Fisher FM, 2014, GASTROENTEROLOGY, V147, P1073, DOI 10.1053/j.gastro.2014.07.044; Fukatsu Y, 2009, ENDOCRINOLOGY, V150, P2683, DOI 10.1210/en.2008-1647; Gaemers IC, 2011, BBA-MOL BASIS DIS, V1812, P447, DOI 10.1016/j.bbadis.2011.01.003; Gao L, 2007, J CHROMATOGR B, V853, P303, DOI 10.1016/j.jchromb.2007.03.029; Gimeno RE, 2014, TRENDS ENDOCRIN MET, V25, P303, DOI 10.1016/j.tem.2014.03.001; Goldberg IJ, 2009, J LIPID RES, V50, pS86, DOI 10.1194/jlr.R800085-JLR200; Huang XQ, 2007, DIABETES, V56, P2501, DOI 10.2337/db07-0648; Inagaki T, 2005, CELL METAB, V2, P217, DOI 10.1016/j.cmet.2005.09.001; Inagaki T, 2008, CELL METAB, V8, P77, DOI 10.1016/j.cmet.2008.05.006; Inagaki T, 2007, CELL METAB, V5, P415, DOI 10.1016/j.cmet.2007.05.003; Ito S, 2000, MECH DEVELOP, V98, P115, DOI 10.1016/S0925-4773(00)00439-1; Ito S, 2005, J CLIN INVEST, V115, P2202, DOI 10.1172/JCI23076; Kimura K, 2012, DIABETES, V61, P61, DOI 10.2337/db10-1684; Klop B, 2013, NUTRIENTS, V5, P1218, DOI 10.3390/nu5041218; Koster A, 2005, ENDOCRINOLOGY, V146, P4943, DOI 10.1210/en.2005-0476; LamonFava S, 1996, ARTERIOSCL THROM VAS, V16, P1509, DOI 10.1161/01.ATV.16.12.1509; Lee YJ, 2012, P NATL ACAD SCI USA, V109, P13656, DOI 10.1073/pnas.1203218109; Li TG, 2013, HEPATOLOGY, V58, P1111, DOI 10.1002/hep.26427; Li TG, 2010, HEPATOLOGY, V52, P678, DOI 10.1002/hep.23721; Li Y, 2014, GASTROENTEROLOGY, V146, P539, DOI 10.1053/j.gastro.2013.10.059; Lundasen T, 2006, J INTERN MED, V260, P530, DOI 10.1111/j.1365-2796.2006.01731.x; Matsuoka N, 2001, AM J PHYSIOL-ENDOC M, V280, pE334, DOI 10.1152/ajpendo.2001.280.2.E334; Matsusue K, 2008, CELL METAB, V7, P302, DOI 10.1016/j.cmet.2008.03.003; Merkel M, 1998, J CLIN INVEST, V102, P893, DOI 10.1172/JCI2912; Moen CJA, 2007, J LIPID RES, V48, P2182, DOI 10.1194/jlr.M700009-JLR200; Out C, 2012, CURR OPIN LIPIDOL, V23, P43, DOI 10.1097/MOL.0b013e32834f0ef3; Owen BM, 2014, CELL METAB, V20, P670, DOI 10.1016/j.cmet.2014.07.012; Owen BM, 2013, NAT MED, V19, P1153, DOI 10.1038/nm.3250; PINKERT CA, 1987, GENE DEV, V1, P268, DOI 10.1101/gad.1.3.268; Russell DW, 2009, J LIPID RES, V50, pS120, DOI 10.1194/jlr.R800026-JLR200; Sakai T, 2007, J BIOL CHEM, V282, P2038, DOI 10.1074/jbc.M608144200; SEMENKOVICH CF, 1989, J LIPID RES, V30, P423; Soga T, 2003, J PROTEOME RES, V2, P488, DOI 10.1021/pr034020m; Tanaka N, 2015, BBA-MOL BASIS DIS, V1852, P1242, DOI 10.1016/j.bbadis.2015.02.012; Tanaka T, 2005, DIABETES, V54, P2365, DOI 10.2337/diabetes.54.8.2365; Tomiyama K, 2010, P NATL ACAD SCI USA, V107, P1666, DOI 10.1073/pnas.0913986107; Usui S, 2002, J LIPID RES, V43, P805; Wang Y, 2013, P NATL ACAD SCI USA, V110, P16109, DOI 10.1073/pnas.1315292110; Watanabe M, 2004, J CLIN INVEST, V113, P1408, DOI 10.1172/JCI200421025; Watanabe M, 2006, NATURE, V439, P484, DOI 10.1038/nature04330; Yu CD, 2005, J BIOL CHEM, V280, P17707, DOI 10.1074/jbc.M411771200; Yu CD, 2000, J BIOL CHEM, V275, P15482, DOI 10.1074/jbc.275.20.15482	49	14	14	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2016	30	2					849	862		10.1096/fj.15-274449	http://dx.doi.org/10.1096/fj.15-274449			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DC7IA	26514166	Green Submitted			2022-12-26	WOS:000369391900033
J	Sipieter, F; Cappe, B; Pisfil, MG; Spriet, C; Bodart, JF; Cailliau-Maggio, K; Vandenabeele, P; Heliot, L; Riquet, FB				Sipieter, Francois; Cappe, Benjamin; Pisfil, Mariano Gonzalez; Spriet, Corentin; Bodart, Jean-Francois; Cailliau-Maggio, Katia; Vandenabeele, Peter; Heliot, Laurent; Riquet, Franck B.			Novel Reporter for Faithful Monitoring of ERK2 Dynamics in Living Cells and Model Organisms	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; SIGNAL-REGULATED KINASE; MAP KINASE; NUCLEAR TRANSLOCATION; IN-VIVO; CASCADE; LOCALIZATION; SPECIFICITY; MECHANISMS; EXPRESSION	Uncoupling of ERK1/2 phosphorylation from subcellular localization is essential towards the understanding of molecular mechanisms that control ERK1/2-mediated cell-fate decision. ERK1/2 non-catalytic functions and discoveries of new specific anchors responsible of the subcellular compartmentalization of ERK1/2 signaling pathway have been proposed as regulation mechanisms for which dynamic monitoring of ERK1/2 localization is necessary. However, studying the spatiotemporal features of ERK2, for instance, in different cellular processes in living cells and tissues requires a tool that can faithfully report on its subcellular distribution. We developed a novel molecular tool, ERK2-LOC, based on the T2A-mediated coexpression of strictly equimolar levels of eGFP-ERK2 and MEK1, to faithfully visualize ERK2 localization patterns. MEK1 and eGFP-ERK2 were expressed reliably and functionally both in vitro and in single living cells. We then assessed the subcellular distribution and mobility of ERK2-LOC using fluorescence microscopy in non-stimulated conditions and after activation/inhibition of the MAPK/ERK1/2 signaling pathway. Finally, we used our coexpression system in Xenopus laevis embryos during the early stages of development. This is the first report on MEK1/ERK2 T2A-mediated coexpression in living embryos, and we show that there is a strong correlation between the spatiotemporal subcellular distribution of ERK2-LOC and the phosphorylation patterns of ERK1/2. Our approach can be used to study the spatiotemporal localization of ERK2 and its dynamics in a variety of processes in living cells and embryonic tissues.	[Sipieter, Francois; Cappe, Benjamin; Vandenabeele, Peter; Riquet, Franck B.] Univ Ghent, Dept Biomed Mol Biol, Mol Signaling & Cell Death Unit, B-9000 Ghent, Belgium; [Sipieter, Francois; Cappe, Benjamin; Vandenabeele, Peter; Riquet, Franck B.] VIB, IRC, Mol Signaling & Cell Death Unit, Ghent, Belgium; [Vandenabeele, Peter] Univ Ghent, Methusalem Program, B-9000 Ghent, Belgium; [Sipieter, Francois; Pisfil, Mariano Gonzalez; Heliot, Laurent] CNRS UMR 8523, Equipe Biophoton Cellulaire Fonct, Lab Phys Lasers Atomes & Mol PhLAM, Villeneuve Dascq, France; [Sipieter, Francois; Bodart, Jean-Francois; Cailliau-Maggio, Katia] Univ Lille 1, Regulat Signal Div Team, Struct & Funct Glycobiol Unit UGSF, CNRS UMR 8576, F-59655 Villeneuve Dascq, France; [Riquet, Franck B.] Univ Lille 1, Struct & Funct Glycobiol Unit UGSF, CNRS UMR 8576, F-59655 Villeneuve Dascq, France; [Spriet, Corentin] Univ Lille 1, Struct & Funct Glycobiol Unit UGSF, TISBio, CNRS UMR 8576,FR3688, F-59655 Villeneuve Dascq, France; [Sipieter, Francois; Cappe, Benjamin; Pisfil, Mariano Gonzalez; Heliot, Laurent; Riquet, Franck B.] GDR2588 MIV CNRS, Groupement Rech Microscopie Imagerie Vivant, Villeneuve Dascq, France	Ghent University; Flanders Institute for Biotechnology (VIB); Ghent University; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Lille - ISITE; Universite de Lille; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Lille - ISITE; Universite de Lille; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Lille - ISITE; Universite de Lille	Riquet, FB (corresponding author), Univ Ghent, Dept Biomed Mol Biol, Mol Signaling & Cell Death Unit, B-9000 Ghent, Belgium.	franck.riquet@irc.vib-ugent.be	Vandenabeele, Peter/AAD-5793-2022; Spriet, Corentin/ABE-4215-2021; Bodart, Jean-François Laurent/AAZ-2075-2021; CAPPE, Benjamin/ABG-5598-2020; Vandenabeele, Peter/C-8597-2009	Vandenabeele, Peter/0000-0002-6669-8822; Spriet, Corentin/0000-0002-5805-3426; Bodart, Jean-François Laurent/0000-0002-6113-7700; CAPPE, Benjamin/0000-0002-8162-9788; cailliau, katia/0000-0003-1772-1034; SIPIETER, FRANCOIS/0000-0002-1332-400X; Cailliau, Katia/0000-0001-7993-8437	Lille 1 University; Centre National de la Recherche Scientifique (CNRS); Fonds Wetenschappelijk Onderzoek [FWO G.0875.11]; Methusalem grant (Bijzonder Onderzoeksfonds) [BOF09/01M00709]; Belgian grants (Interuniversity Attraction Poles) [IAP 7/32]; Flemish grant [FWO G.0973.11, FWO G.0A45.12N, FWO G.0172.12, FWO G.0787.13N, FWO G.0C31.14N]; Ghent University grant; Foundation against Cancer [2012-188]; Vlaams Instituut voor Biotechnologie (VIB); Agence Nationale pour la Recherche (ANR) [ANR-13-BSV2-0016-02]; contrat Plan Etat-Region "Campus Intelligent"; ANR "Multimodal" and DynamIC; Leica Microsystems	Lille 1 University; Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Fonds Wetenschappelijk Onderzoek(FWO); Methusalem grant (Bijzonder Onderzoeksfonds); Belgian grants (Interuniversity Attraction Poles)(Belgian Federal Science Policy Office); Flemish grant; Ghent University grant; Foundation against Cancer; Vlaams Instituut voor Biotechnologie (VIB); Agence Nationale pour la Recherche (ANR)(French National Research Agency (ANR)); contrat Plan Etat-Region "Campus Intelligent"; ANR "Multimodal" and DynamIC(French National Research Agency (ANR)); Leica Microsystems	FS is a joint PhD student between Lille1 University and Ghent University, and is funded by Lille 1 University, the Centre National de la Recherche Scientifique (CNRS), and Vandenabeele's group research funding: Fonds Wetenschappelijk Onderzoek (FWO G.0875.11) and Methusalem grant (Bijzonder Onderzoeksfonds, BOF09/01M00709). PV is senior full professor at Ghent University. FR is a visiting research professor at Ghent University and full associate professor at Lille 1 University. Research in the Vandenabeele group is further supported by Belgian grants (Interuniversity Attraction Poles, IAP 7/32), Flemish grants (FWO G.0973.11, FWO G.0A45.12N, FWO G.0172.12, FWO G.0787.13N, FWO G.0C31.14N), Ghent University grants (Multidisciplinary Research Platforms (MRP), Ghent Researchers On Unfolded Proteins in Inflammatory Disease (GROUP-ID) consortium), grant from the Foundation against Cancer, 2012-188) and grants from Vlaams Instituut voor Biotechnologie (VIB). This research is supported by the Agence Nationale pour la Recherche (ANR): G2Progress program (ANR-13-BSV2-0016-02). This work was funded by grants from contrat Plan Etat-Region "Campus Intelligent" and ANR "Multimodal" and DynamIC and supported by contrat with Leica Microsystems.	Adachi M, 2000, J CELL BIOL, V148, P849, DOI 10.1083/jcb.148.5.849; Ahmed S, 2014, MOL SYST BIOL, V10, DOI 10.1002/msb.134708; Ando R, 2004, SCIENCE, V306, P1370, DOI 10.1126/science.1102506; Aoki K, 2013, MOL CELL, V52, P529, DOI 10.1016/j.molcel.2013.09.015; Brightman FA, 2000, FEBS LETT, V482, P169, DOI 10.1016/S0014-5793(00)02037-8; Burack WR, 2005, J BIOL CHEM, V280, P3832, DOI 10.1074/jbc.M410031200; Cagnol S, 2010, FEBS J, V277, P2, DOI 10.1111/j.1742-4658.2009.07366.x; Caunt CJ, 2008, J BIOL CHEM, V283, P26612, DOI 10.1074/jbc.M801500200; Caunt CJ, 2010, J CELL SCI, V123, P4310, DOI 10.1242/jcs.076349; Christen B, 1999, DEVELOPMENT, V126, P119; Cohen-Saidon C, 2009, MOL CELL, V36, P885, DOI 10.1016/j.molcel.2009.11.025; Costa M, 2006, J CELL SCI, V119, P4952, DOI 10.1242/jcs.03272; Cross TG, 2000, EXP CELL RES, V256, P34, DOI 10.1006/excr.2000.4836; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Dehennaut V, 2008, MOL CELL PROTEOMICS, V7, P2229, DOI 10.1074/mcp.M700494-MCP200; Ebisuya M, 2005, J CELL SCI, V118, P2997, DOI 10.1242/jcs.02505; English J, 1999, EXP CELL RES, V253, P255, DOI 10.1006/excr.1999.4687; Faber J., 1994, NORMAL TABLE XENOPUS, P2; Fang JM, 2005, NAT BIOTECHNOL, V23, P584, DOI 10.1038/nbt1087; Ferrell JE, 1996, TRENDS BIOCHEM SCI, V21, P460, DOI 10.1016/S0968-0004(96)20026-X; Fujioka A, 2006, J BIOL CHEM, V281, P8917, DOI 10.1074/jbc.M509344200; Fukuda M, 1997, EMBO J, V16, P1901, DOI 10.1093/emboj/16.8.1901; Furuno T, 2001, J IMMUNOL, V166, P4416, DOI 10.4049/jimmunol.166.7.4416; Goedhart J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027321; GOTOH Y, 1995, EMBO J, V14, P2491, DOI 10.1002/j.1460-2075.1995.tb07246.x; Hatano N, 2003, GENES CELLS, V8, P847, DOI 10.1046/j.1365-2443.2003.00680.x; Hennecke M, 2001, NUCLEIC ACIDS RES, V29, P3327, DOI 10.1093/nar/29.16.3327; Hong SK, 2009, J BIOL CHEM, V284, P33006, DOI 10.1074/jbc.M109.012591; Horgan AM, 2003, EXP CELL RES, V285, P208, DOI 10.1016/S0014-4827(03)00037-5; Huang CYF, 1996, P NATL ACAD SCI USA, V93, P10078, DOI 10.1073/pnas.93.19.10078; Kholodenko BN, 2010, NAT REV MOL CELL BIO, V11, P414, DOI 10.1038/nrm2901; Kim JG, 2011, INT J SUSTAIN ENG, V4, P215, DOI 10.1080/19397038.2011.556757; Krens SFG, 2008, DEV BIOL, V319, P370, DOI 10.1016/j.ydbio.2008.04.032; LABONNE C, 1995, DEVELOPMENT, V121, P1475; LaBonne C, 1997, DEV BIOL, V183, P9, DOI 10.1006/dbio.1996.8497; Lefloch R, 2008, MOL CELL BIOL, V28, P511, DOI 10.1128/MCB.00800-07; Legewie S, 2007, BIOPHYS J, V93, P2279, DOI 10.1529/biophysj.107.109132; LENORMAND P, 1993, J CELL BIOL, V122, P1079, DOI 10.1083/jcb.122.5.1079; Lidke DS, 2010, J BIOL CHEM, V285, DOI 10.1074/jbc.M109.064972; McKay MM, 2007, ONCOGENE, V26, P3113, DOI 10.1038/sj.onc.1210394; Messenger NJ, 2005, DEV CELL, V8, P599, DOI 10.1016/j.devcel.2005.03.001; Minskaia E, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/291730; Morrison DK, 2003, ANNU REV CELL DEV BI, V19, P91, DOI 10.1146/annurev.cellbio.19.111401.091942; Naor Z, 2000, TRENDS ENDOCRIN MET, V11, P91, DOI 10.1016/S1043-2760(99)00232-5; Papin C, 2000, DEV BIOL, V217, P166, DOI 10.1006/dbio.1999.9531; Phair RD, 2004, METHOD ENZYMOL, V375, P393; Pouyssegur J, 2002, BIOCHEM PHARMACOL, V64, P755, DOI 10.1016/S0006-2952(02)01135-8; Raman M, 2007, ONCOGENE, V26, P3100, DOI 10.1038/sj.onc.1210392; Rauch J, 2011, CELL COMMUN SIGNAL, V9, DOI 10.1186/1478-811X-9-23; Roberts PJ, 2007, ONCOGENE, V26, P3291, DOI 10.1038/sj.onc.1210422; Robinson MJ, 1998, CURR BIOL, V8, P1141, DOI 10.1016/S0960-9822(07)00485-X; Saba-El-Leil MK, 2003, EMBO REP, V4, P964, DOI 10.1038/sj.embor.embor939; Sander JD, 2014, NAT BIOTECHNOL, V32, P347, DOI 10.1038/nbt.2842; Sasagawa S, 2005, NAT CELL BIOL, V7, P365, DOI 10.1038/ncb1233; Schoeberl B, 2002, NAT BIOTECHNOL, V20, P370, DOI 10.1038/nbt0402-370; Shankaran H, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.90; Shaul Yoav, 2006, Curr Protoc Mol Biol, VChapter 18, DOI 10.1002/0471142727.mb1812s73; Shaul YD, 2007, BBA-MOL CELL RES, V1773, P1213, DOI 10.1016/j.bbamcr.2006.10.005; Sipieter F, 2013, PROG MOL BIOL TRANSL, V113, P145, DOI 10.1016/B978-0-12-386932-6.00005-3; Smith JC, 1997, COLD SPRING HARB SYM, V62, P337; Stephens DJ, 2003, SCIENCE, V300, P82, DOI 10.1126/science.1082160; Sturm OE, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001212; Szymczak AL, 2004, NAT BIOTECHNOL, V22, P589, DOI 10.1038/nbt957; Szymczak-Workman Andrea L, 2012, Cold Spring Harb Protoc, V2012, P199, DOI 10.1101/pdb.ip067876; Tang W, 2009, J NEUROSCI, V29, P8621, DOI 10.1523/JNEUROSCI.0359-09.2009; Tomida T, 2015, J PHYSIOL SCI, V65, P37, DOI 10.1007/s12576-014-0332-9; Tomida T, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002983; Trichas G, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-40; Volmat V, 2001, J CELL SCI, V114, P3433; Whitmarsh AJ, 2000, NATURE, V403, P255, DOI 10.1038/35002220; Wortzel Inbal, 2011, Genes Cancer, V2, P195, DOI 10.1177/1947601911407328; Yao Y, 2003, P NATL ACAD SCI USA, V100, P12759, DOI 10.1073/pnas.2134254100; Yao Z, 2001, ONCOGENE, V20, P7588, DOI 10.1038/sj.onc.1204963; Yoon S, 2006, GROWTH FACTORS, V24, P21, DOI 10.1080/02699050500284218; Zehorai E, 2010, MOL CELL ENDOCRINOL, V314, P213, DOI 10.1016/j.mce.2009.04.008; Zhang K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092917	76	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2015	10	10							e0140924	10.1371/journal.pone.0140924	http://dx.doi.org/10.1371/journal.pone.0140924			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0EH	26517832	Green Published, gold, Green Submitted			2022-12-26	WOS:000363920800013
J	Szelid, Z; Lux, A; Kolossvary, M; Toth, A; Vago, H; Lendvai, Z; Kiss, L; Maurovich-Horvat, P; Bagyura, Z; Merkely, B				Szelid, Zsolt; Lux, Arpad; Kolossvary, Marton; Toth, Attila; Vago, Hajnalka; Lendvai, Zsuzsanna; Kiss, Loretta; Maurovich-Horvat, Pal; Bagyura, Zsolt; Merkely, Bela			Right Ventricular Adaptation Is Associated with the Glu298Asp Variant of the NOS3 Gene in Elite Athletes	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; ENDURANCE EXERCISE; COMMON VARIANT; HEART-FAILURE; RISK-FACTOR; POLYMORPHISMS; DISEASE; METAANALYSIS; INDIVIDUALS; ARRHYTHMIAS	Nitric oxide (NO), an important endogenous pulmonary vasodilator is synthetized by the endothelial NO synthase (NOS3). Reduced NO bioavailability and thus the Glu298Asp polymorphism of NOS3 may enhance right ventricular (RV) afterload and hypertrophic remodeling and influence athletic performance. To test this hypothesis world class level athletes (water polo players, kayakers, canoeists, rowers, swimmers, n = 126) with a VO2 maximum greater than 50ml/kg/min were compared with non-athletic volunteers (n = 155). Cardiopulmonary exercise tests and cardiac magnetic resonance imaging (cMRI) were performed to determine structural or functional changes. Genotype distribution of the NOS3 Glu298Asp polymorphism was not affected by gender or physical performance. Cardiac MRI showed increased stroke volume with eccentric hypertrophy in all athletes regardless of their genotype. However, the Asp allelic variant carriers had increased RV mass index (32 +/- 6g versus 27 +/- 6g, p<0.01) and larger RV stroke volume index (71 +/- 10ml versus 64 +/- 10ml, p<0.01) than athletes with a Glu/Glu genotype. Genotype was not significantly associated with athletic performance. In the non-athletic group no genotype related differences were detected. The association between the NOS3 Glu298Asp polymorphism and RV structure and dimension in elite athletes emphasizes the importance of NOS3 gene function and NO bioavailability in sport related cardiac adaptation.	[Szelid, Zsolt; Lux, Arpad; Kolossvary, Marton; Toth, Attila; Vago, Hajnalka; Lendvai, Zsuzsanna; Kiss, Loretta; Maurovich-Horvat, Pal; Bagyura, Zsolt; Merkely, Bela] Semmelweis Univ, Heart & Vasc Ctr, H-1085 Budapest, Hungary; [Kolossvary, Marton; Maurovich-Horvat, Pal] Semmelweis Univ, Heart & Vasc Ctr, MTA SE Cardiovasc Imaging Res Grp, H-1085 Budapest, Hungary	Semmelweis University; Semmelweis University	Szelid, Z (corresponding author), Semmelweis Univ, Heart & Vasc Ctr, H-1085 Budapest, Hungary.	szelid.zsolt@kardio.sote.hu	Toth, Attila/AAM-1031-2020; Vago, Hajnalka/AAG-2647-2019; Maurovich-Horvat, Pal/J-8003-2017; Kolossváry, Márton/R-1138-2016; Kiss, Loretta/P-5994-2019	Toth, Attila/0000-0002-4081-7168; Maurovich-Horvat, Pal/0000-0003-0885-736X; Kolossváry, Márton/0000-0002-5570-991X; Kiss, Loretta/0000-0002-9209-3552; Vago, Hajnalka/0000-0002-3568-3572	Hungarian TAMOP (Social Renewal Operational Program) [4.2.1.B-09/1/KMR]	Hungarian TAMOP (Social Renewal Operational Program)	This work was supported by the Hungarian TAMOP (Social Renewal Operational Program)-4.2.1.B-09/1/KMR research grant. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaron CP, 2011, AM J RESP CRIT CARE, V183, P396, DOI 10.1164/rccm.201003-0469OC; Benito B, 2011, CIRCULATION, V123, P13, DOI 10.1161/CIRCULATIONAHA.110.938282; Bito V, 2010, CARDIOVASC RES, V86, P72, DOI 10.1093/cvr/cvp381; Bookman EB, 2006, AM J MED GENET A, V140A, P1033, DOI 10.1002/ajmg.a.31195; Booz GW, 2005, HYPERTENSION, V45, P341, DOI 10.1161/01.HYP.0000156878.17006.02; Casas JP, 2004, CIRCULATION, V109, P1359, DOI 10.1161/01.CIR.0000121357.76910.A3; Casas JP, 2006, AM J EPIDEMIOL, V164, P921, DOI 10.1093/aje/kwj302; Claessen G, 2014, MED SCI SPORT EXER, V46, P1717, DOI 10.1249/MSS.0000000000000282; Davel AP, 2015, LIFE SCI, V125, P49, DOI 10.1016/j.lfs.2015.01.018; Dell'Omo G, 2007, J HYPERTENS, V25, P1389, DOI 10.1097/HJH.0b013e3281268548; Ector J, 2007, EUR HEART J, V28, P345, DOI 10.1093/eurheartj/ehl468; Fagan KA, 1999, AM J PHYSIOL-LUNG C, V277, pL472, DOI 10.1152/ajplung.1999.277.3.L472; Feletou M, 2001, AM J PHYSIOL-LUNG C, V281, pL258, DOI 10.1152/ajplung.2001.281.1.L258; Gielis JF, 2011, FREE RADICAL BIO MED, V50, P765, DOI 10.1016/j.freeradbiomed.2010.12.018; Hand BD, 2006, INT J SPORTS MED, V27, P951, DOI 10.1055/s-2006-923901; Heidbuchel H, 2003, EUR HEART J, V24, P1473, DOI 10.1016/S0195-668X(03)00282-3; Heusch G, 2000, CIRC RES, V87, P146, DOI 10.1161/01.RES.87.2.146; Hingorani AD, 1999, CIRCULATION, V100, P1515, DOI 10.1161/01.CIR.100.14.1515; Jones SP, 2003, P NATL ACAD SCI USA, V100, P4891, DOI 10.1073/pnas.0837428100; La Gerche A, 2014, PULM CIRC, V4, P407, DOI 10.1086/677355; La Gerche A, 2013, JACC-CARDIOVASC IMAG, V6, P993, DOI 10.1016/j.jcmg.2013.06.003; La Gerche A, 2012, EUR HEART J, V33, P998, DOI 10.1093/eurheartj/ehr397; La Gerche A, 2011, MED SCI SPORT EXER, V43, P974, DOI 10.1249/MSS.0b013e31820607a3; La Gerche A, 2010, J AM COLL CARDIOL, V56, P1263, DOI 10.1016/j.jacc.2010.05.036; Lembo G, 2001, STROKE, V32, P735, DOI 10.1161/01.STR.32.3.735; MARON BJ, 1986, J AM COLL CARDIOL, V7, P190, DOI 10.1016/S0735-1097(86)80282-0; Matsa LS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070523; Matter CM, 1999, CIRCULATION, V99, P2396, DOI 10.1161/01.CIR.99.18.2396; Mcnamara DM, 2009, J CARD FAIL, V15, P191, DOI 10.1016/j.cardfail.2008.10.028; Modesti PA, 2004, HYPERTENSION, V43, P101, DOI 10.1161/01.HYP.0000104720.76179.18; Pereira TV, 2007, J HYPERTENS, V25, P1763, DOI 10.1097/HJH.0b013e3281de740d; Perseghin G, 2007, AM HEART J, V154, P937, DOI 10.1016/j.ahj.2007.06.039; Rankinen T, 2000, HYPERTENSION, V36, P885, DOI 10.1161/01.HYP.36.5.885; Saunders CJ, 2006, HUM MOL GENET, V15, P979, DOI 10.1093/hmg/ddl014; Scharf M, 2010, AM HEART J, V159, P911, DOI 10.1016/j.ahj.2010.02.027; Scharhag J, 2002, J AM COLL CARDIOL, V40, P1856, DOI 10.1016/S0735-1097(02)02478-6; Stamler JS, 2001, PHYSIOL REV, V81, P209, DOI 10.1152/physrev.2001.81.1.209; Steding K, 2010, J CARDIOVASC MAGN R, V12, DOI 10.1186/1532-429X-12-8; Tesauro M, 2000, P NATL ACAD SCI USA, V97, P2832, DOI 10.1073/pnas.97.6.2832; Wolfarth B, 2008, SCAND J MED SCI SPOR, V18, P485, DOI 10.1111/j.1600-0838.2007.00717.x	40	6	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2015	10	10							e0141680	10.1371/journal.pone.0141680	http://dx.doi.org/10.1371/journal.pone.0141680			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0EH	26517550	Green Published, Green Submitted, gold			2022-12-26	WOS:000363920800067
J	Zhou, YM; Lu, JJ; Tan, DY; Baskin, CC; Baskin, JM				Zhou, Yuan M.; Lu, Juan J.; Tan, Dun Y.; Baskin, Carol C.; Baskin, Jerry M.			Seed Germination Ecology of the Cold Desert Annual Isatis violascens (Brassicaceae): Two Levels of Physiological Dormancy and Role of the Pericarp	PLOS ONE			English	Article							RAPHANUS-RAPHANISTRUM; RAPISTRUM-RUGOSUM; STRATEGIES; RESPONSES; PLANTS; FRUIT; WATER	The occurrence of various species of Brassicaceae with indehiscent fruits in the cold deserts of NW China suggests that there are adaptive advantages of this trait. We hypothesized that the pericarp of the single-seeded silicles of Isatis violascens restricts embryo expansion and thus prevents germination for 1 or more years. Thus, our aim was to investigate the role of the pericarp in seed dormancy and germination of this species. The effects of afterripening, treatment with gibberellic acid (GA(3)) and cold stratification on seed dormancy-break were tested using intact silicles and isolated seeds, and germination phenology was monitored in an experimental garden. The pericarp has a role in mechanically inhibiting germination of fresh seeds and promotes germination of nondormant seeds, but it does not facilitate formation of a persistent seed bank. Seeds in silicles in watered soil began to germinate earlier in autumn and germinated to higher percentages than isolated seeds. Sixty-two percent of seeds in the buried silicles germinated by the end of the first spring, and only 3% remained nongerminated and viable. Twenty to twenty-five percent of the seeds have nondeep physiological dormancy (PD) and 75-80% intermediate PD. Seeds with nondeep PD afterripen in summer and germinate inside the silicles in autumn if the soil is moist. Afterripening during summer significantly decreased the amount of cold stratification required to break intermediate PD. The presence of both nondeep and intermediate PD in the seed cohort may be a bet-hedging strategy.	[Zhou, Yuan M.; Lu, Juan J.; Tan, Dun Y.; Baskin, Carol C.; Baskin, Jerry M.] Xinjiang Agr Univ, Coll Grassland & Environm Sci, Xinjiang Key Lab Soil & Plant Ecol Proc, Urumqi, Peoples R China; [Baskin, Carol C.; Baskin, Jerry M.] Univ Kentucky, Dept Biol, Lexington, KY USA; [Baskin, Carol C.] Univ Kentucky, Dept Plant & Soil Sci, Lexington, KY USA	Xinjiang Agricultural University; University of Kentucky; University of Kentucky	Tan, DY (corresponding author), Xinjiang Agr Univ, Coll Grassland & Environm Sci, Xinjiang Key Lab Soil & Plant Ecol Proc, Urumqi, Peoples R China.	tandunyan@163.com; ccbask0@uky.edu			National Natural Science Foundation of China [41361011, 31160063]; Key Project of Chinese Ministry of Education [213038A]; Major National Scientific Research Program of China [2014CB954202]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Project of Chinese Ministry of Education(Ministry of Education, China); Major National Scientific Research Program of China	This work was supported in part by the National Natural Science Foundation of China (41361011, 31160063), the Key Project of Chinese Ministry of Education (213038A) and the Major National Scientific Research Program of China (2014CB954202). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Shehbaz IA, 2006, PLANT SYST EVOL, V259, P89, DOI 10.1007/s00606-006-0415-z; Baskin CC, 2014, SEEDS: ECOLOGY, BIOGEOGRAPHY, AND EVOLUTION OF DORMANCY AND GERMINATION, 2ND EDITION, P1, DOI 10.1016/B978-0-12-416677-6.00001-9; Baskin JM, 2004, SEED SCI RES, V14, P1, DOI 10.1079/SSR2003150; CHEAM AH, 1986, WEED RES, V26, P405, DOI 10.1111/j.1365-3180.1986.tb00724.x; [陈亚宁 Chen Yaning], 2014, [地理学报, Acta Geographica Sinica], V69, P1295; COHEN D, 1966, J THEOR BIOL, V12, P119, DOI 10.1016/0022-5193(66)90188-3; COUSENS R, 1994, WEED RES, V34, P127, DOI 10.1111/j.1365-3180.1994.tb01980.x; Cousens RD, 2010, ANN BOT-LONDON, V105, P101, DOI 10.1093/aob/mcp268; Davis WE, 1930, AM J BOT, V17, P58, DOI 10.2307/2446380; GILLESPIE JH, 1977, AM NAT, V111, P1010, DOI 10.1086/283230; Gremer JR, 2014, ECOL LETT, V17, P380, DOI 10.1111/ele.12241; Hu XW, 2009, ECOL RES, V24, P559, DOI 10.1007/s11284-008-0524-y; Huang Z., 2001, ACTA ECOL SIN, V25, P22; Li Yan, 2014, ACTA BOTANICA BOREALI-OCCIDENTALIA SINICA, V34, P902, DOI 10.7606/j.issn.1000-4025.2014.05.0902; Liu Xiao-Feng, 2007, Zhiwu Shengtai Xuebao, V31, P1019; Lu JJ, 2015, PERSPECT PLANT ECOL, V17, P255, DOI 10.1016/j.ppees.2015.04.001; Lu JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102018; Lu JJ, 2010, ANN BOT-LONDON, V105, P999, DOI 10.1093/aob/mcq041; [马生军 MA ShengJun], 2007, [生态学报, Acta Ecologica Sinica], V27, P486; Mamut J, 2014, ECOL RES, V29, P33, DOI 10.1007/s11284-013-1098-x; MAXWELL CD, 1994, CAN J BOT, V72, P1282, DOI 10.1139/b94-156; MEKENIAN MR, 1975, B TORREY BOT CLUB, V102, P243, DOI 10.2307/2484141; Nikolaeva M.G., 1969, SEEDS; Ohadi S, 2011, WEED SCI, V59, P483, DOI 10.1614/WS-D-10-00153.1; PHILIPPI T, 1989, TRENDS ECOL EVOL, V4, P41, DOI 10.1016/0169-5347(89)90138-9; Qian YB, 2007, CHINESE SCI BULL, V52, P3118, DOI 10.1007/s11434-007-0465-9; Simons AM, 2011, P ROY SOC B-BIOL SCI, V278, P1601, DOI 10.1098/rspb.2011.0176; Sokal R.R., 2012, BIOMETRY; Sun HZ, 2009, S AFR J BOT, V75, P537, DOI 10.1016/j.sajb.2009.05.001; THOMPSON K, 1979, J ECOL, V67, P893, DOI 10.2307/2259220; Venable DL, 2007, ECOLOGY, V88, P1086, DOI 10.1890/06-1495; [Wang Xueqin 王雪芹], 2003, Journal of Geographical Sciences, V13, P323; Wang XQ, 2006, CHINESE SCI BULL, V51, P110, DOI 10.1007/s11434-006-8214-z	33	19	21	2	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2015	10	10							e0140983	10.1371/journal.pone.0140983	http://dx.doi.org/10.1371/journal.pone.0140983			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0ED	26513241	Green Published, gold, Green Submitted			2022-12-26	WOS:000363920300011
J	Hernandez-Imaz, E; Martin, Y; de Conti, L; Melean, G; Valero, A; Baralle, M; Hernandez-Chico, C				Hernandez-Imaz, Elisabete; Martin, Yolanda; de Conti, Laura; Melean, German; Valero, Ana; Baralle, Marco; Hernandez-Chico, Concepcion			Functional Analysis of Mutations in Exon 9 of NF1 Reveals the Presence of Several Elements Regulating Splicing	PLOS ONE			English	Article							NEUROFIBROMATOSIS TYPE-1 GENE; CAUSES FRONTOTEMPORAL DEMENTIA; ENHANCER ELEMENTS; TAU EXON-10; PROTEINS; ENCODES; DOMAIN; GAP; DETERMINANTS; DISRUPTION	Neurofibromatosis type 1 (NF1) is one of the most common human hereditary disorders, predisposing individuals to the development of benign and malignant tumors in the nervous system, as well as other clinical manifestations. NF1 is caused by heterozygous mutations in the NF1 gene and around 25% of the pathogenic changes affect pre-mRNA splicing. Since the molecular mechanisms affected by these mutations are poorly understood, we have analyzed the splicing mutations identified in exon 9 of NF1, which is particularly prone to such changes, to better define the possible splicing regulatory elements. Using a mini-gene approach, we studied the effect of five splicing mutations in this exon described in patients. These highlighted three regulatory motifs within the exon. An in vivo splicing analysis of an extensive collection of changes generated in the minigene demonstrated that the CG motif at c.910-911 is critical for the recognition of exon 9. We also found that the GC motif at c.945-946 is involved in exon recognition through SRSF2 and that this motif is part of a Composite Exon Splicing Regulatory Element made up of physically overlapping enhancer and silencer elements. Finally, through an in vivo splicing analysis and in vitro binding assays, we demonstrated that the c.1007G>A mutation creates an Exonic Splicing Silencer element that binds the hnRNPA1 protein. The complexity of the splicing regulatory elements present in exon 9 is most likely responsible for the fact that mutations in this region represent 25% of all exonic changes that affect splicing in the NF1 gene.	[Hernandez-Imaz, Elisabete; Martin, Yolanda; Melean, German; Valero, Ana; Hernandez-Chico, Concepcion] Hosp Univ Ramon & Cajal, Serv Genet, IRYCIS, Madrid, Spain; [Hernandez-Imaz, Elisabete; Martin, Yolanda; Melean, German; Valero, Ana; Hernandez-Chico, Concepcion] Ctr Invest Biomed Red Enfermedades Rara CIBERER, Madrid, Spain; [de Conti, Laura; Baralle, Marco] Int Ctr Genet Engn & Biotechnol, I-34012 Trieste, Italy	Hospital Universitario Ramon y Cajal; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; International Center for Genetic Engineering & Biotechnology (ICGEB)	Hernandez-Chico, C (corresponding author), Hosp Univ Ramon & Cajal, Serv Genet, IRYCIS, Madrid, Spain.	chchico@salud.madrid.org		Baralle, Marco/0000-0002-0417-1013	Instituto de Salud Carlos III, Madrid, Spain [FIS: PI 10/00536]; European Regional Development; Departamento de Educacion, Universidades e Investigacion from Gobierno Vasco	Instituto de Salud Carlos III, Madrid, Spain(Instituto de Salud Carlos III); European Regional Development(European Commission); Departamento de Educacion, Universidades e Investigacion from Gobierno Vasco	This research was supported by grants from Instituto de Salud Carlos III (http://www.isciii.es/), Madrid, Spain (FIS: PI 10/00536) with co-funding from the European Regional Development and the Departamento de Educacion, Universidades e Investigacion from Gobierno Vasco (E.H.I.).	BALLESTER R, 1990, CELL, V63, P851, DOI 10.1016/0092-8674(90)90151-4; Baralle M, 2006, FEBS LETT, V580, P4449, DOI 10.1016/j.febslet.2006.07.018; Blencowe BJ, 2000, TRENDS BIOCHEM SCI, V25, P106, DOI 10.1016/S0968-0004(00)01549-8; Bottillo I, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-4; Buratti E, 2004, MOL CELL BIOL, V24, P1387, DOI 10.1128/MCB.24.3.1387-1400.2004; Valero MC, 2011, J MOL DIAGN, V13, P113, DOI 10.1016/j.jmoldx.2010.09.002; Cartegni L, 2006, AM J HUM GENET, V78, P63, DOI 10.1086/498853; Cartegni L, 2003, NUCLEIC ACIDS RES, V31, P3568, DOI 10.1093/nar/gkg616; Colapietro P, 2003, HUM GENET, V113, P551, DOI 10.1007/s00439-003-1009-2; Daubner GM, 2012, EMBO J, V31, P162, DOI 10.1038/emboj.2011.367; Dauksaite V, 2002, J BIOL CHEM, V277, P12579, DOI 10.1074/jbc.M107867200; Gao L, 2007, MOL CELL NEUROSCI, V34, P48, DOI 10.1016/j.mcn.2006.10.004; Goina E, 2008, MOL CELL BIOL, V28, P3850, DOI 10.1128/MCB.02253-07; Hoffmeyer S, 1998, AM J HUM GENET, V62, P269, DOI 10.1086/301715; Hofmann Y, 2002, HUM MOL GENET, V11, P2037, DOI 10.1093/hmg/11.17.2037; Kashima T, 2007, HUM MOL GENET, V16, P3149, DOI 10.1093/hmg/ddm276; Lewis HA, 2000, CELL, V100, P323, DOI 10.1016/S0092-8674(00)80668-6; Lim KH, 2011, P NATL ACAD SCI USA, V108, P11093, DOI 10.1073/pnas.1101135108; Llorian M, 2010, NAT STRUCT MOL BIOL, V17, P1114, DOI 10.1038/nsmb.1881; MARTIN GA, 1990, CELL, V63, P843, DOI 10.1016/0092-8674(90)90150-D; Martinez-Contreras R, 2007, ADV EXP MED BIOL, V623, P123, DOI 10.1007/978-0-387-77374-2_8; Messiaen L. M., 2008, V16, P63, DOI 10.1159/000126545; Miro J, 2015, NUCLEIC ACIDS RES, V43, P2378, DOI 10.1093/nar/gkv086; Prior TW, 2009, AM J HUM GENET, V85, P408, DOI 10.1016/j.ajhg.2009.08.002; Pros E, 2006, HUM MUTAT, V27, P1104, DOI 10.1002/humu.20396; Pros E, 2008, HUM MUTAT, V29, pE173, DOI 10.1002/humu.20826; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Skoko N, 2008, FEBS LETT, V582, P2231, DOI 10.1016/j.febslet.2008.05.018; Ule J, 2003, SCIENCE, V302, P1212, DOI 10.1126/science.1090095; Valadkhan S, 2010, PROTEOMICS, V10, P4128, DOI 10.1002/pmic.201000354; Vezain M, 2010, HUM MUTAT, V31, pE1110, DOI 10.1002/humu.21173; Wang JN, 2004, J NEUROCHEM, V88, P1078, DOI 10.1046/j.1471-4159.2003.02232.x; Wang Y, 2011, GENE, V485, P130, DOI 10.1016/j.gene.2011.06.020; Wang ZF, 2008, RNA, V14, P802, DOI 10.1261/rna.876308; Wimmer K, 2007, HUM MUTAT, V28, P599, DOI 10.1002/humu.20493; Wimmer K, 2000, Hum Mutat, V16, P90, DOI 10.1002/1098-1004(200007)16:1<90::AID-HUMU20>3.0.CO;2-J; Witten JT, 2011, TRENDS GENET, V27, P89, DOI 10.1016/j.tig.2010.12.001; Wu YC, 2005, GENOMICS, V86, P329, DOI 10.1016/j.ygeno.2005.05.011; XU GF, 1990, CELL, V62, P599, DOI 10.1016/0092-8674(90)90024-9; Zatkova A, 2004, HUM MUTAT, V24, P491, DOI 10.1002/humu.20103; Zhang CL, 2008, GENE DEV, V22, P2550, DOI 10.1101/gad.1703108	41	5	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2015	10	10							e0141735	10.1371/journal.pone.0141735	http://dx.doi.org/10.1371/journal.pone.0141735			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0DL	26509978	Green Published, gold, Green Submitted			2022-12-26	WOS:000363918100127
J	de Araujo, GCS; Mourao, NT; Pinheiro, IN; Xavier, AR; Gameiro, VS				Serrao de Araujo, Gabriel Costa; Mourao, Natalia Teixeira; Pinheiro, Igor Natario; Xavier, Analucia Rampazzo; Gameiro, Vinicius Schott			Lead Toxicity Risks in Gunshot Victims	PLOS ONE			English	Article							EMERGENCY-DEPARTMENT PATIENTS; BLOOD LEAD; RETAINED BULLET; EXPOSURE; ASSOCIATION; BIOMARKERS; CHILDREN; DISEASE; LEVEL	Background Gunshot wounds require surgeons to decide whether to remove or leave bullet fragments in the body. Surgeons also decide how to follow up with patients who have lead fragments retained in their body. Current literature recommends to remove only intra-articular fragments without the need for a follow-up for patients with the metal retained. Therefore, this study investigates chronic lead toxicity for gunshot wounds. Methods The study was performed in the metropolitan area of Rio de Janeiro/Brazil, between 2013 and 2015. It was a case-control study that included 45 victims of gunshot lesions with metallic fragments retained for more than 6 months. The 45 controls were matched for gender, age, and race. We compared the lead blood levels and frequency of symptoms. Results The control group had average blood lead levels of 2.17 mu g/dL (95% Confidence Interval [CI]; 1.71-2.63) and median 2.1 mu g/dL. The case group had average values of 9.01 mu g/dL (CI; 6.07-11.96) and median values of 6.5 mu g/dL with p-values < = 0.001. The case group reported the following more frequently: irritancy, bad mood, headache, memory losses, day-light drowsiness, myalgia, weakness, abdominal pain, joint pain, trembling, tingling limbs. There was statistical significance for the differences of symptoms frequencies and for odds ratio between groups. Conclusions Although the mean lead levels found were lower than the current laboratory references, low levels have been associated with both rising morbidity and mortality. The WHO stated: "There is no known level of lead exposure that is considered safe". In conclusion, this work showed that bullets retained in the body are not innocuous. There are impacts in the blood lead levels and symptoms related to it, even with few fragments, extra-articular located or existing with low blood lead levels.	[Serrao de Araujo, Gabriel Costa; Pinheiro, Igor Natario; Xavier, Analucia Rampazzo; Gameiro, Vinicius Schott] Univ Fed Fluminense, Fac Med, Hosp Univ Antonio Pedro, Niteroi, RJ, Brazil; [Mourao, Natalia Teixeira] Hosp Cent Policia Mil, Rio De Janeiro, RJ, Brazil	Universidade Federal Fluminense	de Araujo, GCS (corresponding author), Univ Fed Fluminense, Fac Med, Hosp Univ Antonio Pedro, Niteroi, RJ, Brazil.	gabrieldearaujo@gmail.com	Xavier, Analúcia/G-9255-2011	Xavier, Analúcia/0000-0003-4501-1857; Araujo, Gabriel/0000-0002-7048-6726	CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior), a public agency of the Brazilian Ministry of Education	CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior), a public agency of the Brazilian Ministry of Education	GCSA is Master's student that received a student financial support by CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior), a public agency of the Brazilian Ministry of Education. http://www.capes.gov.br. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartlett CS, 2003, CLIN ORTHOP RELAT R, P28, DOI 10.1097/01.blo.0000053164.71678.14; Bolanos AA, 1996, J BONE JOINT SURG AM, V78A, P422, DOI 10.2106/00004623-199603000-00014; Capitani EM, 2009, MEDICINA, V42, P319; Coon S, 2006, ENVIRON HEALTH PERSP, V114, P1872, DOI 10.1289/ehp.9102; de Almeida Lopes A. C., 2015, J TOXICOL ENV HEAL A, V78, P92, DOI DOI 10.1080/15287394.2014.942125; DIMAIO VJM, 1983, AM J FOREN MED PATH, V4, P165; Fang F, 2010, AM J EPIDEMIOL, V171, P1126, DOI 10.1093/aje/kwq063; Farrell SE, 1999, ACAD EMERG MED, V6, P208, DOI 10.1111/j.1553-2712.1999.tb00157.x; Florea A. M., 2013, J LOCAL GLOB HLTH SC, V4, DOI [10.5339/jlghs.2013.4, DOI 10.5339/JLGHS.2013.4]; Ganocy K, 1998, INJURY, V29, P1, DOI 10.1016/S0020-1383(98)90031-6; Gilbert SG, 2006, NEUROTOXICOLOGY, V27, P693, DOI 10.1016/j.neuro.2006.06.008; Gulson BL, 1998, J LAB CLIN MED, V131, P324, DOI 10.1016/S0022-2143(98)90182-2; Jain NB, 2007, ENVIRON HEALTH PERSP, V115, P871, DOI 10.1289/ehp.9629; Khalil N, 2009, ENVIRON HEALTH-GLOB, V8, DOI 10.1186/1476-069X-8-15; LEONARD MH, 1969, CLIN ORTHOP RELAT R, P255; Marturano EM, 2009, MEDICINA RIBEIRAO PR, V42, P291; McQuirter JL, 2004, AM J EPIDEMIOL, V159, P683, DOI 10.1093/aje/kwh074; Moazeni M, 2014, ARCH TRAUMA RES, V3, DOI [10.5812/atr.18950, DOI 10.5812/ATR.18950]; Nawrot TS, 2006, CIRCULATION, V114, P1347, DOI 10.1161/CIRCULATIONAHA.106.650440; Needleman HL, 2002, NEUROTOXICOL TERATOL, V24, P711, DOI 10.1016/S0892-0362(02)00269-6; Nguyen A, 2005, J TRAUMA, V58, P289, DOI 10.1097/01.TA.0000119205.24520.1D; ROUX P, 1988, S AFR MED J, V73, P580; Sanders Talia, 2009, Reviews on Environmental Health, V24, P15; Schnaas L, 2006, ENVIRON HEALTH PERSP, V114, P791, DOI 10.1289/ehp.8552; Souza AM, 2009, MEDICINA RIBEIRAO PR, V42, P337; Theppeang K, 2008, AM J PUBLIC HEALTH, V98, P1248, DOI 10.2105/AJPH.2007.118505	26	11	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2015	10	10							e0140220	10.1371/journal.pone.0140220	http://dx.doi.org/10.1371/journal.pone.0140220			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0DL	26509498	Green Published, gold, Green Submitted			2022-12-26	WOS:000363918100022
J	Ti, LP; Milloy, MJ; Buxton, J; McNeil, R; Dobrer, S; Hayashi, K; Wood, E; Kerr, T				Ti, Lianping; Milloy, M-J; Buxton, Jane; McNeil, Ryan; Dobrer, Sabina; Hayashi, Kanna; Wood, Evan; Kerr, Thomas			Factors Associated with Leaving Hospital against Medical Advice among People Who Use Illicit Drugs in Vancouver, Canada	PLOS ONE			English	Article							COMMUNITY REENTRY; PAIN MANAGEMENT; RISK; DISCHARGE; THERAPY; COHORT; HOME; READMISSION; EMPLOYMENT; MORTALITY	Background Leaving hospital against medical advice (AMA) is common among people who use illicit drugs (PWUD) and is associated with severe health-related harms and costs. However, little is known about the prevalence of and factors associated with leaving AMA among PWUD. Methods Data were collected through two Canadian prospective cohort studies involving PWUD between September 2005 and July 2011 and linked to a hospital admission/discharge database. Bivariable and multivariable generalized estimating equations were used to examine factors associated with leaving hospital AMA among PWUD who were hospitalized. Results Among 488 participants who experienced at least one hospitalization, 212 (43.4%) left the hospital AMA at least once during the study period. In multivariable analyses, factors positively and significantly associated with leaving hospital AMA included: unstable employment (AOR = 1.92; 95% confidence interval [CI]: 1.22-3.03); recent incarceration (AOR = 1.63; 95% CI: 1.07-2.49); >= daily heroin injection (AOR = 1.49; 95% CI: 1.05-2.11); and younger age per year younger (adjusted odds ratio [AOR] = 1.04; 95% CI: 1.02-1.06). Conclusions We found a substantial proportion of PWUD in this setting left hospital AMA and that various markers of risk and vulnerability were associated with this phenomenon. Our findings highlight the need to address substance abuse issues early following hospital admission. These findings further suggest a need to develop novel interventions to minimize PWUD leaving hospital prematurely.	[Ti, Lianping; Milloy, M-J; McNeil, Ryan; Dobrer, Sabina; Hayashi, Kanna; Wood, Evan; Kerr, Thomas] St Pauls Hosp, British Columbia Ctr Excellence HIV AIDS, Vancouver, BC V6Z 1Y6, Canada; [Ti, Lianping; Milloy, M-J; Hayashi, Kanna; Wood, Evan; Kerr, Thomas] Univ British Columbia, Dept Med, Vancouver, BC V5Z 1M9, Canada; [Buxton, Jane] Univ British Columbia, Sch Populat & Publ Hlth, Vancouver, BC V6T 1Z3, Canada; [Buxton, Jane] British Columbia Ctr Dis Control, Vancouver, BC V5Z 4R4, Canada	B.C. Centre for Excellence in HIV/AIDS; St. Paul's Hospital; University of Saskatchewan; University of British Columbia; University of British Columbia	Kerr, T (corresponding author), St Pauls Hosp, British Columbia Ctr Excellence HIV AIDS, 1081 Burrard St, Vancouver, BC V6Z 1Y6, Canada.	uhri-tk@cfenet.ubc.ca	Milloy, M-J/AAY-3618-2020; Dobrer, Sabina/AAD-1070-2021; Dobrer, Sabina/S-4401-2019		US National Institutes of Health [R01DA011591, U01DA038886, R01DA021525]; Canadian Institutes of Health Research; Canada Research Chairs program through a Tier 1 Canada Research Chair in Inner City Medicine; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA021525, R01DA011591, U01DA038886, R01DA033147] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canada Research Chairs program through a Tier 1 Canada Research Chair in Inner City Medicine(Canada Research Chairs); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The VIDUS study was supported by the US National Institutes of Health (R01DA011591, U01DA038886; http://www.drugabuse.gov/). The ACCESS study was supported by the US National Institutes of Health (R01DA021525; http://www.drugabuse.gov/). LT and KH are supported by the Canadian Institutes of Health Research (http://www.cihr.ca/). This research was undertaken, in part, thanks to funding from the Canada Research Chairs program through a Tier 1 Canada Research Chair in Inner City Medicine which supports EW (http://www.chairs-chaires.gc. ca/home-accueil-eng.aspx). M-JM is supported, in part, by the US National Institutes of Health (R01DA021525; http://www.drugabuse.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandre PK, 2004, CONTEMP ECON POLICY, V22, P382, DOI 10.1093/cep/byh028; Alfandre DJ, 2009, MAYO CLIN PROC, V84, P255, DOI 10.1016/S0025-6196(11)61143-9; Aliyu Z, 2002, INT J CLIN PRACT, V56, P325; Anis AH, 2002, CAN MED ASSOC J, V167, P633; Binswanger IA, 2000, CLIN INFECT DIS, V30, P579, DOI 10.1086/313703; Carroll IR, 2004, REGION ANESTH PAIN M, V29, P576, DOI 10.1016/j.rapm.2004.06.009; Chan ACH, 2004, JAIDS-J ACQ IMM DEF, V35, P56, DOI 10.1097/00126334-200401010-00008; Choi M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024459; Chou R, 2009, J PAIN, V10, P113, DOI 10.1016/j.jpain.2008.10.008; de Sa LC, 2013, REV LAT-AM ENFERM, V21, P1195, DOI 10.1590/0104-1169.3126.2354; DeBeck K, 2007, DRUG ALCOHOL DEPEN, V91, P50, DOI 10.1016/j.drugalcdep.2007.05.003; DeSimone J, 2002, J LABOR ECON, V20, P952, DOI 10.1086/342893; Fairbairn N, 2012, J EMERG MED, V43, P236, DOI 10.1016/j.jemermed.2011.05.020; Freudenberg N, 2005, AM J PUBLIC HEALTH, V95, P1725, DOI 10.2105/AJPH.2004.056325; Garland A, 2013, CAN MED ASSOC J, V185, P1207, DOI 10.1503/cmaj.130029; Glasgow JM, 2010, J GEN INTERN MED, V25, P926, DOI 10.1007/s11606-010-1371-4; Hines S, 2008, DRUG ALCOHOL REV, V27, P519, DOI 10.1080/09595230802245519; Huxtable CA, 2011, ANAESTH INTENS CARE, V39, P804, DOI 10.1177/0310057X1103900505; Lloyd-Smith Elisa, 2005, Harm Reduct J, V2, P24, DOI 10.1186/1477-7517-2-24; Lloyd-Smith E, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-327; McCreaddie M, 2010, J CLIN NURS, V19, P2730, DOI 10.1111/j.1365-2702.2010.03284.x; McNeil R, 2014, SOC SCI MED, V105, P59, DOI 10.1016/j.socscimed.2014.01.010; Palepu A, 2001, CAN MED ASSOC J, V165, P415; Pan W, 2001, BIOMETRICS, V57, P120, DOI 10.1111/j.0006-341X.2001.00120.x; Rhodes T., 2002, INT J DRUG POLICY, V13, P85, DOI [10.1016/S0955-3959(02)00007-5, DOI 10.1016/S0955-3959(02)00007-5]; Richardson L, 2010, DRUG ALCOHOL REV, V29, P293, DOI 10.1111/j.1465-3362.2009.00141.x; Sordo L, 2014, DRUG ALCOHOL DEPEN, V142, P1, DOI 10.1016/j.drugalcdep.2014.06.041; Southern WN, 2012, AM J MED, V125, P594, DOI 10.1016/j.amjmed.2011.12.017; Steensma C, 2005, J URBAN HEALTH, V82, P622, DOI 10.1093/jurban/jti121; Strathdee SA, 1998, JAMA-J AM MED ASSOC, V280, P547, DOI 10.1001/jama.280.6.547; Tawk R, 2013, ADM POLICY MENT HLTH, V40, P124, DOI 10.1007/s10488-011-0382-8; Ti L, 2014, DRUG ALCOHOL DEPEND; Tompkins CNE, 2007, INT J PRISON HEALTH, V3, P189, DOI 10.1080/17449200701520123; Tyndall MW, 2003, AIDS, V17, P887, DOI 10.1097/00002030-200304110-00014; van Olphen J, 2006, J URBAN HEALTH, V83, P372, DOI 10.1007/s11524-006-9047-4; van Olphen J, 2009, SUBST ABUSE TREAT PR, V4, DOI 10.1186/1747-597X-4-10; Voon P, 2014, PAIN MANAG, V4, P27, DOI [10.2217/PMT.13.62, 10.2217/pmt.13.62]	37	42	42	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2015	10	10							e0141594	10.1371/journal.pone.0141594	http://dx.doi.org/10.1371/journal.pone.0141594			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CV0DL	26509447	Green Published, Green Submitted, gold			2022-12-26	WOS:000363918100111
J	Xu, ZB; Asman, AJ; Baucom, RB; Abramson, RG; Poulose, BK; Landman, BA				Xu, Zhoubing; Asman, Andrew J.; Baucom, Rebeccah B.; Abramson, Richard G.; Poulose, Benjamin K.; Landman, Bennett A.			Quantitative CT Imaging of Ventral Hernias: Preliminary Validation of an Anatomical Labeling Protocol	PLOS ONE			English	Article							ABDOMINAL-CAVITY VOLUME; INCISIONAL HERNIA; REPAIR; DOMAIN; MESH	Objective We described and validated a quantitative anatomical labeling protocol for extracting clinically relevant quantitative parameters for ventral hernias (VH) from routine computed tomography (CT) scans. This information was then used to predict the need for mesh bridge closure during ventral hernia repair (VHR). Methods A detailed anatomical labeling protocol was proposed to enable quantitative description of VH including shape, location, and surrounding environment (61 scans). Intra- and inter-rater reproducibilities were calculated for labeling on 18 and 10 clinically acquired CT scans, respectively. Preliminary clinical validation was performed by correlating 20 quantitative parameters derived from anatomical labeling with the requirement for mesh bridge closure at surgery (26 scans). Prediction of this clinical endpoint was compared with similar models fit on metrics from the semi-quantitative European Hernia Society Classification for Ventral Hernia (EHSCVH). Results High labeling reproducibilities were achieved for abdominal walls (+/- 2 mm in mean surface distance), key anatomical landmarks (+/- 5 mm in point distance), and hernia volumes (0.8 in Cohen's kappa). 9 out of 20 individual quantitative parameters of hernia properties were significantly different between patients who required mesh bridge closure versus those in whom fascial closure was achieved at the time of VHR (p<0.05). Regression models constructed by two to five metrics presented a prediction with 84.6% accuracy for bridge requirement with cross-validation; similar models constructed by EHSCVH variables yielded 76.9% accuracy. Significance Reproducibility was acceptable for this first formal presentation of a quantitative image labeling protocol for VH on abdominal CT. Labeling-derived metrics presented better prediction of the need for mesh bridge closure than the EHSCVH metrics. This effort is intended as the foundation for future outcomes studies attempting to optimize choice of surgical technique across different anatomical types of VH.	[Xu, Zhoubing; Asman, Andrew J.; Landman, Bennett A.] Vanderbilt Univ, Elect Engn, Nashville, TN 37235 USA; [Baucom, Rebeccah B.; Poulose, Benjamin K.] Vanderbilt Univ, Med Ctr, Dept Surg, Div Gen Surg, Nashville, TN 37235 USA; [Abramson, Richard G.; Landman, Bennett A.] Vanderbilt Univ, Radiol & Radiol Sci, Nashville, TN 37235 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University	Xu, ZB (corresponding author), Vanderbilt Univ, Elect Engn, 221 Kirkland Hall, Nashville, TN 37235 USA.	zhoubing.xu@vanderbilt.edu	Landman, Bennett A/A-2343-2009	Landman, Bennett A/0000-0001-5733-2127; Poulose, Benjamin/0000-0003-1192-6311; Abramson, Richard/0000-0002-1200-0281	Vanderbilt Initiative in Surgery and Engineering / Vanderbilt Institute for Clinical and Translational Research [VR3029]; National Institutes of Health [1R03EB012461]; National Center for Research Resources [UL1 RR024975-01]; National Center for Advancing Translational Sciences [2 UL1 TR000445-06]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000445] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024975] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R03EB012461] Funding Source: NIH RePORTER	Vanderbilt Initiative in Surgery and Engineering / Vanderbilt Institute for Clinical and Translational Research; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Center for Advancing Translational Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This project was supported by Vanderbilt Initiative in Surgery and Engineering (https://www4.vanderbilt.edu/vise) / Vanderbilt Institute for Clinical and Translational Research (https://victr.vanderbilt.edu) VR3029 and National Institutes of Health (http://nih.gov) 1R03EB012461. The project described was also supported by the National Center for Research Resources, Grant UL1 RR024975-01, and is now at the National Center for Advancing Translational Sciences, Grant 2 UL1 TR000445-06. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Breuing K, 2010, SURGERY, V148, P544, DOI 10.1016/j.surg.2010.01.008; Cristianini N, 2000, INTRO SUPPORT VECTOR; Dubay DA, 2007, ANN SURG, V245, P140, DOI 10.1097/01.sla.0000251267.11012.85; Forbes SS, 2009, BRIT J SURG, V96, P851, DOI 10.1002/bjs.6668; Hosmer D. W., 2000, INTRO LOGISTIC REGRE; Kanters AE, 2012, J AM COLL SURGEONS, V215, P787, DOI 10.1016/j.jamcollsurg.2012.08.012; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Luijendijk RW, 2000, NEW ENGL J MED, V343, P392, DOI 10.1056/NEJM200008103430603; McAuliffe M. J., 2001, COMP BAS MED SYST 20; Millikan KW, 2003, SURG CLIN N AM, V83, P1223, DOI 10.1016/S0039-6109(03)00129-4; Muysoms FE, 2009, HERNIA, V13, P407, DOI 10.1007/s10029-009-0518-x; Ousley J, 2014, J AM COLL SURGEONS, V3, pS99; Poulose BK, 2012, HERNIA, V16, P179, DOI 10.1007/s10029-011-0879-9; Sabbagh C, 2011, HERNIA, V15, P559, DOI 10.1007/s10029-011-0832-y; Slater NJ, 2013, HERNIA, P1, DOI [10.1007/s10029-013-, DOI 10.1007/S10029-013-]; Tanaka EY, 2010, HERNIA, V14, P63, DOI 10.1007/s10029-009-0560-8; Wahba G., 1990, SPLINE MODELS OBSERV; Xu ZB, 2013, MED PHYS, V40, DOI 10.1118/1.4828791; Yao J., 2011, SPIE MED IMAGING; Yao S, 2012, COMPUT AIDED SURG, V17, P40, DOI 10.3109/10929088.2011.636453; Zou H, 2005, J R STAT SOC B, V67, P301, DOI 10.1111/j.1467-9868.2005.00503.x	21	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2015	10	10							e0141671	10.1371/journal.pone.0141671	http://dx.doi.org/10.1371/journal.pone.0141671			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0DL	26509450	Green Published, gold, Green Submitted			2022-12-26	WOS:000363918100121
J	Parra, M; Liu, X; Derrick, SC; Yang, A; Molina-Cruz, A; Barillas-Mury, C; Zheng, H; Pham, PT; Sedegah, M; Belmonte, A; Litilit, DD; Waldmann, TA; Kumar, S; Morris, SL; Perera, LP				Parra, Marcela; Liu, Xia; Derrick, Steven C.; Yang, Amy; Molina-Cruz, Alvaro; Barillas-Mury, Carolina; Zheng, Hong; Phuong Thao Pham; Sedegah, Martha; Belmonte, Arnel; Litilit, Dianne D.; Waldmann, Thomas A.; Kumar, Sanjai; Morris, Sheldon L.; Perera, Liyanage P.			Co-expression of Interleukin-15 Enhances the Protective Immune Responses Induced by Immunization with a Murine Malaria MVA-Based Vaccine Encoding the Circumsporozoite Protein	PLOS ONE			English	Article								Malaria remains a major global public health problem with an estimated 200 million cases detected in 2012. Although the most advanced candidate malaria vaccine (RTS,S) has shown promise in clinical trials, its modest efficacy and durability have created uncertainty about the impact of RTS, S immunization (when used alone) on global malaria transmission. Here we describe the development and characterization of a novel modified vaccinia virus Ankara (MVA)-based malaria vaccine which co-expresses the Plasmodium yoelii circumsporozoite protein (CSP) and IL-15. Vaccination/challenge studies showed that C57BL/6 mice immunized with the MVA-CSP/IL15 vaccine were protected significantly better against a P. yoelii 17XNL sporozoite challenge than either mice immunized with an MVA vaccine expressing only CSP or naive controls. Importantly, the levels of total anti-CSP IgG were elevated about 100-fold for the MVA-CSP/IL15 immunized group compared to mice immunized with the MVA-CSP construct that does not express IL-15. Among the IgG subtypes, the IL-15 expressing MVA-CSP vaccine induced levels of IgG1 (8 fold) and IgG2b (80 fold) higher than the MVA-CSP construct. The significantly enhanced humoral responses and protection detected after immunization with the MVA-CSP/IL-15 vaccine suggest that this IL-15 expressing MVA construct could be considered in the development of future malaria immunization strategies.	[Parra, Marcela; Liu, Xia; Derrick, Steven C.; Yang, Amy; Zheng, Hong; Kumar, Sanjai; Morris, Sheldon L.] US FDA, Ctr Biol Evaluat & Res, Silver Spring, MD 20993 USA; [Molina-Cruz, Alvaro; Barillas-Mury, Carolina] NIAID, Lab Malaria & Vector Res, Rockville, MD 20852 USA; [Phuong Thao Pham; Sedegah, Martha; Belmonte, Arnel; Litilit, Dianne D.] Naval Med Res Ctr, Silver Spring, MD 20910 USA; [Waldmann, Thomas A.; Perera, Liyanage P.] NCI, Bethesda, MD 20892 USA	US Food & Drug Administration (FDA); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Naval Medical Research Center (NMRC); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Perera, LP (corresponding author), NCI, Bethesda, MD 20892 USA.	pereral@mail.nih.gov	Waldmann, Thomas/AAT-5972-2021	Waldmann, Thomas/0000-0003-4500-6660	Intramural Research Programs of the National Cancer Institute, Center for Cancer Research, NIH; Food and Drug Administration; NATIONAL CANCER INSTITUTE [ZIBBC010906] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000947] Funding Source: NIH RePORTER	Intramural Research Programs of the National Cancer Institute, Center for Cancer Research, NIH; Food and Drug Administration(United States Department of Health & Human Services); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding was provided by the Intramural Research Programs of the National Cancer Institute, Center for Cancer Research, NIH (T.A.W and L.P.P) and the Food and Drug Administration. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.		0	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2015	10	10							e0141141	10.1371/journal.pone.0141141	http://dx.doi.org/10.1371/journal.pone.0141141			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU8PC	26505634	Green Submitted, gold, Green Published			2022-12-26	WOS:000363804200032
J	Liu, RP; Li, XJY; Qiang, XY; Luo, L; Hylemon, PB; Jiang, ZZ; Zhang, LY; Zhou, HP				Liu, Runping; Li, Xiaojiaoyang; Qiang, Xiaoyan; Luo, Lan; Hylemon, Phillip B.; Jiang, Zhenzhou; Zhang, Luyong; Zhou, Huiping			Taurocholate Induces Cyclooxygenase-2 Expression via the Sphingosine 1-phosphate Receptor 2 in a Human Cholangiocarcinoma Cell Line	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR RECEPTOR; BILE-ACIDS ACTIVATE; NF-KAPPA-B; COX-2 EXPRESSION; INTRAHEPATIC CHOLANGIOCARCINOMA; INDUCTION; PATHWAY; CANCER; PATHOGENESIS; INVOLVEMENT	Cholangiocarcinoma (CCA) is a rare, but highly malignant primary hepatobiliary cancer with a very poor prognosis and limited treatment options. Our recent studies reported that conjugated bile acids (CBAs) promote the invasive growth of CCA via activation of sphingosine 1-phosphate receptor 2 (S1PR2). Cyclooxygenase-2 (COX-2)-derived prostaglandin E-2 (PGE(2)) is the most abundant prostaglandin in various human malignancies including CCA. Previous studies have indicated that COX-2 was highly expressed in CCA tissues, and the survival rate of CCA patients was negatively associated with high COX-2 expression levels. It has also been reported that CBAs induce COX-2 expression, whereas free bile acids inhibit COX-2 expression in CCA mouse models. However, the underlying cellular mechanisms and connection between S1PR2 and COX-2 expression in CCA cells have still not been fully elucidated. In the current study, we examined the role of S1PR2 in conjugated bile acid (taurocholate, (TCA))-induced COX-2 expression in a human HuCCT1 CCA cell line and further identified the potential underlying cellular mechanisms. The results indicated that TCA-induced invasive growth of human CCA cells was correlated with S1PR2-medated up-regulation of COX-2 expression and PGE(2) production. Inhibition of S1PR2 activation with chemical antagonist (JTE-013) or down-regulation of S1PR2 expression with gene-specific shRNA not only reduced COX-2 expression, but also inhibited TCA-induced activation of EGFR and the ERK1/2/Akt-NF-kappa B signaling cascade. In conclusion, S1PR2 plays a critical role in TCA-induced COX-2 expression and CCA growth and may represent a novel therapeutic target for CCA.	[Liu, Runping; Li, Xiaojiaoyang; Qiang, Xiaoyan; Jiang, Zhenzhou; Zhang, Luyong] China Pharmaceut Univ, Jiangsu Key Lab Drug Screening, Nanjing 210009, Jiangsu, Peoples R China; [Liu, Runping; Qiang, Xiaoyan; Hylemon, Phillip B.; Zhou, Huiping] Virginia Commonwealth Univ, Dept Microbiol & Immunol, Richmond, VA 23298 USA; [Luo, Lan; Jiang, Zhenzhou; Zhang, Luyong] Jiangsu Ctr Pharmacodynam Res & Evaluat, Nanjing 210009, Jiangsu, Peoples R China; [Hylemon, Phillip B.; Zhou, Huiping] McGuire Vet Affairs Med Ctr, Richmond, VA 23298 USA	China Pharmaceutical University; Virginia Commonwealth University; Hunter Holmes McGuire Veterinary Affairs Medical Center	Jiang, ZZ (corresponding author), China Pharmaceut Univ, Jiangsu Ctr Pharmacodynam Res & Evaluat, Nanjing 210009, Jiangsu, Peoples R China.	beaglejiang@cpu.edu.cn; lyzhang@cpu.edu.cn; hzhou@vcu.edu	Regan, Clinton/E-6250-2012; Zhou, Huiping/J-3639-2015; Zhou, Huiping/H-6875-2019; Li, Xiaojiaoyang/CAG-6603-2022	Zhou, Huiping/0000-0002-0050-372X; Li, Xiaojiaoyang/0000-0003-0291-5856	National Natural Science Foundation of China [81320108029, 81070245, 81270489]; China National 12th Five-year Plan "Major Project of Science and Technologies for Significant Drug Discovery" [2012Z X09504001-001]; National Institutes of Health [R01 DK-057543]; Veterans Affairs Merit Awards; Virginia Commonwealth University Massey Cancer Pilot [A35362]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK057543] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China National 12th Five-year Plan "Major Project of Science and Technologies for Significant Drug Discovery"; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs Merit Awards(US Department of Veterans Affairs); Virginia Commonwealth University Massey Cancer Pilot; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Natural Science Foundation of China Grants 81320108029 (to L. Z.), 81070245 and 81270489 (to H. Z.), China National 12th Five-year Plan "Major Project of Science and Technologies for Significant Drug Discovery" Grant 2012Z X09504001-001 (to L. Z.), National Institutes of Health Grant R01 DK-057543 (to P. B. H. and H. Z.), Veterans Affairs Merit Awards (to H. Z.), and Virginia Commonwealth University Massey Cancer Pilot Grant A35362 (to H. Z.). The authors declare no competing financial interest with the contents of this article.	Adada M, 2013, FEBS J, V280, P6354, DOI 10.1111/febs.12446; Aishima S, 2013, HUM PATHOL, V44, P1031, DOI 10.1016/j.humpath.2012.09.004; Al-Bahrani R, 2013, ANN CLIN LAB SCI, V43, P195; Aleksandrova K, 2014, HEPATOLOGY, V60, P858, DOI 10.1002/hep.27016; Amonyingcharoen S, 2015, INT J ONCOL, V46, P2317, DOI 10.3892/ijo.2015.2939; Blechacz B, 2011, NAT REV GASTRO HEPAT, V8, P512, DOI 10.1038/nrgastro.2011.131; Bocca C, 2014, EXPERT OPIN THER TAR, V18, P121, DOI 10.1517/14728222.2014.860447; Dai JQ, 2013, CANCER INVEST, V31, P111, DOI 10.3109/07357907.2012.762781; Dai JQ, 2011, J HEMATOL ONCOL, V4, DOI 10.1186/1756-8722-4-41; Eo SH, 2014, EXP THER MED, V7, P640, DOI 10.3892/etm.2014.1484; Fukazawa EM, 2014, INT J GYNECOL PATHOL, V33, P225, DOI 10.1097/PGP.0b013e318290405a; Generali D, 2014, BRIT J CANCER, V111, P46, DOI 10.1038/bjc.2014.236; Ghosh S, 2012, IMMUNOL REV, V246, P5, DOI 10.1111/j.1600-065X.2012.01111.x; Ghouri Yezaz Ahmed, 2015, J Carcinog, V14, P1, DOI 10.4103/1477-3163.151940; Glinghammar B, 2002, CARCINOGENESIS, V23, P839, DOI 10.1093/carcin/23.5.839; Gores GJ, 2003, HEPATOLOGY, V37, P961, DOI 10.1053/jhep.2003.50200; Han C, 2004, CANCER RES, V64, P1369, DOI 10.1158/0008-5472.CAN-03-1086; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Ishii Y, 2013, INT J ONCOL, V43, P1073, DOI 10.3892/ijo.2013.2038; Jongthawin J, 2014, TUMOR BIOL, V35, P8051, DOI 10.1007/s13277-014-2021-y; Jusakul A, 2012, ASIAN PAC J CANCER P, V13, P77, DOI 10.7314/APJCP.2012.13.KKSuppl.77; Kiguchi K, 2014, J HEPATO-BIL-PAN SCI, V21, P371, DOI 10.1002/jhbp.66; Kim HG, 2015, ARCH TOXICOL, V89, P2039, DOI 10.1007/s00204-014-1359-7; Liu RP, 2014, HEPATOLOGY, V60, P908, DOI 10.1002/hep.27085; Lozano E, 2014, MOL CANCER RES, V12, P91, DOI 10.1158/1541-7786.MCR-13-0503; Ma YZ, 2014, J CARDIOVASC PHARM, V64, P28, DOI 10.1097/FJC.0000000000000086; Martinez ON, 2003, MED CLIN-BARCELONA, V121, P743, DOI 10.1016/S0025-7753(03)74082-2; Mathema Vivek Bhakta, 2015, Asian Pac J Cancer Prev, V16, P1307; Mercau ME, 2014, MOL CELL ENDOCRINOL, V384, P43, DOI 10.1016/j.mce.2014.01.007; Nzeako UC, 2002, HEPATOLOGY, V35, P552, DOI 10.1053/jhep.2002.31774; Rao YP, 2002, HEPATOLOGY, V35, P307, DOI 10.1053/jhep.2002.31104; Reader J, 2011, CANCER METAST REV, V30, P449, DOI 10.1007/s10555-011-9303-2; Rizvi S, 2014, DIGEST DIS, V32, P564, DOI 10.1159/000360502; Roelle S, 2003, J BIOL CHEM, V278, P47307, DOI 10.1074/jbc.M304377200; Sirica AE, 2005, HEPATOLOGY, V41, P5, DOI 10.1002/hep.20537; Sirica AE, 2002, SEMIN LIVER DIS, V22, P303, DOI 10.1055/s-2002-34507; Skoura A, 2011, ARTERIOSCL THROM VAS, V31, P81, DOI 10.1161/ATVBAHA.110.213496; Studer E, 2012, HEPATOLOGY, V55, P267, DOI 10.1002/hep.24681; Sun B, 2013, MOL CELL BIOCHEM, V378, P195, DOI 10.1007/s11010-013-1610-1; Surh I, 2011, MOL CARCINOGEN, V50, P458, DOI 10.1002/mc.20730; Volzke A, 2014, BBA-MOL CELL BIOL L, V1841, P11, DOI 10.1016/j.bbalip.2013.09.009; Werneburg NW, 2003, AM J PHYSIOL-GASTR L, V285, pG31, DOI 10.1152/ajpgi.00536.2002; Wu T, 2005, BBA-REV CANCER, V1755, P135, DOI 10.1016/j.bbcan.2005.04.002; Xia XF, 2006, WORLD J GASTROENTERO, V12, P3553, DOI 10.3748/wjg.v12.i22.3553; Yeh CN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069928; Yoon JH, 2002, GASTROENTEROLOGY, V122, P985, DOI 10.1053/gast.2002.32410; Yoshikawa D, 2008, BRIT J CANCER, V98, P418, DOI 10.1038/sj.bjc.6604129; Zhang L, 2007, MOL CELL BIOCHEM, V305, P19, DOI 10.1007/s11010-007-9523-5	48	46	50	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 25	2015	290	52					30988	31002		10.1074/jbc.M115.668277	http://dx.doi.org/10.1074/jbc.M115.668277			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CZ6GK	26518876	hybrid, Green Published			2022-12-26	WOS:000367199000029
J	Kudryashova, NN; Kazbanov, IV; Panfilov, AV; Agladze, KI				Kudryashova, Nina N.; Kazbanov, Ivan V.; Panfilov, Alexander V.; Agladze, Konstantin I.			Conditions for Waveblock Due to Anisotropy in a Model of Human Ventricular Tissue	PLOS ONE			English	Article							ACTION-POTENTIAL PROPAGATION; WAVE-FRONT CURVATURE; SPIRAL WAVES; IONIC CURRENTS; EXCITABILITY; CONDUCTION; DYNAMICS; BREAKUP; ONSET	Waveblock formation is the main cause of reentry. We have performed a comprehensive numerical modeling study of block formation due to anisotropy in Ten Tusscher and Panfilov (2006) ionic model for human ventricular tissue. We have examined the border between different areas of myocardial fiber alignment and have shown that blockage can occur for a wave traveling from a transverse fiber area to a longitudinal one. Such blockage occurs for reasonable values of the anisotropy ratio (AR): from 2.4 to 6.2 with respect to propagation velocities. This critical AR decreases by the suppression of I-Na and I-Ca, slightly decreases by the suppression of I-Kr and I-Ks, and substantially increases by the suppression of I-K1. Hyperkalemia affects the block formation in a complex, biphasic way. We provide examples of reentry formation due to the studied effects and have concluded that the suppression of I-K1 should be the most effective way to prevent waveblock at the areas of abrupt change in anisotropy.	[Kudryashova, Nina N.; Panfilov, Alexander V.; Agladze, Konstantin I.] Moscow Inst Phys & Technol, Life Sci Ctr, Dolgoprudnyi, Russia; [Kudryashova, Nina N.; Kazbanov, Ivan V.; Panfilov, Alexander V.] Univ Ghent, Dept Phys & Astron, B-9000 Ghent, Belgium	Moscow Institute of Physics & Technology; Ghent University	Agladze, KI (corresponding author), Moscow Inst Phys & Technol, Life Sci Ctr, Dolgoprudnyi, Russia.	kagladze@gmail.com	Kudryashova, Nina/O-1036-2014; Agladze, Konstantin/X-5496-2019; Panfilov, Alexander/G-8459-2016; Agladze, Konstantin/J-6142-2012	Kudryashova, Nina/0000-0001-8529-7250; Agladze, Konstantin/0000-0002-9258-436X; Panfilov, Alexander/0000-0003-2643-642X; Agladze, Konstantin/0000-0002-9258-436X	Ministry of Education and Science of the Russian Federation (Federal Program "5top100"); FWO-Flanders	Ministry of Education and Science of the Russian Federation (Federal Program "5top100"); FWO-Flanders(FWO)	The research was fully supported by two sources: the Ministry of Education and Science of the Russian Federation (Federal Program "5top100") and FWO-Flanders. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGLADZE K, 1994, SCIENCE, V264, P1746, DOI 10.1126/science.264.5166.1746; Cabo C, 1996, BIOPHYS J, V70, P1105, DOI 10.1016/S0006-3495(96)79691-1; CABO C, 1994, CIRC RES, V75, P1014, DOI 10.1161/01.RES.75.6.1014; Carmeliet E, 1999, PHYSIOL REV, V79, P917, DOI 10.1152/physrev.1999.79.3.917; Clayton RH, 2011, PROG BIOPHYS MOL BIO, V104, P22, DOI 10.1016/j.pbiomolbio.2010.05.008; Colman MA, 2014, EUROPACE, V16, P416, DOI 10.1093/europace/eut349; Cranefield BPF, 1973, CIRCULATION, VXLVII; CRANEFIELD PF, 1972, J GEN PHYSIOL, V59, P227, DOI 10.1085/jgp.59.2.227; Dhamoon AS, 2005, HEART RHYTHM, V2, P316, DOI 10.1016/j.hrthm.2004.11.012; Dierckx H, 2011, PHYS REV LETT, V2, P1; Faber GM, 2000, BIOPHYS J, V78, P2392, DOI 10.1016/S0006-3495(00)76783-X; Fast VG, 1997, CARDIOVASC RES, V33, P258, DOI 10.1016/S0008-6363(96)00216-7; Grandi E, 2010, J MOL CELL CARDIOL, V48, P112, DOI 10.1016/j.yjmcc.2009.09.019; HAN J, 1964, CIRC RES, V14, P44, DOI 10.1161/01.RES.14.1.44; KARMA A, 1993, PHYS REV LETT, V71, P1103, DOI 10.1103/PhysRevLett.71.1103; Kazbanov IV, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003891; KEENER JP, 1986, SIAM J APPL MATH, V46, P1039, DOI 10.1137/0146062; Krinsky V.I., 1984, SPRINGER SERIES SYNE, VVolume 28, P9; Kudryashova NN, 2014, J MOL CELL CARDIOL, V76, P227, DOI 10.1016/j.yjmcc.2014.09.003; Lee P, 2012, CIRC RES, V110, P1556, DOI 10.1161/CIRCRESAHA.111.262535; LUO CH, 1994, CIRC RES, V74, P1071, DOI 10.1161/01.RES.74.6.1071; Majumder R, 2014, AM J PHYSIOL-HEART C, V307, pH1024, DOI 10.1152/ajpheart.00593.2013; Mayer AG, 1916, P NATL ACAD SCI USA, V2, P721, DOI 10.1073/pnas.2.12.721; MOE GK, 1959, AM HEART J, V58, P59, DOI 10.1016/0002-8703(59)90274-1; PANFILOV AV, 1982, BIOFIZIKA+, V27, P886; PANFILOV AV, 1990, PHYS LETT A, V151, P23, DOI 10.1016/0375-9601(90)90840-K; Panfilov AV, 2009, CARDIAC ELECTROPHYSI, P329; Potse M, 2006, IEEE T BIO-MED ENG, V53, P2425, DOI 10.1109/TBME.2006.880875; Qu ZL, 1999, AM J PHYSIOL-HEART C, V276, pH269, DOI 10.1152/ajpheart.1999.276.1.H269; Ramirez RJ, 2000, AM J PHYSIOL-HEART C, V279, pH1767, DOI 10.1152/ajpheart.2000.279.4.H1767; Rohr S, 1997, SCIENCE          FEB, P275; Rudy Y, 2011, PLOS COMPUTATIONAL B, V7, P5; Samie FH, 2001, CIRC RES, V89, P1216, DOI 10.1161/hh2401.100818; ten Tusscher KHWJ, 2006, AM J PHYSIOL-HEART C, V291, pH1088, DOI 10.1152/ajpheart.00109.2006; ten Tusscher KHWJ, 2004, AM J PHYSIOL-HEART C, V286, pH1573, DOI 10.1152/ajpheart.00794.2003; WATANABE Y, 1971, AM HEART J, V81, P451, DOI 10.1016/0002-8703(71)90359-0; Zemlin CW, 2007, EUROPACE, V9, P59, DOI 10.1093/europace/eum205; Zemlin CW, 2009, PHYSICA D, V238, P969, DOI 10.1016/j.physd.2008.12.004; Zipes DP, 1998, CIRCULATION, V98, P2334, DOI 10.1161/01.CIR.98.21.2334	39	3	4	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2015	10	11							e0141832	10.1371/journal.pone.0141832	http://dx.doi.org/10.1371/journal.pone.0141832			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV1PG	26523734	Green Published, Green Submitted, gold			2022-12-26	WOS:000364029800024
J	Dussourd, DE				Dussourd, David E.			Theroa zethus Caterpillars Use Acid Secretion of Anti-Predator Gland to Deactivate Plant Defense	PLOS ONE			English	Article							VENTRAL EVERSIBLE GLAND; HOST-PLANT; EUPHORBIA; NOTODONTIDAE; LEPIDOPTERA; LATICIFERS; MORPHOLOGY; GROWTH; ELONGATION; DIVERSITY	In North America, notodontid caterpillars feed almost exclusively on hardwood trees. One notable exception, Theroa zethus feeds instead on herbaceous plants in the Euphorbiaceae protected by laticifers. These elongate canals follow leaf veins and contain latex under pressure; rupture causes the immediate release of sticky poisonous exudate. T. zethus larvae deactivate the latex defense of poinsettia and other euphorbs by applying acid from their ventral eversible gland, thereby creating furrows in the veins. The acid secretion softens the veins allowing larvae to compress even large veins with their mandibles and to disrupt laticifers internally often without contacting latex. Acid secretion collected from caterpillars and applied to the vein surface sufficed to create a furrow and to reduce latex exudation distal to the furrow where T. zethus larvae invariably feed. Larvae with their ventral eversible gland blocked were unable to create furrows and suffered reduced growth on poinsettia. The ventral eversible gland in T. zethus and other notodontids ordinarily serves to deter predators; when threatened, larvae spray acid from the gland orifice located between the mouthparts and first pair of legs. To my knowledge, T. zethus is the first caterpillar found to use an anti-predator gland for disabling plant defenses. The novel combination of acid application and vein constriction allows T. zethus to exploit its unusual latex-bearing hosts.	Univ Cent Arkansas, Dept Biol, Conway, AR 72035 USA	University of Central Arkansas	Dussourd, DE (corresponding author), Univ Cent Arkansas, Dept Biol, Conway, AR 72035 USA.	dussourd@uca.edu			University of Central Arkansas Research Council; Arkansas Center for Plant-Powered Production (P3); National Science Foundation [EPS-0701890, EPS-1003970]; Arkansas Science and Technology Authority	University of Central Arkansas Research Council; Arkansas Center for Plant-Powered Production (P3); National Science Foundation(National Science Foundation (NSF)); Arkansas Science and Technology Authority	This study was supported by the University of Central Arkansas Research Council and by the Arkansas Center for Plant-Powered Production (P3). The P3 Center (http://www.plantpoweredproduction.com/) is funded through the RII: Arkansas ASSET Initiatives (AR EPSCoR) I (EPS-0701890) and II (EPS-1003970) by the National Science Foundation and the Arkansas Science and Technology Authority. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1981, CHEM DEFENSES ARTHRO; ATTYGALLE AB, 1993, J CHEM ECOL, V19, P2089, DOI 10.1007/BF00979649; Bauer G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113336; Becerra JX, 2003, P NATL ACAD SCI USA, V100, P12804, DOI 10.1073/pnas.2133013100; Becker Vitor O., 2014, Lepidoptera Novae, V7, P1; Bernays EA, 2004, J INSECT BEHAV, V17, P41, DOI 10.1023/B:JOIR.0000025131.16275.0f; Bowers M. Deane, 1993, P331; BUTTERY BR, 1976, WATER DEFICITS PLANT, V4, P233; Cosgrove DJ, 2015, CURR OPIN PLANT BIOL, V25, P162, DOI 10.1016/j.pbi.2015.05.014; d'Auzac J., 1989, PHYSL RUBBER TREE LA; Detwiler J. D., 1922, Canadian Entomologist, V54, P176; DILLON PM, 1983, BIOTROPICA, V15, P112, DOI 10.2307/2387953; Dussourd DE, 2009, BIOL J LINN SOC, V96, P715, DOI 10.1111/j.1095-8312.2008.01168.x; DUSSOURD DE, 1991, ECOLOGY, V72, P1383, DOI 10.2307/1941110; EHRLICH PR, 1964, EVOLUTION, V18, P586, DOI 10.2307/2406212; EISNER T, 1972, ANN ENTOMOL SOC AM, V65, P765, DOI 10.1093/aesa/65.3.765; Eisner T., 2005, SECRET WEAPONS DEFEN; Fahn A., 1979, SECRETORY TISSUES PL; Fatope MO, 1996, J MED CHEM, V39, P1005, DOI 10.1021/jm950509i; Felton GW, 2014, ANNU PLANT REV, V47, P37, DOI 10.1002/9781118472507.ch2; FINERAN BA, 1983, ANN BOT-LONDON, V52, P279, DOI 10.1093/oxfordjournals.aob.a086576; FINERAN BA, 1982, ANN BOT-LONDON, V50, P207, DOI 10.1093/oxfordjournals.aob.a086358; Frederickson ME, 2005, NATURE, V437, P495, DOI 10.1038/437495a; Ganong CN, 2012, ARTHROPOD-PLANT INTE, V6, P621, DOI 10.1007/s11829-012-9214-3; Greeney HF, 2012, ISJ-INVERT SURVIV J, V9, P7; Hager A, 2003, J PLANT RES, V116, P483, DOI 10.1007/s10265-003-0110-x; Herrick G. W., 1919, Annals of the Entomological Society of America, V12; Holldobler B., 1990, pi; KUTSCHERA U, 1994, NEW PHYTOL, V126, P549, DOI 10.1111/j.1469-8137.1994.tb02951.x; LeBrun EG, 2014, SCIENCE, V343, P1014, DOI 10.1126/science.1245833; Lewinsohn TM, 2000, SERIE OECOLOGIA BRAS, VVIII, P281; Metcalfe C.R., 1983, NORD J BOT, V4, P668; MILLER JS, 1992, BIOSCIENCE, V42, P50, DOI 10.2307/1311628; Mitter C., 1991, P35; Musser RO, 2006, J CHEM ECOL, V32, P981, DOI 10.1007/s10886-006-9049-4; Musser RO, 2002, NATURE, V416, P599, DOI 10.1038/416599a; O'Donovan A., 2013, BIOFUEL TECHNOLOGIES, P97, DOI [10.1007/978-3-642-34519-7_4, DOI 10.1007/978-3-642-34519-7_4]; Oppel CB, 2009, J CHEM ECOL, V35, P625, DOI 10.1007/s10886-009-9643-3; Peiffer M, 2005, ARCH INSECT BIOCHEM, V58, P106, DOI 10.1002/arch.20034; RAYLE D, 1970, PLANT PHYSIOL, V46, P250, DOI 10.1104/pp.46.2.250; RAYLE DL, 1980, PLANT PHYSIOL, V66, P433, DOI 10.1104/pp.66.3.433; ROSOWSKI JR, 1968, BOT GAZ, V129, P113, DOI 10.1086/336422; RUDALL PJ, 1987, BOT J LINN SOC, V94, P143, DOI 10.1111/j.1095-8339.1987.tb01043.x; Schintlmeister A., 2013, NOTODONTIDAE OENOSAN; Tragust S, 2013, CURR BIOL, V23, P76, DOI 10.1016/j.cub.2012.11.034; Van Valkenburg M, 2014, THESIS U CENTRAL ARK; Vegliante F, 2012, ANNU REV ENTOMOL, V57, P187, DOI 10.1146/annurev-ento-120710-100646; Villanueva J, 2015, PHYTOMEDICINE, V22, P689, DOI 10.1016/j.phymed.2015.04.006; Wagner DL, 2015, CATERPILLARS E N AM; WEATHERSTON I, 1986, J CHEM ECOL, V12, P2039, DOI 10.1007/BF01041995; WEATHERSTON J, 1979, J CHEM ECOL, V5, P165, DOI 10.1007/BF00988232; WELLER S J, 1987, Journal of the Lepidopterists' Society, V41, P187; Zebelo S, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-140; Zebelo SA, 2012, ARTHROPOD-PLANT INTE, V6, P543, DOI 10.1007/s11829-012-9200-9	54	7	7	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2015	10	10							e0141924	10.1371/journal.pone.0141924	http://dx.doi.org/10.1371/journal.pone.0141924			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0EH	26517872	Green Submitted, Green Published, gold			2022-12-26	WOS:000363920800094
J	Klarenbeek, PL; Doorenspleet, ME; Esveldt, REE; van Schaik, BDC; Lardy, N; van Kampen, AHC; Tak, PP; Plenge, RM; Baas, F; de Bakker, PIW; de Vries, N				Klarenbeek, Paul L.; Doorenspleet, Marieke E.; Esveldt, Rebecca E. E.; van Schaik, Barbera D. C.; Lardy, Neubury; van Kampen, Antoine H. C.; Tak, Paul P.; Plenge, Robert M.; Baas, Frank; de Bakker, Paul I. W.; de Vries, Niek			Somatic Variation of T-Cell Receptor Genes Strongly Associate with HLA Class Restriction	PLOS ONE			English	Article							AMINO-ACIDS; RATIO; REPERTOIRE; ANTIGENS; TARGETS; CLONES; USAGE; CD4+	Every person carries a vast repertoire of CD4(+) T-helper cells and CD8(+) cytotoxic T cells for a healthy immune system. Somatic VDJ recombination at genomic loci that encode the Tcell receptor (TCR) is a key step during T-cell development, but how a single T cell commits to become either CD4(+) or CD8(+) is poorly understood. To evaluate the influence of TCR sequence variation on CD4(+)/CD8(+) lineage commitment, we sequenced rearranged TCRs for both a and beta chains in naive T cells isolated from healthy donors and investigated gene segment usage and recombination patterns in CD4(+) and CD8(+) T-cell subsets. Our data demonstrate that most V and J gene segments are strongly biased in the naive CD4(+) and CD8(+) subsets with some segments increasing the odds of being CD4(+) (or CD8(+)) up to fivefold. These V and J gene associations are highly reproducible across individuals and independent of classical HLA genotype, explaining similar to 11% of the observed variance in the CD4(+) vs. CD8(+) propensity. In addition, we identified a strong independent association of the electrostatic charge of the complementarity determining region 3 (CDR3) in both a and beta chains, where a positively charged CDR3 is associated with CD4(+) lineage and a negatively charged CDR3 with CD8(+) lineage. Our findings suggest that somatic variation in different parts of the TCR influences T-cell lineage commitment in a predominantly additive fashion. This notion can help delineate how certain structural features of the TCR-peptide-HLA complex influence thymic selection.	[Klarenbeek, Paul L.; Plenge, Robert M.; de Bakker, Paul I. W.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med,Div Genet, Boston, MA 02115 USA; [Klarenbeek, Paul L.; Plenge, Robert M.; de Bakker, Paul I. W.] Broad Inst Harvard & MIT, Program Med & Populat Genet, Cambridge, MA USA; [Klarenbeek, Paul L.; Doorenspleet, Marieke E.; Esveldt, Rebecca E. E.; Tak, Paul P.; de Vries, Niek] Univ Amsterdam, Acad Med Ctr, Dept Clin Immunol & Rheumatol, Expt Immunol Lab, NL-1105 AZ Amsterdam, Netherlands; [Klarenbeek, Paul L.; Doorenspleet, Marieke E.; Baas, Frank] Univ Amsterdam, Acad Med Ctr, Genome Anal Lab, NL-1105 AZ Amsterdam, Netherlands; [van Schaik, Barbera D. C.; van Kampen, Antoine H. C.] Univ Amsterdam, Dept Clin Epidemiol Biostat & Bioinformat, Amsterdam, Netherlands; [Lardy, Neubury] Sanquin Diagnost Serv, Dept Immunogenet, Amsterdam, Netherlands; [de Bakker, Paul I. W.] Univ Med Ctr, Dept Epidemiol, Utrecht, Netherlands; [de Bakker, Paul I. W.] Univ Med Ctr, Dept Med Genet, Utrecht, Netherlands	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center	de Bakker, PIW (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med,Div Genet, Boston, MA 02115 USA.	pdebakker@umcutrecht.nl	Baas, Frank/F-9574-2010; de Vries, Niek/J-9348-2013	Baas, Frank/0000-0003-3912-5428; de Vries, Niek/0000-0002-6257-8604				Emerson R, 2013, J IMMUNOL METHODS, V391, P14, DOI 10.1016/j.jim.2013.02.002; Ferreira MAR, 2010, AM J HUM GENET, V86, P88, DOI 10.1016/j.ajhg.2009.12.008; Folch G, 2000, EXP CLIN IMMUNOGENET, V17, P42, DOI 10.1159/000019123; Freeman JD, 2009, GENOME RES, V19, P1817, DOI 10.1101/gr.092924.109; Germain RN, 2002, NAT REV IMMUNOL, V2, P309, DOI 10.1038/nri798; GRUNEWALD J, 1992, INT IMMUNOL, V4, P643, DOI 10.1093/intimm/4.6.643; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; JEDDITEHRANI M, 1994, HUM IMMUNOL, V40, P93, DOI 10.1016/0198-8859(94)90053-1; Klarenbeek PL, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002889; Klarenbeek PL, 2012, ANN RHEUM DIS, V71, P1088, DOI 10.1136/annrheumdis-2011-200612; Klarenbeek PL, 2010, IMMUNOL LETT, V133, P42, DOI 10.1016/j.imlet.2010.06.011; Lefranc MP, 1999, NUCLEIC ACIDS RES, V27, P209, DOI 10.1093/nar/27.1.209; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Marrack P, 2008, ANNU REV IMMUNOL, V26, P171, DOI 10.1146/annurev.immunol.26.021607.090421; Mingueneau M, 2013, NAT IMMUNOL, V14, P619, DOI 10.1038/ni.2590; Naylor K, 2005, J IMMUNOL, V174, P7446, DOI 10.4049/jimmunol.174.11.7446; Robins HS, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001442; Rudolph MG, 2006, ANNU REV IMMUNOL, V24, P419, DOI 10.1146/annurev.immunol.23.021704.115658; Scott-Browne JP, 2009, NATURE, V458, P1043, DOI 10.1038/nature07812; Shigematsu M, 1996, CLIN EXP IMMUNOL, V103, P149, DOI 10.1046/j.1365-2249.1996.d01-14.x; Sim BC, 1996, SCIENCE, V273, P963, DOI 10.1126/science.273.5277.963; Sim BC, 1998, CURR BIOL, V8, P701, DOI 10.1016/S0960-9822(98)70276-3; Sleckman BP, 2012, J IMMUNOL, V188, P7, DOI 10.4049/jimmunol.1103195; Taniuchi I, 2011, ADV IMMUNOL, V110, P71, DOI [10.1016/B978-012-387663-8.00003-X, 10.1016/B978-0-12-387663-8.00003-X]; TEH HS, 1988, NATURE, V335, P229, DOI 10.1038/335229a0; van den Beemd R, 2000, CYTOMETRY, V40, P336, DOI 10.1002/1097-0320(20000801)40:4<336::AID-CYTO9>3.0.CO;2-0; van Heijst JWJ, 2013, NAT MED, V19, P372, DOI 10.1038/nm.3100; Van Rhijn I, 2013, NAT IMMUNOL, V14, P706, DOI 10.1038/ni.2630; Visscher PM, 2012, AM J HUM GENET, V90, P7, DOI 10.1016/j.ajhg.2011.11.029; Yin L, 2011, IMMUNITY, V35, P23, DOI 10.1016/j.immuni.2011.04.017	30	19	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2015	10	10							e0140815	10.1371/journal.pone.0140815	http://dx.doi.org/10.1371/journal.pone.0140815			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0EH	26517366	Green Published, gold			2022-12-26	WOS:000363920800010
J	Malhis, N; Wong, ETC; Nassar, R; Gsponer, J				Malhis, Nawar; Wong, Eric T. C.; Nassar, Roy; Gsponer, Joerg			Computational Identification of MoRFs in Protein Sequences Using Hierarchical Application of Bayes Rule	PLOS ONE			English	Article							MOLECULAR RECOGNITION FEATURES; INTRINSICALLY DISORDERED REGIONS; BINDING REGIONS; PREDICTION; ACCURATE; SERVER	Motivation Intrinsically disordered regions of proteins play an essential role in the regulation of various biological processes. Key to their regulatory function is often the binding to globular protein domains via sequence elements known as molecular recognition features (MoRFs). Development of computational tools for the identification of candidate MoRF locations in amino acid sequences is an important task and an area of growing interest. Given the relative sparseness of MoRFs in protein sequences, the accuracy of the available MoRF predictors is often inadequate for practical usage, which leaves a significant need and room for improvement. In this work, we introduce MoRFCHiBi_Web, which predicts MoRF locations in protein sequences with higher accuracy compared to current MoRF predictors. Methods Three distinct and largely independent property scores are computed with component predictors and then combined to generate the final MoRF propensity scores. The first score reflects the likelihood of sequence windows to harbour MoRFs and is based on amino acid composition and sequence similarity information. It is generated by MoRFCHiBi using small windows of up to 40 residues in size. The second score identifies long stretches of protein disorder and is generated by ESpritz with the DisProt option. Lastly, the third score reflects residue conservation and is assembled from PSSM files generated by PSI-BLAST. These propensity scores are processed and then hierarchically combined using Bayes rule to generate the final MoRFCHiBi_Web predictions. Results MoRFCHiBi_Web was tested on three datasets. Results show that MoRFCHiBi_Web outperforms previously developed predictors by generating less than half the false positive rate for the same true positive rate at practical threshold values. This level of accuracy paired with its relatively high processing speed makes MoRFCHiBi_Web a practical tool for MoRF prediction.	[Malhis, Nawar; Wong, Eric T. C.; Nassar, Roy; Gsponer, Joerg] Univ British Columbia, Ctr High Throughput Biol, Vancouver, BC V5Z 1M9, Canada; [Wong, Eric T. C.; Gsponer, Joerg] Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V5Z 1M9, Canada	University of British Columbia; University of British Columbia	Malhis, N (corresponding author), Univ British Columbia, Ctr High Throughput Biol, Vancouver, BC V5Z 1M9, Canada.	nmalhis@chibi.ubc.ca; gsponer@chibi.ubc.ca		Malhis, Nawar/0000-0002-1317-833X	Canadian Institute of Health Research (CIHR) [BOP-130835]; Genome BC [Genome BC 175REG]; Michael Smith Foundation for Health Research (MSFHR) [CI-SCH-03020(11-1)]	Canadian Institute of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Genome BC; Michael Smith Foundation for Health Research (MSFHR)(Michael Smith Foundation for Health Research)	This work was supported by grants from the Canadian Institute of Health Research (CIHR) (http://www.cihr-irsc.gc.ca/e/193.html) (BOP-130835, to JG); Genome BC (http://www.genomebc.ca/) (Genome BC 175REG, to JG); and Michael Smith Foundation for Health Research (MSFHR) (http://www.msfhr.org/) (CI-SCH-03020(11-1), to JG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Babu M. M., 2011, CURR OPIN STRUC BIOL, V21, P1; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Buljan M, 2012, MOL CELL, V46, P871, DOI 10.1016/j.molcel.2012.05.039; Cheng YG, 2007, BIOCHEMISTRY-US, V46, P13468, DOI 10.1021/bi7012273; Cumberworth A, 2013, BIOCHEM J, V454, P361, DOI 10.1042/BJ20130545; Derbyshire DJ, 2002, EMBO J, V21, P3863, DOI 10.1093/emboj/cdf383; Disfani FM, 2012, BIOINFORMATICS, V28, pI75, DOI 10.1093/bioinformatics/bts209; Dosztanyi Z, 2005, BIOINFORMATICS, V21, P3433, DOI 10.1093/bioinformatics/bti541; Dosztanyi Z, 2005, J MOL BIOL, V347, P827, DOI 10.1016/j.jmb.2005.01.071; Fang C, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-300; Fang NN, 2014, NAT CELL BIOL, V16, P1227, DOI 10.1038/ncb3054; Han H, 2014, CANCER INFORM, V13, P145, DOI 10.4137/CIN.S13875; Hubbard SJ, 1993, NACCESS COMPUTER PRO; Jones DT, 2015, BIOINFORMATICS, V31, P857, DOI 10.1093/bioinformatics/btu744; Jones DT, 2002, TRENDS BIOCHEM SCI, V27, P161, DOI 10.1016/S0968-0004(01)02039-4; Malhis N, 2015, BIOINFORMATICS, V31, P1738, DOI 10.1093/bioinformatics/btv060; Meszaros B, 2007, J MOL BIOL, V372, P549, DOI 10.1016/j.jmb.2007.07.004; Meszaros B, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000376; Mohan A, 2006, J MOL BIOL, V362, P1043, DOI 10.1016/j.jmb.2006.07.087; Oldfield CJ, 2014, ANNU REV BIOCHEM, V83, P553, DOI 10.1146/annurev-biochem-072711-164947; Oldfield CJ, 2005, BIOCHEMISTRY-US, V44, P12454, DOI 10.1021/bi050736e; R Core Team, 2021, R LANGUAGE ENV STAT; Trudeau T, 2013, STRUCTURE, V21, P332, DOI 10.1016/j.str.2012.12.013; Uversky VN, 2010, BBA-PROTEINS PROTEOM, V1804, P1231, DOI 10.1016/j.bbapap.2010.01.017; Vacic V, 2007, J PROTEOME RES, V6, P2351, DOI 10.1021/pr0701411; van der Lee R, 2014, CHEM REV, V114, P6589, DOI 10.1021/cr400525m; Walsh I, 2012, BIOINFORMATICS, V28, P503, DOI 10.1093/bioinformatics/btr682; Ward JJ, 2004, BIOINFORMATICS, V20, P2138, DOI 10.1093/bioinformatics/bth195; Weatheritt RJ, 2012, TRENDS BIOCHEM SCI, V37, P333, DOI 10.1016/j.tibs.2012.05.001; Wong ETC, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003192; Wright PE, 2015, NAT REV MOL CELL BIO, V16, P18, DOI 10.1038/nrm3920; Zhang T, 2012, J BIOMOL STRUCT DYN, V29, P799, DOI 10.1080/073911012010525022	33	31	31	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2015	10	10							e0141603	10.1371/journal.pone.0141603	http://dx.doi.org/10.1371/journal.pone.0141603			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0EH	26517836	Green Submitted, Green Published, gold			2022-12-26	WOS:000363920800061
J	Cummings, EE; O'Reilly, LP; King, DE; Silverman, RM; Miedel, MT; Luke, CJ; Perlmutter, DH; Silverman, GA; Pak, SC				Cummings, Erin E.; O'Reilly, Linda P.; King, Dale E.; Silverman, Richard M.; Miedel, Mark T.; Luke, Cliff J.; Perlmutter, David H.; Silverman, Gary A.; Pak, Stephen C.			Deficient and Null Variants of SERPINA1 Are Proteotoxic in a Caenorhabditis elegans Model of alpha 1-Antitrypsin Deficiency	PLOS ONE			English	Article							CHRONIC LIVER-DISEASE; VIRAL-HEPATITIS-B; PI-ASTERISK-S; ENDOPLASMIC-RETICULUM; ALPHA(1)-ANTITRYPSIN DEFICIENCY; MUTANT ALPHA(1)-ANTITRYPSIN-Z; HEPATOCELLULAR-CARCINOMA; KINETIC MECHANISM; MOLECULAR-BASIS; ANTI-THROMBIN	alpha 1-antitrypsin deficiency (ATD) predisposes patients to both loss-of-function (emphysema) and gain-of-function (liver cirrhosis) phenotypes depending on the type of mutation. Although the Z mutation (ATZ) is the most prevalent cause of ATD, > 120 mutant alleles have been identified. In general, these mutations are classified as deficient (< 20% normal plasma levels) or null (< 1% normal levels) alleles. The deficient alleles, like ATZ, misfold in the ER where they accumulate as toxic monomers, oligomers and aggregates. Thus, deficient alleles may predispose to both gain-and loss-of-function phenotypes. Null variants, if translated, typically yield truncated proteins that are efficiently degraded after being transiently retained in the ER. Clinically, null alleles are only associated with the loss-of-function phenotype. We recently developed a C. elegans model of ATD in order to further elucidate the mechanisms of proteotoxicity (gain-of-function phenotype) induced by the aggregationprone deficient allele, ATZ. The goal of this study was to use this C. elegans model to determine whether different types of deficient and null alleles, which differentially affect polymerization and secretion rates, correlated to any extent with proteotoxicity. Animals expressing the deficient alleles, Mmalton, Siiyama and S (ATS), showed overall toxicity comparable to that observed in patients. Interestingly, Siiyama expressing animals had smaller intracellular inclusions than ATZ yet appeared to have a greater negative effect on animal fitness. Surprisingly, the null mutants, although efficiently degraded, showed a relatively mild gainof- function proteotoxic phenotype. However, since null variant proteins are degraded differently and do not appear to accumulate, their mechanism of proteotoxicity is likely to be different to that of polymerizing, deficient mutants. Taken together, these studies showed that C. elegans is an inexpensive tool to assess the proteotoxicity of different AT variants using a transgenic approach.	[Cummings, Erin E.; O'Reilly, Linda P.; King, Dale E.; Silverman, Richard M.; Miedel, Mark T.; Luke, Cliff J.; Perlmutter, David H.; Silverman, Gary A.; Pak, Stephen C.] Univ Pittsburgh, Childrens Hosp Pittsburgh, Sch Med, Dept Pediat,UPMC, Pittsburgh, PA 15260 USA; [Perlmutter, David H.; Silverman, Gary A.] Univ Pittsburgh, Sch Med, Dept Cell Biol & Mol Physiol, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Silverman, GA (corresponding author), Univ Pittsburgh, Childrens Hosp Pittsburgh, Sch Med, Dept Pediat,UPMC, Pittsburgh, PA 15260 USA.	gsilverman@upmc.edu; paksc@upmc.edu	Silverman, Gary/AAJ-1269-2020	Miedel, Mark/0000-0002-0132-6032; Silverman, Richard/0000-0003-1423-4847; Pak, Stephen/0000-0002-8089-3237	National Institutes of Health [DK079806, DK081422]; NIH Office of Research Infrastructure Programs [P40 OD010440]; Eunice Kennedy Shriver National Institute of Child Health and Human Development [K12-HD000850]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD000850] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK081422, R01DK079806] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010440] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Office of Research Infrastructure Programs(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was supported by grants from the National Institutes of Health (DK079806 and DK081422) to GAS. Some nematode strains used in this work were provided by the Caenorhabditis Genetics Center (CGC), which is funded by NIH Office of Research Infrastructure Programs (P40 OD010440). DEK was Fellow of the Pediatric Scientist Development Program (K12-HD000850) from the Eunice Kennedy Shriver National Institute of Child Health and Human Development. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amer Thoracic Soc European Respir, 2003, AM J RESP CRIT CARE, V168, P818, DOI 10.1164/rccm.168.7.818; Benilova I, 2012, NAT NEUROSCI, V15, P349, DOI 10.1038/nn.3028; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; CARLSON JA, 1989, J CLIN INVEST, V83, P1183, DOI 10.1172/JCI113999; COX DW, 1988, AM REV RESPIR DIS, V137, P371, DOI 10.1164/ajrccm/137.2.371; COX DW, 1980, HUM GENET, V53, P429, DOI 10.1007/BF00287070; COX DW, 1989, AM J HUM GENET, V44, P844; CRYSTAL RG, 1990, J CLIN INVEST, V85, P1343, DOI 10.1172/JCI114578; CRYSTAL RG, 1989, CHEST, V95, P196, DOI 10.1378/chest.95.1.196; CURIEL DT, 1989, J BIOL CHEM, V264, P13938; Dafforn TR, 1999, J BIOL CHEM, V274, P9548, DOI 10.1074/jbc.274.14.9548; Dahl M, 2005, EUR RESPIR J, V26, P67, DOI 10.1183/09031936.05.00135704; Davis RL, 1999, NATURE, V401, P376, DOI 10.1038/43897; Davis RL, 2002, LANCET, V359, P2242, DOI 10.1016/S0140-6736(02)09293-0; Dawwas MF, 2013, AM J RESP CRIT CARE, V187, P502, DOI 10.1164/rccm.201204-0739OC; de Serres FJ, 2012, THER ADV RESPIR DIS, V6, P277, DOI 10.1177/1753465812457113; Duranton J, 1998, BIOCHEMISTRY-US, V37, P11239, DOI 10.1021/bi980223q; Eigenbrodt ML, 1997, AM J GASTROENTEROL, V92, P602; Elzouki AN, 1996, EUR J GASTROEN HEPAT, V8, P989, DOI 10.1097/00042737-199610000-00010; ERIKSSON S, 1986, NEW ENGL J MED, V314, P736, DOI 10.1056/NEJM198603203141202; Fischer HP, 2000, J HEPATOL, V33, P883, DOI 10.1016/S0168-8278(00)80119-1; Fregonese L, 2008, RESP MED, V102, P876, DOI 10.1016/j.rmed.2008.01.009; GADEK JE, 1981, J CLIN INVEST, V68, P889, DOI 10.1172/JCI110344; Gosai SJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015460; Graziadei IW, 1998, HEPATOLOGY, V28, P1058, DOI 10.1002/hep.510280421; Hamamichi S, 2008, P NATL ACAD SCI USA, V105, P728, DOI 10.1073/pnas.0711018105; Hashemi M, 2005, HEPATOL RES, V33, P292, DOI 10.1016/j.hepres.2005.09.035; Hosokawa N, 2003, J BIOL CHEM, V278, P26287, DOI 10.1074/jbc.M303395200; Hosokawa N, 2007, BIOCHEM BIOPH RES CO, V362, P626, DOI 10.1016/j.bbrc.2007.08.057; Janciauskiene S, 2004, HEPATOLOGY, V40, P1203, DOI 10.1002/hep.20451; Janciauskiene S, 2011, EUR J HUM GENET, V19, DOI 10.1038/ejhg.2010.246; Kamimoto T, 2006, J BIOL CHEM, V281, P4467, DOI 10.1074/jbc.M509409200; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Kervestin S, 2012, NAT REV MOL CELL BIO, V13, P700, DOI 10.1038/nrm3454; Kok KF, 2007, NETH J MED, V65, P160; Kraemer BC, 2006, HUM MOL GENET, V15, P1483, DOI 10.1093/hmg/ddl067; Kruse KB, 2006, MOL BIOL CELL, V17, P203, DOI 10.1091/mbc.e04-09-0779; Kuwahara T, 2008, HUM MOL GENET, V17, P2997, DOI 10.1093/hmg/ddn198; LAURELL CB, 1963, SCAND J CLIN LAB INV, V15, P132, DOI 10.3109/00365516309051324; Lee JH, 2000, RESP MED, V94, pS7, DOI 10.1053/rmed.2000.0851; Lejeune FX, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-91; LEWIS JH, 1978, BLOOD, V51, P129; Lin L, 2001, J BIOL CHEM, V276, P33893, DOI 10.1074/jbc.M105226200; LOMAS DA, 1995, J BIOL CHEM, V270, P16864, DOI 10.1074/jbc.270.28.16864; LOMAS DA, 1993, J BIOL CHEM, V268, P15333; Long OS, 2014, HUM MOL GENET, V23, P5109, DOI 10.1093/hmg/ddu235; Luisetti M, 2004, THORAX, V59, P164, DOI 10.1136/thorax.2003.006494; Mahadeva R, 1998, THORAX, V53, P501, DOI 10.1136/thx.53.6.501; Mahadeva R, 1999, J CLIN INVEST, V103, P999, DOI 10.1172/JCI4874; McGhee James D, 2007, WormBook, P1; Melendez A, 2003, SCIENCE, V301, P1387, DOI 10.1126/science.1087782; Miedel MT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040145; Miranda E, 2010, HEPATOLOGY, V52, P1078, DOI 10.1002/hep.23760; Needham M, 2004, THORAX, V59, P441, DOI 10.1136/thx.2003.006510; Nollen EAA, 2004, P NATL ACAD SCI USA, V101, P6403, DOI 10.1073/pnas.0307697101; O'Reilly LP, 2014, HUM MOL GENET, V23, P5123, DOI 10.1093/hmg/ddu236; OGUSHI F, 1987, J CLIN INVEST, V80, P1366, DOI 10.1172/JCI113214; OGUSHI F, 1988, AM REV RESPIR DIS, V137, P364, DOI 10.1164/ajrccm/137.2.364; OLSEN GN, 1975, J CLIN INVEST, V55, P427, DOI 10.1172/JCI107947; Ordonez A, 2013, HEPATOLOGY, V57, P2049, DOI 10.1002/hep.26173; OWEN MC, 1983, NEW ENGL J MED, V309, P694, DOI 10.1056/NEJM198309223091203; Peelaerts W, 2015, NATURE, V522, P340, DOI 10.1038/nature14547; PELHAM HRB, 1995, CURR OPIN CELL BIOL, V7, P530, DOI 10.1016/0955-0674(95)80010-7; Perlmutter DH, 2006, PEDIATR RES, V60, P233, DOI 10.1203/01.pdr.0000228350.61496.90; Perlmutter DH, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005801; Perlmutter DH, 2011, ANNU REV MED, V62, P333, DOI 10.1146/annurev-med-042409-151920; Perlmutter DH, 2011, MOL PATHOL LIB, V5, P683, DOI 10.1007/978-1-4419-7107-4_46; Perlmutter DH, 2002, J CLIN INVEST, V110, P1219, DOI 10.1172/JCI200216780; Perlmutter DH, 2007, MOL CELLULAR ASPECTS, P483; Qu DF, 1996, J BIOL CHEM, V271, P22791, DOI 10.1074/jbc.271.37.22791; Ranes J, 2005, SEMIN RESP CRIT CARE, V26, P154, DOI 10.1055/s-2005-869536; Ray S, 2005, BBA-MOL BASIS DIS, V1740, P390, DOI 10.1016/j.bbadis.2005.03.010; ROBERTS EA, 1984, AM J CLIN PATHOL, V82, P424, DOI 10.1093/ajcp/82.4.424; Rodriguez-Frias F, 2012, THER ADV RESPIR DIS, V6, P79, DOI 10.1177/1753465811434320; Roth DM, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001998; Rudnick DA, 2005, HEPATOLOGY, V42, P514, DOI 10.1002/hep.20815; Salahuddin P, 2010, CURR PROTEIN PEPT SC, V11, P101, DOI 10.2174/138920310790848368; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; SEYAMA K, 1991, J BIOL CHEM, V266, P12627; Shen XH, 2005, PLOS GENET, V1, P355, DOI 10.1371/journal.pgen.0010037; Shoemaker CJ, 2012, NAT STRUCT MOL BIOL, V19, P594, DOI 10.1038/nsmb.2301; SIFERS RN, 1988, J BIOL CHEM, V263, P7330; SIFERS RN, 1989, AM J RESP CELL MOL, V1, P341, DOI 10.1165/ajrcmb/1.5.341; Silva MC, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002438; Silverman GA, 2009, PEDIATR RES, V65, P10, DOI 10.1203/PDR.0b013e31819009b0; Stockley RA, 2014, TRENDS MOL MED, V20, P105, DOI 10.1016/j.molmed.2013.11.006; Stoller JK, 2005, LANCET, V365, P2225, DOI 10.1016/S0140-6736(05)66781-5; SVEGER T, 1976, NEW ENGL J MED, V294, P1316, DOI 10.1056/NEJM197606102942404; SVEGER T, 1988, ACTA PAEDIATR SCAND, V77, P847, DOI 10.1111/j.1651-2227.1988.tb10767.x; Tanash HA, 2008, THORAX, V63, P1091, DOI 10.1136/thx.2008.095497; Teckman JH, 2000, AM J PHYSIOL-GASTR L, V279, pG961, DOI 10.1152/ajpgi.2000.279.5.G961; Teckman JH, 1996, J BIOL CHEM, V271, P13215, DOI 10.1074/jbc.271.22.13215; Teckman JH, 2001, J BIOL CHEM, V276, P44865, DOI 10.1074/jbc.M103703200; TRAVIS J, 1983, ANNU REV BIOCHEM, V52, P655, DOI 10.1146/annurev.bi.52.070183.003255; van Ham TJ, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000027; Rodrigues LV, 2012, CLIN GENET, V81, P462, DOI 10.1111/j.1399-0004.2011.01670.x; Vilchez D, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6659; Wang J, 2009, POWDER DIFFR, V24, P24, DOI 10.1154/1.3079687; Yamasaki M, 2011, EMBO REP, V12, P1011, DOI 10.1038/embor.2011.171; Yazaki M, 2001, AM J PATHOL, V158, P227, DOI 10.1016/S0002-9440(10)63961-2; Zorzetto M, 2008, CLIN CHEM, V54, P1331, DOI 10.1373/clinchem.2007.102798	101	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2015	10	10							e0141542	10.1371/journal.pone.0141542	http://dx.doi.org/10.1371/journal.pone.0141542			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0ED	26512890	Green Accepted, Green Submitted, gold, Green Published			2022-12-26	WOS:000363920300048
J	Amaniti, EM; Kelman, A; Mason, JO; Theil, T				Amaniti, Eleni-Maria; Kelman, Alexandra; Mason, John O.; Theil, Thomas			Cerebral Cortex Expression of Gli3 Is Required for Normal Development of the Lateral Olfactory Tract	PLOS ONE			English	Article							VENTRAL TANGENTIAL MIGRATION; MITRAL CELL AXONS; PIRIFORM CORTEX; GUIDEPOST NEURONS; CORPUS-CALLOSUM; AFFERENT-FIBERS; GENE-EXPRESSION; MOUSE; SEMAPHORINS; RECEPTOR	Formation of the lateral olfactory tract (LOT) and innervation of the piriform cortex represent fundamental steps to allow the transmission of olfactory information to the cerebral cortex. Several transcription factors, including the zinc finger transcription factor Gli3, influence LOT formation by controlling the development of mitral cells from which LOT axons emanate and/or by specifying the environment through which these axons navigate. Gli3 null and hypomorphic mutants display severe defects throughout the territory covered by the developing lateral olfactory tract, making it difficult to identify specific roles for Gli3 in its development. Here, we used Emx1Cre;Gli3(fl/fl) conditional mutants to investigate LOT formation and colonization of the olfactory cortex in embryos in which loss of Gli3 function is restricted to the dorsal telencephalon. These mutants form an olfactory bulb like structure which does not protrude from the telencephalic surface. Nevertheless, mitral cells are formed and their axons enter the piriform cortex though the LOT is shifted medially. Mitral axons also innervate a larger target area consistent with an enlargement of the piriform cortex and form aberrant projections into the deeper layers of the piriform cortex. No obvious differences were found in the expression patterns of key guidance cues. However, we found that an expansion of the piriform cortex temporally coincides with the arrival of LOT axons, suggesting that Gli3 affects LOT positioning and target area innervation through controlling the development of the piriform cortex.	[Amaniti, Eleni-Maria; Kelman, Alexandra; Mason, John O.; Theil, Thomas] Univ Edinburgh, Ctr Integrat Physiol, Edinburgh EH8 9XD, Midlothian, Scotland	University of Edinburgh	Theil, T (corresponding author), Univ Edinburgh, Ctr Integrat Physiol, Hugh Robson Bldg,George Sq, Edinburgh EH8 9XD, Midlothian, Scotland.	thomas.theil@ed.ac.uk	Mason, John O/A-1926-2010	Mason, John O/0000-0002-0489-2400; Theil, Thomas/0000-0001-6590-8309	Medical Research Council [MR/K013750/1]; MRC [MR/K013750/1] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by a grant from the Medical Research Council to TT (MR/K013750/1).	Amaniti EM, 2015, CEREB CORTEX, V25, P460, DOI 10.1093/cercor/bht244; Amaniti EM, 2013, DEV BIOL, V376, P113, DOI 10.1016/j.ydbio.2013.02.001; Ariens-Kapers CU, 1936, COMP ANATOMY NERVOUS; Arlotta P, 2005, NEURON, V45, P207, DOI 10.1016/j.neuron.2004.12.036; Besse L, 2011, DEVELOPMENT, V138, P2079, DOI 10.1242/dev.059808; Blaess S, 2008, DEVELOPMENT, V135, P2093, DOI 10.1242/dev.015990; Bulfone A, 1998, NEURON, V21, P1273, DOI 10.1016/S0896-6273(00)80647-9; Cave JW, 2010, J NEUROSCI, V30, P4717, DOI 10.1523/JNEUROSCI.0419-10.2010; Chen H, 1997, NEURON, V19, P547, DOI 10.1016/S0896-6273(00)80371-2; Chou SJ, 2009, NAT NEUROSCI, V12, P1381, DOI 10.1038/nn.2427; de Castro F, 1999, J NEUROSCI, V19, P4428; de Castro F, 2009, FRONT NEUROSCI-SWITZ, V3, DOI 10.3389/neuro.22.004.2009; DERER P, 1977, BRAIN RES, V123, P27, DOI 10.1016/0006-8993(77)90641-2; Dufour A, 2003, NEURON, V39, P453, DOI 10.1016/S0896-6273(03)00440-9; Faedo A, 2002, MECH DEVELOP, V116, P157, DOI 10.1016/S0925-4773(02)00114-4; Feng W, 2009, MOL CELL NEUROSCI, V42, P161, DOI 10.1016/j.mcn.2009.06.010; Golshani P, 1997, J COMP NEUROL, V383, P199, DOI 10.1002/(SICI)1096-9861(19970630)383:2<199::AID-CNE7>3.0.CO;2-W; Gorski JA, 2002, J NEUROSCI, V22, P6309; Gottfried JA, 2010, NAT REV NEUROSCI, V11, P628, DOI 10.1038/nrn2883; HABERLY L, 1983, J COMP NEUROL, V219, P448, DOI 10.1002/cne.902190406; Hirata T, 1999, J NEUROBIOL, V38, P93; Ito K, 2008, J NEUROSCI, V28, P4414, DOI 10.1523/JNEUROSCI.0372-08.2008; Jen Y, 1997, DEV DYNAM, V208, P92, DOI 10.1002/(SICI)1097-0177(199701)208:1<92::AID-AJA9>3.0.CO;2-X; Jimenez D, 2000, J COMP NEUROL, V428, P511; JOHNSON DR, 1967, J EMBRYOL EXP MORPH, V17, P543; Kawasaki T, 2006, DEVELOPMENT, V133, P845, DOI 10.1242/dev.02257; Kolodkin AL, 1997, CELL, V90, P753, DOI 10.1016/S0092-8674(00)80535-8; Lett RLM, 2009, CEREB CORTEX, V19, P1408, DOI 10.1093/cercor/bhn179; Lin JH, 1998, CELL, V95, P393, DOI 10.1016/S0092-8674(00)81770-5; Magnani D, 2014, CEREB CORTEX, V24, P186, DOI 10.1093/cercor/bhs303; Magnani D, 2013, CEREB CORTEX, V23, P2542, DOI 10.1093/cercor/bhs237; Matsuoka RL, 2011, NEURON, V71, P460, DOI 10.1016/j.neuron.2011.06.009; NARUSE I, 1995, PROG NEUROBIOL, V47, P135, DOI 10.1016/0301-0082(95)00024-P; NARUSE I, 1990, DEV BRAIN RES, V51, P253, DOI 10.1016/0165-3806(90)90283-5; Nguyen-Ba-Charvet KT, 2002, J NEUROSCI, V22, P5473; Nomura T, 2006, DEVELOPMENT, V133, P1335, DOI 10.1242/dev.02290; Pedraza M, 2012, FRONT NEUROANAT, V6, DOI 10.3389/fnana.2012.00035; Saha B, 2007, J NEUROSCI, V27, P2290, DOI 10.1523/JNEUROSCI.5571-06.2007; Sarma AA, 2011, CEREB CORTEX, V21, P1231, DOI 10.1093/cercor/bhq199; Sato Y, 1998, J NEUROSCI, V18, P7800; SCHWOB JE, 1984, J COMP NEUROL, V223, P203, DOI 10.1002/cne.902230205; SCHWOB JE, 1984, J COMP NEUROL, V223, P177, DOI 10.1002/cne.902230204; Shipley MT, 1996, J NEUROBIOL, V30, P123; Sousa VH, 2009, CEREB CORTEX, V19, pI1, DOI 10.1093/cercor/bhp038; Soussi-Yanicostas N, 2002, CELL, V109, P217, DOI 10.1016/S0092-8674(02)00713-4; Stenman JM, 2003, J NEUROSCI, V23, P10568; Stettler DD, 2009, NEURON, V63, P854, DOI 10.1016/j.neuron.2009.09.005; Sugisaki N, 1996, J NEUROBIOL, V29, P127, DOI 10.1002/(SICI)1097-4695(199602)29:2<127::AID-NEU1>3.0.CO;2-C; Theil T, 2005, DEV BIOL, V286, P559, DOI 10.1016/j.ydbio.2005.08.033; Tomioka N, 2000, J NEUROSCI, V20, P5802, DOI 10.1523/JNEUROSCI.20-15-05802.2000; Vyas A, 2003, J COMP NEUROL, V466, P545, DOI 10.1002/cne.10900; Xu C, 2008, GENE EXPR PATTERNS, V8, P502, DOI 10.1016/j.gep.2008.06.003	52	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2015	10	10							e0141525	10.1371/journal.pone.0141525	http://dx.doi.org/10.1371/journal.pone.0141525			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0DL	26509897	Green Published, gold			2022-12-26	WOS:000363918100097
J	Csaszar, NBM; Angstman, NB; Milz, S; Sprecher, CM; Kobel, P; Farhat, M; Furia, JP; Schmitz, C				Csaszar, Nikolaus B. M.; Angstman, Nicholas B.; Milz, Stefan; Sprecher, Christoph M.; Kobel, Philippe; Farhat, Mohamed; Furia, John P.; Schmitz, Christoph			Radial Shock Wave Devices Generate Cavitation	PLOS ONE			English	Article							ACHILLES TENDINOPATHY; ACOUSTIC FIELD; THERAPY RESWT; PRINCIPLES; SPASTICITY; BODY	Background Conflicting reports in the literature have raised the question whether radial extracorporeal shock wave therapy (rESWT) devices and vibrating massage devices have similar energy signatures and, hence, cause similar bioeffects in treated tissues. Methods and Findings We used laser fiber optic probe hydrophone (FOPH) measurements, high-speed imaging and x-ray film analysis to compare fundamental elements of the energy signatures of two rESWT devices (Swiss DolorClast; Electro Medical Systems, Nyon, Switzerland; D-Actor 200; Storz Medical, Tagerwillen, Switzerland) and a vibrating massage device (Vibracare; G5/General Physiotherapy, Inc., Earth City, MO, USA). To assert potential bioeffects of these treatment modalities we investigated the influence of rESWT and vibrating massage devices on locomotion ability of Caenorhabditis elegans (C. elegans) worms. Results FOPH measurements demonstrated that both rESWT devices generated acoustic waves with comparable pressure and energy flux density. Furthermore, both rESWT devices generated cavitation as evidenced by high-speed imaging and caused mechanical damage on the surface of x-ray film. The vibrating massage device did not show any of these characteristics. Moreover, locomotion ability of C. elegans was statistically significantly impaired after exposure to radial extracorporeal shock waves but was unaffected after exposure of worms to the vibrating massage device. Conclusions The results of the present study indicate that both energy signature and bioeffects of rESWT devices are fundamentally different from those of vibrating massage devices.	[Csaszar, Nikolaus B. M.; Angstman, Nicholas B.; Milz, Stefan; Schmitz, Christoph] Univ Munich, Dept Anat 2, Extracorporeal Shock Wave Res Unit, Munich, Germany; [Sprecher, Christoph M.] AO Res Inst Davos, Davos, Switzerland; [Kobel, Philippe; Farhat, Mohamed] Ecole Polytech Fed Lausanne, Hydraul Machines Lab, Lausanne, Switzerland; [Furia, John P.] SUN Orthopaed Grp, Lewisburg, PA USA	University of Munich; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Schmitz, C (corresponding author), Univ Munich, Dept Anat 2, Extracorporeal Shock Wave Res Unit, Munich, Germany.	christoph_schmitz@med.uni-muenchen.de	Farhat, Mohamed/H-9463-2012; Milz, Stefan/J-8218-2012	Farhat, Mohamed/0000-0002-4782-2170; Milz, Stefan/0000-0002-3859-2107	SUN Orthopaedic Group	SUN Orthopaedic Group	JPF was employed by SUN Orthopaedic Group during this study and received funding in the form of salary. Dr. Furia is paid for clinical work, not for any research activities. Accordingly, neither SUN Orthopaedic Group nor any other organization/institution have had any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angstman NB, 2015, FRONT BEHAV NEUROSCI, V9, DOI 10.3389/fnbeh.2015.00012; [Anonymous], 2008, ACTA ORTHOP BELG, V74, P98; BAUER ML, 1994, J PEDIATR-US, V124, P250, DOI 10.1016/S0022-3476(94)70313-2; Blobaum P, 2006, J MED LIBR ASSOC, V94, P477; Cacchio A, 2011, AM J SPORT MED, V39, P146, DOI 10.1177/0363546510379324; Chen H, 2010, UROL RES, V38, P321, DOI 10.1007/s00240-010-0302-5; Chitnis PV, 2005, AIP C P, P27; Chow IHW, 2007, CLIN REHABIL, V21, P131, DOI 10.1177/0269215506069244; Cleveland RO, 2007, ULTRASOUND MED BIOL, V33, P1327, DOI 10.1016/j.ultrasmedbio.2007.02.014; COLEMAN AJ, 1987, ULTRASOUND MED BIOL, V13, P69, DOI 10.1016/0301-5629(87)90076-7; Contaldo C, 2012, MICROVASC RES, V84, P24, DOI 10.1016/j.mvr.2012.03.006; Greve JMD, 2009, CLINICS, V64, P97, DOI 10.1590/S1807-59322009000200006; Engebretsen K, 2011, PHYS THER, V91, P37, DOI 10.2522/ptj.20090338; Evan AP, 2002, J UROLOGY, V168, P1556, DOI 10.1016/S0022-5347(05)64520-X; Gerdesmeyer L, 2002, ORTHOPADE, V31, P610, DOI 10.1007/s00132-002-0319-8; Gerdesmeyer L, 2008, AM J SPORT MED, V36, P2100, DOI 10.1177/0363546508324176; Gollwitzer H, 2013, ULTRASOUND MED BIOL, V39, P126, DOI 10.1016/j.ultrasmedbio.2012.08.026; Gonkova MI, 2013, INT J REHABIL RES, V36, P284, DOI 10.1097/MRR.0b013e328360e51d; Grecco MV, 2013, CLINICS, V68, P1089, DOI 10.6061/clinics/2013(08)05; He YL, 2013, J PEDIAT RESP DIS, V9, P40; Ibrahim MI, 2010, FOOT ANKLE INT, V31, P391, DOI 10.3113/FAI.2010.0391; Kiessling MC, 2015, SCI REP-UK, V5, DOI 10.1038/srep08281; Kolk A, 2013, BONE JOINT J, V95B, P1521, DOI 10.1302/0301-620X.95B11.31879; Lee SS, 2012, ANN REHABIL MED-ARM, V36, P681, DOI 10.5535/arm.2012.36.5.681; Liu ST, 2012, ULTRASOUND MED BIOL, V38, P727, DOI 10.1016/j.ultrasmedbio.2012.01.024; McClure S., 2003, Clinical Techniques in Equine Practice, V2, P348, DOI 10.1053/j.ctep.2004.04.008; Mehra A, 2003, SURG-J R COLL SURG E, V1, P290, DOI 10.1016/S1479-666X(03)80048-3; Miller DL, 2007, PROG BIOPHYS MOL BIO, V93, P314, DOI 10.1016/j.pbiomolbio.2006.07.027; Obreschkow D, 2013, EXP FLUIDS, V54, DOI 10.1007/s00348-013-1503-9; Ogden JA, 2001, CLIN ORTHOP RELAT R, P8; Perez C, 2013, J ACOUST SOC AM, V134, P1663, DOI 10.1121/1.4812885; Pishchalnikov YA, 2011, J ACOUST SOC AM, V130, pEL87, DOI 10.1121/1.3609920; Rompe JD, 2008, J BONE JOINT SURG AM, V90A, P52, DOI 10.2106/JBJS.F.01494; Rompe JD, 2007, AM J SPORT MED, V35, P374, DOI 10.1177/0363546506295940; Rompe JD, 2010, J BONE JOINT SURG AM, V92A, P2514, DOI 10.2106/JBJS.I.01651; Rompe JD, 2009, AM J SPORT MED, V37, P1981, DOI 10.1177/0363546509334374; Rompe JD, 2009, AM J SPORT MED, V37, P463, DOI 10.1177/0363546508326983; Russe-Wilflingseder K, 2013, J COSMET LASER THER, V15, P155, DOI 10.3109/14764172.2012.759235; Saxena Amol, 2013, Muscles Ligaments Tendons J, V3, P60, DOI 10.11138/mltj/2013.3.2.060; Saxena A, 2011, J FOOT ANKLE SURG, V50, P315, DOI 10.1053/j.jfas.2011.01.003; SCHELLING G, 1994, BIOPHYS J, V66, P133, DOI 10.1016/S0006-3495(94)80758-1; Schlaudraff KU, 2014, CLIN COSMET INVESTI, V7, P171, DOI 10.2147/CCID.S59851; Schmitz C, 2013, J ORTHOP SURG RES, V8, DOI 10.1186/1749-799X-8-31; Shaheen AAM, 2010, IND J PHYSIOTHER OCC, V4, P8; Smith N, 2012, REV SCI INSTRUM, V83, DOI 10.1063/1.3678638; Speed C, 2014, BRIT J SPORT MED, V48, P1538, DOI 10.1136/bjsports-2012-091961; SULSTON JE, 1974, GENETICS, V77, P95; Vidal X, 2011, NEUROREHABILITATION, V29, P413, DOI 10.3233/NRE-2011-0720; WALLIS JW, 1989, IEEE T MED IMAGING, V8, P297, DOI 10.1109/42.41482; Zhao Z, 2012, ARCH ORTHOP TRAUM SU, V132, P1547, DOI 10.1007/s00402-012-1586-4; Zhou Y, 2012, J CONTROL RELEASE, V157, P103, DOI 10.1016/j.jconrel.2011.09.068	51	42	48	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2015	10	10							e0140541	10.1371/journal.pone.0140541	http://dx.doi.org/10.1371/journal.pone.0140541			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0DL	26509573	Green Submitted, Green Published, gold			2022-12-26	WOS:000363918100033
J	Durlak, M; Fugazza, C; Elangovan, S; Marini, MG; Marongiu, MF; Moi, P; Fraietta, I; Cappella, P; Barbarani, G; Font-Monclus, I; Mauri, M; Ottolenghi, S; Gasparri, F; Ronchi, A				Durlak, Marta; Fugazza, Cristina; Elangovan, Sudharshan; Marini, Maria Giuseppina; Marongiu, Maria Franca; Moi, Paolo; Fraietta, Ivan; Cappella, Paolo; Barbarani, Gloria; Font-Monclus, Isaura; Mauri, Mario; Ottolenghi, Sergio; Gasparri, Fabio; Ronchi, Antonella			A Novel High-Content Immunofluorescence Assay as a Tool to Identify at the Single Cell Level gamma-Globin Inducing Compounds	PLOS ONE			English	Article							HEME OXYGENASE-1 DEFICIENCY; FETAL-HEMOGLOBIN INDUCTION; LEUKEMIA-CELLS; ERYTHROID PROGENITORS; GENE-REGULATION; IN-VIVO; ERYTHROPOIESIS; THALASSEMIA; SYSTEM; LINE	The identification of drugs capable of reactivating gamma-globin to ameliorate beta-thalassemia and Sickle Cell anemia is still a challenge, as available gamma-globin inducers still have limited clinical indications. High-throughput screenings (HTS) aimed to identify new potentially therapeutic drugs require suitable first-step-screening methods combining the possibility to detect variation in the gamma/beta globin ratio with the robustness of a cell line. We took advantage of a K562 cell line variant expressing beta-globin (beta-K562) to set up a new multiplexed high-content immunofluorescence assay for the quantification of gamma- and beta-globin content at single-cell level. The assay was validated by using the known globin inducers hemin, hydroxyurea and butyric acid and further tested in a pilot screening that confirmed HDACs as targets for gamma-globin induction (as proved by siRNA-mediated HDAC3 knockdown and by treatment with HDACs inhibitors entinostat and dacinostat) and identified Heme-oxygenases as novel candidate targets for gamma-globin induction. Indeed, Heme-oxygenase2 siRNA knockdown as well as its inhibition by Tin protoporphyrin-IX (TinPPIX) greatly increased gamma-globin expression. This result is particularly interesting as several metalloporphyrins have already been developed for clinical uses and could be tested (alone or in combination with other drugs) to improve pharmacological gamma-globin reactivation for the treatment of beta-hemoglobinopathies.	[Durlak, Marta; Fraietta, Ivan; Cappella, Paolo; Gasparri, Fabio] Nerviano Med Sci Srl, Dept Biol, Milan, Italy; [Fugazza, Cristina; Elangovan, Sudharshan; Barbarani, Gloria; Font-Monclus, Isaura; Ottolenghi, Sergio; Ronchi, Antonella] Univ Milano Bicocca, Dipartimento Biotecnol & Biosci, Milan, Italy; [Marini, Maria Giuseppina; Marongiu, Maria Franca] CNR, Ist Ric Genet & Biomed, Cagliari, Italy; [Moi, Paolo] Univ Cagliari, Dipartimento Sanita Pubbl Med Clin & Mol, Cagliari, Italy; [Mauri, Mario] Univ Milano Bicocca, Dipartimento Sci Salute, Monza, Italy	Nerviano Medical Sciences S.r.l; University of Milano-Bicocca; Consiglio Nazionale delle Ricerche (CNR); Istituto di Ricerca Genetica e Biomedica (IRGB-CNR); University of Cagliari; University of Milano-Bicocca	Ronchi, A (corresponding author), Univ Milano Bicocca, Dipartimento Biotecnol & Biosci, Milan, Italy.	antonella.ronchi@unimib.it	Marini, Maria Giuseppina/AAC-9384-2021; MARONGIU, MARIAFRANCA/AAC-3152-2021; Moi, Paolo/AAC-3161-2019; Gasparri, Fabio/AFN-9316-2022; Cappella, Paolo/ABI-2298-2020; Cappella, Paolo/L-5857-2016	Marini, Maria Giuseppina/0000-0003-0371-9398; MARONGIU, MARIAFRANCA/0000-0003-3363-8046; Cappella, Paolo/0000-0002-3401-4246; Elangovan, Sudharshan/0000-0002-8783-626X; Fugazza, Cristina/0000-0003-4242-0540; Cappella, Paolo/0000-0002-7476-5618; Marini, Maria Giuseppina/0000-0002-2359-2892; RONCHI, ANTONELLA ELLENA/0000-0002-3905-1038; MAURI, MARIO/0000-0002-5876-6215	People Programme (Marie Curie Actions) of the European Union's Seventh Framework Programme FP7 under REA grant [289611]; Fondazione Cariplo [2012.0517]; Marie Curie Actions of the European Union's Seventh Framework Programme FP7 under REA grant [28961]	People Programme (Marie Curie Actions) of the European Union's Seventh Framework Programme FP7 under REA grant; Fondazione Cariplo(Fondazione Cariplo); Marie Curie Actions of the European Union's Seventh Framework Programme FP7 under REA grant	This work was supported by the People Programme (Marie Curie Actions) of the European Union's Seventh Framework Programme FP7/2007-2013/ under REA grant agreement no289611 (HEM_ID Project) and by Fondazione Cariplo for grant no 2012.0517 to AR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. FG and IF are employees in Nerviano Medical Sciences S.r.l., which is a private sector partner in the HEM_ID Project (Marie Curie Actions of the European Union's Seventh Framework Programme FP7/2007-2013/ under REA grant agreement no28961). The present research is the result of a collaborative project and MD is the Marie Curie fellow appointed to Nerviano Medical Sciences S.r.l. within this network. PC was a NMS employee at the time the research was performed (present address: FlowMetric Europe srl, Parco Tecnologico Padano, Via A. Einstein 26900, Lodi, Italy).	Abraham NG, 2008, PHARMACOL REV, V60, P79, DOI 10.1124/pr.107.07104; Banan M, 2013, ANN HEMATOL, V92, P289, DOI 10.1007/s00277-012-1671-3; Bauer DE, 2012, BLOOD, V120, P2945, DOI 10.1182/blood-2012-06-292078; Blagitko-Dorfs N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075258; Bradner JE, 2010, P NATL ACAD SCI USA, V107, P12617, DOI 10.1073/pnas.1006774107; Cantu C, 2011, BLOOD, V117, P3669, DOI 10.1182/blood-2010-04-282350; Chan KSK, 2012, FASEB J, V26, P1736, DOI 10.1096/fj.11-199356; Chen JJ, 2007, BLOOD, V109, P2693, DOI 10.1182/blood-2006-08-041830; Dennery PA, 2005, CURR OPIN PEDIATR, V17, P167, DOI 10.1097/01.mop.0000156270.25640.5a; Ding YY, 2006, FEBS J, V273, P5333, DOI 10.1111/j.1742-4658.2006.05526.x; Flint J, 1998, BAILLIERE CLIN HAEM, V11, P1, DOI 10.1016/S0950-3536(98)80069-3; Forget B G, 1983, Prog Clin Biol Res, V134, P65; Fraser S. T., 2011, ADV HEMATOL, V2011; Fraser ST, 2015, HAEMATOLOGICA, V100, P601, DOI 10.3324/haematol.2014.116368; Gil GP, 2013, HEMOGLOBIN, V37, P315, DOI 10.3109/03630269.2013.789438; GUERRASIO A, 1981, BLOOD CELLS, V7, P165; Jamison DT, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P1; Koizumi S, 2007, PEDIATR INT, V49, P125, DOI 10.1111/j.1442-200X.2007.02353.x; Kovtunovych G, 2010, BLOOD, V116, P6054, DOI 10.1182/blood-2010-03-272138; Kurita R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059890; LOZZIO CB, 1975, BLOOD, V45, P321, DOI 10.1182/blood.V45.3.321.321; Maggio SC, 2004, CANCER RES, V64, P2590, DOI 10.1158/0008-5472.CAN-03-2631; Maines MD, 1997, ANNU REV PHARMACOL, V37, P517, DOI 10.1146/annurev.pharmtox.37.1.517; Mankidy R, 2006, BLOOD, V108, P3179, DOI 10.1182/blood-2005-12-010934; McColl B, 2014, FASEB J, V28, P2306, DOI 10.1096/fj.13-246637; Musallam KM, 2013, BLOOD, V121, P2199, DOI 10.1182/blood-2012-10-408021; Papadopoulos P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051272; PAPAYANNOPOULOU T, 1978, SCIENCE, V199, P1349, DOI 10.1126/science.628844; PAPAYANNOPOULOU T, 1977, P NATL ACAD SCI USA, V74, P2923, DOI 10.1073/pnas.74.7.2923; Patrinos GP, 2004, GENE DEV, V18, P1495, DOI 10.1101/gad.289704; Perrine SP, 2014, HEMATOL ONCOL CLIN N, V28, P233, DOI 10.1016/j.hoc.2013.11.009; Perrine SP, 2010, ANN NY ACAD SCI, V1202, P158, DOI 10.1111/j.1749-6632.2010.05593.x; Peterson KR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107006; Pourfarzad F, 2013, HAEMATOLOGICA, V98, P696, DOI 10.3324/haematol.2012.074492; Rivella S, 2009, CURR OPIN HEMATOL, V16, P187, DOI 10.1097/MOH.0b013e32832990a4; Ronchi A, 2013, HAEMATOLOGICA, V98, P657, DOI 10.3324/haematol.2013.084392; RUTHERFORD TR, 1979, NATURE, V280, P164, DOI 10.1038/280164a0; Sankaran VG, 2010, HEMATOL ONCOL CLIN N, V24, P1005, DOI 10.1016/j.hoc.2010.08.009; Seta F, 2006, AM J PATHOL, V169, P1612, DOI 10.2353/ajpath.2006.060555; Somaschini A, 2013, GENET TEST MOL BIOMA, V17, P254, DOI 10.1089/gtmb.2012.0359; Stintzing S, 2011, J BIOMED BIOTECHNOL, V2011, DOI [10.1155/2011/214143, DOI 10.1155/2011/214143]; Suzuki M, 2014, MOL CELL BIOL, V34, P3560, DOI 10.1128/MCB.00714-14; Thein SL, 2009, HUM MOL GENET, V18, pR216, DOI 10.1093/hmg/ddp401; Tsiftsoglou AS, 2003, PHARMACOL THERAPEUT, V100, P257, DOI 10.1016/j.pharmthera.2003.09.002; Weatherall DJ, 2001, B WORLD HEALTH ORGAN, V79, P704; Weisberg E, 2004, LEUKEMIA, V18, P1951, DOI 10.1038/sj.leu.2403519	46	3	4	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2015	10	10							e0141083	10.1371/journal.pone.0141083	http://dx.doi.org/10.1371/journal.pone.0141083			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0DL	26509275	Green Published, gold, Green Submitted			2022-12-26	WOS:000363918100050
J	Tschinkel, WR				Tschinkel, Walter R.			Experiments Testing the Causes of Namibian Fairy Circles	PLOS ONE			English	Article							PATTERN-FORMATION; MYSTERIOUS CIRCLES; VEGETATION; TERMITE; DESERT; HYPOTHESES; ORIGIN; MODEL	The grasslands on the sandy soils of the eastern edge of the Namib Desert of Namibia are strikingly punctuated by millions of mostly regularly-spaced circular bare spots 2 to 10 m or more in diameter, generally with a margin of taller grasses. The causes of these so called fairy circles are unknown, but several hypotheses have been advanced. In October 2009, we set up experiments that specifically tested four hypothesized causes, and monitored these 5 times between 2009 and 2015. Grass exclusion in circles due to seepage of subterranean vapors or gases was tested by burying an impermeable barrier beneath fairy circles, but seedling density and growth did not differ from barrier-less controls. Plant germination and growth inhibition by allelochemicals or nutrient deficiencies in fairy circle soils were tested by transferring fairy circle soil to artificially cleared circles in the grassy matrix, and matrix soil to fairy circles (along with circle to circle and matrix to matrix controls). None of the transfers changed the seedling density and growth from the control reference conditions. Limitation of plant growth due to micronutrient depletion within fairy circles was tested by supplementing circles with a micronutrient mixture, but did not result in differences in plant seedling density and growth. Short-range vegetation competitive feedbacks were tested by creating artificially-cleared circles of 2 or 4 m diameter located 2 or 6 m from a natural fairy circle. The natural circles remained bare and the artificial circles revegetated. These four experiments provided evidence that fairy circles were not caused by subterranean vapors, that fairy circle soil per se did not inhibit plant growth, and that the circles were not caused by micronutrient deficiency. There was also no evidence that vegetative feedbacks affected fairy circles on a 2 to 10 m scale. Landscape-scale vegetative self-organization is discussed as a more likely cause of fairy circles.	Florida State Univ, Dept Biol Sci, B-157, Tallahassee, FL 32306 USA	State University System of Florida; Florida State University	Tschinkel, WR (corresponding author), Florida State Univ, Dept Biol Sci, B-157, Tallahassee, FL 32306 USA.	tschinkel@bio.fsu.edu			National Geographic Grant [9539-14]	National Geographic Grant(National Geographic Society)	The author received no specific funding for the 2009 experiments, but vehicle rental for the 2015 visit was covered by National Geographic Grant #9539-14 to Nichole Barger.	Albrecht CF, 2001, S AFR J SCI, V97, P23; Becker T, 2000, BASIC APPL ECOL, V1, P149, DOI 10.1078/1439-1791-00021; Couteron P, 2001, J ECOL, V89, P616, DOI 10.1046/j.0022-0477.2001.00588.x; Cramer MD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070876; Crawford C. S., 1994, Journal of African Zoology, V108, P49; Escaff D, 2015, PHYS REV E, V91, DOI 10.1103/PhysRevE.91.022924; Fernandez-Oto C, 2014, PHILOS T R SOC A, V372, DOI 10.1098/rsta.2014.0009; Getzin S, 2015, ECOGRAPHY, V38, P1, DOI 10.1111/ecog.00911; Grube S, 2002, BASIC APPL ECOL, V3, P367, DOI 10.1078/1439-1791-00138; HilleRisLambers R, 2001, ECOLOGY, V82, P50, DOI 10.1890/0012-9658(2001)082[0050:VPFISA]2.0.CO;2; Jankowitz WJ, 2008, S AFR J BOT, V74, P332, DOI 10.1016/j.sajb.2007.10.010; Juergens N, 2015, ECOGRAPHY, V38, P12, DOI 10.1111/ecog.01232; Juergens N, 2013, SCIENCE, V339, P1618, DOI 10.1126/science.1222999; Lefever R, 1997, B MATH BIOL, V59, P263, DOI 10.1007/BF02462004; Lejeune O, 1999, J VEG SCI, V10, P201, DOI 10.2307/3237141; Lejeune O, 1999, ACTA OECOL, V20, P171, DOI 10.1016/S1146-609X(99)80030-7; Meron E, 2012, ECOL MODEL, V234, P70, DOI 10.1016/j.ecolmodel.2011.05.035; Moll E.J., 1994, P 13 PLENARY M AETFA, P1203; Morton SR, 2011, J ARID ENVIRON, V75, P313, DOI 10.1016/j.jaridenv.2010.11.001; Moss JL, 2012, MAR PETROL GEOL, V35, P321, DOI 10.1016/j.marpetgeo.2012.02.019; Naude Y, 2011, J ARID ENVIRON, V75, P446, DOI 10.1016/j.jaridenv.2010.12.018; Picker MD, 2012, ECOL ENTOMOL, V37, P33, DOI 10.1111/j.1365-2311.2011.01332.x; Ramond JB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109539; Rietkerk M, 2002, AM NAT, V160, P524, DOI 10.1086/342078; Rietkerk M, 2008, TRENDS ECOL EVOL, V23, P169, DOI 10.1016/j.tree.2007.10.013; Smith KL, 2004, REMOTE SENS ENVIRON, V92, P207, DOI 10.1016/j.rse.2004.06.002; Theron G.K., 1979, J S AFRICAN BIOL SOC, V20, P43; THIERY JM, 1995, J ECOL, V83, P497, DOI 10.2307/2261602; Tlidi M., 2008, Dissipative Solitons: From Optics to Biology and Medicine, P381, DOI 10.1007/978-3-540-78217-9_15; Tschinkel WR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038056; Tschinkel WR, 2010, J INSECT SCI, V10; van der Meer F, 2002, TERRA NOVA, V14, P1, DOI 10.1046/j.1365-3121.2002.00390.x; van Rooyen MW, 2004, J ARID ENVIRON, V57, P467, DOI 10.1016/S0140-1963(03)00111-3; Vlieghe K, 2015, ECOL ENTOMOL, V40, P42, DOI 10.1111/een.12157; Zeidler J, 1997, THESIS; Zelnik YR, 2015, P NATL ACAD SCI USA, V112, P12327, DOI 10.1073/pnas.1504289112	36	23	23	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2015	10	10							e0140099	10.1371/journal.pone.0140099	http://dx.doi.org/10.1371/journal.pone.0140099			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0DL	26510015	Green Submitted, Green Published, gold			2022-12-26	WOS:000363918100018
J	Zhao, F; Liu, LY; Tao, XX; He, LH; Meng, FL; Zhang, JZ				Zhao, Fei; Liu, Liyong; Tao, Xiaoxia; He, Lihua; Meng, Fanliang; Zhang, Jianzhong			Culture-Independent Detection and Genotyping of Mycoplasma pneumoniae in Clinical Specimens from Beijing, China	PLOS ONE			English	Article							P1 CYTADHESIN GENE; DESORPTION IONIZATION-TIME; FLIGHT MASS-SPECTROMETRY; MACROLIDE RESISTANCE; DNA RECOMBINATION; SEQUENCE-ANALYSIS; GENOME SEQUENCE; ADHESIN GENE; PCR; JAPAN	A duplex real-time PCR assay was designed for simultaneous detection and genotyping of Mycoplasma pneumoniae (M. pneumoniae). The detection/typing performance of this duplex PCR method, targeting specific genes for M. pneumoniae type 1 (mpn 459) and type 2 (mpna 5864), was compared to that of the previously published MpP1 real-time PCR assay and the genotyping method for the adhesin P1 gene (mpn 141). A total of 1,344 throat swab specimens collected from patients in Beijing, China were tested for M. pneumoniae by bacterial culture, MpP1 real-time PCR assay, and our duplex PCR assay, and positive detection rates of 26.9%, 34.4%, and 33.7%, respectively, were obtained. The duplex PCR method demonstrated high sensitivity and accuracy for detecting and genotyping M. pneumoniae, and significant differences in genotyping ability were observed when compared to the conventional P1 gene-based method. M. pneumoniae type 1 was the predominate genotype from 2008 to 2012 in Beijing, and a shift from type 1 to type 2 began to occur in 2013. To our knowledge, this is the first reported incidence of a type shift phenomenon of M. pneumoniae clinical isolates in China. These genotyping results provide important information for understanding recent changes in epidemiological characteristics of M. pneumoniae in Beijing.	[Zhao, Fei; Liu, Liyong; Tao, Xiaoxia; He, Lihua; Meng, Fanliang; Zhang, Jianzhong] Chinese Ctr Dis Control & Prevent, Natl Inst Communicable Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China; [Zhao, Fei; Liu, Liyong; Tao, Xiaoxia; He, Lihua; Meng, Fanliang; Zhang, Jianzhong] Collaborat Innovat Ctr Diag & Treatment Infect Di, Hangzhou, Zhejiang, Peoples R China	Chinese Center for Disease Control & Prevention; National Institute for Communicable Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Collaborative Innovation Center for Diagnosis & Treatment of Infectious Diseases	Zhang, JZ (corresponding author), Chinese Ctr Dis Control & Prevent, Natl Inst Communicable Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China.	zhangjianzhong@icdc.cn	Zhang, Jianzhong/AAM-6179-2021	Zhang, Jianzhong/0000-0001-7056-8206; zhao, fei/0000-0002-4525-2143	National Natural Science Foundation of China [81401637]; National Key Scientific Instrument and Equipment Development Projects [2012YQ18011709]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Scientific Instrument and Equipment Development Projects	This work was supported by the National Natural Science Foundation of China (Grant No. 81401637) and the National Key Scientific Instrument and Equipment Development Projects (Grant No. 2012YQ18011709).	Catrein I, 2004, MICROBIOL-SGM, V150, P3989, DOI 10.1099/mic.0.27506-0; Dandekar T, 2000, NUCLEIC ACIDS RES, V28, P3278, DOI 10.1093/nar/28.17.3278; Daxboeck F, 2005, INT J MED MICROBIOL, V295, P279, DOI 10.1016/j.ijmm.2005.05.001; Daxboeck F, 2003, CLIN MICROBIOL INFEC, V9, P263, DOI 10.1046/j.1469-0691.2003.00590.x; Dorigo-Zetsma JW, 2001, INFECT IMMUN, V69, P5612, DOI 10.1128/IAI.69.9.5612-5618.2001; Dumke R, 2004, INT J MED MICROBIOL, V294, P149, DOI 10.1016/j.ijmm.2004.06.020; Dumke R, 2003, INT J MED MICROBIOL, V292, P513, DOI 10.1078/1438-4221-00231; Dumke R, 2007, J CLIN MICROBIOL, V45, P2726, DOI 10.1128/JCM.00321-07; Dumke R, 2006, J CLIN MICROBIOL, V44, P2567, DOI 10.1128/JCM.00495-06; Himmelreich R, 1996, NUCLEIC ACIDS RES, V24, P4420, DOI 10.1093/nar/24.22.4420; Ishiguro N, 2015, JPN J INFECT DIS; Jacobs E, 1996, EUR J CLIN MICROBIOL, V15, P38, DOI 10.1007/BF01586183; Jacobs E, 2015, INT J MED MICROBIOL; Kenri T, 1999, INFECT IMMUN, V67, P4557, DOI 10.1128/IAI.67.9.4557-4562.1999; Kenri T, 2008, J MED MICROBIOL, V57, P469, DOI 10.1099/jmm.0.47634-0; Kenri T, 2012, J BACTERIOL, V194, P1253, DOI 10.1128/JB.06553-11; Kong FR, 2000, J CLIN MICROBIOL, V38, P4256, DOI 10.1128/JCM.38.11.4256-4259.2000; Kubota H, 2015, JPN J INFECT DIS, V68, P76, DOI 10.7883/yoken.JJID.2014.336; Lluch-Senar M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137354; McIntosh K, 2002, NEW ENGL J MED, V346, P429, DOI 10.1056/NEJMra011994; Morozumi M, 2010, J INFECT CHEMOTHER, V16, P78, DOI 10.1007/s10156-009-0021-4; Musatovova O, 2008, INFECT IMMUN, V76, P1639, DOI 10.1128/IAI.01621-07; Musatovova O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047625; Pereyre S, 2007, J CLIN MICROBIOL, V45, P3534, DOI 10.1128/JCM.01345-07; Pereyre S, 2013, J CLIN MICROBIOL, V51, P3314, DOI 10.1128/JCM.01573-13; Qu JX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082174; RAZIN S, 1992, J GEN MICROBIOL, V138, P407, DOI 10.1099/00221287-138-3-407; Sanchez-Vargas FM, 2008, CLIN MICROBIOL INFEC, V14, P105, DOI 10.1111/j.1469-0691.2007.01834.x; Sasaki T, 1996, J CLIN MICROBIOL, V34, P447, DOI 10.1128/JCM.34.2.447-449.1996; Schwartz SB, 2009, J CLIN MICROBIOL, V47, P4117, DOI 10.1128/JCM.01696-09; Spuesens EB, 2009, MICROBIOLOGY, V55, P2182; Spuesens EBM, 2011, MICROBIOL-SGM, V157, P473, DOI 10.1099/mic.0.045591-0; Spuesens EBM, 2010, J MICROBIOL METH, V82, P214, DOI 10.1016/j.mimet.2010.06.004; SU CJ, 1990, INFECT IMMUN, V58, P2669, DOI 10.1128/IAI.58.8.2669-2674.1990; Tian XJ, 2013, CHINESE MED J-PEKING, V126, P3944, DOI 10.3760/cma.j.issn.0366-6999.20131643; Tsiodras S, 2005, J INFECTION, V51, P343, DOI 10.1016/j.jinf.2005.07.005; Ursi D, 2003, J MICROBIOL METH, V55, P149, DOI 10.1016/S0167-7012(03)00131-3; Waites KB, 2004, CLIN MICROBIOL REV, V17, P697, DOI 10.1128/CMR.17.4.697-728.2004; Winchell JM, 2008, J CLIN MICROBIOL, V46, P3116, DOI 10.1128/JCM.00440-08; Xiao D, 2014, J CLIN MICROBIOL, V52, P3038, DOI 10.1128/JCM.01265-14; Xiao JH, 2014, DIAGN MICR INFEC DIS, V78, P24, DOI 10.1016/j.diagmicrobio.2013.08.008; Xiao L, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1801-0; Xue GH, 2014, J CLIN MICROBIOL, V52, P1478, DOI 10.1128/JCM.03366-13; Yan Xiaosu, 2012, Weishengwu Xuebao, V52, P262; Zhang Li, 2011, Zhonghua Er Ke Za Zhi, V49, P750; Zhao F, 2013, J CLIN MICROBIOL, V51, P636, DOI 10.1128/JCM.02567-12; Zhao F, 2012, BIOMED ENVIRON SCI, V25, P77, DOI 10.3967/0895-3988.2012.01.011; Zhao F, 2011, J CLIN MICROBIOL, V49, P3000, DOI 10.1128/JCM.00105-11; Zhou ZB, 2015, ANTIMICROB AGENTS CH, V59, P1048, DOI 10.1128/AAC.04308-14	49	27	31	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2015	10	10							e0141702	10.1371/journal.pone.0141702	http://dx.doi.org/10.1371/journal.pone.0141702			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0DL	26509651	Green Published, gold, Green Submitted			2022-12-26	WOS:000363918100123
J	Liu, CL; Liu, YH; Shen, ZW; Miao, LP; Zhang, K; Wang, F; Li, YJ				Liu, Chuiliang; Liu, Yanhui; Shen, Zhiwen; Miao, Liping; Zhang, Kun; Wang, Fei; Li, Yujuan			Sevoflurane Preconditioning Reduces Intestinal Ischemia-Reperfusion Injury: Role of Protein Kinase C and Mitochondrial ATP-Sensitive Potassium Channel	PLOS ONE			English	Article							MYOCARDIAL ISCHEMIA/REPERFUSION INJURY; MEDIATED UP-REGULATION; PKC-EPSILON; NITRIC-OXIDE; CARDIOPROTECTION; ACTIVATION; EXPRESSION; ISOFLURANE; PATHWAY; NEUROPROTECTION	Ischemic preconditioning (IPC) has been considered to be a potential therapy to reduce ischemia-reperfusion injury (IRI) since the 1980s. Our previous study indicated that sevoflurane preconditioning (SPC) also reduced intestinal IRI in rats. However, whether the protective effect of SPC is similar to IPC and the mechanisms of SPC are unclear. Thus, we compared the efficacy of SPC and IPC against intestinal IRI and the role of protein kinase C (PKC) and mitochondrial ATP-sensitive potassium channel (mK(ATP)) in SPC. A rat model of intestinal IRI was used in this study. The superior mesenteric artery (SMA) was clamped for 60 min followed by 120 min of reperfusion. Rats with IPC underwent three cycles of SMA occlusion for 5 min and reperfusion for 5 min before intestinal ischemia. Rats with SPC inhaled sevoflurane at 0.5 minimum alveolar concentration (MAC) for 30 min before the intestinal ischemic insult. Additionally, the PKC inhibitor Chelerythrine (CHE) or mK(ATP) inhibitor 5-Hydroxydecanoic (5-HD) was injected intraperitoneally before sevoflurane inhalation. Both SPC and IPC ameliorated intestinal IRI-induced histopathological changes, decreased Chiu's scores, reduced terminal deoxyribonucleotide transferase-mediated dUTP nick end labeling (TUNEL) positive cells in the epithelium, and inhibited the expression of malondialdehyde (MDA) and tumor necrosis factor-alpha (TNF-alpha). These protective effects of SPC were similar to those of IPC. Pretreatment with PKC or mK(ATP) inhibitor abolished SPC-induced protective effects by increasing Chiu's scores, down-regulated the expression of Bcl-2 and activated caspase-3. Our results suggest that pretreatment with 0.5 MAC sevoflurane is as effective as IPC against intestinal IRI. The activation of PKC and mK(ATP) may be involved in the protective mechanisms of SPC.	[Liu, Chuiliang] ChanCheng Ctr Hosp, Dept Anesthesiol, Foshan, Guangdong, Peoples R China; [Liu, Yanhui; Shen, Zhiwen; Miao, Liping; Zhang, Kun; Wang, Fei; Li, Yujuan] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Anesthesiol, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University	Wang, F (corresponding author), Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Anesthesiol, Guangzhou 510275, Guangdong, Peoples R China.	1995wangfei@sina.com.cn; yujuan_04@hotmail.com	Li, yu/HHZ-5236-2022; li, yu/HGL-9518-2022		National Natural Science Foundation of China [81371259]; Guangdong Natural Science Foundation [S2013010016207, 8151040701000062]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Natural Science Foundation(National Natural Science Foundation of Guangdong Province)	This work was supported by grants from the National Natural Science Foundation of China (grant 81371259 to YL) and the Guangdong Natural Science Foundation (S2013010016207 to YL, 8151040701000062 to CL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamczyk S, 2010, BRIT J ANAESTH, V104, P191, DOI 10.1093/bja/aep365; Casanova J, 2011, ANESTH ANALG, V113, P742, DOI 10.1213/ANE.0b013e3182288e01; Cerqueira Nereide Freire, 2005, Acta Cir. Bras., V20, P336, DOI 10.1590/S0102-86502005000400013; Chaudhari N, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00213; Costa ADT, 2008, AM J PHYSIOL-HEART C, V295, pH874, DOI 10.1152/ajpheart.01189.2007; Davis JM, 1999, AM J PHYSIOL-HEART C, V277, pH2476, DOI 10.1152/ajpheart.1999.277.6.H2476; Downey JM, 2007, HEART FAIL REV, V12, P181, DOI 10.1007/s10741-007-9025-2; Ferencz A, 2004, TRANSPLANT P, V36, P286, DOI 10.1016/j.transproceed.2003.12.006; Ferencz A, 2002, SURGERY, V132, P877, DOI 10.1067/msy.2002.129910; Frassdorf J, 2010, ANESTHESIOLOGY, V113, P1289, DOI 10.1097/ALN.0b013e3181f97fec; Gan XL, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/378703; Garlid KD, 2003, BBA-BIOENERGETICS, V1606, P23, DOI 10.1016/S0005-2728(03)00108-7; Hanley PJ, 2002, J PHYSIOL-LONDON, V542, P735, DOI 10.1113/jphysiol.2002.023960; Heusch G, 2008, CIRCULATION, V118, P1915, DOI 10.1161/CIRCULATIONAHA.108.805242; Hotter G, 1996, BIOCHEM BIOPH RES CO, V222, P27, DOI 10.1006/bbrc.1996.0692; Lang XE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052469; Lenaz G, 2012, ADV EXP MED BIOL, V942, P93, DOI 10.1007/978-94-007-2869-1_5; Li DL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073334; Li YJ, 2007, NEUROPHARMACOLOGY, V53, P942, DOI 10.1016/j.neuropharm.2007.09.005; Li YJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093639; Liao ZX, 2014, BRAIN RES BULL, V107, P69, DOI 10.1016/j.brainresbull.2014.07.001; Liu CL, 2015, SURGERY, V157, P924, DOI 10.1016/j.surg.2014.12.013; Liu KX, 2007, CAN J ANAESTH, V54, P366, DOI 10.1007/BF03022659; Liu YG, 1999, ANN NY ACAD SCI, V874, P27, DOI 10.1111/j.1749-6632.1999.tb09222.x; Liu ZG, 2010, CHIN J TRAUMATOL, V13, P284, DOI 10.1002/cjoc.19950130315; Luo CF, 2015, MOL MED REP, V12, P1082, DOI 10.3892/mmr.2015.3527; McCallion K, 2000, SHOCK, V14, P429, DOI 10.1097/00024382-200014040-00002; Obal D, 2005, ANESTH ANALG, V101, P1252, DOI 10.1213/01.ANE.0000181336.96511.32; Ohnuma Y, 2002, AM J PHYSIOL-HEART C, V283, pH440, DOI 10.1152/ajpheart.00434.2001; Orliaguet G, 2001, ANESTHESIOLOGY, V95, P734, DOI 10.1097/00000542-200109000-00028; Piriou V, 2004, ANESTHESIOLOGY, V100, P581, DOI 10.1097/00000542-200403000-00018; Pompermayer K, 2007, EUR J PHARMACOL, V556, P215, DOI 10.1016/j.ejphar.2006.10.065; Pravdic D, 2009, ANESTHESIOLOGY, V111, P267, DOI 10.1097/ALN.0b013e3181a91957; Quaedackers JSLT, 2000, TRANSPLANT P, V32, P1307, DOI 10.1016/S0041-1345(00)01238-0; Raval AP, 2007, BRAIN RES, V1184, P345, DOI 10.1016/j.brainres.2007.09.073; Sahnoun Z, 1997, THERAPIE, V52, P251; Schulz R, 2001, CARDIOVASC RES, V52, P181, DOI 10.1016/S0008-6363(01)00384-4; Shiomi M, 2014, J ANESTH, V28, P593, DOI 10.1007/s00540-013-1755-9; Simkhovich BZ, 2013, J CARDIOVASC PHARM T, V18, P525, DOI 10.1177/1074248413494814; Sola A, 2001, ANN SURG, V234, P98, DOI 10.1097/00000658-200107000-00015; Tamion F, 2002, AM J PHYSIOL-GASTR L, V283, pG408, DOI 10.1152/ajpgi.00348.2001; Tratsiakovich Y, 2013, EUR J PHARMACOL, V712, P16, DOI 10.1016/j.ejphar.2013.04.044; Um JW, 2005, J SURG RES, V124, P289, DOI 10.1016/j.jss.2004.10.011; Voeikov VL, 2006, J ALTERN COMPLEM MED, V12, P111, DOI 10.1089/acm.2006.12.111; Wang C, 2015, BRAZ J MED BIOL RES, V48, P528, DOI 10.1590/1414-431X20143876; Wang C, 2010, EUR J ANAESTH, V27, P747, DOI 10.1097/EJA.0b013e32833bb3ba; Wu B, 2004, AM J PHYSIOL-GASTR L, V286, pG580, DOI 10.1152/ajpgi.00335.2003; Yang QZ, 2011, ANESTH ANALG, V112, P931, DOI 10.1213/ANE.0b013e31820bcfa4; Yang SP, 1999, ACTA PHARMACOL SIN, V20, P341; Yasuhara H, 2005, SURG TODAY, V35, P185, DOI 10.1007/s00595-004-2924-0; Ye Z, 2012, BRAIN RES, V1463, P63, DOI 10.1016/j.brainres.2012.04.050; Ye Z, 2012, MOL BIOL REP, V39, P5049, DOI 10.1007/s11033-011-1290-4; Zhao JL, 2013, CIRCULATION, V128, pS121, DOI 10.1161/CIRCULATIONAHA.112.000045; Zhong CY, 2004, ANESTHESIOLOGY, V100, P540, DOI 10.1097/00000542-200403000-00012	54	10	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2015	10	10							e0141426	10.1371/journal.pone.0141426	http://dx.doi.org/10.1371/journal.pone.0141426			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU8PC	26505750	Green Published, Green Submitted, gold			2022-12-26	WOS:000363804200066
J	Mokdad, AH; Gagnier, MC; Colson, KE; Dansereau, E; Zuniga-Brenes, P; Rios-Zertuche, D; Haakenstad, A; Johanns, CK; Palmisano, EB; Hernandez, B; Iriarte, E				Mokdad, Ali H.; Gagnier, Marielle C.; Colson, K. Ellicott; Dansereau, Emily; Zuniga-Brenes, Paola; Rios-Zertuche, Diego; Haakenstad, Annie; Johanns, Casey K.; Palmisano, Erin B.; Hernandez, Bernardo; Iriarte, Emma			Missed Opportunities for Measles, Mumps, and Rubella (MMR) Immunization in Mesoamerica: Potential Impact on Coverage and Days at Risk	PLOS ONE			English	Article							REMINDERS; VACCINATE; KNOWLEDGE; OUTBREAK	Background Recent outbreaks of measles in the Americas have received news and popular attention, noting the importance of vaccination to population health. To estimate the potential increase in immunization coverage and reduction in days at risk if every opportunity to vaccinate a child was used, we analyzed vaccination histories of children 11-59 months of age from large household surveys in Mesoamerica. Methods Our study included 22,234 children aged less than 59 months in El Salvador, Guatemala, Honduras, Mexico, Nicaragua, and Panama. Child vaccination cards were used to calculate coverage of measles, mumps, and rubella (MMR) and to compute the number of days lived at risk. A child had a missed opportunity for vaccination if their card indicated a visit for vaccinations at which the child was not caught up to schedule for MMR. A Cox proportional hazards model was used to compute the hazard ratio associated with the reduction in days at risk, accounting for missed opportunities. Results El Salvador had the highest proportion of children with a vaccine card (91.2%) while Nicaragua had the lowest (76.5%). Card MMR coverage ranged from 44.6% in Mexico to 79.6% in Honduras while potential coverage accounting for missed opportunities ranged from 70.8% in Nicaragua to 96.4% in El Salvador. Younger children were less likely to have a missed opportunity. In Panama, children from households with higher expenditure were more likely to have a missed opportunity for MMR vaccination compared to the poorest (OR 1.62, 95% CI: 1.06-2.47). In Nicaragua, compared to children of mothers with no education, children of mothers with primary education and secondary education were less likely to have a missed opportunity (OR 0.46, 95% CI: 0.24-0.88 and OR 0.25, 95% CI: 0.096-0.65, respectively). Mean days at risk for MMR ranged from 158 in Panama to 483 in Mexico while potential days at risk ranged from 92 in Panama to 239 in El Salvador. Conclusions Our study found high levels of missed opportunities for immunizing children in Mesoamerica. Our findings cause great concern, as they indicate that families are bringing their children to health facilities, but these children are not receiving all appropriate vaccinations during visits. This points to serious problems in current immunization practices and protocols in poor areas in Mesoamerica. Our study calls for programs to ensure that vaccines are available and that health professionals use every opportunity to vaccinate a child.	[Mokdad, Ali H.; Gagnier, Marielle C.; Dansereau, Emily; Haakenstad, Annie; Johanns, Casey K.; Palmisano, Erin B.; Hernandez, Bernardo] Inst Hlth Metr & Evaluat, Seattle, WA USA; [Colson, K. Ellicott] Univ Calif Berkeley, Sch Publ Hlth, Div Epidemiol, Berkeley, CA 94720 USA; [Zuniga-Brenes, Paola; Rios-Zertuche, Diego; Iriarte, Emma] Interamer Dev Bank, Salud Mesoamer 2015, Panama City, Panama	Institute for Health Metrics & Evaluation; University of California System; University of California Berkeley	Mokdad, AH (corresponding author), Inst Hlth Metr & Evaluat, 2301 5th Ave,Suite 600, Seattle, WA USA.	mokdaa@uw.edu	Mokdad, Ali H./AAD-1232-2022; Rios-Zertuche, Diego/AAG-2710-2020; Prado, Bernardo Hernandez/AAG-9292-2019	Mokdad, Ali H./0000-0002-4994-3339; Rios-Zertuche, Diego/0000-0003-1853-728X; Prado, Bernardo Hernandez/0000-0002-5960-8841	Bill & Melinda Gates Foundation; Spanish Agency for International Development Cooperation; Carlos Slim Health Institute, through the Inter-American Development Bank	Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); Spanish Agency for International Development Cooperation(Spanish Government); Carlos Slim Health Institute, through the Inter-American Development Bank	This study was funded by the Bill & Melinda Gates Foundation, the Spanish Agency for International Development Cooperation, and the Carlos Slim Health Institute, through the Inter-American Development Bank.	[Anonymous], 2014, Wkly Epidemiol Rec, V89, P45; Anonymous, 2009, Morbidity and Mortality Weekly Report, V58, P1321; BERNIER RH, 1993, JAMA-J AM MED ASSOC, V269, P1817, DOI 10.1001/jama.1993.03500140069038; BLOCH AB, 1985, PEDIATRICS, V75, P676; Centers for Disease Control and Prevention (CDC), 1999, MMWR Morb Mortal Wkly Rep, V48, P243; COX DR, 1972, J R STAT SOC B, V34, P187; Grabowsky M, 2014, JAMA PEDIATR, V168, P108, DOI 10.1001/jamapediatrics.2013.4603; KAHN JG, 1995, B WORLD HEALTH ORGAN, V73, P47; McCarthy M, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h436; MCCONNOCHIE KM, 1992, PEDIATRICS, V89, P1019; MCDONALD CJ, 1976, NEW ENGL J MED, V295, P1351, DOI 10.1056/NEJM197612092952405; MCDONALD CJ, 1984, ANN INTERN MED, V100, P130, DOI 10.7326/0003-4819-100-1-130; Mokdad AH, POPUL HLTH METR; Siegel RM, 1996, CLIN PEDIATR, V35, P79, DOI 10.1177/000992289603500205; Strebel PM, 2011, J INFECT DIS, V204, pS1, DOI 10.1093/infdis/jir111; Szilagyi PG, 1996, ARCH PEDIAT ADOL MED, V150, P1193, DOI 10.1001/archpedi.1996.02170360083014; Wood D, 1998, ARCH PEDIAT ADOL MED, V152, P238; Wood D, 1996, PEDIATR INFECT DIS J, V15, P140, DOI 10.1097/00006454-199602000-00010	18	13	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2015	10	10							e0139680	10.1371/journal.pone.0139680	http://dx.doi.org/10.1371/journal.pone.0139680			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU8PC	26506563	Green Submitted, gold, Green Published			2022-12-26	WOS:000363804200006
J	Roldan-Jimenez, C; Bennett, P; Cuesta-Vargas, AI				Roldan-Jimenez, Cristina; Bennett, Paul; Cuesta-Vargas, Antonio I.			Muscular Activity and Fatigue in Lower-Limb and Trunk Muscles during Different Sit-To-Stand Tests	PLOS ONE			English	Article							PHYSICAL-FITNESS; OLDER-ADULTS; 5-TIMES-SIT-TO-STAND TEST; LOWER-EXTREMITY; MOVEMENT CYCLE; HIP ABDUCTION; STRENGTH; CHAIR; ACTIVATION; BALANCE	Sit-to-stand (STS) tests measure the ability to get up from a chair, reproducing an important component of daily living activity. As this functional task is essential for human independence, STS performance has been studied in the past decades using several methods, including electromyography. The aim of this study was to measure muscular activity and fatigue during different repetitions and speeds of STS tasks using surface electromyography in lower-limb and trunk muscles. This cross-sectional study recruited 30 healthy young adults. Average muscle activation, percentage of maximum voluntary contraction, muscle involvement in motion and fatigue were measured using surface electrodes placed on the medial gastrocnemius (MG), biceps femoris (BF), vastus medialis of the quadriceps (QM), the abdominal rectus (AR), erector spinae (ES), rectus femoris (RF), soleus (SO) and the tibialis anterior (TA). Five-repetition STS, 10-repetition STS and 30-second STS variants were performed. MG, BF, QM, ES and RF muscles showed differences in muscle activation, while QM, AR and ES muscles showed significant differences in MVC percentage. Also, significant differences in fatigue were found in QM muscle between different STS tests. There was no statistically significant fatigue in the BF, MG and SO muscles of the leg although there appeared to be a trend of increasing fatigue. These results could be useful in describing the functional movements of the STS test used in rehabilitation programs, notwithstanding that they were measured in healthy young subjects.	[Roldan-Jimenez, Cristina; Cuesta-Vargas, Antonio I.] Univ Malaga, Fac Hlth Sci, Dept Physiotherapy, E-29071 Malaga, Spain; [Bennett, Paul; Cuesta-Vargas, Antonio I.] Queensland Univ Technol, Fac Hlth Sci, Sch Clin Sci, Brisbane, Qld 4001, Australia	Universidad de Malaga; Queensland University of Technology (QUT)	Cuesta-Vargas, AI (corresponding author), Univ Malaga, Fac Hlth Sci, Dept Physiotherapy, E-29071 Malaga, Spain.	acuesta.var@gmail.com	Jiménez, Cristina Roldán/AAT-1415-2020	Cuesta-Vargas, Antonio I/0000-0002-8880-4315; /0000-0002-7355-9740				Alcock L, 2015, PHYSIOTHERAPY, V101, P204, DOI 10.1016/j.physio.2014.09.001; BAER GD, 1995, ARCH PHYS MED REHAB, V76, P844, DOI 10.1016/S0003-9993(95)80550-8; Barbero M., 2012, ATLAS MUSCLE INNERVA, DOI [10.1007/978-88-470-2463-2, DOI 10.1007/978-88-470-2463-2]; Bidargaddi N, 2007, P ANN INT IEEE EMBS, P1884, DOI 10.1109/IEMBS.2007.4352683; Bonato P, 2001, IEEE T BIO-MED ENG, V48, P745, DOI 10.1109/10.930899; Boukadida A, 2015, ANN PHYS REHABIL MED, V58, P167, DOI 10.1016/j.rehab.2015.04.007; Burnfield JM, 2012, GAIT POSTURE, V36, P516, DOI 10.1016/j.gaitpost.2012.05.002; Choi B, 2015, J PHYS THER SCI, V27, P893, DOI 10.1589/jpts.27.893; Criswell E., 2011, CRAMS INTRO SURFACE; CSUKA M, 1985, AM J MED, V78, P77, DOI 10.1016/0002-9343(85)90465-6; Cuesta-Vargas AI, 2013, J ELECTROMYOGR KINES, V23, P1446, DOI 10.1016/j.jelekin.2013.06.001; Cuesta-Vargas AI, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/173148; Daniels L., 1995, MUSCLE TESTING TECHN; Davidson BS, 2013, J ELECTROMYOGR KINES, V23, P1485, DOI 10.1016/j.jelekin.2013.06.008; Dehail P, 2007, CLIN BIOMECH, V22, P1096, DOI 10.1016/j.clinbiomech.2007.07.015; Doheny EP, 2013, GAIT POSTURE, V38, P1021, DOI 10.1016/j.gaitpost.2013.05.013; Doheny EP, 2011, IEEE ENG MED BIO, P3063, DOI 10.1109/IEMBS.2011.6090837; Duncan RP, 2011, ARCH PHYS MED REHAB, V92, P1431, DOI 10.1016/j.apmr.2011.04.008; Fujimoto M, 2012, J BIOMECH, V45, P543, DOI 10.1016/j.jbiomech.2011.11.037; Galli M, 2008, GAIT POSTURE, V28, P80, DOI 10.1016/j.gaitpost.2007.10.003; Gillette JC, 2012, GAIT POSTURE, V35, P78, DOI 10.1016/j.gaitpost.2011.08.010; Goulart FR, 1999, CLIN NEUROPHYSIOL, V110, P1634, DOI 10.1016/S1388-2457(99)00109-1; Hatton AL, 2013, GAIT POSTURE, V37, P506, DOI 10.1016/j.gaitpost.2012.09.004; Helbostad JL, 2010, BMC GERIATR, V10, DOI 10.1186/1471-2318-10-56; Huffman KD, 2015, GAIT POSTURE, V41, P640, DOI 10.1016/j.gaitpost.2015.01.014; Hughes MA, 1996, J BIOMECH, V29, P1509, DOI 10.1016/0021-9290(96)00083-8; Jang EM, 2015, J PHYS THER SCI, V27, P375, DOI 10.1589/jpts.27.375; Janssen WGM, 2002, PHYS THER, V82, P866, DOI 10.1093/ptj/82.9.866; Kerr K., 1994, GAIT POSTURE, V2, P173, DOI [DOI 10.1016/0966-6362(94)90005-1, 10.1016/0966-6362(94)90005-1]; KERR KM, 1994, GAIT POSTURE, V2, P182, DOI DOI 10.1016/0966-6362(94)90006-X; Marschollek M, 2009, Z GERONTOL GERIATR, V42, P317, DOI 10.1007/s00391-009-0035-7; Mazza C, 2005, GAIT POSTURE, V21, P425, DOI 10.1016/j.gaitpost.2004.05.006; Moseng T, 2014, PHYSIOTHERAPY, V100, P319, DOI 10.1016/j.physio.2013.11.005; Najafi B, 2002, IEEE T BIO-MED ENG, V49, P843, DOI 10.1109/TBME.2002.800763; Nam I, 2015, J PHYS THER SCI, V27, P571, DOI 10.1589/jpts.27.571; Paillard T, 2012, NEUROSCI BIOBEHAV R, V36, P162, DOI 10.1016/j.neubiorev.2011.05.009; Perotto A., 2005, ANATOMICAL GUIDE ELE; Ploutz-Snyder LL, 2002, J GERONTOL A-BIOL, V57, pB144, DOI 10.1093/gerona/57.4.B144; RILEY PO, 1991, J BIOMECH, V24, P77, DOI 10.1016/0021-9290(91)90328-K; Savelberg HHCM, 2007, CLIN BIOMECH, V22, P805, DOI 10.1016/j.clinbiomech.2007.05.002; SCHENKMAN M, 1990, PHYS THER, V70, P638, DOI 10.1093/ptj/70.10.638; Schurr K, 2012, CLIN REHABIL, V26, P656, DOI 10.1177/0269215511427323; Spyropoulos G, 2013, GAIT POSTURE, V38, P62, DOI 10.1016/j.gaitpost.2012.10.013; Tully EA, 2005, GAIT POSTURE, V22, P338, DOI 10.1016/j.gaitpost.2004.11.007; Tveter AT, 2014, ARCH PHYS MED REHAB, V95, P1366, DOI 10.1016/j.apmr.2014.02.016; Tveter AT, 2014, J ORTHOP SPORT PHYS, V44, P206, DOI 10.2519/jospt.2014.5042; Van der Heijden MMP, 2009, GAIT POSTURE, V30, P110, DOI 10.1016/j.gaitpost.2009.04.002; Van Lummel RC, 2013, GAIT POSTURE, V38, P153, DOI 10.1016/j.gaitpost.2012.10.008; Whitney SL, 2005, PHYS THER, V85, P1034, DOI 10.1093/ptj/85.10.1034; Yoshioka S, 2012, J BIOMECH, V45, P699, DOI 10.1016/j.jbiomech.2011.11.054	50	48	48	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2015	10	10							e0141675	10.1371/journal.pone.0141675	http://dx.doi.org/10.1371/journal.pone.0141675			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU8PC	26506612	gold, Green Published, Green Submitted			2022-12-26	WOS:000363804200095
J	Ross, BN; Rojas-Lopez, M; Cieza, RJ; McWilliams, BD; Torres, AG				Ross, Brittany N.; Rojas-Lopez, Maricarmen; Cieza, Roberto J.; McWilliams, Brian D.; Torres, Alfredo G.			The Role of Long Polar Fimbriae in Escherichia coli O104:H4 Adhesion and Colonization	PLOS ONE			English	Article							AGGREGATIVE ADHERENCE; EXPRESSION; O157/H7; CELLS; IDENTIFICATION; MARKERS; OPERON	A renewed interest in Shiga toxin-producing Escherichia coli (STEC) strains was sparked due to the appearance of an outbreak in 2011, causing 3,816 diarrheal cases and some deaths in Europe. The causative strain was classified as enteroaggregative E. coli of serotype O104:H4 that had acquired Shiga toxin genes. The ability of STEC O104:H4 to cause disease relies greatly on the bacteria's capacity to colonize, persist, and produce Shiga toxin. However, not much is known about the colonization factors of this strain. Because long polar fimbriae (lpf) lpf1 and lpf2 operons encode important colonization factors in other STEC isolates and E. coli O104:H4 possesses both loci, we hypothesized that Lpf is required for adhesion and colonization. In this study, isogenic lpfA1 and lpfA2 major fimbrial subunit mutants were constructed. To determine their role in O104:H4' s virulence, we assessed their ability to adhere to non-polarized and polarized intestinal epithelial cells. The.lpfA1 showed decreased adherence in both cell systems, while the.lpfA2 only showed a decrease in adherence to polarized Caco-2 cells. We also tested the O104:H4 mutants' ability to form biofilm and found that the.lpfA1 was unable to form a stable biofilm. In an in vivo murine model of intestinal colonization, the.lpfA1 had a reduced ability to colonize the cecum and large intestine, consistent with the in vitro data. Further, we tested the lpfA1 mutants' ability to compete against the wild type. We found that in the in vitro and in vivo models, the presence of the wild type O104:H4 facilitates increased adherence of the.lpfA1 to levels exceeding that of the wild type. Overall, our data demonstrated that Lpf1 is one of the factors responsible for O104:H4 intestinal adhesion and colonization.	[Ross, Brittany N.; Rojas-Lopez, Maricarmen; Cieza, Roberto J.; McWilliams, Brian D.; Torres, Alfredo G.] Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA; [McWilliams, Brian D.; Torres, Alfredo G.] Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA; [McWilliams, Brian D.; Torres, Alfredo G.] Univ Texas Med Branch, Sealy Ctr Vaccine Dev, Galveston, TX 77555 USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston	Torres, AG (corresponding author), Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA.	altorres@utmb.edu		Ross, Brittany/0000-0002-9129-0693; Rojas-Lopez, Maricarmen/0000-0001-7710-2572; Torres, Alfredo/0000-0001-6450-0643	NIH/NIAID [AI079154]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI079154] Funding Source: NIH RePORTER	NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported partially by NIH/NIAID grant AI079154 to A.G.T. The contents are solely the responsibility of the authors and do not necessarily represent the official views of the NIAID or NIH.	Al Safadi R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041628; BAUMLER AJ, 1995, J BACTERIOL, V177, P2087; Bielaszewska M, 2011, LANCET INFECT DIS, V11, P671, DOI 10.1016/S1473-3099(11)70165-7; Boisen N, 2014, J INFECT DIS, V210, P1909, DOI 10.1093/infdis/jiu399; Brzuszkiewicz E, 2011, ARCH MICROBIOL, V193, P883, DOI 10.1007/s00203-011-0725-6; CHANTRET I, 1988, CANCER RES, V48, P1936; Czeczulin JR, 1997, INFECT IMMUN, V65, P4135, DOI 10.1128/IAI.65.10.4135-4145.1997; Farfan MJ, 2013, VET IMMUNOL IMMUNOP, V152, P126, DOI 10.1016/j.vetimm.2012.09.017; Farfan MJ, 2012, INFECT IMMUN, V80, P903, DOI 10.1128/IAI.05907-11; Fitzhenry R, 2006, MICROBES INFECT, V8, P1741, DOI 10.1016/j.micinf.2006.02.012; Frank C, 2011, EURO SURVEILL, V16; Frank C, 2011, NEW ENGL J MED, V365, P1771, DOI 10.1056/NEJMoa1106483; Hicks S, 1996, INFECT IMMUN, V64, P4751, DOI 10.1128/IAI.64.11.4751-4760.1996; Holden NJ, 2004, J MED MICROBIOL, V53, P585, DOI 10.1099/jmm.0.05491-0; Huang DB, 2006, J MED MICROBIOL, V55, P1303, DOI 10.1099/jmm.0.46674-0; Jordan DM, 2004, INFECT IMMUN, V72, P6168, DOI 10.1128/IAI.72.10.6168-6171.2004; Kostakioti M, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a010306; Lloyd SJ, 2012, GUT MICROBES, V3, P272, DOI 10.4161/gmic.20661; Lloyd SJ, 2012, INFECT IMMUN, V80, P914, DOI 10.1128/IAI.05945-11; McWilliams BD, 2014, MICROBIOL SPECTR, V2, DOI [10.1128/microbiospec.EHEC-0003-2013, DOI 10.1128/MICR0BI0SPEC.EHEC-0003-2013]; Munera D, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4080; NATARO JP, 1994, J BACTERIOL, V176, P4691, DOI 10.1128/JB.176.15.4691-4699.1994; Nataro JP, 1998, CLIN MICROBIOL REV, V11, P403; Nataro JP, 1998, EMERG INFECT DIS, V4, P251, DOI 10.3201/eid0402.980212; NATARO JP, 1992, INFECT IMMUN, V60, P2297, DOI 10.1128/IAI.60.6.2297-2304.1992; O'Toole GA, 2011, JOVE-J VIS EXP, DOI 10.3791/2437; Ou G, 2009, SCAND J IMMUNOL, V69, P150, DOI 10.1111/j.1365-3083.2008.02208.x; Scheutz F, 2011, EURO SURVEILL, V16; Struelens MJ, 2011, EURO SURVEILL, V16; Torres AG, 2004, FEMS MICROBIOL LETT, V238, P333, DOI 10.1016/j.femsle.2004.07.053; Torres AG, 2002, INFECT IMMUN, V70, P5416, DOI 10.1128/IAI.70.10.5416-5427.2002; Torres AG, 2001, INFECT IMMUN, V69, P6179, DOI 10.1128/IAI.69.10.6179-6185.2001; Torres AG, 2007, INT J MED MICROBIOL, V297, P177, DOI 10.1016/j.ijmm.2007.01.005; Torres AG, 2009, J CLIN MICROBIOL, V47, P2442, DOI 10.1128/JCM.00566-09; Vergara AF, 2015, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00185; VIAL PA, 1988, J INFECT DIS, V158, P70, DOI 10.1093/infdis/158.1.70; Wang X, 2005, MOL MICROBIOL, V56, P1648, DOI 10.1111/j.1365-2958.2005.04648.x; Zhang WL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066717	38	23	24	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2015	10	10							e0141845	10.1371/journal.pone.0141845	http://dx.doi.org/10.1371/journal.pone.0141845			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0EH	26517878	Green Published, Green Submitted, gold			2022-12-26	WOS:000363920800086
J	Thiyagarajan, V; Tsai, MJ; Weng, CF				Thiyagarajan, Varadharajan; Tsai, May-Jywan; Weng, Ching-Feng			Antroquinonol Targets FAK-Signaling Pathway Suppressed Cell Migration, Invasion, and Tumor Growth of C6 Glioma	PLOS ONE			English	Article							FOCAL-ADHESION KINASE; ANTRODIA-CAMPHORATA EXTRACT; CANCER-CELLS; MESENCHYMAL TRANSITION; MOLECULAR DOCKING; CARCINOMA CELLS; DOWN-REGULATION; FRUITING BODY; CYTOCHROME-C; A549 CELL	Focal adhesion kinase (FAK) is a non-receptor protein tyrosine that is overexpressed in many types of tumors and plays a pivotal role in multiple cell signaling pathways involved in cell survival, migration, and proliferation. This study attempts to determine the effect of synthesized antroquinonol on the modulation of FAK signaling pathways and explore their underlying mechanisms. Antroquinonol significantly inhibits cell viability with an MTT assay in both N18 neuroblastoma and C6 glioma cell lines, which exhibits sub G1 phase cell cycle, and further induction of apoptosis is confirmed by a TUNEL assay. Antroquinonol decreases anti-apoptotic proteins, whereas it increases p53 and pro-apoptotic proteins. Alterations of cell morphology are observed after treatment by atomic force microscopy. Molecular docking results reveal that antroquinonol has an H-bond with the Arg 86 residue of FAK. The protein levels of Src, pSrc, FAK, pFAK, Rac1, and cdc42 are decreased after antroquinonol treatment. Additionally, antroquinonol also regulates the expression of epithelial to mesenchymal transition (EMT) proteins. Furthermore, antroquinonol suppresses the C6 glioma growth in xenograft studies. Together, these results suggest that antroquinonol is a potential anti-tumorigenesis and anti-metastasis inhibitor of FAK.	[Thiyagarajan, Varadharajan; Weng, Ching-Feng] Natl Dong Hwa Univ, Dept Life Sci, Hualien 97401, Taiwan; [Thiyagarajan, Varadharajan; Weng, Ching-Feng] Natl Dong Hwa Univ, Inst Biotechnol, Hualien 97401, Taiwan; [Tsai, May-Jywan] Taipei Vet Gen Hosp, Neurol Inst, Neural Regenerat Lab, Taipei 11217, Taiwan	National Dong Hwa University; National Dong Hwa University; Taipei Veterans General Hospital	Weng, CF (corresponding author), Natl Dong Hwa Univ, Dept Life Sci, Hualien 97401, Taiwan.	cfweng@mail.ndhu.edu.tw		Weng, Ching-Feng/0000-0002-9747-8697				Adamou JE, 1998, INFECT IMMUN, V66, P820, DOI 10.1128/IAI.66.2.820-822.1998; Avizienyte E, 2005, CURR OPIN CELL BIOL, V17, P542, DOI 10.1016/j.ceb.2005.08.007; BENDA P, 1968, SCIENCE, V161, P370, DOI 10.1126/science.161.3839.370; Brunton VG, 2004, BBA-MOL CELL RES, V1692, P121, DOI 10.1016/j.bbamcr.2004.04.010; Chan YY, 2010, J ETHNOPHARMACOL, V127, P652, DOI 10.1016/j.jep.2009.12.008; Chen CC, 2006, J NAT PROD, V69, P689, DOI 10.1021/np0581263; Chen JS, 2010, CLIN EXP METASTAS, V27, P71, DOI 10.1007/s10585-010-9306-3; Chen KC, 2007, NUTR CANCER, V57, P111, DOI 10.1080/01635580701268360; Chiang PC, 2010, BIOCHEM PHARMACOL, V79, P162, DOI 10.1016/j.bcp.2009.08.022; Chipuk JE, 2004, SCIENCE, V303, P1010, DOI 10.1126/science.1092734; Chodniewicz D, 2004, BBA-MOL CELL RES, V1692, P63, DOI 10.1016/j.bbamcr.2004.03.006; COBB BS, 1994, MOL CELL BIOL, V14, P147, DOI 10.1128/MCB.14.1.147; Cregan SP, 2004, ONCOGENE, V23, P2785, DOI 10.1038/sj.onc.1207517; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; Duxbury MS, 2004, SURGERY, V135, P555, DOI 10.1016/j.surg.2003.10.017; Golubovskaya VM, 2010, FRONT BIOSCI-LANDMRK, V15, P901, DOI 10.2741/3653; Graham K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027806; Hsu CY, 2015, BRIT J PHARMACOL, V172, P38, DOI 10.1111/bph.12828; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kluck RM, 1997, SCIENCE, V275, P1132, DOI 10.1126/science.275.5303.1132; Kumar VB, 2011, MUTAT RES-FUND MOL M, V707, P42, DOI 10.1016/j.mrfmmm.2010.12.009; Kurokawa K, 2004, MOL BIOL CELL, V15, P1003, DOI 10.1091/mbc.E03-08-0609; Lee TH, 2007, PLANTA MED, V73, P1412, DOI 10.1055/s-2007-990232; Liu DZ, 2007, J ETHNOPHARMACOL, V113, P45, DOI 10.1016/j.jep.2007.03.037; Liu FS, 2011, INT J GYNECOL CANCER, V21, P1172, DOI 10.1097/IGC.0b013e31821f742c; Liu GY, 2008, CELL BIOL INT, V32, P663, DOI 10.1016/j.cellbi.2008.01.292; Mandal M, 2008, CANCER-AM CANCER SOC, V112, P2088, DOI 10.1002/cncr.23410; McLean GW, 2005, NAT REV CANCER, V5, P505, DOI 10.1038/nrc1647; Mitra SK, 2006, CURR OPIN CELL BIOL, V18, P516, DOI 10.1016/j.ceb.2006.08.011; Navarro A, 2004, FASEB J, V18, P1801, DOI 10.1096/fj.04-2516rev; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; Peng CC, 2007, J ETHNOPHARMACOL, V109, P93, DOI 10.1016/j.jep.2006.07.009; Playford MP, 2004, ONCOGENE, V23, P7928, DOI 10.1038/sj.onc.1208080; Rokhlin OW, 2001, ONCOGENE, V20, P2836, DOI 10.1038/sj.onc.1204410; SCHALLER MD, 1994, CURR OPIN CELL BIOL, V6, P705, DOI 10.1016/0955-0674(94)90097-3; SCHALLER MD, 1994, MOL CELL BIOL, V14, P1680, DOI 10.1128/MCB.14.3.1680; SEEDS NW, 1970, P NATL ACAD SCI USA, V66, P160, DOI 10.1073/pnas.66.1.160; Thiyagarajan V, 2013, BBA-GEN SUBJECTS, V1830, P4091, DOI 10.1016/j.bbagen.2013.04.027; van Nimwegen MJ, 2007, BIOCHEM PHARMACOL, V73, P597, DOI 10.1016/j.bcp.2006.08.011; Vihinen P, 2005, CURR CANCER DRUG TAR, V5, P203, DOI 10.2174/1568009053765799; Wang RX, 2003, J MED CHEM, V46, P2287, DOI 10.1021/jm0203783; Wu H, 2006, PROTEOMICS, V6, P826, DOI 10.1002/pmic.200401341; Yang HL, 2006, AM J CHINESE MED, V34, P217, DOI 10.1142/S0192415X06003783; Yang HL, 2006, CANCER LETT, V231, P215, DOI 10.1016/j.canlet.2005.02.004; Yang J, 1997, SCIENCE, V275, P1129, DOI 10.1126/science.275.5303.1129; Yilmaz M, 2009, CANCER METAST REV, V28, P15, DOI 10.1007/s10555-008-9169-0	46	40	42	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2015	10	10							e0141285	10.1371/journal.pone.0141285	http://dx.doi.org/10.1371/journal.pone.0141285			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0EH	26517117	gold, Green Published, Green Submitted			2022-12-26	WOS:000363920800032
J	Turowski, VR; Aknin, C; Maliandi, MV; Buchensky, C; Leaden, L; Peralta, DA; Busi, MV; Araya, A; Gomez-Casati, DF				Turowski, Valeria R.; Aknin, Cindy; Maliandi, Maria V.; Buchensky, Celeste; Leaden, Laura; Peralta, Diego A.; Busi, Maria V.; Araya, Alejandro; Gomez-Casati, Diego F.			Frataxin Is Localized to Both the Chloroplast and Mitochondrion and Is Involved in Chloroplast Fe-S Protein Function in Arabidopsis	PLOS ONE			English	Article							IRON-SULFUR CLUSTERS; FRIEDREICHS-ATAXIA; SCAFFOLD PROTEIN; CYSTEINE DESULFURASE; GENE-EXPRESSION; NITRIC-OXIDE; BIOGENESIS; HOMOLOG; MATURATION; DEFICIENCY	Frataxin plays a key role in eukaryotic cellular iron metabolism, particularly in mitochondrial heme and iron-sulfur (Fe-S) cluster biosynthesis. However, its precise role has yet to be elucidated. In this work, we studied the subcellular localization of Arabidopsis frataxin, AtFH, using confocal microscopy, and found a novel dual localization for this protein. We demonstrate that plant frataxin is targeted to both the mitochondria and the chloroplast, where it may play a role in Fe-S cluster metabolism as suggested by functional studies on nitrite reductase (NIR) and ferredoxin (Fd), two Fe-S containing chloroplast proteins, in AtFH deficient plants. Our results indicate that frataxin deficiency alters the normal functioning of chloroplasts by affecting the levels of Fe, chlorophyll, and the photosynthetic electron transport chain in this organelle.	[Turowski, Valeria R.; Buchensky, Celeste; Leaden, Laura; Peralta, Diego A.; Busi, Maria V.; Gomez-Casati, Diego F.] Univ Nacl Rosario, CONICET, Ctr Estudios Fotosintet & Bioquim CEFOBI, RA-2000 Rosario, Santa Fe, Argentina; [Aknin, Cindy] CNRS, Microbiol Fondamentale & Pathogenicite UMR5234, F-33076 Bordeaux, France; [Aknin, Cindy] Univ Bordeaux Segalen, F-33076 Bordeaux, France; [Maliandi, Maria V.] UNSAM, CONICET, IIB, Inst Tecnol Chascomus INTECH, RA-7130 Chascomus, Argentina; [Araya, Alejandro] INRA Bordeaux Aquitaine, CNRS, F-33882 Villenave Dornon, France; [Araya, Alejandro] INRA Bordeaux Aquitaine, Biol Fruit & Pathol UMR 1332, F-33882 Villenave Dornon, France	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Rosario; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Centre National de la Recherche Scientifique (CNRS); INRAE; INRAE; UDICE-French Research Universities; Universite de Bordeaux	Gomez-Casati, DF (corresponding author), Univ Nacl Rosario, CONICET, Ctr Estudios Fotosintet & Bioquim CEFOBI, Suipacha 531, RA-2000 Rosario, Santa Fe, Argentina.	gomezcasati@cefobi-conicet.gov.ar	Leaden, Laura/S-1313-2018	Busi, Maria Victoria/0000-0003-3638-7043; Gomez-Casati, Diego/0000-0002-4569-2579; Leaden, Laura/0000-0002-0576-1250	ANPCyT [PICT 0512, 2188, 2184]; PICS-CNRS Program [3641]; Institut National de Recherche Agronomique (INRA, France)	ANPCyT(ANPCyT); PICS-CNRS Program; Institut National de Recherche Agronomique (INRA, France)	This work was supported by grants from ANPCyT (PICT 0512, 2188 and 2184), the PICS-CNRS Program 3641 and the Institut National de Recherche Agronomique (INRA, France). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Ghany SE, 2005, PLANT PHYSIOL, V138, P161, DOI 10.1104/pp.104.058602; Acquaviva F, 2005, J CELL SCI, V118, P3917, DOI 10.1242/jcs.02516; Adinolfi S, 2009, NAT STRUCT MOL BIOL, V16, P390, DOI 10.1038/nsmb.1579; Albrecht AG, 2011, CHEMBIOCHEM, V12, P2052, DOI 10.1002/cbic.201100190; ARNON DI, 1949, PLANT PHYSIOL, V24, P1, DOI 10.1104/pp.24.1.1; Babcock M, 1997, SCIENCE, V276, P1709, DOI 10.1126/science.276.5319.1709; Balk J, 2005, TRENDS PLANT SCI, V10, P324, DOI 10.1016/j.tplants.2005.05.002; Balk J, 2011, TRENDS PLANT SCI, V16, P218, DOI 10.1016/j.tplants.2010.12.006; Berglund AK, 2009, MOL PLANT, V2, P1298, DOI 10.1093/mp/ssp048; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bulteau AL, 2004, SCIENCE, V305, P242, DOI 10.1126/science.1098991; Busi MV, 2006, PLANT J, V48, P873, DOI 10.1111/j.1365-313X.2006.02923.x; Busi MV, 2012, IUBMB LIFE, V64, P56, DOI 10.1002/iub.577; Busi MV, 2011, MOL PLANT, V4, P127, DOI 10.1093/mp/ssq065; Busi MV, 2004, FEBS LETT, V576, P141, DOI 10.1016/j.febslet.2004.09.003; Campuzano V, 1996, SCIENCE, V271, P1423, DOI 10.1126/science.271.5254.1423; Carrie C, 2009, FEBS J, V276, P1187, DOI 10.1111/j.1742-4658.2009.06876.x; Carrie C, 2013, BBA-MOL CELL RES, V1833, P253, DOI 10.1016/j.bbamcr.2012.05.029; Cavadini P, 2000, J BIOL CHEM, V275, P41469, DOI 10.1074/jbc.M006539200; Chen OS, 2002, P NATL ACAD SCI USA, V99, P12321, DOI 10.1073/pnas.192449599; Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x; Condo I, 2006, J BIOL CHEM, V281, P16750, DOI 10.1074/jbc.M511960200; Couturier J, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00259; Dhe-Paganon S, 2000, J BIOL CHEM, V275, P30753, DOI 10.1074/jbc.C000407200; Dolezal P, 2007, EUKARYOT CELL, V6, P1431, DOI 10.1128/EC.00027-07; Dos Santos PC, 2004, CHEM REV, V104, P1159, DOI 10.1021/cr020608l; Elrad D, 2002, PLANT CELL, V14, P1801, DOI 10.1105/tpc.002154; Emanuelsson O, 1999, PROTEIN SCI, V8, P978, DOI 10.1110/ps.8.5.978; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Espineda CE, 1999, P NATL ACAD SCI USA, V96, P10507, DOI 10.1073/pnas.96.18.10507; Fontecave M, 2005, J BIOL INORG CHEM, V10, P713, DOI 10.1007/s00775-005-0025-1; Fuss J, 2013, NEW PHYTOL, V200, P1022, DOI 10.1111/nph.12433; Gibson TJ, 1996, TRENDS NEUROSCI, V19, P465, DOI 10.1016/S0166-2236(96)20054-2; Gomez-Casati DF, 2002, FEBS LETT, V532, P70, DOI 10.1016/S0014-5793(02)03631-1; Gomez-Casati DF, 2002, PLANTA, V214, P428, DOI 10.1007/s004250100634; Gonzalez-Cabo P, 2005, HUM MOL GENET, V14, P2091, DOI 10.1093/hmg/ddi214; Gordon DM, 2001, HUM MOL GENET, V10, P259, DOI 10.1093/hmg/10.3.259; HAJDUKIEWICZ P, 1994, PLANT MOL BIOL, V25, P989, DOI 10.1007/BF00014672; Horie Y, 2009, J BIOL CHEM, V284, P17449, DOI 10.1074/jbc.M109.008912; Huynen MA, 2001, HUM MOL GENET, V10, P2463, DOI 10.1093/hmg/10.21.2463; Lan P, 2011, PLANT PHYSIOL, V155, P821, DOI 10.1104/pp.110.169508; Leon S, 2005, FEBS LETT, V579, P1930, DOI 10.1016/j.febslet.2005.02.038; Lesuisse E, 2003, HUM MOL GENET, V12, P879, DOI 10.1093/hmg/ddg096; Lill R, 2008, ANNU REV BIOCHEM, V77, P669, DOI 10.1146/annurev.biochem.76.052705.162653; Lill R, 2009, NATURE, V460, P831, DOI 10.1038/nature08301; Loiseau L, 2003, J BIOL CHEM, V278, P38352, DOI 10.1074/jbc.M305953200; Maliandi MV, 2007, PROTEIN EXPRES PURIF, V51, P157, DOI 10.1016/j.pep.2006.06.007; Maliandi MV, 2011, FEBS J, V278, P470, DOI 10.1111/j.1742-4658.2010.07968.x; Martin M, 2009, FEBS LETT, V583, P542, DOI 10.1016/j.febslet.2008.12.039; Maxwell K, 2000, J EXP BOT, V51, P659, DOI 10.1093/jexbot/51.345.659; Mielcarek A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122538; Millar AH, 2009, PLANT CELL, V21, P1625, DOI 10.1105/tpc.109.066019; Muhlenhoff U, 2002, HUM MOL GENET, V11, P2025, DOI 10.1093/hmg/11.17.2025; Murthy N, 2007, J BIOL CHEM, V282, P18254, DOI 10.1074/jbc.M701428200; Musco G, 2000, STRUCTURE, V8, P695, DOI 10.1016/S0969-2126(00)00158-1; O'Neill HA, 2005, BIOCHEMISTRY-US, V44, P537, DOI 10.1021/bi048459j; Park S, 2003, J BIOL CHEM, V278, P31340, DOI 10.1074/jbc.M303158200; Park S, 2002, J BIOL CHEM, V277, P38589, DOI 10.1074/jbc.M206711200; Patzer SI, 1999, J BACTERIOL, V181, P3307, DOI 10.1128/JB.181.10.3307-3309.1999; Peeters N, 2001, BBA-MOL CELL RES, V1541, P54, DOI 10.1016/S0167-4889(01)00146-X; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pilon Marinus, 2006, Genet Eng (N Y), V27, P101, DOI 10.1007/0-387-25856-6_7; Puccio H, 2001, NAT GENET, V27, P181, DOI 10.1038/84818; Ramazzotti A, 2004, FEBS LETT, V557, P215, DOI 10.1016/S0014-5793(03)01498-4; Ramirez L, 2010, ANN BOT-LONDON, V105, P801, DOI 10.1093/aob/mcp147; Reichel C, 1996, P NATL ACAD SCI USA, V93, P5888, DOI 10.1073/pnas.93.12.5888; Ristow M, 2000, P NATL ACAD SCI USA, V97, P12239, DOI 10.1073/pnas.220403797; Rotig A, 1997, NAT GENET, V17, P215, DOI 10.1038/ng1097-215; Rubio LM, 2005, J BACTERIOL, V187, P405, DOI 10.1128/JB.187.2.405-414.2005; Schmucker S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016199; Schoenfeld RA, 2005, HUM MOL GENET, V14, P3787, DOI 10.1093/hmg/ddi393; Seigneurin-Berny D, 2008, PLANT PHYSIOL BIOCH, V46, P951, DOI 10.1016/j.plaphy.2008.06.009; Shan YX, 2007, HUM MOL GENET, V16, P929, DOI 10.1093/hmg/ddm038; Shan YX, 2012, HUM MOL GENET, V21, P1457, DOI 10.1093/hmg/ddr582; Stehling O, 2004, HUM MOL GENET, V13, P3007, DOI 10.1093/hmg/ddh324; Stemmler TL, 2010, J BIOL CHEM, V285, P26737, DOI 10.1074/jbc.R110.118679; Takahashi M, 2001, PLANT PHYSIOL, V126, P731, DOI 10.1104/pp.126.2.731; Takahashi Y, 2002, J BIOL CHEM, V277, P28380, DOI 10.1074/jbc.C200365200; Tamarit J, 2006, ANAL BIOCHEM, V351, P149, DOI 10.1016/j.ab.2005.12.001; Thierbach R, 2005, HUM MOL GENET, V14, P3857, DOI 10.1093/hmg/ddi410; Touraine B, 2004, PLANT J, V40, P101, DOI 10.1111/j.1365-313X.2004.02189.x; Turowski VR, 2012, MOL PLANT, V5, P1001, DOI 10.1093/mp/sss037; Van Hoewyk D, 2007, P NATL ACAD SCI USA, V104, P5686, DOI 10.1073/pnas.0700774104; Vazzola V, 2007, FEBS LETT, V581, P667, DOI 10.1016/j.febslet.2007.01.030; Xu XM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007662; Xu XM, 2006, EMBO J, V25, P900, DOI 10.1038/sj.emboj.7600968; Yoo SD, 2007, NAT PROTOC, V2, P1565, DOI 10.1038/nprot.2007.199; Zheng LM, 1998, J BIOL CHEM, V273, P13264, DOI 10.1074/jbc.273.21.13264	88	23	23	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2015	10	10							e0141443	10.1371/journal.pone.0141443	http://dx.doi.org/10.1371/journal.pone.0141443			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0EH	26517126	Green Submitted, gold, Green Published			2022-12-26	WOS:000363920800040
J	Dong, YM; Su, Y; Yu, P; Yang, M; Zhu, SS; Mei, XY; He, XH; Pan, MH; Zhu, YY; Li, CY				Dong, Yumei; Su, Yuan; Yu, Ping; Yang, Min; Zhu, Shusheng; Mei, Xinyue; He, Xiahong; Pan, Manhua; Zhu, Youyong; Li, Chengyun			Proteomic Analysis of the Relationship between Metabolism and Nonhost Resistance in Soybean Exposed to Bipolaris maydis	PLOS ONE			English	Article							MITOCHONDRIAL PROCESSING PEPTIDASE; ISOPRENOID BIOSYNTHESIS; ARABIDOPSIS; STRESS; TOLERANCE; PROTEINS; PATHWAY; GENE; RECOGNITION; DIVERSITY	Nonhost resistance (NHR) pertains to the most common form of plant resistance against pathogenic microorganisms of other species. Bipolaris maydis is a non-adapted pathogen affecting soybeans, particularly of maize/soybean intercropping systems. However, no experimental evidence has described the immune response of soybeans against B. maydis. To elucidate the molecular mechanism underlying NHR in soybeans, proteomics analysis based on two-dimensional polyacrylamide gel electrophoresis (2-DE) was performed to identify proteins involved in the soybean response to B. maydis. The spread of B. maydis spores across soybean leaves induced NHR throughout the plant, which mobilized almost all organelles and various metabolic processes in response to B. maydis. Some enzymes, including ribulose-1,5-bisphosphate carboxylase/oxygenase (RuBisCO), mitochondrial processing peptidase (MPP), oxygen evolving enhancer (OEE), and nucleoside diphosphate kinase (NDKs), were found to be related to NHR in soybeans. These enzymes have been identified in previous studies, and STRING analysis showed that most of the protein functions related to major metabolic processes were induced as a response to B. maydis, which suggested an array of complex interactions between soybeans and B. maydis. These findings suggest a systematic NHR against non-adapted pathogens in soybeans. This response was characterized by an overlap between metabolic processes and response to stimulus. Several metabolic processes provide the soybean with innate immunity to the non-adapted pathogen, B. maydis. This research investigation on NHR in soybeans may foster a better understanding of plant innate immunity, as well as the interactions between plant and non-adapted pathogens in intercropping systems.	[Dong, Yumei; Yang, Min; Zhu, Shusheng; Mei, Xinyue; He, Xiahong; Pan, Manhua; Zhu, Youyong; Li, Chengyun] Yunnan Agr Univ, Key Lab Agrobiodivers & Pest Management, Educ Minist China, Kunming 650201, Peoples R China; [Su, Yuan] Kunming Univ, Life Sci & Technol Dept, Kunming 650214, Peoples R China; [Yu, Ping] Yunnan Acad Agr Sci, Inst Biotechnol & Germplasm Resources, Kunming 650223, Peoples R China	Yunnan Agricultural University; Kunming University; Yunnan Academy of Agricultural Sciences	Li, CY (corresponding author), Yunnan Agr Univ, Key Lab Agrobiodivers & Pest Management, Educ Minist China, Kunming 650201, Peoples R China.	licheng_yun@163.com			973 Program of the Ministry of Science and Technology of China [2011CB100400]	973 Program of the Ministry of Science and Technology of China(National Basic Research Program of China)	This study was financially supported by the 973 Program (2011CB100400) of the Ministry of Science and Technology of China.	Altincicek B, 2001, FEBS LETT, V499, P37, DOI 10.1016/S0014-5793(01)02516-9; Bouvier F, 2005, PROG LIPID RES, V44, P357, DOI 10.1016/j.plipres.2005.09.003; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Braun HP, 1997, INT J BIOCHEM CELL B, V29, P1043, DOI 10.1016/S1357-2725(97)00032-0; Cheng YL, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-96; Cunningham FX, 2000, J BACTERIOL, V182, P5841, DOI 10.1128/JB.182.20.5841-5848.2000; Danis Peter, 2009, Endocr Regul, V43, P39; Diaz-Mendoza M, 2014, J EXP BOT, V65, P3825, DOI 10.1093/jxb/eru043; Domsalla A, 2008, PLANTA MED, V74, P699, DOI 10.1055/s-2008-1074530; Dong YuMei, 2013, Journal of Yunnan Agricultural University, V28, P16; Acero FJF, 2011, INT J MOL SCI, V12, P795, DOI 10.3390/ijms12010795; Gagliano M, 2013, BMC ECOL, V13, DOI 10.1186/1472-6785-13-19; Gagliano M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037382; Garcia-Murria MJ, 2008, BIOCHEM J, V411, P241, DOI 10.1042/BJ20071422; Grienenberger E, 2009, PLANT J, V58, P246, DOI 10.1111/j.1365-313X.2008.03773.x; Hakeem KR, 2012, OMICS, V16, P621, DOI 10.1089/omi.2012.0041; Heath MC, 2000, CURR OPIN PLANT BIOL, V3, P315, DOI 10.1016/S1369-5266(00)00087-X; Heide H, 2014, J PLANT PHYSL, V161, P139; Hossain Z, 2012, J PROTEOMICS, V75, P4151, DOI 10.1016/j.jprot.2012.05.037; Ito A, 1999, BIOCHEM BIOPH RES CO, V265, P611, DOI 10.1006/bbrc.1999.1703; Kim MY, 2010, P NATL ACAD SCI USA, V107, P22032, DOI 10.1073/pnas.1009526107; Kim SG, 2010, PHYSIOL PLANTARUM, V138, P1, DOI 10.1111/j.1399-3054.2009.01290.x; Komatsu S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065301; Komatsu S, 2013, J PROTEOMICS, V79, P231, DOI 10.1016/j.jprot.2012.12.023; Lee HA, 2014, NEW PHYTOL, V203, P926, DOI 10.1111/nph.12861; Li CY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008049; Li J, 2008, MOL PLANT, V1, P482, DOI 10.1093/mp/ssn013; Li YH, 2014, NAT BIOTECHNOL, V32, P1045, DOI 10.1038/nbt.2979; Lipka U, 2010, EUR J CELL BIOL, V89, P194, DOI 10.1016/j.ejcb.2009.11.011; Luo QY, 2005, J PLANT PHYSIOL, V162, P1003, DOI 10.1016/j.jplph.2004.11.008; McConnell JR, 2013, BIOORG MED CHEM LETT, V23, P1923, DOI 10.1016/j.bmcl.2013.02.014; Momcilovic I, 2007, J PLANT PHYSIOL, V164, P90, DOI 10.1016/j.jplph.2006.01.010; Mysore KS, 2004, TRENDS PLANT SCI, V9, P97, DOI 10.1016/j.tplants.2003.12.005; Ning CJ, 2013, PLANT PHYSIOL BIOCH, V70, P1, DOI 10.1016/j.plaphy.2013.05.008; Page JE, 2004, PLANT PHYSIOL, V134, P1401, DOI 10.1104/pp.103.038133; Quach TN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084886; Ramos AA, 2009, J PLANT PHYSIOL, V166, P968, DOI 10.1016/j.jplph.2008.11.008; Senthil-Kumar M, 2013, ANNU REV PHYTOPATHOL, V51, P407, DOI 10.1146/annurev-phyto-082712-102319; Sobhanian H, 2010, PROTEOME SCI, V8, DOI 10.1186/1477-5956-8-19; Su YC, 2014, INT J MOL SCI, V15, P2738, DOI 10.3390/ijms15022738; van der Hoorn RAL, 2008, ANNU REV PLANT BIOL, V59, P191, DOI 10.1146/annurev.arplant.59.032607.092835; van Doorn WG, 2011, CELL DEATH DIFFER, V18, P1241, DOI 10.1038/cdd.2011.36; Wang X, 2015, IEEE T BIO-MED ENG, V62, P80, DOI 10.1109/TBME.2014.2339295; Widjaja I, 2009, PROTEOMICS, V9, P138, DOI 10.1002/pmic.200800293; Yang EJ, 2003, BIOCHEM BIOPH RES CO, V305, P862, DOI 10.1016/S0006-291X(03)00851-9; Yang M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115052; Yun BW, 2003, PLANT J, V34, P768, DOI 10.1046/j.1365-313X.2003.01773.x; Zheng MS, 2004, PLANTA, V218, P740, DOI 10.1007/s00425-003-1169-2; Zimmerli L, 2004, PLANT J, V40, P633, DOI 10.1111/j.1365-313X.2004.02236.x	49	1	2	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2015	10	10							e0141264	10.1371/journal.pone.0141264	http://dx.doi.org/10.1371/journal.pone.0141264			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0ED	26513657	Green Submitted, Green Published, gold			2022-12-26	WOS:000363920300025
J	Schanzer, DL; Saboui, M; Lee, L; Domingo, FR; Mersereau, T				Schanzer, Dena L.; Saboui, Myriam; Lee, Liza; Domingo, Francesca Reyes; Mersereau, Teresa			Leading Indicators and the Evaluation of the Performance of Alerts for Influenza Epidemics	PLOS ONE			English	Article							EMERGENCY-DEPARTMENT; SURVEILLANCE; CANADA	Background Most evaluations of epidemic thresholds for influenza have been limited to internal criteria of the indicator variable. We aimed to initiate discussion on appropriate methods for evaluation and the value of cross-validation in assessing the performance of a candidate indicator for influenza activity. Methods Hospital records of in-patients with a diagnosis of confirmed influenza were extracted from the Canadian Discharge Abstract Database from 2003 to 2011 and aggregated to weekly and regional levels, yielding 7 seasons and 4 regions for evaluation (excluding the 2009 pandemic period). An alert created from the weekly time-series of influenza positive laboratory tests (FluWatch, Public Health Agency of Canada) was evaluated against influenza-confirmed hospitalizations on 5 criteria: lead/lag timing; proportion of influenza hospitalizations covered by the alert period; average length of the influenza alert period; continuity of the alert period and length of the pre-peak alert period. Results Influenza hospitalizations led laboratory positive tests an average of only 1.6 (95% CI: -1.5, 4.7) days. However, the difference in timing exceeded 1 week and was statistically significant at the significance level of 0.01 in 5 out of 28 regional seasons. An alert based primarily on 5% positivity and 15 positive tests produced an average alert period of 16.6 weeks. After allowing for a reporting delay of 2 weeks, the alert period included 80% of all influenza-confirmed hospitalizations. For 20 out of the 28 (71%) seasons, the first alert would have been signalled at least 3 weeks (in real time) prior to the week with maximum number of influenza hospitalizations. Conclusions Virological data collected from laboratories was a good indicator of influenza activity with the resulting alert covering most influenza hospitalizations and providing a reasonable pre-peak warning at the regional level. Though differences in timing were statistically significant, neither time-series consistently led the other.	[Schanzer, Dena L.] Publ Hlth Agcy Canada, Infect Dis Prevent & Control Branch, Ctr Communicable Dis & Infect Control, Ottawa, ON, Canada; [Saboui, Myriam; Lee, Liza; Domingo, Francesca Reyes; Mersereau, Teresa] Publ Hlth Agcy Canada, Infect Dis Prevent & Control Branch, Ctr Immunizat & Resp Infect Dis, Ottawa, ON, Canada	Public Health Agency of Canada; Public Health Agency of Canada	Schanzer, DL (corresponding author), Publ Hlth Agcy Canada, Infect Dis Prevent & Control Branch, Ctr Communicable Dis & Infect Control, Ottawa, ON, Canada.	dena.schanzer@phac-aspc.gc.ca	Schanzer, Dena/G-1593-2011	Schanzer, Dena/0000-0001-7093-4309	Canadian Institute of Health	Canadian Institute of Health(Canadian Institutes of Health Research (CIHR))	The authors acknowledge the support of the National FluWatch Network for access to national influenza surveillance data and the support of the Canadian Institute of Health Information and all those involved in the collection and compilation of the Discharge Abstract Database. As well, the authors wish to thank the Data Coordination and Access Program of the Public Health Agency of Canada for providing access to this database. The cooperation of all involved in these activities is gratefully acknowledged.	[Anonymous], 2010, Can Commun Dis Rep, V36, P1, DOI [10.14745/ccdr.v36i00as2, 10.14745/ccdr.v36i00a05, 10.14745/ccdr.v36i00as3]; Aoki Fred Y, 2015, Can J Infect Dis Med Microbiol, V26, pe1; Biggerstaff M, 2012, AM J PUBLIC HEALTH, V102, pE21, DOI 10.2105/AJPH.2012.300651; Canadian Institute for Health Information, 2014, DISCH ABSTR DAT DAD; Cowling BJ, 2006, INT J EPIDEMIOL, V35, P1314, DOI 10.1093/ije/dyl162; Debin M, 2013, BMC MED INFORM DECIS, V13, DOI 10.1186/1472-6947-13-138; Espino Jeremy U, 2003, AMIA Annu Symp Proc, P215; Ginsberg J, 2009, NATURE, V457, P1012, DOI 10.1038/nature07634; Hiller KM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073832; McIver DJ, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003581; Olson DR, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003256; Ortiz JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018687; Paolotti D, 2014, CLIN MICROBIOL INFEC, V20, P17, DOI 10.1111/1469-0691.12477; Patwardhan A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043611; Public Health Agency of Canada, 2015, FLUWATCH REP; Public Health Agency of Canada, 2015, WEEKL FLUWATCH REP A; Reich NG, 2015, CLIN INFECT DIS, V60, P499, DOI 10.1093/cid/ciu749; SAS Institute Inc, 2015, SAS ENT GUID 5 1; Schanzer D, 2011, AM J EPIDEMIOL, V174, P109, DOI 10.1093/aje/kwr037; Schanzer DL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080481; Schanzer DL, 2013, INFLUENZA OTHER RESP, V7, P799, DOI 10.1111/irv.12011; Schanzer DL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021471; Schanzer DL, 2010, INFLUENZA OTHER RESP, V4, P295, DOI 10.1111/j.1750-2659.2010.00154.x; Schanzer DL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006681; Stiver H Grant, 2015, Can J Infect Dis Med Microbiol, V26, pe5; Tay EL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077244; Thompson LH, 2014, EPIDEMIOL INFECT, V142, P2397, DOI 10.1017/S0950268813003464; Unkel S, 2012, J R STAT SOC A STAT, V175, P49, DOI 10.1111/j.1467-985X.2011.00714.x; Valdivia A, 2010, EUROSURVEILLANCE, P15; Vega T, 2013, INFLUENZA OTHER RESP, V7, P546, DOI 10.1111/j.1750-2659.2012.00422.x; World Health Organization, 2015, ICD 10 INT STAT CLAS; Yih WK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005260	33	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2015	10	10							e0141776	10.1371/journal.pone.0141776	http://dx.doi.org/10.1371/journal.pone.0141776			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0ED	26513364	gold, Green Published, Green Submitted			2022-12-26	WOS:000363920300082
J	Cliquet, F; Picard-Meyer, E; Mojzis, M; Dirbakova, Z; Muizniece, Z; Jaceviciene, I; Mutinelli, F; Matulova, M; Frolichova, J; Rychlik, I; Celer, V				Cliquet, Florence; Picard-Meyer, Evelyne; Mojzis, Miroslav; Dirbakova, Zuzana; Muizniece, Zita; Jaceviciene, Ingrida; Mutinelli, Franco; Matulova, Marta; Frolichova, Jitka; Rychlik, Ivan; Celer, Vladimir			In-Depth Characterization of Live Vaccines Used in Europe for Oral Rabies Vaccination of Wildlife	PLOS ONE			English	Article								Although rabies incidence has fallen sharply over the past decades in Europe, the disease is still present in Eastern Europe. Oral rabies immunization of wild animal rabies has been shown to be the most effective method for the control and elimination of rabies. All rabies vaccines used in Europe are modified live virus vaccines based on the Street Alabama Dufferin (SAD) strain isolated from a naturally-infected dog in 1935. Because of the potential safety risk of a live virus which could revert to virulence, the genetic composition of three commercial attenuated live rabies vaccines was investigated in two independent laboratories using next genome sequencing. This study is the first one reporting on the diversity of variants in oral rabies vaccines as well as the presence of a mix of at least two different variants in all tested batches. The results demonstrate the need for vaccine producers to use new robust methodologies in the context of their routine vaccine quality controls prior to market release.	[Cliquet, Florence; Picard-Meyer, Evelyne] ANSES, Malzeville, France; [Mojzis, Miroslav; Dirbakova, Zuzana] State Vet & Food Inst Zvolen, Zvolen, Slovakia; [Muizniece, Zita] Inst Food Safety Anim Hlth & Environm BIOR, Riga, Latvia; [Jaceviciene, Ingrida] Natl Food & Vet Risk Assessment Inst Lithuania, Vilnius, Lithuania; [Jaceviciene, Ingrida] Univ Appl Sci, Fac Agrotechnol, Vilnius, Lithuania; [Mutinelli, Franco] Ist Zooprofilatt Sperimentale Venezie, Padua, Italy; [Matulova, Marta; Rychlik, Ivan] Vet Res Inst, CS-62132 Brno, Czech Republic; [Frolichova, Jitka; Celer, Vladimir] Univ Vet & Pharmaceut Sci Brno, Dept Infect Dis & Microbiol, Brno, Czech Republic	Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement du Travail (ANSES); Institute of Food Safety, Animal Health & Environment "BIOR"; IZS delle Venezie; Czech Veterinary Research Institute; University of Veterinary Sciences Brno	Cliquet, F (corresponding author), ANSES, Technopole Agricole & Veterinaire,Domaine Pixerec, Malzeville, France.	florence.cliquet@anses.fr	, Ivan/GPS-9674-2022; Celer, Vladimir/AAA-4779-2020; MUTINELLI, FRANCO/K-7525-2018	, Ivan/0000-0001-7995-6483; MUTINELLI, FRANCO/0000-0003-2903-9390; CLIQUET, Florence/0000-0003-2237-1243; Picard-Meyer, Evelyne/0000-0001-9122-9027				Borucki MK, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002555; Capobianchi MR, 2013, CLIN MICROBIOL INFEC, V19, P15, DOI 10.1111/1469-0691.12056; Cliquet F, 2004, DEV BIOLOGICALS, V119, P185; Cliquet F, 2014, EXPERT REV ANTI-INFE, V12, P905, DOI 10.1586/14787210.2014.921570; Cliquet F, 2013, ANTIVIR RES, V100, P84, DOI 10.1016/j.antiviral.2013.07.012; EDQM, 2013, EDQM MON, V0451, P1008; EDQM, 2014, EDQM MON, V0746, P1011; EFSA AHAW Panel, 2015, EFSA J, V13; European Commission, 2002, OR VACC FOX RAB; Freuling CM, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0142; Geue L, 2008, VACCINE, V26, P3227, DOI 10.1016/j.vaccine.2008.04.007; Hanlon CA, 2013, RABIES: SCIENTIFIC BASIS OF THE DISEASE AND ITS MANAGEMENT, 3RD EDITION, P61, DOI 10.1016/B978-0-12-396547-9.00003-1; ICTV. International Committee on Taxonomy of Viruses, 2014, FAM RHABD; Kissi B, 1999, J GEN VIROL, V80, P2041, DOI 10.1099/0022-1317-80-8-2041; Mahl P, 2014, VET RES, V45, DOI 10.1186/s13567-014-0077-8; Morimoto K, 1998, P NATL ACAD SCI USA, V95, P3152, DOI 10.1073/pnas.95.6.3152; OIE, 2013, RAB MAN DIAGN TESTS, P1; Rosatte RC, 2013, RABIES: SCIENTIFIC BASIS OF THE DISEASE AND ITS MANAGEMENT, 3RD EDITION, P617, DOI 10.1016/B978-0-12-396547-9.00018-3; *WHO, 2013, WHO EXP CONS RAB; Woo HJ, 2012, P NATL ACAD SCI USA, V109, P12980, DOI 10.1073/pnas.1117201109; World Organization for Animal Health, MANUAL DIAGNOSTIC TE	21	18	19	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2015	10	10							e0141537	10.1371/journal.pone.0141537	http://dx.doi.org/10.1371/journal.pone.0141537			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0DL	26509266	Green Published, gold, Green Submitted			2022-12-26	WOS:000363918100100
J	Hsieh, YT; Lin, HP; Chen, BM; Huang, PT; Roffler, SR				Hsieh, Yuan-Ting; Lin, Hsuan-Pei; Chen, Bing-Mae; Huang, Ping-Ting; Roffler, Steve R.			Effect of Cellular Location of Human Carboxylesterase 2 on CPT-11 Hydrolysis and Anticancer Activity	PLOS ONE			English	Article							RABBIT LIVER CARBOXYLESTERASE; ENZYME PRODRUG THERAPY; IRINOTECAN CPT-11; ENZYME/PRODRUG THERAPY; COLORECTAL-CANCER; MEDIATED EXPRESSION; BETA-GLUCURONIDASE; MAMMALIAN-CELLS; PHASE-II; ACTIVATION	CPT-11 is an anticancer prodrug that is clinically used for the treatment of metastatic colorectal cancer. Hydrolysis of CPT-11 by human carboxylesterase 2 (CE2) generates SN-38, a topoisomerase I inhibitor that is the active anti-tumor agent. Expression of CE2 in cancer cells is under investigation for the tumor-localized activation of CPT-11. CE2 is normally expressed in the endoplasmic reticulum of cells but can be engineered to direct expression of active enzyme on the plasmamembrane or as a secreted form. Although previous studies have investigated different locations of CE2 expression in cancer cells, it remains unclear if CE2 cellular location affects CPT-11 anticancer activity. In the present study, we directly compared the influence of CE2 cellular location on substrate hydrolysis and CPT-11 cytotoxicity. We linked expression of CE2 and enhanced green fluorescence protein (eGFP) via a foot-and-mouth disease virus 2A (F2A) peptide to facilitate fluorescence-activated cell sorting to achieve similar expression levels of ER-located, secreted or membrane-anchored CE2. Soluble CE2 was detected in the medium of cells that expressed secreted and membrane-anchored CE2, but not in cells that expressed ER-retained CE2. Cancer cells that expressed all three forms of CE2 were more sensitive to CPT-11 as compared to unmodified cancer cells, but the membrane-anchored and ER-retained forms of CE2 were consistently more effective than secreted CE2. We conclude that expression of CE2 in the ER or on the membrane of cancer cells is suitable for enhancing CPT-11 anticancer activity.	[Hsieh, Yuan-Ting] Natl Yang Ming Univ, Inst Microbiol & Immunol, Taipei 112, Taiwan; [Hsieh, Yuan-Ting; Lin, Hsuan-Pei; Chen, Bing-Mae; Huang, Ping-Ting; Roffler, Steve R.] Acad Sinica, Inst Biomed Sci, Taipei 115, Taiwan	National Yang Ming Chiao Tung University; Academia Sinica - Taiwan	Roffler, SR (corresponding author), Acad Sinica, Inst Biomed Sci, Taipei 115, Taiwan.	sroff@ibms.sinica.edu.tw	Roffler, Steve R/N-7791-2018	Roffler, Steve R/0000-0003-2543-7295	National Science Council, Taipei, Taiwan [NSC102-2320-B-001-013-MY3]	National Science Council, Taipei, Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by the research grant from the National Science Council, Taipei, Taiwan (NSC102-2320-B-001-013-MY3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ando Y, 2000, CANCER RES, V60, P6921; Bodurka DC, 2003, J CLIN ONCOL, V21, P291, DOI 10.1200/JCO.2003.02.091; Brzezinski MR, 1997, DRUG METAB DISPOS, V25, P1089; Chen KC, 2007, CANCER GENE THER, V14, P187, DOI 10.1038/sj.cgt.7700999; Chen KC, 2013, MOL PHARMACEUT, V10, P1773, DOI 10.1021/mp300581u; Chen KC, 2008, CHEM BIOL, V15, P1277, DOI 10.1016/j.chembiol.2008.10.008; Chen ZS, 1999, MOL PHARMACOL, V55, P921; Choi W, 2006, CANCER BIOL THER, V5, P1450, DOI 10.4161/cbt.5.11.3271; Danks MK, 2007, CANCER RES, V67, P22, DOI 10.1158/0008-5472.CAN-06-3607; de Felipe P, 2004, TRAFFIC, V5, P616, DOI 10.1111/j.1398-9219.2004.00205.x; Donnelly MLL, 2001, J GEN VIROL, V82, P1013, DOI 10.1099/0022-1317-82-5-1013; Goedhart J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027321; Herszenyi L, 2014, WORLD J GASTROENTERO, V20, P13246, DOI 10.3748/wjg.v20.i37.13246; Huang PT, 2011, CANCER GENE THER, V18, P381, DOI 10.1038/cgt.2011.3; Iyer L, 1998, J CLIN INVEST, V101, P847, DOI 10.1172/JCI915; Jansen WJM, 1997, INT J CANCER, V70, P335, DOI 10.1002/(SICI)1097-0215(19970127)70:3<335::AID-IJC15>3.0.CO;2-E; Jinno H, 2003, DRUG METAB DISPOS, V31, P108, DOI 10.1124/dmd.31.1.108; KAWATO Y, 1991, CANCER RES, V51, P4187; Khanna R, 2000, CANCER RES, V60, P4725; Liao KW, 2003, CANCER GENE THER, V10, P779, DOI 10.1038/sj.cgt.7700637; Liao KW, 2001, BIOTECHNOL BIOENG, V73, P313, DOI 10.1002/bit.1064; Marais R, 1997, NAT BIOTECHNOL, V15, P1373, DOI 10.1038/nbt1297-1373; MARSHALL CJ, 1977, J NATL CANCER I, V58, P1743, DOI 10.1093/jnci/58.6.1743; MENTLEIN R, 1987, BIOCHEM J, V245, P863, DOI 10.1042/bj2450863; MILLER SK, 1980, J BIOL CHEM, V255, P7161; Oosterhoff D, 2005, BRIT J CANCER, V92, P882, DOI 10.1038/sj.bjc.6602362; Oosterhoff D, 2003, MOL CANCER THER, V2, P765; Oosterhoff D, 2002, BRIT J CANCER, V87, P659, DOI 10.1038/sj.bjc.6600519; Oshita F, 2010, BRIT J CANCER, V103, P1325, DOI 10.1038/sj.bjc.6605875; Pavillard V, 2002, CANCER CHEMOTH PHARM, V49, P329, DOI 10.1007/s00280-001-0416-0; Pindel EV, 1997, J BIOL CHEM, V272, P14769, DOI 10.1074/jbc.272.23.14769; Potter PM, 1998, CANCER RES, V58, P3627; Potter PM, 1998, CANCER RES, V58, P2646; Prijovich ZM, 2009, MOL CANCER THER, V8, P940, DOI 10.1158/1535-7163.MCT-08-0812; Rehemtulla A, 2004, ANTICANCER RES, V24, P1393; Ross MK, 2007, ENZYMATIC ACTIVITY H, DOI [10.1002/0471140856.tx0424s33, DOI 10.1002/0471140856.TX0424S33]; Rothenberg ML, 2001, ONCOLOGIST, V6, P66, DOI 10.1634/theoncologist.6-1-66; RYAN MD, 1991, J GEN VIROL, V72, P2727, DOI 10.1099/0022-1317-72-11-2727; RYAN MD, 1994, EMBO J, V13, P928, DOI 10.1002/j.1460-2075.1994.tb06337.x; Saltz LB, 2001, ONCOLOGIST, V6, P81, DOI 10.1634/theoncologist.6-1-81; Sanghani SP, 2004, DRUG METAB DISPOS, V32, P505, DOI 10.1124/dmd.32.5.505; Schwer H, 1997, BIOCHEM BIOPH RES CO, V233, P117, DOI 10.1006/bbrc.1997.6413; Senter PD, 2001, BIOCONJUGATE CHEM, V12, P1074, DOI 10.1021/bc0155420; Uchino J, 2008, CANCER GENE THER, V15, P94, DOI 10.1038/sj.cgt.7701100; Wierdl M, 2008, CANCER GENE THER, V15, P183, DOI 10.1038/sj.cgt.7701112; Wierdl M, 2001, CANCER RES, V61, P5078; Xu G, 2002, CLIN CANCER RES, V8, P2605; Yano H, 2008, CANCER SCI, V99, P2309, DOI 10.1111/j.1349-7006.2008.00936.x	48	12	12	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2015	10	10							e0141088	10.1371/journal.pone.0141088	http://dx.doi.org/10.1371/journal.pone.0141088			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0DL	26509550	gold, Green Published, Green Submitted			2022-12-26	WOS:000363918100052
J	Kaniewska, P; Chan, CKK; Kline, D; Ling, EYS; Rosic, N; Edwards, D; Hoegh-Guldberg, O; Dove, S				Kaniewska, Paulina; Chan, Chon-Kit Kenneth; Kline, David; Ling, Edmund Yew Siang; Rosic, Nedeljka; Edwards, David; Hoegh-Guldberg, Ove; Dove, Sophie			Transcriptomic Changes in Coral Holobionts Provide Insights into Physiological Challenges of Future Climate and Ocean Change	PLOS ONE			English	Article							GENE-EXPRESSION; SEAWATER ACIDIFICATION; DIFFERENTIAL GENE; INTRACELLULAR PH; CARBONIC-ACID; REEF CORAL; STRESS; RESPONSES; REPRODUCTION; RESILIENCE	Tropical reef-building coral stress levels will intensify with the predicted rising atmospheric CO2 resulting in ocean temperature and acidification increase. Most studies to date have focused on the destabilization of coral-dinoflagellate symbioses due to warming oceans, or declining calcification due to ocean acidification. In our study, pH and temperature conditions consistent with the end-of-century scenarios of the Intergovernmental Panel on Climate Change (IPCC) caused major changes in photosynthesis and respiration, in addition to decreased calcification rates in the coral Acropora millepora. Population density of symbiotic dinoflagellates (Symbiodinium) under high levels of ocean acidification and temperature (Representative Concentration Pathway, RCP8.5) decreased to half of that found under present day conditions, with photosynthetic and respiratory rates also being reduced by 40%. These physiological changes were accompanied by evidence for gene regulation of calcium and bicarbonate transporters along with components of the organic matrix. Meta-transcriptomic RNA-Seq data analyses showed an overall down regulation of metabolic transcripts, and an increased abundance of transcripts involved in circadian clock control, controlling the damage of oxidative stress, calcium signaling/homeostasis, cytoskeletal interactions, transcription regulation, DNA repair, Wnt signaling and apoptosis/immunity/toxins. We suggest that increased maintenance costs under ocean acidification and warming, and diversion of cellular ATP to pH homeostasis, oxidative stress response, UPR and DNA repair, along with metabolic suppression, may underpin why Acroporid species tend not to thrive under future environmental stress. Our study highlights the potential increased energy demand when the coral holobiont is exposed to high levels of ocean warming and acidification.	[Kaniewska, Paulina] Australian Inst Marine Sci, Townsville, Qld 4810, Australia; [Kaniewska, Paulina; Kline, David; Rosic, Nedeljka; Dove, Sophie] Univ Queensland, Sch Biol Sci, St Lucia, Qld, Australia; [Chan, Chon-Kit Kenneth; Edwards, David] Univ Queensland, Sch Agr & Food Sci, St Lucia, Qld, Australia; [Kline, David] Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA; [Ling, Edmund Yew Siang] Univ Queensland, Univ Queensland Ctr Clin Res, Herston, Qld, Australia; [Hoegh-Guldberg, Ove; Dove, Sophie] Univ Queensland, Global Change Inst, St Lucia, Qld, Australia; [Hoegh-Guldberg, Ove; Dove, Sophie] Univ Queensland, ARC Ctr Excellence Coral Reef Studies, St Lucia, Qld, Australia	Australian Institute of Marine Science; University of Queensland; University of Queensland; University of California System; University of California San Diego; Scripps Institution of Oceanography; University of Queensland; University of Queensland; University of Queensland	Kaniewska, P (corresponding author), Australian Inst Marine Sci, PMB 3, Townsville, Qld 4810, Australia.	p.kaniewska@uq.edu.au	Edwards, David/H-3710-2015; /AAL-3738-2021; Dove, Sophie/I-7873-2013; Hoegh-Guldberg, Ove/ABA-5420-2020; Chan, Chon-Kit Kenneth/L-9950-2016	Edwards, David/0000-0001-7599-6760; Dove, Sophie/0000-0003-1823-8634; Hoegh-Guldberg, Ove/0000-0001-7510-6713; Chan, Chon-Kit Kenneth/0000-0003-0413-6397; Rosic, Nedeljka/0000-0002-2598-7046; Kline, David/0000-0001-5128-9439	Australian Research Council	Australian Research Council(Australian Research Council)	This work was funded by the Australian Research Council. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Adamovich Y, 2010, CELL METAB, V19, P319; Allemand D, 2011, CORAL REEFS: AN ECOSYSTEM IN TRANSITION, P119, DOI 10.1007/978-94-007-0114-4_9; Anthony KRN, 2008, P NATL ACAD SCI USA, V105, P17442, DOI 10.1073/pnas.0804478105; Baird AH, 2002, MAR ECOL PROG SER, V237, P133, DOI 10.3354/meps237133; Baker AC, 2008, ESTUAR COAST SHELF S, V80, P435, DOI 10.1016/j.ecss.2008.09.003; Barnes D.J., 1990, P109; Baroli I, 2003, PLANT CELL, V15, P992, DOI 10.1105/tpc.010405; Baroli I, 2004, J BIOL CHEM, V279, P6337, DOI 10.1074/jbc.M312919200; Barshis DJ, 2013, P NATL ACAD SCI USA, V110, P1387, DOI 10.1073/pnas.1210224110; Bergh JJ, 2006, AM J PHYSIOL-CELL PH, V290, pC822, DOI 10.1152/ajpcell.00403.2005; Bourne D, 2008, ISME J, V2, P350, DOI 10.1038/ismej.2007.112; Boutet Emmanuel, 2007, V406, P89; Brewer PG, 2014, CLIMATE CHANGE 2014; Brown BE, 1999, CORAL REEFS, V18, P99; Chan NCS, 2013, GLOBAL CHANGE BIOL, V19, P282, DOI 10.1111/gcb.12011; Chaumont D, 1995, J APPL PHYCOL, V7, P529, DOI 10.1007/BF00003939; Ciechanover A, 2005, NAT REV MOL CELL BIO, V6, P79, DOI 10.1038/nrm1552; Cohen AL, 2009, OCEANOGRAPHY, V22, P118, DOI 10.5670/oceanog.2009.102; Cohen AL, 2009, GEOCHEM GEOPHY GEOSY, V10, DOI 10.1029/2009GC002411; Cooper TF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020434; Crawley A, 2010, GLOBAL CHANGE BIOL, V16, P851, DOI 10.1111/j.1365-2486.2009.01943.x; Cui YJ, 2011, NAT MED, V17, P684, DOI 10.1038/nm.2388; DAVIES PS, 1989, MAR BIOL, V101, P389; DemmigAdams B, 1996, TRENDS PLANT SCI, V1, P21, DOI 10.1016/S1360-1385(96)80019-7; Desalvo MK, 2008, MOL ECOL, V17, P3952, DOI 10.1111/j.1365-294X.2008.03879.x; DeSalvo MK, 2012, CORAL REEFS, V31, P215, DOI 10.1007/s00338-011-0833-4; DeSalvo MK, 2010, MAR ECOL PROG SER, V402, P97, DOI 10.3354/meps08372; Dickson AG, 2003, MAR CHEM, V80, P185, DOI 10.1016/S0304-4203(02)00133-0; DICKSON AG, 1987, DEEP-SEA RES, V34, P1733, DOI 10.1016/0198-0149(87)90021-5; Doney SC, 2009, ANNU REV MAR SCI, V1, P169, DOI 10.1146/annurev.marine.010908.163834; Dove SG, 2013, P NATL ACAD SCI USA, V110, P15342, DOI 10.1073/pnas.1302701110; Downs CA, 2012, ECOTOXICOLOGY, V21, P768, DOI 10.1007/s10646-011-0837-4; Dunn SR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046801; Eckel-Mahan K, 2013, PHYSIOL REV, V93, P107, DOI 10.1152/physrev.00016.2012; Edmunds PJ, 2012, GLOBAL CHANGE BIOL, V18, P2173, DOI 10.1111/j.1365-2486.2012.02695.x; Fabricius KE, 2011, NAT CLIM CHANGE, V1, P165, DOI 10.1038/NCLIMATE1122; FALKOWSKI PG, 1981, NATURE, V289, P172, DOI 10.1038/289172a0; Fine M, 2007, SCIENCE, V315, P1811, DOI 10.1126/science.1137094; Furla P, 2000, AM J PHYSIOL-REG I, V278, pR870, DOI 10.1152/ajpregu.2000.278.4.R870; Gibbin EM, 2014, J EXP BIOL, V217, P1963, DOI 10.1242/jeb.099549; Guppy M, 1999, BIOL REV, V74, P1, DOI 10.1017/S0006323198005258; Harvey BP, 2013, ECOL EVOL, V3, P1016, DOI 10.1002/ece3.516; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Hoegh-Guldberg O, 2010, SCIENCE, V328, P1523, DOI 10.1126/science.1189930; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; Inoue S, 2013, NAT CLIM CHANGE, V3, P683, DOI [10.1038/nclimate1855, 10.1038/NCLIMATE1855]; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Kaniewska P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034659; Kleypas JA, 1999, AM ZOOL, V39, P146; Kroeker KJ, 2013, GLOBAL CHANGE BIOL, V19, P1884, DOI 10.1111/gcb.12179; Kroeker KJ, 2010, ECOL LETT, V13, P1419, DOI 10.1111/j.1461-0248.2010.01518.x; Kultz D, 2005, ANNU REV PHYSIOL, V67, P225, DOI 10.1146/annurev.physiol.67.040403.103635; Kurtz S, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-517; Leggat W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026687; Levy O, 2011, SCIENCE, V331, P175, DOI 10.1126/science.1196419; Lough JM, 2008, J ENVIRON MONITOR, V10, P21, DOI [10.1039/b714627m, 10.1039/B714627M]; Loya Y, 2001, ECOL LETT, V4, P122, DOI 10.1046/j.1461-0248.2001.00203.x; Maor-Landaw K, 2014, GLOBAL CHANGE BIOL, V20, P3026, DOI 10.1111/gcb.12592; Marcais G, 2011, BIOINFORMATICS, V27, P764, DOI 10.1093/bioinformatics/btr011; Martin DE, 2004, CELL, V119, P969, DOI 10.1016/j.cell.2004.11.047; Martin JA, 2011, NAT REV GENET, V12, P671, DOI 10.1038/nrg3068; Mazzoccoli G, 2012, CHRONOBIOL INT, V29, P227, DOI 10.3109/07420528.2012.658127; McCulloch M, 2012, NAT CLIM CHANGE, V2, P623, DOI 10.1038/NCLIMATE1473; MEHRBACH C, 1973, LIMNOL OCEANOGR, V18, P897, DOI 10.4319/lo.1973.18.6.0897; Mendes JM, 2002, MAR ECOL PROG SER, V235, P93, DOI 10.3354/meps235093; Meyer E, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-219; Moberg F, 1999, ECOL ECON, V29, P215, DOI 10.1016/S0921-8009(99)00009-9; Moya A, 2012, MOL ECOL, V21, P2440, DOI 10.1111/j.1365-294X.2012.05554.x; Muller P, 2001, PLANT PHYSIOL, V125, P1558, DOI 10.1104/pp.125.4.1558; Munday PL, 2009, P NATL ACAD SCI USA, V106, P1848, DOI 10.1073/pnas.0809996106; Nozawa Y, 2012, BIOL BULL-US, V222, P192, DOI 10.1086/BBLv222n3p192; Obara M, 2008, NEUROCHEM INT, V52, P905, DOI 10.1016/j.neuint.2007.10.015; Pandolfi JM, 2011, SCIENCE, V333, P418, DOI 10.1126/science.1204794; Pelejero C, 2010, TRENDS ECOL EVOL, V25, P332, DOI 10.1016/j.tree.2010.02.002; Perkins ND, 2007, NAT REV MOL CELL BIO, V8, P49, DOI 10.1038/nrm2083; Portner HO, 2008, MAR ECOL PROG SER, V373, P203, DOI 10.3354/meps07768; Reyes-Nivia C, 2013, GLOBAL CHANGE BIOL, V19, P1919, DOI 10.1111/gcb.12158; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Rodolfo-Metalpa R, 2011, NAT CLIM CHANGE, V1, P308, DOI 10.1038/NCLIMATE1200; Rodolfo-Metalpa R, 2010, BIOGEOSCIENCES, V7, P289, DOI 10.5194/bg-7-289-2010; Rodriguez-Lanetty M, 2009, MOL ECOL, V18, P5101, DOI 10.1111/j.1365-294X.2009.04419.x; Rohwer F, 2002, MAR ECOL PROG SER, V243, P1, DOI 10.3354/meps243001; Rosenberg E, 2007, NAT REV MICROBIOL, V5, P355, DOI 10.1038/nrmicro1635; Rosic N, 2015, ISME J, V9, P844, DOI 10.1038/ismej.2014.182; Rosic N, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1052; Rosic NN, 2011, CELL STRESS CHAPERON, V16, P69, DOI 10.1007/s12192-010-0222-x; Schoepf V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075049; Sha L, 2012, MOL PSYCHIATR, V17, P267, DOI 10.1038/mp.2011.73; Shao Y, 2005, DEV DYNAM, V234, P54, DOI 10.1002/dvdy.20517; Shoguchi E, 2013, CURR BIOL, V23, P1399, DOI 10.1016/j.cub.2013.05.062; STIMSON J, 1991, J EXP MAR BIOL ECOL, V153, P63, DOI 10.1016/S0022-0981(05)80006-1; Supuran CT, 2008, CURR PHARM DESIGN, V14, P603, DOI 10.2174/138161208783877884; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; Thurber RV, 2009, ENVIRON MICROBIOL, V11, P2148, DOI 10.1111/j.1462-2920.2009.01935.x; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Ulstrup KE, 2008, MAR ECOL PROG SER, V361, P139, DOI 10.3354/meps07360; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Venn AA, 2009, P NATL ACAD SCI USA, V106, P16574, DOI 10.1073/pnas.0902894106; Venn AA, 2013, P NATL ACAD SCI USA, V110, P1634, DOI 10.1073/pnas.1216153110; Vidal-Dupiol J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058652; Walker NJ, 2002, SCIENCE, V296, P557, DOI 10.1126/science.296.5567.557; Wallace DWR, 1998, PROGRAM DEVELOPED FO; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Wang LK, 2010, BIOINFORMATICS, V26, P136, DOI 10.1093/bioinformatics/btp612; WARD S, 1995, CORAL REEFS, V14, P87, DOI 10.1007/BF00303428; Weis VM, 2008, J EXP BIOL, V211, P3059, DOI 10.1242/jeb.009597; WHITAKER JR, 1980, ANAL BIOCHEM, V109, P156, DOI 10.1016/0003-2697(80)90024-X; Yara Y, 2012, BIOGEOSCIENCES, V9, P4955, DOI 10.5194/bg-9-4955-2012; Yarden O, 2007, APPL ENVIRON MICROB, V73, P2755, DOI 10.1128/AEM.02738-06; Zapata M, 2000, MAR ECOL PROG SER, V195, P29, DOI 10.3354/meps195029	112	52	53	1	93	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2015	10	10							e0139223	10.1371/journal.pone.0139223	http://dx.doi.org/10.1371/journal.pone.0139223			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0DL	26510159	Green Published, gold, Green Submitted			2022-12-26	WOS:000363918100009
J	Kovanen, L; Donner, K; Partonen, T				Kovanen, Leena; Donner, Kati; Partonen, Timo			SIRT1 Polymorphisms Associate with Seasonal Weight Variation, Depressive Disorders, and Diastolic Blood Pressure in the General Population	PLOS ONE			English	Article							METABOLIC SYNDROME; INSULIN-RESISTANCE; MONOAMINE-OXIDASE; PREVALENCE; JAPANESE; MOOD	SIRT1 polymorphisms have previously been associated with depressive and anxiety disorders. We aimed at confirming these earlier findings and extending the analyses to seasonal variations in mood and behavior. Three tag single-nucleotide polymorphisms (SNPs) were selected to capture the common variation in the SIRT1 gene. 5910 individuals (with blood sample, diagnostic interview, self-report of on seasonal changes in mood and behavior) were selected from a representative Finnish nationwide population-based sample. Logistic and linear regression models were used to analyze the associations between the SNPs and depressive and anxiety disorders, metabolic syndrome (EGIR criteria) and its components, and health examination measurements, Homeostasis Model Assessments, and diagnoses of type 2 and type 1 diabetes. SIRT1 rs2273773 showed evidence of association with seasonal variation in weight (C-allele, OR = 0.85, 95% CI = 0.76-0.95, p = 0.005). In addition, our study gave further support for the association of SIRT1 gene with depressive disorders (rs3758391) and diastolic blood pressure (rs2273773).	[Kovanen, Leena; Partonen, Timo] Natl Inst Hlth & Welf THL, Dept Hlth Mental Hlth Unit, Helsinki, Finland; [Donner, Kati] Univ Helsinki, Inst Mol Med Finland, Helsinki, Finland	Finland National Institute for Health & Welfare; University of Helsinki	Kovanen, L (corresponding author), Natl Inst Hlth & Welf THL, Dept Hlth Mental Hlth Unit, Helsinki, Finland.	leena.kovanen@thl.fi	Partonen, Timo/G-1105-2012	Partonen, Timo/0000-0003-1951-2455; Kovanen, Leena/0000-0002-3552-124X				Abe N, 2011, J PSYCHIATR RES, V45, P1106, DOI 10.1016/j.jpsychires.2011.01.016; American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Aromaa A., 2004, HLTH FUNCTIONAL CAPA; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Baur JA, 2012, NAT REV DRUG DISCOV, V11, P443, DOI 10.1038/nrd3738; Cruz M, 2010, DIABETES-METAB RES, V26, P261, DOI 10.1002/dmrr.1082; Hampp G, 2008, CURR BIOL, V18, P678, DOI 10.1016/j.cub.2008.04.012; HOTAMISLIGIL GS, 1991, AM J HUM GENET, V49, P383; Jurinke Christian, 2002, Methods Mol Biol, V187, P179; Kamezaki F, 2013, HYPERTENS RES, V36, P398, DOI 10.1038/hr.2012.197; Kamezaki F, 2010, HYPERTENS RES, V33, P568, DOI 10.1038/hr.2010.32; Kilic U, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090428; Kishi T, 2011, GENES BRAIN BEHAV, V10, P257, DOI 10.1111/j.1601-183X.2010.00661.x; Kishi T, 2010, J AFFECT DISORDERS, V126, P167, DOI 10.1016/j.jad.2010.04.003; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Lahermo P, 2006, HUM MUTAT, V27, P711, DOI 10.1002/humu.20346; Liang FX, 2009, NAT REV ENDOCRINOL, V5, P367, DOI 10.1038/nrendo.2009.101; Libert S, 2011, CELL, V147, P1459, DOI 10.1016/j.cell.2011.10.054; Liguori R, 2014, MOL CELL PROBE, V28, P195, DOI 10.1016/j.mcp.2014.03.004; Partonen T, 1998, LANCET, V352, P1369, DOI 10.1016/S0140-6736(98)01015-0; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Reif A, 2014, MOL PSYCHIATR, V19, P122, DOI 10.1038/mp.2012.172; Rintamaki R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001482; Sahar S, 2009, NAT REV CANCER, V9, P886, DOI 10.1038/nrc2747; Shimoyama Y, 2011, TRANSL RES, V157, P339, DOI 10.1016/j.trsl.2011.02.004; van den Berg SW, 2009, INT J OBESITY, V33, P1143, DOI 10.1038/ijo.2009.152; Wehr T., 1984, SEASONAL PATTERN ASS	27	19	22	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2015	10	10							e0141001	10.1371/journal.pone.0141001	http://dx.doi.org/10.1371/journal.pone.0141001			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0DL	26509718	Green Published, gold, Green Submitted			2022-12-26	WOS:000363918100045
J	Martynov, A; Ishida, Y; Irimura, S; Tajiri, R; O'Hara, T; Fujita, T				Martynov, Alexander; Ishida, Yoshiaki; Irimura, Seiichi; Tajiri, Rie; O'Hara, Timothy; Fujita, Toshihiko			When Ontogeny Matters: A New Japanese Species of Brittle Star Illustrates the Importance of Considering both Adult and Juvenile Characters in Taxonomic Practice	PLOS ONE			English	Article							ECHINODERMATA-OPHIUROIDEA; POSTLARVAL DEVELOPMENT; EVO-DEVO; PHYLOGENY; EVOLUTION; RECONSTRUCTION; PEDOMORPHOSIS; ALLOMETRY; SHALLOW	Current taxonomy offers numerous approaches and methods for species delimitation and description. However, most of them are based on the adult characters and rarely suggest a dynamic representation of developmental transformations of taxonomically important features. Here we show how the underestimation of ontogenetic changes may result in long term lack of recognition of a new species of one of the most common ophiacanthid brittle stars (Echinodermata: Ophiuroidea) from the North Pacific. Based on vast material collected predominantly by various Japanese expeditions in the course of more than 50 years, and thorough study of appropriate type material, we revise the complex of three common species of the ophiuroid genus Ophiacantha which have been persistently confused with each other. The present study thus reveals the previously unrecognized new species Ophiacantha kokusai sp. nov. which is commonly distributed off the Pacific coast of Japan. The new species shows developmental differentiation from the closely related species Ophiacantha rhachophora H. L. Clark, 1911 and retains clearly expressed early juvenile features in the adult morphology. Another species, Ophiacantha clypeata Kyte, 1977, which had been separated from O. rhachophora, is in turn shown to be just a juvenile stage of another North Pacific species, Ophiacantha trachybactra H. L. Clark, 1911. For every species, detailed morphological data from both adult and juvenile specimens based on scanning electron microscopy are presented. A special grinding method showing complex internal features has been utilized for the first time. For all three species in this complex, a clear bathymetric differentiation is revealed: O. rhachophora predominantly inhabits shallow waters, 0-250 m, the new species O. kokusai lives deeper, at 250-600 m, and the third species, O. trachybactra, is found at 500-2,000 m. The present case clearly highlights the importance of considering developmental transformations, not only for a limited number of model organisms, but as part of the taxonomic process.	[Martynov, Alexander] Moscow MV Lomonosov State Univ, Zool Museum, Moscow, Russia; [Ishida, Yoshiaki; Irimura, Seiichi; Fujita, Toshihiko] Natl Museum Nat & Sci, Tsukuba, Ibaraki, Japan; [Tajiri, Rie] Waseda Univ, Dept Earth Sci, Tokyo, Japan; [O'Hara, Timothy] Museum Victoria, Melbourne, Vic, Australia	Lomonosov Moscow State University; National Museum of Nature and Science; Waseda University; Museum Victoria	Martynov, A (corresponding author), Moscow MV Lomonosov State Univ, Zool Museum, Moscow, Russia.	martynov@zmmu.msu.ru	Martynov, Alexander/AAE-3682-2021	O'Hara, Timothy/0000-0003-0885-6578	National Museum of Nature and Science, Japan; Japan Society for the Promotion of Science [25440226]; Moscow State University from the Russian Science Foundation [14-50-00029]; Census of Marine Life grant; Grants-in-Aid for Scientific Research [25440226] Funding Source: KAKEN	National Museum of Nature and Science, Japan; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Moscow State University from the Russian Science Foundation(Russian Science Foundation (RSF)); Census of Marine Life grant; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Census of Marine Life grant to TOH to map the ophiuroid fauna of the global seafloor and by a grant to TF and AM from the Director General of National Museum of Nature and Science, Japan, by a grant to TF from the Japan Society for the Promotion of Science (Scientific Research [C] No. 25440226) and by a grant through Moscow State University to AM from the Russian Science Foundation (grant 14-50-00029, SEM study and depository of selected ophiuroid specimens for comparative purposes).	Ahmadzadeh F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080563; Aizenberg J, 2001, NATURE, V412, P819, DOI 10.1038/35090573; [Anonymous], 1947, NATURE, V159, P446; Belyaev GM, 1976, P PP SHIRSHOV I OCEA, V99, P126; Thuy B, 2011, ZOOTAXA, P1; Thuy B, 2013, J SYST PALAEONTOL, V11, P515, DOI 10.1080/14772019.2012.702691; Bhullar BAS, 2012, NATURE, V487, P223, DOI 10.1038/nature11146; Bleidorn C, 2007, J ZOOL SYST EVOL RES, V45, P299, DOI 10.1111/j.1439-0469.2007.00425.x; Box MS, 2008, BOT J LINN SOC, V157, P429, DOI 10.1111/j.1095-8339.2008.00794.x; Briggs JC, 2012, J BIOGEOGR, V39, P12, DOI 10.1111/j.1365-2699.2011.02613.x; Carroll SB, 2008, CELL, V134, P25, DOI 10.1016/j.cell.2008.06.030; Clark, 1965, B BRIT MUS NAT HIST, V13, P37, DOI [10.5962/p.271717, DOI 10.5962/P.271717]; Clark H. L., 1915, Memoirs Museum of Comparative Zoology Harvard, V25; Clark HL, 1913, B AM MUS NAT HIST, V32, P185; Clark HL., 1911, B US NATL MUSEUM, V75, P1, DOI DOI 10.5479/SI.03629236.75.1; Djakonov AM, 1954, OPREDELITELI FAUNE S, V55; Fujita T, 2010, ECHINODERMS: DURHAM, P193; Fujita Toshihiko, 1997, National Science Museum Monographs, V12, P257; Fujita Toshihiko, 2005, National Science Museum Monographs, P357; Garstang W., 1922, Journal of the Linnean Society Zoology, V35, P81; Gould S. J., 1977, ONTOGENY PHYLOGENY; Haeckel E, 1866, ALLGEMEINE GRUNDZUGE, V1-2; HENDLER G, 1988, BIOL BULL, V174, P20, DOI 10.2307/1541755; HENDLER G, 1978, BIOL BULL, V154, P79, DOI 10.2307/1540776; HENNIG W, 1999, PHYLOGENETIC SYSTEMA; Irimura S., 1991, ECHINODERMS CONTINEN, P111; Irimura S, 2003, ECHINODERM RES 2001, P161; Kelly K, 2008, NATURE, V452, P939, DOI 10.1038/452939a; Klingenberg CP, 2013, SYST BIOL, V62, P591, DOI 10.1093/sysbio/syt025; Klingenberg CP, 1998, BIOL REV, V73, P79, DOI 10.1017/S000632319800512X; Koehler R., 1914, B US NATL MUSEUM, V84, P1, DOI DOI 10.5479/SI.03629236.84.1; Koehler R, 1922, B US NATL MUSEUM, V100, P1, DOI DOI 10.5962/BHL.TITLE.32917; KYTE M A, 1977, Proceedings of the Biological Society of Washington, V90, P55; Love AC, 2003, EVOL DEV, V5, P327, DOI 10.1046/j.1525-142X.2003.03040.x; Ludwig H., 1899, SB Ak Berlin, P210; Martin-Ledo R, 2013, POLAR BIOL, V36, P115, DOI 10.1007/s00300-012-1242-z; Martynov AV, 2012, PALEONTOL J+, V46, P833, DOI 10.1134/S0031030112080072; Martynov AV, 2010, ECHINODERMS: DURHAM, P233; Martynov A, 2015, J MOLLUS STUD, V81, P365, DOI 10.1093/mollus/eyv003; Martynov A, 2010, ZOOTAXA, P1; Martynov A, 2011, ZOOL J LINN SOC-LOND, V163, P585, DOI 10.1111/j.1096-3642.2011.00720.x; Martynov A, 2011, J MOLLUS STUD, V77, P129, DOI 10.1093/mollus/eyq047; Matsumoto, 1917, J COLL SCI IMP U TOK, V38, P1; McNamara K.J., 1989, Geobios Memoire Special (Villeurbanne), P283; MCNAMARA KJ, 1986, J PALEONTOL, V60, P4, DOI 10.1017/S0022336000021454; Minelli A, 2007, ZOOTAXA, P55, DOI 10.11646/zootaxa.1668.1.7; Minelli A, 2015, FRONT ECOL EVOL, V2, DOI 10.3389/fevo.2014.00085; MURAKAMI SHIRO, 1942, JOUR DEPT AGRIC KYUSYU IMP UNIV, V7, P1; Nishimura S., 1981, SEA LIFE EARTH INTRO; O'Hara Timothy D., 2006, Memoires du Museum National d'Histoire Naturelle, V193, P33; O'Hara TD, 2014, CURR BIOL, V24, P1874, DOI 10.1016/j.cub.2014.06.060; OGASAWARA K, 1994, PALAEOGEOGR PALAEOCL, V108, P335, DOI 10.1016/0031-0182(94)90241-0; Ohta S, 1988, B OCEAN RES I U TOKY, V15, P1; Paterson G.L.J., 1985, Bulletin of the British Museum (Natural History) Zoology, V49, P1; Piasecka B, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003476; Quint M, 2012, NATURE, V490, P98, DOI 10.1038/nature11394; Raff RA, 2000, NAT REV GENET, V1, P74, DOI 10.1038/35049594; RIDLEY M, 1986, EVOLUTION CLASSIFICA; Saito Hiroshi, 2009, National Museum of Nature and Science Monographs, P1; SCHOENER A, 1967, DEEP-SEA RES, V14, P645, DOI 10.1016/S0011-7471(67)80003-2; SCHOENER A, 1969, DEEP-SEA RES, V16, P127, DOI 10.1016/0011-7471(69)90069-2; Scotland RW, 2003, SYST BIOL, V52, P539, DOI 10.1080/10635150390223613; Stohr S, 2005, ZOOL J LINN SOC-LOND, V143, P543, DOI 10.1111/j.1096-3642.2005.00155.x; Stohr S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031940; Sumida PYG, 1998, ZOOL J LINN SOC-LOND, V124, P267, DOI 10.1111/j.1096-3642.1998.tb00577.x; Tajiri Rie, 2013, Taxa, V35, P24; Tsai CH, 2014, EVOL BIOL, V41, P299, DOI 10.1007/s11692-014-9269-4; VADON C, 1990, J NAT HIST, V24, P165, DOI 10.1080/00222939000770111; Wagele H, 2011, FRONT ZOOL, V8, DOI 10.1186/1742-9994-8-25; WEBB CM, 1985, MAR BIOL, V89, P281, DOI 10.1007/BF00393662; Webster M, 2005, PALEOBIOLOGY, V31, P354, DOI 10.1666/0094-8373(2005)031[0354:EMOOHA]2.0.CO;2; Wiens JJ, 2005, SYST BIOL, V54, P91, DOI 10.1080/10635150590906037; Wiley EO, 2011, PHYLOGENETICS THEORY; Winston JE, 1999, DESCRIBING SPECIES P; Wolfe JM, 2014, CLADISTICS, V30, P366, DOI 10.1111/cla.12051; Yang ZH, 2012, NAT REV GENET, V13, P303, DOI 10.1038/nrg3186	76	26	27	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2015	10	10							e0139463	10.1371/journal.pone.0139463	http://dx.doi.org/10.1371/journal.pone.0139463			42	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0DL	26509273	Green Submitted, Green Published, gold			2022-12-26	WOS:000363918100010
J	Menoret, A; Svedova, J; Behl, B; Vella, AT				Menoret, Antoine; Svedova, Julia; Behl, Bharat; Vella, Anthony T.			Trace Levels of Staphylococcal Enterotoxin Bioactivity Are Concealed in a Mucosal Niche during Pulmonary Inflammation	PLOS ONE			English	Article							TOXIC-SHOCK-SYNDROME; NECROTIZING ENTEROCOLITIS; BACTERIAL SUPERANTIGENS; AIRWAY INFLAMMATION; PROTEIN LACTOFERRIN; DEPENDENT AIRWAY; TRANSGENIC MICE; INNATE IMMUNITY; IFN-GAMMA; T-CELLS	Pathogen and cellular by-products released during infection or trauma are critical for initiating mucosal inflammation. The localization of these factors, their bioactivity and natural countermeasures remain unclear. This concept was studied in mice undergoing pulmonary inflammation after Staphylococcal enterotoxin A (SEA) inhalation. Highly purified bronchoalveolar lavage fluid (BALF) fractions obtained by sequential chromatography were screened for bioactivity and subjected to mass spectrometry. The Inflammatory and inhibitory potentials of the identified proteins were measured using T cells assays. A potent pro-inflammatory factor was detected in BALF, and we hypothesized SEA could be recovered with its biological activity. Highly purified BALF fractions with bioactivity were subjected to mass spectrometry. SEA was the only identified protein with known inflammatory potential, and unexpectedly, it co-purified with immunosuppressive proteins. Among them was lactoferrin, which inhibited SEA and anti-CD3/-CD28 stimulation by promoting T cell death and reducing TNF synthesis. Higher doses of lactoferrin were required to inhibit effector compared to resting T cells. Inhibition relied on the continual presence of lactoferrin rather than a programming event. The data show a fraction of bioactive SEA resided in a mucosal niche within BALF even after the initiation of inflammation. These results may have clinical value in human diagnostic since traces levels of SEA can be detected using a sensitive bioassay, and may help pinpoint potential mediators of lung inflammation when molecular approaches fail.	[Menoret, Antoine; Svedova, Julia; Behl, Bharat; Vella, Anthony T.] Univ Connecticut Hlth, Dept Immunol MC3710, Farmington, CT 06032 USA	University of Connecticut	Vella, AT (corresponding author), Univ Connecticut Hlth, Dept Immunol MC3710, 263 Farmington Ave, Farmington, CT 06032 USA.	vella@uchc.edu			National Institutes of Health [AI0142858, AI056172]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI056172, R01AI042858] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health AI0142858 (http://projectreporter. nih.gov/project_info_details.cfm?aid=8810630&icde=24503495&ddparam=&ddvalue=&ddsub=&cr=4&csb=default&cs=ASC), and National Institutes of Health AI056172 (http://projectreporter.nih.gov/project_info_details.cfm?aid=8862346&icde=24503495&ddparam=&ddvalue=&ddsub=&cr=5&csb=default& cs=ASC).	Actor JK, 2009, CURR PHARM DESIGN, V15, P1956, DOI 10.2174/138161209788453202; Aggarwal NR, 2014, AM J PHYSIOL-LUNG C, V306, pL709, DOI 10.1152/ajplung.00341.2013; Agrawal A, 2012, AM J PHYSIOL-LUNG C, V303, pL634, DOI 10.1152/ajplung.00195.2012; Borregaard N, 2007, TRENDS IMMUNOL, V28, P340, DOI 10.1016/j.it.2007.06.002; CORRIGAN CJ, 1988, LANCET, V1, P1129; DaSilva L, 2002, J INFECT DIS, V185, P1754, DOI 10.1086/340828; Degauque N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021240; FUKUI Y, 1993, IMMUNOGENETICS, V37, P204, DOI 10.1007/BF00191886; Guven M, 2013, OTOLARYNG HEAD NECK, V148, P302, DOI 10.1177/0194599812465586; Hayworth JL, 2009, CLIN EXP IMMUNOL, V157, P60, DOI 10.1111/j.1365-2249.2009.03963.x; Herz U, 1999, EUR J IMMUNOL, V29, P1021, DOI 10.1002/(SICI)1521-4141(199903)29:03<1021::AID-IMMU1021>3.0.CO;2-3; Highet AR, 2009, FEMS IMMUNOL MED MIC, V57, P151, DOI 10.1111/j.1574-695X.2009.00592.x; Huvenne W, 2013, INT ARCH ALLERGY IMM, V161, P304, DOI 10.1159/000350329; Jacobsen LC, 2008, J LEUKOCYTE BIOL, V83, P1155, DOI 10.1189/jlb.0706442; Krakauer T, 2013, VIRULENCE, V4, P759, DOI 10.4161/viru.23905; Kumar S, 2013, MUCOSAL IMMUNOL, V6, P1006, DOI 10.1038/mi.2012.138; Lee SJ, 2009, J LEUKOCYTE BIOL, V85, P175, DOI 10.1189/jlb.0408248; Legrand D, 2010, BIOMETALS, V23, P365, DOI 10.1007/s10534-010-9297-1; Lewis EC, 2006, P NATL ACAD SCI USA, V103, P16852, DOI 10.1073/pnas.0607917103; Mader JS, 2007, EXP CELL RES, V313, P2634, DOI 10.1016/j.yexcr.2007.05.015; Manzoni P, 2014, EARLY HUM DEV, V90, pS60, DOI 10.1016/S0378-3782(14)70020-9; McAleer JP, 2010, J LEUKOCYTE BIOL, V88, P21, DOI 10.1189/jlb.0909631; McCormick JK, 2001, ANNU REV MICROBIOL, V55, P77, DOI 10.1146/annurev.micro.55.1.77; Menoret A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040184; Menoret A, 2009, J IMMUNOL, V183, P7489, DOI 10.4049/jimmunol.0901414; Mino MJ, 2013, J BURN CARE RES, V34, P142, DOI 10.1097/BCR.0b013e31827778e3; Muralimohan G, 2008, J IMMUNOL, V181, P3698, DOI 10.4049/jimmunol.181.5.3698; Muralimohan G, 2008, INT ARCH ALLERGY IMM, V147, P59, DOI 10.1159/000128660; Ngoi SM, 2012, P NATL ACAD SCI USA, V109, P10486, DOI 10.1073/pnas.1202607109; Petitclerc D, 2007, J DAIRY SCI, V90, P2778, DOI 10.3168/jds.2006-598; Pickett TE, 2000, INFECT IMMUN, V68, P205, DOI 10.1128/IAI.68.1.205-213.2000; POSNETT DN, 1994, J EXP MED, V179, P609, DOI 10.1084/jem.179.2.609; Rajagopalan G, 2006, INFECT IMMUN, V74, P1284, DOI 10.1128/IAI.74.2.1284-1296.2006; Randolph AG, 2011, PEDIATRICS, V128, pE1450, DOI 10.1542/peds.2011-0774; Rasooly R, 2014, SENSORS-BASEL, V14, P8869, DOI 10.3390/s140508869; Rasooly R, 2009, FEMS IMMUNOL MED MIC, V56, P172, DOI 10.1111/j.1574-695X.2009.00561.x; Robinson KM, 2013, J IMMUNOL, V191, P5153, DOI 10.4049/jimmunol.1301237; Rudkjobing VB, 2014, J CYST FIBROS, V13, P645, DOI 10.1016/j.jcf.2014.02.008; Sherman MP, 2014, CURR OPIN PEDIATR, V26, P146, DOI 10.1097/MOP.0000000000000068; Suzuki YA, 2005, CELL MOL LIFE SCI, V62, P2560, DOI 10.1007/s00018-005-5371-1; ten Brinke A, 2005, EUR RESPIR J, V26, P812, DOI 10.1183/09031936.05.00037905; Tiedemann RE, 1995, P NATL ACAD SCI USA, V92, P12156, DOI 10.1073/pnas.92.26.12156; Nguyen T, 2012, CRIT CARE MED, V40, P3246, DOI 10.1097/CCM.0b013e318260c7f8; Tunceroglu H, 2013, IMMUNOL INVEST, V42, P247, DOI 10.3109/08820139.2012.750667; Turin CG, 2014, BIOMETALS, V27, P1007, DOI 10.1007/s10534-014-9754-3; UNKELESS JC, 1979, J EXP MED, V150, P580, DOI 10.1084/jem.150.3.580; VELLA AT, 1995, IMMUNITY, V2, P261, DOI 10.1016/1074-7613(95)90050-0; Younis RT, 1996, ARCH OTOLARYNGOL, V122, P83	48	1	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2015	10	10							e0141548	10.1371/journal.pone.0141548	http://dx.doi.org/10.1371/journal.pone.0141548			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0DL	26509442	Green Published, gold, Green Submitted			2022-12-26	WOS:000363918100101
J	Mentiplay, BF; Perraton, LG; Bower, KJ; Adair, B; Pua, YH; Williams, GP; McGaw, R; Clark, RA				Mentiplay, Benjamin F.; Perraton, Luke G.; Bower, Kelly J.; Adair, Brooke; Pua, Yong-Hao; Williams, Gavin P.; McGaw, Rebekah; Clark, Ross A.			Assessment of Lower Limb Muscle Strength and Power Using Hand-Held and Fixed Dynamometry: A Reliability and Validity Study	PLOS ONE			English	Article							TEST-RETEST RELIABILITY; FORCE DEVELOPMENT; FUNCTIONAL PERFORMANCE; CEREBRAL-PALSY; NEUROMUSCULAR PERFORMANCE; HIP OSTEOARTHRITIS; STROKE; KNEE; ADULTS; ASSOCIATION	Introduction Hand-held dynamometry (HHD) has never previously been used to examine isometric muscle power. Rate of force development (RFD) is often used for muscle power assessment, however no consensus currently exists on the most appropriate method of calculation. The aim of this study was to examine the reliability of different algorithms for RFD calculation and to examine the intra-rater, inter-rater, and inter-device reliability of HHD as well as the concurrent validity of HHD for the assessment of isometric lower limb muscle strength and power. Methods 30 healthy young adults (age: 23 +/- 5yrs, male: 15) were assessed on two sessions. Isometric muscle strength and power were measured using peak force and RFD respectively using two HHDs (Lafayette Model-01165 and Hoggan microFET2) and a criterion-reference KinCom dynamometer. Statistical analysis of reliability and validity comprised intraclass correlation coefficients (ICC), Pearson correlations, concordance correlations, standard error of measurement, and minimal detectable change. Results Comparison of RFD methods revealed that a peak 200ms moving window algorithm provided optimal reliability results. Intra-rater, inter-rater, and inter-device reliability analysis of peak force and RFD revealed mostly good to excellent reliability (coefficients >= 0.70) for all muscle groups. Concurrent validity analysis showed moderate to excellent relationships between HHD and fixed dynamometry for the hip and knee (ICCs >= 0.70) for both peak force and RFD, with mostly poor to good results shown for the ankle muscles (ICCs = 0.31-0.79). Conclusions Hand-held dynamometry has good to excellent reliability and validity for most measures of isometric lower limb strength and power in a healthy population, particularly for proximal muscle groups. To aid implementation we have created freely available software to extract these variables from data stored on the Lafayette device. Future research should examine the reliability and validity of these variables in clinical populations.	[Mentiplay, Benjamin F.; Perraton, Luke G.; Bower, Kelly J.; McGaw, Rebekah; Clark, Ross A.] Australian Catholic Univ, Fac Hlth Sci, Sch Exercise Sci, Melbourne, Vic, Australia; [Adair, Brooke] Australian Catholic Univ, Fac Hlth Sci, Sch Allied Hlth, Melbourne, Vic, Australia; [Pua, Yong-Hao] Singapore Gen Hosp, Dept Physiotherapy, Singapore, Singapore; [Williams, Gavin P.] Epworth Healthcare, Dept Physiotherapy, Melbourne, Vic, Australia; [Williams, Gavin P.] Univ Melbourne, Fac Med Denistry & Hlth Sci, Sch Physiotherapy, Melbourne, Vic, Australia	Australian Catholic University; Australian Catholic University; Singapore General Hospital; University of Melbourne	Clark, RA (corresponding author), Australian Catholic Univ, Fac Hlth Sci, Sch Exercise Sci, Melbourne, Vic, Australia.	ross.clark@acu.edu.au	Clark, Ross A/R-5664-2018; Clark, Ross/K-7613-2019; Adair, Brooke/N-8959-2017; Mentiplay, Benjamin/A-2279-2019; Perraton, Luke/AAE-1788-2022	Clark, Ross A/0000-0002-7291-8553; Clark, Ross/0000-0002-7291-8553; Adair, Brooke/0000-0001-8389-2347; Mentiplay, Benjamin/0000-0002-4360-8310; Pua, Yong-Hao/0000-0003-2313-9665; Perraton, Luke Geoffrey/0000-0003-3854-1390; McGaw, Rebekah/0000-0001-5931-3333; Williams, Gavin/0000-0003-2758-7473				Aagaard P, 2010, SCAND J MED SCI SPOR, V20, P49, DOI 10.1111/j.1600-0838.2009.01084.x; Aagaard P, 2002, J APPL PHYSIOL, V93, P1318, DOI 10.1152/japplphysiol.00283.2002; Alemany JA, 2005, J STRENGTH COND RES, V19, P33; Andersen LL, 2010, SCAND J MED SCI SPOR, V20, pE162, DOI 10.1111/j.1600-0838.2009.00933.x; Andersen LL, 2006, EUR J APPL PHYSIOL, V96, P46, DOI 10.1007/s00421-005-0070-z; Arnold CM, 2010, J STRENGTH COND RES, V24, P815, DOI 10.1519/JSC.0b013e3181aa36b8; Bandinelli S, 1999, AGING-CLIN EXP RES, V11, P287, DOI 10.1007/BF03339802; BASSEY EJ, 1992, CLIN SCI, V82, P321, DOI 10.1042/cs0820321; BEMBEN M G, 1991, Medicine and Science in Sports and Exercise, V23, P1302; Blazevich AJ, 2008, MUSCLE NERVE, V38, P1133, DOI 10.1002/mus.21021; Bohannon RW, 2012, ISOKINET EXERC SCI, V20, P301, DOI 10.3233/IES-2012-0476; BOHANNON RW, 1986, PHYS THER, V66, P206, DOI 10.1093/ptj/66.2.206; BOHANNON RW, 1992, ARCH PHYS MED REHAB, V73, P721; Caserotti P, 2008, SCAND J MED SCI SPOR, V18, P773, DOI 10.1111/j.1600-0838.2007.00732.x; DAVIES CTM, 1983, EUR J APPL PHYSIOL, V51, P37, DOI 10.1007/BF00952535; Doherty TJ, 2003, J APPL PHYSIOL, V95, P1717, DOI 10.1152/japplphysiol.00347.2003; Fimland MS, 2011, EUR J APPL PHYSIOL, V111, P3041, DOI 10.1007/s00421-011-1934-z; FLEMING BE, 1991, ARCH PHYS MED REHAB, V72, P886, DOI 10.1016/0003-9993(91)90006-5; Foldvari M, 2000, J GERONTOL A-BIOL, V55, pM192, DOI 10.1093/gerona/55.4.M192; Fulcher ML, 2010, J SCI MED SPORT, V13, P80, DOI 10.1016/j.jsams.2008.11.007; Garnacho-Castano MV, 2015, J SPORT SCI MED, V14, P128; Gerrits KH, 2009, ARCH PHYS MED REHAB, V90, P480, DOI 10.1016/j.apmr.2008.09.562; Izquierdo M, 1999, EUR J APPL PHYSIOL, V79, P260, DOI 10.1007/s004210050504; KAMINSKI TW, 1995, J SPORT REHABIL, V4, P210; Kelln BM, 2008, J SPORT REHABIL, V17, P160, DOI 10.1123/jsr.17.2.160; Kolber MJ, 2005, PHYS THER REV, V10, P99, DOI 10.1179/108331905X55730; Korhonen MT, 2006, J APPL PHYSIOL, V101, P906, DOI 10.1152/japplphysiol.00299.2006; Kyrolainen H, 2005, SCAND J MED SCI SPOR, V15, P58, DOI 10.1111/j.1600-0838.2004.00390.x; Ludbrook J, 2010, CLIN EXP PHARMACOL P, V37, P143, DOI 10.1111/j.1440-1681.2009.05288.x; Maffiuletti NA, 2010, CLIN ORTHOP RELAT R, V468, P191, DOI 10.1007/s11999-009-0978-4; Malliaras P, 2009, BRIT J SPORT MED, V43, P739, DOI 10.1136/bjsm.2008.055749; Marmon AR, 2013, INT J SPORTS PHYS TH, V8, P820; McMaster DT, 2014, SPORTS MED, V44, P603, DOI 10.1007/s40279-014-0145-2; Mentiplay BF, 2015, BRAIN INJURY, V29, P409, DOI 10.3109/02699052.2014.995231; Moreau NG, 2012, GAIT POSTURE, V35, P154, DOI 10.1016/j.gaitpost.2011.08.027; Moriello C, 2006, ARCH PHYS MED REHAB, V87, P1490, DOI 10.1016/j.apmr.2006.07.261; Pijnappels M, 2008, EUR J APPL PHYSIOL, V102, P585, DOI 10.1007/s00421-007-0613-6; Portney LG, 2009, FDN CLIN RES APPL PR, V3rd, DOI DOI 10.1016/S0039-6257(02)00362-4; Poulsen E, 2012, BMC MUSCULOSKEL DIS, V13, DOI 10.1186/1471-2474-13-242; Pua YH, 2008, ARCH PHYS MED REHAB, V89, P1146, DOI 10.1016/j.apmr.2007.10.028; Richardson Julie, 1998, Physiotherapy Theory and Practice, V14, P49, DOI 10.3109/09593989809070043; Skelton DA, 2002, AGE AGEING, V31, P119, DOI 10.1093/ageing/31.2.119; SLEIVERT GG, 1994, ARCH PHYS MED REHAB, V75, P1315; Stark T, 2011, PM&R, V3, P472, DOI 10.1016/j.pmrj.2010.10.025; Suetta C, 2004, J APPL PHYSIOL, V97, P1954, DOI 10.1152/japplphysiol.01307.2003; Taylor NF, 2004, ARCH PHYS MED REHAB, V85, P77, DOI 10.1016/S0003-9993(03)00379-4; Terwee CB, 2012, QUAL LIFE RES, V21, P651, DOI 10.1007/s11136-011-9960-1; Thorborg K, 2010, SCAND J MED SCI SPOR, V20, P493, DOI 10.1111/j.1600-0838.2009.00958.x; TRUDELLEJACKSON E, 1994, J ORTHOP SPORT PHYS, V20, P302, DOI 10.2519/jospt.1994.20.6.302; Vanpee G, 2011, CRIT CARE MED, V39, P1929, DOI 10.1097/CCM.0b013e31821f050b; Villadsen A, 2012, AM J PHYS MED REHAB, V91, P401, DOI 10.1097/PHM.0b013e3182465ed0; WIKHOLM J B, 1991, Journal of Orthopaedic and Sports Physical Therapy, V13, P191; Wiley ME, 1998, DEV MED CHILD NEUROL, V40, P100, DOI 10.1111/j.1469-8749.1998.tb15369.x; WINTER DA, 1983, CLIN ORTHOP RELAT R, P147; Winters JD, 2014, EUR J APPL PHYSIOL, V114, P273, DOI 10.1007/s00421-013-2759-8	55	198	201	7	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2015	10	10							e0140822	10.1371/journal.pone.0140822	http://dx.doi.org/10.1371/journal.pone.0140822			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0DL	26509265	Green Submitted, Green Published, gold			2022-12-26	WOS:000363918100040
J	Salo, PP; Vaara, S; Kettunen, J; Pirinen, M; Sarin, AP; Huikuri, H; Karhunen, PJ; Eskola, M; Nikus, K; Lokki, ML; Ripatti, S; Havulinna, AS; Salomaa, V; Palotie, A; Nieminen, MS; Sinisalo, J; Perola, M				Salo, Perttu P.; Vaara, Satu; Kettunen, Johannes; Pirinen, Matti; Sarin, Antti-Pekka; Huikuri, Heikki; Karhunen, Pekka J.; Eskola, Markku; Nikus, Kjell; Lokki, Marja-Liisa; Ripatti, Samuli; Havulinna, Aki S.; Salomaa, Veikko; Palotie, Aarno; Nieminen, Markku S.; Sinisalo, Juha; Perola, Markus			Genetic Variants on Chromosome 1p13.3 Are Associated with Non-ST Elevation Myocardial Infarction and the Expression of DRAM2 in the Finnish Population	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; UNIVERSAL DEFINITION; GENOTYPE IMPUTATION; RISK; AUTOPHAGY; LOCI; SUSCEPTIBILITY; SET	Myocardial infarction (MI) is divided into either ST elevation MI (STEMI) or non-ST elevation MI (NSTEMI), differing in a number of clinical characteristics. We sought to identify genetic variants conferring risk to NSTEMI or STEMI by conducting a genome-wide association study (GWAS) of MI stratified into NSTEMI and STEMI in a consecutive sample of 1,579 acute MI cases with 1,576 controls. Subsequently, we followed the results in an independent population-based sample of 562 cases and 566 controls, a partially independent prospective cohort (N = 16,627 with 163 incident NSTEMI cases), and examined the effect of disease-associated variants on gene expression in 513 healthy participants. Genetic variants on chromosome 1p13.3 near the damage-regulated autophagy modulator 2 gene DRAM2 associated with NSTEMI (rs656843; odds ratio 1.57, P = 3.11 x 10(-10)) in the case-control analysis with a consistent but not statistically significant effect in the prospective cohort (rs656843; hazard ratio 1.13, P = 0.43). These variants were not associated with STEMI (rs656843; odds ratio, 1.11, P = 0.20; hazard ratio 0.97, P = 0.87), appearing to have a pronounced effect on NSTEMI risk. A majority of the variants at 1p13.3 associated with NSTEMI were also associated with the expression level of DRAM2 in blood leukocytes of healthy controls (top-ranked variant rs325927, P = 1.50 x 10(-12)). The results suggest that genetic factors may in part influence whether coronary artery disease results in NSTEMI rather than STEMI.	[Salo, Perttu P.; Kettunen, Johannes; Perola, Markus] Natl Inst Hlth & Welf, Dept Hlth, Genom & Biomarkers Unit, Helsinki, Finland; [Salo, Perttu P.; Kettunen, Johannes; Pirinen, Matti; Sarin, Antti-Pekka; Ripatti, Samuli; Palotie, Aarno; Perola, Markus] Univ Helsinki, Inst Mol Med Finland FIMM, Helsinki, Finland; [Salo, Perttu P.] Univ Helsinki, Cent Hosp, Childrens Hosp, Helsinki, Finland; [Vaara, Satu; Nieminen, Markku S.; Sinisalo, Juha] Univ Helsinki, Cent Hosp, Heart & Lung Ctr HUS, Div Cardiol, Helsinki, Finland; [Huikuri, Heikki] Univ Cent Hosp, Dept Internal Med, Inst Clin Med, Oulu, Finland; [Huikuri, Heikki] Univ Oulu, Oulu, Finland; [Karhunen, Pekka J.; Eskola, Markku; Nikus, Kjell] Univ Tampere, Sch Med, FIN-33101 Tampere, Finland; [Karhunen, Pekka J.] Tampere Univ, Hosp Reg, Fimlab Labs Ltd, FIN-33101 Tampere, Finland; [Eskola, Markku; Nikus, Kjell] Tampere Univ Hosp, Ctr Heart, Tampere, Finland; [Lokki, Marja-Liisa] Univ Helsinki, Haartman Inst, Transplantat Lab, Helsinki, Finland; [Havulinna, Aki S.; Salomaa, Veikko] Natl Inst Hlth & Welf, Hlth Monitoring Unit, Dept Hlth, Helsinki, Finland; [Palotie, Aarno] Wellcome Trust Sanger Inst, Cambridge, England; [Palotie, Aarno] Broad Inst, Cambridge, MA USA; [Perola, Markus] Univ Tartu, Estonian Genome Ctr, EE-50090 Tartu, Estonia	Finland National Institute for Health & Welfare; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; Helsinki University Central Hospital; University of Oulu; Tampere University; Tampere University; Tampere University; Tampere University Hospital; University of Helsinki; Finland National Institute for Health & Welfare; Wellcome Trust Sanger Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of Tartu	Salo, PP (corresponding author), Natl Inst Hlth & Welf, Dept Hlth, Genom & Biomarkers Unit, Helsinki, Finland.	perttu.salo@thl.fi	Havulinna, Aki/AAM-4769-2021; Nikus, Kjell/K-7813-2019	Pirinen, Matti/0000-0002-1664-1350; Palotie, Aarno/0000-0002-2527-5874; Sinisalo, Juha/0000-0002-0169-5137; Nikus, Kjell/0000-0002-9345-9851	Aarne Koskelo Foundation; Helsinki University Central Hospital; Tampere University Hospital special government funds (EVO); Finnish Foundation for Cardiovascular research; Academy of Finland; Finnish Funding Agency for Technology and Innovation; Integrative Life Science Doctoral Program of the University of Helsinki; Medical Research Fund of Tampere University Hospital; Pirkanmaa Regional Fund of the Finnish Cultural Foundation; Sigrid Juselius Foundation; Academy of Finland [139635]; Finnish Foundation for Cardiovascular Diseases; Finnish Academy [129388, 269517]; EU [313010, 305280, 261433]; Yrjo Jahnsson Foundation; Juho Vainio Foundation; Aarne Koskelo Foundation; Helsinki University Central Hospital; Tampere University Hospital special government funds (EVO); Finnish Foundation for Cardiovascular research; Academy of Finland; Finnish Funding Agency for Technology and Innovation; Integrative Life Science Doctoral Program of the University of Helsinki; Medical Research Fund of Tampere University Hospital; Pirkanmaa Regional Fund of the Finnish Cultural Foundation; Sigrid Juselius Foundation; Academy of Finland [139635]; Finnish Foundation for Cardiovascular Diseases; Finnish Academy [129388, 269517]; EU [313010, 305280, 261433]; Yrjo Jahnsson Foundation; Juho Vainio Foundation	Aarne Koskelo Foundation; Helsinki University Central Hospital; Tampere University Hospital special government funds (EVO); Finnish Foundation for Cardiovascular research; Academy of Finland(Academy of Finland); Finnish Funding Agency for Technology and Innovation(Finnish Funding Agency for Technology & Innovation (TEKES)); Integrative Life Science Doctoral Program of the University of Helsinki; Medical Research Fund of Tampere University Hospital; Pirkanmaa Regional Fund of the Finnish Cultural Foundation; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Academy of Finland(Academy of Finland); Finnish Foundation for Cardiovascular Diseases; Finnish Academy(Academy of Finland); EU(European Commission); Yrjo Jahnsson Foundation; Juho Vainio Foundation; Aarne Koskelo Foundation; Helsinki University Central Hospital; Tampere University Hospital special government funds (EVO); Finnish Foundation for Cardiovascular research; Academy of Finland(Academy of Finland); Finnish Funding Agency for Technology and Innovation(Finnish Funding Agency for Technology & Innovation (TEKES)); Integrative Life Science Doctoral Program of the University of Helsinki; Medical Research Fund of Tampere University Hospital; Pirkanmaa Regional Fund of the Finnish Cultural Foundation; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Academy of Finland(Academy of Finland); Finnish Foundation for Cardiovascular Diseases; Finnish Academy(Academy of Finland); EU(European Commission); Yrjo Jahnsson Foundation; Juho Vainio Foundation	This work was supported by grants from Aarne Koskelo Foundation, Helsinki University Central Hospital, Tampere University Hospital special government funds (EVO), the Finnish Foundation for Cardiovascular research, the Academy of Finland, and the Finnish Funding Agency for Technology and Innovation. PPS was supported by the Integrative Life Science Doctoral Program of the University of Helsinki. PJK has been supported by the Medical Research Fund of Tampere University Hospital, Pirkanmaa Regional Fund of the Finnish Cultural Foundation and the Finnish Foundation for Cardiovascular Research. HH is supported by the Sigrid Juselius Foundation. VS is supported by the Academy of Finland [grant #139635] and the Finnish Foundation for Cardiovascular Diseases. MSN is partly financially supported for this work by the Finnish Academy [grant #129388]. MP (Markus Perola) is partly financially supported for this work by the EU FP7 under grant agreements nr. 313010 (BBMRI-LPC), nr. 305280 (MIMOmics), and nr. 261433 (BioSHaRE-EU), the Finnish Academy grant no. 269517, the Yrjo Jahnsson Foundation, and the Juho Vainio Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, CATALOG PUBLISHED GE; Bassand JP, 2007, EUR HEART J, V28, P1598, DOI 10.1093/eurheartj/ehm161; Bellenguez C, 2012, NAT GENET, V44, P328, DOI 10.1038/ng.1081; Chambers JC, 2011, NAT GENET, V43, P1131, DOI 10.1038/ng.970; Cunningham F, 2015, NUCLEIC ACIDS RES, V43, pD662, DOI 10.1093/nar/gku1010; Delaneau O, 2012, NAT METHODS, V9, P179, DOI [10.1038/NMETH.1785, 10.1038/nmeth.1785]; Gottlieb RA, 2010, ANNU REV PHYSIOL, V72, P45, DOI 10.1146/annurev-physiol-021909-135757; Helgadottir A, 2007, SCIENCE, V316, P1491, DOI 10.1126/science.1142842; Hong YJ, 2010, J CARDIOL, V56, P15, DOI 10.1016/j.jjcc.2010.01.010; Howie B, 2011, G3-GENES GENOM GENET, V1, P457, DOI 10.1534/g3.111.001198; Inouye M, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.93; Kathiresan S, 2012, CELL, V148, P1242, DOI 10.1016/j.cell.2012.03.001; Langholz B, 1996, STAT SCI, V11, P35; Lappalainen T, 2013, NATURE, V501, P506, DOI 10.1038/nature12531; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Magi R, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-288; Marchini J, 2010, NAT REV GENET, V11, P499, DOI 10.1038/nrg2796; Montalescot G, 2007, EUR HEART J, V28, P1409, DOI 10.1093/eurheartj/ehm031; Nikus KC, 2007, ANN MED, V39, P63, DOI 10.1080/08037060600997534; O'Prey J, 2009, CELL CYCLE, V8, P2260, DOI 10.4161/cc.8.14.9050; Park HW, 2013, INT J CARDIOL, V169, P254, DOI 10.1016/j.ijcard.2013.08.132; Park SM, 2009, BIOCHEM BIOPH RES CO, V390, P1340, DOI 10.1016/j.bbrc.2009.10.149; Peden JF, 2011, NAT GENET, V43, P339, DOI 10.1038/ng.782; Pirinen M, 2012, NAT GENET, V44, P848, DOI 10.1038/ng.2346; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; R Core Team, 2021, R LANGUAGE ENV STAT; Reilly MP, 2011, LANCET, V377, P383, DOI 10.1016/S0140-6736(10)61996-4; Rott D, 2006, AM J CARDIOL, V98, P10, DOI 10.1016/j.amjcard.2006.01.043; Rotter D, 2012, PHARMACOL RES, V66, P494, DOI 10.1016/j.phrs.2012.10.001; Sarafoff N, 2013, J ELECTROCARDIOL, V46, P100, DOI 10.1016/j.jelectrocard.2012.12.017; Schunkert H, 2011, NAT GENET, V43, P333, DOI [10.1038/ng.784, 10.1161/CIRCGENETICS.111.960443]; Stone GW, 2001, CIRCULATION, V104, P636, DOI 10.1161/hc3101.093701; Therneau T.M., 2000, MODELING SURVIVAL DA; Thygesen K, 2007, CIRCULATION, V116, P2634, DOI 10.1161/CIRCULATIONAHA.107.187397; Thygesen K, 2012, J AM COLL CARDIOL, V60, P1581, DOI 10.1016/j.jacc.2012.08.001; Toutouzas K, 2011, AM HEART J, V161, P1192, DOI 10.1016/j.ahj.2011.03.005; Vaara S, 2012, INT J EPIDEMIOL, V41, P1265, DOI 10.1093/ije/dyr090; Vartiainen E, 2000, INT J EPIDEMIOL, V29, P49, DOI 10.1093/ije/29.1.49; Vartiainen E, 2010, INT J EPIDEMIOL, V39, P504, DOI 10.1093/ije/dyp330; Willer CJ, 2008, NAT GENET, V40, P161, DOI 10.1038/ng.76; Wirawan E, 2012, CELL RES, V22, P43, DOI 10.1038/cr.2011.152; Yoon JH, 2012, MOL BIOL REP, V39, P1087, DOI 10.1007/s11033-011-0835-x; Zdravkovic S, 2007, TWIN RES HUM GENET, V10, P848, DOI 10.1375/twin.10.6.848; Zhao XQ, 1999, CIRCULATION, V100, P1609, DOI 10.1161/01.CIR.100.15.1609	45	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2015	10	10							e0140576	10.1371/journal.pone.0140576	http://dx.doi.org/10.1371/journal.pone.0140576			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0DL	26509668	Green Submitted, Green Published, gold			2022-12-26	WOS:000363918100034
J	Singh, BP; Fang, YY; Boersma, M; Collins, D; Van Zwieten, L; Macdonald, LM				Singh, Bhupinder Pal; Fang, Yunying; Boersma, Mark; Collins, Damian; Van Zwieten, Lukas; Macdonald, Lynne M.			In Situ Persistence and Migration of Biochar Carbon and Its Impact on Native Carbon Emission in Contrasting Soils under Managed Temperate Pastures	PLOS ONE			English	Article							BLACK CARBON; ORGANIC-MATTER; PYROGENIC CARBON; WHEAT-STRAW; STABILITY; MINERALIZATION; DECOMPOSITION; GRASSLAND; MOBILITY; CLIMATE	Pyrogenic carbon (PyC) is an important component of the global soil carbon (C) pool, but its fate, persistence, and loss dynamics in contrasting soils and environments under planted field conditions are poorly understood. To fill this knowledge gap, a C-13-labelled biochar, as a surrogate material for PyC, produced from Eucalyptus saligna by slow pyrolysis (450 degrees C; delta C-13 - 36.7%) was surface (0-10 cm) applied in C-3 dominated temperate pasture systems across Arenosol, Cambisol and Ferralsol. The results show a low proportion of the applied biochar-C mineralised over 12 months in a relatively clay- and C-poor Arenosol (i.e., 2.0% loss via mineralisation), followed by a clay- and C-rich Cambisol (4.6%), and clay-, C-and earthworm-rich Ferralsol (7.0%). The biochar-C mean residence time (MRT), estimated by different models, varied between 44 - 1079 (Arenosol), 18 - 172 (Cambisol), and 11 - 29 (Ferralsol) years, with the shorter MRT estimated by a one-pool exponential and the longer MRT by an infinite-pool power or a two-pool exponential model. The two-pool model was best fitted to biochar-C mineralisation. The biochar-C recovery in the 12 - 30 cm soil layer varied from between 1.2% (Arenosol), 2.5 - 2.7% (Cambisol) and 13.8 - 15.7% (Ferralsol) of the applied biochar-C after 8 - 12 months. There was a further migration of biochar-C below the 50-cm depth in the Arenosol, as the combined biochar-C recovery in the mineralised pool and soil profile (up to 30 or 50 cm) was 82%, in contrast to 101% in the Cambisol and 104% in the Ferralsol after 12 months. These results indicate that the downward migration of biochar-C was greatest in the Arenosol (cf. Cambisol and Ferralsol). Cumulative CO2-C emission from native soil-plant sources was lower (p < 0.10) in the biochar-amended vs. non-amended Ferralsol. This field-based study shows that the downward migration of biochar-C exceeded its loss via mineralisation in the Arenosol and Ferralsol, but not in the Cambisol. It is thus important to understand biochar-soil interactions to maximise long-term biochar C sequestration potential in planted soil systems.	[Singh, Bhupinder Pal; Fang, Yunying; Collins, Damian] Elizabeth Macarthur Agr Inst, NSW Dept Primary Ind, Menangle, NSW 2568, Australia; [Boersma, Mark] Univ Tasmania, Tasmanian Inst Agr, Burnie, Tas 7320, Australia; [Van Zwieten, Lukas] Wollongbar Primary Ind Inst, NSW Dept Primary Ind, Wollongbar, NSW 2477, Australia; [Macdonald, Lynne M.] CSIRO Agr, Glen Osmond, SA 5064, Australia	NSW Department of Primary Industries; University of Tasmania; NSW Department of Primary Industries; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Singh, BP (corresponding author), Elizabeth Macarthur Agr Inst, NSW Dept Primary Ind, Menangle, NSW 2568, Australia.	bp.singh@dpi.nsw.gov.au	Macdonald, Lynne M/D-6969-2013; Collins, Damian/AAN-1432-2020; Singh, Bhupinder Pal/D-8670-2017; Boersma, Mark/D-4307-2009; Fang, Yunying/AAU-7401-2021; Van Zwieten, Lukas/U-8486-2018; Fang, Yunying/AAD-8472-2019	Singh, Bhupinder Pal/0000-0003-1952-9070; Boersma, Mark/0000-0002-8501-7412; Van Zwieten, Lukas/0000-0002-8832-360X; Fang, Yunying/0000-0001-6531-0657; Kirton, Jennifer/0000-0001-7992-7164	Australian Department of Agriculture (under their Biochar Capacity Building Program); NSW Department of Primary Industries; University of Tasmania	Australian Department of Agriculture (under their Biochar Capacity Building Program)(Australian GovernmentDepartment of Agriculture and Water Resources); NSW Department of Primary Industries; University of Tasmania	This research was funded to BPS, MB, LVZ, and LMM by the Australian Department of Agriculture (under their Biochar Capacity Building Program). This research was also funded to BPS by the NSW Department of Primary Industries and to MB by the University of Tasmania. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ameloot N, 2013, EUR J SOIL SCI, V64, P379, DOI 10.1111/ejss.12064; Baldock JA, 2013, SOIL RES, V51, P577, DOI 10.1071/SR13077; Barton CVM, 2010, AGR FOREST METEOROL, V150, P941, DOI 10.1016/j.agrformet.2010.03.001; Bird MI, 1999, GLOBAL BIOGEOCHEM CY, V13, P923, DOI 10.1029/1999GB900067; BIRD MI, 1995, INTERDISCIPL SCI REV, V20, P141; Brodowski S, 2007, GEODERMA, V139, P220, DOI 10.1016/j.geoderma.2007.02.004; Bruun S, 2014, EUR J SOIL SCI, V65, P52, DOI 10.1111/ejss.12073; Cayuela ML, 2014, AGR ECOSYST ENVIRON, V191, P5, DOI 10.1016/j.agee.2013.10.009; Chan KY, 2008, AUST J SOIL RES, V46, P437, DOI 10.1071/SR08036; Clements B, GRAZIERS GUIDE PASTU; Fang Y, 2014, EUR J SOIL SCI, V65, P60, DOI 10.1111/ejss.12094; Fang YY, 2015, SOIL BIOL BIOCHEM, V80, P136, DOI 10.1016/j.soilbio.2014.10.006; Fang YY, 2014, AGR ECOSYST ENVIRON, V191, P158, DOI 10.1016/j.agee.2014.02.018; FAO, 2020, SOILS PORTAL WORLD R; Fierer N, 2003, SOIL BIOL BIOCHEM, V35, P167, DOI 10.1016/S0038-0717(02)00251-1; Fontaine S, 2007, NATURE, V450, P277, DOI 10.1038/nature06275; GenStat, 2020, GENSTAT WINDOWS, V9th ed.; Glaser B, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2002GB002019; Goldberg E.D., 1985, BLACK CARBON ENV PRO; Guggenberger G, 2008, GLOBAL CHANGE BIOL, V14, P1367, DOI 10.1111/j.1365-2486.2008.01568.x; Haefele SM, 2011, FIELD CROP RES, V121, P430, DOI 10.1016/j.fcr.2011.01.014; Hamer U, 2004, ORG GEOCHEM, V35, P823, DOI 10.1016/j.orggeochem.2004.03.003; Hilscher A, 2011, SOIL BIOL BIOCHEM, V43, P261, DOI 10.1016/j.soilbio.2010.10.007; Hockaday WC, 2007, GEOCHIM COSMOCHIM AC, V71, P3432, DOI 10.1016/j.gca.2007.02.023; Hogue BA, 2012, SCI TOTAL ENVIRON, V431, P9, DOI 10.1016/j.scitotenv.2012.04.074; Isbell R.F., 2002, AUSTR SOIL CLASSIFIC; Jaffe R, 2013, SCIENCE, V340, P345, DOI 10.1126/science.1231476; Jobbagy EG, 2000, ECOL APPL, V10, P423, DOI 10.1890/1051-0761(2000)010[0423:TVDOSO]2.0.CO;2; Jones MB, 2004, NEW PHYTOL, V164, P423, DOI 10.1111/j.1469-8137.2004.01201.x; Joseph SD, 2010, AUST J SOIL RES, V48, P501, DOI 10.1071/SR10009; Kaal J, 2008, QUATERNARY RES, V69, P56, DOI 10.1016/j.yqres.2007.10.005; Kabuyah RNTM, 2012, SOIL BIOL BIOCHEM, V45, P128, DOI 10.1016/j.soilbio.2011.10.014; Keith A, 2011, ENVIRON SCI TECHNOL, V45, P9611, DOI 10.1021/es202186j; Knicker H, 2013, SOIL BIOL BIOCHEM, V56, P31, DOI 10.1016/j.soilbio.2012.02.021; Kuzyakov Y, 2009, SOIL BIOL BIOCHEM, V41, P210, DOI 10.1016/j.soilbio.2008.10.016; Kuzyakov Y, 2014, SOIL BIOL BIOCHEM, V70, P229, DOI 10.1016/j.soilbio.2013.12.021; Kuzyakov Y, 2010, SOIL BIOL BIOCHEM, V42, P1363, DOI 10.1016/j.soilbio.2010.04.003; Lal R, 2004, GEODERMA, V123, P1, DOI 10.1016/j.geoderma.2004.01.032; Lehmann J., 2006, Mitigation and Adaptation Strategies for Global Change, V11, P403, DOI 10.1007/s11027-005-9006-5; Lehmann J., 2015, BIOCHAR ENV MANAGEME, DOI [10.4324/9780203762264, DOI 10.4324/9780203762264]; Lehmann J, 2015, BIOCHAR ENV MANAGEME, P235, DOI [10.4324/9780203762264, DOI 10.4324/9780203762264]; Lehmann J., 2009, SCI TECHNOL HUM VAL, DOI 10.4324/9781849770552; Lehmann J, 2011, SOIL BIOL BIOCHEM, V43, P1812, DOI 10.1016/j.soilbio.2011.04.022; Leifeld J, 2007, BIOGEOSCIENCES, V4, P425, DOI 10.5194/bg-4-425-2007; Lin Y, 2012, PLANT SOIL, V357, P369, DOI 10.1007/s11104-012-1169-8; Luo Y, 2011, SOIL BIOL BIOCHEM, V43, P2304, DOI 10.1016/j.soilbio.2011.07.020; Maestrini B, 2014, BIOGEOSCIENCES DISCU, V11, P1, DOI DOI 10.5194/BGD-11-1-2014; Major J, 2009, BIOCHAR ENV MANAGEME, P271; Major J, 2010, PLANT SOIL, V333, P117, DOI 10.1007/s11104-010-0327-0; Major J, 2010, GLOBAL CHANGE BIOL, V16, P1366, DOI 10.1111/j.1365-2486.2009.02044.x; Naisse C, 2015, GCB BIOENERGY, V7, P488, DOI 10.1111/gcbb.12158; Nguyen BT, 2010, ENVIRON SCI TECHNOL, V44, P3324, DOI 10.1021/es903016y; Nguyen BT, 2009, ORG GEOCHEM, V40, P846, DOI 10.1016/j.orggeochem.2009.05.004; Preston CM, 2006, BIOGEOSCIENCES, V3, P397, DOI 10.5194/bg-3-397-2006; Qayyum MF, 2012, J ENVIRON QUAL, V41, P1210, DOI 10.2134/jeq2011.0058; Quin PR, 2014, AGR ECOSYST ENVIRON, V191, P142, DOI 10.1016/j.agee.2014.03.022; Rumpel C, 2006, CATENA, V65, P30, DOI 10.1016/j.catena.2005.09.005; Rumpel C., 2015, BIOCHAR ENV MANAGEME, V2, P283; Rutledge S, 2015, AGR ECOSYST ENVIRON, V206, P10, DOI 10.1016/j.agee.2015.03.011; Santos F, 2012, SOIL BIOL BIOCHEM, V51, P115, DOI 10.1016/j.soilbio.2012.04.005; Schimmelpfennig S, 2014, AGR ECOSYST ENVIRON, V191, P39, DOI 10.1016/j.agee.2014.03.027; Singh BP, 2012, ENVIRON SCI TECHNOL, V46, P11770, DOI 10.1021/es302545b; Singh BP, 2010, J ENVIRON QUAL, V39, P1224, DOI 10.2134/jeq2009.0138; SINGH J S, 1977, Botanical Review, V43, P449, DOI 10.1007/BF02860844; Singh N, 2014, GLOBAL CHANGE BIOL, V20, P1629, DOI 10.1111/gcb.12459; Skjemstad J. O., 1996, SOIL RES, V34, P251; Soil Survey Staff, 2010, KEYS SOIL TAXONOMY, Veleventh; Spokas KA, 2014, ENVIRON SCI TECH LET, V1, P326, DOI 10.1021/ez500199t; Taghizadeh-Toosi A, 2011, J ENVIRON QUAL, V40, P468, DOI 10.2134/jeq2010.0419; Van Zwieten L, 2010, PLANT SOIL, V327, P235, DOI 10.1007/s11104-009-0050-x; Ventura M, 2014, GCB BIOENERGY, V7, P1150, DOI [10.1111/gcbb.12219, DOI 10.1111/GCBB.12219]; von Lutzow M, 2006, EUR J SOIL SCI, V57, P426, DOI 10.1111/j.1365-2389.2006.00809.x; Wang T, 2014, SOIL RES, V52, P495, DOI 10.1071/SR13177; Weng Z, 2015, SOIL BIOL BIOCHEM, V90, P111, DOI 10.1016/j.soilbio.2015.08.005; Whitman T., 2015, BIOCHAR ENV MANAGEME, P455, DOI DOI 1016/J.GEODERMA.2013.04.018; Whitman T, 2014, SOIL BIOL BIOCHEM, V73, P33, DOI 10.1016/j.soilbio.2014.02.009; Zimmerman AR, 2013, BIOCHAR AND SOIL BIOTA, P1; Zimmerman AR, 2010, ENVIRON SCI TECHNOL, V44, P1295, DOI 10.1021/es903140c	78	49	51	8	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2015	10	10							e0141560	10.1371/journal.pone.0141560	http://dx.doi.org/10.1371/journal.pone.0141560			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0DL	26509506	Green Published, gold			2022-12-26	WOS:000363918100102
J	Dolle, D; Mateo, JL; Eichenlaub, MP; Sinn, R; Reinhardt, R; Hockendorf, B; Inoue, D; Centanin, L; Ettwiller, L; Wittbrodt, J				Dolle, Dirk; Mateo, Juan L.; Eichenlaub, Michael P.; Sinn, Rebecca; Reinhardt, Robert; Hoeckendorf, Burkhard; Inoue, Daigo; Centanin, Lazaro; Ettwiller, Laurence; Wittbrodt, Joachim			Handling Permutation in Sequence Comparison: Genome-Wide Enhancer Prediction in Vertebrates by a Novel Non-Linear Alignment Scoring Principle	PLOS ONE			English	Article							REGULATORY MODULES; ADAPTIVE EVOLUTION; GENE; ELEMENTS; CIS; DROSOPHILA; DATABASE; IDENTIFICATION; TRANSGENESIS; ARCHITECTURE	Enhancers have been described to evolve by permutation without changing function. This has posed the problem of how to predict enhancer elements that are hidden from alignment-based approaches due to the loss of co-linearity. Alignment-free algorithms have been proposed as one possible solution. However, this approach is hampered by several problems inherent to its underlying working principle. Here we present a new approach, which combines the power of alignment and alignment-free techniques into one algorithm. It allows the prediction of enhancers based on the query and target sequence only, no matter whether the regulatory logic is co-linear or reshuffled. To test our novel approach, we employ it for the prediction of enhancers across the evolutionary distance of similar to 450 Myr between human and medaka. We demonstrate its efficacy by subsequent in vivo validation resulting in 82% (9/11) of the predicted medaka regions showing reporter activity. These include five candidates with partially co-linear and four with reshuffled motif patterns. Orthology in flanking genes and conservation of the detected co-linear motifs indicates that those candidates are likely functionally equivalent enhancers. In sum, our results demonstrate that the proposed principle successfully predicts mutated as well as permuted enhancer regions at an encouragingly high rate.	[Dolle, Dirk; Mateo, Juan L.; Eichenlaub, Michael P.; Sinn, Rebecca; Reinhardt, Robert; Hoeckendorf, Burkhard; Inoue, Daigo; Centanin, Lazaro; Ettwiller, Laurence; Wittbrodt, Joachim] Heidelberg Univ, Ctr Organismal Studies COS Heidelberg, Heidelberg, Germany; [Dolle, Dirk; Eichenlaub, Michael P.; Sinn, Rebecca; Reinhardt, Robert; Hoeckendorf, Burkhard] Heidelberg Univ, Hartmut Hoffmann Berling Int Grad Sch HBIGS, Heidelberg, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg	Dolle, D (corresponding author), Wellcome Trust Sanger Inst, Hinxton, England.	ddd1@sanger.ac.uk; Juan.Mateo@cos.uni-heidelberg.de; Jochen.Wittbrodt@cos.uni-heidelberg.de	Cerdan, Juan Luis Mateo/N-2550-2015; Wittbrodt, Joachim/D-4735-2014	Cerdan, Juan Luis Mateo/0000-0001-9902-6048; Wittbrodt, Joachim/0000-0001-8550-7377; Centanin, Lazaro/0000-0003-3889-4524; Ettwiller, Laurence/0000-0002-3957-6539	Small Collaborative Project Grant from the 7th Framework Programme of the European Commission [FP7-223210]	Small Collaborative Project Grant from the 7th Framework Programme of the European Commission	This work was supported by a Small Collaborative Project Grant from the 7th Framework Programme of the European Commission (FP7-223210 to JW and LE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arunachalam M, 2010, BIOINFORMATICS, V26, P2109, DOI 10.1093/bioinformatics/btq358; Bejerano G, 2004, SCIENCE, V304, P1321, DOI 10.1126/science.1098119; Blanchette M, 2006, GENOME RES, V16, P656, DOI 10.1101/gr.4866006; Blanchette M, 2004, GENOME RES, V14, P708, DOI 10.1101/gr.1933104; Brown CD, 2007, SCIENCE, V317, P1557, DOI 10.1126/science.1145893; Brudno M, 2002, CSB2002: IEEE COMPUTER SOCIETY BIOINFORMATICS CONFERENCE, P138, DOI 10.1109/CSB.2002.1039337; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Chan BY, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-262; Chan YF, 2010, SCIENCE, V327, P302, DOI 10.1126/science.1182213; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Gallo SM, 2011, NUCLEIC ACIDS RES, V39, pD118, DOI 10.1093/nar/gkq999; Hallikas O, 2006, CELL, V124, P47, DOI 10.1016/j.cell.2005.10.042; Hare EE, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000106; Harris RS, 2007, IMPROVED PAIRWISE AL, DOI DOI 10.1093/molbev/msx116; He X, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000299; Heckman KL, 2007, NAT PROTOC, V2, P924, DOI 10.1038/nprot.2007.132; Hide W, 1994, J Comput Biol, V1, P199, DOI 10.1089/cmb.1994.1.199; Howard ML, 2004, DEV BIOL, V271, P109, DOI 10.1016/j.ydbio.2004.03.031; JACOB F, 1977, SCIENCE, V196, P1161, DOI 10.1126/science.860134; Jones FC, 2012, NATURE, V484, P55, DOI 10.1038/nature10944; Kantorovitz MR, 2007, BIOINFORMATICS, V23, pI249, DOI 10.1093/bioinformatics/btm211; Kantorovitz MR, 2009, DEV CELL, V17, P568, DOI 10.1016/j.devcel.2009.09.002; KING MC, 1975, SCIENCE, V188, P107, DOI 10.1126/science.1090005; Koster R, 1997, DEVELOPMENT, V124, P3147; Ludwig MZ, 2000, NATURE, V403, P564, DOI 10.1038/35000615; Marcellini S, 2006, PLOS BIOL, V4, P2252, DOI 10.1371/journal.pbio.0040386; Mathelier A, 2014, NUCLEIC ACIDS RES, V42, pD142, DOI 10.1093/nar/gkt997; Mongin E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019747; Nobrega MA, 2003, SCIENCE, V302, P413, DOI 10.1126/science.1088328; Odom DT, 2007, NAT GENET, V39, P730, DOI 10.1038/ng2047; Ovcharenko I, 2008, MOL BIOL EVOL, V25, P1668, DOI 10.1093/molbev/msn116; Palin K, 2006, NAT PROTOC, V1, P368, DOI 10.1038/nprot.2006.56; Panne D, 2007, CELL, V129, P1111, DOI 10.1016/j.cell.2007.05.019; Pennacchio LA, 2001, NAT REV GENET, V2, P100, DOI 10.1038/35052548; Pennacchio LA, 2006, NATURE, V444, P499, DOI 10.1038/nature05295; Philippakis AA, 2005, PACIFIC SYMPOSIUM ON BIOCOMPUTING 2005, P519; Prud'homme B, 2006, NATURE, V440, P1050, DOI 10.1038/nature04597; Rembold M, 2006, NAT PROTOC, V1, P1133, DOI 10.1038/nprot.2006.165; Ritter DI, 2010, MOL BIOL EVOL, V27, P2322, DOI 10.1093/molbev/msq128; Romano LA, 2003, DEVELOPMENT, V130, P4187, DOI 10.1242/dev.00611; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Sosinsky A, 2007, P NATL ACAD SCI USA, V104, P6305, DOI 10.1073/pnas.0701614104; Stuart GW, 2002, BIOINFORMATICS, V18, P100, DOI 10.1093/bioinformatics/18.1.100; Swanson CI, 2011, CURR BIOL, V21, P1186, DOI 10.1016/j.cub.2011.05.056; Swanson CI, 2010, DEV CELL, V18, P359, DOI 10.1016/j.devcel.2009.12.026; Taher L, 2011, GENOME RES, V21, P1139, DOI 10.1101/gr.119016.110; Thermes V, 2002, MECH DEVELOP, V118, P91, DOI 10.1016/S0925-4773(02)00218-6; Tung J, 2009, NATURE, V460, P388, DOI 10.1038/nature08149; van Helden J, 2004, BIOINFORMATICS, V20, P399, DOI 10.1093/bioinformatics/btg425; Vinga S, 2003, BIOINFORMATICS, V19, P513, DOI 10.1093/bioinformatics/btg005; Visel A, 2008, NAT GENET, V40, P158, DOI 10.1038/ng.2007.55; Visel A, 2007, SEMIN CELL DEV BIOL, V18, P140, DOI 10.1016/j.semcdb.2006.12.014; Visel A, 2007, NUCLEIC ACIDS RES, V35, pD88, DOI 10.1093/nar/gkl822; Yip KY, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-9-r48	54	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2015	10	10							e0141487	10.1371/journal.pone.0141487	http://dx.doi.org/10.1371/journal.pone.0141487			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU8PC	26505748	Green Published, gold			2022-12-26	WOS:000363804200077
J	Esteves, S; Duarte-Silva, S; Naia, L; Neves-Carvalho, A; Teixeira-Castro, A; Rego, AC; Silva-Fernandes, A; Maciel, P				Esteves, Sofia; Duarte-Silva, Sara; Naia, Luana; Neves-Carvalho, Andreia; Teixeira-Castro, Andreia; Rego, Ana Cristina; Silva-Fernandes, Anabela; Maciel, Patricia			Limited Effect of Chronic Valproic Acid Treatment in a Mouse Model of Machado-Joseph Disease	PLOS ONE			English	Article							HISTONE DEACETYLASE INHIBITORS; WEIGHT-GAIN; INTRANUCLEAR INCLUSIONS; NERVOUS-SYSTEM; MOTOR DEFICITS; CELL-DEATH; MECHANISMS; TYPE-3; ATAXIN-3; GRP78	Machado-Joseph disease (MJD) is an inherited neurodegenerative disease, caused by a CAG repeat expansion within the coding region of ATXN3 gene, and which currently lacks effective treatment. In this work we tested the therapeutic efficacy of chronic treatment with valproic acid (VPA) (200mg/kg), a compound with known neuroprotection activity, and previously shown to be effective in cell, fly and nematode models of MJD. We show that chronic VPA treatment in the CMVMJD135 mouse model had limited effects in the motor deficits of these mice, seen mostly at late stages in the motor swimming, beam walk, rotarod and spontaneous locomotor activity tests, and did not modify the ATXN3 inclusion load and astrogliosis in affected brain regions. However, VPA chronic treatment was able to increase GRP78 protein levels at 30 weeks of age, one of its known neuroprotective effects, confirming target engagement. In spite of limited results, the use of another dosage of VPA or of VPA in a combined therapy with molecules targeting other pathways, cannot be excluded as potential strategies for MJD therapeutics.	[Esteves, Sofia; Duarte-Silva, Sara; Neves-Carvalho, Andreia; Teixeira-Castro, Andreia; Silva-Fernandes, Anabela; Maciel, Patricia] Univ Minho, Sch Hlth Sci, Life & Hlth Sci Res Inst ICVS, P-4710057 Braga, Portugal; [Esteves, Sofia; Duarte-Silva, Sara; Neves-Carvalho, Andreia; Teixeira-Castro, Andreia; Silva-Fernandes, Anabela; Maciel, Patricia] ICVS 3Bs PT Govt Associate Lab, Braga, Portugal; [Naia, Luana; Rego, Ana Cristina] Univ Coimbra, CNC Ctr Neurosci & Cell Biol, Coimbra, Portugal; [Naia, Luana; Rego, Ana Cristina] Univ Coimbra, Fac Med, Coimbra, Portugal	Universidade do Minho; Universidade de Coimbra; Universidade de Coimbra	Maciel, P (corresponding author), Univ Minho, Sch Hlth Sci, Life & Hlth Sci Res Inst ICVS, P-4710057 Braga, Portugal.	pmaciel@ecsaude.uminho.pt	Fernandes, Anabela/GLR-5141-2022; Rego, Ana Cristina C/L-4272-2014; Fernandes, Anabela/V-7050-2017; Maciel, Patricia/AAH-2102-2020; Naia, Luana/N-3203-2013; Naia, Luana/AAM-6414-2021; Rego, Ana Cristina/AAH-2606-2020; Duarte-Silva, Sara/T-5134-2018; Maciel, Patrícia/B-5989-2009; Teixeira-Castro, Andreia/T-5167-2018; Silva, Sara/GXM-8709-2022; Carvalho, Andreia/T-5406-2018	Fernandes, Anabela/0000-0002-1187-7815; Rego, Ana Cristina C/0000-0003-0700-3776; Fernandes, Anabela/0000-0002-1187-7815; Maciel, Patricia/0000-0002-0920-6350; Naia, Luana/0000-0002-0886-4634; Duarte-Silva, Sara/0000-0001-9680-4027; Maciel, Patrícia/0000-0002-0920-6350; Teixeira-Castro, Andreia/0000-0003-4999-5996; Carvalho, Andreia/0000-0002-5710-0040	Ataxia UK Grant	Ataxia UK Grant	PM received funding from Ataxia UK Grant (Project: Pharmacologic therapy for Machado-Joseph disease: from a C. elegans drug screen to a mouse model validation). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhtar RS, 2004, BBA-MOL CELL RES, V1644, P189, DOI 10.1016/j.bbamcr.2003.10.013; BARBEAU A, 1984, CAN J NEUROL SCI, V11, P510, DOI 10.1017/S0317167100034983; Bauer PO, 2009, J NEUROCHEM, V110, P1737, DOI 10.1111/j.1471-4159.2009.06302.x; Carter RJ, 1999, J NEUROSCI, V19, P3248; Chou AH, 2011, NEUROBIOL DIS, V41, P481, DOI 10.1016/j.nbd.2010.10.019; CLAYTONSMITH J, 1995, J MED GENET, V32, P724, DOI 10.1136/jmg.32.9.724; Corman CL, 1997, CAN J NEUROL SCI, V24, P240, DOI 10.1017/S0317167100021879; COUTINHO P, 1978, NEUROLOGY, V28, P703, DOI 10.1212/WNL.28.7.703; Evert BO, 2006, CLIN NEUROPATHOL, V25, P272; Feng HL, 2008, NEUROSCIENCE, V155, P567, DOI 10.1016/j.neuroscience.2008.06.040; Ferrante RJ, 2003, J NEUROSCI, V23, P9418; Franklin K.B.J., 2013, PAXINOS FRANKLINS MO; Genton P, 2006, DRUG SAFETY, V29, P1, DOI 10.2165/00002018-200629010-00001; Goodwin DG, 2008, J PARASITOL, V94, P555, DOI 10.1645/GE-1331.1; Gorbatyuk M.S., 2013, J GENET SYNDR GENE T, V4, DOI [10.4172/2157-7412.1000128, DOI 10.4172/2157-7412.1000128]; Grosso S, 2009, ANN PHARMACOTHER, V43, P45, DOI 10.1345/aph.1L414; Hahnen E, 2008, EXPERT OPIN INV DRUG, V17, P169, DOI 10.1517/13543784.17.2.169; Hockly E, 2003, P NATL ACAD SCI USA, V100, P2041, DOI 10.1073/pnas.0437870100; Hoffmann K, 2008, EPILEPSY RES, V81, P107, DOI 10.1016/j.eplepsyres.2008.04.019; Hoffner G, 2015, MOL NEUROBIOL, V52, P1297, DOI 10.1007/s12035-014-8932-1; Isojarvi J, 2008, SEIZURE-EUR J EPILEP, V17, P111, DOI 10.1016/j.seizure.2007.11.007; KAWAGUCHI Y, 1994, NAT GENET, V8, P221, DOI 10.1038/ng1194-221; Kazantsev AG, 2008, NAT REV DRUG DISCOV, V7, P854, DOI 10.1038/nrd2681; LIMA L, 1980, NEUROLOGY, V30, P319, DOI 10.1212/WNL.30.3.319; Lin XP, 2014, INT J DEV NEUROSCI, V38, P17, DOI 10.1016/j.ijdevneu.2014.07.004; Liu H, 1997, J BIOL CHEM, V272, P21751, DOI 10.1074/jbc.272.35.21751; LOSCHER W, 1992, PHARM WEEKBLAD, V14, P139; Mahler M, 2014, LAB ANIM-UK, V48, P178, DOI 10.1177/0023677213516312; Martin CK, 2009, J PSYCHOPHARMACOL, V23, P814, DOI 10.1177/0269881108091595; Minamiyama M, 2004, HUM MOL GENET, V13, P1183, DOI 10.1093/hmg/ddh131; Mologni L, 2009, INT J CANCER, V124, P1990, DOI 10.1002/ijc.24158; Morris JA, 1997, J BIOL CHEM, V272, P4327, DOI 10.1074/jbc.272.7.4327; Ornoy A, 2009, REPROD TOXICOL, V28, P1, DOI 10.1016/j.reprotox.2009.02.014; Pereira C, 2013, ISRN CELL BIOL, V2013, P22, DOI DOI 10.1155/2013/256404; Perucca E, 2002, CNS DRUGS, V16, P695, DOI 10.2165/00023210-200216100-00004; Rafael JA, 2000, MAMM GENOME, V11, P725, DOI 10.1007/s003350010149; Reddy RK, 2003, J BIOL CHEM, V278, P20915, DOI 10.1074/jbc.M212328200; Rosenberg G, 2007, CELL MOL LIFE SCI, V64, P2090, DOI 10.1007/s00018-007-7079-x; Ross CA, 1998, PROG BRAIN RES, V117, P397; Rouaux C, 2007, J NEUROSCI, V27, P5535, DOI 10.1523/JNEUROSCI.1139-07.2007; Rub U, 2002, BRAIN, V125, P2115, DOI 10.1093/brain/awf208; Rub U, 2006, NEUROPATH APPL NEURO, V32, P635, DOI 10.1111/j.1365-2990.2006.00772.x; Rub U, 2008, CURR OPIN NEUROL, V21, P111, DOI 10.1097/WCO.0b013e3282f7673d; Rub U, 2006, BRAIN PATHOL, V16, P218, DOI 10.1111/j.1750-3639.2006.00022.x; Seidel K, 2010, ACTA NEUROPATHOL, V120, P449, DOI 10.1007/s00401-010-0717-7; Shi YY, 2007, BIOORG MED CHEM LETT, V17, P4491, DOI 10.1016/j.bmcl.2007.06.006; Silva-Fernandes A, 2014, NEUROTHERAPEUTICS, V11, P433, DOI 10.1007/s13311-013-0255-9; Silva-Fernandes A, 2010, NEUROBIOL DIS, V40, P163, DOI 10.1016/j.nbd.2010.05.021; Stauber RH, 2012, ONCOTARGET, V3, P31; Steffan JS, 2001, NATURE, V413, P739, DOI 10.1038/35099568; Sultan FA, 2013, ADV EXP MED BIOL, V793, P81, DOI 10.1007/978-1-4614-8289-5_6; Teixeira-Castro A, 2011, HUM MOL GENET, V20, P2996, DOI 10.1093/hmg/ddr203; Tremolizzo L, 2002, P NATL ACAD SCI USA, V99, P17095, DOI 10.1073/pnas.262658999; Tsai LK, 2008, J MOL MED, V86, P1243, DOI 10.1007/s00109-008-0388-1; Valor LM, 2013, J NEUROSCI, V33, P10471, DOI 10.1523/JNEUROSCI.0670-13.2013; Verrotti A, 2011, OBES REV, V12, pe32, DOI 10.1111/j.1467-789X.2010.00800.x; Verrotti A, 2011, REPROD TOXICOL, V31, P519, DOI 10.1016/j.reprotox.2011.02.002; Weber JJ, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/701758; Wirrell EC, 2003, PEDIATR NEUROL, V28, P126, DOI 10.1016/S0887-8994(02)00505-2; Xie CZ, 2010, CLIN CANCER RES, V16, P5499, DOI 10.1158/1078-0432.CCR-10-1707; Yamauchi J, 2007, EXP CELL RES, V313, P1886, DOI 10.1016/j.yexcr.2007.02.019; Yi JP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054792; Zadori D, 2009, PHARMACOL BIOCHEM BE, V94, P148, DOI 10.1016/j.pbb.2009.08.001; Zar JH, 1999, BIOSTATISTICAL ANAL	64	19	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2015	10	10							e0141610	10.1371/journal.pone.0141610	http://dx.doi.org/10.1371/journal.pone.0141610			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU8PC	26505994	Green Published, gold, Green Submitted			2022-12-26	WOS:000363804200090
J	Ikoma-Seki, K; Nakamura, K; Morishita, S; Ono, T; Sugiyama, K; Nishino, H; Hirano, H; Murakoshi, M				Ikoma-Seki, Keiko; Nakamura, Kanae; Morishita, Satoru; Ono, Tomoji; Sugiyama, Keikichi; Nishino, Hoyoku; Hirano, Hisashi; Murakoshi, Michiaki			Role of LRP1 and ERK and cAMP Signaling Pathways in Lactoferrin-Induced Lipolysis in Mature Rat Adipocytes	PLOS ONE			English	Article							HORMONE-SENSITIVE LIPASE; RECEPTOR-RELATED PROTEIN-1; ADENYLYL-CYCLASE; BOVINE LACTOFERRIN; METABOLIC SYNDROME; VISCERAL FAT; PERILIPIN-A; KINASE; PHOSPHORYLATION; GENE	Lactoferrin (LF) is a multifunctional glycoprotein present in milk. A clinical study showed that enteric-coated bovine LF tablets decrease visceral fat accumulation. Furthermore, animal studies revealed that ingested LF is partially delivered to mesenteric fat, and in vitro studies showed that LF promotes lipolysis in mature adipocytes. The aim of the present study was to determine the mechanism underlying the induction of lipolysis in mature adipocytes that is induced by LF. To address this question, we used proteomics techniques to analyze protein expression profiles. Mature adipocytes from primary cultures of rat mesenteric fat were collected at various times after exposure to LF. Proteomic analysis revealed that the expression levels of hormone-sensitive lipase (HSL), which catalyzes the rate-limiting step of lipolysis, were upregulated and that HSL was activated by protein kinase A within 15 min after the cells were treated with LF. We previously reported that LF increases the intracellular concentration of cyclic adenosine monophosphate (cAMP), suggesting that LF activates the cAMP signaling pathway. In this study, we show that the expression level and the activity of the components of the extracellular signal-regulated kinase (ERK) signaling pathway were upregulated. Moreover, LF increased the activity of the transcription factor cAMP response element binding protein (CREB), which acts downstream in the cAMP and ERK signaling pathways and regulates the expression levels of adenylyl cyclase and HSL. Moreover, silencing of the putative LF receptor low-density lipoprotein receptor-related protein 1 (LRP1) attenuated lipolysis in LF-treated adipocytes. These results suggest that LF promoted lipolysis in mature adipocytes by regulating the expression levels of proteins involved in lipolysis through controlling the activity of cAMP/ERK signaling pathways via LRP1.	[Ikoma-Seki, Keiko; Nakamura, Kanae; Morishita, Satoru; Ono, Tomoji; Sugiyama, Keikichi; Murakoshi, Michiaki] Lion Corp, Res & Dev Headquarters, Tokyo, Kanagawa, Japan; [Ikoma-Seki, Keiko; Ono, Tomoji; Hirano, Hisashi; Murakoshi, Michiaki] Yokohama City Univ, Adv Med Res Ctr, Yokohama, Kanagawa, Japan; [Nishino, Hoyoku; Murakoshi, Michiaki] Kyoto Prefectural Univ Med, Kyoto, Japan; [Sugiyama, Keikichi; Nishino, Hoyoku] Ritsumeikan Univ, Kyoto, Shiga, Japan	Lion Corporation; Yokohama City University; Kyoto Prefectural University of Medicine; Ritsumeikan University	Ikoma-Seki, K (corresponding author), Lion Corp, Res & Dev Headquarters, Tokyo, Kanagawa, Japan.	k-ikoma@lion.co.jp			Lion Corporation; Developing Innovation Systems of the Ministry of Education, Culture, Sports, Science and, Technology, Japan [11800122]	Lion Corporation; Developing Innovation Systems of the Ministry of Education, Culture, Sports, Science and, Technology, Japan	KI, KN, SM, TO, and MM are employees of Lion Corporation. HN and KS received consulting fees from Lion Corporation. This work was supported by Lion Corporation and especially Proteomic analysis part was supported by the Establishment of Research Center for Clinical Proteomics of Post-Translational Modifications (a research task of the Creation of " Innovation Centers for Advanced Interdisciplinary Research Areas" Program of Project for Developing Innovation Systems of the Ministry of Education, Culture, Sports, Science and, Technology, Japan (ID: 11800122)). Lion Corporation had role in the study design, conduct of the study, data collection, data interpretation or preparation of the report, and the Establishment of Research Center for Clinical Proteomics of Post-Translational Modifications had a role in the study design, conduct of the study, data collection, data interpretation or preparation of the report in Proteomic analysis part.	Abete I, 2011, NUTR METAB CARDIOVAS, V21, pB1, DOI 10.1016/j.numecd.2011.05.001; Adams JP, 2000, ACTA NEUROBIOL EXP, V60, P377; Barnes H, 2003, ONCOGENE, V22, P3589, DOI 10.1038/sj.onc.1206504; Barnes H, 2001, J BIOL CHEM, V276, P19119, DOI 10.1074/jbc.M011437200; Beazely MA, 2005, MOL PHARMACOL, V67, P250, DOI 10.1124/mol.104.001370; Bockaert J, 2012, B ACAD NAT MED PARIS, V196, P1765, DOI 10.1016/S0001-4079(19)31653-X; Chao JR, 2002, EUR J NEUROSCI, V16, P1284, DOI 10.1046/j.1460-9568.2002.02186.x; Cooper DMF, 2006, TRENDS PHARMACOL SCI, V27, P426, DOI 10.1016/j.tips.2006.06.002; Ding QM, 2004, MOL PHARMACOL, V66, P921, DOI 10.1124/mol.66.4.921; Dougherty MK, 2005, MOL CELL, V17, P215, DOI 10.1016/j.molcel.2004.11.055; Dumaz N, 2005, FEBS J, V272, P3491, DOI 10.1111/j.1742-4658.2005.04763.x; Dumaz N, 2003, J BIOL CHEM, V278, P29819, DOI 10.1074/jbc.C300182200; Duvnjak L, 2009, J PHYSIOL PHARMACOL, V60, P19; Feldman DS, 2002, J BIOL CHEM, V277, P28631, DOI 10.1074/jbc.M204753200; Filardo EJ, 2002, MOL ENDOCRINOL, V16, P70, DOI 10.1210/me.16.1.70; Fruhbeck G, 2014, NUTR RES REV, V27, P63, DOI 10.1017/S095442241400002X; Gao MH, 2004, J BIOL CHEM, V279, P38797, DOI 10.1074/jbc.M405701200; GONZALEZ GA, 1989, CELL, V59, P675, DOI 10.1016/0092-8674(89)90013-5; Goretzki L, 1998, BIOCHEM J, V336, P381, DOI 10.1042/bj3360381; Grey A, 2004, MOL ENDOCRINOL, V18, P2268, DOI 10.1210/me.2003-0456; HARMSEN MC, 1995, J INFECT DIS, V172, P380, DOI 10.1093/infdis/172.2.380; Hashimoto N, 2000, Nihon Rinsho, V58, P405; Herz J, 2001, J CLIN INVEST, V108, P779, DOI 10.1172/JCI200113992; Lafontan M, 2009, PROG LIPID RES, V48, P275, DOI 10.1016/j.plipres.2009.05.001; Lampidonis AD, 2008, GENE, V427, P65, DOI 10.1016/j.gene.2008.09.001; Loukinova E, 2002, J BIOL CHEM, V277, P15499, DOI 10.1074/jbc.M200427200; Moreno-Navarrete JM, 2009, INT J OBESITY, V33, P991, DOI 10.1038/ijo.2009.143; Morishita S, 2013, J OLEO SCI, V62, P97, DOI 10.5650/jos.62.97; Mota Maria, 2004, Rom J Intern Med, V42, P247; Ono T, 2011, BRIT J NUTR, V105, P200, DOI 10.1017/S0007114510003259; Ono T, 2010, BRIT J NUTR, V104, P1688, DOI 10.1017/S0007114510002734; Park HY, 2014, J NEUROSCI, V34, P11744, DOI 10.1523/JNEUROSCI.0864-14.2014; Rappsilber J, 2003, ANAL CHEM, V75, P663, DOI 10.1021/ac026117i; Rommel C, 1999, SCIENCE, V286, P1738, DOI 10.1126/science.286.5445.1738; Roskoski R, 2012, PHARMACOL RES, V66, P105, DOI 10.1016/j.phrs.2012.04.005; Sekine K, 1997, CANCER LETT, V121, P211, DOI 10.1016/S0304-3835(97)00358-3; Shi J, 2012, J FUNCT FOODS, V4, P66, DOI 10.1016/j.jff.2011.08.001; Shi Y, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000188; Shoji H, 2007, PEDIATR RES, V61, P89, DOI 10.1203/01.pdr.0000250198.22735.20; Smit MJ, 1998, P NATL ACAD SCI USA, V95, P15084, DOI 10.1073/pnas.95.25.15084; Souza SC, 2002, J BIOL CHEM, V277, P8267, DOI 10.1074/jbc.M108329200; Su CL, 2003, J BIOL CHEM, V278, P43615, DOI 10.1074/jbc.M301809200; Suzuki YA, 2005, CELL MOL LIFE SCI, V62, P2560, DOI 10.1007/s00018-005-5371-1; Sztalryd C, 2003, J CELL BIOL, V161, P1093, DOI 10.1083/jcb.200210169; Takayama Y, 2003, J BIOL CHEM, V278, P22112, DOI 10.1074/jbc.M300894200; Tan CM, 2001, BIOCHEMISTRY-US, V40, P1702, DOI 10.1021/bi0015818; Tang L, 2010, BRIT J DERMATOL, V163, P38, DOI 10.1111/j.1365-2133.2010.09748.x; Tian J H, 1996, Sheng Li Ke Xue Jin Zhan, V27, P227; TOMITA M, 1991, J DAIRY SCI, V74, P4137, DOI 10.3168/jds.S0022-0302(91)78608-6; Uemura Y, 2013, FASEB J, V27, P25, DOI 10.1096/fj.12-213744; Umekawa T, 1999, DIABETES, V48, P117, DOI 10.2337/diabetes.48.1.117; Xia ZG, 2012, LEARN MEMORY, V19, P369, DOI 10.1101/lm.027128.112; Yagi Motohiko, 2008, J Oral Sci, V50, P419; YAMAMOTO KK, 1988, NATURE, V334, P494, DOI 10.1038/334494a0; You TJ, 2008, J GERONTOL A-BIOL, V63, P414, DOI 10.1093/gerona/63.4.414; Zimecki Michal, 1998, Archivum Immunologiae et Therapiae Experimentalis, V46, P231	56	25	28	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2015	10	10							e0141378	10.1371/journal.pone.0141378	http://dx.doi.org/10.1371/journal.pone.0141378			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU8PC	26506094	Green Published, Green Submitted, gold			2022-12-26	WOS:000363804200058
J	Liakoni, E; Schaub, MP; Maier, LJ; Glauser, GV; Liechti, ME				Liakoni, Evangelia; Schaub, Michael P.; Maier, Larissa J.; Glauser, Gaelle-Vanessa; Liechti, Matthias E.			The Use of Prescription Drugs, Recreational Drugs, and "Soft Enhancers" for Cognitive Enhancement among Swiss Secondary School Students	PLOS ONE			English	Article							DEFICIT-HYPERACTIVITY DISORDER; NONMEDICAL USE; COLLEGE-STUDENTS; UNITED-STATES; STIMULANTS; NEUROENHANCEMENT; MISUSE; ADHD; METHYLPHENIDATE; MEDICATIONS	The use of prescription or recreational drugs for cognitive enhancement (CE) is prevalent among students. However, the prevalence of CE among Swiss school students is unknown. We therefore performed a cross-sectional online survey including >= 16-year-old students from bridge-year schools (10th grade), vocational schools, and upper secondary schools (10th-12th grade) in the Canton of Zurich to investigate the prevalence of and motives for the use of prescription drugs, recreational drugs, and/or freely available soft enhancers for CE. A total of 1,139 students were included. Of these, 54.5% reported the use of prescription drugs (9.2%), recreational drugs including alcohol (6.2%), or soft enhancers (51.3%) explicitly for CE at least once in their lives. The last-year and last-month prevalence for CE considering all substances was 45.5% and 39.5%, respectively. Soft enhancers were the substances that were most commonly used (ever, last-year, and last-month, respectively), including energy drinks (33.3%, 28.4%, and 24.6%), coffee (29.8%, 25.1%, and 21.9%), and tobacco (12.6%, 9.3%, and 8.3%). CE with methylphenidate was less prevalent (4.0%, 2.8%, and 2.0%). However, the use of prescription drugs, alcohol, or illegal drugs for CE was reported by 13.3% of the participants. The most common motives for use were to stay awake and improve concentration. CE was more prevalent among students who reported higher levels of stress or performance pressure and students with psychiatric disorders. In conclusion, half of the school students had used a substance at least once in their lives to improve school performance. Soft enhancers were most commonly used. Prevalence rates were similar to those reported by Swiss university students, indicating that the use of prescription or recreational drugs for CE already occurs before starting higher education. Performance pressure, stress, and psychiatric disorders may be associated with CE.	[Liakoni, Evangelia; Liechti, Matthias E.] Univ Basel Hosp, Dept Clin Res, Div Clin Pharmacol & Toxicol, CH-4031 Basel, Switzerland; [Schaub, Michael P.; Maier, Larissa J.; Glauser, Gaelle-Vanessa] Univ Zurich, Swiss Res Inst Publ Hlth & Addict ISGF, Zurich, Switzerland; [Schaub, Michael P.; Maier, Larissa J.; Glauser, Gaelle-Vanessa] WHO Collaborating Ctr, Zurich, Switzerland	University of Basel; University of Zurich; World Health Organization	Liakoni, E (corresponding author), Univ Basel Hosp, Dept Clin Res, Div Clin Pharmacol & Toxicol, CH-4031 Basel, Switzerland.	evangelia.liakoni@usb.ch	Maier, Larissa/P-8669-2014; Maier, Larissa J/C-2922-2017; Schaub, Michael P./ABF-9468-2021	Maier, Larissa/0000-0002-4302-0488; Maier, Larissa J/0000-0002-4302-0488; Schaub, Michael P./0000-0002-8375-4005	Division of Clinical Pharmacology & Toxicology, University Hospital Basel; Swiss Centre of Applied Human Toxicology (SCAHT); Swiss Research Institute for Public Health and Addiction (ISGF), Zurich	Division of Clinical Pharmacology & Toxicology, University Hospital Basel; Swiss Centre of Applied Human Toxicology (SCAHT); Swiss Research Institute for Public Health and Addiction (ISGF), Zurich	This study was supported by internal funds from the Division of Clinical Pharmacology & Toxicology, University Hospital Basel (to ML), Swiss Centre of Applied Human Toxicology (SCAHT) (to ML), and Swiss Research Institute for Public Health and Addiction (ISGF), Zurich (to MS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arria AM, 2008, PHARMACOTHERAPY, V28, P156, DOI 10.1592/phco.28.2.156; Bagot KS, 2014, ADDICTION, V109, P547, DOI 10.1111/add.12460; Cohen S, 2012, J APPL SOC PSYCHOL, V42, P1320, DOI 10.1111/j.1559-1816.2012.00900.x; de Jongh R, 2008, NEUROSCI BIOBEHAV R, V32, P760, DOI 10.1016/j.neubiorev.2007.12.001; Farah MJ, 2014, WIRES COGN SCI, V5, P95, DOI 10.1002/wcs.1250; Forlini C, 2014, NEUROETHICS; Forlini C, 2009, BMC MED ETHICS, V10, DOI 10.1186/1472-6939-10-9; Franke AG, 2011, PHARMACOPSYCHIATRY, V44, P60, DOI 10.1055/s-0030-1268417; Franke AG, 2010, BUNDESGESUNDHEITSBLA, V53, P853, DOI 10.1007/s00103-010-1105-0; Hall W., 2012, AJOB PRIMARY RES, V3, P81, DOI [DOI 10.1080/21507716.2012.720639, 10.1080/21507716.2012.720639]; Husain M, 2011, TRENDS COGN SCI, V15, P28, DOI 10.1016/j.tics.2010.11.002; Kroutil LA, 2006, DRUG ALCOHOL DEPEN, V84, P135, DOI 10.1016/j.drugalcdep.2005.12.011; Lieb K, 2010, HIMDOPING WARUM WIR; Mache S, 2012, WIEN MED WOCHENSCHR, V162, P262, DOI [10.1007/s10354-012-0115-y, 10.1007/s10354-012-0144-6]; Maier LJ, 2015, EUR PSYCHOL, V20, P155, DOI 10.1027/1016-9040/a000228; Maier LJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129805; Maier LJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077967; McCabe SE, 2005, ADDICTION, V100, P96, DOI 10.1111/j.1360-0443.2005.00944.x; McCabe SE, 2011, ARCH PEDIAT ADOL MED, V165, P729, DOI 10.1001/archpediatrics.2011.114; McCabe SE, 2009, DRUG ALCOHOL DEPEN, V102, P63, DOI 10.1016/j.drugalcdep.2009.01.007; Middendorff E, 2012, HISBUS BEFRAGUNG VER, V1; Novak SP, 2007, SUBST ABUSE TREAT PR, V2, DOI 10.1186/1747-597X-2-32; Ott R, 2014, PHARMACOPSYCHIATRY, V47, P22, DOI 10.1055/s-0033-1358682; Partridge B, 2012, AUST NZ J PSYCHIAT, V46, P958, DOI 10.1177/0004867412450755; Ragan CI, 2013, NEUROPHARMACOLOGY, V64, P588, DOI 10.1016/j.neuropharm.2012.06.016; Repantis D, 2010, PHARMACOL RES, V62, P187, DOI 10.1016/j.phrs.2010.04.002; Schelle KJ, 2014, FRONT SYST NEUROSCI, V8, DOI 10.3389/fnsys.2014.00053; Schermer M, 2009, NEUROETHICS-NETH, V2, P75, DOI 10.1007/s12152-009-9032-1; Vrecko Scott, 2013, AJOB Neurosci, V4, P4; Wilens TE, 2008, J AM ACAD CHILD PSY, V47, P21, DOI 10.1097/chi.0b013e31815a56f1; Wood S, 2014, PHARMACOL REV, V66, P193, DOI 10.1124/pr.112.007054	31	34	34	3	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2015	10	10							e0141289	10.1371/journal.pone.0141289	http://dx.doi.org/10.1371/journal.pone.0141289			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CU8PC	26505633	Green Published, Green Accepted, Green Submitted, gold			2022-12-26	WOS:000363804200043
J	Dalliere, N; Bhatla, N; Luedtke, Z; Ma, DKK; Woolman, J; Walker, RJ; Holden-Dye, L; O'Connor, V				Dalliere, Nicolas; Bhatla, Nikhil; Luedtke, Zara; Ma, Dengke K.; Woolman, Jonathan; Walker, Robert J.; Holden-Dye, Lindy; O'Connor, Vincent			Multiple excitatory and inhibitory neural signals converge to fine-tune Caenorhabditis elegans feeding to food availability	FASEB JOURNAL			English	Article						behavioral plasticity; fasting; glutamate; neuropeptide; UNC-31	PHARYNGEAL NERVOUS-SYSTEM; DENSE-CORE VESICLE; C-ELEGANS; GLUTAMATERGIC NEUROTRANSMISSION; MASS-SPECTROMETRY; GENE FAMILIES; UNC-31 CAPS; BODY-FAT; NEUROPEPTIDE; CIRCUIT	How an animal matches feeding to food availability is a key question for energy homeostasis. We addressed this in the nematode Caenorhabditis elegans, which couples feeding to the presence of its food (bacteria) by regulating pharyngeal activity (pumping). We scored pumping in the presence of food and over an extended time course of food deprivation in wild-type and mutant worms to determine the neural substrates of adaptive behavior. Removal of food initially suppressed pumping but after 2 h this was accompanied by intermittent periods of high activity. We show pumping is fine-tuned by context-specific neural mechanisms and highlight a key role for inhibitory glutamatergic and excitatory cholinergic/peptidergic drives in the absence of food. Additionally, the synaptic protein UNC-31 [calcium-activated protein for secretion (CAPS)] acts through an inhibitory pathway not explained by previously identified contributions of UNC-31/CAPS to neuropeptide or glutamate transmission. Pumping was unaffected by laser ablation of connectivity between the pharyngeal and central nervous system indicating signals are either humoral or intrinsic to the enteric system. This framework in which control is mediated through finely tuned excitatory and inhibitory drives resonates with mammalian hypothalamic control of feeding and suggests that fundamental regulation of this basic animal behavior may be conserved through evolution from nematode to human.	[Dalliere, Nicolas; Luedtke, Zara; Woolman, Jonathan; Walker, Robert J.; Holden-Dye, Lindy; O'Connor, Vincent] Univ Southampton, Fac Nat & Environm Sci, Ctr Biol Sci, Southampton, Hants, England; [Bhatla, Nikhil; Ma, Dengke K.] MIT, Howard Hughes Med Inst, Cambridge, MA USA; [Bhatla, Nikhil; Ma, Dengke K.] MIT, Dept Biol, Cambridge, MA USA	University of Southampton; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Holden-Dye, L (corresponding author), Univ Southampton, Life Sci Bldg 85,Highfield Campus, Southampton SO17 1BJ, Hants, England.	lmhd@soton.ac.uk		O'Connor, Vincent/0000-0003-3185-5709; Holden-Dye, Lindy/0000-0002-9704-1217	Gerald Kerkut Charitable Trust; U.S. National Institutes of Health Office of Research Infrastructure Programs [P40 OD010440]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM117461] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010440] Funding Source: NIH RePORTER	Gerald Kerkut Charitable Trust; U.S. National Institutes of Health Office of Research Infrastructure Programs; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The authors are grateful to Richard Komuniecki for providing the C. elegans eat-4;egl-3 double mutant. N.D. and Z.L. were supported by Ph.D. studentships funded by the Gerald Kerkut Charitable Trust. C. elegans strains were provided by the C. elegans Genetics Center, which is funded by U.S. National Institutes of Health Office of Research Infrastructure Programs (P40 OD010440).	ALBERTSON DG, 1976, PHILOS T ROY SOC B, V275, P299, DOI 10.1098/rstb.1976.0085; ALFONSO A, 1993, SCIENCE, V261, P617, DOI 10.1126/science.8342028; Alkema MJ, 2005, NEURON, V46, P247, DOI 10.1016/j.neuron.2005.02.024; Ann K, 1997, J BIOL CHEM, V272, P19637, DOI 10.1074/jbc.272.32.19637; Aponte Y, 2011, NAT NEUROSCI, V14, P351, DOI 10.1038/nn.2739; Avery L, 2003, J EXP BIOL, V206, P2441, DOI 10.1242/jeb.00433; AVERY L, 1990, J EXP ZOOL, V253, P263, DOI 10.1002/jez.1402530305; AVERY L, 1989, NEURON, V3, P473, DOI 10.1016/0896-6273(89)90206-7; AVERY L, 1993, J EXP BIOL, V175, P283; AVERY L, 1997, C ELEGANS, V2, P679, DOI [10.1101/087969532.33.679, DOI 10.1101/087969532.33.679]; Avery Leon, 1993, Genetics, V134, P455; Berwin B, 1998, NEURON, V21, P137, DOI 10.1016/S0896-6273(00)80521-8; BRENNER S, 1974, GENETICS, V77, P71; Calvo AC, 2011, BIOCHEM J, V434, P133, DOI 10.1042/BJ20101561; Chalasani SH, 2007, NATURE, V450, P63, DOI 10.1038/nature06292; Chalasani SH, 2010, NAT NEUROSCI, V13, P615, DOI 10.1038/nn.2526; CHALFIE M, 1985, J NEUROSCI, V5, P956; Charlie NK, 2006, GENETICS, V172, P943, DOI 10.1534/genetics.105.049577; Cheong MC, 2015, ELIFE, V4, DOI 10.7554/eLife.06683; Cunningham KA, 2012, CELL METAB, V16, P113, DOI 10.1016/j.cmet.2012.05.014; de Bono M, 2005, ANNU REV NEUROSCI, V28, P451, DOI 10.1146/annurev.neuro.27.070203.144259; Dent JA, 1997, EMBO J, V16, P5867, DOI 10.1093/emboj/16.19.5867; Dwyer DS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063851; Fang-Yen C, 2012, METHOD CELL BIOL, V107, P177, DOI 10.1016/B978-0-12-394620-1.00006-0; Flavell SW, 2013, CELL, V154, P1023, DOI 10.1016/j.cell.2013.08.001; Franks Christopher J., 2006, Invertebrate Neuroscience, V6, P105, DOI 10.1007/s10158-006-0023-1; Friedman JM, 2010, NAT MED, V16, P1100, DOI 10.1038/nm1010-1100; Friedman JM, 2009, NATURE, V459, P340, DOI 10.1038/459340a; Gray JM, 2005, P NATL ACAD SCI USA, V102, P3184, DOI 10.1073/pnas.0409009101; Greer ER, 2008, CELL METAB, V8, P118, DOI 10.1016/j.cmet.2008.06.005; Hills T, 2004, J NEUROSCI, V24, P1217, DOI 10.1523/JNEUROSCI.1569-03.2004; Hobson RJ, 2006, GENETICS, V172, P159, DOI 10.1534/genetics.105.044495; Holden-Dye L, 2013, PROTEIN PEPTIDE LETT, V20, P636, DOI 10.2174/0929866511320060004; HORVITZ HR, 1982, SCIENCE, V216, P1012, DOI 10.1126/science.6805073; Husson SJ, 2007, J NEUROCHEM, V102, P246, DOI 10.1111/j.1471-4159.2007.04474.x; Husson SJ, 2006, J NEUROCHEM, V98, P1999, DOI 10.1111/j.1471-4159.2006.04014.x; Jacob TC, 2003, J NEUROSCI, V23, P2122; Jockusch WJ, 2007, CELL, V131, P796, DOI 10.1016/j.cell.2007.11.002; Kass J, 2001, J NEUROSCI, V21, P9265, DOI 10.1523/JNEUROSCI.21-23-09265.2001; Keane J, 2003, GENETICS, V164, P153; Lau HE, 2014, INVERTEBR NEUROSCI, V14, P71, DOI 10.1007/s10158-013-0166-9; Lee JH, 2014, MOL CELL BIOL, V34, P4165, DOI 10.1128/MCB.00722-14; Lee RYN, 1999, J NEUROSCI, V19, P159, DOI 10.1523/JNEUROSCI.19-01-00159.1999; Leinwand SG, 2013, NAT NEUROSCI, V16, P1461, DOI 10.1038/nn.3511; Li C, 1999, ANN NY ACAD SCI, V897, P239, DOI 10.1111/j.1749-6632.1999.tb07895.x; Li C, 1999, BRAIN RES, V848, P26, DOI 10.1016/S0006-8993(99)01972-1; Li C, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00150; Li ZY, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1780; MCINTIRE SL, 1993, NATURE, V364, P337, DOI 10.1038/364337a0; McKay JP, 2004, GENETICS, V166, P161, DOI 10.1534/genetics.166.1.161; Mitchell P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010422; Nathoo AN, 2001, P NATL ACAD SCI USA, V98, P14000, DOI 10.1073/pnas.241231298; Niacaris T, 2003, J EXP BIOL, V206, P223, DOI 10.1242/jeb.00101; Noble T, 2013, CELL METAB, V18, P672, DOI 10.1016/j.cmet.2013.09.007; Packham R, 2010, INVERTEBR NEUROSCI, V10, P47, DOI 10.1007/s10158-010-0107-9; Papaioannou S, 2005, J NEUROBIOL, V65, P304, DOI 10.1002/neu.20201; Papaioannou S, 2008, ACTA BIOL HUNG, V59, P189, DOI 10.1556/ABiol.59.2008.Suppl.28; Papaioannou Sylvana, 2008, Invertebrate Neuroscience, V8, P91, DOI 10.1007/s10158-008-0072-8; Peymen K, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00090; Pierce-Shimomura JT, 1999, J NEUROSCI, V19, P9557; RAIZEN DM, 1995, GENETICS, V141, P1365; RAIZEN DM, 1994, NEURON, V12, P483, DOI 10.1016/0896-6273(94)90207-0; Rogers CM, 2001, J NEUROBIOL, V49, P235, DOI 10.1002/neu.1078; Sawin ER, 2000, NEURON, V26, P619, DOI 10.1016/S0896-6273(00)81199-X; Shingai R, 2000, NEUROSCI RES, V38, P71, DOI 10.1016/S0168-0102(00)00148-6; Shtonda BB, 2006, J EXP BIOL, V209, P89, DOI 10.1242/jeb.01955; Sieburth D, 2007, NAT NEUROSCI, V10, P49, DOI 10.1038/nn1810; Song BM, 2013, ELIFE, V2, DOI 10.7554/eLife.00329; Song BM, 2012, J NEUROSCI, V32, P1920, DOI 10.1523/JNEUROSCI.2064-11.2012; Speese S, 2007, J NEUROSCI, V27, P6150, DOI 10.1523/JNEUROSCI.1466-07.2007; Sugiura M, 2005, J NEUROCHEM, V94, P1146, DOI 10.1111/j.1471-4159.2005.03268.x; Suo S, 2009, EMBO J, V28, P2437, DOI 10.1038/emboj.2009.194; Sze JY, 2000, NATURE, V403, P560, DOI 10.1038/35000609; Tsalik EL, 2003, J NEUROBIOL, V56, P178, DOI 10.1002/neu.10245; Walker DS, 2002, MOL BIOL CELL, V13, P1329, DOI 10.1091/mbc.01-08-0422; WARD S, 1973, P NATL ACAD SCI USA, V70, P817, DOI 10.1073/pnas.70.3.817; Werner KM, 2014, J BIOL CHEM, V289, P26566, DOI 10.1074/jbc.M114.573832; Yoshida M, 2014, J NEUROSCI RES, V92, P671, DOI 10.1002/jnr.23345; You YJ, 2008, CELL METAB, V7, P249, DOI 10.1016/j.cmet.2008.01.005; Zaslaver A, 2015, P NATL ACAD SCI USA, V112, P1185, DOI 10.1073/pnas.1423656112	80	18	18	0	25	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2016	30	2					836	848		10.1096/fj.15-279257	http://dx.doi.org/10.1096/fj.15-279257			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DC7IA	26514165	Green Published			2022-12-26	WOS:000369391900032
J	Gomes, FR; Romaniello, V; Sanchez, A; Weber, C; Narayanan, P; Psol, M; Pardo, LA				Gomes, Fernanda Ramos; Romaniello, Vincenzo; Sanchez, Araceli; Weber, Claudia; Narayanan, Pratibha; Psol, Maryna; Pardo, Luis A.			Alternatively Spliced Isoforms of K(V)10.1 Potassium Channels Modulate Channel Properties and Can Activate Cyclin-dependent Kinase in Xenopus Oocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							A-GO-GO; SURFACE EXPRESSION; HUMAN ETHER; K+ CHANNELS; EAG; CALCIUM; PROTEIN; RAT; IDENTIFICATION; SENSITIVITY	K(V)10.1 is a voltage-gated potassium channel expressed selectively in the mammalian brain but also aberrantly in cancer cells. In this study we identified short splice variants of K(V)10.1 resulting from exon-skipping events (E65 and E70) in human brain and cancer cell lines. The presence of the variants was confirmed by Northern blot and RNase protection assays. Both variants completely lacked the transmembrane domains of the channel and produced cytoplasmic proteins without channel function. In a reconstituted system, both variants co-precipitated with the full-length channel and induced a robust down-regulation of K(V)10.1 current when co-expressed with the full-length form, but their effect was mechanistically different. E65 required a tetramerization domain and induced a reduction in the overall expression of full-length K(V)10.1, whereas E70 mainly affected its glycosylation pattern. E65 triggered the activation of cyclin-dependent kinases in Xenopus laevis oocytes, suggesting a role in cell cycle control. Our observations highlight the relevance of noncanonical functions for the oncogenicity of K(V)10.1, which need to be considered when ion channels are targeted for cancer therapy.	[Gomes, Fernanda Ramos; Weber, Claudia; Narayanan, Pratibha; Psol, Maryna] Max Planck Inst Expt Med, Dept Mol Biol Neuronal Signals, D-37075 Gottingen, Germany; [Romaniello, Vincenzo; Sanchez, Araceli; Pardo, Luis A.] Max Planck Inst Expt Med, Oncophysiol Grp, D-37075 Gottingen, Germany	Max Planck Society; Max Planck Society	Pardo, LA (corresponding author), Max Planck Inst Expt Med, Oncophysiol Grp, Hermann Rein Str 3, D-37075 Gottingen, Germany.	pardo@em.mpg.de	Romaniello, Vincenzo/AAQ-2957-2020; Pardo, Luis/C-5066-2013	Pardo, Luis/0000-0003-1375-4349; Narayanan, Pratibha/0000-0002-8998-5170	Gottingen Graduate School for Neurosciences, Biophysics, and Molecular Biosciences (GGNB)	Gottingen Graduate School for Neurosciences, Biophysics, and Molecular Biosciences (GGNB)	Supported by a scholarship from the Gottingen Graduate School for Neurosciences, Biophysics, and Molecular Biosciences (GGNB).	Adaixo R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059265; Adaixo R, 2010, ACTA CRYSTALLOGR F, V66, P1056, DOI 10.1107/S1744309110027880; Barash Y, 2010, NATURE, V465, P53, DOI 10.1038/nature09000; Bidaux G, 2012, J BIOL CHEM, V287, P2948, DOI 10.1074/jbc.M111.270256; Brelidze TI, 2012, NATURE, V481, P530, DOI 10.1038/nature10735; Brelidze TI, 2009, J BIOL CHEM, V284, P27989, DOI 10.1074/jbc.M109.016337; Bruggemann A, 1997, P NATL ACAD SCI USA, V94, P537, DOI 10.1073/pnas.94.2.537; Camacho J, 2000, PFLUG ARCH EUR J PHY, V441, P167, DOI 10.1007/s004240000420; Chen LN, 2005, J BIOL CHEM, V280, P21418, DOI 10.1074/jbc.M413955200; Chen YT, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0017876, 10.1371/journal.pone.0021428, 10.1371/journal.pone.0017844, 10.1371/journal.pone.0024144, 10.1371/journal.pone.0027163, 10.1371/journal.pone.0027333]; Chiu YH, 2010, MOL PHARMACOL, V77, P497, DOI 10.1124/mol.109.061929; Chu X, 2005, CELL CALCIUM, V37, P173, DOI 10.1016/j.ceca.2004.08.005; Chavez-Lopez MD, 2014, INT J GYNECOL CANCER, V24, P824, DOI 10.1097/IGC.0000000000000151; Downie BR, 2008, J BIOL CHEM, V283, P36234, DOI 10.1074/jbc.M801830200; Erxleben C, 2002, J BIOL CHEM, V277, P27045, DOI 10.1074/jbc.M203087200; Fletcher EV, 2011, J BIOL CHEM, V286, P36700, DOI 10.1074/jbc.M111.250225; Frings S, 1998, J GEN PHYSIOL, V111, P583, DOI 10.1085/jgp.111.4.583; Garcia-Ferreiro RE, 2004, J GEN PHYSIOL, V124, P301, DOI 10.1085/jgp.200409041; Gavrilova-Ruch O, 2002, J MEMBRANE BIOL, V188, P137, DOI 10.1007/s00232-001-0181-3; Gomez-Varela D, 2007, CANCER RES, V67, P7343, DOI 10.1158/0008-5472.CAN-07-0107; Goncalves JT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010873; Guasti L, 2008, MOL CELL BIOL, V28, P5043, DOI 10.1128/MCB.00304-08; Haitin Y, 2013, NATURE, V501, P444, DOI 10.1038/nature12487; Hartung F, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-109; HEINEMANN SH, 1992, METHOD ENZYMOL, V207, P131; Hemmerlein B, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-41; Herrmann S, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00201; Herrmann S, 2012, J BIOL CHEM, V287, P44151, DOI 10.1074/jbc.M112.372540; Hoshi N, 1998, J BIOL CHEM, V273, P23080, DOI 10.1074/jbc.273.36.23080; Hsu PH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041203; Jenke M, 2003, EMBO J, V22, P395, DOI 10.1093/emboj/cdg035; Kohl T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026329; Kupershmidt S, 1998, J BIOL CHEM, V273, P27231, DOI 10.1074/jbc.273.42.27231; Kuzhikandathil EV, 2000, J GEN PHYSIOL, V115, P697, DOI 10.1085/jgp.115.6.697; Lin TF, 2014, J BIOL CHEM, V289, P22815, DOI 10.1074/jbc.M114.574814; Ludwig J, 1997, EMBO J, V16, P6337, DOI 10.1093/emboj/16.21.6337; Martin S, 2008, NEUROSCIENCE, V155, P833, DOI 10.1016/j.neuroscience.2008.05.019; McCartney CE, 2005, P NATL ACAD SCI USA, V102, P17870, DOI 10.1073/pnas.0505270102; Meyer R, 1999, J MEMBRANE BIOL, V171, P107, DOI 10.1007/s002329900563; Mortensen LS, 2015, J PHYSIOL-LONDON, V593, P181, DOI 10.1113/jphysiol.2014.281600; Muskett FW, 2011, J BIOL CHEM, V286, P6184, DOI 10.1074/jbc.M110.199364; Napp J, 2005, J BIOL CHEM, V280, P29506, DOI 10.1074/jbc.M504228200; Ninkovic M, 2012, FEBS LETT, V586, P3077, DOI 10.1016/j.febslet.2012.07.055; Occhiodoro T, 1998, FEBS LETT, V434, P177, DOI 10.1016/S0014-5793(98)00973-9; Ohya S, 2011, J BIOL CHEM, V286, P16940, DOI 10.1074/jbc.M110.184192; Pardo LA, 1999, EMBO J, V18, P5540, DOI 10.1093/emboj/18.20.5540; Pardo LA, 1998, J CELL BIOL, V143, P767, DOI 10.1083/jcb.143.3.767; Piros ET, 1999, J BIOL CHEM, V274, P33677, DOI 10.1074/jbc.274.47.33677; Schonherr R, 2000, EMBO J, V19, P3263, DOI 10.1093/emboj/19.13.3263; Schroeter A, 2010, J MOL CELL CARDIOL, V49, P16, DOI 10.1016/j.yjmcc.2010.04.004; Shi XZ, 2006, ANAL BIOCHEM, V356, P222, DOI 10.1016/j.ab.2006.06.028; Stevens L, 2009, EUR BIOPHYS J BIOPHY, V38, P523, DOI 10.1007/s00249-009-0402-8; Sun XX, 2009, MOL CELL NEUROSCI, V40, P338, DOI 10.1016/j.mcn.2008.11.005; Sun XX, 2004, J BIOL CHEM, V279, P10206, DOI 10.1074/jbc.M310728200; Tan BZ, 2011, J BIOL CHEM, V286, P42725, DOI 10.1074/jbc.M111.265207; Tian LJ, 2001, J BIOL CHEM, V276, P7717, DOI 10.1074/jbc.C000741200; Veale EL, 2010, J BIOL CHEM, V285, P29295, DOI 10.1074/jbc.M110.108423; Wagner V, 2010, J CELL BIOCHEM, V110, P598, DOI 10.1002/jcb.22564; WARMKE JW, 1994, P NATL ACAD SCI USA, V91, P3438, DOI 10.1073/pnas.91.8.3438; Weber C, 2006, J BIOL CHEM, V281, P13030, DOI 10.1074/jbc.M600883200; Zarei MM, 2004, P NATL ACAD SCI USA, V101, P10072, DOI 10.1073/pnas.0302919101; Zhang HY, 2010, BRIT J PHARMACOL, V160, P1631, DOI 10.1111/j.1476-5381.2010.00798.x; Ziechner U, 2006, FEBS J, V273, P1074, DOI 10.1111/j.1742-4658.2006.05134.x	63	13	13	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2015	290	51					30351	30365		10.1074/jbc.M115.668749	http://dx.doi.org/10.1074/jbc.M115.668749			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CY9PG	26518875	Green Published, hybrid			2022-12-26	WOS:000366738200014
J	Nagy, Z; Wynne, K; von Kriegsheim, A; Gambaryan, S; Smolenski, A				Nagy, Zoltan; Wynne, Kieran; von Kriegsheim, Alexander; Gambaryan, Stepan; Smolenski, Albert			Cyclic Nucleotide-dependent Protein Kinases Target ARHGAP17 and ARHGEF6 Complexes in Platelets	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GTPASE-ACTIVATING PROTEIN; PDZ DOMAIN; PHOSPHORYLATION; BINDING; RHO; FAMILY; INHIBITION; REQUIRES; ROLES; RAC1	Endothelial cells release prostacyclin (PGI(2)) and nitric oxide (NO) to inhibit platelet functions. PGI(2) and NO effects are mediated by cyclic nucleotides, cAMP-and cGMP-dependent protein kinases (PKA, PKG), and largely unknown PKA and PKG substrate proteins. The small G-protein Rac1 plays a key role in platelets and was suggested to be a target of cyclic nucleotide signaling. We confirm that PKA and PKG activation reduces Rac1-GTP levels. Screening for potential mediators of this effect resulted in the identification of the Rac1-specific GTPase-activating protein ARHGAP17 and the guanine nucleotide exchange factor ARHGEF6 as new PKA and PKG substrates in platelets. We mapped the PKA/PKG phosphorylation sites to serine 702 on ARHGAP17 using Phos-tag gels and to serine 684 on ARHGEF6. We show that ARHGAP17 binds to the actin-regulating CIP4 protein in platelets and that Ser-702 phosphorylation interferes with this interaction. Reduced CIP4 binding results in enhanced inhibition of cell migration by ARHGAP17. Furthermore, we show that ARHGEF6 is constitutively linked to GIT1, a GAP of Arf family small G proteins, and that ARHGEF6 phosphorylation enables binding of the 14-3-3 adaptor protein to the ARHGEF6/GIT1 complex. PKA and PKG induced rearrangement of ARHGAP17- and ARHGEF6-associated protein complexes might contribute to Rac1 regulation and platelet inhibition.	[Nagy, Zoltan; Smolenski, Albert] Univ Coll Dublin, UCD Conway Inst, Dublin 4, Ireland; [Nagy, Zoltan; Smolenski, Albert] Univ Coll Dublin, Sch Med, Dublin 4, Ireland; [Wynne, Kieran] Univ Coll Dublin, UCD Conway Inst, Mass Spectrometry Resource, Dublin 4, Ireland; [von Kriegsheim, Alexander] Univ Coll Dublin, Syst Biol Ireland, Dublin 4, Ireland; [Gambaryan, Stepan] Russian Acad Sci, Sechenov Inst Evolutionary Physiol & Biochem, St Petersburg 194223, Russia	University College Dublin; University College Dublin; University College Dublin; University College Dublin; Russian Academy of Sciences; Sechenov Institute of Evolutionary Physiology & Biochemistry	Smolenski, A (corresponding author), Univ Coll Dublin, Sch Med, UCD Conway Inst, Dublin 4, Ireland.	albert.smolenski@ucd.ie	Gambaryan, Stepan/I-3940-2016; Nagy, Zoltan/ABE-3429-2020; von Kriegsheim, Alex/C-2371-2016	Gambaryan, Stepan/0000-0002-1470-0791; Nagy, Zoltan/0000-0001-6517-2071; von Kriegsheim, Alex/0000-0002-4952-8573; WYNNE, KIERAN/0000-0001-5759-5285; Smolenski, Albert/0000-0001-9210-9406	Science Foundation Ireland; Irish Research Council	Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Irish Research Council(Irish Research Council for Science, Engineering and Technology)	This work was supported by funding from the Science Foundation Ireland and the Irish Research Council (to A. S.). The authors declare that have no conflict of interest with the contents of this article.	Angrand PO, 2006, MOL CELL PROTEOMICS, V5, P2211, DOI 10.1074/mcp.M600147-MCP200; Aslan JE, 2013, J THROMB HAEMOST, V11, P35, DOI 10.1111/jth.12051; Aslan JE, 2013, AM J PHYSIOL-CELL PH, V305, pC519, DOI 10.1152/ajpcell.00418.2012; Bagrodia S, 1999, J BIOL CHEM, V274, P22393, DOI 10.1074/jbc.274.32.22393; Baird D, 2005, CURR BIOL, V15, P1, DOI 10.1016/j.cub.2004.12.040; Beck F, 2014, BLOOD, V123, pE1, DOI 10.1182/blood-2013-07-512384; Beck S, 2014, CELL SIGNAL, V26, P1975, DOI 10.1016/j.cellsig.2014.03.024; Beck S, 2013, CELL SIGNAL, V25, P236, DOI 10.1016/j.cellsig.2012.09.005; Burkhart JM, 2012, BLOOD, V120, pE73, DOI 10.1182/blood-2012-04-416594; Cha B, 2005, J BIOL CHEM, V280, P16642, DOI 10.1074/jbc.M500505200; Chahdi A, 2008, MOL CELL BIOL, V28, P1679, DOI 10.1128/MCB.00898-07; Chen YLD, 2013, BLOOD, V122, P1695, DOI 10.1182/blood-2013-03-484550; Choi W, 2006, BLOOD, V107, P3145, DOI 10.1182/blood-2005-09-3563; Csepanyi-Komi Roland, 2013, Small GTPases, V4, P90, DOI 10.4161/sgtp.23708; Delaney MK, 2012, ARTERIOSCL THROM VAS, V32, P2761, DOI 10.1161/ATVBAHA.112.254920; Delaney MK, 2014, BLOOD, V124, P1957, DOI 10.1182/blood-2014-03-560821; Dosztanyi Z, 2005, BIOINFORMATICS, V21, P3433, DOI 10.1093/bioinformatics/bti541; Dunker AK, 2005, FEBS J, V272, P5129, DOI 10.1111/j.1742-4658.2005.04948.x; Gegenbauer K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080251; Gegenbauer K, 2012, BLOOD, V119, P3799, DOI 10.1182/blood-2011-11-390369; Gratacap MP, 2001, J BIOL CHEM, V276, P47906, DOI 10.1074/jbc.M104442200; Guidetti GF, 2013, BIOCHEM J, V453, P115, DOI 10.1042/BJ20130131; Hoffmeister M, 2008, J BIOL CHEM, V283, P2297, DOI 10.1074/jbc.M706825200; Hunter T, 2012, PHILOS T R SOC B, V367, P2513, DOI 10.1098/rstb.2012.0013; Jackson SP, 2011, NAT MED, V17, P1423, DOI 10.1038/nm.2515; Karim ZA, 2008, J BIOL CHEM, V283, P11995, DOI 10.1074/jbc.M800146200; KENNELLY PJ, 1991, J BIOL CHEM, V266, P15555; Kinoshita E, 2011, PROTEOMICS, V11, P319, DOI 10.1002/pmic.201000472; Kurokawa K, 2005, BIOCHEM SOC T, V33, P631, DOI 10.1042/BST0330631; Lawson Campbell D, 2014, Small GTPases, V5, pe27958, DOI 10.4161/sgtp.27958; McCarty OJT, 2005, J BIOL CHEM, V280, P39474, DOI 10.1074/jbc.M504672200; McMahon HT, 2015, J CELL SCI, V128, P1065, DOI 10.1242/jcs.114454; MONCADA S, 1976, NATURE, V263, P663, DOI 10.1038/263663a0; Nakamura F, 1995, J BIOL CHEM, V270, P31377, DOI 10.1074/jbc.270.52.31377; Nisar SP, 2012, J BIOL CHEM, V287, P24505, DOI 10.1074/jbc.M112.347104; Nishiya N, 2002, J BIOCHEM, V132, P279, DOI 10.1093/oxfordjournals.jbchem.a003222; Otsuka F, 2012, NAT REV CARDIOL, V9, P439, DOI 10.1038/nrcardio.2012.64; Pleines I, 2009, PFLUG ARCH EUR J PHY, V457, P1173, DOI 10.1007/s00424-008-0573-7; Premont RT, 2004, CELL SIGNAL, V16, P1001, DOI 10.1016/j.cellsig.2004.02.002; Premont RT, 1998, P NATL ACAD SCI USA, V95, P14082, DOI 10.1073/pnas.95.24.14082; RADOMSKI MW, 1987, BRIT J PHARMACOL, V92, P181, DOI 10.1111/j.1476-5381.1987.tb11310.x; Reczek D, 2001, J CELL BIOL, V153, P191, DOI 10.1083/jcb.153.1.191; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Richnau N, 2004, BIOCHEM BIOPH RES CO, V320, P1034, DOI 10.1016/j.bbrc.2004.05.221; Richnau N, 2001, J BIOL CHEM, V276, P35060, DOI 10.1074/jbc.M103540200; Rowley JW, 2011, BLOOD, V118, pE101, DOI 10.1182/blood-2011-03-339705; Saengsawang W, 2013, J CELL SCI, V126, P2411, DOI 10.1242/jcs.117473; Sato H, 2008, BIOCHEM BIOPH RES CO, V368, P157, DOI 10.1016/j.bbrc.2008.01.064; Schlenker O, 2009, J MOL BIOL, V386, P280, DOI 10.1016/j.jmb.2008.12.050; Schultess J, 2005, BLOOD, V105, P3185, DOI 10.1182/blood-2004-09-3605; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Smolenski A, 2012, J THROMB HAEMOST, V10, P167, DOI 10.1111/j.1538-7836.2011.04576.x; Soulet C, 2001, FEBS LETT, V507, P253, DOI 10.1016/S0014-5793(01)02984-2; Subramanian H, 2013, J THROMB HAEMOST, V11, P1574, DOI 10.1111/jth.12271; Turriziani Benedetta, 2014, Biology (Basel), V3, P320, DOI 10.3390/biology3020320; van den Bosch MTJ, 2014, J THROMB HAEMOST, V12, P726, DOI 10.1111/jth.12542; Vitale N, 2000, J BIOL CHEM, V275, P13901, DOI 10.1074/jbc.275.18.13901; Yun CHC, 1997, P NATL ACAD SCI USA, V94, P3010, DOI 10.1073/pnas.94.7.3010	58	19	21	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 11	2015	290	50					29974	29983		10.1074/jbc.M115.678003	http://dx.doi.org/10.1074/jbc.M115.678003			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CY7UL	26507661	hybrid, Green Published, Green Submitted			2022-12-26	WOS:000366614700029
J	Loo, TW; Clarke, DM				Loo, Tip W.; Clarke, David M.			Mapping the Binding Site of the Inhibitor Tariquidar That Stabilizes the First Transmembrane Domain of P-glycoprotein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DRUG-BINDING; NUCLEOTIDE-BINDING; ATPASE ACTIVITY; FUNCTIONAL CONSEQUENCES; CONFORMATIONAL-CHANGES; PROMOTE MATURATION; CROSS-LINKING; RESISTANCE; MUTATIONS; MUTANTS	ABC (ATP-binding cassette) transporters are clinically important because drug pumps like P-glycoprotein (P-gp, ABCB1) confer multidrug resistance and mutant ABC proteins are responsible for many protein-folding diseases such as cystic fibrosis. Identification of the tariquidar-binding site has been the subject of intensive molecular modeling studies because it is the most potent inhibitor and corrector of P-gp. Tariquidar is a unique P-gp inhibitor because it locks the pump in a conformation that blocks drug efflux but activates ATPase activity. In silico docking studies have identified several potential tariquidar-binding sites. Here, we show through cross-linking studies that tariquidar most likely binds to sites within the transmembrane (TM) segments located in one wing or at the interface between the two wings (12 TM segments form 2 divergent wings). We then introduced arginine residues at all positions in the 12 TM segments (223 mutants) of P-gp. The rationale was that a charged residue in the drug-binding pocket would disrupt hydrophobic interaction with tariquidar and inhibit its ability to rescue processing mutants or stimulate ATPase activity. Arginines introduced at 30 positions significantly inhibited tariquidar rescue of a processing mutant and activation of ATPase activity. The results suggest that tariquidar binds to a site within the drug-binding pocket at the interface between the TM segments of both structural wings. Tariquidar differed from other drug substrates, however, as it stabilized the first TM domain. Stabilization of the first TM domain appears to be a key mechanism for high efficiency rescue of ABC processing mutants that cause disease.	Univ Toronto, Dept Med, Toronto, ON M5S 1A8, Canada; Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada	University of Toronto; University of Toronto	Clarke, DM (corresponding author), 1 Kings Coll Circle,Rm 7342,Med Sci Bldg, Toronto, ON M5S 1A8, Canada.	david.clarke@utoronto.ca	Clarke, David M./A-1112-2008	Clarke, David M./0000-0003-4335-7184; Loo, Tip W/0000-0003-2108-0188	Canadian Institutes of Health Research; Cystic Fibrosis Canada	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Cystic Fibrosis Canada	This work was supported in part by a grant from the Canadian Institutes of Health Research and Cystic Fibrosis Canada. The authors declare that they have no conflicts of interest with the contents of this article.	Bhatia A, 2005, BIOCHEMISTRY-US, V44, P10893, DOI 10.1021/bi0503807; Borst P, 2002, ANNU REV BIOCHEM, V71, P537, DOI 10.1146/annurev.biochem.71.102301.093055; Chen EY, 2004, J BIOL CHEM, V279, P39620, DOI 10.1074/jbc.M407887200; Chen EYJ, 2000, BIOCHEMISTRY-US, V39, P3797, DOI 10.1021/bi992620m; Chen YC, 2015, TRENDS PHARMACOL SCI, V36, P78, DOI 10.1016/j.tips.2014.12.001; CHOI K, 1988, CELL, V53, P519, DOI 10.1016/0092-8674(88)90568-5; Chufan EE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082463; CLARKE DM, 1989, NATURE, V339, P476, DOI 10.1038/339476a0; DeLano W. L., 2002, PYMOL MOL GRAPHICS S, DOI DOI 10.1007/S10822-016-9944-X; Dey S, 1997, P NATL ACAD SCI USA, V94, P10594, DOI 10.1073/pnas.94.20.10594; Dorairaj S, 2007, P NATL ACAD SCI USA, V104, P4943, DOI 10.1073/pnas.0610470104; GORMAN CM, 1983, NUCLEIC ACIDS RES, V11, P7631, DOI 10.1093/nar/11.21.7631; Jara GE, 2013, J MOL GRAPH MODEL, V46, P10, DOI 10.1016/j.jmgm.2013.09.001; Jin MS, 2012, NATURE, V490, P566, DOI 10.1038/nature11448; Kannan P, 2011, ACS CHEM NEUROSCI, V2, P82, DOI 10.1021/cn100078a; Kong LL, 2015, SCI REP-UK, V5, DOI 10.1038/srep11747; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; Li JZ, 2014, PROTEIN SCI, V23, P34, DOI 10.1002/pro.2387; Loo TW, 2008, BIOCHEM J, V413, P29, DOI 10.1042/BJ20071690; Loo TW, 2008, J BIOL CHEM, V283, P28190, DOI 10.1074/jbc.M805834200; Loo TW, 2008, J BIOL CHEM, V283, P24860, DOI 10.1074/jbc.M803351200; Loo TW, 2006, BIOCHEM J, V399, P351, DOI 10.1042/BJ20060715; Loo TW, 2006, BIOCHEM J, V396, P537, DOI 10.1042/BJ20060012; Loo TW, 2015, J BIOL CHEM, V290, P16954, DOI 10.1074/jbc.M115.652602; Loo TW, 2014, BIOCHEM PHARMACOL, V92, P558, DOI 10.1016/j.bcp.2014.10.006; Loo TW, 2014, J BIOL CHEM, V289, P24749, DOI 10.1074/jbc.M114.583021; Loo TW, 2014, J BIOL CHEM, V289, P229, DOI 10.1074/jbc.M113.527804; Loo TW, 2013, BIOCHEMISTRY-US, V52, P7167, DOI 10.1021/bi401269m; Loo TW, 2013, BIOCHEMISTRY-US, V52, P5161, DOI 10.1021/bi4008758; Loo TW, 2013, BIOCHEM PHARMACOL, V86, P612, DOI 10.1016/j.bcp.2013.06.028; Loo TW, 2013, BIOCHEMISTRY-US, V52, P3194, DOI 10.1021/bi400425k; Loo TW, 2013, J BIOL CHEM, V288, P20326, DOI 10.1074/jbc.M113.484550; Loo TW, 2012, J BIOL CHEM, V287, P26806, DOI 10.1074/jbc.M112.376202; Loo TW, 2012, BIOCHEM PHARMACOL, V83, P345, DOI 10.1016/j.bcp.2011.11.014; Loo TW, 2010, BIOCHEM BIOPH RES CO, V395, P436, DOI 10.1016/j.bbrc.2010.04.057; Loo TW, 2009, J BIOL CHEM, V284, P24074, DOI 10.1074/jbc.M109.023267; Loo TW, 1997, J BIOL CHEM, V272, P709, DOI 10.1074/jbc.272.2.709; Loo TW, 2003, J BIOL CHEM, V278, P1575, DOI 10.1074/jbc.M211307200; Loo TW, 2003, J BIOL CHEM, V278, P13603, DOI 10.1074/jbc.C300073200; Loo TW, 2005, BIOCHEMISTRY-US, V44, P10250, DOI 10.1021/bi050705j; Loo TW, 2004, BIOCHEMISTRY-US, V43, P12081, DOI 10.1021/bi049045t; Loo TW, 2004, J BIOL CHEM, V279, P7692, DOI 10.1074/jbc.M311825200; Loo TW, 2003, J BIOL CHEM, V278, P50136, DOI 10.1074/jbc.M310448200; Loo TW, 1999, FASEB J, V13, P1724, DOI 10.1096/fasebj.13.13.1724; Loo TW, 2003, J BIOL CHEM, V278, P20449, DOI 10.1074/jbc.C300154200; Loo TW, 1999, J BIOL CHEM, V274, P35388, DOI 10.1074/jbc.274.50.35388; Loo TW, 1997, J BIOL CHEM, V272, P20986, DOI 10.1074/jbc.272.34.20986; LOO TW, 1993, J BIOL CHEM, V268, P3143; LOO TW, 1995, J BIOL CHEM, V270, P843, DOI 10.1074/jbc.270.2.843; LOO TW, 1994, J BIOL CHEM, V269, P7243; Loo TW, 2002, J BIOL CHEM, V277, P41303, DOI 10.1074/jbc.C200484200; Loo TW, 1998, J BIOL CHEM, V273, P14671, DOI 10.1074/jbc.273.24.14671; Loo TW, 2001, J BIOL CHEM, V276, P31800, DOI 10.1074/jbc.M103498200; LOO TW, 1995, J BIOL CHEM, V270, P21449, DOI 10.1074/jbc.270.37.21449; Loo TW, 2001, J BIOL CHEM, V276, P14972, DOI 10.1074/jbc.M100407200; LOO TW, 1995, J BIOL CHEM, V270, P21839, DOI 10.1074/jbc.270.37.21839; LOO TW, 1993, J BIOL CHEM, V268, P19965; Martin C, 1999, BRIT J PHARMACOL, V128, P403, DOI 10.1038/sj.bjp.0702807; McCormick JW, 2015, BIOCHEMISTRY-US, V54, P4374, DOI 10.1021/acs.biochem.5b00018; Pajeva IK, 2013, CHEMMEDCHEM, V8, P1701, DOI 10.1002/cmdc.201300233; Pajeva IK, 2013, CHEMMEDCHEM, V8, P748, DOI 10.1002/cmdc.201200491; Prajapati R, 2014, BBA-BIOMEMBRANES, V1838, P2882, DOI 10.1016/j.bbamem.2014.07.018; SARKADI B, 1992, J BIOL CHEM, V267, P4854; URBATSCH IL, 1995, ARCH BIOCHEM BIOPHYS, V316, P135, DOI 10.1006/abbi.1995.1020; Van Goor F, 2011, P NATL ACAD SCI USA, V108, P18843, DOI 10.1073/pnas.1105787108; Wagner CC, 2009, J NUCL MED, V50, P1954, DOI 10.2967/jnumed.109.063289; Wang Y, 2007, J BIOL CHEM, V282, P33247, DOI 10.1074/jbc.C700175200; Ward AB, 2013, P NATL ACAD SCI USA, V110, P13386, DOI 10.1073/pnas.1309275110; Wen PC, 2013, J BIOL CHEM, V288, P19211, DOI 10.1074/jbc.M113.450114	69	30	31	1	17	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 4	2015	290	49					29389	29401		10.1074/jbc.M115.695171	http://dx.doi.org/10.1074/jbc.M115.695171			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CY7TY	26507655	Green Published, hybrid			2022-12-26	WOS:000366613400024
J	Lim, YM; Yagi, Y; Tsuda, L				Lim, Young-Mi; Yagi, Yoshimasa; Tsuda, Leo			Cellular Defense and Sensory Cell Survival Require Distinct Functions of ebi in Drosophila	PLOS ONE			English	Article							NF-KAPPA-B; INNATE IMMUNE-RESPONSE; COREPRESSOR COMPLEX; SIGNALING PATHWAYS; DOWN-REGULATION; GENE; ACTIVATION; REPRESSION; RECEPTOR; PROTEIN	The innate immune response and stress-induced apoptosis are well-established signaling pathways related to cellular defense. NF-kappa B and AP-1 are redox-sensitive transcription factors that play important roles in those pathways. Here we show that Ebi, a Drosophila homolog of the mammalian co-repressor molecule transducin beta-like 1 (TBL1), variously regulates the expression of specific genes that are targets of redox-sensitive transcription factors. In response to different stimuli, Ebi activated gene expression to support the acute immune response in fat bodies, whereas Ebi repressed genes that are involved in apoptosis in photoreceptor cells. Thus, Ebi seems to act as a regulatory switch for genes that are activated or repressed in response to different external stimuli. Our results offer clear in vivo evidence that the Ebi-containing co-repressor complex acts in a distinct manner to regulate transcription that is required for modulating the output of various processes during Drosophila development.	[Lim, Young-Mi; Tsuda, Leo] NCGG, Ctr Dev Adv Med Dementia CAMD, Anim Models Aging Project Team, Obu, Aichi, Japan; [Yagi, Yoshimasa] Nagoya Univ, Grad Sch Sci, Div Biol Sci, Nagoya, Aichi 4648602, Japan	Nagoya University	Tsuda, L (corresponding author), NCGG, Ctr Dev Adv Med Dementia CAMD, Anim Models Aging Project Team, Obu, Aichi, Japan.	ltsuda@ncgg.go.jp						Aggarwal BB, 2000, ANN RHEUM DIS, V59, P6; Baek SH, 2002, CELL, V110, P55, DOI 10.1016/S0092-8674(02)00809-7; Berger I, 1998, GENE, V211, P375, DOI 10.1016/S0378-1119(98)00120-6; Bonnay F, 2014, EMBO J, V33, P2349, DOI 10.15252/embj.201488456; Boulton SJ, 2000, EMBO J, V19, P5376, DOI 10.1093/emboj/19.20.5376; Boutros M, 2002, DEV CELL, V3, P711, DOI 10.1016/S1534-5807(02)00325-8; Dong XZ, 1999, GENE DEV, V13, P954, DOI 10.1101/gad.13.8.954; Espinosa L, 2003, MOL BIOL CELL, V14, P491, DOI 10.1091/mbc.E02-07-0404; Ganesan S, 2011, CURR TOP MICROBIOL, V349, P25, DOI 10.1007/82_2010_107; Garg AK, 2002, MOL IMMUNOL, V39, P509, DOI 10.1016/S0161-5890(02)00207-9; Georgel P, 2001, DEV CELL, V1, P503, DOI 10.1016/S1534-5807(01)00059-4; Gerald D, 2004, CELL, V118, P781, DOI 10.1016/j.cell.2004.08.025; Guenther MG, 2000, GENE DEV, V14, P1048; HAY BA, 1994, DEVELOPMENT, V120, P2121; Hecht A, 1999, METHOD ENZYMOL, V304, P399; Herbein G, 2006, BIOGERONTOLOGY, V7, P409, DOI 10.1007/s10522-006-9056-4; HSU JC, 1993, CANCER RES, V53, P3789; Huang W, 2009, MOL CELL, V35, P48, DOI 10.1016/j.molcel.2009.05.023; KAPPLER C, 1993, EMBO J, V12, P1561, DOI 10.1002/j.1460-2075.1993.tb05800.x; Kim LK, 2007, PLOS BIOL, V5, P2064, DOI 10.1371/journal.pbio.0050238; Kim T, 2005, NAT IMMUNOL, V6, P211, DOI 10.1038/ni1159; Lee SK, 2000, J BIOL CHEM, V275, P12470, DOI 10.1074/jbc.275.17.12470; Li J, 2008, NAT CELL BIOL, V10, P160, DOI 10.1038/ncb1684; Li SH, 2002, MOL CELL BIOL, V22, P6854, DOI 10.1128/MCB.22.19.6854-6865.2002; Lim YM, 2013, GENES CELLS, V18, P909, DOI 10.1111/gtc.12088; Lim YM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037028; Martin-Blanco E, 1998, GENE DEV, V12, P557, DOI 10.1101/gad.12.4.557; Ogawa S, 2004, P NATL ACAD SCI USA, V101, P14461, DOI 10.1073/pnas.0405786101; Payankaulam S, 2010, CURR BIOL, V20, pR764, DOI 10.1016/j.cub.2010.06.037; Perissi V, 2004, CELL, V116, P511, DOI 10.1016/S0092-8674(04)00133-3; Perissi V, 2008, MOL CELL, V29, P755, DOI 10.1016/j.molcel.2008.01.020; Piette J, 1997, BIOL CHEM, V378, P1237; Pott J, 2012, EMBO REP, V13, P684, DOI 10.1038/embor.2012.96; ROBB JA, 1969, J CELL BIOL, V41, P876, DOI 10.1083/jcb.41.3.876; Rosenfeld MG, 2006, GENE DEV, V20, P1405, DOI 10.1101/gad.1424806; Tomita A, 2004, MOL CELL BIOL, V24, P3337, DOI 10.1128/MCB.24.8.3337-3346.2004; Tsuda L, 2002, CELL, V110, P625, DOI 10.1016/S0092-8674(02)00875-9; Tsuda L, 2006, EMBO J, V25, P3191, DOI 10.1038/sj.emboj.7601179; Yagi Y, 2005, EMBO REP, V6, P1088, DOI 10.1038/sj.embor.7400542; Yagi Y, 2013, GENES CELLS, V18, P934, DOI 10.1111/gtc.12085; Yan JH, 2007, MOL ENDOCRINOL, V21, P1630, DOI 10.1210/me.2007-0072; Yoon HG, 2005, MOL CELL BIOL, V25, P324, DOI 10.1128/MCB.25.1.324-335.2005; Yoon HG, 2003, EMBO J, V22, P1336, DOI 10.1093/emboj/cdg120; Zhang JS, 2002, MOL CELL, V9, P611, DOI 10.1016/S1097-2765(02)00468-9	44	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2015	10	11							e0141457	10.1371/journal.pone.0141457	http://dx.doi.org/10.1371/journal.pone.0141457			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV1PG	26524764	Green Published, gold, Green Submitted			2022-12-26	WOS:000364029800009
J	Dupuis, JR; Sperling, FAH				Dupuis, Julian R.; Sperling, Felix A. H.			Repeated Reticulate Evolution in North American Papilio machaon Group Swallowtail Butterflies	PLOS ONE			English	Article							MITOCHONDRIAL-DNA; GENETIC DIVERSITY; ADAPTIVE INTROGRESSION; POPULATION-STRUCTURE; HYBRID SPECIATION; R-PACKAGE; LEPIDOPTERA; HYBRIDIZATION; PHYLOGENETICS; INFERENCE	Hybridization between distinct populations or species is increasingly recognized as an important process for generating biodiversity. However, the interaction between hybridization and speciation is complex, and the diverse evolutionary outcomes of hybridization are difficult to differentiate. Here we characterize potential hybridization in a species group of swallowtail butterflies using microsatellites, DNA sequences, and morphology, and assess whether adaptive introgression or homoploid hybrid speciation was the primary process leading to each putative hybrid lineage. Four geographically separated hybrid populations were identified in the Papilio machaon species group. One distinct mitochondrial DNA clade from P. machaon was fixed in three hybrid taxa (P. brevicauda, P. joanae, and P. m. kahli), while one hybrid swarm (P. zelicaon x machaon) exhibited this hybrid mtDNA clade as well as widespread parental mtDNA haplotypes from both parental species. Microsatellite markers and morphology showed variable admixture and intermediacy, ranging from signatures of prolonged differential introgression from the paternal species (P. polyxenes/P. zelicaon) to current gene flow with both parental species. Divergences of the hybrid lineages dated to early- to mid-Pleistocene, suggesting that repeated glaciations and subsequent range shifts of parental species, particularly P. machaon hudsonianus, facilitated initial hybridization. Although each lineage is distinct, P. joanae is the only taxon with sufficient evidence (ecological separation from parental species) to define it as a homoploid hybrid species. The repetition of hybridization in this group provides a valuable foundation for future research on hybridization, and these results emphasize the potential for hybridization to drive speciation in diverse ways.	[Dupuis, Julian R.; Sperling, Felix A. H.] Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada	University of Alberta	Dupuis, JR (corresponding author), Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada.	jrdupuis@ualberta.ca	Sperling, Felix A.H./H-8376-2012	Sperling, Felix A.H./0000-0001-5148-4226; Dupuis, Julian/0000-0002-6989-9179	Alberta Conservation Association [RES0008471]; Circumpolar/Boreal Alberta Research [330 390200 0 N011000001]; Natural Sciences and Engineering Research Council of Canada [RES0016259]; Canadian Circumpolar Institute	Alberta Conservation Association; Circumpolar/Boreal Alberta Research; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canadian Circumpolar Institute	Funding provided by Alberta Conservation Association, Grant in Biodiversity RES0008471, JRD, http://www.ab-conservation.com/go/default/, Canadian Circumpolar Institute, Circumpolar/Boreal Alberta Research Grant 330 390200 0 N011000001, JRD, http://www.cci.ualberta.ca/ and Natural Sciences and Engineering Research Council of Canada, Discovery Grant RES0016259, FAHS, www.nserc-crsng.gc.ca/index_eng.asp. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott R, 2013, J EVOLUTION BIOL, V26, P229, DOI 10.1111/j.1420-9101.2012.02599.x; Ae S.A, 1979, Systematic Entomology, V4, P1, DOI 10.1111/j.1365-3113.1979.tb00605.x; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; ALLEN RT, 1990, FLA ENTOMOL, V73, P539, DOI 10.2307/3495270; BARTON NH, 1985, ANNU REV ECOL SYST, V16, P113, DOI 10.1146/annurev.es.16.110185.000553; Bazin E, 2006, SCIENCE, V312, P570, DOI 10.1126/science.1122033; Bird C.D., 1995, ALBERTA BUTTERFLIES; Bromilow SM, 2011, J BIOGEOGR, V38, P299, DOI 10.1111/j.1365-2699.2010.02398.x; Brower AVZ, 2011, GENETICA, V139, P589, DOI 10.1007/s10709-010-9530-4; BROWER JV, 1958, EVOLUTION, V12, P123, DOI 10.1111/j.1558-5646.1958.tb02939.x; Brownstein MJ, 1996, BIOTECHNIQUES, V20, P1004, DOI 10.2144/96206st01; Buggs RJA, 2007, HEREDITY, V99, P301, DOI 10.1038/sj.hdy.6800997; Butlin R, 2012, TRENDS ECOL EVOL, V27, P27, DOI 10.1016/j.tree.2011.09.002; Caterino MS, 1999, MOL PHYLOGENET EVOL, V11, P122, DOI 10.1006/mpev.1998.0549; CHERMOCK F. H., 1937, BULL SO CALIFORNIA ACAD SCI, V36, P11; CLARKE CA, 1986, SYST ENTOMOL, V11, P175; CLARKE CA, 1955, EVOLUTION, V9, P182, DOI 10.1111/j.1558-5646.1955.tb01530.x; Condamine FL, 2012, ECOL LETT, V15, P267, DOI 10.1111/j.1461-0248.2011.01737.x; Cong Q, 2015, CELL REP, V10, P910, DOI 10.1016/j.celrep.2015.01.026; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Dasmahapatra KK, 2012, NATURE, V487, P94, DOI 10.1038/nature11041; DEMARAIS BD, 1992, P NATL ACAD SCI USA, V89, P2747, DOI 10.1073/pnas.89.7.2747; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; EHRLICH PR, 1964, EVOLUTION, V18, P586, DOI 10.2307/2406212; EMMEL JOHN F., 1964, J RES LEPIDOPTERA, V3, P157; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Ferguson DC, 1955, NOVA SCOTIA MUSEUM S, VI; FITCH WM, 1971, SYST ZOOL, V20, P406, DOI 10.2307/2412116; Forest F, 2009, ANN BOT-LONDON, V104, P789, DOI 10.1093/aob/mcp192; Funk DJ, 2003, ANNU REV ECOL EVOL S, V34, P397, DOI 10.1146/annurev.ecolsys.34.011802.132421; Genner MJ, 2012, MOL BIOL EVOL, V29, P195, DOI 10.1093/molbev/msr183; Gernhard T, 2008, J THEOR BIOL, V253, P769, DOI 10.1016/j.jtbi.2008.04.005; Gompert Z, 2014, MOL ECOL, V23, P4555, DOI 10.1111/mec.12811; Gompert Z, 2006, SCIENCE, V314, P1923, DOI 10.1126/science.1135875; Graur D, 2004, TRENDS GENET, V20, P80, DOI 10.1016/j.tig.2003.12.003; Gross BL, 2005, J HERED, V96, P241, DOI 10.1093/jhered/esi026; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Haig SM, 2004, CONSERV BIOL, V18, P1347, DOI 10.1111/j.1523-1739.2004.00206.x; Harrison RG, 2012, EVOLUTION, V66, P3643, DOI 10.1111/j.1558-5646.2012.01785.x; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Hedrick PW, 2013, MOL ECOL, V22, P4606, DOI 10.1111/mec.12415; HEITZMAN J R, 1973, Journal of Research on the Lepidoptera, V12, P1; Hermansen JS, 2011, MOL ECOL, V20, P3812, DOI 10.1111/j.1365-294X.2011.05183.x; HEWITT GM, 1988, TRENDS ECOL EVOL, V3, P158, DOI 10.1016/0169-5347(88)90033-X; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Jiggins CD, 2008, PHILOS T R SOC B, V363, P3047, DOI 10.1098/rstb.2008.0065; Jiggins FM, 2003, GENETICS, V164, P5; Jombart T, 2010, BMC GENET, V11, DOI [DOI 10.1186/1471-2156-11-94, 10.1186/1471-2156-11-94]; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; Kanno Y, 2011, MOL ECOL, V20, P3711, DOI 10.1111/j.1365-294X.2011.05210.x; KLASSEN P, 1989, BUTTERFLIES MANITOBA; Kunte K, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002274; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Latch EK, 2011, MOL ECOL, V20, P5265, DOI 10.1111/j.1365-294X.2011.05349.x; LAYBERRY R., 1998, BUTTERFLIES CANADA; Le S, 2008, J STAT SOFTW, V25, P1, DOI 10.18637/jss.v025.i01; Maddison D. R., 2005, MACCLADE 4 08A ANAL, DOI [DOI 10.1046/J.1420-9101.1996.9020153.X, DOI 10.1007/s13592-012-0141-1]; Maddison WP, 2011, MESQUITE MODULAR SYS; Mallet J, 2004, SYST BIODIVERS, V1, P441; Mallet J, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-28; Mallet J, 2007, NATURE, V446, P279, DOI 10.1038/nature05706; Mavarez J, 2006, NATURE, V441, P868, DOI 10.1038/nature04738; Mayr E, 1955, T R ENTOMOL SOC LOND, V107, P45; McGuire JA, 2007, EVOLUTION, V61, P2879, DOI 10.1111/j.1558-5646.2007.00239.x; Mckay BD, 2010, MOL PHYLOGENET EVOL, V54, P647, DOI 10.1016/j.ympev.2009.08.024; Meirmans PG, 2004, MOL ECOL NOTES, V4, P792, DOI 10.1111/j.1471-8286.2004.00770.x; Melo-Ferreira J, 2012, SYST BIOL, V61, P367, DOI 10.1093/sysbio/syr114; Mickelson DM, 2004, DEV QUA SCI, V1, P1; Monzon J, 2014, MOL ECOL, V23, P182, DOI 10.1111/mec.12570; Morris R.F., 1980, BUTTERFLIES MOTHS NE; Nadeau NJ, 2013, MOL ECOL, V22, P814, DOI 10.1111/j.1365-294X.2012.05730.x; Nolte AW, 2010, TRENDS GENET, V26, P54, DOI 10.1016/j.tig.2009.12.001; Pardo-Diaz C, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002752; Pelham J, 2008, J RES LEPIDOPTERA, V40, pxiv; Pritchard JK, 2000, GENETICS, V155, P945; R Development Core Team, 2013, R VERS 2 0 1; Reed RD, 1999, MOL BIOL EVOL, V16, P286, DOI 10.1093/oxfordjournals.molbev.a026110; REMINGTON CHARLES L., 1968, POSTILLA [YALE PEABODY MUS], V119, P1; Rieseberg LH, 2003, SCIENCE, V301, P1211, DOI 10.1126/science.1086949; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Rothschild W. Hon., 1906, Novitates Zoologicae, V13, P411; Ruegg K, 2008, EVOLUTION, V62, P452, DOI 10.1111/j.1558-5646.2007.00263.x; Schuelke M, 2000, NAT BIOTECHNOL, V18, P233, DOI 10.1038/72708; Schwarz D, 2007, EVOLUTION, V61, P245, DOI 10.1111/j.1558-5646.2007.00027.x; SCHWEITZER D. F., 2011, RARE DECLINING POORL; Scott J. A., 1986, BUTTERFLIES N AM NAT; Scriber JM, 2007, INSECT SCI, V14, P389, DOI 10.1111/j.1744-7917.2007.00166.X; Scriber JM, 2005, ENTOMOL EXP APPL, V115, P247, DOI 10.1111/j.1570-7458.2005.00285.x; Servedio MR, 2003, ANNU REV ECOL EVOL S, V34, P339, DOI 10.1146/annurev.ecolsys.34.011802.132412; Simonsen TJ, 2011, CLADISTICS, V27, P113, DOI 10.1111/j.1096-0031.2010.00326.x; SPERLING F A H, 1987, Quaestiones Entomologicae, V23, P198; SPERLING FAH, 1990, CAN J ZOOL, V68, P1790, DOI 10.1139/z90-260; SPERLING FAH, 1994, EVOLUTION, V48, P408, DOI [10.2307/2410101, 10.1111/j.1558-5646.1994.tb01320.x]; Sperling Felix, 2003, P431; Stemshorn KC, 2011, MOL ECOL, V20, P1475, DOI 10.1111/j.1365-294X.2010.04997.x; Swofford David L., 1990, P411; Swofford DL, 2002, PAUP PHYLOGENETIC AN; Tavare S., 1986, LECT MATH LIFE SCI, V17, P57; Taylor EB, 2006, MOL ECOL, V15, P343, DOI 10.1111/j.1365-294X.2005.02794.x; TEMPLETON AR, 1983, EVOLUTION, V37, P221, DOI 10.1111/j.1558-5646.1983.tb05533.x; TYLER HA, 1994, SWALLOWTAIL BUTTERFL; Via S, 2009, P NATL ACAD SCI USA, V106, P9939, DOI 10.1073/pnas.0901397106; Wagner W. H. Jun., 1970, Taxon, P146; Whitney KD, 2010, NEW PHYTOL, V187, P230, DOI 10.1111/j.1469-8137.2010.03234.x; WILLIAM J, 1995, TRENDS ECOL EVOL, V10, P485, DOI 10.1016/S0169-5347(00)89195-8; Wilson CC, 1998, MOL ECOL, V7, P127, DOI 10.1046/j.1365-294x.1998.00302.x; Yule GU, 1925, PHILOS T R SOC LON B, V213, P21, DOI 10.1098/rstb.1925.0002; Zakharov EV, 2009, HEREDITY, V102, P590, DOI 10.1038/hdy.2009.26; Zakharov EV, 2004, SYST BIOL, V53, P193, DOI 10.1080/10635150490423403; Zakharov EV, 2007, MOL ECOL NOTES, V7, P144, DOI 10.1111/j.1471-8286.2006.01557.x; Zhang W, 2013, GENOME BIOL EVOL, V5, P1233, DOI 10.1093/gbe/evt090; Zwickl DJ., 2006, GENETIC ALGORITHM AP	115	22	23	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2015	10	10							e0141882	10.1371/journal.pone.0141882	http://dx.doi.org/10.1371/journal.pone.0141882			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0EH	26517268	Green Submitted, gold, Green Published			2022-12-26	WOS:000363920800089
J	Feng, JL; Dai, ZY; Zhang, YP; Meng, L; Ye, J; Ma, XT				Feng, Junli; Dai, Zhiyuan; Zhang, Yanping; Meng, Lu; Ye, Jian; Ma, Xuting			Alteration of Gene Expression Profile in Kidney of Spontaneously Hypertensive Rats Treated with Protein Hydrolysate of Blue Mussel (Mytilus edulis) by DNA Microarray Analysis	PLOS ONE			English	Article							ACE INHIBITORY PEPTIDE; ANTIHYPERTENSIVE PEPTIDES; BIOACTIVE PEPTIDES; BLOOD-PRESSURE; MATRIX METALLOPROTEINASE-7; UNCOUPLING PROTEIN-3; DYSFUNCTION; 5-HYDROXYTRYPTOPHAN; PURIFICATION; INCREASES	Marine organisms are rich sources of bioactive components, which are often reported to have antihypertensive effects. However, the underlying mechanisms have yet to be fully identified. The aim of this study was to investigate the antihypertensive effect of enzymatic hydrolysis of blue mussel protein (HBMP) in rats. Peptides with in vitro ACE inhibitory activity were purified from HBMP by ultrafiltration, gel filtration chromatography and reversed-phase high performance liquid chromatography. And the amino acid sequences of isolated peptides were estimated to be Val-Trp, Leu-Gly-Trp, and Met-Val-Trp-Thr. To study its in vivo action, spontaneously hypertensive rats (SHRs) were orally administration with high-or low-dose of HBMP for 28 days. Major components of the renin-angiotensin (RAS) system in serum of SHRs from different groups were analyzed, and gene expression profiling were performed in the kidney of SHRs, using the Whole Rat Genome Oligonucleotide Microarray. Results indicated although genes involved in RAS system were not significantly altered, those related to blood coagulation system, cytokine and growth factor, and fatty acids metabolism were remarkablely changed. Several genes which were seldom reported to be implicated in pathogenesis of hypertension also showed significant expression alterations after oral administration of HBMP. These data provided valuable information for our understanding of the molecular mechanisms that underlie the potential antihypertensive activities of HBMP, and will contribute towards increased value-added utilization of blue mussel protein.	[Feng, Junli; Dai, Zhiyuan; Meng, Lu; Ye, Jian; Ma, Xuting] Zhejiang Gongshang Univ, Inst Seafood, Hangzhou, Zhejiang, Peoples R China; [Zhang, Yanping] Zhejiang Univ Sci & Technol, Sch Biol & Chem Engn, Hangzhou, Zhejiang, Peoples R China	Zhejiang Gongshang University; Zhejiang University of Science & Technology	Dai, ZY (corresponding author), Zhejiang Gongshang Univ, Inst Seafood, Hangzhou, Zhejiang, Peoples R China.	dzy@mail.zjgsu.edu.cn			Scientific Research Fund of Zhejiang Provincial Education Department [Y201534380]; Key Scientific Research Project of Zhejiang Entry-exit Inspection and Quarantine Bureau [2014-ZKZ-010]; National High Technology Research and Development Program of China [2012AA092302]; Major Science and Technology Projects of Zhejiang Province [2012C03009-3]	Scientific Research Fund of Zhejiang Provincial Education Department; Key Scientific Research Project of Zhejiang Entry-exit Inspection and Quarantine Bureau; National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); Major Science and Technology Projects of Zhejiang Province	This work was supported by the Scientific Research Fund of Zhejiang Provincial Education Department (Y201534380), the Key Scientific Research Project of Zhejiang Entry-exit Inspection and Quarantine Bureau (Grant No. 2014-ZKZ-010), the National High Technology Research and Development Program of China (Grant No. 2012AA092302), and the Major Science and Technology Projects of Zhejiang Province (Grant No. 2012C03009-3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguer C, 2013, FASEB J, V27, P4213, DOI 10.1096/fj.13-234302; de la Rosa APB, 2010, NITRIC OXIDE-BIOL CH, V23, P106, DOI 10.1016/j.niox.2010.04.006; BARON A, 1991, PHARMACOLOGY, V42, P15, DOI 10.1159/000138763; Brown JM, 2008, CIRCULATION, V118, P1467, DOI 10.1161/CIRCULATIONAHA.108.793182; Brown JM, 2010, CURR OPIN LIPIDOL, V21, P192, DOI 10.1097/MOL.0b013e32833854ac; Chen ZY, 2009, J AGR FOOD CHEM, V57, P4485, DOI 10.1021/jf900803r; Ngo DH, 2012, INT J BIOL MACROMOL, V51, P378, DOI 10.1016/j.ijbiomac.2012.06.001; Daien V, 2012, AM J HYPERTENS, V25, P126, DOI 10.1038/ajh.2011.180; Dallas PB, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-59; DING XR, 1989, AM J MED SCI, V297, P290, DOI 10.1097/00000441-198905000-00004; Estruch R, 2005, J HYPERTENS, V23, P226, DOI 10.1097/00004872-200501000-00039; Ewart HS, 2009, EUR FOOD RES TECHNOL, V229, P561, DOI 10.1007/s00217-009-1083-3; FREGLY MJ, 1987, J HYPERTENS, V5, P621, DOI 10.1097/00004872-198710000-00018; Fu MQ, 2012, LIPIDS HEALTH DIS, V11, DOI 10.1186/1476-511X-11-106; Furuhashi M, 2014, CLIN MED INSIGHTS-CA, V8, P23, DOI 10.4137/CMC.S17067; Gehring CK, 2009, CURR NUTR FOOD SCI, V5, P17, DOI 10.2174/157340109787314703; Gregorio-King CC, 2002, GENE, V286, P249, DOI 10.1016/S0378-1119(02)00434-1; Hao L, 2004, CIRC RES, V94, P68, DOI 10.1161/01.RES.0000109413.57726.91; Harnedy PA, 2012, J FUNCT FOODS, V4, P6, DOI 10.1016/j.jff.2011.09.001; Hellsten Y, 2007, FREE RADICAL BIO MED, V43, P353, DOI 10.1016/j.freeradbiomed.2007.02.029; Hu C, 2015, FASEB J S811, V29, P8116; ITSKOVITZ HD, 1989, J HYPERTENS, V7, P311; Je JY, 2005, BIORESOURCE TECHNOL, V96, P1624, DOI 10.1016/j.biortech.2005.01.001; Jiang GQ, 2005, J CLIN INVEST, V115, P1030, DOI 10.1172/JCI200523962; Johns EJ, 2014, J HYPERTENS, V32, P735, DOI 10.1097/HJH.0000000000000121; Kearney PM, 2004, J HYPERTENS, V22, P11, DOI 10.1097/00004872-200401000-00003; Kim Sung-Rae, 2012, Fisheries and Aquatic Sciences, V15, P183, DOI 10.5657/FAS.2012.0183; Kim Yeon-Kye, 2011, Fisheries and Aquatic Sciences, V14, P283; Korhonen H, 2003, CURR PHARM DESIGN, V9, P1297, DOI 10.2174/1381612033454892; Lebedeva IV, 2007, INT J ONCOL, V31, P985; Lee KM, 2013, INT J MOL MED, V31, P179, DOI 10.3892/ijmm.2012.1183; Loenarz C, 2008, NAT CHEM BIOL, V4, P152, DOI 10.1038/nchembio0308-152; Loenarz C, 2011, TRENDS BIOCHEM SCI, V36, P7, DOI 10.1016/j.tibs.2010.07.002; Martinez-Maqueda D, 2012, FOOD FUNCT, V3, P350, DOI 10.1039/c2fo10192k; Matsukawa R, 2014, J HYPERTENS, V32, P817, DOI 10.1097/HJH.0000000000000072; McDonough MA, 2010, CURR OPIN STRUC BIOL, V20, P659, DOI 10.1016/j.sbi.2010.08.006; Morey JS, 2006, BIOL PROCED ONLINE, V8, P175, DOI 10.1251/bpo126; Nakada TA, 2011, CHEST, V139, P1042, DOI 10.1378/chest.10-2517; Norris R., 2013, BIOACTIVE FOOD PEPTI, P45, DOI [10.1146/annurev-food-022814-015520, DOI 10.5772/32009]; Ortega FJ, 2010, INT J OBESITY, V34, P487, DOI 10.1038/ijo.2009.263; Pereira NL, 2010, J MOL CELL CARDIOL, V49, P864, DOI 10.1016/j.yjmcc.2010.07.020; Perros F, 2015, J AM COLL CARDIOL, V65, P668, DOI 10.1016/j.jacc.2014.11.050; Pessentheiner AR, 2013, J BIOL CHEM, V288, P36040, DOI 10.1074/jbc.M113.491324; Pravenec M, 2003, J BIOL CHEM, V278, P45209, DOI 10.1074/jbc.M304869200; Rodenhiser D, 2006, CAN MED ASSOC J, V174, P341, DOI 10.1503/cmaj.050774; Sainz-Perez A, 2008, J IMMUNOL, V181, P6051, DOI 10.4049/jimmunol.181.9.6051; Segall L, 2007, NEPHROL DIAL TRANSPL, V22, P2435, DOI 10.1093/ndt/gfm363; Smolarek I, 2010, MED SCI MONITOR, V16, pCR149; Tanaka M, 2008, LIFE SCI, V82, P869, DOI 10.1016/j.lfs.2008.02.001; Udenigwe CC, 2014, J FUNCT FOODS, V8, P45, DOI 10.1016/j.jff.2014.03.002; Vercruysse L, 2005, J AGR FOOD CHEM, V53, P8106, DOI 10.1021/jf0508908; Wang B, 2013, FOOD CHEM, V138, P1713, DOI 10.1016/j.foodchem.2012.12.002; Wang JP, 2008, FOOD CHEM, V111, P302, DOI 10.1016/j.foodchem.2008.03.059; Wang X, 2009, CIRCULATION, V119, P2480, DOI 10.1161/CIRCULATIONAHA.108.835488; Watts SW, 2011, CARDIOVASC THER, V29, P54, DOI 10.1111/j.1755-5922.2010.00173.x; Yamaguchi N, 2009, EUR J PHARMACOL, V620, P71, DOI 10.1016/j.ejphar.2009.08.005; Yamamoto N, 2003, CURR PHARM DESIGN, V9, P1345, DOI 10.2174/1381612033454801; Zhang JL, 2003, DIABETIC MED, V20, P828, DOI 10.1046/j.1464-5491.2003.01057.x	58	4	5	3	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2015	10	10							e0142016	10.1371/journal.pone.0142016	http://dx.doi.org/10.1371/journal.pone.0142016			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0EH	26517713	Green Published, Green Submitted, gold			2022-12-26	WOS:000363920800100
J	Lavielle, P; Talavera, JO; Reynoso, N; Gonzalez, M; Gomez-Diaz, RA; Cruz, M; Vazquez, F; Wacher, NH				Lavielle, Pilar; Talavera, Juan O.; Reynoso, Nancy; Gonzalez, Marissa; Gomez-Diaz, Rita A.; Cruz, Miguel; Vazquez, Felipe; Wacher, Niels H.		DIMSS Study Grp	Prevalence of Cognitive Impairment in Recently Diagnosed Type 2 Diabetes Patients: Are Chronic Inflammatory Diseases Responsible for Cognitive Decline?	PLOS ONE			English	Article							RHEUMATOID-ARTHRITIS; UNITED-STATES; RISK-FACTORS; DEMENTIA; MELLITUS; MORTALITY; PEOPLE; SCREEN	Objective To estimate the prevalence of cognitive impairment (CI) among patients recently diagnosed with type 2 diabetes (RDD) and to identify any relationships between CI and RDD comorbidities. Methods: One thousand seven hundred twelve patients with RDD participated in a cross-sectional study. The patients' sociodemographic and clinical data were registered. Results The sample population had an average age of 51 +/- 11 years, and 63.26% of the patients were female. CI was diagnosed in 38 patients (2.2%) and was more common among both females (2.8% vs. 1.3%, rho = 0.063) and the elderly (0% at an age <= 30 years vs. 10.4% at an age > 70 years, rho = 0.0001). Rheumatoid arthritis (present in 15.8% vs. absent in 2.1%) and asthma (13% vs. 2.1%) correlated significantly with CI based on the results of our logistic regression analysis. Conclusion Age, female gender, rheumatoid arthritis and asthma are risk factors for CI in the setting of RDD.	[Lavielle, Pilar; Talavera, Juan O.; Reynoso, Nancy; Gonzalez, Marissa; Gomez-Diaz, Rita A.; Vazquez, Felipe; Wacher, Niels H.] IMSS, Unidad Invest Epidemiol Clin, UMAE Hosp Especialidades, Ctr Med Nacl Siglo 21, Mexico City, DF, Mexico; [Cruz, Miguel] IMSS, Unidad Invest Bioquim, UMAE Hosp Especialidades, Ctr Med Nacl Siglo 21, Mexico City, DF, Mexico	Instituto Mexicano del Seguro Social; Instituto Mexicano del Seguro Social	Wacher, NH (corresponding author), IMSS, Unidad Invest Epidemiol Clin, UMAE Hosp Especialidades, Ctr Med Nacl Siglo 21, Mexico City, DF, Mexico.	wacherniels@gmail.com	Lopez, Miguel Cruz/O-5493-2018; gomez-diaz, rita/AAS-4030-2021	Lopez, Miguel Cruz/0000-0001-9985-6172; gomez-diaz, rita/0000-0002-2191-4931; wacher, niels/0000-0002-7717-6704				Amer Diabet Assoc, 2009, DIABETES CARE, V32, pS13, DOI 10.2337/dc09-S013; American Psychiatric Association DSM- IV, 1993, DIAGN STAT MAN MENT; Apolinario D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060084; Barnes DE, 2009, FUTUR NEUROL, V4, P555, DOI 10.2217/FNL.09.43; Barnes DE, 2010, ALZHEIMERS DEMENT, V6, P138, DOI 10.1016/j.jalz.2010.01.005; Boustani M, 2003, ANN INTERN MED, V138, P927, DOI 10.7326/0003-4819-138-11-200306030-00015; Brands AMA, 2005, DIABETES CARE, V28, P726, DOI 10.2337/diacare.28.3.726; Brodaty H, 1997, INT J GERIATR PSYCH, V12, P619, DOI 10.1002/(SICI)1099-1166(199706)12:6<619::AID-GPS554>3.0.CO;2-H; Chen YM, 2010, JOINT BONE SPINE, V77, P366, DOI 10.1016/j.jbspin.2010.01.017; Choi SH, 2011, INT PSYCHOGERIATR, V23, P593, DOI 10.1017/S1041610210001626; Di Carlo A, 2000, J AM GERIATR SOC, V48, P775, DOI 10.1111/j.1532-5415.2000.tb04752.x; Ebady SA, 2008, DIABETES RES CLIN PR, V82, P305, DOI 10.1016/j.diabres.2008.08.020; Eknoyan D, 2012, J NEUROPSYCHIATRY CL, V24, P3; Etgen T, 2011, DTSCH ARZTEBL INT, V108, P743, DOI 10.3238/arztebl.2011.0743; Goh DA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096874; HOFFMAN RG, 1989, DIABETES CARE, V12, P193, DOI 10.2337/diacare.12.3.193; Hunt BJ, 2000, LUPUS, V9, P189, DOI 10.1191/096120300678828244; JACOBSSON LTH, 1993, ARTHRITIS RHEUM-US, V36, P1045, DOI 10.1002/art.1780360804; Juncos-Rabadan O, 2013, INT PSYCHOGERIATR, V25, P627, DOI 10.1017/S1041610212002207; Kodl CT, 2008, ENDOCR REV, V29, P494, DOI 10.1210/er.2007-0034; Kozora E, 2001, J INT NEUROPSYCH SOC, V7, P745, DOI 10.1017/S1355617701766106; Kwasny-Krochin B, 2010, THROMB RES, V126, pE11, DOI 10.1016/j.thromres.2010.04.007; Langa KM, 2008, ALZHEIMERS DEMENT, V4, P134, DOI 10.1016/j.jalz.2008.01.001; LANGAN SJ, 1991, DIABETOLOGIA, V34, P337, DOI 10.1007/BF00405006; Llewellyn DJ, 2008, BMC NEUROL, V8, DOI 10.1186/1471-2377-8-12; Luchsinger JA, 2010, J NEUROL SCI, V299, P35, DOI 10.1016/j.jns.2010.08.063; Marioni RE, 2009, PSYCHOSOM MED, V71, P901, DOI 10.1097/PSY.0b013e3181b1e538; Mejía-Arango Silvia, 2007, Salud pública Méx, V49, ps475; Melzer D, 1997, BRIT MED J, V315, P462, DOI 10.1136/bmj.315.7106.462; Moss M, 2005, J CLIN EXP NEUROPSYC, V27, P139, DOI 10.1080/13803390490515450; O'Caoimh R, 2013, AGE AGEING, V42, P324, DOI 10.1093/ageing/aft044; O'Caoimh R, 2012, AGE AGEING, V41, P624, DOI 10.1093/ageing/afs059; Pendlebury ST, 2013, STROKE, V44, P227, DOI 10.1161/STROKEAHA.112.673384; Peters MJL, 2009, ARTHRIT RHEUM-ARTHR, V61, P1571, DOI 10.1002/art.24836; Plassman BL, 2008, ANN INTERN MED, V148, P427, DOI 10.7326/0003-4819-148-6-200803180-00005; Reijmer YD, 2013, DIABETES CARE, V36, P137, DOI 10.2337/dc12-0493; Roberts RO, 2008, ARCH NEUROL-CHICAGO, V65, P1066, DOI 10.1001/archneur.65.8.1066; Strachan MWJ, 2003, DIABETIC MED, V20, P1, DOI 10.1046/j.1464-5491.2003.00855.x; Symmons DPM, 1998, J RHEUMATOL, V25, P1072; WallbergJonsson S, 1997, J RHEUMATOL, V24, P445; Whitmer RA, 2007, CURR NEUROL NEUROSCI, V7, P373, DOI 10.1007/s11910-007-0058-7; WOLFKLEIN GP, 1989, J AM GERIATR SOC, V37, P730, DOI 10.1111/j.1532-5415.1989.tb02234.x	42	4	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2015	10	10							e0141325	10.1371/journal.pone.0141325	http://dx.doi.org/10.1371/journal.pone.0141325			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CV0EH	26517541	Green Published, Green Submitted, gold			2022-12-26	WOS:000363920800035
J	Liu, FX; Guo, J; Zhang, Q; Liu, DW; Wen, L; Yang, Y; Yang, L; Liu, ZS				Liu, Fengxun; Guo, Jia; Zhang, Qian; Liu, Dongwei; Wen, Lu; Yang, Yang; Yang, Liu; Liu, Zhangsuo			The Expression of Tristetraprolin and Its Relationship with Urinary Proteins in Patients with Diabetic Nephropathy	PLOS ONE			English	Article							MESSENGER-RNA; INFLAMMATION; CYTOKINES; CANCER; CELLS; MICE	Objective Tristetraprolin (TTP), also known as zinc finger protein 36, is an RNA binding protein that has a significant role in regulating the expression of mRNAs containing AU-rich elements. We postulated that TTP might regulate interleukin (IL)-6 and IL-18 expression in diabetes. This study aimed to test the hypothesis that the levels of TTP are correlated with nephropathy in patients with type 2 diabetes. Methods Eighty-seven patients (61.3 +/- 9.6 years old) who had been diagnosed with type 2 diabetes mellitus and 41 age and sex matched healthy control subjects were enrolled. The diabetes patients were classified into those without proteinuria, with microalbuminuria, and with clinical proteinuria groups according to the ratio of urinary excretion of albumin/creatinine (ACR). Results Serum and urinary levels of IL-6 and IL-18 were significantly elevated, but those of TTP were significantly decreased in patients with diabetes as compared with control subjects. In addition, serum and urinary levels of IL-6 and IL-18 were significantly higher, but those of TTP were significantly lower in patients with proteinuria than in patients without proteinuria or with microalbuminuria. There was a significant correlation between serum TTP and IL-6/IL-18 (correlation coefficients of -0.572 and -0.685, P < 0.05). Conclusion These results show that diabetes with clinical proteinuria is accompanied by decreased urinary and serum level of TTP and increased levels of IL-6 and IL-18. Decreased TTP expression might occur prior to the increase in IL-6 and IL-18, and decrease of TTP might provide an earlier marker for glomerular dysfunction than IL-6 and IL-18.	[Liu, Fengxun; Guo, Jia; Zhang, Qian; Liu, Dongwei; Wen, Lu; Yang, Yang; Yang, Liu; Liu, Zhangsuo] Zhengzhou Univ, Dept Nephrol, Affiliated Hosp 1, Zhengzhou 450052, Peoples R China; [Liu, Fengxun; Guo, Jia; Zhang, Qian; Liu, Dongwei; Wen, Lu; Yang, Yang; Yang, Liu; Liu, Zhangsuo] Zhengzhou Univ, Nephropathy Res Inst, Zhengzhou 450052, Peoples R China; [Liu, Fengxun; Guo, Jia; Zhang, Qian; Liu, Dongwei; Wen, Lu; Yang, Yang; Yang, Liu; Liu, Zhangsuo] Key Disciplines Lab Clin Med Henan, Zhengzhou, Peoples R China	Zhengzhou University; Zhengzhou University	Liu, ZS (corresponding author), Zhengzhou Univ, Dept Nephrol, Affiliated Hosp 1, Zhengzhou 450052, Peoples R China.	zhangsuoliu@sina.com			National Basic Research Program of China 973 [2012CB517600, 2012CB517606]; National Natural Science Foundation of China [81270807]	National Basic Research Program of China 973(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was funded by the National Basic Research Program of China 973, Program No. 2012CB517600 (No. 2012CB517606) (http://www.cas.cn/ky/kyxm/973xm/), and the National Natural Science Foundation of China (No. 81270807) (http://www.nsfc.gov.cn/).	Cansby E, 2014, MOL CELL ENDOCRINOL, V393, P143, DOI 10.1016/j.mce.2014.06.014; Chow FY, 2006, KIDNEY INT, V69, P73, DOI 10.1038/sj.ki.5000014; Demircan N, 2006, EYE, V20, P1366, DOI 10.1038/sj.eye.6702138; El Mesallamy HO, 2012, CLIN BIOCHEM, V45, P646, DOI 10.1016/j.clinbiochem.2012.02.021; Frasca D, 2007, J IMMUNOL, V179, P918, DOI 10.4049/jimmunol.179.2.918; Jeffcoate WJ, 2005, LANCET, V366, P2058, DOI 10.1016/S0140-6736(05)67029-8; Joe Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088776; Lee HH, 2013, MOL CELLS, V36, P571, DOI 10.1007/s10059-013-0268-6; Lee SH, 2005, NEPHROLOGY, V10, pS32, DOI 10.1111/j.1440-1797.2005.00454.x; Luis-Rodriguez D, 2012, WORLD J DIABETES, V3, P7, DOI 10.4239/wjd.v3.i1.7; Mensah-Brown EPK, 2005, CYTOKINE, V31, P180, DOI 10.1016/j.cyto.2005.04.006; Navarro-Gonzalez JF, 2011, NAT REV NEPHROL, V7, P327, DOI 10.1038/nrneph.2011.51; Rangasamy S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108508; Ray D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057290; Sanduja S, 2012, FRONT BIOSCI-LANDMRK, V17, P174, DOI 10.2741/3920; Sun L, 2007, J BIOL CHEM, V282, P3766, DOI 10.1074/jbc.M607347200; Tuttle KR, 2005, J AM SOC NEPHROL, V16, P1537, DOI 10.1681/ASN.2005040393	17	16	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2015	10	10							e0141471	10.1371/journal.pone.0141471	http://dx.doi.org/10.1371/journal.pone.0141471			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0EH	26517838	Green Published, Green Submitted, gold			2022-12-26	WOS:000363920800045
J	Zhou, J; Zhang, N; Wang, P; Zhang, SC; Li, DQ; Liu, KY; Wang, GX; Wang, XP; Ai, H				Zhou, Jing; Zhang, Na; Wang, Pan; Zhang, Shichang; Li, Daiqin; Liu, Kaiyu; Wang, Guoxiu; Wang, Xiaoping; Ai, Hui			Identification of Host-Plant Volatiles and Characterization of Two Novel General Odorant-Binding Proteins from the Legume Pod Borer, Maruca vitrata Fabricius (Lepidoptera: Crambidae)	PLOS ONE			English	Article							FEMALE SEX-PHEROMONE; BEHAVIORAL-RESPONSES; VIGNA-UNGUICULATA; MANDUCA-SEXTA; EXPRESSION; POPULATIONS; RESISTANCE; PYRALIDAE	Chemoreception is a key feature in selection of host plant by phytophagous insects, and odorant-binding proteins (OBPs) are involved in chemical communication of both insects and vertebrates. The legume pod borer, Maruca vitrata Fabricius (Lepidoptera: Crambidae) is one of the key pest species of cowpea and widely distributed throughout tropical and subtropical regions, causing up to 80% of yield loss. In this study, we investigated the electrophysiological responses of femaleM. vitrata to floral volatiles from V. unguiculata. Seventeen electroantennogram- active compounds were identified from floral volatiles of V. unguiculata by coupled gas chromatography-electroantennography (GC-EAD) and gas chromatography-mass spectrometry (GC-MS). Then, we cloned two novel full-length GOBP genes (MvitGOBP1 and MvitGOBP2) from the antennae ofM. vitrata using reverse transcription PCR. Protein sequence analysis indicated that they shared high sequence similarity with other Pyralididae insect GOBPs and had the typical six-cysteine signature. Real-time PCR analysis indicated that MvitGOBP1-2 mRNA was highly expressed in the antennae of female adult with several thousands-fold difference compare to other tissue. Next, the recombinant MvitGOBP1-2 was expressed in Escherichia coli and purified using Ni ion affinity chromatography. Fluorescence binding assays demonstrated thatMvitGOBP1-2 had different binding affinities with 17 volatile odorant molecules including butanoic acid butyl ester, limonene, 4-ethylpropiophenone, 1H-indol-4-ol, butanoic acid octyl ester and 2-methyl-3-phenylpropanal. In the field trapping experiment, these six floral volatiles could effectively attract femalemoths and showed significant difference compared with the blank lure. These results suggested that MvitGOBPs and the seventeen floral volatiles are likely to function in the olfactory behavior response of female moths, which may have played crucial roles in the selection of oviposition sites. The six compounds that we have identified from the volatiles of V. unguiculata may provide useful information for exploring efficiency monitoring and integrated pest management strategies of this legume pod borer in the field.	[Zhou, Jing; Zhang, Na; Liu, Kaiyu; Wang, Guoxiu; Ai, Hui] Cent China Normal Univ, Sch Life Sci, Hubei Key Lab Genet Regulat & Integrat Biol, Wuhan 430079, Peoples R China; [Wang, Pan; Wang, Xiaoping] Huazhong Agr Univ, Coll Plant Sci & Technol, Key Lab Insect Resource Utilizat & Sustainable Pe, Wuhan 430070, Peoples R China; [Zhang, Shichang; Li, Daiqin] Natl Univ Singapore, Dept Biol Sci, Singapore 117543, Singapore	Central China Normal University; Huazhong Agricultural University; National University of Singapore	Ai, H (corresponding author), Cent China Normal Univ, Sch Life Sci, Hubei Key Lab Genet Regulat & Integrat Biol, Wuhan 430079, Peoples R China.	aihui@mail.ccnu.edu.cn	Li, Daiqin/CAH-3746-2022; Li, Daiqin/D-6922-2013	Li, Daiqin/0000-0001-8269-7734; Li, Daiqin/0000-0001-8269-7734	Chinese National Natural Science Foundation of China [31472052, 31172162, 30971911]; National Higher-education Institution General Research and Development Funding of Central China Normal University [20205130077]	Chinese National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Higher-education Institution General Research and Development Funding of Central China Normal University	This work was supported by Chinese National Natural Science Foundation of China (31472052, 31172162, 30971911) and National Higher-education Institution General Research and Development Funding of Central China Normal University (20205130077). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acin P, 2009, INSECT BIOCHEM MOLEC, V39, P11, DOI 10.1016/j.ibmb.2008.09.007; Adati T, 1999, J CHEM ECOL, V25, P105, DOI 10.1023/A:1020841217376; Allmann S, 2013, ELIFE, V2, DOI 10.7554/eLife.00421; Anfora G, 2009, J CHEM ECOL, V35, P1054, DOI 10.1007/s10886-009-9686-5; Cha DH, 2008, J CHEM ECOL, V34, P622, DOI 10.1007/s10886-008-9474-7; Dannon EA, 2010, J CHEM ECOL, V36, P1083, DOI 10.1007/s10886-010-9859-2; Deng SS, 2012, CHEM SENSES, V37, P141, DOI 10.1093/chemse/bjr084; Downham MCA, 2003, J CHEM ECOL, V29, P989, DOI 10.1023/A:1022996103147; Ekesi S, 1999, INT J PEST MANAGE, V45, P57, DOI 10.1080/096708799228058; Gu SH, 2013, INSECT BIOCHEM MOLEC, V43, P237, DOI 10.1016/j.ibmb.2012.12.009; He XL, 2010, J CHEM ECOL, V36, P1293, DOI 10.1007/s10886-010-9870-7; JACKAI LEN, 1986, ANNU REV ENTOMOL, V31, P95, DOI 10.1146/annurev.en.31.010186.000523; Liu NY, 2015, INSECT MOL BIOL, V24, P167, DOI 10.1111/imb.12143; Liu NY, 2015, COMP BIOCHEM PHYS A, V180, P23, DOI 10.1016/j.cbpa.2014.11.005; Liu SJ, 2012, ARCH INSECT BIOCHEM, V80, P123, DOI 10.1002/arch.21036; Lu PF, 2013, Z NATURFORSCH C, V68, P416; Lu PF, 2008, CHINESE BULL ENTOMOL, V2, P017; Pelosi P, 2006, CELL MOL LIFE SCI, V63, P1658, DOI 10.1007/s00018-005-5607-0; Pinero JC, 2007, ENTOMOL EXP APPL, V125, P185, DOI 10.1111/j.1570-7458.2007.00614.x; Qiao HL, 2012, ENTOMOL EXP APPL, V143, P269, DOI 10.1111/j.1570-7458.2012.01264.x; Sengul MS, 2010, INSECT MOL BIOL, V19, P49, DOI 10.1111/j.1365-2583.2009.00929.x; Sharma HC, 1998, CROP PROT, V17, P373, DOI 10.1016/S0261-2194(98)00045-3; Steinbrecht RA, 1996, ENTOMOL EXP APPL, V80, P15, DOI 10.1007/BF00194714; Sun YL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055132; Tasin M, 2005, J CHEM ECOL, V31, P77, DOI 10.1007/s10886-005-0975-3; Tasin M, 2010, CHEM SENSES, V35, P57, DOI 10.1093/chemse/bjp082; VOGT RG, 1981, NATURE, V293, P161, DOI 10.1038/293161a0; Vogt RG, 2002, J EXP BIOL, V205, P719; VOGT RG, 1991, J NEUROSCI, V11, P2972; Wang HL, 2010, J CHEM ECOL, V36, P305, DOI 10.1007/s10886-010-9754-x; Wang Lin, 2003, Natural Enemies of Insects, V25, P83; Wang P, 2014, ENTOMOL EXP APPL, V152, P248, DOI 10.1111/eea.12216; Wang P, 2013, J INSECT SCI, V13, DOI 10.1673/031.013.12101; [王攀 Wang Pan], 2011, [植物保护, Plant Protection], V37, P33; Yin J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033589; Yule S, 2013, J ASIA-PAC ENTOMOL, V16, P357, DOI 10.1016/j.aspen.2013.05.001; Zeng FF, 2013, BIOCHEM BIOPH RES CO, V433, P463, DOI 10.1016/j.bbrc.2013.03.038; Zhang GH, 2012, J CHEM ECOL, V38, P427, DOI 10.1007/s10886-012-0102-1; Zhang ZC, 2009, J CHEM ECOL, V35, P1188, DOI 10.1007/s10886-009-9697-2	39	25	30	3	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2015	10	10							e0141208	10.1371/journal.pone.0141208	http://dx.doi.org/10.1371/journal.pone.0141208			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0EH	26517714	Green Published, Green Submitted, gold			2022-12-26	WOS:000363920800028
J	Aquila, M; Benedusi, M; Fasoli, A; Rispoli, G				Aquila, Marco; Benedusi, Mascia; Fasoli, Anna; Rispoli, Giorgio			Characterization of Zebrafish Green Cone Photoresponse Recorded with Pressure-Polished Patch Pipettes, Yielding Efficient Intracellular Dialysis	PLOS ONE			English	Article							TRANSDUCIN CIRCUMSTANTIAL EVIDENCE; LOW ACCESS RESISTANCE; PHOTOTRANSDUCTION CASCADE; TRANSIENT COMPLEXES; DARK RHODOPSIN; RETINAL RODS; MODEL; MEMBRANE; SIMULATIONS; RESPONSES	The phototransduction enzymatic cascade in cones is less understood than in rods, and the zebrafish is an ideal model with which to investigate vertebrate and human vision. Therefore, here, for the first time, the zebrafish green cone photoresponse is characterized also to obtain a firm basis for evaluating how it is modulated by exogenous molecules. To this aim, a powerful method was developed to obtain long-lasting recordings with low access resistance, employing pressure-polished patch pipettes. This method also enabled fast, efficient delivery of molecules via a perfusion system coupled with pulled quartz or plastic perfusion tubes, inserted very close to the enlarged pipette tip. Sub-saturating flashes elicited responses in different cells with similar rising phase kinetics but with very different recovery kinetics, suggesting the existence of physiologically distinct cones having different Ca2+ dynamics. Theoretical considerations demonstrate that the different recovery kinetics can be modelled by simulating changes in the Ca2+-buffering capacity of the outer segment. Importantly, the Ca2+-buffer action preserves the fast response rising phase, when the Ca2+-dependent negative feedback is activated by the light-induced decline in intracellular Ca2+.	[Aquila, Marco; Benedusi, Mascia; Fasoli, Anna; Rispoli, Giorgio] Univ Ferrara, Dept Life Sci & Biotechnol, I-44100 Ferrara, Italy	University of Ferrara	Rispoli, G (corresponding author), Univ Ferrara, Dept Life Sci & Biotechnol, I-44100 Ferrara, Italy.	rsg@unife.it		benedusi, mascia/0000-0002-4656-8609; Fasoli, Anna/0000-0003-0031-0482	Ministero dell'Universita e della Ricerca (MIUR), Roma, Italy, Project PRIN (Progetti di Rilevante Interesse Nazionale); University of Ferrara, Project FAR (Fondi di Ateneo per la Ricerca)	Ministero dell'Universita e della Ricerca (MIUR), Roma, Italy, Project PRIN (Progetti di Rilevante Interesse Nazionale)(Ministry of Education, Universities and Research (MIUR)); University of Ferrara, Project FAR (Fondi di Ateneo per la Ricerca)	This study was supported by Ministero dell'Universita e della Ricerca (MIUR), Roma, Italy, Project PRIN 2008 (Progetti di Rilevante Interesse Nazionale), web: http://prin.miur.it/ (GR); University of Ferrara, Project FAR 2008-2012 (Fondi di Ateneo per la Ricerca), web: http://www.unife.it/ricerca/finanziamenti-gestione/far (GR). These two funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aquila M, 2014, METHODS MOL BIOL, V1183, P279, DOI 10.1007/978-1-4939-1096-0_18; Arshavsky VY, 2002, ANNU REV PHYSIOL, V64, P153, DOI 10.1146/annurev.physiol.64.082701.102229; Avdesh A, 2012, JOVE-J VIS EXP, DOI 10.3791/4196; BAYLOR DA, 1979, J PHYSIOL-LONDON, V288, P613; Benedusi M, 2011, EUR BIOPHYS J BIOPHY, V40, P1215, DOI 10.1007/s00249-011-0727-y; Biedermann J, 2015, BIOPHYS J, V108, P457, DOI 10.1016/j.bpj.2014.12.025; Calvert PD, 2000, P NATL ACAD SCI USA, V97, P13913, DOI 10.1073/pnas.250478897; Cao LH, 2014, P NATL ACAD SCI USA, V111, P2752, DOI 10.1073/pnas.1400268111; Chang B, 2002, VISION RES, V42, P517, DOI 10.1016/S0042-6989(01)00146-8; Chen CK, 2005, REV PHYSIOL BIOCH P, V154, P101, DOI 10.1007/s10254-005-0004-5; Cilluffo MC, 2004, VISUAL NEUROSCI, V21, P599, DOI 10.1017/S0952523804214092; Dell'Orco D, 2008, J PHYS CHEM B, V112, P4419, DOI 10.1021/jp709963f; Dell'Orco D, 2015, BIOPHYS J, V108, P775, DOI 10.1016/j.bpj.2014.12.031; Dell'Orco D, 2011, BIOCHEM J, V440, P263, DOI 10.1042/BJ20110871; Ellis-Davies GCR, 2007, NAT METHODS, V4, P619, DOI 10.1038/NMETH1072; Gestri G, 2012, DEV NEUROBIOL, V72, P302, DOI 10.1002/dneu.20919; Hamer RD, 2005, VISUAL NEUROSCI, V22, P417, DOI 10.1017/S0952523805224045; Howes KA, 2002, EMBO J, V21, P1545, DOI 10.1093/emboj/21.7.1545; Invergo BM, 2014, MOL BIOSYST, V10, P1481, DOI 10.1039/c3mb70584f; Invergo BM, 2013, CELL COMMUN SIGNAL, V11, DOI 10.1186/1478-811X-11-36; Kawamura S., 2012, WIRES MEMBR TRANSP S, V1, P675, DOI DOI 10.1002/WMTS.8; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kobilka BK, 2007, BBA-BIOMEMBRANES, V1768, P794, DOI 10.1016/j.bbamem.2006.10.021; LAMB TD, 1979, VISION RES, V19, P385, DOI 10.1016/0042-6989(79)90099-3; Lamb TD, 2006, INVEST OPHTH VIS SCI, V47, P5138, DOI 10.1167/iovs.06-0849; Leskov IB, 2000, NEURON, V27, P525, DOI 10.1016/S0896-6273(00)00063-5; Leung YT, 2007, J PHYSIOL-LONDON, V579, P15, DOI 10.1113/jphysiol.2006.120162; MATTHEWS HR, 1990, J PHYSIOL-LONDON, V420, P447, DOI 10.1113/jphysiol.1990.sp017922; Moriondo A, 2003, PHOTOCH PHOTOBIO SCI, V2, P1292, DOI 10.1039/b303871h; O'Sullivan Gerard J, 2006, Drug Discov Today Technol, V3, P173, DOI 10.1016/j.ddtec.2006.06.005; Peachey NS, 2003, DOC OPHTHALMOL, V107, P13, DOI 10.1023/A:1024448314608; Pugh E.N., 2000, HDB BIOL PHYS, V3, P183, DOI DOI 10.1016/S1383-8121(00)80008-1; Rispoli G, 1998, J PHOTOCH PHOTOBIO B, V44, P1, DOI 10.1016/S1011-1344(98)00083-9; ROBINSON J, 1993, P NATL ACAD SCI USA, V90, P6009, DOI 10.1073/pnas.90.13.6009; Sakurai K, 2011, J NEUROSCI, V31, P7991, DOI 10.1523/JNEUROSCI.6650-10.2011; Schoneberg J, 2015, BIOPHYS J, V108, P778, DOI 10.1016/j.bpj.2014.12.030; Takemoto N, 2009, P NATL ACAD SCI USA, V106, P11788, DOI 10.1073/pnas.0812781106; Takeuchi H, 2002, J PHYSIOL-LONDON, V541, P825, DOI 10.1113/jphysiol.2002.016600; Tischer D, 2014, NAT REV MOL CELL BIO, V15, P551, DOI 10.1038/nrm3837; Venkatakrishnan AJ, 2013, NATURE, V494, P185, DOI 10.1038/nature11896; Wen XH, 2014, FRONT MOL NEUROSCI, V7, DOI 10.3389/fnmol.2014.00045	41	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2015	10	10							e0141727	10.1371/journal.pone.0141727	http://dx.doi.org/10.1371/journal.pone.0141727			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0ED	26513584	Green Published, gold, Green Submitted			2022-12-26	WOS:000363920300074
J	Shi, SH; Zhang, SL; Zhang, QG				Shi, Shuhua; Zhang, Shaolong; Zhang, Qinggang			Probing Difference in Binding Modes of Inhibitors to MDMX by Molecular Dynamics Simulations and Different Free Energy Methods	PLOS ONE			English	Article							PROTEIN-PROTEIN INTERACTIONS; SOLVATED INTERACTION ENERGY; BOUNDARY-ELEMENT METHOD; STRUCTURE-BASED DESIGN; PARTICLE MESH EWALD; P53 PEPTIDE-ANALOG; HIV-1 PROTEASE; MM-PBSA; COMPUTATIONAL ANALYSIS; FORCE-FIELD	The p53-MDMX interaction has attracted extensive attention of anti-cancer drug development in recent years. This current work adopted molecular dynamics (MD) simulations and cross-correlation analysis to investigate conformation changes of MDMX caused by inhibitor bindings. The obtained information indicates that the binding cleft of MDMX undergoes a large conformational change and the dynamic behavior of residues obviously change by the presence of different structural inhibitors. Two different methods of binding free energy predictions were employed to carry out a comparable insight into binding mechanisms of four inhibitors PMI, pDI, WK23 and WW8 to MDMX. The data show that the main factor controlling the inhibitor bindings to MDMX arises from van der Waals interactions. The binding free energies were further divided into contribution of each residue and the derived information gives a conclusion that the hydrophobic interactions, such as CH-CH, CH-pi and pi-pi interactions, are responsible for the inhibitor associations with MDMX.	[Shi, Shuhua] Shandong Jianzhu Univ, Sch Sci, Jinan, Peoples R China; [Zhang, Shaolong; Zhang, Qinggang] Shandong Normal Univ, Coll Phys & Elect, Jinan, Peoples R China	Shandong Jianzhu University; Shandong Normal University	Shi, SH (corresponding author), Shandong Jianzhu Univ, Sch Sci, Jinan, Peoples R China.	sdsfhf@sdjzu.edu.cn			National Natural Science Foundation of China [11274206]; Natural Science Foundation of Shandong Province [ZR2013AM014]; Doctor Foundation of Shandong Jianzhu University [XNBS1268]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Shandong Province(Natural Science Foundation of Shandong Province); Doctor Foundation of Shandong Jianzhu University	This work is supported by the National Natural Science Foundation of China (Nos. 11274206), the Natural Science Foundation of Shandong Province (Nos. ZR2013AM014) and Doctor Foundation of Shandong Jianzhu University (Nos. XNBS1268). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMADEI A, 1993, PROTEINS, V17, P412, DOI 10.1002/prot.340170408; Bottger V, 1999, ONCOGENE, V18, P189, DOI 10.1038/sj.onc.1202281; Case DA, 2012, AMBER 12; Chen JZ, 2015, J BIOMOL STRUCT DYN, V33, P2606, DOI 10.1080/07391102.2014.1003146; Chen JZ, 2015, J CHEM INF MODEL, V55, P1903, DOI 10.1021/acs.jcim.5b00173; Chen JZ, 2014, SCI REP-UK, V4, DOI 10.1038/srep06872; Chen JZ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099862; Chen JZ, 2013, J COMPUT AID MOL DES, V27, P965, DOI 10.1007/s10822-013-9693-z; Chen JZ, 2012, INT J MOL SCI, V13, P2176, DOI 10.3390/ijms13022176; Chen JZ, 2011, J MOL GRAPH MODEL, V30, P46, DOI 10.1016/j.jmgm.2011.06.003; Chen JZ, 2009, J MOL MODEL, V15, P1245, DOI 10.1007/s00894-009-0452-y; Chene P, 2003, NAT REV CANCER, V3, P102, DOI 10.1038/nrc991; Cheng WY, 2012, COMPUT THEOR CHEM, V984, P43, DOI 10.1016/j.comptc.2012.01.010; COLEMAN TG, 1977, ANN BIOMED ENG, V5, P322, DOI 10.1007/BF02367312; Cui QZ, 2008, J MOL BIOL, V379, P787, DOI 10.1016/j.jmb.2008.04.035; Czarna A, 2009, CELL CYCLE, V8, P1176, DOI 10.4161/cc.8.8.8185; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Ding K, 2006, J MED CHEM, V49, P3432, DOI 10.1021/jm051122a; Duan Y, 2003, J COMPUT CHEM, V24, P1999, DOI 10.1002/jcc.10349; ElSawy KM, 2013, CELL CYCLE, V12, P394, DOI 10.4161/cc.23511; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Gao Y, 2012, J PHYS CHEM B, V116, P549, DOI 10.1021/jp208953x; Ghosh M, 2005, CELL CYCLE, V4, P604; Ghosh M, 2003, BIOCHEMISTRY-US, V42, P2291, DOI 10.1021/bi0271291; Gohlke H, 2003, J MOL BIOL, V330, P891, DOI 10.1016/S0022-2836(03)00610-7; Grasberger BL, 2005, J MED CHEM, V48, P909, DOI 10.1021/jm049137g; Han K, ADV EXP MED BIOL; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Hou TJ, 2011, J CHEM INF MODEL, V51, P69, DOI 10.1021/ci100275a; Hu BL, 2006, J BIOL CHEM, V281, P33030, DOI 10.1074/jbc.C600147200; Hu GD, 2014, EUR J MED CHEM, V74, P726, DOI 10.1016/j.ejmech.2013.04.049; Hu GD, 2010, J COMPUT AID MOL DES, V24, P687, DOI 10.1007/s10822-010-9366-0; Joseph TL, 2010, CELL CYCLE, V9, P1167, DOI 10.4161/cc.9.6.11067; Kallen J, 2009, J BIOL CHEM, V284, P8803, DOI 10.1074/jbc.M809096200; Kumari R, 2014, J CHEM INF MODEL, V54, P1951, DOI 10.1021/ci500020m; Li C, 2010, J MOL BIOL, V398, P200, DOI 10.1016/j.jmb.2010.03.005; Li DM, 2011, J AM CHEM SOC, V133, P7416, DOI 10.1021/ja111657j; Marine JC, 2005, BIOCHEM BIOPH RES CO, V331, P750, DOI 10.1016/j.bbrc.2005.03.151; Marine JCW, 2007, J CELL SCI, V120, P371, DOI 10.1242/jcs.03362; Mei Y, 2006, J CHEM PHYS, V125, DOI 10.1063/1.2345201; Miller BR, 2012, J CHEM THEORY COMPUT, V8, P3314, DOI 10.1021/ct300418h; Murray JK, 2007, BIOPOLYMERS, V88, P657, DOI 10.1002/bip.20741; Naim M, 2007, J CHEM INF MODEL, V47, P122, DOI 10.1021/ci600406v; Onufriev A, 2004, PROTEINS, V55, P383, DOI 10.1002/prot.20033; Pazgiera M, 2009, P NATL ACAD SCI USA, V106, P4665, DOI 10.1073/pnas.0900947106; Pei DS, 2012, ONCOTARGET, V3, P228; Perdih A, 2009, J MOL MODEL, V15, P983, DOI 10.1007/s00894-009-0455-8; Phan J, 2010, J BIOL CHEM, V285, P2174, DOI 10.1074/jbc.M109.073056; Popowicz GM, 2007, CELL CYCLE, V6, P2386, DOI 10.4161/cc.6.19.4740; Popowicz GM, 2011, ANGEW CHEM INT EDIT, V50, P2680, DOI 10.1002/anie.201003863; Popowicz GM, 2010, CELL CYCLE, V9, P1104, DOI 10.4161/cc.9.6.10956; PURISIMA EO, 1995, J COMPUT CHEM, V16, P681, DOI 10.1002/jcc.540160604; Purisima EO, 1998, J COMPUT CHEM, V19, P1494, DOI 10.1002/(SICI)1096-987X(199810)19:13<1494::AID-JCC6>3.0.CO;2-L; Riemenschneider MJ, 1999, CANCER RES, V59, P6091; Sakurai K, 2006, J AM CHEM SOC, V128, P11000, DOI 10.1021/ja063102j; Shi S, 2014, J MOL MODEL, V20, P1; Shi SH, 2014, COMPUT THEOR CHEM, V1045, P66, DOI 10.1016/j.comptc.2014.07.002; Shmueli A, 2004, MOL CELL, V13, P4, DOI 10.1016/S1097-2765(03)00529-X; Shvarts A, 1996, EMBO J, V15, P5349, DOI 10.1002/j.1460-2075.1996.tb00919.x; Toledo F, 2006, CANCER CELL, V9, P273, DOI 10.1016/j.ccr.2006.03.014; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Vousden KH, 2007, NAT REV MOL CELL BIO, V8, P275, DOI 10.1038/nrm2147; Wang JN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062745; Wang JN, 2010, J PHYS CHEM B, V114, P15172, DOI 10.1021/jp104508k; Wang JM, 2001, J AM CHEM SOC, V123, P5221, DOI 10.1021/ja003834q; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Wang W, 2001, P NATL ACAD SCI USA, V98, P14937, DOI 10.1073/pnas.251265598; Wang W, 2001, J AM CHEM SOC, V123, P3986, DOI 10.1021/ja003164o; Wang YT, 2009, J CHEM INF MODEL, V49, P2369, DOI 10.1021/ci9002238; Wu EL, 2008, CHEM-EUR J, V14, P8704, DOI 10.1002/chem.200800277; Xu BS, 2011, J COMPUT CHEM, V32, P3188, DOI 10.1002/jcc.21900; Xu Y, 2006, PROTEINS, V64, P1058, DOI 10.1002/prot.21044; Yang MJ, 2010, PROTEINS, V78, P2222, DOI 10.1002/prot.22734; Zhong HZ, 2005, PROTEINS, V58, P222, DOI 10.1002/prot.20275; Zhu T, 2013, J CHEM THEORY COMPUT, V9, P1788, DOI 10.1021/ct301091z; Zhu T, 2012, PHYS CHEM CHEM PHYS, V14, P7837, DOI 10.1039/c2cp23746f	77	5	5	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2015	10	10							e0141409	10.1371/journal.pone.0141409	http://dx.doi.org/10.1371/journal.pone.0141409			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0ED	26513747	Green Published, Green Submitted, gold			2022-12-26	WOS:000363920300036
J	Taniguchi, M; Okamoto, R; Ito, M; Goto, I; Fujita, S; Konishi, K; Mizutani, H; Dohi, K; Hartshorne, DJ; Itoh, T				Taniguchi, Masaya; Okamoto, Ryuji; Ito, Masaaki; Goto, Itaru; Fujita, Satoshi; Konishi, Katsuhisa; Mizutani, Hideo; Dohi, Kaoru; Hartshorne, David J.; Itoh, Takeo			New Isoform of Cardiac Myosin Light Chain Kinase and the Role of Cardiac Myosin Phosphorylation in alpha(1)-Adrenoceptor Mediated Inotropic Response	PLOS ONE			English	Article							FAILING HUMAN-HEART; FORCE DEVELOPMENT; CA2+ SENSITIVITY; SMOOTH-MUSCLE; PHOSPHATASE; CONTRACTION; DEPHOSPHORYLATION; MYOCARDIUM; ACTIVATION; RECEPTORS	Background & Aims Cardiac myosin light chain kinase (cMLCK) plays an obligatory role in maintaining the phosphorylation levels of regulatory myosin light chain (MLC2), which is thought to be crucial for regulation of cardiac function. To test this hypothesis, the role played by ventricular MLC2 (MLC2v) phosphorylation was investigated in the phenylephrine-induced increase in twitch tension using the naturally-occurring mouse strain, C57BL/6N, in which cMLCK is down regulated. Methods and Results By Western blot and nanoLC-MS/MS analysis, cMLCKs with molecular mass of 61-kDa (cMLCK-2) and/or 86-kDa were identified in mice heart. Among various mouse strains, C57BL/6N expressed cMLCK-2 alone and the closest relative strain C57BL/6J expressed both cMLCKs. The levels of MLC2v phosphorylation was significantly lower in C57BL/6N than in C57BL/6J. The papillary muscle twitch tension induced by electrical field stimulation was smaller in C57BL/6N than C57BL/6J. Phenylephrine had no effect on MLC2v phosphorylation in either strains but increased the twitch tension more potently in C57BL/6J than in C57BL/6N. Calyculin A increased papillary muscle MLC2v phosphorylation to a similar extent in both strains but increased the phenylephrine-induced inotropic response only in C57BL/6N. There was a significant positive correlation between the phenylephrine-induced inotropic response and the levels of MLC2v phosphorylation within ranges of 15-30%. Conclusions We identified a new isoform of cMLCK with a molecular mass of 61kDa(cMLCK-2) in mouse heart. In the C57BL/6N strain, only cMLCK-2 was expressed and the basal MLC2v phosphorylation levels and the phenylephrine-induced inotropic response were both smaller. We suggest that a lower phenylephrine-induced inotropic response may be caused by the lower basal MLC2v phosphorylation levels in this strain.	[Taniguchi, Masaya; Okamoto, Ryuji; Ito, Masaaki; Goto, Itaru; Fujita, Satoshi; Konishi, Katsuhisa; Mizutani, Hideo; Dohi, Kaoru] Mie Univ, Grad Sch Med, Dept Cardiol & Nephrol, Tsu, Mie 5148507, Japan; [Hartshorne, David J.] Univ Arizona, Muscle Biol Grp, Tucson, AZ USA; [Itoh, Takeo] Nagoya City Univ, Grad Sch Med Sci, Dept Pharmacol, Nagoya, Aichi 4678601, Japan	Mie University; University of Arizona; Nagoya City University	Ito, M (corresponding author), Mie Univ, Grad Sch Med, Dept Cardiol & Nephrol, Tsu, Mie 5148507, Japan.	mitoka@clin.medic.mie-u.ac.jp; titoh@med.nagoya-cu.ac.jp			Ministry of Education, Science, Technology, Sports and Culture, Japan [19390211, 25460655, 24591113]	Ministry of Education, Science, Technology, Sports and Culture, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part grants-in-aids for Scientific Research from the Ministry of Education, Science, Technology, Sports and Culture, Japan (19390211 to M.I., 25460655 to T.I., 24591113 to R.O.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen GO, 2002, AM J PHYSIOL-HEART C, V283, pH1471, DOI 10.1152/ajpheart.00232.2002; BRISTOW MR, 1988, J PHARMACOL EXP THER, V247, P1039; BRISTOW MR, 1993, J CLIN INVEST, V92, P2737, DOI 10.1172/JCI116891; Chan JY, 2008, CIRC RES, V102, P571, DOI 10.1161/CIRCRESAHA.107.161687; Chang AN, 2010, J BIOL CHEM, V285, P5122, DOI 10.1074/jbc.C109.076489; Colson BA, 2010, J PHYSIOL-LONDON, V588, P981, DOI 10.1113/jphysiol.2009.183897; Davis JS, 2001, CELL, V107, P631, DOI 10.1016/S0092-8674(01)00586-4; Ding PG, 2010, J BIOL CHEM, V285, P40819, DOI 10.1074/jbc.M110.160499; FOWLER MB, 1986, CIRCULATION, V74, P1290, DOI 10.1161/01.CIR.74.6.1290; Fujioka M, 1998, GENOMICS, V49, P59, DOI 10.1006/geno.1998.5222; Grimm M, 2005, CARDIOVASC RES, V65, P211, DOI 10.1016/j.cardiores.2004.09.019; Grimm M, 2006, BRIT J PHARMACOL, V148, P991, DOI 10.1038/sj.bjp.0706803; HARTSHORNE DJ, 1987, PHYSL GASTROINTESTIN, P432; Ihara E, 2007, AM J PHYSIOL-CELL PH, V292, pC1951, DOI 10.1152/ajpcell.00434.2006; Jensen BC, 2009, CIRC-HEART FAIL, V2, P654, DOI 10.1161/CIRCHEARTFAILURE.108.846212; Josephson MP, 2011, BIOCHEM BIOPH RES CO, V416, P367, DOI 10.1016/j.bbrc.2011.11.044; Kamm KE, 2011, J BIOL CHEM, V286, P9941, DOI 10.1074/jbc.R110.198697; Mizutani H, 2010, CIRC J, V74, P120, DOI 10.1253/circj.CJ-09-0462; Mohl MC, 2011, CARDIOVASC RES, V91, P310, DOI 10.1093/cvr/cvr081; NELSON MT, 1988, NATURE, V336, P382, DOI 10.1038/336382a0; NEUMANN J, 1994, J PHARMACOL EXP THER, V271, P535; Okamoto R, 2006, CELL SIGNAL, V18, P1408, DOI 10.1016/j.cellsig.2005.11.001; Okamoto R, 2013, FASEB J, V27, P1439, DOI 10.1096/fj.12-217018; Olsson MC, 2004, AM J PHYSIOL-HEART C, V287, pH2712, DOI 10.1152/ajpheart.01067.2003; Riise J, 2012, EUR J PHARMACOL, V686, P66, DOI 10.1016/j.ejphar.2012.04.022; Sanbe A, 1999, J BIOL CHEM, V274, P21085, DOI 10.1074/jbc.274.30.21085; SCHMITZ W, 1991, EUR HEART J, V12, P83, DOI 10.1093/eurheartj/12.suppl_F.83; Seguchi O, 2007, J CLIN INVEST, V117, P2812, DOI 10.1172/JCI30804; Sheikh F, 2012, J CLIN INVEST, V122, P1209, DOI 10.1172/JCI61134; Skomedal T, 1997, J PHARMACOL EXP THER, V280, P721; SWEENEY HL, 1993, AM J PHYSIOL, V264, pC1085, DOI 10.1152/ajpcell.1993.264.5.C1085; Tsukamoto O, 2013, CIRC J, V77, P2218, DOI 10.1253/circj.CJ-13-0627; van der Velden J, 2003, CARDIOVASC RES, V57, P505, DOI 10.1016/S0008-6363(02)00662-4; VENEMA RC, 1993, BIOCHEM J, V294, P401, DOI 10.1042/bj2940401; Warren SA, 2012, CIRCULATION, V126, P2575, DOI 10.1161/CIRCULATIONAHA.112.116202	35	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2015	10	10							e0141130	10.1371/journal.pone.0141130	http://dx.doi.org/10.1371/journal.pone.0141130			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0ED	26512720	Green Submitted, Green Published, gold			2022-12-26	WOS:000363920300017
J	Kinnear, CL; Strugnell, RA				Kinnear, Clare L.; Strugnell, Richard A.			Vaccination Method Affects Immune Response and Bacterial Growth but Not Protection in the Salmonella Typhimurium Animal Model of Typhoid	PLOS ONE			English	Article							ENTERICA SEROVAR TYPHIMURIUM; VI-CAPSULAR POLYSACCHARIDE; CONTROLLED FIELD TRIAL; ORAL CHALLENGE; M-CELLS; PEYERS-PATCHES; BALB/C MICE; MOUSE MODEL; IFN-GAMMA; T-CELLS	Understanding immune responses elicited by vaccines, together with immune responses required for protection, is fundamental to designing effective vaccines and immunisation programs. This study examines the effects of the route of administration of a live attenuated vaccine on its interactions with, and stimulation of, the murine immune system as well as its ability to increase survival and provide protection from colonisation by a virulent challenge strain. We assess the effect of administration method using the murine model for typhoid, where animals are infected with S. Typhimurium. Mice were vaccinated either intravenously or orally with the same live attenuated S. Typhimurium strain and data were collected on vaccine strain growth, shedding and stimulation of antibodies and cytokines. Following vaccination, mice were challenged with a virulent strain of S. Typhimurium and the protection conferred by the different vaccination routes was measured in terms of challenge suppression and animal survival. The main difference in immune stimulation found in this study was the development of a secretory IgA response in orally-vaccinated mice, which was absent in IV vaccinated mice. While both strains showed similar protection in terms of challenge suppression in systemic organs (spleen and liver) as well as survival, they differed in terms of challenge suppression of virulent pathogens in gut-associated organs. This difference in gut colonisation presents important questions around the ability of vaccines to prevent shedding and transmission. These findings demonstrate that while protection conferred by two vaccines can appear to be the same, the mechanisms controlling the protection can differ and have important implications for infection dynamics within a population.	[Kinnear, Clare L.; Strugnell, Richard A.] Univ Melbourne, Dept Microbiol & Immunol, Melbourne, Vic, Australia; [Kinnear, Clare L.] Univ Melbourne, Dept Biosci, Melbourne, Vic, Australia	University of Melbourne; University of Melbourne	Kinnear, CL (corresponding author), Univ Melbourne, Dept Microbiol & Immunol, Melbourne, Vic, Australia.	kinnear@unimelb.edu.au		Kinnear, Clare/0000-0002-4126-7540; Strugnell, Richard/0000-0003-0614-5641	National Health and Medical Research Council of Australia	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by the National Health and Medical Research Council of Australia (https://www.nhmrc.gov.au), Project and Program Grants to R.A.S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACHARYA IL, 1987, NEW ENGL J MED, V317, P1101, DOI 10.1056/NEJM198710293171801; [Anonymous], 2008, Wkly Epidemiol Rec, V83, P49; Asna SMZH, 2003, JPN J INFECT DIS, V56, P32; BLACK RE, 1990, VACCINE, V8, P81, DOI 10.1016/0264-410X(90)90183-M; Capoor MR, 2010, J GLOB INFECT DIS, V2, P258, DOI 10.4103/0974-777X.68529; CARTER PB, 1974, J EXP MED, V139, P1189, DOI 10.1084/jem.139.5.1189; Crump JA, 2004, B WORLD HEALTH ORGAN, V82, P346; Crump JA, 2010, CLIN INFECT DIS, V50, P241, DOI 10.1086/649541; CURTISS R, 1988, VACCINE, V6, P155, DOI 10.1016/S0264-410X(88)80020-3; Diehl GE, 2013, NATURE, V494, P116, DOI 10.1038/nature11809; Engels EA, 1998, BRIT MED J, V316, P110, DOI 10.1136/bmj.316.7125.110; Everest P, 1998, INFECT IMMUN, V66, P3355, DOI 10.1128/IAI.66.7.3355-3364.1998; Everest P, 1997, J IMMUNOL, V159, P1820; Fang FC, 2012, CELL, V151, P473, DOI 10.1016/j.cell.2012.10.016; Griffin AJ, 2011, MUCOSAL IMMUNOL, V4, P371, DOI 10.1038/mi.2011.2; Halle S, 2007, INFECT IMMUN, V75, P1577, DOI 10.1128/IAI.01392-06; Harrison JA, 1997, IMMUNOLOGY, V90, P618, DOI 10.1046/j.1365-2567.1997.00158.x; Hess J, 1996, J IMMUNOL, V156, P3321; Hohmann EL, 1996, J INFECT DIS, V173, P1408, DOI 10.1093/infdis/173.6.1408; HOISETH SK, 1981, NATURE, V291, P238, DOI 10.1038/291238a0; Hu H, 2009, VACCINE, V27, P1758, DOI 10.1016/j.vaccine.2009.01.021; Jensen VB, 1998, INFECT IMMUN, V66, P3758, DOI 10.1128/IAI.66.8.3758-3766.1998; Jepson MA, 2001, MICROBES INFECT, V3, P1183, DOI 10.1016/S1286-4579(01)01478-2; JONES BD, 1994, J EXP MED, V180, P15, DOI 10.1084/jem.180.1.15; Kantele A, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0082806, DOI 10.1371/J0URNAL.P0NE.0082806]; Kaur J, 2013, BIOLOGIA, V68, P194, DOI 10.2478/s11756-013-0160-z; Klugman KP, 1996, VACCINE, V14, P435, DOI 10.1016/0264-410X(95)00186-5; KLUGMAN KP, 1987, LANCET, V2, P1165; Kupz A, 2013, P NATL ACAD SCI USA, V110, P2252, DOI 10.1073/pnas.1222047110; LEVINE MM, 1990, LANCET, V336, P891; LEVINE MM, 1989, REV INFECT DIS, V11, pS552; Lowe DC, 1999, INFECT IMMUN, V67, P700, DOI 10.1128/IAI.67.2.700-707.1999; Martinoli C, 2007, IMMUNITY, V27, P975, DOI 10.1016/j.immuni.2007.10.011; MASTROENI P, 1993, INFECT IMMUN, V61, P3981, DOI 10.1128/IAI.61.9.3981-3984.1993; MASTROENI P, 1992, MICROB PATHOGENESIS, V13, P477, DOI 10.1016/0882-4010(92)90014-F; Mastroeni P, 1998, INFECT IMMUN, V66, P4767, DOI 10.1128/IAI.66.10.4767-4776.1998; Mastroeni P, 2000, INFECT IMMUN, V68, P46, DOI 10.1128/IAI.68.1.46-53.2000; Mastroeni P, 2011, EXPERT REV MOL MED, V13, DOI 10.1017/S1462399411001840; Mathur R, 2012, CELL, V151, P590, DOI 10.1016/j.cell.2012.08.042; Mian MF, 2011, CELL MOL IMMUNOL, V8, P83, DOI 10.1038/cmi.2010.52; MICHETTI P, 1992, INFECT IMMUN, V60, P1786, DOI 10.1128/IAI.60.5.1786-1792.1992; MILLER SI, 1993, VACCINE, V11, P122, DOI 10.1016/0264-410X(93)90006-J; Mittrucker HW, 1999, J IMMUNOL, V163, P6769; Mittrucker HW, 2000, J IMMUNOL, V164, P1648, DOI 10.4049/jimmunol.164.4.1648; Monack DM, 2000, J EXP MED, V192, P249, DOI 10.1084/jem.192.2.249; NAKONECZNA I, 1980, BRIT J EXP PATHOL, V61, P76; NAUCIEL C, 1990, J IMMUNOL, V145, P1265; Netea MG, 2000, J IMMUNOL, V164, P2644, DOI 10.4049/jimmunol.164.5.2644; Niess JH, 2005, SCIENCE, V307, P254, DOI 10.1126/science.1102901; Price JD, 2007, INFECT IMMUN, V75, P5753, DOI 10.1128/IAI.00971-07; Rueckert C, 2012, PLOS PATHOGENS, V8; Sambrock J, 1989, MOL CLONING LAB MANU, V1; SIMANJUNTAK CH, 1991, LANCET, V338, P1055, DOI 10.1016/0140-6736(91)91910-M; Sinha K, 1997, INFECT IMMUN, V65, P1566, DOI 10.1128/IAI.65.4.1566-1569.1997; Song JM, 2010, CELL HOST MICROBE, V8, P369, DOI 10.1016/j.chom.2010.09.003; STRAHAN K, 1992, MICROB PATHOGENESIS, V12, P311, DOI 10.1016/0882-4010(92)90049-T; STRUGNELL R, 1992, INFECT IMMUN, V60, P3994, DOI 10.1128/IAI.60.10.3994-4002.1992; TACKET CO, 1992, INFECT IMMUN, V60, P536, DOI 10.1128/IAI.60.2.536-541.1992; Tacket CO, 1997, INFECT IMMUN, V65, P452, DOI 10.1128/IAI.65.2.452-456.1997; TACKET CO, 1992, VACCINE, V10, P443, DOI 10.1016/0264-410X(92)90392-W; Uddin AN, 2009, J DRUG TARGET, V17, P553, DOI 10.1080/10611860903067301; Ugrinovic S, 2003, INFECT IMMUN, V71, P6808, DOI 10.1128/IAI.71.12.6808-6819.2003; Uren T., 1999, Immunology Letters, V69, P154; Uren TK, 2005, EUR J IMMUNOL, V35, P180, DOI 10.1002/eji.200425492; van Asten AJAM, 2005, VET MICROBIOL, V108, P149, DOI 10.1016/j.vetmic.2005.04.001; Vazquez-Torres A, 1999, NATURE, V401, P804, DOI 10.1038/44593; WAHDAN MH, 1982, J INFECT DIS, V145, P292, DOI 10.1093/infdis/145.3.292; Wijburg OLC, 2006, J EXP MED, V203, P21, DOI 10.1084/jem.20052093; Zhang X, 1999, MICROB PATHOGENESIS, V26, P121, DOI 10.1006/mpat.1998.0245; Zheng SY, 2012, BMC IMMUNOL, V13	70	4	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2015	10	10							e0141356	10.1371/journal.pone.0141356	http://dx.doi.org/10.1371/journal.pone.0141356			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0DL	26509599	Green Published, gold			2022-12-26	WOS:000363918100073
J	Sans, M; Figueiro, G; Hughes, CE; Lindo, J; Hidalgo, PC; Malhi, RS				Sans, Monica; Figueiro, Gonzalo; Hughes, Cris E.; Lindo, John; Hidalgo, Pedro C.; Malhi, Ripan S.			A South American Prehistoric Mitogenome: Context, Continuity, and the Origin of Haplogroup C1d	PLOS ONE			English	Article							MITOCHONDRIAL-DNA; MTDNA VARIATION; POPULATION; URUGUAY; ANCESTRY; SPREAD; HETEROGENEITY; EVOLUTIONARY; PATTERNS; SEQUENCE	Based on mitochondrial DNA (mtDNA), it has been estimated that at least 15 founder haplogroups peopled the Americas. Subhaplogroup C1d3 was defined based on the mitogenome of a living individual from Uruguay that carried a lineage previously identified in hypervariable region I sequences from ancient and modern Uruguayan individuals. When complete mitogenomes were studied, additional substitutions were found in the coding region of the mitochondrial genome. Using a complete ancient mitogenome and three modern mitogenomes, we aim to clarify the ancestral state of subhaplogroup C1d3 and to better understand the peopling of the region of the Rio de la Plata basin, as well as of the builders of the mounds from which the ancient individuals were recovered. The ancient mitogenome, belonging to a female dated to 1,610 +/- 46 years before present, was identical to the mitogenome of one of the modern individuals. All individuals share the mutations defining subhaplogroup C1d3. We estimated an age of 8,974 (5,748-12,261) years for the most recent common ancestor of C1d3, in agreement with the initial peopling of the geographic region. No individuals belonging to the defined lineage were found outside of Uruguay, which raises questions regarding the mobility of the prehistoric inhabitants of the country. Moreover, the present study shows the continuity of Native lineages over at least 6,000 years.	[Sans, Monica; Figueiro, Gonzalo; Hidalgo, Pedro C.] Univ Republica, Dept Biol Anthropol, Fac Humanidades & Ciencias Educ, Montevideo, Uruguay; [Hughes, Cris E.; Lindo, John; Malhi, Ripan S.] Univ Illinois, Dept Anthropol, Urbana, IL 61801 USA; [Malhi, Ripan S.] Univ Illinois, Carl R Woese Inst Genom Biol, Urbana, IL 61801 USA	Universidad de la Republica, Uruguay; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Sans, M (corresponding author), Univ Republica, Dept Biol Anthropol, Fac Humanidades & Ciencias Educ, Montevideo, Uruguay.	mbsans@gmail.com	Lindo, John/R-5833-2019	Figueiro, Gonzalo/0000-0003-0433-932X; Malhi, Ripan/0000-0002-1484-0292	Agencia Nacional de Investigacion e Innovacion, Uruguay [FCE_2011_1_7157]; National Science Foundation [BCS-745459, BCS-1025139]	Agencia Nacional de Investigacion e Innovacion, Uruguay; National Science Foundation(National Science Foundation (NSF))	The work was supported by Agencia Nacional de Investigacion e Innovacion, Uruguay (www.anii.org.uy/), Grant FCE_2011_1_7157 to MS. The work was also supported by National Science Foundation (www.nsf.gov/), BCS-745459 and BCS-1025139 to RSM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achilli A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001764; Acosta Y Lara E.F., 1985, REV FACULTAD HUMANID, V1, P65; Alves-Silva J, 2000, AM J HUM GENET, V67, P444, DOI 10.1086/303004; Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Bandelt HJ, 2002, AM J HUM GENET, V71, P1150, DOI 10.1086/344397; Behar DM, 2012, AM J HUM GENET, V90, P675, DOI 10.1016/j.ajhg.2012.03.002; Bertoni B., 2004, 10 C UR ARQ ARQ UR A; Bodner M, 2012, GENOME RES, V22, P811, DOI 10.1101/gr.131722.111; Bonilla C, 2015, BMC WOMENS HEALTH, V15, DOI 10.1186/s12905-015-0171-8; Boksar RB, 2006, LAT AM ANTIQ, V17, P511, DOI 10.2307/25063070; Briggs AW, 2007, P NATL ACAD SCI USA, V104, P14616, DOI 10.1073/pnas.0704665104; Cardena MMSG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062005; Catelli ML, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-77; Cox MP, 2008, HUM BIOL, V80, P335, DOI 10.3378/1534-6617-80.4.335; Cui YQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066948; de St Pierre M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051311; DILLEHAY TD, 1990, WORLD ARCHAEOL, V22, P223, DOI 10.1080/00438243.1990.9980142; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Fagundes NJR, 2008, AM J HUM GENET, V82, P583, DOI 10.1016/j.ajhg.2007.11.013; Farina RA, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2211; Figueiro G, 2014, AVANCES RECIENTES BI, P47; Figueiro G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020978; Flegenheimer N, 2003, QUATERN INT, V109, P49, DOI 10.1016/S1040-6182(02)00202-1; Forster P, 1996, AM J HUM GENET, V59, P935; Fridman C, 2014, INT J LEGAL MED, V128, P589, DOI 10.1007/s00414-014-1023-z; Garcia A, 2012, AM J PHYS ANTHROPOL, V149, P583, DOI 10.1002/ajpa.22174; Gianotti C., 2005, AM LATINA REALIDADES, P104; Ginolhac A, 2011, BIOINFORMATICS, V27, P2153, DOI 10.1093/bioinformatics/btr347; Gomez-Carballa A, 2012, AM J PHYS ANTHROPOL, V147, P78, DOI 10.1002/ajpa.21629; Guidon Niede, 1989, MISION RESCATE ARQUE; Hidalgo PC, 2009, NOVENAS JORNADAS NAC; Hilbert Klaus., 1991, ASPECTOS ARQUEOLOG A; Ho SYW, 2008, AM J HUM GENET, V83, P142, DOI 10.1016/j.ajhg.2008.06.014; Iriarte J, 2004, NATURE, V432, P614, DOI 10.1038/nature02983; Krause J, 2010, CURR BIOL, V20, P231, DOI 10.1016/j.cub.2009.11.068; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; Lindgreen Stinus, 2012, BMC Res Notes, V5, P337, DOI 10.1186/1756-0500-5-337; Lopez JM, 1994, CAZADORES RECOLECTOR, V5, P51; Lopez Mazz J. M., 2009, ARQUEOLOGIA COMO PRO, P473; Lopez Mazz J.M., 2001, LAT AM ANTIQ, V12, P231, DOI DOI 10.2307/971631; Mazz JML, 2013, QUATERN INT, V301, P94, DOI 10.1016/j.quaint.2012.07.004; Malhi RS, 2010, AM J PHYS ANTHROPOL, V141, P494, DOI 10.1002/ajpa.21238; Marrero AR, 2007, AM J PHYS ANTHROPOL, V132, P301, DOI 10.1002/ajpa.20515; Marrero AR, 2007, HUM HERED, V64, P160, DOI 10.1159/000102989; Marrero AR, 2005, AM J HUM BIOL, V17, P496, DOI 10.1002/ajhb.20404; Meneghin U., 2004, ORIGENES, V2, P1; Meneghin U., 2006, ORIGENES, V5, P1; Meyer S, 1999, GENETICS, V152, P1103; Ministerio de Instruccion Publica, 1925, LIBR CENT UR 1825 19; Moreno Federica, 2014, Rev Arg Antrop Biol, V16, P65; MORRAL N, 1994, NAT GENET, V7, P169, DOI 10.1038/ng0694-169; Nami H.G., 2013, ARCHAEOLOGICAL DISCO, V1, P1, DOI [10.4236/ad.2013.11001, DOI 10.4236/AD.2013.11001]; Nicholas K.B., 1997, EMBNEW NEWS, V4, P14; Pagano S, 2005, J FORENSIC SCI, V50, P1239; Palencia L, 2010, INT J LEGAL MED, V124, P331, DOI 10.1007/s00414-010-0464-2; Perego UA, 2010, GENOME RES, V20, P1174, DOI 10.1101/gr.109231.110; Perego UA, 2009, CURR BIOL, V19, P1, DOI 10.1016/j.cub.2008.11.058; Polzin T, 2003, OPER RES LETT, V31, P12, DOI 10.1016/S0167-6377(02)00185-2; Sans M, 2011, HUM BIOL, V83, P55, DOI 10.3378/027.083.0104; Sans M, 1999, ARQUEOL BIOANTR TIER, P107; Sans M, 2006, AM J HUM BIOL, V18, P513, DOI 10.1002/ajhb.20520; Sans M, 2012, HUM BIOL, V84, P287, DOI 10.3378/027.084.0303; Soares P, 2009, AM J HUM GENET, V84, P740, DOI 10.1016/j.ajhg.2009.05.001; Suarez X, 2009, ARQUEOLOGIA COMO PRO, P238; Tamm E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000829; van Oven M, 2009, HUM MUTAT, V30, pE386, DOI 10.1002/humu.20921; Wei Z, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr599	70	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2015	10	10							e0141808	10.1371/journal.pone.0141808	http://dx.doi.org/10.1371/journal.pone.0141808			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CV0DL	26509686	Green Published, gold, Green Submitted			2022-12-26	WOS:000363918100134
J	Escalona-Vargas, D; Govindan, RB; Furdea, A; Murphy, P; Lowery, CL; Eswaran, H				Escalona-Vargas, Diana; Govindan, Rathinaswamy B.; Furdea, Adrian; Murphy, Pam; Lowery, Curtis L.; Eswaran, Hari			Characterizing the Propagation of Uterine Electrophysiological Signals Recorded with a Multi-Sensor Abdominal Array in Term Pregnancies	PLOS ONE			English	Article							HUMAN UTERUS; MAGNETOMYOGRAPHIC RECORDINGS; ELECTRICAL PROPAGATION; CONDUCTION-VELOCITY; PRETERM DELIVERY; LABOR; CONTRACTIONS; PREDICTION; SURFACE; RAT	The objective of this study was to quantify the number of segments that have contractile activity and determine the propagation speed from uterine electrophysiological signals recorded over the abdomen. The uterine magnetomyographic (MMG) signals were recorded with a 151 channel SARA (SQUID Array for Reproductive Assessment) system from 36 pregnant women between 37 and 40 weeks of gestational age. The MMG signals were scored and segments were classified based on presence of uterine contractile burst activity. The sensor space was then split into four quadrants and in each quadrant signal strength at each sample was calculated using center-of-gravity (COG). To this end, the cross-correlation analysis of the COG was performed to calculate the delay between pair-wise combinations of quadrants. The relationship in propagation across the quadrants was quantified and propagation speeds were calculated from the delays. MMG recordings were successfully processed from 25 subjects and the average values of propagation speeds ranged from 1.3-9.5 cm/s, which was within the physiological range. The propagation was observed between both vertical and horizontal quadrants confirming multidirectional propagation. After the multiple pairwise test (99% CI), significant differences in speeds can be observed between certain vertical or horizontal combinations and the crossed pair combinations. The number of segments containing contractile activity in any given quadrant pair with a detectable delay was significantly higher in the lower abdominal pairwise combination as compared to all others. The quadrant-based approach using MMG signals provided us with high spatial-temporal information of the uterine contractile activity and will help us in the future to optimize abdominal electromyographic (EMG) recordings that are practical in a clinical setting.	[Escalona-Vargas, Diana; Murphy, Pam; Lowery, Curtis L.; Eswaran, Hari] Univ Arkansas Med Sci, Dept Obstet & Gynecol, Little Rock, AR 72205 USA; [Govindan, Rathinaswamy B.] Childrens Natl Med Ctr, Div Fetal & Transit Med, Washington, DC 20010 USA; [Furdea, Adrian] Univ Tubingen, Inst Med Psychol & Behav Neurobiol, Tubingen, Germany	University of Arkansas System; University of Arkansas Medical Sciences; Children's National Health System; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Eswaran, H (corresponding author), Univ Arkansas Med Sci, Dept Obstet & Gynecol, Little Rock, AR 72205 USA.	eswaranhari@uams.edu	Escalona-Vargas, Diana/AAR-4647-2020	Escalona-Vargas, Diana/0000-0002-9487-0765	NIH/National Institutes of Biomedical Imaging and Bioengineering [R01EB7264]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB007264] Funding Source: NIH RePORTER	NIH/National Institutes of Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	The study was funded by NIH/National Institutes of Biomedical Imaging and Bioengineering grant R01EB7264. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Buhimschi C, 1997, OBSTET GYNECOL, V90, P102, DOI 10.1016/S0029-7844(97)83837-9; Buhimschi C, 1998, AM J OBSTET GYNECOL, V178, P811, DOI 10.1016/S0002-9378(98)70498-3; Caspo A, 1968, ACTA OBSTSET GYNECOL, V47, P181; Csapo A, 1963, NATURE, V200, P68; de Lau H, 2013, COMPUT MATH METHOD M, V2013, DOI 10.1155/2013/627976; Eswaran H, 2004, AM J OBSTET GYNECOL, V190, P1598, DOI 10.1016/j.ajog.2004.03.063; Eswaran H, 2002, AM J OBSTET GYNECOL, V187, P145, DOI 10.1067/mob.2002.123031; Eswaran H, 2009, EUR J OBSTET GYN R B, V144, pS96, DOI 10.1016/j.ejogrb.2009.02.023; Furdea A, 2009, PHYSIOL MEAS, V30, P1051, DOI 10.1088/0967-3334/30/10/006; Furdea A, 2011, IEEE ENG MED BIO, P6025, DOI 10.1109/IEMBS.2011.6091489; Garfield RE, 1998, J PERINAT MED, V26, P413, DOI 10.1515/jpme.1998.26.6.413; Govindan RB, 2011, ANN BIOMED ENG, V39, P964, DOI 10.1007/s10439-010-0231-z; Govindan RB, 2008, NEUROIMAGE, V43, P521, DOI 10.1016/j.neuroimage.2008.07.054; Govindan RB, 2015, REPROD SCI, V22, P595, DOI 10.1177/1933719114556484; HON EHG, 1958, OBSTET GYNECOL, V12, P47, DOI 10.1097/00006250-195807000-00003; KURIYAMA H, 1961, ENDOCRINOLOGY, V68, P1010, DOI 10.1210/endo-68-6-1010; La Rosa Patricio S, 2012, BMC Med Phys, V12, P4, DOI 10.1186/1756-6649-12-4; Lammers WJEP, 2008, AM J PHYSIOL-REG I, V294, pR919, DOI 10.1152/ajpregu.00704.2007; Lammers WJEP, 2013, REPROD SCI, V20, P182, DOI 10.1177/1933719112446082; Lammers WJEP, 1999, PFLUG ARCH EUR J PHY, V437, P363, DOI 10.1007/s004240050790; Lange L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086775; LARKS SD, 1957, J APPL PHYSIOL, V10, P479, DOI 10.1152/jappl.1957.10.3.479; Lucovnik M, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2010.09.024; Maner WL, 2003, OBSTET GYNECOL, V101, P1254, DOI 10.1016/S0029-7844(03)00341-7; Marque C, 1989, APPL BIOSENSORS, P187; Mikkelsen E, 2013, ACTA OBSTET GYN SCAN, V92, P1070, DOI 10.1111/aogs.12190; Rabotti C, 2011, AM J OBSTET GYNECOL, V205, pE9, DOI 10.1016/j.ajog.2011.06.071; Rabotti C, 2010, IEEE T BIO-MED ENG, V57, P2178, DOI 10.1109/TBME.2010.2049111; Sheldon RE, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0458; STEER CM, 1950, AM J OBSTET GYNECOL, V59, P25, DOI 10.1016/0002-9378(50)90337-1; STEER CM, 1954, AM J OBSTET GYNECOL, V68, P867, DOI 10.1016/S0002-9378(16)38329-6; Sureau C, 1965, B FED SOC GYNECOL OB, V17, P79; WOLFS G, 1970, ARCH GYNAKOL, V208, P373, DOI 10.1007/BF00668252; Wolfs G M, 1979, Acta Obstet Gynecol Scand Suppl, V90, P1; Young RC, 2014, PLOS COMPUT BIOL, V16, P10	35	14	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2015	10	10							e0140894	10.1371/journal.pone.0140894	http://dx.doi.org/10.1371/journal.pone.0140894			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU8PC	26505624	Green Submitted, gold, Green Published			2022-12-26	WOS:000363804200021
J	Chattopadhyay, M; Nwadibia, E; Strong, CD; Gralla, EB; Valentine, JS; Whitelegge, JP				Chattopadhyay, Madhuri; Nwadibia, Ekeoma; Strong, Cynthia D.; Gralla, Edith Butler; Valentine, Joan Selverstone; Whitelegge, Julian P.			The Disulfide Bond, but Not Zinc or Dimerization, Controls Initiation and Seeded Growth in Amyotrophic Lateral Sclerosis-linked Cu, Zn Superoxide Dismutase (SOD1) Fibrillation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COPPER CHAPERONE CCS; METAL-ION BINDING; FAMILIAL ALS; WILD-TYPE; CU,ZN-SUPEROXIDE DISMUTASE; MUTANT SOD1; NEURODEGENERATIVE DISEASES; TRANSGENIC MICE; IN-VITRO; AGGREGATION	Aggregation of copper-zinc superoxide dismutase (SOD1) is a defining feature of familial ALS caused by inherited mutations in the sod1 gene, and misfolded and aggregated forms of wildtype SOD1 are found in both sporadic and familial ALS cases. Mature SOD1 owes its exceptional stability to a number of post-translational modifications as follows: formation of the intramolecular disulfide bond, binding of copper and zinc, and dimerization. Loss of stability due to the failure to acquire one or more of these modifications is proposed to lead to aggregation in vivo. Previously, we showed that the presence of apo-, disulfide-reduced SOD1, the most immature form of SOD1, results in initiation of fibrillation of more mature forms that have an intact Cys-57-Cys-146 disulfide bond and are partially metallated. In this study, we examine the ability of each of the above post-translational modifications to modulate fibril initiation and seeded growth. Cobalt or zinc binding, despite conferring great structural stability, neither inhibits the initiation propensity of disulfide-reduced SOD1 nor consistently protects disulfide-oxidized SOD1 from being recruited into growing fibrils across wild-type and a number of ALS mutants. In contrast, reduction of the disulfide bond, known to be necessary for fibril initiation, also allows for faster recruitment during seeded amyloid growth. These results identify separate factors that differently influence seeded growth and initiation and indicate a lack of correlation between the overall thermodynamic stability of partially mature SOD1 states and their ability to initiate fibrillation or be recruited by a growing fibril.	[Chattopadhyay, Madhuri; Nwadibia, Ekeoma; Gralla, Edith Butler; Valentine, Joan Selverstone; Whitelegge, Julian P.] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA; [Strong, Cynthia D.] Cornell Coll, Dept Chem, Mt Vernon, IA 52314 USA; [Whitelegge, Julian P.] Univ Calif Los Angeles, David Geffen Sch Med, NPI Semel Inst Neurosci & Human Behav, Pasarow Mass Spectrometry Lab, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; Cornell University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Chattopadhyay, M (corresponding author), Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA.	madhuri@gmail.com; jpw@chem.ucla.edu	Valentine, Joan S/B-6665-2008	Valentine, Joan S/0000-0002-7174-925X; Whitelegge, Julian/0000-0003-2763-7733	National Institutes of Health from NINDS [P01 NS049134]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS049134] Funding Source: NIH RePORTER	National Institutes of Health from NINDS; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health Program Project Grant P01 NS049134 from NINDS. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Arnesano F, 2004, J BIOL CHEM, V279, P47998, DOI 10.1074/jbc.M406021200; Ayers JI, 2014, ACTA NEUROPATHOL, V128, P791, DOI 10.1007/s00401-014-1342-7; Banci L, 2007, P NATL ACAD SCI USA, V104, P11263, DOI 10.1073/pnas.0704307104; Banci L, 2013, NAT CHEM BIOL, V9, P297, DOI [10.1038/NCHEMBIO.1202, 10.1038/nchembio.1202]; Banci L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023561; Bhatia NK, 2015, BBA-PROTEINS PROTEOM, V1854, P426, DOI 10.1016/j.bbapap.2015.01.014; Bruns CK, 2007, EMBO J, V26, P855, DOI 10.1038/sj.emboj.7601528; Carroll MC, 2004, P NATL ACAD SCI USA, V101, P5964, DOI 10.1073/pnas.0308298101; Caughey B, 2003, ANNU REV NEUROSCI, V26, P267, DOI 10.1146/annurev.neuro.26.010302.081142; Chan PK, 2013, P NATL ACAD SCI USA, V110, P10934, DOI 10.1073/pnas.1309613110; Chattopadhyay M, 2008, P NATL ACAD SCI USA, V105, P18663, DOI 10.1073/pnas.0807058105; Chia R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010627; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Deng HX, 2006, P NATL ACAD SCI USA, V103, P7142, DOI 10.1073/pnas.0602046103; DiDonato M, 2003, J MOL BIOL, V332, P601, DOI 10.1016/S0022-2836(03)00889-1; Ding F, 2008, P NATL ACAD SCI USA, V105, P19696, DOI 10.1073/pnas.0803266105; Doucette PA, 2004, J BIOL CHEM, V279, P54558, DOI 10.1074/jbc.M409744200; Durazo A, 2009, J BIOL CHEM, V284, P34382, DOI 10.1074/jbc.M109.052076; Durer ZAO, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005004; Eisele YS, 2015, NAT REV DRUG DISCOV, V14, P759, DOI 10.1038/nrd4593; Eisenberg D, 2012, CELL, V148, P1188, DOI 10.1016/j.cell.2012.02.022; Furukawa Y, 2005, J BIOL CHEM, V280, P17266, DOI 10.1074/jbc.M500482200; Furukawa Y, 2004, EMBO J, V23, P2872, DOI 10.1038/sj.emboj.7600276; Furukawa Y, 2008, J BIOL CHEM, V283, P24167, DOI 10.1074/jbc.M802083200; Furukawa Y, 2013, FEBS LETT, V587, P2500, DOI 10.1016/j.febslet.2013.06.046; Goto JJ, 2000, J BIOL CHEM, V275, P1007, DOI 10.1074/jbc.275.2.1007; Grad LI, 2011, P NATL ACAD SCI USA, V108, P16398, DOI 10.1073/pnas.1102645108; Graffmo KS, 2013, HUM MOL GENET, V22, P51, DOI 10.1093/hmg/dds399; Harper JD, 1997, ANNU REV BIOCHEM, V66, P385, DOI 10.1146/annurev.biochem.66.1.385; Jaarsma D, 2008, J NEUROSCI, V28, P2075, DOI 10.1523/JNEUROSCI.5258-07.2008; Karch CM, 2009, P NATL ACAD SCI USA, V106, P7774, DOI 10.1073/pnas.0902505106; Kayatekin C, 2008, J MOL BIOL, V384, P540, DOI 10.1016/j.jmb.2008.09.045; Khare SD, 2004, P NATL ACAD SCI USA, V101, P15094, DOI 10.1073/pnas.0406650101; Knowles TPJ, 2009, SCIENCE, V326, P1533, DOI 10.1126/science.1178250; Leinartaite L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078060; Leinartaite L, 2010, J AM CHEM SOC, V132, P13495, DOI 10.1021/ja1057136; Leitch JM, 2009, J BIOL CHEM, V284, P21863, DOI 10.1074/jbc.M109.000489; Lelie HL, 2011, J BIOL CHEM, V286, P2795, DOI 10.1074/jbc.M110.186999; Lindberg MJ, 2005, P NATL ACAD SCI USA, V102, P9754, DOI 10.1073/pnas.0501957102; Luchinat E, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6502; Lyons TJ, 1996, P NATL ACAD SCI USA, V93, P12240, DOI 10.1073/pnas.93.22.12240; Lyons TJ, 1998, J BIOL INORG CHEM, V3, P650, DOI 10.1007/s007750050279; MING LJ, 1988, INORG CHEM, V27, P728, DOI 10.1021/ic00277a029; MING LJ, 1990, J AM CHEM SOC, V112, P4256, DOI 10.1021/ja00167a021; Munch C, 2011, P NATL ACAD SCI USA, V108, P3548, DOI 10.1073/pnas.1017275108; Mulligan VK, 2008, J MOL BIOL, V383, P424, DOI 10.1016/j.jmb.2008.08.024; PANTOLIANO MW, 1982, J AM CHEM SOC, V104, P1717, DOI 10.1021/ja00370a045; Potter SZ, 2007, J AM CHEM SOC, V129, P4575, DOI 10.1021/ja066690+; Potter SZ, 2003, J BIOL INORG CHEM, V8, P373, DOI 10.1007/s00775-003-0447-6; PRENDERGAST FG, 1983, J BIOL CHEM, V258, P7541; Prusiner SB, 2012, SCIENCE, V336, P1511, DOI 10.1126/science.1222951; Rakhit R, 2004, J BIOL CHEM, V279, P15499, DOI 10.1074/jbc.M313295200; Rakhit R, 2007, NAT MED, V13, P754, DOI 10.1038/nm1559; Shaw BF, 2006, J BIOL CHEM, V281, P18167, DOI 10.1074/jbc.M600623200; Sheng YW, 2012, CURR TOP MED CHEM, V12, P2560; Soto C, 2003, NAT REV NEUROSCI, V4, P49, DOI 10.1038/nrn1007; Stathopulos PB, 2003, P NATL ACAD SCI USA, V100, P7021, DOI 10.1073/pnas.1237797100; Svensson AKE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010064; Synofzik M, 2012, HUM MOL GENET, V21, P3568, DOI 10.1093/hmg/dds188; Tiwari A, 2003, J BIOL CHEM, V278, P5984, DOI 10.1074/jbc.M210419200; Tiwari A, 2009, J BIOL CHEM, V284, P27746, DOI 10.1074/jbc.M109.043729; Toichi K, 2013, J BIOL CHEM, V288, P4970, DOI 10.1074/jbc.M112.414235; Valentine JS, 2005, ANNU REV BIOCHEM, V74, P563, DOI 10.1146/annurev.biochem.72.121801.161647; Vassall KA, 2011, P NATL ACAD SCI USA, V108, P2210, DOI 10.1073/pnas.0913021108; Wright GSA, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2750; Xu GL, 2015, HUM MOL GENET, V24, P1019, DOI 10.1093/hmg/ddu517	66	41	42	0	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2015	290	51					30624	30636		10.1074/jbc.M115.666503	http://dx.doi.org/10.1074/jbc.M115.666503			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CY9PG	26511321	hybrid, Green Published			2022-12-26	WOS:000366738200037
J	Fahey, JW; Holtzclaw, WD; Wehage, SL; Wade, KL; Stephenson, KK; Talalay, P				Fahey, Jed W.; Holtzclaw, W. David; Wehage, Scott L.; Wade, Kristina L.; Stephenson, Katherine K.; Talalay, Paul			Sulforaphane Bioavailability from Glucoraphanin-Rich Broccoli: Control by Active Endogenous Myrosinase	PLOS ONE			English	Article							RANDOMIZED CLINICAL-TRIAL; QUANTITATIVE-DETERMINATION; ISOTHIOCYANATES; ACTIVATION; SPROUTS; PHASE; CHEMOPREVENTION; IDENTIFICATION; PURIFICATION; METABOLISM	Glucoraphanin from broccoli and its sprouts and seeds is a water soluble and relatively inert precursor of sulforaphane, the reactive isothiocyanate that potently inhibits neoplastic cellular processes and prevents a number of disease states. Sulforaphane is difficult to deliver in an enriched and stable form for purposes of direct human consumption. We have focused upon evaluating the bioavailability of sulforaphane, either by direct administration of glucoraphanin (a glucosinolate, or beta-thioglucoside-N-hydroxysulfate), or by co-administering glucoraphanin and the enzyme myrosinase to catalyze its conversion to sulforaphane at economic, reproducible and sustainable yields. We show that following administration of glucoraphanin in a commercially prepared dietary supplement to a small number of human volunteers, the volunteers had equivalent output of sulforaphane metabolites in their urine to that which they produced when given an equimolar dose of glucoraphanin in a simple boiled and lyophilized extract of broccoli sprouts. Furthermore, when either broccoli sprouts or seeds are administered directly to subjects without prior extraction and consequent inactivation of endogenous myrosinase, regardless of the delivery matrix or dose, the sulforaphane in those preparations is 3- to 4-fold more bioavailable than sulforaphane from glucoraphanin delivered without active plant myrosinase. These data expand upon earlier reports of inter-and intra-individual variability, when glucoraphanin was delivered in either teas, juices, or gelatin capsules, and they confirm that a variety of delivery matrices may be equally suitable for glucoraphanin supplementation (e.g. fruit juices, water, or various types of capsules and tablets).	[Fahey, Jed W.; Holtzclaw, W. David; Wehage, Scott L.; Wade, Kristina L.; Stephenson, Katherine K.; Talalay, Paul] Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA; [Fahey, Jed W.; Talalay, Paul] Johns Hopkins Univ, Dept Int Hlth, Bloomberg Sch Publ Hlth, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Fahey, JW (corresponding author), Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA.	jfahey@jhmi.edu		Wade, Kristina/0000-0003-0076-3895	Brassica Protection Products LLC; Lewis B. and Dorothy Cullman Foundation	Brassica Protection Products LLC; Lewis B. and Dorothy Cullman Foundation	This work was supported by a generous non-restricted donation from the Lewis B. and Dorothy Cullman Foundation. Funding to cover the cost of including a commercial supplement was provided by Brassica Protection Products LLC, and the supplements themselves were provided free of charge by their manufacturer (Xymogen) as detailed in the manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alumkal JJ, 2015, INVEST NEW DRUG, V33, P480, DOI 10.1007/s10637-014-0189-z; Bierwirth J. E., 2015, NFS Journal, V1, P24, DOI 10.1016/j.nfs.2015.07.001; Brown R, 2015, RESP RES IN PRESS; Cipolla BG, 2015, CANCER PREV RES, V8, P712, DOI 10.1158/1940-6207.CAPR-14-0459; Dinkova-Kostova AT, 2010, ACTA HORTIC, V867, P27, DOI 10.17660/ActaHortic.2010.867.2; Egner PA, 2014, CANCER PREV RES, V7, P813, DOI 10.1158/1940-6207.CAPR-14-0103; Egner PA, 2011, CANCER PREV RES, V4, P384, DOI 10.1158/1940-6207.CAPR-10-0296; Fahey JW, 2007, CHEM RES TOXICOL, V20, P572, DOI 10.1021/tx7000459; Fahey Jed W, 2013, Virtual Mentor, V15, P311, DOI 10.1001/virtualmentor.2013.15.4.stas1-1304; Fahey JW, 2012, CANCER PREV RES, V5, P603, DOI 10.1158/1940-6207.CAPR-11-0538; Fahey JW, 2012, CANCER PREV RES, V5, P179, DOI 10.1158/1940-6207.CAPR-11-0572; Fahey JW, 1997, P NATL ACAD SCI USA, V94, P10367, DOI 10.1073/pnas.94.19.10367; Fahey JW, 2001, PHYTOCHEMISTRY, V56, P5, DOI 10.1016/S0031-9422(00)00316-2; Fisher D, 2005, J LIQ CHROMATOGR R T, V28, P1913, DOI 10.1081/JLC-200063563; Heber D, 2014, FOOD FUNCT, V5, P35, DOI 10.1039/c3fo60277j; Juge N, 2007, CELL MOL LIFE SCI, V64, P1105, DOI 10.1007/s00018-007-6484-5; Kensler TW, 2005, CANCER EPIDEM BIOMAR, V14, P2605, DOI 10.1158/1055-9965.EPI-05-0368; Knatko EV, 2015, CANCER PREV RES, V8, P475, DOI 10.1158/1940-6207.CAPR-14-0362; Poulton EJ, 2013, TOXICOL APPL PHARM, V266, P122, DOI 10.1016/j.taap.2012.10.029; Prestera T, 1996, ANAL BIOCHEM, V239, P168, DOI 10.1006/abio.1996.0312; Shapiro TA, 2001, CANCER EPIDEM BIOMAR, V10, P501; Shapiro TA, 2006, NUTR CANCER, V55, P53, DOI 10.1207/s15327914nc5501_7; Shikita M, 1999, BIOCHEM J, V341, P725, DOI 10.1042/0264-6021:3410725; Singh K, 2014, P NATL ACAD SCI USA, V111, P15550, DOI 10.1073/pnas.1416940111; Talalay P, 2001, J NUTR, V131, p3027S, DOI 10.1093/jn/131.11.3027S; Tang L, 2006, MOL CANCER THER, V5, P935, DOI 10.1158/1535-7163.MCT-05-0476; Wade KL, 2007, J CHROMATOGR A, V1154, P469, DOI 10.1016/j.chroma.2007.04.034; Wade KL, 2015, PHYTOCHEM ANALYSIS, V26, P47, DOI 10.1002/pca.2535; Ye LX, 2002, CLIN CHIM ACTA, V316, P43, DOI 10.1016/S0009-8981(01)00727-6; ZHANG YS, 1992, P NATL ACAD SCI USA, V89, P2399, DOI 10.1073/pnas.89.6.2399; Zhang YS, 1996, ANAL BIOCHEM, V239, P160, DOI 10.1006/abio.1996.0311	31	95	97	3	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2015	10	11							e0140963	10.1371/journal.pone.0140963	http://dx.doi.org/10.1371/journal.pone.0140963			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV1PG	26524341	gold, Green Published, Green Submitted			2022-12-26	WOS:000364029800005
J	Bernard, S; Proust, J; Clement, F				Bernard, Stephane; Proust, Joelle; Clement, Fabrice			Procedural Metacognition and False Belief Understanding in 3-to 5-Year-Old Children	PLOS ONE			English	Article							REINFORCEMENT SIGNALS; MEMORY; INTROSPECTION; KNOWLEDGE; RESPONSES; MIND	Some studies, so far limited in number, suggest the existence of procedural metacognition in young children, that is, the practical capacity to monitor and control one's own cognitive activity in a given task. The link between procedural metacognition and false belief understanding is currently under theoretical discussion. If data with primates seem to indicate that procedural metacognition and false belief understanding are not related, no study in developmental psychology has investigated this relation in young children. The present paper aims, first, to supplement the findings concerning young children's abilities to monitor and control their uncertainty (procedural metacognition) and, second, to explore the relation between procedural metacognition and false belief understanding. To examine this, 82 3- to 5-year-old children were presented with an opt-out task and with 3 false belief tasks. Results show that children can rely on procedural metacognition to evaluate their perceptual access to information, and that success in false belief tasks does not seem related to success in the task we used to evaluate procedural metacognition. These results are coherent with a procedural view of metacognition, and are discussed in the light of recent data from primatology and developmental psychology.	[Bernard, Stephane; Clement, Fabrice] Univ Neuchatel, Ctr Cognit Sci, CH-2000 Neuchatel, Switzerland; [Proust, Joelle] ENS, Inst Jean Nicod, F-75230 Paris 05, France	University of Neuchatel	Bernard, S (corresponding author), Univ Neuchatel, Ctr Cognit Sci, CH-2000 Neuchatel, Switzerland.	stephane.bernard@unine.ch			European Research Council (ERC) Advanced Grant, "Dividnorm" [269616]	European Research Council (ERC) Advanced Grant, "Dividnorm"(European Research Council (ERC))	The study was supported by a European Research Council (ERC) Advanced Grant, "Dividnorm" (Project 269616).	Apperly I, 2011, MINDREADERS THE COGN; Balcomb FK, 2008, DEVELOPMENTAL SCI, V11, P750, DOI 10.1111/j.1467-7687.2008.00725.x; Call J., 2001, ANIM COGN, V3, P207, DOI [10.1007/s100710100078, DOI 10.1007/S100710100078]; Call J, 2010, ANIM COGN, V13, P689, DOI 10.1007/s10071-010-0317-x; Carruthers P., 2012, FDN METACOGNITION ED, P76, DOI 10.1093/acprof:oso/9780199646739.003.0006; Carruthers P, 2009, BEHAV BRAIN SCI, V32, P121, DOI 10.1017/S0140525X09000545; Couchman J. J., 2012, FDN METACOGNITION, P21, DOI 10.1093/acprof:oso/9780199646739.003.0002; Couchman JJ, 2010, J COMP PSYCHOL, V124, P356, DOI 10.1037/a0020129; Crystal J. D., 2012, FDN METACOGNITION, P36, DOI DOI 10.1093/ACPROF:OSO/9780199646739.003.0003; CULTICE JC, 1983, CHILD DEV, V54, P1480, DOI 10.1111/j.1467-8624.1983.tb00063.x; Diana RA, 2004, THINKING AND SEEING, P187; Dunlosky J., 2009, METACOGNITION; Flavell JH, 2004, THINKING AND SEEING, P13; FLAVELL JH, 1995, MONOGR SOC RES CHILD, V60, pR5; Hampton RR, 2009, COMP COGN BEHAV REV, V4, P17, DOI 10.3819/ccbr.2009.40002; Heyes C, 2014, DEVELOPMENTAL SCI, V17, P647, DOI 10.1111/desc.12148; Jenkins JM, 1996, DEV PSYCHOL, V32, P70, DOI 10.1037/0012-1649.32.1.70; Kaminski J, 2008, COGNITION, V109, P224, DOI 10.1016/j.cognition.2008.08.010; Knudsen B, 2012, INFANCY, V17, P672, DOI 10.1111/j.1532-7078.2011.00105.x; Koriat A, 1999, DUAL-PROCESS THEORIES IN SOCIAL PSYCHOLOGY, P483; Lyons KE, 2013, CHILD DEV, V84, P726, DOI 10.1111/cdev.12004; Lyons KE, 2011, CHILD DEV, V82, P1778, DOI 10.1111/j.1467-8624.2011.01649.x; Lyons KE, 2010, TRENDS AND PROSPECTS IN METACOGNITION RESEARCH, P259, DOI 10.1007/978-1-4419-6546-2_12; Marticorena DCW, 2011, DEVELOPMENTAL SCI, V14, P1406, DOI 10.1111/j.1467-7687.2011.01085.x; Onishi KH, 2005, SCIENCE, V308, P255, DOI 10.1126/science.1107621; Paulus M, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00145; Perner J, 2005, SCIENCE, V308, P214, DOI 10.1126/science.1111656; PERNER J, 1987, BRIT J DEV PSYCHOL, V5, P125, DOI 10.1111/j.2044-835X.1987.tb01048.x; Perner J., 2012, FDN METACOGNITION, P94, DOI DOI 10.1093/ACPROF:OSO/9780199646739.001.0001; Perner J, 2007, SYNTHESE, V159, P253, DOI 10.1007/s11229-007-9207-4; Proust J., 2012, FDN METACOGN, P234, DOI 10.1093/acprof:oso/; Proust Joelle, 2013, PHILOS METACOGNITION; Rohwer M, 2012, CHILD DEV, V83, P1869, DOI 10.1111/j.1467-8624.2012.01830.x; Ruffman T, 2014, DEV REV, V34, P265, DOI 10.1016/j.dr.2014.04.001; Schneider W., 2002, APPL METACOGNITION, P224, DOI DOI 10.1017/CBO9780511489976.011; Schneider W, 2008, MIND BRAIN EDUC, V2, P114, DOI 10.1111/j.1751-228X.2008.00041.x; Scott RM, 2010, COGNITIVE PSYCHOL, V61, P366, DOI 10.1016/j.cogpsych.2010.09.001; Smith JD, 2006, J EXP PSYCHOL GEN, V135, P282, DOI 10.1037/0096-3445.135.2.282; Smith JD, 2003, BEHAV BRAIN SCI, V26, P317; Sodian B., 2012, FDN METACOGNITION, P119, DOI DOI 10.1093/ACPROF:OSO/9780199646739.003.0008; Washburn DA, 2010, BIOL LETTERS, V6, P160, DOI 10.1098/rsbl.2009.0737; WIMMER H, 1983, COGNITION, V13, P103, DOI 10.1016/0010-0277(83)90004-5	42	14	14	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2015	10	10							e0141321	10.1371/journal.pone.0141321	http://dx.doi.org/10.1371/journal.pone.0141321			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CV0EH	26517260	Green Submitted, Green Published, gold			2022-12-26	WOS:000363920800033
J	Diabate, S; Druetz, T; Millogo, T; Ly, A; Fregonese, F; Kouanda, S; Haddad, S				Diabate, Souleymane; Druetz, Thomas; Millogo, Tieba; Ly, Antarou; Fregonese, Federica; Kouanda, Seni; Haddad, Slim			Domestic Larval Control Practices and Malaria Prevalence among Under-Five Children in Burkina Faso	PLOS ONE			English	Article							LASTING INSECTICIDAL NETS; COMMUNITY KNOWLEDGE; ANOPHELES-GAMBIAE; VECTORS; OWNERSHIP; KAYA; TOWN	Introduction Larval source management has contributed to malaria decline over the past years. However, little is known about the impact of larval control practices undertaken at the household level on malaria transmission. Methods The study was conducted in Kaya health district after the 2010 mass distribution of insecticide treated-nets and the initiation of malaria awareness campaigns in Burkina Faso. The aim was to (i) estimate the level of domestic larval control practices (cleaning of the house and its surroundings, eradication of larval sources, and elimination of hollow objects that might collect water); (ii) identify key determinants; and (iii) explore the structural relationships between these practices, participation in awareness-raising activities and mothers' knowledge/attitudes/practices, and malaria prevalence among under-five children. Results Overall, 2004 households were surveyed and 1,705 under-five children were examined. Half of the mothers undertook at least one action to control larval proliferation. Mothers who had gone to school had better knowledge about malaria and were more likely to undertake domestic larval control practices. Living in highly exposed rural areas significantly decreased the odds of undertaking larval control actions. Mothers' participation in malaria information sessions increased the adoption of vector control actions and bednet use. Malaria prevalence was statistically lower among children in households where mothers had undertaken at least one vector control action or used bed-nets. There was a 0.16 standard deviation decrease in malaria prevalence for every standard deviation increase in vector control practices. The effect of bednet use on malaria prevalence was of the same magnitude. Conclusion Cleaning the house and its surroundings, eradicating breeding sites, and eliminating hollow objects that might collect water play a substantial role in preventing malaria among under-five. There is a need for national malaria control programs to include or reinforce training activities for community health workers aimed at promoting domestic larval control practices.	[Diabate, Souleymane; Haddad, Slim] Univ Laval, Fac Med, Quebec City, PQ G1K 7P4, Canada; [Diabate, Souleymane; Haddad, Slim] St Sacrement Hosp, CHU Quebec Res Ctr, Quebec City, PQ, Canada; [Druetz, Thomas; Fregonese, Federica] Univ Montreal Hosp Res Ctr CRCHUM, Montreal, PQ, Canada; [Millogo, Tieba] Inst Africain Sante Publ, Ouagadougou, Burkina Faso; [Ly, Antarou; Kouanda, Seni] IRSS CNRST, Ouagadougou, Burkina Faso	Laval University; Laval University; Universite de Montreal	Diabate, S (corresponding author), Univ Laval, Fac Med, Quebec City, PQ G1K 7P4, Canada.	dsouleym@hotmail.com	MILLOGO, Tieba/AAJ-6028-2020	MILLOGO, Tieba/0000-0003-3548-3789; Ly, Antarou/0000-0001-7111-4054; Druetz, Thomas/0000-0002-9234-4286	Canadian Institutes of Health Research (CIHR) [GIR-229157]	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	This work was carried out with a grant from the Canadian Institutes of Health Research (CIHR, grant # GIR-229157), [http://www.cihr-irsc.gc.ca/e/193.html]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abate A, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-312; Amoran Olorunfemi Emmanuel, 2013, Niger Med J, V54, P115, DOI 10.4103/0300-1652.110046; [Anonymous], 2008, MAL RAP DIAGN TEST P; [Anonymous], 2004, COCHRANE DB SYST REV; [Anonymous], 2010, MALAR RES TREAT; Antonakis J, 2010, LEADERSHIP QUART, V21, P1086, DOI 10.1016/j.leaqua.2010.10.010; De Silva PM, 2012, J TROP MED-US, V2012, DOI 10.1155/2012/819563; Diabate S, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-353; Druetz T, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0591-9; Fillinger U, 2004, TROP MED INT HEALTH, V9, P1274, DOI 10.1111/j.1365-3156.2004.01335.x; Fillinger U, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-353; Geissbuhler Y, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-126; Hlongwana KW, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-29; Kabula B, 2012, TROP MED INT HEALTH, V17, P742, DOI 10.1111/j.1365-3156.2012.02986.x; Keating J, 2003, AM J TROP MED HYG, V68, P357; Killeen GF, 2000, AM J TROP MED HYG, V62, P545, DOI 10.4269/ajtmh.2000.62.545; Killeen GF, 2002, LANCET INFECT DIS, V2, P618, DOI 10.1016/S1473-3099(02)00397-3; Kouanda S, 2013, INT J EPIDEMIOL, V42, P741, DOI 10.1093/ije/dyt076; Kweka EJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052084; Menard S. W., 2010, SAGE, DOI DOI 10.4135/9781483348964; Minakawa N, 2002, AM J TROP MED HYG, V67, P32, DOI 10.4269/ajtmh.2002.67.32; Ministere de la sante, 2007, PLAN STRAT LUTT PAL; Ministere de la Sante, 2009, MOD FORM AG SANT COM; Mwangangi Joseph M., 2007, Journal of Vector Borne Diseases, V44, P44; Namountougou M, 2012, ACTA TROP, V7, P48412, DOI DOI 10.1371/J0URNAL.P0NE.0048412; Ndiath MO, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097700; NEDERHOF AJ, 1985, EUR J SOC PSYCHOL, V15, P263, DOI 10.1002/ejsp.2420150303; Ngomane L, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-19; Podsakoff PM, 2003, J APPL PSYCHOL, V88, P879, DOI 10.1037/0021-9010.88.5.879; Ridde V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069865; Roll Back Partenership, 2014, MAL BEH CHANG COMM B; Rothman KJ., 2008, MODERN EPIDEMIOLOGY, V3rd ed; Salkind N. J, 2010, ENCY RES DESIGN, V1, DOI 10.4135/9781412961288.n35.SAGEPublicationsInc; SHOUSHA A. T., 1948, BULL WORLD HEALTH ORGAN, V1, P309; Sichande M, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-378; Singh Rupashree, 2014, J Family Med Prim Care, V3, P39, DOI 10.4103/2249-4863.130271; Sougoufara S, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-125; StataCorp, 2013, STAT REL 13 STAT SOF; Thwing J, 2008, TROP MED INT HEALTH, V13, P827, DOI 10.1111/j.1365-3156.2008.02070.x; Tokponnon FT, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-265; Tusting LS, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008923.pub2; WHO, 2013, WORLD MALARIA REPORT 2013, P1; World Health Organization, 2013, LARV SOURC MAN SUPPL; Worrall E, 2005, TROP MED INT HEALTH, V10, P1047, DOI 10.1111/j.1365-3156.2005.01476.x	44	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2015	10	10							e0141784	10.1371/journal.pone.0141784	http://dx.doi.org/10.1371/journal.pone.0141784			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0EH	26517727	Green Published, gold, Green Submitted			2022-12-26	WOS:000363920800076
J	Faigle, R; Marsh, EB; Llinas, RH; Urrutia, VC				Faigle, Roland; Marsh, Elisabeth B.; Llinas, Rafael H.; Urrutia, Victor C.			Critical Care Needs in Patients with Diffusion-Weighted Imaging Negative MRI after tPA - Does One Size Fit All?	PLOS ONE			English	Article							TISSUE-PLASMINOGEN ACTIVATOR; GLOMERULAR-FILTRATION-RATE; TRANSIENT ISCHEMIC ATTACK; STROKE MIMICS; SERUM CREATININE; RT-PA; THROMBOLYSIS; RISK; ASSOCIATION; MANAGEMENT	Background and Purpose Patients who receive intravenous (IV) tissue plasminogen activator (tPA) for ischemic stroke are currently monitored in an intensive care unit (ICU) or a comparable stroke unit for at least 24 hours due to the high frequency of neurological exams and vital sign checks. The present study evaluates ICU needs in patients with diffusion-weighted imaging (DWI) negative MRI after IV tPA. Methods A retrospective chart review was performed for 209 patients who received IV tPA for acute stroke. Data on stroke risk factors, physiologic parameters, stroke severity, MRI characteristics, and final diagnosis were collected. The timing and nature of ICU interventions, if needed, was recorded. Multivariable logistic regression was used to determine factors associated with subsequent ICU needs. Results Patients with cerebral infarct on MRI after tPA had over 9 times higher odds of requiring ICU care compared to patients with DWI negative MRI (OR 9.2, 95% CI 2.49-34.15). All DWI negative patients requiring ICU care did so by the end of tPA infusion (p = 0.006). Among patients with DWI negative MRI, need for ICU interventions was associated with higher NIH Stroke Scale (NIHSS) scores (p < 0.001), uncontrolled hypertension (p < 0.001), seizure at onset (p = 0.002), and reduced estimated glomerular filtration rate (eGFR) (p = 0.010). Conclusions Only a small number of DWI negative patients required ICU care. In patients without critical care needs by the end of thrombolysis, post-tPA MRI may be considered for triaging DWI negative patients to a less resource intense monitoring environment.	[Faigle, Roland; Marsh, Elisabeth B.; Llinas, Rafael H.; Urrutia, Victor C.] Johns Hopkins Univ, Dept Neurol, Sch Med, Baltimore, MD 21218 USA	Johns Hopkins University	Faigle, R (corresponding author), Johns Hopkins Univ, Dept Neurol, Sch Med, Baltimore, MD 21218 USA.	rfaigle1@jhmi.edu	Faigle, Roland/ABB-9082-2020; Urrutia, Victor/AAH-6683-2021	Faigle, Roland/0000-0002-9074-1915; Urrutia, Victor/0000-0002-4995-6949; Marsh, Elisabeth/0000-0002-2385-5074; Llinas, Rafael/0000-0002-9161-2699	R25 NINDS Research Education Program for Residents and Fellows in Neurology and Neurosurgery [RFA-NS-09-001]	R25 NINDS Research Education Program for Residents and Fellows in Neurology and Neurosurgery	RF was supported by a R25 NINDS Research Education Program for Residents and Fellows in Neurology and Neurosurgery (RFA-NS-09-001); (http://www.ninds.nih.gov/funding/r25_institutions.htm). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chernyshev OY, 2010, NEUROLOGY, V74, P1340, DOI 10.1212/WNL.0b013e3181dad5a6; Faigle R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088652; Freeman JW, 2013, STROKE, V44, P1629, DOI 10.1161/STROKEAHA.111.000486; Gensicke H, 2013, NEUROLOGY, V81, P1780, DOI 10.1212/01.wnl.0000435550.83200.9e; Giraldo EA, 2011, NEUROCRIT CARE, V15, P76, DOI 10.1007/s12028-011-9523-x; Hacke W, 2004, LANCET, V363, P768; Jauch EC, 2013, STROKE, V44, P870, DOI 10.1161/STR.0b013e318284056a; Larrue V, 2001, STROKE, V32, P438, DOI 10.1161/01.STR.32.2.438; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Marsh EB, 2013, MEDICINE, V92, P317, DOI 10.1097/MD.0000000000000006; Naganuma M, 2011, CEREBROVASC DIS, V31, P123, DOI 10.1159/000321516; Oppenheim C, 2000, AM J NEURORADIOL, V21, P1434; Sylaja PN, 2008, STROKE, V39, P1898, DOI 10.1161/STROKEAHA.107.497453; Uchino K, 2010, CEREBROVASC DIS, V29, P57, DOI 10.1159/000255975; Winkler DT, 2009, STROKE, V40, P1522, DOI 10.1161/STROKEAHA.108.530352; Zinkstok SM, 2013, STROKE, V44, P1080, DOI 10.1161/STROKEAHA.111.000126	16	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2015	10	10							e0141204	10.1371/journal.pone.0141204	http://dx.doi.org/10.1371/journal.pone.0141204			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0EH	26517543	Green Published, gold, Green Submitted			2022-12-26	WOS:000363920800027
J	Wang, WQ; Zhang, W; Wu, YR; Maliga, P; Messing, J				Wang, Wenqin; Zhang, Wei; Wu, Yongrui; Maliga, Pal; Messing, Joachim			RNA Editing in Chloroplasts of Spirodela polyrhiza, an Aquatic Monocotelydonous Species	PLOS ONE			English	Article							PLASTID RNA; PLANT; TRANSCRIPT; GENOME; DIVERGENCE; SITES; EXPRESSION; EVENTS	RNA editing is the post-transcriptional conversion from C to U before translation, providing a unique feature in the regulation of gene expression. Here, we used a robust and efficient method based on RNA-seq from non-ribosomal total RNA to simultaneously measure chloroplast-gene expression and RNA editing efficiency in the Greater Duckweed, Spirodela polyrhiza, a species that provides a new reference for the phylogenetic studies of monocoty-ledonous plants. We identified 66 editing sites at the genome-wide level, with an average editing efficiency of 76%. We found that the expression levels of chloroplast genes were relatively constant, but 11 RNA editing sites show significant changes in editing efficiency, when fronds turn into turions. Thus, RNA editing efficiency contributes more to the yield of translatable transcripts than steady state mRNA levels. Comparison of RNA editing sites in coconut, Spirodela, maize, and rice suggests that RNA editing originated from a common ancestor.	[Wang, Wenqin; Zhang, Wei; Wu, Yongrui; Maliga, Pal; Messing, Joachim] Rutgers State Univ, Waksman Inst Microbiol, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick	Messing, J (corresponding author), Rutgers State Univ, Waksman Inst Microbiol, Piscataway, NJ 08854 USA.	messing@waksman.rutgers.edu	Wang, Wenqin/AAR-2970-2021	Wang, Wenqin/0000-0001-6427-6338; Messing, Joachim/0000-0001-8260-2643				BOCK R, 1994, EMBO J, V13, P4623, DOI 10.1002/j.1460-2075.1994.tb06784.x; Chaudhuri S, 1996, EMBO J, V15, P5958, DOI 10.1002/j.1460-2075.1996.tb00982.x; Chen HY, 2011, J INTEGR PLANT BIOL, V53, P961, DOI 10.1111/j.1744-7909.2011.01082.x; Corneille S, 2000, MOL GEN GENET, V264, P419, DOI 10.1007/s004380000295; Freyer R, 1997, P NATL ACAD SCI USA, V94, P6285, DOI 10.1073/pnas.94.12.6285; Freyer R, 1995, PLANT MOL BIOL, V29, P679, DOI 10.1007/BF00041158; Hirose T, 1999, MOL GEN GENET, V262, P462, DOI 10.1007/s004380051106; Huang YY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074736; Junior TC, 2004, CURR GENET, V46, P366, DOI 10.1007/s00294-004-0542-4; Kuhn J, 2001, MOL CELL BIOL, V21, P731, DOI 10.1128/MCB.21.3.731-742.2001; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Lohse M, 2013, NUCLEIC ACIDS RES, V41, pW575, DOI 10.1093/nar/gkt289; Lu BW, 1996, MOL CELL BIOL, V16, P1543; Maier RM, 1996, PLANT MOL BIOL, V32, P343, DOI 10.1007/BF00039390; MAIER RM, 1995, J MOL BIOL, V251, P614, DOI 10.1006/jmbi.1995.0460; Oldenkott B, 2014, RNA, V20, P1499, DOI 10.1261/rna.045575.114; Peeters NM, 2002, RNA, V8, P497, DOI 10.1017/S1355838202029424; Phreaner CG, 1996, PLANT CELL, V8, P107, DOI 10.1105/tpc.8.1.107; Ruwe H, 2013, FEBS LETT, V587, P1429, DOI 10.1016/j.febslet.2013.03.022; Schmitz-Linneweber C, 2005, PLANT CELL, V17, P1815, DOI 10.1105/tpc.105.032474; Schmitz-Linneweber C, 2002, MOL BIOL EVOL, V19, P1602, DOI 10.1093/oxfordjournals.molbev.a004222; Stern DB, 2010, ANNU REV PLANT BIOL, V61, P125, DOI 10.1146/annurev-arplant-042809-112242; Stomp AM, 2005, BIOTECHNOL ANN REV, V11, P69, DOI 10.1016/S1387-2656(05)11002-3; Takenaka M, 2013, ANNU REV GENET, V47, P335, DOI 10.1146/annurev-genet-111212-133519; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Tillich M, 2005, PLANT J, V43, P708, DOI 10.1111/j.1365-313X.2005.02484.x; Tillich M, 2006, MOL BIOL EVOL, V23, P1912, DOI 10.1093/molbev/msl054; Wang W, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4311; Wang WQ, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-60; Wang WQ, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-5; Wang WQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024670; ZELTZ P, 1993, EMBO J, V12, P4291, DOI 10.1002/j.1460-2075.1993.tb06113.x; Zeng WH, 2007, PLANT CELL PHYSIOL, V48, P362, DOI 10.1093/pcp/pcl058	34	23	23	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2015	10	10							e0140285	10.1371/journal.pone.0140285	http://dx.doi.org/10.1371/journal.pone.0140285			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0EH	26517707	Green Submitted, gold, Green Published			2022-12-26	WOS:000363920800004
J	Debouk, H; de Bello, F; Sebastia, MT				Debouk, Haifa; de Bello, Francesco; Sebastia, Maria-Teresa			Functional Trait Changes, Productivity Shifts and Vegetation Stability in Mountain Grasslands during a Short-Term Warming	PLOS ONE			English	Article							PLANT DIVERSITY; NITROGEN MINERALIZATION; ECOSYSTEM FUNCTION; CLIMATIC GRADIENT; BIODIVERSITY; BIOMASS; AVAILABILITY; CONSEQUENCES; COMMUNITIES; TEMPERATURE	Plant functional traits underlie vegetation responses to environmental changes such as global warming, and consequently influence ecosystem processes. While most of the existing studies focus on the effect of warming only on species diversity and productivity, we further investigated (i) how the structure of community plant functional traits in temperate grasslands respond to experimental warming, and (ii) whether species and functional diversity contribute to a greater stability of grasslands, in terms of vegetation composition and productivity. Intact vegetation turves were extracted from temperate subalpine grassland (highland) in the Eastern Pyrenees and transplanted into a warm continental, experimental site in Lleida, in Western Catalonia (lowland). The impacts of simulated warming on plant production and diversity, functional trait structure, and vegetation compositional stability were assessed. We observed an increase in biomass and a reduction in species and functional diversity under short-term warming. The functional structure of the grassland communities changed significantly, in terms of functional diversity and community-weighted means (CWM) for several traits. Acquisitive and fast-growing species with higher SLA, early flowering, erect growth habit, and rhizomatous strategy became dominant in the lowland. Productivity was significantly positively related to species, and to a lower extent, functional diversity, but productivity and stability after warming were more dependent on trait composition (CWM) than on diversity. The turves with more acquisitive species before warming changed less in composition after warming. Results suggest that (i) the short-term warming can lead to the dominance of acquisitive fast growing species over conservative species, thus reducing species richness, and (ii) the functional traits structure in grassland communities had a greater influence on the productivity and stability of the community under short-term warming, compared to diversity effects. In summary, short-term climate warming can greatly alter vegetation functional structure and its relation to productivity.	[Debouk, Haifa; Sebastia, Maria-Teresa] Forest Sci Ctr Catalonia CTFC, Lab Funct Ecol & Global Change ECOFUN, Solsona, Spain; [Debouk, Haifa; Sebastia, Maria-Teresa] Univ Lleida, Sch Agrifood & Forestry Sci & Engn, Grp GAMES, Lleida, Spain; [Debouk, Haifa; Sebastia, Maria-Teresa] Univ Lleida, Sch Agrifood & Forestry Sci & Engn, Dept Hort Bot & Gardening, Lleida, Spain; [de Bello, Francesco] Univ South Bohemia, Fac Sci, Dept Bot, Ceske Budejovice, Czech Republic; [de Bello, Francesco] Czech Acad Sci, Inst Bot, Trebo, Czech Republic	Centre Tecnologic Forestal de Catalunya (CTFC); Universitat de Lleida; Universitat de Lleida; University of South Bohemia Ceske Budejovice; Czech Academy of Sciences; Institute of Botany of the Czech Academy of Sciences	Debouk, H (corresponding author), Forest Sci Ctr Catalonia CTFC, Lab Funct Ecol & Global Change ECOFUN, Solsona, Spain.	haifa.debouk@ctfc.es	de Bello, Francesco/H-1582-2014; de Bello, Francesco/HCI-1196-2022; de Bello, Francesco/AFQ-8650-2022; Sebastia, M. Teresa/B-5479-2013	de Bello, Francesco/0000-0001-9202-8198; de Bello, Francesco/0000-0001-9202-8198; Sebastia, M. Teresa/0000-0002-9017-3575	Spanish Science Foundation [CGL2010-22378-C03-01, CGL2013-49142-C2-1R]; Spanish Ministry of Economy and Competitiveness [BES-2011-047009]	Spanish Science Foundation; Spanish Ministry of Economy and Competitiveness(Spanish Government)	Spanish Science Foundation funded the project CAPAS (CGL2010-22378-C03-01), http://www.fecyt.es/: MTS. Spanish Science Foundation funded the project BIOGEI (CGL2013-49142-C2-1R), http://www.fecyt.es/: MTS. Spanish Ministry of Economy and Competitiveness funded the FPI shortterm visit to the Czech Academy of Sciences (BES-2011-047009): HD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerts R, 1999, J EXP BOT, V50, P29, DOI 10.1093/jexbot/50.330.29; Akaike H, 1973, INFORM THEORY EXTENS, P267, DOI DOI 10.1007/978-1-4612-1694-0_15; Amano T, 2010, P ROY SOC B-BIOL SCI, V277, P2451, DOI 10.1098/rspb.2010.0291; [Anonymous], 1877, DIFFERENT FORMS FLOW; Baldwin AH, 2014, GLOBAL CHANGE BIOL, V20, P835, DOI 10.1111/gcb.12378; Bassler G., 2011, Grassland farming and land management systems in mountainous regions. Proceedings of the 16th Symposium of the European Grassland Federation, Gumpenstein, Austria, 29th-31st August, 2011, P547; BRAY J. ROGER, 1957, ECOL MONOGR, V27, P325, DOI 10.2307/1942268; Cantarel AAM, 2013, J VEG SCI, V24, P113, DOI 10.1111/j.1654-1103.2012.01452.x; Carbognani M, 2014, PLANT SOIL, V376, P277, DOI 10.1007/s11104-013-1982-8; Cardinale BJ, 2007, P NATL ACAD SCI USA, V104, P18123, DOI 10.1073/pnas.0709069104; CHAPIN FS, 1980, ANNU REV ECOL SYST, V11, P233, DOI 10.1146/annurev.es.11.110180.001313; Chesson P, 2000, THEOR POPUL BIOL, V58, P211, DOI 10.1006/tpbi.2000.1486; Cornelissen JHC, 2003, AUST J BOT, V51, P335, DOI 10.1071/BT02124; CRICK JC, 1987, NEW PHYTOL, V107, P403, DOI 10.1111/j.1469-8137.1987.tb00192.x; De Bello F, 2005, J APPL ECOL, V42, P824, DOI 10.1111/j.1365-2664.2005.01079.x; De Bello F, 2007, J VEG SCI, V18, P25, DOI 10.1111/j.1654-1103.2007.tb02512.x; de Bello F, 2006, ECOGRAPHY, V29, P801, DOI 10.1111/j.2006.0906-7590.04683.x; de Bello F, 2011, METHODS ECOL EVOL, V2, P163, DOI 10.1111/j.2041-210X.2010.00071.x; de Bello F, 2010, J VEG SCI, V21, P992, DOI 10.1111/j.1654-1103.2010.01195.x; de Bello F, 2009, AGR ECOSYST ENVIRON, V131, P303, DOI 10.1016/j.agee.2009.02.002; Diaz S, 2004, J VEG SCI, V15, P295, DOI 10.1111/j.1654-1103.2004.tb02266.x; Diaz S, 2007, P NATL ACAD SCI USA, V104, P20684, DOI 10.1073/pnas.0704716104; Elton C., 1958; Endara MJ, 2011, FUNCT ECOL, V25, P389, DOI 10.1111/j.1365-2435.2010.01803.x; Epstein HE, 2000, ECOL APPL, V10, P824, DOI 10.1890/1051-0761(2000)010[0824:ATNBMO]2.0.CO;2; Falster DS, 2003, TRENDS ECOL EVOL, V18, P337, DOI 10.1016/S0169-5347(03)00061-2; Finn JA, 2013, J APPL ECOL, V50, P365, DOI 10.1111/1365-2664.12041; Gause G. F., 1934, STRUGGLE EXISTENCE; GECCC, 2010, 2 GECCC, P1; GOODMAN D, 1975, Q REV BIOL, V50, P237, DOI 10.1086/408563; Gratani L., 2014, ADV BOT, DOI [10.1155/2014/208747, DOI 10.1155/2014/208747]; Grime J. P., 1979, Plant strategies and vegetation processes.; GRIME JP, 1973, NATURE, V242, P344, DOI 10.1038/242344a0; GRIME JP, 1977, AM NAT, V111, P1169, DOI 10.1086/283244; Hector A, 1999, SCIENCE, V286, P1123, DOI 10.1126/science.286.5442.1123; Hughes L, 2000, TRENDS ECOL EVOL, V15, P56, DOI 10.1016/S0169-5347(99)01764-4; Huston MA, 1997, OECOLOGIA, V110, P449, DOI 10.1007/s004420050180; Jost L, 2007, ECOLOGY, V88, P2427, DOI 10.1890/06-1736.1; Jung V, 2014, J ECOL, V102, P45, DOI 10.1111/1365-2745.12177; Kirwan L, 2007, J ECOL, V95, P530, DOI 10.1111/j.1365-2745.2007.01225.x; Kleyer M, 2008, J ECOL, V96, P1266, DOI 10.1111/j.1365-2745.2008.01430.x; Klimesova J, 2005, ZPRAVY CESKE BOT SPL, V20, P53; Korner C, 2004, J BIOGEOGR, V31, P713, DOI 10.1111/j.1365-2699.2003.01043.x; Lavorel S, 2002, FUNCT ECOL, V16, P545, DOI 10.1046/j.1365-2435.2002.00664.x; Lefcheck JS, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7936; Leps J, 2001, OIKOS, V92, P123, DOI 10.1034/j.1600-0706.2001.920115.x; LEPS J, 1982, VEGETATIO, V50, P53, DOI 10.1007/BF00120678; Lin DL, 2010, NEW PHYTOL, V188, P187, DOI 10.1111/j.1469-8137.2010.03347.x; Llebot JE, 2005, INFORM CANVI CLIMATI; Lopez-Moreno JI, 2008, INT J CLIMATOL, V28, P1535, DOI 10.1002/joc.1645; Lopez-Moreno JI, 2009, THEOR APPL CLIMATOL, V95, P375, DOI 10.1007/s00704-008-0015-7; Loreau M, 2001, SCIENCE, V294, P804, DOI 10.1126/science.1064088; MACARTHUR R, 1955, ECOLOGY, V36, P533, DOI 10.2307/1929601; MACGILLIVRAY CW, 1995, FUNCT ECOL, V9, P640, DOI 10.2307/2390156; Majekova M, 2014, ECOLOGY, V95, P2369, DOI 10.1890/13-1880.1; Menzel A, 2006, GLOBAL CHANGE BIOL, V12, P1969, DOI 10.1111/j.1365-2486.2006.01193.x; Naeem S, 2002, ECOLOGY, V83, P1537, DOI 10.1890/0012-9658(2002)083[1537:ECOBLT]2.0.CO;2; Oksanen J., 2020, VEGAN COMMUNITY ECOL; Palmer MW, 1997, J VEG SCI, V8, P235, DOI 10.2307/3237352; Partel M, 2007, ECOLOGY, V88, P1091, DOI 10.1890/06-0997; Pauli H, 2007, GLOBAL CHANGE BIOL, V13, P147, DOI 10.1111/j.1365-2486.2006.01282.x; Pauli H, 2012, SCIENCE, V336, P353, DOI 10.1126/science.1219033; Pfisterer AB, 2002, NATURE, V416, P84, DOI 10.1038/416084a; Polley HW, 2013, OIKOS, V122, P1275, DOI 10.1111/j.1600-0706.2013.00338.x; Poorter H, 1999, NEW PHYTOL, V143, P163, DOI 10.1046/j.1469-8137.1999.00428.x; Price MV, 2000, ECOL APPL, V10, P811, DOI 10.1890/1051-0761(2000)010[0811:ROSMVT]2.0.CO;2; R Core Team, 2021, R LANGUAGE ENV STAT; Ricotta C, 2010, OIKOS, V119, P1089, DOI 10.1111/j.1600-0706.2009.18202.x; Rustad LE, 2001, OECOLOGIA, V126, P543, DOI 10.1007/s004420000544; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Schmidt IK, 1999, APPL SOIL ECOL, V11, P147, DOI 10.1016/S0929-1393(98)00147-4; Sebastia M. T., 2004, Land use systems in grassland dominated regions. Proceedings of the 20th General Meeting of the European Grassland Federation, Luzern, Switzerland, 21-24 June 2004, P290; Sebastia MT, 2007, J APPL ECOL, V44, P158, DOI 10.1111/j.1365-2664.2006.01232.x; Sebastia MT, 2008, J VEG SCI, V19, P299, DOI 10.3170/2008-8-18356; Shaver GR, 2000, BIOSCIENCE, V50, P871, DOI 10.1641/0006-3568(2000)050[0871:GWATEA]2.0.CO;2; Singh S, 2013, SPRINGER SCI BUS MED; Spehn EM, 2000, FUNCT ECOL, V14, P326, DOI 10.1046/j.1365-2435.2000.00437.x; Suding KN, 2008, GLOBAL CHANGE BIOL, V14, P1125, DOI 10.1111/j.1365-2486.2008.01557.x; Tilman D, 1996, NATURE, V379, P718, DOI 10.1038/379718a0; TILMAN D, 1994, NATURE, V367, P363, DOI 10.1038/367363a0; Weintraub MN, 2003, ECOSYSTEMS, V6, P129, DOI 10.1007/s10021-002-0124-6; Westoby M, 2002, ANNU REV ECOL SYST, V33, P125, DOI 10.1146/annurev.ecolsys.33.010802.150452; Wolkovich EM, 2012, NATURE, V485, P494, DOI 10.1038/nature11014; ZIMDAHL RL, 2013, FUNDAMENTALS WEED SC	84	28	30	11	111	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2015	10	10							e0141899	10.1371/journal.pone.0141899	http://dx.doi.org/10.1371/journal.pone.0141899			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0ED	26513148	Green Published, Green Submitted, gold			2022-12-26	WOS:000363920300090
J	Rummel, C; Abela, E; Andrzejak, RG; Hauf, M; Pollo, C; Muller, M; Weisstanner, C; Wiest, R; Schindler, K				Rummel, Christian; Abela, Eugenio; Andrzejak, Ralph G.; Hauf, Martinus; Pollo, Claudio; Mueller, Markus; Weisstanner, Christian; Wiest, Roland; Schindler, Kaspar			Resected Brain Tissue, Seizure Onset Zone and Quantitative EEG Measures: Towards Prediction of Post-Surgical Seizure Control	PLOS ONE			English	Article							HIGH-FREQUENCY OSCILLATIONS; TEMPORAL-LOBE EPILEPSY; INTRACRANIAL EEG; LONG-TERM; DETERMINISTIC DYNAMICS; EPILEPTOGENIC ZONE; INTRACEREBRAL EEG; ORDINAL PATTERNS; TIME-SERIES; LOCALIZATION	Background Epilepsy surgery is a potentially curative treatment option for pharmacoresistent patients. If non-invasive methods alone do not allow to delineate the epileptogenic brain areas the surgical candidates undergo long-term monitoring with intracranial EEG. Visual EEG analysis is then used to identify the seizure onset zone for targeted resection as a standard procedure. Methods Despite of its great potential to assess the epileptogenicty of brain tissue, quantitative EEG analysis has not yet found its way into routine clinical practice. To demonstrate that quantitative EEG may yield clinically highly relevant information we retrospectively investigated how post-operative seizure control is associated with four selected EEG measures evaluated in the resected brain tissue and the seizure onset zone. Importantly, the exact spatial location of the intracranial electrodes was determined by coregistration of pre-operative MRI and post-implantation CT and coregistration with post-resection MRI was used to delineate the extent of tissue resection. Using data-driven thresholding, quantitative EEG results were separated into normally contributing and salient channels. Results In patients with favorable post-surgical seizure control a significantly larger fraction of salient channels in three of the four quantitative EEG measures was resected than in patients with unfavorable outcome in terms of seizure control (median over the whole peri-ictal recordings). The same statistics revealed no association with post-operative seizure control when EEG channels contributing to the seizure onset zone were studied. Conclusions We conclude that quantitative EEG measures provide clinically relevant and objective markers of target tissue, which may be used to optimize epilepsy surgery. The finding that differentiation between favorable and unfavorable outcome was better for the fraction of salient values in the resected brain tissue than in the seizure onset zone is consistent with growing evidence that spatially extended networks might be more relevant for seizure generation, evolution and termination than a single highly localized brain region (i.e. a "focus") where seizures start.	[Rummel, Christian; Abela, Eugenio; Hauf, Martinus; Weisstanner, Christian; Wiest, Roland] Univ Bern, Inselspital, Univ Inst Diagnost & Intervent Neuroradiol, SCAN, CH-3010 Bern, Switzerland; [Abela, Eugenio; Schindler, Kaspar] Univ Bern, Inselspital, Dept Neurol, CH-3010 Bern, Switzerland; [Andrzejak, Ralph G.] Univ Pompeu Fabra, Dept Informat & Commun Technol, Barcelona, Spain; [Hauf, Martinus] Bethesda Epilepsy Clin, Tschugg, Switzerland; [Pollo, Claudio] Univ Bern, Inselspital, Dept Neurosurg, CH-3010 Bern, Switzerland; [Mueller, Markus] Univ Autonoma Estado Morelos, Ctr Invest Ciencias, Cuernavaca, Morelos, Mexico; [Mueller, Markus] Univ Nacl Autonoma Mexico, Ctr Int Ciencias, Cuernavaca 62191, Morelos, Mexico	University of Bern; University Hospital of Bern; University of Bern; University Hospital of Bern; Pompeu Fabra University; University of Bern; University Hospital of Bern; Universidad Autonoma del Estado de Morelos; Universidad Nacional Autonoma de Mexico	Rummel, C (corresponding author), Univ Bern, Inselspital, Univ Inst Diagnost & Intervent Neuroradiol, SCAN, CH-3010 Bern, Switzerland.	crummel@web.de	Schindler, Kaspar/L-7115-2013; Andrzejak, Ralph G/H-7923-2012	Schindler, Kaspar/0000-0002-2387-7767; Andrzejak, Ralph G/0000-0002-7400-2098; Muller, Markus Franziskus/0000-0002-2653-6204; Weisstanner, Christian/0000-0003-2830-1000; Abela, Eugenio/0000-0002-9356-1450; Rummel, Christian/0000-0003-2345-7938	Swiss National Science Foundation (SNF) [122010, 124089, 140332, 155950]; Spanish Ministry of Education and Science [FIS-2010-18204]; Volkswagen Foundation; Consejo Nacional de Ciencia y Technologia, Mexico [156667]	Swiss National Science Foundation (SNF)(Swiss National Science Foundation (SNSF)); Spanish Ministry of Education and Science(Spanish Government); Volkswagen Foundation(Volkswagen); Consejo Nacional de Ciencia y Technologia, Mexico	This study was supported by the Swiss National Science Foundation (SNF) via the projects 122010, 124089, 140332 and 155950. R.G. Andrzejak was supported by grant No. FIS-2010-18204 of the Spanish Ministry of Education and Science and funding from the Volkswagen Foundation. M. Muller acknowledges the Consejo Nacional de Ciencia y Technologia, Mexico, project 156667. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amigo JM, 2006, PHYS LETT A, V355, P27, DOI 10.1016/j.physleta.2006.01.093; Andrzejak RG, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.046203; Andrzejak RG, 2014, PHYS REV E, V90, DOI 10.1103/PhysRevE.90.062906; Andrzejak RG, 2015, BRAIN TOPOGR, V28, P832, DOI 10.1007/s10548-014-0380-8; Andrzejak RG, 2012, PHYS REV E, V86, DOI 10.1103/PhysRevE.86.046206; Andrzejak RG, 2006, EPILEPSY RES, V69, P30, DOI 10.1016/j.eplepsyres.2005.12.004; Andrzejak RG, 2001, EPILEPSY RES, V44, P129, DOI 10.1016/S0920-1211(01)00195-4; [Anonymous], 1987, DIGITAL SPECTRAL ANA; Bartolomei F, 2008, BRAIN, V131, P1818, DOI 10.1093/brain/awn111; Boido D, 2014, HUM BRAIN MAPP, V35, P4267, DOI 10.1002/hbm.22516; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Bulmer M. G, 1967, PRINCIPLES STAT; Carmeli C, 2005, NEUROIMAGE, V25, P339, DOI 10.1016/j.neuroimage.2004.11.049; CASDAGLI M, 1989, PHYSICA D, V35, P335, DOI 10.1016/0167-2789(89)90074-2; Cook MJ, 2013, LANCET NEUROL, V12, P563, DOI 10.1016/S1474-4422(13)70075-9; Cui D, 2010, NEURAL NETWORKS, V23, P698, DOI 10.1016/j.neunet.2010.04.003; de Tisi J, 2011, LANCET, V378, P1388, DOI 10.1016/S0140-6736(11)60890-8; Deichmann R, 2004, NEUROIMAGE, V21, P757, DOI 10.1016/j.neuroimage.2003.09.062; Engel J, 2012, JAMA-J AM MED ASSOC, V307, P922, DOI 10.1001/jama.2012.220; Esteller R, 2001, P ANN INT IEEE EMBS, V23, P1707, DOI 10.1109/IEMBS.2001.1020545; FARMER JD, 1987, PHYS REV LETT, V59, P845, DOI 10.1103/PhysRevLett.59.845; Geier C, 2015, SEIZURE-EUR J EPILEP, V25, P160, DOI 10.1016/j.seizure.2014.10.013; Gnatkovsky V, 2014, EPILEPSIA, V55, P296, DOI 10.1111/epi.12507; Gnatkovsky V, 2011, EPILEPSIA, V52, P477, DOI 10.1111/j.1528-1167.2010.02931.x; GRANGER CWJ, 1969, ECONOMETRICA, V37, P424, DOI 10.2307/1912791; Hlinka J, 2011, NEUROIMAGE, V54, P2218, DOI 10.1016/j.neuroimage.2010.08.042; Huang C, 2012, J PEDIATR EPILEPSY, V1, P211, DOI 10.3233/PEP-12033; Jacobs J, 2010, ANN NEUROL, V67, P209, DOI 10.1002/ana.21847; Jacobs J, 2009, BRAIN, V132, P1022, DOI 10.1093/brain/awn351; JOE H, 1989, J AM STAT ASSOC, V84, P157, DOI 10.2307/2289859; Jung YJ, 2011, SEIZURE-EUR J EPILEP, V20, P449, DOI 10.1016/j.seizure.2011.02.004; Khan S, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.026209; Kim JY, 2014, CLIN EEG NEUROSCI, V45, P169, DOI 10.1177/1550059413495393; Kim JS, 2010, NEUROIMAGE, V52, P1279, DOI 10.1016/j.neuroimage.2010.04.240; Kraskov A, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.066138; Kwan P, 2000, NEW ENGL J MED, V342, P314, DOI 10.1056/NEJM200002033420503; Le van Quyen M, 1999, PHYSICA D, V127, P250; Lehnertz K, 1998, PHYS REV LETT, V80, P5019, DOI 10.1103/PhysRevLett.80.5019; Lehnertz K, 2009, J NEUROSCI METH, V183, P42, DOI 10.1016/j.jneumeth.2009.05.015; Litt B, 2001, NEURON, V30, P51, DOI 10.1016/S0896-6273(01)00262-8; Lopes da Silva F, 1989, Brain Topogr, V2, P9; Maes F, 1997, IEEE T MED IMAGING, V16, P187, DOI 10.1109/42.563664; Garcia AOM, 2013, NEURAL NETWORKS, V46, P154, DOI 10.1016/j.neunet.2013.05.009; Martinerie J, 1998, NAT MED, V4, P1173, DOI 10.1038/2667; Modur PN, 2011, EPILEPSIA, V52, P1792, DOI 10.1111/j.1528-1167.2011.03165.x; Muller M, 2008, EPL-EUROPHYS LETT, V84, DOI 10.1209/0295-5075/84/10009; Naro D, 2014, PHYS REV E, V90, DOI 10.1103/PhysRevE.90.032913; Niederhauser JJ, 2003, IEEE T BIO-MED ENG, V50, P449, DOI [10.1109/TBME.2003.809497, 10.1109/TBMe.2003.809497]; Ouyang GX, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.041146; Park SC, 2012, CLIN NEUROPHYSIOL, V123, P1100, DOI 10.1016/j.clinph.2012.01.008; Pereda E, 2005, PROG NEUROBIOL, V77, P1, DOI 10.1016/j.pneurobio.2005.10.003; Perucca P, 2014, BRAIN, V137, P183, DOI 10.1093/brain/awt299; PIJN J P M, 1990, Neurophysiologie Clinique, V20, P1, DOI 10.1016/S0987-7053(05)80165-0; Pikovsky A, 2001, SYNCHRONIZATION UNIV; PRICHARD D, 1994, PHYS REV LETT, V73, P951, DOI 10.1103/PhysRevLett.73.951; Richardson MP, 2012, J NEUROL NEUROSUR PS, V83, P1238, DOI 10.1136/jnnp-2011-301944; Rorden C, 2012, NEUROIMAGE, V61, P957, DOI 10.1016/j.neuroimage.2012.03.020; Rosenow F, 2001, BRAIN, V124, P1683, DOI 10.1093/brain/124.9.1683; Rummel C, 2013, EUR PHYS J-SPEC TOP, V222, P569, DOI 10.1140/epjst/e2013-01860-9; Rummel C, 2013, NEUROINFORMATICS, V11, P159, DOI 10.1007/s12021-012-9161-2; Rummel C, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.066215; Rummel C, 2010, J NEUROSCI METH, V191, P94, DOI 10.1016/j.jneumeth.2010.05.022; Sachs L, 1984, APPL STAT HDB TECHNI; Schindler K, 2001, CLIN NEUROPHYSIOL, V112, P1006, DOI 10.1016/S1388-2457(01)00522-3; Schindler K, 2007, J NEUROL NEUROSUR PS, V78, P993, DOI 10.1136/jnnp.2006.108753; Schindler K, 2007, BRAIN, V130, P65, DOI 10.1093/brain/awl304; Schindler K, 2011, EPILEPSIA, V52, P1771, DOI 10.1111/j.1528-1167.2011.03202.x; Schmidt D, 2012, CURR OPIN NEUROL, V25, P159, DOI 10.1097/WCO.0b013e3283507e73; Stam CJ, 2005, CLIN NEUROPHYSIOL, V116, P2266, DOI 10.1016/j.clinph.2005.06.011; Tellez-Zenteno JF, 2005, BRAIN, V128, P1188, DOI 10.1093/brain/awh449; Tohka J, 2004, NEUROIMAGE, V23, P84, DOI 10.1016/j.neuroimage.2004.05.007; Urrestarazu E, 2007, BRAIN, V130, P2354, DOI 10.1093/brain/awm149; van Mierlo P, 2014, PROG NEUROBIOL, V121, P19, DOI 10.1016/j.pneurobio.2014.06.004; Weiss SA, 2013, BRAIN, V136, P3796, DOI 10.1093/brain/awt276; Wendling F, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00154; Wiebe S, 2001, NEW ENGL J MED, V345, P311, DOI 10.1056/NEJM200108023450501; Wiebe S, 2012, NAT REV NEUROL, V8, P669, DOI 10.1038/nrneurol.2012.181; Worrell GA, 2008, BRAIN, V131, P928, DOI 10.1093/brain/awn006; Wu JY, 2010, NEUROLOGY, V75, P1686, DOI 10.1212/WNL.0b013e3181fc27d0; Xia MR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068910; Zubler F, 2015, BRAIN TOPOGR, V28, P305, DOI 10.1007/s10548-014-0370-x	82	33	33	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2015	10	10							e0141023	10.1371/journal.pone.0141023	http://dx.doi.org/10.1371/journal.pone.0141023			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0ED	26513359	Green Published, gold			2022-12-26	WOS:000363920300012
J	Ali, F; Wharton, DA				Ali, Farman; Wharton, David A.			Infective Juveniles of the Entomopathogenic Nematode, Steinernema feltiae Produce Cryoprotectants in Response to Freezing and Cold Acclimation	PLOS ONE			English	Article							PANAGROLAIMUS-DAVIDI; ANTARCTIC-NEMATODE; CAENORHABDITIS-ELEGANS; TREHALOSE ACCUMULATION; OSMOTIC DEHYDRATION; WATER-LOSS; TOLERANCE; METABOLISM; SURVIVAL; DESICCATION	Steinernema feltiae is a moderately freeze-tolerant entomopathogenic nematode which survives intracellular freezing. We have detected by gas chromatography that infective juveniles of S. feltiae produce cryoprotectants in response to cold acclimation and to freezing. Since the survival of this nematode varies with temperature, we analyzed their cryoprotectant profiles under different acclimation and freezing regimes. The principal cryoprotectants detected were trehalose and glycerol with glucose being the minor component. The amount of cryoprotectants varied with the temperature and duration of exposure. Trehalose was accumulated in higher concentrations when nematodes were acclimated at 5 degrees C for two weeks whereas glycerol level decreased from that of the non-acclimated controls. Nematodes were seeded with a small ice crystal and held at -1 degrees C, a regime that does not produce freezing of the nematodes but their bodies lose water to the surrounding ice (cryoprotective dehydration). This increased the levels of both trehalose and glycerol, with glycerol reaching a higher concentration than trehalose. Nematodes frozen at -3 degrees C, a regime that produces freezing of the nematodes and results in intracellular ice formation, had elevated glycerol levels while trehalose levels did not change. Steinernema feltiae thus has two strategies of cryoprotectant accumulation: one is an acclimation response to low temperature when the body fluids are in a cooled or supercooled state and the infective juveniles produce trehalose before freezing. During this process a portion of the glycerol is converted to trehalose. The second strategy is a rapid response to freezing which induces the production of glycerol but trehalose levels do not change. These low molecular weight compounds are surmised to act as cryoprotectants for this species and to play an important role in its freezing tolerance.	[Ali, Farman; Wharton, David A.] Univ Otago, Dept Zool, Dunedin, New Zealand	University of Otago	Ali, F (corresponding author), Abdul Wali Khan Univ Mardan, Dept Agr, Mardan, Pakistan.	drfarman@gmail.com	Ali, Farman/GVT-3127-2022	Wharton, David/0000-0001-6369-4984	Postgraduate Otago University Scholarship	Postgraduate Otago University Scholarship	The Lead author acknowledges the support of Postgraduate Otago University Scholarship. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abusharkh SE, 2014, LANGMUIR, V30, P12897, DOI 10.1021/la502654j; Ali F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094179; Ali F, 2013, CRYOBIOLOGY, V66, P24, DOI 10.1016/j.cryobiol.2012.10.004; [Anonymous], 2010, LOW TEMPERATURE BIOL; BEALL PT, 1983, CRYOBIOLOGY, V20, P324, DOI 10.1016/0011-2240(83)90021-4; Behm CA, 1997, INT J PARASITOL, V27, P215, DOI 10.1016/S0020-7519(96)00151-8; Brown IM, 1998, J THERM BIOL, V23, P75, DOI 10.1016/S0306-4565(98)00015-1; Calderon S, 2009, J EXP BIOL, V212, P859, DOI 10.1242/jeb.026864; CROWE JH, 1975, J EXP ZOOL, V193, P323, DOI 10.1002/jez.1401930308; CROWE LM, 1992, ADV SPACE RES-SERIES, V12, P239, DOI 10.1016/0273-1177(92)90178-Z; Gal TZ, 2001, J PARASITOL, V87, P725, DOI 10.1645/0022-3395(2001)087[0725:AITLOG]2.0.CO;2; GREENAWAY P, 1970, J EXP BIOL, V53, P147; Grewal PS, 2011, MOLECULAR AND PHYSIOLOGICAL BASIS OF NEMATODE SURVIVAL, P157, DOI 10.1079/9781845936877.0157; Grewal PS, 2002, BIOCONTROL SCI TECHN, V12, P533, DOI 10.1080/0958315021000016207; Holmstrup M, 2014, J THERM BIOL, V45, P117, DOI 10.1016/j.jtherbio.2014.09.001; Jagdale G. B., 2001, Journal of Nematology, V33, P262; Jagdale GB, 2005, J PARASITOL, V91, P988, DOI 10.1645/GE-504R.1; Jagdale GB, 2003, INT J PARASITOL, V33, P145, DOI 10.1016/S0020-7519(02)00257-6; KNIGHT CA, 1986, CRYOBIOLOGY, V23, P256, DOI 10.1016/0011-2240(86)90051-9; KNIGHT CA, 1995, CRYOBIOLOGY, V32, P23, DOI 10.1006/cryo.1995.1002; Lee R.E. Jr, 1991, P17; Lee Richard E. Jr, 2010, P3, DOI 10.1017/CBO9780511675997.002; Ogura N, 1997, NEMATOLOGICA, V43, P107, DOI 10.1163/004725997X00070; Pellerone FI, 2003, INT J PARASITOL, V33, P1195, DOI 10.1016/S0020-7519(03)00173-5; Perry RN, 2011, MOLECULAR AND PHYSIOLOGICAL BASIS OF NEMATODE SURVIVAL, P1, DOI 10.1079/9781845936877.0000; Qiu LH, 1999, CRYO-LETT, V20, P393; Qiu LH, 2000, COMP BIOCHEM PHYS B, V125, P411, DOI 10.1016/S0305-0491(99)00178-9; Qiu LH, 2002, COMP BIOCHEM PHYS B, V131, P757, DOI 10.1016/S1096-4959(02)00019-2; Rexer-Huber KMJ, 2011, J COMP PHYSIOL B, V181, P781, DOI 10.1007/s00360-011-0561-7; SALT R. W., 1957, CANADIAN ENT, V89, P491; Shapiro Ilan D, 2014, J NEMATOL, V46, P27; Slotsbo S, 2012, COMP BIOCHEM PHYS A, V161, P443, DOI 10.1016/j.cbpa.2012.01.002; SPSS Inc, 2006, STAT PACK SOC SCI WI; STOREY JM, 1985, J COMP PHYSIOL B, V156, P191, DOI 10.1007/BF00695773; Storey KB, 2006, CRYOBIOLOGY, V52, P1, DOI 10.1016/j.cryobiol.2005.09.005; Voituron Y, 2009, J COMP PHYSIOL B, V179, P223, DOI 10.1007/s00360-008-0307-3; WHARTON DA, 1995, J EXP BIOL, V198, P1381; Wharton DA, 2000, J COMP PHYSIOL B, V170, P321, DOI 10.1007/s003600000106; Wharton DA, 2005, CRYOBIOLOGY, V51, P198, DOI 10.1016/j.cryobiol.2005.07.001; Wharton DA, 1996, J EXP BIOL, V199, P1085; Wharton DA, 2015, J COMP PHYSIOL B, V185, P281, DOI 10.1007/s00360-014-0884-2; WHITE G. F., 1927, SCIENCE, V66, P302, DOI 10.1126/science.66.1709.302-a; WOMERSLEY C, 1981, COMP BIOCHEM PHYS B, V70, P579, DOI 10.1016/0305-0491(81)90299-6; Wright JC, 2001, ZOOL ANZ, V240, P563, DOI 10.1078/0044-5231-00068; Yancey PH, 2005, J EXP BIOL, V208, P2819, DOI 10.1242/jeb.01730; ZACHARIASSEN KE, 1985, PHYSIOL REV, V65, P799, DOI 10.1152/physrev.1985.65.4.799	46	10	12	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2015	10	10							e0141810	10.1371/journal.pone.0141810	http://dx.doi.org/10.1371/journal.pone.0141810			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0DL	26509788	Green Published, Green Submitted, gold			2022-12-26	WOS:000363918100135
J	Ando, H; Hirose, M; Gainche, L; Kawaai, K; Bonneau, B; Ijuin, T; Itoh, T; Takenawa, T; Mikoshiba, K				Ando, Hideaki; Hirose, Matsumi; Gainche, Laura; Kawaai, Katsuhiro; Bonneau, Benjamin; Ijuin, Takeshi; Itoh, Toshiki; Takenawa, Tadaomi; Mikoshiba, Katsuhiko			IRBIT Interacts with the Catalytic Core of Phosphatidylinositol Phosphate Kinase Type I alpha and II alpha through Conserved Catalytic Aspartate Residues	PLOS ONE			English	Article							RECEPTOR-BINDING PROTEIN; INOSITOL 1,4,5-TRISPHOSPHATE RECEPTOR; RENAL TUBULAR-ACIDOSIS; INTRINSICALLY DISORDERED PROTEIN; NA+/H+ EXCHANGER NHE3; IP3 RECEPTOR; COTRANSPORTER NBCE1-B; OCULAR ABNORMALITIES; FAMILY; PHOSPHORYLATION	Phosphatidylinositol phosphate kinases (PIPKs) are lipid kinases that generate phosphatidylinositol 4,5-bisphosphate (PI(4,5)P-2), a critical lipid signaling molecule that regulates diverse cellular functions, including the activities of membrane channels and transporters. IRBIT (IP3R-binding protein released with inositol 1,4,5-trisphosphate) is a multifunctional protein that regulates diverse target proteins. Here, we report that IRBIT forms signaling complexes with members of the PIPK family. IRBIT bound to all PIPK isoforms in heterologous expression systems and specifically interacted with PIPK type I alpha (PIPKI alpha) and type II alpha (PIPKII alpha) in mouse cerebellum. Site-directed mutagenesis revealed that two conserved catalytic aspartate residues of PIPKI alpha and PIPKII alpha are involved in the interaction with IRBIT. Furthermore, phosphatidylinositol 4-phosphate, Mg2+, and/or ATP interfered with the interaction, suggesting that IRBIT interacts with catalytic cores of PIPKs. Mutations of phosphorylation sites in the serine-rich region of IRBIT affected the selectivity of its interaction with PIPKI alpha and PIPKII alpha. The structural flexibility of the serine-rich region, located in the intrinsically disordered protein region, is assumed to underlie the mechanism of this interaction. Furthermore, in vitro binding experiments and immunocytochemistry suggest that IRBIT and PIPKI alpha interact with the Na+/HCO3- cotransporter NBCe1-B. These results suggest that IRBIT forms signaling complexes with PIPKI alpha and NBCe1-B, whose activity is regulated by PI(4,5)P-2.	[Ando, Hideaki; Hirose, Matsumi; Gainche, Laura; Kawaai, Katsuhiro; Bonneau, Benjamin; Mikoshiba, Katsuhiko] RIKEN Brain Sci Inst, Dev Neurobiol Lab, Wako, Saitama, Japan; [Ijuin, Takeshi] Kobe Univ, Grad Sch Med, Div Biochem, Kobe, Hyogo 657, Japan; [Itoh, Toshiki; Takenawa, Tadaomi] Kobe Univ, Biosignal Res Ctr, Org Adv Sci & Technol, Kobe, Hyogo 657, Japan	RIKEN; Kobe University; Kobe University	Ando, H (corresponding author), RIKEN Brain Sci Inst, Dev Neurobiol Lab, Wako, Saitama, Japan.	andohide@brain.riken.jp; mikosiba@brain.riken.jp	Ando, Hideaki/D-3876-2017; Kawaai, Katsuhiro/C-9216-2017; Mikoshiba, Katsuhiko/N-7943-2015; Ijuin, Takeshi/H-7016-2017	Kawaai, Katsuhiro/0000-0002-7502-0722; Ijuin, Takeshi/0000-0002-0618-1776; Bonneau, Benjamin/0000-0003-2302-5369	Japan Society for the Promotion of Science [17770120, 21870049, 23500458, 25221002]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by the Japan Society for the Promotion of Science Grants-in-Aid for Scientific research (Grant numbers 17770120, 21870049, and 23500458 to HA, and 25221002 to KM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson RA, 1999, J BIOL CHEM, V274, P9907, DOI 10.1074/jbc.274.15.9907; Ando H, 2003, J BIOL CHEM, V278, P10602, DOI 10.1074/jbc.M210119200; Ando H., 2014, PLOS ONE, V1843, P2195, DOI DOI 10.1016/J.BBAMCR.2014.01.031; Ando H, 2006, MOL CELL, V22, P795, DOI 10.1016/j.molcel.2006.05.017; Ando H, 2009, J NEUROCHEM, V109, P539, DOI 10.1111/j.1471-4159.2009.05979.x; Arnaoutov A, 2014, SCIENCE, V345, P1512, DOI 10.1126/science.1251550; Bah A, 2015, NATURE, V519, P106, DOI 10.1038/nature13999; BORONENKOV IV, 1995, J BIOL CHEM, V270, P2881, DOI 10.1074/jbc.270.7.2881; Bosanac I, 2002, NATURE, V420, P696, DOI 10.1038/nature01268; Bulley Simon J, 2015, Adv Biol Regul, V57, P193, DOI 10.1016/j.jbior.2014.09.007; Castellino AM, 1997, J BIOL CHEM, V272, P5861, DOI 10.1074/jbc.272.9.5861; Choi SY, 2015, BBA-MOL CELL BIOL L, V1851, P711, DOI 10.1016/j.bbalip.2015.01.009; Collins MO, 2005, J BIOL CHEM, V280, P5972, DOI 10.1074/jbc.M411220200; Coppolino MG, 2002, J BIOL CHEM, V277, P43849, DOI 10.1074/jbc.M209046200; Demirci FYK, 2006, MOL VIS, V12, P324; Devogelaere B, 2006, BIOCHEM BIOPH RES CO, V343, P49, DOI 10.1016/j.bbrc.2006.02.119; Devogelaere B, 2007, BIOCHEM J, V407, P303, DOI 10.1042/BJ20070361; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; Dunker AK, 2005, FEBS J, V272, P5129, DOI 10.1111/j.1742-4658.2005.04948.x; Fairn GD, 2009, J CELL BIOL, V187, P701, DOI 10.1083/jcb.200909025; Gomi T, 2008, BBA-PROTEINS PROTEOM, V1784, P1786, DOI 10.1016/j.bbapap.2008.08.016; Grainger DL, 2012, BIOCHEM SOC T, V40, P257, DOI 10.1042/BST20110617; Gribble FM, 2000, J BIOL CHEM, V275, P30046, DOI 10.1074/jbc.M001010200; Grubbs RD, 2002, BIOMETALS, V15, P251, DOI 10.1023/A:1016026831789; He PJ, 2015, J CLIN INVEST, V125, P3519, DOI 10.1172/JCI79552; He PJ, 2010, J BIOL CHEM, V285, P27869, DOI 10.1074/jbc.M110.133066; He PJ, 2008, J BIOL CHEM, V283, P33544, DOI 10.1074/jbc.M805534200; Heck JN, 2007, CRIT REV BIOCHEM MOL, V42, P15, DOI 10.1080/10409230601162752; Hong JH, 2013, P NATL ACAD SCI USA, V110, P4105, DOI 10.1073/pnas.1221410110; Horita S, 2005, J AM SOC NEPHROL, V16, P2270, DOI 10.1681/ASN.2004080667; Igarashi T, 1999, NAT GENET, V23, P264, DOI 10.1038/15440; Ishida T, 2008, BIOINFORMATICS, V24, P1344, DOI 10.1093/bioinformatics/btn195; Ishihara H, 1996, J BIOL CHEM, V271, P23611, DOI 10.1074/jbc.271.39.23611; Ishihara H, 1998, J BIOL CHEM, V273, P8741, DOI 10.1074/jbc.273.15.8741; Itoh T, 1998, J BIOL CHEM, V273, P20292, DOI 10.1074/jbc.273.32.20292; Kawaai K, 2015, P NATL ACAD SCI USA, V112, P5515, DOI 10.1073/pnas.1503310112; Kennedy HJ, 1999, J BIOL CHEM, V274, P13281, DOI 10.1074/jbc.274.19.13281; Kiefer H, 2009, J BIOL CHEM, V284, P10694, DOI 10.1074/jbc.M807136200; Kozlowski LP, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-111; Lecompte O, 2008, TRENDS BIOCHEM SCI, V33, P453, DOI 10.1016/j.tibs.2008.07.002; Lee SK, 2012, AM J PHYSIOL-CELL PH, V302, pC518, DOI 10.1152/ajpcell.00352.2011; Loijens JC, 1996, J BIOL CHEM, V271, P32937, DOI 10.1074/jbc.271.51.32937; Majumdar D, 2008, NEUROSCIENCE, V155, P818, DOI 10.1016/j.neuroscience.2008.05.037; Majumdar D, 2010, NEUROSCIENCE, V171, P951, DOI 10.1016/j.neuroscience.2010.09.037; Mikoshiba K, 2007, J NEUROCHEM, V102, P1426, DOI 10.1111/j.1471-4159.2007.04825.x; Oldfield CJ, 2014, ANNU REV BIOCHEM, V83, P553, DOI 10.1146/annurev-biochem-072711-164947; Park S, 2013, GASTROENTEROLOGY, V145, P232, DOI 10.1053/j.gastro.2013.03.047; Park SJ, 2001, J BIOL CHEM, V276, P4781, DOI 10.1074/jbc.M010177200; Pufall MA, 2005, SCIENCE, V309, P142, DOI 10.1126/science.1111915; Rameh LE, 1997, NATURE, V390, P192, DOI 10.1038/36621; Rao VD, 1998, CELL, V94, P829, DOI 10.1016/S0092-8674(00)81741-9; Romero MF, 2013, MOL ASPECTS MED, V34, P159, DOI 10.1016/j.mam.2012.10.008; Sarkes D, 2010, BIOCHEM J, V428, P375, DOI 10.1042/BJ20100129; Shcheynikov N, 2015, P NATL ACAD SCI USA, V112, pE329, DOI 10.1073/pnas.1415673112; Shibasaki Y, 1997, J BIOL CHEM, V272, P7578, DOI 10.1074/jbc.272.12.7578; Shirakabe K, 2006, P NATL ACAD SCI USA, V103, P9542, DOI 10.1073/pnas.0602250103; Sun Y, 2013, BIOESSAYS, V35, P513, DOI 10.1002/bies.201200171; Suzuki M, 2010, P NATL ACAD SCI USA, V107, P15963, DOI 10.1073/pnas.1008705107; Svichar N, 2011, J NEUROSCI, V31, P6997, DOI 10.1523/JNEUROSCI.6088-10.2011; Theparambil SM, 2014, J NEUROSCI, V34, P1148, DOI 10.1523/JNEUROSCI.2377-13.2014; Thornell IM, 2015, J PHYSIOL-LONDON, V593, P541, DOI 10.1113/jphysiol.2014.284307; Volpicelli-Daley LA, 2010, J BIOL CHEM, V285, P28708, DOI 10.1074/jbc.M110.132191; Wang RH, 1997, J BIOL CHEM, V272, P26405, DOI 10.1074/jbc.272.42.26405; Wisniewska M, 2010, CRYSTAL STRUCTURE HU; Xue B, 2010, BBA-PROTEINS PROTEOM, V1804, P996, DOI 10.1016/j.bbapap.2010.01.011; Yamaguchi S, 2012, BIOCHEM BIOPH RES CO, V424, P433, DOI 10.1016/j.bbrc.2012.06.127; Yang DK, 2011, J CLIN INVEST, V121, P956, DOI 10.1172/JCI43475; Yang DK, 2009, J CLIN INVEST, V119, P193, DOI 10.1172/JCI36983; Zaika O, 2011, J BIOL CHEM, V286, P830, DOI 10.1074/jbc.M110.166033; Zamaraeva MV, 2005, CELL DEATH DIFFER, V12, P1390, DOI 10.1038/sj.cdd.4401661	70	5	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2015	10	10							e0141569	10.1371/journal.pone.0141569	http://dx.doi.org/10.1371/journal.pone.0141569			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0DL	26509711	gold, Green Submitted, Green Published			2022-12-26	WOS:000363918100105
J	Cho, MH; Park, CK; Park, M; Kim, WK; Cho, A; Kim, H				Cho, Min-Hee; Park, Cheol Keun; Park, Minhee; Kim, Won Kyu; Cho, Arthur; Kim, Hoguen			Clinicopathologic Features and Molecular Characteristics of Glucose Metabolism Contributing to F-18-fluorodeoxyglucose Uptake in Gastrointestinal Stromal Tumors	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; CELL LUNG-CANCER; LACTATE-DEHYDROGENASE; F-18-FDG PET; HEXOKINASE-II; HEPATOCELLULAR-CARCINOMA; COLORECTAL-CANCER; EARLY PREDICTION; FDG UPTAKE; EXPRESSION	Fluorine-18 fluorodeoxyglucose (F-18-FDG) positron emission tomography-computed tomography (PET/CT) is useful in the preoperative diagnosis of gastrointestinal stromal tumors (GISTs); however, the molecular characteristics of glucose metabolism of GIST are unknown. We evaluated F-18-FDG uptake on preoperative PET/CT of 40 patients and analyzed the expression of glycolytic enzymes in resected GIST tissues by qRT-PCR, western blotting, and immunohistochemistry. Results of receiver operating characteristic curve analysis showed that the maximum standardized uptake value (SUVmax) cut-off value of 4.99 had a sensitivity of 89.5%, specificity was 76.2%, and accuracy of 82.5% for identifying tumors with a high risk of malignancy. We found that 18F-FDG uptake correlated positively with tumor size, risk grade, and expression levels of glucose transporter 1 (GLUT1), hexokinase 1 (HK1), and lactate dehydrogenase A (LDHA). Elevated HK and LDH activity was found in high-risk tumors. Among the isoforms of GLUT and HK, GLUT1 and HK1 expression increased with higher tumor risk grade. In addition, overexpression of glycolytic enzymes M2 isoform of pyruvate kinase (PKM2) and LDHA was observed in GISTs, especially in high-risk tumors. These results suggest that upregulation of GLUT1, HK1, PKM2, and LDHA may play an important role in GIST tumorigenesis and may be useful in the preoperative prediction of malignant potential.	[Cho, Min-Hee; Park, Cheol Keun; Park, Minhee; Kim, Won Kyu; Kim, Hoguen] Yonsei Univ, Coll Med, Dept Pathol, Seoul 120749, South Korea; [Cho, Min-Hee; Park, Minhee; Kim, Won Kyu; Kim, Hoguen] Yonsei Univ, Coll Med, Brain Korea PLUS Project Med Sci 21, Seoul 120749, South Korea; [Cho, Arthur] Yonsei Univ, Coll Med, Severance Hosp, Dept Nucl Med, Seoul 120749, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Cho, A (corresponding author), Yonsei Univ, Coll Med, Severance Hosp, Dept Nucl Med, Seoul 120749, South Korea.	artycho@yuhs.ac; hkyonsei@yuhs.ac		Cho, Arthur/0000-0001-8670-2473	Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea [HI14C1324]; Midcareer Researcher Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology [2015R1A2A2A01004835]	Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea; Midcareer Researcher Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology	This research was supported by a grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (grant number: HI14C1324; URL: http://rndhospital.khidi.or.kr/rdh) and by the Midcareer Researcher Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (grant number: 2015R1A2A2A01004835; URL: http://www.nrf.re.kr/nrf_tot_cms/index.jsp?pmisso-return2=none).	Archer Michael C, 2011, Genes Cancer, V2, P712, DOI 10.1177/1947601911423029; Brown RS, 2002, NUCL MED BIOL, V29, P443, DOI 10.1016/S0969-8051(02)00288-3; Chung JK, 2004, NUCL MED COMMUN, V25, P11, DOI 10.1097/00006231-200401000-00003; de Geus-Oei LF, 2007, LUNG CANCER, V55, P79, DOI 10.1016/j.lungcan.2006.08.018; de Geus-Oei LF, 2009, J NUCL MED, V50, p43S, DOI 10.2967/jnumed.108.057224; Fantin VR, 2006, CANCER CELL, V9, P425, DOI 10.1016/j.ccr.2006.04.023; Fletcher CDM, 2002, HUM PATHOL, V33, P459, DOI 10.1053/hupa.2002.123545; Gallamini A, 2014, CURR TREAT OPTION ON, V15, P248, DOI 10.1007/s11864-014-0278-4; Gayed I, 2004, J NUCL MED, V45, P17; Kamiyama Y, 2005, WORLD J SURG, V29, P1429, DOI 10.1007/s00268-005-0045-6; Kim JW, 2006, CANCER RES, V66, P8927, DOI 10.1158/0008-5472.CAN-06-1501; Le A, 2010, P NATL ACAD SCI USA, V107, P2037, DOI 10.1073/pnas.0914433107; Marin-Hernandez A, 2009, MINI-REV MED CHEM, V9, P1084, DOI 10.2174/138955709788922610; Miao P, 2013, IUBMB LIFE, V65, P904, DOI 10.1002/iub.1216; Miettinen M, 2006, ARCH PATHOL LAB MED, V130, P1466; Miller DM, 2012, CLIN CANCER RES, V18, P5546, DOI 10.1158/1078-0432.CCR-12-0977; Miller TR, 2003, J NUCL MED, V44, P192; Otomi Y, 2010, J MED INVESTIG, V57, P270, DOI 10.2152/jmi.57.270; Park JW, 2011, J GASTRIC CANCER, V11, P173, DOI 10.5230/jgc.2011.11.3.173; Park SG, 2012, NUCL MED BIOL, V39, P1167, DOI 10.1016/j.nucmedbio.2012.07.003; Paudyal B, 2008, INT J ONCOL, V33, P1047, DOI 10.3892/ijo_00000093; Prior JO, 2009, J CLIN ONCOL, V27, P439, DOI 10.1200/JCO.2008.17.2742; Rong YF, 2013, TUMOR BIOL, V34, P1523, DOI 10.1007/s13277-013-0679-1; Sheng SL, 2012, FEBS J, V279, P3898, DOI 10.1111/j.1742-4658.2012.08748.x; Shim HK, 2009, NUCL MED BIOL, V36, P191, DOI 10.1016/j.nucmedbio.2008.11.009; Shreve P, 2013, RADIOL CLIN N AM, V51, P767, DOI 10.1016/j.rcl.2013.05.001; Tagliabue L, 2014, EUR J INTERN MED, V25, P6, DOI 10.1016/j.ejim.2013.06.012; Takebayashi R, 2013, J EXP CLIN CANC RES, V32, DOI 10.1186/1756-9966-32-34; Tanaka M, 2014, MOL CANCER THER, V13, P767, DOI 10.1158/1535-7163.MCT-13-0393; Tian M, 2004, EUR J NUCL MED MOL I, V31, P5, DOI 10.1007/s00259-003-1316-9; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Wong Nicholas, 2013, Int J Cell Biol, V2013, P242513, DOI 10.1155/2013/242513; Yoshikawa K, 2013, SURG TODAY, V43, P1162, DOI 10.1007/s00595-012-0411-6; Zhou CF, 2012, IUBMB LIFE, V64, P775, DOI 10.1002/iub.1066; Zhou X, 2014, J NUCL MED, V55, P1766, DOI 10.2967/jnumed.114.145490	35	20	22	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2015	10	10							e0141413	10.1371/journal.pone.0141413	http://dx.doi.org/10.1371/journal.pone.0141413			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0DL	26509967	Green Submitted, Green Published, gold			2022-12-26	WOS:000363918100077
J	Gangisetty, O; Wynne, O; Jabbar, S; Nasello, C; Sarkar, DK				Gangisetty, Omkaram; Wynne, Olivia; Jabbar, Shaima; Nasello, Cara; Sarkar, Dipak K.			Fetal Alcohol Exposure Reduces Dopamine Receptor D2 and Increases Pituitary Weight and Prolactin Production via Epigenetic Mechanisms	PLOS ONE			English	Article							DNA METHYLATION; PRENATAL ALCOHOL; MESSENGER-RNA; GENE-EXPRESSION; ADENOMAS; ETHANOL; TUMORS; HYPERPROLACTINEMIA; SUSCEPTIBILITY; RELEASE	Recent evidence indicated that alcohol exposure during the fetal period increases the susceptibility to tumor development in mammary and prostate tissues. Whether fetal alcohol exposure increases the susceptibility to prolactin-producing tumor (prolactinoma) development in the pituitary was studied by employing the animal model of estradiol-induced prolactinomas in Fischer 344 female rats. We employed an animal model of fetal alcohol exposure that simulates binge alcohol drinking during the first two trimesters of human pregnancy and involves feeding pregnant rats with a liquid diet containing 6.7% alcohol during gestational day 7 to day 21. Control rats were pair-fed with isocaloric liquid diet or fed ad libitum with rat chow diet. Adult alcohol exposed and control female offspring rats were used in this study on the day of estrus or after estrogen treatment. Results show that fetal alcohol-exposed rats had increased levels of pituitary weight, pituitary prolactin (PRL) protein and mRNA, and plasma PRL. However, these rats show decreased pituitary levels of dopamine D2 receptor (D2R) mRNA and protein and increased pituitary levels of D2R promoter methylation. Also, they show elevated pituitary mRNA levels of DNA methylating genes (DNMT1, DNMT3b, MeCP2) and histone modifying genes (HDAC2, HDAC4, G9a). When fetal alcohol exposed rats were treated neonatally with a DNA methylation inhibitor 5-Aza deoxycytidine and/or a HDAC inhibitor trichostatin-A their pituitary D2R mRNA, pituitary weights and plasma PRL levels were normalized. These data suggest that fetal alcohol exposure programs the pituitary to increase the susceptibility to the development of prolactinomas possibly by enhancing the methylation of the D2R gene promoter and repressing the synthesis and control of D2R on PRL-producing cells.	[Gangisetty, Omkaram; Wynne, Olivia; Jabbar, Shaima; Sarkar, Dipak K.] Rutgers State Univ, Dept Anim Sci, Endocrine Program, New Brunswick, NJ 08901 USA; [Nasello, Cara] Rutgers State Univ, Dept Genet, New Brunswick, NJ 08901 USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick	Sarkar, DK (corresponding author), Rutgers State Univ, Dept Anim Sci, Endocrine Program, New Brunswick, NJ 08901 USA.	sarkar@aesop.rutgers.edu	Jabbar, Shaima/K-2139-2019; Sarkar, Dipak K/O-7942-2017	Sarkar, Dipak K/0000-0003-3237-9871; Gangisetty, Omkaram/0000-0001-6280-0642	National Institute of Health [R01 AA11591]; Hatch project [NJ06160]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA011591] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hatch project(United States Department of Agriculture (USDA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work is partly supported by a National Institute of Health grant R01 AA11591 and a Hatch project grant NJ06160.	Al-Azzawi H, 2011, ENDOCRINOLOGY, V152, P364, DOI 10.1210/en.2010-0886; Alexander JM, 2001, BRAIN PATHOL, V11, P342; Asa SL, 1998, ENDOCR REV, V19, P798, DOI 10.1210/er.19.6.798; Asa Sylvia L, 2002, Pituitary, V5, P133, DOI 10.1023/A:1022320732718; Baldwin MR, 2007, INT J CIRCUMPOL HEAL, P54; Bekdash RA, 2013, ALCOHOL CLIN EXP RES, V37, P1133, DOI 10.1111/acer.12082; Ben-Jonathan N, 2001, ENDOCR REV, V22, P724, DOI 10.1210/er.22.6.724; Davis CD, 2004, EXP BIOL MED, V229, P988, DOI 10.1177/153537020422901002; De A, 2002, ALCOHOL CLIN EXP RES, V26, P1420, DOI 10.1097/01.ALC.0000030621.35354.E0; De A, 1996, J ENDOCRINOL, V149, P19, DOI 10.1677/joe.0.1490019; Feng J, 2009, INT REV NEUROBIOL, V89, P67, DOI 10.1016/S0074-7742(09)89004-1; Freeman ME, 2000, PHYSIOL REV, V80, P1523, DOI 10.1152/physrev.2000.80.4.1523; Gangisetty O, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113228; Gauthier TW, 2005, ALCOHOL CLIN EXP RES, V29, P1035, DOI 10.1097/01.ALC.0000167956.28160.5E; Govorko D, 2012, BIOL PSYCHIAT, V72, P378, DOI 10.1016/j.biopsych.2012.04.006; Grunstein M, 1997, NATURE, V389, P349, DOI 10.1038/38664; Hellemans KGC, 2010, ALCOHOL CLIN EXP RES, V34, P633, DOI 10.1111/j.1530-0277.2009.01132.x; Hicks SD, 2010, J NEUROCHEM, V114, P1767, DOI 10.1111/j.1471-4159.2010.06886.x; Iaccarino C, 2002, P NATL ACAD SCI USA, V99, P14530, DOI 10.1073/pnas.222319599; Jacobson SW, 1999, DEV PSYCHOPATHOL, V11, P195, DOI 10.1017/S0954579499002011; JOHNSON S, 1981, PEDIATR RES, V15, P908, DOI 10.1203/00006450-198106000-00005; JONES KL, 1973, LANCET, V1, P1267; Kelly MA, 1997, NEURON, V19, P103, DOI 10.1016/S0896-6273(00)80351-7; Lee ESY, 2004, NEUROSCI RES, V48, P335, DOI 10.1016/j.neures.2003.11.010; Lleva RR, 2011, CURR OPIN ONCOL, V23, P53, DOI 10.1097/CCO.0b013e328341000f; Maier SE, 1999, J NEUROBIOL, V41, P414, DOI 10.1002/(SICI)1097-4695(19991115)41:3<414::AID-NEU9>3.0.CO;2-F; MANSOUR A, 1990, J NEUROSCI, V10, P2587; MELLO NK, 1988, J PHARMACOL EXP THER, V245, P895; MILLER MW, 1992, BRAIN RES, V595, P17, DOI 10.1016/0006-8993(92)91447-M; Miranda TB, 2007, J CELL PHYSIOL, V213, P384, DOI 10.1002/jcp.21224; Missale C, 1998, J ENDOCRINOL INVEST, V21, P402, DOI 10.1007/BF03350778; Ogino A, 2005, J NEUROPATH EXP NEUR, V64, P398, DOI 10.1093/jnen/64.5.398; Oomizu S, 2003, ALCOHOL CLIN EXP RES, V27, P975, DOI 10.1097/01.ALC.0000071743.57855.BE; Polanco TA, 2010, ALCOHOL CLIN EXP RES, V34, P1879, DOI 10.1111/j.1530-0277.2010.01276.x; Qian X, 1998, AM J PATHOL, V153, P1475, DOI 10.1016/S0002-9440(10)65735-5; RAYMOND V, 1978, SCIENCE, V200, P1173, DOI 10.1126/science.418505; REDEI E, 1989, ALCOHOL CLIN EXP RES, V13, P439, DOI 10.1111/j.1530-0277.1989.tb00350.x; Robbins TW, 1999, NATURE, V398, P567, DOI 10.1038/19208; Saiardi A, 1997, NEURON, V19, P115, DOI 10.1016/S0896-6273(00)80352-9; Sarkar DK, 2006, FRONT HORM RES, V35, P32, DOI 10.1159/000094307; Sarkar DK, 2015, ADV EXP MED BIOL, V815, P389, DOI 10.1007/978-3-319-09614-8_23; Sarkar DK, 2010, FRONT HORM RES, V38, P32, DOI 10.1159/000318492; SARKAR DK, 1982, SCIENCE, V218, P684, DOI 10.1126/science.7134966; SEKI M, 1991, Japanese Journal of Alcohol Studies and Drug Dependence, V26, P49; Sengupta A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045593; Simpson DJ, 2000, CANCER RES, V60, P1211; Sokol RJ, 2003, JAMA-J AM MED ASSOC, V290, P2996, DOI 10.1001/jama.290.22.2996; Suzuki MM, 2008, NAT REV GENET, V9, P465, DOI 10.1038/nrg2341; Taylor AN, 1999, ALCOHOL CLIN EXP RES, V23, P465, DOI 10.1097/00000374-199903000-00012; Turner BM, 2002, CELL, V111, P285, DOI 10.1016/S0092-8674(02)01080-2; Volkow ND, 1996, ALCOHOL CLIN EXP RES, V20, P1594, DOI 10.1111/j.1530-0277.1996.tb05936.x; Yoshino A, 2007, J NEURO-ONCOL, V83, P153, DOI 10.1007/s11060-006-9316-9; Zhang XQ, 2005, EXP BIOL MED, V230, P376, DOI 10.1177/15353702-0323006-05; Zhao J, 2005, J CLIN ENDOCR METAB, V90, P2179, DOI 10.1210/jc.2004-1848; Zhu XG, 2008, J CLIN ENDOCR METAB, V93, P3610, DOI 10.1210/jc.2008-0578	55	26	28	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2015	10	10							e0140699	10.1371/journal.pone.0140699	http://dx.doi.org/10.1371/journal.pone.0140699			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0DL	26509893	gold, Green Published, Green Submitted			2022-12-26	WOS:000363918100037
J	Ge, YP; Lu, X; Peng, QL; Shu, XM; Wang, GC				Ge, Yongpeng; Lu, Xin; Peng, Qinglin; Shu, Xiaoming; Wang, Guochun			Clinical Characteristics of Anti-3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Antibodies in Chinese Patients with Idiopathic Inflammatory Myopathies	PLOS ONE			English	Article							AUTOANTIBODIES; DERMATOMYOSITIS; POLYMYOSITIS; PROTEINS; DISEASE	Objective The objective of this study was to detect the prevalence of anti-3-hydroxyl-3-methylglutaryl coenzyme A reductase (anti-HMGCR) antibodies in Chinese patients with idiopathic inflammatory myopathies (IIMs), and to analyze the clinical features of the antibody-positive IIM patients. Methods The presence of anti-HMGCR antibodies was detected in 405 patients with IIMs, 90 healthy controls, and 221 patients with other rheumatic diseases by using an ELISA kit. Clinical data from anti-HMGCR antibody-positive and -negative patients were compared. Long-term follow-up of the anti-HMGCR antibody-positive patients was conducted to evaluate the role of anti-HMGCR antibody in IIM disease prognosis. Results Of the 405 IIM patients, 22 (5.4%) were found to carry the anti-HMGCR antibody. These IIM patients were predominantly female (73%), and only 3 anti-HMGCR antibody-positive patients with IIM were exposure to statins. Most patients experienced progressive onset, and presented with muscular weakness. Dysphagia was observed in half of the patients (p < 0.01), and 15% of these patients experienced the complication of interstitial lung disease (ILD) (p > 0.05). Mean creatine kinase (CK) levels were higher in antibody-positive patients than in antibody-negative patients (p < 0.05). Muscle biopsies were available from 12 anti-HMGCR antibody-positive patients, eight who experienced myofiber necrosis and showed very little or no evidence of inflammatory cell infiltrates in their muscle biopsies. Of these eleven patients who were followed-up 2.5-to 29-month, 73% experienced improvement after treatment. A cross-sectional study showed that anti-HMGCR antibody levels were significantly associated with CK levels (r = 0.486, p = 0.026) as well as with Myositis Disease Activity Assessment (MYOACT) scores (r = -0.67, p = 0.003) during the initial visit. However, changes in serum anti-HMGCR antibody levels did not correlate with changes in CK levels, Manual Muscle Testing 8 (MMT-8) scores or MYOACT scores in long-term follow-up. Conclusion The major clinical features of anti-HMGCR antibody-positive Chinese IIM patients were muscle weakness and dysphagia, which were seen in patients with and without statin exposure. This subtype of patients were responsive to immunosuppressive treatment and received good prognoses after treatment, but serum levels of the anti-HMGCR antibody do not correlate with disease activity.	[Ge, Yongpeng; Lu, Xin; Peng, Qinglin; Shu, Xiaoming; Wang, Guochun] China Japan Friendship Hosp, Dept Rheumatol, Beijing 100029, Peoples R China; [Ge, Yongpeng; Wang, Guochun] Peking Union Med Coll, Grad Sch, Beijing 100730, Peoples R China	China-Japan Friendship Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Wang, GC (corresponding author), China Japan Friendship Hosp, Dept Rheumatol, Beijing 100029, Peoples R China.	guochunwang@hotmail.com	Ming, Shu Xiao/AAF-3356-2019	Ge, Yongpeng/0000-0003-3674-9307	National Natural Science Foundation of China [81172860]; Science and Technology Commission Foundation of Beijing [Z121107001012005]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Commission Foundation of Beijing	This research was supported by grants from the National Natural Science Foundation of China (No: 81172860) and the Science and Technology Commission Foundation of Beijing (No: Z121107001012005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allenbach Y, 2014, MEDICINE, V93, P150, DOI 10.1097/MD.0000000000000028; BOHAN A, 1975, NEW ENGL J MED, V292, P403, DOI 10.1056/NEJM197502202920807; BOHAN A, 1975, NEW ENGL J MED, V292, P344, DOI 10.1056/NEJM197502132920706; Casciola-Rosen L, 2012, CURR OPIN RHEUMATOL, V24, P602, DOI 10.1097/BOR.0b013e328358bd85; Christopher-Stine L, 2010, ARTHRITIS RHEUM-US, V62, P2757, DOI 10.1002/art.27572; Drouot L, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/ar4468; Fujimoto M, 2012, ARTHRITIS RHEUM-US, V64, P513, DOI 10.1002/art.33403; Ghirardello A, 2013, CURR RHEUMATOL REP, V15, DOI 10.1007/s11926-013-0335-1; Hoogendijk Jessica E, 2004, Neuromuscul Disord, V14, P337, DOI 10.1016/j.nmd.2004.02.006; Mammen AL, 2011, ARTHRITIS RHEUM-US, V63, P713, DOI 10.1002/art.30156; Musset L, 2014, J IMMUNOL RES, V2014, DOI 10.1155/2014/405956; Ramanathan S, 2015, NEUROL-NEUROIMMUNOL, V2, DOI 10.1212/NXI.0000000000000096; Rider LG, 2010, ARTHRIT CARE RES, V62, P465, DOI 10.1002/acr.20035; Sato S, 2009, ARTHRITIS RHEUM-US, V60, P2193, DOI 10.1002/art.24621; Sultan SM, 2008, ARTHRITIS RHEUM, V58, P3593, DOI 10.1002/art.23963; Watanabe Y, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000416; Werner JL, 2012, ARTHRITIS RHEUM-US, V64, P4087, DOI 10.1002/art.34673	17	45	52	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2015	10	10							e0141616	10.1371/journal.pone.0141616	http://dx.doi.org/10.1371/journal.pone.0141616			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0DL	26509687	Green Submitted, Green Published, gold			2022-12-26	WOS:000363918100114
J	Li, G; Xie, F; Zhang, YH; Bosse, JT; Langford, PR; Wang, CL				Li, Gang; Xie, Fang; Zhang, Yanhe; Bosse, Janine T.; Langford, Paul R.; Wang, Chunlai			Role of (p)ppGpp in Viability and Biofilm Formation of Actinobacillus pleuropneumoniae S8	PLOS ONE			English	Article							AMINO-ACID STARVATION; STRINGENT RESPONSE; ESCHERICHIA-COLI; GENE-EXPRESSION; STATIONARY-PHASE; VIBRIO-CHOLERAE; GROWTH-RATE; IN-VITRO; VIRULENCE; PPGPP	Actinobacillus pleuropneumoniae is a Gram-negative bacterium and the cause of porcine pleuropneumonia. When the bacterium encounters nutritional starvation, the relA-dependent (p) ppGpp-mediated stringent response is activated. The modified nucleotides guanosine 5'-diphosphate 3'-diphosphate (ppGpp) and guanosine 5'-triphosphate 3'-diphosphate (pppGpp) are known to be signaling molecules in other prokaryotes. Here, to investigate the role of (p) ppGpp in A. pleuropneumoniae, we created a mutant A. pleuropneumoniae strain, S8 Delta relA, which lacks the (p) ppGpp-synthesizing enzyme RelA, and investigated its phenotype in vitro. S8 Delta relA did not survive after stationary phase (starvation condition) and grew exclusively as non-extended cells. Compared to the wild-type (WT) strain, the S8 Delta relA mutant had an increased ability to form a biofilm. Transcriptional profiles of early stationary phase cultures revealed that a total of 405 bacterial genes were differentially expressed (including 380 up-regulated and 25 down-regulated genes) in S8 Delta relA as compared with the WT strain. Most of the up-regulated genes are involved in ribosomal structure and biogenesis, amino acid transport and metabolism, translation cell wall/membrane/envelope biogenesis. The data indicate that (p) ppGpp coordinates the growth, viability, morphology, biofilm formation and metabolic ability of A. pleuropneumoniae in starvation conditions. Furthermore, S8 Delta relA could not use certain sugars nor produce urease which has been associated with the virulence of A. pleuropneumoniae, suggesting that (p) ppGpp may directly or indirectly affect the pathogenesis of A. pleuropneumoniae during the infection process. In summary, (p) ppGpp signaling represents an essential component of the regulatory network governing stress adaptation and virulence in A. pleuropneumoniae.	[Li, Gang; Xie, Fang; Zhang, Yanhe; Wang, Chunlai] Chinese Acad Agr Sci, Harbin Vet Res Inst, State Key Lab Vet Biotechnol, Div Bacterial Dis, Harbin, Peoples R China; [Zhang, Yanhe; Bosse, Janine T.] Univ London Imperial Coll Sci Technol & Med, Dept Med, Paediat Sect, London, England	Chinese Academy of Agricultural Sciences; Harbin Veterinary Research Institute, CAAS; Imperial College London	Wang, CL (corresponding author), Chinese Acad Agr Sci, Harbin Vet Res Inst, State Key Lab Vet Biotechnol, Div Bacterial Dis, Harbin, Peoples R China.	chunlai.wang@hvri.ac.cn		Bosse, Janine/0000-0002-8491-4779	National Natural Science Foundation of China [31302091, 31201907]; National High Technology Research and Development Program of China [2011AA10A210]; Special Fund for Agro-scientific Research in the Public Interest [201303034]; Biotechnology and Biological Sciences Research Council [BB/K020765/1] Funding Source: researchfish; BBSRC [BB/K020765/1] Funding Source: UKRI	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); Special Fund for Agro-scientific Research in the Public Interest; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	National Natural Science Foundation of China (No. 31302091, http://www.nsfc.gov.cn), GL, National Natural Science Foundation of China (No. 31201907, http://www.nsfc.gov.cn), YHZ, National High Technology Research and Development Program of China (No. 2011AA10A210, http://www.863.gov.cn), CLW, Special Fund for Agro-scientific Research in the Public Interest (No. 201303034, http://www.moa.gov.cn/), CLW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberg A, 2006, MOL MICROBIOL, V60, P1520, DOI 10.1111/j.1365-2958.2006.05191.x; Alba BM, 2004, MOL MICROBIOL, V52, P613, DOI 10.1111/j.1365-2958.2003.03982.x; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Baltes N, 2003, FEMS MICROBIOL LETT, V220, P41, DOI 10.1016/S0378-1097(03)00064-8; Bittner AN, 2014, J BACTERIOL, V196, P2067, DOI 10.1128/JB.01471-14; Bosse JT, 2010, J BACTERIOL, V192, P2414, DOI 10.1128/JB.01513-09; Bosse JT, 2002, MICROBES INFECT, V4, P225, DOI 10.1016/S1286-4579(01)01534-9; Boutte CC, 2013, TRENDS MICROBIOL, V21, P174, DOI 10.1016/j.tim.2013.01.002; Bowden SD, 2013, MOL MICROBIOL, V90, P457, DOI 10.1111/mmi.12369; Chatnaparat T, 2015, ENVIRON MICROBIOL, V17, P4253, DOI 10.1111/1462-2920.12744; Chatnaparat T, 2015, MOL PLANT MICROBE IN, V28, P776, DOI 10.1094/MPMI-11-14-0378-R; Chiers K, 2010, VET RES, V41, DOI 10.1051/vetres/2010037; Dalebroux ZD, 2010, MICROBIOL MOL BIOL R, V74, P171, DOI 10.1128/MMBR.00046-09; Das B, 2009, MOL MICROBIOL, V72, P380, DOI 10.1111/j.1365-2958.2009.06653.x; de Paz LEC, 2012, APPL ENVIRON MICROB, V78, P1627, DOI 10.1128/AEM.07036-11; Dehio C, 1997, J BACTERIOL, V179, P538, DOI 10.1128/jb.179.2.538-540.1997; DOM P, 1994, INFECT IMMUN, V62, P1262, DOI 10.1128/IAI.62.4.1262-1267.1994; Faron M, 2013, INFECT IMMUN, V81, P2800, DOI 10.1128/IAI.00073-13; Gaca AO, 2013, MBIO, V4, DOI 10.1128/mBio.00646-13; Geiger T, 2010, INFECT IMMUN, V78, P1873, DOI 10.1128/IAI.01439-09; He HJ, 2012, J BACTERIOL, V194, P2962, DOI 10.1128/JB.00014-12; Jain V, 2006, J MICROBIOL, V44, P1; Kabir MS, 2005, MICROBIOL-SGM, V151, P2721, DOI 10.1099/mic.0.28004-0; Kazmierczak KM, 2009, MOL MICROBIOL, V72, P590, DOI 10.1111/j.1365-2958.2009.06669.x; Klinkenberg LG, 2010, J INFECT DIS, V202, P1397, DOI 10.1086/656524; Klitgaard K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035549; Labrie J, 2010, VET RES, V41, DOI 10.1051/vetres/2009051; Li G, 2012, J BACTERIOL, V194, P6606, DOI 10.1128/JB.01650-12; Lone AG, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-195; Maciag-Dorszynska M, 2013, FEBS OPEN BIO, V3, P161, DOI 10.1016/j.fob.2013.03.001; Magnusson LU, 2003, J BIOL CHEM, V278, P968, DOI 10.1074/jbc.M209881200; McLennan MK, 2008, J BACTERIOL, V190, P1097, DOI 10.1128/JB.00516-07; Mouery K, 2006, J BACTERIOL, V188, P5494, DOI 10.1128/JB.00366-06; Nielsen KK, 2005, APPL ENVIRON MICROB, V71, P2949, DOI 10.1128/AEM.71.6.2949-2954.2005; Potrykus K, 2008, ANNU REV MICROBIOL, V62, P35, DOI 10.1146/annurev.micro.62.081307.162903; Potrykus K, 2011, ENVIRON MICROBIOL, V13, P563, DOI 10.1111/j.1462-2920.2010.02357.x; Reiner A, 2003, BIOINFORMATICS, V19, P368, DOI 10.1093/bioinformatics/btf877; Ruffing AM, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-17; Srivatsan A, 2008, CURR OPIN MICROBIOL, V11, P100, DOI 10.1016/j.mib.2008.02.001; Subashchandrabose S, 2009, INFECT IMMUN, V77, P4925, DOI 10.1128/IAI.00671-09; Sugisaki K, 2013, MICROBIOL-SGM, V159, P1379, DOI 10.1099/mic.0.066597-0; Syal K, 2015, ADV EXP MED BIOL, V842, P309, DOI 10.1007/978-3-319-11280-0_20; Traxler MF, 2008, MOL MICROBIOL, V68, P1128, DOI 10.1111/j.1365-2958.2008.06229.x; Vogt SL, 2011, INFECT IMMUN, V79, P4094, DOI 10.1128/IAI.00193-11; Wexselblatt E, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002925; WILLSON PJ, 1989, ANTIMICROB AGENTS CH, V33, P1627, DOI 10.1128/AAC.33.9.1627; Xie F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053600; Zhou Y, 2013, CLIN VACCINE IMMUNOL, V20, P287, DOI 10.1128/CVI.00616-12	48	22	22	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2015	10	10							e0141501	10.1371/journal.pone.0141501	http://dx.doi.org/10.1371/journal.pone.0141501			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0DL	26509499	Green Submitted, Green Published, gold			2022-12-26	WOS:000363918100092
J	Liu, P; Robbins, AH; Marzahn, MR; McClung, SH; Yowell, CA; Stevens, SM; Dame, JB; Dunn, BM				Liu, Peng; Robbins, Arthur H.; Marzahn, Melissa R.; McClung, Scott H.; Yowell, Charles A.; Stevens, Stanley M., Jr.; Dame, John B.; Dunn, Ben M.			Enzymatic Characterization of Recombinant Food Vacuole Plasmepsin 4 from the Rodent Malaria Parasite Plasmodium berghei	PLOS ONE			English	Article							ACTIVE-SITE SPECIFICITY; IN-VIVO EVALUATION; ASPARTIC PROTEINASE; ANTIMALARIAL ACTIVITY; CRYSTAL-STRUCTURES; FALCIPARUM; PROTEASE; INHIBITORS; SEQUENCE; VITRO	The rodent malaria parasite Plasmodium berghei is a practical model organism for experimental studies of human malaria. Plasmepsins are a class of aspartic proteinase isoforms that exert multiple pathological effects in malaria parasites. Plasmepsins residing in the food vacuole (FV) of the parasite hydrolyze hemoglobin in red blood cells. In this study, we cloned PbPM4, the FV plasmepsin gene of P. berghei that encoded an N-terminally truncated pro-segment and the mature enzyme from genomic DNA. We over-expressed this PbPM4 zymogen as inclusion bodies (IB) in Escherichia coli, and purified the protein following in vitro IB refolding. Auto-maturation of the PbPM4 zymogen to mature enzyme was carried out at pH 4.5, 5.0, and 5.5. Interestingly, we found that the PbPM4 zymogen exhibited catalytic activity regardless of the presence of the pro-segment. We determined the optimal catalytic conditions for PbPM4 and studied enzyme kinetics on substrates and inhibitors of aspartic proteinases. Using combinatorial chemistry-based peptide libraries, we studied the active site preferences of PbPM4 at subsites S1, S2, S3, S1', S2' and S3'. Based on these results, we designed and synthesized a selective peptidomimetic compound and tested its inhibition of PbPM4, seven FV plasmepsins from human malaria parasites, and human cathepsin D (hcatD). We showed that this compound exhibited a >10-fold selectivity to PbPM4 and human malaria parasite plasmepsin 4 orthologs versus hcatD. Data from this study furthesr our understanding of enzymatic characteristics of the plasmepsin family and provides leads for anti-malarial drug design.	[Liu, Peng; Robbins, Arthur H.; Marzahn, Melissa R.; Dunn, Ben M.] Univ Florida, Coll Med, Dept Biochem & Mol Biol, Gainesville, FL 32610 USA; [McClung, Scott H.; Stevens, Stanley M., Jr.] Univ Florida, Coll Med, Prot Core, Interdisciplinary Ctr Biotechnol Res, Gainesville, FL USA; [Yowell, Charles A.; Dame, John B.] Univ Florida, Coll Vet Med, Dept Infect Dis & Pathol, Gainesville, FL USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Liu, P (corresponding author), Univ Minnesota, Dept Neurol, Minneapolis, MN 55455 USA.	liuxx726@umn.edu; bdunn@ufl.edu		Stevens, Stanley/0000-0002-1399-0256; Dame, John B./0000-0002-5772-5454	National Institutes of Health grant [AI39211]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI039211] Funding Source: NIH RePORTER	National Institutes of Health grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work is supported by National Institutes of Health (http://www.nih.gov/) grant AI39211 to BMD and JBD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adepiti AO, 2014, PARASITOL RES, V113, P505, DOI 10.1007/s00436-013-3680-0; Aikawa M., 1980, P285; Andrews KT, 2006, ANTIMICROB AGENTS CH, V50, P639, DOI 10.1128/AAC.50.2.639-648.2006; Asojo OA, 2003, J MOL BIOL, V327, P173, DOI 10.1016/S0022-2836(03)00036-6; Banerjee R, 2002, P NATL ACAD SCI USA, V99, P990, DOI 10.1073/pnas.022630099; Beyer BB, 2005, BIOCHEMISTRY-US, V44, P1768, DOI 10.1021/bi047886u; Beyer BB, 2003, TARGETED CHROMOGENIC; Beyer BM, 1996, J BIOL CHEM, V271, P15590, DOI 10.1074/jbc.271.26.15590; Bhaumik P, 2011, J STRUCT BIOL, V175, P73, DOI 10.1016/j.jsb.2011.04.009; Bhaumik P, 2009, J MOL BIOL, V388, P520, DOI 10.1016/j.jmb.2009.03.011; Boddey JA, 2010, NATURE, V463, P627, DOI 10.1038/nature08728; Boniface PK, 2013, J ETHNOPHARMACOL, V145, P373, DOI 10.1016/j.jep.2012.10.025; Bonilla JA, 2007, MOL MICROBIOL, V65, P64, DOI 10.1111/j.1365-2958.2007.05768.x; Bozdech Z, 2003, PLOS BIOL, V1, P85, DOI 10.1371/journal.pbio.0000005; Carcache LM, 2003, BIOORGAN MED CHEM, V11, P551, DOI 10.1016/S0968-0896(02)00448-0; Carlton JMR, 1999, MOL BIOCHEM PARASIT, V101, P23, DOI 10.1016/S0166-6851(99)00045-6; Coombs GH, 2001, TRENDS PARASITOL, V17, P532, DOI 10.1016/S1471-4922(01)02037-2; Dame JB, 2003, MOL BIOCHEM PARASIT, V130, P1, DOI 10.1016/S0166-6851(03)00137-3; DAME JB, 1994, MOL BIOCHEM PARASIT, V64, P177, DOI 10.1016/0166-6851(94)90024-8; Dan N, 2015, EUR J MED CHEM, V95, P324, DOI 10.1016/j.ejmech.2015.03.049; Dunn B M, 1994, Methods Mol Biol, V36, P225; Dunn B, 2011, RSC DRUG DISCOV, V18, P242; DUNN BM, 1986, BIOCHEM J, V237, P899, DOI 10.1042/bj2370899; Dunn BM, 2000, BBA-PROTEIN STRUCT M, V1477, P231, DOI 10.1016/S0167-4838(99)00275-7; EDMAN P, 1949, ARCH BIOCHEM, V22, P475; Ersmark K, 2006, MED RES REV, V26, P626, DOI 10.1002/med.20082; Fischer E., 1894, BER DTSCH CHEM GES, V27, P2985, DOI DOI 10.1002/CBER.18940270364; Francis SE, 1997, J BIOL CHEM, V272, P14961, DOI 10.1074/jbc.272.23.14961; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Gasteiger E., 2005, PROTEOMICS PROTOC HD, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Goodman AL, 2013, SCI REP-UK, V3, DOI 10.1038/srep01706; Hall N, 2002, NATURE, V419, P527, DOI 10.1038/nature01095; HENDERSON PJ, 1972, BIOCHEM J, V127, P321, DOI 10.1042/bj1270321; Hidaka K, 2008, BIOORGAN MED CHEM, V16, P10049, DOI 10.1016/j.bmc.2008.10.011; Hobbs CV, 2009, J INFECT DIS, V199, P134, DOI 10.1086/594369; HSUEH WA, 1981, HYPERTENSION, V3, P22; Humphreys MJ, 1999, FEBS LETT, V463, P43, DOI 10.1016/S0014-5793(99)01597-5; Istvan ES, 2005, J BIOL CHEM, V280, P6890, DOI 10.1074/jbc.M412086200; JANSE CJ, 1989, INT J PARASITOL, V19, P509, DOI 10.1016/0020-7519(89)90080-5; JANSE CJ, 1984, INT J PARASITOL, V14, P317, DOI 10.1016/0020-7519(84)90083-3; KAMIYAMA T, 1992, INT J PARASITOL, V22, P1137, DOI 10.1016/0020-7519(92)90032-G; Khan AR, 1999, P NATL ACAD SCI USA, V96, P10968, DOI 10.1073/pnas.96.20.10968; Killick-Kendrick R., 1978, P1; Kim YM, 2006, J BIOCHEM, V139, P189, DOI 10.1093/jb/mvj018; KOSHLAND DE, 1958, P NATL ACAD SCI USA, V44, P98, DOI 10.1073/pnas.44.2.98; Krugliak M, 2002, MOL BIOCHEM PARASIT, V119, P249, DOI 10.1016/S0166-6851(01)00427-3; Landau I., 1978, P53; LEATHERBARROW RJ, 1985, P NATL ACAD SCI USA, V82, P7840, DOI 10.1073/pnas.82.23.7840; Lew VL, 2003, BLOOD, V101, P4189, DOI 10.1182/blood-2002-08-2654; LI J, 1991, EXP PARASITOL, V72, P450, DOI 10.1016/0014-4894(91)90091-A; Li T, 2004, MOL BIOCHEM PARASIT, V135, P101, DOI 10.1016/j.molbiopara.2004.01.010; Lin Jing-wen, 2011, PLoS One, V6, pe29289, DOI 10.1371/journal.pone.0029289; Liu J, 2005, J BIOL CHEM, V280, P1432, DOI 10.1074/jbc.M409740200; Liu J, 2006, P NATL ACAD SCI USA, V103, P8840, DOI 10.1073/pnas.0601876103; Liu K, 2009, ANGEW CHEM INT EDIT, V48, P8293, DOI 10.1002/anie.200903747; Liu P, 2009, BIOCHEMISTRY-US, V48, P4086, DOI 10.1021/bi802059r; Luker KE, 1996, MOL BIOCHEM PARASIT, V79, P71, DOI 10.1016/0166-6851(96)02651-5; Ma BY, 1999, PROTEIN ENG, V12, P713, DOI 10.1093/protein/12.9.713; MARQUARDT DW, 1963, J SOC IND APPL MATH, V11, P431, DOI 10.1137/0111030; Mastan BS, 2014, MOL BIOCHEM PARASIT, V195, P10, DOI 10.1016/j.molbiopara.2014.05.004; Mesfin A, 2012, J ETHNOPHARMACOL, V139, P221, DOI 10.1016/j.jep.2011.11.006; Meyers MJ, 2012, CURR TOP MED CHEM, V12, P445; Mlambo G, 2008, EUKARYOT CELL, V7, P1875, DOI 10.1128/EC.00242-08; Moon RP, 1997, EUR J BIOCHEM, V244, P552, DOI 10.1111/j.1432-1033.1997.00552.x; MOORE S, 1948, J BIOL CHEM, V176, P367; MORRISON JF, 1969, BIOCHIM BIOPHYS ACTA, V185, P269, DOI 10.1016/0005-2744(69)90420-3; Moura PA, 2009, ANTIMICROB AGENTS CH, V53, P4968, DOI 10.1128/AAC.00882-09; Musila MF, 2013, J ETHNOPHARMACOL, V146, P557, DOI 10.1016/j.jep.2013.01.023; Naughton JA, 2010, MOL BIOCHEM PARASIT, V173, P81, DOI 10.1016/j.molbiopara.2010.05.007; Nezami A, 2003, BIOCHEMISTRY-US, V42, P8459, DOI 10.1021/bi034131z; Nezami A, 2002, BIOCHEMISTRY-US, V41, P2273, DOI 10.1021/bi0117549; Noteberg D, 2003, J MED CHEM, V46, P734, DOI 10.1021/jm020951i; Noteberg D, 2003, J COMB CHEM, V5, P456, DOI 10.1021/cc0301014; Orjuela-Sanchez P, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-366; Parr CL, 2008, FEBS J, V275, P1698, DOI 10.1111/j.1742-4658.2008.06325.x; REDDY GR, 1993, P NATL ACAD SCI USA, V90, P9867, DOI 10.1073/pnas.90.21.9867; Rodrigues-Duarte L, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-231; Russo I, 2010, NATURE, V463, P632, DOI 10.1038/nature08726; SCARBOROUGH PE, 1993, PROTEIN SCI, V2, P264; SHERMAN IW, 1977, B WORLD HEALTH ORGAN, V55, P265; Shi XP, 2001, J BIOL CHEM, V276, P10366, DOI 10.1074/jbc.M009200200; Sinden R.E., 1978, P85; Skinner-Adams TS, 2007, ANTIMICROB AGENTS CH, V51, P759, DOI 10.1128/AAC.00840-06; Skinner-Adams TS, 2004, J INFECT DIS, V190, P1998, DOI 10.1086/425584; Sleebs BE, 2014, J MED CHEM, V57, P7644, DOI 10.1021/jm500797g; Sleebs BE, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001897; Spaccapelo R, 2011, SCI REP-UK, V1, DOI 10.1038/srep00039; Spaccapelo R, 2010, AM J PATHOL, V176, P205, DOI 10.2353/ajpath.2010.090504; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; TRAGER W, 1977, B WORLD HEALTH ORGAN, V55, P363; Tyas L, 1999, FEBS LETT, V454, P210, DOI 10.1016/S0014-5793(99)00805-4; VANVIANEN PH, 1990, EXP PARASITOL, V70, P115, DOI 10.1016/0014-4894(90)90092-Q; WATERS AP, 1991, P NATL ACAD SCI USA, V88, P3140, DOI 10.1073/pnas.88.8.3140; Westling J, 1997, EXP PARASITOL, V87, P185, DOI 10.1006/expr.1997.4225; Westling J, 1999, PROTEIN SCI, V8, P2001, DOI 10.1110/ps.8.10.2001; Wyatt DM, 2002, FEBS LETT, V513, P159, DOI 10.1016/S0014-5793(02)02241-X; Xiao HG, 2014, MOL BIOCHEM PARASIT, V197, P56, DOI 10.1016/j.molbiopara.2014.10.004	97	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2015	10	10							e0141758	10.1371/journal.pone.0141758	http://dx.doi.org/10.1371/journal.pone.0141758			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0DL	26510189	Green Submitted, Green Published, gold			2022-12-26	WOS:000363918100129
J	Zou, Z; Gong, J; Huang, QX; Mo, YY; Yang, LF; Xie, GS				Zou, Zhi; Gong, Jun; Huang, Qixing; Mo, Yeyong; Yang, Lifu; Xie, Guishui			Gene Structures, Evolution, Classification and Expression Profiles of the Aquaporin Gene Family in Castor Bean (Ricinus communis L.)	PLOS ONE			English	Article							MAJOR INTRINSIC PROTEINS; PLASMA-MEMBRANE AQUAPORIN; GENOME-WIDE ANALYSIS; ARABIDOPSIS-THALIANA; VACUOLAR MEMBRANE; PLANT AQUAPORINS; FUNCTIONAL-CHARACTERIZATION; HIGHLY DIVERGENT; WATER CHANNELS; DRAFT GENOME	Aquaporins (AQPs) are a class of integral membrane proteins that facilitate the passive transport of water and other small solutes across biological membranes. Castor bean (Ricinus communis L., Euphobiaceae), an important non-edible oilseed crop, is widely cultivated for industrial, medicinal and cosmetic purposes. Its recently available genome provides an opportunity to analyze specific gene families. In this study, a total of 37 full-length AQP genes were identified from the castor bean genome, which were assigned to five subfamilies, including 10 plasma membrane intrinsic proteins (PIPs), 9 tonoplast intrinsic proteins (TIPs), 8 NOD26-like intrinsic proteins (NIPs), 6 X intrinsic proteins (XIPs) and 4 small basic intrinsic proteins (SIPs) on the basis of sequence similarities. Functional prediction based on the analysis of the aromatic/arginine (ar/R) selectivity filter, Froger's positions and specificity-determining positions (SDPs) showed a remarkable difference in substrate specificity among subfamilies. Homology analysis supported the expression of all 37 RcAQP genes in at least one of examined tissues, e.g., root, leaf, flower, seed and endosperm. Furthermore, global expression profiles with deep transcriptome sequencing data revealed diverse expression patterns among various tissues. The current study presents the first genome-wide analysis of the AQP gene family in castor bean. Results obtained from this study provide valuable information for future functional analysis and utilization.	[Zou, Zhi; Gong, Jun; Mo, Yeyong; Yang, Lifu; Xie, Guishui] Chinese Acad Trop Agr Sci, Rubber Res Inst, Minist Agr, Danzhou Invest & Expt Stn Trop Crops, Danzhou, Hainan, Peoples R China; [Huang, Qixing] Chinese Acad Trop Agr Sci, Inst Trop Biosci & Biotechnol, Haikou, Hainan, Peoples R China	Chinese Academy of Tropical Agricultural Sciences; Ministry of Agriculture & Rural Affairs; Chinese Academy of Tropical Agricultural Sciences	Zou, Z (corresponding author), Chinese Acad Trop Agr Sci, Rubber Res Inst, Minist Agr, Danzhou Invest & Expt Stn Trop Crops, Danzhou, Hainan, Peoples R China.	zouzhi2008@126.com; xie23300459@163.com	Zou, Zhi/F-1266-2018	Zou, Zhi/0000-0003-2881-1932	Natural Science Foundation of Hainan Province [312026]; National Natural Science Foundation of China [31371556]; Fundamental Research Funds for Rubber Research Institute, CATAS [1630022015004]; Earmarked Fund for Modern Agro-industry Technology Research System [CARS-34-GW5]	Natural Science Foundation of Hainan Province; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for Rubber Research Institute, CATAS; Earmarked Fund for Modern Agro-industry Technology Research System	Funded by the Natural Science Foundation of Hainan Province (312026), the National Natural Science Foundation of China (31371556), the Fundamental Research Funds for Rubber Research Institute, CATAS (1630022015004) and the Earmarked Fund for Modern Agro-industry Technology Research System (CARS-34-GW5).	Abascal F, 2014, BBA-GEN SUBJECTS, V1840, P1468, DOI 10.1016/j.bbagen.2013.12.001; Agre Peter, 2006, Proc Am Thorac Soc, V3, P5, DOI 10.1513/pats.200510-109JH; Aharon R, 2003, PLANT CELL, V15, P439, DOI 10.1105/tpc.009225; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Anderberg HI, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00033; Anderberg HI, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-110; Arabidopsis Genome Initiative, 2000, Nature (London), V408, P796, DOI 10.1038/35048692; Aroca R, 2012, J EXP BOT, V63, P43, DOI 10.1093/jxb/err266; Bansal A, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-27; Bernsel A, 2009, NUCLEIC ACIDS RES, V37, pW465, DOI 10.1093/nar/gkp363; Bienert GP, 2006, BBA-BIOMEMBRANES, V1758, P994, DOI 10.1016/j.bbamem.2006.02.015; Bienert GP, 2014, BBA-BIOMEMBRANES, V1838, P216, DOI 10.1016/j.bbamem.2013.08.011; Bienert GP, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-26; Bienert GP, 2011, PLANT J, V66, P306, DOI 10.1111/j.1365-313X.2011.04496.x; Blanc G, 2004, PLANT CELL, V16, P1679, DOI 10.1105/tpc.021410; Bowers JE, 2003, NATURE, V422, P433, DOI 10.1038/nature01521; Brown AP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030100; Chan AP, 2010, NAT BIOTECHNOL, V28, P951, DOI 10.1038/nbt.1674; Chaumont F, 2005, BIOL CELL, V97, P749, DOI 10.1042/BC20040133; Chaumont F, 2001, PLANT PHYSIOL, V125, P1206, DOI 10.1104/pp.125.3.1206; Chou KC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011335; DANIELS MJ, 1994, PLANT PHYSIOL, V106, P1325, DOI 10.1104/pp.106.4.1325; Daniels MJ, 1996, PLANT CELL, V8, P587, DOI 10.1105/tpc.8.4.587; Danielson JAH, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-45; Dean RM, 1999, BIOCHEMISTRY-US, V38, P347, DOI 10.1021/bi982110c; DENKER BM, 1988, J BIOL CHEM, V263, P15634; Deshmukh RK, 2013, PLANT MOL BIOL, V83, P303, DOI 10.1007/s11103-013-0087-3; Doering-Saad C, 2006, J EXP BOT, V57, P3183, DOI 10.1093/jxb/erl082; Dynowski M, 2008, BIOCHEM J, V414, P53, DOI 10.1042/BJ20080287; Dynowski M, 2008, FEBS LETT, V582, P2458, DOI 10.1016/j.febslet.2008.06.012; Eckert M, 1999, J EXP BOT, V50, P1541, DOI 10.1093/jexbot/50.339.1541; Eisenbarth DA, 2005, J EXP BOT, V56, P1831, DOI 10.1093/jxb/eri173; Emmanuel E, 2011, Patent, Patent No. [EP 2279258-A2 756, 2279258]; Fitzpatrick KL, 2009, PLANT CELL ENVIRON, V32, P1357, DOI 10.1111/j.1365-3040.2009.02003.x; Froger A, 1998, PROTEIN SCI, V7, P1458, DOI 10.1002/pro.5560070623; Fu DX, 2000, SCIENCE, V290, P481, DOI 10.1126/science.290.5491.481; Gaspar M, 2003, PLANT SCI, V165, P21, DOI 10.1016/S0168-9452(03)00117-1; Gomes D, 2009, BBA-BIOMEMBRANES, V1788, P1213, DOI 10.1016/j.bbamem.2009.03.009; Guenther JF, 2003, PLANT CELL, V15, P981, DOI 10.1105/tpc.009787; Gupta AB, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-134; Hanba YT, 2004, PLANT CELL PHYSIOL, V45, P521, DOI 10.1093/pcp/pch070; HOFTE H, 1992, PLANT PHYSIOL, V99, P561, DOI 10.1104/pp.99.2.561; Horton P, 2007, NUCLEIC ACIDS RES, V35, pW585, DOI 10.1093/nar/gkm259; Hove RM, 2011, PLANT MOL BIOL, V75, P413, DOI 10.1007/s11103-011-9737-5; Hu B, 2015, BIOINFORMATICS, V31, P1296, DOI 10.1093/bioinformatics/btu817; Ishikawa F, 2005, FEBS LETT, V579, P5814, DOI 10.1016/j.febslet.2005.09.076; Jaillon O, 2007, NATURE, V449, P463, DOI 10.1038/nature06148; Javot H, 2002, ANN BOT-LONDON, V90, P301, DOI 10.1093/aob/mcf199; Jiao YN, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-1-r3; Jiao YN, 2011, NATURE, V473, P97, DOI 10.1038/nature09916; Johanson U, 2001, PLANT PHYSIOL, V126, P1358, DOI 10.1104/pp.126.4.1358; Johansson I, 2000, BBA-BIOMEMBRANES, V1465, P324, DOI 10.1016/S0005-2736(00)00147-4; JOHNSON KD, 1989, PLANT PHYSIOL, V91, P1006, DOI 10.1104/pp.91.3.1006; Klebl F, 2003, FEBS LETT, V547, P69, DOI 10.1016/S0014-5793(03)00671-9; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li GW, 2014, BBA-GEN SUBJECTS, V1840, P1574, DOI 10.1016/j.bbagen.2013.11.004; Li T, 2011, BIOCHEMISTRY-US, V50, P6633, DOI 10.1021/bi2004476; Liu LH, 2003, PLANT PHYSIOL, V133, P1220, DOI 10.1104/pp.103.027409; Lopez D, 2012, J EXP BOT, V63, P2217, DOI 10.1093/jxb/err404; Loque D, 2005, PLANT PHYSIOL, V137, P671, DOI 10.1104/pp.104.051268; Lu CF, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-42; LUDEVID D, 1992, PLANT PHYSIOL, V100, P1633, DOI 10.1104/pp.100.4.1633; Ma JF, 2006, NATURE, V440, P688, DOI 10.1038/nature04590; MAUREL C, 1993, EMBO J, V12, P2241, DOI 10.1002/j.1460-2075.1993.tb05877.x; Maurel C, 2008, ANNU REV PLANT BIOL, V59, P595, DOI 10.1146/annurev.arplant.59.032607.092734; Ming R, 2008, NATURE, V452, P991, DOI 10.1038/nature06856; Mizutani M, 2006, PLANT CELL PHYSIOL, V47, P1420, DOI 10.1093/pcp/pcl004; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Niemietz CM, 2000, FEBS LETT, V465, P110, DOI 10.1016/S0014-5793(99)01729-9; Noronha H, 2014, J EXP BOT, V65, P981, DOI 10.1093/jxb/ert448; Ogunniyi DS, 2006, BIORESOURCE TECHNOL, V97, P1086, DOI 10.1016/j.biortech.2005.03.028; Park W, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-142; Prado K, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00255; Puzio P, 2009, Patent, Patent No. [WO 2009037329-A2 1126, 2009037329]; Qiu LJ, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-278; Quigley F, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2001-3-1-research0001; Regon P, 2014, FUNCT INTEGR GENOMIC, V14, P617, DOI 10.1007/s10142-014-0389-9; Reuscher S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079052; Rivarola M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021743; Ronen G, 2009, Patent, Patent No. [WO 2009083958-A2 1194, 2009083958]; Sakurai J, 2005, PLANT CELL PHYSIOL, V46, P1568, DOI 10.1093/pcp/pci172; Savage DF, 2003, PLOS BIOL, V1, P334, DOI 10.1371/journal.pbio.0000072; Shelden MC, 2009, FUNCT PLANT BIOL, V36, P1065, DOI 10.1071/FP09117; Soto G, 2008, FEBS LETT, V582, P4077, DOI 10.1016/j.febslet.2008.11.002; Sui HX, 2001, NATURE, V414, P872, DOI 10.1038/414872a; Takano J, 2006, PLANT CELL, V18, P1498, DOI 10.1105/tpc.106.041640; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tornroth-Horsefield S, 2006, NATURE, V439, P688, DOI 10.1038/nature04316; Troncoso-Ponce MA, 2011, PLANT J, V68, P1014, DOI 10.1111/j.1365-313X.2011.04751.x; Tuskan GA, 2006, SCIENCE, V313, P1596, DOI 10.1126/science.1128691; Uehlein N, 2003, NATURE, V425, P734, DOI 10.1038/nature02027; VANDELOO FJ, 1995, P NATL ACAD SCI USA, V92, P6743, DOI 10.1073/pnas.92.15.6743; Venkatesh J, 2013, PLANT PHYSIOL BIOCH, V73, P392, DOI 10.1016/j.plaphy.2013.10.025; Wallace IS, 2005, BIOCHEMISTRY-US, V44, P16826, DOI 10.1021/bi0511888; Wallace IS, 2004, PLANT PHYSIOL, V135, P1059, DOI 10.1104/pp.103.033415; Wudick MM, 2009, NEW PHYTOL, V184, P289, DOI 10.1111/j.1469-8137.2009.02985.x; Xu W, 2014, NUCLEIC ACIDS RES, V42, P6987, DOI 10.1093/nar/gku375; Xu W, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-785; [曾祥英 Zeng Xiangying], 2010, [中国给水排水, China Water & Wastewater], V26, P123; Zhang DY, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0056312, 10.1371/journal.pone.0077345]; Zimmermann P, 2004, PLANT PHYSIOL, V136, P2621, DOI 10.1104/pp.104.046367	102	28	29	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2015	10	10							e0141022	10.1371/journal.pone.0141022	http://dx.doi.org/10.1371/journal.pone.0141022			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0DL	26509832	Green Published, gold, Green Submitted			2022-12-26	WOS:000363918100046
J	Chen, C; Zhu, T; Wang, ZJ; Peng, H; Kong, W; Zhou, Y; Shao, Y; Zhu, LM; Lu, W				Chen, Cheng; Zhu, Tao; Wang, Zhijian; Peng, Hong; Kong, Wen; Zhou, Yang; Shao, Yan; Zhu, Limei; Lu, Wei			High Latent TB Infection Rate and Associated Risk Factors in the Eastern China of Low TB Incidence	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS INFECTION; PREVALENCE; EXPOSURE; BCG	Objectives To disclose the associated risk factors for latent tuberculosis infection (LTBI) and the current situation of LTBI in the eastern China. Methods A cross-sectional study was undertaken to evaluate the LTBI rate and risk factors. Results A total of 5305 subjects were finally included, with the IGRA positive rate of 19.98% (1060/5305). The LTBI rates were increasing with age (ORs were in significance from 6.60 to 20.92). Male gender significantly increased the risk of LTBI by 0.52 fold (OR = 1.52). Both smoking and drinking significantly increased the risk of LTBI (OR = 1.83 and OR = 1.67, respectively). Meanwhile, overweight and close contact with tuberculosis were risk factors for LTBI (OR = 1.36 and OR = 2.38, respectively). However, higher level of education and BCG vaccination lowered the risk of LTBI (OR = 0.16 and OR = 0.39, respectively). The multivariate logistic regression showed that age, male gender, smoking, overweight and close contacting with tuberculosis were risk factors for LTBI, but BCG vaccination was a protective factor for LTBI. Conclusions BCG vaccination exerted protective effect on tuberculosis. However, LTBI rate in the Chinese rural area was critical and subjects above 30 years, male, smoking, overweight and close contact with tuberculosis wound be the targets for LTBI screening and source of tuberculosis.	[Chen, Cheng; Peng, Hong; Kong, Wen; Zhou, Yang; Shao, Yan; Zhu, Limei; Lu, Wei] Ctr Dis Control & Prevent Jiangsu Prov, Dept Chron Infect Dis, Nanjing, Jiangsu, Peoples R China; [Zhu, Tao; Wang, Zhijian] Ctr Dis Control & Prevent Danyang Cty, Dept TB control, Danyang, Peoples R China	Jiangsu Provincial Center for Disease Control & Prevention	Lu, W (corresponding author), Ctr Dis Control & Prevent Jiangsu Prov, Dept Chron Infect Dis, Nanjing, Jiangsu, Peoples R China.	jsjkmck@163.com	WANG, JINGYI/GSJ-1241-2022; wang, jie/GRS-0942-2022		national twelfth five-year mega-scientific projects of infectious diseases of China, National Science and Technology Major Project [2013ZX10003004-002]	national twelfth five-year mega-scientific projects of infectious diseases of China, National Science and Technology Major Project	The study was supported by the national twelfth five-year mega-scientific projects of infectious diseases of China, National Science and Technology Major Project, grant number: 2013ZX10003004-002 (http://www.nmp.gov.cn/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, GUID INT TUB CAS FIN; Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; COMSTOCK GW, 1974, AM J EPIDEMIOL, V99, P131, DOI 10.1093/oxfordjournals.aje.a121593; den Boon S, 2005, THORAX, V60, P555, DOI 10.1136/thx.2004.030924; du Preez K, 2011, INT J TUBERC LUNG D, V15, P1490, DOI 10.5588/ijtld.10.0759; Dye C, 1999, JAMA-J AM MED ASSOC, V282, P677, DOI 10.1001/jama.282.7.677; Farhat M, 2006, INT J TUBERC LUNG D, V10, P1192; Feng Y, 2011, INFECT IMMUN, V79, P229, DOI 10.1128/IAI.00709-10; group Tfnts, 2012, CHINESE J ANTITUBERC, V34, P24; Hermansen TS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093986; Horne DJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049050; Lee SK, 2013, LUNG, V191, P565, DOI 10.1007/s00408-013-9481-5; Lindsay RP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093137; Luu Thi L, 2009, PLOS ONE, V4; Mack U, 2009, EUR RESPIR J, V33, P956, DOI 10.1183/09031936.00120908; Mathew A, 2013, J CLIN EPIDEMIOL, V66, P67, DOI 10.1016/j.jclinepi.2011.12.010; Mazurek Gerald H., 2010, Morbidity and Mortality Weekly Report, V59, P1; Patra J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096433; Rhines AS, 2013, TUBERCULOSIS, V93, P104, DOI 10.1016/j.tube.2012.10.012; Roy A, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4643; Shang SB, 2011, J INFECT DIS, V203, P1240, DOI 10.1093/infdis/jir009; Sichletidis L, 2006, INT J TUBERC LUNG D, V10, P1127; Song S, 2012, CHEST, V141, P983, DOI 10.1378/chest.11-1158; Sridhar S, 2014, PEDIATR INFECT DIS J, V33, P1303, DOI 10.1097/INF.0000000000000506; Sterne JAC, 1998, INT J TUBERC LUNG D, V2, P200; Ting WY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110104; Whitworth HS, 2013, METHODS, V61, P52, DOI 10.1016/j.ymeth.2012.12.012; WHO, 2007, INT J TUBERC LUNG D, V11, P12; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; World Health Organization, 2012, REC INV CONT PERS IN	30	43	46	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2015	10	10							e0141511	10.1371/journal.pone.0141511	http://dx.doi.org/10.1371/journal.pone.0141511			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU8PC	26505997	Green Published, Green Submitted, gold			2022-12-26	WOS:000363804200079
J	Guo, SM; Zhang, JD; Zhang, SY; Li, J				Guo, Shimeng; Zhang, Jiandong; Zhang, Shuyong; Li, Jing			A Single Amino Acid Mutation (R104P) in the E/DRY Motif of GPR40 Impairs Receptor Function	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTORS; FREE FATTY-ACIDS; STIMULATED INSULIN-SECRETION; SMALL-MOLECULE AGONISTS; M1 MUSCARINIC RECEPTOR; PANCREATIC BETA-CELLS; DRY MOTIF; ARGININE; GENE; IDENTIFICATION	Type 2 Diabetes Mellitus with insulin resistance, pancreatic beta cell dysfunction, and hepatic glucose overproduction is increasing in epidemic proportions worldwide. G protein-coupled receptor 40 (GPR40), a clinically proven anti-diabetic drug target, is mainly expressed in pancreatic beta cells and insulin-secreting cell lines. Long chain fatty acids (LCFA) increase intracellular calcium concentration and amplify glucose-stimulated insulin secretion by activating GPR40. Here we report that the arginine 104 (R104) is critical for the normal function of GPR40. Mutation of R104 to Proline (R104P) results in complete loss of the receptor function. Linoleic acid, ligand of GPR40, could not elicit calcium increase and ERK phosphorylation in cells expressing this mutant receptor. Further study indicated the R104P mutation reduces cell surface localization of GPR40 without affecting the expression of the protein. The small portion of GPR40 R104P mutant that is still located on the membrane has no physiological function, and does not internalize in response to linoleic acid stimulation. These data demonstrate that R104 in GPR40 is critically involved in the normal receptor functions. Interestingly, R104P is a registered single-nucleotide polymorphism of GPR40. The relationship of this GPR40 variant and type 2 diabetes warrants further investigation.	[Guo, Shimeng] Shanghai Univ, Sch Life Sci, Shanghai, Peoples R China; [Zhang, Jiandong] Nanchang Univ, Coll Pharm, Nanchang, Peoples R China; [Guo, Shimeng; Zhang, Jiandong; Zhang, Shuyong; Li, Jing] Chinese Acad Sci, Shanghai Inst Mat Med, Key Lab Receptor Res, Natl Ctr Drug Screening, Shanghai 200031, Peoples R China	Shanghai University; Nanchang University; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS	Zhang, SY (corresponding author), Chinese Acad Sci, Shanghai Inst Mat Med, Key Lab Receptor Res, Natl Ctr Drug Screening, Shanghai 200031, Peoples R China.	zsy206@163.com; lijing@simm.ac.cn		guo, shimeng/0000-0002-8086-5092; Zhang, Shuyong/0000-0002-9739-2682	National Natural Sciences Foundation of China [81202341]; 973 programme [2014CB541906]; National Science & Technology Major Project "Key New Drug Creation and Manufacturing Program" [2014ZX09507-002]; Shanghai Commission of Science and Technology [15ZR1408200]	National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); 973 programme(National Basic Research Program of China); National Science & Technology Major Project "Key New Drug Creation and Manufacturing Program"; Shanghai Commission of Science and Technology(Shanghai Science & Technology Committee)	This project was supported by grants from the National Natural Sciences Foundation of China (81202341), 973 programme (2014CB541906), the National Science & Technology Major Project "Key New Drug Creation and Manufacturing Program" (2014ZX09507-002) and Shanghai Commission of Science and Technology (15ZR1408200).	Acharya S, 1996, J BIOL CHEM, V271, P25406, DOI 10.1074/jbc.271.41.25406; Alewijnse AE, 2000, MOL PHARMACOL, V57, P890; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Barak LS, 2001, P NATL ACAD SCI USA, V98, P93, DOI 10.1073/pnas.011303698; Briscoe CP, 2003, J BIOL CHEM, V278, P11303, DOI 10.1074/jbc.M211495200; Brown AJ, 2003, J BIOL CHEM, V278, P11312, DOI 10.1074/jbc.M211609200; Burstein ES, 1998, J BIOL CHEM, V273, P24322, DOI 10.1074/jbc.273.38.24322; Chung DA, 2002, BIOCHEM BIOPH RES CO, V293, P1233, DOI 10.1016/S0006-291X(02)00357-1; Fredriksson R, 2003, MOL PHARMACOL, V63, P1256, DOI 10.1124/mol.63.6.1256; Hamid YH, 2005, DIABETIC MED, V22, P74, DOI 10.1111/j.1464-5491.2005.01505.x; Hudson BD, 2013, MOL ENDOCRINOL, V27, P1177, DOI 10.1210/me.2013-1085; Itoh Y, 2003, NATURE, V422, P173, DOI 10.1038/nature01478; Kotarsky K, 2003, BIOCHEM BIOPH RES CO, V301, P406, DOI 10.1016/S0006-291X(02)03064-4; Kuna RS, 2013, AM J PHYSIOL-ENDOC M, V305, pE161, DOI 10.1152/ajpendo.00551.2012; Li C, 2010, CELL PHYSIOL BIOCHEM, V26, P187, DOI 10.1159/000320527; Lu ZL, 1997, MOL PHARMACOL, V51, P234, DOI 10.1124/mol.51.2.234; Milligan G, 2006, CELL SIGNAL, V18, P1360, DOI 10.1016/j.cellsig.2006.03.011; Nadeau DA, 2013, POSTGRAD MED, V125, DOI 10.3810/pgm.2013.05.2666; Ogawa T, 2005, METABOLISM, V54, P296, DOI 10.1016/j.metabol.2004.09.008; Rovati GE, 2007, MOL PHARMACOL, V71, P959, DOI 10.1124/mol.106.029470; Scheer A, 2000, MOL PHARMACOL, V57, P219; Shibata T, 1996, BIOCHEM BIOPH RES CO, V218, P383, DOI 10.1006/bbrc.1996.0067; Smith NJ, 2009, J BIOL CHEM, V284, P17527, DOI 10.1074/jbc.M109.012849; Steneberg R, 2005, CELL METAB, V1, P245, DOI 10.1016/j.cmet.2005.03.007; Suzuki T, 2008, J MED CHEM, V51, P7640, DOI 10.1021/jm800970b; Tan CP, 2008, DIABETES, V57, P2211, DOI 10.2337/db08-0130; Tran TM, 2007, MOL PHARMACOL, V71, P47, DOI 10.1124/mol.106.028456; Vettor R, 2008, J CLIN ENDOCR METAB, V93, P3541, DOI 10.1210/jc.2007-2680; Wong SKF, 2003, NEUROSIGNALS, V12, P1, DOI 10.1159/000068914; Zhang SY, 2014, ACTA PHARMACOL SIN, V35, P540, DOI 10.1038/aps.2014.8; Zhang SY, 2014, P NATL ACAD SCI USA, V111, P14571, DOI 10.1073/pnas.1324130111; ZHU SZ, 1994, MOL PHARMACOL, V45, P517	32	8	9	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2015	10	10							e0141303	10.1371/journal.pone.0141303	http://dx.doi.org/10.1371/journal.pone.0141303			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU8PC	26505901	Green Published, Green Submitted, gold			2022-12-26	WOS:000363804200045
J	Sehgal, V; Seviour, EG; Moss, TJ; Mills, GB; Azencott, R; Ram, PT				Sehgal, Vasudha; Seviour, Elena G.; Moss, Tyler J.; Mills, Gordon B.; Azencott, Robert; Ram, Prahlad T.			Robust Selection Algorithm (RSA) for Multi-Omic Biomarker Discovery; Integration with Functional Network Analysis to Identify miRNA Regulated Pathways in Multiple Cancers	PLOS ONE			English	Article							MICRORNA SIGNATURE; PROGNOSTIC VALUE; EXPRESSION; RNAS; TARGET	MicroRNAs (miRNAs) play a crucial role in the maintenance of cellular homeostasis by regulating the expression of their target genes. As such, the dysregulation of miRNA expression has been frequently linked to cancer. With rapidly accumulating molecular data linked to patient outcome, the need for identification of robust multi-omic molecular markers is critical in order to provide clinical impact. While previous bioinformatic tools have been developed to identify potential biomarkers in cancer, these methods do not allow for rapid classification of oncogenes versus tumor suppressors taking into account robust differential expression, cutoffs, p-values and non-normality of the data. Here, we propose a methodology, Robust Selection Algorithm (RSA) that addresses these important problems in big data omics analysis. The robustness of the survival analysis is ensured by identification of optimal cutoff values of omics expression, strengthened by p-value computed through intensive random resampling taking into account any non-normality in the data and integration into multi-omic functional networks. Here we have analyzed pan-cancer miRNA patient data to identify functional pathways involved in cancer progression that are associated with selected miRNA identified by RSA. Our approach demonstrates the way in which existing survival analysis techniques can be integrated with a functional network analysis framework to efficiently identify promising biomarkers and novel therapeutic candidates across diseases.	[Sehgal, Vasudha; Seviour, Elena G.; Moss, Tyler J.; Mills, Gordon B.; Ram, Prahlad T.] Univ Texas MD Anderson Canc Ctr, Dept Syst Biol, Houston, TX 77030 USA; [Azencott, Robert] Univ Houston, Dept Math, Houston, TX 77204 USA	University of Texas System; UTMD Anderson Cancer Center; University of Houston System; University of Houston	Ram, PT (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Syst Biol, Houston, TX 77030 USA.	pram@mdanderson.org		Seviour, Elena/0000-0003-2885-4246; Ram, Prahlad/0000-0003-4739-3166	National Institutes of Health (NIH) [U54-CA112970]; Blanton-Davis Ovarian Cancer Foundation; Keck Center of the Gulf Coast Consortium [NLM T15LM007093]; Odyssey Program at The University of Texas MD Anderson Cancer Center; CPRIT Computational Cancer Biology Training Program [CPRIT RP101489]; NATIONAL CANCER INSTITUTE [U54CA112970] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [T15LM007093] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Blanton-Davis Ovarian Cancer Foundation; Keck Center of the Gulf Coast Consortium; Odyssey Program at The University of Texas MD Anderson Cancer Center; CPRIT Computational Cancer Biology Training Program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	The work presented here is partly supported by National Institutes of Health (NIH) U54-CA112970 and the Blanton-Davis Ovarian Cancer Foundation (PTR). TJM is supported by a training fellowship from the Keck Center of the Gulf Coast Consortium (NLM T15LM007093) and the Odyssey Program at The University of Texas MD Anderson Cancer Center. VS is supported by a training fellowship from the CPRIT Computational Cancer Biology Training Program (CPRIT RP101489).	Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Fabian MR, 2012, NAT STRUCT MOL BIOL, V19, P586, DOI 10.1038/nsmb.2296; Goswami Chirayu Pankaj, 2012, J Clin Bioinforma, V2, P23, DOI 10.1186/2043-9113-2-23; Hong L, 2014, EXPERT OPIN BIOL TH, V14, P483, DOI 10.1517/14712598.2014.882896; Hong L, 2013, EXPERT OPIN THER TAR, V17, P1073, DOI 10.1517/14728222.2013.819853; Jacobsen A, 2013, NAT STRUCT MOL BIOL, V20, P1325, DOI 10.1038/nsmb.2678; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Komurov K, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-282; Krichevsky AM, 2009, J CELL MOL MED, V13, px, DOI 10.1111/j.1582-4934.2008.00556.x; Lai EC, 2002, NAT GENET, V30, P363, DOI 10.1038/ng865; Lee YS, 2009, ANNU REV PATHOL-MECH, V4, P199, DOI 10.1146/annurev.pathol.4.110807.092222; Lehmann U, 2008, J PATHOL, V214, P17, DOI 10.1002/path.2251; Li XL, 2014, J TRANSL MED, V12, DOI 10.1186/1479-5876-12-159; Liu N, 2014, INT J CANCER, V134, P1359, DOI 10.1002/ijc.28468; Liu N, 2012, LANCET ONCOL, V13, DOI 10.1016/S1470-2045(12)70102-X; Mavrakis KJ, 2010, NAT CELL BIOL, V12, P372, DOI 10.1038/ncb2037; Rico-Rosillo Maria Guadalupe, 2014, Rev Med Inst Mex Seguro Soc, V52, P302; Szymaski M, 2003, INT REV CYTOL, V231, P197, DOI 10.1016/S0074-7696(03)31005-8; Takamizawa J, 2004, CANCER RES, V64, P3753, DOI 10.1158/0008-5472.CAN-04-0637; Thomas LF, 2014, BIOINFORMATICS, V30, P2243, DOI 10.1093/bioinformatics/btu257; Tsang WP, 2008, APOPTOSIS, V13, P1215, DOI 10.1007/s10495-008-0256-z; Tutar L, 2014, CURR PHARM BIOTECHNO, V15, P430, DOI 10.2174/1389201015666140519095304; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; van Vliet MH, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-375; Wang L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096472; Wang Y, 2014, GENE, V533, P389, DOI 10.1016/j.gene.2013.09.038; Zeng Y, 2002, MOL CELL, V9, P1327, DOI 10.1016/S1097-2765(02)00541-5; Zhang BH, 2007, DEV BIOL, V302, P1, DOI 10.1016/j.ydbio.2006.08.028; Zhang JX, 2013, LANCET ONCOL, V14, P1295, DOI 10.1016/S1470-2045(13)70491-1; Zhang L, 2006, P NATL ACAD SCI USA, V103, P9136, DOI 10.1073/pnas.0508889103	30	8	8	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2015	10	10							e0140072	10.1371/journal.pone.0140072	http://dx.doi.org/10.1371/journal.pone.0140072			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU8PC	26505200	Green Submitted, Green Published, gold			2022-12-26	WOS:000363804200008
J	Sloan, AM; Fink, MK; Rodriguez, AJ; Lovitz, AM; Khodaparast, N; Rennaker, RL; Hays, SA				Sloan, Andrew M.; Fink, Melyssa K.; Rodriguez, Amber J.; Lovitz, Adam M.; Khodaparast, Navid; Rennaker, Robert L.; Hays, Seth A.			A Within-Animal Comparison of Skilled Forelimb Assessments in Rats	PLOS ONE			English	Article							VAGUS NERVE-STIMULATION; REACHING TASK; AUTOMATED-METHOD; STROKE; RECOVERY; MODEL; ENDOTHELIN-1; STRENGTH; MICE	A variety of skilled reaching tasks have been developed to evaluate forelimb function in rodent models. The single pellet skilled reaching task and pasta matrix task have provided valuable insight into recovery of forelimb function in models of neurological injury and disease. Recently, several automated measures have been developed to reduce the cost and time burden of forelimb assessment in rodents. Here, we provide a within-subject comparison of three common forelimb assessments to allow direct evaluation of sensitivity and efficiency across tasks. Rats were trained to perform the single pellet skilled reaching task, the pasta matrix task, and the isometric pull task. Once proficient on all three tasks, rats received an ischemic lesion of motor cortex and striatum to impair use of the trained limb. On the second week post-lesion, all three tasks measured a significant deficit in forelimb function. Performance was well-correlated across tasks. By the sixth week post-lesion, only the isometric pull task measured a significant deficit in forelimb function, suggesting that this task is more sensitive to chronic impairments. The number of training days required to reach asymptotic performance was longer for the isometric pull task, but the total experimenter time required to collect and analyze data was substantially lower. These findings suggest that the isometric pull task represents an efficient, sensitive measure of forelimb function to facilitate preclinical evaluation in models of neurological injury and disease.	[Sloan, Andrew M.] Vulintus Inc, Dallas, TX 75252 USA; [Sloan, Andrew M.; Rennaker, Robert L.] Univ Texas Dallas, Texas Biomed Device Ctr, Richardson, TX 75083 USA; [Fink, Melyssa K.; Lovitz, Adam M.; Khodaparast, Navid] Univ Texas Dallas, Brain & Behav Sci, Richardson, TX 75083 USA; [Rodriguez, Amber J.] Univ Texas SW Med Ctr Dallas, Neurol & Neurotherapeut, Dallas, TX 75390 USA; [Rennaker, Robert L.; Hays, Seth A.] Univ Texas Dallas, Bioengn, Richardson, TX 75083 USA	University of Texas System; University of Texas Dallas; University of Texas System; University of Texas Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas	Sloan, AM (corresponding author), Vulintus Inc, Dallas, TX 75252 USA.	drewsloan@utdallas.edu	Hays, Seth/U-4701-2019; Rennaker II, Robert/K-9049-2013	Hays, Seth/0000-0003-4225-241X; Rennaker II, Robert/0000-0003-1260-1973	Small Business Innovation Research (SBIR); National Institute of Neurological Disorders and Stroke of the National Institutes of Health [R44NS086344]; Vulintus, Inc.; Defense Advanced Research Project Agency [HR0011-15-2-0017]; Texas Biomedical Device Center;  [R01NS085167]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R44NS086344, R01NS085167] Funding Source: NIH RePORTER	Small Business Innovation Research (SBIR)(United States Department of Agriculture (USDA)); National Institute of Neurological Disorders and Stroke of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Vulintus, Inc.; Defense Advanced Research Project Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Texas Biomedical Device Center; ; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Research reported in this publication was supported by a Small Business Innovation Research (SBIR) grant made to Vulintus, Inc. by the National Institute of Neurological Disorders and Stroke of the National Institutes of Health under Award Number R44NS086344 to develop products based on this research. Vulintus, Inc. provided support under this award in the form of salaries for authors (AMS, MKF). Authors supported by Vulintus, Inc. participated in study design, data collection and analysis, and preparation of the manuscript, as articulated in the author contributions' section. Vulintus, Inc. did not have any additional role in the decision to publish. Research was also supported by R01NS085167 (RLR), the Defense Advanced Research Project Agency under Award Number HR0011-15-2-0017 (SAH, RLR), and the Texas Biomedical Device Center (RLR). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health, the Defense Advanced Research Project Agency, or the Texas Biomedical Device Center.	Alaverdashvili M, 2013, NEUROSCI BIOBEHAV R, V37, P950, DOI 10.1016/j.neubiorev.2013.03.026; Ballermann M, 2001, J NEUROSCI METH, V106, P39, DOI 10.1016/S0165-0270(01)00326-0; Braun RG, 2012, NEUROREHAB NEURAL RE, V26, P898, DOI 10.1177/1545968312446004; Buitrago MM, 2004, BEHAV BRAIN RES, V155, P249, DOI 10.1016/j.bbr.2004.04.025; Hays SA, 2014, NEUROREPORT, V25, P676, DOI 10.1097/WNR.0000000000000154; Hays SA, 2013, J NEUROSCI METH, V214, P52, DOI 10.1016/j.jneumeth.2012.12.022; Hays SA, 2013, J NEUROSCI METH, V212, P329, DOI 10.1016/j.jneumeth.2012.11.007; Khodaparast N, 2013, NEUROBIOL DIS, V60, P80, DOI 10.1016/j.nbd.2013.08.002; Khodaparast N, 2014, NEUROREHAB NEURAL RE, V28, P698, DOI 10.1177/1545968314521006; Lai S, 2015, NEUROREHAB NEURAL RE, V29, P382, DOI 10.1177/1545968314545174; Metz GAS, 2000, BEHAV BRAIN RES, V116, P111, DOI 10.1016/S0166-4328(00)00245-X; Palmer T, 2012, J NEUROSCI METH, V205, P334, DOI 10.1016/j.jneumeth.2012.01.008; Pruitt D, 2015, J NEUROTRAUMA; Rodriguez LC, 2014, MATERIALS, V7, P6779, DOI 10.3390/ma7096779; Tennant KA, 2009, J NEUROSCI METH, V181, P18, DOI 10.1016/j.jneumeth.2009.04.009; WHISHAW IQ, 1990, BEHAV BRAIN RES, V41, P49, DOI 10.1016/0166-4328(90)90053-H; WHISHAW IQ, 1986, BRAIN, V109, P805, DOI 10.1093/brain/109.5.805; Windle V, 2006, EXP NEUROL, V201, P324, DOI 10.1016/j.expneurol.2006.04.012; Winstein CJ, 2004, ARCH PHYS MED REHAB, V85, P620, DOI 10.1016/j.apmr.2003.06.027; Wong CC, 2015, J NEUROSCI METH, V246, P30, DOI 10.1016/j.jneumeth.2015.03.008; Xu TH, 2009, NATURE, V462, P915, DOI 10.1038/nature08389	21	15	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2015	10	10							e0141254	10.1371/journal.pone.0141254	http://dx.doi.org/10.1371/journal.pone.0141254			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU8PC	26506434	gold, Green Published, Green Submitted			2022-12-26	WOS:000363804200038
J	Takahashi, K; Watanabe, K				Takahashi, Kohske; Watanabe, Katsumi			Mental Summation of Temporal Duration within and across Senses	PLOS ONE			English	Article							OPERATIONAL MOMENTUM; TIME PERCEPTION; LENGTH PERCEPTION; SEGMENTS MODEL; WEIGHTED SUM; MAGNITUDE; JUDGMENT; MEMORY; LINE	Perceiving, memorizing, and estimating temporal durations are key cognitive functions in everyday life. In this study, a duration summation paradigm was used to examine whether summation of temporal durations introduces an underestimation or overestimation bias, and whether this bias is common to visual and auditory modalities. Two within-or acrossmodality stimuli were presented sequentially for variable durations. Participants were asked to reproduce the sum of the two durations (0.6-1.1 s). We found that the sum of two durations was overestimated regardless of stimulus modalities. A subsequent control experiment indicated that the overestimation bias arose from the summation process, not perceptual or memory processes. Furthermore, we observed strong positive correlations between the overestimation bias for different sensory modalities within participants. These results suggest that the sum of two durations is overestimated, and that supra-modal processes may be responsible for this overestimation bias.	[Takahashi, Kohske; Watanabe, Katsumi] Univ Tokyo, Adv Sci & Technol Res Ctr, Meguro Ku, Tokyo, Japan	University of Tokyo	Takahashi, K (corresponding author), Univ Tokyo, Adv Sci & Technol Res Ctr, Meguro Ku, Tokyo, Japan.	ktakahashi@fennel.rcast.u-tokyo.ac.jp	takahashi, kohske/L-6388-2019	takahashi, kohske/0000-0001-6076-4828; Watanabe, Katsumi/0000-0003-1282-9994	JST (Japan Science and Technology Agency) CREST; JSPS (Japan Society for the Promotion of Science) KAKENHI [25700013]	JST (Japan Science and Technology Agency) CREST(Japan Science & Technology Agency (JST)); JSPS (Japan Society for the Promotion of Science) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was partially supported by JST (Japan Science and Technology Agency) CREST (to KW) and JSPS (Japan Society for the Promotion of Science) KAKENHI (25700013 to KT).	Allman MJ, 2014, ANNU REV PSYCHOL, V65, P743, DOI 10.1146/annurev-psych-010213-115117; Block RA, 2010, ACTA PSYCHOL, V134, P330, DOI 10.1016/j.actpsy.2010.03.006; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Bryce D, 2015, ACTA PSYCHOL, V156, P83, DOI 10.1016/j.actpsy.2014.12.007; Bueti D., 2014, TIMING TIME PERCEPT, V2, P261, DOI [10.1163/22134468-00002023, DOI 10.1163/22134468-00002023]; Buhusi CV, 2005, NAT REV NEUROSCI, V6, P755, DOI 10.1038/nrn1764; Charras P, 2010, PSYCHOL RES-PSYCH FO, V74, P196, DOI 10.1007/s00426-009-0243-1; Charras P, 2009, PERCEPTION, V38, P1428, DOI 10.1068/p6287; Chen KM, 2009, ACTA PSYCHOL, V130, P225, DOI 10.1016/j.actpsy.2008.12.008; Droit-Volet S, 2007, J EXP CHILD PSYCHOL, V97, P246, DOI 10.1016/j.jecp.2007.02.003; Eagleman DM, 2009, PHILOS T R SOC B, V364, P1841, DOI 10.1098/rstb.2009.0026; Enns JT, 1999, J GEN PSYCHOL, V126, P355, DOI 10.1080/00221309909595371; Fortin C, 2000, J EXP PSYCHOL HUMAN, V26, P1788, DOI 10.1037/0096-1523.26.6.1788; Fortin C, 2005, J EXP PSYCHOL HUMAN, V31, P276, DOI 10.1037/0096-1523.31.2.276; FREYD JJ, 1984, J EXP PSYCHOL LEARN, V10, P126, DOI 10.1037/0278-7393.10.1.126; Gaudreault R, 2010, ACTA PSYCHOL, V133, P3, DOI 10.1016/j.actpsy.2009.07.013; Gil S, 2012, COGNITION EMOTION, V26, P847, DOI 10.1080/02699931.2011.625401; GOLDSTON.S, 1974, PERCEPT MOTOR SKILL, V39, P63, DOI 10.2466/pms.1974.39.1.63; Grondin S, 2005, J EXP PSYCHOL HUMAN, V31, P869, DOI 10.1037/0096-1523.31.5.869; Grondin S, 2010, ATTEN PERCEPT PSYCHO, V72, P561, DOI 10.3758/APP.72.3.561; Hagura N, 2012, P ROY SOC B-BIOL SCI, V279, P4399, DOI 10.1098/rspb.2012.1339; Heron J, 2012, P ROY SOC B-BIOL SCI, V279, P690, DOI 10.1098/rspb.2011.1131; Ivry RB, 2008, TRENDS COGN SCI, V12, P273, DOI 10.1016/j.tics.2008.04.002; Kleiner M., 2007, WHATS NEW PSYCHTOOLB; Knops A, 2014, Q J EXP PSYCHOL, V67, P1541, DOI 10.1080/17470218.2014.890234; Knops A, 2009, ATTEN PERCEPT PSYCHO, V71, P803, DOI 10.3758/APP.71.4.803; Lapid E, 2009, PSYCHON B REV, V16, P382, DOI 10.3758/PBR.16.2.382; Matthews WJ, 2013, COGNITIVE PSYCHOL, V66, P259, DOI 10.1016/j.cogpsych.2013.01.001; McCrink K, 2007, PERCEPT PSYCHOPHYS, V69, P1324, DOI 10.3758/BF03192949; Nobre AC, 2004, TRENDS COGN SCI, V8, P387, DOI 10.1016/j.tics.2004.07.005; Noulhiane M, 2009, EUR J COGN PSYCHOL, V21, P18, DOI 10.1080/09541440701825981; Ortega L, 2009, BEHAV PROCESS, V81, P270, DOI 10.1016/j.beproc.2009.02.009; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Pinhas M, 2008, COGNITION, V109, P408, DOI 10.1016/j.cognition.2008.09.003; Rao SM, 2001, NAT NEUROSCI, V4, P317, DOI 10.1038/85191; Rattat AC, 2012, PSYCHOL RES-PSYCH FO, V76, P32, DOI 10.1007/s00426-011-0326-7; Seifried T, 2011, ATTEN PERCEPT PSYCHO, V73, P68, DOI 10.3758/s13414-010-0005-6; Takahashi K, 2012, ATTEN PERCEPT PSYCHO, V74, P1623, DOI 10.3758/s13414-012-0347-3; Viau-Quesnel C, 2014, TIMING TIME PERCEPTI, V2, P129, DOI [10.1163/22134468-00002019, DOI 10.1163/22134468-00002019]; Walsh V, 2003, TRENDS COGN SCI, V7, P483, DOI 10.1016/j.tics.2003.09.002	40	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2015	10	10							e0141466	10.1371/journal.pone.0141466	http://dx.doi.org/10.1371/journal.pone.0141466			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CU8PC	26506613	Green Published, gold, Green Submitted			2022-12-26	WOS:000363804200073
J	Yong, WH; Shabihkhani, M; Telesca, D; Yang, S; Tso, JL; Menjivar, JC; Wei, BW; Lucey, GM; Mareninov, S; Chen, ZG; Liau, LM; Lai, A; Nelson, SF; Cloughesy, TF; Tso, CL				Yong, William H.; Shabihkhani, Maryam; Telesca, Donatello; Yang, Shuai; Tso, Jonathan L.; Menjivar, Jimmy C.; Wei, Bowen; Lucey, Gregory M.; Mareninov, Sergey; Chen, Zugen; Liau, Linda M.; Lai, Albert; Nelson, Stanley F.; Cloughesy, Timothy F.; Tso, Cho-Lea			Ribosomal Proteins RPS11 and RPS20, Two Stress-Response Markers of Glioblastoma Stem Cells, Are Novel Predictors of Poor Prognosis in Glioblastoma Patients	PLOS ONE			English	Article							ADJUVANT TEMOZOLOMIDE; RECEPTOR EXPRESSION; CANCER; RADIOTHERAPY; CONCOMITANT; BEVACIZUMAB; SURVIVAL; GENES; CONTRIBUTES; RESISTANCE	Glioblastoma stem cells (GSC) co-exhibiting a tumor-initiating capacity and a radio-chemore-sistant phenotype, are a compelling cellmodel for explaining tumor recurrence. We have previously characterized patient-derived, treatment-resistant GSC clones (TRGC) that survived radiochemotherapy. Compared to glucose-dependent, treatment-sensitive GSC clones (TSGC), TRGC exhibited reduced glucose dependence that favor the fatty acid oxidation pathway as their energy source. Using comparative genome-wide transcriptome analysis, a series of defense signatures associated with TRGC survival were identified and verified by siRNA-based gene knockdown experiments that led to loss of cell integrity. In this study, we investigate the prognostic value of defense signatures in glioblastoma (GBM) patients using gene expression analysis with Probeset Analyzer (131 GBM) and The Cancer Genome Atlas (TCGA) data, and protein expression with a tissuemicroarray (50 GBM), yielding the first TRGC-derived prognostic biomarkers for GBM patients. Ribosomal protein S11 (RPS11), RPS20, individually and together, consistently predicted poor survival of newly diagnosed primary GBM tumors when overexpressed at the RNA or protein level [RPS11: Hazard Ratio (HR) = 11.5, p<0.001; RPS20: HR = 4.5, p = 0.03; RPS11+RPS20: HR = 17.99, p = 0.001]. The prognostic significance of RPS11 and RPS20 was further supported by whole tissue section RPS11 immunostaining (27 GBM; HR = 4.05, p = 0.01) and TCGA gene expression data (578 primary GBM; RPS11: HR = 1.19, p = 0.06; RPS20: HR = 1.25, p = 0.02; RPS11+RPS20: HR = 1.43, p = 0.01). Moreover, tumors that exhibited unmethylated O-6-methylguanine-DNA methyltransferase (MGMT) or wild-type isocitrate dehydrogenase 1 (IDH1) were associated with higher RPS11 expression levels [corr (IDH1, RPS11) = 0.64, p = 0.03); [corr (MGMT, RPS11) = 0.52, p = 0.04]. These data indicate that increased expression of RPS11 and RPS20 predicts shorter patient survival. The study also suggests that TRGC are clinically relevant cells that represent resistant tumorigenic clones from patient tumors and that their properties, at least in part, are reflected in poor-prognosis GBM. The screening of TRGC signatures may represent a novel alternative strategy for identifying new prognostic biomarkers.	[Yong, William H.; Shabihkhani, Maryam; Wei, Bowen; Lucey, Gregory M.; Mareninov, Sergey; Nelson, Stanley F.] Univ Calif Los Angeles, Dept Pathol & Lab Med, Los Angeles, CA USA; [Telesca, Donatello] Univ Calif Los Angeles, Dept Biostat, Los Angeles, CA USA; [Yang, Shuai] Guangzhou Mil Command, Gen Hosp, Dept Neurosurg, Guangzhou, Guangdong, Peoples R China; [Yang, Shuai; Tso, Jonathan L.; Menjivar, Jimmy C.; Tso, Cho-Lea] Univ Calif Los Angeles, Dept Surg Surg Oncol, Los Angeles, CA 90095 USA; [Chen, Zugen; Nelson, Stanley F.] Univ Calif Los Angeles, Dept Human Genet, Los Angeles, CA USA; [Yang, Shuai; Liau, Linda M.] Univ Calif Los Angeles, Dept Neurosurg, Los Angeles, CA USA; [Lai, Albert; Cloughesy, Timothy F.] Univ Calif Los Angeles, Dept Neurol Neurooncol, Los Angeles, CA USA; [Yong, William H.; Telesca, Donatello; Liau, Linda M.; Lai, Albert; Nelson, Stanley F.; Cloughesy, Timothy F.; Tso, Cho-Lea] Univ Calif Los Angeles, David Geffen Sch Med, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Southern Theater Command General Hospital; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Tso, CL (corresponding author), Univ Calif Los Angeles, Dept Surg Surg Oncol, Los Angeles, CA 90095 USA.	ctso@mednet.ucla.edu	Nelson, Stanley F/D-4771-2009; Cloughesy, Timothy Francis/AGV-1013-2022	Nelson, Stanley F/0000-0002-2082-3114; Liau, Linda/0000-0002-4053-0052	American Cancer Society [RSG-07-109-01-CCE]; National Cancer Institute [1 R21 CA140912-01]; National Institutes of Health [1DP2OD006444-01]; Art of the Brain Foundation; Henry E. Singleton Cancer Fund; Bradley Zankel Foundation; NATIONAL CANCER INSTITUTE [R01CA179071, R21CA140912] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD006444] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Art of the Brain Foundation; Henry E. Singleton Cancer Fund; Bradley Zankel Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the American Cancer Society (RSG-07-109-01-CCE), National Cancer Institute (1 R21 CA140912-01), National Institutes of Health (1DP2OD006444-01), Art of the Brain Foundation, Henry E. Singleton Cancer Fund, and the Bradley Zankel Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annabi B, 2009, MOL CARCINOGEN, V48, P910, DOI 10.1002/mc.20541; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Bee A, 2006, CLIN CANCER RES, V12, P2061, DOI 10.1158/1078-0432.CCR-05-2445; Bergamini E, 2007, ANN NY ACAD SCI, V1114, P69, DOI 10.1196/annals.1396.020; BUDWITNOVOTNY DA, 1986, CANCER RES, V46, P5419; Cabelof DC, 2003, DNA REPAIR, V2, P295, DOI 10.1016/S1568-7864(02)00219-7; Chen F W, 1999, Int Rev Immunol, V18, P429, DOI 10.3109/08830189909088492; Chinot OL, 2014, NEW ENGL J MED, V370, P709, DOI 10.1056/NEJMoa1308345; Cohen HY, 2004, SCIENCE, V305, P390, DOI 10.1126/science.1099196; Colman RJ, 2009, SCIENCE, V325, P201, DOI 10.1126/science.1173635; Daftuar L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068667; De Bortoli M, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-223; Deisenroth C, 2010, ONCOGENE, V29, P4253, DOI 10.1038/onc.2010.189; Deisenroth Chad, 2011, Genes Cancer, V2, P392, DOI 10.1177/1947601911409737; Dowsett M, 2008, J CLIN ONCOL, V26, P1059, DOI 10.1200/JCO.2007.12.9437; Eramo A, 2006, CELL DEATH DIFFER, V13, P1238, DOI 10.1038/sj.cdd.4401872; FERRARI S, 1990, CANCER RES, V50, P5825; Fontana L, 2010, SCIENCE, V328, P321, DOI 10.1126/science.1172539; FORNACE AJ, 1989, NUCLEIC ACIDS RES, V17, P1215, DOI 10.1093/nar/17.3.1215; Galli R, 2004, CANCER RES, V64, P7011, DOI 10.1158/0008-5472.CAN-04-1364; Gilbert MR, 2014, NEW ENGL J MED, V370, P699, DOI 10.1056/NEJMoa1308573; Han M, 2015, MOL NEUROBIOL; Hartmann C, 2010, ACTA NEUROPATHOL, V120, P707, DOI 10.1007/s00401-010-0781-z; Hegi ME, 2008, J CLIN ONCOL, V26, P4189, DOI 10.1200/JCO.2007.11.5964; Hemmati HD, 2003, P NATL ACAD SCI USA, V100, P15178, DOI 10.1073/pnas.2036535100; Holmberg Olausson Karl, 2012, Cells, V1, P774, DOI 10.3390/cells1040774; Kasai H, 2003, J HISTOCHEM CYTOCHEM, V51, P567, DOI 10.1177/002215540305100502; Kobayashi T, 2006, INT J MOL MED, V18, P161; Kojima T, 2012, AM J PATHOL, V180, P1879, DOI 10.1016/j.ajpath.2012.01.019; Lai A, 2011, J CLIN ONCOL, V29, P142, DOI 10.1200/JCO.2010.30.2729; Laks DR, 2009, STEM CELLS, V27, P980, DOI 10.1002/stem.15; Lee JE, 2011, EXP GERONTOL, V46, P891, DOI 10.1016/j.exger.2011.07.009; Liu QH, 2009, J NEURO-ONCOL, V94, P1, DOI 10.1007/s11060-009-9919-z; Liu Y, 2014, P NATL ACAD SCI USA, V111, pE2414, DOI 10.1073/pnas.1315605111; Lomonaco SL, 2009, INT J CANCER, V125, P717, DOI 10.1002/ijc.24402; Muller FL, 2007, FREE RADICAL BIO MED, V43, P477, DOI 10.1016/j.freeradbiomed.2007.03.034; Murat A, 2008, J CLIN ONCOL, V26, P3015, DOI 10.1200/JCO.2007.15.7164; Nadano D, 2001, BIOCHEMISTRY-US, V40, P15184, DOI 10.1021/bi0108397; Nakata S, 2013, BRAIN PATHOL, V23, P60, DOI 10.1111/j.1750-3639.2012.00618.x; Naora H, 1999, IMMUNOL CELL BIOL, V77, P197, DOI 10.1046/j.1440-1711.1999.00816.x; Ng HK, 1998, PATHOLOGY, V30, P196, DOI 10.1080/00313029800169236; Nobusawa S, 2009, CLIN CANCER RES, V15, P6002, DOI 10.1158/1078-0432.CCR-09-0715; Palacios JA, 2010, J CELL BIOL, V191, P1299, DOI 10.1083/jcb.201005160; Piccirillo SGM, 2006, NATURE, V444, P761, DOI 10.1038/nature05349; POGUEGEILE K, 1991, MOL CELL BIOL, V11, P3842, DOI 10.1128/MCB.11.8.3842; Rasheed B K, 1999, Curr Opin Oncol, V11, P162; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Sanson M, 2009, J CLIN ONCOL, V27, P4150, DOI 10.1200/JCO.2009.21.9832; Shang F, 2011, FREE RADICAL BIO MED, V51, P5, DOI 10.1016/j.freeradbiomed.2011.03.031; Shibahara I, 2013, NEURO-ONCOLOGY, V15, P1151, DOI 10.1093/neuonc/not066; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Stupp R, 2009, LANCET ONCOL, V10, P459, DOI 10.1016/S1470-2045(09)70025-7; Sun LJ, 2004, CURR OPIN CELL BIOL, V16, P119, DOI 10.1016/j.ceb.2004.02.005; Tso CL, 2006, CANCER RES, V66, P159, DOI 10.1158/0008-5472.CAN-05-0077; Vaarala MH, 1998, INT J CANCER, V78, P27, DOI 10.1002/(SICI)1097-0215(19980925)78:1<27::AID-IJC6>3.3.CO;2-A; Wang Q, 2001, GENE, V263, P205, DOI 10.1016/S0378-1119(00)00570-9; Weller M, 2013, NEURO-ONCOLOGY, V15, P4, DOI 10.1093/neuonc/nos273; Weller M, 2009, J CLIN ONCOL, V27, P5743, DOI 10.1200/JCO.2009.23.0805; Wool IG, 1996, TRENDS BIOCHEM SCI, V21, P164, DOI 10.1016/S0968-0004(96)20011-8; Yamamoto T, 2007, PATHOL INT, V57, P1, DOI 10.1111/j.1440-1827.2007.02049.x; Ye F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080397; Yuan XP, 2004, ONCOGENE, V23, P9392, DOI 10.1038/sj.onc.1208311; Zeppernick F, 2008, CLIN CANCER RES, V14, P123, DOI 10.1158/1078-0432.CCR-07-0932	64	37	38	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2015	10	10							e0141334	10.1371/journal.pone.0141334	http://dx.doi.org/10.1371/journal.pone.0141334			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU8PC	26506620	gold, Green Submitted, Green Published			2022-12-26	WOS:000363804200051
J	Sihn, CR; Kim, HJ; Woltz, RL; Yarov-Yarovoy, V; Yang, PC; Xu, J; Clancy, CE; Zhang, XD; Chiamvimonvat, N; Yamoah, EN				Sihn, Choong-Ryoul; Kim, Hyo Jeong; Woltz, Ryan L.; Yarov-Yarovoy, Vladimir; Yang, Pei-Chi; Xu, Jun; Clancy, Colleen E.; Zhang, Xiao-Dong; Chiamvimonvat, Nipavan; Yamoah, Ebenezer N.			Mechanisms of Calmodulin Regulation of Different Isoforms of Kv7.4 K+ Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEARING-LOSS; HAIR-CELLS; POTASSIUM CHANNELS; VOLTAGE SENSOR; PROTEIN INTERACTIONS; ELECTRICAL-ACTIVITY; CALCIUM-CHANNELS; STRUCTURAL BASIS; SODIUM-CHANNEL; CA2+ CHANNEL	Calmodulin (CaM), a Ca2+-sensing protein, is constitutively bound to IQ domains of the C termini of human Kv7 (hKv7, KCNQ) channels to mediate Ca2+-dependent reduction of Kv7 currents. However, the mechanism remains unclear. We report that CaM binds to two isoforms of the hKv7.4 channel in a Ca2+-independent manner but that only the long isoform (hKv7.4a) is regulated by Ca2+/CaM. Ca2+/CaM mediate reduction of the hKv7.4a channel by decreasing the channel open probability and altering activation kinetics. We took advantage of a known missense mutation (G321S) that has been linked to progressive hearing loss to further examine the inhibitory effects of Ca2+/CaM on the Kv7.4 channel. Using multidisciplinary techniques, we demonstrate that the G321S mutation may destabilize CaM binding, leading to a decrease in the inhibitory effects of Ca2+ on the channels. Our study utilizes an expression system to dissect the biophysical properties of the WT and mutant Kv7.4 channels. This report provides mechanistic insights into the critical roles of Ca2+/CaM regulation of the Kv7.4 channel under physiological and pathological conditions.	[Sihn, Choong-Ryoul; Yamoah, Ebenezer N.] Univ Nevada, Sch Med, Dept Physiol & Cell Biol, Program Commun Sci, Reno, NV 89557 USA; [Kim, Hyo Jeong; Woltz, Ryan L.; Zhang, Xiao-Dong; Chiamvimonvat, Nipavan] Univ Calif Davis, Dept Internal Med, Div Cardiovasc Med, Davis, CA 95616 USA; [Yarov-Yarovoy, Vladimir] Univ Calif Davis, Dept Physiol & Membrane Biol, Davis, CA 95616 USA; [Yang, Pei-Chi; Clancy, Colleen E.] Univ Calif Davis, Dept Pharmacol, Davis, CA 95616 USA; [Yarov-Yarovoy, Vladimir; Zhang, Xiao-Dong; Chiamvimonvat, Nipavan] Dept Vet Affairs, Northern Calif Hlth Care Syst, Mather, CA 95655 USA; [Xu, Jun] Tarleton State Univ, Coll Sci & Technol, Dept Engn Technol, Stephenville, TX 76402 USA; Univ Nevada, Dept Physiol & Cell Biol, Program Commun Sci, Reno, NV 89557 USA	Nevada System of Higher Education (NSHE); University of Nevada Reno; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; Texas A&M University System; Tarleton State University; Nevada System of Higher Education (NSHE); University of Nevada Reno	Yamoah, EN (corresponding author), Univ Nevada, Dept Physiol & Cell Biol, Program Commun Sci, Reno, NV 89557 USA.	enyamoah@gmail.com	Yarov-Yarovoy, Vladimir/ABE-5454-2020	Yarov-Yarovoy, Vladimir/0000-0002-2325-4834; woltz, ryan/0000-0002-0446-2478; Chiamvimonvat, Nipavan/0000-0001-9499-8817	National Institutes of Health [R01 DC0100386, R01 DC007592, DC003826, R01 HL085844, R01 HL085727, R01 HL085844-S1]; Department of Veterans Affairs [I01BX000576]; American Heart Association Western States Beginning Grant [14BGIA18870087]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL085844, R01HL085727, R01HL137228] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC003826, R01DC007592] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000576, I01CX001490] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs(US Department of Veterans Affairs); American Heart Association Western States Beginning Grant(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by National Institutes of Health Grants R01 DC0100386, R01 DC007592, and DC003826 (to E. N. Y.); R01 HL085844 and R01 HL085727 (to N. C.); and R01 HL085844-S1 (to R. L. W.). This work was also supported by Department of Veterans Affairs Merit Review Grant I01BX000576 (to N. C.) and American Heart Association Western States Beginning Grant-in-Aid 14BGIA18870087 (to X. D. Z.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alaimo A, 2009, J BIOL CHEM, V284, P20668, DOI 10.1074/jbc.M109.019539; Andre I, 2007, P NATL ACAD SCI USA, V104, P17656, DOI 10.1073/pnas.0702626104; Bahler M, 2002, FEBS LETT, V513, P107, DOI 10.1016/S0014-5793(01)03239-2; Barhanin J, 1996, NATURE, V384, P78, DOI 10.1038/384078a0; Beisel KW, 2005, J NEUROSCI, V25, P9285, DOI 10.1523/JNEUROSCI.2110-05.2005; Bonneau R, 2001, PROTEINS, V43, P1, DOI 10.1002/1097-0134(20010401)43:1<1::AID-PROT1012>3.0.CO;2-A; Bushell KM, 2008, GENOME RES, V18, P622, DOI 10.1101/gr.7187808; Coucke PJ, 1999, HUM MOL GENET, V8, P1321, DOI 10.1093/hmg/8.7.1321; Dick IE, 2008, NATURE, V451, P830, DOI 10.1038/nature06529; Erickson MG, 2003, NEURON, V39, P97, DOI 10.1016/S0896-6273(03)00395-7; Etxeberria A, 2008, FASEB J, V22, P1135, DOI 10.1096/fj.07-9712com; Gamper N, 2005, MOL BIOL CELL, V16, P3538, DOI 10.1091/mbc.E04-09-0849; Gamper N, 2003, J GEN PHYSIOL, V122, P17, DOI 10.1085/jgp.200208783; GEISER JR, 1991, CELL, V65, P949, DOI 10.1016/0092-8674(91)90547-C; Geleoc GSG, 2004, J NEUROSCI, V24, P11148, DOI 10.1523/JNEUROSCI.2662-04.2004; Ghosh S, 2006, CIRC RES, V98, P1048, DOI 10.1161/01.RES.0000218863.44140.f2; Haitin Y, 2008, J PHYSIOL-LONDON, V586, P1803, DOI 10.1113/jphysiol.2007.149187; Howard RJ, 2007, NEURON, V53, P663, DOI 10.1016/j.neuron.2007.02.010; Hurley KM, 2006, J NEUROSCI, V26, P10253, DOI 10.1523/JNEUROSCI.2596-06.2006; Kalluri R, 2010, J NEUROPHYSIOL, V104, P2034, DOI 10.1152/jn.00396.2010; Kim HJ, 2011, J BIOL CHEM, V286, P1517, DOI 10.1074/jbc.M110.179010; Long SB, 2005, SCIENCE, V309, P903, DOI 10.1126/science.1116270; Long SB, 2007, NATURE, V450, P376, DOI 10.1038/nature06265; Lu Z, 2002, J GEN PHYSIOL, V120, P663, DOI 10.1085/jgp.20028696; Lv P, 2010, J BIOL CHEM, V285, P34699, DOI 10.1074/jbc.M110.136192; Mandell DJ, 2009, NAT METHODS, V6, P551, DOI 10.1038/nmeth0809-551; Maylie J, 2004, J PHYSIOL-LONDON, V554, P255, DOI 10.1113/jphysiol.2003.049072; Mencia A, 2008, HUM GENET, V123, P41, DOI 10.1007/s00439-007-0447-7; Mooseker MS, 1995, ANNU REV CELL DEV BI, V11, P633, DOI 10.1146/annurev.cellbio.11.1.633; Neyroud N, 1997, NAT GENET, V15, P186, DOI 10.1038/ng0297-186; PASIC TR, 1989, J COMP NEUROL, V283, P474, DOI 10.1002/cne.902830403; Peterson BZ, 1999, NEURON, V22, P549, DOI 10.1016/S0896-6273(00)80709-6; Roehm PC, 2008, MOL CELL NEUROSCI, V37, P376, DOI 10.1016/j.mcn.2007.10.014; Rohl CA, 2004, METHOD ENZYMOL, V383, P66; Rothman JS, 2003, J NEUROPHYSIOL, V89, P3097, DOI 10.1152/jn.00127.2002; Rusch A, 1998, J NEUROSCI, V18, P7487; Sanguinetti MC, 1996, NATURE, V384, P80, DOI 10.1038/384080a0; Schuster-Bockler B, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-r9; Schwake M, 2000, J BIOL CHEM, V275, P13343, DOI 10.1074/jbc.275.18.13343; Shamgar L, 2006, CIRC RES, V98, P1055, DOI 10.1161/01.RES.0000218979.40770.69; Sukhareva M, 2003, J GEN PHYSIOL, V122, P541, DOI 10.1085/jgp.200308905; Tadross MR, 2008, CELL, V133, P1228, DOI 10.1016/j.cell.2008.05.025; Van Hauwe P, 2000, AM J MED GENET, V93, P184, DOI 10.1002/1096-8628(20000731)93:3<184::AID-AJMG4>3.0.CO;2-5; Wang C, 2007, J MOL BIOL, V373, P503, DOI 10.1016/j.jmb.2007.07.050; Wen H, 2002, J NEUROSCI, V22, P7991, DOI 10.1523/jneurosci.22-18-07991.2002; Wiener R, 2008, J BIOL CHEM, V283, P5815, DOI 10.1074/jbc.M707541200; Wingo TL, 2004, NAT STRUCT MOL BIOL, V11, P219, DOI 10.1038/nsmb737; Xu Q, 2013, J MOL BIOL, V425, P378, DOI 10.1016/j.jmb.2012.11.023; Xu TH, 2007, J BIOL CHEM, V282, P23899, DOI 10.1074/jbc.M702108200; Yarov-Yarovoy V, 2006, PROTEINS, V62, P1010, DOI 10.1002/prot.20817; Yarov-Yarovoy V, 2006, P NATL ACAD SCI USA, V103, P7292, DOI 10.1073/pnas.0602350103; Yarov-Yarovoy V, 2012, P NATL ACAD SCI USA, V109, pE93, DOI 10.1073/pnas.1118434109; Yus-Najera E, 2002, J BIOL CHEM, V277, P28545, DOI 10.1074/jbc.M204130200	53	10	10	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 29	2016	291	5					2499	2509		10.1074/jbc.M115.668236	http://dx.doi.org/10.1074/jbc.M115.668236			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DD0LB	26515070	Green Published, hybrid			2022-12-26	WOS:000369610400037
J	Navarro, JJ; Garcia-Rubio, J; Olivares, PR				Navarro, Juan-Jose; Garcia-Rubio, Javier; Olivares, Pedro R.			The Relative Age Effect and Its Influence on Academic Performance	PLOS ONE			English	Article							ACHIEVEMENT; SCHOOL; BIRTH; SEASON; EDUCATION; CHILDREN; SPORT	Introduction and Purpose The policy of school organisation for grouping students in the same academic year is based on date of birth. The differences in the experiences and maturation of older students involve a relatively better performance in academic settings, which is known as the relative age effect (RAE). This effect is more important the younger the student is. The goal of this study is to identify the connections of influence that RAE, socioeconomic status (SES), and type of institution have on academic performance in a school population of eighth graders. Methods The study is based on a population-based, representative sample of 15,234 8th graders (50.4% female; average age = 13.61 years) in the 2011 National System of Quality Assessment in Education Survey (SIMCE) from Chile. The SIMCE for global academic performance consists of 4 tests: reading, mathematics, social studies, and science. All tests consist of multiple-choice and closed questions. In addition, in order to have the information of general academic performance, an extra variable expressing the average score of each student was created. Also, the SIMCE includes additional variables for the evaluation process such as SES or type of school. Students were assigned to one of five age groups in terms of date of birth (G1, G2, G3, G4, and G5), in which students belonging to G1 are the oldest and students belonging to G5 are the youngest. Results The results achieved in the structural equation modelling indicate a good global fit. Individual relationships show significant effects of the three variables observed on academic performance, although SES received the highest values. The influence of RAE took place both in the full sample and sub-samples composed according to the SES and academic performance, showing higher values for students with lower scores. Although the influence of RAE decreases when SES is controlled, its effect is still significant and contributes to additionally explain the performance. Conclusions The RAE remains, even with residual values, an explanatory factor in academic performance even in eighth graders. Since the RAE decreases as the influence of schooling increases, the potential adverse effects for some students would be placed in previous and initial moments of formal schooling. These findings may be useful into taking steps towards flexibilisation on age of entry in compulsory schooling. Moreover, the need to implement early, comprehensive evaluation systems which include aspects related to neurodevelopment in order to provide maximum information to parents and educators is also drawn.	[Navarro, Juan-Jose] Univ Autonoma Chile, Inst Estudios Ciencias Educ, Santiago, Chile; [Navarro, Juan-Jose] Univ Seville, Fac Psicol, Individual Differences Language & Cognit LAB, Seville, Spain; [Garcia-Rubio, Javier; Olivares, Pedro R.] Univ Autonoma Chile, Inst Act Fis & Salud, Santiago, Chile	Universidad Autonoma de Chile; University of Sevilla; Universidad Autonoma de Chile	Navarro, JJ (corresponding author), Univ Autonoma Chile, Inst Estudios Ciencias Educ, Santiago, Chile.	jjnavarro@us.es	Hidalgo, Juan José Navarro/J-4841-2014; García, Javier/AAA-9006-2019; Olivares, Pedro R/C-6287-2008; García-Rubio, Javier/H-3679-2016	Hidalgo, Juan José Navarro/0000-0002-3249-1479; Olivares, Pedro R/0000-0001-7371-343X; García-Rubio, Javier/0000-0001-6426-0002				Alvarez A, 2013, CULT EDUC, V25, P137, DOI 10.1174/113564013806631309; Bedard K, 2006, Q J ECON, V121, P1437, DOI 10.1162/qjec.121.4.1437; Bickman L., 1998, HDB APPL SOCIAL RES, pIX; BROWNE MW, 1984, BRIT J MATH STAT PSY, V37, P62, DOI 10.1111/j.2044-8317.1984.tb00789.x; Cervera V, 2013, REV PSICOL DEPORTE, V22, P447; Chandler R.E., 2011, STAT METHODS TREND D; Cobley S, 2009, SPORTS MED, V39, P235, DOI 10.2165/00007256-200939030-00005; Daniels S, 2000, OXFORD REV EDUC, V26, P207, DOI 10.1080/713688530; Dhuey E, 2008, ECON EDUC REV, V27, P173, DOI 10.1016/j.econedurev.2006.08.005; Calero MD, 2013, PSYCHOL SCHOOLS, V50, P705, DOI 10.1002/pits.21701; Educacion Md, 2012, INF RES ED FIS SIMCE, P1; GLEDHILL J, 2002, RES EDUC, V68, P41, DOI DOI 10.7227/RIE.68.4; Hsieh CT, 2006, J PUBLIC ECON, V90, P1477, DOI 10.1016/j.jpubeco.2005.11.002; Garcia-Perez JI, 2014, APPL ECON, V46, P1373, DOI 10.1080/00036846.2013.872761; Jussim L, 2005, PERS SOC PSYCHOL REV, V9, P131, DOI 10.1207/s15327957pspr0902_3; Kline RB, 2005, PRINCIPLES PRACTICE; Lawlor DA, 2006, BRIT J EDUC PSYCHOL, V76, P481, DOI 10.1348/000709905X49700; Lien L, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-102; Lukas J. F., 2004, EVALUACION ED; Luria A, 1983, FUNDAMENTOS PSICOFIS, P299; Marti E., 1999, DESARROLLO PSICOLOGI, VI, P329; Martin CM, 2006, EVALUACION SISTEMA E, P55; Martin RP, 2004, J LEARN DISABIL-US, V37, P307, DOI 10.1177/00222194040370040301; Moyano J, 2012, PRESENTACION GRUPOS; Musch J, 2001, DEV REV, V21, P147, DOI 10.1006/drev.2000.0516; MUTHEN B, 1985, BRIT J MATH STAT PSY, V38, P171, DOI 10.1111/j.2044-8317.1985.tb00832.x; OCDE, 2009, PROGR INT STUD ASS; Palacios J., 1999, DESARROLLO PSICOLOGI, P23; Puhani PA, 2008, STUD EMPIRIC ECON, P105, DOI 10.1007/978-3-7908-2022-5_6; REYNOLDS AJ, 1992, J RES MATH EDUC, V23, P306, DOI 10.2307/749308; Rogoff B., 1990, APPRENTICESHIP THINK; RUSSELL RJH, 1986, PERS INDIV DIFFER, V7, P839, DOI 10.1016/0191-8869(86)90082-6; Seguel Ximena, 2012, Psykhe, V21, P87; SHARP C, 1994, EDUC RES, V36, P107, DOI 10.1080/0013188940360201; SIMCE, 2012, INF TECN SIMC 2011; Sirin SR, 2005, REV EDUC RES, V75, P417, DOI 10.3102/00346543075003417; Sternberg R. J., 2002, DYNAMIC TESTING NATU; Strom B., 2004, STUDENT ACHIEVEMENT; UNESCO, 2013, AG ED POST 2015; Veldhuizen S, 2014, J SPORTS SCI, P1; Verachtert P, 2010, OXFORD REV EDUC, V36, P285, DOI 10.1080/03054981003629896; Vygotski L. S., 1934, OBRAS ESCOGIDAS, VI, P133; Wattie N, 2014, EUROPEAN PHYS ED REV; Wattie N, 2008, J SPORT SCI, V26, P1403, DOI 10.1080/02640410802233034; Wenglinsky H, 1998, EDUC EVAL POLICY AN, V20, P269, DOI 10.2307/1164325	45	35	35	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2015	10	10							e0141895	10.1371/journal.pone.0141895	http://dx.doi.org/10.1371/journal.pone.0141895			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CV0EH	26517552	Green Published, gold, Green Submitted			2022-12-26	WOS:000363920800091
J	Wu, J; Lu, CJ; Li, X; Fang, H; Wan, WC; Yang, QH; Sun, XS; Wang, ML; Hu, XH; Chen, CYO; Wei, XY				Wu, Jie; Lu, Chuanjun; Li, Xue; Fang, Hua; Wan, Wencheng; Yang, Qiaohong; Sun, Xiaosheng; Wang, Meiling; Hu, Xiaohong; Chen, C. -Y. Oliver; Wei, Xiaoyong			Synthesis and Biological Evaluation of Novel Gigantol Derivatives as Potential Agents in Prevention of Diabetic Cataract	PLOS ONE			English	Article							ALDOSE REDUCTASE INHIBITORS; EPITHELIAL-CELL APOPTOSIS; UNFOLDED PROTEIN RESPONSE; NITRIC-OXIDE SYNTHASE; SCAPHYGLOTTIS-LIVIDA; ANTIOXIDANT ACTIVITY; COMPLICATIONS; EXPRESSION; ANALOGS; DESIGN	As a continuation of our efforts directed towards the development of natural anti-diabetic cataract agents, gigantol was isolated from Herba dendrobii and was found to inhibit both aldose reductase (AR) and inducible nitric oxide synthase (iNOS) activity, which play a significant role in the development and progression of diabetic cataracts. To improve its bioefficacy and facilitate use as a therapeutic agent, gigantol (compound 14f) and a series of novel analogs were designed and synthesized. Analogs were formulated to have different substituents on the phenyl ring (compounds 4, 5, 8, 14a-e), substitute the phenyl ring with a larger steric hindrance ring (compounds 10, 17c) or modify the carbon chain (compounds 17a, 17b, 21, 23, 25). All of the analogs were tested for their effect on AR and iNOS activities and on D-galactose-induced apoptosis in cultured human lens epithelial cells. Compounds 5, 10, 14a, 14b, 14d, 14e, 14f, 17b, 17c, 23, and 25 inhibited AR activity, with IC50 values ranging from 5.02 to 288.8 mu M. Compounds 5, 10, 14b, and 14f inhibited iNOS activity with IC50 ranging from 432.6 to 1188.7 mu M. Compounds 5, 8, 10, 14b, 14f, and 17c protected the cells from D-galactose induced apoptosis with viability ranging from 55.2 to 76.26%. Of gigantol and its analogs, compound 10 showed the greatest bioefficacy and is warranted to be developed as a therapeutic agent for diabetic cataracts.	[Wu, Jie; Li, Xue; Fang, Hua; Wan, Wencheng; Yang, Qiaohong; Sun, Xiaosheng; Wang, Meiling; Hu, Xiaohong; Wei, Xiaoyong] Guangzhou Univ Chinese Med, Sch Basic Med Sci, Guangzhou 510006, Guangdong, Peoples R China; [Lu, Chuanjun] Zhejiang Univ Technol, Coll Chem Engn, Hangzhou 310014, Zhejiang, Peoples R China; [Lu, Chuanjun] Sun Yat Sen Univ, Sch Pharmaceut Sci, Inst Drug Synth & Pharmaceut Proc, Guangzhou 510006, Guangdong, Peoples R China; [Chen, C. -Y. Oliver; Wei, Xiaoyong] Tufts Univ, Jean Mayer USDA Human Nutr Res Ctr Aging, Antioxidants Res Lab, Boston, MA 02111 USA	Guangzhou University of Chinese Medicine; Zhejiang University of Technology; Sun Yat Sen University; Tufts University; United States Department of Agriculture (USDA)	Wei, XY (corresponding author), Guangzhou Univ Chinese Med, Sch Basic Med Sci, Guangzhou 510006, Guangdong, Peoples R China.	jidewowxy@163.com			National Natural Science Foundation of China [81274157, 81102674]; Guangzhou Science & Technology Planning Project [2014J4100082]; Guangdong Natural Science Foundation [S2011010005661]; Guangdong Science & Technology Planning Project [2011B031700076, 2009B090300335]; U.S. Department of Agriculture (USDA)/Agricultural Research Service [1950-5100-087]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangzhou Science & Technology Planning Project; Guangdong Natural Science Foundation(National Natural Science Foundation of Guangdong Province); Guangdong Science & Technology Planning Project; U.S. Department of Agriculture (USDA)/Agricultural Research Service(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This work was supported by the National Natural Science Foundation of China (81274157, 81102674), Guangzhou Science & Technology Planning Project (2014J4100082), Guangdong Natural Science Foundation (S2011010005661), Guangdong Science & Technology Planning Project (2011B031700076, 2009B090300335) and the U.S. Department of Agriculture (USDA)/Agricultural Research Service (Cooperative Agreement No. 1950-5100-087).	Alexiou P, 2010, J MED CHEM, V53, P7756, DOI 10.1021/jm101008m; BEN I, 1985, J ORG CHEM, V50, P2236, DOI 10.1021/jo00213a008; Bian Q, 2008, MOL VIS, V14, P403; Bode JW, 1996, J ORG CHEM, V61, P9146, DOI 10.1021/jo961607u; Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a; Chanvorachote P, 2013, NAT PROD COMMUN, V8, P115; Chen X, 2012, CURR MED CHEM, V19, P3578, DOI 10.2174/092986712801323225; Costantino L, 1999, MED RES REV, V19, P3, DOI 10.1002/(SICI)1098-1128(199901)19:1<3::AID-MED2>3.3.CO;2-Z; Estrada S, 1999, PLANTA MED, V65, P109, DOI 10.1055/s-1999-14056; Estrada-Soto S, 2006, FITOTERAPIA, V77, P236, DOI 10.1016/j.fitote.2006.02.006; Fan CQ, 2001, PHYTOCHEMISTRY, V57, P1255, DOI 10.1016/S0031-9422(01)00168-6; Fang H, 2015, J ETHNOPHARMACOL, V172, P238, DOI 10.1016/j.jep.2015.06.034; Frohlich LG, 1999, J MED CHEM, V42, P4108, DOI 10.1021/jm981129a; Gacche RN, 2011, FOOD CHEM TOXICOL, V49, P1806, DOI 10.1016/j.fct.2011.04.032; Halder N, 2003, J ETHNOPHARMACOL, V86, P113, DOI 10.1016/S0378-8741(03)00052-7; Harding JJ, 1998, BRIT J OPHTHALMOL, V82, P526, DOI 10.1136/bjo.82.5.526; HART JH, 1981, ANNU REV PHYTOPATHOL, V19, P437, DOI 10.1146/annurev.py.19.090181.002253; Hernandez-Romero Y, 2005, J AGR FOOD CHEM, V53, P6276, DOI 10.1021/jf0508044; Hofseth LJ, 2005, METHOD ENZYMOL, V396, P326, DOI 10.1016/S0076-6879(05)96027-8; Ibaraki N, 1998, EXP EYE RES, V67, P577, DOI 10.1006/exer.1998.0551; Kim J, 2010, GRAEF ARCH CLIN EXP, V248, P811, DOI 10.1007/s00417-010-1313-1; KINOSHIT.JH, 1974, INVEST OPHTH VISUAL, V13, P713; La Motta C, 2007, J MED CHEM, V50, P4917, DOI 10.1021/jm070398a; Lechner M, 2005, SEMIN CANCER BIOL, V15, P277, DOI 10.1016/j.semcancer.2005.04.004; Lu CJ, 2012, BIOORG MED CHEM LETT, V22, P7683, DOI 10.1016/j.bmcl.2012.09.105; Matsuda H, 2002, CHEM PHARM BULL, V50, P788, DOI 10.1248/cpb.50.788; MAYFIELD CA, 1989, INT J BIOCHEM, V21, P1275, DOI 10.1016/0020-711X(89)90015-3; Miyazawa M, 1997, J AGR FOOD CHEM, V45, P2849, DOI 10.1021/jf9603902; Morikawa T, 2014, J NAT MED-TOKYO, V68, P561, DOI 10.1007/s11418-014-0837-9; Mulhern ML, 2006, INVEST OPHTH VIS SCI, V47, P3951, DOI 10.1167/iovs.06-0193; Oguntibeju O. O, 2013, DIABETES MELLITUS IN; Olofsson EM, 2007, FREE RADICAL BIO MED, V42, P1098, DOI 10.1016/j.freeradbiomed.2007.01.012; Ou Y, 2012, TOXICOL LETT, V215, P25, DOI 10.1016/j.toxlet.2012.09.017; Pathania S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061327; Gutierrez RMP, 2009, J NAT MED-TOKYO, V63, P65, DOI 10.1007/s11418-008-0280-x; Pollreisz A, 2010, J OPHTHALMOL, V2010, DOI 10.1155/2010/608751; Rao VR, 2012, EUR J MED CHEM, V57, P344, DOI 10.1016/j.ejmech.2012.09.014; Reyes-Ramirez A, 2011, EUR J MED CHEM, V46, P2699, DOI 10.1016/j.ejmech.2011.03.057; Saito R, 2009, TETRAHEDRON, V65, P3019, DOI 10.1016/j.tet.2009.01.020; Saraswat M, 2008, ASIA PAC J CLIN NUTR, V17, P558; Shinde, 2014, CURR ENZYM INHIB, V10, P2, DOI [10.2174/15734080113096660007, DOI 10.2174/15734080113096660007]; Simmler C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013713; Song JX, 2010, NEUROCHEM INT, V57, P676, DOI 10.1016/j.neuint.2010.08.007; Stanga P E, 1999, Curr Opin Ophthalmol, V10, P483, DOI 10.1097/00055735-199912000-00018; Steuber H, 2006, J MOL BIOL, V356, P45, DOI 10.1016/j.jmb.2005.10.067; Suzen S, 2003, CURR MED CHEM, V10, P1329, DOI 10.2174/0929867033457377; Tabin G, 2008, CURR OPIN OPHTHALMOL, V19, P55, DOI 10.1097/ICU.0b013e3282f154bd; TERASHIMA H, 1984, J PHARMACOL EXP THER, V229, P226; TEZUKA Y, 1991, CHEM PHARM BULL, V39, P593, DOI 10.1248/cpb.39.593; Won JH, 2006, PLANTA MED, V72, P1181, DOI 10.1055/s-2006-947201; Yadav UCS, 2007, INVEST OPHTH VIS SCI, V48, P4634, DOI 10.1167/iovs.07-0485; Yang L, 2006, J CHROMATOGR A, V1104, P230, DOI 10.1016/j.chroma.2005.12.012	52	22	24	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2015	10	10							e0141092	10.1371/journal.pone.0141092	http://dx.doi.org/10.1371/journal.pone.0141092			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0EH	26517726	Green Published, Green Submitted, gold			2022-12-26	WOS:000363920800020
J	Cerami, C; Dodich, A; Iannaccone, S; Marcone, A; Lettieri, G; Crespi, C; Gianolli, L; Cappa, SF; Perani, D				Cerami, Chiara; Dodich, Alessandra; Iannaccone, Sandro; Marcone, Alessandra; Lettieri, Giada; Crespi, Chiara; Gianolli, Luigi; Cappa, Stefano F.; Perani, Daniela			Right Limbic FDG-PET Hypometabolism Correlates with Emotion Recognition and Attribution in Probable Behavioral Variant of Frontotemporal Dementia Patients	PLOS ONE			English	Article							PROGRESSIVE SUPRANUCLEAR PALSY; CEREBRAL GLUCOSE-METABOLISM; ONSET ALZHEIMERS-DISEASE; LOBAR DEGENERATION; SOCIAL COGNITION; FACIAL EXPRESSIONS; FRONTAL VARIANT; MIND; IMPAIRMENT; EMPATHY	The behavioural variant of frontotemporal dementia (bvFTD) is a rare disease mainly affecting the social brain. FDG-PET fronto-temporal hypometabolism is a supportive feature for the diagnosis. It may also provide specific functional metabolic signatures for altered socio-emotional processing. In this study, we evaluated the emotion recognition and attribution deficits and FDG-PET cerebral metabolic patterns at the group and individual levels in a sample of sporadic bvFTD patients, exploring the cognitive-functional correlations. Seventeen probable mild bvFTD patients (10 male and 7 female; age 67.8 +/- 9.9) were administered standardized and validated version of social cognition tasks assessing the recognition of basic emotions and the attribution of emotions and intentions (i.e., Ekman 60-Faces test-Ek60F and Story-based Empathy task-SET). FDG-PET was analysed using an optimized voxel-based SPM method at the single-subject and group levels. Severe deficits of emotion recognition and processing characterized the bvFTD condition. At the group level, metabolic dysfunction in the right amygdala, temporal pole, and middle cingulate cortex was highly correlated to the emotional recognition and attribution performances. At the single-subject level, however, heterogeneous impairments of social cognition tasks emerged, and different metabolic patterns, involving limbic structures and prefrontal cortices, were also observed. The derangement of a right limbic network is associated with altered socio-emotional processing in bvFTD patients, but different hypometabolic FDG-PET patterns and heterogeneous performances on social tasks at an individual level exist.	[Cerami, Chiara; Dodich, Alessandra; Lettieri, Giada; Crespi, Chiara; Perani, Daniela] Univ Vita Salute San Raffaele, Milan, Italy; [Cerami, Chiara; Dodich, Alessandra; Iannaccone, Sandro; Marcone, Alessandra; Crespi, Chiara; Cappa, Stefano F.; Perani, Daniela] Ist Sci San Raffaele, Div Neurosci, I-20132 Milan, Italy; [Cerami, Chiara; Iannaccone, Sandro; Marcone, Alessandra] Hosp San Raffaele, Dept Clin Neurosci, I-20132 Milan, Italy; [Gianolli, Luigi; Perani, Daniela] Hosp San Raffaele, Dept Nucl Med, I-20132 Milan, Italy; [Cappa, Stefano F.] Ist Univ Studi Super, NeTS Ctr, Pavia, Italy	Vita-Salute San Raffaele University; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele	Cerami, C (corresponding author), Univ Vita Salute San Raffaele, Milan, Italy.	cerami.chiara@hsr.it	Cappa, Stefano/B-1874-2014; Crespi, Chiara/H-5251-2018; Crespi, Chiara/M-9039-2019; Dodich, Alessandra/AAA-5119-2019; Iannaccone, Sandro/K-4252-2018; Perani, Daniela/AAN-3221-2020; Crespi, Chiara/K-6484-2016; Dodich, Alessandra/ABE-1400-2021; gianolli, luigi/AAN-3892-2020	Cappa, Stefano/0000-0003-1003-3925; Crespi, Chiara/0000-0002-7851-9887; Crespi, Chiara/0000-0002-7851-9887; Iannaccone, Sandro/0000-0002-8333-3972; Crespi, Chiara/0000-0002-7851-9887; Cerami, Chiara/0000-0003-1974-3421; Lettieri, Giada/0000-0001-8027-9053	MIUR grant [PRIN2010XPMFW4_008]; Universita degli Studi di Milano-Bicocca CARIPLO grant; Fondazione Eli-Lilly (Eli-Lilly grant)	MIUR grant(Ministry of Education, Universities and Research (MIUR)); Universita degli Studi di Milano-Bicocca CARIPLO grant; Fondazione Eli-Lilly (Eli-Lilly grant)	This work supported by the MIUR grant "I meccanismi neurocognitivi alla base delle interazioni sociali" (PRIN2010XPMFW4_008) (SFC, AD, CC, CCr, and GL), and by the Universita degli Studi di Milano-Bicocca CARIPLO grant "Dottorato ad alta Formazione in Psicologia Sperimentale, Linguistica e Neuroscienze Cognitive" (AD). CC was funded by Fondazione Eli-Lilly (Eli-Lilly grant 2011 "Imaging of neuroinflammation and neurodegeneration in prodromal and presymptomatic Alzheimer's disease phases"). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baez S, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00262; Bernhardt BC, 2012, ANNU REV NEUROSCI, V35, P1, DOI 10.1146/annurev-neuro-062111-150536; Bora E, 2015, J NEUROL NEUROSUR PS, V86, P714, DOI 10.1136/jnnp-2014-309445; Cerami C, 2014, ALZHEIMERS DEMENT, V10, P827, DOI 10.1016/j.jalz.2014.01.005; Cerami C, 2013, NEUROL SCI, V34, P1267, DOI 10.1007/s10072-013-1317-9; Della Rosa PA, 2014, NEUROINFORMATICS, V12, P575, DOI 10.1007/s12021-014-9235-4; Dodich A, 2015, NEUROL SCI, V36, P1907, DOI 10.1007/s10072-015-2281-3; Dodich A, 2014, NEUROL SCI, V35, P1015, DOI 10.1007/s10072-014-1631-x; Eckart JA, 2012, NEUROPSYCHOLOGIA, V50, P786, DOI 10.1016/j.neuropsychologia.2012.01.012; Eslinger PJ, 2011, J NEUROPSYCH CLIN N, V23, P74, DOI 10.1176/appi.neuropsych.23.1.74; Franceschi M, 2005, ANN NEUROL, V57, P216, DOI 10.1002/ana.20365; Freedman M, 2013, ALZ DIS ASSOC DIS, V27, P56, DOI 10.1097/WAD.0b013e31824ea5db; Ghosh BCP, 2012, BRAIN, V135, P2089, DOI 10.1093/brain/aws128; Gregory C, 2002, BRAIN, V125, P752, DOI 10.1093/brain/awf079; Grimmer T, 2004, DEMENT GERIATR COGN, V18, P32, DOI 10.1159/000077732; Grossman M, 2010, NEUROPSYCHOLOGIA, V48, P3505, DOI 10.1016/j.neuropsychologia.2010.07.036; Heitz C, 2015, REV NEUROL-FRANCE, V171, P373, DOI 10.1016/j.neurol.2015.02.010; Henry JD, 2014, NEUROPSYCHOLOGIA, V56, P53, DOI 10.1016/j.neuropsychologia.2013.12.024; Herholz K, 2002, NEUROIMAGE, V17, P302, DOI 10.1006/nimg.2002.1208; Ibach B, 2004, NEUROIMAGE, V23, P739, DOI 10.1016/j.neuroimage.2004.06.041; Ibanez A, 2012, NEUROLOGY, V78, P1354, DOI 10.1212/WNL.0b013e3182518375; Ishii K, 1998, J NUCL MED, V39, P1875; Jeong Y, 2005, J NUCL MED, V46, P233; Kamminga J, 2015, J NEUROL NEUROSUR PS, V86, P1082, DOI 10.1136/jnnp-2014-309120; Kipps CM, 2009, BRAIN, V132, P2566, DOI 10.1093/brain/awp077; Kipps CM, 2009, NEUROCASE, V15, P182, DOI 10.1080/13554790802632892; Kumfor F, 2013, BRAIN, V136, P2992, DOI 10.1093/brain/awt185; Kumfor F, 2012, NEUROPSYCHOL REV, V22, P280, DOI 10.1007/s11065-012-9201-6; Lamm C, 2011, NEUROIMAGE, V54, P2492, DOI 10.1016/j.neuroimage.2010.10.014; Le Bouc R, 2012, BRAIN, V135, P3026, DOI 10.1093/brain/aws237; Lee GJ, 2014, J ALZHEIMERS DIS, V41, P793, DOI 10.3233/JAD-132219; Moll J, 2011, NEUROIMAGE, V54, P1735, DOI 10.1016/j.neuroimage.2010.08.026; O'Keeffe FM, 2007, BRAIN, V130, P753, DOI 10.1093/brain/awl367; Omar R, 2011, J NEUROL NEUROSUR PS, V82, P1341, DOI 10.1136/jnnp.2010.227983; Perani D, 2014, NEUROIMAGE-CLIN, V6, P445, DOI 10.1016/j.nicl.2014.10.009; Perry DC, 2015, ALZ DIS ASSOC DIS, V29, P161, DOI 10.1097/WAD.0000000000000012; Pievani M, 2014, NAT REV NEUROL, V10, P620, DOI 10.1038/nrneurol.2014.178; Piguet O, 2011, LANCET NEUROL, V10, P162, DOI 10.1016/S1474-4422(10)70299-4; Posamentier MT, 2003, NEUROPSYCHOL REV, V13, P113, DOI 10.1023/A:1025519712569; Rankin KP, 2006, BRAIN, V129, P2945, DOI 10.1093/brain/awl254; Rascovsky K, 2011, BRAIN, V134, P2456, DOI 10.1093/brain/awr179; Salmon E, 2006, NEUROIMAGE, V30, P871, DOI 10.1016/j.neuroimage.2005.10.016; Salmon E, 2003, NEUROIMAGE, V20, P435, DOI 10.1016/S1053-8119(03)00346-X; Sarazin M, 2003, J NEUROL, V250, P827, DOI 10.1007/s00415-003-1087-z; Seeley WW, 2012, NEUROSCIENTIST, V18, P373, DOI 10.1177/1073858411410354; Shamay-Tsoory SG, 2011, NEUROSCIENTIST, V17, P18, DOI 10.1177/1073858410379268; Shany-Ur T, 2012, CORTEX, V48, P1329, DOI 10.1016/j.cortex.2011.08.003; Warmus BA, 2014, J NEUROSCI, V34, P16482, DOI 10.1523/JNEUROSCI.3418-14.2014; Woodward MC, 2015, J ALZHEIMERS DIS, V44, P233, DOI 10.3233/JAD-141110; Zahn R, 2009, BRAIN, V132, P604, DOI 10.1093/brain/awn343	50	23	23	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2015	10	10							e0141672	10.1371/journal.pone.0141672	http://dx.doi.org/10.1371/journal.pone.0141672			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0ED	26513651	Green Published, Green Submitted, gold			2022-12-26	WOS:000363920300065
J	Cuartas-Hernandez, S; Medel, R				Cuartas-Hernandez, Sandra; Medel, Rodrigo			Topology of Plant - Flower-Visitor Networks in a Tropical Mountain Forest: Insights on the Role of Altitudinal and Temporal Variation	PLOS ONE			English	Article							HIGH TEMPERATE ANDES; POLLINATION ECOLOGY; MUTUALISTIC NETWORK; CENTRAL CHILE; NESTEDNESS; COMMUNITY; SPECIALIZATION; GRADIENTS; PATTERNS; CONNECTANCE	Understanding the factors determining the spatial and temporal variation of ecological networks is fundamental to the knowledge of their dynamics and functioning. In this study, we evaluate the effect of elevation and time on the structure of plant-flower-visitor networks in a Colombian mountain forest. We examine the level of generalization of plant and animal species and the identity of interactions in 44 bipartite matrices obtained from eight altitudinal levels, from 2200 to 2900 m during eight consecutive months. The contribution of altitude and time to the overall variation in the number of plant (P) and pollinator (A) species, network size (M), number of interactions (I), connectance (C), and nestedness was evaluated. In general, networks were small, showed high connectance values and non-nested patterns of organization. Variation in P, M, I and C was better accounted by time than elevation, seemingly related to temporal variation in precipitation. Most plant and insect species were specialists and the identity of links showed a high turnover over months and at every 100 m elevation. The partition of the whole system into smaller network units allowed us to detect small-scale patterns of interaction that contrasted with patterns commonly described in cumulative networks. The specialized but erratic pattern of network organization observed in this tropical mountain suggests that high connectance coupled with opportunistic attachment may confer robustness to plant-flower-visitor networks occurring at small spatial and temporal units.	[Cuartas-Hernandez, Sandra] Univ Antioquia, Inst Biol, Medellin, Antioquia, Colombia; [Medel, Rodrigo] Univ Chile, Dept Ciencias Ecol, Santiago, Region Metropol, Chile	Universidad de Antioquia; Universidad de Chile	Cuartas-Hernandez, S (corresponding author), Univ Antioquia, Inst Biol, Medellin, Antioquia, Colombia.	sandra.cuartas@udea.edu.co		Medel, Rodrigo/0000-0001-9955-764X	Comite para el Desarrollo de la Investigacion CODI, Universidad de Antioquia; FONDECYT [1150112];  [CPT-0915]	Comite para el Desarrollo de la Investigacion CODI, Universidad de Antioquia; FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); 	This work was supported by Comite para el Desarrollo de la Investigacion CODI, Universidad de Antioquia. Grant Number CPT-0915. www.udea.edu.co/portal/page/portal/Programas/ GruposInvestigacion/SistemaUniversitarioInvestigacion/D.codi. SCH received the funding. R Medel thanks the indirect funding support of FONDECYT 1150112. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alarcon R, 2008, OIKOS, V117, P1796, DOI 10.1111/j.0030-1299.2008.16987.x; Almeida-Neto M, 2008, OIKOS, V117, P1227, DOI 10.1111/j.0030-1299.2008.16644.x; Almeida M, 2007, OIKOS, V116, P716, DOI 10.1111/j.2007.0030-1299.15803.x; ARROYO MTK, 1982, AM J BOT, V69, P82, DOI 10.2307/2442833; ARROYO MTK, 1985, PLANT SYST EVOL, V149, P187, DOI 10.1007/BF00983305; Bascompte J, 2003, P NATL ACAD SCI USA, V100, P9383, DOI 10.1073/pnas.1633576100; Bascompte J, 2007, ANNU REV ECOL EVOL S, V38, P567, DOI 10.1146/annurev.ecolsys.38.091206.095818; Basilio AM, 2006, AUSTRAL ECOL, V31, P975, DOI 10.1111/j.1442-9993.2006.01666.x; Bluthgen N, 2007, CURR BIOL, V17, P341, DOI 10.1016/j.cub.2006.12.039; Bluethgen Nico, 2006, BMC Ecology, V6, P9, DOI 10.1186/1472-6785-6-9; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Cuartas-Hernandez SE, 2015, NEOTROP ENTOMOL; Cuesta F., 2009, BOSQUES MONTANOS AND; Devoto M, 2005, OIKOS, V109, P461, DOI 10.1111/j.0030-1299.2005.13712.x; Diaz-Castelazo C, 2010, ECOLOGY, V91, P793, DOI 10.1890/08-1883.1; Dormann C.F., 2009, OPN ECOL J, V2, P7, DOI 10.2174/1874213000902010007; Dunne JA, 2002, P NATL ACAD SCI USA, V99, P12917, DOI 10.1073/pnas.192407699; Dunne JA, 2002, ECOL LETT, V5, P558, DOI 10.1046/j.1461-0248.2002.00354.x; Dupont YL, 2009, OIKOS, V118, P1261, DOI 10.1111/j.1600-0706.2009.17594.x; Encinas-Viso F, 2012, ECOL LETT, V15, P198, DOI 10.1111/j.1461-0248.2011.01726.x; Gomez JM, 1999, ECOLOGY, V80, P796, DOI 10.1890/0012-9658(1999)080[0796:GVSITP]2.0.CO;2; Guimaraes PR, 2006, ENVIRON MODELL SOFTW, V21, P1512, DOI 10.1016/j.envsoft.2006.04.002; Hammer O., 2011, PALEONTOLOGICALSTATI; Herrera CM, 1997, OIKOS, V78, P601, DOI 10.2307/3545623; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hodkinson ID, 2005, BIOL REV, V80, P489, DOI 10.1017/S1464793105006767; Hubbell SP, 2005, FUNCT ECOL, V19, P166, DOI 10.1111/j.0269-8463.2005.00965.x; Jacquemyn H, 2005, J BIOGEOGR, V32, P1751, DOI 10.1111/j.1365-2699.2005.01307.x; JORDANO P, 1987, AM NAT, V129, P657, DOI 10.1086/284665; Jordano P, 2003, ECOL LETT, V6, P69, DOI 10.1046/j.1461-0248.2003.00403.x; Kallimanis AS, 2009, ECOL MODEL, V220, P684, DOI 10.1016/j.ecolmodel.2008.11.008; Kessler M, 2000, J BIOGEOGR, V27, P275, DOI 10.1046/j.1365-2699.2000.00399.x; Krishna A, 2008, OIKOS, V117, P1609, DOI 10.1111/j.1600-0706.2008.16540.x; Ledesma-Castaneda EA, 2011, THESIS SENA; Lundgren R, 2005, ARCT ANTARCT ALP RES, V37, P514, DOI 10.1657/1523-0430(2005)037[0514:TDAHCW]2.0.CO;2; Malo JE, 2002, DIVERS DISTRIB, V8, P365, DOI 10.1046/j.1472-4642.2002.00161.x; Medan D, 2002, ARCT ANTARCT ALP RES, V34, P233, DOI 10.2307/1552480; Memmott J, 2004, P ROY SOC B-BIOL SCI, V271, P2605, DOI 10.1098/rspb.2004.2909; Michener C.D., 2000, BEES WORLD, V1st, DOI DOI 10.7171/JBT.12-2303-004; Montoya JM, 2006, NATURE, V442, P259, DOI 10.1038/nature04927; Nates-Parra Guiomar, 2001, Biota Colombiana, V2, P233; Nielsen A, 2007, J ECOL, V95, P1134, DOI 10.1111/j.1365-2745.2007.01271.x; Olesen JM, 2008, ECOLOGY, V89, P1573, DOI 10.1890/07-0451.1; Olesen JM, 2007, P NATL ACAD SCI USA, V104, P19891, DOI 10.1073/pnas.0706375104; Olesen JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026455; Olesen JM, 2002, ECOLOGY, V83, P2416, DOI 10.1890/0012-9658(2002)083[2416:GPIPPM]2.0.CO;2; Petanidou T., 1993, Biodiversity Letters, V1, P9, DOI 10.2307/2999643; Petanidou T, 2008, ECOL LETT, V11, P564, DOI 10.1111/j.1461-0248.2008.01170.x; Pradal Clementine, 2009, BMC Ecology, V9, P24, DOI 10.1186/1472-6785-9-24; Primack R.B., 1978, New Zealand Journal of Ecology, V1, P66; Pyrcz TW, 2002, GLOBAL ECOL BIOGEOGR, V11, P211, DOI 10.1046/j.1466-822X.2002.00285.x; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Ramos-Jiliberto R, 2010, ECOL COMPLEX, V7, P86, DOI 10.1016/j.ecocom.2009.06.001; Rico-Gray V, 2012, ARTHROPOD-PLANT INTE, V6, P289, DOI 10.1007/s11829-011-9170-3; Rivera-Hutinel A, 2012, ECOLOGY, V93, P1593, DOI 10.1890/11-1803.1; Schleuning M, 2012, CURR BIOL, V22, P1925, DOI 10.1016/j.cub.2012.08.015; Trojelsgaard K, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.2925; Tylianakis JM, 2007, NATURE, V445, P202, DOI 10.1038/nature05429; Ulrich W, 2009, OIKOS, V118, P3, DOI 10.1111/j.1600-0706.2008.17053.x; Vazquez DP, 2007, OIKOS, V116, P1120, DOI 10.1111/j.0030-1299.2007.15828.x; Vazquez DP, 2009, ECOLOGY, V90, P2039, DOI 10.1890/08-1837.1; Zar JH, 1999, BIOSTATISTICAL ANAL	62	20	21	2	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2015	10	10							e0141804	10.1371/journal.pone.0141804	http://dx.doi.org/10.1371/journal.pone.0141804			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0ED	26513664	Green Submitted, Green Published, gold			2022-12-26	WOS:000363920300085
J	Formica, V; Chan, AKM				Formica, Vincent; Chan, Amanda Kar-Men			No Effect of Host Species on Phenoloxidase Activity in a Mycophagous Beetle	PLOS ONE			English	Article							LIFE-HISTORY TRAITS; IMMUNE FUNCTION; DISEASE RESISTANCE; EPIRRITA-AUTUMNATA; PRACTICAL GUIDE; PLANT-QUALITY; TRADE-OFFS; BODY-SIZE; SYSTEM; SELECTION	Ecological immunology is an interdisciplinary field that helps elucidate interactions between the environment and immune response. The host species individuals experience have profound effects on immune response in many species of insects. However, this conclusion comes from studies of herbivorous insects even though species of mycophagous insects also inhabit many different host species. The goal of this study was to determine if fungal host species as well as individual, sex, body size, and host patch predict one aspect of immune function, phenoloxidase activity (PO). We sampled a metapopulation of Bolitotherus cornutus, a mycophagous beetle in southwestern Virginia. B. cornutus live on three species of fungus that differ in nutritional quality, social environment, and density. A filter paper phenoloxidase assay was used to quantify phenoloxidase activity. Overall, PO activity was significantly repeatable among individuals (0.57) in adult B. cornutus. While there was significant variance among individuals in PO activity, there were surprisingly no significant differences in PO activity among subpopulations, beetles living on different host species, or between the sexes; there was also no effect of body size. Our results suggest that other factors such as age, genotype, disease prevalence, or natal environment may be generating variance among individuals in PO activity.	[Formica, Vincent; Chan, Amanda Kar-Men] Swarthmore Coll, Dept Biol, Swarthmore, PA 19081 USA	Swarthmore College	Formica, V (corresponding author), Swarthmore Coll, Dept Biol, Swarthmore, PA 19081 USA.	vformic1@swarthmore.edu			Mellon Mays Undergraduate Fellowship;  [NSF-IOS-135503]	Mellon Mays Undergraduate Fellowship; 	This work was funded by the Mellon Mays Undergraduate Fellowship to AC and NSF-IOS-135503 to VF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamo SA, 2004, J INSECT PHYSIOL, V50, P209, DOI 10.1016/j.jinsphys.2003.11.011; Bates Douglas, 2014, LME4 LINEAR MIXED EF; Bauerfeind SS, 2014, J INSECT PHYSIOL, V64, P14, DOI 10.1016/j.jinsphys.2014.03.003; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; CONNER J, 1988, EVOLUTION, V42, P736, DOI 10.1111/j.1558-5646.1988.tb02492.x; Cotter SC, 2011, FUNCT ECOL, V25, P186, DOI 10.1111/j.1365-2435.2010.01766.x; Donald HM, 2012, MOL ECOL RESOUR, V12, P856, DOI 10.1111/j.1755-0998.2012.03154.x; Emlen DJ, 1996, EVOLUTION, V50, P1219, DOI [10.1111/j.1558-5646.1996.tb02362.x, 10.2307/2410662]; Epps MJ, 2010, MYCOLOGIA, V102, P785, DOI 10.3852/09-161; Feder D, 1997, J INSECT PHYSIOL, V43, P513, DOI 10.1016/S0022-1910(97)00010-3; Goldsworthy G, 2003, PHYSIOL ENTOMOL, V28, P54, DOI 10.1046/j.1365-3032.2003.00314.x; Gonzalez-Santoyo I, 2012, ENTOMOL EXP APPL, V142, P1, DOI 10.1111/j.1570-7458.2011.01187.x; Gonzalez-Tokman DM, 2012, EVOLUTION, V66, P3294, DOI 10.1111/j.1558-5646.2012.01678.x; Holliday AE, 2009, J CHEM ECOL, V35, P1302, DOI 10.1007/s10886-009-9712-7; Jacot A, 2005, P ROY SOC B-BIOL SCI, V272, P63, DOI 10.1098/rspb.2004.2919; Janz N, 2001, EVOLUTION, V55, P783, DOI 10.1554/0014-3820(2001)055[0783:EDOHPS]2.0.CO;2; Jonsell M, 2004, ECOL ENTOMOL, V29, P697, DOI 10.1111/j.0307-6946.2004.00654.x; Jonsell M, 1999, J INSECT CONSERV, V3, P145, DOI 10.1023/A:1009665513184; Karimzadeh J, 2008, ECOL ENTOMOL, V33, P45, DOI 10.1111/j.1365-2311.2007.00933.x; Klemola N, 2007, ENTOMOL EXP APPL, V123, P167, DOI 10.1111/j.1570-7458.2007.00533.x; Kurtz J, 2001, J INVERTEBR PATHOL, V78, P53, DOI 10.1006/jipa.2001.5040; LACY RC, 1984, ECOL ENTOMOL, V9, P43, DOI 10.1111/j.1365-2311.1984.tb00697.x; LILES M. PFERRER, 1956, OHIO JOUR SCI, V56, P329; Martin LB, 2011, FUNCT ECOL, V25, P1, DOI 10.1111/j.1365-2435.2010.01820.x; Moreno-Garcia M, 2013, B ENTOMOL RES, V103, P127, DOI 10.1017/S000748531200048X; Mucklow PT, 2003, PHYSIOL BIOCHEM ZOOL, V76, P836, DOI 10.1086/378917; Nakagawa S, 2010, BIOL REV, V85, P935, DOI 10.1111/j.1469-185X.2010.00141.x; Pace A. E., 1967, OCCAS PAP MUS ZOOL U, V653, P1114, DOI DOI 10.1017/S1047951110000478; Rantala MJ, 2003, FUNCT ECOL, V17, P534, DOI 10.1046/j.1365-2435.2003.00764.x; Reeson AF, 1998, P ROY SOC B-BIOL SCI, V265, P1787, DOI 10.1098/rspb.1998.0503; Rolff J, 2001, CAN J ZOOL, V79, P2176, DOI 10.1139/cjz-79-12-2176; Ruiz-Gonzalez MX, 2009, BIOL LETTERS, V5, P781, DOI 10.1098/rsbl.2009.0505; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schulenburg H, 2009, PHILOS T R SOC B, V364, P3, DOI 10.1098/rstb.2008.0249; Shikano I, 2010, BASIC APPL ECOL, V11, P15, DOI 10.1016/j.baae.2009.06.008; Siva-Jothy MT, 2002, PHYSIOL ENTOMOL, V27, P206, DOI 10.1046/j.1365-3032.2002.00286.x; Soderhall K, 1998, CURR OPIN IMMUNOL, V10, P23, DOI 10.1016/S0952-7915(98)80026-5; Sorrentino RP, 2002, BIOTECHNIQUES, V32, P815, DOI 10.2144/02324st08; Stoks R, 2006, ECOLOGY, V87, P809, DOI 10.1890/0012-9658(2006)87[809:TCMPPI]2.0.CO;2; TSCHINKEL WR, 1975, J MORPHOL, V145, P355, DOI 10.1002/jmor.1051450308; Urbanski A, 2014, J INSECT PHYSIOL, V60, P98, DOI 10.1016/j.jinsphys.2013.11.009; Vainio L, 2004, EVOL ECOL, V18, P75, DOI 10.1023/B:EVEC.0000017726.73906.b2; Vogelweith F, 2013, PHYSIOL ENTOMOL, V38, P219, DOI 10.1111/phen.12025; Wertheim B, 2000, J ANIM ECOL, V69, P335, DOI 10.1046/j.1365-2656.2000.00396.x; Wilson K, 2003, J ANIM ECOL, V72, P133, DOI 10.1046/j.1365-2656.2003.00680.x; Wilson K, 2002, P NATL ACAD SCI USA, V99, P5471, DOI 10.1073/pnas.082461999; Wolak ME, 2012, METHODS ECOL EVOL, V3, P129, DOI 10.1111/j.2041-210X.2011.00125.x; Wood CW, 2014, BEHAV ECOL, V25, P951, DOI 10.1093/beheco/aru038; Wood CW, 2013, ECOL EVOL, V3, P1484, DOI 10.1002/ece3.560; Yang SY, 2008, ECOL ENTOMOL, V33, P510, DOI 10.1111/j.1365-2311.2008.01000.x; Yang SY, 2007, ANN ZOOL FENN, V44, P89	51	0	0	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2015	10	10							e0141167	10.1371/journal.pone.0141167	http://dx.doi.org/10.1371/journal.pone.0141167			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0ED	26513243	Green Published, gold, Green Submitted			2022-12-26	WOS:000363920300021
J	Takeuchi, K; Izumi, M; Furuta, M; Takeshita, T; Shibata, Y; Kageyama, S; Ganaha, S; Yamashita, Y				Takeuchi, Kenji; Izumi, Maya; Furuta, Michiko; Takeshita, Toru; Shibata, Yukie; Kageyama, Shinya; Ganaha, Seijun; Yamashita, Yoshihisa			Posterior Teeth Occlusion Associated with Cognitive Function in Nursing Home Older Residents: A Cross-Sectional Observational Study	PLOS ONE			English	Article							ORAL-HEALTH STATUS; MINI-MENTAL STATE; TOOTH LOSS; NUTRITIONAL ASSESSMENT; CHEWING ABILITY; GERONTOLOGICAL EVALUATION; MASTICATORY ABILITY; PERIODONTAL-DISEASE; PROSPECTIVE COHORT; BRAIN-FUNCTION	Early detection and subsequent reduction of modifiable risk factors for cognitive decline is important for extending healthy life expectancy in the currently aging society. Although a recent increase in studies on the state or number of the teeth and cognitive function, few studies have focused on the association between posterior teeth occlusion necessary to maintain chewing function and cognitive function among older adults. This study examined the association between posterior teeth occlusion and cognitive function in nursing home older residents. In this cross-sectional study, 279 residents aged >= 60 years from eight nursing homes in Aso City, Japan participated in cognitive function and dental status assessments and completed a comprehensive questionnaire survey in 2014. Cognitive function was measured using a Mini-Mental State Examination (MMSE). Posterior teeth occlusion was assessed using a total number of functional tooth units (total-FTUs), depending on the number and location of the remaining natural and artificial teeth on implant-supported, fixed, and removable prostheses. Linear regression models were used to assess univariate and multivariate associations between total-FTUs and MMSE scores. Models were sequentially adjusted for demographic characteristics, number of natural teeth, socioeconomic status, health behaviors, comorbidities, physical function, and nutritional status. Among the 200 residents included in our analysis, mean MMSE scores and total-FTUs were 11.0 +/- 8.6 and 9.3 +/- 4.6, respectively. Higher total-FTUs were significantly associated with higher MMSE scores after adjustment for demographics and teeth number (B = 0.48, 95% confidence interval [CI] = 0.22-0.74). The association remained significant even after adjustment for all covariates (B = 0.25, 95% CI = 0.01-0.49). The current findings demonstrated that loss of posterior teeth occlusion was independently associated with cognitive decline in nursing home older residents in Japan. Maintenance and restoration of posterior teeth occlusion may be a preventive factor against cognitive decline in aged populations.	[Takeuchi, Kenji; Izumi, Maya; Furuta, Michiko; Takeshita, Toru; Shibata, Yukie; Kageyama, Shinya; Yamashita, Yoshihisa] Kyushu Univ, Fac Dent Sci, Div Oral Hlth Growth & Dev, Sect Prevent & Publ Hlth Dent, Fukuoka, Fukuoka 812, Japan; [Ganaha, Seijun] Aso Kizuna Dent Clin, Kizuna Kai, Kumamoto, Japan	Kyushu University	Yamashita, Y (corresponding author), Kyushu Univ, Fac Dent Sci, Div Oral Hlth Growth & Dev, Sect Prevent & Publ Hlth Dent, Fukuoka, Fukuoka 812, Japan.	yoshi@dent.kyushu-u.ac.jp	Takeshita, Toru/AAT-2321-2021; Takeuchi, Kenji/E-9922-2013	Takeuchi, Kenji/0000-0001-8769-8955; Kageyama, Shinya/0000-0001-9296-9385				Batty GD, 2013, EUR PSYCHIAT, V28, P49, DOI 10.1016/j.eurpsy.2011.07.005; BRAYNE C, 1990, AGE AGEING, V19, P91, DOI 10.1093/ageing/19.2.91; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chen HY, 2015, INT J MED SCI, V12, P502, DOI 10.7150/ijms.11911; Daviglus Martha L, 2010, NIH Consens State Sci Statements, V27, P1; Dewey ME, 2001, INT J GERIATR PSYCH, V16, P751, DOI 10.1002/gps.397.abs; Elsig F, 2015, GERODONTOLOGY, V32, P149, DOI 10.1111/ger.12079; Ferri CP, 2005, LANCET, V366, P2112, DOI 10.1016/S0140-6736(05)67889-0; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Formiga F, 2009, J NUTR HEALTH AGING, V13, P423, DOI 10.1007/s12603-009-0078-x; Furuta M, 2013, COMMUNITY DENT ORAL, V41, P173, DOI 10.1111/cdoe.12000; Gillette-Guyonnet S, 2007, J NUTR HEALTH AGING, V11, P132; Gonzalez S, 2010, INT J FOOD SCI NUTR, V61, P217, DOI 10.3109/09637480903348098; Hirano Y, 2008, NEUROSCI LETT, V436, P189, DOI 10.1016/j.neulet.2008.03.033; Kaiser MJ, 2009, J NUTR HEALTH AGING, V13, P782, DOI 10.1007/s12603-009-0214-7; Kaye EK, 2010, J AM GERIATR SOC, V58, P713, DOI 10.1111/j.1532-5415.2010.02788.x; Kimura Y, 2013, GERIATR GERONTOL INT, V13, P718, DOI 10.1111/ggi.12006; Lexomboon D, 2012, J AM GERIATR SOC, V60, P1951, DOI 10.1111/j.1532-5415.2012.04154.x; Lindroos E, 2014, J NUTR HEALTH AGING, V18, P718, DOI [10.1007/s12603-014-0506-4, 10.1007/s12603-014-0467-7]; MAHONEY F I, 1965, Md State Med J, V14, P61; Malara A, 2014, CLIN INTERV AGING, V9, P105, DOI 10.2147/CIA.S54611; Miura H, 2003, J ORAL REHABIL, V30, P808, DOI 10.1046/j.1365-2842.2003.01124.x; Momose T, 1997, ARCH ORAL BIOL, V42, P57, DOI 10.1016/S0003-9969(96)00081-7; Moriya S, 2011, J ORAL REHABIL, V38, P746, DOI 10.1111/j.1365-2842.2011.02214.x; Naorungroj S, 2015, COMMUNITY DENT ORAL, V43, P47, DOI 10.1111/cdoe.12128; Okamoto N, 2015, J ALZHEIMERS DIS, V44, P777, DOI 10.3233/JAD-141665; Ono Y, 2010, J ORAL REHABIL, V37, P624, DOI 10.1111/j.1365-2842.2010.02079.x; Onozuka M, 2002, J DENT RES, V81, P743, DOI 10.1177/154405910208101104; Qaseem A, 2008, ANN INTERN MED, V148, P370, DOI 10.7326/0003-4819-148-5-200803040-00008; Ragonese P, 2011, NEUROEPIDEMIOLOGY, V36, P169, DOI 10.1159/000326065; Rosenberg PB, 2012, INT J GERIATR PSYCH, V27, P1248, DOI 10.1002/gps.3769; Saarela RKT, 2014, J NUTR HEALTH AGING, V18, P34, DOI 10.1007/s12603-013-0358-3; Samnieng Patcharaphol, 2011, Journal of Nutrition in Gerontology and Geriatrics, V30, P291, DOI 10.1080/21551197.2011.591271; Searle SD, 2015, ALZHEIMERS RES THER, V7, DOI 10.1186/s13195-015-0140-3; Sekita A, 2010, ACTA PSYCHIAT SCAND, V122, P319, DOI 10.1111/j.1600-0447.2010.01587.x; Sheiham A, 2001, J DENT RES, V80, P408, DOI 10.1177/00220345010800020201; Takeuchi K, 2014, J NUTR HEALTH AGING, V18, P352, DOI 10.1007/s12603-014-0025-3; Tsakos G, 2015, J AM GERIATR SOC, V63, P91, DOI 10.1111/jgs.13190; Ueno M, 2010, CLIN ORAL INVEST, V14, P113, DOI 10.1007/s00784-009-0270-8; von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X; Yaffe K, 1999, ARCH GEN PSYCHIAT, V56, P425, DOI 10.1001/archpsyc.56.5.425; Yamamoto T, 2014, BMC ORAL HEALTH, V14, DOI 10.1186/1472-6831-14-130; Yamamoto T, 2012, PSYCHOSOM MED, V74, P241, DOI 10.1097/PSY.0b013e318246dffb; Zimmerman S, 2013, J AM GERIATR SOC, V61, P1399, DOI 10.1111/jgs.12372	44	28	30	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2015	10	10							e0141737	10.1371/journal.pone.0141737	http://dx.doi.org/10.1371/journal.pone.0141737			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0ED	26512900	Green Submitted, Green Published, gold			2022-12-26	WOS:000363920300078
J	Alonso, WJ; Rabaa, MA; Giglio, R; Miller, MA; Schuck-Paim, C				Alonso, Wladimir J.; Rabaa, Maia A.; Giglio, Ricardo; Miller, Mark A.; Schuck-Paim, Cynthia			Modeling the Impact of Alternative Immunization Strategies: Using Matrices as Memory Lanes	PLOS ONE			English	Article							MEASLES EPIDEMICS; DYNAMICS; VACCINATION	Existing modeling approaches are divided between a focus on the constitutive (micro) elements of systems or on higher (macro) organization levels. Micro-level models enable consideration of individual histories and interactions, but can be unstable and subject to cumulative errors. Macro-level models focus on average population properties, but may hide relevant heterogeneity at the micro-scale. We present a framework that integrates both approaches through the use of temporally structured matrices that can take large numbers of variables into account. Matrices are composed of several bidimensional (timexage) grids, each representing a state (e.g. physiological, immunological, socio-demographic). Time and age are primary indices linking grids. These matrices preserve the entire history of all population strata and enable the use of historical events, parameters and states dynamically in the modeling process. This framework is applicable across fields, but particularly suitable to simulate the impact of alternative immunization policies. We demonstrate the framework by examining alternative strategies to accelerate measles elimination in 15 developing countries. The model recaptured long-endorsed policies in measles control, showing that where a single routine measles-containing vaccine is employed with low coverage, any improvement in coverage is more effective than a second dose. It also identified an opportunity to save thousands of lives in India at attractively low costs through the implementation of supplementary immunization campaigns. The flexibility of the approach presented enables estimating the effectiveness of different immunization policies in highly complex contexts involving multiple and historical influences from different hierarchical levels.	[Alonso, Wladimir J.; Rabaa, Maia A.; Miller, Mark A.] NIH, Fogarty Int Ctr, Bethesda, MD 20892 USA; [Alonso, Wladimir J.; Schuck-Paim, Cynthia] Origem Sci Epidemiol & Modeling, Sao Paulo, SP, Brazil; [Rabaa, Maia A.] Univ Oxford, Clin Res Unit, Ho Chi Minh City, Vietnam; [Giglio, Ricardo] Univ Fed Santa Catarina, Dept Econ, Florianopolis, SC, Brazil	National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC); University of Oxford; Universidade Federal de Santa Catarina (UFSC)	Alonso, WJ (corresponding author), NIH, Fogarty Int Ctr, Bldg 10, Bethesda, MD 20892 USA.	Wladimir.Alonso@nih.gov	Schuck-Paim, Cynthia/AGG-9729-2022; Schuck-Paim, Cynthia/G-5503-2013; Rabaa, Maia/AAL-5501-2021; Alonso, Wladimir J./N-9223-2017; Rabaa, Maia/W-2223-2019	Schuck-Paim, Cynthia/0000-0002-9760-7786; Alonso, Wladimir J./0000-0001-7038-0801; Rabaa, Maia/0000-0003-0529-2228	Fogarty International Center, National Institutes of Health; Origem Scientifica (Sao Paulo, Brazil)	Fogarty International Center, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Origem Scientifica (Sao Paulo, Brazil)	This work was supported by intramural funds from Fogarty International Center, National Institutes of Health. CSP and WJA were also funded by Origem Scientifica (Sao Paulo, Brazil), a company specializing in the analyses of global health data. The funder provided support in the form of salaries for authors [CSP, WJA], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anis E, 2009, J INFECTION, V59, P252, DOI 10.1016/j.jinf.2009.07.005; Bauch CT, 2009, VACCINE, V27, P4090, DOI 10.1016/j.vaccine.2009.04.079; Bishai D, 2011, J INFECT DIS, V204, pS107, DOI 10.1093/infdis/jir131; Bjornstad ON, 2002, ECOL MONOGR, V72, P169, DOI 10.1890/0012-9615(2002)072[0169:DOMEES]2.0.CO;2; Bode M, 2011, P NATL ACAD SCI USA, V108, P16317, DOI 10.1073/pnas.1101019108; Bolker BM, 1996, P NATL ACAD SCI USA, V93, P12648, DOI 10.1073/pnas.93.22.12648; BOLKER BM, 1993, P ROY SOC B-BIOL SCI, V251, P75, DOI 10.1098/rspb.1993.0011; Earn DJD, 2000, SCIENCE, V287, P667, DOI 10.1126/science.287.5453.667; El-Sayed Abdulrahman M, 2012, Epidemiol Perspect Innov, V9, P1, DOI 10.1186/1742-5573-9-1; Epstein JM, 2009, NATURE, V460, P687, DOI 10.1038/460687a; Grassly NC, 2008, NAT REV MICROBIOL, V6, P77; Grenfell BT, 2001, NATURE, V414, P716, DOI 10.1038/414716a; Hall R. E., 2004, NBER WORKING PAPER S, V10737; Hoekstra EJ, 2011, J INFECT DIS, V204, pS190, DOI 10.1093/infdis/jir073; Keeling MJ., 2008, MODELING INFECT DIS, DOI DOI 10.1515/9781400841035; Khetsuriani N, 2011, J INFECT DIS, V204, pS343, DOI 10.1093/infdis/jir074; LIU JG, 1995, FOREST ECOL MANAG, V73, P157, DOI 10.1016/0378-1127(94)03490-N; Metcalf CJE, 2011, EPIDEMIOL INFECT, V139, P265, DOI 10.1017/S0950268810001329; Riley S, 2007, SCIENCE, V316, P1298, DOI 10.1126/science.1134695; Schmid D, 2010, EPIDEMIOL INFECT, V138, P415, DOI 10.1017/S0950268809990604; Siebert U, 2012, MED DECIS MAKING, V32, P690, DOI 10.1177/0272989X12455463; Simons Emily, 2012, Lancet, V379, P2173, DOI 10.1016/S0140-6736(12)60522-4; Strebel PM, 2011, J INF DIS S1, P1; Task K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032975; Zhuo JT, 2011, J INFECT DIS, V204, pS455, DOI 10.1093/infdis/jir063	25	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2015	10	10							e0141147	10.1371/journal.pone.0141147	http://dx.doi.org/10.1371/journal.pone.0141147			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0DL	26509976	gold, Green Published			2022-12-26	WOS:000363918100057
J	Knor, M; Tziridis, K; Agaimy, A; Zenk, J; Wendler, O				Knoer, Mareike; Tziridis, Konstantin; Agaimy, Abbas; Zenk, Johannes; Wendler, Olaf			Human Papillomavirus (HPV) Prevalence in Nasal and Antrochoanal Polyps and Association with Clinical Data	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; SQUAMOUS-CELL CARCINOMA; IN-SITU HYBRIDIZATION; GENERAL PRIMERS; NECK-CANCER; PCR; DNA; INFECTION; HEAD; OVEREXPRESSION	Objectives The pathogenesis of sinonasal polyposis remains unclear, in spite of several investigative approaches. Antrochoanal polyps, a subgroup of sinonasal polyposis along with allergic- and chronic-inflammatory nasal polyps, mostly originate from the maxillary sinus and develop as a unilateral, pedunculated mass towards the nasopharynx. The human papillomavirus (HPV) is discussed as a possible causative and influencing factor in development and progression of sinonasal polyposis. This study aims to elucidate HPV frequency in nasal polyps and antrochoanal polyps. Materials and Methods Genomic DNA from 257 tissue specimens (166 nasal polyps, 39 antrochoanal polyps and 52 nasal turbinates) was subjected to three different established HPV-polymerase chain reaction assays, testing for 37 low-and high-risk HPV. In addition, immunohistochemical analyses for HPV16 were carried out, as well as immunohistochemistry and western blots of p16, a biomarker for HPV induced cancer. Results HPV-DNA was detected in 53.8% of antrochoanal polyps, 15.1% of nasal polyps, and 5.8% of nasal turbinates. HPV16 was the predominant type with a detection rate of 76% in nasal polyps and 62% in antrochoanal polyps. Immunohistochemically, HPV positive tissues stained positive for HPV16 antigens and p16 in epithelial cell layers. No significant p16 overexpression was traceable in antrochoanal polyps, nasal polyps and nasal turbinates by western blot. There was no correlation of HPV-status with sex, age, smoking, alcohol consumption or allergic background. Conclusion The present study shows a significant frequency of high-risk type HPV16 in antrochoanal polyps. Absence of oncogenic transformation or correlation of the HPV-status with clinical data suggests a latent superinfection, possibly because of anatomical proximity to the oropharynx.	[Knoer, Mareike; Tziridis, Konstantin; Zenk, Johannes; Wendler, Olaf] Univ Erlangen Nurnberg, Expt Otorhinolaryngol, ENT Hosp, Head & Neck Surg, Erlangen, Germany; [Agaimy, Abbas] Univ Erlangen Nurnberg FAU, Dept Pathol, Erlangen, Germany	University of Erlangen Nuremberg; University of Erlangen Nuremberg	Knor, M (corresponding author), Univ Erlangen Nurnberg, Expt Otorhinolaryngol, ENT Hosp, Head & Neck Surg, Erlangen, Germany.	mareike.knoer@unimedizin-mainz.de; olaf.wendler@uk-erlangen.de	Zenk, Johannes/AAN-9013-2020	Zenk, Johannes/0000-0003-3281-6189; Wendler, Olaf/0000-0002-5443-4889				Aktas Davut, 1998, Rhinology (Utrecht), V36, P81; Baay MFD, 1996, J CLIN MICROBIOL, V34, P745, DOI 10.1128/JCM.34.3.745-747.1996; Basak S, 1998, INT J PEDIATR OTORHI, V46, P197, DOI 10.1016/S0165-5876(98)00160-8; Bateman ND, 2003, J LARYNGOL OTOL, V117, P1, DOI 10.1258/002221503321046577; Begum S, 2005, CLIN CANCER RES, V11, P5694, DOI 10.1158/1078-0432.CCR-05-0587; Bishop JA, 2012, AM J SURG PATHOL, V36, P1874, DOI 10.1097/PAS.0b013e318265fb2b; Chaiwongkot A, 2007, ASIAN PAC J CANCER P, V8, P279; CHAN SY, 1995, J VIROL, V69, P3074, DOI 10.1128/JVI.69.5.3074-3083.1995; Chaturvedi AK, 2011, J CLIN ONCOL, V29, P4294, DOI 10.1200/JCO.2011.36.4596; CHEN JM, 1989, J OTOLARYNGOL, V18, P168; EVANDER M, 1992, J CLIN MICROBIOL, V30, P987, DOI 10.1128/JCM.30.4.987-992.1992; Fokkens W, 2005, RHINOLOGY, V43, P1; Georgy MS, 2012, ALLERGY ASTHMA P S1, V33, pS22, DOI DOI 10.2500/AAP.2012.33.3537; Hoffmann M, 2000, ACTA OTO-LARYNGOL, V120, P872, DOI 10.1080/000164800750061750; Hoffmann M, 2006, CANCER LETT, V239, P64, DOI 10.1016/j.canlet.2005.07.019; Hoffmann M, 2010, INT J CANCER, V127, P1595, DOI 10.1002/ijc.25174; HUSMAN AMDR, 1995, J GEN VIROL, V76, P1057; Husnjak K, 2000, J VIROL METHODS, V88, P125, DOI 10.1016/S0166-0934(00)00194-4; Hwang SJ, 2012, J ONCOL, V2012, DOI [10.1155/2012/507286, DOI 10.1155/2012/507286]; Jordan RC, 2012, AM J SURG PATHOL, V36, P945, DOI 10.1097/PAS.0b013e318253a2d1; Jung AC, 2010, INT J CANCER, V126, P1882, DOI 10.1002/ijc.24911; Kennedy JL, 2013, AM J RHINOL ALLERGY, V27, P367, DOI 10.2500/ajra.2013.27.3906; Klaes R, 2001, INT J CANCER, V92, P276, DOI 10.1002/ijc.1174; Kleter B, 1998, AM J PATHOL, V153, P1731, DOI 10.1016/S0002-9440(10)65688-X; Klingenberg B, 2010, HISTOPATHOLOGY, V56, P957, DOI 10.1111/j.1365-2559.2010.03576.x; KOZAK FK, 1991, J OTOLARYNGOL, V20, P404; Larsen K, 2002, ACTA OTO-LARYNGOL, V122, P179, DOI 10.1080/00016480252814199; Lin CY, 2008, J CLIN VIROL, V42, P361, DOI 10.1016/j.jcv.2008.03.018; Lorenz LD, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003717; MIN YG, 1995, ACTA OTO-LARYNGOL, V115, P543, DOI 10.3109/00016489509139364; Mirghani H, 2014, ORAL ONCOL, V50, P1, DOI 10.1016/j.oraloncology.2013.10.008; Morbini P, 2012, J VIROL METHODS, V186, P99, DOI 10.1016/j.jviromet.2012.09.002; Nikakhlagh Soheila, 2012, Niger J Med, V21, P156; Orvidas LJ, 2001, AM J RHINOL, V15, P321, DOI 10.1177/194589240101500507; Ozcan C, 2005, EUR ARCH OTO-RHINO-L, V262, P55, DOI 10.1007/s00405-003-0729-1; Ozcan C, 2003, INT J PEDIATR OTORHI, V67, P383, DOI 10.1016/S0165-5876(02)00405-6; Pannone G, 2012, INFECT AGENTS CANCER, V7, P4, DOI DOI 10.1186/1750-9378-7-4; Pei F, 2011, J GEN VIROL, V92, P1795, DOI 10.1099/vir.0.031955-0; Rei<ss> M., 2009, FACHARZTWISSEN HNO H; Remmerbach TW, 2004, J CLIN VIROL, V30, P302, DOI 10.1016/j.jcv.2003.12.011; Rizzo R, 2014, J IMMUNOL RES, V2014, DOI [10.1155/2014/407430, DOI 10.1155/2014/407430]; Robinson M, 2012, HEAD NECK PATHOL, V6, pS83, DOI 10.1007/s12105-012-0370-7; Rudack C, 2002, LARYNGO RHINO OTOL, V81, P659, DOI 10.1055/s-2002-34453; Sham CL, 2012, HEAD NECK-J SCI SPEC, V34, P520, DOI 10.1002/hed.21772; Skladzien J, 2001, AURIS NASUS LARYNX, V28, P137, DOI 10.1016/S0385-8146(00)00108-5; Smeets SJ, 2007, INT J CANCER, V121, P2465, DOI 10.1002/ijc.22980; Sotlar K, 2004, J CLIN MICROBIOL, V42, P3176, DOI 10.1128/JCM.42.7.3176-3184.2004; Syrjanen S, 2010, ANN ONCOL, V21, P243, DOI 10.1093/annonc/mdq454; TOS M, 1977, Rhinology (Utrecht), V15, P87; van den Brule AJC, 2002, J CLIN MICROBIOL, V40, P779, DOI 10.1128/JCM.40.3.779-787.2002; Wagner S, 2012, HAUTARZT, V63, P24, DOI 10.1007/s00105-011-2196-8; Waller G, 1976, Laryngol Rhinol Otol (Stuttg), V55, P174; Wentzensen N, 2007, DIS MARKERS, V23, P315, DOI 10.1155/2007/678793; Wittekindt C, 2012, GMS CURR TOP OTORHIN, V11, pDoc09, DOI DOI 10.3205/CTO000091; Yamakoshi K, 2009, J CELL BIOL, V186, P393, DOI 10.1083/jcb.200904105; Yuca K, 2006, J OTOLARYNGOL, V35, P420, DOI 10.2310/7070.2005.0039; Zaravinos A, 2009, J MED VIROL, V81, P1613, DOI 10.1002/jmv.21534; Zhou Y, 2001, J CLIN OTORHINOLARYN, V15, P212; zurHausen H, 1996, BBA-REV CANCER, V1288, pF55	59	21	22	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2015	10	10							e0141722	10.1371/journal.pone.0141722	http://dx.doi.org/10.1371/journal.pone.0141722			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0DL	26509801	gold, Green Submitted, Green Published			2022-12-26	WOS:000363918100125
J	Gambelli, CN; Theisen, D; Willems, PA; Schepens, B				Gambelli, Clement N.; Theisen, Daniel; Willems, Patrick A.; Schepens, Benedicte			Motor Control of Landing from a Jump in Simulated Hypergravity	PLOS ONE			English	Article							NEUROMUSCULAR CONTROL; TASK EXECUTION; DROP-LANDINGS; LEG STIFFNESS; MOVEMENTS; KINEMATICS; KINETICS; GRAVITY; HUMANS; BIOMECHANICS	On Earth, when landing from a counter-movement jump, muscles contract before touchdown to anticipate imminent collision with the ground and place the limbs in a proper position. This study assesses how the control of landing is modified when gravity is increased above 1 g. Hypergravity was simulated in two different ways: (1) by generating centrifugal forces during turns of an aircraft (A300) and (2) by pulling the subject downwards in the laboratory with a Subject Loading System (SLS). Eight subjects were asked to perform counter-movement jumps at 1 g on Earth and at 3 hypergravity levels (1.2, 1.4 and 1.6 g) both in A300 and with SLS. External forces applied to the body, movements of the lower limb segments and muscular activity of 6 lower limb muscles were recorded. Our results show that both in A300 and with SLS, as in 1 g: (1) the anticipation phase is present; (2) during the loading phase (from touchdown until the peak of vertical ground reaction force), lower limb muscles act like a stiff spring, whereas during the second part (from the peak of vertical ground reaction force until the return to the standing position), they act like a compliant spring associated with a damper. (3) With increasing gravity, the preparatory adjustments and the loading phase are modified whereas the second part does not change drastically. (4) The modifications are similar in A300 and with SLS, however the effect of hypergravity is accentuated in A300, probably due to altered sensory inputs. This observation suggests that otolithic information plays an important role in the control of the landing from a jump.	[Gambelli, Clement N.; Willems, Patrick A.; Schepens, Benedicte] Catholic Univ Louvain, Inst Neurosci IoNS, Lab Physiol & Biomech Locomot, Louvain, Belgium; [Theisen, Daniel] Luxembourg Inst Hlth, Sports Med Res Lab, Luxembourg, Luxembourg	Universite Catholique Louvain; Luxembourg Institute of Health	Schepens, B (corresponding author), Catholic Univ Louvain, Inst Neurosci IoNS, Lab Physiol & Biomech Locomot, Louvain, Belgium.	benedicte.schepens@uclouvain.be		Theisen, Daniel/0000-0002-9699-3013; Gambelli, Clement/0000-0002-9172-2636	ESA-Prodex (Belgium) [4000103291]; Government of Luxembourg (Ministry of Higher Education and Research) through an ESA Contract in the Luxembourg Third Party Programme [4000107923/13/NL/KML]	ESA-Prodex (Belgium); Government of Luxembourg (Ministry of Higher Education and Research) through an ESA Contract in the Luxembourg Third Party Programme	This work was supported by ESA-Prodex (4000103291, Belgium) and co-funded by the Government of Luxembourg (Ministry of Higher Education and Research) through an ESA Contract in the Luxembourg Third Party Programme (4000107923/13/NL/KML). The view expressed herein can in no way be taken to reflect the official opinion of the European Space Agency. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arampatzis A, 2003, J ELECTROMYOGR KINES, V13, P533, DOI 10.1016/S1050-6411(03)00059-2; AVELA J, 1994, AVIAT SPACE ENVIR MD, V65, P301; Cavagna GA, 2009, P R SOC B, V276, P4279, DOI 10.1098/rspb.2009.1317; CAVAGNA GA, 1975, J APPL PHYSIOL, V39, P174, DOI 10.1152/jappl.1975.39.1.174; Clark TK, 2015, EXP BRAIN RES, V233, P1409, DOI 10.1007/s00221-015-4215-y; COHEN MM, 1973, PERCEPT PSYCHOPHYS, V14, P401, DOI 10.3758/BF03211174; Crevecoeur F, 2009, J NEUROPHYSIOL, V102, P786, DOI 10.1152/jn.00113.2009; Dai BY, 2015, AM J SPORT MED, V43, P466, DOI 10.1177/0363546514555322; Decker MJ, 2003, CLIN BIOMECH, V18, P662, DOI 10.1016/S0268-0033(03)00090-1; DUFEK JS, 1990, MED SCI SPORT EXER, V22, P370; Duncan A, 2000, J PHYSIOL-LONDON, V526, P457, DOI 10.1111/j.1469-7793.2000.t01-1-00457.x; DYHREPOULSEN P, 1991, J PHYSIOL-LONDON, V437, P287, DOI 10.1113/jphysiol.1991.sp018596; FARLEY CT, 1991, J APPL PHYSIOL, V71, P2127, DOI 10.1152/jappl.1991.71.6.2127; Ferris DP, 1997, J APPL PHYSIOL, V82, P15, DOI 10.1152/jappl.1997.82.1.15; GOLLHOFER A, 1991, INT J SPORTS MED, V12, P34, DOI 10.1055/s-2007-1024652; Gosseye TP, 2010, EUR J APPL PHYSIOL, V110, P709, DOI 10.1007/s00421-010-1549-9; GROSS TS, 1988, MED SCI SPORT EXER, V20, P506; JONES GM, 1971, J PHYSIOL-LONDON, V219, P709, DOI 10.1113/jphysiol.1971.sp009684; Kramer A, 2012, J BIOMECH, V45, P1816, DOI 10.1016/j.jbiomech.2012.04.014; Kulas A, 2008, J BIOMECH, V41, P180, DOI 10.1016/j.jbiomech.2007.06.027; Lebiedowska MK, 2009, J BIOMECH, V42, P762, DOI 10.1016/j.jbiomech.2008.12.021; Leukel C, 2012, HUM MOVEMENT SCI, V31, P152, DOI 10.1016/j.humov.2011.04.006; Liebermann DG, 2007, J ELECTROMYOGR KINES, V17, P212, DOI 10.1016/j.jelekin.2006.01.011; Liebermann DG, 2005, J ELECTROMYOGR KINES, V15, P120, DOI 10.1016/j.jelekin.2004.07.005; MCKINLEY P, 1992, EXP BRAIN RES, V90, P427; MCKINLEY PA, 1983, EXP BRAIN RES, V52, P439; MCNITTGRAY JL, 1993, J BIOMECH, V26, P1037, DOI 10.1016/S0021-9290(05)80003-X; Mrdakovic V, 2008, J SPORT SCI MED, V7, P269; Newman DJ, 1997, EXP BRAIN RES, V117, P30, DOI 10.1007/PL00005788; Santello M, 1998, EXP PHYSIOL, V83, P857, DOI 10.1113/expphysiol.1998.sp004165; Santello M, 2005, GAIT POSTURE, V21, P85, DOI 10.1016/j.gaitpost.2004.01.005; Santello M, 2001, J PHYSIOL-LONDON, V537, P313, DOI 10.1111/j.1469-7793.2001.0313k.x; Schepens B, 1998, J PHYSIOL-LONDON, V509, P927, DOI 10.1111/j.1469-7793.1998.927bm.x; Self BP, 2001, MED SCI SPORT EXER, V33, P1338, DOI 10.1097/00005768-200108000-00015; Zhang SN, 2000, MED SCI SPORT EXER, V32, P812, DOI 10.1097/00005768-200004000-00014; Zuur AT, 2010, J PHYSIOL-LONDON, V588, P799, DOI 10.1113/jphysiol.2009.182709	36	13	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2015	10	10							e0141574	10.1371/journal.pone.0141574	http://dx.doi.org/10.1371/journal.pone.0141574			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU8PC	26505472	Green Submitted, gold, Green Published			2022-12-26	WOS:000363804200086
J	Martinez-Crego, B; Arteaga, P; Ueber, A; Engelen, AH; Santos, R; Molis, M				Martinez-Crego, Begona; Arteaga, Pedro; Ueber, Alexandra; Engelen, Aschwin H.; Santos, Rui; Molis, Markus			Specificity in Mesograzer-Induced Defences in Seagrasses	PLOS ONE			English	Article							INDUCED PLANT-RESPONSES; SEAWEED ASCOPHYLLUM-NODOSUM; MILKWEED ASCLEPIAS-SYRIACA; FRESH-WATER MACROPHYTES; ANTI-HERBIVORY DEFENSES; POSIDONIA-OCEANICA; SECONDARY METABOLITES; INDUCED RESISTANCE; CHEMICAL DEFENSES; SPECIALIST HERBIVORES	Grazing-induced plant defences that reduce palatability to herbivores are widespread in terrestrial plants and seaweeds, but they have not yet been reported in seagrasses. We investigated the ability of two seagrass species to induce defences in response to direct grazing by three associated mesograzers. Specifically, we conducted feeding-assayed induction experiments to examine how mesograzer-specific grazing impact affects seagrass induction of defences within the context of the optimal defence theory. We found that the amphipod Gammarus insensibilis and the isopod Idotea chelipes exerted a low-intensity grazing on older blades of the seagrass Cymodocea nodosa, which reflects a weak grazing impact that may explain the lack of inducible defences. The isopod Synischia hectica exerted the strongest grazing impact on C. nodosa via high-intensity feeding on young blades with a higher fitness value. This isopod grazing induced defences in C. nodosa as indicated by a consistently lower consumption of blades previously grazed for 5, 12 and 16 days. The lower consumption was maintained when offered tissues with no plant structure (agar-reconstituted food), but showing a reduced size of the previous grazing effect. This indicates that structural traits act in combination with chemical traits to reduce seagrass palatability to the isopod. Increase in total phenolics but not in C:N ratio and total nitrogen of grazed C. nodosa suggests chemical defences rather than a modified nutritional quality as primarily induced chemical traits. We detected no induction of defences in Zostera noltei, which showed the ability to replace moderate losses of young biomass to mesograzers via compensatory growth. Our study provides the first experimental evidence of induction of defences against meso-herbivory that reduce further consumption in seagrasses. It also emphasizes the relevance of grazer identity in determining the level of grazing impact triggering resistance and compensatory responses of different seagrass species.	[Martinez-Crego, Begona; Arteaga, Pedro; Engelen, Aschwin H.; Santos, Rui] Ctr Marine Sci CCMAR, Faro, Portugal; [Ueber, Alexandra] Univ Rostock, D-18055 Rostock, Germany; [Molis, Markus] Helmholtz Zentrum Polar & Meeresforsch, Alfred Wegener Inst, Sect Funct Ecol, Bremerhaven, Germany	University of Rostock; Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research	Martinez-Crego, B (corresponding author), Ctr Marine Sci CCMAR, Faro, Portugal.	bmcrego@ualg.pt	Santos, Rui O P/B-4168-2008; Martínez-Crego, Begoña/J-4090-2013; Engelen, Aschwin H/M-3432-2013	Santos, Rui O P/0000-0002-7861-4366; Martínez-Crego, Begoña/0000-0002-9051-6961; Engelen, Aschwin H/0000-0002-9579-9606	Portuguese Foundation for Science and Technology (FCT) [EXPL/MAREST/0818/2013]; European Community's Seventh Framework Program (FP7) [227799-ASSEMBLE]; FCT [SFRH/BPD/75307/2010, SFRH/BPD/63703/2009]	Portuguese Foundation for Science and Technology (FCT)(Portuguese Foundation for Science and Technology); European Community's Seventh Framework Program (FP7); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission)	This research was funded by the Portuguese Foundation for Science and Technology (FCT) through the exploratory project EXPL/MAREST/0818/2013. MM and AU's visit to the Ramalhete station was supported by the European Community's Seventh Framework Program (FP7/2007-2013) under grant agreement no 227799-ASSEMBLE. BMC and AE were supported by FCT post-doctoral fellowships (SFRH/BPD/75307/2010 and SFRH/BPD/63703/2009, respectively). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal AA, 1998, SCIENCE, V279, P1201, DOI 10.1126/science.279.5354.1201; Alcoverro T, 1998, J EXP MAR BIOL ECOL, V230, P1, DOI 10.1016/S0022-0981(98)00022-7; Amsler CD, 2006, ADV BOT RES, V43, P1, DOI 10.1016/S0065-2296(05)43001-3; Amsler CD, 2001, J PHYCOL, V37, P353, DOI 10.1046/j.1529-8817.2001.037003353.x; BALDWIN IT, 1990, TRENDS ECOL EVOL, V5, P91, DOI 10.1016/0169-5347(90)90237-8; BENNETT RN, 1994, NEW PHYTOL, V127, P617, DOI 10.1111/j.1469-8137.1994.tb02968.x; Best RJ, 2014, ECOLOGY, V95, P775, DOI 10.1890/13-0163.1; Boeckler GA, 2011, PHYTOCHEMISTRY, V72, P1497, DOI 10.1016/j.phytochem.2011.01.038; Bolser RC, 1998, J CHEM ECOL, V24, P1639, DOI 10.1023/A:1020816511924; BROWN GC, 1991, J KANSAS ENTOMOL SOC, V64, P388; CASOLA E, 1987, PSZNI MAR ECOL, V8, P285, DOI 10.1111/j.1439-0485.1987.tb00189.x; Cronin G, 1996, ECOLOGY, V77, P2287, DOI 10.2307/2265731; Cronin G, 2002, J CRUSTACEAN BIOL, V22, P708, DOI 10.1651/0278-0372(2002)022[0708:CFPFFM]2.0.CO;2; Cronin G, 2001, CRC MAR SCI, P325; Cunha AH, 2009, J COASTAL RES, P1100; de los Santos CB, 2013, MAR BIOL, V160, P1083, DOI 10.1007/s00227-012-2159-3; DUFFY JE, 1991, ECOLOGY, V72, P1286, DOI 10.2307/1941102; Durako MJ, 2002, AQUAT BOT, V73, P173, DOI 10.1016/S0304-3770(02)00020-7; Ferraro DO, 2002, OIKOS, V98, P125, DOI 10.1034/j.1600-0706.2002.980113.x; Flothe CR, 2013, J PHYCOL, V49, P468, DOI 10.1111/jpy.12059; Fornoff F, 2014, OECOLOGIA, V175, P173, DOI 10.1007/s00442-013-2880-8; Fourqurean JW, 2012, NAT GEOSCI, V5, P505, DOI 10.1038/ngeo1477; Grignon-Dubois M, 2012, ESTUAR COAST SHELF S, V114, P18, DOI 10.1016/j.ecss.2011.09.010; Guimaraes MHME, 2012, J NAT CONSERV, V20, P30, DOI 10.1016/j.jnc.2011.07.005; Hanley ME, 2007, PERSPECT PLANT ECOL, V8, P157, DOI 10.1016/j.ppees.2007.01.001; Hay ME, 1996, J EXP MAR BIOL ECOL, V200, P103, DOI 10.1016/S0022-0981(96)02659-7; HAY ME, 1990, ECOLOGY, V71, P733, DOI 10.2307/1940326; HAY ME, 1994, ECOLOGY, V75, P1714, DOI 10.2307/1939631; Heglmeier A, 2010, BIOCHEM SYST ECOL, V38, P964, DOI 10.1016/j.bse.2010.07.001; Hughes AR, 2004, MAR ECOL PROG SER, V282, P87, DOI 10.3354/meps282087; Huitu O, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00478; Jormalainen V, 2004, J EVOLUTION BIOL, V17, P807, DOI 10.1111/j.1420-9101.2004.00715.x; Karban R, 1999, TRENDS ECOL EVOL, V14, P443, DOI 10.1016/S0169-5347(99)01678-X; KARBAN R, 1989, ANNU REV ECOL SYST, V20, P331, DOI 10.1146/annurev.es.20.110189.001555; Karban R, 2011, FUNCT ECOL, V25, P339, DOI 10.1111/j.1365-2435.2010.01789.x; Karez R, 2000, MAR ECOL PROG SER, V205, P85, DOI 10.3354/meps205085; Kempel A, 2011, P NATL ACAD SCI USA, V108, P5685, DOI 10.1073/pnas.1016508108; Kessler A, 2002, ANNU REV PLANT BIOL, V53, P299, DOI 10.1146/annurev.arplant.53.100301.135207; La Nafie YA, 2012, LIMNOL OCEANOGR, V57, P1664, DOI 10.4319/lo.2012.57.6.1664; Leimu R, 2006, OIKOS, V112, P1, DOI 10.1111/j.0030-1299.2006.41023.x; LEWINSOHN E, 1991, PLANT PHYSIOL, V96, P44, DOI 10.1104/pp.96.1.44; Long JD, 2007, ECOLOGY, V88, P1232, DOI 10.1890/06-1585; Martinez-Crego B, 2008, MAR ECOL PROG SER, V361, P93, DOI 10.3354/meps07358; Maxwell PS, 2014, J ECOL, V102, P54, DOI 10.1111/1365-2745.12167; Molis M, 2008, MAR ECOL PROG SER, V354, P97, DOI 10.3354/meps07255; Moran MD, 2003, OIKOS, V100, P403, DOI 10.1034/j.1600-0706.2003.12010.x; Morrison WE, 2011, OECOLOGIA, V165, P427, DOI 10.1007/s00442-010-1791-1; Muola A, 2010, J EVOLUTION BIOL, V23, P2185, DOI 10.1111/j.1420-9101.2010.02077.x; Nykanen H, 2004, OIKOS, V104, P247, DOI 10.1111/j.0030-1299.2004.12768.x; Ohgushi T, 2005, ANNU REV ECOL EVOL S, V36, P81, DOI 10.1146/annurev.ecolsys.36.091704.175523; Orth RJ, 2006, BIOSCIENCE, V56, P987, DOI 10.1641/0006-3568(2006)56[987:AGCFSE]2.0.CO;2; Pavia H, 2000, ECOLOGY, V81, P3212; Reynolds PL, 2014, LIMNOL OCEANOGR, V59, P1053, DOI 10.4319/lo.2014.59.3.1053; Rohde S, 2008, J EXP MAR BIOL ECOL, V367, P227, DOI 10.1016/j.jembe.2008.10.003; Ruohomaki K, 1997, ECOLOGY, V78, P2105, DOI 10.1890/0012-9658(1997)078[2105:LVEODT]2.0.CO;2; Sanmarti N, 2014, MAR ECOL PROG SER, V517, P159, DOI 10.3354/meps11084; Steele L, 2015, MAR ECOL PROG SER, V524, P83, DOI 10.3354/meps11127; Steele L, 2012, MAR ECOL PROG SER, V466, P81, DOI 10.3354/meps09921; Strauss SY, 1999, TRENDS ECOL EVOL, V14, P179, DOI 10.1016/S0169-5347(98)01576-6; Taylor RB, 2003, OECOLOGIA, V136, P412, DOI 10.1007/s00442-003-1280-x; Tomas F, 2015, GLOBAL CHANGE BIOL, V21, P4021, DOI 10.1111/gcb.13024; Toth GB, 2007, J ECOL, V95, P425, DOI 10.1111/j.1365-2745.2007.01224.x; Underwood A.J., 1997, EXPT ECOLOGY THEIR L, DOI DOI 10.1017/CBO9780511806407; Van Zandt PA, 2004, ECOLOGY, V85, P2616, DOI 10.1890/03-0622; Van Zandt PA, 2004, OIKOS, V104, P401, DOI 10.1111/j.0030-1299.2004.12964.x; Verges A, 2008, OECOLOGIA, V155, P751, DOI 10.1007/s00442-007-0943-4; Verges A, 2007, MAR ECOL PROG SER, V343, P107, DOI 10.3354/meps06885; Verges A, 2011, OECOLOGIA, V166, P381, DOI 10.1007/s00442-010-1830-y; ZIEMAN JC, 1974, AQUACULTURE, V4, P139, DOI 10.1016/0044-8486(74)90029-5	69	7	7	2	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2015	10	10							e0141219	10.1371/journal.pone.0141219	http://dx.doi.org/10.1371/journal.pone.0141219			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU8PC	26506103	Green Published, gold, Green Submitted			2022-12-26	WOS:000363804200036
J	Phan, HTM; Bartelt-Hunt, S; Rodenhausen, KB; Schubert, M; Bartz, JC				Phan, Hanh T. M.; Bartelt-Hunt, Shannon; Rodenhausen, Keith B.; Schubert, Mathias; Bartz, Jason C.			Investigation of Bovine Serum Albumin (BSA) Attachment onto Self-Assembled Monolayers (SAMs) Using Combinatorial Quartz Crystal Microbalance with Dissipation (QCM-D) and Spectroscopic Ellipsometry (SE)	PLOS ONE			English	Article							PROTEIN ADSORPTION; CONFORMATIONAL-CHANGES; FORCE MICROSCOPY; SOLID-SURFACES; GOLD; KINETICS; FILMS; NANOPARTICLES; BEHAVIOR; POWDER	Understanding protein adsorption kinetics to surfaces is of importance for various environmental and biomedical applications. Adsorption of bovine serum albumin to various self-assembled monolayer surfaces including neutral and charged hydrophilic and hydrophobic surfaces was investigated using in-situ combinatorial quartz crystal microbalance with dissipation and spectroscopic ellipsometry. Adsorption of bovine serum albumin varied as a function of surface properties, bovine serum albumin concentration and pH value. Charged surfaces exhibited a greater quantity of bovine serum albumin adsorption, a larger bovine serum albumin layer thickness, and increased density of bovine serum albumin protein compared to neutral surfaces at neutral pH value. The quantity of adsorbed bovine serum albumin protein increased with increasing bovine serum albumin concentration. After equilibrium sorption was reached at pH 7.0, desorption of bovine serum albumin occurred when pH was lowered to 2.0, which is below the isoelectric point of bovine serum albumin. Our data provide further evidence that combinatorial quartz crystal microbalance with dissipation and spectroscopic ellipsometry is a sensitive analytical tool to evaluate attachment and detachment of adsorbed proteins in systems with environmental implications.	[Phan, Hanh T. M.; Bartelt-Hunt, Shannon] Univ Nebraska, Dept Civil Engn, Lincoln, NE 68588 USA; [Rodenhausen, Keith B.; Schubert, Mathias] Univ Nebraska, Dept Elect & Comp Engn, Lincoln, NE USA; [Bartz, Jason C.] Creighton Univ, Dept Med Microbiol & Immunol, Omaha, NE 68178 USA	University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln; Creighton University	Bartelt-Hunt, S (corresponding author), Univ Nebraska, Dept Civil Engn, Lincoln, NE 68588 USA.	sbartelt2@unl.edu	Schubert, Mathias/B-2676-2017	Schubert, Mathias/0000-0001-6238-663X; Bartz, Jason/0000-0003-4081-7886	National Science Foundation [CBET-1149242, EPS-1004094]; Div Of Chem, Bioeng, Env, & Transp Sys [1149242] Funding Source: National Science Foundation; EPSCoR [1004094] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Div Of Chem, Bioeng, Env, & Transp Sys(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG)); EPSCoR(National Science Foundation (NSF)NSF - Office of the Director (OD))	Funding for this work was provided by the National Science Foundation (www.nsf.gov) (award CBET-1149242 to SB and award EPS-1004094 to MS). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Alkan M, 2006, MICROPOR MESOPOR MAT, V96, P331, DOI 10.1016/j.micromeso.2006.07.007; Anzai J, 1996, BIOELECTROCH BIOENER, V40, P35, DOI 10.1016/0302-4598(95)05047-7; BAIN CD, 1989, J AM CHEM SOC, V111, P321, DOI 10.1021/ja00183a049; Bajpai AK, 2000, J APPL POLYM SCI, V78, P933, DOI 10.1002/1097-4628(20001031)78:5<933::AID-APP10>3.0.CO;2-G; Barrett DA, 2005, J SEP SCI, V28, P483, DOI 10.1002/jssc.200301667; Bittrich E, 2010, BIOINTERPHASES, V5, P1, DOI 10.1116/1.3530841; Bradford DC, 2005, J PHYS CHEM B, V109, P20914, DOI 10.1021/jp052764c; Chen KL, 2006, LANGMUIR, V22, P10994, DOI 10.1021/la062072v; Chong KSL, 2005, LANGMUIR, V21, P3903, DOI 10.1021/la0500169; Contreras AE, 2011, ENVIRON SCI TECHNOL, V45, P6309, DOI 10.1021/es200570t; DIMILLA PA, 1994, J AM CHEM SOC, V116, P2225, DOI 10.1021/ja00084a105; Horbett TA, 1995, FUNDAMENTALS APPL; Hourrigan JL, 1996, BOVINE SPONGIFORM EN, P59; Jernstrom F., 2001, SELF ASSEMBLED MONOL; Kasputis T, 2014, THIN SOLID FILMS; Kasputis T, 2014, THIN SOLID FILMS, V571, P637, DOI 10.1016/j.tsf.2014.01.046; Kasputis T, 2013, J PHYS CHEM C, V117, P13971, DOI 10.1021/jp402055h; Koenig M, 2014, ANAL BIOANAL CHEM, V406, P7233, DOI 10.1007/s00216-014-8154-4; Koenig M, 2013, PART PART SYST CHAR, V30, P931, DOI 10.1002/ppsc.201300155; Kopac T, 2008, COLLOID SURFACE A, V322, P19, DOI 10.1016/j.colsurfa.2008.02.010; Kudelski A, 2003, VIB SPECTROSC, V33, P197, DOI 10.1016/j.vibspec.2003.089.003; Love JC, 2005, CHEM REV, V105, P1103, DOI 10.1021/cr0300789; Majorek KA, 2012, MOL IMMUNOL, V52, P174, DOI 10.1016/j.molimm.2012.05.011; McClellan SJ, 2003, COLLOID SURFACE B, V28, P63, DOI 10.1016/S0927-7765(02)00131-5; Mendoza SM, 2007, LANGMUIR, V23, P582, DOI 10.1021/la0605539; NORDE W, 1994, PURE APPL CHEM, V66, P491, DOI 10.1351/pac199466030491; Norde W, 2000, PHYSICAL CHEMISTRY OF BIOLOGICAL INTERFACES, P115; Oliva FY, 2003, J COLLOID INTERF SCI, V261, P299, DOI 10.1016/S0021-9797(03)00029-8; Peters T., 1996, ALL ALBUMIN BIOCH GE; Rabe M, 2011, ADV COLLOID INTERFAC, V162, P87, DOI 10.1016/j.cis.2010.12.007; Roach P, 2005, J AM CHEM SOC, V127, P8168, DOI 10.1021/ja042898o; Rodenhausen KB, 2011, REV SCI INSTRUM, V82, DOI 10.1063/1.3653880; Rodenhausen KB, 2011, THIN SOLID FILMS, V519, P2772, DOI 10.1016/j.tsf.2010.11.079; Rodenhausen KB, 2011, THIN SOLID FILMS, V519, P2817, DOI 10.1016/j.tsf.2010.11.081; Rodenhausen KB, 2012, OPT EXPRESS, V20, P5419, DOI 10.1364/OE.20.005419; Seitz R, 2005, APPL SURF SCI, V252, P154, DOI 10.1016/j.apsusc.2005.02.012; Servagent-Noinville S, 2000, J COLLOID INTERF SCI, V221, P273, DOI 10.1006/jcis.1999.6576; SHIRAHAMA H, 1986, J COLLOID INTERF SCI, V109, P552, DOI 10.1016/0021-9797(86)90336-X; Sigal GB, 1998, J AM CHEM SOC, V120, P3464, DOI 10.1021/ja970819l; Smith DA, 2000, J PHYS CHEM B, V104, P8862, DOI 10.1021/jp0023056; Sun SD, 2003, J MEMBRANE SCI, V222, P3, DOI 10.1016/S0376-7388(03)00313-2; Ulman A, 1996, CHEM REV, V96, P1533, DOI 10.1021/cr9502357; Wassell DTH, 1996, BIOMATERIALS, V17, P859, DOI 10.1016/0142-9612(96)83280-7; WHITESIDES GM, 1990, LANGMUIR, V6, P87, DOI 10.1021/la00091a013; Yohannes G, 2010, ANAL CHIM ACTA, V675, P191, DOI 10.1016/j.aca.2010.07.016; Zhang J, 2000, ANAL CHEM, V72, P1973, DOI 10.1021/ac9913107	46	125	126	3	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2015	10	10							e0141282	10.1371/journal.pone.0141282	http://dx.doi.org/10.1371/journal.pone.0141282			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU8PC	26505481	Green Published, gold			2022-12-26	WOS:000363804200042
J	Rey, C; Faustin, B; Mahouche, I; Ruggieri, R; Brulard, C; Ichas, F; Soubeyran, I; Lartigue, L; De Giorgi, F				Rey, C.; Faustin, B.; Mahouche, I.; Ruggieri, R.; Brulard, C.; Ichas, F.; Soubeyran, I.; Lartigue, L.; De Giorgi, F.			The MAP3K ZAK, a novel modulator of ERK-dependent migration, is upregulated in colorectal cancer	ONCOGENE			English	Article							MIXED-LINEAGE KINASE; PROTEIN TRIPLE KINASE; TUMOR-CELL INVASION; HYPERTROPHIC GROWTH; EXPRESSION PROFILES; ACTIVATION; PHOSPHORYLATION; GTPASE; RHOGDI; JNK	Often described as a mediator of cell cycle arrest or as a pro-apoptotic factor in stressful conditions, the MAP3K ZAK (Sterile alpha motif and leucine zipper-containing kinase) has also been proven to positively regulate epidermal growth factor receptor (EGFR) and WNT signaling pathways, cancer cell proliferation and cellular neoplastic transformation. Here, we show that both isoforms of ZAK, ZAK-alpha and ZAK-beta are key factors in cancer cell migration. While ZAK depletion reduced cell motility of HeLa and HCT116 cells, its overexpression triggered the activation of all three mitogen-activated protein kinases (MAPKs), extracellular signal-regulated kinase (ERK), c-JUN N-terminal kinase (JNK) and p38, as well as an increase in cell motion. On the contrary, the kinase-dead mutants, ZAK-alpha K45M and ZAK-beta K45M, were not able to provoke such events, and instead exerted a dominant-negative effect on MAPK activation and cell migration. Pharmacological inhibition of ZAK by nilotinib, preventing ZAK-autophosphorylation and thereby auto-activation, led to the same results. Activated by epidermal growth factor (EGF), we further showed that ZAK constitutes an essential element of the EGF/ERK-dependent cell migration pathway. Using public transcriptomic databases and tissue microarrays, we finally established that, as strong factors of the EGFR signaling pathway, ZAK-alpha and/or ZAK-beta transcripts and protein(s) are frequently upregulated in colorectal adenoma and carcinoma patients. Notably, gene set enrichment analysis disclosed a significant correlation between ZAK+ colorectal premalignant lesions and gene sets belonging to the MAPK/ERK and motility-related signaling pathways of the reactome database, strongly suggesting that ZAK induces such pro-tumoral reaction cascades in human cancers.	[Rey, C.; Mahouche, I.; Brulard, C.; Lartigue, L.] Univ Bordeaux 2, Inst Bergonie, Lab Validat & Identificat Nouvelles Cibles Oncol, INSERM U916, 229 Cours Argonne, F-33076 Bordeaux, France; [Faustin, B.] CNRS CIRID, Bordeaux, France; [Ruggieri, R.] Feinstein Inst Med Res, Lab Cell Signaling, Manhasset, NY USA; [Ichas, F.; De Giorgi, F.] Fluofarma, 2 Rue R Escarpit, Pessac, France; [Soubeyran, I.] Inst Bergonie, Dept Biopathol, Bordeaux, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; UNICANCER; Institut Bergonie; Northwell Health; UNICANCER; Institut Bergonie	Lartigue, L (corresponding author), Univ Bordeaux 2, Inst Bergonie, Lab Validat & Identificat Nouvelles Cibles Oncol, INSERM U916, 229 Cours Argonne, F-33076 Bordeaux, France.	l.lartigue-faustin@bordeaux.unicancer.fr	Ichas, François/ABD-8277-2020	Ichas, François/0000-0001-8184-5248	French National Institute for Medical Research (INSERM); Aquitaine Region; French Ministry of Research; Institut Bergonie; Association for Cancer Research (ARC); Ligue Contre le Cancer; Canceropole Grand Sud-Ouest; 'Agir Cancer' Gironde; French National Research Agency (ANR)	French National Institute for Medical Research (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Aquitaine Region(Region Nouvelle-Aquitaine); French Ministry of Research(Ministry of Research, FranceEuropean Commission); Institut Bergonie; Association for Cancer Research (ARC); Ligue Contre le Cancer(Ligue nationale contre le cancer); Canceropole Grand Sud-Ouest; 'Agir Cancer' Gironde; French National Research Agency (ANR)(French National Research Agency (ANR))	This work was supported by the French National Institute for Medical Research (INSERM), Aquitaine Region, French Ministry of Research, Institut Bergonie, Association for Cancer Research (ARC), the Ligue Contre le Cancer, and Canceropole Grand Sud-Ouest, 'Agir Cancer' Gironde and The French National Research Agency (ANR). We thank Nicolas Faur, Raphael Moustie and Assia Chaibi for their technical help and Pippa McKelvie-Sebileau of Institut Bergonie for medical editorial assistance.	Adler AS, 2014, GENE DEV, V28, P1068, DOI 10.1101/gad.237206.113; Amano M, 1996, SCIENCE, V271, P648, DOI 10.1126/science.271.5249.648; Barrett T, 2007, NUCLEIC ACIDS RES, V35, pD760, DOI 10.1093/nar/gkl887; Bloem LJ, 2001, J MOL CELL CARDIOL, V33, P1739, DOI 10.1006/jmcc.2001.1437; Cho YY, 2004, CANCER RES, V64, P3855, DOI 10.1158/0008-5472.CAN-04-0201; Choi HS, 2005, J BIOL CHEM, V280, P13545, DOI 10.1074/jbc.M410521200; DerMardirossian C, 2005, TRENDS CELL BIOL, V15, P356, DOI 10.1016/j.tcb.2005.05.001; DerMardirossian C, 2004, MOL CELL, V15, P117, DOI 10.1016/j.molcel.2004.05.019; Firestein R, 2008, NATURE, V455, P547, DOI 10.1038/nature07179; Goi T, 2000, EMBO J, V19, P623, DOI 10.1093/emboj/19.4.623; Gotoh I, 2001, J BIOL CHEM, V276, P4276, DOI 10.1074/jbc.M008595200; Griner EM, 2013, ONCOGENE, V32, P1010, DOI 10.1038/onc.2012.124; Gross EA, 2002, J BIOL CHEM, V277, P13873, DOI 10.1074/jbc.M111994200; Huang C, 2004, J CELL SCI, V117, P4619, DOI 10.1242/jcs.01481; Huang CY, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-56; Huang CY, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-11; Huang CY, 2004, BIOCHEM BIOPH RES CO, V324, P973, DOI 10.1016/j.bbrc.2004.09.156; Korkina O, 2013, J BIOL CHEM, V288, P5364, DOI 10.1074/jbc.M112.414060; Liu JF, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4830; Liu TC, 2000, BIOCHEM BIOPH RES CO, V274, P811, DOI 10.1006/bbrc.2000.3236; Lu ZM, 2001, MOL CELL BIOL, V21, P4016, DOI 10.1128/MCB.21.12.4016-4031.2001; Manley PW, 2010, BBA-PROTEINS PROTEOM, V1804, P445, DOI 10.1016/j.bbapap.2009.11.008; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Rajalingam K, 2005, NAT CELL BIOL, V7, P837, DOI 10.1038/ncb1283; Ray RM, 2012, CELL SIGNAL, V24, P931, DOI 10.1016/j.cellsig.2011.12.016; Reiterer V, 2013, P NATL ACAD SCI USA, V110, pE2934, DOI 10.1073/pnas.1301985110; Rey C, 2013, CELL CYCLE, V12, P1879, DOI 10.4161/cc.24927; Rix U, 2010, LEUKEMIA, V24, P44, DOI 10.1038/leu.2009.228; Rix U, 2007, BLOOD, V110, P4055, DOI 10.1182/blood-2007-07-102061; Sabates-Beliver J, 2007, MOL CANCER RES, V5, P1263, DOI 10.1158/1541-7786.MCR-07-0267; Schaeffer HJ, 1999, MOL CELL BIOL, V19, P2435; Schaller MD, 2010, J CELL SCI, V123, P1007, DOI 10.1242/jcs.045112; Sieg DJ, 2000, NAT CELL BIOL, V2, P249, DOI 10.1038/35010517; Soubeyran I, 2011, AM J PATHOL, V178, P1986, DOI 10.1016/j.ajpath.2011.01.021; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Takahashi M, 2003, J BIOCHEM, V133, P181, DOI 10.1093/jb/mvg022; van Zijl F, 2011, MUTAT RES-REV MUTAT, V728, P23, DOI 10.1016/j.mrrev.2011.05.002; Vinayagam A, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001699; Wagner EF, 2009, NAT REV CANCER, V9, P537, DOI 10.1038/nrc2694; Wang XS, 2005, J BIOL CHEM, V280, P19298, DOI 10.1074/jbc.M413059200; Yang JJ, 2010, CANCER SCI, V101, P1374, DOI 10.1111/j.1349-7006.2010.01537.x; Yang JJ, 2003, BIOCHEM BIOPH RES CO, V301, P71, DOI 10.1016/S0006-291X(02)02980-7; Yang JJ, 2002, BIOCHEM BIOPH RES CO, V297, P105, DOI 10.1016/S0006-291X(02)02123-X; Yoon S, 2006, GROWTH FACTORS, V24, P21, DOI 10.1080/02699050500284218	45	27	27	1	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 16	2016	35	24					3190	3200		10.1038/onc.2015.379	http://dx.doi.org/10.1038/onc.2015.379			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DO9GI	26522728				2022-12-26	WOS:000378092700010
J	Abu-Fanne, R; Maraga, E; Abd-Elrahman, I; Hankin, A; Blum, G; Abdeen, S; Hijazi, N; Cines, DB; Higazi, A				Abu-Fanne, Rami; Maraga, Emad; Abd-Elrahman, Ihab; Hankin, Aviel; Blum, Galia; Abdeen, Suhair; Hijazi, Nuha; Cines, Douglas B.; Higazi, Abd Al-Roof			alpha-Defensins Induce a Post-translational Modification of Low Density Lipoprotein (LDL) That Promotes Atherosclerosis at Normal Levels of Plasma Cholesterol	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANTIMICROBIAL PEPTIDES; PLASMINOGEN-ACTIVATOR; FACTOR-VIII; CELLS; NEUTROPHILS; DEFICIENCY; BINDING; APOLIPOPROTEIN; LL-37	Approximately one-half of the patients who develop clinical atherosclerosis have normal or only modest elevations in plasma lipids, indicating that additional mechanisms contribute to pathogenesis. In view of increasing evidence that inflammation contributes to atherogenesis, we studied the effect of human neutrophil alpha-defensins on low density lipoprotein (LDL) trafficking, metabolism, vascular deposition, and atherogenesis using transgenic mice expressing human alpha-defensins in their polymorphonuclear leukocytes (Def(+/+)). Accelerated Def(+/+) mice developed alpha-defensin.LDL complexes that accelerate the clearance of LDL from the circulation accompanied by enhanced vascular deposition and retention of LDL, induction of endothelial cathepsins, increased endothelial permeability to LDL, and the development of lipid streaks in the aortic roots when fed a regular diet and at normal plasma levels of LDL. Transplantation of bone marrow from Def(+/+) to WT mice increased LDL clearance, increased vascular permeability, and increased vascular deposition of LDL, whereas transplantation of WT bone marrow to Def(+/+) mice prevented these outcomes. The same outcome was obtained by treating Def(+/+) mice with colchicine to inhibit the release of alpha-defensins. These studies identify a potential new link between inflammation and the development of atherosclerosis.	[Abu-Fanne, Rami; Maraga, Emad; Hankin, Aviel; Abdeen, Suhair; Hijazi, Nuha; Higazi, Abd Al-Roof] Hadassah Hebrew Univ, Dept Clin Biochem, IL-91120 Jerusalem, Israel; [Abd-Elrahman, Ihab; Blum, Galia] Hadassah Hebrew Univ, Sch Pharm, IL-91120 Jerusalem, Israel; [Cines, Douglas B.; Higazi, Abd Al-Roof] Univ Penn, Dept Pathol & Lab Med, Perelman Sch Med, 513A Stellar Chance,422 Curie Blvd, Philadelphia, PA 19104 USA	Hebrew University of Jerusalem; Hadassah University Medical Center; Hebrew University of Jerusalem; Hadassah University Medical Center; University of Pennsylvania; Pennsylvania Medicine	Higazi, A (corresponding author), Univ Penn, Dept Pathol & Lab Med, Perelman Sch Med, 513A Stellar Chance,422 Curie Blvd, Philadelphia, PA 19104 USA.	higazi@mail.med.upenn.edu		Cines, Douglas/0000-0001-5986-504X	National Institutes of Health [HL077760, HL805429, HL82545, HL123912]; Israeli Science Foundation [930/04]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL123912, R01HL077760, R56HL123912] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Israeli Science Foundation(Israel Science Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health Grants HL077760, HL805429, HL82545, and HL123912 and by Grant 930/04 from the Israeli Science Foundation. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Agerberth B, 2000, BLOOD, V96, P3086, DOI 10.1182/blood.V96.9.3086.h8003086_3086_3093; Barnathan ES, 1997, AM J PATHOL, V150, P1009; Bdeir K, 1999, BLOOD, V94, P2007; Bdeir K, 2010, AM J RESP CRIT CARE, V181, P935, DOI 10.1164/rccm.200907-1128OC; Blum G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006374; Chen Y, 2015, BBA-MOL CELL RES, V1853, P396, DOI 10.1016/j.bbamcr.2014.11.012; Christensen HM, 2012, EUR J HEART FAIL, V14, P387, DOI 10.1093/eurjhf/hfs021; Drechsler M, 2010, CIRCULATION, V122, P1837, DOI 10.1161/CIRCULATIONAHA.110.961714; EISENHAUER PB, 1992, INFECT IMMUN, V60, P3446, DOI 10.1128/IAI.60.8.3446-3447.1992; Ganz T, 2003, NAT REV IMMUNOL, V3, P710, DOI 10.1038/nri1180; Glenthoj A, 2011, BLOOD, V118, P4440, DOI 10.1182/blood-2011-06-362947; Greene TK, 2014, J THROMB HAEMOST, V12, P2102, DOI 10.1111/jth.12749; Greene TK, 2010, BLOOD, V116, P6114, DOI 10.1182/blood-2010-06-293308; Higazi AA, 2000, BLOOD, V96, P1393; Higazi AAR, 1997, BLOOD, V89, P4290, DOI 10.1182/blood.V89.12.4290; HIGAZI AAR, 1995, J BIOL CHEM, V270, P9472, DOI 10.1074/jbc.270.16.9472; Higazi AAR, 1996, J BIOL CHEM, V271, P17650, DOI 10.1074/jbc.271.30.17650; ISHIBASHI S, 1994, J CLIN INVEST, V93, P1885, DOI 10.1172/JCI117179; Khot UN, 2003, JAMA-J AM MED ASSOC, V290, P898, DOI 10.1001/jama.290.7.898; Kim DE, 2009, MOL IMAGING, V8, P291, DOI 10.2310/7290.2009.00027; Kitamoto S, 2007, CIRCULATION, V115, P2065, DOI 10.1161/CIRCULATIONAHA.107.688523; Kougias P, 2006, J VASC SURG, V43, P357, DOI 10.1016/j.jvs.2005.10.019; Nassar T, 2002, BLOOD, V100, P4026, DOI 10.1182/blood-2002-04-1080; Nidorf SM, 2013, J AM COLL CARDIOL, V61, P404, DOI 10.1016/j.jacc.2012.10.027; NISHINA PM, 1990, J LIPID RES, V31, P859; Nuki George, 2008, Curr Rheumatol Rep, V10, P218; PETERSON MW, 1989, J IMMUNOL, V143, P609; Quinn KL, 2011, ARTERIOSCL THROM VAS, V31, P2070, DOI 10.1161/ATVBAHA.111.227116; Rodriguez-Garcia M, 2007, J LEUKOCYTE BIOL, V82, P1143, DOI 10.1189/jlb.0507295; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Sasaki T, 2010, ATHEROSCLEROSIS, V210, P430, DOI 10.1016/j.atherosclerosis.2009.12.031; Schraufstatter IU, 2003, J IMMUNOL, V171, P6714, DOI 10.4049/jimmunol.171.12.6714; Soehnlein O, 2008, J CLIN INVEST, V118, P3491, DOI 10.1172/JCI35740; Soehnlein O, 2012, CIRC RES, V110, P875, DOI 10.1161/CIRCRESAHA.111.257535; Sukhova GK, 2003, J CLIN INVEST, V111, P897, DOI 10.1172/JCI200314915; TERRITO MC, 1989, J CLIN INVEST, V84, P2017, DOI 10.1172/JCI114394; Urbonaviciene G, 2012, INT J CARDIOL, V160, P89, DOI 10.1016/j.ijcard.2011.03.030; Wong BW, 2011, J HEART LUNG TRANSPL, V30, P955, DOI 10.1016/j.healun.2011.04.007; ZHANG SH, 1992, SCIENCE, V258, P468, DOI 10.1126/science.1411543; Zhao HJ, 2012, J ATHEROSCLER THROMB, V19, P357, DOI 10.5551/jat.10108; Zhou Q, 2012, CIRCULATION, V126, P2236, DOI 10.1161/CIRCULATIONAHA.111.086041; Zughaier SM, 2005, CELL MICROBIOL, V7, P1251, DOI 10.1111/j.1462-5822.2005.00549.x	42	11	11	2	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	2016	291	6					2777	2786		10.1074/jbc.M115.669812	http://dx.doi.org/10.1074/jbc.M115.669812			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DD0RK	26518877	Green Published, hybrid			2022-12-26	WOS:000369626900018
J	Marchesi, VT				Marchesi, Vincent T.			Gain-of-function somatic mutations contribute to inflammation and blood vessel damage that lead to Alzheimer dementia: a hypothesis	FASEB JOURNAL			English	Article						amyloid; oxidative damage; ischemia	DNA	Amyloid deposits are a characteristic feature of advanced Alzheimer dementia (AD), but whether they initiate the disease or are a consequence of it remains an unsettled question. To explore an alternative pathogenic-mechanism, I propose that the triggering events that begin the pathogenic cascade are not amyloid deposits but damaged blood vessels caused by inflammatory reactions that lead to ischemia, amyloid accumulation, axonal degeneration, synaptic loss, and eventually irreversible neuronal cell death. Inflammation and blood vessel damage are well recognized complications of AD, but what causes them and why the cerebral microvasculature is affected have never been adequately addressed. Because heritable autosomal dominant mutations of NLRP3, APP, TREX1, NOTCH3, and Col4A1 are known to provoke inflammatory reactions and damage the brain in a wide variety of diseases, I propose that one or more low abundant, gain-of-function somatic mutations of the same 5 gene families damage the microvasculature of the brain that leads to dementia. This implies that the pathogenic triggers that lead to AD are derived not from external invaders or amyloid but from oxidative damage of our own genes.	[Marchesi, Vincent T.] Yale Univ, Sch Med, Dept Pathol, 295 Congress Ave,BCMM 109,POB 9812, New Haven, CT 06510 USA	Yale University	Marchesi, VT (corresponding author), Yale Univ, Sch Med, Dept Pathol, 295 Congress Ave,BCMM 109,POB 9812, New Haven, CT 06510 USA.	vincent.marchesi@yale.edu						Ahn J, 2014, J IMMUNOL, V193, P4634, DOI 10.4049/jimmunol.1401337; Aksentijevich I, 2002, ARTHRITIS RHEUM-US, V46, P3340, DOI 10.1002/art.10688; Calero M, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00138; Craggs LJL, 2014, BRAIN PATHOL, V24, P495, DOI 10.1111/bpa.12177; Czirr E, 2012, J CLIN INVEST, V122, P1156, DOI 10.1172/JCI58656; Dempsey A, 2015, VIROLOGY, V479, P146, DOI 10.1016/j.virol.2015.03.013; Federico A, 2005, NEUROL SCI, V26, P117, DOI 10.1007/s10072-005-0444-3; Frank SA, 2010, P NATL ACAD SCI USA, V107, P1725, DOI 10.1073/pnas.0909343106; Frigerio CS, 2015, ALZHEIMERS DEMENT, V11, P1265, DOI 10.1016/j.jalz.2015.02.007; Gehrke N, 2013, IMMUNITY, V39, P482, DOI 10.1016/j.immuni.2013.08.004; Herrup K, 2015, NAT NEUROSCI, V18, P794, DOI 10.1038/nn.4017; Hunter JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036893; Kress BT, 2014, ANN NEUROL, V76, P845, DOI 10.1002/ana.24271; Kuo DS, 2012, HUM MOL GENET, V21, pR97, DOI 10.1093/hmg/dds346; Nakagawa K, 2015, ANN RHEUM DIS, V74, P603, DOI 10.1136/annrheumdis-2013-204361; Pamphlett R, 2004, MED HYPOTHESES, V62, P679, DOI 10.1016/j.mehy.2003.11.023; Poduri A, 2013, SCIENCE, V341, P43, DOI 10.1126/science.1237758; Saczynski JS, 2008, J GERONTOL A-BIOL, V63, P848, DOI 10.1093/gerona/63.8.848; Sparrer KMJ, 2015, CURR OPIN MICROBIOL, V26, P1, DOI 10.1016/j.mib.2015.03.001; Weller RO, 2008, BRAIN PATHOL, V18, P253, DOI 10.1111/j.1750-3639.2008.00133.x; West AP, 2015, NATURE, V520, P553, DOI 10.1038/nature14156; Xu F, 2007, NEUROSCIENCE, V146, P98, DOI 10.1016/j.neuroscience.2007.01.043	22	5	5	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2016	30	2					503	506		10.1096/fj.15-282285	http://dx.doi.org/10.1096/fj.15-282285			4	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DC7IA	26527064				2022-12-26	WOS:000369391900003
J	Macauley, MS; Kawasaki, N; Peng, WJ; Wang, SH; He, Y; Arlian, BM; McBride, R; Kannagi, R; Khoo, KH; Paulson, JC				Macauley, Matthew S.; Kawasaki, Norihito; Peng, Wenjie; Wang, Shui-Hua; He, Yuan; Arlian, Britni M.; McBride, Ryan; Kannagi, Reiji; Khoo, Kay-Hooi; Paulson, James C.			Unmasking of CD22 Co-receptor on Germinal Center B-cells Occurs by Alternative Mechanisms in Mouse and Man	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CIS LIGANDS; SIGLECS; ANTIGEN; BINDING; ACID; ACTIVATION; RECEPTOR; PROBES; IDENTIFICATION; TOLERANCE	CD22 is an inhibitory B-cell co-receptor whose function is modulated by sialic acid (Sia)-bearing glycan ligands. Glycan remodeling in the germinal center (GC) alters CD22 ligands, with as yet no ascribed biological consequence. Here, we show in both mice and humans that loss of high affinity ligands on GC B-cells unmasks the binding site of CD22 relative to naive and memory B-cells, promoting recognition of trans ligands. The conserved modulation of CD22 ligands on GC B-cells is striking because high affinity glycan ligands of CD22 are species-specific. In both species, the high affinity ligand is based on the sequence Sia alpha 2-6Gal beta 1-4GlcNAc, which terminates N-glycans. The human ligand has N-acetylneuraminic acid (Neu5Ac) as the sialic acid, and the high affinity ligand on naive B-cells contains 6-O-sulfate on the GlcNAc. On human GC B-cells, this sulfate modification is lost, giving rise to lower affinity CD22 ligands. Ligands of CD22 on naive murine B-cells do not contain the 6-O-sulfate modification. Instead, the high affinity ligand for mouse CD22 hasN-glycolylneuraminic acid (Neu5Gc) as the sialic acid, which is replaced on GC B-cells with Neu5Ac. Human naive and memory B-cells express sulfated glycans as high affinity CD22 ligands, which are lost on GCB-cells. In mice, Neu5Gc-containing glycans serve as high affinity CD22 ligands that are replaced by Neu5Ac-containing glycans on GC B-cells. Our results demonstrate that loss of high affinity CD22 ligands on GC B-cells occurs in both mice and humans through alternative mechanisms, unmasking CD22 relative to naive and memory B-cells.	[Macauley, Matthew S.; Kawasaki, Norihito; Paulson, James C.] Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA; [Peng, Wenjie; He, Yuan; Arlian, Britni M.; McBride, Ryan; Paulson, James C.] Scripps Res Inst, Dept Cell & Mol Biol, La Jolla, CA 92037 USA; [Paulson, James C.] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA; [Wang, Shui-Hua; Khoo, Kay-Hooi] Acad Sinica, Inst Biol Chem, Taipei 115, Taiwan; [Kannagi, Reiji] Acad Sinica, Inst Biomed Sci, Taipei 115, Taiwan	Scripps Research Institute; Scripps Research Institute; Scripps Research Institute; Academia Sinica - Taiwan; Academia Sinica - Taiwan	Paulson, JC (corresponding author), Scripps Res Inst, Dept Cell & Mol Biol, 10550 North Torrey Pines Rd,MB-202, La Jolla, CA 92037 USA.	jpaulson@scripps.edu	McBride, Ryan/E-6812-2011; Paulson, James/AAG-3565-2019; Khoo, Kay-Hooi/E-1989-2019; He, Yuan/GQP-4216-2022; Kannagi, Reiji/Q-6459-2018	Khoo, Kay-Hooi/0000-0003-2906-406X; Kannagi, Reiji/0000-0003-4202-2921; He, Yuan/0000-0002-1712-0776; Macauley, Matthew/0000-0003-4579-1048; Peng, Wenjie/0000-0001-5093-7115	Taiwan National Core Facility Program for Biotechnology, NSC [101-2319-B-001-003, 102-2319-B-001-003]; Biotechnology and Biological Sciences Research Council [BBS/E/F/00044486] Funding Source: researchfish; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI050143, R01AI099141] Funding Source: NIH RePORTER; BBSRC [BBS/E/F/00044486] Funding Source: UKRI	Taiwan National Core Facility Program for Biotechnology, NSC; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank Professor Anne Feeney for coordinating the receipt of human tonsils through the Scripps Green hospital. The MS data were acquired at the Core Facilities for Protein Structural Analysis at Academia Sinica, supported under the Taiwan National Core Facility Program for Biotechnology, NSC Grants 101-2319-B-001-003 and 102-2319-B-001-003.	ARUFFO A, 1992, P NATL ACAD SCI USA, V89, P10242, DOI 10.1073/pnas.89.21.10242; Blixt O, 2004, P NATL ACAD SCI USA, V101, P17033, DOI 10.1073/pnas.0407902101; Blixt O, 2003, J BIOL CHEM, V278, P31007, DOI 10.1074/jbc.M304331200; Cariappa A, 2009, J EXP MED, V206, P125, DOI 10.1084/jem.20081399; Chou HH, 1998, P NATL ACAD SCI USA, V95, P11751, DOI 10.1073/pnas.95.20.11751; Collins BE, 2004, P NATL ACAD SCI USA, V101, P6104, DOI 10.1073/pnas.0400851101; Collins BE, 2006, J IMMUNOL, V177, P2994, DOI 10.4049/jimmunol.177.5.2994; Comelli EM, 2006, J IMMUNOL, V177, P2431, DOI 10.4049/jimmunol.177.4.2431; Croci DO, 2014, CELL, V156, P744, DOI 10.1016/j.cell.2014.01.043; Crocker PR, 2007, NAT REV IMMUNOL, V7, P255, DOI 10.1038/nri2056; Duong BH, 2010, J EXP MED, V207, P173, DOI 10.1084/jem.20091873; Fujimoto M, 2006, J IMMUNOL, V176, P873, DOI 10.4049/jimmunol.176.2.873; Kannagi R, 2009, GLYCOCONJUGATE J, V26, P923, DOI 10.1007/s10719-008-9122-z; KELM S, 1994, GLYCOCONJUGATE J, V11, P576, DOI 10.1007/BF00731309; Khoo KH, 2010, METHOD ENZYMOL, V478, P3, DOI 10.1016/S0076-6879(10)78001-0; Kimura N, 2007, J BIOL CHEM, V282, P32200, DOI 10.1074/jbc.M702341200; Lee M, 2014, NAT IMMUNOL, V15, P982, DOI 10.1038/ni.2983; Macauley MS, 2014, J IMMUNOL, V193, P4312, DOI 10.4049/jimmunol.1401723; Macauley MS, 2014, NAT REV IMMUNOL, V14, P653, DOI 10.1038/nri3737; Macauley MS, 2013, J CLIN INVEST, V123, P3074, DOI 10.1172/JCI69187; Muller J, 2013, P NATL ACAD SCI USA, V110, P12402, DOI 10.1073/pnas.1304888110; Naito Y, 2007, MOL CELL BIOL, V27, P3008, DOI 10.1128/MCB.02047-06; Naito-Matsui Y, 2014, J BIOL CHEM, V289, P1564, DOI 10.1074/jbc.M113.523753; Nitschke L, 1999, J EXP MED, V189, P1513, DOI 10.1084/jem.189.9.1513; Nitschke L, 2014, GLYCOBIOLOGY, V24, P807, DOI 10.1093/glycob/cwu066; Nycholat CM, 2012, ANGEW CHEM INT EDIT, V51, P4860, DOI 10.1002/anie.201200596; Pillai S, 2012, ANNU REV IMMUNOL, V30, P357, DOI 10.1146/annurev-immunol-020711-075018; Razi N, 1998, P NATL ACAD SCI USA, V95, P7469, DOI 10.1073/pnas.95.13.7469; Rillahan CD, 2014, CHEM SCI, V5, P2398, DOI 10.1039/c4sc00451e; Rillahan CD, 2011, ANNU REV BIOCHEM, V80, P797, DOI 10.1146/annurev-biochem-061809-152236; Sakuma K, 2012, BBA-GEN SUBJECTS, V1820, P841, DOI 10.1016/j.bbagen.2012.03.005; SJOBERG ER, 1994, J CELL BIOL, V126, P549, DOI 10.1083/jcb.126.2.549; Victora GD, 2012, ANNU REV IMMUNOL, V30, P429, DOI 10.1146/annurev-immunol-020711-075032; Wang SH, 2013, GLYCOBIOLOGY, V23, P677, DOI 10.1093/glycob/cwt008; Yuan J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064572	35	36	36	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 11	2015	290	50					30066	30077		10.1074/jbc.M115.691337	http://dx.doi.org/10.1074/jbc.M115.691337			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CY7UL	26507663	hybrid, Green Published			2022-12-26	WOS:000366614700037
J	Nigg, PE; Pavlovic, J				Nigg, Patricia E.; Pavlovic, Jovan			Oligomerization and GTP-binding Requirements of MxA for Viral Target Recognition and Antiviral Activity against Influenza A Virus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYACRYLAMIDE-GEL ELECTROPHORESIS; SMOOTH ENDOPLASMIC-RETICULUM; PROTEIN; NUCLEOPROTEIN; RESISTANCE; TRANSCRIPTION; INFECTION; GENES; OVEREXPRESSION; IDENTIFICATION	The IFN-induced human myxovirus resistance protein A (MxA) exhibits a broad antiviral activity against many viruses, including influenza A virus (IAV). MxA belongs to the family of dynamin-like GTPases and assembles in vitro into dimers, tetramers, and oligomeric ring-like structures. The molecular mechanism of action remains to be elucidated. Furthermore, it is not clear whether MxA exerts its antiviral activity in a monomeric and/or multimeric form. Using a set of MxA mutants that form complexes with defined stoichiometry, we observed that, in the presence of guanosine 5'-O-(thiotriphosphate), purified MxA disassembled into tetramers and dimers. Dimeric forms did not further disassemble into monomers. Infection experiments revealed that besides wild-type MxA, dimeric and monomeric variants of MxA also efficiently restricted IAV at a replication step after primary transcription. Moreover, only dimeric MxA was able to form stable complexes with the nucleoprotein (NP) of IAV. MxA interacted with NP independently of other viral components. Interestingly, the dimeric form of MxA was able to efficiently bind to NP from several MxA-sensitive strains but interacted much more weakly with NP from the MxA-resistant PR8 strain derived from the H1N1 1918 lineage. Taken together, these data suggest that, during infection, a fraction of MxA disassembles into dimers that bind to NP synthesized following primary transcription in the cytoplasm, thereby preventing viral replication.	[Nigg, Patricia E.; Pavlovic, Jovan] Univ Zurich, Inst Med Virol, CH-8057 Zurich, Switzerland	University of Zurich	Pavlovic, J (corresponding author), Univ Zurich, Inst Med Virol, Winterthurerstr 190, CH-8057 Zurich, Switzerland.	pavlovic.jovan@virology.uzh.ch			Schweizerischer Nationalfonds zur Forderung der Wissenschaftlichen Forschung [31003A_143834]	Schweizerischer Nationalfonds zur Forderung der Wissenschaftlichen Forschung(Austrian Science Fund (FWF))	This work was funded by Schweizerischer Nationalfonds zur Forderung der Wissenschaftlichen Forschung Grant 31003A_143834. The authors declare that they have no conflicts of interest with the contents of this article.	Accola MA, 2002, J BIOL CHEM, V277, P21829, DOI 10.1074/jbc.M201641200; AEBI M, 1989, MOL CELL BIOL, V9, P5062, DOI 10.1128/MCB.9.11.5062; Brass AL, 2009, CELL, V139, P1243, DOI 10.1016/j.cell.2009.12.017; Chappie JS, 2009, MOL BIOL CELL, V20, P3561, DOI 10.1091/mbc.E09-04-0318; de Veer MJ, 2001, J LEUKOCYTE BIOL, V69, P912; Der SD, 1998, P NATL ACAD SCI USA, V95, P15623, DOI 10.1073/pnas.95.26.15623; Di Paolo C, 1999, J BIOL CHEM, V274, P32071, DOI 10.1074/jbc.274.45.32071; Dicks MDJ, 2016, J VIROL, V90, P22, DOI 10.1128/JVI.02247-15; Dittmann J, 2008, J VIROL, V82, P3624, DOI 10.1128/JVI.01753-07; Fiala GJ, 2011, JOVE-J VIS EXP, DOI 10.3791/2164; Fribourgh JL, 2014, CELL HOST MICROBE, V16, P627, DOI 10.1016/j.chom.2014.09.021; Gao S, 2011, IMMUNITY, V35, P514, DOI 10.1016/j.immuni.2011.07.012; Gao S, 2010, NATURE, V465, P502, DOI 10.1038/nature08972; Goujon C, 2013, NATURE, V502, P559, DOI 10.1038/nature12542; Haller O, 2011, J INTERF CYTOK RES, V31, P79, DOI 10.1089/jir.2010.0076; HUANG T, 1992, J VIROL, V66, P4154, DOI 10.1128/JVI.66.7.4154-4160.1992; Janzen C, 2000, J VIROL, V74, P8202, DOI 10.1128/JVI.74.17.8202-8206.2000; Kochs G, 2002, J BIOL CHEM, V277, P14172, DOI 10.1074/jbc.M200244200; Manz B, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003279; Mitchell PS, 2012, CELL HOST MICROBE, V12, P598, DOI 10.1016/j.chom.2012.09.005; Momose F, 2001, J VIROL, V75, P1899, DOI 10.1128/JVI.75.4.1899-1908.2001; Patzina C, 2014, J BIOL CHEM, V289, P6020, DOI 10.1074/jbc.M113.543892; PAVLOVIC J, 1990, J VIROL, V64, P3370, DOI 10.1128/JVI.64.7.3370-3375.1990; PAVLOVIC J, 1992, J VIROL, V66, P2564, DOI 10.1128/JVI.66.4.2564-2569.1992; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; PITOSSI F, 1993, J VIROL, V67, P6726, DOI 10.1128/JVI.67.11.6726-6732.1993; Ponten A, 1997, J VIROL, V71, P2591, DOI 10.1128/JVI.71.4.2591-2599.1997; Read EKC, 2010, J GEN VIROL, V91, P1290, DOI 10.1099/vir.0.018564-0; REED L. J., 1938, AMER JOUR HYG, V27, P493; Rennie ML, 2014, STRUCTURE, V22, P1433, DOI 10.1016/j.str.2014.08.015; Riegger D, 2015, J VIROL, V89, P2241, DOI 10.1128/JVI.02406-14; Samarajiwa SA, 2009, NUCLEIC ACIDS RES, V37, pD852, DOI 10.1093/nar/gkn732; SCHNEIDERSCHAULIES S, 1994, J VIROL, V68, P6910, DOI 10.1128/JVI.68.11.6910-6917.1994; Schumacher B, 1998, J BIOL CHEM, V273, P28365, DOI 10.1074/jbc.273.43.28365; SCHWEMMLE M, 1995, VIROLOGY, V206, P545, DOI 10.1016/S0042-6822(95)80071-9; Stertz S, 2006, J INTERF CYTOK RES, V26, P650, DOI 10.1089/jir.2006.26.650; STRANDEN AM, 1993, VIROLOGY, V197, P642, DOI 10.1006/viro.1993.1639; Tarus B, 2012, BIOCHIMIE, V94, P776, DOI 10.1016/j.biochi.2011.11.009; Turan K, 2004, NUCLEIC ACIDS RES, V32, P643, DOI 10.1093/nar/gkh192; Verhelst J, 2012, J VIROL, V86, P13445, DOI 10.1128/JVI.01682-12; Walker J M, 1994, Methods Mol Biol, V32, P17; Warnock DE, 1996, J BIOL CHEM, V271, P22310, DOI 10.1074/jbc.271.37.22310; Wisskirchen C, 2011, J BIOL CHEM, V286, P34743, DOI 10.1074/jbc.M111.251843; Wisskirchen C, 2011, J VIROL, V85, P8646, DOI 10.1128/JVI.02559-10; Xiao H, 2013, J VIROL, V87, P13053, DOI 10.1128/JVI.02220-13; Zimmermann P, 2011, J VIROL, V85, P8133, DOI 10.1128/JVI.00712-11; ZURCHER T, 1992, EMBO J, V11, P1657, DOI 10.1002/j.1460-2075.1992.tb05212.x	47	44	46	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 11	2015	290	50					29893	29906		10.1074/jbc.M115.681494	http://dx.doi.org/10.1074/jbc.M115.681494			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CY7UL	26507657	Green Accepted, hybrid, Green Published			2022-12-26	WOS:000366614700022
J	Tan, SL; Ahmad, TS; Ng, WM; Azlina, AA; Azhar, MM; Selvaratnam, L; Kamarul, T				Tan, Sik-Loo; Ahmad, Tunku Sara; Ng, Wuey-Min; Azlina, Amir Abbas; Azhar, Mahmood Merican; Selvaratnam, Lakshmi; Kamarul, Tunku			Identification of Pathways Mediating Growth Differentiation Factor5-Induced Tenogenic Differentiation in Human Bone Marrow Stromal Cells	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; GROWTH/DIFFERENTIATION FACTOR-5 GDF-5; STIMULATES OSTEOGENIC DIFFERENTIATION; IN-VITRO; TENDON; PROLIFERATION; TRANSITION; INCREASES; GTPASES; MARKER	To date, the molecular signalling mechanisms which regulate growth factors-induced MSCs tenogenic differentiation remain largely unknown. Therefore, a study to determine the global gene expression profile of tenogenic differentiation in human bone marrow stromal cells (hMSCs) using growth differentiation factor 5 (GDF5) was conducted. Microarray analyses were conducted on hMSCs cultures supplemented with 100 ng/ml of GDF5 and compared to undifferentiated hMSCs and adult tenocytes. Results of QuantiGene1Plex assay support the use and interpretation of the inferred gene expression profiles and pathways information. From the 27,216 genes assessed, 873 genes (3.21% of the overall human transcriptome) were significantly altered during the tenogenic differentiation process (corrected p<0.05). The genes identified as potentially associated with tenogenic differentiation were ARHGAP29, CCL2, integrin alpha 8 and neurofilament medium polypeptides. These genes, were mainly associated with cytoskeleton reorganization (stress fibers formation) signaling. Pathway analysis demonstrated the potential molecular pathways involved in tenogenic differentiation were: cytoskeleton reorganization related i.e. keratin filament signaling and activin A signaling; cell adhesion related i.e. chemokine and adhesion signaling; and extracellular matrix related i.e. arachidonic acid production signaling. Further investigation using atomic force microscopy and confocal laser scanning microscopy demonstrated apparent cytoskeleton reorganization in GDF5-induced hMSCs suggesting that cytoskeleton reorganization signaling is an important event involved in tenogenic differentiation. Besides, a reduced nucleostemin expression observed suggested a lower cell proliferation rate in hMSCs undergoing tenogenic differentiation. Understanding and elucidating the tenogenic differentiation signalling pathways are important for future optimization of tenogenic hMSCs for functional tendon cell-based therapy and tissue engineering.	[Tan, Sik-Loo; Ahmad, Tunku Sara; Ng, Wuey-Min; Azlina, Amir Abbas; Azhar, Mahmood Merican; Kamarul, Tunku] Univ Malaya, Fac Med, Tissue Engn Grp,Dept Orthopaed Surg, Natl Orthopaed Ctr Excellence Res & Learning, Kuala Lumpur 50603, Malaysia; [Selvaratnam, Lakshmi] Monash Univ, Sch Med & Hlth Sci, Selangor, Malaysia	Universiti Malaya; Monash University; Monash University Sunway	Tan, SL (corresponding author), Univ Malaya, Fac Med, Tissue Engn Grp,Dept Orthopaed Surg, Natl Orthopaed Ctr Excellence Res & Learning, Kuala Lumpur 50603, Malaysia.	tansikloo@gmail.com; tkzrea@um.edu.my	Tunku Zainol Abidin, Tunku Kamarul Zaman/B-9633-2011; Tunku Ahmad Yahaya, Tunku Sara/B-9979-2010; ABBAS, AZLINA AMIR/B-5405-2010; Selvaratnam, L/AAH-4066-2020; Tan, Sik Loo/K-5571-2013; Ng, Wuey Min/J-3196-2016	Tunku Zainol Abidin, Tunku Kamarul Zaman/0000-0002-6028-1313; Tunku Ahmad Yahaya, Tunku Sara/0000-0002-7542-2860; ABBAS, AZLINA AMIR/0000-0003-4423-4653; Selvaratnam, L/0000-0002-2147-1616; Tan, Sik Loo/0000-0003-1723-8384; Ng, Wuey Min/0000-0002-3542-8993	HIRMOHE research grant initiative [A000003-50001]; eScience Grant [12-02-03-2017]; UMRG [RG093/09HTM]; University of Malaya [PS167/2008C, PS360/2009B, PS219/2010A]	HIRMOHE research grant initiative; eScience Grant; UMRG; University of Malaya(Universiti Malaya)	This study was supported by HIRMOHE research grant initiative (Grant number: A000003-50001), eScience Grant (12-02-03-2017), UMRG (RG093/09HTM) and University of Malaya postgraduate student grant (PS167/2008C, PS360/2009B and PS219/2010A). The University of Malaya provided a PhD thesis scholarship for the first author. Herein, the authors would like to state that the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arai F, 2004, CELL, V118, P149, DOI 10.1016/j.cell.2004.07.004; Behr R, 2005, STEM CELLS, V23, P805, DOI 10.1634/stemcells.2004-0234; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bidder M, 2000, J ORTHOPAED RES, V18, P247, DOI 10.1002/jor.1100180212; Bluteau G, 2007, BONE, V40, P568, DOI 10.1016/j.bone.2006.09.024; Buxton P, 2001, J BONE JOINT SURG AM, V83A, pS23; Cilli F, 2004, CLIN J SPORT MED, V14, P232, DOI 10.1097/00042752-200407000-00006; Di Meglio F, 2010, J MOL CELL CARDIOL, V49, P719, DOI 10.1016/j.yjmcc.2010.05.013; Docheva D, 2015, ADV DRUG DELIVER REV, V84, P222, DOI 10.1016/j.addr.2014.11.015; Farng E, 2008, CLIN ORTHOP RELAT R, V466, P1930, DOI 10.1007/s11999-008-0300-x; FILIPAK M, 1989, ENVIRON HEALTH PERSP, V80, P117, DOI 10.2307/3430737; Funes JM, 2007, P NATL ACAD SCI USA, V104, P6223, DOI 10.1073/pnas.0700690104; Galarneau L, 2007, EXP CELL RES, V313, P179, DOI 10.1016/j.yexcr.2006.10.007; Hoffmann A, 2006, J CLIN INVEST, V116, P940, DOI 10.1172/JCI22689; Hong JH, 2006, CELL CYCLE, V5, P176, DOI 10.4161/cc.5.2.2362; Hutter JL, 2005, J MICROSC-OXFORD, V219, P61, DOI 10.1111/j.1365-2818.2005.01497.x; Jelinsky SA, 2010, J ORTHOP RES, V28, P289, DOI 10.1002/jor.20999; Kafienah W, 2006, STEM CELLS, V24, P1113, DOI 10.1634/stemcells.2005-0416; Kaibuchi K, 1999, ANNU REV BIOCHEM, V68, P459, DOI 10.1146/annurev.biochem.68.1.459; Kaiser E, 1999, CRIT REV CL LAB SCI, V36, P65, DOI 10.1080/10408369991239187; Kamarul T., 2009, EUR CELL MAT S1, V18, P47; Kjaer M, 2004, PHYSIOL REV, V84, P649, DOI 10.1152/physrev.00031.2003; Kolsch A, 2010, J CELL SCI, V123, P2266, DOI 10.1242/jcs.068080; Liu TM, 2007, STEM CELLS, V25, P750, DOI 10.1634/stemcells.2006-0394; Liu XB, 2008, ACTA PHARMACOL SIN, V29, P815, DOI 10.1111/j.1745-7254.2008.00811.x; Loranger A, 1997, AM J PATHOL, V151, P1673; Luo Q, 2009, CYTOTECHNOLOGY, V61, P1, DOI 10.1007/s10616-009-9233-9; Menssen A, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-461; Monaco E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032481; Morita Y, 2012, CELL BIOCH BIOPHYSIC; Myster DL, 2000, CURR BIOL, V10, pR302, DOI 10.1016/S0960-9822(00)00435-8; NADALGINARD B, 1978, CELL, V15, P855, DOI 10.1016/0092-8674(78)90270-2; Nakamura K, 1999, EXP CELL RES, V250, P351, DOI 10.1006/excr.1999.4535; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; Orlandini M, 2006, J BIOL CHEM, V281, P17961, DOI 10.1074/jbc.M600413200; Park A, 2010, TISSUE ENG PT A, V16, P2941, DOI 10.1089/ten.tea.2009.0710; Schweitzer R, 2001, DEVELOPMENT, V128, P3855; Shimaoka H, 2004, J BIOMED MATER RES A, V68A, P168, DOI 10.1002/jbm.a.20059; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Su JA, 2010, INT J BIOCHEM CELL B, V42, P2047, DOI 10.1016/j.biocel.2010.09.009; Tan SL, 2013, J ANAT, V222, P437, DOI 10.1111/joa.12032; Tan SL, 2012, CELLS TISSUES ORGANS, V196, P325, DOI 10.1159/000335693; Tan SL, 2011, CELL TISSUE BANK, V12, P59, DOI 10.1007/s10561-009-9164-x; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Wang M, 2009, AM J PHYSIOL-ENDOC M, V297, pE1378, DOI 10.1152/ajpendo.00252.2009; Zeng Q, 2007, BONE, V40, P374, DOI 10.1016/j.bone.2006.09.022	46	25	27	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2015	10	11							e0140869	10.1371/journal.pone.0140869	http://dx.doi.org/10.1371/journal.pone.0140869			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV1QH	26528540	Green Submitted, Green Published, gold			2022-12-26	WOS:000364032600015
J	Barnig, C; Alsaleh, G; Jung, N; Dembele, D; Paul, N; Poirot, A; Uring-Lambert, B; Georgel, P; de Blay, F; Bahram, S				Barnig, Cindy; Alsaleh, Ghada; Jung, Nicolas; Dembele, Doulaye; Paul, Nicodeme; Poirot, Anh; Uring-Lambert, Beatrice; Georgel, Philippe; de Blay, Frederic; Bahram, Seiamak			Circulating Human Eosinophils Share a Similar Transcriptional Profile in Asthma and Other Hypereosinophilic Disorders	PLOS ONE			English	Article							ACID LIPASE DEFICIENCY; RESPIRATORY INFLAMMATION; PERIPHERAL-BLOOD; MEPOLIZUMAB; CYTOKINE; PROTEINS; GENES; MICE; CLASSIFICATION; EXPRESSION	Eosinophils are leukocytes that are released into the peripheral blood in a phenotypically mature state and are capable of being recruited into tissues in response to appropriate stimuli. Eosinophils, traditionally considered cytotoxic effector cells, are leukocytes recruited into the airways of asthma patients where they are believed to contribute to the development of many features of the disease. This perception, however, has been challenged by recent findings suggesting that eosinophils have also immunomodulatory functions and may be involved in tissue homeostasis and wound healing. Here we describe a transcriptome-based approach-in a limited number of patients and controls-to investigate the activation state of circulating human eosinophils isolated by flow cytometry. We provide an overview of the global expression pattern in eosinophils in various relevant conditions, e.g., eosinophilic asthma, hypereosinophilic dermatological diseases, parasitosis and pulmonary aspergillosis. Compared to healthy subjects, circulating eosinophils isolated from asthma patients differed in their gene expression profile which is marked by downregulation of transcripts involved in antigen presentation, pathogen recognition and mucosal innate immunity, whereas up-regulated genes were involved in response to non-specific stimulation, wounding and maintenance of homeostasis. Eosinophils from other hypereosinophilic disorders displayed a very similar transcriptional profile. Taken together, these observations seem to indicate that eosinophils exhibit non-specific immunomodulatory functions important for tissue repair and homeostasis and suggest new roles for these cells in asthma immunobiology.	[Barnig, Cindy; Alsaleh, Ghada; Jung, Nicolas; Paul, Nicodeme; Georgel, Philippe; Bahram, Seiamak] Univ Strasbourg, Federat Med Translat Strasbourg, ImmunoRhumatol Mol, INSERM UMR S 1109,Labex Transplantex, F-67085 Strasbourg, France; [Barnig, Cindy; Poirot, Anh; de Blay, Frederic] Hop Univ Strasbourg, Nouvel Hop Civil, Serv Pneumol, F-67091 Strasbourg, France; [Barnig, Cindy; Alsaleh, Ghada; Paul, Nicodeme; Poirot, Anh; Uring-Lambert, Beatrice; Georgel, Philippe; de Blay, Frederic; Bahram, Seiamak] Federat Hosp Univ, OMICARE, Ctr Rech Immunol & Hematol, F-67085 Strasbourg, France; [Jung, Nicolas] Univ Strasbourg, Labex IRMIA, IRMA, CNRS UMR 7501, F-67084 Strasbourg, France; [Dembele, Doulaye] Univ Strasbourg, Inst Genet & Biol Mol & Cellulaire, INSERM U964, CNRS UMR 7104, F-67404 Illkirch Graffenstaden, France; [Uring-Lambert, Beatrice; Bahram, Seiamak] Hop Univ Strasbourg, Nouvel Hop Civil, Lab Cent Immunol, Pole Biol, F-67091 Strasbourg, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Mathematical Sciences (INSMI); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Bahram, S (corresponding author), Univ Strasbourg, Federat Med Translat Strasbourg, ImmunoRhumatol Mol, INSERM UMR S 1109,Labex Transplantex, F-67085 Strasbourg, France.	siamak@unistra.fr	Bahram, Seiamak/GZA-7150-2022; georgel, philippe/P-5676-2016; Dembélé, Doulaye/O-6513-2017	georgel, philippe/0000-0001-6853-7080; Dembélé, Doulaye/0000-0003-3879-6940; alsaleh, ghada/0000-0002-4211-3420; Barnig, Cindy/0000-0001-8890-3236; Bahram, Seiamak/0000-0002-6928-9952; Paul, Nicodeme/0000-0003-4680-3012	Institut National de la Sante et de la Recherche Medicale (INSERM)	Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm))	This work was supported by a grant (no number applicable) from the Institut National de la Sante et de la Recherche Medicale (INSERM), http://www.inserm.fr. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAGGIOLINI M, 1992, FEBS LETT, V307, P97, DOI 10.1016/0014-5793(92)80909-Z; Bates ME, 2004, AM J RESP CELL MOL, V30, P736, DOI 10.1165/rcmb.2003-0234OC; BISGAARD H, 1984, ALLERGY, V39, P413, DOI 10.1111/j.1398-9995.1984.tb01963.x; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; BOUSQUET J, 1990, NEW ENGL J MED, V323, P1033, DOI 10.1056/NEJM199010113231505; Castro M, 2011, AM J RESP CRIT CARE, V184, P1125, DOI 10.1164/rccm.201103-0396OC; Dembele D, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-14; Du H, 2001, HUM MOL GENET, V10, P1639, DOI 10.1093/hmg/10.16.1639; Esnault S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067560; Fattouh R, 2011, AM J RESP CRIT CARE, V183, P179, DOI 10.1164/rccm.200905-0736OC; Flood-Page P, 2003, J CLIN INVEST, V112, P1029, DOI 10.1172/JCI200317974; Fulkerson PC, 2013, NAT REV DRUG DISCOV, V12, P117, DOI 10.1038/nrd3838; Giembycz MA, 1999, PHARMACOL REV, V51, P213; Gosens R, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-73; Haldar P, 2009, NEW ENGL J MED, V360, P973, DOI 10.1056/NEJMoa0808991; HAMANN KJ, 1987, J PARASITOL, V73, P523, DOI 10.2307/3282130; Hedhli N, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/406273; Heredia JE, 2013, CELL, V153, P376, DOI 10.1016/j.cell.2013.02.053; Hogan SP, 1998, J IMMUNOL, V161, P1501; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Isobe Y, 2012, J BIOL CHEM, V287, P10525, DOI 10.1074/jbc.M112.340612; Jacobsen EA, 2014, ALLERGY, V69, P315, DOI 10.1111/all.12321; Johnsson M, 2011, J INNATE IMMUN, V3, P594, DOI 10.1159/000331326; Leckie MJ, 2000, LANCET, V356, P2144, DOI 10.1016/S0140-6736(00)03496-6; Lian XM, 2004, AM J PHYSIOL-LUNG C, V286, pL801, DOI 10.1152/ajplung.00335.2003; Liang SQ, 2013, RESPIROLOGY, V18, P774, DOI 10.1111/resp.12097; Munoz NM, 2006, NAT PROTOC, V1, P2613, DOI 10.1038/nprot.2006.340; Nair P, 2009, NEW ENGL J MED, V360, P985, DOI 10.1056/NEJMoa0805435; Ochkur SI, 2007, J IMMUNOL, V178, P7879, DOI 10.4049/jimmunol.178.12.7879; Ogawa K, 2003, CLIN EXP IMMUNOL, V131, P436, DOI 10.1046/j.1365-2249.2003.02090.x; Pavord ID, 2012, LANCET, V380, P651, DOI 10.1016/S0140-6736(12)60988-X; Rosen ED, 2014, CELL, V156, P20, DOI 10.1016/j.cell.2013.12.012; Rothenberg ME, 2006, ANNU REV IMMUNOL, V24, P147, DOI 10.1146/annurev.immunol.24.021605.090720; Sherrill JD, 2014, GENES IMMUN, V15, P361, DOI 10.1038/gene.2014.27; Sutherland DB, 2014, IMMUNITY, V40, P455, DOI 10.1016/j.immuni.2014.04.003; Temple R, 2001, AM J RESP CELL MOL, V25, P425, DOI 10.1165/ajrcmb.25.4.4456; Tsitsiou E, 2012, J ALLERGY CLIN IMMUN, V129, P95, DOI 10.1016/j.jaci.2011.08.011; Valent P, 2012, J ALLERGY CLIN IMMUN, V130, P607, DOI 10.1016/j.jaci.2012.02.019; Valent P, 2012, EXPERT REV HEMATOL, V5, P157, DOI [10.1586/EHM.11.81, 10.1586/ehm.11.81]; Wen T, 2015, J ALLERGY CLIN IMMUN, V135, P187, DOI 10.1016/j.jaci.2014.08.043; Wilson SS, 2013, J MOL BIOL, V425, P4965, DOI 10.1016/j.jmb.2013.09.038; Wu T, 1997, J BIOL CHEM, V272, P17145, DOI 10.1074/jbc.272.27.17145	42	17	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2015	10	11							e0141740	10.1371/journal.pone.0141740	http://dx.doi.org/10.1371/journal.pone.0141740			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV1PG	26524763	Green Published, gold, Green Submitted			2022-12-26	WOS:000364029800021
J	Ninivaggi, M; de Laat, M; Lance, MMD; Kicken, CH; Pelkmans, L; Bloemen, S; Dirks, ML; van Loon, LJC; Govers-Riemslag, JWP; Lindhout, T; Konings, J; de Laat, B				Ninivaggi, Marisa; de Laat, Marieke; Lance, Marcus M. D.; Kicken, Cecile H.; Pelkmans, Leonie; Bloemen, Saartje; Dirks, Marlou L.; van Loon, Luc J. C.; Govers-Riemslag, Jose W. P.; Lindhout, Theo; Konings, Joke; de Laat, Bas			Hypoxia Induces a Prothrombotic State Independently of the Physical Activity	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; DEEP-VEIN THROMBOSIS; AIR-TRAVEL; VENOUS THROMBOEMBOLISM; HIGH-ALTITUDE; RISK; COAGULATION; GENERATION; EXERCISE; SYSTEM	Hypoxia (oxygen deprivation) is known to be associated with deep vein thrombosis and venous thromboembolism. We attempted to get a better comprehension of its mechanism by going to high altitude, thereby including the potential contributing role of physical activity. Two groups of 15 healthy individuals were exposed to hypoxia by going to an altitude of 3900 meters, either by climbing actively (active group) or transported passively by cable car (passive group). Both groups were tested for plasma fibrinogen, von Willebrand factor and factor VIII levels, fibrinolysis, thrombin generating capacity, heart rate, oxygen saturation levels and blood pressure. As a control for the passive group, 7 healthy volunteers stayed immobile in bed for 7 days at normoxic conditions. The heart rate increased and oxygen saturation levels decreased with increasing altitude. Fibrinolysis and fibrinogen levels were not affected. Factor VIII and von Willebrand factor levels levels increased significantly in the active group, but not in the passive group. Plasma thrombin generation remained unchanged in both the active and passive group with increasing altitude and during 7 days of immobility in healthy subjects. However, by applying whole blood thrombin generation, we found an increased peak height and endogenous thrombin potential, and a decreased lagtime and time-to-peak with increasing levels of hypoxia in both groups. In conclusion, by applying whole blood thrombin generation we demonstrated that hypoxia causes a prothrombotic state. As thrombin generation in plasma did not increase, our results suggest that the cellular part of the blood is involved in the prothrombotic phenotype induced by hypoxia.	[Ninivaggi, Marisa; de Laat, Marieke; Kicken, Cecile H.; Pelkmans, Leonie; Bloemen, Saartje; Lindhout, Theo; Konings, Joke; de Laat, Bas] Maastricht Univ, Med Ctr, Dept Synapse Bv, Maastricht, Netherlands; [Ninivaggi, Marisa; Pelkmans, Leonie; Bloemen, Saartje; Govers-Riemslag, Jose W. P.; Konings, Joke; de Laat, Bas] Maastricht Univ, Med Ctr, Dept Biochem, Maastricht, Netherlands; [Lance, Marcus M. D.; Kicken, Cecile H.] Maastricht Univ, Med Ctr, Dept Anesthesiol, Maastricht, Netherlands; [Dirks, Marlou L.; van Loon, Luc J. C.] Maastricht Univ, Med Ctr, Sch Nutr & Translat Res Metab, Dept NUTRIM, Maastricht, Netherlands	Maastricht University; Maastricht University; Maastricht University; Maastricht University	de Laat, B (corresponding author), Maastricht Univ, Med Ctr, Dept Synapse Bv, Maastricht, Netherlands.	b.delaat@thrombin.com	Dirks, Marlou/G-5813-2011; van Loon, Luc J C/G-5920-2010; van Loon, Luc J.C./ABG-9158-2020	Dirks, Marlou/0000-0002-9189-1042; van Loon, Luc J C/0000-0002-6768-9231; van Loon, Luc J.C./0000-0002-6768-9231; Kicken, Cecile/0000-0002-8010-8091; Lance, Marcus/0000-0002-7484-5132; Bloemen, Saartje/0000-0003-3297-8196	Netherlands Heart Foundation; Bever Zwerfsport; Stago; Stago BNL; StrijkersBaadjou; Ogimi; Atrium Medisch Centrum Parkstad; Hemker foundation; CARIM (Maastricht University); CTMM (Center for Translational Molecular Medicine)	Netherlands Heart Foundation(Netherlands Heart Foundation); Bever Zwerfsport; Stago; Stago BNL; StrijkersBaadjou; Ogimi; Atrium Medisch Centrum Parkstad; Hemker foundation; CARIM (Maastricht University); CTMM (Center for Translational Molecular Medicine)	This research was supported by the Netherlands Heart Foundation, Bever Zwerfsport, Stago, Stago BNL, Strijkers&Baadjou, Ogimi, Atrium Medisch Centrum Parkstad, the Hemker foundation, CARIM (Maastricht University) and CTMM (Center for Translational Molecular Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson FA, 2003, CIRCULATION, V107, pI9, DOI 10.1161/01.CIR.0000078469.07362.E6; Bartsch P, 2006, JAMA-J AM MED ASSOC, V295, P2297, DOI 10.1001/jama.295.19.2297; Beam DM, 2009, ANN EMERG MED, V54, P147, DOI 10.1016/j.annemergmed.2008.10.033; Bradford A, 2007, CURR PHARM DESIGN, V13, P2668, DOI 10.2174/138161207781662966; Brill A, 2013, J THROMB HAEMOST, V11, P1773, DOI 10.1111/jth.12310; CLAUSS A., 1957, ACTA HAEMATOL, V17, P237; Cvirn G, 2015, EUR J CLIN INVEST, V45, P63, DOI 10.1111/eci.12383; Edwards S, 2003, PROF NURSE, V18, P636; Gatt ME, 2004, THROMB HAEMOSTASIS, V91, P538, DOI 10.1160/TH03-07-0481; Gegick Stephen, 2013, N C Med J, V74, P411; Gilany K., 2010, J PARAMED SCI, V1, P43; Gonzales JU, 2009, EUR J APPL PHYSIOL, V106, P779, DOI 10.1007/s00421-009-1074-x; Haider T, 2013, PHYSIOL REP, V1, DOI 10.1002/phy2.135; Hemker HC, 2006, THROMB HAEMOSTASIS, V96, P553, DOI 10.1160/TH06-07-0408; Hemker HC, 2013, THROMB RES, V131, P3, DOI 10.1016/j.thromres.2012.10.011; Hemker HC, 2002, PATHOPHYSIOL HAEMO T, V32, P249, DOI 10.1159/000073575; Hemker HC, 2003, PATHOPHYSIOL HAEMO T, V33, P4, DOI 10.1159/000071636; Hoeper MM, 2011, AM J RESP CRIT CARE, V184, P1114, DOI 10.1164/rccm.201104-0662CI; Jain KK, 2009, TXB HYPERBARIC MED, P37; Khan MS, 2015, AM J MED, V128, pE7, DOI 10.1016/j.amjmed.2014.10.027; Kuipers S, 2006, J THROMB HAEMOST, V4, P2373, DOI 10.1111/j.1538-7836.2006.02204.x; Kuipers S, 2007, PLOS MED, V4, P1508, DOI 10.1371/journal.pmed.0040290; Levett DZH, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-98; MacNutt MJ, 2008, HIGH ALT MED BIOL, V9, P235, DOI 10.1089/ham.2008.1027; Martin DS, 2012, THROMB HAEMOSTASIS, V107, P1066, DOI 10.1160/TH12-01-0004; Ninivaggi M, 2012, CLIN CHEM, V58, P1252, DOI 10.1373/clinchem.2012.184077; Piazza G, 2012, AM J MED, V125, P1010, DOI 10.1016/j.amjmed.2012.03.007; Ribeiro JL, 2008, CLIN APPL THROMB-HEM, V14, P454, DOI 10.1177/1076029607305530; Rosendaal FR, 2006, J THROMB HAEMOST, V4, P2306, DOI 10.1111/j.1538-7836.2006.02218.x; Rosendaal FR, 2002, PATHOPHYSIOL HAEMO T, V32, P341, DOI 10.1159/000073594; Sabit R, 2010, CHEST, V138, P47, DOI 10.1378/chest.09-2764; Schreijer AJM, 2006, LANCET, V367, P832, DOI 10.1016/S0140-6736(06)68339-6; Schreijer AJM, 2009, BRIT J HAEMATOL, V144, P425, DOI 10.1111/j.1365-2141.2008.07489.x; Shetty R, 2008, J THROMB THROMBOLYS, V26, P35, DOI 10.1007/s11239-007-0157-y; Shitrit D, 2005, THROMB HAEMOSTASIS, V94, P544, DOI 10.1160/TH05-02-0103; Toff WD, 2006, JAMA-J AM MED ASSOC, V295, P2251, DOI 10.1001/jama.295.19.2251; Van den Burg PJM, 2000, J APPL PHYSIOL, V88, P1558, DOI 10.1152/jappl.2000.88.5.1558; Venemans-Jellema A, 2014, J THROMB HAEMOST, V12, P902, DOI 10.1111/jth.12564; Wagenvoord R, 2006, J THROMB HAEMOST, V4, P1331, DOI 10.1111/j.1538-7836.2006.01967.x; Wedzicha JA, 2007, THORAX, V62, P103, DOI 10.1136/thx.2006.073098	40	15	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2015	10	10							e0141797	10.1371/journal.pone.0141797	http://dx.doi.org/10.1371/journal.pone.0141797			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0EH	26516774	Green Published, Green Submitted, gold			2022-12-26	WOS:000363920800079
J	Saw, KG; Aznan, NM; Yam, FK; Ng, SS; Pung, SY				Saw, K. G.; Aznan, N. M.; Yam, F. K.; Ng, S. S.; Pung, S. Y.			New Insights on the Burstein-Moss Shift and Band Gap Narrowing in Indium-Doped Zinc Oxide Thin Films	PLOS ONE			English	Article							PULSED-LASER DEPOSITION; OPTICAL-PROPERTIES; PHYSICAL-PROPERTIES; SPRAY-PYROLYSIS; ZNO; AL; PERFORMANCE; DIAMOND; GROWTH	The Burstein-Moss shift and band gap narrowing of sputtered indium-doped zinc oxide (IZO) thin films are investigated as a function of carrier concentrations. The optical band gap shifts below the carrier concentration of 5.61 x 10(19) cm(-3) are well-described by the Burstein- Moss model. For carrier concentrations higher than 8.71 x 10(19) cm(-3) the shift decreases, indicating that band gap narrowing mechanisms are increasingly significant and are competing with the Burstein-Moss effect. The incorporation of In causes the resistivity to decrease three orders of magnitude. As the mean-free path of carriers is less than the crystallite size, the resistivity is probably affected by ionized impurities as well as defect scattering mechanisms, but not grain boundary scattering. The c lattice constant as well as film stress is observed to increase in stages with increasing carrier concentration. The asymmetric XPS Zn 2p(3/2) peak in the film with the highest carrier concentration of 7.02 x 10(20) cm(-3) suggests the presence of stacking defects in the ZnO lattice. The Raman peak at 274 cm(-1) is attributed to lattice defects introduced by In dopants.	[Saw, K. G.; Aznan, N. M.] Univ Sains Malaysia, Sch Distance Educ, Phys Programme, George Town 11800, Malaysia; [Yam, F. K.] Univ Sains Malaysia, Sch Phys, George Town 11800, Malaysia; [Saw, K. G.; Ng, S. S.] Sains USM, Inst Nanooptoelect Res & Technol, George Town 11900, Malaysia; [Pung, S. Y.] Univ Sains Malaysia, Sch Mat & Mineral Resources Engn, Nibong 14300, Tebal, Malaysia	Universiti Sains Malaysia; Universiti Sains Malaysia; Universiti Sains Malaysia; Universiti Sains Malaysia	Saw, KG (corresponding author), Univ Sains Malaysia, Sch Distance Educ, Phys Programme, George Town 11800, Malaysia.	kgsaw@usm.my	Ng, Sha Shiong/G-6189-2010; Pung, Swee/C-6249-2011; Ng, Sha Shiong/L-6879-2019	Ng, Sha Shiong/0000-0003-2023-6419; Pung, Swee/0000-0002-6473-2484; Ng, Sha Shiong/0000-0003-2023-6419; Saw, Kim Guan/0000-0002-9427-8884	Government of Malaysia [203/PJJAUH/6711290]	Government of Malaysia	This work is supported by the Fundamental Research Grant Scheme (203/PJJAUH/6711290) from the Government of Malaysia.	Agarwal DC, 2006, J APPL PHYS, V99, DOI 10.1063/1.2204333; Bundesmann C, 2003, APPL PHYS LETT, V83, P1974, DOI 10.1063/1.1609251; BURSTEIN E, 1954, PHYS REV, V93, P632, DOI 10.1103/PhysRev.93.632; Cebulla R, 1998, J APPL PHYS, V83, P1087, DOI 10.1063/1.366798; Chang SH, 2014, OPT MATER, V38, P87, DOI 10.1016/j.optmat.2014.10.004; Denny YR, 2012, J ELECTRON SPECTROSC, V185, P18, DOI 10.1016/j.elspec.2011.12.004; Ferreira NG, 2001, DIAM RELAT MATER, V10, P750, DOI 10.1016/S0925-9635(00)00522-7; GOYAL DJ, 1993, J MATER RES, V8, P1052, DOI 10.1557/JMR.1993.1052; Hays J, 2007, J PHYS-CONDENS MAT, V19, DOI 10.1088/0953-8984/19/26/266203; Hu G, 2009, J PHYS CHEM C, V113, P751, DOI 10.1021/jp808432f; Hu ZY, 2011, INT J PHOTOENERGY, V2011, DOI 10.1155/2011/158065; Jain A, 2006, SOLID STATE ELECTRON, V50, P1420, DOI 10.1016/j.sse.2006.07.001; Kang HS, 2004, J APPL PHYS, V95, P1246, DOI 10.1063/1.1633343; Kaschner A, 2002, APPL PHYS LETT, V80, P1909, DOI 10.1063/1.1461903; Kim KJ, 2001, APPL PHYS LETT, V78, P475, DOI 10.1063/1.1342042; Kumar M, 2015, APPL PHYS LETT, V106, DOI 10.1063/1.4922732; Kyaw AKK, PHYS STATUS SOLIDI A, V208, P2635; Lee CH, 2013, J CERAM PROCESS RES, V14, P145; Lee HW, 2004, J CRYST GROWTH, V268, P596, DOI 10.1016/j.jcrysgro.2004.04.098; LIN AWC, 1977, ANAL CHEM, V49, P1228, DOI 10.1021/ac50016a042; Lu JG, 2007, J APPL PHYS, V101, DOI 10.1063/1.2721374; Marotti RE, 2004, SOL ENERG MAT SOL C, V82, P85, DOI 10.1016/j.solmat.2004.01.008; Mass J, 2003, MAT SCI ENG B-SOLID, V103, P9, DOI 10.1016/S0921-5107(03)00127-2; Matsubara K, 2003, THIN SOLID FILMS, V431, P369, DOI 10.1016/S0040-6090(03)00243-8; Mishra YK, 2012, J APPL PHYS, V112, DOI 10.1063/1.4752469; Moulder J. F., 1995, HDB XRAY PHOTOELECTR; Naghavi N, 2001, ELECTROCHIM ACTA, V46, P2007, DOI 10.1016/S0013-4686(01)00417-0; Paraguay F, 1999, THIN SOLID FILMS, V350, P192, DOI 10.1016/S0040-6090(99)00050-4; Pei ZL, 2001, J APPL PHYS, V90, P3432, DOI 10.1063/1.1398070; Rao TP, 2010, J ALLOY COMPD, V506, P788, DOI 10.1016/j.jallcom.2010.07.071; ROTH AP, 1982, PHYS REV B, V25, P7836, DOI 10.1103/PhysRevB.25.7836; ROTH AP, 1981, SOLID STATE COMMUN, V39, P1269, DOI 10.1016/0038-1098(81)90224-6; SERNELIUS BE, 1988, PHYS REV B, V37, P10244, DOI 10.1103/PhysRevB.37.10244; SPITSYN BV, 1981, J CRYST GROWTH, V52, P219, DOI 10.1016/0022-0248(81)90197-4; TANENBAUM M, 1953, PHYS REV, V91, P1561, DOI 10.1103/PhysRev.91.1561.2; Wienke J, 2008, SOL ENERG MAT SOL C, V92, P884, DOI 10.1016/j.solmat.2008.01.023	36	107	108	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2015	10	10							e0141180	10.1371/journal.pone.0141180	http://dx.doi.org/10.1371/journal.pone.0141180			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0EH	26517364	Green Published, gold, Green Submitted			2022-12-26	WOS:000363920800026
J	Avants, BB; Hackman, DA; Betancourt, LM; Lawson, GM; Hurt, H; Farah, MJ				Avants, Brian B.; Hackman, Daniel A.; Betancourt, Laura M.; Lawson, Gwendolyn M.; Hurt, Hallam; Farah, Martha J.			Relation of Childhood Home Environment to Cortical Thickness in Late Adolescence: Specificity of Experience and Timing	PLOS ONE			English	Article							CEREBROSPINAL-FLUID CONCENTRATIONS; UTERO COCAINE EXPOSURE; SOCIOECONOMIC-STATUS; BRAIN-DEVELOPMENT; CHILDREN; ABILITY; VOLUME; POWER	What are the long-term effects of childhood experience on brain development? Research with animals shows that the quality of environmental stimulation and parental nurturance both play important roles in shaping lifelong brain structure and function. Human research has so far been limited to the effects of abnormal experience and pathological development. Using a unique longitudinal dataset of in-home measures of childhood experience at ages 4 and 8 and MRI acquired in late adolescence, we were able to relate normal variation in childhood experience to later life cortical thickness. Environmental stimulation at age 4 predicted cortical thickness in a set of automatically derived regions in temporal and prefrontal cortex. In contrast, age 8 experience was not predictive. Parental nurturance was not predictive at either age. This work reveals an association between childhood experience and later brain structure that is specific relative to aspects of experience, regions of brain, and timing.	[Avants, Brian B.] Univ Penn, Dept Radiol, Philadelphia, PA 19104 USA; [Hackman, Daniel A.; Lawson, Gwendolyn M.; Farah, Martha J.] Univ Penn, Dept Psychol, Philadelphia, PA 19104 USA; [Betancourt, Laura M.; Hurt, Hallam] Childrens Hosp Philadelphia, Div Neonatol, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Avants, BB (corresponding author), Univ Penn, Dept Radiol, Philadelphia, PA 19104 USA.	stnava@gmail.com		Lawson, Gwendolyn/0000-0003-4363-3169; avants, brian/0000-0002-4212-3362; Hackman, Daniel/0000-0002-6968-5701	National Institute of Child Health and Development [R01-HD055689]; National Institute of Drug Abuse [R01-DA14129]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD055689] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA014129] Funding Source: NIH RePORTER	National Institute of Child Health and Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute of Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This research was supported by grants from the National Institute of Child Health and Development (R01-HD055689) and the National Institute of Drug Abuse (R01-DA14129). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avants B, 2012, LECT NOTES COMPUT SC, V7512, P206, DOI 10.1007/978-3-642-33454-2_26; Avants BB, 2007, PEDIATR NEUROL, V37, P275, DOI 10.1016/j.pediatrneurol.2007.06.012; Blokland GAM, 2012, TWIN RES HUM GENET, V15, P351, DOI 10.1017/thg.2012.11; Bradley RH, 2002, ANNU REV PSYCHOL, V53, P371, DOI 10.1146/annurev.psych.53.100901.135233; Brito NH, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00276; Buckingham-Howes S., 2013, PEDIATRICS; Caldwell B., 1984, HOME OBSERVATION MEA; Choi YY, 2008, J NEUROSCI, V28, P10323, DOI 10.1523/JNEUROSCI.3259-08.2008; Coplan JD, 1998, ARCH GEN PSYCHIAT, V55, P473, DOI 10.1001/archpsyc.55.5.473; Coplan JD, 1996, P NATL ACAD SCI USA, V93, P1619, DOI 10.1073/pnas.93.4.1619; Courchesne E, 2007, NEURON, V56, P399, DOI 10.1016/j.neuron.2007.10.016; Dhillon P, NEUROIMAGE IN PRESS, V99, P14; Francis D, 1999, SCIENCE, V286, P1155, DOI 10.1126/science.286.5442.1155; Giedd JN, 2010, NEURON, V67, P728, DOI 10.1016/j.neuron.2010.08.040; Hackman DA, 2010, NAT REV NEUROSCI, V11, P651, DOI 10.1038/nrn2897; Hanson J. L., 2014, BIOL PSYCHIAT; Hurt H, 1997, ARCH PEDIAT ADOL MED, V151, P1237, DOI 10.1001/archpedi.1997.02170490063011; HURT H, 1995, J DEV BEHAV PEDIATR, V16, P29, DOI 10.1097/00004703-199502000-00005; Hurt H, 2009, NEUROTOXICOL TERATOL, V31, P334, DOI 10.1016/j.ntt.2009.08.002; Kandel Benjamin M, 2013, Inf Process Med Imaging, V23, P86, DOI 10.1007/978-3-642-38868-2_8; Karama S, 2009, INTELLIGENCE, V37, P145, DOI 10.1016/j.intell.2008.09.006; Kozorovitskiy Y, 2005, P NATL ACAD SCI USA, V102, P17478, DOI 10.1073/pnas.0508817102; MARTIN NG, 1978, HEREDITY, V40, P97, DOI 10.1038/hdy.1978.10; Peper JS, 2007, HUM BRAIN MAPP, V28, P464, DOI 10.1002/hbm.20398; Shaw P, 2007, P NATL ACAD SCI USA, V104, P19649, DOI 10.1073/pnas.0707741104; Shaw P, 2006, NATURE, V440, P676, DOI 10.1038/nature04513; Slopen N, 2012, ARCH GEN PSYCHIAT, V69, P1022, DOI 10.1001/archgenpsychiatry.2012.444; Sowell ER, 2004, J NEUROSCI, V24, P8223, DOI 10.1523/JNEUROSCI.1798-04.2004; Strang NM, 2012, MONOGR SOC RES CHILD, V77, P61, DOI 10.1111/j.1540-5834.2011.00662.x; Tamnes CK, 2010, CEREB CORTEX, V20, P534, DOI 10.1093/cercor/bhp118; Tottenham N, 2010, DEVELOPMENTAL SCI, V13, P46, DOI 10.1111/j.1467-7687.2009.00852.x; Turkheimer E, 2003, PSYCHOL SCI, V14, P623, DOI 10.1046/j.0956-7976.2003.psci_1475.x; van Praag H, 2000, NAT REV NEUROSCI, V1, P191, DOI 10.1038/35044558; Vul E, 2012, NEUROIMAGE, V62, P945, DOI 10.1016/j.neuroimage.2012.01.027; Yang YL, 2012, NEUROREPORT, V23, P702, DOI 10.1097/WNR.0b013e328355a62a; Zatorre RJ, 2012, NAT NEUROSCI, V15, P528, DOI 10.1038/nn.3045	36	22	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2015	10	10							e0138217	10.1371/journal.pone.0138217	http://dx.doi.org/10.1371/journal.pone.0138217			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CV0DL	26509809	Green Published, Green Submitted, gold			2022-12-26	WOS:000363918100006
J	Muraguchi, H; Umezawa, K; Niikura, M; Yoshida, M; Kozaki, T; Ishii, K; Sakai, K; Shimizu, M; Nakahori, K; Sakamoto, Y; Choi, C; Ngan, CY; Lindquist, E; Lipzen, A; Tritt, A; Haridas, S; Barry, K; Grigoriev, IV; Pukkila, PJ				Muraguchi, Hajime; Umezawa, Kiwamu; Niikura, Mai; Yoshida, Makoto; Kozaki, Toshinori; Ishii, Kazuo; Sakai, Kiyota; Shimizu, Motoyuki; Nakahori, Kiyoshi; Sakamoto, Yuichi; Choi, Cindy; Ngan, Chew Yee; Lindquist, Eika; Lipzen, Anna; Tritt, Andrew; Haridas, Sajeet; Barry, Kerrie; Grigoriev, Igor V.; Pukkila, Patricia J.			Strand-Specific RNA-Seq Analyses of Fruiting Body Development in Coprinopsis cinerea	PLOS ONE			English	Article							BASIDIOMYCETE COPRINUS-CINEREUS; SCHIZOPHYLLUM-COMMUNE; SEXUAL DEVELOPMENT; TRANSCRIPTION FACTORS; LENTINULA-EDODES; GENE-EXPRESSION; MUSHROOM; MORPHOGENESIS; ENCODES; FUNGI	The basidiomycete fungus Coprinopsis cinerea is an important model system for multicellular development. Fruiting bodies of C. cinerea are typical mushrooms, which can be produced synchronously on defined media in the laboratory. To investigate the transcriptome in detail during fruiting body development, high-throughput sequencing (RNA-seq) was performed using cDNA libraries strand-specifically constructed from 13 points (stages/tissues) with two biological replicates. The reads were aligned to 14,245 predicted transcripts, and counted for forward and reverse transcripts. Differentially expressed genes (DEGs) between two adjacent points and between vegetative mycelium and each point were detected by Tag Count Comparison (TCC). To validate RNA-seq data, expression levels of selected genes were compared using RPKM values in RNA-seq data and qRT-PCR data, and DEGs detected in microarray data were examined in MA plots of RNA-seq data by TCC. We discuss events deduced from GO analysis of DEGs. In addition, we uncovered both transcription factor candidates and antisense transcripts that are likely to be involved in developmental regulation for fruiting.	[Muraguchi, Hajime] Akita Prefectural Univ, Fac Bioresource Sci, Dept Biotechnol, Akita 0100195, Japan; [Umezawa, Kiwamu; Niikura, Mai; Yoshida, Makoto] Tokyo Univ Agr & Technol, Dept Environm & Nat Resource Sci, Fac Agr, Fuchu, Tokyo 1838509, Japan; [Kozaki, Toshinori; Ishii, Kazuo] Tokyo Univ Agr & Technol, Fac Agr, Dept Appl Biol Sci, Fuchu, Tokyo 1838509, Japan; [Sakai, Kiyota; Shimizu, Motoyuki] Meijo Univ, Fac Agr, Dept Appl Biol Chem, Nagoya, Aichi 4680073, Japan; [Nakahori, Kiyoshi] Okayama Univ, Grad Sch Nat Sci & Technol, Okayama 7008530, Japan; [Sakamoto, Yuichi] Iwate Biotechnol Res Ctr, Kitakami, Iwate 0240003, Japan; [Choi, Cindy; Ngan, Chew Yee; Lindquist, Eika; Lipzen, Anna; Tritt, Andrew; Haridas, Sajeet; Barry, Kerrie; Grigoriev, Igor V.] US Dept Energy Joint Genome Inst, Walnut Creek, CA 94598 USA; [Pukkila, Patricia J.] Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA	Akita Prefectural University; Tokyo University of Agriculture & Technology; Tokyo University of Agriculture & Technology; Meijo University; Okayama University; Iwate Biotechnology Research Center; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of North Carolina; University of North Carolina Chapel Hill	Muraguchi, H (corresponding author), Akita Prefectural Univ, Fac Bioresource Sci, Dept Biotechnol, Akita 0100195, Japan.	muraguchi@akita-pu.ac.jp	Ishii, Kazuo/M-3099-2016; Sakamoto, Yuichi/AAW-2149-2021; Haridas, Sajeet/H-4018-2019; Barry, Kerrie Whitelaw/AAA-5500-2020; Ishii, Kazuo/N-9946-2019; Yoshida, Makoto/E-8017-2013; ishii, kazuo/K-7428-2014	Ishii, Kazuo/0000-0002-8363-8266; Sakamoto, Yuichi/0000-0003-4167-9112; Haridas, Sajeet/0000-0002-0229-0975; Barry, Kerrie Whitelaw/0000-0002-8999-6785; ngan, chew yee/0000-0001-6055-1072; ishii, kazuo/0000-0001-7801-1891; Sakai, Kiyota/0000-0002-2653-4989; Umezawa, Kiwamu/0000-0003-1277-0558; Lipzen, Anna/0000-0003-2293-9329; Grigoriev, Igor/0000-0002-3136-8903	Office of Science of the US Department of Energy [DE-AC02-05CH11231]; Ministry of Agriculture, Forestry and Fisheries of Japan [23053]	Office of Science of the US Department of Energy(United States Department of Energy (DOE)); Ministry of Agriculture, Forestry and Fisheries of Japan(Ministry of Agriculture Forestry & Fisheries - Japan)	The #326 AmutBmut pab1-1 genome sequencing, assembly and annotation, and the RNA-seq analysis were provided through JGI's Community Sequencing Program "Functional genomics in the model mushroom Coprinopsis cinerea". The work conducted by the US Department of Energy Joint Genome Institute is supported by the Office of Science of the US Department of Energy under Contract No. DE-AC02-05CH11231. This work was supported in part (preparation of total RNA, and sending the samples from Japna to USA) by a fund from the Ministry of Agriculture, Forestry and Fisheries of Japan (23053).	Ando Y, 2013, FUNGAL GENET BIOL, V50, P82, DOI 10.1016/j.fgb.2012.09.010; Arima T, 2004, FUNGAL GENET BIOL, V41, P805, DOI 10.1016/j.fgb.2004.04.003; Bayram O, 2012, FEMS MICROBIOL REV, V36, P1, DOI 10.1111/j.1574-6976.2011.00285.x; Boulianne RP, 2000, MICROBIOL-SGM, V146, P1841, DOI 10.1099/00221287-146-8-1841; Burns C, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001135; Celerin M, 2000, EMBO J, V19, P2739, DOI 10.1093/emboj/19.11.2739; Chavez L, 2014, P NATL ACAD SCI USA, V111, pE5149, DOI 10.1073/pnas.1419513111; Cheng CK, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-195; David L, 2006, P NATL ACAD SCI USA, V103, P5320, DOI 10.1073/pnas.0601091103; DeGroot PWJ, 1996, J MOL BIOL, V257, P1008, DOI 10.1006/jmbi.1996.0219; Gooday G. W., 1985, DEV BIOL HIGHER FUNG, P311; Horst RJ, 2012, EUKARYOT CELL, V11, P368, DOI 10.1128/EC.05191-11; Huber Wolfgang, 2002, Bioinformatics, V18 Suppl 1, pS96; Inada K, 2001, GENETICS, V157, P133; JI JX, 1993, MYCOL RES, V97, P283, DOI 10.1016/S0953-7562(09)81121-0; KAMADA T, 1978, PLANT CELL PHYSIOL, V19, P263; Kamada T, 2010, FUNGAL GENET BIOL, V47, P917, DOI 10.1016/j.fgb.2010.05.003; Katayama S, 2005, SCIENCE, V309, P1564, DOI 10.1126/science.1112009; Kues U, 2000, MICROBIOL MOL BIOL R, V64, P316, DOI 10.1128/MMBR.64.2.316-353.2000; Kuratani M, 2010, FUNGAL GENET BIOL, V47, P152, DOI 10.1016/j.fgb.2009.10.006; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lu BC, 2003, FUNGAL GENET BIOL, V39, P82, DOI 10.1016/S1087-1845(03)00024-0; MATTHEWS TR, 1973, ARCH MIKROBIOL, V88, P169, DOI 10.1007/BF00421843; MOORE D, 1979, NEW PHYTOL, V83, P695, DOI 10.1111/j.1469-8137.1979.tb02301.x; Moore D., 1995, GROWING FUNGUS, P423; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Muraguchi H, 1998, DEVELOPMENT, V125, P3133; Muraguchi H, 2000, FUNGAL GENET BIOL, V29, P49, DOI 10.1006/fgbi.2000.1184; Muraguchi H, 2003, FUNGAL GENET BIOL, V40, P93, DOI 10.1016/S1087-1845(03)00087-2; Nakazawa T, 2011, FUNGAL GENET BIOL, V48, P939, DOI 10.1016/j.fgb.2011.06.003; Ng WL, 2000, FEMS MICROBIOL LETT, V185, P139, DOI 10.1111/j.1574-6968.2000.tb09052.x; Nishizawa H, 2002, BIOSCI BIOTECH BIOCH, V66, P1951, DOI 10.1271/bbb.66.1951; O'Shea SF, 1998, GENETICS, V148, P1081; Ohm RA, 2011, MOL MICROBIOL, V81, P1433, DOI 10.1111/j.1365-2958.2011.07776.x; Ohm RA, 2010, NAT BIOTECHNOL, V28, P957, DOI 10.1038/nbt.1643; Olesnicky NS, 2000, GENETICS, V156, P1025; Pardo EH, 1996, GENETICS, V144, P87; Park HS, 2012, MOL MICROBIOL, V86, P937, DOI 10.1111/mmi.12032; Parkhomchuk D, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp596; Plaza DF, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-492; Polak E, 1997, FUNGAL GENET BIOL, V22, P112, DOI 10.1006/fgbi.1997.1010; RAO PS, 1969, J BACTERIOL, V100, P1222, DOI 10.1128/JB.100.3.1222-1228.1969; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Rosin I. V., 1985, DEV BIOL HIGHER FUNG, P333; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Sakamoto Y, 2007, FUNGAL GENET BIOL, V44, P14, DOI 10.1016/j.fgb.2006.06.002; Seitz LC, 1996, GENETICS, V142, P1105; Shelest E, 2008, FEMS MICROBIOL LETT, V286, P145, DOI 10.1111/j.1574-6968.2008.01293.x; Sherman BT, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-426; Shioya T, 2013, FUNGAL GENET BIOL, V58-59, P80, DOI 10.1016/j.fgb.2013.08.007; Sibthorp C, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-847; Stajich JE, 2010, P NATL ACAD SCI USA, V107, P11889, DOI 10.1073/pnas.1003391107; STEPHENSON NA, 1984, T BRIT MYCOL SOC, V82, P531, DOI 10.1016/S0007-1536(84)80017-0; Sun JQ, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-219; SWAMY S, 1984, J GEN MICROBIOL, V130, P3219; Terashima K, 2005, GENETICS, V171, P101, DOI 10.1534/genetics.104.040048; Todd RB, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-214; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; van Wetter MA, 2000, FUNGAL GENET BIOL, V31, P99, DOI 10.1006/fgbi.2000.1231; VANDERVALK P, 1978, PROTOPLASMA, V95, P57, DOI 10.1007/BF01279695; Yuan CH, 2015, DNA RES, V22, P233, DOI 10.1093/dnares/dsv008; Zahiri A, 2010, MOL PLANT MICROBE IN, V23, P1118, DOI 10.1094/MPMI-23-9-1118	62	57	67	2	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2015	10	10							e0141586	10.1371/journal.pone.0141586	http://dx.doi.org/10.1371/journal.pone.0141586			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0DL	26510163	Green Published, gold, Green Submitted			2022-12-26	WOS:000363918100109
J	Tan, JT; Kan, J; Qiu, G; Zhao, DY; Ren, F; Luo, ZC; Zhang, YJ				Tan, Jintong; Kan, Juan; Qiu, Gang; Zhao, Dongying; Ren, Fang; Luo, Zhongcheng; Zhang, Yongjun			Clinical Prognosis in Neonatal Bacterial Meningitis: The Role of Cerebrospinal Fluid Protein	PLOS ONE			English	Article							PNEUMOCOCCAL MENINGITIS; DEVELOPING-COUNTRIES; INFANTS; INFECTION; SEQUELAE; CHILDREN; TAIWAN; SERIES	Neonates are at high risk of meningitis and of resulting neurologic complications. Early recognition of neonates at risk of poor prognosis would be helpful in providing timely management. From January 2008 to June 2014, we enrolled 232 term neonates with bacterial meningitis admitted to 3 neonatology departments in Shanghai, China. The clinical status on the day of discharge from these hospitals or at a postnatal age of 2.5 to 3 months was evaluated using the Glasgow Outcome Scale (GOS). Patients were classified into two outcome groups: good (167 cases, 72.0%, GOS = 5) or poor (65 cases, 28.0%, GOS = 1-4). Neonates with good outcome had less frequent apnea, drowsiness, poor feeding, bulging fontanelle, irritability and more severe jaundice compared to neonates with poor outcome. The good outcome group also had less pneumonia than the poor outcome group. Besides, there were statistically significant differences in hemoglobin, mean platelet volume, platelet distribution width, C-reaction protein, procalcitonin, cerebrospinal fluid (CSF) glucose and CSF protein. Multivariate logistic regression analyses suggested that poor feeding, pneumonia and CSF protein were the predictors of poor outcome. CSF protein content was significantly higher in patients with poor outcome. The best cut-offs for predicting poor outcome were 1,880 mg/L in CSF protein concentration (sensitivity 70.8%, specificity 86.2%). After 2 weeks of treatment, CSF protein remained higher in the poor outcome group. High CSF protein concentration may prognosticate poor outcome in neonates with bacterial meningitis.	[Tan, Jintong; Zhao, Dongying; Ren, Fang; Zhang, Yongjun] Shanghai Jiao Tong Univ, Sch Med, Xinhua Hosp, Shanghai 200030, Peoples R China; [Kan, Juan] Shanghai Jiao Tong Univ, Sch Med, Peoples Hosp 9, Shanghai 200030, Peoples R China; [Qiu, Gang] Shanghai Jiao Tong Univ, Sch Med, Shanghai Childrens Hosp, Shanghai 200030, Peoples R China; [Luo, Zhongcheng; Zhang, Yongjun] MOE & Shanghai Key Lab Childrens Environm Hlth, Shanghai, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Zhang, YJ (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Xinhua Hosp, Shanghai 200030, Peoples R China.	zhangyongjun@sjtu.edu.cn	Zhao, Doreen/HHN-5678-2022; Luo, Zhong-Cheng/T-3882-2017	Luo, Zhong-Cheng/0000-0002-1794-1312				ANDERSON SG, 1990, J PAEDIATR CHILD H, V26, P212, DOI 10.1111/j.1440-1754.1990.tb02432.x; Auburtin M, 2002, AM J RESP CRIT CARE, V165, P713, DOI 10.1164/ajrccm.165.5.2105110; Bargui F, 2012, EUR J PEDIATR, V171, P1365, DOI 10.1007/s00431-012-1733-5; Barichello T, 2013, J MED MICROBIOL, V62, P1781, DOI 10.1099/jmm.0.059840-0; Ben Hamouda H, 2013, ARCH PEDIATRIE, V20, P938, DOI [10.1016/j.arcped.2013.05.005, 10.1016/j.arcped.2013]; Bentlin MR, 2010, ARQ NEURO-PSIQUIAT, V68, P882, DOI 10.1590/S0004-282X2010000600010; Chang CJ, 2003, PEDIATR NEUROL, V29, P288, DOI 10.1016/S0887-8994(03)00273-X; Chu SM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105294; de Jonge RCJ, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-232; de Louvois J, 2005, EUR J PEDIATR, V164, P730, DOI 10.1007/s00431-005-1747-3; Eslami ST, 2012, PEDIATR INT, V54, P336, DOI 10.1111/j.1442-200X.2011.03551.x; Furyk JS, 2011, TROP MED INT HEALTH, V16, P672, DOI 10.1111/j.1365-3156.2011.02750.x; Garges HP, 2006, PEDIATRICS, V117, P1094, DOI 10.1542/peds.2005-1132; Gaschignard J, 2011, PEDIATR INFECT DIS J, V30, P212, DOI 10.1097/INF.0b013e3181fab1e7; Grimwood K, 1996, J PAEDIATR CHILD H, V32, P457, DOI 10.1111/j.1440-1754.1996.tb00949.x; Heath P. T., 2003, Archives of Disease in Childhood, V88, pF173, DOI 10.1136/fn.88.3.F173; Krebs VLJ, 2007, ARQ NEURO-PSIQUIAT, V65, P1149, DOI 10.1590/S0004-282X2007000700011; Kastenbauer S, 2003, BRAIN, V126, P1015, DOI 10.1093/brain/awg113; Kim KS, 2010, LANCET INFECT DIS, V10, P32, DOI 10.1016/S1473-3099(09)70306-8; Klinger G, 2000, PEDIATRICS, V106, P477, DOI 10.1542/peds.106.3.477; Koster-Rasmussen R, 2008, J INFECTION, V57, P449, DOI 10.1016/j.jinf.2008.09.033; Lin MC, 2012, J MICROBIOL IMMUNOL, V45, P442, DOI 10.1016/j.jmii.2011.12.034; Molyneux E, 2011, LANCET, V377, P1837, DOI 10.1016/S0140-6736(11)60580-1; Okike IO, 2014, CLIN INFECT DIS, V59, pE150, DOI 10.1093/cid/ciu514; Ostergaard C, 2005, BMC INFECT DIS, V5, DOI 10.1186/1471-2334-5-93; PAAP CM, 1992, DRUGS, V43, P700, DOI 10.2165/00003495-199243050-00006; Palazzi DL, 2006, INFECT DIS FETUS NEW, P247, DOI DOI 10.1016/B0-72-160537-0/50008-6; Rajesh NT, 2009, ARCH DIS CHILD-FETAL, V95, pF25, DOI 10.1136/adc.2008.150292; Stevens JP, 2003, ARCH DIS CHILD-FETAL, V88, P179; Thaver D, 2009, PEDIATR INFECT DIS J, V28, pS3, DOI 10.1097/INF.0b013e3181958755; Weber MW, 2003, PEDIATR INFECT DIS J, V22, P711, DOI 10.1097/01.inf.0000078163.80807.88	31	17	22	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2015	10	10							e0141620	10.1371/journal.pone.0141620	http://dx.doi.org/10.1371/journal.pone.0141620			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0DL	26509880	Green Published, gold, Green Submitted			2022-12-26	WOS:000363918100116
J	Overkamp, W; Kuipers, OP				Overkamp, Wout; Kuipers, Oscar P.			Transcriptional Profile of Bacillus subtilis sigF-Mutant during Vegetative Growth	PLOS ONE			English	Article							DNA-MICROARRAY DATA; GENE-EXPRESSION; ENDOSPORE FORMATION; CELL-TYPE; SPORULATION; GENOME; REGULON; SPOIIAB; INFORMATION; RESISTANCE	Sigma factor F is the first forespore specific transcription factor in Bacillus subtilis and controls genes required for the early stages of prespore development. The role of sigF is well studied under conditions that induce sporulation. Here, the impact of sigF disruption on the transcriptome of exponentially growing cultures is studied by micro-array analysis. Under these conditions that typically don't induce sporulation, the transcriptome showed minor signs of sporulation initiation. The number of genes differentially expressed and the magnitude of expression were, as expected, quite small in comparison with sporulation conditions. The genes mildly down-regulated were mostly involved in anabolism and the genes mildly up-regulated, in particular fatty acid degradation genes, were mostly involved in catabolism. This is probably related to the arrest at sporulation stage II occurring in the sigF mutant, because continuation of growth from the formed disporic sporangia may require additional energy. The obtained knowledge is relevant for various experiments, such as industrial fermentation, prolonged experimental evolution or zero-growth studies, where sporulation is an undesirable trait that should be avoided, e.g by a sigF mutation.	[Overkamp, Wout; Kuipers, Oscar P.] Univ Groningen, Dept Mol Genet, Groningen Biomol Sci & Biotechnol Inst, Groningen, Netherlands; [Overkamp, Wout; Kuipers, Oscar P.] Kluyver Ctr Genom Ind Fermentat, Delft, Netherlands	University of Groningen	Kuipers, OP (corresponding author), Univ Groningen, Dept Mol Genet, Groningen Biomol Sci & Biotechnol Inst, Groningen, Netherlands.	o.p.kuipers@rug.nl	Kuipers, Oscar/B-6752-2009	Kuipers, Oscar/0000-0001-5596-7735	Kluyver Centre for Genomics of Industrial Fermentation; Netherlands Genomics Initiative / Netherlands Organisation for Scientific Research (NWO)	Kluyver Centre for Genomics of Industrial Fermentation; Netherlands Genomics Initiative / Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	This work was supported by the Kluyver Centre for Genomics of Industrial Fermentation which is part of the Netherlands Genomics Initiative / Netherlands Organisation for Scientific Research (NWO); http://www.kluyvercentre.nl/ to WO. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANAGNOSTOPOULOS C, 1961, J BACTERIOL, V81, P741, DOI 10.1128/JB.81.5.741-746.1961; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Blom EJ, 2007, BIOINFORMATICS, V23, P1161, DOI 10.1093/bioinformatics/btl658; BURBULYS D, 1991, CELL, V64, P545, DOI 10.1016/0092-8674(91)90238-T; DUNCAN L, 1993, P NATL ACAD SCI USA, V90, P2325, DOI 10.1073/pnas.90.6.2325; Duncan L, 1996, J MOL BIOL, V260, P147, DOI 10.1006/jmbi.1996.0389; Dworkin J, 2005, CELL, V121, P401, DOI 10.1016/j.cell.2005.02.032; EBBOLE DJ, 1987, J BIOL CHEM, V262, P8274; Eijlander RT, 2014, NUCLEIC ACIDS RES, V42, pD685, DOI 10.1093/nar/gkt1007; Errington J, 2003, NAT REV MICROBIOL, V1, P117, DOI 10.1038/nrmicro750; Fawcett P, 2000, P NATL ACAD SCI USA, V97, P8063, DOI 10.1073/pnas.140209597; Florez LA, 2009, DATABASE-OXFORD, DOI 10.1093/database/bap012; FORT P, 1984, J GEN MICROBIOL, V130, P2147; Fujita M, 2005, GENE DEV, V19, P2236, DOI 10.1101/gad.1335705; Gonzalez-Pastor JE, 2003, SCIENCE, V301, P510, DOI 10.1126/science.1086462; GueroutFleury AM, 1995, GENE, V167, P335, DOI 10.1016/0378-1119(95)00652-4; Harwood C.R., 1990, MOL BIOL METHODS BAC; Higgins D, 2012, FEMS MICROBIOL REV, V36, P131, DOI 10.1111/j.1574-6976.2011.00310.x; Hilbert DW, 2004, MICROBIOL MOL BIOL R, V68, P234, DOI 10.1128/MMBR.68.2.234-262.2004; ILLING N, 1991, J BACTERIOL, V173, P3159, DOI 10.1128/JB.173.10.3159-3169.1991; IRETON K, 1993, GENE DEV, V7, P283, DOI 10.1101/gad.7.2.283; KANEDA T, 1977, BACTERIOL REV, V41, P391, DOI 10.1128/MMBR.41.2.391-418.1977; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Koburger T, 2005, MOL GENET GENOMICS, V274, P1, DOI 10.1007/s00438-005-1119-8; Kunst F, 1997, NATURE, V390, P249, DOI 10.1038/36786; Leskela S, 1996, MICROBIOL-SGM, V142, P71, DOI 10.1099/13500872-142-1-71; Long AD, 2001, J BIOL CHEM, V276, P19937, DOI 10.1074/jbc.M010192200; Lulko AT, 2007, J MOL MICROB BIOTECH, V12, P82, DOI 10.1159/000096463; MARGOLIS P, 1991, SCIENCE, V254, P562, DOI 10.1126/science.1948031; Matsuoka H, 2007, J BIOL CHEM, V282, P5180, DOI 10.1074/jbc.M606831200; Molle V, 2003, J BACTERIOL, V185, P1911, DOI 10.1128/JB.185.6.1911-1922.2003; Molle V, 2003, MOL MICROBIOL, V50, P1683, DOI 10.1046/j.1365-2958.2003.03818.x; Nicholson WL, 2000, MICROBIOL MOL BIOL R, V64, P548, DOI 10.1128/MMBR.64.3.548-572.2000; Piggot P, 2002, BACILLUS SUBTILIS IT, P483; PIGGOT PJ, 1976, BACTERIOL REV, V40, P908, DOI 10.1128/MMBR.40.4.908-962.1976; Sambrock J, 1989, MOL CLONING LAB MANU, V1; SCHMIDT R, 1990, P NATL ACAD SCI USA, V87, P9221, DOI 10.1073/pnas.87.23.9221; SETLOW B, 1991, J BACTERIOL, V173, P6270, DOI 10.1128/jb.173.19.6270-6278.1991; Sierro N, 2008, NUCLEIC ACIDS RES, V36, pD93, DOI 10.1093/nar/gkm910; Steil L, 2005, MICROBIOL-SGM, V151, P399, DOI 10.1099/mic.0.27493-0; Stragier P, 1996, ANNU REV GENET, V30, P297, DOI 10.1146/annurev.genet.30.1.297; Tatusov RL, 1997, SCIENCE, V278, P631, DOI 10.1126/science.278.5338.631; Tojo S, 2011, J BACTERIOL, V193, P2388, DOI 10.1128/JB.00016-11; van Hijum Sacha A F T, 2003, Appl Bioinformatics, V2, P241; van Hijum SAFT, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-77; Wang ST, 2006, J MOL BIOL, V358, P16, DOI 10.1016/j.jmb.2006.01.059; WARD JB, 1973, J BACTERIOL, V116, P719, DOI 10.1128/JB.116.2.719-726.1973; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9	48	6	8	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2015	10	10							e0141553	10.1371/journal.pone.0141553	http://dx.doi.org/10.1371/journal.pone.0141553			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU8PC	26506528	Green Published, gold, Green Submitted			2022-12-26	WOS:000363804200083
J	Klein, SD; Torchetti, L; Frei-Erb, M; Wolf, U				Klein, Sabine D.; Torchetti, Loredana; Frei-Erb, Martin; Wolf, Ursula			Usage of Complementary Medicine in Switzerland: Results of the Swiss Health Survey 2012 and Development Since 2007	PLOS ONE			English	Article							ALTERNATIVE MEDICINE; UNITED-STATES; POPULATION; PREGNANCY; CHILDREN; PAIN	Background Complementary medicine (CM) is popular in Switzerland. Several CM methods (traditional Chinese medicine/acupuncture, homeopathy, anthroposophic medicine, neural therapy, and herbal medicine) are currently covered by the mandatory basic health insurance when performed by a certified physician. Treatments by non-medical therapists are partially covered by a supplemental and optional health insurance. In this study, we investigated the frequency of CM use including the evolvement over time, the most popular methods, and the user profile. Methods Data of the Swiss Health Surveys 2007 and 2012 were used. In 2007 and 2012, a population of 14,432 and 18,357, respectively, aged 15 years or older answered the written questionnaire. A set of questions queried about the frequency of use of various CM methods within the last 12 months before the survey. Proportions of usage and 95% confidence intervals were calculated for these methods and CM in general. Users and non-users of CM were compared using logistic regression models. Results The most popular methods in 2012 were homeopathy, naturopathy, osteopathy, herbal medicine, and acupuncture. The average number of treatments within the 12 months preceding the survey ranged from 3 for homeopathy to 6 for acupuncture. 25.0% of the population at the age of 15 and older had used at least one CM method in the previous 12 months. People with a chronic illness or a poor self-perceived health status were more likely to use CM. Similar to other countries, women, people of middle age, and those with higher education were more likely to use CM. 59.9% of the adult population had a supplemental health insurance that partly covered CM treatments. Conclusions Usage of CM in Switzerland remained unchanged between 2007 and 2012. The user profile in Switzerland was similar to other countries, such as Germany, United Kingdom, United States or Australia.	[Klein, Sabine D.; Torchetti, Loredana; Frei-Erb, Martin; Wolf, Ursula] Univ Bern, Inst Complementary Med, Bern, Switzerland	University of Bern	Klein, SD (corresponding author), Univ Bern, Inst Complementary Med, Bern, Switzerland.	sabine.klein@ikom.unibe.ch	Klein, Sabine D./T-2854-2019	Klein, Sabine D./0000-0001-6843-1454; Frei-Erb, Martin/0000-0002-7923-3741				Barnes Patricia M, 2008, Natl Health Stat Report, P1; Birdee GS, 2014, J WOMENS HEALTH, V23, P824, DOI 10.1089/jwh.2013.4568; Bishop JL, 2011, COMPLEMENT THER MED, V19, P303, DOI 10.1016/j.ctim.2011.08.005; Clarke Tainya C, 2015, Natl Health Stat Report, P1; Crivelli L, 2004, INANSPRUCHNAHME 5 TH; EISENBERG DM, 1993, NEW ENGL J MED, V328, P246, DOI 10.1056/NEJM199301283280406; Eisenberg DM, 1998, JAMA-J AM MED ASSOC, V280, P1569, DOI 10.1001/jama.280.18.1569; Eizayaga JE, 2012, HOMEOPATHY, V101, P21, DOI 10.1016/j.homp.2011.09.002; Falkenberg T, 2012, FORSCH KOMPLEMENTMED, V19, P6, DOI 10.1159/000343812; Frass M, 2012, OCHSNER J, V12, P45; Huang TP, 2014, COMPLEMENT THER MED, V22, P500, DOI 10.1016/j.ctim.2014.04.002; Klein SD, 2012, SWISS MED WKLY, V142, DOI 10.4414/smw.2012.13666; Kristoffersen ES, 2013, J HEADACHE PAIN, V14, DOI 10.1186/1129-2377-14-36; Lert F, 2014, HOMEOPATHY, V103, P51, DOI 10.1016/j.homp.2013.09.001; Licciardone JC, 2013, MANUAL THER, V18, P533, DOI 10.1016/j.math.2013.05.006; Lin V, 2015, HEALTH EXPECT, V18, P2651, DOI 10.1111/hex.12239; MacPherson H, 2006, COMPLEMENT THER MED, V14, P39; Nedeljkovic M, 2014, MENOPAUSE, V21, P15, DOI [10.1097/GME.0b013e31829374e8, 10.1097/gme.0b013e31829374e8]; Schenker N, 2001, AM STAT, V55, P182, DOI 10.1198/000313001317097960; Simoes-Wust AP, 2014, J ALTERN COMPLEM MED, V20, P40, DOI 10.1089/acm.2012.0762; Sirois FM, 2014, COMPLEMENT THER MED, V22, P701, DOI 10.1016/j.ctim.2014.07.003; Tan MGE, 2013, ANN ACAD MED SINGAP, V42, P133; von Ammon K, 2012, FORSCH KOMPLEMENTMED, V19, P37, DOI 10.1159/000343129; West BT, 2008, J TRAUMA STRESS, V21, P440, DOI 10.1002/jts.20356; Witt CM, 2010, J ALTERN COMPLEM MED, V16, P347, DOI 10.1089/acm.2009.0376	25	52	52	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2015	10	10							e0141985	10.1371/journal.pone.0141985	http://dx.doi.org/10.1371/journal.pone.0141985			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV0ED	26513370	Green Published, gold, Green Submitted			2022-12-26	WOS:000363920300092
J	Pederson, T				Pederson, Thoru			Molecular Biology of the Gene	FASEB JOURNAL			English	Book Review									[Pederson, Thoru] Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester	Pederson, T (corresponding author), Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Worcester, MA 01605 USA.	thoru.pederson@umassmed.edu						Haynes R., 1948, MOL BIOL LIFE INTRO; Oncley J. L., 1959, BIOPHYSICAL SCI STUD; Pederson T, 2005, FASEB J, V19, P1583, DOI 10.1096/fj.05-1002ufm; Pederson T., 2011, BIOGRAPHICAL MEMOIRS; Pederson T, 2012, MOL BIOL CELL, V23, P3281, DOI 10.1091/mbc.E12-06-0448; Pederson T, 2012, FASEB J, V26, P967, DOI 10.1096/fj.12-0301ufm; Pederson T, 2011, FASEB J, V25, P2512, DOI 10.1096/fj.11-0802; Portugal F. H., 1977, A CENTURY OF DNA; Ptashne M., 1986, A GENETIC SWITCH; Steitz J. A., 2003, INSPIRING SCI J WATS, P159; Stent G., 1963, MOL BIOL BACTERIAL V; Watson J. D., 1965, MOL BIOL GENE; Watson J.D., 1968, DOUBLE HELIX PERSONA; Weatherall DJ., 2011, FASEB J, V25, P2513; WEAVER W, 1938, ANN REPORT ROCKEFELL, P203	15	4	4	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2015	29	11					4399	4401		10.1096/fj.15-1101ufm	http://dx.doi.org/10.1096/fj.15-1101ufm			3	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CV8EZ	26527575				2022-12-26	WOS:000364514700001
J	Looker, KJ; Magaret, AS; Turner, KME; Vickerman, P; Gottlieb, SL; Newman, LM				Looker, Katharine J.; Magaret, Amalia S.; Turner, Katherine M. E.; Vickerman, Peter; Gottlieb, Sami L.; Newman, Lori M.			Global Estimates of Prevalent and Incident Herpes Simplex Virus Type 2 Infections in 2012	PLOS ONE			English	Article							GENITAL HERPES; UNITED-STATES; SEROPOSITIVE WOMEN; HIV ACQUISITION; HSV-2; RISK; TRANSMISSION; MEN; SEROPREVALENCE; SEROCONVERSION	Background: Herpes simplex virus type 2 (HSV-2) infection causes significant disease globally. Adolescent and adult infection may present as painful genital ulcers. Neonatal infection has high morbidity and mortality. Additionally, HSV-2 likely contributes substantially to the spread of HIV infection. The global burden of HSV-2 infection was last estimated for 2003. Here we present new global estimates for 2012 of the burden of prevalent (existing) and incident (new) HSV-2 infection among females and males aged 15-49 years, using updated methodology to adjust for test performance and estimate by World Health Organization (WHO) region. Methods and Findings: We conducted a literature review of HSV-2 prevalence studies world-wide since 2000. We then fitted a model with constant HSV-2 incidence by age to pooled HSV-2 prevalence values by age and sex. Prevalence values were adjusted for test sensitivity and specificity. The model estimated prevalence and incidence by sex for each WHO region to obtain global burden estimates. Uncertainty bounds were computed by refitting the model to reflect the variation in the underlying prevalence data. In 2012, we estimate that there were 417 million people aged 15-49 years (range: 274-678 million) living with HSV-2 infection world-wide (11.3% global prevalence), of whom 267 million were women. We also estimate that in 2012, 19.2 million (range: 13.0-28.6 million) individuals aged 15-49 years were newly-infected (0.5% of all individuals globally). The highest burden was in Africa. However, despite lower prevalence, South-East Asia and Western Pacific regions also contributed large numbers to the global totals because of large population sizes. Conclusions: The global burden of HSV-2 infection is large, leaving over 400 million people at increased risk of genital ulcer disease, HIV acquisition, and transmission of HSV-2 to partners or neonates. These estimates highlight the critical need for development of vaccines, microbicides, and other new HSV prevention strategies.	[Looker, Katharine J.; Turner, Katherine M. E.; Vickerman, Peter] Univ Bristol, Sch Social & Community Med, Bristol, Avon, England; [Magaret, Amalia S.] Univ Washington, Dept Lab Med, Seattle, WA 98195 USA; [Gottlieb, Sami L.; Newman, Lori M.] WHO, Dept Reprod Hlth & Res, CH-1211 Geneva, Switzerland	University of Bristol; University of Washington; University of Washington Seattle; World Health Organization	Looker, KJ (corresponding author), Univ Bristol, Sch Social & Community Med, Bristol, Avon, England.	katharine.looker@bristol.ac.uk	Turner, Katy/R-3853-2019	Turner, Katy/0000-0002-8152-6017; Chen, Yu/0000-0002-1519-4894; Vickerman, Peter/0000-0002-8291-5890	UNDP/UNFPA/UNICEF/WHO/World Bank Special Programme of Research; Development and Research Training in Human Reproduction; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI030731] Funding Source: NIH RePORTER	UNDP/UNFPA/UNICEF/WHO/World Bank Special Programme of Research; Development and Research Training in Human Reproduction; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by the UNDP/UNFPA/UNICEF/WHO/World Bank Special Programme of Research, Development and Research Training in Human Reproduction, http://www.who.int/reproductivehealth/hrp/en/. WHO commissioned the study, advised as required during the study, co-ordinated data requests, helped with redrafts, and approved the manuscript submission. KJL had full access to all the data in the study and had final responsibility for the decision to submit for publication.	Abu-Raddad LJ, 2010, EPIDEMICS-NETH, V2, P173, DOI 10.1016/j.epidem.2010.08.003; [Anonymous], 2010, MMWR MORB MORTAL WKL, V59, P456; Ashley RL, 1999, J CLIN MICROBIOL, V37, P1632, DOI 10.1128/JCM.37.5.1632-1633.1999; Ashley RL, 2001, SEX TRANSM INFECT, V77, P232, DOI 10.1136/sti.77.4.232; Ashley-Morrow R, 2004, CLIN MICROBIOL INFEC, V10, P530, DOI 10.1111/j.1469-0691.2004.00836.x; Ashley-Morrow R, 2003, SEX TRANSM DIS, V30, P310, DOI 10.1097/00007435-200304000-00007; AUGENBRAUN M, 1995, ANN INTERN MED, V123, P845, DOI 10.7326/0003-4819-123-11-199512010-00006; Belshe RB, 2012, NEW ENGL J MED, V366, P34, DOI 10.1056/NEJMoa1103151; BENEDETTI J, 1994, ANN INTERN MED, V121, P847, DOI 10.7326/0003-4819-121-11-199412010-00004; Broutet N, 2014, VACCINE, V32, P1630, DOI 10.1016/j.vaccine.2014.01.053; Brown JM, 2007, AIDS, V21, P1515, DOI 10.1097/QAD.0b013e3282004929; Brown ZA, 2003, JAMA-J AM MED ASSOC, V289, P203, DOI 10.1001/jama.289.2.203; Brown ZA, 1997, NEW ENGL J MED, V337, P509, DOI 10.1056/NEJM199708213370801; Celum C, 2010, NEW ENGL J MED, V362, P427, DOI 10.1056/NEJMoa0904849; Celum C, 2008, LANCET, V371, P2109, DOI 10.1016/S0140-6736(08)60920-4; Corey L, 2004, NEW ENGL J MED, V350, P11, DOI 10.1056/NEJMoa035144; Fleming DT, 1997, NEW ENGL J MED, V337, P1105, DOI 10.1056/NEJM199710163371601; Freeman EE, 2006, AIDS, V20, P73, DOI 10.1097/01.aids.0000198081.09337.a7; Genocea website, GEN ANN POS TOP LIN; Glynn JR, 2001, AIDS, V15, pS51, DOI 10.1097/00002030-200108004-00006; Gray E, 2008, NEW ZEAL MED J, V121, P43; Gray RH, 2001, LANCET, V357, P1149, DOI 10.1016/S0140-6736(00)04331-2; Gupta R, 2007, LANCET, V370, P2127, DOI 10.1016/S0140-6736(07)61908-4; Holmes KK, 2008, SEXUALLY TRANSMITTED, V4th; Johnston C, 2014, VACCINE, V32, P1553, DOI 10.1016/j.vaccine.2013.08.066; Kaushic C, 2011, J REPROD IMMUNOL, V88, P204, DOI 10.1016/j.jri.2010.12.004; Kelsey JL, 1986, METHODS OBSERVATIONS; Kenyon C, 2013, INT J STD AIDS, V24, P375, DOI 10.1177/0956462412472816; Lingappa JR, 2010, LANCET, V375, P824, DOI 10.1016/S0140-6736(09)62038-9; Looker KJ, 2008, B WORLD HEALTH ORGAN, V86, P805, DOI 10.2471/BLT.07.046128; Mercer CH, 2013, LANCET, V382, P1781, DOI 10.1016/S0140-6736(13)62035-8; Morrow R, 2006, CLIN MICROBIOL INFEC, V12, P463, DOI 10.1111/j.1469-0691.2006.01370.x; Muench H., CATALYTIC MODELS EPI, P8928; Pena KC, 2010, J CLIN MICROBIOL, V48, P150, DOI 10.1128/JCM.01336-09; Pinninti SG, 2013, AM J PERINAT, V30, P113, DOI 10.1055/s-0032-1332802; Reynolds SJ, 2003, J INFECT DIS, V187, P1513, DOI 10.1086/368357; Roberts CM, 2003, SEX TRANSM DIS, V30, P797, DOI 10.1097/01.OLQ.0000092387.58746.C7; Ryder N, 2009, SEX TRANSM INFECT, V85, P416, DOI 10.1136/sti.2008.033902; Schacker T, 1998, J INFECT DIS, V178, P1616, DOI 10.1086/314486; Smith JS, 2002, J INFECT DIS, V186, pS3, DOI 10.1086/343739; Tassiopoulos KK, 2007, J INFECT DIS, V195, P493, DOI 10.1086/510537; Todd J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059037; Tuokko H, 2014, SEX TRANSM INFECT; United Nations, 2013, WORLD POP AG 2013; Wald A, 2002, CLIN INFECT DIS, V35, pS173, DOI 10.1086/342104; Wald A, 2002, J INFECT DIS, V185, P45, DOI 10.1086/338231; Watson-Jones D, 2008, NEW ENGL J MED, V358, P1560, DOI 10.1056/NEJMoa0800260; WHO, 2012, GLOB INC PREV SEL CU; Xu FJ, 2006, JAMA-J AM MED ASSOC, V296, P964, DOI 10.1001/jama.296.8.964	49	483	513	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2015	10	1							e114989	10.1371/journal.pone.0114989	http://dx.doi.org/10.1371/journal.pone.0114989			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ4PR	26510007	gold, Green Submitted, Green Published			2022-12-26	WOS:000348205300007
